id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
48379808|NCT00355056|155586755|FG000|Randomization Period|Early Termination|4|||
48379809|NCT00355056|155586756|FG001|Randomization Period|Early Termination|6|||
48379810|NCT03646656|155586757|FG000|Overall Study|Lost to Follow-up|1|||
48379811|NCT03646656|155586758|FG001|Overall Study|Lost to Follow-up|0|||
48379812|NCT03646656|155586757|FG000|Overall Study|Withdrawal by Subject|2|||
48379813|NCT03646656|155586758|FG001|Overall Study|Withdrawal by Subject|0|||
48379814|NCT00084266|155586761|FG000|Overall Study|Death|42|||
48379815|NCT00084266|155586762|FG001|Overall Study|Death|39|||
48379816|NCT00084266|155586761|FG000|Overall Study|Adverse Event|8|||
48379817|NCT00084266|155586762|FG001|Overall Study|Adverse Event|5|||
48379818|NCT00084266|155586761|FG000|Overall Study|Lack of Efficacy|2|||
48379819|NCT00084266|155586762|FG001|Overall Study|Lack of Efficacy|4|||
48379820|NCT00084266|155586761|FG000|Overall Study|Lost to Follow-up|5|||
48379821|NCT00084266|155586762|FG001|Overall Study|Lost to Follow-up|3|||
48379822|NCT00084266|155586761|FG000|Overall Study|Participant not willing to participate|3|||
48379823|NCT00084266|155586762|FG001|Overall Study|Participant not willing to participate|8|||
48379824|NCT00084266|155586761|FG000|Overall Study|Other|360|||
48589049|NCT00513357|156349223|FG000|Overall Study|did not receive allocated placebo|2|||
48379825|NCT00084266|155586762|FG001|Overall Study|Other|344|||
48379826|NCT00084266|155586761|FG000|Overall Study|Randomized not treated|21|||
48379827|NCT00084266|155586762|FG001|Overall Study|Randomized not treated|20|||
48379828|NCT00909792|155586763|FG000|Period 1|Did not meet inclusion criteria|0|||
48379829|NCT00909792|155586764|FG001|Period 1|Did not meet inclusion criteria|1|||
48379830|NCT00909792|155586763|FG000|Period 2|Biomicroscopy|1|||
48379831|NCT00909792|155586764|FG001|Period 2|Biomicroscopy|0|||
48379832|NCT00909792|155586763|FG000|Period 2|Lost to Follow-up|0|||
48379833|NCT00909792|155586764|FG001|Period 2|Lost to Follow-up|1|||
48379834|NCT02544217|155586774|FG000|Overall Study|Withdrawal by Subject|1|||
48379835|NCT02544217|155586775|FG001|Overall Study|Withdrawal by Subject|1|||
48379836|NCT02544217|155586776|FG002|Overall Study|Withdrawal by Subject|0|||
48379837|NCT02544217|155586777|FG003|Overall Study|Withdrawal by Subject|0|||
48379838|NCT02544217|155586778|FG004|Overall Study|Withdrawal by Subject|0|||
48379839|NCT02544217|155586779|FG005|Overall Study|Withdrawal by Subject|0|||
48379840|NCT02808143|155586780|FG000|Maintenance Phase|Disease recurrence|1|||
48379841|NCT02808143|155586781|FG001|Maintenance Phase|Disease recurrence|3|||
48379842|NCT02808143|155586780|FG000|Maintenance Phase|Disease progression|1|||
48379843|NCT02808143|155586781|FG001|Maintenance Phase|Disease progression|2|||
48379844|NCT02808143|155586780|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
48379845|NCT02808143|155586781|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
48379846|NCT02808143|155586780|FG000|Survival Follow-Up|Disease recurrence|0|||
48379847|NCT02808143|155586781|FG001|Survival Follow-Up|Disease recurrence|2|||
48379848|NCT02808143|155586780|FG000|Survival Follow-Up|Adverse Event|0|||
48379849|NCT02808143|155586781|FG001|Survival Follow-Up|Adverse Event|1|||
48379850|NCT02808143|155586780|FG000|Survival Follow-Up|Death|1|||
48379851|NCT02808143|155586781|FG001|Survival Follow-Up|Death|0|||
48379852|NCT00293722|155586790|FG000|Overall Study|Other|427|||
48379853|NCT00667355|155586794|FG000|Overall Study|Adverse Event|5|||
48379854|NCT00667355|155586794|FG000|Overall Study|Lost to Follow-up|1|||
48379855|NCT00667355|155586794|FG000|Overall Study|Other reason was not specified|5|||
48379856|NCT01376349|155586795|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
48379857|NCT01376349|155586796|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
48379858|NCT01376349|155586797|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
48379859|NCT01376349|155586795|FG000|Raondomized Treatment|Adverse Event|13|||
48379860|NCT01376349|155586796|FG001|Raondomized Treatment|Adverse Event|17|||
48379861|NCT01376349|155586797|FG002|Raondomized Treatment|Adverse Event|14|||
48379862|NCT01376349|155586795|FG000|Raondomized Treatment|Unkown|1|||
48379863|NCT01376349|155586796|FG001|Raondomized Treatment|Unkown|2|||
48379864|NCT01376349|155586797|FG002|Raondomized Treatment|Unkown|1|||
48379865|NCT01376349|155586795|FG000|Raondomized Treatment|Alternative Treatment|0|||
48379866|NCT01376349|155586796|FG001|Raondomized Treatment|Alternative Treatment|0|||
48379867|NCT01376349|155586797|FG002|Raondomized Treatment|Alternative Treatment|1|||
48379868|NCT00833911|155586798|FG000|Titration|Adverse Event|18|||
48379869|NCT00833911|155586798|FG000|Titration|Withdrawal by Subject|3|||
48379870|NCT00833911|155586798|FG000|Maintenance Phase I|Adverse Event|73|||
48379871|NCT00833911|155586798|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
48589050|NCT00513357|156349224|FG001|Overall Study|did not receive allocated placebo|3|||
48589051|NCT00513357|156349223|FG000|Overall Study|Adverse Event|4|||
48379872|NCT00833911|155586798|FG000|Maintenance Phase I|Physician Decision|10|||
48379873|NCT00833911|155586798|FG000|Maintenance Phase I|Lack of Efficacy|4|||
48379874|NCT00833911|155586798|FG000|Maintenance Phase II|Adverse Event|6|||
48379875|NCT00833911|155586798|FG000|Maintenance Phase II|Physician Decision|2|||
48379876|NCT00833911|155586798|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
48379877|NCT00833911|155586798|FG000|Maintenance Phase II|Lack of Efficacy|1|||
48379878|NCT00059839|155586799|FG000|Overall Study|Death|1|||
48379879|NCT00059839|155586800|FG001|Overall Study|Death|1|||
48379880|NCT00059839|155586799|FG000|Overall Study|Lack of Efficacy|6|||
48379881|NCT00059839|155586800|FG001|Overall Study|Lack of Efficacy|5|||
48379882|NCT00059839|155586799|FG000|Overall Study|Lost to Follow-up|2|||
48379883|NCT00059839|155586800|FG001|Overall Study|Lost to Follow-up|0|||
48379884|NCT00059839|155586799|FG000|Overall Study|Physician Decision|1|||
48379885|NCT00059839|155586800|FG001|Overall Study|Physician Decision|2|||
48379886|NCT00059839|155586799|FG000|Overall Study|Withdrawal by Subject|1|||
48379887|NCT00059839|155586800|FG001|Overall Study|Withdrawal by Subject|6|||
48379888|NCT00059839|155586799|FG000|Overall Study|Ineligible|1|||
48379889|NCT00059839|155586800|FG001|Overall Study|Ineligible|3|||
48379890|NCT01138007|155586811|FG000|Overall Study|Adverse Event|4|||
48379891|NCT01138007|155586812|FG001|Overall Study|Adverse Event|12|||
48379892|NCT01138007|155586813|FG002|Overall Study|Adverse Event|9|||
48379893|NCT01138007|155586811|FG000|Overall Study|Lack of Efficacy|2|||
48379894|NCT01138007|155586812|FG001|Overall Study|Lack of Efficacy|0|||
48379895|NCT01138007|155586813|FG002|Overall Study|Lack of Efficacy|6|||
48379896|NCT01138007|155586811|FG000|Overall Study|Protocol Violation|2|||
48379897|NCT01138007|155586812|FG001|Overall Study|Protocol Violation|3|||
48379898|NCT01138007|155586813|FG002|Overall Study|Protocol Violation|2|||
48379899|NCT01138007|155586811|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
48379900|NCT01138007|155586812|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
48379901|NCT01138007|155586813|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
48379902|NCT01138007|155586811|FG000|Overall Study|Lost to Follow-up|3|||
48379903|NCT01138007|155586812|FG001|Overall Study|Lost to Follow-up|3|||
48379904|NCT01138007|155586813|FG002|Overall Study|Lost to Follow-up|5|||
48379905|NCT01138007|155586811|FG000|Overall Study|Physician Decision|0|||
48379906|NCT01138007|155586812|FG001|Overall Study|Physician Decision|5|||
48379907|NCT01138007|155586813|FG002|Overall Study|Physician Decision|3|||
48379908|NCT01138007|155586811|FG000|Overall Study|Withdrawal by Subject|5|||
48379909|NCT01138007|155586812|FG001|Overall Study|Withdrawal by Subject|6|||
48379910|NCT01138007|155586813|FG002|Overall Study|Withdrawal by Subject|15|||
48379911|NCT03548987|155586814|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
48379912|NCT03548987|155586815|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
48379913|NCT03548987|155586814|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
48379914|NCT03548987|155586815|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
48379915|NCT03548987|155586814|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
48379916|NCT03548987|155586815|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
48379917|NCT03548987|155586814|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
48379918|NCT03548987|155586815|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
48379919|NCT03548987|155586814|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
48379920|NCT03548987|155586815|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
48379921|NCT03548987|155586814|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
48379922|NCT03548987|155586815|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
48379923|NCT03548987|155586814|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
48379924|NCT03548987|155586815|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
48379925|NCT03548987|155586814|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
48379926|NCT03548987|155586815|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
48379927|NCT03548987|155586814|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
48379928|NCT03548987|155586815|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
48379929|NCT03548987|155586814|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
48379930|NCT03548987|155586815|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
48379931|NCT03548987|155586814|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
48379932|NCT03548987|155586815|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
48379933|NCT03548987|155586814|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
48379934|NCT03548987|155586815|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
48379935|NCT03548987|155586814|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
48379936|NCT03548987|155586815|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
48379937|NCT03548987|155586814|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
48379938|NCT03548987|155586815|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
48379939|NCT00235326|155586821|FG000|Overall Study|Lost to Follow-up|746|||
48379940|NCT00235326|155586822|FG001|Overall Study|Lost to Follow-up|1400|||
48379941|NCT03334409|155586823|FG000|Overall Study|Did not meet inclusion criteria|1|||
48379942|NCT03334409|155586824|FG001|Overall Study|Did not meet inclusion criteria|0|||
48379943|NCT01324323|155586825|FG000|Overall Study|Withdrawal by Subject|1|||
48379944|NCT01790126|155586831|FG000|Overall Study|PSA Progression|12|||
48379945|NCT01790126|155586832|FG001|Overall Study|PSA Progression|16|||
48379946|NCT01790126|155586833|FG002|Overall Study|PSA Progression|16|||
48379947|NCT01790126|155586831|FG000|Overall Study|Other|5|||
48589052|NCT00513357|156349224|FG001|Overall Study|Adverse Event|2|||
48379948|NCT01790126|155586832|FG001|Overall Study|Other|4|||
48379949|NCT01790126|155586833|FG002|Overall Study|Other|8|||
48589053|NCT00513357|156349223|FG000|Overall Study|Death|2|||
48589054|NCT00513357|156349224|FG001|Overall Study|Death|0|||
48379950|NCT01790126|155586831|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
48451245|NCT00355134|155841604|FG001|Core Phase|Lost to Follow-up|13|||
48693081|NCT01602224|156726338|FG000|Overall Study|Adverse Event|0|||
48379951|NCT01790126|155586832|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
48379952|NCT01790126|155586833|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
48379953|NCT01790126|155586831|FG000|Overall Study|Withdrawal by Physician|1|||
48379954|NCT01790126|155586832|FG001|Overall Study|Withdrawal by Physician|1|||
48379955|NCT01790126|155586833|FG002|Overall Study|Withdrawal by Physician|2|||
48379956|NCT01790126|155586831|FG000|Overall Study|Withdrawal by Subject|3|||
48379957|NCT01790126|155586832|FG001|Overall Study|Withdrawal by Subject|1|||
48379958|NCT01790126|155586833|FG002|Overall Study|Withdrawal by Subject|2|||
48379959|NCT01790126|155586831|FG000|Overall Study|Lost to Follow-up|1|||
48379960|NCT01790126|155586832|FG001|Overall Study|Lost to Follow-up|0|||
48379961|NCT01790126|155586833|FG002|Overall Study|Lost to Follow-up|1|||
48379962|NCT01790126|155586831|FG000|Overall Study|Adverse Event|0|||
48379963|NCT01790126|155586832|FG001|Overall Study|Adverse Event|2|||
48379964|NCT01790126|155586833|FG002|Overall Study|Adverse Event|0|||
48379965|NCT01790126|155586831|FG000|Overall Study|Death|2|||
48379966|NCT01790126|155586832|FG001|Overall Study|Death|0|||
48379967|NCT01790126|155586833|FG002|Overall Study|Death|0|||
48379968|NCT01790126|155586831|FG000|Overall Study|Radiographic Progression|3|||
48379969|NCT01790126|155586832|FG001|Overall Study|Radiographic Progression|1|||
48379970|NCT01790126|155586833|FG002|Overall Study|Radiographic Progression|0|||
48379971|NCT00455325|155586834|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
48379972|NCT00455325|155586835|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
48379973|NCT00455325|155586836|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
48379974|NCT00455325|155586837|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
48379975|NCT00455325|155586834|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
48379976|NCT00455325|155586835|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
48379977|NCT00455325|155586836|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
48589055|NCT00513357|156349223|FG000|Overall Study|Withdrawal by Subject|5|||
48589056|NCT00513357|156349224|FG001|Overall Study|Withdrawal by Subject|4|||
48589057|NCT00513357|156349223|FG000|Overall Study|Disease Progression|2|||
48589058|NCT00513357|156349224|FG001|Overall Study|Disease Progression|1|||
48589059|NCT01162122|156349225|FG000|Overall Study|Withdrawal by Subject|52|||
48379978|NCT00455325|155586837|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
48379979|NCT00455325|155586834|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
48379980|NCT00455325|155586835|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
48379981|NCT00455325|155586836|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
48379982|NCT00455325|155586837|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
48379983|NCT00455325|155586834|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
48379984|NCT00455325|155586835|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
48379985|NCT00455325|155586836|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
48379986|NCT00455325|155586837|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
48379987|NCT00455325|155586834|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
48379988|NCT00455325|155586835|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
48379989|NCT00455325|155586836|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
48379990|NCT00455325|155586837|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
48379991|NCT00455325|155586834|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
48379992|NCT00455325|155586835|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
48379993|NCT00455325|155586836|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
48379994|NCT00455325|155586837|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
48379995|NCT00455325|155586834|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
48379996|NCT00455325|155586835|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
48379997|NCT00455325|155586836|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
48379998|NCT00455325|155586837|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
48379999|NCT04620811|155586839|FG000|Overall Study|Withdrawal by Subject|18|||
48380000|NCT04620811|155586840|FG001|Overall Study|Withdrawal by Subject|15|||
48380001|NCT04620811|155586839|FG000|Overall Study|Adverse Event|6|||
48380002|NCT04620811|155586840|FG001|Overall Study|Adverse Event|11|||
48380003|NCT04620811|155586839|FG000|Overall Study|Lost to Follow-up|4|||
48380004|NCT04620811|155586840|FG001|Overall Study|Lost to Follow-up|8|||
48380005|NCT04620811|155586839|FG000|Overall Study|Physician Decision|1|||
48380006|NCT04620811|155586840|FG001|Overall Study|Physician Decision|4|||
48380007|NCT04620811|155586839|FG000|Overall Study|Sponsor Decision|0|||
48380008|NCT04620811|155586840|FG001|Overall Study|Sponsor Decision|1|||
48380009|NCT04620811|155586839|FG000|Overall Study|Elevation of ALT or AST|1|||
48589060|NCT01162122|156349226|FG001|Overall Study|Withdrawal by Subject|43|||
48380010|NCT04620811|155586840|FG001|Overall Study|Elevation of ALT or AST|0|||
48380011|NCT04620811|155586839|FG000|Overall Study|Other|3|||
48380012|NCT04620811|155586840|FG001|Overall Study|Other|5|||
48380013|NCT05116046|155586842|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48380014|NCT05116046|155586843|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48380015|NCT05116046|155586844|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48380016|NCT05116046|155586842|FG000|Overall Study|Study terminated by sponsor|14|||
48380017|NCT05116046|155586843|FG001|Overall Study|Study terminated by sponsor|16|||
48380018|NCT05116046|155586844|FG002|Overall Study|Study terminated by sponsor|1|||
48380019|NCT00928746|155586845|FG000|Overall Study|Adverse Event|2|||
48380020|NCT00928746|155586845|FG000|Overall Study|Protocol Violation|1|||
48380021|NCT00928746|155586845|FG000|Overall Study|Withdrawal by Subject|1|||
48380022|NCT00928746|155586845|FG000|Overall Study|Other|2|||
48380023|NCT00325039|155586846|FG000|Overall Study|Lost to Follow-up|18|||
48380024|NCT00325039|155586847|FG001|Overall Study|Lost to Follow-up|14|||
48380025|NCT01019317|155586848|FG000|Overall Study|Not Eligible|4|||
48380026|NCT00307125|155586853|FG000|Screening Phase|Adverse Event|1|||
48380027|NCT00307125|155586854|FG001|Screening Phase|Adverse Event|0|||
48380028|NCT00307125|155586855|FG002|Screening Phase|Adverse Event|0|||
48380029|NCT00307125|155586853|FG000|Screening Phase|Protocol Violation|27|||
48380030|NCT00307125|155586854|FG001|Screening Phase|Protocol Violation|0|||
48380031|NCT00307125|155586855|FG002|Screening Phase|Protocol Violation|0|||
48380032|NCT00307125|155586853|FG000|Screening Phase|Lost to Follow-up|87|||
48380033|NCT00307125|155586854|FG001|Screening Phase|Lost to Follow-up|0|||
48380034|NCT00307125|155586855|FG002|Screening Phase|Lost to Follow-up|0|||
48380035|NCT00307125|155586853|FG000|Screening Phase|Death|10|||
48380036|NCT00307125|155586854|FG001|Screening Phase|Death|0|||
48380037|NCT00307125|155586855|FG002|Screening Phase|Death|0|||
48380038|NCT00307125|155586853|FG000|Screening Phase|Withdrawal by Subject|77|||
48380039|NCT00307125|155586854|FG001|Screening Phase|Withdrawal by Subject|0|||
48380040|NCT00307125|155586855|FG002|Screening Phase|Withdrawal by Subject|0|||
48380041|NCT00307125|155586853|FG000|Screening Phase|Physician Decision|26|||
48380042|NCT00307125|155586854|FG001|Screening Phase|Physician Decision|0|||
48380043|NCT00307125|155586855|FG002|Screening Phase|Physician Decision|0|||
48380044|NCT00307125|155586853|FG000|Screening Phase|Sponsor Decision|4|||
48380045|NCT00307125|155586854|FG001|Screening Phase|Sponsor Decision|0|||
48380046|NCT00307125|155586855|FG002|Screening Phase|Sponsor Decision|0|||
48380047|NCT00307125|155586853|FG000|Screening Phase|Study Terminated|17|||
48380048|NCT00307125|155586854|FG001|Screening Phase|Study Terminated|0|||
48380049|NCT00307125|155586855|FG002|Screening Phase|Study Terminated|0|||
48380050|NCT00307125|155586853|FG000|Screening Phase|Graft Loss|3|||
48380051|NCT00307125|155586854|FG001|Screening Phase|Graft Loss|0|||
48380052|NCT00307125|155586855|FG002|Screening Phase|Graft Loss|0|||
48380053|NCT00307125|155586853|FG000|Screening Phase|Graft Failure|8|||
48380054|NCT00307125|155586854|FG001|Screening Phase|Graft Failure|0|||
48380055|NCT00307125|155586855|FG002|Screening Phase|Graft Failure|0|||
48380056|NCT00307125|155586853|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
48380057|NCT00307125|155586854|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
48380058|NCT00307125|155586855|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
48380059|NCT00307125|155586853|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
48380060|NCT00307125|155586854|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
48380061|NCT00307125|155586855|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
48380062|NCT00307125|155586853|FG000|Screening Phase|Moved or transferred facilities|34|||
48380063|NCT00307125|155586854|FG001|Screening Phase|Moved or transferred facilities|0|||
48380064|NCT00307125|155586855|FG002|Screening Phase|Moved or transferred facilities|0|||
48380065|NCT00307125|155586853|FG000|Screening Phase|Received Pancreas Transplant|8|||
48380066|NCT00307125|155586854|FG001|Screening Phase|Received Pancreas Transplant|0|||
48380067|NCT00307125|155586855|FG002|Screening Phase|Received Pancreas Transplant|0|||
48380068|NCT00307125|155586853|FG000|Screening Phase|Ineligible for pilot|4|||
48380069|NCT00307125|155586854|FG001|Screening Phase|Ineligible for pilot|0|||
48380070|NCT00307125|155586855|FG002|Screening Phase|Ineligible for pilot|0|||
48380071|NCT00307125|155586853|FG000|Screening Phase|Try to get pregnant|1|||
48380072|NCT00307125|155586854|FG001|Screening Phase|Try to get pregnant|0|||
48380073|NCT00307125|155586855|FG002|Screening Phase|Try to get pregnant|0|||
48380074|NCT00307125|155586853|FG000|Screening Phase|Developed acute leukemia|1|||
48380075|NCT00307125|155586854|FG001|Screening Phase|Developed acute leukemia|0|||
48380076|NCT00307125|155586855|FG002|Screening Phase|Developed acute leukemia|0|||
48380077|NCT00307125|155586853|FG000|Screening Phase|Metastatic colon cancer|1|||
48380078|NCT00307125|155586854|FG001|Screening Phase|Metastatic colon cancer|0|||
48380079|NCT00307125|155586855|FG002|Screening Phase|Metastatic colon cancer|0|||
48380080|NCT00307125|155586853|FG000|Screening Phase|Malignancy|1|||
48380081|NCT00307125|155586854|FG001|Screening Phase|Malignancy|0|||
48380082|NCT00307125|155586855|FG002|Screening Phase|Malignancy|0|||
48380083|NCT00307125|155586853|FG000|Screening Phase|PAK|1|||
48693082|NCT01602224|156726339|FG001|Overall Study|Adverse Event|1|||
48380084|NCT00307125|155586854|FG001|Screening Phase|PAK|0|||
48380085|NCT00307125|155586855|FG002|Screening Phase|PAK|0|||
48380086|NCT00307125|155586853|FG000|Screening Phase|Ineligible|1|||
48380087|NCT00307125|155586854|FG001|Screening Phase|Ineligible|0|||
48380088|NCT00307125|155586855|FG002|Screening Phase|Ineligible|0|||
48380089|NCT00307125|155586853|FG000|Screening Phase|Screen Error|1|||
48380090|NCT00307125|155586854|FG001|Screening Phase|Screen Error|0|||
48380091|NCT00307125|155586855|FG002|Screening Phase|Screen Error|0|||
48380092|NCT00307125|155586853|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
48380093|NCT00307125|155586854|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
48380094|NCT00307125|155586855|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
48380095|NCT00307125|155586853|FG000|Screening Phase|AMR and treated with rituximab|1|||
48380096|NCT00307125|155586854|FG001|Screening Phase|AMR and treated with rituximab|0|||
48380097|NCT00307125|155586855|FG002|Screening Phase|AMR and treated with rituximab|0|||
48380098|NCT00307125|155586853|FG000|Screening Phase|Coronary artery bypass|1|||
48380099|NCT00307125|155586854|FG001|Screening Phase|Coronary artery bypass|0|||
48380100|NCT00307125|155586855|FG002|Screening Phase|Coronary artery bypass|0|||
48380101|NCT00307125|155586853|FG000|Pilot Phase|Lost to Follow-up|0|||
48380102|NCT00307125|155586854|FG001|Pilot Phase|Lost to Follow-up|1|||
48380103|NCT00307125|155586855|FG002|Pilot Phase|Lost to Follow-up|0|||
48380104|NCT00307125|155586853|FG000|Pilot Phase|Withdrawal by Subject|0|||
48380105|NCT00307125|155586854|FG001|Pilot Phase|Withdrawal by Subject|1|||
48380106|NCT00307125|155586855|FG002|Pilot Phase|Withdrawal by Subject|1|||
48380107|NCT01136811|155586865|FG000|Overall Study|Physician Decision|11|||
48380108|NCT00803270|155586866|FG000|Overall Study|Lost to Follow-up|1|||
48380109|NCT00803270|155586867|FG001|Overall Study|Lost to Follow-up|2|||
48380110|NCT02742766|155586870|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380111|NCT02742766|155586871|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380112|NCT02742766|155586872|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380113|NCT02742766|155586873|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380114|NCT02742766|155586874|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380115|NCT02742766|155586875|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380116|NCT02742766|155586876|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380117|NCT02742766|155586877|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380118|NCT02742766|155586878|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380119|NCT02742766|155586879|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380120|NCT02742766|155586880|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380121|NCT02742766|155586881|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380122|NCT02742766|155586882|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380123|NCT02742766|155586883|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
48380124|NCT02742766|155586884|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380125|NCT02742766|155586885|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380126|NCT02742766|155586886|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380127|NCT02742766|155586887|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380128|NCT02742766|155586888|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
48380129|NCT02742766|155586870|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380130|NCT02742766|155586871|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380131|NCT02742766|155586872|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380132|NCT02742766|155586873|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380133|NCT02742766|155586874|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380134|NCT02742766|155586875|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380135|NCT02742766|155586876|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380136|NCT02742766|155586877|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380137|NCT02742766|155586878|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380138|NCT02742766|155586879|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380139|NCT02742766|155586880|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380140|NCT02742766|155586881|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380141|NCT02742766|155586882|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
48380142|NCT02742766|155586883|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
48380143|NCT02742766|155586884|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380144|NCT02742766|155586885|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
48380145|NCT02742766|155586886|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380146|NCT02742766|155586887|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380147|NCT02742766|155586888|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
48380148|NCT01906346|155586891|FG000|Overall Study|AEs|1|||
48380149|NCT03707925|155586892|FG000|Overall Study|Inevaluable|1|||
48380150|NCT01891721|155586899|FG000|Overall Study|Lost to Follow-up|10|||
48380151|NCT01891721|155586900|FG001|Overall Study|Lost to Follow-up|5|||
48380152|NCT01891721|155586901|FG002|Overall Study|Lost to Follow-up|1|||
48380153|NCT04014361|155586902|FG000|Period 2|Physician Decision|0|||
48380154|NCT04014361|155586903|FG001|Period 2|Physician Decision|0|||
48380155|NCT04014361|155586904|FG002|Period 2|Physician Decision|0|||
48380156|NCT04014361|155586905|FG003|Period 2|Physician Decision|1|||
48380157|NCT04014361|155586906|FG004|Period 2|Physician Decision|0|||
48380158|NCT04014361|155586907|FG005|Period 2|Physician Decision|0|||
48589061|NCT01162122|156349225|FG000|Overall Study|Lost to Follow-up|73|||
48589062|NCT01162122|156349226|FG001|Overall Study|Lost to Follow-up|91|||
48589063|NCT01162122|156349225|FG000|Overall Study|Adverse Event|3|||
48589064|NCT01162122|156349226|FG001|Overall Study|Adverse Event|2|||
48589065|NCT01162122|156349225|FG000|Overall Study|Death|51|||
48380159|NCT04014361|155586908|FG006|Period 2|Physician Decision|0|||
48380160|NCT04014361|155586909|FG007|Period 2|Physician Decision|0|||
48380161|NCT01422850|155586914|FG000|Overall Study|Physician Decision|3|||
48380162|NCT03040622|155586918|FG000|Overall Study|unable to implant device|3|||
48380163|NCT00826111|155588331|FG000|Overall Study|Lost to Follow-up|0|||
48380164|NCT00826111|155588332|FG001|Overall Study|Lost to Follow-up|1|||
48380165|NCT00826111|155588331|FG000|Overall Study|Protocol Violation|1|||
48380166|NCT00826111|155588332|FG001|Overall Study|Protocol Violation|0|||
48380167|NCT00826111|155588331|FG000|Overall Study|Withdrawal by Subject|5|||
48380168|NCT00826111|155588332|FG001|Overall Study|Withdrawal by Subject|0|||
48380169|NCT00826111|155588331|FG000|Overall Study|Physician Decision|1|||
48380170|NCT00826111|155588332|FG001|Overall Study|Physician Decision|1|||
48380171|NCT01672788|155588333|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
48380172|NCT01672788|155588334|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
48380173|NCT01672788|155588335|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
48380174|NCT01672788|155588336|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
48380175|NCT01557283|155588337|FG000|Overall Study|Lost to Follow-up|7|||
48380176|NCT01557283|155588337|FG000|Overall Study|Non-responder|19|||
48380177|NCT01557283|155588337|FG000|Overall Study|Adverse Event|7|||
48380178|NCT01557283|155588337|FG000|Overall Study|Lack of Efficacy|1|||
48380179|NCT01557283|155588337|FG000|Overall Study|Non-compliance|1|||
48380180|NCT01557283|155588337|FG000|Overall Study|Withdrawal by Subject|1|||
48380181|NCT01557283|155588337|FG000|Overall Study|Participant's weight too high for dose|1|||
48380182|NCT01557283|155588337|FG000|Overall Study|Worsening of psoriasis|1|||
48380183|NCT01557283|155588337|FG000|Overall Study|Other|6|||
48380184|NCT01678209|155588339|FG000|Overall Study|could not scan twice|1|||
48380185|NCT01678209|155588340|FG001|Overall Study|could not scan twice|1|||
48380186|NCT01678209|155588341|FG002|Overall Study|could not scan twice|1|||
48380187|NCT01678209|155588339|FG000|Overall Study|scheduling conflicts|0|||
48380188|NCT01678209|155588340|FG001|Overall Study|scheduling conflicts|0|||
48380189|NCT01678209|155588341|FG002|Overall Study|scheduling conflicts|1|||
48380190|NCT01678209|155588339|FG000|Overall Study|screen fail|16|||
48380191|NCT01678209|155588340|FG001|Overall Study|screen fail|17|||
48380192|NCT01678209|155588341|FG002|Overall Study|screen fail|16|||
48380193|NCT02120625|155588342|FG000|Overall Study|Physician Decision|2|||
48380194|NCT00892177|155588345|FG000|Phase II|Ineligible|0|||
48380195|NCT00892177|155588346|FG001|Phase II|Ineligible|0|||
48380196|NCT00892177|155588347|FG002|Phase II|Ineligible|0|||
48380197|NCT00892177|155588348|FG003|Phase II|Ineligible|0|||
48380198|NCT00892177|155588349|FG004|Phase II|Ineligible|1|||
48380199|NCT00892177|155588350|FG005|Phase II|Ineligible|1|||
48380200|NCT00892177|155588345|FG000|Phase II|Withdrawal by Subject|0|||
48380201|NCT00892177|155588346|FG001|Phase II|Withdrawal by Subject|0|||
48380202|NCT00892177|155588347|FG002|Phase II|Withdrawal by Subject|0|||
48380203|NCT00892177|155588348|FG003|Phase II|Withdrawal by Subject|0|||
48380204|NCT00892177|155588349|FG004|Phase II|Withdrawal by Subject|4|||
48380205|NCT00892177|155588350|FG005|Phase II|Withdrawal by Subject|1|||
48380206|NCT01009203|155588351|FG000|Overall Study|Withdrawal by Subject|1|||
48380207|NCT01009203|155588351|FG000|Overall Study|Adverse Event|5|||
48380208|NCT01009203|155588351|FG000|Overall Study|Treatment-unrelated death|1|||
48380209|NCT02249767|155588352|FG000|Overall Study|Did not use medication|8|||
48380210|NCT02249767|155588353|FG001|Overall Study|Did not use medication|9|||
48380211|NCT02249767|155588354|FG002|Overall Study|Did not use medication|8|||
48380212|NCT01372410|155588355|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
48380213|NCT01372410|155588356|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
48380214|NCT01372410|155588357|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48380215|NCT01372410|155588358|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48380216|NCT01372410|155588359|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
48380217|NCT01372410|155588360|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48380218|NCT01372410|155588361|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48380219|NCT01372410|155588362|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
48380220|NCT01372410|155588355|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
48380221|NCT01372410|155588356|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
48380222|NCT01372410|155588357|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
48380223|NCT01372410|155588358|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
48380224|NCT01372410|155588359|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
48380225|NCT01372410|155588360|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
48380226|NCT01372410|155588361|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
48380227|NCT01372410|155588362|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
48380228|NCT01372410|155588355|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48380229|NCT01372410|155588356|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48380230|NCT01372410|155588357|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48380231|NCT01372410|155588358|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48380232|NCT01372410|155588359|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
48380233|NCT01372410|155588360|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48380234|NCT01372410|155588361|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48380235|NCT01372410|155588362|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48380236|NCT01372410|155588355|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48380237|NCT01372410|155588356|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48380238|NCT01372410|155588357|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48380239|NCT01372410|155588358|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48380240|NCT01372410|155588359|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48380241|NCT01372410|155588360|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48380242|NCT01372410|155588361|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
48380243|NCT01372410|155588362|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
48380244|NCT01372410|155588355|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
48380245|NCT01372410|155588356|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48380246|NCT01372410|155588357|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48380247|NCT01372410|155588358|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48380248|NCT01372410|155588359|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48380249|NCT01372410|155588360|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48380250|NCT01372410|155588361|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
48380251|NCT01372410|155588362|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
48380252|NCT01372410|155588355|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48380253|NCT01372410|155588356|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48380254|NCT01372410|155588357|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48380255|NCT01372410|155588358|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48380256|NCT01372410|155588359|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
48380257|NCT01372410|155588360|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48380258|NCT01372410|155588361|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48380259|NCT01372410|155588362|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
48380260|NCT01372410|155588355|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48380261|NCT01372410|155588356|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48380262|NCT01372410|155588357|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48380263|NCT01372410|155588358|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48380264|NCT01372410|155588359|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
48380265|NCT01372410|155588360|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
48380266|NCT01372410|155588361|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
48380267|NCT01372410|155588362|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
48380268|NCT01372410|155588355|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48380269|NCT01372410|155588356|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48380270|NCT01372410|155588357|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48380271|NCT01372410|155588358|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48380272|NCT01372410|155588359|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48380273|NCT01372410|155588360|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48380274|NCT01372410|155588361|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
48380275|NCT01372410|155588362|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
48380276|NCT01372410|155588355|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
48380277|NCT01372410|155588356|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
48380278|NCT01372410|155588357|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
48380279|NCT01372410|155588358|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
48380280|NCT01372410|155588359|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
48380281|NCT01372410|155588360|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
48380282|NCT01372410|155588361|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
48380283|NCT01372410|155588362|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
48380284|NCT01372410|155588355|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48380285|NCT01372410|155588356|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48380286|NCT01372410|155588357|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48589066|NCT01162122|156349226|FG001|Overall Study|Death|46|||
48589067|NCT01162122|156349225|FG000|Overall Study|Protocol Violation|2|||
48589068|NCT01162122|156349226|FG001|Overall Study|Protocol Violation|2|||
48589069|NCT01162122|156349225|FG000|Overall Study|Inappropriate enrollment|5|||
48589070|NCT01162122|156349226|FG001|Overall Study|Inappropriate enrollment|4|||
48589071|NCT01162122|156349225|FG000|Overall Study|Administrative reason|1|||
48589072|NCT01162122|156349226|FG001|Overall Study|Administrative reason|1|||
48589073|NCT01162122|156349225|FG000|Overall Study|Unable to classify|3|||
48589074|NCT01162122|156349226|FG001|Overall Study|Unable to classify|7|||
48589075|NCT01162122|156349225|FG000|Overall Study|Missing primary reason|1|||
48589076|NCT01162122|156349226|FG001|Overall Study|Missing primary reason|0|||
48589077|NCT02020512|156349227|FG000|Overall Study|Adverse Event|1|||
48589078|NCT02020512|156349227|FG000|Overall Study|Lost to Follow-up|3|||
48589079|NCT02020512|156349227|FG000|Overall Study|Protocol Violation|4|||
48589080|NCT04490018|156349228|FG000|Overall Study|Protocol Violation|0|||
48589081|NCT04490018|156349229|FG001|Overall Study|Protocol Violation|2|||
48589082|NCT04490018|156349230|FG002|Overall Study|Protocol Violation|1|||
48589083|NCT04490018|156349228|FG000|Overall Study|Lost to Follow-up|2|||
48589084|NCT04490018|156349229|FG001|Overall Study|Lost to Follow-up|2|||
48589085|NCT04490018|156349230|FG002|Overall Study|Lost to Follow-up|0|||
48589086|NCT04490018|156349228|FG000|Overall Study|Withdrawal by Subject|2|||
48693083|NCT01602224|156726340|FG002|Overall Study|Adverse Event|0|||
48798449|NCT03076970|157100471|FG000|Washout Period 2|Adverse Event|0|||
48589087|NCT04490018|156349229|FG001|Overall Study|Withdrawal by Subject|1|||
48589088|NCT04490018|156349230|FG002|Overall Study|Withdrawal by Subject|0|||
48589089|NCT04490018|156349228|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48589090|NCT04490018|156349229|FG001|Overall Study|Withdrawal by parent/guardian|3|||
48589091|NCT04490018|156349230|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48589092|NCT02943785|156349234|FG000|Overall Study|Adverse Event|112|||
48589093|NCT02943785|156349235|FG001|Overall Study|Adverse Event|97|||
48589094|NCT02943785|156349234|FG000|Overall Study|Withdrawal by Subject|63|||
48589095|NCT02943785|156349235|FG001|Overall Study|Withdrawal by Subject|126|||
48589096|NCT02943785|156349234|FG000|Overall Study|Physician Decision|23|||
48589097|NCT02943785|156349235|FG001|Overall Study|Physician Decision|47|||
48589098|NCT02943785|156349234|FG000|Overall Study|Death|46|||
48589099|NCT02943785|156349235|FG001|Overall Study|Death|46|||
48484604|NCT01142466|155969206|FG000|Overall Study|Adverse Event|2|||
48484605|NCT01142466|155969207|FG001|Overall Study|Adverse Event|1|||
48380287|NCT01372410|155588358|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48380288|NCT01372410|155588359|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48380289|NCT01372410|155588360|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
48380290|NCT01372410|155588361|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48380291|NCT01372410|155588362|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
48380292|NCT05395104|155588364|FG000|Overall Study|Met Liver Stopping Criteria|1|||
48380293|NCT05395104|155588364|FG000|Overall Study|Withdrawal by Subject|1|||
48484606|NCT01142466|155969206|FG000|Overall Study|Withdrawal by Subject|1|||
48484607|NCT01142466|155969207|FG001|Overall Study|Withdrawal by Subject|1|||
48589100|NCT02943785|156349234|FG000|Overall Study|Lost to Follow-up|1|||
48589101|NCT02943785|156349235|FG001|Overall Study|Lost to Follow-up|0|||
48589102|NCT02943785|156349234|FG000|Overall Study|Other|16|||
48589103|NCT02943785|156349235|FG001|Overall Study|Other|19|||
48589104|NCT02943785|156349234|FG000|Overall Study|Did not receive any study medication|21|||
48589105|NCT02943785|156349235|FG001|Overall Study|Did not receive any study medication|28|||
48589106|NCT00524680|156349238|FG000|Overall Study|progression|0|||
48589107|NCT00524680|156349239|FG001|Overall Study|progression|0|||
48589108|NCT00524680|156349240|FG002|Overall Study|progression|0|||
48589109|NCT00524680|156349241|FG003|Overall Study|progression|1|||
48589110|NCT00524680|156349238|FG000|Overall Study|Adverse Event|2|||
48589111|NCT00524680|156349239|FG001|Overall Study|Adverse Event|0|||
48589112|NCT00524680|156349240|FG002|Overall Study|Adverse Event|0|||
48589113|NCT00524680|156349241|FG003|Overall Study|Adverse Event|1|||
48589114|NCT00524680|156349238|FG000|Overall Study|Other|0|||
48589115|NCT00524680|156349239|FG001|Overall Study|Other|1|||
48589116|NCT00524680|156349240|FG002|Overall Study|Other|2|||
48589117|NCT00524680|156349241|FG003|Overall Study|Other|3|||
48589118|NCT00524680|156349238|FG000|Overall Study|Withdrawal by Subject|1|||
48589119|NCT00524680|156349239|FG001|Overall Study|Withdrawal by Subject|0|||
48589120|NCT00524680|156349240|FG002|Overall Study|Withdrawal by Subject|1|||
48589121|NCT00524680|156349241|FG003|Overall Study|Withdrawal by Subject|1|||
48589122|NCT03304184|156349245|FG000|Overall Study|Withdrawal by Subject|1|||
48589123|NCT03304184|156349246|FG001|Overall Study|Withdrawal by Subject|2|||
48589124|NCT00821015|156349247|FG000|Overall Study|Lost to Follow-up|12|||
48589125|NCT01281956|156349248|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
48589126|NCT01281956|156349249|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
48589127|NCT03170609|156349250|FG000|Overall Study|Death|0|||
48589128|NCT03170609|156349251|FG001|Overall Study|Death|0|||
48589129|NCT03170609|156349252|FG002|Overall Study|Death|1|||
48589130|NCT03170609|156349253|FG003|Overall Study|Death|0|||
48589131|NCT03170609|156349254|FG004|Overall Study|Death|0|||
48589132|NCT03170609|156349255|FG005|Overall Study|Death|0|||
48589133|NCT03170609|156349256|FG006|Overall Study|Death|0|||
48589134|NCT03170609|156349250|FG000|Overall Study|Withdrawal by Subject|1|||
48589135|NCT03170609|156349251|FG001|Overall Study|Withdrawal by Subject|2|||
48589136|NCT03170609|156349252|FG002|Overall Study|Withdrawal by Subject|0|||
48589137|NCT03170609|156349253|FG003|Overall Study|Withdrawal by Subject|0|||
48589138|NCT03170609|156349254|FG004|Overall Study|Withdrawal by Subject|0|||
48589139|NCT03170609|156349255|FG005|Overall Study|Withdrawal by Subject|0|||
48589140|NCT03170609|156349256|FG006|Overall Study|Withdrawal by Subject|1|||
48589141|NCT03170609|156349250|FG000|Overall Study|Lost to Follow-up|1|||
48589142|NCT03170609|156349251|FG001|Overall Study|Lost to Follow-up|0|||
48589143|NCT03170609|156349252|FG002|Overall Study|Lost to Follow-up|5|||
48589144|NCT03170609|156349253|FG003|Overall Study|Lost to Follow-up|2|||
48589145|NCT03170609|156349254|FG004|Overall Study|Lost to Follow-up|1|||
48589146|NCT03170609|156349255|FG005|Overall Study|Lost to Follow-up|1|||
48589147|NCT03170609|156349256|FG006|Overall Study|Lost to Follow-up|0|||
48589148|NCT03170609|156349250|FG000|Overall Study|Other|1|||
48589149|NCT03170609|156349251|FG001|Overall Study|Other|0|||
48589150|NCT03170609|156349252|FG002|Overall Study|Other|0|||
48380294|NCT05105789|155588370|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
48589151|NCT03170609|156349253|FG003|Overall Study|Other|0|||
48589152|NCT03170609|156349254|FG004|Overall Study|Other|0|||
48589153|NCT03170609|156349255|FG005|Overall Study|Other|1|||
48589154|NCT03170609|156349256|FG006|Overall Study|Other|0|||
48589155|NCT03124537|156349259|FG000|Overall Study|Lost to Follow-up|3|||
48589156|NCT03124537|156349260|FG001|Overall Study|Lost to Follow-up|5|||
48589157|NCT03124537|156349259|FG000|Overall Study|App Crash, Incomplete Data|7|||
48589158|NCT03124537|156349260|FG001|Overall Study|App Crash, Incomplete Data|8|||
48589159|NCT01593254|156349261|FG000|Overall Study|Disease progression|2|||
48589160|NCT01593254|156349262|FG001|Overall Study|Disease progression|7|||
48589161|NCT01593254|156349261|FG000|Overall Study|Study drug toxicity|6|||
48589162|NCT01593254|156349262|FG001|Overall Study|Study drug toxicity|20|||
48589163|NCT01593254|156349261|FG000|Overall Study|Death|3|||
48589164|NCT01593254|156349262|FG001|Overall Study|Death|3|||
48589165|NCT01593254|156349261|FG000|Overall Study|AE unrelated to study drug|0|||
48589166|NCT01593254|156349262|FG001|Overall Study|AE unrelated to study drug|1|||
48589167|NCT01593254|156349261|FG000|Overall Study|participant request to discontinue study treatment|1|||
48589168|NCT01593254|156349262|FG001|Overall Study|participant request to discontinue study treatment|3|||
48589169|NCT01593254|156349261|FG000|Overall Study|participant withdrew consent|0|||
48589170|NCT01593254|156349262|FG001|Overall Study|participant withdrew consent|9|||
48589171|NCT01593254|156349261|FG000|Overall Study|lost to follow up|1|||
48589172|NCT01593254|156349262|FG001|Overall Study|lost to follow up|6|||
48589173|NCT01593254|156349261|FG000|Overall Study|maximum clinical benefit|1|||
48589174|NCT01593254|156349262|FG001|Overall Study|maximum clinical benefit|2|||
48589175|NCT01593254|156349261|FG000|Overall Study|Poor/non compliance|1|||
48589176|NCT01593254|156349262|FG001|Overall Study|Poor/non compliance|1|||
48589177|NCT01593254|156349261|FG000|Overall Study|Pregnancy|0|||
48589178|NCT01593254|156349262|FG001|Overall Study|Pregnancy|3|||
48589179|NCT01593254|156349261|FG000|Overall Study|participant no longer meets study criteria|1|||
48589180|NCT01593254|156349262|FG001|Overall Study|participant no longer meets study criteria|1|||
48589181|NCT01593254|156349261|FG000|Overall Study|Admin reason by sponsor|7|||
48589182|NCT01593254|156349262|FG001|Overall Study|Admin reason by sponsor|3|||
48589183|NCT01593254|156349261|FG000|Overall Study|Imatinib treatment failure|2|||
48589184|NCT01593254|156349262|FG001|Overall Study|Imatinib treatment failure|0|||
48589185|NCT01593254|156349261|FG000|Overall Study|Other Reasons|61|||
48589186|NCT01593254|156349262|FG001|Overall Study|Other Reasons|115|||
48589187|NCT01868165|156349268|FG000|Overall Study|Withdrawal by Subject|36|||
48589188|NCT01868165|156349268|FG000|Overall Study|Physician Decision|2|||
48589189|NCT01868165|156349268|FG000|Overall Study|Lost to Follow-up|3|||
48589190|NCT01868165|156349268|FG000|Overall Study|Death|4|||
48589191|NCT03420222|156349269|FG000|Overall Study|Withdrawal by Subject|5|||
48589192|NCT03420222|156349270|FG001|Overall Study|Withdrawal by Subject|0|||
48589193|NCT03420222|156349269|FG000|Overall Study|Physician Decision|0|||
48589194|NCT03420222|156349270|FG001|Overall Study|Physician Decision|1|||
48589195|NCT01887678|156349271|FG000|Overall Study|Adverse Event|4|||
48589196|NCT01887678|156349272|FG001|Overall Study|Adverse Event|6|||
48589197|NCT01887678|156349271|FG000|Overall Study|Exceeded rescue medication dosage|4|||
48589198|NCT01887678|156349272|FG001|Overall Study|Exceeded rescue medication dosage|5|||
48589199|NCT01887678|156349271|FG000|Overall Study|Withdrawal of consent|3|||
48589200|NCT01887678|156349272|FG001|Overall Study|Withdrawal of consent|4|||
48589201|NCT01887678|156349271|FG000|Overall Study|Lost to Follow-up|4|||
48589202|NCT01887678|156349272|FG001|Overall Study|Lost to Follow-up|2|||
48589203|NCT01887678|156349271|FG000|Overall Study|Deterioration of clinical condition|0|||
48589204|NCT01887678|156349272|FG001|Overall Study|Deterioration of clinical condition|4|||
48589205|NCT01887678|156349271|FG000|Overall Study|Lack of Efficacy|1|||
48589206|NCT01887678|156349272|FG001|Overall Study|Lack of Efficacy|2|||
48589207|NCT01887678|156349271|FG000|Overall Study|Non-compliance|0|||
48589208|NCT01887678|156349272|FG001|Overall Study|Non-compliance|3|||
48589209|NCT01887678|156349271|FG000|Overall Study|Specified|1|||
48589210|NCT01887678|156349272|FG001|Overall Study|Specified|2|||
48589211|NCT03013985|156349273|FG000|Overall Study|Protocol Violation|2|||
48589212|NCT03013985|156349274|FG001|Overall Study|Protocol Violation|2|||
48589213|NCT03013985|156349273|FG000|Overall Study|Withdrawal by Subject|14|||
48589214|NCT03013985|156349274|FG001|Overall Study|Withdrawal by Subject|17|||
48589215|NCT04318132|156349275|FG000|Overall Study|Protocol Violation|0|||
48589216|NCT04318132|156349276|FG001|Overall Study|Protocol Violation|0|||
48589217|NCT04318132|156349277|FG002|Overall Study|Protocol Violation|3|||
48589218|NCT04318132|156349278|FG003|Overall Study|Protocol Violation|0|||
48589219|NCT01260584|156349279|FG000|Period 1|Protocol Violation|0|||
48589220|NCT01260584|156349280|FG001|Period 1|Protocol Violation|0|||
48589221|NCT01260584|156349281|FG002|Period 1|Protocol Violation|1|||
48589222|NCT01260584|156349282|FG003|Period 1|Protocol Violation|1|||
48589223|NCT01260584|156349279|FG000|Period 1|Adverse Event|0|||
48589224|NCT01260584|156349280|FG001|Period 1|Adverse Event|0|||
48589225|NCT01260584|156349281|FG002|Period 1|Adverse Event|1|||
48589226|NCT01260584|156349282|FG003|Period 1|Adverse Event|0|||
48589227|NCT01260584|156349279|FG000|Period 2|Protocol Violation|0|||
48589228|NCT01260584|156349280|FG001|Period 2|Protocol Violation|2|||
48589229|NCT01260584|156349281|FG002|Period 2|Protocol Violation|3|||
48589230|NCT01260584|156349282|FG003|Period 2|Protocol Violation|1|||
48693084|NCT01602224|156726338|FG000|Overall Study|Investigator Decison|1|||
48589231|NCT01260584|156349279|FG000|Period 2|Adverse Event|1|||
48589232|NCT01260584|156349280|FG001|Period 2|Adverse Event|0|||
48589233|NCT01260584|156349281|FG002|Period 2|Adverse Event|2|||
48589234|NCT01260584|156349282|FG003|Period 2|Adverse Event|0|||
48589235|NCT01260584|156349279|FG000|Period 2|Withdrawal by Subject|0|||
48589236|NCT01260584|156349280|FG001|Period 2|Withdrawal by Subject|1|||
48589237|NCT01260584|156349281|FG002|Period 2|Withdrawal by Subject|0|||
48589238|NCT01260584|156349282|FG003|Period 2|Withdrawal by Subject|0|||
48589239|NCT00045734|156349283|FG000|Overall Study|Protocol Violation|1|||
48589240|NCT00621517|156349284|FG000|Overall Study|Lost to Follow-up|3|||
48589241|NCT00621517|156349285|FG001|Overall Study|Lost to Follow-up|3|||
48589242|NCT00621517|156349284|FG000|Overall Study|Withdrawal by Subject|3|||
48589243|NCT00621517|156349285|FG001|Overall Study|Withdrawal by Subject|4|||
48589244|NCT00621517|156349284|FG000|Overall Study|Adverse Event|1|||
48589245|NCT00621517|156349285|FG001|Overall Study|Adverse Event|0|||
48589246|NCT03301831|156349287|FG000|Overall Study|Lost to Follow-up|5|||
48589247|NCT03301831|156349288|FG001|Overall Study|Lost to Follow-up|3|||
48589248|NCT03301831|156349287|FG000|Overall Study|Protocol Violation|4|||
48589249|NCT03301831|156349288|FG001|Overall Study|Protocol Violation|0|||
48589250|NCT03301831|156349287|FG000|Overall Study|Withdrawal by Subject|11|||
48589251|NCT03301831|156349288|FG001|Overall Study|Withdrawal by Subject|0|||
48589252|NCT00585325|156349291|FG000|Overall Study|Withdrawal by Subject|1|||
48589253|NCT00585325|156349292|FG001|Overall Study|Withdrawal by Subject|1|||
48589254|NCT01048099|156349293|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
48589255|NCT01048099|156349293|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
48589256|NCT03469999|156349294|FG000|Overall Study|Lost to Follow-up|2|||
48589257|NCT00508157|156349295|FG000|Overall Study|Adverse Event|0|||
48589258|NCT00508157|156349296|FG001|Overall Study|Adverse Event|1|||
48589259|NCT00508157|156349295|FG000|Overall Study|Subject Withdrew Consent|1|||
48589260|NCT00508157|156349296|FG001|Overall Study|Subject Withdrew Consent|0|||
48589261|NCT00508157|156349295|FG000|Overall Study|Lost to Follow-up|1|||
48589262|NCT00508157|156349296|FG001|Overall Study|Lost to Follow-up|0|||
48589263|NCT00508157|156349295|FG000|Overall Study|Subject no longer met study criteria|0|||
48589264|NCT00508157|156349296|FG001|Overall Study|Subject no longer met study criteria|1|||
48589265|NCT00508157|156349295|FG000|Overall Study|Other known cause|0|||
48589266|NCT00508157|156349296|FG001|Overall Study|Other known cause|1|||
48589267|NCT02087943|156349297|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
48589268|NCT02087943|156349298|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
48589269|NCT02087943|156349299|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
48589270|NCT02087943|156349300|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
48589271|NCT02087943|156349301|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
48589272|NCT02087943|156349297|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
48589273|NCT02087943|156349298|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
48589274|NCT02087943|156349299|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
48589275|NCT02087943|156349300|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
48589276|NCT02087943|156349301|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
48589277|NCT02087943|156349297|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
48589278|NCT02087943|156349298|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
48589279|NCT02087943|156349299|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
48589280|NCT02087943|156349300|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
48589281|NCT02087943|156349301|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
48589282|NCT02087943|156349297|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
48589283|NCT02087943|156349298|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
48589284|NCT02087943|156349299|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
48589285|NCT02087943|156349300|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
48589286|NCT02087943|156349301|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
48589287|NCT02087943|156349297|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
48589288|NCT02087943|156349298|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
48589289|NCT02087943|156349299|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
48589290|NCT02087943|156349300|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
48589291|NCT02087943|156349301|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
48589292|NCT02087943|156349297|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
48589293|NCT02087943|156349298|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
48589294|NCT02087943|156349299|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
48589295|NCT02087943|156349300|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
48589296|NCT02087943|156349301|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
48589297|NCT02087943|156349297|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
48589298|NCT02087943|156349298|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
48589299|NCT02087943|156349299|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
48589300|NCT02087943|156349300|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
48589301|NCT02087943|156349301|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
48589302|NCT02087943|156349297|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
48589303|NCT02087943|156349298|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
48589304|NCT02087943|156349299|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
48589305|NCT02087943|156349300|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
48742912|NCT00745823|156910413|FG000|Overall Study|Adverse Event|5|||
48589306|NCT02087943|156349301|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
48589307|NCT02087943|156349297|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
48589308|NCT02087943|156349298|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
48589309|NCT02087943|156349299|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
48589310|NCT02087943|156349300|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
48589311|NCT02087943|156349301|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
48589312|NCT02087943|156349297|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
48589313|NCT02087943|156349298|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
48589314|NCT02087943|156349299|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
48589315|NCT02087943|156349300|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
48589316|NCT02087943|156349301|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
48589317|NCT02131636|156349304|FG000|Overall Study|Personal Reasons|4|||
48589318|NCT02131636|156349305|FG001|Overall Study|Personal Reasons|4|||
48589319|NCT02131636|156349304|FG000|Overall Study|Lost to Follow-up|4|||
48589320|NCT02131636|156349305|FG001|Overall Study|Lost to Follow-up|0|||
48589321|NCT02131636|156349304|FG000|Overall Study|Adverse Event|4|||
48589322|NCT02131636|156349305|FG001|Overall Study|Adverse Event|1|||
48589323|NCT03484403|156349309|FG000|Overall Study|Withdrawal by Subject|6|||
48589324|NCT03484403|156349310|FG001|Overall Study|Withdrawal by Subject|4|||
48589325|NCT02774005|156349316|FG000|Overall Study|Adverse Event|8|||
48589326|NCT02774005|156349316|FG000|Overall Study|Withdrawal by Subject|23|||
48589327|NCT02774005|156349316|FG000|Overall Study|Lost to Follow-up|7|||
48589328|NCT02774005|156349316|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
48589329|NCT02774005|156349316|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
48589330|NCT02774005|156349316|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
48589331|NCT02774005|156349316|FG000|Overall Study|Death|1|||
48589332|NCT02774005|156349316|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
48589333|NCT02774005|156349316|FG000|Overall Study|Lack of compliance with study medication|4|||
48589334|NCT02774005|156349316|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
48589335|NCT02774005|156349316|FG000|Overall Study|another study|1|||
48589336|NCT02774005|156349316|FG000|Overall Study|cardiologist imposed travel restriction|1|||
48589337|NCT00845676|156349318|FG000|Overall Study|Virologic breakthrough at week 20|1|||
48589338|NCT00845676|156349318|FG000|Overall Study|Adverse Event|1|||
48589339|NCT02636439|156349322|FG000|Overall Study|Adverse Event|2|||
48589340|NCT02636439|156349323|FG001|Overall Study|Adverse Event|2|||
48589341|NCT02636439|156349322|FG000|Overall Study|Lost to Follow-up|1|||
48589342|NCT02636439|156349323|FG001|Overall Study|Lost to Follow-up|0|||
48589343|NCT02636439|156349322|FG000|Overall Study|Non-compliance|1|||
48589344|NCT02636439|156349323|FG001|Overall Study|Non-compliance|1|||
48589345|NCT02636439|156349322|FG000|Overall Study|Personal reasons|2|||
48589346|NCT02636439|156349323|FG001|Overall Study|Personal reasons|0|||
48589347|NCT03035916|156349324|FG000|Overall Study|Puncture failed|0|||
48589348|NCT03035916|156349325|FG001|Overall Study|Puncture failed|2|||
48589349|NCT03035916|156349326|FG002|Overall Study|Puncture failed|0|||
48589350|NCT00448812|156349327|FG000|Year 2|Missed visit but remained in study|4|||
48589351|NCT00448812|156349328|FG001|Year 2|Missed visit but remained in study|1|||
48589352|NCT00448812|156349327|FG000|Year 3|Withdrawal by Subject|1|||
48589353|NCT00448812|156349328|FG001|Year 3|Withdrawal by Subject|3|||
48589354|NCT00448812|156349327|FG000|Year 3|Lost to Follow-up|1|||
48589355|NCT00448812|156349328|FG001|Year 3|Lost to Follow-up|0|||
48589356|NCT00448812|156349327|FG000|Year 3|Missed visit but remained in study|2|||
48589357|NCT00448812|156349328|FG001|Year 3|Missed visit but remained in study|0|||
48589358|NCT00448812|156349327|FG000|Year 5|Missed visit but remained in study|1|||
48589359|NCT00448812|156349328|FG001|Year 5|Missed visit but remained in study|0|||
48380295|NCT01067326|155588371|FG000|Overall Study|Adverse Event|0|||
48589360|NCT00262002|156349329|FG000|Overall Study|Adverse Event|2|||
48380296|NCT01067326|155588372|FG001|Overall Study|Adverse Event|2|||
48380297|NCT01067326|155588371|FG000|Overall Study|Withdrawal by Subject|1|||
48451246|NCT00355134|155841605|FG002|Core Phase|Lost to Follow-up|21|||
48589361|NCT00262002|156349330|FG001|Overall Study|Adverse Event|1|||
48589362|NCT00262002|156349331|FG002|Overall Study|Adverse Event|0|||
48589363|NCT00262002|156349332|FG003|Overall Study|Adverse Event|0|||
48589364|NCT00262002|156349333|FG004|Overall Study|Adverse Event|0|||
48589365|NCT00262002|156349334|FG005|Overall Study|Adverse Event|1|||
48589366|NCT00262002|156349335|FG006|Overall Study|Adverse Event|0|||
48589367|NCT00262002|156349329|FG000|Overall Study|Withdrawal by Subject|4|||
48589368|NCT00262002|156349330|FG001|Overall Study|Withdrawal by Subject|2|||
48589369|NCT00262002|156349331|FG002|Overall Study|Withdrawal by Subject|0|||
48589370|NCT00262002|156349332|FG003|Overall Study|Withdrawal by Subject|1|||
48589371|NCT00262002|156349333|FG004|Overall Study|Withdrawal by Subject|2|||
48589372|NCT00262002|156349334|FG005|Overall Study|Withdrawal by Subject|2|||
48589373|NCT00262002|156349335|FG006|Overall Study|Withdrawal by Subject|2|||
48589374|NCT00262002|156349329|FG000|Overall Study|Lost to Follow-up|2|||
48589375|NCT00262002|156349330|FG001|Overall Study|Lost to Follow-up|0|||
48589376|NCT00262002|156349331|FG002|Overall Study|Lost to Follow-up|0|||
48589377|NCT00262002|156349332|FG003|Overall Study|Lost to Follow-up|2|||
48589378|NCT00262002|156349333|FG004|Overall Study|Lost to Follow-up|0|||
48589379|NCT00262002|156349334|FG005|Overall Study|Lost to Follow-up|1|||
48589380|NCT00262002|156349335|FG006|Overall Study|Lost to Follow-up|0|||
48589381|NCT00262002|156349329|FG000|Overall Study|Inapropriate enrollment|0|||
48589382|NCT00262002|156349330|FG001|Overall Study|Inapropriate enrollment|1|||
48589383|NCT00262002|156349331|FG002|Overall Study|Inapropriate enrollment|0|||
48589384|NCT00262002|156349332|FG003|Overall Study|Inapropriate enrollment|0|||
48589385|NCT00262002|156349333|FG004|Overall Study|Inapropriate enrollment|0|||
48589386|NCT00262002|156349334|FG005|Overall Study|Inapropriate enrollment|0|||
48589387|NCT00262002|156349335|FG006|Overall Study|Inapropriate enrollment|0|||
48589388|NCT00262002|156349329|FG000|Overall Study|Protocol Violation|3|||
48589389|NCT00262002|156349330|FG001|Overall Study|Protocol Violation|2|||
48589390|NCT00262002|156349331|FG002|Overall Study|Protocol Violation|0|||
48589391|NCT00262002|156349332|FG003|Overall Study|Protocol Violation|2|||
48589392|NCT00262002|156349333|FG004|Overall Study|Protocol Violation|5|||
48589393|NCT00262002|156349334|FG005|Overall Study|Protocol Violation|3|||
48589394|NCT00262002|156349335|FG006|Overall Study|Protocol Violation|2|||
48589395|NCT00262002|156349329|FG000|Overall Study|Unable to classify|0|||
48589396|NCT00262002|156349330|FG001|Overall Study|Unable to classify|0|||
48589397|NCT00262002|156349331|FG002|Overall Study|Unable to classify|0|||
48589398|NCT00262002|156349332|FG003|Overall Study|Unable to classify|0|||
48589399|NCT00262002|156349333|FG004|Overall Study|Unable to classify|0|||
48589400|NCT00262002|156349334|FG005|Overall Study|Unable to classify|0|||
48589401|NCT00262002|156349335|FG006|Overall Study|Unable to classify|2|||
48589402|NCT03885999|156349336|FG000|Overall Study|Adverse Event|1|||
48589403|NCT01451554|156349337|FG000|Overall Study|Withdrawal by Subject|14|||
48589404|NCT01451554|156349338|FG001|Overall Study|Withdrawal by Subject|9|||
48589405|NCT00359294|156349341|FG000|Overall Study|Progressive disease|1|||
48589406|NCT00359294|156349342|FG001|Overall Study|Progressive disease|1|||
48589407|NCT00359294|156349343|FG002|Overall Study|Progressive disease|2|||
48589408|NCT00359294|156349344|FG003|Overall Study|Progressive disease|3|||
48589409|NCT00359294|156349345|FG004|Overall Study|Progressive disease|2|||
48589410|NCT00359294|156349341|FG000|Overall Study|Withdrawal by Subject|0|||
48589411|NCT00359294|156349342|FG001|Overall Study|Withdrawal by Subject|0|||
48589412|NCT00359294|156349343|FG002|Overall Study|Withdrawal by Subject|0|||
48589413|NCT00359294|156349344|FG003|Overall Study|Withdrawal by Subject|0|||
48589414|NCT00359294|156349345|FG004|Overall Study|Withdrawal by Subject|1|||
48589415|NCT00359294|156349341|FG000|Overall Study|Not treated|0|||
48589416|NCT00359294|156349342|FG001|Overall Study|Not treated|0|||
48589417|NCT00359294|156349343|FG002|Overall Study|Not treated|0|||
48589418|NCT00359294|156349344|FG003|Overall Study|Not treated|1|||
48589419|NCT00359294|156349345|FG004|Overall Study|Not treated|0|||
48589420|NCT00359294|156349341|FG000|Overall Study|Physician Decision|0|||
48589421|NCT00359294|156349342|FG001|Overall Study|Physician Decision|0|||
48589422|NCT00359294|156349343|FG002|Overall Study|Physician Decision|1|||
48589423|NCT00359294|156349344|FG003|Overall Study|Physician Decision|0|||
48589424|NCT00359294|156349345|FG004|Overall Study|Physician Decision|0|||
48589425|NCT00594386|156349346|FG000|Overall Study|Major protocol violation|2|||
48589426|NCT00594386|156349346|FG000|Overall Study|Lack of Efficacy|12|||
48589427|NCT00594386|156349346|FG000|Overall Study|Adverse Event|68|||
48589428|NCT00594386|156349346|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
48589429|NCT00594386|156349346|FG000|Overall Study|Subject withdrew consent|35|||
48589430|NCT00594386|156349346|FG000|Overall Study|Study ended per sponsor|115|||
48589431|NCT00594386|156349346|FG000|Overall Study|Lost to Follow-up|6|||
48589432|NCT00594386|156349346|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
48589433|NCT00594386|156349346|FG000|Overall Study|Other: Subject moved to Seattle|1|||
48589434|NCT00594386|156349346|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
48589435|NCT00594386|156349346|FG000|Overall Study|Other: Study terminated per investigator|2|||
48589436|NCT00594386|156349346|FG000|Overall Study|Other: Sponsor closure of study|1|||
48589437|NCT00594386|156349346|FG000|Overall Study|Other: Site terminated participation|1|||
48589438|NCT00594386|156349346|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
48589439|NCT00594386|156349346|FG000|Overall Study|Other: Loss of drivers license|1|||
48589440|NCT01790516|156349347|FG000|Overall Study|Physician Decision|1|||
48589441|NCT01790516|156349348|FG001|Overall Study|Physician Decision|0|||
48589442|NCT01554163|156349349|FG000|Overall Study|Adverse Event|3|||
48589443|NCT01554163|156349350|FG001|Overall Study|Adverse Event|0|||
48589444|NCT01554163|156349349|FG000|Overall Study|Lack of Efficacy|1|||
48589445|NCT01554163|156349350|FG001|Overall Study|Lack of Efficacy|0|||
48589446|NCT01554163|156349349|FG000|Overall Study|Lost to Follow-up|1|||
48589447|NCT01554163|156349350|FG001|Overall Study|Lost to Follow-up|0|||
48589448|NCT01554163|156349349|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48589449|NCT01554163|156349350|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48589450|NCT01554163|156349349|FG000|Overall Study|Protocol Violation|0|||
48589451|NCT01554163|156349350|FG001|Overall Study|Protocol Violation|4|||
48589452|NCT01554163|156349349|FG000|Overall Study|Withdrawal by Subject|1|||
48589453|NCT01554163|156349350|FG001|Overall Study|Withdrawal by Subject|5|||
48589454|NCT01554163|156349349|FG000|Overall Study|Not Treated|1|||
48589455|NCT01554163|156349350|FG001|Overall Study|Not Treated|0|||
48589456|NCT01402986|156349351|FG000|Overall Study|Withdrawal by Subject|7|||
48589457|NCT01402986|156349352|FG001|Overall Study|Withdrawal by Subject|10|||
48589458|NCT01402986|156349353|FG002|Overall Study|Withdrawal by Subject|7|||
48589459|NCT01402986|156349354|FG003|Overall Study|Withdrawal by Subject|13|||
48589460|NCT01402986|156349351|FG000|Overall Study|Death|0|||
48589461|NCT01402986|156349352|FG001|Overall Study|Death|0|||
48589462|NCT01402986|156349353|FG002|Overall Study|Death|0|||
48589463|NCT01402986|156349354|FG003|Overall Study|Death|2|||
48589464|NCT01402986|156349351|FG000|Overall Study|Lost to Follow-up|0|||
48589465|NCT01402986|156349352|FG001|Overall Study|Lost to Follow-up|0|||
48589466|NCT01402986|156349353|FG002|Overall Study|Lost to Follow-up|0|||
48589467|NCT01402986|156349354|FG003|Overall Study|Lost to Follow-up|1|||
48589468|NCT01402986|156349351|FG000|Overall Study|Other|2|||
48589469|NCT01402986|156349352|FG001|Overall Study|Other|5|||
48589470|NCT01402986|156349353|FG002|Overall Study|Other|1|||
48589471|NCT01402986|156349354|FG003|Overall Study|Other|6|||
48589472|NCT02427802|156349355|FG000|Overall Study|Adverse Event|11|||
48589473|NCT02427802|156349356|FG001|Overall Study|Adverse Event|3|||
48589474|NCT02427802|156349357|FG002|Overall Study|Adverse Event|7|||
48589475|NCT02427802|156349355|FG000|Overall Study|Death|0|||
48589476|NCT02427802|156349356|FG001|Overall Study|Death|4|||
48589477|NCT02427802|156349357|FG002|Overall Study|Death|1|||
48589478|NCT02427802|156349355|FG000|Overall Study|Lost to Follow-up|13|||
48589479|NCT02427802|156349356|FG001|Overall Study|Lost to Follow-up|8|||
48589480|NCT02427802|156349357|FG002|Overall Study|Lost to Follow-up|8|||
48589481|NCT02427802|156349355|FG000|Overall Study|Physician Decision|4|||
48589482|NCT02427802|156349356|FG001|Overall Study|Physician Decision|2|||
48589483|NCT02427802|156349357|FG002|Overall Study|Physician Decision|4|||
48589484|NCT02427802|156349355|FG000|Overall Study|Withdrawal by Subject|10|||
48589485|NCT02427802|156349356|FG001|Overall Study|Withdrawal by Subject|5|||
48589486|NCT02427802|156349357|FG002|Overall Study|Withdrawal by Subject|11|||
48589487|NCT02427802|156349355|FG000|Overall Study|Protocol Violation|3|||
48589488|NCT02427802|156349356|FG001|Overall Study|Protocol Violation|1|||
48589489|NCT02427802|156349357|FG002|Overall Study|Protocol Violation|1|||
48589490|NCT02427802|156349355|FG000|Overall Study|protocol specific treatment unrelated|18|||
48589491|NCT02427802|156349356|FG001|Overall Study|protocol specific treatment unrelated|11|||
48589492|NCT02427802|156349357|FG002|Overall Study|protocol specific treatment unrelated|11|||
48589493|NCT01085084|156349358|FG000|Overall Study|Withdrawal by Subject|1|||
48589494|NCT01085084|156349359|FG001|Overall Study|Withdrawal by Subject|0|||
48589495|NCT01085084|156349360|FG002|Overall Study|Withdrawal by Subject|0|||
48589496|NCT01085084|156349358|FG000|Overall Study|Lost to Follow-up|2|||
48589497|NCT01085084|156349359|FG001|Overall Study|Lost to Follow-up|1|||
48589498|NCT01085084|156349360|FG002|Overall Study|Lost to Follow-up|1|||
48589499|NCT01085084|156349358|FG000|Overall Study|Adverse Event|4|||
48589500|NCT01085084|156349359|FG001|Overall Study|Adverse Event|3|||
48589501|NCT01085084|156349360|FG002|Overall Study|Adverse Event|6|||
48589502|NCT01085084|156349358|FG000|Overall Study|Treatment Failure|0|||
48589503|NCT01085084|156349359|FG001|Overall Study|Treatment Failure|1|||
48589504|NCT01085084|156349360|FG002|Overall Study|Treatment Failure|2|||
48589505|NCT02749799|156349361|FG000|Overall Study|Adverse Event|2|||
48589506|NCT02749799|156349361|FG000|Overall Study|Lost to Follow-up|4|||
48589507|NCT02749799|156349361|FG000|Overall Study|Protocol Violation|1|||
48589508|NCT02749799|156349361|FG000|Overall Study|Withdrawal by Subject|1|||
48589509|NCT01941537|156349362|FG000|Overall Study|Lack of Efficacy|1|||
48589510|NCT01941537|156349363|FG001|Overall Study|Lack of Efficacy|2|||
48589511|NCT01941537|156349362|FG000|Overall Study|Lost to Follow-up|1|||
48325371|NCT01105975|155389071|FG005|Overall Study|Lost to Follow-up|0|||
48325372|NCT01105975|155389072|FG006|Overall Study|Lost to Follow-up|0|||
48325373|NCT01105975|155389073|FG007|Overall Study|Lost to Follow-up|0|||
48325374|NCT01105975|155389074|FG008|Overall Study|Lost to Follow-up|1|||
48325375|NCT01105975|155389075|FG009|Overall Study|Lost to Follow-up|0|||
48325376|NCT01105975|155389066|FG000|Overall Study|Physician Decision|0|||
48325377|NCT01105975|155389067|FG001|Overall Study|Physician Decision|0|||
48325378|NCT01105975|155389068|FG002|Overall Study|Physician Decision|0|||
48325379|NCT01105975|155389069|FG003|Overall Study|Physician Decision|0|||
48325380|NCT01105975|155389070|FG004|Overall Study|Physician Decision|0|||
48325381|NCT01105975|155389071|FG005|Overall Study|Physician Decision|0|||
48325382|NCT01105975|155389072|FG006|Overall Study|Physician Decision|2|||
48325383|NCT01105975|155389073|FG007|Overall Study|Physician Decision|0|||
48325384|NCT01105975|155389074|FG008|Overall Study|Physician Decision|0|||
48325385|NCT01105975|155389075|FG009|Overall Study|Physician Decision|0|||
48325386|NCT01105975|155389066|FG000|Overall Study|Protocol Violation|0|||
48325387|NCT01105975|155389067|FG001|Overall Study|Protocol Violation|2|||
48325388|NCT01105975|155389068|FG002|Overall Study|Protocol Violation|2|||
48325389|NCT01105975|155389069|FG003|Overall Study|Protocol Violation|0|||
48325390|NCT01105975|155389070|FG004|Overall Study|Protocol Violation|1|||
48325391|NCT01105975|155389071|FG005|Overall Study|Protocol Violation|1|||
48325392|NCT01105975|155389072|FG006|Overall Study|Protocol Violation|1|||
48380298|NCT01067326|155588372|FG001|Overall Study|Withdrawal by Subject|0|||
48380299|NCT01067326|155588371|FG000|Overall Study|Early Study Termination|1|||
48380300|NCT01067326|155588372|FG001|Overall Study|Early Study Termination|1|||
48380301|NCT01230788|155588383|FG000|Overall Study|Prescribed exclusion drug|1|||
48380302|NCT01271803|155588386|FG000|Overall Study|Progressive disease|0|||
48380303|NCT01271803|155588387|FG001|Overall Study|Progressive disease|0|||
48380304|NCT01271803|155588388|FG002|Overall Study|Progressive disease|2|||
48380305|NCT01271803|155588386|FG000|Overall Study|Death|53|||
48380306|NCT01271803|155588387|FG001|Overall Study|Death|34|||
48380307|NCT01271803|155588388|FG002|Overall Study|Death|0|||
48380308|NCT01271803|155588386|FG000|Overall Study|Withdrawal by Subject|1|||
48380309|NCT01271803|155588387|FG001|Overall Study|Withdrawal by Subject|5|||
48380310|NCT01271803|155588388|FG002|Overall Study|Withdrawal by Subject|0|||
48380311|NCT01271803|155588386|FG000|Overall Study|Lost to Follow-up|1|||
48380312|NCT01271803|155588387|FG001|Overall Study|Lost to Follow-up|0|||
48380313|NCT01271803|155588388|FG002|Overall Study|Lost to Follow-up|0|||
48380314|NCT00634010|155588391|FG000|Overall Study|Adverse Event|2|||
48380315|NCT00634010|155588392|FG001|Overall Study|Adverse Event|5|||
48380316|NCT00634010|155588391|FG000|Overall Study|Withdrawal by Subject|5|||
48380317|NCT00634010|155588392|FG001|Overall Study|Withdrawal by Subject|6|||
48380318|NCT00634010|155588391|FG000|Overall Study|Physician Decision|1|||
48380319|NCT00634010|155588392|FG001|Overall Study|Physician Decision|1|||
48380320|NCT00634010|155588391|FG000|Overall Study|Disease Progression|1|||
48380321|NCT00634010|155588392|FG001|Overall Study|Disease Progression|1|||
48380322|NCT00634010|155588391|FG000|Overall Study|Non-Compliant|1|||
48380323|NCT00634010|155588392|FG001|Overall Study|Non-Compliant|1|||
48380324|NCT05211739|155588394|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
48380325|NCT05211739|155588395|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
48380326|NCT05211739|155588394|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
48380327|NCT05211739|155588395|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
48380328|NCT05211739|155588394|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
48380329|NCT05211739|155588395|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
48380330|NCT05211739|155588394|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
48380331|NCT05211739|155588395|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
48380332|NCT01862640|155588396|FG000|Overall Study|Adverse Event|4|||
48380333|NCT01862640|155588397|FG001|Overall Study|Adverse Event|10|||
48380334|NCT01862640|155588398|FG002|Overall Study|Adverse Event|6|||
48380335|NCT01862640|155588399|FG003|Overall Study|Adverse Event|8|||
48380336|NCT01862640|155588396|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
48589512|NCT01941537|156349363|FG001|Overall Study|Lost to Follow-up|0|||
48589513|NCT01941537|156349362|FG000|Overall Study|Pregnancy|1|||
48589514|NCT01941537|156349363|FG001|Overall Study|Pregnancy|0|||
48589515|NCT01941537|156349362|FG000|Overall Study|Adverse Event|1|||
48589516|NCT01941537|156349363|FG001|Overall Study|Adverse Event|0|||
48589517|NCT01941537|156349362|FG000|Overall Study|Withdrawal by Subject|0|||
48589518|NCT01941537|156349363|FG001|Overall Study|Withdrawal by Subject|1|||
48589519|NCT02070978|156349364|FG000|Overall Study|Adverse Event|6|||
48589520|NCT02070978|156349365|FG001|Overall Study|Adverse Event|2|||
48589521|NCT02070978|156349366|FG002|Overall Study|Adverse Event|0|||
48589522|NCT02070978|156349364|FG000|Overall Study|Lost to Follow-up|1|||
48589523|NCT02070978|156349365|FG001|Overall Study|Lost to Follow-up|3|||
48589524|NCT02070978|156349366|FG002|Overall Study|Lost to Follow-up|4|||
48589525|NCT02070978|156349364|FG000|Overall Study|Withdrawal by Subject|3|||
48589526|NCT02070978|156349365|FG001|Overall Study|Withdrawal by Subject|5|||
48589527|NCT02070978|156349366|FG002|Overall Study|Withdrawal by Subject|3|||
48589528|NCT02070978|156349364|FG000|Overall Study|Protocol Violation|1|||
48589529|NCT02070978|156349365|FG001|Overall Study|Protocol Violation|0|||
48589530|NCT02070978|156349366|FG002|Overall Study|Protocol Violation|3|||
48589531|NCT02070978|156349364|FG000|Overall Study|Lack of Efficacy|0|||
48589532|NCT02070978|156349365|FG001|Overall Study|Lack of Efficacy|1|||
48589533|NCT02070978|156349366|FG002|Overall Study|Lack of Efficacy|0|||
48589534|NCT02070978|156349364|FG000|Overall Study|Death|0|||
48589535|NCT02070978|156349365|FG001|Overall Study|Death|0|||
48589536|NCT02070978|156349366|FG002|Overall Study|Death|2|||
48589537|NCT02070978|156349364|FG000|Overall Study|Un-specified|3|||
48589538|NCT02070978|156349365|FG001|Overall Study|Un-specified|2|||
48589539|NCT02070978|156349366|FG002|Overall Study|Un-specified|2|||
48589540|NCT02070978|156349364|FG000|Overall Study|Terminated by Sponsor|33|||
48589541|NCT02070978|156349365|FG001|Overall Study|Terminated by Sponsor|40|||
48589542|NCT02070978|156349366|FG002|Overall Study|Terminated by Sponsor|39|||
48630147|NCT02723955|156504838|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
48630148|NCT02723955|156504839|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
48630149|NCT02723955|156504840|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
48630150|NCT02723955|156504841|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
48630151|NCT02723955|156504842|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
48630152|NCT02723955|156504843|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
48630153|NCT02723955|156504844|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
48589543|NCT00590538|156350530|FG000|Overall Study|Study terminated before completed|2|||
48589544|NCT02700698|156350557|FG000|Overall Study|Withdrawal by Subject|1|||
48589545|NCT02700698|156350558|FG001|Overall Study|Withdrawal by Subject|0|||
48589546|NCT00316914|156350559|FG000|Overall Study|Withdrawal by Subject|5|||
48589547|NCT00316914|156350560|FG001|Overall Study|Withdrawal by Subject|3|||
48589548|NCT00316914|156350559|FG000|Overall Study|Adverse Event|8|||
48589549|NCT00316914|156350560|FG001|Overall Study|Adverse Event|7|||
48589550|NCT00316914|156350559|FG000|Overall Study|Other Problems|6|||
48589551|NCT00316914|156350560|FG001|Overall Study|Other Problems|11|||
48589552|NCT00316914|156350559|FG000|Overall Study|Missing end of treatment documentation|14|||
48589553|NCT00316914|156350560|FG001|Overall Study|Missing end of treatment documentation|15|||
48589554|NCT02309723|156350561|FG000|Overall Study|Withdrawal by Subject|24|||
48589555|NCT02309723|156350562|FG001|Overall Study|Withdrawal by Subject|23|||
48589556|NCT02309723|156350563|FG002|Overall Study|Withdrawal by Subject|24|||
48589557|NCT03810235|156350566|FG000|Overall Study|Withdrawal by Subject|2|||
48589558|NCT03810235|156350567|FG001|Overall Study|Withdrawal by Subject|0|||
48589559|NCT02560623|156350568|FG000|Overall Study|Unable to swallow sponge|0|||
48589560|NCT02560623|156350569|FG001|Overall Study|Unable to swallow sponge|1|||
48589561|NCT02560623|156350570|FG002|Overall Study|Unable to swallow sponge|0|||
48589562|NCT02560623|156350571|FG003|Overall Study|Unable to swallow sponge|0|||
48589563|NCT02560623|156350568|FG000|Overall Study|Intervention prior to sponge administration|0|||
48589564|NCT02560623|156350569|FG001|Overall Study|Intervention prior to sponge administration|1|||
48589565|NCT02560623|156350570|FG002|Overall Study|Intervention prior to sponge administration|0|||
48589566|NCT02560623|156350571|FG003|Overall Study|Intervention prior to sponge administration|0|||
48589567|NCT03313310|156350574|FG000|Phase 2|Lost to Follow-up|4|||
48589568|NCT03313310|156350575|FG001|Phase 2|Lost to Follow-up|0|||
48589569|NCT03313310|156350574|FG000|Phase 3|Lost to Follow-up|0|||
48589570|NCT03313310|156350575|FG001|Phase 3|Lost to Follow-up|1|||
48589571|NCT01903993|156350579|FG000|Overall Study|Death|118|||
48589572|NCT01903993|156350580|FG001|Overall Study|Death|121|||
48589573|NCT01903993|156350579|FG000|Overall Study|Withdrawal by Subject|15|||
48589574|NCT01903993|156350580|FG001|Overall Study|Withdrawal by Subject|4|||
48589575|NCT01903993|156350579|FG000|Overall Study|Lost to Follow-up|2|||
48589576|NCT01903993|156350580|FG001|Overall Study|Lost to Follow-up|3|||
48589577|NCT01903993|156350579|FG000|Overall Study|Study Terminated by Sponsor|8|||
48589578|NCT01903993|156350580|FG001|Overall Study|Study Terminated by Sponsor|14|||
48589579|NCT01903993|156350579|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
48589580|NCT01903993|156350580|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
48589581|NCT00184093|156350581|FG000|Overall Study|Adverse Event|3|||
48589582|NCT00184093|156350581|FG000|Overall Study|Lost to Follow-up|3|||
48325393|NCT01105975|155389073|FG007|Overall Study|Protocol Violation|1|||
48325394|NCT01105975|155389074|FG008|Overall Study|Protocol Violation|2|||
48325395|NCT01105975|155389075|FG009|Overall Study|Protocol Violation|2|||
48325396|NCT01105975|155389066|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48325397|NCT01105975|155389067|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48325398|NCT01105975|155389068|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48325399|NCT01105975|155389069|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48325400|NCT01105975|155389070|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48325401|NCT01105975|155389071|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
48325402|NCT01105975|155389072|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48325403|NCT01105975|155389073|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48325404|NCT01105975|155389074|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
48325405|NCT01105975|155389075|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48325406|NCT01372085|155389076|FG000|Washout Period 2|Physician Decision|0|||
48325407|NCT01372085|155389077|FG001|Washout Period 2|Physician Decision|0|||
48325408|NCT01372085|155389078|FG002|Washout Period 2|Physician Decision|0|||
48325409|NCT01372085|155389079|FG003|Washout Period 2|Physician Decision|0|||
48325410|NCT01372085|155389080|FG004|Washout Period 2|Physician Decision|1|||
48325411|NCT01372085|155389081|FG005|Washout Period 2|Physician Decision|0|||
48325412|NCT01372085|155389082|FG006|Washout Period 2|Physician Decision|0|||
48325413|NCT01372085|155389083|FG007|Washout Period 2|Physician Decision|0|||
48325414|NCT01372085|155389084|FG008|Washout Period 2|Physician Decision|0|||
48325415|NCT01372085|155389085|FG009|Washout Period 2|Physician Decision|0|||
48325416|NCT01372085|155389076|FG000|Washout Period 3|Withdrawal by Subject|0|||
48325417|NCT01372085|155389077|FG001|Washout Period 3|Withdrawal by Subject|0|||
48325418|NCT01372085|155389078|FG002|Washout Period 3|Withdrawal by Subject|0|||
48325419|NCT01372085|155389079|FG003|Washout Period 3|Withdrawal by Subject|0|||
48325420|NCT01372085|155389080|FG004|Washout Period 3|Withdrawal by Subject|0|||
48325421|NCT01372085|155389081|FG005|Washout Period 3|Withdrawal by Subject|2|||
48325422|NCT01372085|155389082|FG006|Washout Period 3|Withdrawal by Subject|0|||
48325423|NCT01372085|155389083|FG007|Washout Period 3|Withdrawal by Subject|0|||
48325424|NCT01372085|155389084|FG008|Washout Period 3|Withdrawal by Subject|0|||
48325425|NCT01372085|155389085|FG009|Washout Period 3|Withdrawal by Subject|0|||
48380337|NCT01862640|155588397|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
48380338|NCT01862640|155588398|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
48380339|NCT01862640|155588399|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
48380340|NCT01862640|155588396|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
48380341|NCT01862640|155588397|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
48380342|NCT01862640|155588398|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
48380343|NCT01862640|155588399|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
48380344|NCT01862640|155588396|FG000|Overall Study|Withdrawal by Subject|2|||
48380345|NCT01862640|155588397|FG001|Overall Study|Withdrawal by Subject|4|||
48380346|NCT01862640|155588398|FG002|Overall Study|Withdrawal by Subject|8|||
48380347|NCT01862640|155588399|FG003|Overall Study|Withdrawal by Subject|5|||
48380348|NCT01862640|155588396|FG000|Overall Study|Protocol Deviation|0|||
48380349|NCT01862640|155588397|FG001|Overall Study|Protocol Deviation|0|||
48380350|NCT01862640|155588398|FG002|Overall Study|Protocol Deviation|1|||
48380351|NCT01862640|155588399|FG003|Overall Study|Protocol Deviation|0|||
48380352|NCT01326533|155588407|FG000|Overall Study|Lost to Follow-up|2|||
48380353|NCT01326533|155588408|FG001|Overall Study|Lost to Follow-up|0|||
48380354|NCT01326533|155588407|FG000|Overall Study|Withdrawal by Subject|1|||
48380355|NCT01326533|155588408|FG001|Overall Study|Withdrawal by Subject|0|||
48380356|NCT01326533|155588407|FG000|Overall Study|Adverse Event|1|||
48380357|NCT01326533|155588408|FG001|Overall Study|Adverse Event|0|||
48380358|NCT01971203|155588409|FG000|Overall Study|Protocol Violation|3|||
48380359|NCT01971203|155588410|FG001|Overall Study|Protocol Violation|2|||
48380360|NCT01971203|155588409|FG000|Overall Study|Withdrawal by Subject|5|||
48589583|NCT00184093|156350581|FG000|Overall Study|Physician Decision|1|||
48589584|NCT00184093|156350581|FG000|Overall Study|Withdrawal by Subject|2|||
48589585|NCT05095311|156350584|FG000|Overall Study|Lost to Follow-up|7|||
48589586|NCT05095311|156350585|FG001|Overall Study|Lost to Follow-up|0|||
48589587|NCT05095311|156350586|FG002|Overall Study|Lost to Follow-up|0|||
48589588|NCT00002525|156350587|FG000|Overall Study|Adverse Event|36|||
48589589|NCT00002525|156350588|FG001|Overall Study|Adverse Event|0|||
48589590|NCT00002525|156350587|FG000|Overall Study|Death|5|||
48589591|NCT00002525|156350588|FG001|Overall Study|Death|0|||
48589592|NCT00002525|156350587|FG000|Overall Study|Withdrawal by Subject|11|||
48589593|NCT00002525|156350588|FG001|Overall Study|Withdrawal by Subject|0|||
48589594|NCT00002525|156350587|FG000|Overall Study|Start non-protocol therapy|1|||
48589595|NCT00002525|156350588|FG001|Overall Study|Start non-protocol therapy|0|||
48589596|NCT00002525|156350587|FG000|Overall Study|Other complicating disease|1|||
48589597|NCT00002525|156350588|FG001|Overall Study|Other complicating disease|0|||
48589598|NCT00002525|156350587|FG000|Overall Study|Duke's A, B1, D disease|92|||
48589599|NCT00002525|156350588|FG001|Overall Study|Duke's A, B1, D disease|0|||
48589600|NCT00002525|156350587|FG000|Overall Study|Error|6|||
48589601|NCT00002525|156350588|FG001|Overall Study|Error|0|||
48589602|NCT00002525|156350587|FG000|Overall Study|Other|26|||
48589603|NCT00002525|156350588|FG001|Overall Study|Other|0|||
48589604|NCT00002525|156350587|FG000|Overall Study|Never start protocol therapy|8|||
48589605|NCT00002525|156350588|FG001|Overall Study|Never start protocol therapy|0|||
48589606|NCT00435188|156350591|FG000|Overall Study|Death|1|||
48589607|NCT00435188|156350592|FG001|Overall Study|Death|6|||
48589608|NCT00435188|156350591|FG000|Overall Study|Withdrawal by Subject|16|||
48589609|NCT00435188|156350592|FG001|Overall Study|Withdrawal by Subject|11|||
48589610|NCT00435188|156350591|FG000|Overall Study|Lost to Follow-up|5|||
48589611|NCT00435188|156350592|FG001|Overall Study|Lost to Follow-up|6|||
48589612|NCT00575510|156350599|FG000|Overall Study|Lost to Follow-up|4|||
48589613|NCT00575510|156350600|FG001|Overall Study|Lost to Follow-up|6|||
48589614|NCT00575510|156350601|FG002|Overall Study|Lost to Follow-up|9|||
48589615|NCT00575510|156350599|FG000|Overall Study|Withdrawal by Subject|1|||
48589616|NCT00575510|156350600|FG001|Overall Study|Withdrawal by Subject|0|||
48589617|NCT00575510|156350601|FG002|Overall Study|Withdrawal by Subject|0|||
48589618|NCT00575510|156350599|FG000|Overall Study|Clinic Called Patient|7|||
48589619|NCT00575510|156350600|FG001|Overall Study|Clinic Called Patient|7|||
48589620|NCT00575510|156350601|FG002|Overall Study|Clinic Called Patient|7|||
48589621|NCT00575510|156350599|FG000|Overall Study|Pregnancy|0|||
48380361|NCT01971203|155588410|FG001|Overall Study|Withdrawal by Subject|6|||
48380362|NCT01971203|155588409|FG000|Overall Study|Adverse Event|1|||
48380363|NCT01971203|155588410|FG001|Overall Study|Adverse Event|0|||
48380364|NCT01717768|155588417|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380365|NCT01717768|155588418|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
48380366|NCT01717768|155588419|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380367|NCT01717768|155588420|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48589622|NCT00575510|156350600|FG001|Overall Study|Pregnancy|0|||
48589623|NCT00575510|156350601|FG002|Overall Study|Pregnancy|1|||
48589624|NCT01146561|156350602|FG000|Overall Study|Withdrawal by Subject|1|||
48589625|NCT01146561|156350602|FG000|Overall Study|Lost to Follow-up|1|||
48589626|NCT01857102|156350603|FG000|Period 1|No longer meets Eligibility Criteria|0|||
48589627|NCT01857102|156350604|FG001|Period 1|No longer meets Eligibility Criteria|2|||
48589628|NCT01857102|156350603|FG000|Period 1|Lost to Follow-up|0|||
48589629|NCT01857102|156350604|FG001|Period 1|Lost to Follow-up|3|||
48589630|NCT01857102|156350603|FG000|Period 1|Unsatisfactory Lens Fit|1|||
48589631|NCT01857102|156350604|FG001|Period 1|Unsatisfactory Lens Fit|0|||
48589632|NCT01857102|156350603|FG000|Period 1|Unsatisfactory Visual Response|1|||
48589633|NCT01857102|156350604|FG001|Period 1|Unsatisfactory Visual Response|0|||
48589634|NCT01857102|156350603|FG000|Period 1|Physician Decision|1|||
48589635|NCT01857102|156350604|FG001|Period 1|Physician Decision|0|||
48589636|NCT01857102|156350603|FG000|Period 2|Lens Discomfort|1|||
48589637|NCT01857102|156350604|FG001|Period 2|Lens Discomfort|0|||
48589638|NCT01857102|156350603|FG000|Period 2|Unsatisfactory Lens Fit|1|||
48589639|NCT01857102|156350604|FG001|Period 2|Unsatisfactory Lens Fit|0|||
48589640|NCT00926536|156350605|FG000|Overall Study|Physician Decision|1|||
48589641|NCT00926536|156350606|FG001|Overall Study|Physician Decision|2|||
48589642|NCT01863732|156350610|FG000|Overall Study|Adverse Event|2|||
48589643|NCT01863732|156350611|FG001|Overall Study|Adverse Event|0|||
48589644|NCT01863732|156350612|FG002|Overall Study|Adverse Event|3|||
48589645|NCT01863732|156350613|FG003|Overall Study|Adverse Event|3|||
48589646|NCT01863732|156350610|FG000|Overall Study|Lack of Efficacy|1|||
48589647|NCT01863732|156350611|FG001|Overall Study|Lack of Efficacy|0|||
48589648|NCT01863732|156350612|FG002|Overall Study|Lack of Efficacy|2|||
48589649|NCT01863732|156350613|FG003|Overall Study|Lack of Efficacy|1|||
48589650|NCT01863732|156350610|FG000|Overall Study|Lost to Follow-up|2|||
48589651|NCT01863732|156350611|FG001|Overall Study|Lost to Follow-up|2|||
48589652|NCT01863732|156350612|FG002|Overall Study|Lost to Follow-up|1|||
48589653|NCT01863732|156350613|FG003|Overall Study|Lost to Follow-up|1|||
48589654|NCT01863732|156350610|FG000|Overall Study|Physician Decision|1|||
48589655|NCT01863732|156350611|FG001|Overall Study|Physician Decision|0|||
48589656|NCT01863732|156350612|FG002|Overall Study|Physician Decision|1|||
48589657|NCT01863732|156350613|FG003|Overall Study|Physician Decision|0|||
48589658|NCT01863732|156350610|FG000|Overall Study|Pregnancy|0|||
48589659|NCT01863732|156350611|FG001|Overall Study|Pregnancy|0|||
48589660|NCT01863732|156350612|FG002|Overall Study|Pregnancy|0|||
48589661|NCT01863732|156350613|FG003|Overall Study|Pregnancy|1|||
48589662|NCT01863732|156350610|FG000|Overall Study|Technical problems|0|||
48589663|NCT01863732|156350611|FG001|Overall Study|Technical problems|1|||
48589664|NCT01863732|156350612|FG002|Overall Study|Technical problems|1|||
48589665|NCT01863732|156350613|FG003|Overall Study|Technical problems|0|||
48589666|NCT01863732|156350610|FG000|Overall Study|Subject/guardian decision|6|||
48589667|NCT01863732|156350611|FG001|Overall Study|Subject/guardian decision|9|||
48380368|NCT01717768|155588421|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380369|NCT01717768|155588422|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380370|NCT01717768|155588423|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380371|NCT01717768|155588424|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380372|NCT01717768|155588425|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380373|NCT01717768|155588426|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380374|NCT01717768|155588427|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380375|NCT01717768|155588428|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
48380376|NCT01717768|155588417|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380377|NCT01717768|155588418|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380378|NCT01717768|155588419|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380379|NCT01717768|155588420|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380380|NCT01717768|155588421|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380381|NCT01717768|155588422|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380382|NCT01717768|155588423|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380383|NCT01717768|155588424|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380384|NCT01717768|155588425|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380385|NCT01717768|155588426|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380386|NCT01717768|155588427|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
48380387|NCT01717768|155588428|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
48380388|NCT01717768|155588417|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380389|NCT01717768|155588418|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380390|NCT01717768|155588419|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380391|NCT01717768|155588420|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380392|NCT01717768|155588421|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380393|NCT01717768|155588422|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48451247|NCT00355134|155841606|FG003|Core Phase|Lost to Follow-up|0|||
48589668|NCT01863732|156350612|FG002|Overall Study|Subject/guardian decision|3|||
48589669|NCT01863732|156350613|FG003|Overall Study|Subject/guardian decision|1|||
48589670|NCT01863732|156350610|FG000|Overall Study|Death|1|||
48589671|NCT01863732|156350611|FG001|Overall Study|Death|0|||
48589672|NCT01863732|156350612|FG002|Overall Study|Death|0|||
48589673|NCT01863732|156350613|FG003|Overall Study|Death|1|||
48589674|NCT02155322|156350614|FG000|Overall Study|Adverse Event|1|||
48589675|NCT02155322|156350614|FG000|Overall Study|Physician Decision|1|||
48589676|NCT02155322|156350614|FG000|Overall Study|Relapse/Recurrence|8|||
48589677|NCT02155322|156350614|FG000|Overall Study|Withdrawal by Subject|4|||
48589678|NCT01578499|156350615|FG000|Overall Study|Reason not Specified|0|||
48589679|NCT01578499|156350616|FG001|Overall Study|Reason not Specified|1|||
48589680|NCT01578499|156350615|FG000|Overall Study|Lost to Follow-up|2|||
48589681|NCT01578499|156350616|FG001|Overall Study|Lost to Follow-up|1|||
48589682|NCT01578499|156350615|FG000|Overall Study|Withdrawal by Subject|10|||
48589683|NCT01578499|156350616|FG001|Overall Study|Withdrawal by Subject|16|||
48589684|NCT01578499|156350615|FG000|Overall Study|Death|20|||
48589685|NCT01578499|156350616|FG001|Overall Study|Death|25|||
48589686|NCT01578499|156350615|FG000|Overall Study|Died and End of Study Page not Completed|2|||
48589687|NCT01578499|156350616|FG001|Overall Study|Died and End of Study Page not Completed|0|||
48589688|NCT00636961|156350617|FG000|Period 1|Administrative problems|1|||
48589689|NCT00636961|156350618|FG001|Period 1|Administrative problems|1|||
48589690|NCT00636961|156350617|FG000|Period 2|Adverse Event|1|||
48589691|NCT00636961|156350618|FG001|Period 2|Adverse Event|0|||
48589692|NCT01900899|156350619|FG000|Overall Study|Withdrawal by Subject|7|||
48589693|NCT01900899|156350620|FG001|Overall Study|Withdrawal by Subject|1|||
48589694|NCT01900899|156350619|FG000|Overall Study|Migrated from study area|2|||
48589695|NCT01900899|156350620|FG001|Overall Study|Migrated from study area|0|||
48589696|NCT03877224|156350621|FG000|Overall Study|Death|3|||
48589697|NCT03877224|156350622|FG001|Overall Study|Death|2|||
48589698|NCT03877224|156350621|FG000|Overall Study|Withdrawal by Subject|1|||
48589699|NCT03877224|156350622|FG001|Overall Study|Withdrawal by Subject|6|||
48589700|NCT03877224|156350621|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
48589701|NCT03877224|156350622|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
48589702|NCT00978341|156350623|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
48589703|NCT00978341|156350624|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
48589704|NCT03749109|156350632|FG000|Overall Study|Adverse Event|2|||
48589705|NCT03749109|156350633|FG001|Overall Study|Adverse Event|0|||
48589706|NCT02634983|156350634|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
48589707|NCT02634983|156350635|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
48589708|NCT01243177|156350636|FG000|Overall Study|Lack of Efficacy|47|||
48589709|NCT01243177|156350637|FG001|Overall Study|Lack of Efficacy|31|||
48589710|NCT01243177|156350636|FG000|Overall Study|Protocol Violation|11|||
48589711|NCT01243177|156350637|FG001|Overall Study|Protocol Violation|10|||
48589712|NCT01243177|156350636|FG000|Overall Study|Lost to Follow-up|15|||
48589713|NCT01243177|156350637|FG001|Overall Study|Lost to Follow-up|18|||
48589714|NCT01243177|156350636|FG000|Overall Study|Withdrawal by Subject|46|||
48589715|NCT01243177|156350637|FG001|Overall Study|Withdrawal by Subject|38|||
48589716|NCT01243177|156350636|FG000|Overall Study|AE, serious fatal|0|||
48589717|NCT01243177|156350637|FG001|Overall Study|AE, serious fatal|1|||
48589718|NCT01243177|156350636|FG000|Overall Study|SAE, non-fatal|7|||
48589719|NCT01243177|156350637|FG001|Overall Study|SAE, non-fatal|9|||
48589720|NCT01243177|156350636|FG000|Overall Study|AE, non-serious non-fatal|40|||
48589721|NCT01243177|156350637|FG001|Overall Study|AE, non-serious non-fatal|58|||
48589722|NCT01243177|156350636|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
48589723|NCT01243177|156350637|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
48589724|NCT01243177|156350636|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48589725|NCT01243177|156350637|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
48589726|NCT01243177|156350636|FG000|Overall Study|Other Reason|11|||
48589727|NCT01243177|156350637|FG001|Overall Study|Other Reason|12|||
48589728|NCT02513394|156350639|FG000|Overall Study|Withdrawal by Subject|11|||
48589729|NCT02513394|156350640|FG001|Overall Study|Withdrawal by Subject|23|||
48589730|NCT02513394|156350639|FG000|Overall Study|Ineligible|1|||
48589731|NCT02513394|156350640|FG001|Overall Study|Ineligible|0|||
48589732|NCT04445831|156350641|FG000|Overall Study|Withdrawal by Subject|2|||
48589733|NCT04445831|156350642|FG001|Overall Study|Withdrawal by Subject|1|||
48589734|NCT04445831|156350643|FG002|Overall Study|Withdrawal by Subject|1|||
48589735|NCT04445831|156350644|FG003|Overall Study|Withdrawal by Subject|0|||
48589736|NCT04445831|156350645|FG004|Overall Study|Withdrawal by Subject|0|||
48589737|NCT04445831|156350646|FG005|Overall Study|Withdrawal by Subject|0|||
48589738|NCT04445831|156350647|FG006|Overall Study|Withdrawal by Subject|0|||
48589739|NCT04445831|156350641|FG000|Overall Study|Subject withdrawal by caregiver|0|||
48589740|NCT04445831|156350642|FG001|Overall Study|Subject withdrawal by caregiver|1|||
48589741|NCT04445831|156350643|FG002|Overall Study|Subject withdrawal by caregiver|0|||
48589742|NCT04445831|156350644|FG003|Overall Study|Subject withdrawal by caregiver|0|||
48589743|NCT04445831|156350645|FG004|Overall Study|Subject withdrawal by caregiver|0|||
48589744|NCT04445831|156350646|FG005|Overall Study|Subject withdrawal by caregiver|0|||
48589745|NCT04445831|156350647|FG006|Overall Study|Subject withdrawal by caregiver|0|||
48589746|NCT05704725|156350648|FG000|Overall Study|Lost to Follow-up|0|||
48589747|NCT05704725|156350649|FG001|Overall Study|Lost to Follow-up|1|||
48589748|NCT05704725|156350648|FG000|Overall Study|Withdrawal by Subject|1|||
48589749|NCT05704725|156350649|FG001|Overall Study|Withdrawal by Subject|0|||
48589750|NCT02039401|156350650|FG000|Overall Study|Adverse Event|0|||
48589751|NCT02039401|156350651|FG001|Overall Study|Adverse Event|1|||
48589752|NCT04937504|156350652|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
48589753|NCT04937504|156350653|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
48589754|NCT04937504|156350652|FG000|9 Months Assessment|Lost to Follow-up|3|||
48589755|NCT04937504|156350653|FG001|9 Months Assessment|Lost to Follow-up|2|||
48589756|NCT04191096|156350654|FG000|Overall Study|Death|102|||
48589757|NCT04191096|156350655|FG001|Overall Study|Death|89|||
48589758|NCT04191096|156350654|FG000|Overall Study|Lost to Follow-up|1|||
48589759|NCT04191096|156350655|FG001|Overall Study|Lost to Follow-up|1|||
48589760|NCT04191096|156350654|FG000|Overall Study|Withdrawal by Subject|5|||
48589761|NCT04191096|156350655|FG001|Overall Study|Withdrawal by Subject|5|||
48589762|NCT04191096|156350654|FG000|Overall Study|Participants Ongoing|518|||
48589763|NCT04191096|156350655|FG001|Overall Study|Participants Ongoing|530|||
48380394|NCT01717768|155588423|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380395|NCT01717768|155588424|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
48380396|NCT01717768|155588425|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380397|NCT01717768|155588426|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48589764|NCT05470114|156350656|FG000|Overall Study|Withdrawal by Subject|1|||
48380398|NCT01717768|155588427|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380399|NCT01717768|155588428|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
48380400|NCT01717768|155588417|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48380401|NCT01717768|155588418|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48380402|NCT01717768|155588419|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48380403|NCT01717768|155588420|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48589765|NCT05470114|156350657|FG001|Overall Study|Withdrawal by Subject|0|||
48589766|NCT05470114|156350656|FG000|Overall Study|Lost to Follow-up|1|||
48589767|NCT05470114|156350657|FG001|Overall Study|Lost to Follow-up|0|||
48589768|NCT00703118|156352134|FG000|Overall Study|Adverse Event|1|||
48589769|NCT00703118|156352135|FG001|Overall Study|Adverse Event|2|||
48589770|NCT00703118|156352136|FG002|Overall Study|Adverse Event|2|||
48589771|NCT00703118|156352134|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
48589772|NCT00703118|156352135|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
48589773|NCT00703118|156352136|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
48589774|NCT00703118|156352134|FG000|Overall Study|Lost to Follow-up|6|||
48589775|NCT00703118|156352135|FG001|Overall Study|Lost to Follow-up|4|||
48589776|NCT00703118|156352136|FG002|Overall Study|Lost to Follow-up|4|||
48589777|NCT00703118|156352134|FG000|Overall Study|Withdrawal by Subject|8|||
48380404|NCT01717768|155588421|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48589778|NCT00703118|156352135|FG001|Overall Study|Withdrawal by Subject|7|||
48589779|NCT00703118|156352136|FG002|Overall Study|Withdrawal by Subject|13|||
48589780|NCT00703118|156352134|FG000|Overall Study|Other|0|||
48589781|NCT00703118|156352135|FG001|Overall Study|Other|0|||
48589782|NCT00703118|156352136|FG002|Overall Study|Other|1|||
48589783|NCT02697734|156352143|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
48589784|NCT02697734|156352144|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
48589785|NCT02697734|156352143|FG000|Core Phase - up to Week 48|Adverse Event|1|||
48589786|NCT02697734|156352144|FG001|Core Phase - up to Week 48|Adverse Event|2|||
48589787|NCT02697734|156352143|FG000|Core Phase - up to Week 48|Physician Decision|1|||
48589788|NCT02697734|156352144|FG001|Core Phase - up to Week 48|Physician Decision|0|||
48589789|NCT02697734|156352143|FG000|Optional Extension Phase|Adverse Event|5|||
48380405|NCT01717768|155588422|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48589790|NCT02697734|156352144|FG001|Optional Extension Phase|Adverse Event|1|||
48589791|NCT02697734|156352143|FG000|Optional Extension Phase|Physician Decision|0|||
48589792|NCT02697734|156352144|FG001|Optional Extension Phase|Physician Decision|1|||
48589793|NCT02588664|156352147|FG000|Overall Study|Death|56|||
48589794|NCT02588664|156352148|FG001|Overall Study|Death|55|||
48589795|NCT02588664|156352147|FG000|Overall Study|Lost to Follow-up|1305|||
48589796|NCT02588664|156352148|FG001|Overall Study|Lost to Follow-up|990|||
48589797|NCT03411902|156352153|FG000|Overall Study|Lost to Follow-up|3|||
48589798|NCT03411902|156352154|FG001|Overall Study|Lost to Follow-up|0|||
48589799|NCT03681184|156352155|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
48589800|NCT03681184|156352156|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
48589801|NCT02334384|156352157|FG000|Overall Study|Lost to Follow-up|1|||
48589802|NCT02334384|156352158|FG001|Overall Study|Lost to Follow-up|1|||
48589803|NCT02651688|156352159|FG000|Overall Study|Non-compliance|0|||
48589804|NCT02651688|156352160|FG001|Overall Study|Non-compliance|0|||
48589805|NCT02651688|156352161|FG002|Overall Study|Non-compliance|1|||
48589806|NCT02651688|156352159|FG000|Overall Study|Principal Investigator (PI) decision|0|||
48589807|NCT02651688|156352160|FG001|Overall Study|Principal Investigator (PI) decision|2|||
48589808|NCT02651688|156352161|FG002|Overall Study|Principal Investigator (PI) decision|0|||
48589809|NCT02651688|156352159|FG000|Overall Study|Lost to Follow-up|1|||
48589810|NCT02651688|156352160|FG001|Overall Study|Lost to Follow-up|3|||
48589811|NCT02651688|156352161|FG002|Overall Study|Lost to Follow-up|0|||
48693085|NCT01602224|156726339|FG001|Overall Study|Investigator Decison|0|||
48589812|NCT02651688|156352159|FG000|Overall Study|Withdrawal by Subject|1|||
48589813|NCT02651688|156352160|FG001|Overall Study|Withdrawal by Subject|0|||
48380406|NCT01717768|155588423|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48380407|NCT01717768|155588424|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48380408|NCT01717768|155588425|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48380409|NCT01717768|155588426|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
48380410|NCT01717768|155588427|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48380411|NCT01717768|155588428|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
48380412|NCT01251120|155588430|FG000|Overall Study|Lack of Efficacy|0|||
48380413|NCT01251120|155588431|FG001|Overall Study|Lack of Efficacy|1|||
48380414|NCT01968070|155588432|FG000|Period 1|Withdrawal by Subject|0|||
48380415|NCT01968070|155588433|FG001|Period 1|Withdrawal by Subject|1|||
48380416|NCT01968070|155588434|FG002|Period 1|Withdrawal by Subject|0|||
48380417|NCT01968070|155588435|FG003|Period 1|Withdrawal by Subject|0|||
48380418|NCT01968070|155588436|FG004|Period 1|Withdrawal by Subject|0|||
48380419|NCT01968070|155588437|FG005|Period 1|Withdrawal by Subject|0|||
48380420|NCT01968070|155588438|FG006|Period 1|Withdrawal by Subject|1|||
48380421|NCT01968070|155588439|FG007|Period 1|Withdrawal by Subject|0|||
48380422|NCT01968070|155588440|FG008|Period 1|Withdrawal by Subject|0|||
48380423|NCT01968070|155588441|FG009|Period 1|Withdrawal by Subject|0|||
48380424|NCT01968070|155588442|FG010|Period 1|Withdrawal by Subject|0|||
48380425|NCT01968070|155588443|FG011|Period 1|Withdrawal by Subject|0|||
48380426|NCT01968070|155588444|FG012|Period 1|Withdrawal by Subject|0|||
48380427|NCT01968070|155588445|FG013|Period 1|Withdrawal by Subject|0|||
48380428|NCT01968070|155588446|FG014|Period 1|Withdrawal by Subject|0|||
48380429|NCT01968070|155588447|FG015|Period 1|Withdrawal by Subject|1|||
48380430|NCT01968070|155588448|FG016|Period 1|Withdrawal by Subject|0|||
48380431|NCT01968070|155588449|FG017|Period 1|Withdrawal by Subject|0|||
48380432|NCT01968070|155588432|FG000|Period 1|Protocol Violation|0|||
48380433|NCT01968070|155588433|FG001|Period 1|Protocol Violation|0|||
48380434|NCT01968070|155588434|FG002|Period 1|Protocol Violation|0|||
48380435|NCT01968070|155588435|FG003|Period 1|Protocol Violation|1|||
48380436|NCT01968070|155588436|FG004|Period 1|Protocol Violation|1|||
48380437|NCT01968070|155588437|FG005|Period 1|Protocol Violation|0|||
48380438|NCT01968070|155588438|FG006|Period 1|Protocol Violation|0|||
48380439|NCT01968070|155588439|FG007|Period 1|Protocol Violation|0|||
48380440|NCT01968070|155588440|FG008|Period 1|Protocol Violation|0|||
48380441|NCT01968070|155588441|FG009|Period 1|Protocol Violation|0|||
48380442|NCT01968070|155588442|FG010|Period 1|Protocol Violation|0|||
48380443|NCT01968070|155588443|FG011|Period 1|Protocol Violation|0|||
48380444|NCT01968070|155588444|FG012|Period 1|Protocol Violation|0|||
48380445|NCT01968070|155588445|FG013|Period 1|Protocol Violation|0|||
48380446|NCT01968070|155588446|FG014|Period 1|Protocol Violation|0|||
48380447|NCT01968070|155588447|FG015|Period 1|Protocol Violation|0|||
48380448|NCT01968070|155588448|FG016|Period 1|Protocol Violation|0|||
48380449|NCT01968070|155588449|FG017|Period 1|Protocol Violation|0|||
48380450|NCT01968070|155588432|FG000|Period 1|Lost to Follow-up|0|||
48380451|NCT01968070|155588433|FG001|Period 1|Lost to Follow-up|0|||
48380452|NCT01968070|155588434|FG002|Period 1|Lost to Follow-up|0|||
48380453|NCT01968070|155588435|FG003|Period 1|Lost to Follow-up|1|||
48380454|NCT01968070|155588436|FG004|Period 1|Lost to Follow-up|0|||
48380455|NCT01968070|155588437|FG005|Period 1|Lost to Follow-up|0|||
48380456|NCT01968070|155588438|FG006|Period 1|Lost to Follow-up|0|||
48380457|NCT01968070|155588439|FG007|Period 1|Lost to Follow-up|0|||
48380458|NCT01968070|155588440|FG008|Period 1|Lost to Follow-up|0|||
48380459|NCT01968070|155588441|FG009|Period 1|Lost to Follow-up|0|||
48380460|NCT01968070|155588442|FG010|Period 1|Lost to Follow-up|0|||
48380461|NCT01968070|155588443|FG011|Period 1|Lost to Follow-up|0|||
48380462|NCT01968070|155588444|FG012|Period 1|Lost to Follow-up|0|||
48380463|NCT01968070|155588445|FG013|Period 1|Lost to Follow-up|0|||
48380464|NCT01968070|155588446|FG014|Period 1|Lost to Follow-up|0|||
48380465|NCT01968070|155588447|FG015|Period 1|Lost to Follow-up|0|||
48380466|NCT01968070|155588448|FG016|Period 1|Lost to Follow-up|0|||
48798450|NCT03076970|157100472|FG001|Washout Period 2|Adverse Event|0|||
48798451|NCT03076970|157100473|FG002|Washout Period 2|Adverse Event|0|||
48380467|NCT01968070|155588449|FG017|Period 1|Lost to Follow-up|0|||
48380468|NCT01968070|155588432|FG000|Period 1|Adverse Event|0|||
48380469|NCT01968070|155588433|FG001|Period 1|Adverse Event|0|||
48380470|NCT01968070|155588434|FG002|Period 1|Adverse Event|0|||
48380471|NCT01968070|155588435|FG003|Period 1|Adverse Event|0|||
48380472|NCT01968070|155588436|FG004|Period 1|Adverse Event|0|||
48380473|NCT01968070|155588437|FG005|Period 1|Adverse Event|0|||
48380474|NCT01968070|155588438|FG006|Period 1|Adverse Event|1|||
48380475|NCT01968070|155588439|FG007|Period 1|Adverse Event|0|||
48380476|NCT01968070|155588440|FG008|Period 1|Adverse Event|0|||
48380477|NCT01968070|155588441|FG009|Period 1|Adverse Event|0|||
48380478|NCT01968070|155588442|FG010|Period 1|Adverse Event|0|||
48380479|NCT01968070|155588443|FG011|Period 1|Adverse Event|0|||
48380480|NCT01968070|155588444|FG012|Period 1|Adverse Event|0|||
48380481|NCT01968070|155588445|FG013|Period 1|Adverse Event|0|||
48380482|NCT01968070|155588446|FG014|Period 1|Adverse Event|0|||
48380483|NCT01968070|155588447|FG015|Period 1|Adverse Event|0|||
48380484|NCT01968070|155588448|FG016|Period 1|Adverse Event|0|||
48380485|NCT01968070|155588449|FG017|Period 1|Adverse Event|0|||
48380486|NCT01968070|155588432|FG000|Period 1|Physician Decision|0|||
48380487|NCT01968070|155588433|FG001|Period 1|Physician Decision|0|||
48380488|NCT01968070|155588434|FG002|Period 1|Physician Decision|0|||
48380489|NCT01968070|155588435|FG003|Period 1|Physician Decision|0|||
48380490|NCT01968070|155588436|FG004|Period 1|Physician Decision|0|||
48380491|NCT01968070|155588437|FG005|Period 1|Physician Decision|0|||
48380492|NCT01968070|155588438|FG006|Period 1|Physician Decision|0|||
48380493|NCT01968070|155588439|FG007|Period 1|Physician Decision|0|||
48380494|NCT01968070|155588440|FG008|Period 1|Physician Decision|0|||
48380495|NCT01968070|155588441|FG009|Period 1|Physician Decision|0|||
48380496|NCT01968070|155588442|FG010|Period 1|Physician Decision|0|||
48380497|NCT01968070|155588443|FG011|Period 1|Physician Decision|1|||
48380498|NCT01968070|155588444|FG012|Period 1|Physician Decision|0|||
48380499|NCT01968070|155588445|FG013|Period 1|Physician Decision|0|||
48380500|NCT01968070|155588446|FG014|Period 1|Physician Decision|0|||
48380501|NCT01968070|155588447|FG015|Period 1|Physician Decision|0|||
48380502|NCT01968070|155588448|FG016|Period 1|Physician Decision|0|||
48380503|NCT01968070|155588449|FG017|Period 1|Physician Decision|0|||
48380504|NCT01968070|155588432|FG000|Period 2|Withdrawal by Subject|0|||
48380505|NCT01968070|155588433|FG001|Period 2|Withdrawal by Subject|0|||
48380506|NCT01968070|155588434|FG002|Period 2|Withdrawal by Subject|0|||
48380507|NCT01968070|155588435|FG003|Period 2|Withdrawal by Subject|0|||
48380508|NCT01968070|155588436|FG004|Period 2|Withdrawal by Subject|1|||
48380509|NCT01968070|155588437|FG005|Period 2|Withdrawal by Subject|0|||
48380510|NCT01968070|155588438|FG006|Period 2|Withdrawal by Subject|0|||
48380511|NCT01968070|155588439|FG007|Period 2|Withdrawal by Subject|0|||
48380512|NCT01968070|155588440|FG008|Period 2|Withdrawal by Subject|0|||
48380513|NCT01968070|155588441|FG009|Period 2|Withdrawal by Subject|0|||
48380514|NCT01968070|155588442|FG010|Period 2|Withdrawal by Subject|0|||
48380515|NCT01968070|155588443|FG011|Period 2|Withdrawal by Subject|0|||
48380516|NCT01968070|155588444|FG012|Period 2|Withdrawal by Subject|0|||
48380517|NCT01968070|155588445|FG013|Period 2|Withdrawal by Subject|0|||
48380518|NCT01968070|155588446|FG014|Period 2|Withdrawal by Subject|0|||
48380519|NCT01968070|155588447|FG015|Period 2|Withdrawal by Subject|0|||
48380520|NCT01968070|155588448|FG016|Period 2|Withdrawal by Subject|0|||
48380521|NCT01968070|155588449|FG017|Period 2|Withdrawal by Subject|0|||
48380522|NCT01774084|155588450|FG000|Overall Study|Personal reasons|1|||
48380523|NCT01774084|155588451|FG001|Overall Study|Personal reasons|0|||
48380524|NCT01387230|155588452|FG000|Overall Study|Adverse Event|0|||
48380525|NCT01387230|155588453|FG001|Overall Study|Adverse Event|1|||
48380526|NCT01387230|155588454|FG002|Overall Study|Adverse Event|3|||
48380527|NCT01387230|155588452|FG000|Overall Study|Lack of Efficacy|8|||
48380528|NCT01387230|155588453|FG001|Overall Study|Lack of Efficacy|5|||
48798452|NCT03076970|157100474|FG003|Washout Period 2|Adverse Event|0|||
48798453|NCT03076970|157100475|FG004|Washout Period 2|Adverse Event|1|||
48798454|NCT03076970|157100476|FG005|Washout Period 2|Adverse Event|0|||
48798455|NCT03076970|157100471|FG000|Period 3|Withdrawal by Subject|0|||
48798456|NCT03076970|157100472|FG001|Period 3|Withdrawal by Subject|0|||
48798457|NCT03076970|157100473|FG002|Period 3|Withdrawal by Subject|0|||
48798458|NCT03076970|157100474|FG003|Period 3|Withdrawal by Subject|0|||
48798459|NCT03076970|157100475|FG004|Period 3|Withdrawal by Subject|0|||
48798460|NCT03076970|157100476|FG005|Period 3|Withdrawal by Subject|1|||
48798461|NCT03076970|157100471|FG000|Period 3|Failure to meet I/E criteria|0|||
48798462|NCT03076970|157100472|FG001|Period 3|Failure to meet I/E criteria|0|||
48798463|NCT03076970|157100473|FG002|Period 3|Failure to meet I/E criteria|0|||
48798464|NCT03076970|157100474|FG003|Period 3|Failure to meet I/E criteria|0|||
48798465|NCT03076970|157100475|FG004|Period 3|Failure to meet I/E criteria|1|||
48798466|NCT03076970|157100476|FG005|Period 3|Failure to meet I/E criteria|0|||
48798467|NCT01345630|157100478|FG000|Overall Study|Adverse Event|22|||
48380529|NCT01387230|155588454|FG002|Overall Study|Lack of Efficacy|4|||
48380530|NCT01387230|155588452|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
48380531|NCT01387230|155588453|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
48380532|NCT01387230|155588454|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
48798468|NCT01345630|157100479|FG001|Overall Study|Adverse Event|23|||
48798469|NCT01345630|157100478|FG000|Overall Study|Lost to Follow-up|17|||
48380533|NCT01387230|155588452|FG000|Overall Study|Lost to Follow-up|0|||
48380534|NCT01387230|155588453|FG001|Overall Study|Lost to Follow-up|0|||
48380535|NCT01387230|155588454|FG002|Overall Study|Lost to Follow-up|1|||
48380536|NCT01387230|155588452|FG000|Overall Study|Withdrawal by Subject|4|||
48380537|NCT01387230|155588453|FG001|Overall Study|Withdrawal by Subject|1|||
48380538|NCT01387230|155588454|FG002|Overall Study|Withdrawal by Subject|0|||
48798470|NCT01345630|157100479|FG001|Overall Study|Lost to Follow-up|16|||
48380539|NCT01055262|155588460|FG000|Overall Study|Adverse Event|5|||
48380540|NCT01055262|155588460|FG000|Overall Study|Protocol Violation|3|||
48380541|NCT01055262|155588460|FG000|Overall Study|Uncooperativeness|1|||
48380542|NCT02678416|155588463|FG000|Part 1|Withdrawal by Subject|1|||
48380543|NCT02678416|155588463|FG000|Part 2|Adverse Event|2|||
48380544|NCT02678416|155588463|FG000|Part 2|Withdrawal by Subject|1|||
48380545|NCT02030405|155588464|FG000|Overall Study|Withdrawal by Subject|1|||
48380546|NCT02030405|155588464|FG000|Overall Study|Lost to Follow-up|1|||
48380547|NCT00972777|155588465|FG000|Overall Study|Adverse Event|3|||
48693086|NCT01602224|156726340|FG002|Overall Study|Investigator Decison|0|||
48798471|NCT01345630|157100478|FG000|Overall Study|Protocol Violation|4|||
48798472|NCT01345630|157100479|FG001|Overall Study|Protocol Violation|1|||
48798473|NCT01345630|157100478|FG000|Overall Study|Medication error without associated AE|0|||
48798474|NCT01345630|157100479|FG001|Overall Study|Medication error without associated AE|1|||
48798475|NCT01345630|157100478|FG000|Overall Study|Study terminated by sponsor|254|||
48798476|NCT01345630|157100479|FG001|Overall Study|Study terminated by sponsor|285|||
48798477|NCT01345630|157100478|FG000|Overall Study|Other reasons|6|||
48798478|NCT01345630|157100479|FG001|Overall Study|Other reasons|8|||
48798479|NCT01345630|157100478|FG000|Overall Study|Withdrawn due to pregnancy|1|||
48798480|NCT01345630|157100479|FG001|Overall Study|Withdrawn due to pregnancy|2|||
48798481|NCT01345630|157100478|FG000|Overall Study|No longer willing to participate|9|||
48798482|NCT01345630|157100479|FG001|Overall Study|No longer willing to participate|12|||
48798483|NCT01345630|157100478|FG000|Overall Study|Insufficient clinical response|48|||
48798484|NCT01345630|157100479|FG001|Overall Study|Insufficient clinical response|11|||
48798485|NCT02119260|157100482|FG000|Overall Study|Adverse Event|1|||
48798486|NCT02119260|157100483|FG001|Overall Study|Adverse Event|0|||
48798487|NCT02119260|157100484|FG002|Overall Study|Adverse Event|0|||
48798488|NCT02119260|157100485|FG003|Overall Study|Adverse Event|0|||
48798489|NCT02119260|157100486|FG004|Overall Study|Adverse Event|0|||
48798490|NCT02119260|157100487|FG005|Overall Study|Adverse Event|0|||
48798491|NCT02119260|157100488|FG006|Overall Study|Adverse Event|0|||
48798492|NCT02119260|157100482|FG000|Overall Study|Withdrew consent|0|||
48798493|NCT02119260|157100483|FG001|Overall Study|Withdrew consent|1|||
48798494|NCT02119260|157100484|FG002|Overall Study|Withdrew consent|1|||
48798495|NCT02119260|157100485|FG003|Overall Study|Withdrew consent|0|||
48798496|NCT02119260|157100486|FG004|Overall Study|Withdrew consent|0|||
48798497|NCT02119260|157100487|FG005|Overall Study|Withdrew consent|0|||
48798498|NCT02119260|157100488|FG006|Overall Study|Withdrew consent|0|||
48798499|NCT02057874|157100489|FG000|Overall Study|participant did not return for scan|1|||
48798500|NCT01266850|157100513|FG000|Overall Study|Lost to Follow-up|19|||
48798501|NCT01266850|157100514|FG001|Overall Study|Lost to Follow-up|19|||
48798502|NCT01266850|157100515|FG002|Overall Study|Lost to Follow-up|13|||
48798503|NCT01266850|157100516|FG003|Overall Study|Lost to Follow-up|13|||
48798504|NCT01266850|157100517|FG004|Overall Study|Lost to Follow-up|12|||
48798505|NCT01266850|157100513|FG000|Overall Study|Withdrawal by Subject|8|||
48798506|NCT01266850|157100514|FG001|Overall Study|Withdrawal by Subject|9|||
48798507|NCT01266850|157100515|FG002|Overall Study|Withdrawal by Subject|6|||
48798508|NCT01266850|157100516|FG003|Overall Study|Withdrawal by Subject|9|||
48798509|NCT01266850|157100517|FG004|Overall Study|Withdrawal by Subject|12|||
48798510|NCT01266850|157100513|FG000|Overall Study|Physician Decision|3|||
48798511|NCT01266850|157100514|FG001|Overall Study|Physician Decision|6|||
48798512|NCT01266850|157100515|FG002|Overall Study|Physician Decision|4|||
48798513|NCT01266850|157100516|FG003|Overall Study|Physician Decision|4|||
48798514|NCT01266850|157100517|FG004|Overall Study|Physician Decision|3|||
48798515|NCT01266850|157100513|FG000|Overall Study|Protocol Violation|0|||
48798516|NCT01266850|157100514|FG001|Overall Study|Protocol Violation|1|||
48798517|NCT01266850|157100515|FG002|Overall Study|Protocol Violation|0|||
48798518|NCT01266850|157100516|FG003|Overall Study|Protocol Violation|1|||
48798519|NCT01266850|157100517|FG004|Overall Study|Protocol Violation|2|||
48798520|NCT01266850|157100513|FG000|Overall Study|Adverse Event|0|||
48798521|NCT01266850|157100514|FG001|Overall Study|Adverse Event|0|||
48798522|NCT01266850|157100515|FG002|Overall Study|Adverse Event|0|||
48798523|NCT01266850|157100516|FG003|Overall Study|Adverse Event|0|||
48798524|NCT01266850|157100517|FG004|Overall Study|Adverse Event|1|||
48798525|NCT01266850|157100513|FG000|Overall Study|Site Closure|0|||
48798526|NCT01266850|157100514|FG001|Overall Study|Site Closure|1|||
48798527|NCT01266850|157100515|FG002|Overall Study|Site Closure|1|||
48798528|NCT01266850|157100516|FG003|Overall Study|Site Closure|1|||
48798529|NCT01266850|157100517|FG004|Overall Study|Site Closure|0|||
48798530|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
48798531|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
48798532|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
48693087|NCT01602224|156726338|FG000|Overall Study|Lost to Follow-up|0|||
48798533|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
48798534|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
48798535|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
48798536|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Death|1|||
48380548|NCT00972777|155588466|FG001|Overall Study|Adverse Event|2|||
48380549|NCT00972777|155588465|FG000|Overall Study|Lost to Follow-up|0|||
48798537|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Death|0|||
48798538|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Adverse Event|1|||
48798539|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Adverse Event|0|||
48798540|NCT02586025|157100520|FG000|Neoadjuvant Treatment|Physician Decision|2|||
48798541|NCT02586025|157100521|FG001|Neoadjuvant Treatment|Physician Decision|1|||
48798542|NCT02586025|157100520|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
48798543|NCT02586025|157100521|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
48798544|NCT02586025|157100520|FG000|Adjuvant Treatment|Recurrent Disease|4|||
48798545|NCT02586025|157100521|FG001|Adjuvant Treatment|Recurrent Disease|5|||
48798546|NCT02586025|157100520|FG000|Adjuvant Treatment|Physician Decision|0|||
48798547|NCT02586025|157100521|FG001|Adjuvant Treatment|Physician Decision|1|||
48798548|NCT02586025|157100520|FG000|Adjuvant Treatment|Pregnancy|1|||
48798549|NCT02586025|157100521|FG001|Adjuvant Treatment|Pregnancy|0|||
48798550|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Death|11|||
48798551|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Death|11|||
48798552|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
48798553|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
48798554|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
48798555|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
48798556|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
48798557|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
48798558|NCT02586025|157100520|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
48798559|NCT02586025|157100521|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
48798560|NCT03014674|157100523|FG000|Overall Study|Withdrawal by Subject|1|||
48798561|NCT03014674|157100524|FG001|Overall Study|Withdrawal by Subject|0|||
48798562|NCT03014674|157100525|FG002|Overall Study|Withdrawal by Subject|0|||
48798563|NCT02173548|157100531|FG000|Overall Study|Lost to Follow-up|0|||
48798564|NCT02173548|157100532|FG001|Overall Study|Lost to Follow-up|2|||
48798565|NCT02173548|157100531|FG000|Overall Study|Withdrawal by Subject|1|||
48798566|NCT02173548|157100532|FG001|Overall Study|Withdrawal by Subject|0|||
48798567|NCT01621126|157100533|FG000|Overall Study|Physician Decision|6|||
48798568|NCT03751631|157100534|FG000|Overall Study|Withdrawal by Subject|0|||
48798569|NCT03751631|157100535|FG001|Overall Study|Withdrawal by Subject|0|||
48798570|NCT03751631|157100536|FG002|Overall Study|Withdrawal by Subject|1|||
48798571|NCT03751631|157100537|FG003|Overall Study|Withdrawal by Subject|1|||
48798572|NCT03751631|157100538|FG004|Overall Study|Withdrawal by Subject|0|||
48798573|NCT03751631|157100539|FG005|Overall Study|Withdrawal by Subject|0|||
48798574|NCT03382782|157100540|FG000|Cohort 1|Withdrawal by Subject|11|||
48798575|NCT03382782|157100541|FG001|Cohort 1|Withdrawal by Subject|5|||
48798576|NCT03382782|157100542|FG002|Cohort 1|Withdrawal by Subject|0|||
48798577|NCT03382782|157100540|FG000|Cohort 2|Withdrawal by Subject|1|||
48798578|NCT03382782|157100541|FG001|Cohort 2|Withdrawal by Subject|1|||
48798579|NCT03382782|157100542|FG002|Cohort 2|Withdrawal by Subject|0|||
48798580|NCT03382782|157100540|FG000|Cohort 3|Withdrawal by Subject|1|||
48798581|NCT03382782|157100541|FG001|Cohort 3|Withdrawal by Subject|2|||
48798582|NCT03382782|157100542|FG002|Cohort 3|Withdrawal by Subject|0|||
48798583|NCT00428090|157100545|FG000|Overall Study|Adverse Event|10|||
48798584|NCT00428090|157100546|FG001|Overall Study|Adverse Event|8|||
48798585|NCT00428090|157100547|FG002|Overall Study|Adverse Event|10|||
48798586|NCT00428090|157100548|FG003|Overall Study|Adverse Event|11|||
48798587|NCT00428090|157100545|FG000|Overall Study|Lost to Follow-up|3|||
48798588|NCT00428090|157100546|FG001|Overall Study|Lost to Follow-up|6|||
48798589|NCT00428090|157100547|FG002|Overall Study|Lost to Follow-up|1|||
48693088|NCT01602224|156726339|FG001|Overall Study|Lost to Follow-up|0|||
48798590|NCT00428090|157100548|FG003|Overall Study|Lost to Follow-up|4|||
48798591|NCT00428090|157100545|FG000|Overall Study|Protocol Violation|3|||
48798592|NCT00428090|157100546|FG001|Overall Study|Protocol Violation|1|||
48798593|NCT00428090|157100547|FG002|Overall Study|Protocol Violation|3|||
48798594|NCT00428090|157100548|FG003|Overall Study|Protocol Violation|3|||
48798595|NCT00428090|157100545|FG000|Overall Study|Withdrawal by Subject|10|||
48798596|NCT00428090|157100546|FG001|Overall Study|Withdrawal by Subject|12|||
48798597|NCT00428090|157100547|FG002|Overall Study|Withdrawal by Subject|15|||
48798598|NCT00428090|157100548|FG003|Overall Study|Withdrawal by Subject|5|||
48798599|NCT00428090|157100545|FG000|Overall Study|Sponsor terminated study|0|||
48798600|NCT00428090|157100546|FG001|Overall Study|Sponsor terminated study|1|||
48798601|NCT00428090|157100547|FG002|Overall Study|Sponsor terminated study|0|||
48798602|NCT00428090|157100548|FG003|Overall Study|Sponsor terminated study|0|||
48798603|NCT00428090|157100545|FG000|Overall Study|Non-compliance|4|||
48798604|NCT00428090|157100546|FG001|Overall Study|Non-compliance|0|||
48798605|NCT00428090|157100547|FG002|Overall Study|Non-compliance|1|||
48798606|NCT00428090|157100548|FG003|Overall Study|Non-compliance|3|||
48798607|NCT00428090|157100545|FG000|Overall Study|Par. did not returned to visit|1|||
48798608|NCT00428090|157100546|FG001|Overall Study|Par. did not returned to visit|0|||
48798609|NCT00428090|157100547|FG002|Overall Study|Par. did not returned to visit|0|||
48798610|NCT00428090|157100548|FG003|Overall Study|Par. did not returned to visit|1|||
48693089|NCT01602224|156726340|FG002|Overall Study|Lost to Follow-up|1|||
48798611|NCT00428090|157100545|FG000|Overall Study|Follow-Up visit not possible|1|||
48798612|NCT00428090|157100546|FG001|Overall Study|Follow-Up visit not possible|0|||
48798613|NCT00428090|157100547|FG002|Overall Study|Follow-Up visit not possible|0|||
48798614|NCT00428090|157100548|FG003|Overall Study|Follow-Up visit not possible|0|||
48693090|NCT01602224|156726338|FG000|Overall Study|Protocol Violation|0|||
48693091|NCT01602224|156726339|FG001|Overall Study|Protocol Violation|1|||
48693092|NCT01602224|156726340|FG002|Overall Study|Protocol Violation|0|||
48693093|NCT01602224|156726338|FG000|Overall Study|Sponsor Decision|2|||
48693094|NCT01602224|156726339|FG001|Overall Study|Sponsor Decision|3|||
48693095|NCT01602224|156726340|FG002|Overall Study|Sponsor Decision|2|||
48693096|NCT01602224|156726338|FG000|Overall Study|Withdrawal by Subject|5|||
48693097|NCT01602224|156726339|FG001|Overall Study|Withdrawal by Subject|3|||
48693098|NCT01602224|156726340|FG002|Overall Study|Withdrawal by Subject|3|||
48693099|NCT04564846|156726343|FG000|Overall Study|Withdrawal by Subject|2|||
48693100|NCT04564846|156726344|FG001|Overall Study|Withdrawal by Subject|1|||
48693101|NCT04564846|156726343|FG000|Overall Study|Physician Decision|0|||
48693102|NCT04564846|156726344|FG001|Overall Study|Physician Decision|1|||
48693103|NCT04564846|156726343|FG000|Overall Study|Lost to Follow-up|0|||
48693104|NCT04564846|156726344|FG001|Overall Study|Lost to Follow-up|1|||
48693105|NCT04564846|156726343|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
48693106|NCT04564846|156726344|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
48693107|NCT04564846|156726343|FG000|Overall Study|Subject non-compliance|1|||
48693108|NCT04564846|156726344|FG001|Overall Study|Subject non-compliance|0|||
48693109|NCT01766050|156726347|FG000|Overall Study|Adverse Event|1|||
48693110|NCT01766050|156726347|FG000|Overall Study|Lost to Follow-up|1|||
48693111|NCT01766050|156726347|FG000|Overall Study|Withdrawal by Subject|2|||
48693112|NCT03811340|156726348|FG000|Overall Study|subjects did not complete the survey.|90|||
48693113|NCT03212326|156726349|FG000|Overall Study|Physician Decision|4|||
48693114|NCT00308139|156726359|FG000|Overall Study|Adverse Event|20|||
48798615|NCT00428090|157100545|FG000|Overall Study|Prohibited medication used for SAE|1|||
48798616|NCT00428090|157100546|FG001|Overall Study|Prohibited medication used for SAE|0|||
48693115|NCT00308139|156726360|FG001|Overall Study|Adverse Event|14|||
48798617|NCT00428090|157100547|FG002|Overall Study|Prohibited medication used for SAE|0|||
48798618|NCT00428090|157100548|FG003|Overall Study|Prohibited medication used for SAE|0|||
48798619|NCT00428090|157100545|FG000|Overall Study|Death of par.|1|||
48798620|NCT00428090|157100546|FG001|Overall Study|Death of par.|0|||
48798621|NCT00428090|157100547|FG002|Overall Study|Death of par.|1|||
48798622|NCT00428090|157100548|FG003|Overall Study|Death of par.|0|||
48798623|NCT00428090|157100545|FG000|Overall Study|Visit 7 exceed the visit window|0|||
48798624|NCT00428090|157100546|FG001|Overall Study|Visit 7 exceed the visit window|1|||
48798625|NCT00428090|157100547|FG002|Overall Study|Visit 7 exceed the visit window|0|||
48798626|NCT00428090|157100548|FG003|Overall Study|Visit 7 exceed the visit window|0|||
48798627|NCT00428090|157100545|FG000|Overall Study|Medical monitor terminated par.|0|||
48798628|NCT00428090|157100546|FG001|Overall Study|Medical monitor terminated par.|1|||
48798629|NCT00428090|157100547|FG002|Overall Study|Medical monitor terminated par.|0|||
48380550|NCT00972777|155588466|FG001|Overall Study|Lost to Follow-up|4|||
48380551|NCT00972777|155588465|FG000|Overall Study|Withdrawal by Subject|4|||
48380552|NCT00972777|155588466|FG001|Overall Study|Withdrawal by Subject|5|||
48380553|NCT00972777|155588465|FG000|Overall Study|Physician Decision|4|||
48380554|NCT00972777|155588466|FG001|Overall Study|Physician Decision|0|||
48380555|NCT00972777|155588465|FG000|Overall Study|Protocol Violation|0|||
48380556|NCT00972777|155588466|FG001|Overall Study|Protocol Violation|2|||
48380557|NCT00972777|155588465|FG000|Overall Study|Screening Failure|2|||
48798630|NCT00428090|157100548|FG003|Overall Study|Medical monitor terminated par.|0|||
48798631|NCT00428090|157100545|FG000|Overall Study|Mental status of par. was|0|||
48798632|NCT00428090|157100546|FG001|Overall Study|Mental status of par. was|1|||
48798633|NCT00428090|157100547|FG002|Overall Study|Mental status of par. was|0|||
48798634|NCT00428090|157100548|FG003|Overall Study|Mental status of par. was|0|||
48798635|NCT00428090|157100545|FG000|Overall Study|Worsening of AD|0|||
48798636|NCT00428090|157100546|FG001|Overall Study|Worsening of AD|0|||
48798637|NCT00428090|157100547|FG002|Overall Study|Worsening of AD|1|||
48380558|NCT00972777|155588466|FG001|Overall Study|Screening Failure|1|||
48798638|NCT00428090|157100548|FG003|Overall Study|Worsening of AD|0|||
48798639|NCT00428090|157100545|FG000|Overall Study|Excluded for concerning QTc value|0|||
48798640|NCT00428090|157100546|FG001|Overall Study|Excluded for concerning QTc value|0|||
48380559|NCT00972777|155588465|FG000|Overall Study|Missed visit|1|||
48380560|NCT00972777|155588466|FG001|Overall Study|Missed visit|0|||
48380561|NCT03267940|155588469|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
48380562|NCT03267940|155588470|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
48798641|NCT00428090|157100547|FG002|Overall Study|Excluded for concerning QTc value|1|||
48798642|NCT00428090|157100548|FG003|Overall Study|Excluded for concerning QTc value|0|||
48380563|NCT03267940|155588471|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
48798643|NCT00428090|157100545|FG000|Overall Study|Insufficient AD documentation|0|||
48380564|NCT03267940|155588472|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
48383833|NCT00436618|155601447|FG000|Overall Study|Other Medical Problems|3|||
48693116|NCT00308139|156726359|FG000|Overall Study|Lost to Follow-up|13|||
48798644|NCT00428090|157100546|FG001|Overall Study|Insufficient AD documentation|0|||
48798645|NCT00428090|157100547|FG002|Overall Study|Insufficient AD documentation|1|||
48798646|NCT00428090|157100548|FG003|Overall Study|Insufficient AD documentation|0|||
48798647|NCT00428090|157100545|FG000|Overall Study|High MMSE scores|0|||
48798648|NCT00428090|157100546|FG001|Overall Study|High MMSE scores|0|||
48798649|NCT00428090|157100547|FG002|Overall Study|High MMSE scores|1|||
48798650|NCT00428090|157100548|FG003|Overall Study|High MMSE scores|0|||
48798651|NCT00428090|157100545|FG000|Overall Study|Deterioration of cognitive status|0|||
48798652|NCT00428090|157100546|FG001|Overall Study|Deterioration of cognitive status|0|||
48798653|NCT00428090|157100547|FG002|Overall Study|Deterioration of cognitive status|1|||
48798654|NCT00428090|157100548|FG003|Overall Study|Deterioration of cognitive status|0|||
48798655|NCT00428090|157100545|FG000|Overall Study|Serious adverse event|0|||
48798656|NCT00428090|157100546|FG001|Overall Study|Serious adverse event|0|||
48798657|NCT00428090|157100547|FG002|Overall Study|Serious adverse event|1|||
48798658|NCT00428090|157100548|FG003|Overall Study|Serious adverse event|0|||
48798659|NCT00428090|157100545|FG000|Overall Study|Excluded for heart insufficiency|0|||
48798660|NCT00428090|157100546|FG001|Overall Study|Excluded for heart insufficiency|0|||
48798661|NCT00428090|157100547|FG002|Overall Study|Excluded for heart insufficiency|1|||
48798662|NCT00428090|157100548|FG003|Overall Study|Excluded for heart insufficiency|0|||
48798663|NCT00428090|157100545|FG000|Overall Study|Raised Creatinine Value|0|||
48798664|NCT00428090|157100546|FG001|Overall Study|Raised Creatinine Value|0|||
48798665|NCT00428090|157100547|FG002|Overall Study|Raised Creatinine Value|0|||
48798666|NCT00428090|157100548|FG003|Overall Study|Raised Creatinine Value|1|||
48798667|NCT03255824|157100555|FG000|Overall Study|Under-sedation|2|||
48798668|NCT03255824|157100556|FG001|Overall Study|Under-sedation|1|||
48798669|NCT03432364|157100558|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
48798670|NCT04493216|157100559|FG000|Overall Study|Study terminated by sponsor|30|||
48798671|NCT04493216|157100560|FG001|Overall Study|Study terminated by sponsor|33|||
48798672|NCT04493216|157100561|FG002|Overall Study|Study terminated by sponsor|28|||
48798673|NCT04493216|157100562|FG003|Overall Study|Study terminated by sponsor|27|||
48798674|NCT04493216|157100559|FG000|Overall Study|Withdrawal by Subject|2|||
48798675|NCT04493216|157100560|FG001|Overall Study|Withdrawal by Subject|1|||
48798676|NCT04493216|157100561|FG002|Overall Study|Withdrawal by Subject|1|||
48798677|NCT04493216|157100562|FG003|Overall Study|Withdrawal by Subject|2|||
48798678|NCT04493216|157100559|FG000|Overall Study|Protocol Violation|1|||
48798679|NCT04493216|157100560|FG001|Overall Study|Protocol Violation|2|||
48798680|NCT04493216|157100561|FG002|Overall Study|Protocol Violation|0|||
48798681|NCT04493216|157100562|FG003|Overall Study|Protocol Violation|2|||
48798682|NCT04493216|157100559|FG000|Overall Study|Physician Decision|0|||
48798683|NCT04493216|157100560|FG001|Overall Study|Physician Decision|0|||
48798684|NCT04493216|157100561|FG002|Overall Study|Physician Decision|1|||
48380565|NCT03267940|155588473|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
48380566|NCT03267940|155588474|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
48380567|NCT03267940|155588469|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48380568|NCT03267940|155588470|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
48380569|NCT03267940|155588471|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48380570|NCT03267940|155588472|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48380571|NCT03267940|155588473|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48380572|NCT03267940|155588474|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
48380573|NCT03267940|155588469|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48380574|NCT03267940|155588470|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
48380575|NCT03267940|155588471|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48380576|NCT03267940|155588472|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48380577|NCT03267940|155588473|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48380578|NCT03267940|155588474|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
48380579|NCT03267940|155588469|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
48380580|NCT03267940|155588470|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
48380581|NCT03267940|155588471|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
48380582|NCT03267940|155588472|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
48380583|NCT03267940|155588473|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
48380584|NCT03267940|155588474|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
48380585|NCT03267940|155588469|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
48380586|NCT03267940|155588470|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
48380587|NCT03267940|155588471|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
48380588|NCT03267940|155588472|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
48798685|NCT04493216|157100562|FG003|Overall Study|Physician Decision|0|||
48798686|NCT04493216|157100559|FG000|Overall Study|Lost to Follow-up|2|||
48798687|NCT04493216|157100560|FG001|Overall Study|Lost to Follow-up|1|||
48798688|NCT04493216|157100561|FG002|Overall Study|Lost to Follow-up|0|||
48798689|NCT04493216|157100562|FG003|Overall Study|Lost to Follow-up|1|||
48798690|NCT04493216|157100559|FG000|Overall Study|Adverse Event|1|||
48798691|NCT04493216|157100560|FG001|Overall Study|Adverse Event|4|||
48798692|NCT04493216|157100561|FG002|Overall Study|Adverse Event|5|||
48380589|NCT03267940|155588473|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
48380590|NCT03267940|155588474|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
48380591|NCT03267940|155588469|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
48380592|NCT03267940|155588470|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
48380593|NCT03267940|155588471|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
48380594|NCT03267940|155588472|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
48798693|NCT04493216|157100562|FG003|Overall Study|Adverse Event|2|||
48798694|NCT04493216|157100559|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
48798695|NCT04493216|157100560|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
48798696|NCT04493216|157100561|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
48798697|NCT04493216|157100562|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
48798698|NCT02623322|157100565|FG000|Overall Study|Lost to Follow-up|2|||
48798699|NCT02623322|157100566|FG001|Overall Study|Lost to Follow-up|1|||
48798700|NCT02623322|157100567|FG002|Overall Study|Lost to Follow-up|0|||
48798701|NCT03232983|157100574|FG000|Period 1|Physician Decision|0|||
48798702|NCT03232983|157100575|FG001|Period 1|Physician Decision|0|||
48798703|NCT03232983|157100576|FG002|Period 1|Physician Decision|1|||
48798704|NCT03232983|157100577|FG003|Period 1|Physician Decision|0|||
48798705|NCT03232983|157100574|FG000|Washout Period 2|Physician Decision|0|||
48798706|NCT03232983|157100575|FG001|Washout Period 2|Physician Decision|0|||
48798707|NCT03232983|157100576|FG002|Washout Period 2|Physician Decision|1|||
48380595|NCT03267940|155588473|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
48380596|NCT03267940|155588474|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
48380597|NCT03267940|155588469|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
48380598|NCT03267940|155588470|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
48380599|NCT03267940|155588471|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
48380600|NCT03267940|155588472|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
48380601|NCT03267940|155588473|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
48380602|NCT03267940|155588474|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
48380603|NCT03267940|155588469|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
48380604|NCT03267940|155588470|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
48380605|NCT03267940|155588471|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
48380606|NCT03267940|155588472|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
48380607|NCT03267940|155588473|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
48798708|NCT03232983|157100577|FG003|Washout Period 2|Physician Decision|0|||
48798709|NCT03232983|157100574|FG000|Washout Period 2|Withdrawal by Subject|0|||
48798710|NCT03232983|157100575|FG001|Washout Period 2|Withdrawal by Subject|0|||
48798711|NCT03232983|157100576|FG002|Washout Period 2|Withdrawal by Subject|0|||
48798712|NCT03232983|157100577|FG003|Washout Period 2|Withdrawal by Subject|1|||
48798713|NCT03232983|157100574|FG000|Period 4|Withdrawal by Subject|1|||
48798714|NCT03232983|157100575|FG001|Period 4|Withdrawal by Subject|0|||
48798715|NCT03232983|157100576|FG002|Period 4|Withdrawal by Subject|0|||
48798716|NCT03232983|157100577|FG003|Period 4|Withdrawal by Subject|0|||
48798717|NCT02157779|157100578|FG000|Overall Study|Logistical|9|||
48798718|NCT02157779|157100579|FG001|Overall Study|Logistical|3|||
48798719|NCT02157779|157100578|FG000|Overall Study|Stopped attending, reason unknown|11|||
48798720|NCT02157779|157100579|FG001|Overall Study|Stopped attending, reason unknown|7|||
48798721|NCT02157779|157100578|FG000|Overall Study|No response to outreach after Baseline|1|||
48798722|NCT02157779|157100579|FG001|Overall Study|No response to outreach after Baseline|1|||
48798723|NCT02157779|157100578|FG000|Overall Study|Moved|1|||
48798724|NCT02157779|157100579|FG001|Overall Study|Moved|0|||
48798725|NCT02157779|157100578|FG000|Overall Study|Medical|1|||
48798726|NCT02157779|157100579|FG001|Overall Study|Medical|0|||
48798727|NCT02157779|157100578|FG000|Overall Study|Legal issue|1|||
48798728|NCT02157779|157100579|FG001|Overall Study|Legal issue|0|||
48798729|NCT01494584|157100591|FG000|Overall Study|Study Closed/Terminated|1|||
48798730|NCT01666808|157100592|FG000|Overall Study|Lost to Follow-up|9|||
48798731|NCT01666808|157100593|FG001|Overall Study|Lost to Follow-up|15|||
48798732|NCT01666808|157100592|FG000|Overall Study|Withdrawal by Subject|3|||
48798733|NCT01666808|157100593|FG001|Overall Study|Withdrawal by Subject|1|||
48380608|NCT03267940|155588474|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
48380609|NCT03267940|155588469|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
48380610|NCT03267940|155588470|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
48798734|NCT01666808|157100592|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
48798735|NCT01666808|157100593|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
48798736|NCT01235403|157100594|FG000|Overall Study|Adverse Event|14|||
48798737|NCT01235403|157100594|FG000|Overall Study|Lost to Follow-up|2|||
48798738|NCT01235403|157100594|FG000|Overall Study|Withdrawal by Subject|4|||
48798739|NCT01235403|157100594|FG000|Overall Study|Lack of Efficacy|2|||
48798740|NCT01235403|157100594|FG000|Overall Study|Other reasons for premature termination|4|||
48798741|NCT04123067|157100597|FG000|Overall Study|Lost to Follow-up|0|||
48798742|NCT04123067|157100598|FG001|Overall Study|Lost to Follow-up|1|||
48798743|NCT03248375|157100599|FG000|Overall Study|Lost to Follow-up|5|||
48380611|NCT03267940|155588471|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
48380612|NCT03267940|155588472|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
48380613|NCT03267940|155588473|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
48380614|NCT03267940|155588474|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
48380615|NCT01605253|155588482|FG000|Overall Study|Physician Decision|3|||
48380616|NCT01605253|155588483|FG001|Overall Study|Physician Decision|2|||
48380617|NCT01605253|155588482|FG000|Overall Study|Lost to Follow-up|3|||
48380618|NCT01605253|155588483|FG001|Overall Study|Lost to Follow-up|1|||
48380619|NCT00999713|155588488|FG000|Overall Study|Physician Decision|2|||
48380620|NCT00999713|155588489|FG001|Overall Study|Physician Decision|0|||
48380621|NCT02279862|155588490|FG000|Overall Study|Study drug toxicity|3|||
48798744|NCT00633464|157100606|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
48798745|NCT00633464|157100607|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
48798746|NCT00633464|157100606|FG000|Overall Study|Never Treated (Randomized in error)|0|||
48798747|NCT00633464|157100607|FG001|Overall Study|Never Treated (Randomized in error)|1|||
48798748|NCT01563536|157100610|FG000|Overall Study|Withdrawal by Subject|0|||
48798749|NCT01563536|157100611|FG001|Overall Study|Withdrawal by Subject|2|||
48798750|NCT01563536|157100610|FG000|Overall Study|Lost to Follow-up|1|||
48798751|NCT01563536|157100611|FG001|Overall Study|Lost to Follow-up|0|||
48798752|NCT00696410|157100613|FG000|Overall Study|Lost to Follow-up|2|||
48798753|NCT00696410|157100614|FG001|Overall Study|Lost to Follow-up|0|||
48798754|NCT00696410|157100613|FG000|Overall Study|Withdrawal by Subject|8|||
48380622|NCT02279862|155588491|FG001|Overall Study|Study drug toxicity|6|||
48798755|NCT00696410|157100614|FG001|Overall Study|Withdrawal by Subject|0|||
48380623|NCT02279862|155588490|FG000|Overall Study|No longer meets criteria|0|||
48380624|NCT02279862|155588491|FG001|Overall Study|No longer meets criteria|1|||
48380625|NCT02279862|155588490|FG000|Overall Study|Administrative reason by sponsor|0|||
48380626|NCT02279862|155588491|FG001|Overall Study|Administrative reason by sponsor|1|||
48380627|NCT02279862|155588490|FG000|Overall Study|Disease progression|5|||
48380628|NCT02279862|155588491|FG001|Overall Study|Disease progression|2|||
48380629|NCT02279862|155588490|FG000|Overall Study|Study closed by sponsor|16|||
48380630|NCT02279862|155588491|FG001|Overall Study|Study closed by sponsor|13|||
48380631|NCT02279862|155588490|FG000|Overall Study|Other|1|||
48380632|NCT02279862|155588491|FG001|Overall Study|Other|2|||
48380633|NCT02279862|155588490|FG000|Overall Study|Withdrawal by Subject|1|||
48380634|NCT02279862|155588491|FG001|Overall Study|Withdrawal by Subject|0|||
48380635|NCT00633061|155588492|FG000|Overall Study|Study closed|86|||
48380636|NCT00633061|155588493|FG001|Overall Study|Study closed|0|||
48380637|NCT04683731|155588494|FG000|Overall Study|Withdrawal by Subject|1|||
48693117|NCT00308139|156726360|FG001|Overall Study|Lost to Follow-up|8|||
48693118|NCT00308139|156726359|FG000|Overall Study|Protocol Violation|3|||
48693119|NCT00308139|156726360|FG001|Overall Study|Protocol Violation|2|||
48693120|NCT00308139|156726359|FG000|Overall Study|Withdrawal of Consent|40|||
48380638|NCT04683731|155588495|FG001|Overall Study|Withdrawal by Subject|0|||
48693121|NCT00308139|156726360|FG001|Overall Study|Withdrawal of Consent|42|||
48798756|NCT00696410|157100613|FG000|Overall Study|Physician Decision|3|||
48380639|NCT04683731|155588496|FG002|Overall Study|Withdrawal by Subject|3|||
48380640|NCT04683731|155588497|FG003|Overall Study|Withdrawal by Subject|2|||
48380641|NCT04683731|155588494|FG000|Overall Study|Determined patient was not eligible|3|||
48380642|NCT04683731|155588495|FG001|Overall Study|Determined patient was not eligible|3|||
48798757|NCT00696410|157100614|FG001|Overall Study|Physician Decision|0|||
48798758|NCT00567190|157100620|FG000|Overall Study|Death|235|||
48798759|NCT00567190|157100621|FG001|Overall Study|Death|280|||
48798760|NCT00567190|157100620|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
48798761|NCT00567190|157100621|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
48798762|NCT01971723|157100622|FG000|Overall Study|Withdrawal by Subject|1|||
48380643|NCT04683731|155588496|FG002|Overall Study|Determined patient was not eligible|12|||
48380644|NCT04683731|155588497|FG003|Overall Study|Determined patient was not eligible|3|||
48380645|NCT00671554|155588498|FG000|Overall Study|Disease progression|3|||
48380646|NCT00708175|155588499|FG000|Overall Study|Adverse Event|4|||
48380647|NCT00708175|155588500|FG001|Overall Study|Adverse Event|5|||
48693122|NCT00308139|156726359|FG000|Overall Study|Investigator Decision|11|||
48798763|NCT01971723|157100623|FG001|Overall Study|Withdrawal by Subject|1|||
48798764|NCT01971723|157100622|FG000|Overall Study|Protocol Violation|1|||
48798765|NCT01971723|157100623|FG001|Overall Study|Protocol Violation|2|||
48798766|NCT00696384|157100624|FG000|Open Label Phase|Adverse Event|27|||
48798767|NCT00696384|157100625|FG001|Open Label Phase|Adverse Event|0|||
48798768|NCT00696384|157100626|FG002|Open Label Phase|Adverse Event|0|||
48798769|NCT00696384|157100624|FG000|Open Label Phase|Protocol Violation|18|||
48380648|NCT00708175|155588499|FG000|Overall Study|Protocol Violation|2|||
48380649|NCT00708175|155588500|FG001|Overall Study|Protocol Violation|3|||
48380650|NCT00708175|155588499|FG000|Overall Study|Lost to Follow-up|5|||
48693123|NCT00308139|156726360|FG001|Overall Study|Investigator Decision|10|||
48798770|NCT00696384|157100625|FG001|Open Label Phase|Protocol Violation|0|||
48380651|NCT00708175|155588500|FG001|Overall Study|Lost to Follow-up|3|||
48380652|NCT00708175|155588499|FG000|Overall Study|Withdrawal by Subject|5|||
48380653|NCT00708175|155588500|FG001|Overall Study|Withdrawal by Subject|7|||
48798771|NCT00696384|157100626|FG002|Open Label Phase|Protocol Violation|0|||
48798772|NCT00696384|157100624|FG000|Open Label Phase|Lost to Follow-up|24|||
48798773|NCT00696384|157100625|FG001|Open Label Phase|Lost to Follow-up|0|||
48798774|NCT00696384|157100626|FG002|Open Label Phase|Lost to Follow-up|0|||
48798775|NCT00696384|157100624|FG000|Open Label Phase|Withdrawal by Subject|37|||
48798776|NCT00696384|157100625|FG001|Open Label Phase|Withdrawal by Subject|0|||
48798777|NCT00696384|157100626|FG002|Open Label Phase|Withdrawal by Subject|0|||
48798778|NCT00696384|157100624|FG000|Open Label Phase|Other|6|||
48798779|NCT00696384|157100625|FG001|Open Label Phase|Other|0|||
48798780|NCT00696384|157100626|FG002|Open Label Phase|Other|0|||
48798781|NCT00696384|157100624|FG000|Open Label Phase|Lack of Efficacy|3|||
48798782|NCT00696384|157100625|FG001|Open Label Phase|Lack of Efficacy|0|||
48798783|NCT00696384|157100626|FG002|Open Label Phase|Lack of Efficacy|0|||
48798784|NCT00696384|157100624|FG000|Open Label Phase|Physician Decision|4|||
48798785|NCT00696384|157100625|FG001|Open Label Phase|Physician Decision|0|||
48798786|NCT00696384|157100626|FG002|Open Label Phase|Physician Decision|0|||
48798787|NCT00696384|157100624|FG000|Double Blind Phase|Adverse Event|0|||
48798788|NCT00696384|157100625|FG001|Double Blind Phase|Adverse Event|2|||
48798789|NCT00696384|157100626|FG002|Double Blind Phase|Adverse Event|2|||
48798790|NCT00696384|157100624|FG000|Double Blind Phase|Lost to Follow-up|0|||
48798791|NCT00696384|157100625|FG001|Double Blind Phase|Lost to Follow-up|2|||
48798792|NCT00696384|157100626|FG002|Double Blind Phase|Lost to Follow-up|1|||
48798793|NCT00696384|157100624|FG000|Double Blind Phase|Withdrawal by Subject|0|||
48798794|NCT00696384|157100625|FG001|Double Blind Phase|Withdrawal by Subject|4|||
48798795|NCT00696384|157100626|FG002|Double Blind Phase|Withdrawal by Subject|3|||
48798796|NCT00696384|157100624|FG000|Double Blind Phase|Lack of Efficacy|0|||
48798797|NCT00696384|157100625|FG001|Double Blind Phase|Lack of Efficacy|1|||
48798798|NCT00696384|157100626|FG002|Double Blind Phase|Lack of Efficacy|0|||
48798799|NCT00696384|157100624|FG000|Double Blind Phase|Physician Decision|0|||
48798800|NCT00696384|157100625|FG001|Double Blind Phase|Physician Decision|2|||
48798801|NCT00696384|157100626|FG002|Double Blind Phase|Physician Decision|0|||
48798802|NCT02027402|157100627|FG000|Overall Study|Withdrawal by Subject|4|||
48798803|NCT02027402|157100628|FG001|Overall Study|Withdrawal by Subject|1|||
48798804|NCT03645759|157100630|FG000|Overall Study|Lost to Follow-up|3|||
48798805|NCT03645759|157100631|FG001|Overall Study|Lost to Follow-up|2|||
48798806|NCT03538951|157100632|FG000|Overall Study|Withdrawal by Subject|1|||
48798807|NCT03538951|157100633|FG001|Overall Study|Withdrawal by Subject|2|||
48798808|NCT01323530|157102129|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
48798809|NCT01323530|157102130|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798810|NCT01323530|157102131|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798811|NCT01323530|157102132|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798812|NCT01323530|157102133|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798813|NCT01323530|157102134|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
48798814|NCT01323530|157102135|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48798815|NCT01323530|157102129|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
48798816|NCT01323530|157102130|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
48798817|NCT01323530|157102131|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
48798818|NCT01323530|157102132|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48798819|NCT01323530|157102133|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
48380654|NCT00708175|155588499|FG000|Overall Study|BMD loss >7%|2|||
48380655|NCT00708175|155588500|FG001|Overall Study|BMD loss >7%|3|||
48798820|NCT01323530|157102134|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48798821|NCT01323530|157102135|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48798822|NCT01323530|157102129|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
48798823|NCT01323530|157102130|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
48798824|NCT01323530|157102131|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
48798825|NCT01323530|157102132|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
48380656|NCT03471871|155588501|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
48380657|NCT03471871|155588502|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
48693124|NCT00308139|156726359|FG000|Overall Study|Loss of Glucose Control|5|||
48693125|NCT00308139|156726360|FG001|Overall Study|Loss of Glucose Control|7|||
48693126|NCT00308139|156726359|FG000|Overall Study|Administrative|1|||
48798826|NCT01323530|157102133|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
48798827|NCT01323530|157102134|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
48798828|NCT01323530|157102135|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
48798829|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798830|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798831|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798832|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798833|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798834|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
48798835|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
48798836|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798837|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798838|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798839|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798840|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798841|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
48798842|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
48798843|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798844|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798845|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798846|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798847|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798848|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
48798849|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
48798850|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798851|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798852|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798853|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798854|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48798855|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
48380658|NCT03471871|155588503|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
48380659|NCT03471871|155588504|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
48380660|NCT03471871|155588505|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
48693127|NCT00308139|156726360|FG001|Overall Study|Administrative|4|||
48693128|NCT00308139|156726359|FG000|Overall Study|Other|1|||
48693129|NCT00308139|156726360|FG001|Overall Study|Other|0|||
48693130|NCT01702844|156726361|FG000|Overall Study|Adverse Event|9|||
48693131|NCT01702844|156726361|FG000|Overall Study|Death|1|||
48693132|NCT01702844|156726361|FG000|Overall Study|Withdrawal by Subject|3|||
48693133|NCT01702844|156726361|FG000|Overall Study|Physician Decision|6|||
48693134|NCT02193776|156726362|FG000|Overall Study|Consent withdrawn|1|||
48693135|NCT02193776|156726363|FG001|Overall Study|Consent withdrawn|0|||
48693136|NCT02193776|156726364|FG002|Overall Study|Consent withdrawn|0|||
48693137|NCT02193776|156726365|FG003|Overall Study|Consent withdrawn|0|||
48693138|NCT02193776|156726362|FG000|Overall Study|Failure to comply with protocol|0|||
48693139|NCT02193776|156726363|FG001|Overall Study|Failure to comply with protocol|1|||
48693140|NCT02193776|156726364|FG002|Overall Study|Failure to comply with protocol|0|||
48693141|NCT02193776|156726365|FG003|Overall Study|Failure to comply with protocol|0|||
48693142|NCT02193776|156726362|FG000|Overall Study|Investigator/Sponsor decision|1|||
48693143|NCT02193776|156726363|FG001|Overall Study|Investigator/Sponsor decision|1|||
48693144|NCT02193776|156726364|FG002|Overall Study|Investigator/Sponsor decision|0|||
48693145|NCT02193776|156726365|FG003|Overall Study|Investigator/Sponsor decision|0|||
48693146|NCT02193776|156726362|FG000|Overall Study|Death|1|||
48693147|NCT02193776|156726363|FG001|Overall Study|Death|0|||
48693148|NCT02193776|156726364|FG002|Overall Study|Death|0|||
48693149|NCT02193776|156726365|FG003|Overall Study|Death|0|||
48693150|NCT02193776|156726362|FG000|Overall Study|Adverse event/Specific toxicity|5|||
48693151|NCT02193776|156726363|FG001|Overall Study|Adverse event/Specific toxicity|5|||
48693152|NCT02193776|156726364|FG002|Overall Study|Adverse event/Specific toxicity|2|||
48693153|NCT02193776|156726365|FG003|Overall Study|Adverse event/Specific toxicity|2|||
48693154|NCT04479787|156726366|FG000|Through 6 Months|Withdrawal by Subject|16|||
48693155|NCT04479787|156726367|FG001|Through 6 Months|Withdrawal by Subject|14|||
48693156|NCT04479787|156726366|FG000|Through 6 Months|Unsuccessful Trial|17|||
48693157|NCT04479787|156726367|FG001|Through 6 Months|Unsuccessful Trial|0|||
48693158|NCT04479787|156726366|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
48380661|NCT03471871|155588501|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
48693159|NCT04479787|156726367|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
48693160|NCT04479787|156726366|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
48693161|NCT04479787|156726367|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
48380662|NCT03471871|155588502|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
48380663|NCT03471871|155588503|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
48380664|NCT03471871|155588504|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
48451248|NCT00355134|155841607|FG004|Core Phase|Lost to Follow-up|0|||
48693162|NCT04479787|156726366|FG000|Through 6 Months|Lost to Follow-up|3|||
48693163|NCT04479787|156726367|FG001|Through 6 Months|Lost to Follow-up|2|||
48693164|NCT04479787|156726366|FG000|Through 6 Months|Death|3|||
48693165|NCT04479787|156726367|FG001|Through 6 Months|Death|0|||
48693166|NCT04479787|156726366|FG000|Through 6 Months|Inclusion/Exclusion|2|||
48742913|NCT00745823|156910414|FG001|Overall Study|Adverse Event|3|||
48693167|NCT04479787|156726367|FG001|Through 6 Months|Inclusion/Exclusion|1|||
48693168|NCT04479787|156726366|FG000|Through 6 Months|Subject Became Pregnant|1|||
48380665|NCT03471871|155588505|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
48693169|NCT04479787|156726367|FG001|Through 6 Months|Subject Became Pregnant|1|||
48693170|NCT04479787|156726366|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
48693171|NCT04479787|156726367|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
48693172|NCT04479787|156726366|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
48693173|NCT04479787|156726367|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
48693174|NCT04479787|156726366|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
48693175|NCT04479787|156726367|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
48693176|NCT04479787|156726366|FG000|After 6 Months|Withdrawal by Subject|3|||
48693177|NCT04479787|156726367|FG001|After 6 Months|Withdrawal by Subject|13|||
48693178|NCT04479787|156726366|FG000|After 6 Months|Unsuccessful Trial|0|||
48693179|NCT04479787|156726367|FG001|After 6 Months|Unsuccessful Trial|7|||
48693180|NCT04479787|156726366|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
48693181|NCT04479787|156726367|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
48693182|NCT04479787|156726366|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
48693183|NCT04479787|156726367|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
48693184|NCT04479787|156726366|FG000|After 6 Months|Death|2|||
48693185|NCT04479787|156726367|FG001|After 6 Months|Death|0|||
48693186|NCT04479787|156726366|FG000|After 6 Months|Lost to Follow-up|1|||
48693187|NCT04479787|156726367|FG001|After 6 Months|Lost to Follow-up|1|||
48693188|NCT04479787|156726366|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
48693189|NCT04479787|156726367|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
48693190|NCT04479787|156726366|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
48693191|NCT04479787|156726367|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
48798856|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
48798857|NCT01323530|157102129|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798858|NCT01323530|157102130|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798859|NCT01323530|157102131|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798860|NCT01323530|157102132|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798861|NCT01323530|157102133|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798862|NCT01323530|157102134|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
48798863|NCT01323530|157102135|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
48798864|NCT01194570|157102136|FG000|Overall Study|Adverse Event|22|||
48798865|NCT01194570|157102137|FG001|Overall Study|Adverse Event|40|||
48798866|NCT01194570|157102136|FG000|Overall Study|Death|6|||
48798867|NCT01194570|157102137|FG001|Overall Study|Death|20|||
48798868|NCT01194570|157102136|FG000|Overall Study|Lack of Efficacy|32|||
48798869|NCT01194570|157102137|FG001|Overall Study|Lack of Efficacy|33|||
48798870|NCT01194570|157102136|FG000|Overall Study|Lost to Follow-up|4|||
48798871|NCT01194570|157102137|FG001|Overall Study|Lost to Follow-up|15|||
48798872|NCT01194570|157102136|FG000|Overall Study|Non-Compliance|2|||
48798873|NCT01194570|157102137|FG001|Overall Study|Non-Compliance|2|||
48798874|NCT01194570|157102136|FG000|Overall Study|Non-Compliance With Study Drug|2|||
48798875|NCT01194570|157102137|FG001|Overall Study|Non-Compliance With Study Drug|2|||
48798876|NCT01194570|157102136|FG000|Overall Study|Other|18|||
48798877|NCT01194570|157102137|FG001|Overall Study|Other|47|||
48380666|NCT03471871|155588501|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
48380667|NCT03471871|155588502|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
48380668|NCT03471871|155588503|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
48380669|NCT03471871|155588504|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
48380670|NCT03471871|155588505|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
48380671|NCT03471871|155588501|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
48380672|NCT03471871|155588502|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
48380673|NCT03471871|155588503|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
48589814|NCT02651688|156352161|FG002|Overall Study|Withdrawal by Subject|2|||
48589815|NCT04527978|156352164|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
48589816|NCT04527978|156352165|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
48589817|NCT00055497|156352166|FG000|Overall Study|Adverse Event|1|||
48589818|NCT00055497|156352167|FG001|Overall Study|Adverse Event|1|||
48589819|NCT00055497|156352168|FG002|Overall Study|Adverse Event|1|||
48380674|NCT03471871|155588504|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
48380675|NCT03471871|155588505|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
48589820|NCT00055497|156352169|FG003|Overall Study|Adverse Event|28|||
48589821|NCT00055497|156352166|FG000|Overall Study|Withdrawal by Subject|3|||
48798878|NCT01194570|157102136|FG000|Overall Study|Physician Decision|10|||
48798879|NCT01194570|157102137|FG001|Overall Study|Physician Decision|25|||
48798880|NCT01194570|157102136|FG000|Overall Study|Protocol Violation|1|||
48798881|NCT01194570|157102137|FG001|Overall Study|Protocol Violation|2|||
48798882|NCT01194570|157102136|FG000|Overall Study|Study Terminated By Sponsor|0|||
48589822|NCT00055497|156352167|FG001|Overall Study|Withdrawal by Subject|1|||
48589823|NCT00055497|156352168|FG002|Overall Study|Withdrawal by Subject|1|||
48589824|NCT00055497|156352169|FG003|Overall Study|Withdrawal by Subject|15|||
48589825|NCT00055497|156352166|FG000|Overall Study|Lost to Follow-up|0|||
48589826|NCT00055497|156352167|FG001|Overall Study|Lost to Follow-up|1|||
48589827|NCT00055497|156352168|FG002|Overall Study|Lost to Follow-up|0|||
48589828|NCT00055497|156352169|FG003|Overall Study|Lost to Follow-up|5|||
48589829|NCT00055497|156352166|FG000|Overall Study|Protocol Violation|0|||
48589830|NCT00055497|156352167|FG001|Overall Study|Protocol Violation|0|||
48589831|NCT00055497|156352168|FG002|Overall Study|Protocol Violation|0|||
48589832|NCT00055497|156352169|FG003|Overall Study|Protocol Violation|3|||
48589833|NCT00055497|156352166|FG000|Overall Study|Lack of Efficacy|1|||
48589834|NCT00055497|156352167|FG001|Overall Study|Lack of Efficacy|0|||
48589835|NCT00055497|156352168|FG002|Overall Study|Lack of Efficacy|0|||
48589836|NCT00055497|156352169|FG003|Overall Study|Lack of Efficacy|27|||
48589837|NCT00055497|156352166|FG000|Overall Study|Administrative Reasons|0|||
48798883|NCT01194570|157102137|FG001|Overall Study|Study Terminated By Sponsor|1|||
48798884|NCT01194570|157102136|FG000|Overall Study|Withdrawal by Subject|57|||
48798885|NCT01194570|157102137|FG001|Overall Study|Withdrawal by Subject|82|||
48798886|NCT01194570|157102136|FG000|Overall Study|Pregnancy|1|||
48798887|NCT01194570|157102137|FG001|Overall Study|Pregnancy|1|||
48798888|NCT00003508|157102138|FG000|Overall Study|Not evaluable|5|||
48798889|NCT01357616|157102139|FG000|Overall Study|Adverse Event|1|||
48798890|NCT01357616|157102140|FG001|Overall Study|Adverse Event|1|||
48798891|NCT01357616|157102139|FG000|Overall Study|Lost to Follow-up|4|||
48798892|NCT01357616|157102140|FG001|Overall Study|Lost to Follow-up|3|||
48798893|NCT01357616|157102139|FG000|Overall Study|Protocol Violation|0|||
48798894|NCT01357616|157102140|FG001|Overall Study|Protocol Violation|2|||
48798895|NCT01357616|157102139|FG000|Overall Study|Inadequate Control of IOP|1|||
48325426|NCT01561300|155389086|FG000|Run in on Placebo|Adverse Event|1|||
48325427|NCT01561300|155389087|FG001|Run in on Placebo|Adverse Event|0|||
48325428|NCT03689946|155389088|FG000|Overall Study|Withdrawal by Subject|3|||
48325429|NCT03689946|155389088|FG000|Overall Study|Lost to Follow-up|3|||
48325430|NCT03689946|155389088|FG000|Overall Study|Data corruption|2|||
48325431|NCT01627561|155389089|FG000|Overall Study|Lost to Follow-up|1|||
48325432|NCT01627561|155389090|FG001|Overall Study|Lost to Follow-up|0|||
48325433|NCT01627561|155389089|FG000|Overall Study|Withdrawal by Subject|0|||
48325434|NCT01627561|155389090|FG001|Overall Study|Withdrawal by Subject|1|||
48325435|NCT01627561|155389089|FG000|Overall Study|Migrated/moved from study area|0|||
48325436|NCT01627561|155389090|FG001|Overall Study|Migrated/moved from study area|2|||
48325437|NCT03220724|155389091|FG000|Overall Study|Lost to Follow-up|2|||
48325438|NCT03220724|155389092|FG001|Overall Study|Lost to Follow-up|2|||
48325439|NCT03220724|155389093|FG002|Overall Study|Lost to Follow-up|0|||
48325440|NCT03220724|155389094|FG003|Overall Study|Lost to Follow-up|3|||
48325441|NCT03220724|155389095|FG004|Overall Study|Lost to Follow-up|1|||
48325442|NCT03220724|155389096|FG005|Overall Study|Lost to Follow-up|0|||
48325443|NCT03220724|155389097|FG006|Overall Study|Lost to Follow-up|2|||
48325444|NCT03220724|155389098|FG007|Overall Study|Lost to Follow-up|1|||
48325445|NCT03220724|155389099|FG008|Overall Study|Lost to Follow-up|0|||
48325446|NCT03220724|155389091|FG000|Overall Study|Withdrawal by Subject|1|||
48325447|NCT03220724|155389092|FG001|Overall Study|Withdrawal by Subject|0|||
48325448|NCT03220724|155389093|FG002|Overall Study|Withdrawal by Subject|1|||
48325449|NCT03220724|155389094|FG003|Overall Study|Withdrawal by Subject|0|||
48325450|NCT03220724|155389095|FG004|Overall Study|Withdrawal by Subject|0|||
48325451|NCT03220724|155389096|FG005|Overall Study|Withdrawal by Subject|0|||
48325452|NCT03220724|155389097|FG006|Overall Study|Withdrawal by Subject|0|||
48325453|NCT03220724|155389098|FG007|Overall Study|Withdrawal by Subject|0|||
48325454|NCT03220724|155389099|FG008|Overall Study|Withdrawal by Subject|0|||
48325455|NCT01185600|155389102|FG000|Overall Study|Adverse Event|1|||
48325456|NCT01185600|155389103|FG001|Overall Study|Adverse Event|1|||
48325457|NCT01185600|155389102|FG000|Overall Study|Death|0|||
48325458|NCT01185600|155389103|FG001|Overall Study|Death|1|||
48325459|NCT01185600|155389102|FG000|Overall Study|Lost to Follow-up|0|||
48325460|NCT01185600|155389103|FG001|Overall Study|Lost to Follow-up|5|||
48325461|NCT01185600|155389102|FG000|Overall Study|Physician Decision|29|||
48325462|NCT01185600|155389103|FG001|Overall Study|Physician Decision|35|||
48325463|NCT01185600|155389102|FG000|Overall Study|Withdrawal by Subject|1|||
48325464|NCT01185600|155389103|FG001|Overall Study|Withdrawal by Subject|1|||
48325465|NCT01185600|155389102|FG000|Overall Study|Hold by DSMB|1|||
48325466|NCT01185600|155389103|FG001|Overall Study|Hold by DSMB|2|||
48325467|NCT00890591|155389104|FG000|Overall Study|Lack of Efficacy|20|||
48325468|NCT00371345|155389105|FG000|Overall Study|Disease Progression|21|||
48325469|NCT00371345|155389106|FG001|Overall Study|Disease Progression|35|||
48325470|NCT00371345|155389105|FG000|Overall Study|Study Drug Toxicity|1|||
48325471|NCT00371345|155389106|FG001|Overall Study|Study Drug Toxicity|7|||
48325472|NCT00371345|155389105|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
48325473|NCT00371345|155389106|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
48798896|NCT01357616|157102140|FG001|Overall Study|Inadequate Control of IOP|2|||
48798897|NCT01357616|157102139|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
48798898|NCT01357616|157102140|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
48798899|NCT01357616|157102139|FG000|Overall Study|Withdrawal by Subject|1|||
48798900|NCT01357616|157102140|FG001|Overall Study|Withdrawal by Subject|0|||
48798901|NCT02001194|157102144|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
48798902|NCT02001194|157102145|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
48798903|NCT02001194|157102146|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
48798904|NCT02001194|157102147|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
48798905|NCT02001194|157102144|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
48798906|NCT02001194|157102145|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
48798907|NCT02001194|157102146|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
48798908|NCT02001194|157102147|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
48798909|NCT00522301|157102148|FG000|Overall Study|Withdrawal by Subject|1|||
48798910|NCT00522301|157102148|FG000|Overall Study|Adverse Event|5|||
48798911|NCT03040713|157102149|FG000|Overall Study|Positive amyloid scan|3|||
48798912|NCT03395405|157102150|FG000|Overall Study|Death|0|||
48798913|NCT03395405|157102151|FG001|Overall Study|Death|2|||
48798914|NCT03395405|157102150|FG000|Overall Study|Lost to Follow-up|0|||
48798915|NCT03395405|157102151|FG001|Overall Study|Lost to Follow-up|1|||
48798916|NCT03395405|157102150|FG000|Overall Study|Protocol Violation|0|||
48798917|NCT03395405|157102151|FG001|Overall Study|Protocol Violation|1|||
48798918|NCT03395405|157102150|FG000|Overall Study|Withdrawal by Subject|3|||
48798919|NCT03395405|157102151|FG001|Overall Study|Withdrawal by Subject|1|||
48798920|NCT03395405|157102150|FG000|Overall Study|COVID-19 Pandemic|1|||
48798921|NCT03395405|157102151|FG001|Overall Study|COVID-19 Pandemic|0|||
48798922|NCT01649232|157102152|FG000|Overall Study|Physician Decision|2|||
48798923|NCT01649232|157102153|FG001|Overall Study|Physician Decision|0|||
48798924|NCT00430248|157102166|FG000|Overall Study|Adverse Event|49|||
48798925|NCT00430248|157102167|FG001|Overall Study|Adverse Event|61|||
48798926|NCT00430248|157102168|FG002|Overall Study|Adverse Event|64|||
48798927|NCT00430248|157102166|FG000|Overall Study|Protocol Violation|10|||
48798928|NCT00430248|157102167|FG001|Overall Study|Protocol Violation|2|||
48798929|NCT00430248|157102168|FG002|Overall Study|Protocol Violation|4|||
48798930|NCT00430248|157102166|FG000|Overall Study|Personal Reasons|12|||
48798931|NCT00430248|157102167|FG001|Overall Study|Personal Reasons|24|||
48798932|NCT00430248|157102168|FG002|Overall Study|Personal Reasons|9|||
48798933|NCT00430248|157102166|FG000|Overall Study|Lost to Follow-up|28|||
48798934|NCT00430248|157102167|FG001|Overall Study|Lost to Follow-up|33|||
48798935|NCT00430248|157102168|FG002|Overall Study|Lost to Follow-up|28|||
48798936|NCT00430248|157102166|FG000|Overall Study|Therapeutic Failure|1|||
48798937|NCT00430248|157102167|FG001|Overall Study|Therapeutic Failure|1|||
48798938|NCT00430248|157102168|FG002|Overall Study|Therapeutic Failure|1|||
48380676|NCT03471871|155588501|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
48380677|NCT03471871|155588502|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
48380678|NCT03471871|155588503|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
48380679|NCT03471871|155588504|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
48380680|NCT03471871|155588505|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
48380681|NCT02673619|155588506|FG000|Overall Study|Lost to Follow-up|1|||
48380682|NCT02673619|155588507|FG001|Overall Study|Lost to Follow-up|0|||
48380683|NCT02673619|155588508|FG002|Overall Study|Lost to Follow-up|0|||
48380684|NCT02673619|155588509|FG003|Overall Study|Lost to Follow-up|0|||
48380685|NCT02673619|155588506|FG000|Overall Study|Withdrawal by Subject|1|||
48380686|NCT02673619|155588507|FG001|Overall Study|Withdrawal by Subject|1|||
48380687|NCT02673619|155588508|FG002|Overall Study|Withdrawal by Subject|1|||
48380688|NCT02673619|155588509|FG003|Overall Study|Withdrawal by Subject|0|||
48380689|NCT02673619|155588506|FG000|Overall Study|Adverse Event|0|||
48380690|NCT02673619|155588507|FG001|Overall Study|Adverse Event|0|||
48380691|NCT02673619|155588508|FG002|Overall Study|Adverse Event|1|||
48380692|NCT02673619|155588509|FG003|Overall Study|Adverse Event|0|||
48380693|NCT02673619|155588506|FG000|Overall Study|Lack of Efficacy|0|||
48380694|NCT02673619|155588507|FG001|Overall Study|Lack of Efficacy|0|||
48380695|NCT02673619|155588508|FG002|Overall Study|Lack of Efficacy|1|||
48380696|NCT02673619|155588509|FG003|Overall Study|Lack of Efficacy|0|||
48380697|NCT01791803|155588510|FG000|Overall Study|Withdrawal by Subject|0|||
48380698|NCT01791803|155588511|FG001|Overall Study|Withdrawal by Subject|0|||
48380699|NCT01791803|155588512|FG002|Overall Study|Withdrawal by Subject|0|||
48380700|NCT01791803|155588513|FG003|Overall Study|Withdrawal by Subject|2|||
48380701|NCT01791803|155588510|FG000|Overall Study|Physician Decision|0|||
48380702|NCT01791803|155588511|FG001|Overall Study|Physician Decision|2|||
48380703|NCT01791803|155588512|FG002|Overall Study|Physician Decision|0|||
48380704|NCT01791803|155588513|FG003|Overall Study|Physician Decision|1|||
48380705|NCT01791803|155588510|FG000|Overall Study|Death|0|||
48380706|NCT01791803|155588511|FG001|Overall Study|Death|0|||
48380707|NCT01791803|155588512|FG002|Overall Study|Death|2|||
48380708|NCT01791803|155588513|FG003|Overall Study|Death|2|||
48380709|NCT01444456|155588514|FG000|Overall Study|Withdrawal by Subject|21|||
48798939|NCT00430248|157102166|FG000|Overall Study|Withdrawal by Subject|14|||
48798940|NCT00430248|157102167|FG001|Overall Study|Withdrawal by Subject|20|||
48798941|NCT00430248|157102168|FG002|Overall Study|Withdrawal by Subject|16|||
48798942|NCT00430248|157102166|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48798943|NCT00430248|157102167|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
48798944|NCT00430248|157102168|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48798945|NCT00430248|157102166|FG000|Overall Study|Gout Flare|3|||
48798946|NCT00430248|157102167|FG001|Overall Study|Gout Flare|7|||
48798947|NCT00430248|157102168|FG002|Overall Study|Gout Flare|2|||
48798948|NCT00430248|157102166|FG000|Overall Study|Reason Not Specified|8|||
48798949|NCT00430248|157102167|FG001|Overall Study|Reason Not Specified|8|||
48798950|NCT00430248|157102168|FG002|Overall Study|Reason Not Specified|11|||
48798951|NCT01301391|157102169|FG000|Overall Study|Death|13|||
48798952|NCT01301391|157102169|FG000|Overall Study|Lost to Follow-up|3|||
48798953|NCT01301391|157102169|FG000|Overall Study|Physician Decision|2|||
48798954|NCT01301391|157102169|FG000|Overall Study|Sponsor's decision|8|||
48798955|NCT02182973|157102174|FG000|Overall Study|Withdrawal by Subject|3|||
48798956|NCT02182973|157102175|FG001|Overall Study|Withdrawal by Subject|0|||
48380710|NCT01444456|155588514|FG000|Overall Study|Physician Decision|9|||
48380711|NCT01444456|155588514|FG000|Overall Study|Lost to Follow-up|37|||
48380712|NCT01444456|155588514|FG000|Overall Study|Death|73|||
48380713|NCT01444456|155588514|FG000|Overall Study|Ineligibility determined|23|||
48380714|NCT01444456|155588514|FG000|Overall Study|Other|18|||
48380715|NCT01444456|155588514|FG000|Overall Study|Not treated|104|||
48383834|NCT00436618|155601448|FG001|Overall Study|Other Medical Problems|1|||
48383835|NCT00436618|155601449|FG002|Overall Study|Other Medical Problems|7|||
48383836|NCT00436618|155601447|FG000|Overall Study|Death|4|||
48383837|NCT00436618|155601448|FG001|Overall Study|Death|2|||
48383838|NCT00436618|155601449|FG002|Overall Study|Death|3|||
48383839|NCT00436618|155601447|FG000|Overall Study|New Primary or Other Reasons|6|||
48383840|NCT00436618|155601448|FG001|Overall Study|New Primary or Other Reasons|2|||
48383841|NCT00436618|155601449|FG002|Overall Study|New Primary or Other Reasons|12|||
48383842|NCT00436618|155601447|FG000|Overall Study|Still on treatment|1|||
48383843|NCT00436618|155601448|FG001|Overall Study|Still on treatment|2|||
48383844|NCT00436618|155601449|FG002|Overall Study|Still on treatment|7|||
48383845|NCT00698451|155601450|FG000|Overall Study|Adverse Event|22|||
48383846|NCT00698451|155601450|FG000|Overall Study|Physician Decision|2|||
48383847|NCT00698451|155601450|FG000|Overall Study|Protocol Violation|6|||
48383848|NCT00698451|155601450|FG000|Overall Study|Withdrawal by Subject|6|||
48383849|NCT00698451|155601450|FG000|Overall Study|Disease progression|3|||
48383850|NCT01179672|155601451|FG000|Overall Study|Adverse Event|17|||
48383851|NCT01179672|155601452|FG001|Overall Study|Adverse Event|8|||
48383852|NCT01179672|155601451|FG000|Overall Study|Withdrawal by Subject|10|||
48383853|NCT01179672|155601452|FG001|Overall Study|Withdrawal by Subject|12|||
48383854|NCT01179672|155601451|FG000|Overall Study|Entry Criteria Not Met|0|||
48383855|NCT01179672|155601452|FG001|Overall Study|Entry Criteria Not Met|2|||
48383856|NCT01179672|155601451|FG000|Overall Study|Lost to Follow-up|0|||
48383857|NCT01179672|155601452|FG001|Overall Study|Lost to Follow-up|1|||
48383858|NCT01179672|155601451|FG000|Overall Study|Protocol Violation|2|||
48383859|NCT01179672|155601452|FG001|Overall Study|Protocol Violation|2|||
48383860|NCT01179672|155601451|FG000|Overall Study|Physician Decision|1|||
48383861|NCT01179672|155601452|FG001|Overall Study|Physician Decision|1|||
48383862|NCT03039023|155601454|FG000|Overall Study|Withdrawal by Subject|1|||
48383863|NCT03039023|155601455|FG001|Overall Study|Withdrawal by Subject|0|||
48383864|NCT03039023|155601456|FG002|Overall Study|Withdrawal by Subject|1|||
48383865|NCT03039023|155601457|FG003|Overall Study|Withdrawal by Subject|1|||
48383866|NCT03039023|155601458|FG004|Overall Study|Withdrawal by Subject|0|||
48383867|NCT03039023|155601454|FG000|Overall Study|Physician Decision|0|||
48383868|NCT03039023|155601455|FG001|Overall Study|Physician Decision|0|||
48383869|NCT03039023|155601456|FG002|Overall Study|Physician Decision|0|||
48383870|NCT03039023|155601457|FG003|Overall Study|Physician Decision|1|||
48383871|NCT03039023|155601458|FG004|Overall Study|Physician Decision|0|||
48383872|NCT02596620|155601459|FG000|Overall Study|Lost to Follow-up|1|||
48383873|NCT02596620|155601460|FG001|Overall Study|Lost to Follow-up|1|||
48383874|NCT00596934|155601461|FG000|Overall Study|Protocol Violation|1|||
48383875|NCT00596934|155601461|FG000|Overall Study|Withdrawal by Subject|1|||
48383876|NCT00450658|155601462|FG000|Overall Study|Adverse Event|24|||
48383877|NCT00450658|155601463|FG001|Overall Study|Adverse Event|15|||
48383878|NCT00450658|155601462|FG000|Overall Study|Withdrawal by Subject|43|||
48383879|NCT00450658|155601463|FG001|Overall Study|Withdrawal by Subject|26|||
48383880|NCT00450658|155601462|FG000|Overall Study|Lost to Follow-up|22|||
48383881|NCT00450658|155601463|FG001|Overall Study|Lost to Follow-up|5|||
48383882|NCT00450658|155601462|FG000|Overall Study|UGI ulcer|33|||
48383883|NCT00450658|155601463|FG001|Overall Study|UGI ulcer|34|||
48383884|NCT00450658|155601462|FG000|Overall Study|misc|21|||
48383885|NCT00450658|155601463|FG001|Overall Study|misc|10|||
48383886|NCT01829360|155601471|FG000|Overall Study|Protocol Violation|0|||
48383887|NCT01829360|155601472|FG001|Overall Study|Protocol Violation|0|||
48383888|NCT01829360|155601473|FG002|Overall Study|Protocol Violation|1|||
48380716|NCT01222507|155590617|FG000|Overall Study|Physician Decision|1|||
48380717|NCT01222507|155590617|FG000|Overall Study|Withdrawal by Subject|1|||
48380718|NCT01940354|155590618|FG000|Overall Study|Withdrawal by Subject|4|||
48380719|NCT01940354|155590619|FG001|Overall Study|Withdrawal by Subject|2|||
48380720|NCT00352885|155590620|FG000|Overall Study|Withdrawal by Subject|0|||
48380721|NCT00352885|155590621|FG001|Overall Study|Withdrawal by Subject|3|||
48380722|NCT00352885|155590620|FG000|Overall Study|Development of major depression|0|||
48380723|NCT00352885|155590621|FG001|Overall Study|Development of major depression|1|||
48380724|NCT00352885|155590620|FG000|Overall Study|Progression of metastatic melanoma|5|||
48380725|NCT00352885|155590621|FG001|Overall Study|Progression of metastatic melanoma|3|||
48380726|NCT00352885|155590620|FG000|Overall Study|Side effects of IL-2 administration|1|||
48380727|NCT00352885|155590621|FG001|Overall Study|Side effects of IL-2 administration|0|||
48380728|NCT01873495|155590622|FG000|Overall Study|Withdrawal by Subject|1|||
48380729|NCT01873495|155590622|FG000|Overall Study|Physician Decision|3|||
48380730|NCT01873495|155590622|FG000|Overall Study|Adverse Event|1|||
48380731|NCT01873495|155590622|FG000|Overall Study|Removed for Transplantation|1|||
48380732|NCT01873495|155590622|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
48798957|NCT01132326|157102178|FG000|Overall Study|Lack of Efficacy|25|||
48798958|NCT01132326|157102178|FG000|Overall Study|Adverse Event|37|||
48798959|NCT01132326|157102178|FG000|Overall Study|Protocol Violation|1|||
48798960|NCT01132326|157102178|FG000|Overall Study|Lost to Follow-up|16|||
48798961|NCT01132326|157102178|FG000|Overall Study|Withdrawal by Subject|40|||
48798962|NCT01132326|157102178|FG000|Overall Study|Physician Decision|10|||
48798963|NCT01132326|157102178|FG000|Overall Study|Study Termination|80|||
48798964|NCT01132326|157102178|FG000|Overall Study|Declining Health|1|||
48798965|NCT01132326|157102178|FG000|Overall Study|Pregnancy|1|||
48380733|NCT00719563|155590623|FG000|Overall Study|Adverse Event|16|||
48380734|NCT00719563|155590624|FG001|Overall Study|Adverse Event|13|||
48380735|NCT00719563|155590623|FG000|Overall Study|Medical condition changed|3|||
48380736|NCT00719563|155590624|FG001|Overall Study|Medical condition changed|5|||
48380737|NCT00719563|155590623|FG000|Overall Study|Lack of Efficacy|3|||
48380738|NCT00719563|155590624|FG001|Overall Study|Lack of Efficacy|7|||
48380739|NCT00719563|155590623|FG000|Overall Study|Personal reasons|6|||
48380740|NCT00719563|155590624|FG001|Overall Study|Personal reasons|7|||
48380741|NCT00719563|155590623|FG000|Overall Study|Unknown reasons|4|||
48380742|NCT00719563|155590624|FG001|Overall Study|Unknown reasons|6|||
48380743|NCT00719563|155590623|FG000|Overall Study|Noncompliant|1|||
48380744|NCT00719563|155590624|FG001|Overall Study|Noncompliant|1|||
48380745|NCT00719563|155590623|FG000|Overall Study|Lost to Follow-up|5|||
48380746|NCT00719563|155590624|FG001|Overall Study|Lost to Follow-up|3|||
48380747|NCT00462865|155590627|FG000|Overall Study|Adverse Event|1|||
48380748|NCT02864381|155590628|FG000|Overall Study|Death|58|||
48380749|NCT02864381|155590629|FG001|Overall Study|Death|61|||
48380750|NCT02864381|155590628|FG000|Overall Study|Withdrew Consent|5|||
48380751|NCT02864381|155590629|FG001|Overall Study|Withdrew Consent|6|||
48380752|NCT02864381|155590628|FG000|Overall Study|Reason Unknown|7|||
48380753|NCT02864381|155590629|FG001|Overall Study|Reason Unknown|3|||
48380754|NCT02864381|155590628|FG000|Overall Study|Lost to Follow-up|1|||
48380755|NCT02864381|155590629|FG001|Overall Study|Lost to Follow-up|1|||
48380756|NCT02864381|155590628|FG000|Overall Study|Investigator's Discretion|1|||
48380757|NCT02864381|155590629|FG001|Overall Study|Investigator's Discretion|0|||
48380758|NCT02864381|155590628|FG000|Overall Study|Protocol Violation|0|||
48380759|NCT02864381|155590629|FG001|Overall Study|Protocol Violation|1|||
48380760|NCT04142450|155590630|FG000|Overall Study|Screen Failure|1|||
48380761|NCT04142450|155590630|FG000|Overall Study|Lost to Follow-up|1|||
48380762|NCT00234494|155590631|FG000|Overall Study|Protocol Violation|2|||
48380763|NCT00888433|155590634|FG000|Overall Study|Withdrawal by Subject|1|||
48380764|NCT00888433|155590635|FG001|Overall Study|Withdrawal by Subject|2|||
48380765|NCT00888433|155590634|FG000|Overall Study|Missed Visit|2|||
48798966|NCT01132326|157102178|FG000|Overall Study|Caregiver Withdrew Consent|1|||
48380766|NCT00888433|155590635|FG001|Overall Study|Missed Visit|1|||
48380767|NCT01521897|155590636|FG000|Overall Study|Protocol Violation|18|||
48380768|NCT01521897|155590636|FG000|Overall Study|Lost to Follow-up|5|||
48380769|NCT00402363|155590642|FG000|Overall Study|Adverse Event|9|||
48798967|NCT01132326|157102178|FG000|Overall Study|Death|5|||
48798968|NCT01132326|157102178|FG000|Overall Study|Subject Unable to Come To Visits|1|||
48380770|NCT00402363|155590643|FG001|Overall Study|Adverse Event|14|||
48380771|NCT00402363|155590644|FG002|Overall Study|Adverse Event|2|||
48380772|NCT00402363|155590645|FG003|Overall Study|Adverse Event|2|||
48380773|NCT00402363|155590642|FG000|Overall Study|Withdrew Consent|10|||
48380774|NCT00402363|155590643|FG001|Overall Study|Withdrew Consent|5|||
48380775|NCT00402363|155590644|FG002|Overall Study|Withdrew Consent|2|||
48380776|NCT00402363|155590645|FG003|Overall Study|Withdrew Consent|1|||
48380777|NCT00402363|155590642|FG000|Overall Study|Protocol Violation|3|||
48589838|NCT00055497|156352167|FG001|Overall Study|Administrative Reasons|0|||
48798969|NCT02355002|157102181|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
48798970|NCT02355002|157102182|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
48798971|NCT02355002|157102181|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
48798972|NCT02355002|157102182|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
48798973|NCT02355002|157102181|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
48798974|NCT02355002|157102182|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
48798975|NCT02355002|157102181|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
48798976|NCT02355002|157102182|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
48798977|NCT02355002|157102181|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
48798978|NCT02355002|157102182|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
48798979|NCT02355002|157102181|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
48798980|NCT02355002|157102182|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
48798981|NCT02355002|157102181|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
48798982|NCT02355002|157102182|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
48798983|NCT00708916|157102183|FG000|Overall Study|Subject Noncompliance|2|||
48798984|NCT00708916|157102183|FG000|Overall Study|Adverse Event|2|||
48798985|NCT02657317|157102184|FG000|Overall Study|Withdrawal by Subject|2|||
48798986|NCT02657317|157102185|FG001|Overall Study|Withdrawal by Subject|0|||
48798987|NCT02657317|157102184|FG000|Overall Study|Lost to Follow-up|3|||
48798988|NCT02657317|157102185|FG001|Overall Study|Lost to Follow-up|3|||
48798989|NCT02110901|157102186|FG000|Overall Study|Death|6|||
48798990|NCT02110901|157102187|FG001|Overall Study|Death|3|||
48798991|NCT02110901|157102186|FG000|Overall Study|Lost to Follow-up|12|||
48798992|NCT02110901|157102187|FG001|Overall Study|Lost to Follow-up|8|||
48798993|NCT02110901|157102186|FG000|Overall Study|Withdrawal by Subject|7|||
48798994|NCT02110901|157102187|FG001|Overall Study|Withdrawal by Subject|3|||
48380778|NCT00402363|155590643|FG001|Overall Study|Protocol Violation|5|||
48380779|NCT00402363|155590644|FG002|Overall Study|Protocol Violation|0|||
48380780|NCT00402363|155590645|FG003|Overall Study|Protocol Violation|3|||
48380781|NCT00402363|155590642|FG000|Overall Study|Lost to Follow-up|5|||
48380782|NCT00402363|155590643|FG001|Overall Study|Lost to Follow-up|4|||
48380783|NCT00402363|155590644|FG002|Overall Study|Lost to Follow-up|0|||
48380784|NCT00402363|155590645|FG003|Overall Study|Lost to Follow-up|2|||
48380785|NCT00402363|155590642|FG000|Overall Study|"Captured as Other"|6|||
48380786|NCT00402363|155590643|FG001|Overall Study|"Captured as Other"|2|||
48380787|NCT00402363|155590644|FG002|Overall Study|"Captured as Other"|2|||
48380788|NCT00402363|155590645|FG003|Overall Study|"Captured as Other"|2|||
48380789|NCT01446016|155590649|FG000|Overall Study|Lost to Follow-up|3|||
48380790|NCT01446016|155590649|FG000|Overall Study|Withdrawal by Subject|1|||
48380791|NCT01446016|155590649|FG000|Overall Study|Toxicity|3|||
48380792|NCT00568321|155590651|FG000|Overall Study|Adverse Event|1|||
48380793|NCT00568321|155590652|FG001|Overall Study|Adverse Event|0|||
48380794|NCT00568321|155590653|FG002|Overall Study|Adverse Event|0|||
48380795|NCT00568321|155590651|FG000|Overall Study|Lack of Efficacy|8|||
48380796|NCT00568321|155590652|FG001|Overall Study|Lack of Efficacy|5|||
48380797|NCT00568321|155590653|FG002|Overall Study|Lack of Efficacy|6|||
48380798|NCT00568321|155590651|FG000|Overall Study|Lost to Follow-up|0|||
48380799|NCT00568321|155590652|FG001|Overall Study|Lost to Follow-up|0|||
48380800|NCT00568321|155590653|FG002|Overall Study|Lost to Follow-up|1|||
48380801|NCT00568321|155590651|FG000|Overall Study|Withdrawal by Subject|2|||
48380802|NCT00568321|155590652|FG001|Overall Study|Withdrawal by Subject|0|||
48380803|NCT00568321|155590653|FG002|Overall Study|Withdrawal by Subject|0|||
48380804|NCT00568321|155590651|FG000|Overall Study|Protocol Violation|0|||
48380805|NCT00568321|155590652|FG001|Overall Study|Protocol Violation|0|||
48380806|NCT00568321|155590653|FG002|Overall Study|Protocol Violation|1|||
48380807|NCT00568321|155590651|FG000|Overall Study|Randomized, not treated|2|||
48380808|NCT00568321|155590652|FG001|Overall Study|Randomized, not treated|0|||
48380809|NCT00568321|155590653|FG002|Overall Study|Randomized, not treated|1|||
48380810|NCT00937833|155590656|FG000|Overall Study|Protocol Violation|1|||
48380811|NCT00937833|155590657|FG001|Overall Study|Protocol Violation|2|||
48380812|NCT00937833|155590656|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
48380813|NCT00937833|155590657|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
48380814|NCT00937833|155590656|FG000|Overall Study|Lost to Follow-up|10|||
48380815|NCT00937833|155590657|FG001|Overall Study|Lost to Follow-up|8|||
48380816|NCT00937833|155590656|FG000|Overall Study|Withdrawal by Subject|4|||
48380817|NCT00937833|155590657|FG001|Overall Study|Withdrawal by Subject|6|||
48380818|NCT00992511|155590660|FG000|Overall Study|Migrated/moved from study area|1|||
48380819|NCT00992511|155590661|FG001|Overall Study|Migrated/moved from study area|0|||
48380820|NCT00992511|155590662|FG002|Overall Study|Migrated/moved from study area|1|||
48380821|NCT00992511|155590663|FG003|Overall Study|Migrated/moved from study area|2|||
48380822|NCT00992511|155590660|FG000|Overall Study|Lost to Follow-up|1|||
48380823|NCT00992511|155590661|FG001|Overall Study|Lost to Follow-up|0|||
48380824|NCT00992511|155590662|FG002|Overall Study|Lost to Follow-up|0|||
48380825|NCT00992511|155590663|FG003|Overall Study|Lost to Follow-up|2|||
48380826|NCT00992511|155590660|FG000|Overall Study|Withdrawal by Subject|0|||
48380827|NCT00992511|155590661|FG001|Overall Study|Withdrawal by Subject|0|||
48380828|NCT00992511|155590662|FG002|Overall Study|Withdrawal by Subject|1|||
48798995|NCT02110901|157102186|FG000|Overall Study|received a kidney transplant|5|||
48798996|NCT02110901|157102187|FG001|Overall Study|received a kidney transplant|0|||
48380829|NCT00992511|155590663|FG003|Overall Study|Withdrawal by Subject|1|||
48380830|NCT03942406|155590670|FG000|Overall Study|Lost to Follow-up|4|||
48798997|NCT01844284|157102188|FG000|Overall Study|Lost to Follow-up|12|||
48798998|NCT01844284|157102189|FG001|Overall Study|Lost to Follow-up|7|||
48798999|NCT00166296|157102190|FG000|Overall Study|Withdrawal by Subject|1|||
48799000|NCT00166296|157102191|FG001|Overall Study|Withdrawal by Subject|3|||
48799001|NCT00166296|157102190|FG000|Overall Study|Adverse Event|2|||
48799002|NCT00166296|157102191|FG001|Overall Study|Adverse Event|4|||
48799003|NCT00166296|157102190|FG000|Overall Study|Lost to Follow-up|4|||
48799004|NCT00166296|157102191|FG001|Overall Study|Lost to Follow-up|2|||
48799005|NCT04259450|157102194|FG000|Overall Study|Adverse event/ Toxicity|0|||
48799006|NCT04259450|157102195|FG001|Overall Study|Adverse event/ Toxicity|3|||
48799007|NCT04259450|157102196|FG002|Overall Study|Adverse event/ Toxicity|0|||
48799008|NCT04259450|157102197|FG003|Overall Study|Adverse event/ Toxicity|1|||
48799009|NCT04259450|157102198|FG004|Overall Study|Adverse event/ Toxicity|0|||
48799010|NCT04259450|157102199|FG005|Overall Study|Adverse event/ Toxicity|0|||
48799011|NCT04259450|157102200|FG006|Overall Study|Adverse event/ Toxicity|0|||
48799012|NCT04259450|157102201|FG007|Overall Study|Adverse event/ Toxicity|1|||
48799013|NCT04259450|157102202|FG008|Overall Study|Adverse event/ Toxicity|0|||
48799014|NCT04259450|157102203|FG009|Overall Study|Adverse event/ Toxicity|3|||
48799015|NCT04259450|157102194|FG000|Overall Study|Disease progression|2|||
48799016|NCT04259450|157102195|FG001|Overall Study|Disease progression|3|||
48799017|NCT04259450|157102196|FG002|Overall Study|Disease progression|4|||
48799018|NCT04259450|157102197|FG003|Overall Study|Disease progression|4|||
48799019|NCT04259450|157102198|FG004|Overall Study|Disease progression|6|||
48799020|NCT04259450|157102199|FG005|Overall Study|Disease progression|6|||
48799021|NCT04259450|157102200|FG006|Overall Study|Disease progression|5|||
48799022|NCT04259450|157102201|FG007|Overall Study|Disease progression|15|||
48799023|NCT04259450|157102202|FG008|Overall Study|Disease progression|6|||
48799024|NCT04259450|157102203|FG009|Overall Study|Disease progression|17|||
48799025|NCT04259450|157102194|FG000|Overall Study|Death|0|||
48799026|NCT04259450|157102195|FG001|Overall Study|Death|0|||
48799027|NCT04259450|157102196|FG002|Overall Study|Death|0|||
48799028|NCT04259450|157102197|FG003|Overall Study|Death|0|||
48799029|NCT04259450|157102198|FG004|Overall Study|Death|0|||
48799030|NCT04259450|157102199|FG005|Overall Study|Death|0|||
48799031|NCT04259450|157102200|FG006|Overall Study|Death|0|||
48799032|NCT04259450|157102201|FG007|Overall Study|Death|1|||
48799033|NCT04259450|157102202|FG008|Overall Study|Death|1|||
48799034|NCT04259450|157102203|FG009|Overall Study|Death|0|||
48799035|NCT04259450|157102194|FG000|Overall Study|Withdrawal by Subject|0|||
48799036|NCT04259450|157102195|FG001|Overall Study|Withdrawal by Subject|0|||
48799037|NCT04259450|157102196|FG002|Overall Study|Withdrawal by Subject|0|||
48799038|NCT04259450|157102197|FG003|Overall Study|Withdrawal by Subject|0|||
48799039|NCT04259450|157102198|FG004|Overall Study|Withdrawal by Subject|0|||
48799040|NCT04259450|157102199|FG005|Overall Study|Withdrawal by Subject|0|||
48799041|NCT04259450|157102200|FG006|Overall Study|Withdrawal by Subject|0|||
48799042|NCT04259450|157102201|FG007|Overall Study|Withdrawal by Subject|1|||
48799043|NCT04259450|157102202|FG008|Overall Study|Withdrawal by Subject|0|||
48799044|NCT04259450|157102203|FG009|Overall Study|Withdrawal by Subject|0|||
48799045|NCT04259450|157102194|FG000|Overall Study|Long Term Adverse Event|0|||
48799046|NCT04259450|157102195|FG001|Overall Study|Long Term Adverse Event|0|||
48799047|NCT04259450|157102196|FG002|Overall Study|Long Term Adverse Event|0|||
48799048|NCT04259450|157102197|FG003|Overall Study|Long Term Adverse Event|0|||
48380831|NCT03942406|155590671|FG001|Overall Study|Lost to Follow-up|5|||
48380832|NCT03942406|155590672|FG002|Overall Study|Lost to Follow-up|3|||
48380833|NCT03942406|155590673|FG003|Overall Study|Lost to Follow-up|7|||
48380834|NCT03942406|155590674|FG004|Overall Study|Lost to Follow-up|1|||
48380835|NCT03942406|155590675|FG005|Overall Study|Lost to Follow-up|0|||
48380836|NCT03942406|155590676|FG006|Overall Study|Lost to Follow-up|0|||
48380837|NCT03942406|155590670|FG000|Overall Study|Withdrawal by Subject|3|||
48380838|NCT03942406|155590671|FG001|Overall Study|Withdrawal by Subject|1|||
48799049|NCT04259450|157102198|FG004|Overall Study|Long Term Adverse Event|0|||
48799050|NCT04259450|157102199|FG005|Overall Study|Long Term Adverse Event|0|||
48799051|NCT04259450|157102200|FG006|Overall Study|Long Term Adverse Event|0|||
48799052|NCT04259450|157102201|FG007|Overall Study|Long Term Adverse Event|0|||
48799053|NCT04259450|157102202|FG008|Overall Study|Long Term Adverse Event|0|||
48799054|NCT04259450|157102203|FG009|Overall Study|Long Term Adverse Event|1|||
48799055|NCT02782169|157102222|FG000|Overall Study|Lost to Follow-up|1|||
48380839|NCT03942406|155590672|FG002|Overall Study|Withdrawal by Subject|1|||
48380840|NCT03942406|155590673|FG003|Overall Study|Withdrawal by Subject|3|||
48799056|NCT02782169|157102223|FG001|Overall Study|Lost to Follow-up|2|||
48799057|NCT03185481|157102227|FG000|Overall Study|Adverse Event|1|||
48799058|NCT03185481|157102227|FG000|Overall Study|Study Terminated by Sponsor|4|||
48799059|NCT01422408|157102228|FG000|Overall Study|Adverse Event|1|||
48799060|NCT01422408|157102228|FG000|Overall Study|Withdrawal by Subject|3|||
48380841|NCT03942406|155590674|FG004|Overall Study|Withdrawal by Subject|0|||
48380842|NCT03942406|155590675|FG005|Overall Study|Withdrawal by Subject|0|||
48380843|NCT03942406|155590676|FG006|Overall Study|Withdrawal by Subject|0|||
48380844|NCT03942406|155590670|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
48799061|NCT01936857|157102239|FG000|Overall Study|Sent to prison or 06 center|11|||
48799062|NCT01936857|157102240|FG001|Overall Study|Sent to prison or 06 center|12|||
48380845|NCT03942406|155590671|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
48380846|NCT03942406|155590672|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
48380847|NCT03942406|155590673|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
48380848|NCT03942406|155590674|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
48380849|NCT03942406|155590675|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
48380850|NCT03942406|155590676|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
48380851|NCT01207596|155590677|FG000|Overall Study|Physician Decision|4|||
48380852|NCT01207596|155590677|FG000|Overall Study|Lack of Efficacy|1|||
48380853|NCT01207596|155590677|FG000|Overall Study|Adverse Event|3|||
48380854|NCT01207596|155590677|FG000|Overall Study|Withdrawal by Subject|1|||
48380855|NCT02982187|155590678|FG000|Overall Study|Withdrawal by Subject|0|||
48380856|NCT02982187|155590679|FG001|Overall Study|Withdrawal by Subject|0|||
48799063|NCT01936857|157102239|FG000|Overall Study|Lost to Follow-up|10|||
48799064|NCT01936857|157102240|FG001|Overall Study|Lost to Follow-up|7|||
48799065|NCT01936857|157102239|FG000|Overall Study|Death|7|||
48799066|NCT01936857|157102240|FG001|Overall Study|Death|3|||
48589839|NCT00055497|156352168|FG002|Overall Study|Administrative Reasons|0|||
48589840|NCT00055497|156352169|FG003|Overall Study|Administrative Reasons|1|||
48589841|NCT00055497|156352166|FG000|Overall Study|Other|0|||
48589842|NCT00055497|156352167|FG001|Overall Study|Other|0|||
48589843|NCT00055497|156352168|FG002|Overall Study|Other|0|||
48589844|NCT00055497|156352169|FG003|Overall Study|Other|11|||
48799067|NCT01936857|157102239|FG000|Overall Study|Moved|2|||
48799068|NCT01936857|157102240|FG001|Overall Study|Moved|1|||
48799069|NCT01936857|157102239|FG000|Overall Study|Withdrawal by Subject|1|||
48799070|NCT01936857|157102240|FG001|Overall Study|Withdrawal by Subject|0|||
48799071|NCT01936857|157102239|FG000|Overall Study|Side effect of medication|1|||
48799072|NCT01936857|157102240|FG001|Overall Study|Side effect of medication|0|||
48799073|NCT01936857|157102239|FG000|Overall Study|Other|2|||
48799074|NCT01936857|157102240|FG001|Overall Study|Other|2|||
48799075|NCT01693068|157102247|FG000|Randomization Period|On-study|2|||
48799076|NCT01693068|157102248|FG001|Randomization Period|On-study|5|||
48799077|NCT01693068|157102249|FG002|Randomization Period|On-study|0|||
48799078|NCT01693068|157102247|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
48799079|NCT01693068|157102248|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
48799080|NCT01693068|157102249|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
48799081|NCT01687257|157102250|FG000|Overall Study|Efficacy Failure|6|||
48799082|NCT01687257|157102251|FG001|Overall Study|Efficacy Failure|0|||
48799083|NCT01687257|157102252|FG002|Overall Study|Efficacy Failure|5|||
48799084|NCT01687257|157102250|FG000|Overall Study|Subject Withdrew Consent|1|||
48799085|NCT01687257|157102251|FG001|Overall Study|Subject Withdrew Consent|1|||
48799086|NCT01687257|157102252|FG002|Overall Study|Subject Withdrew Consent|1|||
48799087|NCT01687257|157102250|FG000|Overall Study|Adverse Event|1|||
48799088|NCT01687257|157102251|FG001|Overall Study|Adverse Event|0|||
48799089|NCT01687257|157102252|FG002|Overall Study|Adverse Event|0|||
48799090|NCT01687257|157102250|FG000|Overall Study|Investigator's Discretion|0|||
48799091|NCT01687257|157102251|FG001|Overall Study|Investigator's Discretion|3|||
48799092|NCT01687257|157102252|FG002|Overall Study|Investigator's Discretion|0|||
48799093|NCT00736645|157102254|FG000|Overall Study|Adverse Event|0|||
48799094|NCT00736645|157102255|FG001|Overall Study|Adverse Event|2|||
48799095|NCT00736645|157102256|FG002|Overall Study|Adverse Event|0|||
48799096|NCT00736645|157102257|FG003|Overall Study|Adverse Event|0|||
48799097|NCT00168038|157102258|FG000|Overall Study|Adverse Event|1|||
48380857|NCT02982187|155590680|FG002|Overall Study|Withdrawal by Subject|0|||
48380858|NCT02982187|155590681|FG003|Overall Study|Withdrawal by Subject|0|||
48380859|NCT02982187|155590682|FG004|Overall Study|Withdrawal by Subject|0|||
48380860|NCT02982187|155590683|FG005|Overall Study|Withdrawal by Subject|0|||
48380861|NCT02982187|155590684|FG006|Overall Study|Withdrawal by Subject|1|||
48380862|NCT02982187|155590685|FG007|Overall Study|Withdrawal by Subject|0|||
48380863|NCT01601847|155590691|FG000|Overall Study|Death|1|||
48380864|NCT01601847|155590692|FG001|Overall Study|Death|0|||
48799098|NCT00168038|157102258|FG000|Overall Study|Therapy failure|1|||
48799099|NCT00717860|157102264|FG000|Overall Study|Clinical adverse experience|5|||
48799100|NCT00717860|157102265|FG001|Overall Study|Clinical adverse experience|9|||
48799101|NCT00717860|157102264|FG000|Overall Study|Laboratory adverse experience|2|||
48799102|NCT00717860|157102265|FG001|Overall Study|Laboratory adverse experience|2|||
48799103|NCT00717860|157102264|FG000|Overall Study|Lack of Efficacy|7|||
48799104|NCT00717860|157102265|FG001|Overall Study|Lack of Efficacy|13|||
48799105|NCT00717860|157102264|FG000|Overall Study|Discontinued for other reason|6|||
48799106|NCT00717860|157102265|FG001|Overall Study|Discontinued for other reason|1|||
48799107|NCT00717860|157102264|FG000|Overall Study|Withdrew consent|7|||
48589845|NCT00396383|156352170|FG000|Overall Study|Death|2|||
48589846|NCT00396383|156352170|FG000|Overall Study|Lost to Follow-up|1|||
48589847|NCT03268005|156352173|FG000|Overall Study|Death|2|||
48589848|NCT03268005|156352174|FG001|Overall Study|Death|1|||
48589849|NCT03268005|156352173|FG000|Overall Study|Lost to Follow-up|2|||
48589850|NCT03268005|156352174|FG001|Overall Study|Lost to Follow-up|2|||
48589851|NCT03268005|156352173|FG000|Overall Study|Withdrawal by Subject|11|||
48589852|NCT03268005|156352174|FG001|Overall Study|Withdrawal by Subject|11|||
48589853|NCT05752487|156352178|FG000|Overall Study|Randomized, not treated|9|||
48589854|NCT05752487|156352178|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
48589855|NCT05752487|156352178|FG000|Overall Study|Withdrawal by Subject|2|||
48589856|NCT05752487|156352178|FG000|Overall Study|Ongoing|137|||
48589857|NCT03092791|156352179|FG000|Overall Study|Lost to Follow-up|0|||
48589858|NCT03092791|156352180|FG001|Overall Study|Lost to Follow-up|0|||
48589859|NCT03092791|156352181|FG002|Overall Study|Lost to Follow-up|0|||
48589860|NCT03092791|156352182|FG003|Overall Study|Lost to Follow-up|0|||
48589861|NCT03092791|156352183|FG004|Overall Study|Lost to Follow-up|0|||
48589862|NCT03092791|156352184|FG005|Overall Study|Lost to Follow-up|0|||
48589863|NCT03092791|156352185|FG006|Overall Study|Lost to Follow-up|1|||
48589864|NCT03092791|156352186|FG007|Overall Study|Lost to Follow-up|0|||
48589865|NCT03092791|156352179|FG000|Overall Study|Withdrawal of Consent|0|||
48589866|NCT03092791|156352180|FG001|Overall Study|Withdrawal of Consent|0|||
48589867|NCT03092791|156352181|FG002|Overall Study|Withdrawal of Consent|0|||
48589868|NCT03092791|156352182|FG003|Overall Study|Withdrawal of Consent|0|||
48589869|NCT03092791|156352183|FG004|Overall Study|Withdrawal of Consent|4|||
48589870|NCT03092791|156352184|FG005|Overall Study|Withdrawal of Consent|12|||
48589871|NCT03092791|156352185|FG006|Overall Study|Withdrawal of Consent|6|||
48589872|NCT03092791|156352186|FG007|Overall Study|Withdrawal of Consent|4|||
48589873|NCT03092791|156352179|FG000|Overall Study|Study Termination|0|||
48589874|NCT03092791|156352180|FG001|Overall Study|Study Termination|0|||
48589875|NCT03092791|156352181|FG002|Overall Study|Study Termination|0|||
48589876|NCT03092791|156352182|FG003|Overall Study|Study Termination|0|||
48589877|NCT03092791|156352183|FG004|Overall Study|Study Termination|55|||
48589878|NCT03092791|156352184|FG005|Overall Study|Study Termination|46|||
48589879|NCT03092791|156352185|FG006|Overall Study|Study Termination|53|||
48589880|NCT03092791|156352186|FG007|Overall Study|Study Termination|55|||
48589881|NCT03092791|156352179|FG000|Overall Study|Death|0|||
48589882|NCT03092791|156352180|FG001|Overall Study|Death|0|||
48589883|NCT03092791|156352181|FG002|Overall Study|Death|0|||
48589884|NCT03092791|156352182|FG003|Overall Study|Death|0|||
48589885|NCT03092791|156352183|FG004|Overall Study|Death|0|||
48589886|NCT03092791|156352184|FG005|Overall Study|Death|1|||
48589887|NCT03092791|156352185|FG006|Overall Study|Death|0|||
48589888|NCT03092791|156352186|FG007|Overall Study|Death|1|||
48589889|NCT03092791|156352179|FG000|Overall Study|Reason Not Specified|0|||
48589890|NCT03092791|156352180|FG001|Overall Study|Reason Not Specified|0|||
48589891|NCT03092791|156352181|FG002|Overall Study|Reason Not Specified|0|||
48589892|NCT03092791|156352182|FG003|Overall Study|Reason Not Specified|0|||
48799108|NCT00717860|157102265|FG001|Overall Study|Withdrew consent|3|||
48799109|NCT04058353|157102266|FG000|Overall Study|Adverse Event|2|||
48799110|NCT04058353|157102267|FG001|Overall Study|Adverse Event|1|||
48799111|NCT04058353|157102266|FG000|Overall Study|Physician Decision|1|||
48799112|NCT04058353|157102267|FG001|Overall Study|Physician Decision|0|||
48799113|NCT04058353|157102266|FG000|Overall Study|Other|1|||
48589893|NCT03092791|156352183|FG004|Overall Study|Reason Not Specified|1|||
48589894|NCT03092791|156352184|FG005|Overall Study|Reason Not Specified|1|||
48799114|NCT04058353|157102267|FG001|Overall Study|Other|0|||
48799115|NCT02495025|157102270|FG000|Overall Study|Lost to Follow-up|21|||
48799116|NCT02495025|157102271|FG001|Overall Study|Lost to Follow-up|14|||
48799117|NCT02495025|157102270|FG000|Overall Study|Withdrawal by Subject|5|||
48799118|NCT02495025|157102271|FG001|Overall Study|Withdrawal by Subject|0|||
48799119|NCT02365519|157102272|FG000|Randomized and Treated|Adverse Event|0|||
48799120|NCT02365519|157102273|FG001|Randomized and Treated|Adverse Event|1|||
48799121|NCT02365519|157102274|FG002|Randomized and Treated|Adverse Event|0|||
48799122|NCT02365519|157102272|FG000|Randomized and Treated|Withdrawal by Subject|0|||
48799123|NCT02365519|157102273|FG001|Randomized and Treated|Withdrawal by Subject|1|||
48799124|NCT02365519|157102274|FG002|Randomized and Treated|Withdrawal by Subject|1|||
48799125|NCT01353222|157102276|FG000|Overall Study|Death|30|||
48799126|NCT01353222|157102277|FG001|Overall Study|Death|30|||
48799127|NCT01353222|157102276|FG000|Overall Study|Withdrawal by Subject|8|||
48589895|NCT03092791|156352185|FG006|Overall Study|Reason Not Specified|0|||
48589896|NCT03092791|156352186|FG007|Overall Study|Reason Not Specified|0|||
48589897|NCT04424914|156352195|FG000|Overall Study|Other|0|||
48589898|NCT04424914|156352196|FG001|Overall Study|Other|0|||
48589899|NCT04424914|156352197|FG002|Overall Study|Other|28|||
48589900|NCT04424914|156352195|FG000|Overall Study|Withdrawal by Subject|3|||
48799128|NCT01353222|157102277|FG001|Overall Study|Withdrawal by Subject|5|||
48799129|NCT01353222|157102276|FG000|Overall Study|Study Terminated|31|||
48799130|NCT01353222|157102277|FG001|Overall Study|Study Terminated|37|||
48799131|NCT01353222|157102276|FG000|Overall Study|Site closed research department|1|||
48799132|NCT01353222|157102277|FG001|Overall Study|Site closed research department|0|||
48799133|NCT04179721|157102278|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
48799134|NCT04179721|157102279|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
48799135|NCT04179721|157102278|FG000|Overall Study|Lost to Follow-up|0|||
48799136|NCT04179721|157102279|FG001|Overall Study|Lost to Follow-up|1|||
48799137|NCT04398537|157102282|FG000|Overall Study|Physician Decision|10|||
48799138|NCT04398537|157102283|FG001|Overall Study|Physician Decision|15|||
48799139|NCT04870710|157102284|FG000|Overall Study|Lost to Follow-up|3|||
48799140|NCT02332720|157104082|FG000|Part A and Part B|Lost to Follow-up|1|||
48799141|NCT02332720|157104083|FG001|Part A and Part B|Lost to Follow-up|0|||
48799142|NCT02332720|157104084|FG002|Part A and Part B|Lost to Follow-up|0|||
48799143|NCT02332720|157104085|FG003|Part A and Part B|Lost to Follow-up|0|||
48799144|NCT02332720|157104086|FG004|Part A and Part B|Lost to Follow-up|0|||
48799145|NCT02332720|157104087|FG005|Part A and Part B|Lost to Follow-up|2|||
48799146|NCT02332720|157104088|FG006|Part A and Part B|Lost to Follow-up|1|||
48799147|NCT02332720|157104089|FG007|Part A and Part B|Lost to Follow-up|1|||
48799148|NCT02332720|157104090|FG008|Part A and Part B|Lost to Follow-up|0|||
48799149|NCT02332720|157104091|FG009|Part A and Part B|Lost to Follow-up|0|||
48799150|NCT02332720|157104092|FG010|Part A and Part B|Lost to Follow-up|0|||
48799151|NCT02332720|157104093|FG011|Part A and Part B|Lost to Follow-up|0|||
48799152|NCT02332720|157104094|FG012|Part A and Part B|Lost to Follow-up|0|||
48799153|NCT02332720|157104095|FG013|Part A and Part B|Lost to Follow-up|0|||
48799154|NCT02332720|157104096|FG014|Part A and Part B|Lost to Follow-up|0|||
48799155|NCT02332720|157104097|FG015|Part A and Part B|Lost to Follow-up|1|||
48799156|NCT02332720|157104098|FG016|Part A and Part B|Lost to Follow-up|0|||
48799157|NCT02332720|157104099|FG017|Part A and Part B|Lost to Follow-up|0|||
48799158|NCT02332720|157104100|FG018|Part A and Part B|Lost to Follow-up|0|||
48799159|NCT02332720|157104101|FG019|Part A and Part B|Lost to Follow-up|0|||
48799160|NCT02332720|157104102|FG020|Part A and Part B|Lost to Follow-up|0|||
48799161|NCT02332720|157104103|FG021|Part A and Part B|Lost to Follow-up|0|||
48799162|NCT02332720|157104104|FG022|Part A and Part B|Lost to Follow-up|0|||
48799163|NCT02332720|157104082|FG000|Part A and Part B|Adverse Event|0|||
48799164|NCT02332720|157104083|FG001|Part A and Part B|Adverse Event|0|||
48799165|NCT02332720|157104084|FG002|Part A and Part B|Adverse Event|0|||
48799166|NCT02332720|157104085|FG003|Part A and Part B|Adverse Event|0|||
48799167|NCT02332720|157104086|FG004|Part A and Part B|Adverse Event|0|||
48799168|NCT02332720|157104087|FG005|Part A and Part B|Adverse Event|0|||
48799169|NCT02332720|157104088|FG006|Part A and Part B|Adverse Event|0|||
48799170|NCT02332720|157104089|FG007|Part A and Part B|Adverse Event|0|||
48799171|NCT02332720|157104090|FG008|Part A and Part B|Adverse Event|0|||
48799172|NCT02332720|157104091|FG009|Part A and Part B|Adverse Event|0|||
48799173|NCT02332720|157104092|FG010|Part A and Part B|Adverse Event|0|||
48799174|NCT02332720|157104093|FG011|Part A and Part B|Adverse Event|0|||
48799175|NCT02332720|157104094|FG012|Part A and Part B|Adverse Event|0|||
48799176|NCT02332720|157104095|FG013|Part A and Part B|Adverse Event|0|||
48799177|NCT02332720|157104096|FG014|Part A and Part B|Adverse Event|0|||
48799178|NCT02332720|157104097|FG015|Part A and Part B|Adverse Event|0|||
48799179|NCT02332720|157104098|FG016|Part A and Part B|Adverse Event|0|||
48799180|NCT02332720|157104099|FG017|Part A and Part B|Adverse Event|1|||
48799181|NCT02332720|157104100|FG018|Part A and Part B|Adverse Event|0|||
48799182|NCT02332720|157104101|FG019|Part A and Part B|Adverse Event|0|||
48799183|NCT02332720|157104102|FG020|Part A and Part B|Adverse Event|0|||
48799184|NCT02332720|157104103|FG021|Part A and Part B|Adverse Event|0|||
48799185|NCT02332720|157104104|FG022|Part A and Part B|Adverse Event|0|||
48799186|NCT02332720|157104082|FG000|Part A and Part B|Physician Decision|0|||
48799187|NCT02332720|157104083|FG001|Part A and Part B|Physician Decision|0|||
48799188|NCT02332720|157104084|FG002|Part A and Part B|Physician Decision|0|||
48799189|NCT02332720|157104085|FG003|Part A and Part B|Physician Decision|0|||
48799190|NCT02332720|157104086|FG004|Part A and Part B|Physician Decision|0|||
48799191|NCT02332720|157104087|FG005|Part A and Part B|Physician Decision|0|||
48799192|NCT02332720|157104088|FG006|Part A and Part B|Physician Decision|0|||
48799193|NCT02332720|157104089|FG007|Part A and Part B|Physician Decision|0|||
48799194|NCT02332720|157104090|FG008|Part A and Part B|Physician Decision|0|||
48799195|NCT02332720|157104091|FG009|Part A and Part B|Physician Decision|0|||
48799196|NCT02332720|157104092|FG010|Part A and Part B|Physician Decision|0|||
48799197|NCT02332720|157104093|FG011|Part A and Part B|Physician Decision|0|||
48799198|NCT02332720|157104094|FG012|Part A and Part B|Physician Decision|0|||
48799199|NCT02332720|157104095|FG013|Part A and Part B|Physician Decision|0|||
48799200|NCT02332720|157104096|FG014|Part A and Part B|Physician Decision|0|||
48799201|NCT02332720|157104097|FG015|Part A and Part B|Physician Decision|0|||
48799202|NCT02332720|157104098|FG016|Part A and Part B|Physician Decision|0|||
48799203|NCT02332720|157104099|FG017|Part A and Part B|Physician Decision|0|||
48380865|NCT01601847|155590691|FG000|Overall Study|Withdrawal by Subject|11|||
48799204|NCT02332720|157104100|FG018|Part A and Part B|Physician Decision|1|||
48799205|NCT02332720|157104101|FG019|Part A and Part B|Physician Decision|0|||
48799206|NCT02332720|157104102|FG020|Part A and Part B|Physician Decision|0|||
48799207|NCT02332720|157104103|FG021|Part A and Part B|Physician Decision|0|||
48799208|NCT02332720|157104104|FG022|Part A and Part B|Physician Decision|0|||
48799209|NCT02332720|157104082|FG000|Part A and Part B|Withdrawal by Subject|0|||
48799210|NCT02332720|157104083|FG001|Part A and Part B|Withdrawal by Subject|0|||
48799211|NCT02332720|157104084|FG002|Part A and Part B|Withdrawal by Subject|0|||
48799212|NCT02332720|157104085|FG003|Part A and Part B|Withdrawal by Subject|0|||
48799213|NCT02332720|157104086|FG004|Part A and Part B|Withdrawal by Subject|0|||
48799214|NCT02332720|157104087|FG005|Part A and Part B|Withdrawal by Subject|1|||
48799215|NCT02332720|157104088|FG006|Part A and Part B|Withdrawal by Subject|0|||
48799216|NCT02332720|157104089|FG007|Part A and Part B|Withdrawal by Subject|0|||
48799217|NCT02332720|157104090|FG008|Part A and Part B|Withdrawal by Subject|0|||
48799218|NCT02332720|157104091|FG009|Part A and Part B|Withdrawal by Subject|0|||
48799219|NCT02332720|157104092|FG010|Part A and Part B|Withdrawal by Subject|0|||
48799220|NCT02332720|157104093|FG011|Part A and Part B|Withdrawal by Subject|0|||
48799221|NCT02332720|157104094|FG012|Part A and Part B|Withdrawal by Subject|0|||
48799222|NCT02332720|157104095|FG013|Part A and Part B|Withdrawal by Subject|0|||
48799223|NCT02332720|157104096|FG014|Part A and Part B|Withdrawal by Subject|0|||
48799224|NCT02332720|157104097|FG015|Part A and Part B|Withdrawal by Subject|0|||
48799225|NCT02332720|157104098|FG016|Part A and Part B|Withdrawal by Subject|0|||
48799226|NCT02332720|157104099|FG017|Part A and Part B|Withdrawal by Subject|0|||
48799227|NCT02332720|157104100|FG018|Part A and Part B|Withdrawal by Subject|0|||
48799228|NCT02332720|157104101|FG019|Part A and Part B|Withdrawal by Subject|1|||
48799229|NCT02332720|157104102|FG020|Part A and Part B|Withdrawal by Subject|0|||
48799230|NCT02332720|157104103|FG021|Part A and Part B|Withdrawal by Subject|0|||
48799231|NCT02332720|157104104|FG022|Part A and Part B|Withdrawal by Subject|0|||
48799232|NCT03338894|157104105|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
48799233|NCT01972529|157104106|FG000|Overall Study|Adverse Event|0|||
48799234|NCT01972529|157104107|FG001|Overall Study|Adverse Event|1|||
48589901|NCT04424914|156352196|FG001|Overall Study|Withdrawal by Subject|0|||
48589902|NCT04424914|156352197|FG002|Overall Study|Withdrawal by Subject|0|||
48589903|NCT04424914|156352195|FG000|Overall Study|Study terminated by sponsor|23|||
48589904|NCT04424914|156352196|FG001|Overall Study|Study terminated by sponsor|7|||
48589905|NCT04424914|156352197|FG002|Overall Study|Study terminated by sponsor|0|||
48589906|NCT04424914|156352195|FG000|Overall Study|Lost to Follow-up|0|||
48589907|NCT04424914|156352196|FG001|Overall Study|Lost to Follow-up|0|||
48589908|NCT04424914|156352197|FG002|Overall Study|Lost to Follow-up|1|||
48589909|NCT04424914|156352195|FG000|Overall Study|Death|3|||
48589910|NCT04424914|156352196|FG001|Overall Study|Death|1|||
48589911|NCT04424914|156352197|FG002|Overall Study|Death|0|||
48589912|NCT00073008|156352198|FG000|Overall Study|Missing|6|||
48589913|NCT00073008|156352199|FG001|Overall Study|Missing|6|||
48589914|NCT00073008|156352198|FG000|Overall Study|Withdrawal by Subject|2|||
48589915|NCT00073008|156352199|FG001|Overall Study|Withdrawal by Subject|2|||
48589916|NCT00073008|156352198|FG000|Overall Study|Lost to Follow-up|1|||
48589917|NCT00073008|156352199|FG001|Overall Study|Lost to Follow-up|3|||
48589918|NCT00073008|156352198|FG000|Overall Study|Death|46|||
48589919|NCT00073008|156352199|FG001|Overall Study|Death|47|||
48589920|NCT00073008|156352198|FG000|Overall Study|"Other selected on Case Report Form"|7|||
48589921|NCT00073008|156352199|FG001|Overall Study|"Other selected on Case Report Form"|5|||
48589922|NCT02069093|156352200|FG000|Overall Study|Disease progression|14|||
48589923|NCT02069093|156352200|FG000|Overall Study|New cancer therapy|1|||
48589924|NCT02069093|156352200|FG000|Overall Study|Death|1|||
48589925|NCT02069093|156352200|FG000|Overall Study|Administrative problems|1|||
48589926|NCT02069093|156352200|FG000|Overall Study|Withdrawal by Subject|2|||
48589927|NCT02069093|156352200|FG000|Overall Study|Abnormal laboratory values|1|||
48589928|NCT02069093|156352200|FG000|Overall Study|Adverse Event|10|||
48589929|NCT03178851|156352206|FG000|Overall Study|Death|48|||
48589930|NCT03178851|156352207|FG001|Overall Study|Death|2|||
48589931|NCT03178851|156352208|FG002|Overall Study|Death|25|||
48799235|NCT01972529|157104108|FG002|Overall Study|Adverse Event|0|||
48799236|NCT01972529|157104109|FG003|Overall Study|Adverse Event|0|||
48799237|NCT01972529|157104106|FG000|Overall Study|Lost to Follow-up|1|||
48799238|NCT01972529|157104107|FG001|Overall Study|Lost to Follow-up|0|||
48799239|NCT01972529|157104108|FG002|Overall Study|Lost to Follow-up|0|||
48799240|NCT01972529|157104109|FG003|Overall Study|Lost to Follow-up|0|||
48380866|NCT01601847|155590692|FG001|Overall Study|Withdrawal by Subject|7|||
48380867|NCT01601847|155590691|FG000|Overall Study|Lost to Follow-up|1|||
48380868|NCT01601847|155590692|FG001|Overall Study|Lost to Follow-up|3|||
48589932|NCT03178851|156352206|FG000|Overall Study|Withdrawal by Subject|8|||
48589933|NCT03178851|156352207|FG001|Overall Study|Withdrawal by Subject|0|||
48589934|NCT03178851|156352208|FG002|Overall Study|Withdrawal by Subject|0|||
48589935|NCT03178851|156352206|FG000|Overall Study|Lost to Follow-up|5|||
48589936|NCT03178851|156352207|FG001|Overall Study|Lost to Follow-up|2|||
48589937|NCT03178851|156352208|FG002|Overall Study|Lost to Follow-up|0|||
48799241|NCT01972529|157104106|FG000|Overall Study|Participant Choice|0|||
48589938|NCT03178851|156352206|FG000|Overall Study|Adverse Event|0|||
48589939|NCT03178851|156352207|FG001|Overall Study|Adverse Event|0|||
48589940|NCT03178851|156352208|FG002|Overall Study|Adverse Event|1|||
48799242|NCT01972529|157104107|FG001|Overall Study|Participant Choice|1|||
48799243|NCT01972529|157104108|FG002|Overall Study|Participant Choice|0|||
48799244|NCT01972529|157104109|FG003|Overall Study|Participant Choice|0|||
48799245|NCT01972529|157104106|FG000|Overall Study|Withdrawl of Consent|1|||
48799246|NCT01972529|157104107|FG001|Overall Study|Withdrawl of Consent|2|||
48799247|NCT01972529|157104108|FG002|Overall Study|Withdrawl of Consent|0|||
48799248|NCT01972529|157104109|FG003|Overall Study|Withdrawl of Consent|1|||
48799249|NCT01972529|157104106|FG000|Overall Study|Other|0|||
48799250|NCT01972529|157104107|FG001|Overall Study|Other|0|||
48799251|NCT01972529|157104108|FG002|Overall Study|Other|0|||
48799252|NCT01972529|157104109|FG003|Overall Study|Other|2|||
48799253|NCT01972529|157104106|FG000|Overall Study|Not treated|0|||
48799254|NCT01972529|157104107|FG001|Overall Study|Not treated|1|||
48799255|NCT01972529|157104108|FG002|Overall Study|Not treated|2|||
48799256|NCT01972529|157104109|FG003|Overall Study|Not treated|1|||
48799257|NCT01896869|157104111|FG000|Overall Study|Withdrawal by Subject|0|||
48799258|NCT01896869|157104112|FG001|Overall Study|Withdrawal by Subject|6|||
48799259|NCT01896869|157104111|FG000|Overall Study|Lost to Follow-up|1|||
48799260|NCT01896869|157104112|FG001|Overall Study|Lost to Follow-up|0|||
48799261|NCT00077064|157104113|FG000|Overall Study|Adverse Event|0|||
48799262|NCT00077064|157104114|FG001|Overall Study|Adverse Event|4|||
48799263|NCT00077064|157104113|FG000|Overall Study|Patient refusal|0|||
48799264|NCT00077064|157104114|FG001|Overall Study|Patient refusal|2|||
48799265|NCT00118716|157104122|FG000|Overall Study|Adverse Event|2|||
48799266|NCT00118716|157104123|FG001|Overall Study|Adverse Event|7|||
48799267|NCT00118716|157104122|FG000|Overall Study|Protocol Violation|5|||
48799268|NCT00118716|157104123|FG001|Overall Study|Protocol Violation|4|||
48799269|NCT00118716|157104122|FG000|Overall Study|Withdrawal by Subject|0|||
48799270|NCT00118716|157104123|FG001|Overall Study|Withdrawal by Subject|1|||
48799271|NCT00118716|157104122|FG000|Overall Study|Exacerbation|2|||
48799272|NCT00118716|157104123|FG001|Overall Study|Exacerbation|2|||
48799273|NCT00118716|157104122|FG000|Overall Study|Discontinued by sponsor|1|||
48799274|NCT00118716|157104123|FG001|Overall Study|Discontinued by sponsor|1|||
48799275|NCT00118716|157104122|FG000|Overall Study|Non-compliance|1|||
48799276|NCT00118716|157104123|FG001|Overall Study|Non-compliance|3|||
48799277|NCT00118716|157104122|FG000|Overall Study|misrandomized|1|||
48799278|NCT00118716|157104123|FG001|Overall Study|misrandomized|1|||
48799279|NCT00118716|157104122|FG000|Overall Study|Expired drug use|1|||
48799280|NCT00118716|157104123|FG001|Overall Study|Expired drug use|2|||
48799281|NCT00118716|157104122|FG000|Overall Study|Investigator discretion|0|||
48799282|NCT00118716|157104123|FG001|Overall Study|Investigator discretion|1|||
48799283|NCT02230956|157104124|FG000|Overall Study|Adverse Event|1|||
48799284|NCT02230956|157104125|FG001|Overall Study|Adverse Event|1|||
48799285|NCT02230956|157104126|FG002|Overall Study|Adverse Event|0|||
48799286|NCT02230956|157104124|FG000|Overall Study|Lack of Efficacy|1|||
48799287|NCT02230956|157104125|FG001|Overall Study|Lack of Efficacy|1|||
48799288|NCT02230956|157104126|FG002|Overall Study|Lack of Efficacy|1|||
48799289|NCT02230956|157104124|FG000|Overall Study|Lost to Follow-up|1|||
48799290|NCT02230956|157104125|FG001|Overall Study|Lost to Follow-up|1|||
48799291|NCT02230956|157104126|FG002|Overall Study|Lost to Follow-up|2|||
48799292|NCT02230956|157104124|FG000|Overall Study|Personal Reasons|2|||
48799293|NCT02230956|157104125|FG001|Overall Study|Personal Reasons|1|||
48799294|NCT02230956|157104126|FG002|Overall Study|Personal Reasons|1|||
48799295|NCT02230956|157104124|FG000|Overall Study|Protocol Violation|0|||
48799296|NCT02230956|157104125|FG001|Overall Study|Protocol Violation|1|||
48799297|NCT02230956|157104126|FG002|Overall Study|Protocol Violation|1|||
48799298|NCT02230956|157104124|FG000|Overall Study|Other Miscellaneous Reason|0|||
48799299|NCT02230956|157104125|FG001|Overall Study|Other Miscellaneous Reason|1|||
48799300|NCT02230956|157104126|FG002|Overall Study|Other Miscellaneous Reason|2|||
48799301|NCT00621543|157104128|FG000|Overall Study|Lost to Follow-up|23|||
48799302|NCT00763958|157104129|FG000|Overall Study|did not meet final criteria|4|||
48799303|NCT00763958|157104130|FG001|Overall Study|did not meet final criteria|4|||
48799304|NCT00763958|157104129|FG000|Overall Study|Lost to Follow-up|10|||
48799305|NCT00763958|157104130|FG001|Overall Study|Lost to Follow-up|2|||
48799306|NCT00763958|157104129|FG000|Overall Study|Believed they were receiving placebo|0|||
48799307|NCT00763958|157104130|FG001|Overall Study|Believed they were receiving placebo|5|||
48799308|NCT02709005|157104131|FG000|Overall Study|Lost to Follow-up|1|||
48799309|NCT02709005|157104132|FG001|Overall Study|Lost to Follow-up|1|||
48799310|NCT02709005|157104131|FG000|Overall Study|Withdrawal by Subject|3|||
48799311|NCT02709005|157104132|FG001|Overall Study|Withdrawal by Subject|0|||
48799312|NCT01428076|157104136|FG000|Overall Study|Adverse Event|0|||
48799313|NCT01428076|157104137|FG001|Overall Study|Adverse Event|1|||
48799314|NCT02216773|157104158|FG000|Overall Study|Disease progression|4|||
48799315|NCT02216773|157104159|FG001|Overall Study|Disease progression|2|||
48799316|NCT02216773|157104158|FG000|Overall Study|Insufficient FLRV|4|||
48799317|NCT02216773|157104159|FG001|Overall Study|Insufficient FLRV|0|||
48799318|NCT02216773|157104158|FG000|Overall Study|Abandoned|4|||
48325474|NCT00371345|155389105|FG000|Overall Study|Participant Request|1|||
48799319|NCT02216773|157104159|FG001|Overall Study|Abandoned|3|||
48799320|NCT03266770|157104160|FG000|Overall Study|Physician Decision|3|||
48799321|NCT03266770|157104160|FG000|Overall Study|Insufficient study supplies|1|||
48799322|NCT03266770|157104160|FG000|Overall Study|Adverse Event|1|||
48799323|NCT04274894|157104161|FG000|Overall Study|Adverse Event|7|||
48799324|NCT04274894|157104161|FG000|Overall Study|Withdrew consent|5|||
48799325|NCT04274894|157104161|FG000|Overall Study|Lost to Follow-up|9|||
48799326|NCT04274894|157104161|FG000|Overall Study|COVID-19 infection|1|||
48799327|NCT04274894|157104161|FG000|Overall Study|Other, not specified|20|||
48799328|NCT03649230|157104169|FG000|Overall Study|Adverse Event|12|||
48799329|NCT03649230|157104169|FG000|Overall Study|Death|8|||
48799330|NCT03649230|157104169|FG000|Overall Study|Withdrawal by Subject|6|||
48799331|NCT03649230|157104169|FG000|Overall Study|Physician Decision|5|||
48799332|NCT03649230|157104169|FG000|Overall Study|Disease progression|5|||
48799333|NCT03649230|157104169|FG000|Overall Study|Switched to non-HEC|5|||
48799334|NCT03649230|157104169|FG000|Overall Study|Chemotherapy discontinued|4|||
48799335|NCT03649230|157104169|FG000|Overall Study|Received only 3 HEC cycles|4|||
48799336|NCT03649230|157104169|FG000|Overall Study|Screen Failure|3|||
48799337|NCT03649230|157104169|FG000|Overall Study|Patient stopped treatment|2|||
48799338|NCT03649230|157104169|FG000|Overall Study|Protocol Violation|1|||
48799339|NCT03649230|157104169|FG000|Overall Study|Non-compliance|1|||
48799340|NCT03649230|157104169|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
48799341|NCT03848403|157104170|FG000|Period 2 (Day 8)|Adverse Event|1|||
48799342|NCT03848403|157104171|FG001|Period 2 (Day 8)|Adverse Event|2|||
48799343|NCT03848403|157104172|FG002|Period 2 (Day 8)|Adverse Event|2|||
48799344|NCT03848403|157104170|FG000|Period 2 (Day 8)|Physician Decision|0|||
48799345|NCT03848403|157104171|FG001|Period 2 (Day 8)|Physician Decision|1|||
48799346|NCT03848403|157104172|FG002|Period 2 (Day 8)|Physician Decision|0|||
48799347|NCT03848403|157104170|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
48799348|NCT03848403|157104171|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
48799349|NCT03848403|157104172|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
48799350|NCT03685591|157104173|FG000|Overall Study|Global Deterioration of Health Status|0|||
48799351|NCT03685591|157104174|FG001|Overall Study|Global Deterioration of Health Status|0|||
48799352|NCT03685591|157104175|FG002|Overall Study|Global Deterioration of Health Status|0|||
48799353|NCT03685591|157104176|FG003|Overall Study|Global Deterioration of Health Status|1|||
48799354|NCT03685591|157104177|FG004|Overall Study|Global Deterioration of Health Status|2|||
48799355|NCT03685591|157104178|FG005|Overall Study|Global Deterioration of Health Status|4|||
48799356|NCT03685591|157104179|FG006|Overall Study|Global Deterioration of Health Status|1|||
48799357|NCT03685591|157104180|FG007|Overall Study|Global Deterioration of Health Status|1|||
48799358|NCT03685591|157104181|FG008|Overall Study|Global Deterioration of Health Status|0|||
48380869|NCT01284062|155590693|FG000|Overall Study|Adverse Event|4|||
48380870|NCT01284062|155590694|FG001|Overall Study|Adverse Event|5|||
48380871|NCT01284062|155590695|FG002|Overall Study|Adverse Event|0|||
48380872|NCT01284062|155590696|FG003|Overall Study|Adverse Event|5|||
48380873|NCT01284062|155590693|FG000|Overall Study|Lack of Efficacy|3|||
48799359|NCT03685591|157104173|FG000|Overall Study|Progressive Disease|1|||
48799360|NCT03685591|157104174|FG001|Overall Study|Progressive Disease|1|||
48799361|NCT03685591|157104175|FG002|Overall Study|Progressive Disease|0|||
48799362|NCT03685591|157104176|FG003|Overall Study|Progressive Disease|3|||
48799363|NCT03685591|157104177|FG004|Overall Study|Progressive Disease|5|||
48799364|NCT03685591|157104178|FG005|Overall Study|Progressive Disease|4|||
48799365|NCT03685591|157104179|FG006|Overall Study|Progressive Disease|3|||
48799366|NCT03685591|157104180|FG007|Overall Study|Progressive Disease|2|||
48799367|NCT03685591|157104181|FG008|Overall Study|Progressive Disease|1|||
48799368|NCT03685591|157104173|FG000|Overall Study|Other|0|||
48799369|NCT03685591|157104174|FG001|Overall Study|Other|0|||
48799370|NCT03685591|157104175|FG002|Overall Study|Other|1|||
48799371|NCT03685591|157104176|FG003|Overall Study|Other|0|||
48799372|NCT03685591|157104177|FG004|Overall Study|Other|2|||
48799373|NCT03685591|157104178|FG005|Overall Study|Other|3|||
48799374|NCT03685591|157104179|FG006|Overall Study|Other|0|||
48799375|NCT03685591|157104180|FG007|Overall Study|Other|0|||
48799376|NCT03685591|157104181|FG008|Overall Study|Other|0|||
48799377|NCT03685591|157104173|FG000|Overall Study|Withdrawal by Subject|0|||
48799378|NCT03685591|157104174|FG001|Overall Study|Withdrawal by Subject|0|||
48799379|NCT03685591|157104175|FG002|Overall Study|Withdrawal by Subject|0|||
48799380|NCT03685591|157104176|FG003|Overall Study|Withdrawal by Subject|0|||
48799381|NCT03685591|157104177|FG004|Overall Study|Withdrawal by Subject|3|||
48799382|NCT03685591|157104178|FG005|Overall Study|Withdrawal by Subject|2|||
48799383|NCT03685591|157104179|FG006|Overall Study|Withdrawal by Subject|0|||
48799384|NCT03685591|157104180|FG007|Overall Study|Withdrawal by Subject|0|||
48799385|NCT03685591|157104181|FG008|Overall Study|Withdrawal by Subject|1|||
48799386|NCT03685591|157104173|FG000|Overall Study|Adverse Event|0|||
48799387|NCT03685591|157104174|FG001|Overall Study|Adverse Event|0|||
48799388|NCT03685591|157104175|FG002|Overall Study|Adverse Event|0|||
48799389|NCT03685591|157104176|FG003|Overall Study|Adverse Event|1|||
48799390|NCT03685591|157104177|FG004|Overall Study|Adverse Event|1|||
48799391|NCT03685591|157104178|FG005|Overall Study|Adverse Event|4|||
48799392|NCT03685591|157104179|FG006|Overall Study|Adverse Event|0|||
48799393|NCT03685591|157104180|FG007|Overall Study|Adverse Event|1|||
48799394|NCT03685591|157104181|FG008|Overall Study|Adverse Event|1|||
48799395|NCT00490282|157104182|FG000|Overall Study|Withdrawal by Subject|3|||
48799396|NCT04510675|157104183|FG000|Overall Study|Withdrawal by Subject|5|||
48799397|NCT00734630|157104187|FG000|Overall Study|Lack of Efficacy|4|||
48799398|NCT00734630|157104188|FG001|Overall Study|Lack of Efficacy|4|||
48799399|NCT00734630|157104187|FG000|Overall Study|Withdrawal by Subject|7|||
48799400|NCT00734630|157104188|FG001|Overall Study|Withdrawal by Subject|9|||
48799401|NCT00734630|157104187|FG000|Overall Study|Lost to Follow-up|13|||
48799402|NCT00734630|157104188|FG001|Overall Study|Lost to Follow-up|7|||
48799403|NCT00734630|157104187|FG000|Overall Study|Protocol Violation|0|||
48799404|NCT00734630|157104188|FG001|Overall Study|Protocol Violation|3|||
48799405|NCT00734630|157104187|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
48799406|NCT00734630|157104188|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
48799407|NCT00734630|157104187|FG000|Overall Study|Adverse Event|3|||
48799408|NCT00734630|157104188|FG001|Overall Study|Adverse Event|6|||
48799409|NCT00734630|157104187|FG000|Overall Study|Randomized in Error|0|||
48380874|NCT01284062|155590694|FG001|Overall Study|Lack of Efficacy|2|||
48799410|NCT00734630|157104188|FG001|Overall Study|Randomized in Error|1|||
48799411|NCT00734630|157104187|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
48799412|NCT00734630|157104188|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
48799413|NCT00734630|157104187|FG000|Overall Study|Poor Compliance|1|||
48799414|NCT00734630|157104188|FG001|Overall Study|Poor Compliance|1|||
48799415|NCT02034708|157104189|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
48799416|NCT02034708|157104190|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
48799417|NCT02034708|157104189|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
48799418|NCT02034708|157104190|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
48799419|NCT02034708|157104189|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
48799420|NCT02034708|157104190|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
48799421|NCT02034708|157104189|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
48799422|NCT02034708|157104190|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
48799423|NCT00733980|157104191|FG000|Overall Study|Adverse Event|5|||
48799424|NCT00733980|157104192|FG001|Overall Study|Adverse Event|2|||
48799425|NCT00733980|157104191|FG000|Overall Study|Lack of Efficacy|0|||
48799426|NCT00733980|157104192|FG001|Overall Study|Lack of Efficacy|1|||
48799427|NCT00733980|157104191|FG000|Overall Study|Protocol Violation|2|||
48799428|NCT00733980|157104192|FG001|Overall Study|Protocol Violation|1|||
48799429|NCT00733980|157104191|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
48799430|NCT00733980|157104192|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
48799431|NCT00733980|157104191|FG000|Overall Study|Lost to Follow-up|6|||
48799432|NCT00733980|157104192|FG001|Overall Study|Lost to Follow-up|11|||
48799433|NCT00733980|157104191|FG000|Overall Study|Physician Decision|2|||
48799434|NCT00733980|157104192|FG001|Overall Study|Physician Decision|3|||
48799435|NCT00733980|157104191|FG000|Overall Study|Withdrawal by Subject|6|||
48799436|NCT00733980|157104192|FG001|Overall Study|Withdrawal by Subject|2|||
48799437|NCT00977665|157104195|FG000|Overall Study|Withdrawal by Subject|1|||
48799438|NCT00977665|157104196|FG001|Overall Study|Withdrawal by Subject|3|||
48799439|NCT00977665|157104195|FG000|Overall Study|Physician Decision|2|||
48799440|NCT00977665|157104196|FG001|Overall Study|Physician Decision|1|||
48799441|NCT00977665|157104195|FG000|Overall Study|Sponsor requested withdrawal|0|||
48799442|NCT00977665|157104196|FG001|Overall Study|Sponsor requested withdrawal|1|||
48799443|NCT00977665|157104195|FG000|Overall Study|Lost to Follow-up|1|||
48799444|NCT00977665|157104196|FG001|Overall Study|Lost to Follow-up|0|||
48799445|NCT00977665|157104195|FG000|Overall Study|Death|3|||
48799446|NCT00977665|157104196|FG001|Overall Study|Death|2|||
48799447|NCT00977665|157104195|FG000|Overall Study|Adverse Event|14|||
48799448|NCT00977665|157104196|FG001|Overall Study|Adverse Event|7|||
48799449|NCT00977665|157104195|FG000|Overall Study|Treatment failure|0|||
48799450|NCT00977665|157104196|FG001|Overall Study|Treatment failure|1|||
48799451|NCT00689026|157104197|FG000|Overall Study|Withdrawal by Subject|13|||
48799452|NCT00689026|157104198|FG001|Overall Study|Withdrawal by Subject|6|||
48799453|NCT01330433|157104199|FG000|Overall Study|Death|1|||
48799454|NCT01330433|157104200|FG001|Overall Study|Death|3|||
48799455|NCT01330433|157104199|FG000|Overall Study|Lost to Follow-up|1|||
48799456|NCT01330433|157104200|FG001|Overall Study|Lost to Follow-up|0|||
48799457|NCT01552954|157104201|FG000|Overall Study|Adverse Event|1|||
48799458|NCT01552954|157104202|FG001|Overall Study|Adverse Event|2|||
48799459|NCT01552954|157104201|FG000|Overall Study|Lost to Follow-up|1|||
48799460|NCT01552954|157104202|FG001|Overall Study|Lost to Follow-up|1|||
48799461|NCT01552954|157104201|FG000|Overall Study|Withdrawal by Subject|1|||
48799462|NCT01552954|157104202|FG001|Overall Study|Withdrawal by Subject|1|||
48799463|NCT01552954|157104201|FG000|Overall Study|Protocol Violation|1|||
48799464|NCT01552954|157104202|FG001|Overall Study|Protocol Violation|2|||
48799465|NCT01552954|157104201|FG000|Overall Study|diagnosed DM|1|||
48799466|NCT01552954|157104202|FG001|Overall Study|diagnosed DM|0|||
48799467|NCT04843930|157104203|FG000|Randomization|Withdrawal by Subject|6|||
48380875|NCT01284062|155590695|FG002|Overall Study|Lack of Efficacy|2|||
48589941|NCT03178851|156352206|FG000|Overall Study|Study Termination by Sponsor|31|||
48799468|NCT04843930|157104204|FG001|Randomization|Withdrawal by Subject|6|||
48799469|NCT04843930|157104205|FG002|Randomization|Withdrawal by Subject|0|||
48799470|NCT04843930|157104206|FG003|Randomization|Withdrawal by Subject|0|||
48799471|NCT04843930|157104203|FG000|Week 6 Assessment|Adverse Event|3|||
48799472|NCT04843930|157104204|FG001|Week 6 Assessment|Adverse Event|0|||
48799473|NCT04843930|157104205|FG002|Week 6 Assessment|Adverse Event|0|||
48380876|NCT01284062|155590696|FG003|Overall Study|Lack of Efficacy|1|||
48380877|NCT01284062|155590693|FG000|Overall Study|Medication error without adverse event|0|||
48380878|NCT01284062|155590694|FG001|Overall Study|Medication error without adverse event|0|||
48380879|NCT01284062|155590695|FG002|Overall Study|Medication error without adverse event|1|||
48380880|NCT01284062|155590696|FG003|Overall Study|Medication error without adverse event|0|||
48380881|NCT01284062|155590693|FG000|Overall Study|Protocol Violation|1|||
48380882|NCT01284062|155590694|FG001|Overall Study|Protocol Violation|0|||
48380883|NCT01284062|155590695|FG002|Overall Study|Protocol Violation|0|||
48380884|NCT01284062|155590696|FG003|Overall Study|Protocol Violation|2|||
48380885|NCT01284062|155590693|FG000|Overall Study|Withdrawal by Subject|3|||
48380886|NCT01284062|155590694|FG001|Overall Study|Withdrawal by Subject|1|||
48380887|NCT01284062|155590695|FG002|Overall Study|Withdrawal by Subject|2|||
48380888|NCT01284062|155590696|FG003|Overall Study|Withdrawal by Subject|5|||
48380889|NCT01284062|155590693|FG000|Overall Study|Other|0|||
48380890|NCT01284062|155590694|FG001|Overall Study|Other|0|||
48380891|NCT01284062|155590695|FG002|Overall Study|Other|0|||
48380892|NCT01284062|155590696|FG003|Overall Study|Other|1|||
48380893|NCT01284062|155590693|FG000|Overall Study|Site Closed|0|||
48380894|NCT01284062|155590694|FG001|Overall Study|Site Closed|0|||
48380895|NCT01284062|155590695|FG002|Overall Study|Site Closed|1|||
48380896|NCT01284062|155590696|FG003|Overall Study|Site Closed|0|||
48380897|NCT00954174|155590697|FG000|Overall Study|Adverse Event|28|||
48380898|NCT00954174|155590698|FG001|Overall Study|Adverse Event|23|||
48380899|NCT00954174|155590699|FG002|Overall Study|Adverse Event|4|||
48380900|NCT00954174|155590700|FG003|Overall Study|Adverse Event|9|||
48380901|NCT00954174|155590697|FG000|Overall Study|Death|4|||
48380902|NCT00954174|155590698|FG001|Overall Study|Death|2|||
48380903|NCT00954174|155590699|FG002|Overall Study|Death|0|||
48380904|NCT00954174|155590700|FG003|Overall Study|Death|0|||
48380905|NCT00954174|155590697|FG000|Overall Study|Lack of Efficacy|32|||
48380906|NCT00954174|155590698|FG001|Overall Study|Lack of Efficacy|22|||
48380907|NCT00954174|155590699|FG002|Overall Study|Lack of Efficacy|8|||
48380908|NCT00954174|155590700|FG003|Overall Study|Lack of Efficacy|6|||
48380909|NCT00954174|155590697|FG000|Overall Study|Withdrawal by Subject|14|||
48380910|NCT00954174|155590698|FG001|Overall Study|Withdrawal by Subject|10|||
48380911|NCT00954174|155590699|FG002|Overall Study|Withdrawal by Subject|4|||
48380912|NCT00954174|155590700|FG003|Overall Study|Withdrawal by Subject|3|||
48380913|NCT00954174|155590697|FG000|Overall Study|Medical Reason|4|||
48380914|NCT00954174|155590698|FG001|Overall Study|Medical Reason|2|||
48380915|NCT00954174|155590699|FG002|Overall Study|Medical Reason|1|||
48380916|NCT00954174|155590700|FG003|Overall Study|Medical Reason|0|||
48380917|NCT00954174|155590697|FG000|Overall Study|Ineligible|40|||
48380918|NCT00954174|155590698|FG001|Overall Study|Ineligible|47|||
48380919|NCT00954174|155590699|FG002|Overall Study|Ineligible|7|||
48380920|NCT00954174|155590700|FG003|Overall Study|Ineligible|4|||
48380921|NCT00954174|155590697|FG000|Overall Study|Never Treated|4|||
48380922|NCT00954174|155590698|FG001|Overall Study|Never Treated|17|||
48380923|NCT00954174|155590699|FG002|Overall Study|Never Treated|0|||
48380924|NCT00954174|155590700|FG003|Overall Study|Never Treated|3|||
48380925|NCT01829425|155590705|FG000|Overall Study|Withdrawal by Subject|4|||
48380926|NCT01829425|155590706|FG001|Overall Study|Withdrawal by Subject|3|||
48380927|NCT01829425|155590705|FG000|Overall Study|Lost to Follow-up|2|||
48380928|NCT01829425|155590706|FG001|Overall Study|Lost to Follow-up|1|||
48380929|NCT00728481|155590709|FG000|Overall Study|Withdrawal by Subject|0|||
48380930|NCT00728481|155590710|FG001|Overall Study|Withdrawal by Subject|1|||
48380931|NCT00728481|155590709|FG000|Overall Study|Adverse Event|0|||
48380932|NCT00728481|155590710|FG001|Overall Study|Adverse Event|1|||
48380933|NCT00728481|155590709|FG000|Overall Study|Study medication non-compliance|0|||
48380934|NCT00728481|155590710|FG001|Overall Study|Study medication non-compliance|2|||
48380935|NCT00728481|155590709|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
48380936|NCT00728481|155590710|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
48380937|NCT00778622|155590711|FG000|Overall Study|Adverse Event|5|||
48380938|NCT00778622|155590712|FG001|Overall Study|Adverse Event|4|||
48380939|NCT00778622|155590713|FG002|Overall Study|Adverse Event|7|||
48380940|NCT00778622|155590711|FG000|Overall Study|Withdrawal by Subject|4|||
48380941|NCT00778622|155590712|FG001|Overall Study|Withdrawal by Subject|5|||
48380942|NCT00778622|155590713|FG002|Overall Study|Withdrawal by Subject|5|||
48380943|NCT00778622|155590711|FG000|Overall Study|Lost to Follow-up|3|||
48380944|NCT00778622|155590712|FG001|Overall Study|Lost to Follow-up|3|||
48380945|NCT00778622|155590713|FG002|Overall Study|Lost to Follow-up|2|||
48380946|NCT00778622|155590711|FG000|Overall Study|Protocol Violation|0|||
48380947|NCT00778622|155590712|FG001|Overall Study|Protocol Violation|3|||
48380948|NCT00778622|155590713|FG002|Overall Study|Protocol Violation|0|||
48380949|NCT00778622|155590711|FG000|Overall Study|Lack of Efficacy|2|||
48380950|NCT00778622|155590712|FG001|Overall Study|Lack of Efficacy|0|||
48380951|NCT00778622|155590713|FG002|Overall Study|Lack of Efficacy|0|||
48380952|NCT00778622|155590711|FG000|Overall Study|immigration|1|||
48380953|NCT00778622|155590712|FG001|Overall Study|immigration|0|||
48380954|NCT00778622|155590713|FG002|Overall Study|immigration|0|||
48380955|NCT00778622|155590711|FG000|Overall Study|Other|1|||
48380956|NCT00778622|155590712|FG001|Overall Study|Other|0|||
48380957|NCT00778622|155590713|FG002|Overall Study|Other|1|||
48380958|NCT01032382|155590714|FG000|Overall Study|Disease dissemination|1|||
48380959|NCT01032382|155590715|FG001|Overall Study|Disease dissemination|1|||
48380960|NCT01032382|155590714|FG000|Overall Study|Treatment failure|3|||
48380961|NCT01032382|155590715|FG001|Overall Study|Treatment failure|1|||
48380962|NCT01032382|155590714|FG000|Overall Study|Index lesion relapse|1|||
48380963|NCT01032382|155590715|FG001|Overall Study|Index lesion relapse|3|||
48380964|NCT00775450|155590716|FG000|Overall Study|Serious Adverse Event|2|||
48380965|NCT00775450|155590717|FG001|Overall Study|Serious Adverse Event|0|||
48380966|NCT00775450|155590718|FG002|Overall Study|Serious Adverse Event|0|||
48380967|NCT00775450|155590719|FG003|Overall Study|Serious Adverse Event|0|||
48380968|NCT00775450|155590720|FG004|Overall Study|Serious Adverse Event|0|||
48380969|NCT00775450|155590716|FG000|Overall Study|Protocol Violation|0|||
48380970|NCT00775450|155590717|FG001|Overall Study|Protocol Violation|0|||
48380971|NCT00775450|155590718|FG002|Overall Study|Protocol Violation|0|||
48380972|NCT00775450|155590719|FG003|Overall Study|Protocol Violation|0|||
48380973|NCT00775450|155590720|FG004|Overall Study|Protocol Violation|1|||
48380974|NCT00775450|155590716|FG000|Overall Study|Withdrawal by Subject|1|||
48380975|NCT00775450|155590717|FG001|Overall Study|Withdrawal by Subject|0|||
48380976|NCT00775450|155590718|FG002|Overall Study|Withdrawal by Subject|0|||
48380977|NCT00775450|155590719|FG003|Overall Study|Withdrawal by Subject|0|||
48380978|NCT00775450|155590720|FG004|Overall Study|Withdrawal by Subject|1|||
48380979|NCT01822522|155590721|FG000|Overall Study|Adverse Event|1|||
48380980|NCT01822522|155590722|FG001|Overall Study|Adverse Event|1|||
48380981|NCT01822522|155590723|FG002|Overall Study|Adverse Event|1|||
48380982|NCT01822522|155590724|FG003|Overall Study|Adverse Event|0|||
48380983|NCT01822522|155590725|FG004|Overall Study|Adverse Event|0|||
48380984|NCT01822522|155590726|FG005|Overall Study|Adverse Event|1|||
48380985|NCT01822522|155590721|FG000|Overall Study|Death|3|||
48380986|NCT01822522|155590722|FG001|Overall Study|Death|0|||
48380987|NCT01822522|155590723|FG002|Overall Study|Death|2|||
48380988|NCT01822522|155590724|FG003|Overall Study|Death|0|||
48380989|NCT01822522|155590725|FG004|Overall Study|Death|0|||
48380990|NCT01822522|155590726|FG005|Overall Study|Death|0|||
48380991|NCT01822522|155590721|FG000|Overall Study|Lost to Follow-up|0|||
48380992|NCT01822522|155590722|FG001|Overall Study|Lost to Follow-up|0|||
48380993|NCT01822522|155590723|FG002|Overall Study|Lost to Follow-up|1|||
48380994|NCT01822522|155590724|FG003|Overall Study|Lost to Follow-up|1|||
48380995|NCT01822522|155590725|FG004|Overall Study|Lost to Follow-up|0|||
48380996|NCT01822522|155590726|FG005|Overall Study|Lost to Follow-up|1|||
48380997|NCT01822522|155590721|FG000|Overall Study|Withdrawal by Subject|0|||
48380998|NCT01822522|155590722|FG001|Overall Study|Withdrawal by Subject|0|||
48380999|NCT01822522|155590723|FG002|Overall Study|Withdrawal by Subject|0|||
48381000|NCT01822522|155590724|FG003|Overall Study|Withdrawal by Subject|1|||
48381001|NCT01822522|155590725|FG004|Overall Study|Withdrawal by Subject|0|||
48381002|NCT01822522|155590726|FG005|Overall Study|Withdrawal by Subject|0|||
48381003|NCT01822522|155590721|FG000|Overall Study|Lack of Efficacy|0|||
48381004|NCT01822522|155590722|FG001|Overall Study|Lack of Efficacy|0|||
48381005|NCT01822522|155590723|FG002|Overall Study|Lack of Efficacy|0|||
48381006|NCT01822522|155590724|FG003|Overall Study|Lack of Efficacy|0|||
48381007|NCT01822522|155590725|FG004|Overall Study|Lack of Efficacy|0|||
48381008|NCT01822522|155590726|FG005|Overall Study|Lack of Efficacy|2|||
48381009|NCT00821431|155590727|FG000|Overall Study|Adverse Event|6|||
48381010|NCT00821431|155590728|FG001|Overall Study|Adverse Event|3|||
48381011|NCT00821431|155590727|FG000|Overall Study|Withdrawal by Subject|5|||
48381012|NCT00821431|155590728|FG001|Overall Study|Withdrawal by Subject|0|||
48381013|NCT00821431|155590727|FG000|Overall Study|Lost to Follow-up|1|||
48381014|NCT00821431|155590728|FG001|Overall Study|Lost to Follow-up|0|||
48381015|NCT00821431|155590727|FG000|Overall Study|Protocol Violation|3|||
48381016|NCT00821431|155590728|FG001|Overall Study|Protocol Violation|1|||
48381017|NCT00821431|155590727|FG000|Overall Study|Physician Decision|0|||
48381018|NCT00821431|155590728|FG001|Overall Study|Physician Decision|1|||
48381019|NCT04556136|155590729|FG000|Overall Study|Lost to Follow-up|6|||
48381020|NCT04556136|155590730|FG001|Overall Study|Lost to Follow-up|6|||
48381021|NCT04556136|155590729|FG000|Overall Study|Physician Decision|2|||
48381022|NCT04556136|155590730|FG001|Overall Study|Physician Decision|1|||
48381023|NCT04556136|155590729|FG000|Overall Study|Withdrawal by Subject|2|||
48381024|NCT04556136|155590730|FG001|Overall Study|Withdrawal by Subject|1|||
48381025|NCT00995007|155590731|FG000|Overall Study|Withdrew consent|1|||
48381026|NCT00995007|155590732|FG001|Overall Study|Withdrew consent|0|||
48381027|NCT00995007|155590731|FG000|Overall Study|Refused further treatment|8|||
48381028|NCT00995007|155590732|FG001|Overall Study|Refused further treatment|2|||
48381029|NCT00995007|155590731|FG000|Overall Study|Toxicity|8|||
48381030|NCT00995007|155590732|FG001|Overall Study|Toxicity|0|||
48381031|NCT03933397|155590733|FG000|Overall Study|No emergency department visit|65|||
48381032|NCT03933397|155590734|FG001|Overall Study|No emergency department visit|71|||
48381033|NCT03933397|155590733|FG000|Overall Study|Missed emergency department visit|25|||
48381034|NCT03933397|155590734|FG001|Overall Study|Missed emergency department visit|30|||
48381035|NCT03933397|155590733|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
48381036|NCT03933397|155590734|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
48381037|NCT03933397|155590733|FG000|Overall Study|Withdrawal by Subject|1|||
48381038|NCT03933397|155590734|FG001|Overall Study|Withdrawal by Subject|0|||
48381039|NCT03933397|155590733|FG000|Overall Study|Physician Decision|1|||
48381040|NCT03933397|155590734|FG001|Overall Study|Physician Decision|1|||
48381041|NCT03933397|155590733|FG000|Overall Study|missing pain score|1|||
48381042|NCT03933397|155590734|FG001|Overall Study|missing pain score|1|||
48381043|NCT03933397|155590733|FG000|Overall Study|Confirmed COVID-19|1|||
48381044|NCT03933397|155590734|FG001|Overall Study|Confirmed COVID-19|2|||
48381045|NCT02066051|155590741|FG000|Overall Study|Subject developed active GVHD|1|||
48693192|NCT04479787|156726366|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
48381046|NCT02469896|155590753|FG000|Overall Study|Withdrawal by Subject|2|||
48381047|NCT02469896|155590754|FG001|Overall Study|Withdrawal by Subject|0|||
48381048|NCT02401412|155590758|FG000|Overall Study|Lost to Follow-up|1|||
48381049|NCT02401412|155590759|FG001|Overall Study|Lost to Follow-up|0|||
48381050|NCT02401412|155590758|FG000|Overall Study|Discontinued Intervention|15|||
48381051|NCT02401412|155590759|FG001|Overall Study|Discontinued Intervention|21|||
48381052|NCT02401412|155590758|FG000|Overall Study|Withdrawal by Subject|4|||
48381053|NCT02401412|155590759|FG001|Overall Study|Withdrawal by Subject|4|||
48381054|NCT02401412|155590758|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
48381055|NCT02401412|155590759|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
48381056|NCT02401412|155590758|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
48381057|NCT02401412|155590759|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
48381058|NCT00564018|155590760|FG000|Overall Study|Withdrawal by Subject|2|||
48381059|NCT00564018|155590761|FG001|Overall Study|Withdrawal by Subject|3|||
48381060|NCT00564018|155590762|FG002|Overall Study|Withdrawal by Subject|1|||
48381061|NCT01840605|155590768|FG000|Overall Study|Adverse Event|0|||
48381062|NCT01840605|155590769|FG001|Overall Study|Adverse Event|1|||
48381063|NCT01840605|155590768|FG000|Overall Study|Physician Decision|2|||
48381064|NCT01840605|155590769|FG001|Overall Study|Physician Decision|1|||
48381065|NCT02921269|155590770|FG000|Overall Study|Did not complete DLT period|1|||
48381066|NCT01119001|155590774|FG000|Overall Study|Withdrawal by Subject|2|||
48381067|NCT03211247|155590775|FG000|Overall Study|Adverse Event|8|||
48381068|NCT03211247|155590776|FG001|Overall Study|Adverse Event|0|||
48381069|NCT03211247|155590777|FG002|Overall Study|Adverse Event|1|||
48381070|NCT03211247|155590778|FG003|Overall Study|Adverse Event|0|||
48381071|NCT03211247|155590779|FG004|Overall Study|Adverse Event|0|||
48381072|NCT03211247|155590775|FG000|Overall Study|Lost to Follow-up|2|||
48381073|NCT03211247|155590776|FG001|Overall Study|Lost to Follow-up|1|||
48381074|NCT03211247|155590777|FG002|Overall Study|Lost to Follow-up|0|||
48381075|NCT03211247|155590778|FG003|Overall Study|Lost to Follow-up|0|||
48381076|NCT03211247|155590779|FG004|Overall Study|Lost to Follow-up|0|||
48381077|NCT03211247|155590775|FG000|Overall Study|Physician Decision|1|||
48381078|NCT03211247|155590776|FG001|Overall Study|Physician Decision|2|||
48381079|NCT03211247|155590777|FG002|Overall Study|Physician Decision|0|||
48381080|NCT03211247|155590778|FG003|Overall Study|Physician Decision|0|||
48381081|NCT03211247|155590779|FG004|Overall Study|Physician Decision|0|||
48381082|NCT03211247|155590775|FG000|Overall Study|Non-compliance with study drug|2|||
48381083|NCT03211247|155590776|FG001|Overall Study|Non-compliance with study drug|0|||
48381084|NCT03211247|155590777|FG002|Overall Study|Non-compliance with study drug|0|||
48381085|NCT03211247|155590778|FG003|Overall Study|Non-compliance with study drug|0|||
48381086|NCT03211247|155590779|FG004|Overall Study|Non-compliance with study drug|0|||
48381087|NCT03211247|155590775|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
48381088|NCT03211247|155590776|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
48381089|NCT03211247|155590777|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
48381090|NCT03211247|155590778|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
48381091|NCT03211247|155590779|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
48381092|NCT03211247|155590775|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
48381093|NCT03211247|155590776|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
48381094|NCT03211247|155590777|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
48381095|NCT03211247|155590778|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
48381096|NCT03211247|155590779|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
48381097|NCT03211247|155590775|FG000|Overall Study|Protocol Violation|0|||
48381098|NCT03211247|155590776|FG001|Overall Study|Protocol Violation|1|||
48381099|NCT03211247|155590777|FG002|Overall Study|Protocol Violation|0|||
48381100|NCT03211247|155590778|FG003|Overall Study|Protocol Violation|0|||
48381101|NCT03211247|155590779|FG004|Overall Study|Protocol Violation|0|||
48381102|NCT03231943|155590781|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381103|NCT03231943|155590782|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
48381104|NCT03231943|155590783|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
48381105|NCT03231943|155590784|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381106|NCT03231943|155590785|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381107|NCT03231943|155590786|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381108|NCT03231943|155590787|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381109|NCT03231943|155590788|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381110|NCT03231943|155590789|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381111|NCT03231943|155590790|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381112|NCT03231943|155590791|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381113|NCT03231943|155590792|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381114|NCT03231943|155590793|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
48381115|NCT03231943|155590781|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381116|NCT03231943|155590782|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
48381117|NCT03231943|155590783|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381118|NCT03231943|155590784|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381119|NCT03231943|155590785|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381120|NCT03231943|155590786|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381121|NCT03231943|155590787|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381122|NCT03231943|155590788|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48383889|NCT01829360|155601474|FG003|Overall Study|Protocol Violation|0|||
48589942|NCT03178851|156352207|FG001|Overall Study|Study Termination by Sponsor|7|||
48589943|NCT03178851|156352208|FG002|Overall Study|Study Termination by Sponsor|26|||
48381123|NCT03231943|155590789|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381124|NCT03231943|155590790|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381125|NCT03231943|155590791|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381126|NCT03231943|155590792|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381127|NCT03231943|155590793|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
48381128|NCT03231943|155590781|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
48381129|NCT03231943|155590782|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381130|NCT03231943|155590783|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381131|NCT03231943|155590784|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381132|NCT03231943|155590785|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381133|NCT03231943|155590786|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381134|NCT03231943|155590787|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381135|NCT03231943|155590788|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381136|NCT03231943|155590789|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381137|NCT03231943|155590790|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381138|NCT03231943|155590791|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381139|NCT03231943|155590792|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381140|NCT03231943|155590793|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
48381141|NCT03231943|155590781|FG000|Part 2|Adverse Event|0|||
48381142|NCT03231943|155590782|FG001|Part 2|Adverse Event|0|||
48693193|NCT04479787|156726367|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
48381143|NCT03231943|155590783|FG002|Part 2|Adverse Event|0|||
48381144|NCT03231943|155590784|FG003|Part 2|Adverse Event|0|||
48381145|NCT03231943|155590785|FG004|Part 2|Adverse Event|0|||
48381146|NCT03231943|155590786|FG005|Part 2|Adverse Event|0|||
48381147|NCT03231943|155590787|FG006|Part 2|Adverse Event|0|||
48381148|NCT03231943|155590788|FG007|Part 2|Adverse Event|0|||
48381149|NCT03231943|155590789|FG008|Part 2|Adverse Event|0|||
48381150|NCT03231943|155590790|FG009|Part 2|Adverse Event|0|||
48381151|NCT03231943|155590791|FG010|Part 2|Adverse Event|1|||
48381152|NCT03231943|155590792|FG011|Part 2|Adverse Event|0|||
48381153|NCT03231943|155590793|FG012|Part 2|Adverse Event|0|||
48381154|NCT03231943|155590781|FG000|Part 2|Withdrawal by Subject|0|||
48381155|NCT03231943|155590782|FG001|Part 2|Withdrawal by Subject|0|||
48381156|NCT03231943|155590783|FG002|Part 2|Withdrawal by Subject|0|||
48381157|NCT03231943|155590784|FG003|Part 2|Withdrawal by Subject|0|||
48381158|NCT03231943|155590785|FG004|Part 2|Withdrawal by Subject|0|||
48381159|NCT03231943|155590786|FG005|Part 2|Withdrawal by Subject|0|||
48381160|NCT03231943|155590787|FG006|Part 2|Withdrawal by Subject|0|||
48381161|NCT03231943|155590788|FG007|Part 2|Withdrawal by Subject|0|||
48381162|NCT03231943|155590789|FG008|Part 2|Withdrawal by Subject|0|||
48381163|NCT03231943|155590790|FG009|Part 2|Withdrawal by Subject|0|||
48381164|NCT03231943|155590791|FG010|Part 2|Withdrawal by Subject|0|||
48381165|NCT03231943|155590792|FG011|Part 2|Withdrawal by Subject|1|||
48381166|NCT03231943|155590793|FG012|Part 2|Withdrawal by Subject|0|||
48381167|NCT05505045|155592700|FG000|Overall Study|Withdrawal by Subject|2|||
48381168|NCT05505045|155592701|FG001|Overall Study|Withdrawal by Subject|1|||
48381169|NCT04104321|155592702|FG000|Overall Study|didn't take the study drug|3|||
48381170|NCT04752475|155592704|FG000|Overall Study|Withdrawal by Subject|1|||
48381171|NCT04752475|155592705|FG001|Overall Study|Withdrawal by Subject|1|||
48381172|NCT03873493|155592710|FG000|Overall Study|Withdrawal by Subject|1|||
48381173|NCT03873493|155592710|FG000|Overall Study|Death|9|||
48381174|NCT03873493|155592710|FG000|Overall Study|Lost to Follow-up|1|||
48381175|NCT03873493|155592710|FG000|Overall Study|Study Terminated by Sponsor|1|||
48381176|NCT03873493|155592710|FG000|Overall Study|Other|2|||
48381177|NCT03756350|155592712|FG000|Overall Study|Lost to Follow-up|1|||
48381178|NCT00702845|155592716|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
48381179|NCT00702845|155592717|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
48381180|NCT00702845|155592716|FG000|Overall Study|Too high ovarian response|5|||
48381181|NCT00702845|155592717|FG001|Overall Study|Too high ovarian response|1|||
48381182|NCT00702845|155592716|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
48381183|NCT00702845|155592717|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
48381184|NCT00702845|155592716|FG000|Overall Study|Insufficient ovarian response|1|||
48381185|NCT00702845|155592717|FG001|Overall Study|Insufficient ovarian response|0|||
48381186|NCT00702845|155592716|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
48381187|NCT00702845|155592717|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
48381188|NCT00702845|155592716|FG000|Overall Study|No or abnormal fertilization|4|||
48381189|NCT00702845|155592717|FG001|Overall Study|No or abnormal fertilization|2|||
48381190|NCT00702845|155592716|FG000|Overall Study|Patient's decision|2|||
48381191|NCT00702845|155592717|FG001|Overall Study|Patient's decision|1|||
48381192|NCT00702845|155592716|FG000|Overall Study|Not randomized|0|||
48381193|NCT00702845|155592717|FG001|Overall Study|Not randomized|1|||
48381194|NCT00928564|155592718|FG000|Overall Study|Lost to Follow-up|6|||
48381195|NCT00928564|155592719|FG001|Overall Study|Lost to Follow-up|0|||
48381196|NCT02460497|155592722|FG000|Overall Study|Participant Requested Withdrawal|4|||
48381197|NCT02460497|155592722|FG000|Overall Study|Non-Compliance|1|||
48381198|NCT02460497|155592722|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
48381199|NCT02460497|155592722|FG000|Overall Study|Lost to Follow-up|2|||
48381200|NCT02460497|155592722|FG000|Overall Study|Investigator Decision|1|||
48381201|NCT01096342|155592723|FG000|Overall Study|Protocol Violation|1|||
48381202|NCT01729156|155592724|FG000|Overall Study|Withdrawal by Subject|1|||
48381203|NCT01729156|155592725|FG001|Overall Study|Withdrawal by Subject|0|||
48381204|NCT01729156|155592726|FG002|Overall Study|Withdrawal by Subject|0|||
48381205|NCT00146328|155592727|FG000|Overall Study|Adverse Event|39|||
48381206|NCT00146328|155592728|FG001|Overall Study|Adverse Event|48|||
48381207|NCT00146328|155592729|FG002|Overall Study|Adverse Event|79|||
48381208|NCT00146328|155592727|FG000|Overall Study|Protocol Violation|11|||
48381209|NCT00146328|155592728|FG001|Overall Study|Protocol Violation|6|||
48381210|NCT00146328|155592729|FG002|Overall Study|Protocol Violation|12|||
48381211|NCT00146328|155592727|FG000|Overall Study|Lost to Follow-up|7|||
48381212|NCT00146328|155592728|FG001|Overall Study|Lost to Follow-up|4|||
48381213|NCT00146328|155592729|FG002|Overall Study|Lost to Follow-up|7|||
48381214|NCT00146328|155592727|FG000|Overall Study|Withdrawal by Subject|16|||
48381215|NCT00146328|155592728|FG001|Overall Study|Withdrawal by Subject|16|||
48381216|NCT00146328|155592729|FG002|Overall Study|Withdrawal by Subject|22|||
48381217|NCT00146328|155592727|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
48381218|NCT00146328|155592728|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
48381219|NCT00146328|155592729|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
48381220|NCT00146328|155592727|FG000|Overall Study|Trial ended/site closed|8|||
48381221|NCT00146328|155592728|FG001|Overall Study|Trial ended/site closed|2|||
48381222|NCT00146328|155592729|FG002|Overall Study|Trial ended/site closed|19|||
48381223|NCT00146328|155592727|FG000|Overall Study|Patient decision to end|0|||
48381224|NCT00146328|155592728|FG001|Overall Study|Patient decision to end|1|||
48381225|NCT00146328|155592729|FG002|Overall Study|Patient decision to end|6|||
48381226|NCT00146328|155592727|FG000|Overall Study|Enroll into other trial|2|||
48381227|NCT00146328|155592728|FG001|Overall Study|Enroll into other trial|4|||
48381228|NCT00146328|155592729|FG002|Overall Study|Enroll into other trial|2|||
48381229|NCT00146328|155592727|FG000|Overall Study|Death|0|||
48381230|NCT00146328|155592728|FG001|Overall Study|Death|1|||
48381231|NCT00146328|155592729|FG002|Overall Study|Death|1|||
48381232|NCT00146328|155592727|FG000|Overall Study|Moved|2|||
48381233|NCT00146328|155592728|FG001|Overall Study|Moved|0|||
48381234|NCT00146328|155592729|FG002|Overall Study|Moved|0|||
48381235|NCT00146328|155592727|FG000|Overall Study|Interaction with other medication|2|||
48381236|NCT00146328|155592728|FG001|Overall Study|Interaction with other medication|0|||
48381237|NCT00146328|155592729|FG002|Overall Study|Interaction with other medication|1|||
48381238|NCT01256658|155592730|FG000|Period 1|Lost to Follow-up|837|||
48381239|NCT01256658|155592731|FG001|Period 1|Lost to Follow-up|661|||
48381240|NCT01256658|155592730|FG000|Period 1|Withdrawal by Subject|35|||
48381241|NCT01256658|155592731|FG001|Period 1|Withdrawal by Subject|43|||
48381242|NCT01256658|155592730|FG000|Period 1|Death|48|||
48381243|NCT01256658|155592731|FG001|Period 1|Death|44|||
48381244|NCT00567268|155592732|FG000|Overall Study|Protocol Violation|7|||
48381245|NCT00567268|155592732|FG000|Overall Study|Lost to Follow-up|36|||
48381246|NCT00567268|155592732|FG000|Overall Study|No Visit After First Day of Treatment|2|||
48381247|NCT00567268|155592732|FG000|Overall Study|No Drug Administration|4|||
48381248|NCT00567268|155592732|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
48381249|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
48381250|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
48381251|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
48381252|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
48381253|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
48381254|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
48381255|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
48381256|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
48381257|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
48381258|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
48381259|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
48381260|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
48381261|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Death|3|||
48381262|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Death|1|||
48381263|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
48381264|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
48381265|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Adverse Event|7|||
48381266|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Adverse Event|8|||
48589944|NCT03951753|156352209|FG000|Overall Study|Adverse Event|1|||
48381267|NCT03236246|155592733|FG000|24-Week Dose Titration Period|Captured as Other|1|||
48381268|NCT03236246|155592734|FG001|24-Week Dose Titration Period|Captured as Other|2|||
48381269|NCT03236246|155592733|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
48381270|NCT03236246|155592734|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
48432071|NCT01683071|155769035|FG004|Part 1|Withdrawal by Subject|0|||
48381271|NCT03236246|155592733|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
48381272|NCT03236246|155592734|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
48381273|NCT03236246|155592733|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
48381274|NCT03236246|155592734|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
48381275|NCT03236246|155592733|FG000|24-Week Dose Maintenance Period|Death|0|||
48381276|NCT03236246|155592734|FG001|24-Week Dose Maintenance Period|Death|1|||
48381277|NCT03236246|155592733|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
48381278|NCT03236246|155592734|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
48381279|NCT01330914|155592735|FG000|Overall Study|Withdrawal by Subject|4|||
48381280|NCT01330914|155592735|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
48381281|NCT02952001|155592738|FG000|Overall Study|Adverse Event|3|||
48381282|NCT02952001|155592739|FG001|Overall Study|Adverse Event|0|||
48589945|NCT03951753|156352210|FG001|Overall Study|Adverse Event|0|||
48589946|NCT03951753|156352211|FG002|Overall Study|Adverse Event|3|||
48589947|NCT03951753|156352209|FG000|Overall Study|Withdrawal by Subject|3|||
48589948|NCT03951753|156352210|FG001|Overall Study|Withdrawal by Subject|1|||
48381283|NCT02952001|155592738|FG000|Overall Study|Prohibited therapy|10|||
48381284|NCT02952001|155592739|FG001|Overall Study|Prohibited therapy|3|||
48381285|NCT02952001|155592738|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
48381286|NCT02952001|155592739|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
48381287|NCT05323084|155592746|FG000|Period 2 - Washout|Lost to Follow-up|0|||
48381288|NCT05323084|155592747|FG001|Period 2 - Washout|Lost to Follow-up|1|||
48381289|NCT01008696|155592753|FG000|Overall Study|Participant's evasion of hospital visit|5|||
48381290|NCT01008696|155592754|FG001|Overall Study|Participant's evasion of hospital visit|4|||
48381291|NCT01008696|155592753|FG000|Overall Study|Withdrawal by Subject|2|||
48381292|NCT01008696|155592754|FG001|Overall Study|Withdrawal by Subject|4|||
48381293|NCT01008696|155592753|FG000|Overall Study|Physician Decision|5|||
48381294|NCT01008696|155592754|FG001|Overall Study|Physician Decision|1|||
48381295|NCT01008696|155592753|FG000|Overall Study|Adverse Event|1|||
48484608|NCT00343642|155969210|FG000|Overall Study|Lost to Follow-up|0|||
48484609|NCT00343642|155969211|FG001|Overall Study|Lost to Follow-up|1|||
48484610|NCT00343642|155969212|FG002|Overall Study|Lost to Follow-up|0|||
48484611|NCT00343642|155969210|FG000|Overall Study|Pregnancy|1|||
48484612|NCT00343642|155969211|FG001|Overall Study|Pregnancy|0|||
48484613|NCT00343642|155969212|FG002|Overall Study|Pregnancy|2|||
48589949|NCT03951753|156352211|FG002|Overall Study|Withdrawal by Subject|0|||
48589950|NCT03951753|156352209|FG000|Overall Study|Lost to Follow-up|0|||
48589951|NCT03951753|156352210|FG001|Overall Study|Lost to Follow-up|0|||
48589952|NCT03951753|156352211|FG002|Overall Study|Lost to Follow-up|1|||
48589953|NCT02226120|156352214|FG000|Overall Study|Adverse Event|60|||
48589954|NCT02226120|156352214|FG000|Overall Study|Death|172|||
48589955|NCT02226120|156352214|FG000|Overall Study|Study terminated by sponsor|1|||
48589956|NCT02226120|156352214|FG000|Overall Study|Technical problems|4|||
48589957|NCT02226120|156352214|FG000|Overall Study|Lost to Follow-up|13|||
48589958|NCT02226120|156352214|FG000|Overall Study|Physician Decision|21|||
48589959|NCT02226120|156352214|FG000|Overall Study|Withdrawal by parent/guardian|36|||
48589960|NCT02226120|156352214|FG000|Overall Study|Non-compliance with study drug|10|||
48589961|NCT02226120|156352214|FG000|Overall Study|Protocol deviation|1|||
48589962|NCT02226120|156352214|FG000|Overall Study|missing treatment disposition pages|2|||
48589963|NCT02208050|156352217|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
48589964|NCT02208050|156352218|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
48589965|NCT00840034|156352219|FG000|Acute Treatment Phase|Adverse Event|6|||
48589966|NCT00840034|156352220|FG001|Acute Treatment Phase|Adverse Event|8|||
48589967|NCT00840034|156352219|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
48589968|NCT00840034|156352220|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
48589969|NCT00840034|156352219|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
48589970|NCT00840034|156352220|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
48589971|NCT00840034|156352219|FG000|Acute Treatment Phase|Physician Decision|0|||
48589972|NCT00840034|156352220|FG001|Acute Treatment Phase|Physician Decision|1|||
48589973|NCT00840034|156352219|FG000|Acute Treatment Phase|Protocol Violation|2|||
48589974|NCT00840034|156352220|FG001|Acute Treatment Phase|Protocol Violation|4|||
48589975|NCT00840034|156352219|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
48589976|NCT00840034|156352220|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
48589977|NCT00840034|156352219|FG000|Taper Phase|Adverse Event|1|||
48589978|NCT00840034|156352220|FG001|Taper Phase|Adverse Event|0|||
48589979|NCT00840034|156352219|FG000|Taper Phase|Lost to Follow-up|1|||
48589980|NCT00840034|156352220|FG001|Taper Phase|Lost to Follow-up|1|||
48589981|NCT00840034|156352219|FG000|Taper Phase|Withdrawal by Subject|1|||
48589982|NCT00840034|156352220|FG001|Taper Phase|Withdrawal by Subject|1|||
48589983|NCT01215435|156352221|FG000|Overall Study|Adverse Event|1|||
48589984|NCT01215435|156352222|FG001|Overall Study|Adverse Event|0|||
48589985|NCT01215435|156352221|FG000|Overall Study|Protocol Violation|2|||
48381296|NCT01008696|155592754|FG001|Overall Study|Adverse Event|0|||
48381297|NCT01008696|155592753|FG000|Overall Study|Participants' non-cooperation|2|||
48381298|NCT01008696|155592754|FG001|Overall Study|Participants' non-cooperation|3|||
48381299|NCT01008696|155592753|FG000|Overall Study|Other|2|||
48381300|NCT01008696|155592754|FG001|Overall Study|Other|3|||
48381301|NCT01008696|155592753|FG000|Overall Study|Other|0|||
48381302|NCT01008696|155592754|FG001|Overall Study|Other|2|||
48381303|NCT02366728|155592755|FG000|Overall Study|Death|0|||
48381304|NCT02366728|155592756|FG001|Overall Study|Death|0|||
48381305|NCT02366728|155592757|FG002|Overall Study|Death|1|||
48381306|NCT02366728|155592755|FG000|Overall Study|Adverse Event|1|||
48381307|NCT02366728|155592756|FG001|Overall Study|Adverse Event|0|||
48381308|NCT02366728|155592757|FG002|Overall Study|Adverse Event|0|||
48381309|NCT02366728|155592755|FG000|Overall Study|Screen Failure|2|||
48381310|NCT02366728|155592756|FG001|Overall Study|Screen Failure|1|||
48381311|NCT02366728|155592757|FG002|Overall Study|Screen Failure|0|||
48381312|NCT02366728|155592755|FG000|Overall Study|Only yielded 2 vaccines|1|||
48381313|NCT02366728|155592756|FG001|Overall Study|Only yielded 2 vaccines|0|||
48381314|NCT02366728|155592757|FG002|Overall Study|Only yielded 2 vaccines|0|||
48381315|NCT00616434|155592758|FG000|Overall Study|Adverse Event|5|||
48381316|NCT00616434|155592759|FG001|Overall Study|Adverse Event|2|||
48381317|NCT00616434|155592758|FG000|Overall Study|Physician Decision|0|||
48381318|NCT00616434|155592759|FG001|Overall Study|Physician Decision|4|||
48381319|NCT00616434|155592758|FG000|Overall Study|Withdrawal by Subject|1|||
48381320|NCT00616434|155592759|FG001|Overall Study|Withdrawal by Subject|1|||
48381321|NCT00616434|155592758|FG000|Overall Study|Protocol deviation|0|||
48381322|NCT00616434|155592759|FG001|Overall Study|Protocol deviation|1|||
48381323|NCT05097716|155592760|FG000|Period 1|Adverse Event|1|||
48381324|NCT05097716|155592760|FG000|Period 1|Close contact with highly-transmissible infection|1|||
48381325|NCT01949155|155592766|FG000|Overall Study|Lost to Follow-up|1|||
48381326|NCT01949155|155592767|FG001|Overall Study|Lost to Follow-up|0|||
48381327|NCT01949155|155592766|FG000|Overall Study|Protocol Violation|1|||
48381328|NCT01949155|155592767|FG001|Overall Study|Protocol Violation|0|||
48381329|NCT00129623|155592768|FG000|Overall Study|Adverse Event|3|||
48381330|NCT00129623|155592769|FG001|Overall Study|Adverse Event|7|||
48381331|NCT00129623|155592768|FG000|Overall Study|Refused Treatment|5|||
48381332|NCT00129623|155592769|FG001|Overall Study|Refused Treatment|3|||
48381333|NCT00129623|155592768|FG000|Overall Study|Failure to Return|1|||
48381334|NCT00129623|155592769|FG001|Overall Study|Failure to Return|1|||
48381335|NCT00129623|155592768|FG000|Overall Study|Relocated job out of state|1|||
48381336|NCT00129623|155592769|FG001|Overall Study|Relocated job out of state|0|||
48381337|NCT00129623|155592768|FG000|Overall Study|Uncertainty to return|0|||
48381338|NCT00129623|155592769|FG001|Overall Study|Uncertainty to return|1|||
48381339|NCT02202551|155592771|FG000|Overall Study|Adverse Event|8|||
48381340|NCT02202551|155592772|FG001|Overall Study|Adverse Event|19|||
48381341|NCT02202551|155592773|FG002|Overall Study|Adverse Event|5|||
48381342|NCT02202551|155592774|FG003|Overall Study|Adverse Event|9|||
48381343|NCT02202551|155592771|FG000|Overall Study|Death|3|||
48381344|NCT02202551|155592772|FG001|Overall Study|Death|2|||
48381345|NCT02202551|155592773|FG002|Overall Study|Death|1|||
48381346|NCT02202551|155592774|FG003|Overall Study|Death|1|||
48381347|NCT02202551|155592771|FG000|Overall Study|Lost to Follow-up|0|||
48381348|NCT02202551|155592772|FG001|Overall Study|Lost to Follow-up|1|||
48381349|NCT02202551|155592773|FG002|Overall Study|Lost to Follow-up|0|||
48381350|NCT02202551|155592774|FG003|Overall Study|Lost to Follow-up|1|||
48381351|NCT02202551|155592771|FG000|Overall Study|Needed to take excluded medication|0|||
48381352|NCT02202551|155592772|FG001|Overall Study|Needed to take excluded medication|2|||
48381353|NCT02202551|155592773|FG002|Overall Study|Needed to take excluded medication|0|||
48381354|NCT02202551|155592774|FG003|Overall Study|Needed to take excluded medication|1|||
48381355|NCT02202551|155592771|FG000|Overall Study|Subject moved away|0|||
48381356|NCT02202551|155592772|FG001|Overall Study|Subject moved away|1|||
48381357|NCT02202551|155592773|FG002|Overall Study|Subject moved away|0|||
48381358|NCT02202551|155592774|FG003|Overall Study|Subject moved away|0|||
48381359|NCT02202551|155592771|FG000|Overall Study|DBS surgery|3|||
48381360|NCT02202551|155592772|FG001|Overall Study|DBS surgery|0|||
48381361|NCT02202551|155592773|FG002|Overall Study|DBS surgery|0|||
48381362|NCT02202551|155592774|FG003|Overall Study|DBS surgery|0|||
48381363|NCT02202551|155592771|FG000|Overall Study|Dyskinesia upon taper|1|||
48381364|NCT02202551|155592772|FG001|Overall Study|Dyskinesia upon taper|0|||
48381365|NCT02202551|155592773|FG002|Overall Study|Dyskinesia upon taper|0|||
48381366|NCT02202551|155592774|FG003|Overall Study|Dyskinesia upon taper|0|||
48381367|NCT02202551|155592771|FG000|Overall Study|Lack of Efficacy|0|||
48381368|NCT02202551|155592772|FG001|Overall Study|Lack of Efficacy|1|||
48381369|NCT02202551|155592773|FG002|Overall Study|Lack of Efficacy|0|||
48381370|NCT02202551|155592774|FG003|Overall Study|Lack of Efficacy|0|||
48381371|NCT02202551|155592771|FG000|Overall Study|Physician Decision|1|||
48381372|NCT02202551|155592772|FG001|Overall Study|Physician Decision|0|||
48381373|NCT02202551|155592773|FG002|Overall Study|Physician Decision|0|||
48381374|NCT02202551|155592774|FG003|Overall Study|Physician Decision|0|||
48381375|NCT02202551|155592771|FG000|Overall Study|Site closure|3|||
48381376|NCT02202551|155592772|FG001|Overall Study|Site closure|0|||
48381377|NCT02202551|155592773|FG002|Overall Study|Site closure|0|||
48381378|NCT02202551|155592774|FG003|Overall Study|Site closure|1|||
48381379|NCT02202551|155592771|FG000|Overall Study|Unable to complete visits per protocol|1|||
48589986|NCT01215435|156352222|FG001|Overall Study|Protocol Violation|0|||
48381380|NCT02202551|155592772|FG001|Overall Study|Unable to complete visits per protocol|0|||
48381381|NCT02202551|155592773|FG002|Overall Study|Unable to complete visits per protocol|0|||
48381382|NCT02202551|155592774|FG003|Overall Study|Unable to complete visits per protocol|0|||
48381383|NCT02202551|155592771|FG000|Overall Study|Worsening Dyskinesia|0|||
48381384|NCT02202551|155592772|FG001|Overall Study|Worsening Dyskinesia|0|||
48381385|NCT02202551|155592773|FG002|Overall Study|Worsening Dyskinesia|0|||
48381386|NCT02202551|155592774|FG003|Overall Study|Worsening Dyskinesia|1|||
48381387|NCT02202551|155592771|FG000|Overall Study|Protocol Violation|0|||
48381388|NCT02202551|155592772|FG001|Overall Study|Protocol Violation|1|||
48381389|NCT02202551|155592773|FG002|Overall Study|Protocol Violation|0|||
48381390|NCT02202551|155592774|FG003|Overall Study|Protocol Violation|0|||
48381391|NCT02202551|155592771|FG000|Overall Study|Sponsor's decision|2|||
48381392|NCT02202551|155592772|FG001|Overall Study|Sponsor's decision|0|||
48381393|NCT02202551|155592773|FG002|Overall Study|Sponsor's decision|0|||
48381394|NCT02202551|155592774|FG003|Overall Study|Sponsor's decision|0|||
48381395|NCT02202551|155592771|FG000|Overall Study|Subject unwilling to proceed|1|||
48381396|NCT02202551|155592772|FG001|Overall Study|Subject unwilling to proceed|5|||
48381397|NCT02202551|155592773|FG002|Overall Study|Subject unwilling to proceed|3|||
48381398|NCT02202551|155592774|FG003|Overall Study|Subject unwilling to proceed|5|||
48381399|NCT02202551|155592771|FG000|Overall Study|Subject consent withdrawn|0|||
48381400|NCT02202551|155592772|FG001|Overall Study|Subject consent withdrawn|3|||
48381401|NCT02202551|155592773|FG002|Overall Study|Subject consent withdrawn|1|||
48381402|NCT02202551|155592774|FG003|Overall Study|Subject consent withdrawn|2|||
48381403|NCT02202551|155592771|FG000|Overall Study|eGFR<50mL/min/m2|2|||
48381404|NCT02202551|155592772|FG001|Overall Study|eGFR<50mL/min/m2|2|||
48381405|NCT02202551|155592773|FG002|Overall Study|eGFR<50mL/min/m2|0|||
48381406|NCT02202551|155592774|FG003|Overall Study|eGFR<50mL/min/m2|1|||
48381407|NCT04178967|155592777|FG000|Induction Period|Adverse Event|4|||
48381408|NCT04178967|155592778|FG001|Induction Period|Adverse Event|6|||
48381409|NCT04178967|155592779|FG002|Induction Period|Adverse Event|0|||
48381410|NCT04178967|155592780|FG003|Induction Period|Adverse Event|0|||
48381411|NCT04178967|155592781|FG004|Induction Period|Adverse Event|0|||
48381412|NCT04178967|155592782|FG005|Induction Period|Adverse Event|0|||
48381413|NCT04178967|155592783|FG006|Induction Period|Adverse Event|0|||
48381414|NCT04178967|155592784|FG007|Induction Period|Adverse Event|0|||
48381415|NCT04178967|155592785|FG008|Induction Period|Adverse Event|0|||
48381416|NCT04178967|155592786|FG009|Induction Period|Adverse Event|0|||
48381417|NCT04178967|155592787|FG010|Induction Period|Adverse Event|0|||
48381418|NCT04178967|155592777|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
48381419|NCT04178967|155592778|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
48381420|NCT04178967|155592779|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
48381421|NCT04178967|155592780|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
48381422|NCT04178967|155592781|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
48381423|NCT04178967|155592782|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
48381424|NCT04178967|155592783|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
48381425|NCT04178967|155592784|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
48381426|NCT04178967|155592785|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
48381427|NCT04178967|155592786|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
48381428|NCT04178967|155592787|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
48381429|NCT04178967|155592777|FG000|Induction Period|Lack of Efficacy|4|||
48381430|NCT04178967|155592778|FG001|Induction Period|Lack of Efficacy|1|||
48381431|NCT04178967|155592779|FG002|Induction Period|Lack of Efficacy|0|||
48381432|NCT04178967|155592780|FG003|Induction Period|Lack of Efficacy|0|||
48381433|NCT04178967|155592781|FG004|Induction Period|Lack of Efficacy|0|||
48381434|NCT04178967|155592782|FG005|Induction Period|Lack of Efficacy|0|||
48381435|NCT04178967|155592783|FG006|Induction Period|Lack of Efficacy|0|||
48381436|NCT04178967|155592784|FG007|Induction Period|Lack of Efficacy|0|||
48381437|NCT04178967|155592785|FG008|Induction Period|Lack of Efficacy|0|||
48381438|NCT04178967|155592786|FG009|Induction Period|Lack of Efficacy|0|||
48381439|NCT04178967|155592787|FG010|Induction Period|Lack of Efficacy|0|||
48381440|NCT04178967|155592777|FG000|Induction Period|Protocol Violation|0|||
48381441|NCT04178967|155592778|FG001|Induction Period|Protocol Violation|6|||
48381442|NCT04178967|155592779|FG002|Induction Period|Protocol Violation|0|||
48381443|NCT04178967|155592780|FG003|Induction Period|Protocol Violation|0|||
48381444|NCT04178967|155592781|FG004|Induction Period|Protocol Violation|0|||
48381445|NCT04178967|155592782|FG005|Induction Period|Protocol Violation|0|||
48381446|NCT04178967|155592783|FG006|Induction Period|Protocol Violation|0|||
48381447|NCT04178967|155592784|FG007|Induction Period|Protocol Violation|0|||
48381448|NCT04178967|155592785|FG008|Induction Period|Protocol Violation|0|||
48381449|NCT04178967|155592786|FG009|Induction Period|Protocol Violation|0|||
48381450|NCT04178967|155592787|FG010|Induction Period|Protocol Violation|0|||
48381451|NCT04178967|155592777|FG000|Induction Period|Withdrawal by Subject|6|||
48381452|NCT04178967|155592778|FG001|Induction Period|Withdrawal by Subject|4|||
48381453|NCT04178967|155592779|FG002|Induction Period|Withdrawal by Subject|0|||
48381454|NCT04178967|155592780|FG003|Induction Period|Withdrawal by Subject|0|||
48381455|NCT04178967|155592781|FG004|Induction Period|Withdrawal by Subject|0|||
48381456|NCT04178967|155592782|FG005|Induction Period|Withdrawal by Subject|0|||
48381457|NCT04178967|155592783|FG006|Induction Period|Withdrawal by Subject|0|||
48381458|NCT04178967|155592784|FG007|Induction Period|Withdrawal by Subject|0|||
48381459|NCT04178967|155592785|FG008|Induction Period|Withdrawal by Subject|0|||
48381460|NCT04178967|155592786|FG009|Induction Period|Withdrawal by Subject|0|||
48381461|NCT04178967|155592787|FG010|Induction Period|Withdrawal by Subject|0|||
48381462|NCT04178967|155592777|FG000|Induction Period|Lost to Follow-up|2|||
48381463|NCT04178967|155592778|FG001|Induction Period|Lost to Follow-up|0|||
48381464|NCT04178967|155592779|FG002|Induction Period|Lost to Follow-up|0|||
48381465|NCT04178967|155592780|FG003|Induction Period|Lost to Follow-up|0|||
48381466|NCT04178967|155592781|FG004|Induction Period|Lost to Follow-up|0|||
48381467|NCT04178967|155592782|FG005|Induction Period|Lost to Follow-up|0|||
48381468|NCT04178967|155592783|FG006|Induction Period|Lost to Follow-up|0|||
48381469|NCT04178967|155592784|FG007|Induction Period|Lost to Follow-up|0|||
48381470|NCT04178967|155592785|FG008|Induction Period|Lost to Follow-up|0|||
48381471|NCT04178967|155592786|FG009|Induction Period|Lost to Follow-up|0|||
48381472|NCT04178967|155592787|FG010|Induction Period|Lost to Follow-up|0|||
48381473|NCT04178967|155592777|FG000|Induction Period|Participant Missed Study Visits|0|||
48381474|NCT04178967|155592778|FG001|Induction Period|Participant Missed Study Visits|1|||
48381475|NCT04178967|155592779|FG002|Induction Period|Participant Missed Study Visits|0|||
48381476|NCT04178967|155592780|FG003|Induction Period|Participant Missed Study Visits|0|||
48381477|NCT04178967|155592781|FG004|Induction Period|Participant Missed Study Visits|0|||
48381478|NCT04178967|155592782|FG005|Induction Period|Participant Missed Study Visits|0|||
48381479|NCT04178967|155592783|FG006|Induction Period|Participant Missed Study Visits|0|||
48381480|NCT04178967|155592784|FG007|Induction Period|Participant Missed Study Visits|0|||
48381481|NCT04178967|155592785|FG008|Induction Period|Participant Missed Study Visits|0|||
48381482|NCT04178967|155592786|FG009|Induction Period|Participant Missed Study Visits|0|||
48381483|NCT04178967|155592787|FG010|Induction Period|Participant Missed Study Visits|0|||
48381484|NCT04178967|155592777|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
48381485|NCT04178967|155592778|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
48381486|NCT04178967|155592779|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
48381487|NCT04178967|155592780|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
48381488|NCT04178967|155592781|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
48381489|NCT04178967|155592782|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
48381490|NCT04178967|155592783|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
48381491|NCT04178967|155592784|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
48381492|NCT04178967|155592785|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
48381493|NCT04178967|155592786|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
48381494|NCT04178967|155592787|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
48381495|NCT04178967|155592777|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381496|NCT04178967|155592778|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381497|NCT04178967|155592779|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381498|NCT04178967|155592780|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381499|NCT04178967|155592781|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381500|NCT04178967|155592782|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
48381501|NCT04178967|155592783|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381502|NCT04178967|155592784|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381503|NCT04178967|155592785|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381504|NCT04178967|155592786|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381505|NCT04178967|155592787|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48381506|NCT04178967|155592777|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381507|NCT04178967|155592778|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381508|NCT04178967|155592779|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381509|NCT04178967|155592780|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
48381510|NCT04178967|155592781|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381511|NCT04178967|155592782|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381512|NCT04178967|155592783|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381513|NCT04178967|155592784|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381514|NCT04178967|155592785|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381515|NCT04178967|155592786|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381516|NCT04178967|155592787|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48381517|NCT04178967|155592777|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381518|NCT04178967|155592778|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381519|NCT04178967|155592779|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381520|NCT04178967|155592780|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
48589987|NCT01215435|156352221|FG000|Overall Study|Withdrawal Criteria|8|||
48589988|NCT01215435|156352222|FG001|Overall Study|Withdrawal Criteria|11|||
48589989|NCT01215435|156352221|FG000|Overall Study|Lost to Follow-up|3|||
48589990|NCT01215435|156352222|FG001|Overall Study|Lost to Follow-up|0|||
48381521|NCT04178967|155592781|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381522|NCT04178967|155592782|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381523|NCT04178967|155592783|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
48381524|NCT04178967|155592784|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381525|NCT04178967|155592785|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381526|NCT04178967|155592786|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381527|NCT04178967|155592787|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
48381528|NCT04178967|155592777|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48381529|NCT04178967|155592778|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48381530|NCT04178967|155592779|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48381531|NCT04178967|155592780|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48381532|NCT04178967|155592781|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
48381533|NCT04178967|155592782|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
48381534|NCT04178967|155592783|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48381535|NCT04178967|155592784|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
48381536|NCT04178967|155592785|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48381537|NCT04178967|155592786|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48381538|NCT04178967|155592787|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48381539|NCT04178967|155592777|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48381540|NCT04178967|155592778|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48381541|NCT04178967|155592779|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
48381542|NCT04178967|155592780|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
48381543|NCT04178967|155592781|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
48381544|NCT04178967|155592782|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
48381545|NCT04178967|155592783|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
48381546|NCT04178967|155592784|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
48381547|NCT04178967|155592785|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48381548|NCT04178967|155592786|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48381549|NCT04178967|155592787|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
48381550|NCT04178967|155592777|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48381551|NCT04178967|155592778|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48381552|NCT04178967|155592779|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48381553|NCT04178967|155592780|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
48381554|NCT04178967|155592781|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48381555|NCT04178967|155592782|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
48381556|NCT04178967|155592783|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
48381557|NCT04178967|155592784|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
48381558|NCT04178967|155592785|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48381559|NCT04178967|155592786|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48381560|NCT04178967|155592787|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48381561|NCT04178967|155592777|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381562|NCT04178967|155592778|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381563|NCT04178967|155592779|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381564|NCT04178967|155592780|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381565|NCT04178967|155592781|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381566|NCT04178967|155592782|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381567|NCT04178967|155592783|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381568|NCT04178967|155592784|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381569|NCT04178967|155592785|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
48381570|NCT04178967|155592786|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
48381571|NCT04178967|155592787|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
48381572|NCT04178967|155592777|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48381573|NCT04178967|155592778|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48381574|NCT04178967|155592779|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48381575|NCT04178967|155592780|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48381576|NCT04178967|155592781|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48381577|NCT04178967|155592782|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48381578|NCT04178967|155592783|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48381579|NCT04178967|155592784|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48381580|NCT04178967|155592785|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
48381581|NCT04178967|155592786|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
48381582|NCT04178967|155592787|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
48381583|NCT04178967|155592777|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381584|NCT04178967|155592778|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381585|NCT04178967|155592779|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48432072|NCT01683071|155769036|FG005|Part 1|Withdrawal by Subject|0|||
48381586|NCT04178967|155592780|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381587|NCT04178967|155592781|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381588|NCT04178967|155592782|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381589|NCT04178967|155592783|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381590|NCT04178967|155592784|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381591|NCT04178967|155592785|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381592|NCT04178967|155592786|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
48381593|NCT04178967|155592787|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48381594|NCT04178967|155592777|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48381595|NCT04178967|155592778|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48381596|NCT04178967|155592779|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48381597|NCT04178967|155592780|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48381598|NCT04178967|155592781|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48381599|NCT04178967|155592782|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48381600|NCT04178967|155592783|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48381601|NCT04178967|155592784|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48381602|NCT04178967|155592785|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
48381603|NCT04178967|155592786|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
48381604|NCT04178967|155592787|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
48381605|NCT04178967|155592777|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381606|NCT04178967|155592778|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381607|NCT04178967|155592779|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381608|NCT04178967|155592780|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381609|NCT04178967|155592781|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381610|NCT04178967|155592782|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381611|NCT04178967|155592783|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381612|NCT04178967|155592784|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381613|NCT04178967|155592785|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381614|NCT04178967|155592786|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
48381615|NCT04178967|155592787|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
48381616|NCT04178967|155592777|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381617|NCT04178967|155592778|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381618|NCT04178967|155592779|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381619|NCT04178967|155592780|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381620|NCT04178967|155592781|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381621|NCT04178967|155592782|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381622|NCT04178967|155592783|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381623|NCT04178967|155592784|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381624|NCT04178967|155592785|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381625|NCT04178967|155592786|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
48381626|NCT04178967|155592787|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
48381627|NCT02187809|155592788|FG000|Overall Study|The study was terminated|3|||
48381628|NCT00986440|155592791|FG000|Overall Study|Progressive disease|27|||
48381629|NCT00986440|155592792|FG001|Overall Study|Progressive disease|37|||
48381630|NCT00986440|155592791|FG000|Overall Study|Serious adverse event or adverse event|9|||
48381631|NCT00986440|155592792|FG001|Overall Study|Serious adverse event or adverse event|2|||
48381632|NCT00986440|155592791|FG000|Overall Study|Withdrawal by Subject|1|||
48381633|NCT00986440|155592792|FG001|Overall Study|Withdrawal by Subject|2|||
48381634|NCT00986440|155592791|FG000|Overall Study|Screen failure (not dosed)|4|||
48381635|NCT00986440|155592792|FG001|Overall Study|Screen failure (not dosed)|2|||
48381636|NCT01494350|155592793|FG000|Overall Study|Worsening of lesion|1|||
48381637|NCT02608879|155592796|FG000|Overall Study|Lost to Follow-up|1|||
48381638|NCT02608879|155592797|FG001|Overall Study|Lost to Follow-up|0|||
48381639|NCT02608879|155592798|FG002|Overall Study|Lost to Follow-up|0|||
48381640|NCT02608879|155592796|FG000|Overall Study|Did not meet continuation criteria|0|||
48381641|NCT02608879|155592797|FG001|Overall Study|Did not meet continuation criteria|0|||
48381642|NCT02608879|155592798|FG002|Overall Study|Did not meet continuation criteria|3|||
48381643|NCT00760669|155592801|FG000|Overall Study|Not assessed for overall improvement|18|||
48381644|NCT00760669|155592801|FG000|Overall Study|Participants missing efficacy assessment|6|||
48381645|NCT00760669|155592801|FG000|Overall Study|Participants with overlapping cases|1|||
48381646|NCT00760669|155592801|FG000|Overall Study|Took drug before entering in contract|5|||
48381647|NCT01009554|155592807|FG000|Overall Study|Adverse Event|1|||
48381648|NCT01009554|155592808|FG001|Overall Study|Adverse Event|1|||
48381649|NCT01009554|155592807|FG000|Overall Study|Withdrawal by Subject|1|||
48381650|NCT01009554|155592808|FG001|Overall Study|Withdrawal by Subject|3|||
48381651|NCT01009554|155592807|FG000|Overall Study|Noncompliant with Study Product|0|||
48381652|NCT01009554|155592808|FG001|Overall Study|Noncompliant with Study Product|3|||
48381653|NCT00639223|155592811|FG000|Overall Study|Lost to Follow-up|0|||
48381654|NCT00639223|155592812|FG001|Overall Study|Lost to Follow-up|2|||
48381655|NCT04201821|155592813|FG000|Overall Study|Withdrawal by Subject|2|||
48381656|NCT01130974|155592814|FG000|Overall Study|Protocol Violation|10|||
48381657|NCT01130974|155592815|FG001|Overall Study|Protocol Violation|10|||
48381658|NCT01130974|155592814|FG000|Overall Study|Withdrawal by Subject|0|||
48381659|NCT01130974|155592815|FG001|Overall Study|Withdrawal by Subject|1|||
48381660|NCT01130974|155592814|FG000|Overall Study|Ineligibility criteria|5|||
48381661|NCT01130974|155592815|FG001|Overall Study|Ineligibility criteria|2|||
48381662|NCT03431857|155592816|FG000|Overall Study|Death|6|||
48381663|NCT03431857|155592816|FG000|Overall Study|Lost to Follow-up|41|||
48381664|NCT03431857|155592816|FG000|Overall Study|Adverse Event|6|||
48381665|NCT03431857|155592816|FG000|Overall Study|Withdrawal by Subject|1|||
48381666|NCT01184053|155592817|FG000|Overall Study|progression while on treatment|3|||
48381667|NCT01159912|155592818|FG000|Overall Study|Adverse Event|2|||
48381668|NCT01159912|155592819|FG001|Overall Study|Adverse Event|2|||
48381669|NCT01159912|155592820|FG002|Overall Study|Adverse Event|3|||
48381670|NCT01159912|155592818|FG000|Overall Study|Lack of Efficacy|23|||
48381671|NCT01159912|155592819|FG001|Overall Study|Lack of Efficacy|15|||
48381672|NCT01159912|155592820|FG002|Overall Study|Lack of Efficacy|14|||
48381673|NCT01159912|155592818|FG000|Overall Study|Protocol Violation|1|||
48381674|NCT01159912|155592819|FG001|Overall Study|Protocol Violation|2|||
48381675|NCT01159912|155592820|FG002|Overall Study|Protocol Violation|3|||
48381676|NCT01159912|155592818|FG000|Overall Study|Lost to Follow-up|4|||
48381677|NCT01159912|155592819|FG001|Overall Study|Lost to Follow-up|0|||
48381678|NCT01159912|155592820|FG002|Overall Study|Lost to Follow-up|0|||
48381679|NCT01159912|155592818|FG000|Overall Study|Physician Decision|0|||
48381680|NCT01159912|155592819|FG001|Overall Study|Physician Decision|0|||
48381681|NCT01159912|155592820|FG002|Overall Study|Physician Decision|3|||
48381682|NCT01159912|155592818|FG000|Overall Study|Withdrawal by Subject|10|||
48381683|NCT01159912|155592819|FG001|Overall Study|Withdrawal by Subject|3|||
48381684|NCT01159912|155592820|FG002|Overall Study|Withdrawal by Subject|3|||
48381685|NCT03359590|155592822|FG000|First Intervention|Withdrawal by Subject|1|||
48381686|NCT03359590|155592823|FG001|First Intervention|Withdrawal by Subject|1|||
48381687|NCT03359590|155592822|FG000|First Intervention|Protocol Violation|0|||
48381688|NCT03359590|155592823|FG001|First Intervention|Protocol Violation|1|||
48381689|NCT04226833|155592824|FG000|Overall Study|Death|0|||
48381690|NCT04226833|155592825|FG001|Overall Study|Death|0|||
48381691|NCT04226833|155592826|FG002|Overall Study|Death|1|||
48381692|NCT04226833|155592827|FG003|Overall Study|Death|0|||
48381693|NCT04399122|155592828|FG000|Overall Study|Lost to Follow-up|2|||
48381694|NCT04399122|155592829|FG001|Overall Study|Lost to Follow-up|0|||
48381695|NCT04399122|155592828|FG000|Overall Study|Withdrawal by Subject|1|||
48381696|NCT04399122|155592829|FG001|Overall Study|Withdrawal by Subject|0|||
48381697|NCT01174238|155592833|FG000|Overall Study|Lost to Follow-up|2|||
48381698|NCT02301936|155592834|FG000|Overall Study|Lost to Follow-up|1|||
48381699|NCT02301936|155592835|FG001|Overall Study|Lost to Follow-up|0|||
48381700|NCT02456662|155592836|FG000|Overall Study|Lost to Follow-up|2|||
48381701|NCT02456662|155592837|FG001|Overall Study|Lost to Follow-up|1|||
48381702|NCT00898443|155592838|FG000|Overall Study|Withdrawal by Subject|1|||
48381703|NCT00898443|155592839|FG001|Overall Study|Withdrawal by Subject|0|||
48381704|NCT02540538|155592840|FG000|Overall Study|Pregnancy|0|||
48381705|NCT02540538|155592841|FG001|Overall Study|Pregnancy|1|||
48381706|NCT02540538|155592842|FG002|Overall Study|Pregnancy|0|||
48381707|NCT01050205|155592844|FG000|Overall Study|Lost to Follow-up|7|||
48381708|NCT01050205|155592845|FG001|Overall Study|Lost to Follow-up|1|||
48381709|NCT01050205|155592844|FG000|Overall Study|Withdrawal by Subject|1|||
48381710|NCT01050205|155592845|FG001|Overall Study|Withdrawal by Subject|1|||
48381711|NCT01050205|155592844|FG000|Overall Study|Relocated from area|1|||
48381712|NCT01050205|155592845|FG001|Overall Study|Relocated from area|2|||
48381713|NCT01050205|155592844|FG000|Overall Study|Discontinued Intervention|2|||
48381714|NCT01050205|155592845|FG001|Overall Study|Discontinued Intervention|0|||
48381715|NCT01472380|155592846|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
48381716|NCT01472380|155592846|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
48381717|NCT03250832|155592847|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
48381718|NCT03250832|155592848|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
48381719|NCT03250832|155592849|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
48381720|NCT03250832|155592850|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
48381721|NCT03250832|155592851|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
48381722|NCT03250832|155592852|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
48381723|NCT03250832|155592853|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
48381724|NCT03250832|155592854|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
48381725|NCT03250832|155592855|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
48381726|NCT03250832|155592856|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
48381727|NCT03250832|155592857|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
48381728|NCT03250832|155592858|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
48381729|NCT03250832|155592847|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
48381730|NCT03250832|155592848|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
48381731|NCT03250832|155592849|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
48381732|NCT03250832|155592850|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
48381733|NCT03250832|155592851|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
48381734|NCT03250832|155592852|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
48381735|NCT03250832|155592853|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
48381736|NCT03250832|155592854|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48381737|NCT03250832|155592855|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48381738|NCT03250832|155592856|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48381739|NCT03250832|155592857|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48381740|NCT03250832|155592858|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
48381741|NCT03250832|155592847|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381742|NCT03250832|155592848|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381743|NCT03250832|155592849|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
48381744|NCT03250832|155592850|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381745|NCT03250832|155592851|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381746|NCT03250832|155592852|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381747|NCT03250832|155592853|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381748|NCT03250832|155592854|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381749|NCT03250832|155592855|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381750|NCT03250832|155592856|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381751|NCT03250832|155592857|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381752|NCT03250832|155592858|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
48381753|NCT03250832|155592847|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381754|NCT03250832|155592848|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381755|NCT03250832|155592849|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381756|NCT03250832|155592850|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381757|NCT03250832|155592851|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381758|NCT03250832|155592852|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381759|NCT03250832|155592853|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381760|NCT03250832|155592854|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
48381761|NCT03250832|155592855|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381762|NCT03250832|155592856|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381763|NCT03250832|155592857|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381764|NCT03250832|155592858|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
48381765|NCT03250832|155592847|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381766|NCT03250832|155592848|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381767|NCT03250832|155592849|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381768|NCT03250832|155592850|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381769|NCT03250832|155592851|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381770|NCT03250832|155592852|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381771|NCT03250832|155592853|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381772|NCT03250832|155592854|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
48381773|NCT03250832|155592855|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381774|NCT03250832|155592856|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381775|NCT03250832|155592857|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381776|NCT03250832|155592858|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
48381777|NCT03250832|155592847|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381778|NCT03250832|155592848|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381779|NCT03250832|155592849|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381780|NCT03250832|155592850|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381781|NCT03250832|155592851|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381782|NCT03250832|155592852|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381783|NCT03250832|155592853|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381784|NCT03250832|155592854|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
48381785|NCT03250832|155592855|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381786|NCT03250832|155592856|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381787|NCT03250832|155592857|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381788|NCT03250832|155592858|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
48381789|NCT03250832|155592847|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381790|NCT03250832|155592848|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381791|NCT03250832|155592849|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381792|NCT03250832|155592850|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381793|NCT03250832|155592851|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48589991|NCT01215435|156352221|FG000|Overall Study|Unclassified|5|||
48381794|NCT03250832|155592852|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381795|NCT03250832|155592853|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381796|NCT03250832|155592854|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
48381797|NCT03250832|155592855|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381798|NCT03250832|155592856|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381799|NCT03250832|155592857|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381800|NCT03250832|155592858|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
48381801|NCT03250832|155592847|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381802|NCT03250832|155592848|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381803|NCT03250832|155592849|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381804|NCT03250832|155592850|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381805|NCT03250832|155592851|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381806|NCT03250832|155592852|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381807|NCT03250832|155592853|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381808|NCT03250832|155592854|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
48381809|NCT03250832|155592855|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381810|NCT03250832|155592856|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381811|NCT03250832|155592857|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381812|NCT03250832|155592858|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
48381813|NCT03250832|155592847|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381814|NCT03250832|155592848|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381815|NCT03250832|155592849|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381816|NCT03250832|155592850|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381817|NCT03250832|155592851|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381818|NCT03250832|155592852|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381819|NCT03250832|155592853|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381820|NCT03250832|155592854|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381821|NCT03250832|155592855|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
48381822|NCT03250832|155592856|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
48381823|NCT03250832|155592857|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381824|NCT03250832|155592858|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
48381825|NCT03250832|155592847|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381826|NCT03250832|155592848|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381827|NCT03250832|155592849|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381828|NCT03250832|155592850|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381829|NCT03250832|155592851|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381830|NCT03250832|155592852|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381831|NCT03250832|155592853|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381832|NCT03250832|155592854|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381833|NCT03250832|155592855|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
48381834|NCT03250832|155592856|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
48381835|NCT03250832|155592857|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381836|NCT03250832|155592858|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
48381837|NCT03250832|155592847|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381838|NCT03250832|155592848|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381839|NCT03250832|155592849|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381840|NCT03250832|155592850|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381841|NCT03250832|155592851|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381842|NCT03250832|155592852|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381843|NCT03250832|155592853|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381844|NCT03250832|155592854|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381845|NCT03250832|155592855|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
48381846|NCT03250832|155592856|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
48381847|NCT03250832|155592857|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381848|NCT03250832|155592858|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
48381849|NCT03250832|155592847|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381850|NCT03250832|155592848|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381851|NCT03250832|155592849|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381852|NCT03250832|155592850|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381853|NCT03250832|155592851|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381854|NCT03250832|155592852|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381855|NCT03250832|155592853|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381856|NCT03250832|155592854|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381857|NCT03250832|155592855|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381858|NCT03250832|155592856|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48381859|NCT03250832|155592857|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
48432073|NCT01683071|155769031|FG000|Part 1|Surgery Cancelled|1|||
48381860|NCT03250832|155592858|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
48381861|NCT00375219|155592859|FG000|Overall Study|Failure to achieve a response|16|||
48381862|NCT00375219|155592860|FG001|Overall Study|Failure to achieve a response|2|||
48381863|NCT00375219|155592861|FG002|Overall Study|Failure to achieve a response|0|||
48381864|NCT00375219|155592859|FG000|Overall Study|Adverse Event|8|||
48381865|NCT00375219|155592860|FG001|Overall Study|Adverse Event|2|||
48381866|NCT00375219|155592861|FG002|Overall Study|Adverse Event|1|||
48381867|NCT00375219|155592859|FG000|Overall Study|Protocol Violation|1|||
48381868|NCT00375219|155592860|FG001|Overall Study|Protocol Violation|0|||
48381869|NCT00375219|155592861|FG002|Overall Study|Protocol Violation|1|||
48381870|NCT00375219|155592859|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
48381871|NCT00375219|155592860|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
48381872|NCT00375219|155592861|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
48381873|NCT00375219|155592859|FG000|Overall Study|Lost to Follow-up|1|||
48381874|NCT00375219|155592860|FG001|Overall Study|Lost to Follow-up|1|||
48381875|NCT00375219|155592861|FG002|Overall Study|Lost to Follow-up|0|||
48381876|NCT00375219|155592859|FG000|Overall Study|Disease progression|18|||
48381877|NCT00375219|155592860|FG001|Overall Study|Disease progression|9|||
48381878|NCT00375219|155592861|FG002|Overall Study|Disease progression|12|||
48381879|NCT00375219|155592859|FG000|Overall Study|Death|4|||
48381880|NCT00375219|155592860|FG001|Overall Study|Death|3|||
48381881|NCT00375219|155592861|FG002|Overall Study|Death|7|||
48381882|NCT00375219|155592859|FG000|Overall Study|Hematologic resistance|1|||
48381883|NCT00375219|155592860|FG001|Overall Study|Hematologic resistance|0|||
48381884|NCT00375219|155592861|FG002|Overall Study|Hematologic resistance|0|||
48381885|NCT00375219|155592859|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
48381886|NCT00375219|155592860|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
48381887|NCT00375219|155592861|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
48381888|NCT00375219|155592859|FG000|Overall Study|Allograft|2|||
48381889|NCT00375219|155592860|FG001|Overall Study|Allograft|0|||
48381890|NCT00375219|155592861|FG002|Overall Study|Allograft|0|||
48381891|NCT00375219|155592859|FG000|Overall Study|Cord blood transplantation|1|||
48484614|NCT00343642|155969210|FG000|Overall Study|Withdrawal by Subject|2|||
48484615|NCT00343642|155969211|FG001|Overall Study|Withdrawal by Subject|3|||
48484616|NCT00343642|155969212|FG002|Overall Study|Withdrawal by Subject|4|||
48484617|NCT00343642|155969210|FG000|Overall Study|Adverse Event|0|||
48484618|NCT00343642|155969211|FG001|Overall Study|Adverse Event|0|||
48484619|NCT00343642|155969212|FG002|Overall Study|Adverse Event|1|||
48484620|NCT00343642|155969210|FG000|Overall Study|Flare up|6|||
48484621|NCT00343642|155969211|FG001|Overall Study|Flare up|4|||
48484622|NCT00343642|155969212|FG002|Overall Study|Flare up|0|||
48484623|NCT04292171|155969215|FG000|Overall Study|Pharmacy error|2|||
48484624|NCT04292171|155969216|FG001|Overall Study|Pharmacy error|0|||
48484625|NCT04292171|155969215|FG000|Overall Study|Delivered prior to procedure|0|||
48484626|NCT04292171|155969216|FG001|Overall Study|Delivered prior to procedure|1|||
48484627|NCT02253654|155969221|FG000|Overall Study|Withdrawal by Subject|12|||
48484628|NCT02253654|155969222|FG001|Overall Study|Withdrawal by Subject|4|||
48484629|NCT02253654|155969221|FG000|Overall Study|Decision by Sponsor|1|||
48484630|NCT02253654|155969222|FG001|Overall Study|Decision by Sponsor|1|||
48484631|NCT02253654|155969221|FG000|Overall Study|Lost to Follow-up|2|||
48484632|NCT02253654|155969222|FG001|Overall Study|Lost to Follow-up|5|||
48484633|NCT02253654|155969221|FG000|Overall Study|Death|4|||
48484634|NCT02253654|155969222|FG001|Overall Study|Death|7|||
48484635|NCT02253654|155969221|FG000|Overall Study|Did Not Receive Study Treatment|4|||
48484636|NCT02253654|155969222|FG001|Overall Study|Did Not Receive Study Treatment|1|||
48484637|NCT03456726|155969227|FG000|Overall Study|Disease Progression|6|||
48484638|NCT03456726|155969228|FG001|Overall Study|Disease Progression|1|||
48484639|NCT03456726|155969227|FG000|Overall Study|Adverse Event|4|||
48484640|NCT03456726|155969228|FG001|Overall Study|Adverse Event|2|||
48484641|NCT03456726|155969227|FG000|Overall Study|Withdrawal by Subject|1|||
48484642|NCT03456726|155969228|FG001|Overall Study|Withdrawal by Subject|0|||
48484643|NCT03456726|155969227|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
48484644|NCT03456726|155969228|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
48484645|NCT01614925|155969231|FG000|Overall Study|Withdrawal by Subject|1|||
48484646|NCT01614925|155969232|FG001|Overall Study|Withdrawal by Subject|0|||
48484647|NCT01614925|155969231|FG000|Overall Study|Protocol Violation|3|||
48484648|NCT01614925|155969232|FG001|Overall Study|Protocol Violation|2|||
48484649|NCT04470622|155969233|FG000|Overall Study|Withdrawal by Subject|0|||
48484650|NCT04470622|155969234|FG001|Overall Study|Withdrawal by Subject|1|||
48484651|NCT04470622|155969233|FG000|Overall Study|Screen Failure|0|||
48484652|NCT04470622|155969234|FG001|Overall Study|Screen Failure|1|||
48484653|NCT04470622|155969233|FG000|Overall Study|Death|0|||
48589992|NCT01215435|156352222|FG001|Overall Study|Unclassified|5|||
48589993|NCT02557516|156352226|FG000|Overall Study|Adverse Event|1|||
48589994|NCT02557516|156352227|FG001|Overall Study|Adverse Event|0|||
48589995|NCT02557516|156352228|FG002|Overall Study|Adverse Event|2|||
48484654|NCT04470622|155969234|FG001|Overall Study|Death|1|||
48484655|NCT01246973|155969235|FG000|Overall Study|Other|38|||
48484656|NCT01246973|155969236|FG001|Overall Study|Other|25|||
48484657|NCT01246973|155969235|FG000|Overall Study|Adverse Event|16|||
48484658|NCT01246973|155969236|FG001|Overall Study|Adverse Event|9|||
48484659|NCT01246973|155969235|FG000|Overall Study|Withdrawal by Subject|7|||
48484660|NCT01246973|155969236|FG001|Overall Study|Withdrawal by Subject|13|||
48484661|NCT01600014|155969237|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
48484662|NCT01600014|155969238|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
48484663|NCT01600014|155969237|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
48484664|NCT01600014|155969238|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
48484665|NCT01600014|155969237|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
48484666|NCT01600014|155969238|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
48484667|NCT01600014|155969237|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
48484668|NCT01600014|155969238|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
48484669|NCT01600014|155969237|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
48484670|NCT01600014|155969238|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
48484671|NCT01600014|155969237|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
48484672|NCT01600014|155969238|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
48484673|NCT01600014|155969237|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
48484674|NCT01600014|155969238|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
48484675|NCT01600014|155969237|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
48484676|NCT01600014|155969238|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
48484677|NCT01600014|155969237|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
48484678|NCT01600014|155969238|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
48484679|NCT01600014|155969237|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
48484680|NCT01600014|155969238|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
48484681|NCT01600014|155969237|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
48484682|NCT01600014|155969238|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
48484683|NCT01600014|155969237|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
48484684|NCT01600014|155969238|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
48484685|NCT01600014|155969237|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
48484686|NCT01600014|155969238|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
48484687|NCT01600014|155969237|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
48484688|NCT01600014|155969238|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
48484689|NCT01600014|155969237|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
48484690|NCT01600014|155969238|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
48484691|NCT01600014|155969237|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
48484692|NCT01600014|155969238|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
48484693|NCT01600014|155969237|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
48484694|NCT01600014|155969238|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
48484695|NCT00399490|155969241|FG000|Overall Study|Adverse Event|19|||
48484696|NCT00399490|155969241|FG000|Overall Study|Lack of Efficacy|31|||
48484697|NCT00399490|155969241|FG000|Overall Study|Lost to Follow-up|5|||
48484698|NCT00399490|155969241|FG000|Overall Study|Withdrawal by Subject|18|||
48484699|NCT00399490|155969241|FG000|Overall Study|Other|25|||
48484700|NCT02414854|155969242|FG000|Overall Study|Adverse Event|9|||
48484701|NCT02414854|155969243|FG001|Overall Study|Adverse Event|7|||
48484702|NCT02414854|155969244|FG002|Overall Study|Adverse Event|1|||
48484703|NCT02414854|155969245|FG003|Overall Study|Adverse Event|12|||
48484704|NCT02414854|155969242|FG000|Overall Study|Poor compliance to protocol|1|||
48484705|NCT02414854|155969243|FG001|Overall Study|Poor compliance to protocol|1|||
48484706|NCT02414854|155969244|FG002|Overall Study|Poor compliance to protocol|2|||
48484707|NCT02414854|155969245|FG003|Overall Study|Poor compliance to protocol|2|||
48484708|NCT02414854|155969242|FG000|Overall Study|Other than specified above|12|||
48484709|NCT02414854|155969243|FG001|Overall Study|Other than specified above|37|||
48484710|NCT02414854|155969244|FG002|Overall Study|Other than specified above|17|||
48484711|NCT02414854|155969245|FG003|Overall Study|Other than specified above|37|||
48484712|NCT02576054|155969246|FG000|Overall Study|Withdrawal by Subject|1|||
48484713|NCT01190098|155969247|FG000|Overall Study|Adverse Event|2|||
48484714|NCT01190098|155969248|FG001|Overall Study|Adverse Event|0|||
48484715|NCT01190098|155969247|FG000|Overall Study|Patient coomorbidity|0|||
48484716|NCT01190098|155969248|FG001|Overall Study|Patient coomorbidity|1|||
48484717|NCT01190098|155969247|FG000|Overall Study|Lack of transportation|1|||
48484718|NCT01190098|155969248|FG001|Overall Study|Lack of transportation|0|||
48484719|NCT01190098|155969247|FG000|Overall Study|Other|0|||
48484720|NCT01190098|155969248|FG001|Overall Study|Other|1|||
48484721|NCT02957682|155969249|FG000|Overall Study|Adverse Event|64|||
48484722|NCT02957682|155969250|FG001|Overall Study|Adverse Event|67|||
48484723|NCT02957682|155969249|FG000|Overall Study|Poor Compliance to Protocol|30|||
48484724|NCT02957682|155969250|FG001|Overall Study|Poor Compliance to Protocol|26|||
48484725|NCT02957682|155969249|FG000|Overall Study|Physician Decision|4|||
48484726|NCT02957682|155969250|FG001|Overall Study|Physician Decision|4|||
48484727|NCT02957682|155969249|FG000|Overall Study|Study Terminated by Sponsor|4|||
48484728|NCT02957682|155969250|FG001|Overall Study|Study Terminated by Sponsor|3|||
48484729|NCT02957682|155969249|FG000|Overall Study|Subject Moved|10|||
48484730|NCT02957682|155969250|FG001|Overall Study|Subject Moved|16|||
48484731|NCT02957682|155969249|FG000|Overall Study|Withdrawal by Subject|64|||
48484732|NCT02957682|155969250|FG001|Overall Study|Withdrawal by Subject|33|||
48484733|NCT02957682|155969249|FG000|Overall Study|Related to IMP Administration|3|||
48484734|NCT02957682|155969250|FG001|Overall Study|Related to IMP Administration|6|||
48484735|NCT02957682|155969249|FG000|Overall Study|Non-disclosed|16|||
48484736|NCT02957682|155969250|FG001|Overall Study|Non-disclosed|12|||
48484737|NCT02957682|155969249|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
48484738|NCT02957682|155969250|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
48484739|NCT00566631|155969259|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
48484740|NCT00566631|155969259|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
48484741|NCT00566631|155969259|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
48484742|NCT00566631|155969259|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
48484743|NCT00566631|155969259|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
48484744|NCT00566631|155969259|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
48484745|NCT00566631|155969259|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
48484746|NCT00566631|155969259|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
48484747|NCT00566631|155969259|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
48484748|NCT00566631|155969259|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
48484749|NCT00566631|155969259|FG000|Part 2: Extension Phase|Adverse Event|11|||
48484750|NCT00566631|155969259|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
48484751|NCT00566631|155969259|FG000|Part 2: Extension Phase|Death|1|||
48484752|NCT00566631|155969259|FG000|Part 2: Extension Phase|Other|5|||
48484753|NCT00751998|155969260|FG000|Overall Study|Lost to Follow-up|7|||
48484754|NCT00751998|155969260|FG000|Overall Study|Death|11|||
48484755|NCT00751998|155969260|FG000|Overall Study|Withdrawal by Subject|2|||
48484756|NCT01155284|155969261|FG000|Overall Study|Withdrawal by Subject|4|||
48484757|NCT01155284|155969262|FG001|Overall Study|Withdrawal by Subject|3|||
48484758|NCT01155284|155969261|FG000|Overall Study|Lost to Follow-up|1|||
48484759|NCT01155284|155969262|FG001|Overall Study|Lost to Follow-up|2|||
48484760|NCT01155284|155969261|FG000|Overall Study|Physician Decision|1|||
48484761|NCT01155284|155969262|FG001|Overall Study|Physician Decision|0|||
48484762|NCT01155284|155969261|FG000|Overall Study|Adverse Event|1|||
48484763|NCT01155284|155969262|FG001|Overall Study|Adverse Event|0|||
48484764|NCT00123487|155969263|FG000|Randomized|Death prior to starting treatment|0|||
48484765|NCT00123487|155969264|FG001|Randomized|Death prior to starting treatment|1|||
48484766|NCT00123487|155969263|FG000|Randomized|SAE prior to starting treatment|1|||
48484767|NCT00123487|155969264|FG001|Randomized|SAE prior to starting treatment|0|||
48484768|NCT00123487|155969263|FG000|Treated With Study Drug|Adverse Event|23|||
48484769|NCT00123487|155969264|FG001|Treated With Study Drug|Adverse Event|22|||
48484770|NCT00123487|155969263|FG000|Treated With Study Drug|Disease Progression|141|||
48484771|NCT00123487|155969264|FG001|Treated With Study Drug|Disease Progression|122|||
48484772|NCT00123487|155969263|FG000|Treated With Study Drug|Physician Decision|8|||
48484773|NCT00123487|155969264|FG001|Treated With Study Drug|Physician Decision|9|||
48484774|NCT00123487|155969263|FG000|Treated With Study Drug|Other|59|||
48484775|NCT00123487|155969264|FG001|Treated With Study Drug|Other|58|||
48484776|NCT00123487|155969263|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
48484777|NCT00123487|155969264|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
48484778|NCT00123487|155969263|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
48484779|NCT00123487|155969264|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
48484780|NCT00123487|155969263|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
48484781|NCT00123487|155969264|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
48484782|NCT00423488|155969267|FG000|Overall Study|No evidence of study drug intake|2|||
48484783|NCT00423488|155969268|FG001|Overall Study|No evidence of study drug intake|1|||
48484784|NCT00423488|155969267|FG000|Overall Study|No post baseline data|3|||
48484785|NCT00423488|155969268|FG001|Overall Study|No post baseline data|0|||
48484786|NCT00811070|155969278|FG000|Overall Study|Death|0|||
48484787|NCT00811070|155969279|FG001|Overall Study|Death|0|||
48484788|NCT00811070|155969280|FG002|Overall Study|Death|0|||
48484789|NCT00811070|155969281|FG003|Overall Study|Death|2|||
48484790|NCT00811070|155969282|FG004|Overall Study|Death|5|||
48484791|NCT00811070|155969283|FG005|Overall Study|Death|0|||
48484792|NCT00811070|155969278|FG000|Overall Study|Other|1|||
48484793|NCT00811070|155969279|FG001|Overall Study|Other|0|||
48484794|NCT00811070|155969280|FG002|Overall Study|Other|0|||
48484795|NCT00811070|155969281|FG003|Overall Study|Other|0|||
48484796|NCT00811070|155969282|FG004|Overall Study|Other|0|||
48484797|NCT00811070|155969283|FG005|Overall Study|Other|0|||
48484798|NCT00811070|155969278|FG000|Overall Study|Withdrawal by Subject|0|||
48484799|NCT00811070|155969279|FG001|Overall Study|Withdrawal by Subject|1|||
48484800|NCT00811070|155969280|FG002|Overall Study|Withdrawal by Subject|0|||
48484801|NCT00811070|155969281|FG003|Overall Study|Withdrawal by Subject|0|||
48484802|NCT00811070|155969282|FG004|Overall Study|Withdrawal by Subject|0|||
48484803|NCT00811070|155969283|FG005|Overall Study|Withdrawal by Subject|0|||
48484804|NCT00811070|155969278|FG000|Overall Study|Physician Decision|0|||
48484805|NCT00811070|155969279|FG001|Overall Study|Physician Decision|0|||
48484806|NCT00811070|155969280|FG002|Overall Study|Physician Decision|0|||
48484807|NCT00811070|155969281|FG003|Overall Study|Physician Decision|0|||
48484808|NCT00811070|155969282|FG004|Overall Study|Physician Decision|0|||
48484809|NCT00811070|155969283|FG005|Overall Study|Physician Decision|1|||
48484810|NCT03940586|155969286|FG000|Overall Study|Death|3|||
48484811|NCT03940586|155969287|FG001|Overall Study|Death|2|||
48484812|NCT03940586|155969288|FG002|Overall Study|Death|0|||
48484813|NCT03940586|155969286|FG000|Overall Study|Physician Decision|1|||
48484814|NCT03940586|155969287|FG001|Overall Study|Physician Decision|0|||
48484815|NCT03940586|155969288|FG002|Overall Study|Physician Decision|1|||
48484816|NCT03940586|155969286|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
48484817|NCT03940586|155969287|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
48484818|NCT03940586|155969288|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
48484819|NCT03940586|155969286|FG000|Overall Study|Not Treated|0|||
48484820|NCT03940586|155969287|FG001|Overall Study|Not Treated|2|||
48484821|NCT03940586|155969288|FG002|Overall Study|Not Treated|0|||
48484822|NCT01890785|155969289|FG000|Third Intervention|Withdrawal by Subject|0|||
48484823|NCT01890785|155969290|FG001|Third Intervention|Withdrawal by Subject|1|||
48484824|NCT01890785|155969291|FG002|Third Intervention|Withdrawal by Subject|0|||
48484825|NCT01890785|155969292|FG003|Third Intervention|Withdrawal by Subject|0|||
48484826|NCT01890785|155969293|FG004|Third Intervention|Withdrawal by Subject|0|||
48484827|NCT01890785|155969294|FG005|Third Intervention|Withdrawal by Subject|0|||
48484828|NCT01715415|155969295|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
48484829|NCT01715415|155969296|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
48484830|NCT01715415|155969295|FG000|Double-blind Treatment|Adverse Event|3|||
48484831|NCT01715415|155969296|FG001|Double-blind Treatment|Adverse Event|0|||
48484832|NCT01715415|155969295|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
48484833|NCT01715415|155969296|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
48484834|NCT01715415|155969295|FG000|Double-blind Treatment|Other|1|||
48484835|NCT01715415|155969296|FG001|Double-blind Treatment|Other|0|||
48484836|NCT01715415|155969295|FG000|Open-label Treatment|Adverse Event|0|||
48484837|NCT01715415|155969296|FG001|Open-label Treatment|Adverse Event|1|||
48484838|NCT01715415|155969295|FG000|Open-label Treatment|Subject Noncompliant|0|||
48484839|NCT01715415|155969296|FG001|Open-label Treatment|Subject Noncompliant|1|||
48484840|NCT01964105|155969297|FG000|Overall Study|Lost to Follow-up|2|||
48484841|NCT01964105|155969298|FG001|Overall Study|Lost to Follow-up|13|||
48484842|NCT01964105|155969299|FG002|Overall Study|Lost to Follow-up|0|||
48484843|NCT01619085|155969310|FG000|Overall Study|Adverse Event|231|||
48484844|NCT01619085|155969310|FG000|Overall Study|Protocol Violation|4|||
48484845|NCT01619085|155969310|FG000|Overall Study|Lost to Follow-up|3|||
48484846|NCT01619085|155969310|FG000|Overall Study|Withdrawal by Subject|45|||
48484847|NCT01619085|155969310|FG000|Overall Study|Other than specified|96|||
48484848|NCT01619085|155969310|FG000|Overall Study|Not treated|1|||
48484849|NCT01619085|155969310|FG000|Overall Study|Death|145|||
48484850|NCT04288115|155969313|FG000|Overall Study|Withdrawal by Subject|0|||
48484851|NCT04288115|155969314|FG001|Overall Study|Withdrawal by Subject|1|||
48484852|NCT04288115|155969313|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
48484853|NCT04288115|155969314|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
48484854|NCT03182686|155969315|FG000|Overall Study|Lost to Follow-up|2|||
48484855|NCT03182686|155969316|FG001|Overall Study|Lost to Follow-up|0|||
48484856|NCT03182686|155969315|FG000|Overall Study|Adverse Event|2|||
48484857|NCT03182686|155969316|FG001|Overall Study|Adverse Event|0|||
48484858|NCT03182686|155969315|FG000|Overall Study|Withdrawal by Subject|3|||
48484859|NCT03182686|155969316|FG001|Overall Study|Withdrawal by Subject|0|||
48484860|NCT00729365|155969317|FG000|Overall Study|Physician Decision|33|||
48484861|NCT00729365|155969318|FG001|Overall Study|Physician Decision|6|||
48484862|NCT00729365|155969319|FG002|Overall Study|Physician Decision|7|||
48484863|NCT01154127|155969321|FG000|Period 1 (21 Days)|Adverse Event|3|||
48484864|NCT01154127|155969322|FG001|Period 1 (21 Days)|Adverse Event|4|||
48484865|NCT01154127|155969321|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
48484866|NCT01154127|155969322|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
48484867|NCT01154127|155969321|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
48484868|NCT01154127|155969322|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
48484869|NCT01154127|155969321|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
48484870|NCT01154127|155969322|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
48484871|NCT01154127|155969321|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
48484872|NCT01154127|155969322|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
48484873|NCT01697449|155969323|FG000|Overall Study|Disease progression|47|||
48484874|NCT01697449|155969323|FG000|Overall Study|Adverse Event|7|||
48484875|NCT01697449|155969323|FG000|Overall Study|Lost to Follow-up|5|||
48484876|NCT01697449|155969323|FG000|Overall Study|Withdrawal by Subject|2|||
48484877|NCT01697449|155969323|FG000|Overall Study|Physician Decision|1|||
48484878|NCT01697449|155969323|FG000|Overall Study|Death|2|||
48484879|NCT01697449|155969323|FG000|Overall Study|Other|1|||
48484880|NCT01697449|155969323|FG000|Overall Study|Missing|25|||
48484881|NCT01169844|155969324|FG000|Overall Study|Adverse Event|0|||
48484882|NCT01169844|155969325|FG001|Overall Study|Adverse Event|1|||
48484883|NCT01169844|155969324|FG000|Overall Study|Patient withdrew consent|4|||
48484884|NCT01169844|155969325|FG001|Overall Study|Patient withdrew consent|0|||
48484885|NCT01169844|155969324|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48484886|NCT01169844|155969325|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48484887|NCT00743119|155969334|FG000|Overall Study|unreliable|3|||
48484888|NCT00743119|155969334|FG000|Overall Study|Withdrawal by Subject|1|||
48484889|NCT04071626|155969336|FG000|Overall Study|Withdrawal by Subject|1|||
48484890|NCT04071626|155969337|FG001|Overall Study|Withdrawal by Subject|1|||
48484891|NCT04071626|155969336|FG000|Overall Study|Protocol Violation|0|||
48484892|NCT04071626|155969337|FG001|Overall Study|Protocol Violation|1|||
48484893|NCT02176642|155969338|FG000|Overall Study|Withdrawal by Subject|0|||
48484894|NCT02176642|155969339|FG001|Overall Study|Withdrawal by Subject|1|||
48484895|NCT01309828|155969341|FG000|Overall Study|Adverse Event|10|||
48484896|NCT01309828|155969342|FG001|Overall Study|Adverse Event|11|||
48484897|NCT01309828|155969341|FG000|Overall Study|Voluntary Withdrawal|5|||
48484898|NCT01309828|155969342|FG001|Overall Study|Voluntary Withdrawal|4|||
48484899|NCT01309828|155969341|FG000|Overall Study|Major Protocol Deviation|0|||
48484900|NCT01309828|155969342|FG001|Overall Study|Major Protocol Deviation|1|||
48484901|NCT01309828|155969341|FG000|Overall Study|Other|1|||
48484902|NCT01309828|155969342|FG001|Overall Study|Other|0|||
48484903|NCT02556632|155969343|FG000|Overall Study|Lost to Follow-up|1|||
48484904|NCT02556632|155969344|FG001|Overall Study|Lost to Follow-up|0|||
48484905|NCT02556632|155969345|FG002|Overall Study|Lost to Follow-up|0|||
48484906|NCT02556632|155969343|FG000|Overall Study|Disliked Intervention|1|||
48484907|NCT02556632|155969344|FG001|Overall Study|Disliked Intervention|1|||
48484908|NCT02556632|155969345|FG002|Overall Study|Disliked Intervention|1|||
48484909|NCT02556632|155969343|FG000|Overall Study|No Reason|1|||
48484910|NCT02556632|155969344|FG001|Overall Study|No Reason|0|||
48484911|NCT02556632|155969345|FG002|Overall Study|No Reason|1|||
48484912|NCT02556632|155969343|FG000|Overall Study|Personal Issues|0|||
48484913|NCT02556632|155969344|FG001|Overall Study|Personal Issues|1|||
48484914|NCT02556632|155969345|FG002|Overall Study|Personal Issues|1|||
48484915|NCT02556632|155969343|FG000|Overall Study|Changed Mind|0|||
48484916|NCT02556632|155969344|FG001|Overall Study|Changed Mind|1|||
48484917|NCT02556632|155969345|FG002|Overall Study|Changed Mind|0|||
48484918|NCT02556632|155969343|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
48484919|NCT02556632|155969344|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
48484920|NCT02556632|155969345|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
48484921|NCT02556632|155969343|FG000|Overall Study|Unrelated Adverse Event|1|||
48484922|NCT02556632|155969344|FG001|Overall Study|Unrelated Adverse Event|0|||
48484923|NCT02556632|155969345|FG002|Overall Study|Unrelated Adverse Event|3|||
48484924|NCT02556632|155969343|FG000|Overall Study|Related Adverse Event|0|||
48484925|NCT02556632|155969344|FG001|Overall Study|Related Adverse Event|1|||
48484926|NCT02556632|155969345|FG002|Overall Study|Related Adverse Event|0|||
48484927|NCT02556632|155969343|FG000|Overall Study|Possibly Related Adverse Event|0|||
48484928|NCT02556632|155969344|FG001|Overall Study|Possibly Related Adverse Event|0|||
48484929|NCT02556632|155969345|FG002|Overall Study|Possibly Related Adverse Event|1|||
48484930|NCT02556632|155969343|FG000|Overall Study|Did Not Start RT|0|||
48484931|NCT02556632|155969344|FG001|Overall Study|Did Not Start RT|1|||
48484932|NCT02556632|155969345|FG002|Overall Study|Did Not Start RT|0|||
48484933|NCT02556632|155969343|FG000|Overall Study|Ineligible|0|||
48484934|NCT02556632|155969344|FG001|Overall Study|Ineligible|1|||
48484935|NCT02556632|155969345|FG002|Overall Study|Ineligible|0|||
48484936|NCT02556632|155969343|FG000|Overall Study|Disliked Study Procedures|0|||
48484937|NCT02556632|155969344|FG001|Overall Study|Disliked Study Procedures|0|||
48484938|NCT02556632|155969345|FG002|Overall Study|Disliked Study Procedures|1|||
48484939|NCT02556632|155969343|FG000|Overall Study|Treatment or Change Delay|0|||
48589996|NCT02557516|156352229|FG003|Overall Study|Adverse Event|1|||
48484940|NCT02556632|155969344|FG001|Overall Study|Treatment or Change Delay|0|||
48484941|NCT02556632|155969345|FG002|Overall Study|Treatment or Change Delay|1|||
48484942|NCT02574260|155969346|FG000|Overall Study|Disease Progression|1|||
48484943|NCT04523831|155969347|FG000|Overall Study|Lost to Follow-up|15|||
48484944|NCT04523831|155969348|FG001|Overall Study|Lost to Follow-up|17|||
48484945|NCT04523831|155969347|FG000|Overall Study|Death|0|||
48484946|NCT04523831|155969348|FG001|Overall Study|Death|3|||
48484947|NCT04523831|155969347|FG000|Overall Study|Adverse Event|2|||
48484948|NCT04523831|155969348|FG001|Overall Study|Adverse Event|0|||
48484949|NCT04385199|155969349|FG000|Overall Study|Withdrawal by Subject|1|||
48484950|NCT04385199|155969350|FG001|Overall Study|Withdrawal by Subject|0|||
48484951|NCT02133352|155969354|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
48484952|NCT04444752|155969355|FG000|Overall Study|Adverse Event|1|||
48484953|NCT04444752|155969356|FG001|Overall Study|Adverse Event|0|||
48484954|NCT04444752|155969357|FG002|Overall Study|Adverse Event|0|||
48484955|NCT04444752|155969358|FG003|Overall Study|Adverse Event|2|||
48484956|NCT04444752|155969355|FG000|Overall Study|Lost to Follow-up|2|||
48484957|NCT04444752|155969356|FG001|Overall Study|Lost to Follow-up|6|||
48484958|NCT04444752|155969357|FG002|Overall Study|Lost to Follow-up|2|||
48484959|NCT04444752|155969358|FG003|Overall Study|Lost to Follow-up|5|||
48484960|NCT04444752|155969355|FG000|Overall Study|Physician Decision|0|||
48484961|NCT04444752|155969356|FG001|Overall Study|Physician Decision|0|||
48484962|NCT04444752|155969357|FG002|Overall Study|Physician Decision|0|||
48484963|NCT04444752|155969358|FG003|Overall Study|Physician Decision|2|||
48484964|NCT04444752|155969355|FG000|Overall Study|Pregnancy|0|||
48484965|NCT04444752|155969356|FG001|Overall Study|Pregnancy|0|||
48484966|NCT04444752|155969357|FG002|Overall Study|Pregnancy|0|||
48484967|NCT04444752|155969358|FG003|Overall Study|Pregnancy|1|||
48484968|NCT04444752|155969355|FG000|Overall Study|Withdrawal by Subject|6|||
48484969|NCT04444752|155969356|FG001|Overall Study|Withdrawal by Subject|5|||
48484970|NCT04444752|155969357|FG002|Overall Study|Withdrawal by Subject|3|||
48484971|NCT04444752|155969358|FG003|Overall Study|Withdrawal by Subject|4|||
48484972|NCT04444752|155969355|FG000|Overall Study|Protocol Violation|1|||
48484973|NCT04444752|155969356|FG001|Overall Study|Protocol Violation|1|||
48484974|NCT04444752|155969357|FG002|Overall Study|Protocol Violation|0|||
48484975|NCT04444752|155969358|FG003|Overall Study|Protocol Violation|0|||
48484976|NCT04444752|155969355|FG000|Overall Study|Patient moving out of town|1|||
48484977|NCT04444752|155969356|FG001|Overall Study|Patient moving out of town|0|||
48484978|NCT04444752|155969357|FG002|Overall Study|Patient moving out of town|0|||
48484979|NCT04444752|155969358|FG003|Overall Study|Patient moving out of town|1|||
48484980|NCT04444752|155969355|FG000|Overall Study|Lack of Efficacy|0|||
48484981|NCT04444752|155969356|FG001|Overall Study|Lack of Efficacy|0|||
48484982|NCT04444752|155969357|FG002|Overall Study|Lack of Efficacy|0|||
48484983|NCT04444752|155969358|FG003|Overall Study|Lack of Efficacy|1|||
48484984|NCT04444752|155969355|FG000|Overall Study|Death|0|||
48484985|NCT04444752|155969356|FG001|Overall Study|Death|0|||
48484986|NCT04444752|155969357|FG002|Overall Study|Death|1|||
48484987|NCT04444752|155969358|FG003|Overall Study|Death|0|||
48484988|NCT00579254|155969359|FG000|Overall Study|Lost to Follow-up|39|||
48484989|NCT00579254|155969359|FG000|Overall Study|Discontinued when study terminated|73|||
48484990|NCT00628745|155969363|FG000|Overall Study|Withdrawal by Subject|63|||
48484991|NCT00628745|155969364|FG001|Overall Study|Withdrawal by Subject|3|||
48484992|NCT00628745|155969365|FG002|Overall Study|Withdrawal by Subject|9|||
48484993|NCT00628745|155969366|FG003|Overall Study|Withdrawal by Subject|2|||
48484994|NCT00628745|155969367|FG004|Overall Study|Withdrawal by Subject|69|||
48484995|NCT00628745|155969363|FG000|Overall Study|Does not meet inclusion criteria|0|||
48484996|NCT00628745|155969364|FG001|Overall Study|Does not meet inclusion criteria|12|||
48484997|NCT00628745|155969365|FG002|Overall Study|Does not meet inclusion criteria|0|||
48484998|NCT00628745|155969366|FG003|Overall Study|Does not meet inclusion criteria|0|||
48484999|NCT00628745|155969367|FG004|Overall Study|Does not meet inclusion criteria|18|||
48485000|NCT00628745|155969363|FG000|Overall Study|Participation in an interventional clinical trial|81|||
48485001|NCT00628745|155969364|FG001|Overall Study|Participation in an interventional clinical trial|4|||
48485002|NCT00628745|155969365|FG002|Overall Study|Participation in an interventional clinical trial|7|||
48485003|NCT00628745|155969366|FG003|Overall Study|Participation in an interventional clinical trial|0|||
48485004|NCT00628745|155969367|FG004|Overall Study|Participation in an interventional clinical trial|63|||
48485005|NCT00628745|155969363|FG000|Overall Study|Physician Decision|8|||
48485006|NCT00628745|155969364|FG001|Overall Study|Physician Decision|4|||
48485007|NCT00628745|155969365|FG002|Overall Study|Physician Decision|3|||
48485008|NCT00628745|155969366|FG003|Overall Study|Physician Decision|0|||
48485009|NCT00628745|155969367|FG004|Overall Study|Physician Decision|30|||
48485010|NCT00628745|155969363|FG000|Overall Study|Lost to Follow-up|109|||
48485011|NCT00628745|155969364|FG001|Overall Study|Lost to Follow-up|7|||
48485012|NCT00628745|155969365|FG002|Overall Study|Lost to Follow-up|7|||
48485013|NCT00628745|155969366|FG003|Overall Study|Lost to Follow-up|0|||
48485014|NCT00628745|155969367|FG004|Overall Study|Lost to Follow-up|498|||
48485015|NCT00628745|155969363|FG000|Overall Study|Death|197|||
48485016|NCT00628745|155969364|FG001|Overall Study|Death|81|||
48485017|NCT00628745|155969365|FG002|Overall Study|Death|12|||
48485018|NCT00628745|155969366|FG003|Overall Study|Death|4|||
48485019|NCT00628745|155969367|FG004|Overall Study|Death|939|||
48485020|NCT00628745|155969363|FG000|Overall Study|Participant transferred to another THAOS site|6|||
48485021|NCT00628745|155969364|FG001|Overall Study|Participant transferred to another THAOS site|0|||
48485022|NCT00628745|155969365|FG002|Overall Study|Participant transferred to another THAOS site|0|||
48485023|NCT00628745|155969366|FG003|Overall Study|Participant transferred to another THAOS site|0|||
48485024|NCT00628745|155969367|FG004|Overall Study|Participant transferred to another THAOS site|7|||
48742914|NCT00745823|156910413|FG000|Overall Study|Lack of Efficacy|20|||
48485025|NCT00628745|155969363|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
48485026|NCT00628745|155969364|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
48485027|NCT00628745|155969365|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
48485028|NCT00628745|155969366|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
48485029|NCT00628745|155969367|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
48485030|NCT00628745|155969363|FG000|Overall Study|Site closure|152|||
48485031|NCT00628745|155969364|FG001|Overall Study|Site closure|146|||
48485032|NCT00628745|155969365|FG002|Overall Study|Site closure|6|||
48485033|NCT00628745|155969366|FG003|Overall Study|Site closure|8|||
48485034|NCT00628745|155969367|FG004|Overall Study|Site closure|691|||
48589997|NCT02557516|156352226|FG000|Overall Study|Disease progression|0|||
48589998|NCT02557516|156352227|FG001|Overall Study|Disease progression|2|||
48589999|NCT02557516|156352228|FG002|Overall Study|Disease progression|0|||
48590000|NCT02557516|156352229|FG003|Overall Study|Disease progression|0|||
48590001|NCT02557516|156352226|FG000|Overall Study|Physician Decision|0|||
48590002|NCT02557516|156352227|FG001|Overall Study|Physician Decision|2|||
48590003|NCT02557516|156352228|FG002|Overall Study|Physician Decision|0|||
48590004|NCT02557516|156352229|FG003|Overall Study|Physician Decision|0|||
48590005|NCT02557516|156352226|FG000|Overall Study|Sponsor decision|0|||
48590006|NCT02557516|156352227|FG001|Overall Study|Sponsor decision|1|||
48590007|NCT02557516|156352228|FG002|Overall Study|Sponsor decision|2|||
48590008|NCT02557516|156352229|FG003|Overall Study|Sponsor decision|8|||
48590009|NCT04399538|156352230|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
48590010|NCT04399538|156352231|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
48590011|NCT04399538|156352232|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
48590012|NCT04399538|156352233|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
48590013|NCT04399538|156352234|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
48590014|NCT04399538|156352230|FG000|Double-Blind Treatment|Adverse Event|0|||
48590015|NCT04399538|156352231|FG001|Double-Blind Treatment|Adverse Event|0|||
48590016|NCT04399538|156352232|FG002|Double-Blind Treatment|Adverse Event|0|||
48590017|NCT04399538|156352233|FG003|Double-Blind Treatment|Adverse Event|0|||
48590018|NCT04399538|156352234|FG004|Double-Blind Treatment|Adverse Event|1|||
48590019|NCT04399538|156352230|FG000|Follow-Up|Adverse Event|0|||
48590020|NCT04399538|156352231|FG001|Follow-Up|Adverse Event|0|||
48590021|NCT04399538|156352232|FG002|Follow-Up|Adverse Event|0|||
48590022|NCT04399538|156352233|FG003|Follow-Up|Adverse Event|0|||
48590023|NCT04399538|156352234|FG004|Follow-Up|Adverse Event|1|||
48590024|NCT04399538|156352230|FG000|Follow-Up|Withdrawal by Subject|0|||
48590025|NCT04399538|156352231|FG001|Follow-Up|Withdrawal by Subject|0|||
48590026|NCT04399538|156352232|FG002|Follow-Up|Withdrawal by Subject|0|||
48590027|NCT04399538|156352233|FG003|Follow-Up|Withdrawal by Subject|2|||
48590028|NCT04399538|156352234|FG004|Follow-Up|Withdrawal by Subject|0|||
48590029|NCT01483599|156352235|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
48590030|NCT01483599|156352236|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590031|NCT01483599|156352237|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590032|NCT01483599|156352238|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
48590033|NCT01483599|156352239|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
48590034|NCT01483599|156352240|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
48590035|NCT01483599|156352241|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
48590036|NCT01483599|156352242|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590037|NCT01483599|156352243|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590038|NCT01483599|156352244|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590039|NCT01483599|156352245|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590040|NCT01483599|156352246|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590041|NCT01483599|156352247|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590042|NCT01483599|156352248|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
48590043|NCT01483599|156352235|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590044|NCT01483599|156352236|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
48590045|NCT01483599|156352237|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590046|NCT01483599|156352238|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
48590047|NCT01483599|156352239|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590048|NCT01483599|156352240|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590049|NCT01483599|156352241|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
48590050|NCT01483599|156352242|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590051|NCT01483599|156352243|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590052|NCT01483599|156352244|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590053|NCT01483599|156352245|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590054|NCT01483599|156352246|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590055|NCT01483599|156352247|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590056|NCT01483599|156352248|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
48590057|NCT01483599|156352235|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
48590058|NCT01483599|156352236|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48485035|NCT00628745|155969363|FG000|Overall Study|Duplicate participant|0|||
48485036|NCT00628745|155969364|FG001|Overall Study|Duplicate participant|0|||
48485037|NCT00628745|155969365|FG002|Overall Study|Duplicate participant|0|||
48485038|NCT00628745|155969366|FG003|Overall Study|Duplicate participant|0|||
48485039|NCT00628745|155969367|FG004|Overall Study|Duplicate participant|1|||
48485040|NCT00628745|155969363|FG000|Overall Study|Missing|4|||
48485041|NCT00628745|155969364|FG001|Overall Study|Missing|3|||
48485042|NCT00628745|155969365|FG002|Overall Study|Missing|0|||
48485043|NCT00628745|155969366|FG003|Overall Study|Missing|0|||
48485044|NCT00628745|155969367|FG004|Overall Study|Missing|10|||
48485045|NCT00628745|155969363|FG000|Overall Study|Othe reasons|987|||
48485046|NCT00628745|155969364|FG001|Overall Study|Othe reasons|373|||
48485047|NCT00628745|155969365|FG002|Overall Study|Othe reasons|105|||
48485048|NCT00628745|155969366|FG003|Overall Study|Othe reasons|1|||
48485049|NCT00628745|155969367|FG004|Overall Study|Othe reasons|1772|||
48485050|NCT03044431|155970801|FG000|Overall Study|Lost to Follow-up|59|||
48485051|NCT00569231|155970802|FG000|Overall Study|Study unrelated surgery|1|||
48485052|NCT00569231|155970802|FG000|Overall Study|Airfare expense|2|||
48485053|NCT00569231|155970802|FG000|Overall Study|Withdrawal by Subject|1|||
48485054|NCT00569231|155970802|FG000|Overall Study|Car accident injury|1|||
48485055|NCT00569231|155970802|FG000|Overall Study|Non-compliance|2|||
48485056|NCT00700310|155970803|FG000|Overall Study|Adverse Event|6|||
48485057|NCT00700310|155970804|FG001|Overall Study|Adverse Event|10|||
48485058|NCT00700310|155970805|FG002|Overall Study|Adverse Event|5|||
48485059|NCT00700310|155970806|FG003|Overall Study|Adverse Event|11|||
48485060|NCT00700310|155970803|FG000|Overall Study|Lost to Follow-up|4|||
48485061|NCT00700310|155970804|FG001|Overall Study|Lost to Follow-up|1|||
48485062|NCT00700310|155970805|FG002|Overall Study|Lost to Follow-up|0|||
48485063|NCT00700310|155970806|FG003|Overall Study|Lost to Follow-up|1|||
48485064|NCT00700310|155970803|FG000|Overall Study|Withdrawal by Subject|8|||
48485065|NCT00700310|155970804|FG001|Overall Study|Withdrawal by Subject|9|||
48485066|NCT00700310|155970805|FG002|Overall Study|Withdrawal by Subject|8|||
48485067|NCT00700310|155970806|FG003|Overall Study|Withdrawal by Subject|8|||
48485068|NCT00700310|155970803|FG000|Overall Study|Lack of Efficacy|0|||
48485069|NCT00700310|155970804|FG001|Overall Study|Lack of Efficacy|3|||
48485070|NCT00700310|155970805|FG002|Overall Study|Lack of Efficacy|0|||
48485071|NCT00700310|155970806|FG003|Overall Study|Lack of Efficacy|1|||
48485072|NCT00700310|155970803|FG000|Overall Study|Administrative/Other|1|||
48485073|NCT00700310|155970804|FG001|Overall Study|Administrative/Other|3|||
48485074|NCT00700310|155970805|FG002|Overall Study|Administrative/Other|1|||
48485075|NCT00700310|155970806|FG003|Overall Study|Administrative/Other|3|||
48485076|NCT00700310|155970803|FG000|Overall Study|Randomized, Not Treated|2|||
48485077|NCT00700310|155970804|FG001|Overall Study|Randomized, Not Treated|0|||
48485078|NCT00700310|155970805|FG002|Overall Study|Randomized, Not Treated|2|||
48485079|NCT00700310|155970806|FG003|Overall Study|Randomized, Not Treated|2|||
48485080|NCT00766506|155970809|FG000|Overall Study|Use rescue medication after 3 hours|3|||
48485081|NCT00766506|155970810|FG001|Overall Study|Use rescue medication after 3 hours|0|||
48485082|NCT00766506|155970809|FG000|Overall Study|Other|2|||
48485083|NCT00766506|155970810|FG001|Overall Study|Other|2|||
48485084|NCT03053622|155970814|FG000|Overall Study|Lost to Follow-up|0|||
48485085|NCT03053622|155970815|FG001|Overall Study|Lost to Follow-up|0|||
48485086|NCT03053622|155970816|FG002|Overall Study|Lost to Follow-up|0|||
48485087|NCT03053622|155970817|FG003|Overall Study|Lost to Follow-up|1|||
48485088|NCT02598622|155970818|FG000|Overall Study|Withdrawal by Subject|3|||
48485089|NCT02598622|155970819|FG001|Overall Study|Withdrawal by Subject|0|||
48485090|NCT02598622|155970818|FG000|Overall Study|Physician Decision|3|||
48485091|NCT02598622|155970819|FG001|Overall Study|Physician Decision|0|||
48485092|NCT01896700|155970831|FG000|Overall Study|Adverse Event|4|||
48485093|NCT01896700|155970832|FG001|Overall Study|Adverse Event|5|||
48485094|NCT01896700|155970831|FG000|Overall Study|Withdrawal by Subject|0|||
48485095|NCT01896700|155970832|FG001|Overall Study|Withdrawal by Subject|1|||
48485096|NCT00267007|155970833|FG000|Overall Study|Withdrawal by Subject|6|||
48485097|NCT00267007|155970834|FG001|Overall Study|Withdrawal by Subject|0|||
48485098|NCT00267007|155970833|FG000|Overall Study|Lost to Follow-up|1|||
48485099|NCT00267007|155970834|FG001|Overall Study|Lost to Follow-up|0|||
48485100|NCT00267007|155970833|FG000|Overall Study|Non-compliance|0|||
48485101|NCT00267007|155970834|FG001|Overall Study|Non-compliance|1|||
48485102|NCT00267007|155970833|FG000|Overall Study|Adverse Event|1|||
48485103|NCT00267007|155970834|FG001|Overall Study|Adverse Event|0|||
48485104|NCT00886782|155970835|FG000|Overall Study|Disease progression|3|||
48485105|NCT00886782|155970836|FG001|Overall Study|Disease progression|3|||
48485106|NCT00886782|155970837|FG002|Overall Study|Disease progression|3|||
48485107|NCT00886782|155970835|FG000|Overall Study|Study drug toxicity|0|||
48485108|NCT00886782|155970836|FG001|Overall Study|Study drug toxicity|0|||
48485109|NCT00886782|155970837|FG002|Overall Study|Study drug toxicity|1|||
48485110|NCT00886782|155970835|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
48485111|NCT00886782|155970836|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
48485112|NCT00886782|155970837|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
48485113|NCT03118765|155970838|FG000|Overall Study|Withdrawal by Subject|0|||
48485114|NCT03118765|155970839|FG001|Overall Study|Withdrawal by Subject|0|||
48485115|NCT03118765|155970840|FG002|Overall Study|Withdrawal by Subject|1|||
48485116|NCT03118765|155970841|FG003|Overall Study|Withdrawal by Subject|0|||
48485117|NCT03118765|155970842|FG004|Overall Study|Withdrawal by Subject|0|||
48485118|NCT03118765|155970838|FG000|Overall Study|Adverse Event|1|||
48485119|NCT03118765|155970839|FG001|Overall Study|Adverse Event|1|||
48485120|NCT03118765|155970840|FG002|Overall Study|Adverse Event|1|||
48485121|NCT03118765|155970841|FG003|Overall Study|Adverse Event|1|||
48485122|NCT03118765|155970842|FG004|Overall Study|Adverse Event|1|||
48485123|NCT03118765|155970838|FG000|Overall Study|Non compliance with Study Procedures|0|||
48485124|NCT03118765|155970839|FG001|Overall Study|Non compliance with Study Procedures|0|||
48485125|NCT03118765|155970840|FG002|Overall Study|Non compliance with Study Procedures|0|||
48485126|NCT03118765|155970841|FG003|Overall Study|Non compliance with Study Procedures|1|||
48485127|NCT03118765|155970842|FG004|Overall Study|Non compliance with Study Procedures|0|||
48485128|NCT03118765|155970838|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
48485129|NCT03118765|155970839|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
48485130|NCT03118765|155970840|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
48485131|NCT03118765|155970841|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
48485132|NCT03118765|155970842|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
48485133|NCT03118765|155970838|FG000|Overall Study|COPD Exacerbation|1|||
48485134|NCT03118765|155970839|FG001|Overall Study|COPD Exacerbation|0|||
48485135|NCT03118765|155970840|FG002|Overall Study|COPD Exacerbation|0|||
48485136|NCT03118765|155970841|FG003|Overall Study|COPD Exacerbation|1|||
48485137|NCT03118765|155970842|FG004|Overall Study|COPD Exacerbation|0|||
48485138|NCT03118765|155970838|FG000|Overall Study|Lost to Follow-up|1|||
48485139|NCT03118765|155970839|FG001|Overall Study|Lost to Follow-up|0|||
48485140|NCT03118765|155970840|FG002|Overall Study|Lost to Follow-up|1|||
48485141|NCT03118765|155970841|FG003|Overall Study|Lost to Follow-up|0|||
48485142|NCT03118765|155970842|FG004|Overall Study|Lost to Follow-up|0|||
48485143|NCT03118765|155970838|FG000|Overall Study|Sponsor Decision|1|||
48485144|NCT03118765|155970839|FG001|Overall Study|Sponsor Decision|0|||
48485145|NCT03118765|155970840|FG002|Overall Study|Sponsor Decision|1|||
48485146|NCT03118765|155970841|FG003|Overall Study|Sponsor Decision|0|||
48485147|NCT03118765|155970842|FG004|Overall Study|Sponsor Decision|1|||
48485148|NCT00849524|155970843|FG000|Overall Study|Lack of Efficacy|3|||
48485149|NCT01418352|155970846|FG000|Overall Study|Lost to Follow-up|2|||
48485150|NCT01418352|155970847|FG001|Overall Study|Lost to Follow-up|0|||
48485151|NCT01418352|155970848|FG002|Overall Study|Lost to Follow-up|0|||
48485152|NCT01418352|155970849|FG003|Overall Study|Lost to Follow-up|0|||
48485153|NCT01418352|155970846|FG000|Overall Study|Adverse Event|0|||
48485154|NCT01418352|155970847|FG001|Overall Study|Adverse Event|1|||
48485155|NCT01418352|155970848|FG002|Overall Study|Adverse Event|0|||
48485156|NCT01418352|155970849|FG003|Overall Study|Adverse Event|0|||
48485157|NCT01418352|155970846|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
48485158|NCT01418352|155970847|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
48485159|NCT01418352|155970848|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
48485160|NCT01418352|155970849|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
48485161|NCT01418352|155970846|FG000|Overall Study|Subject Withdrew Consent|0|||
48485162|NCT01418352|155970847|FG001|Overall Study|Subject Withdrew Consent|1|||
48485163|NCT01418352|155970848|FG002|Overall Study|Subject Withdrew Consent|2|||
48485164|NCT01418352|155970849|FG003|Overall Study|Subject Withdrew Consent|1|||
48485165|NCT01418352|155970846|FG000|Overall Study|Protocol Deviation|0|||
48485166|NCT01418352|155970847|FG001|Overall Study|Protocol Deviation|0|||
48485167|NCT01418352|155970848|FG002|Overall Study|Protocol Deviation|1|||
48485168|NCT01418352|155970849|FG003|Overall Study|Protocol Deviation|0|||
48485169|NCT01418352|155970846|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
48485170|NCT01418352|155970847|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
48485171|NCT01418352|155970848|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
48485172|NCT01418352|155970849|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
48485173|NCT01255722|155970850|FG000|Overall Study|Adverse Event|0|||
48485174|NCT01255722|155970851|FG001|Overall Study|Adverse Event|1|||
48485175|NCT01255722|155970852|FG002|Overall Study|Adverse Event|1|||
48485176|NCT01255722|155970850|FG000|Overall Study|asymptomatic patient|1|||
48485177|NCT01255722|155970851|FG001|Overall Study|asymptomatic patient|0|||
48485178|NCT01255722|155970852|FG002|Overall Study|asymptomatic patient|0|||
48485179|NCT01255722|155970850|FG000|Overall Study|beta-blocker contraindicated|2|||
48485180|NCT01255722|155970851|FG001|Overall Study|beta-blocker contraindicated|0|||
48485181|NCT01255722|155970852|FG002|Overall Study|beta-blocker contraindicated|0|||
48485182|NCT02059187|155970855|FG000|Overall Study|Adverse Event|0|||
48485183|NCT02059187|155970856|FG001|Overall Study|Adverse Event|3|||
48485184|NCT02059187|155970855|FG000|Overall Study|Death|1|||
48485185|NCT02059187|155970856|FG001|Overall Study|Death|1|||
48485186|NCT02059187|155970855|FG000|Overall Study|Lost to Follow-up|9|||
48485187|NCT02059187|155970856|FG001|Overall Study|Lost to Follow-up|8|||
48485188|NCT02059187|155970855|FG000|Overall Study|Non-compliance with study drug|1|||
48485189|NCT02059187|155970856|FG001|Overall Study|Non-compliance with study drug|0|||
48485190|NCT02059187|155970855|FG000|Overall Study|Physician Decision|1|||
48485191|NCT02059187|155970856|FG001|Overall Study|Physician Decision|2|||
48485192|NCT02059187|155970855|FG000|Overall Study|Protocol Violation|1|||
48485193|NCT02059187|155970856|FG001|Overall Study|Protocol Violation|0|||
48485194|NCT02059187|155970855|FG000|Overall Study|Withdrawal by Subject|12|||
48485195|NCT02059187|155970856|FG001|Overall Study|Withdrawal by Subject|8|||
48485196|NCT03712228|155970859|FG000|Treatment Period 1|Lack of Efficacy|0|||
48485197|NCT03712228|155970860|FG001|Treatment Period 1|Lack of Efficacy|0|||
48485198|NCT03712228|155970861|FG002|Treatment Period 1|Lack of Efficacy|0|||
48485199|NCT03712228|155970862|FG003|Treatment Period 1|Lack of Efficacy|0|||
48485200|NCT03712228|155970863|FG004|Treatment Period 1|Lack of Efficacy|0|||
48485201|NCT03712228|155970864|FG005|Treatment Period 1|Lack of Efficacy|1|||
48485202|NCT03712228|155970859|FG000|Treatment Period 2|Pregnancy|0|||
48485203|NCT03712228|155970860|FG001|Treatment Period 2|Pregnancy|0|||
48485204|NCT03712228|155970861|FG002|Treatment Period 2|Pregnancy|0|||
48485205|NCT03712228|155970862|FG003|Treatment Period 2|Pregnancy|1|||
48485206|NCT03712228|155970863|FG004|Treatment Period 2|Pregnancy|0|||
48485207|NCT03712228|155970864|FG005|Treatment Period 2|Pregnancy|0|||
48485208|NCT03712228|155970859|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48485209|NCT03712228|155970860|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48485210|NCT03712228|155970861|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48485211|NCT03712228|155970862|FG003|Treatment Period 2|Withdrawal by Subject|1|||
48485212|NCT03712228|155970863|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48485213|NCT03712228|155970864|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48485214|NCT02746705|155970865|FG000|Overall Study|Physician Decision|1|||
48485215|NCT02746705|155970866|FG001|Overall Study|Physician Decision|1|||
48485216|NCT02746705|155970865|FG000|Overall Study|Lost to Follow-up|1|||
48485217|NCT02746705|155970866|FG001|Overall Study|Lost to Follow-up|0|||
48485218|NCT02746705|155970865|FG000|Overall Study|outlier scores deemed not valid|0|||
48485219|NCT02746705|155970866|FG001|Overall Study|outlier scores deemed not valid|1|||
48485220|NCT00479401|155970867|FG000|Overall Study|Adverse Event|24|||
48485221|NCT00479401|155970868|FG001|Overall Study|Adverse Event|20|||
48485222|NCT00479401|155970869|FG002|Overall Study|Adverse Event|4|||
48485223|NCT00479401|155970867|FG000|Overall Study|Lack of Efficacy|2|||
48485224|NCT00479401|155970868|FG001|Overall Study|Lack of Efficacy|2|||
48485225|NCT00479401|155970869|FG002|Overall Study|Lack of Efficacy|4|||
48485226|NCT00479401|155970867|FG000|Overall Study|Protocol Violation|2|||
48485227|NCT00479401|155970868|FG001|Overall Study|Protocol Violation|1|||
48485228|NCT00479401|155970869|FG002|Overall Study|Protocol Violation|1|||
48485229|NCT00479401|155970867|FG000|Overall Study|Lost to Follow-up|1|||
48485230|NCT00479401|155970868|FG001|Overall Study|Lost to Follow-up|1|||
48485231|NCT00479401|155970869|FG002|Overall Study|Lost to Follow-up|1|||
48485232|NCT00479401|155970867|FG000|Overall Study|Withdrawal by Subject|16|||
48485233|NCT00479401|155970868|FG001|Overall Study|Withdrawal by Subject|10|||
48485234|NCT00479401|155970869|FG002|Overall Study|Withdrawal by Subject|2|||
48485235|NCT00479401|155970867|FG000|Overall Study|Exclusion criteria, relocation|4|||
48485236|NCT00479401|155970868|FG001|Overall Study|Exclusion criteria, relocation|3|||
48485237|NCT00479401|155970869|FG002|Overall Study|Exclusion criteria, relocation|0|||
48485238|NCT00283686|155970870|FG000|Overall Study|Death|1|||
48485239|NCT00283686|155970871|FG001|Overall Study|Death|1|||
48485240|NCT00283686|155970872|FG002|Overall Study|Death|1|||
48485241|NCT00283686|155970873|FG003|Overall Study|Death|0|||
48485242|NCT00283686|155970870|FG000|Overall Study|Lost to Follow-up|21|||
48485243|NCT00283686|155970871|FG001|Overall Study|Lost to Follow-up|31|||
48485244|NCT00283686|155970872|FG002|Overall Study|Lost to Follow-up|26|||
48485245|NCT00283686|155970873|FG003|Overall Study|Lost to Follow-up|20|||
48485246|NCT00283686|155970870|FG000|Overall Study|Less than full participation|7|||
48485247|NCT00283686|155970871|FG001|Overall Study|Less than full participation|9|||
48485248|NCT00283686|155970872|FG002|Overall Study|Less than full participation|6|||
48485249|NCT00283686|155970873|FG003|Overall Study|Less than full participation|12|||
48485250|NCT03296553|155970875|FG000|Overall Study|Withdrawal by Subject|1|||
48485251|NCT03296553|155970876|FG001|Overall Study|Withdrawal by Subject|1|||
48485252|NCT03296553|155970875|FG000|Overall Study|Death|1|||
48485253|NCT03296553|155970876|FG001|Overall Study|Death|0|||
48485254|NCT03707522|155970877|FG000|Overall Study|Lost to Follow-up|24|||
48485255|NCT03707522|155970878|FG001|Overall Study|Lost to Follow-up|27|||
48485256|NCT03707522|155970879|FG002|Overall Study|Lost to Follow-up|41|||
48485257|NCT03707522|155970880|FG003|Overall Study|Lost to Follow-up|36|||
48485258|NCT03797222|155970881|FG000|Overall Study|Withdrawal by Subject|1|||
48485259|NCT02862535|155970883|FG000|Overall Study|Death|7|||
48485260|NCT02862535|155970884|FG001|Overall Study|Death|3|||
48485261|NCT02862535|155970885|FG002|Overall Study|Death|2|||
48485262|NCT02862535|155970886|FG003|Overall Study|Death|5|||
48485263|NCT02862535|155970883|FG000|Overall Study|Study Terminated by Sponsor|1|||
48485264|NCT02862535|155970884|FG001|Overall Study|Study Terminated by Sponsor|3|||
48485265|NCT02862535|155970885|FG002|Overall Study|Study Terminated by Sponsor|8|||
48485266|NCT02862535|155970886|FG003|Overall Study|Study Terminated by Sponsor|5|||
48485267|NCT02862535|155970883|FG000|Overall Study|Enrolled, not Treated|1|||
48485268|NCT02862535|155970884|FG001|Overall Study|Enrolled, not Treated|0|||
48485269|NCT02862535|155970885|FG002|Overall Study|Enrolled, not Treated|0|||
48485270|NCT02862535|155970886|FG003|Overall Study|Enrolled, not Treated|1|||
48485271|NCT00558519|155970887|FG000|Overall Study|Ph+|20|||
48485272|NCT00558519|155970887|FG000|Overall Study|Ineligible|1|||
48485273|NCT00558519|155970887|FG000|Overall Study|Insufficient data|1|||
48485274|NCT00558519|155970887|FG000|Overall Study|Never received treatment|1|||
48485275|NCT03001011|155970888|FG000|Overall Study|Adverse Event|9|||
48485276|NCT03001011|155970889|FG001|Overall Study|Adverse Event|3|||
48485277|NCT03001011|155970888|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
48485278|NCT03001011|155970889|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
48485279|NCT03001011|155970888|FG000|Overall Study|Other than specified above|3|||
48485280|NCT03001011|155970889|FG001|Overall Study|Other than specified above|8|||
48485281|NCT00575328|155970890|FG000|Overall Study|Adverse Event|1|||
48485282|NCT00575328|155970891|FG001|Overall Study|Adverse Event|1|||
48485283|NCT00575328|155970890|FG000|Overall Study|Lost to Follow-up|2|||
48485284|NCT00575328|155970891|FG001|Overall Study|Lost to Follow-up|1|||
48485285|NCT02875067|155970892|FG000|Overall Study|Withdrawal by Subject|1|||
48485286|NCT02875067|155970892|FG000|Overall Study|Withdrawal by Termination of Study|5|||
48485287|NCT00964223|155970893|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
48485288|NCT02278952|155970894|FG000|Overall Study|Insufficient Sample|6|||
48485289|NCT03264066|155970895|FG000|Overall Study|Adverse Event|1|||
48485290|NCT03264066|155970896|FG001|Overall Study|Adverse Event|1|||
48485291|NCT03264066|155970897|FG002|Overall Study|Adverse Event|0|||
48485292|NCT03264066|155970898|FG003|Overall Study|Adverse Event|0|||
48485293|NCT03264066|155970899|FG004|Overall Study|Adverse Event|0|||
48485294|NCT03264066|155970900|FG005|Overall Study|Adverse Event|0|||
48485295|NCT03264066|155970895|FG000|Overall Study|Death|12|||
48485296|NCT03264066|155970896|FG001|Overall Study|Death|12|||
48485297|NCT03264066|155970897|FG002|Overall Study|Death|8|||
48485298|NCT03264066|155970898|FG003|Overall Study|Death|10|||
48485299|NCT03264066|155970899|FG004|Overall Study|Death|6|||
48485300|NCT03264066|155970900|FG005|Overall Study|Death|1|||
48485301|NCT03264066|155970895|FG000|Overall Study|Lost to Follow-up|1|||
48485302|NCT03264066|155970896|FG001|Overall Study|Lost to Follow-up|0|||
48485303|NCT03264066|155970897|FG002|Overall Study|Lost to Follow-up|0|||
48485304|NCT03264066|155970898|FG003|Overall Study|Lost to Follow-up|0|||
48485305|NCT03264066|155970899|FG004|Overall Study|Lost to Follow-up|0|||
48485306|NCT03264066|155970900|FG005|Overall Study|Lost to Follow-up|0|||
48485307|NCT03264066|155970895|FG000|Overall Study|Progressive Disease|0|||
48485308|NCT03264066|155970896|FG001|Overall Study|Progressive Disease|2|||
48485309|NCT03264066|155970897|FG002|Overall Study|Progressive Disease|1|||
48485310|NCT03264066|155970898|FG003|Overall Study|Progressive Disease|0|||
48485311|NCT03264066|155970899|FG004|Overall Study|Progressive Disease|0|||
48485312|NCT03264066|155970900|FG005|Overall Study|Progressive Disease|0|||
48485313|NCT03264066|155970895|FG000|Overall Study|Study Terminated by Sponsor|5|||
48485314|NCT03264066|155970896|FG001|Overall Study|Study Terminated by Sponsor|5|||
48485315|NCT03264066|155970897|FG002|Overall Study|Study Terminated by Sponsor|8|||
48485316|NCT03264066|155970898|FG003|Overall Study|Study Terminated by Sponsor|5|||
48485317|NCT03264066|155970899|FG004|Overall Study|Study Terminated by Sponsor|1|||
48485318|NCT03264066|155970900|FG005|Overall Study|Study Terminated by Sponsor|2|||
48485319|NCT03264066|155970895|FG000|Overall Study|Withdrawal by Subject|1|||
48485320|NCT03264066|155970896|FG001|Overall Study|Withdrawal by Subject|0|||
48485321|NCT03264066|155970897|FG002|Overall Study|Withdrawal by Subject|0|||
48485322|NCT03264066|155970898|FG003|Overall Study|Withdrawal by Subject|5|||
48485323|NCT03264066|155970899|FG004|Overall Study|Withdrawal by Subject|0|||
48485324|NCT03264066|155970900|FG005|Overall Study|Withdrawal by Subject|0|||
48485325|NCT03439293|155970901|FG000|Overall Study|Death|22|||
48485326|NCT03439293|155970901|FG000|Overall Study|Withdrawal by Subject|8|||
48485327|NCT03439293|155970901|FG000|Overall Study|Lost to Follow-up|2|||
48485328|NCT03439293|155970901|FG000|Overall Study|Reason Not Specified|28|||
48485329|NCT03439293|155970901|FG000|Overall Study|Missing|1|||
48485330|NCT00871728|155970902|FG000|Overall Study|Adverse Event|1|||
48485331|NCT00871728|155970902|FG000|Overall Study|Protocol Violation|7|||
48485332|NCT00871728|155970902|FG000|Overall Study|Lost to Follow-up|2|||
48485333|NCT00871728|155970902|FG000|Overall Study|Failed to Visit Hospital|4|||
48485334|NCT00871728|155970902|FG000|Overall Study|Participant Non-compliance|1|||
48485335|NCT00871728|155970902|FG000|Overall Study|Withdrawal of Informed Consent|5|||
48485336|NCT03634488|155970903|FG000|Overall Study|Death|1|||
48485337|NCT03634488|155970904|FG001|Overall Study|Death|0|||
48485338|NCT03634488|155970905|FG002|Overall Study|Death|0|||
48485339|NCT03634488|155970903|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
48485340|NCT03634488|155970904|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
48485341|NCT03634488|155970905|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
48485342|NCT00869089|155970906|FG000|Overall Study|Lost to Follow-up|1|||
48485343|NCT00869089|155970906|FG000|Overall Study|Withdrawal by Subject|1|||
48485344|NCT00869089|155970906|FG000|Overall Study|Screen Fail|1|||
48485345|NCT02340078|155970907|FG000|Overall Study|Protocol Violation|1|||
48485346|NCT02766400|155970909|FG000|Overall Study|Death|1|||
48485347|NCT02766400|155970910|FG001|Overall Study|Death|2|||
48485348|NCT02766400|155970909|FG000|Overall Study|Withdrawal by Subject|1|||
48485349|NCT02766400|155970910|FG001|Overall Study|Withdrawal by Subject|0|||
48485350|NCT02390219|155970911|FG000|Overall Study|Death|1|||
48485351|NCT02390219|155970911|FG000|Overall Study|Physician Decision|1|||
48485352|NCT02390219|155970911|FG000|Overall Study|Adverse Event|6|||
48485353|NCT02390219|155970911|FG000|Overall Study|Withdrawal by Subject|1|||
48485354|NCT02390219|155970911|FG000|Overall Study|Lost to Follow-up|2|||
48485355|NCT02390219|155970911|FG000|Overall Study|Other|2|||
48485356|NCT00529568|155970914|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
48485357|NCT00529568|155970915|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
48485358|NCT00529568|155970916|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
48485359|NCT00529568|155970914|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
48485360|NCT00529568|155970915|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
48485361|NCT00529568|155970916|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
48485362|NCT00529568|155970914|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
48485363|NCT00529568|155970915|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
48485364|NCT00529568|155970916|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
48485365|NCT00529568|155970914|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
48485366|NCT00529568|155970915|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
48485367|NCT00529568|155970916|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
48485368|NCT00529568|155970914|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
48485369|NCT00529568|155970915|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
48485370|NCT00529568|155970916|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
48485371|NCT00529568|155970914|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
48485372|NCT00529568|155970915|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
48485373|NCT00529568|155970916|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
48485374|NCT00529568|155970914|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
48485375|NCT00529568|155970915|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
48485376|NCT00529568|155970916|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
48485377|NCT00529568|155970914|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
48485378|NCT00529568|155970915|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
48485379|NCT00529568|155970916|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
48485380|NCT00529568|155970914|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
48485381|NCT00529568|155970915|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
48485382|NCT00529568|155970916|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
48485383|NCT00529568|155970914|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
48485384|NCT00529568|155970915|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
48485385|NCT00529568|155970916|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
48485386|NCT00529568|155970914|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
48485387|NCT00529568|155970915|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
48485388|NCT00529568|155970916|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
48485389|NCT04128696|155970923|FG000|Overall Study|Lost to Follow-up|3|||
48485390|NCT04128696|155970924|FG001|Overall Study|Lost to Follow-up|7|||
48485391|NCT04128696|155970923|FG000|Overall Study|Withdrawal by Subject|12|||
48485392|NCT04128696|155970924|FG001|Overall Study|Withdrawal by Subject|11|||
48485393|NCT04128696|155970923|FG000|Overall Study|Study Closed/Terminated|26|||
48485394|NCT04128696|155970924|FG001|Overall Study|Study Closed/Terminated|38|||
48485395|NCT04128696|155970923|FG000|Overall Study|Physician Decision|2|||
48485396|NCT04128696|155970924|FG001|Overall Study|Physician Decision|3|||
48485397|NCT01225991|155970929|FG000|Overall Study|Withdrawal by Subject|6|||
48485398|NCT02196506|155970930|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
48485399|NCT02196506|155970931|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
48485400|NCT02196506|155970932|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
48485401|NCT02196506|155970933|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
48485402|NCT02196506|155970930|FG000|Phase A|Withdrawal by Subject|34|||
48485403|NCT02196506|155970931|FG001|Phase A|Withdrawal by Subject|0|||
48485404|NCT02196506|155970932|FG002|Phase A|Withdrawal by Subject|0|||
48485405|NCT02196506|155970933|FG003|Phase A|Withdrawal by Subject|0|||
48485406|NCT02196506|155970930|FG000|Phase A|Adverse Event|22|||
48485407|NCT02196506|155970931|FG001|Phase A|Adverse Event|0|||
48485408|NCT02196506|155970932|FG002|Phase A|Adverse Event|0|||
48485409|NCT02196506|155970933|FG003|Phase A|Adverse Event|0|||
48485410|NCT02196506|155970930|FG000|Phase A|Lost to Follow-up|9|||
48485411|NCT02196506|155970931|FG001|Phase A|Lost to Follow-up|0|||
48485412|NCT02196506|155970932|FG002|Phase A|Lost to Follow-up|0|||
48485413|NCT02196506|155970933|FG003|Phase A|Lost to Follow-up|0|||
48485414|NCT02196506|155970930|FG000|Phase A|Protocol deviation|12|||
48485415|NCT02196506|155970931|FG001|Phase A|Protocol deviation|0|||
48485416|NCT02196506|155970932|FG002|Phase A|Protocol deviation|0|||
48485417|NCT02196506|155970933|FG003|Phase A|Protocol deviation|0|||
48485418|NCT02196506|155970930|FG000|Phase A|Participant withdrawn by investigator|10|||
48485419|NCT02196506|155970931|FG001|Phase A|Participant withdrawn by investigator|0|||
48485420|NCT02196506|155970932|FG002|Phase A|Participant withdrawn by investigator|0|||
48485421|NCT02196506|155970933|FG003|Phase A|Participant withdrawn by investigator|0|||
48485422|NCT02196506|155970930|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
48485423|NCT02196506|155970931|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
48485424|NCT02196506|155970932|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
48485425|NCT02196506|155970933|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
48485426|NCT02196506|155970930|FG000|Phase B|Lack of Efficacy|0|||
48485427|NCT02196506|155970931|FG001|Phase B|Lack of Efficacy|1|||
48485428|NCT02196506|155970932|FG002|Phase B|Lack of Efficacy|2|||
48485429|NCT02196506|155970933|FG003|Phase B|Lack of Efficacy|0|||
48485430|NCT02196506|155970930|FG000|Phase B|Withdrawal by Participant|0|||
48485431|NCT02196506|155970931|FG001|Phase B|Withdrawal by Participant|8|||
48485432|NCT02196506|155970932|FG002|Phase B|Withdrawal by Participant|1|||
48485433|NCT02196506|155970933|FG003|Phase B|Withdrawal by Participant|0|||
48485434|NCT02196506|155970930|FG000|Phase B|Adverse Event|0|||
48485435|NCT02196506|155970931|FG001|Phase B|Adverse Event|4|||
48485436|NCT02196506|155970932|FG002|Phase B|Adverse Event|1|||
48485437|NCT02196506|155970933|FG003|Phase B|Adverse Event|0|||
48485438|NCT02196506|155970930|FG000|Phase B|Lost to Follow-up|0|||
48485439|NCT02196506|155970931|FG001|Phase B|Lost to Follow-up|2|||
48485440|NCT02196506|155970932|FG002|Phase B|Lost to Follow-up|1|||
48485441|NCT02196506|155970933|FG003|Phase B|Lost to Follow-up|0|||
48485442|NCT02196506|155970930|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
48485443|NCT02196506|155970931|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
48485444|NCT02196506|155970932|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
48485445|NCT02196506|155970933|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
48485446|NCT02196506|155970930|FG000|Phase A+|Withdrawal by Participant|0|||
48485447|NCT02196506|155970931|FG001|Phase A+|Withdrawal by Participant|0|||
48485448|NCT02196506|155970932|FG002|Phase A+|Withdrawal by Participant|0|||
48485449|NCT02196506|155970933|FG003|Phase A+|Withdrawal by Participant|5|||
48485450|NCT02196506|155970930|FG000|Phase A+|Adverse Event|0|||
48485451|NCT02196506|155970931|FG001|Phase A+|Adverse Event|0|||
48485452|NCT02196506|155970932|FG002|Phase A+|Adverse Event|0|||
48485453|NCT02196506|155970933|FG003|Phase A+|Adverse Event|1|||
48485454|NCT02196506|155970930|FG000|Phase A+|Lost to Follow-up|0|||
48485455|NCT02196506|155970931|FG001|Phase A+|Lost to Follow-up|0|||
48485456|NCT02196506|155970932|FG002|Phase A+|Lost to Follow-up|0|||
48485457|NCT02196506|155970933|FG003|Phase A+|Lost to Follow-up|6|||
48485458|NCT02196506|155970930|FG000|Phase A+|Participant withdrawn by investigator|0|||
48485459|NCT02196506|155970931|FG001|Phase A+|Participant withdrawn by investigator|0|||
48485460|NCT02196506|155970932|FG002|Phase A+|Participant withdrawn by investigator|0|||
48485461|NCT02196506|155970933|FG003|Phase A+|Participant withdrawn by investigator|1|||
48485462|NCT00789828|155970934|FG000|Core Period (48 Weeks)|Administrative problems|0|||
48485463|NCT00789828|155970935|FG001|Core Period (48 Weeks)|Administrative problems|1|||
48485464|NCT00789828|155970934|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
48485465|NCT00789828|155970935|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
48485466|NCT00789828|155970934|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
48485467|NCT00789828|155970935|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
48485468|NCT00789828|155970934|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
48485469|NCT00789828|155970935|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
48485470|NCT00789828|155970934|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
48485471|NCT00789828|155970935|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
48485472|NCT00789828|155970934|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
48485473|NCT00789828|155970935|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
48485474|NCT00789828|155970934|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
48485475|NCT00789828|155970935|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
48485476|NCT00789828|155970934|FG000|Open-label Extension Period (4 Years)|Death|1|||
48485477|NCT00789828|155970935|FG001|Open-label Extension Period (4 Years)|Death|0|||
48485478|NCT00789828|155970934|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
48485479|NCT00789828|155970935|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
48485480|NCT00789828|155970934|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
48485481|NCT00789828|155970935|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
48584927|NCT00628095|156333709|FG001|Overall Study|Withdrawal by Subject|0|||
48584928|NCT00628095|156333708|FG000|Overall Study|Other|0|||
48584929|NCT00628095|156333709|FG001|Overall Study|Other|1|||
48584930|NCT00743288|156333714|FG000|Overall Study|Adverse Event|1|||
48584931|NCT00743288|156333715|FG001|Overall Study|Adverse Event|1|||
48584932|NCT00743288|156333716|FG002|Overall Study|Adverse Event|2|||
48584933|NCT00743288|156333717|FG003|Overall Study|Adverse Event|2|||
48584934|NCT00743288|156333718|FG004|Overall Study|Adverse Event|1|||
48485482|NCT00860574|155972324|FG000|Overall Study|Death|2|||
48485483|NCT00860574|155972324|FG000|Overall Study|Relapse|1|||
48485484|NCT01246986|155972328|FG000|Overall Study|Lost to Follow-up|0|||
48485485|NCT01246986|155972329|FG001|Overall Study|Lost to Follow-up|1|||
48485486|NCT01246986|155972330|FG002|Overall Study|Lost to Follow-up|3|||
48485487|NCT01246986|155972331|FG003|Overall Study|Lost to Follow-up|0|||
48485488|NCT01246986|155972332|FG004|Overall Study|Lost to Follow-up|0|||
48485489|NCT01246986|155972333|FG005|Overall Study|Lost to Follow-up|1|||
48485490|NCT01246986|155972334|FG006|Overall Study|Lost to Follow-up|0|||
48485491|NCT01246986|155972328|FG000|Overall Study|Withdrawal by Subject|3|||
48485492|NCT01246986|155972329|FG001|Overall Study|Withdrawal by Subject|4|||
48485493|NCT01246986|155972330|FG002|Overall Study|Withdrawal by Subject|3|||
48485494|NCT01246986|155972331|FG003|Overall Study|Withdrawal by Subject|0|||
48485495|NCT01246986|155972332|FG004|Overall Study|Withdrawal by Subject|4|||
48485496|NCT01246986|155972333|FG005|Overall Study|Withdrawal by Subject|0|||
48485497|NCT01246986|155972334|FG006|Overall Study|Withdrawal by Subject|0|||
48485498|NCT00681824|155972335|FG000|Overall Study|withdrawn by investigator|0|||
48485499|NCT00681824|155972336|FG001|Overall Study|withdrawn by investigator|0|||
48485500|NCT00681824|155972337|FG002|Overall Study|withdrawn by investigator|1|||
48485501|NCT00681824|155972335|FG000|Overall Study|scheduling conflict|1|||
48485502|NCT00681824|155972336|FG001|Overall Study|scheduling conflict|0|||
48485503|NCT00681824|155972337|FG002|Overall Study|scheduling conflict|0|||
48485504|NCT00681824|155972335|FG000|Overall Study|Death|0|||
48485505|NCT00681824|155972336|FG001|Overall Study|Death|1|||
48485506|NCT00681824|155972337|FG002|Overall Study|Death|0|||
48485507|NCT03724916|155972338|FG000|Overall Study|Withdrawal by Subject|0|||
48485508|NCT03724916|155972339|FG001|Overall Study|Withdrawal by Subject|1|||
48485509|NCT03724916|155972340|FG002|Overall Study|Withdrawal by Subject|1|||
48485510|NCT03724916|155972341|FG003|Overall Study|Withdrawal by Subject|2|||
48485511|NCT03724916|155972338|FG000|Overall Study|Randomized but not Treated|1|||
48485512|NCT03724916|155972339|FG001|Overall Study|Randomized but not Treated|0|||
48485513|NCT03724916|155972340|FG002|Overall Study|Randomized but not Treated|0|||
48485514|NCT03724916|155972341|FG003|Overall Study|Randomized but not Treated|0|||
48485515|NCT04575038|155972342|FG000|Overall Study|Withdrawal by Subject|1|||
48485516|NCT04575038|155972343|FG001|Overall Study|Withdrawal by Subject|1|||
48485517|NCT01422720|155972345|FG000|Overall Study|Adverse Event|16|||
48485518|NCT01422720|155972345|FG000|Overall Study|Lack of Efficacy|1|||
48485519|NCT01422720|155972345|FG000|Overall Study|Withdrawal by Subject|4|||
48485520|NCT01422720|155972345|FG000|Overall Study|Ineligibility|1|||
48485521|NCT00303316|155972348|FG000|Overall Study|Protocol Violation|1|||
48485522|NCT00303316|155972349|FG001|Overall Study|Protocol Violation|0|||
48485523|NCT00303316|155972348|FG000|Overall Study|Lost to Follow-up|0|||
48485524|NCT00303316|155972349|FG001|Overall Study|Lost to Follow-up|1|||
48485525|NCT00303316|155972348|FG000|Overall Study|Withdrawal by Subject|1|||
48485526|NCT00303316|155972349|FG001|Overall Study|Withdrawal by Subject|2|||
48485527|NCT01726335|155972350|FG000|Overall Study|Lost to Follow-up|2|||
48485528|NCT01726335|155972350|FG000|Overall Study|Withdrawal by Subject|15|||
48485529|NCT01726335|155972350|FG000|Overall Study|Adverse Event|4|||
48485530|NCT01726335|155972350|FG000|Overall Study|Lost to Follow-up|2|||
48485531|NCT01726335|155972350|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
48485532|NCT01586624|155972351|FG000|Overall Study|Adverse Event|3|||
48485533|NCT01586624|155972352|FG001|Overall Study|Adverse Event|0|||
48485534|NCT01586624|155972353|FG002|Overall Study|Adverse Event|2|||
48485535|NCT01586624|155972354|FG003|Overall Study|Adverse Event|1|||
48485536|NCT01586624|155972355|FG004|Overall Study|Adverse Event|3|||
48485537|NCT01586624|155972356|FG005|Overall Study|Adverse Event|3|||
48485538|NCT01586624|155972357|FG006|Overall Study|Adverse Event|2|||
48485539|NCT01586624|155972358|FG007|Overall Study|Adverse Event|3|||
48485540|NCT01586624|155972351|FG000|Overall Study|Physician Decision|0|||
48485541|NCT01586624|155972352|FG001|Overall Study|Physician Decision|1|||
48485542|NCT01586624|155972353|FG002|Overall Study|Physician Decision|1|||
48485543|NCT01586624|155972354|FG003|Overall Study|Physician Decision|0|||
48485544|NCT01586624|155972355|FG004|Overall Study|Physician Decision|2|||
48485545|NCT01586624|155972356|FG005|Overall Study|Physician Decision|0|||
48485546|NCT01586624|155972357|FG006|Overall Study|Physician Decision|1|||
48485547|NCT01586624|155972358|FG007|Overall Study|Physician Decision|1|||
48485548|NCT01586624|155972351|FG000|Overall Study|Withdrawal by Subject|0|||
48485549|NCT01586624|155972352|FG001|Overall Study|Withdrawal by Subject|0|||
48485550|NCT01586624|155972353|FG002|Overall Study|Withdrawal by Subject|0|||
48485551|NCT01586624|155972354|FG003|Overall Study|Withdrawal by Subject|1|||
48485552|NCT01586624|155972355|FG004|Overall Study|Withdrawal by Subject|0|||
48485553|NCT01586624|155972356|FG005|Overall Study|Withdrawal by Subject|0|||
48485554|NCT01586624|155972357|FG006|Overall Study|Withdrawal by Subject|0|||
48485555|NCT01586624|155972358|FG007|Overall Study|Withdrawal by Subject|0|||
48485556|NCT01586624|155972351|FG000|Overall Study|Evidence of disease progression|1|||
48485557|NCT01586624|155972352|FG001|Overall Study|Evidence of disease progression|3|||
48485558|NCT01586624|155972353|FG002|Overall Study|Evidence of disease progression|2|||
48485559|NCT01586624|155972354|FG003|Overall Study|Evidence of disease progression|5|||
48485560|NCT01586624|155972355|FG004|Overall Study|Evidence of disease progression|3|||
48485561|NCT01586624|155972356|FG005|Overall Study|Evidence of disease progression|5|||
48485562|NCT01586624|155972357|FG006|Overall Study|Evidence of disease progression|4|||
48485563|NCT01586624|155972358|FG007|Overall Study|Evidence of disease progression|6|||
48485564|NCT01586624|155972351|FG000|Overall Study|Screen failure (no treatment received)|0|||
48485565|NCT01586624|155972352|FG001|Overall Study|Screen failure (no treatment received)|0|||
48485566|NCT01586624|155972353|FG002|Overall Study|Screen failure (no treatment received)|0|||
48485567|NCT01586624|155972354|FG003|Overall Study|Screen failure (no treatment received)|0|||
48485568|NCT01586624|155972355|FG004|Overall Study|Screen failure (no treatment received)|0|||
48485569|NCT01586624|155972356|FG005|Overall Study|Screen failure (no treatment received)|0|||
48485570|NCT01586624|155972357|FG006|Overall Study|Screen failure (no treatment received)|1|||
48485571|NCT01586624|155972358|FG007|Overall Study|Screen failure (no treatment received)|0|||
48485572|NCT02496221|155972365|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
48485573|NCT02496221|155972366|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
48485574|NCT02496221|155972365|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
48485575|NCT02496221|155972366|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
48485576|NCT02496221|155972365|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
48485577|NCT02496221|155972366|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
48485578|NCT01416142|155972368|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
48485579|NCT01416142|155972369|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
48485580|NCT01416142|155972370|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
48485581|NCT01335399|155972371|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
48485582|NCT01335399|155972372|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
48485583|NCT01335399|155972371|FG000|Pre-treatment Period|Participant request to discontinue|0|||
48485584|NCT01335399|155972372|FG001|Pre-treatment Period|Participant request to discontinue|1|||
48485585|NCT01335399|155972371|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
48485586|NCT01335399|155972372|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
48485587|NCT01335399|155972371|FG000|Pre-treatment Period|Consent withdrawal|3|||
48485588|NCT01335399|155972372|FG001|Pre-treatment Period|Consent withdrawal|0|||
48485589|NCT01335399|155972371|FG000|Treatment Period|Disease progression|117|||
48485590|NCT01335399|155972372|FG001|Treatment Period|Disease progression|145|||
48485591|NCT01335399|155972371|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
48485592|NCT01335399|155972372|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
48485593|NCT01335399|155972371|FG000|Treatment Period|Study drug toxicity|52|||
48485594|NCT01335399|155972372|FG001|Treatment Period|Study drug toxicity|64|||
48485595|NCT01335399|155972371|FG000|Treatment Period|Participant request to discontinue|30|||
48485596|NCT01335399|155972372|FG001|Treatment Period|Participant request to discontinue|22|||
48485597|NCT01335399|155972371|FG000|Treatment Period|Other reasons|30|||
48485598|NCT01335399|155972372|FG001|Treatment Period|Other reasons|30|||
48485599|NCT01335399|155972371|FG000|Treatment Period|Consent withdrawal|10|||
48485600|NCT01335399|155972372|FG001|Treatment Period|Consent withdrawal|7|||
48485601|NCT01335399|155972371|FG000|Treatment Period|Death|7|||
48485602|NCT01335399|155972372|FG001|Treatment Period|Death|6|||
48485603|NCT01335399|155972371|FG000|Treatment Period|Poor/Non-compliance|3|||
48485604|NCT01335399|155972372|FG001|Treatment Period|Poor/Non-compliance|4|||
48485605|NCT01335399|155972371|FG000|Treatment Period|Lost to Follow-up|2|||
48485606|NCT01335399|155972372|FG001|Treatment Period|Lost to Follow-up|2|||
48485607|NCT01335399|155972371|FG000|Treatment Period|Maximum clinical benefit|1|||
48485608|NCT01335399|155972372|FG001|Treatment Period|Maximum clinical benefit|1|||
48485609|NCT01335399|155972371|FG000|Treatment Period|No longer meet study criteria|1|||
48485610|NCT01335399|155972372|FG001|Treatment Period|No longer meet study criteria|1|||
48485611|NCT01335399|155972371|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
48485612|NCT01335399|155972372|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
48485613|NCT02464059|155972373|FG000|Overall Study|Lost to Follow-up|6|||
48485614|NCT01074307|155972375|FG000|Overall Study|No primary endpoint evaluation|14|||
48485615|NCT01074307|155972376|FG001|Overall Study|No primary endpoint evaluation|6|||
48485616|NCT01074307|155972375|FG000|Overall Study|Exclusion criterion|0|||
48485617|NCT01074307|155972376|FG001|Overall Study|Exclusion criterion|1|||
48485618|NCT01074307|155972375|FG000|Overall Study|Protocol Violation|8|||
48485619|NCT01074307|155972376|FG001|Overall Study|Protocol Violation|5|||
48485620|NCT02162511|155972382|FG000|Overall Study|Lack of Efficacy|0|||
48485621|NCT02162511|155972383|FG001|Overall Study|Lack of Efficacy|0|||
48485622|NCT02162511|155972384|FG002|Overall Study|Lack of Efficacy|2|||
48485623|NCT01440595|155972392|FG000|Overall Study|Lost to Follow-up|0|||
48485624|NCT01440595|155972393|FG001|Overall Study|Lost to Follow-up|1|||
48485625|NCT01440595|155972394|FG002|Overall Study|Lost to Follow-up|0|||
48485626|NCT01440595|155972392|FG000|Overall Study|Study terminated by sponsor.|1|||
48485627|NCT01440595|155972393|FG001|Overall Study|Study terminated by sponsor.|2|||
48485628|NCT01440595|155972394|FG002|Overall Study|Study terminated by sponsor.|1|||
48485629|NCT01347879|155972395|FG000|Overall Study|Adverse Event|0|||
48590059|NCT01483599|156352237|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48485630|NCT01347879|155972396|FG001|Overall Study|Adverse Event|12|||
48485631|NCT01347879|155972395|FG000|Overall Study|Lost to Follow-up|2|||
48485632|NCT01347879|155972396|FG001|Overall Study|Lost to Follow-up|0|||
48485633|NCT01347879|155972395|FG000|Overall Study|Withdrawal by Subject|3|||
48485634|NCT01347879|155972396|FG001|Overall Study|Withdrawal by Subject|2|||
48485635|NCT01347879|155972395|FG000|Overall Study|Other|2|||
48485636|NCT01347879|155972396|FG001|Overall Study|Other|3|||
48485637|NCT04126733|155972397|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
48485638|NCT04126733|155972397|FG000|Treatment Period|Adverse Event|8|||
48485639|NCT04126733|155972397|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
48485640|NCT04126733|155972397|FG000|Treatment Period|Physician Decision|5|||
48485641|NCT04126733|155972397|FG000|Treatment Period|Death|1|||
48485642|NCT04126733|155972397|FG000|Treatment Period|Other Reasons|2|||
48485643|NCT04126733|155972397|FG000|Active Follow-up Period|Death|13|||
48485644|NCT04126733|155972397|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
48485645|NCT04126733|155972397|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
48485646|NCT04126733|155972397|FG000|Active Follow-up Period|Other Reasons|1|||
48485647|NCT04126733|155972397|FG000|Long-term Follow-up Period|Death|22|||
48485648|NCT04126733|155972397|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
48485649|NCT04126733|155972397|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
48485650|NCT02981602|155972398|FG000|Overall Study|Adverse Event|0|||
48485651|NCT02981602|155972399|FG001|Overall Study|Adverse Event|0|||
48485652|NCT02981602|155972400|FG002|Overall Study|Adverse Event|0|||
48485653|NCT02981602|155972401|FG003|Overall Study|Adverse Event|1|||
48485654|NCT02981602|155972402|FG004|Overall Study|Adverse Event|0|||
48485655|NCT02164539|155972403|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
48485656|NCT02164539|155972404|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
48485657|NCT02164539|155972405|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
48485658|NCT02164539|155972406|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
48485659|NCT02164539|155972407|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
48485660|NCT02164539|155972408|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
48485661|NCT02164539|155972409|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
48485662|NCT02164539|155972403|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
48485663|NCT02164539|155972404|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
48485664|NCT02164539|155972405|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
48485665|NCT02164539|155972406|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
48485666|NCT02164539|155972407|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
48485667|NCT02164539|155972408|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
48485668|NCT02164539|155972409|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
48485669|NCT02164539|155972403|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
48485670|NCT02164539|155972404|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
48485671|NCT02164539|155972405|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
48485672|NCT02164539|155972406|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
48485673|NCT02164539|155972407|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
48485674|NCT02164539|155972408|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
48485675|NCT02164539|155972409|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
48485676|NCT02164539|155972403|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
48485677|NCT02164539|155972404|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
48485678|NCT02164539|155972405|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
48485679|NCT02164539|155972406|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
48485680|NCT02164539|155972407|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
48485681|NCT02164539|155972408|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
48485682|NCT02164539|155972409|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
48485683|NCT02164539|155972403|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
48485684|NCT02164539|155972404|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
48485685|NCT02164539|155972405|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
48485686|NCT02164539|155972406|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
48485687|NCT02164539|155972407|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
48485688|NCT02164539|155972408|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
48485689|NCT02164539|155972409|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
48485690|NCT02164539|155972403|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
48485691|NCT02164539|155972404|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
48485692|NCT02164539|155972405|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
48485693|NCT02164539|155972406|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
48485694|NCT02164539|155972407|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
48485695|NCT02164539|155972408|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
48485696|NCT02164539|155972409|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
48485697|NCT02643966|155972410|FG000|First Screening Round|ineligible|1|||
48485698|NCT02643966|155972410|FG000|First Screening Round|excluded from analysis|2|||
48485699|NCT02643966|155972410|FG000|First Screening Round|Lost to Follow-up|56|||
48485700|NCT02643966|155972410|FG000|First Screening Round|Withdrawal by Subject|28|||
48485701|NCT02643966|155972410|FG000|First Screening Round|Death|1|||
48485702|NCT02643966|155972410|FG000|Between First and Second Screening|Lost to Follow-up|65|||
48485703|NCT02643966|155972410|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
48485704|NCT02643966|155972410|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
48485705|NCT02643966|155972410|FG000|Second Screening Round|Withdrawal by Subject|20|||
48485706|NCT02643966|155972410|FG000|Second Screening Round|Lost to Follow-up|57|||
48485707|NCT02643966|155972410|FG000|Second Screening Round|Physician Decision|2|||
48485708|NCT02643966|155972410|FG000|Second Screening Round|Death|4|||
48485709|NCT02643966|155972410|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
48485710|NCT02643966|155972410|FG000|Between Second and Third Screening|Death|1|||
48485711|NCT02643966|155972410|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
48485712|NCT02643966|155972410|FG000|Third Screening Round|PI excluded|2|||
48485713|NCT02643966|155972410|FG000|Third Screening Round|Lost to Follow-up|241|||
48485714|NCT01946282|155972411|FG000|Year 1|Did not return FIT kit|4186|||
48485715|NCT01946282|155972412|FG001|Year 1|Did not return FIT kit|608|||
48485716|NCT01946282|155972413|FG002|Year 1|Did not return FIT kit|654|||
48485717|NCT01946282|155972411|FG000|Year 2|Did not return FIT kit|803|||
48485718|NCT01946282|155972412|FG001|Year 2|Did not return FIT kit|131|||
48485719|NCT01946282|155972413|FG002|Year 2|Did not return FIT kit|115|||
48485720|NCT01946282|155972411|FG000|Year 3|Did not return FIT kit|288|||
48485721|NCT01946282|155972412|FG001|Year 3|Did not return FIT kit|43|||
48485722|NCT01946282|155972413|FG002|Year 3|Did not return FIT kit|30|||
48485723|NCT01493531|155972414|FG000|Overall Study|Adverse Event|4|||
48485724|NCT01493531|155972415|FG001|Overall Study|Adverse Event|12|||
48485725|NCT01493531|155972416|FG002|Overall Study|Adverse Event|9|||
48485726|NCT01493531|155972414|FG000|Overall Study|Gout flare|3|||
48485727|NCT01493531|155972415|FG001|Overall Study|Gout flare|0|||
48485728|NCT01493531|155972416|FG002|Overall Study|Gout flare|2|||
48485729|NCT01493531|155972414|FG000|Overall Study|Protocol Violation|8|||
48485730|NCT01493531|155972415|FG001|Overall Study|Protocol Violation|15|||
48485731|NCT01493531|155972416|FG002|Overall Study|Protocol Violation|12|||
48485732|NCT01493531|155972414|FG000|Overall Study|Sponsor terminated study|5|||
48485733|NCT01493531|155972415|FG001|Overall Study|Sponsor terminated study|2|||
48485734|NCT01493531|155972416|FG002|Overall Study|Sponsor terminated study|3|||
48485735|NCT01493531|155972414|FG000|Overall Study|Lost to Follow-up|5|||
48485736|NCT01493531|155972415|FG001|Overall Study|Lost to Follow-up|7|||
48485737|NCT01493531|155972416|FG002|Overall Study|Lost to Follow-up|11|||
48485738|NCT01493531|155972414|FG000|Overall Study|Withdrawal by Subject|16|||
48485739|NCT01493531|155972415|FG001|Overall Study|Withdrawal by Subject|13|||
48485740|NCT01493531|155972416|FG002|Overall Study|Withdrawal by Subject|11|||
48485741|NCT01493531|155972414|FG000|Overall Study|Death|0|||
48485742|NCT01493531|155972415|FG001|Overall Study|Death|1|||
48485743|NCT01493531|155972416|FG002|Overall Study|Death|0|||
48485744|NCT03812679|155972417|FG000|Overall Study|Adverse Event|2|||
48485745|NCT03812679|155972417|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
48485746|NCT03812679|155972417|FG000|Overall Study|Renal transplant|1|||
48485747|NCT03812679|155972417|FG000|Overall Study|Withdrawal by Subject|1|||
48485748|NCT03812679|155972417|FG000|Overall Study|Termination of study|2|||
48485749|NCT03812679|155972417|FG000|Overall Study|Water device replacement|1|||
48485750|NCT03835975|155972418|FG000|Overall Study|Lost to Follow-up|1|||
48485751|NCT03835975|155972419|FG001|Overall Study|Lost to Follow-up|1|||
48485752|NCT03835975|155972420|FG002|Overall Study|Lost to Follow-up|0|||
48485753|NCT03835975|155972421|FG003|Overall Study|Lost to Follow-up|0|||
48485754|NCT03835975|155972422|FG004|Overall Study|Lost to Follow-up|0|||
48485755|NCT03835975|155972418|FG000|Overall Study|No longer met eligibility criteria|0|||
48485756|NCT03835975|155972419|FG001|Overall Study|No longer met eligibility criteria|1|||
48485757|NCT03835975|155972420|FG002|Overall Study|No longer met eligibility criteria|0|||
48485758|NCT03835975|155972421|FG003|Overall Study|No longer met eligibility criteria|0|||
48485759|NCT03835975|155972422|FG004|Overall Study|No longer met eligibility criteria|0|||
48485760|NCT03835975|155972418|FG000|Overall Study|Protocol Violation|1|||
48485761|NCT03835975|155972419|FG001|Overall Study|Protocol Violation|1|||
48485762|NCT03835975|155972420|FG002|Overall Study|Protocol Violation|2|||
48485763|NCT03835975|155972421|FG003|Overall Study|Protocol Violation|0|||
48485764|NCT03835975|155972422|FG004|Overall Study|Protocol Violation|0|||
48485765|NCT03835975|155972418|FG000|Overall Study|Withdrawal by Subject|1|||
48485766|NCT03835975|155972419|FG001|Overall Study|Withdrawal by Subject|0|||
48742915|NCT00745823|156910414|FG001|Overall Study|Lack of Efficacy|6|||
48485767|NCT03835975|155972420|FG002|Overall Study|Withdrawal by Subject|1|||
48485768|NCT03835975|155972421|FG003|Overall Study|Withdrawal by Subject|1|||
48485769|NCT03835975|155972422|FG004|Overall Study|Withdrawal by Subject|0|||
48485770|NCT00827359|155972425|FG000|Overall Study|Progressive Diseas|19|||
48485771|NCT00827359|155972425|FG000|Overall Study|Unacceptable Toxicity|5|||
48485772|NCT00827359|155972425|FG000|Overall Study|Ineligible|1|||
48485773|NCT03031431|155972426|FG000|Overall Study|Infant removed by maternal request|1|||
48485774|NCT01825876|155972427|FG000|Period 2|Withdrawal by Subject|0|||
48485775|NCT01825876|155972428|FG001|Period 2|Withdrawal by Subject|1|||
48485776|NCT01205529|155972429|FG000|Overall Study|Procedure Cancelled|4|||
48485777|NCT01205529|155972429|FG000|Overall Study|Withdrawal by Subject|2|||
48485778|NCT01205529|155972429|FG000|Overall Study|Physician Decision|4|||
48485779|NCT01205529|155972429|FG000|Overall Study|Unstable post op|15|||
48485780|NCT01205529|155972429|FG000|Overall Study|No longer met criteria|30|||
48485781|NCT01027884|155972434|FG000|Overall Study|Adverse Event|2|||
48485782|NCT01027884|155972435|FG001|Overall Study|Adverse Event|1|||
48485783|NCT01027884|155972434|FG000|Overall Study|Protocol Violation|1|||
48485784|NCT01027884|155972435|FG001|Overall Study|Protocol Violation|0|||
48485785|NCT01027884|155972434|FG000|Overall Study|Non-compliance|1|||
48485786|NCT01027884|155972435|FG001|Overall Study|Non-compliance|1|||
48485787|NCT01027884|155972434|FG000|Overall Study|Withdrawal by Subject|0|||
48485788|NCT01027884|155972435|FG001|Overall Study|Withdrawal by Subject|1|||
48590060|NCT01483599|156352238|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48485789|NCT01027884|155972434|FG000|Overall Study|Lost to Follow-up|0|||
48485790|NCT01027884|155972435|FG001|Overall Study|Lost to Follow-up|1|||
48485791|NCT01027884|155972434|FG000|Overall Study|Spinal fixation surgery|0|||
48485792|NCT01027884|155972435|FG001|Overall Study|Spinal fixation surgery|3|||
48485793|NCT03636542|155972436|FG000|Overall Study|Lost to Follow-up|1|||
48485794|NCT03636542|155972437|FG001|Overall Study|Lost to Follow-up|1|||
48485795|NCT03636542|155972436|FG000|Overall Study|Physician Decision|0|||
48485796|NCT03636542|155972437|FG001|Overall Study|Physician Decision|1|||
48485797|NCT03636542|155972436|FG000|Overall Study|Withdrawal by Subject|1|||
48485798|NCT03636542|155972437|FG001|Overall Study|Withdrawal by Subject|0|||
48485799|NCT01271933|155972440|FG000|Single-Blind Phase|Lack of Efficacy|37|||
48485800|NCT01271933|155972441|FG001|Single-Blind Phase|Lack of Efficacy|0|||
48485801|NCT01271933|155972442|FG002|Single-Blind Phase|Lack of Efficacy|0|||
48485802|NCT01271933|155972440|FG000|Single-Blind Phase|Lost to Follow-up|10|||
48485803|NCT01271933|155972441|FG001|Single-Blind Phase|Lost to Follow-up|0|||
48485804|NCT01271933|155972442|FG002|Single-Blind Phase|Lost to Follow-up|0|||
48485805|NCT01271933|155972440|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
48485806|NCT01271933|155972441|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
48485807|NCT01271933|155972442|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
48485808|NCT01271933|155972440|FG000|Single-Blind Phase|Protocol Violation|3|||
48485809|NCT01271933|155972441|FG001|Single-Blind Phase|Protocol Violation|0|||
48485810|NCT01271933|155972442|FG002|Single-Blind Phase|Protocol Violation|0|||
48485811|NCT01271933|155972440|FG000|Single-Blind Phase|Adverse Event|52|||
48485812|NCT01271933|155972441|FG001|Single-Blind Phase|Adverse Event|0|||
48485813|NCT01271933|155972442|FG002|Single-Blind Phase|Adverse Event|0|||
48485814|NCT01271933|155972440|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
48485815|NCT01271933|155972441|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
48485816|NCT01271933|155972442|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
48485817|NCT01271933|155972440|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
48485818|NCT01271933|155972441|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
48485819|NCT01271933|155972442|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
48485820|NCT01271933|155972440|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
48485821|NCT01271933|155972441|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
48485822|NCT01271933|155972442|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
48485823|NCT01271933|155972440|FG000|Double-Blind Phase|Randomized but not treated|0|||
48485824|NCT01271933|155972441|FG001|Double-Blind Phase|Randomized but not treated|0|||
48485825|NCT01271933|155972442|FG002|Double-Blind Phase|Randomized but not treated|1|||
48485826|NCT01271933|155972440|FG000|Double-Blind Phase|Lack of Efficacy|0|||
48485827|NCT01271933|155972441|FG001|Double-Blind Phase|Lack of Efficacy|6|||
48485828|NCT01271933|155972442|FG002|Double-Blind Phase|Lack of Efficacy|9|||
48485829|NCT01271933|155972440|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48485830|NCT01271933|155972441|FG001|Double-Blind Phase|Lost to Follow-up|1|||
48485831|NCT01271933|155972442|FG002|Double-Blind Phase|Lost to Follow-up|1|||
48485832|NCT01271933|155972440|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
48485833|NCT01271933|155972441|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
48485834|NCT01271933|155972442|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
48485835|NCT01271933|155972440|FG000|Double-Blind Phase|Adverse Event|0|||
48485836|NCT01271933|155972441|FG001|Double-Blind Phase|Adverse Event|3|||
48485837|NCT01271933|155972442|FG002|Double-Blind Phase|Adverse Event|0|||
48485838|NCT01271933|155972440|FG000|Double-Blind Phase|Participant request-personal reason|0|||
48485839|NCT01271933|155972441|FG001|Double-Blind Phase|Participant request-personal reason|1|||
48485840|NCT01271933|155972442|FG002|Double-Blind Phase|Participant request-personal reason|0|||
48485841|NCT00449930|155972443|FG000|Overall Study|Adverse Event|9|||
48485842|NCT00449930|155972444|FG001|Overall Study|Adverse Event|19|||
48485843|NCT00449930|155972443|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
48485844|NCT00449930|155972444|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
48485845|NCT00449930|155972443|FG000|Overall Study|Lack of Efficacy|10|||
48485846|NCT00449930|155972444|FG001|Overall Study|Lack of Efficacy|1|||
48485847|NCT00449930|155972443|FG000|Overall Study|Lost to Follow-up|9|||
48485848|NCT00449930|155972444|FG001|Overall Study|Lost to Follow-up|14|||
48590061|NCT01483599|156352239|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48485849|NCT00449930|155972443|FG000|Overall Study|Physician Decision|1|||
48485850|NCT00449930|155972444|FG001|Overall Study|Physician Decision|2|||
48590062|NCT01483599|156352240|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48590063|NCT01483599|156352241|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48485851|NCT00449930|155972443|FG000|Overall Study|Protocol Violation|14|||
48485852|NCT00449930|155972444|FG001|Overall Study|Protocol Violation|15|||
48485853|NCT00449930|155972443|FG000|Overall Study|Withdrawal by Subject|16|||
48485854|NCT00449930|155972444|FG001|Overall Study|Withdrawal by Subject|23|||
48485855|NCT00449930|155972443|FG000|Overall Study|Glycemic discontinuation criteria|1|||
48485856|NCT00449930|155972444|FG001|Overall Study|Glycemic discontinuation criteria|1|||
48485857|NCT00363129|155972445|FG000|Overall Study|Withdrawal by Subject|11|||
48485858|NCT00363129|155972446|FG001|Overall Study|Withdrawal by Subject|18|||
48485859|NCT00363129|155972445|FG000|Overall Study|Adverse Event|8|||
48485860|NCT00363129|155972446|FG001|Overall Study|Adverse Event|3|||
48485861|NCT00363129|155972445|FG000|Overall Study|Alternate Treatment|2|||
48485862|NCT00363129|155972446|FG001|Overall Study|Alternate Treatment|4|||
48485863|NCT00363129|155972445|FG000|Overall Study|Other Medical Problems|2|||
48485864|NCT00363129|155972446|FG001|Overall Study|Other Medical Problems|4|||
48485865|NCT00363129|155972445|FG000|Overall Study|Death|0|||
48485866|NCT00363129|155972446|FG001|Overall Study|Death|1|||
48485867|NCT00363129|155972445|FG000|Overall Study|Other Reasons|6|||
48485868|NCT00363129|155972446|FG001|Overall Study|Other Reasons|3|||
48485869|NCT00065065|155972447|FG000|Overall Study|Adverse Event|3|||
48485870|NCT00065065|155972448|FG001|Overall Study|Adverse Event|2|||
48485871|NCT00065065|155972447|FG000|Overall Study|Withdrawal by Subject|1|||
48485872|NCT00065065|155972448|FG001|Overall Study|Withdrawal by Subject|5|||
48485873|NCT00065065|155972447|FG000|Overall Study|Lack of Efficacy|4|||
48485874|NCT00065065|155972448|FG001|Overall Study|Lack of Efficacy|11|||
48485875|NCT00065065|155972447|FG000|Overall Study|Other|2|||
48485876|NCT00065065|155972448|FG001|Overall Study|Other|2|||
48485877|NCT01201356|155972449|FG000|Overall Study|Adverse Event|170|||
48485878|NCT01201356|155972449|FG000|Overall Study|Abnormal laboratory value(s)|51|||
48485879|NCT01201356|155972449|FG000|Overall Study|Abnormal test procedure result(s)|3|||
48485880|NCT01201356|155972449|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
48485881|NCT01201356|155972449|FG000|Overall Study|Condition no longer requires study drug|12|||
48485882|NCT01201356|155972449|FG000|Overall Study|Withdrawal by Subject|144|||
48485883|NCT01201356|155972449|FG000|Overall Study|Lost to Follow-up|50|||
48485884|NCT01201356|155972449|FG000|Overall Study|administrative problems|74|||
48485885|NCT01201356|155972449|FG000|Overall Study|Death|16|||
48485886|NCT01201356|155972449|FG000|Overall Study|Protocol Violation|12|||
48485887|NCT00217971|155972450|FG000|Overall Study|Adverse Event|1|||
48485888|NCT00217971|155972451|FG001|Overall Study|Adverse Event|1|||
48485889|NCT00217971|155972450|FG000|Overall Study|Lost to Follow-up|15|||
48485890|NCT00217971|155972451|FG001|Overall Study|Lost to Follow-up|19|||
48485891|NCT00217971|155972450|FG000|Overall Study|Physician Decision|0|||
48485892|NCT00217971|155972451|FG001|Overall Study|Physician Decision|1|||
48485893|NCT00217971|155972450|FG000|Overall Study|Withdrawal by Subject|7|||
48485894|NCT00217971|155972451|FG001|Overall Study|Withdrawal by Subject|12|||
48485895|NCT00217971|155972450|FG000|Overall Study|non compliant|1|||
48485896|NCT00217971|155972451|FG001|Overall Study|non compliant|0|||
48485897|NCT00738920|155972453|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
48485898|NCT00738920|155972454|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
48485899|NCT00738920|155972455|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
48485900|NCT00738920|155972453|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
48485901|NCT00738920|155972454|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
48485902|NCT00738920|155972455|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
48485903|NCT00738920|155972453|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
48485904|NCT00738920|155972454|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
48485905|NCT00738920|155972455|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
48485906|NCT00738920|155972453|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
48485907|NCT00738920|155972454|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
48485908|NCT00738920|155972455|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
48485909|NCT00738920|155972453|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
48485910|NCT00738920|155972454|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
48485911|NCT00738920|155972455|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
48485912|NCT00738920|155972453|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
48485913|NCT00738920|155972454|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
48485914|NCT00738920|155972455|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
48485915|NCT00738920|155972453|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
48485916|NCT00738920|155972454|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
48485917|NCT00738920|155972455|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
48485918|NCT00738920|155972453|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
48485919|NCT00738920|155972454|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
48485920|NCT00738920|155972455|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
48485921|NCT00738920|155972453|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
48485922|NCT00738920|155972454|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
48485923|NCT00738920|155972455|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
48485924|NCT00738920|155972453|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
48485925|NCT00738920|155972454|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
48485926|NCT00738920|155972455|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
48485927|NCT01625286|155972456|FG000|Overall Study|Adverse Event|0|||
48485928|NCT01625286|155972457|FG001|Overall Study|Adverse Event|0|||
48485929|NCT01625286|155972458|FG002|Overall Study|Adverse Event|0|||
48485930|NCT01625286|155972459|FG003|Overall Study|Adverse Event|0|||
48485931|NCT01625286|155972460|FG004|Overall Study|Adverse Event|1|||
48485932|NCT01625286|155972461|FG005|Overall Study|Adverse Event|2|||
48485933|NCT01625286|155972462|FG006|Overall Study|Adverse Event|1|||
48485934|NCT01625286|155972456|FG000|Overall Study|Death|0|||
48485935|NCT01625286|155972457|FG001|Overall Study|Death|0|||
48485936|NCT01625286|155972458|FG002|Overall Study|Death|1|||
48485937|NCT01625286|155972459|FG003|Overall Study|Death|1|||
48485938|NCT01625286|155972460|FG004|Overall Study|Death|0|||
48485939|NCT01625286|155972461|FG005|Overall Study|Death|11|||
48485940|NCT01625286|155972462|FG006|Overall Study|Death|16|||
48485941|NCT01625286|155972456|FG000|Overall Study|Withdrawal by Subject|0|||
48485942|NCT01625286|155972457|FG001|Overall Study|Withdrawal by Subject|1|||
48485943|NCT01625286|155972458|FG002|Overall Study|Withdrawal by Subject|0|||
48485944|NCT01625286|155972459|FG003|Overall Study|Withdrawal by Subject|1|||
48485945|NCT01625286|155972460|FG004|Overall Study|Withdrawal by Subject|0|||
48485946|NCT01625286|155972461|FG005|Overall Study|Withdrawal by Subject|0|||
48485947|NCT01625286|155972462|FG006|Overall Study|Withdrawal by Subject|1|||
48485948|NCT01625286|155972456|FG000|Overall Study|Any reason not specifically recorded|0|||
48485949|NCT01625286|155972457|FG001|Overall Study|Any reason not specifically recorded|0|||
48485950|NCT01625286|155972458|FG002|Overall Study|Any reason not specifically recorded|0|||
48485951|NCT01625286|155972459|FG003|Overall Study|Any reason not specifically recorded|0|||
48485952|NCT01625286|155972460|FG004|Overall Study|Any reason not specifically recorded|0|||
48485953|NCT01625286|155972461|FG005|Overall Study|Any reason not specifically recorded|1|||
48485954|NCT01625286|155972462|FG006|Overall Study|Any reason not specifically recorded|0|||
48485955|NCT01625286|155972456|FG000|Overall Study|Progressive disease|6|||
48485956|NCT01625286|155972457|FG001|Overall Study|Progressive disease|3|||
48485957|NCT01625286|155972458|FG002|Overall Study|Progressive disease|4|||
48485958|NCT01625286|155972459|FG003|Overall Study|Progressive disease|5|||
48485959|NCT01625286|155972460|FG004|Overall Study|Progressive disease|5|||
48485960|NCT01625286|155972461|FG005|Overall Study|Progressive disease|0|||
48485961|NCT01625286|155972462|FG006|Overall Study|Progressive disease|0|||
48485962|NCT01625286|155972456|FG000|Overall Study|Lost to Follow-up|0|||
48485963|NCT01625286|155972457|FG001|Overall Study|Lost to Follow-up|0|||
48485964|NCT01625286|155972458|FG002|Overall Study|Lost to Follow-up|0|||
48485965|NCT01625286|155972459|FG003|Overall Study|Lost to Follow-up|0|||
48485966|NCT01625286|155972460|FG004|Overall Study|Lost to Follow-up|0|||
48485967|NCT01625286|155972461|FG005|Overall Study|Lost to Follow-up|0|||
48485968|NCT01625286|155972462|FG006|Overall Study|Lost to Follow-up|1|||
48485969|NCT01458119|155972467|FG000|Overall Study|Physician Decision|4|||
48485970|NCT01458119|155972467|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
48485971|NCT01458119|155972467|FG000|Overall Study|Pregnancy|1|||
48485972|NCT01458119|155972467|FG000|Overall Study|Death|2|||
48485973|NCT01458119|155972467|FG000|Overall Study|Adverse Event|1|||
48485974|NCT01458119|155972467|FG000|Overall Study|Consent Withdrawn by Participant|8|||
48485975|NCT01458119|155972467|FG000|Overall Study|Non-compliance With Study Drug|3|||
48485976|NCT04147611|155972468|FG000|Overall Study|Physician Decision|0|||
48485977|NCT04147611|155972469|FG001|Overall Study|Physician Decision|1|||
48485978|NCT01355523|155973586|FG000|Overall Study|Withdrawal by Subject|1|||
48485979|NCT01355523|155973587|FG001|Overall Study|Withdrawal by Subject|4|||
48485980|NCT01355523|155973586|FG000|Overall Study|Lost to Follow-up|0|||
48485981|NCT01355523|155973587|FG001|Overall Study|Lost to Follow-up|2|||
48485982|NCT01355523|155973586|FG000|Overall Study|Protocol Violation|0|||
48485983|NCT01355523|155973587|FG001|Overall Study|Protocol Violation|2|||
48485984|NCT01355523|155973586|FG000|Overall Study|Adverse Event|0|||
48485985|NCT01355523|155973587|FG001|Overall Study|Adverse Event|2|||
48485986|NCT00084617|155973589|FG000|Overall Study|Withdrawal by Subject|7|||
48485987|NCT00084617|155973589|FG000|Overall Study|Lack of Efficacy|1|||
48485988|NCT00084617|155973589|FG000|Overall Study|Protocol Violation|1|||
48485989|NCT00606801|155973590|FG000|Intervention|Protocol Violation|3|||
48485990|NCT00606801|155973591|FG001|Intervention|Protocol Violation|3|||
48485991|NCT02082262|155973592|FG000|Overall Study|Withdrawal by Subject|3|||
48485992|NCT02082262|155973592|FG000|Overall Study|Adverse Event|48|||
48485993|NCT03262233|155973595|FG000|Overall Study|Withdrawal by Subject|12|||
48485994|NCT03262233|155973596|FG001|Overall Study|Withdrawal by Subject|8|||
48485995|NCT03262233|155973597|FG002|Overall Study|Withdrawal by Subject|21|||
48485996|NCT03262233|155973598|FG003|Overall Study|Withdrawal by Subject|13|||
48485997|NCT03262233|155973595|FG000|Overall Study|Declined due to shock|1|||
48485998|NCT03262233|155973596|FG001|Overall Study|Declined due to shock|2|||
48485999|NCT03262233|155973597|FG002|Overall Study|Declined due to shock|2|||
48486000|NCT03262233|155973598|FG003|Overall Study|Declined due to shock|3|||
48486001|NCT03262233|155973595|FG000|Overall Study|Protocol Violation|5|||
48486002|NCT03262233|155973596|FG001|Overall Study|Protocol Violation|10|||
48486003|NCT03262233|155973597|FG002|Overall Study|Protocol Violation|2|||
48486004|NCT03262233|155973598|FG003|Overall Study|Protocol Violation|13|||
48486005|NCT03262233|155973595|FG000|Overall Study|data collection artifact|0|||
48486006|NCT03262233|155973596|FG001|Overall Study|data collection artifact|1|||
48486007|NCT03262233|155973597|FG002|Overall Study|data collection artifact|0|||
48486008|NCT03262233|155973598|FG003|Overall Study|data collection artifact|0|||
48486009|NCT01160198|155973599|FG000|Overall Study|Withdrawal by Subject|2|||
48486010|NCT01160198|155973600|FG001|Overall Study|Withdrawal by Subject|1|||
48486011|NCT01160198|155973601|FG002|Overall Study|Withdrawal by Subject|0|||
48590064|NCT01483599|156352242|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48486012|NCT01160198|155973599|FG000|Overall Study|Adverse Event|0|||
48486013|NCT01160198|155973600|FG001|Overall Study|Adverse Event|1|||
48486014|NCT01160198|155973601|FG002|Overall Study|Adverse Event|0|||
48486015|NCT01160198|155973599|FG000|Overall Study|Lost to Follow-up|0|||
48486016|NCT01160198|155973600|FG001|Overall Study|Lost to Follow-up|1|||
48486017|NCT01160198|155973601|FG002|Overall Study|Lost to Follow-up|0|||
48486018|NCT01160198|155973599|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
48486019|NCT01160198|155973600|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
48486020|NCT01160198|155973601|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
48486021|NCT01796860|155973604|FG000|Overall Study|Withdrawal by Subject|3|||
48486022|NCT01408576|155973605|FG000|Overall Study|Lack of Efficacy|17|||
48486023|NCT01408576|155973606|FG001|Overall Study|Lack of Efficacy|30|||
48486024|NCT01408576|155973607|FG002|Overall Study|Lack of Efficacy|48|||
48486025|NCT01408576|155973605|FG000|Overall Study|Protocol Violation|1|||
48486026|NCT01408576|155973606|FG001|Overall Study|Protocol Violation|2|||
48486027|NCT01408576|155973607|FG002|Overall Study|Protocol Violation|2|||
48486028|NCT01408576|155973605|FG000|Overall Study|Lost to Follow-up|10|||
48486029|NCT01408576|155973606|FG001|Overall Study|Lost to Follow-up|9|||
48486030|NCT01408576|155973607|FG002|Overall Study|Lost to Follow-up|17|||
48486031|NCT01408576|155973605|FG000|Overall Study|Withdrawal by Subject|34|||
48486032|NCT01408576|155973606|FG001|Overall Study|Withdrawal by Subject|60|||
48486033|NCT01408576|155973607|FG002|Overall Study|Withdrawal by Subject|66|||
48486034|NCT01408576|155973605|FG000|Overall Study|Sponsor terminated study|89|||
48486035|NCT01408576|155973606|FG001|Overall Study|Sponsor terminated study|333|||
48486036|NCT01408576|155973607|FG002|Overall Study|Sponsor terminated study|330|||
48486037|NCT01408576|155973605|FG000|Overall Study|AE, serious fatal|4|||
48486038|NCT01408576|155973606|FG001|Overall Study|AE, serious fatal|4|||
48486039|NCT01408576|155973607|FG002|Overall Study|AE, serious fatal|1|||
48486040|NCT01408576|155973605|FG000|Overall Study|SAE, non-fatal|11|||
48486041|NCT01408576|155973606|FG001|Overall Study|SAE, non-fatal|23|||
48486042|NCT01408576|155973607|FG002|Overall Study|SAE, non-fatal|14|||
48486043|NCT01408576|155973605|FG000|Overall Study|AE, non-serious non-fatal|12|||
48486044|NCT01408576|155973606|FG001|Overall Study|AE, non-serious non-fatal|19|||
48486045|NCT01408576|155973607|FG002|Overall Study|AE, non-serious non-fatal|11|||
48486046|NCT01408576|155973605|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48486047|NCT01408576|155973606|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48486048|NCT01408576|155973607|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48486049|NCT01408576|155973605|FG000|Overall Study|AE, unknown type|0|||
48486050|NCT01408576|155973606|FG001|Overall Study|AE, unknown type|1|||
48486051|NCT01408576|155973607|FG002|Overall Study|AE, unknown type|0|||
48486052|NCT01408576|155973605|FG000|Overall Study|Other|10|||
48486053|NCT01408576|155973606|FG001|Overall Study|Other|16|||
48486054|NCT01408576|155973607|FG002|Overall Study|Other|18|||
48486055|NCT01612702|155973633|FG000|Overall Study|Protocol Violation|11|||
48486056|NCT01612702|155973634|FG001|Overall Study|Protocol Violation|11|||
48486057|NCT03670537|155973635|FG000|Overall Study|Protocol Violation|1|||
48486058|NCT03751020|155973636|FG000|Overall Study|Withdrawal by Subject|2|||
48486059|NCT03751020|155973637|FG001|Overall Study|Withdrawal by Subject|0|||
48486060|NCT03751020|155973638|FG002|Overall Study|Withdrawal by Subject|0|||
48486061|NCT03751020|155973636|FG000|Overall Study|Lost to Follow-up|7|||
48486062|NCT03751020|155973637|FG001|Overall Study|Lost to Follow-up|4|||
48486063|NCT03751020|155973638|FG002|Overall Study|Lost to Follow-up|10|||
48486064|NCT03070431|155973639|FG000|Overall Study|Withdrawal by Subject|2|||
48486065|NCT03070431|155973639|FG000|Overall Study|Lost to Follow-up|2|||
48486066|NCT00033631|155973640|FG000|Overall Study|Protocol Violation|14|||
48486067|NCT00033631|155973641|FG001|Overall Study|Protocol Violation|11|||
48486068|NCT00033631|155973640|FG000|Overall Study|Withdrawal by Subject|4|||
48486069|NCT00033631|155973641|FG001|Overall Study|Withdrawal by Subject|4|||
48486070|NCT01889862|155973642|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
48486071|NCT01889862|155973643|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
48486072|NCT01889862|155973644|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
48486073|NCT01889862|155973645|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
48486074|NCT01889862|155973646|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
48486075|NCT01889862|155973642|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
48486076|NCT01889862|155973643|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
48486077|NCT01889862|155973644|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
48486078|NCT01889862|155973645|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
48486079|NCT01889862|155973646|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
48486080|NCT01889862|155973642|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
48486081|NCT01889862|155973643|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
48486082|NCT01889862|155973644|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
48486083|NCT01889862|155973645|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
48486084|NCT01889862|155973646|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
48486085|NCT01889862|155973642|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
48486086|NCT01889862|155973643|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
48486087|NCT01889862|155973644|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
48486088|NCT01889862|155973645|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
48486089|NCT01889862|155973646|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
48486090|NCT01889862|155973642|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
48486091|NCT01889862|155973643|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
48486092|NCT01889862|155973644|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
48486093|NCT01889862|155973645|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
48486094|NCT01889862|155973646|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
48486095|NCT01889862|155973642|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
48486096|NCT01889862|155973643|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
48486097|NCT01889862|155973644|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
48486098|NCT01889862|155973645|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
48486099|NCT01889862|155973646|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
48486100|NCT01889862|155973642|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
48486101|NCT01889862|155973643|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
48486102|NCT01889862|155973644|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
48486103|NCT01889862|155973645|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
48486104|NCT01889862|155973646|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
48486105|NCT01889862|155973642|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
48486106|NCT01889862|155973643|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
48486107|NCT01889862|155973644|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
48486108|NCT01889862|155973645|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
48486109|NCT01889862|155973646|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
48486110|NCT01889862|155973642|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
48486111|NCT01889862|155973643|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
48486112|NCT01889862|155973644|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
48486113|NCT01889862|155973645|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
48486114|NCT01889862|155973646|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
48486115|NCT01889862|155973642|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
48486116|NCT01889862|155973643|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
48486117|NCT01889862|155973644|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
48486118|NCT01889862|155973645|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
48486119|NCT01889862|155973646|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
48486120|NCT01159769|155973647|FG000|Overall Study|Adverse Event|1|||
48486121|NCT01542736|155973648|FG000|Overall Study|Death|1|||
48486122|NCT00527397|155973649|FG000|Overall Study|Adverse Event|3|||
48486123|NCT00527397|155973649|FG000|Overall Study|Lack of Efficacy|1|||
48486124|NCT00527397|155973649|FG000|Overall Study|Protocol Violation|1|||
48486125|NCT00527397|155973649|FG000|Overall Study|Withdrawal by Subject|6|||
48486126|NCT00527397|155973649|FG000|Overall Study|Study terminated by sponsor|13|||
48486127|NCT00972153|155973650|FG000|Overall Study|Equipment malfunction during case|0|||
48486128|NCT00972153|155973651|FG001|Overall Study|Equipment malfunction during case|1|||
48486129|NCT00972153|155973652|FG002|Overall Study|Equipment malfunction during case|0|||
48486130|NCT02295280|155973658|FG000|Overall Study|Adverse Event|0|||
48486131|NCT02295280|155973659|FG001|Overall Study|Adverse Event|1|||
48486132|NCT01430104|155973660|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
48486133|NCT02124746|155973661|FG000|Overall Study|Adverse Event|2|||
48486134|NCT02124746|155973662|FG001|Overall Study|Adverse Event|1|||
48486135|NCT02124746|155973663|FG002|Overall Study|Adverse Event|2|||
48486136|NCT02124746|155973661|FG000|Overall Study|Death|2|||
48486137|NCT02124746|155973662|FG001|Overall Study|Death|1|||
48486138|NCT02124746|155973663|FG002|Overall Study|Death|3|||
48590065|NCT01483599|156352243|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48590066|NCT01483599|156352244|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48590067|NCT01483599|156352245|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48590068|NCT01483599|156352246|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48590069|NCT01483599|156352247|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48590070|NCT01483599|156352248|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
48590071|NCT01483599|156352235|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
48590072|NCT01483599|156352236|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
48486139|NCT02124746|155973661|FG000|Overall Study|Lack of Efficacy|3|||
48486140|NCT02124746|155973662|FG001|Overall Study|Lack of Efficacy|2|||
48486141|NCT02124746|155973663|FG002|Overall Study|Lack of Efficacy|2|||
48486142|NCT02124746|155973661|FG000|Overall Study|Physician Decision|6|||
48486143|NCT02124746|155973662|FG001|Overall Study|Physician Decision|4|||
48486144|NCT02124746|155973663|FG002|Overall Study|Physician Decision|5|||
48486145|NCT02124746|155973661|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48486146|NCT02124746|155973662|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48486147|NCT02124746|155973663|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48486148|NCT02124746|155973661|FG000|Overall Study|Withdrawal by Subject|3|||
48486149|NCT02124746|155973662|FG001|Overall Study|Withdrawal by Subject|3|||
48486150|NCT02124746|155973663|FG002|Overall Study|Withdrawal by Subject|0|||
48486151|NCT02124746|155973661|FG000|Overall Study|Study Terminated by Sponsor|0|||
48486152|NCT02124746|155973662|FG001|Overall Study|Study Terminated by Sponsor|0|||
48486153|NCT02124746|155973663|FG002|Overall Study|Study Terminated by Sponsor|6|||
48486154|NCT02124746|155973661|FG000|Overall Study|Disease Progression|3|||
48486155|NCT02124746|155973662|FG001|Overall Study|Disease Progression|6|||
48486156|NCT02124746|155973663|FG002|Overall Study|Disease Progression|4|||
48486157|NCT01076166|155973664|FG000|Overall Study|Adverse Event|3|||
48486158|NCT01076166|155973664|FG000|Overall Study|Symptoms improved/resolved|6|||
48486159|NCT02713243|155973668|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
48486160|NCT02713243|155973669|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
48486161|NCT02713243|155973668|FG000|Overall Study|Administrative problems|0|||
48486162|NCT02713243|155973669|FG001|Overall Study|Administrative problems|1|||
48486163|NCT02713243|155973668|FG000|Overall Study|Protocol deviation|0|||
48486164|NCT02713243|155973669|FG001|Overall Study|Protocol deviation|1|||
48486165|NCT01050673|155973670|FG000|Overall Study|Physician Decision|4|||
48486166|NCT01050673|155973671|FG001|Overall Study|Physician Decision|5|||
48486167|NCT05288673|155973672|FG000|Overall Study|Consent withdrawn by subject|0|||
48486168|NCT05288673|155973673|FG001|Overall Study|Consent withdrawn by subject|0|||
48486169|NCT05288673|155973674|FG002|Overall Study|Consent withdrawn by subject|1|||
48486170|NCT04363736|155973676|FG000|Overall Study|Withdrawal by Subject|1|||
48486171|NCT04363736|155973677|FG001|Overall Study|Withdrawal by Subject|0|||
48486172|NCT04363736|155973676|FG000|Overall Study|Lost to Follow-up|10|||
48486173|NCT04363736|155973677|FG001|Overall Study|Lost to Follow-up|7|||
48486174|NCT04363736|155973676|FG000|Overall Study|Death|8|||
48486175|NCT04363736|155973677|FG001|Overall Study|Death|6|||
48486176|NCT01208402|155973678|FG000|Overall Study|Withdrawal by Subject|1|||
48486177|NCT01208402|155973679|FG001|Overall Study|Withdrawal by Subject|0|||
48486178|NCT01261325|155973680|FG000|Overall Study|Lack of Efficacy|1|||
48486179|NCT01261325|155973681|FG001|Overall Study|Lack of Efficacy|1|||
48486180|NCT01261325|155973682|FG002|Overall Study|Lack of Efficacy|0|||
48590073|NCT01483599|156352237|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
48590074|NCT01483599|156352238|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
48590075|NCT01483599|156352239|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
48590076|NCT01483599|156352240|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
48590077|NCT01483599|156352241|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
48590078|NCT01483599|156352242|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
48590079|NCT01483599|156352243|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
48590080|NCT01483599|156352244|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
48590081|NCT01483599|156352245|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
48590082|NCT01483599|156352246|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
48590083|NCT01483599|156352247|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
48590084|NCT01483599|156352248|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
48590085|NCT01483599|156352235|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
48590086|NCT01483599|156352236|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
48590087|NCT01483599|156352237|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
48590088|NCT01483599|156352238|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
48590089|NCT01483599|156352239|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
48590090|NCT01483599|156352240|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
48590091|NCT01483599|156352241|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
48590092|NCT01483599|156352242|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
48590093|NCT01483599|156352243|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
48590094|NCT01483599|156352244|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
48590095|NCT01483599|156352245|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
48590096|NCT01483599|156352246|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
48486181|NCT01261325|155973680|FG000|Overall Study|Withdrawal by Subject|2|||
48486182|NCT01261325|155973681|FG001|Overall Study|Withdrawal by Subject|2|||
48486183|NCT01261325|155973682|FG002|Overall Study|Withdrawal by Subject|4|||
48486184|NCT01261325|155973680|FG000|Overall Study|SAE, non-fatal|1|||
48486185|NCT01261325|155973681|FG001|Overall Study|SAE, non-fatal|5|||
48486186|NCT01261325|155973682|FG002|Overall Study|SAE, non-fatal|1|||
48486187|NCT01261325|155973680|FG000|Overall Study|AE, non-serious non-fatal|9|||
48486188|NCT01261325|155973681|FG001|Overall Study|AE, non-serious non-fatal|15|||
48486189|NCT01261325|155973682|FG002|Overall Study|AE, non-serious non-fatal|13|||
48590097|NCT01483599|156352247|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
48590098|NCT01483599|156352248|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
48486190|NCT01261325|155973680|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48486191|NCT01261325|155973681|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48486192|NCT01261325|155973682|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48486193|NCT01261325|155973680|FG000|Overall Study|Non Compliance|2|||
48486194|NCT01261325|155973681|FG001|Overall Study|Non Compliance|0|||
48486195|NCT01261325|155973682|FG002|Overall Study|Non Compliance|0|||
48486196|NCT01261325|155973680|FG000|Overall Study|Patient Randomized by Mistake|0|||
48486197|NCT01261325|155973681|FG001|Overall Study|Patient Randomized by Mistake|1|||
48486198|NCT01261325|155973682|FG002|Overall Study|Patient Randomized by Mistake|0|||
48486199|NCT01261325|155973680|FG000|Overall Study|Erroneously Randomized|1|||
48486200|NCT01261325|155973681|FG001|Overall Study|Erroneously Randomized|0|||
48486201|NCT01261325|155973682|FG002|Overall Study|Erroneously Randomized|0|||
48486202|NCT01261325|155973680|FG000|Overall Study|Screen Failure|1|||
48486203|NCT01261325|155973681|FG001|Overall Study|Screen Failure|0|||
48486204|NCT01261325|155973682|FG002|Overall Study|Screen Failure|0|||
48486205|NCT01261325|155973680|FG000|Overall Study|Randomized in Error|0|||
48486206|NCT01261325|155973681|FG001|Overall Study|Randomized in Error|0|||
48486207|NCT01261325|155973682|FG002|Overall Study|Randomized in Error|1|||
48486208|NCT01261325|155973680|FG000|Overall Study|Protocol Violation|0|||
48486209|NCT01261325|155973681|FG001|Overall Study|Protocol Violation|3|||
48486210|NCT01261325|155973682|FG002|Overall Study|Protocol Violation|1|||
48486211|NCT01261325|155973680|FG000|Overall Study|Lost to Follow-up|0|||
48486212|NCT01261325|155973681|FG001|Overall Study|Lost to Follow-up|1|||
48486213|NCT01261325|155973682|FG002|Overall Study|Lost to Follow-up|3|||
48486214|NCT01261325|155973680|FG000|Overall Study|AE, serious fatal|0|||
48486215|NCT01261325|155973681|FG001|Overall Study|AE, serious fatal|0|||
48486216|NCT01261325|155973682|FG002|Overall Study|AE, serious fatal|2|||
48486217|NCT01571635|155973683|FG000|Overall Study|Adverse Event|3|||
48486218|NCT01571635|155973684|FG001|Overall Study|Adverse Event|0|||
48486219|NCT01571635|155973685|FG002|Overall Study|Adverse Event|2|||
48486220|NCT01571635|155973686|FG003|Overall Study|Adverse Event|3|||
48486221|NCT01571635|155973687|FG004|Overall Study|Adverse Event|5|||
48486222|NCT01571635|155973683|FG000|Overall Study|Other reasons|2|||
48486223|NCT01571635|155973684|FG001|Overall Study|Other reasons|1|||
48486224|NCT01571635|155973685|FG002|Overall Study|Other reasons|2|||
48486225|NCT01571635|155973686|FG003|Overall Study|Other reasons|2|||
48486226|NCT01571635|155973687|FG004|Overall Study|Other reasons|1|||
48486227|NCT01571635|155973683|FG000|Overall Study|Study terminated by sponsor|0|||
48486228|NCT01571635|155973684|FG001|Overall Study|Study terminated by sponsor|4|||
48486229|NCT01571635|155973685|FG002|Overall Study|Study terminated by sponsor|1|||
48486230|NCT01571635|155973686|FG003|Overall Study|Study terminated by sponsor|3|||
48486231|NCT01571635|155973687|FG004|Overall Study|Study terminated by sponsor|1|||
48486232|NCT01571635|155973683|FG000|Overall Study|Withdrew consent|1|||
48486233|NCT01571635|155973684|FG001|Overall Study|Withdrew consent|1|||
48486234|NCT01571635|155973685|FG002|Overall Study|Withdrew consent|2|||
48486235|NCT01571635|155973686|FG003|Overall Study|Withdrew consent|3|||
48486236|NCT01571635|155973687|FG004|Overall Study|Withdrew consent|0|||
48486237|NCT01571635|155973683|FG000|Overall Study|Lack of Efficacy|0|||
48486238|NCT01571635|155973684|FG001|Overall Study|Lack of Efficacy|2|||
48486239|NCT01571635|155973685|FG002|Overall Study|Lack of Efficacy|0|||
48486240|NCT01571635|155973686|FG003|Overall Study|Lack of Efficacy|1|||
48486241|NCT01571635|155973687|FG004|Overall Study|Lack of Efficacy|2|||
48486242|NCT01328054|155973692|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
48486243|NCT01328054|155973693|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
48486244|NCT01328054|155973692|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
48486245|NCT01328054|155973693|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
48486246|NCT01328054|155973692|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
48486247|NCT01328054|155973693|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
48486248|NCT01298596|155973695|FG000|Overall Study|Withdrawal by Subject|1|||
48486249|NCT01298596|155973696|FG001|Overall Study|Withdrawal by Subject|1|||
48486250|NCT01298596|155973695|FG000|Overall Study|Death|5|||
48486251|NCT01298596|155973696|FG001|Overall Study|Death|3|||
48486252|NCT01298596|155973695|FG000|Overall Study|Lost to Follow-up|6|||
48486253|NCT01298596|155973696|FG001|Overall Study|Lost to Follow-up|14|||
48486254|NCT01298596|155973695|FG000|Overall Study|Referred for further management|16|||
48486255|NCT01298596|155973696|FG001|Overall Study|Referred for further management|15|||
48486256|NCT01559818|155973697|FG000|Overall Study|Physician Decision|1|||
48486257|NCT01559818|155973697|FG000|Overall Study|Pregnancy|1|||
48486258|NCT01559818|155973697|FG000|Overall Study|Study terminated by Sponsor|4|||
48486259|NCT01559818|155973697|FG000|Overall Study|Withdrawal by Subject|1|||
48486260|NCT00096486|155973698|FG000|Overall Study|Withdrawal by Subject|0|||
48486261|NCT00096486|155973699|FG001|Overall Study|Withdrawal by Subject|0|||
48584935|NCT00743288|156333719|FG005|Overall Study|Adverse Event|1|||
48584936|NCT00743288|156333720|FG006|Overall Study|Adverse Event|2|||
48584937|NCT00743288|156333714|FG000|Overall Study|Withdrawal by Subject|0|||
48584938|NCT00743288|156333715|FG001|Overall Study|Withdrawal by Subject|0|||
48584939|NCT00743288|156333716|FG002|Overall Study|Withdrawal by Subject|1|||
48486262|NCT00096486|155973700|FG002|Overall Study|Withdrawal by Subject|1|||
48486263|NCT00096486|155973701|FG003|Overall Study|Withdrawal by Subject|1|||
48486264|NCT00096486|155973698|FG000|Overall Study|Not Treated|0|||
48486265|NCT00096486|155973699|FG001|Overall Study|Not Treated|0|||
48486266|NCT00096486|155973700|FG002|Overall Study|Not Treated|1|||
48486267|NCT00096486|155973701|FG003|Overall Study|Not Treated|1|||
48486268|NCT02475980|155973702|FG000|Overall Study|Lost to Follow-up|4|||
48486269|NCT02475980|155973702|FG000|Overall Study|Withdrawal by Subject|1|||
48486270|NCT05028751|155973703|FG000|Overall Study|Study Terminated by Sponsor|3|||
48486271|NCT05028751|155973704|FG001|Overall Study|Study Terminated by Sponsor|0|||
48486272|NCT05028751|155973705|FG002|Overall Study|Study Terminated by Sponsor|0|||
48486273|NCT05028751|155973706|FG003|Overall Study|Study Terminated by Sponsor|0|||
48486274|NCT05028751|155973703|FG000|Overall Study|Death|9|||
48486275|NCT05028751|155973704|FG001|Overall Study|Death|3|||
48486276|NCT05028751|155973705|FG002|Overall Study|Death|2|||
48486277|NCT05028751|155973706|FG003|Overall Study|Death|4|||
48486278|NCT05028751|155973703|FG000|Overall Study|Withdrawal by Subject|0|||
48486279|NCT05028751|155973704|FG001|Overall Study|Withdrawal by Subject|0|||
48486280|NCT05028751|155973705|FG002|Overall Study|Withdrawal by Subject|1|||
48486281|NCT05028751|155973706|FG003|Overall Study|Withdrawal by Subject|0|||
48486282|NCT05028751|155973703|FG000|Overall Study|Miscellaneous|2|||
48486283|NCT05028751|155973704|FG001|Overall Study|Miscellaneous|0|||
48486284|NCT05028751|155973705|FG002|Overall Study|Miscellaneous|0|||
48486285|NCT05028751|155973706|FG003|Overall Study|Miscellaneous|0|||
48486286|NCT00802529|155975544|FG000|Overall Study|Lost to Follow-up|0|||
48486287|NCT00802529|155975545|FG001|Overall Study|Lost to Follow-up|1|||
48486288|NCT01399125|155975553|FG000|Overall Study|Adverse Event|32|||
48486289|NCT01399125|155975554|FG001|Overall Study|Adverse Event|30|||
48486290|NCT01399125|155975553|FG000|Overall Study|Abnormal Lab values|0|||
48486291|NCT01399125|155975554|FG001|Overall Study|Abnormal Lab values|1|||
48486292|NCT01399125|155975553|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48486293|NCT01399125|155975554|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
48486294|NCT01399125|155975553|FG000|Overall Study|Withdrawal by Subject|5|||
48486295|NCT01399125|155975554|FG001|Overall Study|Withdrawal by Subject|8|||
48486296|NCT01399125|155975553|FG000|Overall Study|Lost to Follow-up|2|||
48486297|NCT01399125|155975554|FG001|Overall Study|Lost to Follow-up|3|||
48486298|NCT01399125|155975553|FG000|Overall Study|Administrative Problems|7|||
48486299|NCT01399125|155975554|FG001|Overall Study|Administrative Problems|11|||
48486300|NCT01399125|155975553|FG000|Overall Study|Death|0|||
48486301|NCT01399125|155975554|FG001|Overall Study|Death|1|||
48486302|NCT01399125|155975553|FG000|Overall Study|Protocol Deviation|5|||
48486303|NCT01399125|155975554|FG001|Overall Study|Protocol Deviation|2|||
48486304|NCT01902134|155975555|FG000|Overall Study|Adverse Event|3|||
48486305|NCT01902134|155975556|FG001|Overall Study|Adverse Event|1|||
48486306|NCT01902134|155975557|FG002|Overall Study|Adverse Event|2|||
48486307|NCT01902134|155975558|FG003|Overall Study|Adverse Event|1|||
48486308|NCT01902134|155975559|FG004|Overall Study|Adverse Event|1|||
48486309|NCT01902134|155975560|FG005|Overall Study|Adverse Event|3|||
48486310|NCT01902134|155975555|FG000|Overall Study|Lack of Efficacy|0|||
48486311|NCT01902134|155975556|FG001|Overall Study|Lack of Efficacy|0|||
48486312|NCT01902134|155975557|FG002|Overall Study|Lack of Efficacy|2|||
48486313|NCT01902134|155975558|FG003|Overall Study|Lack of Efficacy|0|||
48486314|NCT01902134|155975559|FG004|Overall Study|Lack of Efficacy|0|||
48486315|NCT01902134|155975560|FG005|Overall Study|Lack of Efficacy|1|||
48486316|NCT01902134|155975555|FG000|Overall Study|Physician Decision|0|||
48486317|NCT01902134|155975556|FG001|Overall Study|Physician Decision|1|||
48486318|NCT01902134|155975557|FG002|Overall Study|Physician Decision|0|||
48486319|NCT01902134|155975558|FG003|Overall Study|Physician Decision|0|||
48486320|NCT01902134|155975559|FG004|Overall Study|Physician Decision|0|||
48486321|NCT01902134|155975560|FG005|Overall Study|Physician Decision|0|||
48486322|NCT01902134|155975555|FG000|Overall Study|Protocol Violation|0|||
48486323|NCT01902134|155975556|FG001|Overall Study|Protocol Violation|0|||
48486324|NCT01902134|155975557|FG002|Overall Study|Protocol Violation|0|||
48486325|NCT01902134|155975558|FG003|Overall Study|Protocol Violation|0|||
48590099|NCT01483599|156352235|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48742916|NCT00745823|156910413|FG000|Overall Study|Lost to Follow-up|10|||
48486326|NCT01902134|155975559|FG004|Overall Study|Protocol Violation|0|||
48486327|NCT01902134|155975560|FG005|Overall Study|Protocol Violation|1|||
48486328|NCT01902134|155975555|FG000|Overall Study|Withdrawal by Subject|4|||
48486329|NCT01902134|155975556|FG001|Overall Study|Withdrawal by Subject|8|||
48486330|NCT01902134|155975557|FG002|Overall Study|Withdrawal by Subject|9|||
48486331|NCT01902134|155975558|FG003|Overall Study|Withdrawal by Subject|1|||
48486332|NCT01902134|155975559|FG004|Overall Study|Withdrawal by Subject|5|||
48486333|NCT01902134|155975560|FG005|Overall Study|Withdrawal by Subject|4|||
48486334|NCT01902134|155975555|FG000|Overall Study|no compliance|1|||
48486335|NCT01902134|155975556|FG001|Overall Study|no compliance|0|||
48486336|NCT01902134|155975557|FG002|Overall Study|no compliance|0|||
48486337|NCT01902134|155975558|FG003|Overall Study|no compliance|0|||
48486338|NCT01902134|155975559|FG004|Overall Study|no compliance|0|||
48486339|NCT01902134|155975560|FG005|Overall Study|no compliance|0|||
48486340|NCT01902134|155975555|FG000|Overall Study|Other|0|||
48486341|NCT01902134|155975556|FG001|Overall Study|Other|1|||
48486342|NCT01902134|155975557|FG002|Overall Study|Other|2|||
48486343|NCT01902134|155975558|FG003|Overall Study|Other|0|||
48486344|NCT01902134|155975559|FG004|Overall Study|Other|1|||
48486345|NCT01902134|155975560|FG005|Overall Study|Other|0|||
48486346|NCT00305110|155975561|FG000|Overall Study|Missing data|29|||
48486347|NCT00420290|155975564|FG000|Overall Study|Adverse Event|3|||
48486348|NCT00420290|155975565|FG001|Overall Study|Adverse Event|1|||
48486349|NCT00420290|155975564|FG000|Overall Study|Withdrawal by Subject|0|||
48486350|NCT00420290|155975565|FG001|Overall Study|Withdrawal by Subject|2|||
48486351|NCT00420290|155975564|FG000|Overall Study|did not meet inclusion/exclusion|1|||
48486352|NCT00420290|155975565|FG001|Overall Study|did not meet inclusion/exclusion|1|||
48486353|NCT00678379|155975566|FG000|Overall Study|Injection performed after tonsillectomy|2|||
48486354|NCT00678379|155975567|FG001|Overall Study|Injection performed after tonsillectomy|0|||
48486355|NCT00678379|155975568|FG002|Overall Study|Injection performed after tonsillectomy|1|||
48486356|NCT00678379|155975566|FG000|Overall Study|Incomplete Data|4|||
48486357|NCT00678379|155975567|FG001|Overall Study|Incomplete Data|3|||
48486358|NCT00678379|155975568|FG002|Overall Study|Incomplete Data|3|||
48486359|NCT01467570|155975571|FG000|Overall Study|Lost to Follow-up|8|||
48486360|NCT01467570|155975572|FG001|Overall Study|Lost to Follow-up|9|||
48486361|NCT01835470|155975573|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
48486362|NCT01835470|155975573|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
48486363|NCT01120600|155975574|FG000|Overall Study|Adverse Event|7|||
48486364|NCT01120600|155975575|FG001|Overall Study|Adverse Event|7|||
48486365|NCT01120600|155975574|FG000|Overall Study|Excessive Bone Loss|0|||
48486366|NCT01120600|155975575|FG001|Overall Study|Excessive Bone Loss|4|||
48486367|NCT01120600|155975574|FG000|Overall Study|Lost to Follow-up|1|||
48486368|NCT01120600|155975575|FG001|Overall Study|Lost to Follow-up|3|||
48486369|NCT01120600|155975574|FG000|Overall Study|Physician Decision|1|||
48486370|NCT01120600|155975575|FG001|Overall Study|Physician Decision|3|||
48486371|NCT01120600|155975574|FG000|Overall Study|Protocol Violation|0|||
48486372|NCT01120600|155975575|FG001|Overall Study|Protocol Violation|4|||
48486373|NCT01120600|155975574|FG000|Overall Study|Withdrawal by Subject|10|||
48486374|NCT01120600|155975575|FG001|Overall Study|Withdrawal by Subject|11|||
48486375|NCT01011907|155975576|FG000|Overall Study|Withdrawal by Subject|13|||
48486376|NCT01011907|155975577|FG001|Overall Study|Withdrawal by Subject|11|||
48486377|NCT01011907|155975576|FG000|Overall Study|Adverse Event|1|||
48486378|NCT01011907|155975577|FG001|Overall Study|Adverse Event|4|||
48486379|NCT01272193|155975580|FG000|Overall Study|Adverse Event|1|||
48486380|NCT01272193|155975581|FG001|Overall Study|Adverse Event|1|||
48486381|NCT01272193|155975580|FG000|Overall Study|Lack of Efficacy|0|||
48486382|NCT01272193|155975581|FG001|Overall Study|Lack of Efficacy|3|||
48486383|NCT01272193|155975580|FG000|Overall Study|Withdrawal Criteria|1|||
48486384|NCT01272193|155975581|FG001|Overall Study|Withdrawal Criteria|1|||
48486385|NCT01272193|155975580|FG000|Overall Study|Unclassified|8|||
48486386|NCT01272193|155975581|FG001|Overall Study|Unclassified|7|||
48486387|NCT00304954|155975586|FG000|Overall Study|Withdrawal by Subject|0|||
48486388|NCT00304954|155975587|FG001|Overall Study|Withdrawal by Subject|0|||
48486389|NCT00304954|155975588|FG002|Overall Study|Withdrawal by Subject|1|||
48486390|NCT00304954|155975589|FG003|Overall Study|Withdrawal by Subject|0|||
48486391|NCT00304954|155975586|FG000|Overall Study|Adverse Event|1|||
48486392|NCT00304954|155975587|FG001|Overall Study|Adverse Event|0|||
48486393|NCT00304954|155975588|FG002|Overall Study|Adverse Event|0|||
48486394|NCT00304954|155975589|FG003|Overall Study|Adverse Event|0|||
48486395|NCT01440647|155975590|FG000|Overall Study|Death|2|||
48486396|NCT01440647|155975591|FG001|Overall Study|Death|3|||
48486397|NCT01406873|155975598|FG000|Overall Study|Withdrawal by Subject|1|||
48486398|NCT01406873|155975599|FG001|Overall Study|Withdrawal by Subject|1|||
48486399|NCT03990389|155975600|FG000|Overall Study|Lost to Follow-up|3|||
48486400|NCT03990389|155975601|FG001|Overall Study|Lost to Follow-up|0|||
48486401|NCT03066440|155975610|FG000|Overall Study|Physician Decision|1|||
48486402|NCT03066440|155975611|FG001|Overall Study|Physician Decision|1|||
48486403|NCT03066440|155975610|FG000|Overall Study|Protocol Violation|0|||
48486404|NCT03066440|155975611|FG001|Overall Study|Protocol Violation|2|||
48486405|NCT02117479|155975616|FG000|Overall Study|Death|13|||
48381892|NCT00375219|155592860|FG001|Overall Study|Cord blood transplantation|0|||
48381893|NCT00375219|155592861|FG002|Overall Study|Cord blood transplantation|0|||
48486406|NCT02117479|155975617|FG001|Overall Study|Death|8|||
48486407|NCT02117479|155975616|FG000|Overall Study|Adverse Event|8|||
48486408|NCT02117479|155975617|FG001|Overall Study|Adverse Event|16|||
48486409|NCT02117479|155975616|FG000|Overall Study|Subject decision|8|||
48486410|NCT02117479|155975617|FG001|Overall Study|Subject decision|9|||
48486411|NCT02117479|155975616|FG000|Overall Study|Disease progression|104|||
48486412|NCT02117479|155975617|FG001|Overall Study|Disease progression|108|||
48486413|NCT02117479|155975616|FG000|Overall Study|Noncompliance with study treatment|1|||
48486414|NCT02117479|155975617|FG001|Overall Study|Noncompliance with study treatment|0|||
48486415|NCT02117479|155975616|FG000|Overall Study|Study terminated by the sponsor|4|||
48486416|NCT02117479|155975617|FG001|Overall Study|Study terminated by the sponsor|6|||
48486417|NCT02117479|155975616|FG000|Overall Study|Physician Decision|7|||
48486418|NCT02117479|155975617|FG001|Overall Study|Physician Decision|2|||
48486419|NCT02117479|155975616|FG000|Overall Study|Other unspecified|11|||
48486420|NCT02117479|155975617|FG001|Overall Study|Other unspecified|7|||
48486421|NCT02725671|155975618|FG000|Overall Study|Lost to Follow-up|1|||
48486422|NCT01965535|155975619|FG000|Overall Study|Lack of Efficacy|2|||
48486423|NCT01965535|155975620|FG001|Overall Study|Lack of Efficacy|1|||
48486424|NCT00528879|155975621|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
48486425|NCT00528879|155975622|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
48486426|NCT00528879|155975623|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
48486427|NCT00528879|155975624|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
48486428|NCT00528879|155975621|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
48486429|NCT00528879|155975622|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
48486430|NCT00528879|155975623|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
48486431|NCT00528879|155975624|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
48486432|NCT00528879|155975621|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
48486433|NCT00528879|155975622|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
48486434|NCT00528879|155975623|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
48486435|NCT00528879|155975624|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
48486436|NCT00528879|155975621|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
48486437|NCT00528879|155975622|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
48486438|NCT00528879|155975623|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
48486439|NCT00528879|155975624|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
48486440|NCT00528879|155975621|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
48486441|NCT00528879|155975622|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
48486442|NCT00528879|155975623|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
48486443|NCT00528879|155975624|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
48486444|NCT00528879|155975621|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
48486445|NCT00528879|155975622|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
48486446|NCT00528879|155975623|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
48486447|NCT00528879|155975624|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
48486448|NCT00528879|155975621|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
48486449|NCT00528879|155975622|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
48486450|NCT00528879|155975623|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
48486451|NCT00528879|155975624|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
48486452|NCT00528879|155975621|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
48486453|NCT00528879|155975622|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
48486454|NCT00528879|155975623|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
48486455|NCT00528879|155975624|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
48486456|NCT00528879|155975621|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
48486457|NCT00528879|155975622|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
48486458|NCT00528879|155975623|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
48486459|NCT00528879|155975624|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
48486460|NCT00528879|155975621|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
48486461|NCT00528879|155975622|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
48486462|NCT00528879|155975623|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
48486463|NCT00528879|155975624|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
48486464|NCT00528879|155975621|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
48486465|NCT00528879|155975622|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
48486466|NCT00528879|155975623|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
48486467|NCT00528879|155975624|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
48486468|NCT00528879|155975621|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
48486469|NCT00528879|155975622|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
48486470|NCT00528879|155975623|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
48486471|NCT00528879|155975624|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
48486472|NCT00528879|155975621|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
48486473|NCT00528879|155975622|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
48486474|NCT00528879|155975623|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
48486475|NCT00528879|155975624|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
48486476|NCT00528879|155975621|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
48486477|NCT00528879|155975622|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
48486478|NCT00528879|155975623|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
48486479|NCT00528879|155975624|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
48486480|NCT00528879|155975621|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
48486481|NCT00528879|155975622|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
48486482|NCT00528879|155975623|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
48486483|NCT00528879|155975624|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
48486484|NCT00528879|155975621|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
48486485|NCT00528879|155975622|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
48486486|NCT00528879|155975623|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
48486487|NCT00528879|155975624|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
48486488|NCT03840135|155975629|FG000|Overall Study|Protocol Violation|6|||
48486489|NCT03840135|155975630|FG001|Overall Study|Protocol Violation|1|||
48486490|NCT03840135|155975629|FG000|Overall Study|Withdrawal by Subject|1|||
48486491|NCT03840135|155975630|FG001|Overall Study|Withdrawal by Subject|0|||
48486492|NCT00667719|155975631|FG000|Overall Study|Adverse Event|39|||
48486493|NCT00667719|155975631|FG000|Overall Study|Abnormal Test Procedure|1|||
48486494|NCT00667719|155975631|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48486495|NCT00667719|155975631|FG000|Overall Study|Protocol Violation|3|||
48486496|NCT00667719|155975631|FG000|Overall Study|Withdrawal by Subject|17|||
48486497|NCT00667719|155975631|FG000|Overall Study|Lost to Follow-up|8|||
48486498|NCT04133519|155975632|FG000|Overall Study|Withdrawal by Subject|5|||
48486499|NCT04133519|155975633|FG001|Overall Study|Withdrawal by Subject|4|||
48486500|NCT04133519|155975632|FG000|Overall Study|Protocol Violation|0|||
48486501|NCT04133519|155975633|FG001|Overall Study|Protocol Violation|1|||
48486502|NCT04133519|155975632|FG000|Overall Study|Never started treatment|1|||
48486503|NCT04133519|155975633|FG001|Overall Study|Never started treatment|1|||
48486504|NCT00078819|155975634|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
48486505|NCT00078819|155975635|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
48486506|NCT00078819|155975636|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
48486507|NCT00078819|155975637|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
48486508|NCT00078819|155975634|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
48486509|NCT00078819|155975635|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
48486510|NCT00078819|155975636|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
48486511|NCT00078819|155975637|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
48486512|NCT00078819|155975634|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
48486513|NCT00078819|155975635|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
48486514|NCT00078819|155975636|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
48486515|NCT00078819|155975637|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
48486516|NCT00078819|155975634|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
48486517|NCT00078819|155975635|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
48486518|NCT00078819|155975636|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
48486519|NCT00078819|155975637|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
48486520|NCT00078819|155975634|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
48486521|NCT00078819|155975635|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
48486522|NCT00078819|155975636|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
48486523|NCT00078819|155975637|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
48486524|NCT00078819|155975634|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
48486525|NCT00078819|155975635|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
48486526|NCT00078819|155975636|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
48486527|NCT00078819|155975637|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
48486528|NCT00078819|155975634|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
48486529|NCT00078819|155975635|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
48486530|NCT00078819|155975636|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
48486531|NCT00078819|155975637|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
48486532|NCT00078819|155975634|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
48486533|NCT00078819|155975635|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
48486534|NCT00078819|155975636|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
48486535|NCT00078819|155975637|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
48486536|NCT00619619|155975638|FG000|Overall Study|Physician Decision|0|||
48486537|NCT00619619|155975639|FG001|Overall Study|Physician Decision|0|||
48486538|NCT00619619|155975640|FG002|Overall Study|Physician Decision|1|||
48486539|NCT00619619|155975641|FG003|Overall Study|Physician Decision|0|||
48486540|NCT00619619|155975642|FG004|Overall Study|Physician Decision|0|||
48486541|NCT00619619|155975643|FG005|Overall Study|Physician Decision|0|||
48486542|NCT00619619|155975644|FG006|Overall Study|Physician Decision|0|||
48486543|NCT00619619|155975645|FG007|Overall Study|Physician Decision|0|||
48486544|NCT00619619|155975638|FG000|Overall Study|Protocol Violation|0|||
48486545|NCT00619619|155975639|FG001|Overall Study|Protocol Violation|0|||
48486546|NCT00619619|155975640|FG002|Overall Study|Protocol Violation|0|||
48590100|NCT01483599|156352236|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48590101|NCT01483599|156352237|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48486547|NCT00619619|155975641|FG003|Overall Study|Protocol Violation|1|||
48486548|NCT00619619|155975642|FG004|Overall Study|Protocol Violation|0|||
48486549|NCT00619619|155975643|FG005|Overall Study|Protocol Violation|0|||
48486550|NCT00619619|155975644|FG006|Overall Study|Protocol Violation|1|||
48486551|NCT00619619|155975645|FG007|Overall Study|Protocol Violation|1|||
48486552|NCT00619619|155975638|FG000|Overall Study|Adverse Event|0|||
48486553|NCT00619619|155975639|FG001|Overall Study|Adverse Event|0|||
48486554|NCT00619619|155975640|FG002|Overall Study|Adverse Event|0|||
48486555|NCT00619619|155975641|FG003|Overall Study|Adverse Event|0|||
48486556|NCT00619619|155975642|FG004|Overall Study|Adverse Event|2|||
48486557|NCT00619619|155975643|FG005|Overall Study|Adverse Event|0|||
48486558|NCT00619619|155975644|FG006|Overall Study|Adverse Event|0|||
48486559|NCT00619619|155975645|FG007|Overall Study|Adverse Event|2|||
48486560|NCT02555618|155975646|FG000|Overall Study|Sponsor's Circumstances|1|||
48486561|NCT02555618|155975647|FG001|Overall Study|Sponsor's Circumstances|0|||
48486562|NCT00323609|155975648|FG000|Overall Study|Death|16|||
48486563|NCT00323609|155975649|FG001|Overall Study|Death|21|||
48486564|NCT00323609|155975650|FG002|Overall Study|Death|0|||
48486565|NCT00323609|155975651|FG003|Overall Study|Death|0|||
48486566|NCT00323609|155975648|FG000|Overall Study|Lost to Follow-up|9|||
48486567|NCT00323609|155975649|FG001|Overall Study|Lost to Follow-up|10|||
48486568|NCT00323609|155975650|FG002|Overall Study|Lost to Follow-up|0|||
48486569|NCT00323609|155975651|FG003|Overall Study|Lost to Follow-up|0|||
48486570|NCT00323609|155975648|FG000|Overall Study|Physician Decision|2|||
48486571|NCT00323609|155975649|FG001|Overall Study|Physician Decision|0|||
48486572|NCT00323609|155975650|FG002|Overall Study|Physician Decision|0|||
48486573|NCT00323609|155975651|FG003|Overall Study|Physician Decision|1|||
48486574|NCT00323609|155975648|FG000|Overall Study|Withdrawal by Subject|11|||
48486575|NCT00323609|155975649|FG001|Overall Study|Withdrawal by Subject|23|||
48486576|NCT00323609|155975650|FG002|Overall Study|Withdrawal by Subject|4|||
48486577|NCT00323609|155975651|FG003|Overall Study|Withdrawal by Subject|4|||
48486578|NCT00323609|155975648|FG000|Overall Study|Other non-VCF-related medical condition|3|||
48486579|NCT00323609|155975649|FG001|Overall Study|Other non-VCF-related medical condition|2|||
48486580|NCT00323609|155975650|FG002|Overall Study|Other non-VCF-related medical condition|0|||
48486581|NCT00323609|155975651|FG003|Overall Study|Other non-VCF-related medical condition|0|||
48486582|NCT00323609|155975648|FG000|Overall Study|Sponsor discontinued trial|29|||
48486583|NCT00323609|155975649|FG001|Overall Study|Sponsor discontinued trial|29|||
48486584|NCT00323609|155975650|FG002|Overall Study|Sponsor discontinued trial|0|||
48486585|NCT00323609|155975651|FG003|Overall Study|Sponsor discontinued trial|0|||
48486586|NCT00323609|155975648|FG000|Overall Study|Unrelenting or severe back pain|1|||
48486587|NCT00323609|155975649|FG001|Overall Study|Unrelenting or severe back pain|1|||
48486588|NCT00323609|155975650|FG002|Overall Study|Unrelenting or severe back pain|0|||
48486589|NCT00323609|155975651|FG003|Overall Study|Unrelenting or severe back pain|0|||
48486590|NCT00323609|155975648|FG000|Overall Study|Logistical withdrawal|9|||
48486591|NCT00323609|155975649|FG001|Overall Study|Logistical withdrawal|5|||
48486592|NCT00323609|155975650|FG002|Overall Study|Logistical withdrawal|0|||
48486593|NCT00323609|155975651|FG003|Overall Study|Logistical withdrawal|1|||
48486594|NCT00323609|155975648|FG000|Overall Study|Other reason|11|||
48486595|NCT00323609|155975649|FG001|Overall Study|Other reason|8|||
48486596|NCT00323609|155975650|FG002|Overall Study|Other reason|4|||
48486597|NCT00323609|155975651|FG003|Overall Study|Other reason|9|||
48486598|NCT01827371|155975652|FG000|Overall Study|Adverse Event|0|||
48486599|NCT01827371|155975653|FG001|Overall Study|Adverse Event|0|||
48486600|NCT01827371|155975654|FG002|Overall Study|Adverse Event|4|||
48486601|NCT01827371|155975655|FG003|Overall Study|Adverse Event|2|||
48486602|NCT01827371|155975652|FG000|Overall Study|Lost to Follow-up|0|||
48486603|NCT01827371|155975653|FG001|Overall Study|Lost to Follow-up|2|||
48486604|NCT01827371|155975654|FG002|Overall Study|Lost to Follow-up|0|||
48590102|NCT01483599|156352238|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48590103|NCT01483599|156352239|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48590104|NCT01483599|156352240|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48590105|NCT01483599|156352241|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48590106|NCT01483599|156352242|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
48486605|NCT01827371|155975655|FG003|Overall Study|Lost to Follow-up|4|||
48486606|NCT01827371|155975652|FG000|Overall Study|Protocol Violation|1|||
48486607|NCT01827371|155975653|FG001|Overall Study|Protocol Violation|0|||
48486608|NCT01827371|155975654|FG002|Overall Study|Protocol Violation|0|||
48590107|NCT01483599|156352243|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
48590108|NCT01483599|156352244|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48590109|NCT01483599|156352245|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48486609|NCT01827371|155975655|FG003|Overall Study|Protocol Violation|0|||
48486610|NCT01827371|155975652|FG000|Overall Study|Withdrawal by Subject|1|||
48486611|NCT01827371|155975653|FG001|Overall Study|Withdrawal by Subject|2|||
48486612|NCT01827371|155975654|FG002|Overall Study|Withdrawal by Subject|2|||
48486613|NCT01827371|155975655|FG003|Overall Study|Withdrawal by Subject|3|||
48486614|NCT01827371|155975652|FG000|Overall Study|Physician Decision|0|||
48486615|NCT01827371|155975653|FG001|Overall Study|Physician Decision|1|||
48486616|NCT01827371|155975654|FG002|Overall Study|Physician Decision|0|||
48486617|NCT01827371|155975655|FG003|Overall Study|Physician Decision|1|||
48486618|NCT01827371|155975652|FG000|Overall Study|Temporary study halt to vaccinations|11|||
48486619|NCT01827371|155975653|FG001|Overall Study|Temporary study halt to vaccinations|2|||
48486620|NCT01827371|155975654|FG002|Overall Study|Temporary study halt to vaccinations|5|||
48486621|NCT01827371|155975655|FG003|Overall Study|Temporary study halt to vaccinations|13|||
48486622|NCT01783483|155975657|FG000|Overall Study|Death|3|||
48486623|NCT01783483|155975658|FG001|Overall Study|Death|3|||
48486624|NCT01783483|155975657|FG000|Overall Study|Lost to Follow-up|14|||
48486625|NCT01783483|155975658|FG001|Overall Study|Lost to Follow-up|10|||
48486626|NCT01783483|155975657|FG000|Overall Study|Withdrawal by Subject|2|||
48486627|NCT01783483|155975658|FG001|Overall Study|Withdrawal by Subject|1|||
48486628|NCT01783483|155975657|FG000|Overall Study|Physician Decision|1|||
48486629|NCT01783483|155975658|FG001|Overall Study|Physician Decision|1|||
48486630|NCT02217345|155975662|FG000|Overall Study|Lost to Follow-up|2|||
48486631|NCT02217345|155975663|FG001|Overall Study|Lost to Follow-up|1|||
48486632|NCT02217345|155975662|FG000|Overall Study|Withdrawal by Subject|3|||
48486633|NCT02217345|155975663|FG001|Overall Study|Withdrawal by Subject|2|||
48486634|NCT02217345|155975662|FG000|Overall Study|Adverse Event|2|||
48486635|NCT02217345|155975663|FG001|Overall Study|Adverse Event|1|||
48486636|NCT02217345|155975662|FG000|Overall Study|Physician Decision|0|||
48486637|NCT02217345|155975663|FG001|Overall Study|Physician Decision|1|||
48486638|NCT00543439|155975664|FG000|Period 1|Adverse Event|0|||
48486639|NCT00543439|155975665|FG001|Period 1|Adverse Event|2|||
48486640|NCT00543439|155975666|FG002|Period 1|Adverse Event|1|||
48486641|NCT00543439|155975664|FG000|Period 1|Withdrawal by Subject|1|||
48486642|NCT00543439|155975665|FG001|Period 1|Withdrawal by Subject|1|||
48486643|NCT00543439|155975666|FG002|Period 1|Withdrawal by Subject|0|||
48486644|NCT00543439|155975664|FG000|Period 1|Physician Decision|0|||
48486645|NCT00543439|155975665|FG001|Period 1|Physician Decision|0|||
48486646|NCT00543439|155975666|FG002|Period 1|Physician Decision|1|||
48486647|NCT00543439|155975664|FG000|Period 2|Protocol Violation|1|||
48486648|NCT00543439|155975665|FG001|Period 2|Protocol Violation|0|||
48486649|NCT00543439|155975666|FG002|Period 2|Protocol Violation|1|||
48486650|NCT00543439|155975664|FG000|Period 2|Adverse Event|0|||
48486651|NCT00543439|155975665|FG001|Period 2|Adverse Event|1|||
48486652|NCT00543439|155975666|FG002|Period 2|Adverse Event|1|||
48486653|NCT04304950|155975667|FG000|Overall Study|Lost to Follow-up|1|||
48486654|NCT04304950|155975668|FG001|Overall Study|Lost to Follow-up|1|||
48486655|NCT00950599|155975670|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48486656|NCT00950599|155975671|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48486657|NCT00950599|155975672|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48587524|NCT01134263|156343248|FG002|Overall Study|Other adverse event|5|||
48587525|NCT01134263|156343249|FG003|Overall Study|Other adverse event|3|||
48587526|NCT01134263|156343250|FG004|Overall Study|Other adverse event|0|||
48587527|NCT01134263|156343246|FG000|Overall Study|Protocol Violation|8|||
48587528|NCT01134263|156343247|FG001|Overall Study|Protocol Violation|7|||
48587529|NCT01134263|156343248|FG002|Overall Study|Protocol Violation|2|||
48587530|NCT01134263|156343249|FG003|Overall Study|Protocol Violation|4|||
48587531|NCT01134263|156343250|FG004|Overall Study|Protocol Violation|2|||
48587532|NCT01134263|156343246|FG000|Overall Study|Lost to Follow-up|4|||
48587533|NCT01134263|156343247|FG001|Overall Study|Lost to Follow-up|3|||
48587534|NCT01134263|156343248|FG002|Overall Study|Lost to Follow-up|5|||
48587535|NCT01134263|156343249|FG003|Overall Study|Lost to Follow-up|3|||
48587536|NCT01134263|156343250|FG004|Overall Study|Lost to Follow-up|1|||
48587537|NCT01134263|156343246|FG000|Overall Study|Withdrawal by Subject|8|||
48587538|NCT01134263|156343247|FG001|Overall Study|Withdrawal by Subject|6|||
48587539|NCT01134263|156343248|FG002|Overall Study|Withdrawal by Subject|16|||
48587540|NCT01134263|156343249|FG003|Overall Study|Withdrawal by Subject|7|||
48587541|NCT01134263|156343250|FG004|Overall Study|Withdrawal by Subject|5|||
48587542|NCT01134263|156343246|FG000|Overall Study|Enrolled, but not treated|1|||
48587543|NCT01134263|156343247|FG001|Overall Study|Enrolled, but not treated|1|||
48587544|NCT01134263|156343248|FG002|Overall Study|Enrolled, but not treated|0|||
48587545|NCT01134263|156343249|FG003|Overall Study|Enrolled, but not treated|1|||
48587546|NCT01134263|156343250|FG004|Overall Study|Enrolled, but not treated|0|||
48587547|NCT01078298|156343253|FG000|Overall Study|Lost to Follow-up|12|||
48587548|NCT01078298|156343254|FG001|Overall Study|Lost to Follow-up|13|||
48587549|NCT01078298|156343253|FG000|Overall Study|Withdrawal by Subject|31|||
48587550|NCT01078298|156343254|FG001|Overall Study|Withdrawal by Subject|33|||
48587551|NCT01078298|156343253|FG000|Overall Study|Protocol Violation|6|||
48587552|NCT01078298|156343254|FG001|Overall Study|Protocol Violation|6|||
48587553|NCT01078298|156343253|FG000|Overall Study|Adverse Event|6|||
48587554|NCT01078298|156343254|FG001|Overall Study|Adverse Event|5|||
48587555|NCT01078298|156343253|FG000|Overall Study|Death|2|||
48587556|NCT01078298|156343254|FG001|Overall Study|Death|0|||
48587557|NCT01078298|156343253|FG000|Overall Study|Did not meet entrance criteria|0|||
48587558|NCT01078298|156343254|FG001|Overall Study|Did not meet entrance criteria|1|||
48587559|NCT01078298|156343253|FG000|Overall Study|Other|24|||
48587560|NCT01078298|156343254|FG001|Overall Study|Other|32|||
48587561|NCT00481767|156343259|FG000|Overall Study|Withdrawal by Subject|16|||
48486658|NCT00950599|155975673|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
48486659|NCT00950599|155975674|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48486660|NCT00950599|155975675|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48486661|NCT00950599|155975676|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48486662|NCT00950599|155975677|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48486663|NCT00950599|155975678|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48486664|NCT00950599|155975679|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
48486665|NCT00950599|155975670|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48486666|NCT00950599|155975671|FG001|Double-Blind Treatment Period|Adverse Event|1|||
48486667|NCT00950599|155975672|FG002|Double-Blind Treatment Period|Adverse Event|1|||
48486668|NCT00950599|155975673|FG003|Double-Blind Treatment Period|Adverse Event|1|||
48486669|NCT00950599|155975674|FG004|Double-Blind Treatment Period|Adverse Event|1|||
48486670|NCT00950599|155975675|FG005|Double-Blind Treatment Period|Adverse Event|1|||
48590110|NCT01483599|156352246|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
48590111|NCT01483599|156352247|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
48590112|NCT01483599|156352248|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
48590113|NCT01483599|156352235|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590114|NCT01483599|156352236|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590115|NCT01483599|156352237|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590116|NCT01483599|156352238|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590117|NCT01483599|156352239|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590118|NCT01483599|156352240|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590119|NCT01483599|156352241|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590120|NCT01483599|156352242|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590121|NCT01483599|156352243|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
48590122|NCT01483599|156352244|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590123|NCT01483599|156352245|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590124|NCT01483599|156352246|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
48590125|NCT01483599|156352247|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
48590126|NCT01483599|156352248|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
48590127|NCT01483599|156352235|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590128|NCT01483599|156352236|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590129|NCT01483599|156352237|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590130|NCT01483599|156352238|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590131|NCT01483599|156352239|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590132|NCT01483599|156352240|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590133|NCT01483599|156352241|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590134|NCT01483599|156352242|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590135|NCT01483599|156352243|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
48590136|NCT01483599|156352244|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590137|NCT01483599|156352245|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
48590138|NCT01483599|156352246|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590139|NCT01483599|156352247|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
48590140|NCT01483599|156352248|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
48590141|NCT01483599|156352235|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590142|NCT01483599|156352236|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590143|NCT01483599|156352237|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590144|NCT01483599|156352238|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590145|NCT01483599|156352239|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590146|NCT01483599|156352240|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590147|NCT01483599|156352241|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590148|NCT01483599|156352242|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590149|NCT01483599|156352243|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
48590150|NCT01483599|156352244|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590151|NCT01483599|156352245|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590152|NCT01483599|156352246|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
48590153|NCT01483599|156352247|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
48590154|NCT01483599|156352248|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
48590155|NCT01483599|156352235|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
48590156|NCT01483599|156352236|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
48590157|NCT01483599|156352237|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
48590158|NCT01483599|156352238|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
48590159|NCT01483599|156352239|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
48486671|NCT00950599|155975676|FG006|Double-Blind Treatment Period|Adverse Event|0|||
48590160|NCT01483599|156352240|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
48590161|NCT01483599|156352241|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
48590162|NCT01483599|156352242|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
48590163|NCT01483599|156352243|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
48590164|NCT01483599|156352244|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
48590165|NCT01483599|156352245|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
48590166|NCT01483599|156352246|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
48590167|NCT01483599|156352247|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
48590168|NCT01483599|156352248|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
48590169|NCT00593606|156352249|FG000|Overall Study|Adverse Event|13|||
48590170|NCT00593606|156352249|FG000|Overall Study|Withdrawal by Subject|1|||
48590171|NCT00593606|156352249|FG000|Overall Study|Protocol Violation|3|||
48590172|NCT00593606|156352249|FG000|Overall Study|Lost to Follow-up|2|||
48590173|NCT00593606|156352249|FG000|Overall Study|Run-In Failure|5|||
48590174|NCT00593606|156352249|FG000|Overall Study|Screen Failure|3|||
48590175|NCT05645432|156352251|FG000|Overall Study|Withdrawal by Subject|1|||
48590176|NCT03277989|156352252|FG000|Overall Study|Lost to Follow-up|6|||
48590177|NCT03277989|156352252|FG000|Overall Study|Adverse Event|6|||
48590178|NCT03277989|156352252|FG000|Overall Study|Withdrawal by Subject|3|||
48590179|NCT03277989|156352252|FG000|Overall Study|Didn't Receive Study Device|7|||
48590180|NCT03277989|156352252|FG000|Overall Study|Site Closure|26|||
48590181|NCT03277989|156352252|FG000|Overall Study|Sponsor Closure|107|||
48590182|NCT04686266|156352253|FG000|Overall Study|Withdrawal by Subject|0|||
48590183|NCT04686266|156352254|FG001|Overall Study|Withdrawal by Subject|1|||
48590184|NCT03578367|156352255|FG000|Overall Study|Adverse Event|0|||
48590185|NCT03578367|156352256|FG001|Overall Study|Adverse Event|3|||
48590186|NCT03578367|156352257|FG002|Overall Study|Adverse Event|0|||
48590187|NCT03578367|156352258|FG003|Overall Study|Adverse Event|5|||
48590188|NCT03578367|156352255|FG000|Overall Study|Withdrawal by Subject|2|||
48590189|NCT03578367|156352256|FG001|Overall Study|Withdrawal by Subject|2|||
48590190|NCT03578367|156352257|FG002|Overall Study|Withdrawal by Subject|1|||
48590191|NCT03578367|156352258|FG003|Overall Study|Withdrawal by Subject|3|||
48590192|NCT03578367|156352255|FG000|Overall Study|Physician Decision|0|||
48590193|NCT03578367|156352256|FG001|Overall Study|Physician Decision|0|||
48590194|NCT03578367|156352257|FG002|Overall Study|Physician Decision|14|||
48590195|NCT03578367|156352258|FG003|Overall Study|Physician Decision|0|||
48590196|NCT03578367|156352255|FG000|Overall Study|Death|1|||
48590197|NCT03578367|156352256|FG001|Overall Study|Death|0|||
48590198|NCT03578367|156352257|FG002|Overall Study|Death|0|||
48590199|NCT03578367|156352258|FG003|Overall Study|Death|0|||
48590200|NCT03578367|156352255|FG000|Overall Study|Not treated|0|||
48590201|NCT03578367|156352256|FG001|Overall Study|Not treated|0|||
48590202|NCT03578367|156352257|FG002|Overall Study|Not treated|1|||
48590203|NCT03578367|156352258|FG003|Overall Study|Not treated|0|||
48590204|NCT03064490|156352259|FG000|Overall Study|Physician Decision|5|||
48590205|NCT03170349|156352260|FG000|From Implant to the 30-Day Visit|Death|1|||
48590206|NCT03170349|156352260|FG000|From 30-Day to 6-Month Visit|Death|3|||
48590207|NCT03170349|156352260|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
48486672|NCT00950599|155975677|FG007|Double-Blind Treatment Period|Adverse Event|0|||
48486673|NCT00950599|155975678|FG008|Double-Blind Treatment Period|Adverse Event|0|||
48486674|NCT00950599|155975679|FG009|Double-Blind Treatment Period|Adverse Event|0|||
48486675|NCT00950599|155975670|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
48590208|NCT03170349|156352260|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
48590209|NCT03170349|156352260|FG000|From 6-Month to 1-Year Visit|Death|6|||
48590210|NCT03170349|156352260|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
48590211|NCT03170349|156352260|FG000|From 1-Year to 2-Year Visit|Death|13|||
48590212|NCT03170349|156352260|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
48590213|NCT03170349|156352260|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
48590214|NCT03170349|156352260|FG000|From 2-Year to 3-Year Visit|Death|10|||
48486676|NCT00950599|155975671|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
48486677|NCT00950599|155975672|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
48486678|NCT00950599|155975673|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
48486679|NCT00950599|155975674|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
48486680|NCT00950599|155975675|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
48486681|NCT00950599|155975676|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
48486682|NCT00950599|155975677|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
48486683|NCT00950599|155975678|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
48486684|NCT00950599|155975679|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
48486685|NCT00950599|155975670|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48486686|NCT00950599|155975671|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
48590215|NCT03170349|156352260|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
48590216|NCT03170349|156352260|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
48590217|NCT03170349|156352260|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
48590218|NCT02276547|156352261|FG000|Overall Study|Death|2|||
48590219|NCT02276547|156352261|FG000|Overall Study|Explant|2|||
48590220|NCT00908596|156353224|FG000|Overall Study|Other reasons|46|||
48486687|NCT00950599|155975672|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
48486688|NCT00950599|155975673|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
48486689|NCT00950599|155975674|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
48486690|NCT00950599|155975675|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
48486691|NCT00950599|155975676|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
48486692|NCT00950599|155975677|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
48486693|NCT00950599|155975678|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
48486694|NCT00950599|155975679|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
48486695|NCT00950599|155975670|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
48486696|NCT00950599|155975671|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
48486697|NCT00950599|155975672|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
48486698|NCT00950599|155975673|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
48486699|NCT00950599|155975674|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
48486700|NCT00950599|155975675|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
48486701|NCT00950599|155975676|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
48486702|NCT00950599|155975677|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
48486703|NCT00950599|155975678|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
48486704|NCT00950599|155975679|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
48486705|NCT00950599|155975670|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
48486706|NCT00950599|155975671|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
48486707|NCT00950599|155975672|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
48486708|NCT00950599|155975673|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
48486709|NCT00950599|155975674|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
48486710|NCT00950599|155975675|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
48486711|NCT00950599|155975676|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
48486712|NCT00950599|155975677|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
48486713|NCT00950599|155975678|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
48486714|NCT00950599|155975679|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
48486715|NCT00950599|155975670|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
48486716|NCT00950599|155975671|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
48486717|NCT00950599|155975672|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
48486718|NCT00950599|155975673|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
48486719|NCT00950599|155975674|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
48486720|NCT00950599|155975675|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
48486721|NCT00950599|155975676|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
48486722|NCT00950599|155975677|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
48486723|NCT00950599|155975678|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
48486724|NCT00950599|155975679|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
48486725|NCT00950599|155975670|FG000|Follow-Up Period|Adverse Event|0|||
48486726|NCT00950599|155975671|FG001|Follow-Up Period|Adverse Event|0|||
48486727|NCT00950599|155975672|FG002|Follow-Up Period|Adverse Event|0|||
48486728|NCT00950599|155975673|FG003|Follow-Up Period|Adverse Event|0|||
48486729|NCT00950599|155975674|FG004|Follow-Up Period|Adverse Event|0|||
48486730|NCT00950599|155975675|FG005|Follow-Up Period|Adverse Event|0|||
48486731|NCT00950599|155975676|FG006|Follow-Up Period|Adverse Event|0|||
48486732|NCT00950599|155975677|FG007|Follow-Up Period|Adverse Event|0|||
48486733|NCT00950599|155975678|FG008|Follow-Up Period|Adverse Event|1|||
48486734|NCT00950599|155975679|FG009|Follow-Up Period|Adverse Event|0|||
48486735|NCT00950599|155975670|FG000|Follow-Up Period|Lack of Efficacy|0|||
48486736|NCT00950599|155975671|FG001|Follow-Up Period|Lack of Efficacy|0|||
48486737|NCT00950599|155975672|FG002|Follow-Up Period|Lack of Efficacy|0|||
48486738|NCT00950599|155975673|FG003|Follow-Up Period|Lack of Efficacy|0|||
48486739|NCT00950599|155975674|FG004|Follow-Up Period|Lack of Efficacy|0|||
48486740|NCT00950599|155975675|FG005|Follow-Up Period|Lack of Efficacy|0|||
48486741|NCT00950599|155975676|FG006|Follow-Up Period|Lack of Efficacy|0|||
48486742|NCT00950599|155975677|FG007|Follow-Up Period|Lack of Efficacy|0|||
48486743|NCT00950599|155975678|FG008|Follow-Up Period|Lack of Efficacy|3|||
48486744|NCT00950599|155975679|FG009|Follow-Up Period|Lack of Efficacy|0|||
48486745|NCT00950599|155975670|FG000|Follow-Up Period|Lost to Follow-up|0|||
48590221|NCT00908596|156353225|FG001|Overall Study|Other reasons|6|||
48486746|NCT00950599|155975671|FG001|Follow-Up Period|Lost to Follow-up|0|||
48486747|NCT00950599|155975672|FG002|Follow-Up Period|Lost to Follow-up|0|||
48486748|NCT00950599|155975673|FG003|Follow-Up Period|Lost to Follow-up|0|||
48486749|NCT00950599|155975674|FG004|Follow-Up Period|Lost to Follow-up|0|||
48587639|NCT00742027|156343297|FG000|Overall Study|Lost to Follow-up|4|||
48587640|NCT00742027|156343297|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
48587641|NCT00742027|156343297|FG000|Overall Study|Missing|2|||
48587642|NCT00742027|156343297|FG000|Overall Study|Administrative Problems|1|||
48587643|NCT01994902|156343298|FG000|Test Period 1|Withdrawal by Subject|3|||
48587644|NCT01994902|156343299|FG001|Test Period 1|Withdrawal by Subject|0|||
48587645|NCT01994902|156343298|FG000|Test Period 1|device deficiency with adverse event|0|||
48486750|NCT00950599|155975675|FG005|Follow-Up Period|Lost to Follow-up|0|||
48486751|NCT00950599|155975676|FG006|Follow-Up Period|Lost to Follow-up|0|||
48486752|NCT00950599|155975677|FG007|Follow-Up Period|Lost to Follow-up|0|||
48486753|NCT00950599|155975678|FG008|Follow-Up Period|Lost to Follow-up|5|||
48486754|NCT00950599|155975679|FG009|Follow-Up Period|Lost to Follow-up|1|||
48486755|NCT00950599|155975670|FG000|Follow-Up Period|Physician Decision|0|||
48486756|NCT00950599|155975671|FG001|Follow-Up Period|Physician Decision|0|||
48486757|NCT00950599|155975672|FG002|Follow-Up Period|Physician Decision|0|||
48486758|NCT00950599|155975673|FG003|Follow-Up Period|Physician Decision|0|||
48486759|NCT00950599|155975674|FG004|Follow-Up Period|Physician Decision|0|||
48486760|NCT00950599|155975675|FG005|Follow-Up Period|Physician Decision|0|||
48486761|NCT00950599|155975676|FG006|Follow-Up Period|Physician Decision|0|||
48486762|NCT00950599|155975677|FG007|Follow-Up Period|Physician Decision|0|||
48486763|NCT00950599|155975678|FG008|Follow-Up Period|Physician Decision|1|||
48486764|NCT00950599|155975679|FG009|Follow-Up Period|Physician Decision|0|||
48486765|NCT00950599|155975670|FG000|Follow-Up Period|Poor/Noncompliance|0|||
48486766|NCT00950599|155975671|FG001|Follow-Up Period|Poor/Noncompliance|0|||
48486767|NCT00950599|155975672|FG002|Follow-Up Period|Poor/Noncompliance|0|||
48486768|NCT00950599|155975673|FG003|Follow-Up Period|Poor/Noncompliance|0|||
48486769|NCT00950599|155975674|FG004|Follow-Up Period|Poor/Noncompliance|0|||
48486770|NCT00950599|155975675|FG005|Follow-Up Period|Poor/Noncompliance|0|||
48486771|NCT00950599|155975676|FG006|Follow-Up Period|Poor/Noncompliance|0|||
48486772|NCT00950599|155975677|FG007|Follow-Up Period|Poor/Noncompliance|0|||
48486773|NCT00950599|155975678|FG008|Follow-Up Period|Poor/Noncompliance|1|||
48486774|NCT00950599|155975679|FG009|Follow-Up Period|Poor/Noncompliance|0|||
48486775|NCT00950599|155975670|FG000|Follow-Up Period|Subject withdrew Consent|0|||
48486776|NCT00950599|155975671|FG001|Follow-Up Period|Subject withdrew Consent|0|||
48486777|NCT00950599|155975672|FG002|Follow-Up Period|Subject withdrew Consent|0|||
48486778|NCT00950599|155975673|FG003|Follow-Up Period|Subject withdrew Consent|0|||
48486779|NCT00950599|155975674|FG004|Follow-Up Period|Subject withdrew Consent|0|||
48486780|NCT00950599|155975675|FG005|Follow-Up Period|Subject withdrew Consent|0|||
48486781|NCT00950599|155975676|FG006|Follow-Up Period|Subject withdrew Consent|0|||
48486782|NCT00950599|155975677|FG007|Follow-Up Period|Subject withdrew Consent|0|||
48486783|NCT00950599|155975678|FG008|Follow-Up Period|Subject withdrew Consent|2|||
48486784|NCT00950599|155975679|FG009|Follow-Up Period|Subject withdrew Consent|1|||
48486785|NCT02482571|155975680|FG000|Overall Study|Adverse Event|1|||
48486786|NCT02482571|155975680|FG000|Overall Study|Scanner or Respiract failure|3|||
48486787|NCT02482571|155975680|FG000|Overall Study|Withdrawal by Subject|4|||
48486788|NCT02268045|155975681|FG000|Overall Study|Death|4|||
48486789|NCT02268045|155975682|FG001|Overall Study|Death|4|||
48486790|NCT02268045|155975681|FG000|Overall Study|Disease Progression|2|||
48486791|NCT02268045|155975682|FG001|Overall Study|Disease Progression|1|||
48486792|NCT02268045|155975681|FG000|Overall Study|Adverse Event|7|||
48486793|NCT02268045|155975682|FG001|Overall Study|Adverse Event|7|||
48486794|NCT02268045|155975681|FG000|Overall Study|Withdrawal by Subject|2|||
48486795|NCT02268045|155975682|FG001|Overall Study|Withdrawal by Subject|6|||
48486796|NCT02268045|155975681|FG000|Overall Study|Physician Decision|0|||
48486797|NCT02268045|155975682|FG001|Overall Study|Physician Decision|1|||
48486798|NCT02268045|155975681|FG000|Overall Study|Protocol Violation|1|||
48486799|NCT02268045|155975682|FG001|Overall Study|Protocol Violation|1|||
48486800|NCT00971204|155975683|FG000|Overall Study|Did not meet all criteria-not treated|14|||
48486801|NCT00971204|155975683|FG000|Overall Study|Lost to Follow-up|10|||
48486802|NCT04130919|155975684|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
48486803|NCT04130919|155975685|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
48486804|NCT04130919|155975686|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
48486805|NCT04130919|155975687|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
48486806|NCT04130919|155975688|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
48486807|NCT04130919|155975689|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
48486808|NCT04130919|155975684|FG000|Blinded Treatment Phase|Adverse Event|0|||
48486809|NCT04130919|155975685|FG001|Blinded Treatment Phase|Adverse Event|0|||
48590222|NCT00908596|156353226|FG002|Overall Study|Other reasons|2|||
48590223|NCT00908596|156353227|FG003|Overall Study|Other reasons|0|||
48486810|NCT04130919|155975686|FG002|Blinded Treatment Phase|Adverse Event|1|||
48486811|NCT04130919|155975687|FG003|Blinded Treatment Phase|Adverse Event|0|||
48486812|NCT04130919|155975688|FG004|Blinded Treatment Phase|Adverse Event|0|||
48486813|NCT04130919|155975689|FG005|Blinded Treatment Phase|Adverse Event|0|||
48486814|NCT04130919|155975684|FG000|Blinded Treatment Phase|Disease worsening|0|||
48486815|NCT04130919|155975685|FG001|Blinded Treatment Phase|Disease worsening|0|||
48486816|NCT04130919|155975686|FG002|Blinded Treatment Phase|Disease worsening|1|||
48486817|NCT04130919|155975687|FG003|Blinded Treatment Phase|Disease worsening|0|||
48590224|NCT00908596|156353224|FG000|Overall Study|Lost to Follow-up|0|||
48590225|NCT00908596|156353225|FG001|Overall Study|Lost to Follow-up|1|||
48486818|NCT04130919|155975688|FG004|Blinded Treatment Phase|Disease worsening|0|||
48486819|NCT04130919|155975689|FG005|Blinded Treatment Phase|Disease worsening|0|||
48486820|NCT04130919|155975684|FG000|Blinded Treatment Phase|Investigator's decision|0|||
48486821|NCT04130919|155975685|FG001|Blinded Treatment Phase|Investigator's decision|1|||
48486822|NCT04130919|155975686|FG002|Blinded Treatment Phase|Investigator's decision|0|||
48486823|NCT04130919|155975687|FG003|Blinded Treatment Phase|Investigator's decision|0|||
48486824|NCT04130919|155975688|FG004|Blinded Treatment Phase|Investigator's decision|0|||
48486825|NCT04130919|155975689|FG005|Blinded Treatment Phase|Investigator's decision|0|||
48486826|NCT04130919|155975684|FG000|Blinded Treatment Phase|Withdrew consent|1|||
48486827|NCT04130919|155975685|FG001|Blinded Treatment Phase|Withdrew consent|0|||
48486828|NCT04130919|155975686|FG002|Blinded Treatment Phase|Withdrew consent|0|||
48486829|NCT04130919|155975687|FG003|Blinded Treatment Phase|Withdrew consent|0|||
48486830|NCT04130919|155975688|FG004|Blinded Treatment Phase|Withdrew consent|0|||
48486831|NCT04130919|155975689|FG005|Blinded Treatment Phase|Withdrew consent|0|||
48486832|NCT04130919|155975684|FG000|Open-label Treatment Phase|Withdrew consent|0|||
48486833|NCT04130919|155975685|FG001|Open-label Treatment Phase|Withdrew consent|0|||
48486834|NCT04130919|155975686|FG002|Open-label Treatment Phase|Withdrew consent|0|||
48486835|NCT04130919|155975687|FG003|Open-label Treatment Phase|Withdrew consent|1|||
48486836|NCT04130919|155975688|FG004|Open-label Treatment Phase|Withdrew consent|1|||
48486837|NCT04130919|155975689|FG005|Open-label Treatment Phase|Withdrew consent|1|||
48486838|NCT04130919|155975684|FG000|Open-label Treatment Phase|Disease worsening|0|||
48486839|NCT04130919|155975685|FG001|Open-label Treatment Phase|Disease worsening|0|||
48486840|NCT04130919|155975686|FG002|Open-label Treatment Phase|Disease worsening|0|||
48486841|NCT04130919|155975687|FG003|Open-label Treatment Phase|Disease worsening|1|||
48486842|NCT04130919|155975688|FG004|Open-label Treatment Phase|Disease worsening|0|||
48486843|NCT04130919|155975689|FG005|Open-label Treatment Phase|Disease worsening|1|||
48486844|NCT04130919|155975684|FG000|Open-label Treatment Phase|Investigator's decision|0|||
48486845|NCT04130919|155975685|FG001|Open-label Treatment Phase|Investigator's decision|0|||
48486846|NCT04130919|155975686|FG002|Open-label Treatment Phase|Investigator's decision|0|||
48486847|NCT04130919|155975687|FG003|Open-label Treatment Phase|Investigator's decision|1|||
48486848|NCT04130919|155975688|FG004|Open-label Treatment Phase|Investigator's decision|0|||
48486849|NCT04130919|155975689|FG005|Open-label Treatment Phase|Investigator's decision|0|||
48486850|NCT04130919|155975684|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
48486851|NCT04130919|155975685|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
48486852|NCT04130919|155975686|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
48486853|NCT04130919|155975687|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
48486854|NCT04130919|155975688|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
48486855|NCT04130919|155975689|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
48486856|NCT04130919|155975684|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
48486857|NCT04130919|155975685|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
48486858|NCT04130919|155975686|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
48486859|NCT04130919|155975687|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
48486860|NCT04130919|155975688|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
48486861|NCT04130919|155975689|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
48486862|NCT00457665|155975690|FG000|12 Months|Drug allergy|1|||
48486863|NCT00457665|155975691|FG001|12 Months|Drug allergy|1|||
48486864|NCT00457665|155975690|FG000|12 Months|High HIV viral load|5|||
48486865|NCT00457665|155975691|FG001|12 Months|High HIV viral load|1|||
48486866|NCT00457665|155975690|FG000|12 Months|Lipodystrophy|2|||
48486867|NCT00457665|155975691|FG001|12 Months|Lipodystrophy|0|||
48486868|NCT00457665|155975690|FG000|12 Months|Withdrawal by Subject|0|||
48486869|NCT00457665|155975691|FG001|12 Months|Withdrawal by Subject|2|||
48486870|NCT00457665|155975690|FG000|12 Months|Abnormal Liver function tests|0|||
48486871|NCT00457665|155975691|FG001|12 Months|Abnormal Liver function tests|5|||
48486872|NCT00457665|155975690|FG000|24 Months|Withdrawal by Subject|3|||
48486873|NCT00457665|155975691|FG001|24 Months|Withdrawal by Subject|2|||
48486874|NCT00457665|155975690|FG000|24 Months|Lipodystrophy|1|||
48486875|NCT00457665|155975691|FG001|24 Months|Lipodystrophy|1|||
48486876|NCT00457665|155975690|FG000|24 Months|Abnormal liver function tests|1|||
48486877|NCT00457665|155975691|FG001|24 Months|Abnormal liver function tests|5|||
48486878|NCT03056352|155975693|FG000|Overall Study|Lost to Follow-up|1|||
48486879|NCT03586830|155975695|FG000|Overall Study|Site terminated by Sponsor|1|||
48486880|NCT03586830|155975696|FG001|Overall Study|Site terminated by Sponsor|4|||
48486881|NCT03586830|155975697|FG002|Overall Study|Site terminated by Sponsor|3|||
48486882|NCT03586830|155975698|FG003|Overall Study|Site terminated by Sponsor|3|||
48486883|NCT03586830|155975695|FG000|Overall Study|Lost to Follow-up|0|||
48486884|NCT03586830|155975696|FG001|Overall Study|Lost to Follow-up|2|||
48486885|NCT03586830|155975697|FG002|Overall Study|Lost to Follow-up|2|||
48486886|NCT03586830|155975698|FG003|Overall Study|Lost to Follow-up|1|||
48486887|NCT03586830|155975695|FG000|Overall Study|Withdrawal by Subject|1|||
48486888|NCT03586830|155975696|FG001|Overall Study|Withdrawal by Subject|0|||
48486889|NCT03586830|155975697|FG002|Overall Study|Withdrawal by Subject|3|||
48486890|NCT03586830|155975698|FG003|Overall Study|Withdrawal by Subject|1|||
48486891|NCT00931385|155975704|FG000|Overall Study|Adverse Event|2|||
48486892|NCT00931385|155975705|FG001|Overall Study|Adverse Event|1|||
48486893|NCT00931385|155975706|FG002|Overall Study|Adverse Event|0|||
48486894|NCT00931385|155975707|FG003|Overall Study|Adverse Event|3|||
48486895|NCT00931385|155975704|FG000|Overall Study|Protocol Violation|0|||
48486896|NCT00931385|155975705|FG001|Overall Study|Protocol Violation|0|||
48486897|NCT00931385|155975706|FG002|Overall Study|Protocol Violation|1|||
48486898|NCT00931385|155975707|FG003|Overall Study|Protocol Violation|0|||
48486899|NCT00931385|155975704|FG000|Overall Study|Withdrawal by Subject|0|||
48486900|NCT00931385|155975705|FG001|Overall Study|Withdrawal by Subject|1|||
48486901|NCT00931385|155975706|FG002|Overall Study|Withdrawal by Subject|0|||
48486902|NCT00931385|155975707|FG003|Overall Study|Withdrawal by Subject|1|||
48486903|NCT00931385|155975704|FG000|Overall Study|Lost to Follow-up|0|||
48486904|NCT00931385|155975705|FG001|Overall Study|Lost to Follow-up|0|||
48486905|NCT00931385|155975706|FG002|Overall Study|Lost to Follow-up|0|||
48486906|NCT00931385|155975707|FG003|Overall Study|Lost to Follow-up|1|||
48486907|NCT02094937|155975711|FG000|8 Weeks in Period 1|Adverse Event|9|||
48486908|NCT02094937|155975712|FG001|8 Weeks in Period 1|Adverse Event|0|||
48486909|NCT02094937|155975713|FG002|8 Weeks in Period 1|Adverse Event|0|||
48486910|NCT02094937|155975714|FG003|8 Weeks in Period 1|Adverse Event|0|||
48486911|NCT02094937|155975711|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
48486912|NCT02094937|155975712|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
48486913|NCT02094937|155975713|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
48486914|NCT02094937|155975714|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
48486915|NCT02094937|155975711|FG000|8 Weeks in Period 1|Protocol Violation|2|||
48486916|NCT02094937|155975712|FG001|8 Weeks in Period 1|Protocol Violation|0|||
48486917|NCT02094937|155975713|FG002|8 Weeks in Period 1|Protocol Violation|0|||
48486918|NCT02094937|155975714|FG003|8 Weeks in Period 1|Protocol Violation|0|||
48486919|NCT02094937|155975711|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
48486920|NCT02094937|155975712|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
48486921|NCT02094937|155975713|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
48486922|NCT02094937|155975714|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
48486923|NCT02094937|155975711|FG000|8 Weeks in Period 1|Physician Decision|1|||
48486924|NCT02094937|155975712|FG001|8 Weeks in Period 1|Physician Decision|0|||
48486925|NCT02094937|155975713|FG002|8 Weeks in Period 1|Physician Decision|0|||
48486926|NCT02094937|155975714|FG003|8 Weeks in Period 1|Physician Decision|0|||
48486927|NCT02094937|155975711|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
48486928|NCT02094937|155975712|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
48486929|NCT02094937|155975713|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
48486930|NCT02094937|155975714|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
48486931|NCT02094937|155975711|FG000|12 Weeks in Period 2|Adverse Event|0|||
48486932|NCT02094937|155975712|FG001|12 Weeks in Period 2|Adverse Event|2|||
48486933|NCT02094937|155975713|FG002|12 Weeks in Period 2|Adverse Event|4|||
48486934|NCT02094937|155975714|FG003|12 Weeks in Period 2|Adverse Event|1|||
48486935|NCT02094937|155975711|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
48486936|NCT02094937|155975712|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
48486937|NCT02094937|155975713|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
48486938|NCT02094937|155975714|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
48486939|NCT02094937|155975711|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
48486940|NCT02094937|155975712|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
48486941|NCT02094937|155975713|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
48486942|NCT02094937|155975714|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
48486943|NCT02094937|155975711|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
48486944|NCT02094937|155975712|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
48486945|NCT02094937|155975713|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
48486946|NCT02094937|155975714|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
48486947|NCT02094937|155975711|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
48486948|NCT02094937|155975712|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
48486949|NCT02094937|155975713|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
48486950|NCT02094937|155975714|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
48486951|NCT01015612|155975721|FG000|Overall Study|Death|113|||
48486952|NCT01015612|155975721|FG000|Overall Study|Withdrawal by Subject|40|||
48486953|NCT02626182|155977441|FG000|Overall Study|Adverse Event|2|||
48486954|NCT02626182|155977442|FG001|Overall Study|Adverse Event|0|||
48486955|NCT03578276|155977443|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
48486956|NCT03578276|155977444|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
48486957|NCT01084603|155977451|FG000|Baseline|Withdrawal by Subject|2|||
48486958|NCT01084603|155977451|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
48486959|NCT01084603|155977451|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
48486960|NCT01084603|155977451|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
48486961|NCT01084603|155977451|FG000|Washout Period 4|Adverse Event|1|||
48486962|NCT00207714|155977452|FG000|Overall Study|Adverse Event|6|||
48486963|NCT00207714|155977453|FG001|Overall Study|Adverse Event|2|||
48486964|NCT00207714|155977454|FG002|Overall Study|Adverse Event|4|||
48486965|NCT00207714|155977455|FG003|Overall Study|Adverse Event|3|||
48486966|NCT00207714|155977456|FG004|Overall Study|Adverse Event|1|||
48486967|NCT00207714|155977452|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
48486968|NCT00207714|155977453|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48486969|NCT00207714|155977454|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
48486970|NCT00207714|155977455|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
48486971|NCT00207714|155977456|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
48486972|NCT00207714|155977452|FG000|Overall Study|Other|3|||
48486973|NCT00207714|155977453|FG001|Overall Study|Other|2|||
48486974|NCT00207714|155977454|FG002|Overall Study|Other|5|||
48486975|NCT00207714|155977455|FG003|Overall Study|Other|1|||
48486976|NCT00207714|155977456|FG004|Overall Study|Other|0|||
48486977|NCT03627195|155977457|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
48486978|NCT03627195|155977458|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
48486979|NCT03627195|155977459|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
48486980|NCT03627195|155977460|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
48486981|NCT03627195|155977461|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
48486982|NCT03627195|155977462|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
48486983|NCT04335110|155977463|FG000|Overall Study|Withdrawal by Subject|1|||
48486984|NCT04335110|155977464|FG001|Overall Study|Withdrawal by Subject|1|||
48486985|NCT04335110|155977463|FG000|Overall Study|Death|0|||
48486986|NCT04335110|155977464|FG001|Overall Study|Death|1|||
48486987|NCT00350519|155977467|FG000|Overall Study|Death|0|||
48486988|NCT00350519|155977468|FG001|Overall Study|Death|1|||
48486989|NCT00350519|155977467|FG000|Overall Study|Physician Decision|0|||
48486990|NCT00350519|155977468|FG001|Overall Study|Physician Decision|1|||
48486991|NCT00350519|155977467|FG000|Overall Study|Protocol Violation|1|||
48486992|NCT00350519|155977468|FG001|Overall Study|Protocol Violation|2|||
48486993|NCT00350519|155977467|FG000|Overall Study|Withdrawal by Subject|3|||
48486994|NCT00350519|155977468|FG001|Overall Study|Withdrawal by Subject|2|||
48486995|NCT00736099|155977472|FG000|Overall Study|Adverse Event|61|||
48486996|NCT00736099|155977473|FG001|Overall Study|Adverse Event|18|||
48486997|NCT00736099|155977472|FG000|Overall Study|Protocol Violation|10|||
48486998|NCT00736099|155977473|FG001|Overall Study|Protocol Violation|4|||
48486999|NCT00736099|155977472|FG000|Overall Study|Lost to Follow-up|12|||
48487000|NCT00736099|155977473|FG001|Overall Study|Lost to Follow-up|5|||
48487001|NCT00736099|155977472|FG000|Overall Study|Withdrawal by Subject|42|||
48487002|NCT00736099|155977473|FG001|Overall Study|Withdrawal by Subject|13|||
48487003|NCT00736099|155977472|FG000|Overall Study|Lack of Efficacy|15|||
48487004|NCT00736099|155977473|FG001|Overall Study|Lack of Efficacy|8|||
48487005|NCT00736099|155977472|FG000|Overall Study|Other reason|43|||
48487006|NCT00736099|155977473|FG001|Overall Study|Other reason|10|||
48487007|NCT01165242|155977474|FG000|Overall Study|Unreachable Subjects|1|||
48487008|NCT01165242|155977475|FG001|Overall Study|Unreachable Subjects|0|||
48487009|NCT01165242|155977476|FG002|Overall Study|Unreachable Subjects|0|||
48487010|NCT01165242|155977474|FG000|Overall Study|Incarcerated Subjects|0|||
48487011|NCT01165242|155977475|FG001|Overall Study|Incarcerated Subjects|1|||
48487012|NCT01165242|155977476|FG002|Overall Study|Incarcerated Subjects|0|||
48487013|NCT01165242|155977474|FG000|Overall Study|Visit 2 Declined by Subject|0|||
48487014|NCT01165242|155977475|FG001|Overall Study|Visit 2 Declined by Subject|0|||
48487015|NCT01165242|155977476|FG002|Overall Study|Visit 2 Declined by Subject|1|||
48487016|NCT01165242|155977474|FG000|Overall Study|Withdrawal by Subject|0|||
48487017|NCT01165242|155977475|FG001|Overall Study|Withdrawal by Subject|2|||
48487018|NCT01165242|155977476|FG002|Overall Study|Withdrawal by Subject|2|||
48487019|NCT01165242|155977474|FG000|Overall Study|Extended Holiday|0|||
48487020|NCT01165242|155977475|FG001|Overall Study|Extended Holiday|0|||
48487021|NCT01165242|155977476|FG002|Overall Study|Extended Holiday|1|||
48487022|NCT01165242|155977474|FG000|Overall Study|Lost to Follow-up|9|||
48487023|NCT01165242|155977475|FG001|Overall Study|Lost to Follow-up|7|||
48487024|NCT01165242|155977476|FG002|Overall Study|Lost to Follow-up|10|||
48487025|NCT03770000|155977480|FG000|Overall Study|Premature discontinuation due to PD|0|||
48487026|NCT03770000|155977481|FG001|Overall Study|Premature discontinuation due to PD|0|||
48487027|NCT03770000|155977482|FG002|Overall Study|Premature discontinuation due to PD|1|||
48487028|NCT03770000|155977483|FG003|Overall Study|Premature discontinuation due to PD|3|||
48487029|NCT03770000|155977484|FG004|Overall Study|Premature discontinuation due to PD|2|||
48487030|NCT03877237|155977485|FG000|Overall Study|Adverse Event|1|||
48487031|NCT03877237|155977486|FG001|Overall Study|Adverse Event|2|||
48487032|NCT03877237|155977485|FG000|Overall Study|Death|3|||
48487033|NCT03877237|155977486|FG001|Overall Study|Death|2|||
48487034|NCT03877237|155977485|FG000|Overall Study|Physician Decision|1|||
48487035|NCT03877237|155977486|FG001|Overall Study|Physician Decision|0|||
48487036|NCT03877237|155977485|FG000|Overall Study|Withdrawal by Subject|0|||
48487037|NCT03877237|155977486|FG001|Overall Study|Withdrawal by Subject|2|||
48487038|NCT02766088|155977487|FG000|Overall Study|Sponsor study termination|498|||
48487039|NCT02766088|155977487|FG000|Overall Study|Migrated/moved from the study area|1|||
48487040|NCT02766088|155977487|FG000|Overall Study|Lost to Follow-up|5|||
48487041|NCT02766088|155977487|FG000|Overall Study|Other|1|||
48487042|NCT02766088|155977487|FG000|Overall Study|Death|1|||
48487043|NCT01222715|155977488|FG000|Overall Study|Adverse Event|0|||
48487044|NCT01222715|155977489|FG001|Overall Study|Adverse Event|4|||
48487045|NCT01222715|155977488|FG000|Overall Study|Death|0|||
48487046|NCT01222715|155977489|FG001|Overall Study|Death|1|||
48487047|NCT01222715|155977488|FG000|Overall Study|Lack of Efficacy|22|||
48487048|NCT01222715|155977489|FG001|Overall Study|Lack of Efficacy|14|||
48487049|NCT01222715|155977488|FG000|Overall Study|Physician Decision|12|||
48487050|NCT01222715|155977489|FG001|Overall Study|Physician Decision|2|||
48487051|NCT01222715|155977488|FG000|Overall Study|Refusal of further protocol therapy|0|||
48487052|NCT01222715|155977489|FG001|Overall Study|Refusal of further protocol therapy|4|||
48487053|NCT01222715|155977488|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
48487054|NCT01222715|155977489|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
48487055|NCT01222715|155977488|FG000|Overall Study|Ineligible|0|||
48487056|NCT01222715|155977489|FG001|Overall Study|Ineligible|1|||
48487057|NCT01222715|155977488|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
48487058|NCT01222715|155977489|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
48487059|NCT00096382|155977494|FG000|Overall Study|Not treated|1|||
48487060|NCT00096382|155977495|FG001|Overall Study|Not treated|0|||
48487061|NCT00096382|155977494|FG000|Overall Study|Death during treatment|1|||
48487062|NCT00096382|155977495|FG001|Overall Study|Death during treatment|0|||
48487063|NCT03836729|155977496|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
48487064|NCT00948025|155977498|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
48487065|NCT00948025|155977499|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
48487066|NCT00948025|155977498|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
48487067|NCT00948025|155977499|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
48487068|NCT00948025|155977498|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
48487069|NCT00948025|155977499|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
48487070|NCT01537549|155977500|FG000|Overall Study|Lost to Follow-up|1|||
48487071|NCT01537549|155977500|FG000|Overall Study|Withdrawal by Subject|2|||
48487072|NCT01637961|155977501|FG000|Overall Study|Ineligible: wrong primary|1|||
48487073|NCT01637961|155977501|FG000|Overall Study|Ineligible: inadequate pathology|1|||
48487074|NCT02236754|155977504|FG000|Overall Study|Withdrawal by Subject|1|||
48487075|NCT02236754|155977505|FG001|Overall Study|Withdrawal by Subject|0|||
48487076|NCT04006847|155977506|FG000|Overall Study|Product issue|1|||
48487077|NCT03101293|155977510|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
48487078|NCT03101293|155977511|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
48487079|NCT02614703|155977517|FG000|Overall Study|Withdrawal by Subject|7|||
48487080|NCT02614703|155977518|FG001|Overall Study|Withdrawal by Subject|1|||
48487081|NCT01977352|155977519|FG000|Overall Study|Lost to Follow-up|1|||
48487082|NCT01977352|155977520|FG001|Overall Study|Lost to Follow-up|2|||
48487083|NCT02410837|155977523|FG000|Overall Study|Death|387|||
48487084|NCT02410837|155977523|FG000|Overall Study|Lost to Follow-up|50|||
48487085|NCT02410837|155977523|FG000|Overall Study|Withdrawal by Subject|44|||
48487086|NCT02410837|155977523|FG000|Overall Study|Physician Decision|6|||
48487087|NCT02410837|155977523|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
48487088|NCT02624518|155977527|FG000|Overall Study|Physician Decision|1|||
48487089|NCT00845026|155977530|FG000|Study Period III|Adverse Event|23|||
48487090|NCT00845026|155977531|FG001|Study Period III|Adverse Event|19|||
48487091|NCT00845026|155977530|FG000|Study Period III|Perceived lack of efficacy|27|||
48487092|NCT00845026|155977531|FG001|Study Period III|Perceived lack of efficacy|15|||
48487093|NCT00845026|155977530|FG000|Study Period III|Withdrawal by Subject|19|||
48487094|NCT00845026|155977531|FG001|Study Period III|Withdrawal by Subject|15|||
48487095|NCT00845026|155977530|FG000|Study Period III|Entry Criteria not met|8|||
48487096|NCT00845026|155977531|FG001|Study Period III|Entry Criteria not met|11|||
48487097|NCT00845026|155977530|FG000|Study Period III|Lost to Follow-up|4|||
48487098|NCT00845026|155977531|FG001|Study Period III|Lost to Follow-up|5|||
48487099|NCT00845026|155977530|FG000|Study Period III|Protocol Violation|8|||
48487100|NCT00845026|155977531|FG001|Study Period III|Protocol Violation|1|||
48487101|NCT00845026|155977530|FG000|Study Period III|Scheduled conflict|3|||
48487102|NCT00845026|155977531|FG001|Study Period III|Scheduled conflict|1|||
48487103|NCT00845026|155977530|FG000|Study Period III|Subject is moving or has moved|2|||
48487104|NCT00845026|155977531|FG001|Study Period III|Subject is moving or has moved|4|||
48487105|NCT00845026|155977530|FG000|Study Period III|Transportation issues|1|||
48487106|NCT00845026|155977531|FG001|Study Period III|Transportation issues|1|||
48487107|NCT00845026|155977530|FG000|Study Period IV|Adverse Event|4|||
48487108|NCT00845026|155977531|FG001|Study Period IV|Adverse Event|0|||
48487109|NCT00845026|155977530|FG000|Study Period IV|Perceived lack of efficacy|2|||
48487110|NCT00845026|155977531|FG001|Study Period IV|Perceived lack of efficacy|1|||
48487111|NCT00845026|155977530|FG000|Study Period IV|Protocol Violation|3|||
48487112|NCT00845026|155977531|FG001|Study Period IV|Protocol Violation|1|||
48487113|NCT00845026|155977530|FG000|Study Period IV|Lost to Follow-up|1|||
48487114|NCT00845026|155977531|FG001|Study Period IV|Lost to Follow-up|0|||
48487115|NCT00845026|155977530|FG000|Study Period IV|Withdrawal by Subject|4|||
48487116|NCT00845026|155977531|FG001|Study Period IV|Withdrawal by Subject|1|||
48487117|NCT00845026|155977530|FG000|Study Period IV|Entry Criteria Not Met|1|||
48487118|NCT00845026|155977531|FG001|Study Period IV|Entry Criteria Not Met|0|||
48487119|NCT00845026|155977530|FG000|Study Period IV|Subject is moving or has moved|0|||
48487120|NCT00845026|155977531|FG001|Study Period IV|Subject is moving or has moved|1|||
48487121|NCT00845026|155977530|FG000|Study Period IV|Scheduling conflict|1|||
48487122|NCT00845026|155977531|FG001|Study Period IV|Scheduling conflict|0|||
48487123|NCT00370396|155977534|FG000|Overall Study|Withdrawal by Subject|0|||
48487124|NCT00370396|155977535|FG001|Overall Study|Withdrawal by Subject|0|||
48487125|NCT00370396|155977536|FG002|Overall Study|Withdrawal by Subject|1|||
48487126|NCT00370396|155977534|FG000|Overall Study|Lost to Follow-up|11|||
48487127|NCT00370396|155977535|FG001|Overall Study|Lost to Follow-up|1|||
48487128|NCT00370396|155977536|FG002|Overall Study|Lost to Follow-up|0|||
48487129|NCT01325532|155977540|FG000|Overall Study|Withdrawal by Subject|2|||
48487130|NCT01325532|155977541|FG001|Overall Study|Withdrawal by Subject|0|||
48487131|NCT03012815|155977542|FG000|Overall Study|Lost to Follow-up|1|||
48487132|NCT03012815|155977543|FG001|Overall Study|Lost to Follow-up|0|||
48487133|NCT03012815|155977542|FG000|Overall Study|Physician Decision|3|||
48487134|NCT03012815|155977543|FG001|Overall Study|Physician Decision|2|||
48487135|NCT03012815|155977542|FG000|Overall Study|Adverse Event|1|||
48487136|NCT03012815|155977543|FG001|Overall Study|Adverse Event|0|||
48487137|NCT01252238|155977546|FG000|Overall Study|Sponsor terminated study|4|||
48487138|NCT01252238|155977547|FG001|Overall Study|Sponsor terminated study|4|||
48487139|NCT01252238|155977548|FG002|Overall Study|Sponsor terminated study|4|||
48487140|NCT02065791|155977549|FG000|Overall Study|Closed Site|1|||
48487141|NCT02065791|155977550|FG001|Overall Study|Closed Site|1|||
48487142|NCT02065791|155977549|FG000|Overall Study|Withdrawal by Subject|11|||
48487143|NCT02065791|155977550|FG001|Overall Study|Withdrawal by Subject|5|||
48487144|NCT02065791|155977549|FG000|Overall Study|Lost to Follow-up|13|||
48487145|NCT02065791|155977550|FG001|Overall Study|Lost to Follow-up|9|||
48487146|NCT01401478|155977552|FG000|Overall Study|Study drug not available|6|||
48487147|NCT01401478|155977552|FG000|Overall Study|Adverse Event|5|||
48487148|NCT01401478|155977552|FG000|Overall Study|Hyperphosphatemia|5|||
48487149|NCT01401478|155977552|FG000|Overall Study|Lost to Follow-up|5|||
48487150|NCT01401478|155977552|FG000|Overall Study|Kidney transplantation|3|||
48487151|NCT01401478|155977552|FG000|Overall Study|Withdrawal by Subject|3|||
48487152|NCT01401478|155977552|FG000|Overall Study|Blood samples not available|1|||
48487153|NCT01401478|155977552|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
48487154|NCT01401478|155977552|FG000|Overall Study|Low intact parathyroid hormone|1|||
48487155|NCT01401478|155977552|FG000|Overall Study|Serious adverse event|1|||
48487156|NCT02868281|155977553|FG000|Overall Study|Adverse Event|2|||
48487157|NCT02868281|155977554|FG001|Overall Study|Adverse Event|2|||
48487158|NCT02868281|155977553|FG000|Overall Study|Protocol Violation|13|||
48487159|NCT02868281|155977554|FG001|Overall Study|Protocol Violation|10|||
48487160|NCT02868281|155977553|FG000|Overall Study|Lost to Follow-up|3|||
48487161|NCT02868281|155977554|FG001|Overall Study|Lost to Follow-up|6|||
48487162|NCT02868281|155977553|FG000|Overall Study|Withdrawal by Subject|11|||
48487163|NCT02868281|155977554|FG001|Overall Study|Withdrawal by Subject|15|||
48487164|NCT02868281|155977553|FG000|Overall Study|Physician Decision|2|||
48487165|NCT02868281|155977554|FG001|Overall Study|Physician Decision|0|||
48487166|NCT02868281|155977553|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
48487167|NCT02868281|155977554|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
48487168|NCT02868281|155977553|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
48487169|NCT02868281|155977554|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
48487170|NCT02868281|155977553|FG000|Overall Study|Long journey/moving away|1|||
48487171|NCT02868281|155977554|FG001|Overall Study|Long journey/moving away|1|||
48487172|NCT01335464|155977559|FG000|Overall Study|Adverse Event|15|||
48487173|NCT01335464|155977560|FG001|Overall Study|Adverse Event|25|||
48487174|NCT01335464|155977559|FG000|Overall Study|Non compliant with protocol|2|||
48487175|NCT01335464|155977560|FG001|Overall Study|Non compliant with protocol|0|||
48487176|NCT01335464|155977559|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
48487177|NCT01335464|155977560|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
48487178|NCT01335464|155977559|FG000|Overall Study|Not treated|2|||
48487179|NCT01335464|155977560|FG001|Overall Study|Not treated|0|||
48487180|NCT01335464|155977559|FG000|Overall Study|Reason other than those stated above|1|||
48487181|NCT01335464|155977560|FG001|Overall Study|Reason other than those stated above|1|||
48487182|NCT01021137|155977561|FG000|Overall Study|Lost to Follow-up|9|||
48487183|NCT01021137|155977562|FG001|Overall Study|Lost to Follow-up|4|||
48487184|NCT01021137|155977563|FG002|Overall Study|Lost to Follow-up|2|||
48487185|NCT01021137|155977564|FG003|Overall Study|Lost to Follow-up|6|||
48487186|NCT01021137|155977561|FG000|Overall Study|Withdrawal by Subject|1|||
48487187|NCT01021137|155977562|FG001|Overall Study|Withdrawal by Subject|0|||
48487188|NCT01021137|155977563|FG002|Overall Study|Withdrawal by Subject|0|||
48487189|NCT01021137|155977564|FG003|Overall Study|Withdrawal by Subject|3|||
48487190|NCT03156270|155977567|FG000|Overall Study|Failed pre-treatment screening|1|||
48487191|NCT03156270|155977567|FG000|Overall Study|Lost to Follow-up|1|||
48487192|NCT03077828|155977568|FG000|Treatment Cycles|Death|1|||
48487193|NCT03077828|155977568|FG000|Treatment Cycles|Withdrawal by Subject|1|||
48487194|NCT03077828|155977568|FG000|Treatment Cycles|Screen Fail|2|||
48487195|NCT03077828|155977568|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
48487196|NCT03077828|155977568|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
48487197|NCT03077828|155977568|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
48587719|NCT01870297|156344744|FG003|Overall Study|Adverse Event|0|||
48590226|NCT00908596|156353226|FG002|Overall Study|Lost to Follow-up|12|||
48590227|NCT00908596|156353227|FG003|Overall Study|Lost to Follow-up|4|||
48590228|NCT00908596|156353224|FG000|Overall Study|Death|0|||
48590229|NCT00908596|156353225|FG001|Overall Study|Death|5|||
48590230|NCT00908596|156353226|FG002|Overall Study|Death|57|||
48590231|NCT00908596|156353227|FG003|Overall Study|Death|32|||
48590232|NCT00908596|156353224|FG000|Overall Study|Protocol Violation|1|||
48590233|NCT00908596|156353225|FG001|Overall Study|Protocol Violation|0|||
48590234|NCT00908596|156353226|FG002|Overall Study|Protocol Violation|0|||
48590235|NCT00908596|156353227|FG003|Overall Study|Protocol Violation|0|||
48590236|NCT00908596|156353224|FG000|Overall Study|Withdrawal by Subject|0|||
48590237|NCT00908596|156353225|FG001|Overall Study|Withdrawal by Subject|1|||
48590238|NCT00908596|156353226|FG002|Overall Study|Withdrawal by Subject|3|||
48590239|NCT00908596|156353227|FG003|Overall Study|Withdrawal by Subject|1|||
48590240|NCT02570750|156353231|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
48590241|NCT02570750|156353232|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
48590242|NCT02570750|156353231|FG000|Overall Study|Protocol deviation|4|||
48590243|NCT02570750|156353232|FG001|Overall Study|Protocol deviation|2|||
48590244|NCT02570750|156353231|FG000|Overall Study|Withdrawal by Subject|5|||
48590245|NCT02570750|156353232|FG001|Overall Study|Withdrawal by Subject|0|||
48590246|NCT02570750|156353231|FG000|Overall Study|Lost to Follow-up|2|||
48590247|NCT02570750|156353232|FG001|Overall Study|Lost to Follow-up|2|||
48590248|NCT02570750|156353231|FG000|Overall Study|Adverse Event|2|||
48487198|NCT03077828|155977568|FG000|Follow-up|Patients still in follow-up|15|||
48487199|NCT03493698|155977569|FG000|Treatment Period C|Adverse Event|1|||
48487200|NCT03493698|155977569|FG000|Treatment Period C|Withdrawal by Subject|1|||
48487201|NCT02629965|155977570|FG000|Period 1|Adverse Event|1|||
48487202|NCT02629965|155977571|FG001|Period 1|Adverse Event|0|||
48487203|NCT02629965|155977570|FG000|Period 1|Unexpected worsening of disease|2|||
48487204|NCT02629965|155977571|FG001|Period 1|Unexpected worsening of disease|0|||
48487205|NCT02629965|155977570|FG000|Period 1|Other than listed above|1|||
48487206|NCT02629965|155977571|FG001|Period 1|Other than listed above|2|||
48487207|NCT02629965|155977570|FG000|Period 2|Adverse Event|1|||
48487208|NCT02629965|155977571|FG001|Period 2|Adverse Event|0|||
48487209|NCT01360632|155977572|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
48487210|NCT01360632|155977573|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
48487211|NCT01360632|155977574|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
48487212|NCT01360632|155977575|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
48487213|NCT01360632|155977576|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
48487214|NCT01360632|155977572|FG000|Phase A (8 Weeks)|Adverse Event|60|||
48487215|NCT01360632|155977573|FG001|Phase A (8 Weeks)|Adverse Event|0|||
48487216|NCT01360632|155977574|FG002|Phase A (8 Weeks)|Adverse Event|0|||
48487217|NCT01360632|155977575|FG003|Phase A (8 Weeks)|Adverse Event|0|||
48487218|NCT01360632|155977576|FG004|Phase A (8 Weeks)|Adverse Event|0|||
48487219|NCT01360632|155977572|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
48487220|NCT01360632|155977573|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
48487221|NCT01360632|155977574|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
48487222|NCT01360632|155977575|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
48487223|NCT01360632|155977576|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
48487224|NCT01360632|155977572|FG000|Phase A (8 Weeks)|Physician Decision|10|||
48487225|NCT01360632|155977573|FG001|Phase A (8 Weeks)|Physician Decision|0|||
48487226|NCT01360632|155977574|FG002|Phase A (8 Weeks)|Physician Decision|0|||
48487227|NCT01360632|155977575|FG003|Phase A (8 Weeks)|Physician Decision|0|||
48487228|NCT01360632|155977576|FG004|Phase A (8 Weeks)|Physician Decision|0|||
48487229|NCT01360632|155977572|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
48487230|NCT01360632|155977573|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
48487231|NCT01360632|155977574|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
48487232|NCT01360632|155977575|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
48487233|NCT01360632|155977576|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
48487234|NCT01360632|155977572|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
48487235|NCT01360632|155977573|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
48487236|NCT01360632|155977574|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
48487237|NCT01360632|155977575|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
48487238|NCT01360632|155977576|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
48487239|NCT01360632|155977572|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
48487240|NCT01360632|155977573|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
48487241|NCT01360632|155977574|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
48487242|NCT01360632|155977575|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
48487243|NCT01360632|155977576|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
48487244|NCT01360632|155977572|FG000|Phase B (6 Weeks)|Adverse Event|0|||
48487245|NCT01360632|155977573|FG001|Phase B (6 Weeks)|Adverse Event|3|||
48487246|NCT01360632|155977574|FG002|Phase B (6 Weeks)|Adverse Event|9|||
48590249|NCT02570750|156353232|FG001|Overall Study|Adverse Event|1|||
48590250|NCT01125813|156353234|FG000|Overall Study|Death|1|||
48590251|NCT01125813|156353234|FG000|Overall Study|Withdrawal by Subject|1|||
48590252|NCT01125813|156353234|FG000|Overall Study|Screen Failures|4|||
48487247|NCT01360632|155977575|FG003|Phase B (6 Weeks)|Adverse Event|3|||
48590253|NCT04165135|156353235|FG000|Overall Study|Protocol Violation|10|||
48487248|NCT01360632|155977576|FG004|Phase B (6 Weeks)|Adverse Event|0|||
48487249|NCT01360632|155977572|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
48487250|NCT01360632|155977573|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
48487251|NCT01360632|155977574|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
48487252|NCT01360632|155977575|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
48487253|NCT01360632|155977576|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
48487254|NCT01360632|155977572|FG000|Phase B (6 Weeks)|Physician Decision|0|||
48487255|NCT01360632|155977573|FG001|Phase B (6 Weeks)|Physician Decision|0|||
48487256|NCT01360632|155977574|FG002|Phase B (6 Weeks)|Physician Decision|0|||
48487257|NCT01360632|155977575|FG003|Phase B (6 Weeks)|Physician Decision|1|||
48487258|NCT01360632|155977576|FG004|Phase B (6 Weeks)|Physician Decision|0|||
48487259|NCT01360632|155977572|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
48487260|NCT01360632|155977573|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
48487261|NCT01360632|155977574|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
48487262|NCT01360632|155977575|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
48487263|NCT01360632|155977576|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
48487264|NCT01360632|155977572|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
48487265|NCT01360632|155977573|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
48487266|NCT01360632|155977574|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
48487267|NCT01360632|155977575|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
48487268|NCT01360632|155977576|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
48487269|NCT01360632|155977572|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
48487270|NCT01360632|155977573|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
48487271|NCT01360632|155977574|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
48487272|NCT01360632|155977575|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
48487273|NCT01360632|155977576|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
48487274|NCT01360632|155977572|FG000|Phase A+|Lost to Follow-up|0|||
48487275|NCT01360632|155977573|FG001|Phase A+|Lost to Follow-up|0|||
48487276|NCT01360632|155977574|FG002|Phase A+|Lost to Follow-up|0|||
48487277|NCT01360632|155977575|FG003|Phase A+|Lost to Follow-up|0|||
48487278|NCT01360632|155977576|FG004|Phase A+|Lost to Follow-up|2|||
48487279|NCT01360632|155977572|FG000|Phase A+|Adverse Event|0|||
48487280|NCT01360632|155977573|FG001|Phase A+|Adverse Event|0|||
48487281|NCT01360632|155977574|FG002|Phase A+|Adverse Event|0|||
48487282|NCT01360632|155977575|FG003|Phase A+|Adverse Event|0|||
48487283|NCT01360632|155977576|FG004|Phase A+|Adverse Event|2|||
48487284|NCT01360632|155977572|FG000|Phase A+|Met Withdrawal Criteria|0|||
48487285|NCT01360632|155977573|FG001|Phase A+|Met Withdrawal Criteria|0|||
48487286|NCT01360632|155977574|FG002|Phase A+|Met Withdrawal Criteria|0|||
48487287|NCT01360632|155977575|FG003|Phase A+|Met Withdrawal Criteria|0|||
48487288|NCT01360632|155977576|FG004|Phase A+|Met Withdrawal Criteria|7|||
48487289|NCT01360632|155977572|FG000|Phase A+|Physician Decision|0|||
48487290|NCT01360632|155977573|FG001|Phase A+|Physician Decision|0|||
48487291|NCT01360632|155977574|FG002|Phase A+|Physician Decision|0|||
48487292|NCT01360632|155977575|FG003|Phase A+|Physician Decision|0|||
48487293|NCT01360632|155977576|FG004|Phase A+|Physician Decision|3|||
48487294|NCT01360632|155977572|FG000|Phase A+|Withdrawal by Subject|0|||
48487295|NCT01360632|155977573|FG001|Phase A+|Withdrawal by Subject|0|||
48487296|NCT01360632|155977574|FG002|Phase A+|Withdrawal by Subject|0|||
48487297|NCT01360632|155977575|FG003|Phase A+|Withdrawal by Subject|0|||
48487298|NCT01360632|155977576|FG004|Phase A+|Withdrawal by Subject|8|||
48487299|NCT01360632|155977572|FG000|Phase A+|Protocol Deviation|0|||
48487300|NCT01360632|155977573|FG001|Phase A+|Protocol Deviation|0|||
48487301|NCT01360632|155977574|FG002|Phase A+|Protocol Deviation|0|||
48487302|NCT01360632|155977575|FG003|Phase A+|Protocol Deviation|0|||
48487303|NCT01360632|155977576|FG004|Phase A+|Protocol Deviation|3|||
48487304|NCT02230085|155977577|FG000|Overall Study|Physician Decision|1|||
48487305|NCT02230085|155977577|FG000|Overall Study|Withdrawal by Subject|3|||
48487306|NCT03083132|155977583|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
48487307|NCT03083132|155977584|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
48487308|NCT03083132|155977583|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
48487309|NCT03083132|155977584|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
48487310|NCT03083132|155977583|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
48487311|NCT03083132|155977584|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
48487312|NCT02595528|155978911|FG000|Overall Study|Withdrawal by Subject|1|||
48487313|NCT02595528|155978912|FG001|Overall Study|Withdrawal by Subject|2|||
48487314|NCT02595528|155978913|FG002|Overall Study|Withdrawal by Subject|1|||
48487315|NCT02595528|155978914|FG003|Overall Study|Withdrawal by Subject|3|||
48487316|NCT02595528|155978911|FG000|Overall Study|Lost to Follow-up|1|||
48487317|NCT02595528|155978912|FG001|Overall Study|Lost to Follow-up|1|||
48487318|NCT02595528|155978913|FG002|Overall Study|Lost to Follow-up|0|||
48487319|NCT02595528|155978914|FG003|Overall Study|Lost to Follow-up|1|||
48487320|NCT02290028|155978915|FG000|Overall Study|Death|217|||
48487321|NCT02290028|155978915|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
48487322|NCT02290028|155978915|FG000|Overall Study|No longer under care of study physician|76|||
48487323|NCT02290028|155978915|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
48487324|NCT02290028|155978915|FG000|Overall Study|Withdrawal by Subject|52|||
48487325|NCT02290028|155978915|FG000|Overall Study|Study site closure|44|||
48487326|NCT02290028|155978915|FG000|Overall Study|Lost to Follow-up|34|||
48487327|NCT02290028|155978915|FG000|Overall Study|Miscellaneous|10|||
48487328|NCT02290028|155978915|FG000|Overall Study|Transition to EP PASSION|1295|||
48487329|NCT02290028|155978915|FG000|Overall Study|Planned study completion at 12 months|257|||
48487330|NCT02360397|155978916|FG000|Overall Study|Incomplete screening|3|||
48487331|NCT02360397|155978916|FG000|Overall Study|Adverse Event|1|||
48487332|NCT03372083|155978917|FG000|Overall Study|Adverse Event|3|||
48487333|NCT03372083|155978917|FG000|Overall Study|Physician Decision|1|||
48487334|NCT03372083|155978917|FG000|Overall Study|Withdrawal by Subject|1|||
48487335|NCT03202511|155978918|FG000|Overall Study|Withdrawal by Subject|1|||
48590254|NCT04165135|156353235|FG000|Overall Study|Participants withdrawal of consent|5|||
48590255|NCT00530790|156353236|FG000|Overall Study|Adverse Event|2|||
48590256|NCT00530790|156353236|FG000|Overall Study|Withdrawal by Subject|2|||
48590257|NCT00530790|156353236|FG000|Overall Study|Physician Decision|1|||
48590258|NCT02003924|156353245|FG000|Double-blind Phase|Lost to Follow-up|2|||
48590259|NCT02003924|156353246|FG001|Double-blind Phase|Lost to Follow-up|1|||
48590260|NCT02003924|156353247|FG002|Double-blind Phase|Lost to Follow-up|0|||
48590261|NCT02003924|156353245|FG000|Double-blind Phase|Protocol Violation|1|||
48590262|NCT02003924|156353246|FG001|Double-blind Phase|Protocol Violation|2|||
48590263|NCT02003924|156353247|FG002|Double-blind Phase|Protocol Violation|0|||
48590264|NCT02003924|156353245|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
48590265|NCT02003924|156353246|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
48487336|NCT03202511|155978919|FG001|Overall Study|Withdrawal by Subject|0|||
48487337|NCT00833547|155978920|FG000|Overall Study|Withdrawal by Subject|2|||
48487338|NCT00833547|155978921|FG001|Overall Study|Withdrawal by Subject|2|||
48487339|NCT00566098|155978925|FG000|Collection of MILs|Withdrawal by Subject|1|||
48487340|NCT00566098|155978925|FG000|Collection of MILs|Relapsed|1|||
48487341|NCT00566098|155978925|FG000|Generation of MILs Product|Relapsed|1|||
48487342|NCT00566098|155978925|FG000|Administration of ASCT+MILs|Death|10|||
48487343|NCT00566098|155978925|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
48487344|NCT01991977|155978926|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
48487345|NCT01991977|155978926|FG000|Overall Study|Withdrew after start of treatment|5|||
48487346|NCT00686790|155978927|FG000|Overall Study|Adverse Event|2|||
48487347|NCT00686790|155978927|FG000|Overall Study|Withdrawal by Subject|1|||
48487348|NCT00686790|155978927|FG000|Overall Study|Death|1|||
48487349|NCT00686790|155978927|FG000|Overall Study|Lost to Follow-up|12|||
48487350|NCT01690520|155978928|FG000|Overall Study|Death|25|||
48487351|NCT01690520|155978929|FG001|Overall Study|Death|21|||
48487352|NCT01690520|155978928|FG000|Overall Study|Lost to Follow-up|2|||
48487353|NCT01690520|155978929|FG001|Overall Study|Lost to Follow-up|3|||
48487354|NCT01690520|155978928|FG000|Overall Study|Withdrawal by Subject|2|||
48487355|NCT01690520|155978929|FG001|Overall Study|Withdrawal by Subject|0|||
48487356|NCT01690520|155978928|FG000|Overall Study|Relapse|0|||
48487357|NCT01690520|155978929|FG001|Overall Study|Relapse|1|||
48487358|NCT01690520|155978928|FG000|Overall Study|Other|0|||
48487359|NCT01690520|155978929|FG001|Overall Study|Other|1|||
48487360|NCT01690520|155978928|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
48487361|NCT01690520|155978929|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
48487362|NCT00382291|155978930|FG000|Overall Study|Adverse Event|1|||
48487363|NCT00382291|155978931|FG001|Overall Study|Adverse Event|2|||
48487364|NCT00382291|155978932|FG002|Overall Study|Adverse Event|2|||
48487365|NCT00382291|155978930|FG000|Overall Study|Protocol Violation|1|||
48487366|NCT00382291|155978931|FG001|Overall Study|Protocol Violation|0|||
48487367|NCT00382291|155978932|FG002|Overall Study|Protocol Violation|0|||
48487368|NCT00382291|155978930|FG000|Overall Study|Temporary study suspension|2|||
48590266|NCT02003924|156353247|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
48590267|NCT02003924|156353245|FG000|Double-blind Phase|Disease Progression|229|||
48590268|NCT02003924|156353246|FG001|Double-blind Phase|Disease Progression|247|||
48590269|NCT02003924|156353247|FG002|Double-blind Phase|Disease Progression|0|||
48487369|NCT00382291|155978931|FG001|Overall Study|Temporary study suspension|2|||
48590270|NCT02003924|156353245|FG000|Double-blind Phase|Adverse Event|120|||
48590271|NCT02003924|156353246|FG001|Double-blind Phase|Adverse Event|31|||
48487370|NCT00382291|155978932|FG002|Overall Study|Temporary study suspension|5|||
48487371|NCT00382291|155978930|FG000|Overall Study|Withdrawal by Subject|0|||
48487372|NCT00382291|155978931|FG001|Overall Study|Withdrawal by Subject|2|||
48487373|NCT00382291|155978932|FG002|Overall Study|Withdrawal by Subject|0|||
48487374|NCT00382291|155978930|FG000|Overall Study|Physician Decision|0|||
48487375|NCT00382291|155978931|FG001|Overall Study|Physician Decision|1|||
48487376|NCT00382291|155978932|FG002|Overall Study|Physician Decision|0|||
48487377|NCT00382291|155978930|FG000|Overall Study|Lack of Efficacy|0|||
48487378|NCT00382291|155978931|FG001|Overall Study|Lack of Efficacy|0|||
48487379|NCT00382291|155978932|FG002|Overall Study|Lack of Efficacy|1|||
48487380|NCT02266706|155978933|FG000|Overall Study|Withdrawal by Subject|0|||
48487381|NCT02266706|155978934|FG001|Overall Study|Withdrawal by Subject|1|||
48487382|NCT02266706|155978935|FG002|Overall Study|Withdrawal by Subject|1|||
48487383|NCT02266706|155978936|FG003|Overall Study|Withdrawal by Subject|0|||
48487384|NCT02266706|155978937|FG004|Overall Study|Withdrawal by Subject|0|||
48487385|NCT02266706|155978938|FG005|Overall Study|Withdrawal by Subject|1|||
48487386|NCT02266706|155978939|FG006|Overall Study|Withdrawal by Subject|0|||
48487387|NCT02266706|155978940|FG007|Overall Study|Withdrawal by Subject|0|||
48487388|NCT02266706|155978941|FG008|Overall Study|Withdrawal by Subject|0|||
48487389|NCT02266706|155978933|FG000|Overall Study|Screen failure|0|||
48487390|NCT02266706|155978934|FG001|Overall Study|Screen failure|0|||
48487391|NCT02266706|155978935|FG002|Overall Study|Screen failure|0|||
48487392|NCT02266706|155978936|FG003|Overall Study|Screen failure|0|||
48487393|NCT02266706|155978937|FG004|Overall Study|Screen failure|0|||
48487394|NCT02266706|155978938|FG005|Overall Study|Screen failure|1|||
48487395|NCT02266706|155978939|FG006|Overall Study|Screen failure|1|||
48487396|NCT02266706|155978940|FG007|Overall Study|Screen failure|0|||
48487397|NCT02266706|155978941|FG008|Overall Study|Screen failure|0|||
48487398|NCT02266706|155978933|FG000|Overall Study|Enrollment in another study|0|||
48487399|NCT02266706|155978934|FG001|Overall Study|Enrollment in another study|0|||
48487400|NCT02266706|155978935|FG002|Overall Study|Enrollment in another study|0|||
48487401|NCT02266706|155978936|FG003|Overall Study|Enrollment in another study|1|||
48487402|NCT02266706|155978937|FG004|Overall Study|Enrollment in another study|0|||
48487403|NCT02266706|155978938|FG005|Overall Study|Enrollment in another study|0|||
48487404|NCT02266706|155978939|FG006|Overall Study|Enrollment in another study|0|||
48487405|NCT02266706|155978940|FG007|Overall Study|Enrollment in another study|0|||
48487406|NCT02266706|155978941|FG008|Overall Study|Enrollment in another study|0|||
48487407|NCT02402933|155978943|FG000|Overall Study|Withdrawal by Subject|4|||
48487408|NCT02402933|155978943|FG000|Overall Study|Discontinued; Site Termination|10|||
48487409|NCT02544633|155978954|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
48487410|NCT02544633|155978955|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
48487411|NCT02544633|155978956|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
48487412|NCT02544633|155978957|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
48487413|NCT02544633|155978954|FG000|Treatment Period|Adverse Event|7|||
48487414|NCT02544633|155978955|FG001|Treatment Period|Adverse Event|4|||
48487415|NCT02544633|155978956|FG002|Treatment Period|Adverse Event|0|||
48487416|NCT02544633|155978957|FG003|Treatment Period|Adverse Event|5|||
48487417|NCT02544633|155978954|FG000|Treatment Period|Lack of Efficacy|17|||
48487418|NCT02544633|155978955|FG001|Treatment Period|Lack of Efficacy|11|||
48487419|NCT02544633|155978956|FG002|Treatment Period|Lack of Efficacy|5|||
48487420|NCT02544633|155978957|FG003|Treatment Period|Lack of Efficacy|5|||
48487421|NCT02544633|155978954|FG000|Treatment Period|Global Deterioration of Health|3|||
48487422|NCT02544633|155978955|FG001|Treatment Period|Global Deterioration of Health|3|||
48487423|NCT02544633|155978956|FG002|Treatment Period|Global Deterioration of Health|0|||
48487424|NCT02544633|155978957|FG003|Treatment Period|Global Deterioration of Health|1|||
48487425|NCT02544633|155978954|FG000|Treatment Period|Withdrawal by Subject|1|||
48487426|NCT02544633|155978955|FG001|Treatment Period|Withdrawal by Subject|0|||
48487427|NCT02544633|155978956|FG002|Treatment Period|Withdrawal by Subject|0|||
48487428|NCT02544633|155978957|FG003|Treatment Period|Withdrawal by Subject|0|||
48487429|NCT02544633|155978954|FG000|Treatment Period|Lost to Follow-up|0|||
48487430|NCT02544633|155978955|FG001|Treatment Period|Lost to Follow-up|1|||
48487431|NCT02544633|155978956|FG002|Treatment Period|Lost to Follow-up|0|||
48487432|NCT02544633|155978957|FG003|Treatment Period|Lost to Follow-up|0|||
48487433|NCT02544633|155978954|FG000|Treatment Period|Death|0|||
48487434|NCT02544633|155978955|FG001|Treatment Period|Death|0|||
48487435|NCT02544633|155978956|FG002|Treatment Period|Death|1|||
48487436|NCT02544633|155978957|FG003|Treatment Period|Death|0|||
48487437|NCT02544633|155978954|FG000|Treatment Period|Non-compliance|0|||
48487438|NCT02544633|155978955|FG001|Treatment Period|Non-compliance|0|||
48487439|NCT02544633|155978956|FG002|Treatment Period|Non-compliance|1|||
48487440|NCT02544633|155978957|FG003|Treatment Period|Non-compliance|0|||
48487441|NCT02544633|155978954|FG000|Treatment Period|Clinical Disease Progression|0|||
48487442|NCT02544633|155978955|FG001|Treatment Period|Clinical Disease Progression|0|||
48487443|NCT02544633|155978956|FG002|Treatment Period|Clinical Disease Progression|0|||
48487444|NCT02544633|155978957|FG003|Treatment Period|Clinical Disease Progression|1|||
48487445|NCT02544633|155978954|FG000|Survival Follow-up Period|Death|12|||
48487446|NCT02544633|155978955|FG001|Survival Follow-up Period|Death|14|||
48487447|NCT02544633|155978956|FG002|Survival Follow-up Period|Death|3|||
48487448|NCT02544633|155978957|FG003|Survival Follow-up Period|Death|9|||
48587720|NCT01870297|156344745|FG004|Overall Study|Adverse Event|2|||
48587721|NCT01870297|156344746|FG005|Overall Study|Adverse Event|0|||
48587722|NCT01870297|156344747|FG006|Overall Study|Adverse Event|0|||
48587723|NCT01870297|156344741|FG000|Overall Study|Lost to Follow-up|0|||
48587724|NCT01870297|156344742|FG001|Overall Study|Lost to Follow-up|1|||
48587725|NCT01870297|156344743|FG002|Overall Study|Lost to Follow-up|1|||
48587726|NCT01870297|156344744|FG003|Overall Study|Lost to Follow-up|0|||
48587727|NCT01870297|156344745|FG004|Overall Study|Lost to Follow-up|0|||
48587728|NCT01870297|156344746|FG005|Overall Study|Lost to Follow-up|0|||
48587729|NCT01870297|156344747|FG006|Overall Study|Lost to Follow-up|0|||
48587730|NCT01870297|156344741|FG000|Overall Study|Withdrawal by Subject|0|||
48487449|NCT02544633|155978954|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
48487450|NCT02544633|155978955|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
48487451|NCT02544633|155978956|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
48487452|NCT02544633|155978957|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
48487453|NCT02544633|155978954|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
48487454|NCT02544633|155978955|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
48487455|NCT02544633|155978956|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
48487456|NCT02544633|155978957|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
48487457|NCT02544633|155978954|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
48487458|NCT02544633|155978955|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
48487459|NCT02544633|155978956|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
48487460|NCT02544633|155978957|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
48487461|NCT00066807|155978960|FG000|Overall Study|Study was terminated early|14|||
48487462|NCT00066807|155978961|FG001|Overall Study|Study was terminated early|15|||
48487463|NCT01967888|155978962|FG000|Overall Study|Lost to Follow-up|6|||
48487464|NCT01967888|155978963|FG001|Overall Study|Lost to Follow-up|4|||
48487465|NCT01967888|155978962|FG000|Overall Study|Withdrawal by Subject|1|||
48487466|NCT01967888|155978963|FG001|Overall Study|Withdrawal by Subject|1|||
48487467|NCT01967888|155978962|FG000|Overall Study|Did Not Have Transplant|1|||
48487468|NCT01967888|155978963|FG001|Overall Study|Did Not Have Transplant|0|||
48487469|NCT01967888|155978962|FG000|Overall Study|Research visit not done, data recorded|1|||
48487470|NCT01967888|155978963|FG001|Overall Study|Research visit not done, data recorded|0|||
48487471|NCT01967888|155978962|FG000|Overall Study|Subject excluded after randomization|1|||
48487472|NCT01967888|155978963|FG001|Overall Study|Subject excluded after randomization|0|||
48487473|NCT01967888|155978962|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
48487474|NCT01967888|155978963|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
48487475|NCT01967888|155978962|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
48487476|NCT01967888|155978963|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
48487477|NCT02436135|155978966|FG000|Overall Study|Progressive Disease|3|||
48487478|NCT02436135|155978967|FG001|Overall Study|Progressive Disease|1|||
48487479|NCT02436135|155978966|FG000|Overall Study|Investigator Discretion|1|||
48487480|NCT02436135|155978967|FG001|Overall Study|Investigator Discretion|2|||
48487481|NCT02436135|155978966|FG000|Overall Study|Adverse Event|1|||
48487482|NCT02436135|155978967|FG001|Overall Study|Adverse Event|0|||
48487483|NCT02436135|155978966|FG000|Overall Study|Withdrawal by Participant|1|||
48487484|NCT02436135|155978967|FG001|Overall Study|Withdrawal by Participant|0|||
48487485|NCT02436135|155978966|FG000|Overall Study|Study Terminated By Sponsor|0|||
48487486|NCT02436135|155978967|FG001|Overall Study|Study Terminated By Sponsor|1|||
48487487|NCT02729194|155978971|FG000|Overall Study|Withdrawal by Subject|3|||
48487488|NCT00475852|155978977|FG000|Overall Study|Death|444|||
48487489|NCT00475852|155978978|FG001|Overall Study|Death|456|||
48487490|NCT00475852|155978977|FG000|Overall Study|Withdrawal by Subject|19|||
48487491|NCT00475852|155978978|FG001|Overall Study|Withdrawal by Subject|24|||
48487492|NCT00475852|155978977|FG000|Overall Study|Lost to Follow-up|54|||
48487493|NCT00475852|155978978|FG001|Overall Study|Lost to Follow-up|68|||
48487494|NCT02063698|155978979|FG000|Overall Study|did not complete booklet for days 2-8|1|||
48487495|NCT02063698|155978980|FG001|Overall Study|did not complete booklet for days 2-8|2|||
48487496|NCT00272961|155978981|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
48487497|NCT00272961|155978982|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
48487498|NCT00272961|155978983|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
48487499|NCT00272961|155978984|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
48487500|NCT00272961|155978985|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
48487501|NCT00272961|155978981|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
48487502|NCT00272961|155978982|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
48487503|NCT00272961|155978983|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
48588045|NCT01210352|156344820|FG003|Overall Study|Lack of Efficacy|0|||
48588046|NCT01210352|156344821|FG004|Overall Study|Lack of Efficacy|0|||
48588047|NCT01210352|156344822|FG005|Overall Study|Lack of Efficacy|0|||
48588048|NCT01210352|156344823|FG006|Overall Study|Lack of Efficacy|1|||
48588049|NCT01210352|156344824|FG007|Overall Study|Lack of Efficacy|0|||
48588050|NCT01210352|156344825|FG008|Overall Study|Lack of Efficacy|0|||
48588051|NCT01210352|156344817|FG000|Overall Study|Physician Decision|0|||
48588052|NCT01210352|156344818|FG001|Overall Study|Physician Decision|0|||
48588053|NCT01210352|156344819|FG002|Overall Study|Physician Decision|0|||
48588054|NCT01210352|156344820|FG003|Overall Study|Physician Decision|0|||
48588055|NCT01210352|156344821|FG004|Overall Study|Physician Decision|0|||
48588056|NCT01210352|156344822|FG005|Overall Study|Physician Decision|0|||
48588057|NCT01210352|156344823|FG006|Overall Study|Physician Decision|0|||
48588058|NCT01210352|156344824|FG007|Overall Study|Physician Decision|1|||
48588059|NCT01210352|156344825|FG008|Overall Study|Physician Decision|2|||
48588060|NCT01210352|156344817|FG000|Overall Study|Withdrawal by Subject|0|||
48588061|NCT01210352|156344818|FG001|Overall Study|Withdrawal by Subject|0|||
48588062|NCT01210352|156344819|FG002|Overall Study|Withdrawal by Subject|1|||
48590272|NCT02003924|156353247|FG002|Double-blind Phase|Adverse Event|0|||
48590273|NCT02003924|156353245|FG000|Double-blind Phase|Randomized But not Treated|3|||
48590274|NCT02003924|156353246|FG001|Double-blind Phase|Randomized But not Treated|3|||
48590275|NCT02003924|156353247|FG002|Double-blind Phase|Randomized But not Treated|0|||
48590276|NCT02003924|156353245|FG000|Double-blind Phase|Other|29|||
48590277|NCT02003924|156353246|FG001|Double-blind Phase|Other|50|||
48590278|NCT02003924|156353247|FG002|Double-blind Phase|Other|0|||
48590279|NCT02003924|156353245|FG000|Open-label Phase|Lost to Follow-up|0|||
48590280|NCT02003924|156353246|FG001|Open-label Phase|Lost to Follow-up|0|||
48590281|NCT02003924|156353247|FG002|Open-label Phase|Lost to Follow-up|1|||
48590282|NCT02003924|156353245|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
48590283|NCT02003924|156353246|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
48590284|NCT02003924|156353247|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
48487504|NCT00272961|155978984|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
48487505|NCT00272961|155978985|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
48487506|NCT00272961|155978981|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
48487507|NCT00272961|155978982|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
48487508|NCT00272961|155978983|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
48487509|NCT00272961|155978984|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
48487510|NCT00272961|155978985|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
48487511|NCT00272961|155978981|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
48487512|NCT00272961|155978982|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
48487513|NCT00272961|155978983|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
48487514|NCT00272961|155978984|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
48487515|NCT00272961|155978985|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
48487516|NCT00272961|155978981|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
48487517|NCT00272961|155978982|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
48590285|NCT02003924|156353245|FG000|Open-label Phase|Disease Progression|59|||
48590286|NCT02003924|156353246|FG001|Open-label Phase|Disease Progression|0|||
48590287|NCT02003924|156353247|FG002|Open-label Phase|Disease Progression|5|||
48590288|NCT02003924|156353245|FG000|Open-label Phase|Adverse Event|25|||
48590289|NCT02003924|156353246|FG001|Open-label Phase|Adverse Event|0|||
48590290|NCT02003924|156353247|FG002|Open-label Phase|Adverse Event|10|||
48590291|NCT02003924|156353245|FG000|Open-label Phase|Other|7|||
48590292|NCT02003924|156353246|FG001|Open-label Phase|Other|0|||
48590293|NCT02003924|156353247|FG002|Open-label Phase|Other|0|||
48590294|NCT02003924|156353245|FG000|Long-term Follow-up Phase|Death|288|||
48590295|NCT02003924|156353246|FG001|Long-term Follow-up Phase|Death|174|||
48590296|NCT02003924|156353247|FG002|Long-term Follow-up Phase|Death|4|||
48590297|NCT02003924|156353245|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
48590298|NCT02003924|156353246|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
48590299|NCT02003924|156353247|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
48590300|NCT02003924|156353245|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
48590301|NCT02003924|156353246|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
48590302|NCT02003924|156353247|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
48590303|NCT02003924|156353245|FG000|Long-term Follow-up Phase|Other|5|||
48590304|NCT02003924|156353246|FG001|Long-term Follow-up Phase|Other|2|||
48590305|NCT02003924|156353247|FG002|Long-term Follow-up Phase|Other|1|||
48590306|NCT00048165|156353248|FG000|Completed 6 Months Study|Administration/Other|8|||
48590307|NCT00048165|156353249|FG001|Completed 6 Months Study|Administration/Other|8|||
48590308|NCT00048165|156353248|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
48590309|NCT00048165|156353249|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
48487518|NCT00272961|155978983|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
48487519|NCT00272961|155978984|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
48487520|NCT00272961|155978985|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
48487521|NCT00272961|155978981|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
48590310|NCT00048165|156353248|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
48590311|NCT00048165|156353249|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
48590312|NCT00048165|156353248|FG000|Completed 6 Months Study|Death|12|||
48590313|NCT00048165|156353249|FG001|Completed 6 Months Study|Death|6|||
48590314|NCT00048165|156353248|FG000|Completed 6 Months Study|Insufficient therapy|1|||
48590315|NCT00048165|156353249|FG001|Completed 6 Months Study|Insufficient therapy|4|||
48590316|NCT00048165|156353248|FG000|Completed 6 Months Study|Other violation|4|||
48590317|NCT00048165|156353249|FG001|Completed 6 Months Study|Other violation|6|||
48590318|NCT00048165|156353248|FG000|Completed 6 Months Study|Refused treatment|5|||
48590319|NCT00048165|156353249|FG001|Completed 6 Months Study|Refused treatment|5|||
48590320|NCT00048165|156353248|FG000|Completed 6 Months Study|Violation criteria|0|||
48590321|NCT00048165|156353249|FG001|Completed 6 Months Study|Violation criteria|2|||
48590322|NCT00048165|156353248|FG000|Completed 6 Months Study|Did not receive study drug|6|||
48590323|NCT00048165|156353249|FG001|Completed 6 Months Study|Did not receive study drug|6|||
48590324|NCT00048165|156353248|FG000|Completed 12 Months Study|Administration/Other|0|||
48590325|NCT00048165|156353249|FG001|Completed 12 Months Study|Administration/Other|2|||
48590326|NCT00048165|156353248|FG000|Completed 12 Months Study|Death|2|||
48590327|NCT00048165|156353249|FG001|Completed 12 Months Study|Death|1|||
48590328|NCT00048165|156353248|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
48590329|NCT00048165|156353249|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
48590330|NCT01370616|156353254|FG000|Overall Study|Adverse Event|11|||
48590331|NCT01370616|156353255|FG001|Overall Study|Adverse Event|16|||
48590332|NCT01370616|156353254|FG000|Overall Study|Death|1|||
48590333|NCT01370616|156353255|FG001|Overall Study|Death|0|||
48590334|NCT01370616|156353254|FG000|Overall Study|Lack of Efficacy|6|||
48590335|NCT01370616|156353255|FG001|Overall Study|Lack of Efficacy|2|||
48590336|NCT01370616|156353254|FG000|Overall Study|Lost to Follow-up|0|||
48590337|NCT01370616|156353255|FG001|Overall Study|Lost to Follow-up|3|||
48590338|NCT01370616|156353254|FG000|Overall Study|Physician Decision|6|||
48590339|NCT01370616|156353255|FG001|Overall Study|Physician Decision|6|||
48590340|NCT01370616|156353254|FG000|Overall Study|Progressive Disease|0|||
48590341|NCT01370616|156353255|FG001|Overall Study|Progressive Disease|1|||
48590342|NCT01370616|156353254|FG000|Overall Study|Recovery|1|||
48590343|NCT01370616|156353255|FG001|Overall Study|Recovery|0|||
48590344|NCT01370616|156353254|FG000|Overall Study|Technical Problems|3|||
48590345|NCT01370616|156353255|FG001|Overall Study|Technical Problems|5|||
48590346|NCT01370616|156353254|FG000|Overall Study|Withdrawal by Subject|34|||
48590347|NCT01370616|156353255|FG001|Overall Study|Withdrawal by Subject|34|||
48590348|NCT04292743|156353256|FG000|Overall Study|Physician Decision|1|||
48590349|NCT04292743|156353257|FG001|Overall Study|Physician Decision|3|||
48590350|NCT04292743|156353258|FG002|Overall Study|Physician Decision|0|||
48590351|NCT04292743|156353259|FG003|Overall Study|Physician Decision|0|||
48590352|NCT04292743|156353256|FG000|Overall Study|Withdrawal by Subject|0|||
48590353|NCT04292743|156353257|FG001|Overall Study|Withdrawal by Subject|5|||
48590354|NCT04292743|156353258|FG002|Overall Study|Withdrawal by Subject|0|||
48590355|NCT04292743|156353259|FG003|Overall Study|Withdrawal by Subject|0|||
48590356|NCT04292743|156353256|FG000|Overall Study|Death|0|||
48590357|NCT04292743|156353257|FG001|Overall Study|Death|1|||
48590358|NCT04292743|156353258|FG002|Overall Study|Death|0|||
48590359|NCT04292743|156353259|FG003|Overall Study|Death|0|||
48590360|NCT04292743|156353256|FG000|Overall Study|Progression of Disease|2|||
48590361|NCT04292743|156353257|FG001|Overall Study|Progression of Disease|5|||
48590362|NCT04292743|156353258|FG002|Overall Study|Progression of Disease|0|||
48590363|NCT04292743|156353259|FG003|Overall Study|Progression of Disease|0|||
48590364|NCT04292743|156353256|FG000|Overall Study|No Treatment per protocol|0|||
48590365|NCT04292743|156353257|FG001|Overall Study|No Treatment per protocol|2|||
48590366|NCT04292743|156353258|FG002|Overall Study|No Treatment per protocol|0|||
48590367|NCT04292743|156353259|FG003|Overall Study|No Treatment per protocol|0|||
48590368|NCT00460746|156353260|FG000|Overall Study|Adverse Event|1|||
48590369|NCT00460746|156353260|FG000|Overall Study|Lost to Follow-up|1|||
48590370|NCT02598661|156353265|FG000|Overall Study|Death|27|||
48590371|NCT02598661|156353266|FG001|Overall Study|Death|34|||
48590372|NCT02598661|156353267|FG002|Overall Study|Death|14|||
48590373|NCT02598661|156353268|FG003|Overall Study|Death|1|||
48590374|NCT02598661|156353269|FG004|Overall Study|Death|0|||
48590375|NCT02598661|156353265|FG000|Overall Study|Lost to Follow-up|2|||
48590376|NCT02598661|156353266|FG001|Overall Study|Lost to Follow-up|3|||
48590377|NCT02598661|156353267|FG002|Overall Study|Lost to Follow-up|2|||
48590378|NCT02598661|156353268|FG003|Overall Study|Lost to Follow-up|0|||
48590379|NCT02598661|156353269|FG004|Overall Study|Lost to Follow-up|0|||
48590380|NCT02598661|156353265|FG000|Overall Study|Withdrawal by Subject|13|||
48590381|NCT02598661|156353266|FG001|Overall Study|Withdrawal by Subject|24|||
48590382|NCT02598661|156353267|FG002|Overall Study|Withdrawal by Subject|14|||
48590383|NCT02598661|156353268|FG003|Overall Study|Withdrawal by Subject|1|||
48590384|NCT02598661|156353269|FG004|Overall Study|Withdrawal by Subject|1|||
48590385|NCT02598661|156353265|FG000|Overall Study|Adverse Event|0|||
48590386|NCT02598661|156353266|FG001|Overall Study|Adverse Event|0|||
48590387|NCT02598661|156353267|FG002|Overall Study|Adverse Event|1|||
48590388|NCT02598661|156353268|FG003|Overall Study|Adverse Event|0|||
48590389|NCT02598661|156353269|FG004|Overall Study|Adverse Event|0|||
48590390|NCT02598661|156353265|FG000|Overall Study|Randomized, Never Treated|0|||
48590391|NCT02598661|156353266|FG001|Overall Study|Randomized, Never Treated|0|||
48590392|NCT02598661|156353267|FG002|Overall Study|Randomized, Never Treated|0|||
48590393|NCT02598661|156353268|FG003|Overall Study|Randomized, Never Treated|0|||
48590394|NCT02598661|156353269|FG004|Overall Study|Randomized, Never Treated|1|||
48590395|NCT01905592|156353280|FG000|Overall Study|Disease Progression|51|||
48590396|NCT01905592|156353281|FG001|Overall Study|Disease Progression|110|||
48590397|NCT01905592|156353280|FG000|Overall Study|Toxicity|1|||
48590398|NCT01905592|156353281|FG001|Overall Study|Toxicity|16|||
48590399|NCT01905592|156353280|FG000|Overall Study|Physician Decision|0|||
48590400|NCT01905592|156353281|FG001|Overall Study|Physician Decision|2|||
48590401|NCT01905592|156353280|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
48590402|NCT01905592|156353281|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
48590403|NCT01905592|156353280|FG000|Overall Study|Protocol Violation|0|||
48590404|NCT01905592|156353281|FG001|Overall Study|Protocol Violation|1|||
48590405|NCT01905592|156353280|FG000|Overall Study|Sponsor's decision|1|||
48590406|NCT01905592|156353281|FG001|Overall Study|Sponsor's decision|1|||
48590407|NCT01905592|156353280|FG000|Overall Study|Not treated|7|||
48590408|NCT01905592|156353281|FG001|Overall Study|Not treated|3|||
48590409|NCT01905592|156353280|FG000|Overall Study|Withdrawal by Subject|10|||
48590410|NCT01905592|156353281|FG001|Overall Study|Withdrawal by Subject|2|||
48590411|NCT00792116|156353283|FG000|Overall Study|Lost to Follow-up|0|||
48590412|NCT00792116|156353284|FG001|Overall Study|Lost to Follow-up|1|||
48590413|NCT00792116|156353283|FG000|Overall Study|Discontnued intervention|1|||
48590414|NCT00792116|156353284|FG001|Overall Study|Discontnued intervention|0|||
48590415|NCT03628716|156353285|FG000|Overall Study|Adverse Event|1|||
48590416|NCT03628716|156353286|FG001|Overall Study|Adverse Event|1|||
48590417|NCT03628716|156353285|FG000|Overall Study|Death|1|||
48590418|NCT03628716|156353286|FG001|Overall Study|Death|0|||
48590419|NCT03628716|156353285|FG000|Overall Study|Lack of Efficacy|15|||
48590420|NCT03628716|156353286|FG001|Overall Study|Lack of Efficacy|20|||
48590421|NCT03628716|156353285|FG000|Overall Study|Withdrawal by Subject|1|||
48590422|NCT03628716|156353286|FG001|Overall Study|Withdrawal by Subject|2|||
48590423|NCT03628716|156353285|FG000|Overall Study|Study Terminated by Sponsor|1|||
48590424|NCT03628716|156353286|FG001|Overall Study|Study Terminated by Sponsor|0|||
48590425|NCT03034135|156353287|FG000|Overall Study|Withdrawal by Subject|2|||
48590426|NCT02669043|156353288|FG000|Overall Study|Didn't meet I/E criteria|4|||
48590427|NCT05601882|156353291|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
48590428|NCT05601882|156353292|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
48590429|NCT05601882|156353293|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
48590430|NCT05601882|156353294|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
48590431|NCT05601882|156353291|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
48590432|NCT05601882|156353292|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
48590433|NCT05601882|156353293|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
48590434|NCT05601882|156353294|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
48590435|NCT05601882|156353291|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
48590436|NCT05601882|156353292|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
48590437|NCT05601882|156353293|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
48590438|NCT05601882|156353294|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
48590439|NCT05601882|156353291|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
48590440|NCT05601882|156353292|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
48590441|NCT05601882|156353293|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
48590442|NCT05601882|156353294|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
48590443|NCT05601882|156353291|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
48590444|NCT05601882|156353292|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
48590445|NCT05601882|156353293|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
48590446|NCT05601882|156353294|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
48590447|NCT05601882|156353291|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
48590448|NCT05601882|156353292|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
48590449|NCT05601882|156353293|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
48590450|NCT05601882|156353294|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
48590451|NCT04607135|156353313|FG000|Overall Study|Physician Decision|1|||
48590452|NCT04607135|156353313|FG000|Overall Study|Withdrawal by Subject|1|||
48590453|NCT04607135|156353313|FG000|Overall Study|Equipment not working|3|||
48590454|NCT05792423|156353320|FG000|Overall Study|Withdrawal by Subject|2|||
48590455|NCT02000882|156354843|FG000|Overall Study|Adverse Event|3|||
48590456|NCT02000882|156354843|FG000|Overall Study|Physician Decision|2|||
48590457|NCT02000882|156354843|FG000|Overall Study|Withdrawal by Subject|1|||
48590458|NCT03055494|156354844|FG000|Overall Study|Lost to Follow-up|6|||
48590459|NCT03055494|156354845|FG001|Overall Study|Lost to Follow-up|0|||
48590460|NCT03055494|156354844|FG000|Overall Study|Physician Decision|2|||
48590461|NCT03055494|156354845|FG001|Overall Study|Physician Decision|0|||
48590462|NCT03055494|156354844|FG000|Overall Study|Withdrawal by Subject|1|||
48590463|NCT03055494|156354845|FG001|Overall Study|Withdrawal by Subject|0|||
48590464|NCT03055494|156354844|FG000|Overall Study|Adverse Event|0|||
48590465|NCT03055494|156354845|FG001|Overall Study|Adverse Event|1|||
48590466|NCT03055494|156354844|FG000|Overall Study|Non-compliance with study treatment|1|||
48590467|NCT03055494|156354845|FG001|Overall Study|Non-compliance with study treatment|0|||
48590468|NCT02178358|156354846|FG000|Overall Study|Withdrawal by Subject|0|||
48590469|NCT02178358|156354847|FG001|Overall Study|Withdrawal by Subject|2|||
48590470|NCT02178358|156354848|FG002|Overall Study|Withdrawal by Subject|2|||
48590471|NCT02178358|156354846|FG000|Overall Study|Lost to Follow-up|1|||
48590472|NCT02178358|156354847|FG001|Overall Study|Lost to Follow-up|0|||
48590473|NCT02178358|156354848|FG002|Overall Study|Lost to Follow-up|0|||
48590474|NCT02187029|156354849|FG000|Overall Study|Adverse Event|0|||
48590475|NCT02187029|156354850|FG001|Overall Study|Adverse Event|1|||
48590476|NCT02187029|156354851|FG002|Overall Study|Adverse Event|1|||
48590477|NCT02187029|156354852|FG003|Overall Study|Adverse Event|0|||
48590478|NCT02187029|156354849|FG000|Overall Study|Study Terminated by Sponsor|0|||
48590479|NCT02187029|156354850|FG001|Overall Study|Study Terminated by Sponsor|0|||
48590480|NCT02187029|156354851|FG002|Overall Study|Study Terminated by Sponsor|10|||
48590481|NCT02187029|156354852|FG003|Overall Study|Study Terminated by Sponsor|3|||
48590482|NCT02187029|156354849|FG000|Overall Study|Withdrawal by Subject|1|||
48590483|NCT02187029|156354850|FG001|Overall Study|Withdrawal by Subject|0|||
48590484|NCT02187029|156354851|FG002|Overall Study|Withdrawal by Subject|0|||
48590485|NCT02187029|156354852|FG003|Overall Study|Withdrawal by Subject|0|||
48590486|NCT03871829|156354854|FG000|Overall Study|Lost to Follow-up|0|||
48590487|NCT03871829|156354855|FG001|Overall Study|Lost to Follow-up|1|||
48590488|NCT03871829|156354854|FG000|Overall Study|Withdrawal by Subject|1|||
48590489|NCT03871829|156354855|FG001|Overall Study|Withdrawal by Subject|1|||
48590490|NCT03871829|156354854|FG000|Overall Study|Death|12|||
48590491|NCT03871829|156354855|FG001|Overall Study|Death|8|||
48590492|NCT03871829|156354854|FG000|Overall Study|Study terminated by sponsor|31|||
48590493|NCT03871829|156354855|FG001|Overall Study|Study terminated by sponsor|34|||
48590494|NCT00715520|156354856|FG000|Overall Study|Screen failure|8|||
48590495|NCT00715520|156354857|FG001|Overall Study|Screen failure|1|||
48590496|NCT00715520|156354858|FG002|Overall Study|Screen failure|1|||
48590497|NCT00715520|156354856|FG000|Overall Study|Withdrawal by Subject|2|||
48590498|NCT00715520|156354857|FG001|Overall Study|Withdrawal by Subject|0|||
48590499|NCT00715520|156354858|FG002|Overall Study|Withdrawal by Subject|1|||
48590500|NCT01006590|156354859|FG000|Overall Study|Adverse Event|2|||
48590501|NCT01006590|156354860|FG001|Overall Study|Adverse Event|3|||
48590502|NCT01006590|156354859|FG000|Overall Study|Death|1|||
48590503|NCT01006590|156354860|FG001|Overall Study|Death|1|||
48590504|NCT01006590|156354859|FG000|Overall Study|Lost to Follow-up|1|||
48590505|NCT01006590|156354860|FG001|Overall Study|Lost to Follow-up|1|||
48590506|NCT01006590|156354859|FG000|Overall Study|Protocol Violation|1|||
48590507|NCT01006590|156354860|FG001|Overall Study|Protocol Violation|0|||
48590508|NCT01006590|156354859|FG000|Overall Study|Withdrawal by Subject|4|||
48590509|NCT01006590|156354860|FG001|Overall Study|Withdrawal by Subject|2|||
48590510|NCT01006590|156354859|FG000|Overall Study|Study specific discontinuation criteria|16|||
48590511|NCT01006590|156354860|FG001|Overall Study|Study specific discontinuation criteria|23|||
48590512|NCT01006590|156354859|FG000|Overall Study|Other|3|||
48590513|NCT01006590|156354860|FG001|Overall Study|Other|2|||
48590514|NCT01597492|156354865|FG000|Overall Study|Withdrawal by Subject|1|||
48590515|NCT01597492|156354866|FG001|Overall Study|Withdrawal by Subject|2|||
48590516|NCT01597492|156354865|FG000|Overall Study|Adverse Event|3|||
48590517|NCT01597492|156354866|FG001|Overall Study|Adverse Event|0|||
48590518|NCT01597492|156354865|FG000|Overall Study|Lost to Follow-up|0|||
48590519|NCT01597492|156354866|FG001|Overall Study|Lost to Follow-up|2|||
48590520|NCT01597492|156354865|FG000|Overall Study|Other Reason|2|||
48590521|NCT01597492|156354866|FG001|Overall Study|Other Reason|0|||
48590522|NCT00791700|156354867|FG000|Overall Study|Insufficient clinical response|1|||
48590523|NCT00791700|156354868|FG001|Overall Study|Insufficient clinical response|4|||
48590524|NCT00791700|156354869|FG002|Overall Study|Insufficient clinical response|1|||
48590525|NCT00791700|156354870|FG003|Overall Study|Insufficient clinical response|8|||
48590526|NCT00791700|156354867|FG000|Overall Study|No longer willing to participate|1|||
48590527|NCT00791700|156354868|FG001|Overall Study|No longer willing to participate|1|||
48590528|NCT00791700|156354869|FG002|Overall Study|No longer willing to participate|0|||
48590529|NCT00791700|156354870|FG003|Overall Study|No longer willing to participate|8|||
48590530|NCT00791700|156354867|FG000|Overall Study|Non-compliance with study treatment|0|||
48590531|NCT00791700|156354868|FG001|Overall Study|Non-compliance with study treatment|2|||
48590532|NCT00791700|156354869|FG002|Overall Study|Non-compliance with study treatment|0|||
48590533|NCT00791700|156354870|FG003|Overall Study|Non-compliance with study treatment|4|||
48590534|NCT00791700|156354867|FG000|Overall Study|Withdrawn due to pregnancy|0|||
48590535|NCT00791700|156354868|FG001|Overall Study|Withdrawn due to pregnancy|0|||
48590536|NCT00791700|156354869|FG002|Overall Study|Withdrawn due to pregnancy|0|||
48590537|NCT00791700|156354870|FG003|Overall Study|Withdrawn due to pregnancy|1|||
48590538|NCT00791700|156354867|FG000|Overall Study|Other|0|||
48590539|NCT00791700|156354868|FG001|Overall Study|Other|1|||
48590540|NCT00791700|156354869|FG002|Overall Study|Other|0|||
48590541|NCT00791700|156354870|FG003|Overall Study|Other|1|||
48590542|NCT00791700|156354867|FG000|Overall Study|Death|0|||
48590543|NCT00791700|156354868|FG001|Overall Study|Death|0|||
48590544|NCT00791700|156354869|FG002|Overall Study|Death|0|||
48590545|NCT00791700|156354870|FG003|Overall Study|Death|1|||
48590546|NCT00791700|156354867|FG000|Overall Study|Lost to Follow-up|4|||
48590547|NCT00791700|156354868|FG001|Overall Study|Lost to Follow-up|3|||
48590548|NCT00791700|156354869|FG002|Overall Study|Lost to Follow-up|4|||
48590549|NCT00791700|156354870|FG003|Overall Study|Lost to Follow-up|6|||
48590550|NCT00791700|156354867|FG000|Overall Study|Adverse Event|0|||
48590551|NCT00791700|156354868|FG001|Overall Study|Adverse Event|0|||
48590552|NCT00791700|156354869|FG002|Overall Study|Adverse Event|1|||
48590553|NCT00791700|156354870|FG003|Overall Study|Adverse Event|1|||
48590554|NCT02112877|156354879|FG000|Overall Study|Withdrawal by Subject|1|||
48590555|NCT02112877|156354880|FG001|Overall Study|Withdrawal by Subject|7|||
48590556|NCT02112877|156354879|FG000|Overall Study|Visit Missed|1|||
48590557|NCT02112877|156354880|FG001|Overall Study|Visit Missed|6|||
48590558|NCT00419159|156354881|FG000|Overall Study|Adverse Event|7|||
48590559|NCT00419159|156354882|FG001|Overall Study|Adverse Event|15|||
48590560|NCT00419159|156354881|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48590561|NCT00419159|156354882|FG001|Overall Study|Abnormal laboratory value(s)|2|||
48590562|NCT00419159|156354881|FG000|Overall Study|Subject's no longer requires study drug|0|||
48590563|NCT00419159|156354882|FG001|Overall Study|Subject's no longer requires study drug|1|||
48590564|NCT00419159|156354881|FG000|Overall Study|Protocol Violation|1|||
48590565|NCT00419159|156354882|FG001|Overall Study|Protocol Violation|0|||
48590566|NCT00419159|156354881|FG000|Overall Study|Withdrawal by Subject|10|||
48590567|NCT00419159|156354882|FG001|Overall Study|Withdrawal by Subject|3|||
48590568|NCT00419159|156354881|FG000|Overall Study|Lost to Follow-up|0|||
48590569|NCT00419159|156354882|FG001|Overall Study|Lost to Follow-up|1|||
48590570|NCT00419159|156354881|FG000|Overall Study|Death|2|||
48590571|NCT00419159|156354882|FG001|Overall Study|Death|2|||
48590572|NCT00419159|156354881|FG000|Overall Study|Disease progression|79|||
48590573|NCT00419159|156354882|FG001|Overall Study|Disease progression|76|||
48590574|NCT00076999|156354887|FG000|Overall Study|Adverse Event|2|||
48487522|NCT00272961|155978982|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
48487523|NCT00272961|155978983|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
48487524|NCT00272961|155978984|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
48487525|NCT00272961|155978985|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
48487526|NCT00272961|155978981|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
48487527|NCT00272961|155978982|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
48487528|NCT00272961|155978983|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
48487529|NCT00272961|155978984|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
48590575|NCT00076999|156354888|FG001|Overall Study|Adverse Event|8|||
48590576|NCT00076999|156354889|FG002|Overall Study|Adverse Event|6|||
48590577|NCT00076999|156354890|FG003|Overall Study|Adverse Event|0|||
48590578|NCT00076999|156354891|FG004|Overall Study|Adverse Event|2|||
48590579|NCT00076999|156354887|FG000|Overall Study|Protocol Violation|0|||
48590580|NCT00076999|156354888|FG001|Overall Study|Protocol Violation|3|||
48590581|NCT00076999|156354889|FG002|Overall Study|Protocol Violation|4|||
48590582|NCT00076999|156354890|FG003|Overall Study|Protocol Violation|0|||
48590583|NCT00076999|156354891|FG004|Overall Study|Protocol Violation|9|||
48590584|NCT00076999|156354887|FG000|Overall Study|Lost to Follow-up|2|||
48590585|NCT00076999|156354888|FG001|Overall Study|Lost to Follow-up|1|||
48590586|NCT00076999|156354889|FG002|Overall Study|Lost to Follow-up|0|||
48590587|NCT00076999|156354890|FG003|Overall Study|Lost to Follow-up|0|||
48590588|NCT00076999|156354891|FG004|Overall Study|Lost to Follow-up|0|||
48590589|NCT00076999|156354887|FG000|Overall Study|Withdrawal by Subject|0|||
48590590|NCT00076999|156354888|FG001|Overall Study|Withdrawal by Subject|4|||
48590591|NCT00076999|156354889|FG002|Overall Study|Withdrawal by Subject|3|||
48590592|NCT00076999|156354890|FG003|Overall Study|Withdrawal by Subject|0|||
48590593|NCT00076999|156354891|FG004|Overall Study|Withdrawal by Subject|1|||
48590594|NCT00076999|156354887|FG000|Overall Study|Other reason (not specified)|8|||
48590595|NCT00076999|156354888|FG001|Overall Study|Other reason (not specified)|8|||
48590596|NCT00076999|156354889|FG002|Overall Study|Other reason (not specified)|4|||
48590597|NCT00076999|156354890|FG003|Overall Study|Other reason (not specified)|1|||
48590598|NCT00076999|156354891|FG004|Overall Study|Other reason (not specified)|13|||
48590599|NCT02182830|156354896|FG000|Overall Study|Not Treated|1|||
48590600|NCT02182830|156354897|FG001|Overall Study|Not Treated|1|||
48590601|NCT02182830|156354896|FG000|Overall Study|Trial stopped, reason missing|3|||
48590602|NCT02182830|156354897|FG001|Overall Study|Trial stopped, reason missing|3|||
48590603|NCT02182830|156354896|FG000|Overall Study|Consent withdrawn|8|||
48590604|NCT02182830|156354897|FG001|Overall Study|Consent withdrawn|8|||
48590605|NCT02182830|156354896|FG000|Overall Study|Lost to Follow-up|3|||
48590606|NCT02182830|156354897|FG001|Overall Study|Lost to Follow-up|3|||
48590607|NCT00913770|156354908|FG000|Overall Study|Unable to contact|24|||
48590608|NCT00913770|156354909|FG001|Overall Study|Unable to contact|19|||
48590609|NCT00913770|156354910|FG002|Overall Study|Unable to contact|13|||
48590610|NCT00913770|156354908|FG000|Overall Study|Refused|11|||
48590611|NCT00913770|156354909|FG001|Overall Study|Refused|10|||
48590612|NCT00913770|156354910|FG002|Overall Study|Refused|8|||
48590613|NCT03337048|156354911|FG000|Overall Study|Withdrawal by Subject|2|||
48590614|NCT03337048|156354912|FG001|Overall Study|Withdrawal by Subject|0|||
48590615|NCT03337048|156354913|FG002|Overall Study|Withdrawal by Subject|0|||
48590616|NCT01690299|156354914|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
48590617|NCT01690299|156354915|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
48590618|NCT01690299|156354916|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
48590619|NCT01690299|156354917|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
48590620|NCT01690299|156354918|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
48590621|NCT01690299|156354919|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
48590622|NCT01690299|156354914|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
48590623|NCT01690299|156354915|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48590624|NCT01690299|156354916|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48590625|NCT01690299|156354917|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48590626|NCT01690299|156354918|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48590627|NCT01690299|156354919|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48590628|NCT01690299|156354914|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
48590629|NCT01690299|156354915|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
48590630|NCT01690299|156354916|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48590631|NCT01690299|156354917|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48590632|NCT01690299|156354918|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48590633|NCT01690299|156354919|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48590634|NCT01690299|156354914|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
48590635|NCT01690299|156354915|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
48590636|NCT01690299|156354916|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
48590637|NCT01690299|156354917|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
48590638|NCT01690299|156354918|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
48590639|NCT01690299|156354919|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
48590640|NCT01690299|156354914|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
48590641|NCT01690299|156354915|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
48590642|NCT01690299|156354916|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
48590643|NCT01690299|156354917|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
48590644|NCT01690299|156354918|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
48590645|NCT01690299|156354919|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
48590646|NCT01690299|156354914|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
48590647|NCT01690299|156354915|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
48590648|NCT01690299|156354916|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
48590649|NCT01690299|156354917|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
48590650|NCT01690299|156354918|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
48590651|NCT01690299|156354919|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
48590652|NCT01690299|156354914|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
48590653|NCT01690299|156354915|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
48590654|NCT01690299|156354916|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
48590655|NCT01690299|156354917|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
48590656|NCT01690299|156354918|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
48590657|NCT01690299|156354919|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
48590658|NCT01690299|156354914|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
48590659|NCT01690299|156354915|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
48590660|NCT01690299|156354916|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
48590661|NCT01690299|156354917|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
48590662|NCT01690299|156354918|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
48590663|NCT01690299|156354919|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
48590664|NCT01690299|156354914|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
48590665|NCT01690299|156354915|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
48590666|NCT01690299|156354916|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
48590667|NCT01690299|156354917|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
48590668|NCT01690299|156354918|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
48590669|NCT01690299|156354919|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
48590670|NCT01690299|156354914|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
48590671|NCT01690299|156354915|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
48590672|NCT01690299|156354916|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
48590673|NCT01690299|156354917|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
48590674|NCT01690299|156354918|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
48590675|NCT01690299|156354919|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
48590676|NCT02173379|156354920|FG000|Overall Study|Lost to Follow-up|89|||
48590677|NCT02173379|156354921|FG001|Overall Study|Lost to Follow-up|81|||
48590678|NCT02173379|156354920|FG000|Overall Study|Withdrawal by Subject|24|||
48590679|NCT02173379|156354921|FG001|Overall Study|Withdrawal by Subject|29|||
48590680|NCT02173379|156354920|FG000|Overall Study|Physician Decision|8|||
48590681|NCT02173379|156354921|FG001|Overall Study|Physician Decision|8|||
48590682|NCT02173379|156354920|FG000|Overall Study|Death|75|||
48590683|NCT02173379|156354921|FG001|Overall Study|Death|72|||
48590684|NCT02173379|156354920|FG000|Overall Study|Other Reason|1|||
48590685|NCT02173379|156354921|FG001|Overall Study|Other Reason|0|||
48590686|NCT00893971|156354925|FG000|Overall Study|Physician Decision|3|||
48590687|NCT05139992|156354926|FG000|Overall Study|Withdrawal by Subject|12|||
48590688|NCT05139992|156354926|FG000|Overall Study|Lost to Follow-up|6|||
48590689|NCT03570892|156354927|FG000|Overall Study|Death|51|||
48693194|NCT04479787|156726366|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
48590690|NCT03570892|156354928|FG001|Overall Study|Death|45|||
48590691|NCT03570892|156354927|FG000|Overall Study|Subject decision|5|||
48590692|NCT03570892|156354928|FG001|Overall Study|Subject decision|3|||
48590693|NCT03570892|156354927|FG000|Overall Study|Protocol Violation|1|||
48590694|NCT03570892|156354928|FG001|Overall Study|Protocol Violation|4|||
48590695|NCT03570892|156354927|FG000|Overall Study|Physician Decision|0|||
48590696|NCT03570892|156354928|FG001|Overall Study|Physician Decision|2|||
48590697|NCT03593226|156354946|FG000|Overall Study|Disease progression|6|||
48590698|NCT03593226|156354947|FG001|Overall Study|Disease progression|13|||
48590699|NCT03593226|156354948|FG002|Overall Study|Disease progression|5|||
48590700|NCT03593226|156354949|FG003|Overall Study|Disease progression|6|||
48590701|NCT03593226|156354946|FG000|Overall Study|Adverse Event|0|||
48590702|NCT03593226|156354947|FG001|Overall Study|Adverse Event|1|||
48590703|NCT03593226|156354948|FG002|Overall Study|Adverse Event|0|||
48590704|NCT03593226|156354949|FG003|Overall Study|Adverse Event|0|||
48590705|NCT03593226|156354946|FG000|Overall Study|Withdrawal by Subject|0|||
48590706|NCT03593226|156354947|FG001|Overall Study|Withdrawal by Subject|4|||
48590707|NCT03593226|156354948|FG002|Overall Study|Withdrawal by Subject|1|||
48590708|NCT03593226|156354949|FG003|Overall Study|Withdrawal by Subject|0|||
48590709|NCT03593226|156354946|FG000|Overall Study|Physician Decision|0|||
48590710|NCT03593226|156354947|FG001|Overall Study|Physician Decision|1|||
48590711|NCT03593226|156354948|FG002|Overall Study|Physician Decision|0|||
48590712|NCT03593226|156354949|FG003|Overall Study|Physician Decision|0|||
48590713|NCT03593226|156354946|FG000|Overall Study|Clinical disease progression|0|||
48590714|NCT03593226|156354947|FG001|Overall Study|Clinical disease progression|0|||
48590715|NCT03593226|156354948|FG002|Overall Study|Clinical disease progression|1|||
48590716|NCT03593226|156354949|FG003|Overall Study|Clinical disease progression|0|||
48590717|NCT03777657|156354950|FG000|Overall Study|Death|397|||
48590718|NCT03777657|156354951|FG001|Overall Study|Death|431|||
48590719|NCT03777657|156354950|FG000|Overall Study|Study Closed by Sponsor|77|||
48590720|NCT03777657|156354951|FG001|Overall Study|Study Closed by Sponsor|38|||
48590721|NCT03777657|156354950|FG000|Overall Study|Withdrawal by Subject|20|||
48590722|NCT03777657|156354951|FG001|Overall Study|Withdrawal by Subject|17|||
48590723|NCT03777657|156354950|FG000|Overall Study|Lost to Follow-up|6|||
48590724|NCT03777657|156354951|FG001|Overall Study|Lost to Follow-up|10|||
48590725|NCT02401815|156354956|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590726|NCT02401815|156354957|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590727|NCT02401815|156354958|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590728|NCT02401815|156354959|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
48590729|NCT02401815|156354960|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590730|NCT02401815|156354961|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590731|NCT02401815|156354962|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590732|NCT02401815|156354963|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590733|NCT02401815|156354964|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590734|NCT02401815|156354965|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
48590735|NCT02401815|156354956|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
48590736|NCT02401815|156354957|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
48590737|NCT02401815|156354958|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
48590738|NCT02401815|156354959|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
48590739|NCT02401815|156354960|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
48590740|NCT02401815|156354961|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
48590741|NCT02401815|156354962|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
48590742|NCT02401815|156354963|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
48590743|NCT02401815|156354964|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
48590744|NCT02401815|156354965|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
48590745|NCT02401815|156354956|FG000|Dose Escalation (up to 670 Days)|Death|1|||
48590746|NCT02401815|156354957|FG001|Dose Escalation (up to 670 Days)|Death|2|||
48590747|NCT02401815|156354958|FG002|Dose Escalation (up to 670 Days)|Death|3|||
48590748|NCT02401815|156354959|FG003|Dose Escalation (up to 670 Days)|Death|5|||
48590749|NCT02401815|156354960|FG004|Dose Escalation (up to 670 Days)|Death|4|||
48590750|NCT02401815|156354961|FG005|Dose Escalation (up to 670 Days)|Death|0|||
48590751|NCT02401815|156354962|FG006|Dose Escalation (up to 670 Days)|Death|0|||
48590752|NCT02401815|156354963|FG007|Dose Escalation (up to 670 Days)|Death|0|||
48590753|NCT02401815|156354964|FG008|Dose Escalation (up to 670 Days)|Death|0|||
48590754|NCT02401815|156354965|FG009|Dose Escalation (up to 670 Days)|Death|0|||
48590755|NCT02401815|156354956|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
48590756|NCT02401815|156354957|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
48590757|NCT02401815|156354958|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
48590758|NCT02401815|156354959|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
48590759|NCT02401815|156354960|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
48590760|NCT02401815|156354961|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
48590761|NCT02401815|156354962|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
48590762|NCT02401815|156354963|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
48590763|NCT02401815|156354964|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
48590764|NCT02401815|156354965|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
48590765|NCT02401815|156354956|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
48590766|NCT02401815|156354957|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
48590767|NCT02401815|156354958|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
48590768|NCT02401815|156354959|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
48590769|NCT02401815|156354960|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
48590770|NCT02401815|156354961|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
48590771|NCT02401815|156354962|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
48590772|NCT02401815|156354963|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
48590773|NCT02401815|156354964|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
48590774|NCT02401815|156354965|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
48590775|NCT02401815|156354956|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590776|NCT02401815|156354957|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590777|NCT02401815|156354958|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590778|NCT02401815|156354959|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590779|NCT02401815|156354960|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590780|NCT02401815|156354961|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
48590781|NCT02401815|156354962|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590782|NCT02401815|156354963|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590783|NCT02401815|156354964|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590784|NCT02401815|156354965|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
48590785|NCT02401815|156354956|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590786|NCT02401815|156354957|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590787|NCT02401815|156354958|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590788|NCT02401815|156354959|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590789|NCT02401815|156354960|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590790|NCT02401815|156354961|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590791|NCT02401815|156354962|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
48590792|NCT02401815|156354963|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590793|NCT02401815|156354964|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590794|NCT02401815|156354965|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590795|NCT02401815|156354956|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
48590796|NCT02401815|156354957|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
48590797|NCT02401815|156354958|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
48590798|NCT02401815|156354959|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
48590799|NCT02401815|156354960|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
48590800|NCT02401815|156354961|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
48590801|NCT02401815|156354962|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
48590802|NCT02401815|156354963|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
48590803|NCT02401815|156354964|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
48590804|NCT02401815|156354965|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
48590805|NCT02401815|156354956|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590806|NCT02401815|156354957|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590807|NCT02401815|156354958|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590808|NCT02401815|156354959|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590809|NCT02401815|156354960|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590810|NCT02401815|156354961|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
48590811|NCT02401815|156354962|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590812|NCT02401815|156354963|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590813|NCT02401815|156354964|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590814|NCT02401815|156354965|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
48590815|NCT02401815|156354956|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
48590816|NCT02401815|156354957|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
48590817|NCT02401815|156354958|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
48590818|NCT02401815|156354959|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
48590819|NCT02401815|156354960|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
48590820|NCT02401815|156354961|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
48590821|NCT02401815|156354962|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
48590822|NCT02401815|156354963|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
48590823|NCT02401815|156354964|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
48590824|NCT02401815|156354965|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
48381894|NCT00375219|155592859|FG000|Overall Study|Withdrawal by Subject|1|||
48381895|NCT00375219|155592860|FG001|Overall Study|Withdrawal by Subject|0|||
48590825|NCT02401815|156354956|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590826|NCT02401815|156354957|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590827|NCT02401815|156354958|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590828|NCT02401815|156354959|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590829|NCT02401815|156354960|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590830|NCT02401815|156354961|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590831|NCT02401815|156354962|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590832|NCT02401815|156354963|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
48590833|NCT02401815|156354964|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
48590834|NCT02401815|156354965|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
48590835|NCT02401815|156354956|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590836|NCT02401815|156354957|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590837|NCT02401815|156354958|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590838|NCT02401815|156354959|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590839|NCT02401815|156354960|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590840|NCT02401815|156354961|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590841|NCT02401815|156354962|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590842|NCT02401815|156354963|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590843|NCT02401815|156354964|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
48590844|NCT02401815|156354965|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
48590845|NCT02401815|156354956|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590846|NCT02401815|156354957|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590847|NCT02401815|156354958|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590848|NCT02401815|156354959|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590849|NCT02401815|156354960|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590850|NCT02401815|156354961|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590851|NCT02401815|156354962|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590852|NCT02401815|156354963|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590853|NCT02401815|156354964|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
48590854|NCT02401815|156354965|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
48590855|NCT02401815|156354956|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
48590856|NCT02401815|156354957|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
48590857|NCT02401815|156354958|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
48590858|NCT02401815|156354959|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
48590859|NCT02401815|156354960|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
48590860|NCT02401815|156354961|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
48590861|NCT02401815|156354962|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
48590862|NCT02401815|156354963|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
48590863|NCT02401815|156354964|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
48590864|NCT02401815|156354965|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
48590865|NCT03829332|156354968|FG000|Overall Study|Death|145|||
48590866|NCT03829332|156354969|FG001|Overall Study|Death|135|||
48590867|NCT03829332|156354968|FG000|Overall Study|Withdrawal by Subject|10|||
48590868|NCT03829332|156354969|FG001|Overall Study|Withdrawal by Subject|4|||
48590869|NCT03829332|156354968|FG000|Overall Study|Ongoing in Study|154|||
48590870|NCT03829332|156354969|FG001|Overall Study|Ongoing in Study|175|||
48590871|NCT05613907|156354970|FG000|Overall Study|Lost to Follow-up|5|||
48590872|NCT05613907|156354970|FG000|Overall Study|Death|3|||
48590873|NCT05613907|156354970|FG000|Overall Study|Withdrawal by Subject|2|||
48590874|NCT04912856|156354971|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
48590875|NCT04912856|156354972|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
48590876|NCT04912856|156354971|FG000|Overall Study|Not reported in synoptic CSR.|0|||
48590877|NCT04912856|156354972|FG001|Overall Study|Not reported in synoptic CSR.|1|||
48590878|NCT03783871|156354973|FG000|Overall Study|Withdrawal by Subject|15|||
48590879|NCT03783871|156354973|FG000|Overall Study|Death|13|||
48590880|NCT03783871|156354973|FG000|Overall Study|Lost to Follow-up|2|||
48590881|NCT04214288|156354974|FG000|Overall Study|Ongoing in the study|41|||
48590882|NCT04214288|156354975|FG001|Overall Study|Ongoing in the study|51|||
48590883|NCT04214288|156354976|FG002|Overall Study|Ongoing in the study|12|||
48590884|NCT04214288|156354977|FG003|Overall Study|Ongoing in the study|39|||
48590885|NCT04214288|156354974|FG000|Overall Study|Adverse Event|1|||
48590886|NCT04214288|156354975|FG001|Overall Study|Adverse Event|0|||
48590887|NCT04214288|156354976|FG002|Overall Study|Adverse Event|0|||
48590888|NCT04214288|156354977|FG003|Overall Study|Adverse Event|0|||
48590889|NCT04214288|156354974|FG000|Overall Study|Death|22|||
48590890|NCT04214288|156354975|FG001|Overall Study|Death|13|||
48590891|NCT04214288|156354976|FG002|Overall Study|Death|7|||
48590892|NCT04214288|156354977|FG003|Overall Study|Death|19|||
48590893|NCT04214288|156354974|FG000|Overall Study|Lost to Follow-up|1|||
48590894|NCT04214288|156354975|FG001|Overall Study|Lost to Follow-up|2|||
48590895|NCT04214288|156354976|FG002|Overall Study|Lost to Follow-up|1|||
48590896|NCT04214288|156354977|FG003|Overall Study|Lost to Follow-up|0|||
48590897|NCT04214288|156354974|FG000|Overall Study|Other|1|||
48590898|NCT04214288|156354975|FG001|Overall Study|Other|2|||
48590899|NCT04214288|156354976|FG002|Overall Study|Other|0|||
48590900|NCT04214288|156354977|FG003|Overall Study|Other|6|||
48590901|NCT04214288|156354974|FG000|Overall Study|Protocol Violation|0|||
48590902|NCT04214288|156354975|FG001|Overall Study|Protocol Violation|1|||
48590903|NCT04214288|156354976|FG002|Overall Study|Protocol Violation|0|||
48590904|NCT04214288|156354977|FG003|Overall Study|Protocol Violation|0|||
48590905|NCT04214288|156354974|FG000|Overall Study|Withdrawal by Subject|8|||
48590906|NCT04214288|156354975|FG001|Overall Study|Withdrawal by Subject|4|||
48590907|NCT04214288|156354976|FG002|Overall Study|Withdrawal by Subject|0|||
48590908|NCT04214288|156354977|FG003|Overall Study|Withdrawal by Subject|9|||
48590909|NCT03317405|156354978|FG000|Overall Study|Withdrawal by Subject|1|||
48590910|NCT03317405|156354979|FG001|Overall Study|Withdrawal by Subject|0|||
48590911|NCT03317405|156354980|FG002|Overall Study|Withdrawal by Subject|0|||
48590912|NCT03317405|156354978|FG000|Overall Study|Physician Decision|0|||
48590913|NCT03317405|156354979|FG001|Overall Study|Physician Decision|0|||
48590914|NCT03317405|156354980|FG002|Overall Study|Physician Decision|1|||
48590915|NCT03317405|156354978|FG000|Overall Study|Surgery Rescheduled|0|||
48590916|NCT03317405|156354979|FG001|Overall Study|Surgery Rescheduled|1|||
48590917|NCT03317405|156354980|FG002|Overall Study|Surgery Rescheduled|0|||
48590918|NCT00549601|156356458|FG000|Randomized|Protocol Violation|0|||
48590919|NCT00549601|156356459|FG001|Randomized|Protocol Violation|0|||
48590920|NCT00549601|156356460|FG002|Randomized|Protocol Violation|1|||
48590921|NCT00549601|156356458|FG000|Randomized|Withdrawal by Subject|0|||
48590922|NCT00549601|156356459|FG001|Randomized|Withdrawal by Subject|1|||
48590923|NCT00549601|156356460|FG002|Randomized|Withdrawal by Subject|1|||
48590924|NCT00549601|156356458|FG000|Received Study Drug|Adverse Event|2|||
48590925|NCT00549601|156356459|FG001|Received Study Drug|Adverse Event|5|||
48590926|NCT00549601|156356460|FG002|Received Study Drug|Adverse Event|1|||
48590927|NCT00549601|156356458|FG000|Received Study Drug|Death|0|||
48590928|NCT00549601|156356459|FG001|Received Study Drug|Death|1|||
48590929|NCT00549601|156356460|FG002|Received Study Drug|Death|0|||
48590930|NCT00549601|156356458|FG000|Received Study Drug|Lost to Follow-up|0|||
48590931|NCT00549601|156356459|FG001|Received Study Drug|Lost to Follow-up|1|||
48590932|NCT00549601|156356460|FG002|Received Study Drug|Lost to Follow-up|1|||
48590933|NCT00549601|156356458|FG000|Received Study Drug|Protocol Violation|3|||
48590934|NCT00549601|156356459|FG001|Received Study Drug|Protocol Violation|4|||
48590935|NCT00549601|156356460|FG002|Received Study Drug|Protocol Violation|1|||
48590936|NCT00549601|156356458|FG000|Received Study Drug|Withdrawal by Subject|2|||
48590937|NCT00549601|156356459|FG001|Received Study Drug|Withdrawal by Subject|0|||
48590938|NCT00549601|156356460|FG002|Received Study Drug|Withdrawal by Subject|1|||
48590939|NCT02227368|156356461|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
48590940|NCT02227368|156356462|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
48590941|NCT02227368|156356461|FG000|Overall Study|Lost to Follow-up|1|||
48590942|NCT02227368|156356462|FG001|Overall Study|Lost to Follow-up|0|||
48590943|NCT02227368|156356461|FG000|Overall Study|Adverse Event|1|||
48590944|NCT02227368|156356462|FG001|Overall Study|Adverse Event|0|||
48590945|NCT02824562|156356463|FG000|Overall Study|Lost to Follow-up|3|||
48590946|NCT02824562|156356464|FG001|Overall Study|Lost to Follow-up|4|||
48590947|NCT02824562|156356463|FG000|Overall Study|Death|0|||
48590948|NCT02824562|156356464|FG001|Overall Study|Death|1|||
48590949|NCT00224406|156356468|FG000|Overall Study|Re-transplant|0|||
48590950|NCT00224406|156356469|FG001|Overall Study|Re-transplant|2|||
48590951|NCT00224406|156356468|FG000|Overall Study|Death|0|||
48590952|NCT00224406|156356469|FG001|Overall Study|Death|1|||
48590953|NCT00224406|156356468|FG000|Overall Study|Transplant cancelled|0|||
48590954|NCT00224406|156356469|FG001|Overall Study|Transplant cancelled|4|||
48590955|NCT00224406|156356468|FG000|Overall Study|Drug not delivered|2|||
48590956|NCT00224406|156356469|FG001|Overall Study|Drug not delivered|0|||
48590957|NCT00224406|156356468|FG000|Overall Study|Other|4|||
48590958|NCT00224406|156356469|FG001|Overall Study|Other|0|||
48590959|NCT00224406|156356468|FG000|Overall Study|Transplant cancelled|3|||
48590960|NCT00224406|156356469|FG001|Overall Study|Transplant cancelled|0|||
48590961|NCT01390428|156356470|FG000|Overall Study|Elective Surgery|0|||
48590962|NCT01390428|156356471|FG001|Overall Study|Elective Surgery|0|||
48590963|NCT01390428|156356472|FG002|Overall Study|Elective Surgery|0|||
48590964|NCT01390428|156356473|FG003|Overall Study|Elective Surgery|0|||
48590965|NCT01390428|156356474|FG004|Overall Study|Elective Surgery|1|||
48590966|NCT01390428|156356475|FG005|Overall Study|Elective Surgery|0|||
48590967|NCT01390428|156356470|FG000|Overall Study|Withdrawal by Subject|0|||
48590968|NCT01390428|156356471|FG001|Overall Study|Withdrawal by Subject|0|||
48590969|NCT01390428|156356472|FG002|Overall Study|Withdrawal by Subject|1|||
48590970|NCT01390428|156356473|FG003|Overall Study|Withdrawal by Subject|0|||
48590971|NCT01390428|156356474|FG004|Overall Study|Withdrawal by Subject|0|||
48590972|NCT01390428|156356475|FG005|Overall Study|Withdrawal by Subject|0|||
48590973|NCT01687283|156356476|FG000|Overall Study|Adverse Event|11|||
48590974|NCT01687283|156356477|FG001|Overall Study|Adverse Event|4|||
48590975|NCT01687283|156356476|FG000|Overall Study|Lack of Efficacy|3|||
48590976|NCT01687283|156356477|FG001|Overall Study|Lack of Efficacy|1|||
48590977|NCT01687283|156356476|FG000|Overall Study|Protocol Violation|1|||
48590978|NCT01687283|156356477|FG001|Overall Study|Protocol Violation|3|||
48590979|NCT01687283|156356476|FG000|Overall Study|protocol defined stopping criteria|8|||
48590980|NCT01687283|156356477|FG001|Overall Study|protocol defined stopping criteria|10|||
48590981|NCT01687283|156356476|FG000|Overall Study|Lost to Follow-up|1|||
48590982|NCT01687283|156356477|FG001|Overall Study|Lost to Follow-up|1|||
48590983|NCT01687283|156356476|FG000|Overall Study|Investigator discretion|2|||
48590984|NCT01687283|156356477|FG001|Overall Study|Investigator discretion|0|||
48590985|NCT01687283|156356476|FG000|Overall Study|Withdrawal by Subject|9|||
48590986|NCT01687283|156356477|FG001|Overall Study|Withdrawal by Subject|8|||
48590987|NCT02913105|156356478|FG000|Overall Study|Adverse Event|11|||
48590988|NCT02913105|156356479|FG001|Overall Study|Adverse Event|0|||
48590989|NCT02913105|156356480|FG002|Overall Study|Adverse Event|4|||
48590990|NCT02913105|156356478|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48590991|NCT02913105|156356479|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48590992|NCT02913105|156356480|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48590993|NCT02913105|156356478|FG000|Overall Study|Reason Not Specified|3|||
48590994|NCT02913105|156356479|FG001|Overall Study|Reason Not Specified|1|||
48590995|NCT02913105|156356480|FG002|Overall Study|Reason Not Specified|1|||
48590996|NCT02913105|156356478|FG000|Overall Study|Physician Decision|1|||
48590997|NCT02913105|156356479|FG001|Overall Study|Physician Decision|1|||
48590998|NCT02913105|156356480|FG002|Overall Study|Physician Decision|0|||
48590999|NCT02913105|156356478|FG000|Overall Study|Withdrawal by Subject|0|||
48591000|NCT02913105|156356479|FG001|Overall Study|Withdrawal by Subject|3|||
48591001|NCT02913105|156356480|FG002|Overall Study|Withdrawal by Subject|1|||
48591002|NCT01556997|156356481|FG000|Overall Study|Adverse Event|10|||
48591003|NCT01556997|156356482|FG001|Overall Study|Adverse Event|12|||
48591004|NCT01556997|156356483|FG002|Overall Study|Adverse Event|12|||
48591005|NCT01556997|156356481|FG000|Overall Study|Lost to Follow-up|6|||
48591006|NCT01556997|156356482|FG001|Overall Study|Lost to Follow-up|6|||
48591007|NCT01556997|156356483|FG002|Overall Study|Lost to Follow-up|4|||
48591008|NCT01556997|156356481|FG000|Overall Study|Physician Decision|1|||
48591009|NCT01556997|156356482|FG001|Overall Study|Physician Decision|1|||
48591010|NCT01556997|156356483|FG002|Overall Study|Physician Decision|1|||
48591011|NCT01556997|156356481|FG000|Overall Study|Withdrawal by Subject|7|||
48591012|NCT01556997|156356482|FG001|Overall Study|Withdrawal by Subject|6|||
48591013|NCT01556997|156356483|FG002|Overall Study|Withdrawal by Subject|8|||
48591014|NCT01556997|156356481|FG000|Overall Study|Other|2|||
48591015|NCT01556997|156356482|FG001|Overall Study|Other|3|||
48591016|NCT01556997|156356483|FG002|Overall Study|Other|7|||
48591017|NCT00994214|156356484|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
48591018|NCT00994214|156356485|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
48591019|NCT00994214|156356486|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
48591020|NCT00994214|156356487|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
48591021|NCT00994214|156356484|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
48591022|NCT00994214|156356485|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
48591023|NCT00994214|156356486|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
48591024|NCT00994214|156356487|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
48591025|NCT00994214|156356484|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
48591026|NCT00994214|156356485|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
48591027|NCT00994214|156356486|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
48591028|NCT00994214|156356487|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
48591029|NCT00994214|156356484|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
48591030|NCT00994214|156356485|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
48591031|NCT00994214|156356486|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
48591032|NCT00994214|156356487|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
48591033|NCT00994214|156356484|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
48591034|NCT00994214|156356485|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
48591035|NCT00994214|156356486|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
48591036|NCT00994214|156356487|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
48591037|NCT00994214|156356484|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
48591038|NCT00994214|156356485|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
48591039|NCT00994214|156356486|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
48591040|NCT00994214|156356487|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
48591041|NCT00290693|156356493|FG000|Overall Study|Withdrawal by Subject|2|||
48591042|NCT02907619|156356498|FG000|Overall Study|Study terminated by sponsor|18|||
48591043|NCT02907619|156356499|FG001|Overall Study|Study terminated by sponsor|18|||
48591044|NCT02907619|156356500|FG002|Overall Study|Study terminated by sponsor|19|||
48591045|NCT02907619|156356498|FG000|Overall Study|Death|0|||
48591046|NCT02907619|156356499|FG001|Overall Study|Death|0|||
48591047|NCT02907619|156356500|FG002|Overall Study|Death|1|||
48591048|NCT02907619|156356498|FG000|Overall Study|Withdrawal by Subject|1|||
48591049|NCT02907619|156356499|FG001|Overall Study|Withdrawal by Subject|1|||
48591050|NCT02907619|156356500|FG002|Overall Study|Withdrawal by Subject|0|||
48591051|NCT02907619|156356498|FG000|Overall Study|Other|0|||
48591052|NCT02907619|156356499|FG001|Overall Study|Other|1|||
48591053|NCT02907619|156356500|FG002|Overall Study|Other|0|||
48591054|NCT04126317|156356501|FG000|Overall Study|Adverse Event|0|||
48591055|NCT04126317|156356502|FG001|Overall Study|Adverse Event|1|||
48591056|NCT04126317|156356501|FG000|Overall Study|Withdrawal by Subject|4|||
48591057|NCT04126317|156356502|FG001|Overall Study|Withdrawal by Subject|1|||
48591058|NCT03326518|156356503|FG000|Overall Study|Protocol Violation|1|||
48591059|NCT03326518|156356504|FG001|Overall Study|Protocol Violation|0|||
48591060|NCT03326518|156356505|FG002|Overall Study|Protocol Violation|0|||
48591061|NCT03326518|156356503|FG000|Overall Study|Withdrawal by Subject|1|||
48591062|NCT03326518|156356504|FG001|Overall Study|Withdrawal by Subject|0|||
48591063|NCT03326518|156356505|FG002|Overall Study|Withdrawal by Subject|0|||
48591064|NCT03326518|156356503|FG000|Overall Study|Lost to Follow-up|1|||
48591065|NCT03326518|156356504|FG001|Overall Study|Lost to Follow-up|0|||
48591066|NCT03326518|156356505|FG002|Overall Study|Lost to Follow-up|1|||
48591067|NCT01375374|156356506|FG000|Overall Study|Adverse Event|1|||
48591068|NCT01908582|156356507|FG000|Period 2|Physician Decision|1|||
48591069|NCT01908582|156356507|FG000|Period 2|Withdrawal by Subject|1|||
48591070|NCT01066663|156356509|FG000|Overall Study|Adverse Event|0|||
48591071|NCT01066663|156356510|FG001|Overall Study|Adverse Event|0|||
48591072|NCT01066663|156356511|FG002|Overall Study|Adverse Event|1|||
48591073|NCT00707980|156356512|FG000|Overall Study|Adverse Event|49|||
48591074|NCT00707980|156356512|FG000|Overall Study|Lack of Efficacy|35|||
48591075|NCT00707980|156356512|FG000|Overall Study|Non-Compliance with Study Drug|28|||
48591076|NCT00707980|156356512|FG000|Overall Study|Protocol Deviations|19|||
48591077|NCT00707980|156356512|FG000|Overall Study|Withdrawal of Consent|81|||
48591078|NCT00707980|156356512|FG000|Overall Study|Lost to Follow-up|59|||
48591079|NCT00707980|156356512|FG000|Overall Study|Other|39|||
48591080|NCT04401202|156356513|FG000|Overall Study|Lost to Follow-up|2|||
48591081|NCT04401202|156356514|FG001|Overall Study|Lost to Follow-up|2|||
48591082|NCT04401202|156356513|FG000|Overall Study|Adverse Event|0|||
48591083|NCT04401202|156356514|FG001|Overall Study|Adverse Event|1|||
48591084|NCT04401202|156356513|FG000|Overall Study|Hospitalized|4|||
48591085|NCT04401202|156356514|FG001|Overall Study|Hospitalized|1|||
48591086|NCT00631163|156356515|FG000|Number of Participants in Year 1|Adverse Event|12|||
48591087|NCT00631163|156356515|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
48591088|NCT00631163|156356515|FG000|Number of Participants in Year 1|Death|6|||
48591089|NCT00631163|156356515|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
48591090|NCT00631163|156356515|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
48591091|NCT00631163|156356515|FG000|Number of Participants in Year 1|Administrative problems|6|||
48591092|NCT00631163|156356515|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
48591093|NCT00631163|156356515|FG000|Number of Participants in Year 2|Adverse Event|1|||
48591094|NCT00631163|156356515|FG000|Number of Participants in Year 2|Protocol Violation|1|||
48591095|NCT00631163|156356515|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
48591096|NCT00253370|156356516|FG000|Overall Study|Adverse Event|18|||
48591097|NCT00253370|156356516|FG000|Overall Study|Disease progression|13|||
48591098|NCT00253370|156356516|FG000|Overall Study|Death|2|||
48591099|NCT00253370|156356516|FG000|Overall Study|Withdrawal by Subject|6|||
48591100|NCT00253370|156356516|FG000|Overall Study|Non-protocol therapy|1|||
48591101|NCT00253370|156356516|FG000|Overall Study|Physician Decision|1|||
48591102|NCT00253370|156356516|FG000|Overall Study|Protocol Violation|1|||
48591103|NCT00253370|156356516|FG000|Overall Study|Abdominal pain due to disease|1|||
48591104|NCT00004088|156356517|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
48591105|NCT00004088|156356517|FG000|Overall Study|Withdrawal by Subject|1|||
48591106|NCT00004088|156356517|FG000|Overall Study|Protocol Violation|3|||
48591107|NCT00004088|156356517|FG000|Overall Study|Physician Decision|1|||
48591108|NCT00099632|156356526|FG000|Overall Study|Lost to Follow-up|1|||
48591109|NCT00099632|156356527|FG001|Overall Study|Lost to Follow-up|0|||
48591110|NCT00099632|156356528|FG002|Overall Study|Lost to Follow-up|3|||
48591111|NCT00099632|156356529|FG003|Overall Study|Lost to Follow-up|1|||
48591112|NCT00099632|156356530|FG004|Overall Study|Lost to Follow-up|1|||
48591113|NCT00099632|156356531|FG005|Overall Study|Lost to Follow-up|0|||
48591114|NCT00099632|156356526|FG000|Overall Study|Withdrawal by Subject|0|||
48591115|NCT00099632|156356527|FG001|Overall Study|Withdrawal by Subject|1|||
48591116|NCT00099632|156356528|FG002|Overall Study|Withdrawal by Subject|0|||
48591117|NCT00099632|156356529|FG003|Overall Study|Withdrawal by Subject|0|||
48591118|NCT00099632|156356530|FG004|Overall Study|Withdrawal by Subject|0|||
48591119|NCT00099632|156356531|FG005|Overall Study|Withdrawal by Subject|1|||
48591120|NCT00099632|156356526|FG000|Overall Study|Protocol Violation|0|||
48591121|NCT00099632|156356527|FG001|Overall Study|Protocol Violation|0|||
48591122|NCT00099632|156356528|FG002|Overall Study|Protocol Violation|0|||
48591123|NCT00099632|156356529|FG003|Overall Study|Protocol Violation|0|||
48591124|NCT00099632|156356530|FG004|Overall Study|Protocol Violation|0|||
48591125|NCT00099632|156356531|FG005|Overall Study|Protocol Violation|1|||
48591126|NCT03882957|156356536|FG000|Overall Study|Did not complete all three arms|1|||
48591127|NCT00369161|156356537|FG000|Overall Study|Adverse Event|15|||
48591128|NCT00369161|156356538|FG001|Overall Study|Adverse Event|13|||
48591129|NCT00369161|156356537|FG000|Overall Study|Abnormal laboratory value|0|||
48591130|NCT00369161|156356538|FG001|Overall Study|Abnormal laboratory value|1|||
48591131|NCT00369161|156356537|FG000|Overall Study|Lack of Efficacy|3|||
48591132|NCT00369161|156356538|FG001|Overall Study|Lack of Efficacy|1|||
48591133|NCT00369161|156356537|FG000|Overall Study|Protocol Violation|0|||
48591134|NCT00369161|156356538|FG001|Overall Study|Protocol Violation|2|||
48591135|NCT00369161|156356537|FG000|Overall Study|Withdrawal by Subject|2|||
48591136|NCT00369161|156356538|FG001|Overall Study|Withdrawal by Subject|3|||
48591137|NCT00369161|156356537|FG000|Overall Study|Death|1|||
48591138|NCT00369161|156356538|FG001|Overall Study|Death|2|||
48591139|NCT00369161|156356537|FG000|Overall Study|Graft loss|4|||
48591140|NCT00369161|156356538|FG001|Overall Study|Graft loss|0|||
48591141|NCT00369161|156356537|FG000|Overall Study|Administrative Problem|2|||
48591142|NCT00369161|156356538|FG001|Overall Study|Administrative Problem|2|||
48591143|NCT02191046|156356539|FG000|Overall Study|low compliance|5|||
48591144|NCT02191046|156356540|FG001|Overall Study|low compliance|1|||
48591145|NCT02347072|156356541|FG000|Overall Study|Adverse Event|2|||
48591146|NCT02347072|156356541|FG000|Overall Study|Withdrawal by Subject|6|||
48591147|NCT02347072|156356541|FG000|Overall Study|Physician Decision|1|||
48591148|NCT02347072|156356541|FG000|Overall Study|Lost to Follow-up|2|||
48591149|NCT02347072|156356541|FG000|Overall Study|Protocol Violation|1|||
48591150|NCT02347072|156356541|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
48591151|NCT01964716|156356542|FG000|Overall Study|Withdrawal by Subject|2|||
48591152|NCT01964716|156356543|FG001|Overall Study|Withdrawal by Subject|3|||
48591153|NCT01964716|156356542|FG000|Overall Study|Lost to Follow-up|1|||
48591154|NCT01964716|156356543|FG001|Overall Study|Lost to Follow-up|2|||
48591155|NCT01964716|156356542|FG000|Overall Study|No longer met eligibility criteria|1|||
48591156|NCT01964716|156356543|FG001|Overall Study|No longer met eligibility criteria|1|||
48591157|NCT01964716|156356542|FG000|Overall Study|Death|1|||
48591158|NCT01964716|156356543|FG001|Overall Study|Death|0|||
48591159|NCT01464619|156356547|FG000|Overall Study|Lost to Follow-up|3|||
48591160|NCT01464619|156356548|FG001|Overall Study|Lost to Follow-up|4|||
48591161|NCT00404924|156356549|FG000|Overall Study|Adverse Event|75|||
48591162|NCT00404924|156356550|FG001|Overall Study|Adverse Event|16|||
48591163|NCT00404924|156356549|FG000|Overall Study|Condition under investigation worsened|475|||
48591164|NCT00404924|156356550|FG001|Overall Study|Condition under investigation worsened|264|||
48591165|NCT00404924|156356549|FG000|Overall Study|Lost to Follow-up|1|||
48591166|NCT00404924|156356550|FG001|Overall Study|Lost to Follow-up|1|||
48591167|NCT00404924|156356549|FG000|Overall Study|Withdrawal by Subject|26|||
48591168|NCT00404924|156356550|FG001|Overall Study|Withdrawal by Subject|13|||
48591169|NCT00404924|156356549|FG000|Overall Study|Other|25|||
48591170|NCT00404924|156356550|FG001|Overall Study|Other|11|||
48591171|NCT00404924|156356549|FG000|Overall Study|Randomised but not received treatment|1|||
48591172|NCT00404924|156356550|FG001|Overall Study|Randomised but not received treatment|1|||
48591173|NCT03148067|156356552|FG000|Overall Study|Lost to Follow-up|3|||
48591174|NCT03148067|156356552|FG000|Overall Study|Death|1|||
48591175|NCT01404949|156356560|FG000|Overall Study|Not Treated|1|||
48591176|NCT04074330|156356561|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
48591177|NCT04074330|156356562|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
48591178|NCT04074330|156356563|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
48591179|NCT04074330|156356564|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
48591180|NCT04074330|156356565|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
48591181|NCT04074330|156356566|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
48591182|NCT04074330|156356567|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
48591183|NCT04074330|156356568|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
48591184|NCT04074330|156356569|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
48591185|NCT04074330|156356570|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
48591186|NCT04074330|156356561|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
48591187|NCT04074330|156356562|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
48591188|NCT04074330|156356563|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
48591189|NCT04074330|156356564|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
48591190|NCT04074330|156356565|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
48591191|NCT04074330|156356566|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
48591192|NCT04074330|156356567|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
48693195|NCT04479787|156726367|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
48591193|NCT04074330|156356568|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
48591194|NCT04074330|156356569|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
48591195|NCT04074330|156356570|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
48591196|NCT04074330|156356561|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591197|NCT04074330|156356562|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591198|NCT04074330|156356563|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
48591199|NCT04074330|156356564|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591200|NCT04074330|156356565|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591201|NCT04074330|156356566|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591202|NCT04074330|156356567|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591203|NCT04074330|156356568|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591204|NCT04074330|156356569|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591205|NCT04074330|156356570|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
48591206|NCT04074330|156356561|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
48591207|NCT04074330|156356562|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
48591208|NCT04074330|156356563|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
48591209|NCT04074330|156356564|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
48591210|NCT04074330|156356565|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
48591211|NCT04074330|156356566|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
48591212|NCT04074330|156356567|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
48591213|NCT04074330|156356568|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
48591214|NCT04074330|156356569|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
48591215|NCT04074330|156356570|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
48591216|NCT04074330|156356561|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
48591217|NCT04074330|156356562|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
48591218|NCT04074330|156356563|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
48591219|NCT04074330|156356564|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
48591220|NCT04074330|156356565|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
48591221|NCT04074330|156356566|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
48591222|NCT04074330|156356567|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
48591223|NCT04074330|156356568|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
48591224|NCT04074330|156356569|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
48591225|NCT04074330|156356570|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
48591226|NCT04074330|156356561|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
48591227|NCT04074330|156356562|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
48591228|NCT04074330|156356563|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
48591229|NCT04074330|156356564|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
48591230|NCT04074330|156356565|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
48591231|NCT04074330|156356566|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
48591232|NCT04074330|156356567|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
48591233|NCT04074330|156356568|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
48591234|NCT04074330|156356569|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
48591235|NCT04074330|156356570|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
48591236|NCT04074330|156356561|FG000|Dose Expansion (up to 42 Months)|Death|0|||
48591237|NCT04074330|156356562|FG001|Dose Expansion (up to 42 Months)|Death|0|||
48591238|NCT04074330|156356563|FG002|Dose Expansion (up to 42 Months)|Death|0|||
48591239|NCT04074330|156356564|FG003|Dose Expansion (up to 42 Months)|Death|0|||
48591240|NCT04074330|156356565|FG004|Dose Expansion (up to 42 Months)|Death|0|||
48591241|NCT04074330|156356566|FG005|Dose Expansion (up to 42 Months)|Death|0|||
48591242|NCT04074330|156356567|FG006|Dose Expansion (up to 42 Months)|Death|0|||
48591243|NCT04074330|156356568|FG007|Dose Expansion (up to 42 Months)|Death|0|||
48591244|NCT04074330|156356569|FG008|Dose Expansion (up to 42 Months)|Death|1|||
48591245|NCT04074330|156356570|FG009|Dose Expansion (up to 42 Months)|Death|0|||
48591246|NCT04074330|156356561|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
48591247|NCT04074330|156356562|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
48591248|NCT04074330|156356563|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
48591249|NCT04074330|156356564|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
48591250|NCT04074330|156356565|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
48591251|NCT04074330|156356566|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
48591252|NCT04074330|156356567|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
48591253|NCT04074330|156356568|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
48591254|NCT04074330|156356569|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
48591255|NCT04074330|156356570|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
48591256|NCT00791492|156356571|FG000|Overall Study|Withdrawal by Subject|1|||
48591257|NCT00791492|156356572|FG001|Overall Study|Withdrawal by Subject|2|||
48591258|NCT00791492|156356571|FG000|Overall Study|Liver transplantation|5|||
48591259|NCT00791492|156356572|FG001|Overall Study|Liver transplantation|1|||
48591260|NCT02282163|156356573|FG000|Overall Study|Protocol Violation|1|||
48591261|NCT00731731|156356574|FG000|Overall Study|Protocol Violation|0|||
48591262|NCT00731731|156356575|FG001|Overall Study|Protocol Violation|0|||
48591263|NCT00731731|156356576|FG002|Overall Study|Protocol Violation|1|||
48591264|NCT00731731|156356574|FG000|Overall Study|Cancel prior to treatment|0|||
48591265|NCT00731731|156356575|FG001|Overall Study|Cancel prior to treatment|0|||
48591266|NCT00731731|156356576|FG002|Overall Study|Cancel prior to treatment|2|||
48591267|NCT02324699|156356577|FG000|Overall Study|study terminated|1|||
48591268|NCT03970200|156356578|FG000|Overall Study|Death|2|||
48591269|NCT03970200|156356579|FG001|Overall Study|Death|2|||
48591270|NCT03970200|156356580|FG002|Overall Study|Death|1|||
48591271|NCT03970200|156356578|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
48591272|NCT03970200|156356579|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
48591273|NCT03970200|156356580|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
48591274|NCT01216332|156356585|FG000|Overall Study|Withdrawal by Subject|4|||
48591275|NCT01216332|156356586|FG001|Overall Study|Withdrawal by Subject|0|||
48591276|NCT02510820|156358810|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
48591277|NCT02510820|156358811|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48591278|NCT02510820|156358810|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48591279|NCT02510820|156358811|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48591280|NCT02417961|156358817|FG000|Overall Study|Adverse Event|1|||
48591281|NCT02417961|156358817|FG000|Overall Study|Lost to Follow-up|1|||
48591282|NCT02417961|156358817|FG000|Overall Study|Withdrawal by Subject|2|||
48591283|NCT03046056|156358818|FG000|Overall Study|Non-responder at Week 10|6|||
48591284|NCT03046056|156358819|FG001|Overall Study|Non-responder at Week 10|6|||
48591285|NCT03046056|156358820|FG002|Overall Study|Non-responder at Week 10|4|||
48591286|NCT03046056|156358818|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
48591287|NCT03046056|156358819|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
48591288|NCT03046056|156358820|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
48591289|NCT03046056|156358818|FG000|Overall Study|Adverse Event|1|||
48591290|NCT03046056|156358819|FG001|Overall Study|Adverse Event|5|||
48591291|NCT03046056|156358820|FG002|Overall Study|Adverse Event|0|||
48591292|NCT03046056|156358818|FG000|Overall Study|Non-compliance With Study Drug|0|||
48591293|NCT03046056|156358819|FG001|Overall Study|Non-compliance With Study Drug|0|||
48591294|NCT03046056|156358820|FG002|Overall Study|Non-compliance With Study Drug|2|||
48591295|NCT03046056|156358818|FG000|Overall Study|Protocol Violation|1|||
48591296|NCT03046056|156358819|FG001|Overall Study|Protocol Violation|1|||
48591297|NCT03046056|156358820|FG002|Overall Study|Protocol Violation|0|||
48591298|NCT03046056|156358818|FG000|Overall Study|Investigator's Discretion|0|||
48591299|NCT03046056|156358819|FG001|Overall Study|Investigator's Discretion|1|||
48591300|NCT03046056|156358820|FG002|Overall Study|Investigator's Discretion|0|||
48591301|NCT03046056|156358818|FG000|Overall Study|Withdrew Consent|1|||
48591302|NCT03046056|156358819|FG001|Overall Study|Withdrew Consent|0|||
48591303|NCT03046056|156358820|FG002|Overall Study|Withdrew Consent|0|||
48591304|NCT03089853|156358821|FG000|Overall Study|Lost to Follow-up|2|||
48591305|NCT03089853|156358822|FG001|Overall Study|Lost to Follow-up|1|||
48591306|NCT00642954|156358823|FG000|Overall Study|Progressive Disease|3|||
48591307|NCT00642954|156358824|FG001|Overall Study|Progressive Disease|3|||
48591308|NCT00642954|156358825|FG002|Overall Study|Progressive Disease|3|||
48591309|NCT00642954|156358826|FG003|Overall Study|Progressive Disease|3|||
48591310|NCT00642954|156358827|FG004|Overall Study|Progressive Disease|9|||
48591311|NCT00642954|156358823|FG000|Overall Study|Withdrawal by Subject|0|||
48591312|NCT00642954|156358824|FG001|Overall Study|Withdrawal by Subject|0|||
48591313|NCT00642954|156358825|FG002|Overall Study|Withdrawal by Subject|0|||
48591314|NCT00642954|156358826|FG003|Overall Study|Withdrawal by Subject|0|||
48591315|NCT00642954|156358827|FG004|Overall Study|Withdrawal by Subject|1|||
48591316|NCT00642954|156358823|FG000|Overall Study|Adverse Event|1|||
48591317|NCT00642954|156358824|FG001|Overall Study|Adverse Event|1|||
48591318|NCT00642954|156358825|FG002|Overall Study|Adverse Event|0|||
48591319|NCT00642954|156358826|FG003|Overall Study|Adverse Event|0|||
48591320|NCT00642954|156358827|FG004|Overall Study|Adverse Event|6|||
48591321|NCT01317004|156358828|FG000|Overall Study|Withdrawal by Subject|1|||
48591322|NCT01317004|156358829|FG001|Overall Study|Withdrawal by Subject|4|||
48591323|NCT01317004|156358828|FG000|Overall Study|Protocol Violation|0|||
48591324|NCT01317004|156358829|FG001|Overall Study|Protocol Violation|2|||
48591325|NCT01317004|156358828|FG000|Overall Study|Adverse Event|3|||
48591326|NCT01317004|156358829|FG001|Overall Study|Adverse Event|3|||
48591327|NCT02437188|156358832|FG000|Overall Study|Randomized but did not receive surgery|4|||
48591328|NCT02437188|156358833|FG001|Overall Study|Randomized but did not receive surgery|8|||
48591329|NCT02437188|156358832|FG000|Overall Study|Adverse Event|0|||
48591330|NCT02437188|156358833|FG001|Overall Study|Adverse Event|1|||
48591331|NCT01172808|156358836|FG000|Overall Study|Adverse Event|8|||
48591332|NCT01172808|156358837|FG001|Overall Study|Adverse Event|4|||
48591333|NCT01172808|156358838|FG002|Overall Study|Adverse Event|8|||
48591334|NCT01172808|156358839|FG003|Overall Study|Adverse Event|3|||
48591335|NCT01172808|156358836|FG000|Overall Study|Lack of Efficacy|1|||
48591336|NCT01172808|156358837|FG001|Overall Study|Lack of Efficacy|0|||
48591337|NCT01172808|156358838|FG002|Overall Study|Lack of Efficacy|0|||
48591338|NCT01172808|156358839|FG003|Overall Study|Lack of Efficacy|0|||
48591339|NCT01172808|156358836|FG000|Overall Study|Protocol Violation|2|||
48591340|NCT01172808|156358837|FG001|Overall Study|Protocol Violation|2|||
48591341|NCT01172808|156358838|FG002|Overall Study|Protocol Violation|2|||
48591342|NCT01172808|156358839|FG003|Overall Study|Protocol Violation|0|||
48591343|NCT01172808|156358836|FG000|Overall Study|Lost to Follow-up|0|||
48591344|NCT01172808|156358837|FG001|Overall Study|Lost to Follow-up|1|||
48591345|NCT01172808|156358838|FG002|Overall Study|Lost to Follow-up|1|||
48591346|NCT01172808|156358839|FG003|Overall Study|Lost to Follow-up|3|||
48591347|NCT01172808|156358836|FG000|Overall Study|Withdrawal by Subject|4|||
48591348|NCT01172808|156358837|FG001|Overall Study|Withdrawal by Subject|1|||
48591349|NCT01172808|156358838|FG002|Overall Study|Withdrawal by Subject|3|||
48591350|NCT01172808|156358839|FG003|Overall Study|Withdrawal by Subject|2|||
48591351|NCT01172808|156358836|FG000|Overall Study|Other|6|||
48591352|NCT01172808|156358837|FG001|Overall Study|Other|5|||
48591353|NCT01172808|156358838|FG002|Overall Study|Other|9|||
48591354|NCT01172808|156358839|FG003|Overall Study|Other|7|||
48591355|NCT02661061|156358843|FG000|Overall Study|Lack of Efficacy|1|||
48591356|NCT02661061|156358844|FG001|Overall Study|Lack of Efficacy|1|||
48591357|NCT02661061|156358843|FG000|Overall Study|Withdrawal by Subject|1|||
48591358|NCT02661061|156358844|FG001|Overall Study|Withdrawal by Subject|1|||
48591359|NCT01393106|156358846|FG000|Overall Study|Adverse Event|3|||
48591360|NCT01393106|156358846|FG000|Overall Study|Withdrawal by Subject|1|||
48591361|NCT01393106|156358846|FG000|Overall Study|Lack of Efficacy|1|||
48591362|NCT03041467|156358847|FG000|Overall Study|Death|46|||
48591363|NCT03041467|156358848|FG001|Overall Study|Death|39|||
48591364|NCT03041467|156358847|FG000|Overall Study|Withdrawal by Subject|36|||
48591365|NCT03041467|156358848|FG001|Overall Study|Withdrawal by Subject|37|||
48591366|NCT03041467|156358847|FG000|Overall Study|Lost to Follow-up|6|||
48591367|NCT03041467|156358848|FG001|Overall Study|Lost to Follow-up|8|||
48591368|NCT03041467|156358847|FG000|Overall Study|Declined consent for study extension|21|||
48591369|NCT03041467|156358848|FG001|Overall Study|Declined consent for study extension|33|||
48591370|NCT03041467|156358847|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
48591371|NCT03041467|156358848|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
48591372|NCT03396822|156358849|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
48591373|NCT03396822|156358849|FG000|Overall Study|Physician Decision|1|||
48591374|NCT02732015|156358852|FG000|Overall Study|Lost to Follow-up|0|||
48591375|NCT02732015|156358853|FG001|Overall Study|Lost to Follow-up|1|||
48591376|NCT02578940|156358858|FG000|Overall Study|Screening failure|5|||
48591377|NCT02578940|156358858|FG000|Overall Study|Lost to Follow-up|1|||
48591378|NCT03774394|156358862|FG000|Overall Study|Withdrawal by Subject|2|||
48591379|NCT03774394|156358863|FG001|Overall Study|Withdrawal by Subject|0|||
48591380|NCT03334422|156358864|FG000|Overall Study|Adverse Event|1|||
48591381|NCT03334422|156358865|FG001|Overall Study|Adverse Event|3|||
48591382|NCT03334422|156358866|FG002|Overall Study|Adverse Event|2|||
48591383|NCT03334422|156358867|FG003|Overall Study|Adverse Event|2|||
48591384|NCT03334422|156358864|FG000|Overall Study|Lack of Efficacy|10|||
48591385|NCT03334422|156358865|FG001|Overall Study|Lack of Efficacy|2|||
48591386|NCT03334422|156358866|FG002|Overall Study|Lack of Efficacy|7|||
48591387|NCT03334422|156358867|FG003|Overall Study|Lack of Efficacy|3|||
48591388|NCT03334422|156358864|FG000|Overall Study|Withdrawal by Subject|8|||
48591389|NCT03334422|156358865|FG001|Overall Study|Withdrawal by Subject|3|||
48591390|NCT03334422|156358866|FG002|Overall Study|Withdrawal by Subject|1|||
48591391|NCT03334422|156358867|FG003|Overall Study|Withdrawal by Subject|0|||
48591392|NCT03334422|156358864|FG000|Overall Study|Lost to Follow-up|0|||
48591393|NCT03334422|156358865|FG001|Overall Study|Lost to Follow-up|0|||
48591394|NCT03334422|156358866|FG002|Overall Study|Lost to Follow-up|0|||
48591395|NCT03334422|156358867|FG003|Overall Study|Lost to Follow-up|1|||
48591396|NCT03334422|156358864|FG000|Overall Study|Inability to obtain laboratory samples|0|||
48591397|NCT03334422|156358865|FG001|Overall Study|Inability to obtain laboratory samples|1|||
48591398|NCT03334422|156358866|FG002|Overall Study|Inability to obtain laboratory samples|0|||
48591399|NCT03334422|156358867|FG003|Overall Study|Inability to obtain laboratory samples|0|||
48591400|NCT03334422|156358864|FG000|Overall Study|Pregnancy|0|||
48591401|NCT03334422|156358865|FG001|Overall Study|Pregnancy|1|||
48591402|NCT03334422|156358866|FG002|Overall Study|Pregnancy|0|||
48591403|NCT03334422|156358867|FG003|Overall Study|Pregnancy|0|||
48591404|NCT02362425|156358868|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
48591405|NCT02362425|156358869|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
48591406|NCT02362425|156358870|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
48591407|NCT02362425|156358871|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
48591408|NCT02362425|156358868|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
48591409|NCT02362425|156358869|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
48591410|NCT02362425|156358870|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
48591411|NCT02362425|156358871|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
48693196|NCT04062448|156726374|FG000|Overall Study|Lost to Follow-up|1|||
48693197|NCT04062448|156726374|FG000|Overall Study|Withdrawal by Subject|2|||
48693198|NCT04683029|156726376|FG000|Overall Study|Withdrawal by Subject|1|||
48693199|NCT04683029|156726377|FG001|Overall Study|Withdrawal by Subject|0|||
48693200|NCT01038778|156726382|FG000|Overall Study|Withdrawal by Subject|0|||
48693201|NCT01038778|156726383|FG001|Overall Study|Withdrawal by Subject|2|||
48487530|NCT00272961|155978985|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
48487531|NCT00272961|155978981|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
48487532|NCT00272961|155978982|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
48487533|NCT00272961|155978983|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
48487534|NCT00272961|155978984|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
48487535|NCT00272961|155978985|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
48487536|NCT01361607|155978986|FG000|Overall Study|Adverse Event|38|||
48487537|NCT01361607|155978987|FG001|Overall Study|Adverse Event|29|||
48487538|NCT01361607|155978986|FG000|Overall Study|Withdrawal by Subject|19|||
48487539|NCT01361607|155978987|FG001|Overall Study|Withdrawal by Subject|8|||
48487540|NCT01361607|155978986|FG000|Overall Study|Withdrawal by Investigator|5|||
48487541|NCT01361607|155978987|FG001|Overall Study|Withdrawal by Investigator|3|||
48487542|NCT01361607|155978986|FG000|Overall Study|Lost to Follow-up|1|||
48487543|NCT01361607|155978987|FG001|Overall Study|Lost to Follow-up|0|||
48487544|NCT01361607|155978986|FG000|Overall Study|Met Withdrawal Criteria|1|||
48487545|NCT01361607|155978987|FG001|Overall Study|Met Withdrawal Criteria|1|||
48487546|NCT00297479|155978988|FG000|Overall Study|Lost to Follow-up|37|||
48487547|NCT00297479|155978989|FG001|Overall Study|Lost to Follow-up|54|||
48487548|NCT00297479|155978990|FG002|Overall Study|Lost to Follow-up|51|||
48487549|NCT00068237|155979001|FG000|Overall Study|Ineligible|3|||
48487550|NCT00068237|155979001|FG000|Overall Study|No protocol treatment received|2|||
48487551|NCT02280356|155979002|FG000|Overall Study|Not Treated|2|||
48487552|NCT02280356|155979002|FG000|Overall Study|Withdrawal by Subject|1|||
48487553|NCT02280356|155979002|FG000|Overall Study|Not evaluable|2|||
48487554|NCT01722266|155979003|FG000|Overall Study|Withdrawal by Subject|1|||
48487555|NCT01722266|155979004|FG001|Overall Study|Withdrawal by Subject|2|||
48487556|NCT01722266|155979005|FG002|Overall Study|Withdrawal by Subject|0|||
48487557|NCT01722266|155979006|FG003|Overall Study|Withdrawal by Subject|0|||
48487558|NCT01722266|155979003|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
48487559|NCT01722266|155979004|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
48487560|NCT01722266|155979005|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
48487561|NCT01722266|155979006|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
48487562|NCT01722266|155979003|FG000|Overall Study|Dropped out due to Nausea|0|||
48487563|NCT01722266|155979004|FG001|Overall Study|Dropped out due to Nausea|0|||
48487564|NCT01722266|155979005|FG002|Overall Study|Dropped out due to Nausea|2|||
48487565|NCT01722266|155979006|FG003|Overall Study|Dropped out due to Nausea|0|||
48487566|NCT02535000|155979014|FG000|Overall Study|Cancellation of surgery.|1|||
48487567|NCT02535000|155979015|FG001|Overall Study|Cancellation of surgery.|2|||
48588141|NCT02603107|156347547|FG000|Randomized Phase|Lack of Efficacy|1|||
48588142|NCT02603107|156347548|FG001|Randomized Phase|Lack of Efficacy|0|||
48588143|NCT02603107|156347547|FG000|Randomized Phase|Protocol Violation|1|||
48588144|NCT02603107|156347548|FG001|Randomized Phase|Protocol Violation|0|||
48588145|NCT02603107|156347547|FG000|Optional Extension Phase|Lost to Follow-up|3|||
48588146|NCT02603107|156347548|FG001|Optional Extension Phase|Lost to Follow-up|3|||
48588147|NCT02603107|156347547|FG000|Optional Extension Phase|Withdrew consent|3|||
48588148|NCT02603107|156347548|FG001|Optional Extension Phase|Withdrew consent|2|||
48588149|NCT02603107|156347547|FG000|Optional Extension Phase|Investigator's discretion|2|||
48588150|NCT02603107|156347548|FG001|Optional Extension Phase|Investigator's discretion|2|||
48588151|NCT02603107|156347547|FG000|Optional Extension Phase|Pregnancy|0|||
48588152|NCT02603107|156347548|FG001|Optional Extension Phase|Pregnancy|3|||
48588153|NCT02603107|156347547|FG000|Optional Extension Phase|Adverse Event|0|||
48588154|NCT02603107|156347548|FG001|Optional Extension Phase|Adverse Event|2|||
48588155|NCT02603107|156347547|FG000|Optional Extension Phase|Not treated in extension phase|0|||
48588156|NCT02603107|156347548|FG001|Optional Extension Phase|Not treated in extension phase|1|||
48588157|NCT02603107|156347547|FG000|Optional Extension Phase|Protocol Violation|1|||
48588158|NCT02603107|156347548|FG001|Optional Extension Phase|Protocol Violation|0|||
48588159|NCT02007278|156347568|FG000|Overall Study|Failure to comply with an eligibility|0|||
48588160|NCT02007278|156347569|FG001|Overall Study|Failure to comply with an eligibility|1|||
48588161|NCT02007278|156347568|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
48588162|NCT02007278|156347569|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
48588163|NCT02007278|156347568|FG000|Overall Study|Incorrect medication administration|1|||
48588164|NCT02007278|156347569|FG001|Overall Study|Incorrect medication administration|0|||
48588165|NCT02007278|156347568|FG000|Overall Study|Mis-randomization|1|||
48591412|NCT02362425|156358868|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
48591413|NCT02362425|156358869|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
48591414|NCT02362425|156358870|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
48591415|NCT02362425|156358871|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
48591416|NCT02362425|156358868|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
48591417|NCT02362425|156358869|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
48591418|NCT02362425|156358870|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
48591419|NCT02362425|156358871|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
48591420|NCT02362425|156358868|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
48591421|NCT02362425|156358869|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
48591422|NCT02362425|156358870|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
48591423|NCT02362425|156358871|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
48591424|NCT02362425|156358868|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
48591425|NCT02362425|156358869|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
48591426|NCT02362425|156358870|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
48591427|NCT02362425|156358871|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
48591428|NCT02362425|156358868|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
48591429|NCT02362425|156358869|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
48591430|NCT02362425|156358870|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
48591431|NCT02362425|156358871|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
48591432|NCT02362425|156358868|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
48591433|NCT02362425|156358869|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
48591434|NCT02362425|156358870|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
48591435|NCT02362425|156358871|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
48591436|NCT01313221|156358876|FG000|Overall Study|Protocol Violation|0|||
48591437|NCT01313221|156358877|FG001|Overall Study|Protocol Violation|1|||
48591438|NCT01313221|156358878|FG002|Overall Study|Protocol Violation|1|||
48693202|NCT01038778|156726384|FG002|Overall Study|Withdrawal by Subject|3|||
48693203|NCT03502707|156726386|FG000|Overall Study|Adverse Event|0|||
48693204|NCT03502707|156726387|FG001|Overall Study|Adverse Event|0|||
48693205|NCT03502707|156726388|FG002|Overall Study|Adverse Event|0|||
48693206|NCT03502707|156726389|FG003|Overall Study|Adverse Event|0|||
48693207|NCT03502707|156726390|FG004|Overall Study|Adverse Event|0|||
48693208|NCT03502707|156726391|FG005|Overall Study|Adverse Event|0|||
48693209|NCT03502707|156726392|FG006|Overall Study|Adverse Event|0|||
48693210|NCT03502707|156726393|FG007|Overall Study|Adverse Event|0|||
48591439|NCT01313221|156358876|FG000|Overall Study|Non-compliance|3|||
48591440|NCT01313221|156358877|FG001|Overall Study|Non-compliance|0|||
48591441|NCT01313221|156358878|FG002|Overall Study|Non-compliance|2|||
48591442|NCT01313221|156358876|FG000|Overall Study|Withdrawal by Subject|2|||
48591443|NCT01313221|156358877|FG001|Overall Study|Withdrawal by Subject|3|||
48591444|NCT01313221|156358878|FG002|Overall Study|Withdrawal by Subject|5|||
48591445|NCT01313221|156358876|FG000|Overall Study|Requirement for alternative therapy|0|||
48591446|NCT01313221|156358877|FG001|Overall Study|Requirement for alternative therapy|1|||
48591447|NCT01313221|156358878|FG002|Overall Study|Requirement for alternative therapy|1|||
48591448|NCT01313221|156358876|FG000|Overall Study|Lost to Follow-up|6|||
48591449|NCT01313221|156358877|FG001|Overall Study|Lost to Follow-up|3|||
48591450|NCT01313221|156358878|FG002|Overall Study|Lost to Follow-up|1|||
48591451|NCT01313221|156358876|FG000|Overall Study|Other|1|||
48591452|NCT01313221|156358877|FG001|Overall Study|Other|0|||
48591453|NCT01313221|156358878|FG002|Overall Study|Other|0|||
48693211|NCT03502707|156726394|FG008|Overall Study|Adverse Event|0|||
48591454|NCT01313221|156358876|FG000|Overall Study|Adverse Event|0|||
48591455|NCT01313221|156358877|FG001|Overall Study|Adverse Event|0|||
48591456|NCT01313221|156358878|FG002|Overall Study|Adverse Event|7|||
48591457|NCT01313221|156358876|FG000|Overall Study|Disease progression|0|||
48591458|NCT01313221|156358877|FG001|Overall Study|Disease progression|0|||
48591459|NCT01313221|156358878|FG002|Overall Study|Disease progression|2|||
48591460|NCT01313221|156358876|FG000|Overall Study|Physician Decision|0|||
48591461|NCT01313221|156358877|FG001|Overall Study|Physician Decision|0|||
48591462|NCT01313221|156358878|FG002|Overall Study|Physician Decision|2|||
48591463|NCT01313221|156358876|FG000|Overall Study|Pregnancy|0|||
48591464|NCT01313221|156358877|FG001|Overall Study|Pregnancy|0|||
48591465|NCT01313221|156358878|FG002|Overall Study|Pregnancy|2|||
48591466|NCT01937715|156358889|FG000|Overall Study|Death|0|||
48591467|NCT01937715|156358890|FG001|Overall Study|Death|0|||
48591468|NCT01937715|156358891|FG002|Overall Study|Death|0|||
48591469|NCT01937715|156358892|FG003|Overall Study|Death|1|||
48591470|NCT01937715|156358893|FG004|Overall Study|Death|0|||
48591471|NCT01937715|156358889|FG000|Overall Study|Withdrawal by Subject|0|||
48591472|NCT01937715|156358890|FG001|Overall Study|Withdrawal by Subject|1|||
48591473|NCT01937715|156358891|FG002|Overall Study|Withdrawal by Subject|0|||
48591474|NCT01937715|156358892|FG003|Overall Study|Withdrawal by Subject|0|||
48591475|NCT01937715|156358893|FG004|Overall Study|Withdrawal by Subject|2|||
48591476|NCT01937715|156358889|FG000|Overall Study|Other|0|||
48591477|NCT01937715|156358890|FG001|Overall Study|Other|0|||
48591478|NCT01937715|156358891|FG002|Overall Study|Other|0|||
48591479|NCT01937715|156358892|FG003|Overall Study|Other|3|||
48591480|NCT01937715|156358893|FG004|Overall Study|Other|0|||
48591481|NCT02864316|156358896|FG000|Overall Study|Progressive Disease|2|||
48591482|NCT02864316|156358897|FG001|Overall Study|Progressive Disease|1|||
48591483|NCT02864316|156358896|FG000|Overall Study|Adverse Event|0|||
48591484|NCT02864316|156358897|FG001|Overall Study|Adverse Event|1|||
48591485|NCT05459558|156358900|FG000|Overall Study|Adverse Event|1|||
48591486|NCT05459558|156358901|FG001|Overall Study|Adverse Event|0|||
48591487|NCT05459558|156358902|FG002|Overall Study|Adverse Event|0|||
48591488|NCT05459558|156358900|FG000|Overall Study|Scheduling issue|0|||
48591489|NCT05459558|156358901|FG001|Overall Study|Scheduling issue|1|||
48591490|NCT05459558|156358902|FG002|Overall Study|Scheduling issue|3|||
48591491|NCT05459558|156358900|FG000|Overall Study|Withdrawal by Subject|0|||
48591492|NCT05459558|156358901|FG001|Overall Study|Withdrawal by Subject|0|||
48591493|NCT05459558|156358902|FG002|Overall Study|Withdrawal by Subject|2|||
48591494|NCT02412878|156358903|FG000|Overall Study|Withdrawal by Subject|19|||
48591495|NCT02412878|156358904|FG001|Overall Study|Withdrawal by Subject|10|||
48591496|NCT02412878|156358903|FG000|Overall Study|Lost to Follow-up|2|||
48591497|NCT02412878|156358904|FG001|Overall Study|Lost to Follow-up|3|||
48591498|NCT02190721|156358905|FG000|Overall Study|Patient was out of the city|0|||
48591499|NCT02190721|156358906|FG001|Overall Study|Patient was out of the city|1|||
48591500|NCT02190721|156358907|FG002|Overall Study|Patient was out of the city|0|||
48591501|NCT04571385|156358908|FG000|Overall Study|Participant non-compliance|1|||
48591502|NCT04571385|156358909|FG001|Overall Study|Participant non-compliance|0|||
48591503|NCT04571385|156358910|FG002|Overall Study|Participant non-compliance|0|||
48591504|NCT04571385|156358908|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
48591505|NCT04571385|156358909|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
48591506|NCT04571385|156358910|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
48591507|NCT04571385|156358908|FG000|Overall Study|Screen failure|0|||
48591508|NCT04571385|156358909|FG001|Overall Study|Screen failure|0|||
48591509|NCT04571385|156358910|FG002|Overall Study|Screen failure|1|||
48591510|NCT01777139|156358912|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
48591511|NCT01777139|156358913|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
48591512|NCT01777139|156358912|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
48591513|NCT01777139|156358913|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
48591514|NCT01777139|156358912|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
48591515|NCT01777139|156358913|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
48591516|NCT01777139|156358912|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
48591517|NCT01777139|156358913|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
48591518|NCT01777139|156358912|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
48591519|NCT01777139|156358913|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
48591520|NCT01777139|156358912|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
48591521|NCT01777139|156358913|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
48591522|NCT01777139|156358912|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
48591523|NCT01777139|156358913|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
48591524|NCT01777139|156358912|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
48591525|NCT01777139|156358913|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
48591526|NCT00496587|156358916|FG000|Overall Study|Adverse Event|2|||
48591527|NCT00496587|156358916|FG000|Overall Study|Progressive Disease|24|||
48591528|NCT00496587|156358916|FG000|Overall Study|Withdrawal by Subject|2|||
48591529|NCT00496587|156358916|FG000|Overall Study|Death|1|||
48591530|NCT00496587|156358916|FG000|Overall Study|Complications unrelated|2|||
48591531|NCT00162097|156358918|FG000|Overall Study|Participant no longer met study criteria|0|||
48591532|NCT00162097|156358919|FG001|Overall Study|Participant no longer met study criteria|0|||
48591533|NCT00162097|156358920|FG002|Overall Study|Participant no longer met study criteria|0|||
48591534|NCT00162097|156358921|FG003|Overall Study|Participant no longer met study criteria|1|||
48591535|NCT00080483|156358923|FG000|Overall Study|Lost to Follow-up|1|||
48591536|NCT00080483|156358924|FG001|Overall Study|Lost to Follow-up|1|||
48591537|NCT00080483|156358923|FG000|Overall Study|Physician Decision|1|||
48591538|NCT00080483|156358924|FG001|Overall Study|Physician Decision|1|||
48591539|NCT03333486|156358925|FG000|Overall Study|Withdrawal by Subject|1|||
48591540|NCT03333486|156358925|FG000|Overall Study|Lost to Follow-up|1|||
48591541|NCT01087203|156358926|FG000|Overall Study|Lost to Follow-up|2|||
48591542|NCT01087203|156358927|FG001|Overall Study|Lost to Follow-up|0|||
48591543|NCT01087203|156358926|FG000|Overall Study|Withdrawal by Subject|2|||
48591544|NCT01087203|156358927|FG001|Overall Study|Withdrawal by Subject|6|||
48591545|NCT01087203|156358926|FG000|Overall Study|Lack of Efficacy|1|||
48591546|NCT01087203|156358927|FG001|Overall Study|Lack of Efficacy|2|||
48591547|NCT01087203|156358926|FG000|Overall Study|Study terminated by sponsor|27|||
48591548|NCT01087203|156358927|FG001|Overall Study|Study terminated by sponsor|27|||
48591549|NCT01693185|156358928|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
48591550|NCT01693185|156358929|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
48591551|NCT01017601|156358932|FG000|Overall Study|Disease Progression|12|||
48591552|NCT01017601|156358933|FG001|Overall Study|Disease Progression|12|||
48591553|NCT01017601|156358932|FG000|Overall Study|Withdrawal by Subject|0|||
48591554|NCT01017601|156358933|FG001|Overall Study|Withdrawal by Subject|1|||
48591555|NCT02787083|156358938|FG000|Overall Study|Adverse Event|1|||
48591556|NCT02787083|156358939|FG001|Overall Study|Adverse Event|0|||
48591557|NCT02787083|156358938|FG000|Overall Study|Withdrawal by Subject|2|||
48591558|NCT02787083|156358939|FG001|Overall Study|Withdrawal by Subject|2|||
48591559|NCT00069823|156358940|FG000|Overall Study|Did not have follow-up diary cards|6|||
48591560|NCT00069823|156358941|FG001|Overall Study|Did not have follow-up diary cards|3|||
48591561|NCT00187278|156358942|FG000|Overall Study|Protocol Violation|10|||
48591562|NCT00187278|156358943|FG001|Overall Study|Protocol Violation|13|||
48591563|NCT01990768|156358944|FG000|Intervention Started|Found to be ineligible|14|||
48591564|NCT01990768|156358945|FG001|Intervention Started|Found to be ineligible|13|||
48591565|NCT01990768|156358946|FG002|Intervention Started|Found to be ineligible|11|||
48591566|NCT01990768|156358944|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
48591567|NCT01990768|156358945|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
48591568|NCT01990768|156358946|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
48591569|NCT01990768|156358944|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
48591570|NCT01990768|156358945|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
48591571|NCT01990768|156358946|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
48591572|NCT01990768|156358944|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
48591573|NCT01990768|156358945|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
48591574|NCT01990768|156358946|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
48591575|NCT01990768|156358944|FG000|Intervention Started|Patient care priority|1|||
48591576|NCT01990768|156358945|FG001|Intervention Started|Patient care priority|2|||
48591577|NCT01990768|156358946|FG002|Intervention Started|Patient care priority|3|||
48591578|NCT01990768|156358944|FG000|Intervention Started|IV lost|2|||
48591579|NCT01990768|156358945|FG001|Intervention Started|IV lost|2|||
48591580|NCT01990768|156358946|FG002|Intervention Started|IV lost|2|||
48591581|NCT01990768|156358944|FG000|Intervention Started|Required CPR|1|||
48591582|NCT01990768|156358945|FG001|Intervention Started|Required CPR|1|||
48591583|NCT01990768|156358946|FG002|Intervention Started|Required CPR|0|||
48591584|NCT01990768|156358944|FG000|Intervention Started|Seizure or hx of seizure|0|||
48591585|NCT01990768|156358945|FG001|Intervention Started|Seizure or hx of seizure|0|||
48591586|NCT01990768|156358946|FG002|Intervention Started|Seizure or hx of seizure|2|||
48591587|NCT01990768|156358944|FG000|Intervention Started|Discovered to be pregnant|0|||
48591588|NCT01990768|156358945|FG001|Intervention Started|Discovered to be pregnant|1|||
48591589|NCT01990768|156358946|FG002|Intervention Started|Discovered to be pregnant|0|||
48591590|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
48591591|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
48591592|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
48591593|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
48591594|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
48591595|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
48591596|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
48591597|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
48591598|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
48591599|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
48591600|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
48591601|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
48591602|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Death|3|||
48591603|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Death|1|||
48591604|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Death|1|||
48591605|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Discharged|2|||
48591606|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Discharged|1|||
48591607|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Discharged|0|||
48591608|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
48591609|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
48591610|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
48591611|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
48591612|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
48591613|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
48591614|NCT01990768|156358944|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
48591615|NCT01990768|156358945|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
48591616|NCT01990768|156358946|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
48591617|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
48591618|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
48591619|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
48591620|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
48591621|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
48591622|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
48591623|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
48591624|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
48591625|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
48591626|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
48591627|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
48591628|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
48591629|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
48591630|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
48591631|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
48591632|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
48591633|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
48591634|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
48591635|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
48591636|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
48591637|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
48591638|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
48591639|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
48591640|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
48591641|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
48591642|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
48591643|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
48591644|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
48591645|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
48591646|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
48591647|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
48591648|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
48591649|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
48591650|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
48591651|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
48591652|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
48591653|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
48591654|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
48591655|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
48591656|NCT01990768|156358944|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
48591657|NCT01990768|156358945|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
48591658|NCT01990768|156358946|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
48591659|NCT01990768|156358944|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
48591660|NCT01990768|156358945|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
48591661|NCT01990768|156358946|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
48591662|NCT01990768|156358944|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
48591663|NCT01990768|156358945|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
48591664|NCT01990768|156358946|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
48591665|NCT01990768|156358944|FG000|6-Month Follow-up|No contact information|5|||
48591666|NCT01990768|156358945|FG001|6-Month Follow-up|No contact information|6|||
48591667|NCT01990768|156358946|FG002|6-Month Follow-up|No contact information|5|||
48591668|NCT01990768|156358944|FG000|6-Month Follow-up|Homeless|4|||
48591669|NCT01990768|156358945|FG001|6-Month Follow-up|Homeless|3|||
48591670|NCT01990768|156358946|FG002|6-Month Follow-up|Homeless|6|||
48591671|NCT01990768|156358944|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
48591672|NCT01990768|156358945|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
48591673|NCT01990768|156358946|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
48591674|NCT01990768|156358944|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
48591675|NCT01990768|156358945|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
48591676|NCT01990768|156358946|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
48591677|NCT01990768|156358944|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
48591678|NCT01990768|156358945|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
48591679|NCT01990768|156358946|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
48591680|NCT01778751|156358950|FG000|Overall Study|Lost to Follow-up|1|||
48591681|NCT01778751|156358951|FG001|Overall Study|Lost to Follow-up|0|||
48591682|NCT01778751|156358950|FG000|Overall Study|Withdrawal by Subject|0|||
48591683|NCT01778751|156358951|FG001|Overall Study|Withdrawal by Subject|2|||
48591684|NCT01778751|156358950|FG000|Overall Study|Transfered care|1|||
48591685|NCT01778751|156358951|FG001|Overall Study|Transfered care|0|||
48591686|NCT00154375|156358953|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
48591687|NCT00154375|156358954|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
48591688|NCT00154375|156358953|FG000|Overall Study|Adverse Event|18|||
48591689|NCT00154375|156358954|FG001|Overall Study|Adverse Event|20|||
48591690|NCT00154375|156358953|FG000|Overall Study|Withdrawal by Subject|14|||
48591691|NCT00154375|156358954|FG001|Overall Study|Withdrawal by Subject|10|||
48591692|NCT00154375|156358953|FG000|Overall Study|Death|5|||
48591693|NCT00154375|156358954|FG001|Overall Study|Death|13|||
48591694|NCT00154375|156358953|FG000|Overall Study|Study drug no longer required|5|||
48591695|NCT00154375|156358954|FG001|Overall Study|Study drug no longer required|3|||
48591696|NCT00154375|156358953|FG000|Overall Study|Lost to Follow-up|2|||
48591697|NCT00154375|156358954|FG001|Overall Study|Lost to Follow-up|1|||
48591698|NCT00154375|156358953|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48591699|NCT00154375|156358954|FG001|Overall Study|Abnormal laboratory value(s)|2|||
48591700|NCT00154375|156358953|FG000|Overall Study|Protocol Violation|0|||
48591701|NCT00154375|156358954|FG001|Overall Study|Protocol Violation|1|||
48591702|NCT00154375|156358953|FG000|Overall Study|Suspected progression of disease|44|||
48591703|NCT00154375|156358954|FG001|Overall Study|Suspected progression of disease|30|||
48591704|NCT03816007|156358955|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
48591705|NCT03816007|156358956|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
48591706|NCT03816007|156358955|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
48591707|NCT03816007|156358956|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
48591708|NCT03816007|156358955|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
48591709|NCT03816007|156358956|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
48591710|NCT01588405|156358958|FG000|Overall Study|Adverse Event|1|||
48591711|NCT01588405|156358958|FG000|Overall Study|Clinical Worsening|1|||
48591712|NCT02453256|156358959|FG000|Double Blind Period|Death|1|||
48591713|NCT02453256|156358960|FG001|Double Blind Period|Death|1|||
48591714|NCT02453256|156358959|FG000|Double Blind Period|Adverse Event|3|||
48591715|NCT02453256|156358960|FG001|Double Blind Period|Adverse Event|2|||
48591716|NCT02453256|156358959|FG000|Double Blind Period|Withdrawal by Subject|9|||
48591717|NCT02453256|156358960|FG001|Double Blind Period|Withdrawal by Subject|5|||
48591718|NCT02453256|156358959|FG000|Double Blind Period|Other|0|||
48591719|NCT02453256|156358960|FG001|Double Blind Period|Other|1|||
48591720|NCT02453256|156358959|FG000|Open Label Period|Adverse Event|1|||
48591721|NCT02453256|156358960|FG001|Open Label Period|Adverse Event|3|||
48591722|NCT02453256|156358959|FG000|Open Label Period|Death|0|||
48591723|NCT02453256|156358960|FG001|Open Label Period|Death|1|||
48591724|NCT02453256|156358959|FG000|Open Label Period|Lost to Follow-up|1|||
48591725|NCT02453256|156358960|FG001|Open Label Period|Lost to Follow-up|0|||
48591726|NCT02453256|156358959|FG000|Open Label Period|Other|0|||
48591727|NCT02453256|156358960|FG001|Open Label Period|Other|2|||
48591728|NCT02453256|156358959|FG000|Open Label Period|Withdrawal by Subject|5|||
48591729|NCT02453256|156358960|FG001|Open Label Period|Withdrawal by Subject|1|||
48591730|NCT01066871|156358963|FG000|Overall Study|Lost to Follow-up|0|||
48591731|NCT01066871|156358964|FG001|Overall Study|Lost to Follow-up|2|||
48591732|NCT01066871|156358965|FG002|Overall Study|Lost to Follow-up|2|||
48591733|NCT01066871|156358966|FG003|Overall Study|Lost to Follow-up|0|||
48591734|NCT01066871|156358963|FG000|Overall Study|Protocol Violation|1|||
48591735|NCT01066871|156358964|FG001|Overall Study|Protocol Violation|0|||
48591736|NCT01066871|156358965|FG002|Overall Study|Protocol Violation|3|||
48591737|NCT01066871|156358966|FG003|Overall Study|Protocol Violation|2|||
48591738|NCT01066871|156358963|FG000|Overall Study|Lack of Efficacy|0|||
48591739|NCT01066871|156358964|FG001|Overall Study|Lack of Efficacy|0|||
48591740|NCT01066871|156358965|FG002|Overall Study|Lack of Efficacy|0|||
48591741|NCT01066871|156358966|FG003|Overall Study|Lack of Efficacy|1|||
48591742|NCT01066871|156358963|FG000|Overall Study|Withdrawal by Subject|3|||
48591743|NCT01066871|156358964|FG001|Overall Study|Withdrawal by Subject|1|||
48591744|NCT01066871|156358965|FG002|Overall Study|Withdrawal by Subject|0|||
48591745|NCT01066871|156358966|FG003|Overall Study|Withdrawal by Subject|0|||
48591746|NCT01066871|156358963|FG000|Overall Study|Other|0|||
48591747|NCT01066871|156358964|FG001|Overall Study|Other|2|||
48591748|NCT01066871|156358965|FG002|Overall Study|Other|1|||
48591749|NCT01066871|156358966|FG003|Overall Study|Other|2|||
48591750|NCT04114656|156361369|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
48591751|NCT04114656|156361370|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
48591752|NCT04114656|156361369|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
48591753|NCT04114656|156361370|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
48591754|NCT04114656|156361369|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
48591755|NCT04114656|156361370|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
48591756|NCT04114656|156361369|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
48591757|NCT04114656|156361370|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
48591758|NCT04114656|156361369|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
48591759|NCT04114656|156361370|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
48591760|NCT03307837|156361371|FG000|Overall Study|Withdrawal by Subject|0|||
48591761|NCT03307837|156361372|FG001|Overall Study|Withdrawal by Subject|0|||
48591762|NCT03307837|156361373|FG002|Overall Study|Withdrawal by Subject|1|||
48591763|NCT03307837|156361374|FG003|Overall Study|Withdrawal by Subject|0|||
48591764|NCT03307837|156361375|FG004|Overall Study|Withdrawal by Subject|0|||
48591765|NCT03307837|156361376|FG005|Overall Study|Withdrawal by Subject|1|||
48591766|NCT03307837|156361371|FG000|Overall Study|Lost to Follow-up|1|||
48591767|NCT03307837|156361372|FG001|Overall Study|Lost to Follow-up|1|||
48591768|NCT03307837|156361373|FG002|Overall Study|Lost to Follow-up|0|||
48591769|NCT03307837|156361374|FG003|Overall Study|Lost to Follow-up|0|||
48591770|NCT03307837|156361375|FG004|Overall Study|Lost to Follow-up|0|||
48591771|NCT03307837|156361376|FG005|Overall Study|Lost to Follow-up|1|||
48591772|NCT02474355|156361377|FG000|Overall Study|Other|43|||
48591773|NCT02474355|156361377|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
48591774|NCT02474355|156361377|FG000|Overall Study|Lost to Follow-up|98|||
48591775|NCT02474355|156361377|FG000|Overall Study|Withdrawal by Subject|124|||
48591776|NCT02474355|156361377|FG000|Overall Study|Death|1361|||
48591777|NCT00904917|156361378|FG000|Overall Study|Lost to Follow-up|2|||
48591778|NCT00904917|156361379|FG001|Overall Study|Lost to Follow-up|2|||
48591779|NCT00904917|156361380|FG002|Overall Study|Lost to Follow-up|2|||
48591780|NCT00904917|156361381|FG003|Overall Study|Lost to Follow-up|2|||
48591781|NCT01066793|156361382|FG000|Overall Study|Death|4|||
48591782|NCT01066793|156361383|FG001|Overall Study|Death|1|||
48591783|NCT01066793|156361384|FG002|Overall Study|Death|1|||
48591784|NCT01066793|156361385|FG003|Overall Study|Death|0|||
48591785|NCT01066793|156361386|FG004|Overall Study|Death|0|||
48591786|NCT01066793|156361387|FG005|Overall Study|Death|0|||
48591787|NCT01066793|156361382|FG000|Overall Study|Lack of Efficacy|2|||
48591788|NCT01066793|156361383|FG001|Overall Study|Lack of Efficacy|1|||
48591789|NCT01066793|156361384|FG002|Overall Study|Lack of Efficacy|0|||
48591790|NCT01066793|156361385|FG003|Overall Study|Lack of Efficacy|0|||
48591791|NCT01066793|156361386|FG004|Overall Study|Lack of Efficacy|0|||
48591792|NCT01066793|156361387|FG005|Overall Study|Lack of Efficacy|0|||
48591793|NCT01066793|156361382|FG000|Overall Study|Lost to Follow-up|180|||
48591794|NCT01066793|156361383|FG001|Overall Study|Lost to Follow-up|39|||
48591795|NCT01066793|156361384|FG002|Overall Study|Lost to Follow-up|82|||
48591796|NCT01066793|156361385|FG003|Overall Study|Lost to Follow-up|16|||
48591797|NCT01066793|156361386|FG004|Overall Study|Lost to Follow-up|0|||
48591798|NCT01066793|156361387|FG005|Overall Study|Lost to Follow-up|1|||
48591799|NCT01066793|156361382|FG000|Overall Study|Physician Decision|3|||
48591800|NCT01066793|156361383|FG001|Overall Study|Physician Decision|0|||
48591801|NCT01066793|156361384|FG002|Overall Study|Physician Decision|0|||
48591802|NCT01066793|156361385|FG003|Overall Study|Physician Decision|0|||
48591803|NCT01066793|156361386|FG004|Overall Study|Physician Decision|0|||
48591804|NCT01066793|156361387|FG005|Overall Study|Physician Decision|0|||
48591805|NCT01066793|156361382|FG000|Overall Study|Protocol Violation|3|||
48591806|NCT01066793|156361383|FG001|Overall Study|Protocol Violation|2|||
48591807|NCT01066793|156361384|FG002|Overall Study|Protocol Violation|2|||
48591808|NCT01066793|156361385|FG003|Overall Study|Protocol Violation|0|||
48591809|NCT01066793|156361386|FG004|Overall Study|Protocol Violation|0|||
48591810|NCT01066793|156361387|FG005|Overall Study|Protocol Violation|0|||
48591811|NCT01066793|156361382|FG000|Overall Study|Withdrawal by Subject|7|||
48591812|NCT01066793|156361383|FG001|Overall Study|Withdrawal by Subject|4|||
48591813|NCT01066793|156361384|FG002|Overall Study|Withdrawal by Subject|1|||
48591814|NCT01066793|156361385|FG003|Overall Study|Withdrawal by Subject|0|||
48591815|NCT01066793|156361386|FG004|Overall Study|Withdrawal by Subject|0|||
48591816|NCT01066793|156361387|FG005|Overall Study|Withdrawal by Subject|0|||
48591817|NCT01066793|156361382|FG000|Overall Study|Early Termination|3|||
48591818|NCT01066793|156361383|FG001|Overall Study|Early Termination|0|||
48591819|NCT01066793|156361384|FG002|Overall Study|Early Termination|0|||
48591820|NCT01066793|156361385|FG003|Overall Study|Early Termination|0|||
48591821|NCT01066793|156361386|FG004|Overall Study|Early Termination|0|||
48591822|NCT01066793|156361387|FG005|Overall Study|Early Termination|0|||
48591823|NCT01066793|156361382|FG000|Overall Study|Lab test not done|7|||
48591824|NCT01066793|156361383|FG001|Overall Study|Lab test not done|0|||
48591825|NCT01066793|156361384|FG002|Overall Study|Lab test not done|0|||
48591826|NCT01066793|156361385|FG003|Overall Study|Lab test not done|1|||
48591827|NCT01066793|156361386|FG004|Overall Study|Lab test not done|0|||
48591828|NCT01066793|156361387|FG005|Overall Study|Lab test not done|0|||
48591829|NCT01066793|156361382|FG000|Overall Study|Miscellaneous|4|||
48591830|NCT01066793|156361383|FG001|Overall Study|Miscellaneous|5|||
48591831|NCT01066793|156361384|FG002|Overall Study|Miscellaneous|6|||
48591832|NCT01066793|156361385|FG003|Overall Study|Miscellaneous|0|||
48591833|NCT01066793|156361386|FG004|Overall Study|Miscellaneous|0|||
48591834|NCT01066793|156361387|FG005|Overall Study|Miscellaneous|0|||
48591835|NCT01066793|156361382|FG000|Overall Study|Non-responders|104|||
48591836|NCT01066793|156361383|FG001|Overall Study|Non-responders|5|||
48591837|NCT01066793|156361384|FG002|Overall Study|Non-responders|11|||
48591838|NCT01066793|156361385|FG003|Overall Study|Non-responders|25|||
48591839|NCT01066793|156361386|FG004|Overall Study|Non-responders|0|||
48591840|NCT01066793|156361387|FG005|Overall Study|Non-responders|0|||
48591841|NCT01066793|156361382|FG000|Overall Study|Other|15|||
48591842|NCT01066793|156361383|FG001|Overall Study|Other|5|||
48591843|NCT01066793|156361384|FG002|Overall Study|Other|6|||
48591844|NCT01066793|156361385|FG003|Overall Study|Other|2|||
48591845|NCT01066793|156361386|FG004|Overall Study|Other|0|||
48591846|NCT01066793|156361387|FG005|Overall Study|Other|0|||
48591847|NCT01066793|156361382|FG000|Overall Study|Relapse|20|||
48591848|NCT01066793|156361383|FG001|Overall Study|Relapse|8|||
48591849|NCT01066793|156361384|FG002|Overall Study|Relapse|2|||
48591850|NCT01066793|156361385|FG003|Overall Study|Relapse|3|||
48591851|NCT01066793|156361386|FG004|Overall Study|Relapse|0|||
48591852|NCT01066793|156361387|FG005|Overall Study|Relapse|0|||
48591853|NCT01066793|156361382|FG000|Overall Study|Result Not Available|1|||
48591854|NCT01066793|156361383|FG001|Overall Study|Result Not Available|0|||
48591855|NCT01066793|156361384|FG002|Overall Study|Result Not Available|0|||
48591856|NCT01066793|156361385|FG003|Overall Study|Result Not Available|0|||
48591857|NCT01066793|156361386|FG004|Overall Study|Result Not Available|0|||
48591858|NCT01066793|156361387|FG005|Overall Study|Result Not Available|0|||
48591859|NCT01066793|156361382|FG000|Overall Study|Treatment Interrupted|1|||
48591860|NCT01066793|156361383|FG001|Overall Study|Treatment Interrupted|1|||
48591861|NCT01066793|156361384|FG002|Overall Study|Treatment Interrupted|0|||
48591862|NCT01066793|156361385|FG003|Overall Study|Treatment Interrupted|0|||
48591863|NCT01066793|156361386|FG004|Overall Study|Treatment Interrupted|0|||
48591864|NCT01066793|156361387|FG005|Overall Study|Treatment Interrupted|0|||
48591865|NCT01066793|156361382|FG000|Overall Study|Treatment Never Started|18|||
48591866|NCT01066793|156361383|FG001|Overall Study|Treatment Never Started|5|||
48591867|NCT01066793|156361384|FG002|Overall Study|Treatment Never Started|4|||
48591868|NCT01066793|156361385|FG003|Overall Study|Treatment Never Started|1|||
48591869|NCT01066793|156361386|FG004|Overall Study|Treatment Never Started|0|||
48591870|NCT01066793|156361387|FG005|Overall Study|Treatment Never Started|0|||
48591871|NCT01066793|156361382|FG000|Overall Study|Treatment Stopped|2|||
48591872|NCT01066793|156361383|FG001|Overall Study|Treatment Stopped|1|||
48591873|NCT01066793|156361384|FG002|Overall Study|Treatment Stopped|0|||
48591874|NCT01066793|156361385|FG003|Overall Study|Treatment Stopped|1|||
48591875|NCT01066793|156361386|FG004|Overall Study|Treatment Stopped|0|||
48591876|NCT01066793|156361387|FG005|Overall Study|Treatment Stopped|0|||
48591877|NCT03015194|156361390|FG000|Overall Study|Death|10|||
48591878|NCT03015194|156361390|FG000|Overall Study|Withdrawal by Subject|2|||
48591879|NCT03246061|156361391|FG000|Overall Study|Still in follow-up|15|||
48591880|NCT03246061|156361392|FG001|Overall Study|Still in follow-up|21|||
48591881|NCT01754766|156361393|FG000|Overall Study|Personal reasons|1|||
48591882|NCT01754766|156361394|FG001|Overall Study|Personal reasons|1|||
48591883|NCT01754766|156361395|FG002|Overall Study|Personal reasons|0|||
48591884|NCT02469168|156361397|FG000|Overall Study|Trial closed|1|||
48591885|NCT02469168|156361398|FG001|Overall Study|Trial closed|0|||
48591886|NCT00298363|156361399|FG000|Overall Study|Lost to Follow-up|0|||
48591887|NCT00298363|156361400|FG001|Overall Study|Lost to Follow-up|0|||
48591888|NCT00298363|156361401|FG002|Overall Study|Lost to Follow-up|1|||
48591889|NCT00298363|156361399|FG000|Overall Study|Physician Decision|4|||
48591890|NCT00298363|156361400|FG001|Overall Study|Physician Decision|1|||
48591891|NCT00298363|156361401|FG002|Overall Study|Physician Decision|0|||
48591892|NCT00298363|156361399|FG000|Overall Study|Protocol Violation|1|||
48591893|NCT00298363|156361400|FG001|Overall Study|Protocol Violation|1|||
48591894|NCT00298363|156361401|FG002|Overall Study|Protocol Violation|0|||
48487568|NCT02191579|155979016|FG000|Treatment 1|Multiple Reasons Specified|27|||
48591895|NCT00298363|156361399|FG000|Overall Study|Withdrawal by Subject|5|||
48591896|NCT00298363|156361400|FG001|Overall Study|Withdrawal by Subject|1|||
48591897|NCT00298363|156361401|FG002|Overall Study|Withdrawal by Subject|3|||
48591898|NCT00298363|156361399|FG000|Overall Study|Adverse Event|5|||
48591899|NCT00298363|156361400|FG001|Overall Study|Adverse Event|2|||
48591900|NCT00298363|156361401|FG002|Overall Study|Adverse Event|2|||
48591901|NCT00298363|156361399|FG000|Overall Study|Lack of Efficacy|2|||
48487569|NCT02191579|155979017|FG001|Treatment 1|Multiple Reasons Specified|58|||
48591902|NCT00298363|156361400|FG001|Overall Study|Lack of Efficacy|3|||
48591903|NCT00298363|156361401|FG002|Overall Study|Lack of Efficacy|0|||
48591904|NCT00433017|156361402|FG000|Overall Study|Adverse Event|5|||
48591905|NCT00433017|156361403|FG001|Overall Study|Adverse Event|3|||
48591906|NCT00433017|156361402|FG000|Overall Study|Withdrawal by Subject|4|||
48591907|NCT00433017|156361403|FG001|Overall Study|Withdrawal by Subject|5|||
48693212|NCT03502707|156726395|FG009|Overall Study|Adverse Event|0|||
48693213|NCT03502707|156726396|FG010|Overall Study|Adverse Event|0|||
48693214|NCT03502707|156726397|FG011|Overall Study|Adverse Event|0|||
48693215|NCT03502707|156726398|FG012|Overall Study|Adverse Event|0|||
48693216|NCT03502707|156726399|FG013|Overall Study|Adverse Event|0|||
48693217|NCT03502707|156726400|FG014|Overall Study|Adverse Event|0|||
48693218|NCT03502707|156726401|FG015|Overall Study|Adverse Event|1|||
48693219|NCT03502707|156726402|FG016|Overall Study|Adverse Event|5|||
48693220|NCT03502707|156726403|FG017|Overall Study|Adverse Event|0|||
48693221|NCT03502707|156726386|FG000|Overall Study|Death|0|||
48693222|NCT03502707|156726387|FG001|Overall Study|Death|0|||
48693223|NCT03502707|156726388|FG002|Overall Study|Death|0|||
48693224|NCT03502707|156726389|FG003|Overall Study|Death|1|||
48693225|NCT03502707|156726390|FG004|Overall Study|Death|0|||
48693226|NCT03502707|156726391|FG005|Overall Study|Death|0|||
48693227|NCT03502707|156726392|FG006|Overall Study|Death|0|||
48693228|NCT03502707|156726393|FG007|Overall Study|Death|0|||
48693229|NCT03502707|156726394|FG008|Overall Study|Death|1|||
48693230|NCT03502707|156726395|FG009|Overall Study|Death|1|||
48693231|NCT03502707|156726396|FG010|Overall Study|Death|0|||
48693232|NCT03502707|156726397|FG011|Overall Study|Death|0|||
48693233|NCT03502707|156726398|FG012|Overall Study|Death|1|||
48693234|NCT03502707|156726399|FG013|Overall Study|Death|0|||
48693235|NCT03502707|156726400|FG014|Overall Study|Death|0|||
48693236|NCT03502707|156726401|FG015|Overall Study|Death|1|||
48693237|NCT03502707|156726402|FG016|Overall Study|Death|0|||
48693238|NCT03502707|156726403|FG017|Overall Study|Death|0|||
48693239|NCT03502707|156726386|FG000|Overall Study|Lost to Follow-up|0|||
48693240|NCT03502707|156726387|FG001|Overall Study|Lost to Follow-up|0|||
48693241|NCT03502707|156726388|FG002|Overall Study|Lost to Follow-up|0|||
48693242|NCT03502707|156726389|FG003|Overall Study|Lost to Follow-up|0|||
48693243|NCT03502707|156726390|FG004|Overall Study|Lost to Follow-up|0|||
48693244|NCT03502707|156726391|FG005|Overall Study|Lost to Follow-up|0|||
48693245|NCT03502707|156726392|FG006|Overall Study|Lost to Follow-up|0|||
48693246|NCT03502707|156726393|FG007|Overall Study|Lost to Follow-up|5|||
48693247|NCT03502707|156726394|FG008|Overall Study|Lost to Follow-up|0|||
48693248|NCT03502707|156726395|FG009|Overall Study|Lost to Follow-up|2|||
48693249|NCT03502707|156726396|FG010|Overall Study|Lost to Follow-up|1|||
48693250|NCT03502707|156726397|FG011|Overall Study|Lost to Follow-up|2|||
48693251|NCT03502707|156726398|FG012|Overall Study|Lost to Follow-up|1|||
48693252|NCT03502707|156726399|FG013|Overall Study|Lost to Follow-up|1|||
48693253|NCT03502707|156726400|FG014|Overall Study|Lost to Follow-up|0|||
48693254|NCT03502707|156726401|FG015|Overall Study|Lost to Follow-up|4|||
48693255|NCT03502707|156726402|FG016|Overall Study|Lost to Follow-up|9|||
48693256|NCT03502707|156726403|FG017|Overall Study|Lost to Follow-up|2|||
48693257|NCT03502707|156726386|FG000|Overall Study|Physician Decision|0|||
48693258|NCT03502707|156726387|FG001|Overall Study|Physician Decision|0|||
48588166|NCT02007278|156347569|FG001|Overall Study|Mis-randomization|1|||
48588167|NCT03230838|156347572|FG000|Overall Study|Withdrawal by Subject|3|||
48588168|NCT03230838|156347573|FG001|Overall Study|Withdrawal by Subject|0|||
48588169|NCT03230838|156347572|FG000|Overall Study|Temperature excursion|1|||
48588170|NCT03230838|156347573|FG001|Overall Study|Temperature excursion|0|||
48588171|NCT02886884|156347574|FG000|Follow-up|Withdrawal by Subject|0|||
48588172|NCT02886884|156347575|FG001|Follow-up|Withdrawal by Subject|0|||
48588173|NCT02886884|156347576|FG002|Follow-up|Withdrawal by Subject|0|||
48588174|NCT02886884|156347577|FG003|Follow-up|Withdrawal by Subject|1|||
48588175|NCT00350779|156347578|FG000|Overall Study|Adverse Event|4|||
48588176|NCT00350779|156347579|FG001|Overall Study|Adverse Event|2|||
48588177|NCT00350779|156347578|FG000|Overall Study|Lack of Efficacy|0|||
48588178|NCT00350779|156347579|FG001|Overall Study|Lack of Efficacy|4|||
48588179|NCT00350779|156347578|FG000|Overall Study|Lost to Follow-up|2|||
48588180|NCT00350779|156347579|FG001|Overall Study|Lost to Follow-up|0|||
48588181|NCT00350779|156347578|FG000|Overall Study|Physician Decision|2|||
48588182|NCT00350779|156347579|FG001|Overall Study|Physician Decision|4|||
48588183|NCT00350779|156347578|FG000|Overall Study|Protocol Violation|3|||
48588184|NCT00350779|156347579|FG001|Overall Study|Protocol Violation|1|||
48588185|NCT00350779|156347578|FG000|Overall Study|Withdrawal by Subject|9|||
48588186|NCT00350779|156347579|FG001|Overall Study|Withdrawal by Subject|8|||
48588187|NCT00350779|156347578|FG000|Overall Study|Patient Moved|2|||
48588188|NCT00350779|156347579|FG001|Overall Study|Patient Moved|1|||
48588189|NCT00350779|156347578|FG000|Overall Study|Non-compliance with study procedures|0|||
48588190|NCT00350779|156347579|FG001|Overall Study|Non-compliance with study procedures|1|||
48693259|NCT03502707|156726388|FG002|Overall Study|Physician Decision|0|||
48693260|NCT03502707|156726389|FG003|Overall Study|Physician Decision|0|||
48693261|NCT03502707|156726390|FG004|Overall Study|Physician Decision|0|||
48693262|NCT03502707|156726391|FG005|Overall Study|Physician Decision|0|||
48693263|NCT03502707|156726392|FG006|Overall Study|Physician Decision|0|||
48693264|NCT03502707|156726393|FG007|Overall Study|Physician Decision|0|||
48693265|NCT03502707|156726394|FG008|Overall Study|Physician Decision|2|||
48693266|NCT03502707|156726395|FG009|Overall Study|Physician Decision|1|||
48693267|NCT03502707|156726396|FG010|Overall Study|Physician Decision|0|||
48693268|NCT03502707|156726397|FG011|Overall Study|Physician Decision|0|||
48693269|NCT03502707|156726398|FG012|Overall Study|Physician Decision|0|||
48693270|NCT03502707|156726399|FG013|Overall Study|Physician Decision|0|||
48693271|NCT03502707|156726400|FG014|Overall Study|Physician Decision|1|||
48693272|NCT03502707|156726401|FG015|Overall Study|Physician Decision|3|||
48693273|NCT03502707|156726402|FG016|Overall Study|Physician Decision|0|||
48693274|NCT03502707|156726403|FG017|Overall Study|Physician Decision|0|||
48693275|NCT03502707|156726386|FG000|Overall Study|Protocol Violation|0|||
48693276|NCT03502707|156726387|FG001|Overall Study|Protocol Violation|0|||
48693277|NCT03502707|156726388|FG002|Overall Study|Protocol Violation|0|||
48693278|NCT03502707|156726389|FG003|Overall Study|Protocol Violation|0|||
48693279|NCT03502707|156726390|FG004|Overall Study|Protocol Violation|0|||
48693280|NCT03502707|156726391|FG005|Overall Study|Protocol Violation|0|||
48693281|NCT03502707|156726392|FG006|Overall Study|Protocol Violation|0|||
48693282|NCT03502707|156726393|FG007|Overall Study|Protocol Violation|0|||
48693283|NCT03502707|156726394|FG008|Overall Study|Protocol Violation|0|||
48693284|NCT03502707|156726395|FG009|Overall Study|Protocol Violation|0|||
48693285|NCT03502707|156726396|FG010|Overall Study|Protocol Violation|0|||
48693286|NCT03502707|156726397|FG011|Overall Study|Protocol Violation|0|||
48693287|NCT03502707|156726398|FG012|Overall Study|Protocol Violation|0|||
48693288|NCT03502707|156726399|FG013|Overall Study|Protocol Violation|0|||
48693289|NCT03502707|156726400|FG014|Overall Study|Protocol Violation|0|||
48693290|NCT03502707|156726401|FG015|Overall Study|Protocol Violation|1|||
48693291|NCT03502707|156726402|FG016|Overall Study|Protocol Violation|0|||
48693292|NCT03502707|156726403|FG017|Overall Study|Protocol Violation|0|||
48693293|NCT03502707|156726386|FG000|Overall Study|Withdrawal by Subject|1|||
48693294|NCT03502707|156726387|FG001|Overall Study|Withdrawal by Subject|1|||
48693295|NCT03502707|156726388|FG002|Overall Study|Withdrawal by Subject|0|||
48693296|NCT03502707|156726389|FG003|Overall Study|Withdrawal by Subject|0|||
48693297|NCT03502707|156726390|FG004|Overall Study|Withdrawal by Subject|0|||
48693298|NCT03502707|156726391|FG005|Overall Study|Withdrawal by Subject|2|||
48693299|NCT03502707|156726392|FG006|Overall Study|Withdrawal by Subject|0|||
48693300|NCT03502707|156726393|FG007|Overall Study|Withdrawal by Subject|3|||
48693301|NCT03502707|156726394|FG008|Overall Study|Withdrawal by Subject|1|||
48693302|NCT03502707|156726395|FG009|Overall Study|Withdrawal by Subject|2|||
48693303|NCT03502707|156726396|FG010|Overall Study|Withdrawal by Subject|12|||
48693304|NCT03502707|156726397|FG011|Overall Study|Withdrawal by Subject|23|||
48693305|NCT03502707|156726398|FG012|Overall Study|Withdrawal by Subject|5|||
48693306|NCT03502707|156726399|FG013|Overall Study|Withdrawal by Subject|3|||
48693307|NCT03502707|156726400|FG014|Overall Study|Withdrawal by Subject|3|||
48693308|NCT03502707|156726401|FG015|Overall Study|Withdrawal by Subject|43|||
48693309|NCT03502707|156726402|FG016|Overall Study|Withdrawal by Subject|44|||
48693310|NCT03502707|156726403|FG017|Overall Study|Withdrawal by Subject|18|||
48693311|NCT03502707|156726386|FG000|Overall Study|Sponsor's Decision|1|||
48693312|NCT03502707|156726387|FG001|Overall Study|Sponsor's Decision|0|||
48693313|NCT03502707|156726388|FG002|Overall Study|Sponsor's Decision|0|||
48693314|NCT03502707|156726389|FG003|Overall Study|Sponsor's Decision|0|||
48693315|NCT03502707|156726390|FG004|Overall Study|Sponsor's Decision|0|||
48693316|NCT03502707|156726391|FG005|Overall Study|Sponsor's Decision|0|||
48693317|NCT03502707|156726392|FG006|Overall Study|Sponsor's Decision|0|||
48693318|NCT03502707|156726393|FG007|Overall Study|Sponsor's Decision|0|||
48693319|NCT03502707|156726394|FG008|Overall Study|Sponsor's Decision|0|||
48693320|NCT03502707|156726395|FG009|Overall Study|Sponsor's Decision|1|||
48693321|NCT03502707|156726396|FG010|Overall Study|Sponsor's Decision|0|||
48693322|NCT03502707|156726397|FG011|Overall Study|Sponsor's Decision|0|||
48693323|NCT03502707|156726398|FG012|Overall Study|Sponsor's Decision|0|||
48693324|NCT03502707|156726399|FG013|Overall Study|Sponsor's Decision|0|||
48693325|NCT03502707|156726400|FG014|Overall Study|Sponsor's Decision|0|||
48693326|NCT03502707|156726401|FG015|Overall Study|Sponsor's Decision|2|||
48693327|NCT03502707|156726402|FG016|Overall Study|Sponsor's Decision|1|||
48693328|NCT03502707|156726403|FG017|Overall Study|Sponsor's Decision|0|||
48693329|NCT03502707|156726386|FG000|Overall Study|Initiated Prohibited Medication|0|||
48693330|NCT03502707|156726387|FG001|Overall Study|Initiated Prohibited Medication|0|||
48693331|NCT03502707|156726388|FG002|Overall Study|Initiated Prohibited Medication|0|||
48693332|NCT03502707|156726389|FG003|Overall Study|Initiated Prohibited Medication|0|||
48693333|NCT03502707|156726390|FG004|Overall Study|Initiated Prohibited Medication|0|||
48693334|NCT03502707|156726391|FG005|Overall Study|Initiated Prohibited Medication|0|||
48693335|NCT03502707|156726392|FG006|Overall Study|Initiated Prohibited Medication|0|||
48693336|NCT03502707|156726393|FG007|Overall Study|Initiated Prohibited Medication|0|||
48693337|NCT03502707|156726394|FG008|Overall Study|Initiated Prohibited Medication|0|||
48693338|NCT03502707|156726395|FG009|Overall Study|Initiated Prohibited Medication|0|||
48693339|NCT03502707|156726396|FG010|Overall Study|Initiated Prohibited Medication|0|||
48693340|NCT03502707|156726397|FG011|Overall Study|Initiated Prohibited Medication|0|||
48693341|NCT03502707|156726398|FG012|Overall Study|Initiated Prohibited Medication|0|||
48693342|NCT03502707|156726399|FG013|Overall Study|Initiated Prohibited Medication|0|||
48693343|NCT03502707|156726400|FG014|Overall Study|Initiated Prohibited Medication|0|||
48693344|NCT03502707|156726401|FG015|Overall Study|Initiated Prohibited Medication|0|||
48693345|NCT03502707|156726402|FG016|Overall Study|Initiated Prohibited Medication|1|||
48693346|NCT03502707|156726403|FG017|Overall Study|Initiated Prohibited Medication|0|||
48693347|NCT03502707|156726386|FG000|Overall Study|Other|0|||
48693348|NCT03502707|156726387|FG001|Overall Study|Other|0|||
48693349|NCT03502707|156726388|FG002|Overall Study|Other|0|||
48693350|NCT03502707|156726389|FG003|Overall Study|Other|0|||
48693351|NCT03502707|156726390|FG004|Overall Study|Other|0|||
48693352|NCT03502707|156726391|FG005|Overall Study|Other|0|||
48693353|NCT03502707|156726392|FG006|Overall Study|Other|0|||
48693354|NCT03502707|156726393|FG007|Overall Study|Other|0|||
48693355|NCT03502707|156726394|FG008|Overall Study|Other|1|||
48693356|NCT03502707|156726395|FG009|Overall Study|Other|1|||
48693357|NCT03502707|156726396|FG010|Overall Study|Other|2|||
48693358|NCT03502707|156726397|FG011|Overall Study|Other|0|||
48693359|NCT03502707|156726398|FG012|Overall Study|Other|0|||
48693360|NCT03502707|156726399|FG013|Overall Study|Other|0|||
48693361|NCT03502707|156726400|FG014|Overall Study|Other|0|||
48693362|NCT03502707|156726401|FG015|Overall Study|Other|4|||
48693363|NCT03502707|156726402|FG016|Overall Study|Other|1|||
48693364|NCT03502707|156726403|FG017|Overall Study|Other|0|||
48693365|NCT03502707|156726386|FG000|Overall Study|Randomized but not vaccinated|0|||
48693366|NCT03502707|156726387|FG001|Overall Study|Randomized but not vaccinated|0|||
48693367|NCT03502707|156726388|FG002|Overall Study|Randomized but not vaccinated|0|||
48693368|NCT03502707|156726389|FG003|Overall Study|Randomized but not vaccinated|0|||
48693369|NCT03502707|156726390|FG004|Overall Study|Randomized but not vaccinated|0|||
48693370|NCT03502707|156726391|FG005|Overall Study|Randomized but not vaccinated|0|||
48693371|NCT03502707|156726392|FG006|Overall Study|Randomized but not vaccinated|0|||
48693372|NCT03502707|156726393|FG007|Overall Study|Randomized but not vaccinated|0|||
48693373|NCT03502707|156726394|FG008|Overall Study|Randomized but not vaccinated|0|||
48693374|NCT03502707|156726395|FG009|Overall Study|Randomized but not vaccinated|0|||
48693375|NCT03502707|156726396|FG010|Overall Study|Randomized but not vaccinated|0|||
48693376|NCT03502707|156726397|FG011|Overall Study|Randomized but not vaccinated|1|||
48693377|NCT03502707|156726398|FG012|Overall Study|Randomized but not vaccinated|0|||
48693378|NCT03502707|156726399|FG013|Overall Study|Randomized but not vaccinated|0|||
48693379|NCT03502707|156726400|FG014|Overall Study|Randomized but not vaccinated|0|||
48693380|NCT03502707|156726401|FG015|Overall Study|Randomized but not vaccinated|0|||
48693381|NCT03502707|156726402|FG016|Overall Study|Randomized but not vaccinated|0|||
48693382|NCT03502707|156726403|FG017|Overall Study|Randomized but not vaccinated|1|||
48693383|NCT01018030|156726409|FG000|Overall Study|Adverse Event|10|||
48693384|NCT01018030|156726410|FG001|Overall Study|Adverse Event|5|||
48693385|NCT01018030|156726411|FG002|Overall Study|Adverse Event|5|||
48693386|NCT01018030|156726409|FG000|Overall Study|Withdrawal by Subject|2|||
48693387|NCT01018030|156726410|FG001|Overall Study|Withdrawal by Subject|2|||
48693388|NCT01018030|156726411|FG002|Overall Study|Withdrawal by Subject|4|||
48693389|NCT01018030|156726409|FG000|Overall Study|Lost to Follow-up|2|||
48693390|NCT01018030|156726410|FG001|Overall Study|Lost to Follow-up|0|||
48693391|NCT01018030|156726411|FG002|Overall Study|Lost to Follow-up|3|||
48693392|NCT01018030|156726409|FG000|Overall Study|Protocol Violation|2|||
48693393|NCT01018030|156726410|FG001|Overall Study|Protocol Violation|1|||
48693394|NCT01018030|156726411|FG002|Overall Study|Protocol Violation|0|||
48693395|NCT01018030|156726409|FG000|Overall Study|Physician Decision|1|||
48693396|NCT01018030|156726410|FG001|Overall Study|Physician Decision|0|||
48693397|NCT01018030|156726411|FG002|Overall Study|Physician Decision|1|||
48693398|NCT01018030|156726409|FG000|Overall Study|Lack of Efficacy|1|||
48693399|NCT01018030|156726410|FG001|Overall Study|Lack of Efficacy|0|||
48693400|NCT01018030|156726411|FG002|Overall Study|Lack of Efficacy|0|||
48693401|NCT01018030|156726409|FG000|Overall Study|Did Not Receive Study Drug|1|||
48693402|NCT01018030|156726410|FG001|Overall Study|Did Not Receive Study Drug|3|||
48693403|NCT01018030|156726411|FG002|Overall Study|Did Not Receive Study Drug|0|||
48693404|NCT00097500|156726412|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
48693405|NCT00097500|156726413|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
48693406|NCT00097500|156726412|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
48693407|NCT00097500|156726413|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
48693408|NCT00097500|156726412|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
48693409|NCT00097500|156726413|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
48693410|NCT00097500|156726412|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48693411|NCT00097500|156726413|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
48693412|NCT00097500|156726412|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
48693413|NCT00097500|156726413|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
48693414|NCT00097500|156726412|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
48693415|NCT00097500|156726413|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
48693416|NCT00097500|156726412|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
48693417|NCT00097500|156726413|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
48693418|NCT01600885|156726422|FG000|First Period|Adverse Event|1|||
48693419|NCT01600885|156726423|FG001|First Period|Adverse Event|1|||
48693420|NCT01600885|156726422|FG000|First Period|moved out of area|1|||
48693421|NCT01600885|156726423|FG001|First Period|moved out of area|0|||
48693422|NCT02399215|156726424|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
48693423|NCT02399215|156726424|FG000|Overall Study|Withdrawal by Subject|1|||
48693424|NCT03617172|156726425|FG000|Overall Study|Lost to Follow-up|1|||
48693425|NCT03617172|156726426|FG001|Overall Study|Lost to Follow-up|0|||
48693426|NCT00001832|156726427|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
48693427|NCT00001832|156726428|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
48693428|NCT00001832|156726429|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
48693429|NCT00001832|156726430|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
48693430|NCT00001832|156726431|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
48693431|NCT00001832|156726432|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
48693432|NCT00001832|156726433|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
48693433|NCT00001832|156726434|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
48693434|NCT00001832|156726435|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
48693435|NCT00001832|156726436|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
48693436|NCT00001832|156726437|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
48693437|NCT00001832|156726438|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
48693438|NCT00001832|156726439|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
48693439|NCT00001832|156726440|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
48693440|NCT00001832|156726441|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
48693441|NCT00001832|156726427|FG000|Treatment Period|Death during treatment|0|||
48693442|NCT00001832|156726428|FG001|Treatment Period|Death during treatment|0|||
48693443|NCT00001832|156726429|FG002|Treatment Period|Death during treatment|0|||
48693444|NCT00001832|156726430|FG003|Treatment Period|Death during treatment|0|||
48693445|NCT00001832|156726431|FG004|Treatment Period|Death during treatment|0|||
48693446|NCT00001832|156726432|FG005|Treatment Period|Death during treatment|1|||
48693447|NCT00001832|156726433|FG006|Treatment Period|Death during treatment|0|||
48693448|NCT00001832|156726434|FG007|Treatment Period|Death during treatment|0|||
48693449|NCT00001832|156726435|FG008|Treatment Period|Death during treatment|0|||
48693450|NCT00001832|156726436|FG009|Treatment Period|Death during treatment|0|||
48693451|NCT00001832|156726437|FG010|Treatment Period|Death during treatment|0|||
48693452|NCT00001832|156726438|FG011|Treatment Period|Death during treatment|0|||
48693453|NCT00001832|156726439|FG012|Treatment Period|Death during treatment|0|||
48693454|NCT00001832|156726440|FG013|Treatment Period|Death during treatment|0|||
48693455|NCT00001832|156726441|FG014|Treatment Period|Death during treatment|0|||
48693456|NCT00001832|156726427|FG000|Treatment Period|Not treated|0|||
48693457|NCT00001832|156726428|FG001|Treatment Period|Not treated|0|||
48693458|NCT00001832|156726429|FG002|Treatment Period|Not treated|0|||
48693459|NCT00001832|156726430|FG003|Treatment Period|Not treated|0|||
48591908|NCT00433017|156361402|FG000|Overall Study|Lost to Follow-up|3|||
48591909|NCT00433017|156361403|FG001|Overall Study|Lost to Follow-up|4|||
48591910|NCT00433017|156361402|FG000|Overall Study|Administrative problems|80|||
48591911|NCT00433017|156361403|FG001|Overall Study|Administrative problems|86|||
48591912|NCT00433017|156361402|FG000|Overall Study|Protocol Violation|1|||
48591913|NCT00433017|156361403|FG001|Overall Study|Protocol Violation|0|||
48591914|NCT00433017|156361402|FG000|Overall Study|Death|2|||
48591915|NCT00433017|156361403|FG001|Overall Study|Death|2|||
48591916|NCT00433017|156361402|FG000|Overall Study|Subject no longer requires study drug|1|||
48591917|NCT00433017|156361403|FG001|Overall Study|Subject no longer requires study drug|1|||
48591918|NCT04710368|156361404|FG000|Overall Study|Withdrawal by Subject|9|||
48591919|NCT04710368|156361404|FG000|Overall Study|Lost to Follow-up|4|||
48591920|NCT04710368|156361404|FG000|Overall Study|Death|2|||
48591921|NCT04710368|156361404|FG000|Overall Study|Patient preference|11|||
48591922|NCT04710368|156361404|FG000|Overall Study|Treatment discontinuation|1|||
48591923|NCT00135356|156361405|FG000|Overall Study|Adverse Event|6|||
48591924|NCT00135356|156361406|FG001|Overall Study|Adverse Event|2|||
48591925|NCT00135356|156361405|FG000|Overall Study|Lack of Efficacy|2|||
48591926|NCT00135356|156361406|FG001|Overall Study|Lack of Efficacy|0|||
48591927|NCT00135356|156361405|FG000|Overall Study|Lost to Follow-up|3|||
48591928|NCT00135356|156361406|FG001|Overall Study|Lost to Follow-up|1|||
48591929|NCT00135356|156361405|FG000|Overall Study|Surgery for abdominal fat|1|||
48591930|NCT00135356|156361406|FG001|Overall Study|Surgery for abdominal fat|0|||
48591931|NCT00135356|156361405|FG000|Overall Study|Change in antiviral regimen|0|||
48591932|NCT00135356|156361406|FG001|Overall Study|Change in antiviral regimen|1|||
48591933|NCT00135356|156361405|FG000|Overall Study|Poor/noncompliance|1|||
48591934|NCT00135356|156361406|FG001|Overall Study|Poor/noncompliance|1|||
48591935|NCT00135356|156361405|FG000|Overall Study|No longer meets study criteria|2|||
48591936|NCT00135356|156361406|FG001|Overall Study|No longer meets study criteria|0|||
48591937|NCT00135356|156361405|FG000|Overall Study|Withdrawal by Subject|2|||
48591938|NCT00135356|156361406|FG001|Overall Study|Withdrawal by Subject|4|||
48591939|NCT00153816|156361407|FG000|Overall Study|Death|6|||
48591940|NCT00153816|156361408|FG001|Overall Study|Death|5|||
48591941|NCT00153816|156361409|FG002|Overall Study|Death|4|||
48591942|NCT00153816|156361410|FG003|Overall Study|Death|6|||
48591943|NCT00153816|156361411|FG004|Overall Study|Death|0|||
48693460|NCT00001832|156726431|FG004|Treatment Period|Not treated|0|||
48693461|NCT00001832|156726432|FG005|Treatment Period|Not treated|0|||
48693462|NCT00001832|156726433|FG006|Treatment Period|Not treated|0|||
48693463|NCT00001832|156726434|FG007|Treatment Period|Not treated|1|||
48693464|NCT00001832|156726435|FG008|Treatment Period|Not treated|0|||
48693465|NCT00001832|156726436|FG009|Treatment Period|Not treated|0|||
48693466|NCT00001832|156726437|FG010|Treatment Period|Not treated|0|||
48693467|NCT00001832|156726438|FG011|Treatment Period|Not treated|0|||
48693468|NCT00001832|156726439|FG012|Treatment Period|Not treated|0|||
48693469|NCT00001832|156726440|FG013|Treatment Period|Not treated|0|||
48693470|NCT00001832|156726441|FG014|Treatment Period|Not treated|0|||
48693471|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Physician Decision|1|||
48693472|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Physician Decision|0|||
48693473|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
48693474|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
48693475|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
48693476|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
48693477|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Pregnancy|0|||
48693478|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Pregnancy|2|||
48693479|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
48693480|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
48693481|NCT01785719|156726442|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
48693482|NCT01785719|156726443|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
48693483|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
48693484|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
48693485|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
48693486|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
48693487|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
48693488|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
48693489|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
48693490|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
48693491|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
48693492|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
48693493|NCT01785719|156726442|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
48693494|NCT01785719|156726443|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
48693495|NCT01785719|156726442|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
48693496|NCT01785719|156726443|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
48693497|NCT01785719|156726442|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
48693498|NCT01785719|156726443|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
48693499|NCT01785719|156726442|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
48693500|NCT01785719|156726443|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
48693501|NCT04492007|156726444|FG000|Overall Study|Lost to Follow-up|1|||
48693502|NCT04492007|156726445|FG001|Overall Study|Lost to Follow-up|1|||
48693503|NCT04492007|156726446|FG002|Overall Study|Lost to Follow-up|2|||
48693504|NCT04492007|156726447|FG003|Overall Study|Lost to Follow-up|2|||
48693505|NCT04492007|156726444|FG000|Overall Study|Protocol Violation|1|||
48693506|NCT04492007|156726445|FG001|Overall Study|Protocol Violation|1|||
48693507|NCT04492007|156726446|FG002|Overall Study|Protocol Violation|1|||
48693508|NCT04492007|156726447|FG003|Overall Study|Protocol Violation|1|||
48693509|NCT04492007|156726444|FG000|Overall Study|Withdrawal by Subject|0|||
48693510|NCT04492007|156726445|FG001|Overall Study|Withdrawal by Subject|0|||
48693511|NCT04492007|156726446|FG002|Overall Study|Withdrawal by Subject|1|||
48693512|NCT04492007|156726447|FG003|Overall Study|Withdrawal by Subject|1|||
48693513|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
48693514|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
48693515|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693516|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693517|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693518|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
48693519|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
48693520|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693521|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693522|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693523|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693524|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693525|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693526|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
48693527|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693528|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693529|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693530|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693531|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693532|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
48693533|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
48693534|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693535|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693536|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693537|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693538|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693539|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693540|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
48693541|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
48693542|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693543|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693544|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693545|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693546|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693547|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
48693548|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693549|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693550|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693551|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693552|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693553|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693554|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
48693555|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693556|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48742917|NCT00745823|156910414|FG001|Overall Study|Lost to Follow-up|11|||
48591944|NCT00153816|156361412|FG005|Overall Study|Death|2|||
48591945|NCT00153816|156361407|FG000|Overall Study|Lost to Follow-up|7|||
48591946|NCT00153816|156361408|FG001|Overall Study|Lost to Follow-up|8|||
48591947|NCT00153816|156361409|FG002|Overall Study|Lost to Follow-up|5|||
48591948|NCT00153816|156361410|FG003|Overall Study|Lost to Follow-up|8|||
48591949|NCT00153816|156361411|FG004|Overall Study|Lost to Follow-up|7|||
48591950|NCT00153816|156361412|FG005|Overall Study|Lost to Follow-up|9|||
48591951|NCT00153816|156361407|FG000|Overall Study|Withdrawal by Subject|9|||
48591952|NCT00153816|156361408|FG001|Overall Study|Withdrawal by Subject|9|||
48591953|NCT00153816|156361409|FG002|Overall Study|Withdrawal by Subject|9|||
48591954|NCT00153816|156361410|FG003|Overall Study|Withdrawal by Subject|4|||
48591955|NCT00153816|156361411|FG004|Overall Study|Withdrawal by Subject|1|||
48591956|NCT00153816|156361412|FG005|Overall Study|Withdrawal by Subject|5|||
48591957|NCT00153816|156361407|FG000|Overall Study|Follow-up exam not done|8|||
48591958|NCT00153816|156361408|FG001|Overall Study|Follow-up exam not done|7|||
48591959|NCT00153816|156361409|FG002|Overall Study|Follow-up exam not done|11|||
48591960|NCT00153816|156361410|FG003|Overall Study|Follow-up exam not done|10|||
48591961|NCT00153816|156361411|FG004|Overall Study|Follow-up exam not done|8|||
48591962|NCT00153816|156361412|FG005|Overall Study|Follow-up exam not done|9|||
48591963|NCT00153816|156361407|FG000|Overall Study|Follow-up exam done, histology missing|2|||
48591964|NCT00153816|156361408|FG001|Overall Study|Follow-up exam done, histology missing|3|||
48591965|NCT00153816|156361409|FG002|Overall Study|Follow-up exam done, histology missing|3|||
48591966|NCT00153816|156361410|FG003|Overall Study|Follow-up exam done, histology missing|3|||
48591967|NCT00153816|156361411|FG004|Overall Study|Follow-up exam done, histology missing|1|||
48591968|NCT00153816|156361412|FG005|Overall Study|Follow-up exam done, histology missing|2|||
48591969|NCT00885378|156361413|FG000|Overall Study|Lack of Efficacy|2|||
48591970|NCT00885378|156361414|FG001|Overall Study|Lack of Efficacy|2|||
48591971|NCT00885378|156361413|FG000|Overall Study|Withdrawal by Subject|1|||
48591972|NCT00885378|156361414|FG001|Overall Study|Withdrawal by Subject|2|||
48591973|NCT00885378|156361413|FG000|Overall Study|Lost to Follow-up|1|||
48591974|NCT00885378|156361414|FG001|Overall Study|Lost to Follow-up|2|||
48591975|NCT00885378|156361413|FG000|Overall Study|Poor/Noncompliance|2|||
48591976|NCT00885378|156361414|FG001|Overall Study|Poor/Noncompliance|2|||
48591977|NCT00885378|156361413|FG000|Overall Study|Protocol Violation|2|||
48591978|NCT00885378|156361414|FG001|Overall Study|Protocol Violation|0|||
48591979|NCT01533688|156361415|FG000|Overall Study|Withdrawal by Subject|5|||
48591980|NCT01533688|156361416|FG001|Overall Study|Withdrawal by Subject|4|||
48591981|NCT01533688|156361417|FG002|Overall Study|Withdrawal by Subject|3|||
48591982|NCT01533688|156361415|FG000|Overall Study|Medically unstable|1|||
48693557|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693558|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693559|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693560|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
48693561|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
48693562|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693563|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693564|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693565|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693566|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693567|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48591983|NCT01533688|156361416|FG001|Overall Study|Medically unstable|3|||
48591984|NCT01533688|156361417|FG002|Overall Study|Medically unstable|3|||
48591985|NCT01533688|156361415|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
48591986|NCT01533688|156361416|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
48591987|NCT01533688|156361417|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
48591988|NCT02509078|156361422|FG000|Overall Study|Protocol Violation|1|||
48591989|NCT02509078|156361423|FG001|Overall Study|Protocol Violation|1|||
48591990|NCT03959488|156361425|FG000|Season 1|Other|6|||
48591991|NCT03959488|156361426|FG001|Season 1|Other|7|||
48591992|NCT03959488|156361427|FG002|Season 1|Other|0|||
48591993|NCT03959488|156361428|FG003|Season 1|Other|0|||
48591994|NCT03959488|156361429|FG004|Season 1|Other|0|||
48591995|NCT03959488|156361425|FG000|Season 1|Withdrawal by parent/guardian|43|||
48591996|NCT03959488|156361426|FG001|Season 1|Withdrawal by parent/guardian|28|||
48591997|NCT03959488|156361427|FG002|Season 1|Withdrawal by parent/guardian|0|||
48591998|NCT03959488|156361428|FG003|Season 1|Withdrawal by parent/guardian|0|||
48591999|NCT03959488|156361429|FG004|Season 1|Withdrawal by parent/guardian|0|||
48592000|NCT03959488|156361425|FG000|Season 1|Due to COVID-19 pandemic|2|||
48592001|NCT03959488|156361426|FG001|Season 1|Due to COVID-19 pandemic|3|||
48592002|NCT03959488|156361427|FG002|Season 1|Due to COVID-19 pandemic|0|||
48592003|NCT03959488|156361428|FG003|Season 1|Due to COVID-19 pandemic|0|||
48592004|NCT03959488|156361429|FG004|Season 1|Due to COVID-19 pandemic|0|||
48592005|NCT03959488|156361425|FG000|Season 1|Lost to Follow-up|17|||
48592006|NCT03959488|156361426|FG001|Season 1|Lost to Follow-up|7|||
48592007|NCT03959488|156361427|FG002|Season 1|Lost to Follow-up|0|||
48592008|NCT03959488|156361428|FG003|Season 1|Lost to Follow-up|0|||
48592009|NCT03959488|156361429|FG004|Season 1|Lost to Follow-up|0|||
48592010|NCT03959488|156361425|FG000|Season 1|Death|5|||
48592011|NCT03959488|156361426|FG001|Season 1|Death|1|||
48592012|NCT03959488|156361427|FG002|Season 1|Death|0|||
48592013|NCT03959488|156361428|FG003|Season 1|Death|0|||
48592014|NCT03959488|156361429|FG004|Season 1|Death|0|||
48592015|NCT03959488|156361425|FG000|Season 2|Other|0|||
48592016|NCT03959488|156361426|FG001|Season 2|Other|0|||
48592017|NCT03959488|156361427|FG002|Season 2|Other|2|||
48592018|NCT03959488|156361428|FG003|Season 2|Other|0|||
48592019|NCT03959488|156361429|FG004|Season 2|Other|0|||
48592020|NCT03959488|156361425|FG000|Season 2|Withdrawal by parent/guardian|0|||
48592021|NCT03959488|156361426|FG001|Season 2|Withdrawal by parent/guardian|0|||
48592022|NCT03959488|156361427|FG002|Season 2|Withdrawal by parent/guardian|3|||
48592023|NCT03959488|156361428|FG003|Season 2|Withdrawal by parent/guardian|1|||
48592024|NCT03959488|156361429|FG004|Season 2|Withdrawal by parent/guardian|1|||
48592025|NCT03959488|156361425|FG000|Season 2|Lost to Follow-up|0|||
48592026|NCT03959488|156361426|FG001|Season 2|Lost to Follow-up|0|||
48592027|NCT03959488|156361427|FG002|Season 2|Lost to Follow-up|1|||
48592028|NCT03959488|156361428|FG003|Season 2|Lost to Follow-up|0|||
48592029|NCT03959488|156361429|FG004|Season 2|Lost to Follow-up|1|||
48592030|NCT04575584|156361430|FG000|Overall Study|Death|6|||
48592031|NCT04575584|156361431|FG001|Overall Study|Death|4|||
48592032|NCT04575584|156361432|FG002|Overall Study|Death|6|||
48592033|NCT04575584|156361433|FG003|Overall Study|Death|2|||
48592034|NCT04575584|156361434|FG004|Overall Study|Death|0|||
48592035|NCT04575584|156361435|FG005|Overall Study|Death|0|||
48592036|NCT04575584|156361430|FG000|Overall Study|Lost to Follow-up|1|||
48592037|NCT04575584|156361431|FG001|Overall Study|Lost to Follow-up|1|||
48592038|NCT04575584|156361432|FG002|Overall Study|Lost to Follow-up|1|||
48592039|NCT04575584|156361433|FG003|Overall Study|Lost to Follow-up|1|||
48592040|NCT04575584|156361434|FG004|Overall Study|Lost to Follow-up|0|||
48592041|NCT04575584|156361435|FG005|Overall Study|Lost to Follow-up|0|||
48592042|NCT04575584|156361430|FG000|Overall Study|Physician Decision|0|||
48592043|NCT04575584|156361431|FG001|Overall Study|Physician Decision|1|||
48592044|NCT04575584|156361432|FG002|Overall Study|Physician Decision|1|||
48592045|NCT04575584|156361433|FG003|Overall Study|Physician Decision|1|||
48592046|NCT04575584|156361434|FG004|Overall Study|Physician Decision|0|||
48592047|NCT04575584|156361435|FG005|Overall Study|Physician Decision|0|||
48592048|NCT04575584|156361430|FG000|Overall Study|Withdrawal by Subject|7|||
48592049|NCT04575584|156361431|FG001|Overall Study|Withdrawal by Subject|9|||
48592050|NCT04575584|156361432|FG002|Overall Study|Withdrawal by Subject|5|||
48592051|NCT04575584|156361433|FG003|Overall Study|Withdrawal by Subject|3|||
48592052|NCT04575584|156361434|FG004|Overall Study|Withdrawal by Subject|0|||
48592053|NCT04575584|156361435|FG005|Overall Study|Withdrawal by Subject|0|||
48325475|NCT00371345|155389106|FG001|Overall Study|Participant Request|1|||
48592054|NCT04575584|156361430|FG000|Overall Study|Not recorded|0|||
48487570|NCT02191579|155979016|FG000|Treatment 2|Multiple Reasons Specified|0|||
48487571|NCT02191579|155979017|FG001|Treatment 2|Multiple Reasons Specified|25|||
48487572|NCT01484028|155979024|FG000|Period 1|Lost to Follow-up|0|||
48487573|NCT01484028|155979025|FG001|Period 1|Lost to Follow-up|1|||
48487574|NCT01484028|155979026|FG002|Period 1|Lost to Follow-up|0|||
48432074|NCT01683071|155769032|FG001|Part 1|Surgery Cancelled|0|||
48693568|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
48693569|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693570|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693571|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693572|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693573|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693574|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693575|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
48693576|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693577|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693578|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693579|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693580|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693581|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693582|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
48693583|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
48693584|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
48693585|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
48693586|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693587|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693588|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
48693589|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
48693590|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693591|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693592|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693593|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693594|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693595|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693596|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
48693597|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693598|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
48693599|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693600|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693601|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693602|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
48693603|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693604|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693605|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693606|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693607|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48487575|NCT01484028|155979027|FG003|Period 1|Lost to Follow-up|0|||
48487576|NCT01484028|155979024|FG000|Period 1|Non-Compliance to Protocol|0|||
48487577|NCT01484028|155979025|FG001|Period 1|Non-Compliance to Protocol|1|||
48588191|NCT01915771|156347583|FG000|Day 1|Withdrawal by Subject|1|||
48742918|NCT00745823|156910413|FG000|Overall Study|Physician Decision|10|||
48487578|NCT01484028|155979026|FG002|Period 1|Non-Compliance to Protocol|0|||
48693608|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48487579|NCT01484028|155979027|FG003|Period 1|Non-Compliance to Protocol|1|||
48592055|NCT04575584|156361431|FG001|Overall Study|Not recorded|0|||
48487580|NCT01484028|155979024|FG000|Period 1|Lens Discomfort|0|||
48487581|NCT01484028|155979025|FG001|Period 1|Lens Discomfort|1|||
48487582|NCT01484028|155979026|FG002|Period 1|Lens Discomfort|0|||
48487583|NCT01484028|155979027|FG003|Period 1|Lens Discomfort|0|||
48487584|NCT00345683|155979032|FG000|Overall Study|Lost to Follow-up|19|||
48487585|NCT00345683|155979033|FG001|Overall Study|Lost to Follow-up|7|||
48487586|NCT00345683|155979032|FG000|Overall Study|Other|6|||
48487587|NCT00345683|155979033|FG001|Overall Study|Other|2|||
48592056|NCT04575584|156361432|FG002|Overall Study|Not recorded|0|||
48592057|NCT04575584|156361433|FG003|Overall Study|Not recorded|1|||
48592058|NCT04575584|156361434|FG004|Overall Study|Not recorded|0|||
48592059|NCT04575584|156361435|FG005|Overall Study|Not recorded|0|||
48592060|NCT00582426|156361436|FG000|Overall Study|Lost to Follow-up|0|||
48487588|NCT00328783|155979034|FG000|Overall Study|Could not tolerate ABC|21|||
48592061|NCT00582426|156361437|FG001|Overall Study|Lost to Follow-up|2|||
48592062|NCT00582426|156361436|FG000|Overall Study|Adverse Event|4|||
48592063|NCT00582426|156361437|FG001|Overall Study|Adverse Event|2|||
48592064|NCT00582426|156361436|FG000|Overall Study|Protocol Violation|6|||
48592065|NCT00582426|156361437|FG001|Overall Study|Protocol Violation|2|||
48592066|NCT00582426|156361436|FG000|Overall Study|Death|4|||
48592067|NCT00582426|156361437|FG001|Overall Study|Death|3|||
48592068|NCT00582426|156361436|FG000|Overall Study|Withdrawal by Subject|3|||
48592069|NCT00582426|156361437|FG001|Overall Study|Withdrawal by Subject|2|||
48592070|NCT00582426|156361436|FG000|Overall Study|Disease Progression|2|||
48592071|NCT00582426|156361437|FG001|Overall Study|Disease Progression|2|||
48592072|NCT00582426|156361436|FG000|Overall Study|Use of illicit drugs|1|||
48693609|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48592073|NCT00582426|156361437|FG001|Overall Study|Use of illicit drugs|0|||
48592074|NCT02815267|156361438|FG000|Double-Blind Phase|Adverse Event|0|||
48592075|NCT02815267|156361439|FG001|Double-Blind Phase|Adverse Event|3|||
48592076|NCT02815267|156361438|FG000|Double-Blind Phase|Lost to Follow-up|17|||
48592077|NCT02815267|156361439|FG001|Double-Blind Phase|Lost to Follow-up|9|||
48592078|NCT02815267|156361438|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
48693610|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
48693611|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
48693612|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48592079|NCT02815267|156361439|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
48592080|NCT02815267|156361438|FG000|Double-Blind Phase|Protocol Violation|3|||
48592081|NCT02815267|156361439|FG001|Double-Blind Phase|Protocol Violation|2|||
48592082|NCT02815267|156361438|FG000|Double-Blind Phase|Site withdrawal|1|||
48592083|NCT02815267|156361439|FG001|Double-Blind Phase|Site withdrawal|6|||
48592084|NCT02815267|156361438|FG000|Double-Blind Phase|Received a disallowed medication|1|||
48592085|NCT02815267|156361439|FG001|Double-Blind Phase|Received a disallowed medication|1|||
48592086|NCT02815267|156361438|FG000|Open-Label Phase|Adverse Event|1|||
48592087|NCT02815267|156361439|FG001|Open-Label Phase|Adverse Event|1|||
48592088|NCT02815267|156361438|FG000|Open-Label Phase|Lost to Follow-up|23|||
48592089|NCT02815267|156361439|FG001|Open-Label Phase|Lost to Follow-up|9|||
48592090|NCT02815267|156361438|FG000|Open-Label Phase|Withdrawal by Subject|24|||
48592091|NCT02815267|156361439|FG001|Open-Label Phase|Withdrawal by Subject|13|||
48592092|NCT02815267|156361438|FG000|Open-Label Phase|Protocol Violation|0|||
48592093|NCT02815267|156361439|FG001|Open-Label Phase|Protocol Violation|1|||
48592094|NCT02815267|156361438|FG000|Open-Label Phase|Administrative|21|||
48592095|NCT02815267|156361439|FG001|Open-Label Phase|Administrative|12|||
48592096|NCT02815267|156361438|FG000|Open-Label Phase|Other|2|||
48592097|NCT02815267|156361439|FG001|Open-Label Phase|Other|5|||
48592098|NCT00255840|156361444|FG000|Overall Study|Lost to Follow-up|10|||
48592099|NCT00255840|156361445|FG001|Overall Study|Lost to Follow-up|14|||
48592100|NCT00255840|156361444|FG000|Overall Study|Discontinued intervention|53|||
48592101|NCT00255840|156361445|FG001|Overall Study|Discontinued intervention|56|||
48592102|NCT03465709|156361446|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
48592103|NCT03465709|156361446|FG000|Overall Study|Withdrawal by Subject|3|||
48592104|NCT00329745|156361447|FG000|Overall Study|Protocol Violation|1|||
48592105|NCT00329745|156361448|FG001|Overall Study|Protocol Violation|0|||
48592106|NCT00329745|156361447|FG000|Overall Study|Withdrawal by Subject|0|||
48592107|NCT00329745|156361448|FG001|Overall Study|Withdrawal by Subject|1|||
48592108|NCT00329745|156361447|FG000|Overall Study|Lost to Follow-up|86|||
48592109|NCT00329745|156361448|FG001|Overall Study|Lost to Follow-up|101|||
48592110|NCT02290925|156361449|FG000|First Period of Three Months|Lost to Follow-up|2|||
48592111|NCT02290925|156361450|FG001|First Period of Three Months|Lost to Follow-up|1|||
48592112|NCT02290925|156361449|FG000|First Period of Three Months|Death|1|||
48592113|NCT02290925|156361450|FG001|First Period of Three Months|Death|0|||
48592114|NCT02290925|156361449|FG000|First Period of Three Months|Insulin Started|1|||
48592115|NCT02290925|156361450|FG001|First Period of Three Months|Insulin Started|1|||
48592116|NCT02290925|156361449|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
48592117|NCT02290925|156361450|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
48592118|NCT02290925|156361449|FG000|Second Period of 3 Months|insulin started|0|||
48592119|NCT02290925|156361450|FG001|Second Period of 3 Months|insulin started|1|||
48592120|NCT01716520|156361451|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
48592121|NCT01716520|156361452|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
48592122|NCT01716520|156361453|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
48693613|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693614|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693615|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48592123|NCT01716520|156361454|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
48592124|NCT01716520|156361455|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
48592125|NCT01716520|156361456|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
48592126|NCT01716520|156361451|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
48592127|NCT01716520|156361452|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
48592128|NCT01716520|156361453|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
48487589|NCT00328783|155979034|FG000|Overall Study|No heart in RT field|4|||
48487590|NCT00328783|155979034|FG000|Overall Study|Withdrawal by Subject|1|||
48487591|NCT00895583|155979037|FG000|Overall Study|Adverse Event|28|||
48487592|NCT00895583|155979038|FG001|Overall Study|Adverse Event|4|||
48487593|NCT00895583|155979037|FG000|Overall Study|Death|2|||
48487594|NCT00895583|155979038|FG001|Overall Study|Death|1|||
48487595|NCT00895583|155979037|FG000|Overall Study|Physician Decision|3|||
48487596|NCT00895583|155979038|FG001|Overall Study|Physician Decision|1|||
48487597|NCT00895583|155979037|FG000|Overall Study|Lost to Follow-up|1|||
48487598|NCT00895583|155979038|FG001|Overall Study|Lost to Follow-up|3|||
48487599|NCT00895583|155979037|FG000|Overall Study|Protocol Violation|1|||
48487600|NCT00895583|155979038|FG001|Overall Study|Protocol Violation|0|||
48487601|NCT00895583|155979037|FG000|Overall Study|Withdrawal by Subject|4|||
48487602|NCT00895583|155979038|FG001|Overall Study|Withdrawal by Subject|2|||
48487603|NCT00895583|155979037|FG000|Overall Study|Lack of Efficacy|5|||
48487604|NCT00895583|155979038|FG001|Overall Study|Lack of Efficacy|0|||
48487605|NCT00895583|155979037|FG000|Overall Study|Other|0|||
48487606|NCT00895583|155979038|FG001|Overall Study|Other|1|||
48487607|NCT01200394|155979039|FG000|Overall Study|Adverse Event|0|||
48487608|NCT01200394|155979040|FG001|Overall Study|Adverse Event|14|||
48487609|NCT01200394|155979039|FG000|Overall Study|Death|1|||
48487610|NCT01200394|155979040|FG001|Overall Study|Death|0|||
48487611|NCT01200394|155979039|FG000|Overall Study|Lost to Follow-up|0|||
48487612|NCT01200394|155979040|FG001|Overall Study|Lost to Follow-up|1|||
48487613|NCT01200394|155979039|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
48487614|NCT01200394|155979040|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
48487615|NCT01200394|155979039|FG000|Overall Study|Protocol Violation|0|||
48487616|NCT01200394|155979040|FG001|Overall Study|Protocol Violation|3|||
48487617|NCT01200394|155979039|FG000|Overall Study|Withdrawal by Subject|0|||
48487618|NCT01200394|155979040|FG001|Overall Study|Withdrawal by Subject|5|||
48487619|NCT01200394|155979039|FG000|Overall Study|Other|0|||
48487620|NCT01200394|155979040|FG001|Overall Study|Other|1|||
48487621|NCT04079842|155979042|FG000|Overall Study|Request of subject|2|||
48487622|NCT04079842|155979042|FG000|Overall Study|Unable to draw Arterial samples|1|||
48487623|NCT00095199|155979045|FG000|Overall Study|Adverse Event|40|||
48487624|NCT00095199|155979046|FG001|Overall Study|Adverse Event|22|||
48487625|NCT00095199|155979047|FG002|Overall Study|Adverse Event|26|||
48487626|NCT00095199|155979048|FG003|Overall Study|Adverse Event|11|||
48487627|NCT00095199|155979045|FG000|Overall Study|Progressive disease|213|||
48487628|NCT00095199|155979046|FG001|Overall Study|Progressive disease|179|||
48487629|NCT00095199|155979047|FG002|Overall Study|Progressive disease|105|||
48487630|NCT00095199|155979048|FG003|Overall Study|Progressive disease|98|||
48487631|NCT00095199|155979045|FG000|Overall Study|Death|10|||
48487632|NCT00095199|155979046|FG001|Overall Study|Death|6|||
48487633|NCT00095199|155979047|FG002|Overall Study|Death|11|||
48487634|NCT00095199|155979048|FG003|Overall Study|Death|9|||
48487635|NCT00095199|155979045|FG000|Overall Study|Withdrawal by Subject|21|||
48487636|NCT00095199|155979046|FG001|Overall Study|Withdrawal by Subject|16|||
48487637|NCT00095199|155979047|FG002|Overall Study|Withdrawal by Subject|13|||
48487638|NCT00095199|155979048|FG003|Overall Study|Withdrawal by Subject|22|||
48487639|NCT00095199|155979045|FG000|Overall Study|Protocol Violation|4|||
48487640|NCT00095199|155979046|FG001|Overall Study|Protocol Violation|4|||
48487641|NCT00095199|155979047|FG002|Overall Study|Protocol Violation|2|||
48487642|NCT00095199|155979048|FG003|Overall Study|Protocol Violation|0|||
48487643|NCT00095199|155979045|FG000|Overall Study|Liver function test results elevated|0|||
48487644|NCT00095199|155979046|FG001|Overall Study|Liver function test results elevated|0|||
48487645|NCT00095199|155979047|FG002|Overall Study|Liver function test results elevated|1|||
48487646|NCT00095199|155979048|FG003|Overall Study|Liver function test results elevated|1|||
48487647|NCT00095199|155979045|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
48487648|NCT00095199|155979046|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
48487649|NCT00095199|155979047|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
48487650|NCT00095199|155979048|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
48487651|NCT00095199|155979045|FG000|Overall Study|Physician Decision|5|||
48487652|NCT00095199|155979046|FG001|Overall Study|Physician Decision|6|||
48487653|NCT00095199|155979047|FG002|Overall Study|Physician Decision|1|||
48487654|NCT00095199|155979048|FG003|Overall Study|Physician Decision|1|||
48487655|NCT00095199|155979045|FG000|Overall Study|Not eligible|1|||
48487656|NCT00095199|155979046|FG001|Overall Study|Not eligible|7|||
48487657|NCT00095199|155979047|FG002|Overall Study|Not eligible|0|||
48487658|NCT00095199|155979048|FG003|Overall Study|Not eligible|1|||
48487659|NCT00095199|155979045|FG000|Overall Study|Started Palliative Radiotherapy|1|||
48487660|NCT00095199|155979046|FG001|Overall Study|Started Palliative Radiotherapy|0|||
48487661|NCT00095199|155979047|FG002|Overall Study|Started Palliative Radiotherapy|0|||
48487662|NCT00095199|155979048|FG003|Overall Study|Started Palliative Radiotherapy|0|||
48487663|NCT00095199|155979045|FG000|Overall Study|Started radiotherapy regimen|0|||
48487664|NCT00095199|155979046|FG001|Overall Study|Started radiotherapy regimen|1|||
48487665|NCT00095199|155979047|FG002|Overall Study|Started radiotherapy regimen|0|||
48487666|NCT00095199|155979048|FG003|Overall Study|Started radiotherapy regimen|0|||
48693616|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
48693617|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693618|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693619|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693620|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693621|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693622|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693623|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693624|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
48693625|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693626|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693627|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693628|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
48693629|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
48693630|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693631|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693632|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
48693633|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
48693634|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693635|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693636|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693637|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693638|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
48693639|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693640|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693641|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693642|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693643|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693644|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693645|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693646|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
48693647|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
48693648|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693649|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693650|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693651|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693652|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
48693653|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693654|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693655|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693656|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693657|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693658|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693659|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693660|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693661|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
48693662|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693663|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693664|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693665|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693666|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
48693667|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693668|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693669|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693670|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
48693671|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693672|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693673|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693674|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693675|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693676|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693677|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693678|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693679|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693680|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
48693681|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693682|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693683|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693684|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693685|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693686|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693687|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693688|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
48693689|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
48693690|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693691|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693692|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693693|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693694|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
48693695|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693696|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693697|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693698|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693699|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693700|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693701|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693702|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
48693703|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693704|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693705|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693706|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693707|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693708|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
48693709|NCT04033445|156726448|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693710|NCT04033445|156726449|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693711|NCT04033445|156726450|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693712|NCT04033445|156726451|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693713|NCT04033445|156726452|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693714|NCT04033445|156726453|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693715|NCT04033445|156726454|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693716|NCT04033445|156726455|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
48693717|NCT04033445|156726456|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693718|NCT04033445|156726457|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693719|NCT04033445|156726458|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693720|NCT04033445|156726459|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693721|NCT04033445|156726460|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693722|NCT04033445|156726461|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
48693723|NCT04033445|156726448|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693724|NCT04033445|156726449|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693725|NCT04033445|156726450|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693726|NCT04033445|156726451|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693727|NCT04033445|156726452|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693728|NCT04033445|156726453|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693729|NCT04033445|156726454|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693730|NCT04033445|156726455|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693731|NCT04033445|156726456|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
48693732|NCT04033445|156726457|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
48693733|NCT04033445|156726458|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
48693734|NCT04033445|156726459|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
48693735|NCT04033445|156726460|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
48693736|NCT04033445|156726461|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
48693737|NCT04033445|156726448|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693738|NCT04033445|156726449|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693739|NCT04033445|156726450|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693740|NCT04033445|156726451|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693741|NCT04033445|156726452|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693742|NCT04033445|156726453|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693743|NCT04033445|156726454|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693744|NCT04033445|156726455|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693745|NCT04033445|156726456|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
48693746|NCT04033445|156726457|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
48693747|NCT04033445|156726458|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
48693748|NCT04033445|156726459|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
48693749|NCT04033445|156726460|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
48693750|NCT04033445|156726461|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
48693751|NCT04033445|156726448|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693752|NCT04033445|156726449|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693753|NCT04033445|156726450|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693754|NCT04033445|156726451|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693755|NCT04033445|156726452|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693756|NCT04033445|156726453|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48487667|NCT00095199|155979045|FG000|Overall Study|Primary tumor removed in other surgery|0|||
48693757|NCT04033445|156726454|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693758|NCT04033445|156726455|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693759|NCT04033445|156726456|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693760|NCT04033445|156726457|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693761|NCT04033445|156726458|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
48693762|NCT04033445|156726459|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
48693763|NCT04033445|156726460|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
48693764|NCT04033445|156726461|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
48693765|NCT04033445|156726448|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693766|NCT04033445|156726449|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693767|NCT04033445|156726450|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693768|NCT04033445|156726451|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693769|NCT04033445|156726452|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693770|NCT04033445|156726453|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693771|NCT04033445|156726454|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693772|NCT04033445|156726455|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693773|NCT04033445|156726456|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693774|NCT04033445|156726457|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
48693775|NCT04033445|156726458|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
48693776|NCT04033445|156726459|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
48693777|NCT04033445|156726460|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
48693778|NCT04033445|156726461|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
48693779|NCT04033445|156726448|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693780|NCT04033445|156726449|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693781|NCT04033445|156726450|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693782|NCT04033445|156726451|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693783|NCT04033445|156726452|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693784|NCT04033445|156726453|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693785|NCT04033445|156726454|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693786|NCT04033445|156726455|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693787|NCT04033445|156726456|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
48693788|NCT04033445|156726457|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
48693789|NCT04033445|156726458|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
48693790|NCT04033445|156726459|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
48693791|NCT04033445|156726460|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
48693792|NCT04033445|156726461|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
48693793|NCT04033445|156726448|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693794|NCT04033445|156726449|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693795|NCT04033445|156726450|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693796|NCT04033445|156726451|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693797|NCT04033445|156726452|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693798|NCT04033445|156726453|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693799|NCT04033445|156726454|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693800|NCT04033445|156726455|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693801|NCT04033445|156726456|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693802|NCT04033445|156726457|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693803|NCT04033445|156726458|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693804|NCT04033445|156726459|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693805|NCT04033445|156726460|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
48693806|NCT04033445|156726461|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
48693807|NCT04033445|156726448|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693808|NCT04033445|156726449|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693809|NCT04033445|156726450|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693810|NCT04033445|156726451|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693811|NCT04033445|156726452|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693812|NCT04033445|156726453|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693813|NCT04033445|156726454|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693814|NCT04033445|156726455|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693815|NCT04033445|156726456|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
48693816|NCT04033445|156726457|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
48693817|NCT04033445|156726458|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
48693818|NCT04033445|156726459|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
48693819|NCT04033445|156726460|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
48693820|NCT04033445|156726461|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
48693821|NCT04033445|156726448|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693822|NCT04033445|156726449|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693823|NCT04033445|156726450|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693824|NCT04033445|156726451|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693825|NCT04033445|156726452|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693826|NCT04033445|156726453|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693827|NCT04033445|156726454|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693828|NCT04033445|156726455|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693829|NCT04033445|156726456|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693830|NCT04033445|156726457|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
48693831|NCT04033445|156726458|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693832|NCT04033445|156726459|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
48693833|NCT04033445|156726460|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
48693834|NCT04033445|156726461|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
48693835|NCT00001959|156726465|FG000|Overall Study|newly diagnosed colon cancer|1|||
48693836|NCT00001959|156726465|FG000|Overall Study|disabling sedation|1|||
48693837|NCT00001959|156726465|FG000|Overall Study|non-compliance|1|||
48693838|NCT00730158|156726467|FG000|Overall Study|Withdrawal by Subject|1|||
48693839|NCT00730158|156726468|FG001|Overall Study|Withdrawal by Subject|1|||
48693840|NCT02738008|156726469|FG000|Overall Study|Study Terminated by Sponsor|1|||
48693841|NCT02738008|156726470|FG001|Overall Study|Study Terminated by Sponsor|5|||
48693842|NCT02738008|156726471|FG002|Overall Study|Study Terminated by Sponsor|3|||
48693843|NCT02738008|156726469|FG000|Overall Study|Adverse Event|0|||
48693844|NCT02738008|156726470|FG001|Overall Study|Adverse Event|1|||
48693845|NCT02738008|156726471|FG002|Overall Study|Adverse Event|2|||
48693846|NCT02888106|156726478|FG000|Overall Study|Withdrawal by Subject|1|||
48693847|NCT02888106|156726479|FG001|Overall Study|Withdrawal by Subject|2|||
48693848|NCT02888106|156726480|FG002|Overall Study|Withdrawal by Subject|0|||
48693849|NCT02888106|156726481|FG003|Overall Study|Withdrawal by Subject|1|||
48693850|NCT02888106|156726482|FG004|Overall Study|Withdrawal by Subject|0|||
48693851|NCT02888106|156726483|FG005|Overall Study|Withdrawal by Subject|0|||
48693852|NCT02888106|156726478|FG000|Overall Study|Lost to Follow-up|1|||
48693853|NCT02888106|156726479|FG001|Overall Study|Lost to Follow-up|0|||
48693854|NCT02888106|156726480|FG002|Overall Study|Lost to Follow-up|0|||
48693855|NCT02888106|156726481|FG003|Overall Study|Lost to Follow-up|1|||
48693856|NCT02888106|156726482|FG004|Overall Study|Lost to Follow-up|0|||
48693857|NCT02888106|156726483|FG005|Overall Study|Lost to Follow-up|1|||
48693858|NCT02888106|156726478|FG000|Overall Study|Adverse Event|2|||
48693859|NCT02888106|156726479|FG001|Overall Study|Adverse Event|0|||
48693860|NCT02888106|156726480|FG002|Overall Study|Adverse Event|0|||
48693861|NCT02888106|156726481|FG003|Overall Study|Adverse Event|0|||
48693862|NCT02888106|156726482|FG004|Overall Study|Adverse Event|0|||
48693863|NCT02888106|156726483|FG005|Overall Study|Adverse Event|0|||
48693864|NCT02888106|156726478|FG000|Overall Study|Withdrawal of consent|0|||
48693865|NCT02888106|156726479|FG001|Overall Study|Withdrawal of consent|0|||
48693866|NCT02888106|156726480|FG002|Overall Study|Withdrawal of consent|0|||
48693867|NCT02888106|156726481|FG003|Overall Study|Withdrawal of consent|0|||
48693868|NCT02888106|156726482|FG004|Overall Study|Withdrawal of consent|1|||
48693869|NCT02888106|156726483|FG005|Overall Study|Withdrawal of consent|0|||
48693870|NCT02888106|156726478|FG000|Overall Study|Pregnancy|1|||
48693871|NCT02888106|156726479|FG001|Overall Study|Pregnancy|0|||
48693872|NCT02888106|156726480|FG002|Overall Study|Pregnancy|0|||
48693873|NCT02888106|156726481|FG003|Overall Study|Pregnancy|0|||
48693874|NCT02888106|156726482|FG004|Overall Study|Pregnancy|0|||
48693875|NCT02888106|156726483|FG005|Overall Study|Pregnancy|0|||
48693876|NCT01943409|156726490|FG000|Overall Study|resumed oral/entral|24|||
48693877|NCT01943409|156726491|FG001|Overall Study|resumed oral/entral|20|||
48693878|NCT01943409|156726490|FG000|Overall Study|Protocol Violation|14|||
48693879|NCT01943409|156726491|FG001|Overall Study|Protocol Violation|24|||
48693880|NCT01943409|156726490|FG000|Overall Study|Death|3|||
48693881|NCT01943409|156726491|FG001|Overall Study|Death|1|||
48693882|NCT01943409|156726490|FG000|Overall Study|Withdrawal by Subject|4|||
48693883|NCT01943409|156726491|FG001|Overall Study|Withdrawal by Subject|3|||
48693884|NCT00601835|156726495|FG000|Overall Study|Withdrawal by Subject|9|||
48693885|NCT00601835|156726496|FG001|Overall Study|Withdrawal by Subject|6|||
48693886|NCT00601835|156726495|FG000|Overall Study|Physician Decision|1|||
48693887|NCT00601835|156726496|FG001|Overall Study|Physician Decision|0|||
48693888|NCT00601835|156726495|FG000|Overall Study|Lost to Follow-up|37|||
48693889|NCT00601835|156726496|FG001|Overall Study|Lost to Follow-up|5|||
48693890|NCT00601835|156726495|FG000|Overall Study|Adverse Event|1|||
48693891|NCT00601835|156726496|FG001|Overall Study|Adverse Event|1|||
48693892|NCT00601835|156726495|FG000|Overall Study|Relocate|12|||
48693893|NCT00601835|156726496|FG001|Overall Study|Relocate|2|||
48693894|NCT01927497|156726497|FG000|Overall Study|Death|0|||
48693895|NCT01927497|156726498|FG001|Overall Study|Death|1|||
48693896|NCT01927497|156726497|FG000|Overall Study|Protocol Violation|2|||
48693897|NCT01927497|156726498|FG001|Overall Study|Protocol Violation|0|||
48693898|NCT00152503|156726500|FG000|Overall Study|Adverse Event|4|||
48693899|NCT05070546|156726501|FG000|Overall Study|Death|0|||
48693900|NCT05070546|156726502|FG001|Overall Study|Death|0|||
48693901|NCT05070546|156726503|FG002|Overall Study|Death|0|||
48693902|NCT05070546|156726504|FG003|Overall Study|Death|0|||
48592129|NCT01716520|156361454|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
48592130|NCT01716520|156361455|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
48592131|NCT01716520|156361456|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
48592132|NCT01716520|156361451|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48592133|NCT01716520|156361452|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48592134|NCT01716520|156361453|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48592135|NCT01716520|156361454|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48592136|NCT01716520|156361455|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48592137|NCT01716520|156361456|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48592138|NCT01716520|156361451|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
48592139|NCT01716520|156361452|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
48592140|NCT01716520|156361453|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
48592141|NCT01716520|156361454|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
48592142|NCT01716520|156361455|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
48592143|NCT01716520|156361456|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
48592144|NCT01716520|156361451|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48592145|NCT01716520|156361452|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48592146|NCT01716520|156361453|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48592147|NCT01716520|156361454|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48592148|NCT01716520|156361455|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48592149|NCT01716520|156361456|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
48592150|NCT01716520|156361451|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
48592151|NCT01716520|156361452|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
48592152|NCT01716520|156361453|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
48592153|NCT01716520|156361454|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
48592154|NCT01716520|156361455|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
48592155|NCT01716520|156361456|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
48592156|NCT01716520|156361451|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
48592157|NCT01716520|156361452|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
48592158|NCT01716520|156361453|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
48592159|NCT01716520|156361454|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
48592160|NCT01716520|156361455|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
48592161|NCT01716520|156361456|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
48592162|NCT01716520|156361451|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48592163|NCT01716520|156361452|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48592164|NCT01716520|156361453|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48592165|NCT01716520|156361454|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48592166|NCT01716520|156361455|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48592167|NCT01716520|156361456|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48592168|NCT01716520|156361451|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
48592169|NCT01716520|156361452|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
48592170|NCT01716520|156361453|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
48592171|NCT01716520|156361454|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
48592172|NCT01716520|156361455|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
48592173|NCT01716520|156361456|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
48592174|NCT01716520|156361451|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
48592175|NCT01716520|156361452|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
48592176|NCT01716520|156361453|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
48592177|NCT01716520|156361454|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
48693903|NCT05070546|156726505|FG004|Overall Study|Death|0|||
48693904|NCT05070546|156726506|FG005|Overall Study|Death|1|||
48693905|NCT05070546|156726501|FG000|Overall Study|Lost to Follow-up|8|||
48693906|NCT05070546|156726502|FG001|Overall Study|Lost to Follow-up|2|||
48693907|NCT05070546|156726503|FG002|Overall Study|Lost to Follow-up|7|||
48693908|NCT05070546|156726504|FG003|Overall Study|Lost to Follow-up|1|||
48693909|NCT05070546|156726505|FG004|Overall Study|Lost to Follow-up|2|||
48693910|NCT05070546|156726506|FG005|Overall Study|Lost to Follow-up|0|||
48693911|NCT05070546|156726501|FG000|Overall Study|Withdrawal by Subject|1|||
48693912|NCT05070546|156726502|FG001|Overall Study|Withdrawal by Subject|1|||
48693913|NCT05070546|156726503|FG002|Overall Study|Withdrawal by Subject|3|||
48693914|NCT05070546|156726504|FG003|Overall Study|Withdrawal by Subject|0|||
48693915|NCT05070546|156726505|FG004|Overall Study|Withdrawal by Subject|0|||
48693916|NCT05070546|156726506|FG005|Overall Study|Withdrawal by Subject|0|||
48693917|NCT05070546|156726501|FG000|Overall Study|Other|0|||
48693918|NCT05070546|156726502|FG001|Overall Study|Other|0|||
48693919|NCT05070546|156726503|FG002|Overall Study|Other|0|||
48693920|NCT05070546|156726504|FG003|Overall Study|Other|0|||
48693921|NCT05070546|156726505|FG004|Overall Study|Other|3|||
48693922|NCT05070546|156726506|FG005|Overall Study|Other|0|||
48693923|NCT05070546|156726501|FG000|Overall Study|Randomized but not vaccinated|1|||
48693924|NCT05070546|156726502|FG001|Overall Study|Randomized but not vaccinated|0|||
48693925|NCT05070546|156726503|FG002|Overall Study|Randomized but not vaccinated|1|||
48693926|NCT05070546|156726504|FG003|Overall Study|Randomized but not vaccinated|1|||
48693927|NCT05070546|156726505|FG004|Overall Study|Randomized but not vaccinated|3|||
48693928|NCT05070546|156726506|FG005|Overall Study|Randomized but not vaccinated|0|||
48693929|NCT01420861|156726509|FG000|Overall Study|Adverse Event|2|||
48693930|NCT01420861|156726509|FG000|Overall Study|Study terminated by Sponsor|7|||
48693931|NCT01420861|156726509|FG000|Overall Study|Screen failure|7|||
48693932|NCT01420861|156726509|FG000|Overall Study|Randomized not Treated|2|||
48693933|NCT01247324|156726510|FG000|Overall Study|Death|6|||
48693934|NCT01247324|156726511|FG001|Overall Study|Death|10|||
48693935|NCT01247324|156726510|FG000|Overall Study|Physician Decision|2|||
48693936|NCT01247324|156726511|FG001|Overall Study|Physician Decision|3|||
48693937|NCT01247324|156726510|FG000|Overall Study|Non-compliance with study drug|3|||
48693938|NCT01247324|156726511|FG001|Overall Study|Non-compliance with study drug|0|||
48693939|NCT01247324|156726510|FG000|Overall Study|Lack of Efficacy|24|||
48693940|NCT01247324|156726511|FG001|Overall Study|Lack of Efficacy|14|||
48693941|NCT01247324|156726510|FG000|Overall Study|Non-compliance|3|||
48693942|NCT01247324|156726511|FG001|Overall Study|Non-compliance|2|||
48693943|NCT01247324|156726510|FG000|Overall Study|Pregnancy|5|||
48693944|NCT01247324|156726511|FG001|Overall Study|Pregnancy|10|||
48693945|NCT01247324|156726510|FG000|Overall Study|Protocol Violation|1|||
48693946|NCT01247324|156726511|FG001|Overall Study|Protocol Violation|1|||
48693947|NCT01247324|156726510|FG000|Overall Study|Reason not specified|42|||
48693948|NCT01247324|156726511|FG001|Overall Study|Reason not specified|32|||
48693949|NCT01247324|156726510|FG000|Overall Study|Consent withdrawn by participant|41|||
48693950|NCT01247324|156726511|FG001|Overall Study|Consent withdrawn by participant|56|||
48693951|NCT01247324|156726510|FG000|Overall Study|Adverse Event|49|||
48693952|NCT01247324|156726511|FG001|Overall Study|Adverse Event|35|||
48693953|NCT01247324|156726510|FG000|Overall Study|Lost to Follow-up|3|||
48693954|NCT01247324|156726511|FG001|Overall Study|Lost to Follow-up|6|||
48693955|NCT01247324|156726510|FG000|Overall Study|Study Terminated by Sponsor|4|||
48693956|NCT01247324|156726511|FG001|Overall Study|Study Terminated by Sponsor|1|||
48693957|NCT01247324|156726510|FG000|Overall Study|Missing|2|||
48693958|NCT01247324|156726511|FG001|Overall Study|Missing|1|||
48693959|NCT03384654|156726512|FG000|Overall Study|Withdrawal by Subject|0|||
48693960|NCT03384654|156726513|FG001|Overall Study|Withdrawal by Subject|0|||
48693961|NCT03384654|156726514|FG002|Overall Study|Withdrawal by Subject|1|||
48693962|NCT03384654|156726515|FG003|Overall Study|Withdrawal by Subject|0|||
48693963|NCT02888743|156726516|FG000|Overall Study|Withdrawal by Subject|1|||
48693964|NCT02888743|156726517|FG001|Overall Study|Withdrawal by Subject|2|||
48693965|NCT02888743|156726518|FG002|Overall Study|Withdrawal by Subject|2|||
48693966|NCT02888743|156726519|FG003|Overall Study|Withdrawal by Subject|0|||
48693967|NCT02888743|156726520|FG004|Overall Study|Withdrawal by Subject|1|||
48693968|NCT02888743|156726516|FG000|Overall Study|Disease progression before treatment|2|||
48693969|NCT02888743|156726517|FG001|Overall Study|Disease progression before treatment|0|||
48693970|NCT02888743|156726518|FG002|Overall Study|Disease progression before treatment|2|||
48693971|NCT02888743|156726519|FG003|Overall Study|Disease progression before treatment|0|||
48693972|NCT02888743|156726520|FG004|Overall Study|Disease progression before treatment|0|||
48693973|NCT02888743|156726516|FG000|Overall Study|Patient ineligible|1|||
48693974|NCT02888743|156726517|FG001|Overall Study|Patient ineligible|2|||
48693975|NCT02888743|156726518|FG002|Overall Study|Patient ineligible|0|||
48693976|NCT02888743|156726519|FG003|Overall Study|Patient ineligible|0|||
48693977|NCT02888743|156726520|FG004|Overall Study|Patient ineligible|0|||
48742919|NCT00745823|156910414|FG001|Overall Study|Physician Decision|5|||
48742920|NCT00745823|156910413|FG000|Overall Study|Pregnancy|0|||
48742921|NCT00745823|156910414|FG001|Overall Study|Pregnancy|4|||
48742922|NCT00745823|156910413|FG000|Overall Study|Withdrawal by Subject|14|||
48742923|NCT00745823|156910414|FG001|Overall Study|Withdrawal by Subject|8|||
48742924|NCT00745823|156910413|FG000|Overall Study|Study Terminated by Sponsor|326|||
48742925|NCT00745823|156910414|FG001|Overall Study|Study Terminated by Sponsor|349|||
48742926|NCT00717197|156910415|FG000|Overall Study|Unable to purchase study drug|5|||
48742927|NCT00717197|156910415|FG000|Overall Study|Tumor Progression|1|||
48693978|NCT02791230|156727963|FG000|Overall Study|Adverse Event|10|||
48693979|NCT02791230|156727964|FG001|Overall Study|Adverse Event|9|||
48693980|NCT02791230|156727965|FG002|Overall Study|Adverse Event|66|||
48693981|NCT02791230|156727963|FG000|Overall Study|Death|38|||
48693982|NCT02791230|156727964|FG001|Overall Study|Death|25|||
48693983|NCT02791230|156727965|FG002|Overall Study|Death|184|||
48693984|NCT02791230|156727963|FG000|Overall Study|Lack of Efficacy|1|||
48693985|NCT02791230|156727964|FG001|Overall Study|Lack of Efficacy|0|||
48693986|NCT02791230|156727965|FG002|Overall Study|Lack of Efficacy|3|||
48693987|NCT02791230|156727963|FG000|Overall Study|Lost to Follow-up|0|||
48693988|NCT02791230|156727964|FG001|Overall Study|Lost to Follow-up|0|||
48693989|NCT02791230|156727965|FG002|Overall Study|Lost to Follow-up|10|||
48693990|NCT02791230|156727963|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
48693991|NCT02791230|156727964|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
48693992|NCT02791230|156727965|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
48693993|NCT02791230|156727963|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
48693994|NCT02791230|156727964|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
48693995|NCT02791230|156727965|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
48693996|NCT02791230|156727963|FG000|Overall Study|Study sites terminated by sponsor|1|||
48693997|NCT02791230|156727964|FG001|Overall Study|Study sites terminated by sponsor|0|||
48693998|NCT02791230|156727965|FG002|Overall Study|Study sites terminated by sponsor|5|||
48693999|NCT02791230|156727963|FG000|Overall Study|Other|9|||
48694000|NCT02791230|156727964|FG001|Overall Study|Other|1|||
48694001|NCT02791230|156727965|FG002|Overall Study|Other|28|||
48694002|NCT02791230|156727963|FG000|Overall Study|Protocol Violation|0|||
48694003|NCT02791230|156727964|FG001|Overall Study|Protocol Violation|0|||
48694004|NCT02791230|156727965|FG002|Overall Study|Protocol Violation|4|||
48694005|NCT02791230|156727963|FG000|Overall Study|Withdrawal by Subject|24|||
48694006|NCT02791230|156727964|FG001|Overall Study|Withdrawal by Subject|13|||
48694007|NCT02791230|156727965|FG002|Overall Study|Withdrawal by Subject|172|||
48694008|NCT02791230|156727963|FG000|Overall Study|Enrolled but not treated|0|||
48694009|NCT02791230|156727964|FG001|Overall Study|Enrolled but not treated|0|||
48694010|NCT02791230|156727965|FG002|Overall Study|Enrolled but not treated|5|||
48694011|NCT03253393|156727968|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
48694012|NCT03253393|156727969|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
48694013|NCT03253393|156727970|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
48694014|NCT01005251|156727971|FG000|Overall Study|Withdrawal by Subject|2|||
48694015|NCT01005251|156727972|FG001|Overall Study|Withdrawal by Subject|5|||
48694016|NCT01005251|156727973|FG002|Overall Study|Withdrawal by Subject|3|||
48694017|NCT01005251|156727974|FG003|Overall Study|Withdrawal by Subject|4|||
48694018|NCT01005251|156727975|FG004|Overall Study|Withdrawal by Subject|9|||
48694019|NCT01005251|156727971|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
48694020|NCT01005251|156727972|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48694021|NCT01005251|156727973|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
48694022|NCT01005251|156727974|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48694023|NCT01005251|156727975|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
48694024|NCT01005251|156727971|FG000|Overall Study|Adverse Event|2|||
48694025|NCT01005251|156727972|FG001|Overall Study|Adverse Event|6|||
48694026|NCT01005251|156727973|FG002|Overall Study|Adverse Event|8|||
48694027|NCT01005251|156727974|FG003|Overall Study|Adverse Event|5|||
48694028|NCT01005251|156727975|FG004|Overall Study|Adverse Event|4|||
48694029|NCT01005251|156727971|FG000|Overall Study|Protocol Violation|1|||
48694030|NCT01005251|156727972|FG001|Overall Study|Protocol Violation|0|||
48694031|NCT01005251|156727973|FG002|Overall Study|Protocol Violation|0|||
48694032|NCT01005251|156727974|FG003|Overall Study|Protocol Violation|0|||
48694033|NCT01005251|156727975|FG004|Overall Study|Protocol Violation|2|||
48694034|NCT01005251|156727971|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
48694035|NCT01005251|156727972|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
48694036|NCT01005251|156727973|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
48694037|NCT01005251|156727974|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
48694038|NCT01005251|156727975|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
48694039|NCT01005251|156727971|FG000|Overall Study|Lost to Follow-up|1|||
48694040|NCT01005251|156727972|FG001|Overall Study|Lost to Follow-up|4|||
48694041|NCT01005251|156727973|FG002|Overall Study|Lost to Follow-up|2|||
48694042|NCT01005251|156727974|FG003|Overall Study|Lost to Follow-up|0|||
48694043|NCT01005251|156727975|FG004|Overall Study|Lost to Follow-up|0|||
48694044|NCT01005251|156727971|FG000|Overall Study|Physician Decision|0|||
48694045|NCT01005251|156727972|FG001|Overall Study|Physician Decision|0|||
48694046|NCT01005251|156727973|FG002|Overall Study|Physician Decision|0|||
48694047|NCT01005251|156727974|FG003|Overall Study|Physician Decision|0|||
48694048|NCT01005251|156727975|FG004|Overall Study|Physician Decision|2|||
48694049|NCT01005251|156727971|FG000|Overall Study|Patient moved|1|||
48694050|NCT01005251|156727972|FG001|Overall Study|Patient moved|0|||
48694051|NCT01005251|156727973|FG002|Overall Study|Patient moved|0|||
48694052|NCT01005251|156727974|FG003|Overall Study|Patient moved|0|||
48694053|NCT01005251|156727975|FG004|Overall Study|Patient moved|0|||
48694054|NCT01005251|156727971|FG000|Overall Study|Wrong drug dispensed|0|||
48694055|NCT01005251|156727972|FG001|Overall Study|Wrong drug dispensed|1|||
48694056|NCT01005251|156727973|FG002|Overall Study|Wrong drug dispensed|0|||
48694057|NCT01005251|156727974|FG003|Overall Study|Wrong drug dispensed|0|||
48694058|NCT01005251|156727975|FG004|Overall Study|Wrong drug dispensed|0|||
48694059|NCT01005251|156727971|FG000|Overall Study|Randomized in error|0|||
48694060|NCT01005251|156727972|FG001|Overall Study|Randomized in error|0|||
48694061|NCT01005251|156727973|FG002|Overall Study|Randomized in error|1|||
48694062|NCT01005251|156727974|FG003|Overall Study|Randomized in error|1|||
48694063|NCT01005251|156727975|FG004|Overall Study|Randomized in error|0|||
48694064|NCT01005251|156727971|FG000|Overall Study|Lack of Efficacy|0|||
48694065|NCT01005251|156727972|FG001|Overall Study|Lack of Efficacy|0|||
48694066|NCT01005251|156727973|FG002|Overall Study|Lack of Efficacy|1|||
48694067|NCT01005251|156727974|FG003|Overall Study|Lack of Efficacy|1|||
48694068|NCT01005251|156727975|FG004|Overall Study|Lack of Efficacy|0|||
48694069|NCT01884077|156727976|FG000|Overall Study|screen fail|0|||
48694070|NCT01884077|156727977|FG001|Overall Study|screen fail|2|||
48694071|NCT01884077|156727976|FG000|Overall Study|canceled surgery|2|||
48694072|NCT01884077|156727977|FG001|Overall Study|canceled surgery|0|||
48694073|NCT01884077|156727976|FG000|Overall Study|Lost to Follow-up|0|||
48694074|NCT01884077|156727977|FG001|Overall Study|Lost to Follow-up|4|||
48694075|NCT01884077|156727976|FG000|Overall Study|study closed|6|||
48694076|NCT01884077|156727977|FG001|Overall Study|study closed|4|||
48694077|NCT02648204|156727978|FG000|Overall Study|Withdrawal by Subject|12|||
48694078|NCT02648204|156727979|FG001|Overall Study|Withdrawal by Subject|8|||
48694079|NCT02648204|156727980|FG002|Overall Study|Withdrawal by Subject|2|||
48694080|NCT02648204|156727981|FG003|Overall Study|Withdrawal by Subject|6|||
48694081|NCT02648204|156727978|FG000|Overall Study|Lost to Follow-up|5|||
48694082|NCT02648204|156727979|FG001|Overall Study|Lost to Follow-up|8|||
48694083|NCT02648204|156727980|FG002|Overall Study|Lost to Follow-up|4|||
48694084|NCT02648204|156727981|FG003|Overall Study|Lost to Follow-up|6|||
48694085|NCT02648204|156727978|FG000|Overall Study|Missing follow-up information|4|||
48694086|NCT02648204|156727979|FG001|Overall Study|Missing follow-up information|4|||
48694087|NCT02648204|156727980|FG002|Overall Study|Missing follow-up information|4|||
48694088|NCT02648204|156727981|FG003|Overall Study|Missing follow-up information|2|||
48694089|NCT02648204|156727978|FG000|Overall Study|Death|1|||
48694090|NCT02648204|156727979|FG001|Overall Study|Death|1|||
48694091|NCT02648204|156727980|FG002|Overall Study|Death|2|||
48694092|NCT02648204|156727981|FG003|Overall Study|Death|2|||
48694093|NCT02648204|156727978|FG000|Overall Study|Adverse Event|0|||
48694094|NCT02648204|156727979|FG001|Overall Study|Adverse Event|0|||
48694095|NCT02648204|156727980|FG002|Overall Study|Adverse Event|1|||
48694096|NCT02648204|156727981|FG003|Overall Study|Adverse Event|0|||
48694097|NCT03161379|156727983|FG000|Overall Study|Withdrawal by Subject|4|||
48694098|NCT03161379|156727983|FG000|Overall Study|disease progression during chemotherapy|5|||
48694099|NCT03161379|156727983|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
48694100|NCT03161379|156727983|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
48694101|NCT04606771|156727984|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
48694102|NCT04606771|156727985|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
48694103|NCT04606771|156727984|FG000|Overall Study|Death|5|||
48694104|NCT04606771|156727985|FG001|Overall Study|Death|6|||
48694105|NCT04606771|156727984|FG000|Overall Study|Wrong randomisation|0|||
48694106|NCT04606771|156727985|FG001|Overall Study|Wrong randomisation|1|||
48694107|NCT02201524|156727986|FG000|Overall Study|Adverse Event|0|||
48694108|NCT02201524|156727987|FG001|Overall Study|Adverse Event|2|||
48694109|NCT02201524|156727988|FG002|Overall Study|Adverse Event|1|||
48694110|NCT02201524|156727989|FG003|Overall Study|Adverse Event|0|||
48694111|NCT02201524|156727986|FG000|Overall Study|Insufficient clinical response|1|||
48694112|NCT02201524|156727987|FG001|Overall Study|Insufficient clinical response|0|||
48694113|NCT02201524|156727988|FG002|Overall Study|Insufficient clinical response|0|||
48694114|NCT02201524|156727989|FG003|Overall Study|Insufficient clinical response|0|||
48694115|NCT02201524|156727986|FG000|Overall Study|Lost to Follow-up|0|||
48694116|NCT02201524|156727987|FG001|Overall Study|Lost to Follow-up|0|||
48694117|NCT02201524|156727988|FG002|Overall Study|Lost to Follow-up|2|||
48694118|NCT02201524|156727989|FG003|Overall Study|Lost to Follow-up|0|||
48694119|NCT02201524|156727986|FG000|Overall Study|No longer meets eligibility criteria|0|||
48694120|NCT02201524|156727987|FG001|Overall Study|No longer meets eligibility criteria|0|||
48694121|NCT02201524|156727988|FG002|Overall Study|No longer meets eligibility criteria|0|||
48694122|NCT02201524|156727989|FG003|Overall Study|No longer meets eligibility criteria|2|||
48694123|NCT02201524|156727986|FG000|Overall Study|Protocol Violation|0|||
48694124|NCT02201524|156727987|FG001|Overall Study|Protocol Violation|0|||
48694125|NCT02201524|156727988|FG002|Overall Study|Protocol Violation|0|||
48694126|NCT02201524|156727989|FG003|Overall Study|Protocol Violation|1|||
48694127|NCT02201524|156727986|FG000|Overall Study|Withdrawal by Subject|0|||
48694128|NCT02201524|156727987|FG001|Overall Study|Withdrawal by Subject|0|||
48694129|NCT02201524|156727988|FG002|Overall Study|Withdrawal by Subject|1|||
48694130|NCT02201524|156727989|FG003|Overall Study|Withdrawal by Subject|1|||
48694131|NCT02201524|156727986|FG000|Overall Study|Other|1|||
48694132|NCT02201524|156727987|FG001|Overall Study|Other|1|||
48694133|NCT02201524|156727988|FG002|Overall Study|Other|0|||
48694134|NCT02201524|156727989|FG003|Overall Study|Other|0|||
48694135|NCT00074711|156727997|FG000|Overall Study|Withdrawal by Subject|1|||
48694136|NCT00074711|156727998|FG001|Overall Study|Withdrawal by Subject|1|||
48694137|NCT00074711|156727997|FG000|Overall Study|Lost to Follow-up|10|||
48694138|NCT00074711|156727998|FG001|Overall Study|Lost to Follow-up|8|||
48694139|NCT00074711|156727997|FG000|Overall Study|Participant stopped study drug|4|||
48694140|NCT00074711|156727998|FG001|Overall Study|Participant stopped study drug|6|||
48694141|NCT02269124|156727999|FG000|Overall Study|Lost to Follow-up|1|||
48694142|NCT02269124|156728000|FG001|Overall Study|Lost to Follow-up|0|||
48694143|NCT02269124|156727999|FG000|Overall Study|Withdrawal by Subject|0|||
48694144|NCT02269124|156728000|FG001|Overall Study|Withdrawal by Subject|2|||
48694145|NCT02903914|156728001|FG000|Overall Study|Adverse Event|0|||
48694146|NCT02903914|156728002|FG001|Overall Study|Adverse Event|0|||
48694147|NCT02903914|156728003|FG002|Overall Study|Adverse Event|1|||
48694148|NCT02903914|156728004|FG003|Overall Study|Adverse Event|0|||
48694149|NCT02903914|156728005|FG004|Overall Study|Adverse Event|0|||
48694150|NCT02903914|156728006|FG005|Overall Study|Adverse Event|0|||
48694151|NCT02903914|156728007|FG006|Overall Study|Adverse Event|2|||
48694152|NCT02903914|156728008|FG007|Overall Study|Adverse Event|0|||
48694153|NCT02903914|156728001|FG000|Overall Study|Withdrawal by Subject|3|||
48694154|NCT02903914|156728002|FG001|Overall Study|Withdrawal by Subject|1|||
48694155|NCT02903914|156728003|FG002|Overall Study|Withdrawal by Subject|28|||
48694156|NCT02903914|156728004|FG003|Overall Study|Withdrawal by Subject|0|||
48694157|NCT02903914|156728005|FG004|Overall Study|Withdrawal by Subject|1|||
48694158|NCT02903914|156728006|FG005|Overall Study|Withdrawal by Subject|2|||
48694159|NCT02903914|156728007|FG006|Overall Study|Withdrawal by Subject|12|||
48694160|NCT02903914|156728008|FG007|Overall Study|Withdrawal by Subject|0|||
48694161|NCT02903914|156728001|FG000|Overall Study|Progressive Disease|1|||
48694162|NCT02903914|156728002|FG001|Overall Study|Progressive Disease|0|||
48694163|NCT02903914|156728003|FG002|Overall Study|Progressive Disease|4|||
48694164|NCT02903914|156728004|FG003|Overall Study|Progressive Disease|0|||
48694165|NCT02903914|156728005|FG004|Overall Study|Progressive Disease|0|||
48694166|NCT02903914|156728006|FG005|Overall Study|Progressive Disease|0|||
48694167|NCT02903914|156728007|FG006|Overall Study|Progressive Disease|2|||
48694168|NCT02903914|156728008|FG007|Overall Study|Progressive Disease|0|||
48694169|NCT02903914|156728001|FG000|Overall Study|Death|0|||
48694170|NCT02903914|156728002|FG001|Overall Study|Death|0|||
48694171|NCT02903914|156728003|FG002|Overall Study|Death|9|||
48694172|NCT02903914|156728004|FG003|Overall Study|Death|0|||
48694173|NCT02903914|156728005|FG004|Overall Study|Death|1|||
48694174|NCT02903914|156728006|FG005|Overall Study|Death|3|||
48694175|NCT02903914|156728007|FG006|Overall Study|Death|24|||
48694176|NCT02903914|156728008|FG007|Overall Study|Death|2|||
48694177|NCT02903914|156728001|FG000|Overall Study|Lost to Follow-up|0|||
48694178|NCT02903914|156728002|FG001|Overall Study|Lost to Follow-up|1|||
48694179|NCT02903914|156728003|FG002|Overall Study|Lost to Follow-up|0|||
48694180|NCT02903914|156728004|FG003|Overall Study|Lost to Follow-up|0|||
48694181|NCT02903914|156728005|FG004|Overall Study|Lost to Follow-up|2|||
48694182|NCT02903914|156728006|FG005|Overall Study|Lost to Follow-up|0|||
48694183|NCT02903914|156728007|FG006|Overall Study|Lost to Follow-up|1|||
48694184|NCT02903914|156728008|FG007|Overall Study|Lost to Follow-up|0|||
48694185|NCT02903914|156728001|FG000|Overall Study|Physician Decision|0|||
48694186|NCT02903914|156728002|FG001|Overall Study|Physician Decision|0|||
48694187|NCT02903914|156728003|FG002|Overall Study|Physician Decision|1|||
48694188|NCT02903914|156728004|FG003|Overall Study|Physician Decision|0|||
48694189|NCT02903914|156728005|FG004|Overall Study|Physician Decision|0|||
48487668|NCT00095199|155979046|FG001|Overall Study|Primary tumor removed in other surgery|1|||
48694190|NCT02903914|156728006|FG005|Overall Study|Physician Decision|0|||
48694191|NCT02903914|156728007|FG006|Overall Study|Physician Decision|1|||
48694192|NCT02903914|156728008|FG007|Overall Study|Physician Decision|0|||
48694193|NCT02903914|156728001|FG000|Overall Study|Symptomatic Deterioration|0|||
48694194|NCT02903914|156728002|FG001|Overall Study|Symptomatic Deterioration|0|||
48588192|NCT01915771|156347583|FG000|Day 15|Withdrawal by Subject|1|||
48694195|NCT02903914|156728003|FG002|Overall Study|Symptomatic Deterioration|1|||
48694196|NCT02903914|156728004|FG003|Overall Study|Symptomatic Deterioration|0|||
48694197|NCT02903914|156728005|FG004|Overall Study|Symptomatic Deterioration|0|||
48694198|NCT02903914|156728006|FG005|Overall Study|Symptomatic Deterioration|0|||
48694199|NCT02903914|156728007|FG006|Overall Study|Symptomatic Deterioration|0|||
48694200|NCT02903914|156728008|FG007|Overall Study|Symptomatic Deterioration|0|||
48694201|NCT02903914|156728001|FG000|Overall Study|New Cancer Therapy|2|||
48694202|NCT02903914|156728002|FG001|Overall Study|New Cancer Therapy|2|||
48694203|NCT02903914|156728003|FG002|Overall Study|New Cancer Therapy|21|||
48694204|NCT02903914|156728004|FG003|Overall Study|New Cancer Therapy|4|||
48694205|NCT02903914|156728005|FG004|Overall Study|New Cancer Therapy|3|||
48694206|NCT02903914|156728006|FG005|Overall Study|New Cancer Therapy|6|||
48694207|NCT02903914|156728007|FG006|Overall Study|New Cancer Therapy|56|||
48694208|NCT02903914|156728008|FG007|Overall Study|New Cancer Therapy|3|||
48694209|NCT02903914|156728001|FG000|Overall Study|Didn't Return to Site|1|||
48694210|NCT02903914|156728002|FG001|Overall Study|Didn't Return to Site|0|||
48694211|NCT02903914|156728003|FG002|Overall Study|Didn't Return to Site|1|||
48694212|NCT02903914|156728004|FG003|Overall Study|Didn't Return to Site|1|||
48694213|NCT02903914|156728005|FG004|Overall Study|Didn't Return to Site|0|||
48694214|NCT02903914|156728006|FG005|Overall Study|Didn't Return to Site|0|||
48694215|NCT02903914|156728007|FG006|Overall Study|Didn't Return to Site|2|||
48694216|NCT02903914|156728008|FG007|Overall Study|Didn't Return to Site|0|||
48694217|NCT02903914|156728001|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
48694218|NCT02903914|156728002|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
48694219|NCT02903914|156728003|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
48694220|NCT02903914|156728004|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
48694221|NCT02903914|156728005|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
48694222|NCT02903914|156728006|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
48694223|NCT02903914|156728007|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
48694224|NCT02903914|156728008|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
48694225|NCT02903914|156728001|FG000|Overall Study|Follow-up Did Not Occur|0|||
48694226|NCT02903914|156728002|FG001|Overall Study|Follow-up Did Not Occur|1|||
48694227|NCT02903914|156728003|FG002|Overall Study|Follow-up Did Not Occur|1|||
48694228|NCT02903914|156728004|FG003|Overall Study|Follow-up Did Not Occur|0|||
48694229|NCT02903914|156728005|FG004|Overall Study|Follow-up Did Not Occur|2|||
48694230|NCT02903914|156728006|FG005|Overall Study|Follow-up Did Not Occur|0|||
48694231|NCT02903914|156728007|FG006|Overall Study|Follow-up Did Not Occur|8|||
48694232|NCT02903914|156728008|FG007|Overall Study|Follow-up Did Not Occur|0|||
48694233|NCT02903914|156728001|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
48694234|NCT02903914|156728002|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
48694235|NCT02903914|156728003|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
48694236|NCT02903914|156728004|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
48694237|NCT02903914|156728005|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
48694238|NCT02903914|156728006|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
48694239|NCT02903914|156728007|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
48694240|NCT02903914|156728008|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
48694241|NCT02903914|156728001|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694242|NCT02903914|156728002|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694243|NCT02903914|156728003|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
48694244|NCT02903914|156728004|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694245|NCT02903914|156728005|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694246|NCT02903914|156728006|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
48694247|NCT02903914|156728007|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694248|NCT02903914|156728008|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
48694249|NCT02903914|156728001|FG000|Overall Study|Clinical Disease Progression|0|||
48694250|NCT02903914|156728002|FG001|Overall Study|Clinical Disease Progression|0|||
48694251|NCT02903914|156728003|FG002|Overall Study|Clinical Disease Progression|2|||
48694252|NCT02903914|156728004|FG003|Overall Study|Clinical Disease Progression|0|||
48694253|NCT02903914|156728005|FG004|Overall Study|Clinical Disease Progression|0|||
48694254|NCT02903914|156728006|FG005|Overall Study|Clinical Disease Progression|0|||
48694255|NCT02903914|156728007|FG006|Overall Study|Clinical Disease Progression|0|||
48694256|NCT02903914|156728008|FG007|Overall Study|Clinical Disease Progression|0|||
48694257|NCT02903914|156728001|FG000|Overall Study|Completed Follow-up Period|0|||
48694258|NCT02903914|156728002|FG001|Overall Study|Completed Follow-up Period|0|||
48694259|NCT02903914|156728003|FG002|Overall Study|Completed Follow-up Period|6|||
48694260|NCT02903914|156728004|FG003|Overall Study|Completed Follow-up Period|2|||
48694261|NCT02903914|156728005|FG004|Overall Study|Completed Follow-up Period|1|||
48694262|NCT02903914|156728006|FG005|Overall Study|Completed Follow-up Period|0|||
48694263|NCT02903914|156728007|FG006|Overall Study|Completed Follow-up Period|9|||
48694264|NCT02903914|156728008|FG007|Overall Study|Completed Follow-up Period|1|||
48694265|NCT02903914|156728001|FG000|Overall Study|Taken off Treatment per Protocol|0|||
48694266|NCT02903914|156728002|FG001|Overall Study|Taken off Treatment per Protocol|0|||
48694267|NCT02903914|156728003|FG002|Overall Study|Taken off Treatment per Protocol|0|||
48694268|NCT02903914|156728004|FG003|Overall Study|Taken off Treatment per Protocol|0|||
48694269|NCT02903914|156728005|FG004|Overall Study|Taken off Treatment per Protocol|0|||
48694270|NCT02903914|156728006|FG005|Overall Study|Taken off Treatment per Protocol|1|||
48694271|NCT02903914|156728007|FG006|Overall Study|Taken off Treatment per Protocol|0|||
48694272|NCT02903914|156728008|FG007|Overall Study|Taken off Treatment per Protocol|0|||
48487669|NCT00095199|155979047|FG002|Overall Study|Primary tumor removed in other surgery|0|||
48487670|NCT00095199|155979048|FG003|Overall Study|Primary tumor removed in other surgery|0|||
48694273|NCT02903914|156728001|FG000|Overall Study|Refused Further Treatment/Contact|0|||
48694274|NCT02903914|156728002|FG001|Overall Study|Refused Further Treatment/Contact|0|||
48694275|NCT02903914|156728003|FG002|Overall Study|Refused Further Treatment/Contact|0|||
48694276|NCT02903914|156728004|FG003|Overall Study|Refused Further Treatment/Contact|0|||
48694277|NCT02903914|156728005|FG004|Overall Study|Refused Further Treatment/Contact|0|||
48694278|NCT02903914|156728006|FG005|Overall Study|Refused Further Treatment/Contact|0|||
48694279|NCT02903914|156728007|FG006|Overall Study|Refused Further Treatment/Contact|1|||
48694280|NCT02903914|156728008|FG007|Overall Study|Refused Further Treatment/Contact|0|||
48694281|NCT02903914|156728001|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694282|NCT02903914|156728002|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694283|NCT02903914|156728003|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694284|NCT02903914|156728004|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694285|NCT02903914|156728005|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694286|NCT02903914|156728006|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694287|NCT02903914|156728007|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
48694288|NCT02903914|156728008|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
48694289|NCT03305666|156728009|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
48694290|NCT03305666|156728010|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
48694291|NCT06414213|156728011|FG000|Overall Study|Lost to Follow-up|1|||
48694292|NCT06414213|156728012|FG001|Overall Study|Lost to Follow-up|1|||
48694293|NCT06414213|156728013|FG002|Overall Study|Lost to Follow-up|3|||
48694294|NCT04423718|156728014|FG000|Overall Study|Adverse Event|6|||
48694295|NCT04423718|156728015|FG001|Overall Study|Adverse Event|2|||
48694296|NCT04423718|156728016|FG002|Overall Study|Adverse Event|5|||
48694297|NCT04423718|156728014|FG000|Overall Study|Physician Decision|1|||
48694298|NCT04423718|156728015|FG001|Overall Study|Physician Decision|4|||
48694299|NCT04423718|156728016|FG002|Overall Study|Physician Decision|1|||
48694300|NCT04423718|156728014|FG000|Overall Study|Protocol Violation|0|||
48694301|NCT04423718|156728015|FG001|Overall Study|Protocol Violation|1|||
48694302|NCT04423718|156728016|FG002|Overall Study|Protocol Violation|1|||
48694303|NCT04423718|156728014|FG000|Overall Study|Lost to Follow-up|1|||
48694304|NCT04423718|156728015|FG001|Overall Study|Lost to Follow-up|1|||
48694305|NCT04423718|156728016|FG002|Overall Study|Lost to Follow-up|2|||
48694306|NCT04423718|156728014|FG000|Overall Study|Lack of Efficacy|2|||
48694307|NCT04423718|156728015|FG001|Overall Study|Lack of Efficacy|0|||
48694308|NCT04423718|156728016|FG002|Overall Study|Lack of Efficacy|0|||
48694309|NCT04423718|156728014|FG000|Overall Study|Withdrawal by Subject|6|||
48694310|NCT04423718|156728015|FG001|Overall Study|Withdrawal by Subject|8|||
48694311|NCT04423718|156728016|FG002|Overall Study|Withdrawal by Subject|14|||
48694312|NCT04423718|156728014|FG000|Overall Study|Death|5|||
48694313|NCT04423718|156728015|FG001|Overall Study|Death|3|||
48694314|NCT04423718|156728016|FG002|Overall Study|Death|2|||
48694315|NCT04423718|156728014|FG000|Overall Study|COVID-19 pandemic|2|||
48694316|NCT04423718|156728015|FG001|Overall Study|COVID-19 pandemic|2|||
48694317|NCT04423718|156728016|FG002|Overall Study|COVID-19 pandemic|2|||
48694318|NCT04423718|156728014|FG000|Overall Study|Other|6|||
48694319|NCT04423718|156728015|FG001|Overall Study|Other|2|||
48694320|NCT04423718|156728016|FG002|Overall Study|Other|2|||
48694321|NCT04423718|156728014|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
48694322|NCT04423718|156728015|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
48694323|NCT04423718|156728016|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
48694324|NCT04952909|156728017|FG000|Overall Study|Death|3|||
48694325|NCT00753545|156728019|FG000|Overall Study|Death|98|||
48694326|NCT00753545|156728020|FG001|Overall Study|Death|112|||
48694327|NCT00753545|156728019|FG000|Overall Study|Lost to Follow-up|2|||
48694328|NCT00753545|156728020|FG001|Overall Study|Lost to Follow-up|3|||
48694329|NCT00753545|156728019|FG000|Overall Study|Protocol Violation|1|||
48694330|NCT00753545|156728020|FG001|Overall Study|Protocol Violation|0|||
48694331|NCT00753545|156728019|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
48694332|NCT00753545|156728020|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
48694333|NCT05327816|156728021|FG000|Overall Study|Lost to Follow-up|1|||
48694334|NCT05327816|156728022|FG001|Overall Study|Lost to Follow-up|0|||
48694335|NCT05327816|156728023|FG002|Overall Study|Lost to Follow-up|0|||
48694336|NCT05327816|156728024|FG003|Overall Study|Lost to Follow-up|0|||
48694337|NCT05327816|156728025|FG004|Overall Study|Lost to Follow-up|0|||
48694338|NCT05327816|156728026|FG005|Overall Study|Lost to Follow-up|0|||
48694339|NCT05327816|156728027|FG006|Overall Study|Lost to Follow-up|0|||
48694340|NCT05327816|156728028|FG007|Overall Study|Lost to Follow-up|0|||
48694341|NCT05327816|156728029|FG008|Overall Study|Lost to Follow-up|0|||
48694342|NCT05327816|156728030|FG009|Overall Study|Lost to Follow-up|1|||
48694343|NCT05327816|156728031|FG010|Overall Study|Lost to Follow-up|0|||
48694344|NCT05327816|156728021|FG000|Overall Study|Withdrawal by Subject|0|||
48694345|NCT05327816|156728022|FG001|Overall Study|Withdrawal by Subject|0|||
48694346|NCT05327816|156728023|FG002|Overall Study|Withdrawal by Subject|0|||
48694347|NCT05327816|156728024|FG003|Overall Study|Withdrawal by Subject|0|||
48694348|NCT05327816|156728025|FG004|Overall Study|Withdrawal by Subject|1|||
48694349|NCT05327816|156728026|FG005|Overall Study|Withdrawal by Subject|1|||
48694350|NCT05327816|156728027|FG006|Overall Study|Withdrawal by Subject|0|||
48694351|NCT05327816|156728028|FG007|Overall Study|Withdrawal by Subject|0|||
48694352|NCT05327816|156728029|FG008|Overall Study|Withdrawal by Subject|0|||
48694353|NCT05327816|156728030|FG009|Overall Study|Withdrawal by Subject|0|||
48694354|NCT05327816|156728031|FG010|Overall Study|Withdrawal by Subject|0|||
48694355|NCT05327816|156728021|FG000|Overall Study|Study Terminated by Sponsor|11|||
48694356|NCT05327816|156728022|FG001|Overall Study|Study Terminated by Sponsor|12|||
48694357|NCT05327816|156728023|FG002|Overall Study|Study Terminated by Sponsor|12|||
48694358|NCT05327816|156728024|FG003|Overall Study|Study Terminated by Sponsor|12|||
48694359|NCT05327816|156728025|FG004|Overall Study|Study Terminated by Sponsor|11|||
48694360|NCT05327816|156728026|FG005|Overall Study|Study Terminated by Sponsor|11|||
48694361|NCT05327816|156728027|FG006|Overall Study|Study Terminated by Sponsor|11|||
48694362|NCT05327816|156728028|FG007|Overall Study|Study Terminated by Sponsor|11|||
48694363|NCT05327816|156728029|FG008|Overall Study|Study Terminated by Sponsor|11|||
48694364|NCT05327816|156728030|FG009|Overall Study|Study Terminated by Sponsor|11|||
48694365|NCT05327816|156728031|FG010|Overall Study|Study Terminated by Sponsor|12|||
48694366|NCT05327816|156728021|FG000|Overall Study|Randomized but not treated|0|||
48694367|NCT05327816|156728022|FG001|Overall Study|Randomized but not treated|0|||
48694368|NCT05327816|156728023|FG002|Overall Study|Randomized but not treated|0|||
48694369|NCT05327816|156728024|FG003|Overall Study|Randomized but not treated|0|||
48694370|NCT05327816|156728025|FG004|Overall Study|Randomized but not treated|0|||
48694371|NCT05327816|156728026|FG005|Overall Study|Randomized but not treated|0|||
48694372|NCT05327816|156728027|FG006|Overall Study|Randomized but not treated|1|||
48694373|NCT05327816|156728028|FG007|Overall Study|Randomized but not treated|1|||
48694374|NCT05327816|156728029|FG008|Overall Study|Randomized but not treated|1|||
48694375|NCT05327816|156728030|FG009|Overall Study|Randomized but not treated|0|||
48694376|NCT05327816|156728031|FG010|Overall Study|Randomized but not treated|0|||
48694377|NCT04819945|156728032|FG000|Overall Study|Lost to Follow-up|1|||
48694378|NCT05071313|156728037|FG000|Overall Study|Lost to Follow-up|17|||
48694379|NCT05071313|156728038|FG001|Overall Study|Lost to Follow-up|10|||
48694380|NCT05071313|156728037|FG000|Overall Study|Physician Decision|1|||
48694381|NCT05071313|156728038|FG001|Overall Study|Physician Decision|6|||
48694382|NCT05071313|156728037|FG000|Overall Study|Death|1|||
48694383|NCT05071313|156728038|FG001|Overall Study|Death|0|||
48694384|NCT05071313|156728037|FG000|Overall Study|Withdrawal by Subject|10|||
48694385|NCT05071313|156728038|FG001|Overall Study|Withdrawal by Subject|15|||
48694386|NCT05071313|156728037|FG000|Overall Study|Other|1|||
48694387|NCT05071313|156728038|FG001|Overall Study|Other|0|||
48694388|NCT05071313|156728037|FG000|Overall Study|Randomized but not vaccinated|4|||
48694389|NCT05071313|156728038|FG001|Overall Study|Randomized but not vaccinated|2|||
48694390|NCT03550378|156728043|FG000|Overall Study|Death|0|||
48694391|NCT03550378|156728044|FG001|Overall Study|Death|1|||
48694392|NCT04716426|156728045|FG000|Overall Study|Vaccination|1|||
48694393|NCT04716426|156728046|FG001|Overall Study|Vaccination|1|||
48487671|NCT00095199|155979045|FG000|Overall Study|Data inadvertently lost by site|1|||
48694394|NCT04716426|156728045|FG000|Overall Study|Contamination|1|||
48694395|NCT04716426|156728046|FG001|Overall Study|Contamination|0|||
48694396|NCT02146378|156728047|FG000|Overall Study|No information of administration|2|||
48694397|NCT02559622|156728048|FG000|Overall Study|Progressive disease|0|||
48694398|NCT02559622|156728049|FG001|Overall Study|Progressive disease|1|||
48694399|NCT02559622|156728050|FG002|Overall Study|Progressive disease|0|||
48694400|NCT02559622|156728051|FG003|Overall Study|Progressive disease|0|||
48694401|NCT02559622|156728048|FG000|Overall Study|Adverse Event|0|||
48694402|NCT02559622|156728049|FG001|Overall Study|Adverse Event|2|||
48694403|NCT02559622|156728050|FG002|Overall Study|Adverse Event|2|||
48694404|NCT02559622|156728051|FG003|Overall Study|Adverse Event|2|||
48694405|NCT02559622|156728048|FG000|Overall Study|Patient/guardian decision|1|||
48694406|NCT02559622|156728049|FG001|Overall Study|Patient/guardian decision|2|||
48694407|NCT02559622|156728050|FG002|Overall Study|Patient/guardian decision|0|||
48694408|NCT02559622|156728051|FG003|Overall Study|Patient/guardian decision|1|||
48694409|NCT03836625|156728057|FG000|Overall Study|Lost to Follow-up|9|||
48694410|NCT03836625|156728058|FG001|Overall Study|Lost to Follow-up|9|||
48694411|NCT03836625|156728057|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
48694412|NCT03836625|156728058|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
48694413|NCT03836625|156728057|FG000|Overall Study|Death|0|||
48694414|NCT03836625|156728058|FG001|Overall Study|Death|1|||
48694415|NCT03836625|156728057|FG000|Overall Study|Refused follow-up|0|||
48694416|NCT03836625|156728058|FG001|Overall Study|Refused follow-up|1|||
48694417|NCT02091960|156728065|FG000|Overall Study|Death|7|||
48694418|NCT02091960|156728065|FG000|Overall Study|Withdrawal by Subject|1|||
48694419|NCT02091960|156728065|FG000|Overall Study|Miscellaneous Reasons|37|||
48694420|NCT03905096|156728066|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
48694421|NCT03905096|156728067|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
48694422|NCT02887521|156728068|FG000|Overall Study|Withdrawal by Subject|0|||
48694423|NCT02887521|156728069|FG001|Overall Study|Withdrawal by Subject|3|||
48694424|NCT02329847|156728075|FG000|Overall Study|Death|4|||
48694425|NCT02329847|156728076|FG001|Overall Study|Death|4|||
48694426|NCT02329847|156728077|FG002|Overall Study|Death|22|||
48694427|NCT02329847|156728078|FG003|Overall Study|Death|12|||
48694428|NCT02329847|156728079|FG004|Overall Study|Death|20|||
48694429|NCT02329847|156728080|FG005|Overall Study|Death|13|||
48694430|NCT02329847|156728075|FG000|Overall Study|Lost to Follow-up|0|||
48694431|NCT02329847|156728076|FG001|Overall Study|Lost to Follow-up|0|||
48694432|NCT02329847|156728077|FG002|Overall Study|Lost to Follow-up|2|||
48694433|NCT02329847|156728078|FG003|Overall Study|Lost to Follow-up|3|||
48694434|NCT02329847|156728079|FG004|Overall Study|Lost to Follow-up|0|||
48694435|NCT02329847|156728080|FG005|Overall Study|Lost to Follow-up|1|||
48694436|NCT02329847|156728075|FG000|Overall Study|Physician Decision|0|||
48694437|NCT02329847|156728076|FG001|Overall Study|Physician Decision|0|||
48694438|NCT02329847|156728077|FG002|Overall Study|Physician Decision|0|||
48694439|NCT02329847|156728078|FG003|Overall Study|Physician Decision|0|||
48694440|NCT02329847|156728079|FG004|Overall Study|Physician Decision|1|||
48694441|NCT02329847|156728080|FG005|Overall Study|Physician Decision|0|||
48694442|NCT02329847|156728075|FG000|Overall Study|Withdrawal by Subject|2|||
48694443|NCT02329847|156728076|FG001|Overall Study|Withdrawal by Subject|1|||
48694444|NCT02329847|156728077|FG002|Overall Study|Withdrawal by Subject|5|||
48694445|NCT02329847|156728078|FG003|Overall Study|Withdrawal by Subject|7|||
48694446|NCT02329847|156728079|FG004|Overall Study|Withdrawal by Subject|8|||
48694447|NCT02329847|156728080|FG005|Overall Study|Withdrawal by Subject|3|||
48694448|NCT02329847|156728075|FG000|Overall Study|Other|1|||
48694449|NCT02329847|156728076|FG001|Overall Study|Other|2|||
48694450|NCT02329847|156728077|FG002|Overall Study|Other|6|||
48694451|NCT02329847|156728078|FG003|Overall Study|Other|13|||
48694452|NCT02329847|156728079|FG004|Overall Study|Other|10|||
48694453|NCT02329847|156728080|FG005|Overall Study|Other|3|||
48694454|NCT04113018|156728081|FG000|Overall Study|Death|2|||
48694455|NCT04113018|156728081|FG000|Overall Study|Lost to Follow-up|1|||
48694456|NCT04113018|156728081|FG000|Overall Study|Still On Study (on study treatment)|24|||
48694457|NCT04113018|156728081|FG000|Overall Study|Still On Study (in follow up)|12|||
48694458|NCT03142009|156728085|FG000|Overall Study|Lost to Follow-up|45|||
48694459|NCT03142009|156728086|FG001|Overall Study|Lost to Follow-up|30|||
48694460|NCT04018495|156728087|FG000|Overall Study|Physician Decision|1|||
48694461|NCT04481243|156729447|FG000|Overall Study|Withdrawal by Subject|4|||
48694462|NCT04002960|156729448|FG000|Overall Study|Withdrawn prior to Completion|2|||
48694463|NCT00865345|156729450|FG000|Overall Study|Withdrawal by Subject|2|||
48694464|NCT00383552|156729451|FG000|Overall Study|Adverse Event|7|||
48694465|NCT00383552|156729452|FG001|Overall Study|Adverse Event|6|||
48694466|NCT00383552|156729453|FG002|Overall Study|Adverse Event|9|||
48694467|NCT00383552|156729454|FG003|Overall Study|Adverse Event|6|||
48694468|NCT00383552|156729451|FG000|Overall Study|Lack of Efficacy|4|||
48694469|NCT00383552|156729452|FG001|Overall Study|Lack of Efficacy|13|||
48694470|NCT00383552|156729453|FG002|Overall Study|Lack of Efficacy|29|||
48694471|NCT00383552|156729454|FG003|Overall Study|Lack of Efficacy|42|||
48694472|NCT00383552|156729451|FG000|Overall Study|Lost to Follow-up|0|||
48694473|NCT00383552|156729452|FG001|Overall Study|Lost to Follow-up|1|||
48694474|NCT00383552|156729453|FG002|Overall Study|Lost to Follow-up|5|||
48694475|NCT00383552|156729454|FG003|Overall Study|Lost to Follow-up|1|||
48694476|NCT00383552|156729451|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
48694477|NCT00383552|156729452|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
48694478|NCT00383552|156729453|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
48694479|NCT00383552|156729454|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
48694480|NCT00383552|156729451|FG000|Overall Study|Did not wish to continue (related)|1|||
48694481|NCT00383552|156729452|FG001|Overall Study|Did not wish to continue (related)|0|||
48694482|NCT00383552|156729453|FG002|Overall Study|Did not wish to continue (related)|2|||
48694483|NCT00383552|156729454|FG003|Overall Study|Did not wish to continue (related)|3|||
48694484|NCT00383552|156729451|FG000|Overall Study|Noncompliance with the protocol|11|||
48694485|NCT00383552|156729452|FG001|Overall Study|Noncompliance with the protocol|6|||
48694486|NCT00383552|156729453|FG002|Overall Study|Noncompliance with the protocol|8|||
48694487|NCT00383552|156729454|FG003|Overall Study|Noncompliance with the protocol|10|||
48694488|NCT00383552|156729451|FG000|Overall Study|Did not meet protocol eligibility|8|||
48694489|NCT00383552|156729452|FG001|Overall Study|Did not meet protocol eligibility|6|||
48694490|NCT00383552|156729453|FG002|Overall Study|Did not meet protocol eligibility|2|||
48694491|NCT00383552|156729454|FG003|Overall Study|Did not meet protocol eligibility|3|||
48694492|NCT00383552|156729451|FG000|Overall Study|Administrative|1|||
48694493|NCT00383552|156729452|FG001|Overall Study|Administrative|0|||
48592178|NCT01716520|156361455|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
48592179|NCT01716520|156361456|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
48592180|NCT01716520|156361451|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
48592181|NCT01716520|156361452|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
48592182|NCT01716520|156361453|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
48592183|NCT01716520|156361454|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
48592184|NCT01716520|156361455|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
48592185|NCT01716520|156361456|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
48592186|NCT01716520|156361451|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
48592187|NCT01716520|156361452|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
48592188|NCT01716520|156361453|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
48592189|NCT01716520|156361454|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
48592190|NCT01716520|156361455|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
48592191|NCT01716520|156361456|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
48592192|NCT01716520|156361451|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
48592193|NCT01716520|156361452|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
48592194|NCT01716520|156361453|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
48592195|NCT01716520|156361454|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
48592196|NCT01716520|156361455|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
48592197|NCT01716520|156361456|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
48592198|NCT01716520|156361451|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48592199|NCT01716520|156361452|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48592200|NCT01716520|156361453|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48592201|NCT01716520|156361454|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48592202|NCT01716520|156361455|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48592203|NCT01716520|156361456|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
48592204|NCT01716520|156361451|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48592205|NCT01716520|156361452|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48592206|NCT01716520|156361453|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
48592207|NCT01716520|156361454|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48592208|NCT01716520|156361455|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48592209|NCT01716520|156361456|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48592210|NCT01410240|156361462|FG000|Overall Study|Physician Decision|0|||
48592211|NCT01410240|156361463|FG001|Overall Study|Physician Decision|0|||
48592212|NCT01410240|156361464|FG002|Overall Study|Physician Decision|1|||
48592213|NCT01410240|156361462|FG000|Overall Study|Missed week 6 assessments|1|||
48592214|NCT01410240|156361463|FG001|Overall Study|Missed week 6 assessments|1|||
48592215|NCT01410240|156361464|FG002|Overall Study|Missed week 6 assessments|1|||
48592216|NCT04348500|156361465|FG000|Overall Study|Death|2|||
48592217|NCT04348500|156361466|FG001|Overall Study|Death|2|||
48592218|NCT04348500|156361465|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
48592219|NCT04348500|156361466|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
48592220|NCT02776670|156361467|FG000|Overall Study|Adverse Event|0|||
48592221|NCT02776670|156361468|FG001|Overall Study|Adverse Event|2|||
48592222|NCT02776670|156361467|FG000|Overall Study|Protocol Violation|0|||
48592223|NCT02776670|156361468|FG001|Overall Study|Protocol Violation|2|||
48592224|NCT02776670|156361467|FG000|Overall Study|Withdrawal by Subject|0|||
48592225|NCT02776670|156361468|FG001|Overall Study|Withdrawal by Subject|1|||
48592226|NCT02776670|156361467|FG000|Overall Study|Other - Reason not given|0|||
48592227|NCT02776670|156361468|FG001|Overall Study|Other - Reason not given|1|||
48592228|NCT03699540|156361469|FG000|Overall Study|Lost to Follow-up|1|||
48592229|NCT01937884|156361474|FG000|Overall Study|Withdrawal by Subject|1|||
48592230|NCT01937884|156361475|FG001|Overall Study|Withdrawal by Subject|0|||
48592231|NCT03544281|156361476|FG000|Overall Study|Death|3|||
48592232|NCT03544281|156361477|FG001|Overall Study|Death|2|||
48592233|NCT03544281|156361478|FG002|Overall Study|Death|6|||
48592234|NCT03544281|156361479|FG003|Overall Study|Death|8|||
48592235|NCT03544281|156361480|FG004|Overall Study|Death|4|||
48592236|NCT03544281|156361481|FG005|Overall Study|Death|2|||
48592237|NCT03544281|156361482|FG006|Overall Study|Death|4|||
48592238|NCT03544281|156361483|FG007|Overall Study|Death|5|||
48592239|NCT03544281|156361484|FG008|Overall Study|Death|5|||
48592240|NCT03544281|156361485|FG009|Overall Study|Death|8|||
48592241|NCT03544281|156361486|FG010|Overall Study|Death|6|||
48592242|NCT03544281|156361487|FG011|Overall Study|Death|4|||
48592243|NCT03544281|156361476|FG000|Overall Study|Lost to Follow-up|0|||
48592244|NCT03544281|156361477|FG001|Overall Study|Lost to Follow-up|0|||
48592245|NCT03544281|156361478|FG002|Overall Study|Lost to Follow-up|0|||
48592246|NCT03544281|156361479|FG003|Overall Study|Lost to Follow-up|0|||
48592247|NCT03544281|156361480|FG004|Overall Study|Lost to Follow-up|0|||
48592248|NCT03544281|156361481|FG005|Overall Study|Lost to Follow-up|0|||
48592249|NCT03544281|156361482|FG006|Overall Study|Lost to Follow-up|0|||
48592250|NCT03544281|156361483|FG007|Overall Study|Lost to Follow-up|0|||
48592251|NCT03544281|156361484|FG008|Overall Study|Lost to Follow-up|0|||
48694494|NCT00383552|156729453|FG002|Overall Study|Administrative|1|||
48694495|NCT00383552|156729454|FG003|Overall Study|Administrative|1|||
48694496|NCT01517750|156729455|FG000|Overall Study|Lost to Follow-up|1|||
48694497|NCT01517750|156729456|FG001|Overall Study|Lost to Follow-up|2|||
48694498|NCT01517750|156729457|FG002|Overall Study|Lost to Follow-up|4|||
48694499|NCT01517750|156729458|FG003|Overall Study|Lost to Follow-up|1|||
48694500|NCT01405768|156729459|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
48694501|NCT01405768|156729460|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
48694502|NCT03924622|156729463|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
48694503|NCT03924622|156729464|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
48694504|NCT03924622|156729465|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
48694505|NCT03924622|156729466|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
48694506|NCT03924622|156729467|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
48694507|NCT03924622|156729468|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
48694508|NCT00962208|156729469|FG000|Overall Study|Could not achieve good vision|9|||
48694509|NCT00962208|156729470|FG001|Overall Study|Could not achieve good vision|0|||
48694510|NCT00962208|156729469|FG000|Overall Study|Contraindicated to continue study|5|||
48694511|NCT00962208|156729470|FG001|Overall Study|Contraindicated to continue study|1|||
48694512|NCT00962208|156729469|FG000|Overall Study|Lost to Follow-up|0|||
48694513|NCT00962208|156729470|FG001|Overall Study|Lost to Follow-up|9|||
48694514|NCT01064440|156729473|FG000|Overall Study|Lost to Follow-up|1|||
48694515|NCT01064440|156729474|FG001|Overall Study|Lost to Follow-up|1|||
48694516|NCT01064440|156729475|FG002|Overall Study|Lost to Follow-up|1|||
48694517|NCT01064440|156729473|FG000|Overall Study|Non-compliance|0|||
48694518|NCT01064440|156729474|FG001|Overall Study|Non-compliance|1|||
48592252|NCT03544281|156361485|FG009|Overall Study|Lost to Follow-up|0|||
48592253|NCT03544281|156361486|FG010|Overall Study|Lost to Follow-up|1|||
48592254|NCT03544281|156361487|FG011|Overall Study|Lost to Follow-up|0|||
48592255|NCT03544281|156361476|FG000|Overall Study|Physician Decision|0|||
48592256|NCT03544281|156361477|FG001|Overall Study|Physician Decision|0|||
48592257|NCT03544281|156361478|FG002|Overall Study|Physician Decision|0|||
48592258|NCT03544281|156361479|FG003|Overall Study|Physician Decision|0|||
48592259|NCT03544281|156361480|FG004|Overall Study|Physician Decision|0|||
48592260|NCT03544281|156361481|FG005|Overall Study|Physician Decision|0|||
48592261|NCT03544281|156361482|FG006|Overall Study|Physician Decision|0|||
48592262|NCT03544281|156361483|FG007|Overall Study|Physician Decision|1|||
48592263|NCT03544281|156361484|FG008|Overall Study|Physician Decision|0|||
48592264|NCT03544281|156361485|FG009|Overall Study|Physician Decision|0|||
48592265|NCT03544281|156361486|FG010|Overall Study|Physician Decision|0|||
48592266|NCT03544281|156361487|FG011|Overall Study|Physician Decision|0|||
48592267|NCT03544281|156361476|FG000|Overall Study|Withdrawal by Subject|2|||
48592268|NCT03544281|156361477|FG001|Overall Study|Withdrawal by Subject|0|||
48592269|NCT03544281|156361478|FG002|Overall Study|Withdrawal by Subject|1|||
48592270|NCT03544281|156361479|FG003|Overall Study|Withdrawal by Subject|2|||
48592271|NCT03544281|156361480|FG004|Overall Study|Withdrawal by Subject|0|||
48592272|NCT03544281|156361481|FG005|Overall Study|Withdrawal by Subject|0|||
48592273|NCT03544281|156361482|FG006|Overall Study|Withdrawal by Subject|0|||
48592274|NCT03544281|156361483|FG007|Overall Study|Withdrawal by Subject|0|||
48592275|NCT03544281|156361484|FG008|Overall Study|Withdrawal by Subject|2|||
48592276|NCT03544281|156361485|FG009|Overall Study|Withdrawal by Subject|3|||
48592277|NCT03544281|156361486|FG010|Overall Study|Withdrawal by Subject|0|||
48592278|NCT03544281|156361487|FG011|Overall Study|Withdrawal by Subject|4|||
48592279|NCT03544281|156361476|FG000|Overall Study|Ongoing at the time of analysis|7|||
48592280|NCT03544281|156361477|FG001|Overall Study|Ongoing at the time of analysis|2|||
48592281|NCT03544281|156361478|FG002|Overall Study|Ongoing at the time of analysis|6|||
48592282|NCT03544281|156361479|FG003|Overall Study|Ongoing at the time of analysis|6|||
48592283|NCT03544281|156361480|FG004|Overall Study|Ongoing at the time of analysis|8|||
48592284|NCT03544281|156361481|FG005|Overall Study|Ongoing at the time of analysis|10|||
48592285|NCT03544281|156361482|FG006|Overall Study|Ongoing at the time of analysis|8|||
48592286|NCT03544281|156361483|FG007|Overall Study|Ongoing at the time of analysis|6|||
48592287|NCT03544281|156361484|FG008|Overall Study|Ongoing at the time of analysis|6|||
48592288|NCT03544281|156361485|FG009|Overall Study|Ongoing at the time of analysis|6|||
48592289|NCT03544281|156361486|FG010|Overall Study|Ongoing at the time of analysis|5|||
48694519|NCT01064440|156729475|FG002|Overall Study|Non-compliance|0|||
48694520|NCT01064440|156729473|FG000|Overall Study|Death|1|||
48694521|NCT01064440|156729474|FG001|Overall Study|Death|0|||
48694522|NCT01064440|156729475|FG002|Overall Study|Death|1|||
48694523|NCT01064440|156729473|FG000|Overall Study|Withdrawal by Subject|0|||
48694524|NCT01064440|156729474|FG001|Overall Study|Withdrawal by Subject|1|||
48694525|NCT01064440|156729475|FG002|Overall Study|Withdrawal by Subject|1|||
48694526|NCT01064440|156729473|FG000|Overall Study|Other: amputation|1|||
48694527|NCT01064440|156729474|FG001|Overall Study|Other: amputation|0|||
48694528|NCT01064440|156729475|FG002|Overall Study|Other: amputation|0|||
48694529|NCT03833245|156729483|FG000|Overall Study|Death|0|||
48694530|NCT03833245|156729484|FG001|Overall Study|Death|1|||
48694531|NCT05091307|156729485|FG000|Overall Study|Death|0|||
48694532|NCT05091307|156729486|FG001|Overall Study|Death|0|||
48694533|NCT05091307|156729487|FG002|Overall Study|Death|1|||
48694534|NCT05091307|156729488|FG003|Overall Study|Death|0|||
48694535|NCT05091307|156729485|FG000|Overall Study|Lost to Follow-up|33|||
48694536|NCT05091307|156729486|FG001|Overall Study|Lost to Follow-up|33|||
48694537|NCT05091307|156729487|FG002|Overall Study|Lost to Follow-up|2|||
48694538|NCT05091307|156729488|FG003|Overall Study|Lost to Follow-up|0|||
48694539|NCT05091307|156729485|FG000|Overall Study|Physician Decision|1|||
48694540|NCT05091307|156729486|FG001|Overall Study|Physician Decision|0|||
48694541|NCT05091307|156729487|FG002|Overall Study|Physician Decision|0|||
48694542|NCT05091307|156729488|FG003|Overall Study|Physician Decision|0|||
48694543|NCT05091307|156729485|FG000|Overall Study|Protocol Violation|1|||
48694544|NCT05091307|156729486|FG001|Overall Study|Protocol Violation|0|||
48694545|NCT05091307|156729487|FG002|Overall Study|Protocol Violation|0|||
48694546|NCT05091307|156729488|FG003|Overall Study|Protocol Violation|0|||
48694547|NCT05091307|156729485|FG000|Overall Study|Withdrawal by Subject|16|||
48694548|NCT05091307|156729486|FG001|Overall Study|Withdrawal by Subject|16|||
48694549|NCT05091307|156729487|FG002|Overall Study|Withdrawal by Subject|0|||
48694550|NCT05091307|156729488|FG003|Overall Study|Withdrawal by Subject|1|||
48694551|NCT05091307|156729485|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
48694552|NCT05091307|156729486|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
48694553|NCT05091307|156729487|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
48694554|NCT05091307|156729488|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
48694555|NCT05091307|156729485|FG000|Overall Study|Initiated Prohibited Medication|1|||
48694556|NCT05091307|156729486|FG001|Overall Study|Initiated Prohibited Medication|0|||
48694557|NCT05091307|156729487|FG002|Overall Study|Initiated Prohibited Medication|0|||
48694558|NCT05091307|156729488|FG003|Overall Study|Initiated Prohibited Medication|0|||
48694559|NCT05091307|156729485|FG000|Overall Study|Other|4|||
48694560|NCT05091307|156729486|FG001|Overall Study|Other|4|||
48694561|NCT05091307|156729487|FG002|Overall Study|Other|0|||
48694562|NCT05091307|156729488|FG003|Overall Study|Other|0|||
48694563|NCT05091307|156729485|FG000|Overall Study|Randomized but not vaccinated|0|||
48694564|NCT05091307|156729486|FG001|Overall Study|Randomized but not vaccinated|2|||
48694565|NCT05091307|156729487|FG002|Overall Study|Randomized but not vaccinated|0|||
48694566|NCT05091307|156729488|FG003|Overall Study|Randomized but not vaccinated|0|||
48694567|NCT01706458|156729489|FG000|Overall Study|Physician Decision|3|||
48694568|NCT01706458|156729490|FG001|Overall Study|Physician Decision|4|||
48694569|NCT02529852|156729493|FG000|Overall Study|Withdrawal by Subject|2|||
48694570|NCT04034927|156729497|FG000|Overall Study|Adverse Event|4|||
48694571|NCT04034927|156729498|FG001|Overall Study|Adverse Event|9|||
48694572|NCT04034927|156729497|FG000|Overall Study|Death|0|||
48694573|NCT04034927|156729498|FG001|Overall Study|Death|1|||
48694574|NCT04034927|156729497|FG000|Overall Study|Withdrawal by Subject|0|||
48694575|NCT04034927|156729498|FG001|Overall Study|Withdrawal by Subject|3|||
48694576|NCT04034927|156729497|FG000|Overall Study|Still on Treatment|2|||
48694577|NCT04034927|156729498|FG001|Overall Study|Still on Treatment|1|||
48694578|NCT04034927|156729497|FG000|Overall Study|Other|1|||
48694579|NCT04034927|156729498|FG001|Overall Study|Other|1|||
48694580|NCT03582215|156729499|FG000|Overall Study|Adverse Event|1|||
48694581|NCT03582215|156729500|FG001|Overall Study|Adverse Event|0|||
48694582|NCT03582215|156729501|FG002|Overall Study|Adverse Event|0|||
48694583|NCT03582215|156729502|FG003|Overall Study|Adverse Event|0|||
48694584|NCT03582215|156729503|FG004|Overall Study|Adverse Event|0|||
48694585|NCT03582215|156729504|FG005|Overall Study|Adverse Event|0|||
48694586|NCT03582215|156729505|FG006|Overall Study|Adverse Event|2|||
48694587|NCT03582215|156729506|FG007|Overall Study|Adverse Event|2|||
48694588|NCT02913872|156729507|FG000|Overall Study|Withdrawal by Subject|1|||
48694589|NCT02174731|156729508|FG000|Overall Study|Participant decision|67|||
48694590|NCT02174731|156729509|FG001|Overall Study|Participant decision|64|||
48694591|NCT02174731|156729508|FG000|Overall Study|Incorrect enrolment before randomization|0|||
48694592|NCT02174731|156729509|FG001|Overall Study|Incorrect enrolment before randomization|1|||
48694593|NCT02174731|156729508|FG000|Overall Study|Missing|2|||
48694594|NCT02174731|156729509|FG001|Overall Study|Missing|0|||
48694595|NCT01277744|156729510|FG000|Overall Study|Physician Decision|2|||
48694596|NCT03796728|156729511|FG000|Overall Study|Lost to Follow-up|8|||
48694597|NCT03796728|156729511|FG000|Overall Study|Reason not Specified|16|||
48742928|NCT00717197|156910415|FG000|Overall Study|Physician Decision|1|||
48592290|NCT03544281|156361487|FG011|Overall Study|Ongoing at the time of analysis|8|||
48592291|NCT03544281|156361476|FG000|Overall Study|Investigator Site Closed|0|||
48592292|NCT03544281|156361477|FG001|Overall Study|Investigator Site Closed|0|||
48592293|NCT03544281|156361478|FG002|Overall Study|Investigator Site Closed|0|||
48592294|NCT03544281|156361479|FG003|Overall Study|Investigator Site Closed|0|||
48592295|NCT03544281|156361480|FG004|Overall Study|Investigator Site Closed|0|||
48592296|NCT03544281|156361481|FG005|Overall Study|Investigator Site Closed|0|||
48592297|NCT03544281|156361482|FG006|Overall Study|Investigator Site Closed|0|||
48592298|NCT03544281|156361483|FG007|Overall Study|Investigator Site Closed|0|||
48592299|NCT03544281|156361484|FG008|Overall Study|Investigator Site Closed|0|||
48592300|NCT03544281|156361485|FG009|Overall Study|Investigator Site Closed|1|||
48592301|NCT03544281|156361486|FG010|Overall Study|Investigator Site Closed|0|||
48592302|NCT03544281|156361487|FG011|Overall Study|Investigator Site Closed|0|||
48592303|NCT03544281|156361476|FG000|Overall Study|Did not receive study treatment|0|||
48592304|NCT03544281|156361477|FG001|Overall Study|Did not receive study treatment|0|||
48592305|NCT03544281|156361478|FG002|Overall Study|Did not receive study treatment|0|||
48592306|NCT03544281|156361479|FG003|Overall Study|Did not receive study treatment|0|||
48592307|NCT03544281|156361480|FG004|Overall Study|Did not receive study treatment|0|||
48592308|NCT03544281|156361481|FG005|Overall Study|Did not receive study treatment|0|||
48592309|NCT03544281|156361482|FG006|Overall Study|Did not receive study treatment|1|||
48592310|NCT03544281|156361483|FG007|Overall Study|Did not receive study treatment|0|||
48592311|NCT03544281|156361484|FG008|Overall Study|Did not receive study treatment|0|||
48592312|NCT03544281|156361485|FG009|Overall Study|Did not receive study treatment|0|||
48592313|NCT03544281|156361486|FG010|Overall Study|Did not receive study treatment|0|||
48592314|NCT03544281|156361487|FG011|Overall Study|Did not receive study treatment|0|||
48592315|NCT00624832|156361494|FG000|Overall Study|Adverse Event|0|||
48592316|NCT00624832|156361495|FG001|Overall Study|Adverse Event|1|||
48592317|NCT00624832|156361496|FG002|Overall Study|Adverse Event|0|||
48592318|NCT00624832|156361497|FG003|Overall Study|Adverse Event|1|||
48592319|NCT00624832|156361494|FG000|Overall Study|Abnormal Laboratory Value|2|||
48592320|NCT00624832|156361495|FG001|Overall Study|Abnormal Laboratory Value|0|||
48592321|NCT00624832|156361496|FG002|Overall Study|Abnormal Laboratory Value|0|||
48592322|NCT00624832|156361497|FG003|Overall Study|Abnormal Laboratory Value|0|||
48592323|NCT02937636|156361498|FG000|Overall Study|Other (Not specified)|3|||
48592324|NCT02937636|156361499|FG001|Overall Study|Other (Not specified)|2|||
48592325|NCT01030718|156361503|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
48592326|NCT01030718|156361504|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
48592327|NCT01030718|156361505|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
48592328|NCT01030718|156361503|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
48592329|NCT01030718|156361504|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
48592330|NCT01030718|156361505|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
48592331|NCT01030718|156361503|FG000|Studies CA180-031 and -036 Combined|Death|0|||
48592332|NCT01030718|156361504|FG001|Studies CA180-031 and -036 Combined|Death|1|||
48592333|NCT01030718|156361505|FG002|Studies CA180-031 and -036 Combined|Death|0|||
48592334|NCT01030718|156361503|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
48592335|NCT01030718|156361504|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
48592336|NCT01030718|156361505|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
48592337|NCT01030718|156361503|FG000|Study CA180-036 Only|insufficient effect|1|||
48592338|NCT01030718|156361504|FG001|Study CA180-036 Only|insufficient effect|1|||
48592339|NCT01030718|156361505|FG002|Study CA180-036 Only|insufficient effect|5|||
48592340|NCT01030718|156361503|FG000|Study CA180-036 Only|Adverse Event|2|||
48592341|NCT01030718|156361504|FG001|Study CA180-036 Only|Adverse Event|3|||
48592342|NCT01030718|156361505|FG002|Study CA180-036 Only|Adverse Event|0|||
48592343|NCT01030718|156361503|FG000|Study CA180-036 Only|Death|0|||
48592344|NCT01030718|156361504|FG001|Study CA180-036 Only|Death|1|||
48592345|NCT01030718|156361505|FG002|Study CA180-036 Only|Death|0|||
48592346|NCT01030718|156361503|FG000|Study CA180-036 Only|Other Reasons|0|||
48592347|NCT01030718|156361504|FG001|Study CA180-036 Only|Other Reasons|2|||
48592348|NCT01030718|156361505|FG002|Study CA180-036 Only|Other Reasons|0|||
48592349|NCT00423813|156361506|FG000|Overall Study|Adverse Event|11|||
48592350|NCT00423813|156361507|FG001|Overall Study|Adverse Event|30|||
48592351|NCT00423813|156361508|FG002|Overall Study|Adverse Event|40|||
48592352|NCT00423813|156361506|FG000|Overall Study|Withdrawal by Subject|6|||
48592353|NCT00423813|156361507|FG001|Overall Study|Withdrawal by Subject|8|||
48592354|NCT00423813|156361508|FG002|Overall Study|Withdrawal by Subject|5|||
48592355|NCT00423813|156361506|FG000|Overall Study|Lost to Follow-up|5|||
48592356|NCT00423813|156361507|FG001|Overall Study|Lost to Follow-up|4|||
48592357|NCT00423813|156361508|FG002|Overall Study|Lost to Follow-up|4|||
48592358|NCT00423813|156361506|FG000|Overall Study|Lack of Efficacy|23|||
48592359|NCT00423813|156361507|FG001|Overall Study|Lack of Efficacy|18|||
48592360|NCT00423813|156361508|FG002|Overall Study|Lack of Efficacy|19|||
48592361|NCT00423813|156361506|FG000|Overall Study|Physician Decision|2|||
48592362|NCT00423813|156361507|FG001|Overall Study|Physician Decision|0|||
48592363|NCT00423813|156361508|FG002|Overall Study|Physician Decision|0|||
48592364|NCT00423813|156361506|FG000|Overall Study|Sponsor Decision|0|||
48694598|NCT05076708|156729514|FG000|Overall Study|Withdrawal by Subject|4|||
48694599|NCT05076708|156729514|FG000|Overall Study|Lost to study during switch phase|8|||
48694600|NCT00551759|156729519|FG000|Overall Study|Adverse Event|7|||
48694601|NCT00551759|156729519|FG000|Overall Study|Death|5|||
48694602|NCT00551759|156729519|FG000|Overall Study|Ineligible|1|||
48694603|NCT01643668|156729522|FG000|Overall Study|Death|1|||
48694604|NCT00625131|156729525|FG000|Overall Study|Lost to Follow-up|3|||
48694605|NCT00625131|156729526|FG001|Overall Study|Lost to Follow-up|2|||
48694606|NCT00625131|156729527|FG002|Overall Study|Lost to Follow-up|0|||
48694607|NCT00625131|156729525|FG000|Overall Study|Withdrawal by Subject|1|||
48694608|NCT00625131|156729526|FG001|Overall Study|Withdrawal by Subject|0|||
48694609|NCT00625131|156729527|FG002|Overall Study|Withdrawal by Subject|5|||
48694610|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
48694611|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
48694612|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
48694613|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
48694614|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
48694615|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
48694616|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
48694617|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
48694618|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
48694619|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
48694620|NCT03461276|156729529|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
48694621|NCT03461276|156729530|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
48694622|NCT03461276|156729529|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
48694623|NCT03461276|156729530|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
48694624|NCT03461276|156729529|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
48694625|NCT03461276|156729530|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
48694626|NCT03461276|156729529|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
48694627|NCT03461276|156729530|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
48694628|NCT03461276|156729529|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
48694629|NCT03461276|156729530|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
48694630|NCT05083585|156729531|FG000|Overall Study|Death|1|||
48694631|NCT05083585|156729532|FG001|Overall Study|Death|1|||
48694632|NCT05083585|156729531|FG000|Overall Study|Lost to Follow-up|1|||
48694633|NCT05083585|156729532|FG001|Overall Study|Lost to Follow-up|1|||
48694634|NCT05083585|156729531|FG000|Overall Study|Withdrawal by Subject|2|||
48694635|NCT05083585|156729532|FG001|Overall Study|Withdrawal by Subject|0|||
48694636|NCT05083585|156729531|FG000|Overall Study|Randomized but not vaccinated|2|||
48694637|NCT05083585|156729532|FG001|Overall Study|Randomized but not vaccinated|0|||
48694638|NCT03929757|156729533|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
48694639|NCT03929757|156729534|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
48694640|NCT03929757|156729535|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
48694641|NCT03929757|156729533|FG000|Main Study: Up to Day 365|Other|1|||
48694642|NCT03929757|156729534|FG001|Main Study: Up to Day 365|Other|0|||
48694643|NCT03929757|156729535|FG002|Main Study: Up to Day 365|Other|0|||
48694644|NCT03929757|156729533|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
48694645|NCT03929757|156729534|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
48694646|NCT03929757|156729535|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
48694647|NCT01576341|156729536|FG000|Overall Study|Withdrawal by Subject|24|||
48694648|NCT01576341|156729536|FG000|Overall Study|Adverse Event|10|||
48694649|NCT01576341|156729536|FG000|Overall Study|Death|21|||
48694650|NCT01576341|156729536|FG000|Overall Study|Physician Decision|2|||
48694651|NCT01576341|156729536|FG000|Overall Study|Lost to Follow-up|2|||
48694652|NCT01576341|156729536|FG000|Overall Study|Kidney transplantation|10|||
48694653|NCT01576341|156729536|FG000|Overall Study|Protocol Violation|12|||
48487672|NCT00095199|155979046|FG001|Overall Study|Data inadvertently lost by site|0|||
48487673|NCT00095199|155979047|FG002|Overall Study|Data inadvertently lost by site|0|||
48694654|NCT01576341|156729536|FG000|Overall Study|Other|12|||
48694655|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
48694656|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
48694657|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
48694658|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
48694659|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
48694660|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
48694661|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
48694662|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
48694663|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
48694664|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
48694665|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
48694666|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
48694667|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
48694668|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
48694669|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
48694670|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
48694671|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
48694672|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
48694673|NCT03605667|156729537|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
48694674|NCT03605667|156729538|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
48694675|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
48694676|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
48694677|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Other|6|||
48432075|NCT01683071|155769033|FG002|Part 1|Surgery Cancelled|0|||
48592365|NCT00423813|156361507|FG001|Overall Study|Sponsor Decision|1|||
48592366|NCT00423813|156361508|FG002|Overall Study|Sponsor Decision|0|||
48592367|NCT00423813|156361506|FG000|Overall Study|Protocol Violation|9|||
48592368|NCT00423813|156361507|FG001|Overall Study|Protocol Violation|4|||
48592369|NCT00423813|156361508|FG002|Overall Study|Protocol Violation|4|||
48592370|NCT00423813|156361506|FG000|Overall Study|Pregnancy|0|||
48592371|NCT00423813|156361507|FG001|Overall Study|Pregnancy|0|||
48592372|NCT00423813|156361508|FG002|Overall Study|Pregnancy|1|||
48592373|NCT00423813|156361506|FG000|Overall Study|Subject started night shift work|1|||
48592374|NCT00423813|156361507|FG001|Overall Study|Subject started night shift work|0|||
48592375|NCT00423813|156361508|FG002|Overall Study|Subject started night shift work|0|||
48592376|NCT00423813|156361506|FG000|Overall Study|Will start exclusionary medications|0|||
48592377|NCT00423813|156361507|FG001|Overall Study|Will start exclusionary medications|1|||
48592378|NCT00423813|156361508|FG002|Overall Study|Will start exclusionary medications|0|||
48592379|NCT00423813|156361506|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
48592380|NCT00423813|156361507|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
48592381|NCT00423813|156361508|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
48592382|NCT01119846|156361521|FG000|Overall Study|Adverse Event|1|||
48592383|NCT01119846|156361522|FG001|Overall Study|Adverse Event|0|||
48592384|NCT01119846|156361523|FG002|Overall Study|Adverse Event|6|||
48592385|NCT01119846|156361521|FG000|Overall Study|Physician Decision|1|||
48592386|NCT01119846|156361522|FG001|Overall Study|Physician Decision|0|||
48592387|NCT01119846|156361523|FG002|Overall Study|Physician Decision|0|||
48592388|NCT01119846|156361521|FG000|Overall Study|Protocol Violation|0|||
48592389|NCT01119846|156361522|FG001|Overall Study|Protocol Violation|0|||
48592390|NCT01119846|156361523|FG002|Overall Study|Protocol Violation|1|||
48592391|NCT01119846|156361521|FG000|Overall Study|Withdrawal by Subject|0|||
48592392|NCT01119846|156361522|FG001|Overall Study|Withdrawal by Subject|0|||
48592393|NCT01119846|156361523|FG002|Overall Study|Withdrawal by Subject|4|||
48592394|NCT00048997|156361524|FG000|Overall Study|Protocol Violation|7|||
48592395|NCT00048997|156361525|FG001|Overall Study|Protocol Violation|2|||
48592396|NCT00048997|156361524|FG000|Overall Study|Withdrawal by Subject|6|||
48592397|NCT00048997|156361525|FG001|Overall Study|Withdrawal by Subject|1|||
48592398|NCT02385110|156361526|FG000|Overall Study|Early Death|1|||
48592399|NCT02385110|156361527|FG001|Overall Study|Early Death|0|||
48592400|NCT03472521|156361529|FG000|Overall Study|Lost to Follow-up|3|||
48592401|NCT03472521|156361530|FG001|Overall Study|Lost to Follow-up|2|||
48592402|NCT03472521|156361529|FG000|Overall Study|Discontinued intervention|3|||
48592403|NCT03472521|156361530|FG001|Overall Study|Discontinued intervention|1|||
48592404|NCT01663857|156363440|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
48592405|NCT01663857|156363441|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
48592406|NCT01663857|156363442|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
48592407|NCT01663857|156363443|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
48592408|NCT01663857|156363440|FG000|Overall Study|Lost to Follow-up|0|||
48592409|NCT01663857|156363441|FG001|Overall Study|Lost to Follow-up|0|||
48592410|NCT01663857|156363442|FG002|Overall Study|Lost to Follow-up|3|||
48592411|NCT01663857|156363443|FG003|Overall Study|Lost to Follow-up|1|||
48592412|NCT01026818|156363450|FG000|Screening Period|Entry Criteria Not Met|105|||
48592413|NCT01026818|156363451|FG001|Screening Period|Entry Criteria Not Met|0|||
48592414|NCT01026818|156363452|FG002|Screening Period|Entry Criteria Not Met|0|||
48592415|NCT01026818|156363453|FG003|Screening Period|Entry Criteria Not Met|0|||
48592416|NCT01026818|156363450|FG000|Screening Period|Withdrawal by Subject|49|||
48592417|NCT01026818|156363451|FG001|Screening Period|Withdrawal by Subject|0|||
48592418|NCT01026818|156363452|FG002|Screening Period|Withdrawal by Subject|0|||
48592419|NCT01026818|156363453|FG003|Screening Period|Withdrawal by Subject|0|||
48592420|NCT01026818|156363450|FG000|Screening Period|Protocol Deviation|3|||
48592421|NCT01026818|156363451|FG001|Screening Period|Protocol Deviation|0|||
48592422|NCT01026818|156363452|FG002|Screening Period|Protocol Deviation|0|||
48592423|NCT01026818|156363453|FG003|Screening Period|Protocol Deviation|0|||
48592424|NCT01026818|156363450|FG000|Screening Period|Adverse Event|2|||
48592425|NCT01026818|156363451|FG001|Screening Period|Adverse Event|0|||
48592426|NCT01026818|156363452|FG002|Screening Period|Adverse Event|0|||
48592427|NCT01026818|156363453|FG003|Screening Period|Adverse Event|0|||
48694678|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Other|8|||
48694679|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
48694680|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
48694681|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
48694682|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
48694683|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
48694684|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
48694685|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
48694686|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
48694687|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
48694688|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
48694689|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
48694690|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
48694691|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Death|0|||
48694692|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Death|2|||
48694693|NCT03605667|156729537|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
48694694|NCT03605667|156729538|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
48694695|NCT00517296|156729539|FG000|Overall Study|Withdrawal by Subject|1|||
48694696|NCT00517296|156729540|FG001|Overall Study|Withdrawal by Subject|0|||
48694697|NCT05827068|156729543|FG000|Overall Study|Lost to Follow-up|1|||
48694698|NCT05827068|156729544|FG001|Overall Study|Lost to Follow-up|4|||
48694699|NCT05827068|156729545|FG002|Overall Study|Lost to Follow-up|1|||
48694700|NCT05827068|156729546|FG003|Overall Study|Lost to Follow-up|1|||
48694701|NCT05827068|156729547|FG004|Overall Study|Lost to Follow-up|2|||
48694702|NCT05827068|156729548|FG005|Overall Study|Lost to Follow-up|4|||
48694703|NCT05827068|156729549|FG006|Overall Study|Lost to Follow-up|1|||
48694704|NCT05827068|156729543|FG000|Overall Study|Withdrawal by Subject|4|||
48694705|NCT05827068|156729544|FG001|Overall Study|Withdrawal by Subject|0|||
48694706|NCT05827068|156729545|FG002|Overall Study|Withdrawal by Subject|1|||
48694707|NCT05827068|156729546|FG003|Overall Study|Withdrawal by Subject|2|||
48694708|NCT05827068|156729547|FG004|Overall Study|Withdrawal by Subject|3|||
48694709|NCT05827068|156729548|FG005|Overall Study|Withdrawal by Subject|0|||
48694710|NCT05827068|156729549|FG006|Overall Study|Withdrawal by Subject|1|||
48694711|NCT05827068|156729543|FG000|Overall Study|Physician Decision|0|||
48694712|NCT05827068|156729544|FG001|Overall Study|Physician Decision|0|||
48694713|NCT05827068|156729545|FG002|Overall Study|Physician Decision|0|||
48694714|NCT05827068|156729546|FG003|Overall Study|Physician Decision|0|||
48694715|NCT05827068|156729547|FG004|Overall Study|Physician Decision|1|||
48694716|NCT05827068|156729548|FG005|Overall Study|Physician Decision|0|||
48694717|NCT05827068|156729549|FG006|Overall Study|Physician Decision|1|||
48694718|NCT05827068|156729543|FG000|Overall Study|Other Than Specified|0|||
48694719|NCT05827068|156729544|FG001|Overall Study|Other Than Specified|1|||
48694720|NCT05827068|156729545|FG002|Overall Study|Other Than Specified|0|||
48694721|NCT05827068|156729546|FG003|Overall Study|Other Than Specified|0|||
48694722|NCT05827068|156729547|FG004|Overall Study|Other Than Specified|0|||
48694723|NCT05827068|156729548|FG005|Overall Study|Other Than Specified|0|||
48694724|NCT05827068|156729549|FG006|Overall Study|Other Than Specified|0|||
48694725|NCT00098475|156729550|FG000|Step 1|Progressive disease|33|||
48694726|NCT00098475|156729551|FG001|Step 1|Progressive disease|35|||
48694727|NCT00098475|156729552|FG002|Step 1|Progressive disease|2|||
48694728|NCT00098475|156729553|FG003|Step 1|Progressive disease|1|||
48694729|NCT00098475|156729550|FG000|Step 1|Adverse Event|56|||
48694730|NCT00098475|156729551|FG001|Step 1|Adverse Event|37|||
48694731|NCT00098475|156729552|FG002|Step 1|Adverse Event|0|||
48694732|NCT00098475|156729553|FG003|Step 1|Adverse Event|1|||
48694733|NCT00098475|156729550|FG000|Step 1|Death|8|||
48694734|NCT00098475|156729551|FG001|Step 1|Death|5|||
48694735|NCT00098475|156729552|FG002|Step 1|Death|0|||
48694736|NCT00098475|156729553|FG003|Step 1|Death|1|||
48694737|NCT00098475|156729550|FG000|Step 1|Withdrawal by Subject|14|||
48694738|NCT00098475|156729551|FG001|Step 1|Withdrawal by Subject|11|||
48432076|NCT01683071|155769034|FG003|Part 1|Surgery Cancelled|0|||
48694739|NCT00098475|156729552|FG002|Step 1|Withdrawal by Subject|0|||
48694740|NCT00098475|156729553|FG003|Step 1|Withdrawal by Subject|0|||
48694741|NCT00098475|156729550|FG000|Step 1|Physician Decision|5|||
48694742|NCT00098475|156729551|FG001|Step 1|Physician Decision|2|||
48694743|NCT00098475|156729552|FG002|Step 1|Physician Decision|0|||
48694744|NCT00098475|156729553|FG003|Step 1|Physician Decision|0|||
48694745|NCT00098475|156729550|FG000|Step 1|Alternative therapy|31|||
48694746|NCT00098475|156729551|FG001|Step 1|Alternative therapy|43|||
48694747|NCT00098475|156729552|FG002|Step 1|Alternative therapy|1|||
48694748|NCT00098475|156729553|FG003|Step 1|Alternative therapy|0|||
48694749|NCT00098475|156729550|FG000|Step 1|Other disease|2|||
48694750|NCT00098475|156729551|FG001|Step 1|Other disease|1|||
48694751|NCT00098475|156729552|FG002|Step 1|Other disease|1|||
48694752|NCT00098475|156729553|FG003|Step 1|Other disease|0|||
48694753|NCT00098475|156729550|FG000|Step 1|Never started treatment|0|||
48694754|NCT00098475|156729551|FG001|Step 1|Never started treatment|2|||
48694755|NCT00098475|156729552|FG002|Step 1|Never started treatment|0|||
48694756|NCT00098475|156729553|FG003|Step 1|Never started treatment|0|||
48694757|NCT00098475|156729550|FG000|Step 1|Still on treatment as of this analysis|14|||
48694758|NCT00098475|156729551|FG001|Step 1|Still on treatment as of this analysis|27|||
48694759|NCT00098475|156729552|FG002|Step 1|Still on treatment as of this analysis|0|||
48694760|NCT00098475|156729553|FG003|Step 1|Still on treatment as of this analysis|0|||
48694761|NCT00098475|156729550|FG000|Step 1|Knee surgery|1|||
48694762|NCT00098475|156729551|FG001|Step 1|Knee surgery|0|||
48694763|NCT00098475|156729552|FG002|Step 1|Knee surgery|0|||
48694764|NCT00098475|156729553|FG003|Step 1|Knee surgery|0|||
48694765|NCT00098475|156729550|FG000|Step 1|Complications|1|||
48694766|NCT00098475|156729551|FG001|Step 1|Complications|0|||
48694767|NCT00098475|156729552|FG002|Step 1|Complications|0|||
48694768|NCT00098475|156729553|FG003|Step 1|Complications|0|||
48694769|NCT00098475|156729550|FG000|Step 1|Cannot comply due to other tx|0|||
48694770|NCT00098475|156729551|FG001|Step 1|Cannot comply due to other tx|1|||
48694771|NCT00098475|156729552|FG002|Step 1|Cannot comply due to other tx|0|||
48694772|NCT00098475|156729553|FG003|Step 1|Cannot comply due to other tx|0|||
48694773|NCT00098475|156729550|FG000|Step 1|Both patient and physician's decision|2|||
48694774|NCT00098475|156729551|FG001|Step 1|Both patient and physician's decision|1|||
48694775|NCT00098475|156729552|FG002|Step 1|Both patient and physician's decision|0|||
48694776|NCT00098475|156729553|FG003|Step 1|Both patient and physician's decision|0|||
48694777|NCT00098475|156729550|FG000|Step 1|Incorrect disease assessment|2|||
48694778|NCT00098475|156729551|FG001|Step 1|Incorrect disease assessment|0|||
48694779|NCT00098475|156729552|FG002|Step 1|Incorrect disease assessment|0|||
48694780|NCT00098475|156729553|FG003|Step 1|Incorrect disease assessment|0|||
48694781|NCT00098475|156729550|FG000|Step 1|Off treatment for > specified timeframe|1|||
48694782|NCT00098475|156729551|FG001|Step 1|Off treatment for > specified timeframe|1|||
48694783|NCT00098475|156729552|FG002|Step 1|Off treatment for > specified timeframe|0|||
48694784|NCT00098475|156729553|FG003|Step 1|Off treatment for > specified timeframe|0|||
48694785|NCT00098475|156729550|FG000|Step 1|Declining performance status|0|||
48694786|NCT00098475|156729551|FG001|Step 1|Declining performance status|1|||
48694787|NCT00098475|156729552|FG002|Step 1|Declining performance status|0|||
48694788|NCT00098475|156729553|FG003|Step 1|Declining performance status|0|||
48694789|NCT00098475|156729550|FG000|Step 1|Insurance issue|0|||
48694790|NCT00098475|156729551|FG001|Step 1|Insurance issue|1|||
48694791|NCT00098475|156729552|FG002|Step 1|Insurance issue|0|||
48694792|NCT00098475|156729553|FG003|Step 1|Insurance issue|0|||
48694793|NCT00098475|156729550|FG000|Step 1|Rising paraprotein|0|||
48694794|NCT00098475|156729551|FG001|Step 1|Rising paraprotein|1|||
48694795|NCT00098475|156729552|FG002|Step 1|Rising paraprotein|0|||
48694796|NCT00098475|156729553|FG003|Step 1|Rising paraprotein|0|||
48694797|NCT00098475|156729550|FG000|Step 1|Referred to other physicians|0|||
48694798|NCT00098475|156729551|FG001|Step 1|Referred to other physicians|1|||
48694799|NCT00098475|156729552|FG002|Step 1|Referred to other physicians|0|||
48694800|NCT00098475|156729553|FG003|Step 1|Referred to other physicians|0|||
48694801|NCT00098475|156729550|FG000|Step 1|Criteria to continue treatment not met|0|||
48694802|NCT00098475|156729551|FG001|Step 1|Criteria to continue treatment not met|1|||
48694803|NCT00098475|156729552|FG002|Step 1|Criteria to continue treatment not met|0|||
48694804|NCT00098475|156729553|FG003|Step 1|Criteria to continue treatment not met|0|||
48694805|NCT00098475|156729550|FG000|Step 1|Misinterpretation of lab data|0|||
48694806|NCT00098475|156729551|FG001|Step 1|Misinterpretation of lab data|1|||
48694807|NCT00098475|156729552|FG002|Step 1|Misinterpretation of lab data|0|||
48694808|NCT00098475|156729553|FG003|Step 1|Misinterpretation of lab data|0|||
48694809|NCT00098475|156729550|FG000|Step 1|Patient fell with fracture|1|||
48694810|NCT00098475|156729551|FG001|Step 1|Patient fell with fracture|0|||
48694811|NCT00098475|156729552|FG002|Step 1|Patient fell with fracture|0|||
48694812|NCT00098475|156729553|FG003|Step 1|Patient fell with fracture|0|||
48694813|NCT00098475|156729550|FG000|Step 1|Not documented|0|||
48694814|NCT00098475|156729551|FG001|Step 1|Not documented|1|||
48694815|NCT00098475|156729552|FG002|Step 1|Not documented|0|||
48694816|NCT00098475|156729553|FG003|Step 1|Not documented|0|||
48694817|NCT00098475|156729550|FG000|Step 2|Disease progression|1|||
48694818|NCT00098475|156729551|FG001|Step 2|Disease progression|4|||
48694819|NCT00098475|156729552|FG002|Step 2|Disease progression|0|||
48694820|NCT00098475|156729553|FG003|Step 2|Disease progression|0|||
48694821|NCT00098475|156729550|FG000|Step 2|Adverse Event|2|||
48694822|NCT00098475|156729551|FG001|Step 2|Adverse Event|0|||
48694823|NCT00098475|156729552|FG002|Step 2|Adverse Event|0|||
48694824|NCT00098475|156729553|FG003|Step 2|Adverse Event|0|||
48694825|NCT00098475|156729550|FG000|Step 2|Withdrawal by Subject|0|||
48694826|NCT00098475|156729551|FG001|Step 2|Withdrawal by Subject|2|||
48694827|NCT00098475|156729552|FG002|Step 2|Withdrawal by Subject|0|||
48694828|NCT00098475|156729553|FG003|Step 2|Withdrawal by Subject|0|||
48694829|NCT00098475|156729550|FG000|Step 2|Physician Decision|0|||
48694830|NCT00098475|156729551|FG001|Step 2|Physician Decision|1|||
48694831|NCT00098475|156729552|FG002|Step 2|Physician Decision|0|||
48694832|NCT00098475|156729553|FG003|Step 2|Physician Decision|0|||
48694833|NCT00098475|156729550|FG000|Step 2|Alternative therapy|1|||
48694834|NCT00098475|156729551|FG001|Step 2|Alternative therapy|2|||
48694835|NCT00098475|156729552|FG002|Step 2|Alternative therapy|0|||
48694836|NCT00098475|156729553|FG003|Step 2|Alternative therapy|0|||
48694837|NCT00098475|156729550|FG000|Step 2|Never started treatment|1|||
48694838|NCT00098475|156729551|FG001|Step 2|Never started treatment|1|||
48694839|NCT00098475|156729552|FG002|Step 2|Never started treatment|0|||
48694840|NCT00098475|156729553|FG003|Step 2|Never started treatment|0|||
48694841|NCT01974440|156729554|FG000|Overall Study|Lost to Follow-up|7|||
48694842|NCT01974440|156729555|FG001|Overall Study|Lost to Follow-up|7|||
48694843|NCT01974440|156729554|FG000|Overall Study|Withdrawal by Subject|24|||
48694844|NCT01974440|156729555|FG001|Overall Study|Withdrawal by Subject|20|||
48694845|NCT01974440|156729554|FG000|Overall Study|Sponsor decision|109|||
48694846|NCT01974440|156729555|FG001|Overall Study|Sponsor decision|110|||
48694847|NCT02336282|156729563|FG000|Overall Study|Unrelated illness|1|||
48694848|NCT02336282|156729563|FG000|Overall Study|Uncomfortable with technology|1|||
48694849|NCT02336282|156729563|FG000|Overall Study|Lost to Follow-up|1|||
48694850|NCT02336282|156729563|FG000|Overall Study|Not enough time to complete sessions|2|||
48694861|NCT02946996|156729568|FG000|Overall Study|non-evaluable|3|||
48694862|NCT02946996|156729569|FG001|Overall Study|non-evaluable|6|||
48694863|NCT02946996|156729570|FG002|Overall Study|non-evaluable|5|||
48694864|NCT02994108|156732078|FG000|Intervention Messages|Withdrawal by Subject|2|||
48694865|NCT02994108|156732079|FG001|Intervention Messages|Withdrawal by Subject|0|||
48694866|NCT02994108|156732078|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
48694867|NCT02994108|156732079|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
48694868|NCT02994108|156732078|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
48694869|NCT02994108|156732079|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
48694870|NCT02994108|156732078|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
48694871|NCT02994108|156732079|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
48694872|NCT03346434|156732086|FG000|Overall Study|Randomized in Error|0|||
48694873|NCT03346434|156732087|FG001|Overall Study|Randomized in Error|0|||
48694874|NCT03346434|156732088|FG002|Overall Study|Randomized in Error|0|||
48694875|NCT03346434|156732089|FG003|Overall Study|Randomized in Error|0|||
48694876|NCT03346434|156732090|FG004|Overall Study|Randomized in Error|1|||
48694877|NCT03346434|156732091|FG005|Overall Study|Randomized in Error|0|||
48694878|NCT03346434|156732086|FG000|Overall Study|Withdrawal by Subject|0|||
48694879|NCT03346434|156732087|FG001|Overall Study|Withdrawal by Subject|0|||
48694880|NCT03346434|156732088|FG002|Overall Study|Withdrawal by Subject|1|||
48487674|NCT00095199|155979048|FG003|Overall Study|Data inadvertently lost by site|0|||
48487675|NCT03016078|155979049|FG000|Overall Study|Protocol Violation|1|||
48592428|NCT01026818|156363450|FG000|Screening Period|Physician Decision|1|||
48487676|NCT03016078|155979049|FG000|Overall Study|Protocol Violation|1|||
48487677|NCT03387059|155979051|FG000|Overall Study|Study termination|5|||
48487678|NCT03387059|155979052|FG001|Overall Study|Study termination|4|||
48487679|NCT00185211|155979055|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
48487680|NCT00185211|155979056|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
48487681|NCT00185211|155979055|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
48487682|NCT00185211|155979056|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
48592429|NCT01026818|156363451|FG001|Screening Period|Physician Decision|0|||
48592430|NCT01026818|156363452|FG002|Screening Period|Physician Decision|0|||
48592431|NCT01026818|156363453|FG003|Screening Period|Physician Decision|0|||
48592432|NCT01026818|156363450|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
48592433|NCT01026818|156363451|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
48592434|NCT01026818|156363452|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
48592435|NCT01026818|156363453|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
48592436|NCT01026818|156363450|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
48592437|NCT01026818|156363451|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
48592438|NCT01026818|156363452|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
48592439|NCT01026818|156363453|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
48592440|NCT01026818|156363450|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
48592441|NCT01026818|156363451|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
48592442|NCT01026818|156363452|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
48592443|NCT01026818|156363453|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
48592444|NCT01026818|156363450|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
48592445|NCT01026818|156363451|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
48592446|NCT01026818|156363452|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
48592447|NCT01026818|156363453|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
48592448|NCT01026818|156363450|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
48592449|NCT01026818|156363451|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
48592450|NCT01026818|156363452|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
48592451|NCT01026818|156363453|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
48592452|NCT01026818|156363450|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
48694881|NCT03346434|156732089|FG003|Overall Study|Withdrawal by Subject|0|||
48694882|NCT03346434|156732090|FG004|Overall Study|Withdrawal by Subject|1|||
48694883|NCT03346434|156732091|FG005|Overall Study|Withdrawal by Subject|0|||
48592453|NCT01026818|156363451|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
48592454|NCT01026818|156363452|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
48592455|NCT01026818|156363453|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
48592456|NCT01026818|156363450|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
48592457|NCT01026818|156363451|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
48592458|NCT01026818|156363452|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
48592459|NCT01026818|156363453|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
48592460|NCT01026818|156363450|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
48592461|NCT01026818|156363451|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
48592462|NCT01026818|156363452|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
48592463|NCT01026818|156363453|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
48592464|NCT01026818|156363450|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
48592465|NCT01026818|156363451|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
48592466|NCT01026818|156363452|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
48592467|NCT01026818|156363453|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
48592468|NCT01026818|156363450|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
48592469|NCT01026818|156363451|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
48592470|NCT01026818|156363452|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
48592471|NCT01026818|156363453|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
48592472|NCT01026818|156363450|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
48592473|NCT01026818|156363451|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
48592474|NCT01026818|156363452|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
48592475|NCT01026818|156363453|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
48592476|NCT01026818|156363450|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
48592477|NCT01026818|156363451|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
48592478|NCT01026818|156363452|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
48592479|NCT01026818|156363453|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
48592480|NCT01026818|156363450|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
48592481|NCT01026818|156363451|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
48592482|NCT01026818|156363452|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
48592483|NCT01026818|156363453|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
48592484|NCT01026818|156363450|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
48487683|NCT00185211|155979055|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
48487684|NCT00185211|155979056|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
48487685|NCT00185211|155979055|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
48694884|NCT03346434|156732086|FG000|Overall Study|Lost to Follow-up|0|||
48694885|NCT03346434|156732087|FG001|Overall Study|Lost to Follow-up|0|||
48694886|NCT03346434|156732088|FG002|Overall Study|Lost to Follow-up|0|||
48694887|NCT03346434|156732089|FG003|Overall Study|Lost to Follow-up|0|||
48694888|NCT03346434|156732090|FG004|Overall Study|Lost to Follow-up|1|||
48694889|NCT03346434|156732091|FG005|Overall Study|Lost to Follow-up|1|||
48694890|NCT03346434|156732086|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
48694891|NCT03346434|156732087|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
48694892|NCT03346434|156732088|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
48694893|NCT03346434|156732089|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
48694894|NCT03346434|156732090|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
48694895|NCT03346434|156732091|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
48694896|NCT03525444|156732092|FG000|Overall Study|Adverse Event|0|||
48694897|NCT03525444|156732093|FG001|Overall Study|Adverse Event|1|||
48694898|NCT03525444|156732092|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48694899|NCT03525444|156732093|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
48694900|NCT03525444|156732092|FG000|Overall Study|Other|0|||
48694901|NCT03525444|156732093|FG001|Overall Study|Other|1|||
48694902|NCT02973100|156732096|FG000|Overall Study|Adverse Event|1|||
48694903|NCT02973100|156732097|FG001|Overall Study|Adverse Event|2|||
48694904|NCT02973100|156732098|FG002|Overall Study|Adverse Event|1|||
48694905|NCT02973100|156732099|FG003|Overall Study|Adverse Event|2|||
48694906|NCT02973100|156732096|FG000|Overall Study|Lost to Follow-up|3|||
48694907|NCT02973100|156732097|FG001|Overall Study|Lost to Follow-up|1|||
48694908|NCT02973100|156732098|FG002|Overall Study|Lost to Follow-up|1|||
48694909|NCT02973100|156732099|FG003|Overall Study|Lost to Follow-up|0|||
48694910|NCT02973100|156732096|FG000|Overall Study|Withdrawal by Subject|3|||
48694911|NCT02973100|156732097|FG001|Overall Study|Withdrawal by Subject|5|||
48694912|NCT02973100|156732098|FG002|Overall Study|Withdrawal by Subject|1|||
48694913|NCT02973100|156732099|FG003|Overall Study|Withdrawal by Subject|4|||
48694914|NCT02973100|156732096|FG000|Overall Study|Notification of change in address|0|||
48694915|NCT02973100|156732097|FG001|Overall Study|Notification of change in address|0|||
48694916|NCT02973100|156732098|FG002|Overall Study|Notification of change in address|0|||
48694917|NCT02973100|156732099|FG003|Overall Study|Notification of change in address|1|||
48694918|NCT02973100|156732096|FG000|Overall Study|Failed to attend Safety followup period|0|||
48694919|NCT02973100|156732097|FG001|Overall Study|Failed to attend Safety followup period|0|||
48694920|NCT02973100|156732098|FG002|Overall Study|Failed to attend Safety followup period|1|||
48694921|NCT02973100|156732099|FG003|Overall Study|Failed to attend Safety followup period|0|||
48694922|NCT03095651|156732100|FG000|Overall Study|Lost to Follow-up|1|||
48694923|NCT03095651|156732101|FG001|Overall Study|Lost to Follow-up|1|||
48694924|NCT03095651|156732102|FG002|Overall Study|Lost to Follow-up|0|||
48694925|NCT03095651|156732103|FG003|Overall Study|Lost to Follow-up|1|||
48694926|NCT03095651|156732104|FG004|Overall Study|Lost to Follow-up|0|||
48694927|NCT03095651|156732105|FG005|Overall Study|Lost to Follow-up|0|||
48694928|NCT03095651|156732106|FG006|Overall Study|Lost to Follow-up|0|||
48694929|NCT03095651|156732107|FG007|Overall Study|Lost to Follow-up|0|||
48694930|NCT03095651|156732100|FG000|Overall Study|Withdrawal by Subject|0|||
48694931|NCT03095651|156732101|FG001|Overall Study|Withdrawal by Subject|0|||
48694932|NCT03095651|156732102|FG002|Overall Study|Withdrawal by Subject|0|||
48694933|NCT03095651|156732103|FG003|Overall Study|Withdrawal by Subject|0|||
48694934|NCT03095651|156732104|FG004|Overall Study|Withdrawal by Subject|0|||
48694935|NCT03095651|156732105|FG005|Overall Study|Withdrawal by Subject|1|||
48694936|NCT03095651|156732106|FG006|Overall Study|Withdrawal by Subject|0|||
48694937|NCT03095651|156732107|FG007|Overall Study|Withdrawal by Subject|0|||
48694938|NCT03115359|156732111|FG000|Overall Study|Withdrawal by Subject|29|||
48694939|NCT03115359|156732112|FG001|Overall Study|Withdrawal by Subject|39|||
48694940|NCT03115359|156732111|FG000|Overall Study|Scheduling conflict|25|||
48694941|NCT03115359|156732112|FG001|Overall Study|Scheduling conflict|23|||
48694942|NCT03115359|156732111|FG000|Overall Study|Personal reasons including health|12|||
48694943|NCT03115359|156732112|FG001|Overall Study|Personal reasons including health|9|||
48592485|NCT01026818|156363451|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
48742929|NCT00126191|156910416|FG000|Overall Study|Physician Decision|0|||
48592486|NCT01026818|156363452|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
48592487|NCT01026818|156363453|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
48694944|NCT03115359|156732111|FG000|Overall Study|Transportation barriers|3|||
48694945|NCT03115359|156732112|FG001|Overall Study|Transportation barriers|0|||
48694946|NCT03115359|156732111|FG000|Overall Study|No longer interested|5|||
48694947|NCT03115359|156732112|FG001|Overall Study|No longer interested|4|||
48694948|NCT03115359|156732111|FG000|Overall Study|No reason provided|45|||
48694949|NCT03115359|156732112|FG001|Overall Study|No reason provided|47|||
48694950|NCT01731912|156732113|FG000|Overall Study|noncompliance|2|||
48694951|NCT01169103|156732114|FG000|Overall Study|Lost to Follow-up|3|||
48694952|NCT01169103|156732115|FG001|Overall Study|Lost to Follow-up|3|||
48694953|NCT01169103|156732114|FG000|Overall Study|Withdrawal by Subject|3|||
48694954|NCT01169103|156732115|FG001|Overall Study|Withdrawal by Subject|1|||
48694955|NCT03192176|156732120|FG000|Overall Study|Adverse Event|1|||
48694956|NCT03192176|156732121|FG001|Overall Study|Adverse Event|0|||
48694957|NCT03192176|156732122|FG002|Overall Study|Adverse Event|4|||
48694958|NCT03192176|156732123|FG003|Overall Study|Adverse Event|5|||
48694959|NCT03192176|156732124|FG004|Overall Study|Adverse Event|3|||
48694960|NCT03192176|156732125|FG005|Overall Study|Adverse Event|2|||
48694961|NCT03192176|156732126|FG006|Overall Study|Adverse Event|3|||
48694962|NCT03192176|156732127|FG007|Overall Study|Adverse Event|3|||
48694963|NCT03192176|156732120|FG000|Overall Study|Lost to Follow-up|0|||
48694964|NCT03192176|156732121|FG001|Overall Study|Lost to Follow-up|0|||
48694965|NCT03192176|156732122|FG002|Overall Study|Lost to Follow-up|1|||
48694966|NCT03192176|156732123|FG003|Overall Study|Lost to Follow-up|2|||
48694967|NCT03192176|156732124|FG004|Overall Study|Lost to Follow-up|3|||
48694968|NCT03192176|156732125|FG005|Overall Study|Lost to Follow-up|1|||
48694969|NCT03192176|156732126|FG006|Overall Study|Lost to Follow-up|1|||
48694970|NCT03192176|156732127|FG007|Overall Study|Lost to Follow-up|1|||
48694971|NCT03192176|156732120|FG000|Overall Study|Physician Decision|1|||
48694972|NCT03192176|156732121|FG001|Overall Study|Physician Decision|0|||
48694973|NCT03192176|156732122|FG002|Overall Study|Physician Decision|0|||
48694974|NCT03192176|156732123|FG003|Overall Study|Physician Decision|0|||
48694975|NCT03192176|156732124|FG004|Overall Study|Physician Decision|0|||
48694976|NCT03192176|156732125|FG005|Overall Study|Physician Decision|2|||
48694977|NCT03192176|156732126|FG006|Overall Study|Physician Decision|1|||
48694978|NCT03192176|156732127|FG007|Overall Study|Physician Decision|0|||
48694979|NCT03192176|156732120|FG000|Overall Study|Protocol Deviation|1|||
48694980|NCT03192176|156732121|FG001|Overall Study|Protocol Deviation|1|||
48694981|NCT03192176|156732122|FG002|Overall Study|Protocol Deviation|0|||
48694982|NCT03192176|156732123|FG003|Overall Study|Protocol Deviation|0|||
48694983|NCT03192176|156732124|FG004|Overall Study|Protocol Deviation|2|||
48694984|NCT03192176|156732125|FG005|Overall Study|Protocol Deviation|0|||
48694985|NCT03192176|156732126|FG006|Overall Study|Protocol Deviation|0|||
48694986|NCT03192176|156732127|FG007|Overall Study|Protocol Deviation|0|||
48694987|NCT03192176|156732120|FG000|Overall Study|Withdrawal by Subject|3|||
48694988|NCT03192176|156732121|FG001|Overall Study|Withdrawal by Subject|4|||
48694989|NCT03192176|156732122|FG002|Overall Study|Withdrawal by Subject|0|||
48694990|NCT03192176|156732123|FG003|Overall Study|Withdrawal by Subject|4|||
48694991|NCT03192176|156732124|FG004|Overall Study|Withdrawal by Subject|3|||
48694992|NCT03192176|156732125|FG005|Overall Study|Withdrawal by Subject|4|||
48694993|NCT03192176|156732126|FG006|Overall Study|Withdrawal by Subject|4|||
48694994|NCT03192176|156732127|FG007|Overall Study|Withdrawal by Subject|2|||
48694995|NCT03192176|156732120|FG000|Overall Study|Miscellaneous|1|||
48694996|NCT03192176|156732121|FG001|Overall Study|Miscellaneous|0|||
48694997|NCT03192176|156732122|FG002|Overall Study|Miscellaneous|1|||
48694998|NCT03192176|156732123|FG003|Overall Study|Miscellaneous|1|||
48694999|NCT03192176|156732124|FG004|Overall Study|Miscellaneous|1|||
48695000|NCT03192176|156732125|FG005|Overall Study|Miscellaneous|2|||
48695001|NCT03192176|156732126|FG006|Overall Study|Miscellaneous|0|||
48695002|NCT03192176|156732127|FG007|Overall Study|Miscellaneous|1|||
48695003|NCT03532542|156732128|FG000|Overall Study|Death|1|||
48695004|NCT03532542|156732129|FG001|Overall Study|Death|0|||
48695005|NCT03532542|156732128|FG000|Overall Study|Study Terminated by Sponsor|41|||
48695006|NCT03532542|156732129|FG001|Overall Study|Study Terminated by Sponsor|65|||
48695007|NCT03532542|156732128|FG000|Overall Study|Withdrawal by Subject|6|||
48695008|NCT03532542|156732129|FG001|Overall Study|Withdrawal by Subject|5|||
48695009|NCT00614575|156732132|FG000|Overall Study|Adverse Event|106|||
48695010|NCT00614575|156732132|FG000|Overall Study|Lost to Follow-up|55|||
48695011|NCT00614575|156732132|FG000|Overall Study|Lack of Efficacy|14|||
48695012|NCT00614575|156732132|FG000|Overall Study|Withdrawal by Subject|6|||
48695013|NCT00614575|156732132|FG000|Overall Study|Death|3|||
48695014|NCT00614575|156732132|FG000|Overall Study|Physician Decision|2|||
48695015|NCT00614575|156732132|FG000|Overall Study|No data were collected.|18|||
48695016|NCT00614575|156732132|FG000|Overall Study|Irregularly enrolled patients|23|||
48695017|NCT00614575|156732132|FG000|Overall Study|No treatment|1|||
48695018|NCT03452540|156732133|FG000|Overall Study|Adverse Event|1|||
48695019|NCT03452540|156732133|FG000|Overall Study|Withdrawal by Subject|1|||
48695020|NCT03452540|156732133|FG000|Overall Study|Other SAE and AE|2|||
48695021|NCT01045460|156732142|FG000|Overall Study|Physician Decision|3|||
48695022|NCT01045460|156732143|FG001|Overall Study|Physician Decision|2|||
48695023|NCT01045460|156732142|FG000|Overall Study|Lost to Follow-up|0|||
48695024|NCT01045460|156732143|FG001|Overall Study|Lost to Follow-up|1|||
48695025|NCT01045460|156732142|FG000|Overall Study|Lack of Efficacy|3|||
48487686|NCT00185211|155979056|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
48487687|NCT00185211|155979055|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
48695026|NCT01045460|156732143|FG001|Overall Study|Lack of Efficacy|0|||
48432077|NCT01683071|155769035|FG004|Part 1|Surgery Cancelled|0|||
48592488|NCT01026818|156363450|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
48487688|NCT00185211|155979056|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
48432078|NCT01683071|155769036|FG005|Part 1|Surgery Cancelled|0|||
48487689|NCT00185211|155979055|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
48487690|NCT00185211|155979056|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
48695027|NCT00472108|156732146|FG000|Overall Study|Lost to Follow-up|0|||
48695028|NCT00472108|156732147|FG001|Overall Study|Lost to Follow-up|1|||
48487691|NCT00185211|155979055|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
48487692|NCT00185211|155979056|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
48487693|NCT00185211|155979055|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
48487694|NCT00185211|155979056|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
48487695|NCT00185211|155979055|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
48487696|NCT00185211|155979056|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
48592489|NCT01026818|156363451|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
48432079|NCT01683071|155769031|FG000|Part 1|Did not receive study drug|1|||
48695029|NCT02694744|156732150|FG000|Overall Study|Adverse Event|2|||
48695030|NCT02694744|156732151|FG001|Overall Study|Adverse Event|1|||
48695031|NCT02694744|156732150|FG000|Overall Study|Withdrawal by Subject|2|||
48592490|NCT01026818|156363452|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
48742930|NCT00126191|156910417|FG001|Overall Study|Physician Decision|1|||
48592491|NCT01026818|156363453|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
48695032|NCT02694744|156732151|FG001|Overall Study|Withdrawal by Subject|1|||
48487697|NCT00185211|155979055|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
48487698|NCT00185211|155979056|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
48487699|NCT00185211|155979055|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
48487700|NCT00185211|155979056|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
48695033|NCT02694744|156732150|FG000|Overall Study|Physician Decision|1|||
48695034|NCT02694744|156732151|FG001|Overall Study|Physician Decision|2|||
48695035|NCT02694744|156732150|FG000|Overall Study|Lost to Follow-up|1|||
48695036|NCT02694744|156732151|FG001|Overall Study|Lost to Follow-up|0|||
48695037|NCT02694744|156732150|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
48695038|NCT02694744|156732151|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
48695039|NCT00686777|156732152|FG000|Overall Study|Adverse Event|2|||
48695040|NCT00686777|156732152|FG000|Overall Study|Pregnancy|1|||
48695041|NCT00686777|156732152|FG000|Overall Study|Withdrawal by Subject|2|||
48695042|NCT00686777|156732152|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
48695043|NCT00686777|156732152|FG000|Overall Study|No Visit|1|||
48695044|NCT01791244|156732154|FG000|Overall Study|Adverse Event|5|||
48695045|NCT01791244|156732155|FG001|Overall Study|Adverse Event|7|||
48695046|NCT01791244|156732154|FG000|Overall Study|Insufficient clinical response|10|||
48695047|NCT01791244|156732155|FG001|Overall Study|Insufficient clinical response|10|||
48695048|NCT01791244|156732154|FG000|Overall Study|Laboratory Abnormality|0|||
48695049|NCT01791244|156732155|FG001|Overall Study|Laboratory Abnormality|1|||
48695050|NCT00739401|156732156|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
48695051|NCT00739401|156732156|FG000|Overall Study|Death|3|||
48695052|NCT00739401|156732156|FG000|Overall Study|Withdrawal by Subject|4|||
48695053|NCT04739982|156732157|FG000|Overall Study|Lost to Follow-up|176|||
48695054|NCT04739982|156732158|FG001|Overall Study|Lost to Follow-up|65|||
48695055|NCT04739982|156732157|FG000|Overall Study|Withdrawal by Subject|19|||
48695056|NCT04739982|156732158|FG001|Overall Study|Withdrawal by Subject|0|||
48695057|NCT04739982|156732157|FG000|Overall Study|Protocol Violation|0|||
48695058|NCT04739982|156732158|FG001|Overall Study|Protocol Violation|5|||
48695059|NCT02240485|156732159|FG000|3 Months Post-admission|Lost to Follow-up|1|||
48695060|NCT02240485|156732160|FG001|3 Months Post-admission|Lost to Follow-up|5|||
48695061|NCT02240485|156732159|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
48695062|NCT02240485|156732160|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
48695063|NCT02240485|156732159|FG000|9 Months Post-admission|Lost to Follow-up|3|||
48695064|NCT02240485|156732160|FG001|9 Months Post-admission|Lost to Follow-up|1|||
48695065|NCT02240485|156732159|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
48695066|NCT02240485|156732160|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
48695067|NCT02240485|156732159|FG000|18 Months Post-admission|Lost to Follow-up|1|||
48695068|NCT02240485|156732160|FG001|18 Months Post-admission|Lost to Follow-up|1|||
48695069|NCT02240485|156732159|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
48695070|NCT02240485|156732160|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
48695071|NCT02636699|156732161|FG000|Overall Study|Adverse Event|4|||
48695072|NCT02636699|156732162|FG001|Overall Study|Adverse Event|0|||
48695073|NCT02636699|156732161|FG000|Overall Study|Lost to Follow-up|3|||
48695074|NCT02636699|156732162|FG001|Overall Study|Lost to Follow-up|3|||
48695075|NCT02636699|156732161|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
48695076|NCT02636699|156732162|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
48695077|NCT02636699|156732161|FG000|Overall Study|Physician Decision|0|||
48695078|NCT02636699|156732162|FG001|Overall Study|Physician Decision|1|||
48695079|NCT02636699|156732161|FG000|Overall Study|Withdrawal by Subject|13|||
48695080|NCT02636699|156732162|FG001|Overall Study|Withdrawal by Subject|6|||
48695081|NCT02636699|156732161|FG000|Overall Study|Other|3|||
48695082|NCT02636699|156732162|FG001|Overall Study|Other|1|||
48695083|NCT00539981|156732163|FG000|Overall Study|Adverse events (AE)|3|||
48695084|NCT00539981|156732164|FG001|Overall Study|Adverse events (AE)|3|||
48695085|NCT00539981|156732163|FG000|Overall Study|Lost to Follow-up|260|||
48695086|NCT00539981|156732164|FG001|Overall Study|Lost to Follow-up|251|||
48695087|NCT00539981|156732163|FG000|Overall Study|Withdrew consent|22|||
48695088|NCT00539981|156732164|FG001|Overall Study|Withdrew consent|14|||
48695089|NCT00539981|156732163|FG000|Overall Study|Death|1|||
48695090|NCT00539981|156732164|FG001|Overall Study|Death|1|||
48695091|NCT00539981|156732163|FG000|Overall Study|Other reason-unspecified|9|||
48695092|NCT00539981|156732164|FG001|Overall Study|Other reason-unspecified|13|||
48695093|NCT02285855|156732165|FG000|Overall Study|Withdrawal by Subject|2|||
48695094|NCT02285855|156732166|FG001|Overall Study|Withdrawal by Subject|1|||
48695095|NCT00528112|156732170|FG000|Treatment up to 3 Years|Adverse Event|313|||
48695096|NCT00528112|156732171|FG001|Treatment up to 3 Years|Adverse Event|278|||
48695097|NCT00528112|156732170|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
48695098|NCT00528112|156732171|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
48695099|NCT00528112|156732170|FG000|Treatment up to 3 Years|Protocol Violation|16|||
48695100|NCT00528112|156732171|FG001|Treatment up to 3 Years|Protocol Violation|16|||
48695101|NCT00528112|156732170|FG000|Treatment up to 3 Years|Death|0|||
48695102|NCT00528112|156732171|FG001|Treatment up to 3 Years|Death|1|||
48695103|NCT00528112|156732170|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
48695104|NCT00528112|156732171|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
48695105|NCT00528112|156732170|FG000|Treatment up to 3 Years|Pregnancy|9|||
48695106|NCT00528112|156732171|FG001|Treatment up to 3 Years|Pregnancy|10|||
48695107|NCT00528112|156732170|FG000|Treatment up to 3 Years|Other reasons|186|||
48695108|NCT00528112|156732171|FG001|Treatment up to 3 Years|Other reasons|186|||
48695109|NCT00528112|156732170|FG000|Extension Phase|Withdrawal by Subject|0|||
48695110|NCT00528112|156732171|FG001|Extension Phase|Withdrawal by Subject|3|||
48695111|NCT00528112|156732170|FG000|Extension Phase|Other reasons|0|||
48695112|NCT00528112|156732171|FG001|Extension Phase|Other reasons|100|||
48695113|NCT00528112|156732170|FG000|Extension Phase|Pregnancy|0|||
48695114|NCT00528112|156732171|FG001|Extension Phase|Pregnancy|3|||
48695115|NCT00528112|156732170|FG000|Extension Phase|Lost to Follow-up|0|||
48695116|NCT00528112|156732171|FG001|Extension Phase|Lost to Follow-up|12|||
48695117|NCT00528112|156732170|FG000|Extension Phase|Death|0|||
48695118|NCT00528112|156732171|FG001|Extension Phase|Death|1|||
48695119|NCT00528112|156732170|FG000|Extension Phase|Adverse Event|0|||
48695120|NCT00528112|156732171|FG001|Extension Phase|Adverse Event|36|||
48695121|NCT00528112|156732170|FG000|Extension Phase|Protocol Violation|0|||
48695122|NCT00528112|156732171|FG001|Extension Phase|Protocol Violation|2|||
48695123|NCT01323582|156732172|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
48695124|NCT01323582|156732173|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
48695125|NCT01323582|156732172|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
48695126|NCT01323582|156732173|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
48695127|NCT01323582|156732172|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
48695128|NCT01323582|156732173|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
48695129|NCT03416868|156732174|FG000|Overall Study|Withdrawal by Subject|2|||
48695130|NCT03416868|156732174|FG000|Overall Study|Lost to Follow-up|1|||
48695131|NCT02163538|156732177|FG000|Overall Study|Protocol Violation|1|||
48695132|NCT02163538|156732178|FG001|Overall Study|Protocol Violation|0|||
48695133|NCT02163538|156732177|FG000|Overall Study|Physician Decision|0|||
48695134|NCT02163538|156732178|FG001|Overall Study|Physician Decision|1|||
48695135|NCT00894803|156732179|FG000|Overall Study|Death|20|||
48695136|NCT00894803|156732180|FG001|Overall Study|Death|4|||
48695137|NCT00894803|156732179|FG000|Overall Study|Lost to Follow-up|0|||
48695138|NCT00894803|156732180|FG001|Overall Study|Lost to Follow-up|1|||
48695139|NCT02051764|156732181|FG000|Overall Study|Study terminated by sponsor|0|||
48695140|NCT02051764|156732182|FG001|Overall Study|Study terminated by sponsor|7|||
48695141|NCT00168844|156732183|FG000|Overall Study|Adverse Event|31|||
48695142|NCT00168844|156732184|FG001|Overall Study|Adverse Event|32|||
48695143|NCT00168844|156732185|FG002|Overall Study|Adverse Event|48|||
48695144|NCT00168844|156732183|FG000|Overall Study|Lost to Follow-up|4|||
48695145|NCT00168844|156732184|FG001|Overall Study|Lost to Follow-up|5|||
48695146|NCT00168844|156732185|FG002|Overall Study|Lost to Follow-up|11|||
48695147|NCT00168844|156732183|FG000|Overall Study|Withdrawal by Subject|12|||
48695148|NCT00168844|156732184|FG001|Overall Study|Withdrawal by Subject|9|||
48695149|NCT00168844|156732185|FG002|Overall Study|Withdrawal by Subject|19|||
48695150|NCT00168844|156732183|FG000|Overall Study|Protocol Violation|2|||
48695151|NCT00168844|156732184|FG001|Overall Study|Protocol Violation|2|||
48695152|NCT00168844|156732185|FG002|Overall Study|Protocol Violation|4|||
48695153|NCT00168844|156732183|FG000|Overall Study|Other|6|||
48695154|NCT00168844|156732184|FG001|Overall Study|Other|7|||
48695155|NCT00168844|156732185|FG002|Overall Study|Other|9|||
48695156|NCT00591006|156732186|FG000|Overall Study|Withdrawal by Subject|0|||
48695157|NCT00591006|156732187|FG001|Overall Study|Withdrawal by Subject|0|||
48695158|NCT00591006|156732188|FG002|Overall Study|Withdrawal by Subject|0|||
48695159|NCT00591006|156732189|FG003|Overall Study|Withdrawal by Subject|0|||
48695160|NCT00591006|156732190|FG004|Overall Study|Withdrawal by Subject|0|||
48695161|NCT00591006|156732191|FG005|Overall Study|Withdrawal by Subject|0|||
48695162|NCT00591006|156732192|FG006|Overall Study|Withdrawal by Subject|0|||
48695163|NCT00591006|156732193|FG007|Overall Study|Withdrawal by Subject|0|||
48695164|NCT00591006|156732194|FG008|Overall Study|Withdrawal by Subject|0|||
48695165|NCT00591006|156732195|FG009|Overall Study|Withdrawal by Subject|0|||
48695166|NCT00591006|156732196|FG010|Overall Study|Withdrawal by Subject|0|||
48695167|NCT00591006|156732197|FG011|Overall Study|Withdrawal by Subject|0|||
48695168|NCT00591006|156732198|FG012|Overall Study|Withdrawal by Subject|0|||
48695169|NCT00591006|156732199|FG013|Overall Study|Withdrawal by Subject|0|||
48695170|NCT00591006|156732200|FG014|Overall Study|Withdrawal by Subject|0|||
48695171|NCT00591006|156732201|FG015|Overall Study|Withdrawal by Subject|1|||
48695172|NCT00591006|156732202|FG016|Overall Study|Withdrawal by Subject|0|||
48695173|NCT00591006|156732203|FG017|Overall Study|Withdrawal by Subject|0|||
48695174|NCT00591006|156732204|FG018|Overall Study|Withdrawal by Subject|0|||
48695175|NCT00591006|156732205|FG019|Overall Study|Withdrawal by Subject|0|||
48695176|NCT00591006|156732206|FG020|Overall Study|Withdrawal by Subject|0|||
48695177|NCT00591006|156732207|FG021|Overall Study|Withdrawal by Subject|0|||
48695178|NCT00591006|156732208|FG022|Overall Study|Withdrawal by Subject|0|||
48695179|NCT00591006|156732209|FG023|Overall Study|Withdrawal by Subject|1|||
48695180|NCT00591006|156732186|FG000|Overall Study|Adverse Event|0|||
48695181|NCT00591006|156732187|FG001|Overall Study|Adverse Event|0|||
48695182|NCT00591006|156732188|FG002|Overall Study|Adverse Event|0|||
48695183|NCT00591006|156732189|FG003|Overall Study|Adverse Event|0|||
48695184|NCT00591006|156732190|FG004|Overall Study|Adverse Event|0|||
48695185|NCT00591006|156732191|FG005|Overall Study|Adverse Event|0|||
48695186|NCT00591006|156732192|FG006|Overall Study|Adverse Event|0|||
48695187|NCT00591006|156732193|FG007|Overall Study|Adverse Event|0|||
48695188|NCT00591006|156732194|FG008|Overall Study|Adverse Event|0|||
48695189|NCT00591006|156732195|FG009|Overall Study|Adverse Event|0|||
48695190|NCT00591006|156732196|FG010|Overall Study|Adverse Event|0|||
48695191|NCT00591006|156732197|FG011|Overall Study|Adverse Event|0|||
48695192|NCT00591006|156732198|FG012|Overall Study|Adverse Event|0|||
48695193|NCT00591006|156732199|FG013|Overall Study|Adverse Event|0|||
48695194|NCT00591006|156732200|FG014|Overall Study|Adverse Event|0|||
48695195|NCT00591006|156732201|FG015|Overall Study|Adverse Event|0|||
48695196|NCT00591006|156732202|FG016|Overall Study|Adverse Event|0|||
48695197|NCT00591006|156732203|FG017|Overall Study|Adverse Event|0|||
48695198|NCT00591006|156732204|FG018|Overall Study|Adverse Event|0|||
48695199|NCT00591006|156732205|FG019|Overall Study|Adverse Event|0|||
48695200|NCT00591006|156732206|FG020|Overall Study|Adverse Event|0|||
48695201|NCT00591006|156732207|FG021|Overall Study|Adverse Event|0|||
48695202|NCT00591006|156732208|FG022|Overall Study|Adverse Event|1|||
48695203|NCT00591006|156732209|FG023|Overall Study|Adverse Event|0|||
48695204|NCT00976274|156732211|FG000|Overall Study|Lost to Follow-up|5|||
48695205|NCT00976274|156732212|FG001|Overall Study|Lost to Follow-up|5|||
48695206|NCT00976274|156732211|FG000|Overall Study|Withdrawal by Subject|1|||
48695207|NCT00976274|156732212|FG001|Overall Study|Withdrawal by Subject|1|||
48695208|NCT00976274|156732211|FG000|Overall Study|Physician Decision|1|||
48695209|NCT00976274|156732212|FG001|Overall Study|Physician Decision|2|||
48695210|NCT01075243|156732213|FG000|Overall Study|Lost to Follow-up|5|||
48695211|NCT01075243|156732214|FG001|Overall Study|Lost to Follow-up|2|||
48695212|NCT01075243|156732215|FG002|Overall Study|Lost to Follow-up|0|||
48695213|NCT01075243|156732213|FG000|Overall Study|Withdrawal by Subject|1|||
48695214|NCT01075243|156732214|FG001|Overall Study|Withdrawal by Subject|1|||
48695215|NCT01075243|156732215|FG002|Overall Study|Withdrawal by Subject|0|||
48695216|NCT03050801|156732217|FG000|Experiment 1|Lost to Follow-up|0|||
48695217|NCT03050801|156732218|FG001|Experiment 1|Lost to Follow-up|1|||
48695218|NCT03050801|156732219|FG002|Experiment 1|Lost to Follow-up|0|||
48695219|NCT03050801|156732220|FG003|Experiment 1|Lost to Follow-up|0|||
48695220|NCT03050801|156732221|FG004|Experiment 1|Lost to Follow-up|0|||
48695221|NCT03050801|156732222|FG005|Experiment 1|Lost to Follow-up|0|||
48695222|NCT03050801|156732217|FG000|Experiment 1|Physician Decision|0|||
48695223|NCT03050801|156732218|FG001|Experiment 1|Physician Decision|3|||
48695224|NCT03050801|156732219|FG002|Experiment 1|Physician Decision|0|||
48695225|NCT03050801|156732220|FG003|Experiment 1|Physician Decision|0|||
48695226|NCT03050801|156732221|FG004|Experiment 1|Physician Decision|0|||
48695227|NCT03050801|156732222|FG005|Experiment 1|Physician Decision|0|||
48695228|NCT03050801|156732217|FG000|Experiment 1|Change of experimental design|0|||
48695229|NCT03050801|156732218|FG001|Experiment 1|Change of experimental design|3|||
48695230|NCT03050801|156732219|FG002|Experiment 1|Change of experimental design|0|||
48695231|NCT03050801|156732220|FG003|Experiment 1|Change of experimental design|0|||
48695232|NCT03050801|156732221|FG004|Experiment 1|Change of experimental design|0|||
48695233|NCT03050801|156732222|FG005|Experiment 1|Change of experimental design|0|||
48695234|NCT03050801|156732217|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695235|NCT03050801|156732218|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695236|NCT03050801|156732219|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
48695237|NCT03050801|156732220|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695238|NCT03050801|156732221|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695239|NCT03050801|156732222|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
48695240|NCT03050801|156732217|FG000|Experiment 2|Lost to Follow-up|0|||
48695241|NCT03050801|156732218|FG001|Experiment 2|Lost to Follow-up|0|||
48695242|NCT03050801|156732219|FG002|Experiment 2|Lost to Follow-up|0|||
48695243|NCT03050801|156732220|FG003|Experiment 2|Lost to Follow-up|1|||
48695244|NCT03050801|156732221|FG004|Experiment 2|Lost to Follow-up|1|||
48695245|NCT03050801|156732222|FG005|Experiment 2|Lost to Follow-up|0|||
48695246|NCT03050801|156732217|FG000|Experiment 2|Physician Decision|0|||
48695247|NCT03050801|156732218|FG001|Experiment 2|Physician Decision|0|||
48695248|NCT03050801|156732219|FG002|Experiment 2|Physician Decision|0|||
48695249|NCT03050801|156732220|FG003|Experiment 2|Physician Decision|0|||
48695250|NCT03050801|156732221|FG004|Experiment 2|Physician Decision|1|||
48695251|NCT03050801|156732222|FG005|Experiment 2|Physician Decision|0|||
48695252|NCT03050801|156732217|FG000|Experiment 2|Pregnancy|0|||
48695253|NCT03050801|156732218|FG001|Experiment 2|Pregnancy|0|||
48695254|NCT03050801|156732219|FG002|Experiment 2|Pregnancy|0|||
48695255|NCT03050801|156732220|FG003|Experiment 2|Pregnancy|0|||
48695256|NCT03050801|156732221|FG004|Experiment 2|Pregnancy|1|||
48695257|NCT03050801|156732222|FG005|Experiment 2|Pregnancy|0|||
48695258|NCT03050801|156732217|FG000|Experiment 2|Withdrawal by Subject|0|||
48695259|NCT03050801|156732218|FG001|Experiment 2|Withdrawal by Subject|0|||
48695260|NCT03050801|156732219|FG002|Experiment 2|Withdrawal by Subject|0|||
48695261|NCT03050801|156732220|FG003|Experiment 2|Withdrawal by Subject|1|||
48695262|NCT03050801|156732221|FG004|Experiment 2|Withdrawal by Subject|0|||
48695263|NCT03050801|156732222|FG005|Experiment 2|Withdrawal by Subject|0|||
48695264|NCT03050801|156732217|FG000|Experiment 2|Poor data quality|0|||
48695265|NCT03050801|156732218|FG001|Experiment 2|Poor data quality|0|||
48695266|NCT03050801|156732219|FG002|Experiment 2|Poor data quality|0|||
48695267|NCT03050801|156732220|FG003|Experiment 2|Poor data quality|4|||
48695268|NCT03050801|156732221|FG004|Experiment 2|Poor data quality|1|||
48695269|NCT03050801|156732222|FG005|Experiment 2|Poor data quality|0|||
48695270|NCT03050801|156732217|FG000|Experiment 2|Discomfort during stimulation|0|||
48695271|NCT03050801|156732218|FG001|Experiment 2|Discomfort during stimulation|0|||
48695272|NCT03050801|156732219|FG002|Experiment 2|Discomfort during stimulation|0|||
48695273|NCT03050801|156732220|FG003|Experiment 2|Discomfort during stimulation|0|||
48695274|NCT03050801|156732221|FG004|Experiment 2|Discomfort during stimulation|0|||
48695275|NCT03050801|156732222|FG005|Experiment 2|Discomfort during stimulation|2|||
48695276|NCT01844765|156732224|FG000|Overall Study|Adverse Event|6|||
48695277|NCT01844765|156732225|FG001|Overall Study|Adverse Event|8|||
48695278|NCT01844765|156732224|FG000|Overall Study|Withdrawal by Subject|2|||
48695279|NCT01844765|156732225|FG001|Overall Study|Withdrawal by Subject|3|||
48695280|NCT01844765|156732224|FG000|Overall Study|Disease progression|1|||
48695281|NCT01844765|156732225|FG001|Overall Study|Disease progression|0|||
48695282|NCT01844765|156732224|FG000|Overall Study|Administrative problems|3|||
48695283|NCT01844765|156732225|FG001|Overall Study|Administrative problems|4|||
48695284|NCT01844765|156732224|FG000|Overall Study|Protocol deviation|2|||
48695285|NCT01844765|156732225|FG001|Overall Study|Protocol deviation|0|||
48695286|NCT01844765|156732224|FG000|Overall Study|Untreated|1|||
48695287|NCT01844765|156732225|FG001|Overall Study|Untreated|0|||
48695288|NCT00324805|156732226|FG000|Overall Study|Adverse Event|62|||
48695289|NCT00324805|156732227|FG001|Overall Study|Adverse Event|203|||
48695290|NCT00324805|156732226|FG000|Overall Study|Progression|7|||
48695291|NCT00324805|156732227|FG001|Overall Study|Progression|35|||
48695292|NCT00324805|156732226|FG000|Overall Study|Withdrawal by Subject|51|||
48695293|NCT00324805|156732227|FG001|Overall Study|Withdrawal by Subject|174|||
48695294|NCT00324805|156732226|FG000|Overall Study|Death|6|||
48695295|NCT00324805|156732227|FG001|Overall Study|Death|9|||
48695296|NCT00324805|156732226|FG000|Overall Study|Alternative therapy|4|||
48695297|NCT00324805|156732227|FG001|Overall Study|Alternative therapy|8|||
48695298|NCT00324805|156732226|FG000|Overall Study|Other complicating disease|1|||
48695299|NCT00324805|156732227|FG001|Overall Study|Other complicating disease|9|||
48695300|NCT00324805|156732226|FG000|Overall Study|Other reasons|7|||
48695301|NCT00324805|156732227|FG001|Overall Study|Other reasons|26|||
48695302|NCT00324805|156732226|FG000|Overall Study|Other|0|||
48695303|NCT00324805|156732227|FG001|Overall Study|Other|2|||
48695304|NCT00324805|156732226|FG000|Overall Study|Did not start therapy|12|||
48695305|NCT00324805|156732227|FG001|Overall Study|Did not start therapy|17|||
48695306|NCT05496231|156732228|FG000|Overall Study|Adverse Event|1|||
48695307|NCT05496231|156732229|FG001|Overall Study|Adverse Event|1|||
48695308|NCT05496231|156732230|FG002|Overall Study|Adverse Event|0|||
48695309|NCT05496231|156732231|FG003|Overall Study|Adverse Event|4|||
48695310|NCT05496231|156732228|FG000|Overall Study|Withdrawal by Subject|5|||
48695311|NCT05496231|156732229|FG001|Overall Study|Withdrawal by Subject|5|||
48695312|NCT05496231|156732230|FG002|Overall Study|Withdrawal by Subject|4|||
48695313|NCT05496231|156732231|FG003|Overall Study|Withdrawal by Subject|11|||
48695314|NCT05496231|156732228|FG000|Overall Study|Migrated/moved from the study area|3|||
48695315|NCT05496231|156732229|FG001|Overall Study|Migrated/moved from the study area|5|||
48695316|NCT05496231|156732230|FG002|Overall Study|Migrated/moved from the study area|3|||
48695317|NCT05496231|156732231|FG003|Overall Study|Migrated/moved from the study area|3|||
48695318|NCT05496231|156732228|FG000|Overall Study|Lost to Follow-up|13|||
48695319|NCT05496231|156732229|FG001|Overall Study|Lost to Follow-up|6|||
48695320|NCT05496231|156732230|FG002|Overall Study|Lost to Follow-up|11|||
48695321|NCT05496231|156732231|FG003|Overall Study|Lost to Follow-up|6|||
48695322|NCT05496231|156732228|FG000|Overall Study|Other|9|||
48695323|NCT05496231|156732229|FG001|Overall Study|Other|7|||
48695324|NCT05496231|156732230|FG002|Overall Study|Other|7|||
48695325|NCT05496231|156732231|FG003|Overall Study|Other|8|||
48695326|NCT04228783|156732232|FG000|Overall Study|Adverse Event|1|||
48695327|NCT04228783|156732233|FG001|Overall Study|Adverse Event|0|||
48695328|NCT04228783|156732234|FG002|Overall Study|Adverse Event|2|||
48695329|NCT04228783|156732235|FG003|Overall Study|Adverse Event|0|||
48695330|NCT04228783|156732236|FG004|Overall Study|Adverse Event|0|||
48695331|NCT04228783|156732237|FG005|Overall Study|Adverse Event|1|||
48695332|NCT04228783|156732232|FG000|Overall Study|Death|0|||
48695333|NCT04228783|156732233|FG001|Overall Study|Death|0|||
48695334|NCT04228783|156732234|FG002|Overall Study|Death|0|||
48695335|NCT04228783|156732235|FG003|Overall Study|Death|0|||
48695336|NCT04228783|156732236|FG004|Overall Study|Death|1|||
48695337|NCT04228783|156732237|FG005|Overall Study|Death|0|||
48695338|NCT04228783|156732232|FG000|Overall Study|Lost to Follow-up|36|||
48695339|NCT04228783|156732233|FG001|Overall Study|Lost to Follow-up|36|||
48695340|NCT04228783|156732234|FG002|Overall Study|Lost to Follow-up|28|||
48695341|NCT04228783|156732235|FG003|Overall Study|Lost to Follow-up|6|||
48695342|NCT04228783|156732236|FG004|Overall Study|Lost to Follow-up|14|||
48695343|NCT04228783|156732237|FG005|Overall Study|Lost to Follow-up|3|||
48695344|NCT04228783|156732232|FG000|Overall Study|Physician Decision|1|||
48695345|NCT04228783|156732233|FG001|Overall Study|Physician Decision|2|||
48695346|NCT04228783|156732234|FG002|Overall Study|Physician Decision|0|||
48695347|NCT04228783|156732235|FG003|Overall Study|Physician Decision|0|||
48695348|NCT04228783|156732236|FG004|Overall Study|Physician Decision|0|||
48695349|NCT04228783|156732237|FG005|Overall Study|Physician Decision|0|||
48695350|NCT04228783|156732232|FG000|Overall Study|Protocol Violation|0|||
48695351|NCT04228783|156732233|FG001|Overall Study|Protocol Violation|0|||
48695352|NCT04228783|156732234|FG002|Overall Study|Protocol Violation|0|||
48695353|NCT04228783|156732235|FG003|Overall Study|Protocol Violation|1|||
48695354|NCT04228783|156732236|FG004|Overall Study|Protocol Violation|0|||
48695355|NCT04228783|156732237|FG005|Overall Study|Protocol Violation|0|||
48695356|NCT04228783|156732232|FG000|Overall Study|Withdrawal by Subject|6|||
48695357|NCT04228783|156732233|FG001|Overall Study|Withdrawal by Subject|10|||
48695358|NCT04228783|156732234|FG002|Overall Study|Withdrawal by Subject|19|||
48695359|NCT04228783|156732235|FG003|Overall Study|Withdrawal by Subject|1|||
48695360|NCT04228783|156732236|FG004|Overall Study|Withdrawal by Subject|2|||
48695361|NCT04228783|156732237|FG005|Overall Study|Withdrawal by Subject|0|||
48695362|NCT04228783|156732232|FG000|Overall Study|Other|4|||
48695363|NCT04228783|156732233|FG001|Overall Study|Other|3|||
48695364|NCT04228783|156732234|FG002|Overall Study|Other|2|||
48695365|NCT04228783|156732235|FG003|Overall Study|Other|1|||
48695366|NCT04228783|156732236|FG004|Overall Study|Other|0|||
48695367|NCT04228783|156732237|FG005|Overall Study|Other|0|||
48695368|NCT03253679|156732238|FG000|Overall Study|Screen Failure|1|||
48695369|NCT03341299|156732240|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
48695370|NCT03341299|156732241|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
48695371|NCT03341299|156732242|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
48695372|NCT03341299|156732243|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
48695373|NCT00107653|156732244|FG000|Overall Study|Adverse Event|24|||
48695374|NCT00107653|156732245|FG001|Overall Study|Adverse Event|43|||
48695375|NCT00107653|156732244|FG000|Overall Study|Insufficient Therapeutic Response|25|||
48695376|NCT00107653|156732245|FG001|Overall Study|Insufficient Therapeutic Response|11|||
48695377|NCT00107653|156732244|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48695378|NCT00107653|156732245|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48695379|NCT00107653|156732244|FG000|Overall Study|Protocol Violation|1|||
48695380|NCT00107653|156732245|FG001|Overall Study|Protocol Violation|0|||
48695381|NCT00107653|156732244|FG000|Overall Study|Withdrawal by Subject|12|||
48695382|NCT00107653|156732245|FG001|Overall Study|Withdrawal by Subject|13|||
48695383|NCT00107653|156732244|FG000|Overall Study|Lost to Follow-up|13|||
48695384|NCT00107653|156732245|FG001|Overall Study|Lost to Follow-up|5|||
48695385|NCT00107653|156732244|FG000|Overall Study|Administrative Reasons|3|||
48695386|NCT00107653|156732245|FG001|Overall Study|Administrative Reasons|3|||
48695387|NCT03913442|156732247|FG000|Overall Study|Adverse Event|0|||
48695388|NCT03913442|156732248|FG001|Overall Study|Adverse Event|3|||
48695389|NCT03913442|156732247|FG000|Overall Study|Withdrawal by Subject|5|||
48695390|NCT03913442|156732248|FG001|Overall Study|Withdrawal by Subject|5|||
48695391|NCT03913442|156732247|FG000|Overall Study|Terminations|2|||
48695392|NCT03913442|156732248|FG001|Overall Study|Terminations|1|||
48695393|NCT03913442|156732247|FG000|Overall Study|Lost to Follow-up|2|||
48695394|NCT03913442|156732248|FG001|Overall Study|Lost to Follow-up|2|||
48695395|NCT00844844|156732252|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
48695396|NCT00844844|156732252|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
48695397|NCT00844844|156732252|FG000|Extension Treatment Period|Adverse Event|2|||
48695398|NCT00844844|156732252|FG000|Post Treatment Period|Withdrawal by Subject|1|||
48695399|NCT02619682|156732253|FG000|Overall Study|Withdrawal by Subject|3|||
48695400|NCT02619682|156732253|FG000|Overall Study|Lack of Efficacy|8|||
48695401|NCT02619682|156732253|FG000|Overall Study|new secondary cancer|1|||
48695402|NCT02619682|156732253|FG000|Overall Study|post surgery complications|2|||
48695403|NCT02780700|156732254|FG000|Overall Study|Progressive disease|1|||
48695404|NCT04453202|156732255|FG000|Overall Study|Adverse Event|0|||
48695405|NCT04453202|156732256|FG001|Overall Study|Adverse Event|0|||
48695406|NCT04453202|156732257|FG002|Overall Study|Adverse Event|0|||
48695407|NCT04453202|156732258|FG003|Overall Study|Adverse Event|0|||
48695408|NCT04453202|156732259|FG004|Overall Study|Adverse Event|0|||
48695409|NCT04453202|156732260|FG005|Overall Study|Adverse Event|0|||
48695410|NCT04453202|156732261|FG006|Overall Study|Adverse Event|1|||
48695411|NCT04453202|156732262|FG007|Overall Study|Adverse Event|0|||
48695412|NCT04453202|156732263|FG008|Overall Study|Adverse Event|0|||
48695413|NCT04453202|156732264|FG009|Overall Study|Adverse Event|0|||
48695414|NCT04453202|156732265|FG010|Overall Study|Adverse Event|0|||
48695415|NCT04453202|156732255|FG000|Overall Study|Death|0|||
48695416|NCT04453202|156732256|FG001|Overall Study|Death|0|||
48695417|NCT04453202|156732257|FG002|Overall Study|Death|0|||
48695418|NCT04453202|156732258|FG003|Overall Study|Death|0|||
48695419|NCT04453202|156732259|FG004|Overall Study|Death|0|||
48695420|NCT04453202|156732260|FG005|Overall Study|Death|0|||
48695421|NCT04453202|156732261|FG006|Overall Study|Death|0|||
48695422|NCT04453202|156732262|FG007|Overall Study|Death|0|||
48695423|NCT04453202|156732263|FG008|Overall Study|Death|0|||
48695424|NCT04453202|156732264|FG009|Overall Study|Death|1|||
48695425|NCT04453202|156732265|FG010|Overall Study|Death|0|||
48695426|NCT04453202|156732255|FG000|Overall Study|Lost to Follow-up|0|||
48695427|NCT04453202|156732256|FG001|Overall Study|Lost to Follow-up|1|||
48695428|NCT04453202|156732257|FG002|Overall Study|Lost to Follow-up|0|||
48695429|NCT04453202|156732258|FG003|Overall Study|Lost to Follow-up|1|||
48695430|NCT04453202|156732259|FG004|Overall Study|Lost to Follow-up|0|||
48695431|NCT04453202|156732260|FG005|Overall Study|Lost to Follow-up|0|||
48695432|NCT04453202|156732261|FG006|Overall Study|Lost to Follow-up|0|||
48695433|NCT04453202|156732262|FG007|Overall Study|Lost to Follow-up|0|||
48695434|NCT04453202|156732263|FG008|Overall Study|Lost to Follow-up|0|||
48695435|NCT04453202|156732264|FG009|Overall Study|Lost to Follow-up|1|||
48695436|NCT04453202|156732265|FG010|Overall Study|Lost to Follow-up|1|||
48695437|NCT04453202|156732255|FG000|Overall Study|Withdrawal by Subject|1|||
48695438|NCT04453202|156732256|FG001|Overall Study|Withdrawal by Subject|2|||
48695439|NCT04453202|156732257|FG002|Overall Study|Withdrawal by Subject|1|||
48695440|NCT04453202|156732258|FG003|Overall Study|Withdrawal by Subject|2|||
48695441|NCT04453202|156732259|FG004|Overall Study|Withdrawal by Subject|1|||
48695442|NCT04453202|156732260|FG005|Overall Study|Withdrawal by Subject|1|||
48695443|NCT04453202|156732261|FG006|Overall Study|Withdrawal by Subject|0|||
48695444|NCT04453202|156732262|FG007|Overall Study|Withdrawal by Subject|0|||
48695445|NCT04453202|156732263|FG008|Overall Study|Withdrawal by Subject|0|||
48695446|NCT04453202|156732264|FG009|Overall Study|Withdrawal by Subject|1|||
48695447|NCT04453202|156732265|FG010|Overall Study|Withdrawal by Subject|0|||
48695448|NCT04453202|156732255|FG000|Overall Study|Adverse Event|0|||
48695449|NCT04453202|156732256|FG001|Overall Study|Adverse Event|0|||
48695450|NCT04453202|156732257|FG002|Overall Study|Adverse Event|0|||
48695451|NCT04453202|156732258|FG003|Overall Study|Adverse Event|0|||
48695452|NCT04453202|156732259|FG004|Overall Study|Adverse Event|0|||
48695453|NCT04453202|156732260|FG005|Overall Study|Adverse Event|1|||
48695454|NCT04453202|156732261|FG006|Overall Study|Adverse Event|0|||
48695455|NCT04453202|156732262|FG007|Overall Study|Adverse Event|0|||
48695456|NCT04453202|156732263|FG008|Overall Study|Adverse Event|0|||
48695457|NCT04453202|156732264|FG009|Overall Study|Adverse Event|0|||
48695458|NCT04453202|156732265|FG010|Overall Study|Adverse Event|0|||
48695459|NCT03201965|156732268|FG000|Overall Study|Death|5|||
48695460|NCT03201965|156732269|FG001|Overall Study|Death|27|||
48695461|NCT03201965|156732270|FG002|Overall Study|Death|27|||
48695462|NCT03201965|156732268|FG000|Overall Study|Lost to Follow-up|0|||
48695463|NCT03201965|156732269|FG001|Overall Study|Lost to Follow-up|1|||
48695464|NCT03201965|156732270|FG002|Overall Study|Lost to Follow-up|0|||
48695465|NCT03201965|156732268|FG000|Overall Study|Withdrawal by Subject|3|||
48695466|NCT03201965|156732269|FG001|Overall Study|Withdrawal by Subject|13|||
48695467|NCT03201965|156732270|FG002|Overall Study|Withdrawal by Subject|4|||
48695468|NCT03201965|156732268|FG000|Overall Study|Ongoing|20|||
48695469|NCT03201965|156732269|FG001|Overall Study|Ongoing|152|||
48695470|NCT03201965|156732270|FG002|Overall Study|Ongoing|164|||
48695471|NCT05533190|156732271|FG000|Overall Study|Lost to Follow-up|19|||
48695472|NCT05533190|156732272|FG001|Overall Study|Lost to Follow-up|7|||
48695473|NCT05533190|156732271|FG000|Overall Study|Failed to download app|1|||
48695474|NCT05533190|156732272|FG001|Overall Study|Failed to download app|0|||
48695475|NCT05533190|156732271|FG000|Overall Study|Thought app was a scam|1|||
48695476|NCT05533190|156732272|FG001|Overall Study|Thought app was a scam|0|||
48695477|NCT05533190|156732271|FG000|Overall Study|Withdrawal by Subject|2|||
48695478|NCT05533190|156732272|FG001|Overall Study|Withdrawal by Subject|0|||
48695479|NCT02477696|156732276|FG000|Overall Study|Death|89|||
48695480|NCT02477696|156732277|FG001|Overall Study|Death|106|||
48695481|NCT02477696|156732276|FG000|Overall Study|Lost to Follow-up|7|||
48695482|NCT02477696|156732277|FG001|Overall Study|Lost to Follow-up|5|||
48695483|NCT02477696|156732276|FG000|Overall Study|Withdrawal by Subject|37|||
48695484|NCT02477696|156732277|FG001|Overall Study|Withdrawal by Subject|34|||
48695485|NCT02477696|156732276|FG000|Overall Study|Physician Decision|7|||
48695486|NCT02477696|156732277|FG001|Overall Study|Physician Decision|9|||
48695487|NCT02477696|156732276|FG000|Overall Study|Study terminated by sponsor|103|||
48487701|NCT00185211|155979055|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
48695488|NCT02477696|156732277|FG001|Overall Study|Study terminated by sponsor|99|||
48695489|NCT02477696|156732276|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
48695490|NCT02477696|156732277|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
48695491|NCT02477696|156732276|FG000|Overall Study|Missing/Unknown|2|||
48695492|NCT02477696|156732277|FG001|Overall Study|Missing/Unknown|0|||
48695493|NCT03633396|156733689|FG000|Overall Study|Withdrawal by Subject|4|||
48695494|NCT03633396|156733690|FG001|Overall Study|Withdrawal by Subject|4|||
48695495|NCT03633396|156733689|FG000|Overall Study|Adverse Event|1|||
48695496|NCT03633396|156733690|FG001|Overall Study|Adverse Event|1|||
48695497|NCT03633396|156733689|FG000|Overall Study|Lack of Efficacy|1|||
48695498|NCT03633396|156733690|FG001|Overall Study|Lack of Efficacy|0|||
48695499|NCT03633396|156733689|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
48695500|NCT03633396|156733690|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
48695501|NCT03224130|156733691|FG000|Overall Study|consent issue|0|||
48695502|NCT03224130|156733692|FG001|Overall Study|consent issue|1|||
48695503|NCT01690052|156733693|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
48695504|NCT01690052|156733694|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
48695505|NCT02421172|156733695|FG000|Period 1|Adverse Event|1|||
48695506|NCT02421172|156733696|FG001|Period 1|Adverse Event|0|||
48695507|NCT02421172|156733697|FG002|Period 1|Adverse Event|0|||
48695508|NCT02421172|156733698|FG003|Period 1|Adverse Event|0|||
48695509|NCT02421172|156733699|FG004|Period 1|Adverse Event|0|||
48695510|NCT02421172|156733695|FG000|Period 1|Lost to Follow-up|3|||
48695511|NCT02421172|156733696|FG001|Period 1|Lost to Follow-up|1|||
48695512|NCT02421172|156733697|FG002|Period 1|Lost to Follow-up|0|||
48695513|NCT02421172|156733698|FG003|Period 1|Lost to Follow-up|0|||
48695514|NCT02421172|156733699|FG004|Period 1|Lost to Follow-up|0|||
48695515|NCT02421172|156733695|FG000|Period 1|Patient/guardian decision|0|||
48695516|NCT02421172|156733696|FG001|Period 1|Patient/guardian decision|1|||
48695517|NCT02421172|156733697|FG002|Period 1|Patient/guardian decision|0|||
48695518|NCT02421172|156733698|FG003|Period 1|Patient/guardian decision|0|||
48695519|NCT02421172|156733699|FG004|Period 1|Patient/guardian decision|0|||
48695520|NCT02421172|156733695|FG000|Period 2|Adverse Event|0|||
48695521|NCT02421172|156733696|FG001|Period 2|Adverse Event|0|||
48695522|NCT02421172|156733697|FG002|Period 2|Adverse Event|4|||
48695523|NCT02421172|156733698|FG003|Period 2|Adverse Event|0|||
48695524|NCT02421172|156733699|FG004|Period 2|Adverse Event|0|||
48695525|NCT02421172|156733695|FG000|Period 2|Lost to Follow-up|0|||
48695526|NCT02421172|156733696|FG001|Period 2|Lost to Follow-up|0|||
48695527|NCT02421172|156733697|FG002|Period 2|Lost to Follow-up|0|||
48695528|NCT02421172|156733698|FG003|Period 2|Lost to Follow-up|1|||
48695529|NCT02421172|156733699|FG004|Period 2|Lost to Follow-up|0|||
48695530|NCT02421172|156733695|FG000|Period 2|Patient/guardian decision|0|||
48695531|NCT02421172|156733696|FG001|Period 2|Patient/guardian decision|0|||
48695532|NCT02421172|156733697|FG002|Period 2|Patient/guardian decision|3|||
48695533|NCT02421172|156733698|FG003|Period 2|Patient/guardian decision|2|||
48695534|NCT02421172|156733699|FG004|Period 2|Patient/guardian decision|1|||
48695535|NCT00882440|156733702|FG000|Overall Study|Adverse Event|2|||
48695536|NCT00882440|156733703|FG001|Overall Study|Adverse Event|2|||
48695537|NCT00882440|156733704|FG002|Overall Study|Adverse Event|2|||
48695538|NCT00882440|156733705|FG003|Overall Study|Adverse Event|1|||
48695539|NCT00882440|156733706|FG004|Overall Study|Adverse Event|1|||
48695540|NCT00882440|156733707|FG005|Overall Study|Adverse Event|4|||
48695541|NCT00882440|156733708|FG006|Overall Study|Adverse Event|2|||
48695542|NCT00882440|156733702|FG000|Overall Study|Lack of Efficacy|3|||
48695543|NCT00882440|156733703|FG001|Overall Study|Lack of Efficacy|5|||
48695544|NCT00882440|156733704|FG002|Overall Study|Lack of Efficacy|2|||
48695545|NCT00882440|156733705|FG003|Overall Study|Lack of Efficacy|0|||
48695546|NCT00882440|156733706|FG004|Overall Study|Lack of Efficacy|0|||
48695547|NCT00882440|156733707|FG005|Overall Study|Lack of Efficacy|3|||
48695548|NCT00882440|156733708|FG006|Overall Study|Lack of Efficacy|0|||
48695549|NCT00882440|156733702|FG000|Overall Study|Lost to Follow-up|2|||
48695550|NCT00882440|156733703|FG001|Overall Study|Lost to Follow-up|0|||
48695551|NCT00882440|156733704|FG002|Overall Study|Lost to Follow-up|1|||
48695552|NCT00882440|156733705|FG003|Overall Study|Lost to Follow-up|1|||
48695553|NCT00882440|156733706|FG004|Overall Study|Lost to Follow-up|1|||
48695554|NCT00882440|156733707|FG005|Overall Study|Lost to Follow-up|0|||
48695555|NCT00882440|156733708|FG006|Overall Study|Lost to Follow-up|1|||
48695556|NCT00882440|156733702|FG000|Overall Study|Protocol Violation|0|||
48695557|NCT00882440|156733703|FG001|Overall Study|Protocol Violation|0|||
48695558|NCT00882440|156733704|FG002|Overall Study|Protocol Violation|1|||
48695559|NCT00882440|156733705|FG003|Overall Study|Protocol Violation|1|||
48695560|NCT00882440|156733706|FG004|Overall Study|Protocol Violation|1|||
48695561|NCT00882440|156733707|FG005|Overall Study|Protocol Violation|0|||
48695562|NCT00882440|156733708|FG006|Overall Study|Protocol Violation|0|||
48695563|NCT00882440|156733702|FG000|Overall Study|Withdrawal by Subject|2|||
48695564|NCT00882440|156733703|FG001|Overall Study|Withdrawal by Subject|1|||
48695565|NCT00882440|156733704|FG002|Overall Study|Withdrawal by Subject|1|||
48695566|NCT00882440|156733705|FG003|Overall Study|Withdrawal by Subject|0|||
48695567|NCT00882440|156733706|FG004|Overall Study|Withdrawal by Subject|6|||
48695568|NCT00882440|156733707|FG005|Overall Study|Withdrawal by Subject|0|||
48695569|NCT00882440|156733708|FG006|Overall Study|Withdrawal by Subject|1|||
48695570|NCT00882440|156733702|FG000|Overall Study|Patient Uncooperative|2|||
48695571|NCT00882440|156733703|FG001|Overall Study|Patient Uncooperative|0|||
48695572|NCT00882440|156733704|FG002|Overall Study|Patient Uncooperative|0|||
48432080|NCT01683071|155769032|FG001|Part 1|Did not receive study drug|0|||
48695573|NCT00882440|156733705|FG003|Overall Study|Patient Uncooperative|0|||
48695574|NCT00882440|156733706|FG004|Overall Study|Patient Uncooperative|1|||
48695575|NCT00882440|156733707|FG005|Overall Study|Patient Uncooperative|0|||
48695576|NCT00882440|156733708|FG006|Overall Study|Patient Uncooperative|0|||
48695577|NCT02723773|156733717|FG000|Overall Study|Adverse Event|934|||
48695578|NCT02723773|156733718|FG001|Overall Study|Adverse Event|3|||
48695579|NCT02723773|156733719|FG002|Overall Study|Adverse Event|1|||
48695580|NCT02723773|156733720|FG003|Overall Study|Adverse Event|9|||
48695581|NCT02723773|156733717|FG000|Overall Study|Protocol Violation|1|||
48695582|NCT02723773|156733718|FG001|Overall Study|Protocol Violation|0|||
48695583|NCT02723773|156733719|FG002|Overall Study|Protocol Violation|0|||
48695584|NCT02723773|156733720|FG003|Overall Study|Protocol Violation|0|||
48695585|NCT02723773|156733717|FG000|Overall Study|Withdrawal by Subject|360|||
48695586|NCT02723773|156733718|FG001|Overall Study|Withdrawal by Subject|5|||
48695587|NCT02723773|156733719|FG002|Overall Study|Withdrawal by Subject|6|||
48695588|NCT02723773|156733720|FG003|Overall Study|Withdrawal by Subject|10|||
48695589|NCT02723773|156733717|FG000|Overall Study|Migrated/moved from study area|37|||
48695590|NCT02723773|156733718|FG001|Overall Study|Migrated/moved from study area|0|||
48695591|NCT02723773|156733719|FG002|Overall Study|Migrated/moved from study area|0|||
48695592|NCT02723773|156733720|FG003|Overall Study|Migrated/moved from study area|1|||
48695593|NCT02723773|156733717|FG000|Overall Study|Lost to Follow-up|198|||
48695594|NCT02723773|156733718|FG001|Overall Study|Lost to Follow-up|0|||
48695595|NCT02723773|156733719|FG002|Overall Study|Lost to Follow-up|0|||
48695596|NCT02723773|156733720|FG003|Overall Study|Lost to Follow-up|0|||
48695597|NCT02723773|156733717|FG000|Overall Study|Other|189|||
48695598|NCT02723773|156733718|FG001|Overall Study|Other|1|||
48695599|NCT02723773|156733719|FG002|Overall Study|Other|2|||
48695600|NCT02723773|156733720|FG003|Overall Study|Other|2|||
48695601|NCT05482308|156733724|FG000|Overall Study|Withdrawal by Subject|1|||
48695602|NCT05482308|156733725|FG001|Overall Study|Withdrawal by Subject|0|||
48695603|NCT05482308|156733724|FG000|Overall Study|No longer meets eligibility criteria|0|||
48695604|NCT05482308|156733725|FG001|Overall Study|No longer meets eligibility criteria|1|||
48695605|NCT02313766|156733727|FG000|Overall Study|surgery cancelled|1|||
48695606|NCT02313766|156733728|FG001|Overall Study|surgery cancelled|0|||
48695607|NCT02313766|156733729|FG002|Overall Study|surgery cancelled|0|||
48695608|NCT02313766|156733727|FG000|Overall Study|Lost to Follow-up|0|||
48695609|NCT02313766|156733728|FG001|Overall Study|Lost to Follow-up|2|||
48695610|NCT02313766|156733729|FG002|Overall Study|Lost to Follow-up|0|||
48695611|NCT02313766|156733727|FG000|Overall Study|Adverse Event|0|||
48695612|NCT02313766|156733728|FG001|Overall Study|Adverse Event|1|||
48695613|NCT02313766|156733729|FG002|Overall Study|Adverse Event|0|||
48695614|NCT00419393|156733730|FG000|Overall Study|Adverse Event|5|||
48695615|NCT00419393|156733730|FG000|Overall Study|Protocol Violation|5|||
48695616|NCT00419393|156733730|FG000|Overall Study|Withdrawal by Subject|7|||
48695617|NCT00419393|156733730|FG000|Overall Study|Other: Sponsor request|3|||
48695618|NCT00419393|156733730|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
48695619|NCT00419393|156733730|FG000|Overall Study|Other: Site closure|1|||
48695620|NCT00419393|156733730|FG000|Overall Study|Other: Other health problems|1|||
48695621|NCT00419393|156733730|FG000|Overall Study|Other: Investigator decision|1|||
48695622|NCT03985761|156733731|FG000|Overall Study|Withdrawal by Subject|2|||
48695623|NCT03985761|156733732|FG001|Overall Study|Withdrawal by Subject|3|||
48695624|NCT00473434|156733733|FG000|Overall Study|Physician Decision|3|||
48695625|NCT00473434|156733733|FG000|Overall Study|Withdrawal by Subject|9|||
48695626|NCT00473434|156733733|FG000|Overall Study|Compliance|3|||
48695627|NCT00473434|156733733|FG000|Overall Study|Lack of Efficacy|3|||
48695628|NCT00473434|156733733|FG000|Overall Study|Adverse Event|3|||
48695629|NCT00473434|156733733|FG000|Overall Study|Patient was selling medication to others|1|||
48695630|NCT00473434|156733733|FG000|Overall Study|Safety evaluation|1|||
48695631|NCT00473434|156733733|FG000|Overall Study|Reason not specified|6|||
48695632|NCT00473434|156733733|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
48695633|NCT00473434|156733733|FG000|Overall Study|Switching to trial medication|1|||
48695634|NCT00473434|156733733|FG000|Overall Study|No longer required|1|||
48695635|NCT02182895|156733734|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
48695636|NCT02182895|156733735|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
48695637|NCT00642356|156733738|FG000|Overall Study|Adverse Event|1|||
48695638|NCT00642356|156733739|FG001|Overall Study|Adverse Event|0|||
48695639|NCT00642356|156733738|FG000|Overall Study|Protocol Violation|0|||
48695640|NCT00642356|156733739|FG001|Overall Study|Protocol Violation|3|||
48695641|NCT00642356|156733738|FG000|Overall Study|Lack of Efficacy|1|||
48695642|NCT00642356|156733739|FG001|Overall Study|Lack of Efficacy|0|||
48695643|NCT04551989|156733744|FG000|Overall Study|Adverse Event|4|||
48695644|NCT04551989|156733744|FG000|Overall Study|Protocol Violation|3|||
48695645|NCT04551989|156733744|FG000|Overall Study|Lost to Follow-up|1|||
48432081|NCT01683071|155769033|FG002|Part 1|Did not receive study drug|0|||
48695646|NCT04551989|156733744|FG000|Overall Study|Physician Decision|3|||
48695647|NCT00265564|156733745|FG000|Overall Study|Lost to Follow-up|5|||
48695648|NCT00265564|156733746|FG001|Overall Study|Lost to Follow-up|7|||
48695649|NCT00265564|156733745|FG000|Overall Study|met exclusion criteria|5|||
48695650|NCT00265564|156733746|FG001|Overall Study|met exclusion criteria|2|||
48695651|NCT04698343|156733747|FG000|Overall Study|Withdrawal by Subject|6|||
48695652|NCT04698343|156733747|FG000|Overall Study|Physician Decision|2|||
48695653|NCT04698343|156733747|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
48695654|NCT04698343|156733747|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
48695655|NCT04698343|156733747|FG000|Overall Study|Personal reasons|3|||
48695656|NCT04698343|156733747|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
48695657|NCT02163902|156733748|FG000|Overall Study|Subject's Request|3|||
48695658|NCT02163902|156733749|FG001|Overall Study|Subject's Request|4|||
48695659|NCT02163902|156733748|FG000|Overall Study|Lost to Follow-up|6|||
48695660|NCT02163902|156733749|FG001|Overall Study|Lost to Follow-up|7|||
48695661|NCT02163902|156733748|FG000|Overall Study|Administrative Decision|2|||
48695662|NCT02163902|156733749|FG001|Overall Study|Administrative Decision|2|||
48695663|NCT04913610|156733750|FG000|Randomized Participants|Did Not Receive Treatment|0|||
48695664|NCT04913610|156733751|FG001|Randomized Participants|Did Not Receive Treatment|0|||
48695665|NCT04913610|156733752|FG002|Randomized Participants|Did Not Receive Treatment|1|||
48695666|NCT04913610|156733753|FG003|Randomized Participants|Did Not Receive Treatment|1|||
48695667|NCT04913610|156733754|FG004|Randomized Participants|Did Not Receive Treatment|0|||
48695668|NCT04913610|156733750|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
48695669|NCT04913610|156733751|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
48695670|NCT04913610|156733752|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
48695671|NCT04913610|156733753|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
48695672|NCT04913610|156733754|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
48695673|NCT02552966|156733758|FG000|Overall Study|Lost to Follow-up|2|||
48695674|NCT02552966|156733758|FG000|Overall Study|Withdrawal by Subject|3|||
48695675|NCT01476722|156733759|FG000|Overall Study|Adverse Event|1|||
48695676|NCT03261336|156733760|FG000|Overall Study|Adverse Event|1|||
48695677|NCT00771914|156733763|FG000|Overall Study|Physician Decision|0|||
48695678|NCT00771914|156733764|FG001|Overall Study|Physician Decision|0|||
48695679|NCT00771914|156733765|FG002|Overall Study|Physician Decision|0|||
48695680|NCT00771914|156733766|FG003|Overall Study|Physician Decision|1|||
48695681|NCT00771914|156733763|FG000|Overall Study|Lost to Follow-up|0|||
48695682|NCT00771914|156733764|FG001|Overall Study|Lost to Follow-up|0|||
48695683|NCT00771914|156733765|FG002|Overall Study|Lost to Follow-up|0|||
48695684|NCT00771914|156733766|FG003|Overall Study|Lost to Follow-up|1|||
48695685|NCT00918281|156733769|FG000|Overall Study|Physician Decision|29|||
48695686|NCT02978417|156733772|FG000|Overall Study|Lost to Follow-up|2|||
48695687|NCT02978417|156733773|FG001|Overall Study|Lost to Follow-up|2|||
48695688|NCT04842747|156733776|FG000|Overall Study|Withdrawal by Subject|6|||
48695689|NCT04842747|156733777|FG001|Overall Study|Withdrawal by Subject|2|||
48695690|NCT04842747|156733776|FG000|Overall Study|Lost to Follow-up|1|||
48695691|NCT04842747|156733777|FG001|Overall Study|Lost to Follow-up|2|||
48695692|NCT04842747|156733776|FG000|Overall Study|Physician Decision|1|||
48695693|NCT04842747|156733777|FG001|Overall Study|Physician Decision|0|||
48695694|NCT04842747|156733776|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
48695695|NCT04842747|156733777|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
48695696|NCT05083351|156733778|FG000|Overall Study|Adverse Event|3|||
48695697|NCT05083351|156733778|FG000|Overall Study|Did not meet data inclusion criteria|8|||
48695698|NCT05083351|156733778|FG000|Overall Study|Did not meet eligibility criteria|19|||
48695699|NCT05083351|156733778|FG000|Overall Study|Study Staff Decision|19|||
48695700|NCT01743469|156733779|FG000|Active Treatment Phase|Adverse Event|10|||
48695701|NCT01743469|156733780|FG001|Active Treatment Phase|Adverse Event|5|||
48695702|NCT01743469|156733781|FG002|Active Treatment Phase|Adverse Event|8|||
48695703|NCT01743469|156733782|FG003|Active Treatment Phase|Adverse Event|1|||
48695704|NCT01743469|156733779|FG000|Active Treatment Phase|Disease Progression|40|||
48695705|NCT01743469|156733780|FG001|Active Treatment Phase|Disease Progression|47|||
48695706|NCT01743469|156733781|FG002|Active Treatment Phase|Disease Progression|30|||
48695707|NCT01743469|156733782|FG003|Active Treatment Phase|Disease Progression|20|||
48695708|NCT01743469|156733779|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
48695709|NCT01743469|156733780|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
48695710|NCT01743469|156733781|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
48695711|NCT01743469|156733782|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
48695712|NCT01743469|156733779|FG000|Active Treatment Phase|Missing|1|||
48695713|NCT01743469|156733780|FG001|Active Treatment Phase|Missing|0|||
48695714|NCT01743469|156733781|FG002|Active Treatment Phase|Missing|0|||
48695715|NCT01743469|156733782|FG003|Active Treatment Phase|Missing|0|||
48487702|NCT00185211|155979056|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
48487703|NCT02995837|155979057|FG000|Overall Study|Lost to Follow-up|9|||
48487704|NCT02995837|155979058|FG001|Overall Study|Lost to Follow-up|8|||
48487705|NCT01859702|155979059|FG000|Overall Study|Protocol deviation|3|||
48487706|NCT01859702|155979059|FG000|Overall Study|Adverse Event|2|||
48487707|NCT01270841|155980753|FG000|Overall Study|Adverse Event|0|||
48487708|NCT01270841|155980754|FG001|Overall Study|Adverse Event|1|||
48487709|NCT01270841|155980755|FG002|Overall Study|Adverse Event|0|||
48487710|NCT01270841|155980756|FG003|Overall Study|Adverse Event|3|||
48487711|NCT01270841|155980753|FG000|Overall Study|Withdrawal by Subject|3|||
48487712|NCT01270841|155980754|FG001|Overall Study|Withdrawal by Subject|2|||
48487713|NCT01270841|155980755|FG002|Overall Study|Withdrawal by Subject|3|||
48487714|NCT01270841|155980756|FG003|Overall Study|Withdrawal by Subject|3|||
48487715|NCT01270841|155980753|FG000|Overall Study|Lost to Follow-up|3|||
48487716|NCT01270841|155980754|FG001|Overall Study|Lost to Follow-up|1|||
48487717|NCT01270841|155980755|FG002|Overall Study|Lost to Follow-up|4|||
48592492|NCT01026818|156363450|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
48592493|NCT01026818|156363451|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
48592494|NCT01026818|156363452|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
48592495|NCT01026818|156363453|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
48592496|NCT01026818|156363450|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
48592497|NCT01026818|156363451|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
48592498|NCT01026818|156363452|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
48592499|NCT01026818|156363453|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
48592500|NCT01026818|156363450|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
48592501|NCT01026818|156363451|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
48592502|NCT01026818|156363452|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
48592503|NCT01026818|156363453|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
48592504|NCT01026818|156363450|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
48592505|NCT01026818|156363451|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
48592506|NCT01026818|156363452|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
48592507|NCT01026818|156363453|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
48592508|NCT01760447|156363454|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
48592509|NCT01760447|156363455|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
48592510|NCT01760447|156363456|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
48592511|NCT01760447|156363457|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
48592512|NCT01760447|156363454|FG000|Weeks 0-20|Withdrawal by Subject|2|||
48592513|NCT01760447|156363455|FG001|Weeks 0-20|Withdrawal by Subject|0|||
48592514|NCT01760447|156363456|FG002|Weeks 0-20|Withdrawal by Subject|1|||
48592515|NCT01760447|156363457|FG003|Weeks 0-20|Withdrawal by Subject|0|||
48592516|NCT01760447|156363454|FG000|Weeks 0-20|Lost to Follow-up|1|||
48592517|NCT01760447|156363455|FG001|Weeks 0-20|Lost to Follow-up|0|||
48592518|NCT01760447|156363456|FG002|Weeks 0-20|Lost to Follow-up|1|||
48592519|NCT01760447|156363457|FG003|Weeks 0-20|Lost to Follow-up|1|||
48592520|NCT01760447|156363454|FG000|Weeks 0-20|Randomized but not treated|0|||
48592521|NCT01760447|156363455|FG001|Weeks 0-20|Randomized but not treated|0|||
48592522|NCT01760447|156363456|FG002|Weeks 0-20|Randomized but not treated|2|||
48592523|NCT01760447|156363457|FG003|Weeks 0-20|Randomized but not treated|0|||
48592524|NCT01760447|156363454|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
48592525|NCT01760447|156363455|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
48592526|NCT01760447|156363456|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
48592527|NCT01760447|156363457|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
48592528|NCT01760447|156363454|FG000|Weeks 20-54|Withdrawal by Subject|2|||
48592529|NCT01760447|156363455|FG001|Weeks 20-54|Withdrawal by Subject|1|||
48592530|NCT01760447|156363456|FG002|Weeks 20-54|Withdrawal by Subject|1|||
48592531|NCT01760447|156363457|FG003|Weeks 20-54|Withdrawal by Subject|2|||
48592532|NCT01760447|156363454|FG000|Weeks 20-54|Lost to Follow-up|0|||
48592533|NCT01760447|156363455|FG001|Weeks 20-54|Lost to Follow-up|0|||
48592534|NCT01760447|156363456|FG002|Weeks 20-54|Lost to Follow-up|1|||
48592535|NCT01760447|156363457|FG003|Weeks 20-54|Lost to Follow-up|2|||
48592536|NCT01031004|156363458|FG000|Overall Study|Protocol Violation|0|||
48592537|NCT01031004|156363459|FG001|Overall Study|Protocol Violation|1|||
48592538|NCT01031004|156363458|FG000|Overall Study|Lost to Follow-up|1|||
48592539|NCT01031004|156363459|FG001|Overall Study|Lost to Follow-up|0|||
48592540|NCT01887288|156363460|FG000|Overall Study|The study was terminated and the PI has|16|||
48592541|NCT02164318|156363461|FG000|Overall Study|Withdrawal by Subject|0|||
48592542|NCT02164318|156363462|FG001|Overall Study|Withdrawal by Subject|1|||
48592543|NCT02164318|156363463|FG002|Overall Study|Withdrawal by Subject|0|||
48592544|NCT02164318|156363464|FG003|Overall Study|Withdrawal by Subject|1|||
48592545|NCT02335346|156363465|FG000|Overall Study|Adverse Event|11|||
48592546|NCT02335346|156363465|FG000|Overall Study|Withdrawal by Subject|1|||
48592547|NCT01548768|156363466|FG000|Overall Study|Withdrawal by Subject|0|||
48592548|NCT01548768|156363467|FG001|Overall Study|Withdrawal by Subject|2|||
48592549|NCT01548768|156363468|FG002|Overall Study|Withdrawal by Subject|1|||
48592550|NCT01548768|156363469|FG003|Overall Study|Withdrawal by Subject|0|||
48695716|NCT01743469|156733779|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
48695717|NCT01743469|156733780|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
48695718|NCT01743469|156733781|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
48695719|NCT01743469|156733782|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
48695720|NCT01743469|156733779|FG000|Follow-up Period - Post-Treatment|Death|43|||
48695721|NCT01743469|156733780|FG001|Follow-up Period - Post-Treatment|Death|47|||
48695722|NCT01743469|156733781|FG002|Follow-up Period - Post-Treatment|Death|22|||
48695723|NCT01743469|156733782|FG003|Follow-up Period - Post-Treatment|Death|16|||
48695724|NCT01743469|156733779|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
48695725|NCT01743469|156733780|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
48695726|NCT01743469|156733781|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
48695727|NCT01743469|156733782|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
48695728|NCT00449696|156733791|FG000|Overall Study|Other Treatment Required|6|||
48695729|NCT00449696|156733792|FG001|Overall Study|Other Treatment Required|1|||
48695730|NCT00449696|156733791|FG000|Overall Study|Withdrawal by Subject|5|||
48695731|NCT00449696|156733792|FG001|Overall Study|Withdrawal by Subject|5|||
48695732|NCT00449696|156733791|FG000|Overall Study|Lost to Follow-up|2|||
48695733|NCT00449696|156733792|FG001|Overall Study|Lost to Follow-up|3|||
48695734|NCT00449696|156733791|FG000|Overall Study|Others|7|||
48695735|NCT00449696|156733792|FG001|Overall Study|Others|0|||
48695736|NCT02343263|156733798|FG000|Overall Study|Physician Decision|5|||
48695737|NCT02343263|156733799|FG001|Overall Study|Physician Decision|3|||
48695738|NCT02343263|156733800|FG002|Overall Study|Physician Decision|1|||
48695739|NCT01446159|156733802|FG000|Overall Study|Withdrawal by Subject|1|||
48695740|NCT01446159|156733803|FG001|Overall Study|Withdrawal by Subject|0|||
48695741|NCT01446159|156733804|FG002|Overall Study|Withdrawal by Subject|14|||
48695742|NCT01446159|156733805|FG003|Overall Study|Withdrawal by Subject|11|||
48695743|NCT01446159|156733802|FG000|Overall Study|Lost to Follow-up|0|||
48695744|NCT01446159|156733803|FG001|Overall Study|Lost to Follow-up|0|||
48695745|NCT01446159|156733804|FG002|Overall Study|Lost to Follow-up|1|||
48695746|NCT01446159|156733805|FG003|Overall Study|Lost to Follow-up|2|||
48695747|NCT01446159|156733802|FG000|Overall Study|Death|2|||
48695748|NCT01446159|156733803|FG001|Overall Study|Death|3|||
48695749|NCT01446159|156733804|FG002|Overall Study|Death|43|||
48695750|NCT01446159|156733805|FG003|Overall Study|Death|36|||
48695751|NCT01446159|156733802|FG000|Overall Study|Other|0|||
48695752|NCT01446159|156733803|FG001|Overall Study|Other|0|||
48695753|NCT01446159|156733804|FG002|Overall Study|Other|13|||
48695754|NCT01446159|156733805|FG003|Overall Study|Other|13|||
48695755|NCT00468169|156733806|FG000|Overall Study|Withdrawal by Subject|1|||
48695756|NCT00468169|156733807|FG001|Overall Study|Withdrawal by Subject|0|||
48695757|NCT02060721|156733809|FG000|Overall Study|Lost to Follow-up|1|||
48695758|NCT02060721|156733809|FG000|Overall Study|Physician Decision|2|||
48695759|NCT02060721|156733809|FG000|Overall Study|Death|14|||
48695760|NCT02060721|156733809|FG000|Overall Study|Withdrawal by Subject|2|||
48695761|NCT02060721|156733809|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
48695762|NCT05498649|156733810|FG000|Overall Study|Lost to Follow-up|1|||
48695763|NCT03597347|156733812|FG000|Overall Study|Withdrawal by Subject|1|||
48695764|NCT03597347|156733813|FG001|Overall Study|Withdrawal by Subject|1|||
48695765|NCT03597347|156733814|FG002|Overall Study|Withdrawal by Subject|0|||
48695766|NCT03597347|156733812|FG000|Overall Study|Withdrawal due to Covid-19|3|||
48695767|NCT03597347|156733813|FG001|Overall Study|Withdrawal due to Covid-19|0|||
48695768|NCT03597347|156733814|FG002|Overall Study|Withdrawal due to Covid-19|0|||
48695769|NCT03597347|156733812|FG000|Overall Study|Sponsor decision to terminate study|3|||
48695770|NCT03597347|156733813|FG001|Overall Study|Sponsor decision to terminate study|2|||
48695771|NCT03597347|156733814|FG002|Overall Study|Sponsor decision to terminate study|4|||
48695772|NCT03642873|156733815|FG000|Third Intervention (1 Day)|Screen failure|0|||
48695773|NCT03642873|156733816|FG001|Third Intervention (1 Day)|Screen failure|0|||
48695774|NCT03642873|156733817|FG002|Third Intervention (1 Day)|Screen failure|0|||
48695775|NCT03642873|156733818|FG003|Third Intervention (1 Day)|Screen failure|0|||
48695776|NCT03642873|156733819|FG004|Third Intervention (1 Day)|Screen failure|1|||
48695777|NCT03642873|156733820|FG005|Third Intervention (1 Day)|Screen failure|0|||
48695778|NCT02234843|156733821|FG000|Overall Study|Death|1|||
48695779|NCT02234843|156733822|FG001|Overall Study|Death|0|||
48695780|NCT02234843|156733823|FG002|Overall Study|Death|0|||
48695781|NCT02234843|156733824|FG003|Overall Study|Death|0|||
48695782|NCT02234843|156733825|FG004|Overall Study|Death|0|||
48695783|NCT02234843|156733826|FG005|Overall Study|Death|0|||
48695784|NCT02234843|156733827|FG006|Overall Study|Death|0|||
48695785|NCT02234843|156733828|FG007|Overall Study|Death|0|||
48695786|NCT02234843|156733829|FG008|Overall Study|Death|0|||
48695787|NCT02234843|156733830|FG009|Overall Study|Death|0|||
48695788|NCT02234843|156733821|FG000|Overall Study|Protocol Violation|1|||
48695789|NCT02234843|156733822|FG001|Overall Study|Protocol Violation|0|||
48695790|NCT02234843|156733823|FG002|Overall Study|Protocol Violation|1|||
48695791|NCT02234843|156733824|FG003|Overall Study|Protocol Violation|0|||
48695792|NCT02234843|156733825|FG004|Overall Study|Protocol Violation|0|||
48695793|NCT02234843|156733826|FG005|Overall Study|Protocol Violation|0|||
48592551|NCT01548768|156363466|FG000|Overall Study|Physician Decision|1|||
48592552|NCT01548768|156363467|FG001|Overall Study|Physician Decision|0|||
48592553|NCT01548768|156363468|FG002|Overall Study|Physician Decision|0|||
48592554|NCT01548768|156363469|FG003|Overall Study|Physician Decision|0|||
48592555|NCT01548768|156363466|FG000|Overall Study|Adverse Event|0|||
48592556|NCT01548768|156363467|FG001|Overall Study|Adverse Event|0|||
48592557|NCT01548768|156363468|FG002|Overall Study|Adverse Event|0|||
48592558|NCT01548768|156363469|FG003|Overall Study|Adverse Event|1|||
48592559|NCT01548768|156363466|FG000|Overall Study|Non-Compliance|0|||
48592560|NCT01548768|156363467|FG001|Overall Study|Non-Compliance|0|||
48592561|NCT01548768|156363468|FG002|Overall Study|Non-Compliance|0|||
48592562|NCT01548768|156363469|FG003|Overall Study|Non-Compliance|3|||
48592563|NCT00524771|156363470|FG000|Overall Study|Protocol Violation|220|||
48592564|NCT00524771|156363471|FG001|Overall Study|Protocol Violation|585|||
48592565|NCT01796301|156363474|FG000|Overall Study|Withdrawal by Subject|15|||
48592566|NCT01796301|156363475|FG001|Overall Study|Withdrawal by Subject|15|||
48592567|NCT01796301|156363474|FG000|Overall Study|Lost to Follow-up|3|||
48592568|NCT01796301|156363475|FG001|Overall Study|Lost to Follow-up|3|||
48592569|NCT01796301|156363474|FG000|Overall Study|Death|0|||
48592570|NCT01796301|156363475|FG001|Overall Study|Death|1|||
48592571|NCT01796301|156363474|FG000|Overall Study|Decision by Sponsor|0|||
48592572|NCT01796301|156363475|FG001|Overall Study|Decision by Sponsor|1|||
48592573|NCT01108237|156363476|FG000|Overall Study|No alignment data|2|||
48592574|NCT01108237|156363477|FG001|Overall Study|No alignment data|15|||
48592575|NCT01108237|156363476|FG000|Overall Study|Did not meet criteria for analysis|7|||
48592576|NCT01108237|156363477|FG001|Overall Study|Did not meet criteria for analysis|0|||
48592577|NCT03754972|156363484|FG000|Overall Study|Protocol Violation|25|||
48592578|NCT04105842|156363485|FG000|Overall Study|Withdrawal by Subject|2|||
48592579|NCT02734862|156363493|FG000|Part A|Death|3|||
48592580|NCT02734862|156363494|FG001|Part A|Death|4|||
48592581|NCT02734862|156363495|FG002|Part A|Death|6|||
48592582|NCT02734862|156363493|FG000|Part A|Lost to Follow-up|2|||
48592583|NCT02734862|156363494|FG001|Part A|Lost to Follow-up|1|||
48592584|NCT02734862|156363495|FG002|Part A|Lost to Follow-up|1|||
48592585|NCT02734862|156363493|FG000|Part A|Withdrawal by Subject|1|||
48592586|NCT02734862|156363494|FG001|Part A|Withdrawal by Subject|1|||
48592587|NCT02734862|156363495|FG002|Part A|Withdrawal by Subject|2|||
48592588|NCT02734862|156363493|FG000|Part A|Physician Decision|2|||
48592589|NCT02734862|156363494|FG001|Part A|Physician Decision|0|||
48592590|NCT02734862|156363495|FG002|Part A|Physician Decision|1|||
48592591|NCT02734862|156363493|FG000|Part A|Adverse Event|2|||
48592592|NCT02734862|156363494|FG001|Part A|Adverse Event|0|||
48592593|NCT02734862|156363495|FG002|Part A|Adverse Event|1|||
48592594|NCT02734862|156363493|FG000|Part A|Noncompliance|1|||
48592595|NCT02734862|156363494|FG001|Part A|Noncompliance|1|||
48592596|NCT02734862|156363495|FG002|Part A|Noncompliance|0|||
48592597|NCT02734862|156363493|FG000|Part A|Other|1|||
48592598|NCT02734862|156363494|FG001|Part A|Other|1|||
48592599|NCT02734862|156363495|FG002|Part A|Other|3|||
48592600|NCT02734862|156363493|FG000|Part B|Death|8|||
48592601|NCT02734862|156363494|FG001|Part B|Death|3|||
48592602|NCT02734862|156363495|FG002|Part B|Death|5|||
48592603|NCT02734862|156363493|FG000|Part B|Lost to Follow-up|2|||
48592604|NCT02734862|156363494|FG001|Part B|Lost to Follow-up|2|||
48592605|NCT02734862|156363495|FG002|Part B|Lost to Follow-up|0|||
48592606|NCT02734862|156363493|FG000|Part B|Withdrawal by Subject|3|||
48592607|NCT02734862|156363494|FG001|Part B|Withdrawal by Subject|1|||
48592608|NCT02734862|156363495|FG002|Part B|Withdrawal by Subject|0|||
48592609|NCT02734862|156363493|FG000|Part B|Other|0|||
48592610|NCT02734862|156363494|FG001|Part B|Other|1|||
48592611|NCT02734862|156363495|FG002|Part B|Other|0|||
48592612|NCT00564278|156363496|FG000|Overall Study|Lost to Follow-up|35|||
48592613|NCT00564278|156363497|FG001|Overall Study|Lost to Follow-up|33|||
48592614|NCT00564278|156363496|FG000|Overall Study|Physician Decision|1|||
48592615|NCT00564278|156363497|FG001|Overall Study|Physician Decision|2|||
48592616|NCT00564278|156363496|FG000|Overall Study|Withdrawal by Subject|11|||
48592617|NCT00564278|156363497|FG001|Overall Study|Withdrawal by Subject|7|||
48592618|NCT04854057|156363498|FG000|Overall Study|Adverse Event|0|||
48592619|NCT04854057|156363499|FG001|Overall Study|Adverse Event|1|||
48592620|NCT03519919|156363500|FG000|Overall Study|Withdrawal by Subject|1|||
48592621|NCT03519919|156363500|FG000|Overall Study|Lack of Efficacy|1|||
48592622|NCT03519919|156363500|FG000|Overall Study|Screen Failure|1|||
48592623|NCT00560703|156363501|FG000|Overall Study|Adverse Event|0|||
48592624|NCT00560703|156363502|FG001|Overall Study|Adverse Event|2|||
48592625|NCT00560703|156363501|FG000|Overall Study|Protocol Violation|0|||
48592626|NCT00560703|156363502|FG001|Overall Study|Protocol Violation|2|||
48592627|NCT00560703|156363501|FG000|Overall Study|Withdrawal by Subject|0|||
48592628|NCT00560703|156363502|FG001|Overall Study|Withdrawal by Subject|1|||
48592629|NCT00560703|156363501|FG000|Overall Study|non-compliance|0|||
48592630|NCT00560703|156363502|FG001|Overall Study|non-compliance|1|||
48592631|NCT03374488|156363503|FG000|Overall Study|Death|13|||
48592632|NCT03374488|156363504|FG001|Overall Study|Death|13|||
48592633|NCT03374488|156363503|FG000|Overall Study|Withdrawal by Subject|3|||
48592634|NCT03374488|156363504|FG001|Overall Study|Withdrawal by Subject|1|||
48695794|NCT02234843|156733827|FG006|Overall Study|Protocol Violation|0|||
48695795|NCT02234843|156733828|FG007|Overall Study|Protocol Violation|0|||
48695796|NCT02234843|156733829|FG008|Overall Study|Protocol Violation|0|||
48695797|NCT02234843|156733830|FG009|Overall Study|Protocol Violation|0|||
48695798|NCT02234843|156733821|FG000|Overall Study|Efficacy outcome reached|2|||
48695799|NCT02234843|156733822|FG001|Overall Study|Efficacy outcome reached|0|||
48695800|NCT02234843|156733823|FG002|Overall Study|Efficacy outcome reached|0|||
48695801|NCT02234843|156733824|FG003|Overall Study|Efficacy outcome reached|0|||
48695802|NCT02234843|156733825|FG004|Overall Study|Efficacy outcome reached|0|||
48695803|NCT02234843|156733826|FG005|Overall Study|Efficacy outcome reached|2|||
48695804|NCT02234843|156733827|FG006|Overall Study|Efficacy outcome reached|0|||
48695805|NCT02234843|156733828|FG007|Overall Study|Efficacy outcome reached|0|||
48695806|NCT02234843|156733829|FG008|Overall Study|Efficacy outcome reached|0|||
48695807|NCT02234843|156733830|FG009|Overall Study|Efficacy outcome reached|0|||
48695808|NCT02234843|156733821|FG000|Overall Study|Patient convenience|2|||
48695809|NCT02234843|156733822|FG001|Overall Study|Patient convenience|0|||
48695810|NCT02234843|156733823|FG002|Overall Study|Patient convenience|0|||
48695811|NCT02234843|156733824|FG003|Overall Study|Patient convenience|0|||
48695812|NCT02234843|156733825|FG004|Overall Study|Patient convenience|0|||
48695813|NCT02234843|156733826|FG005|Overall Study|Patient convenience|1|||
48695814|NCT02234843|156733827|FG006|Overall Study|Patient convenience|0|||
48695815|NCT02234843|156733828|FG007|Overall Study|Patient convenience|0|||
48695816|NCT02234843|156733829|FG008|Overall Study|Patient convenience|0|||
48695817|NCT02234843|156733830|FG009|Overall Study|Patient convenience|0|||
48695818|NCT02234843|156733821|FG000|Overall Study|Withdrawal by Subject|5|||
48695819|NCT02234843|156733822|FG001|Overall Study|Withdrawal by Subject|1|||
48695820|NCT02234843|156733823|FG002|Overall Study|Withdrawal by Subject|1|||
48695821|NCT02234843|156733824|FG003|Overall Study|Withdrawal by Subject|0|||
48695822|NCT02234843|156733825|FG004|Overall Study|Withdrawal by Subject|0|||
48695823|NCT02234843|156733826|FG005|Overall Study|Withdrawal by Subject|7|||
48695824|NCT02234843|156733827|FG006|Overall Study|Withdrawal by Subject|0|||
48695825|NCT02234843|156733828|FG007|Overall Study|Withdrawal by Subject|0|||
48695826|NCT02234843|156733829|FG008|Overall Study|Withdrawal by Subject|0|||
48695827|NCT02234843|156733830|FG009|Overall Study|Withdrawal by Subject|0|||
48695828|NCT02234843|156733821|FG000|Overall Study|Recovery|1|||
48695829|NCT02234843|156733822|FG001|Overall Study|Recovery|0|||
48695830|NCT02234843|156733823|FG002|Overall Study|Recovery|0|||
48695831|NCT02234843|156733824|FG003|Overall Study|Recovery|0|||
48695832|NCT02234843|156733825|FG004|Overall Study|Recovery|0|||
48695833|NCT02234843|156733826|FG005|Overall Study|Recovery|0|||
48695834|NCT02234843|156733827|FG006|Overall Study|Recovery|0|||
48695835|NCT02234843|156733828|FG007|Overall Study|Recovery|0|||
48695836|NCT02234843|156733829|FG008|Overall Study|Recovery|0|||
48695837|NCT02234843|156733830|FG009|Overall Study|Recovery|0|||
48695838|NCT02234843|156733821|FG000|Overall Study|Other|0|||
48695839|NCT02234843|156733822|FG001|Overall Study|Other|2|||
48695840|NCT02234843|156733823|FG002|Overall Study|Other|0|||
48695841|NCT02234843|156733824|FG003|Overall Study|Other|1|||
48695842|NCT02234843|156733825|FG004|Overall Study|Other|0|||
48695843|NCT02234843|156733826|FG005|Overall Study|Other|1|||
48695844|NCT02234843|156733827|FG006|Overall Study|Other|0|||
48695845|NCT02234843|156733828|FG007|Overall Study|Other|1|||
48695846|NCT02234843|156733829|FG008|Overall Study|Other|0|||
48695847|NCT02234843|156733830|FG009|Overall Study|Other|0|||
48695848|NCT02234843|156733821|FG000|Overall Study|Physician Decision|4|||
48695849|NCT02234843|156733822|FG001|Overall Study|Physician Decision|1|||
48695850|NCT02234843|156733823|FG002|Overall Study|Physician Decision|0|||
48695851|NCT02234843|156733824|FG003|Overall Study|Physician Decision|1|||
48695852|NCT02234843|156733825|FG004|Overall Study|Physician Decision|0|||
48695853|NCT02234843|156733826|FG005|Overall Study|Physician Decision|0|||
48695854|NCT02234843|156733827|FG006|Overall Study|Physician Decision|0|||
48695855|NCT02234843|156733828|FG007|Overall Study|Physician Decision|1|||
48695856|NCT02234843|156733829|FG008|Overall Study|Physician Decision|0|||
48695857|NCT02234843|156733830|FG009|Overall Study|Physician Decision|0|||
48695858|NCT02234843|156733821|FG000|Overall Study|Adverse Event|5|||
48695859|NCT02234843|156733822|FG001|Overall Study|Adverse Event|1|||
48695860|NCT02234843|156733823|FG002|Overall Study|Adverse Event|1|||
48695861|NCT02234843|156733824|FG003|Overall Study|Adverse Event|3|||
48695862|NCT02234843|156733825|FG004|Overall Study|Adverse Event|2|||
48695863|NCT02234843|156733826|FG005|Overall Study|Adverse Event|1|||
48695864|NCT02234843|156733827|FG006|Overall Study|Adverse Event|0|||
48695865|NCT02234843|156733828|FG007|Overall Study|Adverse Event|0|||
48695866|NCT02234843|156733829|FG008|Overall Study|Adverse Event|1|||
48695867|NCT02234843|156733830|FG009|Overall Study|Adverse Event|0|||
48695868|NCT02234843|156733821|FG000|Overall Study|Non-compliance with study drug|1|||
48695869|NCT02234843|156733822|FG001|Overall Study|Non-compliance with study drug|0|||
48695870|NCT02234843|156733823|FG002|Overall Study|Non-compliance with study drug|0|||
48695871|NCT02234843|156733824|FG003|Overall Study|Non-compliance with study drug|0|||
48695872|NCT02234843|156733825|FG004|Overall Study|Non-compliance with study drug|0|||
48695873|NCT02234843|156733826|FG005|Overall Study|Non-compliance with study drug|1|||
48695874|NCT02234843|156733827|FG006|Overall Study|Non-compliance with study drug|1|||
48695875|NCT02234843|156733828|FG007|Overall Study|Non-compliance with study drug|0|||
48695876|NCT02234843|156733829|FG008|Overall Study|Non-compliance with study drug|0|||
48695877|NCT02234843|156733830|FG009|Overall Study|Non-compliance with study drug|0|||
48695878|NCT02234843|156733821|FG000|Overall Study|Lost to Follow-up|0|||
48695879|NCT02234843|156733822|FG001|Overall Study|Lost to Follow-up|1|||
48695880|NCT02234843|156733823|FG002|Overall Study|Lost to Follow-up|0|||
48695881|NCT02234843|156733824|FG003|Overall Study|Lost to Follow-up|0|||
48695882|NCT02234843|156733825|FG004|Overall Study|Lost to Follow-up|0|||
48695883|NCT02234843|156733826|FG005|Overall Study|Lost to Follow-up|0|||
48695884|NCT02234843|156733827|FG006|Overall Study|Lost to Follow-up|1|||
48695885|NCT02234843|156733828|FG007|Overall Study|Lost to Follow-up|0|||
48695886|NCT02234843|156733829|FG008|Overall Study|Lost to Follow-up|0|||
48695887|NCT02234843|156733830|FG009|Overall Study|Lost to Follow-up|0|||
48695888|NCT03157830|156733831|FG000|Overall Study|Lost to Follow-up|1|||
48695889|NCT03157830|156733831|FG000|Overall Study|Withdrawal by Subject|1|||
48695890|NCT02078648|156733834|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
48695891|NCT02078648|156733835|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
48695892|NCT02078648|156733834|FG000|Overall Study|Adverse Event|0|||
48695893|NCT02078648|156733835|FG001|Overall Study|Adverse Event|1|||
48695894|NCT02078648|156733834|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
48695895|NCT02078648|156733835|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
48695896|NCT02078648|156733834|FG000|Overall Study|Withdrawal by Subject|3|||
48695897|NCT02078648|156733835|FG001|Overall Study|Withdrawal by Subject|1|||
48695898|NCT02078648|156733834|FG000|Overall Study|Investigator Decision|5|||
48695899|NCT02078648|156733835|FG001|Overall Study|Investigator Decision|7|||
48592635|NCT03374488|156363503|FG000|Overall Study|Physician Decision|3|||
48592636|NCT03374488|156363504|FG001|Overall Study|Physician Decision|0|||
48592637|NCT01556932|156363507|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
48432082|NCT01683071|155769034|FG003|Part 1|Did not receive study drug|1|||
48432083|NCT01683071|155769035|FG004|Part 1|Did not receive study drug|0|||
48432084|NCT01683071|155769036|FG005|Part 1|Did not receive study drug|0|||
48592638|NCT01556932|156363508|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
48592639|NCT01563913|156363510|FG000|Overall Study|Physician Decision|1|||
48592640|NCT01563913|156363511|FG001|Overall Study|Physician Decision|0|||
48592641|NCT01563913|156363510|FG000|Overall Study|Spouse Passed Away|1|||
48592642|NCT01563913|156363511|FG001|Overall Study|Spouse Passed Away|0|||
48592643|NCT03066778|156363512|FG000|Overall Study|Death|195|||
48592644|NCT03066778|156363513|FG001|Overall Study|Death|205|||
48592645|NCT03066778|156363512|FG000|Overall Study|Withdrawal by Subject|5|||
48592646|NCT03066778|156363513|FG001|Overall Study|Withdrawal by Subject|7|||
48592647|NCT03332095|156363514|FG000|Overall Study|Lost to Follow-up|1|||
48592648|NCT03332095|156363515|FG001|Overall Study|Lost to Follow-up|0|||
48592649|NCT03332095|156363514|FG000|Overall Study|Pregnancy|0|||
48592650|NCT03332095|156363515|FG001|Overall Study|Pregnancy|1|||
48592651|NCT04122625|156363516|FG000|Part A (up to 2.92 Years)|Death|2|||
48592652|NCT04122625|156363517|FG001|Part A (up to 2.92 Years)|Death|4|||
48592653|NCT04122625|156363518|FG002|Part A (up to 2.92 Years)|Death|0|||
48592654|NCT04122625|156363519|FG003|Part A (up to 2.92 Years)|Death|0|||
48592655|NCT04122625|156363520|FG004|Part A (up to 2.92 Years)|Death|0|||
48592656|NCT04122625|156363521|FG005|Part A (up to 2.92 Years)|Death|0|||
48592657|NCT04122625|156363516|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
48592658|NCT04122625|156363517|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
48592659|NCT04122625|156363518|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
48592660|NCT04122625|156363519|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
48592661|NCT04122625|156363520|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
48592662|NCT04122625|156363521|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
48592663|NCT04122625|156363516|FG000|Part B (up to 2.33 Years)|Death|0|||
48592664|NCT04122625|156363517|FG001|Part B (up to 2.33 Years)|Death|0|||
48592665|NCT04122625|156363518|FG002|Part B (up to 2.33 Years)|Death|5|||
48592666|NCT04122625|156363519|FG003|Part B (up to 2.33 Years)|Death|7|||
48592667|NCT04122625|156363520|FG004|Part B (up to 2.33 Years)|Death|6|||
48592668|NCT04122625|156363521|FG005|Part B (up to 2.33 Years)|Death|7|||
48592669|NCT01884545|156363522|FG000|Overall Study|Lost to Follow-up|6|||
48592670|NCT01884545|156363523|FG001|Overall Study|Lost to Follow-up|4|||
48592671|NCT01884545|156363524|FG002|Overall Study|Lost to Follow-up|9|||
48592672|NCT01884545|156363525|FG003|Overall Study|Lost to Follow-up|4|||
48592673|NCT01884545|156363522|FG000|Overall Study|Patient withdrawn|7|||
48592674|NCT01884545|156363523|FG001|Overall Study|Patient withdrawn|12|||
48592675|NCT01884545|156363524|FG002|Overall Study|Patient withdrawn|5|||
48592676|NCT01884545|156363525|FG003|Overall Study|Patient withdrawn|5|||
48592677|NCT01884545|156363522|FG000|Overall Study|Non-adherence|0|||
48592678|NCT01884545|156363523|FG001|Overall Study|Non-adherence|2|||
48592679|NCT01884545|156363524|FG002|Overall Study|Non-adherence|0|||
48592680|NCT01884545|156363525|FG003|Overall Study|Non-adherence|0|||
48592681|NCT02081001|156363528|FG000|Overall Study|Adverse Event|0|||
48592682|NCT02081001|156363529|FG001|Overall Study|Adverse Event|0|||
48592683|NCT02081001|156363530|FG002|Overall Study|Adverse Event|0|||
48592684|NCT02081001|156363531|FG003|Overall Study|Adverse Event|0|||
48592685|NCT02081001|156363532|FG004|Overall Study|Adverse Event|1|||
48592686|NCT02081001|156363533|FG005|Overall Study|Adverse Event|0|||
48592687|NCT02081001|156363534|FG006|Overall Study|Adverse Event|0|||
48592688|NCT02081001|156363535|FG007|Overall Study|Adverse Event|0|||
48592689|NCT02081001|156363536|FG008|Overall Study|Adverse Event|0|||
48592690|NCT02081001|156363537|FG009|Overall Study|Adverse Event|0|||
48592691|NCT02081001|156363538|FG010|Overall Study|Adverse Event|0|||
48592692|NCT02081001|156363539|FG011|Overall Study|Adverse Event|0|||
48592693|NCT03585712|156363540|FG000|Treatment Period 1|Protocol Violation|1|||
48592694|NCT03585712|156363541|FG001|Treatment Period 1|Protocol Violation|0|||
48592695|NCT03585712|156363542|FG002|Treatment Period 1|Protocol Violation|0|||
48592696|NCT03585712|156363540|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
48592697|NCT03585712|156363541|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
48592698|NCT03585712|156363542|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
48592699|NCT03585712|156363540|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
48592700|NCT03585712|156363541|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
48592701|NCT03585712|156363542|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
48592702|NCT03585712|156363540|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
48592703|NCT03585712|156363541|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
48592704|NCT03585712|156363542|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
48592705|NCT00548249|156363543|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
48592706|NCT00548249|156363544|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
48592707|NCT00548249|156363545|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
48592708|NCT00548249|156363546|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
48592709|NCT00548249|156363547|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
48592710|NCT00548249|156363543|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
48592711|NCT00548249|156363544|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
48592712|NCT00548249|156363545|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
48592713|NCT00548249|156363546|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
48592714|NCT00548249|156363547|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
48695900|NCT02078648|156733834|FG000|Overall Study|Death|1|||
48695901|NCT02078648|156733835|FG001|Overall Study|Death|1|||
48695902|NCT02078648|156733834|FG000|Overall Study|Undefined|0|||
48695903|NCT02078648|156733835|FG001|Overall Study|Undefined|1|||
48695904|NCT00633477|156735796|FG000|Overall Study|Death|1|||
48695905|NCT00633477|156735797|FG001|Overall Study|Death|0|||
48695906|NCT00633477|156735796|FG000|Overall Study|Randomized but not treated|1|||
48695907|NCT00633477|156735797|FG001|Overall Study|Randomized but not treated|0|||
48695908|NCT04906499|156735802|FG000|Overall Study|Lack of time|1|||
48695909|NCT01908426|156735803|FG000|Overall Study|Adverse Event|98|||
48695910|NCT01908426|156735804|FG001|Overall Study|Adverse Event|11|||
48695911|NCT01908426|156735803|FG000|Overall Study|Clinical Deterioration|72|||
48695912|NCT01908426|156735804|FG001|Overall Study|Clinical Deterioration|38|||
48695913|NCT01908426|156735803|FG000|Overall Study|Lack of Efficacy|3|||
48695914|NCT01908426|156735804|FG001|Overall Study|Lack of Efficacy|0|||
48695915|NCT01908426|156735803|FG000|Overall Study|Lost to Follow-up|0|||
48695916|NCT01908426|156735804|FG001|Overall Study|Lost to Follow-up|1|||
48695917|NCT01908426|156735803|FG000|Overall Study|Physician Decision|3|||
48695918|NCT01908426|156735804|FG001|Overall Study|Physician Decision|3|||
48695919|NCT01908426|156735803|FG000|Overall Study|Withdrawal by Subject|11|||
48695920|NCT01908426|156735804|FG001|Overall Study|Withdrawal by Subject|6|||
48695921|NCT01908426|156735803|FG000|Overall Study|Progressive Disease|206|||
48487718|NCT01270841|155980756|FG003|Overall Study|Lost to Follow-up|2|||
48695922|NCT01908426|156735804|FG001|Overall Study|Progressive Disease|152|||
48695923|NCT01908426|156735803|FG000|Overall Study|Protocol Violation|1|||
48695924|NCT01908426|156735804|FG001|Overall Study|Protocol Violation|0|||
48695925|NCT01908426|156735803|FG000|Overall Study|No Study Treatment Given|3|||
48695926|NCT01908426|156735804|FG001|Overall Study|No Study Treatment Given|0|||
48695927|NCT00262860|156735808|FG000|Overall Study|Adverse Event|2|||
48695928|NCT02741128|156735809|FG000|Overall Study|Protocol Violation|4|||
48695929|NCT02741128|156735810|FG001|Overall Study|Protocol Violation|1|||
48695930|NCT02741128|156735809|FG000|Overall Study|Withdrawal by Subject|2|||
48695931|NCT02741128|156735810|FG001|Overall Study|Withdrawal by Subject|0|||
48695932|NCT02741128|156735809|FG000|Overall Study|Lost to Follow-up|1|||
48695933|NCT02741128|156735810|FG001|Overall Study|Lost to Follow-up|0|||
48695934|NCT03744312|156735811|FG000|Overall Study|Withdrawal by Subject|0|||
48695935|NCT03744312|156735812|FG001|Overall Study|Withdrawal by Subject|1|||
48695936|NCT03744312|156735811|FG000|Overall Study|Screen fail|0|||
48695937|NCT03744312|156735812|FG001|Overall Study|Screen fail|1|||
48695938|NCT00445549|156735813|FG000|Overall Study|progressive disease|12|||
48695939|NCT00280917|156735823|FG000|Overall Study|Adverse Event|1|||
48695940|NCT00280917|156735824|FG001|Overall Study|Adverse Event|1|||
48695941|NCT00280917|156735825|FG002|Overall Study|Adverse Event|4|||
48695942|NCT00280917|156735826|FG003|Overall Study|Adverse Event|1|||
48695943|NCT00280917|156735823|FG000|Overall Study|Change Therapy|1|||
48695944|NCT00280917|156735824|FG001|Overall Study|Change Therapy|2|||
48695945|NCT00280917|156735825|FG002|Overall Study|Change Therapy|0|||
48695946|NCT00280917|156735826|FG003|Overall Study|Change Therapy|0|||
48695947|NCT00280917|156735823|FG000|Overall Study|Withdrawal by Subject|0|||
48695948|NCT00280917|156735824|FG001|Overall Study|Withdrawal by Subject|2|||
48695949|NCT00280917|156735825|FG002|Overall Study|Withdrawal by Subject|0|||
48695950|NCT00280917|156735826|FG003|Overall Study|Withdrawal by Subject|1|||
48695951|NCT00280917|156735823|FG000|Overall Study|Noncompliance|0|||
48695952|NCT00280917|156735824|FG001|Overall Study|Noncompliance|1|||
48695953|NCT00280917|156735825|FG002|Overall Study|Noncompliance|2|||
48695954|NCT00280917|156735826|FG003|Overall Study|Noncompliance|0|||
48695955|NCT03096834|156735827|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
48695956|NCT03096834|156735828|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
48695957|NCT03096834|156735829|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
48695958|NCT03096834|156735830|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
48695959|NCT03096834|156735827|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
48695960|NCT03096834|156735828|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
48695961|NCT03096834|156735829|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
48695962|NCT03096834|156735830|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
48695963|NCT03096834|156735827|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
48695964|NCT03096834|156735828|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
48695965|NCT03096834|156735829|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
48695966|NCT03096834|156735830|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
48695967|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
48695968|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
48695969|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
48695970|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
48695971|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
48695972|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
48695973|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
48695974|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
48695975|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
48695976|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
48695977|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
48695978|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
48695979|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
48695980|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
48695981|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
48695982|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
48695983|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
48695984|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
48695985|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
48695986|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
48695987|NCT03096834|156735827|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
48695988|NCT03096834|156735828|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
48695989|NCT03096834|156735829|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
48695990|NCT03096834|156735830|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
48695991|NCT03096834|156735827|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
48695992|NCT03096834|156735828|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
48695993|NCT03096834|156735829|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
48695994|NCT03096834|156735830|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
48695995|NCT03096834|156735827|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
48695996|NCT03096834|156735828|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
48695997|NCT03096834|156735829|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
48695998|NCT03096834|156735830|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
48695999|NCT03096834|156735827|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
48696000|NCT03096834|156735828|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
48696001|NCT03096834|156735829|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
48696002|NCT03096834|156735830|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
48696003|NCT04416204|156735835|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
48696004|NCT04416204|156735836|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
48696005|NCT04416204|156735837|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
48696006|NCT04416204|156735838|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
48696007|NCT03858049|156735839|FG000|Overall Study|Adverse Event|16|||
48696008|NCT03858049|156735840|FG001|Overall Study|Adverse Event|9|||
48696009|NCT03858049|156735839|FG000|Overall Study|Other|1|||
48696010|NCT03858049|156735840|FG001|Overall Study|Other|1|||
48696011|NCT00762359|156735841|FG000|Overall Study|Adverse Event|20|||
48696012|NCT00762359|156735842|FG001|Overall Study|Adverse Event|23|||
48696013|NCT00762359|156735841|FG000|Overall Study|Protocol Violation|21|||
48696014|NCT00762359|156735842|FG001|Overall Study|Protocol Violation|13|||
48696015|NCT00762359|156735841|FG000|Overall Study|Withdrawal by Subject|13|||
48696016|NCT00762359|156735842|FG001|Overall Study|Withdrawal by Subject|10|||
48696017|NCT00762359|156735841|FG000|Overall Study|Lack of Efficacy|0|||
48696018|NCT00762359|156735842|FG001|Overall Study|Lack of Efficacy|4|||
48696019|NCT00762359|156735841|FG000|Overall Study|Institution closed|2|||
48696020|NCT00762359|156735842|FG001|Overall Study|Institution closed|3|||
48696021|NCT00762359|156735841|FG000|Overall Study|Physician Decision|2|||
48696022|NCT00762359|156735842|FG001|Overall Study|Physician Decision|3|||
48696023|NCT00762359|156735841|FG000|Overall Study|Removal|0|||
48696024|NCT00762359|156735842|FG001|Overall Study|Removal|1|||
48696025|NCT00762359|156735841|FG000|Overall Study|Withdrew consent|1|||
48696026|NCT00762359|156735842|FG001|Overall Study|Withdrew consent|0|||
48696027|NCT03629886|156735843|FG000|Overall Study|Migrated / moved from the study area|0|||
48696028|NCT03629886|156735844|FG001|Overall Study|Migrated / moved from the study area|55|||
48696029|NCT03629886|156735843|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
48696030|NCT03629886|156735844|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
48696031|NCT03629886|156735843|FG000|Overall Study|Study vaccine not administrated|0|||
48696032|NCT03629886|156735844|FG001|Overall Study|Study vaccine not administrated|3|||
48696033|NCT03629886|156735843|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
48696034|NCT03629886|156735844|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
48696035|NCT03629886|156735843|FG000|Overall Study|Refused vaccination step of the study|0|||
48696036|NCT03629886|156735844|FG001|Overall Study|Refused vaccination step of the study|44|||
48696037|NCT00672555|156735847|FG000|Overall Study|Lost to Follow-up|4|||
48696038|NCT00672555|156735847|FG000|Overall Study|Did not want to answer questionnaire|2|||
48696039|NCT00979901|156735848|FG000|Overall Study|Adverse Event|1|||
48696040|NCT00979901|156735849|FG001|Overall Study|Adverse Event|3|||
48696041|NCT00979901|156735850|FG002|Overall Study|Adverse Event|9|||
48696042|NCT00979901|156735851|FG003|Overall Study|Adverse Event|2|||
48696043|NCT00979901|156735848|FG000|Overall Study|Lack of Efficacy|8|||
48696044|NCT00979901|156735849|FG001|Overall Study|Lack of Efficacy|4|||
48696045|NCT00979901|156735850|FG002|Overall Study|Lack of Efficacy|9|||
48696046|NCT00979901|156735851|FG003|Overall Study|Lack of Efficacy|0|||
48696047|NCT00979901|156735848|FG000|Overall Study|Lost to Follow-up|1|||
48696048|NCT00979901|156735849|FG001|Overall Study|Lost to Follow-up|1|||
48696049|NCT00979901|156735850|FG002|Overall Study|Lost to Follow-up|2|||
48696050|NCT00979901|156735851|FG003|Overall Study|Lost to Follow-up|0|||
48696051|NCT00979901|156735848|FG000|Overall Study|Protocol Violation|2|||
48696052|NCT00979901|156735849|FG001|Overall Study|Protocol Violation|2|||
48696053|NCT00979901|156735850|FG002|Overall Study|Protocol Violation|7|||
48696054|NCT00979901|156735851|FG003|Overall Study|Protocol Violation|1|||
48696055|NCT00979901|156735848|FG000|Overall Study|Withdrawal by Subject|2|||
48696056|NCT00979901|156735849|FG001|Overall Study|Withdrawal by Subject|1|||
48696057|NCT00979901|156735850|FG002|Overall Study|Withdrawal by Subject|1|||
48696058|NCT00979901|156735851|FG003|Overall Study|Withdrawal by Subject|1|||
48696059|NCT00979901|156735848|FG000|Overall Study|Noncompliance|1|||
48696060|NCT00979901|156735849|FG001|Overall Study|Noncompliance|0|||
48696061|NCT00979901|156735850|FG002|Overall Study|Noncompliance|0|||
48696062|NCT00979901|156735851|FG003|Overall Study|Noncompliance|0|||
48696063|NCT00979901|156735848|FG000|Overall Study|out-of-state|1|||
48696064|NCT00979901|156735849|FG001|Overall Study|out-of-state|0|||
48696065|NCT00979901|156735850|FG002|Overall Study|out-of-state|0|||
48696066|NCT00979901|156735851|FG003|Overall Study|out-of-state|0|||
48696067|NCT00979901|156735848|FG000|Overall Study|vacation|1|||
48696068|NCT00979901|156735849|FG001|Overall Study|vacation|0|||
48696069|NCT00979901|156735850|FG002|Overall Study|vacation|0|||
48696070|NCT00979901|156735851|FG003|Overall Study|vacation|0|||
48696071|NCT00979901|156735848|FG000|Overall Study|elevated lab values pre-randomization|1|||
48696072|NCT00979901|156735849|FG001|Overall Study|elevated lab values pre-randomization|0|||
48696073|NCT00979901|156735850|FG002|Overall Study|elevated lab values pre-randomization|0|||
48696074|NCT00979901|156735851|FG003|Overall Study|elevated lab values pre-randomization|0|||
48696075|NCT00979901|156735848|FG000|Overall Study|Discontinued in Error|0|||
48696076|NCT00979901|156735849|FG001|Overall Study|Discontinued in Error|1|||
48696077|NCT00979901|156735850|FG002|Overall Study|Discontinued in Error|0|||
48696078|NCT00979901|156735851|FG003|Overall Study|Discontinued in Error|0|||
48696079|NCT00979901|156735848|FG000|Overall Study|Left Country|0|||
48696080|NCT00979901|156735849|FG001|Overall Study|Left Country|0|||
48696081|NCT00979901|156735850|FG002|Overall Study|Left Country|1|||
48592715|NCT00548249|156363543|FG000|Overall Study|Protocol Violation|1|||
48592716|NCT00548249|156363544|FG001|Overall Study|Protocol Violation|1|||
48592717|NCT00548249|156363545|FG002|Overall Study|Protocol Violation|4|||
48592718|NCT00548249|156363546|FG003|Overall Study|Protocol Violation|0|||
48592719|NCT00548249|156363547|FG004|Overall Study|Protocol Violation|3|||
48592720|NCT00548249|156363543|FG000|Overall Study|Miscellaneous|2|||
48592721|NCT00548249|156363544|FG001|Overall Study|Miscellaneous|3|||
48592722|NCT00548249|156363545|FG002|Overall Study|Miscellaneous|2|||
48592723|NCT00548249|156363546|FG003|Overall Study|Miscellaneous|0|||
48592724|NCT00548249|156363547|FG004|Overall Study|Miscellaneous|2|||
48592725|NCT00548249|156363543|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
48592726|NCT00548249|156363544|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
48592727|NCT00548249|156363545|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
48592728|NCT00548249|156363546|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
48592729|NCT00548249|156363547|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
48592730|NCT00548249|156363543|FG000|Overall Study|Adverse Event|2|||
48592731|NCT00548249|156363544|FG001|Overall Study|Adverse Event|2|||
48592732|NCT00548249|156363545|FG002|Overall Study|Adverse Event|0|||
48592733|NCT00548249|156363546|FG003|Overall Study|Adverse Event|1|||
48592734|NCT00548249|156363547|FG004|Overall Study|Adverse Event|1|||
48592735|NCT00548249|156363543|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
48592736|NCT00548249|156363544|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
48592737|NCT00548249|156363545|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
48592738|NCT00548249|156363546|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
48592739|NCT00548249|156363547|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
48592740|NCT00548249|156363543|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
48696082|NCT00979901|156735851|FG003|Overall Study|Left Country|0|||
48696083|NCT00979901|156735848|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
48696084|NCT00979901|156735849|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
48696085|NCT00979901|156735850|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
48696086|NCT00979901|156735851|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
48696087|NCT03489863|156735852|FG000|Overall Study|Withdrawal by Subject|0|||
48696088|NCT03489863|156735853|FG001|Overall Study|Withdrawal by Subject|1|||
48696089|NCT00346216|156735856|FG000|Overall Study|Other|181|||
48696090|NCT00346216|156735857|FG001|Overall Study|Other|231|||
48696091|NCT00346216|156735858|FG002|Overall Study|Other|205|||
48696092|NCT00346216|156735856|FG000|Overall Study|No longer willing to participate|600|||
48696093|NCT00346216|156735857|FG001|Overall Study|No longer willing to participate|606|||
48696094|NCT00346216|156735858|FG002|Overall Study|No longer willing to participate|585|||
48696095|NCT00346216|156735856|FG000|Overall Study|Withdrawal by Subject|661|||
48696096|NCT00346216|156735857|FG001|Overall Study|Withdrawal by Subject|692|||
48696097|NCT00346216|156735858|FG002|Overall Study|Withdrawal by Subject|651|||
48696098|NCT00346216|156735856|FG000|Overall Study|Lost to Follow-up|611|||
48696099|NCT00346216|156735857|FG001|Overall Study|Lost to Follow-up|588|||
48696100|NCT00346216|156735858|FG002|Overall Study|Lost to Follow-up|542|||
48696101|NCT00346216|156735856|FG000|Overall Study|Physician Decision|80|||
48696102|NCT00346216|156735857|FG001|Overall Study|Physician Decision|76|||
48696103|NCT00346216|156735858|FG002|Overall Study|Physician Decision|59|||
48696104|NCT00346216|156735856|FG000|Overall Study|Does not meet entrance criteria|13|||
48696105|NCT00346216|156735857|FG001|Overall Study|Does not meet entrance criteria|10|||
48696106|NCT00346216|156735858|FG002|Overall Study|Does not meet entrance criteria|8|||
48696107|NCT00346216|156735856|FG000|Overall Study|Death|189|||
48696108|NCT00346216|156735857|FG001|Overall Study|Death|192|||
48696109|NCT00346216|156735858|FG002|Overall Study|Death|228|||
48696110|NCT00346216|156735856|FG000|Overall Study|Study terminated by sponsor|11|||
48696111|NCT00346216|156735857|FG001|Overall Study|Study terminated by sponsor|4|||
48696112|NCT00346216|156735858|FG002|Overall Study|Study terminated by sponsor|8|||
48696113|NCT00346216|156735856|FG000|Overall Study|Missing Subject Summary Status|62|||
48696114|NCT00346216|156735857|FG001|Overall Study|Missing Subject Summary Status|61|||
48696115|NCT00346216|156735858|FG002|Overall Study|Missing Subject Summary Status|62|||
48696116|NCT03284710|156735859|FG000|Overall Study|Withdrawal by Subject|1|||
48592741|NCT00548249|156363544|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
48592742|NCT00548249|156363545|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
48592743|NCT00548249|156363546|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
48592744|NCT00548249|156363547|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
48696117|NCT03284710|156735860|FG001|Overall Study|Withdrawal by Subject|0|||
48696118|NCT03284710|156735861|FG002|Overall Study|Withdrawal by Subject|1|||
48696119|NCT03284710|156735862|FG003|Overall Study|Withdrawal by Subject|6|||
48696120|NCT03284710|156735859|FG000|Overall Study|Lost to Follow-up|3|||
48696121|NCT03284710|156735860|FG001|Overall Study|Lost to Follow-up|3|||
48696122|NCT03284710|156735861|FG002|Overall Study|Lost to Follow-up|1|||
48696123|NCT03284710|156735862|FG003|Overall Study|Lost to Follow-up|0|||
48696124|NCT03284710|156735859|FG000|Overall Study|Physician Decision|1|||
48696125|NCT03284710|156735860|FG001|Overall Study|Physician Decision|0|||
48696126|NCT03284710|156735861|FG002|Overall Study|Physician Decision|0|||
48696127|NCT03284710|156735862|FG003|Overall Study|Physician Decision|0|||
48696128|NCT03284710|156735859|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
48696129|NCT03284710|156735860|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48696130|NCT03284710|156735861|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48696131|NCT03284710|156735862|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
48696132|NCT03284710|156735859|FG000|Overall Study|HIV Infection|0|||
48696133|NCT03284710|156735860|FG001|Overall Study|HIV Infection|2|||
48696134|NCT03284710|156735861|FG002|Overall Study|HIV Infection|2|||
48696135|NCT03284710|156735862|FG003|Overall Study|HIV Infection|1|||
48696136|NCT00141453|156735865|FG000|Overall Study|Protocol Violation|6|||
48696137|NCT00141453|156735866|FG001|Overall Study|Protocol Violation|5|||
48696138|NCT02656017|156735868|FG000|Overall Study|Study burden|3|||
48696139|NCT02656017|156735869|FG001|Overall Study|Study burden|3|||
48696140|NCT02656017|156735868|FG000|Overall Study|Adverse Event|2|||
48696141|NCT02656017|156735869|FG001|Overall Study|Adverse Event|1|||
48696142|NCT02656017|156735868|FG000|Overall Study|Unable/unwilling to take study medication|2|||
48696143|NCT02656017|156735869|FG001|Overall Study|Unable/unwilling to take study medication|1|||
48696144|NCT02656017|156735868|FG000|Overall Study|Began Tolvaptan|1|||
48696145|NCT02656017|156735869|FG001|Overall Study|Began Tolvaptan|1|||
48696146|NCT02656017|156735868|FG000|Overall Study|Withdrawal by Subject|1|||
48696147|NCT02656017|156735869|FG001|Overall Study|Withdrawal by Subject|0|||
48696148|NCT04245111|156735873|FG000|Overall Study|Lost to Follow-up|5|||
48696149|NCT04245111|156735874|FG001|Overall Study|Lost to Follow-up|1|||
48696150|NCT04245111|156735875|FG002|Overall Study|Lost to Follow-up|1|||
48696151|NCT03661723|156735876|FG000|Overall Study|Disease Progression|4|||
48696152|NCT03661723|156735877|FG001|Overall Study|Disease Progression|24|||
48696153|NCT03661723|156735878|FG002|Overall Study|Disease Progression|4|||
48696154|NCT03661723|156735879|FG003|Overall Study|Disease Progression|19|||
48696155|NCT03661723|156735876|FG000|Overall Study|Withdrawal by Subject|1|||
48696156|NCT03661723|156735877|FG001|Overall Study|Withdrawal by Subject|0|||
48696157|NCT03661723|156735878|FG002|Overall Study|Withdrawal by Subject|2|||
48696158|NCT03661723|156735879|FG003|Overall Study|Withdrawal by Subject|4|||
48696159|NCT03661723|156735876|FG000|Overall Study|Physician Decision|1|||
48696160|NCT03661723|156735877|FG001|Overall Study|Physician Decision|0|||
48696161|NCT03661723|156735878|FG002|Overall Study|Physician Decision|0|||
48696162|NCT03661723|156735879|FG003|Overall Study|Physician Decision|0|||
48696163|NCT03661723|156735876|FG000|Overall Study|Clinical Deterioration|0|||
48696164|NCT03661723|156735877|FG001|Overall Study|Clinical Deterioration|0|||
48696165|NCT03661723|156735878|FG002|Overall Study|Clinical Deterioration|0|||
48696166|NCT03661723|156735879|FG003|Overall Study|Clinical Deterioration|1|||
48696167|NCT03760029|156735880|FG000|Overall Study|Death|1|||
48696168|NCT03760029|156735881|FG001|Overall Study|Death|0|||
48696169|NCT03760029|156735882|FG002|Overall Study|Death|0|||
48696170|NCT03760029|156735880|FG000|Overall Study|Lost to Follow-up|0|||
48696171|NCT03760029|156735881|FG001|Overall Study|Lost to Follow-up|2|||
48696172|NCT03760029|156735882|FG002|Overall Study|Lost to Follow-up|1|||
48696173|NCT03760029|156735880|FG000|Overall Study|Withdrawal by Subject|1|||
48696174|NCT03760029|156735881|FG001|Overall Study|Withdrawal by Subject|4|||
48696175|NCT03760029|156735882|FG002|Overall Study|Withdrawal by Subject|1|||
48696176|NCT03760029|156735880|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48696177|NCT03760029|156735881|FG001|Overall Study|Withdrawal by parent/guardian|4|||
48696178|NCT03760029|156735882|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48696179|NCT03760029|156735880|FG000|Overall Study|Other|2|||
48696180|NCT03760029|156735881|FG001|Overall Study|Other|1|||
48696181|NCT03760029|156735882|FG002|Overall Study|Other|0|||
48696182|NCT05196828|156735885|FG000|Overall Study|Withdrawal by Subject|2|||
48696183|NCT05196828|156735886|FG001|Overall Study|Withdrawal by Subject|0|||
48696184|NCT05196828|156735885|FG000|Overall Study|Lost to Follow-up|0|||
48696185|NCT05196828|156735886|FG001|Overall Study|Lost to Follow-up|4|||
48696186|NCT05196828|156735885|FG000|Overall Study|Adverse Event|1|||
48696187|NCT05196828|156735886|FG001|Overall Study|Adverse Event|0|||
48696188|NCT00713609|156735887|FG000|Overall Study|Adverse Event|2|||
48696189|NCT00713609|156735888|FG001|Overall Study|Adverse Event|0|||
48696190|NCT00713609|156735889|FG002|Overall Study|Adverse Event|2|||
48696191|NCT00713609|156735890|FG003|Overall Study|Adverse Event|2|||
48696192|NCT00713609|156735891|FG004|Overall Study|Adverse Event|3|||
48696193|NCT00713609|156735892|FG005|Overall Study|Adverse Event|1|||
48592745|NCT00548249|156363543|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
48696194|NCT00713609|156735887|FG000|Overall Study|Lost to Follow-up|5|||
48696195|NCT00713609|156735888|FG001|Overall Study|Lost to Follow-up|7|||
48592746|NCT00548249|156363544|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
48592747|NCT00548249|156363545|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
48592748|NCT00548249|156363546|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
48592749|NCT00548249|156363547|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
48592750|NCT00548249|156363543|FG000|Overall Study|Prolonged hospitalization|0|||
48592751|NCT00548249|156363544|FG001|Overall Study|Prolonged hospitalization|0|||
48592752|NCT00548249|156363545|FG002|Overall Study|Prolonged hospitalization|2|||
48592753|NCT00548249|156363546|FG003|Overall Study|Prolonged hospitalization|1|||
48592754|NCT00548249|156363547|FG004|Overall Study|Prolonged hospitalization|0|||
48592755|NCT00548249|156363543|FG000|Overall Study|Withdrawal by Subject|2|||
48592756|NCT00548249|156363544|FG001|Overall Study|Withdrawal by Subject|0|||
48592757|NCT00548249|156363545|FG002|Overall Study|Withdrawal by Subject|0|||
48592758|NCT00548249|156363546|FG003|Overall Study|Withdrawal by Subject|0|||
48592759|NCT00548249|156363547|FG004|Overall Study|Withdrawal by Subject|0|||
48592760|NCT00548249|156363543|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
48592761|NCT00548249|156363544|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
48592762|NCT00548249|156363545|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
48592763|NCT00548249|156363546|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
48592764|NCT00548249|156363547|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
48592765|NCT00548249|156363543|FG000|Overall Study|Sponsor's request|0|||
48592766|NCT00548249|156363544|FG001|Overall Study|Sponsor's request|0|||
48592767|NCT00548249|156363545|FG002|Overall Study|Sponsor's request|0|||
48592768|NCT00548249|156363546|FG003|Overall Study|Sponsor's request|1|||
48592769|NCT00548249|156363547|FG004|Overall Study|Sponsor's request|0|||
48592770|NCT00849290|156363548|FG000|Overall Study|Adverse Event|3|||
48592771|NCT00849290|156363548|FG000|Overall Study|Death|14|||
48592772|NCT00849290|156363548|FG000|Overall Study|Withdrawal by Subject|11|||
48592773|NCT00849290|156363548|FG000|Overall Study|Lost to Follow-up|2|||
48592774|NCT00849290|156363548|FG000|Overall Study|Protocol Violation|5|||
48592775|NCT00849290|156363548|FG000|Overall Study|Disease Progression|20|||
48592776|NCT03853291|156363550|FG000|Overall Study|Lost to Follow-up|1|||
48592777|NCT03853291|156363551|FG001|Overall Study|Lost to Follow-up|2|||
48592778|NCT03853291|156363552|FG002|Overall Study|Lost to Follow-up|0|||
48592779|NCT03853291|156363553|FG003|Overall Study|Lost to Follow-up|0|||
48592780|NCT03853291|156363554|FG004|Overall Study|Lost to Follow-up|0|||
48592781|NCT03853291|156363555|FG005|Overall Study|Lost to Follow-up|0|||
48592782|NCT03853291|156363550|FG000|Overall Study|Determined to be ineligible|1|||
48592783|NCT03853291|156363551|FG001|Overall Study|Determined to be ineligible|1|||
48592784|NCT03853291|156363552|FG002|Overall Study|Determined to be ineligible|0|||
48592785|NCT03853291|156363553|FG003|Overall Study|Determined to be ineligible|0|||
48592786|NCT03853291|156363554|FG004|Overall Study|Determined to be ineligible|0|||
48592787|NCT03853291|156363555|FG005|Overall Study|Determined to be ineligible|0|||
48592788|NCT03131687|156363558|FG000|Overall Study|Adverse Event|0|||
48592789|NCT03131687|156363559|FG001|Overall Study|Adverse Event|1|||
48592790|NCT03131687|156363560|FG002|Overall Study|Adverse Event|0|||
48592791|NCT03131687|156363561|FG003|Overall Study|Adverse Event|1|||
48592792|NCT03131687|156363562|FG004|Overall Study|Adverse Event|2|||
48592793|NCT03131687|156363563|FG005|Overall Study|Adverse Event|2|||
48592794|NCT03131687|156363558|FG000|Overall Study|Death|1|||
48592795|NCT03131687|156363559|FG001|Overall Study|Death|0|||
48592796|NCT03131687|156363560|FG002|Overall Study|Death|0|||
48592797|NCT03131687|156363561|FG003|Overall Study|Death|0|||
48592798|NCT03131687|156363562|FG004|Overall Study|Death|0|||
48592799|NCT03131687|156363563|FG005|Overall Study|Death|0|||
48592800|NCT03131687|156363558|FG000|Overall Study|Withdrawal by Subject|3|||
48592801|NCT03131687|156363559|FG001|Overall Study|Withdrawal by Subject|3|||
48592802|NCT03131687|156363560|FG002|Overall Study|Withdrawal by Subject|3|||
48592803|NCT03131687|156363561|FG003|Overall Study|Withdrawal by Subject|1|||
48592804|NCT03131687|156363562|FG004|Overall Study|Withdrawal by Subject|2|||
48696196|NCT00713609|156735889|FG002|Overall Study|Lost to Follow-up|5|||
48487719|NCT01270841|155980753|FG000|Overall Study|Physician Decision|0|||
48592805|NCT03131687|156363563|FG005|Overall Study|Withdrawal by Subject|1|||
48592806|NCT03131687|156363558|FG000|Overall Study|Lost to Follow-up|1|||
48592807|NCT03131687|156363559|FG001|Overall Study|Lost to Follow-up|4|||
48592808|NCT03131687|156363560|FG002|Overall Study|Lost to Follow-up|0|||
48592809|NCT03131687|156363561|FG003|Overall Study|Lost to Follow-up|1|||
48592810|NCT03131687|156363562|FG004|Overall Study|Lost to Follow-up|4|||
48592811|NCT03131687|156363563|FG005|Overall Study|Lost to Follow-up|2|||
48592812|NCT03131687|156363558|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
48592813|NCT03131687|156363559|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
48592814|NCT03131687|156363560|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
48592815|NCT03131687|156363561|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
48592816|NCT03131687|156363562|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
48696197|NCT00713609|156735890|FG003|Overall Study|Lost to Follow-up|5|||
48696198|NCT00713609|156735891|FG004|Overall Study|Lost to Follow-up|7|||
48696199|NCT00713609|156735892|FG005|Overall Study|Lost to Follow-up|0|||
48696200|NCT00713609|156735887|FG000|Overall Study|Lack of Efficacy|1|||
48696201|NCT00713609|156735888|FG001|Overall Study|Lack of Efficacy|3|||
48696202|NCT00713609|156735889|FG002|Overall Study|Lack of Efficacy|0|||
48696203|NCT00713609|156735890|FG003|Overall Study|Lack of Efficacy|0|||
48696204|NCT00713609|156735891|FG004|Overall Study|Lack of Efficacy|1|||
48696205|NCT00713609|156735892|FG005|Overall Study|Lack of Efficacy|0|||
48696206|NCT00713609|156735887|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
48696207|NCT00713609|156735888|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
48696208|NCT00713609|156735889|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
48696209|NCT00713609|156735890|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
48696210|NCT00713609|156735891|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
48696211|NCT00713609|156735892|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
48696212|NCT00713609|156735887|FG000|Overall Study|Withdrawal by Subject|6|||
48696213|NCT00713609|156735888|FG001|Overall Study|Withdrawal by Subject|1|||
48696214|NCT00713609|156735889|FG002|Overall Study|Withdrawal by Subject|5|||
48696215|NCT00713609|156735890|FG003|Overall Study|Withdrawal by Subject|1|||
48696216|NCT00713609|156735891|FG004|Overall Study|Withdrawal by Subject|5|||
48696217|NCT00713609|156735892|FG005|Overall Study|Withdrawal by Subject|7|||
48696218|NCT00713609|156735887|FG000|Overall Study|Protocol Violation|6|||
48696219|NCT00713609|156735888|FG001|Overall Study|Protocol Violation|3|||
48696220|NCT00713609|156735889|FG002|Overall Study|Protocol Violation|1|||
48696221|NCT00713609|156735890|FG003|Overall Study|Protocol Violation|1|||
48696222|NCT00713609|156735891|FG004|Overall Study|Protocol Violation|2|||
48696223|NCT00713609|156735892|FG005|Overall Study|Protocol Violation|0|||
48696224|NCT00005906|156735893|FG000|Overall Study|Lack of Efficacy|3|||
48696225|NCT03267277|156735896|FG000|Overall Study|Withdrawal by Subject|1|||
48696226|NCT04038359|156735897|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
48696227|NCT04038359|156735898|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
48696228|NCT04038359|156735897|FG000|Overall Study|Death|8|||
48696229|NCT04038359|156735898|FG001|Overall Study|Death|7|||
48696230|NCT04038359|156735897|FG000|Overall Study|Lost to Follow-up|3|||
48696231|NCT04038359|156735898|FG001|Overall Study|Lost to Follow-up|0|||
48696232|NCT04038359|156735897|FG000|Overall Study|Participant Moved|1|||
48696233|NCT04038359|156735898|FG001|Overall Study|Participant Moved|0|||
48696234|NCT04038359|156735897|FG000|Overall Study|Withdrawal by Subject|4|||
48696235|NCT04038359|156735898|FG001|Overall Study|Withdrawal by Subject|3|||
48696236|NCT04038359|156735897|FG000|Overall Study|Physician Decision|3|||
48696237|NCT04038359|156735898|FG001|Overall Study|Physician Decision|2|||
48696238|NCT04038359|156735897|FG000|Overall Study|Adverse Event|0|||
48696239|NCT04038359|156735898|FG001|Overall Study|Adverse Event|2|||
48696240|NCT04038359|156735897|FG000|Overall Study|Progressive Disease|0|||
48696241|NCT04038359|156735898|FG001|Overall Study|Progressive Disease|1|||
48696242|NCT03768414|156735899|FG000|Overall Study|Adverse Event or side effects|72|||
48696243|NCT03768414|156735900|FG001|Overall Study|Adverse Event or side effects|28|||
48696244|NCT03768414|156735899|FG000|Overall Study|Refusal unrelated to adverse event|33|||
48696245|NCT03768414|156735900|FG001|Overall Study|Refusal unrelated to adverse event|33|||
48696246|NCT03768414|156735899|FG000|Overall Study|Progression/relapse|132|||
48696247|NCT03768414|156735900|FG001|Overall Study|Progression/relapse|60|||
48696248|NCT03768414|156735899|FG000|Overall Study|Death|9|||
48696249|NCT03768414|156735900|FG001|Overall Study|Death|6|||
48696250|NCT03768414|156735899|FG000|Overall Study|Other - not protocol specified|45|||
48696251|NCT03768414|156735900|FG001|Overall Study|Other - not protocol specified|18|||
48696252|NCT03768414|156735899|FG000|Overall Study|Reason under review|3|||
48696253|NCT03768414|156735900|FG001|Overall Study|Reason under review|2|||
48696254|NCT05121766|156735901|FG000|Overall Study|Covid reinfection|3|||
48696255|NCT05121766|156735902|FG001|Overall Study|Covid reinfection|0|||
48696256|NCT05121766|156735901|FG000|Overall Study|Withdrawal by Subject|3|||
48696257|NCT05121766|156735902|FG001|Overall Study|Withdrawal by Subject|1|||
48696258|NCT05121766|156735901|FG000|Overall Study|Adverse Event|2|||
48696259|NCT05121766|156735902|FG001|Overall Study|Adverse Event|4|||
48696260|NCT05121766|156735901|FG000|Overall Study|Lost to Follow-up|0|||
48696261|NCT05121766|156735902|FG001|Overall Study|Lost to Follow-up|1|||
48696262|NCT03259230|156735903|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
48696263|NCT03259230|156735904|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
48696264|NCT01033240|156735905|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
48696265|NCT01033240|156735906|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
48696266|NCT01033240|156735907|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
48696267|NCT01033240|156735905|FG000|Overall Study|Death|2|||
48696268|NCT01033240|156735906|FG001|Overall Study|Death|0|||
48696269|NCT01033240|156735907|FG002|Overall Study|Death|0|||
48696270|NCT01033240|156735905|FG000|Overall Study|Withdrew Consent|2|||
48696271|NCT01033240|156735906|FG001|Overall Study|Withdrew Consent|9|||
48696272|NCT01033240|156735907|FG002|Overall Study|Withdrew Consent|2|||
48696273|NCT01033240|156735905|FG000|Overall Study|Disease Progression|35|||
48696274|NCT01033240|156735906|FG001|Overall Study|Disease Progression|32|||
48696275|NCT01033240|156735907|FG002|Overall Study|Disease Progression|41|||
48696276|NCT01033240|156735905|FG000|Overall Study|Investigator Discretion|0|||
48696277|NCT01033240|156735906|FG001|Overall Study|Investigator Discretion|0|||
48696278|NCT01033240|156735907|FG002|Overall Study|Investigator Discretion|2|||
48696279|NCT01033240|156735905|FG000|Overall Study|Other|0|||
48696280|NCT01033240|156735906|FG001|Overall Study|Other|1|||
48696281|NCT01033240|156735907|FG002|Overall Study|Other|2|||
48696282|NCT03935126|156735908|FG000|Overall Study|Study termination by sponsor|3|||
48696283|NCT00113841|156735909|FG000|Overall Study|Disease progression|0|||
48696284|NCT00113841|156735910|FG001|Overall Study|Disease progression|2|||
48696285|NCT00113841|156735909|FG000|Overall Study|Non-compliant|1|||
48696286|NCT00113841|156735910|FG001|Overall Study|Non-compliant|0|||
48696287|NCT02520726|156735911|FG000|Overall Study|Lost to Follow-up|3|||
48696288|NCT02520726|156735912|FG001|Overall Study|Lost to Follow-up|2|||
48696289|NCT00918385|156735913|FG000|Monotherapy|Adverse Event|1|||
48696290|NCT00918385|156735914|FG001|Monotherapy|Adverse Event|6|||
48696291|NCT00918385|156735913|FG000|Monotherapy|Complicating illness|1|||
48696292|NCT00918385|156735914|FG001|Monotherapy|Complicating illness|0|||
48696293|NCT00918385|156735913|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
48696294|NCT00918385|156735914|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
48696295|NCT00918385|156735913|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
48696296|NCT00918385|156735914|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
48696297|NCT00918385|156735913|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
48696298|NCT00918385|156735914|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
48696299|NCT00918385|156735913|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
48696300|NCT00918385|156735914|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
48696301|NCT00377520|156735915|FG000|Overall Study|Ineligible (Prior radiation)|1|||
48696302|NCT00322881|156735917|FG000|Overall Study|Death|2|||
48696303|NCT00322881|156735917|FG000|Overall Study|Adverse Event|1|||
48696304|NCT00322881|156735917|FG000|Overall Study|Disease Progression|2|||
48696305|NCT03740048|156735918|FG000|Overall Study|Withdrawal by Subject|1|||
48696306|NCT03740048|156735919|FG001|Overall Study|Withdrawal by Subject|1|||
48696307|NCT03740048|156735918|FG000|Overall Study|Death|1|||
48696308|NCT03740048|156735919|FG001|Overall Study|Death|6|||
48696309|NCT03740048|156735918|FG000|Overall Study|Switched to thrice-weekly HD|2|||
48696310|NCT03740048|156735919|FG001|Overall Study|Switched to thrice-weekly HD|0|||
48696311|NCT03740048|156735918|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
48696312|NCT03740048|156735919|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
48696313|NCT03740048|156735918|FG000|Overall Study|Lost to Follow-up|0|||
48696314|NCT03740048|156735919|FG001|Overall Study|Lost to Follow-up|1|||
48696315|NCT03740048|156735918|FG000|Overall Study|Non-compliance with HD|0|||
48696316|NCT03740048|156735919|FG001|Overall Study|Non-compliance with HD|1|||
48696317|NCT00561652|156735921|FG000|Overall Study|Withdrawal by Subject|0|||
48696318|NCT00561652|156735922|FG001|Overall Study|Withdrawal by Subject|1|||
48696319|NCT00083889|156735923|FG000|Overall Study|Adverse Event|76|||
48696320|NCT00083889|156735924|FG001|Overall Study|Adverse Event|86|||
48696321|NCT00083889|156735923|FG000|Overall Study|Protocol Violation|2|||
48696322|NCT00083889|156735924|FG001|Overall Study|Protocol Violation|2|||
48696323|NCT00083889|156735923|FG000|Overall Study|Withdrawal by Subject|22|||
48696324|NCT00083889|156735924|FG001|Overall Study|Withdrawal by Subject|24|||
48696325|NCT00083889|156735923|FG000|Overall Study|Lack of Efficacy|240|||
48696326|NCT00083889|156735924|FG001|Overall Study|Lack of Efficacy|219|||
48696327|NCT00083889|156735923|FG000|Overall Study|Decision of sponsor|32|||
48696328|NCT00083889|156735924|FG001|Overall Study|Decision of sponsor|4|||
48696329|NCT00083889|156735923|FG000|Overall Study|Randomized: did not take study drug|0|||
48696330|NCT00083889|156735924|FG001|Overall Study|Randomized: did not take study drug|15|||
48696331|NCT00083889|156735923|FG000|Overall Study|Completed on marketed sunitinub|3|||
48696332|NCT00083889|156735924|FG001|Overall Study|Completed on marketed sunitinub|0|||
48696333|NCT00083889|156735923|FG000|Overall Study|Crossover to SU011248|0|||
48696334|NCT00083889|156735924|FG001|Overall Study|Crossover to SU011248|25|||
48696335|NCT00005780|156735928|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
48696336|NCT03600909|156735929|FG000|Overall Study|Not treated|0|||
48696337|NCT03600909|156735930|FG001|Overall Study|Not treated|3|||
48696338|NCT03600909|156735931|FG002|Overall Study|Not treated|0|||
48696339|NCT03309020|156735932|FG000|Overall Study|Death|1|||
48696340|NCT03309020|156735933|FG001|Overall Study|Death|0|||
48696341|NCT03309020|156735932|FG000|Overall Study|Did not undergo surgery|2|||
48696342|NCT03309020|156735933|FG001|Overall Study|Did not undergo surgery|1|||
48696343|NCT00617734|156735934|FG000|Overall Study|Withdrew Consent|2|||
48696344|NCT00617734|156735935|FG001|Overall Study|Withdrew Consent|0|||
48696345|NCT00617734|156735934|FG000|Overall Study|Adverse Event|4|||
48696346|NCT00617734|156735935|FG001|Overall Study|Adverse Event|1|||
48696347|NCT00617734|156735934|FG000|Overall Study|Protocol Violation|1|||
48696348|NCT00617734|156735935|FG001|Overall Study|Protocol Violation|0|||
48696349|NCT00617734|156735934|FG000|Overall Study|Found Ineligible After Randomization|1|||
48696350|NCT00617734|156735935|FG001|Overall Study|Found Ineligible After Randomization|4|||
48696351|NCT00617734|156735934|FG000|Overall Study|Lost to Follow-up|0|||
48696352|NCT00617734|156735935|FG001|Overall Study|Lost to Follow-up|1|||
48696353|NCT04366349|156735938|FG000|Overall Study|Withdrawal by Subject|1|||
48696354|NCT04366349|156735939|FG001|Overall Study|Withdrawal by Subject|0|||
48696355|NCT04366349|156735940|FG002|Overall Study|Withdrawal by Subject|0|||
48696356|NCT04366349|156735941|FG003|Overall Study|Withdrawal by Subject|0|||
48696357|NCT04366349|156735942|FG004|Overall Study|Withdrawal by Subject|0|||
48696358|NCT04366349|156735943|FG005|Overall Study|Withdrawal by Subject|0|||
48696359|NCT03919773|156735946|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
48696360|NCT03919773|156735947|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
48696361|NCT03919773|156735946|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
48696362|NCT03919773|156735947|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
48696363|NCT01352117|156737336|FG000|Overall Study|Death|15|||
48696364|NCT01352117|156737337|FG001|Overall Study|Death|16|||
48696365|NCT01352117|156737336|FG000|Overall Study|Withdrawal by Subject|1|||
48696366|NCT01352117|156737337|FG001|Overall Study|Withdrawal by Subject|0|||
48696367|NCT01352117|156737336|FG000|Overall Study|Lost to Follow-up|2|||
48696368|NCT01352117|156737337|FG001|Overall Study|Lost to Follow-up|7|||
48696369|NCT01352117|156737336|FG000|Overall Study|Non-adherent to study requirements|1|||
48696370|NCT01352117|156737337|FG001|Overall Study|Non-adherent to study requirements|1|||
48696371|NCT01352117|156737336|FG000|Overall Study|Did not initiate study treatment|1|||
48696372|NCT01352117|156737337|FG001|Overall Study|Did not initiate study treatment|0|||
48696373|NCT01352117|156737336|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
48696374|NCT01352117|156737337|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
48696375|NCT03737123|156737338|FG000|Study Treatment|Adverse Event|2|||
48696376|NCT03737123|156737339|FG001|Study Treatment|Adverse Event|0|||
48696377|NCT03737123|156737338|FG000|Study Treatment|Disease Progression|2|||
48696378|NCT03737123|156737339|FG001|Study Treatment|Disease Progression|0|||
48696379|NCT03737123|156737338|FG000|Study Treatment|Withdrawal by Subject|2|||
48696380|NCT03737123|156737339|FG001|Study Treatment|Withdrawal by Subject|0|||
48696381|NCT03737123|156737338|FG000|Follow up|Death|1|||
48696382|NCT03737123|156737339|FG001|Follow up|Death|0|||
48696383|NCT03737123|156737338|FG000|Follow up|Withdrawal by Subject|1|||
48696384|NCT03737123|156737339|FG001|Follow up|Withdrawal by Subject|0|||
48696385|NCT03737123|156737338|FG000|Follow up|Termination of study|4|||
48696386|NCT03737123|156737339|FG001|Follow up|Termination of study|0|||
48696387|NCT04233801|156737340|FG000|Overall Study|Other than listed|0|||
48696388|NCT04233801|156737341|FG001|Overall Study|Other than listed|0|||
48696389|NCT04233801|156737342|FG002|Overall Study|Other than listed|1|||
48696390|NCT04233801|156737340|FG000|Overall Study|Withdrawal by Subject|0|||
48696391|NCT04233801|156737341|FG001|Overall Study|Withdrawal by Subject|2|||
48696392|NCT04233801|156737342|FG002|Overall Study|Withdrawal by Subject|3|||
48696393|NCT00387881|156737343|FG000|Overall Study|Lost to Follow-up|23|||
48696394|NCT00387881|156737344|FG001|Overall Study|Lost to Follow-up|23|||
48696395|NCT00387881|156737343|FG000|Overall Study|Protocol Violation|2|||
48696396|NCT00387881|156737344|FG001|Overall Study|Protocol Violation|12|||
48696397|NCT00387881|156737343|FG000|Overall Study|Withdrawal by Subject|15|||
48696398|NCT00387881|156737344|FG001|Overall Study|Withdrawal by Subject|18|||
48696399|NCT00387881|156737343|FG000|Overall Study|Sponsor terminated Study|0|||
48696400|NCT00387881|156737344|FG001|Overall Study|Sponsor terminated Study|1|||
48696401|NCT00387881|156737343|FG000|Overall Study|Not eligible|6|||
48696402|NCT00387881|156737344|FG001|Overall Study|Not eligible|7|||
48696403|NCT00387881|156737343|FG000|Overall Study|No opportunity to treat headache|32|||
48696404|NCT00387881|156737344|FG001|Overall Study|No opportunity to treat headache|34|||
48696405|NCT00387881|156737343|FG000|Overall Study|Not otherwise specified|11|||
48696406|NCT00387881|156737344|FG001|Overall Study|Not otherwise specified|7|||
48696407|NCT03291067|156737345|FG000|Overall Study|Adverse Event|0|||
48696408|NCT03291067|156737346|FG001|Overall Study|Adverse Event|2|||
48696409|NCT03291067|156737347|FG002|Overall Study|Adverse Event|17|||
48696410|NCT03291067|156737348|FG003|Overall Study|Adverse Event|3|||
48696411|NCT03291067|156737345|FG000|Overall Study|Lost to Follow-up|2|||
48696412|NCT03291067|156737346|FG001|Overall Study|Lost to Follow-up|1|||
48696413|NCT03291067|156737347|FG002|Overall Study|Lost to Follow-up|0|||
48696414|NCT03291067|156737348|FG003|Overall Study|Lost to Follow-up|1|||
48696415|NCT03291067|156737345|FG000|Overall Study|Physician Decision|0|||
48696416|NCT03291067|156737346|FG001|Overall Study|Physician Decision|0|||
48696417|NCT03291067|156737347|FG002|Overall Study|Physician Decision|1|||
48696418|NCT03291067|156737348|FG003|Overall Study|Physician Decision|0|||
48696419|NCT03291067|156737345|FG000|Overall Study|Protocol Violation|5|||
48696420|NCT03291067|156737346|FG001|Overall Study|Protocol Violation|3|||
48696421|NCT03291067|156737347|FG002|Overall Study|Protocol Violation|4|||
48696422|NCT03291067|156737348|FG003|Overall Study|Protocol Violation|2|||
48696423|NCT03291067|156737345|FG000|Overall Study|Withdrawal by Subject|3|||
48696424|NCT03291067|156737346|FG001|Overall Study|Withdrawal by Subject|4|||
48696425|NCT03291067|156737347|FG002|Overall Study|Withdrawal by Subject|7|||
48696426|NCT03291067|156737348|FG003|Overall Study|Withdrawal by Subject|5|||
48696427|NCT03291067|156737345|FG000|Overall Study|Other|0|||
48696428|NCT03291067|156737346|FG001|Overall Study|Other|4|||
48696429|NCT03291067|156737347|FG002|Overall Study|Other|4|||
48696430|NCT03291067|156737348|FG003|Overall Study|Other|6|||
48696431|NCT05473026|156737352|FG000|Overall Study|Lost to Follow-up|5|||
48696432|NCT05473026|156737353|FG001|Overall Study|Lost to Follow-up|2|||
48696433|NCT01285401|156737356|FG000|Overall Study|Prematurely withdrawn from the study|17|||
48696434|NCT01285401|156737357|FG001|Overall Study|Prematurely withdrawn from the study|29|||
48696435|NCT00524485|156737364|FG000|Overall Study|Withdrawal by Subject|5|||
48696436|NCT01089504|156737365|FG000|Overall Study|Lost to Follow-up|1|||
48696437|NCT01089504|156737366|FG001|Overall Study|Lost to Follow-up|1|||
48696438|NCT01089504|156737365|FG000|Overall Study|Withdrawal by Subject|2|||
48696439|NCT01089504|156737366|FG001|Overall Study|Withdrawal by Subject|0|||
48696440|NCT01924845|156737367|FG000|Overall Study|Adverse Event|3|||
48696441|NCT01924845|156737367|FG000|Overall Study|Withdrawal by Subject|2|||
48696442|NCT01924845|156737367|FG000|Overall Study|Protocol Violation|1|||
48696443|NCT01009060|156737368|FG000|Overall Study|Adverse Event|1|||
48696444|NCT01009060|156737369|FG001|Overall Study|Adverse Event|2|||
48696445|NCT01009060|156737368|FG000|Overall Study|Protocol Violation|0|||
48696446|NCT01009060|156737369|FG001|Overall Study|Protocol Violation|1|||
48696447|NCT01009060|156737368|FG000|Overall Study|Lost to Follow-up|1|||
48696448|NCT01009060|156737369|FG001|Overall Study|Lost to Follow-up|0|||
48696449|NCT01009060|156737368|FG000|Overall Study|Physician Decision|1|||
48696450|NCT01009060|156737369|FG001|Overall Study|Physician Decision|1|||
48696451|NCT01009060|156737368|FG000|Overall Study|Withdrawal by Subject|1|||
48696452|NCT01009060|156737369|FG001|Overall Study|Withdrawal by Subject|1|||
48696453|NCT02587221|156737370|FG000|Overall Study|Adverse Event|3|||
48696454|NCT02587221|156737371|FG001|Overall Study|Adverse Event|3|||
48696455|NCT02587221|156737370|FG000|Overall Study|Death|33|||
48696456|NCT02587221|156737371|FG001|Overall Study|Death|34|||
48696457|NCT02587221|156737370|FG000|Overall Study|Withdrawal by Subject|66|||
48696458|NCT02587221|156737371|FG001|Overall Study|Withdrawal by Subject|61|||
48696459|NCT02587221|156737370|FG000|Overall Study|Lost to Follow-up|21|||
48696460|NCT02587221|156737371|FG001|Overall Study|Lost to Follow-up|19|||
48696461|NCT02587221|156737370|FG000|Overall Study|Protocol Violation|6|||
48696462|NCT02587221|156737371|FG001|Overall Study|Protocol Violation|5|||
48696463|NCT02587221|156737370|FG000|Overall Study|Other Reason or Unspecified|2|||
48696464|NCT02587221|156737371|FG001|Overall Study|Other Reason or Unspecified|1|||
48696465|NCT00499486|156737372|FG000|Overall Study|Withdrawal by Subject|16|||
48696466|NCT02546609|156737373|FG000|Overall Study|Withdrawal by Subject|0|||
48696467|NCT02546609|156737374|FG001|Overall Study|Withdrawal by Subject|1|||
48696468|NCT02546609|156737375|FG002|Overall Study|Withdrawal by Subject|2|||
48696469|NCT02546609|156737373|FG000|Overall Study|Adverse Event|0|||
48696470|NCT02546609|156737374|FG001|Overall Study|Adverse Event|6|||
48696471|NCT02546609|156737375|FG002|Overall Study|Adverse Event|1|||
48696472|NCT02546609|156737373|FG000|Overall Study|Protocol Violation|0|||
48696473|NCT02546609|156737374|FG001|Overall Study|Protocol Violation|1|||
48696474|NCT02546609|156737375|FG002|Overall Study|Protocol Violation|1|||
48696475|NCT02546609|156737373|FG000|Overall Study|Lost to Follow-up|2|||
48696476|NCT02546609|156737374|FG001|Overall Study|Lost to Follow-up|3|||
48696477|NCT02546609|156737375|FG002|Overall Study|Lost to Follow-up|1|||
48696478|NCT02546609|156737373|FG000|Overall Study|travel or work schedule restriction|0|||
48696479|NCT02546609|156737374|FG001|Overall Study|travel or work schedule restriction|0|||
48696480|NCT02546609|156737375|FG002|Overall Study|travel or work schedule restriction|2|||
48696481|NCT04201431|156737378|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
48696482|NCT04201431|156737379|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
48696483|NCT04201431|156737380|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
48696484|NCT05236270|156737389|FG000|Overall Study|Lost to Follow-up|3|||
48696485|NCT05236270|156737390|FG001|Overall Study|Lost to Follow-up|2|||
48696486|NCT05236270|156737391|FG002|Overall Study|Lost to Follow-up|0|||
48696487|NCT05236270|156737392|FG003|Overall Study|Lost to Follow-up|0|||
48696488|NCT05236270|156737393|FG004|Overall Study|Lost to Follow-up|2|||
48696489|NCT05236270|156737394|FG005|Overall Study|Lost to Follow-up|0|||
48696490|NCT05236270|156737395|FG006|Overall Study|Lost to Follow-up|1|||
48696491|NCT05236270|156737396|FG007|Overall Study|Lost to Follow-up|3|||
48696492|NCT03915717|156737399|FG000|Overall Study|EchoMark Not Implanted|6|||
48696493|NCT02358473|156737400|FG000|Overall Study|Disease Progession|6|||
48696494|NCT02358473|156737400|FG000|Overall Study|Adverse Event|3|||
48696495|NCT02358473|156737400|FG000|Overall Study|Withdrawal by Subject|2|||
48696496|NCT02358473|156737400|FG000|Overall Study|Physician Decision|2|||
48696497|NCT04079296|156737401|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
48696498|NCT04079296|156737402|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
48696499|NCT04079296|156737403|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
48696500|NCT04079296|156737404|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
48696501|NCT04079296|156737405|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
48696502|NCT04079296|156737401|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
48696503|NCT04079296|156737402|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
48696504|NCT04079296|156737403|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
48696505|NCT04079296|156737404|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
48696506|NCT04079296|156737405|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
48696507|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
48696508|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
48696509|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
48696510|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
48696511|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
48696512|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
48696513|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
48696514|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
48696515|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
48696516|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
48696517|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
48696518|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
48696519|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
48696520|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
48696521|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
48696522|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
48696523|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
48696524|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
48696525|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
48696526|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
48696527|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
48696528|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
48696529|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
48696530|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
48696531|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
48696532|NCT04079296|156737401|FG000|Dose Expansion Phase (168 Days)|Death|0|||
48696533|NCT04079296|156737402|FG001|Dose Expansion Phase (168 Days)|Death|0|||
48696534|NCT04079296|156737403|FG002|Dose Expansion Phase (168 Days)|Death|0|||
48696535|NCT04079296|156737404|FG003|Dose Expansion Phase (168 Days)|Death|1|||
48696536|NCT04079296|156737405|FG004|Dose Expansion Phase (168 Days)|Death|0|||
48696537|NCT02004236|156737406|FG000|Overall Study|Lack of Efficacy|0|||
48696538|NCT02004236|156737407|FG001|Overall Study|Lack of Efficacy|0|||
48696539|NCT02004236|156737408|FG002|Overall Study|Lack of Efficacy|16|||
48696540|NCT02738801|156737410|FG000|Overall Study|Adverse Event|1|||
48696541|NCT02738801|156737411|FG001|Overall Study|Adverse Event|1|||
48696542|NCT02738801|156737410|FG000|Overall Study|Withdrawal by Subject|0|||
48696543|NCT02738801|156737411|FG001|Overall Study|Withdrawal by Subject|1|||
48696544|NCT00758771|156737415|FG000|Overall Study|Withdrawal by Subject|1|||
48696545|NCT00758771|156737416|FG001|Overall Study|Withdrawal by Subject|1|||
48696546|NCT00758771|156737415|FG000|Overall Study|Did not meet eligibility criteria|2|||
48696547|NCT00758771|156737416|FG001|Overall Study|Did not meet eligibility criteria|4|||
48696548|NCT03019406|156737417|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
48696549|NCT03019406|156737418|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
48696550|NCT03019406|156737419|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
48696551|NCT03019406|156737420|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
48696552|NCT02183675|156737421|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696553|NCT02183675|156737422|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696554|NCT02183675|156737423|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696555|NCT02183675|156737424|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696556|NCT02183675|156737425|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
48696557|NCT02183675|156737426|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
48696558|NCT03337308|156737428|FG000|Overall Study|Adverse Event|2|||
48696559|NCT03337308|156737429|FG001|Overall Study|Adverse Event|3|||
48696560|NCT03337308|156737430|FG002|Overall Study|Adverse Event|3|||
48696561|NCT03337308|156737431|FG003|Overall Study|Adverse Event|1|||
48696562|NCT03337308|156737428|FG000|Overall Study|Lost to Follow-up|1|||
48696563|NCT03337308|156737429|FG001|Overall Study|Lost to Follow-up|2|||
48696564|NCT03337308|156737430|FG002|Overall Study|Lost to Follow-up|0|||
48696565|NCT03337308|156737431|FG003|Overall Study|Lost to Follow-up|0|||
48696566|NCT03337308|156737428|FG000|Overall Study|Withdrawal by Subject|2|||
48696567|NCT03337308|156737429|FG001|Overall Study|Withdrawal by Subject|1|||
48696568|NCT03337308|156737430|FG002|Overall Study|Withdrawal by Subject|2|||
48696569|NCT03337308|156737431|FG003|Overall Study|Withdrawal by Subject|1|||
48696570|NCT03337308|156737428|FG000|Overall Study|Protocol Violation|0|||
48696571|NCT03337308|156737429|FG001|Overall Study|Protocol Violation|1|||
48696572|NCT03337308|156737430|FG002|Overall Study|Protocol Violation|0|||
48696573|NCT03337308|156737431|FG003|Overall Study|Protocol Violation|0|||
48696574|NCT03043313|156737432|FG000|Overall Study|Withdrawal by Subject|5|||
48696575|NCT03043313|156737433|FG001|Overall Study|Withdrawal by Subject|1|||
48696576|NCT03043313|156737434|FG002|Overall Study|Withdrawal by Subject|1|||
48696577|NCT03043313|156737432|FG000|Overall Study|Lost to Follow-up|1|||
48696578|NCT03043313|156737433|FG001|Overall Study|Lost to Follow-up|1|||
48696579|NCT03043313|156737434|FG002|Overall Study|Lost to Follow-up|0|||
48696580|NCT03043313|156737432|FG000|Overall Study|Death|28|||
48696581|NCT03043313|156737433|FG001|Overall Study|Death|26|||
48696582|NCT03043313|156737434|FG002|Overall Study|Death|17|||
48696583|NCT03043313|156737432|FG000|Overall Study|Participation terminated by sponsor|11|||
48696584|NCT03043313|156737433|FG001|Overall Study|Participation terminated by sponsor|13|||
48696585|NCT03043313|156737434|FG002|Overall Study|Participation terminated by sponsor|13|||
48696586|NCT05064735|156737438|FG000|Overall Study|Withdrawal by Subject|7|||
48696587|NCT05064735|156737439|FG001|Overall Study|Withdrawal by Subject|8|||
48696588|NCT05064735|156737438|FG000|Overall Study|Lost to Follow-up|7|||
48696589|NCT05064735|156737439|FG001|Overall Study|Lost to Follow-up|2|||
48696590|NCT05064735|156737438|FG000|Overall Study|Physician Decision|2|||
48696591|NCT05064735|156737439|FG001|Overall Study|Physician Decision|1|||
48696592|NCT05064735|156737438|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
48696593|NCT05064735|156737439|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
48696594|NCT05064735|156737438|FG000|Overall Study|Site Closure|7|||
48696595|NCT05064735|156737439|FG001|Overall Study|Site Closure|2|||
48696596|NCT03804528|156737440|FG000|Overall Study|Time Commitment|18|||
48696597|NCT03804528|156737440|FG000|Overall Study|Health Reasons|5|||
48696598|NCT04050553|156737442|FG000|Period 1|Physician Decision|2|||
48696599|NCT04050553|156737443|FG001|Period 1|Physician Decision|2|||
48696600|NCT04050553|156737442|FG000|Period 1|Adverse Event|1|||
48696601|NCT04050553|156737443|FG001|Period 1|Adverse Event|1|||
48696602|NCT04050553|156737442|FG000|Period 1|Withdrawal by Subject|0|||
48696603|NCT04050553|156737443|FG001|Period 1|Withdrawal by Subject|1|||
48696604|NCT04050553|156737442|FG000|Wash-out|Adverse Event|0|||
48696605|NCT04050553|156737443|FG001|Wash-out|Adverse Event|1|||
48696606|NCT04050553|156737442|FG000|Wash-out|Withdrawal by Subject|0|||
48696607|NCT04050553|156737443|FG001|Wash-out|Withdrawal by Subject|1|||
48696608|NCT01535040|156737445|FG000|Overall Study|Physician Decision|0|||
48696609|NCT01535040|156737446|FG001|Overall Study|Physician Decision|1|||
48696610|NCT01535040|156737445|FG000|Overall Study|Withdrawal by Subject|13|||
48696611|NCT01535040|156737446|FG001|Overall Study|Withdrawal by Subject|10|||
48696612|NCT01535040|156737445|FG000|Overall Study|Never Started|9|||
48696613|NCT01535040|156737446|FG001|Overall Study|Never Started|4|||
48696614|NCT01535040|156737445|FG000|Overall Study|Toxicity|7|||
48696615|NCT01535040|156737446|FG001|Overall Study|Toxicity|5|||
48696616|NCT01535040|156737445|FG000|Overall Study|Multiple Reasons|1|||
48696617|NCT01535040|156737446|FG001|Overall Study|Multiple Reasons|1|||
48696618|NCT03724942|156737457|FG000|Overall Study|Adverse Event|20|||
48696619|NCT03724942|156737458|FG001|Overall Study|Adverse Event|14|||
48696620|NCT03724942|156737457|FG000|Overall Study|Lack of Efficacy|0|||
48696621|NCT03724942|156737458|FG001|Overall Study|Lack of Efficacy|1|||
48696622|NCT03724942|156737457|FG000|Overall Study|Physician Decision|5|||
48696623|NCT03724942|156737458|FG001|Overall Study|Physician Decision|2|||
48696624|NCT03724942|156737457|FG000|Overall Study|Protocol Violation|1|||
48696625|NCT03724942|156737458|FG001|Overall Study|Protocol Violation|0|||
48696626|NCT03724942|156737457|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
48696627|NCT03724942|156737458|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
48696628|NCT03724942|156737457|FG000|Overall Study|Withdrawal by Legal Representative|3|||
48696629|NCT03724942|156737458|FG001|Overall Study|Withdrawal by Legal Representative|0|||
48696630|NCT05472090|156737461|FG000|Overall Study|Adverse Event|2|||
48696631|NCT05472090|156737462|FG001|Overall Study|Adverse Event|3|||
48696632|NCT05472090|156737461|FG000|Overall Study|Lack of Efficacy|1|||
48696633|NCT05472090|156737462|FG001|Overall Study|Lack of Efficacy|0|||
48696634|NCT05472090|156737461|FG000|Overall Study|Physician Decision|1|||
48696635|NCT05472090|156737462|FG001|Overall Study|Physician Decision|0|||
48696636|NCT05472090|156737461|FG000|Overall Study|Withdrawal by Subject|2|||
48696637|NCT05472090|156737462|FG001|Overall Study|Withdrawal by Subject|0|||
48696638|NCT05472090|156737461|FG000|Overall Study|Lost to Follow-up|0|||
48696639|NCT05472090|156737462|FG001|Overall Study|Lost to Follow-up|3|||
48696640|NCT00948064|156739113|FG000|Phase I|No treatment received|1|||
48696641|NCT00948064|156739114|FG001|Phase I|No treatment received|0|||
48696642|NCT00948064|156739115|FG002|Phase I|No treatment received|0|||
48696643|NCT00948064|156739113|FG000|Phase II|Physician Decision|0|||
48696644|NCT00948064|156739114|FG001|Phase II|Physician Decision|0|||
48696645|NCT00948064|156739115|FG002|Phase II|Physician Decision|1|||
48696646|NCT00948064|156739113|FG000|Phase II|Withdrawal by Subject|0|||
48696647|NCT00948064|156739114|FG001|Phase II|Withdrawal by Subject|1|||
48696648|NCT00948064|156739115|FG002|Phase II|Withdrawal by Subject|0|||
48696649|NCT00179621|156739116|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
48696650|NCT00179621|156739117|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
48696651|NCT00179621|156739118|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
48696652|NCT00179621|156739119|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
48696653|NCT00179621|156739116|FG000|Double-Blind Period|Adverse Event|2|||
48696654|NCT00179621|156739117|FG001|Double-Blind Period|Adverse Event|7|||
48696655|NCT00179621|156739118|FG002|Double-Blind Period|Adverse Event|4|||
48696656|NCT00179621|156739119|FG003|Double-Blind Period|Adverse Event|0|||
48696657|NCT00179621|156739116|FG000|Double-Blind Period|Withdrawal by Subject|2|||
48696658|NCT00179621|156739117|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48696659|NCT00179621|156739118|FG002|Double-Blind Period|Withdrawal by Subject|3|||
48696660|NCT00179621|156739119|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48696661|NCT00179621|156739116|FG000|Double-Blind Period|Death|0|||
48696662|NCT00179621|156739117|FG001|Double-Blind Period|Death|1|||
48696663|NCT00179621|156739118|FG002|Double-Blind Period|Death|2|||
48696664|NCT00179621|156739119|FG003|Double-Blind Period|Death|0|||
48696665|NCT00179621|156739116|FG000|Double-Blind Period|Protocol Violation|1|||
48592817|NCT03131687|156363563|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
48696666|NCT00179621|156739117|FG001|Double-Blind Period|Protocol Violation|0|||
48696667|NCT00179621|156739118|FG002|Double-Blind Period|Protocol Violation|0|||
48696668|NCT00179621|156739119|FG003|Double-Blind Period|Protocol Violation|0|||
48696669|NCT00179621|156739116|FG000|Double-Blind Period|Other|0|||
48696670|NCT00179621|156739117|FG001|Double-Blind Period|Other|2|||
48696671|NCT00179621|156739118|FG002|Double-Blind Period|Other|2|||
48696672|NCT00179621|156739119|FG003|Double-Blind Period|Other|0|||
48696673|NCT00179621|156739116|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
48696674|NCT00179621|156739117|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
48696675|NCT00179621|156739118|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
48696676|NCT00179621|156739119|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
48696677|NCT00179621|156739116|FG000|Open-Label Period|Adverse Event|0|||
48696678|NCT00179621|156739117|FG001|Open-Label Period|Adverse Event|6|||
48696679|NCT00179621|156739118|FG002|Open-Label Period|Adverse Event|5|||
48696680|NCT00179621|156739119|FG003|Open-Label Period|Adverse Event|6|||
48696681|NCT00179621|156739116|FG000|Open-Label Period|Withdrawal by Subject|0|||
48696682|NCT00179621|156739117|FG001|Open-Label Period|Withdrawal by Subject|2|||
48696683|NCT00179621|156739118|FG002|Open-Label Period|Withdrawal by Subject|2|||
48696684|NCT00179621|156739119|FG003|Open-Label Period|Withdrawal by Subject|2|||
48696685|NCT00179621|156739116|FG000|Open-Label Period|Death|0|||
48696686|NCT00179621|156739117|FG001|Open-Label Period|Death|0|||
48696687|NCT00179621|156739118|FG002|Open-Label Period|Death|1|||
48696688|NCT00179621|156739119|FG003|Open-Label Period|Death|2|||
48696689|NCT00179621|156739116|FG000|Open-Label Period|Other|0|||
48696690|NCT00179621|156739117|FG001|Open-Label Period|Other|1|||
48696691|NCT00179621|156739118|FG002|Open-Label Period|Other|1|||
48696692|NCT00179621|156739119|FG003|Open-Label Period|Other|2|||
48696693|NCT01777308|156739120|FG000|Overall Study|Withdrawal by Subject|5|||
48696694|NCT01777308|156739121|FG001|Overall Study|Withdrawal by Subject|1|||
48696695|NCT01777308|156739120|FG000|Overall Study|Migrated/moved from study area|1|||
48696696|NCT01777308|156739121|FG001|Overall Study|Migrated/moved from study area|0|||
48696697|NCT01777308|156739120|FG000|Overall Study|Lost to Follow-up|7|||
48696698|NCT01777308|156739121|FG001|Overall Study|Lost to Follow-up|2|||
48696699|NCT01777308|156739120|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
48696700|NCT01777308|156739121|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
48696701|NCT00383786|156739123|FG000|Overall Study|Protocol Violation|2|||
48696702|NCT00383786|156739124|FG001|Overall Study|Protocol Violation|6|||
48696703|NCT00383786|156739123|FG000|Overall Study|Withdrawal by Subject|2|||
48696704|NCT00383786|156739124|FG001|Overall Study|Withdrawal by Subject|5|||
48696705|NCT00383786|156739123|FG000|Overall Study|Physician Decision|0|||
48696706|NCT00383786|156739124|FG001|Overall Study|Physician Decision|1|||
48696707|NCT00644423|156739126|FG000|Overall Study|Lost to Follow-up|1|||
48696708|NCT00644423|156739127|FG001|Overall Study|Lost to Follow-up|1|||
48696709|NCT00781768|156739130|FG000|Overall Study|Not transplanted.|0|||
48696710|NCT00781768|156739131|FG001|Overall Study|Not transplanted.|2|||
48696711|NCT00984256|156739132|FG000|Overall Study|Withdrawal by Subject|0|||
48696712|NCT00984256|156739133|FG001|Overall Study|Withdrawal by Subject|1|||
48696713|NCT02426580|156739134|FG000|Overall Study|Death|2|||
48696714|NCT02426580|156739135|FG001|Overall Study|Death|2|||
48696715|NCT02426580|156739134|FG000|Overall Study|Lost to Follow-up|0|||
48696716|NCT02426580|156739135|FG001|Overall Study|Lost to Follow-up|9|||
48696717|NCT02426580|156739134|FG000|Overall Study|transfer to hemodialysis|5|||
48696718|NCT02426580|156739135|FG001|Overall Study|transfer to hemodialysis|5|||
48696719|NCT02426580|156739134|FG000|Overall Study|Kidney transplant|3|||
48696720|NCT02426580|156739135|FG001|Overall Study|Kidney transplant|0|||
48696721|NCT02426580|156739134|FG000|Overall Study|Allergic to egg white|1|||
48696722|NCT02426580|156739135|FG001|Overall Study|Allergic to egg white|0|||
48696723|NCT02647281|156739148|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696724|NCT02647281|156739149|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696725|NCT02647281|156739150|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696726|NCT02647281|156739151|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696727|NCT02647281|156739152|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696728|NCT02647281|156739153|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696729|NCT02647281|156739154|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696730|NCT02647281|156739155|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
48696731|NCT02647281|156739156|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
48696732|NCT04235140|156739157|FG000|Overall Study|Adverse Event|2|||
48696733|NCT04235140|156739157|FG000|Overall Study|Lost to Follow-up|1|||
48696734|NCT04235140|156739157|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
48696735|NCT04235140|156739157|FG000|Overall Study|Commercial drug is available for participants|7|||
48696736|NCT01751061|156739161|FG000|Overall Study|Death|1|||
48696737|NCT01751061|156739162|FG001|Overall Study|Death|0|||
48696738|NCT01751061|156739161|FG000|Overall Study|patient death|5|||
48696739|NCT01751061|156739162|FG001|Overall Study|patient death|0|||
48696740|NCT01751061|156739161|FG000|Overall Study|Lost to Follow-up|40|||
48696741|NCT01751061|156739162|FG001|Overall Study|Lost to Follow-up|25|||
48696742|NCT01751061|156739161|FG000|Overall Study|patient regained decisional capacity|4|||
48696743|NCT01751061|156739162|FG001|Overall Study|patient regained decisional capacity|8|||
48696744|NCT01751061|156739161|FG000|Overall Study|Withdrawal by Subject|4|||
48696745|NCT01751061|156739162|FG001|Overall Study|Withdrawal by Subject|1|||
48696746|NCT01751061|156739161|FG000|Overall Study|Physician Decision|2|||
48696747|NCT01751061|156739162|FG001|Overall Study|Physician Decision|0|||
48696748|NCT02412306|156739163|FG000|Overall Study|Lost to Follow-up|0|||
48696749|NCT02412306|156739164|FG001|Overall Study|Lost to Follow-up|1|||
48696750|NCT02412306|156739165|FG002|Overall Study|Lost to Follow-up|0|||
48696751|NCT02412306|156739166|FG003|Overall Study|Lost to Follow-up|0|||
48696752|NCT02412306|156739167|FG004|Overall Study|Lost to Follow-up|0|||
48696753|NCT02412306|156739163|FG000|Overall Study|Withdrawal by Subject|0|||
48696754|NCT02412306|156739164|FG001|Overall Study|Withdrawal by Subject|0|||
48696755|NCT02412306|156739165|FG002|Overall Study|Withdrawal by Subject|1|||
48696756|NCT02412306|156739166|FG003|Overall Study|Withdrawal by Subject|0|||
48696757|NCT02412306|156739167|FG004|Overall Study|Withdrawal by Subject|0|||
48696758|NCT02412306|156739163|FG000|Overall Study|Death|5|||
48696759|NCT02412306|156739164|FG001|Overall Study|Death|7|||
48696760|NCT02412306|156739165|FG002|Overall Study|Death|15|||
48696761|NCT02412306|156739166|FG003|Overall Study|Death|0|||
48696762|NCT02412306|156739167|FG004|Overall Study|Death|2|||
48696763|NCT03040999|156739168|FG000|Overall Study|Lost to Follow-up|1|||
48696764|NCT03040999|156739169|FG001|Overall Study|Lost to Follow-up|0|||
48696765|NCT03040999|156739168|FG000|Overall Study|Withdrawal by Subject|7|||
48696766|NCT03040999|156739169|FG001|Overall Study|Withdrawal by Subject|12|||
48696767|NCT03040999|156739168|FG000|Overall Study|Death|128|||
48696768|NCT03040999|156739169|FG001|Overall Study|Death|138|||
48696769|NCT03040999|156739168|FG000|Overall Study|Participants Ongoing in Trial|266|||
48696770|NCT03040999|156739169|FG001|Overall Study|Participants Ongoing in Trial|252|||
48696771|NCT05131165|156739170|FG000|Overall Study|Death|1|||
48696772|NCT05131165|156739171|FG001|Overall Study|Death|1|||
48696773|NCT05131165|156739172|FG002|Overall Study|Death|0|||
48696774|NCT05131165|156739170|FG000|Overall Study|Lost to Follow-up|2|||
48696775|NCT05131165|156739171|FG001|Overall Study|Lost to Follow-up|2|||
48696776|NCT05131165|156739172|FG002|Overall Study|Lost to Follow-up|5|||
48696777|NCT05131165|156739170|FG000|Overall Study|Transferred out of clinic|1|||
48696778|NCT05131165|156739171|FG001|Overall Study|Transferred out of clinic|0|||
48696779|NCT05131165|156739172|FG002|Overall Study|Transferred out of clinic|3|||
48696780|NCT05131165|156739170|FG000|Overall Study|Dropped out|1|||
48696781|NCT05131165|156739171|FG001|Overall Study|Dropped out|2|||
48487720|NCT01270841|155980754|FG001|Overall Study|Physician Decision|1|||
48696782|NCT05131165|156739172|FG002|Overall Study|Dropped out|0|||
48696783|NCT00764699|156739173|FG000|Overall Study|PI left and study terminated|3|||
48696784|NCT00435409|156739174|FG000|Overall Study|Protocol Violation|1|||
48696785|NCT00435409|156739175|FG001|Overall Study|Protocol Violation|2|||
48696786|NCT00435409|156739176|FG002|Overall Study|Protocol Violation|0|||
48696787|NCT00435409|156739174|FG000|Overall Study|Lost to Follow-up|1|||
48696788|NCT00435409|156739175|FG001|Overall Study|Lost to Follow-up|2|||
48696789|NCT00435409|156739176|FG002|Overall Study|Lost to Follow-up|0|||
48696790|NCT00435409|156739174|FG000|Overall Study|Death|8|||
48696791|NCT00435409|156739175|FG001|Overall Study|Death|6|||
48696792|NCT00435409|156739176|FG002|Overall Study|Death|6|||
48696793|NCT00435409|156739174|FG000|Overall Study|Objective progression or relapse|158|||
48696794|NCT00435409|156739175|FG001|Overall Study|Objective progression or relapse|93|||
48696795|NCT00435409|156739176|FG002|Overall Study|Objective progression or relapse|58|||
48696796|NCT00435409|156739174|FG000|Overall Study|Global deterioration of health status|0|||
48696797|NCT00435409|156739175|FG001|Overall Study|Global deterioration of health status|0|||
48696798|NCT00435409|156739176|FG002|Overall Study|Global deterioration of health status|4|||
48696799|NCT00435409|156739174|FG000|Overall Study|Withdrawal by Subject|8|||
48696800|NCT00435409|156739175|FG001|Overall Study|Withdrawal by Subject|7|||
48696801|NCT00435409|156739176|FG002|Overall Study|Withdrawal by Subject|1|||
48696802|NCT00435409|156739174|FG000|Overall Study|Other|45|||
48696803|NCT00435409|156739175|FG001|Overall Study|Other|30|||
48696804|NCT00435409|156739176|FG002|Overall Study|Other|1|||
48696805|NCT00435409|156739174|FG000|Overall Study|Adverse Event|0|||
48696806|NCT00435409|156739175|FG001|Overall Study|Adverse Event|0|||
48696807|NCT00435409|156739176|FG002|Overall Study|Adverse Event|8|||
48696808|NCT00435409|156739174|FG000|Overall Study|Sponsor decision|0|||
48696809|NCT00435409|156739175|FG001|Overall Study|Sponsor decision|3|||
48696810|NCT00435409|156739176|FG002|Overall Study|Sponsor decision|0|||
48696811|NCT04890652|156739181|FG000|Overall Study|Withdrawal by Subject|2|||
48696812|NCT05137041|156739184|FG000|Overall Study|Lost to Follow-up|1|||
48696813|NCT05137041|156739185|FG001|Overall Study|Lost to Follow-up|1|||
48696814|NCT05137041|156739184|FG000|Overall Study|Withdrawal by Subject|0|||
48696815|NCT05137041|156739185|FG001|Overall Study|Withdrawal by Subject|2|||
48696816|NCT05137041|156739184|FG000|Overall Study|Reason not Specified|0|||
48696817|NCT05137041|156739185|FG001|Overall Study|Reason not Specified|1|||
48696818|NCT04742556|156739186|FG000|Overall Study|Withdrawal by Subject|0|||
48696819|NCT04742556|156739187|FG001|Overall Study|Withdrawal by Subject|1|||
48696820|NCT04742556|156739188|FG002|Overall Study|Withdrawal by Subject|0|||
48696821|NCT04742556|156739186|FG000|Overall Study|Adverse Event|0|||
48696822|NCT04742556|156739187|FG001|Overall Study|Adverse Event|0|||
48696823|NCT04742556|156739188|FG002|Overall Study|Adverse Event|2|||
48696824|NCT04742556|156739186|FG000|Overall Study|Clinical disease progression|0|||
48696825|NCT04742556|156739187|FG001|Overall Study|Clinical disease progression|1|||
48696826|NCT04742556|156739188|FG002|Overall Study|Clinical disease progression|2|||
48696827|NCT04742556|156739186|FG000|Overall Study|Objective disease progression|3|||
48696828|NCT04742556|156739187|FG001|Overall Study|Objective disease progression|2|||
48696829|NCT04742556|156739188|FG002|Overall Study|Objective disease progression|4|||
48696830|NCT04247347|156739189|FG000|Overall Study|Withdrawal by Subject|2|||
48696831|NCT04247347|156739190|FG001|Overall Study|Withdrawal by Subject|3|||
48696832|NCT04247347|156739191|FG002|Overall Study|Withdrawal by Subject|3|||
48696833|NCT04247347|156739189|FG000|Overall Study|Lost to Follow-up|1|||
48696834|NCT04247347|156739190|FG001|Overall Study|Lost to Follow-up|1|||
48696835|NCT04247347|156739191|FG002|Overall Study|Lost to Follow-up|1|||
48696836|NCT01383928|156739193|FG000|Overall Study|Initiation of ASCT|2|||
48696837|NCT01383928|156739194|FG001|Overall Study|Initiation of ASCT|1|||
48696838|NCT01383928|156739195|FG002|Overall Study|Initiation of ASCT|18|||
48696839|NCT01383928|156739193|FG000|Overall Study|Adverse Event|1|||
48696840|NCT01383928|156739194|FG001|Overall Study|Adverse Event|2|||
48696841|NCT01383928|156739195|FG002|Overall Study|Adverse Event|8|||
48696842|NCT01383928|156739193|FG000|Overall Study|Other|1|||
48696843|NCT01383928|156739194|FG001|Overall Study|Other|3|||
48696844|NCT01383928|156739195|FG002|Overall Study|Other|4|||
48696845|NCT01383928|156739193|FG000|Overall Study|Progressive Disease|1|||
48696846|NCT01383928|156739194|FG001|Overall Study|Progressive Disease|1|||
48696847|NCT01383928|156739195|FG002|Overall Study|Progressive Disease|5|||
48696848|NCT01383928|156739193|FG000|Overall Study|Withdrawal by Subject|0|||
48696849|NCT01383928|156739194|FG001|Overall Study|Withdrawal by Subject|0|||
48696850|NCT01383928|156739195|FG002|Overall Study|Withdrawal by Subject|4|||
48696851|NCT01383928|156739193|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
48696852|NCT01383928|156739194|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
48696853|NCT01383928|156739195|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
48696854|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
48696855|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
48487721|NCT01270841|155980755|FG002|Overall Study|Physician Decision|0|||
48696856|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
48696857|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
48742931|NCT00126191|156910416|FG000|Overall Study|Death|0|||
48696858|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
48696859|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
48696860|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696861|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
48696862|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
48696863|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
48696864|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
48696865|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
48696866|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
48696867|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
48696868|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696869|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696870|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696871|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696872|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696873|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696874|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696875|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696876|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
48696877|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696878|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696879|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696880|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696881|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696882|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696883|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
48696884|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696885|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
48696886|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696887|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696888|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696889|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
48696890|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
48696891|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696892|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696893|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696894|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696895|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48742932|NCT00126191|156910417|FG001|Overall Study|Death|1|||
48487722|NCT01270841|155980756|FG003|Overall Study|Physician Decision|0|||
48696896|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696897|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696898|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696899|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
48696900|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696901|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696902|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696903|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696904|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696905|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696906|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696907|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696908|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696909|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696910|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696911|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696912|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696913|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
48696914|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696915|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696916|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696917|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696918|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696919|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696920|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696921|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696922|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
48696923|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
48696924|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
48696925|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
48696926|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
48696927|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
48696928|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
48696929|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
48696930|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
48696931|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
48696932|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
48696933|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
48696934|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
48696935|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
48696936|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
48696937|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
48696938|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
48696939|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
48696940|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
48696941|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
48696942|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
48696943|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
48696944|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
48696945|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
48696946|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696947|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696948|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696949|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696950|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696951|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696952|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696953|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696954|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
48696955|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696956|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696957|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696958|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696959|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
48742933|NCT00443261|156910418|FG000|Overall Study|Death|1|||
48696960|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696961|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696962|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696963|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696964|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696965|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696966|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696967|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696968|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
48696969|NCT02052778|156739199|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696970|NCT02052778|156739200|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696971|NCT02052778|156739201|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696972|NCT02052778|156739202|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696973|NCT02052778|156739203|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696974|NCT02052778|156739204|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
48696975|NCT02052778|156739205|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696976|NCT02052778|156739206|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696977|NCT02052778|156739207|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696978|NCT02052778|156739208|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696979|NCT02052778|156739209|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696980|NCT02052778|156739210|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696981|NCT02052778|156739211|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
48696982|NCT02052778|156739212|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696983|NCT02052778|156739213|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696984|NCT02052778|156739214|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696985|NCT02052778|156739215|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696986|NCT02052778|156739216|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696987|NCT02052778|156739217|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696988|NCT02052778|156739218|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696989|NCT02052778|156739219|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696990|NCT02052778|156739220|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696991|NCT02052778|156739221|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
48696992|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696993|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696994|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696995|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696996|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696997|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696998|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48696999|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697000|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697001|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697002|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697003|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697004|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697005|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697006|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
48697007|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
48697008|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
48697009|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
48697010|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
48697011|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
48697012|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
48697013|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
48742934|NCT01550289|156910419|FG000|Overall Study|Protocol Violation|1|||
48697014|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
48697015|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697016|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697017|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697018|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697019|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697020|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697021|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697022|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697023|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697024|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697025|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697026|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697027|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697028|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697029|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
48697030|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
48697031|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697032|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
48697033|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
48697034|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
48697035|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
48697036|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
48697037|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
48697038|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697039|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697040|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697041|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697042|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697043|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697044|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697045|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697046|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697047|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697048|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697049|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697050|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697051|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697052|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
48697053|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
48697054|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
48697055|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697056|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
48697057|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
48697058|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697059|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697060|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
48697061|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697062|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697063|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697064|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697065|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697066|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697067|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697068|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697069|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697070|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697071|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697072|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48742935|NCT01550289|156910420|FG001|Overall Study|Protocol Violation|0|||
48592818|NCT03131687|156363558|FG000|Overall Study|Principle Investigator Decision|0|||
48592819|NCT03131687|156363559|FG001|Overall Study|Principle Investigator Decision|1|||
48697073|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697074|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697075|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
48697076|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
48697077|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697078|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697079|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697080|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697081|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697082|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697083|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
48697084|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697085|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697086|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697087|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697088|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697089|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697090|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697091|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697092|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697093|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697094|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697095|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697096|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697097|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697098|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
48697099|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
48697100|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697101|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697102|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697103|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
48697104|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697105|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697106|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
48697107|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
48697108|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
48697109|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
48697110|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
48697111|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
48697112|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
48697113|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
48697114|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
48697115|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
48697116|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
48697117|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
48697118|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
48697119|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
48697120|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
48697121|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
48697122|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
48697123|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
48697124|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
48697125|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
48697126|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
48697127|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
48697128|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
48697129|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
48697130|NCT02052778|156739199|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697131|NCT02052778|156739200|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697132|NCT02052778|156739201|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697133|NCT02052778|156739202|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697134|NCT02052778|156739203|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697135|NCT02052778|156739204|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697136|NCT02052778|156739205|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697137|NCT02052778|156739206|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697138|NCT02052778|156739207|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697139|NCT02052778|156739208|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697140|NCT02052778|156739209|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697141|NCT02052778|156739210|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697142|NCT02052778|156739211|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697143|NCT02052778|156739212|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697144|NCT02052778|156739213|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
48697145|NCT02052778|156739214|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
48697146|NCT02052778|156739215|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
48697147|NCT02052778|156739216|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697148|NCT02052778|156739217|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
48697149|NCT02052778|156739218|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697150|NCT02052778|156739219|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697151|NCT02052778|156739220|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697152|NCT02052778|156739221|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
48697153|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697154|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697155|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697156|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697157|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697158|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697159|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697160|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697161|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697162|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697163|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697164|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697165|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697166|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697167|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697168|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697169|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697170|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697171|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697172|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697173|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697174|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
48697175|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
48697176|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697177|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697178|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697179|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697180|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697181|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697182|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697183|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697184|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697185|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697186|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697187|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697188|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697189|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697190|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697191|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697192|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697193|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697194|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697195|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697196|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697197|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
48697198|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
48697199|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697200|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697201|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697202|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697203|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697204|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697205|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697206|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697207|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697208|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697209|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697210|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697211|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697212|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697213|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697214|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697215|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697216|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697217|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697218|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697219|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697220|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
48697221|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
48697222|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697223|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697224|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697225|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697226|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697227|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697228|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697229|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697230|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697231|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697232|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697233|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697234|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697235|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697236|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697237|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697238|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697239|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697240|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697241|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697242|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697243|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
48697244|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
48697245|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697246|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697247|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697248|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697249|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697250|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697251|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697252|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697253|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697254|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697255|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697256|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697257|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697258|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697259|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697260|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697261|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697262|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697263|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697264|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697265|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697266|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
48697267|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
48697268|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
48697269|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
48697270|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
48697271|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
48697272|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
48697273|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
48697274|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
48697275|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
48697276|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
48697277|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
48697278|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
48697279|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
48697280|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
48697281|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
48697282|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
48697283|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
48697284|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
48697285|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
48697286|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
48697287|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
48697288|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
48697289|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
48697290|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
48697291|NCT02052778|156739199|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697292|NCT02052778|156739200|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697293|NCT02052778|156739201|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697294|NCT02052778|156739202|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697295|NCT02052778|156739203|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697296|NCT02052778|156739204|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697297|NCT02052778|156739205|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697298|NCT02052778|156739206|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697299|NCT02052778|156739207|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697300|NCT02052778|156739208|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697301|NCT02052778|156739209|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697302|NCT02052778|156739210|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697303|NCT02052778|156739211|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697304|NCT02052778|156739212|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697305|NCT02052778|156739213|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697306|NCT02052778|156739214|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697307|NCT02052778|156739215|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697308|NCT02052778|156739216|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697309|NCT02052778|156739217|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697310|NCT02052778|156739218|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697311|NCT02052778|156739219|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697312|NCT02052778|156739220|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
48697313|NCT02052778|156739221|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
48697314|NCT01346358|156739222|FG000|Overall Study|Withdrawal by Subject|1|||
48697315|NCT01346358|156739223|FG001|Overall Study|Withdrawal by Subject|0|||
48697316|NCT01346358|156739224|FG002|Overall Study|Withdrawal by Subject|1|||
48697317|NCT01346358|156739225|FG003|Overall Study|Withdrawal by Subject|1|||
48697318|NCT01346358|156739226|FG004|Overall Study|Withdrawal by Subject|0|||
48697319|NCT01346358|156739227|FG005|Overall Study|Withdrawal by Subject|2|||
48697320|NCT01346358|156739228|FG006|Overall Study|Withdrawal by Subject|1|||
48697321|NCT01346358|156739229|FG007|Overall Study|Withdrawal by Subject|1|||
48697322|NCT01346358|156739230|FG008|Overall Study|Withdrawal by Subject|1|||
48697323|NCT01346358|156739222|FG000|Overall Study|Adverse Event|1|||
48697324|NCT01346358|156739223|FG001|Overall Study|Adverse Event|0|||
48697325|NCT01346358|156739224|FG002|Overall Study|Adverse Event|0|||
48697326|NCT01346358|156739225|FG003|Overall Study|Adverse Event|0|||
48592820|NCT03131687|156363560|FG002|Overall Study|Principle Investigator Decision|0|||
48697327|NCT01346358|156739226|FG004|Overall Study|Adverse Event|1|||
48592821|NCT03131687|156363561|FG003|Overall Study|Principle Investigator Decision|0|||
48697328|NCT01346358|156739227|FG005|Overall Study|Adverse Event|0|||
48697329|NCT01346358|156739228|FG006|Overall Study|Adverse Event|0|||
48697330|NCT01346358|156739229|FG007|Overall Study|Adverse Event|0|||
48697331|NCT01346358|156739230|FG008|Overall Study|Adverse Event|1|||
48697332|NCT01346358|156739222|FG000|Overall Study|Non-Compliance|0|||
48697333|NCT01346358|156739223|FG001|Overall Study|Non-Compliance|0|||
48697334|NCT01346358|156739224|FG002|Overall Study|Non-Compliance|0|||
48697335|NCT01346358|156739225|FG003|Overall Study|Non-Compliance|0|||
48697336|NCT01346358|156739226|FG004|Overall Study|Non-Compliance|0|||
48697337|NCT01346358|156739227|FG005|Overall Study|Non-Compliance|0|||
48697338|NCT01346358|156739228|FG006|Overall Study|Non-Compliance|0|||
48697339|NCT01346358|156739229|FG007|Overall Study|Non-Compliance|2|||
48697340|NCT01346358|156739230|FG008|Overall Study|Non-Compliance|0|||
48697341|NCT01346358|156739222|FG000|Overall Study|Physician Decision|0|||
48697342|NCT01346358|156739223|FG001|Overall Study|Physician Decision|1|||
48697343|NCT01346358|156739224|FG002|Overall Study|Physician Decision|0|||
48697344|NCT01346358|156739225|FG003|Overall Study|Physician Decision|0|||
48697345|NCT01346358|156739226|FG004|Overall Study|Physician Decision|0|||
48697346|NCT01346358|156739227|FG005|Overall Study|Physician Decision|0|||
48697347|NCT01346358|156739228|FG006|Overall Study|Physician Decision|0|||
48697348|NCT01346358|156739229|FG007|Overall Study|Physician Decision|1|||
48697349|NCT01346358|156739230|FG008|Overall Study|Physician Decision|1|||
48697350|NCT03253796|156739235|FG000|Period 1: Run-In|Adverse Event|4|||
48697351|NCT03253796|156739236|FG001|Period 1: Run-In|Adverse Event|0|||
48697352|NCT03253796|156739237|FG002|Period 1: Run-In|Adverse Event|0|||
48697353|NCT03253796|156739238|FG003|Period 1: Run-In|Adverse Event|0|||
48697354|NCT03253796|156739239|FG004|Period 1: Run-In|Adverse Event|0|||
48697355|NCT03253796|156739235|FG000|Period 1: Run-In|Lack of Efficacy|1|||
48697356|NCT03253796|156739236|FG001|Period 1: Run-In|Lack of Efficacy|0|||
48697357|NCT03253796|156739237|FG002|Period 1: Run-In|Lack of Efficacy|0|||
48697358|NCT03253796|156739238|FG003|Period 1: Run-In|Lack of Efficacy|0|||
48697359|NCT03253796|156739239|FG004|Period 1: Run-In|Lack of Efficacy|0|||
48697360|NCT03253796|156739235|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
48697361|NCT03253796|156739236|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
48697362|NCT03253796|156739237|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
48697363|NCT03253796|156739238|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
48697364|NCT03253796|156739239|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
48697365|NCT03253796|156739235|FG000|Period 1: Run-In|Protocol Violation|5|||
48697366|NCT03253796|156739236|FG001|Period 1: Run-In|Protocol Violation|0|||
48697367|NCT03253796|156739237|FG002|Period 1: Run-In|Protocol Violation|0|||
48697368|NCT03253796|156739238|FG003|Period 1: Run-In|Protocol Violation|0|||
48697369|NCT03253796|156739239|FG004|Period 1: Run-In|Protocol Violation|0|||
48697370|NCT03253796|156739235|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
48697371|NCT03253796|156739236|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
48697372|NCT03253796|156739237|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
48697373|NCT03253796|156739238|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
48697374|NCT03253796|156739239|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
48697375|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
48697376|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
48697377|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
48697378|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
48697379|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
48697380|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
48697381|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
48697382|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
48697383|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
48697384|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
48697385|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
48697386|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
48697387|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
48697388|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
48697389|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
48697390|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
48697391|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
48697392|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
48697393|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
48697394|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
48697395|NCT03253796|156739235|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
48697396|NCT03253796|156739236|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
48697397|NCT03253796|156739237|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
48697398|NCT03253796|156739238|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
48697399|NCT03253796|156739239|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
48697400|NCT03253796|156739235|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
48697401|NCT03253796|156739236|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
48697402|NCT03253796|156739237|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
48697403|NCT03253796|156739238|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
48697404|NCT03253796|156739239|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
48697405|NCT01451606|156739242|FG000|Overall Study|Withdrawal by Subject|4|||
48697406|NCT01451606|156739243|FG001|Overall Study|Withdrawal by Subject|3|||
48697407|NCT00388349|156739252|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
48697408|NCT00388349|156739253|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
48697409|NCT01710345|156739254|FG000|Overall Study|Adverse Event|0|||
48697410|NCT01710345|156739255|FG001|Overall Study|Adverse Event|2|||
48697411|NCT01710345|156739256|FG002|Overall Study|Adverse Event|0|||
48697412|NCT01710345|156739254|FG000|Overall Study|Lack of Efficacy|2|||
48697413|NCT01710345|156739255|FG001|Overall Study|Lack of Efficacy|3|||
48697414|NCT01710345|156739256|FG002|Overall Study|Lack of Efficacy|1|||
48697415|NCT01710345|156739254|FG000|Overall Study|Drug Dosing Error|1|||
48697416|NCT01710345|156739255|FG001|Overall Study|Drug Dosing Error|0|||
48697417|NCT01710345|156739256|FG002|Overall Study|Drug Dosing Error|0|||
48697418|NCT01667900|156739260|FG000|Part B|Death|0|||
48697419|NCT01667900|156739261|FG001|Part B|Death|0|||
48697420|NCT01667900|156739262|FG002|Part B|Death|0|||
48697421|NCT01667900|156739263|FG003|Part B|Death|0|||
48697422|NCT01667900|156739264|FG004|Part B|Death|0|||
48697423|NCT01667900|156739265|FG005|Part B|Death|0|||
48697424|NCT01667900|156739266|FG006|Part B|Death|0|||
48697425|NCT01667900|156739267|FG007|Part B|Death|0|||
48697426|NCT01667900|156739268|FG008|Part B|Death|0|||
48697427|NCT01667900|156739269|FG009|Part B|Death|0|||
48697428|NCT01667900|156739270|FG010|Part B|Death|0|||
48697429|NCT01667900|156739271|FG011|Part B|Death|0|||
48697430|NCT01667900|156739272|FG012|Part B|Death|0|||
48697431|NCT01667900|156739273|FG013|Part B|Death|0|||
48697432|NCT01667900|156739274|FG014|Part B|Death|0|||
48697433|NCT01667900|156739275|FG015|Part B|Death|0|||
48697434|NCT01667900|156739276|FG016|Part B|Death|1|||
48697435|NCT01667900|156739277|FG017|Part B|Death|0|||
48697436|NCT01667900|156739278|FG018|Part B|Death|0|||
48697437|NCT01667900|156739279|FG019|Part B|Death|0|||
48697438|NCT04011540|156739281|FG000|Overall Study|Lost to Follow-up|9|||
48697439|NCT04011540|156739282|FG001|Overall Study|Lost to Follow-up|6|||
48697440|NCT01126749|156739284|FG000|Phase 1b|Other|0|||
48697441|NCT01126749|156739285|FG001|Phase 1b|Other|1|||
48697442|NCT01126749|156739286|FG002|Phase 1b|Other|0|||
48697443|NCT01126749|156739287|FG003|Phase 1b|Other|0|||
48697444|NCT01126749|156739284|FG000|Phase 1b|Withdrawal by Subject|0|||
48697445|NCT01126749|156739285|FG001|Phase 1b|Withdrawal by Subject|1|||
48697446|NCT01126749|156739286|FG002|Phase 1b|Withdrawal by Subject|0|||
48697447|NCT01126749|156739287|FG003|Phase 1b|Withdrawal by Subject|0|||
48697448|NCT01126749|156739284|FG000|Phase 1b|Death|3|||
48697449|NCT01126749|156739285|FG001|Phase 1b|Death|4|||
48697450|NCT01126749|156739286|FG002|Phase 1b|Death|0|||
48697451|NCT01126749|156739287|FG003|Phase 1b|Death|0|||
48697452|NCT01126749|156739284|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
48697453|NCT01126749|156739285|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
48697454|NCT01126749|156739286|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
48697455|NCT01126749|156739287|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
48697456|NCT01126749|156739284|FG000|Phase 2|Study Termination by Sponsor|0|||
48697457|NCT01126749|156739285|FG001|Phase 2|Study Termination by Sponsor|0|||
48697458|NCT01126749|156739286|FG002|Phase 2|Study Termination by Sponsor|12|||
48697459|NCT01126749|156739287|FG003|Phase 2|Study Termination by Sponsor|6|||
48697460|NCT01126749|156739284|FG000|Phase 2|Other|0|||
48697461|NCT01126749|156739285|FG001|Phase 2|Other|0|||
48697462|NCT01126749|156739286|FG002|Phase 2|Other|4|||
48697463|NCT01126749|156739287|FG003|Phase 2|Other|2|||
48697464|NCT01126749|156739284|FG000|Phase 2|Withdrawal by Subject|0|||
48697465|NCT01126749|156739285|FG001|Phase 2|Withdrawal by Subject|0|||
48697466|NCT01126749|156739286|FG002|Phase 2|Withdrawal by Subject|0|||
48697467|NCT01126749|156739287|FG003|Phase 2|Withdrawal by Subject|2|||
48697468|NCT01126749|156739284|FG000|Phase 2|Lost to Follow-up|0|||
48697469|NCT01126749|156739285|FG001|Phase 2|Lost to Follow-up|0|||
48697470|NCT01126749|156739286|FG002|Phase 2|Lost to Follow-up|0|||
48697471|NCT01126749|156739287|FG003|Phase 2|Lost to Follow-up|1|||
48697472|NCT01126749|156739284|FG000|Phase 2|Death|0|||
48697473|NCT01126749|156739285|FG001|Phase 2|Death|0|||
48697474|NCT01126749|156739286|FG002|Phase 2|Death|22|||
48697475|NCT01126749|156739287|FG003|Phase 2|Death|22|||
48697476|NCT01126749|156739284|FG000|Phase 2|Adverse Event|0|||
48697477|NCT01126749|156739285|FG001|Phase 2|Adverse Event|0|||
48697478|NCT01126749|156739286|FG002|Phase 2|Adverse Event|0|||
48697479|NCT01126749|156739287|FG003|Phase 2|Adverse Event|1|||
48697480|NCT00537394|156739288|FG000|First Year of Follow-up|Death|7|||
48697481|NCT00537394|156739289|FG001|First Year of Follow-up|Death|0|||
48697482|NCT00537394|156739290|FG002|First Year of Follow-up|Death|0|||
48697483|NCT00537394|156739288|FG000|First Year of Follow-up|Severe debilitation|1|||
48697484|NCT00537394|156739289|FG001|First Year of Follow-up|Severe debilitation|0|||
48697485|NCT00537394|156739290|FG002|First Year of Follow-up|Severe debilitation|1|||
48697486|NCT00537394|156739288|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
48697487|NCT00537394|156739289|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
48697488|NCT00537394|156739290|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
48697489|NCT00537394|156739288|FG000|First Year of Follow-up|Lost to Follow-up|1|||
48697490|NCT00537394|156739289|FG001|First Year of Follow-up|Lost to Follow-up|5|||
48697491|NCT00537394|156739290|FG002|First Year of Follow-up|Lost to Follow-up|1|||
48697492|NCT00537394|156739288|FG000|2nd Year of Follow-up|Death|4|||
48697493|NCT00537394|156739289|FG001|2nd Year of Follow-up|Death|1|||
48697494|NCT00537394|156739290|FG002|2nd Year of Follow-up|Death|2|||
48697495|NCT00537394|156739288|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
48697496|NCT00537394|156739289|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
48697497|NCT00537394|156739290|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
48697498|NCT00537394|156739288|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
48697499|NCT00537394|156739289|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
48697500|NCT00537394|156739290|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
48697501|NCT00537394|156739288|FG000|2nd Year of Follow-up|Clinic site closure|1|||
48697502|NCT00537394|156739289|FG001|2nd Year of Follow-up|Clinic site closure|0|||
48697503|NCT00537394|156739290|FG002|2nd Year of Follow-up|Clinic site closure|0|||
48697504|NCT03668873|156739291|FG000|Overall Study|Lost to Follow-up|6|||
48697505|NCT03668873|156739292|FG001|Overall Study|Lost to Follow-up|3|||
48697506|NCT00627393|156739293|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
48697507|NCT00627393|156739294|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
48697508|NCT00627393|156739293|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
48697509|NCT00627393|156739294|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
48697510|NCT00627393|156739293|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
48697511|NCT00627393|156739294|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
48697512|NCT00627393|156739293|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
48697513|NCT00627393|156739294|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
48697514|NCT00521079|156739297|FG000|Overall Study|Adverse Event|7|||
48697515|NCT00521079|156739298|FG001|Overall Study|Adverse Event|1|||
48697516|NCT00521079|156739297|FG000|Overall Study|Lost to Follow-up|2|||
48697517|NCT00521079|156739298|FG001|Overall Study|Lost to Follow-up|1|||
48697518|NCT00521079|156739297|FG000|Overall Study|Withdrawal by Subject|5|||
48697519|NCT00521079|156739298|FG001|Overall Study|Withdrawal by Subject|3|||
48697520|NCT00829426|156739301|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
48697521|NCT00829426|156739302|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
48697522|NCT00770653|156740595|FG000|Overall Study|Adverse Event|13|||
48697523|NCT00770653|156740596|FG001|Overall Study|Adverse Event|5|||
48697524|NCT00770653|156740595|FG000|Overall Study|Protocol Violation|8|||
48697525|NCT00770653|156740596|FG001|Overall Study|Protocol Violation|6|||
48697526|NCT00770653|156740595|FG000|Overall Study|Withdrawal by Subject|4|||
48697527|NCT00770653|156740596|FG001|Overall Study|Withdrawal by Subject|7|||
48697528|NCT00770653|156740595|FG000|Overall Study|Lack of Compliance|1|||
48697529|NCT00770653|156740596|FG001|Overall Study|Lack of Compliance|4|||
48697530|NCT00770653|156740595|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
48697531|NCT00770653|156740596|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
48697532|NCT00770653|156740595|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
48432162|NCT01199263|155769048|FG001|Overall Study|Ineligible|2|||
48697533|NCT00770653|156740596|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
48697534|NCT00770653|156740595|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
48697535|NCT00770653|156740596|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
48697536|NCT00770653|156740595|FG000|Overall Study|Lost to Follow-up|1|||
48697537|NCT00770653|156740596|FG001|Overall Study|Lost to Follow-up|2|||
48697538|NCT00770653|156740595|FG000|Overall Study|Physician Decision|1|||
48697539|NCT00770653|156740596|FG001|Overall Study|Physician Decision|0|||
48697540|NCT00878501|156740607|FG000|Overall Study|Adverse Event|11|||
48697541|NCT00878501|156740608|FG001|Overall Study|Adverse Event|3|||
48697542|NCT00878501|156740609|FG002|Overall Study|Adverse Event|3|||
48697543|NCT00878501|156740607|FG000|Overall Study|Lack of Efficacy|2|||
48697544|NCT00878501|156740608|FG001|Overall Study|Lack of Efficacy|1|||
48697545|NCT00878501|156740609|FG002|Overall Study|Lack of Efficacy|0|||
48697546|NCT00878501|156740607|FG000|Overall Study|Withdrawal by Subject|2|||
48697547|NCT00878501|156740608|FG001|Overall Study|Withdrawal by Subject|1|||
48697548|NCT00878501|156740609|FG002|Overall Study|Withdrawal by Subject|2|||
48697549|NCT00878501|156740607|FG000|Overall Study|Protocol Violation|0|||
48697550|NCT00878501|156740608|FG001|Overall Study|Protocol Violation|0|||
48697551|NCT00878501|156740609|FG002|Overall Study|Protocol Violation|1|||
48697552|NCT00878501|156740607|FG000|Overall Study|Incorrect enrolment|1|||
48697553|NCT00878501|156740608|FG001|Overall Study|Incorrect enrolment|2|||
48697554|NCT00878501|156740609|FG002|Overall Study|Incorrect enrolment|0|||
48697555|NCT00878501|156740607|FG000|Overall Study|Intake of prohibited concom. medication|0|||
48697556|NCT00878501|156740608|FG001|Overall Study|Intake of prohibited concom. medication|0|||
48697557|NCT00878501|156740609|FG002|Overall Study|Intake of prohibited concom. medication|1|||
48697558|NCT00878501|156740607|FG000|Overall Study|Mis-randomisation of patient|1|||
48697559|NCT00878501|156740608|FG001|Overall Study|Mis-randomisation of patient|0|||
48697560|NCT00878501|156740609|FG002|Overall Study|Mis-randomisation of patient|0|||
48697561|NCT00878501|156740607|FG000|Overall Study|Administrative|0|||
48697562|NCT00878501|156740608|FG001|Overall Study|Administrative|0|||
48697563|NCT00878501|156740609|FG002|Overall Study|Administrative|1|||
48697564|NCT00966654|156740610|FG000|Overall Study|Study was terminated,PI left institution|12|||
48697565|NCT01584232|156740611|FG000|Overall Study|Adverse Event|3|||
48697566|NCT01584232|156740612|FG001|Overall Study|Adverse Event|1|||
48697567|NCT01584232|156740611|FG000|Overall Study|Withdrawal by Subject|2|||
48697568|NCT01584232|156740612|FG001|Overall Study|Withdrawal by Subject|1|||
48697569|NCT01584232|156740611|FG000|Overall Study|Physician Decision|2|||
48697570|NCT01584232|156740612|FG001|Overall Study|Physician Decision|1|||
48697571|NCT01584232|156740611|FG000|Overall Study|Lost to Follow-up|1|||
48697572|NCT01584232|156740612|FG001|Overall Study|Lost to Follow-up|0|||
48697573|NCT01393158|156740614|FG000|Overall Study|Adverse Event|1|||
48697574|NCT01393158|156740615|FG001|Overall Study|Adverse Event|0|||
48697575|NCT00928486|156740618|FG000|Overall Study|Adverse Event|2|||
48697576|NCT00928486|156740618|FG000|Overall Study|Disease Progression|7|||
48697577|NCT00928486|156740618|FG000|Overall Study|Withdrawal by Subject|1|||
48697578|NCT03770260|156740622|FG000|Overall Study|Disease progression|0|||
48697579|NCT03770260|156740623|FG001|Overall Study|Disease progression|1|||
48697580|NCT03770260|156740624|FG002|Overall Study|Disease progression|0|||
48697581|NCT03770260|156740625|FG003|Overall Study|Disease progression|0|||
48697582|NCT03182374|156740628|FG000|Overall Study|Lost to Follow-up|3|||
48697583|NCT03182374|156740629|FG001|Overall Study|Lost to Follow-up|2|||
48697584|NCT03182374|156740628|FG000|Overall Study|Lack of Efficacy|8|||
48697585|NCT03182374|156740629|FG001|Overall Study|Lack of Efficacy|14|||
48697586|NCT03182374|156740628|FG000|Overall Study|Withdrawal by Subject|1|||
48697587|NCT03182374|156740629|FG001|Overall Study|Withdrawal by Subject|1|||
48697588|NCT03182374|156740628|FG000|Overall Study|exit for non-compliance|1|||
48697589|NCT03182374|156740629|FG001|Overall Study|exit for non-compliance|1|||
48697590|NCT03182374|156740628|FG000|Overall Study|one subject was randomized but not treated|1|||
48697591|NCT03182374|156740629|FG001|Overall Study|one subject was randomized but not treated|0|||
48697592|NCT03182374|156740628|FG000|Overall Study|Other reasons|0|||
48697593|NCT03182374|156740629|FG001|Overall Study|Other reasons|3|||
48697594|NCT05526716|156740634|FG000|Overall Study|Death|1|||
48697595|NCT05526716|156740635|FG001|Overall Study|Death|2|||
48697596|NCT05526716|156740634|FG000|Overall Study|Lost to Follow-up|17|||
48697597|NCT05526716|156740635|FG001|Overall Study|Lost to Follow-up|15|||
48697598|NCT05526716|156740634|FG000|Overall Study|Physician Decision|0|||
48697599|NCT05526716|156740635|FG001|Overall Study|Physician Decision|1|||
48697600|NCT05526716|156740634|FG000|Overall Study|Randomized by mistake without study treatment|0|||
48697601|NCT05526716|156740635|FG001|Overall Study|Randomized by mistake without study treatment|1|||
48697602|NCT05526716|156740634|FG000|Overall Study|Withdrawal by Subject|12|||
48697603|NCT05526716|156740635|FG001|Overall Study|Withdrawal by Subject|12|||
48697604|NCT05526716|156740634|FG000|Overall Study|Not reported|0|||
48697605|NCT05526716|156740635|FG001|Overall Study|Not reported|2|||
48697606|NCT02384551|156740637|FG000|Overall Study|Lost to Follow-up|13|||
48697607|NCT02384551|156740638|FG001|Overall Study|Lost to Follow-up|14|||
48697608|NCT02384551|156740639|FG002|Overall Study|Lost to Follow-up|14|||
48697609|NCT02384551|156740640|FG003|Overall Study|Lost to Follow-up|14|||
48697610|NCT00667628|156740641|FG000|Overall Study|Lost to Follow-up|1|||
48697611|NCT00667628|156740642|FG001|Overall Study|Lost to Follow-up|0|||
48697612|NCT00667628|156740641|FG000|Overall Study|Death|6|||
48697613|NCT00667628|156740642|FG001|Overall Study|Death|6|||
48697614|NCT00667628|156740641|FG000|Overall Study|Investigator Considers in Best Interest|1|||
48697615|NCT00667628|156740642|FG001|Overall Study|Investigator Considers in Best Interest|0|||
48697616|NCT00667628|156740641|FG000|Overall Study|Sponsor Terminated Study|17|||
48697617|NCT00667628|156740642|FG001|Overall Study|Sponsor Terminated Study|21|||
48697618|NCT02927301|156740643|FG000|Overall Study|Death|39|||
48697619|NCT02927301|156740643|FG000|Overall Study|Lost to Follow-up|8|||
48697620|NCT02927301|156740643|FG000|Overall Study|Physician Decision|2|||
48697621|NCT02927301|156740643|FG000|Overall Study|Withdrawal by Subject|12|||
48697622|NCT02927301|156740643|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
48697623|NCT04613362|156740644|FG000|3 Month Follow-up|Lost to Follow-up|1|||
48697624|NCT04613362|156740645|FG001|3 Month Follow-up|Lost to Follow-up|2|||
48697625|NCT04613362|156740644|FG000|6 Month Follow-up|Lost to Follow-up|0|||
48697626|NCT04613362|156740645|FG001|6 Month Follow-up|Lost to Follow-up|1|||
48697627|NCT03562195|156740648|FG000|Overall Study|Adverse Event|0|||
48697628|NCT03562195|156740649|FG001|Overall Study|Adverse Event|6|||
48697629|NCT03562195|156740648|FG000|Overall Study|Lack of Efficacy|0|||
48697630|NCT03562195|156740649|FG001|Overall Study|Lack of Efficacy|5|||
48697631|NCT03562195|156740648|FG000|Overall Study|Protocol Violation|0|||
48697632|NCT03562195|156740649|FG001|Overall Study|Protocol Violation|1|||
48697633|NCT03562195|156740648|FG000|Overall Study|Lost to Follow-up|0|||
48697634|NCT03562195|156740649|FG001|Overall Study|Lost to Follow-up|1|||
48697635|NCT03562195|156740648|FG000|Overall Study|Physician Decision|1|||
48697636|NCT03562195|156740649|FG001|Overall Study|Physician Decision|0|||
48697637|NCT03562195|156740648|FG000|Overall Study|Withdrawal by Subject|3|||
48697638|NCT03562195|156740649|FG001|Overall Study|Withdrawal by Subject|0|||
48697639|NCT02218372|156740650|FG000|Overall Study|Adverse Event|1|||
48697640|NCT02218372|156740651|FG001|Overall Study|Adverse Event|1|||
48697641|NCT02218372|156740650|FG000|Overall Study|Miscellaneous|2|||
48697642|NCT02218372|156740651|FG001|Overall Study|Miscellaneous|1|||
48697643|NCT02218372|156740650|FG000|Overall Study|Randomized but did not receive treatment|2|||
48697644|NCT02218372|156740651|FG001|Overall Study|Randomized but did not receive treatment|3|||
48697645|NCT02218372|156740650|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48697646|NCT02218372|156740651|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48697647|NCT01921205|156740654|FG000|Overall Study|Adverse Event|12|||
48697648|NCT01921205|156740655|FG001|Overall Study|Adverse Event|7|||
48697649|NCT01921205|156740654|FG000|Overall Study|Lack of Efficacy|1|||
48697650|NCT01921205|156740655|FG001|Overall Study|Lack of Efficacy|0|||
48697651|NCT01921205|156740654|FG000|Overall Study|Protocol Violation|1|||
48697652|NCT01921205|156740655|FG001|Overall Study|Protocol Violation|3|||
48697653|NCT01921205|156740654|FG000|Overall Study|Lost to Follow-up|1|||
48697654|NCT01921205|156740655|FG001|Overall Study|Lost to Follow-up|1|||
48697655|NCT01921205|156740654|FG000|Overall Study|Withdrawal by Subject|6|||
48697656|NCT01921205|156740655|FG001|Overall Study|Withdrawal by Subject|5|||
48697657|NCT01921205|156740654|FG000|Overall Study|Use Of Prohibited Medication|0|||
48697658|NCT01921205|156740655|FG001|Overall Study|Use Of Prohibited Medication|1|||
48697659|NCT01921205|156740654|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
48697660|NCT01921205|156740655|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
48697661|NCT01921205|156740654|FG000|Overall Study|Non Compliance Of The Parent|0|||
48697662|NCT01921205|156740655|FG001|Overall Study|Non Compliance Of The Parent|1|||
48697663|NCT01921205|156740654|FG000|Overall Study|Non Compliance Of Child|0|||
48697664|NCT01921205|156740655|FG001|Overall Study|Non Compliance Of Child|1|||
48697665|NCT00062439|156740656|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
48697666|NCT00062439|156740656|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
48697667|NCT00062439|156740656|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
48697668|NCT00062439|156740656|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
48697669|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Death|1|||
48697670|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Disease progression|2|||
48697671|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
48697672|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
48697673|NCT00062439|156740656|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
48697674|NCT00062439|156740656|FG000|Surgery|Physician Decision|4|||
48697675|NCT00062439|156740656|FG000|Surgery|Death|1|||
48697676|NCT00062439|156740656|FG000|Surgery|Adverse Event|2|||
48697677|NCT00062439|156740656|FG000|Consolidation Chemotherapy|Adverse Event|2|||
48697678|NCT01527149|156740661|FG000|Overall Study|Death|2|||
48697679|NCT00481832|156740662|FG000|Enrollment|Physician Decision|8|||
48697680|NCT00481832|156740662|FG000|Enrollment|Unable to collect enough stem cells|2|||
48697681|NCT00481832|156740662|FG000|Inter-transplant Period|Adverse Event|4|||
48697682|NCT00481832|156740662|FG000|Inter-transplant Period|Death|3|||
48697683|NCT00481832|156740662|FG000|Inter-transplant Period|Physician Decision|4|||
48697684|NCT00481832|156740662|FG000|Inter-transplant Period|Disease relapse|11|||
48697685|NCT00481832|156740662|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
48697686|NCT03379818|156740663|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
48697687|NCT03379818|156740664|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
48697688|NCT03379818|156740663|FG000|Overall Study|Withdrawal by Subject|2|||
48697689|NCT03379818|156740664|FG001|Overall Study|Withdrawal by Subject|3|||
48697690|NCT03379818|156740663|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
48697691|NCT03379818|156740664|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
48697692|NCT03186209|156740674|FG000|Overall Study|Withdrawal by Subject|11|||
48697693|NCT03186209|156740675|FG001|Overall Study|Withdrawal by Subject|22|||
48697694|NCT03186209|156740674|FG000|Overall Study|Pregnancy|1|||
48697695|NCT03186209|156740675|FG001|Overall Study|Pregnancy|0|||
48697696|NCT03186209|156740674|FG000|Overall Study|Adverse Event|4|||
48697697|NCT03186209|156740675|FG001|Overall Study|Adverse Event|0|||
48697698|NCT03186209|156740674|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
48697699|NCT03186209|156740675|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
48697700|NCT03186209|156740674|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
48697701|NCT03186209|156740675|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
48697702|NCT03186209|156740674|FG000|Overall Study|Fail to meet randomization criteria|0|||
48697703|NCT03186209|156740675|FG001|Overall Study|Fail to meet randomization criteria|1|||
48697704|NCT03186209|156740674|FG000|Overall Study|Lost to Follow-up|0|||
48697705|NCT03186209|156740675|FG001|Overall Study|Lost to Follow-up|1|||
48697706|NCT04575155|156740686|FG000|2 Month|Withdrawal by Subject|1|||
48697707|NCT04575155|156740687|FG001|2 Month|Withdrawal by Subject|1|||
48697708|NCT04575155|156740686|FG000|2 Month|Lost to Follow-up|5|||
48697709|NCT04575155|156740687|FG001|2 Month|Lost to Follow-up|3|||
48697710|NCT04575155|156740686|FG000|2 Month|Ineligible|1|||
48697711|NCT04575155|156740687|FG001|2 Month|Ineligible|0|||
48697712|NCT01263769|156740688|FG000|Overall Study|Non-Compliant with treatment|1|||
48697713|NCT03748823|156740689|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
48697714|NCT03748823|156740690|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
48697715|NCT03748823|156740689|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
48697716|NCT03748823|156740690|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
48697717|NCT03748823|156740689|FG000|Extension Period|Withdrawal by Subject|9|||
48697718|NCT03748823|156740690|FG001|Extension Period|Withdrawal by Subject|12|||
48697719|NCT03748823|156740689|FG000|Extension Period|Death|2|||
48697720|NCT03748823|156740690|FG001|Extension Period|Death|2|||
48697721|NCT03748823|156740689|FG000|Extension Period|Other than Specified|0|||
48697722|NCT03748823|156740690|FG001|Extension Period|Other than Specified|1|||
48697723|NCT03748823|156740689|FG000|Extension Period|Protocol Violation|1|||
48697724|NCT03748823|156740690|FG001|Extension Period|Protocol Violation|0|||
48697725|NCT03748823|156740689|FG000|Extension Period|Lost to Follow-up|0|||
48697726|NCT03748823|156740690|FG001|Extension Period|Lost to Follow-up|1|||
48697727|NCT03748823|156740689|FG000|Extension Period|Lack of Efficacy|0|||
48697728|NCT03748823|156740690|FG001|Extension Period|Lack of Efficacy|1|||
48697729|NCT03748823|156740689|FG000|Extension Period|Physician Decision|1|||
48697730|NCT03748823|156740690|FG001|Extension Period|Physician Decision|2|||
48697731|NCT04949191|156740691|FG000|Overall Study|Non-compliance with Study Drug|1|||
48697732|NCT04949191|156740692|FG001|Overall Study|Non-compliance with Study Drug|0|||
48697733|NCT04949191|156740693|FG002|Overall Study|Non-compliance with Study Drug|0|||
48697734|NCT04949191|156740694|FG003|Overall Study|Non-compliance with Study Drug|0|||
48697735|NCT04949191|156740691|FG000|Overall Study|Progressive Disease|0|||
48697736|NCT04949191|156740692|FG001|Overall Study|Progressive Disease|1|||
48697737|NCT04949191|156740693|FG002|Overall Study|Progressive Disease|0|||
48697738|NCT04949191|156740694|FG003|Overall Study|Progressive Disease|0|||
48697739|NCT04949191|156740691|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
48697740|NCT04949191|156740692|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
48697741|NCT04949191|156740693|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
48697742|NCT04949191|156740694|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
48697743|NCT04949191|156740691|FG000|Overall Study|Sponsor Terminated Study|0|||
48697744|NCT04949191|156740692|FG001|Overall Study|Sponsor Terminated Study|0|||
48697745|NCT04949191|156740693|FG002|Overall Study|Sponsor Terminated Study|1|||
48697746|NCT04949191|156740694|FG003|Overall Study|Sponsor Terminated Study|1|||
48697747|NCT05468814|156740695|FG000|Overall Study|Lost to Follow-up|5|||
48697748|NCT05468814|156740696|FG001|Overall Study|Lost to Follow-up|6|||
48697749|NCT04531176|156740697|FG000|Overall Study|Study was stopped early|24|||
48697750|NCT04531176|156740698|FG001|Overall Study|Study was stopped early|26|||
48697751|NCT04531176|156740699|FG002|Overall Study|Study was stopped early|24|||
48697752|NCT03624881|156740700|FG000|Overall Study|Screen Failure|14|||
48697753|NCT03624881|156740701|FG001|Overall Study|Screen Failure|0|||
48697754|NCT03624881|156740700|FG000|Overall Study|No Catheter Inserted|6|||
48697755|NCT03624881|156740701|FG001|Overall Study|No Catheter Inserted|1|||
48697756|NCT03624881|156740700|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
48697757|NCT03624881|156740701|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
48697758|NCT03624881|156740700|FG000|Overall Study|Death|2|||
48697759|NCT03624881|156740701|FG001|Overall Study|Death|0|||
48697760|NCT03624881|156740700|FG000|Overall Study|Lost to Follow-up|10|||
48697761|NCT03624881|156740701|FG001|Overall Study|Lost to Follow-up|4|||
48697762|NCT03624881|156740700|FG000|Overall Study|Withdrawal by Subject|12|||
48697763|NCT03624881|156740701|FG001|Overall Study|Withdrawal by Subject|1|||
48697764|NCT04484961|156740702|FG000|Overall Study|Lost to Follow-up|9|||
48697765|NCT04484961|156740703|FG001|Overall Study|Lost to Follow-up|9|||
48697766|NCT01339832|156740706|FG000|Overall Study|Lost to Follow-up|3|||
48697767|NCT01339832|156740706|FG000|Overall Study|Death|11|||
48697768|NCT00774046|156740707|FG000|Screening|Not eligible|56|||
48697769|NCT00774046|156740707|FG000|Enrollment|Desired other therapy/refused|28|||
48697770|NCT00774046|156740707|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
48697771|NCT03361137|156740716|FG000|Overall Study|Reason not specified|1|||
48697772|NCT03361137|156740717|FG001|Overall Study|Reason not specified|0|||
48697773|NCT03361137|156740718|FG002|Overall Study|Reason not specified|0|||
48697774|NCT03361137|156740719|FG003|Overall Study|Reason not specified|0|||
48697775|NCT03361137|156740720|FG004|Overall Study|Reason not specified|0|||
48697776|NCT00626106|156740723|FG000|Overall Study|Withdrawal by Subject|2|||
48697777|NCT00626106|156740724|FG001|Overall Study|Withdrawal by Subject|1|||
48697778|NCT00626106|156740723|FG000|Overall Study|Lost to Follow-up|1|||
48697779|NCT00626106|156740724|FG001|Overall Study|Lost to Follow-up|4|||
48697780|NCT00626106|156740723|FG000|Overall Study|Death|64|||
48697781|NCT00626106|156740724|FG001|Overall Study|Death|19|||
48697782|NCT03598036|156741977|FG000|Overall Study|Withdrawal by Subject|1|||
48697783|NCT03598036|156741978|FG001|Overall Study|Withdrawal by Subject|0|||
48697784|NCT04124939|156741979|FG000|Overall Study|Lost to Follow-up|1|||
48697785|NCT04124939|156741980|FG001|Overall Study|Lost to Follow-up|3|||
48697786|NCT04065048|156741982|FG000|Overall Study|Withdrawal by Subject|1|||
48697787|NCT04065048|156741983|FG001|Overall Study|Withdrawal by Subject|2|||
48697788|NCT04065048|156741984|FG002|Overall Study|Withdrawal by Subject|1|||
48697789|NCT04065048|156741985|FG003|Overall Study|Withdrawal by Subject|1|||
48697790|NCT04065048|156741982|FG000|Overall Study|Adverse Event|1|||
48697791|NCT04065048|156741983|FG001|Overall Study|Adverse Event|0|||
48697792|NCT04065048|156741984|FG002|Overall Study|Adverse Event|1|||
48697793|NCT04065048|156741985|FG003|Overall Study|Adverse Event|0|||
48697794|NCT01194830|156741986|FG000|Overall Study|Adverse Event|3|||
48697795|NCT01194830|156741987|FG001|Overall Study|Adverse Event|2|||
48697796|NCT01194830|156741986|FG000|Overall Study|Protocol Violation|5|||
48697797|NCT01194830|156741987|FG001|Overall Study|Protocol Violation|4|||
48697798|NCT01194830|156741986|FG000|Overall Study|Lost to Follow-up|9|||
48697799|NCT01194830|156741987|FG001|Overall Study|Lost to Follow-up|7|||
48697800|NCT01194830|156741986|FG000|Overall Study|Withdrawal by Subject|2|||
48697801|NCT01194830|156741987|FG001|Overall Study|Withdrawal by Subject|1|||
48697802|NCT01194830|156741986|FG000|Overall Study|Lack of Efficacy|1|||
48697803|NCT01194830|156741987|FG001|Overall Study|Lack of Efficacy|1|||
48697804|NCT01194830|156741986|FG000|Overall Study|Non-compliance issues|4|||
48697805|NCT01194830|156741987|FG001|Overall Study|Non-compliance issues|4|||
48697806|NCT01194830|156741986|FG000|Overall Study|Other Reason|12|||
48697807|NCT01194830|156741987|FG001|Overall Study|Other Reason|8|||
48697808|NCT02814916|156741990|FG000|Overall Study|Withdrawal of consent|0|||
48697809|NCT02814916|156741991|FG001|Overall Study|Withdrawal of consent|2|||
48697810|NCT02814916|156741992|FG002|Overall Study|Withdrawal of consent|0|||
48697811|NCT02814916|156741990|FG000|Overall Study|Lost to Follow-up|0|||
48697812|NCT02814916|156741991|FG001|Overall Study|Lost to Follow-up|1|||
48697813|NCT02814916|156741992|FG002|Overall Study|Lost to Follow-up|0|||
48697814|NCT02814916|156741990|FG000|Overall Study|Other, not specified|0|||
48697815|NCT02814916|156741991|FG001|Overall Study|Other, not specified|1|||
48697816|NCT02814916|156741992|FG002|Overall Study|Other, not specified|0|||
48697817|NCT05176314|156742002|FG000|Overall Study|Lost to Follow-up|2|||
48697818|NCT05176314|156742002|FG000|Overall Study|Physician Decision|1|||
48697819|NCT05176314|156742002|FG000|Overall Study|Adverse Event|1|||
48697820|NCT03547518|156742005|FG000|Overall Study|Lost to Follow-up|2|||
48697821|NCT03547518|156742006|FG001|Overall Study|Lost to Follow-up|0|||
48697822|NCT02953652|156742007|FG000|Overall Study|Adverse Event|18|||
48697823|NCT02953652|156742007|FG000|Overall Study|Withdrawal by Subject|6|||
48697824|NCT02953652|156742007|FG000|Overall Study|Protocol Violation|1|||
48697825|NCT02953652|156742007|FG000|Overall Study|Disease Progression|27|||
48697826|NCT04244253|156742010|FG000|Overall Study|Adverse Event|2|||
48697827|NCT04244253|156742011|FG001|Overall Study|Adverse Event|2|||
48697828|NCT04244253|156742012|FG002|Overall Study|Adverse Event|4|||
48697829|NCT04244253|156742010|FG000|Overall Study|Protocol Violation|1|||
48697830|NCT04244253|156742011|FG001|Overall Study|Protocol Violation|2|||
48697831|NCT04244253|156742012|FG002|Overall Study|Protocol Violation|1|||
48697832|NCT04244253|156742010|FG000|Overall Study|Withdrawal by Subject|0|||
48697833|NCT04244253|156742011|FG001|Overall Study|Withdrawal by Subject|1|||
48697834|NCT04244253|156742012|FG002|Overall Study|Withdrawal by Subject|6|||
48697835|NCT04244253|156742010|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48697836|NCT04244253|156742011|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48697837|NCT04244253|156742012|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48697838|NCT00671658|156742017|FG000|Overall Study|Physician Decision|5|||
48697839|NCT05131204|156742020|FG000|Overall Study|Sponsor request|2|||
48697840|NCT05131204|156742021|FG001|Overall Study|Sponsor request|1|||
48697841|NCT00436332|156742022|FG000|Overall Study|Adverse Event|9|||
48697842|NCT00436332|156742022|FG000|Overall Study|Withdrawal by Subject|2|||
48697843|NCT00436332|156742022|FG000|Overall Study|Progression|59|||
48697844|NCT00436332|156742022|FG000|Overall Study|Death|2|||
48697845|NCT00436332|156742022|FG000|Overall Study|Not Protocol Specified|6|||
48697846|NCT00436332|156742022|FG000|Overall Study|Ineligible|2|||
48697847|NCT00436332|156742022|FG000|Overall Study|Never Received Treatment|3|||
48697848|NCT01903356|156742023|FG000|Overall Study|Lost to Follow-up|7|||
48697849|NCT01903356|156742023|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
48697850|NCT01903356|156742023|FG000|Overall Study|Violated the dosage and administration|3|||
48697851|NCT03041038|156742024|FG000|Overall Study|Withdrawal by Subject|4|||
48697852|NCT03041038|156742025|FG001|Overall Study|Withdrawal by Subject|0|||
48697853|NCT03041038|156742024|FG000|Overall Study|Lost to Follow-up|1|||
48697854|NCT03041038|156742025|FG001|Overall Study|Lost to Follow-up|1|||
48697855|NCT03041038|156742024|FG000|Overall Study|Protocol Violation|1|||
48697856|NCT03041038|156742025|FG001|Overall Study|Protocol Violation|1|||
48697857|NCT04529083|156742026|FG000|Overall Study|Withdrawal by Subject|3|||
48697858|NCT00360230|156742027|FG000|Overall Study|Withdrawal by Subject|1|||
48697859|NCT00360230|156742028|FG001|Overall Study|Withdrawal by Subject|1|||
48697860|NCT00360230|156742029|FG002|Overall Study|Withdrawal by Subject|0|||
48697861|NCT00360230|156742030|FG003|Overall Study|Withdrawal by Subject|1|||
48697862|NCT00360230|156742031|FG004|Overall Study|Withdrawal by Subject|1|||
48697863|NCT00360230|156742032|FG005|Overall Study|Withdrawal by Subject|1|||
48697864|NCT00360230|156742033|FG006|Overall Study|Withdrawal by Subject|0|||
48697865|NCT00360230|156742027|FG000|Overall Study|Migrated|4|||
48697866|NCT00360230|156742028|FG001|Overall Study|Migrated|1|||
48697867|NCT00360230|156742029|FG002|Overall Study|Migrated|3|||
48697868|NCT00360230|156742030|FG003|Overall Study|Migrated|1|||
48697869|NCT00360230|156742031|FG004|Overall Study|Migrated|4|||
48697870|NCT00360230|156742032|FG005|Overall Study|Migrated|1|||
48697871|NCT00360230|156742033|FG006|Overall Study|Migrated|1|||
48697872|NCT00360230|156742027|FG000|Overall Study|Other|1|||
48697873|NCT00360230|156742028|FG001|Overall Study|Other|0|||
48697874|NCT00360230|156742029|FG002|Overall Study|Other|0|||
48697875|NCT00360230|156742030|FG003|Overall Study|Other|0|||
48697876|NCT00360230|156742031|FG004|Overall Study|Other|0|||
48697877|NCT00360230|156742032|FG005|Overall Study|Other|0|||
48697878|NCT00360230|156742033|FG006|Overall Study|Other|0|||
48697879|NCT00360230|156742027|FG000|Overall Study|Protocol Violation|0|||
48697880|NCT00360230|156742028|FG001|Overall Study|Protocol Violation|0|||
48697881|NCT00360230|156742029|FG002|Overall Study|Protocol Violation|0|||
48697882|NCT00360230|156742030|FG003|Overall Study|Protocol Violation|0|||
48697883|NCT00360230|156742031|FG004|Overall Study|Protocol Violation|0|||
48697884|NCT00360230|156742032|FG005|Overall Study|Protocol Violation|1|||
48697885|NCT00360230|156742033|FG006|Overall Study|Protocol Violation|0|||
48697886|NCT00360230|156742027|FG000|Overall Study|Death|0|||
48697887|NCT00360230|156742028|FG001|Overall Study|Death|1|||
48697888|NCT00360230|156742029|FG002|Overall Study|Death|0|||
48697889|NCT00360230|156742030|FG003|Overall Study|Death|0|||
48697890|NCT00360230|156742031|FG004|Overall Study|Death|0|||
48697891|NCT00360230|156742032|FG005|Overall Study|Death|1|||
48697892|NCT00360230|156742033|FG006|Overall Study|Death|1|||
48592822|NCT03131687|156363562|FG004|Overall Study|Principle Investigator Decision|0|||
48592823|NCT03131687|156363563|FG005|Overall Study|Principle Investigator Decision|0|||
48697893|NCT04196686|156742034|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
48697894|NCT04196686|156742035|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
48697895|NCT02558894|156742036|FG000|Overall Study|Death; any cause, entire study duration|28|||
48697896|NCT02558894|156742037|FG001|Overall Study|Death; any cause, entire study duration|31|||
48697897|NCT02558894|156742036|FG000|Overall Study|Withdrawal by Subject|2|||
48697898|NCT02558894|156742037|FG001|Overall Study|Withdrawal by Subject|1|||
48697899|NCT02558894|156742036|FG000|Overall Study|Closure of Part A|2|||
48697900|NCT02558894|156742037|FG001|Overall Study|Closure of Part A|1|||
48697901|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
48697902|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
48697903|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
48697904|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
48697905|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
48697906|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
48697907|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
48697908|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
48697909|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
48697910|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
48697911|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
48697912|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
48697913|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
48697914|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
48697915|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
48697916|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Other|1|||
48697917|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Other|5|||
48697918|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Other|0|||
48697919|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Other|2|||
48697920|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Other|3|||
48697921|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
48697922|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
48697923|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
48697924|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
48697925|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
48697926|NCT02006472|156742038|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
48697927|NCT02006472|156742039|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
48697928|NCT02006472|156742040|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
48697929|NCT02006472|156742041|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
48697930|NCT02006472|156742042|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
48697931|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
48697932|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
48697933|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
48697934|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
48697935|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
48697936|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
48697937|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
48697938|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
48697939|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
48697940|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
48697941|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
48697942|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
48697943|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
48697944|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
48697945|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
48697946|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Other|0|||
48697947|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Other|1|||
48697948|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Other|0|||
48697949|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Other|1|||
48697950|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Other|0|||
48697951|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Not treated|0|||
48697952|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Not treated|0|||
48697953|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Not treated|2|||
48697954|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Not treated|0|||
48697955|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Not treated|0|||
48697956|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
48697957|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
48697958|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
48697959|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
48697960|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
48697961|NCT02006472|156742038|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
48697962|NCT02006472|156742039|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
48697963|NCT02006472|156742040|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
48697964|NCT02006472|156742041|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
48697965|NCT02006472|156742042|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
48697966|NCT00784563|156742047|FG000|Years 1 & 2|Withdrawal by Subject|3|||
48697967|NCT00784563|156742048|FG001|Years 1 & 2|Withdrawal by Subject|2|||
48697968|NCT00784563|156742049|FG002|Years 1 & 2|Withdrawal by Subject|0|||
48697969|NCT00784563|156742047|FG000|Years 1 & 2|Adverse Event|0|||
48697970|NCT00784563|156742048|FG001|Years 1 & 2|Adverse Event|3|||
48697971|NCT00784563|156742049|FG002|Years 1 & 2|Adverse Event|0|||
48697972|NCT00784563|156742047|FG000|Year 3|Withdrawal by Subject|0|||
48697973|NCT00784563|156742048|FG001|Year 3|Withdrawal by Subject|0|||
48697974|NCT00784563|156742049|FG002|Year 3|Withdrawal by Subject|2|||
48697975|NCT00784563|156742047|FG000|Year 3|Adverse Event|0|||
48697976|NCT00784563|156742048|FG001|Year 3|Adverse Event|0|||
48697977|NCT00784563|156742049|FG002|Year 3|Adverse Event|1|||
48697978|NCT01614249|156742051|FG000|Overall Study|Lost to Follow-up|11|||
48697979|NCT01614249|156742052|FG001|Overall Study|Lost to Follow-up|23|||
48697980|NCT02954536|156742053|FG000|Overall Study|Adverse Event|2|||
48697981|NCT02954536|156742053|FG000|Overall Study|Death|12|||
48697982|NCT02946580|156742054|FG000|Overall Study|Withdrawal by Subject|1|||
48697983|NCT02946580|156742055|FG001|Overall Study|Withdrawal by Subject|2|||
48697984|NCT02946580|156742054|FG000|Overall Study|Adverse Event|0|||
48697985|NCT02946580|156742055|FG001|Overall Study|Adverse Event|2|||
48592824|NCT03131687|156363558|FG000|Overall Study|Inadvertent Enrollment|0|||
48697986|NCT02946580|156742054|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
48697987|NCT02946580|156742055|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
48697988|NCT02521285|156742060|FG000|Overall Study|Lost to Follow-up|1|||
48697989|NCT02521285|156742061|FG001|Overall Study|Lost to Follow-up|1|||
48697990|NCT02521285|156742060|FG000|Overall Study|Withdrawal by Subject|1|||
48697991|NCT02521285|156742061|FG001|Overall Study|Withdrawal by Subject|1|||
48697992|NCT02521285|156742060|FG000|Overall Study|Adverse Event|0|||
48697993|NCT02521285|156742061|FG001|Overall Study|Adverse Event|1|||
48697994|NCT00980954|156742062|FG000|Overall Study|Protocol Violation|9|||
48697995|NCT00980954|156742063|FG001|Overall Study|Protocol Violation|15|||
48697996|NCT03104868|156742066|FG000|6 Week Follow up|Lost to Follow-up|5|||
48697997|NCT03104868|156742067|FG001|6 Week Follow up|Lost to Follow-up|8|||
48697998|NCT03104868|156742066|FG000|6 Week Follow up|Death|1|||
48697999|NCT03104868|156742067|FG001|6 Week Follow up|Death|1|||
48698000|NCT03104868|156742066|FG000|6 Week Follow up|Withdrawal by Subject|7|||
48698001|NCT03104868|156742067|FG001|6 Week Follow up|Withdrawal by Subject|6|||
48698002|NCT03104868|156742066|FG000|6 Week Follow up|Completed Later Timepoint|24|||
48698003|NCT03104868|156742067|FG001|6 Week Follow up|Completed Later Timepoint|22|||
48698004|NCT03104868|156742066|FG000|6 Month Follow up|Lost to Follow-up|2|||
48698005|NCT03104868|156742067|FG001|6 Month Follow up|Lost to Follow-up|2|||
48698006|NCT03104868|156742066|FG000|6 Month Follow up|Death|0|||
48698007|NCT03104868|156742067|FG001|6 Month Follow up|Death|1|||
48698008|NCT03104868|156742066|FG000|6 Month Follow up|Completed Later Timepoint|22|||
48698009|NCT03104868|156742067|FG001|6 Month Follow up|Completed Later Timepoint|32|||
48698010|NCT03104868|156742066|FG000|12 Month Follow up|Lost to Follow-up|1|||
48698011|NCT03104868|156742067|FG001|12 Month Follow up|Lost to Follow-up|2|||
48698012|NCT03104868|156742066|FG000|12 Month Follow up|Death|0|||
48698013|NCT03104868|156742067|FG001|12 Month Follow up|Death|1|||
48698014|NCT03104868|156742066|FG000|12 Month Follow up|Withdrawal by Subject|0|||
48698015|NCT03104868|156742067|FG001|12 Month Follow up|Withdrawal by Subject|3|||
48698016|NCT03104868|156742066|FG000|12 Month Follow up|Completed Later Timepoint|32|||
48698017|NCT03104868|156742067|FG001|12 Month Follow up|Completed Later Timepoint|29|||
48698018|NCT03104868|156742066|FG000|18 Month Follow up|Lost to Follow-up|7|||
48698019|NCT03104868|156742067|FG001|18 Month Follow up|Lost to Follow-up|11|||
48698020|NCT03104868|156742066|FG000|18 Month Follow up|Death|2|||
48698021|NCT03104868|156742067|FG001|18 Month Follow up|Death|1|||
48698022|NCT03104868|156742066|FG000|18 Month Follow up|Withdrawal by Subject|1|||
48698023|NCT03104868|156742067|FG001|18 Month Follow up|Withdrawal by Subject|2|||
48698024|NCT03104868|156742066|FG000|18 Month Follow up|Graft Loss|1|||
48698025|NCT03104868|156742067|FG001|18 Month Follow up|Graft Loss|1|||
48698026|NCT03104868|156742066|FG000|18 Month Follow up|Completed Later Timepoint|19|||
48698027|NCT03104868|156742067|FG001|18 Month Follow up|Completed Later Timepoint|20|||
48698028|NCT03104868|156742066|FG000|24 Month Follow up|Lost to Follow-up|15|||
48698029|NCT03104868|156742067|FG001|24 Month Follow up|Lost to Follow-up|16|||
48698030|NCT03104868|156742066|FG000|24 Month Follow up|Death|3|||
48698031|NCT03104868|156742067|FG001|24 Month Follow up|Death|2|||
48698032|NCT03104868|156742066|FG000|24 Month Follow up|Withdrawal by Subject|1|||
48698033|NCT03104868|156742067|FG001|24 Month Follow up|Withdrawal by Subject|0|||
48698034|NCT03104868|156742066|FG000|24 Month Follow up|Graft Loss|2|||
48698035|NCT03104868|156742067|FG001|24 Month Follow up|Graft Loss|0|||
48698036|NCT00374140|156742068|FG000|Overall Study|Lost to Follow-up|1|||
48698037|NCT00374140|156742068|FG000|Overall Study|Protocol Violation|1|||
48698038|NCT02018562|156742071|FG000|Overall Study|Withdrawal by Subject|2|||
48698039|NCT02018562|156742072|FG001|Overall Study|Withdrawal by Subject|0|||
48698040|NCT02018562|156742071|FG000|Overall Study|Discharged prior to study completion|1|||
48487723|NCT01270841|155980753|FG000|Overall Study|Did not qualify|6|||
48487724|NCT01270841|155980754|FG001|Overall Study|Did not qualify|3|||
48698041|NCT02018562|156742072|FG001|Overall Study|Discharged prior to study completion|0|||
48698042|NCT04905134|156742073|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
48698043|NCT04905134|156742073|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
48698044|NCT03009058|156742074|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
48698045|NCT03497676|156742075|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
48698046|NCT03497676|156742076|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
48698047|NCT03497676|156742077|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
48698048|NCT03497676|156742078|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
48698049|NCT03497676|156742075|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
48698050|NCT03497676|156742076|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
48698051|NCT03497676|156742077|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
48698052|NCT03497676|156742078|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
48698053|NCT03497676|156742075|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
48698054|NCT03497676|156742076|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
48698055|NCT03497676|156742077|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
48742936|NCT01550289|156910419|FG000|Overall Study|Lost to Follow-up|1|||
48698056|NCT03497676|156742078|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
48698057|NCT03497676|156742075|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
48698058|NCT03497676|156742076|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
48698059|NCT03497676|156742077|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
48698060|NCT03497676|156742078|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
48698061|NCT03497676|156742075|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
48698062|NCT03497676|156742076|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
48698063|NCT03497676|156742077|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
48698064|NCT03497676|156742078|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
48698065|NCT03497676|156742075|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
48698066|NCT03497676|156742076|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
48698067|NCT03497676|156742077|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
48698068|NCT03497676|156742078|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
48698069|NCT03497676|156742075|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
48698070|NCT03497676|156742076|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
48698071|NCT03497676|156742077|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
48698072|NCT03497676|156742078|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
48698073|NCT03497676|156742075|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
48698074|NCT03497676|156742076|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
48698075|NCT03497676|156742077|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
48698076|NCT03497676|156742078|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
48698077|NCT04583618|156742079|FG000|Overall Study|Adverse Event|0|||
48698078|NCT04583618|156742080|FG001|Overall Study|Adverse Event|0|||
48698079|NCT04583618|156742081|FG002|Overall Study|Adverse Event|1|||
48698080|NCT04583618|156742082|FG003|Overall Study|Adverse Event|0|||
48698081|NCT04583618|156742083|FG004|Overall Study|Adverse Event|0|||
48698082|NCT04583618|156742079|FG000|Overall Study|Protocol deviation|1|||
48698083|NCT04583618|156742080|FG001|Overall Study|Protocol deviation|1|||
48698084|NCT04583618|156742081|FG002|Overall Study|Protocol deviation|1|||
48698085|NCT04583618|156742082|FG003|Overall Study|Protocol deviation|0|||
48698086|NCT04583618|156742083|FG004|Overall Study|Protocol deviation|0|||
48698087|NCT04583618|156742079|FG000|Overall Study|Withdrawal by Subject|2|||
48698088|NCT04583618|156742080|FG001|Overall Study|Withdrawal by Subject|1|||
48698089|NCT04583618|156742081|FG002|Overall Study|Withdrawal by Subject|3|||
48698090|NCT04583618|156742082|FG003|Overall Study|Withdrawal by Subject|1|||
48698091|NCT04583618|156742083|FG004|Overall Study|Withdrawal by Subject|1|||
48698092|NCT04583618|156742079|FG000|Overall Study|Lost to Follow-up|0|||
48698093|NCT04583618|156742080|FG001|Overall Study|Lost to Follow-up|1|||
48698094|NCT04583618|156742081|FG002|Overall Study|Lost to Follow-up|3|||
48698095|NCT04583618|156742082|FG003|Overall Study|Lost to Follow-up|1|||
48698096|NCT04583618|156742083|FG004|Overall Study|Lost to Follow-up|1|||
48698097|NCT02783690|156742084|FG000|Overall Study|Withdrawal by Subject|3|||
48698098|NCT02783690|156742085|FG001|Overall Study|Withdrawal by Subject|3|||
48698099|NCT04500158|156742086|FG000|Overall Study|Physician Decision|17|||
48698100|NCT04500158|156742087|FG001|Overall Study|Physician Decision|11|||
48698101|NCT03204188|156742088|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
48698102|NCT03204188|156742088|FG000|Immunotherapy Phase (1 Year)|Death|1|||
48698103|NCT03204188|156742088|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
48698104|NCT03204188|156742088|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
48698105|NCT04515771|156743375|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
48698106|NCT04515771|156743376|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
48698107|NCT04515771|156743375|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
48698108|NCT04515771|156743376|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
48698109|NCT04515771|156743375|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
48698110|NCT04515771|156743376|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
48698111|NCT01474317|156743377|FG000|Overall Study|Adverse Event|1|||
48698112|NCT01474317|156743377|FG000|Overall Study|Subject ineligible for study|1|||
48698113|NCT02891174|156743378|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
48698114|NCT02891174|156743379|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
48698115|NCT02891174|156743378|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
48698116|NCT02891174|156743379|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
48698117|NCT02891174|156743378|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
48698118|NCT02891174|156743379|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
48698119|NCT02891174|156743378|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
48698120|NCT02891174|156743379|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
48698121|NCT02891174|156743378|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
48698122|NCT02891174|156743379|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
48698123|NCT02891174|156743378|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
48698124|NCT02891174|156743379|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
48698125|NCT02891174|156743378|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
48698126|NCT02891174|156743379|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
48698127|NCT01838694|156743380|FG000|Overall Study|Adverse Event|0|||
48698128|NCT01838694|156743381|FG001|Overall Study|Adverse Event|1|||
48698129|NCT04516746|156743382|FG000|Overall Study|Randomized but not Treated|51|||
48698130|NCT04516746|156743383|FG001|Overall Study|Randomized but not Treated|19|||
48698131|NCT04516746|156743382|FG000|Overall Study|Adverse Event|0|||
48698132|NCT04516746|156743383|FG001|Overall Study|Adverse Event|1|||
48698133|NCT04516746|156743382|FG000|Overall Study|Death|62|||
48698134|NCT04516746|156743383|FG001|Overall Study|Death|32|||
48698135|NCT04516746|156743382|FG000|Overall Study|Lost to Follow-up|3431|||
48698136|NCT04516746|156743383|FG001|Overall Study|Lost to Follow-up|1831|||
48698137|NCT04516746|156743382|FG000|Overall Study|Withdrawal by Subject|1946|||
48698138|NCT04516746|156743383|FG001|Overall Study|Withdrawal by Subject|1696|||
48698139|NCT04516746|156743382|FG000|Overall Study|Physician Decision|10|||
48698140|NCT04516746|156743383|FG001|Overall Study|Physician Decision|8|||
48698141|NCT04516746|156743382|FG000|Overall Study|Other|35|||
48698142|NCT04516746|156743383|FG001|Overall Study|Other|16|||
48698143|NCT00248625|156743384|FG000|Overall Study|Withdrawal by Subject|0|||
48698144|NCT00248625|156743385|FG001|Overall Study|Withdrawal by Subject|2|||
48698145|NCT02603146|156743386|FG000|Overall Study|Lost to Follow-up|5|||
48698146|NCT02603146|156743387|FG001|Overall Study|Lost to Follow-up|6|||
48698147|NCT02603146|156743386|FG000|Overall Study|Withdrawal by Subject|8|||
48698148|NCT02603146|156743387|FG001|Overall Study|Withdrawal by Subject|10|||
48698149|NCT02603146|156743386|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
48698150|NCT02603146|156743387|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
48698151|NCT02603146|156743386|FG000|Overall Study|Participant moved|2|||
48698152|NCT02603146|156743387|FG001|Overall Study|Participant moved|0|||
48698153|NCT02603146|156743386|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
48698154|NCT02603146|156743387|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
48698155|NCT05543265|156743390|FG000|Overall Study|Lost to Follow-up|3|||
48698156|NCT05543265|156743391|FG001|Overall Study|Lost to Follow-up|3|||
48698157|NCT05543265|156743390|FG000|Overall Study|Withdrawal by Subject|0|||
48698158|NCT05543265|156743391|FG001|Overall Study|Withdrawal by Subject|1|||
48698159|NCT01231984|156743392|FG000|Study Period 1|Withdrawal by Subject|0|||
48698160|NCT01231984|156743393|FG001|Study Period 1|Withdrawal by Subject|0|||
48698161|NCT01231984|156743394|FG002|Study Period 1|Withdrawal by Subject|0|||
48698162|NCT01231984|156743395|FG003|Study Period 1|Withdrawal by Subject|1|||
48698163|NCT01231984|156743392|FG000|Study Period 1|Lost to Follow-up|1|||
48698164|NCT01231984|156743393|FG001|Study Period 1|Lost to Follow-up|1|||
48698165|NCT01231984|156743394|FG002|Study Period 1|Lost to Follow-up|1|||
48698166|NCT01231984|156743395|FG003|Study Period 1|Lost to Follow-up|0|||
48698167|NCT01231984|156743392|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
48698168|NCT01231984|156743393|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
48698169|NCT01231984|156743394|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
48698170|NCT01231984|156743395|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
48698171|NCT01231984|156743392|FG000|Study Period 1|Screen Failure|0|||
48698172|NCT01231984|156743393|FG001|Study Period 1|Screen Failure|0|||
48698173|NCT01231984|156743394|FG002|Study Period 1|Screen Failure|0|||
48698174|NCT01231984|156743395|FG003|Study Period 1|Screen Failure|1|||
48698175|NCT01231984|156743392|FG000|Study Period 1|Non-compliance with study requirements|5|||
48698176|NCT01231984|156743393|FG001|Study Period 1|Non-compliance with study requirements|0|||
48698177|NCT01231984|156743394|FG002|Study Period 1|Non-compliance with study requirements|2|||
48698178|NCT01231984|156743395|FG003|Study Period 1|Non-compliance with study requirements|1|||
48698179|NCT01231984|156743392|FG000|Study Period 1|Protocol Violation|3|||
48698180|NCT01231984|156743393|FG001|Study Period 1|Protocol Violation|4|||
48698181|NCT01231984|156743394|FG002|Study Period 1|Protocol Violation|2|||
48698182|NCT01231984|156743395|FG003|Study Period 1|Protocol Violation|3|||
48698183|NCT01231984|156743392|FG000|Study Period 1|Adverse Event|1|||
48698184|NCT01231984|156743393|FG001|Study Period 1|Adverse Event|0|||
48698185|NCT01231984|156743394|FG002|Study Period 1|Adverse Event|0|||
48698186|NCT01231984|156743395|FG003|Study Period 1|Adverse Event|0|||
48698187|NCT01231984|156743392|FG000|Study Period 1|Other|0|||
48698188|NCT01231984|156743393|FG001|Study Period 1|Other|0|||
48698189|NCT01231984|156743394|FG002|Study Period 1|Other|0|||
48698190|NCT01231984|156743395|FG003|Study Period 1|Other|1|||
48698191|NCT01231984|156743392|FG000|Study Period 2|Withdrawal by Subject|1|||
48698192|NCT01231984|156743393|FG001|Study Period 2|Withdrawal by Subject|1|||
48698193|NCT01231984|156743394|FG002|Study Period 2|Withdrawal by Subject|0|||
48698194|NCT01231984|156743395|FG003|Study Period 2|Withdrawal by Subject|0|||
48698195|NCT01231984|156743392|FG000|Study Period 2|Lost to Follow-up|1|||
48698196|NCT01231984|156743393|FG001|Study Period 2|Lost to Follow-up|0|||
48698197|NCT01231984|156743394|FG002|Study Period 2|Lost to Follow-up|0|||
48698198|NCT01231984|156743395|FG003|Study Period 2|Lost to Follow-up|3|||
48698199|NCT01231984|156743392|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
48698200|NCT01231984|156743393|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
48698201|NCT01231984|156743394|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
48698202|NCT01231984|156743395|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
48698203|NCT04750824|156743396|FG000|Overall Study|Toxicity/intolerability|3|||
48698204|NCT04750824|156743397|FG001|Overall Study|Toxicity/intolerability|1|||
48698205|NCT04750824|156743396|FG000|Overall Study|Death|1|||
48698206|NCT04750824|156743397|FG001|Overall Study|Death|3|||
48698207|NCT04750824|156743396|FG000|Overall Study|Scheduled duration of therapy complete|1|||
48698208|NCT04750824|156743397|FG001|Overall Study|Scheduled duration of therapy complete|9|||
48698209|NCT04750824|156743396|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
48698210|NCT04750824|156743397|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
48698211|NCT03035032|156743404|FG000|Overall Study|Adverse Event|2|||
48698212|NCT03035032|156743404|FG000|Overall Study|Death|9|||
48698213|NCT03035032|156743404|FG000|Overall Study|Lost to Follow-up|1|||
48698214|NCT03035032|156743404|FG000|Overall Study|Progressive Disease|22|||
48698215|NCT03035032|156743404|FG000|Overall Study|Protocol Violation|2|||
48698216|NCT03035032|156743404|FG000|Overall Study|Withdrawal by Subject|2|||
48698217|NCT03035032|156743404|FG000|Overall Study|Physician Decision|5|||
48698218|NCT03466658|156743405|FG000|Overall Study|Withdrawal by Subject|3|||
48698219|NCT00837434|156743406|FG000|Overall Study|Physician Decision|3|||
48698220|NCT00837434|156743407|FG001|Overall Study|Physician Decision|0|||
48698221|NCT00837434|156743406|FG000|Overall Study|Lost to Follow-up|1|||
48698222|NCT00837434|156743407|FG001|Overall Study|Lost to Follow-up|1|||
48698223|NCT00837434|156743406|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
48698224|NCT00837434|156743407|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
48698225|NCT00837434|156743406|FG000|Overall Study|Noncompliant|2|||
48698226|NCT00837434|156743407|FG001|Overall Study|Noncompliant|0|||
48698227|NCT00837434|156743406|FG000|Overall Study|Baseline assessments not done in time|1|||
48698228|NCT00837434|156743407|FG001|Overall Study|Baseline assessments not done in time|0|||
48698229|NCT00837434|156743406|FG000|Overall Study|Unable to obtain study drug|1|||
48698230|NCT00837434|156743407|FG001|Overall Study|Unable to obtain study drug|0|||
48698231|NCT01349959|156743408|FG000|Overall Study|Adverse Event|7|||
48698232|NCT01680341|156743409|FG000|Overall Study|Adverse Event|3|||
48698233|NCT01680341|156743410|FG001|Overall Study|Adverse Event|2|||
48698234|NCT01680341|156743409|FG000|Overall Study|Unclassified|18|||
48698235|NCT01680341|156743410|FG001|Overall Study|Unclassified|15|||
48698236|NCT02388269|156743414|FG000|Overall Study|Adverse Event|2|||
48698237|NCT02388269|156743415|FG001|Overall Study|Adverse Event|0|||
48698238|NCT02388269|156743416|FG002|Overall Study|Adverse Event|0|||
48698239|NCT02388269|156743414|FG000|Overall Study|Withdrawal by Subject|1|||
48698240|NCT02388269|156743415|FG001|Overall Study|Withdrawal by Subject|2|||
48698241|NCT02388269|156743416|FG002|Overall Study|Withdrawal by Subject|0|||
48698242|NCT02388269|156743414|FG000|Overall Study|less than 50% stimulations|1|||
48698243|NCT02388269|156743415|FG001|Overall Study|less than 50% stimulations|0|||
48698244|NCT02388269|156743416|FG002|Overall Study|less than 50% stimulations|0|||
48698245|NCT02388269|156743414|FG000|Overall Study|no diary data|3|||
48698246|NCT02388269|156743415|FG001|Overall Study|no diary data|0|||
48698247|NCT02388269|156743416|FG002|Overall Study|no diary data|0|||
48698248|NCT02388269|156743414|FG000|Overall Study|Protocol Violation|2|||
48698249|NCT02388269|156743415|FG001|Overall Study|Protocol Violation|0|||
48698250|NCT02388269|156743416|FG002|Overall Study|Protocol Violation|0|||
48698251|NCT02388269|156743414|FG000|Overall Study|Screen Failure|0|||
48698252|NCT02388269|156743415|FG001|Overall Study|Screen Failure|0|||
48698253|NCT02388269|156743416|FG002|Overall Study|Screen Failure|10|||
48698254|NCT03988400|156743418|FG000|Overall Study|Adverse Event|1|||
48698255|NCT03988400|156743419|FG001|Overall Study|Adverse Event|0|||
48698256|NCT03988400|156743418|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
48698257|NCT03988400|156743419|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
48698258|NCT03988400|156743418|FG000|Overall Study|Lost to Follow-up|0|||
48698259|NCT03988400|156743419|FG001|Overall Study|Lost to Follow-up|1|||
48698260|NCT02731638|156743423|FG000|Overall Study|Lost to Follow-up|6|||
48698261|NCT02731638|156743424|FG001|Overall Study|Lost to Follow-up|9|||
48698262|NCT01690143|156743425|FG000|Overall Study|Withdrawal by Subject|1|||
48698263|NCT01838395|156743431|FG000|Overall Study|Withdrawal by Subject|0|||
48698264|NCT01838395|156743432|FG001|Overall Study|Withdrawal by Subject|0|||
48698265|NCT01838395|156743433|FG002|Overall Study|Withdrawal by Subject|0|||
48698266|NCT01838395|156743434|FG003|Overall Study|Withdrawal by Subject|0|||
48698267|NCT01838395|156743435|FG004|Overall Study|Withdrawal by Subject|1|||
48698268|NCT01838395|156743436|FG005|Overall Study|Withdrawal by Subject|0|||
48698269|NCT01838395|156743431|FG000|Overall Study|Death|0|||
48698270|NCT01838395|156743432|FG001|Overall Study|Death|0|||
48698271|NCT01838395|156743433|FG002|Overall Study|Death|1|||
48698272|NCT01838395|156743434|FG003|Overall Study|Death|0|||
48698273|NCT01838395|156743435|FG004|Overall Study|Death|0|||
48698274|NCT01838395|156743436|FG005|Overall Study|Death|0|||
48698275|NCT01838395|156743431|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698276|NCT01838395|156743432|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
48698277|NCT01838395|156743433|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698278|NCT01838395|156743434|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698279|NCT01838395|156743435|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698280|NCT01838395|156743436|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
48698281|NCT03474588|156743440|FG000|Overall Study|Withdrawal by Subject|4|||
48698282|NCT03474588|156743441|FG001|Overall Study|Withdrawal by Subject|3|||
48698283|NCT03474588|156743440|FG000|Overall Study|Death|0|||
48698284|NCT03474588|156743441|FG001|Overall Study|Death|1|||
48592825|NCT03131687|156363559|FG001|Overall Study|Inadvertent Enrollment|0|||
48592826|NCT03131687|156363560|FG002|Overall Study|Inadvertent Enrollment|0|||
48592827|NCT03131687|156363561|FG003|Overall Study|Inadvertent Enrollment|1|||
48592828|NCT03131687|156363562|FG004|Overall Study|Inadvertent Enrollment|0|||
48592829|NCT03131687|156363563|FG005|Overall Study|Inadvertent Enrollment|0|||
48592830|NCT02797678|156363564|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
48592831|NCT02797678|156363565|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
48592832|NCT02797678|156363566|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
48592833|NCT02797678|156363567|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
48592834|NCT02797678|156363564|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
48592835|NCT02797678|156363565|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
48592836|NCT02797678|156363566|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
48592837|NCT02797678|156363567|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
48592838|NCT02797678|156363564|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
48592839|NCT02797678|156363565|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
48592840|NCT02797678|156363566|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
48592841|NCT02797678|156363567|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
48592842|NCT03762681|156363572|FG000|Part 1|Withdrawal by Subject|0|||
48592843|NCT03762681|156363573|FG001|Part 1|Withdrawal by Subject|0|||
48592844|NCT03762681|156363574|FG002|Part 1|Withdrawal by Subject|0|||
48698285|NCT05720897|156743442|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
48698286|NCT05720897|156743443|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
48698287|NCT05430854|156743445|FG000|Overall Study|Trial terminated by Sponsor|39|||
48698288|NCT05430854|156743446|FG001|Overall Study|Trial terminated by Sponsor|50|||
48698289|NCT05430854|156743447|FG002|Overall Study|Trial terminated by Sponsor|46|||
48698290|NCT05430854|156743445|FG000|Overall Study|Withdrawal by Subject|0|||
48698291|NCT05430854|156743446|FG001|Overall Study|Withdrawal by Subject|3|||
48698292|NCT05430854|156743447|FG002|Overall Study|Withdrawal by Subject|0|||
48698293|NCT05138653|156743453|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
48698294|NCT05138653|156743454|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698295|NCT05138653|156743455|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698296|NCT05138653|156743456|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698297|NCT05138653|156743457|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698298|NCT05138653|156743458|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698299|NCT05138653|156743459|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698300|NCT05138653|156743460|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698301|NCT05138653|156743461|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698302|NCT05138653|156743462|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698303|NCT05138653|156743463|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698304|NCT05138653|156743464|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698305|NCT05138653|156743465|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698306|NCT05138653|156743466|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698307|NCT05138653|156743467|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698308|NCT05138653|156743468|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
48698309|NCT05138653|156743453|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698310|NCT05138653|156743454|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
48698311|NCT05138653|156743455|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698312|NCT05138653|156743456|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698313|NCT05138653|156743457|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698314|NCT05138653|156743458|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698315|NCT05138653|156743459|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698316|NCT05138653|156743460|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698317|NCT05138653|156743461|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
48698318|NCT05138653|156743462|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698319|NCT05138653|156743463|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698320|NCT05138653|156743464|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698321|NCT05138653|156743465|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698322|NCT05138653|156743466|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698323|NCT05138653|156743467|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698324|NCT05138653|156743468|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
48698325|NCT05138653|156743453|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698326|NCT05138653|156743454|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
48698327|NCT05138653|156743455|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698328|NCT05138653|156743456|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698329|NCT05138653|156743457|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
48698330|NCT05138653|156743458|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698331|NCT05138653|156743459|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698332|NCT05138653|156743460|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698333|NCT05138653|156743461|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698334|NCT05138653|156743462|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698335|NCT05138653|156743463|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698336|NCT05138653|156743464|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698337|NCT05138653|156743465|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698338|NCT05138653|156743466|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698339|NCT05138653|156743467|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698340|NCT05138653|156743468|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
48698341|NCT05138653|156743453|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698342|NCT05138653|156743454|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698343|NCT05138653|156743455|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698344|NCT05138653|156743456|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698345|NCT05138653|156743457|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698346|NCT05138653|156743458|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698347|NCT05138653|156743459|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
48698348|NCT05138653|156743460|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698349|NCT05138653|156743461|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698350|NCT05138653|156743462|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698351|NCT05138653|156743463|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698352|NCT05138653|156743464|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698353|NCT05138653|156743465|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698354|NCT05138653|156743466|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698355|NCT05138653|156743467|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698356|NCT05138653|156743468|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
48698357|NCT05138653|156743453|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698358|NCT05138653|156743454|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698359|NCT05138653|156743455|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698360|NCT05138653|156743456|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698361|NCT05138653|156743457|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698362|NCT05138653|156743458|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698363|NCT05138653|156743459|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698364|NCT05138653|156743460|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698365|NCT05138653|156743461|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698366|NCT05138653|156743462|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698367|NCT05138653|156743463|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
48698368|NCT05138653|156743464|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698369|NCT05138653|156743465|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
48698370|NCT05138653|156743466|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698371|NCT05138653|156743467|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
48698372|NCT05138653|156743468|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
48698373|NCT05138653|156743453|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698374|NCT05138653|156743454|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698375|NCT05138653|156743455|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698376|NCT05138653|156743456|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698377|NCT05138653|156743457|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698378|NCT05138653|156743458|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698379|NCT05138653|156743459|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698380|NCT05138653|156743460|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698381|NCT05138653|156743461|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698382|NCT05138653|156743462|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698383|NCT05138653|156743463|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698384|NCT05138653|156743464|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698385|NCT05138653|156743465|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698386|NCT05138653|156743466|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698387|NCT05138653|156743467|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
48698388|NCT05138653|156743468|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
48698389|NCT05138653|156743453|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698390|NCT05138653|156743454|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698391|NCT05138653|156743455|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48742937|NCT01550289|156910420|FG001|Overall Study|Lost to Follow-up|1|||
48698392|NCT05138653|156743456|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698393|NCT05138653|156743457|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698394|NCT05138653|156743458|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698395|NCT05138653|156743459|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698396|NCT05138653|156743460|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698397|NCT05138653|156743461|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698398|NCT05138653|156743462|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698399|NCT05138653|156743463|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698400|NCT05138653|156743464|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698401|NCT05138653|156743465|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698402|NCT05138653|156743466|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
48698403|NCT05138653|156743467|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698404|NCT05138653|156743468|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
48698405|NCT02023086|156743469|FG000|Overall Study|Withdrawal by Subject|2|||
48698406|NCT02023086|156743470|FG001|Overall Study|Withdrawal by Subject|0|||
48698407|NCT03389477|156743471|FG000|Step 1|Withdrawal by Subject|1|||
48698408|NCT03389477|156743472|FG001|Step 1|Withdrawal by Subject|0|||
48698409|NCT03389477|156743471|FG000|Step 2|Withdrawal by Subject|1|||
48698410|NCT03389477|156743472|FG001|Step 2|Withdrawal by Subject|2|||
48698411|NCT03389477|156743471|FG000|Step 2|Disease progression|1|||
48698412|NCT03389477|156743472|FG001|Step 2|Disease progression|0|||
48698413|NCT03389477|156743471|FG000|Step 2|Death|0|||
48698414|NCT03389477|156743472|FG001|Step 2|Death|1|||
48698415|NCT03389477|156743471|FG000|Step 2|Poor performance status and nutrition|0|||
48698416|NCT03389477|156743472|FG001|Step 2|Poor performance status and nutrition|1|||
48698417|NCT03389477|156743471|FG000|Step 3|Withdrawal after 3 cycles|0|||
48698418|NCT03389477|156743472|FG001|Step 3|Withdrawal after 3 cycles|1|||
48698419|NCT03389477|156743471|FG000|Step 3|Still receiving active treatment|4|||
48698420|NCT03389477|156743472|FG001|Step 3|Still receiving active treatment|0|||
48698421|NCT03389477|156743471|FG000|Step 3|Progressive disease after 2 cycles|1|||
48698422|NCT03389477|156743472|FG001|Step 3|Progressive disease after 2 cycles|0|||
48698423|NCT04659044|156743473|FG000|Induction|Physician Decision|1|||
48698424|NCT04659044|156743473|FG000|Induction|Adverse Event|2|||
48698425|NCT04966013|156743475|FG000|Overall Study|Withdrawal by Subject|0|||
48698426|NCT04966013|156743476|FG001|Overall Study|Withdrawal by Subject|2|||
48698427|NCT04966013|156743477|FG002|Overall Study|Withdrawal by Subject|1|||
48698428|NCT04966013|156743475|FG000|Overall Study|Adverse Event|2|||
48698429|NCT04966013|156743476|FG001|Overall Study|Adverse Event|1|||
48698430|NCT04966013|156743477|FG002|Overall Study|Adverse Event|1|||
48698431|NCT04825574|156743481|FG000|Overall Study|Commercial treatment became available|1|||
48698432|NCT04825574|156743481|FG000|Overall Study|Disease progression|1|||
48698433|NCT02864394|156743487|FG000|Overall Study|Death|184|||
48698434|NCT02864394|156743488|FG001|Overall Study|Death|189|||
48698435|NCT02864394|156743487|FG000|Overall Study|Lost to Follow-up|0|||
48698436|NCT02864394|156743488|FG001|Overall Study|Lost to Follow-up|2|||
48698437|NCT02864394|156743487|FG000|Overall Study|Sponsor Decision|26|||
48698438|NCT02864394|156743488|FG001|Overall Study|Sponsor Decision|11|||
48698439|NCT02864394|156743487|FG000|Overall Study|Withdrawal by Subject|3|||
48698440|NCT02864394|156743488|FG001|Overall Study|Withdrawal by Subject|10|||
48698441|NCT03409796|156745520|FG000|Overall Study|Adverse Event|2|||
48698442|NCT03409796|156745521|FG001|Overall Study|Adverse Event|0|||
48698443|NCT03409796|156745520|FG000|Overall Study|Other|0|||
48698444|NCT03409796|156745521|FG001|Overall Study|Other|1|||
48698445|NCT00740220|156745522|FG000|Overall Study|screen failures (non-COPD patients)|9|||
48698446|NCT02458313|156745524|FG000|Overall Study|Withdrawal by Subject|6|||
48698447|NCT02458313|156745525|FG001|Overall Study|Withdrawal by Subject|8|||
48698448|NCT02458313|156745524|FG000|Overall Study|Excluded for motion during MRI|1|||
48698449|NCT02458313|156745525|FG001|Overall Study|Excluded for motion during MRI|2|||
48698450|NCT02443688|156745532|FG000|Overall Study|Adverse Event|2|||
48698451|NCT02443688|156745533|FG001|Overall Study|Adverse Event|3|||
48698452|NCT02443688|156745534|FG002|Overall Study|Adverse Event|2|||
48698453|NCT02443688|156745532|FG000|Overall Study|Lost to Follow-up|1|||
48698454|NCT02443688|156745533|FG001|Overall Study|Lost to Follow-up|0|||
48698455|NCT02443688|156745534|FG002|Overall Study|Lost to Follow-up|0|||
48698456|NCT02443688|156745532|FG000|Overall Study|Physician Decision|3|||
48698457|NCT02443688|156745533|FG001|Overall Study|Physician Decision|0|||
48698458|NCT02443688|156745534|FG002|Overall Study|Physician Decision|1|||
48698459|NCT02443688|156745532|FG000|Overall Study|Pregnancy|0|||
48698460|NCT02443688|156745533|FG001|Overall Study|Pregnancy|0|||
48698461|NCT02443688|156745534|FG002|Overall Study|Pregnancy|1|||
48698462|NCT02443688|156745532|FG000|Overall Study|Withdrawal by Subject|3|||
48698463|NCT02443688|156745533|FG001|Overall Study|Withdrawal by Subject|3|||
48698464|NCT02443688|156745534|FG002|Overall Study|Withdrawal by Subject|4|||
48698465|NCT02443688|156745532|FG000|Overall Study|Non-compliance with study drug|1|||
48698466|NCT02443688|156745533|FG001|Overall Study|Non-compliance with study drug|2|||
48698467|NCT02443688|156745534|FG002|Overall Study|Non-compliance with study drug|4|||
48698468|NCT02443688|156745532|FG000|Overall Study|Sponsor Request|2|||
48698469|NCT02443688|156745533|FG001|Overall Study|Sponsor Request|1|||
48698470|NCT02443688|156745534|FG002|Overall Study|Sponsor Request|0|||
48698471|NCT02177123|156745537|FG000|Overall Study|Lost to Follow-up|6|||
48698472|NCT02177123|156745537|FG000|Overall Study|Withdrawal by Subject|4|||
48698473|NCT02177123|156745537|FG000|Overall Study|Adverse Event|4|||
48698474|NCT02177123|156745537|FG000|Overall Study|Physician Decision|3|||
48698475|NCT02177123|156745537|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
48698476|NCT02177123|156745537|FG000|Overall Study|Excluded for medical reasons|2|||
48698477|NCT02177123|156745537|FG000|Overall Study|Death|1|||
48698478|NCT02177123|156745537|FG000|Overall Study|Other|1|||
48698479|NCT02177123|156745537|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
48698480|NCT05635461|156745538|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698481|NCT05635461|156745539|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698482|NCT05635461|156745540|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698483|NCT05635461|156745541|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698484|NCT05635461|156745542|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
48698485|NCT05635461|156745543|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
48698486|NCT05635461|156745538|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698487|NCT05635461|156745539|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
48698488|NCT05635461|156745540|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698489|NCT05635461|156745541|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698490|NCT05635461|156745542|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698491|NCT05635461|156745543|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
48698492|NCT05635461|156745538|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698493|NCT05635461|156745539|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698494|NCT05635461|156745540|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698495|NCT05635461|156745541|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
48698496|NCT05635461|156745542|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698497|NCT05635461|156745543|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
48698498|NCT00981656|156745550|FG000|Overall Study|Protocol Violation|1|||
48698499|NCT00981656|156745550|FG000|Overall Study|Did not start protocol treatment|2|||
48698500|NCT00772538|156745554|FG000|Overall Study|Adverse Event|6|||
48698501|NCT00772538|156745555|FG001|Overall Study|Adverse Event|6|||
48698502|NCT00772538|156745554|FG000|Overall Study|Protocol Violation|3|||
48698503|NCT00772538|156745555|FG001|Overall Study|Protocol Violation|3|||
48698504|NCT00772538|156745554|FG000|Overall Study|Lost to Follow-up|1|||
48698505|NCT00772538|156745555|FG001|Overall Study|Lost to Follow-up|1|||
48698506|NCT00772538|156745554|FG000|Overall Study|Withdrawal by Subject|3|||
48698507|NCT00772538|156745555|FG001|Overall Study|Withdrawal by Subject|8|||
48698508|NCT00772538|156745554|FG000|Overall Study|Lack of Efficacy|0|||
48698509|NCT00772538|156745555|FG001|Overall Study|Lack of Efficacy|1|||
48698510|NCT00772538|156745554|FG000|Overall Study|Other|7|||
48698511|NCT00772538|156745555|FG001|Overall Study|Other|7|||
48698512|NCT02085460|156745557|FG000|Overall Study|Adverse Event|2|||
48698513|NCT02085460|156745558|FG001|Overall Study|Adverse Event|2|||
48698514|NCT02085460|156745559|FG002|Overall Study|Adverse Event|1|||
48698515|NCT02085460|156745557|FG000|Overall Study|Physician Decision|1|||
48698516|NCT02085460|156745558|FG001|Overall Study|Physician Decision|1|||
48698517|NCT02085460|156745559|FG002|Overall Study|Physician Decision|2|||
48698518|NCT02085460|156745557|FG000|Overall Study|Withdrawal by Subject|11|||
48698519|NCT02085460|156745558|FG001|Overall Study|Withdrawal by Subject|5|||
48698520|NCT02085460|156745559|FG002|Overall Study|Withdrawal by Subject|7|||
48698521|NCT02230410|156745561|FG000|Overall Study|Screen Failure|3|||
48698522|NCT04629508|156745565|FG000|Overall Study|Adverse Event|1|||
48698523|NCT04629508|156745565|FG000|Overall Study|Death|2|||
48698524|NCT04629508|156745565|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
48698525|NCT01149096|156745569|FG000|Overall Study|Lost to Follow-up|0|||
48698526|NCT01149096|156745570|FG001|Overall Study|Lost to Follow-up|1|||
48698527|NCT04914364|156745571|FG000|Overall Study|No longer eligible for study|1|||
48698528|NCT04914364|156745571|FG000|Overall Study|Lost to Follow-up|2|||
48698529|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698530|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698531|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698532|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
48698533|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698534|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698535|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698536|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698537|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698538|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
48698539|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
48698540|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
48698541|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698542|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
48698543|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
48698544|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
48698545|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698546|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698547|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698548|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
48698549|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
48698550|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
48698551|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
48698552|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
48698553|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
48698554|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
48698555|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
48698556|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
48698557|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
48698558|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
48698559|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
48698560|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698561|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
48698562|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698563|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
48698564|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
48698565|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698566|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698567|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698568|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
48698569|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
48698570|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698571|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
48698572|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698573|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
48698574|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698575|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698576|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698577|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698578|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
48698579|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
48698580|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698581|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698582|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698583|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
48698584|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
48698585|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698586|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698587|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698588|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
48698589|NCT02365649|156745580|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698590|NCT02365649|156745581|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698591|NCT02365649|156745582|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
48698592|NCT02365649|156745583|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698593|NCT02365649|156745584|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698594|NCT02365649|156745585|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698595|NCT02365649|156745586|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698596|NCT02365649|156745587|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698597|NCT02365649|156745588|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698598|NCT02365649|156745589|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
48698599|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698600|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698601|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698602|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698603|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698604|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698605|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
48698606|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698607|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698608|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
48698609|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698610|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698611|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698612|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698613|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698614|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48698615|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
48698616|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
48592845|NCT03762681|156363575|FG003|Part 1|Withdrawal by Subject|1|||
48698617|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
48698618|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
48698619|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698620|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698621|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698622|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698623|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698624|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
48698625|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
48698626|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
48698627|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
48698628|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
48698629|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698630|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698631|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698632|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698633|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698634|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698635|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
48698636|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
48698637|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
48698638|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
48698639|NCT02365649|156745580|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698640|NCT02365649|156745581|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698641|NCT02365649|156745582|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698642|NCT02365649|156745583|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698643|NCT02365649|156745584|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698644|NCT02365649|156745585|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698645|NCT02365649|156745586|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
48698646|NCT02365649|156745587|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698647|NCT02365649|156745588|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
48698648|NCT02365649|156745589|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
48698649|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
48698650|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
48698651|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
48698652|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
48698653|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
48698654|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
48698655|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
48698656|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
48698657|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
48698658|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
48698659|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
48698660|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
48698661|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
48698662|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
48698663|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
48698664|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
48698665|NCT03773978|156745591|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
48698666|NCT03773978|156745592|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
48698667|NCT03773978|156745591|FG000|DBW Period|Adverse Event|2|||
48698668|NCT03773978|156745592|FG001|DBW Period|Adverse Event|2|||
48698669|NCT03773978|156745591|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
48698670|NCT03773978|156745592|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
48698671|NCT03773978|156745591|FG000|DBW Period|Withdrawal by Subject|2|||
48698672|NCT03773978|156745592|FG001|DBW Period|Withdrawal by Subject|1|||
48698673|NCT03773978|156745591|FG000|DBW Period|Due to epidemic or pandemic|5|||
48698674|NCT03773978|156745592|FG001|DBW Period|Due to epidemic or pandemic|6|||
48698675|NCT03773978|156745591|FG000|DBW Period|Study team decision|1|||
48698676|NCT03773978|156745592|FG001|DBW Period|Study team decision|0|||
48698677|NCT01345240|156745593|FG000|Overall Study|Adverse Event|3|||
48698678|NCT01345240|156745594|FG001|Overall Study|Adverse Event|5|||
48698679|NCT01345240|156745595|FG002|Overall Study|Adverse Event|4|||
48698680|NCT01345240|156745596|FG003|Overall Study|Adverse Event|2|||
48698681|NCT01345240|156745597|FG004|Overall Study|Adverse Event|1|||
48698682|NCT01345240|156745593|FG000|Overall Study|Lost to Follow-up|8|||
48698683|NCT01345240|156745594|FG001|Overall Study|Lost to Follow-up|9|||
48698684|NCT01345240|156745595|FG002|Overall Study|Lost to Follow-up|14|||
48698685|NCT01345240|156745596|FG003|Overall Study|Lost to Follow-up|7|||
48698686|NCT01345240|156745597|FG004|Overall Study|Lost to Follow-up|9|||
48698687|NCT04298697|156745598|FG000|Overall Study|Lost to Follow-up|5|||
48698688|NCT04298697|156745599|FG001|Overall Study|Lost to Follow-up|5|||
48698689|NCT04298697|156745600|FG002|Overall Study|Lost to Follow-up|1|||
48698690|NCT04298697|156745601|FG003|Overall Study|Lost to Follow-up|0|||
48698691|NCT04298697|156745598|FG000|Overall Study|Withdrawal by Subject|0|||
48698692|NCT04298697|156745599|FG001|Overall Study|Withdrawal by Subject|3|||
48698693|NCT04298697|156745600|FG002|Overall Study|Withdrawal by Subject|2|||
48698694|NCT04298697|156745601|FG003|Overall Study|Withdrawal by Subject|3|||
48698695|NCT02246530|156745604|FG000|Overall Study|Lost to Follow-up|4|||
48698696|NCT02246530|156745605|FG001|Overall Study|Lost to Follow-up|0|||
48698697|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
48698698|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
48698699|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
48698700|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
48698701|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
48698702|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
48698703|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
48698704|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
48698705|NCT04576988|156745606|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
48698706|NCT04576988|156745607|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
48698707|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
48698708|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
48698709|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
48698710|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
48698711|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
48698712|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
48698713|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Death|2|||
48698714|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Death|1|||
48698715|NCT04576988|156745606|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
48698716|NCT04576988|156745607|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
48698717|NCT00474812|156745608|FG000|Overall Study|Withdrawal by Subject|5|||
48698718|NCT00474812|156745608|FG000|Overall Study|No Initiation of treatment|2|||
48698719|NCT01506596|156745609|FG000|Overall Study|ineligible pathology|1|||
48698720|NCT00771758|156745610|FG000|Overall Study|Adverse Event|2|||
48698721|NCT00771758|156745611|FG001|Overall Study|Adverse Event|8|||
48698722|NCT00771758|156745612|FG002|Overall Study|Adverse Event|1|||
48698723|NCT00771758|156745610|FG000|Overall Study|Lack of Efficacy|0|||
48698724|NCT00771758|156745611|FG001|Overall Study|Lack of Efficacy|2|||
48698725|NCT00771758|156745612|FG002|Overall Study|Lack of Efficacy|1|||
48698726|NCT00771758|156745610|FG000|Overall Study|Lost to Follow-up|1|||
48698727|NCT00771758|156745611|FG001|Overall Study|Lost to Follow-up|0|||
48698728|NCT00771758|156745612|FG002|Overall Study|Lost to Follow-up|0|||
48698729|NCT00771758|156745610|FG000|Overall Study|Protocol Violation|1|||
48698730|NCT00771758|156745611|FG001|Overall Study|Protocol Violation|0|||
48698731|NCT00771758|156745612|FG002|Overall Study|Protocol Violation|0|||
48698732|NCT00771758|156745610|FG000|Overall Study|Withdrawal by Subject|1|||
48698733|NCT00771758|156745611|FG001|Overall Study|Withdrawal by Subject|0|||
48698734|NCT00771758|156745612|FG002|Overall Study|Withdrawal by Subject|0|||
48698735|NCT00771758|156745610|FG000|Overall Study|Other|3|||
48698736|NCT00771758|156745611|FG001|Overall Study|Other|2|||
48698737|NCT00771758|156745612|FG002|Overall Study|Other|0|||
48698738|NCT05712460|156745615|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698739|NCT05712460|156745616|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698740|NCT05712460|156745617|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698741|NCT05712460|156745618|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698742|NCT05712460|156745619|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698743|NCT05712460|156745620|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698744|NCT05712460|156745621|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698745|NCT05712460|156745622|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
48698746|NCT05712460|156745623|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698747|NCT05712460|156745624|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698748|NCT05712460|156745625|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698749|NCT05712460|156745626|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
48698750|NCT02002598|156745632|FG000|Dose Level 1|Withdrawal by Subject|1|||
48698751|NCT02002598|156745633|FG001|Dose Level 1|Withdrawal by Subject|0|||
48698752|NCT02002598|156745634|FG002|Dose Level 1|Withdrawal by Subject|0|||
48698753|NCT02002598|156745635|FG003|Dose Level 1|Withdrawal by Subject|0|||
48698754|NCT02002598|156745636|FG004|Dose Level 1|Withdrawal by Subject|0|||
48698755|NCT04672239|156745637|FG000|Week 2 Survey|Failed survey check items|1|||
48698756|NCT04672239|156745638|FG001|Week 2 Survey|Failed survey check items|2|||
48698757|NCT04672239|156745639|FG002|Week 2 Survey|Failed survey check items|3|||
48698758|NCT04672239|156745637|FG000|Week 2 Survey|Partially completed survey|7|||
48698759|NCT04672239|156745638|FG001|Week 2 Survey|Partially completed survey|1|||
48698760|NCT04672239|156745639|FG002|Week 2 Survey|Partially completed survey|4|||
48698761|NCT04672239|156745637|FG000|Week 2 Survey|Withdrawal by Subject|0|||
48698762|NCT04672239|156745638|FG001|Week 2 Survey|Withdrawal by Subject|1|||
48698763|NCT04672239|156745639|FG002|Week 2 Survey|Withdrawal by Subject|0|||
48698764|NCT04672239|156745637|FG000|Week 2 Survey|Lost to Follow-up|3|||
48698765|NCT04672239|156745638|FG001|Week 2 Survey|Lost to Follow-up|2|||
48698766|NCT04672239|156745639|FG002|Week 2 Survey|Lost to Follow-up|5|||
48698767|NCT04672239|156745637|FG000|Week 6 Survey|Failed survey check items|2|||
48698768|NCT04672239|156745638|FG001|Week 6 Survey|Failed survey check items|2|||
48698769|NCT04672239|156745639|FG002|Week 6 Survey|Failed survey check items|2|||
48698770|NCT04672239|156745637|FG000|Week 6 Survey|Partially completed survey|3|||
48698771|NCT04672239|156745638|FG001|Week 6 Survey|Partially completed survey|3|||
48698772|NCT04672239|156745639|FG002|Week 6 Survey|Partially completed survey|2|||
48698773|NCT04672239|156745637|FG000|Week 6 Survey|Withdrawal by Subject|1|||
48698774|NCT04672239|156745638|FG001|Week 6 Survey|Withdrawal by Subject|1|||
48698775|NCT04672239|156745639|FG002|Week 6 Survey|Withdrawal by Subject|1|||
48698776|NCT04672239|156745637|FG000|Week 6 Survey|Withdrawn by PI|0|||
48698777|NCT04672239|156745638|FG001|Week 6 Survey|Withdrawn by PI|1|||
48698778|NCT04672239|156745639|FG002|Week 6 Survey|Withdrawn by PI|0|||
48698779|NCT04672239|156745637|FG000|Week 6 Survey|Lost to Follow-up|12|||
48698780|NCT04672239|156745638|FG001|Week 6 Survey|Lost to Follow-up|2|||
48698781|NCT04672239|156745639|FG002|Week 6 Survey|Lost to Follow-up|5|||
48698782|NCT04672239|156745637|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
48698783|NCT04672239|156745638|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
48698784|NCT04672239|156745639|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
48698785|NCT04672239|156745637|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
48698786|NCT04672239|156745638|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
48698787|NCT04672239|156745639|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
48698788|NCT04672239|156745637|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
48698789|NCT04672239|156745638|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
48698790|NCT04672239|156745639|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
48698791|NCT04672239|156745637|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
48698792|NCT04672239|156745638|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
48698793|NCT04672239|156745639|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
48698794|NCT04672239|156745637|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
48698795|NCT04672239|156745638|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
48698796|NCT04672239|156745639|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
48698797|NCT04672239|156745637|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
48698798|NCT04672239|156745638|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
48698799|NCT04672239|156745639|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
48698800|NCT04672239|156745637|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
48698801|NCT04672239|156745638|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
48698802|NCT04672239|156745639|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
48698803|NCT05194124|156745644|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698804|NCT05194124|156745645|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698805|NCT05194124|156745646|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698806|NCT05194124|156745647|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
48698807|NCT05194124|156745648|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698808|NCT05194124|156745649|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
48698809|NCT05194124|156745650|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698810|NCT05194124|156745651|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698811|NCT05194124|156745652|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698812|NCT05194124|156745653|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
48698813|NCT05194124|156745644|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698814|NCT05194124|156745645|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698815|NCT05194124|156745646|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698816|NCT05194124|156745647|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698817|NCT05194124|156745648|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698818|NCT05194124|156745649|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698819|NCT05194124|156745650|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698820|NCT05194124|156745651|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698821|NCT05194124|156745652|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
48698822|NCT05194124|156745653|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
48698823|NCT03221556|156745654|FG000|Allocation|post-randomization exclusion|0|||
48698824|NCT03221556|156745655|FG001|Allocation|post-randomization exclusion|1|||
48698825|NCT03221556|156745654|FG000|Follow-Up|Withdrawal by Subject|0|||
48698826|NCT03221556|156745655|FG001|Follow-Up|Withdrawal by Subject|1|||
48698827|NCT03589859|156745656|FG000|Overall Study|Withdrawal by Subject|0|||
48698828|NCT03589859|156745657|FG001|Overall Study|Withdrawal by Subject|6|||
48698829|NCT05417438|156745658|FG000|Overall Study|Withdrawal by Subject|3|||
48698830|NCT04272242|156745659|FG000|Overall Study|Withdrawal by Subject|3|||
48698831|NCT04272242|156745659|FG000|Overall Study|Lost to Follow-up|1|||
48698832|NCT04272242|156745659|FG000|Overall Study|Adverse Event|1|||
48698833|NCT02702492|156745660|FG000|Overall Study|Disease progression|3|||
48698834|NCT02702492|156745661|FG001|Overall Study|Disease progression|3|||
48698835|NCT02702492|156745662|FG002|Overall Study|Disease progression|2|||
48698836|NCT02702492|156745663|FG003|Overall Study|Disease progression|4|||
48698837|NCT02702492|156745664|FG004|Overall Study|Disease progression|4|||
48698838|NCT02702492|156745665|FG005|Overall Study|Disease progression|1|||
48698839|NCT02702492|156745666|FG006|Overall Study|Disease progression|2|||
48698840|NCT02702492|156745667|FG007|Overall Study|Disease progression|8|||
48698841|NCT02702492|156745668|FG008|Overall Study|Disease progression|5|||
48698842|NCT02702492|156745669|FG009|Overall Study|Disease progression|1|||
48698843|NCT02702492|156745670|FG010|Overall Study|Disease progression|0|||
48698844|NCT02702492|156745671|FG011|Overall Study|Disease progression|3|||
48698845|NCT02702492|156745672|FG012|Overall Study|Disease progression|2|||
48698846|NCT02702492|156745660|FG000|Overall Study|Clinical progression|0|||
48698847|NCT02702492|156745661|FG001|Overall Study|Clinical progression|0|||
48698848|NCT02702492|156745662|FG002|Overall Study|Clinical progression|2|||
48698849|NCT02702492|156745663|FG003|Overall Study|Clinical progression|1|||
48698850|NCT02702492|156745664|FG004|Overall Study|Clinical progression|0|||
48698851|NCT02702492|156745665|FG005|Overall Study|Clinical progression|2|||
48698852|NCT02702492|156745666|FG006|Overall Study|Clinical progression|1|||
48698853|NCT02702492|156745667|FG007|Overall Study|Clinical progression|4|||
48698854|NCT02702492|156745668|FG008|Overall Study|Clinical progression|0|||
48698855|NCT02702492|156745669|FG009|Overall Study|Clinical progression|0|||
48487725|NCT01270841|155980755|FG002|Overall Study|Did not qualify|4|||
48698856|NCT02702492|156745670|FG010|Overall Study|Clinical progression|1|||
48698857|NCT02702492|156745671|FG011|Overall Study|Clinical progression|2|||
48698858|NCT02702492|156745672|FG012|Overall Study|Clinical progression|0|||
48698859|NCT02702492|156745660|FG000|Overall Study|Adverse Event|0|||
48698860|NCT02702492|156745661|FG001|Overall Study|Adverse Event|0|||
48698861|NCT02702492|156745662|FG002|Overall Study|Adverse Event|1|||
48698862|NCT02702492|156745663|FG003|Overall Study|Adverse Event|2|||
48698863|NCT02702492|156745664|FG004|Overall Study|Adverse Event|1|||
48698864|NCT02702492|156745665|FG005|Overall Study|Adverse Event|0|||
48698865|NCT02702492|156745666|FG006|Overall Study|Adverse Event|1|||
48698866|NCT02702492|156745667|FG007|Overall Study|Adverse Event|0|||
48698867|NCT02702492|156745668|FG008|Overall Study|Adverse Event|2|||
48698868|NCT02702492|156745669|FG009|Overall Study|Adverse Event|0|||
48698869|NCT02702492|156745670|FG010|Overall Study|Adverse Event|0|||
48698870|NCT02702492|156745671|FG011|Overall Study|Adverse Event|0|||
48698871|NCT02702492|156745672|FG012|Overall Study|Adverse Event|1|||
48698872|NCT02702492|156745660|FG000|Overall Study|Other|0|||
48698873|NCT02702492|156745661|FG001|Overall Study|Other|0|||
48698874|NCT02702492|156745662|FG002|Overall Study|Other|0|||
48698875|NCT02702492|156745663|FG003|Overall Study|Other|0|||
48698876|NCT02702492|156745664|FG004|Overall Study|Other|0|||
48698877|NCT02702492|156745665|FG005|Overall Study|Other|0|||
48698878|NCT02702492|156745666|FG006|Overall Study|Other|0|||
48698879|NCT02702492|156745667|FG007|Overall Study|Other|0|||
48698880|NCT02702492|156745668|FG008|Overall Study|Other|0|||
48698881|NCT02702492|156745669|FG009|Overall Study|Other|0|||
48698882|NCT02702492|156745670|FG010|Overall Study|Other|0|||
48698883|NCT02702492|156745671|FG011|Overall Study|Other|0|||
48698884|NCT02702492|156745672|FG012|Overall Study|Other|1|||
48698885|NCT01097668|156746832|FG000|Overall Study|Withdrawal by Subject|1|||
48698886|NCT01097668|156746833|FG001|Overall Study|Withdrawal by Subject|2|||
48698887|NCT01097668|156746832|FG000|Overall Study|Lost to Follow-up|1|||
48698888|NCT01097668|156746833|FG001|Overall Study|Lost to Follow-up|0|||
48698889|NCT01419236|156746836|FG000|Overall Study|Adverse Event|1|||
48698890|NCT01419236|156746837|FG001|Overall Study|Adverse Event|0|||
48698891|NCT01419236|156746836|FG000|Overall Study|Lack of Efficacy|0|||
48698892|NCT01419236|156746837|FG001|Overall Study|Lack of Efficacy|1|||
48698893|NCT01419236|156746836|FG000|Overall Study|Lost to Follow-up|1|||
48698894|NCT01419236|156746837|FG001|Overall Study|Lost to Follow-up|0|||
48698895|NCT01419236|156746836|FG000|Overall Study|Physician Decision|1|||
48698896|NCT01419236|156746837|FG001|Overall Study|Physician Decision|0|||
48698897|NCT01419236|156746836|FG000|Overall Study|Withdrawal by Subject|1|||
48698898|NCT01419236|156746837|FG001|Overall Study|Withdrawal by Subject|4|||
48698899|NCT01419236|156746836|FG000|Overall Study|Entry Criteria Not Met|1|||
48698900|NCT01419236|156746837|FG001|Overall Study|Entry Criteria Not Met|0|||
48698901|NCT04456504|156746839|FG000|Overall Study|Lost to Follow-up|2|||
48698902|NCT01131507|156746840|FG000|Overall Study|Adverse Event|1|||
48698903|NCT01131507|156746840|FG000|Overall Study|Lost to Follow-up|1|||
48698904|NCT01131507|156746840|FG000|Overall Study|Withdrawal by Subject|1|||
48698905|NCT02173769|156746849|FG000|Overall Study|Protocol Violation|4|||
48698906|NCT01775501|156746852|FG000|Overall Study|Discontinued prior to treatment|1|||
48698907|NCT05291520|156746857|FG000|Overall Study|Lost to Follow-up|0|||
48698908|NCT05291520|156746858|FG001|Overall Study|Lost to Follow-up|0|||
48698909|NCT05291520|156746859|FG002|Overall Study|Lost to Follow-up|1|||
48698910|NCT00948246|156746863|FG000|Overall Study|Lost to Follow-up|11|||
48698911|NCT00948246|156746863|FG000|Overall Study|Adverse Event|11|||
48698912|NCT00948246|156746863|FG000|Overall Study|Death|1|||
48698913|NCT00948246|156746863|FG000|Overall Study|Withdrawal by Subject|1|||
48698914|NCT04106557|156746864|FG000|Overall Study|Physician Decision|0|||
48698915|NCT04106557|156746865|FG001|Overall Study|Physician Decision|1|||
48698916|NCT04106557|156746866|FG002|Overall Study|Physician Decision|0|||
48698917|NCT04106557|156746864|FG000|Overall Study|Protocol Violation|0|||
48698918|NCT04106557|156746865|FG001|Overall Study|Protocol Violation|1|||
48698919|NCT04106557|156746866|FG002|Overall Study|Protocol Violation|0|||
48698920|NCT04607668|156746869|FG000|Overall Study|Death|49|||
48698921|NCT04607668|156746870|FG001|Overall Study|Death|26|||
48698922|NCT04607668|156746869|FG000|Overall Study|Lost to Follow-up|3|||
48698923|NCT04607668|156746870|FG001|Overall Study|Lost to Follow-up|4|||
48698924|NCT04607668|156746869|FG000|Overall Study|Study terminated by Sponsor|92|||
48698925|NCT04607668|156746870|FG001|Overall Study|Study terminated by Sponsor|114|||
48698926|NCT04607668|156746869|FG000|Overall Study|Withdrawal by Subject|12|||
48698927|NCT04607668|156746870|FG001|Overall Study|Withdrawal by Subject|11|||
48698928|NCT04607668|156746869|FG000|Overall Study|Other, unspecified|8|||
48698929|NCT04607668|156746870|FG001|Overall Study|Other, unspecified|7|||
48698930|NCT02250326|156746871|FG000|Treatment|Death|1|||
48698931|NCT02250326|156746872|FG001|Treatment|Death|13|||
48698932|NCT02250326|156746873|FG002|Treatment|Death|2|||
48698933|NCT02250326|156746871|FG000|Treatment|Adverse Event|8|||
48698934|NCT02250326|156746872|FG001|Treatment|Adverse Event|8|||
48698935|NCT02250326|156746873|FG002|Treatment|Adverse Event|9|||
48698936|NCT02250326|156746871|FG000|Treatment|Progressive Disease|42|||
48698937|NCT02250326|156746872|FG001|Treatment|Progressive Disease|40|||
48698938|NCT02250326|156746873|FG002|Treatment|Progressive Disease|47|||
48698939|NCT02250326|156746871|FG000|Treatment|Symptomatic Deterioration|9|||
48698940|NCT02250326|156746872|FG001|Treatment|Symptomatic Deterioration|4|||
48698941|NCT02250326|156746873|FG002|Treatment|Symptomatic Deterioration|10|||
48698942|NCT02250326|156746871|FG000|Treatment|Withdrawal by Subject|11|||
48698943|NCT02250326|156746872|FG001|Treatment|Withdrawal by Subject|6|||
48698944|NCT02250326|156746873|FG002|Treatment|Withdrawal by Subject|4|||
48698945|NCT02250326|156746871|FG000|Treatment|Other reasons|8|||
48698946|NCT02250326|156746872|FG001|Treatment|Other reasons|7|||
48698947|NCT02250326|156746873|FG002|Treatment|Other reasons|7|||
48698948|NCT02250326|156746871|FG000|Extension Period|Progressive Disease|0|||
48698949|NCT02250326|156746872|FG001|Extension Period|Progressive Disease|2|||
48698950|NCT02250326|156746873|FG002|Extension Period|Progressive Disease|0|||
48698951|NCT02250326|156746871|FG000|Extension Period|Withdrawal by Subject|0|||
48698952|NCT02250326|156746872|FG001|Extension Period|Withdrawal by Subject|1|||
48698953|NCT02250326|156746873|FG002|Extension Period|Withdrawal by Subject|0|||
48698954|NCT02250326|156746871|FG000|Extension Period|Withdrawal by investigator|0|||
48698955|NCT02250326|156746872|FG001|Extension Period|Withdrawal by investigator|1|||
48698956|NCT02250326|156746873|FG002|Extension Period|Withdrawal by investigator|0|||
48698957|NCT04199351|156746875|FG000|Overall Study|Decision by sponsor|0|||
48698958|NCT04199351|156746876|FG001|Overall Study|Decision by sponsor|0|||
48698959|NCT04199351|156746877|FG002|Overall Study|Decision by sponsor|0|||
48698960|NCT04199351|156746878|FG003|Overall Study|Decision by sponsor|2|||
48698961|NCT04199351|156746879|FG004|Overall Study|Decision by sponsor|0|||
48698962|NCT04199351|156746880|FG005|Overall Study|Decision by sponsor|0|||
48698963|NCT04199351|156746881|FG006|Overall Study|Decision by sponsor|0|||
48698964|NCT04199351|156746882|FG007|Overall Study|Decision by sponsor|0|||
48698965|NCT04199351|156746883|FG008|Overall Study|Decision by sponsor|0|||
48698966|NCT04199351|156746884|FG009|Overall Study|Decision by sponsor|6|||
48698967|NCT04199351|156746875|FG000|Overall Study|Lost to Follow-up|0|||
48698968|NCT04199351|156746876|FG001|Overall Study|Lost to Follow-up|0|||
48698969|NCT04199351|156746877|FG002|Overall Study|Lost to Follow-up|1|||
48698970|NCT04199351|156746878|FG003|Overall Study|Lost to Follow-up|0|||
48698971|NCT04199351|156746879|FG004|Overall Study|Lost to Follow-up|0|||
48698972|NCT04199351|156746880|FG005|Overall Study|Lost to Follow-up|1|||
48698973|NCT04199351|156746881|FG006|Overall Study|Lost to Follow-up|0|||
48698974|NCT04199351|156746882|FG007|Overall Study|Lost to Follow-up|0|||
48698975|NCT04199351|156746883|FG008|Overall Study|Lost to Follow-up|0|||
48698976|NCT04199351|156746884|FG009|Overall Study|Lost to Follow-up|0|||
48698977|NCT04199351|156746875|FG000|Overall Study|Withdrawal by Subject|0|||
48698978|NCT04199351|156746876|FG001|Overall Study|Withdrawal by Subject|1|||
48698979|NCT04199351|156746877|FG002|Overall Study|Withdrawal by Subject|0|||
48698980|NCT04199351|156746878|FG003|Overall Study|Withdrawal by Subject|0|||
48698981|NCT04199351|156746879|FG004|Overall Study|Withdrawal by Subject|1|||
48698982|NCT04199351|156746880|FG005|Overall Study|Withdrawal by Subject|4|||
48698983|NCT04199351|156746881|FG006|Overall Study|Withdrawal by Subject|2|||
48698984|NCT04199351|156746882|FG007|Overall Study|Withdrawal by Subject|0|||
48698985|NCT04199351|156746883|FG008|Overall Study|Withdrawal by Subject|3|||
48698986|NCT04199351|156746884|FG009|Overall Study|Withdrawal by Subject|0|||
48698987|NCT03459079|156746885|FG000|Overall Study|Adverse Event|4|||
48698988|NCT03459079|156746886|FG001|Overall Study|Adverse Event|2|||
48698989|NCT03459079|156746887|FG002|Overall Study|Adverse Event|0|||
48698990|NCT03459079|156746885|FG000|Overall Study|Withdrawal by Subject|2|||
48698991|NCT03459079|156746886|FG001|Overall Study|Withdrawal by Subject|2|||
48698992|NCT03459079|156746887|FG002|Overall Study|Withdrawal by Subject|0|||
48698993|NCT01251965|156746898|FG000|Overall Study|Participant/physician decision|1|||
48698994|NCT01251965|156746899|FG001|Overall Study|Participant/physician decision|2|||
48698995|NCT01251965|156746900|FG002|Overall Study|Participant/physician decision|0|||
48698996|NCT01251965|156746898|FG000|Overall Study|Death|0|||
48698997|NCT01251965|156746899|FG001|Overall Study|Death|0|||
48698998|NCT01251965|156746900|FG002|Overall Study|Death|11|||
48698999|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
48699000|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
48699001|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
48699002|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
48699003|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
48699004|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
48699005|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
48699006|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
48699007|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
48699008|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48699009|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48699010|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48699011|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
48699012|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
48699013|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
48699014|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
48699015|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
48432163|NCT01199263|155769047|FG000|Overall Study|Never Treated|6|||
48699016|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
48699017|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
48699018|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
48699019|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
48699020|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
48699021|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48699022|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48699023|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
48699024|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
48699025|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
48699026|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
48699027|NCT04026113|156746906|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48699028|NCT04026113|156746907|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
48699029|NCT04026113|156746908|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48699030|NCT04026113|156746909|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48699031|NCT04026113|156746906|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
48699032|NCT04026113|156746907|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
48699033|NCT04026113|156746908|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
48699034|NCT04026113|156746909|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
48699035|NCT00886379|156746912|FG000|Overall Study|Transferred Schools|0|||
48699036|NCT00886379|156746913|FG001|Overall Study|Transferred Schools|0|||
48699037|NCT00886379|156746914|FG002|Overall Study|Transferred Schools|2|||
48699038|NCT00886379|156746915|FG003|Overall Study|Transferred Schools|1|||
48699039|NCT00886379|156746916|FG004|Overall Study|Transferred Schools|1|||
48699040|NCT00886379|156746912|FG000|Overall Study|Final blood draw not obtained|3|||
48699041|NCT00886379|156746913|FG001|Overall Study|Final blood draw not obtained|3|||
48699042|NCT00886379|156746914|FG002|Overall Study|Final blood draw not obtained|4|||
48699043|NCT00886379|156746915|FG003|Overall Study|Final blood draw not obtained|2|||
48699044|NCT00886379|156746916|FG004|Overall Study|Final blood draw not obtained|2|||
48699045|NCT03962491|156746917|FG000|Overall Study|Lost to Follow-up|4|||
48699046|NCT03962491|156746918|FG001|Overall Study|Lost to Follow-up|5|||
48699047|NCT03675126|156746922|FG000|Overall Study|Study Terminated by Sponsor|9|||
48699048|NCT03675126|156746922|FG000|Overall Study|Death|2|||
48699049|NCT03675126|156746922|FG000|Overall Study|Withdrawal by Subject|4|||
48699050|NCT02718898|156746926|FG000|Blinded Treatment Period|Adverse Event|5|||
48699051|NCT02718898|156746927|FG001|Blinded Treatment Period|Adverse Event|1|||
48699052|NCT02718898|156746928|FG002|Blinded Treatment Period|Adverse Event|0|||
48699053|NCT02718898|156746929|FG003|Blinded Treatment Period|Adverse Event|0|||
48699054|NCT02718898|156746930|FG004|Blinded Treatment Period|Adverse Event|0|||
48699055|NCT02718898|156746931|FG005|Blinded Treatment Period|Adverse Event|0|||
48699056|NCT02718898|156746932|FG006|Blinded Treatment Period|Adverse Event|0|||
48699057|NCT02718898|156746926|FG000|Blinded Treatment Period|Physician Decision|1|||
48699058|NCT02718898|156746927|FG001|Blinded Treatment Period|Physician Decision|0|||
48699059|NCT02718898|156746928|FG002|Blinded Treatment Period|Physician Decision|0|||
48699060|NCT02718898|156746929|FG003|Blinded Treatment Period|Physician Decision|0|||
48699061|NCT02718898|156746930|FG004|Blinded Treatment Period|Physician Decision|0|||
48699062|NCT02718898|156746931|FG005|Blinded Treatment Period|Physician Decision|0|||
48699063|NCT02718898|156746932|FG006|Blinded Treatment Period|Physician Decision|0|||
48699064|NCT02718898|156746926|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
48699065|NCT02718898|156746927|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
48699066|NCT02718898|156746928|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
48699067|NCT02718898|156746929|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
48699068|NCT02718898|156746930|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
48699069|NCT02718898|156746931|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
48699070|NCT02718898|156746932|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
48699071|NCT02718898|156746926|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
48699072|NCT02718898|156746927|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
48699073|NCT02718898|156746928|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
48699074|NCT02718898|156746929|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
48699075|NCT02718898|156746930|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
48699076|NCT02718898|156746931|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
48699077|NCT02718898|156746932|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
48699078|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699079|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699080|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
48699081|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
48699082|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699083|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699084|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
48699085|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699086|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699087|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699088|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
48699089|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699090|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699091|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
48699092|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699093|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699094|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
48699095|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
48699096|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699097|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699098|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48699099|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699100|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699101|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
48699102|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
48699103|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699104|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699105|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
48699106|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699107|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699108|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699109|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
48699110|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699111|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699112|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
48699113|NCT02718898|156746926|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699114|NCT02718898|156746927|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699115|NCT02718898|156746928|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699116|NCT02718898|156746929|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
48699117|NCT02718898|156746930|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699118|NCT02718898|156746931|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699119|NCT02718898|156746932|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
48699120|NCT02718898|156746926|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
48699121|NCT02718898|156746927|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
48699122|NCT02718898|156746928|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
48699123|NCT02718898|156746929|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
48699124|NCT02718898|156746930|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
48699125|NCT02718898|156746931|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
48699126|NCT02718898|156746932|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
48699127|NCT02718898|156746926|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
48699128|NCT02718898|156746927|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
48699129|NCT02718898|156746928|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
48699130|NCT02718898|156746929|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
48699131|NCT02718898|156746930|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
48699132|NCT02718898|156746931|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
48699133|NCT02718898|156746932|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
48699134|NCT02718898|156746926|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699135|NCT02718898|156746927|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699136|NCT02718898|156746928|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699137|NCT02718898|156746929|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699138|NCT02718898|156746930|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48699139|NCT02718898|156746931|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
48699140|NCT02718898|156746932|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
48699141|NCT00231816|156746938|FG000|Overall Study|Adverse Event|1|||
48699142|NCT00231816|156746939|FG001|Overall Study|Adverse Event|0|||
48699143|NCT00231816|156746938|FG000|Overall Study|Lost to Follow-up|8|||
48699144|NCT00231816|156746939|FG001|Overall Study|Lost to Follow-up|5|||
48699145|NCT00231816|156746938|FG000|Overall Study|Protocol Violation|2|||
48699146|NCT00231816|156746939|FG001|Overall Study|Protocol Violation|3|||
48699147|NCT00231816|156746938|FG000|Overall Study|Withdrawal by Subject|3|||
48699148|NCT00231816|156746939|FG001|Overall Study|Withdrawal by Subject|3|||
48699149|NCT00231816|156746938|FG000|Overall Study|Other|2|||
48699150|NCT00231816|156746939|FG001|Overall Study|Other|1|||
48699151|NCT01052493|156746940|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
48798426|NCT02453685|157098660|FG000|Overall Study|Protocol Violation|7|||
48699152|NCT01052493|156746941|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
48699153|NCT01052493|156746942|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
48699154|NCT00004563|156746943|FG000|Overall Study|Withdrawal by Subject|20|||
48699155|NCT00004563|156746944|FG001|Overall Study|Withdrawal by Subject|16|||
48699156|NCT00004563|156746943|FG000|Overall Study|Lack of Efficacy|3|||
48699157|NCT00004563|156746944|FG001|Overall Study|Lack of Efficacy|5|||
48699158|NCT00004563|156746943|FG000|Overall Study|Death|2|||
48699159|NCT00004563|156746944|FG001|Overall Study|Death|3|||
48699160|NCT00762164|156746945|FG000|Overall Study|Lost to Follow-up|1|||
48699161|NCT00762164|156746946|FG001|Overall Study|Lost to Follow-up|1|||
48699162|NCT00762164|156746945|FG000|Overall Study|Discontinued medication|2|||
48699163|NCT00762164|156746946|FG001|Overall Study|Discontinued medication|0|||
48699164|NCT00762164|156746945|FG000|Overall Study|Withdrawal by Subject|0|||
48699165|NCT00762164|156746946|FG001|Overall Study|Withdrawal by Subject|1|||
48699166|NCT03532451|156746949|FG000|Overall Study|Withdrawal by Subject|0|||
48699167|NCT03532451|156746950|FG001|Overall Study|Withdrawal by Subject|1|||
48699168|NCT03532451|156746949|FG000|Overall Study|Did not undergo surgery|1|||
48699169|NCT03532451|156746950|FG001|Overall Study|Did not undergo surgery|1|||
48699170|NCT03534804|156746957|FG000|Overall Study|Withdrawal by Subject|1|||
48699171|NCT04408989|156746958|FG000|Overall Study|Lost to Follow-up|0|||
48699172|NCT04408989|156746959|FG001|Overall Study|Lost to Follow-up|0|||
48699173|NCT04408989|156746960|FG002|Overall Study|Lost to Follow-up|1|||
48699174|NCT04408989|156746958|FG000|Overall Study|Withdrawal by Subject|0|||
48699175|NCT04408989|156746959|FG001|Overall Study|Withdrawal by Subject|0|||
48592846|NCT03762681|156363576|FG004|Part 1|Withdrawal by Subject|0|||
48592847|NCT03762681|156363577|FG005|Part 1|Withdrawal by Subject|0|||
48699176|NCT04408989|156746960|FG002|Overall Study|Withdrawal by Subject|2|||
48699177|NCT01285557|156746965|FG000|Overall Study|Death|173|||
48699178|NCT01285557|156746966|FG001|Overall Study|Death|90|||
48699179|NCT01285557|156746965|FG000|Overall Study|Lost to Follow-up|6|||
48699180|NCT01285557|156746966|FG001|Overall Study|Lost to Follow-up|2|||
48699181|NCT01285557|156746965|FG000|Overall Study|Withdrew Consent|6|||
48699182|NCT01285557|156746966|FG001|Overall Study|Withdrew Consent|1|||
48699183|NCT01285557|156746965|FG000|Overall Study|Sponsor Study Termination|23|||
48699184|NCT01285557|156746966|FG001|Overall Study|Sponsor Study Termination|13|||
48699185|NCT01285557|156746965|FG000|Overall Study|Randomized but not treated|1|||
48699186|NCT01285557|156746966|FG001|Overall Study|Randomized but not treated|1|||
48699187|NCT01285557|156746965|FG000|Overall Study|Study follow-up ongoing|28|||
48592848|NCT03762681|156363578|FG006|Part 1|Withdrawal by Subject|0|||
48699188|NCT01285557|156746966|FG001|Overall Study|Study follow-up ongoing|14|||
48699189|NCT01285557|156746965|FG000|Overall Study|Sponsor Decision|2|||
48699190|NCT01285557|156746966|FG001|Overall Study|Sponsor Decision|1|||
48699191|NCT05523089|156746969|FG000|Overall Study|Withdrawal by Subject|1|||
48487726|NCT01270841|155980756|FG003|Overall Study|Did not qualify|5|||
48699192|NCT05523089|156746970|FG001|Overall Study|Withdrawal by Subject|0|||
48699193|NCT05523089|156746971|FG002|Overall Study|Withdrawal by Subject|0|||
48699194|NCT05523089|156746969|FG000|Overall Study|Lost to Follow-up|1|||
48699195|NCT05523089|156746970|FG001|Overall Study|Lost to Follow-up|0|||
48699196|NCT05523089|156746971|FG002|Overall Study|Lost to Follow-up|0|||
48699197|NCT02681523|156746972|FG000|Overall Study|Adverse Event|1|||
48699198|NCT02681523|156746972|FG000|Overall Study|Patient Non-compliance|1|||
48699199|NCT00079417|156748534|FG000|Overall Study|Physician Decision|2|||
48699200|NCT00079417|156748534|FG000|Overall Study|Ineligible|7|||
48699201|NCT00992108|156748539|FG000|Overall Study|Lost to Follow-up|0|||
48699202|NCT00992108|156748540|FG001|Overall Study|Lost to Follow-up|1|||
48699203|NCT02151058|156748541|FG000|Overall Study|Withdrawal by Subject|1|||
48487727|NCT01270841|155980753|FG000|Overall Study|Protocol Violation|1|||
48699204|NCT02151058|156748542|FG001|Overall Study|Withdrawal by Subject|1|||
48699205|NCT02151058|156748543|FG002|Overall Study|Withdrawal by Subject|3|||
48699206|NCT02151058|156748541|FG000|Overall Study|Lost to Follow-up|1|||
48699207|NCT02151058|156748542|FG001|Overall Study|Lost to Follow-up|0|||
48699208|NCT02151058|156748543|FG002|Overall Study|Lost to Follow-up|2|||
48699209|NCT01280903|156748545|FG000|Overall Study|Lost to Follow-up|23|||
48699210|NCT01280903|156748546|FG001|Overall Study|Lost to Follow-up|16|||
48699211|NCT02177695|156748547|FG000|ITT Analysis|Ineligible|5|||
48699212|NCT02177695|156748548|FG001|ITT Analysis|Ineligible|5|||
48699213|NCT02177695|156748547|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
48699214|NCT02177695|156748548|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
48699215|NCT02177695|156748547|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
48699216|NCT02177695|156748548|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
48699217|NCT02177695|156748547|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
48699218|NCT02177695|156748548|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
48699219|NCT01473134|156748551|FG000|Overall Study|Lost to Follow-up|21|||
48699220|NCT01473134|156748552|FG001|Overall Study|Lost to Follow-up|13|||
48699221|NCT01473134|156748551|FG000|Overall Study|Protocol Violation|32|||
48699222|NCT01473134|156748552|FG001|Overall Study|Protocol Violation|19|||
48699223|NCT01473134|156748551|FG000|Overall Study|Withdrawal by Subject|1|||
48699224|NCT01473134|156748552|FG001|Overall Study|Withdrawal by Subject|2|||
48592849|NCT03762681|156363579|FG007|Part 1|Withdrawal by Subject|0|||
48699225|NCT01473134|156748551|FG000|Overall Study|Death|0|||
48699226|NCT01473134|156748552|FG001|Overall Study|Death|1|||
48699227|NCT01473134|156748551|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
48699228|NCT01473134|156748552|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
48699229|NCT05316597|156748553|FG000|First Session|Withdrawal by Subject|0|||
48699230|NCT05316597|156748554|FG001|First Session|Withdrawal by Subject|1|||
48699231|NCT05316597|156748553|FG000|Washout Period|Lost to Follow-up|1|||
48699232|NCT05316597|156748554|FG001|Washout Period|Lost to Follow-up|2|||
48699233|NCT05316597|156748553|FG000|Washout Period|Physician Decision|1|||
48699234|NCT05316597|156748554|FG001|Washout Period|Physician Decision|1|||
48699235|NCT05316597|156748553|FG000|Washout Period|Excluded before second session|1|||
48699236|NCT05316597|156748554|FG001|Washout Period|Excluded before second session|1|||
48699237|NCT05316597|156748553|FG000|Washout Period|Withdrawal by Subject|0|||
48699238|NCT05316597|156748554|FG001|Washout Period|Withdrawal by Subject|4|||
48699239|NCT04385277|156748555|FG000|Overall Study|Physician Decision|2|||
48699240|NCT04385277|156748555|FG000|Overall Study|Ineligible|1|||
48699241|NCT04385277|156748555|FG000|Overall Study|Patient/Parent Refusal|2|||
48699242|NCT03363841|156748556|FG000|Overall Study|Adverse Event|1|||
48699243|NCT03363841|156748556|FG000|Overall Study|Withdrawal by Subject|1|||
48699244|NCT03363841|156748556|FG000|Overall Study|Death|7|||
48699245|NCT03363841|156748556|FG000|Overall Study|Physician Decision|1|||
48699246|NCT06271993|156748557|FG000|Overall Study|Not reactive to histamine|5|||
48699247|NCT06271993|156748558|FG001|Overall Study|Not reactive to histamine|5|||
48699248|NCT06271993|156748559|FG002|Overall Study|Not reactive to histamine|5|||
48699249|NCT00687596|156748562|FG000|Overall Study|Adverse Event (AE)|10|||
48699250|NCT00687596|156748563|FG001|Overall Study|Adverse Event (AE)|3|||
48699251|NCT00687596|156748562|FG000|Overall Study|Radiological Disease Progression|6|||
48699252|NCT00687596|156748563|FG001|Overall Study|Radiological Disease Progression|2|||
48699253|NCT00687596|156748562|FG000|Overall Study|Clinical Disease Progression|1|||
48699254|NCT00687596|156748563|FG001|Overall Study|Clinical Disease Progression|3|||
48699255|NCT00687596|156748562|FG000|Overall Study|Investigator Discretion|3|||
48699256|NCT00687596|156748563|FG001|Overall Study|Investigator Discretion|1|||
48699257|NCT00687596|156748562|FG000|Overall Study|Sponsor Terminated Study|6|||
48699258|NCT00687596|156748563|FG001|Overall Study|Sponsor Terminated Study|17|||
48699259|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
48699260|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699261|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699262|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699263|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699264|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
48699265|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
48699266|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699267|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
48699268|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699269|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699270|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699271|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699272|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
48699273|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699274|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699275|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
48699276|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699277|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699278|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
48699279|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
48699280|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699281|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699282|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699283|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699284|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
48699285|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699286|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
48699287|NCT02903771|156748565|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699288|NCT02903771|156748566|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699289|NCT02903771|156748567|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699290|NCT02903771|156748568|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
48487728|NCT01270841|155980754|FG001|Overall Study|Protocol Violation|5|||
48699291|NCT02903771|156748569|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699292|NCT02903771|156748570|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
48699293|NCT02903771|156748571|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
48699294|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699295|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699296|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699297|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699298|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
48699299|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699300|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
48699301|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699302|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699303|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699304|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699305|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
48699306|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699307|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
48699308|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699309|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699310|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699311|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699312|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
48487729|NCT01270841|155980755|FG002|Overall Study|Protocol Violation|0|||
48487730|NCT01270841|155980756|FG003|Overall Study|Protocol Violation|0|||
48487731|NCT01270841|155980753|FG000|Overall Study|Enrolled in error|0|||
48699313|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699314|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
48699315|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48699316|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48487732|NCT01270841|155980754|FG001|Overall Study|Enrolled in error|1|||
48487733|NCT01270841|155980755|FG002|Overall Study|Enrolled in error|0|||
48487734|NCT01270841|155980756|FG003|Overall Study|Enrolled in error|0|||
48487735|NCT01326702|155980757|FG000|Overall Study|Other|1|||
48487736|NCT01326702|155980758|FG001|Overall Study|Other|0|||
48487737|NCT01326702|155980759|FG002|Overall Study|Other|0|||
48487738|NCT01326702|155980760|FG003|Overall Study|Other|0|||
48487739|NCT01326702|155980761|FG004|Overall Study|Other|0|||
48487740|NCT01326702|155980762|FG005|Overall Study|Other|1|||
48487741|NCT01326702|155980763|FG006|Overall Study|Other|0|||
48487742|NCT01326702|155980757|FG000|Overall Study|progressive disease|1|||
48487743|NCT01326702|155980758|FG001|Overall Study|progressive disease|1|||
48487744|NCT01326702|155980759|FG002|Overall Study|progressive disease|3|||
48487745|NCT01326702|155980760|FG003|Overall Study|progressive disease|1|||
48487746|NCT01326702|155980761|FG004|Overall Study|progressive disease|3|||
48487747|NCT01326702|155980762|FG005|Overall Study|progressive disease|2|||
48487748|NCT01326702|155980763|FG006|Overall Study|progressive disease|3|||
48487749|NCT01326702|155980757|FG000|Overall Study|Death|0|||
48487750|NCT01326702|155980758|FG001|Overall Study|Death|1|||
48487751|NCT01326702|155980759|FG002|Overall Study|Death|0|||
48487752|NCT01326702|155980760|FG003|Overall Study|Death|0|||
48699317|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48699318|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48699319|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
48699320|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48699321|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
48487753|NCT01326702|155980761|FG004|Overall Study|Death|0|||
48487754|NCT01326702|155980762|FG005|Overall Study|Death|0|||
48487755|NCT01326702|155980763|FG006|Overall Study|Death|0|||
48487756|NCT01326702|155980757|FG000|Overall Study|Adverse Event|0|||
48487757|NCT01326702|155980758|FG001|Overall Study|Adverse Event|0|||
48487758|NCT01326702|155980759|FG002|Overall Study|Adverse Event|1|||
48487759|NCT01326702|155980760|FG003|Overall Study|Adverse Event|1|||
48592850|NCT03762681|156363572|FG000|Part 2a|Pandemic Travel Restrictions|0|||
48592851|NCT03762681|156363573|FG001|Part 2a|Pandemic Travel Restrictions|0|||
48699322|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699323|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699324|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699325|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699326|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
48699327|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699328|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
48699329|NCT02903771|156748565|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699330|NCT02903771|156748566|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699331|NCT02903771|156748567|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699332|NCT02903771|156748568|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699333|NCT02903771|156748569|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
48699334|NCT02903771|156748570|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699335|NCT02903771|156748571|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
48699336|NCT01285323|156748576|FG000|Overall Study|Adverse Event|9|||
48699337|NCT01285323|156748577|FG001|Overall Study|Adverse Event|8|||
48699338|NCT01285323|156748576|FG000|Overall Study|Lack of Efficacy|4|||
48699339|NCT01285323|156748577|FG001|Overall Study|Lack of Efficacy|2|||
48699340|NCT01285323|156748576|FG000|Overall Study|Withdrawal by Subject|15|||
48699341|NCT01285323|156748577|FG001|Overall Study|Withdrawal by Subject|11|||
48699342|NCT01285323|156748576|FG000|Overall Study|Protocol Violation|1|||
48699343|NCT01285323|156748577|FG001|Overall Study|Protocol Violation|2|||
48699344|NCT01285323|156748576|FG000|Overall Study|Non-compliance with study procedures|2|||
48699345|NCT01285323|156748577|FG001|Overall Study|Non-compliance with study procedures|3|||
48699346|NCT01285323|156748576|FG000|Overall Study|Lost to Follow-up|1|||
48699347|NCT01285323|156748577|FG001|Overall Study|Lost to Follow-up|1|||
48699348|NCT01285323|156748576|FG000|Overall Study|Other|1|||
48699349|NCT01285323|156748577|FG001|Overall Study|Other|3|||
48699350|NCT05106959|156748578|FG000|Overall Study|Lost to Follow-up|1|||
48699351|NCT00087152|156748579|FG000|Overall Study|Ineligible|6|||
48699352|NCT03199976|156748580|FG000|Overall Study|Lack of Efficacy|3|||
48699353|NCT03199976|156748581|FG001|Overall Study|Lack of Efficacy|6|||
48699354|NCT03199976|156748582|FG002|Overall Study|Lack of Efficacy|13|||
48699355|NCT03199976|156748580|FG000|Overall Study|Withdrawal by Subject|1|||
48699356|NCT03199976|156748581|FG001|Overall Study|Withdrawal by Subject|0|||
48699357|NCT03199976|156748582|FG002|Overall Study|Withdrawal by Subject|0|||
48699358|NCT03199976|156748580|FG000|Overall Study|Lost to Follow-up|0|||
48699359|NCT03199976|156748581|FG001|Overall Study|Lost to Follow-up|1|||
48699360|NCT03199976|156748582|FG002|Overall Study|Lost to Follow-up|1|||
48699361|NCT01553084|156748583|FG000|Overall Study|Withdrawal by Subject|15|||
48699362|NCT01553084|156748584|FG001|Overall Study|Withdrawal by Subject|13|||
48487760|NCT01326702|155980761|FG004|Overall Study|Adverse Event|0|||
48487761|NCT01326702|155980762|FG005|Overall Study|Adverse Event|3|||
48487762|NCT01326702|155980763|FG006|Overall Study|Adverse Event|1|||
48487763|NCT01326702|155980757|FG000|Overall Study|Withdrawal by Subject|0|||
48487764|NCT01326702|155980758|FG001|Overall Study|Withdrawal by Subject|0|||
48487765|NCT01326702|155980759|FG002|Overall Study|Withdrawal by Subject|1|||
48592852|NCT03762681|156363574|FG002|Part 2a|Pandemic Travel Restrictions|0|||
48699363|NCT01553084|156748585|FG002|Overall Study|Withdrawal by Subject|35|||
48699364|NCT04227899|156748586|FG000|Overall Study|Withdrawal by Subject|6|||
48699365|NCT04227899|156748587|FG001|Overall Study|Withdrawal by Subject|3|||
48699366|NCT04227899|156748586|FG000|Overall Study|Death|12|||
48699367|NCT04227899|156748587|FG001|Overall Study|Death|6|||
48699368|NCT04227899|156748586|FG000|Overall Study|Lost to Follow-up|2|||
48699369|NCT04227899|156748587|FG001|Overall Study|Lost to Follow-up|1|||
48699370|NCT03882021|156748588|FG000|Enrollment|Procedure aborted/cancelled|2|||
48699371|NCT03882021|156748588|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
48699372|NCT03882021|156748588|FG000|Enrollment to 3-Month|Death|1|||
48699373|NCT03882021|156748588|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
48487766|NCT01326702|155980760|FG003|Overall Study|Withdrawal by Subject|0|||
48699374|NCT03882021|156748588|FG000|Enrollment to 3-Month|Missed Visit|4|||
48699375|NCT03882021|156748588|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
48699376|NCT03882021|156748588|FG000|6-Month to 12-Month Visit|Death|1|||
48699377|NCT03882021|156748588|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
48699378|NCT04571944|156748589|FG000|Overall Study|Death|1|||
48699379|NCT04571944|156748590|FG001|Overall Study|Death|0|||
48699380|NCT04571944|156748589|FG000|Overall Study|Withdrawal by Subject|3|||
48699381|NCT04571944|156748590|FG001|Overall Study|Withdrawal by Subject|0|||
48699382|NCT04571944|156748589|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
48699383|NCT04571944|156748590|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
48699384|NCT03119259|156748591|FG000|Overall Study|Withdrawn as no longer eligible|1|||
48699385|NCT03119259|156748592|FG001|Overall Study|Withdrawn as no longer eligible|0|||
48699386|NCT03119259|156748591|FG000|Overall Study|Withdrawal by Subject|4|||
48699387|NCT03119259|156748592|FG001|Overall Study|Withdrawal by Subject|2|||
48699388|NCT03119259|156748591|FG000|Overall Study|Lost to Follow-up|0|||
48699389|NCT03119259|156748592|FG001|Overall Study|Lost to Follow-up|1|||
48699390|NCT03486912|156748596|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
48699391|NCT03486912|156748597|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
48487767|NCT01326702|155980761|FG004|Overall Study|Withdrawal by Subject|1|||
48487768|NCT01326702|155980762|FG005|Overall Study|Withdrawal by Subject|1|||
48487769|NCT01326702|155980763|FG006|Overall Study|Withdrawal by Subject|3|||
48487770|NCT01326702|155980757|FG000|Overall Study|Not Treated|0|||
48487771|NCT01326702|155980758|FG001|Overall Study|Not Treated|0|||
48487772|NCT01326702|155980759|FG002|Overall Study|Not Treated|0|||
48592853|NCT03762681|156363575|FG003|Part 2a|Pandemic Travel Restrictions|0|||
48699392|NCT03486912|156748598|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
48699393|NCT03486912|156748599|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
48699394|NCT03486912|156748596|FG000|Treatment Period|Withdrawal by Subject|3|||
48699395|NCT03486912|156748597|FG001|Treatment Period|Withdrawal by Subject|3|||
48699396|NCT03486912|156748598|FG002|Treatment Period|Withdrawal by Subject|3|||
48699397|NCT03486912|156748599|FG003|Treatment Period|Withdrawal by Subject|2|||
48699398|NCT03486912|156748596|FG000|Treatment Period|Other Reasons|0|||
48699399|NCT03486912|156748597|FG001|Treatment Period|Other Reasons|2|||
48699400|NCT03486912|156748598|FG002|Treatment Period|Other Reasons|1|||
48699401|NCT03486912|156748599|FG003|Treatment Period|Other Reasons|1|||
48699402|NCT03486912|156748596|FG000|Treatment Period|Adverse Event|0|||
48699403|NCT03486912|156748597|FG001|Treatment Period|Adverse Event|1|||
48699404|NCT03486912|156748598|FG002|Treatment Period|Adverse Event|1|||
48699405|NCT03486912|156748599|FG003|Treatment Period|Adverse Event|0|||
48699406|NCT03486912|156748596|FG000|Treatment Period|Lost to Follow-up|1|||
48699407|NCT03486912|156748597|FG001|Treatment Period|Lost to Follow-up|0|||
48699408|NCT03486912|156748598|FG002|Treatment Period|Lost to Follow-up|0|||
48487773|NCT01326702|155980760|FG003|Overall Study|Not Treated|1|||
48699409|NCT03486912|156748599|FG003|Treatment Period|Lost to Follow-up|2|||
48699410|NCT02491684|156748600|FG000|Treatment Phase|Adverse Event|2|||
48699411|NCT02491684|156748601|FG001|Treatment Phase|Adverse Event|2|||
48487774|NCT01326702|155980761|FG004|Overall Study|Not Treated|0|||
48487775|NCT01326702|155980762|FG005|Overall Study|Not Treated|1|||
48699412|NCT02491684|156748600|FG000|Treatment Phase|Incorrect randomisation|1|||
48699413|NCT02491684|156748601|FG001|Treatment Phase|Incorrect randomisation|0|||
48699414|NCT02491684|156748600|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
48699415|NCT02491684|156748601|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
48699416|NCT00412984|156748602|FG000|Overall Study|Death|331|||
48699417|NCT00412984|156748603|FG001|Overall Study|Death|349|||
48699418|NCT00412984|156748602|FG000|Overall Study|Adverse Event|679|||
48699419|NCT00412984|156748603|FG001|Overall Study|Adverse Event|738|||
48699420|NCT00412984|156748602|FG000|Overall Study|Withdrawal by Subject|921|||
48699421|NCT00412984|156748603|FG001|Overall Study|Withdrawal by Subject|989|||
48699422|NCT00412984|156748602|FG000|Overall Study|Lost to Follow-up|51|||
48699423|NCT00412984|156748603|FG001|Overall Study|Lost to Follow-up|39|||
48699424|NCT00412984|156748602|FG000|Overall Study|Poor/Noncompliance|57|||
48699425|NCT00412984|156748603|FG001|Overall Study|Poor/Noncompliance|77|||
48699426|NCT00412984|156748602|FG000|Overall Study|Pregnancy|1|||
48699427|NCT00412984|156748603|FG001|Overall Study|Pregnancy|0|||
48699428|NCT00412984|156748602|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
48699429|NCT00412984|156748603|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
48699430|NCT00412984|156748602|FG000|Overall Study|Administrative Reason by Sponsor|11|||
48699431|NCT00412984|156748603|FG001|Overall Study|Administrative Reason by Sponsor|8|||
48699432|NCT00412984|156748602|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
48699433|NCT00412984|156748603|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
48699434|NCT00412984|156748602|FG000|Overall Study|Other Reason|80|||
48699435|NCT00412984|156748603|FG001|Overall Study|Other Reason|92|||
48699436|NCT00412984|156748602|FG000|Overall Study|Not Reported|11|||
48699437|NCT00412984|156748603|FG001|Overall Study|Not Reported|12|||
48699438|NCT00325897|156748604|FG000|Overall Study|Lost to Follow-up|12|||
48699439|NCT00325897|156748605|FG001|Overall Study|Lost to Follow-up|13|||
48699440|NCT01188343|156748606|FG000|Overall Study|Not vaccinated|0|||
48699441|NCT01188343|156748607|FG001|Overall Study|Not vaccinated|2|||
48699442|NCT01188343|156748608|FG002|Overall Study|Not vaccinated|1|||
48699443|NCT01188343|156748606|FG000|Overall Study|Withdrawal by Subject|1|||
48699444|NCT01188343|156748607|FG001|Overall Study|Withdrawal by Subject|24|||
48699445|NCT01188343|156748608|FG002|Overall Study|Withdrawal by Subject|0|||
48699446|NCT00107198|156748609|FG000|Overall Study|Lack of Efficacy|28|||
48699447|NCT00107198|156748609|FG000|Overall Study|Lost to Follow-up|12|||
48699448|NCT00107198|156748609|FG000|Overall Study|Protocol Violation|1|||
48699449|NCT00107198|156748609|FG000|Overall Study|Withdrawal by Subject|6|||
48699450|NCT00107198|156748609|FG000|Overall Study|Ineligible|5|||
48699451|NCT01521117|156748626|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
48592854|NCT03762681|156363576|FG004|Part 2a|Pandemic Travel Restrictions|0|||
48592855|NCT03762681|156363577|FG005|Part 2a|Pandemic Travel Restrictions|0|||
48699452|NCT01521117|156748627|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
48699453|NCT01521117|156748626|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
48699454|NCT01521117|156748627|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
48699455|NCT01521117|156748626|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
48699456|NCT01521117|156748627|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
48699457|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
48699458|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
48699459|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
48699460|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
48699461|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
48699462|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
48699463|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
48699464|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
48699465|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
48699466|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
48699467|NCT01668784|156748641|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
48699468|NCT01668784|156748642|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
48487776|NCT01326702|155980763|FG006|Overall Study|Not Treated|0|||
48487777|NCT03555890|155980764|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48487778|NCT03555890|155980765|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48487779|NCT03555890|155980766|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48487780|NCT03555890|155980767|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
48487781|NCT01375010|155980768|FG000|Overall Study|Lost to Follow-up|8|||
48487782|NCT01375010|155980769|FG001|Overall Study|Lost to Follow-up|2|||
48487783|NCT01375010|155980768|FG000|Overall Study|Withdrawal by Subject|4|||
48487784|NCT01375010|155980769|FG001|Overall Study|Withdrawal by Subject|2|||
48487785|NCT02082912|155980770|FG000|Overall Study|Physician Decision|0|||
48487786|NCT02082912|155980771|FG001|Overall Study|Physician Decision|1|||
48487787|NCT01835132|155980775|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
48487788|NCT00409188|155980776|FG000|Overall Study|Ongoing at data cut-off|383|||
48487789|NCT00409188|155980777|FG001|Overall Study|Ongoing at data cut-off|175|||
48699469|NCT01668784|156748641|FG000|Treatment Period|Disease Progression|316|||
48699470|NCT01668784|156748642|FG001|Treatment Period|Disease Progression|293|||
48487790|NCT00856778|155980778|FG000|Overall Study|Adverse Event|7|||
48699471|NCT01668784|156748641|FG000|Treatment Period|Study Drug Toxicity|46|||
48699472|NCT01668784|156748642|FG001|Treatment Period|Study Drug Toxicity|53|||
48699473|NCT01668784|156748641|FG000|Treatment Period|Death|1|||
48699474|NCT01668784|156748642|FG001|Treatment Period|Death|1|||
48699475|NCT01668784|156748641|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
48699476|NCT01668784|156748642|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
48699477|NCT01668784|156748641|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
48699478|NCT01668784|156748642|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
48699479|NCT01668784|156748641|FG000|Treatment Period|Withdrawal by Subject|5|||
48699480|NCT01668784|156748642|FG001|Treatment Period|Withdrawal by Subject|3|||
48699481|NCT01668784|156748641|FG000|Treatment Period|Maximal Clinical Benefit|3|||
48699482|NCT01668784|156748642|FG001|Treatment Period|Maximal Clinical Benefit|3|||
48699483|NCT01668784|156748641|FG000|Treatment Period|Other|2|||
48699484|NCT01668784|156748642|FG001|Treatment Period|Other|8|||
48699485|NCT01668784|156748641|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
48699486|NCT01668784|156748642|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
48699487|NCT02761330|156748643|FG000|Treatment Week 1|Withdrawal by Subject|0|||
48699488|NCT02761330|156748644|FG001|Treatment Week 1|Withdrawal by Subject|0|||
48699489|NCT02761330|156748645|FG002|Treatment Week 1|Withdrawal by Subject|0|||
48699490|NCT02761330|156748646|FG003|Treatment Week 1|Withdrawal by Subject|1|||
48699491|NCT02761330|156748647|FG004|Treatment Week 1|Withdrawal by Subject|0|||
48699492|NCT02761330|156748648|FG005|Treatment Week 1|Withdrawal by Subject|1|||
48699493|NCT00392327|156748655|FG000|Overall Study|Death|1|||
48699494|NCT00392327|156748656|FG001|Overall Study|Death|0|||
48699495|NCT00392327|156748657|FG002|Overall Study|Death|1|||
48699496|NCT00392327|156748658|FG003|Overall Study|Death|0|||
48699497|NCT00392327|156748659|FG004|Overall Study|Death|0|||
48699498|NCT00392327|156748660|FG005|Overall Study|Death|0|||
48699499|NCT00392327|156748661|FG006|Overall Study|Death|0|||
48699500|NCT00392327|156748662|FG007|Overall Study|Death|0|||
48699501|NCT00392327|156748655|FG000|Overall Study|Lack of Efficacy|8|||
48699502|NCT00392327|156748656|FG001|Overall Study|Lack of Efficacy|8|||
48699503|NCT00392327|156748657|FG002|Overall Study|Lack of Efficacy|9|||
48699504|NCT00392327|156748658|FG003|Overall Study|Lack of Efficacy|6|||
48699505|NCT00392327|156748659|FG004|Overall Study|Lack of Efficacy|3|||
48699506|NCT00392327|156748660|FG005|Overall Study|Lack of Efficacy|3|||
48699507|NCT00392327|156748661|FG006|Overall Study|Lack of Efficacy|3|||
48699508|NCT00392327|156748662|FG007|Overall Study|Lack of Efficacy|3|||
48699509|NCT00392327|156748655|FG000|Overall Study|Physician Decision|3|||
48699510|NCT00392327|156748656|FG001|Overall Study|Physician Decision|5|||
48699511|NCT00392327|156748657|FG002|Overall Study|Physician Decision|2|||
48699512|NCT00392327|156748658|FG003|Overall Study|Physician Decision|2|||
48699513|NCT00392327|156748659|FG004|Overall Study|Physician Decision|0|||
48699514|NCT00392327|156748660|FG005|Overall Study|Physician Decision|1|||
48699515|NCT00392327|156748661|FG006|Overall Study|Physician Decision|5|||
48699516|NCT00392327|156748662|FG007|Overall Study|Physician Decision|3|||
48699517|NCT00392327|156748655|FG000|Overall Study|Protocol Violation|0|||
48699518|NCT00392327|156748656|FG001|Overall Study|Protocol Violation|0|||
48699519|NCT00392327|156748657|FG002|Overall Study|Protocol Violation|1|||
48699520|NCT00392327|156748658|FG003|Overall Study|Protocol Violation|0|||
48699521|NCT00392327|156748659|FG004|Overall Study|Protocol Violation|0|||
48699522|NCT00392327|156748660|FG005|Overall Study|Protocol Violation|0|||
48699523|NCT00392327|156748661|FG006|Overall Study|Protocol Violation|0|||
48699524|NCT00392327|156748662|FG007|Overall Study|Protocol Violation|0|||
48699525|NCT00392327|156748655|FG000|Overall Study|Withdrawal by Subject|3|||
48699526|NCT00392327|156748656|FG001|Overall Study|Withdrawal by Subject|2|||
48699527|NCT00392327|156748657|FG002|Overall Study|Withdrawal by Subject|4|||
48699528|NCT00392327|156748658|FG003|Overall Study|Withdrawal by Subject|6|||
48699529|NCT00392327|156748659|FG004|Overall Study|Withdrawal by Subject|0|||
48699530|NCT00392327|156748660|FG005|Overall Study|Withdrawal by Subject|1|||
48699531|NCT00392327|156748661|FG006|Overall Study|Withdrawal by Subject|1|||
48699532|NCT00392327|156748662|FG007|Overall Study|Withdrawal by Subject|5|||
48699533|NCT00392327|156748655|FG000|Overall Study|Ineligible|0|||
48699534|NCT00392327|156748656|FG001|Overall Study|Ineligible|4|||
48699535|NCT00392327|156748657|FG002|Overall Study|Ineligible|3|||
48699536|NCT00392327|156748658|FG003|Overall Study|Ineligible|2|||
48699537|NCT00392327|156748659|FG004|Overall Study|Ineligible|0|||
48699538|NCT00392327|156748660|FG005|Overall Study|Ineligible|0|||
48699539|NCT00392327|156748661|FG006|Overall Study|Ineligible|0|||
48699540|NCT00392327|156748662|FG007|Overall Study|Ineligible|0|||
48699541|NCT05615922|156748663|FG000|Overall Study|Lost to Follow-up|1|||
48699542|NCT01607957|156748664|FG000|Overall Study|Not treated|1|||
48699543|NCT01607957|156748665|FG001|Overall Study|Not treated|1|||
48699544|NCT01607957|156748664|FG000|Overall Study|Death|367|||
48699545|NCT01607957|156748665|FG001|Overall Study|Death|211|||
48699546|NCT01607957|156748664|FG000|Overall Study|Lost to Follow-up|3|||
48699547|NCT01607957|156748665|FG001|Overall Study|Lost to Follow-up|3|||
48487791|NCT00856778|155980778|FG000|Overall Study|Withdrawal by Subject|10|||
48699548|NCT01607957|156748664|FG000|Overall Study|Participant refusal|1|||
48699549|NCT01607957|156748665|FG001|Overall Study|Participant refusal|0|||
48699550|NCT00400179|156748666|FG000|Overall Study|Adverse Event|2|||
48699551|NCT00400179|156748667|FG001|Overall Study|Adverse Event|2|||
48699552|NCT00400179|156748666|FG000|Overall Study|Death|1|||
48699553|NCT00400179|156748667|FG001|Overall Study|Death|2|||
48699554|NCT00400179|156748666|FG000|Overall Study|Withdrew Consent|1|||
48699555|NCT00400179|156748667|FG001|Overall Study|Withdrew Consent|5|||
48592856|NCT03762681|156363578|FG006|Part 2a|Pandemic Travel Restrictions|0|||
48699556|NCT00400179|156748666|FG000|Overall Study|Disease progression|1|||
48699557|NCT00400179|156748667|FG001|Overall Study|Disease progression|1|||
48699558|NCT00400179|156748666|FG000|Overall Study|Intercurrent illness|0|||
48699559|NCT00400179|156748667|FG001|Overall Study|Intercurrent illness|1|||
48699560|NCT00400179|156748666|FG000|Overall Study|Investigator judgment|0|||
48699561|NCT00400179|156748667|FG001|Overall Study|Investigator judgment|1|||
48699562|NCT00400179|156748666|FG000|Overall Study|Randomization error/patient ineligible|1|||
48699563|NCT00400179|156748667|FG001|Overall Study|Randomization error/patient ineligible|6|||
48699564|NCT02420717|156748668|FG000|Overall Study|Did not receive all study medication|2|||
48699565|NCT02420717|156748669|FG001|Overall Study|Did not receive all study medication|0|||
48699566|NCT02420717|156748670|FG002|Overall Study|Did not receive all study medication|0|||
48699567|NCT02484391|156748671|FG000|Overall Study|Lack of Efficacy|15|||
48699568|NCT02484391|156748672|FG001|Overall Study|Lack of Efficacy|14|||
48699569|NCT02484391|156748673|FG002|Overall Study|Lack of Efficacy|3|||
48699570|NCT02484391|156748671|FG000|Overall Study|Lost to Follow-up|0|||
48699571|NCT02484391|156748672|FG001|Overall Study|Lost to Follow-up|0|||
48699572|NCT02484391|156748673|FG002|Overall Study|Lost to Follow-up|2|||
48699573|NCT02484391|156748671|FG000|Overall Study|Physician Decision|1|||
48699574|NCT02484391|156748672|FG001|Overall Study|Physician Decision|3|||
48699575|NCT02484391|156748673|FG002|Overall Study|Physician Decision|0|||
48699576|NCT02484391|156748671|FG000|Overall Study|Went to Transplant|5|||
48699577|NCT02484391|156748672|FG001|Overall Study|Went to Transplant|3|||
48699578|NCT02484391|156748673|FG002|Overall Study|Went to Transplant|2|||
48699579|NCT00089297|156750464|FG000|Overall Study|Adverse Event|9|||
48699580|NCT00089297|156750464|FG000|Overall Study|Death|1|||
48699581|NCT00089297|156750464|FG000|Overall Study|Withdrawal by Subject|12|||
48699582|NCT00089297|156750464|FG000|Overall Study|Disease progression|2|||
48699583|NCT00089297|156750464|FG000|Overall Study|Ineligible|11|||
48699584|NCT00089297|156750464|FG000|Overall Study|Secondary malignancy|1|||
48699585|NCT00089297|156750464|FG000|Overall Study|IRB approval not ready|1|||
48699586|NCT00089297|156750464|FG000|Overall Study|Non-compliance|1|||
48699587|NCT03264404|156750465|FG000|Overall Study|Death|2|||
48699588|NCT03264404|156750465|FG000|Overall Study|Physician Decision|1|||
48699589|NCT03264404|156750465|FG000|Overall Study|Disease Progression|28|||
48699590|NCT03264404|156750465|FG000|Overall Study|Adverse Event|1|||
48699591|NCT03264404|156750465|FG000|Overall Study|Off study prior to treatment|2|||
48699592|NCT00904969|156750466|FG000|Overall Study|Lost to Follow-up|4|||
48699593|NCT00904969|156750466|FG000|Overall Study|Withdrawal by Subject|3|||
48699594|NCT00904969|156750466|FG000|Overall Study|Additional Treatments|11|||
48699595|NCT00904969|156750466|FG000|Overall Study|Case Aborted; Subject Exited|1|||
48699596|NCT00199381|156750467|FG000|Overall Study|Withdrawal by Subject|38|||
48699597|NCT00199381|156750467|FG000|Overall Study|Adverse Event|73|||
48699598|NCT00199381|156750467|FG000|Overall Study|Protocol Violation|6|||
48699599|NCT00199381|156750467|FG000|Overall Study|Lack of Efficacy|27|||
48699600|NCT00199381|156750467|FG000|Overall Study|Not including due to early termination|37|||
48699601|NCT00199381|156750467|FG000|Overall Study|Study termination by Sponsor|323|||
48699602|NCT00385671|156750471|FG000|Overall Study|Adverse Event|14|||
48699603|NCT00385671|156750472|FG001|Overall Study|Adverse Event|27|||
48699604|NCT00385671|156750473|FG002|Overall Study|Adverse Event|18|||
48699605|NCT00385671|156750471|FG000|Overall Study|Lack of Efficacy|5|||
48699606|NCT00385671|156750472|FG001|Overall Study|Lack of Efficacy|9|||
48699607|NCT00385671|156750473|FG002|Overall Study|Lack of Efficacy|5|||
48699608|NCT00385671|156750471|FG000|Overall Study|Lost to Follow-up|6|||
48699609|NCT00385671|156750472|FG001|Overall Study|Lost to Follow-up|6|||
48699610|NCT00385671|156750473|FG002|Overall Study|Lost to Follow-up|5|||
48699611|NCT00385671|156750471|FG000|Overall Study|Physician Decision|2|||
48699612|NCT00385671|156750472|FG001|Overall Study|Physician Decision|1|||
48699613|NCT00385671|156750473|FG002|Overall Study|Physician Decision|2|||
48699614|NCT00385671|156750471|FG000|Overall Study|Protocol Violation|5|||
48699615|NCT00385671|156750472|FG001|Overall Study|Protocol Violation|2|||
48699616|NCT00385671|156750473|FG002|Overall Study|Protocol Violation|1|||
48699617|NCT00385671|156750471|FG000|Overall Study|Sponsor Decision|2|||
48699618|NCT00385671|156750472|FG001|Overall Study|Sponsor Decision|2|||
48699619|NCT00385671|156750473|FG002|Overall Study|Sponsor Decision|1|||
48592857|NCT03762681|156363579|FG007|Part 2a|Pandemic Travel Restrictions|1|||
48699620|NCT00385671|156750471|FG000|Overall Study|Withdrawal by Subject|4|||
48699621|NCT00385671|156750472|FG001|Overall Study|Withdrawal by Subject|4|||
48699622|NCT00385671|156750473|FG002|Overall Study|Withdrawal by Subject|4|||
48699623|NCT01586364|156750474|FG000|Overall Study|Withdrawal by Subject|40|||
48699624|NCT01586364|156750474|FG000|Overall Study|Adverse Event|37|||
48699625|NCT01586364|156750474|FG000|Overall Study|Lost to Follow-up|17|||
48432164|NCT01199263|155769048|FG001|Overall Study|Never Treated|0|||
48699626|NCT01586364|156750474|FG000|Overall Study|Protocol Violation|16|||
48699627|NCT01586364|156750474|FG000|Overall Study|Lack of Efficacy|1|||
48699628|NCT01586364|156750474|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
48699629|NCT01586364|156750474|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
48699630|NCT01586364|156750474|FG000|Overall Study|Other-Site closure due to PI illness|1|||
48699631|NCT01586364|156750474|FG000|Overall Study|Other-PI discretion, site closing|2|||
48699632|NCT01586364|156750474|FG000|Overall Study|Other-Not specified|1|||
48699633|NCT00812708|156750475|FG000|Overall Study|Device could not be implanted|2|||
48699634|NCT00812708|156750475|FG000|Overall Study|Lack of medical insurance|1|||
48699635|NCT00812708|156750475|FG000|Overall Study|Switched to another study|1|||
48699636|NCT00812708|156750475|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
48699637|NCT00812708|156750475|FG000|Overall Study|Signed consent but later withdrew|3|||
48699638|NCT00303069|156750476|FG000|Overall Study|Lost to Follow-up|1|||
48699639|NCT00303069|156750477|FG001|Overall Study|Lost to Follow-up|0|||
48699640|NCT00303069|156750478|FG002|Overall Study|Lost to Follow-up|0|||
48699641|NCT00303069|156750479|FG003|Overall Study|Lost to Follow-up|2|||
48699642|NCT00303069|156750476|FG000|Overall Study|subject moved|1|||
48699643|NCT00303069|156750477|FG001|Overall Study|subject moved|0|||
48699644|NCT00303069|156750478|FG002|Overall Study|subject moved|0|||
48699645|NCT00303069|156750479|FG003|Overall Study|subject moved|0|||
48699646|NCT00303069|156750476|FG000|Overall Study|Recruitment into Army Reserves|0|||
48699647|NCT00303069|156750477|FG001|Overall Study|Recruitment into Army Reserves|0|||
48699648|NCT00303069|156750478|FG002|Overall Study|Recruitment into Army Reserves|1|||
48699649|NCT00303069|156750479|FG003|Overall Study|Recruitment into Army Reserves|0|||
48699650|NCT00092417|156750480|FG000|Overall Study|Lost to Follow-up|2|||
48699651|NCT00092417|156750481|FG001|Overall Study|Lost to Follow-up|0|||
48699652|NCT00092417|156750480|FG000|Overall Study|Withdrawal by Subject|2|||
48699653|NCT00092417|156750481|FG001|Overall Study|Withdrawal by Subject|1|||
48699654|NCT00092417|156750480|FG000|Overall Study|Other|1|||
48699655|NCT00092417|156750481|FG001|Overall Study|Other|0|||
48699656|NCT00425269|156750482|FG000|Overall Study|Pregnancy|5|||
48699657|NCT00425269|156750483|FG001|Overall Study|Pregnancy|7|||
48699658|NCT00425269|156750482|FG000|Overall Study|Lost to Follow-up|9|||
48699659|NCT00425269|156750483|FG001|Overall Study|Lost to Follow-up|9|||
48699660|NCT00425269|156750482|FG000|Overall Study|moved or medical reason|5|||
48699661|NCT00425269|156750483|FG001|Overall Study|moved or medical reason|4|||
48699662|NCT01959503|156750484|FG000|Overall Study|Death|2|||
48699663|NCT01959503|156750485|FG001|Overall Study|Death|1|||
48699664|NCT01959503|156750484|FG000|Overall Study|Randomized but not treated|1|||
48699665|NCT01959503|156750485|FG001|Overall Study|Randomized but not treated|1|||
48699666|NCT01600326|156750486|FG000|Overall Study|Lost to Follow-up|1|||
48699667|NCT01600326|156750487|FG001|Overall Study|Lost to Follow-up|1|||
48699668|NCT00751296|156750488|FG000|Overall Study|Adverse Event|2|||
48699669|NCT00394095|156750489|FG000|Overall Study|Adverse Event|1|||
48699670|NCT00394095|156750490|FG001|Overall Study|Adverse Event|0|||
48699671|NCT00474487|156750496|FG000|Overall Study|Withdrawal by Subject|6|||
48699672|NCT00474487|156750497|FG001|Overall Study|Withdrawal by Subject|0|||
48699673|NCT00474487|156750498|FG002|Overall Study|Withdrawal by Subject|0|||
48699674|NCT00474487|156750499|FG003|Overall Study|Withdrawal by Subject|0|||
48699675|NCT00474487|156750496|FG000|Overall Study|Lost to Follow-up|20|||
48699676|NCT00474487|156750497|FG001|Overall Study|Lost to Follow-up|1|||
48699677|NCT00474487|156750498|FG002|Overall Study|Lost to Follow-up|7|||
48699678|NCT00474487|156750499|FG003|Overall Study|Lost to Follow-up|0|||
48699679|NCT00474487|156750496|FG000|Overall Study|Inappropriate enrollment|4|||
48699680|NCT00474487|156750497|FG001|Overall Study|Inappropriate enrollment|0|||
48699681|NCT00474487|156750498|FG002|Overall Study|Inappropriate enrollment|7|||
48699682|NCT00474487|156750499|FG003|Overall Study|Inappropriate enrollment|0|||
48699683|NCT00474487|156750496|FG000|Overall Study|Death|0|||
48699684|NCT00474487|156750497|FG001|Overall Study|Death|1|||
48699685|NCT00474487|156750498|FG002|Overall Study|Death|0|||
48699686|NCT00474487|156750499|FG003|Overall Study|Death|0|||
48699687|NCT03085095|156750500|FG000|Overall Study|Adverse Event|23|||
48699688|NCT03085095|156750501|FG001|Overall Study|Adverse Event|8|||
48699689|NCT03085095|156750500|FG000|Overall Study|Protocol Violation|0|||
48699690|NCT03085095|156750501|FG001|Overall Study|Protocol Violation|1|||
48699691|NCT03085095|156750500|FG000|Overall Study|Lost to Follow-up|2|||
48699692|NCT03085095|156750501|FG001|Overall Study|Lost to Follow-up|1|||
48699693|NCT03085095|156750500|FG000|Overall Study|Withdrawal by Subject|17|||
48699694|NCT03085095|156750501|FG001|Overall Study|Withdrawal by Subject|6|||
48699695|NCT03085095|156750500|FG000|Overall Study|Physician Decision|9|||
48699696|NCT03085095|156750501|FG001|Overall Study|Physician Decision|3|||
48699697|NCT03085095|156750500|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
48699698|NCT03085095|156750501|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
48699699|NCT03085095|156750500|FG000|Overall Study|Did not Receive Study Drug|2|||
48699700|NCT03085095|156750501|FG001|Overall Study|Did not Receive Study Drug|2|||
48699701|NCT03085095|156750500|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
48699702|NCT03085095|156750501|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
48699703|NCT01317472|156750502|FG000|Overall Study|Withdrawal by Subject|1|||
48699704|NCT01317472|156750503|FG001|Overall Study|Withdrawal by Subject|0|||
48699705|NCT01317472|156750502|FG000|Overall Study|Unrelated hospitalization|1|||
48699706|NCT01317472|156750503|FG001|Overall Study|Unrelated hospitalization|0|||
48699707|NCT04945733|156750504|FG000|Overall Study|Physician Decision|1|||
48699708|NCT04945733|156750505|FG001|Overall Study|Physician Decision|3|||
48699709|NCT04945733|156750506|FG002|Overall Study|Physician Decision|0|||
48699710|NCT04945733|156750504|FG000|Overall Study|Withdrawal by Subject|3|||
48699711|NCT04945733|156750505|FG001|Overall Study|Withdrawal by Subject|3|||
48699712|NCT04945733|156750506|FG002|Overall Study|Withdrawal by Subject|0|||
48699713|NCT00456846|156750518|FG000|Overall Study|Adverse Event|2|||
48699714|NCT00456846|156750519|FG001|Overall Study|Adverse Event|15|||
48699715|NCT00456846|156750518|FG000|Overall Study|Physician Decision|11|||
48699716|NCT00456846|156750519|FG001|Overall Study|Physician Decision|6|||
48699717|NCT00456846|156750518|FG000|Overall Study|Protocol Deviation|2|||
48699718|NCT00456846|156750519|FG001|Overall Study|Protocol Deviation|0|||
48699719|NCT00456846|156750518|FG000|Overall Study|Participant Discretion|1|||
48699720|NCT00456846|156750519|FG001|Overall Study|Participant Discretion|5|||
48699721|NCT00456846|156750518|FG000|Overall Study|Other|0|||
48699722|NCT00456846|156750519|FG001|Overall Study|Other|2|||
48699723|NCT00914849|156750522|FG000|Overall Study|Withdrawal by Subject|1|||
48699724|NCT00914849|156750523|FG001|Overall Study|Withdrawal by Subject|0|||
48699725|NCT00914849|156750522|FG000|Overall Study|Not eligible|0|||
48699726|NCT00914849|156750523|FG001|Overall Study|Not eligible|1|||
48699727|NCT01001221|156750524|FG000|Overall Study|Adverse Event|1|||
48699728|NCT01001221|156750525|FG001|Overall Study|Adverse Event|2|||
48699729|NCT01001221|156750526|FG002|Overall Study|Adverse Event|0|||
48699730|NCT01001221|156750527|FG003|Overall Study|Adverse Event|2|||
48699731|NCT01001221|156750528|FG004|Overall Study|Adverse Event|0|||
48487792|NCT00856778|155980778|FG000|Overall Study|Study deviation|2|||
48487793|NCT00856778|155980778|FG000|Overall Study|Lost to Follow-up|5|||
48487794|NCT01681771|155980779|FG000|Overall Study|Lost to Follow-up|4|||
48487795|NCT01681771|155980780|FG001|Overall Study|Lost to Follow-up|2|||
48487796|NCT02092961|155980781|FG000|Overall Study|Not reported|1|||
48487797|NCT02092961|155980782|FG001|Overall Study|Not reported|0|||
48487798|NCT02092961|155980783|FG002|Overall Study|Not reported|1|||
48592858|NCT00003896|156363582|FG000|Overall Study|Adverse Event|16|||
48592859|NCT00003896|156363582|FG000|Overall Study|Withdrawal by Subject|1|||
48487799|NCT02092961|155980781|FG000|Overall Study|Study stopped|13|||
48487800|NCT02092961|155980782|FG001|Overall Study|Study stopped|9|||
48487801|NCT02092961|155980783|FG002|Overall Study|Study stopped|12|||
48487802|NCT02092961|155980781|FG000|Overall Study|Lack of therapeutic response|2|||
48487803|NCT02092961|155980782|FG001|Overall Study|Lack of therapeutic response|1|||
48487804|NCT02092961|155980783|FG002|Overall Study|Lack of therapeutic response|3|||
48487805|NCT02092961|155980781|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
48487806|NCT02092961|155980782|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
48487807|NCT02092961|155980783|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
48487808|NCT02092961|155980781|FG000|Overall Study|Adverse Event|2|||
48699732|NCT01001221|156750524|FG000|Overall Study|Disease progression|3|||
48487809|NCT02092961|155980782|FG001|Overall Study|Adverse Event|4|||
48487810|NCT02092961|155980783|FG002|Overall Study|Adverse Event|0|||
48487811|NCT02270983|155980784|FG000|Overall Study|Adverse Event|3|||
48487812|NCT02270983|155980785|FG001|Overall Study|Adverse Event|2|||
48487813|NCT02270983|155980786|FG002|Overall Study|Adverse Event|6|||
48487814|NCT02270983|155980784|FG000|Overall Study|Lack of Efficacy|2|||
48487815|NCT02270983|155980785|FG001|Overall Study|Lack of Efficacy|1|||
48487816|NCT02270983|155980786|FG002|Overall Study|Lack of Efficacy|1|||
48487817|NCT02270983|155980784|FG000|Overall Study|Withdrawal by Subject|1|||
48487818|NCT02270983|155980785|FG001|Overall Study|Withdrawal by Subject|0|||
48487819|NCT02270983|155980786|FG002|Overall Study|Withdrawal by Subject|2|||
48487820|NCT02270983|155980784|FG000|Overall Study|Lost to Follow-up|1|||
48487821|NCT02270983|155980785|FG001|Overall Study|Lost to Follow-up|1|||
48487822|NCT02270983|155980786|FG002|Overall Study|Lost to Follow-up|2|||
48487823|NCT02270983|155980784|FG000|Overall Study|Protocol Violation|1|||
48487824|NCT02270983|155980785|FG001|Overall Study|Protocol Violation|1|||
48487825|NCT02270983|155980786|FG002|Overall Study|Protocol Violation|1|||
48487826|NCT02270983|155980784|FG000|Overall Study|family emergency|0|||
48487827|NCT02270983|155980785|FG001|Overall Study|family emergency|1|||
48699733|NCT01001221|156750525|FG001|Overall Study|Disease progression|2|||
48699734|NCT01001221|156750526|FG002|Overall Study|Disease progression|2|||
48699735|NCT01001221|156750527|FG003|Overall Study|Disease progression|4|||
48699736|NCT01001221|156750528|FG004|Overall Study|Disease progression|0|||
48487828|NCT02270983|155980786|FG002|Overall Study|family emergency|0|||
48487829|NCT02270983|155980784|FG000|Overall Study|study procedure non-compliance|1|||
48487830|NCT02270983|155980785|FG001|Overall Study|study procedure non-compliance|0|||
48487831|NCT02270983|155980786|FG002|Overall Study|study procedure non-compliance|0|||
48487832|NCT02270983|155980784|FG000|Overall Study|moved away from study site|0|||
48487833|NCT02270983|155980785|FG001|Overall Study|moved away from study site|1|||
48487834|NCT02270983|155980786|FG002|Overall Study|moved away from study site|0|||
48487835|NCT00265083|155980787|FG000|Overall Study|Adverse Event|5|||
48699737|NCT01001221|156750524|FG000|Overall Study|Other|1|||
48699738|NCT01001221|156750525|FG001|Overall Study|Other|1|||
48699739|NCT01001221|156750526|FG002|Overall Study|Other|0|||
48699740|NCT01001221|156750527|FG003|Overall Study|Other|0|||
48699741|NCT01001221|156750528|FG004|Overall Study|Other|0|||
48699742|NCT01001221|156750524|FG000|Overall Study|Not treated; protocol exclusion|0|||
48699743|NCT01001221|156750525|FG001|Overall Study|Not treated; protocol exclusion|0|||
48699744|NCT01001221|156750526|FG002|Overall Study|Not treated; protocol exclusion|1|||
48699745|NCT01001221|156750527|FG003|Overall Study|Not treated; protocol exclusion|0|||
48432165|NCT00430521|155769051|FG000|Overall Study|Adverse Event|0|||
48432166|NCT00430521|155769052|FG001|Overall Study|Adverse Event|0|||
48432167|NCT00430521|155769053|FG002|Overall Study|Adverse Event|0|||
48432168|NCT00430521|155769054|FG003|Overall Study|Adverse Event|0|||
48432169|NCT00430521|155769055|FG004|Overall Study|Adverse Event|0|||
48699746|NCT01001221|156750528|FG004|Overall Study|Not treated; protocol exclusion|0|||
48699747|NCT03405792|156750538|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
48699748|NCT03405792|156750539|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
48699749|NCT03405792|156750538|FG000|Overall Study|o Did not receive pembrolizumab|1|||
48699750|NCT03405792|156750539|FG001|Overall Study|o Did not receive pembrolizumab|0|||
48699751|NCT01310777|156750543|FG000|Overall Study|Adverse Event|23|||
48699752|NCT01310777|156750544|FG001|Overall Study|Adverse Event|1|||
48699753|NCT01310777|156750545|FG002|Overall Study|Adverse Event|15|||
48699754|NCT01310777|156750543|FG000|Overall Study|Lost to Follow-up|0|||
48699755|NCT01310777|156750544|FG001|Overall Study|Lost to Follow-up|4|||
48699756|NCT01310777|156750545|FG002|Overall Study|Lost to Follow-up|1|||
48699757|NCT01310777|156750543|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
48699758|NCT01310777|156750544|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
48699759|NCT01310777|156750545|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
48699760|NCT01310777|156750543|FG000|Overall Study|Inadequate Control of IOP|5|||
48699761|NCT01310777|156750544|FG001|Overall Study|Inadequate Control of IOP|7|||
48699762|NCT01310777|156750545|FG002|Overall Study|Inadequate Control of IOP|10|||
48699763|NCT01310777|156750543|FG000|Overall Study|Other|4|||
48487836|NCT00265083|155980788|FG001|Overall Study|Adverse Event|13|||
48487837|NCT00265083|155980789|FG002|Overall Study|Adverse Event|15|||
48487838|NCT00265083|155980787|FG000|Overall Study|Lost to Follow-up|3|||
48699764|NCT01310777|156750544|FG001|Overall Study|Other|1|||
48699765|NCT01310777|156750545|FG002|Overall Study|Other|2|||
48699766|NCT02476617|156750547|FG000|Overall Study|Adverse Event|1|||
48699767|NCT02476617|156750547|FG000|Overall Study|Lost to Follow-up|1|||
48699768|NCT03521570|156750550|FG000|Overall Study|Not eligible|11|||
48699769|NCT01210313|156750551|FG000|Overall Study|Withdrawal by Subject|3|||
48699770|NCT01210313|156750551|FG000|Overall Study|Adverse Event|2|||
48699771|NCT01210313|156750551|FG000|Overall Study|Distant recurrence|4|||
48699772|NCT01210313|156750551|FG000|Overall Study|Non-compliance|7|||
48699773|NCT03995368|156750552|FG000|Overall Study|Lost to Follow-up|1|||
48699774|NCT03995368|156750553|FG001|Overall Study|Lost to Follow-up|4|||
48699775|NCT03995368|156750554|FG002|Overall Study|Lost to Follow-up|1|||
48699776|NCT03995368|156750552|FG000|Overall Study|Did not meet inclusion criteria|1|||
48699777|NCT03995368|156750553|FG001|Overall Study|Did not meet inclusion criteria|6|||
48699778|NCT03995368|156750554|FG002|Overall Study|Did not meet inclusion criteria|3|||
48699779|NCT03995368|156750552|FG000|Overall Study|Withdrawal by Subject|0|||
48699780|NCT03995368|156750553|FG001|Overall Study|Withdrawal by Subject|1|||
48699781|NCT03995368|156750554|FG002|Overall Study|Withdrawal by Subject|1|||
48699782|NCT03755934|156750555|FG000|Overall Study|Adverse Event|4|||
48699783|NCT03755934|156750556|FG001|Overall Study|Adverse Event|1|||
48699784|NCT03755934|156750557|FG002|Overall Study|Adverse Event|1|||
48699785|NCT03755934|156750558|FG003|Overall Study|Adverse Event|3|||
48699786|NCT03755934|156750555|FG000|Overall Study|Physician Decision|2|||
48699787|NCT03755934|156750556|FG001|Overall Study|Physician Decision|0|||
48699788|NCT03755934|156750557|FG002|Overall Study|Physician Decision|0|||
48699789|NCT03755934|156750558|FG003|Overall Study|Physician Decision|1|||
48699790|NCT03755934|156750555|FG000|Overall Study|Withdrawal by Subject|5|||
48699791|NCT03755934|156750556|FG001|Overall Study|Withdrawal by Subject|0|||
48699792|NCT03755934|156750557|FG002|Overall Study|Withdrawal by Subject|0|||
48699793|NCT03755934|156750558|FG003|Overall Study|Withdrawal by Subject|1|||
48699794|NCT03755934|156750555|FG000|Overall Study|Other|3|||
48592860|NCT00003896|156363582|FG000|Overall Study|Lack of Efficacy|1|||
48699795|NCT03755934|156750556|FG001|Overall Study|Other|1|||
48699796|NCT03755934|156750557|FG002|Overall Study|Other|3|||
48699797|NCT03755934|156750558|FG003|Overall Study|Other|1|||
48699798|NCT01056822|156750559|FG000|Overall Study|Adverse Event|0|||
48699799|NCT01056822|156750560|FG001|Overall Study|Adverse Event|1|||
48699800|NCT01056822|156750559|FG000|Overall Study|Protocol Violation|6|||
48699801|NCT01056822|156750560|FG001|Overall Study|Protocol Violation|5|||
48699802|NCT01056822|156750559|FG000|Overall Study|Withdrawal by Subject|1|||
48699803|NCT01056822|156750560|FG001|Overall Study|Withdrawal by Subject|1|||
48699804|NCT01056822|156750559|FG000|Overall Study|Lost to Follow-up|1|||
48699805|NCT01056822|156750560|FG001|Overall Study|Lost to Follow-up|0|||
48699806|NCT03558737|156750564|FG000|Overall Study|Death|1|||
48699807|NCT03558737|156750565|FG001|Overall Study|Death|1|||
48699808|NCT00453206|156750566|FG000|Overall Study|Death|1|||
48699809|NCT01394016|156750567|FG000|Overall Study|Progressive Disease|2|||
48699810|NCT01394016|156750568|FG001|Overall Study|Progressive Disease|0|||
48699811|NCT01394016|156750569|FG002|Overall Study|Progressive Disease|0|||
48699812|NCT01394016|156750570|FG003|Overall Study|Progressive Disease|0|||
48699813|NCT01394016|156750571|FG004|Overall Study|Progressive Disease|0|||
48699814|NCT01394016|156750572|FG005|Overall Study|Progressive Disease|0|||
48699815|NCT01394016|156750573|FG006|Overall Study|Progressive Disease|0|||
48699816|NCT01394016|156750574|FG007|Overall Study|Progressive Disease|0|||
48699817|NCT01394016|156750575|FG008|Overall Study|Progressive Disease|0|||
48699818|NCT01394016|156750576|FG009|Overall Study|Progressive Disease|0|||
48699819|NCT01394016|156750577|FG010|Overall Study|Progressive Disease|0|||
48699820|NCT01394016|156750578|FG011|Overall Study|Progressive Disease|0|||
48699821|NCT01394016|156750579|FG012|Overall Study|Progressive Disease|0|||
48699822|NCT01394016|156750580|FG013|Overall Study|Progressive Disease|0|||
48699823|NCT01394016|156750581|FG014|Overall Study|Progressive Disease|0|||
48699824|NCT01394016|156750582|FG015|Overall Study|Progressive Disease|0|||
48699825|NCT01394016|156750583|FG016|Overall Study|Progressive Disease|0|||
48699826|NCT01394016|156750584|FG017|Overall Study|Progressive Disease|0|||
48699827|NCT01394016|156750585|FG018|Overall Study|Progressive Disease|0|||
48699828|NCT01394016|156750567|FG000|Overall Study|Withdrawal by Subject|0|||
48699829|NCT01394016|156750568|FG001|Overall Study|Withdrawal by Subject|0|||
48699830|NCT01394016|156750569|FG002|Overall Study|Withdrawal by Subject|0|||
48699831|NCT01394016|156750570|FG003|Overall Study|Withdrawal by Subject|0|||
48699832|NCT01394016|156750571|FG004|Overall Study|Withdrawal by Subject|0|||
48699833|NCT01394016|156750572|FG005|Overall Study|Withdrawal by Subject|0|||
48699834|NCT01394016|156750573|FG006|Overall Study|Withdrawal by Subject|0|||
48699835|NCT01394016|156750574|FG007|Overall Study|Withdrawal by Subject|1|||
48699836|NCT01394016|156750575|FG008|Overall Study|Withdrawal by Subject|1|||
48699837|NCT01394016|156750576|FG009|Overall Study|Withdrawal by Subject|1|||
48699838|NCT01394016|156750577|FG010|Overall Study|Withdrawal by Subject|4|||
48699839|NCT01394016|156750578|FG011|Overall Study|Withdrawal by Subject|0|||
48699840|NCT01394016|156750579|FG012|Overall Study|Withdrawal by Subject|0|||
48699841|NCT01394016|156750580|FG013|Overall Study|Withdrawal by Subject|3|||
48699842|NCT01394016|156750581|FG014|Overall Study|Withdrawal by Subject|1|||
48699843|NCT01394016|156750582|FG015|Overall Study|Withdrawal by Subject|3|||
48699844|NCT01394016|156750583|FG016|Overall Study|Withdrawal by Subject|1|||
48699845|NCT01394016|156750584|FG017|Overall Study|Withdrawal by Subject|1|||
48699846|NCT01394016|156750585|FG018|Overall Study|Withdrawal by Subject|2|||
48487839|NCT00265083|155980788|FG001|Overall Study|Lost to Follow-up|4|||
48487840|NCT00265083|155980789|FG002|Overall Study|Lost to Follow-up|4|||
48699847|NCT01394016|156750567|FG000|Overall Study|Adverse Event|0|||
48699848|NCT01394016|156750568|FG001|Overall Study|Adverse Event|0|||
48699849|NCT01394016|156750569|FG002|Overall Study|Adverse Event|0|||
48699850|NCT01394016|156750570|FG003|Overall Study|Adverse Event|0|||
48699851|NCT01394016|156750571|FG004|Overall Study|Adverse Event|0|||
48699852|NCT01394016|156750572|FG005|Overall Study|Adverse Event|0|||
48699853|NCT01394016|156750573|FG006|Overall Study|Adverse Event|0|||
48699854|NCT01394016|156750574|FG007|Overall Study|Adverse Event|0|||
48699855|NCT01394016|156750575|FG008|Overall Study|Adverse Event|0|||
48699856|NCT01394016|156750576|FG009|Overall Study|Adverse Event|1|||
48699857|NCT01394016|156750577|FG010|Overall Study|Adverse Event|0|||
48699858|NCT01394016|156750578|FG011|Overall Study|Adverse Event|0|||
48699859|NCT01394016|156750579|FG012|Overall Study|Adverse Event|0|||
48699860|NCT01394016|156750580|FG013|Overall Study|Adverse Event|0|||
48699861|NCT01394016|156750581|FG014|Overall Study|Adverse Event|0|||
48699862|NCT01394016|156750582|FG015|Overall Study|Adverse Event|0|||
48699863|NCT01394016|156750583|FG016|Overall Study|Adverse Event|1|||
48699864|NCT01394016|156750584|FG017|Overall Study|Adverse Event|1|||
48699865|NCT01394016|156750585|FG018|Overall Study|Adverse Event|0|||
48699866|NCT01394016|156750567|FG000|Overall Study|Sponsor Decision|0|||
48699867|NCT01394016|156750568|FG001|Overall Study|Sponsor Decision|0|||
48699868|NCT01394016|156750569|FG002|Overall Study|Sponsor Decision|0|||
48699869|NCT01394016|156750570|FG003|Overall Study|Sponsor Decision|0|||
48699870|NCT01394016|156750571|FG004|Overall Study|Sponsor Decision|0|||
48699871|NCT01394016|156750572|FG005|Overall Study|Sponsor Decision|0|||
48699872|NCT01394016|156750573|FG006|Overall Study|Sponsor Decision|0|||
48699873|NCT01394016|156750574|FG007|Overall Study|Sponsor Decision|0|||
48699874|NCT01394016|156750575|FG008|Overall Study|Sponsor Decision|0|||
48699875|NCT01394016|156750576|FG009|Overall Study|Sponsor Decision|0|||
48699876|NCT01394016|156750577|FG010|Overall Study|Sponsor Decision|0|||
48699877|NCT01394016|156750578|FG011|Overall Study|Sponsor Decision|0|||
48699878|NCT01394016|156750579|FG012|Overall Study|Sponsor Decision|1|||
48699879|NCT01394016|156750580|FG013|Overall Study|Sponsor Decision|0|||
48699880|NCT01394016|156750581|FG014|Overall Study|Sponsor Decision|0|||
48699881|NCT01394016|156750582|FG015|Overall Study|Sponsor Decision|0|||
48699882|NCT01394016|156750583|FG016|Overall Study|Sponsor Decision|0|||
48699883|NCT01394016|156750584|FG017|Overall Study|Sponsor Decision|0|||
48699884|NCT01394016|156750585|FG018|Overall Study|Sponsor Decision|0|||
48699885|NCT01394016|156750567|FG000|Overall Study|Lost to Follow-up|0|||
48699886|NCT01394016|156750568|FG001|Overall Study|Lost to Follow-up|0|||
48699887|NCT01394016|156750569|FG002|Overall Study|Lost to Follow-up|0|||
48699888|NCT01394016|156750570|FG003|Overall Study|Lost to Follow-up|0|||
48699889|NCT01394016|156750571|FG004|Overall Study|Lost to Follow-up|0|||
48699890|NCT01394016|156750572|FG005|Overall Study|Lost to Follow-up|0|||
48699891|NCT01394016|156750573|FG006|Overall Study|Lost to Follow-up|0|||
48699892|NCT01394016|156750574|FG007|Overall Study|Lost to Follow-up|0|||
48699893|NCT01394016|156750575|FG008|Overall Study|Lost to Follow-up|0|||
48699894|NCT01394016|156750576|FG009|Overall Study|Lost to Follow-up|0|||
48699895|NCT01394016|156750577|FG010|Overall Study|Lost to Follow-up|0|||
48699896|NCT01394016|156750578|FG011|Overall Study|Lost to Follow-up|0|||
48699897|NCT01394016|156750579|FG012|Overall Study|Lost to Follow-up|0|||
48699898|NCT01394016|156750580|FG013|Overall Study|Lost to Follow-up|0|||
48699899|NCT01394016|156750581|FG014|Overall Study|Lost to Follow-up|0|||
48699900|NCT01394016|156750582|FG015|Overall Study|Lost to Follow-up|0|||
48699901|NCT01394016|156750583|FG016|Overall Study|Lost to Follow-up|0|||
48699902|NCT01394016|156750584|FG017|Overall Study|Lost to Follow-up|0|||
48699903|NCT01394016|156750585|FG018|Overall Study|Lost to Follow-up|1|||
48699904|NCT04123470|156750586|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
48699905|NCT04123470|156750587|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
48699906|NCT04123470|156750586|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
48699907|NCT04123470|156750587|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
48699908|NCT04123470|156750586|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
48699909|NCT04123470|156750587|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
48699910|NCT04123470|156750586|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
48699911|NCT04123470|156750587|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
48699912|NCT04825678|156750592|FG000|Overall Study|Decision by Sponsor|2|||
48699913|NCT04825678|156750593|FG001|Overall Study|Decision by Sponsor|3|||
48699914|NCT04825678|156750592|FG000|Overall Study|Withdrawal of Consent From Study|7|||
48699915|NCT04825678|156750593|FG001|Overall Study|Withdrawal of Consent From Study|9|||
48592861|NCT00003896|156363582|FG000|Overall Study|Death|3|||
48699916|NCT04825678|156750592|FG000|Overall Study|Lost to Follow-up|3|||
48699917|NCT04825678|156750593|FG001|Overall Study|Lost to Follow-up|4|||
48699918|NCT04825678|156750592|FG000|Overall Study|Never Received Investigational Product|1|||
48699919|NCT04825678|156750593|FG001|Overall Study|Never Received Investigational Product|1|||
48699920|NCT00651742|156750595|FG000|Overall Study|Objective Disease Progression|22|||
48699921|NCT00651742|156750595|FG000|Overall Study|Toxicity|3|||
48699922|NCT00651742|156750595|FG000|Overall Study|Investigator Judgment|1|||
48699923|NCT00651742|156750595|FG000|Overall Study|Withdrawal of Consent|1|||
48699924|NCT00651742|156750595|FG000|Overall Study|Enrolled but not treated|1|||
48699925|NCT04780061|156750600|FG000|Overall Study|Withdrawal by Subject|5|||
48699926|NCT04780061|156750601|FG001|Overall Study|Withdrawal by Subject|8|||
48699927|NCT04780061|156750600|FG000|Overall Study|Adverse Event|2|||
48699928|NCT04780061|156750601|FG001|Overall Study|Adverse Event|2|||
48699929|NCT04780061|156750600|FG000|Overall Study|Lost to Follow-up|1|||
48699930|NCT04780061|156750601|FG001|Overall Study|Lost to Follow-up|5|||
48699931|NCT00734149|156750602|FG000|Overall Study|Withdrawal by Subject|1|||
48699932|NCT04607005|156750603|FG000|Overall Study|Adverse Event|0|||
48699933|NCT04607005|156750604|FG001|Overall Study|Adverse Event|1|||
48699934|NCT04607005|156750603|FG000|Overall Study|Lack of Efficacy|1|||
48699935|NCT04607005|156750604|FG001|Overall Study|Lack of Efficacy|6|||
48699936|NCT04607005|156750603|FG000|Overall Study|Withdrawal by Subject|4|||
48699937|NCT04607005|156750604|FG001|Overall Study|Withdrawal by Subject|9|||
48699938|NCT04607005|156750603|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
48699939|NCT04607005|156750604|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
48699940|NCT03043794|156750607|FG000|Overall Study|Lost to Follow-up|1|||
48699941|NCT03173560|156750608|FG000|Overall Study|Ongoing on Treatment|38|||
48699942|NCT03173560|156750609|FG001|Overall Study|Ongoing on Treatment|50|||
48699943|NCT03173560|156750608|FG000|Overall Study|Ongoing Survival Follow-up|56|||
48699944|NCT03173560|156750609|FG001|Overall Study|Ongoing Survival Follow-up|57|||
48699945|NCT03173560|156750608|FG000|Overall Study|Lost to Follow-up|1|||
48699946|NCT03173560|156750609|FG001|Overall Study|Lost to Follow-up|4|||
48699947|NCT03173560|156750608|FG000|Overall Study|Withdrawal by Subject|10|||
48699948|NCT03173560|156750609|FG001|Overall Study|Withdrawal by Subject|5|||
48699949|NCT03173560|156750608|FG000|Overall Study|Other|0|||
48699950|NCT03173560|156750609|FG001|Overall Study|Other|1|||
48699951|NCT02807402|156750612|FG000|Overall Study|Failure to Return|1|||
48699952|NCT02807402|156750612|FG000|Overall Study|Death|3|||
48699953|NCT02807402|156750612|FG000|Overall Study|Other|2|||
48699954|NCT01972217|156751774|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
48699955|NCT01972217|156751775|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
48699956|NCT01972217|156751776|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
48699957|NCT01972217|156751777|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
48699958|NCT01972217|156751774|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
48699959|NCT01972217|156751775|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
48432170|NCT00430521|155769056|FG005|Overall Study|Adverse Event|2|||
48432171|NCT00430521|155769057|FG006|Overall Study|Adverse Event|1|||
48432172|NCT00430521|155769058|FG007|Overall Study|Adverse Event|0|||
48432173|NCT00430521|155769051|FG000|Overall Study|Lost to Follow-up|7|||
48432174|NCT00430521|155769052|FG001|Overall Study|Lost to Follow-up|8|||
48432175|NCT00430521|155769053|FG002|Overall Study|Lost to Follow-up|3|||
48432176|NCT00430521|155769054|FG003|Overall Study|Lost to Follow-up|5|||
48432177|NCT00430521|155769055|FG004|Overall Study|Lost to Follow-up|5|||
48432178|NCT00430521|155769056|FG005|Overall Study|Lost to Follow-up|2|||
48432179|NCT00430521|155769057|FG006|Overall Study|Lost to Follow-up|8|||
48432180|NCT00430521|155769058|FG007|Overall Study|Lost to Follow-up|10|||
48432181|NCT00430521|155769051|FG000|Overall Study|Pregnancy|0|||
48432182|NCT00430521|155769052|FG001|Overall Study|Pregnancy|0|||
48432183|NCT00430521|155769053|FG002|Overall Study|Pregnancy|0|||
48432184|NCT00430521|155769054|FG003|Overall Study|Pregnancy|0|||
48432185|NCT00430521|155769055|FG004|Overall Study|Pregnancy|0|||
48432186|NCT00430521|155769056|FG005|Overall Study|Pregnancy|0|||
48432187|NCT00430521|155769057|FG006|Overall Study|Pregnancy|1|||
48432188|NCT00430521|155769058|FG007|Overall Study|Pregnancy|0|||
48432189|NCT00430521|155769051|FG000|Overall Study|Vaccine Expired|0|||
48432190|NCT00430521|155769052|FG001|Overall Study|Vaccine Expired|0|||
48432191|NCT00430521|155769053|FG002|Overall Study|Vaccine Expired|0|||
48432192|NCT00430521|155769054|FG003|Overall Study|Vaccine Expired|0|||
48432193|NCT00430521|155769055|FG004|Overall Study|Vaccine Expired|0|||
48432194|NCT00430521|155769056|FG005|Overall Study|Vaccine Expired|1|||
48432195|NCT00430521|155769057|FG006|Overall Study|Vaccine Expired|0|||
48432196|NCT00430521|155769058|FG007|Overall Study|Vaccine Expired|0|||
48432197|NCT00430521|155769051|FG000|Overall Study|Protocol Violation|1|||
48432198|NCT00430521|155769052|FG001|Overall Study|Protocol Violation|0|||
48432199|NCT00430521|155769053|FG002|Overall Study|Protocol Violation|0|||
48432200|NCT00430521|155769054|FG003|Overall Study|Protocol Violation|0|||
48432201|NCT00430521|155769055|FG004|Overall Study|Protocol Violation|0|||
48432202|NCT00430521|155769056|FG005|Overall Study|Protocol Violation|0|||
48432203|NCT00430521|155769057|FG006|Overall Study|Protocol Violation|0|||
48432204|NCT00430521|155769058|FG007|Overall Study|Protocol Violation|0|||
48432205|NCT00430521|155769051|FG000|Overall Study|Withdrawal by Subject|3|||
48432206|NCT00430521|155769052|FG001|Overall Study|Withdrawal by Subject|1|||
48432207|NCT00430521|155769053|FG002|Overall Study|Withdrawal by Subject|0|||
48432208|NCT00430521|155769054|FG003|Overall Study|Withdrawal by Subject|3|||
48432209|NCT00430521|155769055|FG004|Overall Study|Withdrawal by Subject|0|||
48432210|NCT00430521|155769056|FG005|Overall Study|Withdrawal by Subject|0|||
48432211|NCT00430521|155769057|FG006|Overall Study|Withdrawal by Subject|0|||
48487841|NCT00265083|155980787|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
48487842|NCT00265083|155980788|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
48487843|NCT00265083|155980789|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
48487844|NCT00265083|155980787|FG000|Overall Study|Other|1|||
48487845|NCT00265083|155980788|FG001|Overall Study|Other|12|||
48487846|NCT00265083|155980789|FG002|Overall Study|Other|9|||
48487847|NCT03208933|155980793|FG000|Overall Study|Death|3|||
48487848|NCT03208933|155980793|FG000|Overall Study|Withdrawal by Subject|3|||
48699960|NCT01972217|156751776|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
48699961|NCT01972217|156751777|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
48699962|NCT01972217|156751774|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
48699963|NCT01972217|156751775|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
48699964|NCT01972217|156751776|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
48699965|NCT01972217|156751777|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
48699966|NCT01972217|156751774|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
48699967|NCT01972217|156751775|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
48699968|NCT01972217|156751776|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
48699969|NCT01972217|156751777|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
48699970|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Death|0|||
48699971|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Death|0|||
48699972|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Death|43|||
48699973|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Death|44|||
48699974|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
48699975|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
48699976|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
48699977|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
48699978|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
48699979|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
48699980|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
48699981|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
48699982|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
48699983|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
48699984|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
48699985|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
48699986|NCT01972217|156751774|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
48699987|NCT01972217|156751775|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
48699988|NCT01972217|156751776|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
48699989|NCT01972217|156751777|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
48699990|NCT01910298|156751778|FG000|Overall Study|Adverse Event|1|||
48699991|NCT01910298|156751779|FG001|Overall Study|Adverse Event|0|||
48699992|NCT01910298|156751778|FG000|Overall Study|Withdrawal by Subject|2|||
48699993|NCT01910298|156751779|FG001|Overall Study|Withdrawal by Subject|7|||
48699994|NCT01910298|156751778|FG000|Overall Study|Protocol Deviation|0|||
48699995|NCT01910298|156751779|FG001|Overall Study|Protocol Deviation|5|||
48487849|NCT03208933|155980793|FG000|Overall Study|Adverse Event|1|||
48487850|NCT03208933|155980793|FG000|Overall Study|Lost to Follow-up|2|||
48699996|NCT01910298|156751778|FG000|Overall Study|Lost to Follow-up|1|||
48699997|NCT01910298|156751779|FG001|Overall Study|Lost to Follow-up|1|||
48699998|NCT01910298|156751778|FG000|Overall Study|Study Terminated by Sponsor|1|||
48699999|NCT01910298|156751779|FG001|Overall Study|Study Terminated by Sponsor|17|||
48700000|NCT01910298|156751778|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48487851|NCT03208933|155980793|FG000|Overall Study|Physician Decision|3|||
48487852|NCT03208933|155980793|FG000|Overall Study|Protocol Violation|1|||
48487853|NCT03372369|155980794|FG000|Qualification Period|Withdrawal by Subject|16|||
48700001|NCT01910298|156751779|FG001|Overall Study|Other Miscellaneous Reasons|2|||
48700002|NCT03591406|156751783|FG000|Overall Study|Adverse Event|5|||
48700003|NCT03591406|156751784|FG001|Overall Study|Adverse Event|3|||
48700004|NCT03591406|156751783|FG000|Overall Study|Protocol Violation|2|||
48700005|NCT03591406|156751784|FG001|Overall Study|Protocol Violation|1|||
48700006|NCT03591406|156751783|FG000|Overall Study|Withdrawal by Subject|0|||
48700007|NCT03591406|156751784|FG001|Overall Study|Withdrawal by Subject|5|||
48700008|NCT02536976|156751785|FG000|Overall Study|Physician Decision|0|||
48700009|NCT02536976|156751786|FG001|Overall Study|Physician Decision|1|||
48700010|NCT02992288|156751788|FG000|Overall Study|Adverse Event|8|||
48700011|NCT02992288|156751789|FG001|Overall Study|Adverse Event|2|||
48700012|NCT02992288|156751790|FG002|Overall Study|Adverse Event|2|||
48700013|NCT02992288|156751791|FG003|Overall Study|Adverse Event|2|||
48700014|NCT02992288|156751792|FG004|Overall Study|Adverse Event|2|||
48700015|NCT02992288|156751793|FG005|Overall Study|Adverse Event|7|||
48700016|NCT02992288|156751788|FG000|Overall Study|Non-compliance with study drug|0|||
48700017|NCT02992288|156751789|FG001|Overall Study|Non-compliance with study drug|1|||
48700018|NCT02992288|156751790|FG002|Overall Study|Non-compliance with study drug|1|||
48700019|NCT02992288|156751791|FG003|Overall Study|Non-compliance with study drug|0|||
48700020|NCT02992288|156751792|FG004|Overall Study|Non-compliance with study drug|1|||
48700021|NCT02992288|156751793|FG005|Overall Study|Non-compliance with study drug|0|||
48700022|NCT02992288|156751788|FG000|Overall Study|Physician Decision|3|||
48700023|NCT02992288|156751789|FG001|Overall Study|Physician Decision|0|||
48700024|NCT02992288|156751790|FG002|Overall Study|Physician Decision|1|||
48700025|NCT02992288|156751791|FG003|Overall Study|Physician Decision|0|||
48700026|NCT02992288|156751792|FG004|Overall Study|Physician Decision|0|||
48700027|NCT02992288|156751793|FG005|Overall Study|Physician Decision|1|||
48700028|NCT02992288|156751788|FG000|Overall Study|Death|2|||
48700029|NCT02992288|156751789|FG001|Overall Study|Death|0|||
48487854|NCT03372369|155980795|FG001|Qualification Period|Withdrawal by Subject|13|||
48487855|NCT03372369|155980794|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
48487856|NCT03372369|155980795|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
48487857|NCT03372369|155980794|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
48487858|NCT03372369|155980795|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
48487859|NCT00854620|155980798|FG000|Overall Study|Adverse Event|1|||
48487860|NCT01623830|155980799|FG000|Overall Study|Withdrawal by Subject|6|||
48487861|NCT01623830|155980800|FG001|Overall Study|Withdrawal by Subject|7|||
48700030|NCT02992288|156751790|FG002|Overall Study|Death|2|||
48700031|NCT02992288|156751791|FG003|Overall Study|Death|1|||
48700032|NCT02992288|156751792|FG004|Overall Study|Death|2|||
48700033|NCT02992288|156751793|FG005|Overall Study|Death|0|||
48700034|NCT02992288|156751788|FG000|Overall Study|Lost to Follow-up|0|||
48700035|NCT02992288|156751789|FG001|Overall Study|Lost to Follow-up|0|||
48700036|NCT02992288|156751790|FG002|Overall Study|Lost to Follow-up|0|||
48487862|NCT01623830|155980799|FG000|Overall Study|Exclusion from Study|1|||
48700037|NCT02992288|156751791|FG003|Overall Study|Lost to Follow-up|1|||
48700038|NCT02992288|156751792|FG004|Overall Study|Lost to Follow-up|0|||
48700039|NCT02992288|156751793|FG005|Overall Study|Lost to Follow-up|0|||
48700040|NCT02992288|156751788|FG000|Overall Study|Protocol Violation|0|||
48700041|NCT02992288|156751789|FG001|Overall Study|Protocol Violation|0|||
48700042|NCT02992288|156751790|FG002|Overall Study|Protocol Violation|0|||
48700043|NCT02992288|156751791|FG003|Overall Study|Protocol Violation|0|||
48700044|NCT02992288|156751792|FG004|Overall Study|Protocol Violation|0|||
48700045|NCT02992288|156751793|FG005|Overall Study|Protocol Violation|1|||
48700046|NCT02992288|156751788|FG000|Overall Study|Withdrawal by Subject|4|||
48700047|NCT02992288|156751789|FG001|Overall Study|Withdrawal by Subject|2|||
48700048|NCT02992288|156751790|FG002|Overall Study|Withdrawal by Subject|1|||
48700049|NCT02992288|156751791|FG003|Overall Study|Withdrawal by Subject|5|||
48700050|NCT02992288|156751792|FG004|Overall Study|Withdrawal by Subject|3|||
48700051|NCT02992288|156751793|FG005|Overall Study|Withdrawal by Subject|4|||
48700052|NCT00581308|156751794|FG000|Pre Discharge|Lost to Follow-up|1|||
48700053|NCT00581308|156751794|FG000|Pre Discharge|Device Removed|1|||
48700054|NCT00581308|156751794|FG000|Month 1|Lost to Follow-up|3|||
48700055|NCT00581308|156751794|FG000|Month 1|Withdrawal by Subject|2|||
48700056|NCT00581308|156751794|FG000|Month 1|Device Removed|2|||
48700057|NCT00581308|156751794|FG000|Month 1|Uknown|1|||
48700058|NCT00581308|156751794|FG000|Month 6|Lost to Follow-up|1|||
48700059|NCT00581308|156751794|FG000|Month 6|Withdrawal by Subject|2|||
48700060|NCT00581308|156751794|FG000|Month 12|Death|1|||
48700061|NCT00581308|156751794|FG000|Month 12|Lost to Follow-up|14|||
48700062|NCT00581308|156751794|FG000|Month 12|Withdrawal by Subject|3|||
48700063|NCT00581308|156751794|FG000|Month 12|Device Removed|1|||
48700064|NCT00581308|156751794|FG000|Month 12|Other|1|||
48700065|NCT04558125|156751796|FG000|Overall Study|Death|1|||
48700066|NCT01207414|156751798|FG000|Overall Study|Adverse Event|25|||
48700067|NCT01207414|156751799|FG001|Overall Study|Adverse Event|39|||
48700068|NCT01207414|156751798|FG000|Overall Study|Abnormal test procedure results|0|||
48700069|NCT01207414|156751799|FG001|Overall Study|Abnormal test procedure results|1|||
48700070|NCT01207414|156751798|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
48700071|NCT01207414|156751799|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48700072|NCT01207414|156751798|FG000|Overall Study|Patient withdrew consent|14|||
48700073|NCT01207414|156751799|FG001|Overall Study|Patient withdrew consent|11|||
48700074|NCT01207414|156751798|FG000|Overall Study|Lost to Follow-up|15|||
48700075|NCT01207414|156751799|FG001|Overall Study|Lost to Follow-up|17|||
48700076|NCT01207414|156751798|FG000|Overall Study|Administrative problems|1|||
48700077|NCT01207414|156751799|FG001|Overall Study|Administrative problems|1|||
48700078|NCT01207414|156751798|FG000|Overall Study|Protocol deviation|12|||
48700079|NCT01207414|156751799|FG001|Overall Study|Protocol deviation|9|||
48700080|NCT01207414|156751798|FG000|Overall Study|Randomized in error|1|||
48700081|NCT01207414|156751799|FG001|Overall Study|Randomized in error|0|||
48700082|NCT03448406|156751800|FG000|Overall Study|Noncompliance of scheduled visits|1|||
48700083|NCT03448406|156751801|FG001|Overall Study|Noncompliance of scheduled visits|2|||
48700084|NCT03448406|156751800|FG000|Overall Study|Withdrawal by Subject|1|||
48700085|NCT03448406|156751801|FG001|Overall Study|Withdrawal by Subject|2|||
48700086|NCT03448406|156751800|FG000|Overall Study|Protocol Violation|1|||
48700087|NCT03448406|156751801|FG001|Overall Study|Protocol Violation|0|||
48700088|NCT03448406|156751800|FG000|Overall Study|Adverse Event|8|||
48700089|NCT03448406|156751801|FG001|Overall Study|Adverse Event|9|||
48700090|NCT01292486|156751802|FG000|Overall Study|Protocol Violation|2|||
48700091|NCT01292486|156751802|FG000|Overall Study|Did not meet screening criteria|2|||
48700092|NCT01292486|156751802|FG000|Overall Study|Adverse Event|1|||
48700093|NCT01292486|156751802|FG000|Overall Study|Physician Decision|1|||
48700094|NCT04596267|156751804|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
48700095|NCT04596267|156751805|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
48700096|NCT04596267|156751804|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
48700097|NCT04596267|156751805|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
48700098|NCT02383576|156751806|FG000|Overall Study|Death|53|||
48700099|NCT02383576|156751807|FG001|Overall Study|Death|33|||
48700100|NCT02383576|156751806|FG000|Overall Study|Lost to Follow-up|7|||
48700101|NCT02383576|156751807|FG001|Overall Study|Lost to Follow-up|1|||
48700102|NCT02383576|156751806|FG000|Overall Study|Withdrew Consent|1|||
48700103|NCT02383576|156751807|FG001|Overall Study|Withdrew Consent|6|||
48700104|NCT02383576|156751806|FG000|Overall Study|Investigator's Decision|0|||
48700105|NCT02383576|156751807|FG001|Overall Study|Investigator's Decision|1|||
48700106|NCT02383576|156751806|FG000|Overall Study|Administrative/Other|2|||
48700107|NCT02383576|156751807|FG001|Overall Study|Administrative/Other|4|||
48700108|NCT04097678|156751810|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
48700109|NCT04097678|156751811|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
48700110|NCT02435212|156751812|FG000|Core Phase|Adverse Event|8|||
48700111|NCT02435212|156751813|FG001|Core Phase|Adverse Event|5|||
48700112|NCT02435212|156751812|FG000|Core Phase|Withdrawal by Subject|3|||
48700113|NCT02435212|156751813|FG001|Core Phase|Withdrawal by Subject|0|||
48700114|NCT02435212|156751812|FG000|Core Phase|Withdrawal by parent/guardian|9|||
48700115|NCT02435212|156751813|FG001|Core Phase|Withdrawal by parent/guardian|4|||
48700116|NCT02435212|156751812|FG000|Core Phase|Protocol Violation|1|||
48700117|NCT02435212|156751813|FG001|Core Phase|Protocol Violation|2|||
48700118|NCT02435212|156751812|FG000|Core Phase|Physician Decision|3|||
48700119|NCT02435212|156751813|FG001|Core Phase|Physician Decision|0|||
48700120|NCT02435212|156751812|FG000|Core Phase|Lost to Follow-up|0|||
48700121|NCT02435212|156751813|FG001|Core Phase|Lost to Follow-up|1|||
48700122|NCT02435212|156751812|FG000|Core Phase|Lack of Efficacy|0|||
48700123|NCT02435212|156751813|FG001|Core Phase|Lack of Efficacy|1|||
48700124|NCT02435212|156751812|FG000|Core Phase|Recovery|1|||
48700125|NCT02435212|156751813|FG001|Core Phase|Recovery|0|||
48700126|NCT02435212|156751812|FG000|Optional Extension Phase|Adverse Event|3|||
48700127|NCT02435212|156751813|FG001|Optional Extension Phase|Adverse Event|9|||
48592862|NCT00003896|156363582|FG000|Overall Study|not protocol specified|3|||
48592863|NCT00003896|156363582|FG000|Overall Study|ineligible|5|||
48700128|NCT02435212|156751812|FG000|Optional Extension Phase|Physician Decision|6|||
48700129|NCT02435212|156751813|FG001|Optional Extension Phase|Physician Decision|8|||
48700130|NCT02435212|156751812|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
48700131|NCT02435212|156751813|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
48700132|NCT02435212|156751812|FG000|Optional Extension Phase|Lack of Efficacy|2|||
48700133|NCT02435212|156751813|FG001|Optional Extension Phase|Lack of Efficacy|3|||
48700134|NCT02435212|156751812|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
48700135|NCT02435212|156751813|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
48700136|NCT02435212|156751812|FG000|Optional Extension Phase|Protocol Violation|0|||
48700137|NCT02435212|156751813|FG001|Optional Extension Phase|Protocol Violation|1|||
48700138|NCT02435212|156751812|FG000|Optional Extension Phase|Recovery|1|||
48700139|NCT02435212|156751813|FG001|Optional Extension Phase|Recovery|1|||
48700140|NCT02435212|156751812|FG000|Optional Extension Phase|Death|1|||
48700141|NCT02435212|156751813|FG001|Optional Extension Phase|Death|0|||
48700142|NCT02435212|156751812|FG000|Optional Extension Phase|Technical problems|2|||
48700143|NCT02435212|156751813|FG001|Optional Extension Phase|Technical problems|0|||
48700144|NCT01502293|156751819|FG000|Overall Study|Progressive Disease|20|||
48700145|NCT01502293|156751820|FG001|Overall Study|Progressive Disease|12|||
48700146|NCT01502293|156751821|FG002|Overall Study|Progressive Disease|2|||
48700147|NCT01502293|156751819|FG000|Overall Study|Withdrawal by Subject|3|||
48700148|NCT01502293|156751820|FG001|Overall Study|Withdrawal by Subject|3|||
48700149|NCT01502293|156751821|FG002|Overall Study|Withdrawal by Subject|1|||
48700150|NCT01502293|156751819|FG000|Overall Study|Adverse Event|0|||
48700151|NCT01502293|156751820|FG001|Overall Study|Adverse Event|2|||
48700152|NCT01502293|156751821|FG002|Overall Study|Adverse Event|0|||
48700153|NCT01502293|156751819|FG000|Overall Study|Reason Not Specified|2|||
48700154|NCT01502293|156751820|FG001|Overall Study|Reason Not Specified|0|||
48700155|NCT01502293|156751821|FG002|Overall Study|Reason Not Specified|0|||
48700156|NCT01502293|156751819|FG000|Overall Study|Physician Decision|0|||
48700157|NCT01502293|156751820|FG001|Overall Study|Physician Decision|0|||
48700158|NCT01502293|156751821|FG002|Overall Study|Physician Decision|1|||
48700159|NCT03815929|156751822|FG000|Overall Study|Lost to Follow-up|2|||
48700160|NCT03815929|156751823|FG001|Overall Study|Lost to Follow-up|1|||
48700161|NCT03815929|156751824|FG002|Overall Study|Lost to Follow-up|0|||
48700162|NCT03815929|156751822|FG000|Overall Study|Physician Decision|2|||
48700163|NCT03815929|156751823|FG001|Overall Study|Physician Decision|2|||
48700164|NCT03815929|156751824|FG002|Overall Study|Physician Decision|0|||
48700165|NCT03815929|156751822|FG000|Overall Study|Withdrawal by Subject|0|||
48700166|NCT03815929|156751823|FG001|Overall Study|Withdrawal by Subject|0|||
48700167|NCT03815929|156751824|FG002|Overall Study|Withdrawal by Subject|1|||
48700168|NCT04973449|156751825|FG000|Overall Study|Withdrawal by Subject|3|||
48700169|NCT04973449|156751826|FG001|Overall Study|Withdrawal by Subject|3|||
48700170|NCT04973449|156751827|FG002|Overall Study|Withdrawal by Subject|2|||
48700171|NCT04973449|156751828|FG003|Overall Study|Withdrawal by Subject|5|||
48700172|NCT04973449|156751829|FG004|Overall Study|Withdrawal by Subject|5|||
48700173|NCT04973449|156751830|FG005|Overall Study|Withdrawal by Subject|4|||
48700174|NCT04973449|156751831|FG006|Overall Study|Withdrawal by Subject|7|||
48700175|NCT04973449|156751832|FG007|Overall Study|Withdrawal by Subject|5|||
48700176|NCT04973449|156751825|FG000|Overall Study|Lost to Follow-up|15|||
48700177|NCT04973449|156751826|FG001|Overall Study|Lost to Follow-up|16|||
48700178|NCT04973449|156751827|FG002|Overall Study|Lost to Follow-up|16|||
48700179|NCT04973449|156751828|FG003|Overall Study|Lost to Follow-up|13|||
48700180|NCT04973449|156751829|FG004|Overall Study|Lost to Follow-up|5|||
48700181|NCT04973449|156751830|FG005|Overall Study|Lost to Follow-up|6|||
48700182|NCT04973449|156751831|FG006|Overall Study|Lost to Follow-up|10|||
48700183|NCT04973449|156751832|FG007|Overall Study|Lost to Follow-up|6|||
48700184|NCT04973449|156751825|FG000|Overall Study|Death|1|||
48700185|NCT04973449|156751826|FG001|Overall Study|Death|0|||
48700186|NCT04973449|156751827|FG002|Overall Study|Death|0|||
48700187|NCT04973449|156751828|FG003|Overall Study|Death|0|||
48700188|NCT04973449|156751829|FG004|Overall Study|Death|0|||
48700189|NCT04973449|156751830|FG005|Overall Study|Death|1|||
48700190|NCT04973449|156751831|FG006|Overall Study|Death|0|||
48700191|NCT04973449|156751832|FG007|Overall Study|Death|0|||
48700192|NCT04973449|156751825|FG000|Overall Study|Other|1|||
48700193|NCT04973449|156751826|FG001|Overall Study|Other|1|||
48700194|NCT04973449|156751827|FG002|Overall Study|Other|2|||
48700195|NCT04973449|156751828|FG003|Overall Study|Other|1|||
48700196|NCT04973449|156751829|FG004|Overall Study|Other|4|||
48700197|NCT04973449|156751830|FG005|Overall Study|Other|0|||
48700198|NCT04973449|156751831|FG006|Overall Study|Other|2|||
48700199|NCT04973449|156751832|FG007|Overall Study|Other|2|||
48700200|NCT02205736|156751833|FG000|Overall Study|Lost to Follow-up|106|||
48700201|NCT03674411|156751834|FG000|Overall Study|Non-treatment|4|||
48700202|NCT02694185|156751838|FG000|Overall Study|Withdrawal by Subject|45|||
48700203|NCT02694185|156751839|FG001|Overall Study|Withdrawal by Subject|0|||
48700204|NCT05082857|156751840|FG000|Overall Study|participants relocated and could not continue|2|||
48700205|NCT05082857|156751841|FG001|Overall Study|participants relocated and could not continue|1|||
48700206|NCT05082857|156751840|FG000|Overall Study|Lost to Follow-up|1|||
48700207|NCT05082857|156751841|FG001|Overall Study|Lost to Follow-up|3|||
48700208|NCT04606134|156751848|FG000|Overall Study|Adverse Event|0|||
48700209|NCT04606134|156751849|FG001|Overall Study|Adverse Event|1|||
48700210|NCT03413891|156751850|FG000|Overall Study|Lost to Follow-up|2|||
48700211|NCT03413891|156751851|FG001|Overall Study|Lost to Follow-up|1|||
48700212|NCT03413891|156751850|FG000|Overall Study|Protocol Violation|0|||
48700213|NCT03413891|156751851|FG001|Overall Study|Protocol Violation|1|||
48700214|NCT03435211|156751860|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
48700215|NCT02195518|156751861|FG000|Overall Study|Adverse Event|1|||
48700216|NCT02195518|156751861|FG000|Overall Study|Protocol Violation|4|||
48700217|NCT02195518|156751861|FG000|Overall Study|Pregnancy|2|||
48700218|NCT02195518|156751861|FG000|Overall Study|Withdrawal by Subject|1|||
48700219|NCT02195518|156751861|FG000|Overall Study|Lost to Follow-up|1|||
48700220|NCT01652235|156751862|FG000|Overall Study|Death|9|||
48700221|NCT01652235|156751862|FG000|Overall Study|Lost to Follow-up|5|||
48700222|NCT01652235|156751862|FG000|Overall Study|Withdrawal by Subject|2|||
48700223|NCT01648751|156751865|FG000|Overall Study|Withdrawal by Subject|2|||
48700224|NCT01648751|156751866|FG001|Overall Study|Withdrawal by Subject|3|||
48700225|NCT02852655|156751868|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
48700226|NCT02852655|156751869|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
48700227|NCT02852655|156751870|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
48700228|NCT02852655|156751868|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
48700229|NCT02852655|156751869|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
48700230|NCT02852655|156751870|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
48700231|NCT02852655|156751868|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
48700232|NCT02852655|156751869|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
48700233|NCT02852655|156751870|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
48700234|NCT02852655|156751868|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
48700235|NCT02852655|156751869|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
48700236|NCT02852655|156751870|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
48700237|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
48487863|NCT01623830|155980800|FG001|Overall Study|Exclusion from Study|2|||
48487864|NCT04242186|155980801|FG000|Overall Study|Death|5|||
48700238|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
48700239|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
48700240|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
48700241|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
48700242|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
48700243|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
48700244|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
48700245|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
48700246|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
48700247|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
48700248|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
48700249|NCT02852655|156751868|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
48700250|NCT02852655|156751869|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
48700251|NCT02852655|156751870|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
48487865|NCT02019979|155980802|FG000|Overall Study|study terminated|14|||
48700252|NCT01967238|156751872|FG000|Overall Study|Adverse Event|1|||
48700253|NCT01967238|156751873|FG001|Overall Study|Adverse Event|1|||
48700254|NCT01967238|156751874|FG002|Overall Study|Adverse Event|0|||
48700255|NCT01967238|156751872|FG000|Overall Study|Lost to Follow-up|1|||
48487866|NCT02513459|155980808|FG000|Overall Study|Adverse Event|7|||
48487867|NCT02513459|155980808|FG000|Overall Study|Withdrew consent|5|||
48487868|NCT02513459|155980808|FG000|Overall Study|Loss of efficacy|2|||
48487869|NCT02513459|155980808|FG000|Overall Study|Pregnancy|2|||
48700256|NCT01967238|156751873|FG001|Overall Study|Lost to Follow-up|0|||
48700257|NCT01967238|156751874|FG002|Overall Study|Lost to Follow-up|1|||
48487870|NCT02513459|155980808|FG000|Overall Study|Subject decision|2|||
48487871|NCT02513459|155980808|FG000|Overall Study|Lack of response|1|||
48487872|NCT02513459|155980808|FG000|Overall Study|Reproductive plans|1|||
48487873|NCT02513459|155980808|FG000|Overall Study|Surgery planned-- not done|1|||
48487874|NCT00379587|155980809|FG000|Overall Study|Lost to Follow-up|2|||
48487875|NCT02257632|155980810|FG000|Overall Study|Withdrawal by Subject|0|||
48700258|NCT01967238|156751872|FG000|Overall Study|Withdrawal by Subject|0|||
48487876|NCT02257632|155980811|FG001|Overall Study|Withdrawal by Subject|1|||
48487877|NCT02257632|155980810|FG000|Overall Study|Adverse Event|1|||
48487878|NCT02257632|155980811|FG001|Overall Study|Adverse Event|2|||
48487879|NCT01605461|155980813|FG000|Overall Study|Lost to Follow-up|3|||
48700259|NCT01967238|156751873|FG001|Overall Study|Withdrawal by Subject|0|||
48700260|NCT01967238|156751874|FG002|Overall Study|Withdrawal by Subject|1|||
48700261|NCT01231906|156751875|FG000|Overall Study|Lack of Efficacy|75|||
48700262|NCT01231906|156751876|FG001|Overall Study|Lack of Efficacy|68|||
48700263|NCT01231906|156751875|FG000|Overall Study|Lost to Follow-up|1|||
48700264|NCT01231906|156751876|FG001|Overall Study|Lost to Follow-up|0|||
48700265|NCT01231906|156751875|FG000|Overall Study|Physician Decision|34|||
48700266|NCT01231906|156751876|FG001|Overall Study|Physician Decision|24|||
48700267|NCT01231906|156751875|FG000|Overall Study|Withdrawal by Subject|0|||
48700268|NCT01231906|156751876|FG001|Overall Study|Withdrawal by Subject|4|||
48700269|NCT01231906|156751875|FG000|Overall Study|Ineligible|10|||
48487880|NCT01605461|155980813|FG000|Overall Study|Withdrawal by Subject|1|||
48487881|NCT03237611|155980814|FG000|Overall Study|Withdrawal by Subject|1|||
48487882|NCT03237611|155980814|FG000|Overall Study|Ineligible|1|||
48487883|NCT02024698|155980818|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
48487884|NCT02024698|155980819|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
48487885|NCT00534092|155980821|FG000|Overall Study|Lost to Follow-up|1|||
48487886|NCT00534092|155980822|FG001|Overall Study|Lost to Follow-up|0|||
48487887|NCT00534092|155980821|FG000|Overall Study|personal reasons/family concerns|1|||
48487888|NCT00534092|155980822|FG001|Overall Study|personal reasons/family concerns|0|||
48487889|NCT01169649|155980823|FG000|Overall Study|Patient Not Treated|3|||
48487890|NCT02598193|155980824|FG000|Overall Study|Adverse Event|13|||
48487891|NCT02598193|155980824|FG000|Overall Study|Withdrawal by Subject|1|||
48487892|NCT02598193|155980824|FG000|Overall Study|Listed in active lung transplant list|1|||
48487893|NCT02598193|155980824|FG000|Overall Study|Does not want to take Nintedanib|1|||
48487894|NCT03255031|155980825|FG000|Overall Study|Adverse Event|5|||
48487895|NCT03255031|155980826|FG001|Overall Study|Adverse Event|3|||
48487896|NCT03255031|155980825|FG000|Overall Study|Physician Decision|2|||
48487897|NCT03255031|155980826|FG001|Overall Study|Physician Decision|1|||
48487898|NCT03255031|155980825|FG000|Overall Study|Withdrawal by Subject|9|||
48487899|NCT03255031|155980826|FG001|Overall Study|Withdrawal by Subject|3|||
48487900|NCT01809314|155980827|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
48487901|NCT01809314|155980827|FG000|Overall Study|Adverse Event|6|||
48487902|NCT01809314|155980827|FG000|Overall Study|Insufficient Therapeutic Response|14|||
48487903|NCT01809314|155980827|FG000|Overall Study|Lost to Follow-up|724|||
48487904|NCT02400905|155980828|FG000|Overall Study|Death|24|||
48487905|NCT02400905|155980828|FG000|Overall Study|Lost to Follow-up|18|||
48487906|NCT02400905|155980828|FG000|Overall Study|Withdrawal by Subject|16|||
48487907|NCT02400905|155980828|FG000|Overall Study|Physician Decision|4|||
48700270|NCT01231906|156751876|FG001|Overall Study|Ineligible|3|||
48700271|NCT01231906|156751875|FG000|Overall Study|No treatment|1|||
48700272|NCT01231906|156751876|FG001|Overall Study|No treatment|2|||
48700273|NCT04929249|156751877|FG000|Overall Study|Adverse Event|2|||
48700274|NCT04929249|156751878|FG001|Overall Study|Adverse Event|1|||
48700275|NCT04929249|156751877|FG000|Overall Study|Death|2|||
48487908|NCT02400905|155980828|FG000|Overall Study|Other|1|||
48487909|NCT01684722|155980829|FG000|Overall Study|Lost to Follow-up|78|||
48487910|NCT01684722|155980830|FG001|Overall Study|Lost to Follow-up|56|||
48487911|NCT01684722|155980831|FG002|Overall Study|Lost to Follow-up|75|||
48487912|NCT01684722|155980832|FG003|Overall Study|Lost to Follow-up|89|||
48487913|NCT01684722|155980829|FG000|Overall Study|Death|19|||
48700276|NCT04929249|156751878|FG001|Overall Study|Death|1|||
48487914|NCT01684722|155980830|FG001|Overall Study|Death|21|||
48487915|NCT01684722|155980831|FG002|Overall Study|Death|19|||
48487916|NCT01684722|155980832|FG003|Overall Study|Death|21|||
48487917|NCT01092702|155980833|FG000|Overall Study|Withdrawal by Subject|7|||
48487918|NCT01092702|155980833|FG000|Overall Study|Lost to Follow-up|2|||
48487919|NCT01580020|155980834|FG000|Overall Study|Lack of Efficacy|0|||
48487920|NCT01580020|155980835|FG001|Overall Study|Lack of Efficacy|5|||
48487921|NCT01580020|155980836|FG002|Overall Study|Lack of Efficacy|0|||
48487922|NCT01580020|155980837|FG003|Overall Study|Lack of Efficacy|1|||
48487923|NCT01580020|155980834|FG000|Overall Study|Withdrawal by Subject|0|||
48487924|NCT01580020|155980835|FG001|Overall Study|Withdrawal by Subject|1|||
48487925|NCT01580020|155980836|FG002|Overall Study|Withdrawal by Subject|1|||
48487926|NCT01580020|155980837|FG003|Overall Study|Withdrawal by Subject|0|||
48487927|NCT01580020|155980834|FG000|Overall Study|Adverse Event|1|||
48487928|NCT01580020|155980835|FG001|Overall Study|Adverse Event|1|||
48487929|NCT01580020|155980836|FG002|Overall Study|Adverse Event|1|||
48487930|NCT01580020|155980837|FG003|Overall Study|Adverse Event|1|||
48487931|NCT01580020|155980834|FG000|Overall Study|Administrative Problems|0|||
48487932|NCT01580020|155980835|FG001|Overall Study|Administrative Problems|0|||
48487933|NCT01580020|155980836|FG002|Overall Study|Administrative Problems|1|||
48487934|NCT01580020|155980837|FG003|Overall Study|Administrative Problems|0|||
48487935|NCT01580020|155980834|FG000|Overall Study|Lost to Follow-up|0|||
48487936|NCT01580020|155980835|FG001|Overall Study|Lost to Follow-up|0|||
48487937|NCT01580020|155980836|FG002|Overall Study|Lost to Follow-up|1|||
48487938|NCT01580020|155980837|FG003|Overall Study|Lost to Follow-up|0|||
48487939|NCT01724359|155980838|FG000|Overall Study|Adverse Event|10|||
48487940|NCT01724359|155980838|FG000|Overall Study|Death|1|||
48487941|NCT01724359|155980838|FG000|Overall Study|Other|20|||
48487942|NCT00320593|155980843|FG000|Overall Study|Lost to Follow-up|3|||
48487943|NCT00320593|155980844|FG001|Overall Study|Lost to Follow-up|0|||
48487944|NCT00320593|155980843|FG000|Overall Study|Moved to another state|1|||
48487945|NCT00320593|155980844|FG001|Overall Study|Moved to another state|0|||
48487946|NCT00320593|155980843|FG000|Overall Study|Withdrawal by Subject|2|||
48487947|NCT00320593|155980844|FG001|Overall Study|Withdrawal by Subject|1|||
48487948|NCT00320593|155980843|FG000|Overall Study|Withdrawal by clinical center|1|||
48487949|NCT00320593|155980844|FG001|Overall Study|Withdrawal by clinical center|0|||
48487950|NCT00481247|155980845|FG000|Overall Study|Death|0|||
48487951|NCT00481247|155980846|FG001|Overall Study|Death|1|||
48487952|NCT00481247|155980845|FG000|Overall Study|Disease progression|18|||
48487953|NCT00481247|155980846|FG001|Overall Study|Disease progression|22|||
48487954|NCT00481247|155980845|FG000|Overall Study|Intolerance|42|||
48700277|NCT04929249|156751877|FG000|Overall Study|Lost to Follow-up|3|||
48487955|NCT00481247|155980846|FG001|Overall Study|Intolerance|17|||
48487956|NCT00481247|155980845|FG000|Overall Study|Treatment failure|10|||
48487957|NCT00481247|155980846|FG001|Overall Study|Treatment failure|14|||
48700278|NCT04929249|156751878|FG001|Overall Study|Lost to Follow-up|11|||
48700279|NCT04929249|156751877|FG000|Overall Study|Technical problems|0|||
48700280|NCT04929249|156751878|FG001|Overall Study|Technical problems|1|||
48700281|NCT04929249|156751877|FG000|Overall Study|Subject decision|6|||
48700282|NCT04929249|156751878|FG001|Overall Study|Subject decision|8|||
48700283|NCT04929249|156751877|FG000|Overall Study|Withdrew consent|0|||
48700284|NCT04929249|156751878|FG001|Overall Study|Withdrew consent|8|||
48700285|NCT04467905|156751879|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
48700286|NCT04467905|156751880|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
48700287|NCT04467905|156751881|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
48700288|NCT04467905|156751879|FG000|Overall Study|Conversion to SR|0|||
48700289|NCT04467905|156751880|FG001|Overall Study|Conversion to SR|0|||
48700290|NCT04467905|156751881|FG002|Overall Study|Conversion to SR|3|||
48700291|NCT04467905|156751879|FG000|Overall Study|Technical issue with Holter ECG|0|||
48700292|NCT04467905|156751880|FG001|Overall Study|Technical issue with Holter ECG|0|||
48700293|NCT04467905|156751881|FG002|Overall Study|Technical issue with Holter ECG|3|||
48700294|NCT04467905|156751879|FG000|Overall Study|Hemodynamic instability|0|||
48700295|NCT04467905|156751880|FG001|Overall Study|Hemodynamic instability|0|||
48700296|NCT04467905|156751881|FG002|Overall Study|Hemodynamic instability|1|||
48700297|NCT04467905|156751879|FG000|Overall Study|Site misinterpretation of protocol|0|||
48798427|NCT02453685|157098661|FG001|Overall Study|Protocol Violation|4|||
48700298|NCT04467905|156751880|FG001|Overall Study|Site misinterpretation of protocol|0|||
48700299|NCT04467905|156751881|FG002|Overall Study|Site misinterpretation of protocol|1|||
48700300|NCT04944992|156753224|FG000|Overall Study|Lost to Follow-up|1|||
48700301|NCT04944992|156753225|FG001|Overall Study|Lost to Follow-up|1|||
48700302|NCT04944992|156753224|FG000|Overall Study|Physician Decision|1|||
48700303|NCT04944992|156753225|FG001|Overall Study|Physician Decision|0|||
48700304|NCT04944992|156753224|FG000|Overall Study|Withdrawal by Subject|6|||
48700305|NCT04944992|156753225|FG001|Overall Study|Withdrawal by Subject|1|||
48700306|NCT00906204|156753226|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
48700307|NCT00906204|156753227|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
48700308|NCT00906204|156753226|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
48700309|NCT00906204|156753227|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
48700310|NCT00906204|156753226|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
48700311|NCT00906204|156753227|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
48700312|NCT00906204|156753226|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
48700313|NCT00906204|156753227|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
48700314|NCT00906204|156753226|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
48700315|NCT00906204|156753227|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
48700316|NCT04639245|156753228|FG000|Overall Study|Death|1|||
48700317|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
48700318|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
48700319|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
48700320|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
48700321|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
48700322|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
48700323|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
48700324|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48700325|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48700326|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
48700327|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
48700328|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
48700329|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48700330|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48700331|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48700332|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48700333|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
48700334|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
48700335|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48700336|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48700337|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48487958|NCT00481247|155980845|FG000|Overall Study|AE unrelated to study drug|13|||
48487959|NCT00481247|155980846|FG001|Overall Study|AE unrelated to study drug|4|||
48487960|NCT00481247|155980845|FG000|Overall Study|Withdrawal by Subject|8|||
48487961|NCT00481247|155980846|FG001|Overall Study|Withdrawal by Subject|13|||
48487962|NCT00481247|155980845|FG000|Overall Study|Pregnancy|2|||
48487963|NCT00481247|155980846|FG001|Overall Study|Pregnancy|1|||
48487964|NCT00481247|155980845|FG000|Overall Study|Lost to Follow-up|1|||
48487965|NCT00481247|155980846|FG001|Overall Study|Lost to Follow-up|2|||
48487966|NCT00481247|155980845|FG000|Overall Study|Poor compliance/noncompliance|1|||
48487967|NCT00481247|155980846|FG001|Overall Study|Poor compliance/noncompliance|7|||
48487968|NCT00481247|155980845|FG000|Overall Study|Administrative reason by sponsor|157|||
48487969|NCT00481247|155980846|FG001|Overall Study|Administrative reason by sponsor|162|||
48487970|NCT00481247|155980845|FG000|Overall Study|Varied|6|||
48487971|NCT00481247|155980846|FG001|Overall Study|Varied|15|||
48487972|NCT00481247|155980845|FG000|Overall Study|Did not receive treatment|1|||
48487973|NCT00481247|155980846|FG001|Overall Study|Did not receive treatment|2|||
48487974|NCT01716754|155980847|FG000|Overall Study|Death|0|||
48487975|NCT01716754|155980848|FG001|Overall Study|Death|0|||
48487976|NCT01716754|155980849|FG002|Overall Study|Death|0|||
48487977|NCT01716754|155980850|FG003|Overall Study|Death|1|||
48487978|NCT01716754|155980847|FG000|Overall Study|Protocol deviation|0|||
48487979|NCT01716754|155980848|FG001|Overall Study|Protocol deviation|2|||
48487980|NCT01716754|155980849|FG002|Overall Study|Protocol deviation|7|||
48487981|NCT01716754|155980850|FG003|Overall Study|Protocol deviation|2|||
48487982|NCT01716754|155980847|FG000|Overall Study|Non-compliance with study treatment|0|||
48487983|NCT01716754|155980848|FG001|Overall Study|Non-compliance with study treatment|0|||
48487984|NCT01716754|155980849|FG002|Overall Study|Non-compliance with study treatment|1|||
48487985|NCT01716754|155980850|FG003|Overall Study|Non-compliance with study treatment|0|||
48487986|NCT01716754|155980847|FG000|Overall Study|Physician Decision|1|||
48487987|NCT01716754|155980848|FG001|Overall Study|Physician Decision|0|||
48487988|NCT01716754|155980849|FG002|Overall Study|Physician Decision|0|||
48487989|NCT01716754|155980850|FG003|Overall Study|Physician Decision|0|||
48487990|NCT01716754|155980847|FG000|Overall Study|Lost to Follow-up|1|||
48487991|NCT01716754|155980848|FG001|Overall Study|Lost to Follow-up|0|||
48487992|NCT01716754|155980849|FG002|Overall Study|Lost to Follow-up|0|||
48487993|NCT01716754|155980850|FG003|Overall Study|Lost to Follow-up|1|||
48487994|NCT01716754|155980847|FG000|Overall Study|Adverse Event|4|||
48487995|NCT01716754|155980848|FG001|Overall Study|Adverse Event|2|||
48487996|NCT01716754|155980849|FG002|Overall Study|Adverse Event|2|||
48487997|NCT01716754|155980850|FG003|Overall Study|Adverse Event|1|||
48487998|NCT01716754|155980847|FG000|Overall Study|Withdrawal by Subject|5|||
48487999|NCT01716754|155980848|FG001|Overall Study|Withdrawal by Subject|0|||
48488000|NCT01716754|155980849|FG002|Overall Study|Withdrawal by Subject|4|||
48488001|NCT01716754|155980850|FG003|Overall Study|Withdrawal by Subject|3|||
48488002|NCT00446654|155980851|FG000|Overall Study|Withdrawal by Subject|1|||
48488003|NCT00446654|155980852|FG001|Overall Study|Withdrawal by Subject|0|||
48488004|NCT00446654|155980851|FG000|Overall Study|Adverse Event|1|||
48488005|NCT00446654|155980852|FG001|Overall Study|Adverse Event|0|||
48488006|NCT00408876|155980853|FG000|Overall Study|Adverse Event|9|||
48488007|NCT00408876|155980854|FG001|Overall Study|Adverse Event|17|||
48488008|NCT00408876|155980855|FG002|Overall Study|Adverse Event|27|||
48488009|NCT00408876|155980856|FG003|Overall Study|Adverse Event|10|||
48488010|NCT00408876|155980853|FG000|Overall Study|Withdrawal by Subject|3|||
48592864|NCT01118663|156363583|FG000|Overall Study|Adverse Event|2|||
48488011|NCT00408876|155980854|FG001|Overall Study|Withdrawal by Subject|6|||
48488012|NCT00408876|155980855|FG002|Overall Study|Withdrawal by Subject|6|||
48488013|NCT00408876|155980856|FG003|Overall Study|Withdrawal by Subject|14|||
48488014|NCT00408876|155980853|FG000|Overall Study|Lack of Efficacy|2|||
48488015|NCT00408876|155980854|FG001|Overall Study|Lack of Efficacy|4|||
48488016|NCT00408876|155980855|FG002|Overall Study|Lack of Efficacy|5|||
48488017|NCT00408876|155980856|FG003|Overall Study|Lack of Efficacy|6|||
48488018|NCT00408876|155980853|FG000|Overall Study|Lost to Follow-up|1|||
48488019|NCT00408876|155980854|FG001|Overall Study|Lost to Follow-up|6|||
48488020|NCT00408876|155980855|FG002|Overall Study|Lost to Follow-up|5|||
48488021|NCT00408876|155980856|FG003|Overall Study|Lost to Follow-up|2|||
48488022|NCT00408876|155980853|FG000|Overall Study|Protocol Violation|0|||
48488023|NCT00408876|155980854|FG001|Overall Study|Protocol Violation|3|||
48488024|NCT00408876|155980855|FG002|Overall Study|Protocol Violation|4|||
48488025|NCT00408876|155980856|FG003|Overall Study|Protocol Violation|3|||
48488026|NCT00408876|155980853|FG000|Overall Study|Physician Decision|1|||
48488027|NCT00408876|155980854|FG001|Overall Study|Physician Decision|0|||
48488028|NCT00408876|155980855|FG002|Overall Study|Physician Decision|3|||
48488029|NCT00408876|155980856|FG003|Overall Study|Physician Decision|0|||
48488030|NCT03760510|155980857|FG000|Overall Study|Not ventilated for 24 hours|105|||
48488031|NCT03760510|155980858|FG001|Overall Study|Not ventilated for 24 hours|97|||
48488032|NCT00926289|155980860|FG000|Overall Study|Adverse Event|9|||
48488033|NCT00926289|155980861|FG001|Overall Study|Adverse Event|11|||
48488034|NCT00926289|155980860|FG000|Overall Study|Protocol Violation|8|||
48488035|NCT00926289|155980861|FG001|Overall Study|Protocol Violation|12|||
48488036|NCT00926289|155980860|FG000|Overall Study|Lost to Follow-up|3|||
48488037|NCT00926289|155980861|FG001|Overall Study|Lost to Follow-up|6|||
48488038|NCT00926289|155980860|FG000|Overall Study|Withdrawal by Subject|4|||
48488039|NCT00926289|155980861|FG001|Overall Study|Withdrawal by Subject|4|||
48488040|NCT00926289|155980860|FG000|Overall Study|Other|1|||
48488041|NCT00926289|155980861|FG001|Overall Study|Other|3|||
48488042|NCT01337050|155980865|FG000|Overall Study|Death|0|||
48488043|NCT01337050|155980866|FG001|Overall Study|Death|0|||
48488044|NCT01337050|155980867|FG002|Overall Study|Death|4|||
48488045|NCT01337050|155980865|FG000|Overall Study|Other|4|||
48488046|NCT01337050|155980866|FG001|Overall Study|Other|6|||
48488047|NCT01337050|155980867|FG002|Overall Study|Other|8|||
48488048|NCT01337050|155980865|FG000|Overall Study|Participants refused further follow-up|0|||
48488049|NCT01337050|155980866|FG001|Overall Study|Participants refused further follow-up|7|||
48488050|NCT01337050|155980867|FG002|Overall Study|Participants refused further follow-up|7|||
48488051|NCT00583596|155980868|FG000|Overall Study|Lost to Follow-up|110|||
48488052|NCT00583596|155980868|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
48488053|NCT00583596|155980868|FG000|Overall Study|Death|2|||
48488054|NCT00583596|155980868|FG000|Overall Study|Withdrawal by Subject|6|||
48488055|NCT00583596|155980868|FG000|Overall Study|Lost to Follow-up|94|||
48488056|NCT00583596|155980868|FG000|Overall Study|Data not complete|1|||
48488057|NCT00583596|155980868|FG000|Overall Study|Not consented|15|||
48488058|NCT00583596|155980868|FG000|Overall Study|Outside f-up window|26|||
48488059|NCT00616928|155980869|FG000|Overall Study|Adverse Event|6|||
48488060|NCT00616928|155980870|FG001|Overall Study|Adverse Event|3|||
48488061|NCT00616928|155980871|FG002|Overall Study|Adverse Event|2|||
48488062|NCT00616928|155980872|FG003|Overall Study|Adverse Event|2|||
48700338|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
48700339|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
48700340|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
48700341|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
48700342|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
48700343|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
48700344|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
48700345|NCT03175367|156753231|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48798428|NCT02453685|157098660|FG000|Overall Study|Lost to Follow-up|0|||
48488063|NCT00616928|155980869|FG000|Overall Study|Other|51|||
48488064|NCT00616928|155980870|FG001|Overall Study|Other|8|||
48488065|NCT00616928|155980871|FG002|Overall Study|Other|15|||
48488066|NCT00616928|155980872|FG003|Overall Study|Other|5|||
48488067|NCT00616928|155980869|FG000|Overall Study|Lost to Follow-up|5|||
48488068|NCT00616928|155980870|FG001|Overall Study|Lost to Follow-up|7|||
48488069|NCT00616928|155980871|FG002|Overall Study|Lost to Follow-up|0|||
48488070|NCT00616928|155980872|FG003|Overall Study|Lost to Follow-up|0|||
48488071|NCT03558997|155980873|FG000|Overall Study|Adverse Event|0|||
48488072|NCT03558997|155980874|FG001|Overall Study|Adverse Event|2|||
48488073|NCT03558997|155980875|FG002|Overall Study|Adverse Event|5|||
48488074|NCT03558997|155980876|FG003|Overall Study|Adverse Event|1|||
48488075|NCT03558997|155980873|FG000|Overall Study|Physician Decision|0|||
48488076|NCT03558997|155980874|FG001|Overall Study|Physician Decision|0|||
48488077|NCT03558997|155980875|FG002|Overall Study|Physician Decision|1|||
48488078|NCT03558997|155980876|FG003|Overall Study|Physician Decision|0|||
48488079|NCT03558997|155980873|FG000|Overall Study|Withdrawal by Subject|1|||
48488080|NCT03558997|155980874|FG001|Overall Study|Withdrawal by Subject|0|||
48488081|NCT03558997|155980875|FG002|Overall Study|Withdrawal by Subject|1|||
48488082|NCT03558997|155980876|FG003|Overall Study|Withdrawal by Subject|1|||
48488083|NCT03558997|155980873|FG000|Overall Study|Lost to Follow-up|0|||
48488084|NCT03558997|155980874|FG001|Overall Study|Lost to Follow-up|0|||
48488085|NCT03558997|155980875|FG002|Overall Study|Lost to Follow-up|1|||
48488086|NCT03558997|155980876|FG003|Overall Study|Lost to Follow-up|0|||
48488087|NCT00409578|155980879|FG000|Overall Study|Adverse Event|27|||
48488088|NCT00409578|155980880|FG001|Overall Study|Adverse Event|37|||
48488089|NCT00409578|155980881|FG002|Overall Study|Adverse Event|25|||
48488090|NCT00409578|155980882|FG003|Overall Study|Adverse Event|33|||
48488091|NCT00409578|155980879|FG000|Overall Study|Abnormal laboratory value(s)|2|||
48488092|NCT00409578|155980880|FG001|Overall Study|Abnormal laboratory value(s)|2|||
48488093|NCT00409578|155980881|FG002|Overall Study|Abnormal laboratory value(s)|2|||
48488094|NCT00409578|155980882|FG003|Overall Study|Abnormal laboratory value(s)|4|||
48488095|NCT00409578|155980879|FG000|Overall Study|Lack of Efficacy|0|||
48488096|NCT00409578|155980880|FG001|Overall Study|Lack of Efficacy|0|||
48488097|NCT00409578|155980881|FG002|Overall Study|Lack of Efficacy|0|||
48488098|NCT00409578|155980882|FG003|Overall Study|Lack of Efficacy|2|||
48488099|NCT00409578|155980879|FG000|Overall Study|Subject no longer requires study drug|0|||
48488100|NCT00409578|155980880|FG001|Overall Study|Subject no longer requires study drug|0|||
48488101|NCT00409578|155980881|FG002|Overall Study|Subject no longer requires study drug|0|||
48488102|NCT00409578|155980882|FG003|Overall Study|Subject no longer requires study drug|1|||
48488103|NCT00409578|155980879|FG000|Overall Study|Withdrawal by Subject|8|||
48488104|NCT00409578|155980880|FG001|Overall Study|Withdrawal by Subject|15|||
48488105|NCT00409578|155980881|FG002|Overall Study|Withdrawal by Subject|16|||
48488106|NCT00409578|155980882|FG003|Overall Study|Withdrawal by Subject|17|||
48592865|NCT01118663|156363584|FG001|Overall Study|Adverse Event|1|||
48592866|NCT01118663|156363583|FG000|Overall Study|Withdrawal by Subject|0|||
48592867|NCT01118663|156363584|FG001|Overall Study|Withdrawal by Subject|1|||
48592868|NCT02383355|156363585|FG000|Overall Study|Adverse Event|2|||
48592869|NCT02383355|156363586|FG001|Overall Study|Adverse Event|0|||
48592870|NCT01603407|156363598|FG000|Overall Study|Adverse Event|1|||
48592871|NCT01603407|156363599|FG001|Overall Study|Adverse Event|1|||
48592872|NCT01603407|156363600|FG002|Overall Study|Adverse Event|1|||
48592873|NCT01603407|156363598|FG000|Overall Study|Protocol Violation|2|||
48592874|NCT01603407|156363599|FG001|Overall Study|Protocol Violation|2|||
48592875|NCT01603407|156363600|FG002|Overall Study|Protocol Violation|0|||
48592876|NCT01603407|156363598|FG000|Overall Study|Withdrawal by Subject|8|||
48592877|NCT01603407|156363599|FG001|Overall Study|Withdrawal by Subject|5|||
48592878|NCT01603407|156363600|FG002|Overall Study|Withdrawal by Subject|7|||
48592879|NCT01603407|156363598|FG000|Overall Study|Lost to Follow-up|0|||
48592880|NCT01603407|156363599|FG001|Overall Study|Lost to Follow-up|3|||
48592881|NCT01603407|156363600|FG002|Overall Study|Lost to Follow-up|2|||
48592882|NCT03162328|156363603|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
48592883|NCT03162328|156363604|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
48592884|NCT03162328|156363605|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
48592885|NCT03162328|156363603|FG000|Screening Period|Withdrawal by Subject|1|||
48592886|NCT03162328|156363604|FG001|Screening Period|Withdrawal by Subject|0|||
48592887|NCT03162328|156363605|FG002|Screening Period|Withdrawal by Subject|0|||
48592888|NCT03162328|156363603|FG000|Study Period|Withdrawal by Subject|0|||
48592889|NCT03162328|156363604|FG001|Study Period|Withdrawal by Subject|0|||
48592890|NCT03162328|156363605|FG002|Study Period|Withdrawal by Subject|1|||
48592891|NCT02348008|156363609|FG000|Overall Study|Adverse Event|2|||
48592892|NCT02348008|156363610|FG001|Overall Study|Adverse Event|3|||
48592893|NCT02348008|156363611|FG002|Overall Study|Adverse Event|3|||
48592894|NCT02348008|156363609|FG000|Overall Study|Disease Progression|1|||
48592895|NCT02348008|156363610|FG001|Overall Study|Disease Progression|5|||
48592896|NCT02348008|156363611|FG002|Overall Study|Disease Progression|16|||
48592897|NCT02348008|156363609|FG000|Overall Study|Withdrawal by Subject|0|||
48592898|NCT02348008|156363610|FG001|Overall Study|Withdrawal by Subject|1|||
48592899|NCT02348008|156363611|FG002|Overall Study|Withdrawal by Subject|0|||
48592900|NCT02348008|156363609|FG000|Overall Study|Symptomatic Deterioration|0|||
48592901|NCT02348008|156363610|FG001|Overall Study|Symptomatic Deterioration|1|||
48592902|NCT02348008|156363611|FG002|Overall Study|Symptomatic Deterioration|0|||
48592903|NCT00441363|156365605|FG000|Overall Study|Adverse Event|4|||
48592904|NCT00441363|156365606|FG001|Overall Study|Adverse Event|2|||
48592905|NCT00441363|156365605|FG000|Overall Study|Withdrawal by Subject|3|||
48592906|NCT00441363|156365606|FG001|Overall Study|Withdrawal by Subject|4|||
48592907|NCT00441363|156365605|FG000|Overall Study|Physician Decision|6|||
48592908|NCT00441363|156365606|FG001|Overall Study|Physician Decision|7|||
48592909|NCT00441363|156365605|FG000|Overall Study|Lost to Follow-up|2|||
48592910|NCT00441363|156365606|FG001|Overall Study|Lost to Follow-up|2|||
48592911|NCT00441363|156365605|FG000|Overall Study|Other|2|||
48592912|NCT00441363|156365606|FG001|Overall Study|Other|0|||
48592913|NCT01048944|156365607|FG000|Overall Study|Protocol Violation|8|||
48592914|NCT01048944|156365608|FG001|Overall Study|Protocol Violation|10|||
48488107|NCT00409578|155980879|FG000|Overall Study|Lost to Follow-up|2|||
48592915|NCT01048944|156365609|FG002|Overall Study|Protocol Violation|10|||
48592916|NCT01048944|156365610|FG003|Overall Study|Protocol Violation|2|||
48592917|NCT01709864|156365611|FG000|Overall Study|Physician Decision|0|||
48592918|NCT01709864|156365612|FG001|Overall Study|Physician Decision|1|||
48592919|NCT01709864|156365611|FG000|Overall Study|subject/guardian decision|5|||
48592920|NCT01709864|156365612|FG001|Overall Study|subject/guardian decision|6|||
48592921|NCT01709864|156365611|FG000|Overall Study|Lost to Follow-up|1|||
48592922|NCT01709864|156365612|FG001|Overall Study|Lost to Follow-up|0|||
48592923|NCT01709864|156365611|FG000|Overall Study|non-compliance with study treatment|1|||
48700346|NCT03175367|156753232|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48592924|NCT01709864|156365612|FG001|Overall Study|non-compliance with study treatment|1|||
48592925|NCT01709864|156365611|FG000|Overall Study|Adverse Event|0|||
48592926|NCT01709864|156365612|FG001|Overall Study|Adverse Event|2|||
48592927|NCT01709864|156365611|FG000|Overall Study|Death|0|||
48592928|NCT01709864|156365612|FG001|Overall Study|Death|1|||
48592929|NCT01421147|156365614|FG000|Treatment Period|Adverse Event|2|||
48592930|NCT01421147|156365615|FG001|Treatment Period|Adverse Event|3|||
48592931|NCT01421147|156365614|FG000|Treatment Period|Lost to Follow-up|2|||
48592932|NCT01421147|156365615|FG001|Treatment Period|Lost to Follow-up|1|||
48592933|NCT01421147|156365614|FG000|Treatment Period|Physician Decision|2|||
48592934|NCT01421147|156365615|FG001|Treatment Period|Physician Decision|2|||
48592935|NCT01421147|156365614|FG000|Treatment Period|Withdrawal by Subject|10|||
48592936|NCT01421147|156365615|FG001|Treatment Period|Withdrawal by Subject|5|||
48592937|NCT01421147|156365614|FG000|Extension Period|Adverse Event|0|||
48592938|NCT01421147|156365615|FG001|Extension Period|Adverse Event|2|||
48592939|NCT01421147|156365614|FG000|Extension Period|Death|0|||
48592940|NCT01421147|156365615|FG001|Extension Period|Death|1|||
48592941|NCT01421147|156365614|FG000|Extension Period|Lost to Follow-up|2|||
48592942|NCT01421147|156365615|FG001|Extension Period|Lost to Follow-up|5|||
48592943|NCT01421147|156365614|FG000|Extension Period|Physician Decision|1|||
48592944|NCT01421147|156365615|FG001|Extension Period|Physician Decision|0|||
48592945|NCT01421147|156365614|FG000|Extension Period|Withdrawal by Subject|5|||
48592946|NCT01421147|156365615|FG001|Extension Period|Withdrawal by Subject|3|||
48592947|NCT01270321|156365616|FG000|Overall Study|Death|3|||
48592948|NCT01270321|156365617|FG001|Overall Study|Death|1|||
48592949|NCT01270321|156365618|FG002|Overall Study|Death|4|||
48592950|NCT01270321|156365616|FG000|Overall Study|Adverse Event|7|||
48592951|NCT01270321|156365617|FG001|Overall Study|Adverse Event|9|||
48592952|NCT01270321|156365618|FG002|Overall Study|Adverse Event|5|||
48488108|NCT00409578|155980880|FG001|Overall Study|Lost to Follow-up|0|||
48488109|NCT00409578|155980881|FG002|Overall Study|Lost to Follow-up|2|||
48488110|NCT00409578|155980882|FG003|Overall Study|Lost to Follow-up|2|||
48488111|NCT00409578|155980879|FG000|Overall Study|Administrative problems|8|||
48488112|NCT00409578|155980880|FG001|Overall Study|Administrative problems|9|||
48488113|NCT00409578|155980881|FG002|Overall Study|Administrative problems|2|||
48488114|NCT00409578|155980882|FG003|Overall Study|Administrative problems|4|||
48488115|NCT00409578|155980879|FG000|Overall Study|Death|2|||
48488116|NCT00409578|155980880|FG001|Overall Study|Death|4|||
48488117|NCT00409578|155980881|FG002|Overall Study|Death|4|||
48488118|NCT00409578|155980882|FG003|Overall Study|Death|2|||
48488119|NCT00409578|155980879|FG000|Overall Study|Protocol Violation|3|||
48488120|NCT00409578|155980880|FG001|Overall Study|Protocol Violation|2|||
48488121|NCT00409578|155980881|FG002|Overall Study|Protocol Violation|3|||
48488122|NCT00409578|155980882|FG003|Overall Study|Protocol Violation|1|||
48488123|NCT00409578|155980879|FG000|Overall Study|Missing|0|||
48488124|NCT00409578|155980880|FG001|Overall Study|Missing|1|||
48488125|NCT00409578|155980881|FG002|Overall Study|Missing|0|||
48488126|NCT00409578|155980882|FG003|Overall Study|Missing|1|||
48488127|NCT00736333|155980885|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
48488128|NCT00736333|155980885|FG000|Overall Study|Data Missing|2|||
48488129|NCT00736333|155980885|FG000|Overall Study|Tumor Progression|75|||
48488130|NCT00736333|155980885|FG000|Overall Study|Toxicity|6|||
48488131|NCT00736333|155980885|FG000|Overall Study|Withdrawal by Subject|10|||
48488132|NCT00736333|155980885|FG000|Overall Study|Death|7|||
48488133|NCT00736333|155980885|FG000|Overall Study|Other|4|||
48488134|NCT02683187|155980886|FG000|Overall Study|Failed IV access|3|||
48488135|NCT02683187|155980886|FG000|Overall Study|Withdrawal by Subject|5|||
48488136|NCT01463683|155980887|FG000|Overall Study|Adverse Event|2|||
48488137|NCT01463683|155980888|FG001|Overall Study|Adverse Event|0|||
48488138|NCT01463683|155980889|FG002|Overall Study|Adverse Event|0|||
48488139|NCT01463683|155980887|FG000|Overall Study|Lost to Follow-up|10|||
48488140|NCT01463683|155980888|FG001|Overall Study|Lost to Follow-up|9|||
48488141|NCT01463683|155980889|FG002|Overall Study|Lost to Follow-up|7|||
48488142|NCT01463683|155980887|FG000|Overall Study|Physician Decision|0|||
48592953|NCT00703326|156365619|FG000|Overall Study|Lost to Follow-up|47|||
48592954|NCT00703326|156365620|FG001|Overall Study|Lost to Follow-up|18|||
48592955|NCT00703326|156365619|FG000|Overall Study|Withdrawal by Subject|54|||
48592956|NCT00703326|156365620|FG001|Overall Study|Withdrawal by Subject|20|||
48488143|NCT01463683|155980888|FG001|Overall Study|Physician Decision|3|||
48488144|NCT01463683|155980889|FG002|Overall Study|Physician Decision|1|||
48488145|NCT01463683|155980887|FG000|Overall Study|Pregnancy|2|||
48592957|NCT00703326|156365619|FG000|Overall Study|Adverse Event|1|||
48592958|NCT00703326|156365620|FG001|Overall Study|Adverse Event|0|||
48592959|NCT01342445|156365624|FG000|Overall Study|Experienced side effects|0|||
48488146|NCT01463683|155980888|FG001|Overall Study|Pregnancy|2|||
48488147|NCT01463683|155980889|FG002|Overall Study|Pregnancy|1|||
48592960|NCT01342445|156365625|FG001|Overall Study|Experienced side effects|2|||
48488148|NCT01463683|155980887|FG000|Overall Study|Withdrawal by Subject|5|||
48488149|NCT01463683|155980888|FG001|Overall Study|Withdrawal by Subject|17|||
48592961|NCT00802672|156365626|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
48488150|NCT01463683|155980889|FG002|Overall Study|Withdrawal by Subject|2|||
48488151|NCT02557672|155980890|FG000|Overall Study|Withdrawal by Subject|4|||
48488152|NCT02557672|155980891|FG001|Overall Study|Withdrawal by Subject|2|||
48488153|NCT02378506|155980892|FG000|Overall Study|Lack of Efficacy|3|||
48488154|NCT02378506|155980892|FG000|Overall Study|Withdrawal by Subject|4|||
48488155|NCT02378506|155980892|FG000|Overall Study|Protocol Violation|2|||
48488156|NCT02378506|155980892|FG000|Overall Study|Death|1|||
48488157|NCT02378506|155980892|FG000|Overall Study|Adverse Event|14|||
48488158|NCT02378506|155980892|FG000|Overall Study|Randomized But Not Treated|1|||
48488159|NCT02123459|155980893|FG000|Washout Period (1 Day)|Adverse Event|1|||
48488160|NCT02123459|155980894|FG001|Washout Period (1 Day)|Adverse Event|0|||
48488161|NCT03705169|155980895|FG000|Overall Study|Lost to Follow-up|0|||
48488162|NCT03705169|155980896|FG001|Overall Study|Lost to Follow-up|0|||
48488163|NCT03705169|155980897|FG002|Overall Study|Lost to Follow-up|0|||
48488164|NCT03705169|155980898|FG003|Overall Study|Lost to Follow-up|2|||
48488165|NCT03705169|155980899|FG004|Overall Study|Lost to Follow-up|0|||
48488166|NCT03705169|155980900|FG005|Overall Study|Lost to Follow-up|2|||
48488167|NCT03705169|155980901|FG006|Overall Study|Lost to Follow-up|1|||
48488168|NCT03705169|155980902|FG007|Overall Study|Lost to Follow-up|0|||
48488169|NCT03705169|155980903|FG008|Overall Study|Lost to Follow-up|0|||
48488170|NCT03705169|155980904|FG009|Overall Study|Lost to Follow-up|1|||
48488171|NCT03705169|155980895|FG000|Overall Study|Adverse Event|0|||
48488172|NCT03705169|155980896|FG001|Overall Study|Adverse Event|0|||
48488173|NCT03705169|155980897|FG002|Overall Study|Adverse Event|0|||
48488174|NCT03705169|155980898|FG003|Overall Study|Adverse Event|1|||
48488175|NCT03705169|155980899|FG004|Overall Study|Adverse Event|0|||
48488176|NCT03705169|155980900|FG005|Overall Study|Adverse Event|0|||
48488177|NCT03705169|155980901|FG006|Overall Study|Adverse Event|0|||
48488178|NCT03705169|155980902|FG007|Overall Study|Adverse Event|0|||
48488179|NCT03705169|155980903|FG008|Overall Study|Adverse Event|0|||
48488180|NCT03705169|155980904|FG009|Overall Study|Adverse Event|0|||
48488181|NCT03705169|155980895|FG000|Overall Study|Site Closure|0|||
48488182|NCT03705169|155980896|FG001|Overall Study|Site Closure|0|||
48488183|NCT03705169|155980897|FG002|Overall Study|Site Closure|0|||
48488184|NCT03705169|155980898|FG003|Overall Study|Site Closure|1|||
48488185|NCT03705169|155980899|FG004|Overall Study|Site Closure|0|||
48488186|NCT03705169|155980900|FG005|Overall Study|Site Closure|0|||
48488187|NCT03705169|155980901|FG006|Overall Study|Site Closure|0|||
48488188|NCT03705169|155980902|FG007|Overall Study|Site Closure|0|||
48488189|NCT03705169|155980903|FG008|Overall Study|Site Closure|0|||
48488190|NCT03705169|155980904|FG009|Overall Study|Site Closure|0|||
48488191|NCT03705169|155980895|FG000|Overall Study|Did not receive study treatment|0|||
48488192|NCT03705169|155980896|FG001|Overall Study|Did not receive study treatment|0|||
48488193|NCT03705169|155980897|FG002|Overall Study|Did not receive study treatment|0|||
48488194|NCT03705169|155980898|FG003|Overall Study|Did not receive study treatment|1|||
48488195|NCT03705169|155980899|FG004|Overall Study|Did not receive study treatment|0|||
48488196|NCT03705169|155980900|FG005|Overall Study|Did not receive study treatment|0|||
48488197|NCT03705169|155980901|FG006|Overall Study|Did not receive study treatment|0|||
48488198|NCT03705169|155980902|FG007|Overall Study|Did not receive study treatment|0|||
48488199|NCT03705169|155980903|FG008|Overall Study|Did not receive study treatment|0|||
48488200|NCT03705169|155980904|FG009|Overall Study|Did not receive study treatment|0|||
48488201|NCT03705169|155980895|FG000|Overall Study|Concerns about study visit compliance|0|||
48488202|NCT03705169|155980896|FG001|Overall Study|Concerns about study visit compliance|0|||
48488203|NCT03705169|155980897|FG002|Overall Study|Concerns about study visit compliance|0|||
48488204|NCT03705169|155980898|FG003|Overall Study|Concerns about study visit compliance|1|||
48488205|NCT03705169|155980899|FG004|Overall Study|Concerns about study visit compliance|0|||
48488206|NCT03705169|155980900|FG005|Overall Study|Concerns about study visit compliance|0|||
48488207|NCT03705169|155980901|FG006|Overall Study|Concerns about study visit compliance|0|||
48488208|NCT03705169|155980902|FG007|Overall Study|Concerns about study visit compliance|0|||
48488209|NCT03705169|155980903|FG008|Overall Study|Concerns about study visit compliance|0|||
48488210|NCT03705169|155980904|FG009|Overall Study|Concerns about study visit compliance|0|||
48488211|NCT00911859|155980905|FG000|Treatment Period|Adverse Event|3|||
48488212|NCT00911859|155980906|FG001|Treatment Period|Adverse Event|3|||
48488213|NCT00911859|155980907|FG002|Treatment Period|Adverse Event|7|||
48488214|NCT00911859|155980905|FG000|Treatment Period|Death|1|||
48488215|NCT00911859|155980906|FG001|Treatment Period|Death|3|||
48488216|NCT00911859|155980907|FG002|Treatment Period|Death|5|||
48488217|NCT00911859|155980905|FG000|Treatment Period|Lack of Efficacy|1|||
48488218|NCT00911859|155980906|FG001|Treatment Period|Lack of Efficacy|7|||
48488219|NCT00911859|155980907|FG002|Treatment Period|Lack of Efficacy|5|||
48488220|NCT00911859|155980905|FG000|Treatment Period|Physician Decision|3|||
48488221|NCT00911859|155980906|FG001|Treatment Period|Physician Decision|3|||
48488222|NCT00911859|155980907|FG002|Treatment Period|Physician Decision|3|||
48488223|NCT00911859|155980905|FG000|Treatment Period|Withdrawal by Subject|0|||
48488224|NCT00911859|155980906|FG001|Treatment Period|Withdrawal by Subject|4|||
48488225|NCT00911859|155980907|FG002|Treatment Period|Withdrawal by Subject|5|||
48488226|NCT00911859|155980905|FG000|Treatment Period|Did not receive study treatment|0|||
48488227|NCT00911859|155980906|FG001|Treatment Period|Did not receive study treatment|1|||
48488228|NCT00911859|155980907|FG002|Treatment Period|Did not receive study treatment|0|||
48488229|NCT00911859|155980905|FG000|Maintainance Period|Lack of Efficacy|0|||
48488230|NCT00911859|155980906|FG001|Maintainance Period|Lack of Efficacy|0|||
48488231|NCT00911859|155980907|FG002|Maintainance Period|Lack of Efficacy|9|||
48488232|NCT00911859|155980905|FG000|Maintainance Period|Physician Decision|0|||
48488233|NCT00911859|155980906|FG001|Maintainance Period|Physician Decision|0|||
48488234|NCT00911859|155980907|FG002|Maintainance Period|Physician Decision|9|||
48488235|NCT00911859|155980905|FG000|Maintainance Period|Withdrawal by Subject|0|||
48488236|NCT00911859|155980906|FG001|Maintainance Period|Withdrawal by Subject|0|||
48488237|NCT00911859|155980907|FG002|Maintainance Period|Withdrawal by Subject|3|||
48488238|NCT00911859|155980905|FG000|Follow-up Period|Death|5|||
48488239|NCT00911859|155980906|FG001|Follow-up Period|Death|8|||
48488240|NCT00911859|155980907|FG002|Follow-up Period|Death|10|||
48488241|NCT00911859|155980905|FG000|Follow-up Period|Lost to Follow-up|1|||
48488242|NCT00911859|155980906|FG001|Follow-up Period|Lost to Follow-up|1|||
48488243|NCT00911859|155980907|FG002|Follow-up Period|Lost to Follow-up|0|||
48488244|NCT00911859|155980905|FG000|Follow-up Period|Withdrawal by Subject|0|||
48488245|NCT00911859|155980906|FG001|Follow-up Period|Withdrawal by Subject|4|||
48488246|NCT00911859|155980907|FG002|Follow-up Period|Withdrawal by Subject|4|||
48488247|NCT00911859|155980905|FG000|Follow-up Period|Study terminated by sponsor|5|||
48488248|NCT00911859|155980906|FG001|Follow-up Period|Study terminated by sponsor|33|||
48488249|NCT00911859|155980907|FG002|Follow-up Period|Study terminated by sponsor|27|||
48488250|NCT01070394|155980908|FG000|Overall Study|Adverse Event|6|||
48488251|NCT01070394|155980908|FG000|Overall Study|Withdrawal by Subject|1|||
48488252|NCT01613131|155982787|FG000|Overall Study|Withdrawal by Subject|3|||
48488253|NCT01613131|155982788|FG001|Overall Study|Withdrawal by Subject|5|||
48488254|NCT02454972|155982791|FG000|Overall Study|Progressive disease|17|||
48488255|NCT02454972|155982792|FG001|Overall Study|Progressive disease|16|||
48488256|NCT02454972|155982793|FG002|Overall Study|Progressive disease|59|||
48488257|NCT02454972|155982794|FG003|Overall Study|Progressive disease|23|||
48488258|NCT02454972|155982795|FG004|Overall Study|Progressive disease|16|||
48488259|NCT02454972|155982796|FG005|Overall Study|Progressive disease|12|||
48488260|NCT02454972|155982797|FG006|Overall Study|Progressive disease|19|||
48488261|NCT02454972|155982798|FG007|Overall Study|Progressive disease|27|||
48488262|NCT02454972|155982799|FG008|Overall Study|Progressive disease|0|||
48488263|NCT02454972|155982791|FG000|Overall Study|Death|0|||
48488264|NCT02454972|155982792|FG001|Overall Study|Death|0|||
48488265|NCT02454972|155982793|FG002|Overall Study|Death|5|||
48488266|NCT02454972|155982794|FG003|Overall Study|Death|1|||
48488267|NCT02454972|155982795|FG004|Overall Study|Death|0|||
48488268|NCT02454972|155982796|FG005|Overall Study|Death|0|||
48488269|NCT02454972|155982797|FG006|Overall Study|Death|0|||
48488270|NCT02454972|155982798|FG007|Overall Study|Death|0|||
48488271|NCT02454972|155982799|FG008|Overall Study|Death|95|||
48488272|NCT02454972|155982791|FG000|Overall Study|Physician Decision|0|||
48488273|NCT02454972|155982792|FG001|Overall Study|Physician Decision|1|||
48488274|NCT02454972|155982793|FG002|Overall Study|Physician Decision|2|||
48488275|NCT02454972|155982794|FG003|Overall Study|Physician Decision|1|||
48488276|NCT02454972|155982795|FG004|Overall Study|Physician Decision|2|||
48488277|NCT02454972|155982796|FG005|Overall Study|Physician Decision|0|||
48488278|NCT02454972|155982797|FG006|Overall Study|Physician Decision|0|||
48488279|NCT02454972|155982798|FG007|Overall Study|Physician Decision|1|||
48700347|NCT03175367|156753233|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
48488280|NCT02454972|155982799|FG008|Overall Study|Physician Decision|0|||
48488281|NCT02454972|155982791|FG000|Overall Study|Non treatment-related adverse event|2|||
48488282|NCT02454972|155982792|FG001|Overall Study|Non treatment-related adverse event|0|||
48488283|NCT02454972|155982793|FG002|Overall Study|Non treatment-related adverse event|1|||
48488284|NCT02454972|155982794|FG003|Overall Study|Non treatment-related adverse event|0|||
48488285|NCT02454972|155982795|FG004|Overall Study|Non treatment-related adverse event|0|||
48488286|NCT02454972|155982796|FG005|Overall Study|Non treatment-related adverse event|1|||
48488287|NCT02454972|155982797|FG006|Overall Study|Non treatment-related adverse event|0|||
48488288|NCT02454972|155982798|FG007|Overall Study|Non treatment-related adverse event|1|||
48488289|NCT02454972|155982799|FG008|Overall Study|Non treatment-related adverse event|0|||
48488290|NCT02454972|155982791|FG000|Overall Study|Treatment-related adverse events|0|||
48488291|NCT02454972|155982792|FG001|Overall Study|Treatment-related adverse events|1|||
48488292|NCT02454972|155982793|FG002|Overall Study|Treatment-related adverse events|1|||
48488293|NCT02454972|155982794|FG003|Overall Study|Treatment-related adverse events|0|||
48488294|NCT02454972|155982795|FG004|Overall Study|Treatment-related adverse events|2|||
48488295|NCT02454972|155982796|FG005|Overall Study|Treatment-related adverse events|0|||
48488296|NCT02454972|155982797|FG006|Overall Study|Treatment-related adverse events|0|||
48488297|NCT02454972|155982798|FG007|Overall Study|Treatment-related adverse events|2|||
48488298|NCT02454972|155982799|FG008|Overall Study|Treatment-related adverse events|0|||
48488299|NCT02454972|155982791|FG000|Overall Study|Patient moves to compassionate use|0|||
48488300|NCT02454972|155982792|FG001|Overall Study|Patient moves to compassionate use|0|||
48488301|NCT02454972|155982793|FG002|Overall Study|Patient moves to compassionate use|0|||
48488302|NCT02454972|155982794|FG003|Overall Study|Patient moves to compassionate use|0|||
48488303|NCT02454972|155982795|FG004|Overall Study|Patient moves to compassionate use|0|||
48488304|NCT02454972|155982796|FG005|Overall Study|Patient moves to compassionate use|0|||
48488305|NCT02454972|155982797|FG006|Overall Study|Patient moves to compassionate use|2|||
48488306|NCT02454972|155982798|FG007|Overall Study|Patient moves to compassionate use|0|||
48488307|NCT02454972|155982799|FG008|Overall Study|Patient moves to compassionate use|0|||
48488308|NCT02454972|155982791|FG000|Overall Study|Withdrawal by Subject|0|||
48488309|NCT02454972|155982792|FG001|Overall Study|Withdrawal by Subject|1|||
48488310|NCT02454972|155982793|FG002|Overall Study|Withdrawal by Subject|5|||
48488311|NCT02454972|155982794|FG003|Overall Study|Withdrawal by Subject|2|||
48488312|NCT02454972|155982795|FG004|Overall Study|Withdrawal by Subject|3|||
48488313|NCT02454972|155982796|FG005|Overall Study|Withdrawal by Subject|2|||
48488314|NCT02454972|155982797|FG006|Overall Study|Withdrawal by Subject|0|||
48488315|NCT02454972|155982798|FG007|Overall Study|Withdrawal by Subject|1|||
48488316|NCT02454972|155982799|FG008|Overall Study|Withdrawal by Subject|2|||
48488317|NCT02454972|155982791|FG000|Overall Study|Multiple delay/holds on treatment|0|||
48488318|NCT02454972|155982792|FG001|Overall Study|Multiple delay/holds on treatment|0|||
48488319|NCT02454972|155982793|FG002|Overall Study|Multiple delay/holds on treatment|0|||
48488320|NCT02454972|155982794|FG003|Overall Study|Multiple delay/holds on treatment|1|||
48488321|NCT02454972|155982795|FG004|Overall Study|Multiple delay/holds on treatment|0|||
48488322|NCT02454972|155982796|FG005|Overall Study|Multiple delay/holds on treatment|0|||
48488323|NCT02454972|155982797|FG006|Overall Study|Multiple delay/holds on treatment|0|||
48488324|NCT02454972|155982798|FG007|Overall Study|Multiple delay/holds on treatment|0|||
48488325|NCT02454972|155982799|FG008|Overall Study|Multiple delay/holds on treatment|0|||
48488326|NCT02454972|155982791|FG000|Overall Study|Never treated|0|||
48488327|NCT02454972|155982792|FG001|Overall Study|Never treated|0|||
48488328|NCT02454972|155982793|FG002|Overall Study|Never treated|3|||
48488329|NCT02454972|155982794|FG003|Overall Study|Never treated|1|||
48488330|NCT02454972|155982795|FG004|Overall Study|Never treated|1|||
48488331|NCT02454972|155982796|FG005|Overall Study|Never treated|0|||
48488332|NCT02454972|155982797|FG006|Overall Study|Never treated|0|||
48488333|NCT02454972|155982798|FG007|Overall Study|Never treated|0|||
48488334|NCT02454972|155982799|FG008|Overall Study|Never treated|5|||
48488335|NCT02454972|155982791|FG000|Overall Study|Lost to Follow-up|0|||
48488336|NCT02454972|155982792|FG001|Overall Study|Lost to Follow-up|0|||
48488337|NCT02454972|155982793|FG002|Overall Study|Lost to Follow-up|0|||
48488338|NCT02454972|155982794|FG003|Overall Study|Lost to Follow-up|0|||
48488339|NCT02454972|155982795|FG004|Overall Study|Lost to Follow-up|0|||
48488340|NCT02454972|155982796|FG005|Overall Study|Lost to Follow-up|0|||
48488341|NCT02454972|155982797|FG006|Overall Study|Lost to Follow-up|0|||
48488342|NCT02454972|155982798|FG007|Overall Study|Lost to Follow-up|0|||
48488343|NCT02454972|155982799|FG008|Overall Study|Lost to Follow-up|2|||
48488344|NCT02454972|155982791|FG000|Overall Study|Study termination|0|||
48488345|NCT02454972|155982792|FG001|Overall Study|Study termination|0|||
48488346|NCT02454972|155982793|FG002|Overall Study|Study termination|0|||
48488347|NCT02454972|155982794|FG003|Overall Study|Study termination|0|||
48488348|NCT02454972|155982795|FG004|Overall Study|Study termination|0|||
48488349|NCT02454972|155982796|FG005|Overall Study|Study termination|0|||
48488350|NCT02454972|155982797|FG006|Overall Study|Study termination|0|||
48488351|NCT02454972|155982798|FG007|Overall Study|Study termination|0|||
48488352|NCT02454972|155982799|FG008|Overall Study|Study termination|6|||
48488353|NCT00830063|155982800|FG000|Overall Study|Adverse Event|7|||
48488354|NCT00830063|155982801|FG001|Overall Study|Adverse Event|13|||
48488355|NCT00830063|155982802|FG002|Overall Study|Adverse Event|16|||
48488356|NCT00830063|155982803|FG003|Overall Study|Adverse Event|13|||
48488357|NCT00830063|155982800|FG000|Overall Study|Death|1|||
48592962|NCT00802672|156365627|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
48592963|NCT00802672|156365628|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
48592964|NCT00802672|156365626|FG000|Overall Study|Adverse Event|1|||
48592965|NCT00802672|156365627|FG001|Overall Study|Adverse Event|1|||
48592966|NCT00802672|156365628|FG002|Overall Study|Adverse Event|1|||
48700348|NCT03175367|156753234|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48700349|NCT03175367|156753235|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
48488358|NCT00830063|155982801|FG001|Overall Study|Death|0|||
48592967|NCT00802672|156365626|FG000|Overall Study|Protocol Violation|2|||
48592968|NCT00802672|156365627|FG001|Overall Study|Protocol Violation|1|||
48592969|NCT00802672|156365628|FG002|Overall Study|Protocol Violation|1|||
48488359|NCT00830063|155982802|FG002|Overall Study|Death|0|||
48592970|NCT00802672|156365626|FG000|Overall Study|Lost to Follow-up|5|||
48488360|NCT00830063|155982803|FG003|Overall Study|Death|0|||
48488361|NCT00830063|155982800|FG000|Overall Study|Lost to Follow-up|0|||
48488362|NCT00830063|155982801|FG001|Overall Study|Lost to Follow-up|0|||
48488363|NCT00830063|155982802|FG002|Overall Study|Lost to Follow-up|3|||
48488364|NCT00830063|155982803|FG003|Overall Study|Lost to Follow-up|1|||
48488365|NCT00830063|155982800|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
48488366|NCT00830063|155982801|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
48592971|NCT00802672|156365627|FG001|Overall Study|Lost to Follow-up|5|||
48592972|NCT00802672|156365628|FG002|Overall Study|Lost to Follow-up|3|||
48592973|NCT00802672|156365626|FG000|Overall Study|Withdrawal by Subject|1|||
48592974|NCT00802672|156365627|FG001|Overall Study|Withdrawal by Subject|1|||
48592975|NCT00802672|156365628|FG002|Overall Study|Withdrawal by Subject|2|||
48592976|NCT00802672|156365626|FG000|Overall Study|other|3|||
48592977|NCT00802672|156365627|FG001|Overall Study|other|1|||
48592978|NCT00802672|156365628|FG002|Overall Study|other|2|||
48592979|NCT04750278|156365629|FG000|Overall Study|Death|9|||
48592980|NCT04750278|156365630|FG001|Overall Study|Death|10|||
48592981|NCT04750278|156365631|FG002|Overall Study|Death|10|||
48592982|NCT04750278|156365629|FG000|Overall Study|Withdrawal by Subject|4|||
48592983|NCT04750278|156365630|FG001|Overall Study|Withdrawal by Subject|1|||
48592984|NCT04750278|156365631|FG002|Overall Study|Withdrawal by Subject|2|||
48592985|NCT04750278|156365629|FG000|Overall Study|Lost to Follow-up|1|||
48592986|NCT04750278|156365630|FG001|Overall Study|Lost to Follow-up|1|||
48592987|NCT04750278|156365631|FG002|Overall Study|Lost to Follow-up|1|||
48592988|NCT04750278|156365629|FG000|Overall Study|Pregnancy|1|||
48592989|NCT04750278|156365630|FG001|Overall Study|Pregnancy|0|||
48592990|NCT04750278|156365631|FG002|Overall Study|Pregnancy|0|||
48592991|NCT04750278|156365629|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
48592992|NCT04750278|156365630|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
48592993|NCT04750278|156365631|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
48700350|NCT03175367|156753236|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48700351|NCT03175367|156753237|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48700352|NCT03175367|156753231|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700353|NCT03175367|156753232|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700354|NCT03175367|156753233|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700355|NCT03175367|156753234|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700356|NCT03175367|156753235|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700357|NCT03175367|156753236|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
48700358|NCT03175367|156753237|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
48700359|NCT03175367|156753231|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700360|NCT03175367|156753232|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700361|NCT03175367|156753233|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700362|NCT03175367|156753234|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700363|NCT03175367|156753235|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48700364|NCT03175367|156753236|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
48700365|NCT03175367|156753237|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
48700366|NCT03453164|156753238|FG000|Overall Study|Lack of Efficacy|16|||
48700367|NCT03453164|156753238|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
48700368|NCT00124943|156753239|FG000|Phase II|Adverse Event|0|||
48700369|NCT00124943|156753240|FG001|Phase II|Adverse Event|2|||
48592994|NCT04750278|156365629|FG000|Overall Study|Non-compliance|0|||
48592995|NCT04750278|156365630|FG001|Overall Study|Non-compliance|0|||
48592996|NCT04750278|156365631|FG002|Overall Study|Non-compliance|1|||
48592997|NCT04750278|156365629|FG000|Overall Study|Transfer to Outside Facility|0|||
48592998|NCT04750278|156365630|FG001|Overall Study|Transfer to Outside Facility|2|||
48592999|NCT04750278|156365631|FG002|Overall Study|Transfer to Outside Facility|1|||
48700370|NCT00124943|156753241|FG002|Phase II|Adverse Event|0|||
48700371|NCT00124943|156753242|FG003|Phase II|Adverse Event|1|||
48700372|NCT00124943|156753239|FG000|Phase II|Protocol Violation|0|||
48700373|NCT00124943|156753240|FG001|Phase II|Protocol Violation|0|||
48700374|NCT00124943|156753241|FG002|Phase II|Protocol Violation|0|||
48700375|NCT00124943|156753242|FG003|Phase II|Protocol Violation|1|||
48700376|NCT00124943|156753239|FG000|Phase II|Lost to Follow-up|0|||
48700377|NCT00124943|156753240|FG001|Phase II|Lost to Follow-up|0|||
48700378|NCT00124943|156753241|FG002|Phase II|Lost to Follow-up|0|||
48700379|NCT00124943|156753242|FG003|Phase II|Lost to Follow-up|1|||
48700380|NCT00124943|156753239|FG000|Phase II|Withdrawal by Subject|0|||
48700381|NCT00124943|156753240|FG001|Phase II|Withdrawal by Subject|0|||
48593000|NCT04750278|156365629|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
48593001|NCT04750278|156365630|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
48593002|NCT04750278|156365631|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
48593003|NCT04750278|156365629|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
48593004|NCT04750278|156365630|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
48593005|NCT04750278|156365631|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
48593006|NCT02263729|156365632|FG000|Overall Study|Lost to Follow-up|1|||
48700382|NCT00124943|156753241|FG002|Phase II|Withdrawal by Subject|0|||
48700383|NCT00124943|156753242|FG003|Phase II|Withdrawal by Subject|2|||
48700384|NCT02153086|156753243|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
48700385|NCT02153086|156753243|FG000|Overall Study|Other|2|||
48593007|NCT02263729|156365633|FG001|Overall Study|Lost to Follow-up|1|||
48593008|NCT01306214|156365635|FG000|Overall Study|Death|0|||
48593009|NCT01306214|156365636|FG001|Overall Study|Death|0|||
48593010|NCT01306214|156365637|FG002|Overall Study|Death|1|||
48593011|NCT01306214|156365635|FG000|Overall Study|Lost to Follow-up|3|||
48593012|NCT01306214|156365636|FG001|Overall Study|Lost to Follow-up|5|||
48593013|NCT01306214|156365637|FG002|Overall Study|Lost to Follow-up|4|||
48700386|NCT03304626|156753254|FG000|Overall Study|Adverse Event|1|||
48700387|NCT03304626|156753255|FG001|Overall Study|Adverse Event|0|||
48700388|NCT03304626|156753254|FG000|Overall Study|Lack of Efficacy|1|||
48700389|NCT03304626|156753255|FG001|Overall Study|Lack of Efficacy|1|||
48700390|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
48700391|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
48700392|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
48700393|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
48700394|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
48700395|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
48593014|NCT01306214|156365635|FG000|Overall Study|Withdrawal by Subject|24|||
48593015|NCT01306214|156365636|FG001|Overall Study|Withdrawal by Subject|22|||
48593016|NCT01306214|156365637|FG002|Overall Study|Withdrawal by Subject|16|||
48593017|NCT01306214|156365635|FG000|Overall Study|Not treated|1|||
48593018|NCT01306214|156365636|FG001|Overall Study|Not treated|1|||
48593019|NCT01306214|156365637|FG002|Overall Study|Not treated|1|||
48593020|NCT01928199|156365640|FG000|Overall Study|Lost to Follow-up|2|||
48593021|NCT01928199|156365641|FG001|Overall Study|Lost to Follow-up|1|||
48593022|NCT01928199|156365640|FG000|Overall Study|Withdrawal by Subject|3|||
48593023|NCT01928199|156365641|FG001|Overall Study|Withdrawal by Subject|5|||
48593024|NCT01616758|156365642|FG000|Overall Study|Adverse Event|1|||
48593025|NCT01616758|156365642|FG000|Overall Study|Withdrawal by Subject|2|||
48593026|NCT01616758|156365642|FG000|Overall Study|Disease progression|18|||
48593027|NCT01616758|156365642|FG000|Overall Study|Study termination by Sponsor|1|||
48593028|NCT02107313|156365643|FG000|Overall Study|One participant did not do the FED cohor|0|||
48593029|NCT02107313|156365644|FG001|Overall Study|One participant did not do the FED cohor|1|||
48593030|NCT02315664|156365645|FG000|Overall Study|Lost to Follow-up|1|||
48593031|NCT02315664|156365646|FG001|Overall Study|Lost to Follow-up|1|||
48593032|NCT02315664|156365645|FG000|Overall Study|Withdrawal by Subject|0|||
48593033|NCT02315664|156365646|FG001|Overall Study|Withdrawal by Subject|3|||
48593034|NCT03488563|156365647|FG000|Overall Study|Lost to Follow-up|7|||
48593035|NCT03488563|156365648|FG001|Overall Study|Lost to Follow-up|6|||
48593036|NCT03488563|156365649|FG002|Overall Study|Lost to Follow-up|7|||
48593037|NCT03488563|156365647|FG000|Overall Study|Withdrawal by Subject|8|||
48593038|NCT03488563|156365648|FG001|Overall Study|Withdrawal by Subject|7|||
48593039|NCT03488563|156365649|FG002|Overall Study|Withdrawal by Subject|7|||
48593040|NCT03488563|156365647|FG000|Overall Study|Physician Decision|0|||
48593041|NCT03488563|156365648|FG001|Overall Study|Physician Decision|0|||
48593042|NCT03488563|156365649|FG002|Overall Study|Physician Decision|1|||
48593043|NCT03488563|156365647|FG000|Overall Study|Protocol Violation|3|||
48593044|NCT03488563|156365648|FG001|Overall Study|Protocol Violation|2|||
48593045|NCT03488563|156365649|FG002|Overall Study|Protocol Violation|6|||
48593046|NCT03488563|156365647|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
48593047|NCT03488563|156365648|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
48593048|NCT03488563|156365649|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
48593049|NCT03488563|156365647|FG000|Overall Study|Use of prohibited medication|2|||
48593050|NCT03488563|156365648|FG001|Overall Study|Use of prohibited medication|0|||
48593051|NCT03488563|156365649|FG002|Overall Study|Use of prohibited medication|0|||
48593052|NCT03488563|156365647|FG000|Overall Study|Adverse Event|1|||
48700396|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
48700397|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
48700398|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
48700399|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
48700400|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
48700401|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
48700402|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
48700403|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
48700404|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
48593053|NCT03488563|156365648|FG001|Overall Study|Adverse Event|0|||
48593054|NCT03488563|156365649|FG002|Overall Study|Adverse Event|1|||
48593055|NCT03488563|156365647|FG000|Overall Study|Subject returned for ET visit|0|||
48593056|NCT03488563|156365648|FG001|Overall Study|Subject returned for ET visit|1|||
48593057|NCT03488563|156365649|FG002|Overall Study|Subject returned for ET visit|0|||
48593058|NCT03488563|156365647|FG000|Overall Study|Sponsor's decision|0|||
48593059|NCT03488563|156365648|FG001|Overall Study|Sponsor's decision|0|||
48700405|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
48700406|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
48700407|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
48700408|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
48593060|NCT03488563|156365649|FG002|Overall Study|Sponsor's decision|1|||
48593061|NCT04336475|156365650|FG000|Overall Study|pain|1|||
48593062|NCT04336475|156365651|FG001|Overall Study|pain|0|||
48593063|NCT04336475|156365650|FG000|Overall Study|upper respiratory infection|1|||
48593064|NCT04336475|156365651|FG001|Overall Study|upper respiratory infection|0|||
48593065|NCT04336475|156365650|FG000|Overall Study|Lost to Follow-up|0|||
48593066|NCT04336475|156365651|FG001|Overall Study|Lost to Follow-up|2|||
48593067|NCT04153565|156365656|FG000|Overall Study|Death|13|||
48593068|NCT02626000|156365671|FG000|Overall Study|Decision by Sponsor|1|||
48593069|NCT02626000|156365671|FG000|Overall Study|Death|29|||
48593070|NCT00199849|156365672|FG000|Overall Study|Unrelated illness or complication|0|||
48593071|NCT00199849|156365673|FG001|Overall Study|Unrelated illness or complication|1|||
48593072|NCT00199849|156365674|FG002|Overall Study|Unrelated illness or complication|0|||
48593073|NCT00199849|156365672|FG000|Overall Study|Progressive disease requiring intervention|0|||
48593074|NCT00199849|156365673|FG001|Overall Study|Progressive disease requiring intervention|0|||
48593075|NCT00199849|156365674|FG002|Overall Study|Progressive disease requiring intervention|1|||
48593076|NCT00199849|156365672|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
48593077|NCT00199849|156365673|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
48593078|NCT00199849|156365674|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
48593079|NCT00662311|156365675|FG000|Overall Study|Respiratory Infection|1|||
48593080|NCT00662311|156365676|FG001|Overall Study|Respiratory Infection|0|||
48593081|NCT00662311|156365677|FG002|Overall Study|Respiratory Infection|0|||
48593082|NCT01490840|156365678|FG000|Phase 1|Lost to Follow-up|1|||
48593083|NCT01490840|156365679|FG001|Phase 1|Lost to Follow-up|0|||
48593084|NCT01490840|156365678|FG000|Phase 1|Adverse Event|2|||
48593085|NCT01490840|156365679|FG001|Phase 1|Adverse Event|1|||
48593086|NCT01490840|156365678|FG000|Phase 1|Withdrawal by Subject|6|||
48593087|NCT01490840|156365679|FG001|Phase 1|Withdrawal by Subject|5|||
48593088|NCT01490840|156365678|FG000|Phase 1|Visit 6a omitted|1|||
48593089|NCT01490840|156365679|FG001|Phase 1|Visit 6a omitted|0|||
48593090|NCT01490840|156365678|FG000|Phase 2|Withdrawal by Subject|4|||
48593091|NCT01490840|156365679|FG001|Phase 2|Withdrawal by Subject|3|||
48593092|NCT01490840|156365678|FG000|Phase 2|Permanent interruption of fingolimod|0|||
48593093|NCT01490840|156365679|FG001|Phase 2|Permanent interruption of fingolimod|1|||
48593094|NCT01490840|156365678|FG000|Phase 2|Lost to Follow-up|1|||
48593095|NCT01490840|156365679|FG001|Phase 2|Lost to Follow-up|1|||
48593096|NCT01490840|156365678|FG000|Phase 2|Adverse Event|1|||
48593097|NCT01490840|156365679|FG001|Phase 2|Adverse Event|1|||
48593098|NCT03594955|156365680|FG000|Overall Study|Adverse Event|1|||
48593099|NCT03594955|156365680|FG000|Overall Study|Progressive disease|5|||
48593100|NCT03594955|156365680|FG000|Overall Study|Sponsor's decision|1|||
48593101|NCT01148459|156365693|FG000|Overall Study|Serious Adverse Event|5|||
48593102|NCT01148459|156365694|FG001|Overall Study|Serious Adverse Event|4|||
48700409|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
48700410|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
48593103|NCT01148459|156365693|FG000|Overall Study|Withdrawal by Subject|1|||
48593104|NCT01148459|156365694|FG001|Overall Study|Withdrawal by Subject|0|||
48593105|NCT01148459|156365693|FG000|Overall Study|Migrated/moved from study area|3|||
48593106|NCT01148459|156365694|FG001|Overall Study|Migrated/moved from study area|6|||
48593107|NCT01148459|156365693|FG000|Overall Study|Lost to Follow-up|2|||
48593108|NCT01148459|156365694|FG001|Overall Study|Lost to Follow-up|0|||
48593109|NCT01148459|156365693|FG000|Overall Study|Refusal|1|||
48593110|NCT01148459|156365694|FG001|Overall Study|Refusal|0|||
48593111|NCT01148459|156365693|FG000|Overall Study|Failure to comply with study procedures|0|||
48593112|NCT01148459|156365694|FG001|Overall Study|Failure to comply with study procedures|1|||
48593113|NCT00694356|156365696|FG000|Overall Study|Adverse Event|1|||
48593114|NCT00694356|156365697|FG001|Overall Study|Adverse Event|0|||
48593115|NCT00694356|156365698|FG002|Overall Study|Adverse Event|0|||
48593116|NCT00694356|156365696|FG000|Overall Study|Progressive Disease|2|||
48593117|NCT00694356|156365697|FG001|Overall Study|Progressive Disease|6|||
48700411|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
48700412|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
48700413|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
48700414|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
48700415|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
48700416|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
48593118|NCT00694356|156365698|FG002|Overall Study|Progressive Disease|6|||
48593119|NCT03042910|156365703|FG000|Overall Study|Adverse Event|1|||
48593120|NCT03042910|156365703|FG000|Overall Study|Disease Progression|2|||
48593121|NCT03042910|156365703|FG000|Overall Study|Withdrawal by Subject|3|||
48593122|NCT03042910|156365703|FG000|Overall Study|Enrolled but not treated|1|||
48593123|NCT01763203|156365705|FG000|Overall Study|Death|4|||
48593124|NCT01763203|156365706|FG001|Overall Study|Death|7|||
48700417|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
48593125|NCT01763203|156365705|FG000|Overall Study|Lost to Follow-up|12|||
48593126|NCT01763203|156365706|FG001|Overall Study|Lost to Follow-up|12|||
48593127|NCT01763203|156365705|FG000|Overall Study|Withdrawal by Subject|8|||
48700418|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700419|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700420|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700421|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700422|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700423|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700424|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
48700425|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700426|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700427|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700428|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700429|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700430|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48700431|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
48488367|NCT00830063|155982802|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
48488368|NCT00830063|155982803|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
48488369|NCT00830063|155982800|FG000|Overall Study|Lack of Efficacy|51|||
48488370|NCT00830063|155982801|FG001|Overall Study|Lack of Efficacy|23|||
48488371|NCT00830063|155982802|FG002|Overall Study|Lack of Efficacy|25|||
48488372|NCT00830063|155982803|FG003|Overall Study|Lack of Efficacy|32|||
48488373|NCT00830063|155982800|FG000|Overall Study|Other|5|||
48488374|NCT00830063|155982801|FG001|Overall Study|Other|5|||
48488375|NCT00830063|155982802|FG002|Overall Study|Other|8|||
48488376|NCT00830063|155982803|FG003|Overall Study|Other|6|||
48488377|NCT00830063|155982800|FG000|Overall Study|Withdrawal by Subject|16|||
48488378|NCT00830063|155982801|FG001|Overall Study|Withdrawal by Subject|10|||
48488379|NCT00830063|155982802|FG002|Overall Study|Withdrawal by Subject|16|||
48488380|NCT00830063|155982803|FG003|Overall Study|Withdrawal by Subject|13|||
48488381|NCT00830063|155982800|FG000|Overall Study|Protocol Violation|1|||
48488382|NCT00830063|155982801|FG001|Overall Study|Protocol Violation|0|||
48488383|NCT00830063|155982802|FG002|Overall Study|Protocol Violation|3|||
48488384|NCT00830063|155982803|FG003|Overall Study|Protocol Violation|2|||
48488385|NCT00830063|155982800|FG000|Overall Study|Randomized But Not Treated|0|||
48488386|NCT00830063|155982801|FG001|Overall Study|Randomized But Not Treated|2|||
48488387|NCT00830063|155982802|FG002|Overall Study|Randomized But Not Treated|0|||
48488388|NCT00830063|155982803|FG003|Overall Study|Randomized But Not Treated|2|||
48488389|NCT00787566|155982810|FG000|Overall Study|AE related to chemotherapy|0|||
48488390|NCT00787566|155982811|FG001|Overall Study|AE related to chemotherapy|1|||
48488391|NCT00787566|155982812|FG002|Overall Study|AE related to chemotherapy|0|||
48488392|NCT03548207|155982813|FG000|Overall Study|Death|10|||
48488393|NCT03548207|155982814|FG001|Overall Study|Death|23|||
48488394|NCT03548207|155982815|FG002|Overall Study|Death|3|||
48488395|NCT03548207|155982813|FG000|Overall Study|Lost to Follow-up|0|||
48488396|NCT03548207|155982814|FG001|Overall Study|Lost to Follow-up|2|||
48488397|NCT03548207|155982815|FG002|Overall Study|Lost to Follow-up|0|||
48488398|NCT03548207|155982813|FG000|Overall Study|Withdrawal by Subject|0|||
48488399|NCT03548207|155982814|FG001|Overall Study|Withdrawal by Subject|3|||
48488400|NCT03548207|155982815|FG002|Overall Study|Withdrawal by Subject|0|||
48488401|NCT03548207|155982813|FG000|Overall Study|Sponsor decision|19|||
48488402|NCT03548207|155982814|FG001|Overall Study|Sponsor decision|40|||
48488403|NCT03548207|155982815|FG002|Overall Study|Sponsor decision|6|||
48488404|NCT03548207|155982813|FG000|Overall Study|Randomized but not treated|6|||
48488405|NCT03548207|155982814|FG001|Overall Study|Randomized but not treated|10|||
48488406|NCT03548207|155982815|FG002|Overall Study|Randomized but not treated|4|||
48488407|NCT01785875|155982816|FG000|Overall Study|Withdrawal by Subject|41|||
48488408|NCT01785875|155982817|FG001|Overall Study|Withdrawal by Subject|34|||
48488409|NCT01785875|155982818|FG002|Overall Study|Withdrawal by Subject|36|||
48488410|NCT01785875|155982816|FG000|Overall Study|Lost to Follow-up|19|||
48488411|NCT01785875|155982817|FG001|Overall Study|Lost to Follow-up|22|||
48488412|NCT01785875|155982818|FG002|Overall Study|Lost to Follow-up|6|||
48488413|NCT01785875|155982816|FG000|Overall Study|Death|27|||
48488414|NCT01785875|155982817|FG001|Overall Study|Death|16|||
48488415|NCT01785875|155982818|FG002|Overall Study|Death|7|||
48488416|NCT01785875|155982816|FG000|Overall Study|Sponsor Decision|0|||
48488417|NCT01785875|155982817|FG001|Overall Study|Sponsor Decision|2|||
48488418|NCT01785875|155982818|FG002|Overall Study|Sponsor Decision|0|||
48488419|NCT01785875|155982816|FG000|Overall Study|Protocol Specified Criteria|207|||
48488420|NCT01785875|155982817|FG001|Overall Study|Protocol Specified Criteria|214|||
48488421|NCT01785875|155982818|FG002|Overall Study|Protocol Specified Criteria|55|||
48488422|NCT01785875|155982816|FG000|Overall Study|Missing|0|||
48488423|NCT01785875|155982817|FG001|Overall Study|Missing|1|||
48488424|NCT01785875|155982818|FG002|Overall Study|Missing|3|||
48700432|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Transplant|0|||
48488425|NCT01814761|155982824|FG000|Overall Study|Other Reasons|1|||
48488426|NCT01814761|155982825|FG001|Overall Study|Other Reasons|10|||
48488427|NCT01814761|155982824|FG000|Overall Study|Ocular Adverse Event|6|||
48488428|NCT01814761|155982825|FG001|Overall Study|Ocular Adverse Event|15|||
48700433|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Transplant|1|||
48488429|NCT01814761|155982824|FG000|Overall Study|Lost to Follow-up|1|||
48488430|NCT01814761|155982825|FG001|Overall Study|Lost to Follow-up|5|||
48488431|NCT00775983|155982826|FG000|Overall Study|Protocol Violation|1|||
48488432|NCT00775983|155982827|FG001|Overall Study|Protocol Violation|2|||
48488433|NCT00936884|155982828|FG000|Double-blind|Withdrawal by Subject|6|||
48488434|NCT00936884|155982829|FG001|Double-blind|Withdrawal by Subject|4|||
48488435|NCT00936884|155982830|FG002|Double-blind|Withdrawal by Subject|0|||
48488436|NCT00936884|155982828|FG000|Double-blind|Death|2|||
48488437|NCT00936884|155982829|FG001|Double-blind|Death|1|||
48488438|NCT00936884|155982830|FG002|Double-blind|Death|0|||
48488439|NCT00936884|155982828|FG000|Double-blind|Lack of Efficacy|1|||
48488440|NCT00936884|155982829|FG001|Double-blind|Lack of Efficacy|1|||
48488441|NCT00936884|155982830|FG002|Double-blind|Lack of Efficacy|0|||
48488442|NCT00936884|155982828|FG000|Double-blind|Adverse Event|1|||
48488443|NCT00936884|155982829|FG001|Double-blind|Adverse Event|0|||
48488444|NCT00936884|155982830|FG002|Double-blind|Adverse Event|0|||
48488445|NCT00936884|155982828|FG000|Double-blind|Physician Decision|1|||
48488446|NCT00936884|155982829|FG001|Double-blind|Physician Decision|0|||
48488447|NCT00936884|155982830|FG002|Double-blind|Physician Decision|0|||
48488448|NCT00936884|155982828|FG000|Double-blind|No post baseline diary entry|1|||
48488449|NCT00936884|155982829|FG001|Double-blind|No post baseline diary entry|0|||
48488450|NCT00936884|155982830|FG002|Double-blind|No post baseline diary entry|0|||
48488451|NCT00936884|155982828|FG000|Double-blind|Did not receive study drug|0|||
48488452|NCT00936884|155982829|FG001|Double-blind|Did not receive study drug|1|||
48488453|NCT00936884|155982830|FG002|Double-blind|Did not receive study drug|0|||
48488454|NCT01663714|155982833|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
48488455|NCT01663714|155982833|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
48488456|NCT01663714|155982833|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
48488457|NCT01663714|155982833|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
48488458|NCT01663714|155982833|FG000|Long-Term Follow-Up|Death|4|||
48488459|NCT01663714|155982833|FG000|Long-Term Follow-Up|Non-compliance|1|||
48488460|NCT01462695|155982838|FG000|Overall Study|Adverse Event|1|||
48488461|NCT01462695|155982839|FG001|Overall Study|Adverse Event|1|||
48488462|NCT01462695|155982838|FG000|Overall Study|Death|2|||
48488463|NCT01462695|155982839|FG001|Overall Study|Death|0|||
48488464|NCT01462695|155982838|FG000|Overall Study|Lack of Efficacy|6|||
48488465|NCT01462695|155982839|FG001|Overall Study|Lack of Efficacy|12|||
48488466|NCT01462695|155982838|FG000|Overall Study|Physician Decision|5|||
48488467|NCT01462695|155982839|FG001|Overall Study|Physician Decision|0|||
48700434|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Transplant|0|||
48700435|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Transplant|0|||
48700436|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Transplant|0|||
48700437|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Transplant|1|||
48700438|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Transplant|0|||
48798429|NCT02453685|157098661|FG001|Overall Study|Lost to Follow-up|1|||
48432438|NCT03504774|155770854|FG001|Overall Study|Protocol Violation|3|||
48432439|NCT03504774|155770853|FG000|Overall Study|failed wk 52 DBPCFC|1|||
48432440|NCT03504774|155770854|FG001|Overall Study|failed wk 52 DBPCFC|0|||
48432441|NCT01856595|155770857|FG000|Overall Study|Withdrawal by Subject|0|||
48432442|NCT01856595|155770858|FG001|Overall Study|Withdrawal by Subject|1|||
48432443|NCT01856595|155770859|FG002|Overall Study|Withdrawal by Subject|0|||
48432444|NCT01856595|155770860|FG003|Overall Study|Withdrawal by Subject|0|||
48432445|NCT01856595|155770861|FG004|Overall Study|Withdrawal by Subject|0|||
48432446|NCT01856595|155770862|FG005|Overall Study|Withdrawal by Subject|0|||
48432447|NCT01856595|155770863|FG006|Overall Study|Withdrawal by Subject|1|||
48432448|NCT01856595|155770864|FG007|Overall Study|Withdrawal by Subject|0|||
48432449|NCT01856595|155770865|FG008|Overall Study|Withdrawal by Subject|0|||
48432450|NCT01930799|155770868|FG000|Overall Study|Withdrawal by Subject|3|||
48432451|NCT01930799|155770868|FG000|Overall Study|Lost to Follow-up|5|||
48432452|NCT01814800|155770869|FG000|Overall Study|Adverse Event|2|||
48432453|NCT01814800|155770869|FG000|Overall Study|Pregnancy|1|||
48432454|NCT01814800|155770869|FG000|Overall Study|Sponsor decision|1|||
48432455|NCT01814800|155770869|FG000|Overall Study|Subject relocation|1|||
48432456|NCT05373706|155770870|FG000|Overall Study|Lost to Follow-up|2|||
48432457|NCT05373706|155770871|FG001|Overall Study|Lost to Follow-up|2|||
48432458|NCT01533935|155770873|FG000|Overall Study|Adverse Event|5|||
48432459|NCT01533935|155770874|FG001|Overall Study|Adverse Event|7|||
48432460|NCT01533935|155770875|FG002|Overall Study|Adverse Event|1|||
48432461|NCT01533935|155770876|FG003|Overall Study|Adverse Event|5|||
48432462|NCT01533935|155770877|FG004|Overall Study|Adverse Event|3|||
48432463|NCT01533935|155770873|FG000|Overall Study|Protocol Violation|0|||
48432464|NCT01533935|155770874|FG001|Overall Study|Protocol Violation|2|||
48432465|NCT01533935|155770875|FG002|Overall Study|Protocol Violation|0|||
48432466|NCT01533935|155770876|FG003|Overall Study|Protocol Violation|0|||
48432467|NCT01533935|155770877|FG004|Overall Study|Protocol Violation|0|||
48432468|NCT01533935|155770873|FG000|Overall Study|Lost to Follow-up|0|||
48432469|NCT01533935|155770874|FG001|Overall Study|Lost to Follow-up|0|||
48488468|NCT01462695|155982838|FG000|Overall Study|Withdrawal by Subject|2|||
48488469|NCT01462695|155982839|FG001|Overall Study|Withdrawal by Subject|0|||
48488470|NCT01462695|155982838|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
48488471|NCT01462695|155982839|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
48488472|NCT01507831|155982840|FG000|Overall Study|Randomized but not treated|0|||
48488473|NCT01507831|155982841|FG001|Overall Study|Randomized but not treated|3|||
48488474|NCT01507831|155982840|FG000|Overall Study|Adverse Event|48|||
48488475|NCT01507831|155982841|FG001|Overall Study|Adverse Event|113|||
48488476|NCT01507831|155982840|FG000|Overall Study|Death|6|||
48488477|NCT01507831|155982841|FG001|Overall Study|Death|2|||
48488478|NCT01507831|155982840|FG000|Overall Study|Poor compliance to protocol|38|||
48488479|NCT01507831|155982841|FG001|Overall Study|Poor compliance to protocol|60|||
48488480|NCT01507831|155982840|FG000|Overall Study|Physician Decision|0|||
48488481|NCT01507831|155982841|FG001|Overall Study|Physician Decision|4|||
48488482|NCT01507831|155982840|FG000|Overall Study|Participant moved|5|||
48488483|NCT01507831|155982841|FG001|Overall Study|Participant moved|19|||
48488484|NCT01507831|155982840|FG000|Overall Study|Consent withdrawn by participant|34|||
48488485|NCT01507831|155982841|FG001|Overall Study|Consent withdrawn by participant|72|||
48488486|NCT01507831|155982840|FG000|Overall Study|Related to study drug administration|5|||
48488487|NCT01507831|155982841|FG001|Overall Study|Related to study drug administration|14|||
48488488|NCT01507831|155982840|FG000|Overall Study|Last visit outside protocol visit window|51|||
48488489|NCT01507831|155982841|FG001|Overall Study|Last visit outside protocol visit window|143|||
48488490|NCT01507831|155982840|FG000|Overall Study|Selection criteria finally not met|0|||
48488491|NCT01507831|155982841|FG001|Overall Study|Selection criteria finally not met|1|||
48488492|NCT01507831|155982840|FG000|Overall Study|Site closure|0|||
48488493|NCT01507831|155982841|FG001|Overall Study|Site closure|3|||
48488494|NCT01507831|155982840|FG000|Overall Study|Potential lost to follow-up|3|||
48488495|NCT01507831|155982841|FG001|Overall Study|Potential lost to follow-up|0|||
48488496|NCT01507831|155982840|FG000|Overall Study|Other|3|||
48488497|NCT01507831|155982841|FG001|Overall Study|Other|6|||
48488498|NCT01664494|155982842|FG000|Overall Study|Withdrawal by Subject|27|||
48488499|NCT01664494|155982842|FG000|Overall Study|Death|18|||
48488500|NCT01664494|155982842|FG000|Overall Study|Other|49|||
48488501|NCT01664494|155982842|FG000|Overall Study|Lost to Follow-up|99|||
48488502|NCT03196791|155982843|FG000|Overall Study|Protocol Violation|7|||
48488503|NCT03196791|155982844|FG001|Overall Study|Protocol Violation|3|||
48488504|NCT03196791|155982843|FG000|Overall Study|Withdrawal by Subject|3|||
48488505|NCT03196791|155982844|FG001|Overall Study|Withdrawal by Subject|2|||
48488506|NCT03263819|155982845|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
48488507|NCT03263819|155982846|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
48488508|NCT01814137|155982848|FG000|Overall Study|Adverse Event|0|||
48488509|NCT01814137|155982849|FG001|Overall Study|Adverse Event|1|||
48488510|NCT01814137|155982848|FG000|Overall Study|Withdrawal by Subject|2|||
48488511|NCT01814137|155982849|FG001|Overall Study|Withdrawal by Subject|2|||
48488512|NCT01814137|155982848|FG000|Overall Study|Physician Decision|1|||
48488513|NCT01814137|155982849|FG001|Overall Study|Physician Decision|1|||
48488514|NCT01814137|155982848|FG000|Overall Study|Unclassified|2|||
48488515|NCT01814137|155982849|FG001|Overall Study|Unclassified|1|||
48488516|NCT01689974|155982850|FG000|Overall Study|Termination of Study|5|||
48488517|NCT01689974|155982851|FG001|Overall Study|Termination of Study|5|||
48488518|NCT00219557|155982853|FG000|Phase 1|Lack of Efficacy|3|||
48488519|NCT00219557|155982854|FG001|Phase 1|Lack of Efficacy|0|||
48488520|NCT00219557|155982855|FG002|Phase 1|Lack of Efficacy|0|||
48488521|NCT00219557|155982853|FG000|Phase 1|Adverse Event|2|||
48488522|NCT00219557|155982854|FG001|Phase 1|Adverse Event|0|||
48488523|NCT00219557|155982855|FG002|Phase 1|Adverse Event|0|||
48488524|NCT00219557|155982853|FG000|Phase 1|Withdrawal by Subject|1|||
48700439|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Transplant|0|||
48700440|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Transplant|0|||
48700441|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Transplant|0|||
48700442|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Transplant|0|||
48700443|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Transplant|0|||
48700444|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Transplant|0|||
48488525|NCT00219557|155982854|FG001|Phase 1|Withdrawal by Subject|0|||
48488526|NCT00219557|155982855|FG002|Phase 1|Withdrawal by Subject|0|||
48488527|NCT00219557|155982853|FG000|Phase 1|Started chemotherapy at other institute|1|||
48488528|NCT00219557|155982854|FG001|Phase 1|Started chemotherapy at other institute|0|||
48700445|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Transplant|0|||
48488529|NCT00219557|155982855|FG002|Phase 1|Started chemotherapy at other institute|0|||
48488530|NCT00219557|155982853|FG000|Phase 2|Lack of Efficacy|0|||
48488531|NCT00219557|155982854|FG001|Phase 2|Lack of Efficacy|21|||
48488532|NCT00219557|155982855|FG002|Phase 2|Lack of Efficacy|15|||
48488533|NCT00219557|155982853|FG000|Phase 2|Adverse Event|0|||
48488534|NCT00219557|155982854|FG001|Phase 2|Adverse Event|22|||
48488535|NCT00219557|155982855|FG002|Phase 2|Adverse Event|2|||
48488536|NCT00219557|155982853|FG000|Phase 2|Death|0|||
48488537|NCT00219557|155982854|FG001|Phase 2|Death|8|||
48488538|NCT00219557|155982855|FG002|Phase 2|Death|2|||
48488539|NCT00219557|155982853|FG000|Phase 2|Other|0|||
48488540|NCT00219557|155982854|FG001|Phase 2|Other|8|||
48488541|NCT00219557|155982855|FG002|Phase 2|Other|6|||
48488542|NCT00219557|155982853|FG000|Phase 2|Withdrawal by Subject|0|||
48488543|NCT00219557|155982854|FG001|Phase 2|Withdrawal by Subject|9|||
48488544|NCT00219557|155982855|FG002|Phase 2|Withdrawal by Subject|5|||
48488545|NCT00219557|155982853|FG000|Phase 2|Treatment not received|0|||
48488546|NCT00219557|155982854|FG001|Phase 2|Treatment not received|1|||
48488547|NCT00219557|155982855|FG002|Phase 2|Treatment not received|3|||
48488548|NCT01427803|155982860|FG000|Overall Study|Lost to Follow-up|32|||
48488549|NCT01427803|155982861|FG001|Overall Study|Lost to Follow-up|26|||
48488550|NCT01427803|155982860|FG000|Overall Study|Withdrawal by Subject|20|||
48488551|NCT01427803|155982861|FG001|Overall Study|Withdrawal by Subject|0|||
48488552|NCT01427803|155982860|FG000|Overall Study|Unable to complete full treatment period|6|||
48488553|NCT01427803|155982861|FG001|Overall Study|Unable to complete full treatment period|0|||
48488554|NCT01427803|155982860|FG000|Overall Study|Protocol Violation|1|||
48488555|NCT01427803|155982861|FG001|Overall Study|Protocol Violation|0|||
48488556|NCT01427803|155982860|FG000|Overall Study|Physician Decision|3|||
48488557|NCT01427803|155982861|FG001|Overall Study|Physician Decision|0|||
48488558|NCT01427803|155982860|FG000|Overall Study|did not take product|1|||
48488559|NCT01427803|155982861|FG001|Overall Study|did not take product|0|||
48488560|NCT00879970|155982863|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
48488561|NCT00879970|155982864|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
48488562|NCT00879970|155982865|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
48488563|NCT00879970|155982866|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
48488564|NCT00879970|155982867|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
48488565|NCT00879970|155982863|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
48488566|NCT00879970|155982864|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
48488567|NCT00879970|155982865|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
48488568|NCT00879970|155982866|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
48488569|NCT00879970|155982867|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
48488570|NCT00879970|155982863|FG000|Period 1 TZD Randomization|Death|2|||
48488571|NCT00879970|155982864|FG001|Period 1 TZD Randomization|Death|1|||
48488572|NCT00879970|155982865|FG002|Period 1 TZD Randomization|Death|0|||
48488573|NCT00879970|155982866|FG003|Period 1 TZD Randomization|Death|0|||
48488574|NCT00879970|155982867|FG004|Period 1 TZD Randomization|Death|0|||
48488575|NCT00879970|155982863|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
48488576|NCT00879970|155982864|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
48700446|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
48700447|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
48700448|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
48700449|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
48700450|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
48700451|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
48700452|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
48700453|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
48488577|NCT00879970|155982865|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
48488578|NCT00879970|155982866|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
48488579|NCT00879970|155982867|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
48700454|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
48700455|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
48700456|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
48700457|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
48700458|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
48700459|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
48700460|NCT02113982|156753260|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
48700461|NCT02113982|156753261|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
48700462|NCT02113982|156753262|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
48700463|NCT02113982|156753263|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
48700464|NCT02113982|156753264|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
48700465|NCT02113982|156753265|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
48700466|NCT02113982|156753266|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
48700467|NCT02113982|156753267|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
48700468|NCT02113982|156753268|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
48700469|NCT02113982|156753269|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
48700470|NCT02113982|156753270|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
48488580|NCT00879970|155982863|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
48700471|NCT02113982|156753271|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
48700472|NCT02113982|156753272|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
48700473|NCT02113982|156753273|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
48488581|NCT00879970|155982864|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
48488582|NCT00879970|155982865|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
48700474|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
48700475|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
48700476|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
48700477|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
48700478|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
48700479|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
48700480|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
48700481|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
48700482|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
48700483|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
48700484|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
48700485|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
48700486|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
48700487|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
48700488|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
48700489|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
48700490|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
48700491|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
48488583|NCT00879970|155982866|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
48488584|NCT00879970|155982867|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
48700492|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
48700493|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
48700494|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
48700495|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
48700496|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
48700497|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
48488585|NCT00879970|155982863|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
48488586|NCT00879970|155982864|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
48488587|NCT00879970|155982865|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
48488588|NCT00879970|155982866|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
48488589|NCT00879970|155982867|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
48488590|NCT00879970|155982863|FG000|Period 2 Vitamin D Randomization|Death|0|||
48488591|NCT00879970|155982864|FG001|Period 2 Vitamin D Randomization|Death|0|||
48488592|NCT00879970|155982865|FG002|Period 2 Vitamin D Randomization|Death|0|||
48488593|NCT00879970|155982866|FG003|Period 2 Vitamin D Randomization|Death|2|||
48488594|NCT00879970|155982867|FG004|Period 2 Vitamin D Randomization|Death|0|||
48488595|NCT00591253|155982868|FG000|Overall Study|Adverse Event|3|||
48488596|NCT00591253|155982869|FG001|Overall Study|Adverse Event|3|||
48488597|NCT00591253|155982870|FG002|Overall Study|Adverse Event|1|||
48488598|NCT00591253|155982868|FG000|Overall Study|Protocol Violation|2|||
48488599|NCT00591253|155982869|FG001|Overall Study|Protocol Violation|2|||
48488600|NCT00591253|155982870|FG002|Overall Study|Protocol Violation|2|||
48488601|NCT00591253|155982868|FG000|Overall Study|Lost to Follow-up|2|||
48488602|NCT00591253|155982869|FG001|Overall Study|Lost to Follow-up|4|||
48488603|NCT00591253|155982870|FG002|Overall Study|Lost to Follow-up|0|||
48488604|NCT00591253|155982868|FG000|Overall Study|Withdrawal by Subject|1|||
48488605|NCT00591253|155982869|FG001|Overall Study|Withdrawal by Subject|7|||
48488606|NCT00591253|155982870|FG002|Overall Study|Withdrawal by Subject|6|||
48488607|NCT00591253|155982868|FG000|Overall Study|Lack of Efficacy|1|||
48488608|NCT00591253|155982869|FG001|Overall Study|Lack of Efficacy|0|||
48488609|NCT00591253|155982870|FG002|Overall Study|Lack of Efficacy|3|||
48488610|NCT00591253|155982868|FG000|Overall Study|Other|5|||
48488611|NCT00591253|155982869|FG001|Overall Study|Other|5|||
48488612|NCT00591253|155982870|FG002|Overall Study|Other|3|||
48488613|NCT03811249|155982872|FG000|Overall Study|Withdrawal by Subject|44|||
48488614|NCT03811249|155982872|FG000|Overall Study|Missed Visit|24|||
48488615|NCT00124449|155982873|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
48488616|NCT00124449|155982874|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
48488617|NCT00124449|155982873|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
48488618|NCT00124449|155982874|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
48488619|NCT00124449|155982873|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
48488620|NCT00124449|155982874|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
48488621|NCT00124449|155982873|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
48488622|NCT00124449|155982874|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
48488623|NCT00124449|155982873|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
48488624|NCT00124449|155982874|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
48488625|NCT00124449|155982873|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
48488626|NCT00124449|155982874|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
48700498|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
48700499|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
48700500|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
48593128|NCT01763203|156365706|FG001|Overall Study|Withdrawal by Subject|12|||
48593129|NCT01763203|156365705|FG000|Overall Study|Moved out of study region|7|||
48593130|NCT01763203|156365706|FG001|Overall Study|Moved out of study region|10|||
48593131|NCT01763203|156365705|FG000|Overall Study|Physician Decision|2|||
48593132|NCT01763203|156365706|FG001|Overall Study|Physician Decision|1|||
48488627|NCT00124449|155982873|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
48488628|NCT00124449|155982874|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
48488629|NCT00124449|155982873|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
48488630|NCT00124449|155982874|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
48488631|NCT00124449|155982873|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
48488632|NCT00124449|155982874|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
48488633|NCT00124449|155982873|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
48488634|NCT00124449|155982874|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
48488635|NCT00124449|155982873|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
48488636|NCT00124449|155982874|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
48488637|NCT00124449|155982873|FG000|18-Month Untreated Observation Period|Relocated|1|||
48488638|NCT00124449|155982874|FG001|18-Month Untreated Observation Period|Relocated|0|||
48488639|NCT04317781|155982878|FG000|Overall Study|Adverse Event|1|||
48488640|NCT04317781|155982878|FG000|Overall Study|Disease relapse|1|||
48488641|NCT04317781|155982878|FG000|Overall Study|Withdrawal by Subject|1|||
48488642|NCT01504867|155982879|FG000|Overall Study|Inclusion criteria not met|2|||
48488643|NCT01504867|155982880|FG001|Overall Study|Inclusion criteria not met|2|||
48488644|NCT01504867|155982879|FG000|Overall Study|Consent revoked|5|||
48488645|NCT01504867|155982880|FG001|Overall Study|Consent revoked|1|||
48488646|NCT00571922|155982882|FG000|Overall Study|Completion unknown|36|||
48488647|NCT00571922|155982883|FG001|Overall Study|Completion unknown|36|||
48488648|NCT03124381|155982906|FG000|Overall Study|Lost to Follow-up|1|||
48488649|NCT03124381|155982907|FG001|Overall Study|Lost to Follow-up|1|||
48488650|NCT03124381|155982906|FG000|Overall Study|Withdrawal by Subject|6|||
48488651|NCT03124381|155982907|FG001|Overall Study|Withdrawal by Subject|3|||
48488652|NCT03124381|155982906|FG000|Overall Study|Protocol Violation|0|||
48488653|NCT03124381|155982907|FG001|Overall Study|Protocol Violation|1|||
48488654|NCT03124381|155982906|FG000|Overall Study|Adverse Event|1|||
48488655|NCT03124381|155982907|FG001|Overall Study|Adverse Event|1|||
48488656|NCT03124381|155982906|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
48488657|NCT03124381|155982907|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
48488658|NCT01783730|155982919|FG000|Overall Study|Failed to meet inclusion criteria|6|||
48488659|NCT01841359|155982920|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
48488660|NCT01841359|155982920|FG000|Overall Study|Concommitant medical issues|2|||
48488661|NCT01841359|155982920|FG000|Overall Study|Adverse Event|3|||
48488662|NCT01841359|155982920|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
48488663|NCT02151461|155982924|FG000|Overall Study|Adverse Event|5|||
48488664|NCT02151461|155982925|FG001|Overall Study|Adverse Event|1|||
48488665|NCT02151461|155982926|FG002|Overall Study|Adverse Event|0|||
48488666|NCT02151461|155982927|FG003|Overall Study|Adverse Event|2|||
48488667|NCT02151461|155982924|FG000|Overall Study|Lost to Follow-up|0|||
48488668|NCT02151461|155982925|FG001|Overall Study|Lost to Follow-up|0|||
48488669|NCT02151461|155982926|FG002|Overall Study|Lost to Follow-up|1|||
48488670|NCT02151461|155982927|FG003|Overall Study|Lost to Follow-up|1|||
48488671|NCT02151461|155982924|FG000|Overall Study|Withdrawal by Subject|1|||
48488672|NCT02151461|155982925|FG001|Overall Study|Withdrawal by Subject|0|||
48488673|NCT02151461|155982926|FG002|Overall Study|Withdrawal by Subject|1|||
48488674|NCT02151461|155982927|FG003|Overall Study|Withdrawal by Subject|1|||
48593133|NCT02756819|156365710|FG000|Overall Study|Lost for observation|23|||
48593134|NCT02756819|156365710|FG000|Overall Study|Patient's unwillingness|16|||
48593135|NCT02756819|156365710|FG000|Overall Study|Insufficient efficacy|2|||
48593136|NCT02756819|156365710|FG000|Overall Study|Adverse Event|2|||
48593137|NCT02756819|156365710|FG000|Overall Study|Reason not Specified|9|||
48593138|NCT01090050|156365714|FG000|Overall Study|Lost to Follow-up|0|||
48593139|NCT01090050|156365715|FG001|Overall Study|Lost to Follow-up|1|||
48593140|NCT01090050|156365714|FG000|Overall Study|Lack of Efficacy|1|||
48593141|NCT01090050|156365715|FG001|Overall Study|Lack of Efficacy|5|||
48593142|NCT01090050|156365714|FG000|Overall Study|Physician Decision|0|||
48593143|NCT01090050|156365715|FG001|Overall Study|Physician Decision|1|||
48593144|NCT01491841|156365716|FG000|Overall Study|Screen Failure|10|||
48700501|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
48700502|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700503|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700504|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700505|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700506|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700507|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700508|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700509|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
48700510|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700511|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
48700512|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
48700513|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700514|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700515|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
48700516|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700517|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48593145|NCT01491841|156365716|FG000|Overall Study|Withdrawal by Subject|1|||
48593146|NCT02933528|156365717|FG000|Overall Study|Lost to Follow-up|2|||
48593147|NCT03539484|156365718|FG000|Overall Study|Death|1|||
48593148|NCT03539484|156365719|FG001|Overall Study|Death|0|||
48593149|NCT03539484|156365720|FG002|Overall Study|Death|0|||
48593150|NCT03539484|156365721|FG003|Overall Study|Death|2|||
48593151|NCT03539484|156365722|FG004|Overall Study|Death|8|||
48593152|NCT03539484|156365723|FG005|Overall Study|Death|3|||
48593153|NCT03539484|156365724|FG006|Overall Study|Death|0|||
48593154|NCT03539484|156365718|FG000|Overall Study|Lost to Follow-up|0|||
48593155|NCT03539484|156365719|FG001|Overall Study|Lost to Follow-up|1|||
48593156|NCT03539484|156365720|FG002|Overall Study|Lost to Follow-up|0|||
48593157|NCT03539484|156365721|FG003|Overall Study|Lost to Follow-up|0|||
48593158|NCT03539484|156365722|FG004|Overall Study|Lost to Follow-up|1|||
48593159|NCT03539484|156365723|FG005|Overall Study|Lost to Follow-up|0|||
48593160|NCT03539484|156365724|FG006|Overall Study|Lost to Follow-up|0|||
48593161|NCT03539484|156365718|FG000|Overall Study|Withdrawal by Subject|0|||
48593162|NCT03539484|156365719|FG001|Overall Study|Withdrawal by Subject|0|||
48593163|NCT03539484|156365720|FG002|Overall Study|Withdrawal by Subject|0|||
48593164|NCT03539484|156365721|FG003|Overall Study|Withdrawal by Subject|0|||
48593165|NCT03539484|156365722|FG004|Overall Study|Withdrawal by Subject|2|||
48593166|NCT03539484|156365723|FG005|Overall Study|Withdrawal by Subject|0|||
48593167|NCT03539484|156365724|FG006|Overall Study|Withdrawal by Subject|1|||
48593168|NCT03539484|156365718|FG000|Overall Study|Study Terminated by Sponsor|0|||
48593169|NCT03539484|156365719|FG001|Overall Study|Study Terminated by Sponsor|0|||
48593170|NCT03539484|156365720|FG002|Overall Study|Study Terminated by Sponsor|1|||
48593171|NCT03539484|156365721|FG003|Overall Study|Study Terminated by Sponsor|1|||
48593172|NCT03539484|156365722|FG004|Overall Study|Study Terminated by Sponsor|2|||
48593173|NCT03539484|156365723|FG005|Overall Study|Study Terminated by Sponsor|2|||
48593174|NCT03539484|156365724|FG006|Overall Study|Study Terminated by Sponsor|1|||
48593175|NCT00741598|156365725|FG000|Overall Study|Lost to Follow-up|3|||
48700518|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700519|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48799474|NCT04843930|157104206|FG003|Week 6 Assessment|Adverse Event|0|||
48593176|NCT00741598|156365726|FG001|Overall Study|Lost to Follow-up|4|||
48593177|NCT00741598|156365725|FG000|Overall Study|Lack of Efficacy|1|||
48593178|NCT00741598|156365726|FG001|Overall Study|Lack of Efficacy|2|||
48593179|NCT00741598|156365725|FG000|Overall Study|Physician Decision|1|||
48593180|NCT00741598|156365726|FG001|Overall Study|Physician Decision|1|||
48593181|NCT00741598|156365725|FG000|Overall Study|Pregnancy|1|||
48593182|NCT00741598|156365726|FG001|Overall Study|Pregnancy|0|||
48593183|NCT00741598|156365725|FG000|Overall Study|Withdrawal by Subject|3|||
48593184|NCT00741598|156365726|FG001|Overall Study|Withdrawal by Subject|2|||
48593185|NCT01301079|156365727|FG000|Overall Study|Lost to Follow-up|2|||
48593186|NCT01301079|156365728|FG001|Overall Study|Lost to Follow-up|2|||
48593187|NCT03297021|156365729|FG000|Overall Study|Incomplete/illegible data sheet|4|||
48593188|NCT03297021|156365730|FG001|Overall Study|Incomplete/illegible data sheet|2|||
48593189|NCT03297021|156365731|FG002|Overall Study|Incomplete/illegible data sheet|3|||
48593190|NCT03297021|156365729|FG000|Overall Study|Missing Post-Op Data|1|||
48593191|NCT03297021|156365730|FG001|Overall Study|Missing Post-Op Data|2|||
48593192|NCT03297021|156365731|FG002|Overall Study|Missing Post-Op Data|1|||
48593193|NCT02779075|156365732|FG000|Overall Study|Withdrawal by Subject|1|||
48700520|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700521|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700522|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700523|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
48700524|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700525|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
48700526|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700527|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700528|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48593194|NCT02779075|156365733|FG001|Overall Study|Withdrawal by Subject|3|||
48593195|NCT02779075|156365732|FG000|Overall Study|IV lost during 2nd study|1|||
48593196|NCT02779075|156365733|FG001|Overall Study|IV lost during 2nd study|0|||
48593197|NCT00482170|156365740|FG000|Overall Study|Adverse Event|5|||
48593198|NCT00482170|156365741|FG001|Overall Study|Adverse Event|14|||
48593199|NCT00482170|156365740|FG000|Overall Study|Withdrawal by Subject|6|||
48593200|NCT00482170|156365741|FG001|Overall Study|Withdrawal by Subject|1|||
48593201|NCT00482170|156365740|FG000|Overall Study|Protocol Violation|2|||
48593202|NCT00482170|156365741|FG001|Overall Study|Protocol Violation|3|||
48593203|NCT00482170|156365740|FG000|Overall Study|Lost to Follow-up|2|||
48593204|NCT00482170|156365741|FG001|Overall Study|Lost to Follow-up|0|||
48593205|NCT00482170|156365740|FG000|Overall Study|Unspecified reason|0|||
48593206|NCT00482170|156365741|FG001|Overall Study|Unspecified reason|2|||
48593207|NCT05446142|156365744|FG000|Period 2|Adverse Event|1|||
48593208|NCT05446142|156365745|FG001|Period 2|Adverse Event|0|||
48700529|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
48700530|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700531|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700532|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700533|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700534|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700535|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700536|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700537|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
48700538|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700539|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700540|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700541|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700542|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700543|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
48700544|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Transplant|0|||
48700545|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Transplant|0|||
48700546|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Transplant|0|||
48700547|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Transplant|0|||
48700548|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Transplant|0|||
48700549|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Transplant|0|||
48700550|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Transplant|0|||
48700551|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Transplant|0|||
48700552|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Transplant|0|||
48700553|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Transplant|4|||
48700554|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Transplant|2|||
48700555|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Transplant|0|||
48700556|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Transplant|0|||
48700557|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Transplant|0|||
48700558|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
48700559|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
48700560|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
48700561|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
48700562|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
48700563|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
48700564|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
48700565|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
48700566|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
48700567|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
48700568|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
48700569|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
48700570|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
48700571|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
48700572|NCT02113982|156753260|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
48700573|NCT02113982|156753261|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
48700574|NCT02113982|156753262|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
48700575|NCT02113982|156753263|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
48700576|NCT02113982|156753264|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
48700577|NCT02113982|156753265|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
48700578|NCT02113982|156753266|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
48700579|NCT02113982|156753267|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
48700580|NCT02113982|156753268|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
48700581|NCT02113982|156753269|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
48700582|NCT02113982|156753270|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
48593209|NCT05446142|156365746|FG002|Period 2|Adverse Event|0|||
48700583|NCT02113982|156753271|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
48700584|NCT02113982|156753272|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
48700585|NCT02113982|156753273|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
48593210|NCT05446142|156365747|FG003|Period 2|Adverse Event|0|||
48593211|NCT05446142|156365748|FG004|Period 2|Adverse Event|0|||
48593212|NCT05446142|156365749|FG005|Period 2|Adverse Event|0|||
48593213|NCT00627926|156365759|FG000|Overall Study|Adverse Event|26|||
48593214|NCT00627926|156365760|FG001|Overall Study|Adverse Event|37|||
48593215|NCT00627926|156365761|FG002|Overall Study|Adverse Event|36|||
48593216|NCT00627926|156365759|FG000|Overall Study|Death|1|||
48593217|NCT00627926|156365760|FG001|Overall Study|Death|0|||
48593218|NCT00627926|156365761|FG002|Overall Study|Death|0|||
48593219|NCT00627926|156365759|FG000|Overall Study|Lost to Follow-up|4|||
48593220|NCT00627926|156365760|FG001|Overall Study|Lost to Follow-up|3|||
48593221|NCT00627926|156365761|FG002|Overall Study|Lost to Follow-up|4|||
48593222|NCT00627926|156365759|FG000|Overall Study|Withdrawal by Subject|2|||
48593223|NCT00627926|156365760|FG001|Overall Study|Withdrawal by Subject|1|||
48593224|NCT00627926|156365761|FG002|Overall Study|Withdrawal by Subject|0|||
48593225|NCT00627926|156365759|FG000|Overall Study|Lack of Efficacy|118|||
48593226|NCT00627926|156365760|FG001|Overall Study|Lack of Efficacy|40|||
48593227|NCT00627926|156365761|FG002|Overall Study|Lack of Efficacy|38|||
48593228|NCT00627926|156365759|FG000|Overall Study|Noncompliance/unspecified|8|||
48593229|NCT00627926|156365760|FG001|Overall Study|Noncompliance/unspecified|23|||
48593230|NCT00627926|156365761|FG002|Overall Study|Noncompliance/unspecified|17|||
48593231|NCT02588092|156365762|FG000|Overall Study|Death|4|||
48593232|NCT02588092|156365763|FG001|Overall Study|Death|3|||
48593233|NCT02588092|156365764|FG002|Overall Study|Death|3|||
48593234|NCT02588092|156365765|FG003|Overall Study|Death|3|||
48593235|NCT02588092|156365766|FG004|Overall Study|Death|2|||
48593236|NCT02588092|156365767|FG005|Overall Study|Death|2|||
48593237|NCT02588092|156365768|FG006|Overall Study|Death|2|||
48593238|NCT02588092|156365769|FG007|Overall Study|Death|1|||
48593239|NCT02588092|156365770|FG008|Overall Study|Death|5|||
48593240|NCT02588092|156365771|FG009|Overall Study|Death|2|||
48593241|NCT02588092|156365762|FG000|Overall Study|Withdrawal by Subject|0|||
48593242|NCT02588092|156365763|FG001|Overall Study|Withdrawal by Subject|0|||
48593243|NCT02588092|156365764|FG002|Overall Study|Withdrawal by Subject|0|||
48593244|NCT02588092|156365765|FG003|Overall Study|Withdrawal by Subject|0|||
48593245|NCT02588092|156365766|FG004|Overall Study|Withdrawal by Subject|0|||
48593246|NCT02588092|156365767|FG005|Overall Study|Withdrawal by Subject|1|||
48593247|NCT02588092|156365768|FG006|Overall Study|Withdrawal by Subject|1|||
48593248|NCT02588092|156365769|FG007|Overall Study|Withdrawal by Subject|2|||
48593249|NCT02588092|156365770|FG008|Overall Study|Withdrawal by Subject|0|||
48593250|NCT02588092|156365771|FG009|Overall Study|Withdrawal by Subject|0|||
48593251|NCT02588092|156365762|FG000|Overall Study|Started Another Treatment|0|||
48593252|NCT02588092|156365763|FG001|Overall Study|Started Another Treatment|0|||
48593253|NCT02588092|156365764|FG002|Overall Study|Started Another Treatment|0|||
48593254|NCT02588092|156365765|FG003|Overall Study|Started Another Treatment|0|||
48593255|NCT02588092|156365766|FG004|Overall Study|Started Another Treatment|1|||
48593256|NCT02588092|156365767|FG005|Overall Study|Started Another Treatment|0|||
48593257|NCT02588092|156365768|FG006|Overall Study|Started Another Treatment|0|||
48593258|NCT02588092|156365769|FG007|Overall Study|Started Another Treatment|1|||
48593259|NCT02588092|156365770|FG008|Overall Study|Started Another Treatment|0|||
48593260|NCT02588092|156365771|FG009|Overall Study|Started Another Treatment|0|||
48593261|NCT02588092|156365762|FG000|Overall Study|Sponsor Decision|0|||
48593262|NCT02588092|156365763|FG001|Overall Study|Sponsor Decision|0|||
48700586|NCT02113982|156753260|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700587|NCT02113982|156753261|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700588|NCT02113982|156753262|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700589|NCT02113982|156753263|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700590|NCT02113982|156753264|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700591|NCT02113982|156753265|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700592|NCT02113982|156753266|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700593|NCT02113982|156753267|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700594|NCT02113982|156753268|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700595|NCT02113982|156753269|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700596|NCT02113982|156753270|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700597|NCT02113982|156753271|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
48700598|NCT02113982|156753272|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700599|NCT02113982|156753273|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
48700600|NCT02113982|156753260|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700601|NCT02113982|156753261|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700602|NCT02113982|156753262|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700603|NCT02113982|156753263|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700604|NCT02113982|156753264|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
48593263|NCT02588092|156365764|FG002|Overall Study|Sponsor Decision|0|||
48593264|NCT02588092|156365765|FG003|Overall Study|Sponsor Decision|0|||
48593265|NCT02588092|156365766|FG004|Overall Study|Sponsor Decision|0|||
48700605|NCT02113982|156753265|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700606|NCT02113982|156753266|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700607|NCT02113982|156753267|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700608|NCT02113982|156753268|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700609|NCT02113982|156753269|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700610|NCT02113982|156753270|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700611|NCT02113982|156753271|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
48700612|NCT02113982|156753272|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
48593266|NCT02588092|156365767|FG005|Overall Study|Sponsor Decision|0|||
48593267|NCT02588092|156365768|FG006|Overall Study|Sponsor Decision|0|||
48593268|NCT02588092|156365769|FG007|Overall Study|Sponsor Decision|0|||
48593269|NCT02588092|156365770|FG008|Overall Study|Sponsor Decision|1|||
48593270|NCT02588092|156365771|FG009|Overall Study|Sponsor Decision|1|||
48593271|NCT01386944|156365772|FG000|Overall Study|Adverse Event|26|||
48593272|NCT01386944|156365772|FG000|Overall Study|Lack of Efficacy|14|||
48593273|NCT01386944|156365772|FG000|Overall Study|Lost to Follow-up|8|||
48593274|NCT01386944|156365772|FG000|Overall Study|Unspecified reason|8|||
48593275|NCT01348100|156365773|FG000|Overall Study|Subject Withdrew Consent|0|||
48593276|NCT01348100|156365774|FG001|Overall Study|Subject Withdrew Consent|0|||
48593277|NCT01348100|156365775|FG002|Overall Study|Subject Withdrew Consent|2|||
48593278|NCT01348100|156365776|FG003|Overall Study|Subject Withdrew Consent|0|||
48593279|NCT01348100|156365777|FG004|Overall Study|Subject Withdrew Consent|1|||
48593280|NCT01348100|156365778|FG005|Overall Study|Subject Withdrew Consent|0|||
48593281|NCT01348100|156365779|FG006|Overall Study|Subject Withdrew Consent|1|||
48593282|NCT01348100|156365773|FG000|Overall Study|Protocol Deviation|0|||
48593283|NCT01348100|156365774|FG001|Overall Study|Protocol Deviation|0|||
48593284|NCT01348100|156365775|FG002|Overall Study|Protocol Deviation|0|||
48593285|NCT01348100|156365776|FG003|Overall Study|Protocol Deviation|1|||
48593286|NCT01348100|156365777|FG004|Overall Study|Protocol Deviation|0|||
48593287|NCT01348100|156365778|FG005|Overall Study|Protocol Deviation|0|||
48593288|NCT01348100|156365779|FG006|Overall Study|Protocol Deviation|0|||
48593289|NCT01348100|156365773|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48593290|NCT01348100|156365774|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48593291|NCT01348100|156365775|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48593292|NCT01348100|156365776|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48593293|NCT01348100|156365777|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48593294|NCT01348100|156365778|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
48593295|NCT01348100|156365779|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48593296|NCT01348100|156365773|FG000|Overall Study|Lost to Follow-up|0|||
48593297|NCT01348100|156365774|FG001|Overall Study|Lost to Follow-up|0|||
48593298|NCT01348100|156365775|FG002|Overall Study|Lost to Follow-up|0|||
48593299|NCT01348100|156365776|FG003|Overall Study|Lost to Follow-up|0|||
48593300|NCT01348100|156365777|FG004|Overall Study|Lost to Follow-up|0|||
48593301|NCT01348100|156365778|FG005|Overall Study|Lost to Follow-up|0|||
48593302|NCT01348100|156365779|FG006|Overall Study|Lost to Follow-up|1|||
48593303|NCT01348100|156365773|FG000|Overall Study|Administrative Problems|0|||
48700613|NCT02113982|156753273|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
48700614|NCT02113982|156753260|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700615|NCT02113982|156753261|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700616|NCT02113982|156753262|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700617|NCT02113982|156753263|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700618|NCT02113982|156753264|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700619|NCT02113982|156753265|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700620|NCT02113982|156753266|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700621|NCT02113982|156753267|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700622|NCT02113982|156753268|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700623|NCT02113982|156753269|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700624|NCT02113982|156753270|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700625|NCT02113982|156753271|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
48700626|NCT02113982|156753272|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700627|NCT02113982|156753273|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
48700628|NCT02113982|156753260|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
48700629|NCT02113982|156753261|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
48700630|NCT02113982|156753262|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
48700631|NCT02113982|156753263|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
48700632|NCT02113982|156753264|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
48700633|NCT02113982|156753265|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
48700634|NCT02113982|156753266|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
48593304|NCT01348100|156365774|FG001|Overall Study|Administrative Problems|0|||
48593305|NCT01348100|156365775|FG002|Overall Study|Administrative Problems|0|||
48593306|NCT01348100|156365776|FG003|Overall Study|Administrative Problems|0|||
48593307|NCT01348100|156365777|FG004|Overall Study|Administrative Problems|0|||
48593308|NCT01348100|156365778|FG005|Overall Study|Administrative Problems|1|||
48593309|NCT01348100|156365779|FG006|Overall Study|Administrative Problems|1|||
48593310|NCT01904032|156365797|FG000|Overall Study|Adverse Event|3|||
48593311|NCT01904032|156365798|FG001|Overall Study|Adverse Event|1|||
48593312|NCT01904032|156365797|FG000|Overall Study|Lost to Follow-up|4|||
48700635|NCT02113982|156753267|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
48700636|NCT02113982|156753268|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
48700637|NCT02113982|156753269|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
48700638|NCT02113982|156753270|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
48700639|NCT02113982|156753271|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
48700640|NCT02113982|156753272|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
48700641|NCT02113982|156753273|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
48700642|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700643|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700644|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700645|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700646|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700647|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48488675|NCT02151461|155982924|FG000|Overall Study|Treatment discontinuation|0|||
48488676|NCT02151461|155982925|FG001|Overall Study|Treatment discontinuation|0|||
48488677|NCT02151461|155982926|FG002|Overall Study|Treatment discontinuation|1|||
48488678|NCT02151461|155982927|FG003|Overall Study|Treatment discontinuation|0|||
48488679|NCT01254045|155982928|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
48488680|NCT01254045|155982929|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
48488681|NCT01254045|155982930|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
48488682|NCT01254045|155982931|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
48488683|NCT01254045|155982932|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
48488684|NCT01254045|155982933|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
48488685|NCT01086215|155982935|FG000|Overall Study|Death|14|||
48488686|NCT01086215|155982936|FG001|Overall Study|Death|8|||
48488687|NCT01086215|155982937|FG002|Overall Study|Death|8|||
48488688|NCT01086215|155982938|FG003|Overall Study|Death|1|||
48488689|NCT01086215|155982935|FG000|Overall Study|Lost to Follow-up|22|||
48488690|NCT01086215|155982936|FG001|Overall Study|Lost to Follow-up|39|||
48488691|NCT01086215|155982937|FG002|Overall Study|Lost to Follow-up|18|||
48488692|NCT01086215|155982938|FG003|Overall Study|Lost to Follow-up|2|||
48488693|NCT02826603|155982946|FG000|Overall Study|Adverse Event|17|||
48488694|NCT02826603|155982947|FG001|Overall Study|Adverse Event|9|||
48488695|NCT02826603|155982946|FG000|Overall Study|Lack of Efficacy|4|||
48488696|NCT02826603|155982947|FG001|Overall Study|Lack of Efficacy|9|||
48488697|NCT02826603|155982946|FG000|Overall Study|Lost to Follow-up|13|||
48488698|NCT02826603|155982947|FG001|Overall Study|Lost to Follow-up|12|||
48488699|NCT02826603|155982946|FG000|Overall Study|Noncompliance with treatment|0|||
48488700|NCT02826603|155982947|FG001|Overall Study|Noncompliance with treatment|2|||
48488701|NCT02826603|155982946|FG000|Overall Study|Physician Decision|1|||
48488702|NCT02826603|155982947|FG001|Overall Study|Physician Decision|7|||
48488703|NCT02826603|155982946|FG000|Overall Study|Pregnancy|1|||
48488704|NCT02826603|155982947|FG001|Overall Study|Pregnancy|2|||
48488705|NCT02826603|155982946|FG000|Overall Study|Protocol Violation|3|||
48488706|NCT02826603|155982947|FG001|Overall Study|Protocol Violation|3|||
48488707|NCT02826603|155982946|FG000|Overall Study|Withdrawal by Subject|20|||
48488708|NCT02826603|155982947|FG001|Overall Study|Withdrawal by Subject|19|||
48488709|NCT02826603|155982946|FG000|Overall Study|Death|2|||
48488710|NCT02826603|155982947|FG001|Overall Study|Death|0|||
48488711|NCT02826603|155982946|FG000|Overall Study|New therapy for study indication|0|||
48488712|NCT02826603|155982947|FG001|Overall Study|New therapy for study indication|1|||
48488713|NCT00003102|155982950|FG000|Overall Study|Physician Decision|1|||
48488714|NCT00003102|155982951|FG001|Overall Study|Physician Decision|1|||
48488715|NCT00003102|155982952|FG002|Overall Study|Physician Decision|0|||
48488716|NCT00003102|155982950|FG000|Overall Study|Progressive Disease|0|||
48488717|NCT00003102|155982951|FG001|Overall Study|Progressive Disease|1|||
48488718|NCT00003102|155982952|FG002|Overall Study|Progressive Disease|0|||
48488719|NCT00003102|155982950|FG000|Overall Study|Adverse Event|0|||
48488720|NCT00003102|155982951|FG001|Overall Study|Adverse Event|1|||
48488721|NCT00003102|155982952|FG002|Overall Study|Adverse Event|1|||
48488722|NCT00003102|155982950|FG000|Overall Study|Death|0|||
48488723|NCT00003102|155982951|FG001|Overall Study|Death|0|||
48488724|NCT00003102|155982952|FG002|Overall Study|Death|1|||
48488725|NCT02139306|155982957|FG000|Overall Study|Withdrawal by Subject|4|||
48488726|NCT02139306|155982958|FG001|Overall Study|Withdrawal by Subject|6|||
48488727|NCT02139306|155982957|FG000|Overall Study|Adverse Event|3|||
48488728|NCT02139306|155982958|FG001|Overall Study|Adverse Event|4|||
48488729|NCT02139306|155982957|FG000|Overall Study|Physician Decision|0|||
48488730|NCT02139306|155982958|FG001|Overall Study|Physician Decision|1|||
48488731|NCT02139306|155982957|FG000|Overall Study|Other Unspecified|2|||
48488732|NCT02139306|155982958|FG001|Overall Study|Other Unspecified|3|||
48488733|NCT02139306|155982957|FG000|Overall Study|Protocol Violation|4|||
48488734|NCT02139306|155982958|FG001|Overall Study|Protocol Violation|0|||
48488735|NCT01606137|155983001|FG000|Overall Study|Adverse Event|85|||
48488736|NCT01606137|155983001|FG000|Overall Study|Withdrawal by Subject|74|||
48488737|NCT01606137|155983001|FG000|Overall Study|Lack of Efficacy|56|||
48488738|NCT01606137|155983001|FG000|Overall Study|Lost to Follow-up|15|||
48488739|NCT01606137|155983001|FG000|Overall Study|Protocol Violation|1|||
48593313|NCT01904032|156365798|FG001|Overall Study|Lost to Follow-up|2|||
48593314|NCT01808222|156365804|FG000|Overall Study|mpMR scan was not performed|1|||
48593315|NCT01398358|156365807|FG000|Overall Study|Lost to Follow-up|11|||
48488740|NCT01606137|155983001|FG000|Overall Study|Patient non-compliance|9|||
48593316|NCT01398358|156365808|FG001|Overall Study|Lost to Follow-up|21|||
48488741|NCT01606137|155983001|FG000|Overall Study|Death|1|||
48488742|NCT01606137|155983001|FG000|Overall Study|Decreased/no pain|4|||
48488743|NCT01606137|155983001|FG000|Overall Study|Issues with driving|4|||
48593317|NCT01398358|156365809|FG002|Overall Study|Lost to Follow-up|18|||
48593318|NCT01398358|156365807|FG000|Overall Study|Withdrawal by Subject|3|||
48593319|NCT01398358|156365808|FG001|Overall Study|Withdrawal by Subject|2|||
48593320|NCT01398358|156365809|FG002|Overall Study|Withdrawal by Subject|2|||
48593321|NCT01398358|156365807|FG000|Overall Study|no longer eligible|1|||
48593322|NCT01398358|156365808|FG001|Overall Study|no longer eligible|0|||
48593323|NCT01398358|156365809|FG002|Overall Study|no longer eligible|1|||
48593324|NCT02819440|156365817|FG000|Overall Study|Adverse Event|3|||
48593325|NCT02819440|156365818|FG001|Overall Study|Adverse Event|1|||
48488744|NCT01606137|155983001|FG000|Overall Study|multiple sclerosis less stable|1|||
48593326|NCT02819440|156365817|FG000|Overall Study|Lost to Follow-up|1|||
48593327|NCT02819440|156365818|FG001|Overall Study|Lost to Follow-up|3|||
48700648|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48488745|NCT01606137|155983001|FG000|Overall Study|Increased bilirubin|1|||
48488746|NCT01606137|155983001|FG000|Overall Study|Spray causes nausea|1|||
48488747|NCT01606137|155983001|FG000|Overall Study|Not enough improvement|4|||
48488748|NCT01606137|155983001|FG000|Overall Study|Wanted to try another treatment|1|||
48488749|NCT01606137|155983001|FG000|Overall Study|Patient leaving country|1|||
48488750|NCT01606137|155983001|FG000|Overall Study|Personal reasons|1|||
48488751|NCT01606137|155983001|FG000|Overall Study|Unable to tolerate study med. taste|1|||
48488752|NCT01606137|155983001|FG000|Overall Study|Patient moving|1|||
48488753|NCT01606137|155983001|FG000|Overall Study|Unable to collect consistent data|1|||
48488754|NCT03862625|155985158|FG000|Overall Study|Lost to Follow-up|0|||
48488755|NCT03862625|155985159|FG001|Overall Study|Lost to Follow-up|1|||
48488756|NCT03769181|155985164|FG000|Overall Study|Adverse Event|1|||
48488757|NCT03769181|155985165|FG001|Overall Study|Adverse Event|0|||
48488758|NCT03769181|155985166|FG002|Overall Study|Adverse Event|2|||
48488759|NCT03769181|155985167|FG003|Overall Study|Adverse Event|4|||
48593328|NCT02819440|156365817|FG000|Overall Study|Withdrawal by Subject|9|||
48593329|NCT02819440|156365818|FG001|Overall Study|Withdrawal by Subject|8|||
48700649|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700650|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700651|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700652|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700653|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700654|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
48700655|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
48700656|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700657|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700658|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700659|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700660|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700661|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700662|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700663|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700664|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700665|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700666|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700667|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
48700668|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
48700669|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
48700670|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700671|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700672|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700673|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700674|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700675|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700676|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700677|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700678|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700679|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700680|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48488760|NCT03769181|155985164|FG000|Overall Study|Withdrawal by Subject|1|||
48488761|NCT03769181|155985165|FG001|Overall Study|Withdrawal by Subject|0|||
48488762|NCT03769181|155985166|FG002|Overall Study|Withdrawal by Subject|2|||
48488763|NCT03769181|155985167|FG003|Overall Study|Withdrawal by Subject|1|||
48488764|NCT03769181|155985164|FG000|Overall Study|Progressive disease|9|||
48488765|NCT03769181|155985165|FG001|Overall Study|Progressive disease|7|||
48488766|NCT03769181|155985166|FG002|Overall Study|Progressive disease|13|||
48700681|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
48700682|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
48700683|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
48700684|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700685|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700686|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700687|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700688|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700689|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700690|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700691|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700692|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700693|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700694|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700695|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
48700696|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
48700697|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
48700698|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700699|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700700|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700701|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700702|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700703|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700704|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700705|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700706|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700707|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700708|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700709|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700710|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
48700711|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
48700712|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700713|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48488767|NCT03769181|155985167|FG003|Overall Study|Progressive disease|6|||
48488768|NCT03769181|155985164|FG000|Overall Study|Other - Unspecified|2|||
48488769|NCT03769181|155985165|FG001|Overall Study|Other - Unspecified|1|||
48488770|NCT03769181|155985166|FG002|Overall Study|Other - Unspecified|0|||
48488771|NCT03769181|155985167|FG003|Overall Study|Other - Unspecified|0|||
48488772|NCT04378010|155985168|FG000|Overall Study|Adverse Event|8|||
48488773|NCT04378010|155985169|FG001|Overall Study|Adverse Event|14|||
48488774|NCT04378010|155985170|FG002|Overall Study|Adverse Event|4|||
48488775|NCT04378010|155985168|FG000|Overall Study|Withdrawal by Subject|0|||
48488776|NCT04378010|155985169|FG001|Overall Study|Withdrawal by Subject|2|||
48488777|NCT04378010|155985170|FG002|Overall Study|Withdrawal by Subject|1|||
48488778|NCT04378010|155985168|FG000|Overall Study|Protocol Violation|2|||
48488779|NCT04378010|155985169|FG001|Overall Study|Protocol Violation|1|||
48488780|NCT04378010|155985170|FG002|Overall Study|Protocol Violation|4|||
48488781|NCT04378010|155985168|FG000|Overall Study|Study terminated by Sponsor|22|||
48488782|NCT04378010|155985169|FG001|Overall Study|Study terminated by Sponsor|16|||
48488783|NCT04378010|155985170|FG002|Overall Study|Study terminated by Sponsor|22|||
48488784|NCT04378010|155985168|FG000|Overall Study|Subject inability to complete study visit|0|||
48488785|NCT04378010|155985169|FG001|Overall Study|Subject inability to complete study visit|0|||
48488786|NCT04378010|155985170|FG002|Overall Study|Subject inability to complete study visit|1|||
48488787|NCT04378010|155985168|FG000|Overall Study|Subject never dosed|0|||
48488788|NCT04378010|155985169|FG001|Overall Study|Subject never dosed|1|||
48488789|NCT04378010|155985170|FG002|Overall Study|Subject never dosed|0|||
48488790|NCT01792284|155985171|FG000|Lead-in Period|Adverse Event|15|||
48488791|NCT01792284|155985172|FG001|Lead-in Period|Adverse Event|0|||
48488792|NCT01792284|155985173|FG002|Lead-in Period|Adverse Event|0|||
48488793|NCT01792284|155985171|FG000|Lead-in Period|Lost to Follow-up|2|||
48488794|NCT01792284|155985172|FG001|Lead-in Period|Lost to Follow-up|0|||
48700714|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700715|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700716|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700717|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700718|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700719|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700720|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700721|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700722|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700723|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700724|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
48700725|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
48700726|NCT02113982|156753260|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700727|NCT02113982|156753261|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700728|NCT02113982|156753262|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700729|NCT02113982|156753263|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700730|NCT02113982|156753264|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700731|NCT02113982|156753265|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700732|NCT02113982|156753266|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700733|NCT02113982|156753267|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700734|NCT02113982|156753268|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700735|NCT02113982|156753269|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700736|NCT02113982|156753270|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700737|NCT02113982|156753271|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700738|NCT02113982|156753272|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
48700739|NCT02113982|156753273|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
48700740|NCT02220920|156753274|FG000|Overall Study|Adverse Event|1|||
48700741|NCT02220920|156753275|FG001|Overall Study|Adverse Event|0|||
48700742|NCT02220920|156753274|FG000|Overall Study|Lack of Efficacy|0|||
48700743|NCT02220920|156753275|FG001|Overall Study|Lack of Efficacy|1|||
48700744|NCT02220920|156753274|FG000|Overall Study|Withdrawal by Subject|1|||
48700745|NCT02220920|156753275|FG001|Overall Study|Withdrawal by Subject|0|||
48700746|NCT02220920|156753274|FG000|Overall Study|Conflict with the stopping criteria|1|||
48700747|NCT02220920|156753275|FG001|Overall Study|Conflict with the stopping criteria|2|||
48700748|NCT03198715|156753276|FG000|Overall Study|Death|0|||
48700749|NCT03198715|156753277|FG001|Overall Study|Death|0|||
48700750|NCT03198715|156753278|FG002|Overall Study|Death|1|||
48700751|NCT03198715|156753279|FG003|Overall Study|Death|0|||
48700752|NCT03198715|156753280|FG004|Overall Study|Death|2|||
48488795|NCT01792284|155985173|FG002|Lead-in Period|Lost to Follow-up|0|||
48488796|NCT01792284|155985171|FG000|Lead-in Period|Protocol Violation|1|||
48488797|NCT01792284|155985172|FG001|Lead-in Period|Protocol Violation|0|||
48488798|NCT01792284|155985173|FG002|Lead-in Period|Protocol Violation|0|||
48488799|NCT01792284|155985171|FG000|Lead-in Period|Withdrawal by Subject|10|||
48488800|NCT01792284|155985172|FG001|Lead-in Period|Withdrawal by Subject|0|||
48488801|NCT01792284|155985173|FG002|Lead-in Period|Withdrawal by Subject|0|||
48488802|NCT01792284|155985171|FG000|Lead-in Period|Physician Decision|1|||
48488803|NCT01792284|155985172|FG001|Lead-in Period|Physician Decision|0|||
48488804|NCT01792284|155985173|FG002|Lead-in Period|Physician Decision|0|||
48488805|NCT01792284|155985171|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
48488806|NCT01792284|155985172|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
48488807|NCT01792284|155985173|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
48488808|NCT01792284|155985171|FG000|Randomization Period 1|Withdrawal by Subject|0|||
48488809|NCT01792284|155985172|FG001|Randomization Period 1|Withdrawal by Subject|1|||
48488810|NCT01792284|155985173|FG002|Randomization Period 1|Withdrawal by Subject|1|||
48488811|NCT01792284|155985171|FG000|Randomization Period 1|Physician Decision|0|||
48488812|NCT01792284|155985172|FG001|Randomization Period 1|Physician Decision|1|||
48488813|NCT01792284|155985173|FG002|Randomization Period 1|Physician Decision|1|||
48488814|NCT01792284|155985171|FG000|Randomization Period 1|Adverse Event|0|||
48593330|NCT02168777|156367660|FG000|Overall Study|Withdrawal by Subject|1|||
48593331|NCT02168777|156367661|FG001|Overall Study|Withdrawal by Subject|0|||
48593332|NCT02168777|156367662|FG002|Overall Study|Withdrawal by Subject|2|||
48593333|NCT02168777|156367660|FG000|Overall Study|Adverse Event|1|||
48700753|NCT03198715|156753276|FG000|Overall Study|Other|0|||
48700754|NCT03198715|156753277|FG001|Overall Study|Other|1|||
48700755|NCT03198715|156753278|FG002|Overall Study|Other|1|||
48700756|NCT03198715|156753279|FG003|Overall Study|Other|0|||
48700757|NCT03198715|156753280|FG004|Overall Study|Other|0|||
48488815|NCT01792284|155985172|FG001|Randomization Period 1|Adverse Event|0|||
48488816|NCT01792284|155985173|FG002|Randomization Period 1|Adverse Event|2|||
48488817|NCT01792284|155985171|FG000|Randomization Period 1|Lost to Follow-up|0|||
48488818|NCT01792284|155985172|FG001|Randomization Period 1|Lost to Follow-up|0|||
48593334|NCT02168777|156367661|FG001|Overall Study|Adverse Event|0|||
48593335|NCT02168777|156367662|FG002|Overall Study|Adverse Event|1|||
48593336|NCT02168777|156367660|FG000|Overall Study|Disease recurrence|0|||
48488819|NCT01792284|155985173|FG002|Randomization Period 1|Lost to Follow-up|1|||
48488820|NCT01792284|155985171|FG000|Randomization Period 2|Protocol Violation|0|||
48593337|NCT02168777|156367661|FG001|Overall Study|Disease recurrence|0|||
48593338|NCT02168777|156367662|FG002|Overall Study|Disease recurrence|1|||
48593339|NCT02168777|156367660|FG000|Overall Study|Radiological disease progression|0|||
48593340|NCT02168777|156367661|FG001|Overall Study|Radiological disease progression|5|||
48593341|NCT02168777|156367662|FG002|Overall Study|Radiological disease progression|5|||
48700758|NCT00853307|156753281|FG000|Overall Study|Adverse Event|1|||
48700759|NCT00853307|156753282|FG001|Overall Study|Adverse Event|2|||
48700760|NCT00853307|156753281|FG000|Overall Study|Withdrawal by Subject|1|||
48488821|NCT01792284|155985172|FG001|Randomization Period 2|Protocol Violation|1|||
48700761|NCT00853307|156753282|FG001|Overall Study|Withdrawal by Subject|2|||
48700762|NCT00853307|156753281|FG000|Overall Study|Reason Not Specified|0|||
48700763|NCT00853307|156753282|FG001|Overall Study|Reason Not Specified|1|||
48700764|NCT00286468|156753283|FG000|Overall Study|Hyperglycemic Rescue|28|||
48700765|NCT00286468|156753284|FG001|Overall Study|Hyperglycemic Rescue|30|||
48700766|NCT00286468|156753285|FG002|Overall Study|Hyperglycemic Rescue|31|||
48700767|NCT00286468|156753283|FG000|Overall Study|Adverse Event|2|||
48700768|NCT00286468|156753284|FG001|Overall Study|Adverse Event|6|||
48700769|NCT00286468|156753285|FG002|Overall Study|Adverse Event|4|||
48700770|NCT00286468|156753283|FG000|Overall Study|Protocol Violation|0|||
48700771|NCT00286468|156753284|FG001|Overall Study|Protocol Violation|3|||
48700772|NCT00286468|156753285|FG002|Overall Study|Protocol Violation|1|||
48700773|NCT00286468|156753283|FG000|Overall Study|Lost to Follow-up|1|||
48700774|NCT00286468|156753284|FG001|Overall Study|Lost to Follow-up|1|||
48700775|NCT00286468|156753285|FG002|Overall Study|Lost to Follow-up|2|||
48700776|NCT00286468|156753283|FG000|Overall Study|Withdrawal by Subject|3|||
48700777|NCT00286468|156753284|FG001|Overall Study|Withdrawal by Subject|8|||
48700778|NCT00286468|156753285|FG002|Overall Study|Withdrawal by Subject|11|||
48700779|NCT00286468|156753283|FG000|Overall Study|Physician Decision|3|||
48700780|NCT00286468|156753284|FG001|Overall Study|Physician Decision|2|||
48700781|NCT00286468|156753285|FG002|Overall Study|Physician Decision|1|||
48700782|NCT00129402|156753307|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
48700783|NCT00129402|156753308|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
48700784|NCT00129402|156753309|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
48488822|NCT01792284|155985173|FG002|Randomization Period 2|Protocol Violation|0|||
48488823|NCT01792284|155985171|FG000|Randomization Period 2|Withdrawal by Subject|0|||
48488824|NCT01792284|155985172|FG001|Randomization Period 2|Withdrawal by Subject|2|||
48488825|NCT01792284|155985173|FG002|Randomization Period 2|Withdrawal by Subject|0|||
48488826|NCT04023994|155985175|FG000|Overall Study|Lost to Follow-up|0|||
48488827|NCT04023994|155985176|FG001|Overall Study|Lost to Follow-up|1|||
48488828|NCT04023994|155985177|FG002|Overall Study|Lost to Follow-up|2|||
48488829|NCT04023994|155985178|FG003|Overall Study|Lost to Follow-up|0|||
48488830|NCT04023994|155985179|FG004|Overall Study|Lost to Follow-up|0|||
48488831|NCT04023994|155985180|FG005|Overall Study|Lost to Follow-up|0|||
48488832|NCT04023994|155985175|FG000|Overall Study|Withdrawal by Subject|0|||
48700785|NCT00129402|156753310|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
48700786|NCT00129402|156753311|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
48700787|NCT00129402|156753312|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
48700788|NCT00129402|156753313|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
48700789|NCT00129402|156753307|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700790|NCT00129402|156753308|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700791|NCT00129402|156753309|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700792|NCT00129402|156753310|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700793|NCT00129402|156753311|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700794|NCT00129402|156753312|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
48700795|NCT00129402|156753313|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
48700796|NCT00129402|156753307|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700797|NCT00129402|156753308|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700798|NCT00129402|156753309|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700799|NCT00129402|156753310|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
48700800|NCT00129402|156753311|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700801|NCT00129402|156753312|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700802|NCT00129402|156753313|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
48700803|NCT00129402|156753307|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700804|NCT00129402|156753308|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700805|NCT00129402|156753309|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
48488833|NCT04023994|155985176|FG001|Overall Study|Withdrawal by Subject|0|||
48700806|NCT00129402|156753310|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700807|NCT00129402|156753311|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
48700808|NCT00129402|156753312|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700809|NCT00129402|156753313|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
48700810|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700811|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700812|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
48700813|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700814|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700815|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700816|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
48700817|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700818|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700819|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
48700820|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700821|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700822|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
48700823|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
48700824|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700825|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700826|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
48700827|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700828|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700829|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700830|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
48700831|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700832|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700833|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
48700834|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700835|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700836|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
48700837|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
48700838|NCT00129402|156753307|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48488834|NCT04023994|155985177|FG002|Overall Study|Withdrawal by Subject|0|||
48488835|NCT04023994|155985178|FG003|Overall Study|Withdrawal by Subject|1|||
48488836|NCT04023994|155985179|FG004|Overall Study|Withdrawal by Subject|0|||
48488837|NCT04023994|155985180|FG005|Overall Study|Withdrawal by Subject|0|||
48488838|NCT00923195|155985186|FG000|Overall Study|Death|0|||
48488839|NCT00923195|155985187|FG001|Overall Study|Death|1|||
48488840|NCT00525031|155985188|FG000|Overall Study|Disease Progression|1|||
48488841|NCT00525031|155985189|FG001|Overall Study|Disease Progression|1|||
48488842|NCT02323295|155985194|FG000|Overall Study|Adverse Event|0|||
48488843|NCT02323295|155985195|FG001|Overall Study|Adverse Event|1|||
48488844|NCT02323295|155985194|FG000|Overall Study|Withdrawal by Subject|0|||
48488845|NCT02323295|155985195|FG001|Overall Study|Withdrawal by Subject|1|||
48488846|NCT02323295|155985194|FG000|Overall Study|Patient did not have surgery as planned.|0|||
48488847|NCT02323295|155985195|FG001|Overall Study|Patient did not have surgery as planned.|1|||
48488848|NCT01847313|155985198|FG000|Overall Study|Death|0|||
48488849|NCT01847313|155985199|FG001|Overall Study|Death|1|||
48488850|NCT01847313|155985198|FG000|Overall Study|Withdrawal by Subject|0|||
48488851|NCT01847313|155985199|FG001|Overall Study|Withdrawal by Subject|1|||
48488852|NCT02370784|155985200|FG000|Overall Study|Patient started prohibited medication|0|||
48488853|NCT02370784|155985201|FG001|Overall Study|Patient started prohibited medication|1|||
48488854|NCT02140164|155985204|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
48488855|NCT01377233|155985205|FG000|Open-label|Adverse Event|1|||
48488856|NCT01377233|155985206|FG001|Open-label|Adverse Event|0|||
48488857|NCT01377233|155985207|FG002|Open-label|Adverse Event|0|||
48488858|NCT01377233|155985208|FG003|Open-label|Adverse Event|0|||
48700839|NCT00129402|156753308|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48700840|NCT00129402|156753309|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
48700841|NCT00129402|156753310|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48700842|NCT00129402|156753311|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48488859|NCT01377233|155985209|FG004|Open-label|Adverse Event|0|||
48488860|NCT01377233|155985205|FG000|Open-label|Withdrawal by Subject|3|||
48488861|NCT01377233|155985206|FG001|Open-label|Withdrawal by Subject|0|||
48488862|NCT01377233|155985207|FG002|Open-label|Withdrawal by Subject|0|||
48488863|NCT01377233|155985208|FG003|Open-label|Withdrawal by Subject|0|||
48488864|NCT01377233|155985209|FG004|Open-label|Withdrawal by Subject|0|||
48488865|NCT01377233|155985205|FG000|Double-blind|Adverse Event|0|||
48488866|NCT01377233|155985206|FG001|Double-blind|Adverse Event|1|||
48488867|NCT01377233|155985207|FG002|Double-blind|Adverse Event|2|||
48488868|NCT01377233|155985208|FG003|Double-blind|Adverse Event|2|||
48700843|NCT00129402|156753312|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
48700844|NCT00129402|156753313|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
48700845|NCT00129402|156753307|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48700846|NCT00129402|156753308|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48488869|NCT01377233|155985209|FG004|Double-blind|Adverse Event|0|||
48700847|NCT00129402|156753309|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48488870|NCT01377233|155985205|FG000|Double-blind|Protocol Violation|0|||
48488871|NCT01377233|155985206|FG001|Double-blind|Protocol Violation|0|||
48700848|NCT00129402|156753310|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48700849|NCT00129402|156753311|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48700850|NCT00129402|156753312|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
48700851|NCT00129402|156753313|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
48700852|NCT00129402|156753307|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700853|NCT00129402|156753308|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700854|NCT00129402|156753309|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700855|NCT00129402|156753310|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700856|NCT00129402|156753311|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700857|NCT00129402|156753312|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
48700858|NCT00129402|156753313|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
48700859|NCT00129402|156753307|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700860|NCT00129402|156753308|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700861|NCT00129402|156753309|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700862|NCT00129402|156753310|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700863|NCT00129402|156753311|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48700864|NCT00129402|156753312|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
48488872|NCT01377233|155985207|FG002|Double-blind|Protocol Violation|0|||
48488873|NCT01377233|155985208|FG003|Double-blind|Protocol Violation|0|||
48488874|NCT01377233|155985209|FG004|Double-blind|Protocol Violation|1|||
48488875|NCT01377233|155985205|FG000|Double-blind|Withdrawal by Subject|0|||
48488876|NCT01377233|155985206|FG001|Double-blind|Withdrawal by Subject|0|||
48488877|NCT01377233|155985207|FG002|Double-blind|Withdrawal by Subject|0|||
48488878|NCT01377233|155985208|FG003|Double-blind|Withdrawal by Subject|1|||
48488879|NCT01377233|155985209|FG004|Double-blind|Withdrawal by Subject|0|||
48488880|NCT01377233|155985205|FG000|Double-blind|Administrative or other|0|||
48488881|NCT01377233|155985206|FG001|Double-blind|Administrative or other|0|||
48488882|NCT01377233|155985207|FG002|Double-blind|Administrative or other|0|||
48488883|NCT01377233|155985208|FG003|Double-blind|Administrative or other|1|||
48488884|NCT01377233|155985209|FG004|Double-blind|Administrative or other|1|||
48488885|NCT00417027|155985212|FG000|Overall Study|Protocol Violation|0|||
48488886|NCT00417027|155985213|FG001|Overall Study|Protocol Violation|5|||
48488887|NCT00417027|155985214|FG002|Overall Study|Protocol Violation|5|||
48488888|NCT03137082|155985215|FG000|Overall Study|Withdrawal by Subject|1|||
48488889|NCT03137082|155985216|FG001|Overall Study|Withdrawal by Subject|1|||
48488890|NCT03137082|155985215|FG000|Overall Study|Lost to Follow-up|1|||
48488891|NCT03137082|155985216|FG001|Overall Study|Lost to Follow-up|0|||
48488892|NCT01155063|155985217|FG000|Overall Study|Adverse Event|1|||
48488893|NCT01155063|155985217|FG000|Overall Study|Withdrawal by Subject|1|||
48488894|NCT01155063|155985217|FG000|Overall Study|Study terminated by sponsor|87|||
48488895|NCT01314703|155985218|FG000|Overall Study|screen failure and closed enrollment|8|||
48488896|NCT00461500|155985219|FG000|Overall Study|Adverse Event|1|||
48488897|NCT00461500|155985220|FG001|Overall Study|Adverse Event|0|||
48488898|NCT00461500|155985219|FG000|Overall Study|Lack of Efficacy|0|||
48488899|NCT00461500|155985220|FG001|Overall Study|Lack of Efficacy|1|||
48488900|NCT00461500|155985219|FG000|Overall Study|Expired Drug Treatment|1|||
48488901|NCT00461500|155985220|FG001|Overall Study|Expired Drug Treatment|1|||
48488902|NCT00461500|155985219|FG000|Overall Study|Study Stopped|1|||
48488903|NCT00461500|155985220|FG001|Overall Study|Study Stopped|2|||
48488904|NCT00461500|155985219|FG000|Overall Study|Drug Treatment Misuse|1|||
48488905|NCT00461500|155985220|FG001|Overall Study|Drug Treatment Misuse|0|||
48488906|NCT00461500|155985219|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
48488907|NCT00461500|155985220|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
48488908|NCT00461500|155985219|FG000|Overall Study|Lost to Follow-up|2|||
48488909|NCT00461500|155985220|FG001|Overall Study|Lost to Follow-up|2|||
48488910|NCT03412019|155985221|FG000|Overall Study|Withdrawal by Subject|1|||
48488911|NCT03412019|155985222|FG001|Overall Study|Withdrawal by Subject|1|||
48488912|NCT00415532|155985235|FG000|Treatment Period|Adverse Event|2|||
48488913|NCT00415532|155985236|FG001|Treatment Period|Adverse Event|3|||
48488914|NCT00415532|155985235|FG000|Treatment Period|Death|2|||
48488915|NCT00415532|155985236|FG001|Treatment Period|Death|1|||
48488916|NCT00415532|155985235|FG000|Treatment Period|Lost to Follow-up|1|||
48488917|NCT00415532|155985236|FG001|Treatment Period|Lost to Follow-up|1|||
48488918|NCT00415532|155985235|FG000|Treatment Period|Protocol Violation|1|||
48488919|NCT00415532|155985236|FG001|Treatment Period|Protocol Violation|0|||
48488920|NCT00415532|155985235|FG000|Treatment Period|Withdrawal by Subject|6|||
48488921|NCT00415532|155985236|FG001|Treatment Period|Withdrawal by Subject|6|||
48488922|NCT00415532|155985235|FG000|Treatment Period|Other|2|||
48488923|NCT00415532|155985236|FG001|Treatment Period|Other|2|||
48488924|NCT00415532|155985235|FG000|Treatment Period|Ineligibility determined|1|||
48488925|NCT00415532|155985236|FG001|Treatment Period|Ineligibility determined|1|||
48488926|NCT00415532|155985235|FG000|Treatment Period|Noncompliance|1|||
48488927|NCT00415532|155985236|FG001|Treatment Period|Noncompliance|1|||
48488928|NCT00415532|155985235|FG000|Treatment Period|Requirement for alternative therapy|1|||
48488929|NCT00415532|155985236|FG001|Treatment Period|Requirement for alternative therapy|0|||
48488930|NCT00415532|155985235|FG000|Safety Follow Up Period|Adverse Event|1|||
48488931|NCT00415532|155985236|FG001|Safety Follow Up Period|Adverse Event|3|||
48488932|NCT00415532|155985235|FG000|Safety Follow Up Period|Death|3|||
48488933|NCT00415532|155985236|FG001|Safety Follow Up Period|Death|0|||
48488934|NCT00415532|155985235|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
48488935|NCT00415532|155985236|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
48488936|NCT00415532|155985235|FG000|Safety Follow Up Period|Other|1|||
48488937|NCT00415532|155985236|FG001|Safety Follow Up Period|Other|4|||
48488938|NCT00415532|155985235|FG000|Safety Follow Up Period|Ineligibility determined|1|||
48488939|NCT00415532|155985236|FG001|Safety Follow Up Period|Ineligibility determined|1|||
48488940|NCT00415532|155985235|FG000|Safety Follow Up Period|Noncompliance|1|||
48488941|NCT00415532|155985236|FG001|Safety Follow Up Period|Noncompliance|0|||
48488942|NCT00415532|155985235|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
48488943|NCT00415532|155985236|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
48488944|NCT00770315|155985237|FG000|Overall Study|Adverse Event|11|||
48488945|NCT00770315|155985238|FG001|Overall Study|Adverse Event|17|||
48488946|NCT00770315|155985239|FG002|Overall Study|Adverse Event|16|||
48488947|NCT00770315|155985240|FG003|Overall Study|Adverse Event|6|||
48488948|NCT00770315|155985237|FG000|Overall Study|Lost to Follow-up|9|||
48488949|NCT00770315|155985238|FG001|Overall Study|Lost to Follow-up|5|||
48488950|NCT00770315|155985239|FG002|Overall Study|Lost to Follow-up|10|||
48488951|NCT00770315|155985240|FG003|Overall Study|Lost to Follow-up|3|||
48488952|NCT00770315|155985237|FG000|Overall Study|Withdrawal by Subject|13|||
48488953|NCT00770315|155985238|FG001|Overall Study|Withdrawal by Subject|17|||
48488954|NCT00770315|155985239|FG002|Overall Study|Withdrawal by Subject|24|||
48488955|NCT00770315|155985240|FG003|Overall Study|Withdrawal by Subject|20|||
48488956|NCT00770315|155985237|FG000|Overall Study|Noncompliance with Protocol|7|||
48488957|NCT00770315|155985238|FG001|Overall Study|Noncompliance with Protocol|4|||
48488958|NCT00770315|155985239|FG002|Overall Study|Noncompliance with Protocol|7|||
48488959|NCT00770315|155985240|FG003|Overall Study|Noncompliance with Protocol|9|||
48593342|NCT02168777|156367660|FG000|Overall Study|Clinical disease progression|0|||
48593343|NCT02168777|156367661|FG001|Overall Study|Clinical disease progression|1|||
48593344|NCT02168777|156367662|FG002|Overall Study|Clinical disease progression|2|||
48593345|NCT02168777|156367660|FG000|Overall Study|Other reason|0|||
48593346|NCT02168777|156367661|FG001|Overall Study|Other reason|1|||
48593347|NCT02168777|156367662|FG002|Overall Study|Other reason|0|||
48593348|NCT00314808|156367665|FG000|Overall Study|Disease Progression without AE|4|||
48593349|NCT00314808|156367665|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
48593350|NCT01698268|156367666|FG000|Overall Study|Physician Decision|2|||
48593351|NCT01698268|156367667|FG001|Overall Study|Physician Decision|1|||
48593352|NCT01709409|156367672|FG000|Overall Study|Protocol Violation|1|||
48700865|NCT00129402|156753313|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
48700866|NCT00129402|156753307|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700867|NCT00129402|156753308|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700868|NCT00129402|156753309|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700869|NCT00129402|156753310|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700870|NCT00129402|156753311|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700871|NCT00129402|156753312|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
48700872|NCT00129402|156753313|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
48700873|NCT03331315|156753314|FG000|Overall Study|Physician Decision|18|||
48700874|NCT03331315|156753315|FG001|Overall Study|Physician Decision|14|||
48700875|NCT01709721|156753316|FG000|Open Label Phase|Withdrawal by Subject|0|||
48488960|NCT00437281|155985241|FG000|Overall Study|Adverse Event|0|||
48488961|NCT00437281|155985242|FG001|Overall Study|Adverse Event|0|||
48488962|NCT00437281|155985243|FG002|Overall Study|Adverse Event|0|||
48488963|NCT00437281|155985244|FG003|Overall Study|Adverse Event|1|||
48488964|NCT00437281|155985245|FG004|Overall Study|Adverse Event|0|||
48488965|NCT00437281|155985246|FG005|Overall Study|Adverse Event|1|||
48593353|NCT01709409|156367673|FG001|Overall Study|Protocol Violation|0|||
48700876|NCT01709721|156753317|FG001|Open Label Phase|Withdrawal by Subject|0|||
48700877|NCT01709721|156753318|FG002|Open Label Phase|Withdrawal by Subject|5|||
48700878|NCT01709721|156753316|FG000|Open Label Phase|Adverse Event|0|||
48700879|NCT01709721|156753317|FG001|Open Label Phase|Adverse Event|0|||
48700880|NCT01709721|156753318|FG002|Open Label Phase|Adverse Event|8|||
48593354|NCT04676152|156367677|FG000|Overall Study|screen fail|9|||
48700881|NCT01709721|156753316|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
48700882|NCT01709721|156753317|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
48700883|NCT01709721|156753318|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
48700884|NCT01709721|156753316|FG000|Open Label Phase|Investigator Decision|0|||
48700885|NCT01709721|156753317|FG001|Open Label Phase|Investigator Decision|0|||
48700886|NCT01709721|156753318|FG002|Open Label Phase|Investigator Decision|1|||
48700887|NCT01709721|156753316|FG000|Open Label Phase|Sponsor Decision|0|||
48700888|NCT01709721|156753317|FG001|Open Label Phase|Sponsor Decision|0|||
48700889|NCT01709721|156753318|FG002|Open Label Phase|Sponsor Decision|2|||
48488966|NCT00437281|155985247|FG006|Overall Study|Adverse Event|0|||
48488967|NCT00437281|155985248|FG007|Overall Study|Adverse Event|0|||
48593355|NCT00759655|156367684|FG000|Overall Study|Termination of the study by sponsor|1|||
48593356|NCT03300050|156367703|FG000|Overall Study|Lost to Follow-up|2|||
48488968|NCT00437281|155985249|FG008|Overall Study|Adverse Event|0|||
48488969|NCT00437281|155985250|FG009|Overall Study|Adverse Event|1|||
48488970|NCT00437281|155985251|FG010|Overall Study|Adverse Event|0|||
48488971|NCT00437281|155985252|FG011|Overall Study|Adverse Event|0|||
48488972|NCT00437281|155985253|FG012|Overall Study|Adverse Event|0|||
48488973|NCT00437281|155985254|FG013|Overall Study|Adverse Event|1|||
48488974|NCT00437281|155985255|FG014|Overall Study|Adverse Event|1|||
48488975|NCT00437281|155985256|FG015|Overall Study|Adverse Event|0|||
48700890|NCT01709721|156753316|FG000|Open Label Phase|Protocol Violation|0|||
48488976|NCT00437281|155985257|FG016|Overall Study|Adverse Event|0|||
48488977|NCT00437281|155985258|FG017|Overall Study|Adverse Event|0|||
48488978|NCT00437281|155985259|FG018|Overall Study|Adverse Event|1|||
48488979|NCT00437281|155985260|FG019|Overall Study|Adverse Event|0|||
48593357|NCT03300050|156367704|FG001|Overall Study|Lost to Follow-up|1|||
48593358|NCT03300050|156367705|FG002|Overall Study|Lost to Follow-up|0|||
48593359|NCT03300050|156367706|FG003|Overall Study|Lost to Follow-up|0|||
48593360|NCT03300050|156367707|FG004|Overall Study|Lost to Follow-up|1|||
48593361|NCT03300050|156367703|FG000|Overall Study|Withdrawal by Subject|1|||
48593362|NCT03300050|156367704|FG001|Overall Study|Withdrawal by Subject|1|||
48593363|NCT03300050|156367705|FG002|Overall Study|Withdrawal by Subject|1|||
48593364|NCT03300050|156367706|FG003|Overall Study|Withdrawal by Subject|0|||
48593365|NCT03300050|156367707|FG004|Overall Study|Withdrawal by Subject|0|||
48593366|NCT03300050|156367703|FG000|Overall Study|Death|0|||
48700891|NCT01709721|156753317|FG001|Open Label Phase|Protocol Violation|0|||
48700892|NCT01709721|156753318|FG002|Open Label Phase|Protocol Violation|1|||
48488980|NCT00437281|155985241|FG000|Overall Study|Lost to Follow-up|0|||
48488981|NCT00437281|155985242|FG001|Overall Study|Lost to Follow-up|0|||
48488982|NCT00437281|155985243|FG002|Overall Study|Lost to Follow-up|0|||
48488983|NCT00437281|155985244|FG003|Overall Study|Lost to Follow-up|0|||
48488984|NCT00437281|155985245|FG004|Overall Study|Lost to Follow-up|0|||
48488985|NCT00437281|155985246|FG005|Overall Study|Lost to Follow-up|0|||
48488986|NCT00437281|155985247|FG006|Overall Study|Lost to Follow-up|0|||
48488987|NCT00437281|155985248|FG007|Overall Study|Lost to Follow-up|0|||
48488988|NCT00437281|155985249|FG008|Overall Study|Lost to Follow-up|0|||
48488989|NCT00437281|155985250|FG009|Overall Study|Lost to Follow-up|0|||
48488990|NCT00437281|155985251|FG010|Overall Study|Lost to Follow-up|0|||
48488991|NCT00437281|155985252|FG011|Overall Study|Lost to Follow-up|0|||
48488992|NCT00437281|155985253|FG012|Overall Study|Lost to Follow-up|0|||
48488993|NCT00437281|155985254|FG013|Overall Study|Lost to Follow-up|0|||
48488994|NCT00437281|155985255|FG014|Overall Study|Lost to Follow-up|0|||
48488995|NCT00437281|155985256|FG015|Overall Study|Lost to Follow-up|0|||
48488996|NCT00437281|155985257|FG016|Overall Study|Lost to Follow-up|0|||
48488997|NCT00437281|155985258|FG017|Overall Study|Lost to Follow-up|0|||
48488998|NCT00437281|155985259|FG018|Overall Study|Lost to Follow-up|0|||
48488999|NCT00437281|155985260|FG019|Overall Study|Lost to Follow-up|1|||
48593367|NCT03300050|156367704|FG001|Overall Study|Death|0|||
48593368|NCT03300050|156367705|FG002|Overall Study|Death|1|||
48489000|NCT05476679|155985261|FG000|Overall Study|Withdrawal by Subject|0|||
48489001|NCT05476679|155985262|FG001|Overall Study|Withdrawal by Subject|0|||
48593369|NCT03300050|156367706|FG003|Overall Study|Death|0|||
48593370|NCT03300050|156367707|FG004|Overall Study|Death|0|||
48700893|NCT01709721|156753316|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
48489002|NCT05476679|155985263|FG002|Overall Study|Withdrawal by Subject|0|||
48489003|NCT05476679|155985264|FG003|Overall Study|Withdrawal by Subject|1|||
48489004|NCT05476679|155985265|FG004|Overall Study|Withdrawal by Subject|0|||
48489005|NCT05476679|155985261|FG000|Overall Study|Lost to Follow-up|0|||
48489006|NCT05476679|155985262|FG001|Overall Study|Lost to Follow-up|0|||
48489007|NCT05476679|155985263|FG002|Overall Study|Lost to Follow-up|0|||
48489008|NCT05476679|155985264|FG003|Overall Study|Lost to Follow-up|1|||
48593371|NCT03300050|156367703|FG000|Overall Study|Not Eligible at Randomization|0|||
48489009|NCT05476679|155985265|FG004|Overall Study|Lost to Follow-up|0|||
48489010|NCT02110706|155985266|FG000|Overall Study|Adverse Event|2|||
48489011|NCT02110706|155985267|FG001|Overall Study|Adverse Event|3|||
48489012|NCT02110706|155985266|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
48489013|NCT02110706|155985267|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
48489014|NCT02533999|155985268|FG000|Overall Study|Lost to Follow-up|3|||
48489015|NCT02533999|155985269|FG001|Overall Study|Lost to Follow-up|5|||
48489016|NCT02533999|155985268|FG000|Overall Study|Protocol Violation|3|||
48489017|NCT02533999|155985269|FG001|Overall Study|Protocol Violation|0|||
48489018|NCT02533999|155985268|FG000|Overall Study|Adverse Event|0|||
48489019|NCT02533999|155985269|FG001|Overall Study|Adverse Event|1|||
48700894|NCT01709721|156753317|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
48700895|NCT01709721|156753318|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
48700896|NCT01709721|156753316|FG000|Open Label Phase|Inadequate Pain Control|0|||
48700897|NCT01709721|156753317|FG001|Open Label Phase|Inadequate Pain Control|0|||
48700898|NCT01709721|156753318|FG002|Open Label Phase|Inadequate Pain Control|37|||
48700899|NCT01709721|156753316|FG000|Open Label Phase|Other, Specify in text field in database|0|||
48700900|NCT01709721|156753317|FG001|Open Label Phase|Other, Specify in text field in database|0|||
48700901|NCT01709721|156753318|FG002|Open Label Phase|Other, Specify in text field in database|14|||
48700902|NCT01709721|156753316|FG000|Randomized Phase|Adverse Event|0|||
48700903|NCT01709721|156753317|FG001|Randomized Phase|Adverse Event|1|||
48700904|NCT01709721|156753318|FG002|Randomized Phase|Adverse Event|0|||
48700905|NCT01709721|156753316|FG000|Randomized Phase|Lost to Follow-up|1|||
48700906|NCT01709721|156753317|FG001|Randomized Phase|Lost to Follow-up|0|||
48700907|NCT01709721|156753318|FG002|Randomized Phase|Lost to Follow-up|0|||
48700908|NCT01709721|156753316|FG000|Randomized Phase|Inadequate Pain Control|1|||
48700909|NCT01709721|156753317|FG001|Randomized Phase|Inadequate Pain Control|2|||
48700910|NCT01709721|156753318|FG002|Randomized Phase|Inadequate Pain Control|0|||
48700911|NCT01709721|156753316|FG000|Randomized Phase|Other, Specify text field in database|1|||
48700912|NCT01709721|156753317|FG001|Randomized Phase|Other, Specify text field in database|3|||
48700913|NCT01709721|156753318|FG002|Randomized Phase|Other, Specify text field in database|0|||
48700914|NCT00656513|156753321|FG000|Overall Study|Protocol Violation|1|||
48700915|NCT00656513|156753322|FG001|Overall Study|Protocol Violation|0|||
48700916|NCT00656513|156753323|FG002|Overall Study|Protocol Violation|2|||
48700917|NCT00656513|156753321|FG000|Overall Study|Withdrawal by Subject|0|||
48700918|NCT00656513|156753322|FG001|Overall Study|Withdrawal by Subject|11|||
48700919|NCT00656513|156753323|FG002|Overall Study|Withdrawal by Subject|4|||
48700920|NCT00656513|156753321|FG000|Overall Study|Death|0|||
48700921|NCT00656513|156753322|FG001|Overall Study|Death|0|||
48700922|NCT00656513|156753323|FG002|Overall Study|Death|1|||
48700923|NCT00656513|156753321|FG000|Overall Study|Missing data|0|||
48700924|NCT00656513|156753322|FG001|Overall Study|Missing data|11|||
48700925|NCT00656513|156753323|FG002|Overall Study|Missing data|9|||
48700926|NCT00656513|156753321|FG000|Overall Study|Incomplete treatment|3|||
48700927|NCT00656513|156753322|FG001|Overall Study|Incomplete treatment|0|||
48700928|NCT00656513|156753323|FG002|Overall Study|Incomplete treatment|0|||
48700929|NCT00656513|156753321|FG000|Overall Study|Treatment completed outside of timeframe|0|||
48700930|NCT00656513|156753322|FG001|Overall Study|Treatment completed outside of timeframe|3|||
48700931|NCT00656513|156753323|FG002|Overall Study|Treatment completed outside of timeframe|1|||
48700932|NCT00656513|156753321|FG000|Overall Study|Missing baseline form|0|||
48700933|NCT00656513|156753322|FG001|Overall Study|Missing baseline form|5|||
48700934|NCT00656513|156753323|FG002|Overall Study|Missing baseline form|5|||
48700935|NCT03044106|156753324|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
48700936|NCT03044106|156753325|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
48700937|NCT01748292|156753326|FG000|Overall Study|Adverse Event|2|||
48700938|NCT01748292|156753327|FG001|Overall Study|Adverse Event|4|||
48700939|NCT01748292|156753326|FG000|Overall Study|Lost to Follow-up|0|||
48700940|NCT01748292|156753327|FG001|Overall Study|Lost to Follow-up|3|||
48700941|NCT01748292|156753326|FG000|Overall Study|Death|0|||
48700942|NCT01748292|156753327|FG001|Overall Study|Death|3|||
48700943|NCT01748292|156753326|FG000|Overall Study|Withdrawal by Subject|0|||
48700944|NCT01748292|156753327|FG001|Overall Study|Withdrawal by Subject|2|||
48700945|NCT01527370|156753328|FG000|Overall Study|Withdrawal by Subject|4|||
48700946|NCT01527370|156753328|FG000|Overall Study|Physician Decision|1|||
48700947|NCT01527370|156753328|FG000|Overall Study|Death|1|||
48700948|NCT05058365|156753331|FG000|Overall Study|Migration|1|||
48700949|NCT05058365|156753332|FG001|Overall Study|Migration|1|||
48700950|NCT02340026|156753333|FG000|Treatment Phase|Withdrawal by Subject|2|||
48700951|NCT02340026|156753334|FG001|Treatment Phase|Withdrawal by Subject|2|||
48700952|NCT02340026|156753333|FG000|Follow-up Phase|Lost to Follow-up|1|||
48700953|NCT02340026|156753334|FG001|Follow-up Phase|Lost to Follow-up|0|||
48700954|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
48700955|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
48700956|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
48489020|NCT02533999|155985268|FG000|Overall Study|Randomized but intervention not received|0|||
48489021|NCT02533999|155985269|FG001|Overall Study|Randomized but intervention not received|1|||
48489022|NCT03210259|155985270|FG000|12-Week Run-in Period|Adverse Event|1|||
48489023|NCT03210259|155985271|FG001|12-Week Run-in Period|Adverse Event|0|||
48489024|NCT03210259|155985272|FG002|12-Week Run-in Period|Adverse Event|0|||
48489025|NCT03210259|155985270|FG000|12-Week Run-in Period|Death|1|||
48489026|NCT03210259|155985271|FG001|12-Week Run-in Period|Death|0|||
48593372|NCT03300050|156367704|FG001|Overall Study|Not Eligible at Randomization|0|||
48593373|NCT03300050|156367705|FG002|Overall Study|Not Eligible at Randomization|1|||
48593374|NCT03300050|156367706|FG003|Overall Study|Not Eligible at Randomization|1|||
48593375|NCT03300050|156367707|FG004|Overall Study|Not Eligible at Randomization|0|||
48593376|NCT02849171|156367708|FG000|Overall Study|Withdrawal by Subject|1|||
48593377|NCT02849171|156367708|FG000|Overall Study|Not treated|1|||
48593378|NCT02372383|156367709|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
48593379|NCT02372383|156367710|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
48593380|NCT02372383|156367711|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
48593381|NCT02769312|156367712|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
48593382|NCT02769312|156367713|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
48593383|NCT02769312|156367712|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
48489027|NCT03210259|155985272|FG002|12-Week Run-in Period|Death|0|||
48489028|NCT03210259|155985270|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
48489029|NCT03210259|155985271|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
48593384|NCT02769312|156367713|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
48593385|NCT02769312|156367712|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
48593386|NCT02769312|156367713|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
48593387|NCT02769312|156367712|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
48593388|NCT02769312|156367713|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
48593389|NCT02769312|156367712|FG000|Follow-up|Lost to Follow-up|1|||
48593390|NCT02769312|156367713|FG001|Follow-up|Lost to Follow-up|1|||
48593391|NCT02065518|156367735|FG000|Overall Study|Lost to Follow-up|3|||
48593392|NCT02065518|156367736|FG001|Overall Study|Lost to Follow-up|4|||
48593393|NCT02065518|156367737|FG002|Overall Study|Lost to Follow-up|0|||
48593394|NCT02065518|156367738|FG003|Overall Study|Lost to Follow-up|3|||
48593395|NCT02065518|156367735|FG000|Overall Study|Withdrawal by Subject|3|||
48593396|NCT02065518|156367736|FG001|Overall Study|Withdrawal by Subject|4|||
48593397|NCT02065518|156367737|FG002|Overall Study|Withdrawal by Subject|9|||
48593398|NCT02065518|156367738|FG003|Overall Study|Withdrawal by Subject|2|||
48593399|NCT00660595|156367739|FG000|Overall Study|Lost to Follow-up|0|||
48593400|NCT00660595|156367740|FG001|Overall Study|Lost to Follow-up|1|||
48593401|NCT00660595|156367739|FG000|Overall Study|Did not consent to participate in study|12|||
48593402|NCT00660595|156367740|FG001|Overall Study|Did not consent to participate in study|8|||
48593403|NCT00660595|156367739|FG000|Overall Study|Participant left hospital|1|||
48593404|NCT00660595|156367740|FG001|Overall Study|Participant left hospital|0|||
48593405|NCT00660595|156367739|FG000|Overall Study|Non Specified reasons|5|||
48593406|NCT00660595|156367740|FG001|Overall Study|Non Specified reasons|0|||
48593407|NCT04446429|156367742|FG000|Overall Study|Lost to Follow-up|6|||
48593408|NCT04446429|156367743|FG001|Overall Study|Lost to Follow-up|0|||
48593409|NCT02187861|156367746|FG000|Overall Study|Adverse Event|2|||
48593410|NCT02187861|156367747|FG001|Overall Study|Adverse Event|1|||
48593411|NCT02187861|156367748|FG002|Overall Study|Adverse Event|2|||
48593412|NCT02187861|156367749|FG003|Overall Study|Adverse Event|1|||
48593413|NCT02187861|156367746|FG000|Overall Study|Death|0|||
48593414|NCT02187861|156367747|FG001|Overall Study|Death|3|||
48593415|NCT02187861|156367748|FG002|Overall Study|Death|1|||
48700957|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
48700958|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
48700959|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
48700960|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
48700961|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48700962|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48700963|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
48700964|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48700965|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48700966|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
48700967|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
48700968|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
48700969|NCT01436149|156753337|FG000|Antidepressant Lead-in Phase|Other|119|||
48700970|NCT01436149|156753338|FG001|Antidepressant Lead-in Phase|Other|0|||
48593416|NCT02187861|156367749|FG003|Overall Study|Death|2|||
48593417|NCT02187861|156367746|FG000|Overall Study|Physician Decision|0|||
48593418|NCT02187861|156367747|FG001|Overall Study|Physician Decision|1|||
48489030|NCT03210259|155985272|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
48593419|NCT02187861|156367748|FG002|Overall Study|Physician Decision|0|||
48593420|NCT02187861|156367749|FG003|Overall Study|Physician Decision|3|||
48593421|NCT02187861|156367746|FG000|Overall Study|Progressive Disease|4|||
48593422|NCT02187861|156367747|FG001|Overall Study|Progressive Disease|42|||
48593423|NCT02187861|156367748|FG002|Overall Study|Progressive Disease|19|||
48593424|NCT02187861|156367749|FG003|Overall Study|Progressive Disease|22|||
48593425|NCT02187861|156367746|FG000|Overall Study|Withdrawal by Subject|0|||
48593426|NCT02187861|156367747|FG001|Overall Study|Withdrawal by Subject|0|||
48593427|NCT02187861|156367748|FG002|Overall Study|Withdrawal by Subject|3|||
48593428|NCT02187861|156367749|FG003|Overall Study|Withdrawal by Subject|3|||
48593429|NCT02187861|156367746|FG000|Overall Study|Other|0|||
48593430|NCT02187861|156367747|FG001|Overall Study|Other|1|||
48593431|NCT02187861|156367748|FG002|Overall Study|Other|7|||
48593432|NCT02187861|156367749|FG003|Overall Study|Other|1|||
48593433|NCT00313586|156367752|FG000|Overall Study|Disease progression|14|||
48593434|NCT00313586|156367753|FG001|Overall Study|Disease progression|19|||
48593435|NCT00313586|156367754|FG002|Overall Study|Disease progression|10|||
48593436|NCT00313586|156367755|FG003|Overall Study|Disease progression|3|||
48593437|NCT00313586|156367752|FG000|Overall Study|Adverse Event|12|||
48593438|NCT00313586|156367753|FG001|Overall Study|Adverse Event|18|||
48593439|NCT00313586|156367754|FG002|Overall Study|Adverse Event|3|||
48593440|NCT00313586|156367755|FG003|Overall Study|Adverse Event|10|||
48593441|NCT00313586|156367752|FG000|Overall Study|Death|11|||
48593442|NCT00313586|156367753|FG001|Overall Study|Death|8|||
48593443|NCT00313586|156367754|FG002|Overall Study|Death|1|||
48593444|NCT00313586|156367755|FG003|Overall Study|Death|7|||
48593445|NCT00313586|156367752|FG000|Overall Study|Withdrawal by Subject|13|||
48593446|NCT00313586|156367753|FG001|Overall Study|Withdrawal by Subject|6|||
48593447|NCT00313586|156367754|FG002|Overall Study|Withdrawal by Subject|6|||
48593448|NCT00313586|156367755|FG003|Overall Study|Withdrawal by Subject|2|||
48593449|NCT00313586|156367752|FG000|Overall Study|Alternative therapy|3|||
48593450|NCT00313586|156367753|FG001|Overall Study|Alternative therapy|6|||
48593451|NCT00313586|156367754|FG002|Overall Study|Alternative therapy|2|||
48593452|NCT00313586|156367755|FG003|Overall Study|Alternative therapy|0|||
48593453|NCT00313586|156367752|FG000|Overall Study|Other complicating disease|2|||
48593454|NCT00313586|156367753|FG001|Overall Study|Other complicating disease|2|||
48593455|NCT00313586|156367754|FG002|Overall Study|Other complicating disease|0|||
48593456|NCT00313586|156367755|FG003|Overall Study|Other complicating disease|0|||
48593457|NCT00313586|156367752|FG000|Overall Study|Did not achieve HI-major/better response|10|||
48593458|NCT00313586|156367753|FG001|Overall Study|Did not achieve HI-major/better response|7|||
48593459|NCT00313586|156367754|FG002|Overall Study|Did not achieve HI-major/better response|2|||
48593460|NCT00313586|156367755|FG003|Overall Study|Did not achieve HI-major/better response|1|||
48593461|NCT00313586|156367752|FG000|Overall Study|Physician Decision|2|||
48593462|NCT00313586|156367753|FG001|Overall Study|Physician Decision|1|||
48593463|NCT00313586|156367754|FG002|Overall Study|Physician Decision|0|||
48593464|NCT00313586|156367755|FG003|Overall Study|Physician Decision|0|||
48593465|NCT00313586|156367752|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
48593466|NCT00313586|156367753|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
48593467|NCT00313586|156367754|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
48593468|NCT00313586|156367755|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
48593469|NCT00313586|156367752|FG000|Overall Study|Lost insurance|0|||
48593470|NCT00313586|156367753|FG001|Overall Study|Lost insurance|1|||
48593471|NCT00313586|156367754|FG002|Overall Study|Lost insurance|0|||
48593472|NCT00313586|156367755|FG003|Overall Study|Lost insurance|0|||
48593473|NCT00313586|156367752|FG000|Overall Study|Moved|0|||
48593474|NCT00313586|156367753|FG001|Overall Study|Moved|1|||
48593475|NCT00313586|156367754|FG002|Overall Study|Moved|0|||
48593476|NCT00313586|156367755|FG003|Overall Study|Moved|0|||
48489031|NCT03210259|155985270|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
48489032|NCT03210259|155985271|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
48489033|NCT03210259|155985272|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
48489034|NCT03210259|155985270|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
48489035|NCT03210259|155985271|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
48489036|NCT03210259|155985272|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
48489037|NCT03210259|155985270|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
48489038|NCT03210259|155985271|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
48489039|NCT03210259|155985272|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
48593477|NCT00313586|156367752|FG000|Overall Study|Death before starting treatment|1|||
48593478|NCT00313586|156367753|FG001|Overall Study|Death before starting treatment|0|||
48593479|NCT00313586|156367754|FG002|Overall Study|Death before starting treatment|0|||
48593480|NCT00313586|156367755|FG003|Overall Study|Death before starting treatment|0|||
48593481|NCT00264290|156367756|FG000|Intervention (8 Weeks)|Adverse Event|1|||
48489040|NCT03210259|155985270|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
48489041|NCT03210259|155985271|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
48489042|NCT03210259|155985272|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
48489043|NCT03210259|155985270|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
48593482|NCT00264290|156367757|FG001|Intervention (8 Weeks)|Adverse Event|0|||
48593483|NCT04472494|156367758|FG000|Pre-treatment|Other reasons|2|||
48593484|NCT04472494|156367759|FG001|Pre-treatment|Other reasons|0|||
48593485|NCT04472494|156367758|FG000|Treatment|Death|5|||
48593486|NCT04472494|156367759|FG001|Treatment|Death|2|||
48593487|NCT04472494|156367758|FG000|Treatment|Hospital discharge|1|||
48593488|NCT04472494|156367759|FG001|Treatment|Hospital discharge|1|||
48593489|NCT00948922|156367763|FG000|Overall Study|Did not start study treatment|2|||
48593490|NCT00948922|156367764|FG001|Overall Study|Did not start study treatment|5|||
48593491|NCT00948922|156367765|FG002|Overall Study|Did not start study treatment|0|||
48593492|NCT00948922|156367763|FG000|Overall Study|Withdrawal by Subject|0|||
48593493|NCT00948922|156367764|FG001|Overall Study|Withdrawal by Subject|2|||
48593494|NCT00948922|156367765|FG002|Overall Study|Withdrawal by Subject|1|||
48593495|NCT00948922|156367763|FG000|Overall Study|Death|3|||
48593496|NCT00948922|156367764|FG001|Overall Study|Death|0|||
48593497|NCT00948922|156367765|FG002|Overall Study|Death|0|||
48593498|NCT00948922|156367763|FG000|Overall Study|Disease progression|0|||
48593499|NCT00948922|156367764|FG001|Overall Study|Disease progression|1|||
48593500|NCT00948922|156367765|FG002|Overall Study|Disease progression|0|||
48593501|NCT00948922|156367763|FG000|Overall Study|Insurance issues|1|||
48593502|NCT00948922|156367764|FG001|Overall Study|Insurance issues|0|||
48593503|NCT00948922|156367765|FG002|Overall Study|Insurance issues|0|||
48593504|NCT00948922|156367763|FG000|Overall Study|Transplant eligibility issues|2|||
48593505|NCT00948922|156367764|FG001|Overall Study|Transplant eligibility issues|3|||
48593506|NCT00948922|156367765|FG002|Overall Study|Transplant eligibility issues|0|||
48593507|NCT00948922|156367763|FG000|Overall Study|Not evaluable at time of analysis|0|||
48593508|NCT00948922|156367764|FG001|Overall Study|Not evaluable at time of analysis|3|||
48593509|NCT00948922|156367765|FG002|Overall Study|Not evaluable at time of analysis|0|||
48593510|NCT02784288|156367766|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
48593511|NCT03334188|156367767|FG000|Overall Study|Withdrawal by Subject|0|||
48593512|NCT03334188|156367768|FG001|Overall Study|Withdrawal by Subject|1|||
48593513|NCT03334188|156367767|FG000|Overall Study|Death|1|||
48593514|NCT03334188|156367768|FG001|Overall Study|Death|0|||
48593515|NCT03334188|156367767|FG000|Overall Study|Never had qualifying clinic visit|7|||
48593516|NCT03334188|156367768|FG001|Overall Study|Never had qualifying clinic visit|7|||
48593517|NCT00645671|156367769|FG000|Overall Study|Protocol Violation|1|||
48593518|NCT00645671|156367770|FG001|Overall Study|Protocol Violation|0|||
48593519|NCT00645671|156367769|FG000|Overall Study|Withdrawal by Subject|0|||
48593520|NCT00645671|156367770|FG001|Overall Study|Withdrawal by Subject|4|||
48593521|NCT00645671|156367769|FG000|Overall Study|Adverse Event|0|||
48593522|NCT00645671|156367770|FG001|Overall Study|Adverse Event|1|||
48489044|NCT03210259|155985271|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
48489045|NCT03210259|155985272|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
48489046|NCT03210259|155985270|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
48489047|NCT03210259|155985271|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
48489048|NCT03210259|155985272|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
48489049|NCT03210259|155985270|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
48489050|NCT03210259|155985271|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
48489051|NCT03210259|155985272|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
48489052|NCT03210259|155985270|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
48489053|NCT03210259|155985271|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
48489054|NCT03210259|155985272|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
48489055|NCT02087059|155985273|FG000|Overall Study|Disease Progression|1|||
48489056|NCT02087059|155985273|FG000|Overall Study|Adverse Event|5|||
48489057|NCT02087059|155985273|FG000|Overall Study|Lost to Follow-up|1|||
48489058|NCT00597207|155985274|FG000|Overall Study|Lost to Follow-up|5|||
48489059|NCT00597207|155985275|FG001|Overall Study|Lost to Follow-up|7|||
48489060|NCT00252187|155985278|FG000|Overall Study|Adverse Event|3|||
48489061|NCT00252187|155985279|FG001|Overall Study|Adverse Event|1|||
48489062|NCT00252187|155985278|FG000|Overall Study|Withdrawal by Subject|1|||
48489063|NCT00252187|155985279|FG001|Overall Study|Withdrawal by Subject|0|||
48489064|NCT04896385|155985280|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
48489065|NCT04896385|155985281|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
48489066|NCT04896385|155985282|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
48489067|NCT04896385|155985283|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
48489068|NCT04896385|155985280|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
48489069|NCT04896385|155985281|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
48593523|NCT00645671|156367769|FG000|Overall Study|Physician Decision|0|||
48593524|NCT00645671|156367770|FG001|Overall Study|Physician Decision|1|||
48593525|NCT05114564|156367772|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
48489070|NCT04896385|155985282|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
48489071|NCT04896385|155985283|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
48489072|NCT04896385|155985280|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
48489073|NCT04896385|155985281|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
48593526|NCT05114564|156367773|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
48593527|NCT05114564|156367772|FG000|First Intervention|Adverse Event|0|||
48593528|NCT05114564|156367773|FG001|First Intervention|Adverse Event|1|||
48593529|NCT03117361|156367774|FG000|Overall Study|Progressive disease|5|||
48593530|NCT03117361|156367774|FG000|Overall Study|Death|1|||
48593531|NCT03117361|156367774|FG000|Overall Study|Physician Decision|2|||
48593532|NCT03117361|156367774|FG000|Overall Study|On study treatment at the end of study|1|||
48593533|NCT03117361|156367774|FG000|Overall Study|Treatment-related adverse event|1|||
48593534|NCT00790556|156367775|FG000|Treatment Period 1|Physician Decision|1|||
48593535|NCT00790556|156367776|FG001|Treatment Period 1|Physician Decision|0|||
48593536|NCT00790556|156367775|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48593537|NCT00790556|156367776|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48593538|NCT02020889|156367779|FG000|Overall Study|Adverse Event|0|||
48593539|NCT02020889|156367780|FG001|Overall Study|Adverse Event|1|||
48593540|NCT02020889|156367779|FG000|Overall Study|Lack of Efficacy|1|||
48593541|NCT02020889|156367780|FG001|Overall Study|Lack of Efficacy|0|||
48593542|NCT02020889|156367779|FG000|Overall Study|Lost to Follow-up|1|||
48593543|NCT02020889|156367780|FG001|Overall Study|Lost to Follow-up|0|||
48593544|NCT02020889|156367779|FG000|Overall Study|Physician Decision|2|||
48593545|NCT02020889|156367780|FG001|Overall Study|Physician Decision|0|||
48593546|NCT02020889|156367779|FG000|Overall Study|Withdrawal by Subject|3|||
48593547|NCT02020889|156367780|FG001|Overall Study|Withdrawal by Subject|2|||
48593548|NCT00809094|156367781|FG000|Overall Study|Lost to Follow-up|0|||
48593549|NCT00809094|156367782|FG001|Overall Study|Lost to Follow-up|1|||
48593550|NCT00272844|156367783|FG000|Overall Study|Withdrawal by Subject|5|||
48593551|NCT01509664|156367786|FG000|Overall Study|Lost to Follow-up|15|||
48593552|NCT01509664|156367787|FG001|Overall Study|Lost to Follow-up|21|||
48593553|NCT02869893|156367788|FG000|Overall Study|participant aversion to IV|5|||
48593554|NCT02869893|156367788|FG000|Overall Study|participant fear of MRI scanner|2|||
48593555|NCT03665077|156367791|FG000|Overall Study|Lost to Follow-up|2|||
48593556|NCT03665077|156367791|FG000|Overall Study|Physician Decision|2|||
48593557|NCT00435461|156367792|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
48593558|NCT00435461|156367793|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
48593559|NCT00435461|156367794|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
48593560|NCT00435461|156367792|FG000|Overall Study|Protocol Violation|6|||
48593561|NCT00435461|156367793|FG001|Overall Study|Protocol Violation|9|||
48593562|NCT00435461|156367794|FG002|Overall Study|Protocol Violation|10|||
48593563|NCT00435461|156367792|FG000|Overall Study|Participant randomized(inadequate score)|1|||
48593564|NCT00435461|156367793|FG001|Overall Study|Participant randomized(inadequate score)|0|||
48593565|NCT00435461|156367794|FG002|Overall Study|Participant randomized(inadequate score)|0|||
48593566|NCT00435461|156367792|FG000|Overall Study|Compliance less than 80 percent|1|||
48593567|NCT00435461|156367793|FG001|Overall Study|Compliance less than 80 percent|0|||
48593568|NCT00435461|156367794|FG002|Overall Study|Compliance less than 80 percent|0|||
48593569|NCT00435461|156367792|FG000|Overall Study|In error, two study medications switched|1|||
48593570|NCT00435461|156367793|FG001|Overall Study|In error, two study medications switched|0|||
48593571|NCT00435461|156367794|FG002|Overall Study|In error, two study medications switched|0|||
48593572|NCT00435461|156367792|FG000|Overall Study|Lack of Efficacy|2|||
48593573|NCT00435461|156367793|FG001|Overall Study|Lack of Efficacy|1|||
48593574|NCT00435461|156367794|FG002|Overall Study|Lack of Efficacy|0|||
48593575|NCT00435461|156367792|FG000|Overall Study|Withdrawal by Subject|1|||
48593576|NCT00435461|156367793|FG001|Overall Study|Withdrawal by Subject|0|||
48593577|NCT00435461|156367794|FG002|Overall Study|Withdrawal by Subject|2|||
48593578|NCT00435461|156367792|FG000|Overall Study|Randomized in error|1|||
48593579|NCT00435461|156367793|FG001|Overall Study|Randomized in error|0|||
48593580|NCT00435461|156367794|FG002|Overall Study|Randomized in error|0|||
48593581|NCT00435461|156367792|FG000|Overall Study|Participant could not tolerate symptoms|0|||
48593582|NCT00435461|156367793|FG001|Overall Study|Participant could not tolerate symptoms|0|||
48593583|NCT00435461|156367794|FG002|Overall Study|Participant could not tolerate symptoms|1|||
48593584|NCT00435461|156367792|FG000|Overall Study|Participant could not swallow capsule|0|||
48593585|NCT00435461|156367793|FG001|Overall Study|Participant could not swallow capsule|0|||
48593586|NCT00435461|156367794|FG002|Overall Study|Participant could not swallow capsule|1|||
48593587|NCT00435461|156367792|FG000|Overall Study|Pregnancy|2|||
48593588|NCT00435461|156367793|FG001|Overall Study|Pregnancy|0|||
48593589|NCT00435461|156367794|FG002|Overall Study|Pregnancy|0|||
48593590|NCT00435461|156367792|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
48593591|NCT00435461|156367793|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
48593592|NCT00435461|156367794|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
48593593|NCT00435461|156367792|FG000|Overall Study|Participant ended study one day early|1|||
48593594|NCT00435461|156367793|FG001|Overall Study|Participant ended study one day early|0|||
48700971|NCT01436149|156753339|FG002|Antidepressant Lead-in Phase|Other|0|||
48700972|NCT01436149|156753337|FG000|Randomized Phase|Adverse Event|9|||
48700973|NCT01436149|156753338|FG001|Randomized Phase|Adverse Event|10|||
48700974|NCT01436149|156753339|FG002|Randomized Phase|Adverse Event|11|||
48700975|NCT01436149|156753337|FG000|Randomized Phase|Protocol Violation|4|||
48593595|NCT00435461|156367794|FG002|Overall Study|Participant ended study one day early|0|||
48593596|NCT00435461|156367792|FG000|Overall Study|Noncompliance with study requirements|1|||
48593597|NCT00435461|156367793|FG001|Overall Study|Noncompliance with study requirements|1|||
48593598|NCT00435461|156367794|FG002|Overall Study|Noncompliance with study requirements|1|||
48593599|NCT00435461|156367792|FG000|Overall Study|Adverse Event|1|||
48593600|NCT00435461|156367793|FG001|Overall Study|Adverse Event|2|||
48593601|NCT00435461|156367794|FG002|Overall Study|Adverse Event|6|||
48593602|NCT00435461|156367792|FG000|Overall Study|Non-Compliance of diary|2|||
48593603|NCT00435461|156367793|FG001|Overall Study|Non-Compliance of diary|0|||
48593604|NCT00435461|156367794|FG002|Overall Study|Non-Compliance of diary|1|||
48593605|NCT00435461|156367792|FG000|Overall Study|Lost to Follow-up|1|||
48593606|NCT00435461|156367793|FG001|Overall Study|Lost to Follow-up|1|||
48593607|NCT00435461|156367794|FG002|Overall Study|Lost to Follow-up|2|||
48593608|NCT02697591|156367795|FG000|Overall Study|Lost to Follow-up|0|||
48593609|NCT02697591|156367796|FG001|Overall Study|Lost to Follow-up|0|||
48593610|NCT02697591|156367797|FG002|Overall Study|Lost to Follow-up|0|||
48593611|NCT02697591|156367798|FG003|Overall Study|Lost to Follow-up|0|||
48593612|NCT02697591|156367799|FG004|Overall Study|Lost to Follow-up|0|||
48593613|NCT02697591|156367800|FG005|Overall Study|Lost to Follow-up|1|||
48593614|NCT02697591|156367801|FG006|Overall Study|Lost to Follow-up|1|||
48593615|NCT02697591|156367802|FG007|Overall Study|Lost to Follow-up|0|||
48593616|NCT02697591|156367803|FG008|Overall Study|Lost to Follow-up|0|||
48593617|NCT02697591|156367804|FG009|Overall Study|Lost to Follow-up|1|||
48593618|NCT02697591|156367795|FG000|Overall Study|Withdrawal by Subject|1|||
48593619|NCT02697591|156367796|FG001|Overall Study|Withdrawal by Subject|1|||
48593620|NCT02697591|156367797|FG002|Overall Study|Withdrawal by Subject|2|||
48593621|NCT02697591|156367798|FG003|Overall Study|Withdrawal by Subject|1|||
48593622|NCT02697591|156367799|FG004|Overall Study|Withdrawal by Subject|7|||
48593623|NCT02697591|156367800|FG005|Overall Study|Withdrawal by Subject|6|||
48593624|NCT02697591|156367801|FG006|Overall Study|Withdrawal by Subject|9|||
48593625|NCT02697591|156367802|FG007|Overall Study|Withdrawal by Subject|1|||
48593626|NCT02697591|156367803|FG008|Overall Study|Withdrawal by Subject|6|||
48593627|NCT02697591|156367804|FG009|Overall Study|Withdrawal by Subject|10|||
48593628|NCT02697591|156367795|FG000|Overall Study|Physician Decision|1|||
48593629|NCT02697591|156367796|FG001|Overall Study|Physician Decision|0|||
48593630|NCT02697591|156367797|FG002|Overall Study|Physician Decision|0|||
48593631|NCT02697591|156367798|FG003|Overall Study|Physician Decision|0|||
48593632|NCT02697591|156367799|FG004|Overall Study|Physician Decision|1|||
48700976|NCT01436149|156753338|FG001|Randomized Phase|Protocol Violation|5|||
48700977|NCT01436149|156753339|FG002|Randomized Phase|Protocol Violation|0|||
48700978|NCT01436149|156753337|FG000|Randomized Phase|Withdrawal by Subject|16|||
48700979|NCT01436149|156753338|FG001|Randomized Phase|Withdrawal by Subject|10|||
48700980|NCT01436149|156753339|FG002|Randomized Phase|Withdrawal by Subject|10|||
48700981|NCT01436149|156753337|FG000|Randomized Phase|Lost to Follow-up|34|||
48700982|NCT01436149|156753338|FG001|Randomized Phase|Lost to Follow-up|5|||
48593633|NCT02697591|156367800|FG005|Overall Study|Physician Decision|2|||
48593634|NCT02697591|156367801|FG006|Overall Study|Physician Decision|0|||
48593635|NCT02697591|156367802|FG007|Overall Study|Physician Decision|0|||
48593636|NCT02697591|156367803|FG008|Overall Study|Physician Decision|1|||
48593637|NCT02697591|156367804|FG009|Overall Study|Physician Decision|1|||
48593638|NCT02697591|156367795|FG000|Overall Study|Death|2|||
48593639|NCT02697591|156367796|FG001|Overall Study|Death|3|||
48593640|NCT02697591|156367797|FG002|Overall Study|Death|1|||
48593641|NCT02697591|156367798|FG003|Overall Study|Death|1|||
48593642|NCT02697591|156367799|FG004|Overall Study|Death|4|||
48593643|NCT02697591|156367800|FG005|Overall Study|Death|5|||
48593644|NCT02697591|156367801|FG006|Overall Study|Death|3|||
48593645|NCT02697591|156367802|FG007|Overall Study|Death|1|||
48593646|NCT02697591|156367803|FG008|Overall Study|Death|1|||
48593647|NCT02697591|156367804|FG009|Overall Study|Death|5|||
48593648|NCT02697591|156367795|FG000|Overall Study|Reason not Specified|0|||
48700983|NCT01436149|156753339|FG002|Randomized Phase|Lost to Follow-up|6|||
48700984|NCT01436149|156753337|FG000|Randomized Phase|Lack of Efficacy|0|||
48700985|NCT01436149|156753338|FG001|Randomized Phase|Lack of Efficacy|0|||
48432470|NCT01533935|155770875|FG002|Overall Study|Lost to Follow-up|1|||
48593649|NCT02697591|156367796|FG001|Overall Study|Reason not Specified|0|||
48593650|NCT02697591|156367797|FG002|Overall Study|Reason not Specified|0|||
48593651|NCT02697591|156367798|FG003|Overall Study|Reason not Specified|1|||
48593652|NCT02697591|156367799|FG004|Overall Study|Reason not Specified|1|||
48593653|NCT02697591|156367800|FG005|Overall Study|Reason not Specified|2|||
48593654|NCT02697591|156367801|FG006|Overall Study|Reason not Specified|3|||
48593655|NCT02697591|156367802|FG007|Overall Study|Reason not Specified|1|||
48593656|NCT02697591|156367803|FG008|Overall Study|Reason not Specified|1|||
48593657|NCT02697591|156367804|FG009|Overall Study|Reason not Specified|3|||
48593658|NCT02080364|156367805|FG000|Baseline Period|Protocol Violation|2|||
48593659|NCT02080364|156367806|FG001|Baseline Period|Protocol Violation|1|||
48593660|NCT02080364|156367807|FG002|Baseline Period|Protocol Violation|0|||
48700986|NCT01436149|156753339|FG002|Randomized Phase|Lack of Efficacy|1|||
48593661|NCT02080364|156367808|FG003|Baseline Period|Protocol Violation|0|||
48593662|NCT02080364|156367805|FG000|Baseline Period|Other|0|||
48593663|NCT02080364|156367806|FG001|Baseline Period|Other|1|||
48593664|NCT02080364|156367807|FG002|Baseline Period|Other|1|||
48593665|NCT02080364|156367808|FG003|Baseline Period|Other|0|||
48593666|NCT02080364|156367805|FG000|Treatment Period|Adverse Event|10|||
48593667|NCT02080364|156367806|FG001|Treatment Period|Adverse Event|15|||
48593668|NCT02080364|156367807|FG002|Treatment Period|Adverse Event|11|||
48593669|NCT02080364|156367808|FG003|Treatment Period|Adverse Event|14|||
48593670|NCT02080364|156367805|FG000|Treatment Period|Lost to Follow-up|2|||
48593671|NCT02080364|156367806|FG001|Treatment Period|Lost to Follow-up|3|||
48593672|NCT02080364|156367807|FG002|Treatment Period|Lost to Follow-up|5|||
48593673|NCT02080364|156367808|FG003|Treatment Period|Lost to Follow-up|0|||
48593674|NCT02080364|156367805|FG000|Treatment Period|Protocol Violation|5|||
48593675|NCT02080364|156367806|FG001|Treatment Period|Protocol Violation|3|||
48593676|NCT02080364|156367807|FG002|Treatment Period|Protocol Violation|5|||
48593677|NCT02080364|156367808|FG003|Treatment Period|Protocol Violation|1|||
48593678|NCT02080364|156367805|FG000|Treatment Period|Withdrawal by Subject|16|||
48593679|NCT02080364|156367806|FG001|Treatment Period|Withdrawal by Subject|16|||
48593680|NCT02080364|156367807|FG002|Treatment Period|Withdrawal by Subject|15|||
48593681|NCT02080364|156367808|FG003|Treatment Period|Withdrawal by Subject|10|||
48593682|NCT02080364|156367805|FG000|Treatment Period|Study Terminated by Sponsor|0|||
48593683|NCT02080364|156367806|FG001|Treatment Period|Study Terminated by Sponsor|0|||
48593684|NCT02080364|156367807|FG002|Treatment Period|Study Terminated by Sponsor|180|||
48593685|NCT02080364|156367808|FG003|Treatment Period|Study Terminated by Sponsor|183|||
48593686|NCT02080364|156367805|FG000|Treatment Period|Other|14|||
48593687|NCT02080364|156367806|FG001|Treatment Period|Other|12|||
48593688|NCT02080364|156367807|FG002|Treatment Period|Other|21|||
48593689|NCT02080364|156367808|FG003|Treatment Period|Other|16|||
48593690|NCT02609984|156367809|FG000|Overall Study|Death|29|||
48593691|NCT02609984|156367810|FG001|Overall Study|Death|26|||
48593692|NCT02609984|156367809|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
48593693|NCT02609984|156367810|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
48593694|NCT02609984|156367809|FG000|Overall Study|Lost to Follow-up|1|||
48593695|NCT02609984|156367810|FG001|Overall Study|Lost to Follow-up|2|||
48593696|NCT02609984|156367809|FG000|Overall Study|Withdrawal by Subject|0|||
48593697|NCT02609984|156367810|FG001|Overall Study|Withdrawal by Subject|1|||
48593698|NCT02609984|156367809|FG000|Overall Study|Disease Progression|2|||
48593699|NCT02609984|156367810|FG001|Overall Study|Disease Progression|0|||
48593700|NCT00398047|156367811|FG000|Overall Study|all patient progressed before completion|3|||
48593701|NCT00303472|156367812|FG000|Treatment Period|Adverse Event|0|||
48593702|NCT00303472|156367813|FG001|Treatment Period|Adverse Event|0|||
48593703|NCT00303472|156367814|FG002|Treatment Period|Adverse Event|0|||
48593704|NCT00303472|156367815|FG003|Treatment Period|Adverse Event|0|||
48593705|NCT00303472|156367816|FG004|Treatment Period|Adverse Event|1|||
48593706|NCT00303472|156367817|FG005|Treatment Period|Adverse Event|0|||
48593707|NCT00303472|156367818|FG006|Treatment Period|Adverse Event|0|||
48593708|NCT00303472|156367812|FG000|Treatment Period|Death|0|||
48593709|NCT00303472|156367813|FG001|Treatment Period|Death|0|||
48593710|NCT00303472|156367814|FG002|Treatment Period|Death|0|||
48593711|NCT00303472|156367815|FG003|Treatment Period|Death|1|||
48593712|NCT00303472|156367816|FG004|Treatment Period|Death|0|||
48593713|NCT00303472|156367817|FG005|Treatment Period|Death|0|||
48593714|NCT00303472|156367818|FG006|Treatment Period|Death|1|||
48593715|NCT00303472|156367812|FG000|Treatment Period|Withdrawal by Subject|0|||
48593716|NCT00303472|156367813|FG001|Treatment Period|Withdrawal by Subject|0|||
48593717|NCT00303472|156367814|FG002|Treatment Period|Withdrawal by Subject|0|||
48593718|NCT00303472|156367815|FG003|Treatment Period|Withdrawal by Subject|1|||
48593719|NCT00303472|156367816|FG004|Treatment Period|Withdrawal by Subject|0|||
48593720|NCT00303472|156367817|FG005|Treatment Period|Withdrawal by Subject|1|||
48700987|NCT01436149|156753337|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
48700988|NCT01436149|156753338|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
48700989|NCT01436149|156753339|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
48700990|NCT01436149|156753337|FG000|Randomized Phase|Other|12|||
48700991|NCT01436149|156753338|FG001|Randomized Phase|Other|5|||
48700992|NCT01436149|156753339|FG002|Randomized Phase|Other|11|||
48700993|NCT03279081|156753354|FG000|Overall Study|Withdrawal by Subject|12|||
48700994|NCT03279081|156753355|FG001|Overall Study|Withdrawal by Subject|20|||
48700995|NCT03279081|156753354|FG000|Overall Study|Physician Decision|4|||
48593721|NCT00303472|156367818|FG006|Treatment Period|Withdrawal by Subject|0|||
48593722|NCT00303472|156367812|FG000|Treatment Period|Other|0|||
48593723|NCT00303472|156367813|FG001|Treatment Period|Other|0|||
48593724|NCT00303472|156367814|FG002|Treatment Period|Other|0|||
48593725|NCT00303472|156367815|FG003|Treatment Period|Other|0|||
48593726|NCT00303472|156367816|FG004|Treatment Period|Other|1|||
48593727|NCT00303472|156367817|FG005|Treatment Period|Other|0|||
48593728|NCT00303472|156367818|FG006|Treatment Period|Other|1|||
48593729|NCT00303472|156367812|FG000|Treatment Period|Disease Progression (to AML)|0|||
48593730|NCT00303472|156367813|FG001|Treatment Period|Disease Progression (to AML)|0|||
48593731|NCT00303472|156367814|FG002|Treatment Period|Disease Progression (to AML)|0|||
48593732|NCT00303472|156367815|FG003|Treatment Period|Disease Progression (to AML)|0|||
48593733|NCT00303472|156367816|FG004|Treatment Period|Disease Progression (to AML)|1|||
48593734|NCT00303472|156367817|FG005|Treatment Period|Disease Progression (to AML)|0|||
48593735|NCT00303472|156367818|FG006|Treatment Period|Disease Progression (to AML)|0|||
48593736|NCT00303472|156367812|FG000|Treatment Extension (Optional)|Adverse Event|1|||
48593737|NCT00303472|156367813|FG001|Treatment Extension (Optional)|Adverse Event|0|||
48593738|NCT00303472|156367814|FG002|Treatment Extension (Optional)|Adverse Event|1|||
48593739|NCT00303472|156367815|FG003|Treatment Extension (Optional)|Adverse Event|0|||
48593740|NCT00303472|156367816|FG004|Treatment Extension (Optional)|Adverse Event|0|||
48593741|NCT00303472|156367817|FG005|Treatment Extension (Optional)|Adverse Event|0|||
48593742|NCT00303472|156367818|FG006|Treatment Extension (Optional)|Adverse Event|0|||
48593743|NCT00303472|156367812|FG000|Treatment Extension (Optional)|Death|2|||
48593744|NCT00303472|156367813|FG001|Treatment Extension (Optional)|Death|0|||
48593745|NCT00303472|156367814|FG002|Treatment Extension (Optional)|Death|1|||
48593746|NCT00303472|156367815|FG003|Treatment Extension (Optional)|Death|0|||
48593747|NCT00303472|156367816|FG004|Treatment Extension (Optional)|Death|0|||
48593748|NCT00303472|156367817|FG005|Treatment Extension (Optional)|Death|0|||
48593749|NCT00303472|156367818|FG006|Treatment Extension (Optional)|Death|0|||
48593750|NCT00303472|156367812|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
48593751|NCT00303472|156367813|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
48593752|NCT00303472|156367814|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
48593753|NCT00303472|156367815|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
48593754|NCT00303472|156367816|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
48593755|NCT00303472|156367817|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
48593756|NCT00303472|156367818|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
48593757|NCT00303472|156367812|FG000|Treatment Extension (Optional)|Physician Decision|0|||
48593758|NCT00303472|156367813|FG001|Treatment Extension (Optional)|Physician Decision|4|||
48593759|NCT00303472|156367814|FG002|Treatment Extension (Optional)|Physician Decision|2|||
48593760|NCT00303472|156367815|FG003|Treatment Extension (Optional)|Physician Decision|3|||
48593761|NCT00303472|156367816|FG004|Treatment Extension (Optional)|Physician Decision|2|||
48593762|NCT00303472|156367817|FG005|Treatment Extension (Optional)|Physician Decision|0|||
48593763|NCT00303472|156367818|FG006|Treatment Extension (Optional)|Physician Decision|0|||
48593764|NCT00303472|156367812|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
48593765|NCT00303472|156367813|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
48593766|NCT00303472|156367814|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
48593767|NCT00303472|156367815|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
48593768|NCT00303472|156367816|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
48593769|NCT00303472|156367817|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
48593770|NCT00303472|156367818|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
48593771|NCT00303472|156367812|FG000|Treatment Extension (Optional)|Other|0|||
48593772|NCT00303472|156367813|FG001|Treatment Extension (Optional)|Other|2|||
48593773|NCT00303472|156367814|FG002|Treatment Extension (Optional)|Other|4|||
48593774|NCT00303472|156367815|FG003|Treatment Extension (Optional)|Other|2|||
48593775|NCT00303472|156367816|FG004|Treatment Extension (Optional)|Other|1|||
48593776|NCT00303472|156367817|FG005|Treatment Extension (Optional)|Other|0|||
48593777|NCT00303472|156367818|FG006|Treatment Extension (Optional)|Other|0|||
48593778|NCT00303472|156367812|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
48593779|NCT00303472|156367813|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
48593780|NCT00303472|156367814|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
48593781|NCT00303472|156367815|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
48593782|NCT00303472|156367816|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
48593783|NCT00303472|156367817|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
48593784|NCT00303472|156367818|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
48593785|NCT01607346|156367819|FG000|Overall Study|Adverse Event|3|||
48593786|NCT01084538|156367820|FG000|Overall Study|Drug not available|30|||
48593787|NCT01084538|156367820|FG000|Overall Study|Adverse Event|9|||
48700996|NCT03279081|156753355|FG001|Overall Study|Physician Decision|1|||
48700997|NCT03279081|156753354|FG000|Overall Study|Lost to Follow-up|8|||
48700998|NCT03279081|156753355|FG001|Overall Study|Lost to Follow-up|8|||
48700999|NCT03279081|156753354|FG000|Overall Study|Death|0|||
48489074|NCT04896385|155985282|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
48593788|NCT01084538|156367820|FG000|Overall Study|Kidney transplant|6|||
48593789|NCT01084538|156367820|FG000|Overall Study|Serious Adverse Event|3|||
48593790|NCT01084538|156367820|FG000|Overall Study|Lack of effectiveness|2|||
48593791|NCT01084538|156367820|FG000|Overall Study|Patient noncompliance|2|||
48593792|NCT01084538|156367820|FG000|Overall Study|Hyperphosphatemia|2|||
48593793|NCT01084538|156367820|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
48593794|NCT01084538|156367820|FG000|Overall Study|Change of residence|2|||
48593795|NCT01084538|156367820|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
48593796|NCT01084538|156367820|FG000|Overall Study|Reason unknown|8|||
48701000|NCT03279081|156753355|FG001|Overall Study|Death|1|||
48701001|NCT03279081|156753354|FG000|Overall Study|Adverse Event|1|||
48701002|NCT03279081|156753355|FG001|Overall Study|Adverse Event|0|||
48701003|NCT03279081|156753354|FG000|Overall Study|Reason not Specified|14|||
48701004|NCT03279081|156753355|FG001|Overall Study|Reason not Specified|4|||
48701005|NCT01283139|156753359|FG000|Overall Study|Lost to Follow-up|5|||
48701006|NCT01283139|156753360|FG001|Overall Study|Lost to Follow-up|2|||
48701007|NCT01283139|156753361|FG002|Overall Study|Lost to Follow-up|3|||
48701008|NCT01283139|156753362|FG003|Overall Study|Lost to Follow-up|1|||
48701009|NCT01283139|156753359|FG000|Overall Study|Withdrawal by Subject|8|||
48701010|NCT01283139|156753360|FG001|Overall Study|Withdrawal by Subject|8|||
48701011|NCT01283139|156753361|FG002|Overall Study|Withdrawal by Subject|6|||
48701012|NCT01283139|156753362|FG003|Overall Study|Withdrawal by Subject|8|||
48701013|NCT01283139|156753359|FG000|Overall Study|Death|2|||
48701014|NCT01283139|156753360|FG001|Overall Study|Death|0|||
48701015|NCT01283139|156753361|FG002|Overall Study|Death|2|||
48701016|NCT01283139|156753362|FG003|Overall Study|Death|2|||
48701017|NCT01283139|156753359|FG000|Overall Study|Lack of Efficacy|1|||
48701018|NCT01283139|156753360|FG001|Overall Study|Lack of Efficacy|2|||
48701019|NCT01283139|156753361|FG002|Overall Study|Lack of Efficacy|2|||
48701020|NCT01283139|156753362|FG003|Overall Study|Lack of Efficacy|1|||
48701021|NCT01283139|156753359|FG000|Overall Study|Early termination due to AE/SAE|1|||
48701022|NCT01283139|156753360|FG001|Overall Study|Early termination due to AE/SAE|1|||
48701023|NCT01283139|156753361|FG002|Overall Study|Early termination due to AE/SAE|0|||
48701024|NCT01283139|156753362|FG003|Overall Study|Early termination due to AE/SAE|0|||
48701025|NCT01283139|156753359|FG000|Overall Study|Participant's refusal to continue|0|||
48701026|NCT01283139|156753360|FG001|Overall Study|Participant's refusal to continue|3|||
48701027|NCT01283139|156753361|FG002|Overall Study|Participant's refusal to continue|1|||
48701028|NCT01283139|156753362|FG003|Overall Study|Participant's refusal to continue|1|||
48701029|NCT01283139|156753359|FG000|Overall Study|Pregnancy|0|||
48701030|NCT01283139|156753360|FG001|Overall Study|Pregnancy|1|||
48701031|NCT01283139|156753361|FG002|Overall Study|Pregnancy|1|||
48701032|NCT01283139|156753362|FG003|Overall Study|Pregnancy|0|||
48701033|NCT01283139|156753359|FG000|Overall Study|Missed follow-up visit|0|||
48701034|NCT01283139|156753360|FG001|Overall Study|Missed follow-up visit|1|||
48701035|NCT01283139|156753361|FG002|Overall Study|Missed follow-up visit|2|||
48701036|NCT01283139|156753362|FG003|Overall Study|Missed follow-up visit|2|||
48701037|NCT01283139|156753359|FG000|Overall Study|Participant randomized in error|0|||
48701038|NCT01283139|156753360|FG001|Overall Study|Participant randomized in error|0|||
48701039|NCT01283139|156753361|FG002|Overall Study|Participant randomized in error|1|||
48701040|NCT01283139|156753362|FG003|Overall Study|Participant randomized in error|0|||
48701041|NCT00307801|156753365|FG000|Overall Study|Adverse Event|12|||
48701042|NCT00307801|156753366|FG001|Overall Study|Adverse Event|4|||
48701043|NCT00307801|156753365|FG000|Overall Study|Withdrawal by Subject|9|||
48701044|NCT00307801|156753366|FG001|Overall Study|Withdrawal by Subject|4|||
48701045|NCT00307801|156753365|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
48701046|NCT00307801|156753366|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
48701047|NCT00307801|156753365|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
48701048|NCT00307801|156753366|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
48701049|NCT00307801|156753365|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
48701050|NCT00307801|156753366|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
48701051|NCT00307801|156753365|FG000|Overall Study|Wrong Randomization|1|||
48701052|NCT00307801|156753366|FG001|Overall Study|Wrong Randomization|0|||
48701053|NCT00307801|156753365|FG000|Overall Study|Lack of Efficacy|0|||
48701054|NCT00307801|156753366|FG001|Overall Study|Lack of Efficacy|2|||
48701055|NCT00307801|156753365|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
48701056|NCT00307801|156753366|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
48701057|NCT00307801|156753365|FG000|Overall Study|Frustration with e-diary|1|||
48701058|NCT00307801|156753366|FG001|Overall Study|Frustration with e-diary|0|||
48701059|NCT00307801|156753365|FG000|Overall Study|Protocol Violation|3|||
48701060|NCT00307801|156753366|FG001|Overall Study|Protocol Violation|2|||
48701061|NCT00307801|156753365|FG000|Overall Study|No reason specified|2|||
48701062|NCT00307801|156753366|FG001|Overall Study|No reason specified|0|||
48701063|NCT00307801|156753365|FG000|Overall Study|Pregnancy|0|||
48701064|NCT00307801|156753366|FG001|Overall Study|Pregnancy|1|||
48701065|NCT03094416|156753371|FG000|Run-in|Screening failure|8|||
48701066|NCT03094416|156753371|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
48701067|NCT03094416|156753371|FG000|Run-in|Withdrawal by Subject|3|||
48701068|NCT03094416|156753371|FG000|Treatment Period|Withdrawal by Subject|2|||
48701069|NCT00926237|156753373|FG000|Overall Study|Withdrawal by Subject|2|||
48701070|NCT00926237|156753374|FG001|Overall Study|Withdrawal by Subject|1|||
48701071|NCT03467750|156753375|FG000|Overall Study|Surgery canceled|1|||
48701072|NCT03467750|156753376|FG001|Overall Study|Surgery canceled|0|||
48701073|NCT03467750|156753375|FG000|Overall Study|Protocol Violation|1|||
48701074|NCT03467750|156753376|FG001|Overall Study|Protocol Violation|1|||
48701075|NCT03467750|156753375|FG000|Overall Study|Withdrawal by Subject|0|||
48701076|NCT03467750|156753376|FG001|Overall Study|Withdrawal by Subject|1|||
48701077|NCT00911170|156753381|FG000|Treatment Period|Randomized in error|1|||
48593797|NCT00534638|156367821|FG000|Overall Study|Withdrawal by Subject|3|||
48593798|NCT00534638|156367822|FG001|Overall Study|Withdrawal by Subject|4|||
48593799|NCT00534638|156367821|FG000|Overall Study|Migrated/moved from study area|13|||
48593800|NCT00534638|156367822|FG001|Overall Study|Migrated/moved from study area|11|||
48593801|NCT00534638|156367821|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
48593802|NCT00534638|156367822|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
48593803|NCT00534638|156367821|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
48593804|NCT00534638|156367822|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
48593805|NCT00534638|156367821|FG000|Overall Study|Other|1685|||
48593806|NCT00534638|156367822|FG001|Overall Study|Other|902|||
48593807|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
48593808|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
48593809|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
48593810|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
48593811|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
48593812|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
48593813|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
48593814|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
48593815|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
48593816|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
48593817|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
48593818|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
48593819|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
48593820|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
48593821|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
48593822|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
48593823|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
48593824|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
48593825|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
48593826|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
48593827|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
48593828|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
48593829|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
48593830|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
48593831|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
48593832|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
48593833|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
48593834|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
48593835|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
48593836|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
48593837|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
48593838|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
48593839|NCT03538691|156367826|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
48593840|NCT03538691|156367827|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
48593841|NCT03538691|156367828|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
48593842|NCT03538691|156367829|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
48593843|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
48701078|NCT00911170|156753382|FG001|Treatment Period|Randomized in error|1|||
48701079|NCT00911170|156753381|FG000|Treatment Period|Ineligibility determined|1|||
48701080|NCT00911170|156753382|FG001|Treatment Period|Ineligibility determined|3|||
48701081|NCT00911170|156753381|FG000|Treatment Period|Protocol deviation|1|||
48701082|NCT00911170|156753382|FG001|Treatment Period|Protocol deviation|2|||
48701083|NCT00911170|156753381|FG000|Treatment Period|Adverse Event|9|||
48701084|NCT00911170|156753382|FG001|Treatment Period|Adverse Event|10|||
48701085|NCT00911170|156753381|FG000|Treatment Period|Withdrawal by Subject|4|||
48701086|NCT00911170|156753382|FG001|Treatment Period|Withdrawal by Subject|4|||
48701087|NCT00911170|156753381|FG000|Treatment Period|Disease progression|0|||
48701088|NCT00911170|156753382|FG001|Treatment Period|Disease progression|2|||
48701089|NCT00911170|156753381|FG000|Treatment Period|Physician Decision|5|||
48701090|NCT00911170|156753382|FG001|Treatment Period|Physician Decision|5|||
48593844|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
48593845|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
48593846|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
48593847|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
48593848|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
48593849|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
48593850|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
48593851|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
48593852|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
48701091|NCT00911170|156753381|FG000|Treatment Period|Lost to Follow-up|0|||
48701092|NCT00911170|156753382|FG001|Treatment Period|Lost to Follow-up|1|||
48701093|NCT00911170|156753381|FG000|Treatment Period|Death|6|||
48701094|NCT00911170|156753382|FG001|Treatment Period|Death|9|||
48701095|NCT00911170|156753381|FG000|Long Term Follow-Up|Continuing in study|274|||
48701096|NCT00911170|156753382|FG001|Long Term Follow-Up|Continuing in study|269|||
48701097|NCT00911170|156753381|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
48701098|NCT00911170|156753382|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
48701099|NCT00911170|156753381|FG000|Long Term Follow-Up|Physician Decision|5|||
48701100|NCT00911170|156753382|FG001|Long Term Follow-Up|Physician Decision|4|||
48701101|NCT00911170|156753381|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
48701102|NCT00911170|156753382|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
48489075|NCT04896385|155985283|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
48489076|NCT04896385|155985280|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
48489077|NCT04896385|155985281|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
48489078|NCT04896385|155985282|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
48489079|NCT04896385|155985283|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
48489080|NCT04896385|155985280|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
48489081|NCT04896385|155985281|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
48489082|NCT04896385|155985282|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
48489083|NCT04896385|155985283|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
48489084|NCT04896385|155985280|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
48489085|NCT04896385|155985281|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
48489086|NCT04896385|155985282|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
48489087|NCT04896385|155985283|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
48489088|NCT01306253|155985284|FG000|Overall Study|Lost to Follow-up|1|||
48489089|NCT01306253|155985285|FG001|Overall Study|Lost to Follow-up|1|||
48489090|NCT03469271|155985286|FG000|Overall Study|Withdrawal by Subject|2|||
48489091|NCT03469271|155985287|FG001|Overall Study|Withdrawal by Subject|0|||
48489092|NCT03469271|155985288|FG002|Overall Study|Withdrawal by Subject|0|||
48489093|NCT03469271|155985289|FG003|Overall Study|Withdrawal by Subject|1|||
48489094|NCT00395083|155985290|FG000|Overall Study|Withdrawal by Subject|6|||
48489095|NCT00395083|155985291|FG001|Overall Study|Withdrawal by Subject|5|||
48489096|NCT00395083|155985290|FG000|Overall Study|Developed another disease|4|||
48489097|NCT00395083|155985291|FG001|Overall Study|Developed another disease|3|||
48489098|NCT04147715|155985294|FG000|Overall Study|Adverse Event|0|||
48489099|NCT04147715|155985295|FG001|Overall Study|Adverse Event|0|||
48489100|NCT04147715|155985296|FG002|Overall Study|Adverse Event|0|||
48489101|NCT04147715|155985297|FG003|Overall Study|Adverse Event|0|||
48489102|NCT04147715|155985298|FG004|Overall Study|Adverse Event|0|||
48489103|NCT04147715|155985299|FG005|Overall Study|Adverse Event|0|||
48489104|NCT04147715|155985300|FG006|Overall Study|Adverse Event|0|||
48489105|NCT04147715|155985301|FG007|Overall Study|Adverse Event|2|||
48489106|NCT04147715|155985302|FG008|Overall Study|Adverse Event|1|||
48489107|NCT04147715|155985303|FG009|Overall Study|Adverse Event|0|||
48489108|NCT04147715|155985304|FG010|Overall Study|Adverse Event|0|||
48489109|NCT04147715|155985305|FG011|Overall Study|Adverse Event|0|||
48489110|NCT02418910|155985306|FG000|Overall Study|Lost to Follow-up|3|||
48489111|NCT02418910|155985306|FG000|Overall Study|Withdrawal by Subject|4|||
48489112|NCT02472977|155985317|FG000|Overall Study|Disease progression|4|||
48489113|NCT02472977|155985318|FG001|Overall Study|Disease progression|25|||
48489114|NCT02472977|155985319|FG002|Overall Study|Disease progression|6|||
48489115|NCT02472977|155985317|FG000|Overall Study|Withdrawal by Subject|0|||
48489116|NCT02472977|155985318|FG001|Overall Study|Withdrawal by Subject|1|||
48489117|NCT02472977|155985319|FG002|Overall Study|Withdrawal by Subject|0|||
48489118|NCT02472977|155985317|FG000|Overall Study|Study drug toxicity|2|||
48489119|NCT02472977|155985318|FG001|Overall Study|Study drug toxicity|0|||
48489120|NCT02472977|155985319|FG002|Overall Study|Study drug toxicity|2|||
48489121|NCT02472977|155985317|FG000|Overall Study|Subject request to discontinue treatment|0|||
48489122|NCT02472977|155985318|FG001|Overall Study|Subject request to discontinue treatment|1|||
48489123|NCT02472977|155985319|FG002|Overall Study|Subject request to discontinue treatment|0|||
48489124|NCT01193517|155985320|FG000|Overall Study|Early Progression|1|||
48489125|NCT01193517|155985321|FG001|Overall Study|Early Progression|0|||
48489126|NCT01193517|155985322|FG002|Overall Study|Early Progression|0|||
48593853|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
48593854|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
48593855|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
48593856|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
48593857|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
48593858|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
48593859|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
48593860|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
48593861|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
48593862|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
48593863|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
48593864|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
48593865|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
48593866|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
48593867|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
48593868|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
48593869|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
48593870|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
48593871|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
48593872|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
48593873|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
48593874|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
48593875|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
48593876|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
48593877|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
48593878|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
48593879|NCT03538691|156367826|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
48593880|NCT03538691|156367827|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
48593881|NCT03538691|156367828|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
48701103|NCT00911170|156753381|FG000|Long Term Follow-Up|Death|116|||
48701104|NCT00911170|156753382|FG001|Long Term Follow-Up|Death|121|||
48701105|NCT02514083|156753386|FG000|Overall Study|Adverse Event|1|||
48701106|NCT00726063|156755185|FG000|Overall Study|Adverse Event|9|||
48701107|NCT00726063|156755186|FG001|Overall Study|Adverse Event|7|||
48701108|NCT03103542|156755187|FG000|Overall Study|Physician Decision|2|||
48593882|NCT03538691|156367829|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
48593883|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
48593884|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
48593885|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
48593886|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
48593887|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
48593888|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
48593889|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
48593890|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
48593891|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
48593892|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
48593893|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
48593894|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
48593895|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
48593896|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
48593897|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
48593898|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
48593899|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
48593900|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
48593901|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
48593902|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
48593903|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
48593904|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
48593905|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
48701109|NCT03103542|156755187|FG000|Overall Study|Adverse Event|2|||
48701110|NCT03103542|156755187|FG000|Overall Study|Other|2|||
48701111|NCT03103542|156755187|FG000|Overall Study|Withdrawal by Subject|1|||
48701112|NCT00910650|156755188|FG000|Overall Study|Death|2|||
48593906|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
48593907|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
48593908|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
48593909|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
48593910|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
48593911|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
48593912|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
48593913|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
48593914|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
48593915|NCT03538691|156367826|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
48593916|NCT03538691|156367827|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
48593917|NCT03538691|156367828|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
48593918|NCT03538691|156367829|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
48593919|NCT00765817|156367830|FG000|Overall Study|Adverse Event|13|||
48593920|NCT00765817|156367831|FG001|Overall Study|Adverse Event|1|||
48593921|NCT00765817|156367830|FG000|Overall Study|Death|0|||
48593922|NCT00765817|156367831|FG001|Overall Study|Death|1|||
48593923|NCT00765817|156367830|FG000|Overall Study|Entry criteria not met|2|||
48593924|NCT00765817|156367831|FG001|Overall Study|Entry criteria not met|2|||
48593925|NCT00765817|156367830|FG000|Overall Study|Loss of glucose control|0|||
48593926|NCT00765817|156367831|FG001|Overall Study|Loss of glucose control|2|||
48593927|NCT00765817|156367830|FG000|Overall Study|Lost to Follow-up|1|||
48593928|NCT00765817|156367831|FG001|Overall Study|Lost to Follow-up|3|||
48593929|NCT00765817|156367830|FG000|Overall Study|Physician Decision|2|||
48593930|NCT00765817|156367831|FG001|Overall Study|Physician Decision|1|||
48593931|NCT00765817|156367830|FG000|Overall Study|Protocol Violation|1|||
48593932|NCT00765817|156367831|FG001|Overall Study|Protocol Violation|1|||
48593933|NCT00765817|156367830|FG000|Overall Study|Subject decision|7|||
48593934|NCT00765817|156367831|FG001|Overall Study|Subject decision|11|||
48593935|NCT01949142|156367836|FG000|Overall Study|Withdrawal of consent|1|||
48593936|NCT01949142|156367837|FG001|Overall Study|Withdrawal of consent|0|||
48593937|NCT01949142|156367836|FG000|Overall Study|Lost to Follow-up|1|||
48593938|NCT01949142|156367837|FG001|Overall Study|Lost to Follow-up|1|||
48593939|NCT01949142|156367836|FG000|Overall Study|Parent changed their mind|1|||
48593940|NCT01949142|156367837|FG001|Overall Study|Parent changed their mind|0|||
48593941|NCT00171158|156368837|FG000|Core Study|Death|27|||
48593942|NCT00171158|156368837|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
48593943|NCT00171158|156368837|FG000|Core Study|Protocol Violation|4|||
48593944|NCT00171158|156368837|FG000|Core Study|Administrative problems|1|||
48593945|NCT00171158|156368837|FG000|Core Study|Adverse event, non-fatal|21|||
48593946|NCT00171158|156368837|FG000|Core Study|Consent withdrawn by subject|6|||
48593947|NCT00171158|156368837|FG000|Core Study|No longer required drug (BMT)|14|||
48593948|NCT00171158|156368837|FG000|Core Study|Abnormal Laboratory Values|2|||
48593949|NCT00171158|156368837|FG000|Core Study|Lost to Follow-up|1|||
48593950|NCT00171158|156368837|FG000|E2 Extension|Other|7|||
48701113|NCT02435992|156755190|FG000|Overall Study|non compliance with protocol|2|||
48701114|NCT02435992|156755191|FG001|Overall Study|non compliance with protocol|0|||
48701115|NCT02435992|156755192|FG002|Overall Study|non compliance with protocol|1|||
48489127|NCT01199601|155985323|FG000|Overall Study|Lost to Follow-up|47|||
48489128|NCT01199601|155985324|FG001|Overall Study|Lost to Follow-up|66|||
48489129|NCT01199601|155985323|FG000|Overall Study|Withdrawal by Subject|15|||
48489130|NCT01199601|155985324|FG001|Overall Study|Withdrawal by Subject|3|||
48489131|NCT01199601|155985323|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
48489132|NCT01199601|155985324|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
48489133|NCT00146770|155985325|FG000|Overall Study|Adverse Event|2|||
48489134|NCT00146770|155985326|FG001|Overall Study|Adverse Event|0|||
48489135|NCT00146770|155985325|FG000|Overall Study|Pregnancy|1|||
48489136|NCT00146770|155985326|FG001|Overall Study|Pregnancy|0|||
48489137|NCT00146770|155985325|FG000|Overall Study|Withdrawal by Subject|2|||
48489138|NCT00146770|155985326|FG001|Overall Study|Withdrawal by Subject|0|||
48489139|NCT00299728|155985327|FG000|Overall Study|Lost to Follow-up|0|||
48489140|NCT00299728|155985328|FG001|Overall Study|Lost to Follow-up|1|||
48489141|NCT00299728|155985327|FG000|Overall Study|Withdrawal by Subject|0|||
48489142|NCT00299728|155985328|FG001|Overall Study|Withdrawal by Subject|1|||
48489143|NCT00299728|155985327|FG000|Overall Study|Progressive disease|0|||
48489144|NCT00299728|155985328|FG001|Overall Study|Progressive disease|1|||
48489145|NCT01512979|155985329|FG000|Overall Study|Adverse Event|2|||
48593951|NCT01980628|156368839|FG000|Overall Study|Adverse Event|12|||
48489146|NCT01512979|155985330|FG001|Overall Study|Adverse Event|2|||
48489147|NCT01512979|155985329|FG000|Overall Study|Protocol Violation|1|||
48489148|NCT01512979|155985330|FG001|Overall Study|Protocol Violation|4|||
48489149|NCT01512979|155985329|FG000|Overall Study|Lost to Follow-up|2|||
48593952|NCT01980628|156368839|FG000|Overall Study|Physician Decision|5|||
48593953|NCT01980628|156368839|FG000|Overall Study|Withdrawal by Subject|4|||
48593954|NCT01980628|156368839|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
48593955|NCT02849704|156368840|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
48593956|NCT02849704|156368841|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
48593957|NCT02849704|156368840|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
48593958|NCT02849704|156368841|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
48593959|NCT02849704|156368840|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
48701116|NCT02435992|156755193|FG003|Overall Study|non compliance with protocol|0|||
48701117|NCT02435992|156755194|FG004|Overall Study|non compliance with protocol|0|||
48701118|NCT02435992|156755190|FG000|Overall Study|Adverse Event|11|||
48701119|NCT02435992|156755191|FG001|Overall Study|Adverse Event|6|||
48701120|NCT02435992|156755192|FG002|Overall Study|Adverse Event|12|||
48701121|NCT02435992|156755193|FG003|Overall Study|Adverse Event|0|||
48701122|NCT02435992|156755194|FG004|Overall Study|Adverse Event|0|||
48701123|NCT02435992|156755190|FG000|Overall Study|Lack of Efficacy|4|||
48593960|NCT02849704|156368841|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
48593961|NCT03536663|156368842|FG000|Endexo|Protocol Violation|1|||
48593962|NCT00734656|156368843|FG000|Lab Session 1|Withdrawal by Subject|2|||
48593963|NCT00734656|156368844|FG001|Lab Session 1|Withdrawal by Subject|0|||
48593964|NCT00734656|156368845|FG002|Lab Session 1|Withdrawal by Subject|0|||
48593965|NCT00734656|156368846|FG003|Lab Session 1|Withdrawal by Subject|0|||
48593966|NCT00734656|156368843|FG000|Washout 1|Withdrawal by Subject|1|||
48593967|NCT00734656|156368844|FG001|Washout 1|Withdrawal by Subject|5|||
48593968|NCT00734656|156368845|FG002|Washout 1|Withdrawal by Subject|2|||
48593969|NCT00734656|156368846|FG003|Washout 1|Withdrawal by Subject|3|||
48593970|NCT00734656|156368843|FG000|Lab Session 2|Withdrawal by Subject|1|||
48593971|NCT00734656|156368844|FG001|Lab Session 2|Withdrawal by Subject|0|||
48593972|NCT00734656|156368845|FG002|Lab Session 2|Withdrawal by Subject|0|||
48593973|NCT00734656|156368846|FG003|Lab Session 2|Withdrawal by Subject|1|||
48593974|NCT00734656|156368843|FG000|Washout 2|Withdrawal by Subject|1|||
48593975|NCT00734656|156368844|FG001|Washout 2|Withdrawal by Subject|1|||
48593976|NCT00734656|156368845|FG002|Washout 2|Withdrawal by Subject|1|||
48593977|NCT00734656|156368846|FG003|Washout 2|Withdrawal by Subject|0|||
48593978|NCT00734656|156368843|FG000|Washout 3|Withdrawal by Subject|1|||
48593979|NCT00734656|156368844|FG001|Washout 3|Withdrawal by Subject|0|||
48593980|NCT00734656|156368845|FG002|Washout 3|Withdrawal by Subject|0|||
48593981|NCT00734656|156368846|FG003|Washout 3|Withdrawal by Subject|1|||
48593982|NCT00734656|156368843|FG000|Lab Session 4|Withdrawal by Subject|0|||
48701124|NCT02435992|156755191|FG001|Overall Study|Lack of Efficacy|10|||
48701125|NCT02435992|156755192|FG002|Overall Study|Lack of Efficacy|9|||
48701126|NCT02435992|156755193|FG003|Overall Study|Lack of Efficacy|0|||
48701127|NCT02435992|156755194|FG004|Overall Study|Lack of Efficacy|0|||
48701128|NCT02435992|156755190|FG000|Overall Study|Withdrawal by Subject|10|||
48701129|NCT02435992|156755191|FG001|Overall Study|Withdrawal by Subject|8|||
48701130|NCT02435992|156755192|FG002|Overall Study|Withdrawal by Subject|20|||
48701131|NCT02435992|156755193|FG003|Overall Study|Withdrawal by Subject|0|||
48701132|NCT02435992|156755194|FG004|Overall Study|Withdrawal by Subject|0|||
48701133|NCT02435992|156755190|FG000|Overall Study|Other Reason|1|||
48701134|NCT02435992|156755191|FG001|Overall Study|Other Reason|0|||
48701135|NCT02435992|156755192|FG002|Overall Study|Other Reason|0|||
48701136|NCT02435992|156755193|FG003|Overall Study|Other Reason|0|||
48701137|NCT02435992|156755194|FG004|Overall Study|Other Reason|0|||
48701138|NCT02435992|156755190|FG000|Overall Study|Physician Decision|0|||
48701139|NCT02435992|156755191|FG001|Overall Study|Physician Decision|0|||
48701140|NCT02435992|156755192|FG002|Overall Study|Physician Decision|1|||
48701141|NCT02435992|156755193|FG003|Overall Study|Physician Decision|0|||
48701142|NCT02435992|156755194|FG004|Overall Study|Physician Decision|0|||
48701143|NCT00423579|156755195|FG000|Overall Study|Lost to Follow-up|3|||
48701144|NCT00423579|156755196|FG001|Overall Study|Lost to Follow-up|0|||
48701145|NCT00423579|156755195|FG000|Overall Study|Protocol Violation|1|||
48701146|NCT00423579|156755196|FG001|Overall Study|Protocol Violation|3|||
48701147|NCT00423579|156755195|FG000|Overall Study|Diagnosis of diabetes|0|||
48701148|NCT00423579|156755196|FG001|Overall Study|Diagnosis of diabetes|1|||
48701149|NCT01761877|156755197|FG000|Overall Study|Adverse Event|7|||
48701150|NCT01761877|156755198|FG001|Overall Study|Adverse Event|0|||
48701151|NCT01761877|156755197|FG000|Overall Study|Withdrawal by Subject|6|||
48701152|NCT01761877|156755198|FG001|Overall Study|Withdrawal by Subject|4|||
48701153|NCT01761877|156755197|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
48701154|NCT01761877|156755198|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
48593983|NCT00734656|156368844|FG001|Lab Session 4|Withdrawal by Subject|0|||
48593984|NCT00734656|156368845|FG002|Lab Session 4|Withdrawal by Subject|0|||
48593985|NCT00734656|156368846|FG003|Lab Session 4|Withdrawal by Subject|1|||
48701155|NCT01761877|156755197|FG000|Overall Study|Death|0|||
48701156|NCT01761877|156755198|FG001|Overall Study|Death|1|||
48701157|NCT01761877|156755197|FG000|Overall Study|MRI intolerant|1|||
48701158|NCT01761877|156755198|FG001|Overall Study|MRI intolerant|6|||
48701159|NCT03879772|156755199|FG000|Overall Study|Adverse Event|2|||
48701160|NCT03879772|156755200|FG001|Overall Study|Adverse Event|2|||
48701161|NCT03879772|156755201|FG002|Overall Study|Adverse Event|3|||
48701162|NCT03879772|156755202|FG003|Overall Study|Adverse Event|4|||
48701163|NCT03879772|156755203|FG004|Overall Study|Adverse Event|3|||
48701164|NCT03879772|156755199|FG000|Overall Study|Treatment Failure|1|||
48701165|NCT03879772|156755200|FG001|Overall Study|Treatment Failure|0|||
48701166|NCT03879772|156755201|FG002|Overall Study|Treatment Failure|0|||
48701167|NCT03879772|156755202|FG003|Overall Study|Treatment Failure|2|||
48701168|NCT03879772|156755203|FG004|Overall Study|Treatment Failure|1|||
48701169|NCT03879772|156755199|FG000|Overall Study|Lost to Follow-up|0|||
48701170|NCT03879772|156755200|FG001|Overall Study|Lost to Follow-up|0|||
48701171|NCT03879772|156755201|FG002|Overall Study|Lost to Follow-up|0|||
48701172|NCT03879772|156755202|FG003|Overall Study|Lost to Follow-up|0|||
48489150|NCT01512979|155985330|FG001|Overall Study|Lost to Follow-up|5|||
48489151|NCT01512979|155985329|FG000|Overall Study|Withdrawal by Subject|1|||
48489152|NCT01512979|155985330|FG001|Overall Study|Withdrawal by Subject|2|||
48489153|NCT01512979|155985329|FG000|Overall Study|Reason other than stated above|13|||
48489154|NCT01512979|155985330|FG001|Overall Study|Reason other than stated above|9|||
48489155|NCT02789111|155985331|FG000|Overall Study|Withdrawal by Subject|1|||
48489156|NCT02789111|155985332|FG001|Overall Study|Withdrawal by Subject|4|||
48489157|NCT03111147|155985333|FG000|Overall Study|Lost to Follow-up|2|||
48489158|NCT03111147|155985334|FG001|Overall Study|Lost to Follow-up|5|||
48489159|NCT03111147|155985333|FG000|Overall Study|Withdrawal by Subject|4|||
48489160|NCT03111147|155985334|FG001|Overall Study|Withdrawal by Subject|3|||
48489161|NCT03111147|155985333|FG000|Overall Study|Protocol Violation|2|||
48489162|NCT03111147|155985334|FG001|Overall Study|Protocol Violation|1|||
48489163|NCT03111147|155985333|FG000|Overall Study|Death|1|||
48489164|NCT03111147|155985334|FG001|Overall Study|Death|1|||
48489165|NCT04409002|155985338|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
48489166|NCT03740100|155985340|FG000|Overall Study|Adverse Event|1|||
48489167|NCT03740100|155985340|FG000|Overall Study|Death|1|||
48489168|NCT00319449|155985341|FG000|Overall Study|Subject did not wish to continue|1|||
48489169|NCT00319449|155985342|FG001|Overall Study|Subject did not wish to continue|0|||
48489170|NCT00319449|155985341|FG000|Overall Study|Noncompliance with the protocol|1|||
48489171|NCT00319449|155985342|FG001|Overall Study|Noncompliance with the protocol|0|||
48489172|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
48489173|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
48489174|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
48489175|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
48489176|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
48489177|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
48489178|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
48489179|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
48489180|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
48489181|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
48489182|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
48489183|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
48489184|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
48489185|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
48489186|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
48489187|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
48489188|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
48489189|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
48489190|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
48489191|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
48489192|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
48489193|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
48489194|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
48489195|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
48489196|NCT00455533|155985343|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
48489197|NCT00455533|155985344|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
48489198|NCT00455533|155985345|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
48489199|NCT00455533|155985343|FG000|Period Two: Randomized Period|Death|0|||
48489200|NCT00455533|155985344|FG001|Period Two: Randomized Period|Death|0|||
48701173|NCT03879772|156755203|FG004|Overall Study|Lost to Follow-up|1|||
48701174|NCT03879772|156755199|FG000|Overall Study|Withdrawal by Subject|0|||
48701175|NCT03879772|156755200|FG001|Overall Study|Withdrawal by Subject|1|||
48489201|NCT00455533|155985345|FG002|Period Two: Randomized Period|Death|3|||
48489202|NCT00455533|155985343|FG000|Period Two: Randomized Period|Disease Progression|0|||
48701176|NCT03879772|156755201|FG002|Overall Study|Withdrawal by Subject|3|||
48593986|NCT01471444|156368847|FG000|Overall Study|Physician Decision|3|||
48593987|NCT01471444|156368848|FG001|Overall Study|Physician Decision|2|||
48593988|NCT01471444|156368847|FG000|Overall Study|Withdrawal by Subject|0|||
48593989|NCT01471444|156368848|FG001|Overall Study|Withdrawal by Subject|1|||
48593990|NCT03251482|156368849|FG000|Overall Study|Withdrawal by Subject|0|||
48593991|NCT03251482|156368850|FG001|Overall Study|Withdrawal by Subject|1|||
48593992|NCT03251482|156368851|FG002|Overall Study|Withdrawal by Subject|0|||
48593993|NCT03251482|156368852|FG003|Overall Study|Withdrawal by Subject|0|||
48593994|NCT03251482|156368853|FG004|Overall Study|Withdrawal by Subject|0|||
48593995|NCT01911793|156368855|FG000|Overall Study|Physician Decision|1|||
48593996|NCT01911793|156368856|FG001|Overall Study|Physician Decision|5|||
48593997|NCT02697916|156368857|FG000|Overall Study|Death|357|||
48593998|NCT02697916|156368858|FG001|Overall Study|Death|315|||
48593999|NCT02697916|156368857|FG000|Overall Study|Withdrawal by Subject|221|||
48594000|NCT02697916|156368858|FG001|Overall Study|Withdrawal by Subject|393|||
48594001|NCT02447328|156368861|FG000|Overall Study|Withdrawal by Subject|1|||
48594002|NCT03915626|156368862|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
48594003|NCT02688764|156368869|FG000|Overall Study|Adverse Event|3|||
48594004|NCT02688764|156368870|FG001|Overall Study|Adverse Event|3|||
48594005|NCT02688764|156368869|FG000|Overall Study|AE/Kidney transplant|1|||
48594006|NCT02688764|156368870|FG001|Overall Study|AE/Kidney transplant|0|||
48594007|NCT02688764|156368869|FG000|Overall Study|AE/Lack of efficacy|1|||
48594008|NCT02688764|156368870|FG001|Overall Study|AE/Lack of efficacy|0|||
48594009|NCT02688764|156368869|FG000|Overall Study|AE/Non-compl.|1|||
48594010|NCT02688764|156368870|FG001|Overall Study|AE/Non-compl.|0|||
48594011|NCT02688764|156368869|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
48594012|NCT02688764|156368870|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
48594013|NCT02688764|156368869|FG000|Overall Study|AE/Other|0|||
48594014|NCT02688764|156368870|FG001|Overall Study|AE/Other|1|||
48594015|NCT02688764|156368869|FG000|Overall Study|AE/Physician decision|1|||
48594016|NCT02688764|156368870|FG001|Overall Study|AE/Physician decision|0|||
48594017|NCT02688764|156368869|FG000|Overall Study|AE/Withd. parent|3|||
48701177|NCT03879772|156755202|FG003|Overall Study|Withdrawal by Subject|1|||
48701178|NCT03879772|156755203|FG004|Overall Study|Withdrawal by Subject|1|||
48701179|NCT03879772|156755199|FG000|Overall Study|Protocol Violation|0|||
48701180|NCT03879772|156755200|FG001|Overall Study|Protocol Violation|0|||
48701181|NCT03879772|156755201|FG002|Overall Study|Protocol Violation|3|||
48701182|NCT03879772|156755202|FG003|Overall Study|Protocol Violation|1|||
48701183|NCT03879772|156755203|FG004|Overall Study|Protocol Violation|2|||
48701184|NCT03879772|156755199|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
48701185|NCT03879772|156755200|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
48701186|NCT03879772|156755201|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
48701187|NCT03879772|156755202|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
48701188|NCT03879772|156755203|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
48701189|NCT03697252|156755205|FG000|Overall Study|Adverse Event|3|||
48701190|NCT03697252|156755206|FG001|Overall Study|Adverse Event|2|||
48701191|NCT03697252|156755205|FG000|Overall Study|Withdrawal by Subject|14|||
48701192|NCT03697252|156755206|FG001|Overall Study|Withdrawal by Subject|14|||
48701193|NCT03697252|156755205|FG000|Overall Study|Lost to Follow-up|0|||
48701194|NCT03697252|156755206|FG001|Overall Study|Lost to Follow-up|1|||
48701195|NCT03697252|156755205|FG000|Overall Study|Physician Decision|1|||
48594018|NCT02688764|156368870|FG001|Overall Study|AE/Withd. parent|0|||
48594019|NCT02688764|156368869|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
48594020|NCT02688764|156368870|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
48594021|NCT02688764|156368869|FG000|Overall Study|AE/Withd. subject|1|||
48594022|NCT02688764|156368870|FG001|Overall Study|AE/Withd. subject|0|||
48594023|NCT02688764|156368869|FG000|Overall Study|Kidney transplant|10|||
48701196|NCT03697252|156755206|FG001|Overall Study|Physician Decision|1|||
48701197|NCT03697252|156755205|FG000|Overall Study|Other|0|||
48701198|NCT03697252|156755206|FG001|Overall Study|Other|1|||
48701199|NCT03125395|156755207|FG000|Overall Study|Adverse Event|2|||
48701200|NCT03125395|156755207|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
48701201|NCT03125395|156755207|FG000|Overall Study|Physician Decision|2|||
48701202|NCT03125395|156755207|FG000|Overall Study|Commercial drug is available|5|||
48701203|NCT04532528|156755208|FG000|Overall Study|Adverse Event|12|||
48594024|NCT02688764|156368870|FG001|Overall Study|Kidney transplant|4|||
48594025|NCT02688764|156368869|FG000|Overall Study|Lack of Efficacy|3|||
48594026|NCT02688764|156368870|FG001|Overall Study|Lack of Efficacy|2|||
48594027|NCT02688764|156368869|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
48594028|NCT02688764|156368870|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
48594029|NCT02688764|156368869|FG000|Overall Study|Non-compliance with study drug|4|||
48594030|NCT02688764|156368870|FG001|Overall Study|Non-compliance with study drug|0|||
48594031|NCT02688764|156368869|FG000|Overall Study|Non-compl./Physician decision|2|||
48594032|NCT02688764|156368870|FG001|Overall Study|Non-compl./Physician decision|0|||
48594033|NCT02688764|156368869|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
48701204|NCT04532528|156755209|FG001|Overall Study|Adverse Event|17|||
48701205|NCT04532528|156755208|FG000|Overall Study|Withdrawal of consent|16|||
48701206|NCT04532528|156755209|FG001|Overall Study|Withdrawal of consent|17|||
48701207|NCT04532528|156755208|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
48701208|NCT04532528|156755209|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
48701209|NCT04532528|156755208|FG000|Overall Study|Lost to Follow-up|69|||
48594034|NCT02688764|156368870|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
48594035|NCT02688764|156368869|FG000|Overall Study|Non-compl./Withd. subject|0|||
48594036|NCT02688764|156368870|FG001|Overall Study|Non-compl./Withd. subject|2|||
48594037|NCT02688764|156368869|FG000|Overall Study|Phosphorus level outside safe range|0|||
48594038|NCT02688764|156368870|FG001|Overall Study|Phosphorus level outside safe range|1|||
48594039|NCT02688764|156368869|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
48594040|NCT02688764|156368870|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
48594041|NCT02688764|156368869|FG000|Overall Study|Study drug taste/Withd. parent|1|||
48594042|NCT02688764|156368870|FG001|Overall Study|Study drug taste/Withd. parent|0|||
48594043|NCT02688764|156368869|FG000|Overall Study|Subject moving out|2|||
48594044|NCT02688764|156368870|FG001|Overall Study|Subject moving out|0|||
48594045|NCT02688764|156368869|FG000|Overall Study|Subject taken off dialysis|1|||
48594046|NCT02688764|156368870|FG001|Overall Study|Subject taken off dialysis|0|||
48594047|NCT02688764|156368869|FG000|Overall Study|Withdrawal by parent|3|||
48594048|NCT02688764|156368870|FG001|Overall Study|Withdrawal by parent|0|||
48594049|NCT02821416|156368871|FG000|Overall Study|Adverse Event|0|||
48594050|NCT02821416|156368872|FG001|Overall Study|Adverse Event|1|||
48594051|NCT02821416|156368871|FG000|Overall Study|Withdrawal by Subject|2|||
48594052|NCT02821416|156368872|FG001|Overall Study|Withdrawal by Subject|0|||
48594053|NCT02821416|156368871|FG000|Overall Study|Lost to Follow-up|1|||
48594054|NCT02821416|156368872|FG001|Overall Study|Lost to Follow-up|0|||
48594055|NCT04399889|156368873|FG000|Overall Study|Death|5|||
48594056|NCT04399889|156368874|FG001|Overall Study|Death|1|||
48594057|NCT04399889|156368875|FG002|Overall Study|Death|1|||
48594058|NCT01135524|156368876|FG000|Overall Study|Withdrawal by Subject|14|||
48594059|NCT01135524|156368876|FG000|Overall Study|Adverse Event|20|||
48594060|NCT01135524|156368876|FG000|Overall Study|Lost to Follow-up|3|||
48594061|NCT01135524|156368876|FG000|Overall Study|Administrative|151|||
48594062|NCT01135524|156368876|FG000|Overall Study|Lack of Efficacy|8|||
48594063|NCT03076515|156368877|FG000|Overall Study|DMC decision based on interim analysis|25|||
48594064|NCT03076515|156368878|FG001|Overall Study|DMC decision based on interim analysis|29|||
48594065|NCT02328937|156368879|FG000|Period 1|Lost to Follow-up|0|||
48594066|NCT02328937|156368880|FG001|Period 1|Lost to Follow-up|0|||
48594067|NCT02328937|156368881|FG002|Period 1|Lost to Follow-up|0|||
48594068|NCT02328937|156368882|FG003|Period 1|Lost to Follow-up|1|||
48594069|NCT02328937|156368883|FG004|Period 1|Lost to Follow-up|0|||
48701210|NCT04532528|156755209|FG001|Overall Study|Lost to Follow-up|68|||
48701211|NCT04532528|156755208|FG000|Overall Study|Administrative problems|12|||
48701212|NCT04532528|156755209|FG001|Overall Study|Administrative problems|14|||
48594070|NCT02328937|156368884|FG005|Period 1|Lost to Follow-up|0|||
48594071|NCT02328937|156368879|FG000|Period 2|Adverse Event|0|||
48594072|NCT02328937|156368880|FG001|Period 2|Adverse Event|0|||
48701213|NCT04532528|156755208|FG000|Overall Study|Death|3|||
48701214|NCT04532528|156755209|FG001|Overall Study|Death|3|||
48701215|NCT04532528|156755208|FG000|Overall Study|Other|38|||
48701216|NCT04532528|156755209|FG001|Overall Study|Other|46|||
48701217|NCT04030143|156755210|FG000|Overall Study|Adverse Event|5|||
48701218|NCT04030143|156755211|FG001|Overall Study|Adverse Event|10|||
48701219|NCT04030143|156755210|FG000|Overall Study|Lost to Follow-up|3|||
48701220|NCT04030143|156755211|FG001|Overall Study|Lost to Follow-up|7|||
48701221|NCT04030143|156755210|FG000|Overall Study|Protocol Deviation|2|||
48701222|NCT04030143|156755211|FG001|Overall Study|Protocol Deviation|2|||
48701223|NCT04030143|156755210|FG000|Overall Study|Withdrawal by Subject|16|||
48701224|NCT04030143|156755211|FG001|Overall Study|Withdrawal by Subject|18|||
48701225|NCT04030143|156755210|FG000|Overall Study|Physician Decision|1|||
48701226|NCT04030143|156755211|FG001|Overall Study|Physician Decision|1|||
48701227|NCT04030143|156755210|FG000|Overall Study|Due to Covid-19|2|||
48701228|NCT04030143|156755211|FG001|Overall Study|Due to Covid-19|3|||
48701229|NCT04030143|156755210|FG000|Overall Study|Not Due to Covid-19|1|||
48701230|NCT04030143|156755211|FG001|Overall Study|Not Due to Covid-19|1|||
48701231|NCT01499940|156755212|FG000|Overall Study|Study was withdrawn before completion.|9|||
48594073|NCT02328937|156368881|FG002|Period 2|Adverse Event|1|||
48594074|NCT02328937|156368882|FG003|Period 2|Adverse Event|0|||
48594075|NCT02328937|156368883|FG004|Period 2|Adverse Event|0|||
48594076|NCT02328937|156368884|FG005|Period 2|Adverse Event|0|||
48594077|NCT02959918|156368885|FG000|Overall Study|Adverse Event|1|||
48701232|NCT00538902|156755213|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
48701233|NCT00538902|156755214|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
48701234|NCT00538902|156755215|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
48594078|NCT02959918|156368886|FG001|Overall Study|Adverse Event|1|||
48594079|NCT02959918|156368887|FG002|Overall Study|Adverse Event|2|||
48594080|NCT02959918|156368888|FG003|Overall Study|Adverse Event|0|||
48594081|NCT02959918|156368889|FG004|Overall Study|Adverse Event|0|||
48594082|NCT02959918|156368890|FG005|Overall Study|Adverse Event|2|||
48594083|NCT02959918|156368891|FG006|Overall Study|Adverse Event|2|||
48594084|NCT02959918|156368892|FG007|Overall Study|Adverse Event|1|||
48594085|NCT02959918|156368893|FG008|Overall Study|Adverse Event|2|||
48594086|NCT02959918|156368894|FG009|Overall Study|Adverse Event|1|||
48594087|NCT02959918|156368895|FG010|Overall Study|Adverse Event|1|||
48594088|NCT02959918|156368896|FG011|Overall Study|Adverse Event|3|||
48594089|NCT02959918|156368897|FG012|Overall Study|Adverse Event|2|||
48594090|NCT02959918|156368898|FG013|Overall Study|Adverse Event|4|||
48594091|NCT02959918|156368885|FG000|Overall Study|Lost to Follow-up|0|||
48594092|NCT02959918|156368886|FG001|Overall Study|Lost to Follow-up|0|||
48594093|NCT02959918|156368887|FG002|Overall Study|Lost to Follow-up|0|||
48594094|NCT02959918|156368888|FG003|Overall Study|Lost to Follow-up|0|||
48594095|NCT02959918|156368889|FG004|Overall Study|Lost to Follow-up|0|||
48594096|NCT02959918|156368890|FG005|Overall Study|Lost to Follow-up|0|||
48594097|NCT02959918|156368891|FG006|Overall Study|Lost to Follow-up|0|||
48594098|NCT02959918|156368892|FG007|Overall Study|Lost to Follow-up|0|||
48594099|NCT02959918|156368893|FG008|Overall Study|Lost to Follow-up|0|||
48594100|NCT02959918|156368894|FG009|Overall Study|Lost to Follow-up|1|||
48594101|NCT02959918|156368895|FG010|Overall Study|Lost to Follow-up|0|||
48701235|NCT00538902|156755213|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
48701236|NCT00538902|156755214|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
48701237|NCT00538902|156755215|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
48701238|NCT00538902|156755213|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
48701239|NCT00538902|156755214|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
48701240|NCT00538902|156755215|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
48701241|NCT00538902|156755213|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
48701242|NCT00538902|156755214|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
48701243|NCT00538902|156755215|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
48701244|NCT00538902|156755213|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
48701245|NCT00538902|156755214|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
48701246|NCT00538902|156755215|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
48701247|NCT00538902|156755213|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
48701248|NCT00538902|156755214|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
48701249|NCT00538902|156755215|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
48701250|NCT00538902|156755213|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
48701251|NCT00538902|156755214|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
48701252|NCT00538902|156755215|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
48701253|NCT00538902|156755213|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
48701254|NCT00538902|156755214|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
48701255|NCT00538902|156755215|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
48701256|NCT04109547|156755217|FG000|Overall Study|Withdrawal by Subject|3|||
48701257|NCT04109547|156755218|FG001|Overall Study|Withdrawal by Subject|2|||
48701258|NCT04109547|156755219|FG002|Overall Study|Withdrawal by Subject|6|||
48701259|NCT04109547|156755220|FG003|Overall Study|Withdrawal by Subject|6|||
48701260|NCT04109547|156755217|FG000|Overall Study|Lost to Follow-up|0|||
48701261|NCT04109547|156755218|FG001|Overall Study|Lost to Follow-up|0|||
48701262|NCT04109547|156755219|FG002|Overall Study|Lost to Follow-up|0|||
48701263|NCT04109547|156755220|FG003|Overall Study|Lost to Follow-up|1|||
48701264|NCT04109547|156755217|FG000|Overall Study|Physician Decision|1|||
48701265|NCT04109547|156755218|FG001|Overall Study|Physician Decision|2|||
48701266|NCT04109547|156755219|FG002|Overall Study|Physician Decision|0|||
48701267|NCT04109547|156755220|FG003|Overall Study|Physician Decision|0|||
48701268|NCT04218240|156755221|FG000|Overall Study|Withdrawal by Subject|6|||
48701269|NCT04218240|156755222|FG001|Overall Study|Withdrawal by Subject|0|||
48701270|NCT04218240|156755221|FG000|Overall Study|Lack of Efficacy|24|||
48701271|NCT04218240|156755222|FG001|Overall Study|Lack of Efficacy|19|||
48701272|NCT04218240|156755221|FG000|Overall Study|Physician Decision|0|||
48701273|NCT04218240|156755222|FG001|Overall Study|Physician Decision|1|||
48701274|NCT04218240|156755221|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
48594102|NCT02959918|156368896|FG011|Overall Study|Lost to Follow-up|0|||
48594103|NCT02959918|156368897|FG012|Overall Study|Lost to Follow-up|1|||
48701275|NCT04218240|156755222|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
48701276|NCT05249582|156755227|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
48701277|NCT05249582|156755228|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
48701278|NCT05249582|156755227|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
48594104|NCT02959918|156368898|FG013|Overall Study|Lost to Follow-up|0|||
48594105|NCT02959918|156368885|FG000|Overall Study|Withdrawal by Subject|0|||
48594106|NCT02959918|156368886|FG001|Overall Study|Withdrawal by Subject|0|||
48594107|NCT02959918|156368887|FG002|Overall Study|Withdrawal by Subject|1|||
48594108|NCT02959918|156368888|FG003|Overall Study|Withdrawal by Subject|2|||
48594109|NCT02959918|156368889|FG004|Overall Study|Withdrawal by Subject|0|||
48594110|NCT02959918|156368890|FG005|Overall Study|Withdrawal by Subject|0|||
48594111|NCT02959918|156368891|FG006|Overall Study|Withdrawal by Subject|1|||
48594112|NCT02959918|156368892|FG007|Overall Study|Withdrawal by Subject|0|||
48594113|NCT02959918|156368893|FG008|Overall Study|Withdrawal by Subject|1|||
48594114|NCT02959918|156368894|FG009|Overall Study|Withdrawal by Subject|1|||
48594115|NCT02959918|156368895|FG010|Overall Study|Withdrawal by Subject|2|||
48594116|NCT02959918|156368896|FG011|Overall Study|Withdrawal by Subject|3|||
48594117|NCT02959918|156368897|FG012|Overall Study|Withdrawal by Subject|1|||
48594118|NCT02959918|156368898|FG013|Overall Study|Withdrawal by Subject|1|||
48594119|NCT02959918|156368885|FG000|Overall Study|Protocol Violation|0|||
48594120|NCT02959918|156368886|FG001|Overall Study|Protocol Violation|0|||
48594121|NCT02959918|156368887|FG002|Overall Study|Protocol Violation|1|||
48594122|NCT02959918|156368888|FG003|Overall Study|Protocol Violation|0|||
48594123|NCT02959918|156368889|FG004|Overall Study|Protocol Violation|0|||
48594124|NCT02959918|156368890|FG005|Overall Study|Protocol Violation|1|||
48701279|NCT05249582|156755228|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
48701280|NCT05249582|156755227|FG000|Overall Study|Declined to use virtual reality headset|1|||
48701281|NCT05249582|156755228|FG001|Overall Study|Declined to use virtual reality headset|0|||
48701282|NCT01498068|156755232|FG000|Overall Study|Withdrawal by Subject|1|||
48701283|NCT01498068|156755233|FG001|Overall Study|Withdrawal by Subject|1|||
48701284|NCT00551642|156755237|FG000|Treatment Period|Protocol Deviation|6|||
48701285|NCT00551642|156755238|FG001|Treatment Period|Protocol Deviation|11|||
48701286|NCT00551642|156755237|FG000|Treatment Period|Delivery device failure|1|||
48701287|NCT00551642|156755238|FG001|Treatment Period|Delivery device failure|3|||
48701288|NCT00551642|156755237|FG000|Treatment Period|Physician Decision|0|||
48701289|NCT00551642|156755238|FG001|Treatment Period|Physician Decision|1|||
48701290|NCT00551642|156755237|FG000|Treatment Period|Death|33|||
48701291|NCT00551642|156755238|FG001|Treatment Period|Death|31|||
48701292|NCT00551642|156755237|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
48701293|NCT00551642|156755238|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
48701294|NCT00551642|156755237|FG000|Treatment Period|Adverse Event|15|||
48701295|NCT00551642|156755238|FG001|Treatment Period|Adverse Event|12|||
48701296|NCT00551642|156755237|FG000|Treatment Period|Withdrawal by Subject|2|||
48701297|NCT00551642|156755238|FG001|Treatment Period|Withdrawal by Subject|1|||
48489203|NCT00455533|155985344|FG001|Period Two: Randomized Period|Disease Progression|1|||
48489204|NCT00455533|155985345|FG002|Period Two: Randomized Period|Disease Progression|1|||
48489205|NCT00455533|155985343|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
48489206|NCT00455533|155985344|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
48489207|NCT00455533|155985345|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
48489208|NCT00455533|155985343|FG000|Period Two: Randomized Period|Other - need reasons|0|||
48489209|NCT00455533|155985344|FG001|Period Two: Randomized Period|Other - need reasons|1|||
48489210|NCT00455533|155985345|FG002|Period Two: Randomized Period|Other - need reasons|0|||
48489211|NCT00455533|155985343|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
48489212|NCT00455533|155985344|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
48489213|NCT00455533|155985345|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
48489214|NCT00455533|155985343|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
48489215|NCT00455533|155985344|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
48489216|NCT00455533|155985345|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
48489217|NCT01025193|155985346|FG000|Overall Study|Protocol Violation|1|||
48489218|NCT01025193|155985346|FG000|Overall Study|Adverse Event|3|||
48489219|NCT02904200|155985347|FG000|Overall Study|Withdrawal by Subject|1|||
48489220|NCT02904200|155985348|FG001|Overall Study|Withdrawal by Subject|0|||
48489221|NCT00254397|155985350|FG000|Overall Study|Disease Progression|4|||
48489222|NCT00254397|155985351|FG001|Overall Study|Disease Progression|1|||
48489223|NCT00254397|155985352|FG002|Overall Study|Disease Progression|16|||
48489224|NCT00254397|155985353|FG003|Overall Study|Disease Progression|23|||
48594125|NCT02959918|156368891|FG006|Overall Study|Protocol Violation|0|||
48701298|NCT01409707|156755244|FG000|Overall Study|Withdrawal by Subject|5|||
48701299|NCT01409707|156755245|FG001|Overall Study|Withdrawal by Subject|17|||
48701300|NCT01409707|156755246|FG002|Overall Study|Withdrawal by Subject|16|||
48701301|NCT00888134|156755251|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
48701302|NCT00888134|156755251|FG000|Follow-up|being followed for long-term survival|1|||
48701303|NCT02667119|156755252|FG000|Overall Study|Lost to Follow-up|3|||
48701304|NCT02667119|156755253|FG001|Overall Study|Lost to Follow-up|0|||
48701305|NCT00432172|156755254|FG000|Overall Study|Physician Decision|0|||
48701306|NCT00432172|156755255|FG001|Overall Study|Physician Decision|0|||
48701307|NCT00432172|156755256|FG002|Overall Study|Physician Decision|2|||
48489225|NCT00254397|155985350|FG000|Overall Study|Non-Compliant|0|||
48489226|NCT00254397|155985351|FG001|Overall Study|Non-Compliant|0|||
48594126|NCT02959918|156368892|FG007|Overall Study|Protocol Violation|0|||
48594127|NCT02959918|156368893|FG008|Overall Study|Protocol Violation|2|||
48594128|NCT02959918|156368894|FG009|Overall Study|Protocol Violation|1|||
48701308|NCT00432172|156755257|FG003|Overall Study|Physician Decision|0|||
48701309|NCT00432172|156755254|FG000|Overall Study|Adverse Event|4|||
48701310|NCT00432172|156755255|FG001|Overall Study|Adverse Event|2|||
48701311|NCT00432172|156755256|FG002|Overall Study|Adverse Event|4|||
48701312|NCT00432172|156755257|FG003|Overall Study|Adverse Event|3|||
48701313|NCT00432172|156755254|FG000|Overall Study|Disease progression|0|||
48701314|NCT00432172|156755255|FG001|Overall Study|Disease progression|2|||
48701315|NCT00432172|156755256|FG002|Overall Study|Disease progression|5|||
48701316|NCT00432172|156755257|FG003|Overall Study|Disease progression|1|||
48701317|NCT00432172|156755254|FG000|Overall Study|Withdrawal by Subject|0|||
48701318|NCT00432172|156755255|FG001|Overall Study|Withdrawal by Subject|1|||
48701319|NCT00432172|156755256|FG002|Overall Study|Withdrawal by Subject|0|||
48701320|NCT00432172|156755257|FG003|Overall Study|Withdrawal by Subject|2|||
48701321|NCT00432172|156755254|FG000|Overall Study|No treatment received|2|||
48701322|NCT00432172|156755255|FG001|Overall Study|No treatment received|2|||
48701323|NCT00432172|156755256|FG002|Overall Study|No treatment received|0|||
48701324|NCT00432172|156755257|FG003|Overall Study|No treatment received|1|||
48701325|NCT00935584|156755260|FG000|Overall Study|Withdrawal by Subject|9|||
48701326|NCT00935584|156755261|FG001|Overall Study|Withdrawal by Subject|0|||
48701327|NCT00935584|156755260|FG000|Overall Study|Death|3|||
48701328|NCT00935584|156755261|FG001|Overall Study|Death|0|||
48701329|NCT00935584|156755260|FG000|Overall Study|Lost to Follow-up|8|||
48701330|NCT00935584|156755261|FG001|Overall Study|Lost to Follow-up|0|||
48701331|NCT00935584|156755260|FG000|Overall Study|No show|9|||
48701332|NCT00935584|156755261|FG001|Overall Study|No show|0|||
48701333|NCT00935584|156755260|FG000|Overall Study|Relocated|3|||
48594129|NCT02959918|156368895|FG010|Overall Study|Protocol Violation|0|||
48594130|NCT02959918|156368896|FG011|Overall Study|Protocol Violation|1|||
48594131|NCT02959918|156368897|FG012|Overall Study|Protocol Violation|1|||
48594132|NCT02959918|156368898|FG013|Overall Study|Protocol Violation|0|||
48594133|NCT02959918|156368885|FG000|Overall Study|Stopping Rule Met|1|||
48594134|NCT02959918|156368886|FG001|Overall Study|Stopping Rule Met|0|||
48594135|NCT02959918|156368887|FG002|Overall Study|Stopping Rule Met|3|||
48594136|NCT02959918|156368888|FG003|Overall Study|Stopping Rule Met|4|||
48594137|NCT02959918|156368889|FG004|Overall Study|Stopping Rule Met|5|||
48594138|NCT02959918|156368890|FG005|Overall Study|Stopping Rule Met|3|||
48594139|NCT02959918|156368891|FG006|Overall Study|Stopping Rule Met|2|||
48594140|NCT02959918|156368892|FG007|Overall Study|Stopping Rule Met|4|||
48594141|NCT02959918|156368893|FG008|Overall Study|Stopping Rule Met|1|||
48594142|NCT02959918|156368894|FG009|Overall Study|Stopping Rule Met|1|||
48594143|NCT02959918|156368895|FG010|Overall Study|Stopping Rule Met|3|||
48594144|NCT02959918|156368896|FG011|Overall Study|Stopping Rule Met|5|||
48594145|NCT02959918|156368897|FG012|Overall Study|Stopping Rule Met|2|||
48594146|NCT02959918|156368898|FG013|Overall Study|Stopping Rule Met|1|||
48594147|NCT02959918|156368885|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
48594148|NCT02959918|156368886|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
48594149|NCT02959918|156368887|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
48594150|NCT02959918|156368888|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
48594151|NCT02959918|156368889|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594152|NCT02959918|156368890|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594153|NCT02959918|156368891|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594154|NCT02959918|156368892|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594155|NCT02959918|156368893|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594156|NCT02959918|156368894|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594157|NCT02959918|156368895|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594158|NCT02959918|156368896|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594159|NCT02959918|156368897|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594160|NCT02959918|156368898|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
48594161|NCT02959918|156368885|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594162|NCT02959918|156368886|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594163|NCT02959918|156368887|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594164|NCT02959918|156368888|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48701334|NCT00935584|156755261|FG001|Overall Study|Relocated|0|||
48701335|NCT00935584|156755260|FG000|Overall Study|Patient changed provider|3|||
48701336|NCT00935584|156755261|FG001|Overall Study|Patient changed provider|0|||
48701337|NCT00935584|156755260|FG000|Overall Study|Provider dropped out of study|14|||
48701338|NCT00935584|156755261|FG001|Overall Study|Provider dropped out of study|4|||
48701339|NCT00791934|156755273|FG000|Overall Study|Withdrawal by Subject|2|||
48701340|NCT00791934|156755273|FG000|Overall Study|Did not consent for extended follow-up|13|||
48701341|NCT00541658|156755275|FG000|Overall Study|Adverse Event|28|||
48701342|NCT00541658|156755276|FG001|Overall Study|Adverse Event|37|||
48701343|NCT00541658|156755277|FG002|Overall Study|Adverse Event|25|||
48701344|NCT00541658|156755275|FG000|Overall Study|Physician Decision|0|||
48594165|NCT02959918|156368889|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594166|NCT02959918|156368890|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594167|NCT02959918|156368891|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594168|NCT02959918|156368892|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
48594169|NCT02959918|156368893|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594170|NCT02959918|156368894|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594171|NCT02959918|156368895|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594172|NCT02959918|156368896|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594173|NCT02959918|156368897|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594174|NCT02959918|156368898|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
48594175|NCT02959918|156368885|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594176|NCT02959918|156368886|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594177|NCT02959918|156368887|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594178|NCT02959918|156368888|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594179|NCT02959918|156368889|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594180|NCT02959918|156368890|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594181|NCT02959918|156368891|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48701345|NCT00541658|156755276|FG001|Overall Study|Physician Decision|0|||
48701346|NCT00541658|156755277|FG002|Overall Study|Physician Decision|4|||
48701347|NCT00541658|156755275|FG000|Overall Study|Lost to Follow-up|3|||
48701348|NCT00541658|156755276|FG001|Overall Study|Lost to Follow-up|3|||
48489227|NCT00254397|155985352|FG002|Overall Study|Non-Compliant|0|||
48489228|NCT00254397|155985353|FG003|Overall Study|Non-Compliant|1|||
48489229|NCT00254397|155985350|FG000|Overall Study|Adverse Event|2|||
48489230|NCT00254397|155985351|FG001|Overall Study|Adverse Event|0|||
48489231|NCT00254397|155985352|FG002|Overall Study|Adverse Event|3|||
48489232|NCT00254397|155985353|FG003|Overall Study|Adverse Event|1|||
48489233|NCT01098240|155985354|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
48489234|NCT01098240|155985355|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
48489235|NCT01098240|155985356|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
48489236|NCT01098240|155985354|FG000|Open-Label Phase|Protocol Violation|4|||
48489237|NCT01098240|155985355|FG001|Open-Label Phase|Protocol Violation|0|||
48701349|NCT00541658|156755277|FG002|Overall Study|Lost to Follow-up|6|||
48701350|NCT00541658|156755275|FG000|Overall Study|Protocol Violation|0|||
48701351|NCT00541658|156755276|FG001|Overall Study|Protocol Violation|1|||
48701352|NCT00541658|156755277|FG002|Overall Study|Protocol Violation|1|||
48701353|NCT00541658|156755275|FG000|Overall Study|Withdrawal by Subject|28|||
48489238|NCT01098240|155985356|FG002|Open-Label Phase|Protocol Violation|0|||
48489239|NCT01098240|155985354|FG000|Open-Label Phase|Lost to Follow-up|13|||
48489240|NCT01098240|155985355|FG001|Open-Label Phase|Lost to Follow-up|0|||
48489241|NCT01098240|155985356|FG002|Open-Label Phase|Lost to Follow-up|0|||
48489242|NCT01098240|155985354|FG000|Open-Label Phase|Other|19|||
48489243|NCT01098240|155985355|FG001|Open-Label Phase|Other|0|||
48489244|NCT01098240|155985356|FG002|Open-Label Phase|Other|0|||
48489245|NCT01098240|155985354|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
48489246|NCT01098240|155985355|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
48489247|NCT01098240|155985356|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
48489248|NCT01098240|155985354|FG000|Open-Label Phase|Pregnancy|1|||
48489249|NCT01098240|155985355|FG001|Open-Label Phase|Pregnancy|0|||
48489250|NCT01098240|155985356|FG002|Open-Label Phase|Pregnancy|0|||
48701354|NCT00541658|156755276|FG001|Overall Study|Withdrawal by Subject|32|||
48701355|NCT00541658|156755277|FG002|Overall Study|Withdrawal by Subject|32|||
48701356|NCT00541658|156755275|FG000|Overall Study|Took No Study Drug|1|||
48701357|NCT00541658|156755276|FG001|Overall Study|Took No Study Drug|0|||
48701358|NCT00541658|156755277|FG002|Overall Study|Took No Study Drug|0|||
48701359|NCT00536744|156755278|FG000|Overall Study|Adverse Event|13|||
48701360|NCT00536744|156755279|FG001|Overall Study|Adverse Event|10|||
48701361|NCT00536744|156755278|FG000|Overall Study|Death|2|||
48701362|NCT00536744|156755279|FG001|Overall Study|Death|1|||
48701363|NCT00536744|156755278|FG000|Overall Study|Physician Decision|3|||
48701364|NCT00536744|156755279|FG001|Overall Study|Physician Decision|1|||
48701365|NCT00536744|156755278|FG000|Overall Study|Lost to Follow-up|3|||
48701366|NCT00536744|156755279|FG001|Overall Study|Lost to Follow-up|5|||
48701367|NCT00536744|156755278|FG000|Overall Study|Withdrawal by Subject|7|||
48701368|NCT00536744|156755279|FG001|Overall Study|Withdrawal by Subject|8|||
48701369|NCT00536744|156755278|FG000|Overall Study|PI tried alternative treatment|1|||
48701370|NCT00536744|156755279|FG001|Overall Study|PI tried alternative treatment|3|||
48701371|NCT05408429|156755280|FG000|Overall Study|Lost to Follow-up|1|||
48489251|NCT01098240|155985354|FG000|Open-Label Phase|Withdrawal by Subject|9|||
48489252|NCT01098240|155985355|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48489253|NCT01098240|155985356|FG002|Open-Label Phase|Withdrawal by Subject|0|||
48489254|NCT01098240|155985354|FG000|Open-Label Phase|Adverse Event|12|||
48489255|NCT01098240|155985355|FG001|Open-Label Phase|Adverse Event|0|||
48594182|NCT02959918|156368892|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594183|NCT02959918|156368893|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
48594184|NCT02959918|156368894|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594185|NCT02959918|156368895|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594186|NCT02959918|156368896|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594187|NCT02959918|156368897|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594188|NCT02959918|156368898|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
48594189|NCT02959918|156368885|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594190|NCT02959918|156368886|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594191|NCT02959918|156368887|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594192|NCT02959918|156368888|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594193|NCT02959918|156368889|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594194|NCT02959918|156368890|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594195|NCT02959918|156368891|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594196|NCT02959918|156368892|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594197|NCT02959918|156368893|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594198|NCT02959918|156368894|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
48594199|NCT02959918|156368895|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594200|NCT02959918|156368896|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594201|NCT02959918|156368897|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594202|NCT02959918|156368898|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
48594203|NCT01502033|156368901|FG000|Overall Study|1 participant had scalp discomfort|1|||
48594204|NCT01502033|156368901|FG000|Overall Study|1 participant had worsening depression|1|||
48594205|NCT01502033|156368901|FG000|Overall Study|1 participant went back to school|1|||
48594206|NCT01424241|156368902|FG000|Overall Study|Withdrawal by Subject|1|||
48594207|NCT01424241|156368902|FG000|Overall Study|Time constraints|2|||
48701372|NCT05408429|156755281|FG001|Overall Study|Lost to Follow-up|1|||
48701373|NCT05408429|156755282|FG002|Overall Study|Lost to Follow-up|0|||
48701374|NCT05408429|156755280|FG000|Overall Study|Withdrawal by Subject|5|||
48701375|NCT05408429|156755281|FG001|Overall Study|Withdrawal by Subject|0|||
48701376|NCT05408429|156755282|FG002|Overall Study|Withdrawal by Subject|1|||
48701377|NCT05530252|156755284|FG000|Overall Study|Lost to Follow-up|1|||
48701378|NCT05530252|156755285|FG001|Overall Study|Lost to Follow-up|1|||
48701379|NCT05530252|156755286|FG002|Overall Study|Lost to Follow-up|1|||
48701380|NCT03818256|156755288|FG000|Overall Study|Withdrawal by Subject|2|||
48701381|NCT03818256|156755289|FG001|Overall Study|Withdrawal by Subject|2|||
48701382|NCT03818256|156755288|FG000|Overall Study|Adverse Event|3|||
48701383|NCT03818256|156755289|FG001|Overall Study|Adverse Event|1|||
48701384|NCT03818256|156755288|FG000|Overall Study|Lost to Follow-up|0|||
48701385|NCT03818256|156755289|FG001|Overall Study|Lost to Follow-up|5|||
48701386|NCT03818256|156755288|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
48701387|NCT03818256|156755289|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
48701388|NCT03818256|156755288|FG000|Overall Study|Not reporting for scheduled visits|1|||
48701389|NCT03818256|156755289|FG001|Overall Study|Not reporting for scheduled visits|0|||
48701390|NCT03818256|156755288|FG000|Overall Study|Non-compliant with investigational product|1|||
48701391|NCT03818256|156755289|FG001|Overall Study|Non-compliant with investigational product|0|||
48701392|NCT01074970|156755292|FG000|Overall Study|Never Treated|0|||
48701393|NCT01074970|156755293|FG001|Overall Study|Never Treated|0|||
48701394|NCT01074970|156755294|FG002|Overall Study|Never Treated|8|||
48701395|NCT01074970|156755295|FG003|Overall Study|Never Treated|1|||
48701396|NCT01074970|156755292|FG000|Overall Study|Adverse Event|1|||
48701397|NCT01074970|156755293|FG001|Overall Study|Adverse Event|0|||
48701398|NCT01074970|156755294|FG002|Overall Study|Adverse Event|4|||
48701399|NCT01074970|156755295|FG003|Overall Study|Adverse Event|3|||
48701400|NCT01074970|156755292|FG000|Overall Study|Disease progression during treatment|3|||
48701401|NCT01074970|156755293|FG001|Overall Study|Disease progression during treatment|1|||
48701402|NCT01074970|156755294|FG002|Overall Study|Disease progression during treatment|2|||
48701403|NCT01074970|156755295|FG003|Overall Study|Disease progression during treatment|9|||
48701404|NCT01074970|156755292|FG000|Overall Study|Lost to Follow-up|0|||
48701405|NCT01074970|156755293|FG001|Overall Study|Lost to Follow-up|0|||
48701406|NCT01074970|156755294|FG002|Overall Study|Lost to Follow-up|1|||
48701407|NCT01074970|156755295|FG003|Overall Study|Lost to Follow-up|0|||
48701408|NCT01074970|156755292|FG000|Overall Study|Withdrawal by Subject|0|||
48701409|NCT01074970|156755293|FG001|Overall Study|Withdrawal by Subject|0|||
48701410|NCT01074970|156755294|FG002|Overall Study|Withdrawal by Subject|6|||
48701411|NCT01074970|156755295|FG003|Overall Study|Withdrawal by Subject|4|||
48701412|NCT04314284|156755296|FG000|Overall Study|Withdrawal by Subject|4|||
48701413|NCT04314284|156755297|FG001|Overall Study|Withdrawal by Subject|7|||
48701414|NCT04314284|156755296|FG000|Overall Study|Consented but did not complete survey|0|||
48701415|NCT04314284|156755297|FG001|Overall Study|Consented but did not complete survey|6|||
48701416|NCT02991768|156755302|FG000|Overall Study|Physician Decision|4|||
48489256|NCT01098240|155985356|FG002|Open-Label Phase|Adverse Event|0|||
48489257|NCT01098240|155985354|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
48489258|NCT01098240|155985355|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
48489259|NCT01098240|155985356|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
48489260|NCT01098240|155985354|FG000|Double-Blind Phase|Protocol Violation|0|||
48489261|NCT01098240|155985355|FG001|Double-Blind Phase|Protocol Violation|2|||
48489262|NCT01098240|155985356|FG002|Double-Blind Phase|Protocol Violation|4|||
48489263|NCT01098240|155985354|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48489264|NCT01098240|155985355|FG001|Double-Blind Phase|Lost to Follow-up|2|||
48489265|NCT01098240|155985356|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48489266|NCT01098240|155985354|FG000|Double-Blind Phase|Other|0|||
48489267|NCT01098240|155985355|FG001|Double-Blind Phase|Other|2|||
48489268|NCT01098240|155985356|FG002|Double-Blind Phase|Other|2|||
48489269|NCT01098240|155985354|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
48489270|NCT01098240|155985355|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
48489271|NCT01098240|155985356|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
48489272|NCT01098240|155985354|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
48489273|NCT01098240|155985355|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
48489274|NCT01098240|155985356|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
48489275|NCT01098240|155985354|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
48489276|NCT01098240|155985355|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
48489277|NCT01098240|155985356|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
48489278|NCT01098240|155985354|FG000|Double-Blind Phase|Adverse Event|0|||
48489279|NCT01098240|155985355|FG001|Double-Blind Phase|Adverse Event|3|||
48489280|NCT01098240|155985356|FG002|Double-Blind Phase|Adverse Event|3|||
48489281|NCT01133392|155985357|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
48489282|NCT01133392|155985358|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
48489283|NCT01133392|155985357|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
48489284|NCT01133392|155985358|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
48489285|NCT03280537|155985359|FG000|Overall Study|Withdrawal by Subject|2|||
48489286|NCT03280537|155985360|FG001|Overall Study|Withdrawal by Subject|4|||
48701417|NCT04163341|156755303|FG000|Overall Study|Withdrawal by Subject|2|||
48701418|NCT04163341|156755304|FG001|Overall Study|Withdrawal by Subject|0|||
48701419|NCT04163341|156755303|FG000|Overall Study|Lost to Follow-up|3|||
48701420|NCT04163341|156755304|FG001|Overall Study|Lost to Follow-up|4|||
48701421|NCT02201953|156755306|FG000|Overall Study|Randomized but Never Treated|1|||
48701422|NCT02201953|156755307|FG001|Overall Study|Randomized but Never Treated|5|||
48701423|NCT02201953|156755306|FG000|Overall Study|Lack of Efficacy|9|||
48701424|NCT02201953|156755307|FG001|Overall Study|Lack of Efficacy|30|||
48701425|NCT02201953|156755306|FG000|Overall Study|Lost to Follow-up|8|||
48701426|NCT02201953|156755307|FG001|Overall Study|Lost to Follow-up|8|||
48701427|NCT02201953|156755306|FG000|Overall Study|Withdrew Consent|2|||
48701428|NCT02201953|156755307|FG001|Overall Study|Withdrew Consent|5|||
48701429|NCT02201953|156755306|FG000|Overall Study|Adverse Event|0|||
48701430|NCT02201953|156755307|FG001|Overall Study|Adverse Event|5|||
48701431|NCT02201953|156755306|FG000|Overall Study|Death|0|||
48701432|NCT02201953|156755307|FG001|Overall Study|Death|3|||
48701433|NCT04730804|156755311|FG000|Overall Study|Physician Decision|0|||
48701434|NCT04730804|156755312|FG001|Overall Study|Physician Decision|0|||
48701435|NCT04730804|156755313|FG002|Overall Study|Physician Decision|0|||
48701436|NCT04730804|156755314|FG003|Overall Study|Physician Decision|0|||
48701437|NCT04730804|156755315|FG004|Overall Study|Physician Decision|0|||
48701438|NCT04730804|156755316|FG005|Overall Study|Physician Decision|1|||
48701439|NCT04730804|156755311|FG000|Overall Study|Withdrawal by Subject|0|||
48701440|NCT04730804|156755312|FG001|Overall Study|Withdrawal by Subject|0|||
48701441|NCT04730804|156755313|FG002|Overall Study|Withdrawal by Subject|0|||
48701442|NCT04730804|156755314|FG003|Overall Study|Withdrawal by Subject|0|||
48701443|NCT04730804|156755315|FG004|Overall Study|Withdrawal by Subject|1|||
48701444|NCT04730804|156755316|FG005|Overall Study|Withdrawal by Subject|2|||
48701445|NCT01615939|156756960|FG000|Overall Study|Lost to Follow-up|5|||
48701446|NCT01615939|156756961|FG001|Overall Study|Lost to Follow-up|0|||
48701447|NCT02121535|156756962|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
48701448|NCT02121535|156756963|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
48489287|NCT01588106|155985361|FG000|Overall Study|Withdrawal by Subject|5|||
48489288|NCT01588106|155985362|FG001|Overall Study|Withdrawal by Subject|4|||
48489289|NCT01759537|155985363|FG000|Overall Study|Death|1|||
48489290|NCT01759537|155985364|FG001|Overall Study|Death|1|||
48489291|NCT01759537|155985363|FG000|Overall Study|Pregnancy|1|||
48701449|NCT02121535|156756962|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
48701450|NCT02121535|156756963|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
48701451|NCT01295814|156756964|FG000|Overall Study|Lack of Efficacy|0|||
48701452|NCT01295814|156756965|FG001|Overall Study|Lack of Efficacy|2|||
48701453|NCT01295814|156756964|FG000|Overall Study|Withdrawal by Subject|2|||
48701454|NCT01295814|156756965|FG001|Overall Study|Withdrawal by Subject|0|||
48701455|NCT01084655|156756969|FG000|Overall Study|Radiographic disease progression|3|||
48701456|NCT01084655|156756970|FG001|Overall Study|Radiographic disease progression|2|||
48701457|NCT01084655|156756971|FG002|Overall Study|Radiographic disease progression|8|||
48701458|NCT01084655|156756969|FG000|Overall Study|Withdrawal by Subject|1|||
48701459|NCT01084655|156756970|FG001|Overall Study|Withdrawal by Subject|0|||
48701460|NCT01084655|156756971|FG002|Overall Study|Withdrawal by Subject|4|||
48701461|NCT01084655|156756969|FG000|Overall Study|Adverse Event|2|||
48701462|NCT01084655|156756970|FG001|Overall Study|Adverse Event|1|||
48701463|NCT01084655|156756971|FG002|Overall Study|Adverse Event|2|||
48701464|NCT01084655|156756969|FG000|Overall Study|Other|0|||
48701465|NCT01084655|156756970|FG001|Overall Study|Other|3|||
48701466|NCT01084655|156756971|FG002|Overall Study|Other|2|||
48701467|NCT01084655|156756969|FG000|Overall Study|Symptomatic deterioration|0|||
48701468|NCT01084655|156756970|FG001|Overall Study|Symptomatic deterioration|0|||
48701469|NCT01084655|156756971|FG002|Overall Study|Symptomatic deterioration|2|||
48701470|NCT01084655|156756969|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
48701471|NCT01084655|156756970|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
48701472|NCT01084655|156756971|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
48701473|NCT02083354|156756972|FG000|Overall Study|Withdrawal by Subject|9|||
48701474|NCT02083354|156756972|FG000|Overall Study|Lost to Follow-up|1|||
48701475|NCT02083354|156756972|FG000|Overall Study|Adverse Event|3|||
48701476|NCT02083354|156756972|FG000|Overall Study|Disease progression|46|||
48701477|NCT02083354|156756972|FG000|Overall Study|Study closed/terminated|5|||
48701478|NCT03312634|156756975|FG000|Overall Study|Adverse Event|11|||
48701479|NCT03312634|156756976|FG001|Overall Study|Adverse Event|0|||
48701480|NCT03312634|156756975|FG000|Overall Study|Sponsor request|2|||
48701481|NCT03312634|156756976|FG001|Overall Study|Sponsor request|0|||
48701482|NCT03312634|156756975|FG000|Overall Study|Withdrawal by Subject|31|||
48701483|NCT03312634|156756976|FG001|Overall Study|Withdrawal by Subject|9|||
48701484|NCT03312634|156756975|FG000|Overall Study|Enrolled in an interventional study|0|||
48701485|NCT03312634|156756976|FG001|Overall Study|Enrolled in an interventional study|52|||
48701486|NCT03312634|156756975|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
48701487|NCT03312634|156756976|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
48489292|NCT01759537|155985364|FG001|Overall Study|Pregnancy|1|||
48489293|NCT01759537|155985363|FG000|Overall Study|Lost to Follow-up|9|||
48489294|NCT01759537|155985364|FG001|Overall Study|Lost to Follow-up|9|||
48489295|NCT01759537|155985363|FG000|Overall Study|Accident involving jaw fracture|1|||
48489296|NCT01759537|155985364|FG001|Overall Study|Accident involving jaw fracture|1|||
48489297|NCT01759537|155985363|FG000|Overall Study|Subcrestal implant too coronal|1|||
48489298|NCT01759537|155985364|FG001|Overall Study|Subcrestal implant too coronal|1|||
48489299|NCT00003782|155985365|FG000|Overall Study|No follow up data|30|||
48489300|NCT00003782|155985366|FG001|Overall Study|No follow up data|31|||
48489301|NCT00003782|155985367|FG002|Overall Study|No follow up data|26|||
48489302|NCT04603937|155985369|FG000|Overall Study|Adverse Event|9|||
48489303|NCT04603937|155985370|FG001|Overall Study|Adverse Event|10|||
48489304|NCT04603937|155985369|FG000|Overall Study|Withdrawal by Subject|7|||
48489305|NCT04603937|155985370|FG001|Overall Study|Withdrawal by Subject|6|||
48489306|NCT04603937|155985369|FG000|Overall Study|Lost to Follow-up|5|||
48489307|NCT04603937|155985370|FG001|Overall Study|Lost to Follow-up|6|||
48489308|NCT04603937|155985369|FG000|Overall Study|Physician Decision|0|||
48489309|NCT04603937|155985370|FG001|Overall Study|Physician Decision|1|||
48489310|NCT04603937|155985369|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
48489311|NCT04603937|155985370|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
48489312|NCT02962882|155986998|FG000|Overall Study|Adverse Event|2|||
48489313|NCT02962882|155986998|FG000|Overall Study|Withdrawal by Subject|2|||
48489314|NCT02962882|155986998|FG000|Overall Study|Transfer from ICU|32|||
48489315|NCT00707174|155986999|FG000|Overall Study|Adverse Event|1|||
48489316|NCT00707174|155987000|FG001|Overall Study|Adverse Event|6|||
48489317|NCT00707174|155986999|FG000|Overall Study|Withdrawal by Subject|4|||
48489318|NCT00707174|155987000|FG001|Overall Study|Withdrawal by Subject|1|||
48489319|NCT00544557|155987001|FG000|Overall Study|Adverse Event|140|||
48489320|NCT00544557|155987001|FG000|Overall Study|Lack of Efficacy|196|||
48489321|NCT00544557|155987001|FG000|Overall Study|Other|98|||
48489322|NCT03763331|155987002|FG000|Overall Study|Lost to Follow-up|1|||
48489323|NCT03763331|155987003|FG001|Overall Study|Lost to Follow-up|0|||
48489324|NCT03763331|155987002|FG000|Overall Study|Withdrawal by Subject|1|||
48489325|NCT03763331|155987003|FG001|Overall Study|Withdrawal by Subject|0|||
48489326|NCT03763331|155987002|FG000|Overall Study|Non-compliance|0|||
48489327|NCT03763331|155987003|FG001|Overall Study|Non-compliance|3|||
48489328|NCT01312779|155987004|FG000|Overall Study|Withdrawal by Subject|2|||
48489329|NCT01312779|155987004|FG000|Overall Study|Death|3|||
48701488|NCT03312634|156756975|FG000|Overall Study|Death|0|||
48701489|NCT03312634|156756976|FG001|Overall Study|Death|1|||
48701490|NCT03312634|156756975|FG000|Overall Study|Non-compliance|0|||
48701491|NCT03312634|156756976|FG001|Overall Study|Non-compliance|2|||
48701492|NCT03312634|156756975|FG000|Overall Study|Lost to Follow-up|0|||
48701493|NCT03312634|156756976|FG001|Overall Study|Lost to Follow-up|1|||
48701494|NCT03312634|156756975|FG000|Overall Study|Enrolled into non-interventional study|0|||
48701495|NCT03312634|156756976|FG001|Overall Study|Enrolled into non-interventional study|5|||
48701496|NCT03312634|156756975|FG000|Overall Study|Worsening clinical condition|0|||
48701497|NCT03312634|156756976|FG001|Overall Study|Worsening clinical condition|1|||
48701498|NCT03312634|156756975|FG000|Overall Study|Participant did not want to travel|0|||
48701499|NCT03312634|156756976|FG001|Overall Study|Participant did not want to travel|1|||
48701500|NCT03312634|156756975|FG000|Overall Study|Physician Decision|1|||
48701501|NCT03312634|156756976|FG001|Overall Study|Physician Decision|0|||
48701502|NCT03312634|156756975|FG000|Overall Study|Other|13|||
48701503|NCT03312634|156756976|FG001|Overall Study|Other|0|||
48701504|NCT01456039|156756977|FG000|Phase 1 (First Step)|Disease Progression|1|||
48701505|NCT01456039|156756978|FG001|Phase 1 (First Step)|Disease Progression|1|||
48701506|NCT01456039|156756979|FG002|Phase 1 (First Step)|Disease Progression|0|||
48701507|NCT01456039|156756977|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
48701508|NCT01456039|156756978|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
48594208|NCT00551525|156368903|FG000|Overall Study|Protocol Violation|5|||
48594209|NCT02782377|156368909|FG000|Overall Study|Physician Decision|5|||
48594210|NCT01210222|156368911|FG000|Overall Study|Ineligible|2|||
48594211|NCT01210222|156368911|FG000|Overall Study|Never treated|1|||
48594212|NCT01737879|156368912|FG000|Overall Study|Death|1|||
48594213|NCT01737879|156368912|FG000|Overall Study|Sponsor decision|40|||
48594214|NCT02098395|156368915|FG000|Overall Study|Protocol Violation|2|||
48594215|NCT02098395|156368916|FG001|Overall Study|Protocol Violation|2|||
48594216|NCT02098395|156368917|FG002|Overall Study|Protocol Violation|0|||
48594217|NCT02098395|156368918|FG003|Overall Study|Protocol Violation|7|||
48594218|NCT02098395|156368915|FG000|Overall Study|Withdrawal by Subject|10|||
48701509|NCT01456039|156756979|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
48701510|NCT01456039|156756977|FG000|Phase 1 (First Step)|Adverse Event|0|||
48701511|NCT01456039|156756978|FG001|Phase 1 (First Step)|Adverse Event|3|||
48701512|NCT01456039|156756979|FG002|Phase 1 (First Step)|Adverse Event|0|||
48701513|NCT01456039|156756977|FG000|Phase 1 (First Step)|Other|0|||
48701514|NCT01456039|156756978|FG001|Phase 1 (First Step)|Other|1|||
48701515|NCT01456039|156756979|FG002|Phase 1 (First Step)|Other|0|||
48701516|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Disease Progression|0|||
48701517|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Disease Progression|0|||
48701518|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Disease Progression|17|||
48701519|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Adverse Event|0|||
48701520|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Adverse Event|0|||
48701521|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Adverse Event|10|||
48701522|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
48701523|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
48701524|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
48701525|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
48701526|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
48701527|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
48701528|NCT01456039|156756977|FG000|Phase 2 (Second Step)|Other|0|||
48594219|NCT02098395|156368916|FG001|Overall Study|Withdrawal by Subject|10|||
48594220|NCT02098395|156368917|FG002|Overall Study|Withdrawal by Subject|5|||
48594221|NCT02098395|156368918|FG003|Overall Study|Withdrawal by Subject|13|||
48594222|NCT02098395|156368915|FG000|Overall Study|Adverse Event|12|||
48594223|NCT02098395|156368916|FG001|Overall Study|Adverse Event|19|||
48594224|NCT02098395|156368917|FG002|Overall Study|Adverse Event|34|||
48594225|NCT02098395|156368918|FG003|Overall Study|Adverse Event|2|||
48594226|NCT02098395|156368915|FG000|Overall Study|Lost to Follow-up|2|||
48701529|NCT01456039|156756978|FG001|Phase 2 (Second Step)|Other|0|||
48701530|NCT01456039|156756979|FG002|Phase 2 (Second Step)|Other|1|||
48701531|NCT01347112|156756980|FG000|Overall Study|Withdrawal by Subject|1|||
48701532|NCT01347112|156756981|FG001|Overall Study|Withdrawal by Subject|7|||
48594227|NCT02098395|156368916|FG001|Overall Study|Lost to Follow-up|1|||
48594228|NCT02098395|156368917|FG002|Overall Study|Lost to Follow-up|0|||
48594229|NCT02098395|156368918|FG003|Overall Study|Lost to Follow-up|3|||
48594230|NCT02098395|156368915|FG000|Overall Study|Unclassified|0|||
48701533|NCT01347112|156756980|FG000|Overall Study|Lost to Follow-up|3|||
48701534|NCT01347112|156756981|FG001|Overall Study|Lost to Follow-up|5|||
48594231|NCT02098395|156368916|FG001|Overall Study|Unclassified|0|||
48594232|NCT02098395|156368917|FG002|Overall Study|Unclassified|3|||
48594233|NCT02098395|156368918|FG003|Overall Study|Unclassified|2|||
48701535|NCT00696072|156756986|FG000|Overall Study|continuing active treatment|10|||
48701536|NCT00696072|156756987|FG001|Overall Study|continuing active treatment|13|||
48701537|NCT00696072|156756986|FG000|Overall Study|Adverse Event|10|||
48701538|NCT00696072|156756987|FG001|Overall Study|Adverse Event|6|||
48701539|NCT00696072|156756986|FG000|Overall Study|Patient Request|3|||
48701540|NCT00696072|156756987|FG001|Overall Study|Patient Request|7|||
48701541|NCT00696072|156756986|FG000|Overall Study|Investigator Request|1|||
48594234|NCT01204918|156368919|FG000|Overall Study|Withdrawal by Subject|4|||
48594235|NCT01204918|156368920|FG001|Overall Study|Withdrawal by Subject|10|||
48594236|NCT01204918|156368921|FG002|Overall Study|Withdrawal by Subject|5|||
48594237|NCT00977613|156368922|FG000|Overall Study|Lost to Follow-up|16|||
48594238|NCT02559570|156368934|FG000|Overall Study|Adverse Event|0|||
48594239|NCT02559570|156368935|FG001|Overall Study|Adverse Event|2|||
48594240|NCT02559570|156368936|FG002|Overall Study|Adverse Event|0|||
48594241|NCT02559570|156368937|FG003|Overall Study|Adverse Event|1|||
48594242|NCT02559570|156368938|FG004|Overall Study|Adverse Event|0|||
48594243|NCT02559570|156368934|FG000|Overall Study|Withdrawal of Consent|0|||
48594244|NCT02559570|156368935|FG001|Overall Study|Withdrawal of Consent|0|||
48594245|NCT02559570|156368936|FG002|Overall Study|Withdrawal of Consent|1|||
48594246|NCT02559570|156368937|FG003|Overall Study|Withdrawal of Consent|2|||
48594247|NCT02559570|156368938|FG004|Overall Study|Withdrawal of Consent|1|||
48594248|NCT02559570|156368934|FG000|Overall Study|Lost to Follow-up|1|||
48594249|NCT02559570|156368935|FG001|Overall Study|Lost to Follow-up|0|||
48594250|NCT02559570|156368936|FG002|Overall Study|Lost to Follow-up|0|||
48594251|NCT02559570|156368937|FG003|Overall Study|Lost to Follow-up|0|||
48594252|NCT02559570|156368938|FG004|Overall Study|Lost to Follow-up|0|||
48594253|NCT02559570|156368934|FG000|Overall Study|Protocol Violation|1|||
48594254|NCT02559570|156368935|FG001|Overall Study|Protocol Violation|0|||
48594255|NCT02559570|156368936|FG002|Overall Study|Protocol Violation|0|||
48701542|NCT00696072|156756987|FG001|Overall Study|Investigator Request|4|||
48701543|NCT00696072|156756986|FG000|Overall Study|Sponsor Request|0|||
48701544|NCT00696072|156756987|FG001|Overall Study|Sponsor Request|1|||
48701545|NCT00696072|156756986|FG000|Overall Study|Disease Progression|32|||
48701546|NCT00696072|156756987|FG001|Overall Study|Disease Progression|30|||
48701547|NCT00696072|156756986|FG000|Overall Study|Non-specified|1|||
48701548|NCT00696072|156756987|FG001|Overall Study|Non-specified|2|||
48701549|NCT01021020|156756988|FG000|Period I|Protocol Violation|1|||
48701550|NCT01021020|156756988|FG000|Period I|Withdrawal by Subject|1|||
48701551|NCT01021020|156756988|FG000|14 Day Washout Period A|Physician Decision|1|||
48701552|NCT01710501|156756991|FG000|Overall Study|Lost to Follow-up|2|||
48701553|NCT01710501|156756992|FG001|Overall Study|Lost to Follow-up|0|||
48701554|NCT01710501|156756993|FG002|Overall Study|Lost to Follow-up|0|||
48701555|NCT01389596|156756994|FG000|Overall Study|Protocol Violation|3|||
48701556|NCT01389596|156756995|FG001|Overall Study|Protocol Violation|4|||
48701557|NCT01389596|156756996|FG002|Overall Study|Protocol Violation|3|||
48701558|NCT01389596|156756994|FG000|Overall Study|Withdrawal by Subject|1|||
48701559|NCT01389596|156756995|FG001|Overall Study|Withdrawal by Subject|2|||
48701560|NCT01389596|156756996|FG002|Overall Study|Withdrawal by Subject|2|||
48701561|NCT01389596|156756994|FG000|Overall Study|Insufficient Clinical Response|3|||
48701562|NCT01389596|156756995|FG001|Overall Study|Insufficient Clinical Response|4|||
48594256|NCT02559570|156368937|FG003|Overall Study|Protocol Violation|0|||
48701563|NCT01389596|156756996|FG002|Overall Study|Insufficient Clinical Response|5|||
48701564|NCT01389596|156756994|FG000|Overall Study|Adverse Event|1|||
48432471|NCT01533935|155770876|FG003|Overall Study|Lost to Follow-up|0|||
48432472|NCT01533935|155770877|FG004|Overall Study|Lost to Follow-up|0|||
48432473|NCT01533935|155770873|FG000|Overall Study|Withdrawal by Subject|0|||
48432474|NCT01533935|155770874|FG001|Overall Study|Withdrawal by Subject|4|||
48432475|NCT01533935|155770875|FG002|Overall Study|Withdrawal by Subject|5|||
48432476|NCT01533935|155770876|FG003|Overall Study|Withdrawal by Subject|2|||
48432477|NCT01533935|155770877|FG004|Overall Study|Withdrawal by Subject|4|||
48432478|NCT01533935|155770873|FG000|Overall Study|Other reason not defined above|1|||
48432479|NCT01533935|155770874|FG001|Overall Study|Other reason not defined above|0|||
48432480|NCT01533935|155770875|FG002|Overall Study|Other reason not defined above|1|||
48432481|NCT01533935|155770876|FG003|Overall Study|Other reason not defined above|0|||
48432482|NCT01533935|155770877|FG004|Overall Study|Other reason not defined above|1|||
48432483|NCT02411201|155770879|FG000|Overall Study|Adverse Event|2|||
48432484|NCT02411201|155770879|FG000|Overall Study|Withdrawal by Subject|2|||
48432485|NCT02411201|155770879|FG000|Overall Study|Age group completed|2|||
48432486|NCT01260467|155770880|FG000|Overall Study|Withdrawal by Subject|2|||
48432487|NCT01727713|155770884|FG000|Overall Study|Lost to Follow-up|5|||
48432488|NCT01727713|155770884|FG000|Overall Study|Adverse Event|10|||
48432489|NCT01727713|155770884|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
48432490|NCT01727713|155770884|FG000|Overall Study|Withdrawal by Subject|13|||
48432491|NCT01727713|155770884|FG000|Overall Study|Protocol Deviation|2|||
48432492|NCT01005719|155770887|FG000|Period 1|Adverse Event|0|||
48432493|NCT01005719|155770888|FG001|Period 1|Adverse Event|0|||
48432494|NCT01005719|155770889|FG002|Period 1|Adverse Event|0|||
48432495|NCT01005719|155770890|FG003|Period 1|Adverse Event|1|||
48432496|NCT01005719|155770891|FG004|Period 1|Adverse Event|0|||
48432497|NCT01005719|155770892|FG005|Period 1|Adverse Event|0|||
48432498|NCT01005719|155770887|FG000|Period 1|Delay in completing study procedures|0|||
48432499|NCT01005719|155770888|FG001|Period 1|Delay in completing study procedures|0|||
48432500|NCT01005719|155770889|FG002|Period 1|Delay in completing study procedures|0|||
48432501|NCT01005719|155770890|FG003|Period 1|Delay in completing study procedures|0|||
48594257|NCT02559570|156368938|FG004|Overall Study|Protocol Violation|1|||
48594258|NCT02559570|156368934|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48594259|NCT02559570|156368935|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48594260|NCT02559570|156368936|FG002|Overall Study|Other Miscellaneous Reasons|1|||
48594261|NCT02559570|156368937|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48594262|NCT02559570|156368938|FG004|Overall Study|Other Miscellaneous Reasons|0|||
48594263|NCT01189461|156368941|FG000|Overall Study|Lack of Efficacy|13|||
48594264|NCT01189461|156368941|FG000|Overall Study|Lost to Follow-up|1|||
48594265|NCT01189461|156368941|FG000|Overall Study|Withdrawal by Subject|6|||
48594266|NCT01189461|156368941|FG000|Overall Study|Protocol Violation|1|||
48594267|NCT01189461|156368941|FG000|Overall Study|Adverse Event|2|||
48594268|NCT01189461|156368941|FG000|Overall Study|Did not meet entrance criteria|3|||
48594269|NCT01189461|156368941|FG000|Overall Study|Other|8|||
48594270|NCT01098162|156368951|FG000|Overall Study|Adverse Event|37|||
48594271|NCT01098162|156368951|FG000|Overall Study|Lack of Efficacy|4|||
48594272|NCT01098162|156368951|FG000|Overall Study|Wish of Patient|7|||
48594273|NCT01098162|156368951|FG000|Overall Study|Lost to Follow-up|9|||
48594274|NCT01098162|156368951|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
48594275|NCT01098162|156368951|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
48594276|NCT01098162|156368951|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
48594277|NCT01098162|156368951|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
48594278|NCT01098162|156368951|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
48594279|NCT01098162|156368951|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
48594280|NCT01098162|156368951|FG000|Overall Study|Other Reason|1|||
48594281|NCT01098162|156368951|FG000|Overall Study|Reason Unknown|26|||
48594282|NCT02903420|156368952|FG000|Overall Study|Death|3|||
48594283|NCT00625183|156368955|FG000|Overall Study|Disease Progression|1|||
48594284|NCT01605825|156368958|FG000|Overall Study|Adverse Event|4|||
48594285|NCT01605825|156368959|FG001|Overall Study|Adverse Event|2|||
48594286|NCT01605825|156368958|FG000|Overall Study|Withdrawal by Subject|0|||
48594287|NCT01605825|156368959|FG001|Overall Study|Withdrawal by Subject|1|||
48594288|NCT01605825|156368958|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
48594289|NCT01605825|156368959|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
48594290|NCT01605825|156368958|FG000|Overall Study|Non-Compliance with Protocol|3|||
48594291|NCT01605825|156368959|FG001|Overall Study|Non-Compliance with Protocol|0|||
48594292|NCT02500719|156368960|FG000|Overall Study|Lost to Follow-up|2|||
48594293|NCT02500719|156368961|FG001|Overall Study|Lost to Follow-up|3|||
48594294|NCT02500719|156368960|FG000|Overall Study|Trauma history|1|||
48594295|NCT02500719|156368961|FG001|Overall Study|Trauma history|0|||
48594296|NCT02500719|156368960|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
48594297|NCT02500719|156368961|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
48594298|NCT02500719|156368960|FG000|Overall Study|Did not meet criteria for PTSD|0|||
48594299|NCT02500719|156368961|FG001|Overall Study|Did not meet criteria for PTSD|1|||
48594300|NCT02500719|156368960|FG000|Overall Study|Claustrophobia|0|||
48594301|NCT02500719|156368961|FG001|Overall Study|Claustrophobia|1|||
48594302|NCT02500719|156368960|FG000|Overall Study|History of head trauma|0|||
48594303|NCT02500719|156368961|FG001|Overall Study|History of head trauma|1|||
48594304|NCT01429441|156368962|FG000|Overall Study|Adverse Event|5|||
48594305|NCT01429441|156368963|FG001|Overall Study|Adverse Event|1|||
48594306|NCT01429441|156368962|FG000|Overall Study|Death|0|||
48594307|NCT01429441|156368963|FG001|Overall Study|Death|2|||
48594308|NCT01429441|156368962|FG000|Overall Study|Lost to Follow-up|5|||
48594309|NCT01429441|156368963|FG001|Overall Study|Lost to Follow-up|2|||
48594310|NCT01429441|156368962|FG000|Overall Study|Physician Decision|1|||
48594311|NCT01429441|156368963|FG001|Overall Study|Physician Decision|0|||
48594312|NCT01429441|156368962|FG000|Overall Study|Withdrawal by Subject|27|||
48594313|NCT01429441|156368963|FG001|Overall Study|Withdrawal by Subject|18|||
48594314|NCT01931397|156368964|FG000|Overall Study|Physician Decision|2|||
48594315|NCT01931397|156368964|FG000|Overall Study|Withdrawal by Subject|8|||
48594316|NCT01931397|156368964|FG000|Overall Study|moved out of state|1|||
48594317|NCT00520039|156368970|FG000|Overall Study|Exclusion criteria met at first visit|7|||
48701565|NCT01389596|156756995|FG001|Overall Study|Adverse Event|4|||
48701566|NCT01389596|156756996|FG002|Overall Study|Adverse Event|0|||
48701567|NCT01389596|156756994|FG000|Overall Study|Death|0|||
48701568|NCT01389596|156756995|FG001|Overall Study|Death|1|||
48701569|NCT01389596|156756996|FG002|Overall Study|Death|0|||
48701570|NCT01389596|156756994|FG000|Overall Study|Other Unspecified|2|||
48594318|NCT00520039|156368971|FG001|Overall Study|Exclusion criteria met at first visit|5|||
48594319|NCT01210482|156368972|FG000|Overall Study|Protocol Violation|1|||
48594320|NCT01210482|156368972|FG000|Overall Study|Case Report Forms were not collected|18|||
48701571|NCT01389596|156756995|FG001|Overall Study|Other Unspecified|1|||
48701572|NCT01389596|156756996|FG002|Overall Study|Other Unspecified|0|||
48701573|NCT03829228|156756998|FG000|Overall Study|Protocol Violation|1|||
48701574|NCT01458392|156756999|FG000|Overall Study|Death|2|||
48701575|NCT01458392|156757000|FG001|Overall Study|Death|11|||
48701576|NCT01458392|156757001|FG002|Overall Study|Death|22|||
48701577|NCT01458392|156756999|FG000|Overall Study|At the discretion of the sponsor|0|||
48594321|NCT01210482|156368972|FG000|Overall Study|Duplicated|2|||
48594322|NCT01210482|156368972|FG000|Overall Study|No Drug Administration|28|||
48594323|NCT02058589|156368974|FG000|Overall Study|Serious Adverse Event|1|||
48594324|NCT02058589|156368975|FG001|Overall Study|Serious Adverse Event|1|||
48594325|NCT02058589|156368974|FG000|Overall Study|Non-Serious Adverse Event|1|||
48594326|NCT02058589|156368975|FG001|Overall Study|Non-Serious Adverse Event|0|||
48594327|NCT02058589|156368974|FG000|Overall Study|Withdrawal by Subject|0|||
48594328|NCT02058589|156368975|FG001|Overall Study|Withdrawal by Subject|1|||
48594329|NCT01859949|156370636|FG000|Overall Study|Family Matters|0|||
48594330|NCT01859949|156370637|FG001|Overall Study|Family Matters|1|||
48594331|NCT01859949|156370636|FG000|Overall Study|Physician Decision|2|||
48594332|NCT01859949|156370637|FG001|Overall Study|Physician Decision|4|||
48594333|NCT01859949|156370636|FG000|Overall Study|Withdrawal by Subject|11|||
48594334|NCT01859949|156370637|FG001|Overall Study|Withdrawal by Subject|10|||
48594335|NCT01859949|156370636|FG000|Overall Study|Protocol Violation|1|||
48594336|NCT01859949|156370637|FG001|Overall Study|Protocol Violation|1|||
48594337|NCT01859949|156370636|FG000|Overall Study|Adverse Event|0|||
48594338|NCT01859949|156370637|FG001|Overall Study|Adverse Event|1|||
48594339|NCT01890759|156370638|FG000|Overall Study|Protocol Violation|0|||
48594340|NCT01890759|156370639|FG001|Overall Study|Protocol Violation|2|||
48594341|NCT01890759|156370638|FG000|Overall Study|Lost to Follow-up|0|||
48594342|NCT01890759|156370639|FG001|Overall Study|Lost to Follow-up|2|||
48594343|NCT01890759|156370638|FG000|Overall Study|Withdrawal by Subject|2|||
48594344|NCT01890759|156370639|FG001|Overall Study|Withdrawal by Subject|8|||
48594345|NCT01344759|156370640|FG000|Overall Study|Patients failed to reach sedation level|0|||
48594346|NCT01344759|156370641|FG001|Overall Study|Patients failed to reach sedation level|2|||
48594347|NCT01153009|156370642|FG000|Overall Study|Adverse Event|4|||
48594348|NCT01153009|156370643|FG001|Overall Study|Adverse Event|14|||
48594349|NCT01153009|156370644|FG002|Overall Study|Adverse Event|14|||
48594350|NCT01153009|156370645|FG003|Overall Study|Adverse Event|10|||
48594351|NCT01153009|156370642|FG000|Overall Study|Lack of Efficacy|9|||
48594352|NCT01153009|156370643|FG001|Overall Study|Lack of Efficacy|0|||
48594353|NCT01153009|156370644|FG002|Overall Study|Lack of Efficacy|2|||
48594354|NCT01153009|156370645|FG003|Overall Study|Lack of Efficacy|1|||
48594355|NCT01153009|156370642|FG000|Overall Study|Noncompliance with Study Medication|1|||
48594356|NCT01153009|156370643|FG001|Overall Study|Noncompliance with Study Medication|3|||
48594357|NCT01153009|156370644|FG002|Overall Study|Noncompliance with Study Medication|4|||
48594358|NCT01153009|156370645|FG003|Overall Study|Noncompliance with Study Medication|1|||
48594359|NCT01153009|156370642|FG000|Overall Study|Protocol Deviations|4|||
48594360|NCT01153009|156370643|FG001|Overall Study|Protocol Deviations|3|||
48594361|NCT01153009|156370644|FG002|Overall Study|Protocol Deviations|3|||
48594362|NCT01153009|156370645|FG003|Overall Study|Protocol Deviations|2|||
48489330|NCT01312779|155987004|FG000|Overall Study|Not Implanted with Device|27|||
48489331|NCT04741503|155987005|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
48489332|NCT04741503|155987006|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
48489333|NCT04741503|155987007|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
48489334|NCT04741503|155987005|FG000|Initial Enrollment|Overquotas removed|0|||
48489335|NCT04741503|155987006|FG001|Initial Enrollment|Overquotas removed|0|||
48489336|NCT04741503|155987007|FG002|Initial Enrollment|Overquotas removed|186|||
48489337|NCT04741503|155987005|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
48489338|NCT04741503|155987006|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
48489339|NCT04741503|155987007|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
48489340|NCT02280421|155987008|FG000|Washout (2 Weeks)|Adverse Event|0|||
48489341|NCT02280421|155987009|FG001|Washout (2 Weeks)|Adverse Event|1|||
48489342|NCT02280421|155987008|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
48489343|NCT02280421|155987009|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
48489344|NCT00597584|155987010|FG000|Overall Study|Adverse Event|4|||
48489345|NCT00597584|155987011|FG001|Overall Study|Adverse Event|2|||
48489346|NCT00597584|155987010|FG000|Overall Study|Death|53|||
48489347|NCT00597584|155987011|FG001|Overall Study|Death|30|||
48489348|NCT00597584|155987010|FG000|Overall Study|Lack of Efficacy|1|||
48489349|NCT00597584|155987011|FG001|Overall Study|Lack of Efficacy|0|||
48489350|NCT00597584|155987010|FG000|Overall Study|Lost to Follow-up|2|||
48489351|NCT00597584|155987011|FG001|Overall Study|Lost to Follow-up|4|||
48489352|NCT00597584|155987010|FG000|Overall Study|Physician Decision|3|||
48489353|NCT00597584|155987011|FG001|Overall Study|Physician Decision|0|||
48489354|NCT00597584|155987010|FG000|Overall Study|Pregnancy|2|||
48594363|NCT01153009|156370642|FG000|Overall Study|Withdrawal of Consent|5|||
48594364|NCT01153009|156370643|FG001|Overall Study|Withdrawal of Consent|5|||
48594365|NCT01153009|156370644|FG002|Overall Study|Withdrawal of Consent|4|||
48489355|NCT00597584|155987011|FG001|Overall Study|Pregnancy|0|||
48594366|NCT01153009|156370645|FG003|Overall Study|Withdrawal of Consent|6|||
48594367|NCT01153009|156370642|FG000|Overall Study|Lost to Follow-up|8|||
48594368|NCT01153009|156370643|FG001|Overall Study|Lost to Follow-up|8|||
48594369|NCT01153009|156370644|FG002|Overall Study|Lost to Follow-up|11|||
48594370|NCT01153009|156370645|FG003|Overall Study|Lost to Follow-up|15|||
48594371|NCT01153009|156370642|FG000|Overall Study|Other|1|||
48594372|NCT01153009|156370643|FG001|Overall Study|Other|1|||
48594373|NCT01153009|156370644|FG002|Overall Study|Other|3|||
48594374|NCT01153009|156370645|FG003|Overall Study|Other|2|||
48701578|NCT01458392|156757000|FG001|Overall Study|At the discretion of the sponsor|2|||
48701579|NCT01458392|156757001|FG002|Overall Study|At the discretion of the sponsor|7|||
48701580|NCT01458392|156756999|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
48701581|NCT01458392|156757000|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
48701582|NCT01458392|156757001|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
48594375|NCT00401193|156370646|FG000|Overall Study|Adverse Event|1|||
48594376|NCT00401193|156370647|FG001|Overall Study|Adverse Event|3|||
48594377|NCT00401193|156370648|FG002|Overall Study|Adverse Event|1|||
48594378|NCT00401193|156370646|FG000|Overall Study|Protocol Violation|3|||
48489356|NCT00597584|155987010|FG000|Overall Study|Withdrawal by Subject|44|||
48489357|NCT00597584|155987011|FG001|Overall Study|Withdrawal by Subject|12|||
48489358|NCT00597584|155987010|FG000|Overall Study|Discontinued Dialysis|0|||
48489359|NCT00597584|155987011|FG001|Overall Study|Discontinued Dialysis|1|||
48489360|NCT00597584|155987010|FG000|Overall Study|Lost ability to consent|1|||
48489361|NCT00597584|155987011|FG001|Overall Study|Lost ability to consent|1|||
48489362|NCT00597584|155987010|FG000|Overall Study|Never dosed|1|||
48489363|NCT00597584|155987011|FG001|Overall Study|Never dosed|0|||
48489364|NCT00597584|155987010|FG000|Overall Study|Relocation|8|||
48489365|NCT00597584|155987011|FG001|Overall Study|Relocation|6|||
48489366|NCT00597584|155987010|FG000|Overall Study|Renal transplant|9|||
48489367|NCT00597584|155987011|FG001|Overall Study|Renal transplant|7|||
48489368|NCT01859390|155987012|FG000|Overall Study|Insufficient Sputum Collected|1|||
48489369|NCT01859390|155987013|FG001|Overall Study|Insufficient Sputum Collected|3|||
48489370|NCT01859390|155987012|FG000|Overall Study|Sample Missing Collection Date|0|||
48489371|NCT01859390|155987013|FG001|Overall Study|Sample Missing Collection Date|1|||
48489372|NCT01859390|155987012|FG000|Overall Study|Tube Cracked|0|||
48489373|NCT01859390|155987013|FG001|Overall Study|Tube Cracked|2|||
48489374|NCT01859390|155987012|FG000|Overall Study|Shipment Error|0|||
48489375|NCT01859390|155987013|FG001|Overall Study|Shipment Error|1|||
48489376|NCT01806597|155987023|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
48489377|NCT01806597|155987024|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
48489378|NCT01806597|155987025|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
48489379|NCT01806597|155987026|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
48489380|NCT01806597|155987027|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
48489381|NCT01806597|155987028|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
48489382|NCT01806597|155987023|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
48489383|NCT01806597|155987024|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
48489384|NCT01806597|155987025|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
48489385|NCT01806597|155987026|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
48489386|NCT01806597|155987027|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
48489387|NCT01806597|155987028|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
48489388|NCT01806597|155987023|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
48489389|NCT01806597|155987024|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
48489390|NCT01806597|155987025|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
48489391|NCT01806597|155987026|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
48489392|NCT01806597|155987027|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
48489393|NCT01806597|155987028|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
48489394|NCT01806597|155987023|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
48489395|NCT01806597|155987024|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
48489396|NCT01806597|155987025|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
48489397|NCT01806597|155987026|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
48489398|NCT01806597|155987027|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
48489399|NCT01806597|155987028|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
48489400|NCT01806597|155987023|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
48489401|NCT01806597|155987024|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
48489402|NCT01806597|155987025|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
48489403|NCT01806597|155987026|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
48489404|NCT01806597|155987027|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
48489405|NCT01806597|155987028|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
48489406|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
48594379|NCT00401193|156370647|FG001|Overall Study|Protocol Violation|1|||
48594380|NCT00401193|156370648|FG002|Overall Study|Protocol Violation|1|||
48701583|NCT00446849|156757004|FG000|Acute Phase|Lack of Efficacy|64|||
48701584|NCT00446849|156757004|FG000|Acute Phase|Protocol Violation|10|||
48489407|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
48489408|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
48489409|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
48594381|NCT00401193|156370646|FG000|Overall Study|Lost to Follow-up|6|||
48594382|NCT00401193|156370647|FG001|Overall Study|Lost to Follow-up|5|||
48594383|NCT00401193|156370648|FG002|Overall Study|Lost to Follow-up|1|||
48594384|NCT00401193|156370646|FG000|Overall Study|Withdrawal by Subject|2|||
48594385|NCT00401193|156370647|FG001|Overall Study|Withdrawal by Subject|0|||
48594386|NCT00401193|156370648|FG002|Overall Study|Withdrawal by Subject|1|||
48594387|NCT00401193|156370646|FG000|Overall Study|Other Event|3|||
48594388|NCT00401193|156370647|FG001|Overall Study|Other Event|2|||
48594389|NCT00401193|156370648|FG002|Overall Study|Other Event|2|||
48594390|NCT00385827|156370649|FG000|Part 1|Adverse Event|1|||
48594391|NCT00385827|156370650|FG001|Part 1|Adverse Event|0|||
48594392|NCT00385827|156370651|FG002|Part 1|Adverse Event|0|||
48594393|NCT00385827|156370649|FG000|Part 1|Death|2|||
48594394|NCT00385827|156370650|FG001|Part 1|Death|0|||
48594395|NCT00385827|156370651|FG002|Part 1|Death|0|||
48594396|NCT00385827|156370649|FG000|Part 1|Lack of Efficacy|5|||
48594397|NCT00385827|156370650|FG001|Part 1|Lack of Efficacy|0|||
48594398|NCT00385827|156370651|FG002|Part 1|Lack of Efficacy|0|||
48594399|NCT00385827|156370649|FG000|Part 1|Other|1|||
48594400|NCT00385827|156370650|FG001|Part 1|Other|0|||
48594401|NCT00385827|156370651|FG002|Part 1|Other|0|||
48594402|NCT00385827|156370649|FG000|Part 2|Adverse Event|0|||
48594403|NCT00385827|156370650|FG001|Part 2|Adverse Event|6|||
48594404|NCT00385827|156370651|FG002|Part 2|Adverse Event|10|||
48594405|NCT00385827|156370649|FG000|Part 2|Death|0|||
48594406|NCT00385827|156370650|FG001|Part 2|Death|0|||
48594407|NCT00385827|156370651|FG002|Part 2|Death|2|||
48594408|NCT00385827|156370649|FG000|Part 2|Lack of Efficacy|0|||
48594409|NCT00385827|156370650|FG001|Part 2|Lack of Efficacy|14|||
48594410|NCT00385827|156370651|FG002|Part 2|Lack of Efficacy|13|||
48594411|NCT00385827|156370649|FG000|Part 2|Randomized but not treated|0|||
48594412|NCT00385827|156370650|FG001|Part 2|Randomized but not treated|2|||
48594413|NCT00385827|156370651|FG002|Part 2|Randomized but not treated|2|||
48594414|NCT00385827|156370649|FG000|Part 2|Other|0|||
48594415|NCT00385827|156370650|FG001|Part 2|Other|11|||
48594416|NCT00385827|156370651|FG002|Part 2|Other|21|||
48594417|NCT00376532|156370652|FG000|Overall Study|Lack sufficient blood sample|6|||
48594418|NCT00376532|156370653|FG001|Overall Study|Lack sufficient blood sample|6|||
48594419|NCT01744483|156370655|FG000|Overall Study|Death|9|||
48594420|NCT01744483|156370656|FG001|Overall Study|Death|4|||
48594421|NCT01744483|156370657|FG002|Overall Study|Death|11|||
48594422|NCT01744483|156370655|FG000|Overall Study|Lost to Follow-up|8|||
48594423|NCT01744483|156370656|FG001|Overall Study|Lost to Follow-up|9|||
48594424|NCT01744483|156370657|FG002|Overall Study|Lost to Follow-up|11|||
48594425|NCT01744483|156370655|FG000|Overall Study|Protocol Violation|1|||
48594426|NCT01744483|156370656|FG001|Overall Study|Protocol Violation|2|||
48594427|NCT01744483|156370657|FG002|Overall Study|Protocol Violation|1|||
48594428|NCT01744483|156370655|FG000|Overall Study|Withdrawal by Subject|4|||
48594429|NCT01744483|156370656|FG001|Overall Study|Withdrawal by Subject|6|||
48594430|NCT01744483|156370657|FG002|Overall Study|Withdrawal by Subject|2|||
48594431|NCT01744483|156370655|FG000|Overall Study|No ICU Admit|5|||
48594432|NCT01744483|156370656|FG001|Overall Study|No ICU Admit|1|||
48594433|NCT01744483|156370657|FG002|Overall Study|No ICU Admit|2|||
48594434|NCT01744483|156370655|FG000|Overall Study|Routed to OSH|2|||
48594435|NCT01744483|156370656|FG001|Overall Study|Routed to OSH|0|||
48594436|NCT01744483|156370657|FG002|Overall Study|Routed to OSH|1|||
48594437|NCT02442206|156370658|FG000|Period 1|Adverse Event|1|||
48594438|NCT02442206|156370659|FG001|Period 1|Adverse Event|1|||
48594439|NCT02442206|156370658|FG000|Period 1|withdrew consent|0|||
48594440|NCT02442206|156370659|FG001|Period 1|withdrew consent|1|||
48594441|NCT02442206|156370658|FG000|Period 1|COPD exacerbation|0|||
48594442|NCT02442206|156370659|FG001|Period 1|COPD exacerbation|1|||
48594443|NCT02442206|156370658|FG000|Period 2|Adverse Event|1|||
48594444|NCT02442206|156370659|FG001|Period 2|Adverse Event|0|||
48594445|NCT02113007|156370660|FG000|Overall Study|Progressive disease|2|||
48594446|NCT02579382|156370661|FG000|Main Study Phase|Lost to Follow-up|0|||
48594447|NCT02579382|156370662|FG001|Main Study Phase|Lost to Follow-up|0|||
48594448|NCT02579382|156370663|FG002|Main Study Phase|Lost to Follow-up|2|||
48594449|NCT02579382|156370664|FG003|Main Study Phase|Lost to Follow-up|0|||
48594450|NCT02579382|156370661|FG000|Main Study Phase|Withdrew Consent|0|||
48594451|NCT02579382|156370662|FG001|Main Study Phase|Withdrew Consent|0|||
48594452|NCT02579382|156370663|FG002|Main Study Phase|Withdrew Consent|0|||
48594453|NCT02579382|156370664|FG003|Main Study Phase|Withdrew Consent|2|||
48594454|NCT02579382|156370661|FG000|Main Study Phase|Lack of Efficacy|0|||
48594455|NCT02579382|156370662|FG001|Main Study Phase|Lack of Efficacy|0|||
48594456|NCT02579382|156370663|FG002|Main Study Phase|Lack of Efficacy|0|||
48594457|NCT02579382|156370664|FG003|Main Study Phase|Lack of Efficacy|1|||
48594458|NCT02579382|156370661|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
48594459|NCT02579382|156370662|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
48594460|NCT02579382|156370663|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
48594461|NCT02579382|156370664|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
48594462|NCT02579382|156370661|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
48594463|NCT02579382|156370662|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
48594464|NCT02579382|156370663|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
48701585|NCT00446849|156757004|FG000|Acute Phase|Consent withdrawn|4|||
48701586|NCT00446849|156757004|FG000|Acute Phase|Lost to Follow-up|2|||
48701587|NCT00446849|156757004|FG000|Acute Phase|Physician Decision|1|||
48701588|NCT00446849|156757004|FG000|Acute Phase|noncompliance|1|||
48701589|NCT00446849|156757004|FG000|Maintenance Phase|Lack of Efficacy|40|||
48701590|NCT00446849|156757004|FG000|Maintenance Phase|Protocol Violation|7|||
48489410|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
48489411|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
48489412|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
48489413|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
48489414|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
48489415|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
48489416|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
48489417|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
48489418|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
48489419|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
48489420|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
48489421|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
48489422|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
48594465|NCT02579382|156370664|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
48594466|NCT02579382|156370661|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
48594467|NCT02579382|156370662|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
48594468|NCT02579382|156370663|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
48594469|NCT02579382|156370664|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
48594470|NCT02579382|156370661|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
48594471|NCT02579382|156370662|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
48594472|NCT02579382|156370663|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
48594473|NCT02579382|156370664|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
48594474|NCT02579382|156370661|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
48594475|NCT02579382|156370662|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
48594476|NCT02579382|156370663|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
48594477|NCT02579382|156370664|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
48594478|NCT02579382|156370661|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
48594479|NCT02579382|156370662|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
48594480|NCT02579382|156370663|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
48594481|NCT02579382|156370664|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
48594482|NCT01212159|156370665|FG000|Overall Study|Withdrawal by Subject|12|||
48594483|NCT01212159|156370666|FG001|Overall Study|Withdrawal by Subject|12|||
48594484|NCT01299896|156370667|FG000|Overall Study|Withdrawal by Subject|1|||
48594485|NCT01299896|156370668|FG001|Overall Study|Withdrawal by Subject|7|||
48594486|NCT01299896|156370667|FG000|Overall Study|Lost to Follow-up|0|||
48594487|NCT01299896|156370668|FG001|Overall Study|Lost to Follow-up|11|||
48594488|NCT02686814|156370669|FG000|Overall Study|Physician Decision|14|||
48594489|NCT02686814|156370669|FG000|Overall Study|Withdrawal by Subject|4|||
48594490|NCT02686814|156370669|FG000|Overall Study|Death|1|||
48594491|NCT01677182|156370675|FG000|Overall Study|Adverse Event|2|||
48594492|NCT01677182|156370676|FG001|Overall Study|Adverse Event|1|||
48594493|NCT01677182|156370677|FG002|Overall Study|Adverse Event|8|||
48594494|NCT01677182|156370675|FG000|Overall Study|Protocol Violation|5|||
48594495|NCT01677182|156370676|FG001|Overall Study|Protocol Violation|1|||
48594496|NCT01677182|156370677|FG002|Overall Study|Protocol Violation|4|||
48701591|NCT00446849|156757004|FG000|Maintenance Phase|Adverse Event|6|||
48489423|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
48489424|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
48489425|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
48489426|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
48489427|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
48489428|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
48489429|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
48489430|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
48489431|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
48489432|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
48594497|NCT01677182|156370675|FG000|Overall Study|Lost to Follow-up|4|||
48594498|NCT01677182|156370676|FG001|Overall Study|Lost to Follow-up|0|||
48701592|NCT00446849|156757004|FG000|Maintenance Phase|Consent withdrawn|5|||
48701593|NCT00446849|156757004|FG000|Maintenance Phase|Lost to Follow-up|3|||
48594499|NCT01677182|156370677|FG002|Overall Study|Lost to Follow-up|3|||
48594500|NCT01677182|156370675|FG000|Overall Study|Withdrawal by Subject|7|||
48594501|NCT01677182|156370676|FG001|Overall Study|Withdrawal by Subject|12|||
48594502|NCT01677182|156370677|FG002|Overall Study|Withdrawal by Subject|10|||
48594503|NCT01677182|156370675|FG000|Overall Study|Study termination|12|||
48594504|NCT01677182|156370676|FG001|Overall Study|Study termination|9|||
48594505|NCT01677182|156370677|FG002|Overall Study|Study termination|11|||
48594506|NCT01677182|156370675|FG000|Overall Study|Lack of Efficacy|3|||
48594507|NCT01677182|156370676|FG001|Overall Study|Lack of Efficacy|0|||
48594508|NCT01677182|156370677|FG002|Overall Study|Lack of Efficacy|1|||
48594509|NCT01677182|156370675|FG000|Overall Study|Other reasons|1|||
48594510|NCT01677182|156370676|FG001|Overall Study|Other reasons|5|||
48594511|NCT01677182|156370677|FG002|Overall Study|Other reasons|2|||
48594512|NCT01641471|156370678|FG000|Overall Study|Withdrawal by Subject|19|||
48594513|NCT01641471|156370679|FG001|Overall Study|Withdrawal by Subject|19|||
48594514|NCT01641471|156370678|FG000|Overall Study|Lost to Follow-up|2|||
48594515|NCT01641471|156370679|FG001|Overall Study|Lost to Follow-up|4|||
48594516|NCT01641471|156370678|FG000|Overall Study|Protocol Violation|2|||
48594517|NCT01641471|156370679|FG001|Overall Study|Protocol Violation|4|||
48594518|NCT00824655|156370680|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
48594519|NCT00824655|156370681|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
48594520|NCT00824655|156370680|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
48594521|NCT00824655|156370681|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
48594522|NCT03782571|156370682|FG000|Period 1|Withdrawal by Subject|1|||
48594523|NCT03782571|156370683|FG001|Period 1|Withdrawal by Subject|0|||
48594524|NCT03782571|156370684|FG002|Period 1|Withdrawal by Subject|0|||
48594525|NCT03782571|156370685|FG003|Period 1|Withdrawal by Subject|0|||
48594526|NCT03782571|156370682|FG000|Period 3|Subject Unable to Attend V5|1|||
48594527|NCT03782571|156370683|FG001|Period 3|Subject Unable to Attend V5|0|||
48594528|NCT03782571|156370684|FG002|Period 3|Subject Unable to Attend V5|0|||
48594529|NCT03782571|156370685|FG003|Period 3|Subject Unable to Attend V5|0|||
48594530|NCT03782571|156370682|FG000|Period 3|Adverse Event|1|||
48594531|NCT03782571|156370683|FG001|Period 3|Adverse Event|0|||
48594532|NCT03782571|156370684|FG002|Period 3|Adverse Event|0|||
48594533|NCT03782571|156370685|FG003|Period 3|Adverse Event|0|||
48594534|NCT03504189|156370686|FG000|Overall Study|Withdrawal by Subject|1|||
48594535|NCT03504189|156370686|FG000|Overall Study|Screening Failure|1|||
48594536|NCT03504189|156370686|FG000|Overall Study|Device Failure|2|||
48594537|NCT02634801|156370687|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
48594538|NCT02634801|156370688|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
48594539|NCT02634801|156370689|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
48594540|NCT02634801|156370687|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
48594541|NCT02634801|156370688|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
48594542|NCT02634801|156370689|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
48594543|NCT02634801|156370687|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
48701594|NCT00446849|156757004|FG000|Maintenance Phase|Pregnancy|1|||
48701595|NCT00446849|156757004|FG000|Maintenance Phase|noncompliance|2|||
48701596|NCT00446849|156757004|FG000|Maintenance Phase|prohibited medication use|2|||
48701597|NCT00446849|156757004|FG000|Maintenance Phase|antibiotic use|1|||
48701598|NCT00446849|156757004|FG000|Maintenance Phase|study closure|1|||
48701599|NCT00446849|156757004|FG000|Maintenance Phase|hydrocodone use|1|||
48594544|NCT02634801|156370688|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
48594545|NCT02634801|156370689|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
48594546|NCT02634801|156370687|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
48594547|NCT02634801|156370688|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
48594548|NCT02634801|156370689|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
48594549|NCT02634801|156370687|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
48594550|NCT02634801|156370688|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
48594551|NCT02634801|156370689|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
48701600|NCT00446849|156757004|FG000|Maintenance Phase|concomitant medication use|1|||
48701601|NCT01815918|156757005|FG000|Overall Study|Patient samples not analyzable|3|||
48701602|NCT01815918|156757006|FG001|Overall Study|Patient samples not analyzable|4|||
48701603|NCT01815918|156757005|FG000|Overall Study|Lack of Efficacy|15|||
48701604|NCT01815918|156757006|FG001|Overall Study|Lack of Efficacy|15|||
48701605|NCT02007096|156757010|FG000|Overall Study|medication not available|2|||
48701606|NCT02007096|156757011|FG001|Overall Study|medication not available|0|||
48701607|NCT02007096|156757010|FG000|Overall Study|did not inject saline|0|||
48701608|NCT02007096|156757011|FG001|Overall Study|did not inject saline|3|||
48701609|NCT02007096|156757010|FG000|Overall Study|did not follow postoperative protocol|8|||
48701610|NCT02007096|156757011|FG001|Overall Study|did not follow postoperative protocol|11|||
48701611|NCT02007096|156757010|FG000|Overall Study|converted to open surgery|1|||
48701612|NCT02007096|156757011|FG001|Overall Study|converted to open surgery|1|||
48701613|NCT02007096|156757010|FG000|Overall Study|no mesh placed|0|||
48701614|NCT02007096|156757011|FG001|Overall Study|no mesh placed|1|||
48701615|NCT01002339|156757013|FG000|Overall Study|Withdrawal by Subject|0|||
48489433|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
48489434|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
48489435|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
48489436|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
48489437|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
48489438|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
48489439|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
48489440|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
48489441|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
48489442|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
48489443|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
48489444|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
48489445|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
48489446|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
48701616|NCT01002339|156757014|FG001|Overall Study|Withdrawal by Subject|1|||
48701617|NCT01002339|156757015|FG002|Overall Study|Withdrawal by Subject|0|||
48701618|NCT01002339|156757013|FG000|Overall Study|Incorrect treatment assignment|0|||
48701619|NCT01002339|156757014|FG001|Overall Study|Incorrect treatment assignment|0|||
48701620|NCT01002339|156757015|FG002|Overall Study|Incorrect treatment assignment|1|||
48701621|NCT01002339|156757013|FG000|Overall Study|Protocol Violation|0|||
48701622|NCT01002339|156757014|FG001|Overall Study|Protocol Violation|0|||
48701623|NCT01002339|156757015|FG002|Overall Study|Protocol Violation|2|||
48701624|NCT01002339|156757013|FG000|Overall Study|Lung cancer detected before transplant|0|||
48701625|NCT01002339|156757014|FG001|Overall Study|Lung cancer detected before transplant|0|||
48701626|NCT01002339|156757015|FG002|Overall Study|Lung cancer detected before transplant|1|||
48701627|NCT01002339|156757013|FG000|Overall Study|Randomized. Not transplanted|0|||
48701628|NCT01002339|156757014|FG001|Overall Study|Randomized. Not transplanted|0|||
48701629|NCT01002339|156757015|FG002|Overall Study|Randomized. Not transplanted|1|||
48701630|NCT00807911|156757016|FG000|Overall Study|Withdrawal by Subject|12|||
48701631|NCT00807911|156757017|FG001|Overall Study|Withdrawal by Subject|10|||
48701632|NCT00807911|156757016|FG000|Overall Study|Ineligible|0|||
48701633|NCT00807911|156757017|FG001|Overall Study|Ineligible|4|||
48701634|NCT02923726|156757020|FG000|Overall Study|Death|196|||
48701635|NCT02923726|156757021|FG001|Overall Study|Death|175|||
48701636|NCT02923726|156757020|FG000|Overall Study|Withdrawal by Subject|337|||
48701637|NCT02923726|156757021|FG001|Overall Study|Withdrawal by Subject|307|||
48701638|NCT00912808|156757022|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
48701639|NCT00912808|156757023|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
48701640|NCT00912808|156757022|FG000|Washout|Withdrawal by Subject|0|||
48701641|NCT00912808|156757023|FG001|Washout|Withdrawal by Subject|1|||
48701642|NCT00912808|156757022|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
48701643|NCT00912808|156757023|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
48701644|NCT00912808|156757022|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
48701645|NCT00912808|156757023|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
48701646|NCT02531802|156757024|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
48489447|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
48489448|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
48489449|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
48489450|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
48489451|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
48489452|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
48489453|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
48489454|NCT01806597|155987023|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
48489455|NCT01806597|155987024|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
48489456|NCT01806597|155987025|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
48489457|NCT01806597|155987026|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
48489458|NCT01806597|155987027|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
48701647|NCT02531802|156757025|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
48701648|NCT02531802|156757026|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
48701649|NCT02531802|156757027|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
48701650|NCT02531802|156757028|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
48701651|NCT02531802|156757029|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
48701652|NCT02531802|156757030|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
48701653|NCT02531802|156757031|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
48701654|NCT02531802|156757032|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
48701655|NCT02531802|156757033|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
48489459|NCT01806597|155987028|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
48701656|NCT02531802|156757034|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
48701657|NCT02531802|156757035|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
48701658|NCT02531802|156757036|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
48701659|NCT02531802|156757037|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
48701660|NCT02531802|156757038|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
48701661|NCT02531802|156757039|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
48701662|NCT02531802|156757040|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
48701663|NCT02531802|156757041|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
48701664|NCT02531802|156757042|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
48701665|NCT02531802|156757043|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
48701666|NCT02531802|156757044|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
48701667|NCT02531802|156757024|FG000|Received Vaccination 2|Physician Decision|0|||
48701668|NCT02531802|156757025|FG001|Received Vaccination 2|Physician Decision|0|||
48701669|NCT02531802|156757026|FG002|Received Vaccination 2|Physician Decision|0|||
48701670|NCT02531802|156757027|FG003|Received Vaccination 2|Physician Decision|0|||
48701671|NCT02531802|156757028|FG004|Received Vaccination 2|Physician Decision|0|||
48489460|NCT01806597|155987023|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
48489461|NCT01806597|155987024|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
48489462|NCT01806597|155987025|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
48489463|NCT01806597|155987026|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
48489464|NCT01806597|155987027|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
48489465|NCT01806597|155987028|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
48489466|NCT01806597|155987023|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
48489467|NCT01806597|155987024|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
48489468|NCT01806597|155987025|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
48489469|NCT01806597|155987026|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
48489470|NCT01806597|155987027|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
48489471|NCT01806597|155987028|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
48489472|NCT01806597|155987023|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
48489473|NCT01806597|155987024|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
48489474|NCT01806597|155987025|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
48701672|NCT02531802|156757029|FG005|Received Vaccination 2|Physician Decision|1|||
48433170|NCT02410902|155774715|FG000|Overall Study|Adverse Event|2|||
48433171|NCT02410902|155774716|FG001|Overall Study|Adverse Event|3|||
48433172|NCT02410902|155774715|FG000|Overall Study|Lost to Follow-up|4|||
48433173|NCT02410902|155774716|FG001|Overall Study|Lost to Follow-up|1|||
48433174|NCT02410902|155774715|FG000|Overall Study|Protocol Violation|1|||
48433175|NCT02410902|155774716|FG001|Overall Study|Protocol Violation|4|||
48433176|NCT02410902|155774715|FG000|Overall Study|Withdrawal by Subject|6|||
48433177|NCT02410902|155774716|FG001|Overall Study|Withdrawal by Subject|8|||
48433178|NCT02410902|155774715|FG000|Overall Study|Non-Compliance|8|||
48433179|NCT02410902|155774716|FG001|Overall Study|Non-Compliance|2|||
48433180|NCT02279524|155774717|FG000|Overall Study|Withdrawal by Subject|3|||
48433181|NCT02279524|155774718|FG001|Overall Study|Withdrawal by Subject|6|||
48433182|NCT02279524|155774719|FG002|Overall Study|Withdrawal by Subject|3|||
48433183|NCT02279524|155774717|FG000|Overall Study|Adverse Event|4|||
48433184|NCT02279524|155774718|FG001|Overall Study|Adverse Event|3|||
48433185|NCT02279524|155774719|FG002|Overall Study|Adverse Event|2|||
48433186|NCT02279524|155774717|FG000|Overall Study|Lost to Follow-up|1|||
48433187|NCT02279524|155774718|FG001|Overall Study|Lost to Follow-up|1|||
48433188|NCT02279524|155774719|FG002|Overall Study|Lost to Follow-up|0|||
48433189|NCT02279524|155774717|FG000|Overall Study|Disallowed medication|1|||
48433190|NCT02279524|155774718|FG001|Overall Study|Disallowed medication|1|||
48433191|NCT02279524|155774719|FG002|Overall Study|Disallowed medication|2|||
48433192|NCT02279524|155774717|FG000|Overall Study|Bariatric surgery|1|||
48433193|NCT02279524|155774718|FG001|Overall Study|Bariatric surgery|0|||
48433194|NCT02279524|155774719|FG002|Overall Study|Bariatric surgery|0|||
48433195|NCT01746732|155774720|FG000|Lead-In Period|Withdrawal by Subject|1|||
48433196|NCT01746732|155774721|FG001|Lead-In Period|Withdrawal by Subject|0|||
48433197|NCT01746732|155774722|FG002|Lead-In Period|Withdrawal by Subject|0|||
48433198|NCT01746732|155774720|FG000|Period 1|Physician Decision|0|||
48433199|NCT01746732|155774721|FG001|Period 1|Physician Decision|1|||
48433200|NCT01746732|155774722|FG002|Period 1|Physician Decision|0|||
48433201|NCT01746732|155774720|FG000|Period 2|Withdrawal by Subject|0|||
48433202|NCT01746732|155774721|FG001|Period 2|Withdrawal by Subject|0|||
48433203|NCT01746732|155774722|FG002|Period 2|Withdrawal by Subject|2|||
48433204|NCT01746732|155774720|FG000|Period 2|Adverse Event|0|||
48433205|NCT01746732|155774721|FG001|Period 2|Adverse Event|0|||
48433206|NCT01746732|155774722|FG002|Period 2|Adverse Event|1|||
48433207|NCT01746732|155774720|FG000|Period 2|Lost to Follow-up|0|||
48489475|NCT01806597|155987026|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
48489476|NCT01806597|155987027|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
48489477|NCT01806597|155987028|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
48489478|NCT01806597|155987023|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
48489479|NCT01806597|155987024|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
48489480|NCT01806597|155987025|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
48489481|NCT01806597|155987026|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
48489482|NCT01806597|155987027|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
48489483|NCT01806597|155987028|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
48489484|NCT01806597|155987023|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
48489485|NCT01806597|155987024|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
48489486|NCT01806597|155987025|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
48489487|NCT01806597|155987026|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
48489488|NCT01806597|155987027|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
48489489|NCT01806597|155987028|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
48489490|NCT02482805|155987029|FG000|Overall Study|Lost to Follow-up|4|||
48489491|NCT02482805|155987030|FG001|Overall Study|Lost to Follow-up|4|||
48489492|NCT02482805|155987031|FG002|Overall Study|Lost to Follow-up|0|||
48489493|NCT01020305|155987032|FG000|Overall Study|Adverse Event|2|||
48489494|NCT00467818|155987033|FG000|Overall Study|Adverse Event|1|||
48489495|NCT00467818|155987034|FG001|Overall Study|Adverse Event|0|||
48489496|NCT00467818|155987033|FG000|Overall Study|Lost to Follow-up|2|||
48489497|NCT00467818|155987034|FG001|Overall Study|Lost to Follow-up|2|||
48489498|NCT02791659|155987041|FG000|Overall Study|Protocol Violation|0|||
48489499|NCT02791659|155987042|FG001|Overall Study|Protocol Violation|1|||
48489500|NCT00881959|155987043|FG000|Overall Study|Lost to Follow-up|2|||
48489501|NCT00881959|155987044|FG001|Overall Study|Lost to Follow-up|4|||
48489502|NCT01456052|155987045|FG000|Overall Study|Adverse Event|1|||
48489503|NCT01456052|155987046|FG001|Overall Study|Adverse Event|1|||
48489504|NCT01456052|155987047|FG002|Overall Study|Adverse Event|2|||
48489505|NCT01456052|155987045|FG000|Overall Study|Consent withdrawn|0|||
48489506|NCT01456052|155987046|FG001|Overall Study|Consent withdrawn|2|||
48489507|NCT01456052|155987047|FG002|Overall Study|Consent withdrawn|1|||
48489508|NCT01456052|155987045|FG000|Overall Study|Protocol Violation|0|||
48489509|NCT01456052|155987046|FG001|Overall Study|Protocol Violation|1|||
48489510|NCT01456052|155987047|FG002|Overall Study|Protocol Violation|0|||
48489511|NCT01456052|155987045|FG000|Overall Study|Physician Decision|1|||
48489512|NCT01456052|155987046|FG001|Overall Study|Physician Decision|0|||
48489513|NCT01456052|155987047|FG002|Overall Study|Physician Decision|1|||
48489514|NCT01456052|155987045|FG000|Overall Study|Treatment Failure|0|||
48489515|NCT01456052|155987046|FG001|Overall Study|Treatment Failure|1|||
48489516|NCT01456052|155987047|FG002|Overall Study|Treatment Failure|1|||
48489517|NCT00618774|155987050|FG000|Overall Study|Adverse Event|5|||
48489518|NCT00618774|155987051|FG001|Overall Study|Adverse Event|3|||
48489519|NCT00618774|155987050|FG000|Overall Study|Withdrawal by Subject|1|||
48489520|NCT00618774|155987051|FG001|Overall Study|Withdrawal by Subject|0|||
48489521|NCT02770716|155987052|FG000|Overall Study|Death|101|||
48489522|NCT02770716|155987053|FG001|Overall Study|Death|45|||
48489523|NCT02770716|155987052|FG000|Overall Study|Withdrawal by Subject|4|||
48489524|NCT02770716|155987053|FG001|Overall Study|Withdrawal by Subject|2|||
48489525|NCT02770716|155987052|FG000|Overall Study|Lost to Follow-up|1|||
48489526|NCT02770716|155987053|FG001|Overall Study|Lost to Follow-up|0|||
48489527|NCT02770716|155987052|FG000|Overall Study|Various reasons|6|||
48489528|NCT02770716|155987053|FG001|Overall Study|Various reasons|2|||
48489529|NCT00463866|155987054|FG000|Overall Study|Adverse Event|70|||
48489530|NCT00463866|155987055|FG001|Overall Study|Adverse Event|93|||
48489531|NCT00463866|155987054|FG000|Overall Study|Withdrawal by Subject|81|||
48489532|NCT00463866|155987055|FG001|Overall Study|Withdrawal by Subject|79|||
48489533|NCT00463866|155987054|FG000|Overall Study|Lost to Follow-up|46|||
48489534|NCT00463866|155987055|FG001|Overall Study|Lost to Follow-up|55|||
48489535|NCT00463866|155987054|FG000|Overall Study|Incorrect Enrolment|64|||
48489536|NCT00463866|155987055|FG001|Overall Study|Incorrect Enrolment|66|||
48489537|NCT00463866|155987054|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
48489538|NCT00463866|155987055|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
48489539|NCT00463866|155987054|FG000|Overall Study|Safety Reason|1|||
48489540|NCT00463866|155987055|FG001|Overall Study|Safety Reason|3|||
48489541|NCT00463866|155987054|FG000|Overall Study|Mis-Randomization of subject|0|||
48489542|NCT00463866|155987055|FG001|Overall Study|Mis-Randomization of subject|1|||
48489543|NCT00463866|155987054|FG000|Overall Study|Other|22|||
48489544|NCT00463866|155987055|FG001|Overall Study|Other|22|||
48489545|NCT02265952|155987056|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
48489546|NCT02265952|155987057|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
48489547|NCT02265952|155987056|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
48489548|NCT02265952|155987057|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
48594552|NCT02634801|156370687|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
48594553|NCT02634801|156370688|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
48594554|NCT02634801|156370689|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
48594555|NCT02634801|156370687|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
48594556|NCT02634801|156370688|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
48594557|NCT02634801|156370689|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
48594558|NCT02634801|156370687|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
48594559|NCT02634801|156370688|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
48594560|NCT02634801|156370689|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
48594561|NCT02634801|156370687|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
48594562|NCT02634801|156370688|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
48594563|NCT02634801|156370689|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
48594564|NCT02634801|156370687|FG000|Follow-up Period|Lost to Follow-up|3|||
48594565|NCT02634801|156370688|FG001|Follow-up Period|Lost to Follow-up|1|||
48594566|NCT02634801|156370689|FG002|Follow-up Period|Lost to Follow-up|2|||
48594567|NCT02634801|156370687|FG000|Follow-up Period|Physician Decision|0|||
48594568|NCT02634801|156370688|FG001|Follow-up Period|Physician Decision|0|||
48594569|NCT02634801|156370689|FG002|Follow-up Period|Physician Decision|1|||
48594570|NCT02634801|156370687|FG000|Follow-up Period|Withdrawal by Subject|1|||
48594571|NCT02634801|156370688|FG001|Follow-up Period|Withdrawal by Subject|2|||
48594572|NCT02634801|156370689|FG002|Follow-up Period|Withdrawal by Subject|5|||
48594573|NCT02634801|156370687|FG000|Follow-up Period|Adverse Event|1|||
48594574|NCT02634801|156370688|FG001|Follow-up Period|Adverse Event|5|||
48594575|NCT02634801|156370689|FG002|Follow-up Period|Adverse Event|0|||
48594576|NCT02906579|156370690|FG000|Overall Study|Adverse Event|1|||
48594577|NCT02906579|156370690|FG000|Overall Study|Physician Decision|1|||
48594578|NCT02793947|156370691|FG000|Overall Study|Death|1|||
48594579|NCT02793947|156370692|FG001|Overall Study|Death|0|||
48594580|NCT02793947|156370691|FG000|Overall Study|Physician Decision|1|||
48594581|NCT02793947|156370692|FG001|Overall Study|Physician Decision|5|||
48594582|NCT00412932|156370695|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
48594583|NCT00412932|156370695|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
48594584|NCT00412932|156370695|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
48594585|NCT00412932|156370695|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
48594586|NCT00412932|156370695|FG000|Olmesartan (Olm) 20 mg|Other|1|||
48594587|NCT00412932|156370695|FG000|Olmesartan 40 mg|Adverse Event|4|||
48594588|NCT00412932|156370695|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
48594589|NCT00412932|156370695|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
48594590|NCT00412932|156370695|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
48594591|NCT00412932|156370695|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
48594592|NCT00412932|156370695|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
48594593|NCT00412932|156370695|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
48594594|NCT01516736|156370696|FG000|Overall Study|Withdrawal by Subject|10|||
48594595|NCT01516736|156370697|FG001|Overall Study|Withdrawal by Subject|4|||
48594596|NCT01516736|156370696|FG000|Overall Study|Adverse Event|4|||
48594597|NCT01516736|156370697|FG001|Overall Study|Adverse Event|5|||
48594598|NCT01516736|156370696|FG000|Overall Study|Death|3|||
48594599|NCT01516736|156370697|FG001|Overall Study|Death|1|||
48594600|NCT01516736|156370696|FG000|Overall Study|Physician Decision|2|||
48594601|NCT01516736|156370697|FG001|Overall Study|Physician Decision|1|||
48594602|NCT01516736|156370696|FG000|Overall Study|Lack of Efficacy|1|||
48594603|NCT01516736|156370697|FG001|Overall Study|Lack of Efficacy|0|||
48594604|NCT01516736|156370696|FG000|Overall Study|Protocol Violation|0|||
48594605|NCT01516736|156370697|FG001|Overall Study|Protocol Violation|1|||
48594606|NCT01516736|156370696|FG000|Overall Study|Other (not specified)|0|||
48594607|NCT01516736|156370697|FG001|Overall Study|Other (not specified)|1|||
48594608|NCT02499263|156370699|FG000|Overall Study|Lost to Follow-up|9|||
48594609|NCT02499263|156370699|FG000|Overall Study|Participant's withdrawal of consent|4|||
48594610|NCT02499263|156370699|FG000|Overall Study|Lack of Efficacy|22|||
48594611|NCT02499263|156370699|FG000|Overall Study|investigator's judgment|12|||
48701673|NCT02531802|156757030|FG006|Received Vaccination 2|Physician Decision|0|||
48701674|NCT02531802|156757031|FG007|Received Vaccination 2|Physician Decision|0|||
48701675|NCT02531802|156757032|FG008|Received Vaccination 2|Physician Decision|0|||
48701676|NCT02531802|156757033|FG009|Received Vaccination 2|Physician Decision|2|||
48701677|NCT02531802|156757034|FG010|Received Vaccination 2|Physician Decision|0|||
48594612|NCT02499263|156370699|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
48594613|NCT02499263|156370699|FG000|Overall Study|Participant's decision|3|||
48594614|NCT02499263|156370699|FG000|Overall Study|Pregnancy|1|||
48594615|NCT02075008|156370708|FG000|Overall Study|Technical problems|1|||
48594616|NCT02075008|156370708|FG000|Overall Study|Pregnancy|1|||
48594617|NCT02075008|156370708|FG000|Overall Study|Physician Decision|1|||
48594618|NCT02075008|156370708|FG000|Overall Study|Lost to Follow-up|1|||
48594619|NCT02075008|156370708|FG000|Overall Study|Lack of Efficacy|1|||
48594620|NCT02075008|156370708|FG000|Overall Study|Death|1|||
48594621|NCT02075008|156370708|FG000|Overall Study|Adverse Event|5|||
48594622|NCT02075008|156370708|FG000|Overall Study|Withdrawal by Subject|6|||
48594623|NCT02075008|156370708|FG000|Overall Study|Study terminated by Sponsor|159|||
48594624|NCT02985021|156370713|FG000|Overall Study|Inability to comply with study procedures|1|||
48594625|NCT02232061|156370714|FG000|Overall Study|Administrative problems|1|||
48594626|NCT02232061|156370714|FG000|Overall Study|Withdrawal by Subject|1|||
48594627|NCT02087670|156370715|FG000|Overall Study|Withdrawal by Subject|3|||
48594628|NCT02087670|156370716|FG001|Overall Study|Withdrawal by Subject|2|||
48594629|NCT01639703|156370717|FG000|Overall Study|Withdrawal by Subject|5|||
48594630|NCT01639703|156370717|FG000|Overall Study|Other reason|7|||
48594631|NCT02496039|156370718|FG000|Overall Study|Adverse Event|3|||
48594632|NCT02496039|156370718|FG000|Overall Study|Protocol Violation|1|||
48594633|NCT00571103|156370719|FG000|Overall Study|Withdrawal by Subject|1|||
48594634|NCT00571103|156370719|FG000|Overall Study|Lost to Follow-up|1|||
48594635|NCT01308463|156370720|FG000|Overall Study|Study Discontinued|23|||
48594636|NCT01308463|156370720|FG000|Overall Study|Death|4|||
48594637|NCT01308463|156370720|FG000|Overall Study|Revision|2|||
48594638|NCT01972464|156370721|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
48594639|NCT01972464|156370722|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
48594640|NCT01972464|156370721|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
48594641|NCT01972464|156370722|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
48594642|NCT01972464|156370721|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
48594643|NCT01972464|156370722|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
48594644|NCT01972464|156370721|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
48594645|NCT01972464|156370722|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
48594646|NCT01042392|156370723|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
48594647|NCT01042392|156370724|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
48594648|NCT01042392|156370725|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
48594649|NCT01042392|156370726|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
48594650|NCT01042392|156370723|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
48594651|NCT01042392|156370724|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
48594652|NCT01042392|156370725|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
48594653|NCT01042392|156370726|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
48594654|NCT01042392|156370723|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
48594655|NCT01042392|156370724|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
48594656|NCT01042392|156370725|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
48594657|NCT01042392|156370726|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
48594658|NCT01042392|156370723|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
48594659|NCT01042392|156370724|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
48594660|NCT01042392|156370725|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
48594661|NCT01042392|156370726|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
48594662|NCT01042392|156370723|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
48594663|NCT01042392|156370724|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
48594664|NCT01042392|156370725|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
48594665|NCT01042392|156370726|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
48594666|NCT01042392|156370723|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
48594667|NCT01042392|156370724|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
48701678|NCT02531802|156757035|FG011|Received Vaccination 2|Physician Decision|0|||
48701679|NCT02531802|156757036|FG012|Received Vaccination 2|Physician Decision|0|||
48701680|NCT02531802|156757037|FG013|Received Vaccination 2|Physician Decision|1|||
48701681|NCT02531802|156757038|FG014|Received Vaccination 2|Physician Decision|0|||
48701682|NCT02531802|156757039|FG015|Received Vaccination 2|Physician Decision|0|||
48701683|NCT02531802|156757040|FG016|Received Vaccination 2|Physician Decision|0|||
48701684|NCT02531802|156757041|FG017|Received Vaccination 2|Physician Decision|1|||
48701685|NCT02531802|156757042|FG018|Received Vaccination 2|Physician Decision|0|||
48701686|NCT02531802|156757043|FG019|Received Vaccination 2|Physician Decision|0|||
48701687|NCT02531802|156757044|FG020|Received Vaccination 2|Physician Decision|0|||
48701688|NCT02531802|156757024|FG000|Received Vaccination 2|Adverse Event|0|||
48701689|NCT02531802|156757025|FG001|Received Vaccination 2|Adverse Event|0|||
48701690|NCT02531802|156757026|FG002|Received Vaccination 2|Adverse Event|0|||
48701691|NCT02531802|156757027|FG003|Received Vaccination 2|Adverse Event|0|||
48701692|NCT02531802|156757028|FG004|Received Vaccination 2|Adverse Event|0|||
48701693|NCT02531802|156757029|FG005|Received Vaccination 2|Adverse Event|2|||
48701694|NCT02531802|156757030|FG006|Received Vaccination 2|Adverse Event|0|||
48701695|NCT02531802|156757031|FG007|Received Vaccination 2|Adverse Event|0|||
48701696|NCT02531802|156757032|FG008|Received Vaccination 2|Adverse Event|0|||
48701697|NCT02531802|156757033|FG009|Received Vaccination 2|Adverse Event|0|||
48701698|NCT02531802|156757034|FG010|Received Vaccination 2|Adverse Event|0|||
48701699|NCT02531802|156757035|FG011|Received Vaccination 2|Adverse Event|0|||
48701700|NCT02531802|156757036|FG012|Received Vaccination 2|Adverse Event|0|||
48701701|NCT02531802|156757037|FG013|Received Vaccination 2|Adverse Event|0|||
48701702|NCT02531802|156757038|FG014|Received Vaccination 2|Adverse Event|0|||
48701703|NCT02531802|156757039|FG015|Received Vaccination 2|Adverse Event|0|||
48701704|NCT02531802|156757040|FG016|Received Vaccination 2|Adverse Event|0|||
48701705|NCT02531802|156757041|FG017|Received Vaccination 2|Adverse Event|2|||
48701706|NCT02531802|156757042|FG018|Received Vaccination 2|Adverse Event|1|||
48701707|NCT02531802|156757043|FG019|Received Vaccination 2|Adverse Event|0|||
48701708|NCT02531802|156757044|FG020|Received Vaccination 2|Adverse Event|1|||
48701709|NCT02531802|156757024|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
48701710|NCT02531802|156757025|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
48701711|NCT02531802|156757026|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
48701712|NCT02531802|156757027|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
48701713|NCT02531802|156757028|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
48701714|NCT02531802|156757029|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
48701715|NCT02531802|156757030|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
48701716|NCT02531802|156757031|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
48701717|NCT02531802|156757032|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
48701718|NCT02531802|156757033|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
48701719|NCT02531802|156757034|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
48701720|NCT02531802|156757035|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
48701721|NCT02531802|156757036|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
48701722|NCT02531802|156757037|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
48701723|NCT02531802|156757038|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
48701724|NCT02531802|156757039|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
48701725|NCT02531802|156757040|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
48701726|NCT02531802|156757041|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
48701727|NCT02531802|156757042|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
48701728|NCT02531802|156757043|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
48701729|NCT02531802|156757044|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
48701730|NCT04885998|156757047|FG000|Overall Study|Ongoing in study|3|||
48701731|NCT04885998|156757048|FG001|Overall Study|Ongoing in study|2|||
48701732|NCT04885998|156757049|FG002|Overall Study|Ongoing in study|2|||
48701733|NCT04885998|156757050|FG003|Overall Study|Ongoing in study|6|||
48701734|NCT04885998|156757047|FG000|Overall Study|Withdrawal by Subject|0|||
48701735|NCT04885998|156757048|FG001|Overall Study|Withdrawal by Subject|2|||
48701736|NCT04885998|156757049|FG002|Overall Study|Withdrawal by Subject|1|||
48701737|NCT04885998|156757050|FG003|Overall Study|Withdrawal by Subject|1|||
48701738|NCT04885998|156757047|FG000|Overall Study|Lost to Follow-up|1|||
48701739|NCT04885998|156757048|FG001|Overall Study|Lost to Follow-up|0|||
48701740|NCT04885998|156757049|FG002|Overall Study|Lost to Follow-up|0|||
48701741|NCT04885998|156757050|FG003|Overall Study|Lost to Follow-up|0|||
48701742|NCT04885998|156757047|FG000|Overall Study|Death|2|||
48701743|NCT04885998|156757048|FG001|Overall Study|Death|1|||
48701744|NCT04885998|156757049|FG002|Overall Study|Death|1|||
48701745|NCT04885998|156757050|FG003|Overall Study|Death|0|||
48701746|NCT03777982|156757051|FG000|Overall Study|Physician Decision|0|||
48489549|NCT02753400|155987060|FG000|Overall Study|Adverse Event|3|||
48489550|NCT02753400|155987061|FG001|Overall Study|Adverse Event|0|||
48489551|NCT02753400|155987060|FG000|Overall Study|Withdrawal by Subject|2|||
48489552|NCT02753400|155987061|FG001|Overall Study|Withdrawal by Subject|1|||
48489553|NCT03989115|155987062|FG000|Overall Study|Withdrawal by Subject|2|||
48489554|NCT03989115|155987063|FG001|Overall Study|Withdrawal by Subject|1|||
48489555|NCT03989115|155987064|FG002|Overall Study|Withdrawal by Subject|3|||
48489556|NCT03989115|155987065|FG003|Overall Study|Withdrawal by Subject|0|||
48489557|NCT03989115|155987066|FG004|Overall Study|Withdrawal by Subject|17|||
48489558|NCT03989115|155987067|FG005|Overall Study|Withdrawal by Subject|1|||
48489559|NCT03989115|155987068|FG006|Overall Study|Withdrawal by Subject|0|||
48489560|NCT03989115|155987069|FG007|Overall Study|Withdrawal by Subject|0|||
48489561|NCT03989115|155987062|FG000|Overall Study|Sponsor decision to terminate the study|1|||
48489562|NCT03989115|155987063|FG001|Overall Study|Sponsor decision to terminate the study|1|||
48701747|NCT03777982|156757052|FG001|Overall Study|Physician Decision|1|||
48701748|NCT00870740|156757053|FG000|Overall Study|Adverse Event|2|||
48701749|NCT00870740|156757054|FG001|Overall Study|Adverse Event|1|||
48701750|NCT00870740|156757055|FG002|Overall Study|Adverse Event|3|||
48701751|NCT00870740|156757056|FG003|Overall Study|Adverse Event|2|||
48701752|NCT00870740|156757057|FG004|Overall Study|Adverse Event|1|||
48489563|NCT03989115|155987064|FG002|Overall Study|Sponsor decision to terminate the study|0|||
48701753|NCT00870740|156757058|FG005|Overall Study|Adverse Event|6|||
48701754|NCT00870740|156757053|FG000|Overall Study|Consent Withdrawn|6|||
48701755|NCT00870740|156757054|FG001|Overall Study|Consent Withdrawn|3|||
48701756|NCT00870740|156757055|FG002|Overall Study|Consent Withdrawn|4|||
48701757|NCT00870740|156757056|FG003|Overall Study|Consent Withdrawn|6|||
48701758|NCT00870740|156757057|FG004|Overall Study|Consent Withdrawn|6|||
48701759|NCT00870740|156757058|FG005|Overall Study|Consent Withdrawn|5|||
48701760|NCT00870740|156757053|FG000|Overall Study|Investigator Decision|2|||
48701761|NCT00870740|156757054|FG001|Overall Study|Investigator Decision|0|||
48701762|NCT00870740|156757055|FG002|Overall Study|Investigator Decision|1|||
48701763|NCT00870740|156757056|FG003|Overall Study|Investigator Decision|0|||
48701764|NCT00870740|156757057|FG004|Overall Study|Investigator Decision|0|||
48701765|NCT00870740|156757058|FG005|Overall Study|Investigator Decision|0|||
48701766|NCT00870740|156757053|FG000|Overall Study|Subject Non-compliance|0|||
48701767|NCT00870740|156757054|FG001|Overall Study|Subject Non-compliance|0|||
48701768|NCT00870740|156757055|FG002|Overall Study|Subject Non-compliance|0|||
48701769|NCT00870740|156757056|FG003|Overall Study|Subject Non-compliance|0|||
48701770|NCT00870740|156757057|FG004|Overall Study|Subject Non-compliance|0|||
48701771|NCT00870740|156757058|FG005|Overall Study|Subject Non-compliance|1|||
48701772|NCT00870740|156757053|FG000|Overall Study|Death|0|||
48701773|NCT00870740|156757054|FG001|Overall Study|Death|0|||
48701774|NCT00870740|156757055|FG002|Overall Study|Death|0|||
48701775|NCT00870740|156757056|FG003|Overall Study|Death|0|||
48701776|NCT00870740|156757057|FG004|Overall Study|Death|1|||
48489564|NCT03989115|155987065|FG003|Overall Study|Sponsor decision to terminate the study|1|||
48489565|NCT03989115|155987066|FG004|Overall Study|Sponsor decision to terminate the study|11|||
48489566|NCT03989115|155987067|FG005|Overall Study|Sponsor decision to terminate the study|0|||
48489567|NCT03989115|155987068|FG006|Overall Study|Sponsor decision to terminate the study|2|||
48489568|NCT03989115|155987069|FG007|Overall Study|Sponsor decision to terminate the study|1|||
48489569|NCT03989115|155987062|FG000|Overall Study|Lost to Follow-up|2|||
48489570|NCT03989115|155987063|FG001|Overall Study|Lost to Follow-up|0|||
48489571|NCT03989115|155987064|FG002|Overall Study|Lost to Follow-up|0|||
48489572|NCT03989115|155987065|FG003|Overall Study|Lost to Follow-up|0|||
48489573|NCT03989115|155987066|FG004|Overall Study|Lost to Follow-up|1|||
48489574|NCT03989115|155987067|FG005|Overall Study|Lost to Follow-up|0|||
48489575|NCT03989115|155987068|FG006|Overall Study|Lost to Follow-up|0|||
48489576|NCT03989115|155987069|FG007|Overall Study|Lost to Follow-up|0|||
48489577|NCT03989115|155987062|FG000|Overall Study|Death|2|||
48489578|NCT03989115|155987063|FG001|Overall Study|Death|2|||
48489579|NCT03989115|155987064|FG002|Overall Study|Death|9|||
48489580|NCT03989115|155987065|FG003|Overall Study|Death|6|||
48489581|NCT03989115|155987066|FG004|Overall Study|Death|31|||
48489582|NCT03989115|155987067|FG005|Overall Study|Death|6|||
48489583|NCT03989115|155987068|FG006|Overall Study|Death|2|||
48489584|NCT03989115|155987069|FG007|Overall Study|Death|3|||
48489585|NCT03989115|155987062|FG000|Overall Study|Other|1|||
48489586|NCT03989115|155987063|FG001|Overall Study|Other|2|||
48489587|NCT03989115|155987064|FG002|Overall Study|Other|0|||
48489588|NCT03989115|155987065|FG003|Overall Study|Other|0|||
48489589|NCT03989115|155987066|FG004|Overall Study|Other|5|||
48489590|NCT03989115|155987067|FG005|Overall Study|Other|0|||
48489591|NCT03989115|155987068|FG006|Overall Study|Other|0|||
48489592|NCT03989115|155987069|FG007|Overall Study|Other|0|||
48489593|NCT01489956|155987071|FG000|Overall Study|Lost to Follow-up|1|||
48489594|NCT01489956|155987072|FG001|Overall Study|Lost to Follow-up|0|||
48489595|NCT01489956|155987073|FG002|Overall Study|Lost to Follow-up|0|||
48489596|NCT01489956|155987071|FG000|Overall Study|Withdrawal by Subject|0|||
48489597|NCT01489956|155987072|FG001|Overall Study|Withdrawal by Subject|0|||
48489598|NCT01489956|155987073|FG002|Overall Study|Withdrawal by Subject|1|||
48489599|NCT02622074|155987074|FG000|Overall Study|Death|4|||
48489600|NCT02622074|155987075|FG001|Overall Study|Death|0|||
48489601|NCT02622074|155987076|FG002|Overall Study|Death|0|||
48489602|NCT02622074|155987077|FG003|Overall Study|Death|1|||
48489603|NCT02622074|155987078|FG004|Overall Study|Death|1|||
48489604|NCT02622074|155987079|FG005|Overall Study|Death|0|||
48489605|NCT02622074|155987074|FG000|Overall Study|Withdrawal by Subject|0|||
48489606|NCT02622074|155987075|FG001|Overall Study|Withdrawal by Subject|1|||
48489607|NCT02622074|155987076|FG002|Overall Study|Withdrawal by Subject|0|||
48489608|NCT02622074|155987077|FG003|Overall Study|Withdrawal by Subject|0|||
48489609|NCT02622074|155987078|FG004|Overall Study|Withdrawal by Subject|0|||
48489610|NCT02622074|155987079|FG005|Overall Study|Withdrawal by Subject|0|||
48489611|NCT01223196|155987080|FG000|Overall Study|Lost to Follow-up|2|||
48489612|NCT01223196|155987081|FG001|Overall Study|Lost to Follow-up|0|||
48489613|NCT01223196|155987080|FG000|Overall Study|Physician Decision|1|||
48489614|NCT01223196|155987081|FG001|Overall Study|Physician Decision|0|||
48489615|NCT01223196|155987080|FG000|Overall Study|Withdrawal by Subject|1|||
48489616|NCT01223196|155987081|FG001|Overall Study|Withdrawal by Subject|0|||
48489617|NCT02629133|155987082|FG000|Overall Study|Lost to Follow-up|3|||
48489618|NCT02629133|155987083|FG001|Overall Study|Lost to Follow-up|1|||
48489619|NCT02629133|155987082|FG000|Overall Study|Withdrawal by Subject|1|||
48489620|NCT02629133|155987083|FG001|Overall Study|Withdrawal by Subject|1|||
48489621|NCT01238822|155987084|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
48489622|NCT00441584|155987085|FG000|Overall Study|Lack of Efficacy|79|||
48701777|NCT00870740|156757058|FG005|Overall Study|Death|0|||
48701778|NCT00870740|156757053|FG000|Overall Study|Other|2|||
48489623|NCT00441584|155987085|FG000|Overall Study|Withdrawal by Subject|8|||
48489624|NCT00441584|155987085|FG000|Overall Study|Adverse Event|6|||
48489625|NCT00441584|155987085|FG000|Overall Study|Protocol Violation|5|||
48701779|NCT00870740|156757054|FG001|Overall Study|Other|5|||
48701780|NCT00870740|156757055|FG002|Overall Study|Other|2|||
48701781|NCT00870740|156757056|FG003|Overall Study|Other|4|||
48701782|NCT00870740|156757057|FG004|Overall Study|Other|3|||
48701783|NCT00870740|156757058|FG005|Overall Study|Other|5|||
48701784|NCT01033019|156757059|FG000|Overall Study|Withdrawal by Subject|1|||
48701785|NCT01033019|156757060|FG001|Overall Study|Withdrawal by Subject|0|||
48701786|NCT03011099|156757064|FG000|Overall Study|Withdrawal by Subject|0|||
48701787|NCT03011099|156757065|FG001|Overall Study|Withdrawal by Subject|2|||
48701788|NCT02158442|156757069|FG000|Overall Study|Withdrawal by Subject|1|||
48701789|NCT02158442|156757070|FG001|Overall Study|Withdrawal by Subject|0|||
48701790|NCT02158442|156757069|FG000|Overall Study|Perfusion staff not available|1|||
48701791|NCT02158442|156757070|FG001|Overall Study|Perfusion staff not available|0|||
48701792|NCT01457703|156757071|FG000|Overall Study|Screen Failure|5|||
48701793|NCT01457703|156757072|FG001|Overall Study|Screen Failure|7|||
48701794|NCT01457703|156757071|FG000|Overall Study|Withdrawal by Subject|1|||
48701795|NCT01457703|156757072|FG001|Overall Study|Withdrawal by Subject|4|||
48701796|NCT00632229|156757075|FG000|Overall Study|Adverse Event|6|||
48701797|NCT00632229|156757076|FG001|Overall Study|Adverse Event|0|||
48701798|NCT00632229|156757075|FG000|Overall Study|Lost to Follow-up|0|||
48701799|NCT00632229|156757076|FG001|Overall Study|Lost to Follow-up|3|||
48701800|NCT00632229|156757075|FG000|Overall Study|Lack of Efficacy|0|||
48701801|NCT00632229|156757076|FG001|Overall Study|Lack of Efficacy|2|||
48701802|NCT00632229|156757075|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
48701803|NCT00632229|156757076|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
48489626|NCT00441584|155987085|FG000|Overall Study|Lost to Follow-up|4|||
48489627|NCT00441584|155987085|FG000|Overall Study|Failure to meet eligibility criteria|3|||
48489628|NCT00863057|155987086|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
48489629|NCT00863057|155987087|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
48489630|NCT00863057|155987088|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
48489631|NCT00863057|155987089|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
48489632|NCT00863057|155987086|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
48489633|NCT00863057|155987087|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
48489634|NCT00863057|155987088|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
48489635|NCT00863057|155987089|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
48594668|NCT01042392|156370725|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
48594669|NCT01042392|156370726|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
48594670|NCT01042392|156370723|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
48594671|NCT01042392|156370724|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
48594672|NCT01042392|156370725|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
48594673|NCT01042392|156370726|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
48594674|NCT01042392|156370723|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
48701804|NCT04322526|156757079|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
48701805|NCT04322526|156757080|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
48701806|NCT04322526|156757079|FG000|Washout (1 Week)|Lost to Follow-up|1|||
48701807|NCT04322526|156757080|FG001|Washout (1 Week)|Lost to Follow-up|2|||
48701808|NCT00888173|156757085|FG000|Overall Study|Wrong Primary|1|||
48701809|NCT00888173|156757085|FG000|Overall Study|Ineligible: required test not done|1|||
48701810|NCT00687193|156757087|FG000|Overall Study|Adverse Event|0|||
48701811|NCT00687193|156757088|FG001|Overall Study|Adverse Event|1|||
48701812|NCT00687193|156757089|FG002|Overall Study|Adverse Event|2|||
48701813|NCT00687193|156757090|FG003|Overall Study|Adverse Event|3|||
48701814|NCT00687193|156757091|FG004|Overall Study|Adverse Event|0|||
48701815|NCT00687193|156757092|FG005|Overall Study|Adverse Event|2|||
48701816|NCT00687193|156757087|FG000|Overall Study|Lack of Efficacy|1|||
48701817|NCT00687193|156757088|FG001|Overall Study|Lack of Efficacy|1|||
48701818|NCT00687193|156757089|FG002|Overall Study|Lack of Efficacy|0|||
48701819|NCT00687193|156757090|FG003|Overall Study|Lack of Efficacy|0|||
48701820|NCT00687193|156757091|FG004|Overall Study|Lack of Efficacy|0|||
48701821|NCT00687193|156757092|FG005|Overall Study|Lack of Efficacy|2|||
48701822|NCT00687193|156757087|FG000|Overall Study|Protocol Violation|1|||
48701823|NCT00687193|156757088|FG001|Overall Study|Protocol Violation|2|||
48701824|NCT00687193|156757089|FG002|Overall Study|Protocol Violation|0|||
48489636|NCT00863057|155987086|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
48489637|NCT00863057|155987087|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
48701825|NCT00687193|156757090|FG003|Overall Study|Protocol Violation|1|||
48701826|NCT00687193|156757091|FG004|Overall Study|Protocol Violation|2|||
48701827|NCT00687193|156757092|FG005|Overall Study|Protocol Violation|0|||
48701828|NCT01724346|156757093|FG000|Overall Study|Death|42|||
48701829|NCT01724346|156757094|FG001|Overall Study|Death|42|||
48701830|NCT01724346|156757093|FG000|Overall Study|Lost to Follow-up|5|||
48701831|NCT01724346|156757094|FG001|Overall Study|Lost to Follow-up|1|||
48701832|NCT01724346|156757093|FG000|Overall Study|Withdrawal by Subject|27|||
48701833|NCT01724346|156757094|FG001|Overall Study|Withdrawal by Subject|19|||
48701834|NCT01724346|156757093|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
48489638|NCT00863057|155987088|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
48489639|NCT00863057|155987089|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
48489640|NCT00863057|155987086|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
48489641|NCT00863057|155987087|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
48489642|NCT00863057|155987088|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
48489643|NCT00863057|155987089|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
48489644|NCT03063632|155987092|FG000|Overall Study|Death|4|||
48489645|NCT03063632|155987093|FG001|Overall Study|Death|6|||
48489646|NCT03063632|155987092|FG000|Overall Study|Lost to Follow-up|0|||
48489647|NCT03063632|155987093|FG001|Overall Study|Lost to Follow-up|1|||
48489648|NCT03063632|155987092|FG000|Overall Study|Withdrawal by Subject|0|||
48489649|NCT03063632|155987093|FG001|Overall Study|Withdrawal by Subject|2|||
48489650|NCT03063632|155987092|FG000|Overall Study|Physician Decision|2|||
48489651|NCT03063632|155987093|FG001|Overall Study|Physician Decision|0|||
48489652|NCT03063632|155987092|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
48489653|NCT03063632|155987093|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
48489654|NCT01798485|155987096|FG000|Overall Study|Adverse Event|32|||
48489655|NCT01798485|155987097|FG001|Overall Study|Adverse Event|40|||
48489656|NCT01798485|155987096|FG000|Overall Study|Withdrawal by Subject|27|||
48489657|NCT01798485|155987097|FG001|Overall Study|Withdrawal by Subject|31|||
48489658|NCT01798485|155987096|FG000|Overall Study|Lost to Follow-up|0|||
48489659|NCT01798485|155987097|FG001|Overall Study|Lost to Follow-up|3|||
48489660|NCT01798485|155987096|FG000|Overall Study|Physician Decision|14|||
48489661|NCT01798485|155987097|FG001|Overall Study|Physician Decision|10|||
48489662|NCT01798485|155987096|FG000|Overall Study|Objective Disease Progression|152|||
48489663|NCT01798485|155987097|FG001|Overall Study|Objective Disease Progression|106|||
48489664|NCT01798485|155987096|FG000|Overall Study|Death|25|||
48489665|NCT01798485|155987097|FG001|Overall Study|Death|22|||
48489666|NCT01798485|155987096|FG000|Overall Study|Sponsor Decision|61|||
48489667|NCT01798485|155987097|FG001|Overall Study|Sponsor Decision|54|||
48489668|NCT01798485|155987096|FG000|Overall Study|Clinical Progression|35|||
48489669|NCT01798485|155987097|FG001|Overall Study|Clinical Progression|24|||
48489670|NCT02741271|155987103|FG000|Overall Study|Lost to Follow-up|2|||
48489671|NCT02741271|155987104|FG001|Overall Study|Lost to Follow-up|0|||
48489672|NCT02741271|155987103|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48489673|NCT02741271|155987104|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48489674|NCT03652961|155987105|FG000|Overall Study|Lost to Follow-up|3|||
48489675|NCT03652961|155987105|FG000|Overall Study|Screen Failure|1|||
48489676|NCT00373685|155987106|FG000|Overall Study|Death|2|||
48489677|NCT00373685|155987107|FG001|Overall Study|Death|1|||
48489678|NCT00373685|155987106|FG000|Overall Study|Adverse Event|278|||
48489679|NCT00373685|155987107|FG001|Overall Study|Adverse Event|253|||
48489680|NCT00373685|155987106|FG000|Overall Study|Insufficient clinical response|169|||
48489681|NCT00373685|155987107|FG001|Overall Study|Insufficient clinical response|119|||
48489682|NCT00373685|155987106|FG000|Overall Study|Did not meet entrance criteria|167|||
48489683|NCT00373685|155987107|FG001|Overall Study|Did not meet entrance criteria|184|||
48489684|NCT00373685|155987106|FG000|Overall Study|Lost to follow up|83|||
48489685|NCT00373685|155987107|FG001|Overall Study|Lost to follow up|103|||
48489686|NCT00373685|155987106|FG000|Overall Study|No longer willing to participate|337|||
48489687|NCT00373685|155987107|FG001|Overall Study|No longer willing to participate|352|||
48489688|NCT00373685|155987106|FG000|Overall Study|Other|149|||
48489689|NCT00373685|155987107|FG001|Overall Study|Other|146|||
48489690|NCT00373685|155987106|FG000|Overall Study|Protocol Violation|191|||
48489691|NCT00373685|155987107|FG001|Overall Study|Protocol Violation|182|||
48489692|NCT00373685|155987106|FG000|Overall Study|Final Status Unknown|12|||
48489693|NCT00373685|155987107|FG001|Overall Study|Final Status Unknown|4|||
48489694|NCT00373685|155987106|FG000|Overall Study|Randomized, not treated|51|||
48489695|NCT00373685|155987107|FG001|Overall Study|Randomized, not treated|77|||
48489696|NCT01953783|155987108|FG000|Overall Study|Progressive disease|2|||
48489697|NCT01620489|155987111|FG000|Overall Study|Adverse Event|17|||
48489698|NCT01620489|155987112|FG001|Overall Study|Adverse Event|4|||
48489699|NCT01620489|155987111|FG000|Overall Study|Protocol Violation|0|||
48489700|NCT01620489|155987112|FG001|Overall Study|Protocol Violation|3|||
48489701|NCT01620489|155987111|FG000|Overall Study|Withdrawal Criteria|17|||
48489702|NCT01620489|155987112|FG001|Overall Study|Withdrawal Criteria|25|||
48489703|NCT01620489|155987111|FG000|Overall Study|Unclassified|1|||
48489704|NCT01620489|155987112|FG001|Overall Study|Unclassified|2|||
48489705|NCT00871169|155987113|FG000|Overall Study|Protocol Violation|1|||
48489706|NCT00871169|155987113|FG000|Overall Study|Patient did not receive study treatment|2|||
48489707|NCT02168270|155987114|FG000|Overall Study|Lack of Efficacy|4|||
48489708|NCT02971605|155987118|FG000|Overall Study|Withdrawal by Subject|1|||
48489709|NCT02649231|155987121|FG000|Overall Study|Adverse Event|0|||
48489710|NCT02649231|155987122|FG001|Overall Study|Adverse Event|0|||
48489711|NCT02649231|155987123|FG002|Overall Study|Adverse Event|0|||
48489712|NCT02649231|155987124|FG003|Overall Study|Adverse Event|1|||
48489713|NCT02649231|155987121|FG000|Overall Study|Lost to Follow-up|2|||
48489714|NCT02649231|155987122|FG001|Overall Study|Lost to Follow-up|1|||
48594675|NCT01042392|156370724|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
48594676|NCT01042392|156370725|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
48594677|NCT01042392|156370726|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
48594678|NCT01042392|156370723|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
48594679|NCT01042392|156370724|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
48594680|NCT01042392|156370725|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
48701835|NCT01724346|156757094|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
48701836|NCT04774094|156757102|FG000|Overall Study|Other|2|||
48701837|NCT04774094|156757102|FG000|Overall Study|Withdrawal by Subject|9|||
48701838|NCT04774094|156757102|FG000|Overall Study|Lost to Follow-up|7|||
48701839|NCT04774094|156757102|FG000|Overall Study|Lack of Efficacy|5|||
48594681|NCT01042392|156370726|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
48594682|NCT00103662|156370728|FG000|Overall Study|Entered Rescue Procedure|0|||
48701840|NCT04774094|156757102|FG000|Overall Study|Death|17|||
48701841|NCT04774094|156757102|FG000|Overall Study|Adverse Event|4|||
48701842|NCT02638220|156757104|FG000|Overall Study|Lost to Follow-up|6|||
48594683|NCT00103662|156370729|FG001|Overall Study|Entered Rescue Procedure|7|||
48594684|NCT00103662|156370728|FG000|Overall Study|Death|7|||
48594685|NCT00103662|156370729|FG001|Overall Study|Death|7|||
48594686|NCT00103662|156370728|FG000|Overall Study|Elective Withdrawal|5|||
48594687|NCT00103662|156370729|FG001|Overall Study|Elective Withdrawal|5|||
48594688|NCT00103662|156370728|FG000|Overall Study|Lost to Follow-up|0|||
48594689|NCT00103662|156370729|FG001|Overall Study|Lost to Follow-up|1|||
48594690|NCT00103662|156370728|FG000|Overall Study|Other|6|||
48594691|NCT00103662|156370729|FG001|Overall Study|Other|9|||
48594692|NCT00103662|156370728|FG000|Overall Study|Failed mobilization|0|||
48594693|NCT00103662|156370729|FG001|Overall Study|Failed mobilization|4|||
48594694|NCT00103662|156370728|FG000|Overall Study|Intercurrent illness|1|||
48594695|NCT00103662|156370729|FG001|Overall Study|Intercurrent illness|0|||
48594696|NCT02757625|156370730|FG000|Overall Study|Investigator's discretion|0|||
48594697|NCT02757625|156370731|FG001|Overall Study|Investigator's discretion|0|||
48594698|NCT02757625|156370732|FG002|Overall Study|Investigator's discretion|1|||
48594699|NCT02757625|156370733|FG003|Overall Study|Investigator's discretion|0|||
48594700|NCT02757625|156370730|FG000|Overall Study|Adverse Event|0|||
48594701|NCT02757625|156370731|FG001|Overall Study|Adverse Event|0|||
48594702|NCT02757625|156370732|FG002|Overall Study|Adverse Event|1|||
48594703|NCT02757625|156370733|FG003|Overall Study|Adverse Event|0|||
48594704|NCT00493311|156370734|FG000|Overall Study|Need for rescue medication|2|||
48594705|NCT00493311|156370735|FG001|Overall Study|Need for rescue medication|2|||
48594706|NCT00587795|156370736|FG000|Overall Study|Withdrawal by Subject|1|||
48594707|NCT00587795|156370737|FG001|Overall Study|Withdrawal by Subject|0|||
48594708|NCT04668209|156370738|FG000|Overall Study|Withdrawal by Subject|2|||
48594709|NCT04668209|156370739|FG001|Overall Study|Withdrawal by Subject|2|||
48594710|NCT04668209|156370738|FG000|Overall Study|Lost to Follow-up|3|||
48594711|NCT04668209|156370739|FG001|Overall Study|Lost to Follow-up|4|||
48594712|NCT04668209|156370738|FG000|Overall Study|Subject Expired|2|||
48594713|NCT04668209|156370739|FG001|Overall Study|Subject Expired|0|||
48594714|NCT04668209|156370738|FG000|Overall Study|Withdrawn from study|0|||
48594715|NCT04668209|156370739|FG001|Overall Study|Withdrawn from study|1|||
48594716|NCT04668209|156370738|FG000|Overall Study|Adverse Event|0|||
48594717|NCT04668209|156370739|FG001|Overall Study|Adverse Event|1|||
48594718|NCT01951573|156370742|FG000|Washout Period|Adverse Event|0|||
48594719|NCT01951573|156370743|FG001|Washout Period|Adverse Event|1|||
48594720|NCT00339833|156370744|FG000|Overall Study|Withdrawal by Subject|1|||
48594721|NCT00339833|156370745|FG001|Overall Study|Withdrawal by Subject|2|||
48594722|NCT00339833|156370744|FG000|Overall Study|toothache|0|||
48594723|NCT00339833|156370745|FG001|Overall Study|toothache|1|||
48594724|NCT00339833|156370744|FG000|Overall Study|indigestion|0|||
48594725|NCT00339833|156370745|FG001|Overall Study|indigestion|1|||
48594726|NCT00339833|156370744|FG000|Overall Study|Chest pain|0|||
48594727|NCT00339833|156370745|FG001|Overall Study|Chest pain|1|||
48594728|NCT00339833|156370744|FG000|Overall Study|minor infection|0|||
48594729|NCT00339833|156370745|FG001|Overall Study|minor infection|1|||
48594730|NCT00339833|156370744|FG000|Overall Study|Poor venous access|2|||
48594731|NCT00339833|156370745|FG001|Overall Study|Poor venous access|2|||
48594732|NCT00339833|156370744|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
48594733|NCT00339833|156370745|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
48594734|NCT00339833|156370744|FG000|Overall Study|Error in data records|1|||
48594735|NCT00339833|156370745|FG001|Overall Study|Error in data records|0|||
48594736|NCT00760487|156370750|FG000|Overall Study|Unilateral implantation|3|||
48594737|NCT00110357|156370753|FG000|Overall Study|Deterioration without progression|2|||
48594738|NCT00110357|156370754|FG001|Overall Study|Deterioration without progression|0|||
48594739|NCT00110357|156370753|FG000|Overall Study|Disease progression/relapse|20|||
48701843|NCT02638220|156757104|FG000|Overall Study|Withdrawal by Subject|3|||
48594740|NCT00110357|156370754|FG001|Overall Study|Disease progression/relapse|15|||
48594741|NCT00110357|156370753|FG000|Overall Study|Study Closure|1|||
48594742|NCT00110357|156370754|FG001|Overall Study|Study Closure|0|||
48594743|NCT00110357|156370753|FG000|Overall Study|Study Drug Toxicity|1|||
48594744|NCT00110357|156370754|FG001|Overall Study|Study Drug Toxicity|3|||
48594745|NCT00110357|156370753|FG000|Overall Study|Withdrawal by Subject|3|||
48594746|NCT00110357|156370754|FG001|Overall Study|Withdrawal by Subject|1|||
48594747|NCT00980655|156370778|FG000|Overall Study|Adverse Event|13|||
48594748|NCT00980655|156370779|FG001|Overall Study|Adverse Event|31|||
48594749|NCT00980655|156370778|FG000|Overall Study|Death|0|||
48594750|NCT00980655|156370779|FG001|Overall Study|Death|7|||
48594751|NCT00980655|156370778|FG000|Overall Study|Protocol Violation|2|||
48594752|NCT00980655|156370779|FG001|Overall Study|Protocol Violation|7|||
48594753|NCT00980655|156370778|FG000|Overall Study|Withdrawal by Subject|0|||
48594754|NCT00980655|156370779|FG001|Overall Study|Withdrawal by Subject|4|||
48594755|NCT00980655|156370778|FG000|Overall Study|Lost to Follow-up|0|||
48594756|NCT00980655|156370779|FG001|Overall Study|Lost to Follow-up|1|||
48594757|NCT00980655|156370778|FG000|Overall Study|Parent/legal guardian request|1|||
48594758|NCT00980655|156370779|FG001|Overall Study|Parent/legal guardian request|0|||
48594759|NCT00980655|156370778|FG000|Overall Study|Other|0|||
48594760|NCT00980655|156370779|FG001|Overall Study|Other|1|||
48594761|NCT00255164|156370780|FG000|Overall Study|Adverse Event|10|||
48594762|NCT00255164|156370781|FG001|Overall Study|Adverse Event|6|||
48594763|NCT00255164|156370782|FG002|Overall Study|Adverse Event|9|||
48594764|NCT00255164|156370780|FG000|Overall Study|Lost to Follow-up|4|||
48594765|NCT00255164|156370781|FG001|Overall Study|Lost to Follow-up|3|||
48594766|NCT00255164|156370782|FG002|Overall Study|Lost to Follow-up|4|||
48594767|NCT00255164|156370780|FG000|Overall Study|Withdrawal by Subject|18|||
48594768|NCT00255164|156370781|FG001|Overall Study|Withdrawal by Subject|17|||
48594769|NCT00255164|156370782|FG002|Overall Study|Withdrawal by Subject|8|||
48594770|NCT00255164|156370780|FG000|Overall Study|Noncompliance|0|||
48594771|NCT00255164|156370781|FG001|Overall Study|Noncompliance|1|||
48594772|NCT00255164|156370782|FG002|Overall Study|Noncompliance|2|||
48594773|NCT00255164|156370780|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
48594774|NCT00255164|156370781|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
48594775|NCT00255164|156370782|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
48594776|NCT00255164|156370780|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
48594777|NCT00255164|156370781|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
48701844|NCT02638220|156757104|FG000|Overall Study|Physician Decision|1|||
48701845|NCT02638220|156757104|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
48701846|NCT05232682|156757105|FG000|Overall Study|Lost to Follow-up|2|||
48701847|NCT02318706|156758506|FG000|Double-blind Phase|Adverse Event|7|||
48701848|NCT02318706|156758507|FG001|Double-blind Phase|Adverse Event|4|||
48701849|NCT02318706|156758508|FG002|Double-blind Phase|Adverse Event|3|||
48701850|NCT02318706|156758509|FG003|Double-blind Phase|Adverse Event|10|||
48701851|NCT02318706|156758510|FG004|Double-blind Phase|Adverse Event|0|||
48701852|NCT02318706|156758506|FG000|Double-blind Phase|Lost to Follow-up|1|||
48701853|NCT02318706|156758507|FG001|Double-blind Phase|Lost to Follow-up|0|||
48701854|NCT02318706|156758508|FG002|Double-blind Phase|Lost to Follow-up|0|||
48701855|NCT02318706|156758509|FG003|Double-blind Phase|Lost to Follow-up|0|||
48701856|NCT02318706|156758510|FG004|Double-blind Phase|Lost to Follow-up|0|||
48701857|NCT02318706|156758506|FG000|Double-blind Phase|Protocol Violation|4|||
48701858|NCT02318706|156758507|FG001|Double-blind Phase|Protocol Violation|2|||
48701859|NCT02318706|156758508|FG002|Double-blind Phase|Protocol Violation|4|||
48701860|NCT02318706|156758509|FG003|Double-blind Phase|Protocol Violation|3|||
48701861|NCT02318706|156758510|FG004|Double-blind Phase|Protocol Violation|0|||
48489715|NCT02649231|155987123|FG002|Overall Study|Lost to Follow-up|1|||
48489716|NCT02649231|155987124|FG003|Overall Study|Lost to Follow-up|0|||
48489717|NCT02649231|155987121|FG000|Overall Study|Withdrawal by Subject|0|||
48489718|NCT02649231|155987122|FG001|Overall Study|Withdrawal by Subject|1|||
48489719|NCT02649231|155987123|FG002|Overall Study|Withdrawal by Subject|0|||
48489720|NCT02649231|155987124|FG003|Overall Study|Withdrawal by Subject|1|||
48489721|NCT02649231|155987121|FG000|Overall Study|Protocol Violation|2|||
48489722|NCT02649231|155987122|FG001|Overall Study|Protocol Violation|1|||
48594778|NCT00255164|156370782|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
48701862|NCT02318706|156758506|FG000|Double-blind Phase|Withdrawal by Subject|9|||
48701863|NCT02318706|156758507|FG001|Double-blind Phase|Withdrawal by Subject|5|||
48701864|NCT02318706|156758508|FG002|Double-blind Phase|Withdrawal by Subject|7|||
48594779|NCT00255164|156370780|FG000|Overall Study|Possible Barrett's Esophagus|1|||
48594780|NCT00255164|156370781|FG001|Overall Study|Possible Barrett's Esophagus|3|||
48594781|NCT00255164|156370782|FG002|Overall Study|Possible Barrett's Esophagus|8|||
48594782|NCT00255164|156370780|FG000|Overall Study|Esophageal Stricture|0|||
48594783|NCT00255164|156370781|FG001|Overall Study|Esophageal Stricture|0|||
48594784|NCT00255164|156370782|FG002|Overall Study|Esophageal Stricture|1|||
48594785|NCT00255164|156370780|FG000|Overall Study|Therapeutic Failure|11|||
48701865|NCT02318706|156758509|FG003|Double-blind Phase|Withdrawal by Subject|10|||
48701866|NCT02318706|156758510|FG004|Double-blind Phase|Withdrawal by Subject|0|||
48489723|NCT02649231|155987123|FG002|Overall Study|Protocol Violation|1|||
48489724|NCT02649231|155987124|FG003|Overall Study|Protocol Violation|0|||
48701867|NCT02318706|156758506|FG000|Double-blind Phase|Other|4|||
48594786|NCT00255164|156370781|FG001|Overall Study|Therapeutic Failure|2|||
48594787|NCT00255164|156370782|FG002|Overall Study|Therapeutic Failure|3|||
48594788|NCT03430856|156370785|FG000|Overall Study|Adverse Event|0|||
48594789|NCT03430856|156370786|FG001|Overall Study|Adverse Event|1|||
48594790|NCT03430856|156370787|FG002|Overall Study|Adverse Event|0|||
48594791|NCT03430856|156370785|FG000|Overall Study|Rescue criteria|1|||
48594792|NCT03430856|156370786|FG001|Overall Study|Rescue criteria|1|||
48594793|NCT03430856|156370787|FG002|Overall Study|Rescue criteria|0|||
48594794|NCT03430856|156370785|FG000|Overall Study|Voluntary withdrawal of consent|1|||
48594795|NCT03430856|156370786|FG001|Overall Study|Voluntary withdrawal of consent|1|||
48594796|NCT03430856|156370787|FG002|Overall Study|Voluntary withdrawal of consent|1|||
48594797|NCT04162795|156370791|FG000|Overall Study|Other|16|||
48594798|NCT04162795|156370791|FG000|Overall Study|Screen failures|10|||
48594799|NCT00565604|156370795|FG000|Overall Study|Failure to treat|2|||
48594800|NCT00565604|156370795|FG000|Overall Study|Lost to Follow-up|2|||
48594801|NCT01121263|156370796|FG000|Overall Study|Death|3|||
48594802|NCT01121263|156370797|FG001|Overall Study|Death|2|||
48594803|NCT01121263|156370796|FG000|Overall Study|Lost to Follow-up|22|||
48594804|NCT01121263|156370797|FG001|Overall Study|Lost to Follow-up|12|||
48594805|NCT01121263|156370796|FG000|Overall Study|Withdrawal by Subject|0|||
48594806|NCT01121263|156370797|FG001|Overall Study|Withdrawal by Subject|1|||
48594807|NCT04003623|156372357|FG000|Overall Study|Withdrawal by Subject|1|||
48594808|NCT04003623|156372358|FG001|Overall Study|Withdrawal by Subject|0|||
48594809|NCT02207400|156372361|FG000|Overall Study|Adverse Event|1|||
48594810|NCT02207400|156372362|FG001|Overall Study|Adverse Event|1|||
48594811|NCT02207400|156372361|FG000|Overall Study|Lost to Follow-up|6|||
48594812|NCT02207400|156372362|FG001|Overall Study|Lost to Follow-up|7|||
48594813|NCT02207400|156372361|FG000|Overall Study|Protocol Violation|1|||
48594814|NCT02207400|156372362|FG001|Overall Study|Protocol Violation|1|||
48594815|NCT02207400|156372361|FG000|Overall Study|Withdrawal by Subject|8|||
48594816|NCT02207400|156372362|FG001|Overall Study|Withdrawal by Subject|4|||
48594817|NCT02207400|156372361|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
48594818|NCT02207400|156372362|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
48594819|NCT03052920|156372367|FG000|Overall Study|Withdrawal by Subject|1|||
48594820|NCT01502956|156372368|FG000|Overall Study|Death|0|||
48594821|NCT01502956|156372369|FG001|Overall Study|Death|2|||
48594822|NCT01502956|156372368|FG000|Overall Study|Lost to Follow-up|14|||
48594823|NCT01502956|156372369|FG001|Overall Study|Lost to Follow-up|11|||
48594824|NCT01502956|156372368|FG000|Overall Study|Physician Decision|2|||
48594825|NCT01502956|156372369|FG001|Overall Study|Physician Decision|3|||
48594826|NCT01502956|156372368|FG000|Overall Study|Withdrawal by Subject|8|||
48594827|NCT01502956|156372369|FG001|Overall Study|Withdrawal by Subject|10|||
48594828|NCT02501161|156372378|FG000|Overall Study|Adverse Event|2|||
48594829|NCT02501161|156372379|FG001|Overall Study|Adverse Event|6|||
48594830|NCT02501161|156372378|FG000|Overall Study|Lost to Follow-up|7|||
48594831|NCT02501161|156372379|FG001|Overall Study|Lost to Follow-up|4|||
48594832|NCT02501161|156372378|FG000|Overall Study|Withdrawal by Subject|10|||
48594833|NCT02501161|156372379|FG001|Overall Study|Withdrawal by Subject|15|||
48594834|NCT02501161|156372378|FG000|Overall Study|Other|3|||
48594835|NCT02501161|156372379|FG001|Overall Study|Other|0|||
48594836|NCT01054222|156372380|FG000|Overall Study|Lack of Efficacy|1|||
48594837|NCT01054222|156372380|FG000|Overall Study|Lost to Follow-up|4|||
48594838|NCT01054222|156372380|FG000|Overall Study|Withdrawal by Subject|6|||
48594839|NCT01467271|156372396|FG000|Overall Study|Death|84|||
48701868|NCT02318706|156758507|FG001|Double-blind Phase|Other|1|||
48701869|NCT02318706|156758508|FG002|Double-blind Phase|Other|2|||
48701870|NCT02318706|156758509|FG003|Double-blind Phase|Other|1|||
48701871|NCT02318706|156758510|FG004|Double-blind Phase|Other|0|||
48701872|NCT02318706|156758506|FG000|Double-blind Phase|Death|0|||
48701873|NCT02318706|156758507|FG001|Double-blind Phase|Death|0|||
48701874|NCT02318706|156758508|FG002|Double-blind Phase|Death|2|||
48701875|NCT02318706|156758509|FG003|Double-blind Phase|Death|0|||
48701876|NCT02318706|156758510|FG004|Double-blind Phase|Death|0|||
48701877|NCT02318706|156758506|FG000|Open-label Extension Phase|Adverse Event|0|||
48701878|NCT02318706|156758507|FG001|Open-label Extension Phase|Adverse Event|0|||
48701879|NCT02318706|156758508|FG002|Open-label Extension Phase|Adverse Event|0|||
48594840|NCT01467271|156372396|FG000|Overall Study|Lost to Follow-up|83|||
48594841|NCT01467271|156372396|FG000|Overall Study|Retraction of patient's consent|21|||
48594842|NCT01467271|156372396|FG000|Overall Study|Other reason|14|||
48594843|NCT00184002|156372401|FG000|Overall Study|Adverse Event|9|||
48594844|NCT00184002|156372401|FG000|Overall Study|Death|3|||
48594845|NCT00184002|156372401|FG000|Overall Study|Physician Decision|1|||
48594846|NCT00184002|156372401|FG000|Overall Study|Withdrawal by Subject|4|||
48594847|NCT02131233|156372407|FG000|Overall Study|Not Treated|2|||
48594848|NCT02131233|156372408|FG001|Overall Study|Not Treated|3|||
48701880|NCT02318706|156758509|FG003|Open-label Extension Phase|Adverse Event|0|||
48701881|NCT02318706|156758510|FG004|Open-label Extension Phase|Adverse Event|21|||
48594849|NCT02131233|156372407|FG000|Overall Study|Adverse Event|7|||
48594850|NCT02131233|156372408|FG001|Overall Study|Adverse Event|6|||
48594851|NCT02131233|156372407|FG000|Overall Study|Death|0|||
48701882|NCT02318706|156758506|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
48701883|NCT02318706|156758507|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
48489725|NCT00638157|155987125|FG000|Overall Study|Adverse Event|0|||
48489726|NCT00638157|155987126|FG001|Overall Study|Adverse Event|1|||
48489727|NCT00638157|155987125|FG000|Overall Study|Clinical (symptomatic) failure|1|||
48489728|NCT00638157|155987126|FG001|Overall Study|Clinical (symptomatic) failure|1|||
48489729|NCT00638157|155987125|FG000|Overall Study|Microbiological failure|1|||
48489730|NCT00638157|155987126|FG001|Overall Study|Microbiological failure|0|||
48489731|NCT00638157|155987125|FG000|Overall Study|Lost to Follow-up|1|||
48489732|NCT00638157|155987126|FG001|Overall Study|Lost to Follow-up|0|||
48489733|NCT00638157|155987125|FG000|Overall Study|Physician Decision|1|||
48489734|NCT00638157|155987126|FG001|Overall Study|Physician Decision|0|||
48489735|NCT00638157|155987125|FG000|Overall Study|Other|1|||
48489736|NCT00638157|155987126|FG001|Overall Study|Other|2|||
48489737|NCT00638157|155987125|FG000|Overall Study|Randomized, not treated|2|||
48489738|NCT00638157|155987126|FG001|Overall Study|Randomized, not treated|0|||
48489739|NCT00520351|155987129|FG000|First Intervention|Withdrawal by Subject|1|||
48489740|NCT00520351|155987130|FG001|First Intervention|Withdrawal by Subject|1|||
48489741|NCT01875445|155987131|FG000|Overall Study|Lost to Follow-up|5|||
48489742|NCT01875445|155987132|FG001|Overall Study|Lost to Follow-up|0|||
48489743|NCT01875445|155987131|FG000|Overall Study|Withdrawal by Subject|2|||
48489744|NCT01875445|155987132|FG001|Overall Study|Withdrawal by Subject|0|||
48489745|NCT01102777|155987133|FG000|Overall Study|Death|2|||
48489746|NCT01102777|155987134|FG001|Overall Study|Death|6|||
48489747|NCT01102777|155987133|FG000|Overall Study|Lost to Follow-up|7|||
48489748|NCT01102777|155987134|FG001|Overall Study|Lost to Follow-up|10|||
48489749|NCT00706706|155987135|FG000|Overall Study|Death|53|||
48489750|NCT00706706|155987135|FG000|Overall Study|Lost to Follow-up|7|||
48489751|NCT00706706|155987135|FG000|Overall Study|Study endpoint had reached|45|||
48489752|NCT00593333|155987136|FG000|Overall Study|Lost to Follow-up|10|||
48489753|NCT00593333|155987137|FG001|Overall Study|Lost to Follow-up|11|||
48489754|NCT01965652|155987139|FG000|Overall Study|Adverse Event|40|||
48489755|NCT01965652|155987140|FG001|Overall Study|Adverse Event|37|||
48489756|NCT01965652|155987139|FG000|Overall Study|Withdrawal by Subject|62|||
48489757|NCT01965652|155987140|FG001|Overall Study|Withdrawal by Subject|69|||
48489758|NCT01965652|155987139|FG000|Overall Study|Lost to Follow-up|53|||
48489759|NCT01965652|155987140|FG001|Overall Study|Lost to Follow-up|40|||
48489760|NCT01965652|155987139|FG000|Overall Study|Protocol Violation|34|||
48489761|NCT01965652|155987140|FG001|Overall Study|Protocol Violation|38|||
48489762|NCT01965652|155987139|FG000|Overall Study|Death|3|||
48489763|NCT01965652|155987140|FG001|Overall Study|Death|4|||
48489764|NCT01965652|155987139|FG000|Overall Study|Other - Miscellaneous|18|||
48489765|NCT01965652|155987140|FG001|Overall Study|Other - Miscellaneous|21|||
48489766|NCT01965652|155987139|FG000|Overall Study|Pregnancy|0|||
48489767|NCT01965652|155987140|FG001|Overall Study|Pregnancy|1|||
48489768|NCT02109133|155987159|FG000|Overall Study|Lost to Follow-up|1|||
48489769|NCT02109133|155987160|FG001|Overall Study|Lost to Follow-up|0|||
48489770|NCT04535583|155987168|FG000|Overall Study|Lost to Follow-up|1|||
48489771|NCT04535583|155987168|FG000|Overall Study|Physician Decision|1|||
48489772|NCT04535583|155987168|FG000|Overall Study|Withdrawal by Subject|1|||
48489773|NCT03828461|155987169|FG000|Overall Study|Lost to Follow-up|1|||
48489774|NCT03828461|155987169|FG000|Overall Study|Withdrawal by Subject|3|||
48489775|NCT02451670|155988771|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
48489776|NCT02451670|155988772|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
48489777|NCT01073020|155988775|FG000|Overall Study|Withdrawal by Subject|6|||
48489778|NCT01073020|155988776|FG001|Overall Study|Withdrawal by Subject|4|||
48489779|NCT01073020|155988777|FG002|Overall Study|Withdrawal by Subject|1|||
48489780|NCT01073020|155988778|FG003|Overall Study|Withdrawal by Subject|2|||
48489781|NCT01073020|155988775|FG000|Overall Study|Physician Decision|1|||
48489782|NCT01073020|155988776|FG001|Overall Study|Physician Decision|0|||
48489783|NCT01073020|155988777|FG002|Overall Study|Physician Decision|2|||
48489784|NCT01073020|155988778|FG003|Overall Study|Physician Decision|0|||
48489785|NCT01073020|155988775|FG000|Overall Study|Death|0|||
48489786|NCT01073020|155988776|FG001|Overall Study|Death|1|||
48489787|NCT01073020|155988777|FG002|Overall Study|Death|0|||
48594852|NCT02131233|156372408|FG001|Overall Study|Death|1|||
48489788|NCT01073020|155988778|FG003|Overall Study|Death|0|||
48489789|NCT01017029|155988788|FG000|Overall Study|Lost to Follow-up|1|||
48489790|NCT01017029|155988789|FG001|Overall Study|Lost to Follow-up|0|||
48489791|NCT01017029|155988788|FG000|Overall Study|Administrative problem|0|||
48489792|NCT01017029|155988789|FG001|Overall Study|Administrative problem|1|||
48489793|NCT01017029|155988788|FG000|Overall Study|Death|3|||
48489794|NCT01017029|155988789|FG001|Overall Study|Death|1|||
48489795|NCT01872689|155988790|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
48489796|NCT01872689|155988791|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
48489797|NCT01872689|155988792|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
48489798|NCT01872689|155988793|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
48489799|NCT01872689|155988790|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
48594853|NCT02131233|156372407|FG000|Overall Study|Lack of Efficacy|6|||
48594854|NCT02131233|156372408|FG001|Overall Study|Lack of Efficacy|3|||
48594855|NCT02131233|156372407|FG000|Overall Study|Lost to Follow-up|14|||
48594856|NCT02131233|156372408|FG001|Overall Study|Lost to Follow-up|13|||
48594857|NCT02131233|156372407|FG000|Overall Study|Non-Compliance With Study Drug|8|||
48594858|NCT02131233|156372408|FG001|Overall Study|Non-Compliance With Study Drug|5|||
48594859|NCT02131233|156372407|FG000|Overall Study|Physician Decision|7|||
48594860|NCT02131233|156372408|FG001|Overall Study|Physician Decision|0|||
48594861|NCT02131233|156372407|FG000|Overall Study|Pregnancy|4|||
48594862|NCT02131233|156372408|FG001|Overall Study|Pregnancy|0|||
48594863|NCT02131233|156372407|FG000|Overall Study|Withdrawal by Subject|18|||
48594864|NCT02131233|156372408|FG001|Overall Study|Withdrawal by Subject|11|||
48594865|NCT00540644|156372410|FG000|Overall Study|Adverse Event|3|||
48594866|NCT00540644|156372411|FG001|Overall Study|Adverse Event|1|||
48594867|NCT00540644|156372410|FG000|Overall Study|Disease Progression|3|||
48594868|NCT00540644|156372411|FG001|Overall Study|Disease Progression|1|||
48594869|NCT00540644|156372410|FG000|Overall Study|Physician Decision|0|||
48594870|NCT00540644|156372411|FG001|Overall Study|Physician Decision|5|||
48594871|NCT00540644|156372410|FG000|Overall Study|Withdrawal by Subject|2|||
48594872|NCT00540644|156372411|FG001|Overall Study|Withdrawal by Subject|2|||
48594873|NCT00540644|156372410|FG000|Overall Study|Noncomplilance|1|||
48594874|NCT00540644|156372411|FG001|Overall Study|Noncomplilance|0|||
48594875|NCT02144077|156372412|FG000|Overall Study|Withdrawal by Subject|3|||
48594876|NCT02144077|156372413|FG001|Overall Study|Withdrawal by Subject|3|||
48594877|NCT02144077|156372412|FG000|Overall Study|Adverse Event|2|||
48701884|NCT02318706|156758508|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
48701885|NCT02318706|156758509|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
48701886|NCT02318706|156758510|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
48701887|NCT02318706|156758506|FG000|Open-label Extension Phase|Death|0|||
48701888|NCT02318706|156758507|FG001|Open-label Extension Phase|Death|0|||
48701889|NCT02318706|156758508|FG002|Open-label Extension Phase|Death|0|||
48701890|NCT02318706|156758509|FG003|Open-label Extension Phase|Death|0|||
48701891|NCT02318706|156758510|FG004|Open-label Extension Phase|Death|1|||
48701892|NCT02318706|156758506|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
48701893|NCT02318706|156758507|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
48701894|NCT02318706|156758508|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
48701895|NCT02318706|156758509|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
48701896|NCT02318706|156758510|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
48594878|NCT02144077|156372413|FG001|Overall Study|Adverse Event|3|||
48594879|NCT02144077|156372412|FG000|Overall Study|Lost to Follow-up|2|||
48594880|NCT02144077|156372413|FG001|Overall Study|Lost to Follow-up|2|||
48701897|NCT01702311|156758511|FG000|Overall Study|Withdrawal by Subject|3|||
48701898|NCT01702311|156758512|FG001|Overall Study|Withdrawal by Subject|2|||
48701899|NCT01702311|156758511|FG000|Overall Study|Discharge less than 24 hours|10|||
48701900|NCT01702311|156758512|FG001|Overall Study|Discharge less than 24 hours|7|||
48701901|NCT01702311|156758511|FG000|Overall Study|Physician Decision|3|||
48701902|NCT01702311|156758512|FG001|Overall Study|Physician Decision|4|||
48701903|NCT02326155|156758513|FG000|Overall Study|Adverse Event|21|||
48701904|NCT02326155|156758514|FG001|Overall Study|Adverse Event|5|||
48701905|NCT02326155|156758513|FG000|Overall Study|Death|3|||
48701906|NCT02326155|156758514|FG001|Overall Study|Death|0|||
48701907|NCT02326155|156758513|FG000|Overall Study|Lack of Efficacy|49|||
48701908|NCT02326155|156758514|FG001|Overall Study|Lack of Efficacy|5|||
48701909|NCT02326155|156758513|FG000|Overall Study|Lost to Follow-up|14|||
48701910|NCT02326155|156758514|FG001|Overall Study|Lost to Follow-up|3|||
48701911|NCT02326155|156758513|FG000|Overall Study|Protocol Violation|2|||
48701912|NCT02326155|156758514|FG001|Overall Study|Protocol Violation|0|||
48701913|NCT02326155|156758513|FG000|Overall Study|Withdrawal by Subject|34|||
48701914|NCT02326155|156758514|FG001|Overall Study|Withdrawal by Subject|11|||
48701915|NCT02326155|156758513|FG000|Overall Study|Disease progression|37|||
48701916|NCT02326155|156758514|FG001|Overall Study|Disease progression|4|||
48701917|NCT02326155|156758513|FG000|Overall Study|Study close|188|||
48701918|NCT02326155|156758514|FG001|Overall Study|Study close|21|||
48701919|NCT02326155|156758513|FG000|Overall Study|except for study close|46|||
48701920|NCT02326155|156758514|FG001|Overall Study|except for study close|13|||
48701921|NCT01074502|156758520|FG000|Overall Study|Withdrawal by Subject|1|||
48701922|NCT04177823|156758529|FG000|Overall Study|Physician Decision|1|||
48701923|NCT04177823|156758529|FG000|Overall Study|Withdrawal by Subject|1|||
48489800|NCT01872689|155988791|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
48594881|NCT02144077|156372412|FG000|Overall Study|Protocol Violation|1|||
48594882|NCT02144077|156372413|FG001|Overall Study|Protocol Violation|2|||
48594883|NCT02144077|156372412|FG000|Overall Study|Death|0|||
48594884|NCT02144077|156372413|FG001|Overall Study|Death|1|||
48594885|NCT02144077|156372412|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
48701924|NCT02351817|156758530|FG000|Period 1|Adverse Event|1|||
48701925|NCT02351817|156758531|FG001|Period 1|Adverse Event|2|||
48701926|NCT02351817|156758530|FG000|Period 1|Lack of Efficacy|0|||
48594886|NCT02144077|156372413|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
48594887|NCT00217581|156372416|FG000|Overall Study|Withdrawal by Subject|1|||
48701927|NCT02351817|156758531|FG001|Period 1|Lack of Efficacy|1|||
48701928|NCT02351817|156758530|FG000|Period 2|Adverse Event|0|||
48701929|NCT02351817|156758531|FG001|Period 2|Adverse Event|2|||
48701930|NCT02351817|156758530|FG000|Period 2|Protocol Violation|1|||
48701931|NCT02351817|156758531|FG001|Period 2|Protocol Violation|0|||
48489801|NCT01872689|155988792|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
48489802|NCT01872689|155988793|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
48489803|NCT01872689|155988790|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
48489804|NCT01872689|155988791|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
48489805|NCT01872689|155988792|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
48489806|NCT01872689|155988793|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
48489807|NCT01872689|155988790|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
48489808|NCT01872689|155988791|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
48489809|NCT01872689|155988792|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
48701932|NCT03137381|156758532|FG000|Overall Study|Adverse Event|3|||
48489810|NCT01872689|155988793|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
48489811|NCT01872689|155988790|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
48489812|NCT01872689|155988791|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
48489813|NCT01872689|155988792|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
48489814|NCT01872689|155988793|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
48489815|NCT01872689|155988790|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
48489816|NCT01872689|155988791|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
48489817|NCT01872689|155988792|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
48489818|NCT01872689|155988793|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
48489819|NCT01872689|155988790|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
48489820|NCT01872689|155988791|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
48489821|NCT01872689|155988792|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
48489822|NCT01872689|155988793|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
48489823|NCT01872689|155988790|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
48489824|NCT01872689|155988791|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
48489825|NCT01872689|155988792|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
48489826|NCT01872689|155988793|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
48489827|NCT01872689|155988790|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
48489828|NCT01872689|155988791|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
48489829|NCT01872689|155988792|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
48489830|NCT01872689|155988793|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
48489831|NCT01872689|155988790|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
48489832|NCT01872689|155988791|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
48489833|NCT01872689|155988792|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
48489834|NCT01872689|155988793|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
48489835|NCT01872689|155988790|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
48489836|NCT01872689|155988791|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
48489837|NCT01872689|155988792|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
48489838|NCT01872689|155988793|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
48489839|NCT01872689|155988790|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
48489840|NCT01872689|155988791|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
48489841|NCT01872689|155988792|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
48489842|NCT01872689|155988793|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
48489843|NCT01872689|155988790|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
48489844|NCT01872689|155988791|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
48489845|NCT01872689|155988792|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
48489846|NCT01872689|155988793|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
48489847|NCT01872689|155988790|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
48489848|NCT01872689|155988791|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
48489849|NCT01872689|155988792|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
48489850|NCT01872689|155988793|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
48489851|NCT00515073|155988794|FG000|Overall Study|Withdrawal by Subject|1|||
48489852|NCT00515073|155988794|FG000|Overall Study|Physician Decision|1|||
48701933|NCT03137381|156758533|FG001|Overall Study|Adverse Event|0|||
48701934|NCT03137381|156758534|FG002|Overall Study|Adverse Event|2|||
48701935|NCT03137381|156758535|FG003|Overall Study|Adverse Event|0|||
48701936|NCT03137381|156758532|FG000|Overall Study|Lost to Follow-up|2|||
48701937|NCT03137381|156758533|FG001|Overall Study|Lost to Follow-up|1|||
48701938|NCT03137381|156758534|FG002|Overall Study|Lost to Follow-up|1|||
48701939|NCT03137381|156758535|FG003|Overall Study|Lost to Follow-up|0|||
48701940|NCT03137381|156758532|FG000|Overall Study|Protocol deviation|1|||
48594888|NCT01909973|156372418|FG000|Overall Study|Lost to Follow-up|1|||
48701941|NCT03137381|156758533|FG001|Overall Study|Protocol deviation|1|||
48701942|NCT03137381|156758534|FG002|Overall Study|Protocol deviation|0|||
48701943|NCT03137381|156758535|FG003|Overall Study|Protocol deviation|1|||
48701944|NCT03137381|156758532|FG000|Overall Study|Withdrawal by Investigator|0|||
48701945|NCT03137381|156758533|FG001|Overall Study|Withdrawal by Investigator|1|||
48701946|NCT03137381|156758534|FG002|Overall Study|Withdrawal by Investigator|1|||
48701947|NCT03137381|156758535|FG003|Overall Study|Withdrawal by Investigator|0|||
48701948|NCT03137381|156758532|FG000|Overall Study|Withdrawal by Subject|3|||
48701949|NCT03137381|156758533|FG001|Overall Study|Withdrawal by Subject|4|||
48701950|NCT03137381|156758534|FG002|Overall Study|Withdrawal by Subject|3|||
48701951|NCT03137381|156758535|FG003|Overall Study|Withdrawal by Subject|0|||
48701952|NCT03137381|156758532|FG000|Overall Study|Pregnancy|0|||
48701953|NCT03137381|156758533|FG001|Overall Study|Pregnancy|0|||
48701954|NCT03137381|156758534|FG002|Overall Study|Pregnancy|1|||
48701955|NCT03137381|156758535|FG003|Overall Study|Pregnancy|0|||
48701956|NCT02488915|156758536|FG000|Overall Study|Death|21|||
48701957|NCT02488915|156758536|FG000|Overall Study|Lost to Follow-up|4|||
48701958|NCT02488915|156758536|FG000|Overall Study|Withdrawal by Subject|1|||
48701959|NCT02556177|156758537|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
48701960|NCT02556177|156758538|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
48701961|NCT01780506|156758539|FG000|Double-Blind Phase|Randomized but not Treated|3|||
48701962|NCT01780506|156758540|FG001|Double-Blind Phase|Randomized but not Treated|2|||
48701963|NCT01780506|156758539|FG000|Double-Blind Phase|Adverse Event|4|||
48701964|NCT01780506|156758540|FG001|Double-Blind Phase|Adverse Event|14|||
48701965|NCT01780506|156758539|FG000|Double-Blind Phase|Death|1|||
48701966|NCT01780506|156758540|FG001|Double-Blind Phase|Death|2|||
48701967|NCT01780506|156758539|FG000|Double-Blind Phase|Pregnancy|2|||
48701968|NCT01780506|156758540|FG001|Double-Blind Phase|Pregnancy|1|||
48701969|NCT01780506|156758539|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48701970|NCT01780506|156758540|FG001|Double-Blind Phase|Lack of Efficacy|1|||
48701971|NCT01780506|156758539|FG000|Double-Blind Phase|Investigator's Discretion|5|||
48701972|NCT01780506|156758540|FG001|Double-Blind Phase|Investigator's Discretion|2|||
48701973|NCT01780506|156758539|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
48701974|NCT01780506|156758540|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
48701975|NCT01780506|156758539|FG000|Double-Blind Phase|Protocol Violation|4|||
48701976|NCT01780506|156758540|FG001|Double-Blind Phase|Protocol Violation|3|||
48701977|NCT01780506|156758539|FG000|Double-Blind Phase|Withdrew Consent|23|||
48701978|NCT01780506|156758540|FG001|Double-Blind Phase|Withdrew Consent|24|||
48701979|NCT01780506|156758539|FG000|Double-Blind Phase|Lost to Follow-up|23|||
48701980|NCT01780506|156758540|FG001|Double-Blind Phase|Lost to Follow-up|26|||
48701981|NCT01780506|156758539|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
48701982|NCT01780506|156758540|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
48701983|NCT01995838|156758541|FG000|Overall Study|Lost to Follow-up|0|||
48701984|NCT01995838|156758542|FG001|Overall Study|Lost to Follow-up|1|||
48701985|NCT01995838|156758543|FG002|Overall Study|Lost to Follow-up|0|||
48701986|NCT01995838|156758544|FG003|Overall Study|Lost to Follow-up|0|||
48701987|NCT01995838|156758545|FG004|Overall Study|Lost to Follow-up|0|||
48701988|NCT01995838|156758546|FG005|Overall Study|Lost to Follow-up|0|||
48701989|NCT01995838|156758547|FG006|Overall Study|Lost to Follow-up|1|||
48701990|NCT01995838|156758541|FG000|Overall Study|Participant choice|2|||
48701991|NCT01995838|156758542|FG001|Overall Study|Participant choice|0|||
48701992|NCT01995838|156758543|FG002|Overall Study|Participant choice|0|||
48701993|NCT01995838|156758544|FG003|Overall Study|Participant choice|0|||
48701994|NCT01995838|156758545|FG004|Overall Study|Participant choice|0|||
48701995|NCT01995838|156758546|FG005|Overall Study|Participant choice|1|||
48701996|NCT01995838|156758547|FG006|Overall Study|Participant choice|1|||
48701997|NCT01995838|156758541|FG000|Overall Study|Adverse Event|0|||
48701998|NCT01995838|156758542|FG001|Overall Study|Adverse Event|0|||
48701999|NCT01995838|156758543|FG002|Overall Study|Adverse Event|0|||
48702000|NCT01995838|156758544|FG003|Overall Study|Adverse Event|0|||
48702001|NCT01995838|156758545|FG004|Overall Study|Adverse Event|0|||
48702002|NCT01995838|156758546|FG005|Overall Study|Adverse Event|0|||
48702003|NCT01995838|156758547|FG006|Overall Study|Adverse Event|1|||
48702004|NCT01995838|156758541|FG000|Overall Study|Withdrawal by Subject|0|||
48702005|NCT01995838|156758542|FG001|Overall Study|Withdrawal by Subject|0|||
48702006|NCT01995838|156758543|FG002|Overall Study|Withdrawal by Subject|0|||
48702007|NCT01995838|156758544|FG003|Overall Study|Withdrawal by Subject|0|||
48702008|NCT01995838|156758545|FG004|Overall Study|Withdrawal by Subject|1|||
48702009|NCT01995838|156758546|FG005|Overall Study|Withdrawal by Subject|0|||
48702010|NCT01995838|156758547|FG006|Overall Study|Withdrawal by Subject|0|||
48702011|NCT01995838|156758541|FG000|Overall Study|Other|3|||
48702012|NCT01995838|156758542|FG001|Overall Study|Other|1|||
48702013|NCT01995838|156758543|FG002|Overall Study|Other|0|||
48702014|NCT01995838|156758544|FG003|Overall Study|Other|2|||
48702015|NCT01995838|156758545|FG004|Overall Study|Other|1|||
48702016|NCT01995838|156758546|FG005|Overall Study|Other|1|||
48702017|NCT01995838|156758547|FG006|Overall Study|Other|2|||
48702018|NCT04798196|156758548|FG000|Overall Study|Lost to Follow-up|3|||
48702019|NCT04798196|156758549|FG001|Overall Study|Lost to Follow-up|1|||
48702020|NCT04798196|156758550|FG002|Overall Study|Lost to Follow-up|3|||
48702021|NCT00728689|156758561|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
48702022|NCT00728689|156758562|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
48702023|NCT02461758|156758563|FG000|Overall Study|Lost to Follow-up|0|||
48702024|NCT02461758|156758564|FG001|Overall Study|Lost to Follow-up|1|||
48702025|NCT02461758|156758565|FG002|Overall Study|Lost to Follow-up|1|||
48702026|NCT02461758|156758566|FG003|Overall Study|Lost to Follow-up|0|||
48702027|NCT00887809|156758571|FG000|Overall Study|Patient Not Treated|3|||
48702028|NCT00887809|156758572|FG001|Overall Study|Patient Not Treated|0|||
48702029|NCT00887809|156758571|FG000|Overall Study|Death|1|||
48702030|NCT00887809|156758572|FG001|Overall Study|Death|0|||
48702031|NCT01782378|156758573|FG000|First Series|Lost to Follow-up|7|||
48702032|NCT01782378|156758574|FG001|First Series|Lost to Follow-up|8|||
48702033|NCT01782378|156758573|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
48702034|NCT01782378|156758574|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
48702035|NCT01782378|156758573|FG000|Second Series|Lost to Follow-up|8|||
48702036|NCT01782378|156758574|FG001|Second Series|Lost to Follow-up|7|||
48702037|NCT01782378|156758573|FG000|Second Series|Did not choose to complete S2 Optional|18|||
48702038|NCT01782378|156758574|FG001|Second Series|Did not choose to complete S2 Optional|0|||
48702039|NCT01352715|156758575|FG000|Overall Study|Death|3|||
48702040|NCT01352715|156758576|FG001|Overall Study|Death|3|||
48702041|NCT01352715|156758575|FG000|Overall Study|Lost to Follow-up|5|||
48702042|NCT01352715|156758576|FG001|Overall Study|Lost to Follow-up|7|||
48702043|NCT01352715|156758575|FG000|Overall Study|Withdrawal by Subject|4|||
48702044|NCT01352715|156758576|FG001|Overall Study|Withdrawal by Subject|8|||
48702045|NCT01352715|156758575|FG000|Overall Study|site closure|16|||
48702046|NCT01352715|156758576|FG001|Overall Study|site closure|15|||
48702047|NCT01352715|156758575|FG000|Overall Study|no final visit in closeout period|15|||
48702048|NCT01352715|156758576|FG001|Overall Study|no final visit in closeout period|12|||
48702049|NCT01352715|156758575|FG000|Overall Study|major ineligibility|2|||
48702050|NCT01352715|156758576|FG001|Overall Study|major ineligibility|1|||
48702051|NCT03023397|156758577|FG000|Run-In|Failed screening allergen challenge|1|||
48702052|NCT03023397|156758578|FG001|Run-In|Failed screening allergen challenge|0|||
48702053|NCT03023397|156758579|FG002|Run-In|Failed screening allergen challenge|0|||
48702054|NCT03023397|156758577|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
48702055|NCT03023397|156758578|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
48702056|NCT03023397|156758579|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
48702057|NCT00999804|156758580|FG000|Overall Study|Lack of Efficacy|9|||
48702058|NCT00999804|156758581|FG001|Overall Study|Lack of Efficacy|2|||
48702059|NCT00999804|156758580|FG000|Overall Study|Adverse Event|4|||
48702060|NCT00999804|156758581|FG001|Overall Study|Adverse Event|3|||
48702061|NCT00999804|156758580|FG000|Overall Study|Withdrawal by Subject|4|||
48702062|NCT00999804|156758581|FG001|Overall Study|Withdrawal by Subject|0|||
48702063|NCT00999804|156758580|FG000|Overall Study|Death|1|||
48702064|NCT00999804|156758581|FG001|Overall Study|Death|0|||
48702065|NCT00999804|156758580|FG000|Overall Study|Ineligible|3|||
48702066|NCT00999804|156758581|FG001|Overall Study|Ineligible|0|||
48702067|NCT00071058|156758582|FG000|Overall Study|brain tumor-removed from study|1|||
48702068|NCT02000440|156758587|FG000|Overall Study|Adverse Event|3|||
48702069|NCT02000440|156758587|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
48702070|NCT01550003|156758588|FG000|Overall Study|Adverse Event|0|||
48702071|NCT01550003|156758589|FG001|Overall Study|Adverse Event|9|||
48702072|NCT01550003|156758590|FG002|Overall Study|Adverse Event|15|||
48702073|NCT01550003|156758588|FG000|Overall Study|Lack of Efficacy|4|||
48702074|NCT01550003|156758589|FG001|Overall Study|Lack of Efficacy|11|||
48702075|NCT01550003|156758590|FG002|Overall Study|Lack of Efficacy|15|||
48702076|NCT01550003|156758588|FG000|Overall Study|Protocol Violation|0|||
48702077|NCT01550003|156758589|FG001|Overall Study|Protocol Violation|3|||
48702078|NCT01550003|156758590|FG002|Overall Study|Protocol Violation|2|||
48702079|NCT01550003|156758588|FG000|Overall Study|Lost to Follow-up|1|||
48702080|NCT01550003|156758589|FG001|Overall Study|Lost to Follow-up|4|||
48702081|NCT01550003|156758590|FG002|Overall Study|Lost to Follow-up|8|||
48702082|NCT01550003|156758588|FG000|Overall Study|Consent withdrawn|2|||
48702083|NCT01550003|156758589|FG001|Overall Study|Consent withdrawn|11|||
48702084|NCT01550003|156758590|FG002|Overall Study|Consent withdrawn|23|||
48702085|NCT01550003|156758588|FG000|Overall Study|Missing|1|||
48702086|NCT01550003|156758589|FG001|Overall Study|Missing|0|||
48702087|NCT01550003|156758590|FG002|Overall Study|Missing|2|||
48702088|NCT01550003|156758588|FG000|Overall Study|Study closure as announced by sponsor|7|||
48702089|NCT01550003|156758589|FG001|Overall Study|Study closure as announced by sponsor|6|||
48702090|NCT01550003|156758590|FG002|Overall Study|Study closure as announced by sponsor|24|||
48702091|NCT01550003|156758588|FG000|Overall Study|Protocol Noncompliance|1|||
48702092|NCT01550003|156758589|FG001|Overall Study|Protocol Noncompliance|0|||
48702093|NCT01550003|156758590|FG002|Overall Study|Protocol Noncompliance|0|||
48702094|NCT01550003|156758588|FG000|Overall Study|Study closure|0|||
48702095|NCT01550003|156758589|FG001|Overall Study|Study closure|1|||
48702096|NCT01550003|156758590|FG002|Overall Study|Study closure|1|||
48702097|NCT01550003|156758588|FG000|Overall Study|Patient reached adulthood|0|||
48702098|NCT01550003|156758589|FG001|Overall Study|Patient reached adulthood|1|||
48702099|NCT01550003|156758590|FG002|Overall Study|Patient reached adulthood|0|||
48702100|NCT01550003|156758588|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
48702101|NCT01550003|156758589|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
48702102|NCT01550003|156758590|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
48702103|NCT01550003|156758588|FG000|Overall Study|Sponsor's order|0|||
48702104|NCT01550003|156758589|FG001|Overall Study|Sponsor's order|3|||
48702105|NCT01550003|156758590|FG002|Overall Study|Sponsor's order|3|||
48702106|NCT01550003|156758588|FG000|Overall Study|Sponsor's decision|1|||
48702107|NCT01550003|156758589|FG001|Overall Study|Sponsor's decision|5|||
48702108|NCT01550003|156758590|FG002|Overall Study|Sponsor's decision|4|||
48702109|NCT01550003|156758588|FG000|Overall Study|Subject mother passed away|0|||
48702110|NCT01550003|156758589|FG001|Overall Study|Subject mother passed away|1|||
48702111|NCT01550003|156758590|FG002|Overall Study|Subject mother passed away|0|||
48702112|NCT01550003|156758588|FG000|Overall Study|Discontinuation|0|||
48702113|NCT01550003|156758589|FG001|Overall Study|Discontinuation|1|||
48702114|NCT01550003|156758590|FG002|Overall Study|Discontinuation|0|||
48702115|NCT01550003|156758588|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
48702116|NCT01550003|156758589|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
48702117|NCT01550003|156758590|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
48702118|NCT01550003|156758588|FG000|Overall Study|Site closure|0|||
48702119|NCT01550003|156758589|FG001|Overall Study|Site closure|2|||
48702120|NCT01550003|156758590|FG002|Overall Study|Site closure|0|||
48702121|NCT01550003|156758588|FG000|Overall Study|Pregnancy|0|||
48702122|NCT01550003|156758589|FG001|Overall Study|Pregnancy|1|||
48702123|NCT01550003|156758590|FG002|Overall Study|Pregnancy|0|||
48702124|NCT01550003|156758588|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
48702125|NCT01550003|156758589|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
48702126|NCT01550003|156758590|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
48702127|NCT01550003|156758588|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
48702128|NCT01550003|156758589|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
48702129|NCT01550003|156758590|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
48702130|NCT01550003|156758588|FG000|Overall Study|Switching to adult rheumatologist|0|||
48702131|NCT01550003|156758589|FG001|Overall Study|Switching to adult rheumatologist|0|||
48702132|NCT01550003|156758590|FG002|Overall Study|Switching to adult rheumatologist|1|||
48702133|NCT01550003|156758588|FG000|Overall Study|Patient transition to adult care|0|||
48702134|NCT01550003|156758589|FG001|Overall Study|Patient transition to adult care|0|||
48594889|NCT01909973|156372419|FG001|Overall Study|Lost to Follow-up|0|||
48594890|NCT00070564|156372420|FG000|Overall Study|Progression|2|||
48594891|NCT00070564|156372421|FG001|Overall Study|Progression|4|||
48594892|NCT00070564|156372422|FG002|Overall Study|Progression|7|||
48594893|NCT00070564|156372423|FG003|Overall Study|Progression|7|||
48594894|NCT00070564|156372424|FG004|Overall Study|Progression|1|||
48594895|NCT00070564|156372425|FG005|Overall Study|Progression|0|||
48594896|NCT00070564|156372420|FG000|Overall Study|Delinquent|1|||
48594897|NCT00070564|156372421|FG001|Overall Study|Delinquent|4|||
48594898|NCT00070564|156372422|FG002|Overall Study|Delinquent|2|||
48594899|NCT00070564|156372423|FG003|Overall Study|Delinquent|0|||
48594900|NCT00070564|156372424|FG004|Overall Study|Delinquent|0|||
48594901|NCT00070564|156372425|FG005|Overall Study|Delinquent|0|||
48594902|NCT00070564|156372420|FG000|Overall Study|Adverse Event|150|||
48594903|NCT00070564|156372421|FG001|Overall Study|Adverse Event|142|||
48594904|NCT00070564|156372422|FG002|Overall Study|Adverse Event|120|||
48594905|NCT00070564|156372423|FG003|Overall Study|Adverse Event|108|||
48594906|NCT00070564|156372424|FG004|Overall Study|Adverse Event|63|||
48594907|NCT00070564|156372425|FG005|Overall Study|Adverse Event|36|||
48594908|NCT00070564|156372420|FG000|Overall Study|Death|4|||
48594909|NCT00070564|156372421|FG001|Overall Study|Death|1|||
48594910|NCT00070564|156372422|FG002|Overall Study|Death|5|||
48594911|NCT00070564|156372423|FG003|Overall Study|Death|3|||
48594912|NCT00070564|156372424|FG004|Overall Study|Death|0|||
48594913|NCT00070564|156372425|FG005|Overall Study|Death|1|||
48594914|NCT00070564|156372420|FG000|Overall Study|Other, not protocol specified|17|||
48594915|NCT00070564|156372421|FG001|Overall Study|Other, not protocol specified|15|||
48702135|NCT01550003|156758590|FG002|Overall Study|Patient transition to adult care|1|||
48702136|NCT01550003|156758588|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
48702137|NCT01550003|156758589|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
48702138|NCT01550003|156758590|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
48702139|NCT01550003|156758588|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
48702140|NCT01550003|156758589|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
48702141|NCT01550003|156758590|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
48702142|NCT01550003|156758588|FG000|Overall Study|Per Sponsor request|1|||
48702143|NCT01550003|156758589|FG001|Overall Study|Per Sponsor request|0|||
48702144|NCT01550003|156758590|FG002|Overall Study|Per Sponsor request|1|||
48702145|NCT01550003|156758588|FG000|Overall Study|Patient not compliance|0|||
48702146|NCT01550003|156758589|FG001|Overall Study|Patient not compliance|0|||
48594916|NCT00070564|156372422|FG002|Overall Study|Other, not protocol specified|14|||
48594917|NCT00070564|156372423|FG003|Overall Study|Other, not protocol specified|19|||
48594918|NCT00070564|156372424|FG004|Overall Study|Other, not protocol specified|6|||
48594919|NCT00070564|156372425|FG005|Overall Study|Other, not protocol specified|7|||
48594920|NCT00070564|156372420|FG000|Overall Study|Withdrawal by Subject|26|||
48594921|NCT00070564|156372421|FG001|Overall Study|Withdrawal by Subject|37|||
48594922|NCT00070564|156372422|FG002|Overall Study|Withdrawal by Subject|23|||
48594923|NCT00070564|156372423|FG003|Overall Study|Withdrawal by Subject|30|||
48594924|NCT00070564|156372424|FG004|Overall Study|Withdrawal by Subject|8|||
48594925|NCT00070564|156372425|FG005|Overall Study|Withdrawal by Subject|8|||
48594926|NCT00070564|156372420|FG000|Overall Study|Not reported|0|||
48594927|NCT00070564|156372421|FG001|Overall Study|Not reported|0|||
48594928|NCT00070564|156372422|FG002|Overall Study|Not reported|0|||
48594929|NCT00070564|156372423|FG003|Overall Study|Not reported|0|||
48594930|NCT00070564|156372424|FG004|Overall Study|Not reported|1|||
48594931|NCT00070564|156372425|FG005|Overall Study|Not reported|0|||
48594932|NCT03077607|156372427|FG000|Period 1 (15 Days)|Adverse Event|1|||
48594933|NCT03077607|156372428|FG001|Period 1 (15 Days)|Adverse Event|0|||
48594934|NCT03077607|156372427|FG000|Period 1 (15 Days)|Death|1|||
48594935|NCT03077607|156372428|FG001|Period 1 (15 Days)|Death|0|||
48594936|NCT03077607|156372427|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
48594937|NCT03077607|156372428|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
48594938|NCT03077607|156372427|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
48594939|NCT03077607|156372428|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
48594940|NCT00397189|156372432|FG000|3 Weeks Period|Lost to Follow-up|5|||
48594941|NCT00397189|156372433|FG001|3 Weeks Period|Lost to Follow-up|4|||
48594942|NCT00397189|156372432|FG000|3 Weeks Period|Adverse Event|3|||
48594943|NCT00397189|156372433|FG001|3 Weeks Period|Adverse Event|2|||
48594944|NCT00397189|156372432|FG000|3 Weeks Period|Withdrawal by Subject|13|||
48594945|NCT00397189|156372433|FG001|3 Weeks Period|Withdrawal by Subject|9|||
48594946|NCT00397189|156372432|FG000|3 Weeks Period|Physician Decision|0|||
48594947|NCT00397189|156372433|FG001|3 Weeks Period|Physician Decision|2|||
48594948|NCT00397189|156372432|FG000|3 Weeks Period|Protocol Violation|0|||
48594949|NCT00397189|156372433|FG001|3 Weeks Period|Protocol Violation|3|||
48594950|NCT00397189|156372432|FG000|3 Weeks Period|Other|0|||
48594951|NCT00397189|156372433|FG001|3 Weeks Period|Other|2|||
48594952|NCT00807612|156372434|FG000|Overall Study|Death|8|||
48594953|NCT00807612|156372434|FG000|Overall Study|Study early termination|5|||
48594954|NCT00807612|156372434|FG000|Overall Study|Withdrawal by Subject|1|||
48594955|NCT04202965|156372435|FG000|Overall Study|Adverse Event|3|||
48594956|NCT04202965|156372435|FG000|Overall Study|Did not meet inclusion criteria|1|||
48594957|NCT00618826|156372436|FG000|Overall Study|Adverse Event|1|||
48594958|NCT02714036|156372439|FG000|Overall Study|Adverse Event|9|||
48594959|NCT02714036|156372440|FG001|Overall Study|Adverse Event|2|||
48594960|NCT02714036|156372439|FG000|Overall Study|Withdrawal by Subject|3|||
48594961|NCT02714036|156372440|FG001|Overall Study|Withdrawal by Subject|2|||
48594962|NCT01882803|156372442|FG000|Overall Study|Disease Progression|1|||
48594963|NCT01882803|156372442|FG000|Overall Study|Withdrawal by Subject|9|||
48594964|NCT01882803|156372442|FG000|Overall Study|Death|68|||
48594965|NCT01882803|156372442|FG000|Overall Study|Physician Decision|3|||
48594966|NCT01882803|156372442|FG000|Overall Study|Lost to Follow-up|3|||
48594967|NCT01882803|156372442|FG000|Overall Study|Follow-up Completed|39|||
48594968|NCT01882803|156372442|FG000|Overall Study|Study Terminated by the Sponsor|6|||
48594969|NCT00321906|156372443|FG000|Overall Study|Adverse Event|36|||
48594970|NCT00321906|156372444|FG001|Overall Study|Adverse Event|44|||
48594971|NCT00321906|156372443|FG000|Overall Study|Death|9|||
48594972|NCT00321906|156372444|FG001|Overall Study|Death|6|||
48594973|NCT00321906|156372443|FG000|Overall Study|Lost to Follow-up|1|||
48594974|NCT00321906|156372444|FG001|Overall Study|Lost to Follow-up|2|||
48594975|NCT00321906|156372443|FG000|Overall Study|Withdrawal by Subject|0|||
48702147|NCT01550003|156758590|FG002|Overall Study|Patient not compliance|1|||
48594976|NCT00321906|156372444|FG001|Overall Study|Withdrawal by Subject|4|||
48594977|NCT03743025|156372447|FG000|Overall Study|Surgery was cancelled|2|||
48594978|NCT03743025|156372448|FG001|Overall Study|Surgery was cancelled|1|||
48594979|NCT00996034|156372451|FG000|Overall Study|Lost to Follow-up|2|||
48594980|NCT00996034|156372451|FG000|Overall Study|withdrawn by PI|1|||
48594981|NCT02105285|156372452|FG000|Overall Study|Adverse Event|1|||
48594982|NCT02105285|156372453|FG001|Overall Study|Adverse Event|1|||
48594983|NCT02105285|156372454|FG002|Overall Study|Adverse Event|0|||
48594984|NCT02105285|156372452|FG000|Overall Study|Protocol Violation|0|||
48594985|NCT02105285|156372453|FG001|Overall Study|Protocol Violation|1|||
48594986|NCT02105285|156372454|FG002|Overall Study|Protocol Violation|0|||
48594987|NCT02105285|156372452|FG000|Overall Study|Withdrawal by Subject|1|||
48594988|NCT02105285|156372453|FG001|Overall Study|Withdrawal by Subject|0|||
48702148|NCT01550003|156758588|FG000|Overall Study|Non-compliance|0|||
48702149|NCT01550003|156758589|FG001|Overall Study|Non-compliance|0|||
48702150|NCT01550003|156758590|FG002|Overall Study|Non-compliance|1|||
48702151|NCT01550003|156758588|FG000|Overall Study|Study closed|0|||
48702152|NCT01550003|156758589|FG001|Overall Study|Study closed|1|||
48702153|NCT01550003|156758590|FG002|Overall Study|Study closed|0|||
48702154|NCT01550003|156758588|FG000|Overall Study|Transitioned to adult rheumatology|0|||
48702155|NCT01550003|156758589|FG001|Overall Study|Transitioned to adult rheumatology|0|||
48702156|NCT01550003|156758590|FG002|Overall Study|Transitioned to adult rheumatology|1|||
48702157|NCT00871975|156758591|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
48594989|NCT02105285|156372454|FG002|Overall Study|Withdrawal by Subject|0|||
48594990|NCT00685360|156372455|FG000|Overall Study|Lost to Follow-up|0|||
48594991|NCT00685360|156372456|FG001|Overall Study|Lost to Follow-up|1|||
48702158|NCT00871975|156758591|FG000|Overall Study|Catheters could not be inserted|1|||
48702159|NCT00871975|156758591|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
48702160|NCT00871975|156758591|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
48702161|NCT04102098|156758594|FG000|Main Study Period|Ongoing in study|302|||
48702162|NCT04102098|156758595|FG001|Main Study Period|Ongoing in study|291|||
48702163|NCT04102098|156758594|FG000|Main Study Period|Death|20|||
48702164|NCT04102098|156758595|FG001|Main Study Period|Death|27|||
48702165|NCT04102098|156758594|FG000|Main Study Period|Lost to Follow-up|1|||
48702166|NCT04102098|156758595|FG001|Main Study Period|Lost to Follow-up|1|||
48702167|NCT04102098|156758594|FG000|Main Study Period|Physician Decision|0|||
48702168|NCT04102098|156758595|FG001|Main Study Period|Physician Decision|1|||
48702169|NCT04102098|156758594|FG000|Main Study Period|Withdrawal by Subject|11|||
48702170|NCT04102098|156758595|FG001|Main Study Period|Withdrawal by Subject|14|||
48702171|NCT04102098|156758594|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
48702172|NCT04102098|156758595|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
48702173|NCT04102098|156758594|FG000|Crossover: AS Who Crossed Over|Death|11|||
48702174|NCT04102098|156758595|FG001|Crossover: AS Who Crossed Over|Death|0|||
48702175|NCT04102098|156758594|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
48702176|NCT04102098|156758595|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
48702177|NCT03592186|156758596|FG000|Overall Study|Withdrawal by Subject|1|||
48702178|NCT03592186|156758597|FG001|Overall Study|Withdrawal by Subject|0|||
48702179|NCT03592186|156758596|FG000|Overall Study|Lost to Follow-up|16|||
48702180|NCT03592186|156758597|FG001|Overall Study|Lost to Follow-up|11|||
48702181|NCT00283296|156758603|FG000|Overall Study|in-home trial not completed|5|||
48702182|NCT02072668|156758604|FG000|Second Intervention|Lost to Follow-up|1|||
48702183|NCT02072668|156758605|FG001|Second Intervention|Lost to Follow-up|0|||
48702184|NCT01353898|156758606|FG000|Overall Study|Study site terminated|0|||
48702185|NCT01353898|156758607|FG001|Overall Study|Study site terminated|0|||
48702186|NCT01353898|156758608|FG002|Overall Study|Study site terminated|0|||
48702187|NCT01353898|156758609|FG003|Overall Study|Study site terminated|0|||
48702188|NCT01353898|156758610|FG004|Overall Study|Study site terminated|0|||
48702189|NCT01353898|156758611|FG005|Overall Study|Study site terminated|1|||
48702190|NCT02589938|156758612|FG000|Overall Study|Withdrawal by Subject|11|||
48702191|NCT02589938|156758613|FG001|Overall Study|Withdrawal by Subject|5|||
48702192|NCT02589938|156758614|FG002|Overall Study|Withdrawal by Subject|6|||
48702193|NCT02589938|156758612|FG000|Overall Study|Lost to Follow-up|3|||
48702194|NCT02589938|156758613|FG001|Overall Study|Lost to Follow-up|3|||
48702195|NCT02589938|156758614|FG002|Overall Study|Lost to Follow-up|3|||
48702196|NCT02589938|156758612|FG000|Overall Study|Death|1|||
48702197|NCT02589938|156758613|FG001|Overall Study|Death|0|||
48702198|NCT02589938|156758614|FG002|Overall Study|Death|1|||
48702199|NCT02589938|156758612|FG000|Overall Study|Protocol Violation|6|||
48702200|NCT02589938|156758613|FG001|Overall Study|Protocol Violation|2|||
48594992|NCT00685360|156372457|FG002|Overall Study|Lost to Follow-up|2|||
48594993|NCT00685360|156372455|FG000|Overall Study|Adverse Event|4|||
48594994|NCT00685360|156372456|FG001|Overall Study|Adverse Event|6|||
48594995|NCT00685360|156372457|FG002|Overall Study|Adverse Event|4|||
48594996|NCT00685360|156372455|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
48594997|NCT00685360|156372456|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
48594998|NCT00685360|156372457|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
48594999|NCT00685360|156372455|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
48595000|NCT00685360|156372456|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
48595001|NCT00685360|156372457|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
48702201|NCT02589938|156758614|FG002|Overall Study|Protocol Violation|3|||
48702202|NCT02589938|156758612|FG000|Overall Study|Physician Decision|1|||
48702203|NCT02589938|156758613|FG001|Overall Study|Physician Decision|0|||
48702204|NCT02589938|156758614|FG002|Overall Study|Physician Decision|0|||
48702205|NCT02589938|156758612|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
48702206|NCT02589938|156758613|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
48702207|NCT02589938|156758614|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
48702208|NCT01294553|156758615|FG000|Overall Study|Duplicated Participants|1|||
48702209|NCT01294553|156758615|FG000|Overall Study|Protocol Violation|268|||
48702210|NCT03133793|156758616|FG000|Overall Study|Withdrawal by Subject|0|||
48702211|NCT03133793|156758617|FG001|Overall Study|Withdrawal by Subject|4|||
48702212|NCT03133793|156758618|FG002|Overall Study|Withdrawal by Subject|2|||
48702213|NCT03133793|156758619|FG003|Overall Study|Withdrawal by Subject|4|||
48702214|NCT03133793|156758616|FG000|Overall Study|Lost to Follow-up|1|||
48702215|NCT03133793|156758617|FG001|Overall Study|Lost to Follow-up|0|||
48702216|NCT03133793|156758618|FG002|Overall Study|Lost to Follow-up|2|||
48702217|NCT03133793|156758619|FG003|Overall Study|Lost to Follow-up|0|||
48702218|NCT03133793|156758616|FG000|Overall Study|Death|0|||
48702219|NCT03133793|156758617|FG001|Overall Study|Death|0|||
48702220|NCT03133793|156758618|FG002|Overall Study|Death|0|||
48702221|NCT03133793|156758619|FG003|Overall Study|Death|1|||
48702222|NCT02651675|156758621|FG000|Overall Study|Death|0|||
48702223|NCT02651675|156758622|FG001|Overall Study|Death|0|||
48702224|NCT02651675|156758623|FG002|Overall Study|Death|1|||
48702225|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
48702226|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
48702227|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
48702228|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
48702229|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Adverse Event|2|||
48702230|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Adverse Event|5|||
48702231|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Adverse Event|1|||
48702232|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Adverse Event|2|||
48702233|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Death|13|||
48702234|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Death|17|||
48702235|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Death|1|||
48702236|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Death|0|||
48702237|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
48702238|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
48702239|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
48702240|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
48702241|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Disease Progression|2|||
48702242|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Disease Progression|0|||
48702243|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Disease Progression|0|||
48702244|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Disease Progression|0|||
48702245|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
48702246|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
48702247|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
48702248|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
48702249|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
48702250|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
48702251|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
48702252|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
48702253|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
48702254|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
48702255|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
48702256|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
48595002|NCT00685360|156372455|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
48595003|NCT00685360|156372456|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
48595004|NCT00685360|156372457|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
48702257|NCT03955146|156758624|FG000|DB Period (48 Weeks)|Participant Decision|9|||
48595005|NCT00685360|156372455|FG000|Overall Study|Protocol Deviation|0|||
48595006|NCT00685360|156372456|FG001|Overall Study|Protocol Deviation|1|||
48595007|NCT00685360|156372457|FG002|Overall Study|Protocol Deviation|1|||
48595008|NCT01223937|156372458|FG000|Overall Study|Withdrawal by Subject|3|||
48595009|NCT01223937|156372459|FG001|Overall Study|Withdrawal by Subject|2|||
48595010|NCT01223937|156372458|FG000|Overall Study|Lost to Follow-up|1|||
48595011|NCT01223937|156372459|FG001|Overall Study|Lost to Follow-up|4|||
48595012|NCT01223937|156372458|FG000|Overall Study|Adverse Event|1|||
48595013|NCT01223937|156372459|FG001|Overall Study|Adverse Event|4|||
48595014|NCT01223937|156372458|FG000|Overall Study|Protocol Violation|8|||
48595015|NCT01223937|156372459|FG001|Overall Study|Protocol Violation|7|||
48595016|NCT01223937|156372458|FG000|Overall Study|Other|4|||
48595017|NCT01223937|156372459|FG001|Overall Study|Other|1|||
48595018|NCT00547157|156372465|FG000|Overall Study|Other|1|||
48595019|NCT00547157|156372466|FG001|Overall Study|Other|0|||
48702258|NCT03955146|156758625|FG001|DB Period (48 Weeks)|Participant Decision|12|||
48702259|NCT03955146|156758626|FG002|DB Period (48 Weeks)|Participant Decision|1|||
48702260|NCT03955146|156758627|FG003|DB Period (48 Weeks)|Participant Decision|1|||
48702261|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
48702262|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
48702263|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
48702264|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
48702265|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
48702266|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
48595020|NCT00547157|156372465|FG000|Overall Study|Death|38|||
48595021|NCT00547157|156372466|FG001|Overall Study|Death|18|||
48595022|NCT00547157|156372465|FG000|Overall Study|Withdrawal by Subject|3|||
48595023|NCT00547157|156372466|FG001|Overall Study|Withdrawal by Subject|1|||
48595024|NCT00547157|156372465|FG000|Overall Study|Administrative decision|3|||
48595025|NCT00547157|156372466|FG001|Overall Study|Administrative decision|2|||
48595026|NCT00547157|156372465|FG000|Overall Study|Lost to Follow-up|4|||
48595027|NCT00547157|156372466|FG001|Overall Study|Lost to Follow-up|2|||
48595028|NCT00549549|156372467|FG000|Overall Study|Adverse Event|5|||
48702267|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
48702268|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
48702269|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
48702270|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
48702271|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
48702272|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
48702273|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
48702274|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
48702275|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
48702276|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
48702277|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
48702278|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
48702279|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
48702280|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
48702281|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
48702282|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
48702283|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
48702284|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
48702285|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
48702286|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
48702287|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
48702288|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
48702289|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
48702290|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
48702291|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
48702292|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
48702293|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
48702294|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
48702295|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
48702296|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
48702297|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
48702298|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
48702299|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
48702300|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
48702301|NCT03955146|156758624|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
48702302|NCT03955146|156758625|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
48702303|NCT03955146|156758626|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
48702304|NCT03955146|156758627|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
48702305|NCT00630838|156758628|FG000|Overall Study|Death|0|||
48702306|NCT00630838|156758629|FG001|Overall Study|Death|1|||
48702307|NCT00630838|156758628|FG000|Overall Study|Lost to Follow-up|0|||
48702308|NCT00630838|156758629|FG001|Overall Study|Lost to Follow-up|1|||
48702309|NCT01099267|156758630|FG000|MDS-003 Study|Adverse Event|37|||
48702310|NCT01099267|156758630|FG000|MDS-003 Study|Lack of Efficacy|52|||
48702311|NCT01099267|156758630|FG000|MDS-003 Study|Withdrawal by Subject|8|||
48702312|NCT01099267|156758630|FG000|MDS-003 Study|Lost to Follow-up|1|||
48702313|NCT01099267|156758630|FG000|MDS-003 Study|Death|11|||
48702314|NCT01099267|156758630|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
48702315|NCT01099267|156758630|FG000|MDS-003 Study|Disease Progression|7|||
48702316|NCT01099267|156758630|FG000|MDS-003 Study|Investigator Decision|2|||
48595029|NCT00549549|156372468|FG001|Overall Study|Adverse Event|3|||
48595030|NCT00549549|156372469|FG002|Overall Study|Adverse Event|1|||
48595031|NCT00549549|156372470|FG003|Overall Study|Adverse Event|9|||
48702317|NCT01099267|156758630|FG000|MDS-003 Study|Non-Compliance|2|||
48702318|NCT01099267|156758630|FG000|MDS-003 Study|Loss of Response|1|||
48702319|NCT01099267|156758630|FG000|MDS-003 Study|Secondary Malign Disease|1|||
48702320|NCT00174187|156758634|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
48702321|NCT00174187|156758635|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
48702322|NCT00174187|156758636|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
48702323|NCT00174187|156758634|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
48702324|NCT00174187|156758635|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
48702325|NCT00174187|156758636|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
48702326|NCT00174187|156758634|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
48702327|NCT00174187|156758635|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
48702328|NCT00174187|156758636|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
48702329|NCT00174187|156758634|FG000|Period 1 (up to 3 Years)|Other|0|||
48702330|NCT00174187|156758635|FG001|Period 1 (up to 3 Years)|Other|1|||
48702331|NCT00174187|156758636|FG002|Period 1 (up to 3 Years)|Other|0|||
48702332|NCT00174187|156758634|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
48702333|NCT00174187|156758635|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
48702334|NCT00174187|156758636|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
48702335|NCT00174187|156758634|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
48702336|NCT00174187|156758635|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
48702337|NCT00174187|156758636|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
48702338|NCT00174187|156758634|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
48702339|NCT00174187|156758635|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
48702340|NCT00174187|156758636|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
48702341|NCT00174187|156758634|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
48702342|NCT00174187|156758635|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
48702343|NCT00174187|156758636|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
48702344|NCT00174187|156758634|FG000|Period 2 (After 3 Years)|Other|0|||
48702345|NCT00174187|156758635|FG001|Period 2 (After 3 Years)|Other|0|||
48702346|NCT00174187|156758636|FG002|Period 2 (After 3 Years)|Other|5|||
48702347|NCT03205423|156758643|FG000|Overall Study|Personal|1|||
48702348|NCT03205423|156758644|FG001|Overall Study|Personal|1|||
48702349|NCT03205423|156758643|FG000|Overall Study|Physician Decision|0|||
48702350|NCT03205423|156758644|FG001|Overall Study|Physician Decision|2|||
48702351|NCT04434937|156758647|FG000|Overall Study|Death|4|||
48702352|NCT04434937|156758647|FG000|Overall Study|Withdrawal by Subject|1|||
48702353|NCT04434937|156758647|FG000|Overall Study|Transitioned to Rollover Study|19|||
48702354|NCT04434937|156758647|FG000|Overall Study|Progressive Disease|18|||
48702355|NCT05767749|156758648|FG000|Overall Study|Withdrawal by Subject|0|||
48702356|NCT05767749|156758649|FG001|Overall Study|Withdrawal by Subject|0|||
48702357|NCT05767749|156758650|FG002|Overall Study|Withdrawal by Subject|2|||
48702358|NCT05767749|156758651|FG003|Overall Study|Withdrawal by Subject|2|||
48702359|NCT05767749|156758652|FG004|Overall Study|Withdrawal by Subject|2|||
48702360|NCT05767749|156758653|FG005|Overall Study|Withdrawal by Subject|2|||
48702361|NCT04949490|156758654|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702362|NCT04949490|156758655|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702363|NCT04949490|156758656|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702364|NCT04949490|156758657|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
48702365|NCT04949490|156758658|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702366|NCT04949490|156758659|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
48702367|NCT04949490|156758654|FG000|Group A and Group B|Withdrawal by Subject|0|||
48702368|NCT04949490|156758655|FG001|Group A and Group B|Withdrawal by Subject|0|||
48702369|NCT04949490|156758656|FG002|Group A and Group B|Withdrawal by Subject|1|||
48702370|NCT04949490|156758657|FG003|Group A and Group B|Withdrawal by Subject|0|||
48702371|NCT04949490|156758658|FG004|Group A and Group B|Withdrawal by Subject|0|||
48702372|NCT04949490|156758659|FG005|Group A and Group B|Withdrawal by Subject|0|||
48702373|NCT04949490|156758654|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702374|NCT04949490|156758655|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702375|NCT04949490|156758656|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702376|NCT04949490|156758657|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702377|NCT04949490|156758658|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
48702378|NCT04949490|156758659|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
48702379|NCT04949490|156758654|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48595032|NCT00549549|156372467|FG000|Overall Study|Lack of Efficacy|9|||
48595033|NCT00549549|156372468|FG001|Overall Study|Lack of Efficacy|6|||
48595034|NCT00549549|156372469|FG002|Overall Study|Lack of Efficacy|4|||
48595035|NCT00549549|156372470|FG003|Overall Study|Lack of Efficacy|2|||
48595036|NCT00549549|156372467|FG000|Overall Study|Lost to Follow-up|1|||
48702380|NCT04949490|156758655|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48595037|NCT00549549|156372468|FG001|Overall Study|Lost to Follow-up|0|||
48595038|NCT00549549|156372469|FG002|Overall Study|Lost to Follow-up|1|||
48595039|NCT00549549|156372470|FG003|Overall Study|Lost to Follow-up|2|||
48595040|NCT00549549|156372467|FG000|Overall Study|Withdrawal by Subject|0|||
48595041|NCT00549549|156372468|FG001|Overall Study|Withdrawal by Subject|4|||
48595042|NCT00549549|156372469|FG002|Overall Study|Withdrawal by Subject|1|||
48595043|NCT00549549|156372470|FG003|Overall Study|Withdrawal by Subject|0|||
48595044|NCT00549549|156372467|FG000|Overall Study|Other|9|||
48702381|NCT04949490|156758656|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48702382|NCT04949490|156758657|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48702383|NCT04949490|156758658|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
48595045|NCT00549549|156372468|FG001|Overall Study|Other|9|||
48595046|NCT00549549|156372469|FG002|Overall Study|Other|9|||
48595047|NCT00549549|156372470|FG003|Overall Study|Other|11|||
48595048|NCT00549549|156372467|FG000|Overall Study|Randomized but not treated|0|||
48595049|NCT00549549|156372468|FG001|Overall Study|Randomized but not treated|0|||
48595050|NCT00549549|156372469|FG002|Overall Study|Randomized but not treated|1|||
48595051|NCT00549549|156372470|FG003|Overall Study|Randomized but not treated|1|||
48595052|NCT00420628|156372472|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
48595053|NCT00420628|156372473|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
48595054|NCT00420628|156372472|FG000|Overall Study|Lost to Follow-up|3|||
48595055|NCT00420628|156372473|FG001|Overall Study|Lost to Follow-up|2|||
48595056|NCT00420628|156372472|FG000|Overall Study|Adverse Event|1|||
48595057|NCT00420628|156372473|FG001|Overall Study|Adverse Event|0|||
48595058|NCT05279131|156372475|FG000|Overall Study|Lost to Follow-up|1|||
48595059|NCT05279131|156372475|FG000|Overall Study|Death|1|||
48595060|NCT05279131|156372475|FG000|Overall Study|Physician Decision|1|||
48595061|NCT00672633|156372484|FG000|Overall Study|Withdrawal by Subject|0|||
48595062|NCT00672633|156372485|FG001|Overall Study|Withdrawal by Subject|1|||
48595063|NCT02499120|156372486|FG000|Overall Study|Death|52|||
48595064|NCT02499120|156372487|FG001|Overall Study|Death|43|||
48595065|NCT02499120|156372486|FG000|Overall Study|Lost to Follow-up|1|||
48595066|NCT02499120|156372487|FG001|Overall Study|Lost to Follow-up|2|||
48595067|NCT02499120|156372486|FG000|Overall Study|Participant refused further follow-up|1|||
48595068|NCT02499120|156372487|FG001|Overall Study|Participant refused further follow-up|0|||
48595069|NCT02499120|156372486|FG000|Overall Study|Withdrawal by Subject|2|||
48595070|NCT02499120|156372487|FG001|Overall Study|Withdrawal by Subject|5|||
48595071|NCT02499120|156372486|FG000|Overall Study|Other|9|||
48595072|NCT02499120|156372487|FG001|Overall Study|Other|10|||
48595073|NCT01429298|156372490|FG000|Overall Study|Protocol Violation|4|||
48595074|NCT01429298|156372491|FG001|Overall Study|Protocol Violation|6|||
48595075|NCT04235504|156372495|FG000|Study Phase|Withdrawal by Subject|5|||
48595076|NCT04235504|156372496|FG001|Study Phase|Withdrawal by Subject|2|||
48595077|NCT04235504|156372497|FG002|Study Phase|Withdrawal by Subject|0|||
48595078|NCT04235504|156372498|FG003|Study Phase|Withdrawal by Subject|0|||
48595079|NCT04235504|156372495|FG000|Continuation Phase|Withdrawal by Subject|0|||
48595080|NCT04235504|156372496|FG001|Continuation Phase|Withdrawal by Subject|4|||
48595081|NCT04235504|156372497|FG002|Continuation Phase|Withdrawal by Subject|0|||
48595082|NCT04235504|156372498|FG003|Continuation Phase|Withdrawal by Subject|0|||
48595083|NCT04235504|156372495|FG000|Continuation Phase|Adverse Event|0|||
48595084|NCT04235504|156372496|FG001|Continuation Phase|Adverse Event|1|||
48595085|NCT04235504|156372497|FG002|Continuation Phase|Adverse Event|0|||
48595086|NCT04235504|156372498|FG003|Continuation Phase|Adverse Event|0|||
48595087|NCT04235504|156372495|FG000|Continuation Phase|Physician Decision|1|||
48595088|NCT04235504|156372496|FG001|Continuation Phase|Physician Decision|2|||
48595089|NCT04235504|156372497|FG002|Continuation Phase|Physician Decision|1|||
48595090|NCT04235504|156372498|FG003|Continuation Phase|Physician Decision|0|||
48595091|NCT05404711|156372499|FG000|Completed Study Visit|Withdrawal by Subject|1|||
48595092|NCT05404711|156372499|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
48595093|NCT05404711|156372499|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
48595094|NCT05404711|156372499|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
48595095|NCT05404711|156372499|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
48595096|NCT05404711|156372499|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
48595097|NCT03859648|156374121|FG000|Overall Study|Lost to Follow-up|1|||
48595098|NCT03859648|156374121|FG000|Overall Study|Adverse Event|1|||
48595099|NCT03026283|156374122|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
48595100|NCT03026283|156374123|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
48595101|NCT03026283|156374124|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
48595102|NCT03026283|156374125|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
48595103|NCT03026283|156374126|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
48595104|NCT03026283|156374127|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
48595105|NCT03026283|156374128|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
48595106|NCT03026283|156374129|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
48702384|NCT04949490|156758659|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
48702385|NCT03278249|156758660|FG000|Overall Study|Withdrawal by Subject|2|||
48702386|NCT03278249|156758660|FG000|Overall Study|Lost to Follow-up|1|||
48702387|NCT03299166|156758661|FG000|Overall Study|Adverse Event|9|||
48702388|NCT03299166|156758662|FG001|Overall Study|Adverse Event|4|||
48702389|NCT03299166|156758661|FG000|Overall Study|Withdrawal by Subject|6|||
48702390|NCT03299166|156758662|FG001|Overall Study|Withdrawal by Subject|5|||
48702391|NCT03299166|156758661|FG000|Overall Study|Physician Decision|1|||
48595107|NCT03026283|156374122|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
48595108|NCT03026283|156374123|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
48702392|NCT03299166|156758662|FG001|Overall Study|Physician Decision|1|||
48702393|NCT03299166|156758661|FG000|Overall Study|Sponsor Decision|3|||
48595109|NCT03026283|156374124|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
48595110|NCT03026283|156374125|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
48595111|NCT03026283|156374126|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
48595112|NCT03026283|156374127|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
48595113|NCT03026283|156374128|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
48595114|NCT03026283|156374129|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
48595115|NCT03026283|156374122|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
48595116|NCT03026283|156374123|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
48595117|NCT03026283|156374124|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
48595118|NCT03026283|156374125|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
48595119|NCT03026283|156374126|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
48595120|NCT03026283|156374127|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
48595121|NCT03026283|156374128|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
48595122|NCT03026283|156374129|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
48595123|NCT03026283|156374122|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
48595124|NCT03026283|156374123|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
48595125|NCT03026283|156374124|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
48595126|NCT03026283|156374125|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
48595127|NCT03026283|156374126|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
48595128|NCT03026283|156374127|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
48595129|NCT03026283|156374128|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
48595130|NCT03026283|156374129|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
48595131|NCT03026283|156374122|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
48595132|NCT03026283|156374123|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
48595133|NCT03026283|156374124|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
48595134|NCT03026283|156374125|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
48595135|NCT03026283|156374126|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
48595136|NCT03026283|156374127|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
48595137|NCT03026283|156374128|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
48595138|NCT03026283|156374129|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
48595139|NCT03026283|156374122|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
48595140|NCT03026283|156374123|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
48595141|NCT03026283|156374124|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
48595142|NCT03026283|156374125|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
48595143|NCT03026283|156374126|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
48595144|NCT03026283|156374127|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
48595145|NCT03026283|156374128|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
48595146|NCT03026283|156374129|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
48595147|NCT03026283|156374122|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
48595148|NCT03026283|156374123|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
48595149|NCT03026283|156374124|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
48595150|NCT03026283|156374125|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
48595151|NCT03026283|156374126|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
48595152|NCT03026283|156374127|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
48595153|NCT03026283|156374128|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
48595154|NCT03026283|156374129|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
48595155|NCT03026283|156374122|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
48595156|NCT03026283|156374123|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
48595157|NCT03026283|156374124|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
48702394|NCT03299166|156758662|FG001|Overall Study|Sponsor Decision|0|||
48702395|NCT03299166|156758661|FG000|Overall Study|Lost to Follow-up|2|||
48702396|NCT03299166|156758662|FG001|Overall Study|Lost to Follow-up|4|||
48702397|NCT03299166|156758661|FG000|Overall Study|Randomization Error|0|||
48702398|NCT03299166|156758662|FG001|Overall Study|Randomization Error|1|||
48702399|NCT03299166|156758661|FG000|Overall Study|Subject unable to return due to COVID|1|||
48702400|NCT03299166|156758662|FG001|Overall Study|Subject unable to return due to COVID|0|||
48702401|NCT03299166|156758661|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
48702402|NCT03299166|156758662|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
48702403|NCT02374450|156758663|FG000|Overall Study|Protocol Violation|0|||
48702404|NCT02374450|156758664|FG001|Overall Study|Protocol Violation|1|||
48702405|NCT02374450|156758665|FG002|Overall Study|Protocol Violation|0|||
48702406|NCT02374450|156758663|FG000|Overall Study|Withdrawal by Subject|91|||
48702407|NCT02374450|156758664|FG001|Overall Study|Withdrawal by Subject|110|||
48702408|NCT02374450|156758665|FG002|Overall Study|Withdrawal by Subject|4|||
48702409|NCT02374450|156758663|FG000|Overall Study|Lost to Follow-up|168|||
48702410|NCT02374450|156758664|FG001|Overall Study|Lost to Follow-up|194|||
48595158|NCT03026283|156374125|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
48595159|NCT03026283|156374126|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
48595160|NCT03026283|156374127|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
48595161|NCT03026283|156374128|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
48595162|NCT03026283|156374129|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
48595163|NCT03026283|156374122|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
48595164|NCT03026283|156374123|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
48595165|NCT03026283|156374124|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
48595166|NCT03026283|156374125|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
48595167|NCT03026283|156374126|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
48595168|NCT03026283|156374127|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
48595169|NCT03026283|156374128|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
48595170|NCT03026283|156374129|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
48595171|NCT00391872|156374142|FG000|Overall Study|Protocol Violation|7|||
48595172|NCT00391872|156374143|FG001|Overall Study|Protocol Violation|2|||
48595173|NCT00391872|156374142|FG000|Overall Study|Withdrawal by Subject|296|||
48595174|NCT00391872|156374143|FG001|Overall Study|Withdrawal by Subject|249|||
48595175|NCT00391872|156374142|FG000|Overall Study|Reason unknown|2|||
48595176|NCT00391872|156374143|FG001|Overall Study|Reason unknown|4|||
48595177|NCT00391872|156374142|FG000|Overall Study|Lost to Follow-up|2|||
48702411|NCT02374450|156758665|FG002|Overall Study|Lost to Follow-up|138|||
48702412|NCT02374450|156758663|FG000|Overall Study|Death|173|||
48702413|NCT02374450|156758664|FG001|Overall Study|Death|185|||
48702414|NCT02374450|156758665|FG002|Overall Study|Death|81|||
48702415|NCT02374450|156758663|FG000|Overall Study|Migrated from the study area|538|||
48702416|NCT02374450|156758664|FG001|Overall Study|Migrated from the study area|648|||
48702417|NCT02374450|156758665|FG002|Overall Study|Migrated from the study area|181|||
48702418|NCT02374450|156758663|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
48702419|NCT02374450|156758664|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
48595178|NCT00391872|156374143|FG001|Overall Study|Lost to Follow-up|0|||
48595179|NCT01465230|156374148|FG000|Overall Study|Withdrawal by Subject|2|||
48595180|NCT00905567|156374149|FG000|Washout|Withdrawal by Subject|0|||
48595181|NCT00905567|156374150|FG001|Washout|Withdrawal by Subject|1|||
48595182|NCT03084302|156374154|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
48595183|NCT03084302|156374154|FG000|Overall Study|No valid objective monitor data|6|||
48595184|NCT00621257|156374155|FG000|Overall Study|Lost to Follow-up|4|||
48595185|NCT00621257|156374156|FG001|Overall Study|Lost to Follow-up|0|||
48595186|NCT00621257|156374157|FG002|Overall Study|Lost to Follow-up|2|||
48595187|NCT00621257|156374158|FG003|Overall Study|Lost to Follow-up|4|||
48595188|NCT00621257|156374159|FG004|Overall Study|Lost to Follow-up|7|||
48595189|NCT00621257|156374155|FG000|Overall Study|Adverse Event|0|||
48595190|NCT00621257|156374156|FG001|Overall Study|Adverse Event|1|||
48595191|NCT00621257|156374157|FG002|Overall Study|Adverse Event|1|||
48595192|NCT00621257|156374158|FG003|Overall Study|Adverse Event|0|||
48595193|NCT00621257|156374159|FG004|Overall Study|Adverse Event|0|||
48595194|NCT00621257|156374155|FG000|Overall Study|Physician Decision|0|||
48595195|NCT00621257|156374156|FG001|Overall Study|Physician Decision|2|||
48595196|NCT00621257|156374157|FG002|Overall Study|Physician Decision|0|||
48595197|NCT00621257|156374158|FG003|Overall Study|Physician Decision|1|||
48595198|NCT00621257|156374159|FG004|Overall Study|Physician Decision|1|||
48595199|NCT00621257|156374155|FG000|Overall Study|Withdrawal by Subject|0|||
48595200|NCT00621257|156374156|FG001|Overall Study|Withdrawal by Subject|0|||
48595201|NCT00621257|156374157|FG002|Overall Study|Withdrawal by Subject|0|||
48595202|NCT00621257|156374158|FG003|Overall Study|Withdrawal by Subject|1|||
48595203|NCT00621257|156374159|FG004|Overall Study|Withdrawal by Subject|1|||
48595204|NCT03959527|156374160|FG000|Overall Study|Withdrawal by Subject|8|||
48595205|NCT03959527|156374161|FG001|Overall Study|Withdrawal by Subject|3|||
48595206|NCT03959527|156374160|FG000|Overall Study|Lost to Follow-up|31|||
48702420|NCT02374450|156758665|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
48702421|NCT02374450|156758663|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
48702422|NCT02374450|156758664|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
48595207|NCT03959527|156374161|FG001|Overall Study|Lost to Follow-up|15|||
48595208|NCT03959527|156374160|FG000|Overall Study|Did not meet eligibility criteria|1|||
48595209|NCT03959527|156374161|FG001|Overall Study|Did not meet eligibility criteria|1|||
48595210|NCT03959527|156374160|FG000|Overall Study|Protocol Violation|10|||
48595211|NCT03959527|156374161|FG001|Overall Study|Protocol Violation|5|||
48595212|NCT02072941|156374162|FG000|Overall Study|Withdrawal by Subject|29|||
48595213|NCT02072941|156374163|FG001|Overall Study|Withdrawal by Subject|21|||
48595214|NCT02072941|156374162|FG000|Overall Study|Lost to Follow-up|4|||
48595215|NCT02072941|156374163|FG001|Overall Study|Lost to Follow-up|4|||
48595216|NCT02072941|156374162|FG000|Overall Study|Death|3|||
48702423|NCT02374450|156758665|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
48702424|NCT02374450|156758663|FG000|Overall Study|Other|0|||
48702425|NCT02374450|156758664|FG001|Overall Study|Other|21|||
48595217|NCT02072941|156374163|FG001|Overall Study|Death|2|||
48595218|NCT02072941|156374162|FG000|Overall Study|Removed by Study Staff|2|||
48595219|NCT02072941|156374163|FG001|Overall Study|Removed by Study Staff|2|||
48595220|NCT01254656|156374165|FG000|Overall Study|Discontinued due to termination of study|40|||
48595221|NCT01254656|156374166|FG001|Overall Study|Discontinued due to termination of study|39|||
48595222|NCT01254656|156374167|FG002|Overall Study|Discontinued due to termination of study|13|||
48595223|NCT01254656|156374165|FG000|Overall Study|Lack of Efficacy|3|||
48595224|NCT01254656|156374166|FG001|Overall Study|Lack of Efficacy|0|||
48595225|NCT01254656|156374167|FG002|Overall Study|Lack of Efficacy|0|||
48595226|NCT01254656|156374165|FG000|Overall Study|Lost to Follow-up|1|||
48595227|NCT01254656|156374166|FG001|Overall Study|Lost to Follow-up|0|||
48595228|NCT01254656|156374167|FG002|Overall Study|Lost to Follow-up|2|||
48595229|NCT01254656|156374165|FG000|Overall Study|Withdrawal by Subject|2|||
48595230|NCT01254656|156374166|FG001|Overall Study|Withdrawal by Subject|2|||
48595231|NCT01254656|156374167|FG002|Overall Study|Withdrawal by Subject|1|||
48595232|NCT01254656|156374165|FG000|Overall Study|Pregnancy|0|||
48595233|NCT01254656|156374166|FG001|Overall Study|Pregnancy|0|||
48595234|NCT01254656|156374167|FG002|Overall Study|Pregnancy|2|||
48595235|NCT01254656|156374165|FG000|Overall Study|Adverse Event|1|||
48595236|NCT01254656|156374166|FG001|Overall Study|Adverse Event|1|||
48595237|NCT01254656|156374167|FG002|Overall Study|Adverse Event|0|||
48595238|NCT01254656|156374165|FG000|Overall Study|Death|0|||
48595239|NCT01254656|156374166|FG001|Overall Study|Death|1|||
48595240|NCT01254656|156374167|FG002|Overall Study|Death|0|||
48595241|NCT01540981|156374186|FG000|Overall Study|Withdrawal by Subject|1|||
48595242|NCT01540981|156374187|FG001|Overall Study|Withdrawal by Subject|0|||
48595243|NCT01005901|156374189|FG000|Overall Study|Withdrawal by Subject|38|||
48595244|NCT01005901|156374190|FG001|Overall Study|Withdrawal by Subject|14|||
48595245|NCT01005901|156374189|FG000|Overall Study|Adverse Event|30|||
48595246|NCT01005901|156374190|FG001|Overall Study|Adverse Event|16|||
48595247|NCT01005901|156374189|FG000|Overall Study|Administrative problems|21|||
48595248|NCT01005901|156374190|FG001|Overall Study|Administrative problems|13|||
48595249|NCT01005901|156374189|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
48595250|NCT01005901|156374190|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
48595251|NCT01005901|156374189|FG000|Overall Study|Protocol Violation|4|||
48595252|NCT01005901|156374190|FG001|Overall Study|Protocol Violation|3|||
48595253|NCT01005901|156374189|FG000|Overall Study|Death|2|||
48595254|NCT01005901|156374190|FG001|Overall Study|Death|3|||
48595255|NCT01005901|156374189|FG000|Overall Study|Lost to Follow-up|1|||
48595256|NCT01005901|156374190|FG001|Overall Study|Lost to Follow-up|2|||
48595257|NCT01005901|156374189|FG000|Overall Study|Patient's inability to use the device|1|||
48595258|NCT01005901|156374190|FG001|Overall Study|Patient's inability to use the device|1|||
48595259|NCT01005901|156374189|FG000|Overall Study|No longer requires study drug|0|||
48595260|NCT01005901|156374190|FG001|Overall Study|No longer requires study drug|1|||
48595261|NCT01300247|156374195|FG000|Overall Study|Death|1|||
48595262|NCT01300247|156374196|FG001|Overall Study|Death|1|||
48595263|NCT01300247|156374195|FG000|Overall Study|Lost to Follow-up|2|||
48595264|NCT01300247|156374196|FG001|Overall Study|Lost to Follow-up|0|||
48595265|NCT01300247|156374195|FG000|Overall Study|Withdrawal by Subject|1|||
48702426|NCT02374450|156758665|FG002|Overall Study|Other|79|||
48595266|NCT01300247|156374196|FG001|Overall Study|Withdrawal by Subject|0|||
48595267|NCT01300247|156374195|FG000|Overall Study|Non-Compliance|0|||
48595268|NCT01300247|156374196|FG001|Overall Study|Non-Compliance|1|||
48595269|NCT02768792|156374197|FG000|Overall Study|Adverse Event|1|||
48595270|NCT03060291|156374198|FG000|3-month Follow-up|Declined to respond|8|||
48595271|NCT03060291|156374199|FG001|3-month Follow-up|Declined to respond|10|||
48595272|NCT03060291|156374200|FG002|3-month Follow-up|Declined to respond|2|||
48702427|NCT02892344|156760606|FG000|Overall Study|Protocol deviation|3|||
48702428|NCT02892344|156760607|FG001|Overall Study|Protocol deviation|4|||
48702429|NCT02892344|156760606|FG000|Overall Study|Adverse Event|1|||
48702430|NCT02892344|156760607|FG001|Overall Study|Adverse Event|8|||
48702431|NCT02892344|156760606|FG000|Overall Study|Lost to Follow-up|0|||
48702432|NCT02892344|156760607|FG001|Overall Study|Lost to Follow-up|1|||
48702433|NCT02892344|156760606|FG000|Overall Study|Non-compliance with study treatment|0|||
48702434|NCT02892344|156760607|FG001|Overall Study|Non-compliance with study treatment|1|||
48702435|NCT02892344|156760606|FG000|Overall Study|Physician Decision|0|||
48702436|NCT02892344|156760607|FG001|Overall Study|Physician Decision|2|||
48702437|NCT02892344|156760606|FG000|Overall Study|Subject/guardian decision|0|||
48595273|NCT03060291|156374198|FG000|6-month Follow-up|Declined to respond|7|||
48595274|NCT03060291|156374199|FG001|6-month Follow-up|Declined to respond|13|||
48595275|NCT03060291|156374200|FG002|6-month Follow-up|Declined to respond|4|||
48595276|NCT03060291|156374198|FG000|12-month Follow-up|Declined to respond|7|||
48595277|NCT03060291|156374199|FG001|12-month Follow-up|Declined to respond|16|||
48595278|NCT03060291|156374200|FG002|12-month Follow-up|Declined to respond|6|||
48702438|NCT02892344|156760607|FG001|Overall Study|Subject/guardian decision|4|||
48702439|NCT02892344|156760606|FG000|Overall Study|Technical problems|0|||
48702440|NCT02892344|156760607|FG001|Overall Study|Technical problems|1|||
48702441|NCT03780244|156760608|FG000|Overall Study|Lost to Follow-up|1|||
48595279|NCT03173456|156374203|FG000|Baseline|Medication dispensing system malfunction'|0|||
48595280|NCT03173456|156374204|FG001|Baseline|Medication dispensing system malfunction'|1|||
48595281|NCT03173456|156374205|FG002|Baseline|Medication dispensing system malfunction'|0|||
48595282|NCT03173456|156374206|FG003|Baseline|Medication dispensing system malfunction'|0|||
48595283|NCT03173456|156374207|FG004|Baseline|Medication dispensing system malfunction'|2|||
48595284|NCT03173456|156374203|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
48595285|NCT03173456|156374204|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
48595286|NCT03173456|156374205|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
48595287|NCT03173456|156374206|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
48595288|NCT03173456|156374207|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
48595289|NCT03727841|156374213|FG000|Overall Study|Physician Decision|3|||
48595290|NCT03727841|156374214|FG001|Overall Study|Physician Decision|1|||
48595291|NCT04501952|156374220|FG000|Overall Study|Adverse Event|0|||
48595292|NCT04501952|156374221|FG001|Overall Study|Adverse Event|3|||
48595293|NCT04501952|156374220|FG000|Overall Study|Investigator's Discretion|0|||
48595294|NCT04501952|156374221|FG001|Overall Study|Investigator's Discretion|1|||
48595295|NCT04501952|156374220|FG000|Overall Study|Protocol Violation|1|||
48595296|NCT04501952|156374221|FG001|Overall Study|Protocol Violation|1|||
48595297|NCT04501952|156374220|FG000|Overall Study|Withdrew Consent|5|||
48595298|NCT04501952|156374221|FG001|Overall Study|Withdrew Consent|4|||
48595299|NCT04501952|156374220|FG000|Overall Study|Lost to Follow-up|7|||
48595300|NCT04501952|156374221|FG001|Overall Study|Lost to Follow-up|2|||
48595301|NCT04501952|156374220|FG000|Overall Study|Randomized and Never Treated|13|||
48595302|NCT04501952|156374221|FG001|Overall Study|Randomized and Never Treated|9|||
48595303|NCT03061188|156374222|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
48595304|NCT03061188|156374223|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
48595305|NCT03061188|156374224|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
48595306|NCT03061188|156374225|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
48595307|NCT03061188|156374222|FG000|On Follow-up for 3 Years|Death|0|||
48595308|NCT03061188|156374223|FG001|On Follow-up for 3 Years|Death|3|||
48595309|NCT03061188|156374224|FG002|On Follow-up for 3 Years|Death|5|||
48595310|NCT03061188|156374225|FG003|On Follow-up for 3 Years|Death|4|||
48595311|NCT03061188|156374222|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
48595312|NCT03061188|156374223|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
48595313|NCT03061188|156374224|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
48595314|NCT03061188|156374225|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
48595315|NCT05225389|156374231|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
48595316|NCT01939223|156374232|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
48702442|NCT03780244|156760609|FG001|Overall Study|Lost to Follow-up|0|||
48702443|NCT02066181|156760610|FG000|Overall Study|Withdrawal by Subject|1|||
48702444|NCT02066181|156760611|FG001|Overall Study|Withdrawal by Subject|1|||
48702445|NCT02851615|156760612|FG000|Overall Study|Cognitive Issue|1|||
48702446|NCT02851615|156760613|FG001|Overall Study|Cognitive Issue|0|||
48489853|NCT02764489|155988795|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
48489854|NCT02764489|155988796|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
48489855|NCT02764489|155988795|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
48489856|NCT02764489|155988796|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
48489857|NCT02764489|155988795|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
48489858|NCT02764489|155988796|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
48489859|NCT02764489|155988795|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
48489860|NCT02764489|155988796|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
48489861|NCT00660790|155988797|FG000|Baseline to 3 Months|Death|1|||
48595317|NCT01939223|156374233|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
48595318|NCT01939223|156374232|FG000|Overall Study|Disease recurrence (radiological)|1|||
48595319|NCT01939223|156374233|FG001|Overall Study|Disease recurrence (radiological)|3|||
48595320|NCT01939223|156374232|FG000|Overall Study|Study stopped by Sponsor|5|||
48595321|NCT01939223|156374233|FG001|Overall Study|Study stopped by Sponsor|7|||
48595322|NCT01939223|156374232|FG000|Overall Study|Withdrawal by Subject|6|||
48595323|NCT01939223|156374233|FG001|Overall Study|Withdrawal by Subject|0|||
48595324|NCT02497404|156374234|FG000|Overall Study|Adverse Event|1|||
48595325|NCT01408901|156374235|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
48595326|NCT01408901|156374236|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
48595327|NCT01408901|156374237|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
48595328|NCT01408901|156374238|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
48595329|NCT01408901|156374235|FG000|6-Week Follow-Up|Death|1|||
48595330|NCT01408901|156374236|FG001|6-Week Follow-Up|Death|0|||
48595331|NCT01408901|156374237|FG002|6-Week Follow-Up|Death|0|||
48595332|NCT01408901|156374238|FG003|6-Week Follow-Up|Death|0|||
48595333|NCT01408901|156374235|FG000|6-Week Follow-Up|Cancelled visit|0|||
48595334|NCT01408901|156374236|FG001|6-Week Follow-Up|Cancelled visit|1|||
48595335|NCT01408901|156374237|FG002|6-Week Follow-Up|Cancelled visit|0|||
48595336|NCT01408901|156374238|FG003|6-Week Follow-Up|Cancelled visit|2|||
48595337|NCT01408901|156374235|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
48702447|NCT02851615|156760612|FG000|Overall Study|Lost to Follow-up|0|||
48702448|NCT02851615|156760613|FG001|Overall Study|Lost to Follow-up|4|||
48702449|NCT00313014|156760614|FG000|Overall Study|Withdrawal by Subject|11|||
48489862|NCT00660790|155988797|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
48489863|NCT00660790|155988797|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
48489864|NCT03840811|155988800|FG000|Overall Study|Lost to Follow-up|0|||
48489865|NCT03840811|155988801|FG001|Overall Study|Lost to Follow-up|0|||
48489866|NCT03840811|155988802|FG002|Overall Study|Lost to Follow-up|1|||
48489867|NCT01904383|155988803|FG000|Overall Study|CRF not collected|117|||
48489868|NCT01904383|155988803|FG000|Overall Study|Reason not listed|147|||
48489869|NCT01904383|155988803|FG000|Overall Study|Lost to Follow-up|674|||
48489870|NCT01904383|155988803|FG000|Overall Study|Lack of Efficacy|370|||
48489871|NCT01904383|155988803|FG000|Overall Study|Improvement|141|||
48489872|NCT01904383|155988803|FG000|Overall Study|Adverse Event|271|||
48489873|NCT01904383|155988803|FG000|Overall Study|No patient visit after entry|54|||
48489874|NCT01625845|155988806|FG000|Overall Study|Adverse Event|1|||
48489875|NCT01625845|155988807|FG001|Overall Study|Adverse Event|2|||
48489876|NCT01625845|155988806|FG000|Overall Study|Lost to Follow-up|2|||
48489877|NCT01625845|155988807|FG001|Overall Study|Lost to Follow-up|1|||
48489878|NCT01625845|155988806|FG000|Overall Study|Withdrawal by Subject|2|||
48595338|NCT01408901|156374236|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
48595339|NCT01408901|156374237|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
48595340|NCT01408901|156374238|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
48595341|NCT01408901|156374235|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
48595342|NCT01408901|156374236|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
48595343|NCT01408901|156374237|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
48595344|NCT01408901|156374238|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
48595345|NCT01408901|156374235|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
48595346|NCT01408901|156374236|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
48595347|NCT01408901|156374237|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
48595348|NCT01408901|156374238|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
48595349|NCT01408901|156374235|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
48595350|NCT01408901|156374236|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
48595351|NCT01408901|156374237|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
48595352|NCT01408901|156374238|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
48595353|NCT01408901|156374235|FG000|26-Week Follow-Up|Death|0|||
48595354|NCT01408901|156374236|FG001|26-Week Follow-Up|Death|1|||
48595355|NCT01408901|156374237|FG002|26-Week Follow-Up|Death|0|||
48595356|NCT01408901|156374238|FG003|26-Week Follow-Up|Death|0|||
48595357|NCT02421419|156374239|FG000|Overall Study|Physician Decision|0|||
48595358|NCT02421419|156374240|FG001|Overall Study|Physician Decision|0|||
48595359|NCT02421419|156374241|FG002|Overall Study|Physician Decision|1|||
48595360|NCT05285787|156374242|FG000|Overall Study|Withdrawal by Subject|1|||
48595361|NCT03382418|156374243|FG000|Overall Study|Withdrawal by Subject|1|||
48595362|NCT03382418|156374244|FG001|Overall Study|Withdrawal by Subject|0|||
48595363|NCT03382418|156374245|FG002|Overall Study|Withdrawal by Subject|0|||
48595364|NCT03382418|156374243|FG000|Overall Study|Lost to Follow-up|2|||
48595365|NCT03382418|156374244|FG001|Overall Study|Lost to Follow-up|3|||
48702450|NCT00313014|156760615|FG001|Overall Study|Withdrawal by Subject|7|||
48702451|NCT00313014|156760616|FG002|Overall Study|Withdrawal by Subject|5|||
48702452|NCT00313014|156760614|FG000|Overall Study|Adverse Event|14|||
48702453|NCT00313014|156760615|FG001|Overall Study|Adverse Event|29|||
48702454|NCT00313014|156760616|FG002|Overall Study|Adverse Event|16|||
48702455|NCT00313014|156760614|FG000|Overall Study|Lost to Follow-up|7|||
48702456|NCT00313014|156760615|FG001|Overall Study|Lost to Follow-up|6|||
48702457|NCT00313014|156760616|FG002|Overall Study|Lost to Follow-up|10|||
48702458|NCT00313014|156760614|FG000|Overall Study|Administrative|9|||
48702459|NCT00313014|156760615|FG001|Overall Study|Administrative|6|||
48702460|NCT00313014|156760616|FG002|Overall Study|Administrative|14|||
48702461|NCT00313014|156760614|FG000|Overall Study|Lack of Efficacy|52|||
48702462|NCT00313014|156760615|FG001|Overall Study|Lack of Efficacy|25|||
48702463|NCT00313014|156760616|FG002|Overall Study|Lack of Efficacy|16|||
48702464|NCT00371150|156760619|FG000|Overall Study|Lost to Follow-up|3|||
48702465|NCT00371150|156760620|FG001|Overall Study|Lost to Follow-up|2|||
48702466|NCT02141295|156760621|FG000|Overall Study|Adverse Event|1|||
48702467|NCT02141295|156760622|FG001|Overall Study|Adverse Event|18|||
48702468|NCT02141295|156760623|FG002|Overall Study|Adverse Event|11|||
48702469|NCT02141295|156760621|FG000|Overall Study|Physician Decision|2|||
48489879|NCT01625845|155988807|FG001|Overall Study|Withdrawal by Subject|0|||
48595366|NCT03382418|156374245|FG002|Overall Study|Lost to Follow-up|0|||
48595367|NCT00770913|156374247|FG000|Overall Study|Adverse Event|1|||
48595368|NCT00770913|156374248|FG001|Overall Study|Adverse Event|3|||
48595369|NCT00770913|156374249|FG002|Overall Study|Adverse Event|6|||
48489880|NCT00686374|155988809|FG000|Overall Study|Lack of Efficacy|10|||
48702470|NCT02141295|156760622|FG001|Overall Study|Physician Decision|19|||
48702471|NCT02141295|156760623|FG002|Overall Study|Physician Decision|14|||
48702472|NCT02141295|156760621|FG000|Overall Study|Study terminated by sponsor|0|||
48702473|NCT02141295|156760622|FG001|Overall Study|Study terminated by sponsor|6|||
48702474|NCT02141295|156760623|FG002|Overall Study|Study terminated by sponsor|6|||
48702475|NCT02141295|156760621|FG000|Overall Study|Non-compliance|0|||
48702476|NCT02141295|156760622|FG001|Overall Study|Non-compliance|1|||
48702477|NCT02141295|156760623|FG002|Overall Study|Non-compliance|0|||
48702478|NCT02141295|156760621|FG000|Overall Study|Progressive disease|3|||
48702479|NCT02141295|156760622|FG001|Overall Study|Progressive disease|32|||
48702480|NCT02141295|156760623|FG002|Overall Study|Progressive disease|50|||
48702481|NCT02141295|156760621|FG000|Overall Study|Reason not specified|0|||
48702482|NCT02141295|156760622|FG001|Overall Study|Reason not specified|9|||
48702483|NCT02141295|156760623|FG002|Overall Study|Reason not specified|10|||
48702484|NCT02141295|156760621|FG000|Overall Study|Withdrawal by Subject|0|||
48702485|NCT02141295|156760622|FG001|Overall Study|Withdrawal by Subject|9|||
48702486|NCT02141295|156760623|FG002|Overall Study|Withdrawal by Subject|4|||
48702487|NCT05050318|156760625|FG000|Overall Study|Protocol Deviation|1|||
48702488|NCT05050318|156760626|FG001|Overall Study|Protocol Deviation|0|||
48702489|NCT05050318|156760627|FG002|Overall Study|Protocol Deviation|0|||
48702490|NCT02345070|156760628|FG000|Overall Study|Adverse Event|12|||
48702491|NCT02345070|156760629|FG001|Overall Study|Adverse Event|8|||
48702492|NCT02345070|156760630|FG002|Overall Study|Adverse Event|16|||
48702493|NCT02345070|156760628|FG000|Overall Study|Poor compliance to protocol|2|||
48702494|NCT02345070|156760629|FG001|Overall Study|Poor compliance to protocol|0|||
48702495|NCT02345070|156760630|FG002|Overall Study|Poor compliance to protocol|0|||
48702496|NCT02345070|156760628|FG000|Overall Study|Other than specified above|6|||
48702497|NCT02345070|156760629|FG001|Overall Study|Other than specified above|3|||
48702498|NCT02345070|156760630|FG002|Overall Study|Other than specified above|7|||
48702499|NCT01942837|156760634|FG000|Overall Study|Death|1|||
48702500|NCT01942837|156760634|FG000|Overall Study|Symptomatic or radiographic progression|49|||
48702501|NCT01942837|156760634|FG000|Overall Study|Adverse Event|6|||
48702502|NCT01942837|156760634|FG000|Overall Study|Physician Decision|3|||
48702503|NCT01942837|156760634|FG000|Overall Study|Withdrawal by Subject|2|||
48702504|NCT01942837|156760634|FG000|Overall Study|Intercurrent Illness|1|||
48702505|NCT01942837|156760634|FG000|Overall Study|On treatment|3|||
48702506|NCT01942837|156760634|FG000|Overall Study|Never initiate the treatment|2|||
48702507|NCT00321620|156760635|FG000|Overall Study|Death|269|||
48702508|NCT00321620|156760636|FG001|Overall Study|Death|294|||
48702509|NCT00321620|156760635|FG000|Overall Study|Withdrawal by Subject|164|||
48702510|NCT00321620|156760636|FG001|Overall Study|Withdrawal by Subject|147|||
48702511|NCT00321620|156760635|FG000|Overall Study|Disease progression|113|||
48702512|NCT00321620|156760636|FG001|Overall Study|Disease progression|117|||
48702513|NCT00321620|156760635|FG000|Overall Study|Adverse Event|43|||
48702514|NCT00321620|156760636|FG001|Overall Study|Adverse Event|56|||
48702515|NCT00321620|156760635|FG000|Overall Study|Lost to Follow-up|13|||
48702516|NCT00321620|156760636|FG001|Overall Study|Lost to Follow-up|9|||
48702517|NCT00321620|156760635|FG000|Overall Study|Physician Decision|4|||
48702518|NCT00321620|156760636|FG001|Overall Study|Physician Decision|1|||
48702519|NCT00321620|156760635|FG000|Overall Study|Noncompliance|14|||
48702520|NCT00321620|156760636|FG001|Overall Study|Noncompliance|7|||
48702521|NCT00321620|156760635|FG000|Overall Study|Protocol deviation|4|||
48702522|NCT00321620|156760636|FG001|Overall Study|Protocol deviation|3|||
48702523|NCT00321620|156760635|FG000|Overall Study|Ineligibility determined|2|||
48702524|NCT00321620|156760636|FG001|Overall Study|Ineligibility determined|3|||
48702525|NCT00321620|156760635|FG000|Overall Study|Participant request|75|||
48702526|NCT00321620|156760636|FG001|Overall Study|Participant request|52|||
48702527|NCT00321620|156760635|FG000|Overall Study|Other|42|||
48702528|NCT00321620|156760636|FG001|Overall Study|Other|33|||
48702529|NCT01198795|156760639|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
48702530|NCT01198795|156760639|FG000|Overall Study|Withdrawal by Subject|17|||
48702531|NCT01198795|156760639|FG000|Overall Study|Lost to Follow-up|15|||
48702532|NCT01198795|156760639|FG000|Overall Study|Adverse Event|9|||
48702533|NCT01198795|156760639|FG000|Overall Study|Lack of Efficacy|5|||
48702534|NCT01198795|156760639|FG000|Overall Study|Protocol Violation|2|||
48702535|NCT01198795|156760639|FG000|Overall Study|Other Reason|4|||
48702536|NCT03038100|156760640|FG000|Overall Study|Death|289|||
48702537|NCT03038100|156760641|FG001|Overall Study|Death|272|||
48702538|NCT03038100|156760640|FG000|Overall Study|Lost to Follow-up|9|||
48702539|NCT03038100|156760641|FG001|Overall Study|Lost to Follow-up|10|||
48702540|NCT03038100|156760640|FG000|Overall Study|Protocol Deviation|1|||
48702541|NCT03038100|156760641|FG001|Overall Study|Protocol Deviation|4|||
48702542|NCT03038100|156760640|FG000|Overall Study|Withdrawal by Subject|45|||
48702543|NCT03038100|156760641|FG001|Overall Study|Withdrawal by Subject|51|||
48702544|NCT03038100|156760640|FG000|Overall Study|Study Terminated By Sponsor|305|||
48702545|NCT03038100|156760641|FG001|Overall Study|Study Terminated By Sponsor|311|||
48702546|NCT03038100|156760640|FG000|Overall Study|Physician Decision|1|||
48702547|NCT03038100|156760641|FG001|Overall Study|Physician Decision|3|||
48702548|NCT00918255|156760642|FG000|Overall Study|Adverse Event|1|||
48702549|NCT00918255|156760643|FG001|Overall Study|Adverse Event|0|||
48702550|NCT00918255|156760644|FG002|Overall Study|Adverse Event|0|||
48702551|NCT00918255|156760642|FG000|Overall Study|Withdrawal by Subject|1|||
48702552|NCT00918255|156760643|FG001|Overall Study|Withdrawal by Subject|0|||
48702553|NCT00918255|156760644|FG002|Overall Study|Withdrawal by Subject|2|||
48702554|NCT00918255|156760642|FG000|Overall Study|Lack of Efficacy|1|||
48702555|NCT00918255|156760643|FG001|Overall Study|Lack of Efficacy|0|||
48702556|NCT00918255|156760644|FG002|Overall Study|Lack of Efficacy|0|||
48702557|NCT00918255|156760642|FG000|Overall Study|Lost to Follow-up|1|||
48702558|NCT00918255|156760643|FG001|Overall Study|Lost to Follow-up|0|||
48702559|NCT00918255|156760644|FG002|Overall Study|Lost to Follow-up|2|||
48702560|NCT00918255|156760642|FG000|Overall Study|Exceeded allowed number of interventions|0|||
48702561|NCT00918255|156760643|FG001|Overall Study|Exceeded allowed number of interventions|0|||
48702562|NCT00918255|156760644|FG002|Overall Study|Exceeded allowed number of interventions|1|||
48702563|NCT00918255|156760642|FG000|Overall Study|Non-compliance|1|||
48702564|NCT00918255|156760643|FG001|Overall Study|Non-compliance|0|||
48702565|NCT00918255|156760644|FG002|Overall Study|Non-compliance|0|||
48702566|NCT00918255|156760642|FG000|Overall Study|Investigator discretion|1|||
48702567|NCT00918255|156760643|FG001|Overall Study|Investigator discretion|0|||
48702568|NCT00918255|156760644|FG002|Overall Study|Investigator discretion|0|||
48702569|NCT00408317|156760646|FG000|First Intervention Period|Adverse Event|0|||
48702570|NCT00408317|156760647|FG001|First Intervention Period|Adverse Event|1|||
48702571|NCT00408317|156760646|FG000|Second Intervention Period|Adverse Event|2|||
48702572|NCT00408317|156760647|FG001|Second Intervention Period|Adverse Event|0|||
48702573|NCT00408317|156760646|FG000|Second Intervention Period|Protocol Violation|0|||
48702574|NCT00408317|156760647|FG001|Second Intervention Period|Protocol Violation|1|||
48702575|NCT00408317|156760646|FG000|Second Intervention Period|Withdrawal of consent|0|||
48702576|NCT00408317|156760647|FG001|Second Intervention Period|Withdrawal of consent|1|||
48702577|NCT02703597|156760648|FG000|Assignment to Baseline|Lost to Follow-up|17|||
48702578|NCT02703597|156760649|FG001|Assignment to Baseline|Lost to Follow-up|16|||
48702579|NCT02703597|156760648|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
48702580|NCT02703597|156760649|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
48702581|NCT02703597|156760648|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
48702582|NCT02703597|156760649|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
48702583|NCT02703597|156760648|FG000|First Post-test to First Follow-up|Site drop out|0|||
48702584|NCT02703597|156760649|FG001|First Post-test to First Follow-up|Site drop out|58|||
48702585|NCT02703597|156760648|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
48702586|NCT02703597|156760649|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
48702587|NCT02703597|156760648|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
48702588|NCT02703597|156760649|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
48702589|NCT02703597|156760648|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
48702590|NCT02703597|156760649|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
48702591|NCT00459316|156760651|FG000|Steps 1 & 2|Other eligibility failure|1|||
48702592|NCT00459316|156760652|FG001|Steps 1 & 2|Other eligibility failure|1|||
48702593|NCT00459316|156760653|FG002|Steps 1 & 2|Other eligibility failure|0|||
48702594|NCT00459316|156760651|FG000|Steps 1 & 2|Death|1|||
48702595|NCT00459316|156760652|FG001|Steps 1 & 2|Death|1|||
48702596|NCT00459316|156760653|FG002|Steps 1 & 2|Death|0|||
48702597|NCT00459316|156760651|FG000|Steps 1 & 2|Not able to get to clinic|7|||
48702598|NCT00459316|156760652|FG001|Steps 1 & 2|Not able to get to clinic|4|||
48702599|NCT00459316|156760653|FG002|Steps 1 & 2|Not able to get to clinic|0|||
48702600|NCT00459316|156760651|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
48702601|NCT00459316|156760652|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
48702602|NCT00459316|156760653|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
48702603|NCT00459316|156760651|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
48702604|NCT00459316|156760652|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
48702605|NCT00459316|156760653|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
48702606|NCT00459316|156760651|FG000|Steps 1 & 2|Lost to Follow-up|5|||
48702607|NCT00459316|156760652|FG001|Steps 1 & 2|Lost to Follow-up|0|||
48702608|NCT00459316|156760653|FG002|Steps 1 & 2|Lost to Follow-up|2|||
48702609|NCT00459316|156760651|FG000|Step 3|Withdrawal by Subject|3|||
48702610|NCT00459316|156760652|FG001|Step 3|Withdrawal by Subject|0|||
48702611|NCT00459316|156760653|FG002|Step 3|Withdrawal by Subject|1|||
48702612|NCT01393821|156760654|FG000|Overall Study|Cancel|1|||
48702613|NCT01393821|156760655|FG001|Overall Study|Cancel|1|||
48702614|NCT01393821|156760654|FG000|Overall Study|not evaluable for primary endpoint|4|||
48702615|NCT01393821|156760655|FG001|Overall Study|not evaluable for primary endpoint|2|||
48702616|NCT01435382|156760661|FG000|Overall Study|Lost to Follow-up|1|||
48702617|NCT01435382|156760662|FG001|Overall Study|Lost to Follow-up|0|||
48702618|NCT01435382|156760663|FG002|Overall Study|Lost to Follow-up|1|||
48702619|NCT01435382|156760664|FG003|Overall Study|Lost to Follow-up|0|||
48702620|NCT01435382|156760661|FG000|Overall Study|Withdrawal by Subject|0|||
48702621|NCT01435382|156760662|FG001|Overall Study|Withdrawal by Subject|2|||
48702622|NCT01435382|156760663|FG002|Overall Study|Withdrawal by Subject|0|||
48702623|NCT01435382|156760664|FG003|Overall Study|Withdrawal by Subject|1|||
48702624|NCT01046396|156760667|FG000|Overall Study|Withdrawal by Subject|5|||
48702625|NCT03367793|156760668|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702626|NCT03367793|156760669|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702627|NCT03367793|156760670|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
48702628|NCT03367793|156760671|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702629|NCT03367793|156760672|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702630|NCT03367793|156760673|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
48702631|NCT00907335|156760674|FG000|Overall Study|Withdrawal by Subject|2|||
48702632|NCT00907335|156760675|FG001|Overall Study|Withdrawal by Subject|0|||
48702633|NCT00907335|156760674|FG000|Overall Study|Adverse Event|4|||
48702634|NCT00907335|156760675|FG001|Overall Study|Adverse Event|1|||
48702635|NCT00907335|156760674|FG000|Overall Study|Lost to Follow-up|2|||
48702636|NCT00907335|156760675|FG001|Overall Study|Lost to Follow-up|0|||
48702637|NCT00260533|156760678|FG000|Overall Study|Other|3|||
48702638|NCT00260533|156760679|FG001|Overall Study|Other|3|||
48702639|NCT02161016|156760680|FG000|Overall Study|withdrawn by IRB|1|||
48702640|NCT03873116|156760681|FG000|Part 1|Study drug discontinuation due to rash|0|||
48702641|NCT03873116|156760682|FG001|Part 1|Study drug discontinuation due to rash|0|||
48702642|NCT03873116|156760683|FG002|Part 1|Study drug discontinuation due to rash|0|||
48702643|NCT03873116|156760684|FG003|Part 1|Study drug discontinuation due to rash|0|||
48702644|NCT03873116|156760685|FG004|Part 1|Study drug discontinuation due to rash|0|||
48702645|NCT03873116|156760686|FG005|Part 1|Study drug discontinuation due to rash|1|||
48702646|NCT03873116|156760681|FG000|Part 2|Withdrawal by Subject|0|||
48702647|NCT03873116|156760682|FG001|Part 2|Withdrawal by Subject|0|||
48702648|NCT03873116|156760683|FG002|Part 2|Withdrawal by Subject|1|||
48702649|NCT03873116|156760684|FG003|Part 2|Withdrawal by Subject|0|||
48702650|NCT03873116|156760685|FG004|Part 2|Withdrawal by Subject|0|||
48702651|NCT03873116|156760686|FG005|Part 2|Withdrawal by Subject|0|||
48702652|NCT03873116|156760681|FG000|Part 2|Lab abnormality or AE|0|||
48702653|NCT03873116|156760682|FG001|Part 2|Lab abnormality or AE|0|||
48702654|NCT03873116|156760683|FG002|Part 2|Lab abnormality or AE|0|||
48702655|NCT03873116|156760684|FG003|Part 2|Lab abnormality or AE|0|||
48702656|NCT03873116|156760685|FG004|Part 2|Lab abnormality or AE|1|||
48702657|NCT03873116|156760686|FG005|Part 2|Lab abnormality or AE|0|||
48702658|NCT03873116|156760681|FG000|Part 3|Withdrawal by Subject|0|||
48702659|NCT03873116|156760682|FG001|Part 3|Withdrawal by Subject|0|||
48702660|NCT03873116|156760683|FG002|Part 3|Withdrawal by Subject|0|||
48702661|NCT03873116|156760684|FG003|Part 3|Withdrawal by Subject|0|||
48702662|NCT03873116|156760685|FG004|Part 3|Withdrawal by Subject|1|||
48702663|NCT03873116|156760686|FG005|Part 3|Withdrawal by Subject|0|||
48702664|NCT00003475|156760687|FG000|Overall Study|Not evaluable|13|||
48702665|NCT00702221|156760688|FG000|Overall Study|Adverse Event|4|||
48702666|NCT00702221|156760689|FG001|Overall Study|Adverse Event|3|||
48702667|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Adverse Event|9|||
48702668|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Adverse Event|3|||
48702669|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Death|7|||
48702670|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Death|7|||
48702671|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
48702672|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
48702673|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Physician Decision|1|||
48489881|NCT00686374|155988809|FG000|Overall Study|Adverse Event|8|||
48489882|NCT00686374|155988809|FG000|Overall Study|Withdrew consent|5|||
48489883|NCT00686374|155988809|FG000|Overall Study|Lost to Follow-up|1|||
48489884|NCT00686374|155988809|FG000|Overall Study|Missing reason|33|||
48489885|NCT00686374|155988809|FG000|Overall Study|Other, not specified|4|||
48489886|NCT01294592|155988812|FG000|Overall Study|Adverse Event|28|||
48489887|NCT01294592|155988813|FG001|Overall Study|Adverse Event|13|||
48489888|NCT01294592|155988812|FG000|Overall Study|Lack of Efficacy|7|||
48489889|NCT01294592|155988813|FG001|Overall Study|Lack of Efficacy|5|||
48489890|NCT01294592|155988812|FG000|Overall Study|Protocol Violation|1|||
48489891|NCT01294592|155988813|FG001|Overall Study|Protocol Violation|7|||
48489892|NCT01294592|155988812|FG000|Overall Study|Lost to Follow-up|7|||
48489893|NCT01294592|155988813|FG001|Overall Study|Lost to Follow-up|9|||
48489894|NCT01294592|155988812|FG000|Overall Study|Physician Decision|6|||
48595370|NCT00770913|156374247|FG000|Overall Study|Refusal to continue participation|6|||
48595371|NCT00770913|156374248|FG001|Overall Study|Refusal to continue participation|4|||
48702674|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Physician Decision|0|||
48702675|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
48702676|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
48702677|NCT02558296|156760690|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
48702678|NCT02558296|156760691|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
48702679|NCT02558296|156760690|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
48702680|NCT02558296|156760691|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
48702681|NCT02558296|156760690|FG000|Completed the Study|Adverse Event|14|||
48702682|NCT02558296|156760691|FG001|Completed the Study|Adverse Event|5|||
48702683|NCT02558296|156760690|FG000|Completed the Study|Death|39|||
48489895|NCT01294592|155988813|FG001|Overall Study|Physician Decision|11|||
48489896|NCT01294592|155988812|FG000|Overall Study|Withdrawal by Subject|28|||
48702684|NCT02558296|156760691|FG001|Completed the Study|Death|25|||
48702685|NCT02558296|156760690|FG000|Completed the Study|Lost to Follow-up|31|||
48702686|NCT02558296|156760691|FG001|Completed the Study|Lost to Follow-up|23|||
48702687|NCT02558296|156760690|FG000|Completed the Study|Physician Decision|6|||
48702688|NCT02558296|156760691|FG001|Completed the Study|Physician Decision|0|||
48702689|NCT02558296|156760690|FG000|Completed the Study|Protocol Violation|2|||
48489897|NCT01294592|155988813|FG001|Overall Study|Withdrawal by Subject|28|||
48489898|NCT02762565|155988814|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
48489899|NCT03549130|155988815|FG000|Overall Study|Adverse Event|0|||
48702690|NCT02558296|156760691|FG001|Completed the Study|Protocol Violation|1|||
48702691|NCT02558296|156760690|FG000|Completed the Study|Withdrawal by Subject|53|||
48702692|NCT02558296|156760691|FG001|Completed the Study|Withdrawal by Subject|31|||
48702693|NCT02558296|156760690|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
48702694|NCT02558296|156760691|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
48702695|NCT00389610|156760692|FG000|Overall Study|Disease Progression|0|||
48702696|NCT00389610|156760693|FG001|Overall Study|Disease Progression|19|||
48702697|NCT00389610|156760692|FG000|Overall Study|Death|0|||
48702698|NCT00389610|156760693|FG001|Overall Study|Death|1|||
48702699|NCT00389610|156760692|FG000|Overall Study|Physician Decision|0|||
48702700|NCT00389610|156760693|FG001|Overall Study|Physician Decision|1|||
48702701|NCT00389610|156760692|FG000|Overall Study|Withdrawal by Subject|0|||
48702702|NCT00389610|156760693|FG001|Overall Study|Withdrawal by Subject|1|||
48702703|NCT00904982|156760699|FG000|Overall Study|Withdrawal by Subject|2|||
48489900|NCT03549130|155988816|FG001|Overall Study|Adverse Event|1|||
48489901|NCT03549130|155988815|FG000|Overall Study|Lost to Follow-up|0|||
48489902|NCT03549130|155988816|FG001|Overall Study|Lost to Follow-up|1|||
48489903|NCT02038634|155988818|FG000|Overall Study|Lost to Follow-up|0|||
48489904|NCT02038634|155988819|FG001|Overall Study|Lost to Follow-up|1|||
48489905|NCT01113710|155988820|FG000|Overall Study|Adverse Event|64|||
48489906|NCT01113710|155988820|FG000|Overall Study|Lack of Efficacy|41|||
48489907|NCT01113710|155988820|FG000|Overall Study|No Information Available|40|||
48489908|NCT01113710|155988820|FG000|Overall Study|Withdrawal by Subject|28|||
48489909|NCT01113710|155988820|FG000|Overall Study|Lost to Follow-up|20|||
48489910|NCT01113710|155988820|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
48489911|NCT01113710|155988820|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
48489912|NCT01113710|155988820|FG000|Overall Study|Lack of Patient's Compliance|8|||
48489913|NCT01113710|155988820|FG000|Overall Study|Other|7|||
48489914|NCT01113710|155988820|FG000|Overall Study|Adverse Event/Other|5|||
48489915|NCT01113710|155988820|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
48489916|NCT01113710|155988820|FG000|Overall Study|Lack of Efficacy/Other|4|||
48489917|NCT01113710|155988820|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
48489918|NCT01113710|155988820|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
48489919|NCT01113710|155988820|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
48489920|NCT01113710|155988820|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
48489921|NCT01113710|155988820|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
48489922|NCT01113710|155988820|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
48489923|NCT01113710|155988820|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
48489924|NCT01113710|155988820|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
48489925|NCT01113710|155988820|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
48489926|NCT01113710|155988820|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
48489927|NCT01113710|155988820|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
48489928|NCT01113710|155988820|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
48489929|NCT01113710|155988820|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
48489930|NCT02742181|155988821|FG000|Overall Study|Physician Decision|1|||
48489931|NCT02742181|155988822|FG001|Overall Study|Physician Decision|0|||
48489932|NCT00623623|155988824|FG000|Overall Study|Previous enrolment into this study|1|||
48489933|NCT00623623|155988825|FG001|Overall Study|Previous enrolment into this study|1|||
48489934|NCT01078623|155988826|FG000|Treatment Period 1|Adverse Event|1|||
48489935|NCT01078623|155988827|FG001|Treatment Period 1|Adverse Event|1|||
48489936|NCT01078623|155988828|FG002|Treatment Period 1|Adverse Event|1|||
48489937|NCT01078623|155988829|FG003|Treatment Period 1|Adverse Event|0|||
48489938|NCT01078623|155988830|FG004|Treatment Period 1|Adverse Event|0|||
48489939|NCT01078623|155988831|FG005|Treatment Period 1|Adverse Event|0|||
48489940|NCT01078623|155988832|FG006|Treatment Period 1|Adverse Event|1|||
48489941|NCT01078623|155988833|FG007|Treatment Period 1|Adverse Event|0|||
48489942|NCT01078623|155988834|FG008|Treatment Period 1|Adverse Event|1|||
48489943|NCT01078623|155988835|FG009|Treatment Period 1|Adverse Event|1|||
48489944|NCT01078623|155988836|FG010|Treatment Period 1|Adverse Event|0|||
48489945|NCT01078623|155988837|FG011|Treatment Period 1|Adverse Event|0|||
48489946|NCT01078623|155988838|FG012|Treatment Period 1|Adverse Event|0|||
48489947|NCT01078623|155988839|FG013|Treatment Period 1|Adverse Event|0|||
48489948|NCT01078623|155988840|FG014|Treatment Period 1|Adverse Event|0|||
48702704|NCT00904982|156760700|FG001|Overall Study|Withdrawal by Subject|0|||
48702705|NCT00904982|156760701|FG002|Overall Study|Withdrawal by Subject|0|||
48702706|NCT00904982|156760702|FG003|Overall Study|Withdrawal by Subject|0|||
48702707|NCT02420821|156760703|FG000|Overall Study|Lost to Follow-up|6|||
48702708|NCT02420821|156760704|FG001|Overall Study|Lost to Follow-up|6|||
48702709|NCT02420821|156760703|FG000|Overall Study|Non-compliance|0|||
48702710|NCT02420821|156760704|FG001|Overall Study|Non-compliance|2|||
48702711|NCT02420821|156760703|FG000|Overall Study|Physician Decision|6|||
48702712|NCT02420821|156760704|FG001|Overall Study|Physician Decision|2|||
48702713|NCT02420821|156760703|FG000|Overall Study|Withdrawal by Subject|32|||
48702714|NCT02420821|156760704|FG001|Overall Study|Withdrawal by Subject|25|||
48702715|NCT02420821|156760703|FG000|Overall Study|Death|270|||
48702716|NCT02420821|156760704|FG001|Overall Study|Death|263|||
48702717|NCT02420821|156760703|FG000|Overall Study|Study Terminated By Sponsor|145|||
48702718|NCT02420821|156760704|FG001|Overall Study|Study Terminated By Sponsor|149|||
48702719|NCT02420821|156760703|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
48702720|NCT02420821|156760704|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
48702721|NCT02420821|156760703|FG000|Overall Study|Adverse Event|0|||
48702722|NCT02420821|156760704|FG001|Overall Study|Adverse Event|1|||
48702723|NCT02420821|156760703|FG000|Overall Study|Protinuria|0|||
48702724|NCT02420821|156760704|FG001|Overall Study|Protinuria|1|||
48702725|NCT02420821|156760703|FG000|Overall Study|Progressive Disease|1|||
48702726|NCT02420821|156760704|FG001|Overall Study|Progressive Disease|1|||
48702727|NCT02420821|156760703|FG000|Overall Study|Disease Progression|0|||
48702728|NCT02420821|156760704|FG001|Overall Study|Disease Progression|1|||
48702729|NCT02420821|156760703|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
48702730|NCT02420821|156760704|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
48702731|NCT01217229|156760706|FG000|Overall Study|Adverse Event|1|||
48702732|NCT01217229|156760706|FG000|Overall Study|Disease progression, deterioration|2|||
48702733|NCT01217229|156760706|FG000|Overall Study|Disease progression, Cheson criteria|14|||
48702734|NCT01217229|156760706|FG000|Overall Study|Protocol Violation|1|||
48702735|NCT01217229|156760706|FG000|Overall Study|Disease progression not confirmed|2|||
48702736|NCT01318915|156760707|FG000|Overall Study|Lost to Follow-up|1|||
48595372|NCT00770913|156374249|FG002|Overall Study|Refusal to continue participation|5|||
48595373|NCT00770913|156374247|FG000|Overall Study|Physician Decision|0|||
48595374|NCT00770913|156374248|FG001|Overall Study|Physician Decision|1|||
48595375|NCT00770913|156374249|FG002|Overall Study|Physician Decision|1|||
48595376|NCT00770913|156374247|FG000|Overall Study|Protocol Violation|3|||
48595377|NCT00770913|156374248|FG001|Overall Study|Protocol Violation|0|||
48595378|NCT00770913|156374249|FG002|Overall Study|Protocol Violation|1|||
48595379|NCT00770913|156374247|FG000|Overall Study|Incorrect drug was allocated|1|||
48595380|NCT00770913|156374248|FG001|Overall Study|Incorrect drug was allocated|0|||
48595381|NCT00770913|156374249|FG002|Overall Study|Incorrect drug was allocated|0|||
48595382|NCT03883477|156374256|FG000|Overall Study|Death|1|||
48595383|NCT03883477|156374257|FG001|Overall Study|Death|0|||
48595384|NCT03883477|156374256|FG000|Overall Study|Protocol Violation|0|||
48595385|NCT03883477|156374257|FG001|Overall Study|Protocol Violation|1|||
48595386|NCT04186221|156374260|FG000|Overall Study|Death|1|||
48595387|NCT02401035|156374261|FG000|Overall Study|Withdrawal by Subject|1|||
48595388|NCT02401035|156374262|FG001|Overall Study|Withdrawal by Subject|0|||
48702737|NCT03058146|156760708|FG000|Overall Study|Withdrawal by Subject|4|||
48702738|NCT03058146|156760709|FG001|Overall Study|Withdrawal by Subject|1|||
48595389|NCT01134393|156374263|FG000|Overall Study|Adverse Event|18|||
48702739|NCT03058146|156760708|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
48702740|NCT03058146|156760709|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
48702741|NCT01599637|156760714|FG000|Overall Study|administrative problems|0|||
48702742|NCT01599637|156760715|FG001|Overall Study|administrative problems|2|||
48702743|NCT01599637|156760716|FG002|Overall Study|administrative problems|0|||
48702744|NCT01599637|156760714|FG000|Overall Study|Adverse Event|1|||
48702745|NCT01599637|156760715|FG001|Overall Study|Adverse Event|0|||
48702746|NCT01599637|156760716|FG002|Overall Study|Adverse Event|0|||
48702747|NCT04139018|156760717|FG000|Overall Study|Screen fail|1|||
48702748|NCT04139018|156760718|FG001|Overall Study|Screen fail|0|||
48702749|NCT04139018|156760717|FG000|Overall Study|Withdrawal by Subject|2|||
48702750|NCT04139018|156760718|FG001|Overall Study|Withdrawal by Subject|0|||
48702751|NCT04139018|156760717|FG000|Overall Study|Lost to Follow-up|0|||
48702752|NCT04139018|156760718|FG001|Overall Study|Lost to Follow-up|1|||
48702753|NCT00577889|156760719|FG000|Overall Study|Withdrawal by Subject|1|||
48702754|NCT00577889|156760720|FG001|Overall Study|Withdrawal by Subject|0|||
48702755|NCT00577889|156760721|FG002|Overall Study|Withdrawal by Subject|0|||
48702756|NCT03486834|156760722|FG000|Overall Study|Withdrawal by Subject|46|||
48702757|NCT03486834|156760723|FG001|Overall Study|Withdrawal by Subject|46|||
48702758|NCT03486834|156760724|FG002|Overall Study|Withdrawal by Subject|52|||
48702759|NCT03486834|156760722|FG000|Overall Study|Adverse Event|8|||
48702760|NCT03486834|156760723|FG001|Overall Study|Adverse Event|7|||
48595390|NCT01134393|156374263|FG000|Overall Study|Lack of Efficacy|2|||
48595391|NCT01134393|156374263|FG000|Overall Study|Protocol Violation|12|||
48595392|NCT01134393|156374263|FG000|Overall Study|Lost to Follow-up|3|||
48595393|NCT01134393|156374263|FG000|Overall Study|Withdrawal by Subject|11|||
48702761|NCT03486834|156760724|FG002|Overall Study|Adverse Event|0|||
48702762|NCT03486834|156760722|FG000|Overall Study|Lost to Follow-up|41|||
48702763|NCT03486834|156760723|FG001|Overall Study|Lost to Follow-up|24|||
48702764|NCT03486834|156760724|FG002|Overall Study|Lost to Follow-up|39|||
48702765|NCT03486834|156760722|FG000|Overall Study|Non-compliance with Study Drug|2|||
48702766|NCT03486834|156760723|FG001|Overall Study|Non-compliance with Study Drug|2|||
48702767|NCT03486834|156760724|FG002|Overall Study|Non-compliance with Study Drug|0|||
48702768|NCT03486834|156760722|FG000|Overall Study|Physician Decision|5|||
48702769|NCT03486834|156760723|FG001|Overall Study|Physician Decision|2|||
48702770|NCT03486834|156760724|FG002|Overall Study|Physician Decision|3|||
48702771|NCT03486834|156760722|FG000|Overall Study|Pregnancy|10|||
48702772|NCT03486834|156760723|FG001|Overall Study|Pregnancy|12|||
48702773|NCT03486834|156760724|FG002|Overall Study|Pregnancy|12|||
48702774|NCT03486834|156760722|FG000|Overall Study|Protocol Deviation|2|||
48702775|NCT03486834|156760723|FG001|Overall Study|Protocol Deviation|3|||
48702776|NCT03486834|156760724|FG002|Overall Study|Protocol Deviation|3|||
48702777|NCT03486834|156760722|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48702778|NCT03486834|156760723|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48702779|NCT03486834|156760724|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48702780|NCT03486834|156760722|FG000|Overall Study|Randomized but not treated|4|||
48702781|NCT03486834|156760723|FG001|Overall Study|Randomized but not treated|4|||
48702782|NCT03486834|156760724|FG002|Overall Study|Randomized but not treated|1|||
48702783|NCT03041181|156760727|FG000|Overall Study|Disease Progression|1|||
48702784|NCT03041181|156760728|FG001|Overall Study|Disease Progression|2|||
48702785|NCT00960999|156760729|FG000|Overall Study|Withdrawal by Subject|1|||
48702786|NCT00960999|156760730|FG001|Overall Study|Withdrawal by Subject|0|||
48702787|NCT00960999|156760729|FG000|Overall Study|Protocol Violation|5|||
48702788|NCT00960999|156760730|FG001|Overall Study|Protocol Violation|2|||
48702789|NCT00960999|156760729|FG000|Overall Study|RT dose constraints not met|2|||
48702790|NCT00960999|156760730|FG001|Overall Study|RT dose constraints not met|0|||
48702791|NCT03067077|156760731|FG000|Overall Study|Did not receive surgery|4|||
48702792|NCT03067077|156760732|FG001|Overall Study|Did not receive surgery|5|||
48702793|NCT03067077|156760731|FG000|Overall Study|Lost to Follow-up|3|||
48702794|NCT03067077|156760732|FG001|Overall Study|Lost to Follow-up|2|||
48702795|NCT04201262|156760739|FG000|Overall Study|Adverse Event|1|||
48702796|NCT04201262|156760740|FG001|Overall Study|Adverse Event|2|||
48702797|NCT04201262|156760739|FG000|Overall Study|Continuing in the study|57|||
48702798|NCT04201262|156760740|FG001|Overall Study|Continuing in the study|0|||
48702799|NCT04201262|156760739|FG000|Overall Study|Withdrawal by Subject|0|||
48702800|NCT04201262|156760740|FG001|Overall Study|Withdrawal by Subject|1|||
48702801|NCT03312231|156760746|FG000|Overall Study|Lost to Follow-up|2|||
48702802|NCT03312231|156760747|FG001|Overall Study|Lost to Follow-up|6|||
48702803|NCT03312231|156760748|FG002|Overall Study|Lost to Follow-up|1|||
48702804|NCT03312231|156760749|FG003|Overall Study|Lost to Follow-up|3|||
48702805|NCT03312231|156760750|FG004|Overall Study|Lost to Follow-up|1|||
48702806|NCT03312231|156760746|FG000|Overall Study|Withdrawal by Subject|0|||
48702807|NCT03312231|156760747|FG001|Overall Study|Withdrawal by Subject|3|||
48489949|NCT01078623|155988841|FG015|Treatment Period 1|Adverse Event|0|||
48702808|NCT03312231|156760748|FG002|Overall Study|Withdrawal by Subject|1|||
48702809|NCT03312231|156760749|FG003|Overall Study|Withdrawal by Subject|0|||
48702810|NCT03312231|156760750|FG004|Overall Study|Withdrawal by Subject|0|||
48702811|NCT03312231|156760746|FG000|Overall Study|Death|0|||
48702812|NCT03312231|156760747|FG001|Overall Study|Death|1|||
48702813|NCT03312231|156760748|FG002|Overall Study|Death|1|||
48702814|NCT03312231|156760749|FG003|Overall Study|Death|0|||
48702815|NCT03312231|156760750|FG004|Overall Study|Death|0|||
48702816|NCT03312231|156760746|FG000|Overall Study|Study Vaccination not Received|1|||
48702817|NCT03312231|156760747|FG001|Overall Study|Study Vaccination not Received|1|||
48702818|NCT03312231|156760748|FG002|Overall Study|Study Vaccination not Received|1|||
48702819|NCT03312231|156760749|FG003|Overall Study|Study Vaccination not Received|0|||
48702820|NCT03312231|156760750|FG004|Overall Study|Study Vaccination not Received|0|||
48702821|NCT03694353|156760753|FG000|Overall Study|Withdrawal by Subject|1|||
48702822|NCT03694353|156760753|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
48702823|NCT01198977|156760754|FG000|Overall Study|Lost to Follow-up|1|||
48702824|NCT01198977|156760755|FG001|Overall Study|Lost to Follow-up|0|||
48702825|NCT05786651|156760760|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
48702826|NCT03472885|156760761|FG000|24-Week Treatment Period|Adverse Event|1|||
48702827|NCT03493464|156760762|FG000|Overall Study|Surgery not performed|1|||
48702828|NCT02017405|156760765|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702829|NCT02017405|156760766|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702830|NCT02017405|156760767|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702831|NCT02017405|156760768|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702832|NCT02017405|156760769|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
48702833|NCT02017405|156760770|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
48702834|NCT02017405|156760765|FG000|Open-label Phase|Adverse Event|1|||
48702835|NCT02017405|156760766|FG001|Open-label Phase|Adverse Event|1|||
48702836|NCT02017405|156760767|FG002|Open-label Phase|Adverse Event|0|||
48702837|NCT02017405|156760768|FG003|Open-label Phase|Adverse Event|0|||
48702838|NCT02017405|156760769|FG004|Open-label Phase|Adverse Event|0|||
48702839|NCT02017405|156760770|FG005|Open-label Phase|Adverse Event|0|||
48702840|NCT04323124|156760771|FG000|Overall Study|Adverse Event|0|||
48702841|NCT04323124|156760772|FG001|Overall Study|Adverse Event|0|||
48702842|NCT04323124|156760773|FG002|Overall Study|Adverse Event|0|||
48702843|NCT04323124|156760774|FG003|Overall Study|Adverse Event|0|||
48702844|NCT04323124|156760775|FG004|Overall Study|Adverse Event|0|||
48702845|NCT04323124|156760776|FG005|Overall Study|Adverse Event|1|||
48595394|NCT01134393|156374263|FG000|Overall Study|Other|6|||
48595395|NCT00869128|156374264|FG000|Overall Study|lack of Compliance|6|||
48595396|NCT00869128|156374265|FG001|Overall Study|lack of Compliance|6|||
48595397|NCT00531947|156374266|FG000|Overall Study|Adverse Event|5|||
48595398|NCT00531947|156374267|FG001|Overall Study|Adverse Event|10|||
48595399|NCT00531947|156374266|FG000|Overall Study|Lost to Follow-up|12|||
48595400|NCT00531947|156374267|FG001|Overall Study|Lost to Follow-up|9|||
48595401|NCT00531947|156374266|FG000|Overall Study|Withdrawal by Subject|14|||
48595402|NCT00531947|156374267|FG001|Overall Study|Withdrawal by Subject|19|||
48595403|NCT00531947|156374266|FG000|Overall Study|Protocol Violation|2|||
48595404|NCT00531947|156374267|FG001|Overall Study|Protocol Violation|1|||
48595405|NCT00531947|156374266|FG000|Overall Study|Non-Compliance|4|||
48595406|NCT00531947|156374267|FG001|Overall Study|Non-Compliance|7|||
48595407|NCT00531947|156374266|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
48595408|NCT00531947|156374267|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
48595409|NCT02998996|156374268|FG000|Overall Study|Lost to Follow-up|0|||
48595410|NCT02998996|156374269|FG001|Overall Study|Lost to Follow-up|0|||
48595411|NCT02998996|156374270|FG002|Overall Study|Lost to Follow-up|1|||
48595412|NCT02998996|156374271|FG003|Overall Study|Lost to Follow-up|0|||
48595413|NCT02998996|156374272|FG004|Overall Study|Lost to Follow-up|0|||
48595414|NCT02998996|156374273|FG005|Overall Study|Lost to Follow-up|0|||
48595415|NCT02998996|156374268|FG000|Overall Study|Pregnancy|0|||
48595416|NCT02998996|156374269|FG001|Overall Study|Pregnancy|1|||
48595417|NCT02998996|156374270|FG002|Overall Study|Pregnancy|0|||
48595418|NCT02998996|156374271|FG003|Overall Study|Pregnancy|0|||
48595419|NCT02998996|156374272|FG004|Overall Study|Pregnancy|0|||
48595420|NCT02998996|156374273|FG005|Overall Study|Pregnancy|0|||
48595421|NCT02998996|156374268|FG000|Overall Study|Family reasons|0|||
48595422|NCT02998996|156374269|FG001|Overall Study|Family reasons|0|||
48595423|NCT02998996|156374270|FG002|Overall Study|Family reasons|0|||
48595424|NCT02998996|156374271|FG003|Overall Study|Family reasons|0|||
48595425|NCT02998996|156374272|FG004|Overall Study|Family reasons|1|||
48595426|NCT02998996|156374273|FG005|Overall Study|Family reasons|0|||
48595427|NCT00985686|156374277|FG000|Overall Study|Lost to Follow-up|1|||
48595428|NCT00985686|156374278|FG001|Overall Study|Lost to Follow-up|1|||
48595429|NCT00985686|156374279|FG002|Overall Study|Lost to Follow-up|0|||
48595430|NCT00985686|156374280|FG003|Overall Study|Lost to Follow-up|2|||
48595431|NCT03134911|156374281|FG000|Overall Study|Screen failure|31|||
48595432|NCT03134911|156374281|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
48595433|NCT01670045|156374282|FG000|Overall Study|Withdrawal by Subject|3|||
48595434|NCT01670045|156374282|FG000|Overall Study|Adverse Event|1|||
48595435|NCT01670045|156374282|FG000|Overall Study|Death|1|||
48595436|NCT01670045|156374282|FG000|Overall Study|Lost to Follow-up|11|||
48595437|NCT03014206|156374283|FG000|Overall Study|Registration Violation|12|||
48702846|NCT04323124|156760777|FG006|Overall Study|Adverse Event|0|||
48702847|NCT04323124|156760778|FG007|Overall Study|Adverse Event|1|||
48595438|NCT03046953|156374285|FG000|Overall Study|Relapse/progressive disease|21|||
48595439|NCT03046953|156374285|FG000|Overall Study|Death|2|||
48595440|NCT03046953|156374285|FG000|Overall Study|Withdrawal by Subject|3|||
48595441|NCT03360019|156374290|FG000|Overall Study|Withdrawal by Subject|2|||
48595442|NCT03360019|156374291|FG001|Overall Study|Withdrawal by Subject|0|||
48595443|NCT03360019|156374292|FG002|Overall Study|Withdrawal by Subject|0|||
48595444|NCT03360019|156374290|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
48595445|NCT03360019|156374291|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
48702848|NCT04323124|156760779|FG008|Overall Study|Adverse Event|1|||
48702849|NCT04323124|156760780|FG009|Overall Study|Adverse Event|0|||
48702850|NCT04323124|156760781|FG010|Overall Study|Adverse Event|0|||
48702851|NCT04323124|156760782|FG011|Overall Study|Adverse Event|0|||
48595446|NCT03360019|156374292|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
48595447|NCT00656175|156374293|FG000|Overall Study|Adverse Event|1|||
48595448|NCT00656175|156374294|FG001|Overall Study|Adverse Event|0|||
48595449|NCT00656175|156374293|FG000|Overall Study|Transportation issues|0|||
48595450|NCT00656175|156374294|FG001|Overall Study|Transportation issues|1|||
48595451|NCT00992017|156374295|FG000|Overall Study|Lost to Follow-up|2|||
48595452|NCT00992017|156374295|FG000|Overall Study|Withdrawal by Subject|2|||
48595453|NCT00992017|156374295|FG000|Overall Study|Unable to get to clinic|5|||
48595454|NCT00992017|156374295|FG000|Overall Study|Not adhere to study requirements|1|||
48595455|NCT02149264|156374296|FG000|Overall Study|Withdrawal by Subject|9|||
48595456|NCT02149264|156374296|FG000|Overall Study|Adverse Event|7|||
48595457|NCT02149264|156374296|FG000|Overall Study|Physician Decision|3|||
48595458|NCT02149264|156374296|FG000|Overall Study|Protocol Violation|1|||
48595459|NCT04877990|156374299|FG000|Treatment|Other reasons|3|||
48595460|NCT04877990|156374300|FG001|Treatment|Other reasons|1|||
48595461|NCT04877990|156374299|FG000|Treatment|Administrative reasons by sponsor|17|||
48595462|NCT04877990|156374300|FG001|Treatment|Administrative reasons by sponsor|33|||
48595463|NCT04877990|156374299|FG000|Treatment|Withdrawal by Subject|2|||
48595464|NCT04877990|156374300|FG001|Treatment|Withdrawal by Subject|6|||
48595465|NCT04877990|156374299|FG000|Treatment|Adverse Event|2|||
48595466|NCT04877990|156374300|FG001|Treatment|Adverse Event|1|||
48595467|NCT03746405|156375848|FG000|Overall Study|Withdrawal by Subject|3|||
48595468|NCT03746405|156375849|FG001|Overall Study|Withdrawal by Subject|0|||
48595469|NCT03746405|156375848|FG000|Overall Study|technical difficulties|0|||
48595470|NCT03746405|156375849|FG001|Overall Study|technical difficulties|2|||
48595471|NCT03479008|156375850|FG000|Overall Study|Withdrawal by Subject|3|||
48595472|NCT02781818|156375857|FG000|Overall Study|Lost to Follow-up|4|||
48595473|NCT02781818|156375858|FG001|Overall Study|Lost to Follow-up|2|||
48595474|NCT02781818|156375859|FG002|Overall Study|Lost to Follow-up|1|||
48595475|NCT02609386|156375864|FG000|Overall Study|Withdrawal by Subject|6|||
48595476|NCT02609386|156375865|FG001|Overall Study|Withdrawal by Subject|1|||
48595477|NCT02609386|156375864|FG000|Overall Study|Lost to Follow-up|3|||
48595478|NCT02609386|156375865|FG001|Overall Study|Lost to Follow-up|5|||
48595479|NCT02609386|156375864|FG000|Overall Study|Death|19|||
48595480|NCT02609386|156375865|FG001|Overall Study|Death|9|||
48595481|NCT02609386|156375864|FG000|Overall Study|Physician Decision|0|||
48595482|NCT02609386|156375865|FG001|Overall Study|Physician Decision|2|||
48595483|NCT02465437|156375866|FG000|Overall Study|Physician Decision|0|||
48595484|NCT02465437|156375867|FG001|Overall Study|Physician Decision|0|||
48595485|NCT02465437|156375868|FG002|Overall Study|Physician Decision|1|||
48595486|NCT02465437|156375869|FG003|Overall Study|Physician Decision|0|||
48595487|NCT02465437|156375866|FG000|Overall Study|Withdrawal by Subject|1|||
48702852|NCT04323124|156760783|FG012|Overall Study|Adverse Event|0|||
48702853|NCT04323124|156760784|FG013|Overall Study|Adverse Event|0|||
48702854|NCT04323124|156760785|FG014|Overall Study|Adverse Event|0|||
48702855|NCT04323124|156760771|FG000|Overall Study|Other|0|||
48702856|NCT04323124|156760772|FG001|Overall Study|Other|0|||
48702857|NCT04323124|156760773|FG002|Overall Study|Other|0|||
48702858|NCT04323124|156760774|FG003|Overall Study|Other|0|||
48702859|NCT04323124|156760775|FG004|Overall Study|Other|1|||
48702860|NCT04323124|156760776|FG005|Overall Study|Other|0|||
48595488|NCT02465437|156375867|FG001|Overall Study|Withdrawal by Subject|0|||
48595489|NCT02465437|156375868|FG002|Overall Study|Withdrawal by Subject|0|||
48595490|NCT02465437|156375869|FG003|Overall Study|Withdrawal by Subject|1|||
48595491|NCT02465437|156375866|FG000|Overall Study|Adverse Event|0|||
48595492|NCT02465437|156375867|FG001|Overall Study|Adverse Event|1|||
48702861|NCT04323124|156760777|FG006|Overall Study|Other|0|||
48595493|NCT02465437|156375868|FG002|Overall Study|Adverse Event|0|||
48595494|NCT02465437|156375869|FG003|Overall Study|Adverse Event|0|||
48702862|NCT04323124|156760778|FG007|Overall Study|Other|0|||
48702863|NCT04323124|156760779|FG008|Overall Study|Other|1|||
48702864|NCT04323124|156760780|FG009|Overall Study|Other|0|||
48702865|NCT04323124|156760781|FG010|Overall Study|Other|0|||
48595495|NCT01979523|156375873|FG000|Overall Study|Withdrawal by Subject|1|||
48595496|NCT01979523|156375874|FG001|Overall Study|Withdrawal by Subject|0|||
48595497|NCT01535443|156375876|FG000|Overall Study|Physician Decision|3|||
48595498|NCT05359952|156375879|FG000|Overall Study|Lost to Follow-up|1|||
48595499|NCT05359952|156375880|FG001|Overall Study|Lost to Follow-up|0|||
48595500|NCT02258659|156375881|FG000|Overall Study|Withdrawal by Subject|1|||
48595501|NCT00705341|156375885|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
48595502|NCT00705341|156375886|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
48595503|NCT00705341|156375887|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
48702866|NCT04323124|156760782|FG011|Overall Study|Other|0|||
48702867|NCT04323124|156760783|FG012|Overall Study|Other|0|||
48702868|NCT04323124|156760784|FG013|Overall Study|Other|0|||
48702869|NCT04323124|156760785|FG014|Overall Study|Other|0|||
48702870|NCT04323124|156760771|FG000|Overall Study|Coming from a red zone (COVID)|0|||
48702871|NCT04323124|156760772|FG001|Overall Study|Coming from a red zone (COVID)|0|||
48702872|NCT04323124|156760773|FG002|Overall Study|Coming from a red zone (COVID)|0|||
48702873|NCT04323124|156760774|FG003|Overall Study|Coming from a red zone (COVID)|0|||
48702874|NCT04323124|156760775|FG004|Overall Study|Coming from a red zone (COVID)|1|||
48702875|NCT04323124|156760776|FG005|Overall Study|Coming from a red zone (COVID)|1|||
48702876|NCT04323124|156760777|FG006|Overall Study|Coming from a red zone (COVID)|0|||
48702877|NCT04323124|156760778|FG007|Overall Study|Coming from a red zone (COVID)|0|||
48702878|NCT04323124|156760779|FG008|Overall Study|Coming from a red zone (COVID)|0|||
48702879|NCT04323124|156760780|FG009|Overall Study|Coming from a red zone (COVID)|0|||
48702880|NCT04323124|156760781|FG010|Overall Study|Coming from a red zone (COVID)|0|||
48702881|NCT04323124|156760782|FG011|Overall Study|Coming from a red zone (COVID)|0|||
48702882|NCT04323124|156760783|FG012|Overall Study|Coming from a red zone (COVID)|0|||
48702883|NCT04323124|156760784|FG013|Overall Study|Coming from a red zone (COVID)|0|||
48702884|NCT04323124|156760785|FG014|Overall Study|Coming from a red zone (COVID)|0|||
48702885|NCT04323124|156760771|FG000|Overall Study|No longer meets eligibility criteria|0|||
48702886|NCT04323124|156760772|FG001|Overall Study|No longer meets eligibility criteria|0|||
48702887|NCT04323124|156760773|FG002|Overall Study|No longer meets eligibility criteria|0|||
48702888|NCT04323124|156760774|FG003|Overall Study|No longer meets eligibility criteria|0|||
48702889|NCT04323124|156760775|FG004|Overall Study|No longer meets eligibility criteria|0|||
48702890|NCT04323124|156760776|FG005|Overall Study|No longer meets eligibility criteria|0|||
48702891|NCT04323124|156760777|FG006|Overall Study|No longer meets eligibility criteria|0|||
48702892|NCT04323124|156760778|FG007|Overall Study|No longer meets eligibility criteria|1|||
48702893|NCT04323124|156760779|FG008|Overall Study|No longer meets eligibility criteria|0|||
48702894|NCT04323124|156760780|FG009|Overall Study|No longer meets eligibility criteria|0|||
48702895|NCT04323124|156760781|FG010|Overall Study|No longer meets eligibility criteria|0|||
48702896|NCT04323124|156760782|FG011|Overall Study|No longer meets eligibility criteria|0|||
48702897|NCT04323124|156760783|FG012|Overall Study|No longer meets eligibility criteria|0|||
48702898|NCT04323124|156760784|FG013|Overall Study|No longer meets eligibility criteria|1|||
48702899|NCT04323124|156760785|FG014|Overall Study|No longer meets eligibility criteria|1|||
48702900|NCT04323124|156760771|FG000|Overall Study|Study terminated by sponsor|0|||
48702901|NCT04323124|156760772|FG001|Overall Study|Study terminated by sponsor|0|||
48702902|NCT04323124|156760773|FG002|Overall Study|Study terminated by sponsor|0|||
48702903|NCT04323124|156760774|FG003|Overall Study|Study terminated by sponsor|0|||
48702904|NCT04323124|156760775|FG004|Overall Study|Study terminated by sponsor|0|||
48702905|NCT04323124|156760776|FG005|Overall Study|Study terminated by sponsor|0|||
48702906|NCT04323124|156760777|FG006|Overall Study|Study terminated by sponsor|0|||
48702907|NCT04323124|156760778|FG007|Overall Study|Study terminated by sponsor|0|||
48702908|NCT04323124|156760779|FG008|Overall Study|Study terminated by sponsor|0|||
48702909|NCT04323124|156760780|FG009|Overall Study|Study terminated by sponsor|0|||
48702910|NCT04323124|156760781|FG010|Overall Study|Study terminated by sponsor|0|||
48702911|NCT04323124|156760782|FG011|Overall Study|Study terminated by sponsor|2|||
48702912|NCT04323124|156760783|FG012|Overall Study|Study terminated by sponsor|1|||
48702913|NCT04323124|156760784|FG013|Overall Study|Study terminated by sponsor|0|||
48702914|NCT04323124|156760785|FG014|Overall Study|Study terminated by sponsor|0|||
48702915|NCT00905164|156760786|FG000|Period 1|Protocol Violation|0|||
48702916|NCT00905164|156760787|FG001|Period 1|Protocol Violation|1|||
48702917|NCT03525678|156760788|FG000|Overall Study|Withdrawal by Subject|8|||
48702918|NCT03525678|156760789|FG001|Overall Study|Withdrawal by Subject|2|||
48702919|NCT03525678|156760790|FG002|Overall Study|Withdrawal by Subject|2|||
48702920|NCT03525678|156760788|FG000|Overall Study|Physician Decision|2|||
48702921|NCT03525678|156760789|FG001|Overall Study|Physician Decision|4|||
48702922|NCT03525678|156760790|FG002|Overall Study|Physician Decision|0|||
48702923|NCT03525678|156760788|FG000|Overall Study|Lost to Follow-up|2|||
48702924|NCT03525678|156760789|FG001|Overall Study|Lost to Follow-up|1|||
48702925|NCT03525678|156760790|FG002|Overall Study|Lost to Follow-up|2|||
48702926|NCT03525678|156760788|FG000|Overall Study|Death|70|||
48702927|NCT03525678|156760789|FG001|Overall Study|Death|80|||
48702928|NCT03525678|156760790|FG002|Overall Study|Death|16|||
48702929|NCT03525678|156760788|FG000|Overall Study|other reasons|14|||
48489950|NCT01078623|155988842|FG016|Treatment Period 1|Adverse Event|0|||
48489951|NCT01078623|155988843|FG017|Treatment Period 1|Adverse Event|0|||
48489952|NCT01078623|155988844|FG018|Treatment Period 1|Adverse Event|0|||
48702930|NCT03525678|156760789|FG001|Overall Study|other reasons|10|||
48702931|NCT03525678|156760790|FG002|Overall Study|other reasons|5|||
48702932|NCT03525678|156760788|FG000|Overall Study|ongoing at the time of analysis|1|||
48702933|NCT03525678|156760789|FG001|Overall Study|ongoing at the time of analysis|2|||
48702934|NCT03525678|156760790|FG002|Overall Study|ongoing at the time of analysis|0|||
48702935|NCT02081677|156762809|FG000|Overall Study|Adverse Event|0|||
48702936|NCT02081677|156762810|FG001|Overall Study|Adverse Event|0|||
48489953|NCT01078623|155988845|FG019|Treatment Period 1|Adverse Event|0|||
48702937|NCT02081677|156762811|FG002|Overall Study|Adverse Event|1|||
48702938|NCT02081677|156762812|FG003|Overall Study|Adverse Event|0|||
48702939|NCT02081677|156762809|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48702940|NCT02081677|156762810|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48702941|NCT02081677|156762811|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
48702942|NCT02081677|156762812|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48702943|NCT02081677|156762809|FG000|Overall Study|Not comfortable with lens care system|1|||
48702944|NCT02081677|156762810|FG001|Overall Study|Not comfortable with lens care system|0|||
48702945|NCT02081677|156762811|FG002|Overall Study|Not comfortable with lens care system|0|||
48702946|NCT02081677|156762812|FG003|Overall Study|Not comfortable with lens care system|0|||
48702947|NCT02081677|156762809|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
48702948|NCT02081677|156762810|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
48702949|NCT02081677|156762811|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
48702950|NCT02081677|156762812|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
48702951|NCT00091949|156762822|FG000|Overall Study|Withdrawal by Subject|117|||
48702952|NCT00091949|156762823|FG001|Overall Study|Withdrawal by Subject|110|||
48702953|NCT00091949|156762822|FG000|Overall Study|Lost to Follow-up|58|||
48702954|NCT00091949|156762823|FG001|Overall Study|Lost to Follow-up|41|||
48702955|NCT01520506|156762824|FG000|Overall Study|Missed Visit|4|||
48702956|NCT01520506|156762824|FG000|Overall Study|Lost to Follow-up|1|||
48702957|NCT01520506|156762824|FG000|Overall Study|Withdrawal by Subject|1|||
48702958|NCT04226742|156762833|FG000|Overall Study|Lost to Follow-up|16|||
48702959|NCT04226742|156762834|FG001|Overall Study|Lost to Follow-up|13|||
48702960|NCT04226742|156762833|FG000|Overall Study|Withdrawal by Subject|5|||
48702961|NCT04226742|156762834|FG001|Overall Study|Withdrawal by Subject|3|||
48702962|NCT01774721|156762835|FG000|Overall Study|Death|133|||
48702963|NCT01774721|156762836|FG001|Overall Study|Death|152|||
48702964|NCT01774721|156762835|FG000|Overall Study|Withdrawal by Subject|20|||
48702965|NCT01774721|156762836|FG001|Overall Study|Withdrawal by Subject|14|||
48702966|NCT01774721|156762835|FG000|Overall Study|Lost to Follow-up|6|||
48702967|NCT01774721|156762836|FG001|Overall Study|Lost to Follow-up|7|||
48702968|NCT01774721|156762835|FG000|Overall Study|Did not meet eligibility criteria|0|||
48702969|NCT01774721|156762836|FG001|Overall Study|Did not meet eligibility criteria|3|||
48702970|NCT01774721|156762835|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
48702971|NCT01774721|156762836|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
48702972|NCT01774721|156762835|FG000|Overall Study|Study terminated by sponsor|5|||
48702973|NCT01774721|156762836|FG001|Overall Study|Study terminated by sponsor|0|||
48702974|NCT01774721|156762835|FG000|Overall Study|Disease progression|5|||
48702975|NCT01774721|156762836|FG001|Overall Study|Disease progression|0|||
48702976|NCT01112917|156762838|FG000|Overall Study|Death|2|||
48702977|NCT01112917|156762839|FG001|Overall Study|Death|11|||
48702978|NCT01112917|156762838|FG000|Overall Study|Lost to Follow-up|1|||
48595504|NCT00705341|156375888|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
48595505|NCT00705341|156375885|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
48595506|NCT00705341|156375886|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
48595507|NCT00705341|156375887|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
48702979|NCT01112917|156762839|FG001|Overall Study|Lost to Follow-up|1|||
48702980|NCT01112917|156762838|FG000|Overall Study|Withdrawal by Subject|1|||
48702981|NCT01112917|156762839|FG001|Overall Study|Withdrawal by Subject|3|||
48702982|NCT01112917|156762838|FG000|Overall Study|Unable to Convert Filter|3|||
48595508|NCT00705341|156375888|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
48595509|NCT01720524|156375899|FG000|Part A|Insufficient Clinical Response|2|||
48595510|NCT01720524|156375900|FG001|Part A|Insufficient Clinical Response|4|||
48595511|NCT01720524|156375899|FG000|Part A|Adverse Event|2|||
48595512|NCT01720524|156375900|FG001|Part A|Adverse Event|2|||
48595513|NCT01720524|156375899|FG000|Part A|Death|2|||
48595514|NCT01720524|156375900|FG001|Part A|Death|1|||
48595515|NCT01720524|156375899|FG000|Part A|Lost to Follow-up|0|||
48702983|NCT01112917|156762839|FG001|Overall Study|Unable to Convert Filter|0|||
48702984|NCT05101122|156762840|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
48702985|NCT05101122|156762840|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
48702986|NCT05101122|156762840|FG000|AD313 80/5|Withdrawal by Subject|1|||
48702987|NCT05101122|156762840|FG000|AD313 80/10|Physician Decision|1|||
48702988|NCT03131219|156762841|FG000|Initial Evaluation Period|Adverse Event|2|||
48702989|NCT03131219|156762842|FG001|Initial Evaluation Period|Adverse Event|0|||
48702990|NCT03131219|156762841|FG000|Initial Evaluation Period|Protocol Violation|1|||
48702991|NCT03131219|156762842|FG001|Initial Evaluation Period|Protocol Violation|0|||
48702992|NCT03131219|156762841|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
48702993|NCT03131219|156762842|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
48702994|NCT03131219|156762841|FG000|Initial Evaluation Period|Physician Decision|1|||
48702995|NCT03131219|156762842|FG001|Initial Evaluation Period|Physician Decision|0|||
48595516|NCT01720524|156375900|FG001|Part A|Lost to Follow-up|1|||
48595517|NCT01720524|156375899|FG000|Part A|Missed 28 day follow-up visit|1|||
48595518|NCT01720524|156375900|FG001|Part A|Missed 28 day follow-up visit|1|||
48595519|NCT01720524|156375899|FG000|Part A|Withdrawal by Subject|0|||
48595520|NCT01720524|156375900|FG001|Part A|Withdrawal by Subject|1|||
48595521|NCT01720524|156375899|FG000|Part A|Other|0|||
48595522|NCT01720524|156375900|FG001|Part A|Other|1|||
48702996|NCT03131219|156762841|FG000|Extension Period|Physician Decision|1|||
48595523|NCT01720524|156375899|FG000|Part A|Lost to Follow-up|0|||
48595524|NCT01720524|156375900|FG001|Part A|Lost to Follow-up|1|||
48595525|NCT01720524|156375899|FG000|Part B|No longer willing to participate in study|1|||
48595526|NCT01720524|156375900|FG001|Part B|No longer willing to participate in study|4|||
48702997|NCT03131219|156762842|FG001|Extension Period|Physician Decision|0|||
48702998|NCT03938259|156762845|FG000|Overall Study|unable to establish baseline for ventilation|1|||
48702999|NCT03938259|156762846|FG001|Overall Study|unable to establish baseline for ventilation|1|||
48703000|NCT00836693|156762847|FG000|Overall Study|Adverse Event|4|||
48703001|NCT00836693|156762848|FG001|Overall Study|Adverse Event|1|||
48703002|NCT00836693|156762847|FG000|Overall Study|Sponsor Decision|0|||
48703003|NCT00836693|156762848|FG001|Overall Study|Sponsor Decision|1|||
48703004|NCT00836693|156762847|FG000|Overall Study|Physician Decision|2|||
48703005|NCT00836693|156762848|FG001|Overall Study|Physician Decision|0|||
48703006|NCT00836693|156762847|FG000|Overall Study|Withdrawal by Subject|9|||
48703007|NCT00836693|156762848|FG001|Overall Study|Withdrawal by Subject|4|||
48703008|NCT00836693|156762847|FG000|Overall Study|Protocol Violation|1|||
48703009|NCT00836693|156762848|FG001|Overall Study|Protocol Violation|0|||
48703010|NCT00836693|156762847|FG000|Overall Study|Lost to Follow-up|1|||
48703011|NCT00836693|156762848|FG001|Overall Study|Lost to Follow-up|0|||
48703012|NCT02612779|156762849|FG000|Overall Study|Administrative reason by sponsor|4|||
48703013|NCT02612779|156762850|FG001|Overall Study|Administrative reason by sponsor|1|||
48703014|NCT02612779|156762849|FG000|Overall Study|No longer meet study criteria|0|||
48703015|NCT02612779|156762850|FG001|Overall Study|No longer meet study criteria|1|||
48703016|NCT02612779|156762849|FG000|Overall Study|Disease progression|29|||
48703017|NCT02612779|156762850|FG001|Overall Study|Disease progression|2|||
48703018|NCT02612779|156762849|FG000|Overall Study|Study drug toxicity|10|||
48703019|NCT02612779|156762850|FG001|Overall Study|Study drug toxicity|1|||
48703020|NCT02612779|156762849|FG000|Overall Study|Death|1|||
48703021|NCT02612779|156762850|FG001|Overall Study|Death|0|||
48703022|NCT02612779|156762849|FG000|Overall Study|Adverse event unrelated to study drug|5|||
48703023|NCT02612779|156762850|FG001|Overall Study|Adverse event unrelated to study drug|0|||
48703024|NCT02612779|156762849|FG000|Overall Study|Participant withdrew consent|4|||
48703025|NCT02612779|156762850|FG001|Overall Study|Participant withdrew consent|0|||
48703026|NCT02612779|156762849|FG000|Overall Study|Lost to Follow-up|1|||
48703027|NCT02612779|156762850|FG001|Overall Study|Lost to Follow-up|0|||
48703028|NCT02612779|156762849|FG000|Overall Study|Maximum clinical benefit|10|||
48703029|NCT02612779|156762850|FG001|Overall Study|Maximum clinical benefit|1|||
48703030|NCT02612779|156762849|FG000|Overall Study|Other reasons|4|||
48703031|NCT02612779|156762850|FG001|Overall Study|Other reasons|0|||
48703032|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
48703033|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
48703034|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
48703035|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Death|9|||
48703036|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Death|0|||
48703037|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Death|0|||
48703038|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
48703039|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
48703040|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
48703041|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
48703042|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
48703043|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
48703044|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Other|135|||
48703045|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Other|0|||
48703046|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Other|0|||
48703047|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
48703048|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
48703049|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
48703050|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
48595527|NCT01720524|156375899|FG000|Part B|Other|2|||
48703051|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
48703052|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
48703053|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
48703054|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
48703055|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
48703056|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Other|3|||
48703057|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Other|0|||
48595528|NCT01720524|156375900|FG001|Part B|Other|0|||
48595529|NCT01720524|156375899|FG000|Part B|Lost to Follow-up|2|||
48595530|NCT01720524|156375900|FG001|Part B|Lost to Follow-up|3|||
48595531|NCT01720524|156375899|FG000|Part B|Death|0|||
48595532|NCT01720524|156375900|FG001|Part B|Death|2|||
48595533|NCT00158262|156375901|FG000|Overall Study|Lost to Follow-up|1|||
48595534|NCT00158262|156375902|FG001|Overall Study|Lost to Follow-up|1|||
48595535|NCT00593918|156375905|FG000|Overall Study|Withdrawal by Subject|5|||
48595536|NCT00593918|156375906|FG001|Overall Study|Withdrawal by Subject|24|||
48595537|NCT01808261|156375907|FG000|Overall Study|Physician Decision|0|||
48595538|NCT01808261|156375908|FG001|Overall Study|Physician Decision|2|||
48595539|NCT01808261|156375907|FG000|Overall Study|Study Closed/Terminated|25|||
48595540|NCT01808261|156375908|FG001|Overall Study|Study Closed/Terminated|23|||
48595541|NCT01808261|156375907|FG000|Overall Study|Adverse event, non-fatal|2|||
48595542|NCT01808261|156375908|FG001|Overall Study|Adverse event, non-fatal|0|||
48595543|NCT01808261|156375907|FG000|Overall Study|Consent withdrawn by subject|6|||
48595544|NCT01808261|156375908|FG001|Overall Study|Consent withdrawn by subject|7|||
48595545|NCT01808261|156375907|FG000|Overall Study|Lost to Follow-up|3|||
48595546|NCT01808261|156375908|FG001|Overall Study|Lost to Follow-up|1|||
48595547|NCT04676724|156375909|FG000|Overall Study|Adverse Event|2|||
48595548|NCT04676724|156375910|FG001|Overall Study|Adverse Event|0|||
48595549|NCT04676724|156375909|FG000|Overall Study|Lost to Follow-up|1|||
48595550|NCT04676724|156375910|FG001|Overall Study|Lost to Follow-up|0|||
48595551|NCT04676724|156375909|FG000|Overall Study|Physician Decision|0|||
48595552|NCT04676724|156375910|FG001|Overall Study|Physician Decision|1|||
48595553|NCT04676724|156375909|FG000|Overall Study|Withdrawal by Subject|3|||
48595554|NCT04676724|156375910|FG001|Overall Study|Withdrawal by Subject|2|||
48703058|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Other|0|||
48703059|NCT02118584|156762851|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
48703060|NCT02118584|156762852|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
48703061|NCT02118584|156762853|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
48703062|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
48703063|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
48703064|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
48703065|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
48703066|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
48703067|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
48703068|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
48703069|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
48703070|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
48703071|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
48703072|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
48703073|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
48703074|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
48703075|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
48703076|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
48703077|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
48703078|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
48703079|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
48703080|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
48703081|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
48703082|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
48703083|NCT02118584|156762851|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
48703084|NCT02118584|156762852|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
48703085|NCT02118584|156762853|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
48703086|NCT01744977|156762854|FG000|Overall Study|Withdrawal by Subject|1|||
48703087|NCT01744977|156762855|FG001|Overall Study|Withdrawal by Subject|2|||
48703088|NCT01744977|156762854|FG000|Overall Study|Death|2|||
48703089|NCT01744977|156762855|FG001|Overall Study|Death|3|||
48703090|NCT01744977|156762854|FG000|Overall Study|Lost to Follow-up|2|||
48703091|NCT01744977|156762855|FG001|Overall Study|Lost to Follow-up|0|||
48703092|NCT01744977|156762854|FG000|Overall Study|No longer meets inclusion|6|||
48703093|NCT01744977|156762855|FG001|Overall Study|No longer meets inclusion|0|||
48703094|NCT02636595|156762856|FG000|Overall Study|Lost to Follow-up|1|||
48703095|NCT02636595|156762856|FG000|Overall Study|Other|1|||
48703096|NCT02156076|156762857|FG000|Treatment Period|no longer meets study criteria|0|||
48703097|NCT02156076|156762858|FG001|Treatment Period|no longer meets study criteria|0|||
48703098|NCT02156076|156762859|FG002|Treatment Period|no longer meets study criteria|1|||
48703099|NCT02156076|156762860|FG003|Treatment Period|no longer meets study criteria|0|||
48703100|NCT02156076|156762857|FG000|Treatment Period|Poor/non-compliance|0|||
48703101|NCT02156076|156762858|FG001|Treatment Period|Poor/non-compliance|1|||
48703102|NCT02156076|156762859|FG002|Treatment Period|Poor/non-compliance|0|||
48595555|NCT02585713|156375914|FG000|Overall Study|Withdrew prior to treatment|2|||
48595556|NCT02585713|156375915|FG001|Overall Study|Withdrew prior to treatment|7|||
48595557|NCT02585713|156375914|FG000|Overall Study|Other|3|||
48703103|NCT02156076|156762860|FG003|Treatment Period|Poor/non-compliance|0|||
48703104|NCT02156076|156762857|FG000|Treatment Period|Lost to Follow-up|0|||
48703105|NCT02156076|156762858|FG001|Treatment Period|Lost to Follow-up|0|||
48703106|NCT02156076|156762859|FG002|Treatment Period|Lost to Follow-up|0|||
48703107|NCT02156076|156762860|FG003|Treatment Period|Lost to Follow-up|1|||
48703108|NCT02156076|156762857|FG000|Treatment Period|Withdrawal by Subject|0|||
48703109|NCT02156076|156762858|FG001|Treatment Period|Withdrawal by Subject|0|||
48703110|NCT02156076|156762859|FG002|Treatment Period|Withdrawal by Subject|1|||
48703111|NCT02156076|156762860|FG003|Treatment Period|Withdrawal by Subject|0|||
48703112|NCT02156076|156762857|FG000|Treatment Period|Subject request to discontinue treatment|0|||
48703113|NCT02156076|156762858|FG001|Treatment Period|Subject request to discontinue treatment|1|||
48703114|NCT02156076|156762859|FG002|Treatment Period|Subject request to discontinue treatment|0|||
48703115|NCT02156076|156762860|FG003|Treatment Period|Subject request to discontinue treatment|0|||
48703116|NCT02156076|156762857|FG000|Treatment Period|Adverse Event|0|||
48703117|NCT02156076|156762858|FG001|Treatment Period|Adverse Event|0|||
48703118|NCT02156076|156762859|FG002|Treatment Period|Adverse Event|0|||
48703119|NCT02156076|156762860|FG003|Treatment Period|Adverse Event|1|||
48703120|NCT02156076|156762857|FG000|Follow-up Period|Withdrawal by Subject|1|||
48703121|NCT02156076|156762858|FG001|Follow-up Period|Withdrawal by Subject|0|||
48703122|NCT02156076|156762859|FG002|Follow-up Period|Withdrawal by Subject|0|||
48703123|NCT02156076|156762860|FG003|Follow-up Period|Withdrawal by Subject|0|||
48703124|NCT02766023|156762861|FG000|Overall Study|Lost to Follow-up|23|||
48703125|NCT02766023|156762862|FG001|Overall Study|Lost to Follow-up|11|||
48703126|NCT02766023|156762861|FG000|Overall Study|Pregnancy|1|||
48703127|NCT02766023|156762862|FG001|Overall Study|Pregnancy|0|||
48703128|NCT02766023|156762861|FG000|Overall Study|Adverse Event|1|||
48703129|NCT02766023|156762862|FG001|Overall Study|Adverse Event|0|||
48703130|NCT02766023|156762861|FG000|Overall Study|Withdrawal by Subject|4|||
48703131|NCT02766023|156762862|FG001|Overall Study|Withdrawal by Subject|5|||
48703132|NCT02766023|156762861|FG000|Overall Study|Physician Decision|1|||
48703133|NCT02766023|156762862|FG001|Overall Study|Physician Decision|0|||
48703134|NCT02766023|156762861|FG000|Overall Study|Not Eligible at Enrollment|0|||
48703135|NCT02766023|156762862|FG001|Overall Study|Not Eligible at Enrollment|1|||
48703136|NCT02939287|156762867|FG000|Overall Study|met exclusion criteria|1|||
48703137|NCT02939287|156762868|FG001|Overall Study|met exclusion criteria|1|||
48703138|NCT02939287|156762869|FG002|Overall Study|met exclusion criteria|1|||
48703139|NCT02939287|156762867|FG000|Overall Study|Did not complete survey|2|||
48703140|NCT02939287|156762868|FG001|Overall Study|Did not complete survey|2|||
48703141|NCT02939287|156762869|FG002|Overall Study|Did not complete survey|0|||
48703142|NCT02939287|156762867|FG000|Overall Study|Withdrawal by Subject|1|||
48703143|NCT02939287|156762868|FG001|Overall Study|Withdrawal by Subject|1|||
48703144|NCT02939287|156762869|FG002|Overall Study|Withdrawal by Subject|0|||
48703145|NCT04225897|156762870|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703146|NCT04225897|156762871|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
48703147|NCT04225897|156762872|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703148|NCT04225897|156762873|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703149|NCT04225897|156762874|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703150|NCT04225897|156762875|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703151|NCT04225897|156762876|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703152|NCT04225897|156762877|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703153|NCT04225897|156762878|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703154|NCT04225897|156762879|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703155|NCT04225897|156762880|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703156|NCT04225897|156762881|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
48703157|NCT04225897|156762870|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703158|NCT04225897|156762871|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703159|NCT04225897|156762872|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
48703160|NCT04225897|156762873|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703161|NCT04225897|156762874|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703162|NCT04225897|156762875|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703163|NCT04225897|156762876|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703164|NCT04225897|156762877|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703165|NCT04225897|156762878|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703166|NCT04225897|156762879|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703167|NCT04225897|156762880|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703168|NCT04225897|156762881|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
48703169|NCT04225897|156762870|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703170|NCT04225897|156762871|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703171|NCT04225897|156762872|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
48703172|NCT04225897|156762873|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703173|NCT04225897|156762874|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703174|NCT04225897|156762875|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703175|NCT04225897|156762876|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703176|NCT04225897|156762877|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703177|NCT04225897|156762878|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703178|NCT04225897|156762879|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703179|NCT04225897|156762880|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703180|NCT04225897|156762881|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
48703181|NCT04225897|156762870|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703182|NCT04225897|156762871|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703183|NCT04225897|156762872|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703184|NCT04225897|156762873|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703185|NCT04225897|156762874|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703186|NCT04225897|156762875|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703187|NCT04225897|156762876|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703188|NCT04225897|156762877|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
48703189|NCT04225897|156762878|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703190|NCT04225897|156762879|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703191|NCT04225897|156762880|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703192|NCT04225897|156762881|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
48703193|NCT03126591|156762882|FG000|Overall Study|Death|6|||
48703194|NCT03126591|156762883|FG001|Overall Study|Death|3|||
48703195|NCT03126591|156762884|FG002|Overall Study|Death|17|||
48703196|NCT03126591|156762882|FG000|Overall Study|Progressive Disease|0|||
48703197|NCT03126591|156762883|FG001|Overall Study|Progressive Disease|1|||
48703198|NCT03126591|156762884|FG002|Overall Study|Progressive Disease|2|||
48703199|NCT03126591|156762882|FG000|Overall Study|Terminated by Sponsor|0|||
48703200|NCT03126591|156762883|FG001|Overall Study|Terminated by Sponsor|1|||
48703201|NCT03126591|156762884|FG002|Overall Study|Terminated by Sponsor|4|||
48703202|NCT03126591|156762882|FG000|Overall Study|Withdrawal by Subject|1|||
48703203|NCT03126591|156762883|FG001|Overall Study|Withdrawal by Subject|1|||
48703204|NCT03126591|156762884|FG002|Overall Study|Withdrawal by Subject|4|||
48703205|NCT01614886|156762885|FG000|Overall Study|Adverse Event|15|||
48703206|NCT01614886|156762886|FG001|Overall Study|Adverse Event|20|||
48703207|NCT01614886|156762885|FG000|Overall Study|Withdrawal by Subject|4|||
48703208|NCT01614886|156762886|FG001|Overall Study|Withdrawal by Subject|4|||
48703209|NCT01614886|156762885|FG000|Overall Study|Death|1|||
48703210|NCT01614886|156762886|FG001|Overall Study|Death|0|||
48703211|NCT01614886|156762885|FG000|Overall Study|Protocol deviation|0|||
48703212|NCT01614886|156762886|FG001|Overall Study|Protocol deviation|2|||
48703213|NCT02177032|156762889|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
48703214|NCT02177032|156762890|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
48703215|NCT02177032|156762891|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
48703216|NCT02177032|156762892|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
48703217|NCT02177032|156762889|FG000|Overall Study|Lost to Follow-up|0|||
48703218|NCT02177032|156762890|FG001|Overall Study|Lost to Follow-up|2|||
48703219|NCT02177032|156762891|FG002|Overall Study|Lost to Follow-up|0|||
48703220|NCT02177032|156762892|FG003|Overall Study|Lost to Follow-up|0|||
48703221|NCT02177032|156762889|FG000|Overall Study|OTHER|2|||
48703222|NCT02177032|156762890|FG001|Overall Study|OTHER|0|||
48703223|NCT02177032|156762891|FG002|Overall Study|OTHER|1|||
48703224|NCT02177032|156762892|FG003|Overall Study|OTHER|0|||
48703225|NCT02177032|156762889|FG000|Overall Study|Withdrawal by Subject|1|||
48703226|NCT02177032|156762890|FG001|Overall Study|Withdrawal by Subject|0|||
48703227|NCT02177032|156762891|FG002|Overall Study|Withdrawal by Subject|1|||
48703228|NCT02177032|156762892|FG003|Overall Study|Withdrawal by Subject|0|||
48703229|NCT00665652|156762893|FG000|Overall Study|Adverse Event|4|||
48703230|NCT00665652|156762893|FG000|Overall Study|Death|1|||
48703231|NCT00665652|156762893|FG000|Overall Study|No longer met inclusion criteria.|1|||
48703232|NCT03096288|156762894|FG000|Overall Study|Withdrawal by Subject|0|||
48703233|NCT03096288|156762895|FG001|Overall Study|Withdrawal by Subject|1|||
48703234|NCT03096288|156762896|FG002|Overall Study|Withdrawal by Subject|0|||
48703235|NCT03096288|156762897|FG003|Overall Study|Withdrawal by Subject|1|||
48703236|NCT01967940|156762900|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
48703237|NCT01967940|156762901|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
48703238|NCT01967940|156762902|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
48703239|NCT01967940|156762903|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
48703240|NCT01967940|156762900|FG000|Part 2|Adverse Event|0|||
48703241|NCT01967940|156762901|FG001|Part 2|Adverse Event|0|||
48703242|NCT01967940|156762902|FG002|Part 2|Adverse Event|0|||
48703243|NCT01967940|156762903|FG003|Part 2|Adverse Event|1|||
48703244|NCT01967940|156762900|FG000|Part 2|Unknown Reason|0|||
48703245|NCT01967940|156762901|FG001|Part 2|Unknown Reason|0|||
48703246|NCT01967940|156762902|FG002|Part 2|Unknown Reason|0|||
48703247|NCT01967940|156762903|FG003|Part 2|Unknown Reason|1|||
48703248|NCT03944577|156762904|FG000|Overall Study|Adverse Event|3|||
48703249|NCT01654302|156762905|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
48703250|NCT01654302|156762906|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
48703251|NCT01352793|156762907|FG000|Overall Study|Lost to Follow-up|289|||
48595558|NCT02585713|156375915|FG001|Overall Study|Other|1|||
48595559|NCT03311841|156375918|FG000|14-day Wash-out|Adverse Event|0|||
48595560|NCT03311841|156375919|FG001|14-day Wash-out|Adverse Event|1|||
48595561|NCT03311841|156375920|FG002|14-day Wash-out|Adverse Event|0|||
48595562|NCT03311841|156375921|FG003|14-day Wash-out|Adverse Event|0|||
48595563|NCT03311841|156375922|FG004|14-day Wash-out|Adverse Event|0|||
48595564|NCT03311841|156375918|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
48595565|NCT03311841|156375919|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
48595566|NCT03311841|156375920|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
48595567|NCT03311841|156375921|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
48595568|NCT03311841|156375922|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
48595569|NCT00436826|156375923|FG000|Double Blind Period (DBP)|Adverse Event|2|||
48703252|NCT01352793|156762908|FG001|Overall Study|Lost to Follow-up|125|||
48703253|NCT01352793|156762907|FG000|Overall Study|Withdrawal by Subject|120|||
48703254|NCT01352793|156762908|FG001|Overall Study|Withdrawal by Subject|55|||
48703255|NCT01352793|156762907|FG000|Overall Study|Protocol Violation|44|||
48703256|NCT01352793|156762908|FG001|Overall Study|Protocol Violation|23|||
48703257|NCT01352793|156762907|FG000|Overall Study|Adverse Event|44|||
48703258|NCT01352793|156762908|FG001|Overall Study|Adverse Event|10|||
48703259|NCT01352793|156762907|FG000|Overall Study|Physician Decision|1|||
48703260|NCT01352793|156762908|FG001|Overall Study|Physician Decision|0|||
48703261|NCT01352793|156762907|FG000|Overall Study|Pregnancy|26|||
48703262|NCT01352793|156762908|FG001|Overall Study|Pregnancy|8|||
48703263|NCT01352793|156762907|FG000|Overall Study|Other|25|||
48703264|NCT01352793|156762908|FG001|Overall Study|Other|7|||
48703265|NCT01352793|156762907|FG000|Overall Study|Medication error|2|||
48703266|NCT01352793|156762908|FG001|Overall Study|Medication error|2|||
48703267|NCT01352793|156762907|FG000|Overall Study|Death|1|||
48703268|NCT01352793|156762908|FG001|Overall Study|Death|0|||
48703269|NCT01352793|156762907|FG000|Overall Study|Randomized but not vaccinated|8|||
48703270|NCT01352793|156762908|FG001|Overall Study|Randomized but not vaccinated|0|||
48703271|NCT01352793|156762907|FG000|Overall Study|No longer meets eligibility criteria|25|||
48703272|NCT01352793|156762908|FG001|Overall Study|No longer meets eligibility criteria|15|||
48703273|NCT04476797|156762912|FG000|Overall Study|Withdrawal by Subject|1|||
48703274|NCT04476797|156762913|FG001|Overall Study|Withdrawal by Subject|0|||
48703275|NCT04476797|156762914|FG002|Overall Study|Withdrawal by Subject|0|||
48703276|NCT04476797|156762912|FG000|Overall Study|Death|0|||
48703277|NCT04476797|156762913|FG001|Overall Study|Death|1|||
48595570|NCT00436826|156375924|FG001|Double Blind Period (DBP)|Adverse Event|0|||
48595571|NCT00436826|156375925|FG002|Double Blind Period (DBP)|Adverse Event|0|||
48595572|NCT00436826|156375926|FG003|Double Blind Period (DBP)|Adverse Event|0|||
48595573|NCT00436826|156375927|FG004|Double Blind Period (DBP)|Adverse Event|0|||
48595574|NCT00436826|156375928|FG005|Double Blind Period (DBP)|Adverse Event|0|||
48595575|NCT00436826|156375923|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
48595576|NCT00436826|156375924|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
48595577|NCT00436826|156375925|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
48595578|NCT00436826|156375926|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
48595579|NCT00436826|156375927|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
48595580|NCT00436826|156375928|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
48703278|NCT04476797|156762914|FG002|Overall Study|Death|2|||
48703279|NCT04476797|156762912|FG000|Overall Study|Sponsor Terminated Study|0|||
48703280|NCT04476797|156762913|FG001|Overall Study|Sponsor Terminated Study|18|||
48703281|NCT04476797|156762914|FG002|Overall Study|Sponsor Terminated Study|17|||
48703282|NCT01716234|156762915|FG000|Overall Study|Protocol Violation|0|||
48703283|NCT01716234|156762916|FG001|Overall Study|Protocol Violation|0|||
48703284|NCT01716234|156762917|FG002|Overall Study|Protocol Violation|0|||
48703285|NCT01716234|156762918|FG003|Overall Study|Protocol Violation|1|||
48703286|NCT01716234|156762919|FG004|Overall Study|Protocol Violation|1|||
48703287|NCT01716234|156762920|FG005|Overall Study|Protocol Violation|1|||
48703288|NCT01716234|156762921|FG006|Overall Study|Protocol Violation|0|||
48595581|NCT00436826|156375923|FG000|Double Blind Period (DBP)|Other|10|||
48595582|NCT00436826|156375924|FG001|Double Blind Period (DBP)|Other|11|||
48595583|NCT00436826|156375925|FG002|Double Blind Period (DBP)|Other|0|||
48595584|NCT00436826|156375926|FG003|Double Blind Period (DBP)|Other|0|||
48703289|NCT01716234|156762915|FG000|Overall Study|Lack of Efficacy|0|||
48703290|NCT01716234|156762916|FG001|Overall Study|Lack of Efficacy|0|||
48703291|NCT01716234|156762917|FG002|Overall Study|Lack of Efficacy|0|||
48703292|NCT01716234|156762918|FG003|Overall Study|Lack of Efficacy|1|||
48703293|NCT01716234|156762919|FG004|Overall Study|Lack of Efficacy|0|||
48595585|NCT00436826|156375927|FG004|Double Blind Period (DBP)|Other|0|||
48595586|NCT00436826|156375928|FG005|Double Blind Period (DBP)|Other|0|||
48595587|NCT00436826|156375923|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
48595588|NCT00436826|156375924|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
48595589|NCT00436826|156375925|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
48595590|NCT00436826|156375926|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
48595591|NCT00436826|156375927|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
48595592|NCT00436826|156375928|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
48595593|NCT00436826|156375923|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
48595594|NCT00436826|156375924|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
48595595|NCT00436826|156375925|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
48595596|NCT00436826|156375926|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
48595597|NCT00436826|156375927|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
48595598|NCT00436826|156375928|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
48595599|NCT00436826|156375923|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
48595600|NCT00436826|156375924|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
48595601|NCT00436826|156375925|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
48595602|NCT00436826|156375926|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
48595603|NCT00436826|156375927|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
48595604|NCT00436826|156375928|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
48595605|NCT04004260|156375929|FG000|Overall Study|Withdrawal by Subject|7|||
48595606|NCT04004260|156375930|FG001|Overall Study|Withdrawal by Subject|3|||
48595607|NCT04004260|156375929|FG000|Overall Study|Lost to Follow-up|22|||
48595608|NCT04004260|156375930|FG001|Overall Study|Lost to Follow-up|12|||
48595609|NCT04004260|156375929|FG000|Overall Study|Did not engage in intervention|13|||
48595610|NCT04004260|156375930|FG001|Overall Study|Did not engage in intervention|17|||
48595611|NCT05464420|156375934|FG000|Overall Study|Death|0|||
48595612|NCT05464420|156375935|FG001|Overall Study|Death|0|||
48595613|NCT05464420|156375936|FG002|Overall Study|Death|0|||
48595614|NCT05464420|156375937|FG003|Overall Study|Death|1|||
48595615|NCT05464420|156375934|FG000|Overall Study|Lost to Follow-up|16|||
48595616|NCT05464420|156375935|FG001|Overall Study|Lost to Follow-up|11|||
48595617|NCT05464420|156375936|FG002|Overall Study|Lost to Follow-up|11|||
48595618|NCT05464420|156375937|FG003|Overall Study|Lost to Follow-up|11|||
48595619|NCT05464420|156375934|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
48595620|NCT05464420|156375935|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
48595621|NCT05464420|156375936|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
48595622|NCT05464420|156375937|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
48595623|NCT05464420|156375934|FG000|Overall Study|Withdrawal by Subject|4|||
48595624|NCT05464420|156375935|FG001|Overall Study|Withdrawal by Subject|8|||
48595625|NCT05464420|156375936|FG002|Overall Study|Withdrawal by Subject|3|||
48595626|NCT05464420|156375937|FG003|Overall Study|Withdrawal by Subject|1|||
48595627|NCT05464420|156375934|FG000|Overall Study|Protocol Violation|0|||
48595628|NCT05464420|156375935|FG001|Overall Study|Protocol Violation|0|||
48595629|NCT05464420|156375936|FG002|Overall Study|Protocol Violation|1|||
48595630|NCT05464420|156375937|FG003|Overall Study|Protocol Violation|1|||
48595631|NCT05464420|156375934|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
48595632|NCT05464420|156375935|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
48595633|NCT05464420|156375936|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
48703294|NCT01716234|156762920|FG005|Overall Study|Lack of Efficacy|0|||
48703295|NCT01716234|156762921|FG006|Overall Study|Lack of Efficacy|0|||
48703296|NCT01716234|156762915|FG000|Overall Study|Did not meet protocol eligibility|0|||
48703297|NCT01716234|156762916|FG001|Overall Study|Did not meet protocol eligibility|0|||
48703298|NCT01716234|156762917|FG002|Overall Study|Did not meet protocol eligibility|1|||
48703299|NCT01716234|156762918|FG003|Overall Study|Did not meet protocol eligibility|0|||
48595634|NCT05464420|156375937|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
48595635|NCT02360280|156375938|FG000|Overall Study|Withdrawal by Subject|2|||
48595636|NCT02360280|156375939|FG001|Overall Study|Withdrawal by Subject|0|||
48595637|NCT02360280|156375938|FG000|Overall Study|Adverse Event|0|||
48595638|NCT02360280|156375939|FG001|Overall Study|Adverse Event|1|||
48595639|NCT02360280|156375938|FG000|Overall Study|Lost to Follow-up|1|||
48595640|NCT02360280|156375939|FG001|Overall Study|Lost to Follow-up|0|||
48595641|NCT01497067|156375940|FG000|Overall Study|Lost to Follow-up|56|||
48703300|NCT01716234|156762919|FG004|Overall Study|Did not meet protocol eligibility|0|||
48595642|NCT01497067|156375940|FG000|Overall Study|Adverse Event|3|||
48703301|NCT01716234|156762920|FG005|Overall Study|Did not meet protocol eligibility|4|||
48703302|NCT01716234|156762921|FG006|Overall Study|Did not meet protocol eligibility|0|||
48703303|NCT01716234|156762915|FG000|Overall Study|Adverse Event|7|||
48703304|NCT01716234|156762916|FG001|Overall Study|Adverse Event|10|||
48703305|NCT01716234|156762917|FG002|Overall Study|Adverse Event|2|||
48703306|NCT01716234|156762918|FG003|Overall Study|Adverse Event|8|||
48703307|NCT01716234|156762919|FG004|Overall Study|Adverse Event|3|||
48703308|NCT01716234|156762920|FG005|Overall Study|Adverse Event|6|||
48703309|NCT01716234|156762921|FG006|Overall Study|Adverse Event|0|||
48703310|NCT01716234|156762915|FG000|Overall Study|Withdrawal by Subject|3|||
48703311|NCT01716234|156762916|FG001|Overall Study|Withdrawal by Subject|0|||
48703312|NCT01716234|156762917|FG002|Overall Study|Withdrawal by Subject|2|||
48703313|NCT01716234|156762918|FG003|Overall Study|Withdrawal by Subject|2|||
48703314|NCT01716234|156762919|FG004|Overall Study|Withdrawal by Subject|1|||
48703315|NCT01716234|156762920|FG005|Overall Study|Withdrawal by Subject|3|||
48703316|NCT01716234|156762921|FG006|Overall Study|Withdrawal by Subject|0|||
48703317|NCT02059278|156762922|FG000|Overall Study|Adverse Event|1|||
48703318|NCT02059278|156762923|FG001|Overall Study|Adverse Event|1|||
48703319|NCT02059278|156762922|FG000|Overall Study|Lost to Follow-up|1|||
48703320|NCT02059278|156762923|FG001|Overall Study|Lost to Follow-up|0|||
48703321|NCT02059278|156762922|FG000|Overall Study|Withdrawal by Subject|0|||
48703322|NCT02059278|156762923|FG001|Overall Study|Withdrawal by Subject|3|||
48703323|NCT02059278|156762922|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
48703324|NCT02059278|156762923|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
48703325|NCT01488890|156762924|FG000|Overall Study|Serious adverse event|2|||
48703326|NCT01488890|156762925|FG001|Overall Study|Serious adverse event|0|||
48703327|NCT01488890|156762926|FG002|Overall Study|Serious adverse event|0|||
48703328|NCT01488890|156762927|FG003|Overall Study|Serious adverse event|0|||
48703329|NCT01488890|156762924|FG000|Overall Study|Protocol Violation|3|||
48703330|NCT01488890|156762925|FG001|Overall Study|Protocol Violation|0|||
48703331|NCT01488890|156762926|FG002|Overall Study|Protocol Violation|4|||
48703332|NCT01488890|156762927|FG003|Overall Study|Protocol Violation|0|||
48703333|NCT01488890|156762924|FG000|Overall Study|Lost to Follow-up|13|||
48703334|NCT01488890|156762925|FG001|Overall Study|Lost to Follow-up|10|||
48703335|NCT01488890|156762926|FG002|Overall Study|Lost to Follow-up|20|||
48703336|NCT01488890|156762927|FG003|Overall Study|Lost to Follow-up|3|||
48703337|NCT01488890|156762924|FG000|Overall Study|Withdrawal by Subject|14|||
48703338|NCT01488890|156762925|FG001|Overall Study|Withdrawal by Subject|10|||
48703339|NCT01488890|156762926|FG002|Overall Study|Withdrawal by Subject|11|||
48703340|NCT01488890|156762927|FG003|Overall Study|Withdrawal by Subject|2|||
48703341|NCT03848728|156762928|FG000|Overall Study|Death|16|||
48703342|NCT03848728|156762929|FG001|Overall Study|Death|13|||
48703343|NCT03848728|156762928|FG000|Overall Study|Outmigrated to non-study community|98|||
48703344|NCT03848728|156762929|FG001|Overall Study|Outmigrated to non-study community|106|||
48703345|NCT03848728|156762928|FG000|Overall Study|Transfered to non-study clinic|32|||
48703346|NCT03848728|156762929|FG001|Overall Study|Transfered to non-study clinic|48|||
48703347|NCT03848728|156762928|FG000|Overall Study|Withdrawal by Subject|1|||
48703348|NCT03848728|156762929|FG001|Overall Study|Withdrawal by Subject|0|||
48703349|NCT05135767|156762930|FG000|Baseline|Lost to Follow-up|1|||
48703350|NCT05135767|156762931|FG001|Baseline|Lost to Follow-up|1|||
48703351|NCT05135767|156762930|FG000|Baseline|Withdrawal by Subject|0|||
48703352|NCT05135767|156762931|FG001|Baseline|Withdrawal by Subject|2|||
48703353|NCT05135767|156762930|FG000|Active Study Phase|Lost to Follow-up|2|||
48703354|NCT05135767|156762931|FG001|Active Study Phase|Lost to Follow-up|0|||
48703355|NCT04498832|156762932|FG000|Overall Study|Adverse Event|1|||
48703356|NCT04498832|156762933|FG001|Overall Study|Adverse Event|3|||
48703357|NCT04498832|156762932|FG000|Overall Study|Withdrawal by Subject|0|||
48703358|NCT04498832|156762933|FG001|Overall Study|Withdrawal by Subject|1|||
48703359|NCT02581410|156762936|FG000|Vaccination Phase|Adverse Event|2|||
48703360|NCT02581410|156762937|FG001|Vaccination Phase|Adverse Event|1|||
48703361|NCT02581410|156762936|FG000|Vaccination Phase|Withdrawal by Subject|0|||
48703362|NCT02581410|156762937|FG001|Vaccination Phase|Withdrawal by Subject|1|||
48703363|NCT02581410|156762936|FG000|Vaccination Phase|Migrated/moved from study area|0|||
48703364|NCT02581410|156762937|FG001|Vaccination Phase|Migrated/moved from study area|1|||
48703365|NCT02581410|156762936|FG000|End of Study Phase|Adverse Event|4|||
48703366|NCT02581410|156762937|FG001|End of Study Phase|Adverse Event|3|||
48703367|NCT02581410|156762936|FG000|End of Study Phase|Withdrawal by Subject|1|||
48703368|NCT02581410|156762937|FG001|End of Study Phase|Withdrawal by Subject|2|||
48703369|NCT02581410|156762936|FG000|End of Study Phase|Migrated/moved from study area|0|||
48703370|NCT02581410|156762937|FG001|End of Study Phase|Migrated/moved from study area|3|||
48703371|NCT02581410|156762936|FG000|End of Study Phase|Lost to Follow-up|0|||
48703372|NCT02581410|156762937|FG001|End of Study Phase|Lost to Follow-up|2|||
48703373|NCT02581410|156762936|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
48703374|NCT02581410|156762937|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
48703375|NCT01063751|156762939|FG000|Overall Study|Site terminated|45|||
48703376|NCT01063751|156762939|FG000|Overall Study|Lost to Follow-up|28|||
48703377|NCT01063751|156762939|FG000|Overall Study|Withdrawal by Subject|25|||
48703378|NCT01063751|156762939|FG000|Overall Study|Revision|6|||
48703379|NCT01063751|156762939|FG000|Overall Study|Death|12|||
48703380|NCT01063751|156762939|FG000|Overall Study|Physician Decision|4|||
48703381|NCT01063751|156762939|FG000|Overall Study|Active|91|||
48703382|NCT03863080|156762940|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
48703383|NCT03863080|156762941|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
48703384|NCT03863080|156762942|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
48703385|NCT03863080|156762943|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
48703386|NCT03863080|156762940|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
48703387|NCT03863080|156762941|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
48703388|NCT03863080|156762942|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
48703389|NCT03863080|156762943|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
48703390|NCT03863080|156762940|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
48703391|NCT03863080|156762941|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
48703392|NCT03863080|156762942|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
48703393|NCT03863080|156762943|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
48703394|NCT04081103|156762946|FG000|Overall Study|Adverse Event|1|||
48703395|NCT04081103|156762947|FG001|Overall Study|Adverse Event|1|||
48703396|NCT04081103|156762948|FG002|Overall Study|Adverse Event|1|||
48703397|NCT04081103|156762946|FG000|Overall Study|Physician Decision|0|||
48703398|NCT04081103|156762947|FG001|Overall Study|Physician Decision|0|||
48703399|NCT04081103|156762948|FG002|Overall Study|Physician Decision|1|||
48703400|NCT03173248|156762949|FG000|Overall Study|Death|28|||
48703401|NCT03173248|156762950|FG001|Overall Study|Death|46|||
48703402|NCT03173248|156762949|FG000|Overall Study|Lost to Follow-up|0|||
48703403|NCT03173248|156762950|FG001|Overall Study|Lost to Follow-up|1|||
48703404|NCT03173248|156762949|FG000|Overall Study|Withdrawal by Subject|6|||
48703405|NCT03173248|156762950|FG001|Overall Study|Withdrawal by Subject|4|||
48703406|NCT03173248|156762949|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
48703407|NCT03173248|156762950|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
48703408|NCT04163016|156762962|FG000|Enrollment|Adverse Event|1|||
48703409|NCT04163016|156762963|FG001|Enrollment|Adverse Event|0|||
48703410|NCT04163016|156762964|FG002|Enrollment|Adverse Event|0|||
48703411|NCT04163016|156762965|FG003|Enrollment|Adverse Event|0|||
48703412|NCT04163016|156762962|FG000|Treatment|Adverse Event|0|||
48703413|NCT04163016|156762963|FG001|Treatment|Adverse Event|1|||
48703414|NCT04163016|156762964|FG002|Treatment|Adverse Event|0|||
48703415|NCT04163016|156762965|FG003|Treatment|Adverse Event|0|||
48703416|NCT04163016|156762962|FG000|Treatment|Withdrawal by Subject|0|||
48703417|NCT04163016|156762963|FG001|Treatment|Withdrawal by Subject|2|||
48703418|NCT04163016|156762964|FG002|Treatment|Withdrawal by Subject|0|||
48703419|NCT04163016|156762965|FG003|Treatment|Withdrawal by Subject|0|||
48703420|NCT04163016|156762962|FG000|Treatment|Indeterminate TB-test|0|||
48703421|NCT04163016|156762963|FG001|Treatment|Indeterminate TB-test|0|||
48703422|NCT04163016|156762964|FG002|Treatment|Indeterminate TB-test|0|||
48703423|NCT04163016|156762965|FG003|Treatment|Indeterminate TB-test|1|||
48703424|NCT04163016|156762962|FG000|Treatment|Participant did not want to continue in study|0|||
48703425|NCT04163016|156762963|FG001|Treatment|Participant did not want to continue in study|0|||
48703426|NCT04163016|156762964|FG002|Treatment|Participant did not want to continue in study|0|||
48703427|NCT04163016|156762965|FG003|Treatment|Participant did not want to continue in study|1|||
48703428|NCT02594124|156762966|FG000|Overall Study|Adverse Event|0|||
48703429|NCT02594124|156762967|FG001|Overall Study|Adverse Event|5|||
48703430|NCT02594124|156762968|FG002|Overall Study|Adverse Event|8|||
48703431|NCT02594124|156762969|FG003|Overall Study|Adverse Event|1|||
48703432|NCT02594124|156762970|FG004|Overall Study|Adverse Event|0|||
48703433|NCT02594124|156762971|FG005|Overall Study|Adverse Event|0|||
48703434|NCT02594124|156762972|FG006|Overall Study|Adverse Event|2|||
48703435|NCT02594124|156762973|FG007|Overall Study|Adverse Event|2|||
48703436|NCT02594124|156762974|FG008|Overall Study|Adverse Event|0|||
48703437|NCT02594124|156762966|FG000|Overall Study|Withdrawal by Subject|2|||
48703438|NCT02594124|156762967|FG001|Overall Study|Withdrawal by Subject|3|||
48703439|NCT02594124|156762968|FG002|Overall Study|Withdrawal by Subject|5|||
48703440|NCT02594124|156762969|FG003|Overall Study|Withdrawal by Subject|1|||
48703441|NCT02594124|156762970|FG004|Overall Study|Withdrawal by Subject|8|||
48703442|NCT02594124|156762971|FG005|Overall Study|Withdrawal by Subject|4|||
48489954|NCT01078623|155988826|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48489955|NCT01078623|155988827|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48489956|NCT01078623|155988828|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48703443|NCT02594124|156762972|FG006|Overall Study|Withdrawal by Subject|13|||
48703444|NCT02594124|156762973|FG007|Overall Study|Withdrawal by Subject|19|||
48703445|NCT02594124|156762974|FG008|Overall Study|Withdrawal by Subject|0|||
48703446|NCT02594124|156762966|FG000|Overall Study|Physician Decision|0|||
48703447|NCT02594124|156762967|FG001|Overall Study|Physician Decision|2|||
48703448|NCT02594124|156762968|FG002|Overall Study|Physician Decision|0|||
48703449|NCT02594124|156762969|FG003|Overall Study|Physician Decision|0|||
48703450|NCT02594124|156762970|FG004|Overall Study|Physician Decision|0|||
48703451|NCT02594124|156762971|FG005|Overall Study|Physician Decision|0|||
48703452|NCT02594124|156762972|FG006|Overall Study|Physician Decision|0|||
48703453|NCT02594124|156762973|FG007|Overall Study|Physician Decision|1|||
48703454|NCT02594124|156762974|FG008|Overall Study|Physician Decision|0|||
48703455|NCT02594124|156762966|FG000|Overall Study|Commercial drug|0|||
48703456|NCT02594124|156762967|FG001|Overall Study|Commercial drug|1|||
48703457|NCT02594124|156762968|FG002|Overall Study|Commercial drug|6|||
48703458|NCT02594124|156762969|FG003|Overall Study|Commercial drug|3|||
48703459|NCT02594124|156762970|FG004|Overall Study|Commercial drug|0|||
48703460|NCT02594124|156762971|FG005|Overall Study|Commercial drug|0|||
48703461|NCT02594124|156762972|FG006|Overall Study|Commercial drug|7|||
48703462|NCT02594124|156762973|FG007|Overall Study|Commercial drug|11|||
48703463|NCT02594124|156762974|FG008|Overall Study|Commercial drug|2|||
48703464|NCT02594124|156762966|FG000|Overall Study|Reason Not Specified|1|||
48703465|NCT02594124|156762967|FG001|Overall Study|Reason Not Specified|3|||
48703466|NCT02594124|156762968|FG002|Overall Study|Reason Not Specified|4|||
48703467|NCT02594124|156762969|FG003|Overall Study|Reason Not Specified|0|||
48703468|NCT02594124|156762970|FG004|Overall Study|Reason Not Specified|0|||
48703469|NCT02594124|156762971|FG005|Overall Study|Reason Not Specified|1|||
48703470|NCT02594124|156762972|FG006|Overall Study|Reason Not Specified|1|||
48703471|NCT02594124|156762973|FG007|Overall Study|Reason Not Specified|6|||
48703472|NCT02594124|156762974|FG008|Overall Study|Reason Not Specified|1|||
48703473|NCT01256788|156764345|FG000|Overall Study|Lost to Follow-up|5|||
48703474|NCT01256788|156764346|FG001|Overall Study|Lost to Follow-up|8|||
48703475|NCT01256788|156764347|FG002|Overall Study|Lost to Follow-up|3|||
48703476|NCT02144610|156764356|FG000|Overall Study|Physician Decision|1|||
48703477|NCT02144610|156764357|FG001|Overall Study|Physician Decision|0|||
48703478|NCT02144610|156764356|FG000|Overall Study|Withdrawal by Subject|1|||
48703479|NCT02144610|156764357|FG001|Overall Study|Withdrawal by Subject|5|||
48703480|NCT02144610|156764356|FG000|Overall Study|Death|2|||
48703481|NCT02144610|156764357|FG001|Overall Study|Death|2|||
48703482|NCT02144610|156764356|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
48703483|NCT02144610|156764357|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
48703484|NCT02144610|156764356|FG000|Overall Study|Other|0|||
48703485|NCT02144610|156764357|FG001|Overall Study|Other|1|||
48703486|NCT01298648|156764358|FG000|Overall Study|Withdrawal by Subject|2|||
48703487|NCT01298648|156764358|FG000|Overall Study|Lost to Follow-up|21|||
48703488|NCT01281124|156764359|FG000|Overall Study|Death|1|||
48703489|NCT01600716|156764363|FG000|Overall Study|Other Reasons|3|||
48703490|NCT01600716|156764364|FG001|Overall Study|Other Reasons|1|||
48703491|NCT01600716|156764363|FG000|Overall Study|Personal Reasons|0|||
48703492|NCT01600716|156764364|FG001|Overall Study|Personal Reasons|2|||
48703493|NCT01600716|156764363|FG000|Overall Study|Lost to Follow-up|0|||
48703494|NCT01600716|156764364|FG001|Overall Study|Lost to Follow-up|2|||
48703495|NCT01600716|156764363|FG000|Overall Study|Pregnancy|1|||
48703496|NCT01600716|156764364|FG001|Overall Study|Pregnancy|0|||
48703497|NCT01600716|156764363|FG000|Overall Study|Lack of Efficacy|2|||
48703498|NCT01600716|156764364|FG001|Overall Study|Lack of Efficacy|1|||
48703499|NCT01600716|156764363|FG000|Overall Study|Adverse Event|1|||
48703500|NCT01600716|156764364|FG001|Overall Study|Adverse Event|1|||
48703501|NCT03557034|156764366|FG000|Overall Study|Withdrawal by Subject|1|||
48703502|NCT03557034|156764367|FG001|Overall Study|Withdrawal by Subject|0|||
48703503|NCT00674817|156764368|FG000|Period 1|Withdrawal by Subject|2|||
48703504|NCT00674817|156764368|FG000|Period 1|Protocol Violation|1|||
48703505|NCT00674817|156764368|FG000|Period 3|Adverse Event|1|||
48703506|NCT00674817|156764368|FG000|Period 3|Protocol Violation|1|||
48703507|NCT00674817|156764368|FG000|Period 4|Adverse Event|1|||
48703508|NCT00473564|156764369|FG000|Overall Study|robot surgery aborted in OR|23|||
48703509|NCT01907854|156764371|FG000|Overall Study|Protocol Violation|1|||
48703510|NCT01907854|156764372|FG001|Overall Study|Protocol Violation|1|||
48703511|NCT01907854|156764371|FG000|Overall Study|Withdrawal by Subject|9|||
48703512|NCT01907854|156764372|FG001|Overall Study|Withdrawal by Subject|7|||
48703513|NCT01907854|156764371|FG000|Overall Study|Lost to Follow-up|2|||
48703514|NCT01907854|156764372|FG001|Overall Study|Lost to Follow-up|2|||
48703515|NCT01907854|156764371|FG000|Overall Study|Unclassified|4|||
48703516|NCT01907854|156764372|FG001|Overall Study|Unclassified|3|||
48703517|NCT03910244|156764373|FG000|Overall Study|Adverse Event|14|||
48703518|NCT03910244|156764374|FG001|Overall Study|Adverse Event|0|||
48703519|NCT03910244|156764373|FG000|Overall Study|Death|1|||
48703520|NCT03910244|156764374|FG001|Overall Study|Death|0|||
48703521|NCT03910244|156764373|FG000|Overall Study|Lost to Follow-up|0|||
48703522|NCT03910244|156764374|FG001|Overall Study|Lost to Follow-up|2|||
48703523|NCT03910244|156764373|FG000|Overall Study|Joint withdrawal decision|1|||
48703524|NCT03910244|156764374|FG001|Overall Study|Joint withdrawal decision|0|||
48703525|NCT03910244|156764373|FG000|Overall Study|Study Terminated by Sponsor|7|||
48703526|NCT03910244|156764374|FG001|Overall Study|Study Terminated by Sponsor|4|||
48703527|NCT03910244|156764373|FG000|Overall Study|Physician Decision|1|||
48433208|NCT01746732|155774721|FG001|Period 2|Lost to Follow-up|0|||
48703528|NCT03910244|156764374|FG001|Overall Study|Physician Decision|0|||
48703529|NCT03910244|156764373|FG000|Overall Study|Protocol Violation|1|||
48703530|NCT03910244|156764374|FG001|Overall Study|Protocol Violation|0|||
48703531|NCT03910244|156764373|FG000|Overall Study|Withdrawal by Subject|7|||
48595643|NCT01497067|156375940|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
48595644|NCT01497067|156375940|FG000|Overall Study|Other|13|||
48595645|NCT05568797|156375951|FG000|Overall Study|Adverse Event|0|||
48595646|NCT05568797|156375952|FG001|Overall Study|Adverse Event|8|||
48595647|NCT05568797|156375951|FG000|Overall Study|Lost to Follow-up|2|||
48595648|NCT05568797|156375952|FG001|Overall Study|Lost to Follow-up|3|||
48595649|NCT05568797|156375951|FG000|Overall Study|Withdrawal by Subject|1|||
48595650|NCT05568797|156375952|FG001|Overall Study|Withdrawal by Subject|10|||
48703532|NCT03910244|156764374|FG001|Overall Study|Withdrawal by Subject|2|||
48703533|NCT00763035|156764375|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
48703534|NCT00763035|156764376|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
48703535|NCT00763035|156764375|FG000|First Intervention|Adverse Event|0|||
48703536|NCT00763035|156764376|FG001|First Intervention|Adverse Event|1|||
48703537|NCT00763035|156764375|FG000|Second Intervention|Adverse Event|1|||
48703538|NCT00763035|156764376|FG001|Second Intervention|Adverse Event|0|||
48703539|NCT00763035|156764375|FG000|Second Intervention|Physician Decision|2|||
48703540|NCT00763035|156764376|FG001|Second Intervention|Physician Decision|0|||
48703541|NCT02606643|156764377|FG000|Overall Study|did not meet inclusion criteria|1|||
48703542|NCT02606643|156764378|FG001|Overall Study|did not meet inclusion criteria|3|||
48703543|NCT03219723|156764380|FG000|Overall Study|Case Report Forms Uncollected|6|||
48703544|NCT03219723|156764380|FG000|Overall Study|Protocol Deviation|4|||
48703545|NCT02796170|156764381|FG000|Overall Study|Lost to Follow-up|3|||
48703546|NCT02796170|156764382|FG001|Overall Study|Lost to Follow-up|0|||
48703547|NCT01980017|156764383|FG000|Overall Study|Lost to Follow-up|30|||
48703548|NCT01980017|156764384|FG001|Overall Study|Lost to Follow-up|21|||
48703549|NCT01980017|156764383|FG000|Overall Study|Death|0|||
48595651|NCT05568797|156375951|FG000|Overall Study|Other|2|||
48595652|NCT05568797|156375952|FG001|Overall Study|Other|2|||
48595653|NCT02716584|156375955|FG000|Overall Study|Lost to Follow-up|8|||
48595654|NCT02716584|156375956|FG001|Overall Study|Lost to Follow-up|5|||
48595655|NCT01462110|156375957|FG000|Overall Study|Adverse Event|1|||
48703550|NCT01980017|156764384|FG001|Overall Study|Death|1|||
48703551|NCT00561925|156764385|FG000|14 Day Lead-In Period|Adverse Event|38|||
48703552|NCT00561925|156764386|FG001|14 Day Lead-In Period|Adverse Event|0|||
48703553|NCT00561925|156764387|FG002|14 Day Lead-In Period|Adverse Event|0|||
48703554|NCT00561925|156764388|FG003|14 Day Lead-In Period|Adverse Event|0|||
48703555|NCT00561925|156764389|FG004|14 Day Lead-In Period|Adverse Event|0|||
48595656|NCT01462110|156375958|FG001|Overall Study|Adverse Event|0|||
48595657|NCT00096538|156375959|FG000|Overall Study|Withdrawal by Subject|1|||
48595658|NCT01938846|156375960|FG000|Overall Study|Progressive disease|26|||
48703556|NCT00561925|156764385|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
48595659|NCT01938846|156375961|FG001|Overall Study|Progressive disease|18|||
48595660|NCT01938846|156375962|FG002|Overall Study|Progressive disease|16|||
48595661|NCT01938846|156375960|FG000|Overall Study|Adverse Event|8|||
48703557|NCT00561925|156764386|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
48703558|NCT00561925|156764387|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
48703559|NCT00561925|156764388|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
48703560|NCT00561925|156764389|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
48703561|NCT00561925|156764385|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
48703562|NCT00561925|156764386|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
48703563|NCT00561925|156764387|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
48703564|NCT00561925|156764388|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
48703565|NCT00561925|156764389|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
48703566|NCT00561925|156764385|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
48703567|NCT00561925|156764386|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
48703568|NCT00561925|156764387|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
48703569|NCT00561925|156764388|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
48595662|NCT01938846|156375961|FG001|Overall Study|Adverse Event|4|||
48703570|NCT00561925|156764389|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
48703571|NCT00561925|156764385|FG000|14 Day Lead-In Period|Other|5|||
48703572|NCT00561925|156764386|FG001|14 Day Lead-In Period|Other|0|||
48703573|NCT00561925|156764387|FG002|14 Day Lead-In Period|Other|0|||
48703574|NCT00561925|156764388|FG003|14 Day Lead-In Period|Other|0|||
48703575|NCT00561925|156764389|FG004|14 Day Lead-In Period|Other|0|||
48703576|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
48703577|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
48703578|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
48595663|NCT01938846|156375962|FG002|Overall Study|Adverse Event|3|||
48595664|NCT01938846|156375960|FG000|Overall Study|Withdrawal by Subject|2|||
48595665|NCT01938846|156375961|FG001|Overall Study|Withdrawal by Subject|2|||
48703579|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
48703580|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
48703581|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
48595666|NCT01938846|156375962|FG002|Overall Study|Withdrawal by Subject|1|||
48595667|NCT01938846|156375960|FG000|Overall Study|Other than listed|5|||
48595668|NCT01938846|156375961|FG001|Overall Study|Other than listed|1|||
48595669|NCT01938846|156375962|FG002|Overall Study|Other than listed|4|||
48595670|NCT04754542|156375968|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
48595671|NCT04754542|156375969|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
48595672|NCT02308228|156375970|FG000|Overall Study|Adverse Event|3|||
48595673|NCT02308228|156375971|FG001|Overall Study|Adverse Event|4|||
48595674|NCT02308228|156375970|FG000|Overall Study|Withdrawal by Subject|5|||
48595675|NCT02308228|156375971|FG001|Overall Study|Withdrawal by Subject|3|||
48703582|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
48703583|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
48703584|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
48595676|NCT02532283|156375974|FG000|Overall Study|Adverse Event|0|||
48595677|NCT02532283|156375975|FG001|Overall Study|Adverse Event|1|||
48595678|NCT02532283|156375974|FG000|Overall Study|Death|1|||
48703585|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
48703586|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
48703587|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
48703588|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
48703589|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
48703590|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
48703591|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
48703592|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
48703593|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
48703594|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
48703595|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
48703596|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
48703597|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
48703598|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
48703599|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
48703600|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
48703601|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
48703602|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
48703603|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
48703604|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
48703605|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
48703606|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Death|0|||
48703607|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Death|6|||
48703608|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Death|3|||
48703609|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Death|0|||
48703610|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Death|0|||
48703611|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
48703612|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
48703613|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
48703614|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
48703615|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
48703616|NCT00561925|156764385|FG000|144-week Double-blind, Double-dummy|Other|0|||
48703617|NCT00561925|156764386|FG001|144-week Double-blind, Double-dummy|Other|8|||
48703618|NCT00561925|156764387|FG002|144-week Double-blind, Double-dummy|Other|11|||
48703619|NCT00561925|156764388|FG003|144-week Double-blind, Double-dummy|Other|0|||
48703620|NCT00561925|156764389|FG004|144-week Double-blind, Double-dummy|Other|0|||
48703621|NCT00561925|156764385|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
48703622|NCT00561925|156764386|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
48595679|NCT02532283|156375975|FG001|Overall Study|Death|0|||
48595680|NCT02532283|156375974|FG000|Overall Study|Lost to Follow-up|0|||
48595681|NCT02532283|156375975|FG001|Overall Study|Lost to Follow-up|1|||
48595682|NCT02532283|156375974|FG000|Overall Study|Withdrawal by Subject|8|||
48595683|NCT02532283|156375975|FG001|Overall Study|Withdrawal by Subject|3|||
48595684|NCT02029274|156375978|FG000|Overall Study|Adverse Event|1|||
48595685|NCT02029274|156375979|FG001|Overall Study|Adverse Event|0|||
48595686|NCT02029274|156375980|FG002|Overall Study|Adverse Event|2|||
48595687|NCT02029274|156375981|FG003|Overall Study|Adverse Event|2|||
48595688|NCT04265261|156375985|FG000|Overall Study|Adverse Event|2|||
48703623|NCT00561925|156764387|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
48703624|NCT00561925|156764388|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
48703625|NCT00561925|156764389|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
48703626|NCT04313244|156764390|FG000|Overall Study|Withdrawal of Consent|3|||
48703627|NCT04313244|156764391|FG001|Overall Study|Withdrawal of Consent|3|||
48703628|NCT04313244|156764390|FG000|Overall Study|Met Exclusion Criteria|1|||
48703629|NCT04313244|156764391|FG001|Overall Study|Met Exclusion Criteria|0|||
48703630|NCT04313244|156764390|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
48595689|NCT04265261|156375986|FG001|Overall Study|Adverse Event|0|||
48595690|NCT04265261|156375987|FG002|Overall Study|Adverse Event|0|||
48703631|NCT04313244|156764391|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
48703632|NCT00684021|156764392|FG000|Overall Study|MRI Contraindicated|1|||
48489957|NCT01078623|155988829|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48595691|NCT04265261|156375985|FG000|Overall Study|Death|1|||
48595692|NCT04265261|156375986|FG001|Overall Study|Death|0|||
48703633|NCT00684021|156764393|FG001|Overall Study|MRI Contraindicated|1|||
48703634|NCT00684021|156764394|FG002|Overall Study|MRI Contraindicated|1|||
48703635|NCT00684021|156764395|FG003|Overall Study|MRI Contraindicated|0|||
48703636|NCT00684021|156764392|FG000|Overall Study|MRI not performed|0|||
48703637|NCT00684021|156764393|FG001|Overall Study|MRI not performed|1|||
48703638|NCT00684021|156764394|FG002|Overall Study|MRI not performed|1|||
48703639|NCT00684021|156764395|FG003|Overall Study|MRI not performed|2|||
48703640|NCT00684021|156764392|FG000|Overall Study|Death|1|||
48703641|NCT00684021|156764393|FG001|Overall Study|Death|0|||
48703642|NCT00684021|156764394|FG002|Overall Study|Death|0|||
48703643|NCT00684021|156764395|FG003|Overall Study|Death|0|||
48703644|NCT00891904|156764396|FG000|Overall Study|Death|1|||
48703645|NCT00891904|156764396|FG000|Overall Study|Adverse Event|1|||
48703646|NCT02976038|156764399|FG000|Overall Study|Physician Decision|22|||
48703647|NCT02976038|156764399|FG000|Overall Study|Withdrawal by Subject|3|||
48703648|NCT02976038|156764399|FG000|Overall Study|Lost to Follow-up|2|||
48703649|NCT02976038|156764399|FG000|Overall Study|Adverse Event|1|||
48703650|NCT01598532|156764402|FG000|Overall Study|Lost to Follow-up|3|||
48703651|NCT01598532|156764402|FG000|Overall Study|Did not meet inclusion criteria|8|||
48703652|NCT02691507|156764408|FG000|Overall Study|Missed Visit 3|0|||
48703653|NCT02691507|156764409|FG001|Overall Study|Missed Visit 3|1|||
48703654|NCT05567783|156764412|FG000|Overall Study|Death|2|||
48703655|NCT05567783|156764413|FG001|Overall Study|Death|3|||
48703656|NCT05567783|156764414|FG002|Overall Study|Death|0|||
48703657|NCT05567783|156764412|FG000|Overall Study|Lost to Follow-up|25|||
48703658|NCT05567783|156764413|FG001|Overall Study|Lost to Follow-up|19|||
48703659|NCT05567783|156764414|FG002|Overall Study|Lost to Follow-up|17|||
48703660|NCT05567783|156764412|FG000|Overall Study|Physician Decision|10|||
48703661|NCT05567783|156764413|FG001|Overall Study|Physician Decision|7|||
48703662|NCT05567783|156764414|FG002|Overall Study|Physician Decision|9|||
48703663|NCT05567783|156764412|FG000|Overall Study|Study Terminated by Sponsor|924|||
48703664|NCT05567783|156764413|FG001|Overall Study|Study Terminated by Sponsor|937|||
48703665|NCT05567783|156764414|FG002|Overall Study|Study Terminated by Sponsor|941|||
48489958|NCT01078623|155988830|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48489959|NCT01078623|155988831|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48489960|NCT01078623|155988832|FG006|Treatment Period 1|Withdrawal by Subject|0|||
48489961|NCT01078623|155988833|FG007|Treatment Period 1|Withdrawal by Subject|1|||
48489962|NCT01078623|155988834|FG008|Treatment Period 1|Withdrawal by Subject|0|||
48489963|NCT01078623|155988835|FG009|Treatment Period 1|Withdrawal by Subject|0|||
48489964|NCT01078623|155988836|FG010|Treatment Period 1|Withdrawal by Subject|1|||
48489965|NCT01078623|155988837|FG011|Treatment Period 1|Withdrawal by Subject|0|||
48489966|NCT01078623|155988838|FG012|Treatment Period 1|Withdrawal by Subject|0|||
48489967|NCT01078623|155988839|FG013|Treatment Period 1|Withdrawal by Subject|0|||
48489968|NCT01078623|155988840|FG014|Treatment Period 1|Withdrawal by Subject|0|||
48489969|NCT01078623|155988841|FG015|Treatment Period 1|Withdrawal by Subject|0|||
48595693|NCT04265261|156375987|FG002|Overall Study|Death|0|||
48595694|NCT04265261|156375985|FG000|Overall Study|Lost to Follow-up|4|||
48703666|NCT05567783|156764412|FG000|Overall Study|Withdrawal by Subject|23|||
48703667|NCT05567783|156764413|FG001|Overall Study|Withdrawal by Subject|27|||
48703668|NCT05567783|156764414|FG002|Overall Study|Withdrawal by Subject|24|||
48703669|NCT05567783|156764412|FG000|Overall Study|Incarcerated|1|||
48703670|NCT05567783|156764413|FG001|Overall Study|Incarcerated|0|||
48703671|NCT05567783|156764414|FG002|Overall Study|Incarcerated|0|||
48703672|NCT05567783|156764412|FG000|Overall Study|Participant randomized in error|4|||
48703673|NCT05567783|156764413|FG001|Overall Study|Participant randomized in error|2|||
48703674|NCT05567783|156764414|FG002|Overall Study|Participant randomized in error|2|||
48703675|NCT02839200|156764421|FG000|Overall Study|Withdrawal by Subject|2|||
48489970|NCT01078623|155988842|FG016|Treatment Period 1|Withdrawal by Subject|0|||
48489971|NCT01078623|155988843|FG017|Treatment Period 1|Withdrawal by Subject|0|||
48489972|NCT01078623|155988844|FG018|Treatment Period 1|Withdrawal by Subject|0|||
48489973|NCT01078623|155988845|FG019|Treatment Period 1|Withdrawal by Subject|0|||
48489974|NCT01078623|155988826|FG000|Treatment Period 1|Protocol Violation|0|||
48489975|NCT01078623|155988827|FG001|Treatment Period 1|Protocol Violation|0|||
48489976|NCT01078623|155988828|FG002|Treatment Period 1|Protocol Violation|0|||
48489977|NCT01078623|155988829|FG003|Treatment Period 1|Protocol Violation|0|||
48489978|NCT01078623|155988830|FG004|Treatment Period 1|Protocol Violation|0|||
48489979|NCT01078623|155988831|FG005|Treatment Period 1|Protocol Violation|1|||
48489980|NCT01078623|155988832|FG006|Treatment Period 1|Protocol Violation|0|||
48489981|NCT01078623|155988833|FG007|Treatment Period 1|Protocol Violation|0|||
48489982|NCT01078623|155988834|FG008|Treatment Period 1|Protocol Violation|0|||
48489983|NCT01078623|155988835|FG009|Treatment Period 1|Protocol Violation|0|||
48489984|NCT01078623|155988836|FG010|Treatment Period 1|Protocol Violation|0|||
48489985|NCT01078623|155988837|FG011|Treatment Period 1|Protocol Violation|0|||
48489986|NCT01078623|155988838|FG012|Treatment Period 1|Protocol Violation|0|||
48489987|NCT01078623|155988839|FG013|Treatment Period 1|Protocol Violation|0|||
48489988|NCT01078623|155988840|FG014|Treatment Period 1|Protocol Violation|0|||
48489989|NCT01078623|155988841|FG015|Treatment Period 1|Protocol Violation|0|||
48489990|NCT01078623|155988842|FG016|Treatment Period 1|Protocol Violation|0|||
48489991|NCT01078623|155988843|FG017|Treatment Period 1|Protocol Violation|0|||
48489992|NCT01078623|155988844|FG018|Treatment Period 1|Protocol Violation|0|||
48489993|NCT01078623|155988845|FG019|Treatment Period 1|Protocol Violation|0|||
48489994|NCT01078623|155988826|FG000|Treatment Period 2|Adverse Event|0|||
48489995|NCT01078623|155988827|FG001|Treatment Period 2|Adverse Event|0|||
48489996|NCT01078623|155988828|FG002|Treatment Period 2|Adverse Event|0|||
48489997|NCT01078623|155988829|FG003|Treatment Period 2|Adverse Event|0|||
48595695|NCT04265261|156375986|FG001|Overall Study|Lost to Follow-up|1|||
48595696|NCT04265261|156375987|FG002|Overall Study|Lost to Follow-up|3|||
48595697|NCT04265261|156375985|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48433209|NCT01746732|155774722|FG002|Period 2|Lost to Follow-up|1|||
48595698|NCT04265261|156375986|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48595699|NCT04265261|156375987|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48595700|NCT04265261|156375985|FG000|Overall Study|Physician Decision|0|||
48595701|NCT04265261|156375986|FG001|Overall Study|Physician Decision|0|||
48595702|NCT04265261|156375987|FG002|Overall Study|Physician Decision|1|||
48595703|NCT04265261|156375985|FG000|Overall Study|Protocol Deviation|0|||
48595704|NCT04265261|156375986|FG001|Overall Study|Protocol Deviation|2|||
48595705|NCT04265261|156375987|FG002|Overall Study|Protocol Deviation|0|||
48595706|NCT04265261|156375985|FG000|Overall Study|Withdrawal by Subject|2|||
48595707|NCT04265261|156375986|FG001|Overall Study|Withdrawal by Subject|1|||
48595708|NCT04265261|156375987|FG002|Overall Study|Withdrawal by Subject|4|||
48595709|NCT00398216|156377770|FG000|Overall Study|Adverse Event|4|||
48595710|NCT00398216|156377771|FG001|Overall Study|Adverse Event|2|||
48595711|NCT00398216|156377772|FG002|Overall Study|Adverse Event|5|||
48595712|NCT00398216|156377773|FG003|Overall Study|Adverse Event|7|||
48595713|NCT00398216|156377774|FG004|Overall Study|Adverse Event|2|||
48595714|NCT00398216|156377770|FG000|Overall Study|Protocol Violation|2|||
48595715|NCT00398216|156377771|FG001|Overall Study|Protocol Violation|4|||
48595716|NCT00398216|156377772|FG002|Overall Study|Protocol Violation|5|||
48595717|NCT00398216|156377773|FG003|Overall Study|Protocol Violation|7|||
48703676|NCT02839200|156764422|FG001|Overall Study|Withdrawal by Subject|0|||
48703677|NCT02839200|156764423|FG002|Overall Study|Withdrawal by Subject|1|||
48703678|NCT02839200|156764424|FG003|Overall Study|Withdrawal by Subject|0|||
48703679|NCT02839200|156764425|FG004|Overall Study|Withdrawal by Subject|0|||
48703680|NCT02839200|156764426|FG005|Overall Study|Withdrawal by Subject|1|||
48703681|NCT02839200|156764421|FG000|Overall Study|Lost to Follow-up|2|||
48703682|NCT02839200|156764422|FG001|Overall Study|Lost to Follow-up|0|||
48703683|NCT02839200|156764423|FG002|Overall Study|Lost to Follow-up|0|||
48703684|NCT02839200|156764424|FG003|Overall Study|Lost to Follow-up|0|||
48703685|NCT02839200|156764425|FG004|Overall Study|Lost to Follow-up|1|||
48703686|NCT02839200|156764426|FG005|Overall Study|Lost to Follow-up|0|||
48703687|NCT02839200|156764421|FG000|Overall Study|Adverse Event|0|||
48703688|NCT02839200|156764422|FG001|Overall Study|Adverse Event|0|||
48703689|NCT02839200|156764423|FG002|Overall Study|Adverse Event|0|||
48703690|NCT02839200|156764424|FG003|Overall Study|Adverse Event|0|||
48703691|NCT02839200|156764425|FG004|Overall Study|Adverse Event|1|||
48703692|NCT02839200|156764426|FG005|Overall Study|Adverse Event|0|||
48703693|NCT02839200|156764421|FG000|Overall Study|Randomized in error|0|||
48703694|NCT02839200|156764422|FG001|Overall Study|Randomized in error|1|||
48595718|NCT00398216|156377774|FG004|Overall Study|Protocol Violation|5|||
48595719|NCT00398216|156377770|FG000|Overall Study|Lost to Follow-up|1|||
48595720|NCT00398216|156377771|FG001|Overall Study|Lost to Follow-up|6|||
48595721|NCT00398216|156377772|FG002|Overall Study|Lost to Follow-up|4|||
48595722|NCT00398216|156377773|FG003|Overall Study|Lost to Follow-up|4|||
48595723|NCT00398216|156377774|FG004|Overall Study|Lost to Follow-up|1|||
48703695|NCT02839200|156764423|FG002|Overall Study|Randomized in error|0|||
48703696|NCT02839200|156764424|FG003|Overall Study|Randomized in error|0|||
48703697|NCT02839200|156764425|FG004|Overall Study|Randomized in error|0|||
48703698|NCT02839200|156764426|FG005|Overall Study|Randomized in error|0|||
48703699|NCT01958164|156764448|FG000|Overall Study|Adverse Event|0|||
48595724|NCT00398216|156377770|FG000|Overall Study|Death|0|||
48595725|NCT00398216|156377771|FG001|Overall Study|Death|3|||
48595726|NCT00398216|156377772|FG002|Overall Study|Death|0|||
48595727|NCT00398216|156377773|FG003|Overall Study|Death|0|||
48595728|NCT00398216|156377774|FG004|Overall Study|Death|0|||
48595729|NCT00398216|156377770|FG000|Overall Study|Withdrawal by Subject|1|||
48595730|NCT00398216|156377771|FG001|Overall Study|Withdrawal by Subject|0|||
48595731|NCT00398216|156377772|FG002|Overall Study|Withdrawal by Subject|3|||
48595732|NCT00398216|156377773|FG003|Overall Study|Withdrawal by Subject|1|||
48595733|NCT00398216|156377774|FG004|Overall Study|Withdrawal by Subject|2|||
48595734|NCT00398216|156377770|FG000|Overall Study|administrative reasons|3|||
48595735|NCT00398216|156377771|FG001|Overall Study|administrative reasons|4|||
48595736|NCT00398216|156377772|FG002|Overall Study|administrative reasons|4|||
48595737|NCT00398216|156377773|FG003|Overall Study|administrative reasons|3|||
48595738|NCT00398216|156377774|FG004|Overall Study|administrative reasons|3|||
48595739|NCT00398216|156377770|FG000|Overall Study|entrance criteria|0|||
48595740|NCT00398216|156377771|FG001|Overall Study|entrance criteria|0|||
48703700|NCT01958164|156764449|FG001|Overall Study|Adverse Event|2|||
48703701|NCT01958164|156764448|FG000|Overall Study|Lost to Follow-up|2|||
48703702|NCT01958164|156764449|FG001|Overall Study|Lost to Follow-up|3|||
48703703|NCT01780974|156764450|FG000|Overall Study|Death|1|||
48703704|NCT01780974|156764451|FG001|Overall Study|Death|0|||
48703705|NCT01780974|156764450|FG000|Overall Study|Adverse Event|1|||
48703706|NCT01780974|156764451|FG001|Overall Study|Adverse Event|3|||
48703707|NCT00525161|156764454|FG000|Overall Study|Adverse Event|1|||
48703708|NCT00750438|156764456|FG000|Overall Study|Protocol Violation|4|||
48703709|NCT00750438|156764457|FG001|Overall Study|Protocol Violation|1|||
48703710|NCT00750438|156764456|FG000|Overall Study|Physician Decision|2|||
48703711|NCT00750438|156764457|FG001|Overall Study|Physician Decision|2|||
48703712|NCT00750438|156764456|FG000|Overall Study|Withdrawal by Subject|1|||
48703713|NCT00750438|156764457|FG001|Overall Study|Withdrawal by Subject|1|||
48703714|NCT01108185|156764461|FG000|Overall Study|Non-compliance|15|||
48703715|NCT01108185|156764461|FG000|Overall Study|Lost to Follow-up|12|||
48703716|NCT00759941|156764462|FG000|Overall Study|Use of medication|1|||
48703717|NCT00759941|156764463|FG001|Overall Study|Use of medication|0|||
48703718|NCT00759941|156764462|FG000|Overall Study|Adverse Event|1|||
48703719|NCT00759941|156764463|FG001|Overall Study|Adverse Event|0|||
48703720|NCT00759941|156764462|FG000|Overall Study|Exited in error by site|1|||
48703721|NCT00759941|156764463|FG001|Overall Study|Exited in error by site|1|||
48703722|NCT02749422|156764471|FG000|Overall Study|Lost to Follow-up|0|||
48703723|NCT02749422|156764472|FG001|Overall Study|Lost to Follow-up|2|||
48703724|NCT02749422|156764471|FG000|Overall Study|Ineligible|0|||
48703725|NCT02749422|156764472|FG001|Overall Study|Ineligible|1|||
48703726|NCT02855125|156764475|FG000|Overall Study|Withdrawal by Subject|2|||
48703727|NCT02855125|156764476|FG001|Overall Study|Withdrawal by Subject|2|||
48703728|NCT02855125|156764475|FG000|Overall Study|Clinical Disease Progression|5|||
48703729|NCT02855125|156764476|FG001|Overall Study|Clinical Disease Progression|4|||
48703730|NCT02855125|156764475|FG000|Overall Study|Radiologic Disease Progression|36|||
48703731|NCT02855125|156764476|FG001|Overall Study|Radiologic Disease Progression|39|||
48703732|NCT02855125|156764475|FG000|Overall Study|Adverse Event|11|||
48703733|NCT02855125|156764476|FG001|Overall Study|Adverse Event|7|||
48703734|NCT02855125|156764475|FG000|Overall Study|Physician Decision|1|||
48703735|NCT02855125|156764476|FG001|Overall Study|Physician Decision|0|||
48703736|NCT02855125|156764475|FG000|Overall Study|On Treatment|9|||
48703737|NCT02855125|156764476|FG001|Overall Study|On Treatment|11|||
48703738|NCT02855125|156764475|FG000|Overall Study|Randomized but not treated|0|||
48595741|NCT00398216|156377772|FG002|Overall Study|entrance criteria|0|||
48595742|NCT00398216|156377773|FG003|Overall Study|entrance criteria|0|||
48595743|NCT00398216|156377774|FG004|Overall Study|entrance criteria|2|||
48595744|NCT04227405|156377777|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
48703739|NCT02855125|156764476|FG001|Overall Study|Randomized but not treated|1|||
48703740|NCT03414983|156765811|FG000|Pre-Treatment|Other reasons|1|||
48703741|NCT03414983|156765812|FG001|Pre-Treatment|Other reasons|0|||
48703742|NCT03414983|156765811|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
48703743|NCT03414983|156765812|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
48703744|NCT03414983|156765811|FG000|Pre-Treatment|Participant withdrew consent|1|||
48703745|NCT03414983|156765812|FG001|Pre-Treatment|Participant withdrew consent|3|||
48703746|NCT03414983|156765811|FG000|Treatment|Participant withdrew consent|4|||
48595745|NCT04227405|156377778|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
48703747|NCT03414983|156765812|FG001|Treatment|Participant withdrew consent|3|||
48703748|NCT03414983|156765811|FG000|Treatment|Participant request to discontinue study treatment|8|||
48703749|NCT03414983|156765812|FG001|Treatment|Participant request to discontinue study treatment|10|||
48703750|NCT03414983|156765811|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
48703751|NCT03414983|156765812|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
48703752|NCT03414983|156765811|FG000|Treatment|Death|0|||
48703753|NCT03414983|156765812|FG001|Treatment|Death|1|||
48703754|NCT03414983|156765811|FG000|Treatment|Study Drug Toxicity|10|||
48703755|NCT03414983|156765812|FG001|Treatment|Study Drug Toxicity|5|||
48703756|NCT03414983|156765811|FG000|Treatment|Disease Progression|75|||
48489998|NCT01078623|155988830|FG004|Treatment Period 2|Adverse Event|0|||
48703757|NCT03414983|156765812|FG001|Treatment|Disease Progression|29|||
48703758|NCT03414983|156765811|FG000|Treatment|Not reported|1|||
48703759|NCT03414983|156765812|FG001|Treatment|Not reported|0|||
48703760|NCT03414983|156765811|FG000|Treatment|Other reasons|3|||
48703761|NCT03414983|156765812|FG001|Treatment|Other reasons|2|||
48703762|NCT03414983|156765811|FG000|Treatment|Poor/non-compliance|2|||
48703763|NCT03414983|156765812|FG001|Treatment|Poor/non-compliance|0|||
48703764|NCT03414983|156765811|FG000|Treatment|Maximum clinical benefit|5|||
48703765|NCT03414983|156765812|FG001|Treatment|Maximum clinical benefit|9|||
48703766|NCT03414983|156765811|FG000|Treatment|Lost to Follow-up|0|||
48703767|NCT03414983|156765812|FG001|Treatment|Lost to Follow-up|1|||
48703768|NCT03414983|156765811|FG000|Treatment|Administrative reasons by sponsor|1|||
48703769|NCT03414983|156765812|FG001|Treatment|Administrative reasons by sponsor|0|||
48703770|NCT00535496|156765833|FG000|Overall Study|Lost to Follow-up|0|||
48703771|NCT00535496|156765834|FG001|Overall Study|Lost to Follow-up|1|||
48703772|NCT00535496|156765835|FG002|Overall Study|Lost to Follow-up|0|||
48703773|NCT00535496|156765836|FG003|Overall Study|Lost to Follow-up|0|||
48703774|NCT00535496|156765833|FG000|Overall Study|Not treated with sugammadex|0|||
48703775|NCT00535496|156765834|FG001|Overall Study|Not treated with sugammadex|1|||
48703776|NCT00535496|156765835|FG002|Overall Study|Not treated with sugammadex|0|||
48703777|NCT00535496|156765836|FG003|Overall Study|Not treated with sugammadex|0|||
48703778|NCT01709084|156765838|FG000|Overall Study|Lost to Follow-up|4|||
48703779|NCT01709084|156765839|FG001|Overall Study|Lost to Follow-up|7|||
48703780|NCT01709084|156765838|FG000|Overall Study|Withdrawal by Subject|2|||
48703781|NCT01709084|156765839|FG001|Overall Study|Withdrawal by Subject|2|||
48703782|NCT01709084|156765838|FG000|Overall Study|Adverse Event|5|||
48703783|NCT01709084|156765839|FG001|Overall Study|Adverse Event|0|||
48703784|NCT01709084|156765838|FG000|Overall Study|Other|5|||
48703785|NCT01709084|156765839|FG001|Overall Study|Other|3|||
48703786|NCT01709084|156765838|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
48703787|NCT01709084|156765839|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
48703788|NCT01709084|156765838|FG000|Overall Study|Not Treated|0|||
48703789|NCT01709084|156765839|FG001|Overall Study|Not Treated|2|||
48703790|NCT03337477|156765848|FG000|Overall Study|not categorized into the listed ones|11|||
48703791|NCT03337477|156765849|FG001|Overall Study|not categorized into the listed ones|9|||
48703792|NCT03337477|156765848|FG000|Overall Study|Withdrawal by Subject|0|||
48703793|NCT03337477|156765849|FG001|Overall Study|Withdrawal by Subject|1|||
48703794|NCT03337477|156765848|FG000|Overall Study|Death|0|||
48703795|NCT03337477|156765849|FG001|Overall Study|Death|1|||
48703796|NCT03337477|156765848|FG000|Overall Study|Lost to Follow-up|0|||
48489999|NCT01078623|155988831|FG005|Treatment Period 2|Adverse Event|0|||
48490000|NCT01078623|155988832|FG006|Treatment Period 2|Adverse Event|1|||
48490001|NCT01078623|155988833|FG007|Treatment Period 2|Adverse Event|0|||
48490002|NCT01078623|155988834|FG008|Treatment Period 2|Adverse Event|0|||
48490003|NCT01078623|155988835|FG009|Treatment Period 2|Adverse Event|0|||
48490004|NCT01078623|155988836|FG010|Treatment Period 2|Adverse Event|0|||
48490005|NCT01078623|155988837|FG011|Treatment Period 2|Adverse Event|0|||
48490006|NCT01078623|155988838|FG012|Treatment Period 2|Adverse Event|0|||
48490007|NCT01078623|155988839|FG013|Treatment Period 2|Adverse Event|0|||
48490008|NCT01078623|155988840|FG014|Treatment Period 2|Adverse Event|0|||
48490009|NCT01078623|155988841|FG015|Treatment Period 2|Adverse Event|0|||
48490010|NCT01078623|155988842|FG016|Treatment Period 2|Adverse Event|0|||
48703797|NCT03337477|156765849|FG001|Overall Study|Lost to Follow-up|2|||
48703798|NCT03181932|156765850|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
48703799|NCT03181932|156765851|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
48703800|NCT03181932|156765850|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
48703801|NCT03181932|156765851|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
48703802|NCT03181932|156765850|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
48703803|NCT03181932|156765851|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
48703804|NCT03181932|156765850|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
48703805|NCT03181932|156765851|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
48703806|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
48703807|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
48703808|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
48703809|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
48703810|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
48703811|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
48703812|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
48703813|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
48703814|NCT03181932|156765850|FG000|Period 2 (Open-label Period)|Reason missing|2|||
48703815|NCT03181932|156765851|FG001|Period 2 (Open-label Period)|Reason missing|0|||
48703816|NCT00744497|156765852|FG000|Overall Study|Withdrawal by Subject|21|||
48703817|NCT00744497|156765853|FG001|Overall Study|Withdrawal by Subject|18|||
48703818|NCT00744497|156765852|FG000|Overall Study|Death|11|||
48703819|NCT00744497|156765853|FG001|Overall Study|Death|9|||
48703820|NCT00744497|156765852|FG000|Overall Study|Lost to Follow-up|4|||
48703821|NCT00744497|156765853|FG001|Overall Study|Lost to Follow-up|2|||
48703822|NCT00744497|156765852|FG000|Overall Study|Poor compliance/noncompliance|9|||
48703823|NCT00744497|156765853|FG001|Overall Study|Poor compliance/noncompliance|5|||
48703824|NCT00744497|156765852|FG000|Overall Study|No longer meets study criteria|7|||
48703825|NCT00744497|156765853|FG001|Overall Study|No longer meets study criteria|3|||
48703826|NCT00744497|156765852|FG000|Overall Study|Administrative Reason By Sponsor|25|||
48703827|NCT00744497|156765853|FG001|Overall Study|Administrative Reason By Sponsor|8|||
48703828|NCT00744497|156765852|FG000|Overall Study|Disease progression|312|||
48703829|NCT00744497|156765853|FG001|Overall Study|Disease progression|219|||
48703830|NCT00744497|156765852|FG000|Overall Study|Study drug toxicity|68|||
48703831|NCT00744497|156765853|FG001|Overall Study|Study drug toxicity|141|||
48703832|NCT00744497|156765852|FG000|Overall Study|Adverse event unrelated to study drug|78|||
48703833|NCT00744497|156765853|FG001|Overall Study|Adverse event unrelated to study drug|122|||
48703834|NCT00744497|156765852|FG000|Overall Study|Patient requested to stop study drug|65|||
48703835|NCT00744497|156765853|FG001|Overall Study|Patient requested to stop study drug|80|||
48703836|NCT00744497|156765852|FG000|Overall Study|Maximum clinical benefit|141|||
48703837|NCT00744497|156765853|FG001|Overall Study|Maximum clinical benefit|142|||
48703838|NCT00744497|156765852|FG000|Overall Study|Not defined|19|||
48703839|NCT00744497|156765853|FG001|Overall Study|Not defined|13|||
48703840|NCT02379728|156765859|FG000|Overall Study|Lost to Follow-up|1|||
48703841|NCT02379728|156765860|FG001|Overall Study|Lost to Follow-up|0|||
48703842|NCT02379728|156765861|FG002|Overall Study|Lost to Follow-up|3|||
48703843|NCT02379728|156765862|FG003|Overall Study|Lost to Follow-up|0|||
48703844|NCT02379728|156765859|FG000|Overall Study|Withdrawal by Subject|5|||
48703845|NCT02379728|156765860|FG001|Overall Study|Withdrawal by Subject|0|||
48703846|NCT02379728|156765861|FG002|Overall Study|Withdrawal by Subject|5|||
48703847|NCT02379728|156765862|FG003|Overall Study|Withdrawal by Subject|3|||
48703848|NCT02379728|156765859|FG000|Overall Study|Protocol Violation|0|||
48703849|NCT02379728|156765860|FG001|Overall Study|Protocol Violation|0|||
48703850|NCT02379728|156765861|FG002|Overall Study|Protocol Violation|2|||
48703851|NCT02379728|156765862|FG003|Overall Study|Protocol Violation|0|||
48703852|NCT00628108|156765863|FG000|Overall Study|Adverse Event|0|||
48703853|NCT00628108|156765864|FG001|Overall Study|Adverse Event|3|||
48703854|NCT00628108|156765863|FG000|Overall Study|Withdrawal by Subject|1|||
48703855|NCT00628108|156765864|FG001|Overall Study|Withdrawal by Subject|0|||
48703856|NCT00815659|156765867|FG000|Overall Study|Adverse Event|9|||
48703857|NCT00815659|156765867|FG000|Overall Study|Withdrawal by Subject|9|||
48703858|NCT00815659|156765867|FG000|Overall Study|Lost to Follow-up|4|||
48703859|NCT00815659|156765867|FG000|Overall Study|Protocol Violation|1|||
48703860|NCT00616759|156765868|FG000|Overall Study|Physician Decision|2|||
48703861|NCT00616759|156765869|FG001|Overall Study|Physician Decision|0|||
48703862|NCT00616759|156765868|FG000|Overall Study|Withdrawal by Subject|1|||
48703863|NCT00616759|156765869|FG001|Overall Study|Withdrawal by Subject|2|||
48703864|NCT01383356|156765870|FG000|Period 1|Adverse Event|5|||
48703865|NCT01383356|156765871|FG001|Period 1|Adverse Event|3|||
48703866|NCT01383356|156765870|FG000|Period 1|Non-compliance|3|||
48703867|NCT01383356|156765871|FG001|Period 1|Non-compliance|0|||
48703868|NCT01383356|156765870|FG000|Period 1|Out of Range Mid-study-Test|0|||
48703869|NCT01383356|156765871|FG001|Period 1|Out of Range Mid-study-Test|1|||
48703870|NCT01383356|156765870|FG000|Period 1|Personal|0|||
48703871|NCT01383356|156765871|FG001|Period 1|Personal|2|||
48703872|NCT02015637|156765876|FG000|Overall Study|Lost to Follow-up|3|||
48703873|NCT02015637|156765877|FG001|Overall Study|Lost to Follow-up|5|||
48703874|NCT02015637|156765876|FG000|Overall Study|Adverse Event|3|||
48703875|NCT02015637|156765877|FG001|Overall Study|Adverse Event|0|||
48703876|NCT02015637|156765876|FG000|Overall Study|Did not take study drug|2|||
48703877|NCT02015637|156765877|FG001|Overall Study|Did not take study drug|0|||
48703878|NCT03722238|156765878|FG000|Overall Study|Protocol Violation|1|||
48703879|NCT03722238|156765879|FG001|Overall Study|Protocol Violation|0|||
48703880|NCT03722238|156765878|FG000|Overall Study|Physician Decision|1|||
48703881|NCT03722238|156765879|FG001|Overall Study|Physician Decision|0|||
48703882|NCT03722238|156765878|FG000|Overall Study|Death|1|||
48703883|NCT03722238|156765879|FG001|Overall Study|Death|0|||
48703884|NCT03722238|156765878|FG000|Overall Study|Lost to Follow-up|6|||
48703885|NCT03722238|156765879|FG001|Overall Study|Lost to Follow-up|0|||
48703886|NCT03722238|156765878|FG000|Overall Study|Partial missing data|44|||
48703887|NCT03722238|156765879|FG001|Overall Study|Partial missing data|1|||
48703888|NCT03722238|156765878|FG000|Overall Study|Withdrawal by Subject|2|||
48703889|NCT03722238|156765879|FG001|Overall Study|Withdrawal by Subject|0|||
48703890|NCT03722238|156765878|FG000|Overall Study|Other|4|||
48703891|NCT03722238|156765879|FG001|Overall Study|Other|0|||
48703892|NCT03722238|156765878|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
48703893|NCT03722238|156765879|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
48703894|NCT03722238|156765878|FG000|Overall Study|Did not meet risk classification group criteria|90|||
48703895|NCT03722238|156765879|FG001|Overall Study|Did not meet risk classification group criteria|0|||
48703896|NCT03722238|156765878|FG000|Overall Study|Did not sign consent|17|||
48703897|NCT03722238|156765879|FG001|Overall Study|Did not sign consent|0|||
48703898|NCT03722238|156765878|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
48703899|NCT03722238|156765879|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
48703900|NCT03722238|156765878|FG000|Overall Study|Not willing to purchase study medication|142|||
48703901|NCT03722238|156765879|FG001|Overall Study|Not willing to purchase study medication|0|||
48703902|NCT03722238|156765878|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
48703903|NCT03722238|156765879|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
48703904|NCT04682366|156765886|FG000|Overall Study|Lost to Follow-up|1|||
48703905|NCT04682366|156765887|FG001|Overall Study|Lost to Follow-up|1|||
48703906|NCT01189032|156765890|FG000|Overall Study|Adverse Event|1|||
48703907|NCT01189032|156765891|FG001|Overall Study|Adverse Event|3|||
48703908|NCT01189032|156765892|FG002|Overall Study|Adverse Event|4|||
48703909|NCT01189032|156765890|FG000|Overall Study|Lack of Efficacy|2|||
48703910|NCT01189032|156765891|FG001|Overall Study|Lack of Efficacy|3|||
48703911|NCT01189032|156765892|FG002|Overall Study|Lack of Efficacy|0|||
48703912|NCT01189032|156765890|FG000|Overall Study|Withdrawal by Subject|1|||
48703913|NCT01189032|156765891|FG001|Overall Study|Withdrawal by Subject|0|||
48703914|NCT01189032|156765892|FG002|Overall Study|Withdrawal by Subject|1|||
48703915|NCT01189032|156765890|FG000|Overall Study|Protocol Violation|1|||
48703916|NCT01189032|156765891|FG001|Overall Study|Protocol Violation|1|||
48703917|NCT01189032|156765892|FG002|Overall Study|Protocol Violation|1|||
48703918|NCT00106704|156765893|FG000|Overall Study|Adverse Event|10|||
48703919|NCT00106704|156765894|FG001|Overall Study|Adverse Event|7|||
48703920|NCT00106704|156765893|FG000|Overall Study|Death|2|||
48433731|NCT02116660|155777133|FG000|Overall Study|Adverse Event|1|||
48703921|NCT00106704|156765894|FG001|Overall Study|Death|1|||
48703922|NCT00106704|156765893|FG000|Overall Study|Lack of Efficacy|67|||
48703923|NCT00106704|156765894|FG001|Overall Study|Lack of Efficacy|69|||
48703924|NCT00106704|156765893|FG000|Overall Study|Lost to Follow-up|7|||
48703925|NCT00106704|156765894|FG001|Overall Study|Lost to Follow-up|3|||
48703926|NCT00106704|156765893|FG000|Overall Study|Pregnancy|1|||
48703927|NCT00106704|156765894|FG001|Overall Study|Pregnancy|0|||
48703928|NCT00106704|156765893|FG000|Overall Study|Protocol Violation|4|||
48703929|NCT00106704|156765894|FG001|Overall Study|Protocol Violation|7|||
48703930|NCT00106704|156765893|FG000|Overall Study|Withdrawal by Subject|14|||
48703931|NCT00106704|156765894|FG001|Overall Study|Withdrawal by Subject|21|||
48703932|NCT00106704|156765893|FG000|Overall Study|Patient moved|1|||
48703933|NCT00106704|156765894|FG001|Overall Study|Patient moved|0|||
48703934|NCT00106704|156765893|FG000|Overall Study|Site terminated|0|||
48703935|NCT00106704|156765894|FG001|Overall Study|Site terminated|1|||
48703936|NCT00106704|156765893|FG000|Overall Study|Planned major surgery|1|||
48703937|NCT00106704|156765894|FG001|Overall Study|Planned major surgery|0|||
48703938|NCT00106704|156765893|FG000|Overall Study|Patient Received Glycemic Medication|22|||
48703939|NCT00106704|156765894|FG001|Overall Study|Patient Received Glycemic Medication|41|||
48703940|NCT00106704|156765893|FG000|Overall Study|Unable to re-enter US|1|||
48703941|NCT00106704|156765894|FG001|Overall Study|Unable to re-enter US|0|||
48703942|NCT00106704|156765893|FG000|Overall Study|Laboratory test|1|||
48703943|NCT00106704|156765894|FG001|Overall Study|Laboratory test|1|||
48703944|NCT01249261|156765895|FG000|Overall Study|Withdrawal by Subject|1|||
48703945|NCT01249261|156765896|FG001|Overall Study|Withdrawal by Subject|0|||
48703946|NCT01327482|156765897|FG000|Overall Study|Adverse Event|1|||
48703947|NCT00391586|156765900|FG000|Overall Study|Progressive disease|13|||
48703948|NCT00391586|156765900|FG000|Overall Study|Adverse Event|5|||
48703949|NCT00391586|156765900|FG000|Overall Study|Physician Decision|2|||
48703950|NCT00391586|156765900|FG000|Overall Study|Death|4|||
48703951|NCT00198822|156765901|FG000|Overall Study|Lost to Follow-up|14|||
48703952|NCT00198822|156765902|FG001|Overall Study|Lost to Follow-up|20|||
48703953|NCT00198822|156765903|FG002|Overall Study|Lost to Follow-up|21|||
48703954|NCT01658436|156765908|FG000|Overall Study|Adverse Event|6|||
48703955|NCT01658436|156765909|FG001|Overall Study|Adverse Event|5|||
48703956|NCT01658436|156765908|FG000|Overall Study|Physician Decision|1|||
48703957|NCT01658436|156765909|FG001|Overall Study|Physician Decision|0|||
48703958|NCT01658436|156765908|FG000|Overall Study|Progressive disease|12|||
48703959|NCT01658436|156765909|FG001|Overall Study|Progressive disease|4|||
48703960|NCT01658436|156765908|FG000|Overall Study|Study terminated by sponsor|0|||
48703961|NCT01658436|156765909|FG001|Overall Study|Study terminated by sponsor|1|||
48703962|NCT01658436|156765908|FG000|Overall Study|Subject/guardian decision|0|||
48703963|NCT01658436|156765909|FG001|Overall Study|Subject/guardian decision|1|||
48703964|NCT01658436|156765908|FG000|Overall Study|Death|1|||
48703965|NCT01658436|156765909|FG001|Overall Study|Death|0|||
48703966|NCT00686712|156765910|FG000|Overall Study|Protocol Violation|8|||
48703967|NCT00686712|156765911|FG001|Overall Study|Protocol Violation|8|||
48703968|NCT00686712|156765912|FG002|Overall Study|Protocol Violation|10|||
48703969|NCT00686712|156765910|FG000|Overall Study|Lost to Follow-up|1|||
48703970|NCT00686712|156765911|FG001|Overall Study|Lost to Follow-up|2|||
48703971|NCT00686712|156765912|FG002|Overall Study|Lost to Follow-up|3|||
48703972|NCT00686712|156765910|FG000|Overall Study|Adverse Event|1|||
48703973|NCT00686712|156765911|FG001|Overall Study|Adverse Event|1|||
48703974|NCT00686712|156765912|FG002|Overall Study|Adverse Event|0|||
48703975|NCT00949702|156765913|FG000|Overall Study|Death|40|||
48703976|NCT00949702|156765913|FG000|Overall Study|Disease progression|7|||
48703977|NCT00949702|156765913|FG000|Overall Study|Withdrawal of consent|1|||
48703978|NCT04119414|156765914|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
48703979|NCT02170077|156765920|FG000|Overall Study|Withdrawal by Subject|3|||
48703980|NCT02170077|156765921|FG001|Overall Study|Withdrawal by Subject|4|||
48703981|NCT02170077|156765922|FG002|Overall Study|Withdrawal by Subject|2|||
48703982|NCT02170077|156765920|FG000|Overall Study|Adverse Event|4|||
48703983|NCT02170077|156765921|FG001|Overall Study|Adverse Event|4|||
48703984|NCT02170077|156765922|FG002|Overall Study|Adverse Event|4|||
48703985|NCT02170077|156765920|FG000|Overall Study|Lost to Follow-up|0|||
48703986|NCT02170077|156765921|FG001|Overall Study|Lost to Follow-up|1|||
48703987|NCT02170077|156765922|FG002|Overall Study|Lost to Follow-up|0|||
48703988|NCT02170077|156765920|FG000|Overall Study|Exclusion criteria|2|||
48433732|NCT02116660|155777134|FG001|Overall Study|Adverse Event|1|||
48703989|NCT02170077|156765921|FG001|Overall Study|Exclusion criteria|2|||
48703990|NCT02170077|156765922|FG002|Overall Study|Exclusion criteria|5|||
48703991|NCT02170077|156765920|FG000|Overall Study|Exacerbation of seizures|0|||
48703992|NCT02170077|156765921|FG001|Overall Study|Exacerbation of seizures|2|||
48703993|NCT02170077|156765922|FG002|Overall Study|Exacerbation of seizures|1|||
48703994|NCT02963506|156765928|FG000|Double-Blind Period|Adverse Event|0|||
48703995|NCT02963506|156765929|FG001|Double-Blind Period|Adverse Event|0|||
48703996|NCT02963506|156765930|FG002|Double-Blind Period|Adverse Event|1|||
48703997|NCT02963506|156765931|FG003|Double-Blind Period|Adverse Event|0|||
48703998|NCT02963506|156765932|FG004|Double-Blind Period|Adverse Event|0|||
48703999|NCT02963506|156765933|FG005|Double-Blind Period|Adverse Event|0|||
48704000|NCT02963506|156765934|FG006|Double-Blind Period|Adverse Event|0|||
48704001|NCT02963506|156765935|FG007|Double-Blind Period|Adverse Event|0|||
48704002|NCT02963506|156765936|FG008|Double-Blind Period|Adverse Event|0|||
48704003|NCT02963506|156765937|FG009|Double-Blind Period|Adverse Event|0|||
48704004|NCT02963506|156765938|FG010|Double-Blind Period|Adverse Event|0|||
48704005|NCT02963506|156765939|FG011|Double-Blind Period|Adverse Event|0|||
48704006|NCT02963506|156765940|FG012|Double-Blind Period|Adverse Event|0|||
48704007|NCT02963506|156765928|FG000|Double-Blind Period|Death|0|||
48704008|NCT02963506|156765929|FG001|Double-Blind Period|Death|0|||
48704009|NCT02963506|156765930|FG002|Double-Blind Period|Death|0|||
48704010|NCT02963506|156765931|FG003|Double-Blind Period|Death|1|||
48704011|NCT02963506|156765932|FG004|Double-Blind Period|Death|0|||
48704012|NCT02963506|156765933|FG005|Double-Blind Period|Death|0|||
48704013|NCT02963506|156765934|FG006|Double-Blind Period|Death|0|||
48704014|NCT02963506|156765935|FG007|Double-Blind Period|Death|0|||
48704015|NCT02963506|156765936|FG008|Double-Blind Period|Death|0|||
48704016|NCT02963506|156765937|FG009|Double-Blind Period|Death|0|||
48704017|NCT02963506|156765938|FG010|Double-Blind Period|Death|0|||
48704018|NCT02963506|156765939|FG011|Double-Blind Period|Death|0|||
48704019|NCT02963506|156765940|FG012|Double-Blind Period|Death|0|||
48704020|NCT02963506|156765928|FG000|Double-Blind Period|Lost to Follow-up|0|||
48704021|NCT02963506|156765929|FG001|Double-Blind Period|Lost to Follow-up|1|||
48704022|NCT02963506|156765930|FG002|Double-Blind Period|Lost to Follow-up|0|||
48704023|NCT02963506|156765931|FG003|Double-Blind Period|Lost to Follow-up|0|||
48704024|NCT02963506|156765932|FG004|Double-Blind Period|Lost to Follow-up|0|||
48704025|NCT02963506|156765933|FG005|Double-Blind Period|Lost to Follow-up|0|||
48704026|NCT02963506|156765934|FG006|Double-Blind Period|Lost to Follow-up|0|||
48704027|NCT02963506|156765935|FG007|Double-Blind Period|Lost to Follow-up|0|||
48704028|NCT02963506|156765936|FG008|Double-Blind Period|Lost to Follow-up|0|||
48704029|NCT02963506|156765937|FG009|Double-Blind Period|Lost to Follow-up|0|||
48704030|NCT02963506|156765938|FG010|Double-Blind Period|Lost to Follow-up|0|||
48704031|NCT02963506|156765939|FG011|Double-Blind Period|Lost to Follow-up|0|||
48704032|NCT02963506|156765940|FG012|Double-Blind Period|Lost to Follow-up|0|||
48704033|NCT02963506|156765928|FG000|Double-Blind Period|Withdrawal by Subject|0|||
48704034|NCT02963506|156765929|FG001|Double-Blind Period|Withdrawal by Subject|0|||
48704035|NCT02963506|156765930|FG002|Double-Blind Period|Withdrawal by Subject|1|||
48704036|NCT02963506|156765931|FG003|Double-Blind Period|Withdrawal by Subject|1|||
48704037|NCT02963506|156765932|FG004|Double-Blind Period|Withdrawal by Subject|0|||
48704038|NCT02963506|156765933|FG005|Double-Blind Period|Withdrawal by Subject|0|||
48704039|NCT02963506|156765934|FG006|Double-Blind Period|Withdrawal by Subject|0|||
48704040|NCT02963506|156765935|FG007|Double-Blind Period|Withdrawal by Subject|0|||
48704041|NCT02963506|156765936|FG008|Double-Blind Period|Withdrawal by Subject|0|||
48704042|NCT02963506|156765937|FG009|Double-Blind Period|Withdrawal by Subject|0|||
48704043|NCT02963506|156765938|FG010|Double-Blind Period|Withdrawal by Subject|0|||
48704044|NCT02963506|156765939|FG011|Double-Blind Period|Withdrawal by Subject|0|||
48704045|NCT02963506|156765940|FG012|Double-Blind Period|Withdrawal by Subject|0|||
48704046|NCT02963506|156765928|FG000|Double-Blind Period|No compliance|0|||
48704047|NCT02963506|156765929|FG001|Double-Blind Period|No compliance|1|||
48704048|NCT02963506|156765930|FG002|Double-Blind Period|No compliance|0|||
48704049|NCT02963506|156765931|FG003|Double-Blind Period|No compliance|0|||
48704050|NCT02963506|156765932|FG004|Double-Blind Period|No compliance|0|||
48704051|NCT02963506|156765933|FG005|Double-Blind Period|No compliance|0|||
48704052|NCT02963506|156765934|FG006|Double-Blind Period|No compliance|0|||
48704053|NCT02963506|156765935|FG007|Double-Blind Period|No compliance|0|||
48704054|NCT02963506|156765936|FG008|Double-Blind Period|No compliance|0|||
48704055|NCT02963506|156765937|FG009|Double-Blind Period|No compliance|0|||
48490011|NCT01078623|155988843|FG017|Treatment Period 2|Adverse Event|0|||
48490012|NCT01078623|155988844|FG018|Treatment Period 2|Adverse Event|1|||
48490013|NCT01078623|155988845|FG019|Treatment Period 2|Adverse Event|0|||
48490014|NCT01078623|155988826|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48490015|NCT01078623|155988827|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48490016|NCT01078623|155988828|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48704056|NCT02963506|156765938|FG010|Double-Blind Period|No compliance|0|||
48704057|NCT02963506|156765939|FG011|Double-Blind Period|No compliance|0|||
48704058|NCT02963506|156765940|FG012|Double-Blind Period|No compliance|0|||
48704059|NCT02963506|156765928|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704060|NCT02963506|156765929|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
48704061|NCT02963506|156765930|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704062|NCT02963506|156765931|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704063|NCT02963506|156765932|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704064|NCT02963506|156765933|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704065|NCT02963506|156765934|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704066|NCT02963506|156765935|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704067|NCT02963506|156765936|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704068|NCT02963506|156765937|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704069|NCT02963506|156765938|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704070|NCT02963506|156765939|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704071|NCT02963506|156765940|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
48704072|NCT02963506|156765928|FG000|Dose-Blind Period|Adverse Event|0|||
48704073|NCT02963506|156765929|FG001|Dose-Blind Period|Adverse Event|0|||
48704074|NCT02963506|156765930|FG002|Dose-Blind Period|Adverse Event|0|||
48704075|NCT02963506|156765931|FG003|Dose-Blind Period|Adverse Event|0|||
48704076|NCT02963506|156765932|FG004|Dose-Blind Period|Adverse Event|0|||
48704077|NCT02963506|156765933|FG005|Dose-Blind Period|Adverse Event|1|||
48704078|NCT02963506|156765934|FG006|Dose-Blind Period|Adverse Event|3|||
48704079|NCT02963506|156765935|FG007|Dose-Blind Period|Adverse Event|2|||
48704080|NCT02963506|156765936|FG008|Dose-Blind Period|Adverse Event|2|||
48704081|NCT02963506|156765937|FG009|Dose-Blind Period|Adverse Event|2|||
48704082|NCT02963506|156765938|FG010|Dose-Blind Period|Adverse Event|1|||
48704083|NCT02963506|156765939|FG011|Dose-Blind Period|Adverse Event|1|||
48704084|NCT02963506|156765940|FG012|Dose-Blind Period|Adverse Event|6|||
48704085|NCT02963506|156765928|FG000|Dose-Blind Period|Lack of Efficacy|0|||
48704086|NCT02963506|156765929|FG001|Dose-Blind Period|Lack of Efficacy|0|||
48704087|NCT02963506|156765930|FG002|Dose-Blind Period|Lack of Efficacy|0|||
48704088|NCT02963506|156765931|FG003|Dose-Blind Period|Lack of Efficacy|0|||
48704089|NCT02963506|156765932|FG004|Dose-Blind Period|Lack of Efficacy|0|||
48704090|NCT02963506|156765933|FG005|Dose-Blind Period|Lack of Efficacy|0|||
48704091|NCT02963506|156765934|FG006|Dose-Blind Period|Lack of Efficacy|0|||
48490017|NCT01078623|155988829|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48490018|NCT01078623|155988830|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48704092|NCT02963506|156765935|FG007|Dose-Blind Period|Lack of Efficacy|1|||
48704093|NCT02963506|156765936|FG008|Dose-Blind Period|Lack of Efficacy|0|||
48704094|NCT02963506|156765937|FG009|Dose-Blind Period|Lack of Efficacy|1|||
48704095|NCT02963506|156765938|FG010|Dose-Blind Period|Lack of Efficacy|0|||
48704096|NCT02963506|156765939|FG011|Dose-Blind Period|Lack of Efficacy|0|||
48704097|NCT02963506|156765940|FG012|Dose-Blind Period|Lack of Efficacy|0|||
48704098|NCT02963506|156765928|FG000|Dose-Blind Period|Lost to Follow-up|0|||
48704099|NCT02963506|156765929|FG001|Dose-Blind Period|Lost to Follow-up|0|||
48704100|NCT02963506|156765930|FG002|Dose-Blind Period|Lost to Follow-up|0|||
48704101|NCT02963506|156765931|FG003|Dose-Blind Period|Lost to Follow-up|0|||
48704102|NCT02963506|156765932|FG004|Dose-Blind Period|Lost to Follow-up|0|||
48704103|NCT02963506|156765933|FG005|Dose-Blind Period|Lost to Follow-up|1|||
48704104|NCT02963506|156765934|FG006|Dose-Blind Period|Lost to Follow-up|0|||
48704105|NCT02963506|156765935|FG007|Dose-Blind Period|Lost to Follow-up|0|||
48704106|NCT02963506|156765936|FG008|Dose-Blind Period|Lost to Follow-up|1|||
48704107|NCT02963506|156765937|FG009|Dose-Blind Period|Lost to Follow-up|0|||
48704108|NCT02963506|156765938|FG010|Dose-Blind Period|Lost to Follow-up|0|||
48704109|NCT02963506|156765939|FG011|Dose-Blind Period|Lost to Follow-up|1|||
48704110|NCT02963506|156765940|FG012|Dose-Blind Period|Lost to Follow-up|0|||
48704111|NCT02963506|156765928|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
48704112|NCT02963506|156765929|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
48704113|NCT02963506|156765930|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
48704114|NCT02963506|156765931|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
48704115|NCT02963506|156765932|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
48704116|NCT02963506|156765933|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
48704117|NCT02963506|156765934|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
48704118|NCT02963506|156765935|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
48704119|NCT02963506|156765936|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
48704120|NCT02963506|156765937|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
48704121|NCT02963506|156765938|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
48704122|NCT02963506|156765939|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
48704123|NCT02963506|156765940|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
48704124|NCT02963506|156765928|FG000|Dose-Blind Period|Sponsor decision|0|||
48704125|NCT02963506|156765929|FG001|Dose-Blind Period|Sponsor decision|0|||
48704126|NCT02963506|156765930|FG002|Dose-Blind Period|Sponsor decision|0|||
48704127|NCT02963506|156765931|FG003|Dose-Blind Period|Sponsor decision|0|||
48704128|NCT02963506|156765932|FG004|Dose-Blind Period|Sponsor decision|0|||
48704129|NCT02963506|156765933|FG005|Dose-Blind Period|Sponsor decision|1|||
48704130|NCT02963506|156765934|FG006|Dose-Blind Period|Sponsor decision|0|||
48704131|NCT02963506|156765935|FG007|Dose-Blind Period|Sponsor decision|0|||
48704132|NCT02963506|156765936|FG008|Dose-Blind Period|Sponsor decision|0|||
48704133|NCT02963506|156765937|FG009|Dose-Blind Period|Sponsor decision|0|||
48704134|NCT02963506|156765938|FG010|Dose-Blind Period|Sponsor decision|0|||
48704135|NCT02963506|156765939|FG011|Dose-Blind Period|Sponsor decision|0|||
48704136|NCT02963506|156765940|FG012|Dose-Blind Period|Sponsor decision|0|||
48704137|NCT02963506|156765928|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704138|NCT02963506|156765929|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704139|NCT02963506|156765930|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704140|NCT02963506|156765931|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704141|NCT02963506|156765932|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704142|NCT02963506|156765933|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704143|NCT02963506|156765934|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704144|NCT02963506|156765935|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704145|NCT02963506|156765936|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704146|NCT02963506|156765937|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704147|NCT02963506|156765938|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704148|NCT02963506|156765939|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
48704149|NCT02963506|156765940|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
48704150|NCT02129699|156765941|FG000|Overall Study|Did not start treatment|3|||
48704151|NCT02129699|156765942|FG001|Overall Study|Did not start treatment|2|||
48704152|NCT01076361|156765943|FG000|Overall Study|22 leads were excluded from analysis|21|||
48704153|NCT00928408|156765944|FG000|Overall Study|Other|2|||
48704154|NCT00928408|156765944|FG000|Overall Study|Withdrawal by Subject|4|||
48704155|NCT00928408|156765944|FG000|Overall Study|Death|5|||
48704156|NCT00928408|156765944|FG000|Overall Study|Lost to Follow-up|12|||
48704157|NCT04393454|156765945|FG000|Overall Study|Death|1|||
48704158|NCT04393454|156765945|FG000|Overall Study|Lost to Follow-up|1|||
48704159|NCT00472030|156765946|FG000|Overall Study|Physician Decision|1|||
48704160|NCT00472030|156765947|FG001|Overall Study|Physician Decision|0|||
48704161|NCT00256997|156765948|FG000|Overall Study|Protocol Violation|1|||
48704162|NCT00256997|156765949|FG001|Overall Study|Protocol Violation|4|||
48704163|NCT00256997|156765948|FG000|Overall Study|Lack of Efficacy|1|||
48704164|NCT00256997|156765949|FG001|Overall Study|Lack of Efficacy|4|||
48704165|NCT00256997|156765948|FG000|Overall Study|Death|2|||
48704166|NCT00256997|156765949|FG001|Overall Study|Death|0|||
48704167|NCT00256997|156765948|FG000|Overall Study|Adverse Event|4|||
48704168|NCT00256997|156765949|FG001|Overall Study|Adverse Event|0|||
48704169|NCT00256997|156765948|FG000|Overall Study|Lost to Follow-up|3|||
48704170|NCT00256997|156765949|FG001|Overall Study|Lost to Follow-up|5|||
48704171|NCT00256997|156765948|FG000|Overall Study|Withdrawal by Subject|13|||
48704172|NCT00256997|156765949|FG001|Overall Study|Withdrawal by Subject|3|||
48704173|NCT00256997|156765948|FG000|Overall Study|Started but not treated|2|||
48704174|NCT00256997|156765949|FG001|Overall Study|Started but not treated|0|||
48704175|NCT00256997|156765948|FG000|Overall Study|Other|5|||
48704176|NCT00256997|156765949|FG001|Overall Study|Other|8|||
48704177|NCT00256997|156765948|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
48704178|NCT00256997|156765949|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
48704179|NCT00256997|156765948|FG000|Overall Study|Participant Non-compliant|3|||
48704180|NCT00256997|156765949|FG001|Overall Study|Participant Non-compliant|6|||
48704181|NCT00256997|156765948|FG000|Overall Study|Investigator Withdrew Participant|2|||
48704182|NCT00256997|156765949|FG001|Overall Study|Investigator Withdrew Participant|1|||
48704183|NCT01868997|156765950|FG000|Overall Study|Adverse Event|2|||
48704184|NCT01868997|156765951|FG001|Overall Study|Adverse Event|5|||
48704185|NCT01868997|156765950|FG000|Overall Study|Lack of Efficacy|2|||
48704186|NCT01868997|156765951|FG001|Overall Study|Lack of Efficacy|0|||
48704187|NCT01868997|156765950|FG000|Overall Study|Other|3|||
48704188|NCT01868997|156765951|FG001|Overall Study|Other|1|||
48704189|NCT00494676|156765952|FG000|Allocation|Withdrawal by Subject|2|||
48704190|NCT00494676|156765953|FG001|Allocation|Withdrawal by Subject|4|||
48704191|NCT00494676|156765952|FG000|First Intervention|Withdrawal by Subject|1|||
48704192|NCT00494676|156765953|FG001|First Intervention|Withdrawal by Subject|3|||
48704193|NCT00494676|156765952|FG000|Second Intervention|Withdrawal by Subject|1|||
48704194|NCT00494676|156765953|FG001|Second Intervention|Withdrawal by Subject|1|||
48704195|NCT02392624|156767222|FG000|Overall Study|Withdrawal by Subject|15|||
48704196|NCT02392624|156767223|FG001|Overall Study|Withdrawal by Subject|12|||
48704197|NCT02392624|156767224|FG002|Overall Study|Withdrawal by Subject|9|||
48704198|NCT02392624|156767222|FG000|Overall Study|Adverse Event|4|||
48704199|NCT02392624|156767223|FG001|Overall Study|Adverse Event|1|||
48704200|NCT02392624|156767224|FG002|Overall Study|Adverse Event|2|||
48704201|NCT02392624|156767222|FG000|Overall Study|Pregnancy|1|||
48704202|NCT02392624|156767223|FG001|Overall Study|Pregnancy|0|||
48704203|NCT02392624|156767224|FG002|Overall Study|Pregnancy|0|||
48704204|NCT02392624|156767222|FG000|Overall Study|Protocol Violation|0|||
48704205|NCT02392624|156767223|FG001|Overall Study|Protocol Violation|0|||
48704206|NCT02392624|156767224|FG002|Overall Study|Protocol Violation|1|||
48704207|NCT02392624|156767222|FG000|Overall Study|Sponsor/Investigator Decision|2|||
48704208|NCT02392624|156767223|FG001|Overall Study|Sponsor/Investigator Decision|1|||
48704209|NCT02392624|156767224|FG002|Overall Study|Sponsor/Investigator Decision|0|||
48704210|NCT02392624|156767222|FG000|Overall Study|Other|49|||
48704211|NCT02392624|156767223|FG001|Overall Study|Other|1|||
48704212|NCT02392624|156767224|FG002|Overall Study|Other|1|||
48704213|NCT00936715|156767225|FG000|Overall Study|Investigators Discretion|1|||
48704214|NCT00936715|156767225|FG000|Overall Study|Protocol Violation|1|||
48704215|NCT00936715|156767225|FG000|Overall Study|Safety or Tolerability Reasons|4|||
48704216|NCT00753506|156767226|FG000|Overall Study|Withdrawal by Subject|4|||
48704217|NCT00753506|156767227|FG001|Overall Study|Withdrawal by Subject|1|||
48704218|NCT00753506|156767226|FG000|Overall Study|Lost to Follow-up|2|||
48704219|NCT00753506|156767227|FG001|Overall Study|Lost to Follow-up|0|||
48704220|NCT00753506|156767226|FG000|Overall Study|Other reason|1|||
48704221|NCT00753506|156767227|FG001|Overall Study|Other reason|1|||
48704222|NCT01193244|156767232|FG000|Overall Study|Withdrawal by Subject|79|||
48704223|NCT01193244|156767233|FG001|Overall Study|Withdrawal by Subject|97|||
48704224|NCT01193244|156767232|FG000|Overall Study|Other|303|||
48704225|NCT01193244|156767233|FG001|Overall Study|Other|278|||
48704226|NCT01193244|156767232|FG000|Overall Study|Lost to Follow-up|6|||
48704227|NCT01193244|156767233|FG001|Overall Study|Lost to Follow-up|15|||
48704228|NCT01337960|156767234|FG000|Overall Study|Lost to Follow-up|1|||
48704229|NCT01337960|156767235|FG001|Overall Study|Lost to Follow-up|0|||
48704230|NCT01337960|156767236|FG002|Overall Study|Lost to Follow-up|0|||
48704231|NCT01337960|156767234|FG000|Overall Study|Withdrawal by Subject|1|||
48704232|NCT01337960|156767235|FG001|Overall Study|Withdrawal by Subject|0|||
48704233|NCT01337960|156767236|FG002|Overall Study|Withdrawal by Subject|0|||
48704234|NCT03877510|156767237|FG000|Overall Study|Death|6|||
48704235|NCT03877510|156767237|FG000|Overall Study|Lost to Follow-up|2|||
48704236|NCT03877510|156767237|FG000|Overall Study|Non-compliance with study drug|2|||
48704237|NCT03877510|156767237|FG000|Overall Study|Lack of Efficacy|14|||
48704238|NCT03877510|156767237|FG000|Overall Study|Adverse Event|20|||
48704239|NCT03877510|156767237|FG000|Overall Study|Withdrawal by Subject|22|||
48704240|NCT03877510|156767237|FG000|Overall Study|Miscellaneous|1|||
48704241|NCT00716417|156767240|FG000|Overall Study|Adverse Event|0|||
48704242|NCT00716417|156767241|FG001|Overall Study|Adverse Event|0|||
48704243|NCT00716417|156767242|FG002|Overall Study|Adverse Event|2|||
48704244|NCT00716417|156767243|FG003|Overall Study|Adverse Event|1|||
48704245|NCT00716417|156767244|FG004|Overall Study|Adverse Event|0|||
48704246|NCT00716417|156767245|FG005|Overall Study|Adverse Event|0|||
48704247|NCT00716417|156767246|FG006|Overall Study|Adverse Event|3|||
48704248|NCT00716417|156767247|FG007|Overall Study|Adverse Event|1|||
48704249|NCT00716417|156767248|FG008|Overall Study|Adverse Event|0|||
48704250|NCT00716417|156767249|FG009|Overall Study|Adverse Event|3|||
48704251|NCT00716417|156767240|FG000|Overall Study|Withdrawal by Subject|0|||
48704252|NCT00716417|156767241|FG001|Overall Study|Withdrawal by Subject|1|||
48704253|NCT00716417|156767242|FG002|Overall Study|Withdrawal by Subject|0|||
48704254|NCT00716417|156767243|FG003|Overall Study|Withdrawal by Subject|2|||
48704255|NCT00716417|156767244|FG004|Overall Study|Withdrawal by Subject|0|||
48704256|NCT00716417|156767245|FG005|Overall Study|Withdrawal by Subject|0|||
48704257|NCT00716417|156767246|FG006|Overall Study|Withdrawal by Subject|1|||
48704258|NCT00716417|156767247|FG007|Overall Study|Withdrawal by Subject|0|||
48704259|NCT00716417|156767248|FG008|Overall Study|Withdrawal by Subject|0|||
48704260|NCT00716417|156767249|FG009|Overall Study|Withdrawal by Subject|0|||
48704261|NCT00716417|156767240|FG000|Overall Study|Progressive disease|3|||
48704262|NCT00716417|156767241|FG001|Overall Study|Progressive disease|5|||
48704263|NCT00716417|156767242|FG002|Overall Study|Progressive disease|3|||
48704264|NCT00716417|156767243|FG003|Overall Study|Progressive disease|8|||
48704265|NCT00716417|156767244|FG004|Overall Study|Progressive disease|0|||
48490019|NCT01078623|155988831|FG005|Treatment Period 2|Withdrawal by Subject|1|||
48704266|NCT00716417|156767245|FG005|Overall Study|Progressive disease|3|||
48704267|NCT00716417|156767246|FG006|Overall Study|Progressive disease|3|||
48704268|NCT00716417|156767247|FG007|Overall Study|Progressive disease|1|||
48704269|NCT00716417|156767248|FG008|Overall Study|Progressive disease|5|||
48704270|NCT00716417|156767249|FG009|Overall Study|Progressive disease|0|||
48704271|NCT00716417|156767240|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
48704272|NCT00716417|156767241|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
48704273|NCT00716417|156767242|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
48704274|NCT00716417|156767243|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
48704275|NCT00716417|156767244|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
48490020|NCT01078623|155988832|FG006|Treatment Period 2|Withdrawal by Subject|0|||
48704276|NCT00716417|156767245|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
48490021|NCT01078623|155988833|FG007|Treatment Period 2|Withdrawal by Subject|0|||
48490022|NCT01078623|155988834|FG008|Treatment Period 2|Withdrawal by Subject|0|||
48490023|NCT01078623|155988835|FG009|Treatment Period 2|Withdrawal by Subject|0|||
48704277|NCT00716417|156767246|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
48704278|NCT00716417|156767247|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
48704279|NCT00716417|156767248|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
48704280|NCT00716417|156767249|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
48704281|NCT00716417|156767240|FG000|Overall Study|On patient request due to toxicities|0|||
48704282|NCT00716417|156767241|FG001|Overall Study|On patient request due to toxicities|0|||
48704283|NCT00716417|156767242|FG002|Overall Study|On patient request due to toxicities|0|||
48704284|NCT00716417|156767243|FG003|Overall Study|On patient request due to toxicities|0|||
48704285|NCT00716417|156767244|FG004|Overall Study|On patient request due to toxicities|0|||
48704286|NCT00716417|156767245|FG005|Overall Study|On patient request due to toxicities|0|||
48704287|NCT00716417|156767246|FG006|Overall Study|On patient request due to toxicities|0|||
48704288|NCT00716417|156767247|FG007|Overall Study|On patient request due to toxicities|1|||
48704289|NCT00716417|156767248|FG008|Overall Study|On patient request due to toxicities|0|||
48704290|NCT00716417|156767249|FG009|Overall Study|On patient request due to toxicities|0|||
48704291|NCT00118417|156767252|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
48704292|NCT00118417|156767253|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
48704293|NCT00118417|156767252|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
48704294|NCT00118417|156767253|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
48704295|NCT00118417|156767252|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
48704296|NCT00118417|156767253|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
48704297|NCT00118417|156767252|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
48704298|NCT00118417|156767253|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
48704299|NCT00118417|156767252|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
48704300|NCT00118417|156767253|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
48704301|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
48704302|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
48704303|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Adverse Event|31|||
48704304|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Adverse Event|21|||
48704305|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
48704306|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
48704307|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
48704308|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
48704309|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
48704310|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
48704311|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
48704312|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
48704313|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Administrative problems|3|||
48704314|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Administrative problems|3|||
48704315|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Death|5|||
48704316|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Death|8|||
48704317|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Disease progression|139|||
48704318|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Disease progression|119|||
48704319|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
48704320|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
48704321|NCT00785785|156767254|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
48704322|NCT00785785|156767255|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
48704323|NCT00785785|156767254|FG000|Optional Extension Phase|Adverse Event|4|||
48704324|NCT00785785|156767255|FG001|Optional Extension Phase|Adverse Event|5|||
48704325|NCT00785785|156767254|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
48704326|NCT00785785|156767255|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
48704327|NCT00785785|156767254|FG000|Optional Extension Phase|Lost to Follow-up|1|||
48704328|NCT00785785|156767255|FG001|Optional Extension Phase|Lost to Follow-up|0|||
48704329|NCT00785785|156767254|FG000|Optional Extension Phase|Administrative problems|2|||
48704330|NCT00785785|156767255|FG001|Optional Extension Phase|Administrative problems|0|||
48704331|NCT00785785|156767254|FG000|Optional Extension Phase|Death|1|||
48704332|NCT00785785|156767255|FG001|Optional Extension Phase|Death|5|||
48704333|NCT00785785|156767254|FG000|Optional Extension Phase|Disease progression|22|||
48704334|NCT00785785|156767255|FG001|Optional Extension Phase|Disease progression|70|||
48704335|NCT00785785|156767254|FG000|Optional Extension Phase|Protocol deviation|0|||
48704336|NCT00785785|156767255|FG001|Optional Extension Phase|Protocol deviation|2|||
48704337|NCT00785785|156767254|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
48704338|NCT00785785|156767255|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
48704339|NCT01391546|156767259|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
48704340|NCT01391546|156767260|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
48704341|NCT05660577|156767261|FG000|Overall Study|Discontinued|9|||
48704342|NCT02118961|156767262|FG000|Overall Study|Withdrawal by Subject|1|||
48704343|NCT02118961|156767263|FG001|Overall Study|Withdrawal by Subject|0|||
48704344|NCT01213472|156767264|FG000|Overall Study|Recurrence/Progressive disease|25|||
48704345|NCT01213472|156767264|FG000|Overall Study|Withdrawal by Subject|1|||
48704346|NCT01213472|156767264|FG000|Overall Study|Physician Decision|1|||
48704347|NCT03774576|156767268|FG000|Period 2|Adverse Event|1|||
48704348|NCT03771664|156767271|FG000|Overall Study|Adverse Event|1|||
48704349|NCT03771664|156767272|FG001|Overall Study|Adverse Event|0|||
48704350|NCT03771664|156767271|FG000|Overall Study|Lost to Follow-up|1|||
48704351|NCT03771664|156767272|FG001|Overall Study|Lost to Follow-up|0|||
48704352|NCT03771664|156767271|FG000|Overall Study|Withdrawal by Participant|1|||
48704353|NCT03771664|156767272|FG001|Overall Study|Withdrawal by Participant|4|||
48704354|NCT03771664|156767271|FG000|Overall Study|Randomized but not Treated|0|||
48704355|NCT03771664|156767272|FG001|Overall Study|Randomized but not Treated|1|||
48704356|NCT00831181|156767274|FG000|Overall Study|Adverse Event|12|||
48704357|NCT02004093|156767277|FG000|Overall Study|Death|2|||
48704358|NCT02004093|156767278|FG001|Overall Study|Death|1|||
48704359|NCT02004093|156767277|FG000|Overall Study|Lack of Efficacy|66|||
48704360|NCT02004093|156767278|FG001|Overall Study|Lack of Efficacy|62|||
48704361|NCT02004093|156767277|FG000|Overall Study|Protocol Violation|0|||
48704362|NCT02004093|156767278|FG001|Overall Study|Protocol Violation|1|||
48704363|NCT02004093|156767277|FG000|Overall Study|Lost to Follow-up|0|||
48704364|NCT02004093|156767278|FG001|Overall Study|Lost to Follow-up|1|||
48704365|NCT02004093|156767277|FG000|Overall Study|Withdrawal by Subject|3|||
48704366|NCT02004093|156767278|FG001|Overall Study|Withdrawal by Subject|7|||
48704367|NCT02004093|156767277|FG000|Overall Study|Other|3|||
48704368|NCT02004093|156767278|FG001|Overall Study|Other|1|||
48704369|NCT00930046|156767279|FG000|Overall Study|Wound catheter malfunctioned|1|||
48704370|NCT00930046|156767280|FG001|Overall Study|Wound catheter malfunctioned|2|||
48704371|NCT03345784|156767287|FG000|Overall Study|Withdrawal by Subject|2|||
48704372|NCT03345784|156767288|FG001|Overall Study|Withdrawal by Subject|1|||
48704373|NCT03216226|156767293|FG000|Overall Study|Adverse Event|3|||
48704374|NCT03216226|156767294|FG001|Overall Study|Adverse Event|0|||
48704375|NCT03216226|156767293|FG000|Overall Study|Protocol Violation|1|||
48704376|NCT03216226|156767294|FG001|Overall Study|Protocol Violation|3|||
48704377|NCT03216226|156767293|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
48704378|NCT03216226|156767294|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
48704379|NCT03216226|156767293|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
48704380|NCT03216226|156767294|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
48704381|NCT03216226|156767293|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
48704382|NCT03216226|156767294|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
48704383|NCT03131570|156767297|FG000|Overall Study|Adverse Event|1|||
48704384|NCT03131570|156767298|FG001|Overall Study|Adverse Event|0|||
48704385|NCT00830440|156767299|FG000|Overall Study|Protocol Violation|1|||
48704386|NCT00830440|156767300|FG001|Overall Study|Protocol Violation|0|||
48704387|NCT00830440|156767299|FG000|Overall Study|Withdrawal by Subject|1|||
48704388|NCT00830440|156767300|FG001|Overall Study|Withdrawal by Subject|0|||
48704389|NCT00830440|156767299|FG000|Overall Study|unsuccessful procedure|4|||
48704390|NCT00830440|156767300|FG001|Overall Study|unsuccessful procedure|0|||
48704391|NCT00830440|156767299|FG000|Overall Study|Adverse Event|2|||
48704392|NCT00830440|156767300|FG001|Overall Study|Adverse Event|0|||
48704393|NCT02592798|156767301|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
48704394|NCT02592798|156767302|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
48704395|NCT02592798|156767301|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
48704396|NCT02592798|156767302|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
48704397|NCT02592798|156767301|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
48704398|NCT02592798|156767302|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
48704399|NCT02592798|156767301|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
48704400|NCT02592798|156767302|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
48704401|NCT02592798|156767301|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
48704402|NCT02592798|156767302|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
48704403|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
48704404|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
48704405|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
48704406|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
48704407|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
48704408|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
48704409|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
48704410|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
48704411|NCT02592798|156767301|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
48704412|NCT02592798|156767302|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
48704413|NCT02592798|156767301|FG000|Transition From DB2 to OLE|Other reasons|1|||
48704414|NCT02592798|156767302|FG001|Transition From DB2 to OLE|Other reasons|0|||
48704415|NCT02592798|156767301|FG000|Open Label Period (OLE)|Other reasons|0|||
48704416|NCT02592798|156767302|FG001|Open Label Period (OLE)|Other reasons|2|||
48704417|NCT02592798|156767301|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
48704418|NCT02592798|156767302|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
48704419|NCT02592798|156767301|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
48704420|NCT02592798|156767302|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
48704421|NCT02592798|156767301|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
48704422|NCT02592798|156767302|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
48704423|NCT02592798|156767301|FG000|Open Label Period (OLE)|Adverse Event|0|||
48704424|NCT02592798|156767302|FG001|Open Label Period (OLE)|Adverse Event|1|||
48704425|NCT01519921|156767303|FG000|Overall Study|Adverse Event|10|||
48433889|NCT00516269|155777241|FG000|Overall Study|Adverse Event|2|||
48704426|NCT01519921|156767304|FG001|Overall Study|Adverse Event|9|||
48704427|NCT01519921|156767303|FG000|Overall Study|Lack of Efficacy|4|||
48704428|NCT01519921|156767304|FG001|Overall Study|Lack of Efficacy|3|||
48704429|NCT01519921|156767303|FG000|Overall Study|Withdrawal by Subject|3|||
48704430|NCT01519921|156767304|FG001|Overall Study|Withdrawal by Subject|0|||
48704431|NCT01519921|156767303|FG000|Overall Study|Lost to Follow-up|2|||
48704432|NCT01519921|156767304|FG001|Overall Study|Lost to Follow-up|1|||
48704433|NCT01519921|156767303|FG000|Overall Study|Treatment refusal|2|||
48704434|NCT01519921|156767304|FG001|Overall Study|Treatment refusal|1|||
48704435|NCT01519921|156767303|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
48704436|NCT01519921|156767304|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
48704437|NCT00705016|156767305|FG000|Overall Study|Adverse Event|6|||
48704438|NCT00705016|156767306|FG001|Overall Study|Adverse Event|11|||
48704439|NCT00705016|156767307|FG002|Overall Study|Adverse Event|10|||
48704440|NCT00705016|156767305|FG000|Overall Study|Death|5|||
48704441|NCT00705016|156767306|FG001|Overall Study|Death|7|||
48704442|NCT00705016|156767307|FG002|Overall Study|Death|5|||
48704443|NCT00705016|156767305|FG000|Overall Study|Protocol Violation|0|||
48704444|NCT00705016|156767306|FG001|Overall Study|Protocol Violation|1|||
48704445|NCT00705016|156767307|FG002|Overall Study|Protocol Violation|1|||
48704446|NCT00705016|156767305|FG000|Overall Study|Withdrawal by Subject|4|||
48704447|NCT00705016|156767306|FG001|Overall Study|Withdrawal by Subject|3|||
48704448|NCT00705016|156767307|FG002|Overall Study|Withdrawal by Subject|2|||
48704449|NCT00705016|156767305|FG000|Overall Study|Progressive Disease|33|||
48704450|NCT00705016|156767306|FG001|Overall Study|Progressive Disease|29|||
48704451|NCT00705016|156767307|FG002|Overall Study|Progressive Disease|33|||
48704452|NCT00705016|156767305|FG000|Overall Study|Symptomatic Deterioration|3|||
48704453|NCT00705016|156767306|FG001|Overall Study|Symptomatic Deterioration|1|||
48704454|NCT00705016|156767307|FG002|Overall Study|Symptomatic Deterioration|1|||
48704455|NCT00705016|156767305|FG000|Overall Study|Other|9|||
48704456|NCT00705016|156767306|FG001|Overall Study|Other|6|||
48704457|NCT00705016|156767307|FG002|Overall Study|Other|6|||
48704458|NCT00942604|156767311|FG000|Overall Study|Protocol Violation|1|||
48704459|NCT00942604|156767312|FG001|Overall Study|Protocol Violation|1|||
48704460|NCT00942604|156767311|FG000|Overall Study|Adverse Event|0|||
48704461|NCT00942604|156767312|FG001|Overall Study|Adverse Event|1|||
48704462|NCT00942604|156767311|FG000|Overall Study|Withdrawal by Subject|0|||
48704463|NCT00942604|156767312|FG001|Overall Study|Withdrawal by Subject|1|||
48704464|NCT00942604|156767311|FG000|Overall Study|Patient relocation|1|||
48704465|NCT00942604|156767312|FG001|Overall Study|Patient relocation|1|||
48704466|NCT01143246|156767313|FG000|Overall Study|Adverse Event|24|||
48704467|NCT01143246|156767314|FG001|Overall Study|Adverse Event|28|||
48704468|NCT01143246|156767313|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
48704469|NCT01143246|156767314|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
48704470|NCT01143246|156767313|FG000|Overall Study|Lost to Follow-up|0|||
48704471|NCT01143246|156767314|FG001|Overall Study|Lost to Follow-up|1|||
48704472|NCT01143246|156767313|FG000|Overall Study|Death|16|||
48704473|NCT01143246|156767314|FG001|Overall Study|Death|15|||
48704474|NCT01143246|156767313|FG000|Overall Study|Reason not Specified|3|||
48704475|NCT01143246|156767314|FG001|Overall Study|Reason not Specified|5|||
48704476|NCT04139798|156767317|FG000|Overall Study|Withdrawal by Subject|6|||
48704477|NCT04139798|156767318|FG001|Overall Study|Withdrawal by Subject|5|||
48704478|NCT04139798|156767317|FG000|Overall Study|Lost to Follow-up|2|||
48704479|NCT04139798|156767318|FG001|Overall Study|Lost to Follow-up|5|||
48704480|NCT04139798|156767317|FG000|Overall Study|Discontinued|4|||
48704481|NCT04139798|156767318|FG001|Overall Study|Discontinued|2|||
48704482|NCT04139798|156767317|FG000|Overall Study|Adverse Event|1|||
48704483|NCT04139798|156767318|FG001|Overall Study|Adverse Event|3|||
48704484|NCT04139798|156767317|FG000|Overall Study|Protocol Violation|1|||
48704485|NCT04139798|156767318|FG001|Overall Study|Protocol Violation|0|||
48704486|NCT00361296|156767321|FG000|Overall Study|Physician Decision|1|||
48704487|NCT00361296|156767321|FG000|Overall Study|Lack of Efficacy|2|||
48704488|NCT03155841|156767324|FG000|Overall Study|Protocol Violation|3|||
48704489|NCT03155841|156767325|FG001|Overall Study|Protocol Violation|4|||
48704490|NCT01499355|156767326|FG000|Run-In Period|Study Termination|15|||
48704491|NCT01499355|156767327|FG001|Run-In Period|Study Termination|0|||
48704492|NCT01499355|156767328|FG002|Run-In Period|Study Termination|0|||
48704493|NCT01499355|156767329|FG003|Run-In Period|Study Termination|0|||
48704494|NCT01499355|156767326|FG000|Run-In Period|Other|3|||
48704495|NCT01499355|156767327|FG001|Run-In Period|Other|0|||
48704496|NCT01499355|156767328|FG002|Run-In Period|Other|0|||
48704497|NCT01499355|156767329|FG003|Run-In Period|Other|0|||
48433890|NCT00516269|155777242|FG001|Overall Study|Adverse Event|1|||
48704498|NCT01499355|156767326|FG000|Run-In Period|Death|2|||
48704499|NCT01499355|156767327|FG001|Run-In Period|Death|0|||
48704500|NCT01499355|156767328|FG002|Run-In Period|Death|0|||
48704501|NCT01499355|156767329|FG003|Run-In Period|Death|0|||
48704502|NCT01499355|156767326|FG000|Run-In Period|Investigator Decision|2|||
48704503|NCT01499355|156767327|FG001|Run-In Period|Investigator Decision|0|||
48704504|NCT01499355|156767328|FG002|Run-In Period|Investigator Decision|0|||
48704505|NCT01499355|156767329|FG003|Run-In Period|Investigator Decision|0|||
48704506|NCT01499355|156767326|FG000|Run-In Period|Consent Withdrawn|1|||
48704507|NCT01499355|156767327|FG001|Run-In Period|Consent Withdrawn|0|||
48704508|NCT01499355|156767328|FG002|Run-In Period|Consent Withdrawn|0|||
48704509|NCT01499355|156767329|FG003|Run-In Period|Consent Withdrawn|0|||
48704510|NCT01499355|156767326|FG000|Run-In Period|Adverse Event|8|||
48704511|NCT01499355|156767327|FG001|Run-In Period|Adverse Event|0|||
48704512|NCT01499355|156767328|FG002|Run-In Period|Adverse Event|0|||
48704513|NCT01499355|156767329|FG003|Run-In Period|Adverse Event|0|||
48704514|NCT01499355|156767326|FG000|Double-Blind Period|Adverse Event|0|||
48704515|NCT01499355|156767327|FG001|Double-Blind Period|Adverse Event|2|||
48704516|NCT01499355|156767328|FG002|Double-Blind Period|Adverse Event|3|||
48704517|NCT01499355|156767329|FG003|Double-Blind Period|Adverse Event|2|||
48704518|NCT01499355|156767326|FG000|Double-Blind Period|Study Termination|0|||
48704519|NCT01499355|156767327|FG001|Double-Blind Period|Study Termination|18|||
48704520|NCT01499355|156767328|FG002|Double-Blind Period|Study Termination|16|||
48704521|NCT01499355|156767329|FG003|Double-Blind Period|Study Termination|14|||
48704522|NCT01499355|156767326|FG000|Double-Blind Period|Other|0|||
48704523|NCT01499355|156767327|FG001|Double-Blind Period|Other|1|||
48704524|NCT01499355|156767328|FG002|Double-Blind Period|Other|2|||
48704525|NCT01499355|156767329|FG003|Double-Blind Period|Other|2|||
48704526|NCT01499355|156767326|FG000|Double-Blind Period|Death|0|||
48704527|NCT01499355|156767327|FG001|Double-Blind Period|Death|1|||
48704528|NCT01499355|156767328|FG002|Double-Blind Period|Death|0|||
48704529|NCT01499355|156767329|FG003|Double-Blind Period|Death|0|||
48704530|NCT01499355|156767326|FG000|Double-Blind Period|Investigator Decision|0|||
48704531|NCT01499355|156767327|FG001|Double-Blind Period|Investigator Decision|0|||
48704532|NCT01499355|156767328|FG002|Double-Blind Period|Investigator Decision|3|||
48704533|NCT01499355|156767329|FG003|Double-Blind Period|Investigator Decision|3|||
48704534|NCT01499355|156767326|FG000|Double-Blind Period|Consent Withdrawn|0|||
48704535|NCT01499355|156767327|FG001|Double-Blind Period|Consent Withdrawn|0|||
48704536|NCT01499355|156767328|FG002|Double-Blind Period|Consent Withdrawn|1|||
48704537|NCT01499355|156767329|FG003|Double-Blind Period|Consent Withdrawn|2|||
48704538|NCT01499355|156767326|FG000|Double-Blind Period|Lost to Follow-up|0|||
48704539|NCT01499355|156767327|FG001|Double-Blind Period|Lost to Follow-up|1|||
48704540|NCT01499355|156767328|FG002|Double-Blind Period|Lost to Follow-up|0|||
48704541|NCT01499355|156767329|FG003|Double-Blind Period|Lost to Follow-up|0|||
48704542|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
48704543|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
48704544|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
48704545|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
48704546|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
48704547|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
48704548|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
48704549|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
48704550|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
48704551|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
48704552|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
48704553|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
48704554|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
48704555|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
48704556|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
48704557|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
48704558|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
48704559|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
48704560|NCT02952820|156767336|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
48704561|NCT02952820|156767337|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
48704562|NCT02952820|156767338|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
48704563|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
48704564|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
48704565|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
48704566|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
48704567|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
48704568|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
48704569|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
48704570|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
48704571|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
48704572|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
48704573|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
48704574|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
48704575|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
48704576|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
48704577|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
48704578|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
48704579|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
48704580|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
48704581|NCT02952820|156767336|FG000|Active Treatment Period (6 Months)|Not treated|0|||
48704582|NCT02952820|156767337|FG001|Active Treatment Period (6 Months)|Not treated|0|||
48704583|NCT02952820|156767338|FG002|Active Treatment Period (6 Months)|Not treated|1|||
48704584|NCT01929317|156767339|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
48704585|NCT01929317|156767340|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
48704586|NCT01929317|156767339|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
48704587|NCT01929317|156767340|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
48704588|NCT01929317|156767339|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
48704589|NCT01929317|156767340|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
48704590|NCT01929317|156767339|FG000|Long-term Phase|Adverse Event|5|||
48704591|NCT01929317|156767340|FG001|Long-term Phase|Adverse Event|1|||
48704592|NCT01929317|156767339|FG000|Long-term Phase|Physician Decision|3|||
48704593|NCT01929317|156767340|FG001|Long-term Phase|Physician Decision|0|||
48704594|NCT01929317|156767339|FG000|Long-term Phase|Withdrawal by Subject|4|||
48704595|NCT01929317|156767340|FG001|Long-term Phase|Withdrawal by Subject|0|||
48704596|NCT01929317|156767339|FG000|Long-term Phase|Protocol Violation|1|||
48704597|NCT01929317|156767340|FG001|Long-term Phase|Protocol Violation|0|||
48704598|NCT01929317|156767339|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
48704599|NCT01929317|156767340|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
48704600|NCT01929317|156767339|FG000|Long-term Phase|Study Closed/Terminated|5|||
48704601|NCT01929317|156767340|FG001|Long-term Phase|Study Closed/Terminated|3|||
48704602|NCT02395081|156767341|FG000|Overall Study|Withdrawal by Subject|1|||
48704603|NCT02395081|156767342|FG001|Overall Study|Withdrawal by Subject|1|||
48704604|NCT02395081|156767343|FG002|Overall Study|Withdrawal by Subject|0|||
48704605|NCT02395081|156767341|FG000|Overall Study|Moved where blood couldn't be collected|4|||
48704606|NCT02395081|156767342|FG001|Overall Study|Moved where blood couldn't be collected|1|||
48704607|NCT02395081|156767343|FG002|Overall Study|Moved where blood couldn't be collected|3|||
48704608|NCT02395081|156767341|FG000|Overall Study|Fetal Loss|2|||
48704609|NCT02395081|156767342|FG001|Overall Study|Fetal Loss|3|||
48704610|NCT02395081|156767343|FG002|Overall Study|Fetal Loss|1|||
48704611|NCT02157883|156767344|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
48704612|NCT02157883|156767344|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
48704613|NCT02157883|156767344|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
48704614|NCT02157883|156767344|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
48704615|NCT02157883|156767344|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
48704616|NCT01523756|156767345|FG000|Baseline Period|Adverse Event|0|||
48704617|NCT01523756|156767346|FG001|Baseline Period|Adverse Event|1|||
48704618|NCT01523756|156767345|FG000|Test Period 1|Adverse Event|1|||
48704619|NCT01523756|156767346|FG001|Test Period 1|Adverse Event|0|||
48704620|NCT01523756|156767345|FG000|Test Period 2|Withdrawal by Subject|0|||
48704621|NCT01523756|156767346|FG001|Test Period 2|Withdrawal by Subject|1|||
48704622|NCT01578486|156767347|FG000|Overall Study|Physician Decision|3|||
48704623|NCT01578486|156767347|FG000|Overall Study|Withdrawal by Subject|2|||
48704624|NCT02536963|156767348|FG000|Overall Study|Withdrawal by Subject|18|||
48704625|NCT04292899|156767349|FG000|Overall Study|Death|21|||
48704626|NCT04292899|156767350|FG001|Overall Study|Death|28|||
48704627|NCT04292899|156767351|FG002|Overall Study|Death|188|||
48704628|NCT04292899|156767352|FG003|Overall Study|Death|371|||
48704629|NCT04292899|156767349|FG000|Overall Study|Lost to Follow-up|8|||
48704630|NCT04292899|156767350|FG001|Overall Study|Lost to Follow-up|4|||
48704631|NCT04292899|156767351|FG002|Overall Study|Lost to Follow-up|22|||
48704632|NCT04292899|156767352|FG003|Overall Study|Lost to Follow-up|235|||
48704633|NCT04292899|156767349|FG000|Overall Study|Withdrew consent|1|||
48704634|NCT04292899|156767350|FG001|Overall Study|Withdrew consent|0|||
48704635|NCT04292899|156767351|FG002|Overall Study|Withdrew consent|11|||
48704636|NCT04292899|156767352|FG003|Overall Study|Withdrew consent|32|||
48704637|NCT04292899|156767349|FG000|Overall Study|Adverse Event|2|||
48704638|NCT04292899|156767350|FG001|Overall Study|Adverse Event|1|||
48704639|NCT04292899|156767351|FG002|Overall Study|Adverse Event|2|||
48704640|NCT04292899|156767352|FG003|Overall Study|Adverse Event|2|||
48704641|NCT04292899|156767349|FG000|Overall Study|Investigator's Discretion|0|||
48704642|NCT04292899|156767350|FG001|Overall Study|Investigator's Discretion|0|||
48704643|NCT04292899|156767351|FG002|Overall Study|Investigator's Discretion|0|||
48704644|NCT04292899|156767352|FG003|Overall Study|Investigator's Discretion|3|||
48704645|NCT04292899|156767349|FG000|Overall Study|Non-compliance With Study Drug|0|||
48704646|NCT04292899|156767350|FG001|Overall Study|Non-compliance With Study Drug|0|||
48704647|NCT04292899|156767351|FG002|Overall Study|Non-compliance With Study Drug|0|||
48704648|NCT04292899|156767352|FG003|Overall Study|Non-compliance With Study Drug|1|||
48704649|NCT04292899|156767349|FG000|Overall Study|Protocol Violation|0|||
48704650|NCT04292899|156767350|FG001|Overall Study|Protocol Violation|0|||
48704651|NCT04292899|156767351|FG002|Overall Study|Protocol Violation|0|||
48704652|NCT04292899|156767352|FG003|Overall Study|Protocol Violation|1|||
48704653|NCT00068419|156767354|FG000|Overall Study|Adverse Event|3|||
48704654|NCT00068419|156767354|FG000|Overall Study|Lack of Efficacy|24|||
48704655|NCT00068419|156767354|FG000|Overall Study|Lost to Follow-up|1|||
48704656|NCT00068419|156767354|FG000|Overall Study|Physician Decision|7|||
48704657|NCT00068419|156767354|FG000|Overall Study|Withdrawal by Subject|14|||
48704658|NCT00068419|156767354|FG000|Overall Study|Ineligible|11|||
48704659|NCT02628873|156767355|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
48704660|NCT02628873|156767356|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
48704661|NCT02628873|156767355|FG000|Second Test (1 Hour)|Physician Decision|1|||
48704662|NCT02628873|156767356|FG001|Second Test (1 Hour)|Physician Decision|0|||
48704663|NCT04237116|156767358|FG000|Overall Study|Adverse Event|0|||
48704664|NCT04237116|156767359|FG001|Overall Study|Adverse Event|1|||
48704665|NCT04237116|156767358|FG000|Overall Study|Study terminated by Sponsor|4|||
48704666|NCT04237116|156767359|FG001|Overall Study|Study terminated by Sponsor|1|||
48704667|NCT00755183|156769256|FG000|Overall Study|Adverse Event|5|||
48704668|NCT00755183|156769257|FG001|Overall Study|Adverse Event|2|||
48704669|NCT00755183|156769256|FG000|Overall Study|Protocol Violation|0|||
48704670|NCT00755183|156769257|FG001|Overall Study|Protocol Violation|1|||
48704671|NCT00755183|156769256|FG000|Overall Study|Withdrawal by Subject|0|||
48704672|NCT00755183|156769257|FG001|Overall Study|Withdrawal by Subject|2|||
48704673|NCT00755183|156769256|FG000|Overall Study|Administrative|2|||
48704674|NCT00755183|156769257|FG001|Overall Study|Administrative|1|||
48595746|NCT04227405|156377777|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
48595747|NCT04227405|156377778|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
48595748|NCT04227405|156377777|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
48595749|NCT04227405|156377778|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
48595750|NCT01190189|156377779|FG000|Overall Study|Lost to Follow-up|4|||
48595751|NCT01190189|156377779|FG000|Overall Study|Withdrawal by Subject|1|||
48704675|NCT00148317|156769258|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
48704676|NCT00148317|156769258|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
48704677|NCT00148317|156769258|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
48704678|NCT00335777|156769260|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
48704679|NCT00335777|156769260|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
48704680|NCT00335777|156769260|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
48704681|NCT00335777|156769260|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
48704682|NCT00335777|156769260|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
48704683|NCT02419001|156769263|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
48704684|NCT02419001|156769264|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
48704685|NCT01524796|156769269|FG000|Overall Study|Adverse Event|13|||
48704686|NCT01524796|156769269|FG000|Overall Study|Lack of Efficacy|3|||
48704687|NCT01524796|156769269|FG000|Overall Study|Lost to Follow-up|1|||
48704688|NCT01524796|156769269|FG000|Overall Study|The price|1|||
48704689|NCT01524796|156769269|FG000|Overall Study|Withdrawal by Subject|4|||
48704690|NCT01524796|156769269|FG000|Overall Study|Move|1|||
48704691|NCT01524796|156769269|FG000|Overall Study|Deterioration of pains|1|||
48704692|NCT01524796|156769269|FG000|Overall Study|Gall stone surgery|1|||
48704693|NCT01524796|156769269|FG000|Overall Study|Nervous about confidentiality|1|||
48704694|NCT01524796|156769269|FG000|Overall Study|Switch to carbamazapine|1|||
48704695|NCT01524796|156769269|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
48704696|NCT00943618|156769270|FG000|Overall Study|Lost to Follow-up|38|||
48704697|NCT00943618|156769271|FG001|Overall Study|Lost to Follow-up|48|||
48704698|NCT00943618|156769272|FG002|Overall Study|Lost to Follow-up|20|||
48704699|NCT00943618|156769270|FG000|Overall Study|Discontinued Medication|17|||
48704700|NCT00943618|156769271|FG001|Overall Study|Discontinued Medication|29|||
48704701|NCT00943618|156769272|FG002|Overall Study|Discontinued Medication|11|||
48704702|NCT01532986|156769273|FG000|Overall Study|Death|9|||
48704703|NCT01532986|156769274|FG001|Overall Study|Death|9|||
48704704|NCT01532986|156769273|FG000|Overall Study|Withdrawal by Subject|7|||
48704705|NCT01532986|156769274|FG001|Overall Study|Withdrawal by Subject|10|||
48704706|NCT01532986|156769273|FG000|Overall Study|Physician Decision|7|||
48704707|NCT01532986|156769274|FG001|Overall Study|Physician Decision|5|||
48704708|NCT02120898|156769277|FG000|Overall Study|Withdrawal by Subject|4|||
48704709|NCT02120898|156769278|FG001|Overall Study|Withdrawal by Subject|2|||
48704710|NCT02120898|156769279|FG002|Overall Study|Withdrawal by Subject|2|||
48704711|NCT02120898|156769277|FG000|Overall Study|Non-compliance with study drug|3|||
48704712|NCT02120898|156769278|FG001|Overall Study|Non-compliance with study drug|0|||
48704713|NCT02120898|156769279|FG002|Overall Study|Non-compliance with study drug|0|||
48704714|NCT02120898|156769277|FG000|Overall Study|Adverse Event|1|||
48704715|NCT02120898|156769278|FG001|Overall Study|Adverse Event|2|||
48704716|NCT02120898|156769279|FG002|Overall Study|Adverse Event|1|||
48704717|NCT02120898|156769277|FG000|Overall Study|Protocol Violation|1|||
48704718|NCT02120898|156769278|FG001|Overall Study|Protocol Violation|2|||
48704719|NCT02120898|156769279|FG002|Overall Study|Protocol Violation|0|||
48704720|NCT02120898|156769277|FG000|Overall Study|Lost to Follow-up|0|||
48704721|NCT02120898|156769278|FG001|Overall Study|Lost to Follow-up|0|||
48704722|NCT02120898|156769279|FG002|Overall Study|Lost to Follow-up|1|||
48704723|NCT01472289|156769280|FG000|Overall Study|Death|2|||
48704724|NCT02863419|156769281|FG000|Overall Study|Lost to Follow-up|0|||
48704725|NCT02863419|156769282|FG001|Overall Study|Lost to Follow-up|1|||
48704726|NCT02863419|156769283|FG002|Overall Study|Lost to Follow-up|4|||
48704727|NCT02863419|156769281|FG000|Overall Study|Withdrawal by Subject|5|||
48704728|NCT02863419|156769282|FG001|Overall Study|Withdrawal by Subject|5|||
48704729|NCT02863419|156769283|FG002|Overall Study|Withdrawal by Subject|3|||
48704730|NCT02863419|156769281|FG000|Overall Study|Died|3|||
48704731|NCT02863419|156769282|FG001|Overall Study|Died|4|||
48704732|NCT02863419|156769283|FG002|Overall Study|Died|1|||
48704733|NCT05021978|156769286|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
48704734|NCT05021978|156769287|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
48704735|NCT05021978|156769288|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
48704736|NCT05021978|156769289|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
48704737|NCT05021978|156769286|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
48704738|NCT05021978|156769287|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
48704739|NCT05021978|156769288|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
48704740|NCT05021978|156769289|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
48704741|NCT04004988|156769290|FG000|Period 1|Physician Decision|2|||
48704742|NCT04004988|156769291|FG001|Period 1|Physician Decision|0|||
48704743|NCT04004988|156769290|FG000|Period 1|Withdrawal by Subject|0|||
48704744|NCT04004988|156769291|FG001|Period 1|Withdrawal by Subject|1|||
48704745|NCT04004988|156769290|FG000|Period 1|Adverse Event|1|||
48704746|NCT04004988|156769291|FG001|Period 1|Adverse Event|2|||
48704747|NCT00414596|156769294|FG000|Overall Study|Protocol Violation|2|||
48704748|NCT00658359|156769296|FG000|Overall Study|Death|3|||
48704749|NCT00658359|156769297|FG001|Overall Study|Death|1|||
48704750|NCT00658359|156769298|FG002|Overall Study|Death|2|||
48704751|NCT00658359|156769296|FG000|Overall Study|Adverse Event|13|||
48704752|NCT00658359|156769297|FG001|Overall Study|Adverse Event|6|||
48704753|NCT00658359|156769298|FG002|Overall Study|Adverse Event|9|||
48704754|NCT00658359|156769296|FG000|Overall Study|Protocol Violation|1|||
48704755|NCT00658359|156769297|FG001|Overall Study|Protocol Violation|0|||
48704756|NCT00658359|156769298|FG002|Overall Study|Protocol Violation|0|||
48704757|NCT00658359|156769296|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
48704758|NCT00658359|156769297|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
48704759|NCT00658359|156769298|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
48704760|NCT00658359|156769296|FG000|Overall Study|Withdrawal by Subject|7|||
48704761|NCT00658359|156769297|FG001|Overall Study|Withdrawal by Subject|4|||
48704762|NCT00658359|156769298|FG002|Overall Study|Withdrawal by Subject|2|||
48704763|NCT00658359|156769296|FG000|Overall Study|Lost to Follow-up|2|||
48704764|NCT00658359|156769297|FG001|Overall Study|Lost to Follow-up|2|||
48704765|NCT00658359|156769298|FG002|Overall Study|Lost to Follow-up|4|||
48704766|NCT00658359|156769296|FG000|Overall Study|Lack of Efficacy|0|||
48704767|NCT00658359|156769297|FG001|Overall Study|Lack of Efficacy|1|||
48704768|NCT00658359|156769298|FG002|Overall Study|Lack of Efficacy|0|||
48704769|NCT02919995|156769299|FG000|Overall Study|Adverse Event|0|||
48704770|NCT02919995|156769300|FG001|Overall Study|Adverse Event|0|||
48704771|NCT02919995|156769301|FG002|Overall Study|Adverse Event|0|||
48704772|NCT02919995|156769302|FG003|Overall Study|Adverse Event|0|||
48704773|NCT02919995|156769303|FG004|Overall Study|Adverse Event|0|||
48704774|NCT02919995|156769304|FG005|Overall Study|Adverse Event|1|||
48704775|NCT00297258|156769306|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
48704776|NCT00297258|156769306|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
48704777|NCT00297258|156769306|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
48704778|NCT00297258|156769306|FG000|Overall Study|Intercurrent Illness|3|||
48704779|NCT00297258|156769306|FG000|Overall Study|Intercurrent Death|2|||
48704780|NCT00297258|156769306|FG000|Overall Study|Deteriorization of General Condition|1|||
48704781|NCT00297258|156769306|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
48704782|NCT00297258|156769306|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
48704783|NCT00297258|156769306|FG000|Overall Study|Switch to Commercial Treatment|1|||
48704784|NCT00297258|156769306|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
48704785|NCT01263197|156769307|FG000|First Intervention (Period 1)|Adverse Event|0|||
48704786|NCT01263197|156769308|FG001|First Intervention (Period 1)|Adverse Event|0|||
48704787|NCT01263197|156769309|FG002|First Intervention (Period 1)|Adverse Event|0|||
48704788|NCT01263197|156769310|FG003|First Intervention (Period 1)|Adverse Event|0|||
48704789|NCT01263197|156769311|FG004|First Intervention (Period 1)|Adverse Event|0|||
48704790|NCT01263197|156769312|FG005|First Intervention (Period 1)|Adverse Event|1|||
48704791|NCT01263197|156769307|FG000|Washout Period 1|Protocol Violation|0|||
48704792|NCT01263197|156769308|FG001|Washout Period 1|Protocol Violation|0|||
48704793|NCT01263197|156769309|FG002|Washout Period 1|Protocol Violation|0|||
48704794|NCT01263197|156769310|FG003|Washout Period 1|Protocol Violation|0|||
48704795|NCT01263197|156769311|FG004|Washout Period 1|Protocol Violation|1|||
48704796|NCT01263197|156769312|FG005|Washout Period 1|Protocol Violation|0|||
48704797|NCT01263197|156769307|FG000|Washout Period 2|Physician Decision|0|||
48704798|NCT01263197|156769308|FG001|Washout Period 2|Physician Decision|0|||
48704799|NCT01263197|156769309|FG002|Washout Period 2|Physician Decision|0|||
48704800|NCT01263197|156769310|FG003|Washout Period 2|Physician Decision|0|||
48704801|NCT01263197|156769311|FG004|Washout Period 2|Physician Decision|0|||
48704802|NCT01263197|156769312|FG005|Washout Period 2|Physician Decision|1|||
48704803|NCT01263197|156769307|FG000|Washout Period 2|Protocol Violation|0|||
48704804|NCT01263197|156769308|FG001|Washout Period 2|Protocol Violation|0|||
48704805|NCT01263197|156769309|FG002|Washout Period 2|Protocol Violation|0|||
48704806|NCT01263197|156769310|FG003|Washout Period 2|Protocol Violation|1|||
48704807|NCT01263197|156769311|FG004|Washout Period 2|Protocol Violation|0|||
48704808|NCT01263197|156769312|FG005|Washout Period 2|Protocol Violation|0|||
48704809|NCT01263197|156769307|FG000|Third Intervention (Period 3)|Adverse Event|0|||
48704810|NCT01263197|156769308|FG001|Third Intervention (Period 3)|Adverse Event|1|||
48704811|NCT01263197|156769309|FG002|Third Intervention (Period 3)|Adverse Event|0|||
48704812|NCT01263197|156769310|FG003|Third Intervention (Period 3)|Adverse Event|0|||
48704813|NCT01263197|156769311|FG004|Third Intervention (Period 3)|Adverse Event|0|||
48704814|NCT01263197|156769312|FG005|Third Intervention (Period 3)|Adverse Event|0|||
48704815|NCT01055197|156769313|FG000|Overall Study|Protocol Violation|7|||
48704816|NCT01055197|156769314|FG001|Overall Study|Protocol Violation|2|||
48704817|NCT01055197|156769313|FG000|Overall Study|Withdrawal by Subject|2|||
48704818|NCT01055197|156769314|FG001|Overall Study|Withdrawal by Subject|0|||
48704819|NCT03818321|156769315|FG000|Overall Study|Withdrawal by Subject|1|||
48704820|NCT03818321|156769316|FG001|Overall Study|Withdrawal by Subject|2|||
48704821|NCT01470326|156769317|FG000|Overall Study|Protocol Violation|32|||
48704822|NCT01470326|156769317|FG000|Overall Study|No Drug Administration Information|2|||
48704823|NCT01470326|156769317|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
48704824|NCT01166282|156769318|FG000|Open-label Period|Adverse Event|0|||
48704825|NCT01166282|156769319|FG001|Open-label Period|Adverse Event|0|||
48704826|NCT01166282|156769320|FG002|Open-label Period|Adverse Event|6|||
48704827|NCT01166282|156769318|FG000|Open-label Period|Withdrawal by Subject|0|||
48704828|NCT01166282|156769319|FG001|Open-label Period|Withdrawal by Subject|0|||
48704829|NCT01166282|156769320|FG002|Open-label Period|Withdrawal by Subject|4|||
48704830|NCT01166282|156769318|FG000|Open-label Period|Lack of Efficacy|0|||
48704831|NCT01166282|156769319|FG001|Open-label Period|Lack of Efficacy|0|||
48704832|NCT01166282|156769320|FG002|Open-label Period|Lack of Efficacy|2|||
48704833|NCT01166282|156769318|FG000|Open-label Period|Remission|0|||
48704834|NCT01166282|156769319|FG001|Open-label Period|Remission|0|||
48704835|NCT01166282|156769320|FG002|Open-label Period|Remission|4|||
48704836|NCT01166282|156769318|FG000|Open-label Period|Irregular Compliance|0|||
48704837|NCT01166282|156769319|FG001|Open-label Period|Irregular Compliance|0|||
48704838|NCT01166282|156769320|FG002|Open-label Period|Irregular Compliance|1|||
48704839|NCT00811018|156769323|FG000|Overall Study|Additional Chronic Treatment|31|||
48704840|NCT00811018|156769323|FG000|Overall Study|Adverse Event|79|||
48704841|NCT00811018|156769323|FG000|Overall Study|Death|147|||
48704842|NCT00811018|156769323|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
48704843|NCT00811018|156769323|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
48704844|NCT00811018|156769323|FG000|Overall Study|Investigator Decision|57|||
48704845|NCT00811018|156769323|FG000|Overall Study|Lost to Follow-up|19|||
48704846|NCT00811018|156769323|FG000|Overall Study|Pregnancy|6|||
48704847|NCT00811018|156769323|FG000|Overall Study|Sponsor Decision|450|||
48704848|NCT00811018|156769323|FG000|Overall Study|Withdrawal by Subject|70|||
48704849|NCT00811018|156769323|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
48704850|NCT00811018|156769323|FG000|Overall Study|Other|26|||
48704851|NCT00345358|156769331|FG000|Primary Vaccination Phase|Other|0|||
48704852|NCT00345358|156769332|FG001|Primary Vaccination Phase|Other|1|||
48704853|NCT00345358|156769333|FG002|Primary Vaccination Phase|Other|1|||
48704854|NCT00345358|156769334|FG003|Primary Vaccination Phase|Other|0|||
48704855|NCT00345358|156769331|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
48704856|NCT00345358|156769332|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
48704857|NCT00345358|156769333|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
48704858|NCT00345358|156769334|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
48704859|NCT00345358|156769331|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
48704860|NCT00345358|156769332|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
48704861|NCT00345358|156769333|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
48704862|NCT00345358|156769334|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
48704863|NCT00345358|156769331|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
48704864|NCT00345358|156769332|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
48704865|NCT00345358|156769333|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
48704866|NCT00345358|156769334|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
48704867|NCT00345358|156769331|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
48704868|NCT00345358|156769332|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
48704869|NCT00345358|156769333|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
48704870|NCT00345358|156769334|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
48704871|NCT00345358|156769331|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
48704872|NCT00345358|156769332|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
48704873|NCT00345358|156769333|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
48704874|NCT00345358|156769334|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
48704875|NCT02892448|156769336|FG000|Overall Study|Screening failure|2|||
48704876|NCT02892448|156769337|FG001|Overall Study|Screening failure|2|||
48704877|NCT02892448|156769338|FG002|Overall Study|Screening failure|1|||
48704878|NCT01012440|156769341|FG000|Overall Study|Withdrawal by Subject|2|||
48704879|NCT01867671|156769342|FG000|Overall Study|Adverse Event|5|||
48704880|NCT01867671|156769343|FG001|Overall Study|Adverse Event|3|||
48704881|NCT01867671|156769342|FG000|Overall Study|Anaphylaxis|0|||
48704882|NCT01867671|156769343|FG001|Overall Study|Anaphylaxis|1|||
48704883|NCT01867671|156769342|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
48704884|NCT01867671|156769343|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
48704885|NCT01867671|156769342|FG000|Overall Study|Lost to Follow-up|0|||
48704886|NCT01867671|156769343|FG001|Overall Study|Lost to Follow-up|1|||
48704887|NCT01867671|156769342|FG000|Overall Study|Non-compliance with Study Drug|1|||
48704888|NCT01867671|156769343|FG001|Overall Study|Non-compliance with Study Drug|2|||
48704889|NCT01867671|156769342|FG000|Overall Study|Withdrawal by Subject|21|||
48704890|NCT01867671|156769343|FG001|Overall Study|Withdrawal by Subject|21|||
48704891|NCT03599089|156769344|FG000|Overall Study|Lost to Follow-up|1|||
48704892|NCT03599089|156769345|FG001|Overall Study|Lost to Follow-up|0|||
48704893|NCT03599089|156769346|FG002|Overall Study|Lost to Follow-up|0|||
48704894|NCT03599089|156769347|FG003|Overall Study|Lost to Follow-up|0|||
48704895|NCT03599089|156769344|FG000|Overall Study|Withdrawal by Subject|2|||
48704896|NCT03599089|156769345|FG001|Overall Study|Withdrawal by Subject|1|||
48704897|NCT03599089|156769346|FG002|Overall Study|Withdrawal by Subject|0|||
48704898|NCT03599089|156769347|FG003|Overall Study|Withdrawal by Subject|0|||
48704899|NCT03599089|156769344|FG000|Overall Study|Lack of Efficacy|0|||
48704900|NCT03599089|156769345|FG001|Overall Study|Lack of Efficacy|0|||
48704901|NCT03599089|156769346|FG002|Overall Study|Lack of Efficacy|1|||
48704902|NCT03599089|156769347|FG003|Overall Study|Lack of Efficacy|2|||
48704903|NCT01523366|156769348|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48704904|NCT01523366|156769349|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48704905|NCT01523366|156769348|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
48704906|NCT01523366|156769349|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
48704907|NCT00131248|156769350|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
48704908|NCT00131248|156769351|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
48704909|NCT02504151|156769354|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
48704910|NCT02504151|156769355|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
48704911|NCT02504151|156769354|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
48704912|NCT02504151|156769355|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
48704913|NCT02504151|156769354|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48704914|NCT02504151|156769355|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48704915|NCT02504151|156769354|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
48704916|NCT02504151|156769355|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
48704917|NCT00318643|156769356|FG000|Overall Study|Adverse Event|0|||
48704918|NCT00318643|156769357|FG001|Overall Study|Adverse Event|0|||
48704919|NCT00318643|156769358|FG002|Overall Study|Adverse Event|0|||
48704920|NCT00318643|156769359|FG003|Overall Study|Adverse Event|0|||
48704921|NCT00318643|156769360|FG004|Overall Study|Adverse Event|1|||
48704922|NCT00318643|156769356|FG000|Overall Study|Participant's Decision|0|||
48704923|NCT00318643|156769357|FG001|Overall Study|Participant's Decision|0|||
48704924|NCT00318643|156769358|FG002|Overall Study|Participant's Decision|0|||
48704925|NCT00318643|156769359|FG003|Overall Study|Participant's Decision|0|||
48704926|NCT00318643|156769360|FG004|Overall Study|Participant's Decision|1|||
48704927|NCT00318643|156769356|FG000|Overall Study|Investigator's Decision|0|||
48704928|NCT00318643|156769357|FG001|Overall Study|Investigator's Decision|0|||
48704929|NCT00318643|156769358|FG002|Overall Study|Investigator's Decision|0|||
48704930|NCT00318643|156769359|FG003|Overall Study|Investigator's Decision|0|||
48704931|NCT00318643|156769360|FG004|Overall Study|Investigator's Decision|1|||
48704932|NCT03051178|156769361|FG000|Overall Study|Withdrawal by Subject|5|||
48704933|NCT01454102|156769362|FG000|Overall Study|Continuing in the treatment period|0|||
48704934|NCT01454102|156769363|FG001|Overall Study|Continuing in the treatment period|0|||
48704935|NCT01454102|156769364|FG002|Overall Study|Continuing in the treatment period|0|||
48704936|NCT01454102|156769365|FG003|Overall Study|Continuing in the treatment period|0|||
48704937|NCT01454102|156769366|FG004|Overall Study|Continuing in the treatment period|3|||
48704938|NCT01454102|156769367|FG005|Overall Study|Continuing in the treatment period|3|||
48704939|NCT01454102|156769368|FG006|Overall Study|Continuing in the treatment period|2|||
48704940|NCT01454102|156769369|FG007|Overall Study|Continuing in the treatment period|0|||
48704941|NCT01454102|156769370|FG008|Overall Study|Continuing in the treatment period|1|||
48704942|NCT01454102|156769371|FG009|Overall Study|Continuing in the treatment period|0|||
48704943|NCT01454102|156769372|FG010|Overall Study|Continuing in the treatment period|0|||
48704944|NCT01454102|156769373|FG011|Overall Study|Continuing in the treatment period|4|||
48704945|NCT01454102|156769374|FG012|Overall Study|Continuing in the treatment period|7|||
48704946|NCT01454102|156769375|FG013|Overall Study|Continuing in the treatment period|4|||
48704947|NCT01454102|156769376|FG014|Overall Study|Continuing in the treatment period|3|||
48704948|NCT01454102|156769377|FG015|Overall Study|Continuing in the treatment period|1|||
48704949|NCT00760617|156769381|FG000|Overall Study|Adverse Event|5|||
48704950|NCT00760617|156769382|FG001|Overall Study|Adverse Event|2|||
48704951|NCT00760617|156769383|FG002|Overall Study|Adverse Event|0|||
48704952|NCT00760617|156769381|FG000|Overall Study|Lost to Follow-up|0|||
48704953|NCT00760617|156769382|FG001|Overall Study|Lost to Follow-up|0|||
48704954|NCT00760617|156769383|FG002|Overall Study|Lost to Follow-up|5|||
48704955|NCT01094119|156769385|FG000|Overall Study|Lack of Efficacy|2|||
48704956|NCT01094119|156769386|FG001|Overall Study|Lack of Efficacy|4|||
48704957|NCT01286480|156769388|FG000|Overall Study|Withdrawal by Subject|5|||
48704958|NCT01286480|156769389|FG001|Overall Study|Withdrawal by Subject|3|||
48704959|NCT00993967|156769390|FG000|Overall Study|Adverse Event|8|||
48704960|NCT00993967|156769390|FG000|Overall Study|Death|1|||
48704961|NCT00993967|156769390|FG000|Overall Study|Lost to Follow-up|14|||
48704962|NCT00993967|156769390|FG000|Overall Study|Withdrawal by Subject|36|||
48704963|NCT00993967|156769390|FG000|Overall Study|Protocol Violation|2|||
48704964|NCT00888940|156769391|FG000|Overall Study|Adverse Event|12|||
48704965|NCT00888940|156769392|FG001|Overall Study|Adverse Event|3|||
48704966|NCT00888940|156769391|FG000|Overall Study|Lost to Follow-up|5|||
48704967|NCT00888940|156769392|FG001|Overall Study|Lost to Follow-up|5|||
48704968|NCT00888940|156769391|FG000|Overall Study|Randomized Not Treated|11|||
48704969|NCT00888940|156769392|FG001|Overall Study|Randomized Not Treated|13|||
48704970|NCT02141204|156769395|FG000|Overall Study|Lost to Follow-up|2|||
48704971|NCT02141204|156769396|FG001|Overall Study|Lost to Follow-up|1|||
48704972|NCT02141204|156769395|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
48490024|NCT01078623|155988836|FG010|Treatment Period 2|Withdrawal by Subject|0|||
48704973|NCT02141204|156769396|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
48704974|NCT02141204|156769395|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
48704975|NCT02141204|156769396|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
48704976|NCT02141204|156769395|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
48704977|NCT02141204|156769396|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
48704978|NCT03224819|156769397|FG000|Overall Study|Withdrawal by Subject|0|||
48704979|NCT03224819|156769398|FG001|Overall Study|Withdrawal by Subject|0|||
48704980|NCT03224819|156769399|FG002|Overall Study|Withdrawal by Subject|0|||
48704981|NCT03224819|156769400|FG003|Overall Study|Withdrawal by Subject|0|||
48704982|NCT03224819|156769401|FG004|Overall Study|Withdrawal by Subject|0|||
48704983|NCT03224819|156769402|FG005|Overall Study|Withdrawal by Subject|0|||
48704984|NCT03224819|156769403|FG006|Overall Study|Withdrawal by Subject|0|||
48704985|NCT03224819|156769404|FG007|Overall Study|Withdrawal by Subject|0|||
48704986|NCT03224819|156769405|FG008|Overall Study|Withdrawal by Subject|0|||
48704987|NCT03224819|156769406|FG009|Overall Study|Withdrawal by Subject|0|||
48704988|NCT03224819|156769407|FG010|Overall Study|Withdrawal by Subject|0|||
48704989|NCT03224819|156769408|FG011|Overall Study|Withdrawal by Subject|0|||
48704990|NCT03224819|156769409|FG012|Overall Study|Withdrawal by Subject|1|||
48704991|NCT03224819|156769410|FG013|Overall Study|Withdrawal by Subject|0|||
48704992|NCT03224819|156769397|FG000|Overall Study|Sponsor Decision|0|||
48704993|NCT03224819|156769398|FG001|Overall Study|Sponsor Decision|0|||
48704994|NCT03224819|156769399|FG002|Overall Study|Sponsor Decision|0|||
48704995|NCT03224819|156769400|FG003|Overall Study|Sponsor Decision|1|||
48704996|NCT03224819|156769401|FG004|Overall Study|Sponsor Decision|1|||
48704997|NCT03224819|156769402|FG005|Overall Study|Sponsor Decision|2|||
48704998|NCT03224819|156769403|FG006|Overall Study|Sponsor Decision|1|||
48704999|NCT03224819|156769404|FG007|Overall Study|Sponsor Decision|1|||
48705000|NCT03224819|156769405|FG008|Overall Study|Sponsor Decision|1|||
48705001|NCT03224819|156769406|FG009|Overall Study|Sponsor Decision|2|||
48705002|NCT03224819|156769407|FG010|Overall Study|Sponsor Decision|1|||
48705003|NCT03224819|156769408|FG011|Overall Study|Sponsor Decision|1|||
48705004|NCT03224819|156769409|FG012|Overall Study|Sponsor Decision|1|||
48705005|NCT03224819|156769410|FG013|Overall Study|Sponsor Decision|0|||
48705006|NCT03224819|156769397|FG000|Overall Study|Lost to Follow-up|0|||
48705007|NCT03224819|156769398|FG001|Overall Study|Lost to Follow-up|0|||
48705008|NCT03224819|156769399|FG002|Overall Study|Lost to Follow-up|0|||
48705009|NCT03224819|156769400|FG003|Overall Study|Lost to Follow-up|0|||
48705010|NCT03224819|156769401|FG004|Overall Study|Lost to Follow-up|0|||
48705011|NCT03224819|156769402|FG005|Overall Study|Lost to Follow-up|0|||
48705012|NCT03224819|156769403|FG006|Overall Study|Lost to Follow-up|0|||
48705013|NCT03224819|156769404|FG007|Overall Study|Lost to Follow-up|0|||
48705014|NCT03224819|156769405|FG008|Overall Study|Lost to Follow-up|1|||
48705015|NCT03224819|156769406|FG009|Overall Study|Lost to Follow-up|0|||
48705016|NCT03224819|156769407|FG010|Overall Study|Lost to Follow-up|0|||
48705017|NCT03224819|156769408|FG011|Overall Study|Lost to Follow-up|0|||
48705018|NCT03224819|156769409|FG012|Overall Study|Lost to Follow-up|0|||
48705019|NCT03224819|156769410|FG013|Overall Study|Lost to Follow-up|0|||
48705020|NCT03224819|156769397|FG000|Overall Study|Death|0|||
48705021|NCT03224819|156769398|FG001|Overall Study|Death|1|||
48705022|NCT03224819|156769399|FG002|Overall Study|Death|0|||
48705023|NCT03224819|156769400|FG003|Overall Study|Death|0|||
48705024|NCT03224819|156769401|FG004|Overall Study|Death|0|||
48705025|NCT03224819|156769402|FG005|Overall Study|Death|0|||
48705026|NCT03224819|156769403|FG006|Overall Study|Death|0|||
48705027|NCT03224819|156769404|FG007|Overall Study|Death|1|||
48705028|NCT03224819|156769405|FG008|Overall Study|Death|0|||
48705029|NCT03224819|156769406|FG009|Overall Study|Death|0|||
48705030|NCT03224819|156769407|FG010|Overall Study|Death|0|||
48705031|NCT03224819|156769408|FG011|Overall Study|Death|1|||
48705032|NCT03224819|156769409|FG012|Overall Study|Death|0|||
48705033|NCT03224819|156769410|FG013|Overall Study|Death|0|||
48705034|NCT02506244|156769413|FG000|Overall Study|Did not undergo active monitoring|458|||
48705035|NCT02506244|156769414|FG001|Overall Study|Did not undergo active monitoring|459|||
48705036|NCT02506244|156769415|FG002|Overall Study|Did not undergo active monitoring|0|||
48705037|NCT04986904|156769429|FG000|Overall Study|Lost to Follow-up|11|||
48705038|NCT04986904|156769429|FG000|Overall Study|Withdrawal by Subject|1|||
48705039|NCT04161157|156769430|FG000|Overall Study|Lost to Follow-up|4|||
48705040|NCT04161157|156769430|FG000|Overall Study|Death|3|||
48705041|NCT04161157|156769430|FG000|Overall Study|Ineligible|2|||
48705042|NCT04161157|156769430|FG000|Overall Study|Withdrawal by Subject|4|||
48705043|NCT00670748|156769440|FG000|Overall Study|Death during treatment|1|||
48705044|NCT00670748|156769441|FG001|Overall Study|Death during treatment|1|||
48705045|NCT00670748|156769442|FG002|Overall Study|Death during treatment|1|||
48705046|NCT00670748|156769443|FG003|Overall Study|Death during treatment|0|||
48705047|NCT00670748|156769440|FG000|Overall Study|Not off study|2|||
48705048|NCT00670748|156769441|FG001|Overall Study|Not off study|1|||
48705049|NCT00670748|156769442|FG002|Overall Study|Not off study|1|||
48705050|NCT00670748|156769443|FG003|Overall Study|Not off study|1|||
48705051|NCT01342211|156769445|FG000|Overall Study|Lost to Follow-up|0|||
48705052|NCT01342211|156769446|FG001|Overall Study|Lost to Follow-up|0|||
48705053|NCT01342211|156769447|FG002|Overall Study|Lost to Follow-up|0|||
48705054|NCT01342211|156769448|FG003|Overall Study|Lost to Follow-up|1|||
48705055|NCT01342211|156769449|FG004|Overall Study|Lost to Follow-up|0|||
48705056|NCT01342211|156769445|FG000|Overall Study|Adverse Event|0|||
48705057|NCT01342211|156769446|FG001|Overall Study|Adverse Event|0|||
48705058|NCT01342211|156769447|FG002|Overall Study|Adverse Event|0|||
48705059|NCT01342211|156769448|FG003|Overall Study|Adverse Event|0|||
48705060|NCT01342211|156769449|FG004|Overall Study|Adverse Event|1|||
48705061|NCT01342211|156769445|FG000|Overall Study|Withdrawal by Subject|0|||
48705062|NCT01342211|156769446|FG001|Overall Study|Withdrawal by Subject|0|||
48705063|NCT01342211|156769447|FG002|Overall Study|Withdrawal by Subject|0|||
48705064|NCT01342211|156769448|FG003|Overall Study|Withdrawal by Subject|1|||
48705065|NCT01342211|156769449|FG004|Overall Study|Withdrawal by Subject|0|||
48705066|NCT01342211|156769445|FG000|Overall Study|Randomized, but not Treated|0|||
48705067|NCT01342211|156769446|FG001|Overall Study|Randomized, but not Treated|2|||
48705068|NCT01342211|156769447|FG002|Overall Study|Randomized, but not Treated|0|||
48705069|NCT01342211|156769448|FG003|Overall Study|Randomized, but not Treated|0|||
48705070|NCT01342211|156769449|FG004|Overall Study|Randomized, but not Treated|1|||
48705071|NCT00912197|156769454|FG000|Overall Study|Withdrawal by Subject|3|||
48705072|NCT00912197|156769455|FG001|Overall Study|Withdrawal by Subject|3|||
48705073|NCT01287741|156769456|FG000|Overall Study|Withdrawal by Subject|35|||
48705074|NCT01287741|156769457|FG001|Overall Study|Withdrawal by Subject|38|||
48705075|NCT01287741|156769456|FG000|Overall Study|Protocol Violation|2|||
48705076|NCT01287741|156769457|FG001|Overall Study|Protocol Violation|0|||
48705077|NCT01287741|156769456|FG000|Overall Study|Physician Decision|15|||
48705078|NCT01287741|156769457|FG001|Overall Study|Physician Decision|23|||
48705079|NCT01287741|156769456|FG000|Overall Study|Non-compliance|8|||
48705080|NCT01287741|156769457|FG001|Overall Study|Non-compliance|6|||
48705081|NCT01287741|156769456|FG000|Overall Study|Lost to Follow-up|10|||
48705082|NCT01287741|156769457|FG001|Overall Study|Lost to Follow-up|8|||
48705083|NCT01287741|156769456|FG000|Overall Study|Death|32|||
48705084|NCT01287741|156769457|FG001|Overall Study|Death|44|||
48705085|NCT01287741|156769456|FG000|Overall Study|Adverse Event|4|||
48705086|NCT01287741|156769457|FG001|Overall Study|Adverse Event|6|||
48705087|NCT01287741|156769456|FG000|Overall Study|Study terminated by Sponsor|307|||
48705088|NCT01287741|156769457|FG001|Overall Study|Study terminated by Sponsor|315|||
48705089|NCT01287741|156769456|FG000|Overall Study|Progressive disease|190|||
48705090|NCT01287741|156769457|FG001|Overall Study|Progressive disease|166|||
48705091|NCT01287741|156769456|FG000|Overall Study|Reason not specified|23|||
48705092|NCT01287741|156769457|FG001|Overall Study|Reason not specified|9|||
48705093|NCT02608684|156771400|FG000|Overall Study|Physician Decision|2|||
48705094|NCT02608684|156771400|FG000|Overall Study|Withdrawal by Subject|1|||
48705095|NCT02202759|156771403|FG000|Overall Study|Study Terminated by Sponsor|3|||
48705096|NCT02202759|156771404|FG001|Overall Study|Study Terminated by Sponsor|3|||
48705097|NCT02202759|156771405|FG002|Overall Study|Study Terminated by Sponsor|3|||
48705098|NCT02202759|156771403|FG000|Overall Study|Withdrawal by Subject|2|||
48705099|NCT02202759|156771404|FG001|Overall Study|Withdrawal by Subject|1|||
48705100|NCT02202759|156771405|FG002|Overall Study|Withdrawal by Subject|1|||
48705101|NCT02202759|156771403|FG000|Overall Study|Reason not Specified|4|||
48705102|NCT02202759|156771404|FG001|Overall Study|Reason not Specified|11|||
48705103|NCT02202759|156771405|FG002|Overall Study|Reason not Specified|10|||
48705104|NCT01083771|156771406|FG000|Overall Study|non-compliant|2|||
48705105|NCT01083771|156771406|FG000|Overall Study|Withdrawal by Subject|3|||
48705106|NCT03841604|156771409|FG000|Overall Study|Withdrawal by Subject|3|||
48705107|NCT03841604|156771410|FG001|Overall Study|Withdrawal by Subject|1|||
48705108|NCT03841604|156771409|FG000|Overall Study|Adverse Event|4|||
48705109|NCT03841604|156771410|FG001|Overall Study|Adverse Event|2|||
48705110|NCT03841604|156771409|FG000|Overall Study|Physician Decision|1|||
48705111|NCT03841604|156771410|FG001|Overall Study|Physician Decision|0|||
48705112|NCT02492763|156771411|FG000|Overall Study|Withdrawal by Subject|0|||
48705113|NCT02492763|156771412|FG001|Overall Study|Withdrawal by Subject|2|||
48705114|NCT02492763|156771413|FG002|Overall Study|Withdrawal by Subject|1|||
48705115|NCT02492763|156771414|FG003|Overall Study|Withdrawal by Subject|0|||
48705116|NCT02492763|156771411|FG000|Overall Study|Adverse Event|3|||
48705117|NCT02492763|156771412|FG001|Overall Study|Adverse Event|1|||
48705118|NCT02492763|156771413|FG002|Overall Study|Adverse Event|1|||
48705119|NCT02492763|156771414|FG003|Overall Study|Adverse Event|2|||
48705120|NCT02492763|156771411|FG000|Overall Study|Death|0|||
48705121|NCT02492763|156771412|FG001|Overall Study|Death|0|||
48705122|NCT02492763|156771413|FG002|Overall Study|Death|1|||
48705123|NCT02492763|156771414|FG003|Overall Study|Death|0|||
48705124|NCT02492763|156771411|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
48705125|NCT02492763|156771412|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
48705126|NCT02492763|156771413|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
48705127|NCT02492763|156771414|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
48705128|NCT02492763|156771411|FG000|Overall Study|Lost to Follow-up|0|||
48705129|NCT02492763|156771412|FG001|Overall Study|Lost to Follow-up|0|||
48705130|NCT02492763|156771413|FG002|Overall Study|Lost to Follow-up|1|||
48705131|NCT02492763|156771414|FG003|Overall Study|Lost to Follow-up|0|||
48705132|NCT02492763|156771411|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48705133|NCT02492763|156771412|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48705134|NCT02492763|156771413|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48705135|NCT02492763|156771414|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48705136|NCT02492763|156771411|FG000|Overall Study|Screen Failure|0|||
48705137|NCT02492763|156771412|FG001|Overall Study|Screen Failure|0|||
48705138|NCT02492763|156771413|FG002|Overall Study|Screen Failure|0|||
48705139|NCT02492763|156771414|FG003|Overall Study|Screen Failure|1|||
48705140|NCT02492763|156771411|FG000|Overall Study|Study Terminated by Sponsor|13|||
48705141|NCT02492763|156771412|FG001|Overall Study|Study Terminated by Sponsor|10|||
48705142|NCT02492763|156771413|FG002|Overall Study|Study Terminated by Sponsor|6|||
48705143|NCT02492763|156771414|FG003|Overall Study|Study Terminated by Sponsor|10|||
48705144|NCT03848832|156771415|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
48705145|NCT03848832|156771416|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
48705146|NCT03848832|156771417|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
48705147|NCT03848832|156771415|FG000|Overall Study|Withdrawal by Subject|0|||
48705148|NCT03848832|156771416|FG001|Overall Study|Withdrawal by Subject|0|||
48705149|NCT03848832|156771417|FG002|Overall Study|Withdrawal by Subject|1|||
48705150|NCT03848832|156771415|FG000|Overall Study|Withdrawal (Covid-19)|0|||
48705151|NCT03848832|156771416|FG001|Overall Study|Withdrawal (Covid-19)|2|||
48705152|NCT03848832|156771417|FG002|Overall Study|Withdrawal (Covid-19)|0|||
48705153|NCT03848832|156771415|FG000|Overall Study|Physician Decision|2|||
48705154|NCT03848832|156771416|FG001|Overall Study|Physician Decision|1|||
48705155|NCT03848832|156771417|FG002|Overall Study|Physician Decision|3|||
48705156|NCT03848832|156771415|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
48705157|NCT03848832|156771416|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
48705158|NCT03848832|156771417|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
48595752|NCT01190189|156377779|FG000|Overall Study|Migrated/moved from study area|1|||
48595753|NCT02757352|156377785|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
48595754|NCT02757352|156377786|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48595755|NCT02757352|156377787|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
48595756|NCT02757352|156377788|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48595757|NCT02757352|156377789|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48595758|NCT02757352|156377790|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48595759|NCT02757352|156377791|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48595760|NCT02757352|156377792|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48595761|NCT02757352|156377793|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48595762|NCT02757352|156377794|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
48595763|NCT02757352|156377785|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595764|NCT02757352|156377786|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595765|NCT02757352|156377787|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
48595766|NCT02757352|156377788|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595767|NCT02757352|156377789|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595768|NCT02757352|156377790|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595769|NCT02757352|156377791|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595770|NCT02757352|156377792|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595771|NCT02757352|156377793|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595772|NCT02757352|156377794|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
48595773|NCT02757352|156377785|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
48595774|NCT02757352|156377786|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
48595775|NCT02757352|156377787|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
48595776|NCT02757352|156377788|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
48595777|NCT02757352|156377789|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
48595778|NCT02757352|156377790|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
48595779|NCT02757352|156377791|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
48595780|NCT02757352|156377792|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
48595781|NCT02757352|156377793|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
48595782|NCT02757352|156377794|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
48595783|NCT02757352|156377785|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595784|NCT02757352|156377786|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
48595785|NCT02757352|156377787|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595786|NCT02757352|156377788|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595787|NCT02757352|156377789|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595788|NCT02757352|156377790|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595789|NCT02757352|156377791|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595790|NCT02757352|156377792|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595791|NCT02757352|156377793|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595792|NCT02757352|156377794|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
48595793|NCT02757352|156377785|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595794|NCT02757352|156377786|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
48595795|NCT02757352|156377787|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595796|NCT02757352|156377788|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595797|NCT02757352|156377789|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595798|NCT02757352|156377790|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595799|NCT02757352|156377791|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595800|NCT02757352|156377792|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595801|NCT02757352|156377793|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595802|NCT02757352|156377794|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595803|NCT02757352|156377785|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
48595804|NCT02757352|156377786|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
48595805|NCT02757352|156377787|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
48595806|NCT02757352|156377788|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595807|NCT02757352|156377789|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595808|NCT02757352|156377790|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595809|NCT02757352|156377791|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595810|NCT02757352|156377792|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595811|NCT02757352|156377793|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595812|NCT02757352|156377794|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595813|NCT02757352|156377785|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
48705159|NCT03848832|156771415|FG000|Overall Study|Adverse Event|1|||
48705160|NCT03848832|156771416|FG001|Overall Study|Adverse Event|0|||
48705161|NCT03848832|156771417|FG002|Overall Study|Adverse Event|0|||
48705162|NCT02453321|156771418|FG000|Overall Study|Weakness|1|||
48705163|NCT02453321|156771419|FG001|Overall Study|Weakness|1|||
48705164|NCT02453321|156771420|FG002|Overall Study|Weakness|2|||
48705165|NCT02453321|156771418|FG000|Overall Study|Deep Venous Thrombosis|0|||
48705166|NCT02453321|156771419|FG001|Overall Study|Deep Venous Thrombosis|1|||
48705167|NCT02453321|156771420|FG002|Overall Study|Deep Venous Thrombosis|0|||
48705168|NCT00882557|156771422|FG000|Overall Study|Withdrawal by Subject|1|||
48705169|NCT00882557|156771423|FG001|Overall Study|Withdrawal by Subject|0|||
48705170|NCT00882557|156771422|FG000|Overall Study|Trouble with Vein Access|1|||
48705171|NCT00882557|156771423|FG001|Overall Study|Trouble with Vein Access|0|||
48705172|NCT00882557|156771422|FG000|Overall Study|Randomized Not Treated|0|||
48705173|NCT00882557|156771423|FG001|Overall Study|Randomized Not Treated|1|||
48705174|NCT02633306|156771426|FG000|Overall Study|Withdrawal by Subject|3|||
48705175|NCT00998296|156771427|FG000|Overall Study|Progressive disease|0|||
48705176|NCT00998296|156771428|FG001|Overall Study|Progressive disease|1|||
48705177|NCT00998296|156771429|FG002|Overall Study|Progressive disease|0|||
48705178|NCT00998296|156771430|FG003|Overall Study|Progressive disease|0|||
48705179|NCT00998296|156771431|FG004|Overall Study|Progressive disease|0|||
48705180|NCT00998296|156771432|FG005|Overall Study|Progressive disease|0|||
48705181|NCT00998296|156771433|FG006|Overall Study|Progressive disease|1|||
48705182|NCT00998296|156771434|FG007|Overall Study|Progressive disease|0|||
48705183|NCT00998296|156771435|FG008|Overall Study|Progressive disease|0|||
48705184|NCT00998296|156771436|FG009|Overall Study|Progressive disease|14|||
48705185|NCT00998296|156771437|FG010|Overall Study|Progressive disease|5|||
48705186|NCT00998296|156771427|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705187|NCT00998296|156771428|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705188|NCT00998296|156771429|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705189|NCT00998296|156771430|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705190|NCT00998296|156771431|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
48705191|NCT00998296|156771432|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705192|NCT00998296|156771433|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
48490025|NCT01078623|155988837|FG011|Treatment Period 2|Withdrawal by Subject|0|||
48490026|NCT01078623|155988838|FG012|Treatment Period 2|Withdrawal by Subject|0|||
48705193|NCT00998296|156771434|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
48705194|NCT00998296|156771435|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
48705195|NCT00998296|156771436|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705196|NCT00998296|156771437|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
48705197|NCT00998296|156771427|FG000|Overall Study|Other adverse event|0|||
48705198|NCT00998296|156771428|FG001|Overall Study|Other adverse event|0|||
48705199|NCT00998296|156771429|FG002|Overall Study|Other adverse event|0|||
48705200|NCT00998296|156771430|FG003|Overall Study|Other adverse event|0|||
48705201|NCT00998296|156771431|FG004|Overall Study|Other adverse event|1|||
48705202|NCT00998296|156771432|FG005|Overall Study|Other adverse event|0|||
48705203|NCT00998296|156771433|FG006|Overall Study|Other adverse event|0|||
48705204|NCT00998296|156771434|FG007|Overall Study|Other adverse event|0|||
48705205|NCT00998296|156771435|FG008|Overall Study|Other adverse event|0|||
48705206|NCT00998296|156771436|FG009|Overall Study|Other adverse event|1|||
48705207|NCT00998296|156771437|FG010|Overall Study|Other adverse event|2|||
48705208|NCT00998296|156771427|FG000|Overall Study|Refused to continue taking trial med.|0|||
48705209|NCT00998296|156771428|FG001|Overall Study|Refused to continue taking trial med.|0|||
48705210|NCT00998296|156771429|FG002|Overall Study|Refused to continue taking trial med.|0|||
48705211|NCT00998296|156771430|FG003|Overall Study|Refused to continue taking trial med.|0|||
48705212|NCT00998296|156771431|FG004|Overall Study|Refused to continue taking trial med.|0|||
48705213|NCT00998296|156771432|FG005|Overall Study|Refused to continue taking trial med.|0|||
48705214|NCT00998296|156771433|FG006|Overall Study|Refused to continue taking trial med.|0|||
48705215|NCT00998296|156771434|FG007|Overall Study|Refused to continue taking trial med.|0|||
48705216|NCT00998296|156771435|FG008|Overall Study|Refused to continue taking trial med.|0|||
48705217|NCT00998296|156771436|FG009|Overall Study|Refused to continue taking trial med.|2|||
48705218|NCT00998296|156771437|FG010|Overall Study|Refused to continue taking trial med.|0|||
48705219|NCT00998296|156771427|FG000|Overall Study|Reason other than those specified above|0|||
48705220|NCT00998296|156771428|FG001|Overall Study|Reason other than those specified above|0|||
48705221|NCT00998296|156771429|FG002|Overall Study|Reason other than those specified above|0|||
48705222|NCT00998296|156771430|FG003|Overall Study|Reason other than those specified above|0|||
48490027|NCT01078623|155988839|FG013|Treatment Period 2|Withdrawal by Subject|0|||
48705223|NCT00998296|156771431|FG004|Overall Study|Reason other than those specified above|0|||
48705224|NCT00998296|156771432|FG005|Overall Study|Reason other than those specified above|0|||
48705225|NCT00998296|156771433|FG006|Overall Study|Reason other than those specified above|0|||
48705226|NCT00998296|156771434|FG007|Overall Study|Reason other than those specified above|0|||
48705227|NCT00998296|156771435|FG008|Overall Study|Reason other than those specified above|0|||
48705228|NCT00998296|156771436|FG009|Overall Study|Reason other than those specified above|1|||
48705229|NCT00998296|156771437|FG010|Overall Study|Reason other than those specified above|0|||
48705230|NCT01746901|156771438|FG000|Naloxone Challenge Phase|Adverse Event|2|||
48705231|NCT01746901|156771439|FG001|Naloxone Challenge Phase|Adverse Event|0|||
48705232|NCT01746901|156771440|FG002|Naloxone Challenge Phase|Adverse Event|0|||
48705233|NCT01746901|156771441|FG003|Naloxone Challenge Phase|Adverse Event|0|||
48705234|NCT01746901|156771442|FG004|Naloxone Challenge Phase|Adverse Event|0|||
48705235|NCT01746901|156771443|FG005|Naloxone Challenge Phase|Adverse Event|0|||
48705236|NCT01746901|156771444|FG006|Naloxone Challenge Phase|Adverse Event|0|||
48705237|NCT01746901|156771445|FG007|Naloxone Challenge Phase|Adverse Event|0|||
48705238|NCT01746901|156771446|FG008|Naloxone Challenge Phase|Adverse Event|0|||
48705239|NCT01746901|156771438|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
48705240|NCT01746901|156771439|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705241|NCT01746901|156771440|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705242|NCT01746901|156771441|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705243|NCT01746901|156771442|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705244|NCT01746901|156771443|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705245|NCT01746901|156771444|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705246|NCT01746901|156771445|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705247|NCT01746901|156771446|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
48705248|NCT01746901|156771438|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705249|NCT01746901|156771439|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
48705250|NCT01746901|156771440|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705251|NCT01746901|156771441|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705252|NCT01746901|156771442|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705253|NCT01746901|156771443|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705254|NCT01746901|156771444|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705255|NCT01746901|156771445|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705256|NCT01746901|156771446|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48705257|NCT01746901|156771438|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705258|NCT01746901|156771439|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
48705259|NCT01746901|156771440|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
48705260|NCT01746901|156771441|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705261|NCT01746901|156771442|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705262|NCT01746901|156771443|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705263|NCT01746901|156771444|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705264|NCT01746901|156771445|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705265|NCT01746901|156771446|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
48705266|NCT01746901|156771438|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705267|NCT01746901|156771439|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
48705268|NCT01746901|156771440|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
48705269|NCT01746901|156771441|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705270|NCT01746901|156771442|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705271|NCT01746901|156771443|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705272|NCT01746901|156771444|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705273|NCT01746901|156771445|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705274|NCT01746901|156771446|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
48705275|NCT01746901|156771438|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705276|NCT01746901|156771439|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
48705277|NCT01746901|156771440|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
48705278|NCT01746901|156771441|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705279|NCT01746901|156771442|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705280|NCT01746901|156771443|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705281|NCT01746901|156771444|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705282|NCT01746901|156771445|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705283|NCT01746901|156771446|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48705284|NCT01746901|156771438|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
48705285|NCT01746901|156771439|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
48705286|NCT01746901|156771440|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
48705287|NCT01746901|156771441|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
48705288|NCT01746901|156771442|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
48705289|NCT01746901|156771443|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
48705290|NCT01746901|156771444|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
48705291|NCT01746901|156771445|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
48705292|NCT01746901|156771446|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
48705293|NCT01746901|156771438|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705294|NCT01746901|156771439|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705295|NCT01746901|156771440|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705296|NCT01746901|156771441|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705297|NCT01746901|156771442|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705298|NCT01746901|156771443|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705299|NCT01746901|156771444|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705300|NCT01746901|156771445|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
48705301|NCT01746901|156771446|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
48705302|NCT01746901|156771438|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705303|NCT01746901|156771439|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705304|NCT01746901|156771440|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705305|NCT01746901|156771441|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705306|NCT01746901|156771442|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705307|NCT01746901|156771443|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
48705308|NCT01746901|156771444|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
48705309|NCT01746901|156771445|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705310|NCT01746901|156771446|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
48705311|NCT01746901|156771438|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705312|NCT01746901|156771439|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705313|NCT01746901|156771440|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705314|NCT01746901|156771441|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
48705315|NCT01746901|156771442|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705316|NCT01746901|156771443|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705317|NCT01746901|156771444|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705318|NCT01746901|156771445|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705319|NCT01746901|156771446|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
48705320|NCT01746901|156771438|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705321|NCT01746901|156771439|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705322|NCT01746901|156771440|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705323|NCT01746901|156771441|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705324|NCT01746901|156771442|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705325|NCT01746901|156771443|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
48705326|NCT01746901|156771444|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705327|NCT01746901|156771445|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
48705328|NCT01746901|156771446|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
48705329|NCT01746901|156771438|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705330|NCT01746901|156771439|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705331|NCT01746901|156771440|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705332|NCT01746901|156771441|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705333|NCT01746901|156771442|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705334|NCT01746901|156771443|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705335|NCT01746901|156771444|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
48705336|NCT01746901|156771445|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
48705337|NCT01746901|156771446|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
48705338|NCT02106390|156771447|FG000|Overall Study|Withdrawal by Subject|15|||
48705339|NCT02106390|156771448|FG001|Overall Study|Withdrawal by Subject|16|||
48705340|NCT02106390|156771449|FG002|Overall Study|Withdrawal by Subject|15|||
48705341|NCT02106390|156771447|FG000|Overall Study|Lost to Follow-up|25|||
48705342|NCT02106390|156771448|FG001|Overall Study|Lost to Follow-up|20|||
48705343|NCT02106390|156771449|FG002|Overall Study|Lost to Follow-up|13|||
48705344|NCT02106390|156771447|FG000|Overall Study|Other: Administrative Reason|8|||
48705345|NCT02106390|156771448|FG001|Overall Study|Other: Administrative Reason|5|||
48705346|NCT02106390|156771449|FG002|Overall Study|Other: Administrative Reason|12|||
48705347|NCT02106390|156771447|FG000|Overall Study|Other: Unspecified|1|||
48705348|NCT02106390|156771448|FG001|Overall Study|Other: Unspecified|4|||
48705349|NCT02106390|156771449|FG002|Overall Study|Other: Unspecified|2|||
48705350|NCT02106390|156771447|FG000|Overall Study|Adverse Event|0|||
48705351|NCT02106390|156771448|FG001|Overall Study|Adverse Event|2|||
48705352|NCT02106390|156771449|FG002|Overall Study|Adverse Event|1|||
48705353|NCT02106390|156771447|FG000|Overall Study|Protocol Violation|0|||
48705354|NCT02106390|156771448|FG001|Overall Study|Protocol Violation|1|||
48705355|NCT02106390|156771449|FG002|Overall Study|Protocol Violation|0|||
48705356|NCT03809104|156771450|FG000|Overall Study|Withdrawal by Subject|3|||
48705357|NCT00790842|156771451|FG000|Dose Level 1|Adverse Event|1|||
48705358|NCT00790842|156771452|FG001|Dose Level 1|Adverse Event|0|||
48705359|NCT00790842|156771453|FG002|Dose Level 1|Adverse Event|0|||
48705360|NCT00790842|156771454|FG003|Dose Level 1|Adverse Event|2|||
48705361|NCT00790842|156771455|FG004|Dose Level 1|Adverse Event|0|||
48705362|NCT00790842|156771456|FG005|Dose Level 1|Adverse Event|0|||
48705363|NCT00790842|156771457|FG006|Dose Level 1|Adverse Event|0|||
48705364|NCT00790842|156771458|FG007|Dose Level 1|Adverse Event|1|||
48705365|NCT00790842|156771459|FG008|Dose Level 1|Adverse Event|0|||
48705366|NCT00790842|156771460|FG009|Dose Level 1|Adverse Event|0|||
48705367|NCT00790842|156771461|FG010|Dose Level 1|Adverse Event|0|||
48705368|NCT00790842|156771451|FG000|Dose Level 1|Physician Decision|1|||
48705369|NCT00790842|156771452|FG001|Dose Level 1|Physician Decision|0|||
48705370|NCT00790842|156771453|FG002|Dose Level 1|Physician Decision|0|||
48705371|NCT00790842|156771454|FG003|Dose Level 1|Physician Decision|0|||
48705372|NCT00790842|156771455|FG004|Dose Level 1|Physician Decision|0|||
48705373|NCT00790842|156771456|FG005|Dose Level 1|Physician Decision|0|||
48705374|NCT00790842|156771457|FG006|Dose Level 1|Physician Decision|0|||
48705375|NCT00790842|156771458|FG007|Dose Level 1|Physician Decision|1|||
48705376|NCT00790842|156771459|FG008|Dose Level 1|Physician Decision|0|||
48433891|NCT00516269|155777241|FG000|Overall Study|Lost to Follow-up|0|||
48705377|NCT00790842|156771460|FG009|Dose Level 1|Physician Decision|0|||
48433892|NCT00516269|155777242|FG001|Overall Study|Lost to Follow-up|1|||
48705378|NCT00790842|156771461|FG010|Dose Level 1|Physician Decision|0|||
48705379|NCT00790842|156771451|FG000|Dose Level 1|Withdrawal by Subject|1|||
48705380|NCT00790842|156771452|FG001|Dose Level 1|Withdrawal by Subject|0|||
48705381|NCT00790842|156771453|FG002|Dose Level 1|Withdrawal by Subject|0|||
48705382|NCT00790842|156771454|FG003|Dose Level 1|Withdrawal by Subject|0|||
48705383|NCT00790842|156771455|FG004|Dose Level 1|Withdrawal by Subject|0|||
48705384|NCT00790842|156771456|FG005|Dose Level 1|Withdrawal by Subject|0|||
48705385|NCT00790842|156771457|FG006|Dose Level 1|Withdrawal by Subject|0|||
48705386|NCT00790842|156771458|FG007|Dose Level 1|Withdrawal by Subject|0|||
48705387|NCT00790842|156771459|FG008|Dose Level 1|Withdrawal by Subject|0|||
48705388|NCT00790842|156771460|FG009|Dose Level 1|Withdrawal by Subject|0|||
48705389|NCT00790842|156771461|FG010|Dose Level 1|Withdrawal by Subject|0|||
48705390|NCT00790842|156771451|FG000|Dose Level 2|Death|0|||
48705391|NCT00790842|156771452|FG001|Dose Level 2|Death|1|||
48705392|NCT00790842|156771453|FG002|Dose Level 2|Death|0|||
48705393|NCT00790842|156771454|FG003|Dose Level 2|Death|0|||
48705394|NCT00790842|156771455|FG004|Dose Level 2|Death|1|||
48705395|NCT00790842|156771456|FG005|Dose Level 2|Death|0|||
48705396|NCT00790842|156771457|FG006|Dose Level 2|Death|0|||
48705397|NCT00790842|156771458|FG007|Dose Level 2|Death|0|||
48705398|NCT00790842|156771459|FG008|Dose Level 2|Death|0|||
48705399|NCT00790842|156771460|FG009|Dose Level 2|Death|0|||
48705400|NCT00790842|156771461|FG010|Dose Level 2|Death|0|||
48705401|NCT00790842|156771451|FG000|Dose Level 2|Physician Decision|0|||
48705402|NCT00790842|156771452|FG001|Dose Level 2|Physician Decision|1|||
48705403|NCT00790842|156771453|FG002|Dose Level 2|Physician Decision|0|||
48705404|NCT00790842|156771454|FG003|Dose Level 2|Physician Decision|0|||
48705405|NCT00790842|156771455|FG004|Dose Level 2|Physician Decision|0|||
48705406|NCT00790842|156771456|FG005|Dose Level 2|Physician Decision|0|||
48705407|NCT00790842|156771457|FG006|Dose Level 2|Physician Decision|0|||
48705408|NCT00790842|156771458|FG007|Dose Level 2|Physician Decision|0|||
48705409|NCT00790842|156771459|FG008|Dose Level 2|Physician Decision|0|||
48705410|NCT00790842|156771460|FG009|Dose Level 2|Physician Decision|0|||
48705411|NCT00790842|156771461|FG010|Dose Level 2|Physician Decision|0|||
48705412|NCT00790842|156771451|FG000|Dose Level 2|Withdrawal by Subject|0|||
48705413|NCT00790842|156771452|FG001|Dose Level 2|Withdrawal by Subject|1|||
48705414|NCT00790842|156771453|FG002|Dose Level 2|Withdrawal by Subject|0|||
48705415|NCT00790842|156771454|FG003|Dose Level 2|Withdrawal by Subject|0|||
48705416|NCT00790842|156771455|FG004|Dose Level 2|Withdrawal by Subject|0|||
48705417|NCT00790842|156771456|FG005|Dose Level 2|Withdrawal by Subject|0|||
48705418|NCT00790842|156771457|FG006|Dose Level 2|Withdrawal by Subject|0|||
48705419|NCT00790842|156771458|FG007|Dose Level 2|Withdrawal by Subject|0|||
48705420|NCT00790842|156771459|FG008|Dose Level 2|Withdrawal by Subject|0|||
48705421|NCT00790842|156771460|FG009|Dose Level 2|Withdrawal by Subject|0|||
48705422|NCT00790842|156771461|FG010|Dose Level 2|Withdrawal by Subject|0|||
48705423|NCT00790842|156771451|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705424|NCT00790842|156771452|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705425|NCT00790842|156771453|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705426|NCT00790842|156771454|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705427|NCT00790842|156771455|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705428|NCT00790842|156771456|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705429|NCT00790842|156771457|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705430|NCT00790842|156771458|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705431|NCT00790842|156771459|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
48705432|NCT00790842|156771460|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705433|NCT00790842|156771461|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
48705434|NCT00790842|156771451|FG000|Dose Level 3|Adverse Event|0|||
48705435|NCT00790842|156771452|FG001|Dose Level 3|Adverse Event|0|||
48705436|NCT00790842|156771453|FG002|Dose Level 3|Adverse Event|1|||
48705437|NCT00790842|156771454|FG003|Dose Level 3|Adverse Event|0|||
48705438|NCT00790842|156771455|FG004|Dose Level 3|Adverse Event|0|||
48705439|NCT00790842|156771456|FG005|Dose Level 3|Adverse Event|0|||
48705440|NCT00790842|156771457|FG006|Dose Level 3|Adverse Event|0|||
48705441|NCT00790842|156771458|FG007|Dose Level 3|Adverse Event|0|||
48705442|NCT00790842|156771459|FG008|Dose Level 3|Adverse Event|0|||
48705443|NCT00790842|156771460|FG009|Dose Level 3|Adverse Event|0|||
48705444|NCT00790842|156771461|FG010|Dose Level 3|Adverse Event|0|||
48705445|NCT00790842|156771451|FG000|Dose Level 3|Withdrawal by Subject|0|||
48705446|NCT00790842|156771452|FG001|Dose Level 3|Withdrawal by Subject|0|||
48705447|NCT00790842|156771453|FG002|Dose Level 3|Withdrawal by Subject|3|||
48705448|NCT00790842|156771454|FG003|Dose Level 3|Withdrawal by Subject|0|||
48705449|NCT00790842|156771455|FG004|Dose Level 3|Withdrawal by Subject|0|||
48705450|NCT00790842|156771456|FG005|Dose Level 3|Withdrawal by Subject|0|||
48705451|NCT00790842|156771457|FG006|Dose Level 3|Withdrawal by Subject|0|||
48705452|NCT00790842|156771458|FG007|Dose Level 3|Withdrawal by Subject|0|||
48705453|NCT00790842|156771459|FG008|Dose Level 3|Withdrawal by Subject|0|||
48705454|NCT00790842|156771460|FG009|Dose Level 3|Withdrawal by Subject|2|||
48705455|NCT00790842|156771461|FG010|Dose Level 3|Withdrawal by Subject|0|||
48705456|NCT00790842|156771451|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705457|NCT00790842|156771452|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705458|NCT00790842|156771453|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705459|NCT00790842|156771454|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705460|NCT00790842|156771455|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705461|NCT00790842|156771456|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
48705462|NCT00790842|156771457|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705463|NCT00790842|156771458|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705464|NCT00790842|156771459|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705465|NCT00790842|156771460|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705466|NCT00790842|156771461|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
48705467|NCT00790842|156771451|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705468|NCT00790842|156771452|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705469|NCT00790842|156771453|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
48705470|NCT00790842|156771454|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705471|NCT00790842|156771455|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705472|NCT00790842|156771456|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705473|NCT00790842|156771457|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705474|NCT00790842|156771458|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705475|NCT00790842|156771459|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705476|NCT00790842|156771460|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705477|NCT00790842|156771461|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
48705478|NCT00790842|156771451|FG000|Dose Level 4|Adverse Event|0|||
48705479|NCT00790842|156771452|FG001|Dose Level 4|Adverse Event|0|||
48705480|NCT00790842|156771453|FG002|Dose Level 4|Adverse Event|0|||
48705481|NCT00790842|156771454|FG003|Dose Level 4|Adverse Event|0|||
48705482|NCT00790842|156771455|FG004|Dose Level 4|Adverse Event|0|||
48705483|NCT00790842|156771456|FG005|Dose Level 4|Adverse Event|0|||
48705484|NCT00790842|156771457|FG006|Dose Level 4|Adverse Event|1|||
48705485|NCT00790842|156771458|FG007|Dose Level 4|Adverse Event|0|||
48705486|NCT00790842|156771459|FG008|Dose Level 4|Adverse Event|0|||
48705487|NCT00790842|156771460|FG009|Dose Level 4|Adverse Event|0|||
48705488|NCT00790842|156771461|FG010|Dose Level 4|Adverse Event|0|||
48705489|NCT00790842|156771451|FG000|Dose Level 4|Physician Decision|0|||
48705490|NCT00790842|156771452|FG001|Dose Level 4|Physician Decision|0|||
48705491|NCT00790842|156771453|FG002|Dose Level 4|Physician Decision|0|||
48705492|NCT00790842|156771454|FG003|Dose Level 4|Physician Decision|0|||
48705493|NCT00790842|156771455|FG004|Dose Level 4|Physician Decision|0|||
48705494|NCT00790842|156771456|FG005|Dose Level 4|Physician Decision|0|||
48705495|NCT00790842|156771457|FG006|Dose Level 4|Physician Decision|1|||
48705496|NCT00790842|156771458|FG007|Dose Level 4|Physician Decision|0|||
48705497|NCT00790842|156771459|FG008|Dose Level 4|Physician Decision|0|||
48705498|NCT00790842|156771460|FG009|Dose Level 4|Physician Decision|0|||
48705499|NCT00790842|156771461|FG010|Dose Level 4|Physician Decision|1|||
48705500|NCT00790842|156771451|FG000|Dose Level 4|Withdrawal by Subject|0|||
48705501|NCT00790842|156771452|FG001|Dose Level 4|Withdrawal by Subject|0|||
48705502|NCT00790842|156771453|FG002|Dose Level 4|Withdrawal by Subject|0|||
48705503|NCT00790842|156771454|FG003|Dose Level 4|Withdrawal by Subject|0|||
48705504|NCT00790842|156771455|FG004|Dose Level 4|Withdrawal by Subject|0|||
48705505|NCT00790842|156771456|FG005|Dose Level 4|Withdrawal by Subject|0|||
48705506|NCT00790842|156771457|FG006|Dose Level 4|Withdrawal by Subject|0|||
48705507|NCT00790842|156771458|FG007|Dose Level 4|Withdrawal by Subject|0|||
48705508|NCT00790842|156771459|FG008|Dose Level 4|Withdrawal by Subject|0|||
48705509|NCT00790842|156771460|FG009|Dose Level 4|Withdrawal by Subject|0|||
48705510|NCT00790842|156771461|FG010|Dose Level 4|Withdrawal by Subject|1|||
48705511|NCT00790842|156771451|FG000|Expansion Cohort|Adverse Event|0|||
48705512|NCT00790842|156771452|FG001|Expansion Cohort|Adverse Event|0|||
48705513|NCT00790842|156771453|FG002|Expansion Cohort|Adverse Event|0|||
48705514|NCT00790842|156771454|FG003|Expansion Cohort|Adverse Event|0|||
48705515|NCT00790842|156771455|FG004|Expansion Cohort|Adverse Event|0|||
48705516|NCT00790842|156771456|FG005|Expansion Cohort|Adverse Event|0|||
48705517|NCT00790842|156771457|FG006|Expansion Cohort|Adverse Event|1|||
48705518|NCT00790842|156771458|FG007|Expansion Cohort|Adverse Event|0|||
48705519|NCT00790842|156771459|FG008|Expansion Cohort|Adverse Event|0|||
48705520|NCT00790842|156771460|FG009|Expansion Cohort|Adverse Event|0|||
48705521|NCT00790842|156771461|FG010|Expansion Cohort|Adverse Event|0|||
48705522|NCT00790842|156771451|FG000|Expansion Cohort|Death|0|||
48705523|NCT00790842|156771452|FG001|Expansion Cohort|Death|0|||
48705524|NCT00790842|156771453|FG002|Expansion Cohort|Death|2|||
48705525|NCT00790842|156771454|FG003|Expansion Cohort|Death|0|||
48705526|NCT00790842|156771455|FG004|Expansion Cohort|Death|0|||
48705527|NCT00790842|156771456|FG005|Expansion Cohort|Death|0|||
48705528|NCT00790842|156771457|FG006|Expansion Cohort|Death|0|||
48705529|NCT00790842|156771458|FG007|Expansion Cohort|Death|0|||
48705530|NCT00790842|156771459|FG008|Expansion Cohort|Death|0|||
48705531|NCT00790842|156771460|FG009|Expansion Cohort|Death|0|||
48705532|NCT00790842|156771461|FG010|Expansion Cohort|Death|0|||
48705533|NCT00790842|156771451|FG000|Expansion Cohort|Physician Decision|0|||
48705534|NCT00790842|156771452|FG001|Expansion Cohort|Physician Decision|0|||
48705535|NCT00790842|156771453|FG002|Expansion Cohort|Physician Decision|1|||
48705536|NCT00790842|156771454|FG003|Expansion Cohort|Physician Decision|0|||
48705537|NCT00790842|156771455|FG004|Expansion Cohort|Physician Decision|0|||
48705538|NCT00790842|156771456|FG005|Expansion Cohort|Physician Decision|0|||
48705539|NCT00790842|156771457|FG006|Expansion Cohort|Physician Decision|0|||
48705540|NCT00790842|156771458|FG007|Expansion Cohort|Physician Decision|0|||
48705541|NCT00790842|156771459|FG008|Expansion Cohort|Physician Decision|0|||
48705542|NCT00790842|156771460|FG009|Expansion Cohort|Physician Decision|0|||
48705543|NCT00790842|156771461|FG010|Expansion Cohort|Physician Decision|0|||
48705544|NCT00790842|156771451|FG000|Expansion Cohort|Withdrawal by Subject|0|||
48705545|NCT00790842|156771452|FG001|Expansion Cohort|Withdrawal by Subject|0|||
48705546|NCT00790842|156771453|FG002|Expansion Cohort|Withdrawal by Subject|3|||
48705547|NCT00790842|156771454|FG003|Expansion Cohort|Withdrawal by Subject|0|||
48705548|NCT00790842|156771455|FG004|Expansion Cohort|Withdrawal by Subject|0|||
48705549|NCT00790842|156771456|FG005|Expansion Cohort|Withdrawal by Subject|0|||
48705550|NCT00790842|156771457|FG006|Expansion Cohort|Withdrawal by Subject|0|||
48705551|NCT00790842|156771458|FG007|Expansion Cohort|Withdrawal by Subject|0|||
48705552|NCT00790842|156771459|FG008|Expansion Cohort|Withdrawal by Subject|0|||
48705553|NCT00790842|156771460|FG009|Expansion Cohort|Withdrawal by Subject|0|||
48705554|NCT00790842|156771461|FG010|Expansion Cohort|Withdrawal by Subject|0|||
48705555|NCT00790842|156771451|FG000|Expansion Cohort|Study Closure|0|||
48705556|NCT00790842|156771452|FG001|Expansion Cohort|Study Closure|0|||
48705557|NCT00790842|156771453|FG002|Expansion Cohort|Study Closure|1|||
48705558|NCT00790842|156771454|FG003|Expansion Cohort|Study Closure|0|||
48705559|NCT00790842|156771455|FG004|Expansion Cohort|Study Closure|0|||
48705560|NCT00790842|156771456|FG005|Expansion Cohort|Study Closure|0|||
48705561|NCT00790842|156771457|FG006|Expansion Cohort|Study Closure|0|||
48705562|NCT00790842|156771458|FG007|Expansion Cohort|Study Closure|0|||
48705563|NCT00790842|156771459|FG008|Expansion Cohort|Study Closure|0|||
48705564|NCT00790842|156771460|FG009|Expansion Cohort|Study Closure|0|||
48705565|NCT00790842|156771461|FG010|Expansion Cohort|Study Closure|0|||
48705566|NCT02131259|156771462|FG000|Overall Study|Progressive disease|751|||
48705567|NCT02131259|156771462|FG000|Overall Study|Adverse Event|341|||
48705568|NCT02131259|156771462|FG000|Overall Study|Lost to Follow-up|7|||
48705569|NCT02131259|156771462|FG000|Overall Study|Relocation|32|||
48705570|NCT02131259|156771462|FG000|Overall Study|Other|63|||
48705571|NCT02131259|156771462|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
48705572|NCT02131259|156771462|FG000|Overall Study|Progressive disease/relocation|1|||
48705573|NCT02131259|156771462|FG000|Overall Study|Progressive disease/other|2|||
48705574|NCT02131259|156771462|FG000|Overall Study|AE/lost to follow-up|1|||
48705575|NCT02131259|156771462|FG000|Overall Study|AE/other|1|||
48705576|NCT02131259|156771462|FG000|Overall Study|Progressive disease/AE/other|1|||
48705577|NCT02131259|156771462|FG000|Overall Study|Missing|3|||
48705578|NCT02158546|156771469|FG000|Overall Study|Physician Decision|0|||
48705579|NCT02158546|156771470|FG001|Overall Study|Physician Decision|1|||
48705580|NCT02158546|156771471|FG002|Overall Study|Physician Decision|0|||
48705581|NCT02158546|156771472|FG003|Overall Study|Physician Decision|0|||
48705582|NCT02158546|156771469|FG000|Overall Study|Non-compliance|0|||
48705583|NCT02158546|156771470|FG001|Overall Study|Non-compliance|1|||
48705584|NCT02158546|156771471|FG002|Overall Study|Non-compliance|0|||
48705585|NCT02158546|156771472|FG003|Overall Study|Non-compliance|1|||
48705586|NCT02158546|156771469|FG000|Overall Study|Failure to meet eligibility criteria|0|||
48705587|NCT02158546|156771470|FG001|Overall Study|Failure to meet eligibility criteria|1|||
48705588|NCT02158546|156771471|FG002|Overall Study|Failure to meet eligibility criteria|0|||
48705589|NCT02158546|156771472|FG003|Overall Study|Failure to meet eligibility criteria|0|||
48705590|NCT02158546|156771469|FG000|Overall Study|Lack of Efficacy|1|||
48705591|NCT02158546|156771470|FG001|Overall Study|Lack of Efficacy|1|||
48705592|NCT02158546|156771471|FG002|Overall Study|Lack of Efficacy|0|||
48705593|NCT02158546|156771472|FG003|Overall Study|Lack of Efficacy|0|||
48705594|NCT02158546|156771469|FG000|Overall Study|Adverse Event|2|||
48705595|NCT02158546|156771470|FG001|Overall Study|Adverse Event|2|||
48705596|NCT02158546|156771471|FG002|Overall Study|Adverse Event|0|||
48705597|NCT02158546|156771472|FG003|Overall Study|Adverse Event|0|||
48705598|NCT02158546|156771469|FG000|Overall Study|Withdrawal by Subject|6|||
48705599|NCT02158546|156771470|FG001|Overall Study|Withdrawal by Subject|2|||
48705600|NCT02158546|156771471|FG002|Overall Study|Withdrawal by Subject|1|||
48705601|NCT02158546|156771472|FG003|Overall Study|Withdrawal by Subject|0|||
48705602|NCT02158546|156771469|FG000|Overall Study|Lost to Follow-up|5|||
48705603|NCT02158546|156771470|FG001|Overall Study|Lost to Follow-up|4|||
48705604|NCT02158546|156771471|FG002|Overall Study|Lost to Follow-up|0|||
48705605|NCT02158546|156771472|FG003|Overall Study|Lost to Follow-up|1|||
48705606|NCT02158546|156771469|FG000|Overall Study|Site Excluded|5|||
48705607|NCT02158546|156771470|FG001|Overall Study|Site Excluded|5|||
48705608|NCT02158546|156771471|FG002|Overall Study|Site Excluded|3|||
48705609|NCT02158546|156771472|FG003|Overall Study|Site Excluded|4|||
48705610|NCT00803569|156771473|FG000|Overall Study|Progressive Disease|3|||
48705611|NCT00803569|156771473|FG000|Overall Study|Noncompliance|1|||
48705612|NCT02057250|156771476|FG000|AID Assessment Phase|Adverse Event|3|||
48705613|NCT02057250|156771477|FG001|AID Assessment Phase|Adverse Event|2|||
48705614|NCT02057250|156771478|FG002|AID Assessment Phase|Adverse Event|6|||
48705615|NCT02057250|156771479|FG003|AID Assessment Phase|Adverse Event|1|||
48705616|NCT02057250|156771480|FG004|AID Assessment Phase|Adverse Event|0|||
48705617|NCT02057250|156771476|FG000|AID Assessment Phase|Other than specified above|1|||
48595814|NCT02757352|156377786|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
48595815|NCT02757352|156377787|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
48595816|NCT02757352|156377788|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
48595817|NCT02757352|156377789|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
48595818|NCT02757352|156377790|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
48595819|NCT02757352|156377791|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
48705618|NCT02057250|156771477|FG001|AID Assessment Phase|Other than specified above|1|||
48705619|NCT02057250|156771478|FG002|AID Assessment Phase|Other than specified above|1|||
48705620|NCT02057250|156771479|FG003|AID Assessment Phase|Other than specified above|1|||
48705621|NCT02057250|156771480|FG004|AID Assessment Phase|Other than specified above|0|||
48705622|NCT02057250|156771476|FG000|Extension Phase|Adverse Event|0|||
48705623|NCT02057250|156771477|FG001|Extension Phase|Adverse Event|0|||
48705624|NCT02057250|156771478|FG002|Extension Phase|Adverse Event|0|||
48705625|NCT02057250|156771479|FG003|Extension Phase|Adverse Event|0|||
48705626|NCT02057250|156771480|FG004|Extension Phase|Adverse Event|15|||
48705627|NCT02057250|156771476|FG000|Extension Phase|Lack of Efficacy|0|||
48705628|NCT02057250|156771477|FG001|Extension Phase|Lack of Efficacy|0|||
48705629|NCT02057250|156771478|FG002|Extension Phase|Lack of Efficacy|0|||
48705630|NCT02057250|156771479|FG003|Extension Phase|Lack of Efficacy|0|||
48705631|NCT02057250|156771480|FG004|Extension Phase|Lack of Efficacy|10|||
48705632|NCT02057250|156771476|FG000|Extension Phase|Entered in this period but not treated|0|||
48705633|NCT02057250|156771477|FG001|Extension Phase|Entered in this period but not treated|0|||
48705634|NCT02057250|156771478|FG002|Extension Phase|Entered in this period but not treated|0|||
48705635|NCT02057250|156771479|FG003|Extension Phase|Entered in this period but not treated|0|||
48705636|NCT02057250|156771480|FG004|Extension Phase|Entered in this period but not treated|4|||
48705637|NCT02057250|156771476|FG000|Extension Phase|Other than specified above|0|||
48705638|NCT02057250|156771477|FG001|Extension Phase|Other than specified above|0|||
48705639|NCT02057250|156771478|FG002|Extension Phase|Other than specified above|0|||
48705640|NCT02057250|156771479|FG003|Extension Phase|Other than specified above|0|||
48705641|NCT02057250|156771480|FG004|Extension Phase|Other than specified above|7|||
48705642|NCT01662102|156771484|FG000|Overall Study|Sponsor's decision|1|||
48705643|NCT01662102|156771485|FG001|Overall Study|Sponsor's decision|0|||
48705644|NCT00927953|156771486|FG000|Overall Study|Death|2|||
48705645|NCT00927953|156771487|FG001|Overall Study|Death|1|||
48705646|NCT00724698|156771488|FG000|Overall Study|Adverse Event|9|||
48705647|NCT00724698|156771488|FG000|Overall Study|Failure of Therapy|4|||
48705648|NCT00724698|156771488|FG000|Overall Study|Poor Compliance|16|||
48705649|NCT00724698|156771488|FG000|Overall Study|Lost to Follow-up|36|||
48705650|NCT00724698|156771488|FG000|Overall Study|No Info|25|||
48705651|NCT00043979|156771489|FG000|Period 1|recipient with progressive disease|7|||
48705652|NCT00043979|156771490|FG001|Period 1|recipient with progressive disease|4|||
48705653|NCT00043979|156771491|FG002|Period 1|recipient with progressive disease|3|||
48705654|NCT01491607|156771493|FG000|Overall Study|Lost to Follow-up|7|||
48705655|NCT01491607|156771493|FG000|Overall Study|Withdrawal by Subject|3|||
48705656|NCT01635153|156771499|FG000|Overall Study|Lost to Follow-up|40|||
48705657|NCT01635153|156771500|FG001|Overall Study|Lost to Follow-up|43|||
48705658|NCT02819804|156771503|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
48705659|NCT00482053|156771507|FG000|Inter-treatment Period|Disease progression|1|||
48705660|NCT01821118|156771508|FG000|Overall Study|Death|0|||
48705661|NCT01821118|156771509|FG001|Overall Study|Death|1|||
48705662|NCT02224560|156771510|FG000|Overall Study|Protocol Deviation|1|||
48705663|NCT02224560|156771511|FG001|Overall Study|Protocol Deviation|0|||
48705664|NCT02224560|156771512|FG002|Overall Study|Protocol Deviation|0|||
48705665|NCT02224560|156771510|FG000|Overall Study|Withdrawal by Subject|2|||
48705666|NCT02224560|156771511|FG001|Overall Study|Withdrawal by Subject|0|||
48705667|NCT02224560|156771512|FG002|Overall Study|Withdrawal by Subject|1|||
48705668|NCT02224560|156771510|FG000|Overall Study|Met Withdrawal Criteria|1|||
48705669|NCT02224560|156771511|FG001|Overall Study|Met Withdrawal Criteria|0|||
48705670|NCT02224560|156771512|FG002|Overall Study|Met Withdrawal Criteria|0|||
48705671|NCT02224560|156771510|FG000|Overall Study|Adverse Event|4|||
48705672|NCT02224560|156771511|FG001|Overall Study|Adverse Event|1|||
48705673|NCT02224560|156771512|FG002|Overall Study|Adverse Event|1|||
48705674|NCT02224560|156771510|FG000|Overall Study|Withdrawn by Investigator|1|||
48705675|NCT02224560|156771511|FG001|Overall Study|Withdrawn by Investigator|1|||
48705676|NCT02224560|156771512|FG002|Overall Study|Withdrawn by Investigator|0|||
48705677|NCT02304367|156771513|FG000|Overall Study|Lack of Response to Bruosumab|1|||
48705678|NCT02304367|156771513|FG000|Overall Study|Sponsor Decision|3|||
48705679|NCT02304367|156771513|FG000|Overall Study|Death|2|||
48705680|NCT02304367|156771513|FG000|Overall Study|Physician Decision|1|||
48705681|NCT02304367|156771513|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
48705682|NCT04154189|156771514|FG000|Overall Study|Withdrawal by Subject|4|||
48705683|NCT04154189|156771515|FG001|Overall Study|Withdrawal by Subject|6|||
48705684|NCT04154189|156771514|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
48705685|NCT04154189|156771515|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
48705686|NCT04154189|156771514|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
48705687|NCT04154189|156771515|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
48705688|NCT04154189|156771514|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
48705689|NCT04154189|156771515|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
48705690|NCT04154189|156771514|FG000|Overall Study|Death|25|||
48705691|NCT04154189|156771515|FG001|Overall Study|Death|25|||
48705692|NCT00929695|156771516|FG000|Overall Study|Death|2|||
48705693|NCT00929695|156771517|FG001|Overall Study|Death|1|||
48705694|NCT00929695|156771516|FG000|Overall Study|Withdrawal by Subject|0|||
48705695|NCT00929695|156771517|FG001|Overall Study|Withdrawal by Subject|2|||
48705696|NCT00929695|156771516|FG000|Overall Study|discharge home|4|||
48705697|NCT00929695|156771517|FG001|Overall Study|discharge home|3|||
48705698|NCT00929695|156771516|FG000|Overall Study|incorrect stratification|2|||
48705699|NCT00929695|156771517|FG001|Overall Study|incorrect stratification|0|||
48705700|NCT01812252|156771518|FG000|Overall Study|Persistent Disease|1|||
48705701|NCT01812252|156771519|FG001|Overall Study|Persistent Disease|0|||
48705702|NCT01812252|156771518|FG000|Overall Study|Not transplanted|11|||
48705703|NCT01812252|156771519|FG001|Overall Study|Not transplanted|11|||
48705704|NCT01812252|156771518|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
48705705|NCT01812252|156771519|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
48705706|NCT01812252|156771518|FG000|Overall Study|Withdrawal by Subject|1|||
48705707|NCT01812252|156771519|FG001|Overall Study|Withdrawal by Subject|1|||
48705708|NCT01812252|156771518|FG000|Overall Study|Screen Failure|1|||
48705709|NCT01812252|156771519|FG001|Overall Study|Screen Failure|0|||
48705710|NCT02557139|156771520|FG000|Overall Study|Significant liver elevation|1|||
48705711|NCT02557139|156771521|FG001|Overall Study|Significant liver elevation|0|||
48705712|NCT02557139|156771522|FG002|Overall Study|Significant liver elevation|1|||
48705713|NCT02557139|156771520|FG000|Overall Study|Withdrawal by Subject|1|||
48705714|NCT02557139|156771521|FG001|Overall Study|Withdrawal by Subject|0|||
48705715|NCT02557139|156771522|FG002|Overall Study|Withdrawal by Subject|0|||
48705716|NCT02557139|156771520|FG000|Overall Study|Illness of prohibited medication|0|||
48705717|NCT02557139|156771521|FG001|Overall Study|Illness of prohibited medication|0|||
48705718|NCT02557139|156771522|FG002|Overall Study|Illness of prohibited medication|1|||
48595820|NCT02757352|156377792|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
48595821|NCT02757352|156377793|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
48595822|NCT02757352|156377794|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
48595823|NCT02757352|156377785|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
48595824|NCT02757352|156377786|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
48595825|NCT02757352|156377787|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
48705719|NCT02500797|156771523|FG000|Overall Study|Cancel (rapid disease progression)|0|||
48705720|NCT02500797|156771524|FG001|Overall Study|Cancel (rapid disease progression)|0|||
48705721|NCT02500797|156771525|FG002|Overall Study|Cancel (rapid disease progression)|0|||
48705722|NCT02500797|156771526|FG003|Overall Study|Cancel (rapid disease progression)|0|||
48705723|NCT02500797|156771527|FG004|Overall Study|Cancel (rapid disease progression)|1|||
48705724|NCT02500797|156771528|FG005|Overall Study|Cancel (rapid disease progression)|1|||
48705725|NCT02500797|156771529|FG006|Overall Study|Cancel (rapid disease progression)|0|||
48705726|NCT02500797|156771530|FG007|Overall Study|Cancel (rapid disease progression)|0|||
48705727|NCT02500797|156771523|FG000|Overall Study|Withdrawal by Subject|1|||
48705728|NCT02500797|156771524|FG001|Overall Study|Withdrawal by Subject|0|||
48705729|NCT02500797|156771525|FG002|Overall Study|Withdrawal by Subject|0|||
48705730|NCT02500797|156771526|FG003|Overall Study|Withdrawal by Subject|0|||
48705731|NCT02500797|156771527|FG004|Overall Study|Withdrawal by Subject|0|||
48705732|NCT02500797|156771528|FG005|Overall Study|Withdrawal by Subject|0|||
48705733|NCT02500797|156771529|FG006|Overall Study|Withdrawal by Subject|0|||
48705734|NCT02500797|156771530|FG007|Overall Study|Withdrawal by Subject|0|||
48705735|NCT00369265|156771536|FG000|Overall Study|Study terminated|4|||
48705736|NCT00369265|156771537|FG001|Overall Study|Study terminated|7|||
48705737|NCT03895840|156771538|FG000|Overall Study|Withdrawal by Subject|21|||
48705738|NCT03857867|156771539|FG000|Overall Study|Physician Decision|1|||
48705739|NCT01869764|156771540|FG000|Overall Study|Withdrawal by Subject|0|||
48705740|NCT01869764|156771541|FG001|Overall Study|Withdrawal by Subject|2|||
48705741|NCT00834093|156771542|FG000|Overall Study|Progressive Disease|3|||
48705742|NCT00834093|156771542|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
48705743|NCT02745119|156771543|FG000|Overall Study|Adverse Event|1|||
48705744|NCT02745119|156771544|FG001|Overall Study|Adverse Event|0|||
48705745|NCT02745119|156771545|FG002|Overall Study|Adverse Event|1|||
48705746|NCT02745119|156771546|FG003|Overall Study|Adverse Event|3|||
48705747|NCT02745119|156771543|FG000|Overall Study|Death|3|||
48705748|NCT02745119|156771544|FG001|Overall Study|Death|3|||
48705749|NCT02745119|156771545|FG002|Overall Study|Death|0|||
48705750|NCT02745119|156771546|FG003|Overall Study|Death|4|||
48705751|NCT02745119|156771543|FG000|Overall Study|Lost to Follow-up|0|||
48705752|NCT02745119|156771544|FG001|Overall Study|Lost to Follow-up|0|||
48705753|NCT02745119|156771545|FG002|Overall Study|Lost to Follow-up|0|||
48705754|NCT02745119|156771546|FG003|Overall Study|Lost to Follow-up|1|||
48705755|NCT02745119|156771543|FG000|Overall Study|Protocol Deviation|0|||
48705756|NCT02745119|156771544|FG001|Overall Study|Protocol Deviation|0|||
48705757|NCT02745119|156771545|FG002|Overall Study|Protocol Deviation|0|||
48705758|NCT02745119|156771546|FG003|Overall Study|Protocol Deviation|1|||
48705759|NCT02745119|156771543|FG000|Overall Study|Withdrawal by Subject|7|||
48705760|NCT02745119|156771544|FG001|Overall Study|Withdrawal by Subject|15|||
48705761|NCT02745119|156771545|FG002|Overall Study|Withdrawal by Subject|8|||
48705762|NCT02745119|156771546|FG003|Overall Study|Withdrawal by Subject|14|||
48705763|NCT02745119|156771543|FG000|Overall Study|Study Terminated by Sponsor|134|||
48705764|NCT02745119|156771544|FG001|Overall Study|Study Terminated by Sponsor|252|||
48705765|NCT02745119|156771545|FG002|Overall Study|Study Terminated by Sponsor|135|||
48705766|NCT02745119|156771546|FG003|Overall Study|Study Terminated by Sponsor|251|||
48705767|NCT02745119|156771543|FG000|Overall Study|Physician Decision|0|||
48705768|NCT02745119|156771544|FG001|Overall Study|Physician Decision|2|||
48705769|NCT02745119|156771545|FG002|Overall Study|Physician Decision|2|||
48705770|NCT02745119|156771546|FG003|Overall Study|Physician Decision|2|||
48705771|NCT02745119|156771543|FG000|Overall Study|Reason Not Specified|0|||
48705772|NCT02745119|156771544|FG001|Overall Study|Reason Not Specified|2|||
48705773|NCT02745119|156771545|FG002|Overall Study|Reason Not Specified|0|||
48705774|NCT02745119|156771546|FG003|Overall Study|Reason Not Specified|1|||
48705775|NCT00515619|156771547|FG000|Overall Study|Adverse Event|34|||
48705776|NCT00515619|156771547|FG000|Overall Study|Lack of Efficacy|92|||
48705777|NCT00515619|156771547|FG000|Overall Study|Withdrawal by Subject|66|||
48705778|NCT00515619|156771547|FG000|Overall Study|Protocol Violation|3|||
48705779|NCT00515619|156771547|FG000|Overall Study|Lost to Follow-up|4|||
48705780|NCT00515619|156771547|FG000|Overall Study|Unsatisfactory compliance|6|||
48705781|NCT00515619|156771547|FG000|Overall Study|Other: Site discontinuing trials|2|||
48705782|NCT00515619|156771547|FG000|Overall Study|Other: Subject cannot attend visits|2|||
48705783|NCT00515619|156771547|FG000|Overall Study|Other: Subject required surgery|1|||
48705784|NCT00515619|156771547|FG000|Overall Study|Other: Subject moved to another country|1|||
48705785|NCT00515619|156771547|FG000|Overall Study|Other: Investigator decision|1|||
48705786|NCT00515619|156771547|FG000|Overall Study|Other: Subject became pregnant|1|||
48705787|NCT00515619|156771547|FG000|Overall Study|Other: Request from sponsor|1|||
48705788|NCT00515619|156771547|FG000|Overall Study|Other: Drug available on license|1|||
48705789|NCT00515619|156771547|FG000|Overall Study|Other: Subject interested in other AED|1|||
48705790|NCT03313037|156771548|FG000|Overall Study|Protocol Violation|4|||
48705791|NCT03313037|156771549|FG001|Overall Study|Protocol Violation|1|||
48705792|NCT03313037|156771548|FG000|Overall Study|Other|1|||
48705793|NCT03313037|156771549|FG001|Overall Study|Other|1|||
48705794|NCT03313037|156771548|FG000|Overall Study|Withdrawal by Subject|4|||
48705795|NCT03313037|156771549|FG001|Overall Study|Withdrawal by Subject|3|||
48705796|NCT03313037|156771548|FG000|Overall Study|No longer meets eligibility criteria|1|||
48705797|NCT03313037|156771549|FG001|Overall Study|No longer meets eligibility criteria|7|||
48705798|NCT03313037|156771548|FG000|Overall Study|Lost to Follow-up|9|||
48705799|NCT03313037|156771549|FG001|Overall Study|Lost to Follow-up|8|||
48705800|NCT03313037|156771548|FG000|Overall Study|Randomized but not treated|1|||
48705801|NCT03313037|156771549|FG001|Overall Study|Randomized but not treated|0|||
48705802|NCT01918306|156771553|FG000|Overall Study|progresive disease|4|||
48705803|NCT01918306|156771554|FG001|Overall Study|progresive disease|0|||
48705804|NCT01918306|156771555|FG002|Overall Study|progresive disease|1|||
48705805|NCT01918306|156771556|FG003|Overall Study|progresive disease|1|||
48705806|NCT01918306|156771553|FG000|Overall Study|Withdrawal by Subject|0|||
48705807|NCT01918306|156771554|FG001|Overall Study|Withdrawal by Subject|0|||
48705808|NCT01918306|156771555|FG002|Overall Study|Withdrawal by Subject|0|||
48705809|NCT01918306|156771556|FG003|Overall Study|Withdrawal by Subject|2|||
48705810|NCT01918306|156771553|FG000|Overall Study|neutropenia|1|||
48705811|NCT01918306|156771554|FG001|Overall Study|neutropenia|0|||
48705812|NCT01918306|156771555|FG002|Overall Study|neutropenia|0|||
48799475|NCT04843930|157104203|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
48799476|NCT04843930|157104204|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
48799477|NCT04843930|157104205|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
48799478|NCT04843930|157104206|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
48799479|NCT04843930|157104203|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
48799480|NCT04843930|157104204|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
48799481|NCT04843930|157104205|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
48799482|NCT04843930|157104206|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
48799483|NCT02220894|157104208|FG000|Overall Study|Adverse Event|127|||
48799484|NCT02220894|157104209|FG001|Overall Study|Adverse Event|74|||
48799485|NCT02220894|157104208|FG000|Overall Study|Death|418|||
48799486|NCT02220894|157104209|FG001|Overall Study|Death|508|||
48799487|NCT02220894|157104208|FG000|Overall Study|Lost to Follow-up|0|||
48799488|NCT02220894|157104209|FG001|Overall Study|Lost to Follow-up|4|||
48799489|NCT02220894|157104208|FG000|Overall Study|Site Terminated by Sponsor|2|||
48799490|NCT02220894|157104209|FG001|Overall Study|Site Terminated by Sponsor|0|||
48799491|NCT02220894|157104208|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
48799492|NCT02220894|157104209|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
48799493|NCT02220894|157104208|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48799494|NCT02220894|157104209|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48799495|NCT02220894|157104208|FG000|Overall Study|Withdrawal by Subject|10|||
48799496|NCT02220894|157104209|FG001|Overall Study|Withdrawal by Subject|9|||
48490028|NCT01078623|155988840|FG014|Treatment Period 2|Withdrawal by Subject|0|||
48705813|NCT01918306|156771556|FG003|Overall Study|neutropenia|0|||
48490029|NCT01078623|155988841|FG015|Treatment Period 2|Withdrawal by Subject|0|||
48705814|NCT01918306|156771553|FG000|Overall Study|Lack of Efficacy|1|||
48705815|NCT01918306|156771554|FG001|Overall Study|Lack of Efficacy|0|||
48705816|NCT01918306|156771555|FG002|Overall Study|Lack of Efficacy|0|||
48705817|NCT01918306|156771556|FG003|Overall Study|Lack of Efficacy|0|||
48705818|NCT01918306|156771553|FG000|Overall Study|progress disease, crossover|0|||
48705819|NCT01918306|156771554|FG001|Overall Study|progress disease, crossover|0|||
48705820|NCT01918306|156771555|FG002|Overall Study|progress disease, crossover|1|||
48705821|NCT01918306|156771556|FG003|Overall Study|progress disease, crossover|0|||
48705822|NCT02379091|156771557|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48705823|NCT02379091|156771558|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
48705824|NCT02379091|156771559|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48705825|NCT02379091|156771560|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
48705826|NCT02379091|156771557|FG000|Overall Study|Principal Investigator Discretion|0|||
48705827|NCT02379091|156771558|FG001|Overall Study|Principal Investigator Discretion|1|||
48705828|NCT02379091|156771559|FG002|Overall Study|Principal Investigator Discretion|0|||
48705829|NCT02379091|156771560|FG003|Overall Study|Principal Investigator Discretion|0|||
48705830|NCT02379091|156771557|FG000|Overall Study|Lost to Follow-up|0|||
48705831|NCT02379091|156771558|FG001|Overall Study|Lost to Follow-up|0|||
48705832|NCT02379091|156771559|FG002|Overall Study|Lost to Follow-up|0|||
48705833|NCT02379091|156771560|FG003|Overall Study|Lost to Follow-up|1|||
48705834|NCT02379091|156771557|FG000|Overall Study|Voluntary Withdrawal|2|||
48705835|NCT02379091|156771558|FG001|Overall Study|Voluntary Withdrawal|5|||
48705836|NCT02379091|156771559|FG002|Overall Study|Voluntary Withdrawal|2|||
48705837|NCT02379091|156771560|FG003|Overall Study|Voluntary Withdrawal|4|||
48705838|NCT02379091|156771557|FG000|Overall Study|Study Termination|7|||
48705839|NCT02379091|156771558|FG001|Overall Study|Study Termination|2|||
48705840|NCT02379091|156771559|FG002|Overall Study|Study Termination|5|||
48705841|NCT02379091|156771560|FG003|Overall Study|Study Termination|8|||
48705842|NCT02379091|156771557|FG000|Overall Study|Lack of Efficacy|3|||
48705843|NCT02379091|156771558|FG001|Overall Study|Lack of Efficacy|0|||
48705844|NCT02379091|156771559|FG002|Overall Study|Lack of Efficacy|0|||
48705845|NCT02379091|156771560|FG003|Overall Study|Lack of Efficacy|0|||
48705846|NCT01467960|156771563|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
48705847|NCT01467960|156771564|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
48705848|NCT01467960|156771565|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
48705849|NCT01467960|156771566|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
48705850|NCT01467960|156771567|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
48705851|NCT01467960|156771568|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
48705852|NCT00737672|156771569|FG000|Overall Study|Graft Abandonment|48|||
48705853|NCT00737672|156771570|FG001|Overall Study|Graft Abandonment|56|||
48705854|NCT00737672|156771569|FG000|Overall Study|Death|23|||
48705855|NCT00737672|156771570|FG001|Overall Study|Death|22|||
48705856|NCT00737672|156771569|FG000|Overall Study|Withdrawal by Subject|1|||
48705857|NCT00737672|156771570|FG001|Overall Study|Withdrawal by Subject|2|||
48705858|NCT00737672|156771569|FG000|Overall Study|Lost to Follow-up|1|||
48705859|NCT00737672|156771570|FG001|Overall Study|Lost to Follow-up|0|||
48705860|NCT00737672|156771569|FG000|Overall Study|Miscellaneous|7|||
48705861|NCT00737672|156771570|FG001|Overall Study|Miscellaneous|1|||
48705862|NCT00737672|156771569|FG000|Overall Study|Physician Decision|0|||
48705863|NCT00737672|156771570|FG001|Overall Study|Physician Decision|2|||
48705864|NCT02447003|156771571|FG000|Overall Study|Other|0|||
48705865|NCT02447003|156771572|FG001|Overall Study|Other|4|||
48705866|NCT02447003|156771571|FG000|Overall Study|Site discontinued|0|||
48705867|NCT02447003|156771572|FG001|Overall Study|Site discontinued|2|||
48705868|NCT02447003|156771571|FG000|Overall Study|Physician Decision|0|||
48705869|NCT02447003|156771572|FG001|Overall Study|Physician Decision|1|||
48705870|NCT02447003|156771571|FG000|Overall Study|Withdrawal by Subject|4|||
48705871|NCT02447003|156771572|FG001|Overall Study|Withdrawal by Subject|3|||
48705872|NCT02447003|156771571|FG000|Overall Study|Sponsor Decision|6|||
48705873|NCT02447003|156771572|FG001|Overall Study|Sponsor Decision|11|||
48705874|NCT02447003|156771571|FG000|Overall Study|Progressive Disease|1|||
48705875|NCT02447003|156771572|FG001|Overall Study|Progressive Disease|0|||
48705876|NCT02447003|156771571|FG000|Overall Study|Lost to Follow-up|5|||
48705877|NCT02447003|156771572|FG001|Overall Study|Lost to Follow-up|0|||
48705878|NCT02447003|156771571|FG000|Overall Study|Death|154|||
48705879|NCT02447003|156771572|FG001|Overall Study|Death|63|||
48705880|NCT00787644|156771573|FG000|Overall Study|Lost to Follow-up|1|||
48705881|NCT00787644|156771574|FG001|Overall Study|Lost to Follow-up|1|||
48705882|NCT00787644|156771573|FG000|Overall Study|Withdrawal by Subject|1|||
48705883|NCT00787644|156771574|FG001|Overall Study|Withdrawal by Subject|1|||
48705884|NCT02930018|156771580|FG000|Overall Study|Lost to Follow-up|1|||
48705885|NCT02930018|156771581|FG001|Overall Study|Lost to Follow-up|1|||
48705886|NCT02930018|156771580|FG000|Overall Study|Withdrawal by Subject|5|||
48705887|NCT02930018|156771581|FG001|Overall Study|Withdrawal by Subject|2|||
48705888|NCT00807001|156773453|FG000|Overall Study|Non-compliance|0|||
48705889|NCT00807001|156773454|FG001|Overall Study|Non-compliance|1|||
48705890|NCT00807001|156773455|FG002|Overall Study|Non-compliance|0|||
48705891|NCT00807001|156773456|FG003|Overall Study|Non-compliance|0|||
48705892|NCT00807001|156773457|FG004|Overall Study|Non-compliance|0|||
48705893|NCT01803607|156773458|FG000|Overall Study|Adverse Event|5|||
48705894|NCT01803607|156773459|FG001|Overall Study|Adverse Event|3|||
48705895|NCT01803607|156773458|FG000|Overall Study|Lack of Efficacy|0|||
48705896|NCT01803607|156773459|FG001|Overall Study|Lack of Efficacy|1|||
48705897|NCT01803607|156773458|FG000|Overall Study|Protocol Violation|3|||
48705898|NCT01803607|156773459|FG001|Overall Study|Protocol Violation|2|||
48705899|NCT01803607|156773458|FG000|Overall Study|Study terminated by sponsor|54|||
48705900|NCT01803607|156773459|FG001|Overall Study|Study terminated by sponsor|56|||
48705901|NCT01803607|156773458|FG000|Overall Study|Withdrawal by Subject|6|||
48705902|NCT01803607|156773459|FG001|Overall Study|Withdrawal by Subject|5|||
48705903|NCT02266888|156773466|FG000|Overall Study|Death|2|||
48705904|NCT02266888|156773467|FG001|Overall Study|Death|2|||
48705905|NCT02266888|156773468|FG002|Overall Study|Death|4|||
48705906|NCT02266888|156773469|FG003|Overall Study|Death|2|||
48705907|NCT02266888|156773466|FG000|Overall Study|Physician Decision|0|||
48705908|NCT02266888|156773467|FG001|Overall Study|Physician Decision|1|||
48705909|NCT02266888|156773468|FG002|Overall Study|Physician Decision|2|||
48705910|NCT02266888|156773469|FG003|Overall Study|Physician Decision|2|||
48705911|NCT02266888|156773466|FG000|Overall Study|Study Terminated|5|||
48705912|NCT02266888|156773467|FG001|Overall Study|Study Terminated|1|||
48705913|NCT02266888|156773468|FG002|Overall Study|Study Terminated|0|||
48705914|NCT02266888|156773469|FG003|Overall Study|Study Terminated|0|||
48705915|NCT02266888|156773466|FG000|Overall Study|No Longer Eligible|0|||
48705916|NCT02266888|156773467|FG001|Overall Study|No Longer Eligible|0|||
48705917|NCT02266888|156773468|FG002|Overall Study|No Longer Eligible|0|||
48705918|NCT02266888|156773469|FG003|Overall Study|No Longer Eligible|2|||
48705919|NCT02266888|156773466|FG000|Overall Study|Randomization Closed|0|||
48705920|NCT02266888|156773467|FG001|Overall Study|Randomization Closed|0|||
48705921|NCT02266888|156773468|FG002|Overall Study|Randomization Closed|4|||
48705922|NCT02266888|156773469|FG003|Overall Study|Randomization Closed|0|||
48705923|NCT02266888|156773466|FG000|Overall Study|Personnel unavailable at transplant|0|||
48705924|NCT02266888|156773467|FG001|Overall Study|Personnel unavailable at transplant|0|||
48705925|NCT02266888|156773468|FG002|Overall Study|Personnel unavailable at transplant|0|||
48705926|NCT02266888|156773469|FG003|Overall Study|Personnel unavailable at transplant|1|||
48705927|NCT02266888|156773466|FG000|Overall Study|Transfer of care|0|||
48705928|NCT02266888|156773467|FG001|Overall Study|Transfer of care|0|||
48705929|NCT02266888|156773468|FG002|Overall Study|Transfer of care|1|||
48705930|NCT02266888|156773469|FG003|Overall Study|Transfer of care|0|||
48705931|NCT02038933|156773472|FG000|Overall Study|Disease progression|104|||
48705932|NCT02038933|156773472|FG000|Overall Study|Study drug toxicity|6|||
48705933|NCT02038933|156773472|FG000|Overall Study|Adverse event unrelated to study drug|6|||
48705934|NCT02038933|156773472|FG000|Overall Study|Participant request to discontinue treatment|2|||
48705935|NCT02038933|156773472|FG000|Overall Study|Lost to Follow-up|1|||
48705936|NCT02038933|156773472|FG000|Overall Study|Other reasons|2|||
48705937|NCT04154904|156773473|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
48705938|NCT04154904|156773474|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
48705939|NCT04154904|156773475|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
48705940|NCT00706238|156773476|FG000|Overall Study|Disease progression|4|||
48705941|NCT00706238|156773476|FG000|Overall Study|Other|1|||
48705942|NCT03819114|156773478|FG000|Overall Study|Protocol Violation|0|||
48705943|NCT03819114|156773479|FG001|Overall Study|Protocol Violation|1|||
48705944|NCT03819114|156773480|FG002|Overall Study|Protocol Violation|1|||
48705945|NCT03819114|156773481|FG003|Overall Study|Protocol Violation|0|||
48705946|NCT03819114|156773478|FG000|Overall Study|Lost to Follow-up|0|||
48705947|NCT03819114|156773479|FG001|Overall Study|Lost to Follow-up|0|||
48705948|NCT03819114|156773480|FG002|Overall Study|Lost to Follow-up|1|||
48705949|NCT03819114|156773481|FG003|Overall Study|Lost to Follow-up|0|||
48705950|NCT01462370|156773482|FG000|Overall Study|Lack of Qualifying Event|1|||
48490030|NCT01078623|155988842|FG016|Treatment Period 2|Withdrawal by Subject|0|||
48490031|NCT01078623|155988843|FG017|Treatment Period 2|Withdrawal by Subject|0|||
48705951|NCT01462370|156773483|FG001|Overall Study|Lack of Qualifying Event|1|||
48705952|NCT01462370|156773482|FG000|Overall Study|Physician Decision|0|||
48705953|NCT01462370|156773483|FG001|Overall Study|Physician Decision|1|||
48490032|NCT01078623|155988844|FG018|Treatment Period 2|Withdrawal by Subject|0|||
48490033|NCT01078623|155988845|FG019|Treatment Period 2|Withdrawal by Subject|0|||
48705954|NCT01462370|156773482|FG000|Overall Study|Withdrawal by Subject|0|||
48705955|NCT01462370|156773483|FG001|Overall Study|Withdrawal by Subject|3|||
48705956|NCT02085161|156773484|FG000|Overall Study|Not Treated|1|||
48705957|NCT02085161|156773485|FG001|Overall Study|Not Treated|0|||
48705958|NCT02085161|156773486|FG002|Overall Study|Not Treated|0|||
48705959|NCT02085161|156773487|FG003|Overall Study|Not Treated|0|||
48705960|NCT02085161|156773484|FG000|Overall Study|Adverse Event|8|||
48705961|NCT02085161|156773485|FG001|Overall Study|Adverse Event|5|||
48705962|NCT02085161|156773486|FG002|Overall Study|Adverse Event|4|||
48705963|NCT02085161|156773487|FG003|Overall Study|Adverse Event|5|||
48705964|NCT02085161|156773484|FG000|Overall Study|Protocol Violation|0|||
48705965|NCT02085161|156773485|FG001|Overall Study|Protocol Violation|1|||
48705966|NCT02085161|156773486|FG002|Overall Study|Protocol Violation|0|||
48705967|NCT02085161|156773487|FG003|Overall Study|Protocol Violation|1|||
48705968|NCT02085161|156773484|FG000|Overall Study|Withdrawal by Subject|2|||
48705969|NCT02085161|156773485|FG001|Overall Study|Withdrawal by Subject|4|||
48705970|NCT02085161|156773486|FG002|Overall Study|Withdrawal by Subject|0|||
48705971|NCT02085161|156773487|FG003|Overall Study|Withdrawal by Subject|3|||
48705972|NCT02085161|156773484|FG000|Overall Study|Other Reason|1|||
48705973|NCT02085161|156773485|FG001|Overall Study|Other Reason|0|||
48705974|NCT02085161|156773486|FG002|Overall Study|Other Reason|1|||
48705975|NCT02085161|156773487|FG003|Overall Study|Other Reason|1|||
48705976|NCT03763877|156773499|FG000|Overall Study|Withdrawal by Subject|3|||
48705977|NCT03763877|156773500|FG001|Overall Study|Withdrawal by Subject|1|||
48705978|NCT03763877|156773501|FG002|Overall Study|Withdrawal by Subject|3|||
48705979|NCT03763877|156773502|FG003|Overall Study|Withdrawal by Subject|4|||
48705980|NCT03763877|156773499|FG000|Overall Study|Adverse Event|1|||
48705981|NCT03763877|156773500|FG001|Overall Study|Adverse Event|1|||
48705982|NCT03763877|156773501|FG002|Overall Study|Adverse Event|3|||
48705983|NCT03763877|156773502|FG003|Overall Study|Adverse Event|1|||
48705984|NCT03763877|156773499|FG000|Overall Study|Protocol Violation|1|||
48705985|NCT03763877|156773500|FG001|Overall Study|Protocol Violation|1|||
48705986|NCT03763877|156773501|FG002|Overall Study|Protocol Violation|0|||
48705987|NCT03763877|156773502|FG003|Overall Study|Protocol Violation|0|||
48705988|NCT03763877|156773499|FG000|Overall Study|Lost to Follow-up|0|||
48705989|NCT03763877|156773500|FG001|Overall Study|Lost to Follow-up|1|||
48705990|NCT03763877|156773501|FG002|Overall Study|Lost to Follow-up|1|||
48705991|NCT03763877|156773502|FG003|Overall Study|Lost to Follow-up|0|||
48705992|NCT03040336|156773503|FG000|Overall Study|Death|1|||
48705993|NCT03040336|156773504|FG001|Overall Study|Death|0|||
48705994|NCT03040336|156773503|FG000|Overall Study|Withdrawal by Subject|2|||
48705995|NCT03040336|156773504|FG001|Overall Study|Withdrawal by Subject|3|||
48705996|NCT01747876|156773505|FG000|Overall Study|Adverse Event|1|||
48705997|NCT01747876|156773506|FG001|Overall Study|Adverse Event|0|||
48705998|NCT01747876|156773507|FG002|Overall Study|Adverse Event|2|||
48705999|NCT01747876|156773505|FG000|Overall Study|Withdrawal by Subject|0|||
48706000|NCT01747876|156773506|FG001|Overall Study|Withdrawal by Subject|1|||
48706001|NCT01747876|156773507|FG002|Overall Study|Withdrawal by Subject|1|||
48706002|NCT01747876|156773505|FG000|Overall Study|Disease progression|4|||
48706003|NCT01747876|156773506|FG001|Overall Study|Disease progression|13|||
48706004|NCT01747876|156773507|FG002|Overall Study|Disease progression|8|||
48706005|NCT01747876|156773505|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
48706006|NCT01747876|156773506|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
48706007|NCT01747876|156773507|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
48706008|NCT03822117|156773508|FG000|Overall Study|Death|18|||
48706009|NCT03822117|156773509|FG001|Overall Study|Death|17|||
48706010|NCT03822117|156773510|FG002|Overall Study|Death|12|||
48706011|NCT03822117|156773511|FG003|Overall Study|Death|4|||
48706012|NCT03822117|156773508|FG000|Overall Study|Lost to Follow-up|1|||
48706013|NCT03822117|156773509|FG001|Overall Study|Lost to Follow-up|2|||
48706014|NCT03822117|156773510|FG002|Overall Study|Lost to Follow-up|3|||
48706015|NCT03822117|156773511|FG003|Overall Study|Lost to Follow-up|0|||
48706016|NCT03822117|156773508|FG000|Overall Study|Study Terminated by Sponsor|25|||
48706017|NCT03822117|156773509|FG001|Overall Study|Study Terminated by Sponsor|11|||
48706018|NCT03822117|156773510|FG002|Overall Study|Study Terminated by Sponsor|6|||
48706019|NCT03822117|156773511|FG003|Overall Study|Study Terminated by Sponsor|0|||
48706020|NCT03822117|156773508|FG000|Overall Study|Withdrawal by Subject|4|||
48706021|NCT03822117|156773509|FG001|Overall Study|Withdrawal by Subject|0|||
48706022|NCT03822117|156773510|FG002|Overall Study|Withdrawal by Subject|3|||
48706023|NCT03822117|156773511|FG003|Overall Study|Withdrawal by Subject|0|||
48706024|NCT03822117|156773508|FG000|Overall Study|Disease Progression|1|||
48706025|NCT03822117|156773509|FG001|Overall Study|Disease Progression|2|||
48706026|NCT03822117|156773510|FG002|Overall Study|Disease Progression|1|||
48706027|NCT03822117|156773511|FG003|Overall Study|Disease Progression|0|||
48706028|NCT03822117|156773508|FG000|Overall Study|Never Returned to Hospital|0|||
48706029|NCT03822117|156773509|FG001|Overall Study|Never Returned to Hospital|0|||
48706030|NCT03822117|156773510|FG002|Overall Study|Never Returned to Hospital|1|||
48706031|NCT03822117|156773511|FG003|Overall Study|Never Returned to Hospital|0|||
48706032|NCT00068692|156773516|FG000|Step 1: Registration|Disese progression/relapse|5|||
48706033|NCT00068692|156773517|FG001|Step 1: Registration|Disese progression/relapse|0|||
48706034|NCT00068692|156773518|FG002|Step 1: Registration|Disese progression/relapse|0|||
48706035|NCT00068692|156773519|FG003|Step 1: Registration|Disese progression/relapse|0|||
48706036|NCT00068692|156773520|FG004|Step 1: Registration|Disese progression/relapse|0|||
48706037|NCT00068692|156773521|FG005|Step 1: Registration|Disese progression/relapse|0|||
48706038|NCT00068692|156773522|FG006|Step 1: Registration|Disese progression/relapse|0|||
48706039|NCT00068692|156773523|FG007|Step 1: Registration|Disese progression/relapse|0|||
48706040|NCT00068692|156773516|FG000|Step 1: Registration|Adverse Event|7|||
48706041|NCT00068692|156773517|FG001|Step 1: Registration|Adverse Event|0|||
48706042|NCT00068692|156773518|FG002|Step 1: Registration|Adverse Event|0|||
48706043|NCT00068692|156773519|FG003|Step 1: Registration|Adverse Event|0|||
48706044|NCT00068692|156773520|FG004|Step 1: Registration|Adverse Event|0|||
48706045|NCT00068692|156773521|FG005|Step 1: Registration|Adverse Event|0|||
48706046|NCT00068692|156773522|FG006|Step 1: Registration|Adverse Event|0|||
48706047|NCT00068692|156773523|FG007|Step 1: Registration|Adverse Event|0|||
48706048|NCT00068692|156773516|FG000|Step 1: Registration|Death|1|||
48706049|NCT00068692|156773517|FG001|Step 1: Registration|Death|0|||
48706050|NCT00068692|156773518|FG002|Step 1: Registration|Death|0|||
48706051|NCT00068692|156773519|FG003|Step 1: Registration|Death|0|||
48706052|NCT00068692|156773520|FG004|Step 1: Registration|Death|0|||
48706053|NCT00068692|156773521|FG005|Step 1: Registration|Death|0|||
48706054|NCT00068692|156773522|FG006|Step 1: Registration|Death|0|||
48706055|NCT00068692|156773523|FG007|Step 1: Registration|Death|0|||
48706056|NCT00068692|156773516|FG000|Step 1: Registration|Withdrawal by Subject|11|||
48706057|NCT00068692|156773517|FG001|Step 1: Registration|Withdrawal by Subject|0|||
48706058|NCT00068692|156773518|FG002|Step 1: Registration|Withdrawal by Subject|0|||
48706059|NCT00068692|156773519|FG003|Step 1: Registration|Withdrawal by Subject|0|||
48706060|NCT00068692|156773520|FG004|Step 1: Registration|Withdrawal by Subject|0|||
48706061|NCT00068692|156773521|FG005|Step 1: Registration|Withdrawal by Subject|0|||
48706062|NCT00068692|156773522|FG006|Step 1: Registration|Withdrawal by Subject|0|||
48706063|NCT00068692|156773523|FG007|Step 1: Registration|Withdrawal by Subject|0|||
48706064|NCT00068692|156773516|FG000|Step 1: Registration|Alternative therapy|2|||
48706065|NCT00068692|156773517|FG001|Step 1: Registration|Alternative therapy|0|||
48706066|NCT00068692|156773518|FG002|Step 1: Registration|Alternative therapy|0|||
48706067|NCT00068692|156773519|FG003|Step 1: Registration|Alternative therapy|0|||
48706068|NCT00068692|156773520|FG004|Step 1: Registration|Alternative therapy|0|||
48706069|NCT00068692|156773521|FG005|Step 1: Registration|Alternative therapy|0|||
48706070|NCT00068692|156773522|FG006|Step 1: Registration|Alternative therapy|0|||
48706071|NCT00068692|156773523|FG007|Step 1: Registration|Alternative therapy|0|||
48706072|NCT00068692|156773516|FG000|Step 1: Registration|Complicating disease|2|||
48706073|NCT00068692|156773517|FG001|Step 1: Registration|Complicating disease|0|||
48706074|NCT00068692|156773518|FG002|Step 1: Registration|Complicating disease|0|||
48706075|NCT00068692|156773519|FG003|Step 1: Registration|Complicating disease|0|||
48706076|NCT00068692|156773520|FG004|Step 1: Registration|Complicating disease|0|||
48706077|NCT00068692|156773521|FG005|Step 1: Registration|Complicating disease|0|||
48706078|NCT00068692|156773522|FG006|Step 1: Registration|Complicating disease|0|||
48706079|NCT00068692|156773523|FG007|Step 1: Registration|Complicating disease|0|||
48706080|NCT00068692|156773516|FG000|Step 1: Registration|Protocol Violation|1|||
48706081|NCT00068692|156773517|FG001|Step 1: Registration|Protocol Violation|0|||
48706082|NCT00068692|156773518|FG002|Step 1: Registration|Protocol Violation|0|||
48706083|NCT00068692|156773519|FG003|Step 1: Registration|Protocol Violation|0|||
48706084|NCT00068692|156773520|FG004|Step 1: Registration|Protocol Violation|0|||
48706085|NCT00068692|156773521|FG005|Step 1: Registration|Protocol Violation|0|||
48706086|NCT00068692|156773522|FG006|Step 1: Registration|Protocol Violation|0|||
48706087|NCT00068692|156773523|FG007|Step 1: Registration|Protocol Violation|0|||
48706088|NCT00068692|156773516|FG000|Step 1: Registration|Not eligible|6|||
48706089|NCT00068692|156773517|FG001|Step 1: Registration|Not eligible|0|||
48706090|NCT00068692|156773518|FG002|Step 1: Registration|Not eligible|0|||
48706091|NCT00068692|156773519|FG003|Step 1: Registration|Not eligible|0|||
48706092|NCT00068692|156773520|FG004|Step 1: Registration|Not eligible|0|||
48706093|NCT00068692|156773521|FG005|Step 1: Registration|Not eligible|0|||
48706094|NCT00068692|156773522|FG006|Step 1: Registration|Not eligible|0|||
48706095|NCT00068692|156773523|FG007|Step 1: Registration|Not eligible|0|||
48706096|NCT00068692|156773516|FG000|Step 1: Registration|Other|2|||
48706097|NCT00068692|156773517|FG001|Step 1: Registration|Other|0|||
48706098|NCT00068692|156773518|FG002|Step 1: Registration|Other|0|||
48706099|NCT00068692|156773519|FG003|Step 1: Registration|Other|0|||
48706100|NCT00068692|156773520|FG004|Step 1: Registration|Other|0|||
48706101|NCT00068692|156773521|FG005|Step 1: Registration|Other|0|||
48706102|NCT00068692|156773522|FG006|Step 1: Registration|Other|0|||
48706103|NCT00068692|156773523|FG007|Step 1: Registration|Other|0|||
48706104|NCT00068692|156773516|FG000|Step 1: Registration|Not start protocol therapy|3|||
48706105|NCT00068692|156773517|FG001|Step 1: Registration|Not start protocol therapy|0|||
48706106|NCT00068692|156773518|FG002|Step 1: Registration|Not start protocol therapy|0|||
48706107|NCT00068692|156773519|FG003|Step 1: Registration|Not start protocol therapy|0|||
48706108|NCT00068692|156773520|FG004|Step 1: Registration|Not start protocol therapy|0|||
48706109|NCT00068692|156773521|FG005|Step 1: Registration|Not start protocol therapy|0|||
48706110|NCT00068692|156773522|FG006|Step 1: Registration|Not start protocol therapy|0|||
48706111|NCT00068692|156773523|FG007|Step 1: Registration|Not start protocol therapy|0|||
48706112|NCT00068692|156773516|FG000|Step 1: Registration|Registered but not randomized|0|||
48706113|NCT00068692|156773517|FG001|Step 1: Registration|Registered but not randomized|1|||
48706114|NCT00068692|156773518|FG002|Step 1: Registration|Registered but not randomized|0|||
48706115|NCT00068692|156773519|FG003|Step 1: Registration|Registered but not randomized|0|||
48706116|NCT00068692|156773520|FG004|Step 1: Registration|Registered but not randomized|0|||
48706117|NCT00068692|156773521|FG005|Step 1: Registration|Registered but not randomized|0|||
48706118|NCT00068692|156773522|FG006|Step 1: Registration|Registered but not randomized|0|||
48706119|NCT00068692|156773523|FG007|Step 1: Registration|Registered but not randomized|0|||
48706120|NCT00068692|156773516|FG000|Step 2: Randomization|Disesae progression/replase|0|||
48706121|NCT00068692|156773517|FG001|Step 2: Randomization|Disesae progression/replase|0|||
48706122|NCT00068692|156773518|FG002|Step 2: Randomization|Disesae progression/replase|1|||
48706123|NCT00068692|156773519|FG003|Step 2: Randomization|Disesae progression/replase|1|||
48706124|NCT00068692|156773520|FG004|Step 2: Randomization|Disesae progression/replase|0|||
48706125|NCT00068692|156773521|FG005|Step 2: Randomization|Disesae progression/replase|0|||
48706126|NCT00068692|156773522|FG006|Step 2: Randomization|Disesae progression/replase|0|||
48706127|NCT00068692|156773523|FG007|Step 2: Randomization|Disesae progression/replase|0|||
48706128|NCT00068692|156773516|FG000|Step 2: Randomization|Adverse Event|0|||
48706129|NCT00068692|156773517|FG001|Step 2: Randomization|Adverse Event|0|||
48706130|NCT00068692|156773518|FG002|Step 2: Randomization|Adverse Event|4|||
48706131|NCT00068692|156773519|FG003|Step 2: Randomization|Adverse Event|2|||
48706132|NCT00068692|156773520|FG004|Step 2: Randomization|Adverse Event|2|||
48706133|NCT00068692|156773521|FG005|Step 2: Randomization|Adverse Event|3|||
48706134|NCT00068692|156773522|FG006|Step 2: Randomization|Adverse Event|4|||
48706135|NCT00068692|156773523|FG007|Step 2: Randomization|Adverse Event|4|||
48706136|NCT00068692|156773516|FG000|Step 2: Randomization|Death|0|||
48706137|NCT00068692|156773517|FG001|Step 2: Randomization|Death|0|||
48706138|NCT00068692|156773518|FG002|Step 2: Randomization|Death|0|||
48706139|NCT00068692|156773519|FG003|Step 2: Randomization|Death|0|||
48706140|NCT00068692|156773520|FG004|Step 2: Randomization|Death|1|||
48706141|NCT00068692|156773521|FG005|Step 2: Randomization|Death|0|||
48706142|NCT00068692|156773522|FG006|Step 2: Randomization|Death|0|||
48706143|NCT00068692|156773523|FG007|Step 2: Randomization|Death|1|||
48706144|NCT00068692|156773516|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
48706145|NCT00068692|156773517|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
48706146|NCT00068692|156773518|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
48706147|NCT00068692|156773519|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
48706148|NCT00068692|156773520|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
48706149|NCT00068692|156773521|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
48706150|NCT00068692|156773522|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
48706151|NCT00068692|156773523|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
48706152|NCT00068692|156773516|FG000|Step 2: Randomization|alternative therapy|0|||
48706153|NCT00068692|156773517|FG001|Step 2: Randomization|alternative therapy|0|||
48706154|NCT00068692|156773518|FG002|Step 2: Randomization|alternative therapy|0|||
48706155|NCT00068692|156773519|FG003|Step 2: Randomization|alternative therapy|1|||
48706156|NCT00068692|156773520|FG004|Step 2: Randomization|alternative therapy|1|||
48706157|NCT00068692|156773521|FG005|Step 2: Randomization|alternative therapy|0|||
48706158|NCT00068692|156773522|FG006|Step 2: Randomization|alternative therapy|0|||
48706159|NCT00068692|156773523|FG007|Step 2: Randomization|alternative therapy|0|||
48706160|NCT00068692|156773516|FG000|Step 2: Randomization|Physician Decision|0|||
48706161|NCT00068692|156773517|FG001|Step 2: Randomization|Physician Decision|0|||
48706162|NCT00068692|156773518|FG002|Step 2: Randomization|Physician Decision|0|||
48706163|NCT00068692|156773519|FG003|Step 2: Randomization|Physician Decision|1|||
48706164|NCT00068692|156773520|FG004|Step 2: Randomization|Physician Decision|1|||
48706165|NCT00068692|156773521|FG005|Step 2: Randomization|Physician Decision|0|||
48706166|NCT00068692|156773522|FG006|Step 2: Randomization|Physician Decision|0|||
48706167|NCT00068692|156773523|FG007|Step 2: Randomization|Physician Decision|0|||
48706168|NCT00068692|156773516|FG000|Step 2: Randomization|Other|0|||
48706169|NCT00068692|156773517|FG001|Step 2: Randomization|Other|0|||
48706170|NCT00068692|156773518|FG002|Step 2: Randomization|Other|0|||
48706171|NCT00068692|156773519|FG003|Step 2: Randomization|Other|1|||
48706172|NCT00068692|156773520|FG004|Step 2: Randomization|Other|0|||
48706173|NCT00068692|156773521|FG005|Step 2: Randomization|Other|1|||
48706174|NCT00068692|156773522|FG006|Step 2: Randomization|Other|0|||
48706175|NCT00068692|156773523|FG007|Step 2: Randomization|Other|0|||
48706176|NCT00068692|156773516|FG000|Step 2: Randomization|never start protocol therapy|0|||
48706177|NCT00068692|156773517|FG001|Step 2: Randomization|never start protocol therapy|0|||
48706178|NCT00068692|156773518|FG002|Step 2: Randomization|never start protocol therapy|1|||
48706179|NCT00068692|156773519|FG003|Step 2: Randomization|never start protocol therapy|0|||
48706180|NCT00068692|156773520|FG004|Step 2: Randomization|never start protocol therapy|1|||
48706181|NCT00068692|156773521|FG005|Step 2: Randomization|never start protocol therapy|0|||
48706182|NCT00068692|156773522|FG006|Step 2: Randomization|never start protocol therapy|0|||
48706183|NCT00068692|156773523|FG007|Step 2: Randomization|never start protocol therapy|0|||
48706184|NCT00248040|156773524|FG000|Overall Study|transplantectomy|2|||
48706185|NCT00248040|156773525|FG001|Overall Study|transplantectomy|1|||
48706186|NCT00248040|156773526|FG002|Overall Study|transplantectomy|3|||
48706187|NCT00248040|156773524|FG000|Overall Study|transplant cancelled post treat start|1|||
48706188|NCT00248040|156773525|FG001|Overall Study|transplant cancelled post treat start|0|||
48706189|NCT00248040|156773526|FG002|Overall Study|transplant cancelled post treat start|0|||
48706190|NCT00248040|156773524|FG000|Overall Study|Death|0|||
48706191|NCT00248040|156773525|FG001|Overall Study|Death|0|||
48706192|NCT00248040|156773526|FG002|Overall Study|Death|1|||
48706193|NCT03387085|156773529|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
48706194|NCT00914316|156773532|FG000|Phase 1|Physician Decision|4|||
48706195|NCT00914316|156773533|FG001|Phase 1|Physician Decision|0|||
48706196|NCT00914316|156773534|FG002|Phase 1|Physician Decision|1|||
48706197|NCT00914316|156773535|FG003|Phase 1|Physician Decision|2|||
48706198|NCT00914316|156773532|FG000|Phase 1|Withdrawal by Subject|0|||
48706199|NCT00914316|156773533|FG001|Phase 1|Withdrawal by Subject|2|||
48706200|NCT00914316|156773534|FG002|Phase 1|Withdrawal by Subject|4|||
48706201|NCT00914316|156773535|FG003|Phase 1|Withdrawal by Subject|0|||
48706202|NCT00914316|156773532|FG000|Phase 1|Adverse Event|1|||
48706203|NCT00914316|156773533|FG001|Phase 1|Adverse Event|0|||
48706204|NCT00914316|156773534|FG002|Phase 1|Adverse Event|0|||
48706205|NCT00914316|156773535|FG003|Phase 1|Adverse Event|0|||
48706206|NCT00914316|156773532|FG000|Phase 2|Withdrawal by Subject|1|||
48706207|NCT00914316|156773533|FG001|Phase 2|Withdrawal by Subject|0|||
48706208|NCT00914316|156773534|FG002|Phase 2|Withdrawal by Subject|1|||
48706209|NCT00914316|156773535|FG003|Phase 2|Withdrawal by Subject|0|||
48706210|NCT03349034|156773538|FG000|Overall Study|catheters dislodged during transport|2|||
48706211|NCT03349034|156773539|FG001|Overall Study|catheters dislodged during transport|0|||
48706212|NCT03349034|156773538|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
48706213|NCT03349034|156773539|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
48706214|NCT03349034|156773538|FG000|Overall Study|soft tissue flap used|1|||
48706215|NCT03349034|156773539|FG001|Overall Study|soft tissue flap used|0|||
48706216|NCT03349034|156773538|FG000|Overall Study|Other|0|||
48706217|NCT03349034|156773539|FG001|Overall Study|Other|1|||
48706218|NCT01759446|156773542|FG000|Overall Study|Protocol Violation|1|||
48706219|NCT01759446|156773543|FG001|Overall Study|Protocol Violation|0|||
48706220|NCT01759446|156773544|FG002|Overall Study|Protocol Violation|1|||
48706221|NCT01759446|156773545|FG003|Overall Study|Protocol Violation|0|||
48706222|NCT01759446|156773546|FG004|Overall Study|Protocol Violation|0|||
48706223|NCT01759446|156773542|FG000|Overall Study|Withdrawal by Subject|0|||
48706224|NCT01759446|156773543|FG001|Overall Study|Withdrawal by Subject|1|||
48706225|NCT01759446|156773544|FG002|Overall Study|Withdrawal by Subject|0|||
48706226|NCT01759446|156773545|FG003|Overall Study|Withdrawal by Subject|1|||
48706227|NCT01759446|156773546|FG004|Overall Study|Withdrawal by Subject|0|||
48706228|NCT02395471|156773548|FG000|Overall Study|Lost to Follow-up|2|||
48706229|NCT02395471|156773549|FG001|Overall Study|Lost to Follow-up|0|||
48706230|NCT02395471|156773548|FG000|Overall Study|Withdrawal by Subject|2|||
48706231|NCT02395471|156773549|FG001|Overall Study|Withdrawal by Subject|1|||
48706232|NCT02395471|156773548|FG000|Overall Study|Physician Decision|1|||
48706233|NCT02395471|156773549|FG001|Overall Study|Physician Decision|0|||
48706234|NCT02395471|156773548|FG000|Overall Study|Protocol Violation|0|||
48706235|NCT02395471|156773549|FG001|Overall Study|Protocol Violation|1|||
48706236|NCT02395471|156773548|FG000|Overall Study|Failure to swollow sponge twice|1|||
48706237|NCT02395471|156773549|FG001|Overall Study|Failure to swollow sponge twice|0|||
48706238|NCT02395471|156773548|FG000|Overall Study|Patient did not return for procedure|0|||
48706239|NCT02395471|156773549|FG001|Overall Study|Patient did not return for procedure|1|||
48706240|NCT02395471|156773548|FG000|Overall Study|Subject not eligible|1|||
48706241|NCT02395471|156773549|FG001|Overall Study|Subject not eligible|0|||
48706242|NCT01413204|156773550|FG000|Overall Study|Adverse Event|1|||
48706243|NCT01413204|156773551|FG001|Overall Study|Adverse Event|2|||
48706244|NCT01413204|156773552|FG002|Overall Study|Adverse Event|2|||
48706245|NCT01413204|156773550|FG000|Overall Study|Physician Decision|3|||
48706246|NCT01413204|156773551|FG001|Overall Study|Physician Decision|0|||
48706247|NCT01413204|156773552|FG002|Overall Study|Physician Decision|2|||
48706248|NCT01413204|156773550|FG000|Overall Study|Withdrawal by Subject|1|||
48706249|NCT01413204|156773551|FG001|Overall Study|Withdrawal by Subject|4|||
48706250|NCT01413204|156773552|FG002|Overall Study|Withdrawal by Subject|4|||
48706251|NCT01413204|156773550|FG000|Overall Study|Clearly not eligible for the study|0|||
48706252|NCT01413204|156773551|FG001|Overall Study|Clearly not eligible for the study|0|||
48706253|NCT01413204|156773552|FG002|Overall Study|Clearly not eligible for the study|1|||
48706254|NCT01413204|156773550|FG000|Overall Study|Fasting plasma glucose level increased|1|||
48706255|NCT01413204|156773551|FG001|Overall Study|Fasting plasma glucose level increased|0|||
48706256|NCT01413204|156773552|FG002|Overall Study|Fasting plasma glucose level increased|10|||
48706257|NCT00354432|156773553|FG000|Overall Study|Adverse Event|3|||
48706258|NCT00354432|156773554|FG001|Overall Study|Adverse Event|1|||
48706259|NCT00354432|156773555|FG002|Overall Study|Adverse Event|5|||
48706260|NCT00354432|156773556|FG003|Overall Study|Adverse Event|5|||
48706261|NCT00354432|156773553|FG000|Overall Study|Off/Toxicity|3|||
48706262|NCT00354432|156773554|FG001|Overall Study|Off/Toxicity|7|||
48706263|NCT00354432|156773555|FG002|Overall Study|Off/Toxicity|5|||
48706264|NCT00354432|156773556|FG003|Overall Study|Off/Toxicity|5|||
48706265|NCT01244893|156773557|FG000|Baseline|Protocol Violation|0|||
48706266|NCT01244893|156773558|FG001|Baseline|Protocol Violation|1|||
48706267|NCT01244893|156773557|FG000|1-Week Follow Up|Lost to Follow-up|1|||
48706268|NCT01244893|156773558|FG001|1-Week Follow Up|Lost to Follow-up|0|||
48706269|NCT00521404|156773559|FG000|Overall Study|Adverse Event|13|||
48706270|NCT00521404|156773559|FG000|Overall Study|Disease Progression|33|||
48706271|NCT00521404|156773559|FG000|Overall Study|Investigator decision|5|||
48706272|NCT00521404|156773559|FG000|Overall Study|Withdrawal of consent|3|||
48706273|NCT00521404|156773559|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
48706274|NCT00521404|156773559|FG000|Overall Study|Other|7|||
48706275|NCT03584789|156773562|FG000|Overall Study|refused EHR permission|19|||
48706276|NCT03584789|156773563|FG001|Overall Study|refused EHR permission|28|||
48706277|NCT03584789|156773564|FG002|Overall Study|refused EHR permission|23|||
48706278|NCT03584789|156773562|FG000|Overall Study|patients tied to a provider who retired|0|||
48706279|NCT03584789|156773563|FG001|Overall Study|patients tied to a provider who retired|0|||
48706280|NCT03584789|156773564|FG002|Overall Study|patients tied to a provider who retired|3|||
48706281|NCT03038880|156773565|FG000|Overall Study|Death|1|||
48706282|NCT03038880|156773566|FG001|Overall Study|Death|2|||
48706283|NCT03038880|156773567|FG002|Overall Study|Death|0|||
48706284|NCT03038880|156773565|FG000|Overall Study|Physician Decision|2|||
48706285|NCT03038880|156773566|FG001|Overall Study|Physician Decision|1|||
48706286|NCT03038880|156773567|FG002|Overall Study|Physician Decision|0|||
48706287|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
48706288|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
48706289|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
48706290|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
48706291|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
48706292|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
48706293|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
48706294|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
48706295|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
48706296|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
48706297|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
48706298|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
48706299|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
48706300|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
48706301|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
48706302|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48706303|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
48706304|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48706305|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
48706306|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48706307|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48706308|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
48706309|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
48706310|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
48595826|NCT02757352|156377788|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
48706311|NCT01106690|156773573|FG000|Core Period: Baseline to Week 26|Other|10|||
48706312|NCT01106690|156773574|FG001|Core Period: Baseline to Week 26|Other|2|||
48706313|NCT01106690|156773575|FG002|Core Period: Baseline to Week 26|Other|6|||
48706314|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
48706315|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
48706316|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
48706317|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48706318|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
48799497|NCT02238379|157104214|FG000|Overall Study|Lost to Follow-up|1|||
48706319|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
48706320|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48706321|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
48706322|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
48706323|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
48706324|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
48706325|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
48706326|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
48706327|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
48706328|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
48706329|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Other|8|||
48706330|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Other|3|||
48706331|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Other|4|||
48706332|NCT01106690|156773573|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
48706333|NCT01106690|156773574|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48706334|NCT01106690|156773575|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48706335|NCT01208207|156773576|FG000|Part I|Adverse Event|19|||
48706336|NCT01208207|156773577|FG001|Part I|Adverse Event|2|||
48706337|NCT01208207|156773578|FG002|Part I|Adverse Event|6|||
48706338|NCT01208207|156773579|FG003|Part I|Adverse Event|0|||
48706339|NCT01208207|156773580|FG004|Part I|Adverse Event|0|||
48706340|NCT01208207|156773581|FG005|Part I|Adverse Event|0|||
48706341|NCT01208207|156773582|FG006|Part I|Adverse Event|0|||
48706342|NCT01208207|156773576|FG000|Part I|Lack of Efficacy|21|||
48706343|NCT01208207|156773577|FG001|Part I|Lack of Efficacy|3|||
48706344|NCT01208207|156773578|FG002|Part I|Lack of Efficacy|2|||
48706345|NCT01208207|156773579|FG003|Part I|Lack of Efficacy|0|||
48706346|NCT01208207|156773580|FG004|Part I|Lack of Efficacy|0|||
48706347|NCT01208207|156773581|FG005|Part I|Lack of Efficacy|0|||
48706348|NCT01208207|156773582|FG006|Part I|Lack of Efficacy|0|||
48706349|NCT01208207|156773576|FG000|Part I|Lost to Follow-up|6|||
48706350|NCT01208207|156773577|FG001|Part I|Lost to Follow-up|1|||
48706351|NCT01208207|156773578|FG002|Part I|Lost to Follow-up|0|||
48706352|NCT01208207|156773579|FG003|Part I|Lost to Follow-up|0|||
48706353|NCT01208207|156773580|FG004|Part I|Lost to Follow-up|0|||
48706354|NCT01208207|156773581|FG005|Part I|Lost to Follow-up|0|||
48706355|NCT01208207|156773582|FG006|Part I|Lost to Follow-up|0|||
48706356|NCT01208207|156773576|FG000|Part I|Non-Compliance With Study Drug|1|||
48706357|NCT01208207|156773577|FG001|Part I|Non-Compliance With Study Drug|0|||
48706358|NCT01208207|156773578|FG002|Part I|Non-Compliance With Study Drug|1|||
48706359|NCT01208207|156773579|FG003|Part I|Non-Compliance With Study Drug|0|||
48706360|NCT01208207|156773580|FG004|Part I|Non-Compliance With Study Drug|0|||
48706361|NCT01208207|156773581|FG005|Part I|Non-Compliance With Study Drug|0|||
48706362|NCT01208207|156773582|FG006|Part I|Non-Compliance With Study Drug|0|||
48706363|NCT01208207|156773576|FG000|Part I|Physician Decision|0|||
48706364|NCT01208207|156773577|FG001|Part I|Physician Decision|1|||
48706365|NCT01208207|156773578|FG002|Part I|Physician Decision|0|||
48706366|NCT01208207|156773579|FG003|Part I|Physician Decision|0|||
48706367|NCT01208207|156773580|FG004|Part I|Physician Decision|0|||
48706368|NCT01208207|156773581|FG005|Part I|Physician Decision|0|||
48706369|NCT01208207|156773582|FG006|Part I|Physician Decision|0|||
48706370|NCT01208207|156773576|FG000|Part I|Progressive Disease|1|||
48706371|NCT01208207|156773577|FG001|Part I|Progressive Disease|0|||
48706372|NCT01208207|156773578|FG002|Part I|Progressive Disease|0|||
48706373|NCT01208207|156773579|FG003|Part I|Progressive Disease|0|||
48706374|NCT01208207|156773580|FG004|Part I|Progressive Disease|0|||
48706375|NCT01208207|156773581|FG005|Part I|Progressive Disease|0|||
48706376|NCT01208207|156773582|FG006|Part I|Progressive Disease|0|||
48706377|NCT01208207|156773576|FG000|Part I|Protocol Violation|8|||
48706378|NCT01208207|156773577|FG001|Part I|Protocol Violation|0|||
48706379|NCT01208207|156773578|FG002|Part I|Protocol Violation|2|||
48706380|NCT01208207|156773579|FG003|Part I|Protocol Violation|0|||
48706381|NCT01208207|156773580|FG004|Part I|Protocol Violation|0|||
48706382|NCT01208207|156773581|FG005|Part I|Protocol Violation|0|||
48706383|NCT01208207|156773582|FG006|Part I|Protocol Violation|0|||
48706384|NCT01208207|156773576|FG000|Part I|Withdrawal by Subject|14|||
48706385|NCT01208207|156773577|FG001|Part I|Withdrawal by Subject|4|||
48706386|NCT01208207|156773578|FG002|Part I|Withdrawal by Subject|4|||
48706387|NCT01208207|156773579|FG003|Part I|Withdrawal by Subject|0|||
48706388|NCT01208207|156773580|FG004|Part I|Withdrawal by Subject|0|||
48706389|NCT01208207|156773581|FG005|Part I|Withdrawal by Subject|0|||
48706390|NCT01208207|156773582|FG006|Part I|Withdrawal by Subject|0|||
48706391|NCT01208207|156773576|FG000|Part II|Withdrawal by Subject|0|||
48706392|NCT01208207|156773577|FG001|Part II|Withdrawal by Subject|0|||
48706393|NCT01208207|156773578|FG002|Part II|Withdrawal by Subject|0|||
48706394|NCT01208207|156773579|FG003|Part II|Withdrawal by Subject|10|||
48706395|NCT01208207|156773580|FG004|Part II|Withdrawal by Subject|9|||
48706396|NCT01208207|156773581|FG005|Part II|Withdrawal by Subject|3|||
48706397|NCT01208207|156773582|FG006|Part II|Withdrawal by Subject|5|||
48706398|NCT01208207|156773576|FG000|Part II|Adverse Event|0|||
48706399|NCT01208207|156773577|FG001|Part II|Adverse Event|0|||
48706400|NCT01208207|156773578|FG002|Part II|Adverse Event|0|||
48706401|NCT01208207|156773579|FG003|Part II|Adverse Event|5|||
48706402|NCT01208207|156773580|FG004|Part II|Adverse Event|9|||
48706403|NCT01208207|156773581|FG005|Part II|Adverse Event|4|||
48706404|NCT01208207|156773582|FG006|Part II|Adverse Event|2|||
48706405|NCT01208207|156773576|FG000|Part II|Lack of Efficacy|0|||
48706406|NCT01208207|156773577|FG001|Part II|Lack of Efficacy|0|||
48706407|NCT01208207|156773578|FG002|Part II|Lack of Efficacy|0|||
48706408|NCT01208207|156773579|FG003|Part II|Lack of Efficacy|6|||
48706409|NCT01208207|156773580|FG004|Part II|Lack of Efficacy|4|||
48706410|NCT01208207|156773581|FG005|Part II|Lack of Efficacy|3|||
48706411|NCT01208207|156773582|FG006|Part II|Lack of Efficacy|3|||
48706412|NCT01208207|156773576|FG000|Part II|Lost to Follow-up|0|||
48706413|NCT01208207|156773577|FG001|Part II|Lost to Follow-up|0|||
48706414|NCT01208207|156773578|FG002|Part II|Lost to Follow-up|0|||
48706415|NCT01208207|156773579|FG003|Part II|Lost to Follow-up|4|||
48706416|NCT01208207|156773580|FG004|Part II|Lost to Follow-up|0|||
48706417|NCT01208207|156773581|FG005|Part II|Lost to Follow-up|2|||
48706418|NCT01208207|156773582|FG006|Part II|Lost to Follow-up|1|||
48706419|NCT01208207|156773576|FG000|Part II|Non-Compliance With Study Drug|0|||
48706420|NCT01208207|156773577|FG001|Part II|Non-Compliance With Study Drug|0|||
48706421|NCT01208207|156773578|FG002|Part II|Non-Compliance With Study Drug|0|||
48706422|NCT01208207|156773579|FG003|Part II|Non-Compliance With Study Drug|4|||
48706423|NCT01208207|156773580|FG004|Part II|Non-Compliance With Study Drug|1|||
48706424|NCT01208207|156773581|FG005|Part II|Non-Compliance With Study Drug|1|||
48706425|NCT01208207|156773582|FG006|Part II|Non-Compliance With Study Drug|0|||
48706426|NCT01208207|156773576|FG000|Part II|Physician Decision|0|||
48706427|NCT01208207|156773577|FG001|Part II|Physician Decision|0|||
48706428|NCT01208207|156773578|FG002|Part II|Physician Decision|0|||
48706429|NCT01208207|156773579|FG003|Part II|Physician Decision|1|||
48706430|NCT01208207|156773580|FG004|Part II|Physician Decision|0|||
48706431|NCT01208207|156773581|FG005|Part II|Physician Decision|2|||
48706432|NCT01208207|156773582|FG006|Part II|Physician Decision|0|||
48706433|NCT01208207|156773576|FG000|Part II|Protocol Violation|0|||
48706434|NCT01208207|156773577|FG001|Part II|Protocol Violation|0|||
48706435|NCT01208207|156773578|FG002|Part II|Protocol Violation|0|||
48706436|NCT01208207|156773579|FG003|Part II|Protocol Violation|1|||
48490034|NCT01078623|155988826|FG000|Treatment Period 3|Adverse Event|0|||
48706437|NCT01208207|156773580|FG004|Part II|Protocol Violation|0|||
48706438|NCT01208207|156773581|FG005|Part II|Protocol Violation|0|||
48706439|NCT01208207|156773582|FG006|Part II|Protocol Violation|0|||
48706440|NCT01208207|156773576|FG000|Part II|Technical Problems|0|||
48706441|NCT01208207|156773577|FG001|Part II|Technical Problems|0|||
48706442|NCT01208207|156773578|FG002|Part II|Technical Problems|0|||
48706443|NCT01208207|156773579|FG003|Part II|Technical Problems|1|||
48706444|NCT01208207|156773580|FG004|Part II|Technical Problems|0|||
48706445|NCT01208207|156773581|FG005|Part II|Technical Problems|1|||
48706446|NCT01208207|156773582|FG006|Part II|Technical Problems|0|||
48490035|NCT01078623|155988827|FG001|Treatment Period 3|Adverse Event|0|||
48706447|NCT03112603|156773583|FG000|End of Randomization Period|Lost to Follow-up|3|||
48706448|NCT03112603|156773584|FG001|End of Randomization Period|Lost to Follow-up|0|||
48706449|NCT03112603|156773585|FG002|End of Randomization Period|Lost to Follow-up|0|||
48706450|NCT03112603|156773583|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
48706451|NCT03112603|156773584|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
48706452|NCT03112603|156773585|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
48706453|NCT03112603|156773583|FG000|End of Randomization Period|Physician Decision|43|||
48706454|NCT03112603|156773584|FG001|End of Randomization Period|Physician Decision|18|||
48706455|NCT03112603|156773585|FG002|End of Randomization Period|Physician Decision|0|||
48706456|NCT03112603|156773583|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
48706457|NCT03112603|156773584|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
48706458|NCT03112603|156773585|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
48706459|NCT03112603|156773583|FG000|End of Randomization Period|Death|10|||
48706460|NCT03112603|156773584|FG001|End of Randomization Period|Death|7|||
48706461|NCT03112603|156773585|FG002|End of Randomization Period|Death|0|||
48706462|NCT03112603|156773583|FG000|End of Randomization Period|Disease Relapse|12|||
48706463|NCT03112603|156773584|FG001|End of Randomization Period|Disease Relapse|7|||
48706464|NCT03112603|156773585|FG002|End of Randomization Period|Disease Relapse|0|||
48799498|NCT02238379|157104215|FG001|Overall Study|Lost to Follow-up|0|||
48706465|NCT03112603|156773583|FG000|End of Randomization Period|Lack of Efficacy|25|||
48706466|NCT03112603|156773584|FG001|End of Randomization Period|Lack of Efficacy|77|||
48706467|NCT03112603|156773585|FG002|End of Randomization Period|Lack of Efficacy|0|||
48706468|NCT03112603|156773583|FG000|End of Randomization Period|Adverse Event|32|||
48706469|NCT03112603|156773584|FG001|End of Randomization Period|Adverse Event|12|||
48706470|NCT03112603|156773585|FG002|End of Randomization Period|Adverse Event|0|||
48706471|NCT03112603|156773583|FG000|End of Cross Over Period|Death|0|||
48706472|NCT03112603|156773584|FG001|End of Cross Over Period|Death|0|||
48706473|NCT03112603|156773585|FG002|End of Cross Over Period|Death|2|||
48706474|NCT03112603|156773583|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
48706475|NCT03112603|156773584|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
48706476|NCT03112603|156773585|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
48706477|NCT03112603|156773583|FG000|End of Cross Over Period|Physician Decision|0|||
48706478|NCT03112603|156773584|FG001|End of Cross Over Period|Physician Decision|0|||
48706479|NCT03112603|156773585|FG002|End of Cross Over Period|Physician Decision|29|||
48706480|NCT03112603|156773583|FG000|End of Cross Over Period|Lack of Efficacy|0|||
48706481|NCT03112603|156773584|FG001|End of Cross Over Period|Lack of Efficacy|0|||
48706482|NCT03112603|156773585|FG002|End of Cross Over Period|Lack of Efficacy|8|||
48706483|NCT03112603|156773583|FG000|End of Cross Over Period|Adverse Event|0|||
48706484|NCT03112603|156773584|FG001|End of Cross Over Period|Adverse Event|0|||
48706485|NCT03112603|156773585|FG002|End of Cross Over Period|Adverse Event|6|||
48706486|NCT03112603|156773583|FG000|End of Cross Over Period|Disease Relapse|0|||
48706487|NCT03112603|156773584|FG001|End of Cross Over Period|Disease Relapse|0|||
48706488|NCT03112603|156773585|FG002|End of Cross Over Period|Disease Relapse|2|||
48706489|NCT02754440|156773588|FG000|Overall Study|Protocol Violation|3|||
48706490|NCT02754440|156773589|FG001|Overall Study|Protocol Violation|2|||
48706491|NCT02754440|156773590|FG002|Overall Study|Protocol Violation|2|||
48706492|NCT02754440|156773591|FG003|Overall Study|Protocol Violation|6|||
48706493|NCT02754440|156773588|FG000|Overall Study|Adverse Event|3|||
48706494|NCT02754440|156773589|FG001|Overall Study|Adverse Event|1|||
48706495|NCT02754440|156773590|FG002|Overall Study|Adverse Event|0|||
48706496|NCT02754440|156773591|FG003|Overall Study|Adverse Event|9|||
48706497|NCT02754440|156773588|FG000|Overall Study|Withdrawal by Subject|0|||
48706498|NCT02754440|156773589|FG001|Overall Study|Withdrawal by Subject|0|||
48706499|NCT02754440|156773590|FG002|Overall Study|Withdrawal by Subject|0|||
48706500|NCT02754440|156773591|FG003|Overall Study|Withdrawal by Subject|1|||
48706501|NCT02754440|156773588|FG000|Overall Study|Equipment failure|0|||
48706502|NCT02754440|156773589|FG001|Overall Study|Equipment failure|5|||
48706503|NCT02754440|156773590|FG002|Overall Study|Equipment failure|5|||
48706504|NCT02754440|156773591|FG003|Overall Study|Equipment failure|7|||
48706505|NCT02754440|156773588|FG000|Overall Study|Subject issues not resulting in AE|0|||
48706506|NCT02754440|156773589|FG001|Overall Study|Subject issues not resulting in AE|0|||
48706507|NCT02754440|156773590|FG002|Overall Study|Subject issues not resulting in AE|0|||
48706508|NCT02754440|156773591|FG003|Overall Study|Subject issues not resulting in AE|12|||
48706509|NCT02900378|156773594|FG000|Randomization (Visit 2)|Adverse Event|14|||
48706510|NCT02900378|156773595|FG001|Randomization (Visit 2)|Adverse Event|11|||
48706511|NCT02900378|156773594|FG000|Randomization (Visit 2)|Death|1|||
48706512|NCT02900378|156773595|FG001|Randomization (Visit 2)|Death|4|||
48706513|NCT02900378|156773594|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
48706514|NCT02900378|156773595|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
48706515|NCT02900378|156773594|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
48706516|NCT02900378|156773595|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
48706517|NCT02900378|156773594|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
48706518|NCT02900378|156773595|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
48706519|NCT02900378|156773594|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
48706520|NCT02900378|156773595|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
48706521|NCT02900378|156773594|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
48706522|NCT02900378|156773595|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
48706523|NCT04960202|156773596|FG000|Overall Study|Other|12|||
48706524|NCT04960202|156773597|FG001|Overall Study|Other|10|||
48706525|NCT04960202|156773596|FG000|Overall Study|Withdrawal by Subject|43|||
48706526|NCT04960202|156773597|FG001|Overall Study|Withdrawal by Subject|45|||
48706527|NCT04960202|156773596|FG000|Overall Study|Lost to Follow-up|20|||
48706528|NCT04960202|156773597|FG001|Overall Study|Lost to Follow-up|17|||
48706529|NCT04960202|156773596|FG000|Overall Study|Death|0|||
48706530|NCT04960202|156773597|FG001|Overall Study|Death|15|||
48706531|NCT00439517|156773600|FG000|Overall Study|Subject on treatment|1|||
48706532|NCT00439517|156773601|FG001|Overall Study|Subject on treatment|0|||
48706533|NCT00439517|156773600|FG000|Overall Study|Subject in survival follow-up|1|||
48706534|NCT00439517|156773601|FG001|Overall Study|Subject in survival follow-up|0|||
48706535|NCT00477386|156773611|FG000|Overall Study|Adverse Event|4|||
48706536|NCT00477386|156773612|FG001|Overall Study|Adverse Event|8|||
48706537|NCT00477386|156773611|FG000|Overall Study|Disease progression, relapse|3|||
48706538|NCT00477386|156773612|FG001|Overall Study|Disease progression, relapse|4|||
48706539|NCT00477386|156773611|FG000|Overall Study|Disease progression, refractory|1|||
48706540|NCT00477386|156773612|FG001|Overall Study|Disease progression, refractory|3|||
48706541|NCT00477386|156773611|FG000|Overall Study|Other|1|||
48706542|NCT00477386|156773612|FG001|Overall Study|Other|2|||
48706543|NCT00477386|156773611|FG000|Overall Study|Physician Decision|1|||
48706544|NCT00477386|156773612|FG001|Overall Study|Physician Decision|0|||
48706545|NCT00477386|156773611|FG000|Overall Study|Withdrawal by Subject|1|||
48706546|NCT00477386|156773612|FG001|Overall Study|Withdrawal by Subject|0|||
48706547|NCT00643162|156773614|FG000|Overall Study|Withdrawal by Subject|1|||
48706548|NCT00643162|156773615|FG001|Overall Study|Withdrawal by Subject|1|||
48706549|NCT00734539|156773618|FG000|Main Study|Death|33|||
48706550|NCT00734539|156773619|FG001|Main Study|Death|32|||
48706551|NCT00734539|156773618|FG000|Main Study|Physician Decision|2|||
48706552|NCT00734539|156773619|FG001|Main Study|Physician Decision|0|||
48706553|NCT00734539|156773618|FG000|Main Study|Withdrawal by Subject|1|||
48706554|NCT00734539|156773619|FG001|Main Study|Withdrawal by Subject|3|||
48706555|NCT00734539|156773618|FG000|Main Study|Enrolled in error; ineligible|1|||
48706556|NCT00734539|156773619|FG001|Main Study|Enrolled in error; ineligible|0|||
48706557|NCT00357006|156773620|FG000|Overall Study|Lost to Follow-up|1|||
48706558|NCT00357006|156773621|FG001|Overall Study|Lost to Follow-up|2|||
48706559|NCT00357006|156773622|FG002|Overall Study|Lost to Follow-up|1|||
48706560|NCT00357006|156773620|FG000|Overall Study|Withdrawal by Subject|1|||
48706561|NCT00357006|156773621|FG001|Overall Study|Withdrawal by Subject|3|||
48706562|NCT00357006|156773622|FG002|Overall Study|Withdrawal by Subject|2|||
48706563|NCT01656408|156773623|FG000|Overall Study|Adverse Event|0|||
48706564|NCT01656408|156773624|FG001|Overall Study|Adverse Event|0|||
48706565|NCT01656408|156773625|FG002|Overall Study|Adverse Event|1|||
48706566|NCT01656408|156773626|FG003|Overall Study|Adverse Event|0|||
48706567|NCT01656408|156773627|FG004|Overall Study|Adverse Event|0|||
48706568|NCT01656408|156773628|FG005|Overall Study|Adverse Event|1|||
48706569|NCT01656408|156773629|FG006|Overall Study|Adverse Event|1|||
48706570|NCT01656408|156773630|FG007|Overall Study|Adverse Event|0|||
48706571|NCT01656408|156773631|FG008|Overall Study|Adverse Event|1|||
48706572|NCT01656408|156773632|FG009|Overall Study|Adverse Event|0|||
48706573|NCT01656408|156773623|FG000|Overall Study|Physician Decision|1|||
48706574|NCT01656408|156773624|FG001|Overall Study|Physician Decision|0|||
48706575|NCT01656408|156773625|FG002|Overall Study|Physician Decision|1|||
48706576|NCT01656408|156773626|FG003|Overall Study|Physician Decision|0|||
48706577|NCT01656408|156773627|FG004|Overall Study|Physician Decision|1|||
48706578|NCT01656408|156773628|FG005|Overall Study|Physician Decision|1|||
48706579|NCT01656408|156773629|FG006|Overall Study|Physician Decision|0|||
48706580|NCT01656408|156773630|FG007|Overall Study|Physician Decision|1|||
48706581|NCT01656408|156773631|FG008|Overall Study|Physician Decision|1|||
48706582|NCT01656408|156773632|FG009|Overall Study|Physician Decision|3|||
48706583|NCT04308291|156773633|FG000|Run-In Phase|Withdrawal by Subject|4|||
48706584|NCT04308291|156773633|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
48706585|NCT04308291|156773633|FG000|Study Phase 6-M|Physician Decision|2|||
48706586|NCT04308291|156773633|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
48706587|NCT04308291|156773633|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
48706588|NCT04308291|156773633|FG000|Study Phase 12-M|Physician Decision|2|||
48706589|NCT04308291|156773633|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
48706590|NCT03610269|156773634|FG000|Overall Study|Physician Decision|10|||
48706591|NCT03610269|156773634|FG000|Overall Study|Protocol Violation|1|||
48706592|NCT03610269|156773634|FG000|Overall Study|Unable to draw blood|1|||
48706593|NCT03610269|156773634|FG000|Overall Study|Screen fail|4|||
48706594|NCT02668653|156773635|FG000|Overall Study|Refractory disease|41|||
48706595|NCT02668653|156773636|FG001|Overall Study|Refractory disease|70|||
48706596|NCT02668653|156773635|FG000|Overall Study|Relapse|44|||
48706597|NCT02668653|156773636|FG001|Overall Study|Relapse|65|||
48706598|NCT02668653|156773635|FG000|Overall Study|Adverse Event|58|||
48706599|NCT02668653|156773636|FG001|Overall Study|Adverse Event|23|||
48706600|NCT02668653|156773635|FG000|Overall Study|Subject decision to stop study drug|25|||
48799499|NCT04241094|157104222|FG000|Overall Study|Dropped out of treatment|4|||
48706601|NCT02668653|156773636|FG001|Overall Study|Subject decision to stop study drug|23|||
48706602|NCT02668653|156773635|FG000|Overall Study|Other reasons not specified|16|||
48706603|NCT02668653|156773636|FG001|Overall Study|Other reasons not specified|11|||
48706604|NCT02668653|156773635|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
48706605|NCT02668653|156773636|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
48706606|NCT02668653|156773635|FG000|Overall Study|Investigator decision|10|||
48706607|NCT02668653|156773636|FG001|Overall Study|Investigator decision|7|||
48706608|NCT02668653|156773635|FG000|Overall Study|Failure to meet continuation criteria|5|||
48706609|NCT02668653|156773636|FG001|Overall Study|Failure to meet continuation criteria|12|||
48706610|NCT02668653|156773635|FG000|Overall Study|Lost to Follow-up|1|||
48706611|NCT02668653|156773636|FG001|Overall Study|Lost to Follow-up|0|||
48706612|NCT02668653|156773635|FG000|Overall Study|Pregnancy|0|||
48706613|NCT02668653|156773636|FG001|Overall Study|Pregnancy|1|||
48706614|NCT02668653|156773635|FG000|Overall Study|Death|0|||
48706615|NCT02668653|156773636|FG001|Overall Study|Death|1|||
48706616|NCT00067002|156773637|FG000|Overall Study|Early Death|1|||
48706617|NCT00067002|156773638|FG001|Overall Study|Early Death|2|||
48706618|NCT00067002|156773637|FG000|Overall Study|Delayed|1|||
48706619|NCT00067002|156773638|FG001|Overall Study|Delayed|1|||
48706620|NCT00067002|156773637|FG000|Overall Study|Graft Failure|5|||
48706621|NCT00067002|156773638|FG001|Overall Study|Graft Failure|6|||
48706622|NCT03399552|156773640|FG000|Overall Study|No evidence of disease|1|||
48706623|NCT03399552|156773640|FG000|Overall Study|Unevaluable|1|||
48706624|NCT02377817|156773641|FG000|Overall Study|Transportation/childcare barriers.|2|||
48706625|NCT02377817|156773642|FG001|Overall Study|Transportation/childcare barriers.|0|||
48706626|NCT02377817|156773641|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
48706627|NCT02377817|156773642|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
48706628|NCT01931566|156773643|FG000|Overall Study|Randomized But Not Treated|6|||
48706629|NCT01931566|156773644|FG001|Overall Study|Randomized But Not Treated|9|||
48706630|NCT01931566|156773645|FG002|Overall Study|Randomized But Not Treated|14|||
48706631|NCT01931566|156773643|FG000|Overall Study|Adverse Event|37|||
48799500|NCT04241094|157104222|FG000|Overall Study|Ineligible after clinical assessment|2|||
48799501|NCT04241094|157104222|FG000|Overall Study|Lost to Follow-up|2|||
48799502|NCT02432105|157104225|FG000|Overall Study|Lost to Follow-up|1|||
48799503|NCT02432105|157104226|FG001|Overall Study|Lost to Follow-up|1|||
48799504|NCT02432105|157104227|FG002|Overall Study|Lost to Follow-up|0|||
48799505|NCT02432105|157104225|FG000|Overall Study|Withdrawal by Subject|1|||
48799506|NCT02432105|157104226|FG001|Overall Study|Withdrawal by Subject|0|||
48799507|NCT02432105|157104227|FG002|Overall Study|Withdrawal by Subject|1|||
48799508|NCT02432105|157104225|FG000|Overall Study|Culture positive for yeast|0|||
48799509|NCT02432105|157104226|FG001|Overall Study|Culture positive for yeast|1|||
48799510|NCT02432105|157104227|FG002|Overall Study|Culture positive for yeast|0|||
48799511|NCT02432105|157104225|FG000|Overall Study|Randomized in error|0|||
48799512|NCT02432105|157104226|FG001|Overall Study|Randomized in error|0|||
48799513|NCT02432105|157104227|FG002|Overall Study|Randomized in error|2|||
48799514|NCT00538590|157104228|FG000|Overall Study|Death|1|||
48799515|NCT00538590|157104229|FG001|Overall Study|Death|0|||
48799516|NCT01256567|157104230|FG000|Overall Study|Withdrawal by Subject|1|||
48799517|NCT00279201|157104234|FG000|Initiation|Death|1|||
48799518|NCT00279201|157104235|FG001|Initiation|Death|5|||
48799519|NCT00279201|157104236|FG002|Initiation|Death|0|||
48799520|NCT00279201|157104237|FG003|Initiation|Death|0|||
48799521|NCT00279201|157104238|FG004|Initiation|Death|0|||
48799522|NCT00279201|157104239|FG005|Initiation|Death|0|||
48799523|NCT00279201|157104234|FG000|Initiation|Adverse Event|6|||
48799524|NCT00279201|157104235|FG001|Initiation|Adverse Event|15|||
48799525|NCT00279201|157104236|FG002|Initiation|Adverse Event|0|||
48799526|NCT00279201|157104237|FG003|Initiation|Adverse Event|0|||
48799527|NCT00279201|157104238|FG004|Initiation|Adverse Event|0|||
48799528|NCT00279201|157104239|FG005|Initiation|Adverse Event|0|||
48799529|NCT00279201|157104234|FG000|Initiation|Lost to Follow-up|42|||
48799530|NCT00279201|157104235|FG001|Initiation|Lost to Follow-up|41|||
48799531|NCT00279201|157104236|FG002|Initiation|Lost to Follow-up|0|||
48799532|NCT00279201|157104237|FG003|Initiation|Lost to Follow-up|0|||
48799533|NCT00279201|157104238|FG004|Initiation|Lost to Follow-up|0|||
48799534|NCT00279201|157104239|FG005|Initiation|Lost to Follow-up|0|||
48799535|NCT00279201|157104234|FG000|Initiation|Entry Criteria Exclusion|7|||
48799536|NCT00279201|157104235|FG001|Initiation|Entry Criteria Exclusion|9|||
48799537|NCT00279201|157104236|FG002|Initiation|Entry Criteria Exclusion|0|||
48706632|NCT01931566|156773644|FG001|Overall Study|Adverse Event|167|||
48799538|NCT00279201|157104237|FG003|Initiation|Entry Criteria Exclusion|0|||
48799539|NCT00279201|157104238|FG004|Initiation|Entry Criteria Exclusion|0|||
48799540|NCT00279201|157104239|FG005|Initiation|Entry Criteria Exclusion|0|||
48799541|NCT00279201|157104234|FG000|Initiation|Protocol Violation|9|||
48799542|NCT00279201|157104235|FG001|Initiation|Protocol Violation|10|||
48799543|NCT00279201|157104236|FG002|Initiation|Protocol Violation|0|||
48799544|NCT00279201|157104237|FG003|Initiation|Protocol Violation|0|||
48799545|NCT00279201|157104238|FG004|Initiation|Protocol Violation|0|||
48799546|NCT00279201|157104239|FG005|Initiation|Protocol Violation|0|||
48799547|NCT00279201|157104234|FG000|Initiation|Withdrawal by Subject|35|||
48799548|NCT00279201|157104235|FG001|Initiation|Withdrawal by Subject|41|||
48799549|NCT00279201|157104236|FG002|Initiation|Withdrawal by Subject|0|||
48799550|NCT00279201|157104237|FG003|Initiation|Withdrawal by Subject|0|||
48799551|NCT00279201|157104238|FG004|Initiation|Withdrawal by Subject|0|||
48799552|NCT00279201|157104239|FG005|Initiation|Withdrawal by Subject|0|||
48799553|NCT00279201|157104234|FG000|Initiation|Physician Decision|15|||
48799554|NCT00279201|157104235|FG001|Initiation|Physician Decision|18|||
48799555|NCT00279201|157104236|FG002|Initiation|Physician Decision|0|||
48799556|NCT00279201|157104237|FG003|Initiation|Physician Decision|0|||
48799557|NCT00279201|157104238|FG004|Initiation|Physician Decision|0|||
48799558|NCT00279201|157104239|FG005|Initiation|Physician Decision|0|||
48799559|NCT00279201|157104234|FG000|Initiation|Sponsor Decision|13|||
48799560|NCT00279201|157104235|FG001|Initiation|Sponsor Decision|5|||
48799561|NCT00279201|157104236|FG002|Initiation|Sponsor Decision|0|||
48799562|NCT00279201|157104237|FG003|Initiation|Sponsor Decision|0|||
48799563|NCT00279201|157104238|FG004|Initiation|Sponsor Decision|0|||
48799564|NCT00279201|157104239|FG005|Initiation|Sponsor Decision|0|||
48799565|NCT00279201|157104234|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799566|NCT00279201|157104235|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
48799567|NCT00279201|157104236|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799568|NCT00279201|157104237|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799569|NCT00279201|157104238|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799570|NCT00279201|157104239|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
48799571|NCT00279201|157104234|FG000|Maintenance|Lack of Efficacy|32|||
48799572|NCT00279201|157104235|FG001|Maintenance|Lack of Efficacy|30|||
48799573|NCT00279201|157104236|FG002|Maintenance|Lack of Efficacy|0|||
48799574|NCT00279201|157104237|FG003|Maintenance|Lack of Efficacy|0|||
48799575|NCT00279201|157104238|FG004|Maintenance|Lack of Efficacy|0|||
48799576|NCT00279201|157104239|FG005|Maintenance|Lack of Efficacy|0|||
48799577|NCT00279201|157104234|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
48799578|NCT00279201|157104235|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
48799579|NCT00279201|157104236|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
48799580|NCT00279201|157104237|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
48799581|NCT00279201|157104238|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
48799582|NCT00279201|157104239|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
48799583|NCT00279201|157104234|FG000|Maintenance|Adverse Event|4|||
48799584|NCT00279201|157104235|FG001|Maintenance|Adverse Event|4|||
48799585|NCT00279201|157104236|FG002|Maintenance|Adverse Event|0|||
48799586|NCT00279201|157104237|FG003|Maintenance|Adverse Event|0|||
48799587|NCT00279201|157104238|FG004|Maintenance|Adverse Event|0|||
48799588|NCT00279201|157104239|FG005|Maintenance|Adverse Event|0|||
48799589|NCT00279201|157104234|FG000|Maintenance|Death|4|||
48799590|NCT00279201|157104235|FG001|Maintenance|Death|4|||
48799591|NCT00279201|157104236|FG002|Maintenance|Death|0|||
48799592|NCT00279201|157104237|FG003|Maintenance|Death|0|||
48799593|NCT00279201|157104238|FG004|Maintenance|Death|0|||
48799594|NCT00279201|157104239|FG005|Maintenance|Death|0|||
48799595|NCT00279201|157104234|FG000|Maintenance|Lost to Follow-up|17|||
48799596|NCT00279201|157104235|FG001|Maintenance|Lost to Follow-up|13|||
48799597|NCT00279201|157104236|FG002|Maintenance|Lost to Follow-up|0|||
48490036|NCT01078623|155988828|FG002|Treatment Period 3|Adverse Event|0|||
48490037|NCT01078623|155988829|FG003|Treatment Period 3|Adverse Event|0|||
48490038|NCT01078623|155988830|FG004|Treatment Period 3|Adverse Event|1|||
48490039|NCT01078623|155988831|FG005|Treatment Period 3|Adverse Event|0|||
48490040|NCT01078623|155988832|FG006|Treatment Period 3|Adverse Event|0|||
48490041|NCT01078623|155988833|FG007|Treatment Period 3|Adverse Event|0|||
48490042|NCT01078623|155988834|FG008|Treatment Period 3|Adverse Event|0|||
48490043|NCT01078623|155988835|FG009|Treatment Period 3|Adverse Event|0|||
48490044|NCT01078623|155988836|FG010|Treatment Period 3|Adverse Event|0|||
48490045|NCT01078623|155988837|FG011|Treatment Period 3|Adverse Event|0|||
48490046|NCT01078623|155988838|FG012|Treatment Period 3|Adverse Event|0|||
48490047|NCT01078623|155988839|FG013|Treatment Period 3|Adverse Event|1|||
48490048|NCT01078623|155988840|FG014|Treatment Period 3|Adverse Event|0|||
48490049|NCT01078623|155988841|FG015|Treatment Period 3|Adverse Event|0|||
48490050|NCT01078623|155988842|FG016|Treatment Period 3|Adverse Event|0|||
48490051|NCT01078623|155988843|FG017|Treatment Period 3|Adverse Event|0|||
48799598|NCT00279201|157104237|FG003|Maintenance|Lost to Follow-up|0|||
48799599|NCT00279201|157104238|FG004|Maintenance|Lost to Follow-up|0|||
48799600|NCT00279201|157104239|FG005|Maintenance|Lost to Follow-up|0|||
48799601|NCT00279201|157104234|FG000|Maintenance|Entry Criteria Exclusion|1|||
48799602|NCT00279201|157104235|FG001|Maintenance|Entry Criteria Exclusion|4|||
48799603|NCT00279201|157104236|FG002|Maintenance|Entry Criteria Exclusion|0|||
48799604|NCT00279201|157104237|FG003|Maintenance|Entry Criteria Exclusion|0|||
48799605|NCT00279201|157104238|FG004|Maintenance|Entry Criteria Exclusion|0|||
48799606|NCT00279201|157104239|FG005|Maintenance|Entry Criteria Exclusion|0|||
48799607|NCT00279201|157104234|FG000|Maintenance|Protocol Violation|16|||
48799608|NCT00279201|157104235|FG001|Maintenance|Protocol Violation|24|||
48799609|NCT00279201|157104236|FG002|Maintenance|Protocol Violation|0|||
48799610|NCT00279201|157104237|FG003|Maintenance|Protocol Violation|0|||
48799611|NCT00279201|157104238|FG004|Maintenance|Protocol Violation|0|||
48490052|NCT01078623|155988844|FG018|Treatment Period 3|Adverse Event|0|||
48799612|NCT00279201|157104239|FG005|Maintenance|Protocol Violation|0|||
48799613|NCT00279201|157104234|FG000|Maintenance|Withdrawal by Subject|18|||
48799614|NCT00279201|157104235|FG001|Maintenance|Withdrawal by Subject|18|||
48799615|NCT00279201|157104236|FG002|Maintenance|Withdrawal by Subject|0|||
48799616|NCT00279201|157104237|FG003|Maintenance|Withdrawal by Subject|0|||
48799617|NCT00279201|157104238|FG004|Maintenance|Withdrawal by Subject|0|||
48799618|NCT00279201|157104239|FG005|Maintenance|Withdrawal by Subject|0|||
48799619|NCT00279201|157104234|FG000|Maintenance|Physician Decision|9|||
48799620|NCT00279201|157104235|FG001|Maintenance|Physician Decision|9|||
48799621|NCT00279201|157104236|FG002|Maintenance|Physician Decision|0|||
48799622|NCT00279201|157104237|FG003|Maintenance|Physician Decision|0|||
48799623|NCT00279201|157104238|FG004|Maintenance|Physician Decision|0|||
48799624|NCT00279201|157104239|FG005|Maintenance|Physician Decision|0|||
48799625|NCT00279201|157104234|FG000|Maintenance|Sponsor Decision|4|||
48799626|NCT00279201|157104235|FG001|Maintenance|Sponsor Decision|0|||
48799627|NCT00279201|157104236|FG002|Maintenance|Sponsor Decision|0|||
48799628|NCT00279201|157104237|FG003|Maintenance|Sponsor Decision|0|||
48799629|NCT00279201|157104238|FG004|Maintenance|Sponsor Decision|0|||
48799630|NCT00279201|157104239|FG005|Maintenance|Sponsor Decision|0|||
48799631|NCT00279201|157104234|FG000|Maintenance|HbA1c>7.5%|123|||
48799632|NCT00279201|157104235|FG001|Maintenance|HbA1c>7.5%|126|||
48799633|NCT00279201|157104236|FG002|Maintenance|HbA1c>7.5%|0|||
48799634|NCT00279201|157104237|FG003|Maintenance|HbA1c>7.5%|0|||
48799635|NCT00279201|157104238|FG004|Maintenance|HbA1c>7.5%|0|||
48799636|NCT00279201|157104239|FG005|Maintenance|HbA1c>7.5%|0|||
48799637|NCT00279201|157104234|FG000|Intensification Addendum|Withdrawal by Subject|0|||
48799638|NCT00279201|157104235|FG001|Intensification Addendum|Withdrawal by Subject|0|||
48799639|NCT00279201|157104236|FG002|Intensification Addendum|Withdrawal by Subject|12|||
48799640|NCT00279201|157104237|FG003|Intensification Addendum|Withdrawal by Subject|14|||
48799641|NCT00279201|157104238|FG004|Intensification Addendum|Withdrawal by Subject|9|||
48799642|NCT00279201|157104239|FG005|Intensification Addendum|Withdrawal by Subject|18|||
48799643|NCT00279201|157104234|FG000|Intensification Addendum|Lost to Follow-up|0|||
48799644|NCT00279201|157104235|FG001|Intensification Addendum|Lost to Follow-up|0|||
48799645|NCT00279201|157104236|FG002|Intensification Addendum|Lost to Follow-up|4|||
48799646|NCT00279201|157104237|FG003|Intensification Addendum|Lost to Follow-up|6|||
48799647|NCT00279201|157104238|FG004|Intensification Addendum|Lost to Follow-up|7|||
48799648|NCT00279201|157104239|FG005|Intensification Addendum|Lost to Follow-up|7|||
48799649|NCT00279201|157104234|FG000|Intensification Addendum|Protocol Violation|0|||
48799650|NCT00279201|157104235|FG001|Intensification Addendum|Protocol Violation|0|||
48799651|NCT00279201|157104236|FG002|Intensification Addendum|Protocol Violation|2|||
48799652|NCT00279201|157104237|FG003|Intensification Addendum|Protocol Violation|2|||
48799653|NCT00279201|157104238|FG004|Intensification Addendum|Protocol Violation|6|||
48799654|NCT00279201|157104239|FG005|Intensification Addendum|Protocol Violation|6|||
48799655|NCT00279201|157104234|FG000|Intensification Addendum|Adverse Event|0|||
48799656|NCT00279201|157104235|FG001|Intensification Addendum|Adverse Event|0|||
48799657|NCT00279201|157104236|FG002|Intensification Addendum|Adverse Event|0|||
48799658|NCT00279201|157104237|FG003|Intensification Addendum|Adverse Event|4|||
48799659|NCT00279201|157104238|FG004|Intensification Addendum|Adverse Event|1|||
48799660|NCT00279201|157104239|FG005|Intensification Addendum|Adverse Event|3|||
48799661|NCT00279201|157104234|FG000|Intensification Addendum|Physician Decision|0|||
48799662|NCT00279201|157104235|FG001|Intensification Addendum|Physician Decision|0|||
48799663|NCT00279201|157104236|FG002|Intensification Addendum|Physician Decision|4|||
48799664|NCT00279201|157104237|FG003|Intensification Addendum|Physician Decision|1|||
48799665|NCT00279201|157104238|FG004|Intensification Addendum|Physician Decision|3|||
48799666|NCT00279201|157104239|FG005|Intensification Addendum|Physician Decision|2|||
48799667|NCT00279201|157104234|FG000|Intensification Addendum|Sponsor Decision|0|||
48799668|NCT00279201|157104235|FG001|Intensification Addendum|Sponsor Decision|0|||
48799669|NCT00279201|157104236|FG002|Intensification Addendum|Sponsor Decision|0|||
48799670|NCT00279201|157104237|FG003|Intensification Addendum|Sponsor Decision|0|||
48799671|NCT00279201|157104238|FG004|Intensification Addendum|Sponsor Decision|1|||
48799672|NCT00279201|157104239|FG005|Intensification Addendum|Sponsor Decision|1|||
48799673|NCT00279201|157104234|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
48490053|NCT01078623|155988845|FG019|Treatment Period 3|Adverse Event|0|||
48799674|NCT00279201|157104235|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
48799675|NCT00279201|157104236|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
48799676|NCT00279201|157104237|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
48799677|NCT00279201|157104238|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
48799678|NCT00279201|157104239|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
48799679|NCT00279201|157104234|FG000|Intensification Addendum|Lack of Efficacy|0|||
48799680|NCT00279201|157104235|FG001|Intensification Addendum|Lack of Efficacy|0|||
48799681|NCT00279201|157104236|FG002|Intensification Addendum|Lack of Efficacy|0|||
48799682|NCT00279201|157104237|FG003|Intensification Addendum|Lack of Efficacy|1|||
48799683|NCT00279201|157104238|FG004|Intensification Addendum|Lack of Efficacy|1|||
48799684|NCT00279201|157104239|FG005|Intensification Addendum|Lack of Efficacy|0|||
48799685|NCT00279201|157104234|FG000|Intensification Addendum|Death|0|||
48799686|NCT00279201|157104235|FG001|Intensification Addendum|Death|0|||
48799687|NCT00279201|157104236|FG002|Intensification Addendum|Death|0|||
48799688|NCT00279201|157104237|FG003|Intensification Addendum|Death|0|||
48799689|NCT00279201|157104238|FG004|Intensification Addendum|Death|1|||
48799690|NCT00279201|157104239|FG005|Intensification Addendum|Death|0|||
48799691|NCT04512066|157104240|FG000|Double-blind Treatment Period|Adverse Event|6|||
48799692|NCT04512066|157104241|FG001|Double-blind Treatment Period|Adverse Event|4|||
48799693|NCT04512066|157104242|FG002|Double-blind Treatment Period|Adverse Event|5|||
48799694|NCT04512066|157104243|FG003|Double-blind Treatment Period|Adverse Event|1|||
48799695|NCT04512066|157104244|FG004|Double-blind Treatment Period|Adverse Event|0|||
48799696|NCT04512066|157104245|FG005|Double-blind Treatment Period|Adverse Event|0|||
48799697|NCT04512066|157104240|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
48799698|NCT04512066|157104241|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
48799699|NCT04512066|157104242|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
48799700|NCT04512066|157104243|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
48799701|NCT04512066|157104244|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
48799702|NCT04512066|157104245|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
48799703|NCT04512066|157104240|FG000|Double-blind Treatment Period|Physician Decision|1|||
48799704|NCT04512066|157104241|FG001|Double-blind Treatment Period|Physician Decision|0|||
48799705|NCT04512066|157104242|FG002|Double-blind Treatment Period|Physician Decision|1|||
48799706|NCT04512066|157104243|FG003|Double-blind Treatment Period|Physician Decision|0|||
48799707|NCT04512066|157104244|FG004|Double-blind Treatment Period|Physician Decision|0|||
48799708|NCT04512066|157104245|FG005|Double-blind Treatment Period|Physician Decision|0|||
48799709|NCT04512066|157104240|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
48799710|NCT04512066|157104241|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
48799711|NCT04512066|157104242|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
48799712|NCT04512066|157104243|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
48799713|NCT04512066|157104244|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
48799714|NCT04512066|157104245|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
48799715|NCT04512066|157104240|FG000|Extension Period|Adverse Event|0|||
48799716|NCT04512066|157104241|FG001|Extension Period|Adverse Event|1|||
48799717|NCT04512066|157104242|FG002|Extension Period|Adverse Event|4|||
48799718|NCT04512066|157104243|FG003|Extension Period|Adverse Event|3|||
48799719|NCT04512066|157104244|FG004|Extension Period|Adverse Event|1|||
48799720|NCT04512066|157104245|FG005|Extension Period|Adverse Event|3|||
48799721|NCT04512066|157104240|FG000|Extension Period|Death|0|||
48799722|NCT04512066|157104241|FG001|Extension Period|Death|0|||
48799723|NCT04512066|157104242|FG002|Extension Period|Death|0|||
48799724|NCT04512066|157104243|FG003|Extension Period|Death|0|||
48799725|NCT04512066|157104244|FG004|Extension Period|Death|0|||
48799726|NCT04512066|157104245|FG005|Extension Period|Death|1|||
48799727|NCT04512066|157104240|FG000|Extension Period|Lack of Efficacy|0|||
48799728|NCT04512066|157104241|FG001|Extension Period|Lack of Efficacy|4|||
48799729|NCT04512066|157104242|FG002|Extension Period|Lack of Efficacy|4|||
48799730|NCT04512066|157104243|FG003|Extension Period|Lack of Efficacy|1|||
48799731|NCT04512066|157104244|FG004|Extension Period|Lack of Efficacy|3|||
48799732|NCT04512066|157104245|FG005|Extension Period|Lack of Efficacy|3|||
48799733|NCT04512066|157104240|FG000|Extension Period|Lost to Follow-up|0|||
48799734|NCT04512066|157104241|FG001|Extension Period|Lost to Follow-up|1|||
48799735|NCT04512066|157104242|FG002|Extension Period|Lost to Follow-up|5|||
48799736|NCT04512066|157104243|FG003|Extension Period|Lost to Follow-up|2|||
48799737|NCT04512066|157104244|FG004|Extension Period|Lost to Follow-up|3|||
48799738|NCT04512066|157104245|FG005|Extension Period|Lost to Follow-up|2|||
48799739|NCT04512066|157104240|FG000|Extension Period|Non-compliance with study drug|0|||
48799740|NCT04512066|157104241|FG001|Extension Period|Non-compliance with study drug|1|||
48799741|NCT04512066|157104242|FG002|Extension Period|Non-compliance with study drug|0|||
48799742|NCT04512066|157104243|FG003|Extension Period|Non-compliance with study drug|0|||
48799743|NCT04512066|157104244|FG004|Extension Period|Non-compliance with study drug|0|||
48799744|NCT04512066|157104245|FG005|Extension Period|Non-compliance with study drug|1|||
48799745|NCT04512066|157104240|FG000|Extension Period|Other|0|||
48799746|NCT04512066|157104241|FG001|Extension Period|Other|2|||
48799747|NCT04512066|157104242|FG002|Extension Period|Other|0|||
48799748|NCT04512066|157104243|FG003|Extension Period|Other|0|||
48490054|NCT01078623|155988826|FG000|Treatment Period 4|Adverse Event|0|||
48799749|NCT04512066|157104244|FG004|Extension Period|Other|0|||
48490055|NCT01078623|155988827|FG001|Treatment Period 4|Adverse Event|0|||
48799750|NCT04512066|157104245|FG005|Extension Period|Other|0|||
48799751|NCT04512066|157104240|FG000|Extension Period|Physician Decision|0|||
48799752|NCT04512066|157104241|FG001|Extension Period|Physician Decision|2|||
48706633|NCT01931566|156773645|FG002|Overall Study|Adverse Event|132|||
48706634|NCT01931566|156773643|FG000|Overall Study|Major Protocol Deviation|5|||
48799753|NCT04512066|157104242|FG002|Extension Period|Physician Decision|0|||
48799754|NCT04512066|157104243|FG003|Extension Period|Physician Decision|1|||
48799755|NCT04512066|157104244|FG004|Extension Period|Physician Decision|1|||
48799756|NCT04512066|157104245|FG005|Extension Period|Physician Decision|0|||
48799757|NCT04512066|157104240|FG000|Extension Period|Withdrawal by Subject|0|||
48799758|NCT04512066|157104241|FG001|Extension Period|Withdrawal by Subject|3|||
48799759|NCT04512066|157104242|FG002|Extension Period|Withdrawal by Subject|7|||
48799760|NCT04512066|157104243|FG003|Extension Period|Withdrawal by Subject|11|||
48799761|NCT04512066|157104244|FG004|Extension Period|Withdrawal by Subject|8|||
48706635|NCT01931566|156773644|FG001|Overall Study|Major Protocol Deviation|14|||
48706636|NCT01931566|156773645|FG002|Overall Study|Major Protocol Deviation|21|||
48706637|NCT01931566|156773643|FG000|Overall Study|Lost to Follow-up|3|||
48706638|NCT01931566|156773644|FG001|Overall Study|Lost to Follow-up|26|||
48706639|NCT01931566|156773645|FG002|Overall Study|Lost to Follow-up|23|||
48706640|NCT01931566|156773643|FG000|Overall Study|Voluntary Withdrawal|78|||
48706641|NCT01931566|156773644|FG001|Overall Study|Voluntary Withdrawal|245|||
48706642|NCT01931566|156773645|FG002|Overall Study|Voluntary Withdrawal|225|||
48706643|NCT01931566|156773643|FG000|Overall Study|Study Termination|289|||
48706644|NCT01931566|156773644|FG001|Overall Study|Study Termination|968|||
48706645|NCT01931566|156773645|FG002|Overall Study|Study Termination|1037|||
48706646|NCT01931566|156773643|FG000|Overall Study|Reason Not Specified|11|||
48706647|NCT01931566|156773644|FG001|Overall Study|Reason Not Specified|47|||
48706648|NCT01931566|156773645|FG002|Overall Study|Reason Not Specified|53|||
48706649|NCT01931566|156773643|FG000|Overall Study|Missing|0|||
48706650|NCT01931566|156773644|FG001|Overall Study|Missing|0|||
48706651|NCT01931566|156773645|FG002|Overall Study|Missing|1|||
48706652|NCT01147874|156773647|FG000|Overall Study|Adverse Event|5|||
48706653|NCT01147874|156773647|FG000|Overall Study|Investigator's Request|1|||
48706654|NCT01147874|156773647|FG000|Overall Study|Lost to Follow-up|25|||
48706655|NCT01147874|156773647|FG000|Overall Study|Other|5|||
48706656|NCT01147874|156773647|FG000|Overall Study|Protocol Violation|5|||
48706657|NCT01147874|156773647|FG000|Overall Study|Sponsor's Decision|2|||
48706658|NCT01147874|156773647|FG000|Overall Study|Withdrawal by Subject|24|||
48706659|NCT01696188|156773651|FG000|Overall Study|Protocol Violation|1|||
48706660|NCT01696188|156773652|FG001|Overall Study|Protocol Violation|1|||
48706661|NCT01987453|156775849|FG000|Overall Study|Death|0|||
48706662|NCT01987453|156775850|FG001|Overall Study|Death|0|||
48706663|NCT01987453|156775851|FG002|Overall Study|Death|1|||
48706664|NCT01987453|156775849|FG000|Overall Study|Lack of Efficacy|1|||
48706665|NCT01987453|156775850|FG001|Overall Study|Lack of Efficacy|12|||
48706666|NCT01987453|156775851|FG002|Overall Study|Lack of Efficacy|0|||
48706667|NCT05366738|156775852|FG000|Overall Study|Adverse Event|0|||
48799762|NCT04512066|157104245|FG005|Extension Period|Withdrawal by Subject|4|||
48799763|NCT02883062|157104246|FG000|Overall Study|Withdrawal by Subject|6|||
48799764|NCT02883062|157104247|FG001|Overall Study|Withdrawal by Subject|0|||
48799765|NCT00316173|157104250|FG000|Run-in Phase|Adverse Event|1|||
48799766|NCT00316173|157104251|FG001|Run-in Phase|Adverse Event|0|||
48799767|NCT00316173|157104250|FG000|Run-in Phase|Protocol Violation|1|||
48799768|NCT00316173|157104251|FG001|Run-in Phase|Protocol Violation|0|||
48799769|NCT00316173|157104250|FG000|Run-in Phase|Study Follow-up Stopped|5|||
48799770|NCT00316173|157104251|FG001|Run-in Phase|Study Follow-up Stopped|0|||
48799771|NCT00316173|157104250|FG000|Treatment Phase|Adverse Event|0|||
48799772|NCT00316173|157104251|FG001|Treatment Phase|Adverse Event|1|||
48799773|NCT00316173|157104250|FG000|Treatment Phase|Lack of Efficacy|0|||
48799774|NCT00316173|157104251|FG001|Treatment Phase|Lack of Efficacy|3|||
48706668|NCT05366738|156775853|FG001|Overall Study|Adverse Event|1|||
48706669|NCT05366738|156775854|FG002|Overall Study|Adverse Event|0|||
48706670|NCT02079246|156775856|FG000|OLEX|Withdrawal before treatment|1|||
48706671|NCT02079246|156775857|FG001|OLEX|Withdrawal before treatment|0|||
48706672|NCT02079246|156775856|FG000|OLEX|Death|11|||
48706673|NCT02079246|156775857|FG001|OLEX|Death|0|||
48706674|NCT02079246|156775856|FG000|OLEX|Adverse Event|66|||
48706675|NCT02079246|156775857|FG001|OLEX|Adverse Event|0|||
48706676|NCT02079246|156775856|FG000|OLEX|Withdrawal by Subject|60|||
48706677|NCT02079246|156775857|FG001|OLEX|Withdrawal by Subject|0|||
48706678|NCT02079246|156775856|FG000|OLEX|Lost to Follow-up|6|||
48706679|NCT02079246|156775857|FG001|OLEX|Lost to Follow-up|0|||
48706680|NCT02079246|156775856|FG000|OLEX|Protocol Violation|6|||
48706681|NCT02079246|156775857|FG001|OLEX|Protocol Violation|0|||
48706682|NCT02079246|156775856|FG000|OLEX|Lack of Efficacy|3|||
48706683|NCT02079246|156775857|FG001|OLEX|Lack of Efficacy|0|||
48706684|NCT02079246|156775856|FG000|OLEX|Results of the lead-in studies|58|||
48706685|NCT02079246|156775857|FG001|OLEX|Results of the lead-in studies|0|||
48706686|NCT02079246|156775856|FG000|OLEX|Other: Disallowed medication|8|||
48706687|NCT02079246|156775857|FG001|OLEX|Other: Disallowed medication|0|||
48706688|NCT02079246|156775856|FG000|OLEX|Other: Insufficient compliance|2|||
48490056|NCT01078623|155988828|FG002|Treatment Period 4|Adverse Event|1|||
48490057|NCT01078623|155988829|FG003|Treatment Period 4|Adverse Event|0|||
48490058|NCT01078623|155988830|FG004|Treatment Period 4|Adverse Event|0|||
48490059|NCT01078623|155988831|FG005|Treatment Period 4|Adverse Event|0|||
48490060|NCT01078623|155988832|FG006|Treatment Period 4|Adverse Event|0|||
48490061|NCT01078623|155988833|FG007|Treatment Period 4|Adverse Event|0|||
48490062|NCT01078623|155988834|FG008|Treatment Period 4|Adverse Event|0|||
48490063|NCT01078623|155988835|FG009|Treatment Period 4|Adverse Event|0|||
48490064|NCT01078623|155988836|FG010|Treatment Period 4|Adverse Event|0|||
48490065|NCT01078623|155988837|FG011|Treatment Period 4|Adverse Event|0|||
48706689|NCT02079246|156775857|FG001|OLEX|Other: Insufficient compliance|0|||
48706690|NCT02079246|156775856|FG000|OLEX|Other: Caregiver unavailable|3|||
48706691|NCT02079246|156775857|FG001|OLEX|Other: Caregiver unavailable|0|||
48490066|NCT01078623|155988838|FG012|Treatment Period 4|Adverse Event|0|||
48706692|NCT02079246|156775856|FG000|OLEX|Other: Coordinator decision|1|||
48706693|NCT02079246|156775857|FG001|OLEX|Other: Coordinator decision|0|||
48706694|NCT02079246|156775856|FG000|OLEX|Other: Worsening of condition|1|||
48706695|NCT02079246|156775857|FG001|OLEX|Other: Worsening of condition|0|||
48706696|NCT02079246|156775856|FG000|OLEX|Other: Moved to nursing home|1|||
48706697|NCT02079246|156775857|FG001|OLEX|Other: Moved to nursing home|0|||
48706698|NCT02079246|156775856|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
48706699|NCT02079246|156775857|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
48706700|NCT02079246|156775856|FG000|OLEX-MEM|Adverse Event|0|||
48706701|NCT02079246|156775857|FG001|OLEX-MEM|Adverse Event|6|||
48706702|NCT02079246|156775856|FG000|OLEX-MEM|Withdrawal by Subject|0|||
48706703|NCT02079246|156775857|FG001|OLEX-MEM|Withdrawal by Subject|7|||
48706704|NCT02079246|156775856|FG000|OLEX-MEM|Protocol Violation|0|||
48706705|NCT02079246|156775857|FG001|OLEX-MEM|Protocol Violation|2|||
48706706|NCT02079246|156775856|FG000|OLEX-MEM|Lost to Follow-up|0|||
48706707|NCT02079246|156775857|FG001|OLEX-MEM|Lost to Follow-up|1|||
48706708|NCT02079246|156775856|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
48706709|NCT02079246|156775857|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
48706710|NCT05024032|156775859|FG000|Overall Study|Withdrawal by Subject|0|||
48706711|NCT05024032|156775860|FG001|Overall Study|Withdrawal by Subject|3|||
48706712|NCT05024032|156775861|FG002|Overall Study|Withdrawal by Subject|4|||
48706713|NCT05024032|156775859|FG000|Overall Study|Adverse Event|0|||
48706714|NCT05024032|156775860|FG001|Overall Study|Adverse Event|1|||
48706715|NCT05024032|156775861|FG002|Overall Study|Adverse Event|0|||
48706716|NCT05024032|156775859|FG000|Overall Study|Protocol Deviation|1|||
48706717|NCT05024032|156775860|FG001|Overall Study|Protocol Deviation|0|||
48706718|NCT05024032|156775861|FG002|Overall Study|Protocol Deviation|0|||
48706719|NCT01209689|156775862|FG000|Overall Study|Insufficient Therapeutic Response|7|||
48706720|NCT01209689|156775863|FG001|Overall Study|Insufficient Therapeutic Response|2|||
48706721|NCT01209689|156775862|FG000|Overall Study|Refused Treatment|8|||
48706722|NCT01209689|156775863|FG001|Overall Study|Refused Treatment|3|||
48706723|NCT01209689|156775862|FG000|Overall Study|Adverse Event|4|||
48706724|NCT01209689|156775863|FG001|Overall Study|Adverse Event|0|||
48706725|NCT01209689|156775862|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48706726|NCT01209689|156775863|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
48706727|NCT01209689|156775862|FG000|Overall Study|Failure to Return|3|||
48706728|NCT01209689|156775863|FG001|Overall Study|Failure to Return|0|||
48706729|NCT01209689|156775862|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
48706730|NCT01209689|156775863|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
48490067|NCT01078623|155988839|FG013|Treatment Period 4|Adverse Event|0|||
48490068|NCT01078623|155988840|FG014|Treatment Period 4|Adverse Event|0|||
48490069|NCT01078623|155988841|FG015|Treatment Period 4|Adverse Event|0|||
48490070|NCT01078623|155988842|FG016|Treatment Period 4|Adverse Event|0|||
48490071|NCT01078623|155988843|FG017|Treatment Period 4|Adverse Event|0|||
48706731|NCT00775190|156775866|FG000|Overall Study|Lost to Follow-up|2|||
48706732|NCT00775190|156775867|FG001|Overall Study|Lost to Follow-up|3|||
48706733|NCT00775190|156775866|FG000|Overall Study|Withdrawal by Subject|1|||
48706734|NCT00775190|156775867|FG001|Overall Study|Withdrawal by Subject|2|||
48706735|NCT00775190|156775866|FG000|Overall Study|Protocol Violation|1|||
48706736|NCT00775190|156775867|FG001|Overall Study|Protocol Violation|0|||
48706737|NCT03714672|156775868|FG000|Overall Study|Adverse Event|0|||
48706738|NCT03714672|156775869|FG001|Overall Study|Adverse Event|0|||
48706739|NCT03714672|156775870|FG002|Overall Study|Adverse Event|3|||
48706740|NCT03714672|156775871|FG003|Overall Study|Adverse Event|0|||
48799775|NCT00316173|157104250|FG000|Treatment Phase|Lost to Follow-up|0|||
48799776|NCT00316173|157104251|FG001|Treatment Phase|Lost to Follow-up|3|||
48799777|NCT00316173|157104250|FG000|Treatment Phase|Withdrawal by Subject|0|||
48799778|NCT00316173|157104251|FG001|Treatment Phase|Withdrawal by Subject|1|||
48799779|NCT00316173|157104250|FG000|Treatment Phase|Study Follow-up Stopped|0|||
48799780|NCT00316173|157104251|FG001|Treatment Phase|Study Follow-up Stopped|34|||
48799781|NCT02390531|157104252|FG000|Overall Study|Death|0|||
48706741|NCT03714672|156775868|FG000|Overall Study|Physician Decision|0|||
48706742|NCT03714672|156775869|FG001|Overall Study|Physician Decision|1|||
48706743|NCT03714672|156775870|FG002|Overall Study|Physician Decision|0|||
48706744|NCT03714672|156775871|FG003|Overall Study|Physician Decision|0|||
48799782|NCT02390531|157104253|FG001|Overall Study|Death|2|||
48799783|NCT02390531|157104254|FG002|Overall Study|Death|0|||
48799784|NCT02390531|157104255|FG003|Overall Study|Death|1|||
48799785|NCT02390531|157104256|FG004|Overall Study|Death|0|||
48799786|NCT02390531|157104257|FG005|Overall Study|Death|0|||
48799787|NCT02390531|157104258|FG006|Overall Study|Death|0|||
48799788|NCT02390531|157104259|FG007|Overall Study|Death|1|||
48799789|NCT02390531|157104252|FG000|Overall Study|Protocol Violation|0|||
48799790|NCT02390531|157104253|FG001|Overall Study|Protocol Violation|0|||
48799791|NCT02390531|157104254|FG002|Overall Study|Protocol Violation|0|||
48799792|NCT02390531|157104255|FG003|Overall Study|Protocol Violation|0|||
48799793|NCT02390531|157104256|FG004|Overall Study|Protocol Violation|1|||
48799794|NCT02390531|157104257|FG005|Overall Study|Protocol Violation|0|||
48799795|NCT02390531|157104258|FG006|Overall Study|Protocol Violation|2|||
48799796|NCT02390531|157104259|FG007|Overall Study|Protocol Violation|0|||
48799797|NCT03260868|157104260|FG000|Overall Study|Poor Compliance to Protocol|0|||
48799798|NCT03260868|157104261|FG001|Overall Study|Poor Compliance to Protocol|2|||
48799799|NCT03260868|157104260|FG000|Overall Study|Study Terminated By Sponsor|2|||
48799800|NCT03260868|157104261|FG001|Overall Study|Study Terminated By Sponsor|1|||
48799801|NCT03260868|157104260|FG000|Overall Study|Other than specified above|1|||
48799802|NCT03260868|157104261|FG001|Overall Study|Other than specified above|0|||
48799803|NCT00511875|157104262|FG000|Overall Study|Lost to Follow-up|4|||
48799804|NCT00511875|157104263|FG001|Overall Study|Lost to Follow-up|0|||
48799805|NCT00511875|157104262|FG000|Overall Study|Missing variables|1|||
48799806|NCT00511875|157104263|FG001|Overall Study|Missing variables|0|||
48799807|NCT01169675|157104264|FG000|Overall Study|Progressive disease|13|||
48799808|NCT01169675|157104265|FG001|Overall Study|Progressive disease|2|||
48799809|NCT01169675|157104266|FG002|Overall Study|Progressive disease|5|||
48799810|NCT01169675|157104267|FG003|Overall Study|Progressive disease|15|||
48799811|NCT01169675|157104268|FG004|Overall Study|Progressive disease|1|||
48799812|NCT01169675|157104264|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48799813|NCT01169675|157104265|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48799814|NCT01169675|157104266|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48799815|NCT01169675|157104267|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48799816|NCT01169675|157104268|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48799817|NCT01169675|157104264|FG000|Overall Study|Adverse Event|5|||
48799818|NCT01169675|157104265|FG001|Overall Study|Adverse Event|1|||
48799819|NCT01169675|157104266|FG002|Overall Study|Adverse Event|2|||
48799820|NCT01169675|157104267|FG003|Overall Study|Adverse Event|0|||
48799821|NCT01169675|157104268|FG004|Overall Study|Adverse Event|0|||
48799822|NCT01169675|157104264|FG000|Overall Study|Withdrawal by Subject|1|||
48706745|NCT03714672|156775868|FG000|Overall Study|Other Reason|1|||
48706746|NCT03714672|156775869|FG001|Overall Study|Other Reason|2|||
48706747|NCT03714672|156775870|FG002|Overall Study|Other Reason|1|||
48706748|NCT03714672|156775871|FG003|Overall Study|Other Reason|1|||
48706749|NCT03714672|156775868|FG000|Overall Study|Lost to Follow-up|1|||
48706750|NCT03714672|156775869|FG001|Overall Study|Lost to Follow-up|1|||
48706751|NCT03714672|156775870|FG002|Overall Study|Lost to Follow-up|0|||
48799823|NCT01169675|157104265|FG001|Overall Study|Withdrawal by Subject|0|||
48799824|NCT01169675|157104266|FG002|Overall Study|Withdrawal by Subject|0|||
48799825|NCT01169675|157104267|FG003|Overall Study|Withdrawal by Subject|1|||
48799826|NCT01169675|157104268|FG004|Overall Study|Withdrawal by Subject|2|||
48799827|NCT01169675|157104264|FG000|Overall Study|Other Reason Not Defined Above|0|||
48799828|NCT01169675|157104265|FG001|Overall Study|Other Reason Not Defined Above|0|||
48799829|NCT01169675|157104266|FG002|Overall Study|Other Reason Not Defined Above|0|||
48799830|NCT01169675|157104267|FG003|Overall Study|Other Reason Not Defined Above|1|||
48799831|NCT01169675|157104268|FG004|Overall Study|Other Reason Not Defined Above|1|||
48799832|NCT00445679|157104269|FG000|Overall Study|Adverse Event|22|||
48490072|NCT01078623|155988844|FG018|Treatment Period 4|Adverse Event|0|||
48490073|NCT01078623|155988845|FG019|Treatment Period 4|Adverse Event|0|||
48490074|NCT01078623|155988826|FG000|Treatment Period 4|Withdrawal by Subject|0|||
48490075|NCT01078623|155988827|FG001|Treatment Period 4|Withdrawal by Subject|0|||
48490076|NCT01078623|155988828|FG002|Treatment Period 4|Withdrawal by Subject|0|||
48490077|NCT01078623|155988829|FG003|Treatment Period 4|Withdrawal by Subject|0|||
48490078|NCT01078623|155988830|FG004|Treatment Period 4|Withdrawal by Subject|0|||
48490079|NCT01078623|155988831|FG005|Treatment Period 4|Withdrawal by Subject|0|||
48706752|NCT03714672|156775871|FG003|Overall Study|Lost to Follow-up|0|||
48490080|NCT01078623|155988832|FG006|Treatment Period 4|Withdrawal by Subject|0|||
48799833|NCT00445679|157104270|FG001|Overall Study|Adverse Event|12|||
48799834|NCT00445679|157104271|FG002|Overall Study|Adverse Event|30|||
48799835|NCT00445679|157104272|FG003|Overall Study|Adverse Event|19|||
48799836|NCT00445679|157104269|FG000|Overall Study|Failed to return|1|||
48706753|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
48799837|NCT00445679|157104270|FG001|Overall Study|Failed to return|3|||
48706754|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706755|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706756|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706757|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706758|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706759|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48706760|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
48706761|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706762|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706763|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706764|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706765|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706766|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
48706767|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
48706768|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706769|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706770|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706771|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706772|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706773|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48706774|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
48706775|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706776|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706777|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706778|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706779|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706780|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48706781|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
48706782|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706783|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706784|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706785|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706786|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706787|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
48706788|NCT01054885|156775872|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
48706789|NCT01054885|156775873|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706790|NCT01054885|156775874|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706791|NCT01054885|156775875|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706792|NCT01054885|156775876|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706793|NCT01054885|156775877|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706794|NCT01054885|156775878|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48706795|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
48706796|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
48706797|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
48706798|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
48706799|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
48706800|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
48706801|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
48706802|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48706803|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48706804|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
48706805|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
48706806|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48799838|NCT00445679|157104271|FG002|Overall Study|Failed to return|2|||
48433893|NCT00516269|155777241|FG000|Overall Study|Protocol Violation|0|||
48799839|NCT00445679|157104272|FG003|Overall Study|Failed to return|2|||
48799840|NCT00445679|157104269|FG000|Overall Study|Physician Decision|0|||
48799841|NCT00445679|157104270|FG001|Overall Study|Physician Decision|0|||
48799842|NCT00445679|157104271|FG002|Overall Study|Physician Decision|1|||
48799843|NCT00445679|157104272|FG003|Overall Study|Physician Decision|0|||
48799844|NCT00445679|157104269|FG000|Overall Study|Lost to Follow-up|10|||
48799845|NCT00445679|157104270|FG001|Overall Study|Lost to Follow-up|6|||
48799846|NCT00445679|157104271|FG002|Overall Study|Lost to Follow-up|6|||
48799847|NCT00445679|157104272|FG003|Overall Study|Lost to Follow-up|5|||
48799848|NCT00445679|157104269|FG000|Overall Study|Compliance|3|||
48799849|NCT00445679|157104270|FG001|Overall Study|Compliance|2|||
48799850|NCT00445679|157104271|FG002|Overall Study|Compliance|1|||
48799851|NCT00445679|157104272|FG003|Overall Study|Compliance|2|||
48799852|NCT00445679|157104269|FG000|Overall Study|Withdrawal of Informed Consent|0|||
48799853|NCT00445679|157104270|FG001|Overall Study|Withdrawal of Informed Consent|0|||
48799854|NCT00445679|157104271|FG002|Overall Study|Withdrawal of Informed Consent|1|||
48799855|NCT00445679|157104272|FG003|Overall Study|Withdrawal of Informed Consent|0|||
48799856|NCT00445679|157104269|FG000|Overall Study|Protocol Violation|2|||
48799857|NCT00445679|157104270|FG001|Overall Study|Protocol Violation|3|||
48799858|NCT00445679|157104271|FG002|Overall Study|Protocol Violation|3|||
48799859|NCT00445679|157104272|FG003|Overall Study|Protocol Violation|1|||
48799860|NCT00445679|157104269|FG000|Overall Study|Withdrawal by Subject|8|||
48799861|NCT00445679|157104270|FG001|Overall Study|Withdrawal by Subject|14|||
48799862|NCT00445679|157104271|FG002|Overall Study|Withdrawal by Subject|20|||
48799863|NCT00445679|157104272|FG003|Overall Study|Withdrawal by Subject|18|||
48799864|NCT00445679|157104269|FG000|Overall Study|Lack of Efficacy|2|||
48799865|NCT00445679|157104270|FG001|Overall Study|Lack of Efficacy|6|||
48799866|NCT00445679|157104271|FG002|Overall Study|Lack of Efficacy|2|||
48799867|NCT00445679|157104272|FG003|Overall Study|Lack of Efficacy|0|||
48799868|NCT04102579|157104277|FG000|Overall Study|Withdrawal by Subject|3|||
48799869|NCT04102579|157104278|FG001|Overall Study|Withdrawal by Subject|4|||
48799870|NCT04102579|157104277|FG000|Overall Study|Lost to Follow-up|0|||
48799871|NCT04102579|157104278|FG001|Overall Study|Lost to Follow-up|1|||
48799872|NCT04102579|157104277|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
48799873|NCT04102579|157104278|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
48799874|NCT04102579|157104277|FG000|Overall Study|Other than Specified|1|||
48799875|NCT04102579|157104278|FG001|Overall Study|Other than Specified|0|||
48799876|NCT04102579|157104277|FG000|Overall Study|Not Dosed with Study Drug|0|||
48799877|NCT04102579|157104278|FG001|Overall Study|Not Dosed with Study Drug|1|||
48799878|NCT00542880|157104279|FG000|Period 1|Eligibility criteria not fulfilled|2|||
48799879|NCT00542880|157104280|FG001|Period 1|Eligibility criteria not fulfilled|6|||
48799880|NCT00542880|157104279|FG000|Period 1|Adverse Event|2|||
48799881|NCT00542880|157104280|FG001|Period 1|Adverse Event|2|||
48799882|NCT00542880|157104279|FG000|Period 1|Development of study-specific criteria|1|||
48799883|NCT00542880|157104280|FG001|Period 1|Development of study-specific criteria|2|||
48799884|NCT00542880|157104279|FG000|Period 1|Withdrawal by Subject|1|||
48799885|NCT00542880|157104280|FG001|Period 1|Withdrawal by Subject|1|||
48799886|NCT00542880|157104279|FG000|Period 1|Protocol Violation|0|||
48799887|NCT00542880|157104280|FG001|Period 1|Protocol Violation|1|||
48799888|NCT00542880|157104279|FG000|Period 2|Adverse Event|5|||
48799889|NCT00542880|157104280|FG001|Period 2|Adverse Event|7|||
48799890|NCT00542880|157104279|FG000|Period 2|Eligibility not fulfilled|0|||
48799891|NCT00542880|157104280|FG001|Period 2|Eligibility not fulfilled|1|||
48799892|NCT00542880|157104279|FG000|Period 2|Discontinuation criteria|2|||
48799893|NCT00542880|157104280|FG001|Period 2|Discontinuation criteria|0|||
48799894|NCT00542880|157104279|FG000|Period 2|Severe non-compliance|0|||
48799895|NCT00542880|157104280|FG001|Period 2|Severe non-compliance|1|||
48799896|NCT00542880|157104279|FG000|Period 2|Other|0|||
48799897|NCT00542880|157104280|FG001|Period 2|Other|1|||
48799898|NCT00542880|157104279|FG000|Period 3|Adverse Event|0|||
48799899|NCT00542880|157104280|FG001|Period 3|Adverse Event|2|||
48799900|NCT05899686|157104281|FG000|Overall Study|Protocol Violation|1|||
48799901|NCT00558064|157104282|FG000|Overall Study|Adverse Event|3|||
48799902|NCT00558064|157104283|FG001|Overall Study|Adverse Event|2|||
48799903|NCT00558064|157104282|FG000|Overall Study|Lack of Efficacy|0|||
48799904|NCT00558064|157104283|FG001|Overall Study|Lack of Efficacy|1|||
48799905|NCT00558064|157104282|FG000|Overall Study|Protocol Violation|1|||
48799906|NCT00558064|157104283|FG001|Overall Study|Protocol Violation|0|||
48799907|NCT00558064|157104282|FG000|Overall Study|Lost to Follow-up|0|||
48799908|NCT00558064|157104283|FG001|Overall Study|Lost to Follow-up|1|||
48799909|NCT00558064|157104282|FG000|Overall Study|Withdrawal by Subject|0|||
48799910|NCT00558064|157104283|FG001|Overall Study|Withdrawal by Subject|1|||
48799911|NCT00558064|157104282|FG000|Overall Study|No visit within allowance period|1|||
48799912|NCT00558064|157104283|FG001|Overall Study|No visit within allowance period|0|||
48799913|NCT03419364|157104284|FG000|Overall Study|Delivery due to maternal condition|2|||
48799914|NCT03419364|157104285|FG001|Overall Study|Delivery due to maternal condition|0|||
48799915|NCT03419364|157104286|FG002|Overall Study|Delivery due to maternal condition|0|||
48799916|NCT01525602|157104287|FG000|Overall Study|Adverse Event|1|||
48799917|NCT01525602|157104288|FG001|Overall Study|Adverse Event|0|||
48799918|NCT01525602|157104289|FG002|Overall Study|Adverse Event|1|||
48799919|NCT01525602|157104290|FG003|Overall Study|Adverse Event|1|||
48799920|NCT01525602|157104291|FG004|Overall Study|Adverse Event|3|||
48799921|NCT01525602|157104292|FG005|Overall Study|Adverse Event|3|||
48799922|NCT01525602|157104293|FG006|Overall Study|Adverse Event|0|||
48799923|NCT01525602|157104294|FG007|Overall Study|Adverse Event|1|||
48799924|NCT01525602|157104287|FG000|Overall Study|Disease progression|6|||
48799925|NCT01525602|157104288|FG001|Overall Study|Disease progression|3|||
48799926|NCT01525602|157104289|FG002|Overall Study|Disease progression|2|||
48799927|NCT01525602|157104290|FG003|Overall Study|Disease progression|5|||
48799928|NCT01525602|157104291|FG004|Overall Study|Disease progression|22|||
48799929|NCT01525602|157104292|FG005|Overall Study|Disease progression|2|||
48799930|NCT01525602|157104293|FG006|Overall Study|Disease progression|3|||
48799931|NCT01525602|157104294|FG007|Overall Study|Disease progression|3|||
48799932|NCT01525602|157104287|FG000|Overall Study|Clinical progression|2|||
48799933|NCT01525602|157104288|FG001|Overall Study|Clinical progression|0|||
48799934|NCT01525602|157104289|FG002|Overall Study|Clinical progression|0|||
48799935|NCT01525602|157104290|FG003|Overall Study|Clinical progression|0|||
48799936|NCT01525602|157104291|FG004|Overall Study|Clinical progression|0|||
48799937|NCT01525602|157104292|FG005|Overall Study|Clinical progression|0|||
48799938|NCT01525602|157104293|FG006|Overall Study|Clinical progression|1|||
48799939|NCT01525602|157104294|FG007|Overall Study|Clinical progression|1|||
48799940|NCT01525602|157104287|FG000|Overall Study|Non-compliance|0|||
48799941|NCT01525602|157104288|FG001|Overall Study|Non-compliance|0|||
48799942|NCT01525602|157104289|FG002|Overall Study|Non-compliance|0|||
48799943|NCT01525602|157104290|FG003|Overall Study|Non-compliance|0|||
48799944|NCT01525602|157104291|FG004|Overall Study|Non-compliance|1|||
48799945|NCT01525602|157104292|FG005|Overall Study|Non-compliance|0|||
48799946|NCT01525602|157104293|FG006|Overall Study|Non-compliance|0|||
48799947|NCT01525602|157104294|FG007|Overall Study|Non-compliance|0|||
48799948|NCT01525602|157104287|FG000|Overall Study|Withdrawal by Subject|0|||
48799949|NCT01525602|157104288|FG001|Overall Study|Withdrawal by Subject|0|||
48799950|NCT01525602|157104289|FG002|Overall Study|Withdrawal by Subject|0|||
48799951|NCT01525602|157104290|FG003|Overall Study|Withdrawal by Subject|0|||
48799952|NCT01525602|157104291|FG004|Overall Study|Withdrawal by Subject|3|||
48799953|NCT01525602|157104292|FG005|Overall Study|Withdrawal by Subject|1|||
48799954|NCT01525602|157104293|FG006|Overall Study|Withdrawal by Subject|0|||
48799955|NCT01525602|157104294|FG007|Overall Study|Withdrawal by Subject|1|||
48799956|NCT01525602|157104287|FG000|Overall Study|Physician Decision|0|||
48799957|NCT01525602|157104288|FG001|Overall Study|Physician Decision|0|||
48799958|NCT01525602|157104289|FG002|Overall Study|Physician Decision|0|||
48799959|NCT01525602|157104290|FG003|Overall Study|Physician Decision|0|||
48799960|NCT01525602|157104291|FG004|Overall Study|Physician Decision|3|||
48799961|NCT01525602|157104292|FG005|Overall Study|Physician Decision|0|||
48799962|NCT01525602|157104293|FG006|Overall Study|Physician Decision|1|||
48799963|NCT01525602|157104294|FG007|Overall Study|Physician Decision|0|||
48799964|NCT01525602|157104287|FG000|Overall Study|Death|0|||
48799965|NCT01525602|157104288|FG001|Overall Study|Death|0|||
48799966|NCT01525602|157104289|FG002|Overall Study|Death|0|||
48799967|NCT01525602|157104290|FG003|Overall Study|Death|0|||
48799968|NCT01525602|157104291|FG004|Overall Study|Death|1|||
48799969|NCT01525602|157104292|FG005|Overall Study|Death|1|||
48799970|NCT01525602|157104293|FG006|Overall Study|Death|0|||
48799971|NCT01525602|157104294|FG007|Overall Study|Death|0|||
48799972|NCT01525602|157104287|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799973|NCT01525602|157104288|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799974|NCT01525602|157104289|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799975|NCT01525602|157104290|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799976|NCT01525602|157104291|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799977|NCT01525602|157104292|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
48799978|NCT01525602|157104293|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
48799979|NCT01525602|157104294|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
48799980|NCT02543658|157106277|FG000|Overall Study|Lack of Efficacy|0|||
48799981|NCT02543658|157106278|FG001|Overall Study|Lack of Efficacy|4|||
48799982|NCT00593567|157106279|FG000|Overall Study|Adverse Event|2|||
48799983|NCT00593567|157106280|FG001|Overall Study|Adverse Event|0|||
48799984|NCT00593567|157106279|FG000|Overall Study|Physician Decision|2|||
48799985|NCT00593567|157106280|FG001|Overall Study|Physician Decision|0|||
48799986|NCT00593567|157106279|FG000|Overall Study|Protocol Violation|13|||
48799987|NCT00593567|157106280|FG001|Overall Study|Protocol Violation|7|||
48799988|NCT00593567|157106279|FG000|Overall Study|Lack of Efficacy|2|||
48799989|NCT00593567|157106280|FG001|Overall Study|Lack of Efficacy|1|||
48799990|NCT00593567|157106279|FG000|Overall Study|Withdrawal by Subject|1|||
48799991|NCT00593567|157106280|FG001|Overall Study|Withdrawal by Subject|2|||
48799992|NCT00789815|157106281|FG000|Overall Study|Protocol Violation|6|||
48799993|NCT00789815|157106282|FG001|Overall Study|Protocol Violation|1|||
48799994|NCT00789815|157106281|FG000|Overall Study|Intubation due to massive bleeding|1|||
48799995|NCT00789815|157106282|FG001|Overall Study|Intubation due to massive bleeding|0|||
48799996|NCT03576768|157106284|FG000|Overall Study|Lost to Follow-up|3|||
48799997|NCT03576768|157106285|FG001|Overall Study|Lost to Follow-up|3|||
48799998|NCT03576768|157106286|FG002|Overall Study|Lost to Follow-up|0|||
48799999|NCT03576768|157106287|FG003|Overall Study|Lost to Follow-up|0|||
48800000|NCT00590902|157106288|FG000|Overall Study|Death|1|||
48800001|NCT00785291|157106289|FG000|Overall Study|Never began treatment|8|||
48800002|NCT00785291|157106290|FG001|Overall Study|Never began treatment|4|||
48800003|NCT00785291|157106291|FG002|Overall Study|Never began treatment|4|||
48800004|NCT00785291|157106289|FG000|Overall Study|Adverse Event|39|||
48800005|NCT00785291|157106290|FG001|Overall Study|Adverse Event|70|||
48595827|NCT02757352|156377789|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
48800006|NCT00785291|157106291|FG002|Overall Study|Adverse Event|56|||
48800007|NCT00785291|157106289|FG000|Overall Study|Death|7|||
48800008|NCT00785291|157106290|FG001|Overall Study|Death|4|||
48800009|NCT00785291|157106291|FG002|Overall Study|Death|3|||
48800010|NCT00785291|157106289|FG000|Overall Study|Withdrawal by Subject|35|||
48595828|NCT02757352|156377790|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
48800011|NCT00785291|157106290|FG001|Overall Study|Withdrawal by Subject|36|||
48800012|NCT00785291|157106291|FG002|Overall Study|Withdrawal by Subject|17|||
48800013|NCT00785291|157106289|FG000|Overall Study|Alternative Therapy|12|||
48800014|NCT00785291|157106290|FG001|Overall Study|Alternative Therapy|6|||
48800015|NCT00785291|157106291|FG002|Overall Study|Alternative Therapy|7|||
48800016|NCT00785291|157106289|FG000|Overall Study|Complicating illness|6|||
48800017|NCT00785291|157106290|FG001|Overall Study|Complicating illness|4|||
48800018|NCT00785291|157106291|FG002|Overall Study|Complicating illness|4|||
48800019|NCT00785291|157106289|FG000|Overall Study|Other Medical Reasons|29|||
48800020|NCT00785291|157106290|FG001|Overall Study|Other Medical Reasons|25|||
48800021|NCT00785291|157106291|FG002|Overall Study|Other Medical Reasons|15|||
48800022|NCT01111123|157106292|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
48706807|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
48706808|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48706809|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
48706810|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
48706811|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
48706812|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
48706813|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
48706814|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
48706815|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
48706816|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48706817|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
48706818|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
48706819|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
48706820|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
48706821|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
48706822|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
48706823|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
48706824|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
48706825|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
48800023|NCT01111123|157106293|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
48800024|NCT01111123|157106292|FG000|Maintenance Phase|Lost to Follow-up|0|||
48800025|NCT01111123|157106293|FG001|Maintenance Phase|Lost to Follow-up|2|||
48800026|NCT00119405|157106294|FG000|Overall Study|Withdrawal by Subject|1|||
48800027|NCT00570674|157106295|FG000|Overall Study|Withdrawal by Subject|0|||
48800028|NCT00570674|157106296|FG001|Overall Study|Withdrawal by Subject|0|||
48800029|NCT00570674|157106297|FG002|Overall Study|Withdrawal by Subject|1|||
48800030|NCT00570674|157106298|FG003|Overall Study|Withdrawal by Subject|0|||
48800031|NCT00570674|157106299|FG004|Overall Study|Withdrawal by Subject|0|||
48800032|NCT00570674|157106300|FG005|Overall Study|Withdrawal by Subject|0|||
48800033|NCT00570674|157106301|FG006|Overall Study|Withdrawal by Subject|0|||
48800034|NCT01735201|157106303|FG000|Overall Study|Adverse Event|1|||
48800035|NCT01735201|157106304|FG001|Overall Study|Adverse Event|1|||
48800036|NCT01735201|157106305|FG002|Overall Study|Adverse Event|0|||
48800037|NCT01735201|157106306|FG003|Overall Study|Adverse Event|1|||
48800038|NCT01735201|157106307|FG004|Overall Study|Adverse Event|1|||
48800039|NCT01735201|157106308|FG005|Overall Study|Adverse Event|3|||
48800040|NCT01735201|157106309|FG006|Overall Study|Adverse Event|2|||
48800041|NCT01735201|157106310|FG007|Overall Study|Adverse Event|1|||
48800042|NCT01735201|157106303|FG000|Overall Study|Personal Reasons|1|||
48800043|NCT01735201|157106304|FG001|Overall Study|Personal Reasons|0|||
48800044|NCT01735201|157106305|FG002|Overall Study|Personal Reasons|0|||
48800045|NCT01735201|157106306|FG003|Overall Study|Personal Reasons|0|||
48800046|NCT01735201|157106307|FG004|Overall Study|Personal Reasons|0|||
48800047|NCT01735201|157106308|FG005|Overall Study|Personal Reasons|0|||
48800048|NCT01735201|157106309|FG006|Overall Study|Personal Reasons|0|||
48800049|NCT01735201|157106310|FG007|Overall Study|Personal Reasons|0|||
48800050|NCT01735201|157106303|FG000|Overall Study|Protocol Violation|1|||
48800051|NCT01735201|157106304|FG001|Overall Study|Protocol Violation|0|||
48800052|NCT01735201|157106305|FG002|Overall Study|Protocol Violation|0|||
48800053|NCT01735201|157106306|FG003|Overall Study|Protocol Violation|0|||
48800054|NCT01735201|157106307|FG004|Overall Study|Protocol Violation|0|||
48800055|NCT01735201|157106308|FG005|Overall Study|Protocol Violation|0|||
48800056|NCT01735201|157106309|FG006|Overall Study|Protocol Violation|0|||
48800057|NCT01735201|157106310|FG007|Overall Study|Protocol Violation|0|||
48800058|NCT01735201|157106303|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48800059|NCT01735201|157106304|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48800060|NCT01735201|157106305|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48800061|NCT01735201|157106306|FG003|Overall Study|Other Miscellaneous Reasons|1|||
48800062|NCT01735201|157106307|FG004|Overall Study|Other Miscellaneous Reasons|0|||
48800063|NCT01735201|157106308|FG005|Overall Study|Other Miscellaneous Reasons|2|||
48800064|NCT01735201|157106309|FG006|Overall Study|Other Miscellaneous Reasons|1|||
48800065|NCT01735201|157106310|FG007|Overall Study|Other Miscellaneous Reasons|1|||
48800066|NCT00289887|157106311|FG000|Overall Study|Adverse Event|3|||
48800067|NCT00289887|157106312|FG001|Overall Study|Adverse Event|3|||
48800068|NCT00289887|157106311|FG000|Overall Study|Lack of Efficacy|3|||
48800069|NCT00289887|157106312|FG001|Overall Study|Lack of Efficacy|11|||
48800070|NCT00289887|157106311|FG000|Overall Study|Lost to Follow-up|3|||
48800071|NCT00289887|157106312|FG001|Overall Study|Lost to Follow-up|3|||
48800072|NCT00289887|157106311|FG000|Overall Study|Protocol Violation|3|||
48800073|NCT00289887|157106312|FG001|Overall Study|Protocol Violation|1|||
48800074|NCT00289887|157106311|FG000|Overall Study|Withdrawal by Subject|3|||
48706826|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
48706827|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
48706828|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
48706829|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
48800075|NCT00289887|157106312|FG001|Overall Study|Withdrawal by Subject|8|||
48800076|NCT00289887|157106311|FG000|Overall Study|Other|7|||
48800077|NCT00289887|157106312|FG001|Overall Study|Other|3|||
48800078|NCT04517864|157106318|FG000|Placebo-Controlled Phase|Adverse Event|1|||
48800079|NCT04517864|157106319|FG001|Placebo-Controlled Phase|Adverse Event|0|||
48800080|NCT04517864|157106318|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
48800081|NCT04517864|157106319|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
48800082|NCT04517864|157106318|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
48800083|NCT04517864|157106319|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
48800084|NCT04517864|157106318|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
48800085|NCT04517864|157106319|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
48800086|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Adverse Event|1|||
48800087|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Adverse Event|0|||
48800088|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
48800089|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
48800090|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
48800091|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
48800092|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Physician Decision|1|||
48800093|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Physician Decision|0|||
48800094|NCT04517864|157106318|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
48800095|NCT04517864|157106319|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
48800096|NCT04517864|157106318|FG000|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|20|||
48800097|NCT04517864|157106319|FG001|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|24|||
48800098|NCT00512148|157106320|FG000|Primay Study Period|Withdrawal by Subject|1|||
48800099|NCT03315143|157106325|FG000|Overall Study|Death|240|||
48800100|NCT03315143|157106326|FG001|Overall Study|Death|246|||
48800101|NCT03315143|157106325|FG000|Overall Study|Withdrawal by Subject|57|||
48800102|NCT03315143|157106326|FG001|Overall Study|Withdrawal by Subject|68|||
48800103|NCT03315143|157106325|FG000|Overall Study|Site Terminated by Sponsor|256|||
48800104|NCT03315143|157106326|FG001|Overall Study|Site Terminated by Sponsor|282|||
48800105|NCT03315143|157106325|FG000|Overall Study|Study Terminated by Sponsor|4723|||
48800106|NCT03315143|157106326|FG001|Overall Study|Study Terminated by Sponsor|4664|||
48800107|NCT03315143|157106325|FG000|Overall Study|Reason not Specified|16|||
48800108|NCT03315143|157106326|FG001|Overall Study|Reason not Specified|32|||
48800109|NCT00526630|157106331|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
48800110|NCT00526630|157106332|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
48800111|NCT00526630|157106331|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
48800112|NCT00526630|157106332|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
48800113|NCT02606279|157106335|FG000|Overall Study|Lost to Follow-up|0|||
48706830|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706831|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706832|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
48706833|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706834|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706835|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
48706836|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
48706837|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48706838|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
48706839|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
48706840|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48706841|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48706842|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
48706843|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48706844|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
48706845|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
48706846|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
48706847|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
48706848|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
48800114|NCT02606279|157106336|FG001|Overall Study|Lost to Follow-up|1|||
48800115|NCT00335452|157106337|FG000|Overall Study|Death|156|||
48800116|NCT00335452|157106338|FG001|Overall Study|Death|144|||
48800117|NCT00335452|157106339|FG002|Overall Study|Death|158|||
48706849|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
48800118|NCT00335452|157106340|FG003|Overall Study|Death|129|||
48800119|NCT00335452|157106337|FG000|Overall Study|Lost to Follow-up|2|||
48800120|NCT00335452|157106338|FG001|Overall Study|Lost to Follow-up|3|||
48800121|NCT00335452|157106339|FG002|Overall Study|Lost to Follow-up|1|||
48800122|NCT00335452|157106340|FG003|Overall Study|Lost to Follow-up|2|||
48800123|NCT01843192|157106345|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
48800124|NCT01843192|157106346|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
48800125|NCT01843192|157106347|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
48800126|NCT02052310|157106350|FG000|Overall Study|Death|64|||
48800127|NCT02052310|157106351|FG001|Overall Study|Death|54|||
48800128|NCT02052310|157106350|FG000|Overall Study|Withdrawal by Subject|37|||
48800129|NCT02052310|157106351|FG001|Overall Study|Withdrawal by Subject|49|||
48800130|NCT02052310|157106350|FG000|Overall Study|Other than specified|32|||
48800131|NCT02052310|157106351|FG001|Overall Study|Other than specified|29|||
48800132|NCT02052310|157106350|FG000|Overall Study|Adverse Event|29|||
48800133|NCT02052310|157106351|FG001|Overall Study|Adverse Event|22|||
48800134|NCT02052310|157106350|FG000|Overall Study|Kidney Transplant|23|||
48800135|NCT02052310|157106351|FG001|Overall Study|Kidney Transplant|29|||
48800136|NCT02052310|157106350|FG000|Overall Study|Physician Decision|14|||
48800137|NCT02052310|157106351|FG001|Overall Study|Physician Decision|7|||
48800138|NCT02052310|157106350|FG000|Overall Study|Lack of Efficacy|6|||
48800139|NCT02052310|157106351|FG001|Overall Study|Lack of Efficacy|1|||
48800140|NCT02052310|157106350|FG000|Overall Study|Site Terminated by Sponsor|5|||
48800141|NCT02052310|157106351|FG001|Overall Study|Site Terminated by Sponsor|13|||
48800142|NCT02052310|157106350|FG000|Overall Study|Lost to Follow-up|4|||
48800143|NCT02052310|157106351|FG001|Overall Study|Lost to Follow-up|2|||
48800144|NCT02052310|157106350|FG000|Overall Study|Protocol Violation|1|||
48800145|NCT02052310|157106351|FG001|Overall Study|Protocol Violation|6|||
48800146|NCT01682213|157106356|FG000|Overall Study|Withdrawal by Subject|2|||
48800147|NCT04605978|157106357|FG000|Overall Study|Adverse Event|2|||
48800148|NCT04605978|157106358|FG001|Overall Study|Adverse Event|1|||
48800149|NCT04605978|157106357|FG000|Overall Study|Withdrawal nonmedical reason|1|||
48800150|NCT04605978|157106358|FG001|Overall Study|Withdrawal nonmedical reason|1|||
48800151|NCT02583425|157106359|FG000|Screening|Did not meet entry criteria|12|||
48800152|NCT02583425|157106359|FG000|Baseline|Did not meet continued criteria|5|||
48800153|NCT02583425|157106359|FG000|Treatment Period|Adverse Event|1|||
48800154|NCT04638998|157106360|FG000|Overall Study|Withdrawal by Subject|1|||
48800155|NCT04638998|157106361|FG001|Overall Study|Withdrawal by Subject|3|||
48800156|NCT01559454|157106364|FG000|Overall Study|Lost to Follow-up|3|||
48800157|NCT01559454|157106365|FG001|Overall Study|Lost to Follow-up|2|||
48800158|NCT01559454|157106364|FG000|Overall Study|Withdrawal by Subject|0|||
48800159|NCT01559454|157106365|FG001|Overall Study|Withdrawal by Subject|1|||
48800160|NCT01559454|157106364|FG000|Overall Study|Physician Decision|0|||
48800161|NCT01559454|157106365|FG001|Overall Study|Physician Decision|1|||
48800162|NCT01559454|157106364|FG000|Overall Study|Protocol Violation|0|||
48800163|NCT01559454|157106365|FG001|Overall Study|Protocol Violation|1|||
48800164|NCT01559454|157106364|FG000|Overall Study|Lack of Efficacy|0|||
48800165|NCT01559454|157106365|FG001|Overall Study|Lack of Efficacy|1|||
48800166|NCT04493931|157106368|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
48800167|NCT04493931|157106369|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800168|NCT04493931|157106370|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800169|NCT04493931|157106371|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800170|NCT04493931|157106372|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800171|NCT04493931|157106373|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800172|NCT04493931|157106374|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
48800173|NCT04493931|157106368|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800174|NCT04493931|157106369|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
48800175|NCT04493931|157106370|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800176|NCT04493931|157106371|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800177|NCT04493931|157106372|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800178|NCT04493931|157106373|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800179|NCT04493931|157106374|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
48800180|NCT04493931|157106368|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800181|NCT04493931|157106369|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
48800182|NCT04493931|157106370|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800183|NCT04493931|157106371|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800184|NCT04493931|157106372|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800185|NCT04493931|157106373|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800186|NCT04493931|157106374|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
48800187|NCT04493931|157106368|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800188|NCT04493931|157106369|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800189|NCT04493931|157106370|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
48800190|NCT04493931|157106371|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800191|NCT04493931|157106372|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800192|NCT04493931|157106373|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800193|NCT04493931|157106374|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
48800194|NCT01949870|157106382|FG000|Overall Study|Lack of Efficacy|2|||
48800195|NCT01949870|157106382|FG000|Overall Study|Adverse Event|1|||
48800196|NCT01949870|157106382|FG000|Overall Study|Study termination|1|||
48800197|NCT01949870|157106382|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
48490081|NCT01078623|155988833|FG007|Treatment Period 4|Withdrawal by Subject|0|||
48490082|NCT01078623|155988834|FG008|Treatment Period 4|Withdrawal by Subject|0|||
48490083|NCT01078623|155988835|FG009|Treatment Period 4|Withdrawal by Subject|0|||
48490084|NCT01078623|155988836|FG010|Treatment Period 4|Withdrawal by Subject|0|||
48490085|NCT01078623|155988837|FG011|Treatment Period 4|Withdrawal by Subject|0|||
48595829|NCT02757352|156377791|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
48706850|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
48595830|NCT02757352|156377792|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
48706851|NCT01054885|156775872|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48706852|NCT01054885|156775873|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
48706853|NCT01054885|156775874|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48706854|NCT01054885|156775875|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
48706855|NCT01054885|156775876|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
48706856|NCT01054885|156775877|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48706857|NCT01054885|156775878|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
48706858|NCT00804908|156775879|FG000|Overall Study|Other|115|||
48706859|NCT00804908|156775880|FG001|Overall Study|Other|116|||
48706860|NCT00804908|156775881|FG002|Overall Study|Other|114|||
48706861|NCT01177397|156775884|FG000|Overall Study|Protocol Violation|0|||
48706862|NCT01177397|156775885|FG001|Overall Study|Protocol Violation|0|||
48706863|NCT01177397|156775886|FG002|Overall Study|Protocol Violation|0|||
48706864|NCT01177397|156775887|FG003|Overall Study|Protocol Violation|0|||
48706865|NCT01177397|156775888|FG004|Overall Study|Protocol Violation|0|||
48706866|NCT01177397|156775889|FG005|Overall Study|Protocol Violation|1|||
48706867|NCT01177397|156775890|FG006|Overall Study|Protocol Violation|0|||
48706868|NCT01177397|156775891|FG007|Overall Study|Protocol Violation|0|||
48706869|NCT01177397|156775892|FG008|Overall Study|Protocol Violation|0|||
48706870|NCT01177397|156775893|FG009|Overall Study|Protocol Violation|0|||
48706871|NCT01177397|156775894|FG010|Overall Study|Protocol Violation|0|||
48800198|NCT01123382|157106383|FG000|Overall Study|Withdrawal by Subject|1|||
48800199|NCT01123382|157106384|FG001|Overall Study|Withdrawal by Subject|4|||
48800200|NCT01123382|157106383|FG000|Overall Study|Lost to Follow-up|1|||
48800201|NCT01123382|157106384|FG001|Overall Study|Lost to Follow-up|2|||
48800202|NCT00330174|157106388|FG000|Overall Study|Withdrawal by Subject|7|||
48800203|NCT00330174|157106389|FG001|Overall Study|Withdrawal by Subject|7|||
48800204|NCT00330174|157106388|FG000|Overall Study|Lost to Follow-up|4|||
48490086|NCT01078623|155988838|FG012|Treatment Period 4|Withdrawal by Subject|0|||
48595831|NCT02757352|156377793|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
48706872|NCT01177397|156775895|FG011|Overall Study|Protocol Violation|0|||
48706873|NCT01177397|156775884|FG000|Overall Study|Lost to Follow-up|0|||
48706874|NCT01177397|156775885|FG001|Overall Study|Lost to Follow-up|0|||
48706875|NCT01177397|156775886|FG002|Overall Study|Lost to Follow-up|0|||
48706876|NCT01177397|156775887|FG003|Overall Study|Lost to Follow-up|0|||
48706877|NCT01177397|156775888|FG004|Overall Study|Lost to Follow-up|1|||
48706878|NCT01177397|156775889|FG005|Overall Study|Lost to Follow-up|0|||
48706879|NCT01177397|156775890|FG006|Overall Study|Lost to Follow-up|0|||
48706880|NCT01177397|156775891|FG007|Overall Study|Lost to Follow-up|2|||
48706881|NCT01177397|156775892|FG008|Overall Study|Lost to Follow-up|0|||
48706882|NCT01177397|156775893|FG009|Overall Study|Lost to Follow-up|0|||
48706883|NCT01177397|156775894|FG010|Overall Study|Lost to Follow-up|0|||
48706884|NCT01177397|156775895|FG011|Overall Study|Lost to Follow-up|0|||
48706885|NCT01177397|156775884|FG000|Overall Study|Death|0|||
48706886|NCT01177397|156775885|FG001|Overall Study|Death|0|||
48706887|NCT01177397|156775886|FG002|Overall Study|Death|1|||
48706888|NCT01177397|156775887|FG003|Overall Study|Death|1|||
48706889|NCT01177397|156775888|FG004|Overall Study|Death|0|||
48706890|NCT01177397|156775889|FG005|Overall Study|Death|0|||
48706891|NCT01177397|156775890|FG006|Overall Study|Death|0|||
48706892|NCT01177397|156775891|FG007|Overall Study|Death|5|||
48706893|NCT01177397|156775892|FG008|Overall Study|Death|2|||
48706894|NCT01177397|156775893|FG009|Overall Study|Death|1|||
48706895|NCT01177397|156775894|FG010|Overall Study|Death|0|||
48706896|NCT01177397|156775895|FG011|Overall Study|Death|0|||
48800205|NCT00330174|157106389|FG001|Overall Study|Lost to Follow-up|1|||
48490087|NCT01078623|155988839|FG013|Treatment Period 4|Withdrawal by Subject|0|||
48490088|NCT01078623|155988840|FG014|Treatment Period 4|Withdrawal by Subject|0|||
48490089|NCT01078623|155988841|FG015|Treatment Period 4|Withdrawal by Subject|1|||
48706897|NCT01177397|156775884|FG000|Overall Study|Withdrawal by Subject|0|||
48706898|NCT01177397|156775885|FG001|Overall Study|Withdrawal by Subject|0|||
48706899|NCT01177397|156775886|FG002|Overall Study|Withdrawal by Subject|1|||
48800206|NCT00330174|157106388|FG000|Overall Study|Clinical deterioration|1|||
48800207|NCT00330174|157106389|FG001|Overall Study|Clinical deterioration|2|||
48800208|NCT00330174|157106388|FG000|Overall Study|Excessive missed visits|3|||
48800209|NCT00330174|157106389|FG001|Overall Study|Excessive missed visits|8|||
48800210|NCT00330174|157106388|FG000|Overall Study|Miscellaneous reasons|7|||
48800211|NCT00330174|157106389|FG001|Overall Study|Miscellaneous reasons|1|||
48800212|NCT01059630|157106396|FG000|Overall Study|Death|100|||
48800213|NCT01059630|157106397|FG001|Overall Study|Death|84|||
48800214|NCT01059630|157106396|FG000|Overall Study|Lost to Follow-up|4|||
48800215|NCT01059630|157106397|FG001|Overall Study|Lost to Follow-up|1|||
48800216|NCT01059630|157106396|FG000|Overall Study|Physician Decision|2|||
48800217|NCT01059630|157106397|FG001|Overall Study|Physician Decision|4|||
48800218|NCT01059630|157106396|FG000|Overall Study|Withdrawal by Subject|21|||
48800219|NCT01059630|157106397|FG001|Overall Study|Withdrawal by Subject|14|||
48800220|NCT02403180|157106398|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
48800221|NCT02403180|157106399|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
48800222|NCT02403180|157106398|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
48800223|NCT02403180|157106399|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
48800224|NCT01445652|157106400|FG000|Overall Study|Not comfortable in lenses|5|||
48800225|NCT01445652|157106401|FG001|Overall Study|Not comfortable in lenses|0|||
48800226|NCT01445652|157106400|FG000|Overall Study|Failed to attend scheduled visit|2|||
48800227|NCT01445652|157106401|FG001|Overall Study|Failed to attend scheduled visit|3|||
48800228|NCT01445652|157106400|FG000|Overall Study|Failed teach session|2|||
48800229|NCT01445652|157106401|FG001|Overall Study|Failed teach session|0|||
48800230|NCT01445652|157106400|FG000|Overall Study|Adverse Event|1|||
48800231|NCT01445652|157106401|FG001|Overall Study|Adverse Event|0|||
48800232|NCT01089374|157106407|FG000|Overall Study|Lost to Follow-up|3|||
48800233|NCT01089374|157106408|FG001|Overall Study|Lost to Follow-up|0|||
48800234|NCT01089374|157106407|FG000|Overall Study|Withdrawal by Subject|1|||
48800235|NCT01089374|157106408|FG001|Overall Study|Withdrawal by Subject|0|||
48800236|NCT01089374|157106407|FG000|Overall Study|Study closed early - low accrual|6|||
48800237|NCT01089374|157106408|FG001|Overall Study|Study closed early - low accrual|0|||
48800238|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
48800239|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
48800240|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
48800241|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
48800242|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
48800243|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
48800244|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
48800245|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
48800246|NCT00117676|157106409|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
48800247|NCT00117676|157106410|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
48800248|NCT00117676|157106409|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
48800249|NCT00117676|157106410|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
48800250|NCT00117676|157106409|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
48800251|NCT00117676|157106410|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
48800252|NCT00117676|157106409|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
48800253|NCT00117676|157106410|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
48800254|NCT00117676|157106409|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
48800255|NCT00117676|157106410|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
48800256|NCT00117676|157106409|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
48800257|NCT00117676|157106410|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
48800258|NCT00117676|157106409|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
48800259|NCT00117676|157106410|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
48800260|NCT00117676|157106409|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
48800261|NCT00117676|157106410|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
48800262|NCT00117676|157106409|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
48800263|NCT00117676|157106410|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
48800264|NCT00117676|157106409|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
48800265|NCT00117676|157106410|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
48800266|NCT00117676|157106409|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
48800267|NCT00117676|157106410|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
48800268|NCT00117676|157106409|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
48800269|NCT00117676|157106410|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
48800270|NCT00117676|157106409|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
48800271|NCT00117676|157106410|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
48800272|NCT00117676|157106409|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
48800273|NCT00117676|157106410|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
48800274|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
48800275|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
48800276|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
48800277|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
48800278|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
48800279|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
48800280|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
48800281|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
48800282|NCT00117676|157106409|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
48800283|NCT00117676|157106410|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
48800284|NCT00117676|157106409|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
48800285|NCT00117676|157106410|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
48800286|NCT00117676|157106409|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
48800287|NCT00117676|157106410|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
48800288|NCT00117676|157106409|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
48800289|NCT00117676|157106410|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
48800290|NCT00117676|157106409|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
48800291|NCT00117676|157106410|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
48800292|NCT00117676|157106409|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
48800293|NCT00117676|157106410|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
48800294|NCT00117676|157106409|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
48800295|NCT00117676|157106410|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
48800296|NCT00117676|157106409|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
48800297|NCT00117676|157106410|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
48800298|NCT00117676|157106409|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
48800299|NCT00117676|157106410|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
48800300|NCT00117676|157106409|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
48800301|NCT00117676|157106410|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
48800302|NCT00117676|157106409|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
48800303|NCT00117676|157106410|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
48800304|NCT00117676|157106409|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
48800305|NCT00117676|157106410|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
48800306|NCT00117676|157106409|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
48800307|NCT00117676|157106410|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
48800308|NCT02063828|157106413|FG000|Overall Study|Withdrawal by Subject|4|||
48800309|NCT02063828|157106414|FG001|Overall Study|Withdrawal by Subject|6|||
48800310|NCT02063828|157106415|FG002|Overall Study|Withdrawal by Subject|3|||
48800311|NCT02063828|157106413|FG000|Overall Study|Death|0|||
48800312|NCT02063828|157106414|FG001|Overall Study|Death|0|||
48800313|NCT02063828|157106415|FG002|Overall Study|Death|1|||
48800314|NCT00031486|157106423|FG000|Overall Study|Adverse Event|1|||
48800315|NCT00031486|157106424|FG001|Overall Study|Adverse Event|0|||
48800316|NCT00031486|157106423|FG000|Overall Study|Lost to Follow-up|0|||
48800317|NCT00031486|157106424|FG001|Overall Study|Lost to Follow-up|1|||
48800318|NCT00031486|157106423|FG000|Overall Study|Withdrawal by Subject|3|||
48800319|NCT00031486|157106424|FG001|Overall Study|Withdrawal by Subject|2|||
48800320|NCT00031486|157106423|FG000|Overall Study|Death|0|||
48800321|NCT00031486|157106424|FG001|Overall Study|Death|3|||
48800322|NCT00031486|157106423|FG000|Overall Study|Non-compliant|0|||
48800323|NCT00031486|157106424|FG001|Overall Study|Non-compliant|4|||
48800324|NCT00031486|157106423|FG000|Overall Study|Did not meet eligibility requirement|2|||
48800325|NCT00031486|157106424|FG001|Overall Study|Did not meet eligibility requirement|1|||
48800326|NCT00031486|157106423|FG000|Overall Study|Other|1|||
48800327|NCT00031486|157106424|FG001|Overall Study|Other|1|||
48800328|NCT00441090|157106429|FG000|Overall Study|Adverse Event|0|||
48800329|NCT00441090|157106430|FG001|Overall Study|Adverse Event|1|||
48800330|NCT00441090|157106431|FG002|Overall Study|Adverse Event|1|||
48800331|NCT00441090|157106432|FG003|Overall Study|Adverse Event|0|||
48800332|NCT00441090|157106433|FG004|Overall Study|Adverse Event|0|||
48800333|NCT00441090|157106429|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
48800334|NCT00441090|157106430|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
48800335|NCT00441090|157106431|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
48800336|NCT00441090|157106432|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
48800337|NCT00441090|157106433|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
48800338|NCT00441090|157106429|FG000|Overall Study|Withdrawal by Subject|1|||
48800339|NCT00441090|157106430|FG001|Overall Study|Withdrawal by Subject|0|||
48800340|NCT00441090|157106431|FG002|Overall Study|Withdrawal by Subject|1|||
48800341|NCT00441090|157106432|FG003|Overall Study|Withdrawal by Subject|0|||
48800342|NCT00441090|157106433|FG004|Overall Study|Withdrawal by Subject|0|||
48800343|NCT00441090|157106429|FG000|Overall Study|Lack of Efficacy|1|||
48800344|NCT00441090|157106430|FG001|Overall Study|Lack of Efficacy|0|||
48800345|NCT00441090|157106431|FG002|Overall Study|Lack of Efficacy|0|||
48800346|NCT00441090|157106432|FG003|Overall Study|Lack of Efficacy|0|||
48800347|NCT00441090|157106433|FG004|Overall Study|Lack of Efficacy|0|||
48800348|NCT01648348|157106437|FG000|Overall Study|Cancel|1|||
48800349|NCT01648348|157106438|FG001|Overall Study|Cancel|0|||
48800350|NCT01648348|157106439|FG002|Overall Study|Cancel|0|||
48800351|NCT01648348|157106440|FG003|Overall Study|Cancel|0|||
48800352|NCT01648348|157106441|FG004|Overall Study|Cancel|3|||
48800353|NCT01648348|157106442|FG005|Overall Study|Cancel|6|||
48800354|NCT01648348|157106437|FG000|Overall Study|Replaced for MTD analysis|1|||
48800355|NCT01648348|157106438|FG001|Overall Study|Replaced for MTD analysis|0|||
48800356|NCT01648348|157106439|FG002|Overall Study|Replaced for MTD analysis|1|||
48706900|NCT01177397|156775887|FG003|Overall Study|Withdrawal by Subject|1|||
48706901|NCT01177397|156775888|FG004|Overall Study|Withdrawal by Subject|1|||
48800357|NCT01648348|157106440|FG003|Overall Study|Replaced for MTD analysis|0|||
48800358|NCT01648348|157106441|FG004|Overall Study|Replaced for MTD analysis|0|||
48595832|NCT02757352|156377794|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
48595833|NCT02757352|156377785|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595834|NCT02757352|156377786|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48706902|NCT01177397|156775889|FG005|Overall Study|Withdrawal by Subject|2|||
48706903|NCT01177397|156775890|FG006|Overall Study|Withdrawal by Subject|0|||
48706904|NCT01177397|156775891|FG007|Overall Study|Withdrawal by Subject|5|||
48706905|NCT01177397|156775892|FG008|Overall Study|Withdrawal by Subject|9|||
48706906|NCT01177397|156775893|FG009|Overall Study|Withdrawal by Subject|1|||
48706907|NCT01177397|156775894|FG010|Overall Study|Withdrawal by Subject|1|||
48706908|NCT01177397|156775895|FG011|Overall Study|Withdrawal by Subject|0|||
48706909|NCT01177397|156775884|FG000|Overall Study|Adverse Event|0|||
48706910|NCT01177397|156775885|FG001|Overall Study|Adverse Event|0|||
48706911|NCT01177397|156775886|FG002|Overall Study|Adverse Event|1|||
48706912|NCT01177397|156775887|FG003|Overall Study|Adverse Event|2|||
48800359|NCT01648348|157106442|FG005|Overall Study|Replaced for MTD analysis|0|||
48800360|NCT00453986|157106449|FG000|Overall Study|Lost to Follow-up|6|||
48800361|NCT00453986|157106450|FG001|Overall Study|Lost to Follow-up|5|||
48800362|NCT00453986|157106451|FG002|Overall Study|Lost to Follow-up|6|||
48800363|NCT00453986|157106452|FG003|Overall Study|Lost to Follow-up|2|||
48800364|NCT00453986|157106453|FG004|Overall Study|Lost to Follow-up|0|||
48800365|NCT00522626|157106454|FG000|Overall Study|Lost to Follow-up|7|||
48800366|NCT02151266|157106455|FG000|Overall Study|Lost to Follow-up|1|||
48800367|NCT02151266|157106456|FG001|Overall Study|Lost to Follow-up|4|||
48800368|NCT02151266|157106457|FG002|Overall Study|Lost to Follow-up|1|||
48800369|NCT02151266|157106455|FG000|Overall Study|Did NOT receive intervention|3|||
48800370|NCT02151266|157106456|FG001|Overall Study|Did NOT receive intervention|6|||
48800371|NCT02151266|157106457|FG002|Overall Study|Did NOT receive intervention|2|||
48800372|NCT02151266|157106455|FG000|Overall Study|Not able to exercise|4|||
48800373|NCT02151266|157106456|FG001|Overall Study|Not able to exercise|5|||
48800374|NCT02151266|157106457|FG002|Overall Study|Not able to exercise|4|||
48800375|NCT02618616|157106458|FG000|Overall Study|Lack of Efficacy|4|||
48800376|NCT02618616|157106459|FG001|Overall Study|Lack of Efficacy|0|||
48800377|NCT02618616|157106458|FG000|Overall Study|Pregnancy|0|||
48800378|NCT02618616|157106459|FG001|Overall Study|Pregnancy|1|||
48800379|NCT02618616|157106458|FG000|Overall Study|Adverse Event|8|||
48800380|NCT02618616|157106459|FG001|Overall Study|Adverse Event|0|||
48800381|NCT02618616|157106458|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
48800382|NCT02618616|157106459|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
48800383|NCT02618616|157106458|FG000|Overall Study|Consent withdrawn by subject|8|||
48800384|NCT02618616|157106459|FG001|Overall Study|Consent withdrawn by subject|5|||
48800385|NCT02618616|157106458|FG000|Overall Study|Lost to Follow-up|0|||
48800386|NCT02618616|157106459|FG001|Overall Study|Lost to Follow-up|1|||
48800387|NCT02170025|157106462|FG000|Overall Study|Adverse Event|2|||
48800388|NCT02170025|157106463|FG001|Overall Study|Adverse Event|0|||
48800389|NCT00118898|157106464|FG000|Overall Study|Death|6|||
48800390|NCT00118898|157106465|FG001|Overall Study|Death|11|||
48800391|NCT00118898|157106466|FG002|Overall Study|Death|6|||
48800392|NCT00118898|157106467|FG003|Overall Study|Death|8|||
48800393|NCT00118898|157106464|FG000|Overall Study|Lost to Follow-up|26|||
48800394|NCT00118898|157106465|FG001|Overall Study|Lost to Follow-up|34|||
48800395|NCT00118898|157106466|FG002|Overall Study|Lost to Follow-up|33|||
48800396|NCT00118898|157106467|FG003|Overall Study|Lost to Follow-up|33|||
48800397|NCT00118898|157106464|FG000|Overall Study|Withdrawal by Subject|10|||
48800398|NCT00118898|157106465|FG001|Overall Study|Withdrawal by Subject|5|||
48800399|NCT00118898|157106466|FG002|Overall Study|Withdrawal by Subject|8|||
48800400|NCT00118898|157106467|FG003|Overall Study|Withdrawal by Subject|8|||
48800401|NCT00118898|157106464|FG000|Overall Study|Site Closure|33|||
48800402|NCT00118898|157106465|FG001|Overall Study|Site Closure|31|||
48800403|NCT00118898|157106466|FG002|Overall Study|Site Closure|28|||
48800404|NCT00118898|157106467|FG003|Overall Study|Site Closure|37|||
48800405|NCT00118898|157106464|FG000|Overall Study|Severe debilitation|1|||
48800406|NCT00118898|157106465|FG001|Overall Study|Severe debilitation|4|||
48800407|NCT00118898|157106466|FG002|Overall Study|Severe debilitation|6|||
48800408|NCT00118898|157106467|FG003|Overall Study|Severe debilitation|4|||
48800409|NCT00118898|157106464|FG000|Overall Study|Not compliant with requirements|11|||
48800410|NCT00118898|157106465|FG001|Overall Study|Not compliant with requirements|13|||
48800411|NCT00118898|157106466|FG002|Overall Study|Not compliant with requirements|11|||
48800412|NCT00118898|157106467|FG003|Overall Study|Not compliant with requirements|11|||
48800413|NCT00118898|157106464|FG000|Overall Study|Not able to get to clinic|34|||
48800414|NCT00118898|157106465|FG001|Overall Study|Not able to get to clinic|43|||
48800415|NCT00118898|157106466|FG002|Overall Study|Not able to get to clinic|31|||
48800416|NCT00118898|157106467|FG003|Overall Study|Not able to get to clinic|40|||
48800417|NCT02160314|157108269|FG000|Overall Study|Adverse Event|0|||
48800418|NCT02160314|157108270|FG001|Overall Study|Adverse Event|6|||
48800419|NCT02160314|157108269|FG000|Overall Study|Protocol Violation|0|||
48800420|NCT02160314|157108270|FG001|Overall Study|Protocol Violation|4|||
48800421|NCT02160314|157108269|FG000|Overall Study|Withdrawal by Subject|1|||
48800422|NCT02160314|157108270|FG001|Overall Study|Withdrawal by Subject|2|||
48800423|NCT02160314|157108269|FG000|Overall Study|Lost to Follow-up|0|||
48800424|NCT02160314|157108270|FG001|Overall Study|Lost to Follow-up|1|||
48800425|NCT00939484|157108273|FG000|Overall Study|Progression/Relapse|8|||
48800426|NCT00939484|157108274|FG001|Overall Study|Progression/Relapse|20|||
48800427|NCT00939484|157108275|FG002|Overall Study|Progression/Relapse|3|||
48800428|NCT01216176|157108279|FG000|Overall Study|Adverse Event|0|||
48800429|NCT01216176|157108280|FG001|Overall Study|Adverse Event|8|||
48800430|NCT01216176|157108281|FG002|Overall Study|Adverse Event|0|||
48800431|NCT01216176|157108279|FG000|Overall Study|Physician Decision|0|||
48800432|NCT01216176|157108280|FG001|Overall Study|Physician Decision|0|||
48800433|NCT01216176|157108281|FG002|Overall Study|Physician Decision|1|||
48800434|NCT02243280|157108282|FG000|Treated|Adverse Event|1|||
48800435|NCT02243280|157108283|FG001|Treated|Adverse Event|0|||
48800436|NCT02243280|157108284|FG002|Treated|Adverse Event|0|||
48800437|NCT02243280|157108285|FG003|Treated|Adverse Event|0|||
48800438|NCT02243280|157108286|FG004|Treated|Adverse Event|0|||
48800439|NCT02243280|157108287|FG005|Treated|Adverse Event|0|||
48800440|NCT02243280|157108288|FG006|Treated|Adverse Event|0|||
48800441|NCT02243280|157108289|FG007|Treated|Adverse Event|0|||
48800442|NCT02243280|157108290|FG008|Treated|Adverse Event|0|||
48800443|NCT02243280|157108291|FG009|Treated|Adverse Event|0|||
48800444|NCT02243280|157108292|FG010|Treated|Adverse Event|1|||
48800445|NCT02243280|157108282|FG000|Treated|Lost to Follow-up|0|||
48800446|NCT02243280|157108283|FG001|Treated|Lost to Follow-up|0|||
48800447|NCT02243280|157108284|FG002|Treated|Lost to Follow-up|0|||
48800448|NCT02243280|157108285|FG003|Treated|Lost to Follow-up|0|||
48800449|NCT02243280|157108286|FG004|Treated|Lost to Follow-up|0|||
48800450|NCT02243280|157108287|FG005|Treated|Lost to Follow-up|0|||
48595835|NCT02757352|156377787|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595836|NCT02757352|156377788|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
48595837|NCT02757352|156377789|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
48595838|NCT02757352|156377790|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
48706913|NCT01177397|156775888|FG004|Overall Study|Adverse Event|0|||
48706914|NCT01177397|156775889|FG005|Overall Study|Adverse Event|12|||
48706915|NCT01177397|156775890|FG006|Overall Study|Adverse Event|1|||
48706916|NCT01177397|156775891|FG007|Overall Study|Adverse Event|14|||
48706917|NCT01177397|156775892|FG008|Overall Study|Adverse Event|8|||
48706918|NCT01177397|156775893|FG009|Overall Study|Adverse Event|6|||
48706919|NCT01177397|156775894|FG010|Overall Study|Adverse Event|3|||
48706920|NCT01177397|156775895|FG011|Overall Study|Adverse Event|7|||
48706921|NCT01177397|156775884|FG000|Overall Study|Disease progression|1|||
48706922|NCT01177397|156775885|FG001|Overall Study|Disease progression|2|||
48706923|NCT01177397|156775886|FG002|Overall Study|Disease progression|5|||
48706924|NCT01177397|156775887|FG003|Overall Study|Disease progression|5|||
48706925|NCT01177397|156775888|FG004|Overall Study|Disease progression|4|||
48706926|NCT01177397|156775889|FG005|Overall Study|Disease progression|10|||
48706927|NCT01177397|156775890|FG006|Overall Study|Disease progression|10|||
48706928|NCT01177397|156775891|FG007|Overall Study|Disease progression|21|||
48706929|NCT01177397|156775892|FG008|Overall Study|Disease progression|18|||
48706930|NCT01177397|156775893|FG009|Overall Study|Disease progression|12|||
48706931|NCT01177397|156775894|FG010|Overall Study|Disease progression|10|||
48706932|NCT01177397|156775895|FG011|Overall Study|Disease progression|8|||
48706933|NCT01177397|156775884|FG000|Overall Study|Other reasons|0|||
48706934|NCT01177397|156775885|FG001|Overall Study|Other reasons|0|||
48706935|NCT01177397|156775886|FG002|Overall Study|Other reasons|1|||
48706936|NCT01177397|156775887|FG003|Overall Study|Other reasons|0|||
48706937|NCT01177397|156775888|FG004|Overall Study|Other reasons|1|||
48706938|NCT01177397|156775889|FG005|Overall Study|Other reasons|1|||
48706939|NCT01177397|156775890|FG006|Overall Study|Other reasons|2|||
48706940|NCT01177397|156775891|FG007|Overall Study|Other reasons|6|||
48706941|NCT01177397|156775892|FG008|Overall Study|Other reasons|10|||
48706942|NCT01177397|156775893|FG009|Overall Study|Other reasons|8|||
48706943|NCT01177397|156775894|FG010|Overall Study|Other reasons|0|||
48800451|NCT02243280|157108288|FG006|Treated|Lost to Follow-up|0|||
48595839|NCT02757352|156377791|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595840|NCT02757352|156377792|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595841|NCT02757352|156377793|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595842|NCT02757352|156377794|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48595843|NCT02757352|156377785|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48595844|NCT02757352|156377786|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48595845|NCT02757352|156377787|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48595846|NCT02757352|156377788|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48595847|NCT02757352|156377789|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
48595848|NCT02757352|156377790|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48595849|NCT02757352|156377791|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48706944|NCT01177397|156775895|FG011|Overall Study|Other reasons|2|||
48800452|NCT02243280|157108289|FG007|Treated|Lost to Follow-up|0|||
48800453|NCT02243280|157108290|FG008|Treated|Lost to Follow-up|1|||
48800454|NCT02243280|157108291|FG009|Treated|Lost to Follow-up|0|||
48800455|NCT02243280|157108292|FG010|Treated|Lost to Follow-up|2|||
48595850|NCT02757352|156377792|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48706945|NCT01760733|156775896|FG000|Waiting List|Death|18|||
48706946|NCT01760733|156775896|FG000|Waiting List|Removed from waiting list|41|||
48800456|NCT01783418|157108297|FG000|Overall Study|Withdrawal by Subject|1|||
48800457|NCT01783418|157108298|FG001|Overall Study|Withdrawal by Subject|0|||
48800458|NCT04279314|157108300|FG000|Overall Study|Adverse Event|55|||
48800459|NCT04279314|157108300|FG000|Overall Study|Withdrawal by Subject|5|||
48800460|NCT04279314|157108300|FG000|Overall Study|Lack of Efficacy|5|||
48800461|NCT04279314|157108300|FG000|Overall Study|Protocol Violation|3|||
48800462|NCT04279314|157108300|FG000|Overall Study|Other (not COVID-19 related)|2|||
48800463|NCT00415610|157108301|FG000|Overall Study|Death|3|||
48800464|NCT00415610|157108302|FG001|Overall Study|Death|2|||
48800465|NCT00415610|157108303|FG002|Overall Study|Death|5|||
48800466|NCT02459262|157108304|FG000|Overall Study|Withdrawal by Subject|0|||
48800467|NCT02459262|157108305|FG001|Overall Study|Withdrawal by Subject|0|||
48800468|NCT02459262|157108306|FG002|Overall Study|Withdrawal by Subject|0|||
48800469|NCT02459262|157108307|FG003|Overall Study|Withdrawal by Subject|0|||
48800470|NCT02459262|157108308|FG004|Overall Study|Withdrawal by Subject|0|||
48800471|NCT02459262|157108309|FG005|Overall Study|Withdrawal by Subject|0|||
48800472|NCT02459262|157108310|FG006|Overall Study|Withdrawal by Subject|0|||
48800473|NCT02459262|157108311|FG007|Overall Study|Withdrawal by Subject|0|||
48800474|NCT02459262|157108312|FG008|Overall Study|Withdrawal by Subject|0|||
48800475|NCT02459262|157108313|FG009|Overall Study|Withdrawal by Subject|1|||
48800476|NCT02459262|157108314|FG010|Overall Study|Withdrawal by Subject|0|||
48800477|NCT05168579|157108315|FG000|Overall Study|Lack of Consent|1|||
48800478|NCT05168579|157108316|FG001|Overall Study|Lack of Consent|0|||
48800479|NCT05168579|157108315|FG000|Overall Study|Conflicts with time|2|||
48800480|NCT05168579|157108316|FG001|Overall Study|Conflicts with time|0|||
48800481|NCT05168579|157108315|FG000|Overall Study|Time slots were full|3|||
48800482|NCT05168579|157108316|FG001|Overall Study|Time slots were full|0|||
48800483|NCT05168579|157108315|FG000|Overall Study|Lost to Follow-up|0|||
48800484|NCT05168579|157108316|FG001|Overall Study|Lost to Follow-up|15|||
48800485|NCT02691182|157108320|FG000|Overall Study|Withdrawal by Subject|4|||
48800486|NCT02691182|157108321|FG001|Overall Study|Withdrawal by Subject|7|||
48800487|NCT02691182|157108322|FG002|Overall Study|Withdrawal by Subject|6|||
48800488|NCT02691182|157108323|FG003|Overall Study|Withdrawal by Subject|8|||
48800489|NCT02691182|157108320|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
48800490|NCT02691182|157108321|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
48800491|NCT02691182|157108322|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
48800492|NCT02691182|157108323|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
48800493|NCT02691182|157108320|FG000|Overall Study|Lost to Follow-up|8|||
48800494|NCT02691182|157108321|FG001|Overall Study|Lost to Follow-up|33|||
48800495|NCT02691182|157108322|FG002|Overall Study|Lost to Follow-up|19|||
48800496|NCT02691182|157108323|FG003|Overall Study|Lost to Follow-up|22|||
48800497|NCT02691182|157108320|FG000|Overall Study|Adverse Event|3|||
48800498|NCT02691182|157108321|FG001|Overall Study|Adverse Event|10|||
48800499|NCT02691182|157108322|FG002|Overall Study|Adverse Event|10|||
48800500|NCT02691182|157108323|FG003|Overall Study|Adverse Event|11|||
48800501|NCT02691182|157108320|FG000|Overall Study|Physician Decision|3|||
48800502|NCT02691182|157108321|FG001|Overall Study|Physician Decision|7|||
48800503|NCT02691182|157108322|FG002|Overall Study|Physician Decision|14|||
48800504|NCT02691182|157108323|FG003|Overall Study|Physician Decision|8|||
48800505|NCT02691182|157108320|FG000|Overall Study|Lack of Efficacy|0|||
48800506|NCT02691182|157108321|FG001|Overall Study|Lack of Efficacy|0|||
48800507|NCT02691182|157108322|FG002|Overall Study|Lack of Efficacy|0|||
48800508|NCT02691182|157108323|FG003|Overall Study|Lack of Efficacy|4|||
48800509|NCT02691182|157108320|FG000|Overall Study|Protocol Violation|2|||
48800510|NCT02691182|157108321|FG001|Overall Study|Protocol Violation|6|||
48800511|NCT02691182|157108322|FG002|Overall Study|Protocol Violation|6|||
48800512|NCT02691182|157108323|FG003|Overall Study|Protocol Violation|8|||
48800513|NCT02691182|157108320|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
48800514|NCT02691182|157108321|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
48800515|NCT02691182|157108322|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
48800516|NCT02691182|157108323|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
48800517|NCT02691182|157108320|FG000|Overall Study|Missing|0|||
48800518|NCT02691182|157108321|FG001|Overall Study|Missing|5|||
48800519|NCT02691182|157108322|FG002|Overall Study|Missing|1|||
48800520|NCT02691182|157108323|FG003|Overall Study|Missing|5|||
48800521|NCT01114204|157108324|FG000|Overall Study|Adverse Event|3|||
48800522|NCT01114204|157108325|FG001|Overall Study|Adverse Event|2|||
48800523|NCT01114204|157108324|FG000|Overall Study|Lost to Follow-up|1|||
48800524|NCT01114204|157108325|FG001|Overall Study|Lost to Follow-up|0|||
48800525|NCT01114204|157108324|FG000|Overall Study|Withdrawal by Subject|10|||
48800526|NCT01114204|157108325|FG001|Overall Study|Withdrawal by Subject|6|||
48800527|NCT01114204|157108324|FG000|Overall Study|Death|1|||
48800528|NCT01114204|157108325|FG001|Overall Study|Death|0|||
48800529|NCT01114204|157108324|FG000|Overall Study|Other-Personal reasons|2|||
48800530|NCT01114204|157108325|FG001|Overall Study|Other-Personal reasons|0|||
48800531|NCT01114204|157108324|FG000|Overall Study|Other-Medical monitor request|1|||
48800532|NCT01114204|157108325|FG001|Overall Study|Other-Medical monitor request|0|||
48800533|NCT01114204|157108324|FG000|Overall Study|Other-Participant request|2|||
48706947|NCT01760733|156775896|FG000|Waiting List|Not received a transplant yet|13|||
48706948|NCT01760733|156775896|FG000|Transplanted|Not reached 10 years post transplant|184|||
48706949|NCT01760733|156775896|FG000|Transplanted|Death|26|||
48706950|NCT01760733|156775896|FG000|Transplanted|Graft loss|7|||
48706951|NCT00865566|156775897|FG000|Overall Study|Death|1|||
48706952|NCT00865566|156775898|FG001|Overall Study|Death|11|||
48706953|NCT00865566|156775897|FG000|Overall Study|Lost to Follow-up|314|||
48706954|NCT00865566|156775898|FG001|Overall Study|Lost to Follow-up|315|||
48706955|NCT00865566|156775897|FG000|Overall Study|Withdrawal by Subject|45|||
48706956|NCT00865566|156775898|FG001|Overall Study|Withdrawal by Subject|65|||
48706957|NCT00865566|156775897|FG000|Overall Study|Physician Decision|0|||
48706958|NCT00865566|156775898|FG001|Overall Study|Physician Decision|1|||
48706959|NCT00865566|156775897|FG000|Overall Study|Participant relocated|78|||
48706960|NCT00865566|156775898|FG001|Overall Study|Participant relocated|107|||
48706961|NCT00865566|156775897|FG000|Overall Study|Participant unable to adhere|27|||
48706962|NCT00865566|156775898|FG001|Overall Study|Participant unable to adhere|42|||
48706963|NCT00865566|156775897|FG000|Overall Study|Other; N=245 due to early study closure|154|||
48706964|NCT00865566|156775898|FG001|Overall Study|Other; N=245 due to early study closure|139|||
48706965|NCT00865566|156775897|FG000|Overall Study|HIV infection|5|||
48706966|NCT00865566|156775898|FG001|Overall Study|HIV infection|7|||
48706967|NCT03847896|156775901|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
48706968|NCT03847896|156775902|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
48706969|NCT03847896|156775903|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
48706970|NCT03847896|156775904|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
48706971|NCT03847896|156775905|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
48706972|NCT03847896|156775901|FG000|Overall Study|Withdrawal by Subject|2|||
48706973|NCT03847896|156775902|FG001|Overall Study|Withdrawal by Subject|10|||
48706974|NCT03847896|156775903|FG002|Overall Study|Withdrawal by Subject|5|||
48706975|NCT03847896|156775904|FG003|Overall Study|Withdrawal by Subject|9|||
48706976|NCT03847896|156775905|FG004|Overall Study|Withdrawal by Subject|8|||
48706977|NCT03847896|156775901|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48706978|NCT03847896|156775902|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48706979|NCT03847896|156775903|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48706980|NCT03847896|156775904|FG003|Overall Study|Withdrawal by parent/guardian|0|||
48706981|NCT03847896|156775905|FG004|Overall Study|Withdrawal by parent/guardian|0|||
48706982|NCT03847896|156775901|FG000|Overall Study|Adverse Event|2|||
48706983|NCT03847896|156775902|FG001|Overall Study|Adverse Event|1|||
48706984|NCT03847896|156775903|FG002|Overall Study|Adverse Event|3|||
48706985|NCT03847896|156775904|FG003|Overall Study|Adverse Event|2|||
48706986|NCT03847896|156775905|FG004|Overall Study|Adverse Event|4|||
48706987|NCT03847896|156775901|FG000|Overall Study|A severe exacerbation event|0|||
48706988|NCT03847896|156775902|FG001|Overall Study|A severe exacerbation event|0|||
48706989|NCT03847896|156775903|FG002|Overall Study|A severe exacerbation event|0|||
48706990|NCT03847896|156775904|FG003|Overall Study|A severe exacerbation event|0|||
48706991|NCT03847896|156775905|FG004|Overall Study|A severe exacerbation event|3|||
48706992|NCT03847896|156775901|FG000|Overall Study|Protocol Violation|0|||
48706993|NCT03847896|156775902|FG001|Overall Study|Protocol Violation|2|||
48706994|NCT03847896|156775903|FG002|Overall Study|Protocol Violation|1|||
48706995|NCT03847896|156775904|FG003|Overall Study|Protocol Violation|0|||
48706996|NCT03847896|156775905|FG004|Overall Study|Protocol Violation|2|||
48706997|NCT03847896|156775901|FG000|Overall Study|Lost to Follow-up|0|||
48706998|NCT03847896|156775902|FG001|Overall Study|Lost to Follow-up|0|||
48706999|NCT03847896|156775903|FG002|Overall Study|Lost to Follow-up|0|||
48707000|NCT03847896|156775904|FG003|Overall Study|Lost to Follow-up|1|||
48707001|NCT03847896|156775905|FG004|Overall Study|Lost to Follow-up|0|||
48707002|NCT03847896|156775901|FG000|Overall Study|Condition under investigation worsened|0|||
48707003|NCT03847896|156775902|FG001|Overall Study|Condition under investigation worsened|0|||
48707004|NCT03847896|156775903|FG002|Overall Study|Condition under investigation worsened|0|||
48707005|NCT03847896|156775904|FG003|Overall Study|Condition under investigation worsened|1|||
48707006|NCT03847896|156775905|FG004|Overall Study|Condition under investigation worsened|1|||
48707007|NCT03847896|156775901|FG000|Overall Study|Lack of Efficacy|0|||
48707008|NCT03847896|156775902|FG001|Overall Study|Lack of Efficacy|0|||
48707009|NCT03847896|156775903|FG002|Overall Study|Lack of Efficacy|0|||
48707010|NCT03847896|156775904|FG003|Overall Study|Lack of Efficacy|2|||
48707011|NCT03847896|156775905|FG004|Overall Study|Lack of Efficacy|2|||
48707012|NCT03847896|156775901|FG000|Overall Study|Other reasons|3|||
48433894|NCT00516269|155777242|FG001|Overall Study|Protocol Violation|1|||
48707013|NCT03847896|156775902|FG001|Overall Study|Other reasons|3|||
48707014|NCT03847896|156775903|FG002|Overall Study|Other reasons|1|||
48707015|NCT03847896|156775904|FG003|Overall Study|Other reasons|2|||
48490090|NCT01078623|155988842|FG016|Treatment Period 4|Withdrawal by Subject|0|||
48490091|NCT01078623|155988843|FG017|Treatment Period 4|Withdrawal by Subject|0|||
48707016|NCT03847896|156775905|FG004|Overall Study|Other reasons|1|||
48707017|NCT00753649|156775906|FG000|Overall Study|Migrated/moved from study area|1|||
48707018|NCT00753649|156775907|FG001|Overall Study|Migrated/moved from study area|0|||
48707019|NCT00753649|156775906|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
48707020|NCT00753649|156775907|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
48707021|NCT00753649|156775906|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
48707022|NCT00753649|156775907|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
48707023|NCT00753649|156775906|FG000|Overall Study|Protocol Violation|2|||
48707024|NCT00753649|156775907|FG001|Overall Study|Protocol Violation|0|||
48707025|NCT01255436|156775910|FG000|Overall Study|Lost to Follow-up|178|||
48707026|NCT01255436|156775911|FG001|Overall Study|Lost to Follow-up|191|||
48707027|NCT01255436|156775910|FG000|Overall Study|Death, stroke, or MI|4|||
48707028|NCT01255436|156775911|FG001|Overall Study|Death, stroke, or MI|3|||
48707029|NCT00602472|156775912|FG000|Overall Study|Adverse Event|5|||
48707030|NCT00602472|156775913|FG001|Overall Study|Adverse Event|23|||
48707031|NCT00602472|156775912|FG000|Overall Study|Protocol Violation|4|||
48707032|NCT00602472|156775913|FG001|Overall Study|Protocol Violation|19|||
48707033|NCT00602472|156775912|FG000|Overall Study|Withdrawal by Subject|8|||
48707034|NCT00602472|156775913|FG001|Overall Study|Withdrawal by Subject|14|||
48707035|NCT00602472|156775912|FG000|Overall Study|Other incl. lack of efficacy|4|||
48707036|NCT00602472|156775913|FG001|Overall Study|Other incl. lack of efficacy|2|||
48707037|NCT02803580|156775916|FG000|Overall Study|Death|13|||
48707038|NCT02803580|156775916|FG000|Overall Study|Lost to Follow-up|19|||
48707039|NCT02803580|156775916|FG000|Overall Study|Withdrawal by Subject|3|||
48707040|NCT02803580|156775916|FG000|Overall Study|Inclusion in clinical trial|1|||
48707041|NCT01554241|156775917|FG000|Overall Study|Death|3|||
48707042|NCT01554241|156775918|FG001|Overall Study|Death|1|||
48707043|NCT01554241|156775919|FG002|Overall Study|Death|1|||
48707044|NCT01554241|156775920|FG003|Overall Study|Death|0|||
48707045|NCT01554241|156775917|FG000|Overall Study|protocol specified renal stone|0|||
48707046|NCT01554241|156775918|FG001|Overall Study|protocol specified renal stone|0|||
48707047|NCT01554241|156775919|FG002|Overall Study|protocol specified renal stone|0|||
48707048|NCT01554241|156775920|FG003|Overall Study|protocol specified renal stone|1|||
48707049|NCT01554241|156775917|FG000|Overall Study|protocol specified change in eGFR|0|||
48707050|NCT01554241|156775918|FG001|Overall Study|protocol specified change in eGFR|0|||
48707051|NCT01554241|156775919|FG002|Overall Study|protocol specified change in eGFR|1|||
48707052|NCT01554241|156775920|FG003|Overall Study|protocol specified change in eGFR|0|||
48707053|NCT01554241|156775917|FG000|Overall Study|Withdrawal by Subject|0|||
48707054|NCT01554241|156775918|FG001|Overall Study|Withdrawal by Subject|0|||
48707055|NCT01554241|156775919|FG002|Overall Study|Withdrawal by Subject|2|||
48707056|NCT01554241|156775920|FG003|Overall Study|Withdrawal by Subject|0|||
48707057|NCT02215252|156775921|FG000|Overall Study|Adverse Event|1|||
48707058|NCT02215252|156775922|FG001|Overall Study|Adverse Event|5|||
48707059|NCT02215252|156775923|FG002|Overall Study|Adverse Event|2|||
48707060|NCT02215252|156775921|FG000|Overall Study|Lost to Follow-up|0|||
48707061|NCT02215252|156775922|FG001|Overall Study|Lost to Follow-up|0|||
48707062|NCT02215252|156775923|FG002|Overall Study|Lost to Follow-up|1|||
48707063|NCT02215252|156775921|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
48707064|NCT02215252|156775922|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
48707065|NCT02215252|156775923|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
48707066|NCT02215252|156775921|FG000|Overall Study|Protocol Violation|0|||
48707067|NCT02215252|156775922|FG001|Overall Study|Protocol Violation|1|||
48707068|NCT02215252|156775923|FG002|Overall Study|Protocol Violation|0|||
48707069|NCT02215252|156775921|FG000|Overall Study|Withdrawal by Subject|1|||
48707070|NCT02215252|156775922|FG001|Overall Study|Withdrawal by Subject|0|||
48707071|NCT02215252|156775923|FG002|Overall Study|Withdrawal by Subject|0|||
48707072|NCT02215252|156775921|FG000|Overall Study|Other|0|||
48595851|NCT02757352|156377793|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48707073|NCT02215252|156775922|FG001|Overall Study|Other|1|||
48707074|NCT02215252|156775923|FG002|Overall Study|Other|1|||
48707075|NCT00892099|156775924|FG000|Overall Study|Death|1|||
48707076|NCT00892099|156775925|FG001|Overall Study|Death|0|||
48707077|NCT00892099|156775926|FG002|Overall Study|Death|1|||
48707078|NCT00892099|156775924|FG000|Overall Study|Adverse Event|1|||
48707079|NCT00892099|156775925|FG001|Overall Study|Adverse Event|0|||
48707080|NCT00892099|156775926|FG002|Overall Study|Adverse Event|0|||
48707081|NCT00892099|156775924|FG000|Overall Study|replocated|1|||
48707082|NCT00892099|156775925|FG001|Overall Study|replocated|0|||
48707083|NCT00892099|156775926|FG002|Overall Study|replocated|2|||
48707084|NCT00892099|156775924|FG000|Overall Study|Prolonged hospitalization|1|||
48707085|NCT00892099|156775925|FG001|Overall Study|Prolonged hospitalization|0|||
48707086|NCT00892099|156775926|FG002|Overall Study|Prolonged hospitalization|1|||
48707087|NCT00892099|156775924|FG000|Overall Study|no further details|1|||
48707088|NCT00892099|156775925|FG001|Overall Study|no further details|0|||
48707089|NCT00892099|156775926|FG002|Overall Study|no further details|1|||
48800534|NCT01114204|157108325|FG001|Overall Study|Other-Participant request|0|||
48800535|NCT01114204|157108324|FG000|Overall Study|Other-Protocol Violation|1|||
48800536|NCT01114204|157108325|FG001|Overall Study|Other-Protocol Violation|0|||
48800537|NCT00863655|157108328|FG000|Overall Study|Protocol Violation|4|||
48800538|NCT00863655|157108329|FG001|Overall Study|Protocol Violation|0|||
48800539|NCT00863655|157108328|FG000|Overall Study|Adverse Event|52|||
48800540|NCT00863655|157108329|FG001|Overall Study|Adverse Event|8|||
48800541|NCT00863655|157108328|FG000|Overall Study|Withdrawal by Subject|47|||
48800542|NCT00863655|157108329|FG001|Overall Study|Withdrawal by Subject|7|||
48800543|NCT00863655|157108328|FG000|Overall Study|Administrative problems|1|||
48800544|NCT00863655|157108329|FG001|Overall Study|Administrative problems|0|||
48707090|NCT00892099|156775924|FG000|Overall Study|kidney function recovered|0|||
48707091|NCT00892099|156775925|FG001|Overall Study|kidney function recovered|1|||
48707092|NCT00892099|156775926|FG002|Overall Study|kidney function recovered|0|||
48707093|NCT00892099|156775924|FG000|Overall Study|investigator decision|0|||
48707094|NCT00892099|156775925|FG001|Overall Study|investigator decision|0|||
48707095|NCT00892099|156775926|FG002|Overall Study|investigator decision|1|||
48707096|NCT00892099|156775924|FG000|Overall Study|Lost to Follow-up|0|||
48707097|NCT00892099|156775925|FG001|Overall Study|Lost to Follow-up|0|||
48707098|NCT00892099|156775926|FG002|Overall Study|Lost to Follow-up|1|||
48707099|NCT02346721|156775927|FG000|Overall Study|Withdrew Consent|3|||
48707100|NCT02346721|156775927|FG000|Overall Study|Lack of Efficacy|1|||
48707101|NCT04543279|156775932|FG000|Overall Study|Withdrawal by Subject|1|||
48707102|NCT04543279|156775933|FG001|Overall Study|Withdrawal by Subject|0|||
48707103|NCT04543279|156775932|FG000|Overall Study|Adverse Event|1|||
48707104|NCT04543279|156775933|FG001|Overall Study|Adverse Event|0|||
48707105|NCT04543279|156775932|FG000|Overall Study|Physician Decision|1|||
48707106|NCT04543279|156775933|FG001|Overall Study|Physician Decision|0|||
48707107|NCT05038982|156775936|FG000|Overall Study|Withdrawal by Subject|0|||
48707108|NCT05038982|156775937|FG001|Overall Study|Withdrawal by Subject|2|||
48707109|NCT04411667|156775943|FG000|Overall Study|Physician Decision|1|||
48707110|NCT04411667|156775944|FG001|Overall Study|Physician Decision|0|||
48707111|NCT02699749|156775951|FG000|Overall Study|Other|0|||
48707112|NCT02699749|156775952|FG001|Overall Study|Other|0|||
48707113|NCT02699749|156775953|FG002|Overall Study|Other|2|||
48707114|NCT02699749|156775954|FG003|Overall Study|Other|0|||
48707115|NCT02699749|156775955|FG004|Overall Study|Other|0|||
48707116|NCT02699749|156775956|FG005|Overall Study|Other|1|||
48707117|NCT02699749|156775957|FG006|Overall Study|Other|1|||
48707118|NCT02699749|156775958|FG007|Overall Study|Other|0|||
48707119|NCT02699749|156775959|FG008|Overall Study|Other|0|||
48707120|NCT02699749|156775960|FG009|Overall Study|Other|0|||
48707121|NCT02699749|156775961|FG010|Overall Study|Other|1|||
48707122|NCT02699749|156775962|FG011|Overall Study|Other|0|||
48707123|NCT02699749|156775963|FG012|Overall Study|Other|0|||
48707124|NCT02699749|156775964|FG013|Overall Study|Other|0|||
48707125|NCT02699749|156775951|FG000|Overall Study|Progressive Disease|3|||
48707126|NCT02699749|156775952|FG001|Overall Study|Progressive Disease|3|||
48707127|NCT02699749|156775953|FG002|Overall Study|Progressive Disease|14|||
48707128|NCT02699749|156775954|FG003|Overall Study|Progressive Disease|3|||
48707129|NCT02699749|156775955|FG004|Overall Study|Progressive Disease|3|||
48707130|NCT02699749|156775956|FG005|Overall Study|Progressive Disease|7|||
48707131|NCT02699749|156775957|FG006|Overall Study|Progressive Disease|5|||
48707132|NCT02699749|156775958|FG007|Overall Study|Progressive Disease|5|||
48707133|NCT02699749|156775959|FG008|Overall Study|Progressive Disease|6|||
48707134|NCT02699749|156775960|FG009|Overall Study|Progressive Disease|6|||
48707135|NCT02699749|156775961|FG010|Overall Study|Progressive Disease|5|||
48707136|NCT02699749|156775962|FG011|Overall Study|Progressive Disease|4|||
48707137|NCT02699749|156775963|FG012|Overall Study|Progressive Disease|3|||
48707138|NCT02699749|156775964|FG013|Overall Study|Progressive Disease|5|||
48707139|NCT02699749|156775951|FG000|Overall Study|Death|0|||
48707140|NCT02699749|156775952|FG001|Overall Study|Death|0|||
48707141|NCT02699749|156775953|FG002|Overall Study|Death|0|||
48707142|NCT02699749|156775954|FG003|Overall Study|Death|0|||
48800545|NCT00863655|157108328|FG000|Overall Study|Death|7|||
48800546|NCT00863655|157108329|FG001|Overall Study|Death|1|||
48800547|NCT00863655|157108328|FG000|Overall Study|New cancer therapy|5|||
48707143|NCT02699749|156775955|FG004|Overall Study|Death|0|||
48707144|NCT02699749|156775956|FG005|Overall Study|Death|0|||
48707145|NCT02699749|156775957|FG006|Overall Study|Death|0|||
48707146|NCT02699749|156775958|FG007|Overall Study|Death|0|||
48707147|NCT02699749|156775959|FG008|Overall Study|Death|0|||
48707148|NCT02699749|156775960|FG009|Overall Study|Death|0|||
48707149|NCT02699749|156775961|FG010|Overall Study|Death|0|||
48707150|NCT02699749|156775962|FG011|Overall Study|Death|0|||
48707151|NCT02699749|156775963|FG012|Overall Study|Death|0|||
48707152|NCT02699749|156775964|FG013|Overall Study|Death|1|||
48707153|NCT02699749|156775951|FG000|Overall Study|Lost to Follow-up|0|||
48707154|NCT02699749|156775952|FG001|Overall Study|Lost to Follow-up|0|||
48707155|NCT02699749|156775953|FG002|Overall Study|Lost to Follow-up|0|||
48707156|NCT02699749|156775954|FG003|Overall Study|Lost to Follow-up|0|||
48707157|NCT02699749|156775955|FG004|Overall Study|Lost to Follow-up|0|||
48800548|NCT00863655|157108329|FG001|Overall Study|New cancer therapy|1|||
48800549|NCT00863655|157108328|FG000|Overall Study|Disease progression|364|||
48800550|NCT00863655|157108329|FG001|Overall Study|Disease progression|221|||
48800551|NCT00863655|157108328|FG000|Overall Study|Treatment completed as per protocol|5|||
48800552|NCT00863655|157108329|FG001|Overall Study|Treatment completed as per protocol|1|||
48800553|NCT01197508|157108330|FG000|Overall Study|Withdrawal by Subject|8|||
48800554|NCT01197508|157108331|FG001|Overall Study|Withdrawal by Subject|7|||
48800555|NCT01197508|157108332|FG002|Overall Study|Withdrawal by Subject|15|||
48490092|NCT01078623|155988844|FG018|Treatment Period 4|Withdrawal by Subject|0|||
48490093|NCT01078623|155988845|FG019|Treatment Period 4|Withdrawal by Subject|0|||
48490094|NCT01725113|155988846|FG000|Overall Study|Kidney Transplant|1|||
48490095|NCT01725113|155988847|FG001|Overall Study|Kidney Transplant|1|||
48490096|NCT01725113|155988846|FG000|Overall Study|Withdrawal by Subject|0|||
48595852|NCT02757352|156377794|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
48707158|NCT02699749|156775956|FG005|Overall Study|Lost to Follow-up|1|||
48707159|NCT02699749|156775957|FG006|Overall Study|Lost to Follow-up|0|||
48707160|NCT02699749|156775958|FG007|Overall Study|Lost to Follow-up|1|||
48707161|NCT02699749|156775959|FG008|Overall Study|Lost to Follow-up|0|||
48707162|NCT02699749|156775960|FG009|Overall Study|Lost to Follow-up|0|||
48707163|NCT02699749|156775961|FG010|Overall Study|Lost to Follow-up|0|||
48707164|NCT02699749|156775962|FG011|Overall Study|Lost to Follow-up|0|||
48707165|NCT02699749|156775963|FG012|Overall Study|Lost to Follow-up|0|||
48707166|NCT02699749|156775964|FG013|Overall Study|Lost to Follow-up|0|||
48707167|NCT02357368|156775965|FG000|Overall Study|Lost to Follow-up|0|||
48707168|NCT02357368|156775966|FG001|Overall Study|Lost to Follow-up|0|||
48707169|NCT02357368|156775967|FG002|Overall Study|Lost to Follow-up|0|||
48707170|NCT02357368|156775968|FG003|Overall Study|Lost to Follow-up|1|||
48707171|NCT02357368|156775965|FG000|Overall Study|Pregnancy|3|||
48490097|NCT01725113|155988847|FG001|Overall Study|Withdrawal by Subject|1|||
48490098|NCT00326885|155988848|FG000|Overall Study|Adverse Event|1|||
48490099|NCT00326885|155988848|FG000|Overall Study|Withdrawal by Subject|3|||
48490100|NCT00326885|155988848|FG000|Overall Study|Physician Decision|1|||
48595853|NCT02757352|156377785|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595854|NCT02757352|156377786|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595855|NCT02757352|156377787|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595856|NCT02757352|156377788|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595857|NCT02757352|156377789|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595858|NCT02757352|156377790|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
48595859|NCT02757352|156377791|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595860|NCT02757352|156377792|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595861|NCT02757352|156377793|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595862|NCT02757352|156377794|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
48595863|NCT02757352|156377785|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595864|NCT02757352|156377786|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595865|NCT02757352|156377787|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595866|NCT02757352|156377788|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
48595867|NCT02757352|156377789|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
48595868|NCT02757352|156377790|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
48595869|NCT02757352|156377791|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595870|NCT02757352|156377792|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595871|NCT02757352|156377793|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595872|NCT02757352|156377794|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48595873|NCT02757352|156377785|FG000|Follow-Up Period|Adverse Event|0|||
48595874|NCT02757352|156377786|FG001|Follow-Up Period|Adverse Event|0|||
48595875|NCT02757352|156377787|FG002|Follow-Up Period|Adverse Event|0|||
48595876|NCT02757352|156377788|FG003|Follow-Up Period|Adverse Event|0|||
48595877|NCT02757352|156377789|FG004|Follow-Up Period|Adverse Event|0|||
48595878|NCT02757352|156377790|FG005|Follow-Up Period|Adverse Event|0|||
48707172|NCT02357368|156775966|FG001|Overall Study|Pregnancy|2|||
48800556|NCT01197508|157108333|FG003|Overall Study|Withdrawal by Subject|4|||
48800557|NCT01197508|157108330|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
48800558|NCT01197508|157108331|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
48800559|NCT01197508|157108332|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
48800560|NCT01197508|157108333|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
48800561|NCT01197508|157108330|FG000|Overall Study|Adverse Event|10|||
48800562|NCT01197508|157108331|FG001|Overall Study|Adverse Event|13|||
48490101|NCT00326885|155988848|FG000|Overall Study|Hospice withdrew consent|2|||
48595879|NCT02757352|156377791|FG006|Follow-Up Period|Adverse Event|1|||
48595880|NCT02757352|156377792|FG007|Follow-Up Period|Adverse Event|0|||
48707173|NCT02357368|156775967|FG002|Overall Study|Pregnancy|0|||
48707174|NCT02357368|156775968|FG003|Overall Study|Pregnancy|0|||
48707175|NCT02357368|156775965|FG000|Overall Study|Withdrawal by Subject|3|||
48707176|NCT02357368|156775966|FG001|Overall Study|Withdrawal by Subject|1|||
48800563|NCT01197508|157108332|FG002|Overall Study|Adverse Event|23|||
48800564|NCT01197508|157108333|FG003|Overall Study|Adverse Event|3|||
48800565|NCT01197508|157108330|FG000|Overall Study|Severe non-compliance to protocol|0|||
48800566|NCT01197508|157108331|FG001|Overall Study|Severe non-compliance to protocol|3|||
48800567|NCT01197508|157108332|FG002|Overall Study|Severe non-compliance to protocol|1|||
48800568|NCT01197508|157108333|FG003|Overall Study|Severe non-compliance to protocol|3|||
48800569|NCT01197508|157108330|FG000|Overall Study|Condition under investigation worsened|1|||
48800570|NCT01197508|157108331|FG001|Overall Study|Condition under investigation worsened|1|||
48800571|NCT01197508|157108332|FG002|Overall Study|Condition under investigation worsened|1|||
48800572|NCT01197508|157108333|FG003|Overall Study|Condition under investigation worsened|1|||
48800573|NCT01197508|157108330|FG000|Overall Study|Lack of Efficacy|1|||
48800574|NCT01197508|157108331|FG001|Overall Study|Lack of Efficacy|2|||
48800575|NCT01197508|157108332|FG002|Overall Study|Lack of Efficacy|2|||
48800576|NCT01197508|157108333|FG003|Overall Study|Lack of Efficacy|1|||
48800577|NCT01197508|157108330|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48800578|NCT01197508|157108331|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48800579|NCT01197508|157108332|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48800580|NCT01197508|157108333|FG003|Overall Study|Study-specific withdrawal criteria|2|||
48800581|NCT01197508|157108330|FG000|Overall Study|Lost to Follow-up|1|||
48800582|NCT01197508|157108331|FG001|Overall Study|Lost to Follow-up|1|||
48800583|NCT01197508|157108332|FG002|Overall Study|Lost to Follow-up|2|||
48800584|NCT01197508|157108333|FG003|Overall Study|Lost to Follow-up|0|||
48800585|NCT01197508|157108330|FG000|Overall Study|Other|2|||
48800586|NCT01197508|157108331|FG001|Overall Study|Other|3|||
48800587|NCT01197508|157108332|FG002|Overall Study|Other|2|||
48800588|NCT01197508|157108333|FG003|Overall Study|Other|2|||
48800589|NCT03295318|157108334|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
48800590|NCT03295318|157108335|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
48800591|NCT03295318|157108336|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
48800592|NCT03295318|157108334|FG000|Overall Study|Death|1|||
48800593|NCT03295318|157108335|FG001|Overall Study|Death|1|||
48800594|NCT03295318|157108336|FG002|Overall Study|Death|1|||
48800595|NCT03295318|157108334|FG000|Overall Study|Protocol Violation|4|||
48800596|NCT03295318|157108335|FG001|Overall Study|Protocol Violation|3|||
48800597|NCT03295318|157108336|FG002|Overall Study|Protocol Violation|3|||
48800598|NCT03295318|157108334|FG000|Overall Study|Withdrawal by Subject|0|||
48800599|NCT03295318|157108335|FG001|Overall Study|Withdrawal by Subject|0|||
48800600|NCT03295318|157108336|FG002|Overall Study|Withdrawal by Subject|1|||
48800601|NCT03295318|157108334|FG000|Overall Study|Subject discontinued due to travel|0|||
48800602|NCT03295318|157108335|FG001|Overall Study|Subject discontinued due to travel|1|||
48800603|NCT03295318|157108336|FG002|Overall Study|Subject discontinued due to travel|0|||
48800604|NCT00266825|157108337|FG000|Completed Follow-Up|Lost to Follow-up|14|||
48800605|NCT00266825|157108338|FG001|Completed Follow-Up|Lost to Follow-up|19|||
48800606|NCT00266825|157108337|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
48800607|NCT00266825|157108338|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
48800608|NCT01078155|157108339|FG000|Overall Study|Adverse Event|7|||
48800609|NCT01078155|157108339|FG000|Overall Study|Lack of Efficacy|16|||
48800610|NCT01078155|157108339|FG000|Overall Study|Participant's Decision|6|||
48800611|NCT01078155|157108339|FG000|Overall Study|Lost to Follow-up|15|||
48800612|NCT01127646|157108342|FG000|Overall Study|Entry Criteria Not Met|1|||
48800613|NCT01127646|157108343|FG001|Overall Study|Entry Criteria Not Met|0|||
48800614|NCT01127646|157108342|FG000|Overall Study|Protocol Violation|0|||
48800615|NCT01127646|157108343|FG001|Overall Study|Protocol Violation|1|||
48800616|NCT01966003|157108347|FG000|Overall Study|Death|43|||
48490102|NCT02424565|155988850|FG000|Period 1 (D0)|Protocol Violation|0|||
48800617|NCT01966003|157108348|FG001|Overall Study|Death|36|||
48800618|NCT01966003|157108347|FG000|Overall Study|Protocol Violation|6|||
48800619|NCT01966003|157108348|FG001|Overall Study|Protocol Violation|4|||
48800620|NCT01966003|157108347|FG000|Overall Study|Lost to Follow-up|4|||
48800621|NCT01966003|157108348|FG001|Overall Study|Lost to Follow-up|3|||
48800622|NCT01966003|157108347|FG000|Overall Study|Physician Decision|12|||
48800623|NCT01966003|157108348|FG001|Overall Study|Physician Decision|13|||
48800624|NCT01966003|157108347|FG000|Overall Study|Withdrawal by Subject|29|||
48800625|NCT01966003|157108348|FG001|Overall Study|Withdrawal by Subject|19|||
48800626|NCT01966003|157108347|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
48800627|NCT01966003|157108348|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
48800628|NCT01966003|157108347|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
48800629|NCT01966003|157108348|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
48800630|NCT01966003|157108347|FG000|Overall Study|Other|1|||
48800631|NCT01966003|157108348|FG001|Overall Study|Other|1|||
48800632|NCT03466086|157108351|FG000|Period 1|Sponsor decision due to study timeline|1|||
48800633|NCT03466086|157108352|FG001|Period 1|Sponsor decision due to study timeline|0|||
48800634|NCT03466086|157108351|FG000|Period 1|Withdrawal by Subject|1|||
48800635|NCT03466086|157108352|FG001|Period 1|Withdrawal by Subject|0|||
48800636|NCT01477853|157108353|FG000|Phase A|Adverse Event|1|||
48800637|NCT01477853|157108354|FG001|Phase A|Adverse Event|2|||
48800638|NCT01477853|157108355|FG002|Phase A|Adverse Event|2|||
48800639|NCT01477853|157108353|FG000|Phase A|Lost to Follow-up|4|||
48490103|NCT02424565|155988851|FG001|Period 1 (D0)|Protocol Violation|1|||
48490104|NCT01473758|155988852|FG000|Cycle 1|Adverse Event|10|||
48707177|NCT02357368|156775967|FG002|Overall Study|Withdrawal by Subject|1|||
48707178|NCT02357368|156775968|FG003|Overall Study|Withdrawal by Subject|2|||
48707179|NCT02565108|156775969|FG000|Overall Study|Adverse Event|1|||
48707180|NCT02565108|156775970|FG001|Overall Study|Adverse Event|0|||
48707181|NCT02565108|156775969|FG000|Overall Study|Withdrew Consent|1|||
48707182|NCT02565108|156775970|FG001|Overall Study|Withdrew Consent|0|||
48707183|NCT00048074|156775971|FG000|Overall Study|Adverse Event|46|||
48707184|NCT00048074|156775972|FG001|Overall Study|Adverse Event|41|||
48707185|NCT00048074|156775973|FG002|Overall Study|Adverse Event|53|||
48707186|NCT00048074|156775971|FG000|Overall Study|Death|3|||
48707187|NCT00048074|156775972|FG001|Overall Study|Death|3|||
48707188|NCT00048074|156775973|FG002|Overall Study|Death|2|||
48707189|NCT00048074|156775971|FG000|Overall Study|Lost to Follow-up|2|||
48707190|NCT00048074|156775972|FG001|Overall Study|Lost to Follow-up|6|||
48707191|NCT00048074|156775973|FG002|Overall Study|Lost to Follow-up|6|||
48707192|NCT00048074|156775971|FG000|Overall Study|Withdrawal by Subject|28|||
48707193|NCT00048074|156775972|FG001|Overall Study|Withdrawal by Subject|30|||
48707194|NCT00048074|156775973|FG002|Overall Study|Withdrawal by Subject|35|||
48707195|NCT00048074|156775971|FG000|Overall Study|Protocol Violation|1|||
48707196|NCT00048074|156775972|FG001|Overall Study|Protocol Violation|3|||
48707197|NCT00048074|156775973|FG002|Overall Study|Protocol Violation|0|||
48707198|NCT00048074|156775971|FG000|Overall Study|Study participation was terminated|0|||
48707199|NCT00048074|156775972|FG001|Overall Study|Study participation was terminated|1|||
48707200|NCT00048074|156775973|FG002|Overall Study|Study participation was terminated|0|||
48707201|NCT00048074|156775971|FG000|Overall Study|Husband ill|0|||
48707202|NCT00048074|156775972|FG001|Overall Study|Husband ill|1|||
48707203|NCT00048074|156775973|FG002|Overall Study|Husband ill|0|||
48707204|NCT00048074|156775971|FG000|Overall Study|Poor compliance|0|||
48707205|NCT00048074|156775972|FG001|Overall Study|Poor compliance|1|||
48707206|NCT00048074|156775973|FG002|Overall Study|Poor compliance|0|||
48707207|NCT00048074|156775971|FG000|Overall Study|Out of station|0|||
48707208|NCT00048074|156775972|FG001|Overall Study|Out of station|1|||
48707209|NCT00048074|156775973|FG002|Overall Study|Out of station|1|||
48707210|NCT00048074|156775971|FG000|Overall Study|Social reasons|1|||
48707211|NCT00048074|156775972|FG001|Overall Study|Social reasons|0|||
48707212|NCT00048074|156775973|FG002|Overall Study|Social reasons|0|||
48707213|NCT02873377|156775974|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
48707214|NCT02873377|156775975|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
48800640|NCT01477853|157108354|FG001|Phase A|Lost to Follow-up|3|||
48800641|NCT01477853|157108355|FG002|Phase A|Lost to Follow-up|2|||
48707215|NCT02873377|156775974|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
48707216|NCT02873377|156775975|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
48707217|NCT01587924|156775976|FG000|Overall Study|Adverse Event|0|||
48707218|NCT01587924|156775977|FG001|Overall Study|Adverse Event|2|||
48707219|NCT01587924|156775978|FG002|Overall Study|Adverse Event|0|||
48707220|NCT01587924|156775979|FG003|Overall Study|Adverse Event|0|||
48707221|NCT01587924|156775976|FG000|Overall Study|Protocol Violation|2|||
48707222|NCT01587924|156775977|FG001|Overall Study|Protocol Violation|1|||
48800642|NCT01477853|157108353|FG000|Phase A|Physician Decision|1|||
48800643|NCT01477853|157108354|FG001|Phase A|Physician Decision|0|||
48800644|NCT01477853|157108355|FG002|Phase A|Physician Decision|1|||
48800645|NCT01477853|157108353|FG000|Phase A|Study terminated by sponsor|37|||
48800646|NCT01477853|157108354|FG001|Phase A|Study terminated by sponsor|40|||
48800647|NCT01477853|157108355|FG002|Phase A|Study terminated by sponsor|39|||
48800648|NCT01477853|157108353|FG000|Phase B|Lost to Follow-up|0|||
48800649|NCT01477853|157108354|FG001|Phase B|Lost to Follow-up|1|||
48800650|NCT01477853|157108355|FG002|Phase B|Lost to Follow-up|0|||
48800651|NCT01477853|157108353|FG000|Phase B|Study terminated by sponsor|12|||
48800652|NCT01477853|157108354|FG001|Phase B|Study terminated by sponsor|10|||
48800653|NCT01477853|157108355|FG002|Phase B|Study terminated by sponsor|11|||
48800654|NCT03086330|157108356|FG000|Overall Study|Withdrawal by Subject|3|||
48800655|NCT03086330|157108357|FG001|Overall Study|Withdrawal by Subject|2|||
48800656|NCT03086330|157108356|FG000|Overall Study|Lost to Follow-up|1|||
48800657|NCT03086330|157108357|FG001|Overall Study|Lost to Follow-up|2|||
48800658|NCT01814748|157108366|FG000|Overall Study|Lost to Follow-up|1|||
48800659|NCT01814748|157108367|FG001|Overall Study|Lost to Follow-up|2|||
48800660|NCT01814748|157108366|FG000|Overall Study|Study site terminated by sponsor|1|||
48800661|NCT01814748|157108367|FG001|Overall Study|Study site terminated by sponsor|1|||
48800662|NCT01814748|157108366|FG000|Overall Study|Withdrawal by Subject|6|||
48800663|NCT01814748|157108367|FG001|Overall Study|Withdrawal by Subject|4|||
48800664|NCT01591382|157108368|FG000|Overall Study|Discharged Prior to Study Completion|2|||
48800665|NCT01591382|157108369|FG001|Overall Study|Discharged Prior to Study Completion|1|||
48800666|NCT01591382|157108368|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
48800667|NCT01591382|157108369|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
48800668|NCT02274857|157108370|FG000|Overall Study|Adverse Event|1|||
48800669|NCT02274857|157108371|FG001|Overall Study|Adverse Event|0|||
48800670|NCT02274857|157108370|FG000|Overall Study|Death|1|||
48800671|NCT02274857|157108371|FG001|Overall Study|Death|2|||
48800672|NCT02274857|157108370|FG000|Overall Study|Lost to Follow-up|3|||
48800673|NCT02274857|157108371|FG001|Overall Study|Lost to Follow-up|0|||
48800674|NCT02274857|157108370|FG000|Overall Study|Physician Decision|2|||
48800675|NCT02274857|157108371|FG001|Overall Study|Physician Decision|0|||
48800676|NCT02274857|157108370|FG000|Overall Study|Trial screen failure|0|||
48800677|NCT02274857|157108371|FG001|Overall Study|Trial screen failure|2|||
48800678|NCT02274857|157108370|FG000|Overall Study|Withdrawal by Subject|11|||
48800679|NCT02274857|157108371|FG001|Overall Study|Withdrawal by Subject|2|||
48800680|NCT02274857|157108370|FG000|Overall Study|Other|2|||
48800681|NCT02274857|157108371|FG001|Overall Study|Other|0|||
48800682|NCT00716092|157108372|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
48800683|NCT00716092|157108373|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
48800684|NCT00716092|157108374|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
48800685|NCT02316769|157108376|FG000|Overall Study|Physician Decision|1|||
48800686|NCT02316769|157108377|FG001|Overall Study|Physician Decision|0|||
48800687|NCT02316769|157108376|FG000|Overall Study|Withdrawal by Subject|1|||
48800688|NCT02316769|157108377|FG001|Overall Study|Withdrawal by Subject|0|||
48800689|NCT02054806|157108378|FG000|Overall Study|Sponsor Decision|31|||
48800690|NCT02054806|157108378|FG000|Overall Study|Withdrawal by Subject|43|||
48800691|NCT02054806|157108378|FG000|Overall Study|Protocol Violation|2|||
48800692|NCT02054806|157108378|FG000|Overall Study|Lost to Follow-up|10|||
48800693|NCT02054806|157108378|FG000|Overall Study|Death|391|||
48800694|NCT00855062|157108381|FG000|Step1|Early Study Closure|5|||
48800695|NCT00855062|157108382|FG001|Step1|Early Study Closure|7|||
48800696|NCT00855062|157108381|FG000|Step1|Adverse Event|1|||
48800697|NCT00855062|157108382|FG001|Step1|Adverse Event|1|||
48800698|NCT00855062|157108381|FG000|Step1|Protocol Violation|1|||
48800699|NCT00855062|157108382|FG001|Step1|Protocol Violation|0|||
48490105|NCT01473758|155988853|FG001|Cycle 1|Adverse Event|2|||
48490106|NCT01473758|155988854|FG002|Cycle 1|Adverse Event|0|||
48490107|NCT01473758|155988855|FG003|Cycle 1|Adverse Event|0|||
48490108|NCT01473758|155988852|FG000|Cycle 1|Withdrawal by Subject|1|||
48490109|NCT01473758|155988853|FG001|Cycle 1|Withdrawal by Subject|1|||
48490110|NCT01473758|155988854|FG002|Cycle 1|Withdrawal by Subject|0|||
48800700|NCT00855062|157108381|FG000|Step1|Pregnancy|1|||
48800701|NCT00855062|157108382|FG001|Step1|Pregnancy|0|||
48800702|NCT00855062|157108381|FG000|Step1|Withdrawal by Subject|2|||
48800703|NCT00855062|157108382|FG001|Step1|Withdrawal by Subject|3|||
48800704|NCT00855062|157108381|FG000|Step2|Early Study Closure|6|||
48800705|NCT00855062|157108382|FG001|Step2|Early Study Closure|2|||
48800706|NCT00855062|157108381|FG000|Step2|Adverse Event|0|||
48800707|NCT00855062|157108382|FG001|Step2|Adverse Event|3|||
48800708|NCT00855062|157108381|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
48800709|NCT00855062|157108382|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
48800710|NCT02007434|157108383|FG000|Overall Study|Lost to Follow-up|0|||
48800711|NCT02007434|157108384|FG001|Overall Study|Lost to Follow-up|1|||
48800712|NCT02007434|157108385|FG002|Overall Study|Lost to Follow-up|0|||
48800713|NCT02007434|157108386|FG003|Overall Study|Lost to Follow-up|0|||
48800714|NCT02007434|157108387|FG004|Overall Study|Lost to Follow-up|0|||
48800715|NCT02007434|157108388|FG005|Overall Study|Lost to Follow-up|0|||
48800716|NCT02007434|157108389|FG006|Overall Study|Lost to Follow-up|0|||
48800717|NCT02007434|157108390|FG007|Overall Study|Lost to Follow-up|0|||
48800718|NCT02007434|157108383|FG000|Overall Study|Non-compliance|1|||
48800719|NCT02007434|157108384|FG001|Overall Study|Non-compliance|0|||
48800720|NCT02007434|157108385|FG002|Overall Study|Non-compliance|1|||
48800721|NCT02007434|157108386|FG003|Overall Study|Non-compliance|0|||
48800722|NCT02007434|157108387|FG004|Overall Study|Non-compliance|0|||
48800723|NCT02007434|157108388|FG005|Overall Study|Non-compliance|0|||
48800724|NCT02007434|157108389|FG006|Overall Study|Non-compliance|0|||
48800725|NCT02007434|157108390|FG007|Overall Study|Non-compliance|0|||
48800726|NCT03002610|157108391|FG000|Overall Study|Withdrawal by Subject|6|||
48800727|NCT03002610|157108392|FG001|Overall Study|Withdrawal by Subject|25|||
48800728|NCT03002610|157108393|FG002|Overall Study|Withdrawal by Subject|13|||
48800729|NCT02192970|157108394|FG000|Overall Study|Lost to Follow-up|6|||
48800730|NCT02192970|157108395|FG001|Overall Study|Lost to Follow-up|0|||
48800731|NCT00929162|157108397|FG000|Overall Study|Adverse Event|8|||
48800732|NCT00929162|157108398|FG001|Overall Study|Adverse Event|5|||
48800733|NCT00929162|157108397|FG000|Overall Study|Withdrawal by Subject|3|||
48800734|NCT00929162|157108398|FG001|Overall Study|Withdrawal by Subject|1|||
48800735|NCT00929162|157108397|FG000|Overall Study|Protocol Violation|32|||
48490111|NCT01473758|155988855|FG003|Cycle 1|Withdrawal by Subject|0|||
48800736|NCT00929162|157108398|FG001|Overall Study|Protocol Violation|30|||
48800737|NCT00929162|157108397|FG000|Overall Study|Other termination reason|5|||
48800738|NCT00929162|157108398|FG001|Overall Study|Other termination reason|6|||
48800739|NCT01822587|157108400|FG000|Overall Study|Lost to Follow-up|7|||
48800740|NCT01822587|157108401|FG001|Overall Study|Lost to Follow-up|9|||
48800741|NCT01822587|157108402|FG002|Overall Study|Lost to Follow-up|12|||
48800742|NCT01822587|157108400|FG000|Overall Study|Physician Decision|9|||
48800743|NCT01822587|157108401|FG001|Overall Study|Physician Decision|6|||
48800744|NCT01822587|157108402|FG002|Overall Study|Physician Decision|6|||
48800745|NCT01281202|157108403|FG000|Overall Study|Adverse Event|2|||
48800746|NCT01281202|157108404|FG001|Overall Study|Adverse Event|0|||
48800747|NCT01281202|157108403|FG000|Overall Study|Withdrawal by Subject|2|||
48800748|NCT01281202|157108404|FG001|Overall Study|Withdrawal by Subject|2|||
48800749|NCT01281202|157108403|FG000|Overall Study|Protocol Violation|11|||
48800750|NCT01281202|157108404|FG001|Overall Study|Protocol Violation|10|||
48800751|NCT01281202|157108403|FG000|Overall Study|Administrative|2|||
48800752|NCT01281202|157108404|FG001|Overall Study|Administrative|8|||
48490112|NCT01473758|155988852|FG000|Cycle 2|Adverse Event|0|||
48490113|NCT01473758|155988853|FG001|Cycle 2|Adverse Event|0|||
48490114|NCT01473758|155988854|FG002|Cycle 2|Adverse Event|5|||
48490115|NCT01473758|155988855|FG003|Cycle 2|Adverse Event|0|||
48800753|NCT01281202|157108403|FG000|Overall Study|Lost to Follow-up|11|||
48800754|NCT01281202|157108404|FG001|Overall Study|Lost to Follow-up|13|||
48800755|NCT01281202|157108403|FG000|Overall Study|Incarceration|0|||
48800756|NCT01281202|157108404|FG001|Overall Study|Incarceration|3|||
48800757|NCT03172702|157108405|FG000|Overall Study|Adverse Event|9|||
48800758|NCT03172702|157108405|FG000|Overall Study|Death|2|||
48800759|NCT03172702|157108405|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
48800760|NCT03172702|157108405|FG000|Overall Study|Withdrawal by Subject|5|||
48800761|NCT03172702|157108405|FG000|Overall Study|Other|2|||
48800762|NCT02835339|157108406|FG000|Overall Study|Did not receive allocated intervention|13|||
48800763|NCT02835339|157108407|FG001|Overall Study|Did not receive allocated intervention|16|||
48800764|NCT01077544|157108408|FG000|Overall Study|New Cancer Therapy|3|||
48800765|NCT01077544|157108409|FG001|Overall Study|New Cancer Therapy|3|||
48800766|NCT01077544|157108408|FG000|Overall Study|Adverse Event|0|||
48800767|NCT01077544|157108409|FG001|Overall Study|Adverse Event|1|||
48800768|NCT01077544|157108408|FG000|Overall Study|Disease Progression|0|||
48800769|NCT01077544|157108409|FG001|Overall Study|Disease Progression|1|||
48800770|NCT03707951|157108410|FG000|Overall Study|Lost to Follow-up|8|||
48800771|NCT03707951|157108411|FG001|Overall Study|Lost to Follow-up|17|||
48800772|NCT03707951|157108410|FG000|Overall Study|Withdrawal by Subject|6|||
48800773|NCT03707951|157108411|FG001|Overall Study|Withdrawal by Subject|6|||
48800774|NCT02753595|157108412|FG000|Overall Study|Sponsor termination|2|||
48800775|NCT02753595|157108413|FG001|Overall Study|Sponsor termination|2|||
48800776|NCT03804710|157108414|FG000|Overall Study|Adverse Event|0|||
48800777|NCT03804710|157108415|FG001|Overall Study|Adverse Event|3|||
48800778|NCT03804710|157108414|FG000|Overall Study|Withdrawal by Subject|2|||
48800779|NCT03804710|157108415|FG001|Overall Study|Withdrawal by Subject|1|||
48800780|NCT03804710|157108414|FG000|Overall Study|Other|0|||
48800781|NCT03804710|157108415|FG001|Overall Study|Other|1|||
48800782|NCT04987762|157108418|FG000|Overall Study|Study was Terminated by Sponsor|103|||
48800783|NCT02953938|157108419|FG000|Overall Study|Adverse Event|0|||
48800784|NCT02953938|157108420|FG001|Overall Study|Adverse Event|1|||
48800785|NCT02953938|157108419|FG000|Overall Study|Withdrawal by Subject|1|||
48800786|NCT02953938|157108420|FG001|Overall Study|Withdrawal by Subject|1|||
48800787|NCT02342886|157108421|FG000|Overall Study|Treatment non-compliance|1|||
48800788|NCT02342886|157108422|FG001|Overall Study|Treatment non-compliance|0|||
48800789|NCT02342886|157108423|FG002|Overall Study|Treatment non-compliance|0|||
48800790|NCT02342886|157108424|FG003|Overall Study|Treatment non-compliance|1|||
48800791|NCT02342886|157108425|FG004|Overall Study|Treatment non-compliance|0|||
48800792|NCT02342886|157108421|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
48800793|NCT02342886|157108422|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
48800794|NCT02342886|157108423|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
48800795|NCT02342886|157108424|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
48800796|NCT02342886|157108425|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
48800797|NCT02342886|157108421|FG000|Overall Study|Adverse event/specific toxicity|4|||
48800798|NCT02342886|157108422|FG001|Overall Study|Adverse event/specific toxicity|3|||
48800799|NCT02342886|157108423|FG002|Overall Study|Adverse event/specific toxicity|11|||
48800800|NCT02342886|157108424|FG003|Overall Study|Adverse event/specific toxicity|2|||
48800801|NCT02342886|157108425|FG004|Overall Study|Adverse event/specific toxicity|1|||
48800802|NCT02342886|157108421|FG000|Overall Study|Lost to Follow-up|1|||
48800803|NCT02342886|157108422|FG001|Overall Study|Lost to Follow-up|0|||
48800804|NCT02342886|157108423|FG002|Overall Study|Lost to Follow-up|0|||
48800805|NCT02342886|157108424|FG003|Overall Study|Lost to Follow-up|0|||
48800806|NCT02342886|157108425|FG004|Overall Study|Lost to Follow-up|0|||
48800807|NCT02342886|157108421|FG000|Overall Study|Death|1|||
48800808|NCT02342886|157108422|FG001|Overall Study|Death|2|||
48800809|NCT02342886|157108423|FG002|Overall Study|Death|1|||
48800810|NCT02342886|157108424|FG003|Overall Study|Death|0|||
48800811|NCT02342886|157108425|FG004|Overall Study|Death|1|||
48800812|NCT02342886|157108421|FG000|Overall Study|Withdrawal by Subject|0|||
48800813|NCT02342886|157108422|FG001|Overall Study|Withdrawal by Subject|1|||
48800814|NCT02342886|157108423|FG002|Overall Study|Withdrawal by Subject|0|||
48800815|NCT02342886|157108424|FG003|Overall Study|Withdrawal by Subject|1|||
48800816|NCT02342886|157108425|FG004|Overall Study|Withdrawal by Subject|0|||
48800817|NCT02342886|157108421|FG000|Overall Study|Investigator/sponsor decision|0|||
48800818|NCT02342886|157108422|FG001|Overall Study|Investigator/sponsor decision|2|||
48800819|NCT02342886|157108423|FG002|Overall Study|Investigator/sponsor decision|0|||
48800820|NCT02342886|157108424|FG003|Overall Study|Investigator/sponsor decision|3|||
48800821|NCT02342886|157108425|FG004|Overall Study|Investigator/sponsor decision|1|||
48800822|NCT02342886|157108421|FG000|Overall Study|Pregnancy|0|||
48800823|NCT02342886|157108422|FG001|Overall Study|Pregnancy|0|||
48800824|NCT02342886|157108423|FG002|Overall Study|Pregnancy|2|||
48800825|NCT02342886|157108424|FG003|Overall Study|Pregnancy|0|||
48800826|NCT02342886|157108425|FG004|Overall Study|Pregnancy|0|||
48800827|NCT02342886|157108421|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
48800828|NCT02342886|157108422|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
48800829|NCT02342886|157108423|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
48800830|NCT02342886|157108424|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
48800831|NCT02342886|157108425|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
48800832|NCT02342886|157108421|FG000|Overall Study|Protocol Violation|0|||
48800833|NCT02342886|157108422|FG001|Overall Study|Protocol Violation|0|||
48800834|NCT02342886|157108423|FG002|Overall Study|Protocol Violation|0|||
48800835|NCT02342886|157108424|FG003|Overall Study|Protocol Violation|2|||
48800836|NCT02342886|157108425|FG004|Overall Study|Protocol Violation|0|||
48800837|NCT01064297|157108426|FG000|Overall Study|Lost to Follow-up|791|||
48800838|NCT01064297|157108427|FG001|Overall Study|Lost to Follow-up|48|||
48800839|NCT01064297|157108428|FG002|Overall Study|Lost to Follow-up|133|||
48800840|NCT00045305|157108429|FG000|Overall Study|Lack of Efficacy|6|||
48800841|NCT00045305|157108429|FG000|Overall Study|Adverse Event|3|||
48800842|NCT00045305|157108429|FG000|Overall Study|Death|3|||
48800843|NCT00045305|157108429|FG000|Overall Study|site error|2|||
48800844|NCT02158884|157108430|FG000|Baseline Assessment|Missed performance assessment|3|||
48595881|NCT02757352|156377793|FG008|Follow-Up Period|Adverse Event|2|||
48595882|NCT02757352|156377794|FG009|Follow-Up Period|Adverse Event|0|||
48595883|NCT02757352|156377785|FG000|Follow-Up Period|Lost to Follow-up|0|||
48595884|NCT02757352|156377786|FG001|Follow-Up Period|Lost to Follow-up|0|||
48595885|NCT02757352|156377787|FG002|Follow-Up Period|Lost to Follow-up|0|||
48595886|NCT02757352|156377788|FG003|Follow-Up Period|Lost to Follow-up|0|||
48595887|NCT02757352|156377789|FG004|Follow-Up Period|Lost to Follow-up|0|||
48595888|NCT02757352|156377790|FG005|Follow-Up Period|Lost to Follow-up|0|||
48595889|NCT02757352|156377791|FG006|Follow-Up Period|Lost to Follow-up|0|||
48595890|NCT02757352|156377792|FG007|Follow-Up Period|Lost to Follow-up|0|||
48595891|NCT02757352|156377793|FG008|Follow-Up Period|Lost to Follow-up|1|||
48800845|NCT02158884|157108430|FG000|Baseline Assessment|Missed SMFA|1|||
48800846|NCT02158884|157108430|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
48800847|NCT02158884|157108430|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
48800848|NCT02158884|157108430|FG000|6 Month Assessment|Missed SMFA|20|||
48800849|NCT02158884|157108430|FG000|12 Month Assessment|Missed SMFA|17|||
48800850|NCT02124265|157108432|FG000|Overall Study|Adverse Event|1|||
48800851|NCT01685138|157108433|FG000|Overall Study|Lost to Follow-up|1|||
48800852|NCT01685138|157108433|FG000|Overall Study|Protocol Violation|1|||
48800853|NCT01685138|157108433|FG000|Overall Study|No longer requires treatment|1|||
48800854|NCT01685138|157108433|FG000|Overall Study|Subject/guardian decision|2|||
48800855|NCT01685138|157108433|FG000|Overall Study|Physician Decision|6|||
48800856|NCT01685138|157108433|FG000|Overall Study|Death|10|||
48800857|NCT01685138|157108433|FG000|Overall Study|Adverse Event|18|||
48800858|NCT01685138|157108433|FG000|Overall Study|Progressive disease|53|||
48800859|NCT01313286|157108434|FG000|Period 1|Withdrawal by Subject|2|||
48800860|NCT01313286|157108435|FG001|Period 1|Withdrawal by Subject|0|||
48800861|NCT02070484|157108438|FG000|Overall Study|Withdrawal by Subject|1|||
48800862|NCT02070484|157108439|FG001|Overall Study|Withdrawal by Subject|0|||
48800863|NCT01669798|157108444|FG000|Overall Study|Physician Decision|5|||
48800864|NCT01489189|157108446|FG000|Overall Study|Withdrawal by Subject|20|||
48800865|NCT01489189|157108447|FG001|Overall Study|Withdrawal by Subject|23|||
48800866|NCT01489189|157108446|FG000|Overall Study|Death|10|||
48800867|NCT01489189|157108447|FG001|Overall Study|Death|8|||
48800868|NCT01489189|157108446|FG000|Overall Study|Missed Visit|1|||
48800869|NCT01489189|157108447|FG001|Overall Study|Missed Visit|4|||
48800870|NCT04225988|157108448|FG000|Overall Study|Withdrawal by Subject|2|||
48800871|NCT04225988|157108449|FG001|Overall Study|Withdrawal by Subject|0|||
48490116|NCT03565211|155988859|FG000|Overall Study|Withdrawal by Subject|2|||
48800872|NCT00404495|157108450|FG000|Overall Study|Death|37|||
48800873|NCT00404495|157108451|FG001|Overall Study|Death|11|||
48595892|NCT02757352|156377794|FG009|Follow-Up Period|Lost to Follow-up|0|||
48595893|NCT02757352|156377785|FG000|Follow-Up Period|Lack of Efficacy|0|||
48595894|NCT02757352|156377786|FG001|Follow-Up Period|Lack of Efficacy|0|||
48595895|NCT02757352|156377787|FG002|Follow-Up Period|Lack of Efficacy|0|||
48595896|NCT02757352|156377788|FG003|Follow-Up Period|Lack of Efficacy|0|||
48595897|NCT02757352|156377789|FG004|Follow-Up Period|Lack of Efficacy|0|||
48595898|NCT02757352|156377790|FG005|Follow-Up Period|Lack of Efficacy|0|||
48800874|NCT00404495|157108450|FG000|Overall Study|Lost to Follow-up|5|||
48800875|NCT00404495|157108451|FG001|Overall Study|Lost to Follow-up|0|||
48800876|NCT00404495|157108450|FG000|Overall Study|Other|1|||
48800877|NCT00404495|157108451|FG001|Overall Study|Other|0|||
48800878|NCT00404495|157108450|FG000|Overall Study|Withdrawal by Subject|1|||
48800879|NCT00404495|157108451|FG001|Overall Study|Withdrawal by Subject|0|||
48490117|NCT03565211|155988859|FG000|Overall Study|Lost to Follow-up|1|||
48800880|NCT03017079|157108452|FG000|Overall Study|Physician Decision|1|||
48800881|NCT03017079|157108453|FG001|Overall Study|Physician Decision|1|||
48800882|NCT03017079|157108452|FG000|Overall Study|Death|3|||
48800883|NCT03017079|157108453|FG001|Overall Study|Death|2|||
48800884|NCT03017079|157108452|FG000|Overall Study|Lack of Efficacy|2|||
48800885|NCT03017079|157108453|FG001|Overall Study|Lack of Efficacy|2|||
48800886|NCT03017079|157108452|FG000|Overall Study|Protocol Violation|0|||
48800887|NCT03017079|157108453|FG001|Overall Study|Protocol Violation|1|||
48800888|NCT01984697|157110230|FG000|Overall Study|Adverse Event|0|||
48800889|NCT01984697|157110231|FG001|Overall Study|Adverse Event|0|||
48800890|NCT01984697|157110232|FG002|Overall Study|Adverse Event|2|||
48800891|NCT01984697|157110233|FG003|Overall Study|Adverse Event|0|||
48800892|NCT01984697|157110234|FG004|Overall Study|Adverse Event|0|||
48800893|NCT01984697|157110230|FG000|Overall Study|Lost to Follow-up|14|||
48800894|NCT01984697|157110231|FG001|Overall Study|Lost to Follow-up|5|||
48800895|NCT01984697|157110232|FG002|Overall Study|Lost to Follow-up|10|||
48800896|NCT01984697|157110233|FG003|Overall Study|Lost to Follow-up|6|||
48800897|NCT01984697|157110234|FG004|Overall Study|Lost to Follow-up|21|||
48800898|NCT01984697|157110230|FG000|Overall Study|Physician Decision|3|||
48800899|NCT01984697|157110231|FG001|Overall Study|Physician Decision|0|||
48800900|NCT01984697|157110232|FG002|Overall Study|Physician Decision|0|||
48800901|NCT01984697|157110233|FG003|Overall Study|Physician Decision|1|||
48800902|NCT01984697|157110234|FG004|Overall Study|Physician Decision|0|||
48800903|NCT01984697|157110230|FG000|Overall Study|Protocol Violation|8|||
48800904|NCT01984697|157110231|FG001|Overall Study|Protocol Violation|5|||
48800905|NCT01984697|157110232|FG002|Overall Study|Protocol Violation|3|||
48800906|NCT01984697|157110233|FG003|Overall Study|Protocol Violation|2|||
48800907|NCT01984697|157110234|FG004|Overall Study|Protocol Violation|0|||
48800908|NCT01984697|157110230|FG000|Overall Study|Withdrawal by Subject|15|||
48800909|NCT01984697|157110231|FG001|Overall Study|Withdrawal by Subject|21|||
48800910|NCT01984697|157110232|FG002|Overall Study|Withdrawal by Subject|13|||
48800911|NCT01984697|157110233|FG003|Overall Study|Withdrawal by Subject|11|||
48800912|NCT01984697|157110234|FG004|Overall Study|Withdrawal by Subject|13|||
48800913|NCT01984697|157110230|FG000|Overall Study|Missed last follow-up visit|1|||
48800914|NCT01984697|157110231|FG001|Overall Study|Missed last follow-up visit|0|||
48800915|NCT01984697|157110232|FG002|Overall Study|Missed last follow-up visit|0|||
48800916|NCT01984697|157110233|FG003|Overall Study|Missed last follow-up visit|0|||
48800917|NCT01984697|157110234|FG004|Overall Study|Missed last follow-up visit|0|||
48800918|NCT01984697|157110230|FG000|Overall Study|Death|0|||
48800919|NCT01984697|157110231|FG001|Overall Study|Death|0|||
48800920|NCT01984697|157110232|FG002|Overall Study|Death|0|||
48800921|NCT01984697|157110233|FG003|Overall Study|Death|1|||
48800922|NCT01984697|157110234|FG004|Overall Study|Death|0|||
48800923|NCT01984697|157110230|FG000|Overall Study|Pregnancy|2|||
48800924|NCT01984697|157110231|FG001|Overall Study|Pregnancy|0|||
48800925|NCT01984697|157110232|FG002|Overall Study|Pregnancy|1|||
48800926|NCT01984697|157110233|FG003|Overall Study|Pregnancy|0|||
48800927|NCT01984697|157110234|FG004|Overall Study|Pregnancy|1|||
48800928|NCT02044848|157110237|FG000|Overall Study|Administrative Problems|2|||
48800929|NCT02044848|157110238|FG001|Overall Study|Administrative Problems|3|||
48800930|NCT02979639|157110241|FG000|Overall Study|Withdrawal based on medical judgement|1|||
48800931|NCT02979639|157110241|FG000|Overall Study|Lost to Follow-up|8|||
48800932|NCT02979639|157110241|FG000|Overall Study|Withdrawal by Subject|3|||
48800933|NCT02979639|157110241|FG000|Overall Study|Adverse Event|2|||
48800934|NCT04539821|157110242|FG000|Overall Study|Withdrawal by Subject|2|||
48800935|NCT04539821|157110242|FG000|Overall Study|continued care with their physician|20|||
48800936|NCT04539821|157110242|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
48800937|NCT01235546|157110244|FG000|Overall Study|Staff error, medication not administered|1|||
48800938|NCT01235546|157110245|FG001|Overall Study|Staff error, medication not administered|0|||
48800939|NCT01235546|157110244|FG000|Overall Study|Protocol Violation|1|||
48800940|NCT01235546|157110245|FG001|Overall Study|Protocol Violation|1|||
48800941|NCT00677235|157110253|FG000|Overall Study|Withdrawal by Subject|1|||
48800942|NCT00677235|157110254|FG001|Overall Study|Withdrawal by Subject|1|||
48800943|NCT00677235|157110253|FG000|Overall Study|Lost to Follow-up|2|||
48800944|NCT00677235|157110254|FG001|Overall Study|Lost to Follow-up|1|||
48800945|NCT00677235|157110253|FG000|Overall Study|Death|37|||
48800946|NCT00677235|157110254|FG001|Overall Study|Death|36|||
48800947|NCT00677235|157110253|FG000|Overall Study|Adverse Experience|1|||
48800948|NCT00677235|157110254|FG001|Overall Study|Adverse Experience|0|||
48800949|NCT03595332|157110270|FG000|Overall Study|Lost to Follow-up|16|||
48800950|NCT03595332|157110271|FG001|Overall Study|Lost to Follow-up|22|||
48800951|NCT03595332|157110270|FG000|Overall Study|Unable to retrieve ID from school|0|||
48800952|NCT03595332|157110271|FG001|Overall Study|Unable to retrieve ID from school|2|||
48800953|NCT02227875|157110272|FG000|Overall Study|Protocol Violation|10|||
48800954|NCT02227875|157110273|FG001|Overall Study|Protocol Violation|7|||
48800955|NCT02227875|157110272|FG000|Overall Study|Other|1|||
48800956|NCT02227875|157110273|FG001|Overall Study|Other|3|||
48800957|NCT02227875|157110272|FG000|Overall Study|Physician Decision|1|||
48800958|NCT02227875|157110273|FG001|Overall Study|Physician Decision|0|||
48800959|NCT02227875|157110272|FG000|Overall Study|Adverse Event|3|||
48800960|NCT02227875|157110273|FG001|Overall Study|Adverse Event|0|||
48800961|NCT02227875|157110272|FG000|Overall Study|Withdrawal by Subject|12|||
48800962|NCT02227875|157110273|FG001|Overall Study|Withdrawal by Subject|13|||
48800963|NCT02227875|157110272|FG000|Overall Study|Lost to Follow-up|10|||
48800964|NCT02227875|157110273|FG001|Overall Study|Lost to Follow-up|10|||
48800965|NCT01058304|157110289|FG000|Overall Study|Withdrawal by Subject|8|||
48800966|NCT01058304|157110290|FG001|Overall Study|Withdrawal by Subject|5|||
48800967|NCT01058304|157110289|FG000|Overall Study|Lost to Follow-up|13|||
48800968|NCT01058304|157110290|FG001|Overall Study|Lost to Follow-up|16|||
48800969|NCT01058304|157110289|FG000|Overall Study|Developed exclusion criterion|6|||
48800970|NCT01058304|157110290|FG001|Overall Study|Developed exclusion criterion|12|||
48800971|NCT01820559|157110291|FG000|Overall Study|Adverse Event|4|||
48800972|NCT01820559|157110292|FG001|Overall Study|Adverse Event|6|||
48800973|NCT01820559|157110293|FG002|Overall Study|Adverse Event|13|||
48800974|NCT01820559|157110291|FG000|Overall Study|Withdrawal by Subject|1|||
48800975|NCT01820559|157110292|FG001|Overall Study|Withdrawal by Subject|2|||
48800976|NCT01820559|157110293|FG002|Overall Study|Withdrawal by Subject|5|||
48800977|NCT01820559|157110291|FG000|Overall Study|Protocol Violation|2|||
48800978|NCT01820559|157110292|FG001|Overall Study|Protocol Violation|1|||
48800979|NCT01820559|157110293|FG002|Overall Study|Protocol Violation|3|||
48800980|NCT01820559|157110291|FG000|Overall Study|Subject's non-compliance|1|||
48800981|NCT01820559|157110292|FG001|Overall Study|Subject's non-compliance|0|||
48800982|NCT01820559|157110293|FG002|Overall Study|Subject's non-compliance|2|||
48800983|NCT01820559|157110291|FG000|Overall Study|Lost to Follow-up|3|||
48433895|NCT03213626|155777243|FG000|Overall Study|Adverse Event|1|||
48595899|NCT02757352|156377791|FG006|Follow-Up Period|Lack of Efficacy|0|||
48595900|NCT02757352|156377792|FG007|Follow-Up Period|Lack of Efficacy|0|||
48595901|NCT02757352|156377793|FG008|Follow-Up Period|Lack of Efficacy|1|||
48595902|NCT02757352|156377794|FG009|Follow-Up Period|Lack of Efficacy|1|||
48595903|NCT02757352|156377785|FG000|Follow-Up Period|Withdrawal by Subject|0|||
48595904|NCT02757352|156377786|FG001|Follow-Up Period|Withdrawal by Subject|0|||
48595905|NCT02757352|156377787|FG002|Follow-Up Period|Withdrawal by Subject|0|||
48707223|NCT01587924|156775978|FG002|Overall Study|Protocol Violation|2|||
48707224|NCT01587924|156775979|FG003|Overall Study|Protocol Violation|1|||
48707225|NCT01587924|156775976|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
48707226|NCT01587924|156775977|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
48707227|NCT01587924|156775978|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
48707228|NCT01587924|156775979|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
48707229|NCT01587924|156775976|FG000|Overall Study|Withdrawal by Subject|0|||
48707230|NCT01587924|156775977|FG001|Overall Study|Withdrawal by Subject|1|||
48707231|NCT01587924|156775978|FG002|Overall Study|Withdrawal by Subject|1|||
48707232|NCT01587924|156775979|FG003|Overall Study|Withdrawal by Subject|0|||
48707233|NCT01106248|156775980|FG000|Overall Study|Adverse Event|1|||
48707234|NCT01106248|156775980|FG000|Overall Study|Administrative|2|||
48707235|NCT01668589|156775981|FG000|Overall Study|Lost to Follow-up|29|||
48707236|NCT01668589|156775982|FG001|Overall Study|Lost to Follow-up|37|||
48707237|NCT01668589|156775983|FG002|Overall Study|Lost to Follow-up|15|||
48707238|NCT01668589|156775984|FG003|Overall Study|Lost to Follow-up|5|||
48707239|NCT01668589|156775981|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
48707240|NCT01668589|156775982|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
48707241|NCT01668589|156775983|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
48707242|NCT01668589|156775984|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
48707243|NCT01668589|156775981|FG000|Overall Study|Death|12|||
48707244|NCT01668589|156775982|FG001|Overall Study|Death|3|||
48707245|NCT01668589|156775983|FG002|Overall Study|Death|2|||
48707246|NCT01668589|156775984|FG003|Overall Study|Death|11|||
48707247|NCT01668589|156775981|FG000|Overall Study|Other|44|||
48707248|NCT01668589|156775982|FG001|Overall Study|Other|10|||
48707249|NCT01668589|156775983|FG002|Overall Study|Other|7|||
48707250|NCT01668589|156775984|FG003|Overall Study|Other|15|||
48707251|NCT00828204|156775987|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
48707252|NCT00828204|156775988|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
48707253|NCT00828204|156775987|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
48707254|NCT00828204|156775988|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
48707255|NCT00828204|156775987|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
48707256|NCT00828204|156775988|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
48707257|NCT00828204|156775987|FG000|Main Study: After Study Restart|Adverse Event|0|||
48707258|NCT00828204|156775988|FG001|Main Study: After Study Restart|Adverse Event|2|||
48707259|NCT00828204|156775987|FG000|Main Study: After Study Restart|Noncompliance|0|||
48707260|NCT00828204|156775988|FG001|Main Study: After Study Restart|Noncompliance|1|||
48707261|NCT00828204|156775987|FG000|Extension Study|Lost to Follow-up|0|||
48707262|NCT00828204|156775988|FG001|Extension Study|Lost to Follow-up|1|||
48707263|NCT00828204|156775987|FG000|Extension Study|Physician Decision|0|||
48707264|NCT00828204|156775988|FG001|Extension Study|Physician Decision|2|||
48707265|NCT01642589|156775994|FG000|Overall Study|Withdrawal by Subject|1|||
48707266|NCT01642589|156775995|FG001|Overall Study|Withdrawal by Subject|1|||
48490118|NCT03565211|155988859|FG000|Overall Study|Adverse Event|44|||
48490119|NCT03565211|155988859|FG000|Overall Study|Personal issues|1|||
48490120|NCT01612156|155988860|FG000|Overall Study|Protocol Violation|2|||
48490121|NCT01612156|155988861|FG001|Overall Study|Protocol Violation|0|||
48490122|NCT01698320|155988862|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
48490123|NCT01698320|155988863|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
48490124|NCT01698320|155988864|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
48490125|NCT01698320|155988862|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
48490126|NCT01698320|155988863|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
48490127|NCT01698320|155988864|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
48490128|NCT01698320|155988862|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
48490129|NCT01698320|155988863|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
48490130|NCT01698320|155988864|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
48490131|NCT01698320|155988862|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
48490132|NCT01698320|155988863|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
48490133|NCT01698320|155988864|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
48490134|NCT01698320|155988862|FG000|12-Week Double-Blind Period|Adverse Event|0|||
48490135|NCT01698320|155988863|FG001|12-Week Double-Blind Period|Adverse Event|1|||
48490136|NCT01698320|155988864|FG002|12-Week Double-Blind Period|Adverse Event|1|||
48490137|NCT01698320|155988862|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
48490138|NCT01698320|155988863|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
48490139|NCT01698320|155988864|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
48490140|NCT01698320|155988862|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
48490141|NCT01698320|155988863|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
48490142|NCT01698320|155988864|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
48490143|NCT01698320|155988862|FG000|12-Week Double-Blind Period|Pregnancy|0|||
48490144|NCT01698320|155988863|FG001|12-Week Double-Blind Period|Pregnancy|1|||
48490145|NCT01698320|155988864|FG002|12-Week Double-Blind Period|Pregnancy|1|||
48490146|NCT01698320|155988862|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
48490147|NCT01698320|155988863|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
48490148|NCT01698320|155988864|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
48490149|NCT01698320|155988862|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
48490150|NCT01698320|155988863|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
48490151|NCT01698320|155988864|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
48490152|NCT01698320|155988862|FG000|40-Week Open-Label Period|Adverse Event|0|||
48490153|NCT01698320|155988863|FG001|40-Week Open-Label Period|Adverse Event|3|||
48490154|NCT01698320|155988864|FG002|40-Week Open-Label Period|Adverse Event|2|||
48490155|NCT01698320|155988862|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
48490156|NCT01698320|155988863|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
48490157|NCT01698320|155988864|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
48490158|NCT01698320|155988862|FG000|40-Week Open-Label Period|Pregnancy|0|||
48490159|NCT01698320|155988863|FG001|40-Week Open-Label Period|Pregnancy|2|||
48490160|NCT01698320|155988864|FG002|40-Week Open-Label Period|Pregnancy|1|||
48490161|NCT01698320|155988862|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
48490162|NCT01698320|155988863|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
48490163|NCT01698320|155988864|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
48490164|NCT01698320|155988862|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
48490165|NCT01698320|155988863|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
48490166|NCT01698320|155988864|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
48707267|NCT01120964|156775996|FG000|Overall Study|Did not receive full treatment|1|||
48707268|NCT01120964|156775997|FG001|Overall Study|Did not receive full treatment|0|||
48707269|NCT01704599|156776000|FG000|Overall Study|Adverse Event|1|||
48707270|NCT02840461|156776004|FG000|Overall Study|Adverse Event|1|||
48707271|NCT02840461|156776005|FG001|Overall Study|Adverse Event|5|||
48490167|NCT01952574|155988865|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
48490168|NCT01952574|155988866|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
48490169|NCT01952574|155988867|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
48490170|NCT01952574|155988868|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
48490171|NCT01952574|155988869|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48707272|NCT02840461|156776006|FG002|Overall Study|Adverse Event|3|||
48707273|NCT02840461|156776004|FG000|Overall Study|Lost to Follow-up|10|||
48800984|NCT01820559|157110292|FG001|Overall Study|Lost to Follow-up|2|||
48800985|NCT01820559|157110293|FG002|Overall Study|Lost to Follow-up|2|||
48800986|NCT01820559|157110291|FG000|Overall Study|At sponsor request|0|||
48800987|NCT01820559|157110292|FG001|Overall Study|At sponsor request|0|||
48800988|NCT01820559|157110293|FG002|Overall Study|At sponsor request|1|||
48595906|NCT02757352|156377788|FG003|Follow-Up Period|Withdrawal by Subject|0|||
48800989|NCT01820559|157110291|FG000|Overall Study|Lack of Efficacy|3|||
48800990|NCT01820559|157110292|FG001|Overall Study|Lack of Efficacy|2|||
48800991|NCT01820559|157110293|FG002|Overall Study|Lack of Efficacy|3|||
48800992|NCT03205371|157110294|FG000|Overall Study|Withdrawal by Subject|4|||
48800993|NCT03205371|157110295|FG001|Overall Study|Withdrawal by Subject|1|||
48800994|NCT03205371|157110296|FG002|Overall Study|Withdrawal by Subject|0|||
48800995|NCT03205371|157110297|FG003|Overall Study|Withdrawal by Subject|0|||
48800996|NCT03205371|157110298|FG004|Overall Study|Withdrawal by Subject|0|||
48800997|NCT03205371|157110299|FG005|Overall Study|Withdrawal by Subject|0|||
48800998|NCT03205371|157110300|FG006|Overall Study|Withdrawal by Subject|4|||
48800999|NCT03205371|157110301|FG007|Overall Study|Withdrawal by Subject|0|||
48801000|NCT03205371|157110302|FG008|Overall Study|Withdrawal by Subject|2|||
48801001|NCT03205371|157110303|FG009|Overall Study|Withdrawal by Subject|0|||
48801002|NCT03205371|157110304|FG010|Overall Study|Withdrawal by Subject|0|||
48801003|NCT03205371|157110305|FG011|Overall Study|Withdrawal by Subject|1|||
48801004|NCT03205371|157110294|FG000|Overall Study|Lost to Follow-up|0|||
48801005|NCT03205371|157110295|FG001|Overall Study|Lost to Follow-up|0|||
48801006|NCT03205371|157110296|FG002|Overall Study|Lost to Follow-up|0|||
48801007|NCT03205371|157110297|FG003|Overall Study|Lost to Follow-up|0|||
48801008|NCT03205371|157110298|FG004|Overall Study|Lost to Follow-up|0|||
48801009|NCT03205371|157110299|FG005|Overall Study|Lost to Follow-up|0|||
48801010|NCT03205371|157110300|FG006|Overall Study|Lost to Follow-up|5|||
48801011|NCT03205371|157110301|FG007|Overall Study|Lost to Follow-up|2|||
48801012|NCT03205371|157110302|FG008|Overall Study|Lost to Follow-up|3|||
48801013|NCT03205371|157110303|FG009|Overall Study|Lost to Follow-up|0|||
48801014|NCT03205371|157110304|FG010|Overall Study|Lost to Follow-up|0|||
48801015|NCT03205371|157110305|FG011|Overall Study|Lost to Follow-up|0|||
48801016|NCT03205371|157110294|FG000|Overall Study|Protocol Violation|0|||
48801017|NCT03205371|157110295|FG001|Overall Study|Protocol Violation|0|||
48801018|NCT03205371|157110296|FG002|Overall Study|Protocol Violation|0|||
48801019|NCT03205371|157110297|FG003|Overall Study|Protocol Violation|0|||
48801020|NCT03205371|157110298|FG004|Overall Study|Protocol Violation|0|||
48801021|NCT03205371|157110299|FG005|Overall Study|Protocol Violation|0|||
48595907|NCT02757352|156377789|FG004|Follow-Up Period|Withdrawal by Subject|0|||
48801022|NCT03205371|157110300|FG006|Overall Study|Protocol Violation|1|||
48801023|NCT03205371|157110301|FG007|Overall Study|Protocol Violation|0|||
48801024|NCT03205371|157110302|FG008|Overall Study|Protocol Violation|0|||
48595908|NCT02757352|156377790|FG005|Follow-Up Period|Withdrawal by Subject|0|||
48595909|NCT02757352|156377791|FG006|Follow-Up Period|Withdrawal by Subject|0|||
48707274|NCT02840461|156776005|FG001|Overall Study|Lost to Follow-up|7|||
48707275|NCT02840461|156776006|FG002|Overall Study|Lost to Follow-up|6|||
48707276|NCT02840461|156776004|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
48707277|NCT02840461|156776005|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
48707278|NCT02840461|156776006|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
48707279|NCT02840461|156776004|FG000|Overall Study|Protocol Violation|2|||
48707280|NCT02840461|156776005|FG001|Overall Study|Protocol Violation|3|||
48707281|NCT02840461|156776006|FG002|Overall Study|Protocol Violation|1|||
48707282|NCT02840461|156776004|FG000|Overall Study|Withdrawal by Subject|10|||
48707283|NCT02840461|156776005|FG001|Overall Study|Withdrawal by Subject|6|||
48707284|NCT02840461|156776006|FG002|Overall Study|Withdrawal by Subject|2|||
48707285|NCT02840461|156776004|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
48707286|NCT02840461|156776005|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
48707287|NCT02840461|156776006|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
48707288|NCT00721968|156776009|FG000|Overall Study|Lost to Follow-up|2|||
48707289|NCT00721968|156776010|FG001|Overall Study|Lost to Follow-up|0|||
48707290|NCT02970942|156776011|FG000|Overall Study|Death|0|||
48707291|NCT02970942|156776012|FG001|Overall Study|Death|1|||
48707292|NCT02970942|156776013|FG002|Overall Study|Death|0|||
48707293|NCT02970942|156776014|FG003|Overall Study|Death|0|||
48707294|NCT02970942|156776011|FG000|Overall Study|Lost to Follow-up|1|||
48707295|NCT02970942|156776012|FG001|Overall Study|Lost to Follow-up|0|||
48707296|NCT02970942|156776013|FG002|Overall Study|Lost to Follow-up|2|||
48707297|NCT02970942|156776014|FG003|Overall Study|Lost to Follow-up|1|||
48707298|NCT02970942|156776011|FG000|Overall Study|Withdrawal by Subject|3|||
48707299|NCT02970942|156776012|FG001|Overall Study|Withdrawal by Subject|5|||
48707300|NCT02970942|156776013|FG002|Overall Study|Withdrawal by Subject|3|||
48707301|NCT02970942|156776014|FG003|Overall Study|Withdrawal by Subject|2|||
48707302|NCT04328077|156777482|FG000|Overall Study|Lost to Follow-up|0|||
48707303|NCT04328077|156777483|FG001|Overall Study|Lost to Follow-up|1|||
48707304|NCT04328077|156777484|FG002|Overall Study|Lost to Follow-up|0|||
48707305|NCT04328077|156777485|FG003|Overall Study|Lost to Follow-up|0|||
48707306|NCT04328077|156777482|FG000|Overall Study|Withdrawal by Subject|0|||
48595910|NCT02757352|156377792|FG007|Follow-Up Period|Withdrawal by Subject|1|||
48707307|NCT04328077|156777483|FG001|Overall Study|Withdrawal by Subject|1|||
48707308|NCT04328077|156777484|FG002|Overall Study|Withdrawal by Subject|1|||
48707309|NCT04328077|156777485|FG003|Overall Study|Withdrawal by Subject|3|||
48707310|NCT01597596|156777486|FG000|Overall Study|Study terminated by sponsor|1|||
48490172|NCT01952574|155988870|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48595911|NCT02757352|156377793|FG008|Follow-Up Period|Withdrawal by Subject|6|||
48707311|NCT01597596|156777487|FG001|Overall Study|Study terminated by sponsor|0|||
48707312|NCT01597596|156777486|FG000|Overall Study|Physician Decision|0|||
48707313|NCT01597596|156777487|FG001|Overall Study|Physician Decision|1|||
48707314|NCT00939393|156777488|FG000|Overall Study|Withdrawal by Subject|1|||
48707315|NCT00939393|156777489|FG001|Overall Study|Withdrawal by Subject|0|||
48707316|NCT00939393|156777488|FG000|Overall Study|Lost to Follow-up|3|||
48707317|NCT00939393|156777489|FG001|Overall Study|Lost to Follow-up|0|||
48707318|NCT01399372|156777492|FG000|Overall Study|Protocol Violation|3|||
48707319|NCT01399372|156777493|FG001|Overall Study|Protocol Violation|1|||
48707320|NCT01376804|156777494|FG000|Treatment Period|Withdrawal by Subject|1|||
48707321|NCT01376804|156777494|FG000|Treatment Period|Adverse Event|6|||
48707322|NCT01376804|156777494|FG000|Treatment Period|Patient did not receive study drug|1|||
48707323|NCT00463567|156777497|FG000|Overall Study|Adverse Event|29|||
48707324|NCT00463567|156777498|FG001|Overall Study|Adverse Event|26|||
48707325|NCT00463567|156777499|FG002|Overall Study|Adverse Event|17|||
48707326|NCT00463567|156777500|FG003|Overall Study|Adverse Event|46|||
48707327|NCT00463567|156777501|FG004|Overall Study|Adverse Event|10|||
48707328|NCT00463567|156777502|FG005|Overall Study|Adverse Event|10|||
48707329|NCT00463567|156777503|FG006|Overall Study|Adverse Event|4|||
48707330|NCT00463567|156777497|FG000|Overall Study|Withdrawal by Subject|29|||
48707331|NCT00463567|156777498|FG001|Overall Study|Withdrawal by Subject|22|||
48707332|NCT00463567|156777499|FG002|Overall Study|Withdrawal by Subject|20|||
48707333|NCT00463567|156777500|FG003|Overall Study|Withdrawal by Subject|37|||
48707334|NCT00463567|156777501|FG004|Overall Study|Withdrawal by Subject|6|||
48707335|NCT00463567|156777502|FG005|Overall Study|Withdrawal by Subject|5|||
48707336|NCT00463567|156777503|FG006|Overall Study|Withdrawal by Subject|1|||
48707337|NCT00463567|156777497|FG000|Overall Study|Protocol Deviation|13|||
48707338|NCT00463567|156777498|FG001|Overall Study|Protocol Deviation|9|||
48707339|NCT00463567|156777499|FG002|Overall Study|Protocol Deviation|14|||
48707340|NCT00463567|156777500|FG003|Overall Study|Protocol Deviation|11|||
48707341|NCT00463567|156777501|FG004|Overall Study|Protocol Deviation|1|||
48707342|NCT00463567|156777502|FG005|Overall Study|Protocol Deviation|1|||
48707343|NCT00463567|156777503|FG006|Overall Study|Protocol Deviation|2|||
48707344|NCT00463567|156777497|FG000|Overall Study|Lost to Follow-up|12|||
48707345|NCT00463567|156777498|FG001|Overall Study|Lost to Follow-up|6|||
48707346|NCT00463567|156777499|FG002|Overall Study|Lost to Follow-up|13|||
48707347|NCT00463567|156777500|FG003|Overall Study|Lost to Follow-up|8|||
48707348|NCT00463567|156777501|FG004|Overall Study|Lost to Follow-up|1|||
48707349|NCT00463567|156777502|FG005|Overall Study|Lost to Follow-up|1|||
48707350|NCT00463567|156777503|FG006|Overall Study|Lost to Follow-up|1|||
48707351|NCT00463567|156777497|FG000|Overall Study|Administrative problems|5|||
48707352|NCT00463567|156777498|FG001|Overall Study|Administrative problems|3|||
48707353|NCT00463567|156777499|FG002|Overall Study|Administrative problems|6|||
48707354|NCT00463567|156777500|FG003|Overall Study|Administrative problems|9|||
48707355|NCT00463567|156777501|FG004|Overall Study|Administrative problems|3|||
48707356|NCT00463567|156777502|FG005|Overall Study|Administrative problems|2|||
48707357|NCT00463567|156777503|FG006|Overall Study|Administrative problems|2|||
48707358|NCT00463567|156777497|FG000|Overall Study|Lack of Efficacy|4|||
48707359|NCT00463567|156777498|FG001|Overall Study|Lack of Efficacy|9|||
48707360|NCT00463567|156777499|FG002|Overall Study|Lack of Efficacy|9|||
48707361|NCT00463567|156777500|FG003|Overall Study|Lack of Efficacy|17|||
48707362|NCT00463567|156777501|FG004|Overall Study|Lack of Efficacy|1|||
48707363|NCT00463567|156777502|FG005|Overall Study|Lack of Efficacy|0|||
48707364|NCT00463567|156777503|FG006|Overall Study|Lack of Efficacy|1|||
48707365|NCT00463567|156777497|FG000|Overall Study|Abnormal lab value(s)|1|||
48707366|NCT00463567|156777498|FG001|Overall Study|Abnormal lab value(s)|1|||
48707367|NCT00463567|156777499|FG002|Overall Study|Abnormal lab value(s)|2|||
48707368|NCT00463567|156777500|FG003|Overall Study|Abnormal lab value(s)|1|||
48707369|NCT00463567|156777501|FG004|Overall Study|Abnormal lab value(s)|1|||
48707370|NCT00463567|156777502|FG005|Overall Study|Abnormal lab value(s)|0|||
48707371|NCT00463567|156777503|FG006|Overall Study|Abnormal lab value(s)|0|||
48707372|NCT00463567|156777497|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48707373|NCT00463567|156777498|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48707374|NCT00463567|156777499|FG002|Overall Study|Abnormal test procedure result(s)|6|||
48707375|NCT00463567|156777500|FG003|Overall Study|Abnormal test procedure result(s)|2|||
48707376|NCT00463567|156777501|FG004|Overall Study|Abnormal test procedure result(s)|0|||
48707377|NCT00463567|156777502|FG005|Overall Study|Abnormal test procedure result(s)|2|||
48707378|NCT00463567|156777503|FG006|Overall Study|Abnormal test procedure result(s)|0|||
48707379|NCT00463567|156777497|FG000|Overall Study|Death|1|||
48707380|NCT00463567|156777498|FG001|Overall Study|Death|0|||
48707381|NCT00463567|156777499|FG002|Overall Study|Death|2|||
48707382|NCT00463567|156777500|FG003|Overall Study|Death|0|||
48707383|NCT00463567|156777501|FG004|Overall Study|Death|0|||
48707384|NCT00463567|156777502|FG005|Overall Study|Death|0|||
48707385|NCT00463567|156777503|FG006|Overall Study|Death|0|||
48707386|NCT01432730|156777504|FG000|Period 1|Adverse Event|2|||
48801025|NCT03205371|157110303|FG009|Overall Study|Protocol Violation|0|||
48801026|NCT03205371|157110304|FG010|Overall Study|Protocol Violation|0|||
48801027|NCT03205371|157110305|FG011|Overall Study|Protocol Violation|0|||
48801028|NCT03205371|157110294|FG000|Overall Study|Adverse Event|0|||
48801029|NCT03205371|157110295|FG001|Overall Study|Adverse Event|0|||
48801030|NCT03205371|157110296|FG002|Overall Study|Adverse Event|0|||
48801031|NCT03205371|157110297|FG003|Overall Study|Adverse Event|0|||
48801032|NCT03205371|157110298|FG004|Overall Study|Adverse Event|0|||
48801033|NCT03205371|157110299|FG005|Overall Study|Adverse Event|0|||
48801034|NCT03205371|157110300|FG006|Overall Study|Adverse Event|0|||
48801035|NCT03205371|157110301|FG007|Overall Study|Adverse Event|1|||
48801036|NCT03205371|157110302|FG008|Overall Study|Adverse Event|0|||
48801037|NCT03205371|157110303|FG009|Overall Study|Adverse Event|0|||
48801038|NCT03205371|157110304|FG010|Overall Study|Adverse Event|0|||
48801039|NCT03205371|157110305|FG011|Overall Study|Adverse Event|0|||
48801040|NCT03574597|157110312|FG000|Overall Study|Withdrawal by Subject|67|||
48801041|NCT03574597|157110313|FG001|Overall Study|Withdrawal by Subject|96|||
48801042|NCT03574597|157110312|FG000|Overall Study|Lost to Follow-up|192|||
48801043|NCT03574597|157110313|FG001|Overall Study|Lost to Follow-up|188|||
48801044|NCT02355743|157110314|FG000|Overall Study|Withdrawal by Subject|1|||
48801045|NCT02355743|157110314|FG000|Overall Study|Lost to Follow-up|1|||
48801046|NCT04247282|157110315|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
48801047|NCT04247282|157110316|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
48801048|NCT04247282|157110317|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
48801049|NCT04247282|157110318|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
48801050|NCT04247282|157110315|FG000|Overall Study|Refused further treatment|0|||
48801051|NCT04247282|157110316|FG001|Overall Study|Refused further treatment|1|||
48801052|NCT04247282|157110317|FG002|Overall Study|Refused further treatment|0|||
48801053|NCT04247282|157110318|FG003|Overall Study|Refused further treatment|0|||
48801054|NCT00386022|157110322|FG000|Plus Estrogen|Lost to Follow-up|2|||
48801055|NCT00386022|157110323|FG001|Plus Estrogen|Lost to Follow-up|0|||
48801056|NCT00386022|157110322|FG000|Plus Estrogen|Adverse Event|0|||
48801057|NCT00386022|157110323|FG001|Plus Estrogen|Adverse Event|1|||
48801058|NCT00724152|157110324|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
48801059|NCT00724152|157110325|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
48801060|NCT00724152|157110326|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
48801061|NCT00724152|157110324|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
48801062|NCT00724152|157110325|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
48801063|NCT00724152|157110326|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
48801064|NCT00295022|157110327|FG000|Overall Study|Adverse Event|1|||
48801065|NCT00295022|157110328|FG001|Overall Study|Adverse Event|1|||
48801066|NCT00295022|157110329|FG002|Overall Study|Adverse Event|2|||
48801067|NCT00295022|157110327|FG000|Overall Study|Lost to Follow-up|0|||
48801068|NCT00295022|157110328|FG001|Overall Study|Lost to Follow-up|0|||
48707387|NCT01432730|156777505|FG001|Period 1|Adverse Event|0|||
48707388|NCT01432730|156777504|FG000|Period 2|Adverse Event|0|||
48707389|NCT01432730|156777505|FG001|Period 2|Adverse Event|4|||
48707390|NCT00641667|156777508|FG000|Overall Study|Withdrawal by Subject|1|||
48707391|NCT00641667|156777508|FG000|Overall Study|Adverse Event|1|||
48707392|NCT00641667|156777508|FG000|Overall Study|Physician Decision|1|||
48707393|NCT00641667|156777508|FG000|Overall Study|Worsening of underlying disease|3|||
48707394|NCT01421719|156777509|FG000|Overall Study|Withdrawal by Subject|4|||
48707395|NCT03077412|156777518|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
48707396|NCT03077412|156777519|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
48707397|NCT03077412|156777520|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
48707398|NCT03077412|156777518|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
48707399|NCT03077412|156777519|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
48801069|NCT00295022|157110329|FG002|Overall Study|Lost to Follow-up|1|||
48801070|NCT00295022|157110327|FG000|Overall Study|Withdrawal by Subject|0|||
48801071|NCT00295022|157110328|FG001|Overall Study|Withdrawal by Subject|0|||
48801072|NCT00295022|157110329|FG002|Overall Study|Withdrawal by Subject|2|||
48801073|NCT02068495|157110332|FG000|Overall Study|Case Report Forms Uncollected|60|||
48801074|NCT02068495|157110332|FG000|Overall Study|Protocol Deviation|49|||
48801075|NCT00654901|157110335|FG000|Overall Study|Lost to Follow-up|1|||
48801076|NCT00654901|157110336|FG001|Overall Study|Lost to Follow-up|0|||
48801077|NCT00654901|157110337|FG002|Overall Study|Lost to Follow-up|1|||
48490173|NCT01952574|155988871|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48490174|NCT01952574|155988865|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
48490175|NCT01952574|155988866|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
48490176|NCT01952574|155988867|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
48490177|NCT01952574|155988868|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
48490178|NCT01952574|155988869|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
48801078|NCT00654901|157110338|FG003|Overall Study|Lost to Follow-up|0|||
48801079|NCT00654901|157110335|FG000|Overall Study|Withdrawal by Subject|3|||
48801080|NCT00654901|157110336|FG001|Overall Study|Withdrawal by Subject|0|||
48801081|NCT00654901|157110337|FG002|Overall Study|Withdrawal by Subject|1|||
48801082|NCT00654901|157110338|FG003|Overall Study|Withdrawal by Subject|0|||
48801083|NCT00779779|157110339|FG000|Overall Study|Adverse Event|1|||
48801084|NCT00779779|157110339|FG000|Overall Study|Protocol Violation|14|||
48801085|NCT00779779|157110339|FG000|Overall Study|Withdrawal by Subject|4|||
48801086|NCT00779779|157110339|FG000|Overall Study|Lost to Follow-up|5|||
48801087|NCT01412801|157110343|FG000|Overall Study|Death|0|||
48801088|NCT01412801|157110344|FG001|Overall Study|Death|1|||
48801089|NCT01412801|157110345|FG002|Overall Study|Death|0|||
48801090|NCT01412801|157110346|FG003|Overall Study|Death|4|||
48801091|NCT01412801|157110347|FG004|Overall Study|Death|2|||
48801092|NCT01412801|157110348|FG005|Overall Study|Death|2|||
48801093|NCT01412801|157110343|FG000|Overall Study|Lost to Follow-up|1|||
48801094|NCT01412801|157110344|FG001|Overall Study|Lost to Follow-up|2|||
48801095|NCT01412801|157110345|FG002|Overall Study|Lost to Follow-up|4|||
48801096|NCT01412801|157110346|FG003|Overall Study|Lost to Follow-up|0|||
48801097|NCT01412801|157110347|FG004|Overall Study|Lost to Follow-up|1|||
48801098|NCT01412801|157110348|FG005|Overall Study|Lost to Follow-up|1|||
48801099|NCT01412801|157110343|FG000|Overall Study|Withdrawal by Subject|3|||
48801100|NCT01412801|157110344|FG001|Overall Study|Withdrawal by Subject|2|||
48801101|NCT01412801|157110345|FG002|Overall Study|Withdrawal by Subject|1|||
48801102|NCT01412801|157110346|FG003|Overall Study|Withdrawal by Subject|0|||
48801103|NCT01412801|157110347|FG004|Overall Study|Withdrawal by Subject|0|||
48801104|NCT01412801|157110348|FG005|Overall Study|Withdrawal by Subject|0|||
48801105|NCT01412801|157110343|FG000|Overall Study|Relocated to another area|0|||
48801106|NCT01412801|157110344|FG001|Overall Study|Relocated to another area|0|||
48801107|NCT01412801|157110345|FG002|Overall Study|Relocated to another area|2|||
48801108|NCT01412801|157110346|FG003|Overall Study|Relocated to another area|0|||
48801109|NCT01412801|157110347|FG004|Overall Study|Relocated to another area|0|||
48801110|NCT01412801|157110348|FG005|Overall Study|Relocated to another area|0|||
48801111|NCT02296190|157110349|FG000|Overall Study|Lost to Follow-up|0|||
48801112|NCT02296190|157110350|FG001|Overall Study|Lost to Follow-up|0|||
48801113|NCT02296190|157110351|FG002|Overall Study|Lost to Follow-up|0|||
48801114|NCT02296190|157110352|FG003|Overall Study|Lost to Follow-up|0|||
48801115|NCT02296190|157110353|FG004|Overall Study|Lost to Follow-up|1|||
48801116|NCT02296190|157110354|FG005|Overall Study|Lost to Follow-up|0|||
48801117|NCT02296190|157110349|FG000|Overall Study|Failure to induce PSVT|6|||
48801118|NCT02296190|157110350|FG001|Overall Study|Failure to induce PSVT|10|||
48801119|NCT02296190|157110351|FG002|Overall Study|Failure to induce PSVT|5|||
48801120|NCT02296190|157110352|FG003|Overall Study|Failure to induce PSVT|13|||
48801121|NCT02296190|157110353|FG004|Overall Study|Failure to induce PSVT|8|||
48801122|NCT02296190|157110354|FG005|Overall Study|Failure to induce PSVT|0|||
48801123|NCT02296190|157110349|FG000|Overall Study|Physician Decision|1|||
48801124|NCT02296190|157110350|FG001|Overall Study|Physician Decision|1|||
48801125|NCT02296190|157110351|FG002|Overall Study|Physician Decision|0|||
48801126|NCT02296190|157110352|FG003|Overall Study|Physician Decision|1|||
48801127|NCT02296190|157110353|FG004|Overall Study|Physician Decision|2|||
48801128|NCT02296190|157110354|FG005|Overall Study|Physician Decision|0|||
48801129|NCT02296190|157110349|FG000|Overall Study|Withdrawal by Subject|0|||
48801130|NCT02296190|157110350|FG001|Overall Study|Withdrawal by Subject|1|||
48801131|NCT02296190|157110351|FG002|Overall Study|Withdrawal by Subject|0|||
48801132|NCT02296190|157110352|FG003|Overall Study|Withdrawal by Subject|0|||
48801133|NCT02296190|157110353|FG004|Overall Study|Withdrawal by Subject|0|||
48801134|NCT02296190|157110354|FG005|Overall Study|Withdrawal by Subject|0|||
48801135|NCT02296190|157110349|FG000|Overall Study|PSVT < 5 minutes|5|||
48801136|NCT02296190|157110350|FG001|Overall Study|PSVT < 5 minutes|6|||
48801137|NCT02296190|157110351|FG002|Overall Study|PSVT < 5 minutes|6|||
48801138|NCT02296190|157110352|FG003|Overall Study|PSVT < 5 minutes|6|||
48801139|NCT02296190|157110353|FG004|Overall Study|PSVT < 5 minutes|5|||
48801140|NCT02296190|157110354|FG005|Overall Study|PSVT < 5 minutes|0|||
48801141|NCT02296190|157110349|FG000|Overall Study|Patient was given Propofol|0|||
48801142|NCT02296190|157110350|FG001|Overall Study|Patient was given Propofol|1|||
48801143|NCT02296190|157110351|FG002|Overall Study|Patient was given Propofol|0|||
48801144|NCT02296190|157110352|FG003|Overall Study|Patient was given Propofol|1|||
48801145|NCT02296190|157110353|FG004|Overall Study|Patient was given Propofol|0|||
48801146|NCT02296190|157110354|FG005|Overall Study|Patient was given Propofol|0|||
48801147|NCT02296190|157110349|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
48801148|NCT02296190|157110350|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
48801149|NCT02296190|157110351|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
48801150|NCT02296190|157110352|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
48801151|NCT02296190|157110353|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
48801152|NCT02296190|157110354|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
48801153|NCT02296190|157110349|FG000|Overall Study|Blood pressure <100 after sedation|0|||
48801154|NCT02296190|157110350|FG001|Overall Study|Blood pressure <100 after sedation|0|||
48801155|NCT02296190|157110351|FG002|Overall Study|Blood pressure <100 after sedation|0|||
48801156|NCT02296190|157110352|FG003|Overall Study|Blood pressure <100 after sedation|1|||
48801157|NCT02296190|157110353|FG004|Overall Study|Blood pressure <100 after sedation|0|||
48801158|NCT02296190|157110354|FG005|Overall Study|Blood pressure <100 after sedation|0|||
48801159|NCT02296190|157110349|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
48801160|NCT02296190|157110350|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
48801161|NCT02296190|157110351|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
48801162|NCT02296190|157110352|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
48801163|NCT02296190|157110353|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
48801164|NCT02296190|157110354|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
48801165|NCT02296190|157110349|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
48801166|NCT02296190|157110350|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
48801167|NCT02296190|157110351|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
48801168|NCT02296190|157110352|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
48801169|NCT02296190|157110353|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
48801170|NCT02296190|157110354|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
48801171|NCT02296190|157110349|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801172|NCT02296190|157110350|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
48801173|NCT02296190|157110351|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801174|NCT02296190|157110352|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801175|NCT02296190|157110353|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801176|NCT02296190|157110354|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
48801177|NCT02296190|157110349|FG000|Overall Study|Lab result not available in time|1|||
48801178|NCT02296190|157110350|FG001|Overall Study|Lab result not available in time|0|||
48801179|NCT02296190|157110351|FG002|Overall Study|Lab result not available in time|0|||
48801180|NCT02296190|157110352|FG003|Overall Study|Lab result not available in time|0|||
48801181|NCT02296190|157110353|FG004|Overall Study|Lab result not available in time|0|||
48801182|NCT02296190|157110354|FG005|Overall Study|Lab result not available in time|0|||
48801183|NCT02178566|157110355|FG000|Overall Study|patient did not complete due to noncompliance|0|||
48801184|NCT02178566|157110356|FG001|Overall Study|patient did not complete due to noncompliance|1|||
48801185|NCT02658630|157110359|FG000|Overall Study|Withdrawal by Subject|4|||
48801186|NCT00085202|157110360|FG000|Overall Study|Still on therapy|2|||
48801187|NCT00085202|157110361|FG001|Overall Study|Still on therapy|0|||
48801188|NCT00085202|157110360|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
48801189|NCT00085202|157110361|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
48801190|NCT00085202|157110360|FG000|Overall Study|Excessive toxicity|6|||
48801191|NCT00085202|157110361|FG001|Overall Study|Excessive toxicity|5|||
48801192|NCT00085202|157110360|FG000|Overall Study|Non-specified|3|||
48801193|NCT00085202|157110361|FG001|Overall Study|Non-specified|5|||
48801194|NCT00085202|157110360|FG000|Overall Study|Withdrawal by Subject|2|||
48801195|NCT00085202|157110361|FG001|Overall Study|Withdrawal by Subject|1|||
48801196|NCT00085202|157110360|FG000|Overall Study|Physician Decision|4|||
48801197|NCT00085202|157110361|FG001|Overall Study|Physician Decision|1|||
48801198|NCT00085202|157110360|FG000|Overall Study|Progressive disease|1|||
48801199|NCT00085202|157110361|FG001|Overall Study|Progressive disease|11|||
48801200|NCT00394355|157110362|FG000|Overall Study|Adverse Event|10|||
48801201|NCT00394355|157110363|FG001|Overall Study|Adverse Event|6|||
48801202|NCT00394355|157110364|FG002|Overall Study|Adverse Event|7|||
48801203|NCT00394355|157110365|FG003|Overall Study|Adverse Event|8|||
48801204|NCT00394355|157110362|FG000|Overall Study|Did not meet protocol eligibility|1|||
48801205|NCT00394355|157110363|FG001|Overall Study|Did not meet protocol eligibility|5|||
48801206|NCT00394355|157110364|FG002|Overall Study|Did not meet protocol eligibility|4|||
48801207|NCT00394355|157110365|FG003|Overall Study|Did not meet protocol eligibility|2|||
48801208|NCT00394355|157110362|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
48801209|NCT00394355|157110363|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
48801210|NCT00394355|157110364|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
48801211|NCT00394355|157110365|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
48801212|NCT00394355|157110362|FG000|Overall Study|Subject withdrawal - related to drug|1|||
48801213|NCT00394355|157110363|FG001|Overall Study|Subject withdrawal - related to drug|0|||
48801214|NCT00394355|157110364|FG002|Overall Study|Subject withdrawal - related to drug|0|||
48801215|NCT00394355|157110365|FG003|Overall Study|Subject withdrawal - related to drug|0|||
48801216|NCT00394355|157110362|FG000|Overall Study|Lost to Follow-up|7|||
48801217|NCT00394355|157110363|FG001|Overall Study|Lost to Follow-up|5|||
48801218|NCT00394355|157110364|FG002|Overall Study|Lost to Follow-up|4|||
48801219|NCT00394355|157110365|FG003|Overall Study|Lost to Follow-up|3|||
48801220|NCT00394355|157110362|FG000|Overall Study|Noncompliance with protocol|4|||
48801221|NCT00394355|157110363|FG001|Overall Study|Noncompliance with protocol|3|||
48801222|NCT00394355|157110364|FG002|Overall Study|Noncompliance with protocol|10|||
48801223|NCT00394355|157110365|FG003|Overall Study|Noncompliance with protocol|8|||
48801224|NCT00394355|157110362|FG000|Overall Study|Administrative|0|||
48801225|NCT00394355|157110363|FG001|Overall Study|Administrative|1|||
48801226|NCT00394355|157110364|FG002|Overall Study|Administrative|1|||
48801227|NCT00394355|157110365|FG003|Overall Study|Administrative|1|||
48801228|NCT00394355|157110362|FG000|Overall Study|Lack of Efficacy|0|||
48801229|NCT00394355|157110363|FG001|Overall Study|Lack of Efficacy|0|||
48707400|NCT03077412|156777520|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
48707401|NCT03077412|156777518|FG000|Overall Study|Adverse Event|1|||
48707402|NCT03077412|156777519|FG001|Overall Study|Adverse Event|2|||
48707403|NCT03077412|156777520|FG002|Overall Study|Adverse Event|2|||
48707404|NCT03077412|156777518|FG000|Overall Study|Investigator's Discretion|0|||
48707405|NCT03077412|156777519|FG001|Overall Study|Investigator's Discretion|1|||
48707406|NCT03077412|156777520|FG002|Overall Study|Investigator's Discretion|1|||
48707407|NCT03077412|156777518|FG000|Overall Study|Withdrew Consent|0|||
48707408|NCT03077412|156777519|FG001|Overall Study|Withdrew Consent|2|||
48707409|NCT03077412|156777520|FG002|Overall Study|Withdrew Consent|0|||
48707410|NCT03436082|156777525|FG000|Overall Study|Did not undergo procedure|1|||
48707411|NCT03436082|156777526|FG001|Overall Study|Did not undergo procedure|0|||
48707412|NCT04646044|156777529|FG000|Overall Study|Lost to Follow-up|0|||
48707413|NCT04646044|156777530|FG001|Overall Study|Lost to Follow-up|0|||
48707414|NCT04646044|156777531|FG002|Overall Study|Lost to Follow-up|1|||
48707415|NCT04646044|156777532|FG003|Overall Study|Lost to Follow-up|0|||
48707416|NCT04646044|156777529|FG000|Overall Study|Withdrawal by Subject|0|||
48707417|NCT04646044|156777530|FG001|Overall Study|Withdrawal by Subject|1|||
48707418|NCT04646044|156777531|FG002|Overall Study|Withdrawal by Subject|0|||
48707419|NCT04646044|156777532|FG003|Overall Study|Withdrawal by Subject|0|||
48707420|NCT01938716|156777533|FG000|Overall Study|Physician Decision|2|||
48707421|NCT01938716|156777533|FG000|Overall Study|Withdrawal by Subject|2|||
48707422|NCT01657019|156777534|FG000|Overall Study|Withdrawal by Subject|65|||
48707423|NCT01657019|156777534|FG000|Overall Study|Adverse Event|55|||
48707424|NCT01657019|156777534|FG000|Overall Study|Lost to Follow-up|48|||
48707425|NCT01657019|156777534|FG000|Overall Study|Protocol Violation|6|||
48707426|NCT01657019|156777534|FG000|Overall Study|Lack of Efficacy|3|||
48707427|NCT01657019|156777534|FG000|Overall Study|Other|58|||
48707428|NCT01750229|156777535|FG000|Randomized Crossover Phase|Adverse Event|1|||
48707429|NCT01750229|156777535|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
48707430|NCT01750229|156777535|FG000|Long-term Follow-up Phase|Adverse Event|2|||
48707431|NCT01750229|156777535|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
48707432|NCT01092546|156777536|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
48707433|NCT02578706|156777539|FG000|Overall Study|Withdrawal by Subject|1|||
48707434|NCT02578706|156777540|FG001|Overall Study|Withdrawal by Subject|0|||
48707435|NCT02578706|156777541|FG002|Overall Study|Withdrawal by Subject|0|||
48707436|NCT02578706|156777539|FG000|Overall Study|Lost to Follow-up|0|||
48707437|NCT02578706|156777540|FG001|Overall Study|Lost to Follow-up|4|||
48707438|NCT02578706|156777541|FG002|Overall Study|Lost to Follow-up|0|||
48707439|NCT02578706|156777539|FG000|Overall Study|Physician Decision|0|||
48707440|NCT02578706|156777540|FG001|Overall Study|Physician Decision|1|||
48707441|NCT02578706|156777541|FG002|Overall Study|Physician Decision|0|||
48707442|NCT04396639|156777542|FG000|Overall Study|Withdrawal by Subject|1|||
48707443|NCT04396639|156777542|FG000|Overall Study|Other|1|||
48707444|NCT00885170|156777543|FG000|Overall Study|Adverse Event|12|||
48707445|NCT00885170|156777544|FG001|Overall Study|Adverse Event|4|||
48707446|NCT00885170|156777543|FG000|Overall Study|Excessive bone loss|6|||
48707447|NCT00885170|156777544|FG001|Overall Study|Excessive bone loss|3|||
48707448|NCT00885170|156777543|FG000|Overall Study|Lost to Follow-up|2|||
48801230|NCT00394355|157110364|FG002|Overall Study|Lack of Efficacy|2|||
48801231|NCT00394355|157110365|FG003|Overall Study|Lack of Efficacy|3|||
48801232|NCT02686034|157110370|FG000|Run-In Period 1|Eligibility|12|||
48801233|NCT02686034|157110371|FG001|Run-In Period 1|Eligibility|10|||
48801234|NCT02686034|157110370|FG000|Run-In Period 1|Withdrawal by Subject|4|||
48707449|NCT00885170|156777544|FG001|Overall Study|Lost to Follow-up|1|||
48707450|NCT00885170|156777543|FG000|Overall Study|Physician Decision|2|||
48707451|NCT00885170|156777544|FG001|Overall Study|Physician Decision|1|||
48707452|NCT00885170|156777543|FG000|Overall Study|Protocol Violation|3|||
48707453|NCT00885170|156777544|FG001|Overall Study|Protocol Violation|1|||
48707454|NCT00885170|156777543|FG000|Overall Study|Withdrawal by Subject|13|||
48707455|NCT00885170|156777544|FG001|Overall Study|Withdrawal by Subject|13|||
48707456|NCT02454517|156777545|FG000|Overall Study|Withdrawal by Subject|3|||
48707457|NCT02454517|156777546|FG001|Overall Study|Withdrawal by Subject|0|||
48707458|NCT02454517|156777545|FG000|Overall Study|Lost to Follow-up|4|||
48707459|NCT02454517|156777546|FG001|Overall Study|Lost to Follow-up|7|||
48801235|NCT02686034|157110371|FG001|Run-In Period 1|Withdrawal by Subject|3|||
48595912|NCT02757352|156377794|FG009|Follow-Up Period|Withdrawal by Subject|2|||
48595913|NCT04999085|156377795|FG000|Overall Study|Death|1|||
48595914|NCT00497146|156377796|FG000|Treatment Period|Adverse Event|6|||
48595915|NCT00497146|156377797|FG001|Treatment Period|Adverse Event|2|||
48595916|NCT00497146|156377796|FG000|Treatment Period|Withdrawal by Subject|5|||
48595917|NCT00497146|156377797|FG001|Treatment Period|Withdrawal by Subject|9|||
48595918|NCT00497146|156377796|FG000|Treatment Period|Lost to Follow-up|1|||
48595919|NCT00497146|156377797|FG001|Treatment Period|Lost to Follow-up|3|||
48595920|NCT00497146|156377796|FG000|Treatment Period|Required dialysis|4|||
48595921|NCT00497146|156377797|FG001|Treatment Period|Required dialysis|1|||
48595922|NCT00497146|156377796|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
48707460|NCT02454517|156777545|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
48707461|NCT02454517|156777546|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
48707462|NCT01254422|156777549|FG000|Overall Study|Protocol Violation|1|||
48707463|NCT01254422|156777550|FG001|Overall Study|Protocol Violation|0|||
48707464|NCT01254422|156777549|FG000|Overall Study|Adverse Event|1|||
48707465|NCT01254422|156777550|FG001|Overall Study|Adverse Event|0|||
48707466|NCT01254422|156777549|FG000|Overall Study|Serious adverse event|0|||
48707467|NCT01254422|156777550|FG001|Overall Study|Serious adverse event|1|||
48707468|NCT01254422|156777549|FG000|Overall Study|Lost to Follow-up|1|||
48707469|NCT01254422|156777550|FG001|Overall Study|Lost to Follow-up|0|||
48707470|NCT00953056|156777553|FG000|Overall Study|Withdrew Consent|0|||
48707471|NCT00953056|156777554|FG001|Overall Study|Withdrew Consent|0|||
48707472|NCT00953056|156777555|FG002|Overall Study|Withdrew Consent|0|||
48707473|NCT00953056|156777556|FG003|Overall Study|Withdrew Consent|0|||
48707474|NCT00953056|156777557|FG004|Overall Study|Withdrew Consent|2|||
48707475|NCT00953056|156777558|FG005|Overall Study|Withdrew Consent|3|||
48707476|NCT00953056|156777553|FG000|Overall Study|Serious Adverse Event|0|||
48707477|NCT00953056|156777554|FG001|Overall Study|Serious Adverse Event|0|||
48707478|NCT00953056|156777555|FG002|Overall Study|Serious Adverse Event|0|||
48707479|NCT00953056|156777556|FG003|Overall Study|Serious Adverse Event|0|||
48707480|NCT00953056|156777557|FG004|Overall Study|Serious Adverse Event|0|||
48707481|NCT00953056|156777558|FG005|Overall Study|Serious Adverse Event|1|||
48707482|NCT01598506|156777559|FG000|Overall Study|Withdrawal by Subject|2|||
48707483|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
48707484|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
48707485|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
48707486|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
48707487|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48707488|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
48707489|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
48707490|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
48707491|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
48707492|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
48707493|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
48707494|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
48707495|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
48707496|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
48707497|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
48707498|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
48707499|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
48801236|NCT02686034|157110370|FG000|Run-In Period 1|Lost to Follow-up|4|||
48595923|NCT00497146|156377797|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
48595924|NCT00497146|156377796|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
48595925|NCT00497146|156377797|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
48595926|NCT00497146|156377796|FG000|Treatment Period|Other Reason|2|||
48595927|NCT00497146|156377797|FG001|Treatment Period|Other Reason|3|||
48595928|NCT00497146|156377796|FG000|Long-term Follow-up Period|Adverse Event|2|||
48433896|NCT03213626|155777243|FG000|Overall Study|Progressive Disease|6|||
48595929|NCT00497146|156377797|FG001|Long-term Follow-up Period|Adverse Event|2|||
48595930|NCT00497146|156377796|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
48595931|NCT00497146|156377797|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
48595932|NCT00497146|156377796|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
48707500|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
48707501|NCT03739203|156777560|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
48707502|NCT03739203|156777561|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
48707503|NCT03739203|156777562|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
48707504|NCT03739203|156777560|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
48707505|NCT03739203|156777561|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
48707506|NCT03739203|156777562|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
48707507|NCT03739203|156777560|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
48707508|NCT03739203|156777561|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
48707509|NCT03739203|156777562|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
48707510|NCT03739203|156777560|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
48707511|NCT03739203|156777561|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
48707512|NCT03739203|156777562|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
48707513|NCT03739203|156777560|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
48707514|NCT03739203|156777561|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
48707515|NCT03739203|156777562|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
48707516|NCT01077076|156777565|FG000|First Intervention|Withdrawal by Subject|1|||
48707517|NCT01077076|156777566|FG001|First Intervention|Withdrawal by Subject|0|||
48707518|NCT01077076|156777567|FG002|First Intervention|Withdrawal by Subject|0|||
48707519|NCT01077076|156777568|FG003|First Intervention|Withdrawal by Subject|0|||
48707520|NCT01077076|156777569|FG004|First Intervention|Withdrawal by Subject|0|||
48707521|NCT01077076|156777570|FG005|First Intervention|Withdrawal by Subject|0|||
48707522|NCT01077076|156777565|FG000|Third Intervention|Death in the participant's family|0|||
48707523|NCT01077076|156777566|FG001|Third Intervention|Death in the participant's family|0|||
48707524|NCT01077076|156777567|FG002|Third Intervention|Death in the participant's family|0|||
48707525|NCT01077076|156777568|FG003|Third Intervention|Death in the participant's family|0|||
48707526|NCT01077076|156777569|FG004|Third Intervention|Death in the participant's family|0|||
48707527|NCT01077076|156777570|FG005|Third Intervention|Death in the participant's family|1|||
48707528|NCT03710161|156777575|FG000|Overall Study|Study halted due to COVID pandemic|3|||
48707529|NCT03710161|156777576|FG001|Overall Study|Study halted due to COVID pandemic|2|||
48707530|NCT00363480|156777578|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
48707531|NCT00363480|156777578|FG000|Overall Study|Adverse Event|4|||
48707532|NCT00363480|156777578|FG000|Overall Study|Lost to Follow-up|5|||
48707533|NCT00363480|156777578|FG000|Overall Study|Withdrawal by Subject|5|||
48707534|NCT00363480|156777578|FG000|Overall Study|Non-compliance of subject|1|||
48707535|NCT00363480|156777578|FG000|Overall Study|Participant discontinued on its own|1|||
48707536|NCT01301027|156777579|FG000|Overall Study|Physician Decision|2|||
48707537|NCT01301027|156777580|FG001|Overall Study|Physician Decision|0|||
48595933|NCT00497146|156377797|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
48595934|NCT00497146|156377796|FG000|Long-term Follow-up Period|Other|0|||
48595935|NCT00497146|156377797|FG001|Long-term Follow-up Period|Other|1|||
48595936|NCT02155309|156377800|FG000|Overall Study|Protocol Violation|0|||
48595937|NCT02155309|156377801|FG001|Overall Study|Protocol Violation|0|||
48595938|NCT02155309|156377802|FG002|Overall Study|Protocol Violation|1|||
48595939|NCT04304508|156377803|FG000|Overall Study|Subject Decision|29|||
48595940|NCT04304508|156377804|FG001|Overall Study|Subject Decision|39|||
48595941|NCT04304508|156377805|FG002|Overall Study|Subject Decision|37|||
48707538|NCT01301027|156777579|FG000|Overall Study|Withdrawal by Subject|2|||
48707539|NCT01301027|156777580|FG001|Overall Study|Withdrawal by Subject|3|||
48707540|NCT01301027|156777579|FG000|Overall Study|Adverse Event|0|||
48707541|NCT01301027|156777580|FG001|Overall Study|Adverse Event|2|||
48707542|NCT01301027|156777579|FG000|Overall Study|Fracture|1|||
48707543|NCT01301027|156777580|FG001|Overall Study|Fracture|3|||
48707544|NCT01301027|156777579|FG000|Overall Study|Transplant|0|||
48707545|NCT01301027|156777580|FG001|Overall Study|Transplant|2|||
48707546|NCT01301027|156777579|FG000|Overall Study|Volume Overload|3|||
48707547|NCT01301027|156777580|FG001|Overall Study|Volume Overload|0|||
48707548|NCT00541385|156777581|FG000|Overall Study|Adverse Event|6|||
48707549|NCT00541385|156777582|FG001|Overall Study|Adverse Event|3|||
48707550|NCT00541385|156777581|FG000|Overall Study|Withdrawal by Subject|2|||
48707551|NCT00541385|156777582|FG001|Overall Study|Withdrawal by Subject|2|||
48595942|NCT04304508|156377806|FG003|Overall Study|Subject Decision|48|||
48595943|NCT04304508|156377803|FG000|Overall Study|Death|6|||
48595944|NCT04304508|156377804|FG001|Overall Study|Death|1|||
48801237|NCT02686034|157110371|FG001|Run-In Period 1|Lost to Follow-up|4|||
48595945|NCT04304508|156377805|FG002|Overall Study|Death|8|||
48801238|NCT02686034|157110370|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
48801239|NCT02686034|157110371|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
48801240|NCT02686034|157110370|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
48801241|NCT02686034|157110371|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
48801242|NCT02686034|157110370|FG000|Randomized Controlled Period 2|Adverse Event|0|||
48801243|NCT02686034|157110371|FG001|Randomized Controlled Period 2|Adverse Event|2|||
48801244|NCT02686034|157110370|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
48801245|NCT02686034|157110371|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
48801246|NCT02686034|157110370|FG000|Open Label Period 3|Lost to Follow-up|0|||
48801247|NCT02686034|157110371|FG001|Open Label Period 3|Lost to Follow-up|1|||
48801248|NCT02636270|157110372|FG000|Overall Study|Adverse Event|1|||
48801249|NCT02636270|157110373|FG001|Overall Study|Adverse Event|0|||
48801250|NCT02636270|157110374|FG002|Overall Study|Adverse Event|0|||
48801251|NCT02636270|157110372|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
48801252|NCT02636270|157110373|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
48801253|NCT02636270|157110374|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
48801254|NCT01678131|157110375|FG000|Overall Study|Adverse Event|0|||
48801255|NCT01678131|157110376|FG001|Overall Study|Adverse Event|1|||
48801256|NCT01678131|157110377|FG002|Overall Study|Adverse Event|0|||
48801257|NCT01678131|157110375|FG000|Overall Study|Withdrawal by Subject|0|||
48801258|NCT01678131|157110376|FG001|Overall Study|Withdrawal by Subject|0|||
48801259|NCT01678131|157110377|FG002|Overall Study|Withdrawal by Subject|2|||
48801260|NCT00982930|157110382|FG000|Overall Study|Adverse Event|1|||
48801261|NCT00982930|157110382|FG000|Overall Study|Withdrawal by Subject|1|||
48801262|NCT00982930|157110382|FG000|Overall Study|Administrative Problems|2|||
48801263|NCT00552084|157110383|FG000|Overall Study|Adverse Event|2|||
48801264|NCT00552084|157110384|FG001|Overall Study|Adverse Event|3|||
48801265|NCT00552084|157110383|FG000|Overall Study|Withdrawal by Subject|4|||
48801266|NCT00552084|157110384|FG001|Overall Study|Withdrawal by Subject|5|||
48801267|NCT00552084|157110383|FG000|Overall Study|Protocol Violation|1|||
48801268|NCT00552084|157110384|FG001|Overall Study|Protocol Violation|0|||
48801269|NCT00552084|157110383|FG000|Overall Study|change in anti-arrythmic drug|1|||
48801270|NCT00552084|157110384|FG001|Overall Study|change in anti-arrythmic drug|1|||
48801271|NCT02946918|157110385|FG000|Overall Study|Patient unblinded himself|1|||
48801272|NCT02946918|157110386|FG001|Overall Study|Patient unblinded himself|0|||
48801273|NCT02946918|157110385|FG000|Overall Study|Physician Decision|0|||
48801274|NCT02946918|157110386|FG001|Overall Study|Physician Decision|2|||
48801275|NCT02946918|157110385|FG000|Overall Study|Ran out of study medication|0|||
48801276|NCT02946918|157110386|FG001|Overall Study|Ran out of study medication|1|||
48801277|NCT02969525|157110387|FG000|Double-Blind Period|Adverse Event|0|||
48801278|NCT02969525|157110388|FG001|Double-Blind Period|Adverse Event|0|||
48801279|NCT02969525|157110389|FG002|Double-Blind Period|Adverse Event|1|||
48801280|NCT02969525|157110390|FG003|Double-Blind Period|Adverse Event|1|||
48801281|NCT02969525|157110391|FG004|Double-Blind Period|Adverse Event|0|||
48801282|NCT02969525|157110392|FG005|Double-Blind Period|Adverse Event|0|||
48801283|NCT02969525|157110393|FG006|Double-Blind Period|Adverse Event|0|||
48801284|NCT02969525|157110394|FG007|Double-Blind Period|Adverse Event|0|||
48801285|NCT02969525|157110395|FG008|Double-Blind Period|Adverse Event|0|||
48801286|NCT02969525|157110396|FG009|Double-Blind Period|Adverse Event|0|||
48801287|NCT02969525|157110397|FG010|Double-Blind Period|Adverse Event|0|||
48801288|NCT02969525|157110398|FG011|Double-Blind Period|Adverse Event|0|||
48801289|NCT02969525|157110387|FG000|Double-Blind Period|LOW EGFR|0|||
48801290|NCT02969525|157110388|FG001|Double-Blind Period|LOW EGFR|0|||
48801291|NCT02969525|157110389|FG002|Double-Blind Period|LOW EGFR|0|||
48801292|NCT02969525|157110390|FG003|Double-Blind Period|LOW EGFR|1|||
48801293|NCT02969525|157110391|FG004|Double-Blind Period|LOW EGFR|0|||
48801294|NCT02969525|157110392|FG005|Double-Blind Period|LOW EGFR|0|||
48801295|NCT02969525|157110393|FG006|Double-Blind Period|LOW EGFR|0|||
48801296|NCT02969525|157110394|FG007|Double-Blind Period|LOW EGFR|0|||
48801297|NCT02969525|157110395|FG008|Double-Blind Period|LOW EGFR|0|||
48801298|NCT02969525|157110396|FG009|Double-Blind Period|LOW EGFR|0|||
48801299|NCT02969525|157110397|FG010|Double-Blind Period|LOW EGFR|0|||
48801300|NCT02969525|157110398|FG011|Double-Blind Period|LOW EGFR|0|||
48801301|NCT02969525|157110387|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
48801302|NCT02969525|157110388|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801303|NCT02969525|157110389|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801304|NCT02969525|157110390|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
48801305|NCT02969525|157110391|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801306|NCT02969525|157110392|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801307|NCT02969525|157110393|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801308|NCT02969525|157110394|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801309|NCT02969525|157110395|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801310|NCT02969525|157110396|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801311|NCT02969525|157110397|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801312|NCT02969525|157110398|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
48801313|NCT02969525|157110387|FG000|Dose-Blind Period|Adverse Event|0|||
48801314|NCT02969525|157110388|FG001|Dose-Blind Period|Adverse Event|0|||
48801315|NCT02969525|157110389|FG002|Dose-Blind Period|Adverse Event|0|||
48801316|NCT02969525|157110390|FG003|Dose-Blind Period|Adverse Event|0|||
48801317|NCT02969525|157110391|FG004|Dose-Blind Period|Adverse Event|0|||
48801318|NCT02969525|157110392|FG005|Dose-Blind Period|Adverse Event|0|||
48801319|NCT02969525|157110393|FG006|Dose-Blind Period|Adverse Event|0|||
48801320|NCT02969525|157110394|FG007|Dose-Blind Period|Adverse Event|0|||
48801321|NCT02969525|157110395|FG008|Dose-Blind Period|Adverse Event|0|||
48801322|NCT02969525|157110396|FG009|Dose-Blind Period|Adverse Event|1|||
48801323|NCT02969525|157110397|FG010|Dose-Blind Period|Adverse Event|1|||
48801324|NCT02969525|157110398|FG011|Dose-Blind Period|Adverse Event|1|||
48801325|NCT02969525|157110387|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
48801326|NCT02969525|157110388|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
48801327|NCT02969525|157110389|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
48801328|NCT02969525|157110390|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
48801329|NCT02969525|157110391|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
48801330|NCT02969525|157110392|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
48801331|NCT02969525|157110393|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
48801332|NCT02969525|157110394|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
48801333|NCT02969525|157110395|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
48801334|NCT02969525|157110396|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
48801335|NCT02969525|157110397|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
48707552|NCT00541385|156777581|FG000|Overall Study|Lost to Follow-up|6|||
48707553|NCT00541385|156777582|FG001|Overall Study|Lost to Follow-up|1|||
48707554|NCT00541385|156777581|FG000|Overall Study|Parasite reappearance/malaria|67|||
48707555|NCT00541385|156777582|FG001|Overall Study|Parasite reappearance/malaria|32|||
48707556|NCT01469377|156777583|FG000|Overall Study|Protocol Deviation|7|||
48707557|NCT01469377|156777584|FG001|Overall Study|Protocol Deviation|10|||
48707558|NCT01469377|156777585|FG002|Overall Study|Protocol Deviation|10|||
48707559|NCT01469377|156777583|FG000|Overall Study|Lost to Follow-up|3|||
48707560|NCT01469377|156777584|FG001|Overall Study|Lost to Follow-up|2|||
48707561|NCT01469377|156777585|FG002|Overall Study|Lost to Follow-up|5|||
48707562|NCT01469377|156777583|FG000|Overall Study|Withdrawal of Consent|12|||
48707563|NCT01469377|156777584|FG001|Overall Study|Withdrawal of Consent|14|||
48707564|NCT01469377|156777585|FG002|Overall Study|Withdrawal of Consent|15|||
48707565|NCT01469377|156777583|FG000|Overall Study|Adverse Event|8|||
48801336|NCT02969525|157110398|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
48801337|NCT02969525|157110387|FG000|Dose-Blind Period|Non-cooperating patient|0|||
48707566|NCT01469377|156777584|FG001|Overall Study|Adverse Event|18|||
48707567|NCT01469377|156777585|FG002|Overall Study|Adverse Event|36|||
48707568|NCT01469377|156777583|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48801338|NCT02969525|157110388|FG001|Dose-Blind Period|Non-cooperating patient|0|||
48707569|NCT01469377|156777584|FG001|Overall Study|Insufficient Therapeutic Response|4|||
48707570|NCT01469377|156777585|FG002|Overall Study|Insufficient Therapeutic Response|0|||
48801339|NCT02969525|157110389|FG002|Dose-Blind Period|Non-cooperating patient|0|||
48801340|NCT02969525|157110390|FG003|Dose-Blind Period|Non-cooperating patient|0|||
48801341|NCT02969525|157110391|FG004|Dose-Blind Period|Non-cooperating patient|0|||
48707571|NCT01469377|156777583|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48801342|NCT02969525|157110392|FG005|Dose-Blind Period|Non-cooperating patient|0|||
48801343|NCT02969525|157110393|FG006|Dose-Blind Period|Non-cooperating patient|0|||
48801344|NCT02969525|157110394|FG007|Dose-Blind Period|Non-cooperating patient|0|||
48801345|NCT02969525|157110395|FG008|Dose-Blind Period|Non-cooperating patient|0|||
48801346|NCT02969525|157110396|FG009|Dose-Blind Period|Non-cooperating patient|0|||
48801347|NCT02969525|157110397|FG010|Dose-Blind Period|Non-cooperating patient|0|||
48801348|NCT02969525|157110398|FG011|Dose-Blind Period|Non-cooperating patient|1|||
48801349|NCT02969525|157110387|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801350|NCT02969525|157110388|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801351|NCT02969525|157110389|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801352|NCT02969525|157110390|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801353|NCT02969525|157110391|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801354|NCT02969525|157110392|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801355|NCT02969525|157110393|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801356|NCT02969525|157110394|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801357|NCT02969525|157110395|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801358|NCT02969525|157110396|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801359|NCT02969525|157110397|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
48801360|NCT02969525|157110398|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
48801361|NCT03445065|157110399|FG000|Overall Study|Withdrawal by Subject|3|||
48801362|NCT03445065|157110400|FG001|Overall Study|Withdrawal by Subject|6|||
48801363|NCT03445065|157110401|FG002|Overall Study|Withdrawal by Subject|2|||
48801364|NCT03445065|157110402|FG003|Overall Study|Withdrawal by Subject|2|||
48801365|NCT03445065|157110399|FG000|Overall Study|Other|4|||
48801366|NCT03445065|157110400|FG001|Overall Study|Other|3|||
48801367|NCT03445065|157110401|FG002|Overall Study|Other|3|||
48801368|NCT03445065|157110402|FG003|Overall Study|Other|1|||
48801369|NCT04349280|157110403|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
48801370|NCT04349280|157110404|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
48801371|NCT04349280|157110403|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
48801372|NCT04349280|157110404|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
48801373|NCT04349280|157110403|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
48801374|NCT04349280|157110404|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
48490179|NCT01952574|155988870|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
48801375|NCT02172625|157110405|FG000|Overall Study|Adverse Event|0|||
48801376|NCT02172625|157110406|FG001|Overall Study|Adverse Event|1|||
48490180|NCT01952574|155988871|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
48490181|NCT01952574|155988865|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
48801377|NCT02172625|157110405|FG000|Overall Study|Pregnancy|0|||
48801378|NCT02172625|157110406|FG001|Overall Study|Pregnancy|1|||
48801379|NCT02172625|157110405|FG000|Overall Study|car accident|0|||
48801380|NCT02172625|157110406|FG001|Overall Study|car accident|1|||
48801381|NCT02089230|157110415|FG000|Overall Study|Death|0|||
48801382|NCT02089230|157110416|FG001|Overall Study|Death|0|||
48801383|NCT02089230|157110417|FG002|Overall Study|Death|2|||
48801384|NCT02089230|157110415|FG000|Overall Study|Seeking Alternative Therapy|0|||
48707572|NCT01469377|156777584|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48707573|NCT01469377|156777585|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48707574|NCT01721044|156777586|FG000|Treatment Period|Adverse Event|7|||
48707575|NCT01721044|156777587|FG001|Treatment Period|Adverse Event|7|||
48707576|NCT01721044|156777588|FG002|Treatment Period|Adverse Event|10|||
48707577|NCT01721044|156777586|FG000|Treatment Period|Death|0|||
48707578|NCT01721044|156777587|FG001|Treatment Period|Death|0|||
48707579|NCT01721044|156777588|FG002|Treatment Period|Death|1|||
48707580|NCT01721044|156777586|FG000|Treatment Period|Lack of Efficacy|16|||
48707581|NCT01721044|156777587|FG001|Treatment Period|Lack of Efficacy|4|||
48707582|NCT01721044|156777588|FG002|Treatment Period|Lack of Efficacy|4|||
48707583|NCT01721044|156777586|FG000|Treatment Period|Lost to Follow-up|0|||
48707584|NCT01721044|156777587|FG001|Treatment Period|Lost to Follow-up|0|||
48707585|NCT01721044|156777588|FG002|Treatment Period|Lost to Follow-up|1|||
48707586|NCT01721044|156777586|FG000|Treatment Period|Physician Decision|1|||
48707587|NCT01721044|156777587|FG001|Treatment Period|Physician Decision|0|||
48707588|NCT01721044|156777588|FG002|Treatment Period|Physician Decision|2|||
48707589|NCT01721044|156777586|FG000|Treatment Period|Protocol Violation|1|||
48707590|NCT01721044|156777587|FG001|Treatment Period|Protocol Violation|0|||
48707591|NCT01721044|156777588|FG002|Treatment Period|Protocol Violation|0|||
48707592|NCT01721044|156777586|FG000|Treatment Period|Withdrawal by Subject|7|||
48707593|NCT01721044|156777587|FG001|Treatment Period|Withdrawal by Subject|6|||
48707594|NCT01721044|156777588|FG002|Treatment Period|Withdrawal by Subject|1|||
48707595|NCT04634253|156777589|FG000|Overall Study|Adverse Event|1|||
48707596|NCT04634253|156777590|FG001|Overall Study|Adverse Event|1|||
48707597|NCT04634253|156777591|FG002|Overall Study|Adverse Event|0|||
48707598|NCT04634253|156777589|FG000|Overall Study|Physician Decision|0|||
48707599|NCT04634253|156777590|FG001|Overall Study|Physician Decision|1|||
48707600|NCT04634253|156777591|FG002|Overall Study|Physician Decision|0|||
48801385|NCT02089230|157110416|FG001|Overall Study|Seeking Alternative Therapy|0|||
48490182|NCT01952574|155988866|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
48490183|NCT01952574|155988867|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
48707601|NCT04634253|156777589|FG000|Overall Study|Withdrawal by Subject|1|||
48707602|NCT04634253|156777590|FG001|Overall Study|Withdrawal by Subject|0|||
48707603|NCT04634253|156777591|FG002|Overall Study|Withdrawal by Subject|3|||
48707604|NCT01526733|156777592|FG000|Phase 1|Protocol Violation|1|||
48707605|NCT01526733|156777593|FG001|Phase 1|Protocol Violation|0|||
48801386|NCT02089230|157110417|FG002|Overall Study|Seeking Alternative Therapy|4|||
48801387|NCT03308825|157111522|FG000|Overall Study|Lost to Follow-up|2|||
48595946|NCT04304508|156377806|FG003|Overall Study|Death|5|||
48707606|NCT01526733|156777592|FG000|Phase 1|Withdrawal by Subject|1|||
48707607|NCT01526733|156777593|FG001|Phase 1|Withdrawal by Subject|1|||
48707608|NCT04032093|156777594|FG000|Overall Study|Lost to Follow-up|7|||
48707609|NCT04032093|156777595|FG001|Overall Study|Lost to Follow-up|7|||
48707610|NCT04032093|156777596|FG002|Overall Study|Lost to Follow-up|6|||
48707611|NCT04032093|156777597|FG003|Overall Study|Lost to Follow-up|10|||
48707612|NCT04032093|156777598|FG004|Overall Study|Lost to Follow-up|13|||
48707613|NCT04032093|156777599|FG005|Overall Study|Lost to Follow-up|7|||
48707614|NCT04032093|156777600|FG006|Overall Study|Lost to Follow-up|7|||
48707615|NCT04032093|156777601|FG007|Overall Study|Lost to Follow-up|5|||
48707616|NCT04032093|156777602|FG008|Overall Study|Lost to Follow-up|9|||
48707617|NCT04032093|156777603|FG009|Overall Study|Lost to Follow-up|12|||
48707618|NCT04032093|156777594|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707619|NCT04032093|156777595|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707620|NCT04032093|156777596|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707621|NCT04032093|156777597|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
48707622|NCT04032093|156777598|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
48707623|NCT04032093|156777599|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707624|NCT04032093|156777600|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707625|NCT04032093|156777601|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
48707626|NCT04032093|156777602|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
48707627|NCT04032093|156777603|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
48707628|NCT04032093|156777594|FG000|Overall Study|Other|1|||
48707629|NCT04032093|156777595|FG001|Overall Study|Other|0|||
48707630|NCT04032093|156777596|FG002|Overall Study|Other|0|||
48707631|NCT04032093|156777597|FG003|Overall Study|Other|1|||
48707632|NCT04032093|156777598|FG004|Overall Study|Other|1|||
48707633|NCT04032093|156777599|FG005|Overall Study|Other|0|||
48707634|NCT04032093|156777600|FG006|Overall Study|Other|0|||
48490184|NCT01952574|155988868|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
48490185|NCT01952574|155988869|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
48490186|NCT01952574|155988870|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
48490187|NCT01952574|155988871|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
48490188|NCT01952574|155988865|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
48707635|NCT04032093|156777601|FG007|Overall Study|Other|0|||
48707636|NCT04032093|156777602|FG008|Overall Study|Other|0|||
48707637|NCT04032093|156777603|FG009|Overall Study|Other|1|||
48490189|NCT01952574|155988866|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
48707638|NCT04032093|156777594|FG000|Overall Study|Withdrawal by Subject|1|||
48801388|NCT03308825|157111523|FG001|Overall Study|Lost to Follow-up|2|||
48801389|NCT03308825|157111524|FG002|Overall Study|Lost to Follow-up|1|||
48801390|NCT03308825|157111525|FG003|Overall Study|Lost to Follow-up|0|||
48801391|NCT03308825|157111522|FG000|Overall Study|Protocol Violation|0|||
48801392|NCT03308825|157111523|FG001|Overall Study|Protocol Violation|2|||
48801393|NCT03308825|157111524|FG002|Overall Study|Protocol Violation|0|||
48801394|NCT03308825|157111525|FG003|Overall Study|Protocol Violation|0|||
48801395|NCT00844857|157111527|FG000|Overall Study|Adverse Event|24|||
48801396|NCT00844857|157111528|FG001|Overall Study|Adverse Event|5|||
48801397|NCT00844857|157111527|FG000|Overall Study|Sponsor Decision|1|||
48801398|NCT00844857|157111528|FG001|Overall Study|Sponsor Decision|1|||
48801399|NCT00844857|157111527|FG000|Overall Study|Physician Decision|2|||
48801400|NCT00844857|157111528|FG001|Overall Study|Physician Decision|0|||
48801401|NCT00844857|157111527|FG000|Overall Study|Parent/Caregiver Decision|6|||
48801402|NCT00844857|157111528|FG001|Overall Study|Parent/Caregiver Decision|2|||
48801403|NCT00844857|157111527|FG000|Overall Study|Withdrawal by Subject|8|||
48801404|NCT00844857|157111528|FG001|Overall Study|Withdrawal by Subject|7|||
48801405|NCT00844857|157111527|FG000|Overall Study|Protocol Violation|6|||
48801406|NCT00844857|157111528|FG001|Overall Study|Protocol Violation|0|||
48801407|NCT00844857|157111527|FG000|Overall Study|Lack of Efficacy|5|||
48801408|NCT00844857|157111528|FG001|Overall Study|Lack of Efficacy|5|||
48801409|NCT00844857|157111527|FG000|Overall Study|Clinical Relapse|0|||
48801410|NCT00844857|157111528|FG001|Overall Study|Clinical Relapse|1|||
48801411|NCT00844857|157111527|FG000|Overall Study|Entry Criteria Not Met|0|||
48801412|NCT00844857|157111528|FG001|Overall Study|Entry Criteria Not Met|1|||
48801413|NCT00844857|157111527|FG000|Overall Study|Lost to Follow-up|2|||
48801414|NCT00844857|157111528|FG001|Overall Study|Lost to Follow-up|3|||
48801415|NCT00844857|157111527|FG000|Overall Study|Did Not Take Study Drug|3|||
48801416|NCT00844857|157111528|FG001|Overall Study|Did Not Take Study Drug|1|||
48801417|NCT00844857|157111527|FG000|Overall Study|Good Clinical Practice Violations|21|||
48801418|NCT00844857|157111528|FG001|Overall Study|Good Clinical Practice Violations|11|||
48801419|NCT01553318|157111533|FG000|Overall Study|Protocol Violation|3|||
48801420|NCT01553318|157111534|FG001|Overall Study|Protocol Violation|2|||
48801421|NCT00685945|157111539|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
48801422|NCT02178059|157111542|FG000|Washout|Physician Decision|1|||
48801423|NCT02178059|157111543|FG001|Washout|Physician Decision|0|||
48801424|NCT00662857|157111546|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
48801425|NCT00662857|157111547|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
48801426|NCT00662857|157111546|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
48801427|NCT00662857|157111547|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
48801428|NCT00662857|157111546|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
48801429|NCT00662857|157111547|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
48801430|NCT00989092|157111548|FG000|Overall Study|Physician Decision|9|||
48801431|NCT00989092|157111549|FG001|Overall Study|Physician Decision|6|||
48801432|NCT00989092|157111548|FG000|Overall Study|Adverse Event|20|||
48801433|NCT00989092|157111549|FG001|Overall Study|Adverse Event|1|||
48801434|NCT00989092|157111548|FG000|Overall Study|Chemotherapy initiated|12|||
48801435|NCT00989092|157111549|FG001|Overall Study|Chemotherapy initiated|4|||
48801436|NCT00989092|157111548|FG000|Overall Study|Withdrawal by Subject|17|||
48595947|NCT04304508|156377803|FG000|Overall Study|Non-compliance With Study Drug|3|||
48595948|NCT04304508|156377804|FG001|Overall Study|Non-compliance With Study Drug|1|||
48595949|NCT04304508|156377805|FG002|Overall Study|Non-compliance With Study Drug|2|||
48595950|NCT04304508|156377806|FG003|Overall Study|Non-compliance With Study Drug|0|||
48595951|NCT04304508|156377803|FG000|Overall Study|Switching To Other Therapy|1|||
48801437|NCT00989092|157111549|FG001|Overall Study|Withdrawal by Subject|9|||
48801438|NCT00989092|157111548|FG000|Overall Study|Death|14|||
48801439|NCT00989092|157111549|FG001|Overall Study|Death|2|||
48801440|NCT00989092|157111548|FG000|Overall Study|Ineligibility determined|3|||
48801441|NCT00989092|157111549|FG001|Overall Study|Ineligibility determined|3|||
48801442|NCT00989092|157111548|FG000|Overall Study|Lost to Follow-up|6|||
48801443|NCT00989092|157111549|FG001|Overall Study|Lost to Follow-up|2|||
48801444|NCT00989092|157111548|FG000|Overall Study|Other|3|||
48801445|NCT00989092|157111549|FG001|Overall Study|Other|1|||
48801446|NCT00989092|157111548|FG000|Overall Study|Protocol deviation|2|||
48801447|NCT00989092|157111549|FG001|Overall Study|Protocol deviation|0|||
48801448|NCT00989092|157111548|FG000|Overall Study|Erythropoietin therapy initiated|2|||
48801449|NCT00989092|157111549|FG001|Overall Study|Erythropoietin therapy initiated|0|||
48801450|NCT00989092|157111548|FG000|Overall Study|Did not receive study drug|2|||
48801451|NCT00989092|157111549|FG001|Overall Study|Did not receive study drug|0|||
48801452|NCT01061333|157111550|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
48801453|NCT01061333|157111551|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
48801454|NCT00089141|157111554|FG000|Overall Study|Termination of trial|18|||
48595952|NCT04304508|156377804|FG001|Overall Study|Switching To Other Therapy|1|||
48801455|NCT00089141|157111555|FG001|Overall Study|Termination of trial|24|||
48801456|NCT00337272|157111571|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
48801457|NCT00337272|157111572|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
48707639|NCT04032093|156777595|FG001|Overall Study|Withdrawal by Subject|3|||
48707640|NCT04032093|156777596|FG002|Overall Study|Withdrawal by Subject|2|||
48707641|NCT04032093|156777597|FG003|Overall Study|Withdrawal by Subject|2|||
48707642|NCT04032093|156777598|FG004|Overall Study|Withdrawal by Subject|3|||
48707643|NCT04032093|156777599|FG005|Overall Study|Withdrawal by Subject|0|||
48707644|NCT04032093|156777600|FG006|Overall Study|Withdrawal by Subject|0|||
48707645|NCT04032093|156777601|FG007|Overall Study|Withdrawal by Subject|0|||
48707646|NCT04032093|156777602|FG008|Overall Study|Withdrawal by Subject|0|||
48707647|NCT04032093|156777603|FG009|Overall Study|Withdrawal by Subject|0|||
48707648|NCT04032093|156777594|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48707649|NCT04032093|156777595|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48707650|NCT04032093|156777596|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48707651|NCT04032093|156777597|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48707652|NCT04032093|156777598|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48707653|NCT04032093|156777599|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
48707654|NCT04032093|156777600|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
48707655|NCT04032093|156777601|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
48707656|NCT04032093|156777602|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
48707657|NCT04032093|156777603|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
48707658|NCT04032093|156777594|FG000|Overall Study|Adverse Event|0|||
48707659|NCT04032093|156777595|FG001|Overall Study|Adverse Event|0|||
48707660|NCT04032093|156777596|FG002|Overall Study|Adverse Event|0|||
48707661|NCT04032093|156777597|FG003|Overall Study|Adverse Event|0|||
48707662|NCT04032093|156777598|FG004|Overall Study|Adverse Event|0|||
48707663|NCT04032093|156777599|FG005|Overall Study|Adverse Event|0|||
48707664|NCT04032093|156777600|FG006|Overall Study|Adverse Event|0|||
48707665|NCT04032093|156777601|FG007|Overall Study|Adverse Event|0|||
48707666|NCT04032093|156777602|FG008|Overall Study|Adverse Event|0|||
48707667|NCT04032093|156777603|FG009|Overall Study|Adverse Event|1|||
48707668|NCT04032093|156777594|FG000|Overall Study|Physician Decision|0|||
48707669|NCT04032093|156777595|FG001|Overall Study|Physician Decision|0|||
48707670|NCT04032093|156777596|FG002|Overall Study|Physician Decision|0|||
48707671|NCT04032093|156777597|FG003|Overall Study|Physician Decision|0|||
48707672|NCT04032093|156777598|FG004|Overall Study|Physician Decision|0|||
48707673|NCT04032093|156777599|FG005|Overall Study|Physician Decision|1|||
48707674|NCT04032093|156777600|FG006|Overall Study|Physician Decision|0|||
48707675|NCT04032093|156777601|FG007|Overall Study|Physician Decision|0|||
48707676|NCT04032093|156777602|FG008|Overall Study|Physician Decision|0|||
48707677|NCT04032093|156777603|FG009|Overall Study|Physician Decision|0|||
48707678|NCT03350672|156777604|FG000|Overall Study|Withdrawal by Subject|7|||
48707679|NCT03350672|156777605|FG001|Overall Study|Withdrawal by Subject|0|||
48707680|NCT03350672|156777606|FG002|Overall Study|Withdrawal by Subject|0|||
48707681|NCT01354314|156777609|FG000|Overall Study|Lost to Follow-up|1|||
48707682|NCT01354314|156777610|FG001|Overall Study|Lost to Follow-up|0|||
48707683|NCT01354314|156777611|FG002|Overall Study|Lost to Follow-up|1|||
48707684|NCT01354314|156777612|FG003|Overall Study|Lost to Follow-up|1|||
48707685|NCT01354314|156777609|FG000|Overall Study|Withdrawal by Subject|0|||
48707686|NCT01354314|156777610|FG001|Overall Study|Withdrawal by Subject|0|||
48707687|NCT01354314|156777611|FG002|Overall Study|Withdrawal by Subject|1|||
48707688|NCT01354314|156777612|FG003|Overall Study|Withdrawal by Subject|0|||
48707689|NCT01354314|156777609|FG000|Overall Study|Adverse Event|0|||
48707690|NCT01354314|156777610|FG001|Overall Study|Adverse Event|0|||
48707691|NCT01354314|156777611|FG002|Overall Study|Adverse Event|0|||
48707692|NCT01354314|156777612|FG003|Overall Study|Adverse Event|1|||
48707693|NCT01354314|156777609|FG000|Overall Study|Protocol Violation|1|||
48707694|NCT01354314|156777610|FG001|Overall Study|Protocol Violation|1|||
48707695|NCT01354314|156777611|FG002|Overall Study|Protocol Violation|0|||
48707696|NCT01354314|156777612|FG003|Overall Study|Protocol Violation|0|||
48707697|NCT01354314|156777609|FG000|Overall Study|Less than 90% Adherence|4|||
48707698|NCT01354314|156777610|FG001|Overall Study|Less than 90% Adherence|2|||
48801458|NCT00337272|157111571|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
48801459|NCT00337272|157111572|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
48801460|NCT00337272|157111571|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
48801461|NCT00337272|157111572|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
48801462|NCT00337272|157111571|FG000|Treatment Period|Non-compliance|1|||
48801463|NCT00337272|157111572|FG001|Treatment Period|Non-compliance|1|||
48801464|NCT00337272|157111571|FG000|Treatment Period|Withdrawal by Subject|0|||
48801465|NCT00337272|157111572|FG001|Treatment Period|Withdrawal by Subject|1|||
48801466|NCT00337272|157111571|FG000|Withdrawal Period|Non-compliance|0|||
48801467|NCT00337272|157111572|FG001|Withdrawal Period|Non-compliance|1|||
48801468|NCT00742079|157111575|FG000|Overall Study|Lost to Follow-up|0|||
48801469|NCT00742079|157111576|FG001|Overall Study|Lost to Follow-up|1|||
48801470|NCT01181726|157111577|FG000|First Intervention|Adverse Event|1|||
48801471|NCT01181726|157111578|FG001|First Intervention|Adverse Event|0|||
48801472|NCT01964326|157111579|FG000|Overall Study|Adverse Event|48|||
48801473|NCT01964326|157111579|FG000|Overall Study|Death|2|||
48801474|NCT01964326|157111579|FG000|Overall Study|Protocol Violation|4|||
48801475|NCT01964326|157111579|FG000|Overall Study|Lost to Follow-up|88|||
48801476|NCT01964326|157111579|FG000|Overall Study|Withdrawal by Subject|87|||
48801477|NCT01964326|157111579|FG000|Overall Study|Pregnancy|1|||
48801478|NCT01964326|157111579|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
48801479|NCT01964326|157111579|FG000|Overall Study|Physician Decision|55|||
48801480|NCT01964326|157111579|FG000|Overall Study|Investigator Discretion|1|||
48801481|NCT01964326|157111579|FG000|Overall Study|Other|9|||
48801482|NCT01964326|157111579|FG000|Overall Study|Did not meet eligibility criteria|1|||
48801483|NCT01644734|157111580|FG000|Overall Study|Adverse Event|4|||
48801484|NCT01644734|157111580|FG000|Overall Study|Lost to Follow-up|17|||
48801485|NCT01644734|157111580|FG000|Overall Study|Reasons other than stated above|7|||
48801486|NCT01644734|157111580|FG000|Overall Study|Missing documentation|238|||
48801487|NCT01424930|157111581|FG000|Overall Study|Adverse Event|0|||
48801488|NCT01424930|157111582|FG001|Overall Study|Adverse Event|1|||
48801489|NCT01424930|157111581|FG000|Overall Study|Death|1|||
48801490|NCT01424930|157111582|FG001|Overall Study|Death|0|||
48801491|NCT01424930|157111581|FG000|Overall Study|Progressive Disease|3|||
48801492|NCT01424930|157111582|FG001|Overall Study|Progressive Disease|6|||
48801493|NCT01424930|157111581|FG000|Overall Study|Screen Failure|0|||
48801494|NCT01424930|157111582|FG001|Overall Study|Screen Failure|1|||
48801495|NCT01424930|157111581|FG000|Overall Study|Reason not specified|0|||
48801496|NCT01424930|157111582|FG001|Overall Study|Reason not specified|6|||
48801497|NCT00002558|157111583|FG000|Overall Study|Withdrawal by Subject|0|||
48801498|NCT00002558|157111584|FG001|Overall Study|Withdrawal by Subject|1|||
48801499|NCT01538472|157111586|FG000|Overall Study|Disease Progression|3|||
48801500|NCT01538472|157111586|FG000|Overall Study|Death|1|||
48707699|NCT01354314|156777611|FG002|Overall Study|Less than 90% Adherence|6|||
48707700|NCT01354314|156777612|FG003|Overall Study|Less than 90% Adherence|4|||
48707701|NCT00478023|156777613|FG000|Overall Study|Adverse Event|11|||
48707702|NCT00478023|156777614|FG001|Overall Study|Adverse Event|7|||
48707703|NCT00478023|156777615|FG002|Overall Study|Adverse Event|8|||
48707704|NCT00478023|156777616|FG003|Overall Study|Adverse Event|14|||
48707705|NCT00478023|156777617|FG004|Overall Study|Adverse Event|6|||
48707706|NCT00478023|156777613|FG000|Overall Study|Death|1|||
48707707|NCT00478023|156777614|FG001|Overall Study|Death|0|||
48707708|NCT00478023|156777615|FG002|Overall Study|Death|0|||
48707709|NCT00478023|156777616|FG003|Overall Study|Death|0|||
48707710|NCT00478023|156777617|FG004|Overall Study|Death|0|||
48707711|NCT00478023|156777613|FG000|Overall Study|Lack of Efficacy|11|||
48707712|NCT00478023|156777614|FG001|Overall Study|Lack of Efficacy|10|||
48707713|NCT00478023|156777615|FG002|Overall Study|Lack of Efficacy|4|||
48707714|NCT00478023|156777616|FG003|Overall Study|Lack of Efficacy|5|||
48707715|NCT00478023|156777617|FG004|Overall Study|Lack of Efficacy|41|||
48707716|NCT00478023|156777613|FG000|Overall Study|Lost to Follow-up|3|||
48707717|NCT00478023|156777614|FG001|Overall Study|Lost to Follow-up|1|||
48707718|NCT00478023|156777615|FG002|Overall Study|Lost to Follow-up|1|||
48707719|NCT00478023|156777616|FG003|Overall Study|Lost to Follow-up|1|||
48707720|NCT00478023|156777617|FG004|Overall Study|Lost to Follow-up|0|||
48707721|NCT00478023|156777613|FG000|Overall Study|Withdrawal by Subject|2|||
48707722|NCT00478023|156777614|FG001|Overall Study|Withdrawal by Subject|3|||
48707723|NCT00478023|156777615|FG002|Overall Study|Withdrawal by Subject|2|||
48707724|NCT00478023|156777616|FG003|Overall Study|Withdrawal by Subject|4|||
48707725|NCT00478023|156777617|FG004|Overall Study|Withdrawal by Subject|5|||
48801501|NCT02740049|157111587|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
48707726|NCT00478023|156777613|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
48707727|NCT00478023|156777614|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
48707728|NCT00478023|156777615|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
48707729|NCT00478023|156777616|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
48707730|NCT00478023|156777617|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
48707731|NCT00714870|156777621|FG000|Overall Study|Lost to Follow-up|22|||
48707732|NCT00714870|156777622|FG001|Overall Study|Lost to Follow-up|5|||
48801502|NCT00454571|157111588|FG000|Overall Study|Adverse Event|2|||
48801503|NCT00454571|157111589|FG001|Overall Study|Adverse Event|0|||
48801504|NCT00454571|157111588|FG000|Overall Study|Physician Decision|0|||
48801505|NCT00454571|157111589|FG001|Overall Study|Physician Decision|1|||
48801506|NCT00454571|157111588|FG000|Overall Study|Protocol Violation|1|||
48801507|NCT00454571|157111589|FG001|Overall Study|Protocol Violation|0|||
48801508|NCT00454571|157111588|FG000|Overall Study|Withdrawal by Subject|10|||
48801509|NCT00454571|157111589|FG001|Overall Study|Withdrawal by Subject|5|||
48801510|NCT02436811|157111600|FG000|Overall Study|Lost to Follow-up|2|||
48801511|NCT02436811|157111601|FG001|Overall Study|Lost to Follow-up|9|||
48801512|NCT02436811|157111602|FG002|Overall Study|Lost to Follow-up|7|||
48801513|NCT04209725|157111605|FG000|Overall Study|Adverse Event|1|||
48801514|NCT02856113|157111606|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48801515|NCT02856113|157111607|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48801516|NCT02856113|157111606|FG000|Overall Study|Significant Protocol Deviation|1|||
48801517|NCT02856113|157111607|FG001|Overall Study|Significant Protocol Deviation|0|||
48801518|NCT02856113|157111606|FG000|Overall Study|Lost to Follow-up|3|||
48801519|NCT02856113|157111607|FG001|Overall Study|Lost to Follow-up|5|||
48595953|NCT04304508|156377805|FG002|Overall Study|Switching To Other Therapy|1|||
48595954|NCT04304508|156377806|FG003|Overall Study|Switching To Other Therapy|2|||
48801520|NCT02856113|157111606|FG000|Overall Study|Voluntary Withdrawal|3|||
48801521|NCT02856113|157111607|FG001|Overall Study|Voluntary Withdrawal|5|||
48801522|NCT02856113|157111606|FG000|Overall Study|Pregnancy|0|||
48801523|NCT02856113|157111607|FG001|Overall Study|Pregnancy|1|||
48801524|NCT02856113|157111606|FG000|Overall Study|Principal Investigator Discretion|2|||
48801525|NCT02856113|157111607|FG001|Overall Study|Principal Investigator Discretion|1|||
48801526|NCT02856113|157111606|FG000|Overall Study|Randomized but not Treated|1|||
48801527|NCT02856113|157111607|FG001|Overall Study|Randomized but not Treated|0|||
48801528|NCT02856113|157111606|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
48707733|NCT00714870|156777621|FG000|Overall Study|patient unable to come b/c back pain|1|||
48707734|NCT00714870|156777622|FG001|Overall Study|patient unable to come b/c back pain|0|||
48707735|NCT00714870|156777621|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
48707736|NCT00714870|156777622|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
48707737|NCT01064947|156777624|FG000|Overall Study|negative culture|41|||
48707738|NCT00560352|156777625|FG000|Overall Study|Adverse event unrelated to study drug|2|||
48707739|NCT00560352|156777626|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48707740|NCT00560352|156777627|FG002|Overall Study|Adverse event unrelated to study drug|1|||
48707741|NCT00560352|156777625|FG000|Overall Study|Study drug toxicity|3|||
48707742|NCT00560352|156777626|FG001|Overall Study|Study drug toxicity|0|||
48707743|NCT00560352|156777627|FG002|Overall Study|Study drug toxicity|1|||
48707744|NCT00560352|156777625|FG000|Overall Study|Disease progression|0|||
48707745|NCT00560352|156777626|FG001|Overall Study|Disease progression|1|||
48707746|NCT00560352|156777627|FG002|Overall Study|Disease progression|1|||
48707747|NCT00560352|156777625|FG000|Overall Study|Withdrawal by Subject|1|||
48707748|NCT00560352|156777626|FG001|Overall Study|Withdrawal by Subject|1|||
48707749|NCT00560352|156777627|FG002|Overall Study|Withdrawal by Subject|1|||
48707750|NCT00560352|156777625|FG000|Overall Study|Maximum clinical benefit|1|||
48707751|NCT00560352|156777626|FG001|Overall Study|Maximum clinical benefit|0|||
48707752|NCT00560352|156777627|FG002|Overall Study|Maximum clinical benefit|0|||
48707753|NCT02904954|156778999|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
48707754|NCT02904954|156779000|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
48707755|NCT02904954|156778999|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
48707756|NCT02904954|156779000|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
48707757|NCT02904954|156778999|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
48707758|NCT02904954|156779000|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
48707759|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Recurrence|2|||
48707760|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Recurrence|0|||
48707761|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Adverse Event|2|||
48707762|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Adverse Event|6|||
48595955|NCT04304508|156377803|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
48595956|NCT04304508|156377804|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
48801529|NCT02856113|157111607|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
48801530|NCT00658567|157111609|FG000|Overall Study|Adverse Event|5|||
48801531|NCT00658567|157111610|FG001|Overall Study|Adverse Event|2|||
48801532|NCT00658567|157111611|FG002|Overall Study|Adverse Event|3|||
48801533|NCT00658567|157111609|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
48801534|NCT00658567|157111610|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
48801535|NCT00658567|157111611|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
48801536|NCT00658567|157111609|FG000|Overall Study|Physician Decision|0|||
48801537|NCT00658567|157111610|FG001|Overall Study|Physician Decision|1|||
48801538|NCT00658567|157111611|FG002|Overall Study|Physician Decision|0|||
48801539|NCT00658567|157111609|FG000|Overall Study|At Discretion of Sponsor|1|||
48801540|NCT00658567|157111610|FG001|Overall Study|At Discretion of Sponsor|1|||
48801541|NCT00658567|157111611|FG002|Overall Study|At Discretion of Sponsor|1|||
48801542|NCT00691938|157111615|FG000|Overall Study|QTc prolongation|1|||
48801543|NCT00691938|157111616|FG001|Overall Study|QTc prolongation|0|||
48801544|NCT00691938|157111617|FG002|Overall Study|QTc prolongation|0|||
48801545|NCT00691938|157111618|FG003|Overall Study|QTc prolongation|0|||
48801546|NCT00691938|157111619|FG004|Overall Study|QTc prolongation|0|||
48801547|NCT00691938|157111620|FG005|Overall Study|QTc prolongation|0|||
48801548|NCT00691938|157111621|FG006|Overall Study|QTc prolongation|0|||
48801549|NCT04860518|157111622|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
48801550|NCT04860518|157111623|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
48801551|NCT02831257|157111629|FG000|Overall Study|Lack of Efficacy|3|||
48801552|NCT02831257|157111629|FG000|Overall Study|Adverse Event|2|||
48801553|NCT02831257|157111629|FG000|Overall Study|Physician Decision|1|||
48801554|NCT02831257|157111629|FG000|Overall Study|Withdrawal by Subject|6|||
48801555|NCT02755597|157111630|FG000|Overall Study|Withdrew consent|27|||
48801556|NCT02755597|157111631|FG001|Overall Study|Withdrew consent|11|||
48801557|NCT02755597|157111630|FG000|Overall Study|Lost to Follow-up|1|||
48801558|NCT02755597|157111631|FG001|Overall Study|Lost to Follow-up|0|||
48801559|NCT02755597|157111630|FG000|Overall Study|Death|78|||
48801560|NCT02755597|157111631|FG001|Overall Study|Death|36|||
48801561|NCT02755597|157111630|FG000|Overall Study|Study terminated by Sponsor|67|||
48801562|NCT02755597|157111631|FG001|Overall Study|Study terminated by Sponsor|47|||
48801563|NCT02755597|157111630|FG000|Overall Study|Other, not specified|20|||
48801564|NCT02755597|157111631|FG001|Overall Study|Other, not specified|3|||
48801565|NCT02755597|157111630|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
48801566|NCT02755597|157111631|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
48801567|NCT02889133|157111637|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
48801568|NCT02889133|157111638|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
48801569|NCT02889133|157111637|FG000|Completed Primary Outcome|Manufacturing error|3|||
48801570|NCT02889133|157111638|FG001|Completed Primary Outcome|Manufacturing error|8|||
48801571|NCT02889133|157111637|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
48801572|NCT02889133|157111638|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
48801573|NCT02889133|157111637|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
48801574|NCT02889133|157111638|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
48801575|NCT02889133|157111637|FG000|Completed Primary Outcome|Protocol Violation|1|||
48801576|NCT02889133|157111638|FG001|Completed Primary Outcome|Protocol Violation|0|||
48801577|NCT02889133|157111637|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
48801578|NCT02889133|157111638|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
48801579|NCT02889133|157111637|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
48801580|NCT02889133|157111638|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
48801581|NCT02889133|157111637|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
48801582|NCT02889133|157111638|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
48490190|NCT01952574|155988867|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
48490191|NCT01952574|155988868|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
48490192|NCT01952574|155988869|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
48490193|NCT01952574|155988870|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
48490194|NCT01952574|155988871|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
48490195|NCT01952574|155988865|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
48490196|NCT01952574|155988866|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
48490197|NCT01952574|155988867|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
48490198|NCT01952574|155988868|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
48490199|NCT01952574|155988869|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
48490200|NCT01952574|155988870|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
48490201|NCT01952574|155988871|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
48490202|NCT01952574|155988865|FG000|Open-label Treatment Phase|Missing|0|||
48707763|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Participant wishes|12|||
48707764|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Participant wishes|7|||
48707765|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Physician Decision|2|||
48707766|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Physician Decision|1|||
48707767|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
48707768|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
48707769|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Death|0|||
48707770|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Death|1|||
48707771|NCT02904954|156778999|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
48707772|NCT02904954|156779000|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
48707773|NCT05097963|156779001|FG000|Overall Study|Protocol Violation|13|||
48707774|NCT05097963|156779001|FG000|Overall Study|Withdrawal by Subject|21|||
48707775|NCT01772316|156779004|FG000|Overall Study|Serious adverse event|1|||
48707776|NCT01772316|156779004|FG000|Overall Study|Inform consent withdrawn|1|||
48707777|NCT01772316|156779004|FG000|Overall Study|Withdrawn by sponsor decision|5|||
48707778|NCT01936870|156779007|FG000|Overall Study|No Visit After Treatment|176|||
48707779|NCT01936870|156779007|FG000|Overall Study|Protocol Violation|12|||
48707780|NCT01936870|156779007|FG000|Overall Study|No Drug Administration|1|||
48707781|NCT01039519|156779013|FG000|Treatment|Progressive disease|20|||
48707782|NCT01039519|156779013|FG000|Treatment|Treatment failure|2|||
48707783|NCT01039519|156779013|FG000|Treatment|Adverse Event|3|||
48707784|NCT01039519|156779013|FG000|Treatment|Physician Decision|2|||
48490203|NCT01952574|155988866|FG001|Open-label Treatment Phase|Missing|0|||
48707785|NCT01039519|156779013|FG000|Survival Follow-up|Death|23|||
48707786|NCT01039519|156779013|FG000|Survival Follow-up|Sponsor decision|4|||
48707787|NCT01229267|156779014|FG000|Overall Study|Adverse Event|4|||
48707788|NCT01229267|156779015|FG001|Overall Study|Adverse Event|6|||
48707789|NCT01229267|156779016|FG002|Overall Study|Adverse Event|3|||
48707790|NCT01229267|156779017|FG003|Overall Study|Adverse Event|2|||
48707791|NCT01229267|156779018|FG004|Overall Study|Adverse Event|10|||
48707792|NCT01229267|156779014|FG000|Overall Study|Death|40|||
48707793|NCT01229267|156779015|FG001|Overall Study|Death|37|||
48707794|NCT01229267|156779016|FG002|Overall Study|Death|35|||
48707795|NCT01229267|156779017|FG003|Overall Study|Death|13|||
48707796|NCT01229267|156779018|FG004|Overall Study|Death|103|||
48707797|NCT01229267|156779014|FG000|Overall Study|Withdrawal by Subject|23|||
48707798|NCT01229267|156779015|FG001|Overall Study|Withdrawal by Subject|22|||
48707799|NCT01229267|156779016|FG002|Overall Study|Withdrawal by Subject|32|||
48707800|NCT01229267|156779017|FG003|Overall Study|Withdrawal by Subject|14|||
48707801|NCT01229267|156779018|FG004|Overall Study|Withdrawal by Subject|59|||
48490204|NCT01952574|155988867|FG002|Open-label Treatment Phase|Missing|0|||
48490205|NCT01952574|155988868|FG003|Open-label Treatment Phase|Missing|0|||
48490206|NCT01952574|155988869|FG004|Open-label Treatment Phase|Missing|4|||
48490207|NCT01952574|155988870|FG005|Open-label Treatment Phase|Missing|0|||
48490208|NCT01952574|155988871|FG006|Open-label Treatment Phase|Missing|0|||
48490209|NCT01952574|155988865|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
48490210|NCT01952574|155988866|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
48490211|NCT01952574|155988867|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
48490212|NCT01952574|155988868|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
48490213|NCT01952574|155988869|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
48490214|NCT01952574|155988870|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
48490215|NCT01952574|155988871|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
48490216|NCT01952574|155988865|FG000|Open-label Treatment Phase|Death|0|||
48490217|NCT01952574|155988866|FG001|Open-label Treatment Phase|Death|0|||
48490218|NCT01952574|155988867|FG002|Open-label Treatment Phase|Death|0|||
48490219|NCT01952574|155988868|FG003|Open-label Treatment Phase|Death|0|||
48490220|NCT01952574|155988869|FG004|Open-label Treatment Phase|Death|1|||
48490221|NCT01952574|155988870|FG005|Open-label Treatment Phase|Death|0|||
48490222|NCT01952574|155988871|FG006|Open-label Treatment Phase|Death|0|||
48490223|NCT01952574|155988865|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
48490224|NCT01952574|155988866|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
48490225|NCT01952574|155988867|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
48707802|NCT01229267|156779014|FG000|Overall Study|Protocol Violation|0|||
48801583|NCT02889133|157111637|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
48801584|NCT02889133|157111638|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
48801585|NCT02889133|157111637|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
48801586|NCT02889133|157111638|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
48801587|NCT01060553|157111639|FG000|Overall Study|Lost to Follow-up|3|||
48801588|NCT01060553|157111640|FG001|Overall Study|Lost to Follow-up|5|||
48801589|NCT01060553|157111639|FG000|Overall Study|Withdrawal by Subject|5|||
48801590|NCT01060553|157111640|FG001|Overall Study|Withdrawal by Subject|5|||
48801591|NCT01060553|157111639|FG000|Overall Study|Lack of Efficacy|1|||
48801592|NCT01060553|157111640|FG001|Overall Study|Lack of Efficacy|0|||
48801593|NCT02719990|157111643|FG000|Overall Study|Physician Decision|2|||
48801594|NCT02719990|157111643|FG000|Overall Study|Withdrawal by Subject|2|||
48801595|NCT02719990|157111643|FG000|Overall Study|Study Terminated By Sponsor|32|||
48801596|NCT00766675|157113907|FG000|Overall Study|Adverse Event|16|||
48801597|NCT00766675|157113907|FG000|Overall Study|Lost to Follow-up|2|||
48801598|NCT00766675|157113907|FG000|Overall Study|Withdrawal by Subject|11|||
48801599|NCT00766675|157113907|FG000|Overall Study|Protocol Violation|8|||
48801600|NCT00766675|157113907|FG000|Overall Study|Participant took prohibited medication|1|||
48801601|NCT00766675|157113907|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
48801602|NCT00766675|157113907|FG000|Overall Study|Insufficient therapy|1|||
48801603|NCT01337674|157113913|FG000|Treatment Period 1|Adverse Event|0|||
48801604|NCT01337674|157113914|FG001|Treatment Period 1|Adverse Event|1|||
48801605|NCT01337674|157113915|FG002|Treatment Period 1|Adverse Event|0|||
48801606|NCT01337674|157113916|FG003|Treatment Period 1|Adverse Event|0|||
48801607|NCT01337674|157113913|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
48801608|NCT01337674|157113914|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
48801609|NCT01337674|157113915|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
48801610|NCT01337674|157113916|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
48801611|NCT01337674|157113913|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48801612|NCT01337674|157113914|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48801613|NCT01337674|157113915|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48801614|NCT01337674|157113916|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48801615|NCT00437645|157113917|FG000|Overall Study|Adverse Event|15|||
48801616|NCT00437645|157113918|FG001|Overall Study|Adverse Event|84|||
48801617|NCT00437645|157113917|FG000|Overall Study|Withdrawal by Subject|10|||
48801618|NCT00437645|157113918|FG001|Overall Study|Withdrawal by Subject|22|||
48801619|NCT00437645|157113917|FG000|Overall Study|Protocol Violation|3|||
48801620|NCT00437645|157113918|FG001|Overall Study|Protocol Violation|3|||
48801621|NCT00437645|157113917|FG000|Overall Study|Lost to Follow-up|2|||
48801622|NCT00437645|157113918|FG001|Overall Study|Lost to Follow-up|3|||
48801623|NCT00437645|157113917|FG000|Overall Study|Administrative problems|2|||
48801624|NCT00437645|157113918|FG001|Overall Study|Administrative problems|1|||
48801625|NCT00437645|157113917|FG000|Overall Study|Lack of Efficacy|2|||
48801626|NCT00437645|157113918|FG001|Overall Study|Lack of Efficacy|1|||
48801627|NCT00437645|157113917|FG000|Overall Study|Condition no longer requires study drug|1|||
48801628|NCT00437645|157113918|FG001|Overall Study|Condition no longer requires study drug|1|||
48801629|NCT02710292|157113919|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
48801630|NCT02710292|157113920|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
48595957|NCT04304508|156377805|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
48707803|NCT01229267|156779015|FG001|Overall Study|Protocol Violation|1|||
48707804|NCT01229267|156779016|FG002|Overall Study|Protocol Violation|0|||
48707805|NCT01229267|156779017|FG003|Overall Study|Protocol Violation|0|||
48707806|NCT01229267|156779018|FG004|Overall Study|Protocol Violation|0|||
48707807|NCT01229267|156779014|FG000|Overall Study|Progressive disease|0|||
48707808|NCT01229267|156779015|FG001|Overall Study|Progressive disease|0|||
48707809|NCT01229267|156779016|FG002|Overall Study|Progressive disease|0|||
48707810|NCT01229267|156779017|FG003|Overall Study|Progressive disease|0|||
48707811|NCT01229267|156779018|FG004|Overall Study|Progressive disease|1|||
48707812|NCT01229267|156779014|FG000|Overall Study|Physician Decision|8|||
48707813|NCT01229267|156779015|FG001|Overall Study|Physician Decision|11|||
48707814|NCT01229267|156779016|FG002|Overall Study|Physician Decision|8|||
48707815|NCT01229267|156779017|FG003|Overall Study|Physician Decision|3|||
48707816|NCT01229267|156779018|FG004|Overall Study|Physician Decision|25|||
48707817|NCT01229267|156779014|FG000|Overall Study|Lost to Follow-up|6|||
48707818|NCT01229267|156779015|FG001|Overall Study|Lost to Follow-up|5|||
48707819|NCT01229267|156779016|FG002|Overall Study|Lost to Follow-up|8|||
48707820|NCT01229267|156779017|FG003|Overall Study|Lost to Follow-up|3|||
48707821|NCT01229267|156779018|FG004|Overall Study|Lost to Follow-up|22|||
48707822|NCT00711191|156779021|FG000|Overall Study|Adverse Event|1|||
48707823|NCT00711191|156779022|FG001|Overall Study|Adverse Event|1|||
48707824|NCT00711191|156779023|FG002|Overall Study|Adverse Event|2|||
48707825|NCT00711191|156779021|FG000|Overall Study|Objective progression or relapse|2|||
48707826|NCT00711191|156779022|FG001|Overall Study|Objective progression or relapse|3|||
48707827|NCT00711191|156779023|FG002|Overall Study|Objective progression or relapse|7|||
48707828|NCT00711191|156779021|FG000|Overall Study|Withdrawal by Subject|0|||
48707829|NCT00711191|156779022|FG001|Overall Study|Withdrawal by Subject|1|||
48707830|NCT00711191|156779023|FG002|Overall Study|Withdrawal by Subject|3|||
48707831|NCT02035267|156779024|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
48707832|NCT02035267|156779025|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
48707833|NCT02035267|156779026|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
48707834|NCT02035267|156779027|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
48707835|NCT02035267|156779024|FG000|Overall Study|Adverse Event|0|||
48707836|NCT02035267|156779025|FG001|Overall Study|Adverse Event|0|||
48707837|NCT02035267|156779026|FG002|Overall Study|Adverse Event|1|||
48707838|NCT02035267|156779027|FG003|Overall Study|Adverse Event|0|||
48707839|NCT02035267|156779024|FG000|Overall Study|Lost to Follow-up|0|||
48707840|NCT02035267|156779025|FG001|Overall Study|Lost to Follow-up|0|||
48707841|NCT02035267|156779026|FG002|Overall Study|Lost to Follow-up|0|||
48707842|NCT02035267|156779027|FG003|Overall Study|Lost to Follow-up|1|||
48707843|NCT02035267|156779024|FG000|Overall Study|Other unspecified|0|||
48707844|NCT02035267|156779025|FG001|Overall Study|Other unspecified|1|||
48707845|NCT02035267|156779026|FG002|Overall Study|Other unspecified|0|||
48707846|NCT02035267|156779027|FG003|Overall Study|Other unspecified|0|||
48707847|NCT04294680|156779033|FG000|Overall Study|Withdrawal by Subject|2|||
48707848|NCT04294680|156779034|FG001|Overall Study|Withdrawal by Subject|1|||
48707849|NCT04294680|156779033|FG000|Overall Study|Follow-up visits completed outside of window|1|||
48707850|NCT04294680|156779034|FG001|Overall Study|Follow-up visits completed outside of window|0|||
48707851|NCT02858362|156779039|FG000|Overall Study|Protocol Violation|0|||
48707852|NCT02858362|156779040|FG001|Overall Study|Protocol Violation|1|||
48707853|NCT02858362|156779041|FG002|Overall Study|Protocol Violation|0|||
48707854|NCT02858362|156779039|FG000|Overall Study|Withdrawal by Subject|1|||
48707855|NCT02858362|156779040|FG001|Overall Study|Withdrawal by Subject|0|||
48707856|NCT02858362|156779041|FG002|Overall Study|Withdrawal by Subject|0|||
48707857|NCT02858362|156779039|FG000|Overall Study|Early Study Termination|0|||
48707858|NCT02858362|156779040|FG001|Overall Study|Early Study Termination|0|||
48707859|NCT02858362|156779041|FG002|Overall Study|Early Study Termination|3|||
48707860|NCT02858362|156779039|FG000|Overall Study|Lost to Follow-up|1|||
48707861|NCT02858362|156779040|FG001|Overall Study|Lost to Follow-up|0|||
48707862|NCT02858362|156779041|FG002|Overall Study|Lost to Follow-up|0|||
48707863|NCT03967444|156779042|FG000|Overall Study|Lost to Follow-up|1|||
48707864|NCT03967444|156779043|FG001|Overall Study|Lost to Follow-up|2|||
48707865|NCT01605799|156779050|FG000|Overall Study|Withdrawal by Subject|2|||
48707866|NCT01605799|156779051|FG001|Overall Study|Withdrawal by Subject|1|||
48707867|NCT03527732|156779053|FG000|Overall Study|Lost to Follow-up|21|||
48707868|NCT03527732|156779054|FG001|Overall Study|Lost to Follow-up|23|||
48707869|NCT03527732|156779055|FG002|Overall Study|Lost to Follow-up|80|||
48707870|NCT03527732|156779056|FG003|Overall Study|Lost to Follow-up|62|||
48801631|NCT02710292|157113919|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
48801632|NCT02710292|157113920|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
48801633|NCT00514943|157113926|FG000|Stage 1|Progressive disease|4|||
48801634|NCT00514943|157113927|FG001|Stage 1|Progressive disease|8|||
48801635|NCT00514943|157113926|FG000|Stage 1|Other Adverse Event|16|||
48801636|NCT00514943|157113927|FG001|Stage 1|Other Adverse Event|6|||
48801637|NCT00514943|157113926|FG000|Stage 1|Not treated|1|||
48801638|NCT00514943|157113927|FG001|Stage 1|Not treated|2|||
48801639|NCT00514943|157113926|FG000|Stage 1|Patient refused to continue study meds|8|||
48801640|NCT00514943|157113927|FG001|Stage 1|Patient refused to continue study meds|3|||
48801641|NCT00514943|157113926|FG000|Stage 1|Other than stated above|1|||
48801642|NCT00514943|157113927|FG001|Stage 1|Other than stated above|7|||
48801643|NCT00514943|157113926|FG000|Stage 2|Progressive disease|27|||
48801644|NCT00514943|157113927|FG001|Stage 2|Progressive disease|24|||
48801645|NCT00514943|157113926|FG000|Stage 2|Other Adverse Event|3|||
48801646|NCT00514943|157113927|FG001|Stage 2|Other Adverse Event|10|||
48801647|NCT00514943|157113926|FG000|Stage 2|Patient refused to continue study meds|2|||
48801648|NCT00514943|157113927|FG001|Stage 2|Patient refused to continue study meds|0|||
48801649|NCT00514943|157113926|FG000|Stage 2|Other than stated above|0|||
48801650|NCT00514943|157113927|FG001|Stage 2|Other than stated above|2|||
48801651|NCT01370525|157113936|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
48801652|NCT01370525|157113937|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
48801653|NCT01370525|157113936|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48801654|NCT01370525|157113937|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48801655|NCT01370525|157113936|FG000|Overall Study|Adverse Event|0|||
48801656|NCT01370525|157113937|FG001|Overall Study|Adverse Event|1|||
48801657|NCT01370525|157113936|FG000|Overall Study|Protocol Violation|2|||
48801658|NCT01370525|157113937|FG001|Overall Study|Protocol Violation|1|||
48801659|NCT01370525|157113936|FG000|Overall Study|Lost to follow up|2|||
48801660|NCT01370525|157113937|FG001|Overall Study|Lost to follow up|6|||
48801661|NCT01756352|157113941|FG000|Overall Study|moved away and lost to followup|1|||
48801662|NCT00514683|157113945|FG000|Overall Study|Not treated|2|||
48801663|NCT00514683|157113946|FG001|Overall Study|Not treated|1|||
48801664|NCT00514683|157113947|FG002|Overall Study|Not treated|0|||
48801665|NCT00514683|157113948|FG003|Overall Study|Not treated|0|||
48801666|NCT00514683|157113949|FG004|Overall Study|Not treated|1|||
48801667|NCT00514683|157113945|FG000|Overall Study|Adverse Event|21|||
48801668|NCT00514683|157113946|FG001|Overall Study|Adverse Event|20|||
48801669|NCT00514683|157113947|FG002|Overall Study|Adverse Event|15|||
48801670|NCT00514683|157113948|FG003|Overall Study|Adverse Event|13|||
48801671|NCT00514683|157113949|FG004|Overall Study|Adverse Event|27|||
48801672|NCT00514683|157113945|FG000|Overall Study|Protocol Violation|1|||
48801673|NCT00514683|157113946|FG001|Overall Study|Protocol Violation|1|||
48801674|NCT00514683|157113947|FG002|Overall Study|Protocol Violation|0|||
48801675|NCT00514683|157113948|FG003|Overall Study|Protocol Violation|1|||
48801676|NCT00514683|157113949|FG004|Overall Study|Protocol Violation|0|||
48801677|NCT00514683|157113945|FG000|Overall Study|Withdrawal by Subject|2|||
48801678|NCT00514683|157113946|FG001|Overall Study|Withdrawal by Subject|2|||
48801679|NCT00514683|157113947|FG002|Overall Study|Withdrawal by Subject|1|||
48801680|NCT00514683|157113948|FG003|Overall Study|Withdrawal by Subject|0|||
48801681|NCT00514683|157113949|FG004|Overall Study|Withdrawal by Subject|4|||
48801682|NCT00514683|157113945|FG000|Overall Study|Reason other than listed above|0|||
48801683|NCT00514683|157113946|FG001|Overall Study|Reason other than listed above|1|||
48801684|NCT00514683|157113947|FG002|Overall Study|Reason other than listed above|2|||
48801685|NCT00514683|157113948|FG003|Overall Study|Reason other than listed above|0|||
48801686|NCT00514683|157113949|FG004|Overall Study|Reason other than listed above|1|||
48801687|NCT00840801|157113950|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
48801688|NCT00840801|157113951|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
48801689|NCT00840801|157113952|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
48801690|NCT00840801|157113950|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
48801691|NCT00840801|157113951|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
48801692|NCT00840801|157113952|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
48801693|NCT00840801|157113950|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
48801694|NCT00840801|157113951|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
48801695|NCT00840801|157113952|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
48801696|NCT00840801|157113950|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
48801697|NCT00840801|157113951|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
48801698|NCT00840801|157113952|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
48801699|NCT01242748|157113953|FG000|Overall Study|Adverse Event|10|||
48801700|NCT01242748|157113954|FG001|Overall Study|Adverse Event|5|||
48801701|NCT01242748|157113953|FG000|Overall Study|Lost to Follow-up|6|||
48801702|NCT01242748|157113954|FG001|Overall Study|Lost to Follow-up|2|||
48801703|NCT01242748|157113953|FG000|Overall Study|Physician Decision|3|||
48801704|NCT01242748|157113954|FG001|Overall Study|Physician Decision|2|||
48801705|NCT01242748|157113953|FG000|Overall Study|Protocol Violation|1|||
48801706|NCT01242748|157113954|FG001|Overall Study|Protocol Violation|0|||
48801707|NCT01242748|157113953|FG000|Overall Study|Withdrawal by Subject|10|||
48801708|NCT01242748|157113954|FG001|Overall Study|Withdrawal by Subject|2|||
48801709|NCT01242748|157113953|FG000|Overall Study|Miscellaneous reasons|8|||
48801710|NCT01242748|157113954|FG001|Overall Study|Miscellaneous reasons|3|||
48801711|NCT05056870|157113957|FG000|Period 1|Site COVID-19 Related|3|||
48801712|NCT05056870|157113958|FG001|Period 1|Site COVID-19 Related|3|||
48801713|NCT05056870|157113957|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
48801714|NCT05056870|157113958|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
48801715|NCT05056870|157113957|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
48801716|NCT05056870|157113958|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
48801717|NCT05056870|157113957|FG000|Period 2|COVID-19 Related|1|||
48801718|NCT05056870|157113958|FG001|Period 2|COVID-19 Related|0|||
48801719|NCT05056870|157113957|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
48801720|NCT05056870|157113958|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
48801721|NCT04082884|157113959|FG000|Overall Study|Withdrawal by Subject|1|||
48801722|NCT00331344|157113962|FG000|Phase I|Adverse Event|0|||
48801723|NCT00331344|157113963|FG001|Phase I|Adverse Event|0|||
48801724|NCT00331344|157113964|FG002|Phase I|Adverse Event|0|||
48801725|NCT00331344|157113965|FG003|Phase I|Adverse Event|1|||
48801726|NCT00331344|157113966|FG004|Phase I|Adverse Event|2|||
48801727|NCT00331344|157113967|FG005|Phase I|Adverse Event|2|||
48801728|NCT00331344|157113968|FG006|Phase I|Adverse Event|0|||
48801729|NCT00331344|157113969|FG007|Phase I|Adverse Event|1|||
48801730|NCT00331344|157113970|FG008|Phase I|Adverse Event|0|||
48801731|NCT00331344|157113962|FG000|Phase II|Death|0|||
48801732|NCT00331344|157113963|FG001|Phase II|Death|0|||
48801733|NCT00331344|157113964|FG002|Phase II|Death|0|||
48801734|NCT00331344|157113965|FG003|Phase II|Death|0|||
48801735|NCT00331344|157113966|FG004|Phase II|Death|0|||
48801736|NCT00331344|157113967|FG005|Phase II|Death|0|||
48801737|NCT00331344|157113968|FG006|Phase II|Death|0|||
48801738|NCT00331344|157113969|FG007|Phase II|Death|0|||
48801739|NCT00331344|157113970|FG008|Phase II|Death|4|||
48801740|NCT01373931|157113971|FG000|Lead-in Period|Adverse Event|2|||
48801741|NCT01373931|157113972|FG001|Lead-in Period|Adverse Event|0|||
48801742|NCT01373931|157113971|FG000|Period 1|Adverse Event|2|||
48801743|NCT01373931|157113972|FG001|Period 1|Adverse Event|0|||
48801744|NCT01373931|157113971|FG000|Period 1|Withdrawal by Subject|0|||
48801745|NCT01373931|157113972|FG001|Period 1|Withdrawal by Subject|2|||
48801746|NCT02940574|157113973|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
48801747|NCT02940574|157113974|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
48801748|NCT02940574|157113973|FG000|1-year Follow-up|Lost to Follow-up|3|||
48801749|NCT02940574|157113974|FG001|1-year Follow-up|Lost to Follow-up|4|||
48801750|NCT00387894|157113975|FG000|Overall Study|Withdrawal by Subject|1|||
48801751|NCT00659490|157113976|FG000|Overall Study|Lost to Follow-up|2|||
48801752|NCT00659490|157113977|FG001|Overall Study|Lost to Follow-up|0|||
48801753|NCT00659490|157113978|FG002|Overall Study|Lost to Follow-up|1|||
48801754|NCT02347657|157113983|FG000|Overall Study|Physician Decision|0|||
48801755|NCT02347657|157113984|FG001|Overall Study|Physician Decision|1|||
48801756|NCT02347657|157113983|FG000|Overall Study|Adverse Event|8|||
48801757|NCT02347657|157113984|FG001|Overall Study|Adverse Event|4|||
48801758|NCT02347657|157113983|FG000|Overall Study|Withdrawal by Subject|6|||
48801759|NCT02347657|157113984|FG001|Overall Study|Withdrawal by Subject|7|||
48801760|NCT02347657|157113983|FG000|Overall Study|Randomized but not treated|1|||
48801761|NCT02347657|157113984|FG001|Overall Study|Randomized but not treated|0|||
48801762|NCT02347657|157113983|FG000|Overall Study|Other|3|||
48801763|NCT02347657|157113984|FG001|Overall Study|Other|3|||
48801764|NCT01757665|157113985|FG000|Overall Study|Still on Study - Visit Completed|240|||
48801765|NCT01757665|157113986|FG001|Overall Study|Still on Study - Visit Completed|30|||
48801766|NCT01757665|157113985|FG000|Overall Study|Still on Study - Visit Pending|398|||
48801767|NCT01757665|157113986|FG001|Overall Study|Still on Study - Visit Pending|40|||
48801768|NCT01757665|157113985|FG000|Overall Study|Still on Study - Missed Visit|14|||
48801769|NCT01757665|157113986|FG001|Overall Study|Still on Study - Missed Visit|1|||
48801770|NCT01757665|157113985|FG000|Overall Study|Death|25|||
48801771|NCT01757665|157113986|FG001|Overall Study|Death|8|||
48801772|NCT01757665|157113985|FG000|Overall Study|Explant|1|||
48801773|NCT01757665|157113986|FG001|Overall Study|Explant|2|||
48801774|NCT01757665|157113985|FG000|Overall Study|Withdrawal by Subject|10|||
48801775|NCT01757665|157113986|FG001|Overall Study|Withdrawal by Subject|0|||
48801776|NCT01757665|157113985|FG000|Overall Study|Lost to Follow-up|1|||
48801777|NCT01757665|157113986|FG001|Overall Study|Lost to Follow-up|1|||
48801778|NCT01757665|157113985|FG000|Overall Study|Not Implanted with Device|5|||
48801779|NCT01757665|157113986|FG001|Overall Study|Not Implanted with Device|1|||
48801780|NCT02428296|157113991|FG000|Overall Study|Adverse Event|7|||
48801781|NCT02428296|157113991|FG000|Overall Study|Withdrawal by Subject|2|||
48801782|NCT01505387|157113992|FG000|Overall Study|Protocol Violation|1|||
48801783|NCT01505387|157113993|FG001|Overall Study|Protocol Violation|0|||
48490226|NCT01952574|155988868|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
48801784|NCT01505387|157113992|FG000|Overall Study|Withdrawal by Subject|1|||
48801785|NCT01505387|157113993|FG001|Overall Study|Withdrawal by Subject|1|||
48801786|NCT00620750|157113994|FG000|Overall Study|Lost to Follow-up|25|||
48801787|NCT04477187|157113995|FG000|Overall Study|Lost to Follow-up|2|||
48801788|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
48801789|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
48801790|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
48801791|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
48801792|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
48801793|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
48801794|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
48801795|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
48801796|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
48801797|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
48801798|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
48801799|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
48801800|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48801801|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48801802|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48801803|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
48801804|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
48801805|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48801806|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48801807|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48801808|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Death|2|||
48801809|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Death|2|||
48801810|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Death|0|||
48801811|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Death|0|||
48801812|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Death|0|||
48801813|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
48801814|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
48801815|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
48801816|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
48801817|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
48801818|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
48801819|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
48801820|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
48801821|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
48801822|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
48801823|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
48801824|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
48801825|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
48801826|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
48801827|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
48801828|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
48801829|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
48801830|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
48801831|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
48801832|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
48801833|NCT03420781|157113999|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
48801834|NCT03420781|157114000|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
48801835|NCT03420781|157114001|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
48801836|NCT03420781|157114002|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
48801837|NCT03420781|157114003|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
48801838|NCT03420781|157113999|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
48801839|NCT03420781|157114000|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
48801840|NCT03420781|157114001|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
48801841|NCT03420781|157114002|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
48490227|NCT01952574|155988869|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
48490228|NCT01952574|155988870|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
48490229|NCT01952574|155988871|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
48490230|NCT01952574|155988865|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
48490231|NCT01952574|155988866|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
48490232|NCT01952574|155988867|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
48490233|NCT01952574|155988868|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
48490234|NCT01952574|155988869|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
48490235|NCT01952574|155988870|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
48490236|NCT01952574|155988871|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
48490237|NCT00681863|155988872|FG000|Overall Study|Adverse Event|1|||
48490238|NCT00681863|155988872|FG000|Overall Study|Lost to Follow-up|2|||
48490239|NCT00681863|155988872|FG000|Overall Study|Lack of Efficacy|2|||
48707871|NCT03527732|156779057|FG004|Overall Study|Lost to Follow-up|12|||
48707872|NCT03527732|156779058|FG005|Overall Study|Lost to Follow-up|20|||
48707873|NCT02207088|156779063|FG000|Overall Study|Adverse Event|2|||
48707874|NCT00060840|156779066|FG000|Overall Study|Change in surgical plan|2|||
48707875|NCT00060840|156779067|FG001|Overall Study|Change in surgical plan|6|||
48490240|NCT00681863|155988872|FG000|Overall Study|Other|18|||
48490241|NCT01023269|155988876|FG000|Overall Study|early termination of the study|2|||
48707876|NCT00060840|156779066|FG000|Overall Study|Death|0|||
48707877|NCT00060840|156779067|FG001|Overall Study|Death|1|||
48707878|NCT00060840|156779066|FG000|Overall Study|Withdrawal by Subject|0|||
48707879|NCT00060840|156779067|FG001|Overall Study|Withdrawal by Subject|1|||
48707880|NCT00060840|156779066|FG000|Overall Study|Subinvestigator unavailable|0|||
48707881|NCT00060840|156779067|FG001|Overall Study|Subinvestigator unavailable|1|||
48707882|NCT00060840|156779066|FG000|Overall Study|Physician Decision|1|||
48801842|NCT03420781|157114003|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
48801843|NCT03420781|157113999|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
48801844|NCT03420781|157114000|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
48801845|NCT03420781|157114001|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
48801846|NCT03420781|157114002|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
48801847|NCT03420781|157114003|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
48801848|NCT03420781|157113999|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
48801849|NCT03420781|157114000|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
48801850|NCT03420781|157114001|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
48801851|NCT03420781|157114002|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
48801852|NCT03420781|157114003|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
48801853|NCT00420199|157114004|FG000|Overall Study|Participant no longer met study criteria|1|||
48801854|NCT00420199|157114005|FG001|Overall Study|Participant no longer met study criteria|0|||
48801855|NCT03286751|157114006|FG000|Washout Period 1|Withdrawal by Subject|0|||
48801856|NCT03286751|157114007|FG001|Washout Period 1|Withdrawal by Subject|0|||
48801857|NCT03286751|157114008|FG002|Washout Period 1|Withdrawal by Subject|0|||
48801858|NCT03286751|157114009|FG003|Washout Period 1|Withdrawal by Subject|0|||
48801859|NCT03286751|157114010|FG004|Washout Period 1|Withdrawal by Subject|1|||
48801860|NCT03286751|157114011|FG005|Washout Period 1|Withdrawal by Subject|0|||
48801861|NCT03286751|157114006|FG000|Washout Period 2|Personal Reasons|0|||
48801862|NCT03286751|157114007|FG001|Washout Period 2|Personal Reasons|1|||
48801863|NCT03286751|157114008|FG002|Washout Period 2|Personal Reasons|0|||
48801864|NCT03286751|157114009|FG003|Washout Period 2|Personal Reasons|0|||
48801865|NCT03286751|157114010|FG004|Washout Period 2|Personal Reasons|0|||
48801866|NCT03286751|157114011|FG005|Washout Period 2|Personal Reasons|0|||
48801867|NCT03286751|157114006|FG000|Washout Period 5|Adverse Event|0|||
48801868|NCT03286751|157114007|FG001|Washout Period 5|Adverse Event|0|||
48801869|NCT03286751|157114008|FG002|Washout Period 5|Adverse Event|0|||
48801870|NCT03286751|157114009|FG003|Washout Period 5|Adverse Event|0|||
48801871|NCT03286751|157114010|FG004|Washout Period 5|Adverse Event|1|||
48801872|NCT03286751|157114011|FG005|Washout Period 5|Adverse Event|0|||
48801873|NCT02923739|157114016|FG000|Overall Study|Withdrawal by Subject|2|||
48801874|NCT02923739|157114017|FG001|Overall Study|Withdrawal by Subject|0|||
48801875|NCT02923739|157114018|FG002|Overall Study|Withdrawal by Subject|0|||
48801876|NCT02923739|157114019|FG003|Overall Study|Withdrawal by Subject|0|||
48801877|NCT02923739|157114016|FG000|Overall Study|Failed Screening|3|||
48801878|NCT02923739|157114017|FG001|Overall Study|Failed Screening|0|||
48801879|NCT02923739|157114018|FG002|Overall Study|Failed Screening|0|||
48801880|NCT02923739|157114019|FG003|Overall Study|Failed Screening|0|||
48801881|NCT01376323|157114027|FG000|Overall Study|Adverse Event|1|||
48801882|NCT01376323|157114028|FG001|Overall Study|Adverse Event|0|||
48801883|NCT01376323|157114029|FG002|Overall Study|Adverse Event|0|||
48707883|NCT00060840|156779067|FG001|Overall Study|Physician Decision|0|||
48707884|NCT00060840|156779066|FG000|Overall Study|Other|1|||
48707885|NCT00060840|156779067|FG001|Overall Study|Other|0|||
48707886|NCT01388335|156779068|FG000|Period 1|Progressive Disease|1|||
48707887|NCT01388335|156779068|FG000|Period 2|Progressive Disease|2|||
48707888|NCT01388335|156779068|FG000|Period 2|Sponsor Decision|1|||
48707889|NCT01388335|156779068|FG000|Safety Extension|Progressive Disease|7|||
48707890|NCT00976560|156779070|FG000|Overall Study|Adverse Event|5|||
48707891|NCT00976560|156779071|FG001|Overall Study|Adverse Event|5|||
48707892|NCT00976560|156779070|FG000|Overall Study|Lack of Efficacy|3|||
48707893|NCT00976560|156779071|FG001|Overall Study|Lack of Efficacy|5|||
48707894|NCT00976560|156779070|FG000|Overall Study|Protocol Violation|1|||
48707895|NCT00976560|156779071|FG001|Overall Study|Protocol Violation|0|||
48707896|NCT00976560|156779070|FG000|Overall Study|Lost to Follow-up|1|||
48707897|NCT00976560|156779071|FG001|Overall Study|Lost to Follow-up|0|||
48707898|NCT00976560|156779070|FG000|Overall Study|Physician Decision|2|||
48707899|NCT00976560|156779071|FG001|Overall Study|Physician Decision|0|||
48707900|NCT00976560|156779070|FG000|Overall Study|Withdrawal by Subject|2|||
48707901|NCT00976560|156779071|FG001|Overall Study|Withdrawal by Subject|3|||
48707902|NCT01216189|156779072|FG000|Overall Study|Lost to Follow-up|21|||
48707903|NCT01216189|156779073|FG001|Overall Study|Lost to Follow-up|3|||
48707904|NCT01216189|156779072|FG000|Overall Study|Death|4|||
48707905|NCT01216189|156779073|FG001|Overall Study|Death|2|||
48707906|NCT00670306|156779074|FG000|Overall Study|Adverse Event|8|||
48707907|NCT00670306|156779074|FG000|Overall Study|Lack of Efficacy|10|||
48801884|NCT01376323|157114030|FG003|Overall Study|Adverse Event|2|||
48801885|NCT01376323|157114031|FG004|Overall Study|Adverse Event|0|||
48433897|NCT02596711|155777244|FG000|Overall Study|Lost to Follow-up|1|||
48433898|NCT02596711|155777245|FG001|Overall Study|Lost to Follow-up|2|||
48433899|NCT02596711|155777246|FG002|Overall Study|Lost to Follow-up|3|||
48433900|NCT02618928|155777247|FG000|Overall Study|Failure to Return|28|||
48801886|NCT01376323|157114027|FG000|Overall Study|Lost to Follow-up|0|||
48801887|NCT01376323|157114028|FG001|Overall Study|Lost to Follow-up|0|||
48801888|NCT01376323|157114029|FG002|Overall Study|Lost to Follow-up|0|||
48801889|NCT01376323|157114030|FG003|Overall Study|Lost to Follow-up|2|||
48801890|NCT01376323|157114031|FG004|Overall Study|Lost to Follow-up|0|||
48801891|NCT01376323|157114027|FG000|Overall Study|Physician Decision|1|||
48801892|NCT01376323|157114028|FG001|Overall Study|Physician Decision|0|||
48801893|NCT01376323|157114029|FG002|Overall Study|Physician Decision|2|||
48801894|NCT01376323|157114030|FG003|Overall Study|Physician Decision|1|||
48801895|NCT01376323|157114031|FG004|Overall Study|Physician Decision|1|||
48801896|NCT01376323|157114027|FG000|Overall Study|Withdrawal by Subject|0|||
48801897|NCT01376323|157114028|FG001|Overall Study|Withdrawal by Subject|1|||
48801898|NCT01376323|157114029|FG002|Overall Study|Withdrawal by Subject|1|||
48801899|NCT01376323|157114030|FG003|Overall Study|Withdrawal by Subject|0|||
48801900|NCT01376323|157114031|FG004|Overall Study|Withdrawal by Subject|0|||
48801901|NCT04806594|157114040|FG000|Overall Study|Withdrawal by Subject|2|||
48801902|NCT04806594|157114040|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
48801903|NCT02467270|157114041|FG000|Overall Study|Participants Never Treated|0|||
48801904|NCT02467270|157114042|FG001|Overall Study|Participants Never Treated|1|||
48801905|NCT02467270|157114043|FG002|Overall Study|Participants Never Treated|0|||
48801906|NCT02467270|157114041|FG000|Overall Study|Ongoing|50|||
48801907|NCT02467270|157114042|FG001|Overall Study|Ongoing|41|||
48801908|NCT02467270|157114043|FG002|Overall Study|Ongoing|43|||
48801909|NCT02467270|157114041|FG000|Overall Study|Adverse Event|16|||
48801910|NCT02467270|157114042|FG001|Overall Study|Adverse Event|15|||
48801911|NCT02467270|157114043|FG002|Overall Study|Adverse Event|14|||
48801912|NCT02467270|157114041|FG000|Overall Study|Progressive Disease|7|||
48801913|NCT02467270|157114042|FG001|Overall Study|Progressive Disease|7|||
48801914|NCT02467270|157114043|FG002|Overall Study|Progressive Disease|4|||
48801915|NCT02467270|157114041|FG000|Overall Study|Death|2|||
48801916|NCT02467270|157114042|FG001|Overall Study|Death|0|||
48801917|NCT02467270|157114043|FG002|Overall Study|Death|2|||
48801918|NCT02467270|157114041|FG000|Overall Study|Lack of Efficacy|12|||
48801919|NCT02467270|157114042|FG001|Overall Study|Lack of Efficacy|18|||
48801920|NCT02467270|157114043|FG002|Overall Study|Lack of Efficacy|23|||
48801921|NCT02467270|157114041|FG000|Overall Study|Non-compliance With Study Drug|0|||
48801922|NCT02467270|157114042|FG001|Overall Study|Non-compliance With Study Drug|2|||
48801923|NCT02467270|157114043|FG002|Overall Study|Non-compliance With Study Drug|1|||
48801924|NCT02467270|157114041|FG000|Overall Study|Lost to Follow-up|2|||
48801925|NCT02467270|157114042|FG001|Overall Study|Lost to Follow-up|1|||
48801926|NCT02467270|157114043|FG002|Overall Study|Lost to Follow-up|0|||
48801927|NCT02467270|157114041|FG000|Overall Study|Pregnancy|0|||
48801928|NCT02467270|157114042|FG001|Overall Study|Pregnancy|1|||
48801929|NCT02467270|157114043|FG002|Overall Study|Pregnancy|0|||
48801930|NCT02467270|157114041|FG000|Overall Study|Physician Decision|0|||
48801931|NCT02467270|157114042|FG001|Overall Study|Physician Decision|4|||
48801932|NCT02467270|157114043|FG002|Overall Study|Physician Decision|1|||
48801933|NCT02467270|157114041|FG000|Overall Study|Withdrawal by Subject|4|||
48801934|NCT02467270|157114042|FG001|Overall Study|Withdrawal by Subject|3|||
48801935|NCT02467270|157114043|FG002|Overall Study|Withdrawal by Subject|5|||
48801936|NCT02467270|157114041|FG000|Overall Study|Reason not Specified|1|||
48801937|NCT02467270|157114042|FG001|Overall Study|Reason not Specified|2|||
48801938|NCT02467270|157114043|FG002|Overall Study|Reason not Specified|1|||
48801939|NCT04632992|157114044|FG000|Overall Study|Adverse Event|0|||
48801940|NCT04632992|157114045|FG001|Overall Study|Adverse Event|0|||
48801941|NCT04632992|157114046|FG002|Overall Study|Adverse Event|0|||
48801942|NCT04632992|157114047|FG003|Overall Study|Adverse Event|0|||
48801943|NCT04632992|157114048|FG004|Overall Study|Adverse Event|0|||
48801944|NCT04632992|157114049|FG005|Overall Study|Adverse Event|0|||
48801945|NCT04632992|157114050|FG006|Overall Study|Adverse Event|0|||
48801946|NCT04632992|157114051|FG007|Overall Study|Adverse Event|0|||
48801947|NCT04632992|157114052|FG008|Overall Study|Adverse Event|0|||
48801948|NCT04632992|157114053|FG009|Overall Study|Adverse Event|0|||
48801949|NCT04632992|157114054|FG010|Overall Study|Adverse Event|0|||
48801950|NCT04632992|157114055|FG011|Overall Study|Adverse Event|0|||
48801951|NCT04632992|157114056|FG012|Overall Study|Adverse Event|1|||
48801952|NCT04632992|157114057|FG013|Overall Study|Adverse Event|0|||
48801953|NCT04632992|157114044|FG000|Overall Study|Death|17|||
48801954|NCT04632992|157114045|FG001|Overall Study|Death|1|||
48801955|NCT04632992|157114046|FG002|Overall Study|Death|14|||
48801956|NCT04632992|157114047|FG003|Overall Study|Death|14|||
48801957|NCT04632992|157114048|FG004|Overall Study|Death|13|||
48801958|NCT04632992|157114049|FG005|Overall Study|Death|6|||
48801959|NCT04632992|157114050|FG006|Overall Study|Death|7|||
48801960|NCT04632992|157114051|FG007|Overall Study|Death|12|||
48801961|NCT04632992|157114052|FG008|Overall Study|Death|15|||
48801962|NCT04632992|157114053|FG009|Overall Study|Death|20|||
48801963|NCT04632992|157114054|FG010|Overall Study|Death|8|||
48801964|NCT04632992|157114055|FG011|Overall Study|Death|2|||
48801965|NCT04632992|157114056|FG012|Overall Study|Death|10|||
48801966|NCT04632992|157114057|FG013|Overall Study|Death|1|||
48801967|NCT04632992|157114044|FG000|Overall Study|Lost to Follow-up|1|||
48801968|NCT04632992|157114045|FG001|Overall Study|Lost to Follow-up|0|||
48801969|NCT04632992|157114046|FG002|Overall Study|Lost to Follow-up|1|||
48801970|NCT04632992|157114047|FG003|Overall Study|Lost to Follow-up|0|||
48801971|NCT04632992|157114048|FG004|Overall Study|Lost to Follow-up|2|||
48801972|NCT04632992|157114049|FG005|Overall Study|Lost to Follow-up|0|||
48801973|NCT04632992|157114050|FG006|Overall Study|Lost to Follow-up|1|||
48801974|NCT04632992|157114051|FG007|Overall Study|Lost to Follow-up|1|||
48801975|NCT04632992|157114052|FG008|Overall Study|Lost to Follow-up|1|||
48801976|NCT04632992|157114053|FG009|Overall Study|Lost to Follow-up|1|||
48801977|NCT04632992|157114054|FG010|Overall Study|Lost to Follow-up|2|||
48801978|NCT04632992|157114055|FG011|Overall Study|Lost to Follow-up|0|||
48801979|NCT04632992|157114056|FG012|Overall Study|Lost to Follow-up|0|||
48801980|NCT04632992|157114057|FG013|Overall Study|Lost to Follow-up|0|||
48801981|NCT04632992|157114044|FG000|Overall Study|Reason not Specified|2|||
48801982|NCT04632992|157114045|FG001|Overall Study|Reason not Specified|0|||
48801983|NCT04632992|157114046|FG002|Overall Study|Reason not Specified|1|||
48801984|NCT04632992|157114047|FG003|Overall Study|Reason not Specified|1|||
48801985|NCT04632992|157114048|FG004|Overall Study|Reason not Specified|0|||
48801986|NCT04632992|157114049|FG005|Overall Study|Reason not Specified|0|||
48801987|NCT04632992|157114050|FG006|Overall Study|Reason not Specified|0|||
48801988|NCT04632992|157114051|FG007|Overall Study|Reason not Specified|0|||
48801989|NCT04632992|157114052|FG008|Overall Study|Reason not Specified|0|||
48801990|NCT04632992|157114053|FG009|Overall Study|Reason not Specified|0|||
48801991|NCT04632992|157114054|FG010|Overall Study|Reason not Specified|1|||
48801992|NCT04632992|157114055|FG011|Overall Study|Reason not Specified|0|||
48801993|NCT04632992|157114056|FG012|Overall Study|Reason not Specified|0|||
48801994|NCT04632992|157114057|FG013|Overall Study|Reason not Specified|0|||
48801995|NCT04632992|157114044|FG000|Overall Study|Physician Decision|0|||
48801996|NCT04632992|157114045|FG001|Overall Study|Physician Decision|0|||
48801997|NCT04632992|157114046|FG002|Overall Study|Physician Decision|0|||
48801998|NCT04632992|157114047|FG003|Overall Study|Physician Decision|2|||
48801999|NCT04632992|157114048|FG004|Overall Study|Physician Decision|1|||
48802000|NCT04632992|157114049|FG005|Overall Study|Physician Decision|0|||
48802001|NCT04632992|157114050|FG006|Overall Study|Physician Decision|0|||
48802002|NCT04632992|157114051|FG007|Overall Study|Physician Decision|0|||
48802003|NCT04632992|157114052|FG008|Overall Study|Physician Decision|0|||
48802004|NCT04632992|157114053|FG009|Overall Study|Physician Decision|0|||
48802005|NCT04632992|157114054|FG010|Overall Study|Physician Decision|0|||
48802006|NCT04632992|157114055|FG011|Overall Study|Physician Decision|0|||
48802007|NCT04632992|157114056|FG012|Overall Study|Physician Decision|3|||
48802008|NCT04632992|157114057|FG013|Overall Study|Physician Decision|0|||
48802009|NCT04632992|157114044|FG000|Overall Study|Progressive Disease|0|||
48802010|NCT04632992|157114045|FG001|Overall Study|Progressive Disease|0|||
48802011|NCT04632992|157114046|FG002|Overall Study|Progressive Disease|0|||
48802012|NCT04632992|157114047|FG003|Overall Study|Progressive Disease|0|||
48802013|NCT04632992|157114048|FG004|Overall Study|Progressive Disease|1|||
48802014|NCT04632992|157114049|FG005|Overall Study|Progressive Disease|0|||
48802015|NCT04632992|157114050|FG006|Overall Study|Progressive Disease|0|||
48802016|NCT04632992|157114051|FG007|Overall Study|Progressive Disease|0|||
48802017|NCT04632992|157114052|FG008|Overall Study|Progressive Disease|0|||
48802018|NCT04632992|157114053|FG009|Overall Study|Progressive Disease|1|||
48802019|NCT04632992|157114054|FG010|Overall Study|Progressive Disease|1|||
48802020|NCT04632992|157114055|FG011|Overall Study|Progressive Disease|0|||
48802021|NCT04632992|157114056|FG012|Overall Study|Progressive Disease|2|||
48802022|NCT04632992|157114057|FG013|Overall Study|Progressive Disease|0|||
48802023|NCT04632992|157114044|FG000|Overall Study|Withdrawal by Subject|4|||
48802024|NCT04632992|157114045|FG001|Overall Study|Withdrawal by Subject|1|||
48802025|NCT04632992|157114046|FG002|Overall Study|Withdrawal by Subject|5|||
48802026|NCT04632992|157114047|FG003|Overall Study|Withdrawal by Subject|4|||
48802027|NCT04632992|157114048|FG004|Overall Study|Withdrawal by Subject|3|||
48802028|NCT04632992|157114049|FG005|Overall Study|Withdrawal by Subject|3|||
48802029|NCT04632992|157114050|FG006|Overall Study|Withdrawal by Subject|0|||
48802030|NCT04632992|157114051|FG007|Overall Study|Withdrawal by Subject|5|||
48802031|NCT04632992|157114052|FG008|Overall Study|Withdrawal by Subject|0|||
48802032|NCT04632992|157114053|FG009|Overall Study|Withdrawal by Subject|2|||
48802033|NCT04632992|157114054|FG010|Overall Study|Withdrawal by Subject|8|||
48802034|NCT04632992|157114055|FG011|Overall Study|Withdrawal by Subject|0|||
48802035|NCT04632992|157114056|FG012|Overall Study|Withdrawal by Subject|1|||
48802036|NCT04632992|157114057|FG013|Overall Study|Withdrawal by Subject|1|||
48802037|NCT00733499|157114067|FG000|Pre-operative|Protocol Violation|0|||
48802038|NCT00733499|157114068|FG001|Pre-operative|Protocol Violation|1|||
48802039|NCT00733499|157114067|FG000|3 Months Follow-up|Death|1|||
48802040|NCT00733499|157114068|FG001|3 Months Follow-up|Death|2|||
48802041|NCT00733499|157114067|FG000|6 Months Follow-up|Death|0|||
48802042|NCT00733499|157114068|FG001|6 Months Follow-up|Death|2|||
48802043|NCT00733499|157114067|FG000|6 Months Follow-up|Adverse Event|0|||
48802044|NCT00733499|157114068|FG001|6 Months Follow-up|Adverse Event|1|||
48802045|NCT00733499|157114067|FG000|12 Months Follow-up|Death|2|||
48802046|NCT00733499|157114068|FG001|12 Months Follow-up|Death|1|||
48802047|NCT00733499|157114067|FG000|24 Months Follow-up|Death|0|||
48802048|NCT00733499|157114068|FG001|24 Months Follow-up|Death|1|||
48802049|NCT00733499|157114067|FG000|5 Year Followup|Adverse Event|2|||
48802050|NCT00733499|157114068|FG001|5 Year Followup|Adverse Event|2|||
48802051|NCT00733499|157114067|FG000|5 Year Followup|Non device related AE|0|||
48802052|NCT00733499|157114068|FG001|5 Year Followup|Non device related AE|1|||
48802053|NCT00733499|157114067|FG000|5 Year Followup|Revision of Study Implant|0|||
48802054|NCT00733499|157114068|FG001|5 Year Followup|Revision of Study Implant|1|||
48802055|NCT00733499|157114067|FG000|5 Year Followup|Lost to Follow-up|2|||
48802056|NCT00733499|157114068|FG001|5 Year Followup|Lost to Follow-up|0|||
48802057|NCT00733499|157114067|FG000|5 Year Followup|Death|13|||
48802058|NCT00733499|157114068|FG001|5 Year Followup|Death|19|||
48802059|NCT00733499|157114067|FG000|5 Year Followup|missing, unable to locate|0|||
48802060|NCT00733499|157114068|FG001|5 Year Followup|missing, unable to locate|1|||
48802061|NCT00733499|157114067|FG000|5 Year Followup|Withdrawal by Subject|4|||
48802062|NCT00733499|157114068|FG001|5 Year Followup|Withdrawal by Subject|1|||
48802063|NCT00733499|157114067|FG000|10 Year Followup|Death|9|||
48802064|NCT00733499|157114068|FG001|10 Year Followup|Death|7|||
48802065|NCT00733499|157114067|FG000|10 Year Followup|Adverse Event|3|||
48802066|NCT00733499|157114068|FG001|10 Year Followup|Adverse Event|3|||
48802067|NCT00733499|157114067|FG000|10 Year Followup|Lost to Follow-up|3|||
48802068|NCT00733499|157114068|FG001|10 Year Followup|Lost to Follow-up|2|||
48802069|NCT00733499|157114067|FG000|10 Year Followup|Withdrawal by Subject|5|||
48802070|NCT00733499|157114068|FG001|10 Year Followup|Withdrawal by Subject|5|||
48802071|NCT00733499|157114067|FG000|10 Year Followup|missing, unable to locate|0|||
48802072|NCT00733499|157114068|FG001|10 Year Followup|missing, unable to locate|2|||
48802073|NCT05158296|157114069|FG000|Overall Study|Sponsor Decision|2|||
48802074|NCT05158296|157114070|FG001|Overall Study|Sponsor Decision|3|||
48802075|NCT05158296|157114071|FG002|Overall Study|Sponsor Decision|2|||
48802076|NCT03078816|157114072|FG000|Overall Study|Withdrawal by Subject|1|||
48802077|NCT01778556|157114073|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
48802078|NCT01778556|157114074|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
48802079|NCT01778556|157114073|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48802080|NCT01778556|157114074|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
48802081|NCT01778556|157114073|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
48802082|NCT01778556|157114074|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
48802083|NCT01778556|157114073|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
48802084|NCT01778556|157114074|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
48802085|NCT03188120|157114075|FG000|Overall Study|Adverse Event|4|||
48802086|NCT03188120|157114075|FG000|Overall Study|Insufficient Effectiveness|8|||
48802087|NCT03188120|157114075|FG000|Overall Study|Improved|12|||
48802088|NCT03188120|157114075|FG000|Overall Study|Lost to Follow-up|7|||
48802089|NCT03188120|157114075|FG000|Overall Study|Other than specified|3|||
48802090|NCT03188120|157114075|FG000|Overall Study|No visit after the first visit|13|||
48802091|NCT03764072|157114081|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802092|NCT03764072|157114082|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802093|NCT03764072|157114083|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
48802094|NCT03764072|157114084|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802095|NCT03764072|157114085|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802096|NCT03764072|157114086|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
48802097|NCT03764072|157114081|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
48802098|NCT03764072|157114082|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
48595958|NCT04304508|156377806|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
48595959|NCT04304508|156377803|FG000|Overall Study|Withdrawal by Subject|7|||
48595960|NCT04304508|156377804|FG001|Overall Study|Withdrawal by Subject|5|||
48802099|NCT03764072|157114083|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
48802100|NCT03764072|157114084|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
48802101|NCT03764072|157114085|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
48802102|NCT03764072|157114086|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
48802103|NCT03764072|157114081|FG000|Overall Study|Lost to Follow-up|0|||
48802104|NCT03764072|157114082|FG001|Overall Study|Lost to Follow-up|0|||
48802105|NCT03764072|157114083|FG002|Overall Study|Lost to Follow-up|0|||
48802106|NCT03764072|157114084|FG003|Overall Study|Lost to Follow-up|0|||
48802107|NCT03764072|157114085|FG004|Overall Study|Lost to Follow-up|1|||
48802108|NCT03764072|157114086|FG005|Overall Study|Lost to Follow-up|0|||
48802109|NCT02355028|157114087|FG000|Overall Study|Adverse Event|2|||
48802110|NCT02355028|157114088|FG001|Overall Study|Adverse Event|0|||
48802111|NCT02355028|157114087|FG000|Overall Study|Withdrawal by Subject|1|||
48802112|NCT02355028|157114088|FG001|Overall Study|Withdrawal by Subject|1|||
48802113|NCT02355028|157114087|FG000|Overall Study|Deemed ineligible after randomization|8|||
48802114|NCT02355028|157114088|FG001|Overall Study|Deemed ineligible after randomization|4|||
48802115|NCT00459342|157114089|FG000|Overall Study|Not eligible|1|||
48802116|NCT01833143|157114090|FG000|Overall Study|Not Treated|1|||
48802117|NCT00116844|157114100|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
48802118|NCT00116844|157114101|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
48802119|NCT00116844|157114100|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
48802120|NCT00116844|157114101|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
48802121|NCT00116844|157114100|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
48802122|NCT00116844|157114101|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
48802123|NCT00116844|157114100|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
48802124|NCT00116844|157114101|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
48802125|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
48802126|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
48802127|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
48802128|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
48802129|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
48802130|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
48802131|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
48802132|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
48802133|NCT00116844|157114100|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
48802134|NCT00116844|157114101|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
48802135|NCT00847405|157116148|FG000|First Intervention|Adverse Event|0|||
48802136|NCT00847405|157116149|FG001|First Intervention|Adverse Event|1|||
48802137|NCT00847405|157116148|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48802138|NCT00847405|157116149|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48802139|NCT03928028|157116153|FG000|Overall Study|Physician Decision|9|||
48802140|NCT03928028|157116154|FG001|Overall Study|Physician Decision|6|||
48802141|NCT03928028|157116155|FG002|Overall Study|Physician Decision|3|||
48802142|NCT03928028|157116153|FG000|Overall Study|Withdrawal by Subject|12|||
48802143|NCT03928028|157116154|FG001|Overall Study|Withdrawal by Subject|3|||
48802144|NCT03928028|157116155|FG002|Overall Study|Withdrawal by Subject|3|||
48802145|NCT03025789|157116159|FG000|Overall Study|Lack of Efficacy|6|||
48802146|NCT03025789|157116160|FG001|Overall Study|Lack of Efficacy|1|||
48802147|NCT03025789|157116159|FG000|Overall Study|Death|1|||
48802148|NCT03025789|157116160|FG001|Overall Study|Death|0|||
48802149|NCT03025789|157116159|FG000|Overall Study|Withdrawal by Subject|0|||
48802150|NCT03025789|157116160|FG001|Overall Study|Withdrawal by Subject|2|||
48802151|NCT00800202|157116161|FG000|Overall Study|Adverse Event|7|||
48802152|NCT00800202|157116162|FG001|Overall Study|Adverse Event|6|||
48802153|NCT00800202|157116161|FG000|Overall Study|Death|1|||
48802154|NCT00800202|157116162|FG001|Overall Study|Death|0|||
48802155|NCT00800202|157116161|FG000|Overall Study|Other|5|||
48802156|NCT00800202|157116162|FG001|Overall Study|Other|0|||
48802157|NCT00800202|157116161|FG000|Overall Study|Disease Progression|54|||
48802158|NCT00800202|157116162|FG001|Overall Study|Disease Progression|18|||
48802159|NCT04440176|157116166|FG000|Overall Study|Withdrawal by Subject|5|||
48802160|NCT04440176|157116167|FG001|Overall Study|Withdrawal by Subject|3|||
48802161|NCT04440176|157116166|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48802162|NCT04440176|157116167|FG001|Overall Study|Withdrawal by parent/guardian|5|||
48802163|NCT04440176|157116166|FG000|Overall Study|Adverse Event|2|||
48802164|NCT04440176|157116167|FG001|Overall Study|Adverse Event|6|||
48802165|NCT04440176|157116166|FG000|Overall Study|Lost to Follow-up|22|||
48802166|NCT04440176|157116167|FG001|Overall Study|Lost to Follow-up|23|||
48802167|NCT04440176|157116166|FG000|Overall Study|Medication error without associated adverse event|0|||
48802168|NCT04440176|157116167|FG001|Overall Study|Medication error without associated adverse event|1|||
48802169|NCT04440176|157116166|FG000|Overall Study|No longer met eligibility criteria|7|||
48802170|NCT04440176|157116167|FG001|Overall Study|No longer met eligibility criteria|1|||
48802171|NCT04440176|157116166|FG000|Overall Study|Other|1|||
48802172|NCT04440176|157116167|FG001|Overall Study|Other|2|||
48802173|NCT04440176|157116166|FG000|Overall Study|Protocol deviation|6|||
48802174|NCT04440176|157116167|FG001|Overall Study|Protocol deviation|8|||
48802175|NCT04440176|157116166|FG000|Overall Study|Randomized but not vaccinated|6|||
48802176|NCT04440176|157116167|FG001|Overall Study|Randomized but not vaccinated|3|||
48802177|NCT00985725|157116168|FG000|Overall Study|Adverse Event|4|||
48802178|NCT00985725|157116169|FG001|Overall Study|Adverse Event|1|||
48802179|NCT00985725|157116168|FG000|Overall Study|Protocol Violation|1|||
48802180|NCT00985725|157116169|FG001|Overall Study|Protocol Violation|3|||
48802181|NCT00985725|157116168|FG000|Overall Study|Withdrawal by Subject|4|||
48802182|NCT00985725|157116169|FG001|Overall Study|Withdrawal by Subject|4|||
48802183|NCT00985725|157116168|FG000|Overall Study|Lost to Follow-up|1|||
48802184|NCT00985725|157116169|FG001|Overall Study|Lost to Follow-up|1|||
48802185|NCT00985725|157116168|FG000|Overall Study|Lack of Efficacy|0|||
48802186|NCT00985725|157116169|FG001|Overall Study|Lack of Efficacy|1|||
48802187|NCT00985725|157116168|FG000|Overall Study|Non-compliance|1|||
48802188|NCT00985725|157116169|FG001|Overall Study|Non-compliance|2|||
48802189|NCT00985725|157116168|FG000|Overall Study|Out-of-window visits|0|||
48802190|NCT00985725|157116169|FG001|Overall Study|Out-of-window visits|1|||
48802191|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
48802192|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
48802193|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
48802194|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
48802195|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
48802196|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
48802197|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
48802198|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
48802199|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
48802200|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
48802201|NCT00261495|157116172|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
48802202|NCT00261495|157116173|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
48802203|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
48802204|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
48802205|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
48802206|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
48802207|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
48802208|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
48802209|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
48802210|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
48802211|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
48802212|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
48802213|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
48802214|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
48802215|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
48802216|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
48802217|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
48802218|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
48802219|NCT00261495|157116172|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
48802220|NCT00261495|157116173|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
48802221|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
48802222|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
48802223|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
48802224|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48802225|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
48802226|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
48802227|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48802228|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
48802229|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
48802230|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
48802231|NCT00261495|157116172|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
48802232|NCT00261495|157116173|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48802233|NCT00429663|157116176|FG000|Overall Study|Lost to Follow-up|24|||
48802234|NCT00429663|157116177|FG001|Overall Study|Lost to Follow-up|31|||
48802235|NCT00429663|157116176|FG000|Overall Study|Physician Decision|6|||
48802236|NCT00429663|157116177|FG001|Overall Study|Physician Decision|3|||
48802237|NCT00429663|157116176|FG000|Overall Study|Withdrawal by Subject|2|||
48802238|NCT00429663|157116177|FG001|Overall Study|Withdrawal by Subject|5|||
48802239|NCT00429663|157116176|FG000|Overall Study|Death|4|||
48802240|NCT00429663|157116177|FG001|Overall Study|Death|0|||
48802241|NCT01690130|157116182|FG000|Overall Study|Subject have cancelled visit.|1|||
48595961|NCT04304508|156377805|FG002|Overall Study|Withdrawal by Subject|11|||
48802242|NCT01690130|157116183|FG001|Overall Study|Subject have cancelled visit.|0|||
48802243|NCT00152464|157116184|FG000|Overall Study|Adverse Event|3|||
48802244|NCT00152464|157116185|FG001|Overall Study|Adverse Event|6|||
48802245|NCT00152464|157116184|FG000|Overall Study|Lost to Follow-up|8|||
48802246|NCT00152464|157116185|FG001|Overall Study|Lost to Follow-up|4|||
48802247|NCT00152464|157116184|FG000|Overall Study|Protocol Violation|3|||
48595962|NCT04304508|156377806|FG003|Overall Study|Withdrawal by Subject|6|||
48802248|NCT00152464|157116185|FG001|Overall Study|Protocol Violation|1|||
48802249|NCT00152464|157116184|FG000|Overall Study|Withdrawal by Subject|21|||
48802250|NCT00152464|157116185|FG001|Overall Study|Withdrawal by Subject|22|||
48802251|NCT00152464|157116184|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
48802252|NCT00152464|157116185|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
48802253|NCT00152464|157116184|FG000|Overall Study|Eczema deterioration|0|||
48802254|NCT00152464|157116185|FG001|Overall Study|Eczema deterioration|1|||
48802255|NCT00152464|157116184|FG000|Overall Study|Parent decision|1|||
48802256|NCT00152464|157116185|FG001|Overall Study|Parent decision|1|||
48802257|NCT00152464|157116184|FG000|Overall Study|Investigator decision|1|||
48802258|NCT00152464|157116185|FG001|Overall Study|Investigator decision|0|||
48802259|NCT00152464|157116184|FG000|Overall Study|Lack of Efficacy|1|||
48802260|NCT00152464|157116185|FG001|Overall Study|Lack of Efficacy|0|||
48802261|NCT00152464|157116184|FG000|Overall Study|Eczema poorly controlled|1|||
48802262|NCT00152464|157116185|FG001|Overall Study|Eczema poorly controlled|0|||
48802263|NCT00152464|157116184|FG000|Overall Study|Patient relocated|1|||
48802264|NCT00152464|157116185|FG001|Overall Study|Patient relocated|0|||
48802265|NCT01330316|157116196|FG000|Overall Study|Adverse Event|2|||
48802266|NCT01330316|157116197|FG001|Overall Study|Adverse Event|2|||
48802267|NCT01330316|157116196|FG000|Overall Study|Lack of Efficacy|0|||
48802268|NCT01330316|157116197|FG001|Overall Study|Lack of Efficacy|10|||
48802269|NCT01330316|157116196|FG000|Overall Study|Lost to Follow-up|0|||
48802270|NCT01330316|157116197|FG001|Overall Study|Lost to Follow-up|1|||
48802271|NCT01330316|157116196|FG000|Overall Study|Withdrawal by Subject|0|||
48802272|NCT01330316|157116197|FG001|Overall Study|Withdrawal by Subject|1|||
48802273|NCT01330316|157116196|FG000|Overall Study|other than above|0|||
48802274|NCT01330316|157116197|FG001|Overall Study|other than above|1|||
48802275|NCT04176939|157116198|FG000|Overall Study|Adverse Event|7|||
48802276|NCT04176939|157116198|FG000|Overall Study|Unspecified reason|2|||
48802277|NCT04176939|157116198|FG000|Overall Study|Migrated/Moved from the study area|1|||
48802278|NCT04176939|157116198|FG000|Overall Study|Withdrawal by Subject|4|||
48802279|NCT04176939|157116198|FG000|Overall Study|In follow-up|54|||
48802280|NCT00595504|157116199|FG000|Overall Study|Withdrawal by Subject|1|||
48802281|NCT00595504|157116200|FG001|Overall Study|Withdrawal by Subject|3|||
48802282|NCT00595504|157116199|FG000|Overall Study|Physician Decision|1|||
48802283|NCT00595504|157116200|FG001|Overall Study|Physician Decision|0|||
48802284|NCT01662063|157116201|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
48802285|NCT01662063|157116202|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
48802286|NCT01662063|157116203|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
48802287|NCT01662063|157116201|FG000|Overall Study|Lack of Efficacy|1|||
48802288|NCT01662063|157116202|FG001|Overall Study|Lack of Efficacy|6|||
48802289|NCT01662063|157116203|FG002|Overall Study|Lack of Efficacy|0|||
48802290|NCT01662063|157116201|FG000|Overall Study|Lost to Follow-up|0|||
48802291|NCT01662063|157116202|FG001|Overall Study|Lost to Follow-up|4|||
48802292|NCT01662063|157116203|FG002|Overall Study|Lost to Follow-up|0|||
48802293|NCT01662063|157116201|FG000|Overall Study|Protocol Violation|1|||
48802294|NCT01662063|157116202|FG001|Overall Study|Protocol Violation|0|||
48802295|NCT01662063|157116203|FG002|Overall Study|Protocol Violation|0|||
48802296|NCT01662063|157116201|FG000|Overall Study|Withdrawal by Subject|2|||
48802297|NCT01662063|157116202|FG001|Overall Study|Withdrawal by Subject|4|||
48802298|NCT01662063|157116203|FG002|Overall Study|Withdrawal by Subject|1|||
48802299|NCT01662063|157116201|FG000|Overall Study|Physician Decision|0|||
48802300|NCT01662063|157116202|FG001|Overall Study|Physician Decision|2|||
48802301|NCT01662063|157116203|FG002|Overall Study|Physician Decision|0|||
48802302|NCT01662063|157116201|FG000|Overall Study|Other|0|||
48802303|NCT01662063|157116202|FG001|Overall Study|Other|1|||
48802304|NCT01662063|157116203|FG002|Overall Study|Other|0|||
48802305|NCT00615264|157116204|FG000|Overall Study|Withdrawal by Subject|17|||
48802306|NCT00615264|157116205|FG001|Overall Study|Withdrawal by Subject|19|||
48802307|NCT00615264|157116204|FG000|Overall Study|Lost to Follow-up|6|||
48802308|NCT00615264|157116205|FG001|Overall Study|Lost to Follow-up|13|||
48802309|NCT00615264|157116204|FG000|Overall Study|Adverse Event|8|||
48802310|NCT00615264|157116205|FG001|Overall Study|Adverse Event|5|||
48802311|NCT00615264|157116204|FG000|Overall Study|Death|1|||
48802312|NCT00615264|157116205|FG001|Overall Study|Death|1|||
48802313|NCT00615264|157116204|FG000|Overall Study|Protocol Violation|11|||
48802314|NCT00615264|157116205|FG001|Overall Study|Protocol Violation|7|||
48802315|NCT00615264|157116204|FG000|Overall Study|Not defined|7|||
48802316|NCT00615264|157116205|FG001|Overall Study|Not defined|4|||
48802317|NCT00615264|157116204|FG000|Overall Study|Dermal Hypersensitivity|0|||
48802318|NCT00615264|157116205|FG001|Overall Study|Dermal Hypersensitivity|3|||
48802319|NCT01520402|157116206|FG000|Overall Study|Withdrawal by Subject|2|||
48802320|NCT01520402|157116206|FG000|Overall Study|Physician Decision|3|||
48802321|NCT02313909|157116208|FG000|Overall Study|Consent withdrawn by participant|33|||
48802322|NCT02313909|157116209|FG001|Overall Study|Consent withdrawn by participant|33|||
48802323|NCT02313909|157116208|FG000|Overall Study|Lost to Follow-up|24|||
48802324|NCT02313909|157116209|FG001|Overall Study|Lost to Follow-up|17|||
48802325|NCT01982435|157116218|FG000|Overall Study|Adverse Event|1|||
48802326|NCT01982435|157116219|FG001|Overall Study|Adverse Event|0|||
48802327|NCT00638235|157116223|FG000|Overall Study|Lost to Follow-up|31|||
48802328|NCT00638235|157116224|FG001|Overall Study|Lost to Follow-up|3|||
48802329|NCT00638235|157116225|FG002|Overall Study|Lost to Follow-up|18|||
48802330|NCT00638235|157116226|FG003|Overall Study|Lost to Follow-up|10|||
48802331|NCT00638235|157116227|FG004|Overall Study|Lost to Follow-up|13|||
48802332|NCT00638235|157116228|FG005|Overall Study|Lost to Follow-up|26|||
48802333|NCT00638235|157116229|FG006|Overall Study|Lost to Follow-up|0|||
48802334|NCT00638235|157116230|FG007|Overall Study|Lost to Follow-up|1|||
48802335|NCT00638235|157116231|FG008|Overall Study|Lost to Follow-up|18|||
48802336|NCT04026165|157116237|FG000|Run-in Placebo Period|Enrollment Error|13|||
48802337|NCT04026165|157116238|FG001|Run-in Placebo Period|Enrollment Error|0|||
48802338|NCT04026165|157116239|FG002|Run-in Placebo Period|Enrollment Error|0|||
48802339|NCT04026165|157116240|FG003|Run-in Placebo Period|Enrollment Error|0|||
48802340|NCT04026165|157116237|FG000|Run-in Placebo Period|Run-in Failure|4|||
48802341|NCT04026165|157116238|FG001|Run-in Placebo Period|Run-in Failure|0|||
48802342|NCT04026165|157116239|FG002|Run-in Placebo Period|Run-in Failure|0|||
48802343|NCT04026165|157116240|FG003|Run-in Placebo Period|Run-in Failure|0|||
48802344|NCT04026165|157116237|FG000|Run-in Placebo Period|Protocol Violation|2|||
48802345|NCT04026165|157116238|FG001|Run-in Placebo Period|Protocol Violation|0|||
48802346|NCT04026165|157116239|FG002|Run-in Placebo Period|Protocol Violation|0|||
48802347|NCT04026165|157116240|FG003|Run-in Placebo Period|Protocol Violation|0|||
48802348|NCT04026165|157116237|FG000|Run-in Placebo Period|Withdrew Consent|2|||
48802349|NCT04026165|157116238|FG001|Run-in Placebo Period|Withdrew Consent|0|||
48802350|NCT04026165|157116239|FG002|Run-in Placebo Period|Withdrew Consent|0|||
48802351|NCT04026165|157116240|FG003|Run-in Placebo Period|Withdrew Consent|0|||
48802352|NCT04026165|157116237|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
48802353|NCT04026165|157116238|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
48802354|NCT04026165|157116239|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
48802355|NCT04026165|157116240|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
48802356|NCT04026165|157116237|FG000|Run-in SEL Period|Run-in Failure|0|||
48802357|NCT04026165|157116238|FG001|Run-in SEL Period|Run-in Failure|26|||
48802358|NCT04026165|157116239|FG002|Run-in SEL Period|Run-in Failure|0|||
48802359|NCT04026165|157116240|FG003|Run-in SEL Period|Run-in Failure|0|||
48802360|NCT04026165|157116237|FG000|Run-in SEL Period|Withdrew Consent|0|||
48802361|NCT04026165|157116238|FG001|Run-in SEL Period|Withdrew Consent|10|||
48802362|NCT04026165|157116239|FG002|Run-in SEL Period|Withdrew Consent|0|||
48802363|NCT04026165|157116240|FG003|Run-in SEL Period|Withdrew Consent|0|||
48802364|NCT04026165|157116237|FG000|Run-in SEL Period|Enrollment Error|0|||
48802365|NCT04026165|157116238|FG001|Run-in SEL Period|Enrollment Error|4|||
48802366|NCT04026165|157116239|FG002|Run-in SEL Period|Enrollment Error|0|||
48802367|NCT04026165|157116240|FG003|Run-in SEL Period|Enrollment Error|0|||
48802368|NCT04026165|157116237|FG000|Run-in SEL Period|Protocol Violation|0|||
48802369|NCT04026165|157116238|FG001|Run-in SEL Period|Protocol Violation|3|||
48802370|NCT04026165|157116239|FG002|Run-in SEL Period|Protocol Violation|0|||
48802371|NCT04026165|157116240|FG003|Run-in SEL Period|Protocol Violation|0|||
48802372|NCT04026165|157116237|FG000|Run-in SEL Period|Investigator's Discretion|0|||
48802373|NCT04026165|157116238|FG001|Run-in SEL Period|Investigator's Discretion|2|||
48802374|NCT04026165|157116239|FG002|Run-in SEL Period|Investigator's Discretion|0|||
48595963|NCT04304508|156377803|FG000|Overall Study|Logistical Difficulties|2|||
48707908|NCT00670306|156779074|FG000|Overall Study|Withdrawal by Subject|9|||
48707909|NCT00670306|156779074|FG000|Overall Study|Physician Decision|1|||
48707910|NCT00670306|156779074|FG000|Overall Study|Lost to Follow-up|8|||
48707911|NCT00670306|156779074|FG000|Overall Study|incl/excl criterias did not meet|19|||
48707912|NCT01663103|156779078|FG000|Overall Study|Withdrawal by Subject|1|||
48707913|NCT01663103|156779079|FG001|Overall Study|Withdrawal by Subject|2|||
48707914|NCT01663103|156779078|FG000|Overall Study|Adverse Event|1|||
48707915|NCT01663103|156779079|FG001|Overall Study|Adverse Event|0|||
48707916|NCT01663103|156779078|FG000|Overall Study|dog bite|1|||
48707917|NCT01663103|156779079|FG001|Overall Study|dog bite|0|||
48707918|NCT05375760|156779080|FG000|Overall Study|Adverse Event|1|||
48707919|NCT05375760|156779081|FG001|Overall Study|Adverse Event|0|||
48707920|NCT05375760|156779080|FG000|Overall Study|Death|0|||
48707921|NCT05375760|156779081|FG001|Overall Study|Death|1|||
48595964|NCT04304508|156377804|FG001|Overall Study|Logistical Difficulties|2|||
48707922|NCT05375760|156779080|FG000|Overall Study|Lost to Follow-up|6|||
48707923|NCT05375760|156779081|FG001|Overall Study|Lost to Follow-up|6|||
48802375|NCT04026165|157116240|FG003|Run-in SEL Period|Investigator's Discretion|0|||
48802376|NCT04026165|157116237|FG000|Run-in SEL Period|Death|0|||
48802377|NCT04026165|157116238|FG001|Run-in SEL Period|Death|1|||
48802378|NCT04026165|157116239|FG002|Run-in SEL Period|Death|0|||
48802379|NCT04026165|157116240|FG003|Run-in SEL Period|Death|0|||
48802380|NCT04026165|157116237|FG000|Randomized Period|Withdrew Consent|0|||
48802381|NCT04026165|157116238|FG001|Randomized Period|Withdrew Consent|0|||
48802382|NCT04026165|157116239|FG002|Randomized Period|Withdrew Consent|5|||
48802383|NCT04026165|157116240|FG003|Randomized Period|Withdrew Consent|8|||
48802384|NCT04026165|157116237|FG000|Randomized Period|Death|0|||
48802385|NCT04026165|157116238|FG001|Randomized Period|Death|0|||
48802386|NCT04026165|157116239|FG002|Randomized Period|Death|5|||
48802387|NCT04026165|157116240|FG003|Randomized Period|Death|7|||
48802388|NCT04026165|157116237|FG000|Randomized Period|Investigator's Discretion|0|||
48802389|NCT04026165|157116238|FG001|Randomized Period|Investigator's Discretion|0|||
48802390|NCT04026165|157116239|FG002|Randomized Period|Investigator's Discretion|2|||
48802391|NCT04026165|157116240|FG003|Randomized Period|Investigator's Discretion|2|||
48802392|NCT04026165|157116237|FG000|Randomized Period|Lost to Follow-up|0|||
48802393|NCT04026165|157116238|FG001|Randomized Period|Lost to Follow-up|0|||
48802394|NCT04026165|157116239|FG002|Randomized Period|Lost to Follow-up|2|||
48802395|NCT04026165|157116240|FG003|Randomized Period|Lost to Follow-up|2|||
48802396|NCT02992925|157116241|FG000|Cohort 2|Physician Decision|0|||
48802397|NCT02992925|157116242|FG001|Cohort 2|Physician Decision|0|||
48802398|NCT02992925|157116243|FG002|Cohort 2|Physician Decision|1|||
48802399|NCT02992925|157116244|FG003|Cohort 2|Physician Decision|0|||
48802400|NCT02992925|157116241|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
48802401|NCT02992925|157116242|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
48802402|NCT02992925|157116243|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
48802403|NCT02992925|157116244|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
48802404|NCT00948974|157116249|FG000|Overall Study|Lost to Follow-up|23|||
48802405|NCT00948974|157116250|FG001|Overall Study|Lost to Follow-up|20|||
48802406|NCT02487810|157116251|FG000|Overall Study|Withdrawal by Subject|1|||
48802407|NCT02487810|157116252|FG001|Overall Study|Withdrawal by Subject|0|||
48802408|NCT02569437|157116253|FG000|Overall Study|Lost to Follow-up|12|||
48802409|NCT02569437|157116254|FG001|Overall Study|Lost to Follow-up|14|||
48802410|NCT04650269|157116261|FG000|Overall Study|Death|3|||
48802411|NCT04650269|157116261|FG000|Overall Study|Lost to Follow-up|6|||
48802412|NCT00946296|157116262|FG000|Overall Study|Physician Decision|3|||
48802413|NCT00946296|157116263|FG001|Overall Study|Physician Decision|0|||
48802414|NCT03252847|157116264|FG000|Overall Study|Withdrawal by Subject|0|||
48802415|NCT03252847|157116265|FG001|Overall Study|Withdrawal by Subject|0|||
48802416|NCT03252847|157116266|FG002|Overall Study|Withdrawal by Subject|1|||
48802417|NCT03252847|157116267|FG003|Overall Study|Withdrawal by Subject|0|||
48802418|NCT03252847|157116268|FG004|Overall Study|Withdrawal by Subject|0|||
48802419|NCT03252847|157116269|FG005|Overall Study|Withdrawal by Subject|0|||
48802420|NCT03252847|157116270|FG006|Overall Study|Withdrawal by Subject|0|||
48802421|NCT03252847|157116264|FG000|Overall Study|Other: Patient decision|0|||
48802422|NCT03252847|157116265|FG001|Overall Study|Other: Patient decision|0|||
48802423|NCT03252847|157116266|FG002|Overall Study|Other: Patient decision|0|||
48802424|NCT03252847|157116267|FG003|Overall Study|Other: Patient decision|0|||
48802425|NCT03252847|157116268|FG004|Overall Study|Other: Patient decision|1|||
48802426|NCT03252847|157116269|FG005|Overall Study|Other: Patient decision|0|||
48802427|NCT03252847|157116270|FG006|Overall Study|Other: Patient decision|0|||
48802428|NCT02010632|157116292|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
48802429|NCT02010632|157116293|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
48802430|NCT02612064|157116297|FG000|Overall Study|Withdrawal by Subject|1|||
48802431|NCT02612064|157116298|FG001|Overall Study|Withdrawal by Subject|1|||
48802432|NCT02612064|157116297|FG000|Overall Study|Other|0|||
48707924|NCT05375760|156779080|FG000|Overall Study|Withdrawal by Subject|17|||
48707925|NCT05375760|156779081|FG001|Overall Study|Withdrawal by Subject|19|||
48707926|NCT05375760|156779080|FG000|Overall Study|Dosing halted by FDA|96|||
48707927|NCT05375760|156779081|FG001|Overall Study|Dosing halted by FDA|100|||
48707928|NCT05375760|156779080|FG000|Overall Study|Not compliant with study visit|2|||
48707929|NCT05375760|156779081|FG001|Overall Study|Not compliant with study visit|0|||
48707930|NCT05375760|156779080|FG000|Overall Study|Physician Decision|1|||
48707931|NCT05375760|156779081|FG001|Overall Study|Physician Decision|0|||
48707932|NCT05375760|156779080|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
48707933|NCT05375760|156779081|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
48707934|NCT05375760|156779080|FG000|Overall Study|Participant moved|1|||
48707935|NCT05375760|156779081|FG001|Overall Study|Participant moved|0|||
48707936|NCT03636893|156779082|FG000|Overall Study|Death|0|||
48707937|NCT03636893|156779083|FG001|Overall Study|Death|1|||
48707938|NCT03636893|156779082|FG000|Overall Study|Protocol Violation|0|||
48802433|NCT02612064|157116298|FG001|Overall Study|Other|2|||
48802434|NCT01651403|157116299|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
48802435|NCT01651403|157116300|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
48802436|NCT01651403|157116299|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
48802437|NCT01651403|157116300|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
48802438|NCT01651403|157116299|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
48802439|NCT01651403|157116300|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
48802440|NCT01651403|157116299|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
48802441|NCT01651403|157116300|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
48802442|NCT01651403|157116299|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
48802443|NCT01651403|157116300|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
48802444|NCT01651403|157116299|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
48802445|NCT01651403|157116300|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
48802446|NCT01120249|157116301|FG000|Overall Study|No protocol treatment received|21|||
48802447|NCT01120249|157116302|FG001|Overall Study|No protocol treatment received|15|||
48802448|NCT01120249|157116301|FG000|Overall Study|Disease recurrence|107|||
48802449|NCT01120249|157116302|FG001|Overall Study|Disease recurrence|57|||
48802450|NCT01120249|157116301|FG000|Overall Study|Death|1|||
48802451|NCT01120249|157116302|FG001|Overall Study|Death|0|||
48802452|NCT01120249|157116301|FG000|Overall Study|Adverse Event|40|||
48802453|NCT01120249|157116302|FG001|Overall Study|Adverse Event|276|||
48802454|NCT01120249|157116301|FG000|Overall Study|Participant refusal|34|||
48802455|NCT01120249|157116302|FG001|Overall Study|Participant refusal|42|||
48802456|NCT01120249|157116301|FG000|Overall Study|Other reasons, not protocol specified|29|||
48802457|NCT01120249|157116302|FG001|Overall Study|Other reasons, not protocol specified|22|||
48802458|NCT04689256|157116303|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
48802459|NCT04689256|157116304|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
48802460|NCT04741776|157116305|FG000|Overall Study|Withdrawal by Subject|7|||
48802461|NCT04741776|157116306|FG001|Overall Study|Withdrawal by Subject|10|||
48802462|NCT04741776|157116307|FG002|Overall Study|Withdrawal by Subject|10|||
48802463|NCT04741776|157116308|FG003|Overall Study|Withdrawal by Subject|17|||
48802464|NCT04741776|157116305|FG000|Overall Study|Death|0|||
48802465|NCT04741776|157116306|FG001|Overall Study|Death|0|||
48802466|NCT04741776|157116307|FG002|Overall Study|Death|1|||
48802467|NCT04741776|157116308|FG003|Overall Study|Death|0|||
48802468|NCT03520400|157116309|FG000|Overall Study|Physician Decision|15|||
48802469|NCT03520400|157116310|FG001|Overall Study|Physician Decision|7|||
48802470|NCT01654601|157116313|FG000|1st Administration|Withdrawal by Subject|2|||
48802471|NCT01654601|157116314|FG001|1st Administration|Withdrawal by Subject|0|||
48802472|NCT01654601|157116313|FG000|1st Administration|Protocol Violation|0|||
48802473|NCT01654601|157116314|FG001|1st Administration|Protocol Violation|2|||
48802474|NCT01654601|157116313|FG000|2nd Administration|Adverse Event|1|||
48802475|NCT01654601|157116314|FG001|2nd Administration|Adverse Event|0|||
48802476|NCT01654601|157116313|FG000|2nd Administration|Protocol Violation|0|||
48802477|NCT01654601|157116314|FG001|2nd Administration|Protocol Violation|1|||
48802478|NCT01119898|157116315|FG000|Overall Study|Adverse Event|4|||
48802479|NCT01119898|157116316|FG001|Overall Study|Adverse Event|5|||
48802480|NCT01119898|157116315|FG000|Overall Study|Withdrawal by Subject|1|||
48802481|NCT01119898|157116316|FG001|Overall Study|Withdrawal by Subject|4|||
48802482|NCT01119898|157116315|FG000|Overall Study|Lack of Efficacy|0|||
48802483|NCT01119898|157116316|FG001|Overall Study|Lack of Efficacy|2|||
48802484|NCT01119898|157116315|FG000|Overall Study|Protocol Violation|1|||
48802485|NCT01119898|157116316|FG001|Overall Study|Protocol Violation|1|||
48802486|NCT01119898|157116315|FG000|Overall Study|Medical procedure|1|||
48802487|NCT01119898|157116316|FG001|Overall Study|Medical procedure|0|||
48802488|NCT01119898|157116315|FG000|Overall Study|Randomized in error did not participate|1|||
48802489|NCT01119898|157116316|FG001|Overall Study|Randomized in error did not participate|0|||
48802490|NCT01122381|157116317|FG000|Overall Study|study terminated early|0|||
48802491|NCT01122381|157116318|FG001|Overall Study|study terminated early|1|||
48802492|NCT04108000|157116319|FG000|Overall Study|Death of patient|1|||
48802493|NCT04108000|157116320|FG001|Overall Study|Death of patient|0|||
48802494|NCT04108000|157116321|FG002|Overall Study|Death of patient|1|||
48802495|NCT04108000|157116322|FG003|Overall Study|Death of patient|0|||
48802496|NCT04108000|157116319|FG000|Overall Study|Withdrawal by Subject|2|||
48802497|NCT04108000|157116320|FG001|Overall Study|Withdrawal by Subject|2|||
48802498|NCT04108000|157116321|FG002|Overall Study|Withdrawal by Subject|0|||
48802499|NCT04108000|157116322|FG003|Overall Study|Withdrawal by Subject|0|||
48802500|NCT04108000|157116319|FG000|Overall Study|Death of surrogate partner|0|||
48802501|NCT04108000|157116320|FG001|Overall Study|Death of surrogate partner|1|||
48802502|NCT04108000|157116321|FG002|Overall Study|Death of surrogate partner|0|||
48802503|NCT04108000|157116322|FG003|Overall Study|Death of surrogate partner|1|||
48802504|NCT02272725|157116326|FG000|Overall Study|equipment malfunction|2|||
48802505|NCT02272725|157116327|FG001|Overall Study|equipment malfunction|0|||
48802506|NCT02323646|157117786|FG000|Treatment Course 1|Adverse Event|1|||
48802507|NCT02323646|157117787|FG001|Treatment Course 1|Adverse Event|0|||
48802508|NCT02323646|157117788|FG002|Treatment Course 1|Adverse Event|1|||
48707939|NCT03636893|156779083|FG001|Overall Study|Protocol Violation|3|||
48707940|NCT03636893|156779082|FG000|Overall Study|Withdrawal by Subject|1|||
48707941|NCT03636893|156779083|FG001|Overall Study|Withdrawal by Subject|2|||
48707942|NCT03636893|156779082|FG000|Overall Study|Refusal to surgery|4|||
48707943|NCT03636893|156779083|FG001|Overall Study|Refusal to surgery|3|||
48707944|NCT03636893|156779082|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
48707945|NCT03636893|156779083|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
48707946|NCT03636893|156779082|FG000|Overall Study|Adverse Event|1|||
48707947|NCT03636893|156779083|FG001|Overall Study|Adverse Event|1|||
48707948|NCT00996333|156779084|FG000|Overall Study|Screen failure|1|||
48707949|NCT00996333|156779084|FG000|Overall Study|Withdrawal by Subject|1|||
48707950|NCT00996333|156779084|FG000|Overall Study|Death|4|||
48707951|NCT00996333|156779084|FG000|Overall Study|Adverse Event|1|||
48707952|NCT00996333|156779084|FG000|Overall Study|Physician Decision|1|||
48707953|NCT00996333|156779084|FG000|Overall Study|Other|5|||
48707954|NCT00611026|156779089|FG000|Randomized to Double-blind Treatment|Not treated|2|||
48707955|NCT00611026|156779090|FG001|Randomized to Double-blind Treatment|Not treated|1|||
48707956|NCT00611026|156779091|FG002|Randomized to Double-blind Treatment|Not treated|3|||
48707957|NCT00611026|156779089|FG000|Double-blind Treatment Period|Death|1|||
48707958|NCT00611026|156779090|FG001|Double-blind Treatment Period|Death|0|||
48707959|NCT00611026|156779091|FG002|Double-blind Treatment Period|Death|0|||
48707960|NCT00611026|156779089|FG000|Double-blind Treatment Period|Adverse Event|9|||
48707961|NCT00611026|156779090|FG001|Double-blind Treatment Period|Adverse Event|28|||
48707962|NCT00611026|156779091|FG002|Double-blind Treatment Period|Adverse Event|46|||
48707963|NCT00611026|156779089|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
48707964|NCT00611026|156779090|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
48707965|NCT00611026|156779091|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
48707966|NCT00611026|156779089|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
48707967|NCT00611026|156779090|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
48707968|NCT00611026|156779091|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
48707969|NCT00611026|156779089|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
48707970|NCT00611026|156779090|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
48707971|NCT00611026|156779091|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
48707972|NCT00611026|156779089|FG000|Double-blind Treatment Period|Other|13|||
48707973|NCT00611026|156779090|FG001|Double-blind Treatment Period|Other|20|||
48707974|NCT00611026|156779091|FG002|Double-blind Treatment Period|Other|18|||
48707975|NCT01310075|156779092|FG000|Overall Study|Lost to Follow-up|1|||
48707976|NCT01310075|156779093|FG001|Overall Study|Lost to Follow-up|0|||
48707977|NCT01310075|156779092|FG000|Overall Study|Physician Decision|10|||
48707978|NCT01310075|156779093|FG001|Overall Study|Physician Decision|7|||
48707979|NCT01310075|156779092|FG000|Overall Study|Protocol Violation|2|||
48707980|NCT01310075|156779093|FG001|Overall Study|Protocol Violation|2|||
48707981|NCT01310075|156779092|FG000|Overall Study|Withdrawal by Subject|1|||
48707982|NCT01310075|156779093|FG001|Overall Study|Withdrawal by Subject|1|||
48707983|NCT03614156|156779094|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
48707984|NCT03614156|156779095|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
48707985|NCT03614156|156779096|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
48707986|NCT03614156|156779097|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
48707987|NCT03614156|156779094|FG000|Open-Label Treatment Period|Adverse Event|7|||
48707988|NCT03614156|156779095|FG001|Open-Label Treatment Period|Adverse Event|0|||
48707989|NCT03614156|156779096|FG002|Open-Label Treatment Period|Adverse Event|0|||
48707990|NCT03614156|156779097|FG003|Open-Label Treatment Period|Adverse Event|0|||
48707991|NCT03614156|156779094|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
48707992|NCT03614156|156779095|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
48707993|NCT03614156|156779096|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
48707994|NCT03614156|156779097|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
48707995|NCT03614156|156779094|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
48707996|NCT03614156|156779095|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
48707997|NCT03614156|156779096|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
48707998|NCT03614156|156779097|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
48707999|NCT03614156|156779094|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
48708000|NCT03614156|156779095|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
48708001|NCT03614156|156779096|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
48802509|NCT02323646|157117786|FG000|Treatment Course 1|Heavy Bleeding|1|||
48802510|NCT02323646|157117787|FG001|Treatment Course 1|Heavy Bleeding|1|||
48802511|NCT02323646|157117788|FG002|Treatment Course 1|Heavy Bleeding|0|||
48802512|NCT02323646|157117786|FG000|Treatment Course 1|Lost to Follow-up|1|||
48802513|NCT02323646|157117787|FG001|Treatment Course 1|Lost to Follow-up|0|||
48802514|NCT02323646|157117788|FG002|Treatment Course 1|Lost to Follow-up|2|||
48708002|NCT03614156|156779097|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
48708003|NCT03614156|156779094|FG000|Open-Label Treatment Period|Protocol Violation|2|||
48708004|NCT03614156|156779095|FG001|Open-Label Treatment Period|Protocol Violation|0|||
48708005|NCT03614156|156779096|FG002|Open-Label Treatment Period|Protocol Violation|0|||
48708006|NCT03614156|156779097|FG003|Open-Label Treatment Period|Protocol Violation|0|||
48708007|NCT03614156|156779094|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
48708008|NCT03614156|156779095|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
48708009|NCT03614156|156779096|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
48708010|NCT03614156|156779097|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
48708011|NCT03614156|156779094|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
48708012|NCT03614156|156779095|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
48708013|NCT03614156|156779096|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
48708014|NCT03614156|156779097|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
48708015|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
48708016|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
48708017|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
48708018|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
48708019|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48708020|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
48708021|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48708022|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48708023|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48708024|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48708025|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
48708026|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
48708027|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
48708028|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
48708029|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
48708030|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
48708031|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
48708032|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
48708033|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
48708034|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
48708035|NCT03614156|156779094|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
48708036|NCT03614156|156779095|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
48708037|NCT03614156|156779096|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
48708038|NCT03614156|156779097|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
48708039|NCT03614156|156779094|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
48708040|NCT03614156|156779095|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
48708041|NCT03614156|156779096|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
48708042|NCT03614156|156779097|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
48708043|NCT03614156|156779094|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
48708044|NCT03614156|156779095|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
48708045|NCT03614156|156779096|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
48708046|NCT03614156|156779097|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
48708047|NCT03614156|156779094|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
48708048|NCT03614156|156779095|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
48708049|NCT03614156|156779096|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
48708050|NCT03614156|156779097|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
48708051|NCT02991040|156779101|FG000|Overall Study|Withdrawal by Subject|2|||
48708052|NCT02991040|156779101|FG000|Overall Study|Lost to Follow-up|2|||
48708053|NCT04287517|156779103|FG000|Overall Study|Withdrawal by Subject|1|||
48802515|NCT02323646|157117786|FG000|Treatment Course 1|Withdrawal by Subject|0|||
48802516|NCT02323646|157117787|FG001|Treatment Course 1|Withdrawal by Subject|2|||
48802517|NCT02323646|157117788|FG002|Treatment Course 1|Withdrawal by Subject|0|||
48802518|NCT02323646|157117786|FG000|Treatment Course 2|Adverse Event|1|||
48802519|NCT02323646|157117787|FG001|Treatment Course 2|Adverse Event|0|||
48802520|NCT02323646|157117788|FG002|Treatment Course 2|Adverse Event|1|||
48802521|NCT02323646|157117786|FG000|Treatment Course 2|Lost to Follow-up|0|||
48802522|NCT02323646|157117787|FG001|Treatment Course 2|Lost to Follow-up|0|||
48802523|NCT02323646|157117788|FG002|Treatment Course 2|Lost to Follow-up|1|||
48802524|NCT02323646|157117786|FG000|Treatment Course 2|Non-compliance|0|||
48802525|NCT02323646|157117787|FG001|Treatment Course 2|Non-compliance|1|||
48802526|NCT02323646|157117788|FG002|Treatment Course 2|Non-compliance|1|||
48802527|NCT00508261|157117789|FG000|Overall Study|Other|0|||
48802528|NCT00508261|157117790|FG001|Overall Study|Other|1|||
48802529|NCT00508261|157117791|FG002|Overall Study|Other|1|||
48802530|NCT00508261|157117792|FG003|Overall Study|Other|0|||
48802531|NCT00508261|157117789|FG000|Overall Study|Serious Adverse Event|0|||
48802532|NCT00508261|157117790|FG001|Overall Study|Serious Adverse Event|1|||
48802533|NCT00508261|157117791|FG002|Overall Study|Serious Adverse Event|0|||
48802534|NCT00508261|157117792|FG003|Overall Study|Serious Adverse Event|0|||
48802535|NCT00508261|157117789|FG000|Overall Study|Withdrawal by Subject|3|||
48802536|NCT00508261|157117790|FG001|Overall Study|Withdrawal by Subject|4|||
48802537|NCT00508261|157117791|FG002|Overall Study|Withdrawal by Subject|4|||
48802538|NCT00508261|157117792|FG003|Overall Study|Withdrawal by Subject|0|||
48802539|NCT00508261|157117789|FG000|Overall Study|Migrated/ moved from study area|0|||
48802540|NCT00508261|157117790|FG001|Overall Study|Migrated/ moved from study area|1|||
48802541|NCT00508261|157117791|FG002|Overall Study|Migrated/ moved from study area|0|||
48802542|NCT00508261|157117792|FG003|Overall Study|Migrated/ moved from study area|0|||
48802543|NCT00508261|157117789|FG000|Overall Study|Lost to Follow-up|0|||
48802544|NCT00508261|157117790|FG001|Overall Study|Lost to Follow-up|1|||
48802545|NCT00508261|157117791|FG002|Overall Study|Lost to Follow-up|1|||
48802546|NCT00508261|157117792|FG003|Overall Study|Lost to Follow-up|1|||
48802547|NCT03517553|157117795|FG000|Overall Study|Withdrawal by Subject|2|||
48802548|NCT02736825|157117798|FG000|Overall Study|Lost to Follow-up|10|||
48802549|NCT02736825|157117799|FG001|Overall Study|Lost to Follow-up|11|||
48802550|NCT02736825|157117798|FG000|Overall Study|Early Termination|0|||
48802551|NCT02736825|157117799|FG001|Overall Study|Early Termination|1|||
48802552|NCT00790452|157117800|FG000|Overall Study|Drug supply issue|1|||
48802553|NCT00790452|157117801|FG001|Overall Study|Drug supply issue|0|||
48802554|NCT01564368|157117802|FG000|Overall Study|Ineligible|18|||
48802555|NCT01564368|157117802|FG000|Overall Study|Not Randomized in Parent study|116|||
48802556|NCT01564368|157117802|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
48802557|NCT01564368|157117802|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
48802558|NCT03320018|157117808|FG000|Treatment Period|Withdrawal by Subject|1|||
48802559|NCT03320018|157117809|FG001|Treatment Period|Withdrawal by Subject|0|||
48802560|NCT03320018|157117808|FG000|Day 90 Follow up|Death|0|||
48802561|NCT03320018|157117809|FG001|Day 90 Follow up|Death|1|||
48802562|NCT01699022|157117810|FG000|Overall Study|Early discontinuation from the study|3|||
48802563|NCT00827541|157117811|FG000|Overall Study|Exitus|1|||
48802564|NCT00827541|157117812|FG001|Overall Study|Exitus|8|||
48802565|NCT00827541|157117811|FG000|Overall Study|Other|1|||
48802566|NCT00827541|157117812|FG001|Overall Study|Other|3|||
48802567|NCT00827541|157117811|FG000|Overall Study|Pathogen not susceptible|1|||
48802568|NCT00827541|157117812|FG001|Overall Study|Pathogen not susceptible|0|||
48802569|NCT00827541|157117811|FG000|Overall Study|Lack of effectiveness|1|||
48802570|NCT00827541|157117812|FG001|Overall Study|Lack of effectiveness|0|||
48802571|NCT01750879|157117813|FG000|Overall Study|Adverse Event|8|||
48802572|NCT01750879|157117814|FG001|Overall Study|Adverse Event|0|||
48802573|NCT01750879|157117813|FG000|Overall Study|Lack of Efficacy|1|||
48802574|NCT01750879|157117814|FG001|Overall Study|Lack of Efficacy|0|||
48802575|NCT01750879|157117813|FG000|Overall Study|Withdrawal by Subject|1|||
48802576|NCT01750879|157117814|FG001|Overall Study|Withdrawal by Subject|0|||
48802577|NCT01750879|157117813|FG000|Overall Study|Did not complete per protocol|0|||
48802578|NCT01750879|157117814|FG001|Overall Study|Did not complete per protocol|3|||
48802579|NCT01995539|157117815|FG000|Overall Study|Screening Failure|1|||
48802580|NCT01995539|157117815|FG000|Overall Study|Withdrawal by Investigator|15|||
48802581|NCT01995539|157117815|FG000|Overall Study|Withdrawal by Subject|11|||
48802582|NCT01995539|157117815|FG000|Overall Study|Lost to Follow-up|5|||
48802583|NCT01995539|157117815|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
48802584|NCT01287611|157117816|FG000|Overall Study|Lost to Follow-up|29|||
48802585|NCT01287611|157117817|FG001|Overall Study|Lost to Follow-up|16|||
48802586|NCT01287611|157117816|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
48802587|NCT01287611|157117817|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
48802588|NCT03476187|157117824|FG000|Overall Study|Protocol Violation|7|||
48802589|NCT03476187|157117824|FG000|Overall Study|Physician Decision|5|||
48802590|NCT03879408|157117825|FG000|Overall Study|Lost to Follow-up|0|||
48802591|NCT03879408|157117826|FG001|Overall Study|Lost to Follow-up|3|||
48802592|NCT03879408|157117827|FG002|Overall Study|Lost to Follow-up|2|||
48802593|NCT03879408|157117828|FG003|Overall Study|Lost to Follow-up|1|||
48802594|NCT03879408|157117829|FG004|Overall Study|Lost to Follow-up|0|||
48802595|NCT03879408|157117825|FG000|Overall Study|Withdrawal by Subject|2|||
48802596|NCT03879408|157117826|FG001|Overall Study|Withdrawal by Subject|1|||
48802597|NCT03879408|157117827|FG002|Overall Study|Withdrawal by Subject|1|||
48802598|NCT03879408|157117828|FG003|Overall Study|Withdrawal by Subject|0|||
48802599|NCT03879408|157117829|FG004|Overall Study|Withdrawal by Subject|1|||
48802600|NCT05239455|157117834|FG000|Overall Study|Adverse Event|1|||
48802601|NCT05239455|157117834|FG000|Overall Study|Sponsor Decision|5|||
48802602|NCT05239455|157117834|FG000|Overall Study|Incomplete Blood Collection|1|||
48802603|NCT02277743|157117841|FG000|Overall Study|Protocol Violation|1|||
48802604|NCT02277743|157117842|FG001|Overall Study|Protocol Violation|1|||
48802605|NCT02277743|157117843|FG002|Overall Study|Protocol Violation|1|||
48802606|NCT02277743|157117841|FG000|Overall Study|Adverse Event|10|||
48802607|NCT02277743|157117842|FG001|Overall Study|Adverse Event|6|||
48802608|NCT02277743|157117843|FG002|Overall Study|Adverse Event|6|||
48802609|NCT02277743|157117841|FG000|Overall Study|Lack of Efficacy|11|||
48802610|NCT02277743|157117842|FG001|Overall Study|Lack of Efficacy|4|||
48802611|NCT02277743|157117843|FG002|Overall Study|Lack of Efficacy|3|||
48802612|NCT02277743|157117841|FG000|Overall Study|Other than specified above|18|||
48802613|NCT02277743|157117842|FG001|Overall Study|Other than specified above|5|||
48802614|NCT02277743|157117843|FG002|Overall Study|Other than specified above|16|||
48802615|NCT00782496|157117846|FG000|Overall Study|Lost to Follow-up|14|||
48802616|NCT00782496|157117847|FG001|Overall Study|Lost to Follow-up|15|||
48802617|NCT01987817|157117848|FG000|Overall Study|Adverse Event|4|||
48802618|NCT01987817|157117849|FG001|Overall Study|Adverse Event|0|||
48802619|NCT01987817|157117848|FG000|Overall Study|Withdrawal by Subject|1|||
48802620|NCT01987817|157117849|FG001|Overall Study|Withdrawal by Subject|1|||
48802621|NCT01987817|157117848|FG000|Overall Study|Physician Decision|1|||
48708054|NCT04287517|156779104|FG001|Overall Study|Withdrawal by Subject|1|||
48708055|NCT02721966|156779105|FG000|Overall Study|Protocol Violation|1|||
48708056|NCT02721966|156779106|FG001|Overall Study|Protocol Violation|0|||
48708057|NCT02721966|156779107|FG002|Overall Study|Protocol Violation|0|||
48708058|NCT02721966|156779108|FG003|Overall Study|Protocol Violation|0|||
48708059|NCT02721966|156779109|FG004|Overall Study|Protocol Violation|0|||
48708060|NCT02721966|156779105|FG000|Overall Study|Withdrawal by Subject|9|||
48708061|NCT02721966|156779106|FG001|Overall Study|Withdrawal by Subject|2|||
48708062|NCT02721966|156779107|FG002|Overall Study|Withdrawal by Subject|3|||
48708063|NCT02721966|156779108|FG003|Overall Study|Withdrawal by Subject|7|||
48708064|NCT02721966|156779109|FG004|Overall Study|Withdrawal by Subject|0|||
48708065|NCT02721966|156779105|FG000|Overall Study|Adverse Event|4|||
48708066|NCT02721966|156779106|FG001|Overall Study|Adverse Event|4|||
48708067|NCT02721966|156779107|FG002|Overall Study|Adverse Event|3|||
48708068|NCT02721966|156779108|FG003|Overall Study|Adverse Event|0|||
48708069|NCT02721966|156779109|FG004|Overall Study|Adverse Event|0|||
48708070|NCT02721966|156779105|FG000|Overall Study|Death|1|||
48708071|NCT02721966|156779106|FG001|Overall Study|Death|0|||
48708072|NCT02721966|156779107|FG002|Overall Study|Death|0|||
48708073|NCT02721966|156779108|FG003|Overall Study|Death|0|||
48708074|NCT02721966|156779109|FG004|Overall Study|Death|0|||
48708075|NCT02721966|156779105|FG000|Overall Study|Lack of Efficacy|7|||
48708076|NCT02721966|156779106|FG001|Overall Study|Lack of Efficacy|4|||
48708077|NCT02721966|156779107|FG002|Overall Study|Lack of Efficacy|0|||
48708078|NCT02721966|156779108|FG003|Overall Study|Lack of Efficacy|0|||
48708079|NCT02721966|156779109|FG004|Overall Study|Lack of Efficacy|0|||
48708080|NCT02721966|156779105|FG000|Overall Study|Lost to Follow-up|0|||
48708081|NCT02721966|156779106|FG001|Overall Study|Lost to Follow-up|0|||
48708082|NCT02721966|156779107|FG002|Overall Study|Lost to Follow-up|3|||
48708083|NCT02721966|156779108|FG003|Overall Study|Lost to Follow-up|0|||
48708084|NCT02721966|156779109|FG004|Overall Study|Lost to Follow-up|0|||
48708085|NCT02721966|156779105|FG000|Overall Study|Physician Decision|1|||
48708086|NCT02721966|156779106|FG001|Overall Study|Physician Decision|1|||
48708087|NCT02721966|156779107|FG002|Overall Study|Physician Decision|0|||
48708088|NCT02721966|156779108|FG003|Overall Study|Physician Decision|0|||
48708089|NCT02721966|156779109|FG004|Overall Study|Physician Decision|0|||
48708090|NCT02721966|156779105|FG000|Overall Study|Pregnancy|1|||
48708091|NCT02721966|156779106|FG001|Overall Study|Pregnancy|0|||
48708092|NCT02721966|156779107|FG002|Overall Study|Pregnancy|0|||
48708093|NCT02721966|156779108|FG003|Overall Study|Pregnancy|0|||
48708094|NCT02721966|156779109|FG004|Overall Study|Pregnancy|0|||
48708095|NCT02721966|156779105|FG000|Overall Study|Did not continue to period 2|5|||
48708096|NCT02721966|156779106|FG001|Overall Study|Did not continue to period 2|12|||
48708097|NCT02721966|156779107|FG002|Overall Study|Did not continue to period 2|0|||
48802622|NCT01987817|157117849|FG001|Overall Study|Physician Decision|0|||
48802623|NCT02130284|157117850|FG000|Overall Study|Withdrawal by Subject|3|||
48802624|NCT02130284|157117850|FG000|Overall Study|Subject Withdrew Consent|1|||
48802625|NCT02130284|157117850|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
48802626|NCT02130284|157117850|FG000|Overall Study|Subject was screened as backup for study|3|||
48802627|NCT02130284|157117850|FG000|Overall Study|Screen Failure|1|||
48802628|NCT00682643|157117851|FG000|Overall Study|Adverse Event|12|||
48802629|NCT00682643|157117852|FG001|Overall Study|Adverse Event|23|||
48802630|NCT00682643|157117851|FG000|Overall Study|Lack of Efficacy|2|||
48802631|NCT00682643|157117852|FG001|Overall Study|Lack of Efficacy|0|||
48802632|NCT00682643|157117851|FG000|Overall Study|Protocol Violation|38|||
48802633|NCT00682643|157117852|FG001|Overall Study|Protocol Violation|76|||
48802634|NCT00682643|157117851|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
48708098|NCT02721966|156779108|FG003|Overall Study|Did not continue to period 2|0|||
48708099|NCT02721966|156779109|FG004|Overall Study|Did not continue to period 2|5|||
48708100|NCT01192191|156779110|FG000|Overall Study|Adverse Event|7|||
48708101|NCT01192191|156779111|FG001|Overall Study|Adverse Event|12|||
48708102|NCT01192191|156779110|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
48708103|NCT01192191|156779111|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
48708104|NCT01192191|156779110|FG000|Overall Study|Lost to Follow-up|0|||
48708105|NCT01192191|156779111|FG001|Overall Study|Lost to Follow-up|1|||
48708106|NCT01192191|156779110|FG000|Overall Study|Withdrawal by Subject|1|||
48708107|NCT01192191|156779111|FG001|Overall Study|Withdrawal by Subject|6|||
48708108|NCT03070964|156779112|FG000|Overall Study|Progressive disease|8|||
48708109|NCT03070964|156779112|FG000|Overall Study|Treatment-unrelated adverse event|2|||
48708110|NCT03070964|156779112|FG000|Overall Study|Never treated|1|||
48708111|NCT03070964|156779112|FG000|Overall Study|Physician Decision|1|||
48802635|NCT00682643|157117852|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
48802636|NCT00682643|157117851|FG000|Overall Study|Lost to Follow-up|1|||
48802637|NCT00682643|157117852|FG001|Overall Study|Lost to Follow-up|6|||
48802638|NCT00682643|157117851|FG000|Overall Study|Physician Decision|2|||
48802639|NCT00682643|157117852|FG001|Overall Study|Physician Decision|6|||
48595965|NCT04304508|156377805|FG002|Overall Study|Logistical Difficulties|3|||
48802640|NCT00682643|157117851|FG000|Overall Study|Withdrawal by Subject|19|||
48802641|NCT00682643|157117852|FG001|Overall Study|Withdrawal by Subject|53|||
48802642|NCT00682643|157117851|FG000|Overall Study|Did Not Receive Study Drug|1|||
48802643|NCT00682643|157117852|FG001|Overall Study|Did Not Receive Study Drug|1|||
48802644|NCT01875185|157117853|FG000|Overall Study|study was terminated|52|||
48802645|NCT01875185|157117854|FG001|Overall Study|study was terminated|48|||
48802646|NCT03403426|157117858|FG000|Overall Study|Death|1|||
48802647|NCT03403426|157117858|FG000|Overall Study|Lost to Follow-up|2|||
48802648|NCT00736489|157117860|FG000|Period 1|Lost to Follow-up|1|||
48802649|NCT00736489|157117861|FG001|Period 1|Lost to Follow-up|0|||
48802650|NCT00736489|157117862|FG002|Period 1|Lost to Follow-up|0|||
48802651|NCT00736489|157117863|FG003|Period 1|Lost to Follow-up|0|||
48802652|NCT00736489|157117864|FG004|Period 1|Lost to Follow-up|0|||
48802653|NCT00736489|157117865|FG005|Period 1|Lost to Follow-up|0|||
48802654|NCT00736489|157117860|FG000|Period 1|Withdrawal by Subject|0|||
48802655|NCT00736489|157117861|FG001|Period 1|Withdrawal by Subject|0|||
48802656|NCT00736489|157117862|FG002|Period 1|Withdrawal by Subject|0|||
48802657|NCT00736489|157117863|FG003|Period 1|Withdrawal by Subject|0|||
48802658|NCT00736489|157117864|FG004|Period 1|Withdrawal by Subject|0|||
48802659|NCT00736489|157117865|FG005|Period 1|Withdrawal by Subject|1|||
48802660|NCT03995784|157117866|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
48802661|NCT00941798|157117867|FG000|Overall Study|Withdrawal by Subject|72|||
48802662|NCT00941798|157117868|FG001|Overall Study|Withdrawal by Subject|74|||
48802663|NCT00941798|157117867|FG000|Overall Study|Adverse Event|43|||
48802664|NCT00941798|157117868|FG001|Overall Study|Adverse Event|23|||
48802665|NCT00941798|157117867|FG000|Overall Study|Lost to Follow-up|29|||
48802666|NCT00941798|157117868|FG001|Overall Study|Lost to Follow-up|23|||
48708112|NCT03070964|156779112|FG000|Overall Study|Withdrawal by Subject|1|||
48708113|NCT03070964|156779112|FG000|Overall Study|Adverse Event|1|||
48708114|NCT00467753|156779115|FG000|Overall Study|Lost to Follow-up|1|||
48708115|NCT00467753|156779116|FG001|Overall Study|Lost to Follow-up|2|||
48708116|NCT00467753|156779115|FG000|Overall Study|Adverse Event|2|||
48708117|NCT00467753|156779116|FG001|Overall Study|Adverse Event|0|||
48708118|NCT03530124|156779117|FG000|Overall Study|Withdrawal by Subject|0|||
48708119|NCT03530124|156779118|FG001|Overall Study|Withdrawal by Subject|1|||
48708120|NCT03530124|156779117|FG000|Overall Study|Protocol Violation|1|||
48708121|NCT03530124|156779118|FG001|Overall Study|Protocol Violation|0|||
48708122|NCT03530124|156779117|FG000|Overall Study|Discharged prior to study completion|1|||
48708123|NCT03530124|156779118|FG001|Overall Study|Discharged prior to study completion|0|||
48708124|NCT02175030|156779119|FG000|Overall Study|Failed screen after consent|7|||
48708125|NCT02175030|156779120|FG001|Overall Study|Failed screen after consent|6|||
48708126|NCT02175030|156779119|FG000|Overall Study|Failed IUD Insertion|20|||
48708127|NCT02175030|156779120|FG001|Overall Study|Failed IUD Insertion|21|||
48708128|NCT02175030|156779119|FG000|Overall Study|Physician Decision|1|||
48708129|NCT02175030|156779120|FG001|Overall Study|Physician Decision|1|||
48708130|NCT02175030|156779119|FG000|Overall Study|Lost to Follow-up|6|||
48708131|NCT02175030|156779120|FG001|Overall Study|Lost to Follow-up|6|||
48708132|NCT02175030|156779119|FG000|Overall Study|Withdrawal by Subject|1|||
48708133|NCT02175030|156779120|FG001|Overall Study|Withdrawal by Subject|4|||
48802667|NCT00941798|157117867|FG000|Overall Study|Protocol Violation|17|||
48802668|NCT00941798|157117868|FG001|Overall Study|Protocol Violation|20|||
48802669|NCT00941798|157117867|FG000|Overall Study|Administrative problems|13|||
48802670|NCT00941798|157117868|FG001|Overall Study|Administrative problems|23|||
48802671|NCT00941798|157117867|FG000|Overall Study|Lack of Efficacy|10|||
48802672|NCT00941798|157117868|FG001|Overall Study|Lack of Efficacy|17|||
48802673|NCT00941798|157117867|FG000|Overall Study|Patient's inability to use device|6|||
48802674|NCT00941798|157117868|FG001|Overall Study|Patient's inability to use device|1|||
48802675|NCT00941798|157117867|FG000|Overall Study|Abnormal test procedure results|3|||
48802676|NCT00941798|157117868|FG001|Overall Study|Abnormal test procedure results|1|||
48802677|NCT00941798|157117867|FG000|Overall Study|Abnormal laboratory values|1|||
48802678|NCT00941798|157117868|FG001|Overall Study|Abnormal laboratory values|2|||
48802679|NCT00941798|157117867|FG000|Overall Study|Death|0|||
48802680|NCT00941798|157117868|FG001|Overall Study|Death|1|||
48802681|NCT02395133|157117869|FG000|Overall Study|Adverse Event|4|||
48802682|NCT02395133|157117870|FG001|Overall Study|Adverse Event|1|||
48802683|NCT02395133|157117871|FG002|Overall Study|Adverse Event|3|||
48802684|NCT02395133|157117872|FG003|Overall Study|Adverse Event|0|||
48802685|NCT02395133|157117869|FG000|Overall Study|Lack of Efficacy|1|||
48802686|NCT02395133|157117870|FG001|Overall Study|Lack of Efficacy|0|||
48802687|NCT02395133|157117871|FG002|Overall Study|Lack of Efficacy|1|||
48802688|NCT02395133|157117872|FG003|Overall Study|Lack of Efficacy|1|||
48802689|NCT02395133|157117869|FG000|Overall Study|Protocol Violation|1|||
48802690|NCT02395133|157117870|FG001|Overall Study|Protocol Violation|1|||
48802691|NCT02395133|157117871|FG002|Overall Study|Protocol Violation|0|||
48802692|NCT02395133|157117872|FG003|Overall Study|Protocol Violation|3|||
48802693|NCT02395133|157117869|FG000|Overall Study|Lost to Follow-up|0|||
48802694|NCT02395133|157117870|FG001|Overall Study|Lost to Follow-up|1|||
48802695|NCT02395133|157117871|FG002|Overall Study|Lost to Follow-up|1|||
48802696|NCT02395133|157117872|FG003|Overall Study|Lost to Follow-up|0|||
48802697|NCT02395133|157117869|FG000|Overall Study|Pregnancy|0|||
48802698|NCT02395133|157117870|FG001|Overall Study|Pregnancy|0|||
48802699|NCT02395133|157117871|FG002|Overall Study|Pregnancy|3|||
48802700|NCT02395133|157117872|FG003|Overall Study|Pregnancy|0|||
48802701|NCT02395133|157117869|FG000|Overall Study|Consent withdrawn with no reason given|1|||
48802702|NCT02395133|157117870|FG001|Overall Study|Consent withdrawn with no reason given|3|||
48802703|NCT02395133|157117871|FG002|Overall Study|Consent withdrawn with no reason given|0|||
48802704|NCT02395133|157117872|FG003|Overall Study|Consent withdrawn with no reason given|2|||
48802705|NCT02395133|157117869|FG000|Overall Study|Consent withdrawn with personal reason|0|||
48802706|NCT02395133|157117870|FG001|Overall Study|Consent withdrawn with personal reason|1|||
48708134|NCT01583296|156779121|FG000|Overall Study|Withdrawal by Subject|11|||
48708135|NCT01583296|156779122|FG001|Overall Study|Withdrawal by Subject|10|||
48802707|NCT02395133|157117871|FG002|Overall Study|Consent withdrawn with personal reason|0|||
48802708|NCT02395133|157117872|FG003|Overall Study|Consent withdrawn with personal reason|3|||
48802709|NCT02395133|157117869|FG000|Overall Study|Sponsor decision|2|||
48802710|NCT02395133|157117870|FG001|Overall Study|Sponsor decision|0|||
48802711|NCT02395133|157117871|FG002|Overall Study|Sponsor decision|0|||
48802712|NCT02395133|157117872|FG003|Overall Study|Sponsor decision|1|||
48802713|NCT02395133|157117869|FG000|Overall Study|Other than specified above|5|||
48802714|NCT02395133|157117870|FG001|Overall Study|Other than specified above|2|||
48802715|NCT02395133|157117871|FG002|Overall Study|Other than specified above|2|||
48802716|NCT02395133|157117872|FG003|Overall Study|Other than specified above|4|||
48802717|NCT00539279|157117882|FG000|Treatment|Withdrawal by Subject|10|||
48490242|NCT01023269|155988877|FG001|Overall Study|early termination of the study|0|||
48490243|NCT01138150|155988882|FG000|Overall Study|blood unable to be processed|0|||
48490244|NCT01138150|155988883|FG001|Overall Study|blood unable to be processed|1|||
48490245|NCT01138150|155988882|FG000|Overall Study|Physician Decision|1|||
48490246|NCT01138150|155988883|FG001|Overall Study|Physician Decision|0|||
48490247|NCT01620983|155988884|FG000|Overall Study|Lost to Follow-up|8|||
48490248|NCT01620983|155988885|FG001|Overall Study|Lost to Follow-up|4|||
48490249|NCT01620983|155988886|FG002|Overall Study|Lost to Follow-up|9|||
48490250|NCT01620983|155988884|FG000|Overall Study|Withdrawal by Subject|6|||
48490251|NCT01620983|155988885|FG001|Overall Study|Withdrawal by Subject|8|||
48490252|NCT01620983|155988886|FG002|Overall Study|Withdrawal by Subject|1|||
48490253|NCT01620983|155988884|FG000|Overall Study|Death|2|||
48490254|NCT01620983|155988885|FG001|Overall Study|Death|0|||
48490255|NCT01620983|155988886|FG002|Overall Study|Death|0|||
48490256|NCT01620983|155988884|FG000|Overall Study|Physician Decision|3|||
48490257|NCT01620983|155988885|FG001|Overall Study|Physician Decision|10|||
48490258|NCT01620983|155988886|FG002|Overall Study|Physician Decision|5|||
48802718|NCT00539279|157117883|FG001|Treatment|Withdrawal by Subject|8|||
48802719|NCT00539279|157117882|FG000|Treatment|Death|1|||
48802720|NCT00539279|157117883|FG001|Treatment|Death|0|||
48802721|NCT00539279|157117882|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
48802722|NCT00539279|157117883|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
48802723|NCT00539279|157117882|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
48802724|NCT00539279|157117883|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
48802725|NCT03315130|157117884|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
48802726|NCT03315130|157117885|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
48802727|NCT03315130|157117886|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
48802728|NCT03315130|157117887|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
48802729|NCT03315130|157117884|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
48802730|NCT03315130|157117885|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
48802731|NCT03315130|157117886|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
48802732|NCT03315130|157117887|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
48802733|NCT03315130|157117884|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
48802734|NCT03315130|157117885|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
48802735|NCT03315130|157117886|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
48802736|NCT03315130|157117887|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
48802737|NCT03315130|157117884|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
48802738|NCT03315130|157117885|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
48802739|NCT03315130|157117886|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
48802740|NCT03315130|157117887|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
48802741|NCT03315130|157117884|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
48802742|NCT03315130|157117885|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
48802743|NCT03315130|157117886|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
48802744|NCT03315130|157117887|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
48802745|NCT03315130|157117884|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
48802746|NCT03315130|157117885|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
48802747|NCT03315130|157117886|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
48802748|NCT03315130|157117887|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
48802749|NCT02532179|157119799|FG000|Overall Study|Lost to Follow-up|1|||
48802750|NCT02532179|157119799|FG000|Overall Study|Pregnancy|1|||
48490259|NCT05085964|155988887|FG000|Overall Study|Premature termination of study|21|||
48490260|NCT05085964|155988888|FG001|Overall Study|Premature termination of study|0|||
48708136|NCT03179319|156779123|FG000|Overall Study|Lost to Follow-up|6|||
48708137|NCT03179319|156779124|FG001|Overall Study|Lost to Follow-up|0|||
48708138|NCT00885534|156779130|FG000|Overall Study|Patient deemed ineligible|1|||
48708139|NCT02817464|156779131|FG000|Overall Study|Lost to Follow-up|1|||
48708140|NCT02817464|156779132|FG001|Overall Study|Lost to Follow-up|0|||
48802751|NCT02532179|157119799|FG000|Overall Study|Subject received depot steroid injection|1|||
48802752|NCT01712009|157119800|FG000|Overall Study|Withdrawal by Subject|24|||
48802753|NCT01712009|157119801|FG001|Overall Study|Withdrawal by Subject|15|||
48802754|NCT01712009|157119802|FG002|Overall Study|Withdrawal by Subject|8|||
48708141|NCT02817464|156779131|FG000|Overall Study|Discontinued early due to personal decision|1|||
48708142|NCT02817464|156779132|FG001|Overall Study|Discontinued early due to personal decision|1|||
48708143|NCT00357903|156779134|FG000|Overall Study|Adverse Event|87|||
48708144|NCT00357903|156779135|FG001|Overall Study|Adverse Event|4|||
48708145|NCT00357903|156779134|FG000|Overall Study|Death|33|||
48708146|NCT00357903|156779135|FG001|Overall Study|Death|0|||
48708147|NCT00357903|156779134|FG000|Overall Study|Lost to Follow-up|23|||
48708148|NCT00357903|156779135|FG001|Overall Study|Lost to Follow-up|4|||
48708149|NCT00357903|156779134|FG000|Overall Study|Physician Decision|39|||
48708150|NCT00357903|156779135|FG001|Overall Study|Physician Decision|5|||
48708151|NCT00357903|156779134|FG000|Overall Study|Withdrawal by Subject|57|||
48708152|NCT00357903|156779135|FG001|Overall Study|Withdrawal by Subject|7|||
48708153|NCT00357903|156779134|FG000|Overall Study|Completed month 12 only|0|||
48708154|NCT00357903|156779135|FG001|Overall Study|Completed month 12 only|1|||
48708155|NCT00357903|156779134|FG000|Overall Study|Protocol issues|14|||
48708156|NCT00357903|156779135|FG001|Overall Study|Protocol issues|3|||
48708157|NCT00357903|156779134|FG000|Overall Study|Response status|61|||
48708158|NCT00357903|156779135|FG001|Overall Study|Response status|9|||
48708159|NCT00357903|156779134|FG000|Overall Study|Other|49|||
48708160|NCT00357903|156779135|FG001|Overall Study|Other|10|||
48708161|NCT00606593|156779136|FG000|Overall Study|Adverse Event|0|||
48708162|NCT00606593|156779137|FG001|Overall Study|Adverse Event|0|||
48802755|NCT01712009|157119800|FG000|Overall Study|Lost to Follow-up|2|||
48802756|NCT01712009|157119801|FG001|Overall Study|Lost to Follow-up|0|||
48802757|NCT01712009|157119802|FG002|Overall Study|Lost to Follow-up|1|||
48802758|NCT01712009|157119800|FG000|Overall Study|Decision by Sponsor|12|||
48802759|NCT01712009|157119801|FG001|Overall Study|Decision by Sponsor|14|||
48802760|NCT01712009|157119802|FG002|Overall Study|Decision by Sponsor|12|||
48802761|NCT02240108|157119803|FG000|Overall Study|Other than specified|8|||
48490261|NCT00545233|155988889|FG000|Overall Study|Adverse Event|10|||
48490262|NCT00545233|155988890|FG001|Overall Study|Adverse Event|5|||
48490263|NCT00545233|155988889|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
48708163|NCT00606593|156779138|FG002|Overall Study|Adverse Event|0|||
48708164|NCT00606593|156779139|FG003|Overall Study|Adverse Event|1|||
48708165|NCT00606593|156779140|FG004|Overall Study|Adverse Event|1|||
48708166|NCT00606593|156779141|FG005|Overall Study|Adverse Event|0|||
48708167|NCT00606593|156779142|FG006|Overall Study|Adverse Event|1|||
48708168|NCT00606593|156779143|FG007|Overall Study|Adverse Event|2|||
48708169|NCT00606593|156779144|FG008|Overall Study|Adverse Event|1|||
48708170|NCT00606593|156779145|FG009|Overall Study|Adverse Event|0|||
48708171|NCT00606593|156779136|FG000|Overall Study|Withdrawal of consent|1|||
48708172|NCT00606593|156779137|FG001|Overall Study|Withdrawal of consent|0|||
48708173|NCT00606593|156779138|FG002|Overall Study|Withdrawal of consent|1|||
48708174|NCT00606593|156779139|FG003|Overall Study|Withdrawal of consent|0|||
48708175|NCT00606593|156779140|FG004|Overall Study|Withdrawal of consent|0|||
48708176|NCT00606593|156779141|FG005|Overall Study|Withdrawal of consent|0|||
48708177|NCT00606593|156779142|FG006|Overall Study|Withdrawal of consent|0|||
48708178|NCT00606593|156779143|FG007|Overall Study|Withdrawal of consent|0|||
48708179|NCT00606593|156779144|FG008|Overall Study|Withdrawal of consent|0|||
48708180|NCT00606593|156779145|FG009|Overall Study|Withdrawal of consent|0|||
48708181|NCT00606593|156779136|FG000|Overall Study|Administrative/Other|0|||
48708182|NCT00606593|156779137|FG001|Overall Study|Administrative/Other|0|||
48708183|NCT00606593|156779138|FG002|Overall Study|Administrative/Other|1|||
48708184|NCT00606593|156779139|FG003|Overall Study|Administrative/Other|0|||
48708185|NCT00606593|156779140|FG004|Overall Study|Administrative/Other|0|||
48708186|NCT00606593|156779141|FG005|Overall Study|Administrative/Other|0|||
48708187|NCT00606593|156779142|FG006|Overall Study|Administrative/Other|0|||
48708188|NCT00606593|156779143|FG007|Overall Study|Administrative/Other|0|||
48708189|NCT00606593|156779144|FG008|Overall Study|Administrative/Other|0|||
48708190|NCT00606593|156779145|FG009|Overall Study|Administrative/Other|0|||
48708191|NCT03695367|156779148|FG000|Overall Study|Missed the Day 28 visit.|1|||
48708192|NCT03695367|156779149|FG001|Overall Study|Missed the Day 28 visit.|0|||
48708193|NCT03695367|156779148|FG000|Overall Study|Lost to Follow-up|0|||
48708194|NCT03695367|156779149|FG001|Overall Study|Lost to Follow-up|1|||
48708195|NCT03695367|156779148|FG000|Overall Study|Withdrawal by Subject|0|||
48708196|NCT03695367|156779149|FG001|Overall Study|Withdrawal by Subject|1|||
48708197|NCT03695367|156779148|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
48708198|NCT03695367|156779149|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
48708199|NCT00829504|156779150|FG000|First Intervention|Adverse Event|1|||
48708200|NCT00829504|156779151|FG001|First Intervention|Adverse Event|0|||
48708201|NCT00829504|156779150|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48708202|NCT00829504|156779151|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48708203|NCT00829504|156779150|FG000|Second Intervention|Physician Decision|1|||
48708204|NCT00829504|156779151|FG001|Second Intervention|Physician Decision|0|||
48708205|NCT00599339|156779152|FG000|Overall Study|Adverse Event|79|||
48708206|NCT00599339|156779152|FG000|Overall Study|Withdrawal by Subject|137|||
48708207|NCT00599339|156779152|FG000|Overall Study|Other Reason|179|||
48802762|NCT02240108|157119804|FG001|Overall Study|Other than specified|6|||
48802763|NCT02240108|157119803|FG000|Overall Study|Adverse Event|1|||
48802764|NCT02240108|157119804|FG001|Overall Study|Adverse Event|9|||
48802765|NCT02240108|157119803|FG000|Overall Study|Pregnancy|1|||
48802766|NCT02240108|157119804|FG001|Overall Study|Pregnancy|0|||
48802767|NCT02240108|157119803|FG000|Overall Study|Withdrawal by Subject|4|||
48802768|NCT02240108|157119804|FG001|Overall Study|Withdrawal by Subject|9|||
48802769|NCT02240108|157119803|FG000|Overall Study|StudyTerminated by Sponsor|0|||
48802770|NCT02240108|157119804|FG001|Overall Study|StudyTerminated by Sponsor|1|||
48802771|NCT01377480|157119805|FG000|Overall Study|Protocol Violation|0|||
48802772|NCT01377480|157119806|FG001|Overall Study|Protocol Violation|0|||
48802773|NCT01377480|157119807|FG002|Overall Study|Protocol Violation|0|||
48802774|NCT01377480|157119808|FG003|Overall Study|Protocol Violation|4|||
48802775|NCT01377480|157119805|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
48802776|NCT01377480|157119806|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
48802777|NCT01377480|157119807|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
48802778|NCT01377480|157119808|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
48802779|NCT01377480|157119805|FG000|Overall Study|Withdrawal by Subject|0|||
48802780|NCT01377480|157119806|FG001|Overall Study|Withdrawal by Subject|0|||
48802781|NCT01377480|157119807|FG002|Overall Study|Withdrawal by Subject|1|||
48802782|NCT01377480|157119808|FG003|Overall Study|Withdrawal by Subject|0|||
48802783|NCT01377480|157119805|FG000|Overall Study|Serious adverse event|0|||
48802784|NCT01377480|157119806|FG001|Overall Study|Serious adverse event|0|||
48802785|NCT01377480|157119807|FG002|Overall Study|Serious adverse event|1|||
48802786|NCT01377480|157119808|FG003|Overall Study|Serious adverse event|1|||
48802787|NCT01377480|157119805|FG000|Overall Study|Other|0|||
48802788|NCT01377480|157119806|FG001|Overall Study|Other|0|||
48802789|NCT01377480|157119807|FG002|Overall Study|Other|7|||
48802790|NCT01377480|157119808|FG003|Overall Study|Other|6|||
48802791|NCT00045708|157119809|FG000|Phase 1|early progressive disease|0|||
48802792|NCT00045708|157119810|FG001|Phase 1|early progressive disease|1|||
48802793|NCT00045708|157119811|FG002|Phase 1|early progressive disease|0|||
48802794|NCT01986881|157119820|FG000|Overall Study|Death|228|||
48802795|NCT01986881|157119821|FG001|Overall Study|Death|233|||
48802796|NCT01986881|157119822|FG002|Overall Study|Death|247|||
48802797|NCT01986881|157119820|FG000|Overall Study|Lost to Follow-up|51|||
48802798|NCT01986881|157119821|FG001|Overall Study|Lost to Follow-up|44|||
48802799|NCT01986881|157119822|FG002|Overall Study|Lost to Follow-up|55|||
48802800|NCT01986881|157119820|FG000|Overall Study|Physician Decision|7|||
48802801|NCT01986881|157119821|FG001|Overall Study|Physician Decision|4|||
48802802|NCT01986881|157119822|FG002|Overall Study|Physician Decision|6|||
48802803|NCT01986881|157119820|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
48802804|NCT01986881|157119821|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
48802805|NCT01986881|157119822|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
48802806|NCT01986881|157119820|FG000|Overall Study|Withdrawal by Subject|41|||
48802807|NCT01986881|157119821|FG001|Overall Study|Withdrawal by Subject|60|||
48802808|NCT01986881|157119822|FG002|Overall Study|Withdrawal by Subject|45|||
48802809|NCT01986881|157119820|FG000|Overall Study|Subject Moved|0|||
48802810|NCT01986881|157119821|FG001|Overall Study|Subject Moved|1|||
48802811|NCT01986881|157119822|FG002|Overall Study|Subject Moved|0|||
48802812|NCT01986881|157119820|FG000|Overall Study|Other|1|||
48802813|NCT01986881|157119821|FG001|Overall Study|Other|2|||
48802814|NCT01986881|157119822|FG002|Overall Study|Other|2|||
48802815|NCT04128293|157119824|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
48802816|NCT04128293|157119825|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
48802817|NCT04128293|157119826|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
48802818|NCT04128293|157119827|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
48802819|NCT02259517|157119828|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
48490264|NCT00545233|155988890|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48490265|NCT00545233|155988889|FG000|Overall Study|Protocol Violation|2|||
48802820|NCT02259517|157119829|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
48802821|NCT02259517|157119830|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
48802822|NCT02259517|157119828|FG000|Overall Study|Withdrawal by Subject|0|||
48802823|NCT02259517|157119829|FG001|Overall Study|Withdrawal by Subject|0|||
48802824|NCT02259517|157119830|FG002|Overall Study|Withdrawal by Subject|3|||
48802825|NCT00838682|157119835|FG000|Overall Study|Lost to Follow-up|21|||
48802826|NCT00838682|157119836|FG001|Overall Study|Lost to Follow-up|14|||
48802827|NCT00838682|157119835|FG000|Overall Study|detection of exclusion criteria|4|||
48802828|NCT00838682|157119836|FG001|Overall Study|detection of exclusion criteria|3|||
48802829|NCT00838682|157119835|FG000|Overall Study|Protocol Violation|0|||
48802830|NCT00838682|157119836|FG001|Overall Study|Protocol Violation|1|||
48802831|NCT00838682|157119835|FG000|Overall Study|Withdrawal by Subject|0|||
48802832|NCT00838682|157119836|FG001|Overall Study|Withdrawal by Subject|1|||
48802833|NCT00710606|157119837|FG000|Overall Study|Adverse Event|0|||
48802834|NCT00710606|157119838|FG001|Overall Study|Adverse Event|2|||
48802835|NCT03243422|157119853|FG000|Overall Study|Death|20|||
48802836|NCT03243422|157119854|FG001|Overall Study|Death|21|||
48802837|NCT03243422|157119853|FG000|Overall Study|Lost to Follow-up|9|||
48802838|NCT03243422|157119854|FG001|Overall Study|Lost to Follow-up|21|||
48802839|NCT03243422|157119853|FG000|Overall Study|Withdrawal by Subject|22|||
48802840|NCT03243422|157119854|FG001|Overall Study|Withdrawal by Subject|8|||
48802841|NCT00508404|157119855|FG000|Overall Study|Ongoing at Data Cut-off|12|||
48802842|NCT00508404|157119855|FG000|Overall Study|Adverse Event|2|||
48802843|NCT00508404|157119855|FG000|Overall Study|Death|16|||
48802844|NCT00508404|157119855|FG000|Overall Study|Physician Decision|2|||
48802845|NCT00508404|157119855|FG000|Overall Study|Withdrawal by Subject|3|||
48802846|NCT00508404|157119855|FG000|Overall Study|Protocol-specified Criteria|2|||
48802847|NCT00508404|157119855|FG000|Overall Study|Lost to Follow-up|2|||
48802848|NCT00508404|157119855|FG000|Overall Study|Other - Not Specified|3|||
48802849|NCT02799784|157119862|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
48802850|NCT02799784|157119863|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
48802851|NCT02799784|157119862|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
48802852|NCT02799784|157119863|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
48802853|NCT02799784|157119862|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
48802854|NCT02799784|157119863|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
48802855|NCT02799784|157119862|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
48802856|NCT02799784|157119863|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
48802857|NCT02799784|157119862|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
48802858|NCT02799784|157119863|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
48802859|NCT02799784|157119862|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
48802860|NCT02799784|157119863|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
48802861|NCT03988634|157119864|FG000|Double-Blind|Adverse Event|4|||
48802862|NCT03988634|157119865|FG001|Double-Blind|Adverse Event|0|||
48802863|NCT03988634|157119866|FG002|Double-Blind|Adverse Event|0|||
48802864|NCT03988634|157119864|FG000|Double-Blind|Death|18|||
48802865|NCT03988634|157119865|FG001|Double-Blind|Death|26|||
48802866|NCT03988634|157119866|FG002|Double-Blind|Death|0|||
48802867|NCT03988634|157119864|FG000|Double-Blind|Lost to Follow-up|6|||
48802868|NCT03988634|157119865|FG001|Double-Blind|Lost to Follow-up|7|||
48802869|NCT03988634|157119866|FG002|Double-Blind|Lost to Follow-up|0|||
48802870|NCT03988634|157119864|FG000|Double-Blind|Physician Decision|9|||
48802871|NCT03988634|157119865|FG001|Double-Blind|Physician Decision|5|||
48802872|NCT03988634|157119866|FG002|Double-Blind|Physician Decision|0|||
48802873|NCT03988634|157119864|FG000|Double-Blind|Subject decision|24|||
48802874|NCT03988634|157119865|FG001|Double-Blind|Subject decision|13|||
48802875|NCT03988634|157119866|FG002|Double-Blind|Subject decision|0|||
48802876|NCT03988634|157119864|FG000|Open-Label|Adverse Event|0|||
48802877|NCT03988634|157119865|FG001|Open-Label|Adverse Event|0|||
48802878|NCT03988634|157119866|FG002|Open-Label|Adverse Event|7|||
48802879|NCT03988634|157119864|FG000|Open-Label|Physician Decision|0|||
48802880|NCT03988634|157119865|FG001|Open-Label|Physician Decision|0|||
48802881|NCT03988634|157119866|FG002|Open-Label|Physician Decision|1|||
48802882|NCT03988634|157119864|FG000|Open-Label|Technical problems|0|||
48490266|NCT00545233|155988890|FG001|Overall Study|Protocol Violation|0|||
48802883|NCT03988634|157119865|FG001|Open-Label|Technical problems|0|||
48802884|NCT03988634|157119866|FG002|Open-Label|Technical problems|1|||
48802885|NCT01226511|157119867|FG000|Acute Treatment Period|Adverse Event|7|||
48802886|NCT01226511|157119868|FG001|Acute Treatment Period|Adverse Event|6|||
48802887|NCT01226511|157119867|FG000|Acute Treatment Period|Lack of Efficacy|2|||
48802888|NCT01226511|157119868|FG001|Acute Treatment Period|Lack of Efficacy|1|||
48802889|NCT01226511|157119867|FG000|Acute Treatment Period|Lost to Follow-up|3|||
48802890|NCT01226511|157119868|FG001|Acute Treatment Period|Lost to Follow-up|6|||
48802891|NCT01226511|157119867|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
48802892|NCT01226511|157119868|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
48802893|NCT01226511|157119867|FG000|Acute Treatment Period|Protocol Violation|5|||
48802894|NCT01226511|157119868|FG001|Acute Treatment Period|Protocol Violation|5|||
48802895|NCT01226511|157119867|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
48802896|NCT01226511|157119868|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
48802897|NCT01226511|157119867|FG000|Extension Treatment Period|Adverse Event|8|||
48802898|NCT01226511|157119868|FG001|Extension Treatment Period|Adverse Event|8|||
48802899|NCT01226511|157119867|FG000|Extension Treatment Period|Lack of Efficacy|3|||
48802900|NCT01226511|157119868|FG001|Extension Treatment Period|Lack of Efficacy|2|||
48802901|NCT01226511|157119867|FG000|Extension Treatment Period|Lost to Follow-up|4|||
48802902|NCT01226511|157119868|FG001|Extension Treatment Period|Lost to Follow-up|3|||
48802903|NCT01226511|157119867|FG000|Extension Treatment Period|Protocol Violation|2|||
48802904|NCT01226511|157119868|FG001|Extension Treatment Period|Protocol Violation|2|||
48802905|NCT01226511|157119867|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
48802906|NCT01226511|157119868|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
48802907|NCT01226511|157119867|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
48802908|NCT01226511|157119868|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
48802909|NCT01226511|157119867|FG000|Extension Treatment Period|Sponsor Decision|1|||
48802910|NCT01226511|157119868|FG001|Extension Treatment Period|Sponsor Decision|1|||
48802911|NCT01226511|157119867|FG000|Taper Period|Adverse Event|1|||
48802912|NCT01226511|157119868|FG001|Taper Period|Adverse Event|0|||
48802913|NCT01226511|157119867|FG000|Taper Period|Lost to Follow-up|2|||
48802914|NCT01226511|157119868|FG001|Taper Period|Lost to Follow-up|2|||
48802915|NCT01226511|157119867|FG000|Taper Period|Protocol Violation|1|||
48802916|NCT01226511|157119868|FG001|Taper Period|Protocol Violation|0|||
48802917|NCT01226511|157119867|FG000|Taper Period|Parent/Caregiver Decision|1|||
48802918|NCT01226511|157119868|FG001|Taper Period|Parent/Caregiver Decision|1|||
48802919|NCT01337986|157119869|FG000|Overall Study|Adverse Event|2|||
48802920|NCT01337986|157119870|FG001|Overall Study|Adverse Event|2|||
48802921|NCT01337986|157119869|FG000|Overall Study|Lost to Follow-up|1|||
48802922|NCT01337986|157119870|FG001|Overall Study|Lost to Follow-up|0|||
48802923|NCT01337986|157119869|FG000|Overall Study|Protocol Violation|0|||
48802924|NCT01337986|157119870|FG001|Overall Study|Protocol Violation|3|||
48802925|NCT00058422|157119871|FG000|Overall Study|Not treated|2|||
48802926|NCT02287584|157119872|FG000|the Double-blind Phase|Adverse Event|17|||
48802927|NCT02287584|157119873|FG001|the Double-blind Phase|Adverse Event|17|||
48802928|NCT02287584|157119874|FG002|the Double-blind Phase|Adverse Event|12|||
48802929|NCT02287584|157119875|FG003|the Double-blind Phase|Adverse Event|0|||
48802930|NCT02287584|157119876|FG004|the Double-blind Phase|Adverse Event|0|||
48802931|NCT02287584|157119877|FG005|the Double-blind Phase|Adverse Event|0|||
48802932|NCT02287584|157119872|FG000|the Double-blind Phase|Lack of Efficacy|18|||
48802933|NCT02287584|157119873|FG001|the Double-blind Phase|Lack of Efficacy|8|||
48802934|NCT02287584|157119874|FG002|the Double-blind Phase|Lack of Efficacy|8|||
48802935|NCT02287584|157119875|FG003|the Double-blind Phase|Lack of Efficacy|0|||
48802936|NCT02287584|157119876|FG004|the Double-blind Phase|Lack of Efficacy|0|||
48802937|NCT02287584|157119877|FG005|the Double-blind Phase|Lack of Efficacy|0|||
48802938|NCT02287584|157119872|FG000|the Double-blind Phase|Lost to Follow-up|0|||
48802939|NCT02287584|157119873|FG001|the Double-blind Phase|Lost to Follow-up|1|||
48802940|NCT02287584|157119874|FG002|the Double-blind Phase|Lost to Follow-up|1|||
48802941|NCT02287584|157119875|FG003|the Double-blind Phase|Lost to Follow-up|0|||
48802942|NCT02287584|157119876|FG004|the Double-blind Phase|Lost to Follow-up|0|||
48802943|NCT02287584|157119877|FG005|the Double-blind Phase|Lost to Follow-up|0|||
48802944|NCT02287584|157119872|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
48802945|NCT02287584|157119873|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
48802946|NCT02287584|157119874|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
48802947|NCT02287584|157119875|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
48802948|NCT02287584|157119876|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
48802949|NCT02287584|157119877|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
48802950|NCT02287584|157119872|FG000|the Double-blind Phase|Pregnancy|0|||
48802951|NCT02287584|157119873|FG001|the Double-blind Phase|Pregnancy|1|||
48802952|NCT02287584|157119874|FG002|the Double-blind Phase|Pregnancy|0|||
48802953|NCT02287584|157119875|FG003|the Double-blind Phase|Pregnancy|0|||
48802954|NCT02287584|157119876|FG004|the Double-blind Phase|Pregnancy|0|||
48802955|NCT02287584|157119877|FG005|the Double-blind Phase|Pregnancy|0|||
48802956|NCT02287584|157119872|FG000|the Double-blind Phase|Protocol Violation|0|||
48802957|NCT02287584|157119873|FG001|the Double-blind Phase|Protocol Violation|3|||
48802958|NCT02287584|157119874|FG002|the Double-blind Phase|Protocol Violation|0|||
48802959|NCT02287584|157119875|FG003|the Double-blind Phase|Protocol Violation|0|||
48802960|NCT02287584|157119876|FG004|the Double-blind Phase|Protocol Violation|0|||
48802961|NCT02287584|157119877|FG005|the Double-blind Phase|Protocol Violation|0|||
48802962|NCT02287584|157119872|FG000|the Double-blind Phase|other reasons|0|||
48802963|NCT02287584|157119873|FG001|the Double-blind Phase|other reasons|0|||
48802964|NCT02287584|157119874|FG002|the Double-blind Phase|other reasons|1|||
48802965|NCT02287584|157119875|FG003|the Double-blind Phase|other reasons|0|||
48802966|NCT02287584|157119876|FG004|the Double-blind Phase|other reasons|0|||
48802967|NCT02287584|157119877|FG005|the Double-blind Phase|other reasons|0|||
48802968|NCT02287584|157119872|FG000|the Open-label Phase|Did not receive drug|0|||
48802969|NCT02287584|157119873|FG001|the Open-label Phase|Did not receive drug|0|||
48802970|NCT02287584|157119874|FG002|the Open-label Phase|Did not receive drug|0|||
48802971|NCT02287584|157119875|FG003|the Open-label Phase|Did not receive drug|7|||
48802972|NCT02287584|157119876|FG004|the Open-label Phase|Did not receive drug|6|||
48802973|NCT02287584|157119877|FG005|the Open-label Phase|Did not receive drug|4|||
48802974|NCT02287584|157119872|FG000|the Open-label Phase|Adverse Event|0|||
48802975|NCT02287584|157119873|FG001|the Open-label Phase|Adverse Event|0|||
48802976|NCT02287584|157119874|FG002|the Open-label Phase|Adverse Event|0|||
48802977|NCT02287584|157119875|FG003|the Open-label Phase|Adverse Event|15|||
48802978|NCT02287584|157119876|FG004|the Open-label Phase|Adverse Event|12|||
48802979|NCT02287584|157119877|FG005|the Open-label Phase|Adverse Event|16|||
48802980|NCT02287584|157119872|FG000|the Open-label Phase|Lack of Efficacy|0|||
48802981|NCT02287584|157119873|FG001|the Open-label Phase|Lack of Efficacy|0|||
48802982|NCT02287584|157119874|FG002|the Open-label Phase|Lack of Efficacy|0|||
48802983|NCT02287584|157119875|FG003|the Open-label Phase|Lack of Efficacy|8|||
48802984|NCT02287584|157119876|FG004|the Open-label Phase|Lack of Efficacy|3|||
48802985|NCT02287584|157119877|FG005|the Open-label Phase|Lack of Efficacy|7|||
48802986|NCT02287584|157119872|FG000|the Open-label Phase|Lost to Follow-up|0|||
48802987|NCT02287584|157119873|FG001|the Open-label Phase|Lost to Follow-up|0|||
48802988|NCT02287584|157119874|FG002|the Open-label Phase|Lost to Follow-up|0|||
48802989|NCT02287584|157119875|FG003|the Open-label Phase|Lost to Follow-up|4|||
48802990|NCT02287584|157119876|FG004|the Open-label Phase|Lost to Follow-up|1|||
48802991|NCT02287584|157119877|FG005|the Open-label Phase|Lost to Follow-up|2|||
48802992|NCT02287584|157119872|FG000|the Open-label Phase|Withdrawal by Subject|0|||
48802993|NCT02287584|157119873|FG001|the Open-label Phase|Withdrawal by Subject|0|||
48802994|NCT02287584|157119874|FG002|the Open-label Phase|Withdrawal by Subject|0|||
48802995|NCT02287584|157119875|FG003|the Open-label Phase|Withdrawal by Subject|18|||
48802996|NCT02287584|157119876|FG004|the Open-label Phase|Withdrawal by Subject|29|||
48802997|NCT02287584|157119877|FG005|the Open-label Phase|Withdrawal by Subject|21|||
48802998|NCT02287584|157119872|FG000|the Open-label Phase|non-compliance|0|||
48802999|NCT02287584|157119873|FG001|the Open-label Phase|non-compliance|0|||
48803000|NCT02287584|157119874|FG002|the Open-label Phase|non-compliance|0|||
48803001|NCT02287584|157119875|FG003|the Open-label Phase|non-compliance|2|||
48803002|NCT02287584|157119876|FG004|the Open-label Phase|non-compliance|5|||
48803003|NCT02287584|157119877|FG005|the Open-label Phase|non-compliance|1|||
48803004|NCT02287584|157119872|FG000|the Open-label Phase|other reasons|0|||
48490267|NCT00545233|155988889|FG000|Overall Study|Refused Treatment|9|||
48803005|NCT02287584|157119873|FG001|the Open-label Phase|other reasons|0|||
48803006|NCT02287584|157119874|FG002|the Open-label Phase|other reasons|0|||
48490268|NCT00545233|155988890|FG001|Overall Study|Refused Treatment|7|||
48803007|NCT02287584|157119875|FG003|the Open-label Phase|other reasons|3|||
48803008|NCT02287584|157119876|FG004|the Open-label Phase|other reasons|6|||
48803009|NCT02287584|157119877|FG005|the Open-label Phase|other reasons|6|||
48803010|NCT00106184|157119878|FG000|Overall Study|Withdrawal by Subject|3|||
48803011|NCT00106184|157119879|FG001|Overall Study|Withdrawal by Subject|2|||
48803012|NCT01572389|157119881|FG000|Overall Study|Death|1|||
48803013|NCT01572389|157119882|FG001|Overall Study|Death|3|||
48490269|NCT00545233|155988889|FG000|Overall Study|Failure to Return|4|||
48803014|NCT01572389|157119881|FG000|Overall Study|Withdrawal by Subject|14|||
48490270|NCT00545233|155988890|FG001|Overall Study|Failure to Return|6|||
48803015|NCT01572389|157119882|FG001|Overall Study|Withdrawal by Subject|2|||
48490271|NCT00545233|155988889|FG000|Overall Study|Insufficient response|14|||
48490272|NCT00545233|155988890|FG001|Overall Study|Insufficient response|15|||
48490273|NCT00545233|155988889|FG000|Overall Study|Physician Decision|2|||
48490274|NCT00545233|155988890|FG001|Overall Study|Physician Decision|1|||
48490275|NCT05017493|155988891|FG000|Overall Study|Withdrawal by Subject|26|||
48490276|NCT05017493|155988892|FG001|Overall Study|Withdrawal by Subject|0|||
48490277|NCT05017493|155988891|FG000|Overall Study|Physician Decision|15|||
48490278|NCT05017493|155988892|FG001|Overall Study|Physician Decision|0|||
48490279|NCT05017493|155988891|FG000|Overall Study|Protocol Violation|81|||
48490280|NCT05017493|155988892|FG001|Overall Study|Protocol Violation|0|||
48490281|NCT02175966|155988897|FG000|Follow-up Period|Lack of Efficacy|10|||
48490282|NCT02175966|155988898|FG001|Follow-up Period|Lack of Efficacy|6|||
48490283|NCT01851590|155988900|FG000|Overall Study|Withdrawal by Subject|0|||
48490284|NCT01851590|155988901|FG001|Overall Study|Withdrawal by Subject|0|||
48490285|NCT01851590|155988902|FG002|Overall Study|Withdrawal by Subject|1|||
48490286|NCT01851590|155988900|FG000|Overall Study|Adverse Event|0|||
48490287|NCT01851590|155988901|FG001|Overall Study|Adverse Event|0|||
48490288|NCT01851590|155988902|FG002|Overall Study|Adverse Event|2|||
48490289|NCT01851590|155988900|FG000|Overall Study|Lack of Efficacy|0|||
48490290|NCT01851590|155988901|FG001|Overall Study|Lack of Efficacy|1|||
48490291|NCT01851590|155988902|FG002|Overall Study|Lack of Efficacy|0|||
48490292|NCT00876733|155988904|FG000|Overall Study|Adverse Event|34|||
48490293|NCT00876733|155988905|FG001|Overall Study|Adverse Event|20|||
48490294|NCT00876733|155988906|FG002|Overall Study|Adverse Event|10|||
48490295|NCT00876733|155988907|FG003|Overall Study|Adverse Event|3|||
48490296|NCT00876733|155988904|FG000|Overall Study|Lack of Efficacy|17|||
48490297|NCT00876733|155988905|FG001|Overall Study|Lack of Efficacy|9|||
48490298|NCT00876733|155988906|FG002|Overall Study|Lack of Efficacy|10|||
48490299|NCT00876733|155988907|FG003|Overall Study|Lack of Efficacy|1|||
48490300|NCT00876733|155988904|FG000|Overall Study|Lost to Follow-up|26|||
48708208|NCT00599339|156779152|FG000|Overall Study|Lost to Follow-up|221|||
48490301|NCT00876733|155988905|FG001|Overall Study|Lost to Follow-up|10|||
48490302|NCT00876733|155988906|FG002|Overall Study|Lost to Follow-up|3|||
48490303|NCT00876733|155988907|FG003|Overall Study|Lost to Follow-up|2|||
48490304|NCT00876733|155988904|FG000|Overall Study|Data not available|14|||
48708209|NCT00599339|156779152|FG000|Overall Study|No valid data consent|36|||
48490305|NCT00876733|155988905|FG001|Overall Study|Data not available|3|||
48490306|NCT00876733|155988906|FG002|Overall Study|Data not available|7|||
48490307|NCT00876733|155988907|FG003|Overall Study|Data not available|1|||
48490308|NCT01154153|155988912|FG000|Overall Study|Poor compliance to protocol|2|||
48490309|NCT01154153|155988913|FG001|Overall Study|Poor compliance to protocol|0|||
48490310|NCT01154153|155988912|FG000|Overall Study|Unable to use labs|2|||
48490311|NCT01154153|155988913|FG001|Overall Study|Unable to use labs|3|||
48708210|NCT00599339|156779152|FG000|Overall Study|Study Termination Status Unknown|12|||
48708211|NCT04421027|156779153|FG000|Treatment Period|Adverse Event|5|||
48708212|NCT04421027|156779154|FG001|Treatment Period|Adverse Event|3|||
48708213|NCT04421027|156779155|FG002|Treatment Period|Adverse Event|0|||
48708214|NCT04421027|156779156|FG003|Treatment Period|Adverse Event|0|||
48708215|NCT04421027|156779153|FG000|Treatment Period|Death|98|||
48490312|NCT01154153|155988912|FG000|Overall Study|Withdrew consent|1|||
48708216|NCT04421027|156779154|FG001|Treatment Period|Death|61|||
48708217|NCT04421027|156779155|FG002|Treatment Period|Death|0|||
48708218|NCT04421027|156779156|FG003|Treatment Period|Death|0|||
48708219|NCT04421027|156779153|FG000|Treatment Period|Lost to Follow-up|22|||
48708220|NCT04421027|156779154|FG001|Treatment Period|Lost to Follow-up|20|||
48708221|NCT04421027|156779155|FG002|Treatment Period|Lost to Follow-up|0|||
48708222|NCT04421027|156779156|FG003|Treatment Period|Lost to Follow-up|0|||
48708223|NCT04421027|156779153|FG000|Treatment Period|Other-Unknown|15|||
48708224|NCT04421027|156779154|FG001|Treatment Period|Other-Unknown|9|||
48708225|NCT04421027|156779155|FG002|Treatment Period|Other-Unknown|0|||
48708226|NCT04421027|156779156|FG003|Treatment Period|Other-Unknown|0|||
48708227|NCT04421027|156779153|FG000|Treatment Period|Physician Decision|1|||
48708228|NCT04421027|156779154|FG001|Treatment Period|Physician Decision|1|||
48708229|NCT04421027|156779155|FG002|Treatment Period|Physician Decision|0|||
48708230|NCT04421027|156779156|FG003|Treatment Period|Physician Decision|0|||
48708231|NCT04421027|156779153|FG000|Treatment Period|Withdrawal by Subject|7|||
48708232|NCT04421027|156779154|FG001|Treatment Period|Withdrawal by Subject|12|||
48708233|NCT04421027|156779155|FG002|Treatment Period|Withdrawal by Subject|0|||
48708234|NCT04421027|156779156|FG003|Treatment Period|Withdrawal by Subject|0|||
48708235|NCT04421027|156779153|FG000|Treatment Period|Randomized Not Dosed|9|||
48708236|NCT04421027|156779154|FG001|Treatment Period|Randomized Not Dosed|14|||
48708237|NCT04421027|156779155|FG002|Treatment Period|Randomized Not Dosed|0|||
48708238|NCT04421027|156779156|FG003|Treatment Period|Randomized Not Dosed|0|||
48708239|NCT04421027|156779153|FG000|Follow-Up Period|Adverse Event|0|||
48708240|NCT04421027|156779154|FG001|Follow-Up Period|Adverse Event|0|||
48708241|NCT04421027|156779155|FG002|Follow-Up Period|Adverse Event|0|||
48708242|NCT04421027|156779156|FG003|Follow-Up Period|Adverse Event|3|||
48708243|NCT04421027|156779153|FG000|Follow-Up Period|Death|0|||
48708244|NCT04421027|156779154|FG001|Follow-Up Period|Death|0|||
48708245|NCT04421027|156779155|FG002|Follow-Up Period|Death|16|||
48708246|NCT04421027|156779156|FG003|Follow-Up Period|Death|17|||
48708247|NCT04421027|156779153|FG000|Follow-Up Period|Lost to Follow-up|0|||
48708248|NCT04421027|156779154|FG001|Follow-Up Period|Lost to Follow-up|0|||
48708249|NCT04421027|156779155|FG002|Follow-Up Period|Lost to Follow-up|7|||
48708250|NCT04421027|156779156|FG003|Follow-Up Period|Lost to Follow-up|7|||
48708251|NCT04421027|156779153|FG000|Follow-Up Period|Protocol Deviation|0|||
48708252|NCT04421027|156779154|FG001|Follow-Up Period|Protocol Deviation|0|||
48708253|NCT04421027|156779155|FG002|Follow-Up Period|Protocol Deviation|1|||
48708254|NCT04421027|156779156|FG003|Follow-Up Period|Protocol Deviation|0|||
48708255|NCT04421027|156779153|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
48708256|NCT04421027|156779154|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
48708257|NCT04421027|156779155|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
48708258|NCT04421027|156779156|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
48708259|NCT04421027|156779153|FG000|Follow-Up Period|Left message, participant did not call back|0|||
48708260|NCT04421027|156779154|FG001|Follow-Up Period|Left message, participant did not call back|0|||
48708261|NCT04421027|156779155|FG002|Follow-Up Period|Left message, participant did not call back|0|||
48708262|NCT04421027|156779156|FG003|Follow-Up Period|Left message, participant did not call back|1|||
48708263|NCT04421027|156779153|FG000|Follow-Up Period|Participant died|0|||
48708264|NCT04421027|156779154|FG001|Follow-Up Period|Participant died|0|||
48708265|NCT04421027|156779155|FG002|Follow-Up Period|Participant died|0|||
48708266|NCT04421027|156779156|FG003|Follow-Up Period|Participant died|1|||
48490313|NCT01154153|155988913|FG001|Overall Study|Withdrew consent|0|||
48490314|NCT01862328|155988916|FG000|Overall Study|Progressive Disease|3|||
48490315|NCT01862328|155988917|FG001|Overall Study|Progressive Disease|11|||
48490316|NCT01862328|155988918|FG002|Overall Study|Progressive Disease|5|||
48708267|NCT04421027|156779153|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
48708268|NCT04421027|156779154|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
48708269|NCT04421027|156779155|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
48490317|NCT01862328|155988919|FG003|Overall Study|Progressive Disease|6|||
48742938|NCT01550289|156910419|FG000|Overall Study|Withdrawal by Subject|11|||
48803016|NCT01572389|157119881|FG000|Overall Study|Lost to Follow-up|25|||
48803017|NCT01572389|157119882|FG001|Overall Study|Lost to Follow-up|14|||
48803018|NCT01572389|157119881|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
48803019|NCT01572389|157119882|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
48803020|NCT01111838|157119885|FG000|Overall Study|Patient Ineligible|2|||
48803021|NCT01111838|157119885|FG000|Overall Study|Not Treated|3|||
48803022|NCT01111838|157119885|FG000|Overall Study|Clinical deterioration|1|||
48803023|NCT01111838|157119885|FG000|Overall Study|Other Complicating Disease|1|||
48803024|NCT01780935|157119888|FG000|Overall Study|Admin problems due to early termination|321|||
48803025|NCT01780935|157119889|FG001|Overall Study|Admin problems due to early termination|309|||
48803026|NCT01780935|157119888|FG000|Overall Study|Adverse Event|2|||
48803027|NCT01780935|157119889|FG001|Overall Study|Adverse Event|4|||
48803028|NCT01780935|157119888|FG000|Overall Study|Death|1|||
48803029|NCT01780935|157119889|FG001|Overall Study|Death|6|||
48803030|NCT01780935|157119888|FG000|Overall Study|Lost to Follow-up|2|||
48803031|NCT01780935|157119889|FG001|Overall Study|Lost to Follow-up|6|||
48803032|NCT01780935|157119888|FG000|Overall Study|Physician Decision|1|||
48803033|NCT01780935|157119889|FG001|Overall Study|Physician Decision|1|||
48803034|NCT01780935|157119888|FG000|Overall Study|Protocol deviation|0|||
48803035|NCT01780935|157119889|FG001|Overall Study|Protocol deviation|1|||
48803036|NCT01780935|157119888|FG000|Overall Study|Patient withdrew consent|8|||
48803037|NCT01780935|157119889|FG001|Overall Study|Patient withdrew consent|9|||
48803038|NCT01480596|157119890|FG000|Overall Study|Adverse Event|3|||
48803039|NCT01480596|157119891|FG001|Overall Study|Adverse Event|0|||
48803040|NCT01480596|157119890|FG000|Overall Study|MG exacerbation or change in medication|2|||
48803041|NCT01480596|157119891|FG001|Overall Study|MG exacerbation or change in medication|2|||
48803042|NCT02277990|157119895|FG000|Overall Study|Death|170|||
48803043|NCT02277990|157119896|FG001|Overall Study|Death|188|||
48803044|NCT02277990|157119895|FG000|Overall Study|Withdrawal by Subject|64|||
48803045|NCT02277990|157119896|FG001|Overall Study|Withdrawal by Subject|53|||
48803046|NCT02277990|157119895|FG000|Overall Study|Physician Decision|40|||
48803047|NCT02277990|157119896|FG001|Overall Study|Physician Decision|34|||
48803048|NCT02277990|157119895|FG000|Overall Study|Lost to Follow-up|66|||
48803049|NCT02277990|157119896|FG001|Overall Study|Lost to Follow-up|69|||
48803050|NCT02277990|157119895|FG000|Overall Study|Had other reason|26|||
48803051|NCT02277990|157119896|FG001|Overall Study|Had other reason|32|||
48803052|NCT04359771|157119897|FG000|Overall Study|Lack of Efficacy|2|||
48803053|NCT04359771|157119898|FG001|Overall Study|Lack of Efficacy|2|||
48803054|NCT01498822|157119899|FG000|Overall Study|Protocol Violation|8|||
48803055|NCT01498822|157119900|FG001|Overall Study|Protocol Violation|4|||
48803056|NCT01498822|157119899|FG000|Overall Study|Other Reason|5|||
48803057|NCT01498822|157119900|FG001|Overall Study|Other Reason|2|||
48803058|NCT01498822|157119899|FG000|Overall Study|Lack of Efficacy|7|||
48803059|NCT01498822|157119900|FG001|Overall Study|Lack of Efficacy|2|||
48803060|NCT01498822|157119899|FG000|Overall Study|AE, non-serious non-fatal|8|||
48803061|NCT01498822|157119900|FG001|Overall Study|AE, non-serious non-fatal|17|||
48803062|NCT01498822|157119899|FG000|Overall Study|SAE, non-fatal|2|||
48803063|NCT01498822|157119900|FG001|Overall Study|SAE, non-fatal|2|||
48803064|NCT01498822|157119899|FG000|Overall Study|Adverse Event, serious fatal|1|||
48803065|NCT01498822|157119900|FG001|Overall Study|Adverse Event, serious fatal|1|||
48803066|NCT01498822|157119899|FG000|Overall Study|Withdrawal by Subject|15|||
48803067|NCT01498822|157119900|FG001|Overall Study|Withdrawal by Subject|25|||
48803068|NCT01498822|157119899|FG000|Overall Study|Lost to Follow-up|8|||
48803069|NCT01498822|157119900|FG001|Overall Study|Lost to Follow-up|3|||
48803070|NCT03131960|157119901|FG000|Overall Study|Adverse Event|0|||
48803071|NCT03131960|157119902|FG001|Overall Study|Adverse Event|1|||
48803072|NCT01566695|157119903|FG000|Overall Study|Lack of Efficacy|1|||
48803073|NCT01566695|157119904|FG001|Overall Study|Lack of Efficacy|0|||
48803074|NCT01566695|157119903|FG000|Overall Study|Adverse Event|3|||
48803075|NCT01566695|157119904|FG001|Overall Study|Adverse Event|0|||
48803076|NCT01566695|157119903|FG000|Overall Study|Death|79|||
48803077|NCT01566695|157119904|FG001|Overall Study|Death|86|||
48803078|NCT01566695|157119903|FG000|Overall Study|Withdrawal by Subject|13|||
48803079|NCT01566695|157119904|FG001|Overall Study|Withdrawal by Subject|12|||
48803080|NCT01566695|157119903|FG000|Overall Study|Lost to Follow-up|0|||
48803081|NCT01566695|157119904|FG001|Overall Study|Lost to Follow-up|3|||
48803082|NCT01566695|157119903|FG000|Overall Study|Other reasons|11|||
48803083|NCT01566695|157119904|FG001|Overall Study|Other reasons|8|||
48803084|NCT04111536|157119916|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48803085|NCT04111536|157119917|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48803086|NCT04111536|157119916|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
48803087|NCT04111536|157119917|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
48803088|NCT04111536|157119916|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
48803089|NCT04111536|157119917|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
48803090|NCT04111536|157119916|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
48803091|NCT04111536|157119917|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
48803092|NCT06037369|157119918|FG000|Overall Study|Lost to Follow-up|0|||
48803093|NCT06037369|157119919|FG001|Overall Study|Lost to Follow-up|1|||
48595966|NCT04304508|156377806|FG003|Overall Study|Logistical Difficulties|2|||
48595967|NCT04304508|156377803|FG000|Overall Study|Missing Information|1|||
48595968|NCT04304508|156377804|FG001|Overall Study|Missing Information|2|||
48595969|NCT04304508|156377805|FG002|Overall Study|Missing Information|1|||
48595970|NCT04304508|156377806|FG003|Overall Study|Missing Information|3|||
48595971|NCT04304508|156377803|FG000|Overall Study|Other|7|||
48595972|NCT04304508|156377804|FG001|Overall Study|Other|6|||
48595973|NCT04304508|156377805|FG002|Overall Study|Other|5|||
48595974|NCT04304508|156377806|FG003|Overall Study|Other|4|||
48595975|NCT04304508|156377803|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
48595976|NCT04304508|156377804|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
48595977|NCT04304508|156377805|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
48595978|NCT04304508|156377806|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
48708270|NCT04421027|156779156|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
48708271|NCT04198714|156779157|FG000|Overall Study|Physician Decision|0|||
48708272|NCT04198714|156779158|FG001|Overall Study|Physician Decision|1|||
48708273|NCT01104311|156779159|FG000|Overall Study|Withdrawal by Subject|6|||
48708274|NCT01104311|156779160|FG001|Overall Study|Withdrawal by Subject|6|||
48708275|NCT01104311|156779159|FG000|Overall Study|Protocol Violation|0|||
48708276|NCT01104311|156779160|FG001|Overall Study|Protocol Violation|1|||
48708277|NCT01104311|156779159|FG000|Overall Study|Physician Decision|2|||
48708278|NCT01104311|156779160|FG001|Overall Study|Physician Decision|2|||
48708279|NCT01104311|156779159|FG000|Overall Study|low compliance|1|||
48708280|NCT01104311|156779160|FG001|Overall Study|low compliance|1|||
48708281|NCT01104311|156779159|FG000|Overall Study|Adverse Event|1|||
48708282|NCT01104311|156779160|FG001|Overall Study|Adverse Event|2|||
48708283|NCT00214201|156780882|FG000|Overall Study|Withdrawal by Subject|2|||
48708284|NCT00214201|156780883|FG001|Overall Study|Withdrawal by Subject|0|||
48708285|NCT00214201|156780882|FG000|Overall Study|Death|0|||
48708286|NCT00214201|156780883|FG001|Overall Study|Death|2|||
48708287|NCT02351856|156780885|FG000|Overall Study|Adverse Event|2|||
48708288|NCT02351856|156780885|FG000|Overall Study|Physician Decision|5|||
48708289|NCT02351856|156780885|FG000|Overall Study|Study terminated by sponsor|1|||
48708290|NCT01039376|156780886|FG000|Overall Study|Lost to Follow-up|5|||
48708291|NCT01039376|156780887|FG001|Overall Study|Lost to Follow-up|12|||
48708292|NCT01039376|156780886|FG000|Overall Study|Physician Decision|15|||
48708293|NCT01039376|156780887|FG001|Overall Study|Physician Decision|10|||
48708294|NCT01039376|156780886|FG000|Overall Study|Withdrawal by Subject|20|||
48708295|NCT01039376|156780887|FG001|Overall Study|Withdrawal by Subject|32|||
48708296|NCT01039376|156780886|FG000|Overall Study|Study terminated by Sponsor|90|||
48708297|NCT01039376|156780887|FG001|Overall Study|Study terminated by Sponsor|72|||
48708298|NCT00114517|156780888|FG000|Overall Study|Adverse Event|6|||
48708299|NCT00114517|156780889|FG001|Overall Study|Adverse Event|1|||
48708300|NCT00114517|156780890|FG002|Overall Study|Adverse Event|6|||
48708301|NCT00114517|156780891|FG003|Overall Study|Adverse Event|3|||
48708302|NCT00114517|156780888|FG000|Overall Study|Lost to Follow-up|2|||
48708303|NCT00114517|156780889|FG001|Overall Study|Lost to Follow-up|2|||
48708304|NCT00114517|156780890|FG002|Overall Study|Lost to Follow-up|2|||
48708305|NCT00114517|156780891|FG003|Overall Study|Lost to Follow-up|1|||
48708306|NCT00114517|156780888|FG000|Overall Study|Too busy|3|||
48708307|NCT00114517|156780889|FG001|Overall Study|Too busy|1|||
48708308|NCT00114517|156780890|FG002|Overall Study|Too busy|1|||
48708309|NCT00114517|156780891|FG003|Overall Study|Too busy|2|||
48708310|NCT00114517|156780888|FG000|Overall Study|Moved from area|0|||
48708311|NCT00114517|156780889|FG001|Overall Study|Moved from area|3|||
48708312|NCT00114517|156780890|FG002|Overall Study|Moved from area|2|||
48708313|NCT00114517|156780891|FG003|Overall Study|Moved from area|1|||
48708314|NCT00114517|156780888|FG000|Overall Study|Did not want estradiol|1|||
48708315|NCT00114517|156780889|FG001|Overall Study|Did not want estradiol|1|||
48708316|NCT00114517|156780890|FG002|Overall Study|Did not want estradiol|0|||
48708317|NCT00114517|156780891|FG003|Overall Study|Did not want estradiol|0|||
48708318|NCT00114517|156780888|FG000|Overall Study|Armed-services duty|0|||
48708319|NCT00114517|156780889|FG001|Overall Study|Armed-services duty|1|||
48708320|NCT00114517|156780890|FG002|Overall Study|Armed-services duty|0|||
48708321|NCT00114517|156780891|FG003|Overall Study|Armed-services duty|1|||
48708322|NCT00114517|156780888|FG000|Overall Study|Competing family issue|0|||
48708323|NCT00114517|156780889|FG001|Overall Study|Competing family issue|1|||
48708324|NCT00114517|156780890|FG002|Overall Study|Competing family issue|0|||
48708325|NCT00114517|156780891|FG003|Overall Study|Competing family issue|1|||
48595979|NCT04304508|156377803|FG000|Overall Study|Physician Decision|3|||
48708326|NCT00114517|156780888|FG000|Overall Study|Physician Decision|0|||
48708327|NCT00114517|156780889|FG001|Overall Study|Physician Decision|1|||
48708328|NCT00114517|156780890|FG002|Overall Study|Physician Decision|0|||
48708329|NCT00114517|156780891|FG003|Overall Study|Physician Decision|0|||
48708330|NCT00114517|156780888|FG000|Overall Study|Lost interest|0|||
48708331|NCT00114517|156780889|FG001|Overall Study|Lost interest|0|||
48708332|NCT00114517|156780890|FG002|Overall Study|Lost interest|1|||
48708333|NCT00114517|156780891|FG003|Overall Study|Lost interest|0|||
48708334|NCT00114517|156780888|FG000|Overall Study|Weight increase|0|||
48803094|NCT04181762|157119920|FG000|Overall Study|Adverse Event|1|||
48803095|NCT04181762|157119921|FG001|Overall Study|Adverse Event|3|||
48803096|NCT04181762|157119920|FG000|Overall Study|Lost to Follow-up|1|||
48803097|NCT04181762|157119921|FG001|Overall Study|Lost to Follow-up|1|||
48803098|NCT04181762|157119920|FG000|Overall Study|Physician Decision|1|||
48803099|NCT04181762|157119921|FG001|Overall Study|Physician Decision|3|||
48803100|NCT04181762|157119920|FG000|Overall Study|Pregnancy|0|||
48803101|NCT04181762|157119921|FG001|Overall Study|Pregnancy|1|||
48803102|NCT04181762|157119920|FG000|Overall Study|Lack of Efficacy|2|||
48803103|NCT04181762|157119921|FG001|Overall Study|Lack of Efficacy|2|||
48803104|NCT04181762|157119920|FG000|Overall Study|Study terminated by sponsor|95|||
48803105|NCT04181762|157119921|FG001|Overall Study|Study terminated by sponsor|97|||
48708335|NCT00114517|156780889|FG001|Overall Study|Weight increase|0|||
48708336|NCT00114517|156780890|FG002|Overall Study|Weight increase|1|||
48595980|NCT04304508|156377804|FG001|Overall Study|Physician Decision|4|||
48708337|NCT00114517|156780891|FG003|Overall Study|Weight increase|0|||
48708338|NCT00114517|156780888|FG000|Overall Study|Concern about blood clots|0|||
48708339|NCT00114517|156780889|FG001|Overall Study|Concern about blood clots|0|||
48708340|NCT00114517|156780890|FG002|Overall Study|Concern about blood clots|1|||
48708341|NCT00114517|156780891|FG003|Overall Study|Concern about blood clots|0|||
48708342|NCT00114517|156780888|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
48708343|NCT00114517|156780889|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
48708344|NCT00114517|156780890|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
48708345|NCT00114517|156780891|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
48708346|NCT03252925|156780892|FG000|Overall Study|Withdrawal by Subject|1|||
48708347|NCT03252925|156780893|FG001|Overall Study|Withdrawal by Subject|0|||
48708348|NCT03252925|156780892|FG000|Overall Study|Protocol Violation|6|||
48708349|NCT03252925|156780893|FG001|Overall Study|Protocol Violation|0|||
48708350|NCT03252925|156780892|FG000|Overall Study|Adverse Event|1|||
48708351|NCT03252925|156780893|FG001|Overall Study|Adverse Event|0|||
48708352|NCT03252925|156780892|FG000|Overall Study|Lost to Follow-up|6|||
48708353|NCT03252925|156780893|FG001|Overall Study|Lost to Follow-up|6|||
48708354|NCT00357552|156780894|FG000|Screening|Did not meet eligibility criteria|84|||
48708355|NCT00357552|156780894|FG000|Weeks 0 to 24|Death|1|||
48708356|NCT00357552|156780894|FG000|Weeks 24 to 104|Death|3|||
48708357|NCT00357552|156780894|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
48708358|NCT01908803|156780909|FG000|Overall Study|Adverse Event|1|||
48708359|NCT01908803|156780910|FG001|Overall Study|Adverse Event|0|||
48708360|NCT01908803|156780909|FG000|Overall Study|Physician Decision|0|||
48708361|NCT01908803|156780910|FG001|Overall Study|Physician Decision|1|||
48708362|NCT01908803|156780909|FG000|Overall Study|Withdrawal by Subject|1|||
48708363|NCT01908803|156780910|FG001|Overall Study|Withdrawal by Subject|0|||
48708364|NCT01908803|156780909|FG000|Overall Study|Randomization Error|1|||
48708365|NCT01908803|156780910|FG001|Overall Study|Randomization Error|0|||
48708366|NCT01908803|156780909|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
48708367|NCT01908803|156780910|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
48708368|NCT00867815|156780911|FG000|Overall Study|Lost to Follow-up|1|||
48708369|NCT02404025|156780912|FG000|Overall Study|Adverse Event|1|||
48708370|NCT02404025|156780912|FG000|Overall Study|Lack of Efficacy|3|||
48708371|NCT00098813|156780913|FG000|Overall Study|Death|8|||
48708372|NCT00098813|156780913|FG000|Overall Study|Protocol Violation|1|||
48708373|NCT00098813|156780913|FG000|Overall Study|Withdrawal by Subject|7|||
48708374|NCT00098813|156780913|FG000|Overall Study|Progression of Disease|1|||
48708375|NCT00098813|156780913|FG000|Overall Study|Other complicating disease|1|||
48803106|NCT04181762|157119920|FG000|Overall Study|Subject decision|11|||
48803107|NCT04181762|157119921|FG001|Overall Study|Subject decision|4|||
48803108|NCT04181762|157119920|FG000|Overall Study|Death|1|||
48803109|NCT04181762|157119921|FG001|Overall Study|Death|1|||
48434134|NCT01781429|155779131|FG010|Overall Study|Disease Progression|15|||
48434135|NCT01781429|155779132|FG011|Overall Study|Disease Progression|15|||
48434136|NCT01781429|155779133|FG012|Overall Study|Disease Progression|15|||
48434137|NCT01781429|155779134|FG013|Overall Study|Disease Progression|4|||
48490318|NCT01862328|155988920|FG004|Overall Study|Progressive Disease|7|||
48490319|NCT01862328|155988921|FG005|Overall Study|Progressive Disease|4|||
48708376|NCT00098813|156780913|FG000|Overall Study|Reversal of RAI resistance|1|||
48708377|NCT01716052|156780914|FG000|Overall Study|Withdrawal of funding|1|||
48708378|NCT01716052|156780915|FG001|Overall Study|Withdrawal of funding|1|||
48708379|NCT00372593|156780916|FG000|Overall Study|Adverse Event|43|||
48708380|NCT00372593|156780917|FG001|Overall Study|Adverse Event|45|||
48708381|NCT00372593|156780918|FG002|Overall Study|Adverse Event|0|||
48490320|NCT01862328|155988922|FG006|Overall Study|Progressive Disease|3|||
48708382|NCT00372593|156780916|FG000|Overall Study|Death|16|||
48803110|NCT04181762|157119920|FG000|Overall Study|Protocol deviation|1|||
48803111|NCT04181762|157119921|FG001|Overall Study|Protocol deviation|0|||
48803112|NCT04181762|157119920|FG000|Overall Study|Withdrawal of informed consent|1|||
48803113|NCT04181762|157119921|FG001|Overall Study|Withdrawal of informed consent|3|||
48803114|NCT01368900|157119922|FG000|Overall Study|Lost to Follow-up|7|||
48803115|NCT04027348|157119923|FG000|Overall Study|Adverse Event|2|||
48803116|NCT02487472|157119924|FG000|Overall Study|Did not complete telephonic interviews|9|||
48803117|NCT02487472|157119924|FG000|Overall Study|Other|2|||
48803118|NCT01224158|157119925|FG000|Overall Study|Withdrawal by Subject|1|||
48803119|NCT01224158|157119926|FG001|Overall Study|Withdrawal by Subject|0|||
48803120|NCT02055157|157119927|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
48803121|NCT02055157|157119928|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
48803122|NCT02055157|157119929|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
48803123|NCT02055157|157119930|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
48803124|NCT02055157|157119927|FG000|Initial 6 Months|Adverse Event|0|||
48803125|NCT02055157|157119928|FG001|Initial 6 Months|Adverse Event|0|||
48803126|NCT02055157|157119929|FG002|Initial 6 Months|Adverse Event|0|||
48803127|NCT02055157|157119930|FG003|Initial 6 Months|Adverse Event|1|||
48803128|NCT02055157|157119927|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
48803129|NCT02055157|157119928|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
48803130|NCT02055157|157119929|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
48803131|NCT02055157|157119930|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
48803132|NCT02055157|157119927|FG000|18-month Extension|Investigator decision|0|||
48803133|NCT02055157|157119928|FG001|18-month Extension|Investigator decision|1|||
48803134|NCT02055157|157119929|FG002|18-month Extension|Investigator decision|0|||
48803135|NCT02055157|157119930|FG003|18-month Extension|Investigator decision|0|||
48803136|NCT02055157|157119927|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
48803137|NCT02055157|157119928|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
48803138|NCT02055157|157119929|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
48803139|NCT02055157|157119930|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
48803140|NCT03988166|157119931|FG000|Overall Study|Lost to Follow-up|2|||
48803141|NCT03988166|157119931|FG000|Overall Study|Death|1|||
48803142|NCT01807650|157119934|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
48803143|NCT01807650|157119934|FG000|Overall Study|Adverse Event|5|||
48803144|NCT01807650|157119934|FG000|Overall Study|Other|2|||
48803145|NCT02090634|157119937|FG000|Overall Study|Lost to Follow-up|0|||
48803146|NCT02090634|157119938|FG001|Overall Study|Lost to Follow-up|1|||
48803147|NCT02090634|157119937|FG000|Overall Study|Death|0|||
48803148|NCT02090634|157119938|FG001|Overall Study|Death|1|||
48803149|NCT02090634|157119937|FG000|Overall Study|Protocol Violation|3|||
48803150|NCT02090634|157119938|FG001|Overall Study|Protocol Violation|1|||
48803151|NCT02090634|157119937|FG000|Overall Study|Adverse Event|2|||
48803152|NCT02090634|157119938|FG001|Overall Study|Adverse Event|0|||
48803153|NCT00895622|157119939|FG000|Overall Study|Protocol Violation|5|||
48803154|NCT00895622|157119940|FG001|Overall Study|Protocol Violation|4|||
48803155|NCT00895622|157119941|FG002|Overall Study|Protocol Violation|4|||
48803156|NCT00695786|157121724|FG000|Overall Study|Adverse Event|0|||
48803157|NCT00695786|157121725|FG001|Overall Study|Adverse Event|3|||
48803158|NCT00695786|157121726|FG002|Overall Study|Adverse Event|4|||
48803159|NCT00695786|157121727|FG003|Overall Study|Adverse Event|2|||
48803160|NCT00695786|157121724|FG000|Overall Study|Lost to Follow-up|0|||
48803161|NCT00695786|157121725|FG001|Overall Study|Lost to Follow-up|5|||
48803162|NCT00695786|157121726|FG002|Overall Study|Lost to Follow-up|1|||
48803163|NCT00695786|157121727|FG003|Overall Study|Lost to Follow-up|1|||
48803164|NCT00695786|157121724|FG000|Overall Study|Withdrawal by Subject|0|||
48803165|NCT00695786|157121725|FG001|Overall Study|Withdrawal by Subject|4|||
48803166|NCT00695786|157121726|FG002|Overall Study|Withdrawal by Subject|3|||
48803167|NCT00695786|157121727|FG003|Overall Study|Withdrawal by Subject|1|||
48803168|NCT00695786|157121724|FG000|Overall Study|Deemed Ineligible|1|||
48803169|NCT00695786|157121725|FG001|Overall Study|Deemed Ineligible|0|||
48803170|NCT00695786|157121726|FG002|Overall Study|Deemed Ineligible|0|||
48803171|NCT00695786|157121727|FG003|Overall Study|Deemed Ineligible|0|||
48803172|NCT00695786|157121724|FG000|Overall Study|Lack of Efficacy|0|||
48803173|NCT00695786|157121725|FG001|Overall Study|Lack of Efficacy|0|||
48803174|NCT00695786|157121726|FG002|Overall Study|Lack of Efficacy|0|||
48803175|NCT00695786|157121727|FG003|Overall Study|Lack of Efficacy|4|||
48803176|NCT03092375|157121732|FG000|Overall Study|Lack of Efficacy|0|||
48803177|NCT03092375|157121733|FG001|Overall Study|Lack of Efficacy|1|||
48803178|NCT03092375|157121734|FG002|Overall Study|Lack of Efficacy|1|||
48803179|NCT03092375|157121735|FG003|Overall Study|Lack of Efficacy|0|||
48803180|NCT04098406|157121738|FG000|Overall Study|Adverse Event|2|||
48803181|NCT04098406|157121739|FG001|Overall Study|Adverse Event|1|||
48803182|NCT04098406|157121738|FG000|Overall Study|Withdrawal by Subject|1|||
48803183|NCT04098406|157121739|FG001|Overall Study|Withdrawal by Subject|0|||
48803184|NCT02832622|157121740|FG000|Overall Study|MPP not programmed|1259|||
48803185|NCT02832622|157121740|FG000|Overall Study|Withdrawal by Subject|123|||
48803186|NCT02832622|157121740|FG000|Overall Study|Death|119|||
48803187|NCT02832622|157121740|FG000|Overall Study|Unsuccessful CRT implant|93|||
48803188|NCT02832622|157121740|FG000|Overall Study|Lost to Follow-up|45|||
48803189|NCT02832622|157121740|FG000|Overall Study|Patient non-compliance|42|||
48803190|NCT02832622|157121740|FG000|Overall Study|Withdrawal by other reasons|25|||
48803191|NCT02832622|157121740|FG000|Overall Study|System explant|24|||
48803192|NCT02832622|157121740|FG000|Overall Study|Physician Decision|6|||
48803193|NCT02472652|157121743|FG000|Overall Study|Lost to Follow-up|1|||
48803194|NCT00998400|157121744|FG000|Overall Study|Lack of interest/motivation|1|||
48803195|NCT00998400|157121745|FG001|Overall Study|Lack of interest/motivation|2|||
48803196|NCT00998400|157121744|FG000|Overall Study|Logistical problems|1|||
48803197|NCT00998400|157121745|FG001|Overall Study|Logistical problems|0|||
48803198|NCT03122119|157121746|FG000|Overall Study|Did not meet eligibility critria|1|||
48803199|NCT02127372|157121747|FG000|Overall Study|Withdrawal by Subject|1|||
48803200|NCT02127372|157121748|FG001|Overall Study|Withdrawal by Subject|0|||
48803201|NCT01191840|157121749|FG000|Overall Study|withdrew consent|2|||
48803202|NCT01191840|157121750|FG001|Overall Study|withdrew consent|1|||
48803203|NCT01191840|157121749|FG000|Overall Study|Subject discontinued treatment|1|||
48803204|NCT01191840|157121750|FG001|Overall Study|Subject discontinued treatment|2|||
48803205|NCT01191840|157121749|FG000|Overall Study|Lost to Follow-up|4|||
48803206|NCT01191840|157121750|FG001|Overall Study|Lost to Follow-up|6|||
48803207|NCT01191840|157121749|FG000|Overall Study|Non Staph Infection|4|||
48803208|NCT01191840|157121750|FG001|Overall Study|Non Staph Infection|3|||
48803209|NCT01191840|157121749|FG000|Overall Study|ineligible at enrollment|1|||
48803210|NCT01191840|157121750|FG001|Overall Study|ineligible at enrollment|0|||
48803211|NCT01191840|157121749|FG000|Overall Study|IRB approval lapse|0|||
48803212|NCT01191840|157121750|FG001|Overall Study|IRB approval lapse|2|||
48803213|NCT01191840|157121749|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
48803214|NCT01191840|157121750|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
48803215|NCT01191840|157121749|FG000|Overall Study|Withdrawal by Subject|2|||
48803216|NCT01191840|157121750|FG001|Overall Study|Withdrawal by Subject|0|||
48803217|NCT01392300|157121751|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
48803218|NCT01392300|157121752|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
48803219|NCT01392300|157121753|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
48803220|NCT01392300|157121751|FG000|Main Period (MP)|Withdrawal by Subject|5|||
48803221|NCT01392300|157121752|FG001|Main Period (MP)|Withdrawal by Subject|1|||
48803222|NCT01392300|157121753|FG002|Main Period (MP)|Withdrawal by Subject|0|||
48803223|NCT01392300|157121751|FG000|Main Period (MP)|Lost to Follow-up|3|||
48803224|NCT01392300|157121752|FG001|Main Period (MP)|Lost to Follow-up|3|||
48803225|NCT01392300|157121753|FG002|Main Period (MP)|Lost to Follow-up|0|||
48803226|NCT01392300|157121751|FG000|Main Period (MP)|Non-compliance|1|||
48803227|NCT01392300|157121752|FG001|Main Period (MP)|Non-compliance|0|||
48803228|NCT01392300|157121753|FG002|Main Period (MP)|Non-compliance|0|||
48803229|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
48803230|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
48490321|NCT01862328|155988916|FG000|Overall Study|Adverse Event|0|||
48490322|NCT01862328|155988917|FG001|Overall Study|Adverse Event|4|||
48490323|NCT01862328|155988918|FG002|Overall Study|Adverse Event|0|||
48708383|NCT00372593|156780917|FG001|Overall Study|Death|20|||
48490324|NCT01862328|155988919|FG003|Overall Study|Adverse Event|1|||
48490325|NCT01862328|155988920|FG004|Overall Study|Adverse Event|0|||
48490326|NCT01862328|155988921|FG005|Overall Study|Adverse Event|2|||
48490327|NCT01862328|155988922|FG006|Overall Study|Adverse Event|4|||
48490328|NCT01862328|155988916|FG000|Overall Study|Other|0|||
48490329|NCT01862328|155988917|FG001|Overall Study|Other|2|||
48490330|NCT01862328|155988918|FG002|Overall Study|Other|1|||
48490331|NCT01862328|155988919|FG003|Overall Study|Other|0|||
48490332|NCT01862328|155988920|FG004|Overall Study|Other|4|||
48490333|NCT01862328|155988921|FG005|Overall Study|Other|0|||
48490334|NCT01862328|155988922|FG006|Overall Study|Other|1|||
48595981|NCT04304508|156377805|FG002|Overall Study|Physician Decision|9|||
48708384|NCT00372593|156780918|FG002|Overall Study|Death|1|||
48708385|NCT00372593|156780916|FG000|Overall Study|Lack of Efficacy|82|||
48708386|NCT00372593|156780917|FG001|Overall Study|Lack of Efficacy|71|||
48708387|NCT00372593|156780918|FG002|Overall Study|Lack of Efficacy|2|||
48708388|NCT00372593|156780916|FG000|Overall Study|Lost to Follow-up|1|||
48708389|NCT00372593|156780917|FG001|Overall Study|Lost to Follow-up|0|||
48708390|NCT00372593|156780918|FG002|Overall Study|Lost to Follow-up|0|||
48708391|NCT00372593|156780916|FG000|Overall Study|Physician Decision|42|||
48708392|NCT00372593|156780917|FG001|Overall Study|Physician Decision|41|||
48708393|NCT00372593|156780918|FG002|Overall Study|Physician Decision|0|||
48708394|NCT00372593|156780916|FG000|Overall Study|Ineligible|20|||
48708395|NCT00372593|156780917|FG001|Overall Study|Ineligible|21|||
48708396|NCT00372593|156780918|FG002|Overall Study|Ineligible|1|||
48708397|NCT02779556|156780924|FG000|Baseline|Partial baseline interview completed|1|||
48708398|NCT02779556|156780925|FG001|Baseline|Partial baseline interview completed|0|||
48708399|NCT02779556|156780924|FG000|3 Months|Lost to Follow-up|40|||
48708400|NCT02779556|156780925|FG001|3 Months|Lost to Follow-up|29|||
48708401|NCT02779556|156780924|FG000|3 Months|Missed 3 month clinic visit|27|||
48708402|NCT02779556|156780925|FG001|3 Months|Missed 3 month clinic visit|19|||
48708403|NCT02779556|156780924|FG000|6 Month|Lost to Follow-up|33|||
48708404|NCT02779556|156780925|FG001|6 Month|Lost to Follow-up|39|||
48708405|NCT02779556|156780924|FG000|6 Month HbA1c|No value collected during window|69|||
48708406|NCT02779556|156780925|FG001|6 Month HbA1c|No value collected during window|50|||
48708407|NCT02779556|156780924|FG000|12 Month HbA1c|No value collected during window|138|||
48708408|NCT02779556|156780925|FG001|12 Month HbA1c|No value collected during window|102|||
48708409|NCT01544335|156780926|FG000|Overall Study|Lost to Follow-up|27|||
48708410|NCT01544335|156780926|FG000|Overall Study|Death|4|||
48708411|NCT01544335|156780926|FG000|Overall Study|Disease progression|3|||
48490335|NCT01862328|155988916|FG000|Overall Study|Withdrawal by Subject|1|||
48490336|NCT01862328|155988917|FG001|Overall Study|Withdrawal by Subject|1|||
48490337|NCT01862328|155988918|FG002|Overall Study|Withdrawal by Subject|0|||
48490338|NCT01862328|155988919|FG003|Overall Study|Withdrawal by Subject|0|||
48490339|NCT01862328|155988920|FG004|Overall Study|Withdrawal by Subject|1|||
48490340|NCT01862328|155988921|FG005|Overall Study|Withdrawal by Subject|1|||
48490341|NCT01862328|155988922|FG006|Overall Study|Withdrawal by Subject|1|||
48490342|NCT01862328|155988916|FG000|Overall Study|Symptomatic Deterioration|0|||
48490343|NCT01862328|155988917|FG001|Overall Study|Symptomatic Deterioration|0|||
48490344|NCT01862328|155988918|FG002|Overall Study|Symptomatic Deterioration|0|||
48490345|NCT01862328|155988919|FG003|Overall Study|Symptomatic Deterioration|0|||
48490346|NCT01862328|155988920|FG004|Overall Study|Symptomatic Deterioration|0|||
48490347|NCT01862328|155988921|FG005|Overall Study|Symptomatic Deterioration|0|||
48490348|NCT01862328|155988922|FG006|Overall Study|Symptomatic Deterioration|1|||
48490349|NCT01348542|155988923|FG000|Overall Study|Withdrawal by Subject|3|||
48490350|NCT01348542|155988924|FG001|Overall Study|Withdrawal by Subject|0|||
48490351|NCT01121900|155988925|FG000|First Intervention Period|Adverse Event|1|||
48490352|NCT01121900|155988926|FG001|First Intervention Period|Adverse Event|1|||
48490353|NCT01121900|155988925|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
48490354|NCT01121900|155988926|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48490355|NCT00467584|155988927|FG000|Overall Study|Withdrawal by Subject|4|||
48490356|NCT00467584|155988928|FG001|Overall Study|Withdrawal by Subject|5|||
48490357|NCT00467584|155988929|FG002|Overall Study|Withdrawal by Subject|1|||
48490358|NCT00936975|155988930|FG000|Overall Study|Withdrawal by Subject|1|||
48490359|NCT00936975|155988930|FG000|Overall Study|Disease progression|3|||
48490360|NCT00936975|155988930|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
48490361|NCT03404206|155988931|FG000|Overall Study|Withdrawal by Subject|1|||
48490362|NCT03404206|155988932|FG001|Overall Study|Withdrawal by Subject|1|||
48595982|NCT04304508|156377806|FG003|Overall Study|Physician Decision|7|||
48595983|NCT04304508|156377803|FG000|Overall Study|Study drug never administered|10|||
48595984|NCT04304508|156377804|FG001|Overall Study|Study drug never administered|4|||
48595985|NCT04304508|156377805|FG002|Overall Study|Study drug never administered|4|||
48595986|NCT04304508|156377806|FG003|Overall Study|Study drug never administered|4|||
48595987|NCT04304508|156377803|FG000|Overall Study|Adverse Event|49|||
48595988|NCT04304508|156377804|FG001|Overall Study|Adverse Event|50|||
48490363|NCT03404206|155988933|FG002|Overall Study|Withdrawal by Subject|0|||
48595989|NCT04304508|156377805|FG002|Overall Study|Adverse Event|51|||
48595990|NCT04304508|156377806|FG003|Overall Study|Adverse Event|56|||
48595991|NCT04304508|156377803|FG000|Overall Study|Lost to Follow-up|1|||
48595992|NCT04304508|156377804|FG001|Overall Study|Lost to Follow-up|5|||
48595993|NCT04304508|156377805|FG002|Overall Study|Lost to Follow-up|2|||
48595994|NCT04304508|156377806|FG003|Overall Study|Lost to Follow-up|3|||
48595995|NCT03272347|156377807|FG000|Overall Study|Death|0|||
48595996|NCT03272347|156377808|FG001|Overall Study|Death|0|||
48595997|NCT03272347|156377809|FG002|Overall Study|Death|0|||
48595998|NCT03272347|156377810|FG003|Overall Study|Death|1|||
48595999|NCT03272347|156377807|FG000|Overall Study|Lost to Follow-up|1|||
48596000|NCT03272347|156377808|FG001|Overall Study|Lost to Follow-up|3|||
48596001|NCT03272347|156377809|FG002|Overall Study|Lost to Follow-up|5|||
48596002|NCT03272347|156377810|FG003|Overall Study|Lost to Follow-up|1|||
48490364|NCT03404206|155988931|FG000|Overall Study|Lost to Follow-up|3|||
48490365|NCT03404206|155988932|FG001|Overall Study|Lost to Follow-up|1|||
48490366|NCT03404206|155988933|FG002|Overall Study|Lost to Follow-up|0|||
48490367|NCT02521948|155988934|FG000|Overall Study|Adverse Event|2|||
48490368|NCT02521948|155988934|FG000|Overall Study|Death|4|||
48490369|NCT02521948|155988934|FG000|Overall Study|Lost to Follow-up|1|||
48490370|NCT02521948|155988934|FG000|Overall Study|Did not attend one or both follow-ups|6|||
48596003|NCT03272347|156377807|FG000|Overall Study|Physician Decision|4|||
48596004|NCT03272347|156377808|FG001|Overall Study|Physician Decision|2|||
48490371|NCT01488578|155988935|FG000|Overall Study|Protocol Violation|1836|||
48490372|NCT01077713|155990706|FG000|Overall Study|Withdrawal by Subject|1|||
48490373|NCT01077713|155990707|FG001|Overall Study|Withdrawal by Subject|2|||
48490374|NCT01077713|155990706|FG000|Overall Study|Progressive Disease (PD)|0|||
48490375|NCT01077713|155990707|FG001|Overall Study|Progressive Disease (PD)|1|||
48490376|NCT01077713|155990706|FG000|Overall Study|Death|28|||
48490377|NCT01077713|155990707|FG001|Overall Study|Death|29|||
48490378|NCT01077713|155990706|FG000|Overall Study|Lost to Follow-up|1|||
48490379|NCT01077713|155990707|FG001|Overall Study|Lost to Follow-up|1|||
48490380|NCT01077713|155990706|FG000|Overall Study|Adverse Event|2|||
48596005|NCT03272347|156377809|FG002|Overall Study|Physician Decision|5|||
48708412|NCT01544335|156780926|FG000|Overall Study|Baseline Measurements not Available|19|||
48708413|NCT00622440|156780927|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
48708414|NCT00622440|156780928|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
48708415|NCT00622440|156780927|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
48708416|NCT00622440|156780928|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
48708417|NCT00622440|156780927|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
48708418|NCT00622440|156780928|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
48490381|NCT01077713|155990707|FG001|Overall Study|Adverse Event|1|||
48490382|NCT01077713|155990706|FG000|Overall Study|Other|4|||
48490383|NCT01077713|155990707|FG001|Overall Study|Other|2|||
48490384|NCT03031899|155990709|FG000|Overall Study|Protocol Violation|1|||
48490385|NCT03031899|155990709|FG000|Overall Study|lesion disappeared after stopping habit|1|||
48490386|NCT01664052|155990710|FG000|Phase 1|No device placement|6|||
48490387|NCT01664052|155990711|FG001|Phase 1|No device placement|0|||
48490388|NCT01664052|155990710|FG000|Phase 1|No HSG 1 hr post placement|1|||
48490389|NCT01664052|155990711|FG001|Phase 1|No HSG 1 hr post placement|0|||
48803231|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
48803232|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
48803233|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
48803234|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
48803235|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
48803236|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
48803237|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
48803238|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Death|0|||
48803239|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Death|0|||
48803240|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Death|4|||
48803241|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
48803242|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
48803243|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
48803244|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
48803245|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
48803246|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
48803247|NCT01392300|157121751|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
48803248|NCT01392300|157121752|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
48803249|NCT01392300|157121753|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
48803250|NCT00521144|157121756|FG000|Overall Study|Not Treated|0|||
48803251|NCT00521144|157121757|FG001|Overall Study|Not Treated|0|||
48803252|NCT00521144|157121758|FG002|Overall Study|Not Treated|0|||
48803253|NCT00521144|157121759|FG003|Overall Study|Not Treated|1|||
48803254|NCT00521144|157121760|FG004|Overall Study|Not Treated|0|||
48803255|NCT00521144|157121756|FG000|Overall Study|Adverse Event|0|||
48803256|NCT00521144|157121757|FG001|Overall Study|Adverse Event|1|||
48803257|NCT00521144|157121758|FG002|Overall Study|Adverse Event|0|||
48803258|NCT00521144|157121759|FG003|Overall Study|Adverse Event|0|||
48803259|NCT00521144|157121760|FG004|Overall Study|Adverse Event|1|||
48803260|NCT00521144|157121756|FG000|Overall Study|Progressive Disease|4|||
48803261|NCT00521144|157121757|FG001|Overall Study|Progressive Disease|2|||
48803262|NCT00521144|157121758|FG002|Overall Study|Progressive Disease|2|||
48803263|NCT00521144|157121759|FG003|Overall Study|Progressive Disease|0|||
48803264|NCT00521144|157121760|FG004|Overall Study|Progressive Disease|6|||
48803265|NCT00180479|157121762|FG000|Overall Study|Death|4|||
48803266|NCT00180479|157121763|FG001|Overall Study|Death|2|||
48803267|NCT00180479|157121762|FG000|Overall Study|Lost to Follow-up|9|||
48803268|NCT00180479|157121763|FG001|Overall Study|Lost to Follow-up|7|||
48803269|NCT00180479|157121762|FG000|Overall Study|Withdrawal by Subject|3|||
48803270|NCT00180479|157121763|FG001|Overall Study|Withdrawal by Subject|3|||
48803271|NCT00180479|157121762|FG000|Overall Study|Informed consent not signed|0|||
48803272|NCT00180479|157121763|FG001|Overall Study|Informed consent not signed|1|||
48803273|NCT02991482|157121764|FG000|Overall Study|Disease progression|56|||
48803274|NCT02991482|157121765|FG001|Overall Study|Disease progression|47|||
48803275|NCT02991482|157121764|FG000|Overall Study|Death|4|||
48490390|NCT01664052|155990710|FG000|Phase 2|No device placement|0|||
48803276|NCT02991482|157121765|FG001|Overall Study|Death|4|||
48490391|NCT01664052|155990711|FG001|Phase 2|No device placement|4|||
48490392|NCT01706198|155990712|FG000|Overall Study|Adverse Event|12|||
48490393|NCT01706198|155990713|FG001|Overall Study|Adverse Event|15|||
48490394|NCT01706198|155990712|FG000|Overall Study|Protocol Violation|7|||
48490395|NCT01706198|155990713|FG001|Overall Study|Protocol Violation|5|||
48490396|NCT01706198|155990712|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
48490397|NCT01706198|155990713|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
48490398|NCT01706198|155990712|FG000|Overall Study|Lost to Follow-up|97|||
48708419|NCT00622440|156780927|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
48708420|NCT00622440|156780928|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
48708421|NCT04455815|156780929|FG000|Randomisation Phase|Adverse Event|1|||
48708422|NCT04455815|156780930|FG001|Randomisation Phase|Adverse Event|0|||
48708423|NCT04455815|156780929|FG000|Treatment Phase|Adverse Event|0|||
48708424|NCT04455815|156780930|FG001|Treatment Phase|Adverse Event|1|||
48708425|NCT04455815|156780929|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
48708426|NCT04455815|156780930|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
48708427|NCT04455815|156780929|FG000|Treatment Phase|Withdrawal by Subject|1|||
48708428|NCT04455815|156780930|FG001|Treatment Phase|Withdrawal by Subject|1|||
48708429|NCT03682770|156780939|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708430|NCT03682770|156780940|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
48708431|NCT03682770|156780941|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708432|NCT03682770|156780942|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708433|NCT03682770|156780943|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708434|NCT03682770|156780944|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708435|NCT03682770|156780945|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
48708436|NCT03682770|156780939|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
48708437|NCT03682770|156780940|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
48708438|NCT03682770|156780941|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708439|NCT03682770|156780942|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708440|NCT03682770|156780943|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708441|NCT03682770|156780944|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708442|NCT03682770|156780945|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
48708443|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48708444|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48708445|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
48708446|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
48596006|NCT03272347|156377810|FG003|Overall Study|Physician Decision|4|||
48596007|NCT03272347|156377807|FG000|Overall Study|Screen Failure|1|||
48708447|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48490399|NCT01706198|155990713|FG001|Overall Study|Lost to Follow-up|93|||
48596008|NCT03272347|156377808|FG001|Overall Study|Screen Failure|0|||
48803277|NCT02991482|157121764|FG000|Overall Study|Adverse Event|1|||
48803278|NCT02991482|157121765|FG001|Overall Study|Adverse Event|6|||
48803279|NCT02991482|157121764|FG000|Overall Study|Patient decision|1|||
48803280|NCT02991482|157121765|FG001|Overall Study|Patient decision|1|||
48803281|NCT02991482|157121764|FG000|Overall Study|Physician Decision|0|||
48803282|NCT02991482|157121765|FG001|Overall Study|Physician Decision|6|||
48803283|NCT02991482|157121764|FG000|Overall Study|Clinical deterioration|1|||
48803284|NCT02991482|157121765|FG001|Overall Study|Clinical deterioration|0|||
48803285|NCT02991482|157121764|FG000|Overall Study|Patient feeling too unwell|1|||
48803286|NCT02991482|157121765|FG001|Overall Study|Patient feeling too unwell|0|||
48803287|NCT02991482|157121764|FG000|Overall Study|Worsening of performance status|0|||
48803288|NCT02991482|157121765|FG001|Overall Study|Worsening of performance status|1|||
48803289|NCT02991482|157121764|FG000|Overall Study|Death prior to study drug initiation|1|||
48803290|NCT02991482|157121765|FG001|Overall Study|Death prior to study drug initiation|0|||
48803291|NCT02991482|157121764|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
48803292|NCT02991482|157121765|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
48803293|NCT02901626|157121766|FG000|Overall Study|Lost to Follow-up|1|||
48803294|NCT02901626|157121767|FG001|Overall Study|Lost to Follow-up|1|||
48803295|NCT04810221|157121768|FG000|Overall Study|Physician Decision|3|||
48803296|NCT00105235|157121769|FG000|Overall Study|Death|4|||
48803297|NCT00105235|157121769|FG000|Overall Study|Physician Decision|1|||
48803298|NCT00105235|157121769|FG000|Overall Study|Withdrawal by Subject|2|||
48803299|NCT00991341|157121770|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
48803300|NCT00991341|157121771|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
48803301|NCT00991341|157121770|FG000|Overall Study|Death|3|||
48803302|NCT00991341|157121771|FG001|Overall Study|Death|0|||
48803303|NCT00991341|157121770|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
48803304|NCT00991341|157121771|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
48803305|NCT00991341|157121770|FG000|Overall Study|Physician Decision|1|||
48803306|NCT00991341|157121771|FG001|Overall Study|Physician Decision|2|||
48803307|NCT00991341|157121770|FG000|Overall Study|Withdrawal by Subject|3|||
48803308|NCT00991341|157121771|FG001|Overall Study|Withdrawal by Subject|4|||
48803309|NCT02207725|157121772|FG000|Overall Study|Did Not Receive Treatment|0|||
48803310|NCT02207725|157121773|FG001|Overall Study|Did Not Receive Treatment|1|||
48803311|NCT02207725|157121774|FG002|Overall Study|Did Not Receive Treatment|1|||
48803312|NCT02207725|157121775|FG003|Overall Study|Did Not Receive Treatment|1|||
48803313|NCT01621880|157121782|FG000|Overall Study|Adverse Event|5|||
48803314|NCT01621880|157121783|FG001|Overall Study|Adverse Event|1|||
48803315|NCT01621880|157121782|FG000|Overall Study|Withdrawal by Subject|5|||
48803316|NCT01621880|157121783|FG001|Overall Study|Withdrawal by Subject|4|||
48803317|NCT00674570|157121784|FG000|Overall Study|Withdrawal by Subject|0|||
48803318|NCT00674570|157121785|FG001|Overall Study|Withdrawal by Subject|2|||
48803319|NCT00674570|157121786|FG002|Overall Study|Withdrawal by Subject|0|||
48803320|NCT03633929|157121787|FG000|Overall Study|Lost to Follow-up|1|||
48803321|NCT03633929|157121787|FG000|Overall Study|Did not login to software. Did not participate|3|||
48803322|NCT05292534|157121788|FG000|Overall Study|Protocol Violation|3|||
48803323|NCT05292534|157121789|FG001|Overall Study|Protocol Violation|4|||
48803324|NCT05292534|157121788|FG000|Overall Study|Withdrawal by Subject|0|||
48803325|NCT05292534|157121789|FG001|Overall Study|Withdrawal by Subject|1|||
48803326|NCT01889186|157121790|FG000|Overall Study|Adverse event- not related to progression|18|||
48803327|NCT01889186|157121791|FG001|Overall Study|Adverse event- not related to progression|5|||
48803328|NCT01889186|157121790|FG000|Overall Study|Adverse event- related to progression|7|||
48490400|NCT01706198|155990712|FG000|Overall Study|Physician Decision|23|||
48490401|NCT01706198|155990713|FG001|Overall Study|Physician Decision|37|||
48803329|NCT01889186|157121791|FG001|Overall Study|Adverse event- related to progression|2|||
48803330|NCT01889186|157121790|FG000|Overall Study|COVID-19 logistical restrictions|1|||
48596009|NCT03272347|156377809|FG002|Overall Study|Screen Failure|0|||
48596010|NCT03272347|156377810|FG003|Overall Study|Screen Failure|0|||
48596011|NCT03272347|156377807|FG000|Overall Study|Withdrawal by Subject|5|||
48596012|NCT03272347|156377808|FG001|Overall Study|Withdrawal by Subject|1|||
48596013|NCT03272347|156377809|FG002|Overall Study|Withdrawal by Subject|2|||
48596014|NCT03272347|156377810|FG003|Overall Study|Withdrawal by Subject|1|||
48596015|NCT00703677|156377811|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
48596016|NCT03091738|156377812|FG000|Overall Study|Adverse Event|1|||
48596017|NCT03091738|156377812|FG000|Overall Study|Lost to Follow-up|1|||
48596018|NCT00215644|156377814|FG000|Overall Study|Disease Progression|28|||
48596019|NCT00215644|156377815|FG001|Overall Study|Disease Progression|10|||
48596020|NCT00215644|156377814|FG000|Overall Study|Adverse Event|2|||
48596021|NCT00215644|156377815|FG001|Overall Study|Adverse Event|9|||
48708448|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48596022|NCT00215644|156377814|FG000|Overall Study|Death|1|||
48596023|NCT00215644|156377815|FG001|Overall Study|Death|2|||
48596024|NCT00215644|156377814|FG000|Overall Study|Withdrawal by Subject|1|||
48596025|NCT00215644|156377815|FG001|Overall Study|Withdrawal by Subject|0|||
48596026|NCT00215644|156377814|FG000|Overall Study|Other|3|||
48596027|NCT00215644|156377815|FG001|Overall Study|Other|15|||
48596028|NCT00215644|156377814|FG000|Overall Study|Randomized but Not Treated|1|||
48596029|NCT00215644|156377815|FG001|Overall Study|Randomized but Not Treated|0|||
48596030|NCT01763827|156377818|FG000|Overall Study|Withdrawal by Subject|1|||
48596031|NCT01763827|156377819|FG001|Overall Study|Withdrawal by Subject|0|||
48596032|NCT01763827|156377820|FG002|Overall Study|Withdrawal by Subject|0|||
48596033|NCT01763827|156377821|FG003|Overall Study|Withdrawal by Subject|0|||
48596034|NCT01763827|156377822|FG004|Overall Study|Withdrawal by Subject|2|||
48596035|NCT01763827|156377823|FG005|Overall Study|Withdrawal by Subject|0|||
48596036|NCT01763827|156377818|FG000|Overall Study|Decision by sponsor|2|||
48596037|NCT01763827|156377819|FG001|Overall Study|Decision by sponsor|0|||
48708449|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
48708450|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708451|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708452|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708453|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
48708454|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708455|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708456|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
48708457|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48708458|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48708459|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
48708460|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
48708461|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48708462|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48596038|NCT01763827|156377820|FG002|Overall Study|Decision by sponsor|3|||
48490402|NCT01706198|155990712|FG000|Overall Study|Withdrawal by Subject|23|||
48490403|NCT01706198|155990713|FG001|Overall Study|Withdrawal by Subject|31|||
48490404|NCT01042977|155990715|FG000|Overall Study|Adverse Event|4|||
48490405|NCT01042977|155990716|FG001|Overall Study|Adverse Event|12|||
48803331|NCT01889186|157121791|FG001|Overall Study|COVID-19 logistical restrictions|0|||
48803332|NCT01889186|157121790|FG000|Overall Study|Investigator request|1|||
48803333|NCT01889186|157121791|FG001|Overall Study|Investigator request|1|||
48803334|NCT01889186|157121790|FG000|Overall Study|Progressive disease- Richter's|12|||
48803335|NCT01889186|157121791|FG001|Overall Study|Progressive disease- Richter's|7|||
48803336|NCT01889186|157121790|FG000|Overall Study|Progressive disease per protocol|46|||
48803337|NCT01889186|157121791|FG001|Overall Study|Progressive disease per protocol|17|||
48803338|NCT01889186|157121790|FG000|Overall Study|Stem cell transplant|2|||
48803339|NCT01889186|157121791|FG001|Overall Study|Stem cell transplant|1|||
48803340|NCT01889186|157121790|FG000|Overall Study|Withdrew consent|2|||
48803341|NCT01889186|157121791|FG001|Overall Study|Withdrew consent|3|||
48803342|NCT01889186|157121790|FG000|Overall Study|Other, not specified|18|||
48803343|NCT01889186|157121791|FG001|Overall Study|Other, not specified|15|||
48803344|NCT02768662|157121794|FG000|Overall Study|Adverse Event|1|||
48803345|NCT02768662|157121794|FG000|Overall Study|Lost to Follow-up|4|||
48803346|NCT02768662|157121794|FG000|Overall Study|Withdrawal by Subject|3|||
48803347|NCT02768662|157121794|FG000|Overall Study|Study terminated by Sponsor|78|||
48803348|NCT01755702|157121795|FG000|Wash Out Period I|Other Reason|3|||
48803349|NCT01755702|157121795|FG000|Washout Period II|Other Reason|5|||
48803350|NCT00571701|157121796|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
48803351|NCT00571701|157121797|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
48803352|NCT00571701|157121796|FG000|First Intervention 12 Months|Death|1|||
48803353|NCT00571701|157121797|FG001|First Intervention 12 Months|Death|0|||
48803354|NCT00571701|157121796|FG000|Second Intervention 12 Months|Adverse Event|0|||
48803355|NCT00571701|157121797|FG001|Second Intervention 12 Months|Adverse Event|1|||
48803356|NCT00571701|157121796|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
48803357|NCT00571701|157121797|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
48803358|NCT00758459|157121799|FG000|Overall Study|Adverse Event|3|||
48803359|NCT00758459|157121800|FG001|Overall Study|Adverse Event|2|||
48803360|NCT00758459|157121799|FG000|Overall Study|Protocol Violation|0|||
48803361|NCT00758459|157121800|FG001|Overall Study|Protocol Violation|1|||
48803362|NCT00758459|157121799|FG000|Overall Study|Withdrawal by Subject|0|||
48803363|NCT00758459|157121800|FG001|Overall Study|Withdrawal by Subject|1|||
48803364|NCT00691132|157121801|FG000|Overall Study|Adverse Event|2|||
48803365|NCT00691132|157121802|FG001|Overall Study|Adverse Event|3|||
48803366|NCT00691132|157121801|FG000|Overall Study|Withdrawal by Subject|10|||
48803367|NCT00691132|157121802|FG001|Overall Study|Withdrawal by Subject|10|||
48803368|NCT02036645|157121804|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803369|NCT02036645|157121805|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803370|NCT02036645|157121806|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803371|NCT02036645|157121807|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803372|NCT02036645|157121808|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803373|NCT02036645|157121809|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803374|NCT02036645|157121810|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
48803375|NCT02036645|157121811|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803376|NCT02036645|157121812|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803377|NCT02036645|157121813|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803378|NCT02036645|157121814|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803379|NCT02036645|157121815|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
48803380|NCT02036645|157121804|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803381|NCT02036645|157121805|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803382|NCT02036645|157121806|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803383|NCT02036645|157121807|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
48803384|NCT02036645|157121808|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803385|NCT02036645|157121809|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803386|NCT02036645|157121810|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803387|NCT02036645|157121811|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803388|NCT02036645|157121812|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803389|NCT02036645|157121813|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803390|NCT02036645|157121814|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803391|NCT02036645|157121815|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
48803392|NCT00652938|157121816|FG000|Overall Study|Adverse Event|1|||
48803393|NCT00652938|157121817|FG001|Overall Study|Adverse Event|0|||
48803394|NCT00652938|157121818|FG002|Overall Study|Adverse Event|2|||
48490406|NCT01042977|155990715|FG000|Overall Study|Death|2|||
48803395|NCT00652938|157121816|FG000|Overall Study|Withdrawal by Subject|0|||
48803396|NCT00652938|157121817|FG001|Overall Study|Withdrawal by Subject|6|||
48803397|NCT00652938|157121818|FG002|Overall Study|Withdrawal by Subject|1|||
48803398|NCT00652938|157121816|FG000|Overall Study|Lost to Follow-up|0|||
48803399|NCT00652938|157121817|FG001|Overall Study|Lost to Follow-up|0|||
48803400|NCT00652938|157121818|FG002|Overall Study|Lost to Follow-up|2|||
48803401|NCT00652938|157121816|FG000|Overall Study|fear of blood sampling|0|||
48803402|NCT00652938|157121817|FG001|Overall Study|fear of blood sampling|1|||
48803403|NCT00652938|157121818|FG002|Overall Study|fear of blood sampling|0|||
48803404|NCT02978443|157121819|FG000|Overall Study|Withdrawal by Subject|1|||
48803405|NCT02978443|157121819|FG000|Overall Study|Adverse Event|3|||
48803406|NCT02978443|157121819|FG000|Overall Study|Disease Progression on study|6|||
48803407|NCT02978443|157121819|FG000|Overall Study|Death|1|||
48803408|NCT02978443|157121819|FG000|Overall Study|Physician Decision|1|||
48803409|NCT02978443|157121819|FG000|Overall Study|Switch to alternative therapy|1|||
48803410|NCT02978443|157121819|FG000|Overall Study|Refused further treatment|1|||
48803411|NCT00117156|157121820|FG000|Overall Study|Adverse Event|9|||
48803412|NCT00117156|157121820|FG000|Overall Study|Physician Decision|1|||
48803413|NCT00117156|157121820|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
48803414|NCT04066205|157121821|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
48803415|NCT04066205|157121822|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
48803416|NCT04066205|157121821|FG000|T2 Immediate Post-Intervention|did not respond|5|||
48803417|NCT04066205|157121822|FG001|T2 Immediate Post-Intervention|did not respond|3|||
48803418|NCT01436201|157121830|FG000|Overall Study|Adverse Event|2|||
48803419|NCT01436201|157121830|FG000|Overall Study|Withdrawal by Subject|1|||
48803420|NCT01436201|157121830|FG000|Overall Study|Protocol Violation|1|||
48803421|NCT01435655|157121831|FG000|Overall Study|Death|2|||
48803422|NCT01435655|157121831|FG000|Overall Study|Other|1|||
48803423|NCT00110890|157121832|FG000|Overall Study|Adverse Event|30|||
48803424|NCT00110890|157121833|FG001|Overall Study|Adverse Event|7|||
48803425|NCT00110890|157121832|FG000|Overall Study|Death|16|||
48803426|NCT00110890|157121833|FG001|Overall Study|Death|9|||
48803427|NCT00110890|157121832|FG000|Overall Study|Lost to Follow-up|3|||
48803428|NCT00110890|157121833|FG001|Overall Study|Lost to Follow-up|1|||
48803429|NCT00110890|157121832|FG000|Overall Study|Physician Decision|4|||
48803430|NCT00110890|157121833|FG001|Overall Study|Physician Decision|5|||
48803431|NCT00110890|157121832|FG000|Overall Study|Withdrawal by Subject|17|||
48803432|NCT00110890|157121833|FG001|Overall Study|Withdrawal by Subject|5|||
48803433|NCT00110890|157121832|FG000|Overall Study|Protocol Deviation|1|||
48803434|NCT00110890|157121833|FG001|Overall Study|Protocol Deviation|0|||
48803435|NCT00110890|157121832|FG000|Overall Study|Noncompliance|10|||
48803436|NCT00110890|157121833|FG001|Overall Study|Noncompliance|0|||
48803437|NCT00110890|157121832|FG000|Overall Study|Kidney Transplant|16|||
48803438|NCT00110890|157121833|FG001|Overall Study|Kidney Transplant|12|||
48803439|NCT00110890|157121832|FG000|Overall Study|Invest. Product Commercially Available|217|||
48803440|NCT00110890|157121833|FG001|Overall Study|Invest. Product Commercially Available|110|||
48803441|NCT00110890|157121832|FG000|Overall Study|Other|34|||
48803442|NCT00110890|157121833|FG001|Overall Study|Other|23|||
48803443|NCT00110890|157121832|FG000|Overall Study|Ineligibility determined|3|||
48803444|NCT00110890|157121833|FG001|Overall Study|Ineligibility determined|0|||
48803445|NCT00110890|157121832|FG000|Overall Study|Requirement for alternative therapy|0|||
48803446|NCT00110890|157121833|FG001|Overall Study|Requirement for alternative therapy|1|||
48803447|NCT00110890|157121832|FG000|Overall Study|Disease progression|0|||
48803448|NCT00110890|157121833|FG001|Overall Study|Disease progression|1|||
48803449|NCT00110890|157121832|FG000|Overall Study|Parathyroidectomy|0|||
48803450|NCT00110890|157121833|FG001|Overall Study|Parathyroidectomy|1|||
48803451|NCT00110890|157121832|FG000|Overall Study|Did not enter follow-up phase|10|||
48803452|NCT00110890|157121833|FG001|Overall Study|Did not enter follow-up phase|4|||
48803453|NCT02839343|157121834|FG000|Overall Study|Withdrawal by Subject|3|||
48803454|NCT02839343|157121835|FG001|Overall Study|Withdrawal by Subject|1|||
48803455|NCT02839343|157121834|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
48803456|NCT02839343|157121835|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
48803457|NCT02839343|157121834|FG000|Overall Study|Adverse Event|1|||
48803458|NCT02839343|157121835|FG001|Overall Study|Adverse Event|0|||
48803459|NCT00622180|157121838|FG000|Overall Study|Lost to Follow-up|1|||
48803460|NCT00622180|157121839|FG001|Overall Study|Lost to Follow-up|2|||
48803461|NCT03916744|157121840|FG000|Overall Study|Withdrawal by Subject|0|||
48803462|NCT03916744|157121841|FG001|Overall Study|Withdrawal by Subject|1|||
48803463|NCT03916744|157121842|FG002|Overall Study|Withdrawal by Subject|2|||
48803464|NCT00661661|157121845|FG000|Overall Study|Adverse Event|99|||
48803465|NCT00661661|157121846|FG001|Overall Study|Adverse Event|24|||
48803466|NCT00661661|157121845|FG000|Overall Study|Lack of Efficacy|3|||
48803467|NCT00661661|157121846|FG001|Overall Study|Lack of Efficacy|2|||
48803468|NCT00661661|157121845|FG000|Overall Study|Lost to Follow-up|0|||
48803469|NCT00661661|157121846|FG001|Overall Study|Lost to Follow-up|1|||
48803470|NCT00661661|157121845|FG000|Overall Study|Withdrawal by Subject|15|||
48803471|NCT00661661|157121846|FG001|Overall Study|Withdrawal by Subject|5|||
48803472|NCT00661661|157121845|FG000|Overall Study|Other|22|||
48803473|NCT00661661|157121846|FG001|Overall Study|Other|7|||
48803474|NCT00661661|157121845|FG000|Overall Study|Not assigned treatment|1|||
48803475|NCT00661661|157121846|FG001|Overall Study|Not assigned treatment|0|||
48803476|NCT02569710|157121847|FG000|Overall Study|Adverse Event|1|||
48803477|NCT02569710|157121848|FG001|Overall Study|Adverse Event|0|||
48803478|NCT02569710|157121849|FG002|Overall Study|Adverse Event|0|||
48803479|NCT02569710|157121850|FG003|Overall Study|Adverse Event|0|||
48803480|NCT02569710|157121851|FG004|Overall Study|Adverse Event|0|||
48490407|NCT01042977|155990716|FG001|Overall Study|Death|1|||
48803481|NCT02569710|157121852|FG005|Overall Study|Adverse Event|0|||
48803482|NCT02569710|157121853|FG006|Overall Study|Adverse Event|0|||
48803483|NCT02569710|157121854|FG007|Overall Study|Adverse Event|0|||
48803484|NCT02569710|157121855|FG008|Overall Study|Adverse Event|0|||
48803485|NCT02569710|157121856|FG009|Overall Study|Adverse Event|0|||
48803486|NCT02569710|157121847|FG000|Overall Study|Lost to Follow-up|0|||
48803487|NCT02569710|157121848|FG001|Overall Study|Lost to Follow-up|0|||
48803488|NCT02569710|157121849|FG002|Overall Study|Lost to Follow-up|0|||
48803489|NCT02569710|157121850|FG003|Overall Study|Lost to Follow-up|0|||
48803490|NCT02569710|157121851|FG004|Overall Study|Lost to Follow-up|0|||
48803491|NCT02569710|157121852|FG005|Overall Study|Lost to Follow-up|0|||
48803492|NCT02569710|157121853|FG006|Overall Study|Lost to Follow-up|1|||
48803493|NCT02569710|157121854|FG007|Overall Study|Lost to Follow-up|0|||
48803494|NCT02569710|157121855|FG008|Overall Study|Lost to Follow-up|1|||
48803495|NCT02569710|157121856|FG009|Overall Study|Lost to Follow-up|0|||
48803496|NCT02569710|157121847|FG000|Overall Study|Virologic failure|0|||
48803497|NCT02569710|157121848|FG001|Overall Study|Virologic failure|0|||
48803498|NCT02569710|157121849|FG002|Overall Study|Virologic failure|0|||
48803499|NCT02569710|157121850|FG003|Overall Study|Virologic failure|0|||
48803500|NCT02569710|157121851|FG004|Overall Study|Virologic failure|1|||
48803501|NCT02569710|157121852|FG005|Overall Study|Virologic failure|0|||
48803502|NCT02569710|157121853|FG006|Overall Study|Virologic failure|1|||
48803503|NCT02569710|157121854|FG007|Overall Study|Virologic failure|0|||
48803504|NCT02569710|157121855|FG008|Overall Study|Virologic failure|0|||
48803505|NCT02569710|157121856|FG009|Overall Study|Virologic failure|0|||
48803506|NCT02569710|157121847|FG000|Overall Study|Withdrawal by Subject|0|||
48803507|NCT02569710|157121848|FG001|Overall Study|Withdrawal by Subject|0|||
48803508|NCT02569710|157121849|FG002|Overall Study|Withdrawal by Subject|0|||
48803509|NCT02569710|157121850|FG003|Overall Study|Withdrawal by Subject|0|||
48803510|NCT02569710|157121851|FG004|Overall Study|Withdrawal by Subject|0|||
48803511|NCT02569710|157121852|FG005|Overall Study|Withdrawal by Subject|1|||
48803512|NCT02569710|157121853|FG006|Overall Study|Withdrawal by Subject|0|||
48803513|NCT02569710|157121854|FG007|Overall Study|Withdrawal by Subject|0|||
48803514|NCT02569710|157121855|FG008|Overall Study|Withdrawal by Subject|0|||
48803515|NCT02569710|157121856|FG009|Overall Study|Withdrawal by Subject|0|||
48803516|NCT05597722|157121859|FG000|Overall Study|Study was terminated|6|||
48803517|NCT05597722|157121860|FG001|Overall Study|Study was terminated|1|||
48803518|NCT01965938|157121868|FG000|Overall Study|Withdrawal by Subject|1|||
48803519|NCT01965938|157121869|FG001|Overall Study|Withdrawal by Subject|0|||
48803520|NCT03021486|157122939|FG000|Overall Study|Withdrawal by Subject|1|||
48803521|NCT03021486|157122940|FG001|Overall Study|Withdrawal by Subject|1|||
48803522|NCT03021486|157122941|FG002|Overall Study|Withdrawal by Subject|3|||
48803523|NCT03021486|157122939|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
48803524|NCT03021486|157122940|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
48803525|NCT03021486|157122941|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
48803526|NCT01693120|157122942|FG000|Enrollment|Lost to Follow-up|1|||
48803527|NCT01693120|157122942|FG000|Enrollment|Withdrawal by Subject|10|||
48803528|NCT01693120|157122942|FG000|Enrollment|Protocol Violation|46|||
48803529|NCT01693120|157122942|FG000|Enrollment|Physician Decision|3|||
48803530|NCT01693120|157122942|FG000|Enrollment|Adverse Event|1|||
48803531|NCT01693120|157122942|FG000|Enrollment|Study closed|8|||
48803532|NCT01693120|157122942|FG000|Enrollment|Other|1|||
48803533|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
48803534|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
48803535|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
48803536|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
48803537|NCT01693120|157122942|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
48803538|NCT00676130|157122945|FG000|Overall Study|Lost to Follow-up|0|||
48803539|NCT00676130|157122946|FG001|Overall Study|Lost to Follow-up|1|||
48803540|NCT00676130|157122945|FG000|Overall Study|Found ineligible|3|||
48803541|NCT00676130|157122946|FG001|Overall Study|Found ineligible|2|||
48803542|NCT00676130|157122945|FG000|Overall Study|Withdrawal by Subject|0|||
48490408|NCT01042977|155990715|FG000|Overall Study|Withdrawal by Subject|8|||
48490409|NCT01042977|155990716|FG001|Overall Study|Withdrawal by Subject|16|||
48803543|NCT00676130|157122946|FG001|Overall Study|Withdrawal by Subject|1|||
48803544|NCT03642938|157122948|FG000|Overall Study|Withdrawal by Subject|0|||
48803545|NCT03642938|157122949|FG001|Overall Study|Withdrawal by Subject|0|||
48803546|NCT03642938|157122950|FG002|Overall Study|Withdrawal by Subject|0|||
48803547|NCT03642938|157122951|FG003|Overall Study|Withdrawal by Subject|1|||
48803548|NCT02243202|157122952|FG000|Overall Study|Adverse Event|5|||
48803549|NCT02243202|157122953|FG001|Overall Study|Adverse Event|6|||
48803550|NCT02243202|157122954|FG002|Overall Study|Adverse Event|10|||
48803551|NCT02243202|157122955|FG003|Overall Study|Adverse Event|4|||
48803552|NCT02243202|157122952|FG000|Overall Study|Lost to Follow-up|9|||
48803553|NCT02243202|157122953|FG001|Overall Study|Lost to Follow-up|9|||
48803554|NCT02243202|157122954|FG002|Overall Study|Lost to Follow-up|14|||
48803555|NCT02243202|157122955|FG003|Overall Study|Lost to Follow-up|11|||
48803556|NCT02243202|157122952|FG000|Overall Study|Protocol Violation|3|||
48803557|NCT02243202|157122953|FG001|Overall Study|Protocol Violation|1|||
48803558|NCT02243202|157122954|FG002|Overall Study|Protocol Violation|2|||
48803559|NCT02243202|157122955|FG003|Overall Study|Protocol Violation|1|||
48803560|NCT02243202|157122952|FG000|Overall Study|Withdrawal by Subject|7|||
48803561|NCT02243202|157122953|FG001|Overall Study|Withdrawal by Subject|6|||
48803562|NCT02243202|157122954|FG002|Overall Study|Withdrawal by Subject|4|||
48803563|NCT02243202|157122955|FG003|Overall Study|Withdrawal by Subject|4|||
48803564|NCT02243202|157122952|FG000|Overall Study|Other|1|||
48803565|NCT02243202|157122953|FG001|Overall Study|Other|3|||
48803566|NCT02243202|157122954|FG002|Overall Study|Other|1|||
48803567|NCT02243202|157122955|FG003|Overall Study|Other|2|||
48803568|NCT02243202|157122952|FG000|Overall Study|Randomized but not received treatment|0|||
48803569|NCT02243202|157122953|FG001|Overall Study|Randomized but not received treatment|0|||
48803570|NCT02243202|157122954|FG002|Overall Study|Randomized but not received treatment|0|||
48803571|NCT02243202|157122955|FG003|Overall Study|Randomized but not received treatment|1|||
48803572|NCT00642902|157122960|FG000|Overall Study|Adverse Event|0|||
48803573|NCT00642902|157122961|FG001|Overall Study|Adverse Event|1|||
48803574|NCT00642902|157122962|FG002|Overall Study|Adverse Event|3|||
48803575|NCT00642902|157122963|FG003|Overall Study|Adverse Event|1|||
48803576|NCT00642902|157122960|FG000|Overall Study|Lost to Follow-up|1|||
48803577|NCT00642902|157122961|FG001|Overall Study|Lost to Follow-up|1|||
48803578|NCT00642902|157122962|FG002|Overall Study|Lost to Follow-up|0|||
48803579|NCT00642902|157122963|FG003|Overall Study|Lost to Follow-up|0|||
48803580|NCT00642902|157122960|FG000|Overall Study|Lack of Efficacy|0|||
48803581|NCT00642902|157122961|FG001|Overall Study|Lack of Efficacy|3|||
48803582|NCT00642902|157122962|FG002|Overall Study|Lack of Efficacy|3|||
48803583|NCT00642902|157122963|FG003|Overall Study|Lack of Efficacy|0|||
48803584|NCT00642902|157122960|FG000|Overall Study|Death|1|||
48803585|NCT00642902|157122961|FG001|Overall Study|Death|0|||
48803586|NCT00642902|157122962|FG002|Overall Study|Death|0|||
48803587|NCT00642902|157122963|FG003|Overall Study|Death|0|||
48803588|NCT00642902|157122960|FG000|Overall Study|Premature termination of clinical trial|37|||
48803589|NCT00642902|157122961|FG001|Overall Study|Premature termination of clinical trial|32|||
48803590|NCT00642902|157122962|FG002|Overall Study|Premature termination of clinical trial|35|||
48803591|NCT00642902|157122963|FG003|Overall Study|Premature termination of clinical trial|35|||
48803592|NCT00642902|157122960|FG000|Overall Study|Randomized, but not treated|0|||
48803593|NCT00642902|157122961|FG001|Overall Study|Randomized, but not treated|0|||
48803594|NCT00642902|157122962|FG002|Overall Study|Randomized, but not treated|1|||
48803595|NCT00642902|157122963|FG003|Overall Study|Randomized, but not treated|0|||
48803596|NCT00642902|157122960|FG000|Overall Study|Other|1|||
48803597|NCT00642902|157122961|FG001|Overall Study|Other|5|||
48803598|NCT00642902|157122962|FG002|Overall Study|Other|1|||
48803599|NCT00642902|157122963|FG003|Overall Study|Other|4|||
48803600|NCT04538417|157122964|FG000|Overall Study|Withdrawal by Subject|2|||
48803601|NCT02173054|157122965|FG000|Overall Study|lack of compliance|1|||
48803602|NCT02173054|157122966|FG001|Overall Study|lack of compliance|0|||
48803603|NCT02173054|157122967|FG002|Overall Study|lack of compliance|0|||
48803604|NCT02173054|157122965|FG000|Overall Study|Withdrawal by Subject|0|||
48803605|NCT02173054|157122966|FG001|Overall Study|Withdrawal by Subject|0|||
48803606|NCT02173054|157122967|FG002|Overall Study|Withdrawal by Subject|1|||
48803607|NCT04074590|157122977|FG000|Overall Study|Adverse Event|1|||
48803608|NCT04074590|157122978|FG001|Overall Study|Adverse Event|0|||
48803609|NCT04074590|157122977|FG000|Overall Study|Physician Decision|1|||
48803610|NCT04074590|157122978|FG001|Overall Study|Physician Decision|0|||
48803611|NCT04074590|157122977|FG000|Overall Study|Withdrawal by Subject|2|||
48803612|NCT04074590|157122978|FG001|Overall Study|Withdrawal by Subject|0|||
48803613|NCT03299686|157122979|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
48803614|NCT03299686|157122980|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
48803615|NCT03299686|157122979|FG000|Treatment Epoch|Physician Decision|1|||
48803616|NCT03299686|157122980|FG001|Treatment Epoch|Physician Decision|0|||
48803617|NCT03299686|157122979|FG000|Treatment Epoch|Adverse Event|8|||
48803618|NCT03299686|157122980|FG001|Treatment Epoch|Adverse Event|4|||
48803619|NCT03299686|157122979|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
48803620|NCT03299686|157122980|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
48803621|NCT01201811|157122982|FG000|Overall Study|Adverse Event|6|||
48803622|NCT01201811|157122982|FG000|Overall Study|Disease progression|3|||
48803623|NCT01201811|157122982|FG000|Overall Study|Withdrawal by Subject|3|||
48803624|NCT01201811|157122982|FG000|Overall Study|Death|4|||
48803625|NCT01201811|157122982|FG000|Overall Study|Treatment Failure|2|||
48803626|NCT01201811|157122982|FG000|Overall Study|Physician Decision|1|||
48803627|NCT02857426|157122983|FG000|Overall Study|Disease progression|34|||
48803628|NCT02857426|157122984|FG001|Overall Study|Disease progression|13|||
48803629|NCT02857426|157122983|FG000|Overall Study|Study drug toxicity|4|||
48803630|NCT02857426|157122984|FG001|Overall Study|Study drug toxicity|1|||
48803631|NCT02857426|157122983|FG000|Overall Study|Death|1|||
48803632|NCT02857426|157122984|FG001|Overall Study|Death|0|||
48803633|NCT02857426|157122983|FG000|Overall Study|Adverse event unrelated to study drug|6|||
48803634|NCT02857426|157122984|FG001|Overall Study|Adverse event unrelated to study drug|2|||
48803635|NCT02857426|157122983|FG000|Overall Study|Participant withdrew consent|1|||
48803636|NCT02857426|157122984|FG001|Overall Study|Participant withdrew consent|1|||
48803637|NCT02857426|157122983|FG000|Overall Study|Maximum clinical benefit|1|||
48803638|NCT02857426|157122984|FG001|Overall Study|Maximum clinical benefit|0|||
48803639|NCT02857426|157122983|FG000|Overall Study|Completed treatment|0|||
48803640|NCT02857426|157122984|FG001|Overall Study|Completed treatment|2|||
48803641|NCT01960725|157122985|FG000|Overall Study|Lost to Follow-up|4|||
48803642|NCT01960725|157122986|FG001|Overall Study|Lost to Follow-up|3|||
48803643|NCT01960725|157122985|FG000|Overall Study|Withdrawal by Subject|1|||
48803644|NCT01960725|157122986|FG001|Overall Study|Withdrawal by Subject|0|||
48803645|NCT01960725|157122985|FG000|Overall Study|unable to obtain blood sample|1|||
48803646|NCT01960725|157122986|FG001|Overall Study|unable to obtain blood sample|2|||
48803647|NCT03587142|157122987|FG000|Overall Study|Lost to Follow-up|5|||
48803648|NCT03587142|157122988|FG001|Overall Study|Lost to Follow-up|3|||
48803649|NCT03587142|157122987|FG000|Overall Study|Did not complete the f4 visit|3|||
48803650|NCT03587142|157122988|FG001|Overall Study|Did not complete the f4 visit|7|||
48803651|NCT04766086|157122989|FG000|Overall Study|Lost to Follow-up|3|||
48803652|NCT04766086|157122990|FG001|Overall Study|Lost to Follow-up|5|||
48803653|NCT04766086|157122991|FG002|Overall Study|Lost to Follow-up|3|||
48803654|NCT04766086|157122989|FG000|Overall Study|Withdrawal by Subject|1|||
48803655|NCT04766086|157122990|FG001|Overall Study|Withdrawal by Subject|1|||
48803656|NCT04766086|157122991|FG002|Overall Study|Withdrawal by Subject|2|||
48803657|NCT04766086|157122989|FG000|Overall Study|Other|0|||
48803658|NCT04766086|157122990|FG001|Overall Study|Other|0|||
48803659|NCT04766086|157122991|FG002|Overall Study|Other|1|||
48803660|NCT03072238|157123000|FG000|Overall Study|Withdrawal by Subject|30|||
48803661|NCT03072238|157123001|FG001|Overall Study|Withdrawal by Subject|51|||
48803662|NCT03072238|157123000|FG000|Overall Study|Lost to Follow-up|7|||
48803663|NCT03072238|157123001|FG001|Overall Study|Lost to Follow-up|4|||
48803664|NCT03072238|157123000|FG000|Overall Study|Physician Decision|1|||
48803665|NCT03072238|157123001|FG001|Overall Study|Physician Decision|3|||
48803666|NCT03072238|157123000|FG000|Overall Study|Death|139|||
48803667|NCT03072238|157123001|FG001|Overall Study|Death|121|||
48803668|NCT03072238|157123000|FG000|Overall Study|Other|0|||
48803669|NCT03072238|157123001|FG001|Overall Study|Other|1|||
48803670|NCT03072238|157123000|FG000|Overall Study|Ongoing on study|377|||
48803671|NCT03072238|157123001|FG001|Overall Study|Ongoing on study|367|||
48803672|NCT03502616|157123002|FG000|Up to Week 16|Withdrawal by Subject|1|||
48803673|NCT03502616|157123003|FG001|Up to Week 16|Withdrawal by Subject|2|||
48803674|NCT03502616|157123002|FG000|Up to Week 16|Lost to Follow-up|0|||
48803675|NCT03502616|157123003|FG001|Up to Week 16|Lost to Follow-up|1|||
48803676|NCT03502616|157123002|FG000|Up to Week 16|Randomized, but not treated|1|||
48803677|NCT03502616|157123003|FG001|Up to Week 16|Randomized, but not treated|0|||
48803678|NCT03502616|157123002|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
48803679|NCT03502616|157123003|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
48803680|NCT03502616|157123002|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
48803681|NCT03502616|157123003|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
48803682|NCT00312702|157123004|FG000|Immunization Phase|Lost to Follow-up|0|||
48803683|NCT00312702|157123005|FG001|Immunization Phase|Lost to Follow-up|1|||
48803684|NCT00312702|157123006|FG002|Immunization Phase|Lost to Follow-up|0|||
48803685|NCT01859793|157123011|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
48803686|NCT01859793|157123012|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
48803687|NCT01859793|157123011|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
48803688|NCT01859793|157123012|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
48803689|NCT01859793|157123011|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
48803690|NCT01859793|157123012|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48803691|NCT01859793|157123011|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
48803692|NCT01859793|157123012|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
48803693|NCT04552223|157123014|FG000|Overall Study|Withdrawal by Subject|1|||
48803694|NCT04332926|157123015|FG000|Overall Study|Withdrawal by Subject|6|||
48803695|NCT04332926|157123015|FG000|Overall Study|Physician Decision|6|||
48803696|NCT04662931|157123019|FG000|Overall Study|Withdrawal by Subject|17|||
48803697|NCT04662931|157123019|FG000|Overall Study|Death|3|||
48803698|NCT04662931|157123019|FG000|Overall Study|Lost to Follow-up|3|||
48803699|NCT04662931|157123019|FG000|Overall Study|Guardian Decision|1|||
48803700|NCT04899245|157123022|FG000|Overall Study|Withdrawal by Subject|3|||
48803701|NCT04899245|157123023|FG001|Overall Study|Withdrawal by Subject|5|||
48803702|NCT04899245|157123024|FG002|Overall Study|Withdrawal by Subject|2|||
48803703|NCT04899245|157123022|FG000|Overall Study|No longer eligible - Left staff position|0|||
48803704|NCT04899245|157123023|FG001|Overall Study|No longer eligible - Left staff position|0|||
48803705|NCT04899245|157123024|FG002|Overall Study|No longer eligible - Left staff position|1|||
48803706|NCT04899245|157123022|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
48803707|NCT04899245|157123023|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
48803708|NCT04899245|157123024|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
48803709|NCT04899245|157123022|FG000|Overall Study|No longer eligible - Moved away from area|2|||
48803710|NCT04899245|157123023|FG001|Overall Study|No longer eligible - Moved away from area|2|||
48803711|NCT04899245|157123024|FG002|Overall Study|No longer eligible - Moved away from area|0|||
48803712|NCT01456949|157123025|FG000|Enrollment|PI death- incomplete data|6|||
48803713|NCT01456949|157123025|FG000|Enrollment|Death|1|||
48803714|NCT01456949|157123025|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
48803715|NCT01456949|157123025|FG000|Enrollment|Physician Decision|10|||
48803716|NCT01456949|157123025|FG000|Enrollment|Withdrawal by Subject|7|||
48803717|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
48803718|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
48803719|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
48803720|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
48803721|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
48803722|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
48803723|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
48803724|NCT01456949|157123025|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
48803725|NCT03976466|157123029|FG000|Overall Study|Lost to Follow-up|1|||
48803726|NCT03976466|157123030|FG001|Overall Study|Lost to Follow-up|3|||
48803727|NCT00943306|157123033|FG000|Overall Study|Physician Decision|1|||
48803728|NCT00943306|157123033|FG000|Overall Study|Death|1|||
48803729|NCT00943306|157123033|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
48803730|NCT01395823|157123035|FG000|Overall Study|Death|4|||
48803731|NCT01395823|157123036|FG001|Overall Study|Death|4|||
48803732|NCT01395823|157123035|FG000|Overall Study|Physician Decision|3|||
48803733|NCT01395823|157123036|FG001|Overall Study|Physician Decision|1|||
48803734|NCT01395823|157123035|FG000|Overall Study|Lost to Follow-up|1|||
48803735|NCT01395823|157123036|FG001|Overall Study|Lost to Follow-up|0|||
48803736|NCT01395823|157123035|FG000|Overall Study|Transplant|1|||
48803737|NCT01395823|157123036|FG001|Overall Study|Transplant|0|||
48803738|NCT01395823|157123035|FG000|Overall Study|GI symptoms|1|||
48803739|NCT01395823|157123036|FG001|Overall Study|GI symptoms|0|||
48803740|NCT01395823|157123035|FG000|Overall Study|Withdrawal by Subject|5|||
48803741|NCT01395823|157123036|FG001|Overall Study|Withdrawal by Subject|4|||
48803742|NCT00717314|157123037|FG000|Overall Study|Adverse Event|3|||
48803743|NCT00717314|157123038|FG001|Overall Study|Adverse Event|2|||
48803744|NCT00717314|157123037|FG000|Overall Study|Protocol Violation|1|||
48803745|NCT00717314|157123038|FG001|Overall Study|Protocol Violation|0|||
48803746|NCT00717314|157123037|FG000|Overall Study|Lost to Follow-up|1|||
48803747|NCT00717314|157123038|FG001|Overall Study|Lost to Follow-up|5|||
48803748|NCT00717314|157123037|FG000|Overall Study|Withdrawal by Subject|1|||
48803749|NCT00717314|157123038|FG001|Overall Study|Withdrawal by Subject|3|||
48803750|NCT02613221|157123039|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
48803751|NCT02613221|157123039|FG000|Overall Study|Adverse Event|2|||
48803752|NCT02613221|157123039|FG000|Overall Study|Voluntary Discontinuation|1|||
48803753|NCT02613221|157123039|FG000|Overall Study|Delayed Treatment|1|||
48803754|NCT02613221|157123039|FG000|Overall Study|Enrolled but Not Treated|1|||
48803755|NCT04095039|157123040|FG000|Overall Study|Withdrawal by Subject|2|||
48803756|NCT04095039|157123041|FG001|Overall Study|Withdrawal by Subject|16|||
48803757|NCT04095039|157123040|FG000|Overall Study|Transplanted|21|||
48803758|NCT04095039|157123041|FG001|Overall Study|Transplanted|24|||
48803759|NCT04095039|157123040|FG000|Overall Study|Transferred to Non-study Facility|47|||
48803760|NCT04095039|157123041|FG001|Overall Study|Transferred to Non-study Facility|44|||
48803761|NCT04095039|157123040|FG000|Overall Study|Withdrawal from internvention target|0|||
48803762|NCT04095039|157123041|FG001|Overall Study|Withdrawal from internvention target|2|||
48803763|NCT04095039|157123040|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
48803764|NCT04095039|157123041|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
48803765|NCT04095039|157123040|FG000|Overall Study|Cacliphylaxis|0|||
48803766|NCT04095039|157123041|FG001|Overall Study|Cacliphylaxis|1|||
48803767|NCT04095039|157123040|FG000|Overall Study|Pregnancy|1|||
48803768|NCT04095039|157123041|FG001|Overall Study|Pregnancy|0|||
48803769|NCT00886639|157123044|FG000|Overall Study|acute exacerbation|14|||
48803770|NCT00886639|157123044|FG000|Overall Study|non-compliance|2|||
48803771|NCT01396317|157123045|FG000|Overall Study|Adverse Event|1|||
48803772|NCT01396317|157123046|FG001|Overall Study|Adverse Event|0|||
48803773|NCT03156465|157123047|FG000|Overall Study|Withdrawal by Subject|2|||
48803774|NCT01786330|157123048|FG000|Overall Study|Withdrawal by Subject|0|||
48803775|NCT01786330|157123049|FG001|Overall Study|Withdrawal by Subject|1|||
48803776|NCT01786330|157123048|FG000|Overall Study|Lost to Follow-up|0|||
48803777|NCT01786330|157123049|FG001|Overall Study|Lost to Follow-up|1|||
48803778|NCT01786330|157123048|FG000|Overall Study|Excluded intraoperatively|0|||
48803779|NCT01786330|157123049|FG001|Overall Study|Excluded intraoperatively|1|||
48803780|NCT01786330|157123048|FG000|Overall Study|Protocol Violation|1|||
48490410|NCT01042977|155990715|FG000|Overall Study|Lost to Follow-up|0|||
48490411|NCT01042977|155990716|FG001|Overall Study|Lost to Follow-up|2|||
48490412|NCT01042977|155990715|FG000|Overall Study|Poor/non-compliance|3|||
48490413|NCT01042977|155990716|FG001|Overall Study|Poor/non-compliance|4|||
48490414|NCT01042977|155990715|FG000|Overall Study|Subject no longer meets study criteria|15|||
48596039|NCT01763827|156377821|FG003|Overall Study|Decision by sponsor|0|||
48803781|NCT01786330|157123049|FG001|Overall Study|Protocol Violation|0|||
48803782|NCT03012841|157124104|FG000|Overall Study|Protocol Violation|0|||
48803783|NCT03012841|157124105|FG001|Overall Study|Protocol Violation|10|||
48803784|NCT03012841|157124104|FG000|Overall Study|Lost to Follow-up|6|||
48803785|NCT03012841|157124105|FG001|Overall Study|Lost to Follow-up|1|||
48803786|NCT03012841|157124104|FG000|Overall Study|Withdrawal by Subject|6|||
48803787|NCT03012841|157124105|FG001|Overall Study|Withdrawal by Subject|0|||
48803788|NCT03012841|157124104|FG000|Overall Study|Unable to complete 12 month visit|6|||
48803789|NCT03012841|157124105|FG001|Overall Study|Unable to complete 12 month visit|0|||
48803790|NCT03012841|157124104|FG000|Overall Study|Subject relocation|1|||
48803791|NCT03012841|157124105|FG001|Overall Study|Subject relocation|0|||
48803792|NCT03012841|157124104|FG000|Overall Study|Seasonal winter travel|1|||
48803793|NCT03012841|157124105|FG001|Overall Study|Seasonal winter travel|0|||
48803794|NCT03012841|157124104|FG000|Overall Study|Physician Decision|0|||
48803795|NCT03012841|157124105|FG001|Overall Study|Physician Decision|2|||
48803796|NCT03012841|157124104|FG000|Overall Study|No ablation performed|0|||
48803797|NCT03012841|157124105|FG001|Overall Study|No ablation performed|2|||
48803798|NCT03012841|157124104|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
48803799|NCT03012841|157124105|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
48803800|NCT03012841|157124104|FG000|Overall Study|Insurance change|0|||
48803801|NCT03012841|157124105|FG001|Overall Study|Insurance change|1|||
48803802|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
48803803|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
48803804|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
48803805|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
48803806|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
48803807|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
48803808|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
48803809|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
48803810|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
48803811|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
48803812|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
48803813|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
48803814|NCT01493687|157124111|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
48803815|NCT01493687|157124112|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
48803816|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
48803817|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
48803818|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
48803819|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
48803820|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
48803821|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
48803822|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
48803823|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
48803824|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
48803825|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
48803826|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
48803827|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
48803828|NCT01493687|157124111|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
48803829|NCT01493687|157124112|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
48803830|NCT01493687|157124111|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
48803831|NCT01493687|157124112|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
48803832|NCT02739347|157124113|FG000|Overall Study|Adverse Event|3|||
48803833|NCT02739347|157124114|FG001|Overall Study|Adverse Event|0|||
48803834|NCT02739347|157124113|FG000|Overall Study|Protocol Violation|0|||
48803835|NCT02739347|157124114|FG001|Overall Study|Protocol Violation|1|||
48803836|NCT02739347|157124113|FG000|Overall Study|Lost to Follow-up|0|||
48803837|NCT02739347|157124114|FG001|Overall Study|Lost to Follow-up|2|||
48803838|NCT04836858|157124115|FG000|Overall Study|Adverse Event|0|||
48803839|NCT04836858|157124116|FG001|Overall Study|Adverse Event|0|||
48803840|NCT04836858|157124117|FG002|Overall Study|Adverse Event|0|||
48803841|NCT04836858|157124118|FG003|Overall Study|Adverse Event|1|||
48803842|NCT04836858|157124115|FG000|Overall Study|Lost to Follow-up|1|||
48803843|NCT04836858|157124116|FG001|Overall Study|Lost to Follow-up|0|||
48803844|NCT04836858|157124117|FG002|Overall Study|Lost to Follow-up|0|||
48803845|NCT04836858|157124118|FG003|Overall Study|Lost to Follow-up|0|||
48803846|NCT04836858|157124115|FG000|Overall Study|Subject/Guardian decision|3|||
48803847|NCT04836858|157124116|FG001|Overall Study|Subject/Guardian decision|0|||
48803848|NCT04836858|157124117|FG002|Overall Study|Subject/Guardian decision|0|||
48803849|NCT04836858|157124118|FG003|Overall Study|Subject/Guardian decision|1|||
48803850|NCT04836858|157124115|FG000|Overall Study|Randomized but not treated|4|||
48803851|NCT04836858|157124116|FG001|Overall Study|Randomized but not treated|0|||
48803852|NCT04836858|157124117|FG002|Overall Study|Randomized but not treated|0|||
48803853|NCT04836858|157124118|FG003|Overall Study|Randomized but not treated|0|||
48803854|NCT03124199|157124119|FG000|Overall Study|Lost to Follow-up|4|||
48803855|NCT01782872|157124120|FG000|Overall Study|Protocol Violation|0|||
48803856|NCT01782872|157124121|FG001|Overall Study|Protocol Violation|0|||
48803857|NCT01782872|157124122|FG002|Overall Study|Protocol Violation|0|||
48803858|NCT01782872|157124123|FG003|Overall Study|Protocol Violation|1|||
48803859|NCT01782872|157124120|FG000|Overall Study|Withdrawal by Subject|0|||
48803860|NCT01782872|157124121|FG001|Overall Study|Withdrawal by Subject|1|||
48803861|NCT01782872|157124122|FG002|Overall Study|Withdrawal by Subject|0|||
48803862|NCT01782872|157124123|FG003|Overall Study|Withdrawal by Subject|0|||
48803863|NCT02228395|157124124|FG000|First Intervention Period|No longer willing to participate|1|||
48803864|NCT02228395|157124125|FG001|First Intervention Period|No longer willing to participate|0|||
48803865|NCT02228395|157124126|FG002|First Intervention Period|No longer willing to participate|0|||
48803866|NCT02228395|157124124|FG000|First Intervention Period|Unable to comply with study dates|0|||
48803867|NCT02228395|157124125|FG001|First Intervention Period|Unable to comply with study dates|1|||
48803868|NCT02228395|157124126|FG002|First Intervention Period|Unable to comply with study dates|1|||
48803869|NCT02724878|157124127|FG000|Overall Study|Still on Active Therapy|15|||
48803870|NCT02724878|157124127|FG000|Overall Study|Disease Progression|31|||
48803871|NCT02724878|157124127|FG000|Overall Study|Toxicity|5|||
48803872|NCT02724878|157124127|FG000|Overall Study|Death|1|||
48803873|NCT02724878|157124127|FG000|Overall Study|Withdrawal by Subject|4|||
48803874|NCT02724878|157124127|FG000|Overall Study|Lost to Follow-up|2|||
48803875|NCT02724878|157124127|FG000|Overall Study|Protocol Violation|1|||
48803876|NCT02724878|157124127|FG000|Overall Study|Ineligible for Study Drug|5|||
48803877|NCT02724878|157124127|FG000|Overall Study|not started|1|||
48803878|NCT04710927|157124128|FG000|Overall Study|Lost to Follow-up|7|||
48803879|NCT04710927|157124129|FG001|Overall Study|Lost to Follow-up|6|||
48803880|NCT04710927|157124130|FG002|Overall Study|Lost to Follow-up|5|||
48803881|NCT02634788|157124132|FG000|Overall Study|Adverse Event|0|||
48803882|NCT02634788|157124133|FG001|Overall Study|Adverse Event|8|||
48803883|NCT02634788|157124134|FG002|Overall Study|Adverse Event|3|||
48803884|NCT02634788|157124135|FG003|Overall Study|Adverse Event|1|||
48803885|NCT02634788|157124132|FG000|Overall Study|Lack of Efficacy|4|||
48803886|NCT02634788|157124133|FG001|Overall Study|Lack of Efficacy|0|||
48803887|NCT02634788|157124134|FG002|Overall Study|Lack of Efficacy|1|||
48803888|NCT02634788|157124135|FG003|Overall Study|Lack of Efficacy|4|||
48803889|NCT02634788|157124132|FG000|Overall Study|Lost to Follow-up|0|||
48803890|NCT02634788|157124133|FG001|Overall Study|Lost to Follow-up|1|||
48803891|NCT02634788|157124134|FG002|Overall Study|Lost to Follow-up|0|||
48803892|NCT02634788|157124135|FG003|Overall Study|Lost to Follow-up|0|||
48803893|NCT02634788|157124132|FG000|Overall Study|Withdrawal by Subject|0|||
48803894|NCT02634788|157124133|FG001|Overall Study|Withdrawal by Subject|1|||
48708463|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
48708464|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708465|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708466|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
48708467|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708468|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708469|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708470|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
48708471|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708472|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708473|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
48708474|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708475|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708476|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708477|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
48708478|NCT03682770|156780939|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708479|NCT03682770|156780940|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708480|NCT03682770|156780941|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708481|NCT03682770|156780942|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
48708482|NCT03682770|156780943|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708483|NCT03682770|156780944|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708484|NCT03682770|156780945|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
48708485|NCT03682770|156780939|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
48708486|NCT03682770|156780940|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
48708487|NCT03682770|156780941|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
48708488|NCT03682770|156780942|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
48708489|NCT03682770|156780943|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
48708490|NCT03682770|156780944|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
48708491|NCT03682770|156780945|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
48708492|NCT03682770|156780939|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48803895|NCT02634788|157124134|FG002|Overall Study|Withdrawal by Subject|1|||
48803896|NCT02634788|157124135|FG003|Overall Study|Withdrawal by Subject|0|||
48803897|NCT01959347|157124139|FG000|Overall Study|Protocol Violation|9|||
48803898|NCT01959347|157124140|FG001|Overall Study|Protocol Violation|7|||
48803899|NCT01691521|157124143|FG000|Overall Study|Adverse Event|4|||
48803900|NCT01691521|157124144|FG001|Overall Study|Adverse Event|0|||
48803901|NCT01691521|157124145|FG002|Overall Study|Adverse Event|1|||
48803902|NCT01691521|157124143|FG000|Overall Study|Lack of Efficacy|1|||
48803903|NCT01691521|157124144|FG001|Overall Study|Lack of Efficacy|1|||
48803904|NCT01691521|157124145|FG002|Overall Study|Lack of Efficacy|2|||
48803905|NCT01691521|157124143|FG000|Overall Study|Protocol Violation|0|||
48803906|NCT01691521|157124144|FG001|Overall Study|Protocol Violation|3|||
48708493|NCT03682770|156780940|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708494|NCT03682770|156780941|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708495|NCT03682770|156780942|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708496|NCT03682770|156780943|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
48708497|NCT03682770|156780944|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708498|NCT03682770|156780945|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
48708499|NCT03682770|156780939|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708500|NCT03682770|156780940|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708501|NCT03682770|156780941|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708502|NCT03682770|156780942|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708503|NCT03682770|156780943|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708504|NCT03682770|156780944|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
48708505|NCT03682770|156780945|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
48708506|NCT03682770|156780939|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708507|NCT03682770|156780940|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708508|NCT03682770|156780941|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708509|NCT03682770|156780942|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708510|NCT03682770|156780943|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
48708511|NCT03682770|156780944|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
48708512|NCT03682770|156780945|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
48708513|NCT00196313|156780946|FG000|Overall Study|Protocol Violation|2|||
48708514|NCT00196313|156780947|FG001|Overall Study|Protocol Violation|3|||
48708515|NCT00196313|156780946|FG000|Overall Study|Withdrawal by Subject|3|||
48708516|NCT00196313|156780947|FG001|Overall Study|Withdrawal by Subject|1|||
48708517|NCT00196313|156780946|FG000|Overall Study|Adverse Event|3|||
48708518|NCT00196313|156780947|FG001|Overall Study|Adverse Event|1|||
48708519|NCT00196313|156780946|FG000|Overall Study|Subject Pregnant|1|||
48708520|NCT00196313|156780947|FG001|Overall Study|Subject Pregnant|1|||
48708521|NCT00196313|156780946|FG000|Overall Study|Lost to Follow-up|2|||
48708522|NCT00196313|156780947|FG001|Overall Study|Lost to Follow-up|2|||
48708523|NCT02362282|156780948|FG000|Overall Study|Withdrawal by Subject|1|||
48708524|NCT02362282|156780949|FG001|Overall Study|Withdrawal by Subject|0|||
48708525|NCT04085289|156780950|FG000|Overall Study|Withdrawal by Subject|0|||
48708526|NCT04085289|156780951|FG001|Overall Study|Withdrawal by Subject|0|||
48708527|NCT04085289|156780952|FG002|Overall Study|Withdrawal by Subject|1|||
48708528|NCT04639258|156780953|FG000|Overall Study|Screen failure|5|||
48708529|NCT04639258|156780953|FG000|Overall Study|Physician Decision|2|||
48708530|NCT04639258|156780953|FG000|Overall Study|Early study termination|3|||
48708531|NCT04639258|156780953|FG000|Overall Study|Withdrawal by Subject|1|||
48708532|NCT01941186|156780955|FG000|Follow-up|Lost to Follow-up|1|||
48708533|NCT01941186|156780956|FG001|Follow-up|Lost to Follow-up|0|||
48708534|NCT02560558|156780958|FG000|Overall Study|Adverse Event|1|||
48708535|NCT02560558|156780959|FG001|Overall Study|Adverse Event|0|||
48708536|NCT02560558|156780958|FG000|Overall Study|Death|0|||
48708537|NCT02560558|156780959|FG001|Overall Study|Death|2|||
48708538|NCT02560558|156780958|FG000|Overall Study|Lost to Follow-up|0|||
48708539|NCT02560558|156780959|FG001|Overall Study|Lost to Follow-up|4|||
48708540|NCT02560558|156780958|FG000|Overall Study|Protocol Violation|3|||
48708541|NCT02560558|156780959|FG001|Overall Study|Protocol Violation|0|||
48708542|NCT02560558|156780958|FG000|Overall Study|Withdrawal by Subject|3|||
48708543|NCT02560558|156780959|FG001|Overall Study|Withdrawal by Subject|0|||
48708544|NCT02999672|156780972|FG000|Overall Study|Death|0|||
48708545|NCT02999672|156780973|FG001|Overall Study|Death|1|||
48708546|NCT02999672|156780972|FG000|Overall Study|Study Terminated by Sponsor|0|||
48708547|NCT02999672|156780973|FG001|Overall Study|Study Terminated by Sponsor|1|||
48708548|NCT02999672|156780972|FG000|Overall Study|Progressive Disease|9|||
48708549|NCT02999672|156780973|FG001|Overall Study|Progressive Disease|5|||
48708550|NCT02999672|156780972|FG000|Overall Study|Adverse Event|4|||
48708551|NCT02999672|156780973|FG001|Overall Study|Adverse Event|0|||
48708552|NCT02577718|156780974|FG000|Overall Study|Death|6|||
48708553|NCT02577718|156780974|FG000|Overall Study|Withdrawal by Subject|2|||
48708554|NCT00275509|156780975|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
48708555|NCT00275509|156780976|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
48708556|NCT01967576|156780977|FG000|Overall Study|Withdrawal by Subject|3|||
48708557|NCT01967576|156780977|FG000|Overall Study|Progressed/Removed from treatment|1|||
48708558|NCT01967576|156780977|FG000|Overall Study|Study closing at site|1|||
48708559|NCT01967576|156780977|FG000|Overall Study|Adverse Event|1|||
48803907|NCT01691521|157124145|FG002|Overall Study|Protocol Violation|0|||
48803908|NCT01691521|157124143|FG000|Overall Study|Lost to Follow-up|0|||
48803909|NCT01691521|157124144|FG001|Overall Study|Lost to Follow-up|2|||
48803910|NCT01691521|157124145|FG002|Overall Study|Lost to Follow-up|2|||
48803911|NCT01691521|157124143|FG000|Overall Study|Physician Decision|2|||
48803912|NCT01691521|157124144|FG001|Overall Study|Physician Decision|1|||
48803913|NCT01691521|157124145|FG002|Overall Study|Physician Decision|0|||
48803914|NCT01691521|157124143|FG000|Overall Study|Withdrawal by Subject|5|||
48803915|NCT01691521|157124144|FG001|Overall Study|Withdrawal by Subject|9|||
48803916|NCT01691521|157124145|FG002|Overall Study|Withdrawal by Subject|4|||
48803917|NCT01314118|157124146|FG000|Overall Study|Adverse Event|9|||
48803918|NCT01314118|157124146|FG000|Overall Study|Progressive disease|27|||
48803919|NCT01314118|157124146|FG000|Overall Study|Physician Decision|11|||
48803920|NCT01314118|157124146|FG000|Overall Study|Death|4|||
48803921|NCT01314118|157124146|FG000|Overall Study|Protocol Violation|5|||
48803922|NCT01314118|157124146|FG000|Overall Study|Withdrawal by Subject|11|||
48803923|NCT01314118|157124146|FG000|Overall Study|Other|2|||
48803924|NCT01314118|157124146|FG000|Overall Study|Ongoing|62|||
48803925|NCT03453619|157124147|FG000|Core Study (Part A)|Physician Decision|0|||
48803926|NCT03453619|157124148|FG001|Core Study (Part A)|Physician Decision|0|||
48803927|NCT03453619|157124149|FG002|Core Study (Part A)|Physician Decision|2|||
48803928|NCT03453619|157124150|FG003|Core Study (Part A)|Physician Decision|0|||
48803929|NCT03453619|157124147|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
48803930|NCT03453619|157124148|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
48490415|NCT01042977|155990716|FG001|Overall Study|Subject no longer meets study criteria|13|||
48490416|NCT01042977|155990715|FG000|Overall Study|Incorrect enrollment|6|||
48490417|NCT01042977|155990716|FG001|Overall Study|Incorrect enrollment|4|||
48490418|NCT01042977|155990715|FG000|Overall Study|Safety|0|||
48490419|NCT01042977|155990716|FG001|Overall Study|Safety|2|||
48490420|NCT01042977|155990715|FG000|Overall Study|Administrative reason by sponsor|0|||
48490421|NCT01042977|155990716|FG001|Overall Study|Administrative reason by sponsor|1|||
48490422|NCT01042977|155990715|FG000|Overall Study|Various|3|||
48490423|NCT01042977|155990716|FG001|Overall Study|Various|0|||
48490424|NCT02499354|155990717|FG000|Overall Study|Withdrawal by Subject|1|||
48490425|NCT02499354|155990718|FG001|Overall Study|Withdrawal by Subject|0|||
48708560|NCT01967576|156780977|FG000|Overall Study|Refused further treatment|1|||
48708561|NCT03388164|156780981|FG000|Overall Study|Withdrawal by Subject|3|||
48708562|NCT03388164|156780982|FG001|Overall Study|Withdrawal by Subject|1|||
48708563|NCT02561832|156780984|FG000|Overall Study|Withdrawal by Subject|1|||
48708564|NCT02561832|156780985|FG001|Overall Study|Withdrawal by Subject|1|||
48708565|NCT02561832|156780984|FG000|Overall Study|Adverse Event|3|||
48708566|NCT02561832|156780985|FG001|Overall Study|Adverse Event|0|||
48708567|NCT02561832|156780984|FG000|Overall Study|Disease progression|3|||
48708568|NCT02561832|156780985|FG001|Overall Study|Disease progression|3|||
48708569|NCT00346697|156780986|FG000|Overall Study|Lost to Follow-up|0|||
48708570|NCT00346697|156780987|FG001|Overall Study|Lost to Follow-up|1|||
48708571|NCT00686686|156780988|FG000|Overall Study|Non-compliance|1|||
48708572|NCT00686686|156780988|FG000|Overall Study|Adverse Event|2|||
48708573|NCT00686686|156780988|FG000|Overall Study|Lost to Follow-up|3|||
48708574|NCT02367833|156780990|FG000|Overall Study|Withdrawal by Subject|1|||
48708575|NCT02367833|156780991|FG001|Overall Study|Withdrawal by Subject|1|||
48708576|NCT02367833|156780992|FG002|Overall Study|Withdrawal by Subject|0|||
48708577|NCT01459497|156780993|FG000|Overall Study|Inability to meet trial constraints.|1|||
48708578|NCT01459497|156780994|FG001|Overall Study|Inability to meet trial constraints.|0|||
48708579|NCT01459497|156780993|FG000|Overall Study|Physician Decision|1|||
48708580|NCT01459497|156780994|FG001|Overall Study|Physician Decision|1|||
48708581|NCT01459497|156780993|FG000|Overall Study|Hospitalization.|0|||
48708582|NCT01459497|156780994|FG001|Overall Study|Hospitalization.|3|||
48708583|NCT01459497|156780993|FG000|Overall Study|Disease progression.|0|||
48708584|NCT01459497|156780994|FG001|Overall Study|Disease progression.|1|||
48708585|NCT02447302|156781006|FG000|Overall Study|Physician Decision|1|||
48708586|NCT02447302|156781007|FG001|Overall Study|Physician Decision|0|||
48708587|NCT02447302|156781008|FG002|Overall Study|Physician Decision|0|||
48708588|NCT02447302|156781006|FG000|Overall Study|Adverse Event|4|||
48708589|NCT02447302|156781007|FG001|Overall Study|Adverse Event|3|||
48708590|NCT02447302|156781008|FG002|Overall Study|Adverse Event|0|||
48708591|NCT02447302|156781006|FG000|Overall Study|Withdrawal by Subject|0|||
48708592|NCT02447302|156781007|FG001|Overall Study|Withdrawal by Subject|1|||
48708593|NCT02447302|156781008|FG002|Overall Study|Withdrawal by Subject|5|||
48708594|NCT02447302|156781006|FG000|Overall Study|Sponsor Decision|0|||
48708595|NCT02447302|156781007|FG001|Overall Study|Sponsor Decision|0|||
48708596|NCT02447302|156781008|FG002|Overall Study|Sponsor Decision|1|||
48803931|NCT03453619|157124149|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
48708597|NCT05334212|156781009|FG000|Overall Study|Study terminated prematurely|7|||
48708598|NCT00396253|156781015|FG000|Overall Study|Protocol Violation|1|||
48708599|NCT00396253|156781015|FG000|Overall Study|Withdrawal by Subject|7|||
48708600|NCT00396253|156781015|FG000|Overall Study|Death|3|||
48803932|NCT03453619|157124150|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
48803933|NCT03453619|157124147|FG000|Core Study (Part A)|Other|0|||
48803934|NCT03453619|157124148|FG001|Core Study (Part A)|Other|1|||
48803935|NCT03453619|157124149|FG002|Core Study (Part A)|Other|0|||
48803936|NCT03453619|157124150|FG003|Core Study (Part A)|Other|0|||
48803937|NCT03453619|157124147|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
48803938|NCT03453619|157124148|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
48803939|NCT03453619|157124149|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
48803940|NCT03453619|157124150|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
48803941|NCT03453619|157124147|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
48803942|NCT03453619|157124148|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
48803943|NCT03453619|157124149|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
48803944|NCT03453619|157124150|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
48803945|NCT03453619|157124147|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
48803946|NCT03453619|157124148|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
48803947|NCT03453619|157124149|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
48803948|NCT03453619|157124150|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
48803949|NCT03453619|157124147|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
48803950|NCT03453619|157124148|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
48803951|NCT03453619|157124149|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
48803952|NCT03453619|157124150|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
48708601|NCT00396253|156781015|FG000|Overall Study|Physician Decision|1|||
48708602|NCT00396253|156781015|FG000|Overall Study|Change in eligibility status|1|||
48708603|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
48708604|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
48708605|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
48708606|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
48708607|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
48708608|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
48708609|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
48708610|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
48708611|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
48708612|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
48708613|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708614|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
48708615|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708616|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708617|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708618|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708619|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708620|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
48708621|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708622|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
48708623|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708624|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708625|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708626|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
48708627|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
48708628|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
48708629|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
48708630|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|Other|0|||
48708631|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|Other|0|||
48708632|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|Other|1|||
48708633|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|Other|1|||
48708634|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|Other|0|||
48708635|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|Other|0|||
48708636|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|Other|0|||
48708637|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|Other|1|||
48708638|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|Other|0|||
48708639|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|Death|0|||
48708640|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|Death|0|||
48708641|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|Death|0|||
48708642|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|Death|0|||
48708643|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|Death|0|||
48708644|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|Death|1|||
48708645|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|Death|0|||
48708646|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|Death|0|||
48708647|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|Death|0|||
48708648|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708649|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48803953|NCT01148862|157124154|FG000|Second Intervention|Withdrawal by Subject|0|||
48803954|NCT01148862|157124155|FG001|Second Intervention|Withdrawal by Subject|2|||
48803955|NCT05520190|157124156|FG000|Overall Study|Lost to Follow-up|7|||
48803956|NCT05520190|157124156|FG000|Overall Study|Withdrawal by Subject|2|||
48803957|NCT03138733|157124157|FG000|Overall Study|Death|17|||
48803958|NCT03138733|157124158|FG001|Overall Study|Death|18|||
48803959|NCT03138733|157124157|FG000|Overall Study|Withdrawal by Subject|11|||
48803960|NCT03138733|157124158|FG001|Overall Study|Withdrawal by Subject|6|||
48803961|NCT03138733|157124157|FG000|Overall Study|Lost to Follow-up|3|||
48803962|NCT03138733|157124158|FG001|Overall Study|Lost to Follow-up|2|||
48803963|NCT03138733|157124157|FG000|Overall Study|Adverse Event|1|||
48803964|NCT03138733|157124158|FG001|Overall Study|Adverse Event|0|||
48803965|NCT03138733|157124157|FG000|Overall Study|Protocol Violation|1|||
48803966|NCT03138733|157124158|FG001|Overall Study|Protocol Violation|3|||
48803967|NCT03138733|157124157|FG000|Overall Study|Administrative or logistical reason|1|||
48803968|NCT03138733|157124158|FG001|Overall Study|Administrative or logistical reason|0|||
48803969|NCT03138733|157124157|FG000|Overall Study|The patient was transferred to another hospital|1|||
48803970|NCT03138733|157124158|FG001|Overall Study|The patient was transferred to another hospital|0|||
48803971|NCT03338933|157124159|FG000|Screening Visit|Lost to Follow-up|1|||
48803972|NCT03338933|157124160|FG001|Screening Visit|Lost to Follow-up|3|||
48803973|NCT03338933|157124161|FG002|Screening Visit|Lost to Follow-up|1|||
48803974|NCT03338933|157124162|FG003|Screening Visit|Lost to Follow-up|4|||
48803975|NCT03338933|157124159|FG000|Screening Visit|Screen fail after consent|2|||
48803976|NCT03338933|157124160|FG001|Screening Visit|Screen fail after consent|7|||
48803977|NCT03338933|157124161|FG002|Screening Visit|Screen fail after consent|1|||
48803978|NCT03338933|157124162|FG003|Screening Visit|Screen fail after consent|4|||
48803979|NCT03338933|157124159|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
48803980|NCT03338933|157124160|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
48803981|NCT03338933|157124161|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
48803982|NCT03338933|157124162|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
48803983|NCT03338933|157124159|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
48803984|NCT03338933|157124160|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
48803985|NCT03338933|157124161|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
48803986|NCT03338933|157124162|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
48803987|NCT03338933|157124159|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
48803988|NCT03338933|157124160|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
48803989|NCT03338933|157124161|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
48803990|NCT03338933|157124162|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
48803991|NCT01415882|157124165|FG000|Overall Study|Ineligible|1|||
48803992|NCT01415882|157124166|FG001|Overall Study|Ineligible|0|||
48803993|NCT01415882|157124167|FG002|Overall Study|Ineligible|0|||
48803994|NCT01415882|157124168|FG003|Overall Study|Ineligible|3|||
48803995|NCT01415882|157124169|FG004|Overall Study|Ineligible|0|||
48803996|NCT01415882|157124165|FG000|Overall Study|Withdrawal by Subject|0|||
48803997|NCT01415882|157124166|FG001|Overall Study|Withdrawal by Subject|1|||
48803998|NCT01415882|157124167|FG002|Overall Study|Withdrawal by Subject|0|||
48803999|NCT01415882|157124168|FG003|Overall Study|Withdrawal by Subject|1|||
48804000|NCT01415882|157124169|FG004|Overall Study|Withdrawal by Subject|0|||
48804001|NCT05200845|157124172|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
48804002|NCT05200845|157124173|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
48804003|NCT05200845|157124174|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
48804004|NCT05200845|157124175|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
48804005|NCT05200845|157124172|FG000|Overall Study|Withdrawal by Subject|0|||
48804006|NCT05200845|157124173|FG001|Overall Study|Withdrawal by Subject|1|||
48804007|NCT05200845|157124174|FG002|Overall Study|Withdrawal by Subject|1|||
48804008|NCT05200845|157124175|FG003|Overall Study|Withdrawal by Subject|0|||
48596040|NCT01763827|156377822|FG004|Overall Study|Decision by sponsor|2|||
48596041|NCT01763827|156377823|FG005|Overall Study|Decision by sponsor|1|||
48804009|NCT02552238|157124179|FG000|Overall Study|Withdrawal by Subject|2|||
48804010|NCT02552238|157124179|FG000|Overall Study|Adverse Event|2|||
48804011|NCT00263328|157124181|FG000|Overall Study|Death|0|||
48434138|NCT01781429|155779135|FG014|Overall Study|Disease Progression|11|||
48804012|NCT00263328|157124182|FG001|Overall Study|Death|0|||
48804013|NCT00263328|157124183|FG002|Overall Study|Death|1|||
48596042|NCT01763827|156377818|FG000|Overall Study|Lost to Follow-up|0|||
48596043|NCT01763827|156377819|FG001|Overall Study|Lost to Follow-up|1|||
48596044|NCT01763827|156377820|FG002|Overall Study|Lost to Follow-up|1|||
48596045|NCT01763827|156377821|FG003|Overall Study|Lost to Follow-up|1|||
48596046|NCT01763827|156377822|FG004|Overall Study|Lost to Follow-up|2|||
48596047|NCT01763827|156377823|FG005|Overall Study|Lost to Follow-up|1|||
48596048|NCT02753816|156377828|FG000|Overall Study|Protocol Violation|0|||
48596049|NCT02753816|156377829|FG001|Overall Study|Protocol Violation|1|||
48596050|NCT02753816|156377830|FG002|Overall Study|Protocol Violation|0|||
48596051|NCT02542397|156377831|FG000|Overall Study|Death|2|||
48596052|NCT02542397|156377831|FG000|Overall Study|Physician Decision|6|||
48596053|NCT02542397|156377831|FG000|Overall Study|Withdrawal by Subject|6|||
48596054|NCT02542397|156377831|FG000|Overall Study|Lost to Follow-up|2|||
48596055|NCT01724177|156377836|FG000|Overall Study|Adverse Event|8|||
48596056|NCT01724177|156377836|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
48596057|NCT01724177|156377836|FG000|Overall Study|Nervous participant|1|||
48596058|NCT01724177|156377836|FG000|Overall Study|Serious Adverse Event Related|1|||
48596059|NCT00424593|156377839|FG000|Acute Double-Blind Period|Adverse Event|16|||
48596060|NCT00424593|156377840|FG001|Acute Double-Blind Period|Adverse Event|7|||
48596061|NCT00424593|156377839|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
48596062|NCT00424593|156377840|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
48596063|NCT00424593|156377839|FG000|Acute Double-Blind Period|Protocol Violation|2|||
48596064|NCT00424593|156377840|FG001|Acute Double-Blind Period|Protocol Violation|2|||
48596065|NCT00424593|156377839|FG000|Acute Double-Blind Period|Physician Decision|1|||
48596066|NCT00424593|156377840|FG001|Acute Double-Blind Period|Physician Decision|2|||
48596067|NCT00424593|156377839|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
48596068|NCT00424593|156377840|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
48596069|NCT00424593|156377839|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
48596070|NCT00424593|156377840|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
48596071|NCT00424593|156377839|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
48596072|NCT00424593|156377840|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
48596073|NCT00424593|156377839|FG000|Dose-Blind Extension Period|Adverse Event|18|||
48596074|NCT00424593|156377840|FG001|Dose-Blind Extension Period|Adverse Event|0|||
48596075|NCT00424593|156377839|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
48596076|NCT00424593|156377840|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
48596077|NCT00424593|156377839|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
48596078|NCT00424593|156377840|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
48596079|NCT00424593|156377839|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
48596080|NCT00424593|156377840|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
48596081|NCT00424593|156377839|FG000|Dose-Blind Extension Period|Physician Decision|3|||
48596082|NCT00424593|156377840|FG001|Dose-Blind Extension Period|Physician Decision|0|||
48596083|NCT00632125|156377841|FG000|Overall Study|Death|82|||
48596084|NCT00632125|156377841|FG000|Overall Study|Withdrawal by Subject|44|||
48596085|NCT00632125|156377841|FG000|Overall Study|Adverse Event|36|||
48596086|NCT00632125|156377841|FG000|Overall Study|Renal transplantation|17|||
48596087|NCT00632125|156377841|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
48596088|NCT00632125|156377841|FG000|Overall Study|Non-compliance|8|||
48596089|NCT00632125|156377841|FG000|Overall Study|Development of uncontrolled hypertension|5|||
48596090|NCT00632125|156377841|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
48596091|NCT00572455|156377842|FG000|Stage I (14 Days)|Adverse Event|0|||
48596092|NCT00572455|156377843|FG001|Stage I (14 Days)|Adverse Event|0|||
48596093|NCT00572455|156377844|FG002|Stage I (14 Days)|Adverse Event|0|||
48596094|NCT00572455|156377845|FG003|Stage I (14 Days)|Adverse Event|0|||
48804014|NCT00263328|157124181|FG000|Overall Study|Lost to Follow-up|1|||
48804015|NCT00263328|157124182|FG001|Overall Study|Lost to Follow-up|1|||
48804016|NCT00263328|157124183|FG002|Overall Study|Lost to Follow-up|0|||
48804017|NCT00263328|157124181|FG000|Overall Study|Withdrawal by Subject|3|||
48804018|NCT00263328|157124182|FG001|Overall Study|Withdrawal by Subject|0|||
48804019|NCT00263328|157124183|FG002|Overall Study|Withdrawal by Subject|1|||
48804020|NCT00263328|157124181|FG000|Overall Study|Other|3|||
48804021|NCT00263328|157124182|FG001|Overall Study|Other|0|||
48804022|NCT00263328|157124183|FG002|Overall Study|Other|1|||
48804023|NCT00263328|157124181|FG000|Overall Study|Adverse Event|1|||
48804024|NCT00263328|157124182|FG001|Overall Study|Adverse Event|1|||
48804025|NCT00263328|157124183|FG002|Overall Study|Adverse Event|4|||
48804026|NCT01065350|157124187|FG000|Overall Study|Received incorrect drug allocation|0|||
48804027|NCT01065350|157124188|FG001|Overall Study|Received incorrect drug allocation|1|||
48804028|NCT03477175|157124194|FG000|Overall Study|Unable to travel due to COVID-19|0|||
48804029|NCT03477175|157124195|FG001|Overall Study|Unable to travel due to COVID-19|1|||
48804030|NCT03477175|157124194|FG000|Overall Study|Physician Decision|1|||
48804031|NCT03477175|157124195|FG001|Overall Study|Physician Decision|0|||
48804032|NCT03477175|157124194|FG000|Overall Study|Transitioned to commercial drug|6|||
48804033|NCT03477175|157124195|FG001|Overall Study|Transitioned to commercial drug|6|||
48804034|NCT03477175|157124194|FG000|Overall Study|Lost to Follow-up|1|||
48804035|NCT03477175|157124195|FG001|Overall Study|Lost to Follow-up|1|||
48804036|NCT03477175|157124194|FG000|Overall Study|Withdrawal by Subject|3|||
48804037|NCT03477175|157124195|FG001|Overall Study|Withdrawal by Subject|1|||
48804038|NCT03477175|157124194|FG000|Overall Study|Adverse Event|1|||
48804039|NCT03477175|157124195|FG001|Overall Study|Adverse Event|5|||
48804040|NCT03477175|157124194|FG000|Overall Study|Disease Progression|7|||
48804041|NCT03477175|157124195|FG001|Overall Study|Disease Progression|7|||
48804042|NCT02073097|157124196|FG000|Overall Study|Adverse Event|0|||
48804043|NCT02073097|157124197|FG001|Overall Study|Adverse Event|0|||
48804044|NCT02073097|157124198|FG002|Overall Study|Adverse Event|0|||
48804045|NCT02073097|157124199|FG003|Overall Study|Adverse Event|0|||
48596095|NCT00572455|156377846|FG004|Stage I (14 Days)|Adverse Event|0|||
48804046|NCT02073097|157124200|FG004|Overall Study|Adverse Event|0|||
48804047|NCT02073097|157124201|FG005|Overall Study|Adverse Event|0|||
48804048|NCT02073097|157124202|FG006|Overall Study|Adverse Event|0|||
48596096|NCT00572455|156377847|FG005|Stage I (14 Days)|Adverse Event|3|||
48804049|NCT02073097|157124203|FG007|Overall Study|Adverse Event|2|||
48804050|NCT02073097|157124196|FG000|Overall Study|Withdrawal by Subject|0|||
48804051|NCT02073097|157124197|FG001|Overall Study|Withdrawal by Subject|0|||
48804052|NCT02073097|157124198|FG002|Overall Study|Withdrawal by Subject|0|||
48804053|NCT02073097|157124199|FG003|Overall Study|Withdrawal by Subject|0|||
48804054|NCT02073097|157124200|FG004|Overall Study|Withdrawal by Subject|0|||
48804055|NCT02073097|157124201|FG005|Overall Study|Withdrawal by Subject|0|||
48804056|NCT02073097|157124202|FG006|Overall Study|Withdrawal by Subject|0|||
48804057|NCT02073097|157124203|FG007|Overall Study|Withdrawal by Subject|2|||
48804058|NCT02073097|157124196|FG000|Overall Study|Death|0|||
48596097|NCT00572455|156377848|FG006|Stage I (14 Days)|Adverse Event|0|||
48596098|NCT00572455|156377849|FG007|Stage I (14 Days)|Adverse Event|0|||
48804059|NCT02073097|157124197|FG001|Overall Study|Death|0|||
48804060|NCT02073097|157124198|FG002|Overall Study|Death|0|||
48804061|NCT02073097|157124199|FG003|Overall Study|Death|0|||
48804062|NCT02073097|157124200|FG004|Overall Study|Death|0|||
48804063|NCT02073097|157124201|FG005|Overall Study|Death|0|||
48804064|NCT02073097|157124202|FG006|Overall Study|Death|0|||
48804065|NCT02073097|157124203|FG007|Overall Study|Death|1|||
48804066|NCT02073097|157124196|FG000|Overall Study|Physician Decision|0|||
48804067|NCT02073097|157124197|FG001|Overall Study|Physician Decision|0|||
48804068|NCT02073097|157124198|FG002|Overall Study|Physician Decision|0|||
48804069|NCT02073097|157124199|FG003|Overall Study|Physician Decision|0|||
48804070|NCT02073097|157124200|FG004|Overall Study|Physician Decision|0|||
48804071|NCT02073097|157124201|FG005|Overall Study|Physician Decision|0|||
48804072|NCT02073097|157124202|FG006|Overall Study|Physician Decision|0|||
48804073|NCT02073097|157124203|FG007|Overall Study|Physician Decision|1|||
48804074|NCT01728792|157125384|FG000|Overall Study|Withdrawal of Consent|1|||
48804075|NCT01728792|157125385|FG001|Overall Study|Withdrawal of Consent|1|||
48804076|NCT01728792|157125386|FG002|Overall Study|Withdrawal of Consent|0|||
48804077|NCT01728792|157125387|FG003|Overall Study|Withdrawal of Consent|1|||
48804078|NCT01728792|157125388|FG004|Overall Study|Withdrawal of Consent|0|||
48804079|NCT01728792|157125384|FG000|Overall Study|Lost to Follow-up|2|||
48804080|NCT01728792|157125385|FG001|Overall Study|Lost to Follow-up|1|||
48804081|NCT01728792|157125386|FG002|Overall Study|Lost to Follow-up|4|||
48804082|NCT01728792|157125387|FG003|Overall Study|Lost to Follow-up|2|||
48804083|NCT01728792|157125388|FG004|Overall Study|Lost to Follow-up|0|||
48804084|NCT01224925|157125389|FG000|Overall Study|Lost to Follow-up|3|||
48804085|NCT01224925|157125390|FG001|Overall Study|Lost to Follow-up|2|||
48804086|NCT01203930|157125393|FG000|Overall Study|Disease Progression|0|||
48596099|NCT00572455|156377850|FG008|Stage I (14 Days)|Adverse Event|0|||
48596100|NCT00572455|156377851|FG009|Stage I (14 Days)|Adverse Event|0|||
48596101|NCT00572455|156377852|FG010|Stage I (14 Days)|Adverse Event|0|||
48804087|NCT01203930|157125394|FG001|Overall Study|Disease Progression|4|||
48804088|NCT01203930|157125393|FG000|Overall Study|Death|3|||
48804089|NCT01203930|157125394|FG001|Overall Study|Death|1|||
48804090|NCT01203930|157125393|FG000|Overall Study|Withdrew Consent|1|||
48804091|NCT01203930|157125394|FG001|Overall Study|Withdrew Consent|10|||
48804092|NCT01203930|157125393|FG000|Overall Study|Investigator Request|0|||
48804093|NCT01203930|157125394|FG001|Overall Study|Investigator Request|8|||
48804094|NCT01203930|157125393|FG000|Overall Study|Study Terminated by Sponsor|0|||
48804095|NCT01203930|157125394|FG001|Overall Study|Study Terminated by Sponsor|12|||
48804096|NCT01203930|157125393|FG000|Overall Study|Poor tolerance of study drug|0|||
48804097|NCT01203930|157125394|FG001|Overall Study|Poor tolerance of study drug|1|||
48804098|NCT01203930|157125393|FG000|Overall Study|Adverse Event|17|||
48804099|NCT01203930|157125394|FG001|Overall Study|Adverse Event|5|||
48804100|NCT00245102|157125395|FG000|Overall Study|Not Treated|1|||
48804101|NCT00245102|157125396|FG001|Overall Study|Not Treated|0|||
48804102|NCT00245102|157125397|FG002|Overall Study|Not Treated|1|||
48804103|NCT00245102|157125398|FG003|Overall Study|Not Treated|0|||
48804104|NCT00245102|157125399|FG004|Overall Study|Not Treated|0|||
48804105|NCT00245102|157125400|FG005|Overall Study|Not Treated|0|||
48804106|NCT00245102|157125395|FG000|Overall Study|Protocol Violation|1|||
48804107|NCT00245102|157125396|FG001|Overall Study|Protocol Violation|0|||
48804108|NCT00245102|157125397|FG002|Overall Study|Protocol Violation|0|||
48804109|NCT00245102|157125398|FG003|Overall Study|Protocol Violation|0|||
48804110|NCT00245102|157125399|FG004|Overall Study|Protocol Violation|0|||
48804111|NCT00245102|157125400|FG005|Overall Study|Protocol Violation|0|||
48804112|NCT00245102|157125395|FG000|Overall Study|Death|0|||
48804113|NCT00245102|157125396|FG001|Overall Study|Death|0|||
48804114|NCT00245102|157125397|FG002|Overall Study|Death|0|||
48804115|NCT00245102|157125398|FG003|Overall Study|Death|1|||
48804116|NCT00245102|157125399|FG004|Overall Study|Death|0|||
48804117|NCT00245102|157125400|FG005|Overall Study|Death|0|||
48804118|NCT00245102|157125395|FG000|Overall Study|Adverse Event|4|||
48804119|NCT00245102|157125396|FG001|Overall Study|Adverse Event|2|||
48804120|NCT00245102|157125397|FG002|Overall Study|Adverse Event|5|||
48804121|NCT00245102|157125398|FG003|Overall Study|Adverse Event|1|||
48804122|NCT00245102|157125399|FG004|Overall Study|Adverse Event|0|||
48804123|NCT00245102|157125400|FG005|Overall Study|Adverse Event|2|||
48804124|NCT00245102|157125395|FG000|Overall Study|Decline in performance|0|||
48804125|NCT00245102|157125396|FG001|Overall Study|Decline in performance|2|||
48804126|NCT00245102|157125397|FG002|Overall Study|Decline in performance|0|||
48804127|NCT00245102|157125398|FG003|Overall Study|Decline in performance|1|||
48804128|NCT00245102|157125399|FG004|Overall Study|Decline in performance|0|||
48804129|NCT00245102|157125400|FG005|Overall Study|Decline in performance|2|||
48804130|NCT00245102|157125395|FG000|Overall Study|Participant needed surgery|0|||
48804131|NCT00245102|157125396|FG001|Overall Study|Participant needed surgery|0|||
48804132|NCT00245102|157125397|FG002|Overall Study|Participant needed surgery|1|||
48804133|NCT00245102|157125398|FG003|Overall Study|Participant needed surgery|0|||
48804134|NCT00245102|157125399|FG004|Overall Study|Participant needed surgery|0|||
48804135|NCT00245102|157125400|FG005|Overall Study|Participant needed surgery|0|||
48804136|NCT00245102|157125395|FG000|Overall Study|Clinical progression|1|||
48804137|NCT00245102|157125396|FG001|Overall Study|Clinical progression|0|||
48804138|NCT00245102|157125397|FG002|Overall Study|Clinical progression|0|||
48804139|NCT00245102|157125398|FG003|Overall Study|Clinical progression|0|||
48804140|NCT00245102|157125399|FG004|Overall Study|Clinical progression|0|||
48804141|NCT00245102|157125400|FG005|Overall Study|Clinical progression|0|||
48804142|NCT04858802|157125404|FG000|Overall Study|Lost to Follow-up|1|||
48804143|NCT04858802|157125405|FG001|Overall Study|Lost to Follow-up|1|||
48804144|NCT04858802|157125404|FG000|Overall Study|Withdrawal by Subject|1|||
48804145|NCT04858802|157125405|FG001|Overall Study|Withdrawal by Subject|1|||
48804146|NCT03391765|157125406|FG000|Overall Study|Adverse Event|2|||
48804147|NCT03391765|157125407|FG001|Overall Study|Adverse Event|0|||
48804148|NCT03391765|157125408|FG002|Overall Study|Adverse Event|0|||
48804149|NCT03391765|157125409|FG003|Overall Study|Adverse Event|2|||
48804150|NCT03391765|157125406|FG000|Overall Study|Withdrew consent|5|||
48804151|NCT03391765|157125407|FG001|Overall Study|Withdrew consent|7|||
48804152|NCT03391765|157125408|FG002|Overall Study|Withdrew consent|2|||
48804153|NCT03391765|157125409|FG003|Overall Study|Withdrew consent|5|||
48804154|NCT03391765|157125406|FG000|Overall Study|Other, not specified|44|||
48804155|NCT03391765|157125407|FG001|Overall Study|Other, not specified|38|||
48804156|NCT03391765|157125408|FG002|Overall Study|Other, not specified|21|||
48804157|NCT03391765|157125409|FG003|Overall Study|Other, not specified|16|||
48804158|NCT03966053|157125410|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
48804159|NCT04425902|157125415|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
48804160|NCT04607044|157125421|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
48804161|NCT04607044|157125421|FG000|Overall Study|Adverse Event|1|||
48804162|NCT04607044|157125421|FG000|Overall Study|Did not receive study device|3|||
48804163|NCT04607044|157125421|FG000|Overall Study|Death|1|||
48804164|NCT04152200|157125422|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
48804165|NCT04152200|157125423|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
48804166|NCT03585296|157125430|FG000|Overall Study|Adverse Event|1|||
48804167|NCT03585296|157125430|FG000|Overall Study|Lost to Follow-up|2|||
48804168|NCT03585296|157125430|FG000|Overall Study|Withdrawal by Subject|2|||
48804169|NCT01059643|157125431|FG000|Overall Study|Adverse Event|3|||
48804170|NCT01059643|157125431|FG000|Overall Study|Withdrawal by Subject|2|||
48804171|NCT01059643|157125431|FG000|Overall Study|Physician Decision|1|||
48804172|NCT00185640|157125432|FG000|Overall Study|Not Eligible|4|||
48804173|NCT00185640|157125432|FG000|Overall Study|Withdrawal by Subject|3|||
48804174|NCT00185640|157125432|FG000|Overall Study|Death|138|||
48804175|NCT00708435|157125434|FG000|Overall Study|Death / Serious Adverse Event|10|||
48804176|NCT00708435|157125435|FG001|Overall Study|Death / Serious Adverse Event|5|||
48804177|NCT00708435|157125434|FG000|Overall Study|Lost to Follow-up|9|||
48804178|NCT00708435|157125435|FG001|Overall Study|Lost to Follow-up|4|||
48804179|NCT00708435|157125434|FG000|Overall Study|Withdrawal by Subject|3|||
48804180|NCT00708435|157125435|FG001|Overall Study|Withdrawal by Subject|7|||
48804181|NCT00708435|157125434|FG000|Overall Study|Adverse Event|1|||
48804182|NCT00708435|157125435|FG001|Overall Study|Adverse Event|0|||
48804183|NCT00708435|157125434|FG000|Overall Study|Protocol Violation|0|||
48804184|NCT00708435|157125435|FG001|Overall Study|Protocol Violation|1|||
48804185|NCT00708435|157125434|FG000|Overall Study|Intervention by primary care physician|1|||
48804186|NCT00708435|157125435|FG001|Overall Study|Intervention by primary care physician|0|||
48804187|NCT00708435|157125434|FG000|Overall Study|Refused hospitalization|1|||
48804188|NCT00708435|157125435|FG001|Overall Study|Refused hospitalization|0|||
48804189|NCT02437318|157125436|FG000|Overall Study|Progressive disease|207|||
48804190|NCT02437318|157125437|FG001|Overall Study|Progressive disease|240|||
48804191|NCT02437318|157125436|FG000|Overall Study|Subject/guardian decision|24|||
48804192|NCT02437318|157125437|FG001|Overall Study|Subject/guardian decision|11|||
48804193|NCT02437318|157125436|FG000|Overall Study|Physician Decision|29|||
48804194|NCT02437318|157125437|FG001|Overall Study|Physician Decision|22|||
48804195|NCT02437318|157125436|FG000|Overall Study|Adverse Event|14|||
48804196|NCT02437318|157125437|FG001|Overall Study|Adverse Event|4|||
48804197|NCT02437318|157125436|FG000|Overall Study|Death|4|||
48804198|NCT02437318|157125437|FG001|Overall Study|Death|4|||
48804199|NCT02437318|157125436|FG000|Overall Study|Protocol deviation|5|||
48804200|NCT02437318|157125437|FG001|Overall Study|Protocol deviation|7|||
48804201|NCT02437318|157125436|FG000|Overall Study|Sponsor decision|1|||
48804202|NCT02437318|157125437|FG001|Overall Study|Sponsor decision|0|||
48804203|NCT01446796|157125438|FG000|Overall Study|Withdrawal by Subject|1|||
48490426|NCT04313283|155990719|FG000|Overall Study|did not complete intervention|4|||
48490427|NCT01084005|155990720|FG000|Overall Study|Adverse Event|1|||
48490428|NCT01084005|155990721|FG001|Overall Study|Adverse Event|8|||
48490429|NCT01084005|155990720|FG000|Overall Study|Protocol Violation|3|||
48804204|NCT01446796|157125439|FG001|Overall Study|Withdrawal by Subject|0|||
48804205|NCT01426425|157125440|FG000|Overall Study|Exited prior to EP study|22|||
48804206|NCT01426425|157125440|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
48804207|NCT01426425|157125440|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
48804208|NCT00909480|157125441|FG000|Overall Study|Adverse Event|5|||
48804209|NCT00909480|157125442|FG001|Overall Study|Adverse Event|3|||
48804210|NCT00909480|157125441|FG000|Overall Study|Protocol Violation|6|||
48804211|NCT00909480|157125442|FG001|Overall Study|Protocol Violation|8|||
48804212|NCT00909480|157125441|FG000|Overall Study|Withdrawal criteria|9|||
48804213|NCT00909480|157125442|FG001|Overall Study|Withdrawal criteria|11|||
48804214|NCT00909480|157125441|FG000|Overall Study|Unclassified|18|||
48804215|NCT00909480|157125442|FG001|Overall Study|Unclassified|19|||
48804216|NCT01999075|157125447|FG000|Overall Study|Lost to Follow-up|0|||
48804217|NCT01999075|157125448|FG001|Overall Study|Lost to Follow-up|2|||
48804218|NCT01999075|157125447|FG000|Overall Study|Withdrawal by Subject|2|||
48804219|NCT01999075|157125448|FG001|Overall Study|Withdrawal by Subject|7|||
48804220|NCT01999075|157125447|FG000|Overall Study|Enrolled in drug trial|3|||
48804221|NCT01999075|157125448|FG001|Overall Study|Enrolled in drug trial|1|||
48804222|NCT01999075|157125447|FG000|Overall Study|Became ineligible|0|||
48804223|NCT01999075|157125448|FG001|Overall Study|Became ineligible|2|||
48804224|NCT04995419|157125449|FG000|Overall Study|Withdrawal by Subject|3|||
48804225|NCT04995419|157125449|FG000|Overall Study|Progressive Disease|19|||
48804226|NCT04995419|157125449|FG000|Overall Study|Adverse Event|2|||
48804227|NCT04995419|157125449|FG000|Overall Study|Ongoing|16|||
48804228|NCT04096040|157125454|FG000|Overall Study|Protocol Violation|12|||
48804229|NCT04096040|157125454|FG000|Overall Study|Non-compliant site|4|||
48804230|NCT04524598|157125455|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
48804231|NCT04524598|157125456|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
48804232|NCT04524598|157125457|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
48804233|NCT04524598|157125458|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
48804234|NCT04524598|157125459|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
48804235|NCT04524598|157125455|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
48804236|NCT04524598|157125456|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
48804237|NCT04524598|157125457|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804238|NCT04524598|157125458|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804239|NCT04524598|157125459|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804240|NCT04524598|157125455|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
48804241|NCT04524598|157125456|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
48804242|NCT04524598|157125457|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
48804243|NCT04524598|157125458|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
48804244|NCT04524598|157125459|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
48804245|NCT04524598|157125455|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
48804246|NCT04524598|157125456|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
48804247|NCT04524598|157125457|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
48804248|NCT04524598|157125458|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
48804249|NCT04524598|157125459|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
48804250|NCT04524598|157125455|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804251|NCT04524598|157125456|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804252|NCT04524598|157125457|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
48804253|NCT04524598|157125458|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
48804254|NCT04524598|157125459|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804255|NCT04524598|157125455|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
48804256|NCT04524598|157125456|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
48804257|NCT04524598|157125457|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
48804258|NCT04524598|157125458|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
48804259|NCT04524598|157125459|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
48804260|NCT04524598|157125455|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804261|NCT04524598|157125456|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804262|NCT04524598|157125457|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804263|NCT04524598|157125458|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
48804264|NCT04524598|157125459|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
48804265|NCT02668016|157125460|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
48804266|NCT02668016|157125460|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
48804267|NCT02668016|157125460|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
48804268|NCT02668016|157125460|FG000|Month 4|Withdrawal due to severe symptoms|1|||
48804269|NCT02668016|157125460|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
48804270|NCT02668016|157125460|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
48804271|NCT02668016|157125460|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
48804272|NCT02668016|157125460|FG000|Month 6|Withdrawal due to severe symptoms|2|||
48804273|NCT02668016|157125460|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
48804274|NCT02668016|157125460|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
48804275|NCT02668016|157125460|FG000|Month 8|Withdrawal due to severe symptoms|1|||
48804276|NCT02668016|157125460|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
48804277|NCT02668016|157125460|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
48804278|NCT02668016|157125460|FG000|Month 10|Withdrawal due to severe symptoms|1|||
48804279|NCT02668016|157125460|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
48804280|NCT00962247|157125461|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
48804281|NCT00962247|157125461|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
48804282|NCT03474549|157125462|FG000|Overall Study|Death|31|||
48804283|NCT03474549|157125462|FG000|Overall Study|Lost to Follow-up|4|||
48804284|NCT03474549|157125462|FG000|Overall Study|Withdrawal by Subject|2|||
48804285|NCT04109066|157125468|FG000|Pre-treatment|Participant withdrew consent|2|||
48804286|NCT04109066|157125469|FG001|Pre-treatment|Participant withdrew consent|0|||
48804287|NCT04109066|157125468|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
48804288|NCT04109066|157125469|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
48804289|NCT04109066|157125468|FG000|Treatment|Lack of Efficacy|2|||
48804290|NCT04109066|157125469|FG001|Treatment|Lack of Efficacy|4|||
48804291|NCT04109066|157125468|FG000|Treatment|Adverse Event|23|||
48804292|NCT04109066|157125469|FG001|Treatment|Adverse Event|7|||
48804293|NCT04109066|157125468|FG000|Treatment|Participant request to discontinue Study treatment|15|||
48804294|NCT04109066|157125469|FG001|Treatment|Participant request to discontinue Study treatment|14|||
48804295|NCT04109066|157125468|FG000|Treatment|Withdrawal by Subject|8|||
48804296|NCT04109066|157125469|FG001|Treatment|Withdrawal by Subject|8|||
48804297|NCT04109066|157125468|FG000|Treatment|Death|3|||
48804298|NCT04109066|157125469|FG001|Treatment|Death|0|||
48804299|NCT04109066|157125468|FG000|Treatment|Participant no longer meets study criteria|2|||
48804300|NCT04109066|157125469|FG001|Treatment|Participant no longer meets study criteria|2|||
48804301|NCT04109066|157125468|FG000|Treatment|Administrative reasons by sponsor|2|||
48804302|NCT04109066|157125469|FG001|Treatment|Administrative reasons by sponsor|3|||
48804303|NCT04109066|157125468|FG000|Treatment|Other reasons|17|||
48804304|NCT04109066|157125469|FG001|Treatment|Other reasons|23|||
48804305|NCT04109066|157125468|FG000|Treatment|Disease Progression|4|||
48804306|NCT04109066|157125469|FG001|Treatment|Disease Progression|7|||
48804307|NCT04109066|157125468|FG000|Treatment|Study drug toxicity|12|||
48804308|NCT04109066|157125469|FG001|Treatment|Study drug toxicity|5|||
48804309|NCT04109066|157125468|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
48804310|NCT04109066|157125469|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
48804311|NCT04109066|157125468|FG000|Treatment|Disease Recurrence|0|||
48804312|NCT04109066|157125469|FG001|Treatment|Disease Recurrence|2|||
48804313|NCT04109066|157125468|FG000|Treatment|Not reported|4|||
48804314|NCT04109066|157125469|FG001|Treatment|Not reported|8|||
48804315|NCT03386032|157126467|FG000|Overall Study|Lack of Efficacy|6|||
48804316|NCT03386032|157126468|FG001|Overall Study|Lack of Efficacy|2|||
48804317|NCT03386032|157126469|FG002|Overall Study|Lack of Efficacy|0|||
48804318|NCT03386032|157126467|FG000|Overall Study|Adverse Event|2|||
48804319|NCT03386032|157126468|FG001|Overall Study|Adverse Event|2|||
48804320|NCT03386032|157126469|FG002|Overall Study|Adverse Event|0|||
48804321|NCT03386032|157126467|FG000|Overall Study|Withdrawal by Subject|1|||
48804322|NCT03386032|157126468|FG001|Overall Study|Withdrawal by Subject|0|||
48804323|NCT03386032|157126469|FG002|Overall Study|Withdrawal by Subject|0|||
48804324|NCT03386032|157126467|FG000|Overall Study|Lost to Follow-up|9|||
48804325|NCT03386032|157126468|FG001|Overall Study|Lost to Follow-up|3|||
48804326|NCT03386032|157126469|FG002|Overall Study|Lost to Follow-up|0|||
48804327|NCT04907474|157126474|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
48804328|NCT04907474|157126475|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
48804329|NCT02364180|157126476|FG000|Overall Study|Screen Fail|1|||
48804330|NCT02487498|157126481|FG000|Period: Period 1|Adverse Event|2|||
48804331|NCT02487498|157126482|FG001|Period: Period 1|Adverse Event|4|||
48804332|NCT02487498|157126481|FG000|Period: Period 1|Subject/guardian decision|2|||
48804333|NCT02487498|157126482|FG001|Period: Period 1|Subject/guardian decision|4|||
48804334|NCT02487498|157126481|FG000|Period: Period 1|Lost to Follow-up|0|||
48804335|NCT02487498|157126482|FG001|Period: Period 1|Lost to Follow-up|2|||
48804336|NCT02487498|157126481|FG000|Period: Period 1|Lack of Efficacy|1|||
48804337|NCT02487498|157126482|FG001|Period: Period 1|Lack of Efficacy|0|||
48804338|NCT02487498|157126481|FG000|Period: Period 1|Physician Decision|0|||
48804339|NCT02487498|157126482|FG001|Period: Period 1|Physician Decision|1|||
48804340|NCT02487498|157126481|FG000|Period: Period 1|Protocol deviation|1|||
48804341|NCT02487498|157126482|FG001|Period: Period 1|Protocol deviation|0|||
48804342|NCT02487498|157126481|FG000|Period: Washout|Subject/guardian decision|0|||
48804343|NCT02487498|157126482|FG001|Period: Washout|Subject/guardian decision|5|||
48804344|NCT02487498|157126481|FG000|Period: Washout|Lack of Efficacy|1|||
48804345|NCT02487498|157126482|FG001|Period: Washout|Lack of Efficacy|1|||
48804346|NCT02487498|157126481|FG000|Period: Washout|Physician Decision|1|||
48804347|NCT02487498|157126482|FG001|Period: Washout|Physician Decision|0|||
48804348|NCT02487498|157126481|FG000|Period: Washout|Non-compliance with study treatment|0|||
48804349|NCT02487498|157126482|FG001|Period: Washout|Non-compliance with study treatment|1|||
48804350|NCT02487498|157126481|FG000|Period: Period 2|Adverse Event|2|||
48804351|NCT02487498|157126482|FG001|Period: Period 2|Adverse Event|2|||
48804352|NCT02487498|157126481|FG000|Period: Period 2|Subject/guardian decision|2|||
48804353|NCT02487498|157126482|FG001|Period: Period 2|Subject/guardian decision|1|||
48804354|NCT02487498|157126481|FG000|Period: Period 2|Lost to Follow-up|1|||
48804355|NCT02487498|157126482|FG001|Period: Period 2|Lost to Follow-up|1|||
48804356|NCT02487498|157126481|FG000|Period: Period 2|Death|0|||
48804357|NCT02487498|157126482|FG001|Period: Period 2|Death|1|||
48804358|NCT02487498|157126481|FG000|Period: Period 2|Physician Decision|1|||
48804359|NCT02487498|157126482|FG001|Period: Period 2|Physician Decision|0|||
48804360|NCT04934722|157126483|FG000|Overall Study|Death|4|||
48804361|NCT04934722|157126484|FG001|Overall Study|Death|3|||
48804362|NCT04934722|157126483|FG000|Overall Study|Participants Ongoing|88|||
48804363|NCT04934722|157126484|FG001|Overall Study|Participants Ongoing|91|||
48804364|NCT02513563|157126485|FG000|Overall Study|Death|4|||
48804365|NCT02513563|157126485|FG000|Overall Study|Withdrawal by Subject|4|||
48804366|NCT02513563|157126485|FG000|Overall Study|Physician Decision|1|||
48596102|NCT00572455|156377853|FG011|Stage I (14 Days)|Adverse Event|0|||
48596103|NCT00572455|156377854|FG012|Stage I (14 Days)|Adverse Event|0|||
48596104|NCT00572455|156377855|FG013|Stage I (14 Days)|Adverse Event|0|||
48596105|NCT00572455|156377842|FG000|Stage I (14 Days)|Other|0|||
48596106|NCT00572455|156377843|FG001|Stage I (14 Days)|Other|0|||
48804367|NCT04908397|157126486|FG000|Overall Study|Withdrawal by Subject|2|||
48804368|NCT02231164|157126488|FG000|Overall Study|Adverse Event|1|||
48804369|NCT02231164|157126489|FG001|Overall Study|Adverse Event|1|||
48804370|NCT02231164|157126488|FG000|Overall Study|Lack of Efficacy|4|||
48596107|NCT00572455|156377844|FG002|Stage I (14 Days)|Other|0|||
48596108|NCT00572455|156377845|FG003|Stage I (14 Days)|Other|0|||
48596109|NCT00572455|156377846|FG004|Stage I (14 Days)|Other|1|||
48804371|NCT02231164|157126489|FG001|Overall Study|Lack of Efficacy|3|||
48804372|NCT02231164|157126488|FG000|Overall Study|Withdrawal by Subject|1|||
48804373|NCT02231164|157126489|FG001|Overall Study|Withdrawal by Subject|2|||
48804374|NCT04765384|157126490|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
48804375|NCT04765384|157126491|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
48804376|NCT04765384|157126492|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
48804377|NCT04765384|157126493|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
48804378|NCT04765384|157126494|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
48804379|NCT04765384|157126495|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
48804380|NCT04765384|157126490|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
48804381|NCT04765384|157126491|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
48804382|NCT04765384|157126492|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
48804383|NCT04765384|157126493|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
48804384|NCT04765384|157126494|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
48804385|NCT04765384|157126495|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
48804386|NCT04765384|157126490|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804387|NCT04765384|157126491|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804388|NCT04765384|157126492|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804389|NCT04765384|157126493|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804390|NCT04765384|157126494|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
48804391|NCT04765384|157126495|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
48804392|NCT04765384|157126490|FG000|Post-natal: Neonates and Infants|Death|0|||
48804393|NCT04765384|157126491|FG001|Post-natal: Neonates and Infants|Death|0|||
48804394|NCT04765384|157126492|FG002|Post-natal: Neonates and Infants|Death|0|||
48804395|NCT04765384|157126493|FG003|Post-natal: Neonates and Infants|Death|1|||
48804396|NCT04765384|157126494|FG004|Post-natal: Neonates and Infants|Death|0|||
48804397|NCT04765384|157126495|FG005|Post-natal: Neonates and Infants|Death|0|||
48804398|NCT04765384|157126490|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804399|NCT04765384|157126491|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804400|NCT04765384|157126492|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804401|NCT04765384|157126493|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804402|NCT04765384|157126494|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
48804403|NCT04765384|157126495|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
48804404|NCT04568486|157126496|FG000|Overall Study|Withdrawal by Subject|26|||
48804405|NCT04568486|157126496|FG000|Overall Study|Lost to Follow-up|7|||
48804406|NCT04517253|157126497|FG000|Overall Study|Adverse Event|1|||
48804407|NCT04517253|157126498|FG001|Overall Study|Adverse Event|0|||
48804408|NCT04517253|157126499|FG002|Overall Study|Adverse Event|0|||
48804409|NCT04517253|157126497|FG000|Overall Study|Death|0|||
48804410|NCT04517253|157126498|FG001|Overall Study|Death|1|||
48804411|NCT04517253|157126499|FG002|Overall Study|Death|0|||
48804412|NCT04830800|157126501|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
48804413|NCT04830800|157126502|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
48804414|NCT04830800|157126503|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
48804415|NCT04830800|157126504|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
48804416|NCT04830800|157126505|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
48804417|NCT01036022|157126509|FG000|Overall Study|Adverse Event|1|||
48804418|NCT01036022|157126510|FG001|Overall Study|Adverse Event|3|||
48804419|NCT01036022|157126511|FG002|Overall Study|Adverse Event|2|||
48804420|NCT01036022|157126512|FG003|Overall Study|Adverse Event|1|||
48804421|NCT01036022|157126513|FG004|Overall Study|Adverse Event|0|||
48804422|NCT01036022|157126514|FG005|Overall Study|Adverse Event|2|||
48804423|NCT01036022|157126509|FG000|Overall Study|Lack of Efficacy|1|||
48804424|NCT01036022|157126510|FG001|Overall Study|Lack of Efficacy|1|||
48804425|NCT01036022|157126511|FG002|Overall Study|Lack of Efficacy|1|||
48804426|NCT01036022|157126512|FG003|Overall Study|Lack of Efficacy|0|||
48804427|NCT01036022|157126513|FG004|Overall Study|Lack of Efficacy|1|||
48804428|NCT01036022|157126514|FG005|Overall Study|Lack of Efficacy|1|||
48804429|NCT01036022|157126509|FG000|Overall Study|Physician Decision|0|||
48804430|NCT01036022|157126510|FG001|Overall Study|Physician Decision|0|||
48804431|NCT01036022|157126511|FG002|Overall Study|Physician Decision|1|||
48804432|NCT01036022|157126512|FG003|Overall Study|Physician Decision|0|||
48804433|NCT01036022|157126513|FG004|Overall Study|Physician Decision|0|||
48804434|NCT01036022|157126514|FG005|Overall Study|Physician Decision|0|||
48804435|NCT01036022|157126509|FG000|Overall Study|Withdrawal by Subject|0|||
48490430|NCT01084005|155990721|FG001|Overall Study|Protocol Violation|7|||
48804436|NCT01036022|157126510|FG001|Overall Study|Withdrawal by Subject|0|||
48804437|NCT01036022|157126511|FG002|Overall Study|Withdrawal by Subject|0|||
48804438|NCT01036022|157126512|FG003|Overall Study|Withdrawal by Subject|1|||
48804439|NCT01036022|157126513|FG004|Overall Study|Withdrawal by Subject|2|||
48804440|NCT01036022|157126514|FG005|Overall Study|Withdrawal by Subject|0|||
48804441|NCT01483937|157126517|FG000|Overall Study|Withdrawal by Subject|4|||
48804442|NCT01483937|157126518|FG001|Overall Study|Withdrawal by Subject|3|||
48804443|NCT01919970|157126519|FG000|Overall Study|Withdrawal by Subject|3|||
48804444|NCT01919970|157126520|FG001|Overall Study|Withdrawal by Subject|0|||
48804445|NCT03334630|157126521|FG000|Overall Study|Withdrawal by Subject|7|||
48804446|NCT03334630|157126522|FG001|Overall Study|Withdrawal by Subject|7|||
48804447|NCT03334630|157126521|FG000|Overall Study|Lost to Follow-up|3|||
48804448|NCT03334630|157126522|FG001|Overall Study|Lost to Follow-up|1|||
48804449|NCT03334630|157126521|FG000|Overall Study|Adverse Event|0|||
48804450|NCT03334630|157126522|FG001|Overall Study|Adverse Event|1|||
48804451|NCT03334630|157126521|FG000|Overall Study|Physician Decision|1|||
48804452|NCT03334630|157126522|FG001|Overall Study|Physician Decision|1|||
48804453|NCT03334630|157126521|FG000|Overall Study|Enrollment closed|2|||
48804454|NCT03334630|157126522|FG001|Overall Study|Enrollment closed|1|||
48804455|NCT03334630|157126521|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
48804456|NCT03334630|157126522|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
48804457|NCT03334630|157126521|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
48804458|NCT03334630|157126522|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
48804459|NCT03389802|157126523|FG000|Overall Study|Lack of Efficacy|3|||
48804460|NCT03389802|157126524|FG001|Overall Study|Lack of Efficacy|3|||
48804461|NCT03389802|157126525|FG002|Overall Study|Lack of Efficacy|13|||
48804462|NCT03389802|157126526|FG003|Overall Study|Lack of Efficacy|6|||
48804463|NCT03389802|157126527|FG004|Overall Study|Lack of Efficacy|1|||
48804464|NCT03389802|157126523|FG000|Overall Study|Adverse Event|0|||
48804465|NCT03389802|157126524|FG001|Overall Study|Adverse Event|0|||
48804466|NCT03389802|157126525|FG002|Overall Study|Adverse Event|1|||
48804467|NCT03389802|157126526|FG003|Overall Study|Adverse Event|0|||
48804468|NCT03389802|157126527|FG004|Overall Study|Adverse Event|4|||
48804469|NCT03389802|157126523|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
48804470|NCT03389802|157126524|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
48804471|NCT03389802|157126525|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
48804472|NCT03389802|157126526|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
48804473|NCT03389802|157126527|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
48804474|NCT05218096|157126534|FG000|Primary Evaluation|Withdrawal by Subject|0|||
48804475|NCT05218096|157126535|FG001|Primary Evaluation|Withdrawal by Subject|0|||
48804476|NCT05218096|157126536|FG002|Primary Evaluation|Withdrawal by Subject|2|||
48804477|NCT05218096|157126537|FG003|Primary Evaluation|Withdrawal by Subject|0|||
48804478|NCT05218096|157126538|FG004|Primary Evaluation|Withdrawal by Subject|0|||
48804479|NCT05218096|157126534|FG000|Primary Evaluation|Physician Decision|1|||
48804480|NCT05218096|157126535|FG001|Primary Evaluation|Physician Decision|0|||
48804481|NCT05218096|157126536|FG002|Primary Evaluation|Physician Decision|0|||
48804482|NCT05218096|157126537|FG003|Primary Evaluation|Physician Decision|0|||
48804483|NCT05218096|157126538|FG004|Primary Evaluation|Physician Decision|0|||
48804484|NCT05218096|157126534|FG000|Extended Treatment|Clinical Deterioration|1|||
48804485|NCT05218096|157126535|FG001|Extended Treatment|Clinical Deterioration|1|||
48804486|NCT05218096|157126536|FG002|Extended Treatment|Clinical Deterioration|0|||
48804487|NCT05218096|157126537|FG003|Extended Treatment|Clinical Deterioration|0|||
48804488|NCT05218096|157126538|FG004|Extended Treatment|Clinical Deterioration|0|||
48804489|NCT05218096|157126534|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
48804490|NCT05218096|157126535|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
48804491|NCT05218096|157126536|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
48804492|NCT05218096|157126537|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
48804493|NCT05218096|157126538|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
48804494|NCT05218096|157126534|FG000|Extended Treatment|Withdrawal by Subject|1|||
48804495|NCT05218096|157126535|FG001|Extended Treatment|Withdrawal by Subject|3|||
48804496|NCT05218096|157126536|FG002|Extended Treatment|Withdrawal by Subject|0|||
48804497|NCT05218096|157126537|FG003|Extended Treatment|Withdrawal by Subject|2|||
48804498|NCT05218096|157126538|FG004|Extended Treatment|Withdrawal by Subject|2|||
48804499|NCT05218096|157126534|FG000|Extended Treatment|Lack of Efficacy|3|||
48804500|NCT05218096|157126535|FG001|Extended Treatment|Lack of Efficacy|0|||
48804501|NCT05218096|157126536|FG002|Extended Treatment|Lack of Efficacy|0|||
48804502|NCT05218096|157126537|FG003|Extended Treatment|Lack of Efficacy|0|||
48804503|NCT05218096|157126538|FG004|Extended Treatment|Lack of Efficacy|0|||
48804504|NCT05218096|157126534|FG000|Extended Treatment|Physician Decision|0|||
48804505|NCT05218096|157126535|FG001|Extended Treatment|Physician Decision|1|||
48804506|NCT05218096|157126536|FG002|Extended Treatment|Physician Decision|0|||
48804507|NCT05218096|157126537|FG003|Extended Treatment|Physician Decision|0|||
48804508|NCT05218096|157126538|FG004|Extended Treatment|Physician Decision|0|||
48804509|NCT05218096|157126534|FG000|Open-label Extension|Adverse Event|1|||
48804510|NCT05218096|157126535|FG001|Open-label Extension|Adverse Event|0|||
48804511|NCT05218096|157126536|FG002|Open-label Extension|Adverse Event|0|||
48804512|NCT05218096|157126537|FG003|Open-label Extension|Adverse Event|0|||
48804513|NCT05218096|157126538|FG004|Open-label Extension|Adverse Event|1|||
48804514|NCT05218096|157126534|FG000|Open-label Extension|Pregnancy|0|||
48804515|NCT05218096|157126535|FG001|Open-label Extension|Pregnancy|0|||
48596110|NCT00572455|156377847|FG005|Stage I (14 Days)|Other|0|||
48596111|NCT00572455|156377848|FG006|Stage I (14 Days)|Other|0|||
48804516|NCT05218096|157126536|FG002|Open-label Extension|Pregnancy|0|||
48804517|NCT05218096|157126537|FG003|Open-label Extension|Pregnancy|0|||
48804518|NCT05218096|157126538|FG004|Open-label Extension|Pregnancy|1|||
48804519|NCT05218096|157126534|FG000|Open-label Extension|Lack of Efficacy|1|||
48596112|NCT00572455|156377849|FG007|Stage I (14 Days)|Other|0|||
48596113|NCT00572455|156377850|FG008|Stage I (14 Days)|Other|0|||
48596114|NCT00572455|156377851|FG009|Stage I (14 Days)|Other|0|||
48596115|NCT00572455|156377852|FG010|Stage I (14 Days)|Other|0|||
48596116|NCT00572455|156377853|FG011|Stage I (14 Days)|Other|0|||
48804520|NCT05218096|157126535|FG001|Open-label Extension|Lack of Efficacy|2|||
48804521|NCT05218096|157126536|FG002|Open-label Extension|Lack of Efficacy|0|||
48804522|NCT05218096|157126537|FG003|Open-label Extension|Lack of Efficacy|0|||
48596117|NCT00572455|156377854|FG012|Stage I (14 Days)|Other|0|||
48596118|NCT00572455|156377855|FG013|Stage I (14 Days)|Other|0|||
48596119|NCT00572455|156377842|FG000|Stage II (28 Days)|Adverse Event|0|||
48596120|NCT00572455|156377843|FG001|Stage II (28 Days)|Adverse Event|0|||
48596121|NCT00572455|156377844|FG002|Stage II (28 Days)|Adverse Event|0|||
48708650|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708651|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708652|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708653|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
48804523|NCT05218096|157126538|FG004|Open-label Extension|Lack of Efficacy|0|||
48804524|NCT05218096|157126534|FG000|Open-label Extension|Lost to Follow-up|1|||
48804525|NCT05218096|157126535|FG001|Open-label Extension|Lost to Follow-up|0|||
48804526|NCT05218096|157126536|FG002|Open-label Extension|Lost to Follow-up|0|||
48804527|NCT05218096|157126537|FG003|Open-label Extension|Lost to Follow-up|0|||
48804528|NCT05218096|157126538|FG004|Open-label Extension|Lost to Follow-up|0|||
48804529|NCT05218096|157126534|FG000|Open-label Extension|Death|0|||
48804530|NCT05218096|157126535|FG001|Open-label Extension|Death|0|||
48804531|NCT05218096|157126536|FG002|Open-label Extension|Death|0|||
48804532|NCT05218096|157126537|FG003|Open-label Extension|Death|1|||
48804533|NCT05218096|157126538|FG004|Open-label Extension|Death|0|||
48804534|NCT05218096|157126534|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
48804535|NCT05218096|157126535|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
48804536|NCT05218096|157126536|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
48804537|NCT05218096|157126537|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
48804538|NCT05218096|157126538|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
48804539|NCT03362476|157126539|FG000|Overall Study|Withdrawal by Subject|0|||
48804540|NCT03362476|157126540|FG001|Overall Study|Withdrawal by Subject|1|||
48804541|NCT03108157|157126541|FG000|Overall Study|Protocol Violation|15|||
48804542|NCT03108157|157126542|FG001|Overall Study|Protocol Violation|4|||
48804543|NCT03287414|157126543|FG000|Treatment Epoch|Adverse Event|0|||
48804544|NCT03287414|157126544|FG001|Treatment Epoch|Adverse Event|1|||
48804545|NCT03287414|157126543|FG000|Treatment Epoch|Study terminated by sponsor|2|||
48804546|NCT03287414|157126544|FG001|Treatment Epoch|Study terminated by sponsor|2|||
48490431|NCT01084005|155990720|FG000|Overall Study|Withdrawal by Subject|1|||
48490432|NCT01084005|155990721|FG001|Overall Study|Withdrawal by Subject|1|||
48490433|NCT03740698|155990722|FG000|Overall Study|Physician Decision|0|||
48490434|NCT03740698|155990723|FG001|Overall Study|Physician Decision|1|||
48490435|NCT03740698|155990724|FG002|Overall Study|Physician Decision|1|||
48490436|NCT00549198|155990725|FG000|Overall Study|Adverse Event|28|||
48490437|NCT00549198|155990726|FG001|Overall Study|Adverse Event|26|||
48490438|NCT00549198|155990725|FG000|Overall Study|Insufficient Viral Load Response|4|||
48490439|NCT00549198|155990726|FG001|Overall Study|Insufficient Viral Load Response|2|||
48596122|NCT00572455|156377845|FG003|Stage II (28 Days)|Adverse Event|0|||
48596123|NCT00572455|156377846|FG004|Stage II (28 Days)|Adverse Event|0|||
48596124|NCT00572455|156377847|FG005|Stage II (28 Days)|Adverse Event|0|||
48708654|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
48708655|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708656|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
48708657|NCT00557856|156781020|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
48804547|NCT03287414|157126543|FG000|Treatment Epoch|Subject/Guardian decision|4|||
48804548|NCT03287414|157126544|FG001|Treatment Epoch|Subject/Guardian decision|0|||
48804549|NCT03287414|157126543|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
48804550|NCT03287414|157126544|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
48804551|NCT03287414|157126543|FG000|Treatment Epoch|Withdrawal by Subject|1|||
48804552|NCT03287414|157126544|FG001|Treatment Epoch|Withdrawal by Subject|0|||
48490440|NCT00549198|155990725|FG000|Overall Study|Protocol-defined Virological Failure|7|||
48490441|NCT00549198|155990726|FG001|Overall Study|Protocol-defined Virological Failure|0|||
48490442|NCT00549198|155990725|FG000|Overall Study|Non-compliance|2|||
48490443|NCT00549198|155990726|FG001|Overall Study|Non-compliance|4|||
48596125|NCT00572455|156377848|FG006|Stage II (28 Days)|Adverse Event|0|||
48596126|NCT00572455|156377849|FG007|Stage II (28 Days)|Adverse Event|0|||
48596127|NCT00572455|156377850|FG008|Stage II (28 Days)|Adverse Event|1|||
48596128|NCT00572455|156377851|FG009|Stage II (28 Days)|Adverse Event|3|||
48596129|NCT00572455|156377852|FG010|Stage II (28 Days)|Adverse Event|3|||
48596130|NCT00572455|156377853|FG011|Stage II (28 Days)|Adverse Event|4|||
48596131|NCT00572455|156377854|FG012|Stage II (28 Days)|Adverse Event|5|||
48596132|NCT00572455|156377855|FG013|Stage II (28 Days)|Adverse Event|1|||
48596133|NCT00572455|156377842|FG000|Stage II (28 Days)|Death|0|||
48596134|NCT00572455|156377843|FG001|Stage II (28 Days)|Death|0|||
48708658|NCT00557856|156781021|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708659|NCT00557856|156781022|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708660|NCT00557856|156781023|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708661|NCT00557856|156781024|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708662|NCT00557856|156781025|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708663|NCT00557856|156781026|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708664|NCT00557856|156781027|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708665|NCT00557856|156781028|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
48708666|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708667|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
48804553|NCT03287414|157126543|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
48804554|NCT03287414|157126544|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
48804555|NCT03287414|157126543|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
48708668|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
48804556|NCT03287414|157126544|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
48804557|NCT01301274|157126547|FG000|Overall Study|Physician Decision|2|||
48804558|NCT01301274|157126548|FG001|Overall Study|Physician Decision|1|||
48804559|NCT01314105|157126550|FG000|Overall Study|Progressive Disease|6|||
48804560|NCT01314105|157126551|FG001|Overall Study|Progressive Disease|10|||
48804561|NCT01314105|157126550|FG000|Overall Study|Refused to continue taking medication|0|||
48804562|NCT01314105|157126551|FG001|Overall Study|Refused to continue taking medication|1|||
48804563|NCT01314105|157126550|FG000|Overall Study|Other Adverse Event|1|||
48804564|NCT01314105|157126551|FG001|Overall Study|Other Adverse Event|1|||
48804565|NCT00112580|157126554|FG000|Overall Study|Adverse Event|1|||
48804566|NCT00112580|157126555|FG001|Overall Study|Adverse Event|2|||
48804567|NCT00112580|157126554|FG000|Overall Study|Disease progression|5|||
48804568|NCT00112580|157126555|FG001|Overall Study|Disease progression|16|||
48804569|NCT00112580|157126554|FG000|Overall Study|Participant withdrew consent|2|||
48490444|NCT00549198|155990725|FG000|Overall Study|Lost to Follow-up|7|||
48490445|NCT00549198|155990726|FG001|Overall Study|Lost to Follow-up|8|||
48804570|NCT00112580|157126555|FG001|Overall Study|Participant withdrew consent|1|||
48490446|NCT00549198|155990725|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
48490447|NCT00549198|155990726|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48490448|NCT00549198|155990725|FG000|Overall Study|Protocol Violation|7|||
48490449|NCT00549198|155990726|FG001|Overall Study|Protocol Violation|2|||
48490450|NCT00549198|155990725|FG000|Overall Study|Investigator Decision|4|||
48490451|NCT00549198|155990726|FG001|Overall Study|Investigator Decision|3|||
48490452|NCT00549198|155990725|FG000|Overall Study|Withdrawal by Subject|7|||
48490453|NCT00549198|155990726|FG001|Overall Study|Withdrawal by Subject|7|||
48490454|NCT00549198|155990725|FG000|Overall Study|Disease Progression|1|||
48490455|NCT00549198|155990726|FG001|Overall Study|Disease Progression|0|||
48490456|NCT00549198|155990725|FG000|Overall Study|Participant Moved|2|||
48490457|NCT00549198|155990726|FG001|Overall Study|Participant Moved|0|||
48490458|NCT00549198|155990725|FG000|Overall Study|Participant not able to perform Week 96|1|||
48596135|NCT00572455|156377844|FG002|Stage II (28 Days)|Death|0|||
48596136|NCT00572455|156377845|FG003|Stage II (28 Days)|Death|0|||
48596137|NCT00572455|156377846|FG004|Stage II (28 Days)|Death|0|||
48596138|NCT00572455|156377847|FG005|Stage II (28 Days)|Death|0|||
48596139|NCT00572455|156377848|FG006|Stage II (28 Days)|Death|0|||
48490459|NCT00549198|155990726|FG001|Overall Study|Participant not able to perform Week 96|0|||
48596140|NCT00572455|156377849|FG007|Stage II (28 Days)|Death|0|||
48596141|NCT00572455|156377850|FG008|Stage II (28 Days)|Death|1|||
48596142|NCT00572455|156377851|FG009|Stage II (28 Days)|Death|0|||
48596143|NCT00572455|156377852|FG010|Stage II (28 Days)|Death|0|||
48596144|NCT00572455|156377853|FG011|Stage II (28 Days)|Death|0|||
48596145|NCT00572455|156377854|FG012|Stage II (28 Days)|Death|0|||
48596146|NCT00572455|156377855|FG013|Stage II (28 Days)|Death|0|||
48596147|NCT00572455|156377842|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
48596148|NCT00572455|156377843|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
48596149|NCT00572455|156377844|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
48596150|NCT00572455|156377845|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
48596151|NCT00572455|156377846|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
48596152|NCT00572455|156377847|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
48596153|NCT00572455|156377848|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
48596154|NCT00572455|156377849|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
48596155|NCT00572455|156377850|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
48596156|NCT00572455|156377851|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
48596157|NCT00572455|156377852|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
48596158|NCT00572455|156377853|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
48596159|NCT00572455|156377854|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
48596160|NCT00572455|156377855|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
48596161|NCT00572455|156377842|FG000|Stage II (28 Days)|Other|0|||
48596162|NCT00572455|156377843|FG001|Stage II (28 Days)|Other|0|||
48596163|NCT00572455|156377844|FG002|Stage II (28 Days)|Other|0|||
48596164|NCT00572455|156377845|FG003|Stage II (28 Days)|Other|0|||
48596165|NCT00572455|156377846|FG004|Stage II (28 Days)|Other|0|||
48596166|NCT00572455|156377847|FG005|Stage II (28 Days)|Other|0|||
48596167|NCT00572455|156377848|FG006|Stage II (28 Days)|Other|0|||
48596168|NCT00572455|156377849|FG007|Stage II (28 Days)|Other|0|||
48596169|NCT00572455|156377850|FG008|Stage II (28 Days)|Other|1|||
48596170|NCT00572455|156377851|FG009|Stage II (28 Days)|Other|0|||
48596171|NCT00572455|156377852|FG010|Stage II (28 Days)|Other|0|||
48596172|NCT00572455|156377853|FG011|Stage II (28 Days)|Other|0|||
48708669|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708670|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708671|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708672|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708673|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
48708674|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
48708675|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708676|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708677|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708678|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708679|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708680|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708681|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708682|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
48708683|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
48708684|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
48708685|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
48708686|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
48708687|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
48708688|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
48708689|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
48708690|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
48596173|NCT00572455|156377854|FG012|Stage II (28 Days)|Other|0|||
48596174|NCT00572455|156377855|FG013|Stage II (28 Days)|Other|0|||
48596175|NCT00572455|156377842|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
48596176|NCT00572455|156377843|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
48596177|NCT00572455|156377844|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
48596178|NCT00572455|156377845|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
48596179|NCT00572455|156377846|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
48596180|NCT00572455|156377847|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
48596181|NCT00572455|156377848|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
48596182|NCT00572455|156377849|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
48596183|NCT00572455|156377850|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
48596184|NCT00572455|156377851|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
48804571|NCT03118518|157126558|FG000|Overall Study|Early Exit after treatment|2|||
48804572|NCT03118518|157126559|FG001|Overall Study|Early Exit after treatment|8|||
48804573|NCT03118518|157126558|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
48804574|NCT03118518|157126559|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
48804575|NCT03812614|157126560|FG000|Intervention|Withdrawal by Subject|7|||
48804576|NCT03812614|157126561|FG001|Intervention|Withdrawal by Subject|2|||
48804577|NCT03812614|157126562|FG002|Intervention|Withdrawal by Subject|7|||
48804578|NCT03812614|157126563|FG003|Intervention|Withdrawal by Subject|2|||
48804579|NCT03812614|157126560|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
48804580|NCT03812614|157126561|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
48804581|NCT03812614|157126562|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
48490460|NCT00549198|155990725|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
48490461|NCT00549198|155990726|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
48490462|NCT00549198|155990725|FG000|Overall Study|Prohibited Medication|1|||
48490463|NCT00549198|155990726|FG001|Overall Study|Prohibited Medication|2|||
48490464|NCT00549198|155990725|FG000|Overall Study|Participant planning pregnancy|1|||
48490465|NCT00549198|155990726|FG001|Overall Study|Participant planning pregnancy|0|||
48490466|NCT00549198|155990725|FG000|Overall Study|Participant overweight, no scan possible|1|||
48490467|NCT00549198|155990726|FG001|Overall Study|Participant overweight, no scan possible|0|||
48490468|NCT00549198|155990725|FG000|Overall Study|No scan facilities|0|||
48490469|NCT00549198|155990726|FG001|Overall Study|No scan facilities|2|||
48490470|NCT00549198|155990725|FG000|Overall Study|Pregnancy|0|||
48490471|NCT00549198|155990726|FG001|Overall Study|Pregnancy|3|||
48490472|NCT00549198|155990725|FG000|Overall Study|Not Exposed to Study Drug|3|||
48490473|NCT00549198|155990726|FG001|Overall Study|Not Exposed to Study Drug|4|||
48490474|NCT04356573|155990728|FG000|Overall Study|Didn't Qualify|1|||
48490475|NCT04356573|155990729|FG001|Overall Study|Didn't Qualify|0|||
48490476|NCT02480010|155990736|FG000|Overall Study|Adverse Event|3|||
48804582|NCT03812614|157126563|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
48804583|NCT03812614|157126560|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
48804584|NCT03812614|157126561|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
48804585|NCT03812614|157126562|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
48804586|NCT03812614|157126563|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
48804587|NCT03812614|157126560|FG000|6-month Follow-up|Lost to Follow-up|0|||
48804588|NCT03812614|157126561|FG001|6-month Follow-up|Lost to Follow-up|0|||
48804589|NCT03812614|157126562|FG002|6-month Follow-up|Lost to Follow-up|12|||
48804590|NCT03812614|157126563|FG003|6-month Follow-up|Lost to Follow-up|8|||
48804591|NCT03812614|157126560|FG000|12-month Follow-up|Lost to Follow-up|18|||
48804592|NCT03812614|157126561|FG001|12-month Follow-up|Lost to Follow-up|17|||
48804593|NCT03812614|157126562|FG002|12-month Follow-up|Lost to Follow-up|5|||
48804594|NCT03812614|157126563|FG003|12-month Follow-up|Lost to Follow-up|2|||
48804595|NCT03459846|157126564|FG000|Overall Study|Death|52|||
48804596|NCT03459846|157126565|FG001|Overall Study|Death|46|||
48804597|NCT03459846|157126564|FG000|Overall Study|Study terminated by sponsor|24|||
48804598|NCT03459846|157126565|FG001|Overall Study|Study terminated by sponsor|28|||
48804599|NCT03459846|157126564|FG000|Overall Study|Withdrawal by Subject|2|||
48804600|NCT03459846|157126565|FG001|Overall Study|Withdrawal by Subject|2|||
48804601|NCT02228967|157127861|FG000|Overall Study|Lost to Follow-up|146|||
48804602|NCT02228967|157127862|FG001|Overall Study|Lost to Follow-up|142|||
48804603|NCT02228967|157127861|FG000|Overall Study|Withdrawal by Subject|13|||
48804604|NCT02228967|157127862|FG001|Overall Study|Withdrawal by Subject|18|||
48804605|NCT03625882|157127863|FG000|Overall Study|Protocol Violation|3|||
48804606|NCT01264380|157127866|FG000|Period C|Disease Progression|0|||
48804607|NCT01264380|157127867|FG001|Period C|Disease Progression|0|||
48804608|NCT01264380|157127868|FG002|Period C|Disease Progression|4|||
48804609|NCT01264380|157127866|FG000|Period C|Death|0|||
48804610|NCT01264380|157127867|FG001|Period C|Death|0|||
48804611|NCT01264380|157127868|FG002|Period C|Death|2|||
48804612|NCT01264380|157127866|FG000|Period C|Follow-up for survival status|0|||
48804613|NCT01264380|157127867|FG001|Period C|Follow-up for survival status|0|||
48804614|NCT01264380|157127868|FG002|Period C|Follow-up for survival status|6|||
48804615|NCT01264380|157127866|FG000|Period C|Withdrawal by Subject|0|||
48490477|NCT02480010|155990737|FG001|Overall Study|Adverse Event|1|||
48490478|NCT02480010|155990736|FG000|Overall Study|Death|1|||
48490479|NCT02480010|155990737|FG001|Overall Study|Death|0|||
48490480|NCT02480010|155990736|FG000|Overall Study|Insufficient therapeutic response|31|||
48490481|NCT02480010|155990737|FG001|Overall Study|Insufficient therapeutic response|29|||
48490482|NCT02480010|155990736|FG000|Overall Study|Refused Treatment|0|||
48490483|NCT02480010|155990737|FG001|Overall Study|Refused Treatment|3|||
48804616|NCT01264380|157127867|FG001|Period C|Withdrawal by Subject|0|||
48804617|NCT01264380|157127868|FG002|Period C|Withdrawal by Subject|1|||
48490484|NCT01677910|155990738|FG000|Double-Blind Treatment Period|Adverse Event|6|||
48490485|NCT01677910|155990739|FG001|Double-Blind Treatment Period|Adverse Event|2|||
48490486|NCT01677910|155990740|FG002|Double-Blind Treatment Period|Adverse Event|3|||
48490487|NCT01677910|155990741|FG003|Double-Blind Treatment Period|Adverse Event|0|||
48490488|NCT01677910|155990738|FG000|Double-Blind Treatment Period|Physician Decision|0|||
48490489|NCT01677910|155990739|FG001|Double-Blind Treatment Period|Physician Decision|0|||
48490490|NCT01677910|155990740|FG002|Double-Blind Treatment Period|Physician Decision|1|||
48490491|NCT01677910|155990741|FG003|Double-Blind Treatment Period|Physician Decision|0|||
48490492|NCT01677910|155990738|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
48490493|NCT01677910|155990739|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
48490494|NCT01677910|155990740|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
48490495|NCT01677910|155990741|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
48490496|NCT01677910|155990738|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
48490497|NCT01677910|155990739|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
48490498|NCT01677910|155990740|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
48490499|NCT01677910|155990741|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
48490500|NCT01677910|155990738|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
48490501|NCT01677910|155990739|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
48490502|NCT01677910|155990740|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
48490503|NCT01677910|155990741|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
48490504|NCT01677910|155990738|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48490505|NCT01677910|155990739|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48490506|NCT01677910|155990740|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48490507|NCT01677910|155990741|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
48490508|NCT01677910|155990738|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48490509|NCT01677910|155990739|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48490510|NCT01677910|155990740|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48490511|NCT01677910|155990741|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
48490512|NCT01677910|155990738|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48490513|NCT01677910|155990739|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48490514|NCT01677910|155990740|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48490515|NCT01677910|155990741|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
48490516|NCT01677910|155990738|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
48490517|NCT01677910|155990739|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
48490518|NCT01677910|155990740|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
48490519|NCT01677910|155990741|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
48490520|NCT01677910|155990738|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
48490521|NCT01677910|155990739|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
48708691|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
48490522|NCT01677910|155990740|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
48490523|NCT01677910|155990741|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
48490524|NCT03705351|155990743|FG000|Overall Study|Study termination|3|||
48490525|NCT03705351|155990743|FG000|Overall Study|Death|1|||
48490526|NCT03705351|155990743|FG000|Overall Study|Lack of Efficacy|2|||
48490527|NCT03705351|155990743|FG000|Overall Study|Withdrawal by Subject|1|||
48490528|NCT03141177|155990744|FG000|Overall Study|Death|62|||
48490529|NCT03141177|155990745|FG001|Overall Study|Death|13|||
48490530|NCT03141177|155990746|FG002|Overall Study|Death|84|||
48596185|NCT00572455|156377852|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
48596186|NCT00572455|156377853|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
48596187|NCT00572455|156377854|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
48596188|NCT00572455|156377855|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
48596189|NCT02384538|156377856|FG000|Overall Study|Adverse Event|1|||
48596190|NCT02384538|156377857|FG001|Overall Study|Adverse Event|4|||
48596191|NCT02384538|156377856|FG000|Overall Study|Lack of Efficacy|4|||
48596192|NCT02384538|156377857|FG001|Overall Study|Lack of Efficacy|4|||
48596193|NCT02384538|156377856|FG000|Overall Study|Withdrew Consent|0|||
48596194|NCT02384538|156377857|FG001|Overall Study|Withdrew Consent|4|||
48596195|NCT02384538|156377856|FG000|Overall Study|Other|1|||
48708692|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
48708693|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|Other|0|||
48708694|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|Other|0|||
48708695|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|Other|0|||
48596196|NCT02384538|156377857|FG001|Overall Study|Other|3|||
48596197|NCT02256917|156377860|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
48596198|NCT02256917|156377860|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
48596199|NCT02256917|156377860|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
48596200|NCT02256917|156377860|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
48596201|NCT02256917|156377860|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
48596202|NCT04152083|156377861|FG000|Overall Study|Lost to Follow-up|2|||
48596203|NCT04152083|156377862|FG001|Overall Study|Lost to Follow-up|1|||
48596204|NCT04152083|156377861|FG000|Overall Study|Adverse Event|1|||
48596205|NCT04152083|156377862|FG001|Overall Study|Adverse Event|0|||
48596206|NCT04152083|156377861|FG000|Overall Study|Randomized but not treated|3|||
48596207|NCT04152083|156377862|FG001|Overall Study|Randomized but not treated|2|||
48596208|NCT02095197|156377869|FG000|Overall Study|Lost to Follow-up|0|||
48596209|NCT02095197|156377870|FG001|Overall Study|Lost to Follow-up|3|||
48596210|NCT03076996|156377871|FG000|Overall Study|Withdrawal by Subject|2|||
48596211|NCT03076996|156377871|FG000|Overall Study|Lost to Follow-up|3|||
48596212|NCT03076996|156377871|FG000|Overall Study|Literacy precluded participation|1|||
48596213|NCT01831427|156377876|FG000|Overall Study|Adverse Event|0|||
48596214|NCT01831427|156377877|FG001|Overall Study|Adverse Event|1|||
48596215|NCT01831427|156377878|FG002|Overall Study|Adverse Event|0|||
48596216|NCT01831427|156377879|FG003|Overall Study|Adverse Event|0|||
48596217|NCT01831427|156377880|FG004|Overall Study|Adverse Event|0|||
48596218|NCT01831427|156377881|FG005|Overall Study|Adverse Event|1|||
48596219|NCT01831427|156377882|FG006|Overall Study|Adverse Event|0|||
48804618|NCT01264380|157127866|FG000|Period C|Adverse Event|0|||
48804619|NCT01264380|157127867|FG001|Period C|Adverse Event|0|||
48804620|NCT01264380|157127868|FG002|Period C|Adverse Event|1|||
48596220|NCT01831427|156377883|FG007|Overall Study|Adverse Event|1|||
48596221|NCT01831427|156377884|FG008|Overall Study|Adverse Event|0|||
48596222|NCT01831427|156377885|FG009|Overall Study|Adverse Event|0|||
48596223|NCT01831427|156377886|FG010|Overall Study|Adverse Event|2|||
48596224|NCT01831427|156377876|FG000|Overall Study|Investigator's Discretion|0|||
48596225|NCT01831427|156377877|FG001|Overall Study|Investigator's Discretion|0|||
48596226|NCT01831427|156377878|FG002|Overall Study|Investigator's Discretion|0|||
48596227|NCT01831427|156377879|FG003|Overall Study|Investigator's Discretion|1|||
48596228|NCT01831427|156377880|FG004|Overall Study|Investigator's Discretion|0|||
48596229|NCT01831427|156377881|FG005|Overall Study|Investigator's Discretion|0|||
48596230|NCT01831427|156377882|FG006|Overall Study|Investigator's Discretion|0|||
48596231|NCT01831427|156377883|FG007|Overall Study|Investigator's Discretion|0|||
48708696|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|Other|0|||
48708697|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|Other|0|||
48708698|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|Other|0|||
48708699|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|Other|0|||
48708700|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|Other|0|||
48708701|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|Other|1|||
48708702|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|Death|0|||
48708703|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|Death|0|||
48708704|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|Death|0|||
48708705|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|Death|0|||
48708706|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|Death|0|||
48434139|NCT01781429|155779136|FG015|Overall Study|Disease Progression|0|||
48708707|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|Death|0|||
48708708|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|Death|0|||
48708709|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|Death|0|||
48596232|NCT01831427|156377884|FG008|Overall Study|Investigator's Discretion|0|||
48596233|NCT01831427|156377885|FG009|Overall Study|Investigator's Discretion|0|||
48596234|NCT01831427|156377886|FG010|Overall Study|Investigator's Discretion|0|||
48596235|NCT01831427|156377876|FG000|Overall Study|Withdrew Consent|0|||
48596236|NCT01831427|156377877|FG001|Overall Study|Withdrew Consent|0|||
48708710|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|Death|2|||
48708711|NCT00557856|156781020|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
48804621|NCT02563002|157127869|FG000|Overall Study|Death|72|||
48708712|NCT00557856|156781021|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708713|NCT00557856|156781022|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708714|NCT00557856|156781023|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708715|NCT00557856|156781024|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708716|NCT00557856|156781025|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708717|NCT00557856|156781026|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708718|NCT00557856|156781027|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
48708719|NCT00557856|156781028|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
48708720|NCT00802945|156781029|FG000|Overall Study|Death|27|||
48708721|NCT00802945|156781030|FG001|Overall Study|Death|23|||
48708722|NCT00802945|156781029|FG000|Overall Study|Terminated by sponsor|8|||
48708723|NCT00802945|156781030|FG001|Overall Study|Terminated by sponsor|12|||
48708724|NCT01442103|156782182|FG000|Overall Study|Lost to Follow-up|2|||
48708725|NCT01671319|156782184|FG000|Overall Study|Withdrawal by Subject|1|||
48708726|NCT01677377|156782189|FG000|Overall Study|Protocol Violation|1|||
48708727|NCT01677377|156782190|FG001|Overall Study|Protocol Violation|0|||
48708728|NCT01677377|156782191|FG002|Overall Study|Protocol Violation|0|||
48490531|NCT03141177|155990744|FG000|Overall Study|Participant withdrew consent|9|||
48490532|NCT03141177|155990745|FG001|Overall Study|Participant withdrew consent|2|||
48490533|NCT03141177|155990746|FG002|Overall Study|Participant withdrew consent|13|||
48490534|NCT03141177|155990744|FG000|Overall Study|Not reported|1|||
48490535|NCT03141177|155990745|FG001|Overall Study|Not reported|0|||
48490536|NCT03141177|155990746|FG002|Overall Study|Not reported|1|||
48490537|NCT03141177|155990744|FG000|Overall Study|Lost to Follow-up|2|||
48596237|NCT01831427|156377878|FG002|Overall Study|Withdrew Consent|0|||
48596238|NCT01831427|156377879|FG003|Overall Study|Withdrew Consent|0|||
48596239|NCT01831427|156377880|FG004|Overall Study|Withdrew Consent|0|||
48596240|NCT01831427|156377881|FG005|Overall Study|Withdrew Consent|0|||
48596241|NCT01831427|156377882|FG006|Overall Study|Withdrew Consent|2|||
48596242|NCT01831427|156377883|FG007|Overall Study|Withdrew Consent|0|||
48596243|NCT01831427|156377884|FG008|Overall Study|Withdrew Consent|0|||
48596244|NCT01831427|156377885|FG009|Overall Study|Withdrew Consent|1|||
48596245|NCT01831427|156377886|FG010|Overall Study|Withdrew Consent|1|||
48596246|NCT03442088|156377887|FG000|Overall Study|Adverse Event|1|||
48596247|NCT03442088|156377887|FG000|Overall Study|Lack of Efficacy|2|||
48596248|NCT03442088|156377887|FG000|Overall Study|Lost to Follow-up|2|||
48596249|NCT01001520|156377888|FG000|Medication Period 1|Withdrawal by Subject|2|||
48596250|NCT01001520|156377889|FG001|Medication Period 1|Withdrawal by Subject|2|||
48596251|NCT01001520|156377888|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
48596252|NCT01001520|156377889|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
48596253|NCT01001520|156377888|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
48596254|NCT01001520|156377889|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
48596255|NCT01001520|156377888|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
48596256|NCT01001520|156377889|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
48596257|NCT01001520|156377888|FG000|Washout Period|Withdrawal by Subject|2|||
48596258|NCT01001520|156377889|FG001|Washout Period|Withdrawal by Subject|1|||
48596259|NCT01001520|156377888|FG000|Medication Period 2|Withdrawal by Subject|0|||
48596260|NCT01001520|156377889|FG001|Medication Period 2|Withdrawal by Subject|3|||
48596261|NCT00536510|156377890|FG000|Overall Study|Adverse Event|27|||
48596262|NCT00536510|156377891|FG001|Overall Study|Adverse Event|4|||
48596263|NCT00536510|156377890|FG000|Overall Study|Lost to Follow-up|11|||
48596264|NCT00536510|156377891|FG001|Overall Study|Lost to Follow-up|8|||
48596265|NCT00536510|156377890|FG000|Overall Study|Protocol Violation|4|||
48596266|NCT00536510|156377891|FG001|Overall Study|Protocol Violation|5|||
48596267|NCT00536510|156377890|FG000|Overall Study|Withdrawal by Subject|16|||
48596268|NCT00536510|156377891|FG001|Overall Study|Withdrawal by Subject|9|||
48596269|NCT00536510|156377890|FG000|Overall Study|Flushing with Product|20|||
48596270|NCT00536510|156377891|FG001|Overall Study|Flushing with Product|0|||
48596271|NCT00536510|156377890|FG000|Overall Study|Laboratory Adverse Event|2|||
48596272|NCT00536510|156377891|FG001|Overall Study|Laboratory Adverse Event|1|||
48708729|NCT01677377|156782189|FG000|Overall Study|Lost to Follow-up|0|||
48708730|NCT01677377|156782190|FG001|Overall Study|Lost to Follow-up|1|||
48708731|NCT01677377|156782191|FG002|Overall Study|Lost to Follow-up|1|||
48596273|NCT00536510|156377890|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
48596274|NCT00536510|156377891|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
48596275|NCT00943397|156377899|FG000|Overall Study|Adverse Event|0|||
48596276|NCT00943397|156377900|FG001|Overall Study|Adverse Event|6|||
48596277|NCT00943397|156377899|FG000|Overall Study|Lost to Follow-up|0|||
48708732|NCT01677377|156782189|FG000|Overall Study|Withdrawal by Subject|0|||
48708733|NCT01677377|156782190|FG001|Overall Study|Withdrawal by Subject|0|||
48708734|NCT01677377|156782191|FG002|Overall Study|Withdrawal by Subject|3|||
48490538|NCT03141177|155990745|FG001|Overall Study|Lost to Follow-up|1|||
48490539|NCT03141177|155990746|FG002|Overall Study|Lost to Follow-up|1|||
48490540|NCT03141177|155990744|FG000|Overall Study|Other reasons|4|||
48490541|NCT03141177|155990745|FG001|Overall Study|Other reasons|0|||
48596278|NCT00943397|156377900|FG001|Overall Study|Lost to Follow-up|4|||
48596279|NCT00943397|156377899|FG000|Overall Study|Protocol Violation|2|||
48596280|NCT00943397|156377900|FG001|Overall Study|Protocol Violation|5|||
48596281|NCT00943397|156377899|FG000|Overall Study|Withdrawal by Subject|1|||
48596282|NCT00943397|156377900|FG001|Overall Study|Withdrawal by Subject|1|||
48596283|NCT00943397|156377899|FG000|Overall Study|Site terminated and other|12|||
48596284|NCT00943397|156377900|FG001|Overall Study|Site terminated and other|56|||
48596285|NCT00460239|156377901|FG000|Overall Study|Physician Decision|0|||
48596286|NCT00460239|156377902|FG001|Overall Study|Physician Decision|1|||
48596287|NCT00460239|156377903|FG002|Overall Study|Physician Decision|0|||
48596288|NCT00460239|156377904|FG003|Overall Study|Physician Decision|0|||
48596289|NCT00460239|156377905|FG004|Overall Study|Physician Decision|0|||
48596290|NCT00460239|156377906|FG005|Overall Study|Physician Decision|2|||
48596291|NCT00460239|156377907|FG006|Overall Study|Physician Decision|0|||
48596292|NCT00460239|156377908|FG007|Overall Study|Physician Decision|0|||
48596293|NCT00460239|156377909|FG008|Overall Study|Physician Decision|0|||
48596294|NCT00460239|156377901|FG000|Overall Study|Withdrawal by Subject|0|||
48596295|NCT00460239|156377902|FG001|Overall Study|Withdrawal by Subject|0|||
48596296|NCT00460239|156377903|FG002|Overall Study|Withdrawal by Subject|0|||
48596297|NCT00460239|156377904|FG003|Overall Study|Withdrawal by Subject|0|||
48596298|NCT00460239|156377905|FG004|Overall Study|Withdrawal by Subject|0|||
48596299|NCT00460239|156377906|FG005|Overall Study|Withdrawal by Subject|1|||
48596300|NCT00460239|156377907|FG006|Overall Study|Withdrawal by Subject|0|||
48596301|NCT00460239|156377908|FG007|Overall Study|Withdrawal by Subject|0|||
48596302|NCT00460239|156377909|FG008|Overall Study|Withdrawal by Subject|0|||
48596303|NCT02028507|156377912|FG000|Overall Study|Progressive Disease|122|||
48596304|NCT02028507|156377913|FG001|Overall Study|Progressive Disease|90|||
48596305|NCT02028507|156377914|FG002|Overall Study|Progressive Disease|102|||
48596306|NCT02028507|156377915|FG003|Overall Study|Progressive Disease|89|||
48596307|NCT02028507|156377912|FG000|Overall Study|Adverse Event|8|||
48596308|NCT02028507|156377913|FG001|Overall Study|Adverse Event|25|||
48596309|NCT02028507|156377914|FG002|Overall Study|Adverse Event|3|||
48596310|NCT02028507|156377915|FG003|Overall Study|Adverse Event|16|||
48596311|NCT02028507|156377912|FG000|Overall Study|Withdrawal by Subject|6|||
48596312|NCT02028507|156377913|FG001|Overall Study|Withdrawal by Subject|8|||
48596313|NCT02028507|156377914|FG002|Overall Study|Withdrawal by Subject|5|||
48596314|NCT02028507|156377915|FG003|Overall Study|Withdrawal by Subject|9|||
48596315|NCT02028507|156377912|FG000|Overall Study|Protocol Violation|2|||
48596316|NCT02028507|156377913|FG001|Overall Study|Protocol Violation|4|||
48596317|NCT02028507|156377914|FG002|Overall Study|Protocol Violation|1|||
48596318|NCT02028507|156377915|FG003|Overall Study|Protocol Violation|3|||
48596319|NCT02028507|156377912|FG000|Overall Study|Physician Decision|0|||
48596320|NCT02028507|156377913|FG001|Overall Study|Physician Decision|4|||
48596321|NCT02028507|156377914|FG002|Overall Study|Physician Decision|0|||
48596322|NCT02028507|156377915|FG003|Overall Study|Physician Decision|0|||
48596323|NCT02028507|156377912|FG000|Overall Study|Death|1|||
48596324|NCT02028507|156377913|FG001|Overall Study|Death|0|||
48596325|NCT02028507|156377914|FG002|Overall Study|Death|1|||
48596326|NCT02028507|156377915|FG003|Overall Study|Death|3|||
48596327|NCT02028507|156377912|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
48708735|NCT01677377|156782189|FG000|Overall Study|Lack of Efficacy|0|||
48708736|NCT01677377|156782190|FG001|Overall Study|Lack of Efficacy|0|||
48708737|NCT01677377|156782191|FG002|Overall Study|Lack of Efficacy|1|||
48708738|NCT01677377|156782189|FG000|Overall Study|Pregnancy|0|||
48708739|NCT01677377|156782190|FG001|Overall Study|Pregnancy|0|||
48708740|NCT01677377|156782191|FG002|Overall Study|Pregnancy|1|||
48708741|NCT01712399|156782196|FG000|Overall Study|Lost to Follow-up|1|||
48708742|NCT01712399|156782196|FG000|Overall Study|Withdrawal by Subject|39|||
48708743|NCT01712399|156782196|FG000|Overall Study|Death|1|||
48708744|NCT01712399|156782196|FG000|Overall Study|Adverse Event|11|||
48708745|NCT01712399|156782196|FG000|Overall Study|Study closure|345|||
48708746|NCT01227018|156782197|FG000|Overall Study|Disease progression|9|||
48708747|NCT01227018|156782197|FG000|Overall Study|Toxicity|2|||
48708748|NCT01227018|156782197|FG000|Overall Study|Withdrew after beginning treatment|4|||
48708749|NCT02136069|156782209|FG000|Overall Study|UC flare-up|1|||
48708750|NCT02136069|156782210|FG001|Overall Study|UC flare-up|0|||
48708751|NCT02136069|156782209|FG000|Overall Study|Adverse Event|6|||
48708752|NCT02136069|156782210|FG001|Overall Study|Adverse Event|8|||
48708753|NCT02136069|156782209|FG000|Overall Study|Death|0|||
48708754|NCT02136069|156782210|FG001|Overall Study|Death|1|||
48708755|NCT02136069|156782209|FG000|Overall Study|Lack of Efficacy|10|||
48708756|NCT02136069|156782210|FG001|Overall Study|Lack of Efficacy|4|||
48708757|NCT02136069|156782209|FG000|Overall Study|Lost to Follow-up|1|||
48708758|NCT02136069|156782210|FG001|Overall Study|Lost to Follow-up|0|||
48708759|NCT02136069|156782209|FG000|Overall Study|Non-Compliance|1|||
48708760|NCT02136069|156782210|FG001|Overall Study|Non-Compliance|0|||
48708761|NCT02136069|156782209|FG000|Overall Study|Physician Decision|5|||
48708762|NCT02136069|156782210|FG001|Overall Study|Physician Decision|4|||
48708763|NCT02136069|156782209|FG000|Overall Study|Withdrawal by Subject|10|||
48708764|NCT02136069|156782210|FG001|Overall Study|Withdrawal by Subject|11|||
48708765|NCT04041414|156782211|FG000|Overall Study|Lost to Follow-up|1|||
48708766|NCT04041414|156782212|FG001|Overall Study|Lost to Follow-up|2|||
48708767|NCT00774566|156782213|FG000|Overall Study|Protocol Violation|18|||
48708768|NCT00774566|156782214|FG001|Overall Study|Protocol Violation|15|||
48708769|NCT00499083|156782215|FG000|Overall Study|Not evaluable|3|||
48596328|NCT02028507|156377913|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
48596329|NCT02028507|156377914|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
48596330|NCT02028507|156377915|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
48596331|NCT02028507|156377912|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
48596332|NCT02028507|156377913|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
48708770|NCT00594815|156782218|FG000|Overall Study|Never Treated|3|||
48708771|NCT00594815|156782218|FG000|Overall Study|Withdrawal by Subject|2|||
48708772|NCT00594815|156782218|FG000|Overall Study|Toxicity|4|||
48708773|NCT03214666|156782219|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708774|NCT03214666|156782220|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708775|NCT03214666|156782221|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708776|NCT03214666|156782222|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708777|NCT03214666|156782223|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
48708778|NCT03214666|156782224|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
48708779|NCT00526071|156782225|FG000|Overall Study|Adverse Event|1|||
48708780|NCT00526071|156782225|FG000|Overall Study|Withdrawal by Subject|1|||
48708781|NCT00526071|156782225|FG000|Overall Study|Lack of Response to Study Drug|4|||
48596333|NCT02028507|156377914|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
48596334|NCT02028507|156377915|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
48596335|NCT02028507|156377912|FG000|Overall Study|Randomized But Not Treated|3|||
48596336|NCT02028507|156377913|FG001|Overall Study|Randomized But Not Treated|6|||
48596337|NCT02028507|156377914|FG002|Overall Study|Randomized But Not Treated|0|||
48596338|NCT02028507|156377915|FG003|Overall Study|Randomized But Not Treated|4|||
48596339|NCT02028507|156377912|FG000|Overall Study|Enzyme defect|0|||
48708782|NCT05300763|156782228|FG000|Overall Study|Adverse Event|0|||
48708783|NCT05300763|156782229|FG001|Overall Study|Adverse Event|1|||
48708784|NCT05300763|156782228|FG000|Overall Study|Major Protocol Deviation|1|||
48708785|NCT05300763|156782229|FG001|Overall Study|Major Protocol Deviation|0|||
48708786|NCT05300763|156782228|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
48708787|NCT05300763|156782229|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
48708788|NCT00975780|156782232|FG000|Follow Up|Death|88|||
48708789|NCT00975780|156782233|FG001|Follow Up|Death|122|||
48708790|NCT00975780|156782232|FG000|Follow Up|Facility Withdrawal|7|||
48708791|NCT00975780|156782233|FG001|Follow Up|Facility Withdrawal|23|||
48708792|NCT00975780|156782232|FG000|Follow Up|Discharged from Facility|7|||
48708793|NCT00975780|156782233|FG001|Follow Up|Discharged from Facility|12|||
48708794|NCT02625909|156782234|FG000|Overall Study|Death|2|||
48708795|NCT02625909|156782235|FG001|Overall Study|Death|0|||
48804622|NCT02563002|157127870|FG001|Overall Study|Death|87|||
48708796|NCT02625909|156782234|FG000|Overall Study|Lost to Follow-up|3|||
48708797|NCT02625909|156782235|FG001|Overall Study|Lost to Follow-up|5|||
48708798|NCT02625909|156782234|FG000|Overall Study|Lack of Efficacy|9|||
48708799|NCT02625909|156782235|FG001|Overall Study|Lack of Efficacy|2|||
48708800|NCT02625909|156782234|FG000|Overall Study|Reinfection|3|||
48708801|NCT02625909|156782235|FG001|Overall Study|Reinfection|2|||
48708802|NCT00889720|156782240|FG000|Overall Study|Withdrawal by Subject|4|||
48708803|NCT00889720|156782240|FG000|Overall Study|Other|4|||
48708804|NCT01339052|156782241|FG000|Overall Study|Disease progression|13|||
48708805|NCT01339052|156782242|FG001|Overall Study|Disease progression|46|||
48708806|NCT01339052|156782241|FG000|Overall Study|Adverse Event|1|||
48708807|NCT01339052|156782242|FG001|Overall Study|Adverse Event|1|||
48596340|NCT02028507|156377913|FG001|Overall Study|Enzyme defect|0|||
48596341|NCT02028507|156377914|FG002|Overall Study|Enzyme defect|0|||
48596342|NCT02028507|156377915|FG003|Overall Study|Enzyme defect|1|||
48596343|NCT02028507|156377912|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
48596344|NCT02028507|156377913|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
48596345|NCT02028507|156377914|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
48596346|NCT02028507|156377915|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
48596347|NCT02028507|156377912|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
48596348|NCT02028507|156377913|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
48596349|NCT02028507|156377914|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
48596350|NCT02028507|156377915|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
48596351|NCT02091414|156377916|FG000|Overall Study|Withdrawal by Subject|2|||
48596352|NCT02091414|156377916|FG000|Overall Study|Death|2|||
48596353|NCT01383018|156377924|FG000|Overall Study|Adverse Event|14|||
48596354|NCT01383018|156377924|FG000|Overall Study|Death|10|||
48596355|NCT01383018|156377924|FG000|Overall Study|Lost to Follow-up|5|||
48596356|NCT01383018|156377924|FG000|Overall Study|Physician Decision|5|||
48596357|NCT01383018|156377924|FG000|Overall Study|Withdrawal by Subject|9|||
48596358|NCT01383018|156377924|FG000|Overall Study|Subject not implanted|76|||
48596359|NCT01383018|156377924|FG000|Overall Study|Missed Visit|247|||
48596360|NCT01383018|156377924|FG000|Overall Study|Site closed early-not compliance related|7|||
48596361|NCT01383018|156377924|FG000|Overall Study|Patient moved away from site|1|||
48596362|NCT01383018|156377924|FG000|Overall Study|Subject Incarcerated|1|||
48596363|NCT01051817|156377926|FG000|Overall Study|Adverse Event|0|||
48596364|NCT01051817|156377927|FG001|Overall Study|Adverse Event|2|||
48596365|NCT01051817|156377926|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
48596366|NCT01051817|156377927|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
48596367|NCT01051817|156377926|FG000|Overall Study|Withdrawal by Subject|3|||
48596368|NCT01051817|156377927|FG001|Overall Study|Withdrawal by Subject|5|||
48708808|NCT01339052|156782241|FG000|Overall Study|Withdrawal by Subject|0|||
48708809|NCT01339052|156782242|FG001|Overall Study|Withdrawal by Subject|3|||
48708810|NCT01339052|156782241|FG000|Overall Study|Physician Decision|1|||
48708811|NCT01339052|156782242|FG001|Overall Study|Physician Decision|0|||
48708812|NCT03566485|156782244|FG000|Overall Study|Disease progression|5|||
48708813|NCT03566485|156782245|FG001|Overall Study|Disease progression|4|||
48708814|NCT03566485|156782244|FG000|Overall Study|Clinical progression|0|||
48708815|NCT03566485|156782245|FG001|Overall Study|Clinical progression|1|||
48708816|NCT03566485|156782244|FG000|Overall Study|Toxicity|0|||
48708817|NCT03566485|156782245|FG001|Overall Study|Toxicity|2|||
48708818|NCT03241368|156782246|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
48708819|NCT03241368|156782246|FG000|Overall Study|Lost to Follow-up|1|||
48708820|NCT03241368|156782246|FG000|Overall Study|Physician Decision|6|||
48708821|NCT03241368|156782246|FG000|Overall Study|Withdrawal by Subject|6|||
48708822|NCT03241368|156782246|FG000|Overall Study|Protocol Violation|1|||
48708823|NCT00787267|156782248|FG000|Overall Study|Screen failure/Ineligible|10|||
48708824|NCT00787267|156782248|FG000|Overall Study|No Reason Provided|1|||
48708825|NCT00787267|156782248|FG000|Overall Study|Withdrawal by Subject|1|||
48708826|NCT00981058|156782249|FG000|Overall Study|Adverse Event|1|||
48434670|NCT04167306|155779286|FG003|Overall Study|non-compliance|0|||
48596369|NCT01051817|156377926|FG000|Overall Study|Protocol Violation|0|||
48596370|NCT01051817|156377927|FG001|Overall Study|Protocol Violation|1|||
48708827|NCT00981058|156782250|FG001|Overall Study|Adverse Event|1|||
48708828|NCT00981058|156782249|FG000|Overall Study|Progressive Disease|61|||
48708829|NCT00981058|156782250|FG001|Overall Study|Progressive Disease|49|||
48708830|NCT00981058|156782249|FG000|Overall Study|Lost to Follow-up|16|||
48708831|NCT00981058|156782250|FG001|Overall Study|Lost to Follow-up|15|||
48708832|NCT00981058|156782249|FG000|Overall Study|New Anticancer Therapy|6|||
48804623|NCT02563002|157127869|FG000|Overall Study|Lost to Follow-up|5|||
48804624|NCT02563002|157127870|FG001|Overall Study|Lost to Follow-up|0|||
48804625|NCT02563002|157127869|FG000|Overall Study|Physician Decision|0|||
48804626|NCT02563002|157127870|FG001|Overall Study|Physician Decision|2|||
48804627|NCT02563002|157127869|FG000|Overall Study|Withdrawal by Subject|2|||
48804628|NCT02563002|157127870|FG001|Overall Study|Withdrawal by Subject|10|||
48804629|NCT02563002|157127869|FG000|Overall Study|Sponsor decision|74|||
48804630|NCT02563002|157127870|FG001|Overall Study|Sponsor decision|55|||
48804631|NCT02013388|157127871|FG000|Overall Study|work emergency|1|||
48804632|NCT02013388|157127872|FG001|Overall Study|work emergency|0|||
48804633|NCT02013388|157127873|FG002|Overall Study|work emergency|0|||
48804634|NCT02013388|157127874|FG003|Overall Study|work emergency|0|||
48804635|NCT02013388|157127875|FG004|Overall Study|work emergency|1|||
48804636|NCT02013388|157127876|FG005|Overall Study|work emergency|0|||
48804637|NCT02013388|157127877|FG006|Overall Study|work emergency|0|||
48804638|NCT02013388|157127878|FG007|Overall Study|work emergency|0|||
48804639|NCT04207840|157127879|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
48804640|NCT04207840|157127880|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
48804641|NCT04207840|157127881|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
48804642|NCT04207840|157127879|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
48804643|NCT04207840|157127880|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
48804644|NCT04207840|157127881|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
48804645|NCT05382936|157127884|FG000|Overall Study|Progressive Disease|3|||
48804646|NCT05382936|157127885|FG001|Overall Study|Progressive Disease|5|||
48804647|NCT05382936|157127886|FG002|Overall Study|Progressive Disease|2|||
48804648|NCT05382936|157127887|FG003|Overall Study|Progressive Disease|5|||
48804649|NCT05382936|157127884|FG000|Overall Study|Adverse Event|0|||
48804650|NCT05382936|157127885|FG001|Overall Study|Adverse Event|1|||
48804651|NCT05382936|157127886|FG002|Overall Study|Adverse Event|1|||
48804652|NCT05382936|157127887|FG003|Overall Study|Adverse Event|0|||
48804653|NCT05382936|157127884|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
48804654|NCT05382936|157127885|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
48804655|NCT05382936|157127886|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
48804656|NCT05382936|157127887|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
48804657|NCT05382936|157127884|FG000|Overall Study|Withdrawal by Subject|0|||
48804658|NCT05382936|157127885|FG001|Overall Study|Withdrawal by Subject|0|||
48804659|NCT05382936|157127886|FG002|Overall Study|Withdrawal by Subject|1|||
48804660|NCT05382936|157127887|FG003|Overall Study|Withdrawal by Subject|1|||
48804661|NCT00215540|157127898|FG000|Overall Study|Withdrew from study medication|1|||
48804662|NCT00215540|157127899|FG001|Overall Study|Withdrew from study medication|0|||
48804663|NCT00215540|157127900|FG002|Overall Study|Withdrew from study medication|0|||
48804664|NCT03145766|157127901|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
48804665|NCT03145766|157127902|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
48804666|NCT03145766|157127903|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
48804667|NCT03145766|157127904|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
48804668|NCT03145766|157127905|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
48804669|NCT03145766|157127901|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
48804670|NCT03145766|157127902|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
48804671|NCT03145766|157127903|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
48804672|NCT03145766|157127904|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
48804673|NCT03145766|157127905|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
48804674|NCT03145766|157127901|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
48490542|NCT03141177|155990746|FG002|Overall Study|Other reasons|11|||
48804675|NCT03145766|157127902|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
48804676|NCT03145766|157127903|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
48804677|NCT03145766|157127904|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
48804678|NCT03145766|157127905|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
48596371|NCT02472886|156377928|FG000|Overall Study|Lack of Efficacy|0|||
48804679|NCT03145766|157127901|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
48804680|NCT03145766|157127902|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
48596372|NCT02472886|156377929|FG001|Overall Study|Lack of Efficacy|2|||
48596373|NCT02472886|156377930|FG002|Overall Study|Lack of Efficacy|1|||
48804681|NCT03145766|157127903|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
48804682|NCT03145766|157127904|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
48804683|NCT03145766|157127905|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
48804684|NCT03145766|157127901|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
48804685|NCT03145766|157127902|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
48804686|NCT03145766|157127903|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
48804687|NCT03145766|157127904|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
48804688|NCT03145766|157127905|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
48804689|NCT03145766|157127901|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
48804690|NCT03145766|157127902|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
48804691|NCT03145766|157127903|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
48804692|NCT03145766|157127904|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
48804693|NCT03145766|157127905|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
48804694|NCT03145766|157127901|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
48804695|NCT03145766|157127902|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
48804696|NCT03145766|157127903|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
48804697|NCT03145766|157127904|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
48804698|NCT03145766|157127905|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
48804699|NCT00246337|157127906|FG000|Overall Study|Lost to Follow-up|3|||
48804700|NCT00246337|157127907|FG001|Overall Study|Lost to Follow-up|0|||
48804701|NCT00246337|157127908|FG002|Overall Study|Lost to Follow-up|0|||
48804702|NCT00246337|157127909|FG003|Overall Study|Lost to Follow-up|0|||
48804703|NCT00246337|157127910|FG004|Overall Study|Lost to Follow-up|2|||
48804704|NCT00246337|157127911|FG005|Overall Study|Lost to Follow-up|2|||
48804705|NCT00246337|157127912|FG006|Overall Study|Lost to Follow-up|1|||
48804706|NCT00246337|157127913|FG007|Overall Study|Lost to Follow-up|2|||
48804707|NCT00246337|157127914|FG008|Overall Study|Lost to Follow-up|0|||
48804708|NCT00246337|157127906|FG000|Overall Study|Protocol Violation|1|||
48804709|NCT00246337|157127907|FG001|Overall Study|Protocol Violation|0|||
48804710|NCT00246337|157127908|FG002|Overall Study|Protocol Violation|0|||
48804711|NCT00246337|157127909|FG003|Overall Study|Protocol Violation|0|||
48804712|NCT00246337|157127910|FG004|Overall Study|Protocol Violation|1|||
48804713|NCT00246337|157127911|FG005|Overall Study|Protocol Violation|0|||
48804714|NCT00246337|157127912|FG006|Overall Study|Protocol Violation|1|||
48804715|NCT00246337|157127913|FG007|Overall Study|Protocol Violation|1|||
48804716|NCT00246337|157127914|FG008|Overall Study|Protocol Violation|0|||
48804717|NCT00246337|157127906|FG000|Overall Study|Withdrawal by Subject|2|||
48804718|NCT00246337|157127907|FG001|Overall Study|Withdrawal by Subject|0|||
48804719|NCT00246337|157127908|FG002|Overall Study|Withdrawal by Subject|0|||
48804720|NCT00246337|157127909|FG003|Overall Study|Withdrawal by Subject|0|||
48804721|NCT00246337|157127910|FG004|Overall Study|Withdrawal by Subject|0|||
48804722|NCT00246337|157127911|FG005|Overall Study|Withdrawal by Subject|0|||
48804723|NCT00246337|157127912|FG006|Overall Study|Withdrawal by Subject|1|||
48804724|NCT00246337|157127913|FG007|Overall Study|Withdrawal by Subject|1|||
48804725|NCT00246337|157127914|FG008|Overall Study|Withdrawal by Subject|0|||
48804726|NCT00246337|157127906|FG000|Overall Study|Lack of Qualifying Event|8|||
48804727|NCT00246337|157127907|FG001|Overall Study|Lack of Qualifying Event|2|||
48804728|NCT00246337|157127908|FG002|Overall Study|Lack of Qualifying Event|1|||
48804729|NCT00246337|157127909|FG003|Overall Study|Lack of Qualifying Event|1|||
48804730|NCT00246337|157127910|FG004|Overall Study|Lack of Qualifying Event|1|||
48804731|NCT00246337|157127911|FG005|Overall Study|Lack of Qualifying Event|3|||
48804732|NCT00246337|157127912|FG006|Overall Study|Lack of Qualifying Event|3|||
48804733|NCT00246337|157127913|FG007|Overall Study|Lack of Qualifying Event|2|||
48804734|NCT00246337|157127914|FG008|Overall Study|Lack of Qualifying Event|5|||
48804735|NCT00246337|157127906|FG000|Overall Study|Site Terminated|10|||
48804736|NCT00246337|157127907|FG001|Overall Study|Site Terminated|0|||
48804737|NCT00246337|157127908|FG002|Overall Study|Site Terminated|0|||
48804738|NCT00246337|157127909|FG003|Overall Study|Site Terminated|0|||
48804739|NCT00246337|157127910|FG004|Overall Study|Site Terminated|0|||
48804740|NCT00246337|157127911|FG005|Overall Study|Site Terminated|7|||
48804741|NCT00246337|157127912|FG006|Overall Study|Site Terminated|1|||
48804742|NCT00246337|157127913|FG007|Overall Study|Site Terminated|6|||
48804743|NCT00246337|157127914|FG008|Overall Study|Site Terminated|2|||
48804744|NCT00246337|157127906|FG000|Overall Study|Abnormal baseline lab values|7|||
48804745|NCT00246337|157127907|FG001|Overall Study|Abnormal baseline lab values|0|||
48804746|NCT00246337|157127908|FG002|Overall Study|Abnormal baseline lab values|2|||
48804747|NCT00246337|157127909|FG003|Overall Study|Abnormal baseline lab values|0|||
48804748|NCT00246337|157127910|FG004|Overall Study|Abnormal baseline lab values|0|||
48804749|NCT00246337|157127911|FG005|Overall Study|Abnormal baseline lab values|2|||
48804750|NCT00246337|157127912|FG006|Overall Study|Abnormal baseline lab values|2|||
48804751|NCT00246337|157127913|FG007|Overall Study|Abnormal baseline lab values|0|||
48804752|NCT00246337|157127914|FG008|Overall Study|Abnormal baseline lab values|4|||
48804753|NCT00246337|157127906|FG000|Overall Study|Overwhelmed|0|||
48804754|NCT00246337|157127907|FG001|Overall Study|Overwhelmed|0|||
48804755|NCT00246337|157127908|FG002|Overall Study|Overwhelmed|0|||
48804756|NCT00246337|157127909|FG003|Overall Study|Overwhelmed|0|||
48804757|NCT00246337|157127910|FG004|Overall Study|Overwhelmed|0|||
48804758|NCT00246337|157127911|FG005|Overall Study|Overwhelmed|1|||
48804759|NCT00246337|157127912|FG006|Overall Study|Overwhelmed|0|||
48804760|NCT00246337|157127913|FG007|Overall Study|Overwhelmed|0|||
48804761|NCT00246337|157127914|FG008|Overall Study|Overwhelmed|0|||
48804762|NCT00246337|157127906|FG000|Overall Study|Protocol Violator|1|||
48804763|NCT00246337|157127907|FG001|Overall Study|Protocol Violator|0|||
48804764|NCT00246337|157127908|FG002|Overall Study|Protocol Violator|0|||
48804765|NCT00246337|157127909|FG003|Overall Study|Protocol Violator|0|||
48804766|NCT00246337|157127910|FG004|Overall Study|Protocol Violator|0|||
48804767|NCT00246337|157127911|FG005|Overall Study|Protocol Violator|0|||
48708833|NCT00981058|156782250|FG001|Overall Study|New Anticancer Therapy|6|||
48708834|NCT00981058|156782249|FG000|Overall Study|Noncompliance|1|||
48708835|NCT00981058|156782250|FG001|Overall Study|Noncompliance|0|||
48708836|NCT00981058|156782249|FG000|Overall Study|Radiologist Error|0|||
48708837|NCT00981058|156782250|FG001|Overall Study|Radiologist Error|1|||
48708838|NCT00981058|156782249|FG000|Overall Study|Randomization Error|1|||
48804768|NCT00246337|157127912|FG006|Overall Study|Protocol Violator|0|||
48804769|NCT00246337|157127913|FG007|Overall Study|Protocol Violator|0|||
48804770|NCT00246337|157127914|FG008|Overall Study|Protocol Violator|0|||
48804771|NCT00246337|157127906|FG000|Overall Study|Reported as completing trial in error|0|||
48708839|NCT00981058|156782250|FG001|Overall Study|Randomization Error|2|||
48804772|NCT00246337|157127907|FG001|Overall Study|Reported as completing trial in error|0|||
48804773|NCT00246337|157127908|FG002|Overall Study|Reported as completing trial in error|0|||
48708840|NCT00981058|156782249|FG000|Overall Study|Withdrawal by Subject|25|||
48708841|NCT00981058|156782250|FG001|Overall Study|Withdrawal by Subject|23|||
48708842|NCT00981058|156782249|FG000|Overall Study|On study treatment at conclusion|9|||
48708843|NCT00981058|156782250|FG001|Overall Study|On study treatment at conclusion|0|||
48708844|NCT00635999|156782251|FG000|Overall Study|Withdrawal by Subject|4|||
48708845|NCT00635999|156782252|FG001|Overall Study|Withdrawal by Subject|2|||
48708846|NCT00635999|156782253|FG002|Overall Study|Withdrawal by Subject|1|||
48708847|NCT01561313|156782255|FG000|Overall Study|Withdrawal by Subject|1|||
48708848|NCT01561313|156782256|FG001|Overall Study|Withdrawal by Subject|0|||
48708849|NCT01561313|156782255|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
48804774|NCT00246337|157127909|FG003|Overall Study|Reported as completing trial in error|0|||
48804775|NCT00246337|157127910|FG004|Overall Study|Reported as completing trial in error|0|||
48804776|NCT00246337|157127911|FG005|Overall Study|Reported as completing trial in error|0|||
48804777|NCT00246337|157127912|FG006|Overall Study|Reported as completing trial in error|0|||
48804778|NCT00246337|157127913|FG007|Overall Study|Reported as completing trial in error|1|||
48804779|NCT00246337|157127914|FG008|Overall Study|Reported as completing trial in error|0|||
48804780|NCT02801669|157127915|FG000|Overall Study|Death|66|||
48804781|NCT02801669|157127916|FG001|Overall Study|Death|69|||
48804782|NCT02801669|157127915|FG000|Overall Study|Withdrawal by Subject|81|||
48804783|NCT02801669|157127916|FG001|Overall Study|Withdrawal by Subject|77|||
48804784|NCT02801669|157127915|FG000|Overall Study|Other|4|||
48804785|NCT02801669|157127916|FG001|Overall Study|Other|6|||
48804786|NCT00643123|157127917|FG000|Overall Study|Lost to Follow-up|4|||
48804787|NCT00643123|157127918|FG001|Overall Study|Lost to Follow-up|0|||
48804788|NCT00643123|157127917|FG000|Overall Study|Withdrawal by Subject|1|||
48708850|NCT01561313|156782256|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
48804789|NCT00643123|157127918|FG001|Overall Study|Withdrawal by Subject|1|||
48708851|NCT02695420|156782257|FG000|Overall Study|Death|0|||
48708852|NCT02695420|156782258|FG001|Overall Study|Death|1|||
48708853|NCT02695420|156782259|FG002|Overall Study|Death|0|||
48708854|NCT02695420|156782260|FG003|Overall Study|Death|0|||
48708855|NCT00092443|156782262|FG000|Overall Study|Adverse Event|9|||
48708856|NCT00092443|156782263|FG001|Overall Study|Adverse Event|13|||
48708857|NCT00092443|156782262|FG000|Overall Study|Lost to Follow-up|7|||
48708858|NCT00092443|156782263|FG001|Overall Study|Lost to Follow-up|3|||
48708859|NCT00092443|156782262|FG000|Overall Study|Protocol Violation|11|||
48708860|NCT00092443|156782263|FG001|Overall Study|Protocol Violation|9|||
48708861|NCT00092443|156782262|FG000|Overall Study|Withdrawal by Subject|9|||
48708862|NCT00092443|156782263|FG001|Overall Study|Withdrawal by Subject|11|||
48708863|NCT00092443|156782262|FG000|Overall Study|Moved|5|||
48708864|NCT00092443|156782263|FG001|Overall Study|Moved|5|||
48708865|NCT00092443|156782262|FG000|Overall Study|Other|17|||
48708866|NCT00092443|156782263|FG001|Overall Study|Other|13|||
48708867|NCT00314795|156782266|FG000|Overall Study|Adverse Event|8|||
48708868|NCT00314795|156782266|FG000|Overall Study|Death|4|||
48708869|NCT00314795|156782266|FG000|Overall Study|Reason not Specified|3|||
48708870|NCT00314795|156782266|FG000|Overall Study|Renal Transplant|3|||
48708871|NCT00314795|156782266|FG000|Overall Study|Participants Withdrew Consent|2|||
48708872|NCT03500224|156782268|FG000|Overall Study|Withdrawal by Subject|2|||
48708873|NCT01500720|156782269|FG000|Overall Study|Randomized But Not Treated|1|||
48708874|NCT01500720|156782270|FG001|Overall Study|Randomized But Not Treated|1|||
48708875|NCT01500720|156782269|FG000|Overall Study|Other|4|||
48708876|NCT01500720|156782270|FG001|Overall Study|Other|8|||
48708877|NCT02633020|156782272|FG000|Overall Study|Adverse Event|1|||
48708878|NCT02633020|156782273|FG001|Overall Study|Adverse Event|0|||
48804790|NCT00509236|157127923|FG000|Overall Study|Adverse Event|7|||
48804791|NCT00509236|157127924|FG001|Overall Study|Adverse Event|9|||
48804792|NCT00509236|157127923|FG000|Overall Study|Withdrawal by Subject|5|||
48804793|NCT00509236|157127924|FG001|Overall Study|Withdrawal by Subject|10|||
48804794|NCT00509236|157127923|FG000|Overall Study|Protocol Violation|3|||
48804795|NCT00509236|157127924|FG001|Overall Study|Protocol Violation|0|||
48804796|NCT00509236|157127923|FG000|Overall Study|Excluded Medication|1|||
48804797|NCT00509236|157127924|FG001|Overall Study|Excluded Medication|1|||
48804798|NCT00509236|157127923|FG000|Overall Study|Scheduled Kidney Transplant|1|||
48804799|NCT00509236|157127924|FG001|Overall Study|Scheduled Kidney Transplant|0|||
48804800|NCT03745222|157127925|FG000|Overall Study|Withdrawal by Subject|0|||
48804801|NCT03745222|157127926|FG001|Overall Study|Withdrawal by Subject|1|||
48804802|NCT03745222|157127927|FG002|Overall Study|Withdrawal by Subject|0|||
48490543|NCT03141177|155990744|FG000|Overall Study|Participants did not start treatment period|3|||
48490544|NCT03141177|155990745|FG001|Overall Study|Participants did not start treatment period|0|||
48490545|NCT03141177|155990746|FG002|Overall Study|Participants did not start treatment period|8|||
48490546|NCT02114931|155990747|FG000|Overall Study|Withdrawal by Subject|15|||
48490547|NCT02114931|155990748|FG001|Overall Study|Withdrawal by Subject|18|||
48490548|NCT02114931|155990747|FG000|Overall Study|Adverse Event|4|||
48804803|NCT02535364|157127928|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
48804804|NCT02535364|157127928|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
48804805|NCT02535364|157127928|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
48804806|NCT02535364|157127928|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
48804807|NCT02535364|157127928|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
48804808|NCT02535364|157127928|FG000|Part B Screening|Death|2|||
48804809|NCT02535364|157127928|FG000|Part B Screening|Physician Decision|1|||
48804810|NCT02535364|157127928|FG000|Part B Screening|Withdrawal by Subject|1|||
48804811|NCT02535364|157127928|FG000|Part B Screening|Adverse Event|1|||
48804812|NCT02535364|157127928|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
48804813|NCT02535364|157127928|FG000|Study Treatment|Death|1|||
48804814|NCT02535364|157127928|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
48804815|NCT02535364|157127928|FG000|12-Month Follow-up Period|Disease progression|22|||
48490549|NCT02114931|155990748|FG001|Overall Study|Adverse Event|6|||
48490550|NCT02114931|155990747|FG000|Overall Study|Lost to Follow-up|3|||
48490551|NCT02114931|155990748|FG001|Overall Study|Lost to Follow-up|3|||
48490552|NCT02114931|155990747|FG000|Overall Study|Physician Decision|1|||
48490553|NCT02114931|155990748|FG001|Overall Study|Physician Decision|2|||
48490554|NCT02114931|155990747|FG000|Overall Study|Other|2|||
48804816|NCT02535364|157127928|FG000|12-Month Follow-up Period|Death|5|||
48804817|NCT02535364|157127928|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
48804818|NCT02535364|157127928|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
48804819|NCT02535364|157127928|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
48804820|NCT00499863|157127929|FG000|Overall Study|Lack of Efficacy|21|||
48804821|NCT00499863|157127930|FG001|Overall Study|Lack of Efficacy|27|||
48804822|NCT00499863|157127929|FG000|Overall Study|Protocol Violation|12|||
48804823|NCT00499863|157127930|FG001|Overall Study|Protocol Violation|7|||
48490555|NCT02114931|155990748|FG001|Overall Study|Other|1|||
48490556|NCT02385526|155990749|FG000|Overall Study|Withdrawal by Subject|0|||
48490557|NCT02385526|155990750|FG001|Overall Study|Withdrawal by Subject|2|||
48490558|NCT02385526|155990751|FG002|Overall Study|Withdrawal by Subject|0|||
48490559|NCT02385526|155990749|FG000|Overall Study|Lost to Follow-up|0|||
48490560|NCT02385526|155990750|FG001|Overall Study|Lost to Follow-up|1|||
48490561|NCT02385526|155990751|FG002|Overall Study|Lost to Follow-up|0|||
48490562|NCT02385526|155990749|FG000|Overall Study|Physician Decision|1|||
48490563|NCT02385526|155990750|FG001|Overall Study|Physician Decision|0|||
48490564|NCT02385526|155990751|FG002|Overall Study|Physician Decision|0|||
48804824|NCT00499863|157127929|FG000|Overall Study|Withdrawal by Subject|6|||
48804825|NCT00499863|157127930|FG001|Overall Study|Withdrawal by Subject|4|||
48804826|NCT00499863|157127929|FG000|Overall Study|Adverse Event|8|||
48490565|NCT02385526|155990749|FG000|Overall Study|Protocol Violation|1|||
48596374|NCT00320788|156377931|FG000|Overall Study|Adverse Event|0|||
48596375|NCT00320788|156377932|FG001|Overall Study|Adverse Event|0|||
48596376|NCT00320788|156377933|FG002|Overall Study|Adverse Event|0|||
48804827|NCT00499863|157127930|FG001|Overall Study|Adverse Event|2|||
48804828|NCT00499863|157127929|FG000|Overall Study|Sponsor decision|2|||
48804829|NCT00499863|157127930|FG001|Overall Study|Sponsor decision|2|||
48804830|NCT00499863|157127929|FG000|Overall Study|Lost to Follow-up|1|||
48804831|NCT00499863|157127930|FG001|Overall Study|Lost to Follow-up|1|||
48804832|NCT01800201|157127931|FG000|Overall Study|Withdrawal by Subject|2|||
48804833|NCT01800201|157127932|FG001|Overall Study|Withdrawal by Subject|0|||
48804834|NCT01800201|157127931|FG000|Overall Study|patient privacy concerns|1|||
48804835|NCT01800201|157127932|FG001|Overall Study|patient privacy concerns|1|||
48804836|NCT01800201|157127931|FG000|Overall Study|did not want to use device|0|||
48804837|NCT01800201|157127932|FG001|Overall Study|did not want to use device|1|||
48804838|NCT01800201|157127931|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
48804839|NCT01800201|157127932|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
48804840|NCT04704154|157127935|FG000|Overall Study|Adverse Event|2|||
48804841|NCT04704154|157127936|FG001|Overall Study|Adverse Event|1|||
48804842|NCT04704154|157127937|FG002|Overall Study|Adverse Event|3|||
48804843|NCT04704154|157127938|FG003|Overall Study|Adverse Event|2|||
48804844|NCT04704154|157127939|FG004|Overall Study|Adverse Event|3|||
48804845|NCT04704154|157127940|FG005|Overall Study|Adverse Event|0|||
48804846|NCT04704154|157127935|FG000|Overall Study|Death|3|||
48804847|NCT04704154|157127936|FG001|Overall Study|Death|0|||
48804848|NCT04704154|157127937|FG002|Overall Study|Death|0|||
48804849|NCT04704154|157127938|FG003|Overall Study|Death|0|||
48804850|NCT04704154|157127939|FG004|Overall Study|Death|3|||
48804851|NCT04704154|157127940|FG005|Overall Study|Death|0|||
48804852|NCT04704154|157127935|FG000|Overall Study|Physician Decision|1|||
48804853|NCT04704154|157127936|FG001|Overall Study|Physician Decision|0|||
48804854|NCT04704154|157127937|FG002|Overall Study|Physician Decision|0|||
48804855|NCT04704154|157127938|FG003|Overall Study|Physician Decision|0|||
48804856|NCT04704154|157127939|FG004|Overall Study|Physician Decision|1|||
48804857|NCT04704154|157127940|FG005|Overall Study|Physician Decision|0|||
48804858|NCT04704154|157127935|FG000|Overall Study|Participant Decision|1|||
48804859|NCT04704154|157127936|FG001|Overall Study|Participant Decision|1|||
48804860|NCT04704154|157127937|FG002|Overall Study|Participant Decision|0|||
48804861|NCT04704154|157127938|FG003|Overall Study|Participant Decision|0|||
48804862|NCT04704154|157127939|FG004|Overall Study|Participant Decision|0|||
48490566|NCT02385526|155990750|FG001|Overall Study|Protocol Violation|0|||
48708879|NCT04200352|156782289|FG000|Overall Study|Death|1|||
48708880|NCT04200352|156782289|FG000|Overall Study|Adverse Event|6|||
48708881|NCT04200352|156782289|FG000|Overall Study|Withdrawal by parent/guardian|6|||
48708882|NCT04200352|156782289|FG000|Overall Study|Lack of Efficacy|1|||
48708883|NCT04200352|156782289|FG000|Overall Study|Other than specified|6|||
48708884|NCT00806819|156782292|FG000|Overall Study|progressive disease (modified RECIST )|217|||
48708885|NCT00806819|156782293|FG001|Overall Study|progressive disease (modified RECIST )|216|||
48708886|NCT00806819|156782292|FG000|Overall Study|Worsening or AE of underlying disease|18|||
48708887|NCT00806819|156782293|FG001|Overall Study|Worsening or AE of underlying disease|25|||
48708888|NCT00806819|156782292|FG000|Overall Study|Other AE|38|||
48708889|NCT00806819|156782293|FG001|Overall Study|Other AE|40|||
48708890|NCT00806819|156782292|FG000|Overall Study|Protocol Violation|9|||
48708891|NCT00806819|156782293|FG001|Overall Study|Protocol Violation|4|||
48708892|NCT00806819|156782292|FG000|Overall Study|Lost to Follow-up|1|||
48708893|NCT00806819|156782293|FG001|Overall Study|Lost to Follow-up|0|||
48708894|NCT00806819|156782292|FG000|Overall Study|Withdrawal by Subject|32|||
48708895|NCT00806819|156782293|FG001|Overall Study|Withdrawal by Subject|29|||
48708896|NCT00806819|156782292|FG000|Overall Study|Not treated|6|||
48708897|NCT00806819|156782293|FG001|Overall Study|Not treated|3|||
48708898|NCT00806819|156782292|FG000|Overall Study|Reasons other than stated above|25|||
48708899|NCT00806819|156782293|FG001|Overall Study|Reasons other than stated above|41|||
48708900|NCT00233064|156782296|FG000|Overall Study|Lost to Follow-up|7|||
48708901|NCT00233064|156782297|FG001|Overall Study|Lost to Follow-up|7|||
48708902|NCT00233064|156782296|FG000|Overall Study|Withdrawal by Subject|5|||
48708903|NCT00233064|156782297|FG001|Overall Study|Withdrawal by Subject|3|||
48708904|NCT00233064|156782296|FG000|Overall Study|Death|0|||
48708905|NCT00233064|156782297|FG001|Overall Study|Death|1|||
48708906|NCT00233064|156782296|FG000|Overall Study|Relocation|0|||
48708907|NCT00233064|156782297|FG001|Overall Study|Relocation|1|||
48708908|NCT00233064|156782296|FG000|Overall Study|Protocol Violation|1|||
48708909|NCT00233064|156782297|FG001|Overall Study|Protocol Violation|0|||
48708910|NCT00233064|156782296|FG000|Overall Study|Moved to Dom. Republic|1|||
48708911|NCT00233064|156782297|FG001|Overall Study|Moved to Dom. Republic|0|||
48708912|NCT02302339|156782298|FG000|Overall Study|Lost to Follow-up|1|||
48708913|NCT02302339|156782299|FG001|Overall Study|Lost to Follow-up|0|||
48708914|NCT02302339|156782300|FG002|Overall Study|Lost to Follow-up|0|||
48708915|NCT02302339|156782301|FG003|Overall Study|Lost to Follow-up|0|||
48708916|NCT02302339|156782298|FG000|Overall Study|Withdrawal by Subject|0|||
48708917|NCT02302339|156782299|FG001|Overall Study|Withdrawal by Subject|2|||
48708918|NCT02302339|156782300|FG002|Overall Study|Withdrawal by Subject|1|||
48708919|NCT02302339|156782301|FG003|Overall Study|Withdrawal by Subject|0|||
48708920|NCT03212144|156782302|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
48708921|NCT03212144|156782303|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
48708922|NCT03212144|156782302|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
48708923|NCT03212144|156782303|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
48708924|NCT01185080|156782304|FG000|Overall Study|Adverse Event|1|||
48708925|NCT01185080|156782305|FG001|Overall Study|Adverse Event|1|||
48708926|NCT01185080|156782306|FG002|Overall Study|Adverse Event|0|||
48804863|NCT04704154|157127940|FG005|Overall Study|Participant Decision|0|||
48804864|NCT04704154|157127935|FG000|Overall Study|Progressive Disease|16|||
48804865|NCT04704154|157127936|FG001|Overall Study|Progressive Disease|17|||
48804866|NCT04704154|157127937|FG002|Overall Study|Progressive Disease|20|||
48804867|NCT04704154|157127938|FG003|Overall Study|Progressive Disease|18|||
48804868|NCT04704154|157127939|FG004|Overall Study|Progressive Disease|36|||
48804869|NCT04704154|157127940|FG005|Overall Study|Progressive Disease|30|||
48804870|NCT04704154|157127935|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804871|NCT04704154|157127936|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804872|NCT04704154|157127937|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804873|NCT04704154|157127938|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804874|NCT04704154|157127939|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
48804875|NCT04704154|157127940|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
48804876|NCT00855595|157127943|FG000|Overall Study|Withdrawal by Subject|1|||
48596377|NCT00320788|156377934|FG003|Overall Study|Adverse Event|1|||
48596378|NCT00320788|156377935|FG004|Overall Study|Adverse Event|0|||
48596379|NCT00320788|156377931|FG000|Overall Study|Death|0|||
48804877|NCT00855595|157127944|FG001|Overall Study|Withdrawal by Subject|2|||
48804878|NCT00855595|157127943|FG000|Overall Study|Lost to Follow-up|3|||
48804879|NCT00855595|157127944|FG001|Overall Study|Lost to Follow-up|3|||
48804880|NCT00855595|157127943|FG000|Overall Study|Adverse Event|1|||
48804881|NCT00855595|157127944|FG001|Overall Study|Adverse Event|1|||
48804882|NCT00855595|157127943|FG000|Overall Study|patient moved out of state|1|||
48804883|NCT00855595|157127944|FG001|Overall Study|patient moved out of state|0|||
48804884|NCT00855595|157127943|FG000|Overall Study|patient left country|0|||
48804885|NCT00855595|157127944|FG001|Overall Study|patient left country|1|||
48804886|NCT04555096|157127945|FG000|Overall Study|Death|4|||
48804887|NCT04555096|157127946|FG001|Overall Study|Death|4|||
48804888|NCT04555096|157127945|FG000|Overall Study|Withdrawal by Subject|1|||
48804889|NCT04555096|157127946|FG001|Overall Study|Withdrawal by Subject|0|||
48804890|NCT04555096|157127945|FG000|Overall Study|Other|0|||
48804891|NCT04555096|157127946|FG001|Overall Study|Other|1|||
48596380|NCT00320788|156377932|FG001|Overall Study|Death|0|||
48804892|NCT02343003|157127949|FG000|Overall Study|Withdrawal by Subject|9|||
48804893|NCT02343003|157127950|FG001|Overall Study|Withdrawal by Subject|4|||
48804894|NCT02343003|157127949|FG000|Overall Study|Lost to Follow-up|5|||
48804895|NCT02343003|157127950|FG001|Overall Study|Lost to Follow-up|1|||
48804896|NCT02343003|157127949|FG000|Overall Study|Protocol Violation|1|||
48804897|NCT02343003|157127950|FG001|Overall Study|Protocol Violation|0|||
48804898|NCT02343003|157127949|FG000|Overall Study|Death|0|||
48804899|NCT02343003|157127950|FG001|Overall Study|Death|1|||
48804900|NCT02343003|157127949|FG000|Overall Study|exclusion criteria met|1|||
48804901|NCT02343003|157127950|FG001|Overall Study|exclusion criteria met|1|||
48804902|NCT02343003|157127949|FG000|Overall Study|terminated by sponsor|2|||
48804903|NCT02343003|157127950|FG001|Overall Study|terminated by sponsor|0|||
48804904|NCT03954743|157127951|FG000|Overall Study|Adverse Event|1|||
48804905|NCT03954743|157127952|FG001|Overall Study|Adverse Event|0|||
48804906|NCT03954743|157127951|FG000|Overall Study|Lost to Follow-up|6|||
48804907|NCT03954743|157127952|FG001|Overall Study|Lost to Follow-up|4|||
48804908|NCT03954743|157127951|FG000|Overall Study|Protocol Violation|1|||
48804909|NCT03954743|157127952|FG001|Overall Study|Protocol Violation|0|||
48804910|NCT03954743|157127951|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
48804911|NCT03954743|157127952|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
48804912|NCT03954743|157127951|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
48804913|NCT03954743|157127952|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48804914|NCT02496767|157127955|FG000|Open-label Lead-in Phase|Adverse Event|176|||
48804915|NCT02496767|157127956|FG001|Open-label Lead-in Phase|Adverse Event|0|||
48804916|NCT02496767|157127957|FG002|Open-label Lead-in Phase|Adverse Event|0|||
48804917|NCT02496767|157127958|FG003|Open-label Lead-in Phase|Adverse Event|0|||
48804918|NCT02496767|157127959|FG004|Open-label Lead-in Phase|Adverse Event|0|||
48804919|NCT02496767|157127960|FG005|Open-label Lead-in Phase|Adverse Event|0|||
48804920|NCT02496767|157127961|FG006|Open-label Lead-in Phase|Adverse Event|0|||
48804921|NCT02496767|157127962|FG007|Open-label Lead-in Phase|Adverse Event|0|||
48804922|NCT02496767|157127955|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
48804923|NCT02496767|157127956|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
48804924|NCT02496767|157127957|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
48804925|NCT02496767|157127958|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
48804926|NCT02496767|157127959|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
48804927|NCT02496767|157127960|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
48804928|NCT02496767|157127961|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
48804929|NCT02496767|157127962|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
48804930|NCT02496767|157127955|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
48804931|NCT02496767|157127956|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804932|NCT02496767|157127957|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804933|NCT02496767|157127958|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804934|NCT02496767|157127959|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804935|NCT02496767|157127960|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804936|NCT02496767|157127961|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804937|NCT02496767|157127962|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
48804938|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48804939|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
48804940|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
48804941|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
48804942|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
48804943|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48804944|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48804945|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48596381|NCT00320788|156377933|FG002|Overall Study|Death|1|||
48804946|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
48804947|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
48490567|NCT02385526|155990751|FG002|Overall Study|Protocol Violation|0|||
48490568|NCT02570165|155990752|FG000|Overall Study|Adverse Event|1|||
48490569|NCT02570165|155990753|FG001|Overall Study|Adverse Event|0|||
48490570|NCT02570165|155990754|FG002|Overall Study|Adverse Event|2|||
48490571|NCT02570165|155990755|FG003|Overall Study|Adverse Event|0|||
48490572|NCT02570165|155990756|FG004|Overall Study|Adverse Event|0|||
48490573|NCT02570165|155990757|FG005|Overall Study|Adverse Event|0|||
48490574|NCT02570165|155990758|FG006|Overall Study|Adverse Event|0|||
48490575|NCT02570165|155990752|FG000|Overall Study|Lack of Efficacy|0|||
48490576|NCT02570165|155990753|FG001|Overall Study|Lack of Efficacy|1|||
48490577|NCT02570165|155990754|FG002|Overall Study|Lack of Efficacy|0|||
48596382|NCT00320788|156377934|FG003|Overall Study|Death|0|||
48596383|NCT00320788|156377935|FG004|Overall Study|Death|1|||
48596384|NCT00320788|156377931|FG000|Overall Study|Lost to Follow-up|0|||
48596385|NCT00320788|156377932|FG001|Overall Study|Lost to Follow-up|2|||
48596386|NCT00320788|156377933|FG002|Overall Study|Lost to Follow-up|1|||
48596387|NCT00320788|156377934|FG003|Overall Study|Lost to Follow-up|0|||
48490578|NCT02570165|155990755|FG003|Overall Study|Lack of Efficacy|0|||
48490579|NCT02570165|155990756|FG004|Overall Study|Lack of Efficacy|4|||
48490580|NCT02570165|155990757|FG005|Overall Study|Lack of Efficacy|0|||
48490581|NCT02570165|155990758|FG006|Overall Study|Lack of Efficacy|0|||
48490582|NCT02570165|155990752|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
48596388|NCT00320788|156377935|FG004|Overall Study|Lost to Follow-up|0|||
48708927|NCT01185080|156782304|FG000|Overall Study|Personal reasons|0|||
48708928|NCT01185080|156782305|FG001|Overall Study|Personal reasons|0|||
48708929|NCT01185080|156782306|FG002|Overall Study|Personal reasons|1|||
48708930|NCT03894813|156784151|FG000|Overall Study|Adverse Event|1|||
48708931|NCT03894813|156784152|FG001|Overall Study|Adverse Event|1|||
48708932|NCT03894813|156784151|FG000|Overall Study|Lack of Efficacy|3|||
48708933|NCT03894813|156784152|FG001|Overall Study|Lack of Efficacy|3|||
48708934|NCT03894813|156784151|FG000|Overall Study|Lost to Follow-up|1|||
48708935|NCT03894813|156784152|FG001|Overall Study|Lost to Follow-up|0|||
48708936|NCT03894813|156784151|FG000|Overall Study|Pregnancy|2|||
48708937|NCT03894813|156784152|FG001|Overall Study|Pregnancy|1|||
48708938|NCT03894813|156784151|FG000|Overall Study|Protocol Violation|3|||
48708939|NCT03894813|156784152|FG001|Overall Study|Protocol Violation|7|||
48708940|NCT03894813|156784151|FG000|Overall Study|Withdrawal by Subject|1|||
48708941|NCT03894813|156784152|FG001|Overall Study|Withdrawal by Subject|3|||
48708942|NCT03894813|156784151|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
48708943|NCT03894813|156784152|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
48708944|NCT03083873|156784153|FG000|Overall Study|Death|6|||
48708945|NCT03083873|156784154|FG001|Overall Study|Death|15|||
48708946|NCT03083873|156784155|FG002|Overall Study|Death|13|||
48708947|NCT03083873|156784156|FG003|Overall Study|Death|9|||
48708948|NCT03083873|156784157|FG004|Overall Study|Death|0|||
48708949|NCT03083873|156784153|FG000|Overall Study|Sponsor Terminated Study|0|||
48708950|NCT03083873|156784154|FG001|Overall Study|Sponsor Terminated Study|1|||
48708951|NCT03083873|156784155|FG002|Overall Study|Sponsor Terminated Study|2|||
48708952|NCT03083873|156784156|FG003|Overall Study|Sponsor Terminated Study|3|||
48708953|NCT03083873|156784157|FG004|Overall Study|Sponsor Terminated Study|0|||
48708954|NCT03083873|156784153|FG000|Overall Study|Lost to Follow-up|0|||
48708955|NCT03083873|156784154|FG001|Overall Study|Lost to Follow-up|1|||
48708956|NCT03083873|156784155|FG002|Overall Study|Lost to Follow-up|1|||
48708957|NCT03083873|156784156|FG003|Overall Study|Lost to Follow-up|0|||
48708958|NCT03083873|156784157|FG004|Overall Study|Lost to Follow-up|0|||
48708959|NCT03083873|156784153|FG000|Overall Study|Withdrawal by Subject|2|||
48708960|NCT03083873|156784154|FG001|Overall Study|Withdrawal by Subject|0|||
48708961|NCT03083873|156784155|FG002|Overall Study|Withdrawal by Subject|0|||
48708962|NCT03083873|156784156|FG003|Overall Study|Withdrawal by Subject|0|||
48708963|NCT03083873|156784157|FG004|Overall Study|Withdrawal by Subject|0|||
48708964|NCT03083873|156784153|FG000|Overall Study|Did Not Receive TIL|2|||
48708965|NCT03083873|156784154|FG001|Overall Study|Did Not Receive TIL|5|||
48708966|NCT03083873|156784155|FG002|Overall Study|Did Not Receive TIL|3|||
48708967|NCT03083873|156784156|FG003|Overall Study|Did Not Receive TIL|1|||
48708968|NCT03083873|156784157|FG004|Overall Study|Did Not Receive TIL|0|||
48708969|NCT03983317|156784158|FG000|Overall Study|Physician Decision|5|||
48708970|NCT01069900|156784165|FG000|Overall Study|Technical problems|0|||
48804948|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
48804949|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
48804950|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
48804951|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
48804952|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
48804953|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
48804954|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
48804955|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
48804956|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
48804957|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
48804958|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
48804959|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
48804960|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
48804961|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
48804962|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
48804963|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
48804964|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
48804965|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
48804966|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
48804967|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
48804968|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
48804969|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
48804970|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48804971|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
48804972|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
48804973|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
48804974|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
48804975|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48804976|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48804977|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48804978|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804979|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
48804980|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
48804981|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804982|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804983|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804984|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804985|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48804986|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804987|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
48804988|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804989|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
48804990|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
48804991|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804992|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804993|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48804994|NCT02496767|157127955|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48804995|NCT02496767|157127956|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
48804996|NCT02496767|157127957|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48804997|NCT02496767|157127958|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48804998|NCT02496767|157127959|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48804999|NCT02496767|157127960|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48805000|NCT02496767|157127961|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48805001|NCT02496767|157127962|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
48805002|NCT02496767|157127955|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805003|NCT02496767|157127956|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805004|NCT02496767|157127957|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805005|NCT02496767|157127958|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805006|NCT02496767|157127959|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805007|NCT02496767|157127960|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
48805008|NCT02496767|157127961|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
48805009|NCT02496767|157127962|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
48805010|NCT02496767|157127955|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
48490583|NCT02570165|155990753|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
48490584|NCT02570165|155990754|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
48490585|NCT02570165|155990755|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
48805011|NCT02496767|157127956|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
48490586|NCT02570165|155990756|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
48490587|NCT02570165|155990757|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
48490588|NCT02570165|155990758|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
48490589|NCT02570165|155990752|FG000|Overall Study|Lost to Follow-up|0|||
48805012|NCT02496767|157127957|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
48805013|NCT02496767|157127958|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
48805014|NCT02496767|157127959|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
48805015|NCT02496767|157127960|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
48805016|NCT02496767|157127961|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
48805017|NCT02496767|157127962|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
48805018|NCT02496767|157127955|FG000|Double-blind, Withdrawal Phase|Death|0|||
48805019|NCT02496767|157127956|FG001|Double-blind, Withdrawal Phase|Death|0|||
48805020|NCT02496767|157127957|FG002|Double-blind, Withdrawal Phase|Death|0|||
48805021|NCT02496767|157127958|FG003|Double-blind, Withdrawal Phase|Death|0|||
48805022|NCT02496767|157127959|FG004|Double-blind, Withdrawal Phase|Death|0|||
48805023|NCT02496767|157127960|FG005|Double-blind, Withdrawal Phase|Death|0|||
48805024|NCT02496767|157127961|FG006|Double-blind, Withdrawal Phase|Death|1|||
48805025|NCT02496767|157127962|FG007|Double-blind, Withdrawal Phase|Death|2|||
48805026|NCT02496767|157127955|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805027|NCT02496767|157127956|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805028|NCT02496767|157127957|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805029|NCT02496767|157127958|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805030|NCT02496767|157127959|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
48805031|NCT02496767|157127960|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
48805032|NCT02496767|157127961|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
48805033|NCT02496767|157127962|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
48805034|NCT05687916|157127964|FG000|Overall Study|Adverse Event|1|||
48805035|NCT05687916|157127965|FG001|Overall Study|Adverse Event|2|||
48805036|NCT05687916|157127966|FG002|Overall Study|Adverse Event|0|||
48805037|NCT05687916|157127964|FG000|Overall Study|Withdrawal by Subject|1|||
48805038|NCT05687916|157127965|FG001|Overall Study|Withdrawal by Subject|0|||
48805039|NCT05687916|157127966|FG002|Overall Study|Withdrawal by Subject|1|||
48805040|NCT05687916|157127964|FG000|Overall Study|Protocol Violation|0|||
48805041|NCT05687916|157127965|FG001|Overall Study|Protocol Violation|2|||
48805042|NCT05687916|157127966|FG002|Overall Study|Protocol Violation|1|||
48805043|NCT05687916|157127964|FG000|Overall Study|Reason not Specified|1|||
48805044|NCT05687916|157127965|FG001|Overall Study|Reason not Specified|0|||
48805045|NCT05687916|157127966|FG002|Overall Study|Reason not Specified|0|||
48805046|NCT01490125|157127967|FG000|Period I|Adverse Event|4|||
48805047|NCT01490125|157127968|FG001|Period I|Adverse Event|1|||
48805048|NCT01490125|157127969|FG002|Period I|Adverse Event|1|||
48805049|NCT01490125|157127970|FG003|Period I|Adverse Event|3|||
48805050|NCT01490125|157127971|FG004|Period I|Adverse Event|2|||
48805051|NCT01490125|157127972|FG005|Period I|Adverse Event|4|||
48805052|NCT01490125|157127967|FG000|Period I|Protocol Violation|1|||
48805053|NCT01490125|157127968|FG001|Period I|Protocol Violation|1|||
48805054|NCT01490125|157127969|FG002|Period I|Protocol Violation|1|||
48805055|NCT01490125|157127970|FG003|Period I|Protocol Violation|1|||
48805056|NCT01490125|157127971|FG004|Period I|Protocol Violation|0|||
48805057|NCT01490125|157127972|FG005|Period I|Protocol Violation|0|||
48805058|NCT01490125|157127967|FG000|Period I|Withdrawal by Subject|1|||
48805059|NCT01490125|157127968|FG001|Period I|Withdrawal by Subject|3|||
48805060|NCT01490125|157127969|FG002|Period I|Withdrawal by Subject|2|||
48805061|NCT01490125|157127970|FG003|Period I|Withdrawal by Subject|1|||
48805062|NCT01490125|157127971|FG004|Period I|Withdrawal by Subject|2|||
48805063|NCT01490125|157127972|FG005|Period I|Withdrawal by Subject|1|||
48490590|NCT02570165|155990753|FG001|Overall Study|Lost to Follow-up|0|||
48490591|NCT02570165|155990754|FG002|Overall Study|Lost to Follow-up|1|||
48490592|NCT02570165|155990755|FG003|Overall Study|Lost to Follow-up|1|||
48490593|NCT02570165|155990756|FG004|Overall Study|Lost to Follow-up|0|||
48596389|NCT00320788|156377931|FG000|Overall Study|Decision by the Sponsor|1|||
48805064|NCT01490125|157127967|FG000|Period II|Adverse Event|2|||
48805065|NCT01490125|157127968|FG001|Period II|Adverse Event|3|||
48490594|NCT02570165|155990757|FG005|Overall Study|Lost to Follow-up|0|||
48490595|NCT02570165|155990758|FG006|Overall Study|Lost to Follow-up|0|||
48596390|NCT00320788|156377932|FG001|Overall Study|Decision by the Sponsor|1|||
48805066|NCT01490125|157127969|FG002|Period II|Adverse Event|2|||
48805067|NCT01490125|157127970|FG003|Period II|Adverse Event|2|||
48490596|NCT02570165|155990752|FG000|Overall Study|Physician Decision|0|||
48596391|NCT00320788|156377933|FG002|Overall Study|Decision by the Sponsor|0|||
48490597|NCT02570165|155990753|FG001|Overall Study|Physician Decision|1|||
48596392|NCT00320788|156377934|FG003|Overall Study|Decision by the Sponsor|0|||
48490598|NCT02570165|155990754|FG002|Overall Study|Physician Decision|0|||
48805068|NCT01490125|157127971|FG004|Period II|Adverse Event|4|||
48490599|NCT02570165|155990755|FG003|Overall Study|Physician Decision|0|||
48805069|NCT01490125|157127972|FG005|Period II|Adverse Event|2|||
48490600|NCT02570165|155990756|FG004|Overall Study|Physician Decision|0|||
48490601|NCT02570165|155990757|FG005|Overall Study|Physician Decision|0|||
48490602|NCT02570165|155990758|FG006|Overall Study|Physician Decision|0|||
48490603|NCT02570165|155990752|FG000|Overall Study|Withdrawal by Subject|0|||
48490604|NCT02570165|155990753|FG001|Overall Study|Withdrawal by Subject|0|||
48490605|NCT02570165|155990754|FG002|Overall Study|Withdrawal by Subject|0|||
48490606|NCT02570165|155990755|FG003|Overall Study|Withdrawal by Subject|2|||
48490607|NCT02570165|155990756|FG004|Overall Study|Withdrawal by Subject|1|||
48490608|NCT02570165|155990757|FG005|Overall Study|Withdrawal by Subject|0|||
48490609|NCT02570165|155990758|FG006|Overall Study|Withdrawal by Subject|0|||
48805070|NCT01490125|157127967|FG000|Period II|Protocol Violation|0|||
48805071|NCT01490125|157127968|FG001|Period II|Protocol Violation|0|||
48805072|NCT01490125|157127969|FG002|Period II|Protocol Violation|1|||
48805073|NCT01490125|157127970|FG003|Period II|Protocol Violation|1|||
48805074|NCT01490125|157127971|FG004|Period II|Protocol Violation|0|||
48805075|NCT01490125|157127972|FG005|Period II|Protocol Violation|0|||
48805076|NCT01490125|157127967|FG000|Period II|Lost to Follow-up|0|||
48805077|NCT01490125|157127968|FG001|Period II|Lost to Follow-up|1|||
48805078|NCT01490125|157127969|FG002|Period II|Lost to Follow-up|0|||
48805079|NCT01490125|157127970|FG003|Period II|Lost to Follow-up|0|||
48805080|NCT01490125|157127971|FG004|Period II|Lost to Follow-up|0|||
48805081|NCT01490125|157127972|FG005|Period II|Lost to Follow-up|0|||
48805082|NCT01490125|157127967|FG000|Period II|Withdrawal by Subject|1|||
48805083|NCT01490125|157127968|FG001|Period II|Withdrawal by Subject|0|||
48805084|NCT01490125|157127969|FG002|Period II|Withdrawal by Subject|0|||
48805085|NCT01490125|157127970|FG003|Period II|Withdrawal by Subject|0|||
48805086|NCT01490125|157127971|FG004|Period II|Withdrawal by Subject|0|||
48805087|NCT01490125|157127972|FG005|Period II|Withdrawal by Subject|0|||
48805088|NCT01490125|157127967|FG000|Period III|Adverse Event|3|||
48805089|NCT01490125|157127968|FG001|Period III|Adverse Event|1|||
48805090|NCT01490125|157127969|FG002|Period III|Adverse Event|0|||
48805091|NCT01490125|157127970|FG003|Period III|Adverse Event|1|||
48805092|NCT01490125|157127971|FG004|Period III|Adverse Event|0|||
48805093|NCT01490125|157127972|FG005|Period III|Adverse Event|0|||
48805094|NCT01490125|157127967|FG000|Period III|Death|0|||
48805095|NCT01490125|157127968|FG001|Period III|Death|0|||
48805096|NCT01490125|157127969|FG002|Period III|Death|0|||
48805097|NCT01490125|157127970|FG003|Period III|Death|1|||
48805098|NCT01490125|157127971|FG004|Period III|Death|0|||
48805099|NCT01490125|157127972|FG005|Period III|Death|0|||
48805100|NCT01490125|157127967|FG000|Period III|Lack of Efficacy|0|||
48490610|NCT02570165|155990752|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
48490611|NCT02570165|155990753|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
48490612|NCT02570165|155990754|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
48596393|NCT00320788|156377935|FG004|Overall Study|Decision by the Sponsor|1|||
48805101|NCT01490125|157127968|FG001|Period III|Lack of Efficacy|0|||
48805102|NCT01490125|157127969|FG002|Period III|Lack of Efficacy|0|||
48805103|NCT01490125|157127970|FG003|Period III|Lack of Efficacy|0|||
48805104|NCT01490125|157127971|FG004|Period III|Lack of Efficacy|1|||
48805105|NCT01490125|157127972|FG005|Period III|Lack of Efficacy|0|||
48805106|NCT02237508|157127973|FG000|Overall Study|Withdrawal by Subject|0|||
48805107|NCT02237508|157127974|FG001|Overall Study|Withdrawal by Subject|2|||
48805108|NCT02237508|157127975|FG002|Overall Study|Withdrawal by Subject|0|||
48805109|NCT02237508|157127976|FG003|Overall Study|Withdrawal by Subject|1|||
48805110|NCT02237508|157127977|FG004|Overall Study|Withdrawal by Subject|0|||
48805111|NCT02237508|157127978|FG005|Overall Study|Withdrawal by Subject|1|||
48805112|NCT02237508|157127979|FG006|Overall Study|Withdrawal by Subject|1|||
48805113|NCT02237508|157127980|FG007|Overall Study|Withdrawal by Subject|0|||
48805114|NCT02237508|157127981|FG008|Overall Study|Withdrawal by Subject|1|||
48805115|NCT02237508|157127982|FG009|Overall Study|Withdrawal by Subject|0|||
48805116|NCT02237508|157127973|FG000|Overall Study|Physician Decision|0|||
48805117|NCT02237508|157127974|FG001|Overall Study|Physician Decision|1|||
48805118|NCT02237508|157127975|FG002|Overall Study|Physician Decision|0|||
48805119|NCT02237508|157127976|FG003|Overall Study|Physician Decision|0|||
48805120|NCT02237508|157127977|FG004|Overall Study|Physician Decision|0|||
48805121|NCT02237508|157127978|FG005|Overall Study|Physician Decision|0|||
48805122|NCT02237508|157127979|FG006|Overall Study|Physician Decision|0|||
48805123|NCT02237508|157127980|FG007|Overall Study|Physician Decision|0|||
48805124|NCT02237508|157127981|FG008|Overall Study|Physician Decision|0|||
48805125|NCT02237508|157127982|FG009|Overall Study|Physician Decision|0|||
48805126|NCT02237508|157127973|FG000|Overall Study|Protocol Violation|0|||
48805127|NCT02237508|157127974|FG001|Overall Study|Protocol Violation|0|||
48805128|NCT02237508|157127975|FG002|Overall Study|Protocol Violation|1|||
48805129|NCT02237508|157127976|FG003|Overall Study|Protocol Violation|0|||
48805130|NCT02237508|157127977|FG004|Overall Study|Protocol Violation|0|||
48805131|NCT02237508|157127978|FG005|Overall Study|Protocol Violation|0|||
48805132|NCT02237508|157127979|FG006|Overall Study|Protocol Violation|0|||
48805133|NCT02237508|157127980|FG007|Overall Study|Protocol Violation|0|||
48805134|NCT02237508|157127981|FG008|Overall Study|Protocol Violation|0|||
48805135|NCT02237508|157127982|FG009|Overall Study|Protocol Violation|0|||
48805136|NCT01931735|157127985|FG000|Randomized Phase|Lost to Follow-up|2|||
48805137|NCT01931735|157127986|FG001|Randomized Phase|Lost to Follow-up|2|||
48805138|NCT01931735|157127987|FG002|Randomized Phase|Lost to Follow-up|5|||
48805139|NCT01931735|157127988|FG003|Randomized Phase|Lost to Follow-up|0|||
48805140|NCT01931735|157127985|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
48805141|NCT01931735|157127986|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
48805142|NCT01931735|157127987|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
48805143|NCT01931735|157127988|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
48805144|NCT01931735|157127985|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
48805145|NCT01931735|157127986|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
48805146|NCT01931735|157127987|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
48805147|NCT01931735|157127988|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
48805148|NCT00990340|157127991|FG000|First 14-day Treatment|Not Compliant|2|||
48805149|NCT00990340|157127992|FG001|First 14-day Treatment|Not Compliant|1|||
48805150|NCT00990340|157127991|FG000|First 14-day Treatment|Lost to Follow-up|2|||
48805151|NCT00990340|157127992|FG001|First 14-day Treatment|Lost to Follow-up|1|||
48805152|NCT00990340|157127991|FG000|First 14-day Treatment|Protocol Violation|2|||
48805153|NCT00990340|157127992|FG001|First 14-day Treatment|Protocol Violation|2|||
48805154|NCT04209855|157127994|FG000|Overall Study|Adverse Event|20|||
48805155|NCT04209855|157127995|FG001|Overall Study|Adverse Event|28|||
48805156|NCT04209855|157127994|FG000|Overall Study|Death|3|||
48805157|NCT04209855|157127995|FG001|Overall Study|Death|1|||
48805158|NCT04209855|157127994|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
48805159|NCT04209855|157127995|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
48805160|NCT04209855|157127994|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
48805161|NCT04209855|157127995|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
48805162|NCT04209855|157127994|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
48805163|NCT04209855|157127995|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
48805164|NCT04209855|157127994|FG000|Overall Study|Progressive Disease|154|||
48805165|NCT04209855|157127995|FG001|Overall Study|Progressive Disease|145|||
48805166|NCT04209855|157127994|FG000|Overall Study|Protocol Deviation|1|||
48805167|NCT04209855|157127995|FG001|Overall Study|Protocol Deviation|1|||
48805168|NCT04209855|157127994|FG000|Overall Study|Other Than Specified|5|||
48805169|NCT04209855|157127995|FG001|Overall Study|Other Than Specified|10|||
48805170|NCT01933880|157127996|FG000|Overall Study|Withdrawal by Subject|5|||
48805171|NCT01933880|157127997|FG001|Overall Study|Withdrawal by Subject|0|||
48805172|NCT01933880|157127996|FG000|Overall Study|Lack of Efficacy|1|||
48805173|NCT01933880|157127997|FG001|Overall Study|Lack of Efficacy|0|||
48805174|NCT01933880|157127996|FG000|Overall Study|Concomitant medication Interference|0|||
48805175|NCT01933880|157127997|FG001|Overall Study|Concomitant medication Interference|1|||
48805176|NCT01933880|157127996|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
48805177|NCT01933880|157127997|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
48805178|NCT01933880|157127996|FG000|Overall Study|Other|4|||
48805179|NCT01933880|157127997|FG001|Overall Study|Other|0|||
48805180|NCT01933880|157127996|FG000|Overall Study|Protocol Violation|1|||
48596394|NCT00320788|156377931|FG000|Overall Study|Other|1|||
48596395|NCT00320788|156377932|FG001|Overall Study|Other|2|||
48805181|NCT01933880|157127997|FG001|Overall Study|Protocol Violation|0|||
48805182|NCT00118092|157127998|FG000|Overall Study|Withdrawal by Subject|1|||
48805183|NCT00118092|157127998|FG000|Overall Study|Protocol Violation|1|||
48805184|NCT03091192|157128005|FG000|Overall Study|Study terminated by sponsor|21|||
48805185|NCT03091192|157128006|FG001|Overall Study|Study terminated by sponsor|14|||
48805186|NCT03091192|157128005|FG000|Overall Study|Death|9|||
48805187|NCT03091192|157128006|FG001|Overall Study|Death|13|||
48805188|NCT03091192|157128005|FG000|Overall Study|Withdrawal by Subject|2|||
48805189|NCT03091192|157128006|FG001|Overall Study|Withdrawal by Subject|0|||
48805190|NCT03091192|157128005|FG000|Overall Study|Lost to Follow-up|1|||
48805191|NCT03091192|157128006|FG001|Overall Study|Lost to Follow-up|0|||
48805192|NCT03183388|157129300|FG000|Overall Study|Lost to Follow-up|3|||
48805193|NCT03183388|157129301|FG001|Overall Study|Lost to Follow-up|5|||
48805194|NCT03183388|157129300|FG000|Overall Study|Physician Decision|1|||
48805195|NCT03183388|157129301|FG001|Overall Study|Physician Decision|4|||
48805196|NCT03183388|157129300|FG000|Overall Study|Withdrawal by Subject|4|||
48805197|NCT03183388|157129301|FG001|Overall Study|Withdrawal by Subject|1|||
48805198|NCT03183388|157129300|FG000|Overall Study|Moved|1|||
48805199|NCT03183388|157129301|FG001|Overall Study|Moved|0|||
48805200|NCT03183388|157129300|FG000|Overall Study|Met Exclusion Criteria|2|||
48805201|NCT03183388|157129301|FG001|Overall Study|Met Exclusion Criteria|2|||
48805202|NCT03183388|157129300|FG000|Overall Study|COVID Pandemic Related|2|||
48805203|NCT03183388|157129301|FG001|Overall Study|COVID Pandemic Related|4|||
48805204|NCT02799472|157129303|FG000|Overall Study|Withdrawal by Subject|2|||
48805205|NCT02799472|157129304|FG001|Overall Study|Withdrawal by Subject|4|||
48805206|NCT02799472|157129303|FG000|Overall Study|Lack of Efficacy|2|||
48805207|NCT02799472|157129304|FG001|Overall Study|Lack of Efficacy|0|||
48596396|NCT00320788|156377933|FG002|Overall Study|Other|1|||
48596397|NCT00320788|156377934|FG003|Overall Study|Other|1|||
48596398|NCT00320788|156377935|FG004|Overall Study|Other|1|||
48596399|NCT00320788|156377931|FG000|Overall Study|Physician Decision|1|||
48596400|NCT00320788|156377932|FG001|Overall Study|Physician Decision|1|||
48596401|NCT00320788|156377933|FG002|Overall Study|Physician Decision|0|||
48596402|NCT00320788|156377934|FG003|Overall Study|Physician Decision|0|||
48596403|NCT00320788|156377935|FG004|Overall Study|Physician Decision|0|||
48596404|NCT00320788|156377931|FG000|Overall Study|Protocol Violation|0|||
48596405|NCT00320788|156377932|FG001|Overall Study|Protocol Violation|0|||
48596406|NCT00320788|156377933|FG002|Overall Study|Protocol Violation|0|||
48805208|NCT02799472|157129303|FG000|Overall Study|Lost to Follow-up|0|||
48805209|NCT02799472|157129304|FG001|Overall Study|Lost to Follow-up|1|||
48805210|NCT02696564|157129305|FG000|Overall Study|Death|1|||
48805211|NCT02696564|157129306|FG001|Overall Study|Death|2|||
48805212|NCT02696564|157129305|FG000|Overall Study|Withdrawal by Subject|3|||
48805213|NCT02696564|157129306|FG001|Overall Study|Withdrawal by Subject|2|||
48805214|NCT02696564|157129305|FG000|Overall Study|Lost to Follow-up|3|||
48805215|NCT02696564|157129306|FG001|Overall Study|Lost to Follow-up|3|||
48805216|NCT02696564|157129305|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
48805217|NCT02696564|157129306|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
48805218|NCT02696564|157129305|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
48805219|NCT02696564|157129306|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
48596407|NCT00320788|156377934|FG003|Overall Study|Protocol Violation|0|||
48596408|NCT00320788|156377935|FG004|Overall Study|Protocol Violation|1|||
48596409|NCT00320788|156377931|FG000|Overall Study|Withdrawal by Subject|3|||
48708971|NCT01069900|156784166|FG001|Overall Study|Technical problems|1|||
48708972|NCT01069900|156784165|FG000|Overall Study|Lost to Follow-up|7|||
48708973|NCT01069900|156784166|FG001|Overall Study|Lost to Follow-up|1|||
48708974|NCT01069900|156784165|FG000|Overall Study|Withdrawal by Subject|6|||
48708975|NCT01069900|156784166|FG001|Overall Study|Withdrawal by Subject|1|||
48708976|NCT01069900|156784165|FG000|Overall Study|Protocol Violation|4|||
48708977|NCT01069900|156784166|FG001|Overall Study|Protocol Violation|1|||
48708978|NCT01069900|156784165|FG000|Overall Study|Insufficient Therapeutic effect|1|||
48708979|NCT01069900|156784166|FG001|Overall Study|Insufficient Therapeutic effect|0|||
48708980|NCT01417377|156784168|FG000|Overall Study|Lost to Follow-up|12|||
48708981|NCT01417377|156784168|FG000|Overall Study|Enrolled, but not treated|1|||
48708982|NCT01621802|156784169|FG000|Overall Study|Protocol Violation|0|||
48708983|NCT01621802|156784170|FG001|Overall Study|Protocol Violation|0|||
48708984|NCT01621802|156784171|FG002|Overall Study|Protocol Violation|0|||
48708985|NCT01621802|156784172|FG003|Overall Study|Protocol Violation|0|||
48490613|NCT02570165|155990755|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
48708986|NCT01621802|156784173|FG004|Overall Study|Protocol Violation|0|||
48708987|NCT01621802|156784174|FG005|Overall Study|Protocol Violation|1|||
48490614|NCT02570165|155990756|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
48490615|NCT02570165|155990757|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
48490616|NCT02570165|155990758|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
48490617|NCT02570165|155990752|FG000|Overall Study|Withdrawal Request by GSK|0|||
48490618|NCT02570165|155990753|FG001|Overall Study|Withdrawal Request by GSK|0|||
48490619|NCT02570165|155990754|FG002|Overall Study|Withdrawal Request by GSK|2|||
48490620|NCT02570165|155990755|FG003|Overall Study|Withdrawal Request by GSK|0|||
48490621|NCT02570165|155990756|FG004|Overall Study|Withdrawal Request by GSK|0|||
48708988|NCT01621802|156784169|FG000|Overall Study|Withdrawal by Subject|8|||
48805220|NCT02696564|157129305|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
48805221|NCT02696564|157129306|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
48805222|NCT02696564|157129305|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
48805223|NCT02696564|157129306|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
48805224|NCT02696564|157129305|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
48805225|NCT02696564|157129306|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
48805226|NCT04067401|157129307|FG000|Overall Study|Withdrawal by Subject|7|||
48805227|NCT04067401|157129308|FG001|Overall Study|Withdrawal by Subject|0|||
48805228|NCT04067401|157129307|FG000|Overall Study|no data provided|1|||
48805229|NCT04067401|157129308|FG001|Overall Study|no data provided|0|||
48805230|NCT01722162|157129317|FG000|Overall Study|Withdrawal by Subject|1|||
48805231|NCT01722162|157129318|FG001|Overall Study|Withdrawal by Subject|1|||
48805232|NCT01722162|157129317|FG000|Overall Study|Found ineligible|1|||
48805233|NCT01722162|157129318|FG001|Overall Study|Found ineligible|0|||
48805234|NCT01722162|157129317|FG000|Overall Study|Unrelated to study adverse event|2|||
48805235|NCT01722162|157129318|FG001|Overall Study|Unrelated to study adverse event|2|||
48805236|NCT01722162|157129317|FG000|Overall Study|Adverse Event|1|||
48805237|NCT01722162|157129318|FG001|Overall Study|Adverse Event|1|||
48805238|NCT01722162|157129317|FG000|Overall Study|Insurance denial post enrollment|0|||
48805239|NCT01722162|157129318|FG001|Overall Study|Insurance denial post enrollment|1|||
48805240|NCT01722162|157129317|FG000|Overall Study|Noncompliance|0|||
48805241|NCT01722162|157129318|FG001|Overall Study|Noncompliance|1|||
48805242|NCT02312856|157129320|FG000|Overall Study|Death|1|||
48805243|NCT02312856|157129320|FG000|Overall Study|Lost to Follow-up|3|||
48805244|NCT02309112|157129321|FG000|Overall Study|Withdrawal by Subject|1|||
48805245|NCT02309112|157129322|FG001|Overall Study|Withdrawal by Subject|0|||
48805246|NCT02309112|157129323|FG002|Overall Study|Withdrawal by Subject|1|||
48805247|NCT02309112|157129321|FG000|Overall Study|Lost to Follow-up|0|||
48805248|NCT02309112|157129322|FG001|Overall Study|Lost to Follow-up|1|||
48805249|NCT02309112|157129323|FG002|Overall Study|Lost to Follow-up|0|||
48805250|NCT01892345|157129324|FG000|Overall Study|Adverse Event|0|||
48805251|NCT01892345|157129325|FG001|Overall Study|Adverse Event|2|||
48805252|NCT01892345|157129324|FG000|Overall Study|Death|1|||
48805253|NCT01892345|157129325|FG001|Overall Study|Death|0|||
48805254|NCT01892345|157129324|FG000|Overall Study|Lost to Follow-up|3|||
48805255|NCT01892345|157129325|FG001|Overall Study|Lost to Follow-up|0|||
48805256|NCT01892345|157129324|FG000|Overall Study|Withdrawal by Subject|12|||
48805257|NCT01892345|157129325|FG001|Overall Study|Withdrawal by Subject|1|||
48805258|NCT04673929|157129328|FG000|Overall Study|Death|73|||
48805259|NCT04673929|157129328|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
48805260|NCT00985985|157129331|FG000|Overall Study|Adverse Event|4|||
48805261|NCT00985985|157129332|FG001|Overall Study|Adverse Event|2|||
48805262|NCT00985985|157129333|FG002|Overall Study|Adverse Event|2|||
48805263|NCT00985985|157129334|FG003|Overall Study|Adverse Event|2|||
48805264|NCT00985985|157129331|FG000|Overall Study|Lost to Follow-up|4|||
48805265|NCT00985985|157129332|FG001|Overall Study|Lost to Follow-up|11|||
48805266|NCT00985985|157129333|FG002|Overall Study|Lost to Follow-up|2|||
48805267|NCT00985985|157129334|FG003|Overall Study|Lost to Follow-up|3|||
48805268|NCT00985985|157129331|FG000|Overall Study|Protocol Violation|1|||
48805269|NCT00985985|157129332|FG001|Overall Study|Protocol Violation|2|||
48805270|NCT00985985|157129333|FG002|Overall Study|Protocol Violation|0|||
48805271|NCT00985985|157129334|FG003|Overall Study|Protocol Violation|1|||
48805272|NCT00985985|157129331|FG000|Overall Study|Lack of Efficacy|5|||
48805273|NCT00985985|157129332|FG001|Overall Study|Lack of Efficacy|6|||
48805274|NCT00985985|157129333|FG002|Overall Study|Lack of Efficacy|1|||
48805275|NCT00985985|157129334|FG003|Overall Study|Lack of Efficacy|3|||
48805276|NCT00985985|157129331|FG000|Overall Study|Withdrawal by Subject|4|||
48805277|NCT00985985|157129332|FG001|Overall Study|Withdrawal by Subject|2|||
48805278|NCT00985985|157129333|FG002|Overall Study|Withdrawal by Subject|2|||
48805279|NCT00985985|157129334|FG003|Overall Study|Withdrawal by Subject|2|||
48805280|NCT00985985|157129331|FG000|Overall Study|Other Reason|6|||
48805281|NCT00985985|157129332|FG001|Overall Study|Other Reason|1|||
48805282|NCT00985985|157129333|FG002|Overall Study|Other Reason|4|||
48805283|NCT00985985|157129334|FG003|Overall Study|Other Reason|2|||
48805284|NCT01364597|157129337|FG000|Overall Study|Adverse Event|4|||
48805285|NCT01364597|157129338|FG001|Overall Study|Adverse Event|5|||
48805286|NCT01364597|157129339|FG002|Overall Study|Adverse Event|16|||
48805287|NCT01364597|157129340|FG003|Overall Study|Adverse Event|7|||
48805288|NCT01364597|157129337|FG000|Overall Study|Lack of Efficacy|4|||
48805289|NCT01364597|157129338|FG001|Overall Study|Lack of Efficacy|4|||
48805290|NCT01364597|157129339|FG002|Overall Study|Lack of Efficacy|23|||
48805291|NCT01364597|157129340|FG003|Overall Study|Lack of Efficacy|8|||
48805292|NCT01364597|157129337|FG000|Overall Study|Protocol Violation|0|||
48805293|NCT01364597|157129338|FG001|Overall Study|Protocol Violation|0|||
48805294|NCT01364597|157129339|FG002|Overall Study|Protocol Violation|2|||
48805295|NCT01364597|157129340|FG003|Overall Study|Protocol Violation|0|||
48805296|NCT01364597|157129337|FG000|Overall Study|Lost to Follow-up|0|||
48805297|NCT01364597|157129338|FG001|Overall Study|Lost to Follow-up|0|||
48805298|NCT01364597|157129339|FG002|Overall Study|Lost to Follow-up|5|||
48805299|NCT01364597|157129340|FG003|Overall Study|Lost to Follow-up|3|||
48805300|NCT01364597|157129337|FG000|Overall Study|Withdrawal by Subject|4|||
48805301|NCT01364597|157129338|FG001|Overall Study|Withdrawal by Subject|1|||
48805302|NCT01364597|157129339|FG002|Overall Study|Withdrawal by Subject|18|||
48805303|NCT01364597|157129340|FG003|Overall Study|Withdrawal by Subject|6|||
48805304|NCT01364597|157129337|FG000|Overall Study|Non compliance|1|||
48805305|NCT01364597|157129338|FG001|Overall Study|Non compliance|0|||
48805306|NCT01364597|157129339|FG002|Overall Study|Non compliance|1|||
48805307|NCT01364597|157129340|FG003|Overall Study|Non compliance|0|||
48805308|NCT01364597|157129337|FG000|Overall Study|Lack of compliance|1|||
48805309|NCT01364597|157129338|FG001|Overall Study|Lack of compliance|0|||
48805310|NCT01364597|157129339|FG002|Overall Study|Lack of compliance|0|||
48805311|NCT01364597|157129340|FG003|Overall Study|Lack of compliance|0|||
48805312|NCT01364597|157129337|FG000|Overall Study|End of treatment epilepsy|1|||
48805313|NCT01364597|157129338|FG001|Overall Study|End of treatment epilepsy|0|||
48805314|NCT01364597|157129339|FG002|Overall Study|End of treatment epilepsy|0|||
48805315|NCT01364597|157129340|FG003|Overall Study|End of treatment epilepsy|0|||
48805316|NCT01364597|157129337|FG000|Overall Study|No Seizures|1|||
48805317|NCT01364597|157129338|FG001|Overall Study|No Seizures|0|||
48805318|NCT01364597|157129339|FG002|Overall Study|No Seizures|0|||
48805319|NCT01364597|157129340|FG003|Overall Study|No Seizures|0|||
48805320|NCT01364597|157129337|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
48805321|NCT01364597|157129338|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
48805322|NCT01364597|157129339|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
48805323|NCT01364597|157129340|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
48805324|NCT01364597|157129337|FG000|Overall Study|Cure|1|||
48805325|NCT01364597|157129338|FG001|Overall Study|Cure|0|||
48805326|NCT01364597|157129339|FG002|Overall Study|Cure|0|||
48805327|NCT01364597|157129340|FG003|Overall Study|Cure|0|||
48805328|NCT01364597|157129337|FG000|Overall Study|Patient was moving|0|||
48805329|NCT01364597|157129338|FG001|Overall Study|Patient was moving|1|||
48805330|NCT01364597|157129339|FG002|Overall Study|Patient was moving|0|||
48805331|NCT01364597|157129340|FG003|Overall Study|Patient was moving|0|||
48805332|NCT01364597|157129337|FG000|Overall Study|Seizures resolved|0|||
48490622|NCT02570165|155990757|FG005|Overall Study|Withdrawal Request by GSK|0|||
48805333|NCT01364597|157129338|FG001|Overall Study|Seizures resolved|0|||
48805334|NCT01364597|157129339|FG002|Overall Study|Seizures resolved|1|||
48805335|NCT01364597|157129340|FG003|Overall Study|Seizures resolved|0|||
48490623|NCT02570165|155990758|FG006|Overall Study|Withdrawal Request by GSK|0|||
48805336|NCT01364597|157129337|FG000|Overall Study|Patient became seizure-free after surgery|0|||
48805337|NCT01364597|157129338|FG001|Overall Study|Patient became seizure-free after surgery|0|||
48805338|NCT01364597|157129339|FG002|Overall Study|Patient became seizure-free after surgery|1|||
48805339|NCT01364597|157129340|FG003|Overall Study|Patient became seizure-free after surgery|0|||
48805340|NCT01364597|157129337|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
48708989|NCT01621802|156784170|FG001|Overall Study|Withdrawal by Subject|4|||
48708990|NCT01621802|156784171|FG002|Overall Study|Withdrawal by Subject|4|||
48805341|NCT01364597|157129338|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
48805342|NCT01364597|157129339|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
48805343|NCT01364597|157129340|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
48805344|NCT01364597|157129337|FG000|Overall Study|Patient cured from Epilepsy|0|||
48805345|NCT01364597|157129338|FG001|Overall Study|Patient cured from Epilepsy|0|||
48805346|NCT01364597|157129339|FG002|Overall Study|Patient cured from Epilepsy|1|||
48805347|NCT01364597|157129340|FG003|Overall Study|Patient cured from Epilepsy|0|||
48805348|NCT01364597|157129337|FG000|Overall Study|Investigator decision|0|||
48805349|NCT01364597|157129338|FG001|Overall Study|Investigator decision|0|||
48805350|NCT01364597|157129339|FG002|Overall Study|Investigator decision|1|||
48805351|NCT01364597|157129340|FG003|Overall Study|Investigator decision|0|||
48805352|NCT01364597|157129337|FG000|Overall Study|Sponsor recommended discontinuation|0|||
48805353|NCT01364597|157129338|FG001|Overall Study|Sponsor recommended discontinuation|0|||
48805354|NCT01364597|157129339|FG002|Overall Study|Sponsor recommended discontinuation|0|||
48805355|NCT01364597|157129340|FG003|Overall Study|Sponsor recommended discontinuation|1|||
48805356|NCT01364597|157129337|FG000|Overall Study|Parents went abroad with the patient|0|||
48805357|NCT01364597|157129338|FG001|Overall Study|Parents went abroad with the patient|0|||
48805358|NCT01364597|157129339|FG002|Overall Study|Parents went abroad with the patient|1|||
48805359|NCT01364597|157129340|FG003|Overall Study|Parents went abroad with the patient|0|||
48805360|NCT01364597|157129337|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
48805361|NCT01364597|157129338|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
48805362|NCT01364597|157129339|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
48708991|NCT01621802|156784172|FG003|Overall Study|Withdrawal by Subject|2|||
48708992|NCT01621802|156784173|FG004|Overall Study|Withdrawal by Subject|2|||
48708993|NCT01621802|156784174|FG005|Overall Study|Withdrawal by Subject|0|||
48708994|NCT01621802|156784169|FG000|Overall Study|Migrated/moved from study area|0|||
48708995|NCT01621802|156784170|FG001|Overall Study|Migrated/moved from study area|0|||
48708996|NCT01621802|156784171|FG002|Overall Study|Migrated/moved from study area|2|||
48708997|NCT01621802|156784172|FG003|Overall Study|Migrated/moved from study area|0|||
48708998|NCT01621802|156784173|FG004|Overall Study|Migrated/moved from study area|1|||
48708999|NCT01621802|156784174|FG005|Overall Study|Migrated/moved from study area|0|||
48709000|NCT01621802|156784169|FG000|Overall Study|Others|3|||
48709001|NCT01621802|156784170|FG001|Overall Study|Others|3|||
48709002|NCT01621802|156784171|FG002|Overall Study|Others|3|||
48709003|NCT01621802|156784172|FG003|Overall Study|Others|2|||
48709004|NCT01621802|156784173|FG004|Overall Study|Others|1|||
48709005|NCT01621802|156784174|FG005|Overall Study|Others|0|||
48709006|NCT01621802|156784169|FG000|Overall Study|Lost to Follow-up|36|||
48709007|NCT01621802|156784170|FG001|Overall Study|Lost to Follow-up|16|||
48709008|NCT01621802|156784171|FG002|Overall Study|Lost to Follow-up|24|||
48709009|NCT01621802|156784172|FG003|Overall Study|Lost to Follow-up|7|||
48709010|NCT01621802|156784173|FG004|Overall Study|Lost to Follow-up|31|||
48709011|NCT01621802|156784174|FG005|Overall Study|Lost to Follow-up|11|||
48709012|NCT02948634|156784175|FG000|Overall Study|Lack of efficacy and study suspended|10|||
48709013|NCT02948634|156784176|FG001|Overall Study|Lack of efficacy and study suspended|2|||
48709014|NCT00719472|156784177|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
48709015|NCT00719472|156784177|FG000|Enrolled in Study|Subject decision to withdraw|8|||
48709016|NCT00719472|156784177|FG000|Enrolled in Study|Various Reasons|17|||
48709017|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
48709018|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Death|5|||
48709019|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
48709020|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
48709021|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
48709022|NCT00719472|156784177|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
48709023|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
48709024|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Death|6|||
48709025|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Disease progression|3|||
48709026|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
48709027|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
48709028|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
48709029|NCT00719472|156784177|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
48709030|NCT01149148|156784180|FG000|Overall Study|Lost to Follow-up|1|||
48490624|NCT00410410|155990759|FG000|Induction Period (IP)|Death|1|||
48709031|NCT01149148|156784181|FG001|Overall Study|Lost to Follow-up|2|||
48709032|NCT01149148|156784180|FG000|Overall Study|Death|1|||
48709033|NCT01149148|156784181|FG001|Overall Study|Death|0|||
48709034|NCT00123422|156784184|FG000|Overall Study|Physician Decision|2|||
48709035|NCT00123422|156784185|FG001|Overall Study|Physician Decision|2|||
48709036|NCT00123422|156784186|FG002|Overall Study|Physician Decision|6|||
48709037|NCT00123422|156784184|FG000|Overall Study|Withdrawal by Subject|1|||
48709038|NCT00123422|156784185|FG001|Overall Study|Withdrawal by Subject|2|||
48709039|NCT00123422|156784186|FG002|Overall Study|Withdrawal by Subject|2|||
48709040|NCT00123422|156784184|FG000|Overall Study|Lost to Follow-up|1|||
48709041|NCT00123422|156784185|FG001|Overall Study|Lost to Follow-up|2|||
48709042|NCT00123422|156784186|FG002|Overall Study|Lost to Follow-up|2|||
48709043|NCT04555616|156784187|FG000|Overall Study|Death|1|||
48709044|NCT04555616|156784188|FG001|Overall Study|Death|0|||
48709045|NCT04555616|156784189|FG002|Overall Study|Death|1|||
48709046|NCT04555616|156784187|FG000|Overall Study|Withdrawal by Subject|2|||
48709047|NCT04555616|156784188|FG001|Overall Study|Withdrawal by Subject|1|||
48709048|NCT04555616|156784189|FG002|Overall Study|Withdrawal by Subject|0|||
48709049|NCT03544333|156784190|FG000|Overall Study|Withdrawal by Subject|1|||
48709050|NCT03544333|156784191|FG001|Overall Study|Withdrawal by Subject|0|||
48709051|NCT04816669|156784192|FG000|Part 1|Adverse Event|1|||
48709052|NCT04816669|156784193|FG001|Part 1|Adverse Event|1|||
48709053|NCT04816669|156784194|FG002|Part 1|Adverse Event|0|||
48709054|NCT04816669|156784195|FG003|Part 1|Adverse Event|0|||
48709055|NCT04816669|156784192|FG000|Part 1|Lost to Follow-up|2|||
48709056|NCT04816669|156784193|FG001|Part 1|Lost to Follow-up|2|||
48709057|NCT04816669|156784194|FG002|Part 1|Lost to Follow-up|0|||
48709058|NCT04816669|156784195|FG003|Part 1|Lost to Follow-up|0|||
48709059|NCT04816669|156784192|FG000|Part 1|Protocol Violation|0|||
48709060|NCT04816669|156784193|FG001|Part 1|Protocol Violation|1|||
48709061|NCT04816669|156784194|FG002|Part 1|Protocol Violation|0|||
48709062|NCT04816669|156784195|FG003|Part 1|Protocol Violation|0|||
48709063|NCT04816669|156784192|FG000|Part 1|Withdrawal by Subject|1|||
48709064|NCT04816669|156784193|FG001|Part 1|Withdrawal by Subject|2|||
48709065|NCT04816669|156784194|FG002|Part 1|Withdrawal by Subject|0|||
48709066|NCT04816669|156784195|FG003|Part 1|Withdrawal by Subject|0|||
48709067|NCT04816669|156784192|FG000|Part 2|Other|0|||
48709068|NCT04816669|156784193|FG001|Part 2|Other|0|||
48709069|NCT04816669|156784194|FG002|Part 2|Other|1|||
48709070|NCT04816669|156784195|FG003|Part 2|Other|0|||
48709071|NCT04816669|156784192|FG000|Part 2|Withdrawal by Subject|0|||
48805363|NCT01364597|157129340|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
48490625|NCT00410410|155990760|FG001|Induction Period (IP)|Death|0|||
48490626|NCT00410410|155990761|FG002|Induction Period (IP)|Death|0|||
48490627|NCT00410410|155990762|FG003|Induction Period (IP)|Death|0|||
48490628|NCT00410410|155990763|FG004|Induction Period (IP)|Death|0|||
48490629|NCT00410410|155990764|FG005|Induction Period (IP)|Death|0|||
48490630|NCT00410410|155990765|FG006|Induction Period (IP)|Death|0|||
48490631|NCT00410410|155990766|FG007|Induction Period (IP)|Death|0|||
48709072|NCT04816669|156784193|FG001|Part 2|Withdrawal by Subject|0|||
48709073|NCT04816669|156784194|FG002|Part 2|Withdrawal by Subject|0|||
48709074|NCT04816669|156784195|FG003|Part 2|Withdrawal by Subject|1|||
48709075|NCT04816669|156784192|FG000|Part 2|Lost to Follow-up|0|||
48709076|NCT04816669|156784193|FG001|Part 2|Lost to Follow-up|0|||
48709077|NCT04816669|156784194|FG002|Part 2|Lost to Follow-up|1|||
48709078|NCT04816669|156784195|FG003|Part 2|Lost to Follow-up|0|||
48709079|NCT01528969|156784196|FG000|Overall Study|absent from the school at baseline|2|||
48709080|NCT01528969|156784197|FG001|Overall Study|absent from the school at baseline|0|||
48709081|NCT02282605|156784198|FG000|Overall Study|negative SA result on Day -1|3|||
48709082|NCT02282605|156784199|FG001|Overall Study|negative SA result on Day -1|0|||
48709083|NCT02282605|156784200|FG002|Overall Study|negative SA result on Day -1|0|||
48709084|NCT02399163|156784201|FG000|Overall Study|Adverse Event|2|||
48709085|NCT02399163|156784201|FG000|Overall Study|Protocol Deviation|2|||
48709086|NCT02399163|156784201|FG000|Overall Study|Withdrawal by Participant|5|||
48709087|NCT00808080|156784203|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
48709088|NCT00387790|156784206|FG000|Overall Study|Adverse Event|5|||
48709089|NCT00387790|156784206|FG000|Overall Study|Lack of Efficacy|2|||
48709090|NCT00387790|156784206|FG000|Overall Study|Physician Decision|2|||
48709091|NCT00387790|156784206|FG000|Overall Study|Withdrawal by Subject|3|||
48709092|NCT00387790|156784206|FG000|Overall Study|Ineligible for study|2|||
48709093|NCT03085797|156784207|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
48709094|NCT03085797|156784208|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
48709095|NCT03085797|156784207|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
48709096|NCT03085797|156784208|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
48709097|NCT03085797|156784207|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
48709098|NCT03085797|156784208|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
48709099|NCT02974543|156784211|FG000|Overall Study|Withdrawal by Subject|1|||
48709100|NCT02974543|156784212|FG001|Overall Study|Withdrawal by Subject|0|||
48709101|NCT02597478|156784213|FG000|Overall Study|Withdrawal by Subject|2|||
48709102|NCT02597478|156784214|FG001|Overall Study|Withdrawal by Subject|0|||
48709103|NCT02597478|156784213|FG000|Overall Study|Change of opioid dose|1|||
48709104|NCT02597478|156784214|FG001|Overall Study|Change of opioid dose|0|||
48709105|NCT02597478|156784213|FG000|Overall Study|Insufficient exertional dyspnea|0|||
48709106|NCT02597478|156784214|FG001|Overall Study|Insufficient exertional dyspnea|1|||
48709107|NCT03110770|156784217|FG000|Overall Study|Death|1|||
48709108|NCT03110770|156784218|FG001|Overall Study|Death|0|||
48709109|NCT03110770|156784219|FG002|Overall Study|Death|0|||
48709110|NCT03110770|156784220|FG003|Overall Study|Death|1|||
48709111|NCT03110770|156784221|FG004|Overall Study|Death|0|||
48709112|NCT03110770|156784217|FG000|Overall Study|Enrolled but did not receive product|0|||
48709113|NCT03110770|156784218|FG001|Overall Study|Enrolled but did not receive product|0|||
48709114|NCT03110770|156784219|FG002|Overall Study|Enrolled but did not receive product|0|||
48709115|NCT03110770|156784220|FG003|Overall Study|Enrolled but did not receive product|8|||
48709116|NCT03110770|156784221|FG004|Overall Study|Enrolled but did not receive product|7|||
48709117|NCT03110770|156784217|FG000|Overall Study|Lost to Follow-up|0|||
48709118|NCT03110770|156784218|FG001|Overall Study|Lost to Follow-up|0|||
48709119|NCT03110770|156784219|FG002|Overall Study|Lost to Follow-up|0|||
48709120|NCT03110770|156784220|FG003|Overall Study|Lost to Follow-up|53|||
48709121|NCT03110770|156784221|FG004|Overall Study|Lost to Follow-up|45|||
48709122|NCT03110770|156784217|FG000|Overall Study|Investigator Decision|0|||
48709123|NCT03110770|156784218|FG001|Overall Study|Investigator Decision|0|||
48709124|NCT03110770|156784219|FG002|Overall Study|Investigator Decision|0|||
48709125|NCT03110770|156784220|FG003|Overall Study|Investigator Decision|5|||
48709126|NCT03110770|156784221|FG004|Overall Study|Investigator Decision|3|||
48709127|NCT03110770|156784217|FG000|Overall Study|Withdrawal by Subject|0|||
48709128|NCT03110770|156784218|FG001|Overall Study|Withdrawal by Subject|0|||
48709129|NCT03110770|156784219|FG002|Overall Study|Withdrawal by Subject|0|||
48709130|NCT03110770|156784220|FG003|Overall Study|Withdrawal by Subject|24|||
48709131|NCT03110770|156784221|FG004|Overall Study|Withdrawal by Subject|24|||
48709132|NCT03110770|156784217|FG000|Overall Study|Moved from area|5|||
48596410|NCT00320788|156377932|FG001|Overall Study|Withdrawal by Subject|0|||
48709133|NCT03110770|156784218|FG001|Overall Study|Moved from area|0|||
48709134|NCT03110770|156784219|FG002|Overall Study|Moved from area|2|||
48805364|NCT01364597|157129337|FG000|Overall Study|BRV administration dropout|0|||
48805365|NCT01364597|157129338|FG001|Overall Study|BRV administration dropout|0|||
48709135|NCT03110770|156784220|FG003|Overall Study|Moved from area|42|||
48709136|NCT03110770|156784221|FG004|Overall Study|Moved from area|43|||
48596411|NCT00320788|156377933|FG002|Overall Study|Withdrawal by Subject|0|||
48596412|NCT00320788|156377934|FG003|Overall Study|Withdrawal by Subject|3|||
48709137|NCT03110770|156784217|FG000|Overall Study|Illness/Injury unrelated to product|0|||
48709138|NCT03110770|156784218|FG001|Overall Study|Illness/Injury unrelated to product|0|||
48709139|NCT03110770|156784219|FG002|Overall Study|Illness/Injury unrelated to product|0|||
48709140|NCT03110770|156784220|FG003|Overall Study|Illness/Injury unrelated to product|0|||
48709141|NCT03110770|156784221|FG004|Overall Study|Illness/Injury unrelated to product|1|||
48709142|NCT03198507|156784222|FG000|Overall Study|Withdrawal by Subject|1|||
48709143|NCT03198507|156784223|FG001|Overall Study|Withdrawal by Subject|0|||
48805366|NCT01364597|157129339|FG002|Overall Study|BRV administration dropout|1|||
48805367|NCT01364597|157129340|FG003|Overall Study|BRV administration dropout|0|||
48709144|NCT02888119|156784224|FG000|Overall Study|Lost to Follow-up|5|||
48709145|NCT02888119|156784225|FG001|Overall Study|Lost to Follow-up|4|||
48709146|NCT02888119|156784226|FG002|Overall Study|Lost to Follow-up|0|||
48709147|NCT00241839|156784227|FG000|Overall Study|Withdrawal by Subject|18|||
48709148|NCT00241839|156784228|FG001|Overall Study|Withdrawal by Subject|17|||
48709149|NCT00241839|156784227|FG000|Overall Study|Adverse Event|1|||
48709150|NCT00241839|156784228|FG001|Overall Study|Adverse Event|1|||
48709151|NCT00419952|156784229|FG000|Overall Study|Adverse Event|8|||
48709152|NCT00419952|156784230|FG001|Overall Study|Adverse Event|10|||
48709153|NCT00419952|156784229|FG000|Overall Study|Withdrawal by Subject|44|||
48709154|NCT00419952|156784230|FG001|Overall Study|Withdrawal by Subject|43|||
48709155|NCT00419952|156784229|FG000|Overall Study|Lost to Follow-up|43|||
48805368|NCT01364597|157129337|FG000|Overall Study|Dropout|0|||
48805369|NCT01364597|157129338|FG001|Overall Study|Dropout|0|||
48805370|NCT01364597|157129339|FG002|Overall Study|Dropout|3|||
48596413|NCT00320788|156377935|FG004|Overall Study|Withdrawal by Subject|1|||
48596414|NCT01765569|156377938|FG000|Period B|Withdrawal by Subject|1|||
48596415|NCT01765569|156377938|FG000|Period C|Death|1|||
48596416|NCT00805129|156377939|FG000|Overall Study|Not treated|1|||
48596417|NCT01676012|156377944|FG000|Overall Study|Adverse Event|2|||
48596418|NCT01676012|156377944|FG000|Overall Study|incomplete set of videos|1|||
48596419|NCT01827592|156377945|FG000|Overall Study|Adverse Event|11|||
48596420|NCT01827592|156377946|FG001|Overall Study|Adverse Event|9|||
48596421|NCT01827592|156377947|FG002|Overall Study|Adverse Event|2|||
48596422|NCT01827592|156377945|FG000|Overall Study|Physician Decision|0|||
48596423|NCT01827592|156377946|FG001|Overall Study|Physician Decision|2|||
48596424|NCT01827592|156377947|FG002|Overall Study|Physician Decision|1|||
48596425|NCT01827592|156377945|FG000|Overall Study|Protocol Violation|2|||
48596426|NCT01827592|156377946|FG001|Overall Study|Protocol Violation|1|||
48596427|NCT01827592|156377947|FG002|Overall Study|Protocol Violation|0|||
48596428|NCT01827592|156377945|FG000|Overall Study|Lost to Follow-up|1|||
48805371|NCT01364597|157129340|FG003|Overall Study|Dropout|1|||
48596429|NCT01827592|156377946|FG001|Overall Study|Lost to Follow-up|2|||
48596430|NCT01827592|156377947|FG002|Overall Study|Lost to Follow-up|2|||
48596431|NCT01827592|156377945|FG000|Overall Study|Withdrawal by Subject|12|||
48709156|NCT00419952|156784230|FG001|Overall Study|Lost to Follow-up|34|||
48709157|NCT00419952|156784229|FG000|Overall Study|Protocol Violation|32|||
48805372|NCT01364597|157129337|FG000|Overall Study|Unreliable subject|0|||
48709158|NCT00419952|156784230|FG001|Overall Study|Protocol Violation|24|||
48709159|NCT00419952|156784229|FG000|Overall Study|Pregnancy|4|||
48709160|NCT00419952|156784230|FG001|Overall Study|Pregnancy|2|||
48596432|NCT01827592|156377946|FG001|Overall Study|Withdrawal by Subject|11|||
48596433|NCT01827592|156377947|FG002|Overall Study|Withdrawal by Subject|11|||
48596434|NCT01827592|156377945|FG000|Overall Study|Patient's substantial non-compliance|1|||
48805373|NCT01364597|157129338|FG001|Overall Study|Unreliable subject|0|||
48805374|NCT01364597|157129339|FG002|Overall Study|Unreliable subject|0|||
48805375|NCT01364597|157129340|FG003|Overall Study|Unreliable subject|1|||
48805376|NCT01364597|157129337|FG000|Overall Study|Other|0|||
48805377|NCT01364597|157129338|FG001|Overall Study|Other|0|||
48805378|NCT01364597|157129339|FG002|Overall Study|Other|0|||
48805379|NCT01364597|157129340|FG003|Overall Study|Other|1|||
48805380|NCT05436262|157129343|FG000|Pre-Randomization|Withdrawal by Subject|1|||
48805381|NCT05436262|157129344|FG001|Pre-Randomization|Withdrawal by Subject|0|||
48805382|NCT05436262|157129345|FG002|Pre-Randomization|Withdrawal by Subject|0|||
48805383|NCT05436262|157129343|FG000|Randomization|Withdrawal by Subject|0|||
48805384|NCT05436262|157129344|FG001|Randomization|Withdrawal by Subject|1|||
48805385|NCT05436262|157129345|FG002|Randomization|Withdrawal by Subject|0|||
48805386|NCT03324880|157129348|FG000|Overall Study|Adverse Event|0|||
48805387|NCT03324880|157129349|FG001|Overall Study|Adverse Event|2|||
48805388|NCT03324880|157129348|FG000|Overall Study|Withdrawal by Subject|2|||
48805389|NCT03324880|157129349|FG001|Overall Study|Withdrawal by Subject|2|||
48805390|NCT03324880|157129348|FG000|Overall Study|Lost to Follow-up|0|||
48805391|NCT03324880|157129349|FG001|Overall Study|Lost to Follow-up|1|||
48709161|NCT00419952|156784229|FG000|Overall Study|Physician Decision|1|||
48709162|NCT00419952|156784230|FG001|Overall Study|Physician Decision|3|||
48709163|NCT00419952|156784229|FG000|Overall Study|Incorrectly enrolled|10|||
48709164|NCT00419952|156784230|FG001|Overall Study|Incorrectly enrolled|3|||
48709165|NCT00419952|156784229|FG000|Overall Study|Intake of prohibited medication|2|||
48709166|NCT00419952|156784230|FG001|Overall Study|Intake of prohibited medication|2|||
48709167|NCT00419952|156784229|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
48709168|NCT00419952|156784230|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
48709169|NCT00419952|156784229|FG000|Overall Study|Diary or medication non-compliance|2|||
48709170|NCT00419952|156784230|FG001|Overall Study|Diary or medication non-compliance|4|||
48709171|NCT00419952|156784229|FG000|Overall Study|Abnormal ECG|1|||
48709172|NCT00419952|156784230|FG001|Overall Study|Abnormal ECG|0|||
48709173|NCT02675634|156784231|FG000|Test Period 1|Adverse Event|0|||
48709174|NCT02675634|156784232|FG001|Test Period 1|Adverse Event|1|||
48709175|NCT02675634|156784233|FG002|Test Period 1|Adverse Event|0|||
48709176|NCT02675634|156784234|FG003|Test Period 1|Adverse Event|1|||
48709177|NCT02675634|156784235|FG004|Test Period 1|Adverse Event|0|||
48709178|NCT02675634|156784236|FG005|Test Period 1|Adverse Event|0|||
48709179|NCT02675634|156784231|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
48709180|NCT02675634|156784232|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
48709181|NCT02675634|156784233|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
48709182|NCT02675634|156784234|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
48709183|NCT02675634|156784235|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
48709184|NCT02675634|156784236|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
48709185|NCT02675634|156784231|FG000|Test Period 2|Lack of Efficacy|1|||
48709186|NCT02675634|156784232|FG001|Test Period 2|Lack of Efficacy|0|||
48709187|NCT02675634|156784233|FG002|Test Period 2|Lack of Efficacy|0|||
48709188|NCT02675634|156784234|FG003|Test Period 2|Lack of Efficacy|0|||
48709189|NCT02675634|156784235|FG004|Test Period 2|Lack of Efficacy|0|||
48709190|NCT02675634|156784236|FG005|Test Period 2|Lack of Efficacy|0|||
48709191|NCT02675634|156784231|FG000|Test Period 2|Adverse Event|0|||
48805392|NCT03324880|157129348|FG000|Overall Study|Product Recall|0|||
48805393|NCT03324880|157129349|FG001|Overall Study|Product Recall|1|||
48805394|NCT00116272|157129350|FG000|Overall Study|Lost to Follow-up|11|||
48709192|NCT02675634|156784232|FG001|Test Period 2|Adverse Event|0|||
48709193|NCT02675634|156784233|FG002|Test Period 2|Adverse Event|0|||
48709194|NCT02675634|156784234|FG003|Test Period 2|Adverse Event|0|||
48709195|NCT02675634|156784235|FG004|Test Period 2|Adverse Event|0|||
48709196|NCT02675634|156784236|FG005|Test Period 2|Adverse Event|1|||
48709197|NCT01652534|156784237|FG000|Overall Study|Lack of Efficacy|1|||
48805395|NCT00116272|157129351|FG001|Overall Study|Lost to Follow-up|6|||
48805396|NCT00405639|157129354|FG000|Overall Study|Withdrawal by Subject|1|||
48490632|NCT00410410|155990767|FG008|Induction Period (IP)|Death|0|||
48490633|NCT00410410|155990759|FG000|Induction Period (IP)|Adverse Event|3|||
48490634|NCT00410410|155990760|FG001|Induction Period (IP)|Adverse Event|4|||
48490635|NCT00410410|155990761|FG002|Induction Period (IP)|Adverse Event|2|||
48490636|NCT00410410|155990762|FG003|Induction Period (IP)|Adverse Event|4|||
48490637|NCT00410410|155990763|FG004|Induction Period (IP)|Adverse Event|1|||
48709198|NCT01652534|156784238|FG001|Overall Study|Lack of Efficacy|0|||
48709199|NCT01411891|156784239|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
48709200|NCT01411891|156784240|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
48709201|NCT03860259|156784248|FG000|Overall Study|Lost to Follow-up|5|||
48709202|NCT03860259|156784249|FG001|Overall Study|Lost to Follow-up|5|||
48709203|NCT03860259|156784248|FG000|Overall Study|Protocol Violation|1|||
48709204|NCT03860259|156784249|FG001|Overall Study|Protocol Violation|0|||
48709205|NCT00392769|156784254|FG000|Overall Study|Clinical Deterioration|9|||
48709206|NCT00392769|156784254|FG000|Overall Study|Adverse Event|1|||
48709207|NCT02280408|156784255|FG000|Overall Study|Lost to Follow-up|0|||
48709208|NCT02280408|156784256|FG001|Overall Study|Lost to Follow-up|2|||
48709209|NCT02280408|156784257|FG002|Overall Study|Lost to Follow-up|0|||
48709210|NCT02280408|156784258|FG003|Overall Study|Lost to Follow-up|0|||
48709211|NCT00470275|156784259|FG000|Overall Study|Death|1|||
48709212|NCT00470275|156784259|FG000|Overall Study|Lack of Efficacy|7|||
48709213|NCT00470275|156784259|FG000|Overall Study|Withdrawal by Subject|2|||
48709214|NCT02474069|156784260|FG000|Selection Phase (SP)|Adverse Event|8|||
48709215|NCT02474069|156784261|FG001|Selection Phase (SP)|Adverse Event|0|||
48709216|NCT02474069|156784262|FG002|Selection Phase (SP)|Adverse Event|0|||
48709217|NCT02474069|156784260|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
48709218|NCT02474069|156784261|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
48709219|NCT02474069|156784262|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
48709220|NCT02474069|156784260|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
48709221|NCT02474069|156784261|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
48709222|NCT02474069|156784262|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
48709223|NCT02474069|156784260|FG000|Selection Phase (SP)|Physician Decision|1|||
48709224|NCT02474069|156784261|FG001|Selection Phase (SP)|Physician Decision|0|||
48709225|NCT02474069|156784262|FG002|Selection Phase (SP)|Physician Decision|0|||
48709226|NCT02474069|156784260|FG000|Selection Phase (SP)|Protocol Violation|1|||
48709227|NCT02474069|156784261|FG001|Selection Phase (SP)|Protocol Violation|0|||
48709228|NCT02474069|156784262|FG002|Selection Phase (SP)|Protocol Violation|0|||
48709229|NCT02474069|156784260|FG000|Selection Phase (SP)|No longer requires treatment|1|||
48709230|NCT02474069|156784261|FG001|Selection Phase (SP)|No longer requires treatment|0|||
48709231|NCT02474069|156784262|FG002|Selection Phase (SP)|No longer requires treatment|0|||
48709232|NCT02474069|156784260|FG000|Selection Phase (SP)|Technical Problem|1|||
48709233|NCT02474069|156784261|FG001|Selection Phase (SP)|Technical Problem|0|||
48709234|NCT02474069|156784262|FG002|Selection Phase (SP)|Technical Problem|0|||
48709235|NCT02474069|156784260|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
48709236|NCT02474069|156784261|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
48709237|NCT02474069|156784262|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
48709238|NCT02474069|156784260|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
48709239|NCT02474069|156784261|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
48709240|NCT02474069|156784262|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
48709241|NCT02474069|156784260|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
48709242|NCT02474069|156784261|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
48709243|NCT02474069|156784262|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
48709244|NCT02474069|156784260|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
48709245|NCT02474069|156784261|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
48709246|NCT02474069|156784262|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
48709247|NCT02474069|156784260|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
48709248|NCT02474069|156784261|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
48709249|NCT02474069|156784262|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
48709250|NCT02474069|156784260|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
48709251|NCT02474069|156784261|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
48709252|NCT02474069|156784262|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
48709253|NCT00035932|156784268|FG000|Overall Study|Adverse Event|10|||
48709254|NCT00035932|156784269|FG001|Overall Study|Adverse Event|9|||
48709255|NCT00035932|156784270|FG002|Overall Study|Adverse Event|9|||
48709256|NCT00035932|156784268|FG000|Overall Study|Death|0|||
48709257|NCT00035932|156784269|FG001|Overall Study|Death|0|||
48709258|NCT00035932|156784270|FG002|Overall Study|Death|1|||
48709259|NCT00035932|156784268|FG000|Overall Study|Disease Progression / Relapse|1|||
48709260|NCT00035932|156784269|FG001|Overall Study|Disease Progression / Relapse|1|||
48709261|NCT00035932|156784270|FG002|Overall Study|Disease Progression / Relapse|0|||
48709262|NCT00035932|156784268|FG000|Overall Study|Lost to Follow-up|4|||
48709263|NCT00035932|156784269|FG001|Overall Study|Lost to Follow-up|4|||
48709264|NCT00035932|156784270|FG002|Overall Study|Lost to Follow-up|3|||
48709265|NCT00035932|156784268|FG000|Overall Study|Noncompliance|6|||
48709266|NCT00035932|156784269|FG001|Overall Study|Noncompliance|7|||
48709267|NCT00035932|156784270|FG002|Overall Study|Noncompliance|6|||
48709268|NCT00035932|156784268|FG000|Overall Study|Protocol Violation While on Study|0|||
48709269|NCT00035932|156784269|FG001|Overall Study|Protocol Violation While on Study|1|||
48709270|NCT00035932|156784270|FG002|Overall Study|Protocol Violation While on Study|2|||
48709271|NCT00035932|156784268|FG000|Overall Study|Withdrawal by Subject|1|||
48709272|NCT00035932|156784269|FG001|Overall Study|Withdrawal by Subject|5|||
48709273|NCT00035932|156784270|FG002|Overall Study|Withdrawal by Subject|0|||
48709274|NCT00035932|156784268|FG000|Overall Study|Study Termination by Sponsor|1|||
48709275|NCT00035932|156784269|FG001|Overall Study|Study Termination by Sponsor|0|||
48709276|NCT00035932|156784270|FG002|Overall Study|Study Termination by Sponsor|0|||
48709277|NCT00035932|156784268|FG000|Overall Study|Lack of Efficacy|33|||
48709278|NCT00035932|156784269|FG001|Overall Study|Lack of Efficacy|33|||
48709279|NCT00035932|156784270|FG002|Overall Study|Lack of Efficacy|28|||
48709280|NCT02284243|156784271|FG000|Overall Study|Lack of Efficacy|3|||
48709281|NCT02284243|156784272|FG001|Overall Study|Lack of Efficacy|3|||
48709282|NCT02284243|156784271|FG000|Overall Study|Adverse Event|1|||
48709283|NCT02284243|156784272|FG001|Overall Study|Adverse Event|0|||
48709284|NCT00125164|156784273|FG000|Overall Study|Adverse Event|0|||
48709285|NCT00125164|156784274|FG001|Overall Study|Adverse Event|0|||
48709286|NCT00125164|156784275|FG002|Overall Study|Adverse Event|2|||
48709287|NCT00125164|156784276|FG003|Overall Study|Adverse Event|4|||
48709288|NCT00125164|156784273|FG000|Overall Study|Lost to Follow-up|0|||
48709289|NCT00125164|156784274|FG001|Overall Study|Lost to Follow-up|0|||
48709290|NCT00125164|156784275|FG002|Overall Study|Lost to Follow-up|1|||
48709291|NCT00125164|156784276|FG003|Overall Study|Lost to Follow-up|1|||
48709292|NCT00125164|156784273|FG000|Overall Study|Withdrawal by Subject|2|||
48709293|NCT00125164|156784274|FG001|Overall Study|Withdrawal by Subject|0|||
48709294|NCT00125164|156784275|FG002|Overall Study|Withdrawal by Subject|1|||
48709295|NCT00125164|156784276|FG003|Overall Study|Withdrawal by Subject|1|||
48709296|NCT04080167|156784277|FG000|Overall Study|Lost to Follow-up-Patients|7|||
48709297|NCT04080167|156784278|FG001|Overall Study|Lost to Follow-up-Patients|14|||
48709298|NCT04080167|156784279|FG002|Overall Study|Lost to Follow-up-Patients|0|||
48709299|NCT04080167|156784277|FG000|Overall Study|Lost to Follow-up-Providers|2|||
48805397|NCT00405639|157129355|FG001|Overall Study|Withdrawal by Subject|0|||
48805398|NCT00405639|157129354|FG000|Overall Study|Adverse Event|1|||
48805399|NCT00405639|157129355|FG001|Overall Study|Adverse Event|0|||
48805400|NCT00405639|157129354|FG000|Overall Study|Seizure prior to receiving BNP|1|||
48805401|NCT00405639|157129355|FG001|Overall Study|Seizure prior to receiving BNP|0|||
48805402|NCT05076149|157129356|FG000|Overall Study|Adverse Event|3|||
48805403|NCT05076149|157129357|FG001|Overall Study|Adverse Event|9|||
48805404|NCT05076149|157129356|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
48805405|NCT05076149|157129357|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
48805406|NCT05076149|157129356|FG000|Overall Study|Lost to Follow-up|0|||
48805407|NCT05076149|157129357|FG001|Overall Study|Lost to Follow-up|1|||
48805408|NCT05076149|157129356|FG000|Overall Study|Commercial drug is available for participant|0|||
48805409|NCT05076149|157129357|FG001|Overall Study|Commercial drug is available for participant|1|||
48805410|NCT05076149|157129356|FG000|Overall Study|Other non compliance|1|||
48805411|NCT05076149|157129357|FG001|Overall Study|Other non compliance|1|||
48805412|NCT05076149|157129356|FG000|Overall Study|Physician Decision|0|||
48805413|NCT05076149|157129357|FG001|Overall Study|Physician Decision|1|||
48805414|NCT05076149|157129356|FG000|Overall Study|Other|5|||
48805415|NCT05076149|157129357|FG001|Overall Study|Other|4|||
48805416|NCT05096208|157129358|FG000|Overall Study|Lost to Follow-up|3|||
48805417|NCT05096208|157129359|FG001|Overall Study|Lost to Follow-up|5|||
48805418|NCT05096208|157129360|FG002|Overall Study|Lost to Follow-up|5|||
48805419|NCT05096208|157129361|FG003|Overall Study|Lost to Follow-up|2|||
48805420|NCT05096208|157129358|FG000|Overall Study|Withdrawal by Subject|0|||
48805421|NCT05096208|157129359|FG001|Overall Study|Withdrawal by Subject|1|||
48805422|NCT05096208|157129360|FG002|Overall Study|Withdrawal by Subject|2|||
48805423|NCT05096208|157129361|FG003|Overall Study|Withdrawal by Subject|3|||
48805424|NCT05096208|157129358|FG000|Overall Study|No longer met eligibility criteria|1|||
48805425|NCT05096208|157129359|FG001|Overall Study|No longer met eligibility criteria|0|||
48709300|NCT04080167|156784278|FG001|Overall Study|Lost to Follow-up-Providers|2|||
48709301|NCT04080167|156784279|FG002|Overall Study|Lost to Follow-up-Providers|0|||
48709302|NCT04080167|156784277|FG000|Overall Study|Withdrawal by Subject|1|||
48709303|NCT04080167|156784278|FG001|Overall Study|Withdrawal by Subject|2|||
48709304|NCT04080167|156784279|FG002|Overall Study|Withdrawal by Subject|0|||
48709305|NCT04080167|156784277|FG000|Overall Study|Withdrawal by Provider|0|||
48709306|NCT04080167|156784278|FG001|Overall Study|Withdrawal by Provider|0|||
48709307|NCT04080167|156784279|FG002|Overall Study|Withdrawal by Provider|4|||
48709308|NCT04080167|156784277|FG000|Overall Study|Death-Patient|2|||
48709309|NCT04080167|156784278|FG001|Overall Study|Death-Patient|1|||
48709310|NCT04080167|156784279|FG002|Overall Study|Death-Patient|0|||
48709311|NCT04080167|156784277|FG000|Overall Study|Hydroxyurea New Starts|0|||
48805426|NCT05096208|157129360|FG002|Overall Study|No longer met eligibility criteria|0|||
48805427|NCT05096208|157129361|FG003|Overall Study|No longer met eligibility criteria|0|||
48805428|NCT05096208|157129358|FG000|Overall Study|Other|0|||
48805429|NCT05096208|157129359|FG001|Overall Study|Other|0|||
48805430|NCT05096208|157129360|FG002|Overall Study|Other|1|||
48805431|NCT05096208|157129361|FG003|Overall Study|Other|0|||
48805432|NCT00612534|157129362|FG000|Overall Study|Adverse Event|0|||
48805433|NCT00612534|157129363|FG001|Overall Study|Adverse Event|4|||
48805434|NCT00612534|157129364|FG002|Overall Study|Adverse Event|2|||
48805435|NCT00612534|157129365|FG003|Overall Study|Adverse Event|1|||
48805436|NCT00612534|157129362|FG000|Overall Study|Lack of Efficacy|13|||
48805437|NCT00612534|157129363|FG001|Overall Study|Lack of Efficacy|12|||
48805438|NCT00612534|157129364|FG002|Overall Study|Lack of Efficacy|5|||
48805439|NCT00612534|157129365|FG003|Overall Study|Lack of Efficacy|16|||
48805440|NCT00612534|157129362|FG000|Overall Study|Other Reason|0|||
48805441|NCT00612534|157129363|FG001|Overall Study|Other Reason|1|||
48805442|NCT00612534|157129364|FG002|Overall Study|Other Reason|0|||
48805443|NCT00612534|157129365|FG003|Overall Study|Other Reason|0|||
48805444|NCT04043962|157129366|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
48805445|NCT04043962|157129366|FG000|Post-Treatment|Withdrawal by Subject|5|||
48805446|NCT04043962|157129366|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
48805447|NCT01521884|157129369|FG000|Overall Study|Non Responders|10|||
48805448|NCT01521884|157129369|FG000|Overall Study|Adverse Event|5|||
48805449|NCT01521884|157129369|FG000|Overall Study|Pregnancy|1|||
48490638|NCT00410410|155990764|FG005|Induction Period (IP)|Adverse Event|0|||
48490639|NCT00410410|155990765|FG006|Induction Period (IP)|Adverse Event|0|||
48805450|NCT01521884|157129369|FG000|Overall Study|Withdrawal by Subject|1|||
48596435|NCT01827592|156377946|FG001|Overall Study|Patient's substantial non-compliance|1|||
48805451|NCT01521884|157129369|FG000|Overall Study|Physician Decision|2|||
48805452|NCT01521884|157129369|FG000|Overall Study|Protocol Violation|3|||
48805453|NCT01521884|157129369|FG000|Overall Study|Participant non-eligible|1|||
48805454|NCT01521884|157129369|FG000|Overall Study|Lost to Follow-up|4|||
48805455|NCT05170841|157129370|FG000|Single Dose Phase|Adverse Event|1|||
48805456|NCT05170841|157129371|FG001|Single Dose Phase|Adverse Event|2|||
48805457|NCT05170841|157129372|FG002|Single Dose Phase|Adverse Event|0|||
48596436|NCT01827592|156377947|FG002|Overall Study|Patient's substantial non-compliance|6|||
48596437|NCT01827592|156377945|FG000|Overall Study|Trial terminated by Sponsor|47|||
48596438|NCT01827592|156377946|FG001|Overall Study|Trial terminated by Sponsor|53|||
48596439|NCT01827592|156377947|FG002|Overall Study|Trial terminated by Sponsor|51|||
48490640|NCT00410410|155990766|FG007|Induction Period (IP)|Adverse Event|0|||
48490641|NCT00410410|155990767|FG008|Induction Period (IP)|Adverse Event|0|||
48490642|NCT00410410|155990759|FG000|Induction Period (IP)|Lack of Efficacy|26|||
48596440|NCT01827592|156377945|FG000|Overall Study|Others|0|||
48596441|NCT01827592|156377946|FG001|Overall Study|Others|1|||
48596442|NCT01827592|156377947|FG002|Overall Study|Others|3|||
48596443|NCT02324361|156377952|FG000|Overall Study|Lost to Follow-up|5|||
48596444|NCT02324361|156377953|FG001|Overall Study|Lost to Follow-up|2|||
48596445|NCT03518086|156377963|FG000|Overall Study|Adverse Event|23|||
48490643|NCT00410410|155990760|FG001|Induction Period (IP)|Lack of Efficacy|24|||
48490644|NCT00410410|155990761|FG002|Induction Period (IP)|Lack of Efficacy|8|||
48490645|NCT00410410|155990762|FG003|Induction Period (IP)|Lack of Efficacy|8|||
48490646|NCT00410410|155990763|FG004|Induction Period (IP)|Lack of Efficacy|7|||
48490647|NCT00410410|155990764|FG005|Induction Period (IP)|Lack of Efficacy|7|||
48490648|NCT00410410|155990765|FG006|Induction Period (IP)|Lack of Efficacy|0|||
48490649|NCT00410410|155990766|FG007|Induction Period (IP)|Lack of Efficacy|0|||
48490650|NCT00410410|155990767|FG008|Induction Period (IP)|Lack of Efficacy|0|||
48490651|NCT00410410|155990759|FG000|Induction Period (IP)|Lost to Follow-up|2|||
48596446|NCT03518086|156377964|FG001|Overall Study|Adverse Event|15|||
48596447|NCT03518086|156377965|FG002|Overall Study|Adverse Event|0|||
48805458|NCT05170841|157129373|FG003|Single Dose Phase|Adverse Event|2|||
48805459|NCT05170841|157129370|FG000|Multiple Dose Phase|Adverse Event|1|||
48490652|NCT00410410|155990760|FG001|Induction Period (IP)|Lost to Follow-up|2|||
48490653|NCT00410410|155990761|FG002|Induction Period (IP)|Lost to Follow-up|2|||
48805460|NCT05170841|157129371|FG001|Multiple Dose Phase|Adverse Event|2|||
48805461|NCT05170841|157129372|FG002|Multiple Dose Phase|Adverse Event|1|||
48805462|NCT05170841|157129373|FG003|Multiple Dose Phase|Adverse Event|4|||
48490654|NCT00410410|155990762|FG003|Induction Period (IP)|Lost to Follow-up|3|||
48490655|NCT00410410|155990763|FG004|Induction Period (IP)|Lost to Follow-up|0|||
48596448|NCT03518086|156377966|FG003|Overall Study|Adverse Event|0|||
48596449|NCT03518086|156377963|FG000|Overall Study|Withdrawal by Subject|8|||
48596450|NCT03518086|156377964|FG001|Overall Study|Withdrawal by Subject|5|||
48596451|NCT03518086|156377965|FG002|Overall Study|Withdrawal by Subject|0|||
48490656|NCT00410410|155990764|FG005|Induction Period (IP)|Lost to Follow-up|1|||
48596452|NCT03518086|156377966|FG003|Overall Study|Withdrawal by Subject|0|||
48596453|NCT03518086|156377963|FG000|Overall Study|Lack of Efficacy|5|||
48805463|NCT05170841|157129370|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
48805464|NCT05170841|157129371|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
48805465|NCT05170841|157129372|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
48805466|NCT05170841|157129373|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
48805467|NCT00903786|157129376|FG000|Overall Study|Physician Decision|6|||
48805468|NCT00903786|157129376|FG000|Overall Study|Lack of Efficacy|5|||
48805469|NCT00903786|157129376|FG000|Overall Study|Reason other than lack of efficacy|4|||
48805470|NCT00746096|157129377|FG000|Overall Study|Adverse Event|1|||
48805471|NCT00746096|157129378|FG001|Overall Study|Adverse Event|0|||
48805472|NCT00746096|157129377|FG000|Overall Study|Withdrawal by Subject|5|||
48805473|NCT00746096|157129378|FG001|Overall Study|Withdrawal by Subject|1|||
48805474|NCT00746096|157129377|FG000|Overall Study|Lost to Follow-up|2|||
48805475|NCT00746096|157129378|FG001|Overall Study|Lost to Follow-up|1|||
48805476|NCT00746096|157129377|FG000|Overall Study|Protocol Violation|1|||
48805477|NCT00746096|157129378|FG001|Overall Study|Protocol Violation|0|||
48805478|NCT00746096|157129377|FG000|Overall Study|No study drug treatment|1|||
48805479|NCT00746096|157129378|FG001|Overall Study|No study drug treatment|1|||
48805480|NCT01852058|157129379|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
48805481|NCT01852058|157129380|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805482|NCT01852058|157129381|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805483|NCT01852058|157129382|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805484|NCT01852058|157129383|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805485|NCT01852058|157129384|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805486|NCT01852058|157129385|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805487|NCT01852058|157129386|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805488|NCT01852058|157129387|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805489|NCT01852058|157129388|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805490|NCT01852058|157129389|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805491|NCT01852058|157129390|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
48805492|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805493|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805494|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48490657|NCT00410410|155990765|FG006|Induction Period (IP)|Lost to Follow-up|0|||
48805495|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805496|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
48805497|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805498|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805499|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805500|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805501|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805502|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805503|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
48805504|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805505|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805506|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48490658|NCT00410410|155990766|FG007|Induction Period (IP)|Lost to Follow-up|0|||
48490659|NCT00410410|155990767|FG008|Induction Period (IP)|Lost to Follow-up|0|||
48490660|NCT00410410|155990759|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
48490661|NCT00410410|155990760|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
48490662|NCT00410410|155990761|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
48490663|NCT00410410|155990762|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
48490664|NCT00410410|155990763|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
48490665|NCT00410410|155990764|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
48596454|NCT03518086|156377964|FG001|Overall Study|Lack of Efficacy|5|||
48596455|NCT03518086|156377965|FG002|Overall Study|Lack of Efficacy|0|||
48805507|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805508|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
48490666|NCT00410410|155990765|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
48490667|NCT00410410|155990766|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
48490668|NCT00410410|155990767|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
48490669|NCT00410410|155990759|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
48596456|NCT03518086|156377966|FG003|Overall Study|Lack of Efficacy|0|||
48596457|NCT03518086|156377963|FG000|Overall Study|Protocol Violation|1|||
48490670|NCT00410410|155990760|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
48490671|NCT00410410|155990761|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
48490672|NCT00410410|155990762|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
48490673|NCT00410410|155990763|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
48490674|NCT00410410|155990764|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
48490675|NCT00410410|155990765|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
48490676|NCT00410410|155990766|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
48490677|NCT00410410|155990767|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
48490678|NCT00410410|155990759|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
48490679|NCT00410410|155990760|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
48490680|NCT00410410|155990761|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
48490681|NCT00410410|155990762|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
48490682|NCT00410410|155990763|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
48490683|NCT00410410|155990764|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
48490684|NCT00410410|155990765|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
48490685|NCT00410410|155990766|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
48490686|NCT00410410|155990767|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
48490687|NCT00410410|155990759|FG000|Induction Period (IP)|Other|0|||
48709312|NCT04080167|156784278|FG001|Overall Study|Hydroxyurea New Starts|0|||
48709313|NCT04080167|156784279|FG002|Overall Study|Hydroxyurea New Starts|1|||
48709314|NCT04080167|156784277|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
48709315|NCT04080167|156784278|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
48709316|NCT04080167|156784279|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
48709317|NCT03339219|156784280|FG000|Overall Study|Death|12|||
48709318|NCT03339219|156784280|FG000|Overall Study|Site Terminated by Sponsor|22|||
48709319|NCT03339219|156784280|FG000|Overall Study|Withdrawal by Subject|1|||
48709320|NCT02167139|156784281|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
48709321|NCT02167139|156784282|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
48709322|NCT02167139|156784283|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
48709323|NCT02167139|156784284|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
48709324|NCT02167139|156784281|FG000|Randomised, Double-blind|Adverse Event|2|||
48709325|NCT02167139|156784282|FG001|Randomised, Double-blind|Adverse Event|9|||
48709326|NCT02167139|156784283|FG002|Randomised, Double-blind|Adverse Event|0|||
48709327|NCT02167139|156784284|FG003|Randomised, Double-blind|Adverse Event|0|||
48709328|NCT02167139|156784281|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
48709329|NCT02167139|156784282|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
48709330|NCT02167139|156784283|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
48709331|NCT02167139|156784284|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
48709332|NCT02167139|156784281|FG000|Randomised, Double-blind|Other|3|||
48709333|NCT02167139|156784282|FG001|Randomised, Double-blind|Other|0|||
48490688|NCT00410410|155990760|FG001|Induction Period (IP)|Other|0|||
48490689|NCT00410410|155990761|FG002|Induction Period (IP)|Other|1|||
48490690|NCT00410410|155990762|FG003|Induction Period (IP)|Other|0|||
48709334|NCT02167139|156784283|FG002|Randomised, Double-blind|Other|0|||
48709335|NCT02167139|156784284|FG003|Randomised, Double-blind|Other|0|||
48709336|NCT02167139|156784281|FG000|Transition-extension|Adverse Event|2|||
48709337|NCT02167139|156784282|FG001|Transition-extension|Adverse Event|0|||
48709338|NCT02167139|156784283|FG002|Transition-extension|Adverse Event|2|||
48709339|NCT02167139|156784284|FG003|Transition-extension|Adverse Event|3|||
48709340|NCT02167139|156784281|FG000|Transition-extension|Withdrawal by Subject|2|||
48709341|NCT02167139|156784282|FG001|Transition-extension|Withdrawal by Subject|0|||
48709342|NCT02167139|156784283|FG002|Transition-extension|Withdrawal by Subject|4|||
48709343|NCT02167139|156784284|FG003|Transition-extension|Withdrawal by Subject|1|||
48709344|NCT02167139|156784281|FG000|Transition-extension|Lack of Efficacy|0|||
48805509|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
48805510|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805511|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805512|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805513|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805514|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805515|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
48805516|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805517|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805518|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805519|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805520|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
48805521|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805522|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805523|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805524|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805525|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805526|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48490691|NCT00410410|155990763|FG004|Induction Period (IP)|Other|0|||
48490692|NCT00410410|155990764|FG005|Induction Period (IP)|Other|0|||
48490693|NCT00410410|155990765|FG006|Induction Period (IP)|Other|0|||
48490694|NCT00410410|155990766|FG007|Induction Period (IP)|Other|0|||
48490695|NCT00410410|155990767|FG008|Induction Period (IP)|Other|0|||
48490696|NCT00410410|155990759|FG000|Maintenance Period (MP)|Death|0|||
48490697|NCT00410410|155990760|FG001|Maintenance Period (MP)|Death|0|||
48490698|NCT00410410|155990761|FG002|Maintenance Period (MP)|Death|0|||
48490699|NCT00410410|155990762|FG003|Maintenance Period (MP)|Death|0|||
48709345|NCT02167139|156784282|FG001|Transition-extension|Lack of Efficacy|0|||
48709346|NCT02167139|156784283|FG002|Transition-extension|Lack of Efficacy|1|||
48709347|NCT02167139|156784284|FG003|Transition-extension|Lack of Efficacy|1|||
48805527|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
48805528|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805529|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805530|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805531|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805532|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
48805533|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
48805534|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805535|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805536|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805537|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805538|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805539|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
48805540|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805541|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805542|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805543|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
48805544|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805545|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805546|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805547|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805548|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805549|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805550|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805551|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
48805552|NCT01852058|157129379|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805553|NCT01852058|157129380|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805554|NCT01852058|157129381|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48709348|NCT02167139|156784281|FG000|Transition-extension|Other|1|||
48709349|NCT02167139|156784282|FG001|Transition-extension|Other|0|||
48709350|NCT02167139|156784283|FG002|Transition-extension|Other|1|||
48709351|NCT02167139|156784284|FG003|Transition-extension|Other|0|||
48709352|NCT02167139|156784281|FG000|Transition-extension|Lost to Follow-up|1|||
48709353|NCT02167139|156784282|FG001|Transition-extension|Lost to Follow-up|0|||
48709354|NCT02167139|156784283|FG002|Transition-extension|Lost to Follow-up|0|||
48709355|NCT02167139|156784284|FG003|Transition-extension|Lost to Follow-up|0|||
48709356|NCT01146795|156784285|FG000|Overall Study|Withdrawal by Subject|4|||
48709357|NCT01146795|156784285|FG000|Overall Study|Adverse Event|6|||
48709358|NCT01146795|156784285|FG000|Overall Study|Still in treatment at study closure|10|||
48709359|NCT00845897|156784288|FG000|Overall Study|Lost to Follow-up|1|||
48709360|NCT00845897|156784289|FG001|Overall Study|Lost to Follow-up|1|||
48709361|NCT00845897|156784290|FG002|Overall Study|Lost to Follow-up|0|||
48709362|NCT00845897|156784288|FG000|Overall Study|Withdrawal by Subject|0|||
48709363|NCT00845897|156784289|FG001|Overall Study|Withdrawal by Subject|3|||
48709364|NCT00845897|156784290|FG002|Overall Study|Withdrawal by Subject|2|||
48709365|NCT00845897|156784288|FG000|Overall Study|Ulcer did not heal|1|||
48709366|NCT00845897|156784289|FG001|Overall Study|Ulcer did not heal|0|||
48709367|NCT00845897|156784290|FG002|Overall Study|Ulcer did not heal|1|||
48709368|NCT00845897|156784288|FG000|Overall Study|Too ill to participate|0|||
48709369|NCT00845897|156784289|FG001|Overall Study|Too ill to participate|1|||
48709370|NCT00845897|156784290|FG002|Overall Study|Too ill to participate|0|||
48709371|NCT00074490|156784291|FG000|Overall Study|Progressive malignancy|0|||
48709372|NCT00074490|156784292|FG001|Overall Study|Progressive malignancy|7|||
48709373|NCT00074490|156784293|FG002|Overall Study|Progressive malignancy|0|||
48709374|NCT00074490|156784294|FG003|Overall Study|Progressive malignancy|0|||
48709375|NCT00074490|156784295|FG004|Overall Study|Progressive malignancy|3|||
48709376|NCT00074490|156784296|FG005|Overall Study|Progressive malignancy|0|||
48709377|NCT00566696|156784297|FG000|Overall Study|Met Exclusion Criteria|2|||
48805555|NCT01852058|157129382|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805556|NCT01852058|157129383|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
48805557|NCT01852058|157129384|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
48596458|NCT03518086|156377964|FG001|Overall Study|Protocol Violation|5|||
48709378|NCT00566696|156784297|FG000|Overall Study|Muromonab not available|1|||
48709379|NCT00566696|156784297|FG000|Overall Study|Health Status Change|1|||
48709380|NCT00566696|156784297|FG000|Overall Study|Physician Decision|1|||
48709381|NCT00566696|156784297|FG000|Overall Study|Non-Patient Donors|37|||
48709382|NCT01276054|156784303|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
48709383|NCT01276054|156784304|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
48709384|NCT01626872|156784305|FG000|Overall Study|Physician Decision|13|||
48805558|NCT01852058|157129385|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805559|NCT01852058|157129386|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805560|NCT01852058|157129387|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805561|NCT01852058|157129388|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805562|NCT01852058|157129389|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805563|NCT01852058|157129390|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
48805564|NCT01852058|157129379|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805565|NCT01852058|157129380|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805566|NCT01852058|157129381|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805567|NCT01852058|157129382|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805568|NCT01852058|157129383|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805569|NCT01852058|157129384|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805570|NCT01852058|157129385|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805571|NCT01852058|157129386|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
48805572|NCT01852058|157129387|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805573|NCT01852058|157129388|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805574|NCT01852058|157129389|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805575|NCT01852058|157129390|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
48805576|NCT01852058|157129379|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805577|NCT01852058|157129380|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805578|NCT01852058|157129381|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805579|NCT01852058|157129382|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805580|NCT01852058|157129383|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805581|NCT01852058|157129384|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805582|NCT01852058|157129385|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805583|NCT01852058|157129386|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805584|NCT01852058|157129387|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
48805585|NCT01852058|157129388|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805586|NCT01852058|157129389|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805587|NCT01852058|157129390|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
48805588|NCT01279343|157129391|FG000|Overall Study|Did not receive treatment|2|||
48805589|NCT01279343|157129392|FG001|Overall Study|Did not receive treatment|6|||
48805590|NCT02759185|157129393|FG000|Stage 1|Adverse Event|0|||
48805591|NCT02759185|157129394|FG001|Stage 1|Adverse Event|1|||
48805592|NCT02759185|157129395|FG002|Stage 1|Adverse Event|3|||
48805593|NCT02759185|157129396|FG003|Stage 1|Adverse Event|0|||
48805594|NCT02759185|157129397|FG004|Stage 1|Adverse Event|0|||
48805595|NCT02759185|157129398|FG005|Stage 1|Adverse Event|0|||
48490700|NCT00410410|155990763|FG004|Maintenance Period (MP)|Death|0|||
48490701|NCT00410410|155990764|FG005|Maintenance Period (MP)|Death|0|||
48490702|NCT00410410|155990765|FG006|Maintenance Period (MP)|Death|1|||
48490703|NCT00410410|155990766|FG007|Maintenance Period (MP)|Death|0|||
48490704|NCT00410410|155990767|FG008|Maintenance Period (MP)|Death|0|||
48490705|NCT00410410|155990759|FG000|Maintenance Period (MP)|Adverse Event|0|||
48490706|NCT00410410|155990760|FG001|Maintenance Period (MP)|Adverse Event|0|||
48490707|NCT00410410|155990761|FG002|Maintenance Period (MP)|Adverse Event|0|||
48490708|NCT00410410|155990762|FG003|Maintenance Period (MP)|Adverse Event|0|||
48490709|NCT00410410|155990763|FG004|Maintenance Period (MP)|Adverse Event|0|||
48490710|NCT00410410|155990764|FG005|Maintenance Period (MP)|Adverse Event|0|||
48490711|NCT00410410|155990765|FG006|Maintenance Period (MP)|Adverse Event|1|||
48490712|NCT00410410|155990766|FG007|Maintenance Period (MP)|Adverse Event|3|||
48490713|NCT00410410|155990767|FG008|Maintenance Period (MP)|Adverse Event|0|||
48490714|NCT00410410|155990759|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
48490715|NCT00410410|155990760|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
48490716|NCT00410410|155990761|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
48490717|NCT00410410|155990762|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
48490718|NCT00410410|155990763|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
48490719|NCT00410410|155990764|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
48490720|NCT00410410|155990765|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
48490721|NCT00410410|155990766|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
48490722|NCT00410410|155990767|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
48490723|NCT00410410|155990759|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
48490724|NCT00410410|155990760|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
48490725|NCT00410410|155990761|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
48490726|NCT00410410|155990762|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
48596459|NCT03518086|156377965|FG002|Overall Study|Protocol Violation|0|||
48596460|NCT03518086|156377966|FG003|Overall Study|Protocol Violation|0|||
48490727|NCT00410410|155990763|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
48490728|NCT00410410|155990764|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
48596461|NCT03518086|156377963|FG000|Overall Study|Lost to Follow-up|0|||
48596462|NCT03518086|156377964|FG001|Overall Study|Lost to Follow-up|3|||
48596463|NCT03518086|156377965|FG002|Overall Study|Lost to Follow-up|0|||
48596464|NCT03518086|156377966|FG003|Overall Study|Lost to Follow-up|0|||
48596465|NCT03518086|156377963|FG000|Overall Study|Insufficient Diary Data|0|||
48596466|NCT03518086|156377964|FG001|Overall Study|Insufficient Diary Data|2|||
48596467|NCT03518086|156377965|FG002|Overall Study|Insufficient Diary Data|0|||
48596468|NCT03518086|156377966|FG003|Overall Study|Insufficient Diary Data|0|||
48596469|NCT03518086|156377963|FG000|Overall Study|Non- compliance to Protocol|0|||
48596470|NCT03518086|156377964|FG001|Overall Study|Non- compliance to Protocol|1|||
48596471|NCT03518086|156377965|FG002|Overall Study|Non- compliance to Protocol|0|||
48596472|NCT03518086|156377966|FG003|Overall Study|Non- compliance to Protocol|0|||
48596473|NCT03518086|156377963|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
48596474|NCT03518086|156377964|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
48596475|NCT03518086|156377965|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
48596476|NCT03518086|156377966|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
48596477|NCT03518086|156377963|FG000|Overall Study|Site Terminated by Sponsor|0|||
48596478|NCT03518086|156377964|FG001|Overall Study|Site Terminated by Sponsor|1|||
48596479|NCT03518086|156377965|FG002|Overall Study|Site Terminated by Sponsor|0|||
48596480|NCT03518086|156377966|FG003|Overall Study|Site Terminated by Sponsor|0|||
48596481|NCT03560869|156377967|FG000|Overall Study|Withdrawal by Subject|3|||
48596482|NCT03560869|156377968|FG001|Overall Study|Withdrawal by Subject|4|||
48596483|NCT03560869|156377967|FG000|Overall Study|Screening failure|4|||
48596484|NCT03560869|156377968|FG001|Overall Study|Screening failure|4|||
48596485|NCT03560869|156377967|FG000|Overall Study|Withdrawal by PI|0|||
48596486|NCT03560869|156377968|FG001|Overall Study|Withdrawal by PI|1|||
48596487|NCT01395810|156377971|FG000|Overall Study|Adverse Event|0|||
48596488|NCT01395810|156377972|FG001|Overall Study|Adverse Event|1|||
48596489|NCT01395810|156377973|FG002|Overall Study|Adverse Event|0|||
48596490|NCT01395810|156377974|FG003|Overall Study|Adverse Event|0|||
48596491|NCT01395810|156377971|FG000|Overall Study|Lack of Efficacy|0|||
48596492|NCT01395810|156377972|FG001|Overall Study|Lack of Efficacy|1|||
48596493|NCT01395810|156377973|FG002|Overall Study|Lack of Efficacy|0|||
48596494|NCT01395810|156377974|FG003|Overall Study|Lack of Efficacy|0|||
48596495|NCT01395810|156377971|FG000|Overall Study|Withdrawal criteria|0|||
48596496|NCT01395810|156377972|FG001|Overall Study|Withdrawal criteria|2|||
48596497|NCT01395810|156377973|FG002|Overall Study|Withdrawal criteria|0|||
48596498|NCT01395810|156377974|FG003|Overall Study|Withdrawal criteria|0|||
48596499|NCT01395810|156377971|FG000|Overall Study|Unclassified|2|||
48596500|NCT01395810|156377972|FG001|Overall Study|Unclassified|0|||
48596501|NCT01395810|156377973|FG002|Overall Study|Unclassified|0|||
48596502|NCT01395810|156377974|FG003|Overall Study|Unclassified|0|||
48596503|NCT05027815|156377975|FG000|Overall Study|Death|2|||
48596504|NCT05027815|156377976|FG001|Overall Study|Death|1|||
48596505|NCT00490919|156377977|FG000|Open-label Run-in Period|Adverse Event|239|||
48596506|NCT00490919|156377978|FG001|Open-label Run-in Period|Adverse Event|0|||
48596507|NCT00490919|156377979|FG002|Open-label Run-in Period|Adverse Event|0|||
48596508|NCT00490919|156377977|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
48596509|NCT00490919|156377978|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
48596510|NCT00490919|156377979|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
48596511|NCT00490919|156377977|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
48596512|NCT00490919|156377978|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
48596513|NCT00490919|156377979|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
48596514|NCT00490919|156377977|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
48596515|NCT00490919|156377978|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
48596516|NCT00490919|156377979|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
48596517|NCT00490919|156377977|FG000|Open-label Run-in Period|Administrative|40|||
48596518|NCT00490919|156377978|FG001|Open-label Run-in Period|Administrative|0|||
48596519|NCT00490919|156377979|FG002|Open-label Run-in Period|Administrative|0|||
48596520|NCT00490919|156377977|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
48805596|NCT02759185|157129399|FG006|Stage 1|Adverse Event|0|||
48805597|NCT02759185|157129393|FG000|Stage 1|Withdrawal by Subject|1|||
48805598|NCT02759185|157129394|FG001|Stage 1|Withdrawal by Subject|0|||
48805599|NCT02759185|157129395|FG002|Stage 1|Withdrawal by Subject|0|||
48805600|NCT02759185|157129396|FG003|Stage 1|Withdrawal by Subject|0|||
48805601|NCT02759185|157129397|FG004|Stage 1|Withdrawal by Subject|0|||
48805602|NCT02759185|157129398|FG005|Stage 1|Withdrawal by Subject|0|||
48805603|NCT02759185|157129399|FG006|Stage 1|Withdrawal by Subject|0|||
48805604|NCT02759185|157129393|FG000|Stage 2|Adverse Event|0|||
48805605|NCT02759185|157129394|FG001|Stage 2|Adverse Event|0|||
48805606|NCT02759185|157129395|FG002|Stage 2|Adverse Event|0|||
48805607|NCT02759185|157129396|FG003|Stage 2|Adverse Event|0|||
48805608|NCT02759185|157129397|FG004|Stage 2|Adverse Event|1|||
48805609|NCT02759185|157129398|FG005|Stage 2|Adverse Event|2|||
48805610|NCT02759185|157129399|FG006|Stage 2|Adverse Event|0|||
48805611|NCT02759185|157129393|FG000|Stage 2|Withdrawal by Subject|0|||
48805612|NCT02759185|157129394|FG001|Stage 2|Withdrawal by Subject|0|||
48805613|NCT02759185|157129395|FG002|Stage 2|Withdrawal by Subject|0|||
48805614|NCT02759185|157129396|FG003|Stage 2|Withdrawal by Subject|0|||
48805615|NCT02759185|157129397|FG004|Stage 2|Withdrawal by Subject|1|||
48805616|NCT02759185|157129398|FG005|Stage 2|Withdrawal by Subject|1|||
48805617|NCT02759185|157129399|FG006|Stage 2|Withdrawal by Subject|1|||
48805618|NCT01806584|157129400|FG000|Overall Study|Adverse Event|2|||
48805619|NCT01806584|157129401|FG001|Overall Study|Adverse Event|1|||
48805620|NCT01806584|157129400|FG000|Overall Study|Death|1|||
48805621|NCT01806584|157129401|FG001|Overall Study|Death|0|||
48805622|NCT01806584|157129400|FG000|Overall Study|Lost to Follow-up|0|||
48805623|NCT01806584|157129401|FG001|Overall Study|Lost to Follow-up|2|||
48805624|NCT01806584|157129400|FG000|Overall Study|Study terminated by sponsor|9|||
48805625|NCT01806584|157129401|FG001|Overall Study|Study terminated by sponsor|14|||
48805626|NCT01806584|157129400|FG000|Overall Study|Withdrawal by Subject|1|||
48805627|NCT01806584|157129401|FG001|Overall Study|Withdrawal by Subject|1|||
48805628|NCT01806584|157129400|FG000|Overall Study|Other unspecified|1|||
48805629|NCT01806584|157129401|FG001|Overall Study|Other unspecified|0|||
48805630|NCT03021668|157129402|FG000|Overall Study|Physician Decision|0|||
48805631|NCT03021668|157129403|FG001|Overall Study|Physician Decision|1|||
48805632|NCT02234063|157129412|FG000|Overall Study|Lost to Follow-up|235|||
48805633|NCT02234063|157129413|FG001|Overall Study|Lost to Follow-up|42|||
48805634|NCT02234063|157129412|FG000|Overall Study|Withdrawal by Subject|20|||
48805635|NCT02234063|157129413|FG001|Overall Study|Withdrawal by Subject|1|||
48805636|NCT00069784|157129414|FG000|Overall Study|Adverse Event|105|||
48805637|NCT00069784|157129415|FG001|Overall Study|Adverse Event|0|||
48805638|NCT00069784|157129414|FG000|Overall Study|Withdrawal by Subject|1090|||
48805639|NCT00069784|157129415|FG001|Overall Study|Withdrawal by Subject|0|||
48805640|NCT00069784|157129414|FG000|Overall Study|Other|17|||
48805641|NCT00069784|157129415|FG001|Overall Study|Other|0|||
48805642|NCT03573908|157129416|FG000|Treatment Period|Adverse Event|4|||
48805643|NCT03573908|157129417|FG001|Treatment Period|Adverse Event|9|||
48805644|NCT03573908|157129418|FG002|Treatment Period|Adverse Event|0|||
48805645|NCT03573908|157129419|FG003|Treatment Period|Adverse Event|0|||
48805646|NCT03573908|157129420|FG004|Treatment Period|Adverse Event|0|||
48805647|NCT03573908|157129416|FG000|Treatment Period|Protocol Violation|1|||
48805648|NCT03573908|157129417|FG001|Treatment Period|Protocol Violation|0|||
48805649|NCT03573908|157129418|FG002|Treatment Period|Protocol Violation|0|||
48805650|NCT03573908|157129419|FG003|Treatment Period|Protocol Violation|0|||
48805651|NCT03573908|157129420|FG004|Treatment Period|Protocol Violation|0|||
48805652|NCT03573908|157129416|FG000|Treatment Period|Withdrawal by Subject|7|||
48805653|NCT03573908|157129417|FG001|Treatment Period|Withdrawal by Subject|5|||
48805654|NCT03573908|157129418|FG002|Treatment Period|Withdrawal by Subject|0|||
48805655|NCT03573908|157129419|FG003|Treatment Period|Withdrawal by Subject|0|||
48805656|NCT03573908|157129420|FG004|Treatment Period|Withdrawal by Subject|0|||
48805657|NCT03573908|157129416|FG000|Treatment Period|Lost to Follow-up|7|||
48805658|NCT03573908|157129417|FG001|Treatment Period|Lost to Follow-up|6|||
48805659|NCT03573908|157129418|FG002|Treatment Period|Lost to Follow-up|0|||
48805660|NCT03573908|157129419|FG003|Treatment Period|Lost to Follow-up|0|||
48805661|NCT03573908|157129420|FG004|Treatment Period|Lost to Follow-up|0|||
48805662|NCT03573908|157129416|FG000|Treatment Period|Pregnancy|1|||
48805663|NCT03573908|157129417|FG001|Treatment Period|Pregnancy|0|||
48805664|NCT03573908|157129418|FG002|Treatment Period|Pregnancy|0|||
48805665|NCT03573908|157129419|FG003|Treatment Period|Pregnancy|0|||
48805666|NCT03573908|157129420|FG004|Treatment Period|Pregnancy|0|||
48805667|NCT03573908|157129416|FG000|Treatment Period|Other, Not Specified|4|||
48805668|NCT03573908|157129417|FG001|Treatment Period|Other, Not Specified|6|||
48805669|NCT03573908|157129418|FG002|Treatment Period|Other, Not Specified|0|||
48805670|NCT03573908|157129419|FG003|Treatment Period|Other, Not Specified|0|||
48805671|NCT03573908|157129420|FG004|Treatment Period|Other, Not Specified|0|||
48805672|NCT03573908|157129416|FG000|Randomized Withdrawal Period|Adverse Event|0|||
48805673|NCT03573908|157129417|FG001|Randomized Withdrawal Period|Adverse Event|0|||
48490729|NCT00410410|155990765|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
48490730|NCT00410410|155990766|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
48490731|NCT00410410|155990767|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
48490732|NCT00410410|155990759|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
48490733|NCT00410410|155990760|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
48490734|NCT00410410|155990761|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
48490735|NCT00410410|155990762|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
48490736|NCT00410410|155990763|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
48490737|NCT00410410|155990764|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
48490738|NCT00410410|155990765|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
48490739|NCT00410410|155990766|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
48490740|NCT00410410|155990767|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
48490741|NCT00410410|155990759|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
48709385|NCT01626872|156784306|FG001|Overall Study|Physician Decision|9|||
48709386|NCT01626872|156784307|FG002|Overall Study|Physician Decision|6|||
48709387|NCT01626872|156784305|FG000|Overall Study|Withdrawal by Subject|19|||
48709388|NCT01626872|156784306|FG001|Overall Study|Withdrawal by Subject|27|||
48709389|NCT01626872|156784307|FG002|Overall Study|Withdrawal by Subject|8|||
48709390|NCT01626872|156784305|FG000|Overall Study|Adverse Event (including Death)|20|||
48709391|NCT01626872|156784306|FG001|Overall Study|Adverse Event (including Death)|28|||
48709392|NCT01626872|156784307|FG002|Overall Study|Adverse Event (including Death)|8|||
48709393|NCT01626872|156784305|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
48709394|NCT01626872|156784306|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
48709395|NCT01626872|156784307|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
48709396|NCT02998268|156784308|FG000|Overall Study|Adverse Event|0|||
48709397|NCT02998268|156784309|FG001|Overall Study|Adverse Event|2|||
48709398|NCT02998268|156784308|FG000|Overall Study|Withdrawal by Subject|0|||
48709399|NCT02998268|156784309|FG001|Overall Study|Withdrawal by Subject|1|||
48709400|NCT01273519|156784310|FG000|Overall Study|Adverse Event|3|||
48709401|NCT01273519|156784311|FG001|Overall Study|Adverse Event|0|||
48709402|NCT01273519|156784312|FG002|Overall Study|Adverse Event|0|||
48709403|NCT01273519|156784310|FG000|Overall Study|Lost to Follow-up|2|||
48709404|NCT01273519|156784311|FG001|Overall Study|Lost to Follow-up|1|||
48709405|NCT01273519|156784312|FG002|Overall Study|Lost to Follow-up|3|||
48709406|NCT01273519|156784310|FG000|Overall Study|Lack of Efficacy|8|||
48709407|NCT01273519|156784311|FG001|Overall Study|Lack of Efficacy|3|||
48709408|NCT01273519|156784312|FG002|Overall Study|Lack of Efficacy|4|||
48709409|NCT01273519|156784310|FG000|Overall Study|Other|6|||
48709410|NCT01273519|156784311|FG001|Overall Study|Other|1|||
48709411|NCT01273519|156784312|FG002|Overall Study|Other|1|||
48709412|NCT02425943|156784320|FG000|Overall Study|Adverse Event|3|||
48805674|NCT03573908|157129418|FG002|Randomized Withdrawal Period|Adverse Event|3|||
48805675|NCT03573908|157129419|FG003|Randomized Withdrawal Period|Adverse Event|0|||
48805676|NCT03573908|157129420|FG004|Randomized Withdrawal Period|Adverse Event|0|||
48805677|NCT03573908|157129416|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48805678|NCT03573908|157129417|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48805679|NCT03573908|157129418|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48805680|NCT03573908|157129419|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48709413|NCT02425943|156784321|FG001|Overall Study|Adverse Event|1|||
48709414|NCT02425943|156784320|FG000|Overall Study|Lost to Follow-up|59|||
48709415|NCT02425943|156784321|FG001|Overall Study|Lost to Follow-up|37|||
48805681|NCT03573908|157129420|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
48805682|NCT03573908|157129416|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
48805683|NCT03573908|157129417|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
48805684|NCT03573908|157129418|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
48805685|NCT03573908|157129419|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
48805686|NCT03573908|157129420|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
48805687|NCT03573908|157129416|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
48805688|NCT03573908|157129417|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
48805689|NCT03573908|157129418|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
48805690|NCT03573908|157129419|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
48805691|NCT03573908|157129420|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
48805692|NCT02669095|157129421|FG000|Overall Study|Adverse Event|1|||
48805693|NCT02669095|157129422|FG001|Overall Study|Adverse Event|0|||
48805694|NCT02669095|157129421|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
48805695|NCT02669095|157129422|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
48805696|NCT02669095|157129421|FG000|Overall Study|Torn Lens|0|||
48805697|NCT02669095|157129422|FG001|Overall Study|Torn Lens|1|||
48805698|NCT02669095|157129421|FG000|Overall Study|Visit 5 assessments not completed|0|||
48805699|NCT02669095|157129422|FG001|Overall Study|Visit 5 assessments not completed|1|||
48805700|NCT00738101|157129423|FG000|Overall Study|Physician Decision|5|||
48805701|NCT00738101|157129423|FG000|Overall Study|Death|1|||
48805702|NCT00738101|157129423|FG000|Overall Study|Repeat enrollment|1|||
48805703|NCT01555164|157129424|FG000|Overall Study|Adverse Event|5|||
48805704|NCT01555164|157129425|FG001|Overall Study|Adverse Event|7|||
48805705|NCT01555164|157129424|FG000|Overall Study|Hyperglycemia|0|||
48805706|NCT01555164|157129425|FG001|Overall Study|Hyperglycemia|1|||
48805707|NCT01555164|157129424|FG000|Overall Study|Investigator's Discretion|2|||
48490742|NCT00410410|155990760|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
48805708|NCT01555164|157129425|FG001|Overall Study|Investigator's Discretion|2|||
48805709|NCT01555164|157129424|FG000|Overall Study|Lost to Follow-up|4|||
48805710|NCT01555164|157129425|FG001|Overall Study|Lost to Follow-up|3|||
48490743|NCT00410410|155990761|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
48490744|NCT00410410|155990762|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
48490745|NCT00410410|155990763|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
48490746|NCT00410410|155990764|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
48709416|NCT02425943|156784320|FG000|Overall Study|Protocol Violation|4|||
48709417|NCT02425943|156784321|FG001|Overall Study|Protocol Violation|1|||
48709418|NCT02425943|156784320|FG000|Overall Study|Withdrawal by Subject|64|||
48709419|NCT02425943|156784321|FG001|Overall Study|Withdrawal by Subject|31|||
48709420|NCT02425943|156784320|FG000|Overall Study|Other|6|||
48709421|NCT02425943|156784321|FG001|Overall Study|Other|0|||
48709422|NCT02668393|156784322|FG000|Overall Study|Progressive disease|6|||
48709423|NCT02668393|156784323|FG001|Overall Study|Progressive disease|3|||
48709424|NCT02668393|156784322|FG000|Overall Study|Adverse Event|0|||
48709425|NCT02668393|156784323|FG001|Overall Study|Adverse Event|2|||
48709426|NCT02668393|156784322|FG000|Overall Study|Withdrawal from the trial|0|||
48709427|NCT02668393|156784323|FG001|Overall Study|Withdrawal from the trial|1|||
48709428|NCT02668393|156784322|FG000|Overall Study|Lack of benefit and side effects|1|||
48709429|NCT02668393|156784323|FG001|Overall Study|Lack of benefit and side effects|0|||
48709430|NCT00607373|156784327|FG000|Treatment Period|Adverse Event|0|||
48709431|NCT00607373|156784328|FG001|Treatment Period|Adverse Event|4|||
48805711|NCT01555164|157129424|FG000|Overall Study|Protocol Violation|9|||
48805712|NCT01555164|157129425|FG001|Overall Study|Protocol Violation|5|||
48805713|NCT01555164|157129424|FG000|Overall Study|Subject Non-compliance|14|||
48805714|NCT01555164|157129425|FG001|Overall Study|Subject Non-compliance|6|||
48805715|NCT01555164|157129424|FG000|Overall Study|Subject Withdrew Consent|6|||
48490747|NCT00410410|155990765|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
48709432|NCT00607373|156784327|FG000|Treatment Period|Physician Decision|0|||
48709433|NCT00607373|156784328|FG001|Treatment Period|Physician Decision|1|||
48709434|NCT00607373|156784327|FG000|Treatment Period|Withdrawal by Subject|0|||
48805716|NCT01555164|157129425|FG001|Overall Study|Subject Withdrew Consent|11|||
48805717|NCT01518946|157129439|FG000|Open-label Phase|Other|4|||
48805718|NCT01518946|157129440|FG001|Open-label Phase|Other|0|||
48805719|NCT01518946|157129441|FG002|Open-label Phase|Other|0|||
48805720|NCT01518946|157129439|FG000|Randomized Phase (First Intervention)|Other|0|||
48805721|NCT01518946|157129440|FG001|Randomized Phase (First Intervention)|Other|1|||
48805722|NCT01518946|157129441|FG002|Randomized Phase (First Intervention)|Other|0|||
48805723|NCT05718687|157129442|FG000|Overall Study|Withdrawal by Subject|3|||
48805724|NCT05134337|157130902|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
48805725|NCT05134337|157130903|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
48805726|NCT04244396|157130907|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
48805727|NCT04244396|157130907|FG000|Overall Study|Withdrawal by Subject|2|||
48805728|NCT04244396|157130907|FG000|Overall Study|Study termination|37|||
48805729|NCT03237858|157130908|FG000|Overall Study|Death|19|||
48805730|NCT03237858|157130908|FG000|Overall Study|Withdrawal by Subject|37|||
48805731|NCT01787097|157130909|FG000|Overall Study|Withdrawal by Subject|1|||
48805732|NCT01787097|157130910|FG001|Overall Study|Withdrawal by Subject|0|||
48805733|NCT01787097|157130911|FG002|Overall Study|Withdrawal by Subject|0|||
48805734|NCT01787097|157130912|FG003|Overall Study|Withdrawal by Subject|0|||
48805735|NCT03749447|157130913|FG000|Overall Study|Adverse Event|11|||
48805736|NCT03749447|157130914|FG001|Overall Study|Adverse Event|3|||
48805737|NCT03749447|157130913|FG000|Overall Study|Death|1|||
48805738|NCT03749447|157130914|FG001|Overall Study|Death|1|||
48805739|NCT03749447|157130913|FG000|Overall Study|Lost to Follow-up|2|||
48805740|NCT03749447|157130914|FG001|Overall Study|Lost to Follow-up|2|||
48805741|NCT03749447|157130913|FG000|Overall Study|Reason Not Specified|0|||
48805742|NCT03749447|157130914|FG001|Overall Study|Reason Not Specified|3|||
48805743|NCT03749447|157130913|FG000|Overall Study|Physician Decision|4|||
48805744|NCT03749447|157130914|FG001|Overall Study|Physician Decision|3|||
48805745|NCT03749447|157130913|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
48805746|NCT03749447|157130914|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
48805747|NCT03749447|157130913|FG000|Overall Study|Study Terminated By Sponsor|112|||
48805748|NCT03749447|157130914|FG001|Overall Study|Study Terminated By Sponsor|105|||
48805749|NCT03749447|157130913|FG000|Overall Study|Withdrawal by Subject|12|||
48805750|NCT03749447|157130914|FG001|Overall Study|Withdrawal by Subject|6|||
48805751|NCT03749447|157130913|FG000|Overall Study|Non-compliance With Study Drug|0|||
48805752|NCT03749447|157130914|FG001|Overall Study|Non-compliance With Study Drug|1|||
48805753|NCT05178121|157130915|FG000|Overall Study|Other|4|||
48805754|NCT05178121|157130915|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
48805755|NCT01782742|157130916|FG000|Double-blind Treatment Phase|Adverse Event|1|||
48805756|NCT01782742|157130917|FG001|Double-blind Treatment Phase|Adverse Event|0|||
48805757|NCT01953003|157130924|FG000|Overall Study|Not treated|0|||
48490748|NCT00410410|155990766|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
48709435|NCT00607373|156784328|FG001|Treatment Period|Withdrawal by Subject|1|||
48709436|NCT00607373|156784327|FG000|Follow-up Period|Other|0|||
48709437|NCT00607373|156784328|FG001|Follow-up Period|Other|1|||
48709438|NCT00607373|156784327|FG000|Follow-up Period|Protocol Violation|0|||
48709439|NCT00607373|156784328|FG001|Follow-up Period|Protocol Violation|1|||
48709440|NCT00607373|156784327|FG000|Follow-up Period|Withdrawal by Subject|1|||
48709441|NCT00607373|156784328|FG001|Follow-up Period|Withdrawal by Subject|3|||
48709442|NCT01396070|156784329|FG000|Overall Study|Withdrawal by Subject|2|||
48709443|NCT01396070|156784329|FG000|Overall Study|Death|2|||
48709444|NCT01396070|156784329|FG000|Overall Study|Adverse Event|8|||
48709445|NCT01396070|156784329|FG000|Overall Study|Physician Decision|3|||
48709446|NCT01396070|156784329|FG000|Overall Study|Lack of Efficacy|4|||
48709447|NCT01742286|156784335|FG000|Escalation Phase|Administrative problems|1|||
48709448|NCT01742286|156784336|FG001|Escalation Phase|Administrative problems|1|||
48709449|NCT01742286|156784337|FG002|Escalation Phase|Administrative problems|0|||
48709450|NCT01742286|156784338|FG003|Escalation Phase|Administrative problems|0|||
48709451|NCT01742286|156784339|FG004|Escalation Phase|Administrative problems|0|||
48709452|NCT01742286|156784340|FG005|Escalation Phase|Administrative problems|0|||
48709453|NCT01742286|156784341|FG006|Escalation Phase|Administrative problems|2|||
48805758|NCT01953003|157130925|FG001|Overall Study|Not treated|1|||
48490749|NCT00410410|155990767|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
48805759|NCT01953003|157130924|FG000|Overall Study|Progressive disease|35|||
48805760|NCT01953003|157130925|FG001|Overall Study|Progressive disease|45|||
48805761|NCT01953003|157130924|FG000|Overall Study|Related Adverse events|7|||
48805762|NCT01953003|157130925|FG001|Overall Study|Related Adverse events|2|||
48805763|NCT01953003|157130924|FG000|Overall Study|Non-related adverse events|0|||
48805764|NCT01953003|157130925|FG001|Overall Study|Non-related adverse events|2|||
48805765|NCT01953003|157130924|FG000|Overall Study|Protocol Violation|0|||
48805766|NCT01953003|157130925|FG001|Overall Study|Protocol Violation|1|||
48805767|NCT01953003|157130924|FG000|Overall Study|Withdrawal by Subject|14|||
48805768|NCT01953003|157130925|FG001|Overall Study|Withdrawal by Subject|4|||
48805769|NCT04737109|157130926|FG000|Study Treatment|Disease Progression|5|||
48709454|NCT01742286|156784335|FG000|Escalation Phase|Adverse Event|0|||
48709455|NCT01742286|156784336|FG001|Escalation Phase|Adverse Event|1|||
48709456|NCT01742286|156784337|FG002|Escalation Phase|Adverse Event|2|||
48805770|NCT04737109|157130927|FG001|Study Treatment|Disease Progression|0|||
48805771|NCT04737109|157130928|FG002|Study Treatment|Disease Progression|0|||
48805772|NCT04737109|157130929|FG003|Study Treatment|Disease Progression|0|||
48805773|NCT04737109|157130926|FG000|Study Treatment|Death on study|1|||
48805774|NCT04737109|157130927|FG001|Study Treatment|Death on study|0|||
48805775|NCT04737109|157130928|FG002|Study Treatment|Death on study|0|||
48805776|NCT04737109|157130929|FG003|Study Treatment|Death on study|0|||
48805777|NCT01529008|157130931|FG000|Bone Marrow Harvesting|Physician Decision|1|||
48805778|NCT01529008|157130932|FG001|Bone Marrow Harvesting|Physician Decision|1|||
48805779|NCT01529008|157130931|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
48805780|NCT01529008|157130932|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
48805781|NCT01529008|157130931|FG000|Treatment|Adverse Event|6|||
48805782|NCT01529008|157130932|FG001|Treatment|Adverse Event|0|||
48805783|NCT01529008|157130931|FG000|Treatment|Other|3|||
48805784|NCT01529008|157130932|FG001|Treatment|Other|1|||
48805785|NCT01529008|157130931|FG000|Efficacy Analysis|Protocol Violation|2|||
48805786|NCT01529008|157130932|FG001|Efficacy Analysis|Protocol Violation|0|||
48805787|NCT01529008|157130931|FG000|Efficacy Analysis|Physician Decision|0|||
48805788|NCT01529008|157130932|FG001|Efficacy Analysis|Physician Decision|1|||
48805789|NCT01529008|157130931|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
48805790|NCT01529008|157130932|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
48805791|NCT00224770|157130933|FG000|Overall Study|Lost to Follow-up|4|||
48805792|NCT00224770|157130934|FG001|Overall Study|Lost to Follow-up|2|||
48805793|NCT00224770|157130935|FG002|Overall Study|Lost to Follow-up|0|||
48805794|NCT01255592|157130936|FG000|Overall Study|Adverse Event|5|||
48805795|NCT01255592|157130937|FG001|Overall Study|Adverse Event|0|||
48805796|NCT01255592|157130936|FG000|Overall Study|Withdrawal by Subject|1|||
48805797|NCT01255592|157130937|FG001|Overall Study|Withdrawal by Subject|0|||
48805798|NCT01255592|157130936|FG000|Overall Study|Other|0|||
48805799|NCT01255592|157130937|FG001|Overall Study|Other|1|||
48805800|NCT03346538|157130938|FG000|Overall Study|Physician Decision|0|||
48805801|NCT03346538|157130939|FG001|Overall Study|Physician Decision|1|||
48805802|NCT03346538|157130940|FG002|Overall Study|Physician Decision|0|||
48805803|NCT03346538|157130938|FG000|Overall Study|Withdrawal by Subject|3|||
48805804|NCT03346538|157130939|FG001|Overall Study|Withdrawal by Subject|2|||
48805805|NCT03346538|157130940|FG002|Overall Study|Withdrawal by Subject|0|||
48805806|NCT03346538|157130938|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
48805807|NCT03346538|157130939|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
48805808|NCT03346538|157130940|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
48805809|NCT05687903|157130941|FG000|Overall Study|Protocol Deviation|1|||
48805810|NCT05687903|157130942|FG001|Overall Study|Protocol Deviation|1|||
48805811|NCT05687903|157130943|FG002|Overall Study|Protocol Deviation|0|||
48805812|NCT05687903|157130944|FG003|Overall Study|Protocol Deviation|1|||
48805813|NCT05687903|157130945|FG004|Overall Study|Protocol Deviation|0|||
48805814|NCT05044325|157130946|FG000|Part A:Treatment Period 1|Adverse Event|0|||
48805815|NCT05044325|157130947|FG001|Part A:Treatment Period 1|Adverse Event|0|||
48805816|NCT05044325|157130948|FG002|Part A:Treatment Period 1|Adverse Event|0|||
48805817|NCT05044325|157130949|FG003|Part A:Treatment Period 1|Adverse Event|0|||
48805818|NCT05044325|157130950|FG004|Part A:Treatment Period 1|Adverse Event|0|||
48805819|NCT05044325|157130951|FG005|Part A:Treatment Period 1|Adverse Event|1|||
48490750|NCT00410410|155990759|FG000|Open-Label Period (OL)|Death|0|||
48490751|NCT00410410|155990760|FG001|Open-Label Period (OL)|Death|0|||
48805820|NCT05044325|157130952|FG006|Part A:Treatment Period 1|Adverse Event|0|||
48805821|NCT05044325|157130953|FG007|Part A:Treatment Period 1|Adverse Event|1|||
48805822|NCT05044325|157130954|FG008|Part A:Treatment Period 1|Adverse Event|0|||
48805823|NCT05044325|157130955|FG009|Part A:Treatment Period 1|Adverse Event|0|||
48805824|NCT05044325|157130946|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805825|NCT05044325|157130947|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805826|NCT05044325|157130948|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805827|NCT05044325|157130949|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
48805828|NCT05044325|157130950|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
48805829|NCT05044325|157130951|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
48805830|NCT05044325|157130952|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805831|NCT05044325|157130953|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805832|NCT05044325|157130954|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805833|NCT05044325|157130955|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
48805834|NCT05044325|157130946|FG000|Part A:Treatment Period 1|Physician Decision|0|||
48805835|NCT05044325|157130947|FG001|Part A:Treatment Period 1|Physician Decision|0|||
48805836|NCT05044325|157130948|FG002|Part A:Treatment Period 1|Physician Decision|0|||
48805837|NCT05044325|157130949|FG003|Part A:Treatment Period 1|Physician Decision|0|||
48805838|NCT05044325|157130950|FG004|Part A:Treatment Period 1|Physician Decision|0|||
48805839|NCT05044325|157130951|FG005|Part A:Treatment Period 1|Physician Decision|0|||
48805840|NCT05044325|157130952|FG006|Part A:Treatment Period 1|Physician Decision|1|||
48805841|NCT05044325|157130953|FG007|Part A:Treatment Period 1|Physician Decision|0|||
48805842|NCT05044325|157130954|FG008|Part A:Treatment Period 1|Physician Decision|0|||
48805843|NCT05044325|157130955|FG009|Part A:Treatment Period 1|Physician Decision|0|||
48805844|NCT05044325|157130946|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805845|NCT05044325|157130947|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805846|NCT05044325|157130948|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
48805847|NCT05044325|157130949|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805848|NCT05044325|157130950|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805849|NCT05044325|157130951|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805850|NCT05044325|157130952|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805851|NCT05044325|157130953|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805852|NCT05044325|157130954|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805853|NCT05044325|157130955|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
48805854|NCT05044325|157130946|FG000|Part A:Treatment Period 2|Adverse Event|0|||
48805855|NCT05044325|157130947|FG001|Part A:Treatment Period 2|Adverse Event|1|||
48805856|NCT05044325|157130948|FG002|Part A:Treatment Period 2|Adverse Event|0|||
48805857|NCT05044325|157130949|FG003|Part A:Treatment Period 2|Adverse Event|0|||
48805858|NCT05044325|157130950|FG004|Part A:Treatment Period 2|Adverse Event|1|||
48805859|NCT05044325|157130951|FG005|Part A:Treatment Period 2|Adverse Event|1|||
48805860|NCT05044325|157130952|FG006|Part A:Treatment Period 2|Adverse Event|0|||
48805861|NCT05044325|157130953|FG007|Part A:Treatment Period 2|Adverse Event|0|||
48805862|NCT05044325|157130954|FG008|Part A:Treatment Period 2|Adverse Event|0|||
48805863|NCT05044325|157130955|FG009|Part A:Treatment Period 2|Adverse Event|0|||
48805864|NCT05044325|157130946|FG000|Part A:Treatment Period 2|Physician Decision|0|||
48805865|NCT05044325|157130947|FG001|Part A:Treatment Period 2|Physician Decision|0|||
48805866|NCT05044325|157130948|FG002|Part A:Treatment Period 2|Physician Decision|0|||
48805867|NCT05044325|157130949|FG003|Part A:Treatment Period 2|Physician Decision|0|||
48805868|NCT05044325|157130950|FG004|Part A:Treatment Period 2|Physician Decision|0|||
48805869|NCT05044325|157130951|FG005|Part A:Treatment Period 2|Physician Decision|1|||
48805870|NCT05044325|157130952|FG006|Part A:Treatment Period 2|Physician Decision|0|||
48805871|NCT05044325|157130953|FG007|Part A:Treatment Period 2|Physician Decision|0|||
48805872|NCT05044325|157130954|FG008|Part A:Treatment Period 2|Physician Decision|0|||
48805873|NCT05044325|157130955|FG009|Part A:Treatment Period 2|Physician Decision|0|||
48805874|NCT05044325|157130946|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805875|NCT05044325|157130947|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805876|NCT05044325|157130948|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805877|NCT05044325|157130949|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
48805878|NCT05044325|157130950|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
48805879|NCT05044325|157130951|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805880|NCT05044325|157130952|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805881|NCT05044325|157130953|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805882|NCT05044325|157130954|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805883|NCT05044325|157130955|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
48805884|NCT04382924|157130958|FG000|Overall Study|Death|2|||
48805885|NCT04382924|157130959|FG001|Overall Study|Death|5|||
48805886|NCT04382924|157130960|FG002|Overall Study|Death|4|||
48805887|NCT04382924|157130958|FG000|Overall Study|Protocol Violation|0|||
48490752|NCT00410410|155990761|FG002|Open-Label Period (OL)|Death|0|||
48490753|NCT00410410|155990762|FG003|Open-Label Period (OL)|Death|0|||
48490754|NCT00410410|155990763|FG004|Open-Label Period (OL)|Death|0|||
48490755|NCT00410410|155990764|FG005|Open-Label Period (OL)|Death|0|||
48490756|NCT00410410|155990765|FG006|Open-Label Period (OL)|Death|0|||
48490757|NCT00410410|155990766|FG007|Open-Label Period (OL)|Death|0|||
48490758|NCT00410410|155990767|FG008|Open-Label Period (OL)|Death|1|||
48490759|NCT00410410|155990759|FG000|Open-Label Period (OL)|Adverse Event|0|||
48490760|NCT00410410|155990760|FG001|Open-Label Period (OL)|Adverse Event|0|||
48490761|NCT00410410|155990761|FG002|Open-Label Period (OL)|Adverse Event|0|||
48490762|NCT00410410|155990762|FG003|Open-Label Period (OL)|Adverse Event|0|||
48490763|NCT00410410|155990763|FG004|Open-Label Period (OL)|Adverse Event|0|||
48490764|NCT00410410|155990764|FG005|Open-Label Period (OL)|Adverse Event|0|||
48490765|NCT00410410|155990765|FG006|Open-Label Period (OL)|Adverse Event|0|||
48490766|NCT00410410|155990766|FG007|Open-Label Period (OL)|Adverse Event|0|||
48490767|NCT00410410|155990767|FG008|Open-Label Period (OL)|Adverse Event|10|||
48490768|NCT00410410|155990759|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
48490769|NCT00410410|155990760|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
48490770|NCT00410410|155990761|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
48490771|NCT00410410|155990762|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
48490772|NCT00410410|155990763|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
48490773|NCT00410410|155990764|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
48490774|NCT00410410|155990765|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
48490775|NCT00410410|155990766|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
48490776|NCT00410410|155990767|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
48490777|NCT00410410|155990759|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
48490778|NCT00410410|155990760|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
48709457|NCT01742286|156784338|FG003|Escalation Phase|Adverse Event|0|||
48709458|NCT01742286|156784339|FG004|Escalation Phase|Adverse Event|0|||
48709459|NCT01742286|156784340|FG005|Escalation Phase|Adverse Event|1|||
48709460|NCT01742286|156784341|FG006|Escalation Phase|Adverse Event|0|||
48709461|NCT01742286|156784335|FG000|Escalation Phase|Disease progression|3|||
48709462|NCT01742286|156784336|FG001|Escalation Phase|Disease progression|7|||
48709463|NCT01742286|156784337|FG002|Escalation Phase|Disease progression|4|||
48709464|NCT01742286|156784338|FG003|Escalation Phase|Disease progression|1|||
48709465|NCT01742286|156784339|FG004|Escalation Phase|Disease progression|4|||
48709466|NCT01742286|156784340|FG005|Escalation Phase|Disease progression|3|||
48709467|NCT01742286|156784341|FG006|Escalation Phase|Disease progression|2|||
48709468|NCT01742286|156784335|FG000|Escalation Phase|Death|0|||
48709469|NCT01742286|156784336|FG001|Escalation Phase|Death|0|||
48709470|NCT01742286|156784337|FG002|Escalation Phase|Death|0|||
48709471|NCT01742286|156784338|FG003|Escalation Phase|Death|0|||
48709472|NCT01742286|156784339|FG004|Escalation Phase|Death|0|||
48709473|NCT01742286|156784340|FG005|Escalation Phase|Death|1|||
48709474|NCT01742286|156784341|FG006|Escalation Phase|Death|0|||
48490779|NCT00410410|155990761|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
48490780|NCT00410410|155990762|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
48490781|NCT00410410|155990763|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
48490782|NCT00410410|155990764|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
48490783|NCT00410410|155990765|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
48490784|NCT00410410|155990766|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
48490785|NCT00410410|155990767|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
48490786|NCT00410410|155990759|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
48709475|NCT01742286|156784335|FG000|Escalation Phase|Physician Decision|0|||
48709476|NCT01742286|156784336|FG001|Escalation Phase|Physician Decision|3|||
48805888|NCT04382924|157130959|FG001|Overall Study|Protocol Violation|1|||
48805889|NCT04382924|157130960|FG002|Overall Study|Protocol Violation|1|||
48805890|NCT04382924|157130958|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
48805891|NCT04382924|157130959|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
48805892|NCT04382924|157130960|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
48805893|NCT04382924|157130958|FG000|Overall Study|Withdrawal by Subject|6|||
48805894|NCT04382924|157130959|FG001|Overall Study|Withdrawal by Subject|3|||
48805895|NCT04382924|157130960|FG002|Overall Study|Withdrawal by Subject|6|||
48805896|NCT03518125|157130961|FG000|Overall Study|Lost to Follow-up|0|||
48805897|NCT03518125|157130962|FG001|Overall Study|Lost to Follow-up|2|||
48805898|NCT03518125|157130963|FG002|Overall Study|Lost to Follow-up|0|||
48805899|NCT03518125|157130964|FG003|Overall Study|Lost to Follow-up|0|||
48805900|NCT03518125|157130965|FG004|Overall Study|Lost to Follow-up|3|||
48805901|NCT03518125|157130966|FG005|Overall Study|Lost to Follow-up|5|||
48805902|NCT03518125|157130961|FG000|Overall Study|Physician Decision|0|||
48805903|NCT03518125|157130962|FG001|Overall Study|Physician Decision|1|||
48805904|NCT03518125|157130963|FG002|Overall Study|Physician Decision|0|||
48805905|NCT03518125|157130964|FG003|Overall Study|Physician Decision|0|||
48805906|NCT03518125|157130965|FG004|Overall Study|Physician Decision|0|||
48805907|NCT03518125|157130966|FG005|Overall Study|Physician Decision|0|||
48805908|NCT03518125|157130961|FG000|Overall Study|Withdrawal by Subject|1|||
48805909|NCT03518125|157130962|FG001|Overall Study|Withdrawal by Subject|1|||
48490787|NCT00410410|155990760|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
48805910|NCT03518125|157130963|FG002|Overall Study|Withdrawal by Subject|0|||
48805911|NCT03518125|157130964|FG003|Overall Study|Withdrawal by Subject|1|||
48805912|NCT03518125|157130965|FG004|Overall Study|Withdrawal by Subject|1|||
48805913|NCT03518125|157130966|FG005|Overall Study|Withdrawal by Subject|3|||
48805914|NCT03518125|157130961|FG000|Overall Study|Missed Day 394 Visit|1|||
48805915|NCT03518125|157130962|FG001|Overall Study|Missed Day 394 Visit|0|||
48805916|NCT03518125|157130963|FG002|Overall Study|Missed Day 394 Visit|0|||
48805917|NCT03518125|157130964|FG003|Overall Study|Missed Day 394 Visit|0|||
48805918|NCT03518125|157130965|FG004|Overall Study|Missed Day 394 Visit|0|||
48805919|NCT03518125|157130966|FG005|Overall Study|Missed Day 394 Visit|0|||
48805920|NCT02066402|157130968|FG000|Overall Study|Adverse Event|1|||
48805921|NCT02066402|157130969|FG001|Overall Study|Adverse Event|2|||
48805922|NCT02066402|157130968|FG000|Overall Study|Lost to Follow-up|11|||
48805923|NCT02066402|157130969|FG001|Overall Study|Lost to Follow-up|8|||
48805924|NCT02066402|157130968|FG000|Overall Study|Withdrawal by Subject|14|||
48805925|NCT02066402|157130969|FG001|Overall Study|Withdrawal by Subject|11|||
48805926|NCT02066402|157130968|FG000|Overall Study|Progressive disease-clinical progression|0|||
48805927|NCT02066402|157130969|FG001|Overall Study|Progressive disease-clinical progression|1|||
48805928|NCT02066402|157130968|FG000|Overall Study|Protocol driven decision point|0|||
48805929|NCT02066402|157130969|FG001|Overall Study|Protocol driven decision point|1|||
48805930|NCT03303469|157130975|FG000|Overall Study|Lost to Follow-up|2|||
48805931|NCT05061537|157130976|FG000|Treatment Phase|Progressive disease|0|||
48805932|NCT05061537|157130977|FG001|Treatment Phase|Progressive disease|1|||
48805933|NCT05061537|157130978|FG002|Treatment Phase|Progressive disease|2|||
48805934|NCT05061537|157130979|FG003|Treatment Phase|Progressive disease|0|||
48805935|NCT05061537|157130980|FG004|Treatment Phase|Progressive disease|0|||
48805936|NCT05061537|157130976|FG000|Treatment Phase|Adverse Event|0|||
48805937|NCT05061537|157130977|FG001|Treatment Phase|Adverse Event|0|||
48709477|NCT01742286|156784337|FG002|Escalation Phase|Physician Decision|0|||
48709478|NCT01742286|156784338|FG003|Escalation Phase|Physician Decision|1|||
48709479|NCT01742286|156784339|FG004|Escalation Phase|Physician Decision|0|||
48709480|NCT01742286|156784340|FG005|Escalation Phase|Physician Decision|0|||
48709481|NCT01742286|156784341|FG006|Escalation Phase|Physician Decision|2|||
48709482|NCT01742286|156784335|FG000|Escalation Phase|Subject/guardian decision|1|||
48709483|NCT01742286|156784336|FG001|Escalation Phase|Subject/guardian decision|0|||
48709484|NCT01742286|156784337|FG002|Escalation Phase|Subject/guardian decision|0|||
48709485|NCT01742286|156784338|FG003|Escalation Phase|Subject/guardian decision|0|||
48709486|NCT01742286|156784339|FG004|Escalation Phase|Subject/guardian decision|0|||
48709487|NCT01742286|156784340|FG005|Escalation Phase|Subject/guardian decision|0|||
48709488|NCT01742286|156784341|FG006|Escalation Phase|Subject/guardian decision|0|||
48709489|NCT01742286|156784335|FG000|Expansion Phase|Administrative problems|0|||
48709490|NCT01742286|156784336|FG001|Expansion Phase|Administrative problems|0|||
48709491|NCT01742286|156784337|FG002|Expansion Phase|Administrative problems|0|||
48805938|NCT05061537|157130978|FG002|Treatment Phase|Adverse Event|2|||
48805939|NCT05061537|157130979|FG003|Treatment Phase|Adverse Event|0|||
48805940|NCT05061537|157130980|FG004|Treatment Phase|Adverse Event|0|||
48805941|NCT05061537|157130976|FG000|Treatment Phase|Global deterioration of health status|0|||
48805942|NCT05061537|157130977|FG001|Treatment Phase|Global deterioration of health status|1|||
48709492|NCT01742286|156784338|FG003|Expansion Phase|Administrative problems|0|||
48709493|NCT01742286|156784339|FG004|Expansion Phase|Administrative problems|0|||
48805943|NCT05061537|157130978|FG002|Treatment Phase|Global deterioration of health status|0|||
48490788|NCT00410410|155990761|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
48490789|NCT00410410|155990762|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
48490790|NCT00410410|155990763|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
48490791|NCT00410410|155990764|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
48490792|NCT00410410|155990765|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
48490793|NCT00410410|155990766|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
48490794|NCT00410410|155990767|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
48490795|NCT00410410|155990759|FG000|Open-Label Period (OL)|Pregnancy|0|||
48490796|NCT00410410|155990760|FG001|Open-Label Period (OL)|Pregnancy|0|||
48490797|NCT00410410|155990761|FG002|Open-Label Period (OL)|Pregnancy|0|||
48805944|NCT05061537|157130979|FG003|Treatment Phase|Global deterioration of health status|0|||
48805945|NCT05061537|157130980|FG004|Treatment Phase|Global deterioration of health status|0|||
48805946|NCT05061537|157130976|FG000|Follow up|Other|2|||
48805947|NCT05061537|157130977|FG001|Follow up|Other|0|||
48805948|NCT05061537|157130978|FG002|Follow up|Other|2|||
48805949|NCT05061537|157130979|FG003|Follow up|Other|0|||
48805950|NCT05061537|157130980|FG004|Follow up|Other|0|||
48805951|NCT05061537|157130976|FG000|Follow up|Study terminated by sponsor|0|||
48805952|NCT05061537|157130977|FG001|Follow up|Study terminated by sponsor|0|||
48805953|NCT05061537|157130978|FG002|Follow up|Study terminated by sponsor|2|||
48805954|NCT05061537|157130979|FG003|Follow up|Study terminated by sponsor|0|||
48805955|NCT05061537|157130980|FG004|Follow up|Study terminated by sponsor|0|||
48805956|NCT05061537|157130976|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
48805957|NCT05061537|157130977|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
48805958|NCT05061537|157130978|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
48805959|NCT05061537|157130979|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
48805960|NCT05061537|157130980|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
48805961|NCT05061537|157130976|FG000|Long-term Follow-up|Death|0|||
48805962|NCT05061537|157130977|FG001|Long-term Follow-up|Death|1|||
48805963|NCT05061537|157130978|FG002|Long-term Follow-up|Death|0|||
48805964|NCT05061537|157130979|FG003|Long-term Follow-up|Death|0|||
48805965|NCT05061537|157130980|FG004|Long-term Follow-up|Death|0|||
48805966|NCT01576367|157130981|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48805967|NCT01576367|157130981|FG000|Overall Study|Moved to commercial use after 6 months|1|||
48805968|NCT03496168|157130991|FG000|Overall Study|Other Reasons|1|||
48805969|NCT03496168|157130991|FG000|Overall Study|Adverse Event|1|||
48805970|NCT03663569|157130992|FG000|Overall Study|Discontinuation of study|11|||
48805971|NCT03663569|157130992|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
48805972|NCT03663569|157130992|FG000|Overall Study|Deceased patient|6|||
48805973|NCT03663569|157130992|FG000|Overall Study|Lost to Follow-up|18|||
48805974|NCT03663569|157130992|FG000|Overall Study|Withdrawal of consent|5|||
48805975|NCT03663569|157130992|FG000|Overall Study|Patient's request|11|||
48805976|NCT03663569|157130992|FG000|Overall Study|Adverse Event|4|||
48805977|NCT03663569|157130992|FG000|Overall Study|Not come to second visit|3|||
48805978|NCT03663569|157130992|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
48805979|NCT03663569|157130992|FG000|Overall Study|Serious adverse event|1|||
48805980|NCT00321048|157131001|FG000|Overall Study|Withdrawal by Subject|6|||
48805981|NCT00321048|157131002|FG001|Overall Study|Withdrawal by Subject|8|||
48805982|NCT01693692|157131011|FG000|Overall Study|Withdrawal by Subject|12|||
48805983|NCT01693692|157131012|FG001|Overall Study|Withdrawal by Subject|10|||
48805984|NCT01693692|157131013|FG002|Overall Study|Withdrawal by Subject|11|||
48805985|NCT01693692|157131011|FG000|Overall Study|Adverse Event|7|||
48805986|NCT01693692|157131012|FG001|Overall Study|Adverse Event|14|||
48805987|NCT01693692|157131013|FG002|Overall Study|Adverse Event|9|||
48805988|NCT01693692|157131011|FG000|Overall Study|Physician Decision|0|||
48805989|NCT01693692|157131012|FG001|Overall Study|Physician Decision|0|||
48805990|NCT01693692|157131013|FG002|Overall Study|Physician Decision|1|||
48805991|NCT01693692|157131011|FG000|Overall Study|Protocol Violation|5|||
48805992|NCT01693692|157131012|FG001|Overall Study|Protocol Violation|4|||
48805993|NCT01693692|157131013|FG002|Overall Study|Protocol Violation|6|||
48805994|NCT01693692|157131011|FG000|Overall Study|Lost to Follow-up|2|||
48805995|NCT01693692|157131012|FG001|Overall Study|Lost to Follow-up|2|||
48805996|NCT01693692|157131013|FG002|Overall Study|Lost to Follow-up|3|||
48805997|NCT01693692|157131011|FG000|Overall Study|Other|4|||
48805998|NCT01693692|157131012|FG001|Overall Study|Other|4|||
48805999|NCT01693692|157131013|FG002|Overall Study|Other|6|||
48806000|NCT02404389|157131014|FG000|Overall Study|Adverse Event|1|||
48806001|NCT02404389|157131015|FG001|Overall Study|Adverse Event|0|||
48806002|NCT02404389|157131016|FG002|Overall Study|Adverse Event|1|||
48806003|NCT02404389|157131017|FG003|Overall Study|Adverse Event|0|||
48806004|NCT02404389|157131018|FG004|Overall Study|Adverse Event|2|||
48806005|NCT02404389|157131014|FG000|Overall Study|Subject/guardian decision|1|||
48806006|NCT02404389|157131015|FG001|Overall Study|Subject/guardian decision|0|||
48806007|NCT02404389|157131016|FG002|Overall Study|Subject/guardian decision|0|||
48806008|NCT02404389|157131017|FG003|Overall Study|Subject/guardian decision|1|||
48806009|NCT02404389|157131018|FG004|Overall Study|Subject/guardian decision|1|||
48806010|NCT03300570|157131019|FG000|Overall Study|Adverse Event|0|||
48806011|NCT03300570|157131020|FG001|Overall Study|Adverse Event|1|||
48806012|NCT03300570|157131019|FG000|Overall Study|Withdrawal by Subject|1|||
48806013|NCT03300570|157131020|FG001|Overall Study|Withdrawal by Subject|0|||
48806014|NCT03300570|157131019|FG000|Overall Study|Inadequate bowel prep|1|||
48806015|NCT03300570|157131020|FG001|Overall Study|Inadequate bowel prep|0|||
48806016|NCT00384059|157131023|FG000|Infant Series|Not consented|2|||
48806017|NCT00384059|157131024|FG001|Infant Series|Not consented|6|||
48806018|NCT00384059|157131023|FG000|Infant Series|Withdrawal by Subject|2|||
48806019|NCT00384059|157131024|FG001|Infant Series|Withdrawal by Subject|2|||
48806020|NCT00384059|157131023|FG000|Infant Series|Adverse Event|1|||
48806021|NCT00384059|157131024|FG001|Infant Series|Adverse Event|2|||
48806022|NCT00384059|157131023|FG000|Infant Series|Protocol Violation|1|||
48596521|NCT00490919|156377978|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
48596522|NCT00490919|156377979|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
48596523|NCT00490919|156377977|FG000|Double-blind Phase|Adverse Event|0|||
48490798|NCT00410410|155990762|FG003|Open-Label Period (OL)|Pregnancy|0|||
48490799|NCT00410410|155990763|FG004|Open-Label Period (OL)|Pregnancy|0|||
48490800|NCT00410410|155990764|FG005|Open-Label Period (OL)|Pregnancy|0|||
48490801|NCT00410410|155990765|FG006|Open-Label Period (OL)|Pregnancy|0|||
48596524|NCT00490919|156377978|FG001|Double-blind Phase|Adverse Event|40|||
48596525|NCT00490919|156377979|FG002|Double-blind Phase|Adverse Event|20|||
48596526|NCT00490919|156377977|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48596527|NCT00490919|156377978|FG001|Double-blind Phase|Withdrawal by Subject|10|||
48806023|NCT00384059|157131024|FG001|Infant Series|Protocol Violation|2|||
48806024|NCT00384059|157131023|FG000|Infant Series|Lost to Follow-up|0|||
48806025|NCT00384059|157131024|FG001|Infant Series|Lost to Follow-up|1|||
48806026|NCT00384059|157131023|FG000|After Infant Series|Protocol Violation|2|||
48806027|NCT00384059|157131024|FG001|After Infant Series|Protocol Violation|3|||
48490802|NCT00410410|155990766|FG007|Open-Label Period (OL)|Pregnancy|0|||
48490803|NCT00410410|155990767|FG008|Open-Label Period (OL)|Pregnancy|1|||
48490804|NCT00410410|155990759|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
48490805|NCT00410410|155990760|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
48490806|NCT00410410|155990761|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
48490807|NCT00410410|155990762|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
48490808|NCT00410410|155990763|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
48490809|NCT00410410|155990764|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
48490810|NCT00410410|155990765|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
48490811|NCT00410410|155990766|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
48490812|NCT00410410|155990767|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
48490813|NCT00410410|155990759|FG000|Open-Label Period (OL)|Other|0|||
48490814|NCT00410410|155990760|FG001|Open-Label Period (OL)|Other|0|||
48490815|NCT00410410|155990761|FG002|Open-Label Period (OL)|Other|0|||
48490816|NCT00410410|155990762|FG003|Open-Label Period (OL)|Other|0|||
48490817|NCT00410410|155990763|FG004|Open-Label Period (OL)|Other|0|||
48490818|NCT00410410|155990764|FG005|Open-Label Period (OL)|Other|0|||
48490819|NCT00410410|155990765|FG006|Open-Label Period (OL)|Other|0|||
48490820|NCT00410410|155990766|FG007|Open-Label Period (OL)|Other|0|||
48490821|NCT00410410|155990767|FG008|Open-Label Period (OL)|Other|7|||
48490822|NCT01783496|155990768|FG000|Overall Study|Lost to Follow-up|0|||
48490823|NCT01783496|155990769|FG001|Overall Study|Lost to Follow-up|0|||
48490824|NCT01783496|155990770|FG002|Overall Study|Lost to Follow-up|0|||
48490825|NCT01783496|155990771|FG003|Overall Study|Lost to Follow-up|2|||
48490826|NCT01783496|155990772|FG004|Overall Study|Lost to Follow-up|0|||
48490827|NCT01783496|155990773|FG005|Overall Study|Lost to Follow-up|1|||
48490828|NCT01783496|155990768|FG000|Overall Study|Withdrawal by Subject|1|||
48490829|NCT01783496|155990769|FG001|Overall Study|Withdrawal by Subject|0|||
48490830|NCT01783496|155990770|FG002|Overall Study|Withdrawal by Subject|0|||
48490831|NCT01783496|155990771|FG003|Overall Study|Withdrawal by Subject|0|||
48490832|NCT01783496|155990772|FG004|Overall Study|Withdrawal by Subject|0|||
48490833|NCT01783496|155990773|FG005|Overall Study|Withdrawal by Subject|0|||
48490834|NCT01789281|155990774|FG000|Overall Study|Disease progression|15|||
48490835|NCT01789281|155990775|FG001|Overall Study|Disease progression|4|||
48490836|NCT01789281|155990774|FG000|Overall Study|Adverse Event|5|||
48490837|NCT01789281|155990775|FG001|Overall Study|Adverse Event|5|||
48490838|NCT01789281|155990774|FG000|Overall Study|Withdrawal by Subject|1|||
48490839|NCT01789281|155990775|FG001|Overall Study|Withdrawal by Subject|0|||
48596528|NCT00490919|156377979|FG002|Double-blind Phase|Withdrawal by Subject|11|||
48596529|NCT00490919|156377977|FG000|Double-blind Phase|Lost to Follow-up|0|||
48596530|NCT00490919|156377978|FG001|Double-blind Phase|Lost to Follow-up|8|||
48596531|NCT00490919|156377979|FG002|Double-blind Phase|Lost to Follow-up|11|||
48596532|NCT00490919|156377977|FG000|Double-blind Phase|Lack of Efficacy|0|||
48806028|NCT00384059|157131023|FG000|After Infant Series|Withdrawal by Subject|2|||
48806029|NCT00384059|157131024|FG001|After Infant Series|Withdrawal by Subject|2|||
48806030|NCT00384059|157131023|FG000|After Infant Series|Failed to Return|0|||
48806031|NCT00384059|157131024|FG001|After Infant Series|Failed to Return|2|||
48806032|NCT00384059|157131023|FG000|After Infant Series|Adverse Event|0|||
48806033|NCT00384059|157131024|FG001|After Infant Series|Adverse Event|1|||
48806034|NCT00384059|157131023|FG000|After Infant Series|Physician Decision|0|||
48490840|NCT01789281|155990774|FG000|Overall Study|Lost to Follow-up|1|||
48490841|NCT01789281|155990775|FG001|Overall Study|Lost to Follow-up|0|||
48490842|NCT01789281|155990774|FG000|Overall Study|Administrative problems|0|||
48490843|NCT01789281|155990775|FG001|Overall Study|Administrative problems|1|||
48490844|NCT00106028|155990780|FG000|Overall Study|Adverse Event|3|||
48490845|NCT00106028|155990781|FG001|Overall Study|Adverse Event|2|||
48490846|NCT00106028|155990780|FG000|Overall Study|Protocol Violation|1|||
48490847|NCT00106028|155990781|FG001|Overall Study|Protocol Violation|1|||
48490848|NCT00106028|155990780|FG000|Overall Study|Withdrawal by Subject|2|||
48596533|NCT00490919|156377978|FG001|Double-blind Phase|Lack of Efficacy|22|||
48596534|NCT00490919|156377979|FG002|Double-blind Phase|Lack of Efficacy|36|||
48596535|NCT00490919|156377977|FG000|Double-blind Phase|Administrative|0|||
48596536|NCT00490919|156377978|FG001|Double-blind Phase|Administrative|6|||
48596537|NCT00490919|156377979|FG002|Double-blind Phase|Administrative|6|||
48596538|NCT02526160|156379286|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
48596539|NCT02526160|156379287|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
48596540|NCT02526160|156379286|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
48596541|NCT02526160|156379287|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
48596542|NCT02526160|156379286|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
48596543|NCT02526160|156379287|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
48596544|NCT02526160|156379286|FG000|Open-Label Treatment Extension Period I|Death|0|||
48596545|NCT02526160|156379287|FG001|Open-Label Treatment Extension Period I|Death|1|||
48596546|NCT02526160|156379286|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
48596547|NCT02526160|156379287|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
48596548|NCT02526160|156379286|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
48806035|NCT00384059|157131024|FG001|After Infant Series|Physician Decision|1|||
48806036|NCT00384059|157131023|FG000|After Infant Series|Lost to Follow-up|0|||
48806037|NCT00384059|157131024|FG001|After Infant Series|Lost to Follow-up|1|||
48806038|NCT00384059|157131023|FG000|Toddler Dose|Lost to Follow-up|1|||
48806039|NCT00384059|157131024|FG001|Toddler Dose|Lost to Follow-up|1|||
48806040|NCT00384059|157131023|FG000|Toddler Dose|Failed to return|0|||
48806041|NCT00384059|157131024|FG001|Toddler Dose|Failed to return|1|||
48806042|NCT01396395|157131025|FG000|Overall Study|Withdrawal by Subject|10|||
48806043|NCT01396395|157131026|FG001|Overall Study|Withdrawal by Subject|12|||
48806044|NCT01396395|157131025|FG000|Overall Study|Protocol Violation|3|||
48806045|NCT01396395|157131026|FG001|Overall Study|Protocol Violation|1|||
48806046|NCT01396395|157131025|FG000|Overall Study|Adverse Event|10|||
48806047|NCT01396395|157131026|FG001|Overall Study|Adverse Event|2|||
48806048|NCT01396395|157131025|FG000|Overall Study|Lost to Follow-up|17|||
48806049|NCT01396395|157131026|FG001|Overall Study|Lost to Follow-up|11|||
48490849|NCT00106028|155990781|FG001|Overall Study|Withdrawal by Subject|8|||
48490850|NCT00106028|155990780|FG000|Overall Study|Lost to Follow-up|0|||
48490851|NCT00106028|155990781|FG001|Overall Study|Lost to Follow-up|1|||
48490852|NCT00686920|155990784|FG000|Overall Study|Death|45|||
48490853|NCT00686920|155990785|FG001|Overall Study|Death|14|||
48490854|NCT00686920|155990784|FG000|Overall Study|Liver Transplant|23|||
48490855|NCT00686920|155990785|FG001|Overall Study|Liver Transplant|8|||
48490856|NCT00686920|155990784|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
48490857|NCT00686920|155990785|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
48490858|NCT00686920|155990784|FG000|Overall Study|Withdrawal by Subject|23|||
48490859|NCT00686920|155990785|FG001|Overall Study|Withdrawal by Subject|5|||
48490860|NCT00686920|155990784|FG000|Overall Study|Protocol Violation|2|||
48490861|NCT00686920|155990785|FG001|Overall Study|Protocol Violation|1|||
48490862|NCT00686920|155990784|FG000|Overall Study|Adverse Event|10|||
48490863|NCT00686920|155990785|FG001|Overall Study|Adverse Event|2|||
48490864|NCT00686920|155990784|FG000|Overall Study|Personal Reason|0|||
48490865|NCT00686920|155990785|FG001|Overall Study|Personal Reason|1|||
48490866|NCT00686920|155990784|FG000|Overall Study|Lost to Follow-up|15|||
48490867|NCT00686920|155990785|FG001|Overall Study|Lost to Follow-up|3|||
48490868|NCT00686920|155990784|FG000|Overall Study|Moved to Another State|1|||
48490869|NCT00686920|155990785|FG001|Overall Study|Moved to Another State|0|||
48490870|NCT00686920|155990784|FG000|Overall Study|Transferred to Nursing Home|1|||
48490871|NCT00686920|155990785|FG001|Overall Study|Transferred to Nursing Home|0|||
48490872|NCT00686920|155990784|FG000|Overall Study|Noncompliance|9|||
48490873|NCT00686920|155990785|FG001|Overall Study|Noncompliance|0|||
48490874|NCT00686920|155990784|FG000|Overall Study|Principal Investigator Decision|2|||
48596549|NCT02526160|156379287|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
48806050|NCT01396395|157131025|FG000|Overall Study|Other|0|||
48806051|NCT01396395|157131026|FG001|Overall Study|Other|1|||
48806052|NCT03682705|157131027|FG000|Overall Study|Adverse Event|1|||
48806053|NCT03682705|157131028|FG001|Overall Study|Adverse Event|1|||
48806054|NCT03682705|157131029|FG002|Overall Study|Adverse Event|1|||
48806055|NCT03682705|157131030|FG003|Overall Study|Adverse Event|0|||
48806056|NCT03682705|157131031|FG004|Overall Study|Adverse Event|1|||
48806057|NCT03682705|157131032|FG005|Overall Study|Adverse Event|1|||
48806058|NCT03682705|157131027|FG000|Overall Study|Withdrawal by Subject|1|||
48490875|NCT00686920|155990785|FG001|Overall Study|Principal Investigator Decision|0|||
48806059|NCT03682705|157131028|FG001|Overall Study|Withdrawal by Subject|3|||
48490876|NCT01280981|155990786|FG000|Overall Study|Withdrawal by Subject|11|||
48490877|NCT01280981|155990786|FG000|Overall Study|Protocol Violation|2|||
48806060|NCT03682705|157131029|FG002|Overall Study|Withdrawal by Subject|2|||
48806061|NCT03682705|157131030|FG003|Overall Study|Withdrawal by Subject|4|||
48490878|NCT01280981|155990786|FG000|Overall Study|Lack of Efficacy|13|||
48490879|NCT01280981|155990786|FG000|Overall Study|Lost to Follow-up|3|||
48490880|NCT01280981|155990786|FG000|Overall Study|Adverse Event|6|||
48806062|NCT03682705|157131031|FG004|Overall Study|Withdrawal by Subject|0|||
48806063|NCT03682705|157131032|FG005|Overall Study|Withdrawal by Subject|1|||
48806064|NCT03682705|157131027|FG000|Overall Study|Other, not specified|0|||
48806065|NCT03682705|157131028|FG001|Overall Study|Other, not specified|0|||
48806066|NCT03682705|157131029|FG002|Overall Study|Other, not specified|0|||
48806067|NCT03682705|157131030|FG003|Overall Study|Other, not specified|1|||
48709494|NCT01742286|156784340|FG005|Expansion Phase|Administrative problems|0|||
48806068|NCT03682705|157131031|FG004|Overall Study|Other, not specified|2|||
48806069|NCT03682705|157131032|FG005|Overall Study|Other, not specified|0|||
48806070|NCT03682705|157131027|FG000|Overall Study|Lost to Follow-up|0|||
48806071|NCT03682705|157131028|FG001|Overall Study|Lost to Follow-up|0|||
48806072|NCT03682705|157131029|FG002|Overall Study|Lost to Follow-up|0|||
48806073|NCT03682705|157131030|FG003|Overall Study|Lost to Follow-up|0|||
48806074|NCT03682705|157131031|FG004|Overall Study|Lost to Follow-up|3|||
48806075|NCT03682705|157131032|FG005|Overall Study|Lost to Follow-up|0|||
48806076|NCT00709059|157131036|FG000|Overall Study|Lost to Follow-up|34|||
48806077|NCT00709059|157131036|FG000|Overall Study|Withdrawal by Subject|19|||
48806078|NCT00709059|157131036|FG000|Overall Study|Physician Decision|7|||
48806079|NCT00709059|157131036|FG000|Overall Study|Disease complication|3|||
48806080|NCT00709059|157131036|FG000|Overall Study|Side effects|20|||
48806081|NCT00709059|157131036|FG000|Overall Study|Serious side effects|11|||
48806082|NCT00524030|157131037|FG000|Overall Study|Lack of Efficacy|10|||
48806083|NCT00524030|157131038|FG001|Overall Study|Lack of Efficacy|24|||
48806084|NCT00524030|157131037|FG000|Overall Study|Lost to Follow-up|0|||
48806085|NCT00524030|157131038|FG001|Overall Study|Lost to Follow-up|2|||
48806086|NCT00524030|157131037|FG000|Overall Study|Withdrawal by Subject|3|||
48806087|NCT00524030|157131038|FG001|Overall Study|Withdrawal by Subject|8|||
48806088|NCT00524030|157131037|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
48806089|NCT00524030|157131038|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
48806090|NCT00524030|157131037|FG000|Overall Study|Protocol Violation|0|||
48806091|NCT00524030|157131038|FG001|Overall Study|Protocol Violation|1|||
48806092|NCT00524030|157131037|FG000|Overall Study|Pregnancy|1|||
48806093|NCT00524030|157131038|FG001|Overall Study|Pregnancy|0|||
48806094|NCT00524030|157131037|FG000|Overall Study|Adverse Event|3|||
48806095|NCT00524030|157131038|FG001|Overall Study|Adverse Event|21|||
48806096|NCT00524030|157131037|FG000|Overall Study|Death|0|||
48806097|NCT00524030|157131038|FG001|Overall Study|Death|1|||
48806098|NCT04247802|157131039|FG000|Overall Study|Withdrawal by Subject|1|||
48806099|NCT04247802|157131040|FG001|Overall Study|Withdrawal by Subject|3|||
48806100|NCT04247802|157131039|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
48806101|NCT04247802|157131040|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
48806102|NCT03704584|157132451|FG000|Overall Study|Withdrawal by Subject|1|||
48806103|NCT03704584|157132452|FG001|Overall Study|Withdrawal by Subject|0|||
48806104|NCT03439189|157132455|FG000|Overall Study|Protocol Violation|19|||
48806105|NCT03439189|157132455|FG000|Overall Study|Lack of Efficacy|63|||
48709495|NCT01742286|156784341|FG006|Expansion Phase|Administrative problems|5|||
48709496|NCT01742286|156784335|FG000|Expansion Phase|Physician Decision|0|||
48709497|NCT01742286|156784336|FG001|Expansion Phase|Physician Decision|0|||
48709498|NCT01742286|156784337|FG002|Expansion Phase|Physician Decision|4|||
48709499|NCT01742286|156784338|FG003|Expansion Phase|Physician Decision|0|||
48709500|NCT01742286|156784339|FG004|Expansion Phase|Physician Decision|0|||
48709501|NCT01742286|156784340|FG005|Expansion Phase|Physician Decision|0|||
48709502|NCT01742286|156784341|FG006|Expansion Phase|Physician Decision|9|||
48709503|NCT01742286|156784335|FG000|Expansion Phase|Adverse Event|0|||
48709504|NCT01742286|156784336|FG001|Expansion Phase|Adverse Event|0|||
48709505|NCT01742286|156784337|FG002|Expansion Phase|Adverse Event|0|||
48709506|NCT01742286|156784338|FG003|Expansion Phase|Adverse Event|0|||
48709507|NCT01742286|156784339|FG004|Expansion Phase|Adverse Event|0|||
48709508|NCT01742286|156784340|FG005|Expansion Phase|Adverse Event|0|||
48709509|NCT01742286|156784341|FG006|Expansion Phase|Adverse Event|6|||
48709510|NCT01742286|156784335|FG000|Expansion Phase|Disease progression|0|||
48709511|NCT01742286|156784336|FG001|Expansion Phase|Disease progression|0|||
48709512|NCT01742286|156784337|FG002|Expansion Phase|Disease progression|3|||
48709513|NCT01742286|156784338|FG003|Expansion Phase|Disease progression|0|||
48806106|NCT01807156|157132456|FG000|Overall Study|Physician Decision|1|||
48709514|NCT01742286|156784339|FG004|Expansion Phase|Disease progression|0|||
48709515|NCT01742286|156784340|FG005|Expansion Phase|Disease progression|0|||
48806107|NCT00659984|157132460|FG000|Overall Study|Adverse Event|1|||
48806108|NCT00792103|157132469|FG000|Overall Study|Enrolled, not treated|15|||
48596550|NCT02526160|156379286|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
48709516|NCT01742286|156784341|FG006|Expansion Phase|Disease progression|15|||
48709517|NCT01742286|156784335|FG000|Expansion Phase|Withdrawal by Subject|0|||
48709518|NCT01742286|156784336|FG001|Expansion Phase|Withdrawal by Subject|0|||
48709519|NCT01742286|156784337|FG002|Expansion Phase|Withdrawal by Subject|0|||
48806109|NCT00792103|157132469|FG000|Overall Study|Lost to Follow-up|17|||
48806110|NCT00792103|157132469|FG000|Overall Study|Adverse Event|25|||
48806111|NCT00792103|157132469|FG000|Overall Study|Withdrawal by Subject|52|||
48490881|NCT01280981|155990786|FG000|Overall Study|Irregular or discontinued menses|3|||
48490882|NCT01280981|155990786|FG000|Overall Study|Failed to return|45|||
48490883|NCT01280981|155990786|FG000|Overall Study|Non-compliance with protocol|3|||
48490884|NCT01280981|155990786|FG000|Overall Study|Withdrawal of consent|3|||
48490885|NCT01280981|155990786|FG000|Overall Study|Elective surgery|2|||
48490886|NCT01280981|155990786|FG000|Overall Study|Study site closure|1|||
48490887|NCT01752920|155990795|FG000|Overall Study|Adverse Event|1|||
48490888|NCT01752920|155990796|FG001|Overall Study|Adverse Event|0|||
48490889|NCT01752920|155990797|FG002|Overall Study|Adverse Event|5|||
48490890|NCT01752920|155990798|FG003|Overall Study|Adverse Event|10|||
48490891|NCT01752920|155990795|FG000|Overall Study|Clinical Disease Progression|6|||
48490892|NCT01752920|155990796|FG001|Overall Study|Clinical Disease Progression|4|||
48490893|NCT01752920|155990797|FG002|Overall Study|Clinical Disease Progression|1|||
48490894|NCT01752920|155990798|FG003|Overall Study|Clinical Disease Progression|13|||
48490895|NCT01752920|155990795|FG000|Overall Study|Physician Decision|1|||
48490896|NCT01752920|155990796|FG001|Overall Study|Physician Decision|0|||
48490897|NCT01752920|155990797|FG002|Overall Study|Physician Decision|0|||
48490898|NCT01752920|155990798|FG003|Overall Study|Physician Decision|3|||
48490899|NCT01752920|155990795|FG000|Overall Study|Radiographic Disease Progression|20|||
48490900|NCT01752920|155990796|FG001|Overall Study|Radiographic Disease Progression|7|||
48596551|NCT02526160|156379287|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
48596552|NCT02526160|156379286|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
48596553|NCT02526160|156379287|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
48596554|NCT00410072|156379289|FG000|Day 1 to Week 48|Adverse Event|1|||
48596555|NCT00410072|156379290|FG001|Day 1 to Week 48|Adverse Event|2|||
48596556|NCT00410072|156379289|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
48596557|NCT00410072|156379290|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
48490901|NCT01752920|155990797|FG002|Overall Study|Radiographic Disease Progression|12|||
48596558|NCT00410072|156379289|FG000|Day 1 to Week 48|Other|0|||
48596559|NCT00410072|156379290|FG001|Day 1 to Week 48|Other|1|||
48596560|NCT00410072|156379289|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
48596561|NCT00410072|156379290|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
48596562|NCT00410072|156379289|FG000|Day 1 to Week 48|Pregnancy|0|||
48596563|NCT00410072|156379290|FG001|Day 1 to Week 48|Pregnancy|2|||
48596564|NCT00410072|156379289|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
48596565|NCT00410072|156379290|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
48596566|NCT00410072|156379289|FG000|After Week 48 to Week 96|Adverse Event|1|||
48596567|NCT00410072|156379290|FG001|After Week 48 to Week 96|Adverse Event|2|||
48596568|NCT00410072|156379289|FG000|After Week 48 to Week 96|Death|0|||
48596569|NCT00410072|156379290|FG001|After Week 48 to Week 96|Death|1|||
48490902|NCT01752920|155990798|FG003|Overall Study|Radiographic Disease Progression|29|||
48490903|NCT01752920|155990795|FG000|Overall Study|Study Terminated by Sponsor|0|||
48490904|NCT01752920|155990796|FG001|Overall Study|Study Terminated by Sponsor|0|||
48490905|NCT01752920|155990797|FG002|Overall Study|Study Terminated by Sponsor|0|||
48596570|NCT00410072|156379289|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
48596571|NCT00410072|156379290|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
48596572|NCT00410072|156379289|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
48596573|NCT00410072|156379290|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
48596574|NCT00410072|156379289|FG000|After Week 48 to Week 96|Other|2|||
48596575|NCT00410072|156379290|FG001|After Week 48 to Week 96|Other|0|||
48490906|NCT01752920|155990798|FG003|Overall Study|Study Terminated by Sponsor|1|||
48490907|NCT01752920|155990795|FG000|Overall Study|Withdrawal by Subject|0|||
48490908|NCT01752920|155990796|FG001|Overall Study|Withdrawal by Subject|1|||
48490909|NCT01752920|155990797|FG002|Overall Study|Withdrawal by Subject|0|||
48490910|NCT01752920|155990798|FG003|Overall Study|Withdrawal by Subject|1|||
48490911|NCT01752920|155990795|FG000|Overall Study|Lack of clinical benefit|1|||
48490912|NCT01752920|155990796|FG001|Overall Study|Lack of clinical benefit|1|||
48490913|NCT01752920|155990797|FG002|Overall Study|Lack of clinical benefit|1|||
48490914|NCT01752920|155990798|FG003|Overall Study|Lack of clinical benefit|1|||
48490915|NCT02970669|155990801|FG000|Double-blind Period|Adverse Event|4|||
48490916|NCT02970669|155990802|FG001|Double-blind Period|Adverse Event|0|||
48490917|NCT02970669|155990801|FG000|Double-blind Period|Death|1|||
48490918|NCT02970669|155990802|FG001|Double-blind Period|Death|0|||
48490919|NCT02970669|155990801|FG000|Double-blind Period|Study terminated by sponsor|1|||
48490920|NCT02970669|155990802|FG001|Double-blind Period|Study terminated by sponsor|2|||
48490921|NCT02970669|155990801|FG000|Double-blind Period|Physician Decision|0|||
48490922|NCT02970669|155990802|FG001|Double-blind Period|Physician Decision|2|||
48490923|NCT02970669|155990801|FG000|Double-blind Period|Withdrawal by Subject|2|||
48490924|NCT02970669|155990802|FG001|Double-blind Period|Withdrawal by Subject|2|||
48490925|NCT02970669|155990801|FG000|Open-label Period|Withdrawal by Subject|2|||
48490926|NCT02970669|155990802|FG001|Open-label Period|Withdrawal by Subject|2|||
48490927|NCT02970669|155990801|FG000|Open-label Period|Adverse Event|1|||
48490928|NCT02970669|155990802|FG001|Open-label Period|Adverse Event|0|||
48490929|NCT02970669|155990801|FG000|Open-label Period|Physician Decision|1|||
48490930|NCT02970669|155990802|FG001|Open-label Period|Physician Decision|0|||
48490931|NCT01738581|155990804|FG000|Overall Study|Lost to Follow-up|1|||
48490932|NCT01738581|155990805|FG001|Overall Study|Lost to Follow-up|0|||
48490933|NCT00696709|155990806|FG000|Overall Study|Withdrawal by Subject|1|||
48490934|NCT00696709|155990807|FG001|Overall Study|Withdrawal by Subject|2|||
48490935|NCT00696709|155990808|FG002|Overall Study|Withdrawal by Subject|1|||
48490936|NCT00696709|155990809|FG003|Overall Study|Withdrawal by Subject|4|||
48490937|NCT00696709|155990810|FG004|Overall Study|Withdrawal by Subject|3|||
48490938|NCT00696709|155990806|FG000|Overall Study|Protocol Violation|1|||
48490939|NCT00696709|155990807|FG001|Overall Study|Protocol Violation|0|||
48490940|NCT00696709|155990808|FG002|Overall Study|Protocol Violation|0|||
48490941|NCT00696709|155990809|FG003|Overall Study|Protocol Violation|0|||
48490942|NCT00696709|155990810|FG004|Overall Study|Protocol Violation|0|||
48490943|NCT00696709|155990806|FG000|Overall Study|Lost to Follow-up|1|||
48490944|NCT00696709|155990807|FG001|Overall Study|Lost to Follow-up|1|||
48490945|NCT00696709|155990808|FG002|Overall Study|Lost to Follow-up|0|||
48709520|NCT01742286|156784338|FG003|Expansion Phase|Withdrawal by Subject|0|||
48709521|NCT01742286|156784339|FG004|Expansion Phase|Withdrawal by Subject|0|||
48709522|NCT01742286|156784340|FG005|Expansion Phase|Withdrawal by Subject|0|||
48709523|NCT01742286|156784341|FG006|Expansion Phase|Withdrawal by Subject|1|||
48709524|NCT01010867|156784343|FG000|Overall Study|< 50% adherence to probiotic|1|||
48709525|NCT00993148|156784344|FG000|Overall Study|Lost to Follow-up|2|||
48709526|NCT00993148|156784344|FG000|Overall Study|never initiated treatment|1|||
48709527|NCT01077050|156786464|FG000|Overall Study|Subjects signed ICF could not be located|1|||
48709528|NCT01077050|156786464|FG000|Overall Study|Screen failure|8|||
48709529|NCT04953728|156786475|FG000|Overall Study|Withdrawal by Subject|3|||
48709530|NCT04953728|156786475|FG000|Overall Study|Physician Decision|1|||
48709531|NCT01148979|156786476|FG000|Overall Study|Lost to Follow-up|0|||
48709532|NCT01148979|156786477|FG001|Overall Study|Lost to Follow-up|1|||
48709533|NCT01646125|156786480|FG000|Overall Study|Untreated|2|||
48709534|NCT01646125|156786481|FG001|Overall Study|Untreated|5|||
48709535|NCT01646125|156786480|FG000|Overall Study|Adverse Event|2|||
48709536|NCT01646125|156786481|FG001|Overall Study|Adverse Event|1|||
48709537|NCT01646125|156786480|FG000|Overall Study|Death|1|||
48709538|NCT01646125|156786481|FG001|Overall Study|Death|1|||
48709539|NCT01646125|156786480|FG000|Overall Study|Physician Decision|1|||
48709540|NCT01646125|156786481|FG001|Overall Study|Physician Decision|3|||
48709541|NCT01646125|156786480|FG000|Overall Study|Progressive disease|22|||
48709542|NCT01646125|156786481|FG001|Overall Study|Progressive disease|16|||
48709543|NCT01646125|156786480|FG000|Overall Study|Study terminated by sponsor|2|||
48709544|NCT01646125|156786481|FG001|Overall Study|Study terminated by sponsor|1|||
48806112|NCT00792103|157132469|FG000|Overall Study|Protocol Violation|10|||
48490946|NCT00696709|155990809|FG003|Overall Study|Lost to Follow-up|0|||
48490947|NCT00696709|155990810|FG004|Overall Study|Lost to Follow-up|0|||
48490948|NCT00696709|155990806|FG000|Overall Study|Adverse Event|0|||
48490949|NCT00696709|155990807|FG001|Overall Study|Adverse Event|0|||
48490950|NCT00696709|155990808|FG002|Overall Study|Adverse Event|0|||
48490951|NCT00696709|155990809|FG003|Overall Study|Adverse Event|1|||
48709545|NCT01646125|156786480|FG000|Overall Study|Subject/Guardian decision|1|||
48709546|NCT01646125|156786481|FG001|Overall Study|Subject/Guardian decision|1|||
48709547|NCT00990704|156786484|FG000|Overall Study|Adverse Event|1|||
48709548|NCT00990704|156786485|FG001|Overall Study|Adverse Event|1|||
48709549|NCT00990704|156786484|FG000|Overall Study|Physician Decision|0|||
48709550|NCT00990704|156786485|FG001|Overall Study|Physician Decision|1|||
48596576|NCT00410072|156379289|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
48596577|NCT00410072|156379290|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
48596578|NCT00410072|156379289|FG000|After Week 48 to Week 96|Pregnancy|0|||
48596579|NCT00410072|156379290|FG001|After Week 48 to Week 96|Pregnancy|2|||
48596580|NCT00410072|156379289|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
48596581|NCT00410072|156379290|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
48596582|NCT01962948|156379291|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
48596583|NCT01962948|156379292|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
48596584|NCT01962948|156379293|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
48596585|NCT01962948|156379294|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
48596586|NCT01133704|156379295|FG000|Overall Study|Death|44|||
48596587|NCT01133704|156379296|FG001|Overall Study|Death|26|||
48596588|NCT01133704|156379295|FG000|Overall Study|Patient refused to continue|4|||
48596589|NCT01133704|156379296|FG001|Overall Study|Patient refused to continue|0|||
48596590|NCT01133704|156379295|FG000|Overall Study|Study Closure|1|||
48596591|NCT01133704|156379296|FG001|Overall Study|Study Closure|0|||
48596592|NCT01990573|156379297|FG000|Overall Study|Physician Decision|0|||
48596593|NCT01990573|156379298|FG001|Overall Study|Physician Decision|0|||
48596594|NCT01990573|156379299|FG002|Overall Study|Physician Decision|1|||
48596595|NCT00758498|156379304|FG000|Overall Study|Adverse Event|2|||
48596596|NCT00758498|156379305|FG001|Overall Study|Adverse Event|2|||
48596597|NCT00758498|156379306|FG002|Overall Study|Adverse Event|3|||
48596598|NCT00758498|156379304|FG000|Overall Study|Subject legally detained out of state|1|||
48596599|NCT00758498|156379305|FG001|Overall Study|Subject legally detained out of state|0|||
48596600|NCT00758498|156379306|FG002|Overall Study|Subject legally detained out of state|0|||
48596601|NCT00758498|156379304|FG000|Overall Study|Withdrawal by Subject|0|||
48596602|NCT00758498|156379305|FG001|Overall Study|Withdrawal by Subject|0|||
48596603|NCT00758498|156379306|FG002|Overall Study|Withdrawal by Subject|1|||
48596604|NCT00758498|156379304|FG000|Overall Study|Noncompliance to study procedures|0|||
48596605|NCT00758498|156379305|FG001|Overall Study|Noncompliance to study procedures|0|||
48596606|NCT00758498|156379306|FG002|Overall Study|Noncompliance to study procedures|1|||
48596607|NCT01310127|156379307|FG000|Overall Study|Protocol Violation|1|||
48596608|NCT01310127|156379308|FG001|Overall Study|Protocol Violation|1|||
48596609|NCT01310127|156379307|FG000|Overall Study|advanced psc cataract outlier|1|||
48596610|NCT01310127|156379308|FG001|Overall Study|advanced psc cataract outlier|0|||
48596611|NCT04147247|156379309|FG000|Overall Study|Progressive disease|3|||
48596612|NCT04147247|156379310|FG001|Overall Study|Progressive disease|3|||
48596613|NCT04147247|156379311|FG002|Overall Study|Progressive disease|4|||
48596614|NCT04147247|156379312|FG003|Overall Study|Progressive disease|4|||
48596615|NCT04147247|156379313|FG004|Overall Study|Progressive disease|3|||
48596616|NCT04147247|156379309|FG000|Overall Study|Physician Decision|0|||
48596617|NCT04147247|156379310|FG001|Overall Study|Physician Decision|1|||
48596618|NCT04147247|156379311|FG002|Overall Study|Physician Decision|0|||
48596619|NCT04147247|156379312|FG003|Overall Study|Physician Decision|0|||
48596620|NCT04147247|156379313|FG004|Overall Study|Physician Decision|0|||
48596621|NCT04147247|156379309|FG000|Overall Study|Clinical Disease Progression|0|||
48596622|NCT04147247|156379310|FG001|Overall Study|Clinical Disease Progression|0|||
48596623|NCT04147247|156379311|FG002|Overall Study|Clinical Disease Progression|0|||
48596624|NCT04147247|156379312|FG003|Overall Study|Clinical Disease Progression|0|||
48596625|NCT04147247|156379313|FG004|Overall Study|Clinical Disease Progression|1|||
48596626|NCT04147247|156379309|FG000|Overall Study|Adverse Event|0|||
48596627|NCT04147247|156379310|FG001|Overall Study|Adverse Event|0|||
48596628|NCT04147247|156379311|FG002|Overall Study|Adverse Event|1|||
48709551|NCT04040933|156786486|FG000|Overall Study|Protocol Violation|1|||
48709552|NCT04040933|156786486|FG000|Overall Study|Withdrawal by Subject|2|||
48709553|NCT02656693|156786500|FG000|Overall Study|Pregnancy|1|||
48709554|NCT02656693|156786501|FG001|Overall Study|Pregnancy|1|||
48709555|NCT02656693|156786502|FG002|Overall Study|Pregnancy|1|||
48709556|NCT02656693|156786500|FG000|Overall Study|Bariatric surgery|0|||
48709557|NCT02656693|156786501|FG001|Overall Study|Bariatric surgery|1|||
48709558|NCT02656693|156786502|FG002|Overall Study|Bariatric surgery|2|||
48709559|NCT01124006|156786506|FG000|Overall Study|Withdrawal by Subject|2|||
48709560|NCT01124006|156786507|FG001|Overall Study|Withdrawal by Subject|2|||
48709561|NCT01124006|156786508|FG002|Overall Study|Withdrawal by Subject|0|||
48709562|NCT01124006|156786506|FG000|Overall Study|Lost to Follow-up|1|||
48709563|NCT01124006|156786507|FG001|Overall Study|Lost to Follow-up|0|||
48709564|NCT01124006|156786508|FG002|Overall Study|Lost to Follow-up|1|||
48709565|NCT01124006|156786506|FG000|Overall Study|Other|0|||
48709566|NCT01124006|156786507|FG001|Overall Study|Other|0|||
48709567|NCT01124006|156786508|FG002|Overall Study|Other|1|||
48709568|NCT00796419|156786509|FG000|Overall Study|Death|0|||
48709569|NCT00796419|156786510|FG001|Overall Study|Death|1|||
48709570|NCT02840799|156786511|FG000|Phase 1|Physician Decision|1|||
48596629|NCT04147247|156379312|FG003|Overall Study|Adverse Event|0|||
48596630|NCT04147247|156379313|FG004|Overall Study|Adverse Event|1|||
48596631|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
48596632|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
48596633|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
48596634|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
48596635|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
48596636|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
48709571|NCT02840799|156786512|FG001|Phase 1|Physician Decision|3|||
48709572|NCT02840799|156786511|FG000|Phase 1|Withdrawal by Subject|4|||
48709573|NCT02840799|156786512|FG001|Phase 1|Withdrawal by Subject|0|||
48709574|NCT02840799|156786511|FG000|Phase 2 (Crossover)|Adverse Event|0|||
48709575|NCT02840799|156786512|FG001|Phase 2 (Crossover)|Adverse Event|1|||
48709576|NCT02840799|156786511|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
48709577|NCT02840799|156786512|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
48709578|NCT02736578|156786516|FG000|Overall Study|Adverse Event|1|||
48709579|NCT02736578|156786517|FG001|Overall Study|Adverse Event|0|||
48709580|NCT01837823|156786528|FG000|Overall Study|Lost to Follow-up|6|||
48709581|NCT02054104|156786529|FG000|Overall Study|Did not want to continue due to college classes|1|||
48709582|NCT02054104|156786530|FG001|Overall Study|Did not want to continue due to college classes|0|||
48709583|NCT02054104|156786529|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
48709584|NCT02054104|156786530|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
48709585|NCT02054104|156786529|FG000|Overall Study|No evidence of immunologic response|2|||
48709586|NCT02054104|156786530|FG001|Overall Study|No evidence of immunologic response|2|||
48709587|NCT02054104|156786529|FG000|Overall Study|Disease Progression On Study|4|||
48709588|NCT02054104|156786530|FG001|Overall Study|Disease Progression On Study|5|||
48709589|NCT02054104|156786529|FG000|Overall Study|Diagnosis of lymphoma|0|||
48709590|NCT02054104|156786530|FG001|Overall Study|Diagnosis of lymphoma|1|||
48709591|NCT02054104|156786529|FG000|Overall Study|Inconclusive response|0|||
48709592|NCT02054104|156786530|FG001|Overall Study|Inconclusive response|1|||
48709593|NCT00823615|156786531|FG000|Period 2|Lost to Follow-up|2|||
48709594|NCT00823615|156786532|FG001|Period 2|Lost to Follow-up|0|||
48709595|NCT00823615|156786531|FG000|Period 2|Time/Job Conflict|1|||
48709596|NCT00823615|156786532|FG001|Period 2|Time/Job Conflict|2|||
48709597|NCT01864603|156786537|FG000|Stage 2|DSMB design modification|86056|||
48709598|NCT01864603|156786538|FG001|Stage 2|DSMB design modification|92558|||
48709599|NCT00485134|156786540|FG000|Overall Study|Lost to Follow-up|1|||
48709600|NCT00485134|156786541|FG001|Overall Study|Lost to Follow-up|0|||
48709601|NCT00485134|156786542|FG002|Overall Study|Lost to Follow-up|0|||
48709602|NCT00485134|156786543|FG003|Overall Study|Lost to Follow-up|0|||
48709603|NCT00485134|156786544|FG004|Overall Study|Lost to Follow-up|0|||
48709604|NCT00485134|156786545|FG005|Overall Study|Lost to Follow-up|0|||
48709605|NCT00485134|156786546|FG006|Overall Study|Lost to Follow-up|0|||
48709606|NCT00485134|156786547|FG007|Overall Study|Lost to Follow-up|0|||
48709607|NCT00485134|156786540|FG000|Overall Study|Withdrawal by Subject|0|||
48709608|NCT00485134|156786541|FG001|Overall Study|Withdrawal by Subject|1|||
48709609|NCT00485134|156786542|FG002|Overall Study|Withdrawal by Subject|0|||
48709610|NCT00485134|156786543|FG003|Overall Study|Withdrawal by Subject|0|||
48709611|NCT00485134|156786544|FG004|Overall Study|Withdrawal by Subject|0|||
48709612|NCT00485134|156786545|FG005|Overall Study|Withdrawal by Subject|0|||
48709613|NCT00485134|156786546|FG006|Overall Study|Withdrawal by Subject|0|||
48709614|NCT00485134|156786547|FG007|Overall Study|Withdrawal by Subject|0|||
48709615|NCT00485134|156786540|FG000|Overall Study|Change in health status|0|||
48709616|NCT00485134|156786541|FG001|Overall Study|Change in health status|1|||
48709617|NCT00485134|156786542|FG002|Overall Study|Change in health status|2|||
48709618|NCT00485134|156786543|FG003|Overall Study|Change in health status|1|||
48709619|NCT00485134|156786544|FG004|Overall Study|Change in health status|0|||
48709620|NCT00485134|156786545|FG005|Overall Study|Change in health status|1|||
48709621|NCT00485134|156786546|FG006|Overall Study|Change in health status|0|||
48709622|NCT00485134|156786547|FG007|Overall Study|Change in health status|0|||
48709623|NCT00485134|156786540|FG000|Overall Study|Withdrew for adverse event|0|||
48709624|NCT00485134|156786541|FG001|Overall Study|Withdrew for adverse event|0|||
48709625|NCT00485134|156786542|FG002|Overall Study|Withdrew for adverse event|1|||
48709626|NCT00485134|156786543|FG003|Overall Study|Withdrew for adverse event|0|||
48709627|NCT00485134|156786544|FG004|Overall Study|Withdrew for adverse event|0|||
48709628|NCT00485134|156786545|FG005|Overall Study|Withdrew for adverse event|0|||
48709629|NCT00485134|156786546|FG006|Overall Study|Withdrew for adverse event|0|||
48709630|NCT00485134|156786547|FG007|Overall Study|Withdrew for adverse event|0|||
48709631|NCT00485134|156786540|FG000|Overall Study|Positive drug test|0|||
48709632|NCT00485134|156786541|FG001|Overall Study|Positive drug test|0|||
48709633|NCT00485134|156786542|FG002|Overall Study|Positive drug test|0|||
48709634|NCT00485134|156786543|FG003|Overall Study|Positive drug test|0|||
48709635|NCT00485134|156786544|FG004|Overall Study|Positive drug test|2|||
48709636|NCT00485134|156786545|FG005|Overall Study|Positive drug test|1|||
48709637|NCT00485134|156786546|FG006|Overall Study|Positive drug test|0|||
48709638|NCT00485134|156786547|FG007|Overall Study|Positive drug test|0|||
48806113|NCT00792103|157132469|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
48806114|NCT03673462|157132470|FG000|Overall Study|Adverse Event|11|||
48806115|NCT03673462|157132471|FG001|Overall Study|Adverse Event|1|||
48806116|NCT03673462|157132470|FG000|Overall Study|Protocol Violation|25|||
48806117|NCT03673462|157132471|FG001|Overall Study|Protocol Violation|11|||
48806118|NCT03673462|157132470|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
48806119|NCT03673462|157132471|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
48806120|NCT03673462|157132470|FG000|Overall Study|Lost to Follow-up|102|||
48806121|NCT03673462|157132471|FG001|Overall Study|Lost to Follow-up|19|||
48806122|NCT00113360|157132475|FG000|Overall Study|Adverse Event|3|||
48806123|NCT00113360|157132475|FG000|Overall Study|Subject required surgery|1|||
48806124|NCT00113360|157132475|FG000|Overall Study|Did not meet eligibility criteria|3|||
48806125|NCT03002038|157132482|FG000|Overall Study|Adverse Event|3|||
48806126|NCT03002038|157132483|FG001|Overall Study|Adverse Event|1|||
48806127|NCT03002038|157132482|FG000|Overall Study|Withdrawal by Subject|8|||
48806128|NCT03002038|157132483|FG001|Overall Study|Withdrawal by Subject|4|||
48806129|NCT03002038|157132482|FG000|Overall Study|Immigration to another region|0|||
48806130|NCT03002038|157132483|FG001|Overall Study|Immigration to another region|2|||
48806131|NCT03351738|157132486|FG000|Overall Study|Withdrawal by Subject|0|||
48806132|NCT03351738|157132487|FG001|Overall Study|Withdrawal by Subject|1|||
48806133|NCT03351738|157132488|FG002|Overall Study|Withdrawal by Subject|0|||
48806134|NCT03351738|157132489|FG003|Overall Study|Withdrawal by Subject|1|||
48806135|NCT03351738|157132490|FG004|Overall Study|Withdrawal by Subject|0|||
48806136|NCT03351738|157132491|FG005|Overall Study|Withdrawal by Subject|0|||
48806137|NCT02243709|157132496|FG000|Phase 1|Lost to Follow-up|0|||
48709639|NCT00485134|156786540|FG000|Overall Study|Non-compliance|0|||
48709640|NCT00485134|156786541|FG001|Overall Study|Non-compliance|0|||
48709641|NCT00485134|156786542|FG002|Overall Study|Non-compliance|0|||
48709642|NCT00485134|156786543|FG003|Overall Study|Non-compliance|0|||
48709643|NCT00485134|156786544|FG004|Overall Study|Non-compliance|1|||
48709644|NCT00485134|156786545|FG005|Overall Study|Non-compliance|2|||
48709645|NCT00485134|156786546|FG006|Overall Study|Non-compliance|2|||
48709646|NCT00485134|156786547|FG007|Overall Study|Non-compliance|0|||
48709647|NCT00485134|156786540|FG000|Overall Study|Unable to comply with study schedule|0|||
48709648|NCT00485134|156786541|FG001|Overall Study|Unable to comply with study schedule|0|||
48709649|NCT00485134|156786542|FG002|Overall Study|Unable to comply with study schedule|0|||
48709650|NCT00485134|156786543|FG003|Overall Study|Unable to comply with study schedule|0|||
48709651|NCT00485134|156786544|FG004|Overall Study|Unable to comply with study schedule|0|||
48709652|NCT00485134|156786545|FG005|Overall Study|Unable to comply with study schedule|0|||
48709653|NCT00485134|156786546|FG006|Overall Study|Unable to comply with study schedule|0|||
48709654|NCT00485134|156786547|FG007|Overall Study|Unable to comply with study schedule|1|||
48709655|NCT00485134|156786540|FG000|Overall Study|Pregnancy|0|||
48709656|NCT00485134|156786541|FG001|Overall Study|Pregnancy|0|||
48709657|NCT00485134|156786542|FG002|Overall Study|Pregnancy|0|||
48709658|NCT00485134|156786543|FG003|Overall Study|Pregnancy|0|||
48709659|NCT00485134|156786544|FG004|Overall Study|Pregnancy|0|||
48709660|NCT00485134|156786545|FG005|Overall Study|Pregnancy|0|||
48709661|NCT00485134|156786546|FG006|Overall Study|Pregnancy|1|||
48709662|NCT00485134|156786547|FG007|Overall Study|Pregnancy|0|||
48709663|NCT00001213|156786550|FG000|Overall Study|Death|18|||
48709664|NCT00975689|156786554|FG000|Overall Study|Adverse Event|0|||
48709665|NCT00975689|156786555|FG001|Overall Study|Adverse Event|3|||
48709666|NCT00975689|156786554|FG000|Overall Study|Withdrawal by Subject|1|||
48709667|NCT00975689|156786555|FG001|Overall Study|Withdrawal by Subject|0|||
48709668|NCT00975689|156786554|FG000|Overall Study|Physician Decision|1|||
48709669|NCT00975689|156786555|FG001|Overall Study|Physician Decision|0|||
48709670|NCT04335136|156786556|FG000|Overall Study|Death|8|||
48709671|NCT04335136|156786557|FG001|Overall Study|Death|4|||
48709672|NCT04335136|156786556|FG000|Overall Study|Lost to Follow-up|2|||
48709673|NCT04335136|156786557|FG001|Overall Study|Lost to Follow-up|0|||
48709674|NCT04335136|156786556|FG000|Overall Study|Protocol Violation|1|||
48709675|NCT04335136|156786557|FG001|Overall Study|Protocol Violation|0|||
48709676|NCT04335136|156786556|FG000|Overall Study|Withdrawal by Subject|1|||
48709677|NCT04335136|156786557|FG001|Overall Study|Withdrawal by Subject|1|||
48709678|NCT04335136|156786556|FG000|Overall Study|Health-threatening condition|0|||
48709679|NCT04335136|156786557|FG001|Overall Study|Health-threatening condition|1|||
48709680|NCT04335136|156786556|FG000|Overall Study|Adverse Event|0|||
48709681|NCT04335136|156786557|FG001|Overall Study|Adverse Event|1|||
48709682|NCT04335136|156786556|FG000|Overall Study|Erroneously randomized|2|||
48709683|NCT04335136|156786557|FG001|Overall Study|Erroneously randomized|0|||
48709684|NCT00433004|156786558|FG000|Overall Study|Lost to Follow-up|5|||
48709685|NCT00433004|156786559|FG001|Overall Study|Lost to Follow-up|7|||
48709686|NCT00742235|156786560|FG000|Overall Study|Lost to Follow-up|0|||
48709687|NCT00742235|156786561|FG001|Overall Study|Lost to Follow-up|31|||
48709688|NCT03534180|156786562|FG000|Overall Study|Withdrawal by Subject|1|||
48806138|NCT02243709|157132497|FG001|Phase 1|Lost to Follow-up|1|||
48806139|NCT02243709|157132496|FG000|Phase 1|Withdrawal by Subject|1|||
48709689|NCT00330967|156786563|FG000|Overall Study|Withdrawal by Subject|0|||
48709690|NCT00330967|156786564|FG001|Overall Study|Withdrawal by Subject|5|||
48709691|NCT00330967|156786563|FG000|Overall Study|Physician Decision|0|||
48709692|NCT00330967|156786564|FG001|Overall Study|Physician Decision|9|||
48709693|NCT00473382|156786567|FG000|Core Study|Adverse Event|3|||
48709694|NCT00473382|156786568|FG001|Core Study|Adverse Event|1|||
48709695|NCT00473382|156786569|FG002|Core Study|Adverse Event|1|||
48709696|NCT00473382|156786567|FG000|Core Study|Death|3|||
48709697|NCT00473382|156786568|FG001|Core Study|Death|5|||
48709698|NCT00473382|156786569|FG002|Core Study|Death|10|||
48709699|NCT00473382|156786567|FG000|Core Study|Lost to Follow-up|3|||
48806140|NCT02243709|157132497|FG001|Phase 1|Withdrawal by Subject|0|||
48806141|NCT02243709|157132496|FG000|Phase 1|Protocol Violation|0|||
48806142|NCT02243709|157132497|FG001|Phase 1|Protocol Violation|1|||
48806143|NCT02243709|157132496|FG000|Phase 1|Adverse Event|0|||
48806144|NCT02243709|157132497|FG001|Phase 1|Adverse Event|1|||
48806145|NCT01013792|157132501|FG000|Overall Study|Study suspended|2|||
48806146|NCT01013792|157132502|FG001|Overall Study|Study suspended|1|||
48709700|NCT00473382|156786568|FG001|Core Study|Lost to Follow-up|3|||
48709701|NCT00473382|156786569|FG002|Core Study|Lost to Follow-up|3|||
48709702|NCT00473382|156786567|FG000|Core Study|Physician Decision|1|||
48709703|NCT00473382|156786568|FG001|Core Study|Physician Decision|2|||
48709704|NCT00473382|156786569|FG002|Core Study|Physician Decision|2|||
48709705|NCT00473382|156786567|FG000|Core Study|Subject non-compliance|5|||
48709706|NCT00473382|156786568|FG001|Core Study|Subject non-compliance|2|||
48709707|NCT00473382|156786569|FG002|Core Study|Subject non-compliance|1|||
48709708|NCT00473382|156786567|FG000|Core Study|Subject needed other treatment|1|||
48709709|NCT00473382|156786568|FG001|Core Study|Subject needed other treatment|3|||
48709710|NCT00473382|156786569|FG002|Core Study|Subject needed other treatment|2|||
48709711|NCT00473382|156786567|FG000|Core Study|Subject's decision|12|||
48709712|NCT00473382|156786568|FG001|Core Study|Subject's decision|11|||
48709713|NCT00473382|156786569|FG002|Core Study|Subject's decision|10|||
48709714|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
48709715|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
48709716|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
48709717|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Death|1|||
48709718|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Death|3|||
48709719|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Death|3|||
48709720|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
48709721|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
48709722|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
48709723|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
48709724|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
48709725|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
48806147|NCT01013792|157132501|FG000|Overall Study|Adverse Event|0|||
48806148|NCT01013792|157132502|FG001|Overall Study|Adverse Event|3|||
48806149|NCT01013792|157132501|FG000|Overall Study|Lost to Follow-up|0|||
48490952|NCT00696709|155990810|FG004|Overall Study|Adverse Event|0|||
48490953|NCT02984683|155990815|FG000|Overall Study|Adverse Event|3|||
48709726|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
48490954|NCT02984683|155990816|FG001|Overall Study|Adverse Event|3|||
48709727|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
48709728|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
48709729|NCT00473382|156786567|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
48709730|NCT00473382|156786568|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
48709731|NCT00473382|156786569|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
48490955|NCT02984683|155990815|FG000|Overall Study|Withdrawal by Subject|1|||
48490956|NCT02984683|155990816|FG001|Overall Study|Withdrawal by Subject|0|||
48490957|NCT02984683|155990815|FG000|Overall Study|Disease progression|7|||
48490958|NCT02984683|155990816|FG001|Overall Study|Disease progression|9|||
48490959|NCT00321711|155990817|FG000|Part A|Adverse Event|3|||
48490960|NCT00321711|155990818|FG001|Part A|Adverse Event|3|||
48490961|NCT00321711|155990819|FG002|Part A|Adverse Event|2|||
48709732|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
48709733|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
48709734|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
48806150|NCT01013792|157132502|FG001|Overall Study|Lost to Follow-up|1|||
48806151|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
48806152|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
48806153|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
48806154|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
48806155|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
48806156|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
48490962|NCT00321711|155990820|FG003|Part A|Adverse Event|0|||
48490963|NCT00321711|155990821|FG004|Part A|Adverse Event|0|||
48490964|NCT00321711|155990817|FG000|Part A|Withdrawal by Subject|1|||
48490965|NCT00321711|155990818|FG001|Part A|Withdrawal by Subject|1|||
48490966|NCT00321711|155990819|FG002|Part A|Withdrawal by Subject|1|||
48490967|NCT00321711|155990820|FG003|Part A|Withdrawal by Subject|0|||
48490968|NCT00321711|155990821|FG004|Part A|Withdrawal by Subject|0|||
48490969|NCT00321711|155990817|FG000|Part A|Disease progression|0|||
48490970|NCT00321711|155990818|FG001|Part A|Disease progression|1|||
48490971|NCT00321711|155990819|FG002|Part A|Disease progression|0|||
48490972|NCT00321711|155990820|FG003|Part A|Disease progression|0|||
48490973|NCT00321711|155990821|FG004|Part A|Disease progression|0|||
48490974|NCT00321711|155990817|FG000|Part A|Requirement for alternative therapy|0|||
48490975|NCT00321711|155990818|FG001|Part A|Requirement for alternative therapy|2|||
48490976|NCT00321711|155990819|FG002|Part A|Requirement for alternative therapy|1|||
48490977|NCT00321711|155990820|FG003|Part A|Requirement for alternative therapy|0|||
48490978|NCT00321711|155990821|FG004|Part A|Requirement for alternative therapy|0|||
48596637|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
48596638|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
48596639|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
48806157|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
48806158|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Physician Decision|4|||
48806159|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Physician Decision|1|||
48806160|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Physician Decision|3|||
48806161|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Physician Decision|0|||
48806162|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Physician Decision|0|||
48806163|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Physician Decision|1|||
48806164|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Physician Decision|0|||
48806165|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Other|0|||
48490979|NCT00321711|155990817|FG000|Part A|Physician Decision|0|||
48596640|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
48806166|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Other|1|||
48806167|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Other|0|||
48806168|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Other|0|||
48806169|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Other|0|||
48490980|NCT00321711|155990818|FG001|Part A|Physician Decision|1|||
48596641|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
48596642|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
48596643|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
48596644|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
48596645|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Death|1|||
48596646|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Death|0|||
48596647|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
48596648|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
48596649|NCT00105989|156379314|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
48596650|NCT00105989|156379315|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
48596651|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
48596652|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
48596653|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
48596654|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
48596655|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
48596656|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
48596657|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
48596658|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
48596659|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
48596660|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
48596661|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
48596662|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
48596663|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
48596664|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
48596665|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Death|0|||
48596666|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Death|0|||
48596667|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
48596668|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
48596669|NCT00105989|156379314|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
48806170|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Other|0|||
48806171|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Other|0|||
48490981|NCT00321711|155990819|FG002|Part A|Physician Decision|3|||
48490982|NCT00321711|155990820|FG003|Part A|Physician Decision|0|||
48490983|NCT00321711|155990821|FG004|Part A|Physician Decision|0|||
48490984|NCT00321711|155990817|FG000|Part A|Other|1|||
48806172|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806173|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806174|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806175|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806176|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806177|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
48806178|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
48806179|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
48806180|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
48806181|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
48806182|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
48806183|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
48806184|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
48806185|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
48806186|NCT05375955|157132505|FG000|Treatment (12 Weeks)|Pregnancy|0|||
48806187|NCT05375955|157132506|FG001|Treatment (12 Weeks)|Pregnancy|0|||
48806188|NCT05375955|157132507|FG002|Treatment (12 Weeks)|Pregnancy|1|||
48806189|NCT05375955|157132508|FG003|Treatment (12 Weeks)|Pregnancy|0|||
48806190|NCT05375955|157132509|FG004|Treatment (12 Weeks)|Pregnancy|0|||
48806191|NCT05375955|157132510|FG005|Treatment (12 Weeks)|Pregnancy|0|||
48806192|NCT05375955|157132511|FG006|Treatment (12 Weeks)|Pregnancy|0|||
48806193|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806194|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806195|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
48806196|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806197|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806198|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806199|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
48806200|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
48806201|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
48806202|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
48806203|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
48806204|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
48806205|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
48806206|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
48806207|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Other|0|||
48806208|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Other|1|||
48806209|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Other|0|||
48806210|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Other|0|||
48806211|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Other|0|||
48490985|NCT00321711|155990818|FG001|Part A|Other|2|||
48806212|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Other|0|||
48806213|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Other|0|||
48806214|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
48806215|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806216|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
48806217|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806218|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806219|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806220|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
48806221|NCT05375955|157132505|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
48806222|NCT05375955|157132506|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
48806223|NCT05375955|157132507|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
48806224|NCT05375955|157132508|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
48806225|NCT05375955|157132509|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
48490986|NCT00321711|155990819|FG002|Part A|Other|3|||
48490987|NCT00321711|155990820|FG003|Part A|Other|0|||
48490988|NCT00321711|155990821|FG004|Part A|Other|0|||
48490989|NCT00321711|155990817|FG000|Part A|Protocol deviation|0|||
48490990|NCT00321711|155990818|FG001|Part A|Protocol deviation|0|||
48806226|NCT05375955|157132510|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
48806227|NCT05375955|157132511|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
48806228|NCT02485938|157132515|FG000|Overall Study|Withdrawal of consent|2|||
48806229|NCT02485938|157132516|FG001|Overall Study|Withdrawal of consent|0|||
48806230|NCT04195698|157132517|FG000|Overall Study|Adverse Event|4|||
48806231|NCT04195698|157132518|FG001|Overall Study|Adverse Event|11|||
48806232|NCT04195698|157132517|FG000|Overall Study|Withdrawal by Subject|9|||
48806233|NCT04195698|157132518|FG001|Overall Study|Withdrawal by Subject|10|||
48806234|NCT04195698|157132517|FG000|Overall Study|Lost to Follow-up|5|||
48806235|NCT04195698|157132518|FG001|Overall Study|Lost to Follow-up|4|||
48806236|NCT04195698|157132517|FG000|Overall Study|Lack of Efficacy|2|||
48806237|NCT04195698|157132518|FG001|Overall Study|Lack of Efficacy|10|||
48806238|NCT04195698|157132517|FG000|Overall Study|Other|5|||
48806239|NCT04195698|157132518|FG001|Overall Study|Other|4|||
48806240|NCT04282148|157132519|FG000|Overall Study|Death|7|||
48806241|NCT04282148|157132519|FG000|Overall Study|Withdrawal by Subject|1|||
48806242|NCT04282148|157132519|FG000|Overall Study|Physician Decision|1|||
48806243|NCT01547299|157132520|FG000|Overall Study|Withdrawal by Subject|2|||
48806244|NCT01547299|157132521|FG001|Overall Study|Withdrawal by Subject|2|||
48806245|NCT02087501|157132522|FG000|Overall Study|Death|7|||
48806246|NCT02087501|157132522|FG000|Overall Study|Open repair of aneurysm|1|||
48806247|NCT02087501|157132522|FG000|Overall Study|Lost to Follow-up|2|||
48806248|NCT00265330|157132523|FG000|Overall Study|Adverse Event|41|||
48806249|NCT00265330|157132523|FG000|Overall Study|Lost to Follow-up|8|||
48806250|NCT00265330|157132523|FG000|Overall Study|Withdrawal by Subject|34|||
48806251|NCT00265330|157132523|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
48806252|NCT00265330|157132523|FG000|Overall Study|Lack of Efficacy|4|||
48434813|NCT00568958|155780520|FG000|Follow-Up|Withdrawal by Subject|6|||
48806253|NCT00265330|157132523|FG000|Overall Study|Family Scheduling Conflicts|1|||
48806254|NCT00265330|157132523|FG000|Overall Study|Began Taking Formulary Geodon|1|||
48806255|NCT00265330|157132523|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
48806256|NCT00265330|157132523|FG000|Overall Study|Site Closed by Sponsor|1|||
48806257|NCT00265330|157132523|FG000|Overall Study|Principal Investigators Request|1|||
48806258|NCT00265330|157132523|FG000|Overall Study|Withdrew Consent|1|||
48806259|NCT00265330|157132523|FG000|Overall Study|Protocol Violation|1|||
48806260|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
48806261|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
48806262|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
48806263|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
48806264|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
48806265|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
48806266|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
48806267|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
48806268|NCT01336621|157132526|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
48806269|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
48806270|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
48806271|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
48806272|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
48806273|NCT01336621|157132526|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
48806274|NCT01874145|157132527|FG000|Core Period|Non-compliance|1|||
48806275|NCT01874145|157132528|FG001|Core Period|Non-compliance|0|||
48806276|NCT01874145|157132527|FG000|Core Period|Protocol Violation|1|||
48806277|NCT01874145|157132528|FG001|Core Period|Protocol Violation|1|||
48806278|NCT01874145|157132527|FG000|Core Period|Physician Decision|1|||
48806279|NCT01874145|157132528|FG001|Core Period|Physician Decision|1|||
48806280|NCT01874145|157132527|FG000|Core Period|Adverse Event|0|||
48806281|NCT01874145|157132528|FG001|Core Period|Adverse Event|1|||
48806282|NCT01874145|157132527|FG000|Core Period|Withdrawal by Subject|0|||
48806283|NCT01874145|157132528|FG001|Core Period|Withdrawal by Subject|4|||
48806284|NCT01874145|157132527|FG000|Extension Period|Adverse Event|3|||
48806285|NCT01874145|157132528|FG001|Extension Period|Adverse Event|2|||
48806286|NCT01874145|157132527|FG000|Extension Period|Withdrawal by Subject|2|||
48806287|NCT01874145|157132528|FG001|Extension Period|Withdrawal by Subject|1|||
48490991|NCT00321711|155990819|FG002|Part A|Protocol deviation|1|||
48490992|NCT00321711|155990820|FG003|Part A|Protocol deviation|0|||
48490993|NCT00321711|155990821|FG004|Part A|Protocol deviation|0|||
48490994|NCT00321711|155990817|FG000|Part B|Noncompliance|0|||
48490995|NCT00321711|155990818|FG001|Part B|Noncompliance|0|||
48806288|NCT01874145|157132527|FG000|Extension Period|Lost to Follow-up|1|||
48806289|NCT01874145|157132528|FG001|Extension Period|Lost to Follow-up|1|||
48806290|NCT01960452|157132529|FG000|Overall Study|Withdrawal by Subject|2|||
48490996|NCT00321711|155990819|FG002|Part B|Noncompliance|0|||
48490997|NCT00321711|155990820|FG003|Part B|Noncompliance|0|||
48490998|NCT00321711|155990821|FG004|Part B|Noncompliance|1|||
48490999|NCT00321711|155990817|FG000|Part B|Adverse Event|0|||
48491000|NCT00321711|155990818|FG001|Part B|Adverse Event|0|||
48491001|NCT00321711|155990819|FG002|Part B|Adverse Event|0|||
48491002|NCT00321711|155990820|FG003|Part B|Adverse Event|2|||
48491003|NCT00321711|155990821|FG004|Part B|Adverse Event|1|||
48596670|NCT00105989|156379315|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
48596671|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
48491004|NCT00321711|155990817|FG000|Part B|Disease progression|0|||
48491005|NCT00321711|155990818|FG001|Part B|Disease progression|0|||
48491006|NCT00321711|155990819|FG002|Part B|Disease progression|0|||
48491007|NCT00321711|155990820|FG003|Part B|Disease progression|1|||
48491008|NCT00321711|155990821|FG004|Part B|Disease progression|0|||
48491009|NCT00321711|155990817|FG000|Part B|Physician Decision|0|||
48491010|NCT00321711|155990818|FG001|Part B|Physician Decision|0|||
48491011|NCT00321711|155990819|FG002|Part B|Physician Decision|0|||
48491012|NCT00321711|155990820|FG003|Part B|Physician Decision|1|||
48491013|NCT00321711|155990821|FG004|Part B|Physician Decision|2|||
48491014|NCT00321711|155990817|FG000|Part B|Death|0|||
48491015|NCT00321711|155990818|FG001|Part B|Death|0|||
48806291|NCT01960452|157132530|FG001|Overall Study|Withdrawal by Subject|1|||
48806292|NCT01960452|157132529|FG000|Overall Study|Sleep apnea in Night 1|1|||
48806293|NCT01960452|157132530|FG001|Overall Study|Sleep apnea in Night 1|0|||
48806294|NCT01960452|157132529|FG000|Overall Study|Poor Sleep in Night 1|0|||
48806295|NCT01960452|157132530|FG001|Overall Study|Poor Sleep in Night 1|2|||
48806296|NCT01960452|157132529|FG000|Overall Study|No Sex/Age Match Night 1|1|||
48806297|NCT01960452|157132530|FG001|Overall Study|No Sex/Age Match Night 1|0|||
48806298|NCT01960452|157132529|FG000|Overall Study|No Sex/Age Match Night 2|0|||
48806299|NCT01960452|157132530|FG001|Overall Study|No Sex/Age Match Night 2|2|||
48806300|NCT01960452|157132529|FG000|Overall Study|Technical Difficulties Night 2|2|||
48806301|NCT01960452|157132530|FG001|Overall Study|Technical Difficulties Night 2|0|||
48806302|NCT03565068|157132533|FG000|Overall Study|Protocol Violation|0|||
48806303|NCT03565068|157132534|FG001|Overall Study|Protocol Violation|0|||
48806304|NCT03565068|157132535|FG002|Overall Study|Protocol Violation|0|||
48806305|NCT03565068|157132536|FG003|Overall Study|Protocol Violation|0|||
48806306|NCT03565068|157132537|FG004|Overall Study|Protocol Violation|1|||
48806307|NCT03565068|157132538|FG005|Overall Study|Protocol Violation|0|||
48806308|NCT03565068|157132539|FG006|Overall Study|Protocol Violation|0|||
48806309|NCT03565068|157132540|FG007|Overall Study|Protocol Violation|1|||
48806310|NCT03565068|157132541|FG008|Overall Study|Protocol Violation|0|||
48806311|NCT03565068|157132533|FG000|Overall Study|Sponsor decision|0|||
48806312|NCT03565068|157132534|FG001|Overall Study|Sponsor decision|0|||
48806313|NCT03565068|157132535|FG002|Overall Study|Sponsor decision|0|||
48806314|NCT03565068|157132536|FG003|Overall Study|Sponsor decision|0|||
48806315|NCT03565068|157132537|FG004|Overall Study|Sponsor decision|1|||
48806316|NCT03565068|157132538|FG005|Overall Study|Sponsor decision|1|||
48806317|NCT03565068|157132539|FG006|Overall Study|Sponsor decision|0|||
48806318|NCT03565068|157132540|FG007|Overall Study|Sponsor decision|0|||
48806319|NCT03565068|157132541|FG008|Overall Study|Sponsor decision|0|||
48806320|NCT03565068|157132533|FG000|Overall Study|Withdrawal by Subject|0|||
48806321|NCT03565068|157132534|FG001|Overall Study|Withdrawal by Subject|0|||
48806322|NCT03565068|157132535|FG002|Overall Study|Withdrawal by Subject|1|||
48806323|NCT03565068|157132536|FG003|Overall Study|Withdrawal by Subject|0|||
48491016|NCT00321711|155990819|FG002|Part B|Death|0|||
48491017|NCT00321711|155990820|FG003|Part B|Death|2|||
48491018|NCT00321711|155990821|FG004|Part B|Death|1|||
48491019|NCT01118728|155990822|FG000|Overall Study|Adverse Event|17|||
48491020|NCT01118728|155990822|FG000|Overall Study|Lack of Efficacy|27|||
48491021|NCT01118728|155990822|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
48491022|NCT01118728|155990822|FG000|Overall Study|Withdrawal by Subject|3|||
48491023|NCT01118728|155990822|FG000|Overall Study|Lost to Follow-up|4|||
48491024|NCT03521999|155990823|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
48491025|NCT03521999|155990824|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
48491026|NCT03521999|155990823|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
48806324|NCT03565068|157132537|FG004|Overall Study|Withdrawal by Subject|2|||
48806325|NCT03565068|157132538|FG005|Overall Study|Withdrawal by Subject|0|||
48806326|NCT03565068|157132539|FG006|Overall Study|Withdrawal by Subject|1|||
48806327|NCT03565068|157132540|FG007|Overall Study|Withdrawal by Subject|5|||
48806328|NCT03565068|157132541|FG008|Overall Study|Withdrawal by Subject|1|||
48806329|NCT03565068|157132533|FG000|Overall Study|Physician Decision|0|||
48806330|NCT03565068|157132534|FG001|Overall Study|Physician Decision|0|||
48491027|NCT03521999|155990824|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
48491028|NCT03521999|155990823|FG000|Completed 3 Month Follow up|Death|0|||
48806331|NCT03565068|157132535|FG002|Overall Study|Physician Decision|0|||
48806332|NCT03565068|157132536|FG003|Overall Study|Physician Decision|0|||
48491029|NCT03521999|155990824|FG001|Completed 3 Month Follow up|Death|1|||
48491030|NCT03521999|155990823|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
48491031|NCT03521999|155990824|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
48491032|NCT02843074|155990825|FG000|Overall Study|Withdrawal by Subject|5|||
48491033|NCT02843074|155990825|FG000|Overall Study|Progressive disease|1|||
48806333|NCT03565068|157132537|FG004|Overall Study|Physician Decision|0|||
48806334|NCT03565068|157132538|FG005|Overall Study|Physician Decision|0|||
48806335|NCT03565068|157132539|FG006|Overall Study|Physician Decision|0|||
48806336|NCT03565068|157132540|FG007|Overall Study|Physician Decision|1|||
48806337|NCT03565068|157132541|FG008|Overall Study|Physician Decision|0|||
48806338|NCT03565068|157132533|FG000|Overall Study|Lost to Follow-up|0|||
48806339|NCT03565068|157132534|FG001|Overall Study|Lost to Follow-up|0|||
48491034|NCT02843074|155990825|FG000|Overall Study|Physician Decision|1|||
48491035|NCT02843074|155990825|FG000|Overall Study|Lost to Follow-up|1|||
48491036|NCT02843074|155990825|FG000|Overall Study|Death|9|||
48491037|NCT03361956|155990826|FG000|Overall Study|Adverse Event|1|||
48491038|NCT03361956|155990827|FG001|Overall Study|Adverse Event|0|||
48491039|NCT03361956|155990828|FG002|Overall Study|Adverse Event|1|||
48491040|NCT03361956|155990829|FG003|Overall Study|Adverse Event|1|||
48709735|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Death|1|||
48709736|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Death|7|||
48709737|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Death|4|||
48709738|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
48806340|NCT03565068|157132535|FG002|Overall Study|Lost to Follow-up|0|||
48806341|NCT03565068|157132536|FG003|Overall Study|Lost to Follow-up|0|||
48806342|NCT03565068|157132537|FG004|Overall Study|Lost to Follow-up|0|||
48806343|NCT03565068|157132538|FG005|Overall Study|Lost to Follow-up|0|||
48806344|NCT03565068|157132539|FG006|Overall Study|Lost to Follow-up|0|||
48806345|NCT03565068|157132540|FG007|Overall Study|Lost to Follow-up|1|||
48806346|NCT03565068|157132541|FG008|Overall Study|Lost to Follow-up|0|||
48806347|NCT01893827|157132550|FG000|Overall Study|Lost to Follow-up|19|||
48806348|NCT01893827|157132551|FG001|Overall Study|Lost to Follow-up|26|||
48491041|NCT03361956|155990830|FG004|Overall Study|Adverse Event|0|||
48806349|NCT02217280|157132554|FG000|Overall Study|Withdrawal by Subject|2|||
48806350|NCT02217280|157132554|FG000|Overall Study|Post-consent sceen fail|2|||
48806351|NCT02293395|157133599|FG000|Overall Study|Lost to Follow-up|1|||
48806352|NCT02293395|157133600|FG001|Overall Study|Lost to Follow-up|0|||
48806353|NCT02293395|157133599|FG000|Overall Study|Withdrawal by Subject|8|||
48806354|NCT02293395|157133600|FG001|Overall Study|Withdrawal by Subject|7|||
48806355|NCT00755222|157133601|FG000|Overall Study|Withdrawal by Subject|4|||
48806356|NCT00755222|157133602|FG001|Overall Study|Withdrawal by Subject|2|||
48806357|NCT00755222|157133601|FG000|Overall Study|Adverse Event|2|||
48806358|NCT00755222|157133602|FG001|Overall Study|Adverse Event|0|||
48806359|NCT00755222|157133601|FG000|Overall Study|Protocol Violation|2|||
48806360|NCT00755222|157133602|FG001|Overall Study|Protocol Violation|0|||
48806361|NCT01802437|157133603|FG000|Overall Study|Lost to Follow-up|1|||
48806362|NCT01802437|157133604|FG001|Overall Study|Lost to Follow-up|0|||
48806363|NCT01802437|157133603|FG000|Overall Study|Withdrawal by Subject|3|||
48806364|NCT01802437|157133604|FG001|Overall Study|Withdrawal by Subject|4|||
48806365|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
48806366|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
48806367|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
48806368|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48806369|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48806370|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48806371|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48806372|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48806373|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
48806374|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
48806375|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48806376|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48491042|NCT03361956|155990826|FG000|Overall Study|Other|0|||
48709739|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
48709740|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
48709741|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
48709742|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
48709743|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
48709744|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
48709745|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
48709746|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
48709747|NCT00473382|156786567|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
48709748|NCT00473382|156786568|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
48709749|NCT00473382|156786569|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
48709750|NCT01134055|156786570|FG000|Overall Study|Adverse Event|5|||
48709751|NCT01134055|156786571|FG001|Overall Study|Adverse Event|2|||
48709752|NCT01134055|156786572|FG002|Overall Study|Adverse Event|2|||
48709753|NCT01134055|156786573|FG003|Overall Study|Adverse Event|2|||
48709754|NCT01134055|156786574|FG004|Overall Study|Adverse Event|5|||
48709755|NCT01134055|156786575|FG005|Overall Study|Adverse Event|7|||
48709756|NCT01134055|156786576|FG006|Overall Study|Adverse Event|2|||
48806377|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48806378|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48806379|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
48491043|NCT03361956|155990827|FG001|Overall Study|Other|0|||
48806380|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
48596672|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
48596673|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
48596674|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
48596675|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
48596676|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
48596677|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
48596678|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
48596679|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
48596680|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
48596681|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
48596682|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
48596683|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
48596684|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
48596685|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
48806381|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
48806382|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48806383|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48806384|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48806385|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48806386|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
48806387|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
48806388|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
48806389|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48491044|NCT03361956|155990828|FG002|Overall Study|Other|0|||
48491045|NCT03361956|155990829|FG003|Overall Study|Other|1|||
48491046|NCT03361956|155990830|FG004|Overall Study|Other|0|||
48491047|NCT03361956|155990826|FG000|Overall Study|Withdrawal by Subject|2|||
48491048|NCT03361956|155990827|FG001|Overall Study|Withdrawal by Subject|2|||
48491049|NCT03361956|155990828|FG002|Overall Study|Withdrawal by Subject|2|||
48491050|NCT03361956|155990829|FG003|Overall Study|Withdrawal by Subject|0|||
48491051|NCT03361956|155990830|FG004|Overall Study|Withdrawal by Subject|3|||
48491052|NCT03361956|155990826|FG000|Overall Study|Disease Relapse|0|||
48491053|NCT03361956|155990827|FG001|Overall Study|Disease Relapse|0|||
48491054|NCT03361956|155990828|FG002|Overall Study|Disease Relapse|1|||
48491055|NCT03361956|155990829|FG003|Overall Study|Disease Relapse|0|||
48491056|NCT03361956|155990830|FG004|Overall Study|Disease Relapse|0|||
48491057|NCT03361956|155990826|FG000|Overall Study|Physician Decision|0|||
48491058|NCT03361956|155990827|FG001|Overall Study|Physician Decision|2|||
48491059|NCT03361956|155990828|FG002|Overall Study|Physician Decision|0|||
48491060|NCT03361956|155990829|FG003|Overall Study|Physician Decision|1|||
48491061|NCT03361956|155990830|FG004|Overall Study|Physician Decision|0|||
48491062|NCT03361956|155990826|FG000|Overall Study|Lost to Follow-up|0|||
48491063|NCT03361956|155990827|FG001|Overall Study|Lost to Follow-up|0|||
48491064|NCT03361956|155990828|FG002|Overall Study|Lost to Follow-up|1|||
48491065|NCT03361956|155990829|FG003|Overall Study|Lost to Follow-up|1|||
48491066|NCT03361956|155990830|FG004|Overall Study|Lost to Follow-up|2|||
48491067|NCT02115256|155990835|FG000|Overall Study|Withdrawal by Subject|0|||
48596686|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
48596687|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
48596688|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
48596689|NCT00105989|156379314|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
48596690|NCT00105989|156379315|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
48596691|NCT00613366|156379316|FG000|Overall Study|Withdrawal by Subject|3|||
48596692|NCT00613366|156379317|FG001|Overall Study|Withdrawal by Subject|2|||
48596693|NCT01673984|156379318|FG000|Overall Study|Adverse Event|1|||
48596694|NCT01673984|156379319|FG001|Overall Study|Adverse Event|0|||
48596695|NCT01673984|156379318|FG000|Overall Study|Study termination|9|||
48596696|NCT01673984|156379319|FG001|Overall Study|Study termination|6|||
48596697|NCT00943592|156379320|FG000|Overall Study|Death|3|||
48596698|NCT00878800|156379321|FG000|Overall Study|Adverse Event|0|||
48596699|NCT00878800|156379322|FG001|Overall Study|Adverse Event|0|||
48596700|NCT00878800|156379323|FG002|Overall Study|Adverse Event|2|||
48596701|NCT00878800|156379324|FG003|Overall Study|Adverse Event|0|||
48596702|NCT00878800|156379325|FG004|Overall Study|Adverse Event|1|||
48596703|NCT00878800|156379321|FG000|Overall Study|Progressive disease|1|||
48596704|NCT00878800|156379322|FG001|Overall Study|Progressive disease|5|||
48596705|NCT00878800|156379323|FG002|Overall Study|Progressive disease|6|||
48596706|NCT00878800|156379324|FG003|Overall Study|Progressive disease|5|||
48596707|NCT00878800|156379325|FG004|Overall Study|Progressive disease|13|||
48596708|NCT00878800|156379321|FG000|Overall Study|Withdrew consent|1|||
48596709|NCT00878800|156379322|FG001|Overall Study|Withdrew consent|1|||
48806390|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48806391|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48491068|NCT02115256|155990836|FG001|Overall Study|Withdrawal by Subject|1|||
48491069|NCT00566709|155990838|FG000|Overall Study|Protocol Violation|5|||
48491070|NCT00566709|155990839|FG001|Overall Study|Protocol Violation|0|||
48491071|NCT02330081|155990840|FG000|Overall Study|Adverse Event|1|||
48491072|NCT02330081|155990840|FG000|Overall Study|Donation did not meet criteria|1|||
48491073|NCT02330081|155990840|FG000|Overall Study|Protocol Violation|6|||
48491074|NCT02668302|155990845|FG000|Overall Study|Withdrawal by Subject|1|||
48491075|NCT02668302|155990846|FG001|Overall Study|Withdrawal by Subject|0|||
48491076|NCT01626885|155990847|FG000|Overall Study|Adverse Event|8|||
48491077|NCT01626885|155990847|FG000|Overall Study|Withdrawal by Subject|4|||
48491078|NCT02308111|155990848|FG000|Overall Study|Adverse Event|31|||
48491079|NCT02308111|155990849|FG001|Overall Study|Adverse Event|19|||
48491080|NCT02308111|155990848|FG000|Overall Study|Death|9|||
48491081|NCT02308111|155990849|FG001|Overall Study|Death|6|||
48491082|NCT02308111|155990848|FG000|Overall Study|Lost to Follow-up|2|||
48491083|NCT02308111|155990849|FG001|Overall Study|Lost to Follow-up|7|||
48491084|NCT02308111|155990848|FG000|Overall Study|Physician Decision|6|||
48491085|NCT02308111|155990849|FG001|Overall Study|Physician Decision|17|||
48491086|NCT02308111|155990848|FG000|Overall Study|Protocol Violation|0|||
48491087|NCT02308111|155990849|FG001|Overall Study|Protocol Violation|1|||
48491088|NCT02308111|155990848|FG000|Overall Study|Withdrawal by Subject|28|||
48491089|NCT02308111|155990849|FG001|Overall Study|Withdrawal by Subject|38|||
48491090|NCT02308111|155990848|FG000|Overall Study|Study Terminated by Sponsor|72|||
48491091|NCT02308111|155990849|FG001|Overall Study|Study Terminated by Sponsor|61|||
48491092|NCT02308111|155990848|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
48491093|NCT02308111|155990849|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
48491094|NCT02308111|155990848|FG000|Overall Study|Site Closure|3|||
48491095|NCT02308111|155990849|FG001|Overall Study|Site Closure|3|||
48491096|NCT02308111|155990848|FG000|Overall Study|Non-compliance with Study Drug|3|||
48491097|NCT02308111|155990849|FG001|Overall Study|Non-compliance with Study Drug|1|||
48491098|NCT02308111|155990848|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
48491099|NCT02308111|155990849|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
48806392|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48806393|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
48806394|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806395|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806396|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806397|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806398|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806399|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
48806400|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48491100|NCT02308111|155990848|FG000|Overall Study|Liver Transplant|3|||
48491101|NCT02308111|155990849|FG001|Overall Study|Liver Transplant|3|||
48491102|NCT02308111|155990848|FG000|Overall Study|Liver Transplant Waitlist|2|||
48596710|NCT00878800|156379323|FG002|Overall Study|Withdrew consent|0|||
48596711|NCT00878800|156379324|FG003|Overall Study|Withdrew consent|1|||
48596712|NCT00878800|156379325|FG004|Overall Study|Withdrew consent|1|||
48596713|NCT00878800|156379321|FG000|Overall Study|Death|0|||
48709757|NCT01134055|156786570|FG000|Overall Study|Lost to Follow-up|0|||
48709758|NCT01134055|156786571|FG001|Overall Study|Lost to Follow-up|1|||
48709759|NCT01134055|156786572|FG002|Overall Study|Lost to Follow-up|0|||
48709760|NCT01134055|156786573|FG003|Overall Study|Lost to Follow-up|1|||
48709761|NCT01134055|156786574|FG004|Overall Study|Lost to Follow-up|0|||
48709762|NCT01134055|156786575|FG005|Overall Study|Lost to Follow-up|0|||
48709763|NCT01134055|156786576|FG006|Overall Study|Lost to Follow-up|0|||
48709764|NCT01134055|156786570|FG000|Overall Study|Withdrawal by Subject|3|||
48709765|NCT01134055|156786571|FG001|Overall Study|Withdrawal by Subject|3|||
48709766|NCT01134055|156786572|FG002|Overall Study|Withdrawal by Subject|1|||
48709767|NCT01134055|156786573|FG003|Overall Study|Withdrawal by Subject|2|||
48709768|NCT01134055|156786574|FG004|Overall Study|Withdrawal by Subject|0|||
48709769|NCT01134055|156786575|FG005|Overall Study|Withdrawal by Subject|0|||
48709770|NCT01134055|156786576|FG006|Overall Study|Withdrawal by Subject|8|||
48709771|NCT01134055|156786570|FG000|Overall Study|Protocol Violation|0|||
48709772|NCT01134055|156786571|FG001|Overall Study|Protocol Violation|0|||
48709773|NCT01134055|156786572|FG002|Overall Study|Protocol Violation|0|||
48709774|NCT01134055|156786573|FG003|Overall Study|Protocol Violation|1|||
48709775|NCT01134055|156786574|FG004|Overall Study|Protocol Violation|1|||
48709776|NCT01134055|156786575|FG005|Overall Study|Protocol Violation|0|||
48709777|NCT01134055|156786576|FG006|Overall Study|Protocol Violation|0|||
48709778|NCT01134055|156786570|FG000|Overall Study|Physician Decision|0|||
48709779|NCT01134055|156786571|FG001|Overall Study|Physician Decision|0|||
48709780|NCT01134055|156786572|FG002|Overall Study|Physician Decision|0|||
48709781|NCT01134055|156786573|FG003|Overall Study|Physician Decision|0|||
48709782|NCT01134055|156786574|FG004|Overall Study|Physician Decision|0|||
48709783|NCT01134055|156786575|FG005|Overall Study|Physician Decision|0|||
48709784|NCT01134055|156786576|FG006|Overall Study|Physician Decision|1|||
48709785|NCT01075685|156786577|FG000|Overall Study|Protocol Violation|9|||
48709786|NCT01075685|156786578|FG001|Overall Study|Protocol Violation|1|||
48709787|NCT01075685|156786577|FG000|Overall Study|Withdrawal by Subject|20|||
48709788|NCT01075685|156786578|FG001|Overall Study|Withdrawal by Subject|5|||
48709789|NCT01075685|156786577|FG000|Overall Study|Lost to Follow-up|563|||
48709790|NCT01075685|156786578|FG001|Overall Study|Lost to Follow-up|220|||
48434814|NCT00568958|155780521|FG001|Follow-Up|Withdrawal by Subject|6|||
48434815|NCT00568958|155780520|FG000|Follow-Up|Physician Decision|1|||
48434816|NCT00568958|155780521|FG001|Follow-Up|Physician Decision|1|||
48434817|NCT00568958|155780520|FG000|Follow-Up|Family Emergency|1|||
48434818|NCT00568958|155780521|FG001|Follow-Up|Family Emergency|0|||
48434819|NCT00568958|155780520|FG000|Follow-Up|Adverse Event|1|||
48434820|NCT00568958|155780521|FG001|Follow-Up|Adverse Event|0|||
48434821|NCT01640925|155780522|FG000|Overall Study|Withdrawal by Subject|1|||
48434822|NCT01640925|155780523|FG001|Overall Study|Withdrawal by Subject|0|||
48434823|NCT01640925|155780522|FG000|Overall Study|Previously enrolled in this trial|13|||
48806401|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806402|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
48806403|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806404|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806405|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806406|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
48806407|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48806408|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48806409|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
48709791|NCT00934362|156786583|FG000|Overall Study|Adverse Event|1|||
48709792|NCT00934362|156786584|FG001|Overall Study|Adverse Event|0|||
48709793|NCT00202878|156786585|FG000|Overall Study|Death|964|||
48709794|NCT00202878|156786586|FG001|Overall Study|Death|968|||
48709795|NCT00202878|156786585|FG000|Overall Study|Only Vital Status Known|357|||
48709796|NCT00202878|156786586|FG001|Overall Study|Only Vital Status Known|356|||
48709797|NCT00202878|156786585|FG000|Overall Study|Lost to Follow-up|44|||
48709798|NCT00202878|156786586|FG001|Overall Study|Lost to Follow-up|49|||
48709799|NCT00202878|156786585|FG000|Overall Study|Site Closure|39|||
48709800|NCT00202878|156786586|FG001|Overall Study|Site Closure|36|||
48709801|NCT00202878|156786585|FG000|Overall Study|Withdrawal by Subject|795|||
48709802|NCT00202878|156786586|FG001|Overall Study|Withdrawal by Subject|808|||
48806410|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48806411|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48806412|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48709803|NCT01587014|156786587|FG000|Overall Study|Death|2|||
48709804|NCT03962504|156786590|FG000|Overall Study|Other|11|||
48709805|NCT03962504|156786591|FG001|Overall Study|Other|32|||
48709806|NCT02637037|156786594|FG000|Overall Study|Positive drug screen at admission|1|||
48709807|NCT02637037|156786595|FG001|Overall Study|Positive drug screen at admission|0|||
48709808|NCT02637037|156786594|FG000|Overall Study|Withdrawal by Subject|2|||
48709809|NCT02637037|156786595|FG001|Overall Study|Withdrawal by Subject|1|||
48806413|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
48806414|NCT04242446|157133605|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806415|NCT04242446|157133606|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
48806416|NCT04242446|157133607|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
48806417|NCT04242446|157133608|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806418|NCT04242446|157133609|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806419|NCT04242446|157133610|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806420|NCT04242446|157133611|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48806421|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48806422|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48806423|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48806424|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
48806425|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
48806426|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
48806427|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
48806428|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48806429|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48806430|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48806431|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
48806432|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
48806433|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
48806434|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
48434903|NCT01980706|155780570|FG001|Overall Study|miscellaneous|5|||
48434904|NCT01980706|155780571|FG002|Overall Study|miscellaneous|3|||
48434905|NCT01188564|155780572|FG000|Double-blind Phase|randomized not treated|1|||
48434906|NCT01188564|155780573|FG001|Double-blind Phase|randomized not treated|0|||
48434907|NCT02492997|155780574|FG000|Overall Study|Withdrawal by Subject|1|||
48434908|NCT02492997|155780575|FG001|Overall Study|Withdrawal by Subject|0|||
48434909|NCT02492997|155780574|FG000|Overall Study|Gained Weight|1|||
48434910|NCT02492997|155780575|FG001|Overall Study|Gained Weight|0|||
48434911|NCT02492997|155780574|FG000|Overall Study|Lost to Follow-up|0|||
48434912|NCT02492997|155780575|FG001|Overall Study|Lost to Follow-up|1|||
48434913|NCT01934894|155780576|FG000|Overall Study|Adverse Event|1|||
48434914|NCT01934894|155780577|FG001|Overall Study|Adverse Event|2|||
48434915|NCT01934894|155780576|FG000|Overall Study|Death|2|||
48434916|NCT01934894|155780577|FG001|Overall Study|Death|0|||
48434917|NCT01934894|155780576|FG000|Overall Study|Withdrawal by Subject|0|||
48434918|NCT01934894|155780577|FG001|Overall Study|Withdrawal by Subject|1|||
48434919|NCT01934894|155780576|FG000|Overall Study|Progressive Disease|3|||
48434920|NCT01934894|155780577|FG001|Overall Study|Progressive Disease|2|||
48434921|NCT04580394|155780587|FG000|First Intervention|Incorrectly Randomized|1|||
48434922|NCT04580394|155780587|FG000|First Intervention|Physician Decision|1|||
48434923|NCT04580394|155780587|FG000|First Intervention|Lost to Follow-up|1|||
48434924|NCT04580394|155780587|FG000|Washout (One Week)|Withdrawal by Subject|1|||
48434925|NCT04580394|155780587|FG000|Washout (One Week)|Adverse Event|1|||
48434926|NCT04580394|155780587|FG000|Washout (One Week)|Withdrawal by Subject|2|||
48434927|NCT04580394|155780587|FG000|Third Intervention|Adverse Event|1|||
48434928|NCT04580394|155780587|FG000|Third Intervention|Withdrawal by Subject|1|||
48451323|NCT01451398|155841608|FG000|Overall Study|Physician Decision|1|||
48806435|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48806436|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48806437|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48806438|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
48806439|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
48806440|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
48806441|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
48806442|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48806443|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48806444|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48806445|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
48806446|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
48806447|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
48806448|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
48806449|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48806450|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48806451|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48806452|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
48806453|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
48806454|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
48806455|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
48806456|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806457|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806458|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806459|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
48806460|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806461|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806462|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
48806463|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806464|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806465|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806466|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806467|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
48806468|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806469|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
48806470|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806471|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806472|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806473|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806474|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
48806475|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48709810|NCT02637037|156786594|FG000|Overall Study|Adverse Event|1|||
48709811|NCT02637037|156786595|FG001|Overall Study|Adverse Event|0|||
48709812|NCT04413617|156786596|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
48709813|NCT04413617|156786597|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
48709814|NCT04413617|156786598|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
48709815|NCT04413617|156786599|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
48709816|NCT04413617|156786600|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
48435005|NCT00195260|155780608|FG002|Part 1: Dose Escalation|Death|0|||
48806476|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
48806477|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806478|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806479|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806480|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806481|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
48806482|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806483|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
48806484|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806485|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806486|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806487|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806488|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
48806489|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806490|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
48806491|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806492|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806493|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806494|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806495|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
48806496|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806497|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
48806498|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806499|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806500|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806501|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806502|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48491103|NCT02308111|155990849|FG001|Overall Study|Liver Transplant Waitlist|2|||
48491104|NCT02308111|155990848|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
48491105|NCT02308111|155990849|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
48491106|NCT01078090|155990850|FG000|Overall Study|Lost to Follow-up|2363|||
48806503|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
48806504|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
48806505|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806506|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806507|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806508|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806509|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806510|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
48806511|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
48806512|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806513|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806514|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806515|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806516|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48806517|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
48709817|NCT04413617|156786596|FG000|Overall Study|Protocol Violation|0|||
48491107|NCT01078090|155990850|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
48491108|NCT01078090|155990850|FG000|Overall Study|Lack of Efficacy|1193|||
48491109|NCT01078090|155990850|FG000|Overall Study|ADR and lack of efficacy|61|||
48709818|NCT04413617|156786597|FG001|Overall Study|Protocol Violation|1|||
48709819|NCT04413617|156786598|FG002|Overall Study|Protocol Violation|0|||
48709820|NCT04413617|156786599|FG003|Overall Study|Protocol Violation|0|||
48709821|NCT04413617|156786600|FG004|Overall Study|Protocol Violation|1|||
48709822|NCT04413617|156786596|FG000|Overall Study|Lack of Efficacy|2|||
48709823|NCT04413617|156786597|FG001|Overall Study|Lack of Efficacy|0|||
48709824|NCT04413617|156786598|FG002|Overall Study|Lack of Efficacy|2|||
48709825|NCT04413617|156786599|FG003|Overall Study|Lack of Efficacy|1|||
48709826|NCT04413617|156786600|FG004|Overall Study|Lack of Efficacy|0|||
48709827|NCT04413617|156786596|FG000|Overall Study|Withdrawal by Subject|3|||
48709828|NCT04413617|156786597|FG001|Overall Study|Withdrawal by Subject|4|||
48709829|NCT04413617|156786598|FG002|Overall Study|Withdrawal by Subject|2|||
48709830|NCT04413617|156786599|FG003|Overall Study|Withdrawal by Subject|5|||
48709831|NCT04413617|156786600|FG004|Overall Study|Withdrawal by Subject|3|||
48709832|NCT04413617|156786596|FG000|Overall Study|Death|1|||
48709833|NCT04413617|156786597|FG001|Overall Study|Death|0|||
48709834|NCT04413617|156786598|FG002|Overall Study|Death|0|||
48709835|NCT04413617|156786599|FG003|Overall Study|Death|0|||
48709836|NCT04413617|156786600|FG004|Overall Study|Death|0|||
48709837|NCT04413617|156786596|FG000|Overall Study|Adverse Event|1|||
48709838|NCT04413617|156786597|FG001|Overall Study|Adverse Event|0|||
48709839|NCT04413617|156786598|FG002|Overall Study|Adverse Event|0|||
48709840|NCT04413617|156786599|FG003|Overall Study|Adverse Event|1|||
48709841|NCT04413617|156786600|FG004|Overall Study|Adverse Event|1|||
48709842|NCT04413617|156786596|FG000|Overall Study|COVID-19|0|||
48709843|NCT04413617|156786597|FG001|Overall Study|COVID-19|1|||
48709844|NCT04413617|156786598|FG002|Overall Study|COVID-19|0|||
48709845|NCT04413617|156786599|FG003|Overall Study|COVID-19|0|||
48709846|NCT04413617|156786600|FG004|Overall Study|COVID-19|0|||
48709847|NCT02533453|156786605|FG000|Overall Study|Adverse Event|6|||
48709848|NCT02533453|156786605|FG000|Overall Study|Protocol Violation|1|||
48806518|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
48806519|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806520|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806521|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806522|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806523|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806524|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
48806525|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
48806526|NCT04242446|157133605|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806527|NCT04242446|157133606|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806528|NCT04242446|157133607|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806529|NCT04242446|157133608|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806530|NCT04242446|157133609|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806531|NCT04242446|157133610|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
48806532|NCT04242446|157133611|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
48806533|NCT05674890|157133612|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
48806534|NCT05674890|157133613|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
48806535|NCT05674890|157133612|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
48806536|NCT05674890|157133613|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
48806537|NCT05674890|157133612|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
48806538|NCT05674890|157133613|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
48806539|NCT02421666|157133614|FG000|6-month Follow-up|Lost to Follow-up|8|||
48806540|NCT02421666|157133615|FG001|6-month Follow-up|Lost to Follow-up|7|||
48806541|NCT02421666|157133614|FG000|6-month Follow-up|Withdrawal by Subject|5|||
48806542|NCT02421666|157133615|FG001|6-month Follow-up|Withdrawal by Subject|6|||
48806543|NCT02421666|157133614|FG000|12-month Follow-up|Lost to Follow-up|5|||
48806544|NCT02421666|157133615|FG001|12-month Follow-up|Lost to Follow-up|5|||
48806545|NCT02421666|157133614|FG000|12-month Follow-up|Withdrawal by Subject|6|||
48806546|NCT02421666|157133615|FG001|12-month Follow-up|Withdrawal by Subject|11|||
48806547|NCT00255346|157133616|FG000|Overall Study|Adverse Event|1|||
48806548|NCT00255346|157133617|FG001|Overall Study|Adverse Event|0|||
48806549|NCT00255346|157133618|FG002|Overall Study|Adverse Event|0|||
48806550|NCT00255346|157133619|FG003|Overall Study|Adverse Event|0|||
48806551|NCT00255346|157133620|FG004|Overall Study|Adverse Event|0|||
48806552|NCT00768430|157133621|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
48806553|NCT00768430|157133622|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
48806554|NCT02093663|157133623|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
48806555|NCT02093663|157133624|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
48806556|NCT02093663|157133625|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
48806557|NCT02093663|157133626|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
48806558|NCT02093663|157133627|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
48806559|NCT02093663|157133623|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
48709849|NCT02533453|156786605|FG000|Overall Study|Withdrawal by Subject|2|||
48709850|NCT02453711|156786608|FG000|Overall Study|Withdrawal by Subject|5|||
48709851|NCT02453711|156786609|FG001|Overall Study|Withdrawal by Subject|4|||
48709852|NCT02453711|156786610|FG002|Overall Study|Withdrawal by Subject|6|||
48709853|NCT02453711|156786611|FG003|Overall Study|Withdrawal by Subject|4|||
48491110|NCT01078090|155990850|FG000|Overall Study|Other|523|||
48491111|NCT01688037|155990851|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
48491112|NCT01688037|155990852|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
48491113|NCT01688037|155990853|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
48491114|NCT01688037|155990851|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
48491115|NCT01688037|155990852|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
48491116|NCT01688037|155990853|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
48491117|NCT01688037|155990851|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
48491118|NCT01688037|155990852|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
48491119|NCT01688037|155990853|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
48491120|NCT01688037|155990851|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
48491121|NCT01688037|155990852|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
48491122|NCT01688037|155990853|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
48491123|NCT01688037|155990851|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
48491124|NCT01688037|155990852|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
48491125|NCT01688037|155990853|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
48491126|NCT01688037|155990851|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
48491127|NCT01688037|155990852|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
48491128|NCT01688037|155990853|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
48491129|NCT01688037|155990851|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
48491130|NCT01688037|155990852|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
48491131|NCT01688037|155990853|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
48491132|NCT01688037|155990851|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
48491133|NCT01688037|155990852|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
48491134|NCT01688037|155990853|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
48491135|NCT01688037|155990851|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
48491136|NCT01688037|155990852|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
48491137|NCT01688037|155990853|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
48491138|NCT01688037|155990851|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
48709854|NCT02453711|156786612|FG004|Overall Study|Withdrawal by Subject|1|||
48709855|NCT02453711|156786613|FG005|Overall Study|Withdrawal by Subject|1|||
48709856|NCT02453711|156786614|FG006|Overall Study|Withdrawal by Subject|0|||
48709857|NCT02453711|156786615|FG007|Overall Study|Withdrawal by Subject|1|||
48709858|NCT02453711|156786616|FG008|Overall Study|Withdrawal by Subject|7|||
48709859|NCT02453711|156786608|FG000|Overall Study|Lost to Follow-up|5|||
48709860|NCT02453711|156786609|FG001|Overall Study|Lost to Follow-up|3|||
48709861|NCT02453711|156786610|FG002|Overall Study|Lost to Follow-up|2|||
48709862|NCT02453711|156786611|FG003|Overall Study|Lost to Follow-up|3|||
48709863|NCT02453711|156786612|FG004|Overall Study|Lost to Follow-up|1|||
48709864|NCT02453711|156786613|FG005|Overall Study|Lost to Follow-up|5|||
48709865|NCT02453711|156786614|FG006|Overall Study|Lost to Follow-up|2|||
48709866|NCT02453711|156786615|FG007|Overall Study|Lost to Follow-up|6|||
48806560|NCT02093663|157133624|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806561|NCT02093663|157133625|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48709867|NCT02453711|156786616|FG008|Overall Study|Lost to Follow-up|6|||
48709868|NCT02453711|156786608|FG000|Overall Study|Death|0|||
48709869|NCT02453711|156786609|FG001|Overall Study|Death|0|||
48709870|NCT02453711|156786610|FG002|Overall Study|Death|0|||
48709871|NCT02453711|156786611|FG003|Overall Study|Death|0|||
48709872|NCT02453711|156786612|FG004|Overall Study|Death|0|||
48709873|NCT02453711|156786613|FG005|Overall Study|Death|0|||
48806562|NCT02093663|157133626|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806563|NCT02093663|157133627|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806564|NCT02093663|157133623|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
48806565|NCT02093663|157133624|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
48806566|NCT02093663|157133625|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
48806567|NCT02093663|157133626|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
48806568|NCT02093663|157133627|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
48806569|NCT02093663|157133623|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
48806570|NCT02093663|157133624|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
48806571|NCT02093663|157133625|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
48806572|NCT02093663|157133626|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
48806573|NCT02093663|157133627|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
48806574|NCT02093663|157133623|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806575|NCT02093663|157133624|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806576|NCT02093663|157133625|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
48806577|NCT02093663|157133626|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48806578|NCT02093663|157133627|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
48491139|NCT01688037|155990852|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
48491140|NCT01688037|155990853|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
48491141|NCT00576199|155990854|FG000|Overall Study|Adverse Event|12|||
48491142|NCT00576199|155990854|FG000|Overall Study|Insufficient Therapeutic Response|14|||
48491143|NCT00576199|155990854|FG000|Overall Study|Refused Treatment|2|||
48491144|NCT00576199|155990854|FG000|Overall Study|Reason Unspecified|2|||
48491145|NCT00580983|155990855|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
48491146|NCT02102490|155990856|FG000|Overall Study|Death|6|||
48491147|NCT02102490|155990856|FG000|Overall Study|Lost to Follow-up|1|||
48491148|NCT04345471|155990857|FG000|Overall Study|Adverse Event|8|||
48709874|NCT02453711|156786614|FG006|Overall Study|Death|1|||
48709875|NCT02453711|156786615|FG007|Overall Study|Death|0|||
48709876|NCT02453711|156786616|FG008|Overall Study|Death|0|||
48709877|NCT02453711|156786608|FG000|Overall Study|Unclassified|1|||
48806579|NCT02093663|157133623|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
48709878|NCT02453711|156786609|FG001|Overall Study|Unclassified|0|||
48709879|NCT02453711|156786610|FG002|Overall Study|Unclassified|1|||
48709880|NCT02453711|156786611|FG003|Overall Study|Unclassified|0|||
48806580|NCT02093663|157133624|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
48806581|NCT02093663|157133625|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
48806582|NCT02093663|157133626|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
48806583|NCT02093663|157133627|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
48806584|NCT02093663|157133623|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
48806585|NCT02093663|157133624|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
48806586|NCT02093663|157133625|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
48806587|NCT02093663|157133626|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
48806588|NCT02093663|157133627|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
48806589|NCT02093663|157133623|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
48806590|NCT02093663|157133624|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
48806591|NCT02093663|157133625|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
48806592|NCT02093663|157133626|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
48709881|NCT02453711|156786612|FG004|Overall Study|Unclassified|0|||
48709882|NCT02453711|156786613|FG005|Overall Study|Unclassified|0|||
48709883|NCT02453711|156786614|FG006|Overall Study|Unclassified|0|||
48709884|NCT02453711|156786615|FG007|Overall Study|Unclassified|0|||
48709885|NCT02453711|156786616|FG008|Overall Study|Unclassified|0|||
48709886|NCT02504216|156786617|FG000|Overall Study|Lost to Follow-up|3|||
48709887|NCT02504216|156786618|FG001|Overall Study|Lost to Follow-up|3|||
48709888|NCT02504216|156786617|FG000|Overall Study|Withdrawal by Subject|8|||
48709889|NCT02504216|156786618|FG001|Overall Study|Withdrawal by Subject|12|||
48709890|NCT00862082|156786619|FG000|Overall Study|Sponsor decision to terminate the study|5|||
48709891|NCT00862082|156786620|FG001|Overall Study|Sponsor decision to terminate the study|0|||
48709892|NCT00862082|156786619|FG000|Overall Study|Withdrawal by Subject|0|||
48709893|NCT00862082|156786620|FG001|Overall Study|Withdrawal by Subject|1|||
48709894|NCT02598583|156786621|FG000|Extension Period|Withdrawal by Subject|1|||
48709895|NCT02598583|156786622|FG001|Extension Period|Withdrawal by Subject|0|||
48709896|NCT02792829|156786623|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709897|NCT02792829|156786624|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
48709898|NCT02792829|156786625|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709899|NCT02792829|156786626|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709900|NCT02792829|156786627|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709901|NCT02792829|156786628|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709902|NCT02792829|156786629|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709903|NCT02792829|156786630|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
48709904|NCT02792829|156786623|FG000|Treatment Period 2|Adverse Event|0|||
48709905|NCT02792829|156786624|FG001|Treatment Period 2|Adverse Event|0|||
48709906|NCT02792829|156786625|FG002|Treatment Period 2|Adverse Event|0|||
48709907|NCT02792829|156786626|FG003|Treatment Period 2|Adverse Event|0|||
48709908|NCT02792829|156786627|FG004|Treatment Period 2|Adverse Event|1|||
48709909|NCT02792829|156786628|FG005|Treatment Period 2|Adverse Event|0|||
48709910|NCT02792829|156786629|FG006|Treatment Period 2|Adverse Event|1|||
48709911|NCT02792829|156786630|FG007|Treatment Period 2|Adverse Event|1|||
48709912|NCT02792829|156786623|FG000|Treatment Period 2|Use of proscribed medications|0|||
48709913|NCT02792829|156786624|FG001|Treatment Period 2|Use of proscribed medications|0|||
48709914|NCT02792829|156786625|FG002|Treatment Period 2|Use of proscribed medications|0|||
48709915|NCT02792829|156786626|FG003|Treatment Period 2|Use of proscribed medications|0|||
48709916|NCT02792829|156786627|FG004|Treatment Period 2|Use of proscribed medications|0|||
48806593|NCT02093663|157133627|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
48806594|NCT02093663|157133623|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
48806595|NCT02093663|157133624|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
48806596|NCT02093663|157133625|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
48806597|NCT02093663|157133626|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
48806598|NCT02093663|157133627|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
48491149|NCT04345471|155990858|FG001|Overall Study|Adverse Event|5|||
48491150|NCT04345471|155990859|FG002|Overall Study|Adverse Event|6|||
48491151|NCT04345471|155990857|FG000|Overall Study|Lack of Efficacy|1|||
48491152|NCT04345471|155990858|FG001|Overall Study|Lack of Efficacy|1|||
48491153|NCT04345471|155990859|FG002|Overall Study|Lack of Efficacy|0|||
48491154|NCT04345471|155990857|FG000|Overall Study|Protocol Violation|0|||
48491155|NCT04345471|155990858|FG001|Overall Study|Protocol Violation|1|||
48491156|NCT04345471|155990859|FG002|Overall Study|Protocol Violation|2|||
48709917|NCT02792829|156786628|FG005|Treatment Period 2|Use of proscribed medications|0|||
48709918|NCT02792829|156786629|FG006|Treatment Period 2|Use of proscribed medications|0|||
48709919|NCT02792829|156786630|FG007|Treatment Period 2|Use of proscribed medications|1|||
48709920|NCT00947882|156786634|FG000|Overall Study|Adverse Event|0|||
48709921|NCT00947882|156786635|FG001|Overall Study|Adverse Event|1|||
48709922|NCT00947882|156786636|FG002|Overall Study|Adverse Event|4|||
48709923|NCT00947882|156786637|FG003|Overall Study|Adverse Event|4|||
48709924|NCT00947882|156786634|FG000|Overall Study|Withdrawal by Subject|2|||
48709925|NCT00947882|156786635|FG001|Overall Study|Withdrawal by Subject|0|||
48709926|NCT00947882|156786636|FG002|Overall Study|Withdrawal by Subject|8|||
48709927|NCT00947882|156786637|FG003|Overall Study|Withdrawal by Subject|2|||
48709928|NCT00947882|156786634|FG000|Overall Study|Protocol Violation|0|||
48709929|NCT00947882|156786635|FG001|Overall Study|Protocol Violation|0|||
48709930|NCT00947882|156786636|FG002|Overall Study|Protocol Violation|1|||
48709931|NCT00947882|156786637|FG003|Overall Study|Protocol Violation|0|||
48709932|NCT00947882|156786634|FG000|Overall Study|Lost to Follow-up|0|||
48709933|NCT00947882|156786635|FG001|Overall Study|Lost to Follow-up|2|||
48709934|NCT00947882|156786636|FG002|Overall Study|Lost to Follow-up|1|||
48709935|NCT00947882|156786637|FG003|Overall Study|Lost to Follow-up|0|||
48709936|NCT00947882|156786634|FG000|Overall Study|Other/Unknown|10|||
48709937|NCT00947882|156786635|FG001|Overall Study|Other/Unknown|13|||
48709938|NCT00947882|156786636|FG002|Overall Study|Other/Unknown|3|||
48709939|NCT00947882|156786637|FG003|Overall Study|Other/Unknown|6|||
48709940|NCT00947882|156786634|FG000|Overall Study|Trial Terminated by Sponsor|62|||
48709941|NCT00947882|156786635|FG001|Overall Study|Trial Terminated by Sponsor|61|||
48709942|NCT00947882|156786636|FG002|Overall Study|Trial Terminated by Sponsor|62|||
48709943|NCT00947882|156786637|FG003|Overall Study|Trial Terminated by Sponsor|70|||
48709944|NCT01026324|156786638|FG000|Follow up/Survival|Withdrawal by Subject|1|||
48806599|NCT03010462|157133628|FG000|Overall Study|Withdrawal by Subject|3|||
48806600|NCT03010462|157133629|FG001|Overall Study|Withdrawal by Subject|1|||
48491157|NCT04345471|155990857|FG000|Overall Study|Withdrawal by Subject|10|||
48491158|NCT04345471|155990858|FG001|Overall Study|Withdrawal by Subject|5|||
48491159|NCT04345471|155990859|FG002|Overall Study|Withdrawal by Subject|10|||
48491160|NCT02415959|155990860|FG000|Overall Study|Adverse Event|0|||
48491161|NCT02415959|155990861|FG001|Overall Study|Adverse Event|1|||
48491162|NCT02415959|155990862|FG002|Overall Study|Adverse Event|0|||
48709945|NCT01026324|156786639|FG001|Follow up/Survival|Withdrawal by Subject|0|||
48709946|NCT01026324|156786640|FG002|Follow up/Survival|Withdrawal by Subject|0|||
48709947|NCT01209325|156786644|FG000|Overall Study|Lost to Follow-up|24|||
48709948|NCT01209325|156786644|FG000|Overall Study|Adverse Event|1|||
48709949|NCT01209325|156786644|FG000|Overall Study|Relocated|3|||
48709950|NCT01209325|156786644|FG000|Overall Study|Refusal after starting therapy|8|||
48709951|NCT01209325|156786644|FG000|Overall Study|Protocol Violation|4|||
48709952|NCT01209325|156786644|FG000|Overall Study|Refusal prior to therapy|1|||
48709953|NCT01209325|156786644|FG000|Overall Study|Incarceration|2|||
48709954|NCT02876601|156786645|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
48806601|NCT01492686|157133631|FG000|Double-blind Phase|Adverse Event|0|||
48806602|NCT01492686|157133632|FG001|Double-blind Phase|Adverse Event|2|||
48806603|NCT01492686|157133631|FG000|Double-blind Phase|Physician Decision|0|||
48806604|NCT01492686|157133632|FG001|Double-blind Phase|Physician Decision|1|||
48806605|NCT01492686|157133631|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48806606|NCT01492686|157133632|FG001|Double-blind Phase|Withdrawal by Subject|2|||
48806607|NCT01492686|157133631|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
48806608|NCT01492686|157133632|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
48806609|NCT01492686|157133631|FG000|Open-label Phase|Adverse Event|1|||
48806610|NCT01492686|157133632|FG001|Open-label Phase|Adverse Event|2|||
48806611|NCT01492686|157133631|FG000|Open-label Phase|Physician Decision|1|||
48806612|NCT01492686|157133632|FG001|Open-label Phase|Physician Decision|0|||
48806613|NCT01492686|157133631|FG000|Open-label Phase|Withdrawal by Subject|6|||
48806614|NCT01492686|157133632|FG001|Open-label Phase|Withdrawal by Subject|7|||
48806615|NCT01492686|157133631|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
48806616|NCT01492686|157133632|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
48806617|NCT03086018|157133634|FG000|Final Testing for End of Trial|Adverse Event|1|||
48806618|NCT03086018|157133634|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
48806619|NCT01785563|157133635|FG000|Overall Study|Physician Decision|10|||
48806620|NCT01785563|157133635|FG000|Overall Study|Withdrawal by Subject|1|||
48806621|NCT01785563|157133635|FG000|Overall Study|Protocol Violation|2|||
48806622|NCT01282801|157133636|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
48806623|NCT01282801|157133637|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
48491163|NCT02415959|155990863|FG003|Overall Study|Adverse Event|0|||
48491164|NCT02415959|155990864|FG004|Overall Study|Adverse Event|0|||
48806624|NCT01453348|157133638|FG000|Overall Study|Death|0|||
48806625|NCT01453348|157133639|FG001|Overall Study|Death|0|||
48806626|NCT01453348|157133640|FG002|Overall Study|Death|1|||
48491165|NCT02415959|155990860|FG000|Overall Study|Protocol Violation|0|||
48491166|NCT02415959|155990861|FG001|Overall Study|Protocol Violation|0|||
48491167|NCT02415959|155990862|FG002|Overall Study|Protocol Violation|0|||
48491168|NCT02415959|155990863|FG003|Overall Study|Protocol Violation|1|||
48491169|NCT02415959|155990864|FG004|Overall Study|Protocol Violation|0|||
48491170|NCT00669955|155990865|FG000|Overall Study|Adverse Event|3|||
48491171|NCT00669955|155990866|FG001|Overall Study|Adverse Event|5|||
48491172|NCT00669955|155990865|FG000|Overall Study|Death|0|||
48491173|NCT00669955|155990866|FG001|Overall Study|Death|1|||
48491174|NCT00669955|155990865|FG000|Overall Study|Withdrawal by Subject|2|||
48491175|NCT00669955|155990866|FG001|Overall Study|Withdrawal by Subject|3|||
48491176|NCT00669955|155990865|FG000|Overall Study|Lost to Follow-up|5|||
48491177|NCT00669955|155990866|FG001|Overall Study|Lost to Follow-up|7|||
48491178|NCT00669955|155990865|FG000|Overall Study|Protocol Violation|2|||
48491179|NCT00669955|155990866|FG001|Overall Study|Protocol Violation|7|||
48491180|NCT00669955|155990865|FG000|Overall Study|Investigator Sponsor Judgement|0|||
48491181|NCT00669955|155990866|FG001|Overall Study|Investigator Sponsor Judgement|1|||
48491182|NCT00669955|155990865|FG000|Overall Study|not compliant with study drug/visit|2|||
48491183|NCT00669955|155990866|FG001|Overall Study|not compliant with study drug/visit|3|||
48491184|NCT00752856|155990867|FG000|Overall Study|randomized but did not do viral kinetics|0|||
48491185|NCT00752856|155990868|FG001|Overall Study|randomized but did not do viral kinetics|1|||
48491186|NCT02260492|155990869|FG000|Overall Study|Adverse Event|6|||
48491187|NCT02260492|155990870|FG001|Overall Study|Adverse Event|1|||
48491188|NCT02260492|155990871|FG002|Overall Study|Adverse Event|2|||
48491189|NCT02260492|155990869|FG000|Overall Study|Death|0|||
48491190|NCT02260492|155990870|FG001|Overall Study|Death|1|||
48491191|NCT02260492|155990871|FG002|Overall Study|Death|0|||
48491192|NCT02260492|155990869|FG000|Overall Study|Lost to Follow-up|12|||
48491193|NCT02260492|155990870|FG001|Overall Study|Lost to Follow-up|9|||
48491194|NCT02260492|155990871|FG002|Overall Study|Lost to Follow-up|0|||
48491195|NCT02260492|155990869|FG000|Overall Study|Physician Decision|2|||
48491196|NCT02260492|155990870|FG001|Overall Study|Physician Decision|0|||
48491197|NCT02260492|155990871|FG002|Overall Study|Physician Decision|1|||
48491198|NCT02260492|155990869|FG000|Overall Study|Withdrawal by Subject|3|||
48491199|NCT02260492|155990870|FG001|Overall Study|Withdrawal by Subject|2|||
48491200|NCT02260492|155990871|FG002|Overall Study|Withdrawal by Subject|2|||
48491201|NCT03131999|155990872|FG000|Overall Study|Withdrawal by Subject|0|||
48491202|NCT03131999|155990873|FG001|Overall Study|Withdrawal by Subject|1|||
48491203|NCT02497391|155992526|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
48491204|NCT02497391|155992527|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
48491205|NCT02497391|155992528|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
48596714|NCT00878800|156379322|FG001|Overall Study|Death|0|||
48806627|NCT01453348|157133638|FG000|Overall Study|Withdrawal by Subject|0|||
48491206|NCT02497391|155992529|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
48491207|NCT02497391|155992530|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
48491208|NCT02497391|155992531|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
48491209|NCT02497391|155992526|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
48491210|NCT02497391|155992527|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
48596715|NCT00878800|156379323|FG002|Overall Study|Death|1|||
48806628|NCT01453348|157133639|FG001|Overall Study|Withdrawal by Subject|1|||
48806629|NCT01453348|157133640|FG002|Overall Study|Withdrawal by Subject|0|||
48806630|NCT01453348|157133638|FG000|Overall Study|Protocol Violation|1|||
48806631|NCT01453348|157133639|FG001|Overall Study|Protocol Violation|0|||
48806632|NCT01453348|157133640|FG002|Overall Study|Protocol Violation|0|||
48806633|NCT03579290|157133641|FG000|Overall Study|Lost to Follow-up|9|||
48806634|NCT04707196|157133642|FG000|Overall Study|Withdrawal by Subject|9|||
48806635|NCT04707196|157133643|FG001|Overall Study|Withdrawal by Subject|6|||
48806636|NCT04707196|157133642|FG000|Overall Study|Lost to Follow-up|1|||
48806637|NCT04707196|157133643|FG001|Overall Study|Lost to Follow-up|0|||
48806638|NCT04707196|157133642|FG000|Overall Study|Protocol Violation|4|||
48806639|NCT04707196|157133643|FG001|Overall Study|Protocol Violation|1|||
48806640|NCT04707196|157133642|FG000|Overall Study|Adverse Event|2|||
48806641|NCT04707196|157133643|FG001|Overall Study|Adverse Event|2|||
48806642|NCT04707196|157133642|FG000|Overall Study|Death|3|||
48806643|NCT04707196|157133643|FG001|Overall Study|Death|1|||
48806644|NCT04707196|157133642|FG000|Overall Study|Non-compliance with study drug|1|||
48806645|NCT04707196|157133643|FG001|Overall Study|Non-compliance with study drug|0|||
48806646|NCT04707196|157133642|FG000|Overall Study|Progressive disease|9|||
48806647|NCT04707196|157133643|FG001|Overall Study|Progressive disease|10|||
48806648|NCT00622713|157133644|FG000|Overall Study|Adverse Event|35|||
48806649|NCT00622713|157133644|FG000|Overall Study|Administrative problems|4|||
48806650|NCT00622713|157133644|FG000|Overall Study|Withdrawal by Subject|11|||
48806651|NCT00622713|157133644|FG000|Overall Study|Lost to Follow-up|5|||
48806652|NCT00622713|157133644|FG000|Overall Study|Death|2|||
48806653|NCT00622713|157133644|FG000|Overall Study|Subject no longer required study drug|1|||
48806654|NCT00622713|157133644|FG000|Overall Study|Did not meet eligibility criteria|1|||
48806655|NCT04404478|157133647|FG000|Overall Study|Withdrawal by Subject|1|||
48806656|NCT04404478|157133648|FG001|Overall Study|Withdrawal by Subject|3|||
48806657|NCT03485911|157133649|FG000|Part 1|Perceived lack of efficacy|1|||
48806658|NCT03485911|157133650|FG001|Part 1|Perceived lack of efficacy|1|||
48806659|NCT03485911|157133651|FG002|Part 1|Perceived lack of efficacy|2|||
48806660|NCT03485911|157133652|FG003|Part 1|Perceived lack of efficacy|0|||
48806661|NCT03485911|157133649|FG000|Part 1|Subject withdrew consent|0|||
48806662|NCT03485911|157133650|FG001|Part 1|Subject withdrew consent|1|||
48806663|NCT03485911|157133651|FG002|Part 1|Subject withdrew consent|0|||
48806664|NCT03485911|157133652|FG003|Part 1|Subject withdrew consent|1|||
48806665|NCT03485911|157133649|FG000|Part 1|Lab abnormalities/AEs|3|||
48806666|NCT03485911|157133650|FG001|Part 1|Lab abnormalities/AEs|1|||
48806667|NCT03485911|157133651|FG002|Part 1|Lab abnormalities/AEs|1|||
48806668|NCT03485911|157133652|FG003|Part 1|Lab abnormalities/AEs|0|||
48806669|NCT03485911|157133649|FG000|Part 1|Withdrew Consent prior to dosing|0|||
48806670|NCT03485911|157133650|FG001|Part 1|Withdrew Consent prior to dosing|0|||
48806671|NCT03485911|157133651|FG002|Part 1|Withdrew Consent prior to dosing|0|||
48709955|NCT02876601|156786646|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
48709956|NCT02876601|156786647|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
48709957|NCT02876601|156786648|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
48709958|NCT02873702|156788721|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
48709959|NCT02873702|156788722|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
48709960|NCT02873702|156788723|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
48709961|NCT02873702|156788724|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
48709962|NCT02873702|156788721|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
48709963|NCT02873702|156788722|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
48709964|NCT02873702|156788723|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
48709965|NCT02873702|156788724|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
48709966|NCT02873702|156788721|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
48709967|NCT02873702|156788722|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
48709968|NCT02873702|156788723|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
48806672|NCT03485911|157133652|FG003|Part 1|Withdrew Consent prior to dosing|1|||
48709969|NCT02873702|156788724|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
48709970|NCT02873702|156788721|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
48709971|NCT02873702|156788722|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
48709972|NCT02873702|156788723|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
48709973|NCT02873702|156788724|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
48806673|NCT03485911|157133649|FG000|Part 1|Other NOS|0|||
48806674|NCT03485911|157133650|FG001|Part 1|Other NOS|0|||
48806675|NCT03485911|157133651|FG002|Part 1|Other NOS|0|||
48806676|NCT03485911|157133652|FG003|Part 1|Other NOS|1|||
48806677|NCT03485911|157133649|FG000|Part 2|Perceived lack of efficacy|5|||
48806678|NCT03485911|157133650|FG001|Part 2|Perceived lack of efficacy|3|||
48806679|NCT03485911|157133651|FG002|Part 2|Perceived lack of efficacy|0|||
48806680|NCT03485911|157133652|FG003|Part 2|Perceived lack of efficacy|2|||
48806681|NCT03485911|157133649|FG000|Part 2|Subject withdrew consent|1|||
48806682|NCT03485911|157133650|FG001|Part 2|Subject withdrew consent|0|||
48806683|NCT03485911|157133651|FG002|Part 2|Subject withdrew consent|2|||
48806684|NCT03485911|157133652|FG003|Part 2|Subject withdrew consent|1|||
48806685|NCT03485911|157133649|FG000|Part 2|Lab abnormalities/AEs|1|||
48806686|NCT03485911|157133650|FG001|Part 2|Lab abnormalities/AEs|2|||
48806687|NCT03485911|157133651|FG002|Part 2|Lab abnormalities/AEs|0|||
48806688|NCT03485911|157133652|FG003|Part 2|Lab abnormalities/AEs|0|||
48806689|NCT03485911|157133649|FG000|Part 2|Other NOS|0|||
48806690|NCT03485911|157133650|FG001|Part 2|Other NOS|1|||
48806691|NCT03485911|157133651|FG002|Part 2|Other NOS|0|||
48806692|NCT03485911|157133652|FG003|Part 2|Other NOS|0|||
48806693|NCT03485911|157133649|FG000|Part 2|Intercurrent illness/new medical condition|1|||
48806694|NCT03485911|157133650|FG001|Part 2|Intercurrent illness/new medical condition|0|||
48806695|NCT03485911|157133651|FG002|Part 2|Intercurrent illness/new medical condition|0|||
48806696|NCT03485911|157133652|FG003|Part 2|Intercurrent illness/new medical condition|0|||
48806697|NCT03485911|157133649|FG000|Part 2|Investigator judgement|1|||
48806698|NCT03485911|157133650|FG001|Part 2|Investigator judgement|0|||
48806699|NCT03485911|157133651|FG002|Part 2|Investigator judgement|0|||
48806700|NCT03485911|157133652|FG003|Part 2|Investigator judgement|0|||
48806701|NCT03485911|157133649|FG000|Part 3|Perceived lack of efficacy|2|||
48806702|NCT03485911|157133650|FG001|Part 3|Perceived lack of efficacy|2|||
48806703|NCT03485911|157133651|FG002|Part 3|Perceived lack of efficacy|2|||
48806704|NCT03485911|157133652|FG003|Part 3|Perceived lack of efficacy|0|||
48806705|NCT03485911|157133649|FG000|Part 3|Subject withdrew consent|1|||
48806706|NCT03485911|157133650|FG001|Part 3|Subject withdrew consent|4|||
48806707|NCT03485911|157133651|FG002|Part 3|Subject withdrew consent|0|||
48806708|NCT03485911|157133652|FG003|Part 3|Subject withdrew consent|1|||
48806709|NCT03485911|157133649|FG000|Part 3|Lab abnormalities/AEs|1|||
48806710|NCT03485911|157133650|FG001|Part 3|Lab abnormalities/AEs|1|||
48806711|NCT03485911|157133651|FG002|Part 3|Lab abnormalities/AEs|0|||
48806712|NCT03485911|157133652|FG003|Part 3|Lab abnormalities/AEs|2|||
48806713|NCT03485911|157133649|FG000|Part 3|Other NOS|1|||
48806714|NCT03485911|157133650|FG001|Part 3|Other NOS|1|||
48806715|NCT03485911|157133651|FG002|Part 3|Other NOS|0|||
48806716|NCT03485911|157133652|FG003|Part 3|Other NOS|0|||
48806717|NCT03485911|157133649|FG000|Part 3|Intercurrent illness/new medical condition|0|||
48806718|NCT03485911|157133650|FG001|Part 3|Intercurrent illness/new medical condition|1|||
48806719|NCT03485911|157133651|FG002|Part 3|Intercurrent illness/new medical condition|1|||
48806720|NCT03485911|157133652|FG003|Part 3|Intercurrent illness/new medical condition|0|||
48806721|NCT03485911|157133649|FG000|Part 3|Sponsor discontinuation|1|||
48806722|NCT03485911|157133650|FG001|Part 3|Sponsor discontinuation|0|||
48806723|NCT03485911|157133651|FG002|Part 3|Sponsor discontinuation|0|||
48806724|NCT03485911|157133652|FG003|Part 3|Sponsor discontinuation|0|||
48806725|NCT03485911|157133649|FG000|Part 3|Berotralstat provided by alternative means|13|||
48806726|NCT03485911|157133650|FG001|Part 3|Berotralstat provided by alternative means|13|||
48806727|NCT03485911|157133651|FG002|Part 3|Berotralstat provided by alternative means|7|||
48806728|NCT03485911|157133652|FG003|Part 3|Berotralstat provided by alternative means|7|||
48806729|NCT01350505|157133654|FG000|Overall Study|Lost to Follow-up|4|||
48806730|NCT03528174|157133655|FG000|Overall Study|Adverse Event|1|||
48806731|NCT03528174|157133655|FG000|Overall Study|sensors dislodged|1|||
48806732|NCT01725386|157133658|FG000|Overall Study|Death|84|||
48806733|NCT01725386|157133659|FG001|Overall Study|Death|40|||
48806734|NCT01725386|157133658|FG000|Overall Study|Lost to Follow-up|81|||
48806735|NCT01725386|157133659|FG001|Overall Study|Lost to Follow-up|6|||
48806736|NCT01725386|157133658|FG000|Overall Study|Withdrawal by Subject|10|||
48806737|NCT01725386|157133659|FG001|Overall Study|Withdrawal by Subject|0|||
48806738|NCT00393523|157133661|FG000|Overall Study|Lost to Follow-up|0|||
48806739|NCT00393523|157133662|FG001|Overall Study|Lost to Follow-up|0|||
48806740|NCT00393523|157133663|FG002|Overall Study|Lost to Follow-up|0|||
48806741|NCT00393523|157133664|FG003|Overall Study|Lost to Follow-up|2|||
48806742|NCT00393523|157133665|FG004|Overall Study|Lost to Follow-up|1|||
48806743|NCT00393523|157133661|FG000|Overall Study|Protocol Violation|6|||
48596716|NCT00878800|156379324|FG003|Overall Study|Death|0|||
48596717|NCT00878800|156379325|FG004|Overall Study|Death|0|||
48806744|NCT00393523|157133662|FG001|Overall Study|Protocol Violation|2|||
48806745|NCT00393523|157133663|FG002|Overall Study|Protocol Violation|0|||
48806746|NCT00393523|157133664|FG003|Overall Study|Protocol Violation|1|||
48806747|NCT00393523|157133665|FG004|Overall Study|Protocol Violation|0|||
48806748|NCT00393523|157133661|FG000|Overall Study|Withdrawal by Subject|6|||
48806749|NCT00393523|157133662|FG001|Overall Study|Withdrawal by Subject|7|||
48806750|NCT00393523|157133663|FG002|Overall Study|Withdrawal by Subject|2|||
48806751|NCT00393523|157133664|FG003|Overall Study|Withdrawal by Subject|3|||
48806752|NCT00393523|157133665|FG004|Overall Study|Withdrawal by Subject|0|||
48806753|NCT00393523|157133661|FG000|Overall Study|Difficulties in specimen collection|0|||
48806754|NCT00393523|157133662|FG001|Overall Study|Difficulties in specimen collection|0|||
48806755|NCT00393523|157133663|FG002|Overall Study|Difficulties in specimen collection|1|||
48806756|NCT00393523|157133664|FG003|Overall Study|Difficulties in specimen collection|0|||
48806757|NCT00393523|157133665|FG004|Overall Study|Difficulties in specimen collection|0|||
48806758|NCT00393523|157133661|FG000|Overall Study|Vaccine supply issue|0|||
48596718|NCT00878800|156379321|FG000|Overall Study|Other|1|||
48806759|NCT00393523|157133662|FG001|Overall Study|Vaccine supply issue|0|||
48806760|NCT00393523|157133663|FG002|Overall Study|Vaccine supply issue|1|||
48806761|NCT00393523|157133664|FG003|Overall Study|Vaccine supply issue|0|||
48806762|NCT00393523|157133665|FG004|Overall Study|Vaccine supply issue|0|||
48806763|NCT02002182|157133666|FG000|Overall Study|Withdraw from study|3|||
48806764|NCT02002182|157133667|FG001|Overall Study|Withdraw from study|1|||
48806765|NCT02002182|157133666|FG000|Overall Study|Health Reasons|1|||
48806766|NCT02002182|157133667|FG001|Overall Study|Health Reasons|0|||
48806767|NCT02002182|157133666|FG000|Overall Study|Death|1|||
48806768|NCT02002182|157133667|FG001|Overall Study|Death|0|||
48806769|NCT00744263|157133668|FG000|Overall Study|Death|3006|||
48806770|NCT00744263|157133669|FG001|Overall Study|Death|3005|||
48806771|NCT00744263|157133668|FG000|Overall Study|Lost to Follow-up|2038|||
48806772|NCT00744263|157133669|FG001|Overall Study|Lost to Follow-up|2135|||
48806773|NCT00744263|157133668|FG000|Overall Study|Withdrawal by Subject|166|||
48806774|NCT00744263|157133669|FG001|Overall Study|Withdrawal by Subject|150|||
48806775|NCT00744263|157133668|FG000|Overall Study|Physician Decision|20|||
48806776|NCT00744263|157133669|FG001|Overall Study|Physician Decision|23|||
48806777|NCT00744263|157133668|FG000|Overall Study|Protocol Violation|3|||
48806778|NCT00744263|157133669|FG001|Overall Study|Protocol Violation|5|||
48806779|NCT00744263|157133668|FG000|Overall Study|Adverse Event|1|||
48806780|NCT00744263|157133669|FG001|Overall Study|Adverse Event|0|||
48806781|NCT00744263|157133668|FG000|Overall Study|Other|2|||
48806782|NCT00744263|157133669|FG001|Overall Study|Other|2|||
48806783|NCT03891667|157133671|FG000|Overall Study|Physician Decision|1|||
48806784|NCT03891667|157133672|FG001|Overall Study|Physician Decision|1|||
48806785|NCT03891667|157133671|FG000|Overall Study|COVID related pause|1|||
48806786|NCT03891667|157133672|FG001|Overall Study|COVID related pause|0|||
48806787|NCT03891667|157133671|FG000|Overall Study|Withdrawal by Subject|0|||
48806788|NCT03891667|157133672|FG001|Overall Study|Withdrawal by Subject|1|||
48806789|NCT03891667|157133671|FG000|Overall Study|Adverse Event|0|||
48806790|NCT03891667|157133672|FG001|Overall Study|Adverse Event|1|||
48806791|NCT02276885|157133678|FG000|Overall Study|Withdrawal by Subject|2|||
48806792|NCT02276885|157133679|FG001|Overall Study|Withdrawal by Subject|0|||
48806793|NCT02276885|157133678|FG000|Overall Study|Lost to Follow-up|5|||
48806794|NCT02276885|157133679|FG001|Overall Study|Lost to Follow-up|2|||
48806795|NCT05783102|157133680|FG000|Overall Study|Lost to Follow-up|1|||
48806796|NCT05783102|157133680|FG000|Overall Study|Withdrawal by Subject|2|||
48806797|NCT05008835|157133681|FG000|Overall Study|Adverse Event|5|||
48806798|NCT05008835|157133682|FG001|Overall Study|Adverse Event|2|||
48806799|NCT05008835|157133683|FG002|Overall Study|Adverse Event|1|||
48806800|NCT05008835|157133681|FG000|Overall Study|Lack of Efficacy|0|||
48806801|NCT05008835|157133682|FG001|Overall Study|Lack of Efficacy|0|||
48491211|NCT02497391|155992528|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
48491212|NCT02497391|155992529|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
48491213|NCT02497391|155992530|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
48491214|NCT02497391|155992531|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
48491215|NCT02497391|155992526|FG000|Period 3 (14 Days)|Adverse Event|0|||
48491216|NCT02497391|155992527|FG001|Period 3 (14 Days)|Adverse Event|1|||
48491217|NCT02497391|155992528|FG002|Period 3 (14 Days)|Adverse Event|0|||
48491218|NCT02497391|155992529|FG003|Period 3 (14 Days)|Adverse Event|0|||
48806802|NCT05008835|157133683|FG002|Overall Study|Lack of Efficacy|1|||
48806803|NCT05008835|157133681|FG000|Overall Study|Study terminated by sponsor|0|||
48806804|NCT05008835|157133682|FG001|Overall Study|Study terminated by sponsor|0|||
48806805|NCT05008835|157133683|FG002|Overall Study|Study terminated by sponsor|1|||
48806806|NCT05008835|157133681|FG000|Overall Study|Not further specified|3|||
48806807|NCT05008835|157133682|FG001|Overall Study|Not further specified|2|||
48806808|NCT05008835|157133683|FG002|Overall Study|Not further specified|1|||
48806809|NCT02721732|157133685|FG000|Overall Study|Adverse Event|2|||
48806810|NCT02721732|157133686|FG001|Overall Study|Adverse Event|0|||
48806811|NCT02721732|157133687|FG002|Overall Study|Adverse Event|2|||
48806812|NCT02721732|157133688|FG003|Overall Study|Adverse Event|0|||
48491219|NCT02497391|155992530|FG004|Period 3 (14 Days)|Adverse Event|0|||
48491220|NCT02497391|155992531|FG005|Period 3 (14 Days)|Adverse Event|0|||
48491221|NCT02497391|155992526|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
48806813|NCT02721732|157133689|FG004|Overall Study|Adverse Event|1|||
48806814|NCT02721732|157133690|FG005|Overall Study|Adverse Event|0|||
48806815|NCT02721732|157133691|FG006|Overall Study|Adverse Event|1|||
48806816|NCT02721732|157133692|FG007|Overall Study|Adverse Event|0|||
48806817|NCT02721732|157133693|FG008|Overall Study|Adverse Event|1|||
48491222|NCT02497391|155992527|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
48491223|NCT02497391|155992528|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
48806818|NCT02721732|157133694|FG009|Overall Study|Adverse Event|1|||
48806819|NCT02721732|157133685|FG000|Overall Study|Death|0|||
48806820|NCT02721732|157133686|FG001|Overall Study|Death|0|||
48806821|NCT02721732|157133687|FG002|Overall Study|Death|0|||
48806822|NCT02721732|157133688|FG003|Overall Study|Death|0|||
48806823|NCT02721732|157133689|FG004|Overall Study|Death|1|||
48806824|NCT02721732|157133690|FG005|Overall Study|Death|0|||
48806825|NCT02721732|157133691|FG006|Overall Study|Death|1|||
48806826|NCT02721732|157133692|FG007|Overall Study|Death|0|||
48806827|NCT02721732|157133693|FG008|Overall Study|Death|0|||
48806828|NCT02721732|157133694|FG009|Overall Study|Death|1|||
48806829|NCT02721732|157133685|FG000|Overall Study|Lack of Efficacy|12|||
48806830|NCT02721732|157133686|FG001|Overall Study|Lack of Efficacy|11|||
48806831|NCT02721732|157133687|FG002|Overall Study|Lack of Efficacy|18|||
48806832|NCT02721732|157133688|FG003|Overall Study|Lack of Efficacy|5|||
48806833|NCT02721732|157133689|FG004|Overall Study|Lack of Efficacy|21|||
48806834|NCT02721732|157133690|FG005|Overall Study|Lack of Efficacy|2|||
48806835|NCT02721732|157133691|FG006|Overall Study|Lack of Efficacy|8|||
48806836|NCT02721732|157133692|FG007|Overall Study|Lack of Efficacy|11|||
48806837|NCT02721732|157133693|FG008|Overall Study|Lack of Efficacy|10|||
48806838|NCT02721732|157133694|FG009|Overall Study|Lack of Efficacy|20|||
48806839|NCT02721732|157133685|FG000|Overall Study|Physician Decision|0|||
48806840|NCT02721732|157133686|FG001|Overall Study|Physician Decision|0|||
48806841|NCT02721732|157133687|FG002|Overall Study|Physician Decision|1|||
48806842|NCT02721732|157133688|FG003|Overall Study|Physician Decision|0|||
48806843|NCT02721732|157133689|FG004|Overall Study|Physician Decision|0|||
48806844|NCT02721732|157133690|FG005|Overall Study|Physician Decision|0|||
48806845|NCT02721732|157133691|FG006|Overall Study|Physician Decision|0|||
48806846|NCT02721732|157133692|FG007|Overall Study|Physician Decision|0|||
48806847|NCT02721732|157133693|FG008|Overall Study|Physician Decision|0|||
48806848|NCT02721732|157133694|FG009|Overall Study|Physician Decision|0|||
48806849|NCT02721732|157133685|FG000|Overall Study|Withdrawal by Subject|1|||
48806850|NCT02721732|157133686|FG001|Overall Study|Withdrawal by Subject|0|||
48806851|NCT02721732|157133687|FG002|Overall Study|Withdrawal by Subject|0|||
48806852|NCT02721732|157133688|FG003|Overall Study|Withdrawal by Subject|0|||
48806853|NCT02721732|157133689|FG004|Overall Study|Withdrawal by Subject|3|||
48806854|NCT02721732|157133690|FG005|Overall Study|Withdrawal by Subject|0|||
48806855|NCT02721732|157133691|FG006|Overall Study|Withdrawal by Subject|1|||
48806856|NCT02721732|157133692|FG007|Overall Study|Withdrawal by Subject|1|||
48806857|NCT02721732|157133693|FG008|Overall Study|Withdrawal by Subject|0|||
48806858|NCT02721732|157133694|FG009|Overall Study|Withdrawal by Subject|1|||
48806859|NCT02721732|157133685|FG000|Overall Study|Participant Choice|1|||
48806860|NCT02721732|157133686|FG001|Overall Study|Participant Choice|0|||
48806861|NCT02721732|157133687|FG002|Overall Study|Participant Choice|0|||
48491224|NCT02497391|155992529|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
48491225|NCT02497391|155992530|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
48491226|NCT02497391|155992531|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
48806862|NCT02721732|157133688|FG003|Overall Study|Participant Choice|0|||
48806863|NCT02721732|157133689|FG004|Overall Study|Participant Choice|0|||
48806864|NCT02721732|157133690|FG005|Overall Study|Participant Choice|0|||
48806865|NCT02721732|157133691|FG006|Overall Study|Participant Choice|0|||
48806866|NCT02721732|157133692|FG007|Overall Study|Participant Choice|0|||
48806867|NCT02721732|157133693|FG008|Overall Study|Participant Choice|0|||
48806868|NCT02721732|157133694|FG009|Overall Study|Participant Choice|1|||
48491227|NCT02497391|155992526|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
48491228|NCT02497391|155992527|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
48491229|NCT02497391|155992528|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
48491230|NCT02497391|155992529|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
48491231|NCT02497391|155992530|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
48491232|NCT02497391|155992531|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
48491233|NCT02853929|155992532|FG000|Overall Study|Lost to Follow-up|3|||
48806869|NCT02721732|157133685|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806870|NCT02721732|157133686|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806871|NCT02721732|157133687|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
48806872|NCT02721732|157133688|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806873|NCT02721732|157133689|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806874|NCT02721732|157133690|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806875|NCT02721732|157133691|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806876|NCT02721732|157133692|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48491234|NCT02853929|155992533|FG001|Overall Study|Lost to Follow-up|0|||
48491235|NCT02853929|155992532|FG000|Overall Study|Withdrawal by Subject|1|||
48491236|NCT02853929|155992533|FG001|Overall Study|Withdrawal by Subject|0|||
48491237|NCT02853929|155992532|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
48491238|NCT02853929|155992533|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
48491239|NCT01070966|155992534|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
48491240|NCT01070966|155992534|FG000|Participants for Safety Evaluation|Off-label use|9|||
48491241|NCT01070966|155992534|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
48491242|NCT01070966|155992534|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
48491243|NCT01070966|155992534|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
48491244|NCT01070966|155992534|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
48491245|NCT01070966|155992534|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
48491246|NCT01070966|155992534|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
48491247|NCT00693784|155992536|FG000|Overall Study|Lost to Follow-up|2|||
48491248|NCT00693784|155992536|FG000|Overall Study|Withdrawal by Subject|2|||
48491249|NCT04274192|155992539|FG000|Overall Study|Protocol Violation|1|||
48491250|NCT04274192|155992540|FG001|Overall Study|Protocol Violation|0|||
48491251|NCT00006721|155992541|FG000|Overall Study|Adverse Event|0|||
48491252|NCT00006721|155992542|FG001|Overall Study|Adverse Event|4|||
48491253|NCT00006721|155992543|FG002|Overall Study|Adverse Event|4|||
48491254|NCT00006721|155992541|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
48491255|NCT00006721|155992542|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
48491256|NCT00006721|155992543|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
48491257|NCT00006721|155992541|FG000|Overall Study|Progression/Relapse|0|||
48596719|NCT00878800|156379322|FG001|Overall Study|Other|1|||
48596720|NCT00878800|156379323|FG002|Overall Study|Other|0|||
48596721|NCT00878800|156379324|FG003|Overall Study|Other|0|||
48596722|NCT00878800|156379325|FG004|Overall Study|Other|1|||
48596723|NCT01152996|156379326|FG000|Overall Study|Withdrawal by Subject|142|||
48596724|NCT01152996|156379326|FG000|Overall Study|Adverse Event|115|||
48596725|NCT01152996|156379326|FG000|Overall Study|Lost to Follow-up|112|||
48596726|NCT01152996|156379326|FG000|Overall Study|Lack of Efficacy|68|||
48596727|NCT01152996|156379326|FG000|Overall Study|Noncompliance|41|||
48596728|NCT01152996|156379326|FG000|Overall Study|Other|36|||
48596729|NCT01152996|156379326|FG000|Overall Study|Protocol Violation|22|||
48596730|NCT01152996|156379326|FG000|Overall Study|Elevated liver enzymes|1|||
48596731|NCT01768559|156379327|FG000|Overall Study|Randomized but not treated|0|||
48596732|NCT01768559|156379328|FG001|Overall Study|Randomized but not treated|0|||
48596733|NCT01768559|156379329|FG002|Overall Study|Randomized but not treated|1|||
48596734|NCT01768559|156379327|FG000|Overall Study|Adverse Event|15|||
48596735|NCT01768559|156379328|FG001|Overall Study|Adverse Event|2|||
48596736|NCT01768559|156379329|FG002|Overall Study|Adverse Event|5|||
48596737|NCT01768559|156379327|FG000|Overall Study|Lack of Efficacy|6|||
48596738|NCT01768559|156379328|FG001|Overall Study|Lack of Efficacy|4|||
48596739|NCT01768559|156379329|FG002|Overall Study|Lack of Efficacy|0|||
48596740|NCT01768559|156379327|FG000|Overall Study|Poor compliance to protocol|0|||
48596741|NCT01768559|156379328|FG001|Overall Study|Poor compliance to protocol|3|||
48491258|NCT00006721|155992542|FG001|Overall Study|Progression/Relapse|1|||
48491259|NCT00006721|155992543|FG002|Overall Study|Progression/Relapse|2|||
48596742|NCT01768559|156379329|FG002|Overall Study|Poor compliance to protocol|2|||
48596743|NCT01768559|156379327|FG000|Overall Study|Other than specified|9|||
48596744|NCT01768559|156379328|FG001|Overall Study|Other than specified|8|||
48596745|NCT01768559|156379329|FG002|Overall Study|Other than specified|5|||
48596746|NCT03146741|156379335|FG000|Overall Study|Txp with non-HCV+ heart|4|||
48596747|NCT03146741|156379335|FG000|Overall Study|Listeted for MOT|2|||
48491260|NCT00006721|155992541|FG000|Overall Study|Death|0|||
48491261|NCT00006721|155992542|FG001|Overall Study|Death|1|||
48806877|NCT02721732|157133693|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806878|NCT02721732|157133694|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
48806879|NCT02721732|157133685|FG000|Overall Study|Progression and withdrew consent|1|||
48806880|NCT02721732|157133686|FG001|Overall Study|Progression and withdrew consent|1|||
48806881|NCT02721732|157133687|FG002|Overall Study|Progression and withdrew consent|0|||
48806882|NCT02721732|157133688|FG003|Overall Study|Progression and withdrew consent|0|||
48806883|NCT02721732|157133689|FG004|Overall Study|Progression and withdrew consent|0|||
48806884|NCT02721732|157133690|FG005|Overall Study|Progression and withdrew consent|0|||
48806885|NCT02721732|157133691|FG006|Overall Study|Progression and withdrew consent|0|||
48806886|NCT02721732|157133692|FG007|Overall Study|Progression and withdrew consent|0|||
48806887|NCT02721732|157133693|FG008|Overall Study|Progression and withdrew consent|0|||
48806888|NCT02721732|157133694|FG009|Overall Study|Progression and withdrew consent|1|||
48806889|NCT02721732|157133685|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
48806890|NCT02721732|157133686|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
48806891|NCT02721732|157133687|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
48806892|NCT02721732|157133688|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
48806893|NCT02721732|157133689|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
48806894|NCT02721732|157133690|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
48806895|NCT02721732|157133691|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
48491262|NCT00006721|155992543|FG002|Overall Study|Death|2|||
48491263|NCT00006721|155992541|FG000|Overall Study|Other - Not Protocol Specified|0|||
48491264|NCT00006721|155992542|FG001|Overall Study|Other - Not Protocol Specified|7|||
48491265|NCT00006721|155992543|FG002|Overall Study|Other - Not Protocol Specified|7|||
48491266|NCT00006721|155992541|FG000|Overall Study|Ineligible|2|||
48491267|NCT00006721|155992542|FG001|Overall Study|Ineligible|12|||
48491268|NCT00006721|155992543|FG002|Overall Study|Ineligible|10|||
48491269|NCT00006721|155992541|FG000|Overall Study|Eligible but no Treatment Received|1|||
48491270|NCT00006721|155992542|FG001|Overall Study|Eligible but no Treatment Received|0|||
48491271|NCT00006721|155992543|FG002|Overall Study|Eligible but no Treatment Received|0|||
48491272|NCT02763579|155992544|FG000|Global Period|Death|167|||
48491273|NCT02763579|155992545|FG001|Global Period|Death|151|||
48491274|NCT02763579|155992546|FG002|Global Period|Death|0|||
48491275|NCT02763579|155992547|FG003|Global Period|Death|0|||
48491276|NCT02763579|155992544|FG000|Global Period|Lost to Follow-up|2|||
48491277|NCT02763579|155992545|FG001|Global Period|Lost to Follow-up|4|||
48491278|NCT02763579|155992546|FG002|Global Period|Lost to Follow-up|0|||
48491279|NCT02763579|155992547|FG003|Global Period|Lost to Follow-up|0|||
48491280|NCT02763579|155992544|FG000|Global Period|Physician Decision|0|||
48491281|NCT02763579|155992545|FG001|Global Period|Physician Decision|2|||
48491282|NCT02763579|155992546|FG002|Global Period|Physician Decision|0|||
48491283|NCT02763579|155992547|FG003|Global Period|Physician Decision|0|||
48491284|NCT02763579|155992544|FG000|Global Period|Study Terminated By Sponsor|21|||
48491285|NCT02763579|155992545|FG001|Global Period|Study Terminated By Sponsor|26|||
48596748|NCT03146741|156379335|FG000|Overall Study|Physician Decision|2|||
48806896|NCT02721732|157133692|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
48491286|NCT02763579|155992546|FG002|Global Period|Study Terminated By Sponsor|0|||
48806897|NCT02721732|157133693|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
48491287|NCT02763579|155992547|FG003|Global Period|Study Terminated By Sponsor|0|||
48491288|NCT02763579|155992544|FG000|Global Period|Withdrawal by Subject|12|||
48806898|NCT02721732|157133694|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
48806899|NCT01845974|157133703|FG000|Overall Study|screen failure|1|||
48806900|NCT01845974|157133704|FG001|Overall Study|screen failure|0|||
48806901|NCT04954586|157133705|FG000|Overall Study|Withdrawal by Subject|5|||
48806902|NCT03489057|157133706|FG000|Overall Study|Lost to Follow-up|16|||
48596749|NCT03146741|156379335|FG000|Overall Study|Awaiting txp|2|||
48596750|NCT01421641|156379336|FG000|Overall Study|Protocol Violation|2|||
48596751|NCT01421641|156379337|FG001|Overall Study|Protocol Violation|2|||
48596752|NCT02420119|156379341|FG000|Overall Study|insufficient laboratory data|5|||
48596753|NCT00837967|156379342|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
48596754|NCT00837967|156379343|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
48596755|NCT02658669|156379346|FG000|Overall Study|Lost to Follow-up|7|||
48596756|NCT02658669|156379347|FG001|Overall Study|Lost to Follow-up|5|||
48596757|NCT00186485|156379348|FG000|Overall Study|Lost to Follow-up|3|||
48596758|NCT01733121|156379349|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
48596759|NCT01733121|156379350|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
48596760|NCT01733121|156379349|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
48596761|NCT01733121|156379350|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
48596762|NCT01733121|156379349|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
48596763|NCT01733121|156379350|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
48596764|NCT01733121|156379349|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
48596765|NCT01733121|156379350|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
48596766|NCT01601496|156379357|FG000|Overall Study|Physician Decision|1|||
48596767|NCT01601496|156379357|FG000|Overall Study|Withdrawal by Subject|1|||
48596768|NCT01601496|156379357|FG000|Overall Study|Lost to Follow-up|6|||
48596769|NCT01601496|156379357|FG000|Overall Study|Death|4|||
48596770|NCT01601496|156379357|FG000|Overall Study|Other: patient refusal to continue|3|||
48596771|NCT03126786|156379358|FG000|Overall Study|Adverse Event|3|||
48596772|NCT03126786|156379359|FG001|Overall Study|Adverse Event|0|||
48596773|NCT03126786|156379358|FG000|Overall Study|Lost to Follow-up|0|||
48596774|NCT03126786|156379359|FG001|Overall Study|Lost to Follow-up|1|||
48596775|NCT03126786|156379358|FG000|Overall Study|Withdrawal by Subject|3|||
48596776|NCT03126786|156379359|FG001|Overall Study|Withdrawal by Subject|1|||
48596777|NCT03243305|156379360|FG000|Overall Study|Lost to Follow-up|250|||
48596778|NCT03243305|156379360|FG000|Overall Study|Withdrawal by Subject|170|||
48596779|NCT03243305|156379360|FG000|Overall Study|Pregnancy|104|||
48596780|NCT03243305|156379360|FG000|Overall Study|Non-Compliance with Study Drug|38|||
48596781|NCT03243305|156379360|FG000|Overall Study|Adverse Event|23|||
48596782|NCT03243305|156379360|FG000|Overall Study|No sexually active|26|||
48596783|NCT03243305|156379360|FG000|Overall Study|Physician Decision|22|||
48596784|NCT03243305|156379360|FG000|Overall Study|Protocol Violation|22|||
48596785|NCT03243305|156379360|FG000|Overall Study|Study method no longer primary method|12|||
48596786|NCT03243305|156379360|FG000|Overall Study|Study Terminated by Sponsor|1|||
48806903|NCT03489057|157133707|FG001|Overall Study|Lost to Follow-up|16|||
48806904|NCT03489057|157133708|FG002|Overall Study|Lost to Follow-up|14|||
48806905|NCT03489057|157133709|FG003|Overall Study|Lost to Follow-up|14|||
48596787|NCT03243305|156379360|FG000|Overall Study|Early terminations|267|||
48596788|NCT02521792|156379361|FG000|Overall Study|Study Terminated|6|||
48596789|NCT02504320|156379362|FG000|Treatment Period 1|Positive Drug Screen|0|||
48596790|NCT02504320|156379363|FG001|Treatment Period 1|Positive Drug Screen|0|||
48596791|NCT02504320|156379364|FG002|Treatment Period 1|Positive Drug Screen|1|||
48596792|NCT02504320|156379365|FG003|Treatment Period 1|Positive Drug Screen|0|||
48596793|NCT02504320|156379362|FG000|Treatment Period 2|Positive Drug Screen|0|||
48596794|NCT02504320|156379363|FG001|Treatment Period 2|Positive Drug Screen|1|||
48596795|NCT02504320|156379364|FG002|Treatment Period 2|Positive Drug Screen|0|||
48596796|NCT02504320|156379365|FG003|Treatment Period 2|Positive Drug Screen|0|||
48596797|NCT02504320|156379362|FG000|Treatment Period 3|Positive Drug Screen|0|||
48596798|NCT02504320|156379363|FG001|Treatment Period 3|Positive Drug Screen|0|||
48596799|NCT02504320|156379364|FG002|Treatment Period 3|Positive Drug Screen|0|||
48596800|NCT02504320|156379365|FG003|Treatment Period 3|Positive Drug Screen|1|||
48596801|NCT02504320|156379362|FG000|Treatment Period 3|Adverse Event|0|||
48596802|NCT02504320|156379363|FG001|Treatment Period 3|Adverse Event|0|||
48596803|NCT02504320|156379364|FG002|Treatment Period 3|Adverse Event|1|||
48596804|NCT02504320|156379365|FG003|Treatment Period 3|Adverse Event|0|||
48491289|NCT02763579|155992545|FG001|Global Period|Withdrawal by Subject|18|||
48491290|NCT02763579|155992546|FG002|Global Period|Withdrawal by Subject|0|||
48491291|NCT02763579|155992547|FG003|Global Period|Withdrawal by Subject|0|||
48491292|NCT02763579|155992544|FG000|China Period|Death|0|||
48491293|NCT02763579|155992545|FG001|China Period|Death|0|||
48491294|NCT02763579|155992546|FG002|China Period|Death|46|||
48491295|NCT02763579|155992547|FG003|China Period|Death|48|||
48491296|NCT02763579|155992544|FG000|China Period|Lost to Follow-up|0|||
48491297|NCT02763579|155992545|FG001|China Period|Lost to Follow-up|0|||
48491298|NCT02763579|155992546|FG002|China Period|Lost to Follow-up|1|||
48491299|NCT02763579|155992547|FG003|China Period|Lost to Follow-up|1|||
48491300|NCT02763579|155992544|FG000|China Period|Physician Decision|0|||
48491301|NCT02763579|155992545|FG001|China Period|Physician Decision|0|||
48596805|NCT00905424|156379366|FG000|Overall Study|Lost to Follow-up|3|||
48596806|NCT00905424|156379367|FG001|Overall Study|Lost to Follow-up|3|||
48596807|NCT00905424|156379366|FG000|Overall Study|Withdrawal by Subject|1|||
48596808|NCT00905424|156379367|FG001|Overall Study|Withdrawal by Subject|2|||
48596809|NCT00905424|156379366|FG000|Overall Study|Adverse Event|4|||
48596810|NCT00905424|156379367|FG001|Overall Study|Adverse Event|2|||
48596811|NCT00905424|156379366|FG000|Overall Study|Non-compliance with study medication|2|||
48596812|NCT00905424|156379367|FG001|Overall Study|Non-compliance with study medication|0|||
48806906|NCT03489057|157133706|FG000|Overall Study|Withdrawal by Subject|12|||
48806907|NCT03489057|157133707|FG001|Overall Study|Withdrawal by Subject|12|||
48806908|NCT03489057|157133708|FG002|Overall Study|Withdrawal by Subject|8|||
48806909|NCT03489057|157133709|FG003|Overall Study|Withdrawal by Subject|8|||
48806910|NCT03489057|157133706|FG000|Overall Study|Protocol Violation|7|||
48806911|NCT03489057|157133707|FG001|Overall Study|Protocol Violation|7|||
48806912|NCT03489057|157133708|FG002|Overall Study|Protocol Violation|2|||
48806913|NCT03489057|157133709|FG003|Overall Study|Protocol Violation|2|||
48806914|NCT03599661|157133710|FG000|Overall Study|Lost to Follow-up|9|||
48806915|NCT03635489|157133711|FG000|Overall Study|Death|19|||
48806916|NCT03635489|157133712|FG001|Overall Study|Death|13|||
48806917|NCT03635489|157133711|FG000|Overall Study|Lost to Follow-up|1|||
48806918|NCT03635489|157133712|FG001|Overall Study|Lost to Follow-up|2|||
48806919|NCT03635489|157133711|FG000|Overall Study|Withdrawal by Subject|1|||
48806920|NCT03635489|157133712|FG001|Overall Study|Withdrawal by Subject|2|||
48806921|NCT03635489|157133711|FG000|Overall Study|Study Ended by Sponsor|28|||
48806922|NCT03635489|157133712|FG001|Overall Study|Study Ended by Sponsor|34|||
48806923|NCT03929562|157133713|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
48806924|NCT03929562|157133714|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
48806925|NCT03929562|157133713|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
48806926|NCT03929562|157133714|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
48806927|NCT03929562|157133713|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
48806928|NCT03929562|157133714|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
48806929|NCT00576732|157133719|FG000|DOUBLE BLIND|Adverse Event|0|||
48806930|NCT00576732|157133720|FG001|DOUBLE BLIND|Adverse Event|0|||
48806931|NCT00576732|157133721|FG002|DOUBLE BLIND|Adverse Event|1|||
48806932|NCT00576732|157133722|FG003|DOUBLE BLIND|Adverse Event|0|||
48806933|NCT00576732|157133723|FG004|DOUBLE BLIND|Adverse Event|0|||
48806934|NCT00576732|157133724|FG005|DOUBLE BLIND|Adverse Event|0|||
48596813|NCT00905424|156379366|FG000|Overall Study|Sponsor decision|1|||
48596814|NCT00905424|156379367|FG001|Overall Study|Sponsor decision|0|||
48596815|NCT00905424|156379366|FG000|Overall Study|Positive urine drug screen|0|||
48596816|NCT00905424|156379367|FG001|Overall Study|Positive urine drug screen|1|||
48806935|NCT00576732|157133719|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
48806936|NCT00576732|157133720|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
48806937|NCT00576732|157133721|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
48806938|NCT00576732|157133722|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
48806939|NCT00576732|157133723|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
48806940|NCT00576732|157133724|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
48491302|NCT02763579|155992546|FG002|China Period|Physician Decision|0|||
48491303|NCT02763579|155992547|FG003|China Period|Physician Decision|1|||
48491304|NCT02763579|155992544|FG000|China Period|Study Terminated By Sponsor|0|||
48806941|NCT00576732|157133719|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
48806942|NCT00576732|157133720|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
48806943|NCT00576732|157133721|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
48806944|NCT00576732|157133722|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
48806945|NCT00576732|157133723|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
48806946|NCT00576732|157133724|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
48806947|NCT00576732|157133719|FG000|DOUBLE BLIND|OTHER|0|||
48806948|NCT00576732|157133720|FG001|DOUBLE BLIND|OTHER|2|||
48806949|NCT00576732|157133721|FG002|DOUBLE BLIND|OTHER|1|||
48806950|NCT00576732|157133722|FG003|DOUBLE BLIND|OTHER|0|||
48806951|NCT00576732|157133723|FG004|DOUBLE BLIND|OTHER|0|||
48806952|NCT00576732|157133724|FG005|DOUBLE BLIND|OTHER|0|||
48806953|NCT00576732|157133719|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
48806954|NCT00576732|157133720|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
48806955|NCT00576732|157133721|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
48806956|NCT00576732|157133722|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
48806957|NCT00576732|157133723|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
48806958|NCT00576732|157133724|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
48806959|NCT00576732|157133719|FG000|DOUBLE BLIND|Protocol Violation|1|||
48806960|NCT00576732|157133720|FG001|DOUBLE BLIND|Protocol Violation|0|||
48806961|NCT00576732|157133721|FG002|DOUBLE BLIND|Protocol Violation|0|||
48806962|NCT00576732|157133722|FG003|DOUBLE BLIND|Protocol Violation|0|||
48806963|NCT00576732|157133723|FG004|DOUBLE BLIND|Protocol Violation|0|||
48806964|NCT00576732|157133724|FG005|DOUBLE BLIND|Protocol Violation|0|||
48806965|NCT00576732|157133719|FG000|OPEN LABEL|Adverse Event|0|||
48806966|NCT00576732|157133720|FG001|OPEN LABEL|Adverse Event|0|||
48806967|NCT00576732|157133721|FG002|OPEN LABEL|Adverse Event|0|||
48806968|NCT00576732|157133722|FG003|OPEN LABEL|Adverse Event|4|||
48806969|NCT00576732|157133723|FG004|OPEN LABEL|Adverse Event|0|||
48806970|NCT00576732|157133724|FG005|OPEN LABEL|Adverse Event|1|||
48806971|NCT00576732|157133719|FG000|OPEN LABEL|Lost to Follow-up|0|||
48806972|NCT00576732|157133720|FG001|OPEN LABEL|Lost to Follow-up|0|||
48806973|NCT00576732|157133721|FG002|OPEN LABEL|Lost to Follow-up|0|||
48806974|NCT00576732|157133722|FG003|OPEN LABEL|Lost to Follow-up|2|||
48806975|NCT00576732|157133723|FG004|OPEN LABEL|Lost to Follow-up|1|||
48806976|NCT00576732|157133724|FG005|OPEN LABEL|Lost to Follow-up|1|||
48806977|NCT00576732|157133719|FG000|OPEN LABEL|Withdrawal by Subject|0|||
48806978|NCT00576732|157133720|FG001|OPEN LABEL|Withdrawal by Subject|0|||
48596817|NCT00905424|156379366|FG000|Overall Study|Non-adherence to visit schedule|0|||
48806979|NCT00576732|157133721|FG002|OPEN LABEL|Withdrawal by Subject|0|||
48806980|NCT00576732|157133722|FG003|OPEN LABEL|Withdrawal by Subject|1|||
48806981|NCT00576732|157133723|FG004|OPEN LABEL|Withdrawal by Subject|0|||
48806982|NCT00576732|157133724|FG005|OPEN LABEL|Withdrawal by Subject|1|||
48806983|NCT00576732|157133719|FG000|OPEN LABEL|OTHER|0|||
48806984|NCT00576732|157133720|FG001|OPEN LABEL|OTHER|0|||
48806985|NCT00576732|157133721|FG002|OPEN LABEL|OTHER|0|||
48806986|NCT00576732|157133722|FG003|OPEN LABEL|OTHER|0|||
48806987|NCT00576732|157133723|FG004|OPEN LABEL|OTHER|0|||
48806988|NCT00576732|157133724|FG005|OPEN LABEL|OTHER|2|||
48806989|NCT00576732|157133719|FG000|OPEN LABEL|Lack of Efficacy|0|||
48806990|NCT00576732|157133720|FG001|OPEN LABEL|Lack of Efficacy|0|||
48806991|NCT00576732|157133721|FG002|OPEN LABEL|Lack of Efficacy|0|||
48806992|NCT00576732|157133722|FG003|OPEN LABEL|Lack of Efficacy|2|||
48806993|NCT00576732|157133723|FG004|OPEN LABEL|Lack of Efficacy|2|||
48806994|NCT00576732|157133724|FG005|OPEN LABEL|Lack of Efficacy|3|||
48806995|NCT00576732|157133719|FG000|OPEN LABEL|Protocol Violation|0|||
48806996|NCT00576732|157133720|FG001|OPEN LABEL|Protocol Violation|0|||
48806997|NCT00576732|157133721|FG002|OPEN LABEL|Protocol Violation|0|||
48806998|NCT00576732|157133722|FG003|OPEN LABEL|Protocol Violation|2|||
48806999|NCT00576732|157133723|FG004|OPEN LABEL|Protocol Violation|1|||
48807000|NCT00576732|157133724|FG005|OPEN LABEL|Protocol Violation|0|||
48807001|NCT00094328|157133725|FG000|Overall Study|Lost to Follow-up|1|||
48807002|NCT04737330|157133730|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
48807003|NCT04737330|157133731|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
48807004|NCT04737330|157133730|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
48807005|NCT04737330|157133731|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
48807006|NCT04737330|157133730|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
48807007|NCT04737330|157133731|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
48807008|NCT04737330|157133730|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
48807009|NCT04737330|157133731|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
48807010|NCT04737330|157133730|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
48807011|NCT04737330|157133731|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
48807012|NCT04737330|157133730|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
48807013|NCT04737330|157133731|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
48807014|NCT00949884|157134869|FG000|Overall Study|Adverse Event|14|||
48491305|NCT02763579|155992545|FG001|China Period|Study Terminated By Sponsor|0|||
48491306|NCT02763579|155992546|FG002|China Period|Study Terminated By Sponsor|3|||
48491307|NCT02763579|155992547|FG003|China Period|Study Terminated By Sponsor|4|||
48491308|NCT02763579|155992544|FG000|China Period|Withdrawal by Subject|0|||
48491309|NCT02763579|155992545|FG001|China Period|Withdrawal by Subject|0|||
48491310|NCT02763579|155992546|FG002|China Period|Withdrawal by Subject|3|||
48491311|NCT02763579|155992547|FG003|China Period|Withdrawal by Subject|3|||
48491312|NCT00606684|155992548|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
48709974|NCT02873702|156788721|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
48709975|NCT02873702|156788722|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
48709976|NCT02873702|156788723|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
48709977|NCT02873702|156788724|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
48709978|NCT02978781|156788725|FG000|Part A|Adverse Event|1|||
48709979|NCT02978781|156788726|FG001|Part A|Adverse Event|1|||
48709980|NCT02978781|156788727|FG002|Part A|Adverse Event|0|||
48709981|NCT02978781|156788728|FG003|Part A|Adverse Event|0|||
48709982|NCT02978781|156788729|FG004|Part A|Adverse Event|0|||
48709983|NCT02978781|156788725|FG000|Part A|Withdrawal by Subject|0|||
48709984|NCT02978781|156788726|FG001|Part A|Withdrawal by Subject|1|||
48807015|NCT00949884|157134870|FG001|Overall Study|Adverse Event|3|||
48807016|NCT00949884|157134871|FG002|Overall Study|Adverse Event|12|||
48807017|NCT00949884|157134869|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
48709985|NCT02978781|156788727|FG002|Part A|Withdrawal by Subject|0|||
48709986|NCT02978781|156788728|FG003|Part A|Withdrawal by Subject|0|||
48709987|NCT02978781|156788729|FG004|Part A|Withdrawal by Subject|0|||
48807018|NCT00949884|157134870|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
48807019|NCT00949884|157134871|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
48807020|NCT00949884|157134869|FG000|Overall Study|Lost to Follow-up|7|||
48807021|NCT00949884|157134870|FG001|Overall Study|Lost to Follow-up|5|||
48807022|NCT00949884|157134871|FG002|Overall Study|Lost to Follow-up|5|||
48807023|NCT00949884|157134869|FG000|Overall Study|Physician Decision|5|||
48807024|NCT00949884|157134870|FG001|Overall Study|Physician Decision|0|||
48807025|NCT00949884|157134871|FG002|Overall Study|Physician Decision|6|||
48807026|NCT00949884|157134869|FG000|Overall Study|Treatment non-compliance|5|||
48807027|NCT00949884|157134870|FG001|Overall Study|Treatment non-compliance|0|||
48807028|NCT00949884|157134871|FG002|Overall Study|Treatment non-compliance|8|||
48807029|NCT00949884|157134869|FG000|Overall Study|Withdrawal by Subject|13|||
48807030|NCT00949884|157134870|FG001|Overall Study|Withdrawal by Subject|4|||
48807031|NCT00949884|157134871|FG002|Overall Study|Withdrawal by Subject|16|||
48807032|NCT00949884|157134869|FG000|Overall Study|Lack of Efficacy|4|||
48807033|NCT00949884|157134870|FG001|Overall Study|Lack of Efficacy|2|||
48807034|NCT00949884|157134871|FG002|Overall Study|Lack of Efficacy|7|||
48807035|NCT00949884|157134869|FG000|Overall Study|Study terminated by sponsor|0|||
48807036|NCT00949884|157134870|FG001|Overall Study|Study terminated by sponsor|0|||
48807037|NCT00949884|157134871|FG002|Overall Study|Study terminated by sponsor|1|||
48807038|NCT00949715|157134877|FG000|Overall Study|Physician Decision|1|||
48807039|NCT00949715|157134878|FG001|Overall Study|Physician Decision|0|||
48807040|NCT00949715|157134877|FG000|Overall Study|Lost to Follow-up|1|||
48807041|NCT00949715|157134878|FG001|Overall Study|Lost to Follow-up|0|||
48807042|NCT00949715|157134877|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
48807043|NCT00949715|157134878|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
48807044|NCT02026232|157134879|FG000|Overall Study|incomplete visit/missing data|3|||
48807045|NCT02026232|157134880|FG001|Overall Study|incomplete visit/missing data|2|||
48807046|NCT04170686|157134888|FG000|Screening|Physician Decision|12|||
48807047|NCT04170686|157134889|FG001|Screening|Physician Decision|13|||
48807048|NCT04170686|157134888|FG000|Randomization and Treatment|Lost to Follow-up|26|||
48807049|NCT04170686|157134889|FG001|Randomization and Treatment|Lost to Follow-up|15|||
48807050|NCT00861614|157134890|FG000|Overall Study|Disease Progression|182|||
48807051|NCT00861614|157134891|FG001|Overall Study|Disease Progression|263|||
48807052|NCT00861614|157134890|FG000|Overall Study|Study Drug Toxicity|79|||
48807053|NCT00861614|157134891|FG001|Overall Study|Study Drug Toxicity|6|||
48807054|NCT00861614|157134890|FG000|Overall Study|Death|32|||
48807055|NCT00861614|157134891|FG001|Overall Study|Death|19|||
48807056|NCT00861614|157134890|FG000|Overall Study|Adverse Event|27|||
48807057|NCT00861614|157134891|FG001|Overall Study|Adverse Event|23|||
48807058|NCT00861614|157134890|FG000|Overall Study|Withdrawal by Subject|34|||
48807059|NCT00861614|157134891|FG001|Overall Study|Withdrawal by Subject|35|||
48807060|NCT00861614|157134890|FG000|Overall Study|Other|17|||
48807061|NCT00861614|157134891|FG001|Overall Study|Other|22|||
48807062|NCT05050578|157134896|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
48807063|NCT05050578|157134897|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
48807064|NCT05050578|157134896|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
48807065|NCT05050578|157134897|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
48807066|NCT05050578|157134896|FG000|Period 2, 30 Days|Protocol Violation|0|||
48807067|NCT05050578|157134897|FG001|Period 2, 30 Days|Protocol Violation|1|||
48807068|NCT04525547|157134900|FG000|Overall Study|Not treated with Ofev|2|||
48807069|NCT04525547|157134900|FG000|Overall Study|Off-label use|2|||
48491313|NCT00606684|155992549|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
48807070|NCT04525547|157134900|FG000|Overall Study|Lost to Follow-up|1|||
48807071|NCT00787319|157134906|FG000|Overall Study|Lost to Follow-up|2|||
48807072|NCT00787319|157134906|FG000|Overall Study|Withdrawal by Subject|15|||
48807073|NCT00787319|157134906|FG000|Overall Study|Adverse Event|3|||
48807074|NCT00787319|157134906|FG000|Overall Study|Objective progression or relapse|30|||
48807075|NCT00787319|157134906|FG000|Overall Study|Lack of Efficacy|1|||
48807076|NCT00787319|157134906|FG000|Overall Study|Budget exhausted/exceeded|1|||
48807077|NCT00787319|157134906|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
48807078|NCT00787319|157134906|FG000|Overall Study|No health insurance reimbursement|2|||
48807079|NCT00787319|157134906|FG000|Overall Study|Stabilized disease findings|3|||
48807080|NCT00787319|157134906|FG000|Overall Study|Inactive disease|5|||
48807081|NCT03214081|157134907|FG000|Overall Study|Case Report Forms Uncollected|9|||
48807082|NCT03214081|157134907|FG000|Overall Study|Protocol Deviation|54|||
48807083|NCT01054573|157134908|FG000|Overall Study|Adverse Event|1|||
48807084|NCT01054573|157134909|FG001|Overall Study|Adverse Event|0|||
48807085|NCT01054573|157134910|FG002|Overall Study|Adverse Event|1|||
48807086|NCT01054573|157134911|FG003|Overall Study|Adverse Event|1|||
48491314|NCT00606684|155992550|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
48491315|NCT00606684|155992551|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
48491316|NCT00606684|155992552|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
48491317|NCT00606684|155992553|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
48491318|NCT00606684|155992554|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
48491319|NCT00606684|155992548|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
48491320|NCT00606684|155992549|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
48709988|NCT02978781|156788725|FG000|Part B|Withdrawal by Subject|0|||
48709989|NCT02978781|156788726|FG001|Part B|Withdrawal by Subject|0|||
48709990|NCT02978781|156788727|FG002|Part B|Withdrawal by Subject|0|||
48709991|NCT02978781|156788728|FG003|Part B|Withdrawal by Subject|1|||
48709992|NCT02978781|156788729|FG004|Part B|Withdrawal by Subject|0|||
48709993|NCT02978781|156788725|FG000|Part C|Adverse Event|0|||
48709994|NCT02978781|156788726|FG001|Part C|Adverse Event|0|||
48709995|NCT02978781|156788727|FG002|Part C|Adverse Event|0|||
48709996|NCT02978781|156788728|FG003|Part C|Adverse Event|0|||
48709997|NCT02978781|156788729|FG004|Part C|Adverse Event|2|||
48709998|NCT02978781|156788725|FG000|Part C|Withdrawal by Subject|0|||
48709999|NCT02978781|156788726|FG001|Part C|Withdrawal by Subject|0|||
48710000|NCT02978781|156788727|FG002|Part C|Withdrawal by Subject|0|||
48807087|NCT01054573|157134908|FG000|Overall Study|Lost to Follow-up|0|||
48807088|NCT01054573|157134909|FG001|Overall Study|Lost to Follow-up|2|||
48807089|NCT01054573|157134910|FG002|Overall Study|Lost to Follow-up|0|||
48807090|NCT01054573|157134911|FG003|Overall Study|Lost to Follow-up|0|||
48807091|NCT01054573|157134908|FG000|Overall Study|Withdrawal by Subject|0|||
48807092|NCT01054573|157134909|FG001|Overall Study|Withdrawal by Subject|2|||
48807093|NCT01054573|157134910|FG002|Overall Study|Withdrawal by Subject|2|||
48807094|NCT01054573|157134911|FG003|Overall Study|Withdrawal by Subject|1|||
48807095|NCT01216163|157134913|FG000|Overall Study|Withdrawal by Subject|1|||
48710001|NCT02978781|156788728|FG003|Part C|Withdrawal by Subject|0|||
48710002|NCT02978781|156788729|FG004|Part C|Withdrawal by Subject|1|||
48807096|NCT01216163|157134914|FG001|Overall Study|Withdrawal by Subject|1|||
48807097|NCT01216163|157134915|FG002|Overall Study|Withdrawal by Subject|0|||
48807098|NCT00152009|157134916|FG000|Overall Study|Adverse Event|9|||
48710003|NCT02978781|156788725|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
48491321|NCT00606684|155992550|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
48491322|NCT00606684|155992551|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
48710004|NCT02978781|156788726|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
48710005|NCT02978781|156788727|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
48491323|NCT00606684|155992552|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
48491324|NCT00606684|155992553|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
48491325|NCT00606684|155992554|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
48491326|NCT00606684|155992548|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
48491327|NCT00606684|155992549|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
48491328|NCT00606684|155992550|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
48491329|NCT00606684|155992551|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
48491330|NCT00606684|155992552|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
48491331|NCT00606684|155992553|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
48491332|NCT00606684|155992554|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
48491333|NCT00606684|155992548|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
48491334|NCT00606684|155992549|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
48491335|NCT00606684|155992550|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
48491336|NCT00606684|155992551|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
48491337|NCT00606684|155992552|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
48491338|NCT00606684|155992553|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
48491339|NCT00606684|155992554|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
48491340|NCT00606684|155992548|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
48491341|NCT00606684|155992549|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
48491342|NCT00606684|155992550|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
48491343|NCT00606684|155992551|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
48491344|NCT00606684|155992552|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
48596818|NCT00905424|156379367|FG001|Overall Study|Non-adherence to visit schedule|1|||
48596819|NCT01211145|156379369|FG000|Overall Study|Reason not specified|3|||
48596820|NCT01211145|156379370|FG001|Overall Study|Reason not specified|2|||
48596821|NCT01211145|156379371|FG002|Overall Study|Reason not specified|2|||
48596822|NCT01211145|156379372|FG003|Overall Study|Reason not specified|1|||
48596823|NCT01211145|156379369|FG000|Overall Study|Lost to Follow-up|3|||
48596824|NCT01211145|156379370|FG001|Overall Study|Lost to Follow-up|2|||
48596825|NCT01211145|156379371|FG002|Overall Study|Lost to Follow-up|1|||
48596826|NCT01211145|156379372|FG003|Overall Study|Lost to Follow-up|2|||
48596827|NCT01211145|156379369|FG000|Overall Study|Study-specific withdrawal criteria|1|||
48491345|NCT00606684|155992553|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
48710006|NCT02978781|156788728|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
48596828|NCT01211145|156379370|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48596829|NCT01211145|156379371|FG002|Overall Study|Study-specific withdrawal criteria|0|||
48596830|NCT01211145|156379372|FG003|Overall Study|Study-specific withdrawal criteria|0|||
48596831|NCT01211145|156379369|FG000|Overall Study|Severe noncompliance to protocol|1|||
48596832|NCT01211145|156379370|FG001|Overall Study|Severe noncompliance to protocol|0|||
48596833|NCT01211145|156379371|FG002|Overall Study|Severe noncompliance to protocol|0|||
48596834|NCT01211145|156379372|FG003|Overall Study|Severe noncompliance to protocol|0|||
48710007|NCT02978781|156788729|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
48491346|NCT00606684|155992554|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
48491347|NCT00606684|155992548|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
48491348|NCT00606684|155992549|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
48491349|NCT00606684|155992550|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
48491350|NCT00606684|155992551|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
48491351|NCT00606684|155992552|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
48491352|NCT00606684|155992553|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
48491353|NCT00606684|155992554|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
48491354|NCT00606684|155992548|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
48491355|NCT00606684|155992549|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
48491356|NCT00606684|155992550|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
48491357|NCT00606684|155992551|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
48491358|NCT00606684|155992552|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
48710008|NCT02563067|156788730|FG000|Overall Study|Subject/guardian decision|14|||
48710009|NCT02563067|156788731|FG001|Overall Study|Subject/guardian decision|20|||
48491359|NCT00606684|155992553|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
48710010|NCT02563067|156788732|FG002|Overall Study|Subject/guardian decision|16|||
48710011|NCT02563067|156788730|FG000|Overall Study|Physician Decision|0|||
48710012|NCT02563067|156788731|FG001|Overall Study|Physician Decision|1|||
48710013|NCT02563067|156788732|FG002|Overall Study|Physician Decision|3|||
48710014|NCT02563067|156788730|FG000|Overall Study|Lost to Follow-up|1|||
48710015|NCT02563067|156788731|FG001|Overall Study|Lost to Follow-up|2|||
48491360|NCT00606684|155992554|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
48491361|NCT00606684|155992548|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48491362|NCT00606684|155992549|FG001|Double-Blind Treatment Period|Adverse Event|3|||
48491363|NCT00606684|155992550|FG002|Double-Blind Treatment Period|Adverse Event|2|||
48491364|NCT00606684|155992551|FG003|Double-Blind Treatment Period|Adverse Event|4|||
48491365|NCT00606684|155992552|FG004|Double-Blind Treatment Period|Adverse Event|2|||
48491366|NCT00606684|155992553|FG005|Double-Blind Treatment Period|Adverse Event|0|||
48491367|NCT00606684|155992554|FG006|Double-Blind Treatment Period|Adverse Event|1|||
48491368|NCT00606684|155992548|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
48491369|NCT00606684|155992549|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
48710016|NCT02563067|156788732|FG002|Overall Study|Lost to Follow-up|0|||
48491370|NCT00606684|155992550|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
48491371|NCT00606684|155992551|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
48491372|NCT00606684|155992552|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
48491373|NCT00606684|155992553|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
48491374|NCT00606684|155992554|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
48491375|NCT00606684|155992548|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48491376|NCT00606684|155992549|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
48491377|NCT00606684|155992550|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
48491378|NCT00606684|155992551|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
48491379|NCT00606684|155992552|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
48491380|NCT00606684|155992553|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
48491381|NCT00606684|155992554|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
48491382|NCT00606684|155992548|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
48491383|NCT00606684|155992549|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
48491384|NCT00606684|155992550|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
48710017|NCT02563067|156788730|FG000|Overall Study|Technical problems|0|||
48710018|NCT02563067|156788731|FG001|Overall Study|Technical problems|1|||
48710019|NCT02563067|156788732|FG002|Overall Study|Technical problems|0|||
48710020|NCT02563067|156788730|FG000|Overall Study|Lack of Efficacy|1|||
48710021|NCT02563067|156788731|FG001|Overall Study|Lack of Efficacy|0|||
48710022|NCT02563067|156788732|FG002|Overall Study|Lack of Efficacy|0|||
48710023|NCT02563067|156788730|FG000|Overall Study|Death|0|||
48710024|NCT02563067|156788731|FG001|Overall Study|Death|1|||
48710025|NCT02563067|156788732|FG002|Overall Study|Death|1|||
48710026|NCT02563067|156788730|FG000|Overall Study|Adverse Event|2|||
48710027|NCT02563067|156788731|FG001|Overall Study|Adverse Event|1|||
48710028|NCT02563067|156788732|FG002|Overall Study|Adverse Event|0|||
48710029|NCT02563067|156788730|FG000|Overall Study|Death post Treatment/safety period|1|||
48710030|NCT02563067|156788731|FG001|Overall Study|Death post Treatment/safety period|0|||
48710031|NCT02563067|156788732|FG002|Overall Study|Death post Treatment/safety period|0|||
48710032|NCT03583385|156788740|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48491385|NCT00606684|155992551|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
48710033|NCT03583385|156788741|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48710034|NCT03583385|156788740|FG000|Treatment Period 2|Adverse Event|1|||
48710035|NCT03583385|156788741|FG001|Treatment Period 2|Adverse Event|0|||
48710036|NCT00423917|156788742|FG000|Overall Study|Cancel|2|||
48710037|NCT00423917|156788742|FG000|Overall Study|Ineligible|1|||
48710038|NCT00220636|156788746|FG000|Overall Study|Withdrawal by Subject|4|||
48710039|NCT01092117|156788753|FG000|Index Procedure to 1 Month|Death|1|||
48710040|NCT01092117|156788753|FG000|1 Month|Death|1|||
48710041|NCT01092117|156788753|FG000|1 Month|Withdrawal by Subject|1|||
48710042|NCT01092117|156788753|FG000|1 Month|Lost to Follow-up|1|||
48710043|NCT01092117|156788753|FG000|6 Months|Death|2|||
48710044|NCT01092117|156788753|FG000|6 Months|Withdrawal by Subject|3|||
48710045|NCT01092117|156788753|FG000|12 Month|Death|11|||
48710046|NCT01092117|156788753|FG000|12 Month|Withdrawal by Subject|2|||
48710047|NCT01092117|156788753|FG000|12 Month|Lost to Follow-up|1|||
48807099|NCT00152009|157134917|FG001|Overall Study|Adverse Event|13|||
48807100|NCT00152009|157134918|FG002|Overall Study|Adverse Event|20|||
48807101|NCT00152009|157134919|FG003|Overall Study|Adverse Event|1|||
48807102|NCT00152009|157134916|FG000|Overall Study|Protocol Violation|3|||
48807103|NCT00152009|157134917|FG001|Overall Study|Protocol Violation|0|||
48807104|NCT00152009|157134918|FG002|Overall Study|Protocol Violation|0|||
48807105|NCT00152009|157134919|FG003|Overall Study|Protocol Violation|1|||
48807106|NCT00152009|157134916|FG000|Overall Study|Withdrawal by Subject|2|||
48807107|NCT00152009|157134917|FG001|Overall Study|Withdrawal by Subject|3|||
48807108|NCT00152009|157134918|FG002|Overall Study|Withdrawal by Subject|4|||
48807109|NCT00152009|157134919|FG003|Overall Study|Withdrawal by Subject|9|||
48807110|NCT00152009|157134916|FG000|Overall Study|Lost to Follow-up|2|||
48807111|NCT00152009|157134917|FG001|Overall Study|Lost to Follow-up|4|||
48807112|NCT00152009|157134918|FG002|Overall Study|Lost to Follow-up|3|||
48807113|NCT00152009|157134919|FG003|Overall Study|Lost to Follow-up|3|||
48807114|NCT00152009|157134916|FG000|Overall Study|Lack of Efficacy|8|||
48710048|NCT01092117|156788753|FG000|Year 2|Death|5|||
48710049|NCT01092117|156788753|FG000|Year 2|Withdrawal by Subject|4|||
48710050|NCT01092117|156788753|FG000|Year 2|Lost to Follow-up|1|||
48807115|NCT00152009|157134917|FG001|Overall Study|Lack of Efficacy|6|||
48807116|NCT00152009|157134918|FG002|Overall Study|Lack of Efficacy|7|||
48710051|NCT01092117|156788753|FG000|Year 3|Death|7|||
48807117|NCT00152009|157134919|FG003|Overall Study|Lack of Efficacy|15|||
48807118|NCT00152009|157134916|FG000|Overall Study|ECG abnormalities|2|||
48807119|NCT00152009|157134917|FG001|Overall Study|ECG abnormalities|2|||
48710052|NCT01092117|156788753|FG000|Year 3|Withdrawal by Subject|9|||
48710053|NCT01092117|156788753|FG000|Year 3|Lost to Follow-up|3|||
48710054|NCT01092117|156788753|FG000|Year 4|Death|8|||
48710055|NCT01092117|156788753|FG000|Year 4|Withdrawal by Subject|4|||
48710056|NCT01092117|156788753|FG000|Year 4|Lost to Follow-up|4|||
48710057|NCT01623050|156788754|FG000|Overall Study|Lost to Follow-up|9|||
48710058|NCT03048578|156788755|FG000|Overall Study|Withdrawal by Subject|5|||
48710059|NCT03048578|156788756|FG001|Overall Study|Withdrawal by Subject|6|||
48710060|NCT03048578|156788755|FG000|Overall Study|Lost to Follow-up|22|||
48710061|NCT03048578|156788756|FG001|Overall Study|Lost to Follow-up|10|||
48710062|NCT03048578|156788755|FG000|Overall Study|Adverse Event|1|||
48710063|NCT03048578|156788756|FG001|Overall Study|Adverse Event|2|||
48710064|NCT03048578|156788755|FG000|Overall Study|Terminated|3|||
48710065|NCT03048578|156788756|FG001|Overall Study|Terminated|2|||
48710066|NCT03710083|156788757|FG000|Overall Study|Withdrawal by Subject|2|||
48710067|NCT03710083|156788757|FG000|Overall Study|Unsuccessful Procedure|1|||
48710068|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
48710069|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
48710070|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
48710071|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
48710072|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
48710073|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
48710074|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
48710075|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
48710076|NCT02283762|156788758|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
48710077|NCT02283762|156788759|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
48710078|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
48710079|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
48710080|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
48710081|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
48710082|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
48710083|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
48710084|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
48710085|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
48710086|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
48710087|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
48710088|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
48710089|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
48710090|NCT02283762|156788758|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
48710091|NCT02283762|156788759|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
48710092|NCT01137604|156788760|FG000|Overall Study|Adverse Event|3|||
48710093|NCT01137604|156788761|FG001|Overall Study|Adverse Event|6|||
48710094|NCT01137604|156788762|FG002|Overall Study|Adverse Event|9|||
48710095|NCT01137604|156788763|FG003|Overall Study|Adverse Event|9|||
48710096|NCT01137604|156788760|FG000|Overall Study|Participant Choice|0|||
48710097|NCT01137604|156788761|FG001|Overall Study|Participant Choice|2|||
48710098|NCT01137604|156788762|FG002|Overall Study|Participant Choice|2|||
48710099|NCT01137604|156788763|FG003|Overall Study|Participant Choice|0|||
48710100|NCT01137604|156788760|FG000|Overall Study|Withdrawal of consent|0|||
48710101|NCT01137604|156788761|FG001|Overall Study|Withdrawal of consent|0|||
48710102|NCT01137604|156788762|FG002|Overall Study|Withdrawal of consent|0|||
48710103|NCT01137604|156788763|FG003|Overall Study|Withdrawal of consent|2|||
48710104|NCT01137604|156788760|FG000|Overall Study|Clinical progression/deterioration|1|||
48710105|NCT01137604|156788761|FG001|Overall Study|Clinical progression/deterioration|2|||
48710106|NCT01137604|156788762|FG002|Overall Study|Clinical progression/deterioration|2|||
48710107|NCT01137604|156788763|FG003|Overall Study|Clinical progression/deterioration|0|||
48491386|NCT00606684|155992552|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
48491387|NCT00606684|155992553|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
48710108|NCT01409811|156788764|FG000|Overall Study|Insurance denial|1|||
48710109|NCT00838513|156788765|FG000|Screening Period|Screen Failure|3|||
48710110|NCT00838513|156788765|FG000|Extension Treatment Period|Death|1|||
48710111|NCT00838513|156788765|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
48710112|NCT00312195|156788770|FG000|Overall Study|Adverse Event|4|||
48710113|NCT00312195|156788771|FG001|Overall Study|Adverse Event|6|||
48710114|NCT00312195|156788770|FG000|Overall Study|Lost to Follow-up|1|||
48710115|NCT00312195|156788771|FG001|Overall Study|Lost to Follow-up|0|||
48710116|NCT00312195|156788770|FG000|Overall Study|Protocol Violation|1|||
48710117|NCT00312195|156788771|FG001|Overall Study|Protocol Violation|0|||
48710118|NCT02023697|156788772|FG000|Treatment Period|Radiological progression|13|||
48710119|NCT02023697|156788773|FG001|Treatment Period|Radiological progression|17|||
48710120|NCT02023697|156788774|FG002|Treatment Period|Radiological progression|26|||
48710121|NCT02023697|156788772|FG000|Treatment Period|Never Treated|5|||
48710122|NCT02023697|156788773|FG001|Treatment Period|Never Treated|6|||
48710123|NCT02023697|156788774|FG002|Treatment Period|Never Treated|10|||
48710124|NCT02023697|156788772|FG000|Treatment Period|Adverse Event|13|||
48710125|NCT02023697|156788773|FG001|Treatment Period|Adverse Event|25|||
48710126|NCT02023697|156788774|FG002|Treatment Period|Adverse Event|23|||
48710127|NCT02023697|156788772|FG000|Treatment Period|Logistical difficulties|1|||
48710128|NCT02023697|156788773|FG001|Treatment Period|Logistical difficulties|1|||
48710129|NCT02023697|156788774|FG002|Treatment Period|Logistical difficulties|1|||
48710130|NCT02023697|156788772|FG000|Treatment Period|Clinical progression|10|||
48710131|NCT02023697|156788773|FG001|Treatment Period|Clinical progression|8|||
48710132|NCT02023697|156788774|FG002|Treatment Period|Clinical progression|28|||
48710133|NCT02023697|156788772|FG000|Treatment Period|Withdrawal by Subject|4|||
48807120|NCT00152009|157134918|FG002|Overall Study|ECG abnormalities|2|||
48491388|NCT00606684|155992554|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
48491389|NCT00606684|155992548|FG000|Double-Blind Treatment Period|Physician Decision|0|||
48491390|NCT00606684|155992549|FG001|Double-Blind Treatment Period|Physician Decision|5|||
48491391|NCT00606684|155992550|FG002|Double-Blind Treatment Period|Physician Decision|1|||
48491392|NCT00606684|155992551|FG003|Double-Blind Treatment Period|Physician Decision|0|||
48491393|NCT00606684|155992552|FG004|Double-Blind Treatment Period|Physician Decision|3|||
48491394|NCT00606684|155992553|FG005|Double-Blind Treatment Period|Physician Decision|1|||
48491395|NCT00606684|155992554|FG006|Double-Blind Treatment Period|Physician Decision|2|||
48491396|NCT00606684|155992548|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48491397|NCT00606684|155992549|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48491398|NCT00606684|155992550|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48491399|NCT00606684|155992551|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48491400|NCT00606684|155992552|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48491401|NCT00606684|155992553|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48491402|NCT00606684|155992554|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48491403|NCT03568500|155992555|FG000|Overall Study|Lost to Follow-up|1|||
48491404|NCT03568500|155992556|FG001|Overall Study|Lost to Follow-up|1|||
48491405|NCT03568500|155992557|FG002|Overall Study|Lost to Follow-up|2|||
48491406|NCT03568500|155992555|FG000|Overall Study|Adverse Event|1|||
48491407|NCT03568500|155992556|FG001|Overall Study|Adverse Event|1|||
48491408|NCT03568500|155992557|FG002|Overall Study|Adverse Event|2|||
48491409|NCT03568500|155992555|FG000|Overall Study|Physician Decision|1|||
48491410|NCT03568500|155992556|FG001|Overall Study|Physician Decision|0|||
48491411|NCT03568500|155992557|FG002|Overall Study|Physician Decision|0|||
48491412|NCT03568500|155992555|FG000|Overall Study|Withdrawal by Subject|4|||
48491413|NCT03568500|155992556|FG001|Overall Study|Withdrawal by Subject|2|||
48491414|NCT03568500|155992557|FG002|Overall Study|Withdrawal by Subject|0|||
48491415|NCT03568500|155992555|FG000|Overall Study|Technical Problems|2|||
48491416|NCT03568500|155992556|FG001|Overall Study|Technical Problems|1|||
48491417|NCT03568500|155992557|FG002|Overall Study|Technical Problems|0|||
48491418|NCT03568500|155992555|FG000|Overall Study|Participant Noncompliance|1|||
48491419|NCT03568500|155992556|FG001|Overall Study|Participant Noncompliance|1|||
48491420|NCT03568500|155992557|FG002|Overall Study|Participant Noncompliance|0|||
48491421|NCT03650400|155992568|FG000|Overall Study|Study terminated by sponsor|0|||
48491422|NCT03650400|155992569|FG001|Overall Study|Study terminated by sponsor|5|||
48491423|NCT01034137|155992570|FG000|Overall Study|Adverse Event|9|||
48491424|NCT01034137|155992571|FG001|Overall Study|Adverse Event|10|||
48491425|NCT01034137|155992572|FG002|Overall Study|Adverse Event|8|||
48491426|NCT01034137|155992570|FG000|Overall Study|Withdrawal by Subject|4|||
48491427|NCT01034137|155992571|FG001|Overall Study|Withdrawal by Subject|3|||
48710134|NCT02023697|156788773|FG001|Treatment Period|Withdrawal by Subject|5|||
48710135|NCT02023697|156788774|FG002|Treatment Period|Withdrawal by Subject|13|||
48710136|NCT02023697|156788772|FG000|Treatment Period|Safety outcome reached|0|||
48710137|NCT02023697|156788773|FG001|Treatment Period|Safety outcome reached|1|||
48710138|NCT02023697|156788774|FG002|Treatment Period|Safety outcome reached|0|||
48710139|NCT02023697|156788772|FG000|Treatment Period|Physician Decision|0|||
48710140|NCT02023697|156788773|FG001|Treatment Period|Physician Decision|0|||
48710141|NCT02023697|156788774|FG002|Treatment Period|Physician Decision|1|||
48807121|NCT00152009|157134919|FG003|Overall Study|ECG abnormalities|1|||
48807122|NCT00152009|157134916|FG000|Overall Study|Sponsor's decision|3|||
48807123|NCT00152009|157134917|FG001|Overall Study|Sponsor's decision|3|||
48807124|NCT00152009|157134918|FG002|Overall Study|Sponsor's decision|1|||
48807125|NCT00152009|157134919|FG003|Overall Study|Sponsor's decision|3|||
48807126|NCT02914314|157134920|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
48807127|NCT02914314|157134921|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
48807128|NCT02914314|157134922|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
48807129|NCT02914314|157134923|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
48807130|NCT02914314|157134920|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
48807131|NCT02914314|157134921|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
48807132|NCT02914314|157134922|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
48807133|NCT02914314|157134923|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
48807134|NCT02914314|157134920|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
48807135|NCT02914314|157134921|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
48807136|NCT02914314|157134922|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
48807137|NCT02914314|157134923|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
48807138|NCT02914314|157134920|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
48807139|NCT02914314|157134921|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
48807140|NCT02914314|157134922|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
48807141|NCT02914314|157134923|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
48807142|NCT02914314|157134920|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
48807143|NCT02914314|157134921|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
48807144|NCT02914314|157134922|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
48807145|NCT02914314|157134923|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
48807146|NCT05256706|157134928|FG000|Overall Study|Lost to Follow-up|9|||
48807147|NCT05256706|157134929|FG001|Overall Study|Lost to Follow-up|3|||
48807148|NCT05256706|157134928|FG000|Overall Study|Withdrawal by Subject|7|||
48807149|NCT05256706|157134929|FG001|Overall Study|Withdrawal by Subject|11|||
48807150|NCT05256706|157134928|FG000|Overall Study|Screen Failures|3|||
48807151|NCT05256706|157134929|FG001|Overall Study|Screen Failures|0|||
48807152|NCT02285114|157134930|FG000|Overall Study|Investigator's Discretion|0|||
48807153|NCT02285114|157134931|FG001|Overall Study|Investigator's Discretion|2|||
48807154|NCT02285114|157134932|FG002|Overall Study|Investigator's Discretion|0|||
48807155|NCT02285114|157134930|FG000|Overall Study|Withdrew Consent|0|||
48807156|NCT02285114|157134931|FG001|Overall Study|Withdrew Consent|0|||
48807157|NCT02285114|157134932|FG002|Overall Study|Withdrew Consent|1|||
48807158|NCT02285114|157134930|FG000|Overall Study|Enrolled but not treated|1|||
48807159|NCT02285114|157134931|FG001|Overall Study|Enrolled but not treated|0|||
48807160|NCT02285114|157134932|FG002|Overall Study|Enrolled but not treated|0|||
48807161|NCT02285114|157134930|FG000|Overall Study|Still on study|21|||
48491428|NCT01034137|155992572|FG002|Overall Study|Withdrawal by Subject|3|||
48491429|NCT01034137|155992570|FG000|Overall Study|Lack of Efficacy|9|||
48491430|NCT01034137|155992571|FG001|Overall Study|Lack of Efficacy|4|||
48491431|NCT01034137|155992572|FG002|Overall Study|Lack of Efficacy|13|||
48710142|NCT02023697|156788772|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
48807162|NCT02285114|157134931|FG001|Overall Study|Still on study|5|||
48807163|NCT02285114|157134932|FG002|Overall Study|Still on study|2|||
48807164|NCT01125722|157134940|FG000|Overall Study|Withdrawal by Subject|2|||
48807165|NCT01125722|157134941|FG001|Overall Study|Withdrawal by Subject|1|||
48807166|NCT01125722|157134940|FG000|Overall Study|Lost to Follow-up|1|||
48807167|NCT01125722|157134941|FG001|Overall Study|Lost to Follow-up|0|||
48807168|NCT00621296|157134950|FG000|Overall Study|Adverse Event|2|||
48807169|NCT00621296|157134950|FG000|Overall Study|Lack of Efficacy|1|||
48807170|NCT00621296|157134950|FG000|Overall Study|Physician Decision|7|||
48807171|NCT00621296|157134950|FG000|Overall Study|Unmatch Criteria|1|||
48807172|NCT00621296|157134950|FG000|Overall Study|Stopping Criteria|3|||
48807173|NCT02944656|157134954|FG000|Overall Study|No longer eligible|3|||
48807174|NCT02944656|157134955|FG001|Overall Study|No longer eligible|0|||
48807175|NCT02944656|157134954|FG000|Overall Study|Lost to Follow-up|7|||
48807176|NCT02944656|157134955|FG001|Overall Study|Lost to Follow-up|10|||
48807177|NCT04158739|157134956|FG000|Overall Study|Adverse Event|1|||
48807178|NCT04158739|157134957|FG001|Overall Study|Adverse Event|0|||
48807179|NCT04158739|157134956|FG000|Overall Study|Death|0|||
48807180|NCT04158739|157134957|FG001|Overall Study|Death|1|||
48807181|NCT04158739|157134956|FG000|Overall Study|Lack of Efficacy|3|||
48807182|NCT04158739|157134957|FG001|Overall Study|Lack of Efficacy|7|||
48807183|NCT04158739|157134956|FG000|Overall Study|Physician Decision|0|||
48807184|NCT04158739|157134957|FG001|Overall Study|Physician Decision|1|||
48807185|NCT04158739|157134956|FG000|Overall Study|Withdrawal by Subject|3|||
48807186|NCT04158739|157134957|FG001|Overall Study|Withdrawal by Subject|0|||
48807187|NCT02601937|157134960|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807188|NCT02601937|157134961|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807189|NCT02601937|157134962|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807190|NCT02601937|157134963|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807191|NCT02601937|157134964|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807192|NCT02601937|157134965|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
48807193|NCT02601937|157134966|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807194|NCT02601937|157134967|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807195|NCT02601937|157134968|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807196|NCT02601937|157134969|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807197|NCT02601937|157134970|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
48807198|NCT02601937|157134960|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
48807199|NCT02601937|157134961|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807200|NCT02601937|157134962|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48491432|NCT01034137|155992570|FG000|Overall Study|Protocol Violation|2|||
48491433|NCT01034137|155992571|FG001|Overall Study|Protocol Violation|2|||
48491434|NCT01034137|155992572|FG002|Overall Study|Protocol Violation|1|||
48491435|NCT01034137|155992570|FG000|Overall Study|Refused treatment or did not cooperate|2|||
48807201|NCT02601937|157134963|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807202|NCT02601937|157134964|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807203|NCT02601937|157134965|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807204|NCT02601937|157134966|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
48596835|NCT01211145|156379369|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
48596836|NCT01211145|156379370|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
48596837|NCT01211145|156379371|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
48596838|NCT01211145|156379372|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
48596839|NCT01211145|156379369|FG000|Overall Study|Patient decision|2|||
48596840|NCT01211145|156379370|FG001|Overall Study|Patient decision|1|||
48596841|NCT01211145|156379371|FG002|Overall Study|Patient decision|0|||
48596842|NCT01211145|156379372|FG003|Overall Study|Patient decision|2|||
48596843|NCT00426764|156379373|FG000|Overall Study|Protocol Violation|1|||
48596844|NCT00426764|156379373|FG000|Overall Study|Withdrawal by Subject|4|||
48596845|NCT00426764|156379373|FG000|Overall Study|Physician Decision|6|||
48596846|NCT00426764|156379373|FG000|Overall Study|Compassionate Use|1|||
48596847|NCT00426764|156379373|FG000|Overall Study|Progressive Disease|83|||
48596848|NCT00426764|156379373|FG000|Overall Study|Adverse Event|24|||
48807205|NCT02601937|157134967|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807206|NCT02601937|157134968|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807207|NCT02601937|157134969|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807208|NCT02601937|157134970|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
48807209|NCT02601937|157134960|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807210|NCT02601937|157134961|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807211|NCT02601937|157134962|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
48807212|NCT02601937|157134963|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807213|NCT02601937|157134964|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807214|NCT02601937|157134965|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807215|NCT02601937|157134966|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807216|NCT02601937|157134967|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807217|NCT02601937|157134968|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807218|NCT02601937|157134969|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807219|NCT02601937|157134970|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
48807220|NCT02601937|157134960|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
48807221|NCT02601937|157134961|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
48807222|NCT02601937|157134962|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
48807223|NCT02601937|157134963|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
48807224|NCT02601937|157134964|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
48807225|NCT02601937|157134965|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
48807226|NCT02601937|157134966|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
48807227|NCT02601937|157134967|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
48807228|NCT02601937|157134968|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
48807229|NCT02601937|157134969|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
48807230|NCT02601937|157134970|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
48807231|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807232|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807233|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807234|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807235|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807236|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807237|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807238|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807239|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48807240|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
48596849|NCT00426764|156379373|FG000|Overall Study|Other|1|||
48596850|NCT00426764|156379373|FG000|Overall Study|Death|1|||
48596851|NCT00426764|156379373|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
48596852|NCT02306850|156379374|FG000|Overall Study|Lack of Efficacy|2|||
48807241|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
48596853|NCT01922258|156379375|FG000|Overall Study|Lost to Follow-up|1|||
48807242|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807243|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807244|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807245|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807246|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807247|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807248|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807249|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
48807250|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807251|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807252|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
48807253|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807254|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807255|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807256|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807257|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807258|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807259|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807260|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807261|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
48807262|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
48807263|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
48807264|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807265|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807266|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807267|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807268|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807269|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807270|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
48807271|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
48807272|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
48807273|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
48807274|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
48807275|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Other|0|||
48807276|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Other|0|||
48807277|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Other|0|||
48807278|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Other|0|||
48807279|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Other|0|||
48807280|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Other|0|||
48807281|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Other|0|||
48807282|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Other|0|||
48807283|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Other|2|||
48807284|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Other|2|||
48807285|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Other|0|||
48807286|NCT02601937|157134960|FG000|Period 2: Dose Expansion Cohort|Death|0|||
48807287|NCT02601937|157134961|FG001|Period 2: Dose Expansion Cohort|Death|0|||
48807288|NCT02601937|157134962|FG002|Period 2: Dose Expansion Cohort|Death|0|||
48807289|NCT02601937|157134963|FG003|Period 2: Dose Expansion Cohort|Death|0|||
48807290|NCT02601937|157134964|FG004|Period 2: Dose Expansion Cohort|Death|0|||
48807291|NCT02601937|157134965|FG005|Period 2: Dose Expansion Cohort|Death|0|||
48807292|NCT02601937|157134966|FG006|Period 2: Dose Expansion Cohort|Death|0|||
48807293|NCT02601937|157134967|FG007|Period 2: Dose Expansion Cohort|Death|0|||
48807294|NCT02601937|157134968|FG008|Period 2: Dose Expansion Cohort|Death|1|||
48807295|NCT02601937|157134969|FG009|Period 2: Dose Expansion Cohort|Death|0|||
48807296|NCT02601937|157134970|FG010|Period 2: Dose Expansion Cohort|Death|0|||
48807297|NCT00284141|157136540|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
48807298|NCT00284141|157136540|FG000|Overall Study|Adverse Event|19|||
48807299|NCT00284141|157136540|FG000|Overall Study|Participant's request|9|||
48807300|NCT00284141|157136540|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
48807301|NCT00284141|157136540|FG000|Overall Study|Clinical deterioration / death|2|||
48807302|NCT00284141|157136540|FG000|Overall Study|General decline|1|||
48807303|NCT00284141|157136540|FG000|Overall Study|Pneumonia|1|||
48807304|NCT00284141|157136540|FG000|Overall Study|Did not take study medication|2|||
48807305|NCT00284141|157136540|FG000|Overall Study|Ongoing treatment|2|||
48807306|NCT01090310|157136541|FG000|Core Study|Adverse Event|2|||
48807307|NCT01090310|157136542|FG001|Core Study|Adverse Event|2|||
48807308|NCT01090310|157136543|FG002|Core Study|Adverse Event|1|||
48807309|NCT01090310|157136544|FG003|Core Study|Adverse Event|1|||
48807310|NCT01090310|157136541|FG000|Core Study|Subject withdrew consent|0|||
48807311|NCT01090310|157136542|FG001|Core Study|Subject withdrew consent|3|||
48807312|NCT01090310|157136543|FG002|Core Study|Subject withdrew consent|1|||
48807313|NCT01090310|157136544|FG003|Core Study|Subject withdrew consent|1|||
48807314|NCT01090310|157136541|FG000|Core Study|Abnormal test procedure result|0|||
48807315|NCT01090310|157136542|FG001|Core Study|Abnormal test procedure result|0|||
48807316|NCT01090310|157136543|FG002|Core Study|Abnormal test procedure result|1|||
48807317|NCT01090310|157136544|FG003|Core Study|Abnormal test procedure result|0|||
48807318|NCT01090310|157136541|FG000|Core Study|Administrative reasons|5|||
48807319|NCT01090310|157136542|FG001|Core Study|Administrative reasons|6|||
48807320|NCT01090310|157136543|FG002|Core Study|Administrative reasons|4|||
48807321|NCT01090310|157136544|FG003|Core Study|Administrative reasons|4|||
48807322|NCT01090310|157136541|FG000|Core Study|Protocol deviation|1|||
48807323|NCT01090310|157136542|FG001|Core Study|Protocol deviation|0|||
48807324|NCT01090310|157136543|FG002|Core Study|Protocol deviation|0|||
48807325|NCT01090310|157136544|FG003|Core Study|Protocol deviation|1|||
48807326|NCT01090310|157136541|FG000|Extension Study|Aministrative problems|13|||
48807327|NCT01090310|157136542|FG001|Extension Study|Aministrative problems|15|||
48807328|NCT01090310|157136543|FG002|Extension Study|Aministrative problems|14|||
48807329|NCT01090310|157136544|FG003|Extension Study|Aministrative problems|18|||
48807330|NCT01090310|157136541|FG000|Extension Study|Adverse Event|0|||
48807331|NCT01090310|157136542|FG001|Extension Study|Adverse Event|0|||
48807332|NCT01090310|157136543|FG002|Extension Study|Adverse Event|0|||
48807333|NCT01090310|157136544|FG003|Extension Study|Adverse Event|1|||
48807334|NCT01090310|157136541|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
48807335|NCT01090310|157136542|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
48807336|NCT01090310|157136543|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
48807337|NCT01090310|157136544|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
48807338|NCT01090310|157136541|FG000|Extension Study|Subject withdrew consent|0|||
48807339|NCT01090310|157136542|FG001|Extension Study|Subject withdrew consent|1|||
48807340|NCT01090310|157136543|FG002|Extension Study|Subject withdrew consent|0|||
48807341|NCT01090310|157136544|FG003|Extension Study|Subject withdrew consent|0|||
48807342|NCT02202434|157136545|FG000|Overall Study|Death|70|||
48807343|NCT02202434|157136546|FG001|Overall Study|Death|39|||
48807344|NCT02202434|157136547|FG002|Overall Study|Death|13|||
48807345|NCT02202434|157136548|FG003|Overall Study|Death|27|||
48807346|NCT02202434|157136545|FG000|Overall Study|Lost to Follow-up|1|||
48807347|NCT02202434|157136546|FG001|Overall Study|Lost to Follow-up|1|||
48807348|NCT02202434|157136547|FG002|Overall Study|Lost to Follow-up|1|||
48807349|NCT02202434|157136548|FG003|Overall Study|Lost to Follow-up|0|||
48807350|NCT02202434|157136545|FG000|Overall Study|Physician Decision|2|||
48807351|NCT02202434|157136546|FG001|Overall Study|Physician Decision|3|||
48807352|NCT02202434|157136547|FG002|Overall Study|Physician Decision|0|||
48807353|NCT02202434|157136548|FG003|Overall Study|Physician Decision|0|||
48807354|NCT02202434|157136545|FG000|Overall Study|Withdrawal by Subject|13|||
48807355|NCT02202434|157136546|FG001|Overall Study|Withdrawal by Subject|14|||
48807356|NCT02202434|157136547|FG002|Overall Study|Withdrawal by Subject|1|||
48807357|NCT02202434|157136548|FG003|Overall Study|Withdrawal by Subject|4|||
48807358|NCT02202434|157136545|FG000|Overall Study|Completed Study|1|||
48807359|NCT02202434|157136546|FG001|Overall Study|Completed Study|0|||
48807360|NCT02202434|157136547|FG002|Overall Study|Completed Study|0|||
48807361|NCT02202434|157136548|FG003|Overall Study|Completed Study|0|||
48807362|NCT02202434|157136545|FG000|Overall Study|Visit Missed|21|||
48807363|NCT02202434|157136546|FG001|Overall Study|Visit Missed|12|||
48807364|NCT02202434|157136547|FG002|Overall Study|Visit Missed|0|||
48807365|NCT02202434|157136548|FG003|Overall Study|Visit Missed|5|||
48807366|NCT02202434|157136545|FG000|Overall Study|Other|1|||
48596854|NCT01922258|156379376|FG001|Overall Study|Lost to Follow-up|1|||
48596855|NCT01922258|156379375|FG000|Overall Study|Adverse Event|9|||
48596856|NCT01922258|156379376|FG001|Overall Study|Adverse Event|2|||
48807367|NCT02202434|157136546|FG001|Overall Study|Other|0|||
48807368|NCT02202434|157136547|FG002|Overall Study|Other|0|||
48807369|NCT02202434|157136548|FG003|Overall Study|Other|1|||
48807370|NCT01160484|157136551|FG000|Overall Study|Lack of Efficacy|9|||
48807371|NCT01160484|157136551|FG000|Overall Study|Adverse Event|6|||
48807372|NCT01160484|157136551|FG000|Overall Study|Withdrawal by Subject|2|||
48807373|NCT01160484|157136551|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
48807374|NCT00553501|157136554|FG000|Overall Study|Adverse Event|2|||
48807375|NCT00553501|157136554|FG000|Overall Study|Death|1|||
48807376|NCT00553501|157136554|FG000|Overall Study|Progression|1|||
48807377|NCT02035332|157136555|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
48807378|NCT01352585|157136556|FG000|Overall Study|Adverse Event|2|||
48807379|NCT01352585|157136557|FG001|Overall Study|Adverse Event|1|||
48807380|NCT01352585|157136556|FG000|Overall Study|Lost to Follow-up|1|||
48807381|NCT01352585|157136557|FG001|Overall Study|Lost to Follow-up|0|||
48807382|NCT01352585|157136556|FG000|Overall Study|Other|5|||
48807383|NCT01352585|157136557|FG001|Overall Study|Other|2|||
48807384|NCT03185832|157136558|FG000|Overall Study|Death|9|||
48807385|NCT03185832|157136559|FG001|Overall Study|Death|14|||
48807386|NCT03185832|157136560|FG002|Overall Study|Death|9|||
48807387|NCT03185832|157136561|FG003|Overall Study|Death|7|||
48807388|NCT03185832|157136558|FG000|Overall Study|Withdrawn - vital status available|0|||
48807389|NCT03185832|157136559|FG001|Overall Study|Withdrawn - vital status available|1|||
48807390|NCT03185832|157136560|FG002|Overall Study|Withdrawn - vital status available|1|||
48491436|NCT01034137|155992571|FG001|Overall Study|Refused treatment or did not cooperate|0|||
48491437|NCT01034137|155992572|FG002|Overall Study|Refused treatment or did not cooperate|1|||
48491438|NCT01034137|155992570|FG000|Overall Study|Administrative or other|2|||
48491439|NCT01034137|155992571|FG001|Overall Study|Administrative or other|3|||
48491440|NCT01034137|155992572|FG002|Overall Study|Administrative or other|4|||
48491441|NCT03572933|155992573|FG000|Overall Study|Adverse Event|4|||
48491442|NCT03572933|155992574|FG001|Overall Study|Adverse Event|1|||
48491443|NCT03572933|155992573|FG000|Overall Study|Withdrawal by Subject|0|||
48491444|NCT03572933|155992574|FG001|Overall Study|Withdrawal by Subject|1|||
48491445|NCT02143947|155992577|FG000|Overall Study|Lost to Follow-up|4|||
48491446|NCT02143947|155992578|FG001|Overall Study|Lost to Follow-up|2|||
48491447|NCT01764854|155992584|FG000|Overall Study|Adverse Event|0|||
48491448|NCT01764854|155992585|FG001|Overall Study|Adverse Event|0|||
48491449|NCT01764854|155992586|FG002|Overall Study|Adverse Event|2|||
48491450|NCT01764854|155992587|FG003|Overall Study|Adverse Event|0|||
48491451|NCT01764854|155992584|FG000|Overall Study|Withdrawal by Subject|0|||
48491452|NCT01764854|155992585|FG001|Overall Study|Withdrawal by Subject|0|||
48491453|NCT01764854|155992586|FG002|Overall Study|Withdrawal by Subject|1|||
48491454|NCT01764854|155992587|FG003|Overall Study|Withdrawal by Subject|0|||
48491455|NCT01764854|155992584|FG000|Overall Study|relocation|0|||
48491456|NCT01764854|155992585|FG001|Overall Study|relocation|0|||
48491457|NCT01764854|155992586|FG002|Overall Study|relocation|2|||
48491458|NCT01764854|155992587|FG003|Overall Study|relocation|0|||
48491459|NCT01764854|155992584|FG000|Overall Study|Protocol Violation|0|||
48491460|NCT01764854|155992585|FG001|Overall Study|Protocol Violation|0|||
48807391|NCT03185832|157136561|FG003|Overall Study|Withdrawn - vital status available|4|||
48807392|NCT01083641|157136562|FG000|Overall Study|Withdrawal by Subject|2|||
48491461|NCT01764854|155992586|FG002|Overall Study|Protocol Violation|1|||
48491462|NCT01764854|155992587|FG003|Overall Study|Protocol Violation|2|||
48491463|NCT01466686|155992598|FG000|Overall Study|Withdrawal by Subject|1|||
48491464|NCT01759381|155992603|FG000|Overall Study|Death|1|||
48491465|NCT01759381|155992604|FG001|Overall Study|Death|0|||
48491466|NCT00633152|155992611|FG000|Overall Study|Adverse Event|1|||
48491467|NCT00633152|155992612|FG001|Overall Study|Adverse Event|0|||
48491468|NCT00633152|155992611|FG000|Overall Study|Randomized, did not receive study drug|5|||
48491469|NCT00633152|155992612|FG001|Overall Study|Randomized, did not receive study drug|2|||
48491470|NCT00633152|155992611|FG000|Overall Study|Withdrawal by Subject|1|||
48596857|NCT01922258|156379375|FG000|Overall Study|Met Withdrawal Criteria|0|||
48596858|NCT01922258|156379376|FG001|Overall Study|Met Withdrawal Criteria|4|||
48491471|NCT00633152|155992612|FG001|Overall Study|Withdrawal by Subject|1|||
48491472|NCT00633152|155992611|FG000|Overall Study|Lost to Follow-up|4|||
48491473|NCT00633152|155992612|FG001|Overall Study|Lost to Follow-up|1|||
48491474|NCT00633152|155992611|FG000|Overall Study|Miscellaneous Other|3|||
48807393|NCT01777321|157136563|FG000|Overall Study|Withdrawal by Subject|0|||
48807394|NCT01777321|157136564|FG001|Overall Study|Withdrawal by Subject|1|||
48491475|NCT00633152|155992612|FG001|Overall Study|Miscellaneous Other|2|||
48491476|NCT02049359|155992613|FG000|Overall Study|Lost to Follow-up|26|||
48491477|NCT02049359|155992614|FG001|Overall Study|Lost to Follow-up|19|||
48491478|NCT01907087|155992615|FG000|Overall Study|Withdrawal by Subject|1|||
48491479|NCT03273387|155992616|FG000|Overall Study|Death|2|||
48491480|NCT03273387|155992617|FG001|Overall Study|Death|2|||
48807395|NCT01119768|157136566|FG000|Treatment Period|Lack of Efficacy|18|||
48807396|NCT01119768|157136567|FG001|Treatment Period|Lack of Efficacy|25|||
48807397|NCT04461795|157136568|FG000|Overall Study|Lost to Follow-up|2|||
48807398|NCT04461795|157136568|FG000|Overall Study|Withdrawal by Subject|2|||
48807399|NCT04461795|157136568|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
48807400|NCT01641926|157136570|FG000|Overall Study|Adverse Event|5|||
48807401|NCT01641926|157136571|FG001|Overall Study|Adverse Event|2|||
48807402|NCT01641926|157136572|FG002|Overall Study|Adverse Event|3|||
48807403|NCT01641926|157136573|FG003|Overall Study|Adverse Event|1|||
48807404|NCT01641926|157136570|FG000|Overall Study|Lost to Follow-up|2|||
48807405|NCT01641926|157136571|FG001|Overall Study|Lost to Follow-up|2|||
48807406|NCT01641926|157136572|FG002|Overall Study|Lost to Follow-up|1|||
48807407|NCT01641926|157136573|FG003|Overall Study|Lost to Follow-up|0|||
48807408|NCT01641926|157136570|FG000|Overall Study|Physician Decision|6|||
48807409|NCT01641926|157136571|FG001|Overall Study|Physician Decision|5|||
48807410|NCT01641926|157136572|FG002|Overall Study|Physician Decision|0|||
48807411|NCT01641926|157136573|FG003|Overall Study|Physician Decision|1|||
48807412|NCT01641926|157136570|FG000|Overall Study|Protocol Violation|1|||
48807413|NCT01641926|157136571|FG001|Overall Study|Protocol Violation|0|||
48807414|NCT01641926|157136572|FG002|Overall Study|Protocol Violation|0|||
48491481|NCT03273387|155992616|FG000|Overall Study|Withdrawal by Subject|1|||
48491482|NCT03273387|155992617|FG001|Overall Study|Withdrawal by Subject|1|||
48491483|NCT01244815|155992618|FG000|Overall Study|Not Treated|0|||
48491484|NCT01244815|155992619|FG001|Overall Study|Not Treated|1|||
48491485|NCT01244815|155992620|FG002|Overall Study|Not Treated|0|||
48807415|NCT01641926|157136573|FG003|Overall Study|Protocol Violation|1|||
48807416|NCT01641926|157136570|FG000|Overall Study|Withdrawal by Subject|13|||
48807417|NCT01641926|157136571|FG001|Overall Study|Withdrawal by Subject|5|||
48807418|NCT01641926|157136572|FG002|Overall Study|Withdrawal by Subject|6|||
48807419|NCT01641926|157136573|FG003|Overall Study|Withdrawal by Subject|1|||
48807420|NCT01641926|157136570|FG000|Overall Study|Not Treated|1|||
48807421|NCT01641926|157136571|FG001|Overall Study|Not Treated|1|||
48807422|NCT01641926|157136572|FG002|Overall Study|Not Treated|1|||
48807423|NCT01641926|157136573|FG003|Overall Study|Not Treated|0|||
48807424|NCT01287520|157136574|FG000|Overall Study|Adverse Event|2|||
48807425|NCT01287520|157136575|FG001|Overall Study|Adverse Event|2|||
48807426|NCT01287520|157136576|FG002|Overall Study|Adverse Event|2|||
48807427|NCT01287520|157136577|FG003|Overall Study|Adverse Event|1|||
48807428|NCT01287520|157136578|FG004|Overall Study|Adverse Event|1|||
48807429|NCT01287520|157136579|FG005|Overall Study|Adverse Event|2|||
48807430|NCT01287520|157136580|FG006|Overall Study|Adverse Event|0|||
48807431|NCT01287520|157136581|FG007|Overall Study|Adverse Event|2|||
48807432|NCT01287520|157136582|FG008|Overall Study|Adverse Event|0|||
48807433|NCT01287520|157136574|FG000|Overall Study|Physician Decision|1|||
48491486|NCT01244815|155992621|FG003|Overall Study|Not Treated|0|||
48807434|NCT01287520|157136575|FG001|Overall Study|Physician Decision|1|||
48807435|NCT01287520|157136576|FG002|Overall Study|Physician Decision|2|||
48807436|NCT01287520|157136577|FG003|Overall Study|Physician Decision|0|||
48807437|NCT01287520|157136578|FG004|Overall Study|Physician Decision|1|||
48807438|NCT01287520|157136579|FG005|Overall Study|Physician Decision|1|||
48807439|NCT01287520|157136580|FG006|Overall Study|Physician Decision|0|||
48807440|NCT01287520|157136581|FG007|Overall Study|Physician Decision|1|||
48807441|NCT01287520|157136582|FG008|Overall Study|Physician Decision|0|||
48807442|NCT01287520|157136574|FG000|Overall Study|Progressive disease|0|||
48807443|NCT01287520|157136575|FG001|Overall Study|Progressive disease|4|||
48807444|NCT01287520|157136576|FG002|Overall Study|Progressive disease|1|||
48491487|NCT01244815|155992618|FG000|Overall Study|Adverse Event|4|||
48596859|NCT01922258|156379375|FG000|Overall Study|Withdrawn by the Investigator|1|||
48807445|NCT01287520|157136577|FG003|Overall Study|Progressive disease|6|||
48491488|NCT01244815|155992619|FG001|Overall Study|Adverse Event|7|||
48491489|NCT01244815|155992620|FG002|Overall Study|Adverse Event|5|||
48491490|NCT01244815|155992621|FG003|Overall Study|Adverse Event|5|||
48491491|NCT01244815|155992618|FG000|Overall Study|Treatment Failure|0|||
48491492|NCT01244815|155992619|FG001|Overall Study|Treatment Failure|0|||
48491493|NCT01244815|155992620|FG002|Overall Study|Treatment Failure|0|||
48807446|NCT01287520|157136578|FG004|Overall Study|Progressive disease|1|||
48807447|NCT01287520|157136579|FG005|Overall Study|Progressive disease|0|||
48807448|NCT01287520|157136580|FG006|Overall Study|Progressive disease|2|||
48807449|NCT01287520|157136581|FG007|Overall Study|Progressive disease|2|||
48807450|NCT01287520|157136582|FG008|Overall Study|Progressive disease|4|||
48807451|NCT01287520|157136574|FG000|Overall Study|Withdrawal by Subject|0|||
48807452|NCT01287520|157136575|FG001|Overall Study|Withdrawal by Subject|0|||
48807453|NCT01287520|157136576|FG002|Overall Study|Withdrawal by Subject|0|||
48807454|NCT01287520|157136577|FG003|Overall Study|Withdrawal by Subject|0|||
48807455|NCT01287520|157136578|FG004|Overall Study|Withdrawal by Subject|0|||
48807456|NCT01287520|157136579|FG005|Overall Study|Withdrawal by Subject|1|||
48807457|NCT01287520|157136580|FG006|Overall Study|Withdrawal by Subject|0|||
48807458|NCT01287520|157136581|FG007|Overall Study|Withdrawal by Subject|0|||
48807459|NCT01287520|157136582|FG008|Overall Study|Withdrawal by Subject|1|||
48807460|NCT04035200|157136584|FG000|Overall Study|Lost to Follow-up|0|||
48807461|NCT04035200|157136585|FG001|Overall Study|Lost to Follow-up|1|||
48807462|NCT04035200|157136586|FG002|Overall Study|Lost to Follow-up|0|||
48807463|NCT04035200|157136584|FG000|Overall Study|Withdrawal by Subject|1|||
48807464|NCT04035200|157136585|FG001|Overall Study|Withdrawal by Subject|4|||
48807465|NCT04035200|157136586|FG002|Overall Study|Withdrawal by Subject|4|||
48807466|NCT04035200|157136584|FG000|Overall Study|COVID-19|1|||
48807467|NCT04035200|157136585|FG001|Overall Study|COVID-19|0|||
48807468|NCT04035200|157136586|FG002|Overall Study|COVID-19|0|||
48807469|NCT04035200|157136584|FG000|Overall Study|Early Termination|0|||
48807470|NCT04035200|157136585|FG001|Overall Study|Early Termination|1|||
48807471|NCT04035200|157136586|FG002|Overall Study|Early Termination|0|||
48807472|NCT04035200|157136584|FG000|Overall Study|Non-compliance|0|||
48807473|NCT04035200|157136585|FG001|Overall Study|Non-compliance|1|||
48596860|NCT01922258|156379376|FG001|Overall Study|Withdrawn by the Investigator|4|||
48807474|NCT04035200|157136586|FG002|Overall Study|Non-compliance|0|||
48435006|NCT00195260|155780609|FG003|Part 1: Dose Escalation|Death|0|||
48596861|NCT01922258|156379375|FG000|Overall Study|Withdrawal by participant|5|||
48807475|NCT04399356|157136587|FG000|Overall Study|Lost to Follow-up|1|||
48491494|NCT01244815|155992621|FG003|Overall Study|Treatment Failure|1|||
48710143|NCT02023697|156788773|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
48491495|NCT01244815|155992618|FG000|Overall Study|Lost to Follow-up|3|||
48491496|NCT01244815|155992619|FG001|Overall Study|Lost to Follow-up|2|||
48710144|NCT02023697|156788774|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
48710145|NCT02023697|156788772|FG000|Active Follow-up Period|Lost to Follow-up|1|||
48710146|NCT02023697|156788773|FG001|Active Follow-up Period|Lost to Follow-up|1|||
48710147|NCT02023697|156788774|FG002|Active Follow-up Period|Lost to Follow-up|1|||
48710148|NCT02023697|156788772|FG000|Active Follow-up Period|Deterioration of general condition|1|||
48710149|NCT02023697|156788773|FG001|Active Follow-up Period|Deterioration of general condition|1|||
48710150|NCT02023697|156788774|FG002|Active Follow-up Period|Deterioration of general condition|1|||
48710151|NCT02023697|156788772|FG000|Active Follow-up Period|Other unspecified|2|||
48710152|NCT02023697|156788773|FG001|Active Follow-up Period|Other unspecified|0|||
48710153|NCT02023697|156788774|FG002|Active Follow-up Period|Other unspecified|1|||
48710154|NCT02023697|156788772|FG000|Active Follow-up Period|Clinical progression|0|||
48710155|NCT02023697|156788773|FG001|Active Follow-up Period|Clinical progression|2|||
48710156|NCT02023697|156788774|FG002|Active Follow-up Period|Clinical progression|1|||
48710157|NCT02023697|156788772|FG000|Active Follow-up Period|Radiological progression|0|||
48710158|NCT02023697|156788773|FG001|Active Follow-up Period|Radiological progression|0|||
48710159|NCT02023697|156788774|FG002|Active Follow-up Period|Radiological progression|1|||
48710160|NCT02023697|156788772|FG000|Active Follow-up Period|Death|83|||
48710161|NCT02023697|156788773|FG001|Active Follow-up Period|Death|82|||
48710162|NCT02023697|156788774|FG002|Active Follow-up Period|Death|87|||
48710163|NCT02023697|156788772|FG000|Long-term Follow-up Period|Death|9|||
48710164|NCT02023697|156788773|FG001|Long-term Follow-up Period|Death|6|||
48710165|NCT02023697|156788774|FG002|Long-term Follow-up Period|Death|4|||
48710166|NCT02023697|156788772|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
48710167|NCT02023697|156788773|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
48710168|NCT02023697|156788774|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
48710169|NCT02023697|156788772|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
48710170|NCT02023697|156788773|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
48710171|NCT02023697|156788774|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
48710172|NCT02023697|156788772|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
48710173|NCT02023697|156788773|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
48710174|NCT02023697|156788774|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
48710175|NCT02023697|156788772|FG000|Long-term Follow-up Period|Technical problems|0|||
48710176|NCT02023697|156788773|FG001|Long-term Follow-up Period|Technical problems|0|||
48710177|NCT02023697|156788774|FG002|Long-term Follow-up Period|Technical problems|1|||
48710178|NCT02023697|156788772|FG000|Long-term Follow-up Period|Other unspecified|6|||
48710179|NCT02023697|156788773|FG001|Long-term Follow-up Period|Other unspecified|3|||
48710180|NCT02023697|156788774|FG002|Long-term Follow-up Period|Other unspecified|5|||
48710181|NCT01733680|156788775|FG000|Overall Study|Withdrawal by Subject|0|||
48710182|NCT01733680|156788776|FG001|Overall Study|Withdrawal by Subject|1|||
48710183|NCT00476229|156788777|FG000|Overall Study|Progressive shortness of breath|1|||
48710184|NCT02164461|156788778|FG000|Overall Study|Adverse Event|0|||
48710185|NCT02164461|156788779|FG001|Overall Study|Adverse Event|0|||
48710186|NCT02164461|156788780|FG002|Overall Study|Adverse Event|1|||
48807476|NCT04399356|157136588|FG001|Overall Study|Lost to Follow-up|1|||
48807477|NCT04399356|157136587|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
48807478|NCT04399356|157136588|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
48807479|NCT04399356|157136587|FG000|Overall Study|Withdrawal by Subject|1|||
48807480|NCT04399356|157136588|FG001|Overall Study|Withdrawal by Subject|0|||
48807481|NCT01121484|157136592|FG000|Overall Study|Adverse Event|12|||
48807482|NCT01121484|157136593|FG001|Overall Study|Adverse Event|5|||
48807483|NCT01121484|157136592|FG000|Overall Study|Lack of Efficacy|3|||
48807484|NCT01121484|157136593|FG001|Overall Study|Lack of Efficacy|11|||
48807485|NCT01121484|157136592|FG000|Overall Study|Lost to Follow-up|5|||
48807486|NCT01121484|157136593|FG001|Overall Study|Lost to Follow-up|9|||
48807487|NCT01121484|157136592|FG000|Overall Study|Physician Decision|0|||
48807488|NCT01121484|157136593|FG001|Overall Study|Physician Decision|3|||
48807489|NCT01121484|157136592|FG000|Overall Study|Protocol Violation|1|||
48807490|NCT01121484|157136593|FG001|Overall Study|Protocol Violation|0|||
48807491|NCT01121484|157136592|FG000|Overall Study|Withdrawal by Subject|8|||
48710187|NCT02164461|156788778|FG000|Overall Study|Disease Progression|1|||
48710188|NCT02164461|156788779|FG001|Overall Study|Disease Progression|3|||
48710189|NCT02164461|156788780|FG002|Overall Study|Disease Progression|4|||
48710190|NCT02164461|156788778|FG000|Overall Study|Withdrawal by Subject|0|||
48710191|NCT02164461|156788779|FG001|Overall Study|Withdrawal by Subject|3|||
48710192|NCT02164461|156788780|FG002|Overall Study|Withdrawal by Subject|0|||
48710193|NCT04145219|156788783|FG000|Overall Study|Adverse Event|18|||
48807492|NCT01121484|157136593|FG001|Overall Study|Withdrawal by Subject|7|||
48807493|NCT01121484|157136592|FG000|Overall Study|Discontinuation of study by sponsor|0|||
48807494|NCT01121484|157136593|FG001|Overall Study|Discontinuation of study by sponsor|1|||
48807495|NCT01121484|157136592|FG000|Overall Study|Other|3|||
48596862|NCT01922258|156379376|FG001|Overall Study|Withdrawal by participant|5|||
48596863|NCT00673257|156379377|FG000|Overall Study|Withdrawal by Subject|4|||
48596864|NCT00673257|156379377|FG000|Overall Study|Unable to obtain specimen|1|||
48807496|NCT01121484|157136593|FG001|Overall Study|Other|3|||
48807497|NCT01121484|157136592|FG000|Overall Study|Randomized, not treated|1|||
48807498|NCT01121484|157136593|FG001|Overall Study|Randomized, not treated|4|||
48807499|NCT01834222|157136597|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
48807500|NCT01375205|157136598|FG000|Overall Study|Lost to Follow-up|15|||
48491497|NCT01244815|155992620|FG002|Overall Study|Lost to Follow-up|3|||
48491498|NCT01244815|155992621|FG003|Overall Study|Lost to Follow-up|2|||
48491499|NCT01244815|155992618|FG000|Overall Study|Withdrawal by Subject|0|||
48491500|NCT01244815|155992619|FG001|Overall Study|Withdrawal by Subject|2|||
48491501|NCT01244815|155992620|FG002|Overall Study|Withdrawal by Subject|0|||
48491502|NCT01244815|155992621|FG003|Overall Study|Withdrawal by Subject|3|||
48710194|NCT04145219|156788784|FG001|Overall Study|Adverse Event|6|||
48710195|NCT04145219|156788783|FG000|Overall Study|Lost to Follow-up|2|||
48710196|NCT04145219|156788784|FG001|Overall Study|Lost to Follow-up|3|||
48710197|NCT04145219|156788783|FG000|Overall Study|Physician Decision|0|||
48710198|NCT04145219|156788784|FG001|Overall Study|Physician Decision|2|||
48710199|NCT04145219|156788783|FG000|Overall Study|Withdrawal by Subject|12|||
48710200|NCT04145219|156788784|FG001|Overall Study|Withdrawal by Subject|8|||
48710201|NCT04145219|156788783|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
48710202|NCT04145219|156788784|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
48710203|NCT02722499|156788785|FG000|Overall Study|Lost to Follow-up|2|||
48710204|NCT02722499|156788786|FG001|Overall Study|Lost to Follow-up|0|||
48710205|NCT02722499|156788787|FG002|Overall Study|Lost to Follow-up|1|||
48710206|NCT01047553|156788801|FG000|Overall Study|Adverse Event|10|||
48710207|NCT01047553|156788802|FG001|Overall Study|Adverse Event|5|||
48710208|NCT01047553|156788801|FG000|Overall Study|Withdrawal by Subject|4|||
48710209|NCT01047553|156788802|FG001|Overall Study|Withdrawal by Subject|2|||
48807501|NCT01375205|157136599|FG001|Overall Study|Lost to Follow-up|12|||
48596865|NCT01188668|156379378|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
48596866|NCT01188668|156379378|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
48596867|NCT01188668|156379378|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
48596868|NCT01585246|156379379|FG000|Overall Study|Lost to Follow-up|0|||
48596869|NCT01585246|156379380|FG001|Overall Study|Lost to Follow-up|0|||
48596870|NCT01585246|156379381|FG002|Overall Study|Lost to Follow-up|2|||
48596871|NCT01585246|156379382|FG003|Overall Study|Lost to Follow-up|1|||
48596872|NCT01585246|156379383|FG004|Overall Study|Lost to Follow-up|0|||
48596873|NCT01585246|156379379|FG000|Overall Study|Protocol Violation|0|||
48596874|NCT01585246|156379380|FG001|Overall Study|Protocol Violation|0|||
48596875|NCT01585246|156379381|FG002|Overall Study|Protocol Violation|0|||
48596876|NCT01585246|156379382|FG003|Overall Study|Protocol Violation|0|||
48596877|NCT01585246|156379383|FG004|Overall Study|Protocol Violation|1|||
48596878|NCT01585246|156379379|FG000|Overall Study|Withdrawal by Subject|0|||
48596879|NCT01585246|156379380|FG001|Overall Study|Withdrawal by Subject|0|||
48710210|NCT01047553|156788801|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
48710211|NCT01047553|156788802|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
48710212|NCT01047553|156788801|FG000|Overall Study|Lost to Follow-up|1|||
48710213|NCT01047553|156788802|FG001|Overall Study|Lost to Follow-up|0|||
48710214|NCT01047553|156788801|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
48596880|NCT01585246|156379381|FG002|Overall Study|Withdrawal by Subject|1|||
48596881|NCT01585246|156379382|FG003|Overall Study|Withdrawal by Subject|2|||
48596882|NCT01585246|156379383|FG004|Overall Study|Withdrawal by Subject|1|||
48596883|NCT01585246|156379379|FG000|Overall Study|Other|0|||
48596884|NCT01585246|156379380|FG001|Overall Study|Other|1|||
48596885|NCT01585246|156379381|FG002|Overall Study|Other|1|||
48596886|NCT01585246|156379382|FG003|Overall Study|Other|1|||
48596887|NCT01585246|156379383|FG004|Overall Study|Other|0|||
48596888|NCT00237692|156379384|FG000|Overall Study|Lost to Follow-up|9|||
48596889|NCT00237692|156379385|FG001|Overall Study|Lost to Follow-up|3|||
48596890|NCT00237692|156379386|FG002|Overall Study|Lost to Follow-up|5|||
48596891|NCT00237692|156379387|FG003|Overall Study|Lost to Follow-up|3|||
48596892|NCT00237692|156379384|FG000|Overall Study|Death|1|||
48596893|NCT00237692|156379385|FG001|Overall Study|Death|2|||
48596894|NCT00237692|156379386|FG002|Overall Study|Death|2|||
48596895|NCT00237692|156379387|FG003|Overall Study|Death|3|||
48596896|NCT00237692|156379384|FG000|Overall Study|Excluded - did not meet criteria|4|||
48596897|NCT00237692|156379385|FG001|Overall Study|Excluded - did not meet criteria|3|||
48710215|NCT01047553|156788802|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
48710216|NCT01047553|156788801|FG000|Overall Study|PI's decision|0|||
48807502|NCT01375205|157136598|FG000|Overall Study|Withdrawal by Subject|6|||
48807503|NCT01375205|157136599|FG001|Overall Study|Withdrawal by Subject|1|||
48807504|NCT01674621|157136603|FG000|Overall Study|Adverse Event|3|||
48807505|NCT01674621|157136604|FG001|Overall Study|Adverse Event|2|||
48807506|NCT01674621|157136605|FG002|Overall Study|Adverse Event|5|||
48807507|NCT01674621|157136606|FG003|Overall Study|Adverse Event|5|||
48807508|NCT01674621|157136607|FG004|Overall Study|Adverse Event|1|||
48807509|NCT01674621|157136603|FG000|Overall Study|Inability to Complete Study Procedures|0|||
48807510|NCT01674621|157136604|FG001|Overall Study|Inability to Complete Study Procedures|0|||
48807511|NCT01674621|157136605|FG002|Overall Study|Inability to Complete Study Procedures|0|||
48807512|NCT01674621|157136606|FG003|Overall Study|Inability to Complete Study Procedures|0|||
48807513|NCT01674621|157136607|FG004|Overall Study|Inability to Complete Study Procedures|2|||
48807514|NCT01674621|157136603|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
48596898|NCT00237692|156379386|FG002|Overall Study|Excluded - did not meet criteria|5|||
48807515|NCT01674621|157136604|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
48435007|NCT00195260|155780610|FG004|Part 1: Dose Escalation|Death|0|||
48596899|NCT00237692|156379387|FG003|Overall Study|Excluded - did not meet criteria|9|||
48596900|NCT00237692|156379384|FG000|Overall Study|Withdrawal by Subject|4|||
48596901|NCT00237692|156379385|FG001|Overall Study|Withdrawal by Subject|6|||
48596902|NCT00237692|156379386|FG002|Overall Study|Withdrawal by Subject|10|||
48596903|NCT00237692|156379387|FG003|Overall Study|Withdrawal by Subject|4|||
48596904|NCT02420262|156379388|FG000|Overall Study|Adverse Event|1|||
48596905|NCT02420262|156379389|FG001|Overall Study|Adverse Event|0|||
48596906|NCT02420262|156379388|FG000|Overall Study|Withdrawal by Subject|1|||
48710217|NCT01047553|156788802|FG001|Overall Study|PI's decision|1|||
48710218|NCT05343624|156788803|FG000|Overall Study|Chart review not completed|1|||
48710219|NCT01262820|156788804|FG000|Overall Study|Adverse Event|5|||
48710220|NCT01262820|156788804|FG000|Overall Study|Lack of Efficacy|9|||
48710221|NCT01262820|156788804|FG000|Overall Study|Drug held for 21+ days|1|||
48710222|NCT03181529|156788805|FG000|Overall Study|Withdrawal by Subject|1|||
48710223|NCT03181529|156788806|FG001|Overall Study|Withdrawal by Subject|1|||
48710224|NCT03181529|156788805|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
48710225|NCT03181529|156788806|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
48710226|NCT00104520|156788808|FG000|Overall Study|Unrelated adverse event|34|||
48710227|NCT00104520|156788809|FG001|Overall Study|Unrelated adverse event|47|||
48710228|NCT00104520|156788808|FG000|Overall Study|Study drug intolerance|0|||
48710229|NCT00104520|156788809|FG001|Overall Study|Study drug intolerance|1|||
48710230|NCT00104520|156788808|FG000|Overall Study|Related adverse event|13|||
48710231|NCT00104520|156788809|FG001|Overall Study|Related adverse event|15|||
48710232|NCT00104520|156788808|FG000|Overall Study|Lost to Follow-up|1|||
48710233|NCT00104520|156788809|FG001|Overall Study|Lost to Follow-up|0|||
48710234|NCT00104520|156788808|FG000|Overall Study|Noncompliance|0|||
48710235|NCT00104520|156788809|FG001|Overall Study|Noncompliance|2|||
48710236|NCT00104520|156788808|FG000|Overall Study|Personal/administrative|1|||
48710237|NCT00104520|156788809|FG001|Overall Study|Personal/administrative|1|||
48710238|NCT00104520|156788808|FG000|Overall Study|Other|1|||
48710239|NCT00104520|156788809|FG001|Overall Study|Other|5|||
48710240|NCT02379637|156788819|FG000|Overall Study|Protocol Violation|0|||
48710241|NCT02379637|156788820|FG001|Overall Study|Protocol Violation|1|||
48710242|NCT02379637|156788819|FG000|Overall Study|Adverse Event|1|||
48710243|NCT02379637|156788820|FG001|Overall Study|Adverse Event|0|||
48710244|NCT02379637|156788819|FG000|Overall Study|Withdrawal by Subject|1|||
48710245|NCT02379637|156788820|FG001|Overall Study|Withdrawal by Subject|0|||
48710246|NCT00706342|156788825|FG000|Overall Study|Adverse Event|3|||
48710247|NCT00706342|156788825|FG000|Overall Study|Not responding to treatment|2|||
48710248|NCT00706342|156788825|FG000|Overall Study|Withdrawn due to failure to respond|1|||
48710249|NCT00706342|156788825|FG000|Overall Study|Death|1|||
48710250|NCT00706342|156788825|FG000|Overall Study|Withdrew from the study on his own.|1|||
48710251|NCT00706342|156788825|FG000|Overall Study|Investigator discretion|2|||
48710252|NCT00706342|156788825|FG000|Overall Study|Non-responder Week 12|1|||
48710253|NCT00706342|156788825|FG000|Overall Study|Ongoing|6|||
48710254|NCT00706342|156788825|FG000|Overall Study|WIthdrawal of consent|1|||
48710255|NCT01781299|156788827|FG000|Overall Study|Withdrawal by Subject|0|||
48710256|NCT01781299|156788828|FG001|Overall Study|Withdrawal by Subject|1|||
48710257|NCT01798849|156788829|FG000|Overall Study|Physician Decision|0|||
48710258|NCT01798849|156788830|FG001|Overall Study|Physician Decision|0|||
48710259|NCT01798849|156788831|FG002|Overall Study|Physician Decision|1|||
48710260|NCT04254913|156788832|FG000|Overall Study|Adverse Event|1|||
48710261|NCT04535453|156788833|FG000|Overall Study|Death|0|||
48710262|NCT04535453|156788834|FG001|Overall Study|Death|1|||
48710263|NCT04535453|156788835|FG002|Overall Study|Death|0|||
48710264|NCT04535453|156788836|FG003|Overall Study|Death|0|||
48710265|NCT04535453|156788837|FG004|Overall Study|Death|0|||
48710266|NCT04535453|156788838|FG005|Overall Study|Death|0|||
48710267|NCT04535453|156788839|FG006|Overall Study|Death|0|||
48710268|NCT04535453|156788840|FG007|Overall Study|Death|0|||
48710269|NCT04535453|156788841|FG008|Overall Study|Death|0|||
48710270|NCT04535453|156788842|FG009|Overall Study|Death|0|||
48710271|NCT04535453|156788843|FG010|Overall Study|Death|0|||
48710272|NCT04535453|156788844|FG011|Overall Study|Death|0|||
48710273|NCT04535453|156788833|FG000|Overall Study|Lost to Follow-up|1|||
48710274|NCT04535453|156788834|FG001|Overall Study|Lost to Follow-up|1|||
48710275|NCT04535453|156788835|FG002|Overall Study|Lost to Follow-up|1|||
48710276|NCT04535453|156788836|FG003|Overall Study|Lost to Follow-up|0|||
48710277|NCT04535453|156788837|FG004|Overall Study|Lost to Follow-up|3|||
48710278|NCT04535453|156788838|FG005|Overall Study|Lost to Follow-up|1|||
48710279|NCT04535453|156788839|FG006|Overall Study|Lost to Follow-up|0|||
48710280|NCT04535453|156788840|FG007|Overall Study|Lost to Follow-up|0|||
48710281|NCT04535453|156788841|FG008|Overall Study|Lost to Follow-up|1|||
48710282|NCT04535453|156788842|FG009|Overall Study|Lost to Follow-up|1|||
48710283|NCT04535453|156788843|FG010|Overall Study|Lost to Follow-up|0|||
48710284|NCT04535453|156788844|FG011|Overall Study|Lost to Follow-up|0|||
48710285|NCT04535453|156788833|FG000|Overall Study|Physician Decision|0|||
48710286|NCT04535453|156788834|FG001|Overall Study|Physician Decision|0|||
48710287|NCT04535453|156788835|FG002|Overall Study|Physician Decision|0|||
48710288|NCT04535453|156788836|FG003|Overall Study|Physician Decision|1|||
48710289|NCT04535453|156788837|FG004|Overall Study|Physician Decision|0|||
48710290|NCT04535453|156788838|FG005|Overall Study|Physician Decision|0|||
48710291|NCT04535453|156788839|FG006|Overall Study|Physician Decision|0|||
48710292|NCT04535453|156788840|FG007|Overall Study|Physician Decision|0|||
48710293|NCT04535453|156788841|FG008|Overall Study|Physician Decision|0|||
48710294|NCT04535453|156788842|FG009|Overall Study|Physician Decision|0|||
48710295|NCT04535453|156788843|FG010|Overall Study|Physician Decision|0|||
48710296|NCT04535453|156788844|FG011|Overall Study|Physician Decision|0|||
48710297|NCT04535453|156788833|FG000|Overall Study|Withdrawal by Subject|3|||
48710298|NCT04535453|156788834|FG001|Overall Study|Withdrawal by Subject|6|||
48710299|NCT04535453|156788835|FG002|Overall Study|Withdrawal by Subject|3|||
48710300|NCT04535453|156788836|FG003|Overall Study|Withdrawal by Subject|3|||
48710301|NCT04535453|156788837|FG004|Overall Study|Withdrawal by Subject|2|||
48710302|NCT04535453|156788838|FG005|Overall Study|Withdrawal by Subject|1|||
48710303|NCT04535453|156788839|FG006|Overall Study|Withdrawal by Subject|1|||
48710304|NCT04535453|156788840|FG007|Overall Study|Withdrawal by Subject|1|||
48710305|NCT04535453|156788841|FG008|Overall Study|Withdrawal by Subject|1|||
48710306|NCT04535453|156788842|FG009|Overall Study|Withdrawal by Subject|1|||
48710307|NCT04535453|156788843|FG010|Overall Study|Withdrawal by Subject|0|||
48710308|NCT04535453|156788844|FG011|Overall Study|Withdrawal by Subject|1|||
48710309|NCT04535453|156788833|FG000|Overall Study|Other|0|||
48710310|NCT04535453|156788834|FG001|Overall Study|Other|0|||
48710311|NCT04535453|156788835|FG002|Overall Study|Other|1|||
48710312|NCT04535453|156788836|FG003|Overall Study|Other|0|||
48710313|NCT04535453|156788837|FG004|Overall Study|Other|1|||
48710314|NCT04535453|156788838|FG005|Overall Study|Other|0|||
48710315|NCT04535453|156788839|FG006|Overall Study|Other|1|||
48710316|NCT04535453|156788840|FG007|Overall Study|Other|1|||
48710317|NCT04535453|156788841|FG008|Overall Study|Other|1|||
48710318|NCT04535453|156788842|FG009|Overall Study|Other|0|||
48710319|NCT04535453|156788843|FG010|Overall Study|Other|0|||
48710320|NCT04535453|156788844|FG011|Overall Study|Other|0|||
48710321|NCT00916929|156788845|FG000|Overall Study|Lost to Follow-up|1|||
48710322|NCT00916929|156788846|FG001|Overall Study|Lost to Follow-up|3|||
48710323|NCT00916929|156788845|FG000|Overall Study|Death|5|||
48710324|NCT00916929|156788846|FG001|Overall Study|Death|10|||
48710325|NCT00916929|156788845|FG000|Overall Study|Withdrawal by Subject|1|||
48710326|NCT00916929|156788846|FG001|Overall Study|Withdrawal by Subject|5|||
48710327|NCT00916929|156788845|FG000|Overall Study|Left ventricular epicardial lead|1|||
48710328|NCT00916929|156788846|FG001|Overall Study|Left ventricular epicardial lead|2|||
48710329|NCT00916929|156788845|FG000|Overall Study|Transferred to hospice care|1|||
48710330|NCT00916929|156788846|FG001|Overall Study|Transferred to hospice care|1|||
48710331|NCT00916929|156788845|FG000|Overall Study|System explant|1|||
48710332|NCT00916929|156788846|FG001|Overall Study|System explant|0|||
48710333|NCT00916929|156788845|FG000|Overall Study|Moved to another state|0|||
48710334|NCT00916929|156788846|FG001|Overall Study|Moved to another state|1|||
48710335|NCT00916929|156788845|FG000|Overall Study|Device unable to process impedance data|0|||
48491503|NCT01244815|155992618|FG000|Overall Study|Protocol Violation|7|||
48491504|NCT01244815|155992619|FG001|Overall Study|Protocol Violation|4|||
48491505|NCT01244815|155992620|FG002|Overall Study|Protocol Violation|3|||
48491506|NCT01244815|155992621|FG003|Overall Study|Protocol Violation|1|||
48491507|NCT01244815|155992618|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
48491508|NCT01244815|155992619|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
48491509|NCT01244815|155992620|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
48710336|NCT00916929|156788846|FG001|Overall Study|Device unable to process impedance data|7|||
48710337|NCT02929407|156788847|FG000|Overall Study|Adverse Event|1|||
48710338|NCT01160822|156788850|FG000|Overall Study|Adverse Event|0|||
48710339|NCT01160822|156788851|FG001|Overall Study|Adverse Event|0|||
48491510|NCT01244815|155992621|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
48710340|NCT01160822|156788852|FG002|Overall Study|Adverse Event|0|||
48710341|NCT01160822|156788853|FG003|Overall Study|Adverse Event|0|||
48710342|NCT01160822|156788854|FG004|Overall Study|Adverse Event|1|||
48710343|NCT01160822|156788855|FG005|Overall Study|Adverse Event|2|||
48710344|NCT01160822|156788856|FG006|Overall Study|Adverse Event|5|||
48710345|NCT01160822|156788850|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48710346|NCT01160822|156788851|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48710347|NCT01160822|156788852|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48710348|NCT01160822|156788853|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48710349|NCT01160822|156788854|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
48710350|NCT01160822|156788855|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
48710351|NCT01160822|156788856|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
48710352|NCT01160822|156788850|FG000|Overall Study|Withdrawal by Subject|0|||
48710353|NCT01160822|156788851|FG001|Overall Study|Withdrawal by Subject|0|||
48710354|NCT01160822|156788852|FG002|Overall Study|Withdrawal by Subject|0|||
48710355|NCT01160822|156788853|FG003|Overall Study|Withdrawal by Subject|0|||
48710356|NCT01160822|156788854|FG004|Overall Study|Withdrawal by Subject|0|||
48710357|NCT01160822|156788855|FG005|Overall Study|Withdrawal by Subject|0|||
48807516|NCT01674621|157136605|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
48807517|NCT01674621|157136606|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
48807518|NCT01674621|157136607|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
48807519|NCT01674621|157136603|FG000|Overall Study|Withdrawal by Subject|2|||
48807520|NCT01674621|157136604|FG001|Overall Study|Withdrawal by Subject|5|||
48807521|NCT01674621|157136605|FG002|Overall Study|Withdrawal by Subject|2|||
48807522|NCT01674621|157136606|FG003|Overall Study|Withdrawal by Subject|0|||
48807523|NCT01674621|157136607|FG004|Overall Study|Withdrawal by Subject|1|||
48807524|NCT01674621|157136603|FG000|Overall Study|Other than specified|0|||
48807525|NCT01674621|157136604|FG001|Overall Study|Other than specified|1|||
48807526|NCT01674621|157136605|FG002|Overall Study|Other than specified|0|||
48807527|NCT01674621|157136606|FG003|Overall Study|Other than specified|0|||
48807528|NCT01674621|157136607|FG004|Overall Study|Other than specified|2|||
48807529|NCT04772053|157136620|FG000|Overall Study|Physician Decision|2|||
48807530|NCT04772053|157136620|FG000|Overall Study|Withdrawal by Subject|3|||
48807531|NCT04772053|157136620|FG000|Overall Study|Study Terminated by Sponsor|1|||
48807532|NCT04146896|157136621|FG000|Overall Study|Adverse Event|5|||
48807533|NCT04146896|157136622|FG001|Overall Study|Adverse Event|8|||
48807534|NCT04146896|157136621|FG000|Overall Study|Lack of Efficacy|3|||
48807535|NCT04146896|157136622|FG001|Overall Study|Lack of Efficacy|2|||
48807536|NCT04146896|157136621|FG000|Overall Study|Lost to Follow-up|0|||
48807537|NCT04146896|157136622|FG001|Overall Study|Lost to Follow-up|1|||
48807538|NCT04146896|157136621|FG000|Overall Study|Non-compliance|5|||
48807539|NCT04146896|157136622|FG001|Overall Study|Non-compliance|4|||
48807540|NCT04146896|157136621|FG000|Overall Study|Withdrawal by Subject|3|||
48807541|NCT04146896|157136622|FG001|Overall Study|Withdrawal by Subject|5|||
48807542|NCT04146896|157136621|FG000|Overall Study|Randomized in error|1|||
48807543|NCT04146896|157136622|FG001|Overall Study|Randomized in error|2|||
48807544|NCT02118337|157136623|FG000|Overall Study|Other|1|||
48807545|NCT02118337|157136624|FG001|Overall Study|Other|0|||
48807546|NCT02118337|157136625|FG002|Overall Study|Other|0|||
48807547|NCT02118337|157136626|FG003|Overall Study|Other|0|||
48807548|NCT02118337|157136627|FG004|Overall Study|Other|2|||
48807549|NCT02118337|157136628|FG005|Overall Study|Other|3|||
48807550|NCT02118337|157136629|FG006|Overall Study|Other|1|||
48710358|NCT01160822|156788856|FG006|Overall Study|Withdrawal by Subject|1|||
48710359|NCT01160822|156788850|FG000|Overall Study|Lost to Follow-up|0|||
48710360|NCT01160822|156788851|FG001|Overall Study|Lost to Follow-up|0|||
48710361|NCT01160822|156788852|FG002|Overall Study|Lost to Follow-up|0|||
48710362|NCT01160822|156788853|FG003|Overall Study|Lost to Follow-up|0|||
48710363|NCT01160822|156788854|FG004|Overall Study|Lost to Follow-up|1|||
48710364|NCT01160822|156788855|FG005|Overall Study|Lost to Follow-up|0|||
48710365|NCT01160822|156788856|FG006|Overall Study|Lost to Follow-up|0|||
48710366|NCT01160822|156788850|FG000|Overall Study|Administrative problems|0|||
48807551|NCT02118337|157136630|FG007|Overall Study|Other|28|||
48807552|NCT02118337|157136631|FG008|Overall Study|Other|15|||
48807553|NCT02118337|157136623|FG000|Overall Study|Lost to Follow-up|0|||
48807554|NCT02118337|157136624|FG001|Overall Study|Lost to Follow-up|0|||
48807555|NCT02118337|157136625|FG002|Overall Study|Lost to Follow-up|0|||
48807556|NCT02118337|157136626|FG003|Overall Study|Lost to Follow-up|0|||
48596907|NCT02420262|156379389|FG001|Overall Study|Withdrawal by Subject|4|||
48596908|NCT02420262|156379388|FG000|Overall Study|Unclassified|0|||
48596909|NCT02420262|156379389|FG001|Overall Study|Unclassified|1|||
48596910|NCT02716779|156379390|FG000|Monotherapy|Adverse Event|0|||
48596911|NCT02716779|156379391|FG001|Monotherapy|Adverse Event|1|||
48596912|NCT02716779|156379392|FG002|Monotherapy|Adverse Event|1|||
48596913|NCT02716779|156379390|FG000|Combination Therapy|Adverse Event|0|||
48596914|NCT02716779|156379391|FG001|Combination Therapy|Adverse Event|2|||
48596915|NCT02716779|156379392|FG002|Combination Therapy|Adverse Event|1|||
48596916|NCT02600923|156379393|FG000|Overall Study|Death|10|||
48596917|NCT02600923|156379393|FG000|Overall Study|Adverse Event|3|||
48596918|NCT02600923|156379393|FG000|Overall Study|Global deterioration of health status|2|||
48710367|NCT01160822|156788851|FG001|Overall Study|Administrative problems|0|||
48710368|NCT01160822|156788852|FG002|Overall Study|Administrative problems|0|||
48710369|NCT01160822|156788853|FG003|Overall Study|Administrative problems|0|||
48710370|NCT01160822|156788854|FG004|Overall Study|Administrative problems|1|||
48710371|NCT01160822|156788855|FG005|Overall Study|Administrative problems|0|||
48710372|NCT01160822|156788856|FG006|Overall Study|Administrative problems|0|||
48710373|NCT01160822|156788850|FG000|Overall Study|Protocol deviation|0|||
48710374|NCT01160822|156788851|FG001|Overall Study|Protocol deviation|0|||
48710375|NCT01160822|156788852|FG002|Overall Study|Protocol deviation|0|||
48710376|NCT01160822|156788853|FG003|Overall Study|Protocol deviation|0|||
48710377|NCT01160822|156788854|FG004|Overall Study|Protocol deviation|2|||
48710378|NCT01160822|156788855|FG005|Overall Study|Protocol deviation|0|||
48710379|NCT01160822|156788856|FG006|Overall Study|Protocol deviation|0|||
48710380|NCT03037580|156788857|FG000|Overall Study|Withdrawal by Subject|3|||
48710381|NCT03037580|156788858|FG001|Overall Study|Withdrawal by Subject|0|||
48710382|NCT03037580|156788857|FG000|Overall Study|Adverse Event|1|||
48710383|NCT03037580|156788858|FG001|Overall Study|Adverse Event|0|||
48710384|NCT03037580|156788857|FG000|Overall Study|Study Terminated by Sponsor|12|||
48710385|NCT03037580|156788858|FG001|Overall Study|Study Terminated by Sponsor|15|||
48710386|NCT03037580|156788857|FG000|Overall Study|Death|0|||
48710387|NCT03037580|156788858|FG001|Overall Study|Death|1|||
48710388|NCT02442804|156788859|FG000|Overall Study|Withdrawal by Subject|0|||
48710389|NCT02442804|156788860|FG001|Overall Study|Withdrawal by Subject|1|||
48710390|NCT02442804|156788859|FG000|Overall Study|Adverse Event|1|||
48710391|NCT02442804|156788860|FG001|Overall Study|Adverse Event|0|||
48710392|NCT02036853|156788861|FG000|Overall Study|Adverse Event|0|||
48710393|NCT02036853|156788862|FG001|Overall Study|Adverse Event|2|||
48710394|NCT02036853|156788861|FG000|Overall Study|Lack of Efficacy|0|||
48710395|NCT02036853|156788862|FG001|Overall Study|Lack of Efficacy|2|||
48710396|NCT02036853|156788861|FG000|Overall Study|Physician Decision|0|||
48710397|NCT02036853|156788862|FG001|Overall Study|Physician Decision|1|||
48710398|NCT02036853|156788861|FG000|Overall Study|Withdrawal by Subject|0|||
48710399|NCT02036853|156788862|FG001|Overall Study|Withdrawal by Subject|1|||
48710400|NCT02039843|156788865|FG000|Randomization and Observation Period|Adverse Event|2|||
48710401|NCT02039843|156788866|FG001|Randomization and Observation Period|Adverse Event|0|||
48710402|NCT02039843|156788865|FG000|Randomization and Observation Period|Death|1|||
48710403|NCT02039843|156788866|FG001|Randomization and Observation Period|Death|0|||
48710404|NCT02039843|156788865|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
48710405|NCT02039843|156788866|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
48710406|NCT02039843|156788865|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
48710407|NCT02039843|156788866|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
48710408|NCT02039843|156788865|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
48710409|NCT02039843|156788866|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
48710410|NCT02039843|156788865|FG000|Pairing With a Study Dog|Death|1|||
48710411|NCT02039843|156788866|FG001|Pairing With a Study Dog|Death|0|||
48710412|NCT02039843|156788865|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
48710413|NCT02039843|156788866|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
48710414|NCT02039843|156788865|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
48710415|NCT02039843|156788866|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
48710416|NCT02039843|156788865|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
48710417|NCT02039843|156788866|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
48710418|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
48710419|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
48710420|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
48710421|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
48596919|NCT02600923|156379393|FG000|Overall Study|Insufficient clinical response|6|||
48596920|NCT02600923|156379393|FG000|Overall Study|Lost to Follow-up|1|||
48807557|NCT02118337|157136627|FG004|Overall Study|Lost to Follow-up|0|||
48807558|NCT02118337|157136628|FG005|Overall Study|Lost to Follow-up|0|||
48807559|NCT02118337|157136629|FG006|Overall Study|Lost to Follow-up|0|||
48807560|NCT02118337|157136630|FG007|Overall Study|Lost to Follow-up|1|||
48807561|NCT02118337|157136631|FG008|Overall Study|Lost to Follow-up|0|||
48807562|NCT02118337|157136623|FG000|Overall Study|Withdrawal by Subject|1|||
48807563|NCT02118337|157136624|FG001|Overall Study|Withdrawal by Subject|3|||
48807564|NCT02118337|157136625|FG002|Overall Study|Withdrawal by Subject|2|||
48807565|NCT02118337|157136626|FG003|Overall Study|Withdrawal by Subject|1|||
48491511|NCT03377556|155992624|FG000|Overall Study|Adverse Event|5|||
48807566|NCT02118337|157136627|FG004|Overall Study|Withdrawal by Subject|2|||
48807567|NCT02118337|157136628|FG005|Overall Study|Withdrawal by Subject|2|||
48807568|NCT02118337|157136629|FG006|Overall Study|Withdrawal by Subject|1|||
48807569|NCT02118337|157136630|FG007|Overall Study|Withdrawal by Subject|4|||
48807570|NCT02118337|157136631|FG008|Overall Study|Withdrawal by Subject|2|||
48807571|NCT02118337|157136623|FG000|Overall Study|Death|2|||
48807572|NCT02118337|157136624|FG001|Overall Study|Death|2|||
48807573|NCT02118337|157136625|FG002|Overall Study|Death|1|||
48807574|NCT02118337|157136626|FG003|Overall Study|Death|2|||
48807575|NCT02118337|157136627|FG004|Overall Study|Death|5|||
48807576|NCT02118337|157136628|FG005|Overall Study|Death|1|||
48807577|NCT02118337|157136629|FG006|Overall Study|Death|2|||
48807578|NCT02118337|157136630|FG007|Overall Study|Death|9|||
48807579|NCT02118337|157136631|FG008|Overall Study|Death|4|||
48807580|NCT03107377|157136632|FG000|Overall Study|Adverse Event|3|||
48807581|NCT03107377|157136633|FG001|Overall Study|Adverse Event|3|||
48807582|NCT03107377|157136632|FG000|Overall Study|Protocol Violation|9|||
48807583|NCT03107377|157136633|FG001|Overall Study|Protocol Violation|12|||
48807584|NCT03107377|157136632|FG000|Overall Study|Physician Decision|3|||
48807585|NCT03107377|157136633|FG001|Overall Study|Physician Decision|6|||
48807586|NCT03107377|157136632|FG000|Overall Study|Pregnancy|7|||
48491512|NCT03377556|155992624|FG000|Overall Study|Refusal unrelated to adverse events|1|||
48491513|NCT03377556|155992624|FG000|Overall Study|Progression/relapse|38|||
48491514|NCT03377556|155992624|FG000|Overall Study|Death|3|||
48491515|NCT05216978|155992626|FG000|Overall Study|Withdrawal by Subject|3|||
48807587|NCT03107377|157136633|FG001|Overall Study|Pregnancy|7|||
48807588|NCT03107377|157136632|FG000|Overall Study|Withdrawal by Subject|16|||
48807589|NCT03107377|157136633|FG001|Overall Study|Withdrawal by Subject|22|||
48491516|NCT05216978|155992626|FG000|Overall Study|Lost to Follow-up|5|||
48491517|NCT02180061|155992627|FG000|Overall Study|Adverse Event|4|||
48807590|NCT03107377|157136632|FG000|Overall Study|Lost to Follow-up|37|||
48807591|NCT03107377|157136633|FG001|Overall Study|Lost to Follow-up|34|||
48807592|NCT03107377|157136632|FG000|Overall Study|Other reason not specified|16|||
48807593|NCT03107377|157136633|FG001|Overall Study|Other reason not specified|15|||
48807594|NCT01515189|157136634|FG000|Induction|Disease Progression|109|||
48491518|NCT02180061|155992628|FG001|Overall Study|Adverse Event|2|||
48491519|NCT02180061|155992627|FG000|Overall Study|Clinical Progression|5|||
48491520|NCT02180061|155992628|FG001|Overall Study|Clinical Progression|1|||
48807595|NCT01515189|157136635|FG001|Induction|Disease Progression|155|||
48807596|NCT01515189|157136634|FG000|Induction|Study drug toxicity|86|||
48710422|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Death|3|||
48710423|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Death|0|||
48710424|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Death|0|||
48710425|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Death|0|||
48710426|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
48710427|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
48710428|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
48710429|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
48807597|NCT01515189|157136635|FG001|Induction|Study drug toxicity|36|||
48491521|NCT02180061|155992627|FG000|Overall Study|Progressive Disease|15|||
48491522|NCT02180061|155992628|FG001|Overall Study|Progressive Disease|5|||
48710430|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
48710431|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
48807598|NCT01515189|157136634|FG000|Induction|Death|24|||
48807599|NCT01515189|157136635|FG001|Induction|Death|17|||
48807600|NCT01515189|157136634|FG000|Induction|Adverse Event|14|||
48807601|NCT01515189|157136635|FG001|Induction|Adverse Event|9|||
48491523|NCT02180061|155992627|FG000|Overall Study|Physician Decision|1|||
48491524|NCT02180061|155992628|FG001|Overall Study|Physician Decision|0|||
48491525|NCT01808209|155992632|FG000|Overall Study|Lost to Follow-up|0|||
48491526|NCT01808209|155992633|FG001|Overall Study|Lost to Follow-up|1|||
48491527|NCT00472446|155992634|FG000|Overall Study|Protocol Violation|0|||
48491528|NCT00472446|155992635|FG001|Overall Study|Protocol Violation|0|||
48491529|NCT00472446|155992636|FG002|Overall Study|Protocol Violation|0|||
48491530|NCT00472446|155992637|FG003|Overall Study|Protocol Violation|1|||
48491531|NCT00472446|155992634|FG000|Overall Study|Reintervention|0|||
48491532|NCT00472446|155992635|FG001|Overall Study|Reintervention|0|||
48491533|NCT00472446|155992636|FG002|Overall Study|Reintervention|1|||
48491534|NCT00472446|155992637|FG003|Overall Study|Reintervention|1|||
48491535|NCT00472446|155992634|FG000|Overall Study|Questionnaires not returned|5|||
48491536|NCT00472446|155992635|FG001|Overall Study|Questionnaires not returned|6|||
48491537|NCT00472446|155992636|FG002|Overall Study|Questionnaires not returned|6|||
48807602|NCT01515189|157136634|FG000|Induction|Withdrawal by Subject|3|||
48491538|NCT00472446|155992637|FG003|Overall Study|Questionnaires not returned|4|||
48491539|NCT00910858|155992638|FG000|Pharmacokinetic Phase|Adverse Event|1|||
48491540|NCT00910858|155992639|FG001|Pharmacokinetic Phase|Adverse Event|0|||
48491541|NCT00910858|155992640|FG002|Pharmacokinetic Phase|Adverse Event|0|||
48491542|NCT00910858|155992638|FG000|Monotherapy Phase|Adverse Event|3|||
48491543|NCT00910858|155992639|FG001|Monotherapy Phase|Adverse Event|2|||
48491544|NCT00910858|155992640|FG002|Monotherapy Phase|Adverse Event|0|||
48491545|NCT00910858|155992638|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
48491546|NCT00910858|155992639|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
48710432|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
48710433|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
48710434|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
48710435|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
48807603|NCT01515189|157136635|FG001|Induction|Withdrawal by Subject|9|||
48807604|NCT01515189|157136634|FG000|Induction|No longer meets study criteria|0|||
48807605|NCT01515189|157136635|FG001|Induction|No longer meets study criteria|2|||
48807606|NCT01515189|157136634|FG000|Induction|Lost to Follow-up|1|||
48807607|NCT01515189|157136635|FG001|Induction|Lost to Follow-up|0|||
48807608|NCT01515189|157136634|FG000|Induction|Other|0|||
48807609|NCT01515189|157136635|FG001|Induction|Other|4|||
48807610|NCT01515189|157136634|FG000|First Re-Induction Phase|Disease progression|6|||
48807611|NCT01515189|157136635|FG001|First Re-Induction Phase|Disease progression|14|||
48807612|NCT01515189|157136634|FG000|First Re-Induction Phase|Study drug toxicity|5|||
48807613|NCT01515189|157136635|FG001|First Re-Induction Phase|Study drug toxicity|0|||
48807614|NCT01515189|157136634|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
48807615|NCT01515189|157136635|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
48807616|NCT01515189|157136634|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
48491547|NCT00910858|155992640|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
48491548|NCT00910858|155992638|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
48491549|NCT00910858|155992639|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
48491550|NCT00910858|155992640|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
48491551|NCT00910858|155992638|FG000|Monotherapy Phase|Protocol Violation|1|||
48491552|NCT00910858|155992639|FG001|Monotherapy Phase|Protocol Violation|0|||
48596921|NCT02600923|156379393|FG000|Overall Study|Withdrawal by Subject|5|||
48596922|NCT02600923|156379393|FG000|Overall Study|Objective progression or relapse|50|||
48596923|NCT02600923|156379393|FG000|Overall Study|Study terminated by Sponsor|53|||
48596924|NCT02600923|156379393|FG000|Overall Study|Not treated|1|||
48596925|NCT00181883|156379403|FG000|Overall Study|Lack of Efficacy|2|||
48596926|NCT00181883|156379403|FG000|Overall Study|Treatment Limiting AEs|3|||
48596927|NCT00181883|156379403|FG000|Overall Study|Withdrawal by Subject|4|||
48596928|NCT00181883|156379403|FG000|Overall Study|Lost to Follow-up|1|||
48807617|NCT01515189|157136635|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
48807618|NCT01515189|157136634|FG000|First Re-Induction Phase|Other|1|||
48807619|NCT01515189|157136635|FG001|First Re-Induction Phase|Other|0|||
48807620|NCT04064164|157136636|FG000|Overall Study|Withdrawal by Subject|8|||
48807621|NCT04064164|157136637|FG001|Overall Study|Withdrawal by Subject|8|||
48807622|NCT06190691|157136638|FG000|Overall Study|Adverse Event|2|||
48807623|NCT06190691|157136639|FG001|Overall Study|Adverse Event|0|||
48807624|NCT06190691|157136640|FG002|Overall Study|Adverse Event|0|||
48807625|NCT06190691|157136641|FG003|Overall Study|Adverse Event|0|||
48807626|NCT01320943|157136642|FG000|Overall Study|Lost to Follow-up|1|||
48807627|NCT01320943|157136643|FG001|Overall Study|Lost to Follow-up|0|||
48807628|NCT01320943|157136642|FG000|Overall Study|Physician Decision|0|||
48807629|NCT01320943|157136643|FG001|Overall Study|Physician Decision|1|||
48807630|NCT01320943|157136642|FG000|Overall Study|Randomized but not Treated|0|||
48807631|NCT01320943|157136643|FG001|Overall Study|Randomized but not Treated|1|||
48807632|NCT04000594|157136644|FG000|Overall Study|Withdrawal by Subject|1|||
48807633|NCT04000594|157136645|FG001|Overall Study|Withdrawal by Subject|0|||
48807634|NCT04000594|157136646|FG002|Overall Study|Withdrawal by Subject|0|||
48807635|NCT01407354|157136650|FG000|First Intervention|Withdrawal by Subject|0|||
48807636|NCT01407354|157136651|FG001|First Intervention|Withdrawal by Subject|2|||
48807637|NCT01407354|157136650|FG000|First Intervention|Adverse Event|1|||
48807638|NCT01407354|157136651|FG001|First Intervention|Adverse Event|0|||
48807639|NCT01407354|157136650|FG000|First Intervention|Physician Decision|1|||
48807640|NCT01407354|157136651|FG001|First Intervention|Physician Decision|0|||
48807641|NCT02204579|157136652|FG000|Overall Study|Screen failures|2|||
48807642|NCT04615182|157136655|FG000|Overall Study|Re-transplanted|2|||
48807643|NCT04615182|157136655|FG000|Overall Study|Protocol Violation|6|||
48807644|NCT04615182|157136655|FG000|Overall Study|Death|6|||
48807645|NCT04615182|157136655|FG000|Overall Study|Death and protocol violation|1|||
48807646|NCT01370005|157136656|FG000|Overall Study|Not treated|1|||
48807647|NCT01370005|157136657|FG001|Overall Study|Not treated|0|||
48807648|NCT01370005|157136658|FG002|Overall Study|Not treated|0|||
48807649|NCT01370005|157136656|FG000|Overall Study|Adverse Event|5|||
48807650|NCT01370005|157136657|FG001|Overall Study|Adverse Event|5|||
48807651|NCT01370005|157136658|FG002|Overall Study|Adverse Event|6|||
48807652|NCT01370005|157136656|FG000|Overall Study|Lack of Efficacy|1|||
48807653|NCT01370005|157136657|FG001|Overall Study|Lack of Efficacy|0|||
48807654|NCT01370005|157136658|FG002|Overall Study|Lack of Efficacy|0|||
48807655|NCT01370005|157136656|FG000|Overall Study|Non compliant with protocol|0|||
48596929|NCT02895295|156379404|FG000|Overall Study|Survey Non-response|71|||
48807656|NCT01370005|157136657|FG001|Overall Study|Non compliant with protocol|1|||
48807657|NCT01370005|157136658|FG002|Overall Study|Non compliant with protocol|2|||
48710436|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
48710437|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
48491553|NCT00910858|155992640|FG002|Monotherapy Phase|Protocol Violation|0|||
48710438|NCT00884741|156788867|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
48710439|NCT00884741|156788868|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
48710440|NCT00884741|156788869|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
48710441|NCT00884741|156788870|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
48710442|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
48710443|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
48710444|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
48710445|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
48710446|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
48491554|NCT00910858|155992638|FG000|Monotherapy Phase|Other|3|||
48710447|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
48710448|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
48491555|NCT00910858|155992639|FG001|Monotherapy Phase|Other|4|||
48710449|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
48491556|NCT00910858|155992640|FG002|Monotherapy Phase|Other|2|||
48491557|NCT00910858|155992638|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
48710450|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
48710451|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
48710452|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
48710453|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
48710454|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
48710455|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
48710456|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
48710457|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
48710458|NCT00884741|156788867|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
48491558|NCT00910858|155992639|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
48491559|NCT00910858|155992640|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
48491560|NCT00910858|155992638|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
48491561|NCT00910858|155992639|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
48491562|NCT00910858|155992640|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
48491563|NCT00910858|155992638|FG000|Combined Treatment Phase|Protocol Violation|1|||
48491564|NCT00910858|155992639|FG001|Combined Treatment Phase|Protocol Violation|0|||
48491565|NCT00910858|155992640|FG002|Combined Treatment Phase|Protocol Violation|0|||
48491566|NCT00910858|155992638|FG000|Combined Treatment Phase|Other|0|||
48491567|NCT00910858|155992639|FG001|Combined Treatment Phase|Other|2|||
48491568|NCT00910858|155992640|FG002|Combined Treatment Phase|Other|1|||
48491569|NCT01333033|155992647|FG000|Overall Study|Ineligible|0|||
48491570|NCT01333033|155992648|FG001|Overall Study|Ineligible|0|||
48491571|NCT01333033|155992649|FG002|Overall Study|Ineligible|0|||
48491572|NCT01333033|155992650|FG003|Overall Study|Ineligible|0|||
48491573|NCT01333033|155992651|FG004|Overall Study|Ineligible|6|||
48491574|NCT01333033|155992652|FG005|Overall Study|Ineligible|8|||
48491575|NCT01333033|155992647|FG000|Overall Study|Withdrawal by Subject|0|||
48491576|NCT01333033|155992648|FG001|Overall Study|Withdrawal by Subject|0|||
48491577|NCT01333033|155992649|FG002|Overall Study|Withdrawal by Subject|0|||
48491578|NCT01333033|155992650|FG003|Overall Study|Withdrawal by Subject|0|||
48491579|NCT01333033|155992651|FG004|Overall Study|Withdrawal by Subject|4|||
48491580|NCT01333033|155992652|FG005|Overall Study|Withdrawal by Subject|2|||
48491581|NCT01333033|155992647|FG000|Overall Study|PET inevaluable|0|||
48491582|NCT01333033|155992648|FG001|Overall Study|PET inevaluable|0|||
48491583|NCT01333033|155992649|FG002|Overall Study|PET inevaluable|0|||
48491584|NCT01333033|155992650|FG003|Overall Study|PET inevaluable|0|||
48491585|NCT01333033|155992651|FG004|Overall Study|PET inevaluable|2|||
48491586|NCT01333033|155992652|FG005|Overall Study|PET inevaluable|4|||
48491587|NCT01333033|155992647|FG000|Overall Study|Adverse Event|0|||
48491588|NCT01333033|155992648|FG001|Overall Study|Adverse Event|0|||
48491589|NCT01333033|155992649|FG002|Overall Study|Adverse Event|0|||
48491590|NCT01333033|155992650|FG003|Overall Study|Adverse Event|0|||
48491591|NCT01333033|155992651|FG004|Overall Study|Adverse Event|2|||
48491592|NCT01333033|155992652|FG005|Overall Study|Adverse Event|1|||
48491593|NCT01333033|155992647|FG000|Overall Study|Progression|0|||
48491594|NCT01333033|155992648|FG001|Overall Study|Progression|0|||
48491595|NCT01333033|155992649|FG002|Overall Study|Progression|0|||
48491596|NCT01333033|155992650|FG003|Overall Study|Progression|0|||
48491597|NCT01333033|155992651|FG004|Overall Study|Progression|0|||
48491598|NCT01333033|155992652|FG005|Overall Study|Progression|1|||
48710459|NCT00884741|156788868|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
48710460|NCT00884741|156788869|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
48710461|NCT00884741|156788870|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
48710462|NCT00884741|156788867|FG000|Randomization|Protocol Violation|0|||
48710463|NCT00884741|156788868|FG001|Randomization|Protocol Violation|0|||
48710464|NCT00884741|156788869|FG002|Randomization|Protocol Violation|8|||
48710465|NCT00884741|156788870|FG003|Randomization|Protocol Violation|8|||
48710466|NCT00530816|156788872|FG000|Overall Study|Progressive Disease|16|||
48710467|NCT00530816|156788873|FG001|Overall Study|Progressive Disease|24|||
48710468|NCT00530816|156788874|FG002|Overall Study|Progressive Disease|24|||
48710469|NCT00530816|156788872|FG000|Overall Study|Adverse Event|6|||
48710470|NCT00530816|156788873|FG001|Overall Study|Adverse Event|13|||
48710471|NCT00530816|156788874|FG002|Overall Study|Adverse Event|7|||
48710472|NCT00530816|156788872|FG000|Overall Study|Other|3|||
48710473|NCT00530816|156788873|FG001|Overall Study|Other|3|||
48710474|NCT00530816|156788874|FG002|Overall Study|Other|4|||
48710475|NCT00530816|156788872|FG000|Overall Study|Withdrawal by Subject|1|||
48710476|NCT00530816|156788873|FG001|Overall Study|Withdrawal by Subject|2|||
48710477|NCT00530816|156788874|FG002|Overall Study|Withdrawal by Subject|6|||
48710478|NCT02116205|156788875|FG000|Overall Study|Withdrawal by Subject|2|||
48710479|NCT02116205|156788876|FG001|Overall Study|Withdrawal by Subject|4|||
48710480|NCT02116205|156788877|FG002|Overall Study|Withdrawal by Subject|1|||
48710481|NCT02116205|156788878|FG003|Overall Study|Withdrawal by Subject|3|||
48710482|NCT02116205|156788875|FG000|Overall Study|Lost to Follow-up|0|||
48710483|NCT02116205|156788876|FG001|Overall Study|Lost to Follow-up|2|||
48710484|NCT02116205|156788877|FG002|Overall Study|Lost to Follow-up|1|||
48710485|NCT02116205|156788878|FG003|Overall Study|Lost to Follow-up|2|||
48710486|NCT02116205|156788875|FG000|Overall Study|Physician Decision|0|||
48710487|NCT02116205|156788876|FG001|Overall Study|Physician Decision|1|||
48710488|NCT02116205|156788877|FG002|Overall Study|Physician Decision|1|||
48710489|NCT02116205|156788878|FG003|Overall Study|Physician Decision|1|||
48710490|NCT02116205|156788875|FG000|Overall Study|Exclusion criteria|0|||
48710491|NCT02116205|156788876|FG001|Overall Study|Exclusion criteria|0|||
48710492|NCT02116205|156788877|FG002|Overall Study|Exclusion criteria|1|||
48710493|NCT02116205|156788878|FG003|Overall Study|Exclusion criteria|0|||
48710494|NCT02954172|156788879|FG000|Overall Study|Protocol Violation|3|||
48710495|NCT02954172|156788880|FG001|Overall Study|Protocol Violation|0|||
48710496|NCT02954172|156788879|FG000|Overall Study|allergic reaction|2|||
48710497|NCT02954172|156788880|FG001|Overall Study|allergic reaction|1|||
48710498|NCT02954172|156788879|FG000|Overall Study|non-measurable lesions at baseline|1|||
48710499|NCT02954172|156788880|FG001|Overall Study|non-measurable lesions at baseline|2|||
48710500|NCT00853567|156788883|FG000|Overall Study|Study prematurely terminated|71|||
48710501|NCT02055118|156788884|FG000|Overall Study|Withdrawal by Subject|0|||
48710502|NCT02055118|156788885|FG001|Overall Study|Withdrawal by Subject|2|||
48710503|NCT02055118|156788886|FG002|Overall Study|Withdrawal by Subject|0|||
48710504|NCT02281383|156788895|FG000|Overall Study|Progressive Disease|1|||
48710505|NCT02281383|156788895|FG000|Overall Study|Withdrawal by Subject|6|||
48710506|NCT02281383|156788895|FG000|Overall Study|Protocol Violation|2|||
48710507|NCT02281383|156788895|FG000|Overall Study|Death|1|||
48710508|NCT02281383|156788895|FG000|Overall Study|Adverse Event|2|||
48710509|NCT01215097|156788896|FG000|Overall Study|Adverse Event|1|||
48710510|NCT01215097|156788897|FG001|Overall Study|Adverse Event|3|||
48710511|NCT01215097|156788896|FG000|Overall Study|Protocol Violation|0|||
48710512|NCT01215097|156788897|FG001|Overall Study|Protocol Violation|2|||
48710513|NCT01215097|156788896|FG000|Overall Study|Lost to Follow-up|2|||
48710514|NCT01215097|156788897|FG001|Overall Study|Lost to Follow-up|0|||
48710515|NCT01215097|156788896|FG000|Overall Study|Withdrawal by Subject|6|||
48710516|NCT01215097|156788897|FG001|Overall Study|Withdrawal by Subject|3|||
48710517|NCT01215097|156788896|FG000|Overall Study|Lack of Efficacy|0|||
48710518|NCT01215097|156788897|FG001|Overall Study|Lack of Efficacy|3|||
48807658|NCT01370005|157136656|FG000|Overall Study|Lost to Follow-up|1|||
48807659|NCT01370005|157136657|FG001|Overall Study|Lost to Follow-up|1|||
48710519|NCT01215097|156788896|FG000|Overall Study|patient's refusal to come|2|||
48710520|NCT01215097|156788897|FG001|Overall Study|patient's refusal to come|2|||
48710521|NCT01215097|156788896|FG000|Overall Study|patient's private reason|1|||
48710522|NCT01215097|156788897|FG001|Overall Study|patient's private reason|1|||
48710523|NCT01711216|156788898|FG000|Overall Study|Adverse Event|4|||
48710524|NCT01711216|156788898|FG000|Overall Study|Pregnancy|56|||
48710525|NCT01711216|156788898|FG000|Overall Study|Withdrawal by Subject|6|||
48710526|NCT01711216|156788898|FG000|Overall Study|Lost to Follow-up|46|||
48710527|NCT01711216|156788898|FG000|Overall Study|variety of other minor reasons|83|||
48710528|NCT01711216|156788898|FG000|Overall Study|no reason specified|22|||
48710529|NCT02541604|156788899|FG000|Overall Study|Death|6|||
48710530|NCT02541604|156788900|FG001|Overall Study|Death|5|||
48710531|NCT02541604|156788901|FG002|Overall Study|Death|7|||
48710532|NCT02541604|156788902|FG003|Overall Study|Death|2|||
48710533|NCT02541604|156788903|FG004|Overall Study|Death|9|||
48710534|NCT02541604|156788904|FG005|Overall Study|Death|8|||
48807660|NCT01370005|157136658|FG002|Overall Study|Lost to Follow-up|1|||
48710535|NCT02541604|156788905|FG006|Overall Study|Death|9|||
48710536|NCT02541604|156788906|FG007|Overall Study|Death|9|||
48710537|NCT02541604|156788907|FG008|Overall Study|Death|3|||
48710538|NCT02541604|156788908|FG009|Overall Study|Death|4|||
48710539|NCT02541604|156788909|FG010|Overall Study|Death|2|||
48710540|NCT02541604|156788910|FG011|Overall Study|Death|3|||
48710541|NCT02541604|156788899|FG000|Overall Study|Lost to Follow-up|2|||
48710542|NCT02541604|156788900|FG001|Overall Study|Lost to Follow-up|0|||
48710543|NCT02541604|156788901|FG002|Overall Study|Lost to Follow-up|1|||
48710544|NCT02541604|156788902|FG003|Overall Study|Lost to Follow-up|0|||
48710545|NCT02541604|156788903|FG004|Overall Study|Lost to Follow-up|0|||
48710546|NCT02541604|156788904|FG005|Overall Study|Lost to Follow-up|1|||
48710547|NCT02541604|156788905|FG006|Overall Study|Lost to Follow-up|1|||
48710548|NCT02541604|156788906|FG007|Overall Study|Lost to Follow-up|0|||
48710549|NCT02541604|156788907|FG008|Overall Study|Lost to Follow-up|0|||
48710550|NCT02541604|156788908|FG009|Overall Study|Lost to Follow-up|0|||
48710551|NCT02541604|156788909|FG010|Overall Study|Lost to Follow-up|0|||
48710552|NCT02541604|156788910|FG011|Overall Study|Lost to Follow-up|0|||
48710553|NCT02541604|156788899|FG000|Overall Study|Withdrawal by Subject|2|||
48710554|NCT02541604|156788900|FG001|Overall Study|Withdrawal by Subject|0|||
48710555|NCT02541604|156788901|FG002|Overall Study|Withdrawal by Subject|1|||
48807661|NCT01370005|157136656|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
48807662|NCT01370005|157136657|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
48807663|NCT01370005|157136658|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
48807664|NCT01370005|157136656|FG000|Overall Study|Other reason not defined above|3|||
48596930|NCT02895295|156379405|FG001|Overall Study|Survey Non-response|94|||
48807665|NCT01370005|157136657|FG001|Overall Study|Other reason not defined above|0|||
48807666|NCT01370005|157136658|FG002|Overall Study|Other reason not defined above|2|||
48807667|NCT04631705|157136659|FG000|Overall Study|Withdrawal by Subject|0|||
48807668|NCT04631705|157136660|FG001|Overall Study|Withdrawal by Subject|0|||
48807669|NCT04631705|157136661|FG002|Overall Study|Withdrawal by Subject|0|||
48807670|NCT04631705|157136662|FG003|Overall Study|Withdrawal by Subject|0|||
48807671|NCT04631705|157136663|FG004|Overall Study|Withdrawal by Subject|0|||
48807672|NCT04631705|157136664|FG005|Overall Study|Withdrawal by Subject|0|||
48807673|NCT04631705|157136665|FG006|Overall Study|Withdrawal by Subject|1|||
48807674|NCT04631705|157136666|FG007|Overall Study|Withdrawal by Subject|0|||
48807675|NCT04631705|157136667|FG008|Overall Study|Withdrawal by Subject|0|||
48807676|NCT01686581|157136670|FG000|Overall Study|Side-effects or Health Problems|15|||
48596931|NCT02895295|156379406|FG002|Overall Study|Survey Non-response|92|||
48596932|NCT05176717|156379408|FG000|Overall Study|Sponsor Decision|1|||
48596933|NCT05176717|156379409|FG001|Overall Study|Sponsor Decision|2|||
48596934|NCT05176717|156379410|FG002|Overall Study|Sponsor Decision|2|||
48596935|NCT02143024|156379411|FG000|Overall Study|Lost to Follow-up|1|||
48596936|NCT02143024|156379412|FG001|Overall Study|Lost to Follow-up|1|||
48596937|NCT02143024|156379411|FG000|Overall Study|Withdrawal by Subject|1|||
48596938|NCT02143024|156379412|FG001|Overall Study|Withdrawal by Subject|0|||
48596939|NCT04888494|156379419|FG000|Overall Study|Lost to Follow-up|2|||
48596940|NCT04888494|156379420|FG001|Overall Study|Lost to Follow-up|3|||
48596941|NCT04888494|156379419|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
48596942|NCT04888494|156379420|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
48596943|NCT03677869|156379421|FG000|Overall Study|Withdrawal by Subject|1|||
48596944|NCT03630705|156381820|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
48596945|NCT03630705|156381821|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
48596946|NCT03630705|156381822|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48596947|NCT03630705|156381823|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48596948|NCT03630705|156381820|FG000|Overall Study|Lost to Follow-up|1|||
48596949|NCT03630705|156381821|FG001|Overall Study|Lost to Follow-up|2|||
48596950|NCT03630705|156381822|FG002|Overall Study|Lost to Follow-up|0|||
48710556|NCT02541604|156788902|FG003|Overall Study|Withdrawal by Subject|0|||
48710557|NCT02541604|156788903|FG004|Overall Study|Withdrawal by Subject|1|||
48807677|NCT01686581|157136670|FG000|Overall Study|Lack of Efficacy|90|||
48807678|NCT01686581|157136670|FG000|Overall Study|Participant Concerned about Risks|6|||
48807679|NCT01686581|157136670|FG000|Overall Study|Thinks Injections Too Painful|8|||
48596951|NCT03630705|156381823|FG003|Overall Study|Lost to Follow-up|0|||
48596952|NCT02576977|156381824|FG000|Overall Study|Adverse Event|13|||
48710558|NCT02541604|156788904|FG005|Overall Study|Withdrawal by Subject|1|||
48710559|NCT02541604|156788905|FG006|Overall Study|Withdrawal by Subject|0|||
48710560|NCT02541604|156788906|FG007|Overall Study|Withdrawal by Subject|0|||
48710561|NCT02541604|156788907|FG008|Overall Study|Withdrawal by Subject|1|||
48807680|NCT01686581|157136670|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
48807681|NCT01686581|157136670|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
48596953|NCT02576977|156381825|FG001|Overall Study|Adverse Event|2|||
48596954|NCT02576977|156381824|FG000|Overall Study|Death|73|||
48596955|NCT02576977|156381825|FG001|Overall Study|Death|60|||
48710562|NCT02541604|156788908|FG009|Overall Study|Withdrawal by Subject|0|||
48710563|NCT02541604|156788909|FG010|Overall Study|Withdrawal by Subject|0|||
48710564|NCT02541604|156788910|FG011|Overall Study|Withdrawal by Subject|0|||
48710565|NCT02541604|156788899|FG000|Overall Study|Study Terminated by Sponsor|1|||
48710566|NCT02541604|156788900|FG001|Overall Study|Study Terminated by Sponsor|4|||
48710567|NCT02541604|156788901|FG002|Overall Study|Study Terminated by Sponsor|2|||
48710568|NCT02541604|156788902|FG003|Overall Study|Study Terminated by Sponsor|1|||
48710569|NCT02541604|156788903|FG004|Overall Study|Study Terminated by Sponsor|0|||
48710570|NCT02541604|156788904|FG005|Overall Study|Study Terminated by Sponsor|0|||
48710571|NCT02541604|156788905|FG006|Overall Study|Study Terminated by Sponsor|0|||
48710572|NCT02541604|156788906|FG007|Overall Study|Study Terminated by Sponsor|0|||
48807682|NCT01686581|157136670|FG000|Overall Study|Thinks it is Inconvenient|17|||
48710573|NCT02541604|156788907|FG008|Overall Study|Study Terminated by Sponsor|0|||
48710574|NCT02541604|156788908|FG009|Overall Study|Study Terminated by Sponsor|0|||
48807683|NCT01686581|157136670|FG000|Overall Study|Other Miscellaneous Reasons|36|||
48807684|NCT01686581|157136670|FG000|Overall Study|Reason Missing|1|||
48807685|NCT04534114|157136671|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
48807686|NCT04534114|157136672|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
48807687|NCT04534114|157136673|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
48807688|NCT04534114|157136674|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
48807689|NCT04534114|157136671|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
48807690|NCT04534114|157136672|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
48807691|NCT04534114|157136673|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
48710575|NCT02541604|156788909|FG010|Overall Study|Study Terminated by Sponsor|0|||
48710576|NCT02541604|156788910|FG011|Overall Study|Study Terminated by Sponsor|0|||
48710577|NCT02541604|156788899|FG000|Overall Study|Medical condition may jeopardize safety|0|||
48710578|NCT02541604|156788900|FG001|Overall Study|Medical condition may jeopardize safety|0|||
48710579|NCT02541604|156788901|FG002|Overall Study|Medical condition may jeopardize safety|0|||
48710580|NCT02541604|156788902|FG003|Overall Study|Medical condition may jeopardize safety|0|||
48710581|NCT02541604|156788903|FG004|Overall Study|Medical condition may jeopardize safety|0|||
48710582|NCT02541604|156788904|FG005|Overall Study|Medical condition may jeopardize safety|0|||
48710583|NCT02541604|156788905|FG006|Overall Study|Medical condition may jeopardize safety|0|||
48710584|NCT02541604|156788906|FG007|Overall Study|Medical condition may jeopardize safety|1|||
48710585|NCT02541604|156788907|FG008|Overall Study|Medical condition may jeopardize safety|0|||
48710586|NCT02541604|156788908|FG009|Overall Study|Medical condition may jeopardize safety|0|||
48710587|NCT02541604|156788909|FG010|Overall Study|Medical condition may jeopardize safety|0|||
48710588|NCT02541604|156788910|FG011|Overall Study|Medical condition may jeopardize safety|0|||
48710589|NCT01033448|156788911|FG000|Overall Study|Withdrawal by Subject|4|||
48710590|NCT01033448|156788911|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
48710591|NCT01033448|156788911|FG000|Overall Study|Lost to Follow-up|3|||
48710592|NCT01033448|156788911|FG000|Overall Study|Withdrew due to other reasons|3|||
48710593|NCT01033448|156788911|FG000|Overall Study|Unknown disposition|1|||
48710594|NCT00554216|156791308|FG000|Overall Study|Lost to Follow-up|92|||
48710595|NCT00554216|156791309|FG001|Overall Study|Lost to Follow-up|31|||
48710596|NCT00554216|156791310|FG002|Overall Study|Lost to Follow-up|63|||
48710597|NCT00554216|156791308|FG000|Overall Study|Adverse Event|16|||
48710598|NCT00554216|156791309|FG001|Overall Study|Adverse Event|16|||
48710599|NCT00554216|156791310|FG002|Overall Study|Adverse Event|36|||
48710600|NCT00554216|156791308|FG000|Overall Study|Withdrawal by Subject|92|||
48710601|NCT00554216|156791309|FG001|Overall Study|Withdrawal by Subject|31|||
48710602|NCT00554216|156791310|FG002|Overall Study|Withdrawal by Subject|43|||
48710603|NCT00554216|156791308|FG000|Overall Study|Non compliance|10|||
48710604|NCT00554216|156791309|FG001|Overall Study|Non compliance|4|||
48710605|NCT00554216|156791310|FG002|Overall Study|Non compliance|5|||
48710606|NCT00554216|156791308|FG000|Overall Study|Pregnancy|2|||
48710607|NCT00554216|156791309|FG001|Overall Study|Pregnancy|1|||
48710608|NCT00554216|156791310|FG002|Overall Study|Pregnancy|14|||
48807692|NCT04534114|157136674|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
48807693|NCT04534114|157136671|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
48710609|NCT00554216|156791308|FG000|Overall Study|Restricted med|3|||
48710610|NCT00554216|156791309|FG001|Overall Study|Restricted med|1|||
48710611|NCT00554216|156791310|FG002|Overall Study|Restricted med|1|||
48710612|NCT00554216|156791308|FG000|Overall Study|Other|12|||
48710613|NCT00554216|156791309|FG001|Overall Study|Other|7|||
48807694|NCT04534114|157136672|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
48596956|NCT02576977|156381824|FG000|Overall Study|Screen failure|1|||
48596957|NCT02576977|156381825|FG001|Overall Study|Screen failure|0|||
48596958|NCT02576977|156381824|FG000|Overall Study|Study Terminated at Selected Sites|27|||
48596959|NCT02576977|156381825|FG001|Overall Study|Study Terminated at Selected Sites|50|||
48596960|NCT02576977|156381824|FG000|Overall Study|Withdrawal by Subject|11|||
48596961|NCT02576977|156381825|FG001|Overall Study|Withdrawal by Subject|11|||
48596962|NCT02576977|156381824|FG000|Overall Study|Final Disposition Unknown|0|||
48596963|NCT02576977|156381825|FG001|Overall Study|Final Disposition Unknown|1|||
48596964|NCT02576977|156381824|FG000|Overall Study|Lost to Follow-up|1|||
48596965|NCT02576977|156381825|FG001|Overall Study|Lost to Follow-up|0|||
48596966|NCT02576977|156381824|FG000|Overall Study|Progressive Disease|0|||
48596967|NCT02576977|156381825|FG001|Overall Study|Progressive Disease|1|||
48596968|NCT00762034|156381826|FG000|Induction Period|Protocol Violation|1|||
48596969|NCT00762034|156381827|FG001|Induction Period|Protocol Violation|2|||
48596970|NCT00762034|156381826|FG000|Induction Period|Entry Criterion Not Met|12|||
48596971|NCT00762034|156381827|FG001|Induction Period|Entry Criterion Not Met|11|||
48596972|NCT00762034|156381826|FG000|Induction Period|Adverse Event|27|||
48710614|NCT00554216|156791310|FG002|Overall Study|Other|10|||
48710615|NCT00554216|156791308|FG000|Overall Study|Lack of Efficacy|15|||
48710616|NCT00554216|156791309|FG001|Overall Study|Lack of Efficacy|3|||
48710617|NCT00554216|156791310|FG002|Overall Study|Lack of Efficacy|0|||
48710618|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
48596973|NCT00762034|156381827|FG001|Induction Period|Adverse Event|38|||
48596974|NCT00762034|156381826|FG000|Induction Period|Lost to Follow-up|1|||
48596975|NCT00762034|156381827|FG001|Induction Period|Lost to Follow-up|1|||
48596976|NCT00762034|156381826|FG000|Induction Period|Progressive Disease|73|||
48596977|NCT00762034|156381827|FG001|Induction Period|Progressive Disease|55|||
48596978|NCT00762034|156381826|FG000|Induction Period|Physician Decision|21|||
48596979|NCT00762034|156381827|FG001|Induction Period|Physician Decision|20|||
48596980|NCT00762034|156381826|FG000|Induction Period|Withdrawal by Subject|15|||
48596981|NCT00762034|156381827|FG001|Induction Period|Withdrawal by Subject|19|||
48596982|NCT00762034|156381826|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
48596983|NCT00762034|156381827|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
48596984|NCT00762034|156381826|FG000|Induction Period|Deaths Due to Study Disease|9|||
48596985|NCT00762034|156381827|FG001|Induction Period|Deaths Due to Study Disease|9|||
48596986|NCT00762034|156381826|FG000|Maintenance Period|Protocol Violation|1|||
48596987|NCT00762034|156381827|FG001|Maintenance Period|Protocol Violation|3|||
48596988|NCT00762034|156381826|FG000|Maintenance Period|Entry Criterion Not Met|0|||
48596989|NCT00762034|156381827|FG001|Maintenance Period|Entry Criterion Not Met|2|||
48596990|NCT00762034|156381826|FG000|Maintenance Period|Adverse Event|42|||
48596991|NCT00762034|156381827|FG001|Maintenance Period|Adverse Event|26|||
48596992|NCT00762034|156381826|FG000|Maintenance Period|Progressive Disease|186|||
48596993|NCT00762034|156381827|FG001|Maintenance Period|Progressive Disease|224|||
48596994|NCT00762034|156381826|FG000|Maintenance Period|Physician Decision|25|||
48596995|NCT00762034|156381827|FG001|Maintenance Period|Physician Decision|20|||
48596996|NCT00762034|156381826|FG000|Maintenance Period|Withdrawal by Subject|34|||
48596997|NCT00762034|156381827|FG001|Maintenance Period|Withdrawal by Subject|14|||
48596998|NCT00762034|156381826|FG000|Maintenance Period|Death not due to study disease|2|||
48596999|NCT00762034|156381827|FG001|Maintenance Period|Death not due to study disease|5|||
48597000|NCT00762034|156381826|FG000|Maintenance Period|Death due to study disease|3|||
48597001|NCT00762034|156381827|FG001|Maintenance Period|Death due to study disease|3|||
48597002|NCT00762034|156381826|FG000|Maintenance Period|Other|1|||
48597003|NCT00762034|156381827|FG001|Maintenance Period|Other|1|||
48597004|NCT03214679|156381828|FG000|Overall Study|Lost to Follow-up|12|||
48597005|NCT03214679|156381829|FG001|Overall Study|Lost to Follow-up|14|||
48710619|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
48710620|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Patient requirement|20|||
48710621|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Death|5|||
48710622|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Change of therapy|6|||
48710623|NCT01071798|156791321|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
48710624|NCT01071798|156791321|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
48710625|NCT01071798|156791321|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
48710626|NCT01071798|156791321|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
48710627|NCT01071798|156791321|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
48710628|NCT01330108|156791329|FG000|Overall Study|Withdrawal by Subject|4|||
48710629|NCT02446899|156791330|FG000|Overall Study|Adverse Event|4|||
48710630|NCT02446899|156791331|FG001|Overall Study|Adverse Event|7|||
48710631|NCT02446899|156791330|FG000|Overall Study|Condition Under Investigation Worsened|1|||
48597006|NCT03214679|156381828|FG000|Overall Study|not eligible|2|||
48597007|NCT03214679|156381829|FG001|Overall Study|not eligible|0|||
48597008|NCT04530838|156381831|FG000|Overall Study|Other|2|||
48597009|NCT04530838|156381832|FG001|Overall Study|Other|1|||
48597010|NCT04530838|156381833|FG002|Overall Study|Other|0|||
48710632|NCT02446899|156791331|FG001|Overall Study|Condition Under Investigation Worsened|4|||
48710633|NCT02446899|156791330|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
48597011|NCT04530838|156381831|FG000|Overall Study|Physician Decision|0|||
48597012|NCT04530838|156381832|FG001|Overall Study|Physician Decision|0|||
48597013|NCT04530838|156381833|FG002|Overall Study|Physician Decision|1|||
48597014|NCT04530838|156381831|FG000|Overall Study|Death|0|||
48597015|NCT04530838|156381832|FG001|Overall Study|Death|0|||
48597016|NCT04530838|156381833|FG002|Overall Study|Death|1|||
48710634|NCT02446899|156791331|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
48710635|NCT02446899|156791330|FG000|Overall Study|Lack of Efficacy|2|||
48710636|NCT02446899|156791331|FG001|Overall Study|Lack of Efficacy|8|||
48710637|NCT02446899|156791330|FG000|Overall Study|Lost to Follow-up|1|||
48710638|NCT02446899|156791331|FG001|Overall Study|Lost to Follow-up|3|||
48710639|NCT02446899|156791330|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
48710640|NCT02446899|156791331|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
48710641|NCT02446899|156791330|FG000|Overall Study|Withdrawal by Subject|11|||
48710642|NCT02446899|156791331|FG001|Overall Study|Withdrawal by Subject|19|||
48710643|NCT02446899|156791330|FG000|Overall Study|Miscellaneous|5|||
48710644|NCT02446899|156791331|FG001|Overall Study|Miscellaneous|4|||
48710645|NCT02446899|156791330|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
48710646|NCT02446899|156791331|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
48710647|NCT00373113|156791332|FG000|Overall Study|Death|1|||
48710648|NCT00373113|156791333|FG001|Overall Study|Death|7|||
48710649|NCT00373113|156791332|FG000|Overall Study|Adverse Event|38|||
48807695|NCT04534114|157136673|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
48807696|NCT04534114|157136674|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
48807697|NCT04534114|157136671|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
48807698|NCT04534114|157136672|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
48807699|NCT04534114|157136673|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
48807700|NCT04534114|157136674|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
48807701|NCT04534114|157136671|FG000|Main Treatment Period|Physician Decision|0|||
48807702|NCT04534114|157136672|FG001|Main Treatment Period|Physician Decision|0|||
48807703|NCT04534114|157136673|FG002|Main Treatment Period|Physician Decision|0|||
48807704|NCT04534114|157136674|FG003|Main Treatment Period|Physician Decision|1|||
48807705|NCT04534114|157136671|FG000|Main Treatment Period|Death|1|||
48807706|NCT04534114|157136672|FG001|Main Treatment Period|Death|0|||
48807707|NCT04534114|157136673|FG002|Main Treatment Period|Death|0|||
48807708|NCT04534114|157136674|FG003|Main Treatment Period|Death|1|||
48807709|NCT04534114|157136671|FG000|Main Treatment Period|Other reason|1|||
48807710|NCT04534114|157136672|FG001|Main Treatment Period|Other reason|1|||
48807711|NCT04534114|157136673|FG002|Main Treatment Period|Other reason|0|||
48807712|NCT04534114|157136674|FG003|Main Treatment Period|Other reason|0|||
48807713|NCT04534114|157136671|FG000|Main Treatment Period|Participant decision|1|||
48807714|NCT04534114|157136672|FG001|Main Treatment Period|Participant decision|3|||
48807715|NCT04534114|157136673|FG002|Main Treatment Period|Participant decision|3|||
48807716|NCT04534114|157136674|FG003|Main Treatment Period|Participant decision|1|||
48807717|NCT04534114|157136671|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
48807718|NCT04534114|157136672|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
48807719|NCT04534114|157136673|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
48807720|NCT04534114|157136674|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
48807721|NCT04534114|157136671|FG000|Main Treatment Period|Adverse Event|4|||
48807722|NCT04534114|157136672|FG001|Main Treatment Period|Adverse Event|2|||
48807723|NCT04534114|157136673|FG002|Main Treatment Period|Adverse Event|1|||
48807724|NCT04534114|157136674|FG003|Main Treatment Period|Adverse Event|2|||
48807725|NCT04534114|157136671|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
48807726|NCT04534114|157136672|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
48807727|NCT04534114|157136673|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
48807728|NCT04534114|157136674|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
48807729|NCT04534114|157136671|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
48807730|NCT04534114|157136672|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
48710650|NCT00373113|156791333|FG001|Overall Study|Adverse Event|24|||
48710651|NCT00373113|156791332|FG000|Overall Study|Study terminated by sponsor|9|||
48710652|NCT00373113|156791333|FG001|Overall Study|Study terminated by sponsor|1|||
48597017|NCT04530838|156381831|FG000|Overall Study|Adverse Event|0|||
48710653|NCT00373113|156791332|FG000|Overall Study|Global deterioration of health status|10|||
48710654|NCT00373113|156791333|FG001|Overall Study|Global deterioration of health status|7|||
48710655|NCT00373113|156791332|FG000|Overall Study|Lost to Follow-up|1|||
48710656|NCT00373113|156791333|FG001|Overall Study|Lost to Follow-up|3|||
48597018|NCT04530838|156381832|FG001|Overall Study|Adverse Event|1|||
48807731|NCT04534114|157136673|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
48807732|NCT04534114|157136674|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
48807733|NCT04534114|157136671|FG000|Extension Treatment Period|Other reason|0|||
48807734|NCT04534114|157136672|FG001|Extension Treatment Period|Other reason|1|||
48807735|NCT04534114|157136673|FG002|Extension Treatment Period|Other reason|0|||
48807736|NCT04534114|157136674|FG003|Extension Treatment Period|Other reason|0|||
48807737|NCT04534114|157136671|FG000|Extension Treatment Period|Death|0|||
48807738|NCT04534114|157136672|FG001|Extension Treatment Period|Death|0|||
48807739|NCT04534114|157136673|FG002|Extension Treatment Period|Death|1|||
48807740|NCT04534114|157136674|FG003|Extension Treatment Period|Death|2|||
48807741|NCT04534114|157136671|FG000|Extension Treatment Period|Adverse Event|0|||
48807742|NCT04534114|157136672|FG001|Extension Treatment Period|Adverse Event|1|||
48807743|NCT04534114|157136673|FG002|Extension Treatment Period|Adverse Event|0|||
48807744|NCT04534114|157136674|FG003|Extension Treatment Period|Adverse Event|1|||
48807745|NCT04534114|157136671|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
48807746|NCT04534114|157136672|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
48807747|NCT04534114|157136673|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
48807748|NCT04534114|157136674|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
48807749|NCT02301156|157136675|FG000|Overall Study|Adverse Event|13|||
48807750|NCT02301156|157136676|FG001|Overall Study|Adverse Event|14|||
48807751|NCT02301156|157136675|FG000|Overall Study|Death|1|||
48807752|NCT02301156|157136676|FG001|Overall Study|Death|5|||
48807753|NCT02301156|157136675|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
48807754|NCT02301156|157136676|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
48807755|NCT02301156|157136675|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
48807756|NCT02301156|157136676|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
48807757|NCT02301156|157136675|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
48807758|NCT02301156|157136676|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
48807759|NCT02301156|157136675|FG000|Overall Study|Reason not Specified|6|||
48807760|NCT02301156|157136676|FG001|Overall Study|Reason not Specified|3|||
48597019|NCT04530838|156381833|FG002|Overall Study|Adverse Event|0|||
48597020|NCT04530838|156381831|FG000|Overall Study|No longer meets eligibility criteria|1|||
48597021|NCT04530838|156381832|FG001|Overall Study|No longer meets eligibility criteria|0|||
48597022|NCT04530838|156381833|FG002|Overall Study|No longer meets eligibility criteria|2|||
48597023|NCT04530838|156381831|FG000|Overall Study|Withdrawal by parent/guardian|5|||
48597024|NCT04530838|156381832|FG001|Overall Study|Withdrawal by parent/guardian|2|||
48597025|NCT04530838|156381833|FG002|Overall Study|Withdrawal by parent/guardian|2|||
48597026|NCT01073163|156381835|FG000|Overall Study|Adverse Event|1|||
48597027|NCT01073163|156381835|FG000|Overall Study|Disease Progression|1|||
48597028|NCT01073163|156381835|FG000|Overall Study|Early termination|1|||
48597029|NCT01775787|156381836|FG000|First 7-10 Days|Adverse Event|0|||
48597030|NCT01775787|156381837|FG001|First 7-10 Days|Adverse Event|1|||
48597031|NCT01775787|156381836|FG000|First 7-10 Days|family emergency|0|||
48597032|NCT01775787|156381837|FG001|First 7-10 Days|family emergency|1|||
48597033|NCT01775787|156381836|FG000|First 7-10 Days|time commitment|0|||
48597034|NCT01775787|156381837|FG001|First 7-10 Days|time commitment|2|||
48597035|NCT01775787|156381836|FG000|First 7-10 Days|concerns with using IV|1|||
48597036|NCT01775787|156381837|FG001|First 7-10 Days|concerns with using IV|2|||
48597037|NCT01775787|156381836|FG000|Second 7-10 Days|time commitment|0|||
48597038|NCT01775787|156381837|FG001|Second 7-10 Days|time commitment|1|||
48597039|NCT01775787|156381836|FG000|Second 7-10 Days|concerns with using IV|0|||
48597040|NCT01775787|156381837|FG001|Second 7-10 Days|concerns with using IV|1|||
48597041|NCT03252145|156381839|FG000|Overall Study|Withdrawal by Subject|1|||
48597042|NCT03252145|156381840|FG001|Overall Study|Withdrawal by Subject|0|||
48597043|NCT03252145|156381839|FG000|Overall Study|Complicating Disease|1|||
48597044|NCT03252145|156381840|FG001|Overall Study|Complicating Disease|2|||
48597045|NCT02748057|156381841|FG000|Overall Study|Adverse Event|1|||
48597046|NCT02748057|156381842|FG001|Overall Study|Adverse Event|0|||
48597047|NCT02748057|156381841|FG000|Overall Study|Physician Decision|0|||
48597048|NCT02748057|156381842|FG001|Overall Study|Physician Decision|1|||
48597049|NCT02748057|156381841|FG000|Overall Study|Protocol Violation|2|||
48597050|NCT02748057|156381842|FG001|Overall Study|Protocol Violation|1|||
48597051|NCT02748057|156381841|FG000|Overall Study|Participant Moved|1|||
48807761|NCT00785707|157136677|FG000|Overall Study|Lost to Follow-up|7|||
48807762|NCT04035486|157136680|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
48807763|NCT04035486|157136681|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
48597052|NCT02748057|156381842|FG001|Overall Study|Participant Moved|0|||
48491599|NCT01333033|155992647|FG000|Overall Study|MD Decision|0|||
48597053|NCT02748057|156381841|FG000|Overall Study|Withdrawal by Subject|1|||
48597054|NCT02748057|156381842|FG001|Overall Study|Withdrawal by Subject|0|||
48597055|NCT00905632|156381843|FG000|Overall Study|Adverse Event|0|||
48491600|NCT01333033|155992648|FG001|Overall Study|MD Decision|0|||
48597056|NCT00905632|156381844|FG001|Overall Study|Adverse Event|0|||
48491601|NCT01333033|155992649|FG002|Overall Study|MD Decision|0|||
48491602|NCT01333033|155992650|FG003|Overall Study|MD Decision|0|||
48491603|NCT01333033|155992651|FG004|Overall Study|MD Decision|0|||
48491604|NCT01333033|155992652|FG005|Overall Study|MD Decision|2|||
48710657|NCT00373113|156791332|FG000|Overall Study|Objective progression or relapse|150|||
48710658|NCT00373113|156791333|FG001|Overall Study|Objective progression or relapse|169|||
48710659|NCT00373113|156791332|FG000|Overall Study|Other|14|||
48710660|NCT00373113|156791333|FG001|Overall Study|Other|17|||
48710661|NCT00373113|156791332|FG000|Overall Study|Protocol Violation|5|||
48710662|NCT00373113|156791333|FG001|Overall Study|Protocol Violation|1|||
48710663|NCT00373113|156791332|FG000|Overall Study|Withdrawal by Subject|10|||
48710664|NCT00373113|156791333|FG001|Overall Study|Withdrawal by Subject|15|||
48491605|NCT02006147|155992655|FG000|Overall Study|Protocol Violation|1|||
48491606|NCT02006147|155992656|FG001|Overall Study|Protocol Violation|1|||
48710665|NCT03275350|156791334|FG000|Overall Study|Lost to Follow-up|4|||
48710666|NCT03275350|156791335|FG001|Overall Study|Lost to Follow-up|6|||
48710667|NCT03275350|156791334|FG000|Overall Study|Death|2|||
48710668|NCT03275350|156791335|FG001|Overall Study|Death|1|||
48710669|NCT03275350|156791334|FG000|Overall Study|Physician Decision|1|||
48710670|NCT03275350|156791335|FG001|Overall Study|Physician Decision|0|||
48710671|NCT03275350|156791334|FG000|Overall Study|Incarcerated|1|||
48710672|NCT03275350|156791335|FG001|Overall Study|Incarcerated|1|||
48710673|NCT01402102|156791336|FG000|Overall Study|Protocol Violation|1|||
48491607|NCT02006147|155992657|FG002|Overall Study|Protocol Violation|0|||
48491608|NCT02006147|155992658|FG003|Overall Study|Protocol Violation|0|||
48710674|NCT01402102|156791337|FG001|Overall Study|Protocol Violation|0|||
48710675|NCT01402102|156791336|FG000|Overall Study|Insufficiency of compliance|1|||
48491609|NCT02006147|155992655|FG000|Overall Study|Withdrawal by Subject|0|||
48491610|NCT02006147|155992656|FG001|Overall Study|Withdrawal by Subject|1|||
48491611|NCT02006147|155992657|FG002|Overall Study|Withdrawal by Subject|0|||
48491612|NCT02006147|155992658|FG003|Overall Study|Withdrawal by Subject|0|||
48491613|NCT02006147|155992655|FG000|Overall Study|Withdrawal by Sponsor|1|||
48491614|NCT02006147|155992656|FG001|Overall Study|Withdrawal by Sponsor|0|||
48491615|NCT02006147|155992657|FG002|Overall Study|Withdrawal by Sponsor|0|||
48491616|NCT02006147|155992658|FG003|Overall Study|Withdrawal by Sponsor|0|||
48491617|NCT02611752|155992659|FG000|Overall Study|Adverse Event|0|||
48491618|NCT02611752|155992660|FG001|Overall Study|Adverse Event|1|||
48491619|NCT00310856|155992661|FG000|Overall Study|Withdrawal by Subject|2|||
48491620|NCT00310856|155992662|FG001|Overall Study|Withdrawal by Subject|2|||
48491621|NCT00310856|155992663|FG002|Overall Study|Withdrawal by Subject|2|||
48491622|NCT00310856|155992661|FG000|Overall Study|Lost to Follow-up|1|||
48491623|NCT00310856|155992662|FG001|Overall Study|Lost to Follow-up|2|||
48491624|NCT00310856|155992663|FG002|Overall Study|Lost to Follow-up|6|||
48491625|NCT00310856|155992661|FG000|Overall Study|Inappropriate enrollment|1|||
48491626|NCT00310856|155992662|FG001|Overall Study|Inappropriate enrollment|1|||
48491627|NCT00310856|155992663|FG002|Overall Study|Inappropriate enrollment|0|||
48491628|NCT00310856|155992661|FG000|Overall Study|Unable to classify|1|||
48491629|NCT00310856|155992662|FG001|Overall Study|Unable to classify|0|||
48491630|NCT00310856|155992663|FG002|Overall Study|Unable to classify|0|||
48491631|NCT01564758|155992670|FG000|Overall Study|Death|8|||
48491632|NCT01564758|155992670|FG000|Overall Study|Adverse Event|3|||
48491633|NCT01564758|155992670|FG000|Overall Study|Other|3|||
48710676|NCT01402102|156791337|FG001|Overall Study|Insufficiency of compliance|1|||
48710677|NCT01402102|156791336|FG000|Overall Study|Withdrawal by Subject|0|||
48710678|NCT01402102|156791337|FG001|Overall Study|Withdrawal by Subject|2|||
48710679|NCT02813577|156791341|FG000|Overall Study|Study terminated|4|||
48710680|NCT01976741|156791342|FG000|Overall Study|Withdrawal by Subject|1|||
48710681|NCT01976741|156791343|FG001|Overall Study|Withdrawal by Subject|0|||
48491634|NCT00905489|155992671|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
48710682|NCT01976741|156791344|FG002|Overall Study|Withdrawal by Subject|1|||
48710683|NCT01976741|156791345|FG003|Overall Study|Withdrawal by Subject|1|||
48710684|NCT01976741|156791346|FG004|Overall Study|Withdrawal by Subject|0|||
48710685|NCT01976741|156791347|FG005|Overall Study|Withdrawal by Subject|0|||
48710686|NCT01976741|156791348|FG006|Overall Study|Withdrawal by Subject|1|||
48710687|NCT01976741|156791349|FG007|Overall Study|Withdrawal by Subject|4|||
48710688|NCT01976741|156791350|FG008|Overall Study|Withdrawal by Subject|0|||
48710689|NCT01976741|156791351|FG009|Overall Study|Withdrawal by Subject|0|||
48710690|NCT01976741|156791342|FG000|Overall Study|Adverse Event|0|||
48710691|NCT01976741|156791343|FG001|Overall Study|Adverse Event|0|||
48710692|NCT01976741|156791344|FG002|Overall Study|Adverse Event|2|||
48710693|NCT01976741|156791345|FG003|Overall Study|Adverse Event|0|||
48710694|NCT01976741|156791346|FG004|Overall Study|Adverse Event|0|||
48710695|NCT01976741|156791347|FG005|Overall Study|Adverse Event|0|||
48710696|NCT01976741|156791348|FG006|Overall Study|Adverse Event|3|||
48710697|NCT01976741|156791349|FG007|Overall Study|Adverse Event|8|||
48710698|NCT01976741|156791350|FG008|Overall Study|Adverse Event|1|||
48710699|NCT01976741|156791351|FG009|Overall Study|Adverse Event|4|||
48710700|NCT03052426|156791352|FG000|Overall Study|Withdrawal by Subject|0|||
48710701|NCT03052426|156791353|FG001|Overall Study|Withdrawal by Subject|1|||
48710702|NCT03052426|156791354|FG002|Overall Study|Withdrawal by Subject|0|||
48710703|NCT03052426|156791352|FG000|Overall Study|Lost to Follow-up|2|||
48710704|NCT03052426|156791353|FG001|Overall Study|Lost to Follow-up|0|||
48710705|NCT03052426|156791354|FG002|Overall Study|Lost to Follow-up|1|||
48710706|NCT00775593|156791357|FG000|Overall Study|Unmet eligibility criteria|6|||
48710707|NCT00775593|156791357|FG000|Overall Study|Death|1|||
48710708|NCT02067676|156791358|FG000|Overall Study|Withdrawal by Subject|1|||
48710709|NCT02067676|156791359|FG001|Overall Study|Withdrawal by Subject|0|||
48710710|NCT02067676|156791360|FG002|Overall Study|Withdrawal by Subject|0|||
48710711|NCT02067676|156791361|FG003|Overall Study|Withdrawal by Subject|0|||
48710712|NCT02067676|156791362|FG004|Overall Study|Withdrawal by Subject|0|||
48710713|NCT02067676|156791363|FG005|Overall Study|Withdrawal by Subject|0|||
48710714|NCT02100696|156791365|FG000|Induction Phase|Adverse Event|0|||
48710715|NCT02100696|156791366|FG001|Induction Phase|Adverse Event|0|||
48710716|NCT02100696|156791367|FG002|Induction Phase|Adverse Event|1|||
48710717|NCT02100696|156791368|FG003|Induction Phase|Adverse Event|0|||
48710718|NCT02100696|156791369|FG004|Induction Phase|Adverse Event|0|||
48710719|NCT02100696|156791370|FG005|Induction Phase|Adverse Event|0|||
48710720|NCT02100696|156791365|FG000|Induction Phase|Lost to Follow-up|1|||
48710721|NCT02100696|156791366|FG001|Induction Phase|Lost to Follow-up|0|||
48710722|NCT02100696|156791367|FG002|Induction Phase|Lost to Follow-up|1|||
48710723|NCT02100696|156791368|FG003|Induction Phase|Lost to Follow-up|0|||
48710724|NCT02100696|156791369|FG004|Induction Phase|Lost to Follow-up|0|||
48710725|NCT02100696|156791370|FG005|Induction Phase|Lost to Follow-up|0|||
48710726|NCT02100696|156791365|FG000|Induction Phase|Protocol Violation|0|||
48710727|NCT02100696|156791366|FG001|Induction Phase|Protocol Violation|1|||
48710728|NCT02100696|156791367|FG002|Induction Phase|Protocol Violation|1|||
48710729|NCT02100696|156791368|FG003|Induction Phase|Protocol Violation|0|||
48710730|NCT02100696|156791369|FG004|Induction Phase|Protocol Violation|0|||
48710731|NCT02100696|156791370|FG005|Induction Phase|Protocol Violation|0|||
48710732|NCT02100696|156791365|FG000|Induction Phase|Withdrawal by Subject|8|||
48710733|NCT02100696|156791366|FG001|Induction Phase|Withdrawal by Subject|2|||
48710734|NCT02100696|156791367|FG002|Induction Phase|Withdrawal by Subject|13|||
48710735|NCT02100696|156791368|FG003|Induction Phase|Withdrawal by Subject|0|||
48710736|NCT02100696|156791369|FG004|Induction Phase|Withdrawal by Subject|0|||
48710737|NCT02100696|156791370|FG005|Induction Phase|Withdrawal by Subject|0|||
48710738|NCT02100696|156791365|FG000|Induction Phase|Physician Decision|1|||
48710739|NCT02100696|156791366|FG001|Induction Phase|Physician Decision|0|||
48710740|NCT02100696|156791367|FG002|Induction Phase|Physician Decision|2|||
48710741|NCT02100696|156791368|FG003|Induction Phase|Physician Decision|0|||
48710742|NCT02100696|156791369|FG004|Induction Phase|Physician Decision|0|||
48710743|NCT02100696|156791370|FG005|Induction Phase|Physician Decision|0|||
48710744|NCT02100696|156791365|FG000|Induction Phase|Multiple Reasons|5|||
48710745|NCT02100696|156791366|FG001|Induction Phase|Multiple Reasons|2|||
48710746|NCT02100696|156791367|FG002|Induction Phase|Multiple Reasons|8|||
48710747|NCT02100696|156791368|FG003|Induction Phase|Multiple Reasons|0|||
48710748|NCT02100696|156791369|FG004|Induction Phase|Multiple Reasons|0|||
48710749|NCT02100696|156791370|FG005|Induction Phase|Multiple Reasons|0|||
48710750|NCT02100696|156791365|FG000|Maintenance Phase|Adverse Event|0|||
48710751|NCT02100696|156791366|FG001|Maintenance Phase|Adverse Event|0|||
48710752|NCT02100696|156791367|FG002|Maintenance Phase|Adverse Event|0|||
48710753|NCT02100696|156791368|FG003|Maintenance Phase|Adverse Event|0|||
48710754|NCT02100696|156791369|FG004|Maintenance Phase|Adverse Event|0|||
48710755|NCT02100696|156791370|FG005|Maintenance Phase|Adverse Event|2|||
48710756|NCT02100696|156791365|FG000|Maintenance Phase|Lost to Follow-up|0|||
48710757|NCT02100696|156791366|FG001|Maintenance Phase|Lost to Follow-up|0|||
48710758|NCT02100696|156791367|FG002|Maintenance Phase|Lost to Follow-up|0|||
48710759|NCT02100696|156791368|FG003|Maintenance Phase|Lost to Follow-up|0|||
48710760|NCT02100696|156791369|FG004|Maintenance Phase|Lost to Follow-up|1|||
48807764|NCT04035486|157136682|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
48807765|NCT04035486|157136683|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
48807766|NCT04035486|157136680|FG000|Overall Study|Death|6|||
48807767|NCT04035486|157136681|FG001|Overall Study|Death|3|||
48807768|NCT04035486|157136682|FG002|Overall Study|Death|70|||
48807769|NCT04035486|157136683|FG003|Overall Study|Death|77|||
48807770|NCT04035486|157136680|FG000|Overall Study|Screen Failure|0|||
48807771|NCT04035486|157136681|FG001|Overall Study|Screen Failure|0|||
48807772|NCT04035486|157136682|FG002|Overall Study|Screen Failure|1|||
48491635|NCT00905489|155992671|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
48491636|NCT00905489|155992671|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
48491637|NCT00745251|155992673|FG000|Overall Study|Adverse Event|1|||
48710761|NCT02100696|156791370|FG005|Maintenance Phase|Lost to Follow-up|0|||
48710762|NCT02100696|156791365|FG000|Maintenance Phase|Protocol Violation|0|||
48710763|NCT02100696|156791366|FG001|Maintenance Phase|Protocol Violation|0|||
48710764|NCT02100696|156791367|FG002|Maintenance Phase|Protocol Violation|0|||
48710765|NCT02100696|156791368|FG003|Maintenance Phase|Protocol Violation|0|||
48710766|NCT02100696|156791369|FG004|Maintenance Phase|Protocol Violation|1|||
48710767|NCT02100696|156791370|FG005|Maintenance Phase|Protocol Violation|0|||
48710768|NCT02100696|156791365|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48710769|NCT02100696|156791366|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48710770|NCT02100696|156791367|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48807773|NCT04035486|157136683|FG003|Overall Study|Screen Failure|1|||
48807774|NCT04035486|157136680|FG000|Overall Study|Withdrawal by Subject|1|||
48807775|NCT04035486|157136681|FG001|Overall Study|Withdrawal by Subject|1|||
48807776|NCT04035486|157136682|FG002|Overall Study|Withdrawal by Subject|11|||
48807777|NCT04035486|157136683|FG003|Overall Study|Withdrawal by Subject|9|||
48807778|NCT04006925|157136684|FG000|Overall Study|Side effects|2|||
48807779|NCT04006925|157136685|FG001|Overall Study|Side effects|0|||
48491638|NCT00745251|155992674|FG001|Overall Study|Adverse Event|2|||
48491639|NCT00745251|155992673|FG000|Overall Study|Withdrawal by Subject|1|||
48491640|NCT00745251|155992674|FG001|Overall Study|Withdrawal by Subject|1|||
48491641|NCT03035227|155992675|FG000|Overall Study|study stopped due to PI leaving institut|1|||
48491642|NCT03035227|155992676|FG001|Overall Study|study stopped due to PI leaving institut|1|||
48491643|NCT02100956|155992677|FG000|At Least One Week Between Injections|Adverse Event|0|||
48491644|NCT02100956|155992678|FG001|At Least One Week Between Injections|Adverse Event|1|||
48491645|NCT00859469|155992679|FG000|Overall Study|Adverse Event|2|||
48491646|NCT00859469|155992679|FG000|Overall Study|Lack of Efficacy|9|||
48491647|NCT00859469|155992679|FG000|Overall Study|Withdrawal by Subject|1|||
48491648|NCT00859469|155992679|FG000|Overall Study|Death|16|||
48491649|NCT01309919|155992680|FG000|Overall Study|Did not receive a postpartum IUD|17|||
48491650|NCT01309919|155992681|FG001|Overall Study|Did not receive a postpartum IUD|48|||
48491651|NCT00634179|155992682|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
48491652|NCT00767325|155992683|FG000|Overall Study|Lack of Efficacy|2|||
48491653|NCT00767325|155992683|FG000|Overall Study|Adverse Event|7|||
48491654|NCT00767325|155992683|FG000|Overall Study|Lost to Follow-up|3|||
48491655|NCT00767325|155992683|FG000|Overall Study|No longer met study criteria|2|||
48491656|NCT00767325|155992683|FG000|Overall Study|Missed visit due to family reasons|1|||
48491657|NCT03538756|155992684|FG000|Long-Term Follow-up|Adverse Event|0|||
48491658|NCT03538756|155992685|FG001|Long-Term Follow-up|Adverse Event|0|||
48491659|NCT03538756|155992686|FG002|Long-Term Follow-up|Adverse Event|6|||
48491660|NCT03538756|155992684|FG000|Long-Term Follow-up|Death|0|||
48807780|NCT01598298|157136690|FG000|Overall Study|Not eligible|5|||
48807781|NCT01598298|157136691|FG001|Overall Study|Not eligible|5|||
48807782|NCT01598298|157136690|FG000|Overall Study|Adverse Event|21|||
48491661|NCT03538756|155992685|FG001|Long-Term Follow-up|Death|0|||
48491662|NCT03538756|155992686|FG002|Long-Term Follow-up|Death|1|||
48491663|NCT03538756|155992684|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
48491664|NCT03538756|155992685|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
48597057|NCT00905632|156381845|FG002|Overall Study|Adverse Event|0|||
48710771|NCT02100696|156791368|FG003|Maintenance Phase|Withdrawal by Subject|1|||
48807783|NCT01598298|157136691|FG001|Overall Study|Adverse Event|19|||
48807784|NCT01598298|157136690|FG000|Overall Study|Progression/relapse|0|||
48807785|NCT01598298|157136691|FG001|Overall Study|Progression/relapse|2|||
48807786|NCT01598298|157136690|FG000|Overall Study|Withdrawal by Subject|10|||
48807787|NCT01598298|157136691|FG001|Overall Study|Withdrawal by Subject|15|||
48807788|NCT01598298|157136690|FG000|Overall Study|Other reason (not protocol specified)|4|||
48807789|NCT01598298|157136691|FG001|Overall Study|Other reason (not protocol specified)|0|||
48807790|NCT00803101|157138112|FG000|Overall Study|Death / Serious Adverse Event|4|||
48807791|NCT00803101|157138113|FG001|Overall Study|Death / Serious Adverse Event|6|||
48807792|NCT00803101|157138112|FG000|Overall Study|Withdrawal by Subject|6|||
48807793|NCT00803101|157138113|FG001|Overall Study|Withdrawal by Subject|4|||
48807794|NCT00803101|157138112|FG000|Overall Study|Lost to Follow-up|2|||
48807795|NCT00803101|157138113|FG001|Overall Study|Lost to Follow-up|2|||
48807796|NCT00803101|157138112|FG000|Overall Study|Protocol Violation|1|||
48807797|NCT00803101|157138113|FG001|Overall Study|Protocol Violation|7|||
48807798|NCT00803101|157138112|FG000|Overall Study|Surgery finished outside protocol window|1|||
48807799|NCT00803101|157138113|FG001|Overall Study|Surgery finished outside protocol window|1|||
48807800|NCT00803101|157138112|FG000|Overall Study|Patient died outside SAE report period|1|||
48491665|NCT03538756|155992686|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
48491666|NCT03538756|155992684|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
48710772|NCT02100696|156791369|FG004|Maintenance Phase|Withdrawal by Subject|4|||
48491667|NCT03538756|155992685|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
48491668|NCT03538756|155992686|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
48710773|NCT02100696|156791370|FG005|Maintenance Phase|Withdrawal by Subject|2|||
48710774|NCT02100696|156791365|FG000|Maintenance Phase|Physician Decision|0|||
48710775|NCT02100696|156791366|FG001|Maintenance Phase|Physician Decision|0|||
48710776|NCT02100696|156791367|FG002|Maintenance Phase|Physician Decision|0|||
48710777|NCT02100696|156791368|FG003|Maintenance Phase|Physician Decision|0|||
48710778|NCT02100696|156791369|FG004|Maintenance Phase|Physician Decision|1|||
48710779|NCT02100696|156791370|FG005|Maintenance Phase|Physician Decision|0|||
48710780|NCT02100696|156791365|FG000|Maintenance Phase|Multiple Reasons|0|||
48710781|NCT02100696|156791366|FG001|Maintenance Phase|Multiple Reasons|0|||
48710782|NCT02100696|156791367|FG002|Maintenance Phase|Multiple Reasons|0|||
48710783|NCT02100696|156791368|FG003|Maintenance Phase|Multiple Reasons|0|||
48710784|NCT02100696|156791369|FG004|Maintenance Phase|Multiple Reasons|2|||
48710785|NCT02100696|156791370|FG005|Maintenance Phase|Multiple Reasons|1|||
48710786|NCT03865381|156791371|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
48710787|NCT03865381|156791371|FG000|Overall Study|Withdrawal by Subject|2|||
48710788|NCT02424578|156791372|FG000|Overall Study|Withdrawal by Subject|0|||
48807801|NCT00803101|157138113|FG001|Overall Study|Patient died outside SAE report period|0|||
48807802|NCT00803101|157138112|FG000|Overall Study|Patient did not attend scheduled visit|2|||
48807803|NCT00803101|157138113|FG001|Overall Study|Patient did not attend scheduled visit|1|||
48807804|NCT00803101|157138112|FG000|Overall Study|Patient did not have surgery|1|||
48807805|NCT00803101|157138113|FG001|Overall Study|Patient did not have surgery|1|||
48807806|NCT01106430|157138118|FG000|Overall Study|Adverse Event|8|||
48710789|NCT02424578|156791373|FG001|Overall Study|Withdrawal by Subject|1|||
48710790|NCT01063283|156791377|FG000|Cycle 1|Adverse Event|2|||
48597058|NCT00905632|156381846|FG003|Overall Study|Adverse Event|0|||
48710791|NCT01063283|156791378|FG001|Cycle 1|Adverse Event|0|||
48710792|NCT01063283|156791379|FG002|Cycle 1|Adverse Event|0|||
48710793|NCT01063283|156791377|FG000|Cycle 1|Technical failure in data collection|1|||
48710794|NCT01063283|156791378|FG001|Cycle 1|Technical failure in data collection|0|||
48710795|NCT01063283|156791379|FG002|Cycle 1|Technical failure in data collection|0|||
48710796|NCT01120717|156791380|FG000|Overall Study|Withdrawal by Subject|11|||
48710797|NCT01120717|156791381|FG001|Overall Study|Withdrawal by Subject|6|||
48710798|NCT01120717|156791380|FG000|Overall Study|Adverse Event|10|||
48710799|NCT01120717|156791381|FG001|Overall Study|Adverse Event|6|||
48710800|NCT01120717|156791380|FG000|Overall Study|Protocol Deviation|2|||
48710801|NCT01120717|156791381|FG001|Overall Study|Protocol Deviation|5|||
48710802|NCT01120717|156791380|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48710803|NCT01120717|156791381|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48710804|NCT01120717|156791380|FG000|Overall Study|Lost to Follow-up|2|||
48710805|NCT01120717|156791381|FG001|Overall Study|Lost to Follow-up|3|||
48710806|NCT01120717|156791380|FG000|Overall Study|Death|3|||
48710807|NCT01120717|156791381|FG001|Overall Study|Death|1|||
48710808|NCT01120717|156791380|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
48710809|NCT01120717|156791381|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
48710810|NCT00865280|156791382|FG000|Overall Study|Withdrawal by Subject|4|||
48710811|NCT00865280|156791383|FG001|Overall Study|Withdrawal by Subject|1|||
48710812|NCT00865280|156791382|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
48710813|NCT00865280|156791383|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
48710814|NCT00865280|156791382|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
48710815|NCT00865280|156791383|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
48710816|NCT00865280|156791382|FG000|Overall Study|Exclusion Condition|1|||
48710817|NCT00865280|156791383|FG001|Overall Study|Exclusion Condition|0|||
48710818|NCT00865280|156791382|FG000|Overall Study|Adverse Event|0|||
48710819|NCT00865280|156791383|FG001|Overall Study|Adverse Event|1|||
48710820|NCT00948441|156791384|FG000|Overall Study|no longer meet inclusion criteria|1|||
48710821|NCT00948441|156791385|FG001|Overall Study|no longer meet inclusion criteria|4|||
48710822|NCT01134705|156791392|FG000|Overall Study|Adverse Event|1|||
48710823|NCT01134705|156791393|FG001|Overall Study|Adverse Event|7|||
48710824|NCT01134705|156791392|FG000|Overall Study|Withdrawal by Subject|6|||
48710825|NCT01134705|156791393|FG001|Overall Study|Withdrawal by Subject|6|||
48710826|NCT01134705|156791392|FG000|Overall Study|Pregnancy|1|||
48710827|NCT01134705|156791393|FG001|Overall Study|Pregnancy|0|||
48710828|NCT01134705|156791392|FG000|Overall Study|Lost to Follow-up|5|||
48710829|NCT01134705|156791393|FG001|Overall Study|Lost to Follow-up|2|||
48491669|NCT03538756|155992684|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
48491670|NCT03538756|155992685|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
48491671|NCT03538756|155992686|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
48491672|NCT03495869|155992687|FG000|Overall Study|Lost to Follow-up|4|||
48491673|NCT03495869|155992688|FG001|Overall Study|Lost to Follow-up|17|||
48491674|NCT03495869|155992689|FG002|Overall Study|Lost to Follow-up|8|||
48491675|NCT03495869|155992690|FG003|Overall Study|Lost to Follow-up|14|||
48491676|NCT03495869|155992687|FG000|Overall Study|Withdrawal by Subject|0|||
48491677|NCT03495869|155992688|FG001|Overall Study|Withdrawal by Subject|3|||
48491678|NCT03495869|155992689|FG002|Overall Study|Withdrawal by Subject|0|||
48491679|NCT03495869|155992690|FG003|Overall Study|Withdrawal by Subject|3|||
48491680|NCT03495869|155992687|FG000|Overall Study|Dropped from study|0|||
48491681|NCT03495869|155992688|FG001|Overall Study|Dropped from study|7|||
48491682|NCT03495869|155992689|FG002|Overall Study|Dropped from study|2|||
48491683|NCT03495869|155992690|FG003|Overall Study|Dropped from study|4|||
48491684|NCT04634409|155992691|FG000|Overall Study|Death|0|||
48491685|NCT04634409|155992692|FG001|Overall Study|Death|0|||
48491686|NCT04634409|155992693|FG002|Overall Study|Death|0|||
48491687|NCT04634409|155992694|FG003|Overall Study|Death|0|||
48491688|NCT04634409|155992695|FG004|Overall Study|Death|0|||
48491689|NCT04634409|155992696|FG005|Overall Study|Death|0|||
48597059|NCT00905632|156381847|FG004|Overall Study|Adverse Event|0|||
48597060|NCT00905632|156381848|FG005|Overall Study|Adverse Event|1|||
48710830|NCT01134705|156791392|FG000|Overall Study|Protocol Violation|1|||
48710831|NCT01134705|156791393|FG001|Overall Study|Protocol Violation|1|||
48710832|NCT01134705|156791392|FG000|Overall Study|Other|1|||
48491690|NCT04634409|155992697|FG006|Overall Study|Death|0|||
48491691|NCT04634409|155992698|FG007|Overall Study|Death|0|||
48491692|NCT04634409|155992699|FG008|Overall Study|Death|0|||
48597061|NCT00905632|156381849|FG006|Overall Study|Adverse Event|4|||
48597062|NCT01845597|156381850|FG000|Overall Study|Death|8|||
48597063|NCT01845597|156381850|FG000|Overall Study|Lost to Follow-up|22|||
48597064|NCT02581488|156381859|FG000|Overall Study|Adverse Event|6|||
48597065|NCT02581488|156381860|FG001|Overall Study|Adverse Event|7|||
48597066|NCT02581488|156381859|FG000|Overall Study|Lost to Follow-up|1|||
48597067|NCT02581488|156381860|FG001|Overall Study|Lost to Follow-up|0|||
48597068|NCT02581488|156381859|FG000|Overall Study|Withdrawal by Subject|1|||
48597069|NCT02581488|156381860|FG001|Overall Study|Withdrawal by Subject|0|||
48597070|NCT02581488|156381859|FG000|Overall Study|Non-Compliance|1|||
48597071|NCT02581488|156381860|FG001|Overall Study|Non-Compliance|0|||
48597072|NCT02581488|156381859|FG000|Overall Study|Protocol Violation|0|||
48597073|NCT02581488|156381860|FG001|Overall Study|Protocol Violation|4|||
48597074|NCT01877668|156381861|FG000|Overall Study|Death|0|||
48597075|NCT01877668|156381862|FG001|Overall Study|Death|0|||
48597076|NCT01877668|156381863|FG002|Overall Study|Death|0|||
48597077|NCT01877668|156381864|FG003|Overall Study|Death|1|||
48597078|NCT01877668|156381865|FG004|Overall Study|Death|0|||
48597079|NCT01877668|156381861|FG000|Overall Study|No longer met study criteria|1|||
48597080|NCT01877668|156381862|FG001|Overall Study|No longer met study criteria|0|||
48597081|NCT01877668|156381863|FG002|Overall Study|No longer met study criteria|1|||
48597082|NCT01877668|156381864|FG003|Overall Study|No longer met study criteria|0|||
48597083|NCT01877668|156381865|FG004|Overall Study|No longer met study criteria|0|||
48710833|NCT01134705|156791393|FG001|Overall Study|Other|6|||
48710834|NCT01324401|156791396|FG000|Overall Study|Withdrawn before any treatment|0|||
48710835|NCT01324401|156791397|FG001|Overall Study|Withdrawn before any treatment|3|||
48710836|NCT01324401|156791396|FG000|Overall Study|Adverse Event|1|||
48710837|NCT01324401|156791397|FG001|Overall Study|Adverse Event|3|||
48710838|NCT01708902|156791398|FG000|Overall Study|Adverse Event|3|||
48710839|NCT01708902|156791399|FG001|Overall Study|Adverse Event|4|||
48710840|NCT01708902|156791400|FG002|Overall Study|Adverse Event|9|||
48710841|NCT01708902|156791401|FG003|Overall Study|Adverse Event|2|||
48710842|NCT01708902|156791402|FG004|Overall Study|Adverse Event|7|||
48710843|NCT01708902|156791403|FG005|Overall Study|Adverse Event|3|||
48710844|NCT01708902|156791404|FG006|Overall Study|Adverse Event|5|||
48710845|NCT01708902|156791398|FG000|Overall Study|Lack of Efficacy|3|||
48491693|NCT04634409|155992700|FG009|Overall Study|Death|0|||
48491694|NCT04634409|155992701|FG010|Overall Study|Death|1|||
48597084|NCT01877668|156381861|FG000|Overall Study|Insufficient clinical response|0|||
48597085|NCT01877668|156381862|FG001|Overall Study|Insufficient clinical response|1|||
48710846|NCT01708902|156791399|FG001|Overall Study|Lack of Efficacy|1|||
48491695|NCT04634409|155992702|FG011|Overall Study|Death|0|||
48807807|NCT01106430|157138119|FG001|Overall Study|Adverse Event|10|||
48807808|NCT01106430|157138118|FG000|Overall Study|Lack of Efficacy|2|||
48807809|NCT01106430|157138119|FG001|Overall Study|Lack of Efficacy|13|||
48807810|NCT01106430|157138118|FG000|Overall Study|Lost to Follow-up|5|||
48807811|NCT01106430|157138119|FG001|Overall Study|Lost to Follow-up|1|||
48807812|NCT01106430|157138118|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
48807813|NCT01106430|157138119|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
48491696|NCT04634409|155992703|FG012|Overall Study|Death|1|||
48491697|NCT04634409|155992704|FG013|Overall Study|Death|0|||
48491698|NCT04634409|155992705|FG014|Overall Study|Death|0|||
48491699|NCT04634409|155992706|FG015|Overall Study|Death|0|||
48491700|NCT04634409|155992707|FG016|Overall Study|Death|0|||
48491701|NCT04634409|155992708|FG017|Overall Study|Death|0|||
48491702|NCT04634409|155992709|FG018|Overall Study|Death|0|||
48491703|NCT04634409|155992710|FG019|Overall Study|Death|0|||
48597086|NCT01877668|156381863|FG002|Overall Study|Insufficient clinical response|2|||
48597087|NCT01877668|156381864|FG003|Overall Study|Insufficient clinical response|2|||
48597088|NCT01877668|156381865|FG004|Overall Study|Insufficient clinical response|0|||
48597089|NCT01877668|156381861|FG000|Overall Study|Lost to Follow-up|0|||
48597090|NCT01877668|156381862|FG001|Overall Study|Lost to Follow-up|2|||
48597091|NCT01877668|156381863|FG002|Overall Study|Lost to Follow-up|1|||
48597092|NCT01877668|156381864|FG003|Overall Study|Lost to Follow-up|0|||
48597093|NCT01877668|156381865|FG004|Overall Study|Lost to Follow-up|0|||
48597094|NCT01877668|156381861|FG000|Overall Study|Withdrawal by Subject|2|||
48597095|NCT01877668|156381862|FG001|Overall Study|Withdrawal by Subject|0|||
48597096|NCT01877668|156381863|FG002|Overall Study|Withdrawal by Subject|3|||
48597097|NCT01877668|156381864|FG003|Overall Study|Withdrawal by Subject|2|||
48597098|NCT01877668|156381865|FG004|Overall Study|Withdrawal by Subject|2|||
48597099|NCT01877668|156381861|FG000|Overall Study|Other|1|||
48597100|NCT01877668|156381862|FG001|Overall Study|Other|1|||
48807814|NCT01106430|157138118|FG000|Overall Study|Moved Out Of State|0|||
48807815|NCT01106430|157138119|FG001|Overall Study|Moved Out Of State|1|||
48597101|NCT01877668|156381863|FG002|Overall Study|Other|1|||
48597102|NCT01877668|156381864|FG003|Overall Study|Other|1|||
48807816|NCT01106430|157138118|FG000|Overall Study|Refused To Take Medication|0|||
48491704|NCT04634409|155992711|FG020|Overall Study|Death|0|||
48491705|NCT04634409|155992712|FG021|Overall Study|Death|0|||
48807817|NCT01106430|157138119|FG001|Overall Study|Refused To Take Medication|1|||
48807818|NCT01106430|157138118|FG000|Overall Study|Noncompliance|0|||
48807819|NCT01106430|157138119|FG001|Overall Study|Noncompliance|1|||
48807820|NCT01106430|157138118|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
48807821|NCT01106430|157138119|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
48807822|NCT01106430|157138118|FG000|Overall Study|Previous Use Of Marijuana|1|||
48807823|NCT01106430|157138119|FG001|Overall Study|Previous Use Of Marijuana|0|||
48807824|NCT01106430|157138118|FG000|Overall Study|Protocol Violation|7|||
48807825|NCT01106430|157138119|FG001|Overall Study|Protocol Violation|2|||
48807826|NCT01106430|157138118|FG000|Overall Study|Withdrawal by Subject|8|||
48807827|NCT01106430|157138119|FG001|Overall Study|Withdrawal by Subject|4|||
48807828|NCT01289418|157138120|FG000|Day 8 Survey|email address invalid|283|||
48807829|NCT01289418|157138120|FG000|Day 8 Survey|participants did not complete the survey|1935|||
48807830|NCT01289418|157138120|FG000|Day 29 Survey|email address invalid|283|||
48807831|NCT01289418|157138120|FG000|Day 29 Survey|participants did not complete the survey|2185|||
48807832|NCT02276066|157138123|FG000|Overall Study|Lost to Follow-up|21|||
48807833|NCT02276066|157138124|FG001|Overall Study|Lost to Follow-up|11|||
48807834|NCT02567825|157138132|FG000|Overall Study|No follow-up post-randomization|5|||
48807835|NCT02567825|157138133|FG001|Overall Study|No follow-up post-randomization|1|||
48807836|NCT02567825|157138132|FG000|Overall Study|Follow-up less than 23 months|16|||
48807837|NCT02567825|157138133|FG001|Overall Study|Follow-up less than 23 months|20|||
48807838|NCT02424591|157138153|FG000|Overall Study|Protocol Violation|2|||
48807839|NCT02424591|157138154|FG001|Overall Study|Protocol Violation|3|||
48807840|NCT00954733|157138159|FG000|Overall Study|blood gas machine did not work|1|||
48807841|NCT01781390|157138160|FG000|Overall Study|Withdrawal of Consent|0|||
48807842|NCT01781390|157138161|FG001|Overall Study|Withdrawal of Consent|3|||
48807843|NCT01781390|157138162|FG002|Overall Study|Withdrawal of Consent|1|||
48807844|NCT01781390|157138160|FG000|Overall Study|Lost to Follow-up|1|||
48807845|NCT01781390|157138161|FG001|Overall Study|Lost to Follow-up|1|||
48807846|NCT01781390|157138162|FG002|Overall Study|Lost to Follow-up|1|||
48807847|NCT01781390|157138160|FG000|Overall Study|Adverse Event|1|||
48807848|NCT01781390|157138161|FG001|Overall Study|Adverse Event|2|||
48807849|NCT01781390|157138162|FG002|Overall Study|Adverse Event|1|||
48807850|NCT01781390|157138160|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
48807851|NCT01781390|157138161|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
48807852|NCT01781390|157138162|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
48807853|NCT01862796|157138165|FG000|Overall Study|Prohibited medications|0|||
48491706|NCT04634409|155992713|FG022|Overall Study|Death|0|||
48807854|NCT01862796|157138166|FG001|Overall Study|Prohibited medications|0|||
48807855|NCT01862796|157138167|FG002|Overall Study|Prohibited medications|1|||
48807856|NCT01462162|157138168|FG000|Overall Study|Adverse Event|5|||
48807857|NCT01462162|157138168|FG000|Overall Study|Lack of Efficacy|4|||
48807858|NCT01462162|157138168|FG000|Overall Study|Abnormal laboratory parameters|1|||
48807859|NCT01462162|157138168|FG000|Overall Study|Other|2|||
48807860|NCT02712398|157138198|FG000|Overall Study|Withdrawal by Subject|6|||
48807861|NCT02712398|157138198|FG000|Overall Study|Lost to Follow-up|6|||
48807862|NCT02712398|157138198|FG000|Overall Study|Sponsor Decision|1|||
48807863|NCT02712398|157138198|FG000|Overall Study|Physician Decision|1|||
48807864|NCT02712398|157138198|FG000|Overall Study|Death|2|||
48807865|NCT02712398|157138198|FG000|Overall Study|Re-operation|21|||
48491707|NCT04634409|155992714|FG023|Overall Study|Death|0|||
48491708|NCT04634409|155992715|FG024|Overall Study|Death|0|||
48491709|NCT04634409|155992716|FG025|Overall Study|Death|0|||
48491710|NCT04634409|155992717|FG026|Overall Study|Death|0|||
48491711|NCT04634409|155992691|FG000|Overall Study|Adverse Event|0|||
48491712|NCT04634409|155992692|FG001|Overall Study|Adverse Event|0|||
48491713|NCT04634409|155992693|FG002|Overall Study|Adverse Event|1|||
48491714|NCT04634409|155992694|FG003|Overall Study|Adverse Event|0|||
48491715|NCT04634409|155992695|FG004|Overall Study|Adverse Event|0|||
48491716|NCT04634409|155992696|FG005|Overall Study|Adverse Event|1|||
48491717|NCT04634409|155992697|FG006|Overall Study|Adverse Event|0|||
48491718|NCT04634409|155992698|FG007|Overall Study|Adverse Event|0|||
48491719|NCT04634409|155992699|FG008|Overall Study|Adverse Event|0|||
48807866|NCT01735396|157138199|FG000|Overall Study|not evaluable|1|||
48807867|NCT03724396|157138200|FG000|Overall Study|Lost to Follow-up|1|||
48807868|NCT03724396|157138201|FG001|Overall Study|Lost to Follow-up|1|||
48807869|NCT03724396|157138200|FG000|Overall Study|Withdrawal by Subject|1|||
48807870|NCT03724396|157138201|FG001|Overall Study|Withdrawal by Subject|0|||
48491720|NCT04634409|155992700|FG009|Overall Study|Adverse Event|0|||
48491721|NCT04634409|155992701|FG010|Overall Study|Adverse Event|0|||
48491722|NCT04634409|155992702|FG011|Overall Study|Adverse Event|0|||
48491723|NCT04634409|155992703|FG012|Overall Study|Adverse Event|0|||
48491724|NCT04634409|155992704|FG013|Overall Study|Adverse Event|0|||
48491725|NCT04634409|155992705|FG014|Overall Study|Adverse Event|0|||
48491726|NCT04634409|155992706|FG015|Overall Study|Adverse Event|0|||
48491727|NCT04634409|155992707|FG016|Overall Study|Adverse Event|0|||
48491728|NCT04634409|155992708|FG017|Overall Study|Adverse Event|0|||
48491729|NCT04634409|155992709|FG018|Overall Study|Adverse Event|0|||
48710847|NCT01708902|156791400|FG002|Overall Study|Lack of Efficacy|0|||
48710848|NCT01708902|156791401|FG003|Overall Study|Lack of Efficacy|0|||
48710849|NCT01708902|156791402|FG004|Overall Study|Lack of Efficacy|0|||
48710850|NCT01708902|156791403|FG005|Overall Study|Lack of Efficacy|1|||
48491730|NCT04634409|155992710|FG019|Overall Study|Adverse Event|0|||
48491731|NCT04634409|155992711|FG020|Overall Study|Adverse Event|0|||
48491732|NCT04634409|155992712|FG021|Overall Study|Adverse Event|0|||
48491733|NCT04634409|155992713|FG022|Overall Study|Adverse Event|0|||
48597103|NCT01877668|156381865|FG004|Overall Study|Other|3|||
48710851|NCT01708902|156791404|FG006|Overall Study|Lack of Efficacy|0|||
48710852|NCT01708902|156791398|FG000|Overall Study|Non compliance with protocol|0|||
48710853|NCT01708902|156791399|FG001|Overall Study|Non compliance with protocol|2|||
48710854|NCT01708902|156791400|FG002|Overall Study|Non compliance with protocol|1|||
48710855|NCT01708902|156791401|FG003|Overall Study|Non compliance with protocol|3|||
48710856|NCT01708902|156791402|FG004|Overall Study|Non compliance with protocol|0|||
48710857|NCT01708902|156791403|FG005|Overall Study|Non compliance with protocol|0|||
48710858|NCT01708902|156791404|FG006|Overall Study|Non compliance with protocol|0|||
48710859|NCT01708902|156791398|FG000|Overall Study|Lost to Follow-up|2|||
48710860|NCT01708902|156791399|FG001|Overall Study|Lost to Follow-up|1|||
48710861|NCT01708902|156791400|FG002|Overall Study|Lost to Follow-up|2|||
48710862|NCT01708902|156791401|FG003|Overall Study|Lost to Follow-up|2|||
48710863|NCT01708902|156791402|FG004|Overall Study|Lost to Follow-up|0|||
48710864|NCT01708902|156791403|FG005|Overall Study|Lost to Follow-up|0|||
48710865|NCT01708902|156791404|FG006|Overall Study|Lost to Follow-up|1|||
48710866|NCT01708902|156791398|FG000|Overall Study|Refused to continue trial medication|8|||
48710867|NCT01708902|156791399|FG001|Overall Study|Refused to continue trial medication|0|||
48710868|NCT01708902|156791400|FG002|Overall Study|Refused to continue trial medication|4|||
48710869|NCT01708902|156791401|FG003|Overall Study|Refused to continue trial medication|2|||
48710870|NCT01708902|156791402|FG004|Overall Study|Refused to continue trial medication|8|||
48710871|NCT01708902|156791403|FG005|Overall Study|Refused to continue trial medication|1|||
48710872|NCT01708902|156791404|FG006|Overall Study|Refused to continue trial medication|1|||
48710873|NCT01708902|156791398|FG000|Overall Study|Other Reason|1|||
48710874|NCT01708902|156791399|FG001|Overall Study|Other Reason|0|||
48710875|NCT01708902|156791400|FG002|Overall Study|Other Reason|1|||
48710876|NCT01708902|156791401|FG003|Overall Study|Other Reason|1|||
48710877|NCT01708902|156791402|FG004|Overall Study|Other Reason|1|||
48710878|NCT01708902|156791403|FG005|Overall Study|Other Reason|2|||
48710879|NCT01708902|156791404|FG006|Overall Study|Other Reason|0|||
48710880|NCT00499590|156791405|FG000|Overall Study|Study Terminated|112|||
48710881|NCT00499590|156791406|FG001|Overall Study|Study Terminated|112|||
48710882|NCT00499590|156791407|FG002|Overall Study|Study Terminated|112|||
48710883|NCT00499590|156791405|FG000|Overall Study|Not treated|1|||
48710884|NCT00499590|156791406|FG001|Overall Study|Not treated|0|||
48710885|NCT00499590|156791407|FG002|Overall Study|Not treated|1|||
48710886|NCT02624986|156791408|FG000|Overall Study|Death|0|||
48710887|NCT02624986|156791409|FG001|Overall Study|Death|1|||
48710888|NCT02624986|156791410|FG002|Overall Study|Death|2|||
48710889|NCT02624986|156791411|FG003|Overall Study|Death|2|||
48710890|NCT02624986|156791412|FG004|Overall Study|Death|2|||
48710891|NCT02624986|156791413|FG005|Overall Study|Death|0|||
48710892|NCT02624986|156791414|FG006|Overall Study|Death|0|||
48710893|NCT02624986|156791415|FG007|Overall Study|Death|1|||
48597104|NCT01877668|156381861|FG000|Overall Study|Protocol Violation|1|||
48597105|NCT01877668|156381862|FG001|Overall Study|Protocol Violation|1|||
48597106|NCT01877668|156381863|FG002|Overall Study|Protocol Violation|0|||
48597107|NCT01877668|156381864|FG003|Overall Study|Protocol Violation|0|||
48597108|NCT01877668|156381865|FG004|Overall Study|Protocol Violation|3|||
48597109|NCT01877668|156381861|FG000|Overall Study|Adverse event related to study drug|2|||
48597110|NCT01877668|156381862|FG001|Overall Study|Adverse event related to study drug|2|||
48597111|NCT01877668|156381863|FG002|Overall Study|Adverse event related to study drug|2|||
48597112|NCT01877668|156381864|FG003|Overall Study|Adverse event related to study drug|2|||
48597113|NCT01877668|156381865|FG004|Overall Study|Adverse event related to study drug|1|||
48597114|NCT01877668|156381861|FG000|Overall Study|Adverse event unrelated to study drug|4|||
48597115|NCT01877668|156381862|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48597116|NCT01877668|156381863|FG002|Overall Study|Adverse event unrelated to study drug|2|||
48710894|NCT02624986|156791408|FG000|Overall Study|Study Terminated by Sponsor|1|||
48710895|NCT02624986|156791409|FG001|Overall Study|Study Terminated by Sponsor|1|||
48710896|NCT02624986|156791410|FG002|Overall Study|Study Terminated by Sponsor|0|||
48710897|NCT02624986|156791411|FG003|Overall Study|Study Terminated by Sponsor|1|||
48710898|NCT02624986|156791412|FG004|Overall Study|Study Terminated by Sponsor|2|||
48710899|NCT02624986|156791413|FG005|Overall Study|Study Terminated by Sponsor|2|||
48710900|NCT02624986|156791414|FG006|Overall Study|Study Terminated by Sponsor|4|||
48597117|NCT01877668|156381864|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48597118|NCT01877668|156381865|FG004|Overall Study|Adverse event unrelated to study drug|1|||
48597119|NCT01302418|156381866|FG000|Overall Study|Protocol Violation|9|||
48597120|NCT01302418|156381866|FG000|Overall Study|Non-evaluable|9|||
48597121|NCT01957579|156381868|FG000|Overall Study|Withdrawal of concent|0|||
48597122|NCT01957579|156381869|FG001|Overall Study|Withdrawal of concent|1|||
48597123|NCT01957579|156381870|FG002|Overall Study|Withdrawal of concent|0|||
48597124|NCT01957579|156381871|FG003|Overall Study|Withdrawal of concent|0|||
48597125|NCT01957579|156381868|FG000|Overall Study|Death|0|||
48597126|NCT01957579|156381869|FG001|Overall Study|Death|0|||
48597127|NCT01957579|156381870|FG002|Overall Study|Death|2|||
48597128|NCT01957579|156381871|FG003|Overall Study|Death|0|||
48597129|NCT01639144|156381874|FG000|Overall Study|Withdrawal by Subject|4|||
48597130|NCT01639144|156381875|FG001|Overall Study|Withdrawal by Subject|2|||
48597131|NCT01639144|156381874|FG000|Overall Study|Physician Decision|2|||
48597132|NCT01639144|156381875|FG001|Overall Study|Physician Decision|0|||
48597133|NCT01639144|156381874|FG000|Overall Study|Met postoperative exclusion criteria|4|||
48597134|NCT01639144|156381875|FG001|Overall Study|Met postoperative exclusion criteria|3|||
48597135|NCT02019550|156381876|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
48597136|NCT02019550|156381877|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
48597137|NCT01307891|156381878|FG000|Overall Study|Progressive Disease|3|||
48597138|NCT01307891|156381879|FG001|Overall Study|Progressive Disease|1|||
48710901|NCT02624986|156791415|FG007|Overall Study|Study Terminated by Sponsor|3|||
48710902|NCT02624986|156791408|FG000|Overall Study|Progressive Disease|0|||
48710903|NCT02624986|156791409|FG001|Overall Study|Progressive Disease|1|||
48807871|NCT00728962|157138205|FG000|Implant Placement Surgery|Adverse Event|8|||
48807872|NCT00728962|157138205|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
48807873|NCT00728962|157138205|FG000|Implant Placement Surgery|Protocol Violation|1|||
48807874|NCT00728962|157138205|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
48807875|NCT00728962|157138205|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
48807876|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
48807877|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48807878|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48807879|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48597139|NCT03365934|156381880|FG000|Overall Study|Adverse Event|1|||
48597140|NCT03365934|156381880|FG000|Overall Study|Withdrawal by Subject|1|||
48597141|NCT02937740|156381881|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
48597142|NCT02937740|156381882|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
48597143|NCT02937740|156381881|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
48597144|NCT02937740|156381882|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
48597145|NCT02937740|156381881|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
48597146|NCT02937740|156381882|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
48597147|NCT02937740|156381881|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
48597148|NCT02937740|156381882|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
48597149|NCT02937740|156381881|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
48597150|NCT02937740|156381882|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
48807880|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48491734|NCT04634409|155992714|FG023|Overall Study|Adverse Event|0|||
48491735|NCT04634409|155992715|FG024|Overall Study|Adverse Event|0|||
48491736|NCT04634409|155992716|FG025|Overall Study|Adverse Event|0|||
48491737|NCT04634409|155992717|FG026|Overall Study|Adverse Event|0|||
48491738|NCT04634409|155992691|FG000|Overall Study|Lost to Follow-up|3|||
48491739|NCT04634409|155992692|FG001|Overall Study|Lost to Follow-up|1|||
48491740|NCT04634409|155992693|FG002|Overall Study|Lost to Follow-up|1|||
48491741|NCT04634409|155992694|FG003|Overall Study|Lost to Follow-up|3|||
48710904|NCT02624986|156791410|FG002|Overall Study|Progressive Disease|0|||
48710905|NCT02624986|156791411|FG003|Overall Study|Progressive Disease|0|||
48710906|NCT02624986|156791412|FG004|Overall Study|Progressive Disease|0|||
48710907|NCT02624986|156791413|FG005|Overall Study|Progressive Disease|0|||
48710908|NCT02624986|156791414|FG006|Overall Study|Progressive Disease|0|||
48597151|NCT02937740|156381881|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
48597152|NCT02937740|156381882|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
48597153|NCT01473940|156381883|FG000|Induction Therapy|Death|0|||
48597154|NCT01473940|156381884|FG001|Induction Therapy|Death|0|||
48710909|NCT02624986|156791415|FG007|Overall Study|Progressive Disease|0|||
48491742|NCT04634409|155992695|FG004|Overall Study|Lost to Follow-up|1|||
48807881|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48807882|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48597155|NCT01473940|156381885|FG002|Induction Therapy|Death|1|||
48807883|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
48807884|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807885|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807886|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807887|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807888|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807889|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48807890|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
48807891|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807892|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807893|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807894|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807895|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48807896|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48597156|NCT01473940|156381886|FG003|Induction Therapy|Death|1|||
48597157|NCT01473940|156381883|FG000|Induction Therapy|Progressive Disease|0|||
48597158|NCT01473940|156381884|FG001|Induction Therapy|Progressive Disease|1|||
48597159|NCT01473940|156381885|FG002|Induction Therapy|Progressive Disease|1|||
48597160|NCT01473940|156381886|FG003|Induction Therapy|Progressive Disease|0|||
48597161|NCT01473940|156381883|FG000|Maintenance Therapy|Progressive Disease|1|||
48597162|NCT01473940|156381884|FG001|Maintenance Therapy|Progressive Disease|2|||
48710910|NCT02624986|156791408|FG000|Overall Study|Protocol Violation|1|||
48710911|NCT02624986|156791409|FG001|Overall Study|Protocol Violation|0|||
48710912|NCT02624986|156791410|FG002|Overall Study|Protocol Violation|0|||
48710913|NCT02624986|156791411|FG003|Overall Study|Protocol Violation|0|||
48710914|NCT02624986|156791412|FG004|Overall Study|Protocol Violation|0|||
48710915|NCT02624986|156791413|FG005|Overall Study|Protocol Violation|0|||
48710916|NCT02624986|156791414|FG006|Overall Study|Protocol Violation|0|||
48710917|NCT02624986|156791415|FG007|Overall Study|Protocol Violation|0|||
48710918|NCT02624986|156791408|FG000|Overall Study|Withdrawal by Subject|0|||
48710919|NCT02624986|156791409|FG001|Overall Study|Withdrawal by Subject|0|||
48710920|NCT02624986|156791410|FG002|Overall Study|Withdrawal by Subject|0|||
48807897|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
48807898|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807899|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807900|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807901|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807902|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807903|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48807904|NCT01576718|157138208|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
48807905|NCT01576718|157138209|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807906|NCT01576718|157138210|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807907|NCT01576718|157138211|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807908|NCT01576718|157138212|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807909|NCT01576718|157138213|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807910|NCT01576718|157138214|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48807911|NCT01576718|157138208|FG000|Treatment Period|Adverse Event|0|||
48807912|NCT01576718|157138209|FG001|Treatment Period|Adverse Event|1|||
48807913|NCT01576718|157138210|FG002|Treatment Period|Adverse Event|1|||
48807914|NCT01576718|157138211|FG003|Treatment Period|Adverse Event|1|||
48807915|NCT01576718|157138212|FG004|Treatment Period|Adverse Event|1|||
48807916|NCT01576718|157138213|FG005|Treatment Period|Adverse Event|1|||
48597163|NCT01473940|156381885|FG002|Maintenance Therapy|Progressive Disease|1|||
48597164|NCT01473940|156381886|FG003|Maintenance Therapy|Progressive Disease|4|||
48597165|NCT00547248|156381887|FG000|Overall Study|Protocol Violation|0|||
48710921|NCT02624986|156791411|FG003|Overall Study|Withdrawal by Subject|0|||
48710922|NCT02624986|156791412|FG004|Overall Study|Withdrawal by Subject|0|||
48710923|NCT02624986|156791413|FG005|Overall Study|Withdrawal by Subject|0|||
48710924|NCT02624986|156791414|FG006|Overall Study|Withdrawal by Subject|0|||
48710925|NCT02624986|156791415|FG007|Overall Study|Withdrawal by Subject|1|||
48710926|NCT00740857|156791416|FG000|Overall Study|Withdrawal by Subject|1|||
48807917|NCT01576718|157138214|FG006|Treatment Period|Adverse Event|0|||
48807918|NCT01576718|157138208|FG000|Treatment Period|Withdrawal by Subject|0|||
48807919|NCT01576718|157138209|FG001|Treatment Period|Withdrawal by Subject|1|||
48597166|NCT00547248|156381888|FG001|Overall Study|Protocol Violation|0|||
48597167|NCT00547248|156381889|FG002|Overall Study|Protocol Violation|1|||
48710927|NCT00740857|156791417|FG001|Overall Study|Withdrawal by Subject|0|||
48710928|NCT00740857|156791418|FG002|Overall Study|Withdrawal by Subject|0|||
48807920|NCT01576718|157138210|FG002|Treatment Period|Withdrawal by Subject|1|||
48807921|NCT01576718|157138211|FG003|Treatment Period|Withdrawal by Subject|0|||
48807922|NCT01576718|157138212|FG004|Treatment Period|Withdrawal by Subject|2|||
48807923|NCT01576718|157138213|FG005|Treatment Period|Withdrawal by Subject|4|||
48807924|NCT01576718|157138214|FG006|Treatment Period|Withdrawal by Subject|2|||
48807925|NCT01576718|157138208|FG000|Treatment Period|Physician Decision|0|||
48807926|NCT01576718|157138209|FG001|Treatment Period|Physician Decision|1|||
48807927|NCT01576718|157138210|FG002|Treatment Period|Physician Decision|1|||
48807928|NCT01576718|157138211|FG003|Treatment Period|Physician Decision|1|||
48807929|NCT01576718|157138212|FG004|Treatment Period|Physician Decision|1|||
48807930|NCT01576718|157138213|FG005|Treatment Period|Physician Decision|0|||
48807931|NCT01576718|157138214|FG006|Treatment Period|Physician Decision|0|||
48807932|NCT01576718|157138208|FG000|Treatment Period|Protocol Violation|0|||
48807933|NCT01576718|157138209|FG001|Treatment Period|Protocol Violation|5|||
48807934|NCT01576718|157138210|FG002|Treatment Period|Protocol Violation|4|||
48807935|NCT01576718|157138211|FG003|Treatment Period|Protocol Violation|10|||
48807936|NCT01576718|157138212|FG004|Treatment Period|Protocol Violation|6|||
48807937|NCT01576718|157138213|FG005|Treatment Period|Protocol Violation|8|||
48807938|NCT01576718|157138214|FG006|Treatment Period|Protocol Violation|12|||
48807939|NCT01576718|157138208|FG000|Treatment Period|Sponsor request|0|||
48807940|NCT01576718|157138209|FG001|Treatment Period|Sponsor request|1|||
48807941|NCT01576718|157138210|FG002|Treatment Period|Sponsor request|0|||
48807942|NCT01576718|157138211|FG003|Treatment Period|Sponsor request|0|||
48807943|NCT01576718|157138212|FG004|Treatment Period|Sponsor request|0|||
48807944|NCT01576718|157138213|FG005|Treatment Period|Sponsor request|1|||
48807945|NCT01576718|157138214|FG006|Treatment Period|Sponsor request|0|||
48807946|NCT01576718|157138208|FG000|Treatment Period|Met stopping criteria|0|||
48807947|NCT01576718|157138209|FG001|Treatment Period|Met stopping criteria|16|||
48807948|NCT01576718|157138210|FG002|Treatment Period|Met stopping criteria|13|||
48807949|NCT01576718|157138211|FG003|Treatment Period|Met stopping criteria|19|||
48807950|NCT01576718|157138212|FG004|Treatment Period|Met stopping criteria|16|||
48807951|NCT01576718|157138213|FG005|Treatment Period|Met stopping criteria|33|||
48807952|NCT01576718|157138214|FG006|Treatment Period|Met stopping criteria|15|||
48807953|NCT01576718|157138208|FG000|Treatment Period|Lost to Follow-up|0|||
48807954|NCT01576718|157138209|FG001|Treatment Period|Lost to Follow-up|0|||
48807955|NCT01576718|157138210|FG002|Treatment Period|Lost to Follow-up|0|||
48807956|NCT01576718|157138211|FG003|Treatment Period|Lost to Follow-up|0|||
48710929|NCT02152956|156791419|FG000|Overall Study|Adverse Event|0|||
48710930|NCT02152956|156791420|FG001|Overall Study|Adverse Event|0|||
48807957|NCT01576718|157138212|FG004|Treatment Period|Lost to Follow-up|1|||
48807958|NCT01576718|157138213|FG005|Treatment Period|Lost to Follow-up|0|||
48807959|NCT01576718|157138214|FG006|Treatment Period|Lost to Follow-up|0|||
48807960|NCT01576718|157138208|FG000|Treatment Period|Noncompliance to study medication|0|||
48807961|NCT01576718|157138209|FG001|Treatment Period|Noncompliance to study medication|0|||
48807962|NCT01576718|157138210|FG002|Treatment Period|Noncompliance to study medication|0|||
48807963|NCT01576718|157138211|FG003|Treatment Period|Noncompliance to study medication|0|||
48807964|NCT01576718|157138212|FG004|Treatment Period|Noncompliance to study medication|0|||
48807965|NCT01576718|157138213|FG005|Treatment Period|Noncompliance to study medication|1|||
48807966|NCT01576718|157138214|FG006|Treatment Period|Noncompliance to study medication|1|||
48807967|NCT01126060|157138215|FG000|Overall Study|Protocol Violation|0|||
48807968|NCT01126060|157138216|FG001|Overall Study|Protocol Violation|2|||
48807969|NCT02821819|157138221|FG000|Overall Study|Protocol Violation|1|||
48807970|NCT00856661|157138222|FG000|Overall Study|Death|15|||
48807971|NCT00856661|157138223|FG001|Overall Study|Death|18|||
48807972|NCT00856661|157138222|FG000|Overall Study|Protocol Violation|2|||
48710931|NCT02152956|156791421|FG002|Overall Study|Adverse Event|0|||
48710932|NCT02152956|156791422|FG003|Overall Study|Adverse Event|0|||
48710933|NCT02152956|156791423|FG004|Overall Study|Adverse Event|0|||
48710934|NCT02152956|156791424|FG005|Overall Study|Adverse Event|0|||
48710935|NCT02152956|156791425|FG006|Overall Study|Adverse Event|0|||
48710936|NCT02152956|156791426|FG007|Overall Study|Adverse Event|0|||
48710937|NCT02152956|156791427|FG008|Overall Study|Adverse Event|0|||
48710938|NCT02152956|156791428|FG009|Overall Study|Adverse Event|0|||
48710939|NCT02152956|156791429|FG010|Overall Study|Adverse Event|0|||
48710940|NCT02152956|156791430|FG011|Overall Study|Adverse Event|4|||
48710941|NCT02152956|156791431|FG012|Overall Study|Adverse Event|0|||
48710942|NCT02152956|156791419|FG000|Overall Study|Death|0|||
48710943|NCT02152956|156791420|FG001|Overall Study|Death|3|||
48710944|NCT02152956|156791421|FG002|Overall Study|Death|3|||
48710945|NCT02152956|156791422|FG003|Overall Study|Death|4|||
48710946|NCT02152956|156791423|FG004|Overall Study|Death|1|||
48710947|NCT02152956|156791424|FG005|Overall Study|Death|2|||
48807973|NCT00856661|157138223|FG001|Overall Study|Protocol Violation|1|||
48807974|NCT00856661|157138222|FG000|Overall Study|Withdrawal by Subject|1|||
48710948|NCT02152956|156791425|FG006|Overall Study|Death|6|||
48710949|NCT02152956|156791426|FG007|Overall Study|Death|6|||
48807975|NCT00856661|157138223|FG001|Overall Study|Withdrawal by Subject|2|||
48807976|NCT00856661|157138222|FG000|Overall Study|Lost to Follow-up|1|||
48597168|NCT00547248|156381890|FG003|Overall Study|Protocol Violation|1|||
48597169|NCT00547248|156381887|FG000|Overall Study|Migrated/moved from study area|0|||
48807977|NCT00856661|157138223|FG001|Overall Study|Lost to Follow-up|3|||
48807978|NCT00856661|157138222|FG000|Overall Study|Physician Judgement|8|||
48807979|NCT00856661|157138223|FG001|Overall Study|Physician Judgement|5|||
48807980|NCT04395183|157138225|FG000|Overall Study|Withdrawal by Subject|1|||
48807981|NCT04395183|157138226|FG001|Overall Study|Withdrawal by Subject|0|||
48807982|NCT04395183|157138227|FG002|Overall Study|Withdrawal by Subject|2|||
48807983|NCT04395183|157138228|FG003|Overall Study|Withdrawal by Subject|2|||
48807984|NCT01008475|157138229|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
48807985|NCT01008475|157138230|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
48807986|NCT01008475|157138231|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
48807987|NCT01008475|157138232|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
48807988|NCT01008475|157138233|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
48807989|NCT01008475|157138234|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
48807990|NCT01008475|157138235|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
48807991|NCT02306122|157138237|FG000|Initial Physician Randomization|Physician Decision|0|||
48807992|NCT02306122|157138238|FG001|Initial Physician Randomization|Physician Decision|0|||
48807993|NCT02306122|157138239|FG002|Initial Physician Randomization|Physician Decision|0|||
48807994|NCT02306122|157138240|FG003|Initial Physician Randomization|Physician Decision|0|||
48807995|NCT02306122|157138241|FG004|Initial Physician Randomization|Physician Decision|0|||
48807996|NCT02306122|157138242|FG005|Initial Physician Randomization|Physician Decision|0|||
48807997|NCT02306122|157138243|FG006|Initial Physician Randomization|Physician Decision|0|||
48807998|NCT02306122|157138244|FG007|Initial Physician Randomization|Physician Decision|0|||
48807999|NCT02306122|157138245|FG008|Initial Physician Randomization|Physician Decision|1|||
48808000|NCT02306122|157138246|FG009|Initial Physician Randomization|Physician Decision|0|||
48808001|NCT02306122|157138247|FG010|Initial Physician Randomization|Physician Decision|0|||
48808002|NCT00399763|157138248|FG000|Overall Study|Lost to Follow-up|2|||
48808003|NCT00399763|157138249|FG001|Overall Study|Lost to Follow-up|3|||
48808004|NCT02638623|157138251|FG000|Overall Study|Surgery timing|5|||
48808005|NCT02638623|157138252|FG001|Overall Study|Surgery timing|6|||
48808006|NCT02638623|157138251|FG000|Overall Study|Not given intervention|2|||
48808007|NCT02638623|157138252|FG001|Overall Study|Not given intervention|0|||
48808008|NCT01657266|157138253|FG000|Overall Study|Lost to Follow-up|2|||
48808009|NCT01657266|157138254|FG001|Overall Study|Lost to Follow-up|2|||
48491743|NCT04634409|155992696|FG005|Overall Study|Lost to Follow-up|1|||
48491744|NCT04634409|155992697|FG006|Overall Study|Lost to Follow-up|1|||
48491745|NCT04634409|155992698|FG007|Overall Study|Lost to Follow-up|3|||
48491746|NCT04634409|155992699|FG008|Overall Study|Lost to Follow-up|3|||
48491747|NCT04634409|155992700|FG009|Overall Study|Lost to Follow-up|11|||
48491748|NCT04634409|155992701|FG010|Overall Study|Lost to Follow-up|8|||
48491749|NCT04634409|155992702|FG011|Overall Study|Lost to Follow-up|15|||
48491750|NCT04634409|155992703|FG012|Overall Study|Lost to Follow-up|3|||
48491751|NCT04634409|155992704|FG013|Overall Study|Lost to Follow-up|2|||
48491752|NCT04634409|155992705|FG014|Overall Study|Lost to Follow-up|7|||
48491753|NCT04634409|155992706|FG015|Overall Study|Lost to Follow-up|0|||
48491754|NCT04634409|155992707|FG016|Overall Study|Lost to Follow-up|0|||
48597170|NCT00547248|156381888|FG001|Overall Study|Migrated/moved from study area|0|||
48808010|NCT01657266|157138253|FG000|Overall Study|Adverse Event|2|||
48808011|NCT01657266|157138254|FG001|Overall Study|Adverse Event|3|||
48808012|NCT00909428|157138258|FG000|Overall Study|Lost to Follow-up|13|||
48808013|NCT00909428|157138259|FG001|Overall Study|Lost to Follow-up|10|||
48808014|NCT00909428|157138260|FG002|Overall Study|Lost to Follow-up|9|||
48808015|NCT00457639|157138261|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
48491755|NCT04634409|155992708|FG017|Overall Study|Lost to Follow-up|0|||
48491756|NCT04634409|155992709|FG018|Overall Study|Lost to Follow-up|0|||
48491757|NCT04634409|155992710|FG019|Overall Study|Lost to Follow-up|0|||
48491758|NCT04634409|155992711|FG020|Overall Study|Lost to Follow-up|0|||
48491759|NCT04634409|155992712|FG021|Overall Study|Lost to Follow-up|0|||
48491760|NCT04634409|155992713|FG022|Overall Study|Lost to Follow-up|0|||
48491761|NCT04634409|155992714|FG023|Overall Study|Lost to Follow-up|0|||
48491762|NCT04634409|155992715|FG024|Overall Study|Lost to Follow-up|0|||
48491763|NCT04634409|155992716|FG025|Overall Study|Lost to Follow-up|0|||
48491764|NCT04634409|155992717|FG026|Overall Study|Lost to Follow-up|0|||
48491765|NCT04634409|155992691|FG000|Overall Study|Withdrawal by Subject|3|||
48491766|NCT04634409|155992692|FG001|Overall Study|Withdrawal by Subject|1|||
48491767|NCT04634409|155992693|FG002|Overall Study|Withdrawal by Subject|6|||
48491768|NCT04634409|155992694|FG003|Overall Study|Withdrawal by Subject|4|||
48491769|NCT04634409|155992695|FG004|Overall Study|Withdrawal by Subject|2|||
48491770|NCT04634409|155992696|FG005|Overall Study|Withdrawal by Subject|0|||
48491771|NCT04634409|155992697|FG006|Overall Study|Withdrawal by Subject|0|||
48491772|NCT04634409|155992698|FG007|Overall Study|Withdrawal by Subject|2|||
48491773|NCT04634409|155992699|FG008|Overall Study|Withdrawal by Subject|3|||
48491774|NCT04634409|155992700|FG009|Overall Study|Withdrawal by Subject|2|||
48491775|NCT04634409|155992701|FG010|Overall Study|Withdrawal by Subject|3|||
48491776|NCT04634409|155992702|FG011|Overall Study|Withdrawal by Subject|2|||
48491777|NCT04634409|155992703|FG012|Overall Study|Withdrawal by Subject|2|||
48491778|NCT04634409|155992704|FG013|Overall Study|Withdrawal by Subject|1|||
48491779|NCT04634409|155992705|FG014|Overall Study|Withdrawal by Subject|5|||
48491780|NCT04634409|155992706|FG015|Overall Study|Withdrawal by Subject|0|||
48491781|NCT04634409|155992707|FG016|Overall Study|Withdrawal by Subject|0|||
48491782|NCT04634409|155992708|FG017|Overall Study|Withdrawal by Subject|1|||
48491783|NCT04634409|155992709|FG018|Overall Study|Withdrawal by Subject|0|||
48491784|NCT04634409|155992710|FG019|Overall Study|Withdrawal by Subject|0|||
48491785|NCT04634409|155992711|FG020|Overall Study|Withdrawal by Subject|0|||
48491786|NCT04634409|155992712|FG021|Overall Study|Withdrawal by Subject|0|||
48491787|NCT04634409|155992713|FG022|Overall Study|Withdrawal by Subject|0|||
48491788|NCT04634409|155992714|FG023|Overall Study|Withdrawal by Subject|1|||
48491789|NCT04634409|155992715|FG024|Overall Study|Withdrawal by Subject|0|||
48491790|NCT04634409|155992716|FG025|Overall Study|Withdrawal by Subject|0|||
48491791|NCT04634409|155992717|FG026|Overall Study|Withdrawal by Subject|0|||
48491792|NCT04634409|155992691|FG000|Overall Study|Other - As reported by Investigator|1|||
48491793|NCT04634409|155992692|FG001|Overall Study|Other - As reported by Investigator|0|||
48491794|NCT04634409|155992693|FG002|Overall Study|Other - As reported by Investigator|0|||
48491795|NCT04634409|155992694|FG003|Overall Study|Other - As reported by Investigator|0|||
48491796|NCT04634409|155992695|FG004|Overall Study|Other - As reported by Investigator|0|||
48491797|NCT04634409|155992696|FG005|Overall Study|Other - As reported by Investigator|0|||
48491798|NCT04634409|155992697|FG006|Overall Study|Other - As reported by Investigator|0|||
48491799|NCT04634409|155992698|FG007|Overall Study|Other - As reported by Investigator|6|||
48491800|NCT04634409|155992699|FG008|Overall Study|Other - As reported by Investigator|4|||
48491801|NCT04634409|155992700|FG009|Overall Study|Other - As reported by Investigator|0|||
48491802|NCT04634409|155992701|FG010|Overall Study|Other - As reported by Investigator|1|||
48491803|NCT04634409|155992702|FG011|Overall Study|Other - As reported by Investigator|2|||
48491804|NCT04634409|155992703|FG012|Overall Study|Other - As reported by Investigator|2|||
48491805|NCT04634409|155992704|FG013|Overall Study|Other - As reported by Investigator|1|||
48491806|NCT04634409|155992705|FG014|Overall Study|Other - As reported by Investigator|0|||
48491807|NCT04634409|155992706|FG015|Overall Study|Other - As reported by Investigator|0|||
48491808|NCT04634409|155992707|FG016|Overall Study|Other - As reported by Investigator|0|||
48491809|NCT04634409|155992708|FG017|Overall Study|Other - As reported by Investigator|0|||
48491810|NCT04634409|155992709|FG018|Overall Study|Other - As reported by Investigator|0|||
48491811|NCT04634409|155992710|FG019|Overall Study|Other - As reported by Investigator|0|||
48491812|NCT04634409|155992711|FG020|Overall Study|Other - As reported by Investigator|0|||
48491813|NCT04634409|155992712|FG021|Overall Study|Other - As reported by Investigator|0|||
48491814|NCT04634409|155992713|FG022|Overall Study|Other - As reported by Investigator|0|||
48491815|NCT04634409|155992714|FG023|Overall Study|Other - As reported by Investigator|0|||
48491816|NCT04634409|155992715|FG024|Overall Study|Other - As reported by Investigator|0|||
48491817|NCT04634409|155992716|FG025|Overall Study|Other - As reported by Investigator|0|||
48491818|NCT04634409|155992717|FG026|Overall Study|Other - As reported by Investigator|0|||
48491819|NCT01415921|155994172|FG000|Overall Study|Adverse Event|0|||
48491820|NCT01415921|155994173|FG001|Overall Study|Adverse Event|1|||
48491821|NCT01415921|155994172|FG000|Overall Study|Physician Decision|1|||
48710950|NCT02152956|156791427|FG008|Overall Study|Death|4|||
48710951|NCT02152956|156791428|FG009|Overall Study|Death|5|||
48710952|NCT02152956|156791429|FG010|Overall Study|Death|3|||
48710953|NCT02152956|156791430|FG011|Overall Study|Death|143|||
48710954|NCT02152956|156791431|FG012|Overall Study|Death|12|||
48710955|NCT02152956|156791419|FG000|Overall Study|Lost to Follow-up|0|||
48710956|NCT02152956|156791420|FG001|Overall Study|Lost to Follow-up|1|||
48808016|NCT00457639|157138262|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
48491822|NCT01415921|155994173|FG001|Overall Study|Physician Decision|1|||
48710957|NCT02152956|156791421|FG002|Overall Study|Lost to Follow-up|0|||
48710958|NCT02152956|156791422|FG003|Overall Study|Lost to Follow-up|0|||
48710959|NCT02152956|156791423|FG004|Overall Study|Lost to Follow-up|0|||
48710960|NCT02152956|156791424|FG005|Overall Study|Lost to Follow-up|0|||
48710961|NCT02152956|156791425|FG006|Overall Study|Lost to Follow-up|0|||
48710962|NCT02152956|156791426|FG007|Overall Study|Lost to Follow-up|0|||
48710963|NCT02152956|156791427|FG008|Overall Study|Lost to Follow-up|0|||
48710964|NCT02152956|156791428|FG009|Overall Study|Lost to Follow-up|0|||
48710965|NCT02152956|156791429|FG010|Overall Study|Lost to Follow-up|0|||
48710966|NCT02152956|156791430|FG011|Overall Study|Lost to Follow-up|3|||
48808017|NCT00457639|157138261|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
48808018|NCT00457639|157138262|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
48808019|NCT00457639|157138261|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
48808020|NCT00457639|157138262|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
48808021|NCT02322814|157138265|FG000|Overall Study|Death|7|||
48808022|NCT02322814|157138266|FG001|Overall Study|Death|29|||
48808023|NCT02322814|157138267|FG002|Overall Study|Death|32|||
48597171|NCT00547248|156381889|FG002|Overall Study|Migrated/moved from study area|2|||
48597172|NCT00547248|156381890|FG003|Overall Study|Migrated/moved from study area|0|||
48597173|NCT00547248|156381887|FG000|Overall Study|Withdrawal by Subject|0|||
48597174|NCT00547248|156381888|FG001|Overall Study|Withdrawal by Subject|0|||
48597175|NCT00547248|156381889|FG002|Overall Study|Withdrawal by Subject|7|||
48597176|NCT00547248|156381890|FG003|Overall Study|Withdrawal by Subject|1|||
48597177|NCT00534248|156381891|FG000|Overall Study|Adverse Event|19|||
48597178|NCT00534248|156381892|FG001|Overall Study|Adverse Event|29|||
48597179|NCT00534248|156381891|FG000|Overall Study|Lost to Follow-up|353|||
48597180|NCT00534248|156381892|FG001|Overall Study|Lost to Follow-up|375|||
48597181|NCT00534248|156381891|FG000|Overall Study|Other protocol specified criteria|13|||
48597182|NCT00534248|156381892|FG001|Overall Study|Other protocol specified criteria|3|||
48597183|NCT00534248|156381891|FG000|Overall Study|Physician Decision|10|||
48597184|NCT00534248|156381892|FG001|Overall Study|Physician Decision|7|||
48597185|NCT00534248|156381891|FG000|Overall Study|Protocol Violation|3|||
48597186|NCT00534248|156381892|FG001|Overall Study|Protocol Violation|4|||
48597187|NCT00534248|156381891|FG000|Overall Study|Withdrawal by Subject|263|||
48597188|NCT00534248|156381892|FG001|Overall Study|Withdrawal by Subject|255|||
48597189|NCT02532257|156381893|FG000|Overall Study|Adverse Event|2|||
48597190|NCT02532257|156381893|FG000|Overall Study|Physician Decision|4|||
48597191|NCT02532257|156381893|FG000|Overall Study|Withdrawal by Subject|3|||
48597192|NCT02532257|156381893|FG000|Overall Study|Progressive Disease|10|||
48597193|NCT00697593|156381897|FG000|Overall Study|Adverse Event|3|||
48597194|NCT00697593|156381897|FG000|Overall Study|Protocol Violation|1|||
48597195|NCT00697593|156381897|FG000|Overall Study|Lack of Efficacy|3|||
48597196|NCT00697593|156381897|FG000|Overall Study|Suspension of the study by sponsor|12|||
48597197|NCT02964338|156381901|FG000|Overall Study|Sponsor terminated study for futility|12|||
48597198|NCT02964338|156381902|FG001|Overall Study|Sponsor terminated study for futility|15|||
48597199|NCT02964338|156381903|FG002|Overall Study|Sponsor terminated study for futility|14|||
48597200|NCT02964338|156381901|FG000|Overall Study|Lack of Efficacy|0|||
48597201|NCT02964338|156381902|FG001|Overall Study|Lack of Efficacy|3|||
48597202|NCT02964338|156381903|FG002|Overall Study|Lack of Efficacy|0|||
48597203|NCT02964338|156381901|FG000|Overall Study|Lost to Follow-up|1|||
48597204|NCT02964338|156381902|FG001|Overall Study|Lost to Follow-up|0|||
48597205|NCT02964338|156381903|FG002|Overall Study|Lost to Follow-up|3|||
48597206|NCT02964338|156381901|FG000|Overall Study|Protocol Violation|0|||
48597207|NCT02964338|156381902|FG001|Overall Study|Protocol Violation|1|||
48597208|NCT02964338|156381903|FG002|Overall Study|Protocol Violation|0|||
48597209|NCT02964338|156381901|FG000|Overall Study|Withdrawal by Subject|1|||
48597210|NCT02964338|156381902|FG001|Overall Study|Withdrawal by Subject|3|||
48597211|NCT02964338|156381903|FG002|Overall Study|Withdrawal by Subject|1|||
48597212|NCT02964338|156381901|FG000|Overall Study|Adverse Event|2|||
48597213|NCT02964338|156381902|FG001|Overall Study|Adverse Event|1|||
48597214|NCT02964338|156381903|FG002|Overall Study|Adverse Event|1|||
48597215|NCT02964338|156381901|FG000|Overall Study|Non-compliant with e-diary|0|||
48597216|NCT02964338|156381902|FG001|Overall Study|Non-compliant with e-diary|1|||
48597217|NCT02964338|156381903|FG002|Overall Study|Non-compliant with e-diary|0|||
48597218|NCT02964338|156381901|FG000|Overall Study|Did not meet criteria|1|||
48597219|NCT02964338|156381902|FG001|Overall Study|Did not meet criteria|0|||
48597220|NCT02964338|156381903|FG002|Overall Study|Did not meet criteria|0|||
48597221|NCT01214668|156381909|FG000|Overall Study|Adverse Event|0|||
48597222|NCT01214668|156381910|FG001|Overall Study|Adverse Event|1|||
48597223|NCT01214668|156381911|FG002|Overall Study|Adverse Event|0|||
48597224|NCT01214668|156381912|FG003|Overall Study|Adverse Event|2|||
48597225|NCT01214668|156381913|FG004|Overall Study|Adverse Event|1|||
48597226|NCT01214668|156381914|FG005|Overall Study|Adverse Event|1|||
48597227|NCT01214668|156381909|FG000|Overall Study|Death|0|||
48597228|NCT01214668|156381910|FG001|Overall Study|Death|0|||
48597229|NCT01214668|156381911|FG002|Overall Study|Death|1|||
48710967|NCT02152956|156791431|FG012|Overall Study|Lost to Follow-up|0|||
48597230|NCT01214668|156381912|FG003|Overall Study|Death|0|||
48597231|NCT01214668|156381913|FG004|Overall Study|Death|0|||
48597232|NCT01214668|156381914|FG005|Overall Study|Death|0|||
48710968|NCT02152956|156791419|FG000|Overall Study|Withdrawal by Subject|1|||
48808024|NCT02322814|157138268|FG003|Overall Study|Death|23|||
48808025|NCT02322814|157138269|FG004|Overall Study|Death|14|||
48808026|NCT02322814|157138265|FG000|Overall Study|Lost to Follow-up|1|||
48808027|NCT02322814|157138266|FG001|Overall Study|Lost to Follow-up|3|||
48808028|NCT02322814|157138267|FG002|Overall Study|Lost to Follow-up|3|||
48808029|NCT02322814|157138268|FG003|Overall Study|Lost to Follow-up|1|||
48808030|NCT02322814|157138269|FG004|Overall Study|Lost to Follow-up|0|||
48808031|NCT02322814|157138265|FG000|Overall Study|Various Reasons|2|||
48808032|NCT02322814|157138266|FG001|Overall Study|Various Reasons|0|||
48808033|NCT02322814|157138267|FG002|Overall Study|Various Reasons|1|||
48808034|NCT02322814|157138268|FG003|Overall Study|Various Reasons|1|||
48597233|NCT01214668|156381909|FG000|Overall Study|Progressive Disease|4|||
48597234|NCT01214668|156381910|FG001|Overall Study|Progressive Disease|2|||
48597235|NCT01214668|156381911|FG002|Overall Study|Progressive Disease|5|||
48597236|NCT01214668|156381912|FG003|Overall Study|Progressive Disease|4|||
48597237|NCT01214668|156381913|FG004|Overall Study|Progressive Disease|4|||
48597238|NCT01214668|156381914|FG005|Overall Study|Progressive Disease|5|||
48597239|NCT01214668|156381909|FG000|Overall Study|Withdrawal by Subject|0|||
48597240|NCT01214668|156381910|FG001|Overall Study|Withdrawal by Subject|0|||
48597241|NCT01214668|156381911|FG002|Overall Study|Withdrawal by Subject|0|||
48597242|NCT01214668|156381912|FG003|Overall Study|Withdrawal by Subject|0|||
48597243|NCT01214668|156381913|FG004|Overall Study|Withdrawal by Subject|1|||
48597244|NCT01214668|156381914|FG005|Overall Study|Withdrawal by Subject|0|||
48597245|NCT01964989|156381915|FG000|Overall Study|Protocol Violation|3|||
48597246|NCT01964989|156381916|FG001|Overall Study|Protocol Violation|4|||
48597247|NCT01964989|156381915|FG000|Overall Study|Administrative Reason|103|||
48597248|NCT01964989|156381916|FG001|Overall Study|Administrative Reason|95|||
48597249|NCT01964989|156381915|FG000|Overall Study|Adverse Event|0|||
48597250|NCT01964989|156381916|FG001|Overall Study|Adverse Event|1|||
48597251|NCT01964989|156381915|FG000|Overall Study|Death|1|||
48597252|NCT01964989|156381916|FG001|Overall Study|Death|3|||
48597253|NCT01964989|156381915|FG000|Overall Study|Withdrawal by Subject|156|||
48597254|NCT01964989|156381916|FG001|Overall Study|Withdrawal by Subject|160|||
48597255|NCT01964989|156381915|FG000|Overall Study|Lost to Follow-up|254|||
48597256|NCT01964989|156381916|FG001|Overall Study|Lost to Follow-up|232|||
48597257|NCT01964989|156381915|FG000|Overall Study|Other|267|||
48597258|NCT01964989|156381916|FG001|Overall Study|Other|252|||
48597259|NCT02061813|156381917|FG000|Overall Study|Withdrawal by Subject|1|||
48597260|NCT02061813|156381917|FG000|Overall Study|Protocol Violation|2|||
48597261|NCT02299388|156381923|FG000|Overall Study|Withdrawal by Subject|0|||
48597262|NCT02299388|156381924|FG001|Overall Study|Withdrawal by Subject|1|||
48597263|NCT00941304|156381927|FG000|Overall Study|Lost to Follow-up|1|||
48597264|NCT00941304|156381928|FG001|Overall Study|Lost to Follow-up|0|||
48597265|NCT00941304|156381929|FG002|Overall Study|Lost to Follow-up|0|||
48597266|NCT00941304|156381930|FG003|Overall Study|Lost to Follow-up|0|||
48597267|NCT00941304|156381931|FG004|Overall Study|Lost to Follow-up|0|||
48597268|NCT02256839|156381932|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
48597269|NCT02256839|156381933|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
48597270|NCT01843803|156381934|FG000|Overall Study|not a Veteran, did not see provider|1|||
48597271|NCT01843803|156381935|FG001|Overall Study|not a Veteran, did not see provider|3|||
48597272|NCT04633226|156381944|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48597273|NCT04633226|156381944|FG000|Overall Study|Randomized by mistake without study treatment|1|||
48597274|NCT02227784|156381946|FG000|Double-Blind Phase|Adverse Event|3|||
48597275|NCT02227784|156381947|FG001|Double-Blind Phase|Adverse Event|2|||
48597276|NCT02227784|156381948|FG002|Double-Blind Phase|Adverse Event|1|||
48597277|NCT02227784|156381949|FG003|Double-Blind Phase|Adverse Event|3|||
48597278|NCT02227784|156381950|FG004|Double-Blind Phase|Adverse Event|0|||
48597279|NCT02227784|156381946|FG000|Double-Blind Phase|Physician Decision|1|||
48597280|NCT02227784|156381947|FG001|Double-Blind Phase|Physician Decision|0|||
48597281|NCT02227784|156381948|FG002|Double-Blind Phase|Physician Decision|0|||
48597282|NCT02227784|156381949|FG003|Double-Blind Phase|Physician Decision|1|||
48597283|NCT02227784|156381950|FG004|Double-Blind Phase|Physician Decision|0|||
48597284|NCT02227784|156381946|FG000|Double-Blind Phase|Protocol Violation|0|||
48597285|NCT02227784|156381947|FG001|Double-Blind Phase|Protocol Violation|0|||
48597286|NCT02227784|156381948|FG002|Double-Blind Phase|Protocol Violation|1|||
48808035|NCT02322814|157138269|FG004|Overall Study|Various Reasons|0|||
48808036|NCT02322814|157138265|FG000|Overall Study|Progressive Disease|0|||
48808037|NCT02322814|157138266|FG001|Overall Study|Progressive Disease|0|||
48597287|NCT02227784|156381949|FG003|Double-Blind Phase|Protocol Violation|1|||
48597288|NCT02227784|156381950|FG004|Double-Blind Phase|Protocol Violation|0|||
48597289|NCT02227784|156381946|FG000|Double-Blind Phase|Sponsor Decision|34|||
48597290|NCT02227784|156381947|FG001|Double-Blind Phase|Sponsor Decision|15|||
48597291|NCT02227784|156381948|FG002|Double-Blind Phase|Sponsor Decision|14|||
48597292|NCT02227784|156381949|FG003|Double-Blind Phase|Sponsor Decision|32|||
48597293|NCT02227784|156381950|FG004|Double-Blind Phase|Sponsor Decision|0|||
48597294|NCT02227784|156381946|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
48808038|NCT02322814|157138267|FG002|Overall Study|Progressive Disease|0|||
48808039|NCT02322814|157138268|FG003|Overall Study|Progressive Disease|1|||
48808040|NCT02322814|157138269|FG004|Overall Study|Progressive Disease|1|||
48808041|NCT02322814|157138265|FG000|Overall Study|Protocol Violation|1|||
48808042|NCT02322814|157138266|FG001|Overall Study|Protocol Violation|0|||
48808043|NCT02322814|157138267|FG002|Overall Study|Protocol Violation|0|||
48808044|NCT02322814|157138268|FG003|Overall Study|Protocol Violation|0|||
48808045|NCT02322814|157138269|FG004|Overall Study|Protocol Violation|0|||
48808046|NCT02322814|157138265|FG000|Overall Study|Study Terminated by Sponsor|0|||
48808047|NCT02322814|157138266|FG001|Overall Study|Study Terminated by Sponsor|7|||
48808048|NCT02322814|157138267|FG002|Overall Study|Study Terminated by Sponsor|9|||
48808049|NCT02322814|157138268|FG003|Overall Study|Study Terminated by Sponsor|5|||
48808050|NCT02322814|157138269|FG004|Overall Study|Study Terminated by Sponsor|13|||
48808051|NCT02322814|157138265|FG000|Overall Study|Withdrawal by Subject|5|||
48808052|NCT02322814|157138266|FG001|Overall Study|Withdrawal by Subject|4|||
48808053|NCT02322814|157138267|FG002|Overall Study|Withdrawal by Subject|2|||
48808054|NCT02322814|157138268|FG003|Overall Study|Withdrawal by Subject|1|||
48808055|NCT02322814|157138269|FG004|Overall Study|Withdrawal by Subject|3|||
48808056|NCT01861522|157138270|FG000|Overall Study|Adverse Event|1|||
48808057|NCT01861522|157138271|FG001|Overall Study|Adverse Event|0|||
48808058|NCT01861522|157138270|FG000|Overall Study|Withdrawal by Subject|2|||
48808059|NCT01861522|157138271|FG001|Overall Study|Withdrawal by Subject|0|||
48808060|NCT00550550|157138272|FG000|Overall Study|Adverse Event|13|||
48808061|NCT00550550|157138273|FG001|Overall Study|Adverse Event|5|||
48808062|NCT00550550|157138272|FG000|Overall Study|Treatment Failure|0|||
48808063|NCT00550550|157138273|FG001|Overall Study|Treatment Failure|1|||
48808064|NCT00550550|157138272|FG000|Overall Study|Lost to Follow-up|4|||
48808065|NCT00550550|157138273|FG001|Overall Study|Lost to Follow-up|0|||
48808066|NCT00550550|157138272|FG000|Overall Study|Withdrawal by Subject|10|||
48808067|NCT00550550|157138273|FG001|Overall Study|Withdrawal by Subject|8|||
48808068|NCT00550550|157138272|FG000|Overall Study|Protocol Violation|5|||
48808069|NCT00550550|157138273|FG001|Overall Study|Protocol Violation|14|||
48808070|NCT00550550|157138272|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
48808071|NCT00550550|157138273|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
48808072|NCT00550550|157138272|FG000|Overall Study|Randomized But Not Treated|1|||
48808073|NCT00550550|157138273|FG001|Overall Study|Randomized But Not Treated|0|||
48808074|NCT01164228|157138274|FG000|Overall Study|Progression|24|||
48808075|NCT01164228|157138275|FG001|Overall Study|Progression|25|||
48808076|NCT01164228|157138274|FG000|Overall Study|Adverse Event|13|||
48808077|NCT01164228|157138275|FG001|Overall Study|Adverse Event|7|||
48808078|NCT01164228|157138274|FG000|Overall Study|Death|1|||
48808079|NCT01164228|157138275|FG001|Overall Study|Death|1|||
48808080|NCT01164228|157138274|FG000|Overall Study|Withdrawal by Subject|2|||
48808081|NCT01164228|157138275|FG001|Overall Study|Withdrawal by Subject|0|||
48808082|NCT01164228|157138274|FG000|Overall Study|Physician Decision|1|||
48808083|NCT01164228|157138275|FG001|Overall Study|Physician Decision|2|||
48808084|NCT01164228|157138274|FG000|Overall Study|Symptomatic deterioration|1|||
48808085|NCT01164228|157138275|FG001|Overall Study|Symptomatic deterioration|0|||
48808086|NCT01164228|157138274|FG000|Overall Study|Never started treatment|1|||
48808087|NCT01164228|157138275|FG001|Overall Study|Never started treatment|3|||
48808088|NCT01164228|157138274|FG000|Overall Study|Ineligible|1|||
48808089|NCT01164228|157138275|FG001|Overall Study|Ineligible|0|||
48808090|NCT03757234|157138276|FG000|Overall Study|Adverse Event|0|||
48808091|NCT03757234|157138277|FG001|Overall Study|Adverse Event|0|||
48808092|NCT03757234|157138278|FG002|Overall Study|Adverse Event|0|||
48808093|NCT03757234|157138279|FG003|Overall Study|Adverse Event|0|||
48808094|NCT03757234|157138280|FG004|Overall Study|Adverse Event|1|||
48808095|NCT03757234|157138276|FG000|Overall Study|Lost to Follow-up|1|||
48597295|NCT02227784|156381947|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
48597296|NCT02227784|156381948|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
48597297|NCT02227784|156381949|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
48597298|NCT02227784|156381950|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
48597299|NCT02227784|156381946|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
48808096|NCT03757234|157138277|FG001|Overall Study|Lost to Follow-up|0|||
48808097|NCT03757234|157138278|FG002|Overall Study|Lost to Follow-up|0|||
48808098|NCT03757234|157138279|FG003|Overall Study|Lost to Follow-up|0|||
48808099|NCT03757234|157138280|FG004|Overall Study|Lost to Follow-up|1|||
48808100|NCT03757234|157138276|FG000|Overall Study|Withdrawal by Subject|1|||
48808101|NCT03757234|157138277|FG001|Overall Study|Withdrawal by Subject|1|||
48808102|NCT03757234|157138278|FG002|Overall Study|Withdrawal by Subject|0|||
48597300|NCT02227784|156381947|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
48808103|NCT03757234|157138279|FG003|Overall Study|Withdrawal by Subject|1|||
48808104|NCT03757234|157138280|FG004|Overall Study|Withdrawal by Subject|2|||
48808105|NCT03757234|157138276|FG000|Overall Study|Other|1|||
48808106|NCT03757234|157138277|FG001|Overall Study|Other|1|||
48808107|NCT03757234|157138278|FG002|Overall Study|Other|0|||
48808108|NCT03757234|157138279|FG003|Overall Study|Other|0|||
48808109|NCT03757234|157138280|FG004|Overall Study|Other|0|||
48808110|NCT03311230|157138283|FG000|Overall Study|Withdrawal by Subject|1|||
48808111|NCT03311230|157138284|FG001|Overall Study|Withdrawal by Subject|4|||
48808112|NCT03311230|157138285|FG002|Overall Study|Withdrawal by Subject|2|||
48808113|NCT03311230|157138286|FG003|Overall Study|Withdrawal by Subject|7|||
48808114|NCT03311230|157138283|FG000|Overall Study|Unrelated injury|0|||
48808115|NCT03311230|157138284|FG001|Overall Study|Unrelated injury|1|||
48808116|NCT03311230|157138285|FG002|Overall Study|Unrelated injury|0|||
48808117|NCT03311230|157138286|FG003|Overall Study|Unrelated injury|0|||
48808118|NCT02041923|157138288|FG000|Overall Study|Lost to Follow-up|26|||
48808119|NCT02041923|157138289|FG001|Overall Study|Lost to Follow-up|30|||
48808120|NCT00876460|157138290|FG000|Combination Therapy Phase|Progressive disease|2|||
48808121|NCT00876460|157138291|FG001|Combination Therapy Phase|Progressive disease|3|||
48808122|NCT00876460|157138292|FG002|Combination Therapy Phase|Progressive disease|3|||
48808123|NCT00876460|157138293|FG003|Combination Therapy Phase|Progressive disease|3|||
48808124|NCT00876460|157138294|FG004|Combination Therapy Phase|Progressive disease|3|||
48808125|NCT00876460|157138295|FG005|Combination Therapy Phase|Progressive disease|1|||
48808126|NCT00876460|157138296|FG006|Combination Therapy Phase|Progressive disease|1|||
48808127|NCT00876460|157138297|FG007|Combination Therapy Phase|Progressive disease|1|||
48808128|NCT00876460|157138290|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
48808129|NCT00876460|157138291|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
48808130|NCT00876460|157138292|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
48808131|NCT00876460|157138293|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
48808132|NCT00876460|157138294|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
48808133|NCT00876460|157138295|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
48808134|NCT00876460|157138296|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
48808135|NCT00876460|157138297|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
48808136|NCT00876460|157138290|FG000|Combination Therapy Phase|Adverse Event|0|||
48808137|NCT00876460|157138291|FG001|Combination Therapy Phase|Adverse Event|2|||
48808138|NCT00876460|157138292|FG002|Combination Therapy Phase|Adverse Event|0|||
48808139|NCT00876460|157138293|FG003|Combination Therapy Phase|Adverse Event|2|||
48808140|NCT00876460|157138294|FG004|Combination Therapy Phase|Adverse Event|2|||
48808141|NCT00876460|157138295|FG005|Combination Therapy Phase|Adverse Event|0|||
48808142|NCT00876460|157138296|FG006|Combination Therapy Phase|Adverse Event|3|||
48808143|NCT00876460|157138297|FG007|Combination Therapy Phase|Adverse Event|2|||
48808144|NCT00876460|157138290|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
48808145|NCT00876460|157138291|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
48808146|NCT00876460|157138292|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
48808147|NCT00876460|157138293|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
48808148|NCT00876460|157138294|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
48808149|NCT00876460|157138295|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
48808150|NCT00876460|157138296|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
48808151|NCT00876460|157138297|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
48808152|NCT00876460|157138290|FG000|Combination Therapy Phase|Other reason not defined above|0|||
48808153|NCT00876460|157138291|FG001|Combination Therapy Phase|Other reason not defined above|0|||
48808154|NCT00876460|157138292|FG002|Combination Therapy Phase|Other reason not defined above|0|||
48808155|NCT00876460|157138293|FG003|Combination Therapy Phase|Other reason not defined above|0|||
48808156|NCT00876460|157138294|FG004|Combination Therapy Phase|Other reason not defined above|0|||
48808157|NCT00876460|157138295|FG005|Combination Therapy Phase|Other reason not defined above|0|||
48808158|NCT00876460|157138296|FG006|Combination Therapy Phase|Other reason not defined above|1|||
48808159|NCT00876460|157138297|FG007|Combination Therapy Phase|Other reason not defined above|2|||
48808160|NCT00876460|157138290|FG000|Combination Therapy Phase|Not treated|0|||
48808161|NCT00876460|157138291|FG001|Combination Therapy Phase|Not treated|0|||
48808162|NCT00876460|157138292|FG002|Combination Therapy Phase|Not treated|0|||
48808163|NCT00876460|157138293|FG003|Combination Therapy Phase|Not treated|0|||
48808164|NCT00876460|157138294|FG004|Combination Therapy Phase|Not treated|0|||
48808165|NCT00876460|157138295|FG005|Combination Therapy Phase|Not treated|0|||
48808166|NCT00876460|157138296|FG006|Combination Therapy Phase|Not treated|1|||
48808167|NCT00876460|157138297|FG007|Combination Therapy Phase|Not treated|0|||
48808168|NCT00876460|157138290|FG000|Mono Therapy Phase|Progressive disease|0|||
48808169|NCT00876460|157138291|FG001|Mono Therapy Phase|Progressive disease|0|||
48808170|NCT00876460|157138292|FG002|Mono Therapy Phase|Progressive disease|0|||
48808171|NCT00876460|157138293|FG003|Mono Therapy Phase|Progressive disease|0|||
48808172|NCT00876460|157138294|FG004|Mono Therapy Phase|Progressive disease|2|||
48808173|NCT00876460|157138295|FG005|Mono Therapy Phase|Progressive disease|0|||
48808174|NCT00876460|157138296|FG006|Mono Therapy Phase|Progressive disease|1|||
48435008|NCT00195260|155780611|FG005|Part 1: Dose Escalation|Death|0|||
48435009|NCT00195260|155780612|FG006|Part 1: Dose Escalation|Death|0|||
48435010|NCT00195260|155780613|FG007|Part 1: Dose Escalation|Death|1|||
48435011|NCT00195260|155780614|FG008|Part 1: Dose Escalation|Death|0|||
48435012|NCT00195260|155780615|FG009|Part 1: Dose Escalation|Death|0|||
48435013|NCT00195260|155780616|FG010|Part 1: Dose Escalation|Death|0|||
48435014|NCT00195260|155780606|FG000|Part 1: Dose Escalation|Disease Progression|3|||
48435015|NCT00195260|155780607|FG001|Part 1: Dose Escalation|Disease Progression|2|||
48808175|NCT00876460|157138297|FG007|Mono Therapy Phase|Progressive disease|3|||
48808176|NCT00876460|157138290|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
48808177|NCT00876460|157138291|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
48808178|NCT00876460|157138292|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
48808179|NCT00876460|157138293|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
48808180|NCT00876460|157138294|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
48808181|NCT00876460|157138295|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
48808182|NCT00876460|157138296|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
48808183|NCT00876460|157138297|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
48808184|NCT00876460|157138290|FG000|Mono Therapy Phase|Adverse Event|0|||
48808185|NCT00876460|157138291|FG001|Mono Therapy Phase|Adverse Event|0|||
48808186|NCT00876460|157138292|FG002|Mono Therapy Phase|Adverse Event|0|||
48808187|NCT00876460|157138293|FG003|Mono Therapy Phase|Adverse Event|1|||
48808188|NCT00876460|157138294|FG004|Mono Therapy Phase|Adverse Event|0|||
48808189|NCT00876460|157138295|FG005|Mono Therapy Phase|Adverse Event|0|||
48808190|NCT00876460|157138296|FG006|Mono Therapy Phase|Adverse Event|0|||
48808191|NCT00876460|157138297|FG007|Mono Therapy Phase|Adverse Event|0|||
48808192|NCT03443713|157138302|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
48808193|NCT03443713|157138303|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
48808194|NCT03443713|157138304|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
48808195|NCT03713021|157138306|FG000|Overall Study|Did not have CT sim scan available|6|||
48808196|NCT03713021|157138306|FG000|Overall Study|Not eligible|4|||
48808197|NCT03713021|157138306|FG000|Overall Study|Issues with TraceIT markers|5|||
48808198|NCT01672853|157138307|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
48808199|NCT01672853|157138308|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
48808200|NCT01672853|157138309|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
48808201|NCT01672853|157138307|FG000|Overall Study|Pregnancy|0|||
48808202|NCT01672853|157138308|FG001|Overall Study|Pregnancy|1|||
48808203|NCT01672853|157138309|FG002|Overall Study|Pregnancy|0|||
48808204|NCT01672853|157138307|FG000|Overall Study|Investigator's Discretion|1|||
48808205|NCT01672853|157138308|FG001|Overall Study|Investigator's Discretion|0|||
48808206|NCT01672853|157138309|FG002|Overall Study|Investigator's Discretion|0|||
48808207|NCT01672853|157138307|FG000|Overall Study|Withdrew Consent|5|||
48808208|NCT01672853|157138308|FG001|Overall Study|Withdrew Consent|5|||
48808209|NCT01672853|157138309|FG002|Overall Study|Withdrew Consent|5|||
48808210|NCT01672853|157138307|FG000|Overall Study|Adverse Event|4|||
48808211|NCT01672853|157138308|FG001|Overall Study|Adverse Event|6|||
48808212|NCT01672853|157138309|FG002|Overall Study|Adverse Event|8|||
48808213|NCT01672853|157138307|FG000|Overall Study|Lost to Follow-up|0|||
48808214|NCT01672853|157138308|FG001|Overall Study|Lost to Follow-up|1|||
48808215|NCT01672853|157138309|FG002|Overall Study|Lost to Follow-up|0|||
48808216|NCT01672853|157138307|FG000|Overall Study|Randomized but Never Treated|0|||
48808217|NCT01672853|157138308|FG001|Overall Study|Randomized but Never Treated|0|||
48808218|NCT01672853|157138309|FG002|Overall Study|Randomized but Never Treated|1|||
48808219|NCT05660434|157138310|FG000|Overall Study|Never obtained study materials|2|||
48808220|NCT05660434|157138311|FG001|Overall Study|Never obtained study materials|1|||
48808221|NCT03880955|157138312|FG000|Overall Study|Adverse Event|1|||
48808222|NCT03880955|157138312|FG000|Overall Study|Death|1|||
48808223|NCT03880955|157138312|FG000|Overall Study|Lost to Follow-up|12|||
48808224|NCT03880955|157138312|FG000|Overall Study|Withdrawal by Subject|4|||
48808225|NCT03880955|157138312|FG000|Overall Study|Missing- Study Site Closed|27|||
48808226|NCT04159519|157138313|FG000|Overall Study|Adverse Event|1|||
48808227|NCT04159519|157138314|FG001|Overall Study|Adverse Event|1|||
48808228|NCT04159519|157138313|FG000|Overall Study|Lack of Efficacy|1|||
48808229|NCT04159519|157138314|FG001|Overall Study|Lack of Efficacy|0|||
48808230|NCT04159519|157138313|FG000|Overall Study|Discontinued from study|1|||
48808231|NCT04159519|157138314|FG001|Overall Study|Discontinued from study|0|||
48808232|NCT04159519|157138313|FG000|Overall Study|Protocol Violation|1|||
48808233|NCT04159519|157138314|FG001|Overall Study|Protocol Violation|1|||
48808234|NCT04159519|157138313|FG000|Overall Study|Withdrawal by Subject|4|||
48808235|NCT04159519|157138314|FG001|Overall Study|Withdrawal by Subject|4|||
48808236|NCT03391960|157138315|FG000|Overall Study|Protocol Violation|0|||
48808237|NCT03391960|157138316|FG001|Overall Study|Protocol Violation|0|||
48808238|NCT01364922|157140160|FG000|Open-label (OL) Period|Adverse Event|7|||
48808239|NCT01364922|157140161|FG001|Open-label (OL) Period|Adverse Event|0|||
48808240|NCT01364922|157140162|FG002|Open-label (OL) Period|Adverse Event|0|||
48808241|NCT01364922|157140160|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
48808242|NCT01364922|157140161|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
48808243|NCT01364922|157140162|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
48808244|NCT01364922|157140160|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
48808245|NCT01364922|157140161|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
48808246|NCT01364922|157140162|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
48808247|NCT01364922|157140160|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
48808248|NCT01364922|157140161|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
48808249|NCT01364922|157140162|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
48808250|NCT01364922|157140160|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
48808251|NCT01364922|157140161|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
48808252|NCT01364922|157140162|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
48808253|NCT01364922|157140160|FG000|Open-label (OL) Period|Other, Unspecified|1|||
48808254|NCT01364922|157140161|FG001|Open-label (OL) Period|Other, Unspecified|0|||
48808255|NCT01364922|157140162|FG002|Open-label (OL) Period|Other, Unspecified|0|||
48808256|NCT01364922|157140160|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
48808257|NCT01364922|157140161|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
48808258|NCT01364922|157140162|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
48808259|NCT01364922|157140160|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
48808260|NCT01364922|157140161|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
48808261|NCT01364922|157140162|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
48808262|NCT01364922|157140160|FG000|Double-Blind (DB) Period|Adverse Event|0|||
48808263|NCT01364922|157140161|FG001|Double-Blind (DB) Period|Adverse Event|0|||
48808264|NCT01364922|157140162|FG002|Double-Blind (DB) Period|Adverse Event|1|||
48808265|NCT01364922|157140160|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
48808266|NCT01364922|157140161|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
48808267|NCT01364922|157140162|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
48808268|NCT03559218|157140163|FG000|Overall Study|Withdrawal by Subject|1|||
48808269|NCT03559218|157140164|FG001|Overall Study|Withdrawal by Subject|0|||
48808270|NCT04277455|157140167|FG000|Overall Study|Lost to Follow-up|1|||
48808271|NCT01659658|157140170|FG000|Overall Study|Withdrawal by Patient|18|||
48808272|NCT01659658|157140171|FG001|Overall Study|Withdrawal by Patient|4|||
48808273|NCT01659658|157140172|FG002|Overall Study|Withdrawal by Patient|2|||
48808274|NCT01659658|157140173|FG003|Overall Study|Withdrawal by Patient|0|||
48808275|NCT01659658|157140174|FG004|Overall Study|Withdrawal by Patient|11|||
48808276|NCT01659658|157140170|FG000|Overall Study|Study Terminated by Sponsor|9|||
48808277|NCT01659658|157140171|FG001|Overall Study|Study Terminated by Sponsor|7|||
48808278|NCT01659658|157140172|FG002|Overall Study|Study Terminated by Sponsor|0|||
48808279|NCT01659658|157140173|FG003|Overall Study|Study Terminated by Sponsor|1|||
48808280|NCT01659658|157140174|FG004|Overall Study|Study Terminated by Sponsor|4|||
48808281|NCT01659658|157140170|FG000|Overall Study|Reason not Specified|61|||
48808282|NCT01659658|157140171|FG001|Overall Study|Reason not Specified|15|||
48808283|NCT01659658|157140172|FG002|Overall Study|Reason not Specified|8|||
48808284|NCT01659658|157140173|FG003|Overall Study|Reason not Specified|1|||
48808285|NCT01659658|157140174|FG004|Overall Study|Reason not Specified|34|||
48808286|NCT01659658|157140170|FG000|Overall Study|Lost to Follow-up|2|||
48808287|NCT01659658|157140171|FG001|Overall Study|Lost to Follow-up|0|||
48808288|NCT01659658|157140172|FG002|Overall Study|Lost to Follow-up|0|||
48808289|NCT01659658|157140173|FG003|Overall Study|Lost to Follow-up|0|||
48808290|NCT01659658|157140174|FG004|Overall Study|Lost to Follow-up|0|||
48808291|NCT01679301|157140175|FG000|Screening Period|screen failure|3|||
48808292|NCT01679301|157140176|FG001|Screening Period|screen failure|0|||
48808293|NCT01679301|157140177|FG002|Screening Period|screen failure|0|||
48808294|NCT01582789|157140182|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
48808295|NCT01582789|157140183|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
48808296|NCT03328143|157140184|FG000|Overall Study|Declined|3|||
48808297|NCT03328143|157140184|FG000|Overall Study|Required increased sedation|4|||
48808298|NCT03328143|157140184|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
48808299|NCT03328143|157140184|FG000|Overall Study|Surgery cancelled|1|||
48808300|NCT03610737|157140185|FG000|Overall Study|Withdrawal by Subject|1|||
48808301|NCT03610737|157140186|FG001|Overall Study|Withdrawal by Subject|5|||
48808302|NCT03610737|157140185|FG000|Overall Study|Death|1|||
48808303|NCT03610737|157140186|FG001|Overall Study|Death|0|||
48808304|NCT03610737|157140185|FG000|Overall Study|Not treated|5|||
48808305|NCT03610737|157140186|FG001|Overall Study|Not treated|2|||
48808306|NCT03610737|157140185|FG000|Overall Study|Missed Visit|1|||
48808307|NCT03610737|157140186|FG001|Overall Study|Missed Visit|2|||
48808308|NCT00944658|157140187|FG000|Treatment 12 Weeks|Adverse Event|0|||
48808309|NCT00944658|157140188|FG001|Treatment 12 Weeks|Adverse Event|2|||
48808310|NCT02254408|157140192|FG000|Overall Study|Randomized But Not Treated|1|||
48808311|NCT02254408|157140193|FG001|Overall Study|Randomized But Not Treated|3|||
48808312|NCT02254408|157140192|FG000|Overall Study|Adverse Event|1|||
48808313|NCT02254408|157140193|FG001|Overall Study|Adverse Event|0|||
48808314|NCT02254408|157140192|FG000|Overall Study|Death|2|||
48808315|NCT02254408|157140193|FG001|Overall Study|Death|3|||
48808316|NCT02254408|157140192|FG000|Overall Study|Investigator's Discretion|0|||
48808317|NCT02254408|157140193|FG001|Overall Study|Investigator's Discretion|1|||
48808318|NCT02254408|157140192|FG000|Overall Study|Withdrawal by Subject|3|||
48808319|NCT02254408|157140193|FG001|Overall Study|Withdrawal by Subject|3|||
48808320|NCT02254408|157140192|FG000|Overall Study|Lost to Follow-up|1|||
48808321|NCT02254408|157140193|FG001|Overall Study|Lost to Follow-up|0|||
48808322|NCT01993017|157140194|FG000|Overall Study|Death|23|||
48808323|NCT01993017|157140195|FG001|Overall Study|Death|26|||
48808324|NCT01993017|157140196|FG002|Overall Study|Death|18|||
48808325|NCT01993017|157140194|FG000|Overall Study|Could not be contacted|43|||
48808326|NCT01993017|157140195|FG001|Overall Study|Could not be contacted|42|||
48808327|NCT01993017|157140196|FG002|Overall Study|Could not be contacted|38|||
48808328|NCT01993017|157140194|FG000|Overall Study|Dropped out|19|||
48808329|NCT01993017|157140195|FG001|Overall Study|Dropped out|6|||
48808330|NCT01993017|157140196|FG002|Overall Study|Dropped out|11|||
48808331|NCT01993017|157140194|FG000|Overall Study|Other reasons|17|||
48808332|NCT01993017|157140195|FG001|Overall Study|Other reasons|11|||
48808333|NCT01993017|157140196|FG002|Overall Study|Other reasons|7|||
48808334|NCT01993017|157140194|FG000|Overall Study|Ineligible after randomization|4|||
48808335|NCT01993017|157140195|FG001|Overall Study|Ineligible after randomization|5|||
48808336|NCT01993017|157140196|FG002|Overall Study|Ineligible after randomization|5|||
48808337|NCT01161472|157140197|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
48808338|NCT01161472|157140198|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
48808339|NCT01161472|157140199|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
48808340|NCT01161472|157140200|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
48808341|NCT00003511|157140201|FG000|Overall Study|Not evaluable|4|||
48808342|NCT00603265|157140219|FG000|Overall Study|Adverse Event|2|||
48808343|NCT00603265|157140220|FG001|Overall Study|Adverse Event|11|||
48808344|NCT00603265|157140221|FG002|Overall Study|Adverse Event|1|||
48808345|NCT00603265|157140219|FG000|Overall Study|Withdrawal by Subject|1|||
48597301|NCT02227784|156381948|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
48808346|NCT00603265|157140220|FG001|Overall Study|Withdrawal by Subject|2|||
48808347|NCT00603265|157140221|FG002|Overall Study|Withdrawal by Subject|1|||
48808348|NCT00603265|157140219|FG000|Overall Study|Lack of Efficacy|3|||
48808349|NCT00603265|157140220|FG001|Overall Study|Lack of Efficacy|0|||
48808350|NCT00603265|157140221|FG002|Overall Study|Lack of Efficacy|3|||
48808351|NCT00603265|157140219|FG000|Overall Study|Lost to Follow-up|0|||
48808352|NCT00603265|157140220|FG001|Overall Study|Lost to Follow-up|1|||
48808353|NCT00603265|157140221|FG002|Overall Study|Lost to Follow-up|0|||
48808354|NCT00603265|157140219|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
48808355|NCT00603265|157140220|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
48808356|NCT00603265|157140221|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
48808357|NCT00603265|157140219|FG000|Overall Study|Participant Left Country, No Responses|0|||
48808358|NCT00603265|157140220|FG001|Overall Study|Participant Left Country, No Responses|1|||
48808359|NCT00603265|157140221|FG002|Overall Study|Participant Left Country, No Responses|0|||
48808360|NCT00603265|157140219|FG000|Overall Study|Protocol Violation|1|||
48808361|NCT00603265|157140220|FG001|Overall Study|Protocol Violation|0|||
48808362|NCT00603265|157140221|FG002|Overall Study|Protocol Violation|0|||
48808363|NCT02002884|157140223|FG000|Main Period (MP)|Other|0|||
48808364|NCT02002884|157140224|FG001|Main Period (MP)|Other|3|||
48808365|NCT02002884|157140225|FG002|Main Period (MP)|Other|3|||
48808366|NCT02002884|157140226|FG003|Main Period (MP)|Other|0|||
48808367|NCT02002884|157140223|FG000|Main Period (MP)|Adverse Event|0|||
48808368|NCT02002884|157140224|FG001|Main Period (MP)|Adverse Event|1|||
48808369|NCT02002884|157140225|FG002|Main Period (MP)|Adverse Event|1|||
48808370|NCT02002884|157140226|FG003|Main Period (MP)|Adverse Event|0|||
48808371|NCT02002884|157140223|FG000|Main Period (MP)|Withdrawal by Subject|6|||
48808372|NCT02002884|157140224|FG001|Main Period (MP)|Withdrawal by Subject|2|||
48808373|NCT02002884|157140225|FG002|Main Period (MP)|Withdrawal by Subject|2|||
48808374|NCT02002884|157140226|FG003|Main Period (MP)|Withdrawal by Subject|0|||
48808375|NCT02002884|157140223|FG000|Main Period (MP)|Lost to Follow-up|0|||
48808376|NCT02002884|157140224|FG001|Main Period (MP)|Lost to Follow-up|0|||
48808377|NCT02002884|157140225|FG002|Main Period (MP)|Lost to Follow-up|2|||
48808378|NCT02002884|157140226|FG003|Main Period (MP)|Lost to Follow-up|0|||
48808379|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Other|0|||
48808380|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Other|0|||
48808381|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Other|0|||
48808382|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Other|24|||
48808383|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
48808384|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
48808385|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
48808386|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
48808387|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
48808388|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
48808389|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
48808390|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
48808391|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
48808392|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
48808393|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
48808394|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
48808395|NCT02002884|157140223|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
48808396|NCT02002884|157140224|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
48808397|NCT02002884|157140225|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
48808398|NCT02002884|157140226|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
48808399|NCT00462670|157140227|FG000|Overall Study|Adverse Event|3|||
48808400|NCT00462670|157140228|FG001|Overall Study|Adverse Event|5|||
48808401|NCT00462670|157140227|FG000|Overall Study|Lack of Efficacy|1|||
48808402|NCT00462670|157140228|FG001|Overall Study|Lack of Efficacy|0|||
48808403|NCT00462670|157140227|FG000|Overall Study|Protocol Violation|1|||
48808404|NCT00462670|157140228|FG001|Overall Study|Protocol Violation|0|||
48808405|NCT00462670|157140227|FG000|Overall Study|Resolution of signs and symptoms|0|||
48808406|NCT00462670|157140228|FG001|Overall Study|Resolution of signs and symptoms|2|||
48808407|NCT02966002|157140229|FG000|Overall Study|Withdrawal by Subject|2|||
48808408|NCT02966002|157140229|FG000|Overall Study|Adverse Event|1|||
48808409|NCT02966002|157140229|FG000|Overall Study|Lost to Follow-up|1|||
48808410|NCT05340751|157140230|FG000|Overall Study|Physician Decision|3|||
48808411|NCT02110732|157140243|FG000|Overall Study|Physician Decision|5|||
48808412|NCT02110732|157140244|FG001|Overall Study|Physician Decision|2|||
48808413|NCT02110732|157140243|FG000|Overall Study|Lost to Follow-up|1|||
48808414|NCT02110732|157140244|FG001|Overall Study|Lost to Follow-up|1|||
48808415|NCT01642602|157140245|FG000|Overall Study|Adverse Event|2|||
48808416|NCT04887948|157140246|FG000|Overall Study|Death|1|||
48808417|NCT04887948|157140247|FG001|Overall Study|Death|0|||
48808418|NCT04887948|157140248|FG002|Overall Study|Death|0|||
48808419|NCT04887948|157140246|FG000|Overall Study|Lost to Follow-up|1|||
48808420|NCT04887948|157140247|FG001|Overall Study|Lost to Follow-up|0|||
48808421|NCT04887948|157140248|FG002|Overall Study|Lost to Follow-up|3|||
48808422|NCT04887948|157140246|FG000|Overall Study|Physician Decision|0|||
48808423|NCT04887948|157140247|FG001|Overall Study|Physician Decision|4|||
48808424|NCT04887948|157140248|FG002|Overall Study|Physician Decision|1|||
48808425|NCT04887948|157140246|FG000|Overall Study|Protocol Violation|1|||
48808426|NCT04887948|157140247|FG001|Overall Study|Protocol Violation|1|||
48808427|NCT04887948|157140248|FG002|Overall Study|Protocol Violation|0|||
48808428|NCT04887948|157140246|FG000|Overall Study|Withdrawal by Subject|0|||
48808429|NCT04887948|157140247|FG001|Overall Study|Withdrawal by Subject|6|||
48808430|NCT04887948|157140248|FG002|Overall Study|Withdrawal by Subject|1|||
48808431|NCT04887948|157140246|FG000|Overall Study|No longer met eligibility criteria|1|||
48808432|NCT04887948|157140247|FG001|Overall Study|No longer met eligibility criteria|2|||
48808433|NCT04887948|157140248|FG002|Overall Study|No longer met eligibility criteria|1|||
48808434|NCT04887948|157140246|FG000|Overall Study|Other|2|||
48808435|NCT04887948|157140247|FG001|Overall Study|Other|1|||
48808436|NCT04887948|157140248|FG002|Overall Study|Other|1|||
48808437|NCT02748694|157140251|FG000|Overall Study|Voluntary Withdrawal|0|||
48808438|NCT02748694|157140252|FG001|Overall Study|Voluntary Withdrawal|0|||
48808439|NCT02748694|157140253|FG002|Overall Study|Voluntary Withdrawal|0|||
48808440|NCT02748694|157140254|FG003|Overall Study|Voluntary Withdrawal|0|||
48808441|NCT02748694|157140255|FG004|Overall Study|Voluntary Withdrawal|0|||
48808442|NCT02748694|157140256|FG005|Overall Study|Voluntary Withdrawal|0|||
48808443|NCT02748694|157140257|FG006|Overall Study|Voluntary Withdrawal|0|||
48808444|NCT02748694|157140258|FG007|Overall Study|Voluntary Withdrawal|0|||
48808445|NCT02748694|157140259|FG008|Overall Study|Voluntary Withdrawal|0|||
48808446|NCT02748694|157140260|FG009|Overall Study|Voluntary Withdrawal|0|||
48808447|NCT02748694|157140261|FG010|Overall Study|Voluntary Withdrawal|0|||
48808448|NCT02748694|157140262|FG011|Overall Study|Voluntary Withdrawal|0|||
48491823|NCT01415921|155994172|FG000|Overall Study|Withdrawal by Subject|0|||
48491824|NCT01415921|155994173|FG001|Overall Study|Withdrawal by Subject|1|||
48491825|NCT01415921|155994172|FG000|Overall Study|Other|2|||
48491826|NCT01415921|155994173|FG001|Overall Study|Other|0|||
48491827|NCT01830920|155994202|FG000|Overall Study|Adverse Event|1|||
48491828|NCT01830920|155994203|FG001|Overall Study|Adverse Event|0|||
48491829|NCT01830920|155994204|FG002|Overall Study|Adverse Event|1|||
48808449|NCT02748694|157140263|FG012|Overall Study|Voluntary Withdrawal|0|||
48808450|NCT02748694|157140264|FG013|Overall Study|Voluntary Withdrawal|0|||
48808451|NCT02748694|157140265|FG014|Overall Study|Voluntary Withdrawal|2|||
48491830|NCT01830920|155994205|FG003|Overall Study|Adverse Event|0|||
48808452|NCT01350141|157140266|FG000|Overall Study|Lost to Follow-up|1|||
48808453|NCT01350141|157140267|FG001|Overall Study|Lost to Follow-up|0|||
48808454|NCT01350141|157140268|FG002|Overall Study|Lost to Follow-up|1|||
48808455|NCT01350141|157140266|FG000|Overall Study|Withdrawal by Subject|1|||
48808456|NCT01350141|157140267|FG001|Overall Study|Withdrawal by Subject|0|||
48808457|NCT01350141|157140268|FG002|Overall Study|Withdrawal by Subject|0|||
48808458|NCT01350141|157140266|FG000|Overall Study|Randomized but not treated|1|||
48808459|NCT01350141|157140267|FG001|Overall Study|Randomized but not treated|0|||
48808460|NCT01350141|157140268|FG002|Overall Study|Randomized but not treated|0|||
48808461|NCT00539643|157140271|FG000|Overall Study|Adverse Event|1|||
48808462|NCT00539643|157140272|FG001|Overall Study|Adverse Event|0|||
48808463|NCT00539643|157140271|FG000|Overall Study|Death|2|||
48808464|NCT00539643|157140272|FG001|Overall Study|Death|1|||
48808465|NCT00539643|157140271|FG000|Overall Study|Physician Decision|3|||
48808466|NCT00539643|157140272|FG001|Overall Study|Physician Decision|1|||
48808467|NCT00539643|157140271|FG000|Overall Study|Withdrawal by Subject|0|||
48808468|NCT00539643|157140272|FG001|Overall Study|Withdrawal by Subject|1|||
48808469|NCT02508532|157140273|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808470|NCT02508532|157140274|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808471|NCT02508532|157140275|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808472|NCT02508532|157140276|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808473|NCT02508532|157140277|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808474|NCT02508532|157140278|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808475|NCT02508532|157140279|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
48808476|NCT02508532|157140280|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808477|NCT02508532|157140281|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
48808478|NCT02508532|157140273|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808479|NCT02508532|157140274|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808480|NCT02508532|157140275|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808481|NCT02508532|157140276|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808482|NCT02508532|157140277|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808483|NCT02508532|157140278|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808484|NCT02508532|157140279|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808485|NCT02508532|157140280|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
48808486|NCT02508532|157140281|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
48808487|NCT02508532|157140273|FG000|Part 2 - Treatment|Disease Progression|0|||
48808488|NCT02508532|157140274|FG001|Part 2 - Treatment|Disease Progression|0|||
48808489|NCT02508532|157140275|FG002|Part 2 - Treatment|Disease Progression|0|||
48808490|NCT02508532|157140276|FG003|Part 2 - Treatment|Disease Progression|0|||
48808491|NCT02508532|157140277|FG004|Part 2 - Treatment|Disease Progression|0|||
48808492|NCT02508532|157140278|FG005|Part 2 - Treatment|Disease Progression|0|||
48808493|NCT02508532|157140279|FG006|Part 2 - Treatment|Disease Progression|0|||
48808494|NCT02508532|157140280|FG007|Part 2 - Treatment|Disease Progression|0|||
48808495|NCT02508532|157140281|FG008|Part 2 - Treatment|Disease Progression|118|||
48808496|NCT02508532|157140273|FG000|Part 2 - Treatment|Adverse Event|0|||
48808497|NCT02508532|157140274|FG001|Part 2 - Treatment|Adverse Event|0|||
48808498|NCT02508532|157140275|FG002|Part 2 - Treatment|Adverse Event|0|||
48808499|NCT02508532|157140276|FG003|Part 2 - Treatment|Adverse Event|0|||
48808500|NCT02508532|157140277|FG004|Part 2 - Treatment|Adverse Event|0|||
48808501|NCT02508532|157140278|FG005|Part 2 - Treatment|Adverse Event|0|||
48808502|NCT02508532|157140279|FG006|Part 2 - Treatment|Adverse Event|0|||
48808503|NCT02508532|157140280|FG007|Part 2 - Treatment|Adverse Event|0|||
48808504|NCT02508532|157140281|FG008|Part 2 - Treatment|Adverse Event|49|||
48808505|NCT02508532|157140273|FG000|Part 2 - Treatment|Physician Decision|0|||
48808506|NCT02508532|157140274|FG001|Part 2 - Treatment|Physician Decision|0|||
48808507|NCT02508532|157140275|FG002|Part 2 - Treatment|Physician Decision|0|||
48808508|NCT02508532|157140276|FG003|Part 2 - Treatment|Physician Decision|0|||
48808509|NCT02508532|157140277|FG004|Part 2 - Treatment|Physician Decision|0|||
48808510|NCT02508532|157140278|FG005|Part 2 - Treatment|Physician Decision|0|||
48808511|NCT02508532|157140279|FG006|Part 2 - Treatment|Physician Decision|0|||
48808512|NCT02508532|157140280|FG007|Part 2 - Treatment|Physician Decision|0|||
48808513|NCT02508532|157140281|FG008|Part 2 - Treatment|Physician Decision|12|||
48808514|NCT02508532|157140273|FG000|Part 2 - Treatment|Administrative|0|||
48808515|NCT02508532|157140274|FG001|Part 2 - Treatment|Administrative|0|||
48808516|NCT02508532|157140275|FG002|Part 2 - Treatment|Administrative|0|||
48808517|NCT02508532|157140276|FG003|Part 2 - Treatment|Administrative|0|||
48808518|NCT02508532|157140277|FG004|Part 2 - Treatment|Administrative|0|||
48808519|NCT02508532|157140278|FG005|Part 2 - Treatment|Administrative|0|||
48808520|NCT02508532|157140279|FG006|Part 2 - Treatment|Administrative|0|||
48491831|NCT01830920|155994206|FG004|Overall Study|Adverse Event|0|||
48491832|NCT01830920|155994202|FG000|Overall Study|Withdrawal by Subject|2|||
48491833|NCT01830920|155994203|FG001|Overall Study|Withdrawal by Subject|2|||
48491834|NCT01830920|155994204|FG002|Overall Study|Withdrawal by Subject|1|||
48491835|NCT01830920|155994205|FG003|Overall Study|Withdrawal by Subject|7|||
48808521|NCT02508532|157140280|FG007|Part 2 - Treatment|Administrative|0|||
48808522|NCT02508532|157140281|FG008|Part 2 - Treatment|Administrative|3|||
48808523|NCT02508532|157140273|FG000|Part 2 - Treatment|Sponsor Decision|0|||
48808524|NCT02508532|157140274|FG001|Part 2 - Treatment|Sponsor Decision|0|||
48808525|NCT02508532|157140275|FG002|Part 2 - Treatment|Sponsor Decision|0|||
48808526|NCT02508532|157140276|FG003|Part 2 - Treatment|Sponsor Decision|0|||
48808527|NCT02508532|157140277|FG004|Part 2 - Treatment|Sponsor Decision|0|||
48808528|NCT02508532|157140278|FG005|Part 2 - Treatment|Sponsor Decision|0|||
48808529|NCT02508532|157140279|FG006|Part 2 - Treatment|Sponsor Decision|0|||
48808530|NCT02508532|157140280|FG007|Part 2 - Treatment|Sponsor Decision|0|||
48808531|NCT02508532|157140281|FG008|Part 2 - Treatment|Sponsor Decision|28|||
48808532|NCT02508532|157140273|FG000|Part 2 - Treatment|Death|0|||
48808533|NCT02508532|157140274|FG001|Part 2 - Treatment|Death|0|||
48808534|NCT02508532|157140275|FG002|Part 2 - Treatment|Death|0|||
48808535|NCT02508532|157140276|FG003|Part 2 - Treatment|Death|0|||
48808536|NCT02508532|157140277|FG004|Part 2 - Treatment|Death|0|||
48808537|NCT02508532|157140278|FG005|Part 2 - Treatment|Death|0|||
48808538|NCT02508532|157140279|FG006|Part 2 - Treatment|Death|0|||
48808539|NCT02508532|157140280|FG007|Part 2 - Treatment|Death|0|||
48808540|NCT02508532|157140281|FG008|Part 2 - Treatment|Death|1|||
48808541|NCT02508532|157140273|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
48808542|NCT02508532|157140274|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
48808543|NCT02508532|157140275|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
48808544|NCT02508532|157140276|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
48808545|NCT02508532|157140277|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
48808546|NCT02508532|157140278|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
48808547|NCT02508532|157140279|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
48808548|NCT02508532|157140280|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
48808549|NCT02508532|157140281|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
48808550|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
48808551|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808552|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808553|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808554|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808555|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808556|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
48808557|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
48808558|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
48808559|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
48808560|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808561|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
48808562|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808563|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808564|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808565|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808566|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
48808567|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
48808568|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Death|0|||
48808569|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Death|4|||
48808570|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Death|2|||
48808571|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Death|4|||
48808572|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Death|3|||
48808573|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Death|0|||
48808574|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Death|0|||
48808575|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Death|1|||
48808576|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Death|111|||
48808577|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
48808578|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
48808579|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
48808580|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808581|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808582|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808583|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808584|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
48808585|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
48808586|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808587|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808588|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808589|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808590|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808591|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808592|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808593|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
48808594|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
48808595|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
48435233|NCT00492856|155782418|FG002|Post-consolidation|Death|0|||
48435234|NCT00492856|155782419|FG003|Post-consolidation|Death|0|||
48435235|NCT00492856|155782416|FG000|Post-consolidation|Not protocol specified|0|||
48435236|NCT00492856|155782417|FG001|Post-consolidation|Not protocol specified|1|||
48435237|NCT00492856|155782418|FG002|Post-consolidation|Not protocol specified|0|||
48435238|NCT00492856|155782419|FG003|Post-consolidation|Not protocol specified|0|||
48710969|NCT02152956|156791420|FG001|Overall Study|Withdrawal by Subject|0|||
48710970|NCT02152956|156791421|FG002|Overall Study|Withdrawal by Subject|1|||
48710971|NCT02152956|156791422|FG003|Overall Study|Withdrawal by Subject|0|||
48710972|NCT02152956|156791423|FG004|Overall Study|Withdrawal by Subject|2|||
48710973|NCT02152956|156791424|FG005|Overall Study|Withdrawal by Subject|2|||
48710974|NCT02152956|156791425|FG006|Overall Study|Withdrawal by Subject|0|||
48710975|NCT02152956|156791426|FG007|Overall Study|Withdrawal by Subject|0|||
48710976|NCT02152956|156791427|FG008|Overall Study|Withdrawal by Subject|1|||
48710977|NCT02152956|156791428|FG009|Overall Study|Withdrawal by Subject|0|||
48710978|NCT02152956|156791429|FG010|Overall Study|Withdrawal by Subject|0|||
48710979|NCT02152956|156791430|FG011|Overall Study|Withdrawal by Subject|4|||
48710980|NCT02152956|156791431|FG012|Overall Study|Withdrawal by Subject|0|||
48710981|NCT02152956|156791419|FG000|Overall Study|Physician Decision|0|||
48710982|NCT02152956|156791420|FG001|Overall Study|Physician Decision|0|||
48710983|NCT02152956|156791421|FG002|Overall Study|Physician Decision|0|||
48710984|NCT02152956|156791422|FG003|Overall Study|Physician Decision|0|||
48710985|NCT02152956|156791423|FG004|Overall Study|Physician Decision|0|||
48710986|NCT02152956|156791424|FG005|Overall Study|Physician Decision|0|||
48710987|NCT02152956|156791425|FG006|Overall Study|Physician Decision|0|||
48710988|NCT02152956|156791426|FG007|Overall Study|Physician Decision|0|||
48710989|NCT02152956|156791427|FG008|Overall Study|Physician Decision|0|||
48710990|NCT02152956|156791428|FG009|Overall Study|Physician Decision|0|||
48710991|NCT02152956|156791429|FG010|Overall Study|Physician Decision|0|||
48710992|NCT02152956|156791430|FG011|Overall Study|Physician Decision|1|||
48710993|NCT02152956|156791431|FG012|Overall Study|Physician Decision|0|||
48710994|NCT02152956|156791419|FG000|Overall Study|Study terminated by sponsor|0|||
48710995|NCT02152956|156791420|FG001|Overall Study|Study terminated by sponsor|0|||
48710996|NCT02152956|156791421|FG002|Overall Study|Study terminated by sponsor|0|||
48710997|NCT02152956|156791422|FG003|Overall Study|Study terminated by sponsor|0|||
48710998|NCT02152956|156791423|FG004|Overall Study|Study terminated by sponsor|0|||
48710999|NCT02152956|156791424|FG005|Overall Study|Study terminated by sponsor|0|||
48711000|NCT02152956|156791425|FG006|Overall Study|Study terminated by sponsor|0|||
48711001|NCT02152956|156791426|FG007|Overall Study|Study terminated by sponsor|0|||
48711002|NCT02152956|156791427|FG008|Overall Study|Study terminated by sponsor|0|||
48711003|NCT02152956|156791428|FG009|Overall Study|Study terminated by sponsor|0|||
48711004|NCT02152956|156791429|FG010|Overall Study|Study terminated by sponsor|0|||
48711005|NCT02152956|156791430|FG011|Overall Study|Study terminated by sponsor|29|||
48711006|NCT02152956|156791431|FG012|Overall Study|Study terminated by sponsor|0|||
48711007|NCT02152956|156791419|FG000|Overall Study|progressive disease|0|||
48711008|NCT02152956|156791420|FG001|Overall Study|progressive disease|0|||
48711009|NCT02152956|156791421|FG002|Overall Study|progressive disease|0|||
48711010|NCT02152956|156791422|FG003|Overall Study|progressive disease|0|||
48711011|NCT02152956|156791423|FG004|Overall Study|progressive disease|0|||
48711012|NCT02152956|156791424|FG005|Overall Study|progressive disease|0|||
48711013|NCT02152956|156791425|FG006|Overall Study|progressive disease|0|||
48711014|NCT02152956|156791426|FG007|Overall Study|progressive disease|0|||
48711015|NCT02152956|156791427|FG008|Overall Study|progressive disease|1|||
48711016|NCT02152956|156791428|FG009|Overall Study|progressive disease|0|||
48711017|NCT02152956|156791429|FG010|Overall Study|progressive disease|0|||
48711018|NCT02152956|156791430|FG011|Overall Study|progressive disease|1|||
48711019|NCT02152956|156791431|FG012|Overall Study|progressive disease|0|||
48711020|NCT02527421|156791432|FG000|Overall Study|Withdrawal by Subject|1|||
48711021|NCT02527421|156791433|FG001|Overall Study|Withdrawal by Subject|0|||
48711022|NCT00782834|156791434|FG000|Treatment Phase|fibrous tumor not GIST|1|||
48711023|NCT02259088|156791435|FG000|Overall Study|Adverse Event|6|||
48711024|NCT02259088|156791436|FG001|Overall Study|Adverse Event|4|||
48711025|NCT02259088|156791435|FG000|Overall Study|Lost to Follow-up|2|||
48711026|NCT02259088|156791436|FG001|Overall Study|Lost to Follow-up|0|||
48808596|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
48435318|NCT00960934|155782444|FG003|Overall Study|Protocol Violation|3|||
48711027|NCT02259088|156791435|FG000|Overall Study|Death|2|||
48711028|NCT02259088|156791436|FG001|Overall Study|Death|0|||
48711029|NCT02259088|156791435|FG000|Overall Study|Physician Decision|5|||
48711030|NCT02259088|156791436|FG001|Overall Study|Physician Decision|2|||
48711031|NCT02259088|156791435|FG000|Overall Study|Protocol deviation|5|||
48711032|NCT02259088|156791436|FG001|Overall Study|Protocol deviation|0|||
48711033|NCT02259088|156791435|FG000|Overall Study|Subject/guardian decision|8|||
48711034|NCT02259088|156791436|FG001|Overall Study|Subject/guardian decision|8|||
48711035|NCT02252939|156791439|FG000|Overall Study|Lost to Follow-up|3|||
48711036|NCT02660983|156791440|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
48711037|NCT02660983|156791441|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
48711038|NCT02660983|156791440|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
48711039|NCT02660983|156791441|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
48808597|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
48808598|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
48808599|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
48808600|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
48808601|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
48808602|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
48808603|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
48808604|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808605|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808606|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808607|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808608|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808609|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808610|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808611|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
48808612|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
48808613|NCT02508532|157140273|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
48808614|NCT02508532|157140274|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
48808615|NCT02508532|157140275|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
48808616|NCT02508532|157140276|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
48808617|NCT02508532|157140277|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
48808618|NCT02508532|157140278|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
48808619|NCT02508532|157140279|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
48808620|NCT02508532|157140280|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
48808621|NCT02508532|157140281|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
48808622|NCT00927355|157140285|FG000|Overall Study|Adverse Event|1|||
48808623|NCT00927355|157140286|FG001|Overall Study|Adverse Event|1|||
48808624|NCT03097861|157140290|FG000|Overall Study|Adverse Event|3|||
48808625|NCT03097861|157140291|FG001|Overall Study|Adverse Event|8|||
48491836|NCT01830920|155994206|FG004|Overall Study|Withdrawal by Subject|1|||
48491837|NCT01830920|155994202|FG000|Overall Study|Death|3|||
48491838|NCT01830920|155994203|FG001|Overall Study|Death|3|||
48711040|NCT02660983|156791440|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
48711041|NCT02660983|156791441|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
48711042|NCT02660983|156791440|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
48711043|NCT02660983|156791441|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
48711044|NCT02660983|156791440|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
48711045|NCT02660983|156791441|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
48711046|NCT02660983|156791440|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
48808626|NCT03097861|157140292|FG002|Overall Study|Adverse Event|4|||
48808627|NCT03097861|157140290|FG000|Overall Study|Investigator Decision|0|||
48711047|NCT02660983|156791441|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
48711048|NCT02660983|156791440|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
48711049|NCT02660983|156791441|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
48711050|NCT01497366|156791445|FG000|Overall Study|Virologic failure|2|||
48711051|NCT01497366|156791446|FG001|Overall Study|Virologic failure|50|||
48711052|NCT01497366|156791445|FG000|Overall Study|Lost to Follow-up|11|||
48711053|NCT01497366|156791446|FG001|Overall Study|Lost to Follow-up|10|||
48711054|NCT01497366|156791445|FG000|Overall Study|Withdrawal by Subject|6|||
48808628|NCT03097861|157140291|FG001|Overall Study|Investigator Decision|1|||
48808629|NCT03097861|157140292|FG002|Overall Study|Investigator Decision|0|||
48808630|NCT03097861|157140290|FG000|Overall Study|Lost to Follow-up|0|||
48808631|NCT03097861|157140291|FG001|Overall Study|Lost to Follow-up|7|||
48808632|NCT03097861|157140292|FG002|Overall Study|Lost to Follow-up|1|||
48808633|NCT03097861|157140290|FG000|Overall Study|Withdrawal by Subject|1|||
48808634|NCT03097861|157140291|FG001|Overall Study|Withdrawal by Subject|5|||
48808635|NCT03097861|157140292|FG002|Overall Study|Withdrawal by Subject|3|||
48808636|NCT03097861|157140290|FG000|Overall Study|Reason not provided|3|||
48808637|NCT03097861|157140291|FG001|Overall Study|Reason not provided|1|||
48808638|NCT03097861|157140292|FG002|Overall Study|Reason not provided|1|||
48808639|NCT04503096|157140294|FG000|Overall Study|Withdrawal by Subject|3|||
48491839|NCT01830920|155994204|FG002|Overall Study|Death|5|||
48491840|NCT01830920|155994205|FG003|Overall Study|Death|4|||
48491841|NCT01830920|155994206|FG004|Overall Study|Death|4|||
48491842|NCT01830920|155994202|FG000|Overall Study|Other|15|||
48491843|NCT01830920|155994203|FG001|Overall Study|Other|1|||
48491844|NCT01830920|155994204|FG002|Overall Study|Other|1|||
48491845|NCT01830920|155994205|FG003|Overall Study|Other|5|||
48491846|NCT01830920|155994206|FG004|Overall Study|Other|3|||
48491847|NCT02585258|155994209|FG000|Overall Study|Adverse Event|28|||
48491848|NCT02585258|155994210|FG001|Overall Study|Adverse Event|29|||
48491849|NCT02585258|155994209|FG000|Overall Study|Death|3|||
48491850|NCT02585258|155994210|FG001|Overall Study|Death|2|||
48491851|NCT02585258|155994209|FG000|Overall Study|Lack of Efficacy|7|||
48491852|NCT02585258|155994210|FG001|Overall Study|Lack of Efficacy|9|||
48491853|NCT02585258|155994209|FG000|Overall Study|includes covid-related access problems|42|||
48491854|NCT02585258|155994210|FG001|Overall Study|includes covid-related access problems|46|||
48491855|NCT02585258|155994209|FG000|Overall Study|Lost to Follow-up|5|||
48491856|NCT02585258|155994210|FG001|Overall Study|Lost to Follow-up|2|||
48491857|NCT01405950|155994211|FG000|Overall Study|Withdrawal by Subject|1|||
48491858|NCT01405950|155994212|FG001|Overall Study|Withdrawal by Subject|0|||
48491859|NCT01405950|155994213|FG002|Overall Study|Withdrawal by Subject|0|||
48491860|NCT01405950|155994214|FG003|Overall Study|Withdrawal by Subject|0|||
48491861|NCT01960816|155994215|FG000|Overall Study|Lost to Follow-up|1|||
48491862|NCT01703741|155994216|FG000|Overall Study|Withdrawal by Subject|6|||
48597302|NCT02227784|156381949|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
48711055|NCT01497366|156791446|FG001|Overall Study|Withdrawal by Subject|6|||
48491863|NCT01703741|155994216|FG000|Overall Study|Adverse Event|2|||
48491864|NCT01703741|155994216|FG000|Overall Study|Physician Decision|2|||
48491865|NCT01703741|155994216|FG000|Overall Study|Protocol Violation|1|||
48491866|NCT01703741|155994216|FG000|Overall Study|Lost to Follow-up|3|||
48491867|NCT01703741|155994216|FG000|Overall Study|Subject did not want to continue|2|||
48711056|NCT01497366|156791445|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
48808640|NCT01153269|157140298|FG000|Overall Study|Withdrawal by Subject|1|||
48808641|NCT01153269|157140298|FG000|Overall Study|Antiretroviral therapy break|1|||
48491868|NCT01703741|155994216|FG000|Overall Study|Subject cannot comply with study visits|1|||
48711057|NCT01497366|156791446|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
48711058|NCT01497366|156791445|FG000|Overall Study|Other|5|||
48711059|NCT01497366|156791446|FG001|Overall Study|Other|0|||
48808642|NCT03541044|157140299|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
48808643|NCT03541044|157140300|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
48808644|NCT03541044|157140299|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
48808645|NCT03541044|157140300|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
48808646|NCT03560258|157140301|FG000|Overall Study|Lost to Follow-up|3|||
48711060|NCT01497366|156791445|FG000|Overall Study|Death|1|||
48711061|NCT01497366|156791446|FG001|Overall Study|Death|1|||
48711062|NCT01497366|156791445|FG000|Overall Study|Randomized but not treated|7|||
48711063|NCT01497366|156791446|FG001|Overall Study|Randomized but not treated|21|||
48711064|NCT02703337|156791447|FG000|Period One (Part A)|Withdrawal by Subject|0|||
48711065|NCT02703337|156791448|FG001|Period One (Part A)|Withdrawal by Subject|0|||
48711066|NCT02703337|156791449|FG002|Period One (Part A)|Withdrawal by Subject|0|||
48711067|NCT02703337|156791450|FG003|Period One (Part A)|Withdrawal by Subject|0|||
48711068|NCT02703337|156791451|FG004|Period One (Part A)|Withdrawal by Subject|1|||
48711069|NCT02703337|156791452|FG005|Period One (Part A)|Withdrawal by Subject|0|||
48808647|NCT03560258|157140302|FG001|Overall Study|Lost to Follow-up|0|||
48808648|NCT03560258|157140303|FG002|Overall Study|Lost to Follow-up|0|||
48808649|NCT03560258|157140301|FG000|Overall Study|Protocol Violation|0|||
48808650|NCT03560258|157140302|FG001|Overall Study|Protocol Violation|1|||
48808651|NCT03560258|157140303|FG002|Overall Study|Protocol Violation|0|||
48808652|NCT03560258|157140301|FG000|Overall Study|Withdrawal by Subject|0|||
48808653|NCT03560258|157140302|FG001|Overall Study|Withdrawal by Subject|0|||
48808654|NCT03560258|157140303|FG002|Overall Study|Withdrawal by Subject|1|||
48491869|NCT01703741|155994216|FG000|Overall Study|Subject started testosterone injections|1|||
48711070|NCT02703337|156791453|FG006|Period One (Part A)|Withdrawal by Subject|0|||
48711071|NCT02703337|156791454|FG007|Period One (Part A)|Withdrawal by Subject|0|||
48711072|NCT02745080|156791463|FG000|Overall Study|Adverse Event|13|||
48711073|NCT02745080|156791464|FG001|Overall Study|Adverse Event|21|||
48808655|NCT01460160|157140304|FG000|Treatment Phase|Lack of Efficacy|3|||
48808656|NCT01460160|157140304|FG000|Treatment Phase|Study Drug Toxicity|2|||
48491870|NCT00697112|155994217|FG000|Overall Study|Adverse Event|8|||
48491871|NCT00697112|155994217|FG000|Overall Study|Lost to Follow-up|1|||
48808657|NCT01460160|157140304|FG000|Treatment Phase|Adverse Event|8|||
48491872|NCT00697112|155994217|FG000|Overall Study|Did not meet inclusion criteria|1|||
48711074|NCT02745080|156791463|FG000|Overall Study|Lack of Efficacy|11|||
48808658|NCT01460160|157140304|FG000|Treatment Phase|Withdrawal by Subject|4|||
48711075|NCT02745080|156791464|FG001|Overall Study|Lack of Efficacy|23|||
48711076|NCT02745080|156791463|FG000|Overall Study|Lost to Follow-up|3|||
48808659|NCT01460160|157140304|FG000|Treatment Phase|Death|2|||
48711077|NCT02745080|156791464|FG001|Overall Study|Lost to Follow-up|3|||
48711078|NCT02745080|156791463|FG000|Overall Study|Physician Decision|3|||
48711079|NCT02745080|156791464|FG001|Overall Study|Physician Decision|0|||
48711080|NCT02745080|156791463|FG000|Overall Study|Protocol Violation|3|||
48711081|NCT02745080|156791464|FG001|Overall Study|Protocol Violation|1|||
48711082|NCT02745080|156791463|FG000|Overall Study|Withdrawal by Subject|22|||
48711083|NCT02745080|156791464|FG001|Overall Study|Withdrawal by Subject|41|||
48711084|NCT00282308|156791470|FG000|Treatment Period|Lost to Follow-up|1|||
48711085|NCT00282308|156791471|FG001|Treatment Period|Lost to Follow-up|0|||
48711086|NCT00282308|156791472|FG002|Treatment Period|Lost to Follow-up|0|||
48711087|NCT00282308|156791470|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
48711088|NCT00282308|156791471|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
48711089|NCT00282308|156791472|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
48711090|NCT00282308|156791470|FG000|Treatment Period|Adverse Event|0|||
48711091|NCT00282308|156791471|FG001|Treatment Period|Adverse Event|2|||
48711092|NCT00282308|156791472|FG002|Treatment Period|Adverse Event|0|||
48711093|NCT00282308|156791470|FG000|Treatment Period|Not Treated with Study Drug|1|||
48711094|NCT00282308|156791471|FG001|Treatment Period|Not Treated with Study Drug|0|||
48711095|NCT00282308|156791472|FG002|Treatment Period|Not Treated with Study Drug|0|||
48711096|NCT00282308|156791470|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
48711097|NCT00282308|156791471|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
48711098|NCT00282308|156791472|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
48711099|NCT00282308|156791470|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
48808660|NCT01460160|157140304|FG000|Treatment Phase|Other reasons|9|||
48808661|NCT01460160|157140304|FG000|Follow-up Phase|Withdrawal by Subject|4|||
48808662|NCT01460160|157140304|FG000|Follow-up Phase|Death|14|||
48808663|NCT01460160|157140304|FG000|Follow-up Phase|Lost to Follow-up|7|||
48808664|NCT01460160|157140304|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
48808665|NCT01460160|157140304|FG000|Follow-up Phase|Other and not reported reasons|5|||
48808666|NCT01872910|157140305|FG000|Overall Study|Lost to Follow-up|2|||
48808667|NCT01872910|157140306|FG001|Overall Study|Lost to Follow-up|0|||
48808668|NCT01872910|157140307|FG002|Overall Study|Lost to Follow-up|2|||
48808669|NCT01872910|157140308|FG003|Overall Study|Lost to Follow-up|0|||
48808670|NCT01872910|157140309|FG004|Overall Study|Lost to Follow-up|0|||
48808671|NCT01872910|157140310|FG005|Overall Study|Lost to Follow-up|0|||
48808672|NCT02635724|157140311|FG000|Overall Study|Withdrawal by Subject|0|||
48808673|NCT02635724|157140312|FG001|Overall Study|Withdrawal by Subject|1|||
48808674|NCT02635724|157140313|FG002|Overall Study|Withdrawal by Subject|0|||
48808675|NCT00860067|157140314|FG000|Overall Study|Lost to Follow-up|46|||
48808676|NCT00860067|157140315|FG001|Overall Study|Lost to Follow-up|9|||
48808677|NCT00860067|157140316|FG002|Overall Study|Lost to Follow-up|9|||
48808678|NCT00860067|157140314|FG000|Overall Study|Withdrawal by Subject|4|||
48808679|NCT00860067|157140315|FG001|Overall Study|Withdrawal by Subject|0|||
48808680|NCT00860067|157140316|FG002|Overall Study|Withdrawal by Subject|0|||
48808681|NCT00860067|157140314|FG000|Overall Study|Pregnancy|1|||
48808682|NCT00860067|157140315|FG001|Overall Study|Pregnancy|0|||
48808683|NCT00860067|157140316|FG002|Overall Study|Pregnancy|0|||
48808684|NCT00100932|157140317|FG000|Overall Study|Adverse Event|11|||
48808685|NCT00100932|157140318|FG001|Overall Study|Adverse Event|2|||
48808686|NCT00100932|157140317|FG000|Overall Study|Withdrawal by Subject|6|||
48808687|NCT00100932|157140318|FG001|Overall Study|Withdrawal by Subject|0|||
48808688|NCT00100932|157140317|FG000|Overall Study|Progressive Disease|44|||
48711100|NCT00282308|156791471|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
48808689|NCT00100932|157140318|FG001|Overall Study|Progressive Disease|18|||
48808690|NCT00100932|157140317|FG000|Overall Study|Physician Decision|7|||
48808691|NCT00100932|157140318|FG001|Overall Study|Physician Decision|5|||
48808692|NCT00100932|157140317|FG000|Overall Study|Other|5|||
48808693|NCT00100932|157140318|FG001|Overall Study|Other|2|||
48808694|NCT00744328|157140319|FG000|Overall Study|Lost to Follow-up|2|||
48808695|NCT00744328|157140320|FG001|Overall Study|Lost to Follow-up|5|||
48808696|NCT00744328|157140321|FG002|Overall Study|Lost to Follow-up|3|||
48808697|NCT00744328|157140319|FG000|Overall Study|Withdrawal by Subject|5|||
48808698|NCT00744328|157140320|FG001|Overall Study|Withdrawal by Subject|3|||
48711101|NCT00282308|156791472|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
48491873|NCT01170364|155994226|FG000|Overall Study|Protocol Violation|4|||
48711102|NCT00282308|156791470|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
48808699|NCT00744328|157140321|FG002|Overall Study|Withdrawal by Subject|4|||
48808700|NCT00744328|157140319|FG000|Overall Study|Found ineligible after randomization|0|||
48808701|NCT00744328|157140320|FG001|Overall Study|Found ineligible after randomization|0|||
48808702|NCT00744328|157140321|FG002|Overall Study|Found ineligible after randomization|1|||
48808703|NCT02387996|157140324|FG000|Overall Study|Disease Progression|167|||
48808704|NCT02387996|157140324|FG000|Overall Study|Study Drug Toxicity|31|||
48808705|NCT02387996|157140324|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
48808706|NCT02387996|157140324|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
48808707|NCT02387996|157140324|FG000|Overall Study|Subject Withdrew Consent|5|||
48808708|NCT02387996|157140324|FG000|Overall Study|Lost to Follow-up|1|||
48808709|NCT02387996|157140324|FG000|Overall Study|Poor/Non-Compliance|1|||
48808710|NCT02387996|157140324|FG000|Overall Study|Other Reasons|5|||
48808711|NCT02387996|157140324|FG000|Overall Study|Death|1|||
48808712|NCT00770432|157140325|FG000|Overall Study|Other|4|||
48808713|NCT00770432|157140326|FG001|Overall Study|Other|6|||
48808714|NCT00770432|157140325|FG000|Overall Study|Non-compliance|0|||
48808715|NCT00770432|157140326|FG001|Overall Study|Non-compliance|1|||
48808716|NCT02756832|157140332|FG000|Overall Study|Lost for Observation after Baseline|6|||
48808717|NCT02756832|157140332|FG000|Overall Study|Lost for Observation|13|||
48808718|NCT02756832|157140332|FG000|Overall Study|Patient's Unwillingness|12|||
48808719|NCT02756832|157140332|FG000|Overall Study|Insufficient Efficacy|2|||
48808720|NCT02756832|157140332|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
48808721|NCT02756832|157140332|FG000|Overall Study|Reason not Specified|9|||
48808722|NCT02756832|157140332|FG000|Overall Study|Protocol Deviation|10|||
48808723|NCT04522180|157140333|FG000|Overall Study|Investigator judgement|3|||
48808724|NCT04522180|157140334|FG001|Overall Study|Investigator judgement|4|||
48808725|NCT04522180|157140333|FG000|Overall Study|Voluntary withdrawal|1|||
48808726|NCT04522180|157140334|FG001|Overall Study|Voluntary withdrawal|0|||
48808727|NCT04522180|157140333|FG000|Overall Study|Pregnancy|0|||
48808728|NCT04522180|157140334|FG001|Overall Study|Pregnancy|1|||
48808729|NCT04522180|157140333|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
48808730|NCT04522180|157140334|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
48808731|NCT04522180|157140333|FG000|Overall Study|Reason not specified|8|||
48808732|NCT04522180|157140334|FG001|Overall Study|Reason not specified|5|||
48808733|NCT03691948|157140335|FG000|Overall Study|Lost to Follow-up|1|||
48808734|NCT03691948|157140336|FG001|Overall Study|Lost to Follow-up|3|||
48808735|NCT00402337|157140339|FG000|Overall Study|Adverse Event|0|||
48808736|NCT00402337|157140340|FG001|Overall Study|Adverse Event|2|||
48808737|NCT00402337|157140341|FG002|Overall Study|Adverse Event|2|||
48808738|NCT00402337|157140342|FG003|Overall Study|Adverse Event|3|||
48808739|NCT00402337|157140343|FG004|Overall Study|Adverse Event|2|||
48808740|NCT00402337|157140339|FG000|Overall Study|Noncompliance|0|||
48808741|NCT00402337|157140340|FG001|Overall Study|Noncompliance|0|||
48808742|NCT00402337|157140341|FG002|Overall Study|Noncompliance|0|||
48808743|NCT00402337|157140342|FG003|Overall Study|Noncompliance|0|||
48808744|NCT00402337|157140343|FG004|Overall Study|Noncompliance|2|||
48808745|NCT00402337|157140339|FG000|Overall Study|Withdrawal by Subject|5|||
48808746|NCT00402337|157140340|FG001|Overall Study|Withdrawal by Subject|3|||
48808747|NCT00402337|157140341|FG002|Overall Study|Withdrawal by Subject|1|||
48808748|NCT00402337|157140342|FG003|Overall Study|Withdrawal by Subject|6|||
48808749|NCT00402337|157140343|FG004|Overall Study|Withdrawal by Subject|4|||
48808750|NCT00402337|157140339|FG000|Overall Study|Lost to Follow-up|0|||
48808751|NCT00402337|157140340|FG001|Overall Study|Lost to Follow-up|0|||
48808752|NCT00402337|157140341|FG002|Overall Study|Lost to Follow-up|1|||
48808753|NCT00402337|157140342|FG003|Overall Study|Lost to Follow-up|2|||
48808754|NCT00402337|157140343|FG004|Overall Study|Lost to Follow-up|0|||
48808755|NCT00402337|157140339|FG000|Overall Study|Physician Decision|0|||
48808756|NCT00402337|157140340|FG001|Overall Study|Physician Decision|0|||
48808757|NCT00402337|157140341|FG002|Overall Study|Physician Decision|0|||
48808758|NCT00402337|157140342|FG003|Overall Study|Physician Decision|1|||
48808759|NCT00402337|157140343|FG004|Overall Study|Physician Decision|0|||
48808760|NCT00402337|157140339|FG000|Overall Study|Other Reason|0|||
48808761|NCT00402337|157140340|FG001|Overall Study|Other Reason|1|||
48808762|NCT00402337|157140341|FG002|Overall Study|Other Reason|0|||
48597303|NCT02227784|156381950|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
48597304|NCT02227784|156381946|FG000|Open-Label Extension Phase (OLE)|Death|0|||
48597305|NCT02227784|156381947|FG001|Open-Label Extension Phase (OLE)|Death|0|||
48597306|NCT02227784|156381948|FG002|Open-Label Extension Phase (OLE)|Death|0|||
48597307|NCT02227784|156381949|FG003|Open-Label Extension Phase (OLE)|Death|0|||
48808763|NCT00402337|157140342|FG003|Overall Study|Other Reason|0|||
48808764|NCT00402337|157140343|FG004|Overall Study|Other Reason|0|||
48808765|NCT04152343|157140348|FG000|Overall Study|Transplanted|5|||
48808766|NCT04152343|157140348|FG000|Overall Study|Death|20|||
48808767|NCT04152343|157140348|FG000|Overall Study|Lost to Follow-up|3|||
48808768|NCT03824366|157140349|FG000|Overall Study|Death|1|||
48808769|NCT03824366|157140349|FG000|Overall Study|Previously unidentified metal artifact|1|||
48808770|NCT03824366|157140349|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
48808771|NCT03824366|157140349|FG000|Overall Study|Withdrawal by Subject|1|||
48808772|NCT01464021|157141510|FG000|Overall Study|Withdrawal by Subject|13|||
48808773|NCT01464021|157141510|FG000|Overall Study|Lost to Follow-up|1|||
48808774|NCT01464021|157141510|FG000|Overall Study|Lack of Efficacy|1|||
48808775|NCT01464021|157141510|FG000|Overall Study|various|11|||
48808776|NCT01108458|157141511|FG000|Overall Study|Withdrawal by Subject|1|||
48808777|NCT01382602|157141512|FG000|Overall Study|Protocol Violation|0|||
48808778|NCT01382602|157141513|FG001|Overall Study|Protocol Violation|3|||
48808779|NCT01382602|157141512|FG000|Overall Study|Withdrawal by Subject|0|||
48808780|NCT01382602|157141513|FG001|Overall Study|Withdrawal by Subject|1|||
48808781|NCT02790073|157141514|FG000|Overall Study|Death|1|||
48808782|NCT02790073|157141514|FG000|Overall Study|Withdrawal from HD|1|||
48808783|NCT02790073|157141514|FG000|Overall Study|Withdrawal by Subject|1|||
48808784|NCT04524390|157141517|FG000|Double Blind|Consent Withdrawal by subject|2|||
48808785|NCT04524390|157141518|FG001|Double Blind|Consent Withdrawal by subject|1|||
48808786|NCT04524390|157141519|FG002|Double Blind|Consent Withdrawal by subject|0|||
48808787|NCT04524390|157141517|FG000|Double Blind|Adverse Event|5|||
48808788|NCT04524390|157141518|FG001|Double Blind|Adverse Event|3|||
48808789|NCT04524390|157141519|FG002|Double Blind|Adverse Event|0|||
48808790|NCT04524390|157141517|FG000|Double Blind|Liver Transplant|5|||
48808791|NCT04524390|157141518|FG001|Double Blind|Liver Transplant|6|||
48808792|NCT04524390|157141519|FG002|Double Blind|Liver Transplant|0|||
48808793|NCT04524390|157141517|FG000|Double Blind|Disease Progression|0|||
48808794|NCT04524390|157141518|FG001|Double Blind|Disease Progression|1|||
48808795|NCT04524390|157141519|FG002|Double Blind|Disease Progression|0|||
48808796|NCT04524390|157141517|FG000|Open-Label|Drug interruption criteria|0|||
48808797|NCT04524390|157141518|FG001|Open-Label|Drug interruption criteria|0|||
48808798|NCT04524390|157141519|FG002|Open-Label|Drug interruption criteria|1|||
48808799|NCT04524390|157141517|FG000|Open-Label|Liver Transplant|0|||
48808800|NCT04524390|157141518|FG001|Open-Label|Liver Transplant|0|||
48808801|NCT04524390|157141519|FG002|Open-Label|Liver Transplant|1|||
48808802|NCT04524390|157141517|FG000|Open-Label|Disease Progression|0|||
48808803|NCT04524390|157141518|FG001|Open-Label|Disease Progression|0|||
48808804|NCT04524390|157141519|FG002|Open-Label|Disease Progression|1|||
48808805|NCT04524390|157141517|FG000|Open-Label|Adverse Event|0|||
48808806|NCT04524390|157141518|FG001|Open-Label|Adverse Event|0|||
48808807|NCT04524390|157141519|FG002|Open-Label|Adverse Event|3|||
48808808|NCT04524390|157141517|FG000|Open-Label|Study Termination by sponsor|0|||
48808809|NCT04524390|157141518|FG001|Open-Label|Study Termination by sponsor|0|||
48808810|NCT04524390|157141519|FG002|Open-Label|Study Termination by sponsor|45|||
48808811|NCT01336634|157141523|FG000|Overall Study|Study closed/terminated|5|||
48808812|NCT01336634|157141524|FG001|Overall Study|Study closed/terminated|6|||
48808813|NCT01336634|157141525|FG002|Overall Study|Study closed/terminated|6|||
48808814|NCT01336634|157141523|FG000|Overall Study|Lost to Follow-up|2|||
48808815|NCT01336634|157141524|FG001|Overall Study|Lost to Follow-up|1|||
48808816|NCT01336634|157141525|FG002|Overall Study|Lost to Follow-up|1|||
48808817|NCT01336634|157141523|FG000|Overall Study|Physician Decision|1|||
48808818|NCT01336634|157141524|FG001|Overall Study|Physician Decision|1|||
48808819|NCT01336634|157141525|FG002|Overall Study|Physician Decision|0|||
48808820|NCT01336634|157141523|FG000|Overall Study|Withdrawal by Subject|6|||
48808821|NCT01336634|157141524|FG001|Overall Study|Withdrawal by Subject|0|||
48808822|NCT01336634|157141525|FG002|Overall Study|Withdrawal by Subject|2|||
48808823|NCT02798211|157141530|FG000|Period 1|Adverse Event|1|||
48808824|NCT02798211|157141531|FG001|Period 1|Adverse Event|1|||
48808825|NCT02798211|157141532|FG002|Period 1|Adverse Event|0|||
48808826|NCT02798211|157141533|FG003|Period 1|Adverse Event|0|||
48808827|NCT02798211|157141534|FG004|Period 1|Adverse Event|0|||
48808828|NCT02798211|157141535|FG005|Period 1|Adverse Event|0|||
48808829|NCT02798211|157141530|FG000|Period 1|Lost to Follow-up|2|||
48808830|NCT02798211|157141531|FG001|Period 1|Lost to Follow-up|1|||
48808831|NCT02798211|157141532|FG002|Period 1|Lost to Follow-up|0|||
48808832|NCT02798211|157141533|FG003|Period 1|Lost to Follow-up|0|||
48808833|NCT02798211|157141534|FG004|Period 1|Lost to Follow-up|0|||
48808834|NCT02798211|157141535|FG005|Period 1|Lost to Follow-up|0|||
48491874|NCT01170364|155994227|FG001|Overall Study|Protocol Violation|1|||
48808835|NCT02798211|157141530|FG000|Period 1|Protocol Violation|0|||
48808836|NCT02798211|157141531|FG001|Period 1|Protocol Violation|0|||
48808837|NCT02798211|157141532|FG002|Period 1|Protocol Violation|2|||
48808838|NCT02798211|157141533|FG003|Period 1|Protocol Violation|0|||
48808839|NCT02798211|157141534|FG004|Period 1|Protocol Violation|0|||
48808840|NCT02798211|157141535|FG005|Period 1|Protocol Violation|0|||
48808841|NCT02798211|157141530|FG000|Period 1|Withdrawal by Subject|1|||
48808842|NCT02798211|157141531|FG001|Period 1|Withdrawal by Subject|1|||
48808843|NCT02798211|157141532|FG002|Period 1|Withdrawal by Subject|0|||
48808844|NCT02798211|157141533|FG003|Period 1|Withdrawal by Subject|0|||
48808845|NCT02798211|157141534|FG004|Period 1|Withdrawal by Subject|0|||
48711103|NCT00282308|156791471|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
48711104|NCT00282308|156791472|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
48711105|NCT00282308|156791470|FG000|Safety Follow-up Period|Adverse Event|0|||
48711106|NCT00282308|156791471|FG001|Safety Follow-up Period|Adverse Event|0|||
48711107|NCT00282308|156791472|FG002|Safety Follow-up Period|Adverse Event|1|||
48711108|NCT00282308|156791470|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
48711109|NCT00282308|156791471|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
48711110|NCT00282308|156791472|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
48711111|NCT00282308|156791470|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
48711112|NCT00282308|156791471|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
48711113|NCT00282308|156791472|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
48711114|NCT00282308|156791470|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
48711115|NCT00282308|156791471|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
48711116|NCT00282308|156791472|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
48711117|NCT00946153|156791474|FG000|Phase 2|Adverse Event|0|||
48711118|NCT00946153|156791475|FG001|Phase 2|Adverse Event|0|||
48711119|NCT00946153|156791476|FG002|Phase 2|Adverse Event|0|||
48711120|NCT00946153|156791477|FG003|Phase 2|Adverse Event|0|||
48711121|NCT00946153|156791478|FG004|Phase 2|Adverse Event|6|||
48711122|NCT00946153|156791474|FG000|Phase 2|Need more reduction of dose|0|||
48711123|NCT00946153|156791475|FG001|Phase 2|Need more reduction of dose|0|||
48711124|NCT00946153|156791476|FG002|Phase 2|Need more reduction of dose|0|||
48711125|NCT00946153|156791477|FG003|Phase 2|Need more reduction of dose|0|||
48711126|NCT00946153|156791478|FG004|Phase 2|Need more reduction of dose|2|||
48711127|NCT00946153|156791474|FG000|Phase 2|Physician Decision|0|||
48711128|NCT00946153|156791475|FG001|Phase 2|Physician Decision|0|||
48711129|NCT00946153|156791476|FG002|Phase 2|Physician Decision|0|||
48711130|NCT00946153|156791477|FG003|Phase 2|Physician Decision|0|||
48711131|NCT00946153|156791478|FG004|Phase 2|Physician Decision|1|||
48711132|NCT00946153|156791474|FG000|Phase 2|14 days washout for recovery due to AE|0|||
48711133|NCT00946153|156791475|FG001|Phase 2|14 days washout for recovery due to AE|0|||
48711134|NCT00946153|156791476|FG002|Phase 2|14 days washout for recovery due to AE|0|||
48808846|NCT02798211|157141535|FG005|Period 1|Withdrawal by Subject|0|||
48808847|NCT02798211|157141530|FG000|Period 1|Death|0|||
48808848|NCT02798211|157141531|FG001|Period 1|Death|0|||
48808849|NCT02798211|157141532|FG002|Period 1|Death|1|||
48808850|NCT02798211|157141533|FG003|Period 1|Death|0|||
48808851|NCT02798211|157141534|FG004|Period 1|Death|0|||
48808852|NCT02798211|157141535|FG005|Period 1|Death|0|||
48808853|NCT02798211|157141530|FG000|Period 1|Withdrawal of Informed Consent|2|||
48808854|NCT02798211|157141531|FG001|Period 1|Withdrawal of Informed Consent|7|||
48808855|NCT02798211|157141532|FG002|Period 1|Withdrawal of Informed Consent|3|||
48808856|NCT02798211|157141533|FG003|Period 1|Withdrawal of Informed Consent|0|||
48808857|NCT02798211|157141534|FG004|Period 1|Withdrawal of Informed Consent|0|||
48808858|NCT02798211|157141535|FG005|Period 1|Withdrawal of Informed Consent|0|||
48808859|NCT02798211|157141530|FG000|Period 2|Withdrawal by Subject|2|||
48808860|NCT02798211|157141531|FG001|Period 2|Withdrawal by Subject|0|||
48808861|NCT02798211|157141532|FG002|Period 2|Withdrawal by Subject|0|||
48808862|NCT02798211|157141533|FG003|Period 2|Withdrawal by Subject|0|||
48808863|NCT02798211|157141534|FG004|Period 2|Withdrawal by Subject|2|||
48808864|NCT02798211|157141535|FG005|Period 2|Withdrawal by Subject|2|||
48808865|NCT02798211|157141530|FG000|Period 2|Adverse Event|5|||
48808866|NCT02798211|157141531|FG001|Period 2|Adverse Event|0|||
48808867|NCT02798211|157141532|FG002|Period 2|Adverse Event|0|||
48808868|NCT02798211|157141533|FG003|Period 2|Adverse Event|0|||
48808869|NCT02798211|157141534|FG004|Period 2|Adverse Event|1|||
48808870|NCT02798211|157141535|FG005|Period 2|Adverse Event|0|||
48808871|NCT02798211|157141530|FG000|Period 2|Lack of Efficacy|1|||
48808872|NCT02798211|157141531|FG001|Period 2|Lack of Efficacy|0|||
48808873|NCT02798211|157141532|FG002|Period 2|Lack of Efficacy|0|||
48808874|NCT02798211|157141533|FG003|Period 2|Lack of Efficacy|1|||
48808875|NCT02798211|157141534|FG004|Period 2|Lack of Efficacy|0|||
48808876|NCT02798211|157141535|FG005|Period 2|Lack of Efficacy|1|||
48808877|NCT02798211|157141530|FG000|Period 2|Lost to Follow-up|3|||
48808878|NCT02798211|157141531|FG001|Period 2|Lost to Follow-up|0|||
48808879|NCT02798211|157141532|FG002|Period 2|Lost to Follow-up|0|||
48808880|NCT02798211|157141533|FG003|Period 2|Lost to Follow-up|0|||
48808881|NCT02798211|157141534|FG004|Period 2|Lost to Follow-up|2|||
48808882|NCT02798211|157141535|FG005|Period 2|Lost to Follow-up|0|||
48808883|NCT02798211|157141530|FG000|Period 2|Physician Decision|1|||
48808884|NCT02798211|157141531|FG001|Period 2|Physician Decision|0|||
48808885|NCT02798211|157141532|FG002|Period 2|Physician Decision|0|||
48808886|NCT02798211|157141533|FG003|Period 2|Physician Decision|1|||
48808887|NCT02798211|157141534|FG004|Period 2|Physician Decision|1|||
48808888|NCT02798211|157141535|FG005|Period 2|Physician Decision|0|||
48808889|NCT02798211|157141530|FG000|Period 2|Pregnancy|0|||
48808890|NCT02798211|157141531|FG001|Period 2|Pregnancy|0|||
48808891|NCT02798211|157141532|FG002|Period 2|Pregnancy|0|||
48808892|NCT02798211|157141533|FG003|Period 2|Pregnancy|2|||
48808893|NCT02798211|157141534|FG004|Period 2|Pregnancy|0|||
48808894|NCT02798211|157141535|FG005|Period 2|Pregnancy|0|||
48808895|NCT02798211|157141530|FG000|Period 2|Technical problems|1|||
48808896|NCT02798211|157141531|FG001|Period 2|Technical problems|0|||
48808897|NCT02798211|157141532|FG002|Period 2|Technical problems|0|||
48808898|NCT02798211|157141533|FG003|Period 2|Technical problems|1|||
48808899|NCT02798211|157141534|FG004|Period 2|Technical problems|0|||
48808900|NCT02798211|157141535|FG005|Period 2|Technical problems|0|||
48808901|NCT02798211|157141530|FG000|Period 2|Withdrawal of Informed Consent|1|||
48808902|NCT02798211|157141531|FG001|Period 2|Withdrawal of Informed Consent|0|||
48808903|NCT02798211|157141532|FG002|Period 2|Withdrawal of Informed Consent|0|||
48808904|NCT02798211|157141533|FG003|Period 2|Withdrawal of Informed Consent|2|||
48808905|NCT02798211|157141534|FG004|Period 2|Withdrawal of Informed Consent|2|||
48808906|NCT02798211|157141535|FG005|Period 2|Withdrawal of Informed Consent|3|||
48808907|NCT02281760|157141536|FG000|Overall Study|Withdrawal by Subject|1|||
48808908|NCT04581200|157141537|FG000|Overall Study|Lost to Follow-up|6|||
48808909|NCT04581200|157141538|FG001|Overall Study|Lost to Follow-up|5|||
48808910|NCT04488003|157141540|FG000|Assessed for Eligibility|Screen Failure|24|||
48808911|NCT04488003|157141541|FG001|Assessed for Eligibility|Screen Failure|0|||
48808912|NCT04488003|157141542|FG002|Assessed for Eligibility|Screen Failure|0|||
48808913|NCT04488003|157141540|FG000|Assessed for Eligibility|Adverse Event|1|||
48711135|NCT00946153|156791477|FG003|Phase 2|14 days washout for recovery due to AE|0|||
48711136|NCT00946153|156791478|FG004|Phase 2|14 days washout for recovery due to AE|4|||
48711137|NCT01001325|156791479|FG000|Overall Study|Lost to Follow-up|16|||
48711138|NCT01001325|156791480|FG001|Overall Study|Lost to Follow-up|10|||
48711139|NCT01001325|156791479|FG000|Overall Study|Protocol Violation|2|||
48711140|NCT01001325|156791480|FG001|Overall Study|Protocol Violation|0|||
48711141|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
48711142|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
48711143|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
48711144|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
48711145|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
48711146|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
48711147|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
48711148|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
48711149|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
48711150|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
48711151|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
48711152|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
48711153|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
48711154|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
48711155|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
48711156|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
48711157|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
48711158|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
48711159|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
48711160|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
48711161|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
48711162|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
48711163|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
48711164|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
48711165|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
48711166|NCT01584440|156791481|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
48711167|NCT01584440|156791482|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
48711168|NCT01584440|156791483|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
48711169|NCT01584440|156791484|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
48711170|NCT01584440|156791485|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
48711171|NCT01584440|156791481|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
48711172|NCT01584440|156791482|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
48711173|NCT01584440|156791483|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
48711174|NCT01584440|156791484|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
48435319|NCT00960934|155782445|FG004|Overall Study|Protocol Violation|3|||
48711175|NCT01584440|156791485|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
48711176|NCT01584440|156791481|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
48711177|NCT01584440|156791482|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
48711178|NCT01584440|156791483|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
48711179|NCT01584440|156791484|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
48711180|NCT01584440|156791485|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
48711181|NCT01584440|156791481|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
48711182|NCT01584440|156791482|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
48711183|NCT01584440|156791483|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
48808914|NCT04488003|157141541|FG001|Assessed for Eligibility|Adverse Event|0|||
48808915|NCT04488003|157141542|FG002|Assessed for Eligibility|Adverse Event|0|||
48808916|NCT04488003|157141540|FG000|Assessed for Eligibility|Death|1|||
48808917|NCT04488003|157141541|FG001|Assessed for Eligibility|Death|0|||
48808918|NCT04488003|157141542|FG002|Assessed for Eligibility|Death|0|||
48808919|NCT04488003|157141540|FG000|Assessed for Eligibility|Physician Decision|1|||
48808920|NCT04488003|157141541|FG001|Assessed for Eligibility|Physician Decision|0|||
48808921|NCT04488003|157141542|FG002|Assessed for Eligibility|Physician Decision|0|||
48808922|NCT04488003|157141540|FG000|Allocated to Treatment|Progressive Disease|51|||
48808923|NCT04488003|157141541|FG001|Allocated to Treatment|Progressive Disease|0|||
48808924|NCT04488003|157141542|FG002|Allocated to Treatment|Progressive Disease|0|||
48808925|NCT04488003|157141540|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
48808926|NCT04488003|157141541|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
48808927|NCT04488003|157141542|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
48808928|NCT04488003|157141540|FG000|Allocated to Treatment|Adverse Event|6|||
48808929|NCT04488003|157141541|FG001|Allocated to Treatment|Adverse Event|0|||
48808930|NCT04488003|157141542|FG002|Allocated to Treatment|Adverse Event|0|||
48808931|NCT04488003|157141540|FG000|Allocated to Treatment|Other|5|||
48808932|NCT04488003|157141541|FG001|Allocated to Treatment|Other|0|||
48808933|NCT04488003|157141542|FG002|Allocated to Treatment|Other|0|||
48808934|NCT04488003|157141540|FG000|Allocated to Treatment|Physician Decision|4|||
48808935|NCT04488003|157141541|FG001|Allocated to Treatment|Physician Decision|0|||
48808936|NCT04488003|157141542|FG002|Allocated to Treatment|Physician Decision|0|||
48808937|NCT04488003|157141540|FG000|Allocated to Treatment|Death|4|||
48808938|NCT04488003|157141541|FG001|Allocated to Treatment|Death|0|||
48808939|NCT04488003|157141542|FG002|Allocated to Treatment|Death|0|||
48808940|NCT01737996|157141543|FG000|Overall Study|Adverse Event|0|||
48808941|NCT01737996|157141544|FG001|Overall Study|Adverse Event|1|||
48808942|NCT01737996|157141545|FG002|Overall Study|Adverse Event|1|||
48808943|NCT01737996|157141543|FG000|Overall Study|Withdrawal by Subject|0|||
48808944|NCT01737996|157141544|FG001|Overall Study|Withdrawal by Subject|0|||
48808945|NCT01737996|157141545|FG002|Overall Study|Withdrawal by Subject|1|||
48808946|NCT03283696|157141546|FG000|Overall Study|Physician Decision|5|||
48808947|NCT03283696|157141547|FG001|Overall Study|Physician Decision|6|||
48808948|NCT03283696|157141546|FG000|Overall Study|Withdrawal by Subject|2|||
48808949|NCT03283696|157141547|FG001|Overall Study|Withdrawal by Subject|0|||
48808950|NCT00007475|157141548|FG000|Overall Study|Withdrawal by Subject|1|||
48808951|NCT00007475|157141549|FG001|Overall Study|Withdrawal by Subject|0|||
48808952|NCT00007475|157141550|FG002|Overall Study|Withdrawal by Subject|0|||
48808953|NCT00007475|157141551|FG003|Overall Study|Withdrawal by Subject|0|||
48808954|NCT00007475|157141548|FG000|Overall Study|Adverse Event|3|||
48808955|NCT00007475|157141549|FG001|Overall Study|Adverse Event|0|||
48808956|NCT00007475|157141550|FG002|Overall Study|Adverse Event|0|||
48808957|NCT00007475|157141551|FG003|Overall Study|Adverse Event|0|||
48808958|NCT02904902|157141553|FG000|Overall Study|Withdrawal by Subject|1|||
48808959|NCT01372605|157141557|FG000|Overall Study|Death|1|||
48808960|NCT01372605|157141558|FG001|Overall Study|Death|2|||
48808961|NCT01372605|157141557|FG000|Overall Study|Lost to Follow-up|2|||
48808962|NCT01372605|157141558|FG001|Overall Study|Lost to Follow-up|1|||
48808963|NCT01372605|157141557|FG000|Overall Study|Withdrawal by Subject|4|||
48808964|NCT01372605|157141558|FG001|Overall Study|Withdrawal by Subject|7|||
48808965|NCT01372605|157141557|FG000|Overall Study|Moved|3|||
48808966|NCT01372605|157141558|FG001|Overall Study|Moved|0|||
48808967|NCT01372605|157141557|FG000|Overall Study|Changed medical home|2|||
48808968|NCT01372605|157141558|FG001|Overall Study|Changed medical home|0|||
48808969|NCT02912468|157141559|FG000|Overall Study|Adverse Event|3|||
48808970|NCT02912468|157141560|FG001|Overall Study|Adverse Event|2|||
48808971|NCT02912468|157141559|FG000|Overall Study|Withdrawal by Subject|6|||
48808972|NCT02912468|157141560|FG001|Overall Study|Withdrawal by Subject|2|||
48808973|NCT02912468|157141559|FG000|Overall Study|Randomized and not treated|0|||
48808974|NCT02912468|157141560|FG001|Overall Study|Randomized and not treated|1|||
48808975|NCT00692406|157141566|FG000|Overall Study|PI dropped, bad data|57|||
48808976|NCT04145037|157141567|FG000|Overall Study|Study terminated|2|||
48808977|NCT04145037|157141568|FG001|Overall Study|Study terminated|0|||
48808978|NCT04145037|157141567|FG000|Overall Study|Withdrawal by Subject|1|||
48808979|NCT04145037|157141568|FG001|Overall Study|Withdrawal by Subject|0|||
48808980|NCT04145037|157141567|FG000|Overall Study|Lost to Follow-up|1|||
48808981|NCT04145037|157141568|FG001|Overall Study|Lost to Follow-up|0|||
48808982|NCT04599101|157141569|FG000|Overall Study|Lost to Follow-up|5|||
48808983|NCT04599101|157141570|FG001|Overall Study|Lost to Follow-up|5|||
48808984|NCT00525265|157141571|FG000|Overall Study|Protocol Violation|1|||
48808985|NCT00525265|157141572|FG001|Overall Study|Protocol Violation|0|||
48808986|NCT00960752|157141578|FG000|Overall Study|Adverse Event|0|||
48808987|NCT00960752|157141579|FG001|Overall Study|Adverse Event|0|||
48808988|NCT00960752|157141580|FG002|Overall Study|Adverse Event|1|||
48808989|NCT00960752|157141578|FG000|Overall Study|Progression|0|||
48808990|NCT00960752|157141579|FG001|Overall Study|Progression|0|||
48808991|NCT00960752|157141580|FG002|Overall Study|Progression|1|||
48808992|NCT01975220|157141583|FG000|Test Period 1|Not treated|0|||
48808993|NCT01975220|157141584|FG001|Test Period 1|Not treated|1|||
48808994|NCT01975220|157141585|FG002|Test Period 1|Not treated|0|||
48808995|NCT01975220|157141586|FG003|Test Period 1|Not treated|0|||
48808996|NCT01975220|157141587|FG004|Test Period 1|Not treated|0|||
48808997|NCT01975220|157141588|FG005|Test Period 1|Not treated|0|||
48808998|NCT02460263|157141589|FG000|Transition Period|Withdrawal by Subject|1|||
48808999|NCT02460263|157141589|FG000|Transition Period|Death|1|||
48809000|NCT03176238|157141590|FG000|Overall Study|Unacceptable AEs|15|||
48809001|NCT03176238|157141591|FG001|Overall Study|Unacceptable AEs|8|||
48809002|NCT03176238|157141590|FG000|Overall Study|Abnormal lab value(s)|2|||
48809003|NCT03176238|157141591|FG001|Overall Study|Abnormal lab value(s)|0|||
48809004|NCT03176238|157141590|FG000|Overall Study|Inter-current illness|0|||
48809005|NCT03176238|157141591|FG001|Overall Study|Inter-current illness|1|||
48809006|NCT03176238|157141590|FG000|Overall Study|Consent withdrawal|14|||
48809007|NCT03176238|157141591|FG001|Overall Study|Consent withdrawal|2|||
48809008|NCT03176238|157141590|FG000|Overall Study|Lost to Follow-up|3|||
48809009|NCT03176238|157141591|FG001|Overall Study|Lost to Follow-up|0|||
48809010|NCT03176238|157141590|FG000|Overall Study|Administrative problems|1|||
48809011|NCT03176238|157141591|FG001|Overall Study|Administrative problems|0|||
48809012|NCT03176238|157141590|FG000|Overall Study|Death|3|||
48809013|NCT03176238|157141591|FG001|Overall Study|Death|0|||
48809014|NCT03176238|157141590|FG000|Overall Study|Disease Progression|133|||
48809015|NCT03176238|157141591|FG001|Overall Study|Disease Progression|22|||
48809016|NCT03176238|157141590|FG000|Overall Study|Tx duration completed per EAP|0|||
48809017|NCT03176238|157141591|FG001|Overall Study|Tx duration completed per EAP|1|||
48809018|NCT03176238|157141590|FG000|Overall Study|Patient is switched to commercial drug|16|||
48809019|NCT03176238|157141591|FG001|Overall Study|Patient is switched to commercial drug|1|||
48809020|NCT03176238|157141590|FG000|Overall Study|Protocol Violation|1|||
48809021|NCT03176238|157141591|FG001|Overall Study|Protocol Violation|0|||
48809022|NCT03176238|157141590|FG000|Overall Study|Changes in the patient's condition|2|||
48809023|NCT03176238|157141591|FG001|Overall Study|Changes in the patient's condition|1|||
48809024|NCT03176238|157141590|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
48809025|NCT03176238|157141591|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
48809026|NCT03556358|157141592|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
48809027|NCT03556358|157141593|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
48809028|NCT03556358|157141592|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
48809029|NCT03556358|157141593|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
48809030|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
48809031|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
48809032|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
48809033|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
48597308|NCT02227784|156381950|FG004|Open-Label Extension Phase (OLE)|Death|1|||
48597309|NCT02227784|156381946|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
48597310|NCT02227784|156381947|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
48597311|NCT02227784|156381948|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
48597312|NCT02227784|156381949|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
48597313|NCT02227784|156381950|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
48597314|NCT02227784|156381946|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
48597315|NCT02227784|156381947|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
48597316|NCT02227784|156381948|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
48597317|NCT02227784|156381949|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
48597318|NCT02227784|156381950|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
48597319|NCT02155699|156381954|FG000|Overall Study|Withdrawal by Subject|0|||
48809034|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
48809035|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
48809036|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
48809037|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
48597320|NCT02155699|156381955|FG001|Overall Study|Withdrawal by Subject|3|||
48597321|NCT02155699|156381956|FG002|Overall Study|Withdrawal by Subject|6|||
48597322|NCT02155699|156381957|FG003|Overall Study|Withdrawal by Subject|1|||
48597323|NCT02155699|156381954|FG000|Overall Study|Lost to Follow-up|0|||
48597324|NCT02155699|156381955|FG001|Overall Study|Lost to Follow-up|0|||
48597325|NCT02155699|156381956|FG002|Overall Study|Lost to Follow-up|0|||
48597326|NCT02155699|156381957|FG003|Overall Study|Lost to Follow-up|3|||
48597327|NCT02155699|156381954|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
48597328|NCT02155699|156381955|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
48597329|NCT02155699|156381956|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
48597330|NCT02155699|156381957|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
48597331|NCT05415462|156381958|FG000|Overall Study|Death|18|||
48809038|NCT03556358|157141592|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
48809039|NCT03556358|157141593|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
48809040|NCT01351025|157141596|FG000|Week 0 - 20|Lost to Follow-up|2|||
48809041|NCT01351025|157141597|FG001|Week 0 - 20|Lost to Follow-up|1|||
48809042|NCT01351025|157141596|FG000|Week 0 - 20|Withdrawal by Subject|1|||
48809043|NCT01351025|157141597|FG001|Week 0 - 20|Withdrawal by Subject|0|||
48809044|NCT01351025|157141596|FG000|Week 24 - 44|Lost to Follow-up|0|||
48809045|NCT01351025|157141597|FG001|Week 24 - 44|Lost to Follow-up|2|||
48809046|NCT01351025|157141596|FG000|Week 24 - 44|Site closed|0|||
48809047|NCT01351025|157141597|FG001|Week 24 - 44|Site closed|1|||
48809048|NCT01351025|157141596|FG000|Week 24 - 44|unable to get to clinic|1|||
48809049|NCT01351025|157141597|FG001|Week 24 - 44|unable to get to clinic|1|||
48809050|NCT03012061|157141608|FG000|Overall Study|Withdrawal by Subject|1|||
48809051|NCT03012061|157141609|FG001|Overall Study|Withdrawal by Subject|5|||
48809052|NCT03012061|157141610|FG002|Overall Study|Withdrawal by Subject|4|||
48809053|NCT03012061|157141608|FG000|Overall Study|Investigator Site Closed|1|||
48809054|NCT03012061|157141609|FG001|Overall Study|Investigator Site Closed|2|||
48809055|NCT03012061|157141610|FG002|Overall Study|Investigator Site Closed|0|||
48809056|NCT03012061|157141608|FG000|Overall Study|Lost to Follow-up|2|||
48809057|NCT03012061|157141609|FG001|Overall Study|Lost to Follow-up|1|||
48809058|NCT03012061|157141610|FG002|Overall Study|Lost to Follow-up|0|||
48809059|NCT03012061|157141608|FG000|Overall Study|Study closed/ Terminated|0|||
48809060|NCT03012061|157141609|FG001|Overall Study|Study closed/ Terminated|0|||
48809061|NCT03012061|157141610|FG002|Overall Study|Study closed/ Terminated|1|||
48809062|NCT03012061|157141608|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
48809063|NCT03012061|157141609|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
48809064|NCT03012061|157141610|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
48809065|NCT03012061|157141608|FG000|Overall Study|Protocol Violation|0|||
48809066|NCT03012061|157141609|FG001|Overall Study|Protocol Violation|0|||
48809067|NCT03012061|157141610|FG002|Overall Study|Protocol Violation|2|||
48809068|NCT03012061|157141608|FG000|Overall Study|Lack of Efficacy|0|||
48809069|NCT03012061|157141609|FG001|Overall Study|Lack of Efficacy|1|||
48809070|NCT03012061|157141610|FG002|Overall Study|Lack of Efficacy|0|||
48809071|NCT03012061|157141608|FG000|Overall Study|Adverse Event|2|||
48809072|NCT03012061|157141609|FG001|Overall Study|Adverse Event|0|||
48809073|NCT03012061|157141610|FG002|Overall Study|Adverse Event|0|||
48809074|NCT00510458|157141611|FG000|Overall Study|5 year not evaluable/missed|21|||
48809075|NCT00510458|157141611|FG000|Overall Study|Death|1|||
48809076|NCT00510458|157141611|FG000|Overall Study|Terminated|14|||
48597332|NCT05415462|156381959|FG001|Overall Study|Death|10|||
48597333|NCT05415462|156381958|FG000|Overall Study|Lost to Follow-up|72|||
48597334|NCT05415462|156381959|FG001|Overall Study|Lost to Follow-up|64|||
48597335|NCT05415462|156381958|FG000|Overall Study|Physician Decision|5|||
48597336|NCT05415462|156381959|FG001|Overall Study|Physician Decision|5|||
48597337|NCT05415462|156381958|FG000|Overall Study|Protocol Deviation|1|||
48597338|NCT05415462|156381959|FG001|Overall Study|Protocol Deviation|0|||
48597339|NCT05415462|156381958|FG000|Overall Study|Withdrawal by Subject|129|||
48597340|NCT05415462|156381959|FG001|Overall Study|Withdrawal by Subject|101|||
48597341|NCT05415462|156381958|FG000|Overall Study|Other Than Specified|8|||
48597342|NCT05415462|156381959|FG001|Overall Study|Other Than Specified|8|||
48597343|NCT04391842|156381962|FG000|Overall Study|Withdrawal by Subject|2|||
48597344|NCT04039204|156381963|FG000|Overall Study|Withdrawal by Subject|0|||
48597345|NCT04039204|156381964|FG001|Overall Study|Withdrawal by Subject|2|||
48597346|NCT00972283|156381970|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
48597347|NCT00972283|156381971|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
48597348|NCT00972283|156381970|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
48597349|NCT00972283|156381971|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
48597350|NCT00972283|156381970|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
48597351|NCT00972283|156381971|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
48597352|NCT00972283|156381970|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
48597353|NCT00972283|156381971|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
48597354|NCT00972283|156381970|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
48597355|NCT00972283|156381971|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
48597356|NCT00972283|156381970|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
48597357|NCT00972283|156381971|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
48597358|NCT00972283|156381970|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
48597359|NCT00972283|156381971|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
48597360|NCT00972283|156381970|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
48597361|NCT00972283|156381971|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
48597362|NCT00972283|156381970|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
48597363|NCT00972283|156381971|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
48597364|NCT00972283|156381970|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
48809077|NCT00510458|157141611|FG000|Overall Study|Lost to Follow-up|6|||
48809078|NCT00510458|157141611|FG000|Overall Study|Withdrawal by Subject|3|||
48809079|NCT00510458|157141611|FG000|Overall Study|Revision|2|||
48809080|NCT01871558|157141612|FG000|Overall Study|Other reason|0|||
48809081|NCT01871558|157141613|FG001|Overall Study|Other reason|1|||
48809082|NCT01871558|157141612|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
48809083|NCT01871558|157141613|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
48809084|NCT01871558|157141612|FG000|Overall Study|Withdrawal by Subject|2|||
48809085|NCT01871558|157141613|FG001|Overall Study|Withdrawal by Subject|0|||
48809086|NCT00171873|157141614|FG000|Overall Study|Withdrawal by Subject|4|||
48809087|NCT00171873|157141615|FG001|Overall Study|Withdrawal by Subject|2|||
48809088|NCT00171873|157141614|FG000|Overall Study|Adverse Event|5|||
48809089|NCT00171873|157141615|FG001|Overall Study|Adverse Event|0|||
48809090|NCT00171873|157141614|FG000|Overall Study|Switched to Octreotide|0|||
48809091|NCT00171873|157141615|FG001|Overall Study|Switched to Octreotide|1|||
48809092|NCT01338012|157141619|FG000|Overall Study|Death|4|||
48809093|NCT01338012|157141619|FG000|Overall Study|Study terminated|4|||
48809094|NCT04179175|157142605|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
48809095|NCT04179175|157142606|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
48809096|NCT04179175|157142607|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
48809097|NCT04179175|157142608|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
48491875|NCT01381900|155994229|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
48597365|NCT00972283|156381971|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
48809098|NCT04179175|157142609|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
48809099|NCT04179175|157142610|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
48809100|NCT04179175|157142605|FG000|Overall Study|Adverse Event|5|||
48597366|NCT04577794|156381972|FG000|Overall Study|Adverse Event|1|||
48491876|NCT01381900|155994230|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
48491877|NCT01381900|155994231|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
48491878|NCT01381900|155994229|FG000|Overall Study|Adverse Event|4|||
48491879|NCT01381900|155994230|FG001|Overall Study|Adverse Event|6|||
48491880|NCT01381900|155994231|FG002|Overall Study|Adverse Event|7|||
48491881|NCT01381900|155994229|FG000|Overall Study|Noncompliance with study drug|0|||
48491882|NCT01381900|155994230|FG001|Overall Study|Noncompliance with study drug|0|||
48491883|NCT01381900|155994231|FG002|Overall Study|Noncompliance with study drug|1|||
48491884|NCT01381900|155994229|FG000|Overall Study|Physician Decision|0|||
48491885|NCT01381900|155994230|FG001|Overall Study|Physician Decision|1|||
48491886|NCT01381900|155994231|FG002|Overall Study|Physician Decision|1|||
48491887|NCT01381900|155994229|FG000|Overall Study|Protocol Violation|0|||
48491888|NCT01381900|155994230|FG001|Overall Study|Protocol Violation|1|||
48491889|NCT01381900|155994231|FG002|Overall Study|Protocol Violation|1|||
48491890|NCT01381900|155994229|FG000|Overall Study|Withdrawal by Subject|0|||
48491891|NCT01381900|155994230|FG001|Overall Study|Withdrawal by Subject|0|||
48491892|NCT01381900|155994231|FG002|Overall Study|Withdrawal by Subject|1|||
48491893|NCT01381900|155994229|FG000|Overall Study|Early withdraw|3|||
48491894|NCT01381900|155994230|FG001|Overall Study|Early withdraw|1|||
48491895|NCT01381900|155994231|FG002|Overall Study|Early withdraw|1|||
48491896|NCT00368537|155994232|FG000|Randomization|No study drug dosed|13|||
48491897|NCT00368537|155994233|FG001|Randomization|No study drug dosed|6|||
48491898|NCT00368537|155994232|FG000|Baseline Participants|Lost to Follow-up|16|||
48491899|NCT00368537|155994233|FG001|Baseline Participants|Lost to Follow-up|17|||
48491900|NCT00368537|155994232|FG000|Baseline Participants|Withdrawal by Subject|6|||
48491901|NCT00368537|155994233|FG001|Baseline Participants|Withdrawal by Subject|4|||
48491902|NCT00368537|155994232|FG000|Baseline Participants|Death|1|||
48491903|NCT00368537|155994233|FG001|Baseline Participants|Death|2|||
48491904|NCT00368537|155994232|FG000|Baseline Participants|No susceptibility|1|||
48491905|NCT00368537|155994233|FG001|Baseline Participants|No susceptibility|0|||
48491906|NCT00368537|155994232|FG000|Baseline Participants|Patient uncompliant|0|||
48491907|NCT00368537|155994233|FG001|Baseline Participants|Patient uncompliant|1|||
48491908|NCT01368276|155994241|FG000|Overall Study|Death|1|||
48491909|NCT01368276|155994242|FG001|Overall Study|Death|10|||
48491910|NCT01427920|155994245|FG000|Overall Study|Adverse Event|1|||
48491911|NCT01427920|155994246|FG001|Overall Study|Adverse Event|2|||
48491912|NCT01427920|155994245|FG000|Overall Study|Lack of Efficacy|1|||
48491913|NCT01427920|155994246|FG001|Overall Study|Lack of Efficacy|0|||
48491914|NCT01427920|155994245|FG000|Overall Study|Protocol Violation|1|||
48491915|NCT01427920|155994246|FG001|Overall Study|Protocol Violation|3|||
48491916|NCT01427920|155994245|FG000|Overall Study|Withdrawal Criteria|4|||
48491917|NCT01427920|155994246|FG001|Overall Study|Withdrawal Criteria|4|||
48491918|NCT01427920|155994245|FG000|Overall Study|Unclassified|2|||
48491919|NCT01427920|155994246|FG001|Overall Study|Unclassified|8|||
48491920|NCT03341273|155994249|FG000|Overall Study|Lost to Follow-up|7|||
48491921|NCT03341273|155994250|FG001|Overall Study|Lost to Follow-up|7|||
48491922|NCT03341273|155994249|FG000|Overall Study|Withdrawal by Subject|4|||
48597367|NCT04577794|156381973|FG001|Overall Study|Adverse Event|1|||
48597368|NCT00447902|156381974|FG000|Overall Study|Adverse Event|0|||
48597369|NCT00447902|156381975|FG001|Overall Study|Adverse Event|3|||
48597370|NCT00447902|156381974|FG000|Overall Study|Protocol Violation|1|||
48597371|NCT00447902|156381975|FG001|Overall Study|Protocol Violation|0|||
48809101|NCT04179175|157142606|FG001|Overall Study|Adverse Event|3|||
48809102|NCT04179175|157142607|FG002|Overall Study|Adverse Event|3|||
48809103|NCT04179175|157142608|FG003|Overall Study|Adverse Event|4|||
48809104|NCT04179175|157142609|FG004|Overall Study|Adverse Event|6|||
48809105|NCT04179175|157142610|FG005|Overall Study|Adverse Event|6|||
48809106|NCT04179175|157142605|FG000|Overall Study|Lack of Efficacy|5|||
48809107|NCT04179175|157142606|FG001|Overall Study|Lack of Efficacy|1|||
48809108|NCT04179175|157142607|FG002|Overall Study|Lack of Efficacy|3|||
48809109|NCT04179175|157142608|FG003|Overall Study|Lack of Efficacy|2|||
48809110|NCT04179175|157142609|FG004|Overall Study|Lack of Efficacy|18|||
48809111|NCT04179175|157142610|FG005|Overall Study|Lack of Efficacy|7|||
48809112|NCT04179175|157142605|FG000|Overall Study|Lost to Follow-up|5|||
48809113|NCT04179175|157142606|FG001|Overall Study|Lost to Follow-up|3|||
48809114|NCT04179175|157142607|FG002|Overall Study|Lost to Follow-up|2|||
48491923|NCT03341273|155994250|FG001|Overall Study|Withdrawal by Subject|2|||
48491924|NCT03341273|155994249|FG000|Overall Study|Physician Decision|1|||
48491925|NCT03341273|155994250|FG001|Overall Study|Physician Decision|0|||
48491926|NCT03341273|155994249|FG000|Overall Study|Protocol Violation|0|||
48491927|NCT03341273|155994250|FG001|Overall Study|Protocol Violation|1|||
48597372|NCT00447902|156381974|FG000|Overall Study|Withdrawal by Subject|0|||
48809115|NCT04179175|157142608|FG003|Overall Study|Lost to Follow-up|2|||
48491928|NCT03341273|155994249|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
48809116|NCT04179175|157142609|FG004|Overall Study|Lost to Follow-up|4|||
48491929|NCT03341273|155994250|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
48597373|NCT00447902|156381975|FG001|Overall Study|Withdrawal by Subject|1|||
48809117|NCT04179175|157142610|FG005|Overall Study|Lost to Follow-up|5|||
48711184|NCT01584440|156791484|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
48711185|NCT01584440|156791485|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
48711186|NCT00899431|156791486|FG000|Overall Study|Physician Decision|1|||
48711187|NCT00899431|156791487|FG001|Overall Study|Physician Decision|0|||
48711188|NCT00899431|156791488|FG002|Overall Study|Physician Decision|0|||
48711189|NCT01821560|156791493|FG000|Overall Study|Lost to Follow-up|5|||
48711190|NCT01821560|156791494|FG001|Overall Study|Lost to Follow-up|5|||
48711191|NCT01821560|156791493|FG000|Overall Study|Withdrawal by Subject|1|||
48711192|NCT01821560|156791494|FG001|Overall Study|Withdrawal by Subject|1|||
48711193|NCT01821560|156791493|FG000|Overall Study|Protocol Violation|0|||
48711194|NCT01821560|156791494|FG001|Overall Study|Protocol Violation|1|||
48711195|NCT01253577|156791505|FG000|Overall Study|Lost to Follow-up|3|||
48711196|NCT00334113|156791508|FG000|Overall Study|Lost to Follow-up|2|||
48711197|NCT00334113|156791509|FG001|Overall Study|Lost to Follow-up|2|||
48711198|NCT00334113|156791508|FG000|Overall Study|Withdrawal by Subject|0|||
48711199|NCT00334113|156791509|FG001|Overall Study|Withdrawal by Subject|1|||
48711200|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
48711201|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
48711202|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
48711203|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
48711204|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Other|2|||
48711205|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
48711206|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
48711207|NCT02509026|156791510|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
48711208|NCT02509026|156791510|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
48711209|NCT02509026|156791510|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
48711210|NCT02509026|156791510|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
48711211|NCT02509026|156791510|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
48711212|NCT02509026|156791510|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
48711213|NCT01165216|156791511|FG000|Overall Study|Adverse Event|6|||
48711214|NCT01165216|156791512|FG001|Overall Study|Adverse Event|3|||
48809118|NCT04179175|157142605|FG000|Overall Study|Physician Decision|2|||
48809119|NCT04179175|157142606|FG001|Overall Study|Physician Decision|0|||
48809120|NCT04179175|157142607|FG002|Overall Study|Physician Decision|2|||
48809121|NCT04179175|157142608|FG003|Overall Study|Physician Decision|3|||
48809122|NCT04179175|157142609|FG004|Overall Study|Physician Decision|1|||
48809123|NCT04179175|157142610|FG005|Overall Study|Physician Decision|1|||
48809124|NCT04179175|157142605|FG000|Overall Study|Pregnancy|3|||
48491930|NCT03341273|155994249|FG000|Overall Study|Became ineligible after enrollment|1|||
48711215|NCT01165216|156791511|FG000|Overall Study|Withdrawal by Subject|1|||
48809125|NCT04179175|157142606|FG001|Overall Study|Pregnancy|0|||
48809126|NCT04179175|157142607|FG002|Overall Study|Pregnancy|3|||
48491931|NCT03341273|155994250|FG001|Overall Study|Became ineligible after enrollment|0|||
48491932|NCT03341273|155994249|FG000|Overall Study|Not Eligible at Enrollment|0|||
48491933|NCT03341273|155994250|FG001|Overall Study|Not Eligible at Enrollment|1|||
48491934|NCT03341273|155994249|FG000|Overall Study|Participant incarcerated|1|||
48491935|NCT03341273|155994250|FG001|Overall Study|Participant incarcerated|0|||
48491936|NCT00555009|155994253|FG000|Overall Study|Withdrawal by Subject|0|||
48491937|NCT00555009|155994254|FG001|Overall Study|Withdrawal by Subject|1|||
48491938|NCT00555009|155994253|FG000|Overall Study|Terminated by Sponsor|2|||
48491939|NCT00555009|155994254|FG001|Overall Study|Terminated by Sponsor|5|||
48491940|NCT01717456|155994255|FG000|End of Treatment|Physician Decision|0|||
48491941|NCT01717456|155994256|FG001|End of Treatment|Physician Decision|1|||
48491942|NCT01717456|155994255|FG000|End of Treatment|Lost to Follow-up|0|||
48491943|NCT01717456|155994256|FG001|End of Treatment|Lost to Follow-up|1|||
48491944|NCT01717456|155994255|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
48491945|NCT01717456|155994256|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
48491946|NCT02040428|155994261|FG000|Overall Study|Death|4|||
48491947|NCT02040428|155994262|FG001|Overall Study|Death|3|||
48491948|NCT02040428|155994261|FG000|Overall Study|Withdrawal by Subject|1|||
48491949|NCT02040428|155994262|FG001|Overall Study|Withdrawal by Subject|1|||
48491950|NCT00891774|155994263|FG000|Overall Study|Lost to Follow-up|5|||
48491951|NCT00891774|155994263|FG000|Overall Study|Illness (Self/Mother)|3|||
48491952|NCT00891774|155994263|FG000|Overall Study|Withdrawal by Subject|2|||
48491953|NCT00891774|155994263|FG000|Overall Study|Protocol Violation|4|||
48491954|NCT01405820|155994264|FG000|Randomized Treatment Period|Adverse Event|3|||
48491955|NCT01405820|155994265|FG001|Randomized Treatment Period|Adverse Event|3|||
48491956|NCT01405820|155994266|FG002|Randomized Treatment Period|Adverse Event|3|||
48491957|NCT01405820|155994267|FG003|Randomized Treatment Period|Adverse Event|0|||
48491958|NCT01405820|155994268|FG004|Randomized Treatment Period|Adverse Event|2|||
48711216|NCT01165216|156791512|FG001|Overall Study|Withdrawal by Subject|1|||
48711217|NCT01165216|156791511|FG000|Overall Study|Disease progression|1|||
48809127|NCT04179175|157142608|FG003|Overall Study|Pregnancy|0|||
48809128|NCT04179175|157142609|FG004|Overall Study|Pregnancy|1|||
48809129|NCT04179175|157142610|FG005|Overall Study|Pregnancy|2|||
48491959|NCT01405820|155994269|FG005|Randomized Treatment Period|Adverse Event|1|||
48711218|NCT01165216|156791512|FG001|Overall Study|Disease progression|3|||
48597374|NCT00447902|156381974|FG000|Overall Study|included patients who discontinued|1|||
48597375|NCT00447902|156381975|FG001|Overall Study|included patients who discontinued|1|||
48597376|NCT00447902|156381974|FG000|Overall Study|Lack of Efficacy|2|||
48597377|NCT00447902|156381975|FG001|Overall Study|Lack of Efficacy|1|||
48597378|NCT02849080|156381978|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
48597379|NCT02849080|156381979|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
48597380|NCT02849080|156381980|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
48597381|NCT02849080|156381981|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
48597382|NCT02849080|156381978|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
48597383|NCT02849080|156381979|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
48597384|NCT02849080|156381980|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
48597385|NCT02849080|156381981|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
48597386|NCT02849080|156381978|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
48597387|NCT02849080|156381979|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
48597388|NCT02849080|156381980|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
48597389|NCT02849080|156381981|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
48597390|NCT02849080|156381978|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
48597391|NCT02849080|156381979|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
48597392|NCT02849080|156381980|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
48597393|NCT02849080|156381981|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
48597394|NCT02849080|156381978|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
48597395|NCT02849080|156381979|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
48597396|NCT02849080|156381980|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
48597397|NCT02849080|156381981|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
48597398|NCT02849080|156381978|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
48597399|NCT02849080|156381979|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
48597400|NCT02849080|156381980|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
48597401|NCT02849080|156381981|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
48597402|NCT02155985|156381982|FG000|Overall Study|Withdrawal by Subject|0|||
48597403|NCT02155985|156381983|FG001|Overall Study|Withdrawal by Subject|0|||
48597404|NCT02155985|156381984|FG002|Overall Study|Withdrawal by Subject|1|||
48597405|NCT02155985|156381982|FG000|Overall Study|Lost to Follow-up|1|||
48597406|NCT02155985|156381983|FG001|Overall Study|Lost to Follow-up|0|||
48597407|NCT02155985|156381984|FG002|Overall Study|Lost to Follow-up|0|||
48597408|NCT02998151|156381985|FG000|Overall Study|Withdrawal by Subject|3|||
48597409|NCT02998151|156381985|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
48597410|NCT02998151|156381985|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
48597411|NCT00751140|156381986|FG000|Overall Study|benign angioma excluded from analysis|1|||
48597412|NCT03654729|156383486|FG000|Overall Study|Death|9|||
48597413|NCT03654729|156383487|FG001|Overall Study|Death|9|||
48597414|NCT03654729|156383488|FG002|Overall Study|Death|16|||
48597415|NCT03654729|156383486|FG000|Overall Study|Withdrawal by Subject|8|||
48597416|NCT03654729|156383487|FG001|Overall Study|Withdrawal by Subject|6|||
48597417|NCT03654729|156383488|FG002|Overall Study|Withdrawal by Subject|4|||
48597418|NCT03654729|156383486|FG000|Overall Study|Study terminated by Sponsor|3|||
48597419|NCT03654729|156383487|FG001|Overall Study|Study terminated by Sponsor|5|||
48597420|NCT03654729|156383488|FG002|Overall Study|Study terminated by Sponsor|4|||
48597421|NCT03654729|156383486|FG000|Overall Study|Not reported|2|||
48597422|NCT03654729|156383487|FG001|Overall Study|Not reported|4|||
48597423|NCT03654729|156383488|FG002|Overall Study|Not reported|5|||
48597424|NCT03654729|156383486|FG000|Overall Study|Progressive disease|3|||
48597425|NCT03654729|156383487|FG001|Overall Study|Progressive disease|0|||
48597426|NCT03654729|156383488|FG002|Overall Study|Progressive disease|0|||
48597427|NCT03654729|156383486|FG000|Overall Study|Lost to Follow-up|2|||
48597428|NCT03654729|156383487|FG001|Overall Study|Lost to Follow-up|0|||
48597429|NCT03654729|156383488|FG002|Overall Study|Lost to Follow-up|0|||
48597430|NCT03654729|156383486|FG000|Overall Study|Physician Decision|2|||
48597431|NCT03654729|156383487|FG001|Overall Study|Physician Decision|0|||
48597432|NCT03654729|156383488|FG002|Overall Study|Physician Decision|0|||
48597433|NCT03654729|156383486|FG000|Overall Study|Protocol Violation|1|||
48597434|NCT03654729|156383487|FG001|Overall Study|Protocol Violation|1|||
48597435|NCT03654729|156383488|FG002|Overall Study|Protocol Violation|0|||
48597436|NCT03654729|156383486|FG000|Overall Study|Non-compliance with study drug|0|||
48597437|NCT03654729|156383487|FG001|Overall Study|Non-compliance with study drug|1|||
48597438|NCT03654729|156383488|FG002|Overall Study|Non-compliance with study drug|0|||
48597439|NCT03654729|156383486|FG000|Overall Study|Site terminated by Sponsor|1|||
48597440|NCT03654729|156383487|FG001|Overall Study|Site terminated by Sponsor|0|||
48597441|NCT03654729|156383488|FG002|Overall Study|Site terminated by Sponsor|0|||
48597442|NCT00588146|156383493|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
48597443|NCT00588146|156383494|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
48597444|NCT00463801|156383499|FG000|Overall Study|Protocol Violation|1|||
48597445|NCT00463801|156383499|FG000|Overall Study|Lack of Efficacy|2|||
48597446|NCT00463801|156383499|FG000|Overall Study|Adverse Event|4|||
48597447|NCT00463801|156383499|FG000|Overall Study|Lost to Follow-up|5|||
48711219|NCT03645434|156791513|FG000|Period 1|Adverse Event|0|||
48711220|NCT03645434|156791514|FG001|Period 1|Adverse Event|0|||
48711221|NCT03645434|156791515|FG002|Period 1|Adverse Event|0|||
48711222|NCT03645434|156791516|FG003|Period 1|Adverse Event|1|||
48711223|NCT03645434|156791517|FG004|Period 1|Adverse Event|0|||
48711224|NCT03645434|156791518|FG005|Period 1|Adverse Event|0|||
48711225|NCT03645434|156791513|FG000|Period 1|COPD exacerbation|0|||
48711226|NCT03645434|156791514|FG001|Period 1|COPD exacerbation|0|||
48711227|NCT03645434|156791515|FG002|Period 1|COPD exacerbation|0|||
48711228|NCT03645434|156791516|FG003|Period 1|COPD exacerbation|0|||
48711229|NCT03645434|156791517|FG004|Period 1|COPD exacerbation|1|||
48711230|NCT03645434|156791518|FG005|Period 1|COPD exacerbation|0|||
48711231|NCT01379508|156791519|FG000|Treatment to Week 104|Adverse Event|2|||
48711232|NCT01379508|156791520|FG001|Treatment to Week 104|Adverse Event|0|||
48711233|NCT01379508|156791521|FG002|Treatment to Week 104|Adverse Event|5|||
48711234|NCT01379508|156791522|FG003|Treatment to Week 104|Adverse Event|0|||
48711235|NCT01379508|156791519|FG000|Treatment to Week 104|Abnormal lab value|1|||
48711236|NCT01379508|156791520|FG001|Treatment to Week 104|Abnormal lab value|0|||
48711237|NCT01379508|156791521|FG002|Treatment to Week 104|Abnormal lab value|0|||
48711238|NCT01379508|156791522|FG003|Treatment to Week 104|Abnormal lab value|0|||
48711239|NCT01379508|156791519|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
48711240|NCT01379508|156791520|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
48711241|NCT01379508|156791521|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
48435320|NCT00960934|155782446|FG005|Overall Study|Protocol Violation|2|||
48711242|NCT01379508|156791522|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
48711243|NCT01379508|156791519|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
48711244|NCT01379508|156791520|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
48711245|NCT01379508|156791521|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
48711246|NCT01379508|156791522|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
48711247|NCT01379508|156791519|FG000|Treatment to Week 104|Lost to Follow-up|5|||
48711248|NCT01379508|156791520|FG001|Treatment to Week 104|Lost to Follow-up|0|||
48491960|NCT01405820|155994264|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
48491961|NCT01405820|155994265|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
48491962|NCT01405820|155994266|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
48491963|NCT01405820|155994267|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
48491964|NCT01405820|155994268|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
48491965|NCT01405820|155994269|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
48491966|NCT01405820|155994264|FG000|Randomized Treatment Period|Other|2|||
48491967|NCT01405820|155994265|FG001|Randomized Treatment Period|Other|2|||
48491968|NCT01405820|155994266|FG002|Randomized Treatment Period|Other|1|||
48491969|NCT01405820|155994267|FG003|Randomized Treatment Period|Other|1|||
48491970|NCT01405820|155994268|FG004|Randomized Treatment Period|Other|0|||
48491971|NCT01405820|155994269|FG005|Randomized Treatment Period|Other|0|||
48597448|NCT00463801|156383499|FG000|Overall Study|No longer require therapy|1|||
48597449|NCT00940888|156383500|FG000|Overall Study|Unsuccessful Implant|4|||
48597450|NCT00940888|156383500|FG000|Overall Study|Death|461|||
48597451|NCT00940888|156383500|FG000|Overall Study|Withdrawn - Non-Death|364|||
48597452|NCT00940888|156383500|FG000|Overall Study|Lost to Follow-up|6|||
48597453|NCT04441788|156383503|FG000|Overall Study|Voluntary Withdrawl|0|||
48597454|NCT04441788|156383504|FG001|Overall Study|Voluntary Withdrawl|1|||
48597455|NCT04441788|156383505|FG002|Overall Study|Voluntary Withdrawl|0|||
48809130|NCT04179175|157142605|FG000|Overall Study|Withdrawal by Subject|22|||
48809131|NCT04179175|157142606|FG001|Overall Study|Withdrawal by Subject|10|||
48809132|NCT04179175|157142607|FG002|Overall Study|Withdrawal by Subject|12|||
48809133|NCT04179175|157142608|FG003|Overall Study|Withdrawal by Subject|8|||
48809134|NCT04179175|157142609|FG004|Overall Study|Withdrawal by Subject|23|||
48809135|NCT04179175|157142610|FG005|Overall Study|Withdrawal by Subject|31|||
48809136|NCT04179175|157142605|FG000|Overall Study|Technical problems|0|||
48809137|NCT04179175|157142606|FG001|Overall Study|Technical problems|0|||
48809138|NCT04179175|157142607|FG002|Overall Study|Technical problems|1|||
48809139|NCT04179175|157142608|FG003|Overall Study|Technical problems|1|||
48809140|NCT04179175|157142609|FG004|Overall Study|Technical problems|0|||
48809141|NCT04179175|157142610|FG005|Overall Study|Technical problems|0|||
48809142|NCT02576509|157142611|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
48809143|NCT02576509|157142612|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
48809144|NCT02576509|157142611|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
48809145|NCT02576509|157142612|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
48809146|NCT02576509|157142611|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
48809147|NCT02576509|157142612|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
48809148|NCT02576509|157142611|FG000|Treatment Period|Disease progression|263|||
48809149|NCT02576509|157142612|FG001|Treatment Period|Disease progression|244|||
48809150|NCT02576509|157142611|FG000|Treatment Period|Study drug toxicity|37|||
48809151|NCT02576509|157142612|FG001|Treatment Period|Study drug toxicity|41|||
48809152|NCT02576509|157142611|FG000|Treatment Period|Death|1|||
48809153|NCT02576509|157142612|FG001|Treatment Period|Death|1|||
48809154|NCT02576509|157142611|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
48809155|NCT02576509|157142612|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
48809156|NCT02576509|157142611|FG000|Treatment Period|Participant request to stop treatment|8|||
48809157|NCT02576509|157142612|FG001|Treatment Period|Participant request to stop treatment|18|||
48809158|NCT02576509|157142611|FG000|Treatment Period|Participant withdrew consent|3|||
48809159|NCT02576509|157142612|FG001|Treatment Period|Participant withdrew consent|7|||
48809160|NCT02576509|157142611|FG000|Treatment Period|Lost to Follow-up|0|||
48809161|NCT02576509|157142612|FG001|Treatment Period|Lost to Follow-up|1|||
48809162|NCT02576509|157142611|FG000|Treatment Period|Maximum clinical benefit|1|||
48809163|NCT02576509|157142612|FG001|Treatment Period|Maximum clinical benefit|0|||
48809164|NCT02576509|157142611|FG000|Treatment Period|Poor/non-compliance|1|||
48597456|NCT04441788|156383503|FG000|Overall Study|Ineligibility|1|||
48597457|NCT04441788|156383504|FG001|Overall Study|Ineligibility|0|||
48809165|NCT02576509|157142612|FG001|Treatment Period|Poor/non-compliance|1|||
48597458|NCT04441788|156383505|FG002|Overall Study|Ineligibility|0|||
48597459|NCT04441788|156383503|FG000|Overall Study|Adverse Event|0|||
48597460|NCT04441788|156383504|FG001|Overall Study|Adverse Event|0|||
48597461|NCT04441788|156383505|FG002|Overall Study|Adverse Event|4|||
48597462|NCT04441788|156383503|FG000|Overall Study|Study Terminated by Sponsor|16|||
48597463|NCT04441788|156383504|FG001|Overall Study|Study Terminated by Sponsor|16|||
48597464|NCT04441788|156383505|FG002|Overall Study|Study Terminated by Sponsor|12|||
48597465|NCT00667992|156383508|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
48711249|NCT01379508|156791521|FG002|Treatment to Week 104|Lost to Follow-up|3|||
48597466|NCT00667992|156383509|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
48597467|NCT00667992|156383508|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
48597468|NCT00667992|156383509|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
48597469|NCT00667992|156383508|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
48597470|NCT00667992|156383509|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
48597471|NCT00667992|156383508|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
48597472|NCT00667992|156383509|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
48597473|NCT00667992|156383508|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
48597474|NCT00667992|156383509|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
48597475|NCT00667992|156383508|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
48597476|NCT00667992|156383509|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
48597477|NCT00667992|156383508|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
48597478|NCT00667992|156383509|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
48597479|NCT00667992|156383508|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
48597480|NCT00667992|156383509|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
48597481|NCT00667992|156383508|FG000|Wash-out|Not within one doubling dilution|4|||
48597482|NCT00667992|156383509|FG001|Wash-out|Not within one doubling dilution|3|||
48711250|NCT01379508|156791522|FG003|Treatment to Week 104|Lost to Follow-up|0|||
48711251|NCT01379508|156791519|FG000|Treatment to Week 104|Administrative problems|3|||
48711252|NCT01379508|156791520|FG001|Treatment to Week 104|Administrative problems|1|||
48711253|NCT01379508|156791521|FG002|Treatment to Week 104|Administrative problems|0|||
48711254|NCT01379508|156791522|FG003|Treatment to Week 104|Administrative problems|0|||
48711255|NCT01379508|156791519|FG000|Treatment to Week 104|Protocol Violation|1|||
48809166|NCT02576509|157142611|FG000|Treatment Period|Participant no longer meets criteria|1|||
48491972|NCT01405820|155994264|FG000|Randomized Treatment Period|Physician Decision|0|||
48597483|NCT00667992|156383508|FG000|Wash-out|Failure to wash-out|2|||
48597484|NCT00667992|156383509|FG001|Wash-out|Failure to wash-out|2|||
48809167|NCT02576509|157142612|FG001|Treatment Period|Participant no longer meets criteria|0|||
48809168|NCT02576509|157142611|FG000|Treatment Period|Other reason|12|||
48809169|NCT02576509|157142612|FG001|Treatment Period|Other reason|8|||
48809170|NCT02576509|157142611|FG000|Treatment Period|NOT REPORTED|1|||
48809171|NCT02576509|157142612|FG001|Treatment Period|NOT REPORTED|0|||
48809172|NCT02576509|157142611|FG000|Treatment Period|Administrative reason by sponsor|0|||
48809173|NCT02576509|157142612|FG001|Treatment Period|Administrative reason by sponsor|1|||
48809174|NCT03152786|157142614|FG000|Overall Study|Withdrawal by Subject|2|||
48809175|NCT03152786|157142615|FG001|Overall Study|Withdrawal by Subject|1|||
48809176|NCT05934292|157142619|FG000|Overall Study|Lost to Follow-up|0|||
48809177|NCT05934292|157142620|FG001|Overall Study|Lost to Follow-up|0|||
48809178|NCT05934292|157142621|FG002|Overall Study|Lost to Follow-up|1|||
48809179|NCT05934292|157142622|FG003|Overall Study|Lost to Follow-up|0|||
48809180|NCT05672667|157142625|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
48809181|NCT03416023|157142626|FG000|Overall Study|Exclusion criteria failure|1|||
48809182|NCT03416023|157142626|FG000|Overall Study|Withdrawal by Subject|6|||
48809183|NCT03416023|157142626|FG000|Overall Study|Explanted|7|||
48809184|NCT03416023|157142626|FG000|Overall Study|Physician Decision|1|||
48809185|NCT03416023|157142626|FG000|Overall Study|Lost to Follow-up|1|||
48809186|NCT03416023|157142626|FG000|Overall Study|Death|1|||
48809187|NCT05110495|157142627|FG000|Overall Study|Lost to Follow-up|1|||
48809188|NCT05110495|157142627|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
48809189|NCT02387216|157142628|FG000|Overall Study|Progressive disease|2|||
48809190|NCT02387216|157142629|FG001|Overall Study|Progressive disease|0|||
48809191|NCT02387216|157142628|FG000|Overall Study|Withdrawal by Subject|3|||
48809192|NCT02387216|157142629|FG001|Overall Study|Withdrawal by Subject|5|||
48809193|NCT02387216|157142628|FG000|Overall Study|Physician Decision|2|||
48809194|NCT02387216|157142629|FG001|Overall Study|Physician Decision|0|||
48809195|NCT02387216|157142628|FG000|Overall Study|Sponsor Decision|28|||
48809196|NCT02387216|157142629|FG001|Overall Study|Sponsor Decision|12|||
48809197|NCT02387216|157142628|FG000|Overall Study|Death|60|||
48809198|NCT02387216|157142629|FG001|Overall Study|Death|23|||
48809199|NCT02387216|157142628|FG000|Overall Study|Other|5|||
48809200|NCT02387216|157142629|FG001|Overall Study|Other|4|||
48809201|NCT02387216|157142628|FG000|Overall Study|Lost to Follow-up|0|||
48809202|NCT02387216|157142629|FG001|Overall Study|Lost to Follow-up|3|||
48809203|NCT00154310|157142630|FG000|Overall Study|Adverse Event|19|||
48809204|NCT00154310|157142631|FG001|Overall Study|Adverse Event|9|||
48809205|NCT00154310|157142630|FG000|Overall Study|Lack of Efficacy|5|||
48809206|NCT00154310|157142631|FG001|Overall Study|Lack of Efficacy|4|||
48809207|NCT00154310|157142630|FG000|Overall Study|Protocol Violation|4|||
48809208|NCT00154310|157142631|FG001|Overall Study|Protocol Violation|2|||
48809209|NCT00154310|157142630|FG000|Overall Study|Withdrawal by Subject|9|||
48809210|NCT00154310|157142631|FG001|Overall Study|Withdrawal by Subject|3|||
48809211|NCT00154310|157142630|FG000|Overall Study|Lost to Follow-up|0|||
48809212|NCT00154310|157142631|FG001|Overall Study|Lost to Follow-up|8|||
48809213|NCT00154310|157142630|FG000|Overall Study|Administrative problems|0|||
48809214|NCT00154310|157142631|FG001|Overall Study|Administrative problems|1|||
48809215|NCT00154310|157142630|FG000|Overall Study|Death|0|||
48809216|NCT00154310|157142631|FG001|Overall Study|Death|1|||
48809217|NCT01540565|157142632|FG000|Overall Study|Ineligible|2|||
48809218|NCT03101241|157142633|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
48809219|NCT03101241|157142634|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
48809220|NCT03101241|157142633|FG000|Overall Study|Participant withdrew consent|3|||
48809221|NCT03101241|157142634|FG001|Overall Study|Participant withdrew consent|1|||
48809222|NCT03101241|157142633|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
48809223|NCT03101241|157142634|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
48809224|NCT03101241|157142633|FG000|Overall Study|Lost to Follow-up|2|||
48809225|NCT03101241|157142634|FG001|Overall Study|Lost to Follow-up|0|||
48809226|NCT03101241|157142633|FG000|Overall Study|Lack of Efficacy|0|||
48809227|NCT03101241|157142634|FG001|Overall Study|Lack of Efficacy|1|||
48809228|NCT03101241|157142633|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
48809229|NCT03101241|157142634|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
48809230|NCT03592277|157142642|FG000|Overall Study|Withdrawal by Subject|6|||
48809231|NCT03592277|157142643|FG001|Overall Study|Withdrawal by Subject|8|||
48809232|NCT00669903|157142644|FG000|Overall Study|Adverse Event|0|||
48809233|NCT00669903|157142645|FG001|Overall Study|Adverse Event|1|||
48809234|NCT00669903|157142646|FG002|Overall Study|Adverse Event|3|||
48809235|NCT00669903|157142647|FG003|Overall Study|Adverse Event|1|||
48809236|NCT00669903|157142644|FG000|Overall Study|Withdrawal by Subject|0|||
48809237|NCT00669903|157142645|FG001|Overall Study|Withdrawal by Subject|2|||
48597485|NCT00667992|156383508|FG000|Wash-out|Withdrawal by Subject|1|||
48809238|NCT00669903|157142646|FG002|Overall Study|Withdrawal by Subject|2|||
48809239|NCT00669903|157142647|FG003|Overall Study|Withdrawal by Subject|2|||
48809240|NCT00669903|157142644|FG000|Overall Study|Lost to Follow-up|1|||
48809241|NCT00669903|157142645|FG001|Overall Study|Lost to Follow-up|1|||
48809242|NCT00669903|157142646|FG002|Overall Study|Lost to Follow-up|0|||
48809243|NCT00669903|157142647|FG003|Overall Study|Lost to Follow-up|1|||
48809244|NCT00669903|157142644|FG000|Overall Study|Protocol Violation|0|||
48809245|NCT00669903|157142645|FG001|Overall Study|Protocol Violation|1|||
48809246|NCT00669903|157142646|FG002|Overall Study|Protocol Violation|0|||
48809247|NCT00669903|157142647|FG003|Overall Study|Protocol Violation|0|||
48809248|NCT01678820|157142648|FG000|Overall Study|Study Terminated by Sponsor|45|||
48597486|NCT00667992|156383509|FG001|Wash-out|Withdrawal by Subject|0|||
48597487|NCT00667992|156383508|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
48597488|NCT00667992|156383509|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
48597489|NCT00667992|156383508|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
48597490|NCT00667992|156383509|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
48809249|NCT01678820|157142649|FG001|Overall Study|Study Terminated by Sponsor|43|||
48809250|NCT01678820|157142650|FG002|Overall Study|Study Terminated by Sponsor|43|||
48809251|NCT01678820|157142648|FG000|Overall Study|Withdrawal by Subject|2|||
48809252|NCT01678820|157142649|FG001|Overall Study|Withdrawal by Subject|5|||
48809253|NCT01678820|157142650|FG002|Overall Study|Withdrawal by Subject|2|||
48809254|NCT01678820|157142648|FG000|Overall Study|Protocol Specified Criteria|2|||
48809255|NCT01678820|157142649|FG001|Overall Study|Protocol Specified Criteria|3|||
48809256|NCT01678820|157142650|FG002|Overall Study|Protocol Specified Criteria|1|||
48809257|NCT01678820|157142648|FG000|Overall Study|Adverse Event|2|||
48809258|NCT01678820|157142649|FG001|Overall Study|Adverse Event|2|||
48809259|NCT01678820|157142650|FG002|Overall Study|Adverse Event|2|||
48809260|NCT01678820|157142648|FG000|Overall Study|Lost to Follow-up|7|||
48809261|NCT01678820|157142649|FG001|Overall Study|Lost to Follow-up|2|||
48809262|NCT01678820|157142650|FG002|Overall Study|Lost to Follow-up|2|||
48809263|NCT01678820|157142648|FG000|Overall Study|Non-compliance with study drug|0|||
48809264|NCT01678820|157142649|FG001|Overall Study|Non-compliance with study drug|1|||
48809265|NCT01678820|157142650|FG002|Overall Study|Non-compliance with study drug|0|||
48809266|NCT01678820|157142648|FG000|Overall Study|Physician Decision|0|||
48809267|NCT01678820|157142649|FG001|Overall Study|Physician Decision|0|||
48809268|NCT01678820|157142650|FG002|Overall Study|Physician Decision|1|||
48809269|NCT01678820|157142648|FG000|Overall Study|Protocol Violation|4|||
48809270|NCT01678820|157142649|FG001|Overall Study|Protocol Violation|5|||
48809271|NCT01678820|157142650|FG002|Overall Study|Protocol Violation|4|||
48809272|NCT01678820|157142648|FG000|Overall Study|Not treated with double-blind study drug|0|||
48809273|NCT01678820|157142649|FG001|Overall Study|Not treated with double-blind study drug|2|||
48809274|NCT01678820|157142650|FG002|Overall Study|Not treated with double-blind study drug|2|||
48809275|NCT04041440|157142651|FG000|Overall Study|Withdrawal by Subject|0|||
48809276|NCT04041440|157142652|FG001|Overall Study|Withdrawal by Subject|1|||
48809277|NCT04041440|157142651|FG000|Overall Study|Lost to Follow-up|0|||
48809278|NCT04041440|157142652|FG001|Overall Study|Lost to Follow-up|1|||
48809279|NCT01381874|157142653|FG000|Overall Study|Lost to Follow-up|1|||
48809280|NCT01381874|157142654|FG001|Overall Study|Lost to Follow-up|1|||
48809281|NCT01381874|157142655|FG002|Overall Study|Lost to Follow-up|0|||
48809282|NCT01381874|157142653|FG000|Overall Study|Withdrawal by Subject|9|||
48809283|NCT01381874|157142654|FG001|Overall Study|Withdrawal by Subject|10|||
48809284|NCT01381874|157142655|FG002|Overall Study|Withdrawal by Subject|9|||
48809285|NCT01381874|157142653|FG000|Overall Study|Other|67|||
48809286|NCT01381874|157142654|FG001|Overall Study|Other|52|||
48809287|NCT01381874|157142655|FG002|Overall Study|Other|67|||
48809288|NCT02086162|157142656|FG000|Overall Study|Withdrawal by Subject|4|||
48809289|NCT02086162|157142657|FG001|Overall Study|Withdrawal by Subject|4|||
48809290|NCT02086162|157142656|FG000|Overall Study|moved|1|||
48809291|NCT02086162|157142657|FG001|Overall Study|moved|1|||
48809292|NCT02086162|157142656|FG000|Overall Study|Lost to Follow-up|4|||
48809293|NCT02086162|157142657|FG001|Overall Study|Lost to Follow-up|2|||
48809294|NCT02086162|157142656|FG000|Overall Study|Death|1|||
48809295|NCT02086162|157142657|FG001|Overall Study|Death|0|||
48809296|NCT00452413|157142658|FG000|Overall Study|Progressive Disease|4|||
48809297|NCT00452413|157142659|FG001|Overall Study|Progressive Disease|11|||
48809298|NCT00452413|157142660|FG002|Overall Study|Progressive Disease|30|||
48597491|NCT01409915|156383517|FG000|Overall Study|Adverse Event|0|||
48597492|NCT01409915|156383518|FG001|Overall Study|Adverse Event|2|||
48809299|NCT00452413|157142658|FG000|Overall Study|Withdrawal by Subject|0|||
48597493|NCT01409915|156383517|FG000|Overall Study|Withdrawal by Subject|0|||
48809300|NCT00452413|157142659|FG001|Overall Study|Withdrawal by Subject|1|||
48809301|NCT00452413|157142660|FG002|Overall Study|Withdrawal by Subject|4|||
48809302|NCT00452413|157142658|FG000|Overall Study|Adverse Event|0|||
48809303|NCT00452413|157142659|FG001|Overall Study|Adverse Event|0|||
48809304|NCT00452413|157142660|FG002|Overall Study|Adverse Event|5|||
48809305|NCT00452413|157142658|FG000|Overall Study|Physician Decision|0|||
48809306|NCT00452413|157142659|FG001|Overall Study|Physician Decision|0|||
48809307|NCT00452413|157142660|FG002|Overall Study|Physician Decision|4|||
48597494|NCT01409915|156383518|FG001|Overall Study|Withdrawal by Subject|1|||
48809308|NCT00452413|157142658|FG000|Overall Study|Death due to study disease|0|||
48809309|NCT00452413|157142659|FG001|Overall Study|Death due to study disease|0|||
48809310|NCT00452413|157142660|FG002|Overall Study|Death due to study disease|2|||
48809311|NCT00452413|157142658|FG000|Overall Study|Death due to adverse event (AE)|0|||
48809312|NCT00452413|157142659|FG001|Overall Study|Death due to adverse event (AE)|0|||
48809313|NCT00452413|157142660|FG002|Overall Study|Death due to adverse event (AE)|1|||
48809314|NCT00452413|157142658|FG000|Overall Study|On treatment|0|||
48809315|NCT00452413|157142659|FG001|Overall Study|On treatment|0|||
48809316|NCT00452413|157142660|FG002|Overall Study|On treatment|3|||
48809317|NCT00114634|157142661|FG000|Overall Study|failure to return forms|3|||
48809318|NCT01346514|157142662|FG000|Overall Study|Lost to Follow-up|19|||
48809319|NCT01346514|157142663|FG001|Overall Study|Lost to Follow-up|30|||
48809320|NCT01346514|157142662|FG000|Overall Study|Withdrawal by Subject|7|||
48809321|NCT01346514|157142663|FG001|Overall Study|Withdrawal by Subject|3|||
48809322|NCT01346514|157142662|FG000|Overall Study|Death|3|||
48809323|NCT01346514|157142663|FG001|Overall Study|Death|4|||
48809324|NCT00684762|157142664|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
48809325|NCT00684762|157142665|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
48809326|NCT01215357|157142666|FG000|Overall Study|Withdrawal by Subject|3|||
48809327|NCT01215357|157142666|FG000|Overall Study|Protocol Violation|9|||
48809328|NCT04562649|157142675|FG000|Overall Study|Withdrawal by Subject|11|||
48809329|NCT04562649|157142676|FG001|Overall Study|Withdrawal by Subject|8|||
48809330|NCT04562649|157142675|FG000|Overall Study|Lost to Follow-up|26|||
48809331|NCT04562649|157142676|FG001|Overall Study|Lost to Follow-up|20|||
48809332|NCT03997383|157142677|FG000|Double-blind Treatment Period|Adverse Event|4|||
48809333|NCT03997383|157142678|FG001|Double-blind Treatment Period|Adverse Event|3|||
48809334|NCT03997383|157142677|FG000|Double-blind Treatment Period|Death|4|||
48809335|NCT03997383|157142678|FG001|Double-blind Treatment Period|Death|4|||
48809336|NCT03997383|157142677|FG000|Double-blind Treatment Period|Physician Decision|2|||
48809337|NCT03997383|157142678|FG001|Double-blind Treatment Period|Physician Decision|0|||
48809338|NCT03997383|157142677|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
48809339|NCT03997383|157142678|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
48809340|NCT03997383|157142677|FG000|Open-label Extension Period|Ongoing|148|||
48491973|NCT01405820|155994265|FG001|Randomized Treatment Period|Physician Decision|2|||
48491974|NCT01405820|155994266|FG002|Randomized Treatment Period|Physician Decision|1|||
48491975|NCT01405820|155994267|FG003|Randomized Treatment Period|Physician Decision|0|||
48491976|NCT01405820|155994268|FG004|Randomized Treatment Period|Physician Decision|0|||
48809341|NCT03997383|157142678|FG001|Open-label Extension Period|Ongoing|151|||
48809342|NCT03997383|157142677|FG000|Open-label Extension Period|Adverse Event|4|||
48809343|NCT03997383|157142678|FG001|Open-label Extension Period|Adverse Event|1|||
48809344|NCT03997383|157142677|FG000|Open-label Extension Period|Death|8|||
48809345|NCT03997383|157142678|FG001|Open-label Extension Period|Death|9|||
48809346|NCT03997383|157142677|FG000|Open-label Extension Period|Physician Decision|1|||
48809347|NCT03997383|157142678|FG001|Open-label Extension Period|Physician Decision|1|||
48491977|NCT01405820|155994269|FG005|Randomized Treatment Period|Physician Decision|0|||
48809348|NCT03997383|157142677|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
48809349|NCT03997383|157142678|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
48809350|NCT03997383|157142677|FG000|Open-label Extension Period|Reason Not Specified|2|||
48809351|NCT03997383|157142678|FG001|Open-label Extension Period|Reason Not Specified|0|||
48809352|NCT01821898|157142680|FG000|Overall Study|Withdrawal by Subject|2|||
48809353|NCT01821898|157142681|FG001|Overall Study|Withdrawal by Subject|1|||
48809354|NCT01535274|157142682|FG000|Overall Study|Determined to be ineligible|0|||
48809355|NCT01535274|157142683|FG001|Overall Study|Determined to be ineligible|1|||
48809356|NCT01535274|157142682|FG000|Overall Study|Misallocated to propofol intervention|0|||
48809357|NCT01535274|157142683|FG001|Overall Study|Misallocated to propofol intervention|1|||
48809358|NCT02690077|157142684|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
48809359|NCT02690077|157142685|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
48809360|NCT02690077|157142684|FG000|Overall Study|Withdrawal by Subject|0|||
48809361|NCT02690077|157142685|FG001|Overall Study|Withdrawal by Subject|5|||
48809362|NCT02690077|157142684|FG000|Overall Study|Excluded by IRB|0|||
48809363|NCT02690077|157142685|FG001|Overall Study|Excluded by IRB|2|||
48809364|NCT00337662|157142690|FG000|Study Period II|Lost to Follow-up|0|||
48809365|NCT00337662|157142691|FG001|Study Period II|Lost to Follow-up|0|||
48809366|NCT00337662|157142692|FG002|Study Period II|Lost to Follow-up|0|||
48809367|NCT00337662|157142693|FG003|Study Period II|Lost to Follow-up|35|||
48809368|NCT00337662|157142690|FG000|Study Period II|Withdrawal by Subject|0|||
48809369|NCT00337662|157142691|FG001|Study Period II|Withdrawal by Subject|0|||
48809370|NCT00337662|157142692|FG002|Study Period II|Withdrawal by Subject|0|||
48809371|NCT00337662|157142693|FG003|Study Period II|Withdrawal by Subject|20|||
48809372|NCT00337662|157142690|FG000|Study Period II|Adverse Event|0|||
48809373|NCT00337662|157142691|FG001|Study Period II|Adverse Event|0|||
48809374|NCT00337662|157142692|FG002|Study Period II|Adverse Event|0|||
48809375|NCT00337662|157142693|FG003|Study Period II|Adverse Event|16|||
48809376|NCT00337662|157142690|FG000|Study Period II|Physician Decision|0|||
48809377|NCT00337662|157142691|FG001|Study Period II|Physician Decision|0|||
48809378|NCT00337662|157142692|FG002|Study Period II|Physician Decision|0|||
48809379|NCT00337662|157142693|FG003|Study Period II|Physician Decision|13|||
48809380|NCT00337662|157142690|FG000|Study Period II|Entry Criteria Not Met|0|||
48809381|NCT00337662|157142691|FG001|Study Period II|Entry Criteria Not Met|0|||
48809382|NCT00337662|157142692|FG002|Study Period II|Entry Criteria Not Met|0|||
48809383|NCT00337662|157142693|FG003|Study Period II|Entry Criteria Not Met|6|||
48809384|NCT00337662|157142690|FG000|Study Period II|Protocol Violation|0|||
48809385|NCT00337662|157142691|FG001|Study Period II|Protocol Violation|0|||
48809386|NCT00337662|157142692|FG002|Study Period II|Protocol Violation|0|||
48809387|NCT00337662|157142693|FG003|Study Period II|Protocol Violation|6|||
48809388|NCT00337662|157142690|FG000|Study Period II|Lack of Efficacy|0|||
48809389|NCT00337662|157142691|FG001|Study Period II|Lack of Efficacy|0|||
48809390|NCT00337662|157142692|FG002|Study Period II|Lack of Efficacy|0|||
48809391|NCT00337662|157142693|FG003|Study Period II|Lack of Efficacy|7|||
48809392|NCT00337662|157142690|FG000|Study Period II|Sponsor Decision|0|||
48809393|NCT00337662|157142691|FG001|Study Period II|Sponsor Decision|0|||
48809394|NCT00337662|157142692|FG002|Study Period II|Sponsor Decision|0|||
48809395|NCT00337662|157142693|FG003|Study Period II|Sponsor Decision|2|||
48809396|NCT00337662|157142690|FG000|Study Period II|Parent/Caregiver Decision|0|||
48809397|NCT00337662|157142691|FG001|Study Period II|Parent/Caregiver Decision|0|||
48809398|NCT00337662|157142692|FG002|Study Period II|Parent/Caregiver Decision|0|||
48809399|NCT00337662|157142693|FG003|Study Period II|Parent/Caregiver Decision|1|||
48809400|NCT00337662|157142690|FG000|Study Period III|Lost to Follow-up|14|||
48809401|NCT00337662|157142691|FG001|Study Period III|Lost to Follow-up|16|||
48809402|NCT00337662|157142692|FG002|Study Period III|Lost to Follow-up|14|||
48809403|NCT00337662|157142693|FG003|Study Period III|Lost to Follow-up|0|||
48809404|NCT00337662|157142690|FG000|Study Period III|Withdrawal by Subject|18|||
48809405|NCT00337662|157142691|FG001|Study Period III|Withdrawal by Subject|14|||
48809406|NCT00337662|157142692|FG002|Study Period III|Withdrawal by Subject|12|||
48809407|NCT00337662|157142693|FG003|Study Period III|Withdrawal by Subject|0|||
48809408|NCT00337662|157142690|FG000|Study Period III|Adverse Event|9|||
48809409|NCT00337662|157142691|FG001|Study Period III|Adverse Event|10|||
48809410|NCT00337662|157142692|FG002|Study Period III|Adverse Event|8|||
48809411|NCT00337662|157142693|FG003|Study Period III|Adverse Event|0|||
48809412|NCT00337662|157142690|FG000|Study Period III|Protocol Violation|3|||
48809413|NCT00337662|157142691|FG001|Study Period III|Protocol Violation|8|||
48809414|NCT00337662|157142692|FG002|Study Period III|Protocol Violation|2|||
48597495|NCT01409915|156383517|FG000|Overall Study|Protocol Violation|1|||
48711256|NCT01379508|156791520|FG001|Treatment to Week 104|Protocol Violation|1|||
48711257|NCT01379508|156791521|FG002|Treatment to Week 104|Protocol Violation|1|||
48711258|NCT01379508|156791522|FG003|Treatment to Week 104|Protocol Violation|0|||
48711259|NCT01379508|156791519|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
48711260|NCT01379508|156791520|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
48711261|NCT01379508|156791521|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
48711262|NCT01379508|156791522|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
48711263|NCT01379508|156791519|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
48711264|NCT01379508|156791520|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
48711265|NCT01379508|156791521|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
48711266|NCT01379508|156791522|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
48711267|NCT01379508|156791519|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
48711268|NCT01379508|156791520|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
48711269|NCT01379508|156791521|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
48711270|NCT01379508|156791522|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
48711271|NCT01379508|156791519|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
48711272|NCT01379508|156791520|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
48711273|NCT01379508|156791521|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
48711274|NCT01379508|156791522|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
48711275|NCT01590888|156793155|FG000|Overall Study|Adverse Event|3|||
48711276|NCT01590888|156793156|FG001|Overall Study|Adverse Event|0|||
48711277|NCT01590888|156793157|FG002|Overall Study|Adverse Event|1|||
48711278|NCT01590888|156793155|FG000|Overall Study|Lost to Follow-up|1|||
48711279|NCT01590888|156793156|FG001|Overall Study|Lost to Follow-up|0|||
48711280|NCT01590888|156793157|FG002|Overall Study|Lost to Follow-up|0|||
48711281|NCT00684060|156793160|FG000|Overall Study|Lost to Follow-up|1|||
48711282|NCT00684060|156793161|FG001|Overall Study|Lost to Follow-up|0|||
48711283|NCT00684060|156793160|FG000|Overall Study|New stenosis identified|1|||
48711284|NCT00684060|156793161|FG001|Overall Study|New stenosis identified|0|||
48711285|NCT00684060|156793160|FG000|Overall Study|Unable to collect MRI|1|||
48711286|NCT00684060|156793161|FG001|Overall Study|Unable to collect MRI|2|||
48711287|NCT00684060|156793160|FG000|Overall Study|Death|0|||
48711288|NCT00684060|156793161|FG001|Overall Study|Death|1|||
48711289|NCT02331277|156793162|FG000|Overall Study|Withdrawal by Subject|1|||
48711290|NCT02331277|156793163|FG001|Overall Study|Withdrawal by Subject|0|||
48711291|NCT02269267|156793164|FG000|Overall Study|Death|5|||
48711292|NCT01474239|156793165|FG000|Overall Study|Disease Progression|37|||
48711293|NCT01474239|156793166|FG001|Overall Study|Disease Progression|25|||
48711294|NCT01474239|156793165|FG000|Overall Study|Adverse Event|12|||
48711295|NCT01474239|156793166|FG001|Overall Study|Adverse Event|3|||
48711296|NCT01474239|156793165|FG000|Overall Study|Withdrawal by Subject|1|||
48711297|NCT01474239|156793166|FG001|Overall Study|Withdrawal by Subject|2|||
48711298|NCT01474239|156793165|FG000|Overall Study|Death|1|||
48711299|NCT01474239|156793166|FG001|Overall Study|Death|1|||
48711300|NCT01474239|156793165|FG000|Overall Study|Clinical Disease Progression|7|||
48711301|NCT01474239|156793166|FG001|Overall Study|Clinical Disease Progression|1|||
48711302|NCT01474239|156793165|FG000|Overall Study|Withdrawal for Economic Reason|1|||
48711303|NCT01474239|156793166|FG001|Overall Study|Withdrawal for Economic Reason|0|||
48711304|NCT02139592|156793172|FG000|Overall Study|Case Report Forms Uncollected|8|||
48711305|NCT00145158|156793175|FG000|Overall Study|premature withdrawal|2|||
48711306|NCT00145158|156793176|FG001|Overall Study|premature withdrawal|3|||
48711307|NCT03180840|156793177|FG000|Overall Study|Withdrawal by Subject|1|||
48711308|NCT03887702|156793178|FG000|Overall Study|Study terminated|0|||
48711309|NCT03887702|156793179|FG001|Overall Study|Study terminated|0|||
48711310|NCT03887702|156793180|FG002|Overall Study|Study terminated|2|||
48711311|NCT03887702|156793181|FG003|Overall Study|Study terminated|2|||
48711312|NCT01705509|156793182|FG000|Inclusion CPET|Screen Failure|5|||
48711313|NCT01705509|156793182|FG000|Inclusion CPET|Withdrawal by Subject|2|||
48711314|NCT01705509|156793182|FG000|CPET w/ Ranexa|Screen Failure|2|||
48711315|NCT00950859|156793183|FG000|Overall Study|Adverse Event|3|||
48711316|NCT00950859|156793184|FG001|Overall Study|Adverse Event|3|||
48809415|NCT00337662|157142693|FG003|Study Period III|Protocol Violation|0|||
48809416|NCT00337662|157142690|FG000|Study Period III|Physician Decision|6|||
48809417|NCT00337662|157142691|FG001|Study Period III|Physician Decision|5|||
48809418|NCT00337662|157142692|FG002|Study Period III|Physician Decision|0|||
48809419|NCT00337662|157142693|FG003|Study Period III|Physician Decision|0|||
48809420|NCT00337662|157142690|FG000|Study Period III|Entry Criteria Not Met|4|||
48809421|NCT00337662|157142691|FG001|Study Period III|Entry Criteria Not Met|1|||
48809422|NCT00337662|157142692|FG002|Study Period III|Entry Criteria Not Met|3|||
48809423|NCT00337662|157142693|FG003|Study Period III|Entry Criteria Not Met|0|||
48809424|NCT00337662|157142690|FG000|Study Period III|Lack of Efficacy|4|||
48809425|NCT00337662|157142691|FG001|Study Period III|Lack of Efficacy|4|||
48809426|NCT00337662|157142692|FG002|Study Period III|Lack of Efficacy|2|||
48809427|NCT00337662|157142693|FG003|Study Period III|Lack of Efficacy|0|||
48809428|NCT00337662|157142690|FG000|Study Period III|Parent/Caregiver Decision|0|||
48809429|NCT00337662|157142691|FG001|Study Period III|Parent/Caregiver Decision|0|||
48809430|NCT00337662|157142692|FG002|Study Period III|Parent/Caregiver Decision|2|||
48491978|NCT01405820|155994264|FG000|Randomized Treatment Period|Rescue|0|||
48491979|NCT01405820|155994265|FG001|Randomized Treatment Period|Rescue|1|||
48809431|NCT00337662|157142693|FG003|Study Period III|Parent/Caregiver Decision|0|||
48809432|NCT00337662|157142690|FG000|Study Period III|Sponsor Decision|1|||
48809433|NCT00337662|157142691|FG001|Study Period III|Sponsor Decision|0|||
48809434|NCT00337662|157142692|FG002|Study Period III|Sponsor Decision|1|||
48809435|NCT00337662|157142693|FG003|Study Period III|Sponsor Decision|0|||
48809436|NCT00337662|157142690|FG000|Study Period III|Clinical Relapse|1|||
48809437|NCT00337662|157142691|FG001|Study Period III|Clinical Relapse|0|||
48809438|NCT00337662|157142692|FG002|Study Period III|Clinical Relapse|0|||
48809439|NCT00337662|157142693|FG003|Study Period III|Clinical Relapse|0|||
48809440|NCT02213328|157142696|FG000|Overall Study|Withdrawal by Subject|10|||
48809441|NCT02213328|157142696|FG000|Overall Study|Physician Decision|2|||
48809442|NCT02213328|157142696|FG000|Overall Study|Lost to Follow-up|16|||
48809443|NCT02344537|157142697|FG000|Overall Study|Protocol Violation|1|||
48809444|NCT02344537|157142698|FG001|Overall Study|Protocol Violation|1|||
48809445|NCT02344537|157142697|FG000|Overall Study|Subject started another treatment after wk 6|1|||
48809446|NCT02344537|157142698|FG001|Overall Study|Subject started another treatment after wk 6|0|||
48809447|NCT02344537|157142697|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
48809448|NCT02344537|157142698|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
48809449|NCT02302066|157142699|FG000|Overall Study|Adverse Event|1|||
48809450|NCT02302066|157142700|FG001|Overall Study|Adverse Event|1|||
48809451|NCT02302066|157142701|FG002|Overall Study|Adverse Event|3|||
48809452|NCT02302066|157142702|FG003|Overall Study|Adverse Event|0|||
48809453|NCT02302066|157142699|FG000|Overall Study|Lost to Follow-up|4|||
48809454|NCT02302066|157142700|FG001|Overall Study|Lost to Follow-up|5|||
48809455|NCT02302066|157142701|FG002|Overall Study|Lost to Follow-up|24|||
48809456|NCT02302066|157142702|FG003|Overall Study|Lost to Follow-up|7|||
48809457|NCT02302066|157142699|FG000|Overall Study|Withdrawal by Subject|25|||
48809458|NCT02302066|157142700|FG001|Overall Study|Withdrawal by Subject|58|||
48809459|NCT02302066|157142701|FG002|Overall Study|Withdrawal by Subject|124|||
48809460|NCT02302066|157142702|FG003|Overall Study|Withdrawal by Subject|33|||
48809461|NCT02302066|157142699|FG000|Overall Study|Pregnancy|2|||
48809462|NCT02302066|157142700|FG001|Overall Study|Pregnancy|10|||
48809463|NCT02302066|157142701|FG002|Overall Study|Pregnancy|12|||
48809464|NCT02302066|157142702|FG003|Overall Study|Pregnancy|0|||
48809465|NCT02302066|157142699|FG000|Overall Study|Reason Not Specified|1|||
48809466|NCT02302066|157142700|FG001|Overall Study|Reason Not Specified|1|||
48809467|NCT02302066|157142701|FG002|Overall Study|Reason Not Specified|9|||
48809468|NCT02302066|157142702|FG003|Overall Study|Reason Not Specified|1|||
48809469|NCT02917941|157142704|FG000|Treatment Period|Adverse Event|11|||
48809470|NCT02917941|157142704|FG000|Treatment Period|Progressive Disease|11|||
48809471|NCT02917941|157142704|FG000|Treatment Period|Reason not Specified|2|||
48809472|NCT02917941|157142704|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
48809473|NCT02917941|157142704|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
48809474|NCT00926003|157142705|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
48809475|NCT00926003|157142706|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
48809476|NCT00926003|157142707|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
48809477|NCT00926003|157142705|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
48809478|NCT00926003|157142706|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
48809479|NCT00926003|157142707|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
48809480|NCT03203694|157142708|FG000|Overall Study|Withdrawal by Subject|2|||
48809481|NCT03203694|157142709|FG001|Overall Study|Withdrawal by Subject|0|||
48809482|NCT03203694|157142710|FG002|Overall Study|Withdrawal by Subject|0|||
48809483|NCT03203694|157142711|FG003|Overall Study|Withdrawal by Subject|0|||
48809484|NCT03203694|157142712|FG004|Overall Study|Withdrawal by Subject|0|||
48809485|NCT03203694|157142713|FG005|Overall Study|Withdrawal by Subject|0|||
48809486|NCT02401308|157142714|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
48809487|NCT02401308|157142715|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
48809488|NCT02736968|157142719|FG000|Overall Study|Lost to Follow-up|0|||
48809489|NCT02736968|157142720|FG001|Overall Study|Lost to Follow-up|0|||
48809490|NCT02736968|157142721|FG002|Overall Study|Lost to Follow-up|0|||
48809491|NCT02736968|157142722|FG003|Overall Study|Lost to Follow-up|0|||
48809492|NCT02736968|157142723|FG004|Overall Study|Lost to Follow-up|0|||
48809493|NCT02736968|157142724|FG005|Overall Study|Lost to Follow-up|0|||
48809494|NCT02736968|157142725|FG006|Overall Study|Lost to Follow-up|5|||
48809495|NCT02736968|157142726|FG007|Overall Study|Lost to Follow-up|2|||
48809496|NCT02736968|157142719|FG000|Overall Study|COVID-19 Pandemic|0|||
48809497|NCT02736968|157142720|FG001|Overall Study|COVID-19 Pandemic|0|||
48809498|NCT02736968|157142721|FG002|Overall Study|COVID-19 Pandemic|0|||
48809499|NCT02736968|157142722|FG003|Overall Study|COVID-19 Pandemic|0|||
48809500|NCT02736968|157142723|FG004|Overall Study|COVID-19 Pandemic|0|||
48809501|NCT02736968|157142724|FG005|Overall Study|COVID-19 Pandemic|0|||
48809502|NCT02736968|157142725|FG006|Overall Study|COVID-19 Pandemic|2|||
48809503|NCT02736968|157142726|FG007|Overall Study|COVID-19 Pandemic|0|||
48809504|NCT02736968|157142719|FG000|Overall Study|Withdrawal by Subject|0|||
48809505|NCT02736968|157142720|FG001|Overall Study|Withdrawal by Subject|0|||
48809506|NCT02736968|157142721|FG002|Overall Study|Withdrawal by Subject|0|||
48809507|NCT02736968|157142722|FG003|Overall Study|Withdrawal by Subject|0|||
48809508|NCT02736968|157142723|FG004|Overall Study|Withdrawal by Subject|0|||
48809509|NCT02736968|157142724|FG005|Overall Study|Withdrawal by Subject|0|||
48809510|NCT02736968|157142725|FG006|Overall Study|Withdrawal by Subject|1|||
48809511|NCT02736968|157142726|FG007|Overall Study|Withdrawal by Subject|0|||
48809512|NCT01709305|157142727|FG000|Phase 1|Clinical Adverse Event|80|||
48809513|NCT01709305|157142728|FG001|Phase 1|Clinical Adverse Event|0|||
48809514|NCT01709305|157142729|FG002|Phase 1|Clinical Adverse Event|0|||
48809515|NCT01709305|157142730|FG003|Phase 1|Clinical Adverse Event|0|||
48809516|NCT01709305|157142731|FG004|Phase 1|Clinical Adverse Event|0|||
48809517|NCT01709305|157142727|FG000|Phase 1|Death|2|||
48809518|NCT01709305|157142728|FG001|Phase 1|Death|0|||
48809519|NCT01709305|157142729|FG002|Phase 1|Death|0|||
48809520|NCT01709305|157142730|FG003|Phase 1|Death|0|||
48809521|NCT01709305|157142731|FG004|Phase 1|Death|0|||
48809522|NCT01709305|157142727|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
48809523|NCT01709305|157142728|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
48809524|NCT01709305|157142729|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
48809525|NCT01709305|157142730|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
48809526|NCT01709305|157142731|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
48809527|NCT01709305|157142727|FG000|Phase 1|Laboratory Adverse Event|16|||
48809528|NCT01709305|157142728|FG001|Phase 1|Laboratory Adverse Event|0|||
48809529|NCT01709305|157142729|FG002|Phase 1|Laboratory Adverse Event|0|||
48809530|NCT01709305|157142730|FG003|Phase 1|Laboratory Adverse Event|0|||
48809531|NCT01709305|157142731|FG004|Phase 1|Laboratory Adverse Event|0|||
48809532|NCT01709305|157142727|FG000|Phase 1|Lost to Follow-up|147|||
48809533|NCT01709305|157142728|FG001|Phase 1|Lost to Follow-up|0|||
48809534|NCT01709305|157142729|FG002|Phase 1|Lost to Follow-up|0|||
48809535|NCT01709305|157142730|FG003|Phase 1|Lost to Follow-up|0|||
48809536|NCT01709305|157142731|FG004|Phase 1|Lost to Follow-up|0|||
48809537|NCT01709305|157142727|FG000|Phase 1|Travel, moving, etc.|30|||
48809538|NCT01709305|157142728|FG001|Phase 1|Travel, moving, etc.|0|||
48809539|NCT01709305|157142729|FG002|Phase 1|Travel, moving, etc.|0|||
48809540|NCT01709305|157142730|FG003|Phase 1|Travel, moving, etc.|0|||
48597496|NCT01409915|156383518|FG001|Overall Study|Protocol Violation|0|||
48597497|NCT04826484|156383519|FG000|Overall Study|Lost to Follow-up|2|||
48597498|NCT04826484|156383520|FG001|Overall Study|Lost to Follow-up|0|||
48597499|NCT04727528|156383521|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
48597500|NCT04727528|156383522|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
48597501|NCT04727528|156383521|FG000|Open-label Period|Randomized who did not receive treatment|1|||
48597502|NCT04727528|156383522|FG001|Open-label Period|Randomized who did not receive treatment|0|||
48597503|NCT04727528|156383521|FG000|Double-blind Treatment Phase|Adverse Event|0|||
48809541|NCT01709305|157142731|FG004|Phase 1|Travel, moving, etc.|0|||
48809542|NCT01709305|157142727|FG000|Phase 1|Physician Decision|13|||
48809543|NCT01709305|157142728|FG001|Phase 1|Physician Decision|0|||
48809544|NCT01709305|157142729|FG002|Phase 1|Physician Decision|0|||
48809545|NCT01709305|157142730|FG003|Phase 1|Physician Decision|0|||
48809546|NCT01709305|157142731|FG004|Phase 1|Physician Decision|0|||
48809547|NCT01709305|157142727|FG000|Phase 1|Protocol Violation|118|||
48809548|NCT01709305|157142728|FG001|Phase 1|Protocol Violation|0|||
48809549|NCT01709305|157142729|FG002|Phase 1|Protocol Violation|0|||
48809550|NCT01709305|157142730|FG003|Phase 1|Protocol Violation|0|||
48809551|NCT01709305|157142731|FG004|Phase 1|Protocol Violation|0|||
48809552|NCT01709305|157142727|FG000|Phase 1|Withdrawal by Subject|218|||
48809553|NCT01709305|157142728|FG001|Phase 1|Withdrawal by Subject|0|||
48809554|NCT01709305|157142729|FG002|Phase 1|Withdrawal by Subject|0|||
48809555|NCT01709305|157142730|FG003|Phase 1|Withdrawal by Subject|0|||
48809556|NCT01709305|157142731|FG004|Phase 1|Withdrawal by Subject|0|||
48809557|NCT01709305|157142727|FG000|Phase 2|Clinical Adverse Event|0|||
48809558|NCT01709305|157142728|FG001|Phase 2|Clinical Adverse Event|10|||
48809559|NCT01709305|157142729|FG002|Phase 2|Clinical Adverse Event|10|||
48809560|NCT01709305|157142730|FG003|Phase 2|Clinical Adverse Event|6|||
48809561|NCT01709305|157142731|FG004|Phase 2|Clinical Adverse Event|11|||
48809562|NCT01709305|157142727|FG000|Phase 2|Death|0|||
48809563|NCT01709305|157142728|FG001|Phase 2|Death|0|||
48809564|NCT01709305|157142729|FG002|Phase 2|Death|1|||
48809565|NCT01709305|157142730|FG003|Phase 2|Death|0|||
48809566|NCT01709305|157142731|FG004|Phase 2|Death|0|||
48809567|NCT01709305|157142727|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
48809568|NCT01709305|157142728|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
48809569|NCT01709305|157142729|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
48809570|NCT01709305|157142730|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
48809571|NCT01709305|157142731|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
48809572|NCT01709305|157142727|FG000|Phase 2|Laboratory Adverse Event|0|||
48809573|NCT01709305|157142728|FG001|Phase 2|Laboratory Adverse Event|1|||
48809574|NCT01709305|157142729|FG002|Phase 2|Laboratory Adverse Event|0|||
48809575|NCT01709305|157142730|FG003|Phase 2|Laboratory Adverse Event|1|||
48809576|NCT01709305|157142731|FG004|Phase 2|Laboratory Adverse Event|1|||
48809577|NCT01709305|157142727|FG000|Phase 2|Lost to Follow-up|0|||
48809578|NCT01709305|157142728|FG001|Phase 2|Lost to Follow-up|10|||
48809579|NCT01709305|157142729|FG002|Phase 2|Lost to Follow-up|6|||
48809580|NCT01709305|157142730|FG003|Phase 2|Lost to Follow-up|9|||
48809581|NCT01709305|157142731|FG004|Phase 2|Lost to Follow-up|5|||
48809582|NCT01709305|157142727|FG000|Phase 2|Travel, moving, etc.|0|||
48809583|NCT01709305|157142728|FG001|Phase 2|Travel, moving, etc.|2|||
48809584|NCT01709305|157142729|FG002|Phase 2|Travel, moving, etc.|3|||
48809585|NCT01709305|157142730|FG003|Phase 2|Travel, moving, etc.|3|||
48809586|NCT01709305|157142731|FG004|Phase 2|Travel, moving, etc.|5|||
48809587|NCT01709305|157142727|FG000|Phase 2|Physician Decision|0|||
48809588|NCT01709305|157142728|FG001|Phase 2|Physician Decision|2|||
48809589|NCT01709305|157142729|FG002|Phase 2|Physician Decision|0|||
48809590|NCT01709305|157142730|FG003|Phase 2|Physician Decision|1|||
48809591|NCT01709305|157142731|FG004|Phase 2|Physician Decision|2|||
48809592|NCT01709305|157142727|FG000|Phase 2|Protocol Violation|0|||
48809593|NCT01709305|157142728|FG001|Phase 2|Protocol Violation|19|||
48809594|NCT01709305|157142729|FG002|Phase 2|Protocol Violation|19|||
48809595|NCT01709305|157142730|FG003|Phase 2|Protocol Violation|13|||
48809596|NCT01709305|157142731|FG004|Phase 2|Protocol Violation|9|||
48809597|NCT01709305|157142727|FG000|Phase 2|Withdrawal by Subject|0|||
48809598|NCT01709305|157142728|FG001|Phase 2|Withdrawal by Subject|8|||
48809599|NCT01709305|157142729|FG002|Phase 2|Withdrawal by Subject|6|||
48809600|NCT01709305|157142730|FG003|Phase 2|Withdrawal by Subject|15|||
48809601|NCT01709305|157142731|FG004|Phase 2|Withdrawal by Subject|12|||
48809602|NCT01103960|157142732|FG000|Overall Study|Adverse Event|2|||
48809603|NCT01103960|157142733|FG001|Overall Study|Adverse Event|1|||
48809604|NCT01103960|157142732|FG000|Overall Study|Withdrawal by Subject|2|||
48809605|NCT01103960|157142733|FG001|Overall Study|Withdrawal by Subject|1|||
48809606|NCT01103960|157142732|FG000|Overall Study|Other|1|||
48809607|NCT01103960|157142733|FG001|Overall Study|Other|0|||
48809608|NCT01032044|157142734|FG000|Overall Study|Protocol Violation|14|||
48809609|NCT01032044|157142735|FG001|Overall Study|Protocol Violation|8|||
48809610|NCT01032044|157142734|FG000|Overall Study|Adverse Event|0|||
48809611|NCT01032044|157142735|FG001|Overall Study|Adverse Event|1|||
48809612|NCT01032044|157142734|FG000|Overall Study|Lost to Follow-up|11|||
48809613|NCT01032044|157142735|FG001|Overall Study|Lost to Follow-up|11|||
48809614|NCT02961374|157142736|FG000|Overall Study|Adverse Event|4|||
48809615|NCT02924389|157142737|FG000|Overall Study|Lost to Follow-up|1|||
48809616|NCT02924389|157142738|FG001|Overall Study|Lost to Follow-up|0|||
48809617|NCT02924389|157142737|FG000|Overall Study|Physician Decision|2|||
48809618|NCT02924389|157142738|FG001|Overall Study|Physician Decision|0|||
48809619|NCT02924389|157142737|FG000|Overall Study|Withdrawal by Subject|3|||
48809620|NCT02924389|157142738|FG001|Overall Study|Withdrawal by Subject|0|||
48809621|NCT02924389|157142737|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
48809622|NCT02924389|157142738|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
48809623|NCT02824029|157143504|FG000|Overall Study|Didn't receive treatment|2|||
48809624|NCT02824029|157143504|FG000|Overall Study|Patient decision to discontinue treatment|3|||
48809625|NCT02824029|157143504|FG000|Overall Study|Non-compliant|5|||
48809626|NCT02824029|157143504|FG000|Overall Study|Progression of disease|15|||
48809627|NCT02824029|157143504|FG000|Overall Study|Inadequate response to therapy|2|||
48809628|NCT02824029|157143504|FG000|Overall Study|Possible progression per treating physician|1|||
48809629|NCT01894061|157143507|FG000|Overall Study|Screen failure|1|||
48809630|NCT01894061|157143507|FG000|Overall Study|Withdrawal by Subject|1|||
48809631|NCT03789656|157143508|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
48809632|NCT03789656|157143509|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
48809633|NCT03789656|157143510|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
48809634|NCT03789656|157143511|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
48809635|NCT03789656|157143512|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
48809636|NCT03789656|157143508|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
48809637|NCT03789656|157143509|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
48809638|NCT03789656|157143510|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
48809639|NCT03789656|157143511|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
48809640|NCT03789656|157143512|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
48809641|NCT03789656|157143508|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
48809642|NCT03789656|157143509|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
48809643|NCT03789656|157143510|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
48809644|NCT03789656|157143511|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
48809645|NCT03789656|157143512|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
48809646|NCT03789656|157143508|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
48809647|NCT03789656|157143509|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
48809648|NCT03789656|157143510|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
48809649|NCT03789656|157143511|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
48809650|NCT03789656|157143512|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
48809651|NCT05714059|157143513|FG000|Overall Study|Withdrawal by Subject|2|||
48809652|NCT05714059|157143514|FG001|Overall Study|Withdrawal by Subject|2|||
48809653|NCT05714059|157143513|FG000|Overall Study|Adverse Event|0|||
48809654|NCT05714059|157143514|FG001|Overall Study|Adverse Event|1|||
48809655|NCT05714059|157143513|FG000|Overall Study|Lost to Follow-up|0|||
48809656|NCT05714059|157143514|FG001|Overall Study|Lost to Follow-up|1|||
48809657|NCT05714059|157143513|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
48809658|NCT05714059|157143514|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
48809659|NCT05714059|157143513|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
48809660|NCT05714059|157143514|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
48809661|NCT02991807|157143515|FG000|Overall Study|Withdrawal by Subject|2|||
48809662|NCT02991807|157143516|FG001|Overall Study|Withdrawal by Subject|1|||
48809663|NCT02991807|157143515|FG000|Overall Study|Physician Decision|0|||
48809664|NCT02991807|157143516|FG001|Overall Study|Physician Decision|1|||
48809665|NCT02991807|157143515|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
48809666|NCT02991807|157143516|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
48809667|NCT03774472|157143517|FG000|Overall Study|Physician Decision|1|||
48809668|NCT03774472|157143518|FG001|Overall Study|Physician Decision|0|||
48809669|NCT03774472|157143519|FG002|Overall Study|Physician Decision|0|||
48809670|NCT03774472|157143517|FG000|Overall Study|Progression prior to 4 weeks|0|||
48809671|NCT03774472|157143518|FG001|Overall Study|Progression prior to 4 weeks|1|||
48809672|NCT03774472|157143519|FG002|Overall Study|Progression prior to 4 weeks|0|||
48809673|NCT03774472|157143517|FG000|Overall Study|Withdrawal by Subject|0|||
48809674|NCT03774472|157143518|FG001|Overall Study|Withdrawal by Subject|1|||
48809675|NCT03774472|157143519|FG002|Overall Study|Withdrawal by Subject|0|||
48809676|NCT05018143|157143524|FG000|Overall Study|Lost to Follow-up|5|||
48809677|NCT05018143|157143525|FG001|Overall Study|Lost to Follow-up|4|||
48809678|NCT05018143|157143524|FG000|Overall Study|Withdrawal by Subject|0|||
48809679|NCT05018143|157143525|FG001|Overall Study|Withdrawal by Subject|1|||
48809680|NCT05141903|157143526|FG000|Overall Study|Withdrawal by Subject|0|||
48809681|NCT05141903|157143527|FG001|Overall Study|Withdrawal by Subject|1|||
48809682|NCT05141903|157143528|FG002|Overall Study|Withdrawal by Subject|1|||
48597504|NCT04727528|156383522|FG001|Double-blind Treatment Phase|Adverse Event|1|||
48597505|NCT04727528|156383521|FG000|Double-blind Treatment Phase|Death|0|||
48597506|NCT04727528|156383522|FG001|Double-blind Treatment Phase|Death|1|||
48809683|NCT05141903|157143529|FG003|Overall Study|Withdrawal by Subject|0|||
48809684|NCT05141903|157143530|FG004|Overall Study|Withdrawal by Subject|0|||
48809685|NCT05141903|157143526|FG000|Overall Study|Other|1|||
48809686|NCT05141903|157143527|FG001|Overall Study|Other|1|||
48809687|NCT05141903|157143528|FG002|Overall Study|Other|0|||
48809688|NCT05141903|157143529|FG003|Overall Study|Other|0|||
48809689|NCT05141903|157143530|FG004|Overall Study|Other|0|||
48809690|NCT03066622|157143533|FG000|Overall Study|Lost to Follow-up|24|||
48809691|NCT03066622|157143534|FG001|Overall Study|Lost to Follow-up|25|||
48809692|NCT03066622|157143533|FG000|Overall Study|Withdrawal by Subject|2|||
48809693|NCT03066622|157143534|FG001|Overall Study|Withdrawal by Subject|1|||
48809694|NCT02006121|157143535|FG000|Double Blind Phase|Adverse Event|6|||
48809695|NCT02006121|157143536|FG001|Double Blind Phase|Adverse Event|0|||
48809696|NCT02006121|157143535|FG000|Double Blind Phase|Lack of Efficacy|1|||
48809697|NCT02006121|157143536|FG001|Double Blind Phase|Lack of Efficacy|16|||
48491980|NCT01405820|155994266|FG002|Randomized Treatment Period|Rescue|13|||
48491981|NCT01405820|155994267|FG003|Randomized Treatment Period|Rescue|10|||
48491982|NCT01405820|155994268|FG004|Randomized Treatment Period|Rescue|8|||
48491983|NCT01405820|155994269|FG005|Randomized Treatment Period|Rescue|8|||
48491984|NCT01405820|155994264|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
48491985|NCT01405820|155994265|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
48491986|NCT01405820|155994266|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
48491987|NCT01405820|155994267|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
48491988|NCT01405820|155994268|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
48491989|NCT01405820|155994269|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
48491990|NCT01405820|155994264|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
48491991|NCT01405820|155994265|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
48809698|NCT02006121|157143535|FG000|Double Blind Phase|Withdrawal by Subject|3|||
48491992|NCT01405820|155994266|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
48491993|NCT01405820|155994267|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
48491994|NCT01405820|155994268|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
48491995|NCT01405820|155994269|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
48809699|NCT02006121|157143536|FG001|Double Blind Phase|Withdrawal by Subject|4|||
48809700|NCT02006121|157143535|FG000|Double Blind Phase|Non-compliance with study drug|1|||
48809701|NCT02006121|157143536|FG001|Double Blind Phase|Non-compliance with study drug|3|||
48809702|NCT02006121|157143535|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
48809703|NCT02006121|157143536|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
48809704|NCT02006121|157143535|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
48809705|NCT02006121|157143536|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
48809706|NCT02006121|157143535|FG000|Open Label Phase|Adverse Event|15|||
48809707|NCT02006121|157143536|FG001|Open Label Phase|Adverse Event|0|||
48809708|NCT02006121|157143535|FG000|Open Label Phase|Lack of Efficacy|2|||
48491996|NCT01405820|155994264|FG000|Randomized Treatment Period|Death|0|||
48491997|NCT01405820|155994265|FG001|Randomized Treatment Period|Death|0|||
48491998|NCT01405820|155994266|FG002|Randomized Treatment Period|Death|0|||
48491999|NCT01405820|155994267|FG003|Randomized Treatment Period|Death|1|||
48597507|NCT04727528|156383521|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
48809709|NCT02006121|157143536|FG001|Open Label Phase|Lack of Efficacy|0|||
48809710|NCT02006121|157143535|FG000|Open Label Phase|Protocol Violation|2|||
48809711|NCT02006121|157143536|FG001|Open Label Phase|Protocol Violation|0|||
48809712|NCT02006121|157143535|FG000|Open Label Phase|Withdrawal by Subject|3|||
48809713|NCT02006121|157143536|FG001|Open Label Phase|Withdrawal by Subject|0|||
48809714|NCT02006121|157143535|FG000|Open Label Phase|Non-compliance with study drug|3|||
48809715|NCT02006121|157143536|FG001|Open Label Phase|Non-compliance with study drug|0|||
48711317|NCT00950859|156793183|FG000|Overall Study|Insufficient Viral Load Response|12|||
48711318|NCT00950859|156793184|FG001|Overall Study|Insufficient Viral Load Response|3|||
48711319|NCT00950859|156793183|FG000|Overall Study|Protocol Violation|1|||
48711320|NCT00950859|156793184|FG001|Overall Study|Protocol Violation|1|||
48711321|NCT00950859|156793183|FG000|Overall Study|Lost to Follow-up|0|||
48711322|NCT00950859|156793184|FG001|Overall Study|Lost to Follow-up|3|||
48711323|NCT01358721|156793185|FG000|Overall Study|Withdrawal by Subject|0|||
48711324|NCT01358721|156793186|FG001|Overall Study|Withdrawal by Subject|0|||
48711325|NCT01358721|156793187|FG002|Overall Study|Withdrawal by Subject|0|||
48711326|NCT01358721|156793188|FG003|Overall Study|Withdrawal by Subject|1|||
48711327|NCT01358721|156793185|FG000|Overall Study|Death|0|||
48711328|NCT01358721|156793186|FG001|Overall Study|Death|2|||
48711329|NCT01358721|156793187|FG002|Overall Study|Death|0|||
48711330|NCT01358721|156793188|FG003|Overall Study|Death|0|||
48711331|NCT01358721|156793185|FG000|Overall Study|Study Drug Toxicity|1|||
48711332|NCT01358721|156793186|FG001|Overall Study|Study Drug Toxicity|3|||
48711333|NCT01358721|156793187|FG002|Overall Study|Study Drug Toxicity|4|||
48711334|NCT01358721|156793188|FG003|Overall Study|Study Drug Toxicity|5|||
48711335|NCT01358721|156793185|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
48711336|NCT01358721|156793186|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
48711337|NCT01358721|156793187|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
48711338|NCT01358721|156793188|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
48711339|NCT01358721|156793185|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
48711340|NCT01358721|156793186|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
48711341|NCT01358721|156793187|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
48711342|NCT01358721|156793188|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
48711343|NCT01358721|156793185|FG000|Overall Study|Adverse Event related to study drug|1|||
48711344|NCT01358721|156793186|FG001|Overall Study|Adverse Event related to study drug|0|||
48711345|NCT01358721|156793187|FG002|Overall Study|Adverse Event related to study drug|0|||
48711346|NCT01358721|156793188|FG003|Overall Study|Adverse Event related to study drug|1|||
48711347|NCT01358721|156793185|FG000|Overall Study|Disease Progression|19|||
48711348|NCT01358721|156793186|FG001|Overall Study|Disease Progression|15|||
48711349|NCT01358721|156793187|FG002|Overall Study|Disease Progression|17|||
48711350|NCT01358721|156793188|FG003|Overall Study|Disease Progression|15|||
48711351|NCT01358721|156793185|FG000|Overall Study|Out of State/Unmet Criteria|0|||
48711352|NCT01358721|156793186|FG001|Overall Study|Out of State/Unmet Criteria|0|||
48711353|NCT01358721|156793187|FG002|Overall Study|Out of State/Unmet Criteria|1|||
48711354|NCT01358721|156793188|FG003|Overall Study|Out of State/Unmet Criteria|0|||
48711355|NCT00436345|156793189|FG000|Overall Study|ICU resident beyond follow-up period|3|||
48711356|NCT00436345|156793190|FG001|Overall Study|ICU resident beyond follow-up period|0|||
48711357|NCT04248491|156793191|FG000|Overall Study|Lost to Follow-up|1|||
48711358|NCT04248491|156793192|FG001|Overall Study|Lost to Follow-up|0|||
48711359|NCT03830892|156793193|FG000|Overall Study|Physician Decision|2|||
48711360|NCT03830892|156793194|FG001|Overall Study|Physician Decision|3|||
48711361|NCT03830892|156793193|FG000|Overall Study|Study terminated due to COVID|4|||
48711362|NCT03830892|156793194|FG001|Overall Study|Study terminated due to COVID|0|||
48711363|NCT03830892|156793193|FG000|Overall Study|Protocol Violation|0|||
48711364|NCT03830892|156793194|FG001|Overall Study|Protocol Violation|1|||
48711365|NCT03830892|156793193|FG000|Overall Study|Withdrawal by Subject|0|||
48435465|NCT02175771|155782473|FG003|Treatment Period|Noncompliance|0|||
48711366|NCT03830892|156793194|FG001|Overall Study|Withdrawal by Subject|2|||
48711367|NCT01499277|156793195|FG000|Overall Study|Adverse Event|3|||
48711368|NCT01499277|156793196|FG001|Overall Study|Adverse Event|6|||
48711369|NCT01499277|156793195|FG000|Overall Study|Death|3|||
48809716|NCT01748448|157143540|FG000|Treatment Period|Consent withdrawn by subject|1|||
48809717|NCT01748448|157143541|FG001|Treatment Period|Consent withdrawn by subject|0|||
48809718|NCT01748448|157143540|FG000|Treatment Period|Adverse Event|1|||
48809719|NCT01748448|157143541|FG001|Treatment Period|Adverse Event|0|||
48809720|NCT01748448|157143540|FG000|Treatment Period|Personal|0|||
48809721|NCT01748448|157143541|FG001|Treatment Period|Personal|1|||
48809722|NCT03691493|157143542|FG000|Overall Study|Withdrawal by Subject|1|||
48809723|NCT01155661|157143555|FG000|Overall Study|Adverse Event|101|||
48809724|NCT01155661|157143555|FG000|Overall Study|Death|1|||
48809725|NCT01155661|157143555|FG000|Overall Study|Lack of Efficacy|32|||
48809726|NCT01155661|157143555|FG000|Overall Study|Lost to Follow-up|22|||
48809727|NCT01155661|157143555|FG000|Overall Study|Physician Decision|3|||
48809728|NCT01155661|157143555|FG000|Overall Study|Protocol Violation|35|||
48809729|NCT01155661|157143555|FG000|Overall Study|Withdrawal by Subject|73|||
48809730|NCT01155661|157143555|FG000|Overall Study|Sponsor Decision|13|||
48809731|NCT03679767|157143556|FG000|Overall Study|Death|16|||
48809732|NCT03679767|157143557|FG001|Overall Study|Death|11|||
48809733|NCT03679767|157143558|FG002|Overall Study|Death|17|||
48809734|NCT03679767|157143559|FG003|Overall Study|Death|10|||
48809735|NCT03679767|157143556|FG000|Overall Study|Lost to Follow-up|1|||
48809736|NCT03679767|157143557|FG001|Overall Study|Lost to Follow-up|1|||
48809737|NCT03679767|157143558|FG002|Overall Study|Lost to Follow-up|1|||
48809738|NCT03679767|157143559|FG003|Overall Study|Lost to Follow-up|1|||
48809739|NCT03679767|157143556|FG000|Overall Study|Withdrawal by Subject|0|||
48809740|NCT03679767|157143557|FG001|Overall Study|Withdrawal by Subject|0|||
48809741|NCT03679767|157143558|FG002|Overall Study|Withdrawal by Subject|0|||
48809742|NCT03679767|157143559|FG003|Overall Study|Withdrawal by Subject|1|||
48809743|NCT03679767|157143556|FG000|Overall Study|Follow-up Completed|18|||
48809744|NCT03679767|157143557|FG001|Overall Study|Follow-up Completed|11|||
48809745|NCT03679767|157143558|FG002|Overall Study|Follow-up Completed|11|||
48809746|NCT03679767|157143559|FG003|Overall Study|Follow-up Completed|20|||
48809747|NCT03679767|157143556|FG000|Overall Study|Entered Hospice Care|0|||
48809748|NCT03679767|157143557|FG001|Overall Study|Entered Hospice Care|0|||
48809749|NCT03679767|157143558|FG002|Overall Study|Entered Hospice Care|0|||
48809750|NCT03679767|157143559|FG003|Overall Study|Entered Hospice Care|1|||
48809751|NCT03679767|157143556|FG000|Overall Study|Progressive Disease|0|||
48809752|NCT03679767|157143557|FG001|Overall Study|Progressive Disease|0|||
48809753|NCT03679767|157143558|FG002|Overall Study|Progressive Disease|0|||
48809754|NCT03679767|157143559|FG003|Overall Study|Progressive Disease|1|||
48809755|NCT02180438|157143563|FG000|Overall Study|Lost to Follow-up|1|||
48809756|NCT00105586|157143566|FG000|Overall Study|Adverse Event|4|||
48809757|NCT00105586|157143567|FG001|Overall Study|Adverse Event|3|||
48809758|NCT00105586|157143566|FG000|Overall Study|Physician Decision|13|||
48711370|NCT01499277|156793196|FG001|Overall Study|Death|2|||
48711371|NCT01499277|156793195|FG000|Overall Study|Lost to Follow-up|15|||
48711372|NCT01499277|156793196|FG001|Overall Study|Lost to Follow-up|8|||
48711373|NCT01499277|156793195|FG000|Overall Study|Protocol Violation|2|||
48809759|NCT00105586|157143567|FG001|Overall Study|Physician Decision|13|||
48809760|NCT05822921|157143568|FG000|Overall Study|Lost to Follow-up|1|||
48809761|NCT05822921|157143569|FG001|Overall Study|Lost to Follow-up|1|||
48809762|NCT01567865|157143578|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
48711374|NCT01499277|156793196|FG001|Overall Study|Protocol Violation|3|||
48711375|NCT01499277|156793195|FG000|Overall Study|Withdrawal by Subject|16|||
48711376|NCT01499277|156793196|FG001|Overall Study|Withdrawal by Subject|6|||
48711377|NCT01499277|156793195|FG000|Overall Study|Lack of therapeutic response and other|8|||
48711378|NCT01499277|156793196|FG001|Overall Study|Lack of therapeutic response and other|7|||
48711379|NCT01652469|156793200|FG000|Overall Study|Withdrawal by Subject|1|||
48711380|NCT01652469|156793201|FG001|Overall Study|Withdrawal by Subject|4|||
48711381|NCT01652469|156793200|FG000|Overall Study|Lost to Follow-up|0|||
48711382|NCT01652469|156793201|FG001|Overall Study|Lost to Follow-up|2|||
48711383|NCT00567398|156793202|FG000|Overall Study|Adverse Event|6|||
48711384|NCT00567398|156793203|FG001|Overall Study|Adverse Event|14|||
48711385|NCT00567398|156793202|FG000|Overall Study|Physician Decision|0|||
48809763|NCT01567865|157143579|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
48809764|NCT01567865|157143580|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
48809765|NCT01567865|157143581|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
48809766|NCT01567865|157143578|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
48809767|NCT01567865|157143579|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
48809768|NCT01567865|157143580|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
48809769|NCT01567865|157143581|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
48809770|NCT02049710|157143584|FG000|Overall Study|Lost to Follow-up|319|||
48809771|NCT02049710|157143585|FG001|Overall Study|Lost to Follow-up|324|||
48809772|NCT01078662|157143586|FG000|Overall Study|Death|41|||
48809773|NCT01078662|157143587|FG001|Overall Study|Death|103|||
48492000|NCT01405820|155994268|FG004|Randomized Treatment Period|Death|0|||
48492001|NCT01405820|155994269|FG005|Randomized Treatment Period|Death|0|||
48492002|NCT01405820|155994264|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
48711386|NCT00567398|156793203|FG001|Overall Study|Physician Decision|4|||
48809774|NCT01078662|157143588|FG002|Overall Study|Death|18|||
48809775|NCT01078662|157143589|FG003|Overall Study|Death|5|||
48809776|NCT01078662|157143590|FG004|Overall Study|Death|8|||
48492003|NCT01405820|155994265|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
48492004|NCT01405820|155994266|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
48492005|NCT01405820|155994267|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
48492006|NCT01405820|155994268|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
48492007|NCT01405820|155994269|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
48492008|NCT01405820|155994264|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
48492009|NCT01405820|155994265|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
48492010|NCT01405820|155994266|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
48492011|NCT01405820|155994267|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
48492012|NCT01405820|155994268|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
48492013|NCT01405820|155994269|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
48492014|NCT01405820|155994264|FG000|Open-Label Treatment Period|Other|1|||
48492015|NCT01405820|155994265|FG001|Open-Label Treatment Period|Other|1|||
48492016|NCT01405820|155994266|FG002|Open-Label Treatment Period|Other|1|||
48492017|NCT01405820|155994267|FG003|Open-Label Treatment Period|Other|1|||
48492018|NCT01405820|155994268|FG004|Open-Label Treatment Period|Other|1|||
48711387|NCT00567398|156793202|FG000|Overall Study|Withdrawal by Subject|0|||
48711388|NCT00567398|156793203|FG001|Overall Study|Withdrawal by Subject|2|||
48711389|NCT00567398|156793202|FG000|Overall Study|Renal Transplantation|0|||
48711390|NCT00567398|156793203|FG001|Overall Study|Renal Transplantation|3|||
48711391|NCT00567398|156793202|FG000|Overall Study|Other|1|||
48492019|NCT01405820|155994269|FG005|Open-Label Treatment Period|Other|1|||
48711392|NCT00567398|156793203|FG001|Overall Study|Other|0|||
48711393|NCT03120351|156793204|FG000|Overall Study|Physician Decision|1|||
48711394|NCT03120351|156793205|FG001|Overall Study|Physician Decision|1|||
48711395|NCT00337675|156793206|FG000|Overall Study|Adverse Event|10|||
48711396|NCT00337675|156793207|FG001|Overall Study|Adverse Event|9|||
48711397|NCT00337675|156793208|FG002|Overall Study|Adverse Event|19|||
48711398|NCT00337675|156793206|FG000|Overall Study|Lack of Efficacy|10|||
48809777|NCT01078662|157143586|FG000|Overall Study|Patients reached data cut-off|12|||
48809778|NCT01078662|157143587|FG001|Overall Study|Patients reached data cut-off|53|||
48809779|NCT01078662|157143588|FG002|Overall Study|Patients reached data cut-off|2|||
48809780|NCT01078662|157143589|FG003|Overall Study|Patients reached data cut-off|2|||
48809781|NCT01078662|157143590|FG004|Overall Study|Patients reached data cut-off|3|||
48809782|NCT01078662|157143586|FG000|Overall Study|Withdrawal by Subject|4|||
48809783|NCT01078662|157143587|FG001|Overall Study|Withdrawal by Subject|11|||
48809784|NCT01078662|157143588|FG002|Overall Study|Withdrawal by Subject|1|||
48492020|NCT01405820|155994264|FG000|Open-Label Treatment Period|Physician Decision|0|||
48809785|NCT01078662|157143589|FG003|Overall Study|Withdrawal by Subject|0|||
48809786|NCT01078662|157143590|FG004|Overall Study|Withdrawal by Subject|0|||
48809787|NCT01078662|157143586|FG000|Overall Study|Protocol Violation|0|||
48809788|NCT01078662|157143587|FG001|Overall Study|Protocol Violation|1|||
48809789|NCT01078662|157143588|FG002|Overall Study|Protocol Violation|0|||
48809790|NCT01078662|157143589|FG003|Overall Study|Protocol Violation|0|||
48809791|NCT01078662|157143590|FG004|Overall Study|Protocol Violation|0|||
48809792|NCT01078662|157143586|FG000|Overall Study|Lost to Follow-up|1|||
48809793|NCT01078662|157143587|FG001|Overall Study|Lost to Follow-up|0|||
48809794|NCT01078662|157143588|FG002|Overall Study|Lost to Follow-up|0|||
48809795|NCT01078662|157143589|FG003|Overall Study|Lost to Follow-up|0|||
48809796|NCT01078662|157143590|FG004|Overall Study|Lost to Follow-up|0|||
48809797|NCT00874432|157143591|FG000|Overall Study|Withdrawal by Subject|1|||
48809798|NCT00874432|157143592|FG001|Overall Study|Withdrawal by Subject|0|||
48809799|NCT00874432|157143593|FG002|Overall Study|Withdrawal by Subject|0|||
48809800|NCT00874432|157143594|FG003|Overall Study|Withdrawal by Subject|0|||
48809801|NCT00874432|157143591|FG000|Overall Study|Physician Decision|1|||
48809802|NCT00874432|157143592|FG001|Overall Study|Physician Decision|0|||
48809803|NCT00874432|157143593|FG002|Overall Study|Physician Decision|0|||
48809804|NCT00874432|157143594|FG003|Overall Study|Physician Decision|0|||
48809805|NCT00874432|157143591|FG000|Overall Study|Other|1|||
48809806|NCT00874432|157143592|FG001|Overall Study|Other|2|||
48809807|NCT00874432|157143593|FG002|Overall Study|Other|8|||
48809808|NCT00874432|157143594|FG003|Overall Study|Other|3|||
48809809|NCT04088227|157143597|FG000|Overall Study|Withdrawal by Subject|1|||
48809810|NCT04088227|157143598|FG001|Overall Study|Withdrawal by Subject|0|||
48809811|NCT04088227|157143597|FG000|Overall Study|Surgery postponed >5weeks|1|||
48809812|NCT04088227|157143598|FG001|Overall Study|Surgery postponed >5weeks|0|||
48809813|NCT03516942|157143599|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
48809814|NCT03516942|157143599|FG000|Registration Through Baseline Survey Com|Death|8|||
48809815|NCT03516942|157143599|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
48809816|NCT03516942|157143599|FG000|T0: Baseline|LOST|13|||
48809817|NCT03516942|157143599|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
48809818|NCT03516942|157143599|FG000|T1: 3 Months Survey|Death|10|||
48809819|NCT03516942|157143599|FG000|T1: 3 Months Survey|Lost|163|||
48809820|NCT03516942|157143599|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
48809821|NCT03516942|157143599|FG000|T2: 6 Month Survey|Death|14|||
48809822|NCT03516942|157143599|FG000|T2: 6 Month Survey|Lost|180|||
48809823|NCT03516942|157143599|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
48809824|NCT03516942|157143599|FG000|T3: 12 Month Survey|Death|19|||
48809825|NCT03516942|157143599|FG000|T3: 12 Month Survey|Lost|209|||
48809826|NCT00041756|157144459|FG000|Overall Study|Adverse Event|4|||
48809827|NCT00041756|157144460|FG001|Overall Study|Adverse Event|10|||
48809828|NCT00041756|157144461|FG002|Overall Study|Adverse Event|6|||
48809829|NCT00041756|157144462|FG003|Overall Study|Adverse Event|11|||
48809830|NCT00041756|157144463|FG004|Overall Study|Adverse Event|34|||
48711399|NCT00337675|156793207|FG001|Overall Study|Lack of Efficacy|7|||
48809831|NCT00041756|157144459|FG000|Overall Study|Protocol Violation|1|||
48809832|NCT00041756|157144460|FG001|Overall Study|Protocol Violation|1|||
48809833|NCT00041756|157144461|FG002|Overall Study|Protocol Violation|2|||
48711400|NCT00337675|156793208|FG002|Overall Study|Lack of Efficacy|9|||
48711401|NCT00337675|156793206|FG000|Overall Study|Lost to Follow-up|22|||
48809834|NCT00041756|157144462|FG003|Overall Study|Protocol Violation|2|||
48809835|NCT00041756|157144463|FG004|Overall Study|Protocol Violation|1|||
48809836|NCT00041756|157144459|FG000|Overall Study|Withdrawal by Subject|3|||
48711402|NCT00337675|156793207|FG001|Overall Study|Lost to Follow-up|19|||
48809837|NCT00041756|157144460|FG001|Overall Study|Withdrawal by Subject|3|||
48809838|NCT00041756|157144461|FG002|Overall Study|Withdrawal by Subject|4|||
48809839|NCT00041756|157144462|FG003|Overall Study|Withdrawal by Subject|2|||
48809840|NCT00041756|157144463|FG004|Overall Study|Withdrawal by Subject|3|||
48711403|NCT00337675|156793208|FG002|Overall Study|Lost to Follow-up|17|||
48809841|NCT00041756|157144459|FG000|Overall Study|Lost to Follow-up|0|||
48809842|NCT00041756|157144460|FG001|Overall Study|Lost to Follow-up|1|||
48809843|NCT00041756|157144461|FG002|Overall Study|Lost to Follow-up|0|||
48809844|NCT00041756|157144462|FG003|Overall Study|Lost to Follow-up|1|||
48809845|NCT00041756|157144463|FG004|Overall Study|Lost to Follow-up|0|||
48809846|NCT00041756|157144459|FG000|Overall Study|Unable to meet protocol criteria|0|||
48809847|NCT00041756|157144460|FG001|Overall Study|Unable to meet protocol criteria|0|||
48809848|NCT00041756|157144461|FG002|Overall Study|Unable to meet protocol criteria|1|||
48809849|NCT00041756|157144462|FG003|Overall Study|Unable to meet protocol criteria|0|||
48809850|NCT00041756|157144463|FG004|Overall Study|Unable to meet protocol criteria|1|||
48809851|NCT00041756|157144459|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
48809852|NCT00041756|157144460|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
48809853|NCT00041756|157144461|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
48809854|NCT00041756|157144462|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
48809855|NCT00041756|157144463|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
48809856|NCT03980184|157144464|FG000|Overall Study|Dropped out before treatment|2|||
48809857|NCT03980184|157144465|FG001|Overall Study|Dropped out before treatment|2|||
48809858|NCT03980184|157144464|FG000|Overall Study|Lost to Follow-up|11|||
48809859|NCT03980184|157144465|FG001|Overall Study|Lost to Follow-up|13|||
48809860|NCT00482274|157144466|FG000|Overall Study|Adverse Event|1|||
48809861|NCT02440594|157144467|FG000|Overall Study|Lost to Follow-up|34|||
48809862|NCT02440594|157144468|FG001|Overall Study|Lost to Follow-up|33|||
48809863|NCT02440594|157144469|FG002|Overall Study|Lost to Follow-up|54|||
48809864|NCT02440594|157144470|FG003|Overall Study|Lost to Follow-up|47|||
48597508|NCT04727528|156383522|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
48597509|NCT04727528|156383521|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
48597510|NCT04727528|156383522|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
48597511|NCT04727528|156383521|FG000|Double-blind Treatment Phase|Physician Decision|0|||
48597512|NCT04727528|156383522|FG001|Double-blind Treatment Phase|Physician Decision|1|||
48597513|NCT04727528|156383521|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
48597514|NCT04727528|156383522|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48597515|NCT01826981|156383523|FG000|Overall Study|Lack of Efficacy|0|||
48597516|NCT01826981|156383524|FG001|Overall Study|Lack of Efficacy|1|||
48597517|NCT01826981|156383525|FG002|Overall Study|Lack of Efficacy|0|||
48597518|NCT01826981|156383526|FG003|Overall Study|Lack of Efficacy|0|||
48597519|NCT01826981|156383527|FG004|Overall Study|Lack of Efficacy|5|||
48597520|NCT01826981|156383528|FG005|Overall Study|Lack of Efficacy|0|||
48597521|NCT01826981|156383529|FG006|Overall Study|Lack of Efficacy|0|||
48597522|NCT01826981|156383530|FG007|Overall Study|Lack of Efficacy|8|||
48597523|NCT01826981|156383531|FG008|Overall Study|Lack of Efficacy|7|||
48597524|NCT01826981|156383532|FG009|Overall Study|Lack of Efficacy|0|||
48597525|NCT01826981|156383533|FG010|Overall Study|Lack of Efficacy|1|||
48597526|NCT01826981|156383534|FG011|Overall Study|Lack of Efficacy|0|||
48597527|NCT01826981|156383535|FG012|Overall Study|Lack of Efficacy|0|||
48597528|NCT01826981|156383536|FG013|Overall Study|Lack of Efficacy|3|||
48597529|NCT01826981|156383537|FG014|Overall Study|Lack of Efficacy|0|||
48597530|NCT01826981|156383523|FG000|Overall Study|Lost to Follow-up|0|||
48597531|NCT01826981|156383524|FG001|Overall Study|Lost to Follow-up|0|||
48597532|NCT01826981|156383525|FG002|Overall Study|Lost to Follow-up|0|||
48597533|NCT01826981|156383526|FG003|Overall Study|Lost to Follow-up|0|||
48711404|NCT00337675|156793206|FG000|Overall Study|Physician Decision|9|||
48597534|NCT01826981|156383527|FG004|Overall Study|Lost to Follow-up|1|||
48597535|NCT01826981|156383528|FG005|Overall Study|Lost to Follow-up|1|||
48597536|NCT01826981|156383529|FG006|Overall Study|Lost to Follow-up|0|||
48597537|NCT01826981|156383530|FG007|Overall Study|Lost to Follow-up|1|||
48711405|NCT00337675|156793207|FG001|Overall Study|Physician Decision|17|||
48711406|NCT00337675|156793208|FG002|Overall Study|Physician Decision|14|||
48711407|NCT00337675|156793206|FG000|Overall Study|Protocol Violation|21|||
48711408|NCT00337675|156793207|FG001|Overall Study|Protocol Violation|24|||
48711409|NCT00337675|156793208|FG002|Overall Study|Protocol Violation|19|||
48711410|NCT00337675|156793206|FG000|Overall Study|Withdrawal by Subject|25|||
48711411|NCT00337675|156793207|FG001|Overall Study|Withdrawal by Subject|25|||
48711412|NCT00337675|156793208|FG002|Overall Study|Withdrawal by Subject|19|||
48711413|NCT00337675|156793206|FG000|Overall Study|Progressive Disease|0|||
48711414|NCT00337675|156793207|FG001|Overall Study|Progressive Disease|2|||
48711415|NCT00337675|156793208|FG002|Overall Study|Progressive Disease|0|||
48711416|NCT00337675|156793206|FG000|Overall Study|Trial Terminated|0|||
48711417|NCT00337675|156793207|FG001|Overall Study|Trial Terminated|0|||
48809865|NCT02440594|157144471|FG004|Overall Study|Lost to Follow-up|5|||
48809866|NCT02440594|157144472|FG005|Overall Study|Lost to Follow-up|4|||
48809867|NCT02440594|157144473|FG006|Overall Study|Lost to Follow-up|28|||
48809868|NCT02440594|157144474|FG007|Overall Study|Lost to Follow-up|48|||
48809869|NCT02440594|157144467|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
48809870|NCT02440594|157144468|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
48809871|NCT02440594|157144469|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
48809872|NCT02440594|157144470|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
48809873|NCT02440594|157144471|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
48809874|NCT02440594|157144472|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
48809875|NCT02440594|157144473|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
48809876|NCT02440594|157144474|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
48809877|NCT02440594|157144467|FG000|Overall Study|Withdrawal by Subject|81|||
48809878|NCT02440594|157144468|FG001|Overall Study|Withdrawal by Subject|67|||
48809879|NCT02440594|157144469|FG002|Overall Study|Withdrawal by Subject|59|||
48809880|NCT02440594|157144470|FG003|Overall Study|Withdrawal by Subject|38|||
48809881|NCT02440594|157144471|FG004|Overall Study|Withdrawal by Subject|2|||
48809882|NCT02440594|157144472|FG005|Overall Study|Withdrawal by Subject|2|||
48809883|NCT02440594|157144473|FG006|Overall Study|Withdrawal by Subject|7|||
48809884|NCT02440594|157144474|FG007|Overall Study|Withdrawal by Subject|7|||
48809885|NCT02440594|157144467|FG000|Overall Study|Administratively w/drawn|3|||
48809886|NCT02440594|157144468|FG001|Overall Study|Administratively w/drawn|2|||
48809887|NCT02440594|157144469|FG002|Overall Study|Administratively w/drawn|0|||
48809888|NCT02440594|157144470|FG003|Overall Study|Administratively w/drawn|0|||
48809889|NCT02440594|157144471|FG004|Overall Study|Administratively w/drawn|0|||
48809890|NCT02440594|157144472|FG005|Overall Study|Administratively w/drawn|0|||
48809891|NCT02440594|157144473|FG006|Overall Study|Administratively w/drawn|2|||
48809892|NCT02440594|157144474|FG007|Overall Study|Administratively w/drawn|1|||
48809893|NCT04250337|157144475|FG000|Overall Study|Adverse Event|0|||
48809894|NCT04250337|157144476|FG001|Overall Study|Adverse Event|3|||
48809895|NCT04250337|157144475|FG000|Overall Study|Lack of Efficacy|1|||
48809896|NCT04250337|157144476|FG001|Overall Study|Lack of Efficacy|3|||
48809897|NCT04250337|157144475|FG000|Overall Study|Physician Decision|1|||
48809898|NCT04250337|157144476|FG001|Overall Study|Physician Decision|0|||
48809899|NCT04250337|157144475|FG000|Overall Study|Protocol Deviation|2|||
48809900|NCT04250337|157144476|FG001|Overall Study|Protocol Deviation|2|||
48809901|NCT04250337|157144475|FG000|Overall Study|Withdrawal by Subject|4|||
48809902|NCT04250337|157144476|FG001|Overall Study|Withdrawal by Subject|3|||
48809903|NCT00641719|157144477|FG000|Overall Study|Lack of Efficacy|1|||
48809904|NCT00641719|157144478|FG001|Overall Study|Lack of Efficacy|2|||
48809905|NCT00641719|157144477|FG000|Overall Study|Adverse Event|24|||
48809906|NCT00641719|157144478|FG001|Overall Study|Adverse Event|29|||
48809907|NCT00641719|157144477|FG000|Overall Study|Withdrawal by Subject|4|||
48809908|NCT00641719|157144478|FG001|Overall Study|Withdrawal by Subject|4|||
48809909|NCT00641719|157144477|FG000|Overall Study|Reason Not Specified|1|||
48809910|NCT00641719|157144478|FG001|Overall Study|Reason Not Specified|2|||
48809911|NCT00885352|157144479|FG000|Overall Study|Adverse Event|2|||
48809912|NCT00885352|157144480|FG001|Overall Study|Adverse Event|3|||
48809913|NCT00885352|157144479|FG000|Overall Study|Lost to Follow-up|2|||
48809914|NCT00885352|157144480|FG001|Overall Study|Lost to Follow-up|2|||
48597538|NCT01826981|156383531|FG008|Overall Study|Lost to Follow-up|0|||
48809915|NCT00885352|157144479|FG000|Overall Study|Physician Decision|0|||
48809916|NCT00885352|157144480|FG001|Overall Study|Physician Decision|3|||
48809917|NCT00885352|157144479|FG000|Overall Study|Protocol Violation|0|||
48809918|NCT00885352|157144480|FG001|Overall Study|Protocol Violation|2|||
48809919|NCT00885352|157144479|FG000|Overall Study|Withdrawal by Subject|1|||
48809920|NCT00885352|157144480|FG001|Overall Study|Withdrawal by Subject|5|||
48809921|NCT00885352|157144479|FG000|Overall Study|Contradiction to study medication|0|||
48809922|NCT00885352|157144480|FG001|Overall Study|Contradiction to study medication|2|||
48809923|NCT00885352|157144479|FG000|Overall Study|Excluded medication|2|||
48809924|NCT00885352|157144480|FG001|Overall Study|Excluded medication|2|||
48711418|NCT00337675|156793208|FG002|Overall Study|Trial Terminated|2|||
48711419|NCT02350478|156793218|FG000|Overall Study|Lost to Follow-up|5|||
48711420|NCT02350478|156793219|FG001|Overall Study|Lost to Follow-up|1|||
48711421|NCT02223858|156793220|FG000|Overall Study|Death|1|||
48711422|NCT02223858|156793221|FG001|Overall Study|Death|1|||
48711423|NCT02223858|156793220|FG000|Overall Study|Lost to Follow-up|6|||
48711424|NCT02223858|156793221|FG001|Overall Study|Lost to Follow-up|11|||
48711425|NCT02223858|156793220|FG000|Overall Study|Withdrawal by Subject|8|||
48711426|NCT02223858|156793221|FG001|Overall Study|Withdrawal by Subject|5|||
48711427|NCT02223858|156793220|FG000|Overall Study|Refused|9|||
48711428|NCT02223858|156793221|FG001|Overall Study|Refused|9|||
48711429|NCT03565497|156793222|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
48711430|NCT03565497|156793223|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
48711431|NCT03565497|156793224|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
48711432|NCT03565497|156793222|FG000|Overall Study|Lost to Follow-up|1|||
48711433|NCT03565497|156793223|FG001|Overall Study|Lost to Follow-up|1|||
48711434|NCT03565497|156793224|FG002|Overall Study|Lost to Follow-up|2|||
48711435|NCT03565497|156793222|FG000|Overall Study|Withdrawal by Subject|1|||
48711436|NCT03565497|156793223|FG001|Overall Study|Withdrawal by Subject|1|||
48711437|NCT03565497|156793224|FG002|Overall Study|Withdrawal by Subject|1|||
48711438|NCT00380367|156793225|FG000|Overall Study|Lost to Follow-up|1|||
48711439|NCT00380367|156793225|FG000|Overall Study|Withdrawal by Subject|1|||
48711440|NCT02238080|156793226|FG000|Overall Study|Death|13|||
48711441|NCT02238080|156793226|FG000|Overall Study|Treatment interrupted|6|||
48711442|NCT02238080|156793226|FG000|Overall Study|Withdrawal by Subject|2|||
48711443|NCT02238080|156793226|FG000|Overall Study|Other|4|||
48711444|NCT01519869|156793237|FG000|Overall Study|Lost to Follow-up|1|||
48711445|NCT02920242|156793246|FG000|Overall Study|Withdrawal by Subject|1|||
48711446|NCT02920242|156793247|FG001|Overall Study|Withdrawal by Subject|0|||
48711447|NCT02920242|156793248|FG002|Overall Study|Withdrawal by Subject|1|||
48711448|NCT02920242|156793246|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
48711449|NCT02920242|156793247|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
48711450|NCT02920242|156793248|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
48711451|NCT01474018|156793249|FG000|Overall Study|Lost to Follow-up|0|||
48711452|NCT01474018|156793250|FG001|Overall Study|Lost to Follow-up|1|||
48711453|NCT01474018|156793249|FG000|Overall Study|Withdrawal by Subject|0|||
48711454|NCT01474018|156793250|FG001|Overall Study|Withdrawal by Subject|2|||
48711455|NCT02433080|156793252|FG000|Overall Study|Lost to Follow-up|1|||
48711456|NCT02433080|156793253|FG001|Overall Study|Lost to Follow-up|2|||
48711457|NCT02433080|156793252|FG000|Overall Study|Withdrawal by Subject|0|||
48711458|NCT02433080|156793253|FG001|Overall Study|Withdrawal by Subject|2|||
48711459|NCT00486291|156793259|FG000|Overall Study|Adverse Event|3|||
48711460|NCT00486291|156793260|FG001|Overall Study|Adverse Event|4|||
48711461|NCT00486291|156793259|FG000|Overall Study|Lost to Follow-up|3|||
48711462|NCT00486291|156793260|FG001|Overall Study|Lost to Follow-up|7|||
48711463|NCT00486291|156793259|FG000|Overall Study|protocol non-compliance|10|||
48711464|NCT00486291|156793260|FG001|Overall Study|protocol non-compliance|15|||
48711465|NCT00486291|156793259|FG000|Overall Study|requirement for restricted medication|0|||
48711466|NCT00486291|156793260|FG001|Overall Study|requirement for restricted medication|3|||
48711467|NCT00126490|156793265|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
48711468|NCT00759564|156793271|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
48711469|NCT00759564|156793272|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
48711470|NCT00759564|156793273|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
48711471|NCT00759564|156793274|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
48711472|NCT00759564|156793275|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
48711473|NCT02657408|156793281|FG000|Overall Study|Adverse Event|3|||
48711474|NCT02657408|156793282|FG001|Overall Study|Adverse Event|7|||
48711475|NCT00080899|156793292|FG000|Overall Study|Adverse Event|1|||
48711476|NCT02872935|156793293|FG000|Overall Study|Other|0|||
48711477|NCT02872935|156793294|FG001|Overall Study|Other|1|||
48711478|NCT03237286|156793295|FG000|Overall Study|Withdrawal by Subject|1|||
48711479|NCT03237286|156793296|FG001|Overall Study|Withdrawal by Subject|0|||
48711480|NCT03237286|156793297|FG002|Overall Study|Withdrawal by Subject|2|||
48711481|NCT03237286|156793295|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
48711482|NCT03237286|156793296|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
48711483|NCT03237286|156793297|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
48711484|NCT03783078|156793298|FG000|Overall Study|Death|31|||
48711485|NCT03783078|156793298|FG000|Overall Study|Sponsor Decision|23|||
48711486|NCT03783078|156793298|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48711487|NCT01519167|156793299|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
48711488|NCT01519167|156793300|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
48711489|NCT01519167|156793299|FG000|Overall Study|Adverse Event|0|||
48711490|NCT01519167|156793300|FG001|Overall Study|Adverse Event|1|||
48711491|NCT01519167|156793299|FG000|Overall Study|Lack of Efficacy|0|||
48711492|NCT01519167|156793300|FG001|Overall Study|Lack of Efficacy|1|||
48492021|NCT01405820|155994265|FG001|Open-Label Treatment Period|Physician Decision|0|||
48492022|NCT01405820|155994266|FG002|Open-Label Treatment Period|Physician Decision|1|||
48711493|NCT01519167|156793299|FG000|Overall Study|Medical condition changes&deep sedation|0|||
48711494|NCT01519167|156793300|FG001|Overall Study|Medical condition changes&deep sedation|2|||
48711495|NCT01519167|156793299|FG000|Overall Study|Physician Decision|0|||
48711496|NCT01519167|156793300|FG001|Overall Study|Physician Decision|1|||
48711497|NCT03304249|156793303|FG000|Overall Study|Lost to Follow-up|8|||
48711498|NCT03304249|156793304|FG001|Overall Study|Lost to Follow-up|10|||
48711499|NCT03304249|156793303|FG000|Overall Study|Withdrawal by Subject|12|||
48711500|NCT03304249|156793304|FG001|Overall Study|Withdrawal by Subject|2|||
48711501|NCT03304249|156793303|FG000|Overall Study|Moved Out of District|4|||
48711502|NCT03304249|156793304|FG001|Overall Study|Moved Out of District|2|||
48711503|NCT01601652|156793305|FG000|Overall Study|Death|1|||
48711504|NCT00777153|156794841|FG000|Overall Study|Lost to Follow-up|1|||
48711505|NCT00777153|156794842|FG001|Overall Study|Lost to Follow-up|1|||
48711506|NCT00777153|156794843|FG002|Overall Study|Lost to Follow-up|0|||
48711507|NCT00777153|156794841|FG000|Overall Study|Death|85|||
48711508|NCT00777153|156794842|FG001|Overall Study|Death|73|||
48711509|NCT00777153|156794843|FG002|Overall Study|Death|33|||
48711510|NCT00777153|156794841|FG000|Overall Study|Withdrawal by Subject|3|||
48711511|NCT00777153|156794842|FG001|Overall Study|Withdrawal by Subject|4|||
48711512|NCT00777153|156794843|FG002|Overall Study|Withdrawal by Subject|3|||
48711513|NCT00777153|156794841|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
48711514|NCT00777153|156794842|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
48711515|NCT00777153|156794843|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
48711516|NCT01354899|156794844|FG000|Overall Study|discharge from the hospital|2|||
48711517|NCT01354899|156794844|FG000|Overall Study|Protocol Violation|1|||
48711518|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
48711519|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
48711520|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
48711521|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
48711522|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
48711523|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
48711524|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
48711525|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
48711526|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
48711527|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
48711528|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
48711529|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
48711530|NCT00479687|156794845|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
48711531|NCT00479687|156794846|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
48711532|NCT00479687|156794847|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
48711533|NCT00479687|156794845|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
48711534|NCT00479687|156794846|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
48711535|NCT00479687|156794847|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
48711536|NCT00479687|156794845|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
48711537|NCT00479687|156794846|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
48711538|NCT00479687|156794847|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
48711539|NCT00479687|156794845|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
48711540|NCT00479687|156794846|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
48711541|NCT00479687|156794847|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
48711542|NCT00479687|156794845|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
48711543|NCT00479687|156794846|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
48711544|NCT00479687|156794847|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
48711545|NCT00295880|156794848|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
48711546|NCT00295880|156794848|FG000|Overall Study|Unit randomization did not occur|1|||
48711547|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
48711548|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
48711549|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
48711550|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
48711551|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
48809925|NCT00885352|157144479|FG000|Overall Study|Lab abnormalities|1|||
48809926|NCT00885352|157144480|FG001|Overall Study|Lab abnormalities|1|||
48809927|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
48809928|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
48809929|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48809930|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
48809931|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
48809932|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
48809933|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
48809934|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
48809935|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
48809936|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
48809937|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
48809938|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
48809939|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
48809940|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
48809941|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
48809942|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
48809943|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
48809944|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
48809945|NCT00365378|157144481|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
48809946|NCT00365378|157144482|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
48809947|NCT00365378|157144483|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
48809948|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
48492023|NCT01405820|155994267|FG003|Open-Label Treatment Period|Physician Decision|2|||
48492024|NCT01405820|155994268|FG004|Open-Label Treatment Period|Physician Decision|1|||
48492025|NCT01405820|155994269|FG005|Open-Label Treatment Period|Physician Decision|0|||
48492026|NCT01405820|155994264|FG000|Open-Label Treatment Period|Adverse Event|0|||
48492027|NCT01405820|155994265|FG001|Open-Label Treatment Period|Adverse Event|0|||
48492028|NCT01405820|155994266|FG002|Open-Label Treatment Period|Adverse Event|0|||
48492029|NCT01405820|155994267|FG003|Open-Label Treatment Period|Adverse Event|1|||
48492030|NCT01405820|155994268|FG004|Open-Label Treatment Period|Adverse Event|0|||
48492031|NCT01405820|155994269|FG005|Open-Label Treatment Period|Adverse Event|0|||
48492032|NCT00947011|155994272|FG000|Overall Study|Study was terminated,PI left institution|12|||
48492033|NCT00770991|155994273|FG000|Overall Study|Physician Decision|2|||
48492034|NCT00770991|155994274|FG001|Overall Study|Physician Decision|0|||
48492035|NCT00770991|155994273|FG000|Overall Study|Withdrawal by Subject|1|||
48492036|NCT00770991|155994274|FG001|Overall Study|Withdrawal by Subject|0|||
48492037|NCT00770991|155994273|FG000|Overall Study|Adverse Event|1|||
48492038|NCT00770991|155994274|FG001|Overall Study|Adverse Event|5|||
48492039|NCT00770991|155994273|FG000|Overall Study|Pregnancy|1|||
48492040|NCT00770991|155994274|FG001|Overall Study|Pregnancy|0|||
48492041|NCT03687125|155994275|FG000|Overall Study|Progressive Disease|2|||
48492042|NCT03687125|155994276|FG001|Overall Study|Progressive Disease|1|||
48492043|NCT03687125|155994275|FG000|Overall Study|Protocol Violation|1|||
48492044|NCT03687125|155994276|FG001|Overall Study|Protocol Violation|0|||
48492045|NCT01992107|155994277|FG000|Overall Study|Administrative reasons|2|||
48492046|NCT01992107|155994278|FG001|Overall Study|Administrative reasons|0|||
48492047|NCT01992107|155994279|FG002|Overall Study|Administrative reasons|0|||
48492048|NCT01992107|155994277|FG000|Overall Study|Adverse Event|0|||
48492049|NCT01992107|155994278|FG001|Overall Study|Adverse Event|1|||
48492050|NCT01992107|155994279|FG002|Overall Study|Adverse Event|0|||
48492051|NCT01992107|155994277|FG000|Overall Study|Lost to Follow-up|46|||
48711552|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
48809949|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
48809950|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
48492052|NCT01992107|155994278|FG001|Overall Study|Lost to Follow-up|22|||
48492053|NCT01992107|155994279|FG002|Overall Study|Lost to Follow-up|26|||
48492054|NCT01992107|155994277|FG000|Overall Study|noncompliance and were unavailable|7|||
48492055|NCT01992107|155994278|FG001|Overall Study|noncompliance and were unavailable|3|||
48711553|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
48711554|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
48711555|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
48711556|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
48711557|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
48711558|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
48711559|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
48711560|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
48711561|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
48711562|NCT01235741|156794851|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
48711563|NCT01235741|156794852|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
48742939|NCT01550289|156910420|FG001|Overall Study|Withdrawal by Subject|3|||
48742940|NCT02469298|156910422|FG000|Overall Study|Protocol Violation|0|||
48742941|NCT02469298|156910423|FG001|Overall Study|Protocol Violation|1|||
48742942|NCT02469298|156910424|FG002|Overall Study|Protocol Violation|1|||
48742943|NCT02469298|156910425|FG003|Overall Study|Protocol Violation|0|||
48742944|NCT02469298|156910422|FG000|Overall Study|Lost to Follow-up|1|||
48742945|NCT02469298|156910423|FG001|Overall Study|Lost to Follow-up|0|||
48742946|NCT02469298|156910424|FG002|Overall Study|Lost to Follow-up|1|||
48742947|NCT02469298|156910425|FG003|Overall Study|Lost to Follow-up|0|||
48742948|NCT02469298|156910422|FG000|Overall Study|Physician Decision|0|||
48742949|NCT02469298|156910423|FG001|Overall Study|Physician Decision|0|||
48742950|NCT02469298|156910424|FG002|Overall Study|Physician Decision|0|||
48742951|NCT02469298|156910425|FG003|Overall Study|Physician Decision|1|||
48742952|NCT02469298|156910422|FG000|Overall Study|Withdrawal by Subject|0|||
48742953|NCT02469298|156910423|FG001|Overall Study|Withdrawal by Subject|0|||
48742954|NCT02469298|156910424|FG002|Overall Study|Withdrawal by Subject|0|||
48742955|NCT02469298|156910425|FG003|Overall Study|Withdrawal by Subject|1|||
48742956|NCT02955602|156910430|FG000|Overall Study|Adverse Event|0|||
48742957|NCT02955602|156910431|FG001|Overall Study|Adverse Event|3|||
48742958|NCT02955602|156910432|FG002|Overall Study|Adverse Event|0|||
48742959|NCT02955602|156910430|FG000|Overall Study|Withdrawal of informed consent|1|||
48742960|NCT02955602|156910431|FG001|Overall Study|Withdrawal of informed consent|3|||
48742961|NCT02955602|156910432|FG002|Overall Study|Withdrawal of informed consent|2|||
48742962|NCT02955602|156910430|FG000|Overall Study|Lost to Follow-up|0|||
48742963|NCT02955602|156910431|FG001|Overall Study|Lost to Follow-up|0|||
48742964|NCT02955602|156910432|FG002|Overall Study|Lost to Follow-up|1|||
48742965|NCT02955602|156910430|FG000|Overall Study|Other|0|||
48742966|NCT02955602|156910431|FG001|Overall Study|Other|1|||
48742967|NCT02955602|156910432|FG002|Overall Study|Other|3|||
48742968|NCT00844831|156910433|FG000|Overall Study|Withdrawal by Subject|4|||
48742969|NCT00844831|156910433|FG000|Overall Study|Adverse Event|1|||
48742970|NCT00844831|156910433|FG000|Overall Study|Physician Decision|1|||
48742971|NCT04015336|156910446|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
48742972|NCT02478632|156910449|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
48742973|NCT02478632|156910450|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
48742974|NCT02478632|156910449|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
48742975|NCT02478632|156910450|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
48742976|NCT02478632|156910449|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
48742977|NCT02478632|156910450|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
48742978|NCT04678661|156910451|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
48742979|NCT04678661|156910452|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
48742980|NCT04678661|156910451|FG000|Overall Study|Protocol Violation|2|||
48742981|NCT04678661|156910452|FG001|Overall Study|Protocol Violation|0|||
48742982|NCT04678661|156910451|FG000|Overall Study|Withdrawal by Subject|1|||
48742983|NCT04678661|156910452|FG001|Overall Study|Withdrawal by Subject|0|||
48742984|NCT04678661|156910451|FG000|Overall Study|Lost to Follow-up|2|||
48742985|NCT04678661|156910452|FG001|Overall Study|Lost to Follow-up|0|||
48742986|NCT04678661|156910451|FG000|Overall Study|Death|2|||
48742987|NCT04678661|156910452|FG001|Overall Study|Death|0|||
48742988|NCT01086033|156910453|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
48742989|NCT01086033|156910453|FG000|Overall Study|Lost to Follow-up|86|||
48742990|NCT01086033|156910453|FG000|Overall Study|Adverse Event|42|||
48742991|NCT01086033|156910453|FG000|Overall Study|Withdrawal by Subject|41|||
48742992|NCT01086033|156910453|FG000|Overall Study|Other|14|||
48742993|NCT01086033|156910453|FG000|Overall Study|Other|13|||
48742994|NCT01086033|156910453|FG000|Overall Study|AE and Withdrew Consent|5|||
48742995|NCT01086033|156910453|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
48742996|NCT01086033|156910453|FG000|Overall Study|Withdrew consent and Other Reason|4|||
48711564|NCT01235741|156794853|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
48711565|NCT01235741|156794851|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
48711566|NCT01235741|156794852|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
48711567|NCT01235741|156794853|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
48711568|NCT01235741|156794851|FG000|Randomized to Treatment|Adverse Event|0|||
48711569|NCT01235741|156794852|FG001|Randomized to Treatment|Adverse Event|1|||
48711570|NCT01235741|156794853|FG002|Randomized to Treatment|Adverse Event|1|||
48711571|NCT01235741|156794851|FG000|Randomized to Treatment|Sponsor terminated study|0|||
48711572|NCT01235741|156794852|FG001|Randomized to Treatment|Sponsor terminated study|35|||
48711573|NCT01235741|156794853|FG002|Randomized to Treatment|Sponsor terminated study|34|||
48711574|NCT01235741|156794851|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
48711575|NCT01235741|156794852|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
48711576|NCT01235741|156794853|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
48711577|NCT01235741|156794851|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
48711578|NCT01235741|156794852|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
48711579|NCT01235741|156794853|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
48711580|NCT01235741|156794851|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
48711581|NCT01235741|156794852|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
48711582|NCT01235741|156794853|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
48711583|NCT00539864|156794858|FG000|Overall Study|Lost to Follow-up|0|||
48711584|NCT00539864|156794859|FG001|Overall Study|Lost to Follow-up|1|||
48711585|NCT00539864|156794858|FG000|Overall Study|Withdrawal by Subject|1|||
48711586|NCT00539864|156794859|FG001|Overall Study|Withdrawal by Subject|1|||
48711587|NCT01250145|156794860|FG000|Overall Study|Adverse Event|2|||
48711588|NCT01250145|156794861|FG001|Overall Study|Adverse Event|1|||
48711589|NCT01250145|156794860|FG000|Overall Study|Withdrawal by Subject|0|||
48711590|NCT01250145|156794861|FG001|Overall Study|Withdrawal by Subject|4|||
48711591|NCT02273596|156794862|FG000|24-Week Treatment Period|Adverse Event|3|||
48711592|NCT02273596|156794862|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
48711593|NCT02273596|156794862|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
48711594|NCT02273596|156794862|FG000|24-Week Treatment Period|Physician Decision|1|||
48711595|NCT02273596|156794862|FG000|24-Week Treatment Period|Protocol Deviation|1|||
48711596|NCT02273596|156794862|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
48711597|NCT02273596|156794862|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
48711598|NCT02273596|156794862|FG000|Extension Period|Lost to Follow-up|1|||
48809951|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
48809952|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
48809953|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
48809954|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
48809955|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
48809956|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
48809957|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
48809958|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
48492056|NCT01992107|155994279|FG002|Overall Study|noncompliance and were unavailable|2|||
48492057|NCT01992107|155994277|FG000|Overall Study|Withdrawal by Subject|13|||
48492058|NCT01992107|155994278|FG001|Overall Study|Withdrawal by Subject|7|||
48809959|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
48809960|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
48711599|NCT02273596|156794862|FG000|Extension Period|Protocol Deviation|1|||
48711600|NCT02604160|156794863|FG000|Overall Study|Protocol Violation|0|||
48809961|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
48809962|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
48809963|NCT00365378|157144481|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
48809964|NCT00365378|157144482|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
48809965|NCT00365378|157144483|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
48809966|NCT00365378|157144481|FG000|Extension|Adverse Event|0|||
48809967|NCT00365378|157144482|FG001|Extension|Adverse Event|0|||
48809968|NCT00365378|157144483|FG002|Extension|Adverse Event|1|||
48711601|NCT02604160|156794864|FG001|Overall Study|Protocol Violation|1|||
48711602|NCT02604160|156794863|FG000|Overall Study|Physician Decision|0|||
48492059|NCT01992107|155994279|FG002|Overall Study|Withdrawal by Subject|8|||
48711603|NCT02604160|156794864|FG001|Overall Study|Physician Decision|1|||
48711604|NCT04610281|156794865|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
48711605|NCT04610281|156794866|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
48711606|NCT01088048|156794867|FG000|Overall Study|Adverse Event|7|||
48711607|NCT01088048|156794868|FG001|Overall Study|Adverse Event|9|||
48711608|NCT01088048|156794869|FG002|Overall Study|Adverse Event|7|||
48809969|NCT00365378|157144481|FG000|Extension|Moved|0|||
48809970|NCT00365378|157144482|FG001|Extension|Moved|0|||
48492060|NCT02035137|155994282|FG000|Overall Study|Physician Decision|0|||
48809971|NCT00365378|157144483|FG002|Extension|Moved|8|||
48809972|NCT00365378|157144481|FG000|Extension|Lost to Follow-up|0|||
48809973|NCT00365378|157144482|FG001|Extension|Lost to Follow-up|0|||
48809974|NCT00365378|157144483|FG002|Extension|Lost to Follow-up|57|||
48809975|NCT00365378|157144481|FG000|Extension|Protocol Violation|0|||
48809976|NCT00365378|157144482|FG001|Extension|Protocol Violation|0|||
48809977|NCT00365378|157144483|FG002|Extension|Protocol Violation|2|||
48809978|NCT00365378|157144481|FG000|Extension|Withdrawal by Subject|0|||
48809979|NCT00365378|157144482|FG001|Extension|Withdrawal by Subject|0|||
48809980|NCT00365378|157144483|FG002|Extension|Withdrawal by Subject|98|||
48809981|NCT00365378|157144481|FG000|Extension|Other|0|||
48809982|NCT00365378|157144482|FG001|Extension|Other|0|||
48809983|NCT00365378|157144483|FG002|Extension|Other|31|||
48809984|NCT02693834|157144484|FG000|Baseline Measurement|Withdrawal by Subject|1|||
48711609|NCT01088048|156794870|FG003|Overall Study|Adverse Event|5|||
48711610|NCT01088048|156794871|FG004|Overall Study|Adverse Event|6|||
48711611|NCT01088048|156794872|FG005|Overall Study|Adverse Event|3|||
48711612|NCT01088048|156794873|FG006|Overall Study|Adverse Event|3|||
48711613|NCT01088048|156794874|FG007|Overall Study|Adverse Event|0|||
48711614|NCT01088048|156794875|FG008|Overall Study|Adverse Event|2|||
48711615|NCT01088048|156794876|FG009|Overall Study|Adverse Event|2|||
48711616|NCT01088048|156794867|FG000|Overall Study|Withdrew Consent|1|||
48711617|NCT01088048|156794868|FG001|Overall Study|Withdrew Consent|1|||
48711618|NCT01088048|156794869|FG002|Overall Study|Withdrew Consent|1|||
48711619|NCT01088048|156794870|FG003|Overall Study|Withdrew Consent|1|||
48809985|NCT02693834|157144485|FG001|Baseline Measurement|Withdrawal by Subject|0|||
48809986|NCT02693834|157144484|FG000|Baseline Measurement|Adverse Event|1|||
48809987|NCT02693834|157144485|FG001|Baseline Measurement|Adverse Event|0|||
48809988|NCT02693834|157144484|FG000|Week 2 Practice|Adverse Event|0|||
48809989|NCT02693834|157144485|FG001|Week 2 Practice|Adverse Event|1|||
48809990|NCT02441946|157144492|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
48809991|NCT02441946|157144493|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
48809992|NCT02441946|157144494|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
48809993|NCT02441946|157144492|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
48809994|NCT02441946|157144493|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
48809995|NCT02441946|157144494|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
48809996|NCT02441946|157144492|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48809997|NCT02441946|157144493|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
48809998|NCT02441946|157144494|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48809999|NCT02441946|157144492|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
48810000|NCT02441946|157144493|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
48810001|NCT02441946|157144494|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
48711620|NCT01088048|156794871|FG004|Overall Study|Withdrew Consent|2|||
48711621|NCT01088048|156794872|FG005|Overall Study|Withdrew Consent|1|||
48711622|NCT01088048|156794873|FG006|Overall Study|Withdrew Consent|0|||
48711623|NCT01088048|156794874|FG007|Overall Study|Withdrew Consent|2|||
48711624|NCT01088048|156794875|FG008|Overall Study|Withdrew Consent|2|||
48810002|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
48810003|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
48810004|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
48810005|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
48810006|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
48810007|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
48810008|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
48810009|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
48810010|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
48810011|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
48810012|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
48810013|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
48810014|NCT02441946|157144492|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
48810015|NCT02441946|157144493|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
48810016|NCT02441946|157144494|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
48711625|NCT01088048|156794876|FG009|Overall Study|Withdrew Consent|1|||
48810017|NCT02441946|157144492|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
48810018|NCT02441946|157144493|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
48810019|NCT02441946|157144494|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
48810020|NCT02441946|157144492|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
48810021|NCT02441946|157144493|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48810022|NCT02441946|157144494|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48810023|NCT01719224|157144495|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
48711626|NCT01088048|156794867|FG000|Overall Study|Concomitant Medication Prohibited|1|||
48711627|NCT01088048|156794868|FG001|Overall Study|Concomitant Medication Prohibited|0|||
48810024|NCT01719224|157144496|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
48711628|NCT01088048|156794869|FG002|Overall Study|Concomitant Medication Prohibited|0|||
48711629|NCT01088048|156794870|FG003|Overall Study|Concomitant Medication Prohibited|0|||
48711630|NCT01088048|156794871|FG004|Overall Study|Concomitant Medication Prohibited|0|||
48711631|NCT01088048|156794872|FG005|Overall Study|Concomitant Medication Prohibited|0|||
48711632|NCT01088048|156794873|FG006|Overall Study|Concomitant Medication Prohibited|0|||
48711633|NCT01088048|156794874|FG007|Overall Study|Concomitant Medication Prohibited|0|||
48711634|NCT01088048|156794875|FG008|Overall Study|Concomitant Medication Prohibited|0|||
48711635|NCT01088048|156794876|FG009|Overall Study|Concomitant Medication Prohibited|0|||
48711636|NCT01088048|156794867|FG000|Overall Study|Investigator Request|2|||
48711637|NCT01088048|156794868|FG001|Overall Study|Investigator Request|2|||
48711638|NCT01088048|156794869|FG002|Overall Study|Investigator Request|0|||
48810025|NCT00879996|157144498|FG000|Overall Study|Lost to Follow-up|7|||
48810026|NCT00879996|157144499|FG001|Overall Study|Lost to Follow-up|6|||
48810027|NCT00879996|157144498|FG000|Overall Study|non-compliance|6|||
48810028|NCT00879996|157144499|FG001|Overall Study|non-compliance|4|||
48810029|NCT00879996|157144498|FG000|Overall Study|Physician Decision|1|||
48711639|NCT01088048|156794870|FG003|Overall Study|Investigator Request|0|||
48711640|NCT01088048|156794871|FG004|Overall Study|Investigator Request|3|||
48711641|NCT01088048|156794872|FG005|Overall Study|Investigator Request|1|||
48711642|NCT01088048|156794873|FG006|Overall Study|Investigator Request|1|||
48711643|NCT01088048|156794874|FG007|Overall Study|Investigator Request|0|||
48711644|NCT01088048|156794875|FG008|Overall Study|Investigator Request|0|||
48810030|NCT00879996|157144499|FG001|Overall Study|Physician Decision|2|||
48810031|NCT00879996|157144498|FG000|Overall Study|psychiatric problem|0|||
48810032|NCT00879996|157144499|FG001|Overall Study|psychiatric problem|1|||
48810033|NCT00879996|157144498|FG000|Overall Study|put on parole|1|||
48810034|NCT00879996|157144499|FG001|Overall Study|put on parole|0|||
48810035|NCT00423852|157144500|FG000|Overall Study|Removed pior to the high-dose portion|3|||
48810036|NCT00980005|157144501|FG000|Overall Study|Withdrawal by Subject|6|||
48810037|NCT00980005|157144502|FG001|Overall Study|Withdrawal by Subject|17|||
48810038|NCT00980005|157144501|FG000|Overall Study|Lost to Follow-up|37|||
48810039|NCT00980005|157144502|FG001|Overall Study|Lost to Follow-up|43|||
48810040|NCT00980005|157144501|FG000|Overall Study|Other|4|||
48810041|NCT00980005|157144502|FG001|Overall Study|Other|3|||
48810042|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
48810043|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
48810044|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
48810045|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
48810046|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
48810047|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
48810048|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
48810049|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
48810050|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
48810051|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
48810052|NCT02307513|157144506|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
48810053|NCT02307513|157144507|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
48810054|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
48810055|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
48810056|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
48810057|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
48810058|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
48810059|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
48810060|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
48810061|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
48810062|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
48810063|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
48810064|NCT02307513|157144506|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
48810065|NCT02307513|157144507|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
48810066|NCT02307513|157144506|FG000|Long-term Extension|Physician Decision|1|||
48810067|NCT02307513|157144507|FG001|Long-term Extension|Physician Decision|0|||
48711645|NCT01088048|156794876|FG009|Overall Study|Investigator Request|0|||
48711646|NCT01088048|156794867|FG000|Overall Study|Patient Non-compliance|0|||
48711647|NCT01088048|156794868|FG001|Overall Study|Patient Non-compliance|1|||
48492061|NCT02035137|155994283|FG001|Overall Study|Physician Decision|0|||
48492062|NCT02035137|155994284|FG002|Overall Study|Physician Decision|1|||
48492063|NCT02035137|155994282|FG000|Overall Study|Withdrawal by Subject|0|||
48711648|NCT01088048|156794869|FG002|Overall Study|Patient Non-compliance|0|||
48711649|NCT01088048|156794870|FG003|Overall Study|Patient Non-compliance|0|||
48711650|NCT01088048|156794871|FG004|Overall Study|Patient Non-compliance|0|||
48711651|NCT01088048|156794872|FG005|Overall Study|Patient Non-compliance|0|||
48492064|NCT02035137|155994283|FG001|Overall Study|Withdrawal by Subject|1|||
48492065|NCT02035137|155994284|FG002|Overall Study|Withdrawal by Subject|2|||
48492066|NCT02035137|155994282|FG000|Overall Study|Ineligible|0|||
48492067|NCT02035137|155994283|FG001|Overall Study|Ineligible|1|||
48597539|NCT01826981|156383532|FG009|Overall Study|Lost to Follow-up|1|||
48597540|NCT01826981|156383533|FG010|Overall Study|Lost to Follow-up|1|||
48597541|NCT01826981|156383534|FG011|Overall Study|Lost to Follow-up|1|||
48597542|NCT01826981|156383535|FG012|Overall Study|Lost to Follow-up|1|||
48597543|NCT01826981|156383536|FG013|Overall Study|Lost to Follow-up|0|||
48597544|NCT01826981|156383537|FG014|Overall Study|Lost to Follow-up|0|||
48711652|NCT01088048|156794873|FG006|Overall Study|Patient Non-compliance|0|||
48711653|NCT01088048|156794874|FG007|Overall Study|Patient Non-compliance|0|||
48711654|NCT01088048|156794875|FG008|Overall Study|Patient Non-compliance|0|||
48711655|NCT01088048|156794876|FG009|Overall Study|Patient Non-compliance|0|||
48711656|NCT01088048|156794867|FG000|Overall Study|Disease Progression|7|||
48597545|NCT01826981|156383523|FG000|Overall Study|Withdrew Consent|0|||
48597546|NCT01826981|156383524|FG001|Overall Study|Withdrew Consent|0|||
48597547|NCT01826981|156383525|FG002|Overall Study|Withdrew Consent|0|||
48597548|NCT01826981|156383526|FG003|Overall Study|Withdrew Consent|0|||
48711657|NCT01088048|156794868|FG001|Overall Study|Disease Progression|4|||
48711658|NCT01088048|156794869|FG002|Overall Study|Disease Progression|3|||
48711659|NCT01088048|156794870|FG003|Overall Study|Disease Progression|5|||
48711660|NCT01088048|156794871|FG004|Overall Study|Disease Progression|3|||
48711661|NCT01088048|156794872|FG005|Overall Study|Disease Progression|3|||
48711662|NCT01088048|156794873|FG006|Overall Study|Disease Progression|2|||
48711663|NCT01088048|156794874|FG007|Overall Study|Disease Progression|1|||
48711664|NCT01088048|156794875|FG008|Overall Study|Disease Progression|0|||
48711665|NCT01088048|156794876|FG009|Overall Study|Disease Progression|0|||
48711666|NCT01088048|156794867|FG000|Overall Study|Death|1|||
48711667|NCT01088048|156794868|FG001|Overall Study|Death|5|||
48711668|NCT01088048|156794869|FG002|Overall Study|Death|3|||
48711669|NCT01088048|156794870|FG003|Overall Study|Death|3|||
48711670|NCT01088048|156794871|FG004|Overall Study|Death|1|||
48711671|NCT01088048|156794872|FG005|Overall Study|Death|3|||
48711672|NCT01088048|156794873|FG006|Overall Study|Death|0|||
48711673|NCT01088048|156794874|FG007|Overall Study|Death|0|||
48711674|NCT01088048|156794875|FG008|Overall Study|Death|3|||
48711675|NCT01088048|156794876|FG009|Overall Study|Death|1|||
48711676|NCT01088048|156794867|FG000|Overall Study|Other|3|||
48711677|NCT01088048|156794868|FG001|Overall Study|Other|5|||
48711678|NCT01088048|156794869|FG002|Overall Study|Other|0|||
48711679|NCT01088048|156794870|FG003|Overall Study|Other|0|||
48711680|NCT01088048|156794871|FG004|Overall Study|Other|2|||
48711681|NCT01088048|156794872|FG005|Overall Study|Other|0|||
48492068|NCT02035137|155994284|FG002|Overall Study|Ineligible|2|||
48492069|NCT02035137|155994282|FG000|Overall Study|Disease progression prior to treatment start|2|||
48492070|NCT02035137|155994283|FG001|Overall Study|Disease progression prior to treatment start|0|||
48597549|NCT01826981|156383527|FG004|Overall Study|Withdrew Consent|0|||
48597550|NCT01826981|156383528|FG005|Overall Study|Withdrew Consent|0|||
48711682|NCT01088048|156794873|FG006|Overall Study|Other|0|||
48711683|NCT01088048|156794874|FG007|Overall Study|Other|2|||
48711684|NCT01088048|156794875|FG008|Overall Study|Other|0|||
48711685|NCT01088048|156794876|FG009|Overall Study|Other|0|||
48711686|NCT00488683|156794877|FG000|Overall Study|Withdrawal by Subject|1|||
48711687|NCT00488683|156794878|FG001|Overall Study|Withdrawal by Subject|2|||
48711688|NCT00488683|156794879|FG002|Overall Study|Withdrawal by Subject|2|||
48711689|NCT00488683|156794877|FG000|Overall Study|Lost to Follow-up|5|||
48711690|NCT00488683|156794878|FG001|Overall Study|Lost to Follow-up|3|||
48711691|NCT00488683|156794879|FG002|Overall Study|Lost to Follow-up|0|||
48711692|NCT00488683|156794877|FG000|Overall Study|Protocol Violation|5|||
48711693|NCT00488683|156794878|FG001|Overall Study|Protocol Violation|1|||
48711694|NCT00488683|156794879|FG002|Overall Study|Protocol Violation|0|||
48711695|NCT00488683|156794877|FG000|Overall Study|Unable to Classify|1|||
48711696|NCT00488683|156794878|FG001|Overall Study|Unable to Classify|0|||
48711697|NCT00488683|156794879|FG002|Overall Study|Unable to Classify|0|||
48711698|NCT00970684|156794880|FG000|Overall Study|Lack of Efficacy|5|||
48711699|NCT00970684|156794880|FG000|Overall Study|Adverse Event|4|||
48711700|NCT00970684|156794880|FG000|Overall Study|Withdrawal by Subject|1|||
48711701|NCT00084136|156794881|FG000|PI Comparison|Death|10|||
48711702|NCT00084136|156794882|FG001|PI Comparison|Death|9|||
48711703|NCT00084136|156794883|FG002|PI Comparison|Death|0|||
48711704|NCT00084136|156794881|FG000|PI Comparison|Lost to Follow-up|11|||
48711705|NCT00084136|156794882|FG001|PI Comparison|Lost to Follow-up|8|||
48711706|NCT00084136|156794883|FG002|PI Comparison|Lost to Follow-up|0|||
48810068|NCT00318149|157144521|FG000|Overall Study|Adverse Event|0|||
48810069|NCT00318149|157144522|FG001|Overall Study|Adverse Event|0|||
48810070|NCT00318149|157144523|FG002|Overall Study|Adverse Event|0|||
48810071|NCT00318149|157144524|FG003|Overall Study|Adverse Event|0|||
48810072|NCT00318149|157144525|FG004|Overall Study|Adverse Event|0|||
48810073|NCT00318149|157144526|FG005|Overall Study|Adverse Event|2|||
48810074|NCT04296890|157144527|FG000|Overall Study|Withdrawal by Subject|1|||
48810075|NCT04296890|157144527|FG000|Overall Study|Death|62|||
48810076|NCT04296890|157144527|FG000|Overall Study|Lost to Follow-up|3|||
48810077|NCT04296890|157144527|FG000|Overall Study|Other than specified|2|||
48810078|NCT03734991|157144531|FG000|Overall Study|Adverse Event|4|||
48810079|NCT03734991|157144532|FG001|Overall Study|Adverse Event|0|||
48810080|NCT03734991|157144531|FG000|Overall Study|Lost to Follow-up|4|||
48810081|NCT03734991|157144532|FG001|Overall Study|Lost to Follow-up|0|||
48810082|NCT03734991|157144531|FG000|Overall Study|Physician Decision|0|||
48810083|NCT03734991|157144532|FG001|Overall Study|Physician Decision|1|||
48810084|NCT03734991|157144531|FG000|Overall Study|Pregnancy|1|||
48810085|NCT03734991|157144532|FG001|Overall Study|Pregnancy|0|||
48810086|NCT03734991|157144531|FG000|Overall Study|Withdrawal by Subject|6|||
48810087|NCT03734991|157144532|FG001|Overall Study|Withdrawal by Subject|3|||
48810088|NCT03734991|157144531|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
48810089|NCT03734991|157144532|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
48810090|NCT03734991|157144531|FG000|Overall Study|Other|2|||
48810091|NCT03734991|157144532|FG001|Overall Study|Other|2|||
48810092|NCT04182880|157144533|FG000|Overall Study|Pregnancy|1|||
48810093|NCT04182880|157144534|FG001|Overall Study|Pregnancy|0|||
48810094|NCT02716038|157144535|FG000|Overall Study|Not evaluable|1|||
48711707|NCT00084136|156794881|FG000|PI Comparison|Withdrawal by Subject|33|||
48711708|NCT00084136|156794882|FG001|PI Comparison|Withdrawal by Subject|30|||
48711709|NCT00084136|156794883|FG002|PI Comparison|Withdrawal by Subject|0|||
48711710|NCT00084136|156794881|FG000|PI Comparison|Clinic site closed|1|||
48711711|NCT00084136|156794882|FG001|PI Comparison|Clinic site closed|0|||
48711712|NCT00084136|156794883|FG002|PI Comparison|Clinic site closed|0|||
48711713|NCT00084136|156794881|FG000|NRTI Comparison|Death|20|||
48711714|NCT00084136|156794882|FG001|NRTI Comparison|Death|0|||
48711715|NCT00084136|156794883|FG002|NRTI Comparison|Death|18|||
48711716|NCT00084136|156794881|FG000|NRTI Comparison|Lost to Follow-up|14|||
48711717|NCT00084136|156794882|FG001|NRTI Comparison|Lost to Follow-up|0|||
48711718|NCT00084136|156794883|FG002|NRTI Comparison|Lost to Follow-up|12|||
48711719|NCT00084136|156794881|FG000|NRTI Comparison|Withdrawal by Subject|54|||
48711720|NCT00084136|156794882|FG001|NRTI Comparison|Withdrawal by Subject|0|||
48711721|NCT00084136|156794883|FG002|NRTI Comparison|Withdrawal by Subject|38|||
48711722|NCT00084136|156794881|FG000|NRTI Comparison|Clinic site closed|12|||
48711723|NCT00084136|156794882|FG001|NRTI Comparison|Clinic site closed|0|||
48711724|NCT00084136|156794883|FG002|NRTI Comparison|Clinic site closed|14|||
48711725|NCT00084136|156794881|FG000|NRTI Comparison|Not reason above|1|||
48711726|NCT00084136|156794882|FG001|NRTI Comparison|Not reason above|0|||
48711727|NCT00084136|156794883|FG002|NRTI Comparison|Not reason above|0|||
48711728|NCT01296672|156794884|FG000|Overall Study|Lost to Follow-up|73|||
48711729|NCT01296672|156794885|FG001|Overall Study|Lost to Follow-up|18|||
48711730|NCT04661579|156794888|FG000|Overall Study|Lost to Follow-up|19|||
48711731|NCT04661579|156794889|FG001|Overall Study|Lost to Follow-up|10|||
48711732|NCT04661579|156794890|FG002|Overall Study|Lost to Follow-up|2|||
48711733|NCT04661579|156794891|FG003|Overall Study|Lost to Follow-up|7|||
48711734|NCT04661579|156794892|FG004|Overall Study|Lost to Follow-up|11|||
48711735|NCT04661579|156794888|FG000|Overall Study|Physician Decision|2|||
48711736|NCT04661579|156794889|FG001|Overall Study|Physician Decision|0|||
48810095|NCT02716038|157144535|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
48810096|NCT02716038|157144535|FG000|Overall Study|Unresectable|3|||
48810097|NCT00591864|157144536|FG000|Overall Study|Incomplete Imaging|5|||
48810098|NCT02459093|157144537|FG000|Overall Study|Protocol Violation|6|||
48810099|NCT02459093|157144538|FG001|Overall Study|Protocol Violation|11|||
48810100|NCT02459093|157144537|FG000|Overall Study|Lost to Follow-up|6|||
48810101|NCT02459093|157144538|FG001|Overall Study|Lost to Follow-up|7|||
48492071|NCT02035137|155994284|FG002|Overall Study|Disease progression prior to treatment start|0|||
48810102|NCT00383240|157144539|FG000|Overall Study|Adverse Event|4|||
48810103|NCT00383240|157144540|FG001|Overall Study|Adverse Event|6|||
48810104|NCT00383240|157144541|FG002|Overall Study|Adverse Event|9|||
48810105|NCT00383240|157144542|FG003|Overall Study|Adverse Event|7|||
48810106|NCT00383240|157144539|FG000|Overall Study|Treatment Failure|8|||
48810107|NCT00383240|157144540|FG001|Overall Study|Treatment Failure|13|||
48810108|NCT00383240|157144541|FG002|Overall Study|Treatment Failure|47|||
48810109|NCT00383240|157144542|FG003|Overall Study|Treatment Failure|46|||
48810110|NCT00383240|157144539|FG000|Overall Study|Lost to Follow-up|3|||
48810111|NCT00383240|157144540|FG001|Overall Study|Lost to Follow-up|0|||
48810112|NCT00383240|157144541|FG002|Overall Study|Lost to Follow-up|0|||
48810113|NCT00383240|157144542|FG003|Overall Study|Lost to Follow-up|2|||
48492072|NCT02022007|155994285|FG000|Overall Study|Withdrawal by Subject|1|||
48492073|NCT02022007|155994286|FG001|Overall Study|Withdrawal by Subject|1|||
48492074|NCT02022007|155994287|FG002|Overall Study|Withdrawal by Subject|1|||
48492075|NCT02022007|155994285|FG000|Overall Study|Noncompliant|0|||
48492076|NCT02022007|155994286|FG001|Overall Study|Noncompliant|0|||
48810114|NCT00383240|157144539|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
48810115|NCT00383240|157144540|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
48810116|NCT00383240|157144541|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
48492077|NCT02022007|155994287|FG002|Overall Study|Noncompliant|1|||
48810117|NCT00383240|157144542|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
48492078|NCT05266456|155994294|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
48492079|NCT05266456|155994295|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
48492080|NCT05266456|155994296|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
48492081|NCT05266456|155994297|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
48492082|NCT05266456|155994294|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
48492083|NCT05266456|155994295|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
48810118|NCT00383240|157144539|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
48810119|NCT00383240|157144540|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
48810120|NCT00383240|157144541|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
48810121|NCT00383240|157144542|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
48810122|NCT00383240|157144539|FG000|Overall Study|Protocol Violation|4|||
48810123|NCT00383240|157144540|FG001|Overall Study|Protocol Violation|5|||
48810124|NCT00383240|157144541|FG002|Overall Study|Protocol Violation|9|||
48810125|NCT00383240|157144542|FG003|Overall Study|Protocol Violation|6|||
48810126|NCT00383240|157144539|FG000|Overall Study|Did not meet protocol eligibility|9|||
48810127|NCT00383240|157144540|FG001|Overall Study|Did not meet protocol eligibility|4|||
48810128|NCT00383240|157144541|FG002|Overall Study|Did not meet protocol eligibility|9|||
48810129|NCT00383240|157144542|FG003|Overall Study|Did not meet protocol eligibility|3|||
48810130|NCT00383240|157144539|FG000|Overall Study|Administrative|1|||
48492084|NCT05266456|155994296|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
48492085|NCT05266456|155994297|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
48492086|NCT05266456|155994294|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
48492087|NCT05266456|155994295|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
48492088|NCT05266456|155994296|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
48492089|NCT05266456|155994297|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
48597551|NCT01826981|156383529|FG006|Overall Study|Withdrew Consent|1|||
48810131|NCT00383240|157144540|FG001|Overall Study|Administrative|1|||
48810132|NCT00383240|157144541|FG002|Overall Study|Administrative|0|||
48810133|NCT00383240|157144542|FG003|Overall Study|Administrative|0|||
48810134|NCT01370603|157144543|FG000|Period 1|Adverse Event|5|||
48810135|NCT01370603|157144544|FG001|Period 1|Adverse Event|3|||
48810136|NCT01370603|157144543|FG000|Period 1|Lost to Follow-up|2|||
48810137|NCT01370603|157144544|FG001|Period 1|Lost to Follow-up|0|||
48810138|NCT01370603|157144543|FG000|Period 1|Protocol Violation|2|||
48492090|NCT05266456|155994294|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
48492091|NCT05266456|155994295|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
48810139|NCT01370603|157144544|FG001|Period 1|Protocol Violation|2|||
48810140|NCT01370603|157144543|FG000|Period 1|Withdrawal by Subject|5|||
48810141|NCT01370603|157144544|FG001|Period 1|Withdrawal by Subject|5|||
48810142|NCT01370603|157144543|FG000|Crossover Washout|Adverse Event|2|||
48810143|NCT01370603|157144544|FG001|Crossover Washout|Adverse Event|1|||
48810144|NCT01370603|157144543|FG000|Crossover Washout|Lost to Follow-up|2|||
48810145|NCT01370603|157144544|FG001|Crossover Washout|Lost to Follow-up|0|||
48810146|NCT01370603|157144543|FG000|Crossover Washout|Protocol Violation|1|||
48810147|NCT01370603|157144544|FG001|Crossover Washout|Protocol Violation|0|||
48810148|NCT01370603|157144543|FG000|Crossover Washout|Withdrawal by Subject|4|||
48492092|NCT05266456|155994296|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
48492093|NCT05266456|155994297|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
48492094|NCT05266456|155994294|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
48492095|NCT05266456|155994295|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
48810149|NCT01370603|157144544|FG001|Crossover Washout|Withdrawal by Subject|1|||
48810150|NCT01370603|157144543|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
48810151|NCT01370603|157144544|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
48492096|NCT05266456|155994296|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
48597552|NCT01826981|156383530|FG007|Overall Study|Withdrew Consent|1|||
48810152|NCT01370603|157144543|FG000|Period 2|Adverse Event|1|||
48597553|NCT01826981|156383531|FG008|Overall Study|Withdrew Consent|0|||
48597554|NCT01826981|156383532|FG009|Overall Study|Withdrew Consent|0|||
48597555|NCT01826981|156383533|FG010|Overall Study|Withdrew Consent|0|||
48597556|NCT01826981|156383534|FG011|Overall Study|Withdrew Consent|1|||
48597557|NCT01826981|156383535|FG012|Overall Study|Withdrew Consent|0|||
48597558|NCT01826981|156383536|FG013|Overall Study|Withdrew Consent|1|||
48597559|NCT01826981|156383537|FG014|Overall Study|Withdrew Consent|0|||
48597560|NCT01826981|156383523|FG000|Overall Study|Adverse Event|0|||
48597561|NCT01826981|156383524|FG001|Overall Study|Adverse Event|0|||
48597562|NCT01826981|156383525|FG002|Overall Study|Adverse Event|0|||
48597563|NCT01826981|156383526|FG003|Overall Study|Adverse Event|0|||
48597564|NCT01826981|156383527|FG004|Overall Study|Adverse Event|1|||
48597565|NCT01826981|156383528|FG005|Overall Study|Adverse Event|0|||
48810153|NCT01370603|157144544|FG001|Period 2|Adverse Event|4|||
48810154|NCT01370603|157144543|FG000|Period 2|Lost to Follow-up|1|||
48810155|NCT01370603|157144544|FG001|Period 2|Lost to Follow-up|0|||
48810156|NCT01370603|157144543|FG000|Period 2|Withdrawal by Subject|1|||
48597566|NCT01826981|156383529|FG006|Overall Study|Adverse Event|0|||
48597567|NCT01826981|156383530|FG007|Overall Study|Adverse Event|0|||
48597568|NCT01826981|156383531|FG008|Overall Study|Adverse Event|0|||
48597569|NCT01826981|156383532|FG009|Overall Study|Adverse Event|0|||
48597570|NCT01826981|156383533|FG010|Overall Study|Adverse Event|0|||
48810157|NCT01370603|157144544|FG001|Period 2|Withdrawal by Subject|0|||
48810158|NCT03872388|157144546|FG000|Overall Study|Disease Progression|0|||
48810159|NCT03872388|157144547|FG001|Overall Study|Disease Progression|0|||
48810160|NCT03872388|157144548|FG002|Overall Study|Disease Progression|0|||
48810161|NCT03872388|157144549|FG003|Overall Study|Disease Progression|0|||
48810162|NCT03872388|157144550|FG004|Overall Study|Disease Progression|0|||
48810163|NCT03872388|157144551|FG005|Overall Study|Disease Progression|0|||
48810164|NCT03872388|157144552|FG006|Overall Study|Disease Progression|1|||
48810165|NCT03872388|157144553|FG007|Overall Study|Disease Progression|1|||
48810166|NCT03008382|157144554|FG000|Overall Study|Withdrawal by Subject|2|||
48810167|NCT03008382|157144555|FG001|Overall Study|Withdrawal by Subject|5|||
48810168|NCT03008382|157144556|FG002|Overall Study|Withdrawal by Subject|2|||
48810169|NCT03008382|157144557|FG003|Overall Study|Withdrawal by Subject|0|||
48810170|NCT03008382|157144554|FG000|Overall Study|Protocol Violation|1|||
48810171|NCT03008382|157144555|FG001|Overall Study|Protocol Violation|0|||
48810172|NCT03008382|157144556|FG002|Overall Study|Protocol Violation|0|||
48810173|NCT03008382|157144557|FG003|Overall Study|Protocol Violation|0|||
48810174|NCT03008382|157144554|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
48810175|NCT03008382|157144555|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
48810176|NCT03008382|157144556|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
48810177|NCT03008382|157144557|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
48810178|NCT03008382|157144554|FG000|Overall Study|Lost to Follow-up|0|||
48810179|NCT03008382|157144555|FG001|Overall Study|Lost to Follow-up|0|||
48810180|NCT03008382|157144556|FG002|Overall Study|Lost to Follow-up|1|||
48810181|NCT03008382|157144557|FG003|Overall Study|Lost to Follow-up|0|||
48810182|NCT03008382|157144554|FG000|Overall Study|Screenfail|0|||
48810183|NCT03008382|157144555|FG001|Overall Study|Screenfail|0|||
48810184|NCT03008382|157144556|FG002|Overall Study|Screenfail|2|||
48810185|NCT03008382|157144557|FG003|Overall Study|Screenfail|0|||
48810186|NCT06688357|157144558|FG000|Overall Study|Adverse Event|0|||
48810187|NCT06688357|157144559|FG001|Overall Study|Adverse Event|1|||
48810188|NCT02678689|157144560|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
48810189|NCT02678689|157144561|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
48810190|NCT04306367|157144564|FG000|Overall Study|Progression of Disease|9|||
48810191|NCT04306367|157144564|FG000|Overall Study|Adverse Event|3|||
48810192|NCT04306367|157144564|FG000|Overall Study|Withdrawal by Subject|1|||
48810193|NCT02337686|157144565|FG000|Overall Study|Adverse Event|1|||
48810194|NCT01266642|157144568|FG000|Overall Study|Protocol Violation|0|||
48810195|NCT01266642|157144569|FG001|Overall Study|Protocol Violation|1|||
48810196|NCT00332332|157146292|FG000|Overall Study|Adverse Event|13|||
48810197|NCT00332332|157146292|FG000|Overall Study|Death|1|||
48810198|NCT00332332|157146292|FG000|Overall Study|Withdrawal by Subject|8|||
48810199|NCT00332332|157146292|FG000|Overall Study|Physician Decision|1|||
48810200|NCT00332332|157146292|FG000|Overall Study|Lost to Follow-up|3|||
48810201|NCT00332332|157146292|FG000|Overall Study|Protocol deviation|4|||
48810202|NCT00332332|157146292|FG000|Overall Study|Noncompliance|2|||
48810203|NCT00332332|157146292|FG000|Overall Study|Disease progression|2|||
48597571|NCT01826981|156383534|FG011|Overall Study|Adverse Event|0|||
48597572|NCT01826981|156383535|FG012|Overall Study|Adverse Event|0|||
48597573|NCT01826981|156383536|FG013|Overall Study|Adverse Event|0|||
48597574|NCT01826981|156383537|FG014|Overall Study|Adverse Event|0|||
48597575|NCT01826981|156383523|FG000|Overall Study|Upper G-I Haemorrhage|0|||
48492097|NCT05266456|155994297|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
48492098|NCT00903383|155994298|FG000|Overall Study|Adverse Event|1|||
48492099|NCT00903383|155994299|FG001|Overall Study|Adverse Event|2|||
48492100|NCT00903383|155994300|FG002|Overall Study|Adverse Event|3|||
48492101|NCT00903383|155994301|FG003|Overall Study|Adverse Event|1|||
48492102|NCT00903383|155994298|FG000|Overall Study|Physician Decision|1|||
48492103|NCT00903383|155994299|FG001|Overall Study|Physician Decision|2|||
48492104|NCT00903383|155994300|FG002|Overall Study|Physician Decision|0|||
48492105|NCT00903383|155994301|FG003|Overall Study|Physician Decision|0|||
48492106|NCT00903383|155994298|FG000|Overall Study|Lost to Follow-up|0|||
48711737|NCT04661579|156794890|FG002|Overall Study|Physician Decision|0|||
48711738|NCT04661579|156794891|FG003|Overall Study|Physician Decision|1|||
48492107|NCT00903383|155994299|FG001|Overall Study|Lost to Follow-up|0|||
48492108|NCT00903383|155994300|FG002|Overall Study|Lost to Follow-up|0|||
48492109|NCT00903383|155994301|FG003|Overall Study|Lost to Follow-up|1|||
48492110|NCT00903383|155994298|FG000|Overall Study|Decision of Sponsor|1|||
48492111|NCT00903383|155994299|FG001|Overall Study|Decision of Sponsor|0|||
48711739|NCT04661579|156794892|FG004|Overall Study|Physician Decision|0|||
48711740|NCT04661579|156794888|FG000|Overall Study|Withdrawal by Subject|1|||
48711741|NCT04661579|156794889|FG001|Overall Study|Withdrawal by Subject|4|||
48711742|NCT04661579|156794890|FG002|Overall Study|Withdrawal by Subject|0|||
48711743|NCT04661579|156794891|FG003|Overall Study|Withdrawal by Subject|2|||
48711744|NCT04661579|156794892|FG004|Overall Study|Withdrawal by Subject|0|||
48810204|NCT00332332|157146292|FG000|Overall Study|Other|18|||
48810205|NCT00332332|157146292|FG000|Overall Study|Did not receive study treatment|16|||
48810206|NCT02200939|157146293|FG000|Overall Study|Participant withdrew consent|0|||
48810207|NCT02200939|157146294|FG001|Overall Study|Participant withdrew consent|1|||
48810208|NCT02200939|157146293|FG000|Overall Study|Lost to Follow-up|2|||
48810209|NCT02200939|157146294|FG001|Overall Study|Lost to Follow-up|9|||
48810210|NCT02200939|157146293|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
48810211|NCT02200939|157146294|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
48810212|NCT00244374|157146299|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
48810213|NCT00244374|157146300|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
48810214|NCT00244374|157146301|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
48810215|NCT00244374|157146302|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
48810216|NCT00244374|157146303|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
48810217|NCT00244374|157146299|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
48810218|NCT00244374|157146300|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
48810219|NCT00244374|157146301|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
48810220|NCT00244374|157146302|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
48810221|NCT00244374|157146303|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
48810222|NCT00244374|157146299|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
48810223|NCT00244374|157146300|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
48810224|NCT00244374|157146301|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
48810225|NCT00244374|157146302|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
48810226|NCT00244374|157146303|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
48810227|NCT00244374|157146299|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
48810228|NCT00244374|157146300|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
48492112|NCT00903383|155994300|FG002|Overall Study|Decision of Sponsor|0|||
48492113|NCT00903383|155994301|FG003|Overall Study|Decision of Sponsor|0|||
48492114|NCT00903383|155994298|FG000|Overall Study|Withdrawal by Subject|4|||
48492115|NCT00903383|155994299|FG001|Overall Study|Withdrawal by Subject|1|||
48492116|NCT00903383|155994300|FG002|Overall Study|Withdrawal by Subject|0|||
48492117|NCT00903383|155994301|FG003|Overall Study|Withdrawal by Subject|2|||
48492118|NCT00903383|155994298|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
48492119|NCT00903383|155994299|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
48711745|NCT04661579|156794888|FG000|Overall Study|Death|1|||
48711746|NCT04661579|156794889|FG001|Overall Study|Death|0|||
48492120|NCT00903383|155994300|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
48492121|NCT00903383|155994301|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
48492122|NCT00903383|155994298|FG000|Overall Study|Patient Decision|0|||
48492123|NCT00903383|155994299|FG001|Overall Study|Patient Decision|0|||
48492124|NCT00903383|155994300|FG002|Overall Study|Patient Decision|0|||
48492125|NCT00903383|155994301|FG003|Overall Study|Patient Decision|1|||
48492126|NCT01211769|155994305|FG000|Overall Study|Lost to Follow-up|7|||
48711747|NCT04661579|156794890|FG002|Overall Study|Death|0|||
48711748|NCT04661579|156794891|FG003|Overall Study|Death|0|||
48711749|NCT04661579|156794892|FG004|Overall Study|Death|0|||
48711750|NCT04661579|156794888|FG000|Overall Study|Other|1|||
48711751|NCT04661579|156794889|FG001|Overall Study|Other|2|||
48711752|NCT04661579|156794890|FG002|Overall Study|Other|1|||
48711753|NCT04661579|156794891|FG003|Overall Study|Other|1|||
48711754|NCT04661579|156794892|FG004|Overall Study|Other|1|||
48711755|NCT04661579|156794888|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
48711756|NCT04661579|156794889|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
48711757|NCT04661579|156794890|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
48711758|NCT04661579|156794891|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
48711759|NCT04661579|156794892|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
48711760|NCT01305577|156794894|FG000|Overall Study|Adverse Event|2|||
48711761|NCT01305577|156794895|FG001|Overall Study|Adverse Event|2|||
48711762|NCT01305577|156794896|FG002|Overall Study|Adverse Event|1|||
48711763|NCT01305577|156794894|FG000|Overall Study|Withdrawal by Subject|7|||
48711764|NCT01305577|156794895|FG001|Overall Study|Withdrawal by Subject|5|||
48711765|NCT01305577|156794896|FG002|Overall Study|Withdrawal by Subject|6|||
48711766|NCT01305577|156794894|FG000|Overall Study|Lost to Follow-up|4|||
48711767|NCT01305577|156794895|FG001|Overall Study|Lost to Follow-up|3|||
48711768|NCT01305577|156794896|FG002|Overall Study|Lost to Follow-up|2|||
48711769|NCT01305577|156794894|FG000|Overall Study|Protocol Deviation|0|||
48492127|NCT01211769|155994306|FG001|Overall Study|Lost to Follow-up|9|||
48492128|NCT01211769|155994307|FG002|Overall Study|Lost to Follow-up|5|||
48492129|NCT01211769|155994308|FG003|Overall Study|Lost to Follow-up|9|||
48492130|NCT01211769|155994305|FG000|Overall Study|Physician Decision|2|||
48492131|NCT01211769|155994306|FG001|Overall Study|Physician Decision|0|||
48492132|NCT01211769|155994307|FG002|Overall Study|Physician Decision|2|||
48492133|NCT01211769|155994308|FG003|Overall Study|Physician Decision|1|||
48492134|NCT01211769|155994305|FG000|Overall Study|Adverse Event|0|||
48492135|NCT01211769|155994306|FG001|Overall Study|Adverse Event|1|||
48492136|NCT01211769|155994307|FG002|Overall Study|Adverse Event|1|||
48597576|NCT01826981|156383524|FG001|Overall Study|Upper G-I Haemorrhage|0|||
48711770|NCT01305577|156794895|FG001|Overall Study|Protocol Deviation|1|||
48711771|NCT01305577|156794896|FG002|Overall Study|Protocol Deviation|1|||
48711772|NCT00856518|156794912|FG000|Overall Study|Lost to Follow-up|4|||
48711773|NCT00856518|156794913|FG001|Overall Study|Lost to Follow-up|2|||
48711774|NCT01317277|156794915|FG000|Overall Study|Lost to Follow-up|3|||
48810229|NCT00244374|157146301|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
48810230|NCT00244374|157146302|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
48810231|NCT00244374|157146303|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
48810232|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
48810233|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
48810234|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
48492137|NCT01211769|155994308|FG003|Overall Study|Adverse Event|1|||
48492138|NCT01214330|155994309|FG000|Overall Study|Withdrawal by Subject|2|||
48492139|NCT01214330|155994309|FG000|Overall Study|Withdrawal by Subject|2|||
48492140|NCT01186978|155994310|FG000|Overall Study|Withdrawal by Subject|1|||
48492141|NCT00210626|155994311|FG000|Overall Study|Adverse Event|1|||
48492142|NCT00210626|155994312|FG001|Overall Study|Adverse Event|2|||
48492143|NCT00210626|155994311|FG000|Overall Study|Protocol Violation|1|||
48492144|NCT00210626|155994312|FG001|Overall Study|Protocol Violation|5|||
48492145|NCT00210626|155994311|FG000|Overall Study|Lost to Follow-up|11|||
48492146|NCT00210626|155994312|FG001|Overall Study|Lost to Follow-up|11|||
48810235|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
48810236|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
48810237|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
48810238|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
48810239|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
48492147|NCT00210626|155994311|FG000|Overall Study|Death|1|||
48492148|NCT00210626|155994312|FG001|Overall Study|Death|0|||
48492149|NCT00210626|155994311|FG000|Overall Study|Withdrawal by Subject|29|||
48492150|NCT00210626|155994312|FG001|Overall Study|Withdrawal by Subject|20|||
48492151|NCT00210626|155994311|FG000|Overall Study|Physician Decision|0|||
48492152|NCT00210626|155994312|FG001|Overall Study|Physician Decision|2|||
48492153|NCT00210626|155994311|FG000|Overall Study|Sponser Request|1|||
48492154|NCT00210626|155994312|FG001|Overall Study|Sponser Request|0|||
48492155|NCT00210626|155994311|FG000|Overall Study|Other|4|||
48492156|NCT00210626|155994312|FG001|Overall Study|Other|5|||
48492157|NCT01227668|155994313|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
48492158|NCT01227668|155994314|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
48492159|NCT01227668|155994313|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
48492160|NCT01227668|155994314|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
48492161|NCT01227668|155994313|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
48492162|NCT01227668|155994314|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
48492163|NCT01227668|155994313|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
48492164|NCT01227668|155994314|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
48810240|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
48810241|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
48810242|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
48810243|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
48810244|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
48810245|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
48810246|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
48810247|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
48810248|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
48810249|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
48810250|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
48810251|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
48810252|NCT00244374|157146299|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
48810253|NCT00244374|157146300|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
48810254|NCT00244374|157146301|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
48597577|NCT01826981|156383525|FG002|Overall Study|Upper G-I Haemorrhage|0|||
48597578|NCT01826981|156383526|FG003|Overall Study|Upper G-I Haemorrhage|0|||
48597579|NCT01826981|156383527|FG004|Overall Study|Upper G-I Haemorrhage|0|||
48597580|NCT01826981|156383528|FG005|Overall Study|Upper G-I Haemorrhage|0|||
48597581|NCT01826981|156383529|FG006|Overall Study|Upper G-I Haemorrhage|0|||
48597582|NCT01826981|156383530|FG007|Overall Study|Upper G-I Haemorrhage|0|||
48597583|NCT01826981|156383531|FG008|Overall Study|Upper G-I Haemorrhage|0|||
48597584|NCT01826981|156383532|FG009|Overall Study|Upper G-I Haemorrhage|0|||
48597585|NCT01826981|156383533|FG010|Overall Study|Upper G-I Haemorrhage|0|||
48597586|NCT01826981|156383534|FG011|Overall Study|Upper G-I Haemorrhage|0|||
48597587|NCT01826981|156383535|FG012|Overall Study|Upper G-I Haemorrhage|0|||
48597588|NCT01826981|156383536|FG013|Overall Study|Upper G-I Haemorrhage|1|||
48597589|NCT01826981|156383537|FG014|Overall Study|Upper G-I Haemorrhage|0|||
48597590|NCT01826981|156383523|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597591|NCT01826981|156383524|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597592|NCT01826981|156383525|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597593|NCT01826981|156383526|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597594|NCT01826981|156383527|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597595|NCT01826981|156383528|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597596|NCT01826981|156383529|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597597|NCT01826981|156383530|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
48597598|NCT01826981|156383531|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597599|NCT01826981|156383532|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597600|NCT01826981|156383533|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597601|NCT01826981|156383534|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597602|NCT01826981|156383535|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597603|NCT01826981|156383536|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597604|NCT01826981|156383537|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
48597605|NCT02030119|156383540|FG000|Overall Study|Withdrawal by Subject|3|||
48597606|NCT02030119|156383541|FG001|Overall Study|Withdrawal by Subject|1|||
48597607|NCT02030119|156383542|FG002|Overall Study|Withdrawal by Subject|5|||
48597608|NCT02030119|156383543|FG003|Overall Study|Withdrawal by Subject|3|||
48597609|NCT02030119|156383540|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
48597610|NCT02030119|156383541|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
48597611|NCT02030119|156383542|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
48597612|NCT02030119|156383543|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
48597613|NCT02861664|156383544|FG000|Overall Study|Withdrawal of Consent|0|||
48810255|NCT00244374|157146302|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
48810256|NCT00244374|157146303|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
48492165|NCT01227668|155994313|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
48492166|NCT01227668|155994314|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
48492167|NCT01227668|155994313|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
48492168|NCT01227668|155994314|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
48492169|NCT01227668|155994313|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
48492170|NCT01227668|155994314|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
48492171|NCT01227668|155994313|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
48597614|NCT02861664|156383545|FG001|Overall Study|Withdrawal of Consent|1|||
48597615|NCT02213380|156383549|FG000|Underwent Randomization|Withdrawal by Subject|2|||
48597616|NCT02213380|156383550|FG001|Underwent Randomization|Withdrawal by Subject|0|||
48597617|NCT02213380|156383549|FG000|Underwent Randomization|Not treated|3|||
48597618|NCT02213380|156383550|FG001|Underwent Randomization|Not treated|3|||
48711775|NCT01317277|156794916|FG001|Overall Study|Lost to Follow-up|1|||
48711776|NCT01317277|156794915|FG000|Overall Study|Lost MEMS|1|||
48711777|NCT01317277|156794916|FG001|Overall Study|Lost MEMS|1|||
48492172|NCT01227668|155994314|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
48711778|NCT01317277|156794915|FG000|Overall Study|Unable to comply with intervention|1|||
48711779|NCT01317277|156794916|FG001|Overall Study|Unable to comply with intervention|0|||
48711780|NCT01317277|156794915|FG000|Overall Study|Withdrawal by Subject|1|||
48711781|NCT01317277|156794916|FG001|Overall Study|Withdrawal by Subject|0|||
48711782|NCT01317277|156794915|FG000|Overall Study|Adverse Event|1|||
48711783|NCT01317277|156794916|FG001|Overall Study|Adverse Event|0|||
48711784|NCT04380519|156794917|FG000|Overall Study|Withdrawal by Subject|4|||
48711785|NCT04380519|156794918|FG001|Overall Study|Withdrawal by Subject|0|||
48711786|NCT04380519|156794919|FG002|Overall Study|Withdrawal by Subject|1|||
48711787|NCT04380519|156794917|FG000|Overall Study|Death|14|||
48711788|NCT04380519|156794918|FG001|Overall Study|Death|9|||
48711789|NCT04380519|156794919|FG002|Overall Study|Death|6|||
48711790|NCT04380519|156794917|FG000|Overall Study|Adverse Event|0|||
48711791|NCT04380519|156794918|FG001|Overall Study|Adverse Event|1|||
48711792|NCT04380519|156794919|FG002|Overall Study|Adverse Event|0|||
48711793|NCT04380519|156794917|FG000|Overall Study|relatives' decision|0|||
48711794|NCT04380519|156794918|FG001|Overall Study|relatives' decision|1|||
48711795|NCT04380519|156794919|FG002|Overall Study|relatives' decision|0|||
48711796|NCT01485172|156794920|FG000|Overall Study|Adverse Event|2|||
48711797|NCT01485172|156794921|FG001|Overall Study|Adverse Event|1|||
48711798|NCT01485172|156794922|FG002|Overall Study|Adverse Event|2|||
48711799|NCT01485172|156794923|FG003|Overall Study|Adverse Event|2|||
48711800|NCT01485172|156794924|FG004|Overall Study|Adverse Event|1|||
48711801|NCT01485172|156794925|FG005|Overall Study|Adverse Event|2|||
48711802|NCT01485172|156794920|FG000|Overall Study|Lack of Efficacy|2|||
48711803|NCT01485172|156794921|FG001|Overall Study|Lack of Efficacy|0|||
48711804|NCT01485172|156794922|FG002|Overall Study|Lack of Efficacy|0|||
48711805|NCT01485172|156794923|FG003|Overall Study|Lack of Efficacy|0|||
48711806|NCT01485172|156794924|FG004|Overall Study|Lack of Efficacy|0|||
48711807|NCT01485172|156794925|FG005|Overall Study|Lack of Efficacy|0|||
48711808|NCT01485172|156794920|FG000|Overall Study|Protocol Violation|0|||
48711809|NCT01485172|156794921|FG001|Overall Study|Protocol Violation|0|||
48711810|NCT01485172|156794922|FG002|Overall Study|Protocol Violation|4|||
48711811|NCT01485172|156794923|FG003|Overall Study|Protocol Violation|5|||
48711812|NCT01485172|156794924|FG004|Overall Study|Protocol Violation|1|||
48711813|NCT01485172|156794925|FG005|Overall Study|Protocol Violation|0|||
48711814|NCT01485172|156794920|FG000|Overall Study|Protocol defined stopping criteria|1|||
48711815|NCT01485172|156794921|FG001|Overall Study|Protocol defined stopping criteria|0|||
48711816|NCT01485172|156794922|FG002|Overall Study|Protocol defined stopping criteria|0|||
48711817|NCT01485172|156794923|FG003|Overall Study|Protocol defined stopping criteria|0|||
48711818|NCT01485172|156794924|FG004|Overall Study|Protocol defined stopping criteria|1|||
48711819|NCT01485172|156794925|FG005|Overall Study|Protocol defined stopping criteria|0|||
48711820|NCT01485172|156794920|FG000|Overall Study|Lost to Follow-up|0|||
48711821|NCT01485172|156794921|FG001|Overall Study|Lost to Follow-up|0|||
48711822|NCT01485172|156794922|FG002|Overall Study|Lost to Follow-up|1|||
48711823|NCT01485172|156794923|FG003|Overall Study|Lost to Follow-up|0|||
48711824|NCT01485172|156794924|FG004|Overall Study|Lost to Follow-up|0|||
48711825|NCT01485172|156794925|FG005|Overall Study|Lost to Follow-up|1|||
48711826|NCT01485172|156794920|FG000|Overall Study|Physician Decision|0|||
48711827|NCT01485172|156794921|FG001|Overall Study|Physician Decision|0|||
48492173|NCT01227668|155994313|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
48492174|NCT01227668|155994314|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
48492175|NCT01227668|155994313|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
48492176|NCT01227668|155994314|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
48492177|NCT01227668|155994313|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
48492178|NCT01227668|155994314|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
48492179|NCT01227668|155994313|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
48492180|NCT01227668|155994314|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
48492181|NCT00947856|155994316|FG000|Treatment Period|Progressive Disease|33|||
48711828|NCT01485172|156794922|FG002|Overall Study|Physician Decision|0|||
48711829|NCT01485172|156794923|FG003|Overall Study|Physician Decision|0|||
48711830|NCT01485172|156794924|FG004|Overall Study|Physician Decision|1|||
48711831|NCT01485172|156794925|FG005|Overall Study|Physician Decision|0|||
48711832|NCT01485172|156794920|FG000|Overall Study|Withdrawal by Subject|2|||
48711833|NCT01485172|156794921|FG001|Overall Study|Withdrawal by Subject|0|||
48711834|NCT01485172|156794922|FG002|Overall Study|Withdrawal by Subject|0|||
48711835|NCT01485172|156794923|FG003|Overall Study|Withdrawal by Subject|1|||
48711836|NCT01485172|156794924|FG004|Overall Study|Withdrawal by Subject|1|||
48711837|NCT01485172|156794925|FG005|Overall Study|Withdrawal by Subject|1|||
48711838|NCT01297491|156794931|FG000|Overall Study|Adverse Event|11|||
48711839|NCT01297491|156794932|FG001|Overall Study|Adverse Event|6|||
48711840|NCT01297491|156794931|FG000|Overall Study|Physician Decision|3|||
48711841|NCT01297491|156794932|FG001|Overall Study|Physician Decision|2|||
48711842|NCT01297491|156794931|FG000|Overall Study|Progressive disease|11|||
48711843|NCT01297491|156794932|FG001|Overall Study|Progressive disease|20|||
48711844|NCT01297491|156794931|FG000|Overall Study|Patient/Guardian decision|3|||
48711845|NCT01297491|156794932|FG001|Overall Study|Patient/Guardian decision|4|||
48711846|NCT01297491|156794931|FG000|Overall Study|Death|2|||
48711847|NCT01297491|156794932|FG001|Overall Study|Death|1|||
48711848|NCT01015638|156794933|FG000|Overall Study|Withdrawal by Subject|1|||
48711849|NCT01015638|156794934|FG001|Overall Study|Withdrawal by Subject|0|||
48711850|NCT01932437|156794935|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711851|NCT01932437|156794936|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711852|NCT01932437|156794937|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711853|NCT01932437|156794938|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711854|NCT01932437|156794939|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
48711855|NCT01932437|156794940|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
48711856|NCT01640314|156794941|FG000|Overall Study|Protocol Violation|0|||
48711857|NCT01640314|156794942|FG001|Overall Study|Protocol Violation|1|||
48711858|NCT00329797|156794944|FG000|Overall Study|Protocol Violation|1|||
48711859|NCT00329797|156794945|FG001|Overall Study|Protocol Violation|0|||
48711860|NCT00329797|156794944|FG000|Overall Study|Withdrawal by Subject|6|||
48711861|NCT00329797|156794945|FG001|Overall Study|Withdrawal by Subject|6|||
48711862|NCT03091348|156794946|FG000|Overall Study|Lost to Follow-up|2|||
48711863|NCT03091348|156794947|FG001|Overall Study|Lost to Follow-up|1|||
48711864|NCT01032889|156794953|FG000|Overall Study|Adverse Event|2|||
48711865|NCT01032889|156794954|FG001|Overall Study|Adverse Event|2|||
48711866|NCT01032889|156794955|FG002|Overall Study|Adverse Event|0|||
48711867|NCT01032889|156794953|FG000|Overall Study|Withdrawal of Consent|1|||
48711868|NCT01032889|156794954|FG001|Overall Study|Withdrawal of Consent|2|||
48711869|NCT01032889|156794955|FG002|Overall Study|Withdrawal of Consent|1|||
48711870|NCT01032889|156794953|FG000|Overall Study|Patient Request|0|||
48711871|NCT01032889|156794954|FG001|Overall Study|Patient Request|1|||
48711872|NCT01032889|156794955|FG002|Overall Study|Patient Request|0|||
48711873|NCT01032889|156794953|FG000|Overall Study|Lost to Follow-up|1|||
48711874|NCT01032889|156794954|FG001|Overall Study|Lost to Follow-up|1|||
48711875|NCT01032889|156794955|FG002|Overall Study|Lost to Follow-up|0|||
48711876|NCT01032889|156794953|FG000|Overall Study|Lack of Submental Fat|2|||
48711877|NCT01032889|156794954|FG001|Overall Study|Lack of Submental Fat|8|||
48711878|NCT01032889|156794955|FG002|Overall Study|Lack of Submental Fat|1|||
48711879|NCT01032889|156794953|FG000|Overall Study|Miscellaneous Reasons|2|||
48711880|NCT01032889|156794954|FG001|Overall Study|Miscellaneous Reasons|1|||
48711881|NCT01032889|156794955|FG002|Overall Study|Miscellaneous Reasons|1|||
48711882|NCT04530136|156794956|FG000|Overall Study|Lost to Follow-up|2|||
48711883|NCT04530136|156794957|FG001|Overall Study|Lost to Follow-up|3|||
48711884|NCT04530136|156794956|FG000|Overall Study|Withdrawal by Subject|1|||
48711885|NCT04530136|156794957|FG001|Overall Study|Withdrawal by Subject|0|||
48711886|NCT04530136|156794956|FG000|Overall Study|Death|0|||
48711887|NCT04530136|156794957|FG001|Overall Study|Death|1|||
48711888|NCT02228980|156794960|FG000|Overall Study|Adverse Event|14|||
48711889|NCT02228980|156794961|FG001|Overall Study|Adverse Event|0|||
48711890|NCT02228980|156794962|FG002|Overall Study|Adverse Event|0|||
48711891|NCT02228980|156794963|FG003|Overall Study|Adverse Event|0|||
48711892|NCT02228980|156794960|FG000|Overall Study|Protocol Violation|7|||
48711893|NCT02228980|156794961|FG001|Overall Study|Protocol Violation|0|||
48711894|NCT02228980|156794962|FG002|Overall Study|Protocol Violation|0|||
48711895|NCT02228980|156794963|FG003|Overall Study|Protocol Violation|0|||
48711896|NCT02228980|156794960|FG000|Overall Study|Withdrawal by Subject|3|||
48711897|NCT02228980|156794961|FG001|Overall Study|Withdrawal by Subject|3|||
48711898|NCT02228980|156794962|FG002|Overall Study|Withdrawal by Subject|2|||
48711899|NCT02228980|156794963|FG003|Overall Study|Withdrawal by Subject|3|||
48711900|NCT04270370|156794964|FG000|Overall Study|Lost to Follow-up|1|||
48711901|NCT04270370|156794965|FG001|Overall Study|Lost to Follow-up|0|||
48711902|NCT04270370|156794966|FG002|Overall Study|Lost to Follow-up|0|||
48711903|NCT04270370|156794967|FG003|Overall Study|Lost to Follow-up|0|||
48810257|NCT00720902|157146306|FG000|Overall Study|Withdrawal by Subject|1|||
48711904|NCT04270370|156794968|FG004|Overall Study|Lost to Follow-up|0|||
48711905|NCT04270370|156794969|FG005|Overall Study|Lost to Follow-up|0|||
48711906|NCT04270370|156794970|FG006|Overall Study|Lost to Follow-up|0|||
48711907|NCT04270370|156794971|FG007|Overall Study|Lost to Follow-up|0|||
48810258|NCT00720902|157146307|FG001|Overall Study|Withdrawal by Subject|0|||
48711908|NCT04270370|156794972|FG008|Overall Study|Lost to Follow-up|1|||
48711909|NCT04270370|156794973|FG009|Overall Study|Lost to Follow-up|0|||
48711910|NCT04270370|156794974|FG010|Overall Study|Lost to Follow-up|0|||
48711911|NCT04270370|156794975|FG011|Overall Study|Lost to Follow-up|0|||
48711912|NCT02744040|156794976|FG000|Overall Study|Withdrawal by Subject|3|||
48711913|NCT02744040|156794977|FG001|Overall Study|Withdrawal by Subject|2|||
48711914|NCT02744040|156794978|FG002|Overall Study|Withdrawal by Subject|2|||
48711915|NCT02744040|156794976|FG000|Overall Study|Physician Decision|0|||
48711916|NCT02744040|156794977|FG001|Overall Study|Physician Decision|8|||
48711917|NCT02744040|156794978|FG002|Overall Study|Physician Decision|13|||
48810259|NCT00720902|157146306|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
48810260|NCT00720902|157146307|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
48810261|NCT01062763|157146308|FG000|Overall Study|Adverse Event|3|||
48810262|NCT01062763|157146309|FG001|Overall Study|Adverse Event|4|||
48810263|NCT02392611|157146311|FG000|Overall Study|Adverse Event|0|||
48810264|NCT02392611|157146312|FG001|Overall Study|Adverse Event|0|||
48810265|NCT02392611|157146313|FG002|Overall Study|Adverse Event|0|||
48810266|NCT02392611|157146314|FG003|Overall Study|Adverse Event|1|||
48810267|NCT02392611|157146315|FG004|Overall Study|Adverse Event|0|||
48810268|NCT02392611|157146316|FG005|Overall Study|Adverse Event|0|||
48810269|NCT02392611|157146317|FG006|Overall Study|Adverse Event|0|||
48810270|NCT02392611|157146318|FG007|Overall Study|Adverse Event|0|||
48810271|NCT02392611|157146319|FG008|Overall Study|Adverse Event|0|||
48810272|NCT02392611|157146311|FG000|Overall Study|Progressive disease|0|||
48810273|NCT02392611|157146312|FG001|Overall Study|Progressive disease|0|||
48810274|NCT02392611|157146313|FG002|Overall Study|Progressive disease|0|||
48810275|NCT02392611|157146314|FG003|Overall Study|Progressive disease|2|||
48810276|NCT02392611|157146315|FG004|Overall Study|Progressive disease|1|||
48810277|NCT02392611|157146316|FG005|Overall Study|Progressive disease|0|||
48810278|NCT02392611|157146317|FG006|Overall Study|Progressive disease|0|||
48810279|NCT02392611|157146318|FG007|Overall Study|Progressive disease|0|||
48810280|NCT02392611|157146319|FG008|Overall Study|Progressive disease|0|||
48810281|NCT02392611|157146311|FG000|Overall Study|Death|1|||
48810282|NCT02392611|157146312|FG001|Overall Study|Death|0|||
48810283|NCT02392611|157146313|FG002|Overall Study|Death|0|||
48810284|NCT02392611|157146314|FG003|Overall Study|Death|0|||
48810285|NCT02392611|157146315|FG004|Overall Study|Death|0|||
48810286|NCT02392611|157146316|FG005|Overall Study|Death|1|||
48810287|NCT02392611|157146317|FG006|Overall Study|Death|0|||
48810288|NCT02392611|157146318|FG007|Overall Study|Death|0|||
48810289|NCT02392611|157146319|FG008|Overall Study|Death|0|||
48810290|NCT02392611|157146311|FG000|Overall Study|Withdrawal by Subject|0|||
48810291|NCT02392611|157146312|FG001|Overall Study|Withdrawal by Subject|0|||
48810292|NCT02392611|157146313|FG002|Overall Study|Withdrawal by Subject|0|||
48810293|NCT02392611|157146314|FG003|Overall Study|Withdrawal by Subject|1|||
48810294|NCT02392611|157146315|FG004|Overall Study|Withdrawal by Subject|0|||
48810295|NCT02392611|157146316|FG005|Overall Study|Withdrawal by Subject|0|||
48810296|NCT02392611|157146317|FG006|Overall Study|Withdrawal by Subject|0|||
48810297|NCT02392611|157146318|FG007|Overall Study|Withdrawal by Subject|0|||
48810298|NCT02392611|157146319|FG008|Overall Study|Withdrawal by Subject|0|||
48810299|NCT02392611|157146311|FG000|Overall Study|Lost to Follow-up|0|||
48810300|NCT02392611|157146312|FG001|Overall Study|Lost to Follow-up|0|||
48810301|NCT02392611|157146313|FG002|Overall Study|Lost to Follow-up|0|||
48810302|NCT02392611|157146314|FG003|Overall Study|Lost to Follow-up|0|||
48810303|NCT02392611|157146315|FG004|Overall Study|Lost to Follow-up|0|||
48810304|NCT02392611|157146316|FG005|Overall Study|Lost to Follow-up|0|||
48810305|NCT02392611|157146317|FG006|Overall Study|Lost to Follow-up|1|||
48810306|NCT02392611|157146318|FG007|Overall Study|Lost to Follow-up|0|||
48810307|NCT02392611|157146319|FG008|Overall Study|Lost to Follow-up|0|||
48810308|NCT02392611|157146311|FG000|Overall Study|Enrolled, not treated|0|||
48810309|NCT02392611|157146312|FG001|Overall Study|Enrolled, not treated|0|||
48810310|NCT02392611|157146313|FG002|Overall Study|Enrolled, not treated|0|||
48810311|NCT02392611|157146314|FG003|Overall Study|Enrolled, not treated|2|||
48810312|NCT02392611|157146315|FG004|Overall Study|Enrolled, not treated|0|||
48810313|NCT02392611|157146316|FG005|Overall Study|Enrolled, not treated|0|||
48810314|NCT02392611|157146317|FG006|Overall Study|Enrolled, not treated|0|||
48810315|NCT02392611|157146318|FG007|Overall Study|Enrolled, not treated|0|||
48810316|NCT02392611|157146319|FG008|Overall Study|Enrolled, not treated|0|||
48810317|NCT02714868|157146324|FG000|Overall Study|Withdrawal by Subject|3|||
48810318|NCT02714868|157146325|FG001|Overall Study|Withdrawal by Subject|0|||
48810319|NCT02714868|157146324|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
48810320|NCT02714868|157146325|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
48810321|NCT02714868|157146324|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
48810322|NCT02714868|157146325|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
48810323|NCT00369681|157146326|FG000|Overall Study|Death|1|||
48810324|NCT02914184|157146329|FG000|Overall Study|Lost to Follow-up|7|||
48810325|NCT02914184|157146330|FG001|Overall Study|Lost to Follow-up|10|||
48810326|NCT02914184|157146331|FG002|Overall Study|Lost to Follow-up|8|||
48810327|NCT02914184|157146332|FG003|Overall Study|Lost to Follow-up|7|||
48810328|NCT02914184|157146329|FG000|Overall Study|Withdrawal by Subject|4|||
48810329|NCT02914184|157146330|FG001|Overall Study|Withdrawal by Subject|2|||
48810330|NCT02914184|157146331|FG002|Overall Study|Withdrawal by Subject|7|||
48810331|NCT02914184|157146332|FG003|Overall Study|Withdrawal by Subject|3|||
48810332|NCT02914184|157146329|FG000|Overall Study|Other|1|||
48810333|NCT02914184|157146330|FG001|Overall Study|Other|0|||
48810334|NCT02914184|157146331|FG002|Overall Study|Other|0|||
48810335|NCT02914184|157146332|FG003|Overall Study|Other|0|||
48810336|NCT02914184|157146329|FG000|Overall Study|Migrated/moved from the study area|2|||
48711918|NCT02744040|156794976|FG000|Overall Study|Lost to Follow-up|3|||
48711919|NCT02744040|156794977|FG001|Overall Study|Lost to Follow-up|1|||
48711920|NCT02744040|156794978|FG002|Overall Study|Lost to Follow-up|7|||
48711921|NCT00781885|156794987|FG000|Overall Study|Physician Decision|1|||
48711922|NCT03698591|156794988|FG000|Overall Study|Withdrawal by Subject|2|||
48711923|NCT03698591|156794989|FG001|Overall Study|Withdrawal by Subject|2|||
48711924|NCT03698591|156794988|FG000|Overall Study|Failed drug screen|1|||
48711925|NCT03698591|156794989|FG001|Overall Study|Failed drug screen|1|||
48711926|NCT03698591|156794988|FG000|Overall Study|Failed health screen|0|||
48711927|NCT03698591|156794989|FG001|Overall Study|Failed health screen|1|||
48711928|NCT03698591|156794988|FG000|Overall Study|Ineligible for financial compensation|1|||
48711929|NCT03698591|156794989|FG001|Overall Study|Ineligible for financial compensation|0|||
48711930|NCT03698591|156794988|FG000|Overall Study|Equipment Error|1|||
48711931|NCT03698591|156794989|FG001|Overall Study|Equipment Error|0|||
48711932|NCT03698591|156794988|FG000|Overall Study|Could not establish TMS dosage|0|||
48711933|NCT03698591|156794989|FG001|Overall Study|Could not establish TMS dosage|1|||
48711934|NCT00661427|156794993|FG000|Overall Study|Adverse Event|5|||
48711935|NCT00661427|156794994|FG001|Overall Study|Adverse Event|5|||
48711936|NCT00661427|156794993|FG000|Overall Study|Patient not treated|0|||
48711937|NCT00661427|156794994|FG001|Overall Study|Patient not treated|2|||
48711938|NCT01011309|156794995|FG000|Overall Study|Adverse Event|2|||
48711939|NCT01011309|156794996|FG001|Overall Study|Adverse Event|1|||
48711940|NCT01011309|156794997|FG002|Overall Study|Adverse Event|2|||
48492182|NCT00947856|155994317|FG001|Treatment Period|Progressive Disease|12|||
48492183|NCT00947856|155994316|FG000|Treatment Period|Adverse Event|15|||
48492184|NCT00947856|155994317|FG001|Treatment Period|Adverse Event|9|||
48492185|NCT00947856|155994316|FG000|Treatment Period|Physician Decision|14|||
48492186|NCT00947856|155994317|FG001|Treatment Period|Physician Decision|6|||
48492187|NCT00947856|155994316|FG000|Treatment Period|Study Stopped by Sponsor|4|||
48492188|NCT00947856|155994317|FG001|Treatment Period|Study Stopped by Sponsor|4|||
48492189|NCT00947856|155994316|FG000|Treatment Period|Withdrawal by Subject|12|||
48492190|NCT00947856|155994317|FG001|Treatment Period|Withdrawal by Subject|1|||
48492191|NCT00947856|155994316|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
48492192|NCT00947856|155994317|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
48492193|NCT00947856|155994316|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
48492194|NCT00947856|155994317|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
48492195|NCT00947856|155994316|FG000|Follow-up Period|Lost to Follow-up|7|||
48492196|NCT00947856|155994317|FG001|Follow-up Period|Lost to Follow-up|0|||
48492197|NCT00947856|155994316|FG000|Follow-up Period|Patient unavailable for site visits|1|||
48492198|NCT00947856|155994317|FG001|Follow-up Period|Patient unavailable for site visits|0|||
48492199|NCT00947856|155994316|FG000|Follow-up Period|Withdrawal by Subject|1|||
48492200|NCT00947856|155994317|FG001|Follow-up Period|Withdrawal by Subject|0|||
48492201|NCT01855126|155994324|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
48492202|NCT01855126|155994325|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
48492203|NCT01855126|155994324|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
48492204|NCT01855126|155994325|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
48492205|NCT00526890|155994326|FG000|Overall Study|Adverse Event|2|||
48492206|NCT04049552|155994327|FG000|Overall Study|Lost to Follow-up|1|||
48492207|NCT03271528|155994328|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
48492208|NCT03271528|155994329|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
48711941|NCT01011309|156794995|FG000|Overall Study|Lack of Efficacy|0|||
48711942|NCT01011309|156794996|FG001|Overall Study|Lack of Efficacy|1|||
48711943|NCT01011309|156794997|FG002|Overall Study|Lack of Efficacy|0|||
48711944|NCT01011309|156794995|FG000|Overall Study|Protocol Violation|0|||
48711945|NCT01011309|156794996|FG001|Overall Study|Protocol Violation|1|||
48711946|NCT01011309|156794997|FG002|Overall Study|Protocol Violation|3|||
48711947|NCT00530504|156794998|FG000|Overall Study|Death|54|||
48711948|NCT00530504|156794998|FG000|Overall Study|Lost to Follow-up|26|||
48711949|NCT00530504|156794998|FG000|Overall Study|Withdrawal by Subject|39|||
48711950|NCT00530504|156794998|FG000|Overall Study|Exited study due to other reasons|33|||
48492209|NCT03271528|155994328|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
48492210|NCT03271528|155994329|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
48492211|NCT03271528|155994328|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
48492212|NCT03271528|155994329|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
48492213|NCT03271528|155994328|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
48492214|NCT03271528|155994329|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
48492215|NCT03271528|155994328|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
48711951|NCT00006289|156794999|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
48711952|NCT00006289|156795000|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
48492216|NCT03271528|155994329|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
48711953|NCT00006289|156794999|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
48711954|NCT00006289|156795000|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
48492217|NCT03271528|155994328|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
48492218|NCT03271528|155994329|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
48492219|NCT03271528|155994328|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
48492220|NCT03271528|155994329|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
48492221|NCT00979628|155994336|FG000|Overall Study|received regimen < 24 hours|7|||
48492222|NCT00979628|155994337|FG001|Overall Study|received regimen < 24 hours|6|||
48492223|NCT00979628|155994338|FG002|Overall Study|received regimen < 24 hours|5|||
48492224|NCT00979628|155994336|FG000|Overall Study|received steroids|1|||
48492225|NCT00979628|155994337|FG001|Overall Study|received steroids|1|||
48492226|NCT00979628|155994338|FG002|Overall Study|received steroids|0|||
48492227|NCT00979628|155994336|FG000|Overall Study|transferred to ICU|1|||
48492228|NCT00979628|155994337|FG001|Overall Study|transferred to ICU|2|||
48492229|NCT00979628|155994338|FG002|Overall Study|transferred to ICU|1|||
48492230|NCT03896490|155994339|FG000|Overall Study|Withdrawal by Subject|1|||
48492231|NCT03896490|155994340|FG001|Overall Study|Withdrawal by Subject|1|||
48492232|NCT00928252|155995670|FG000|Overall Study|Physician Decision|3|||
48711955|NCT01675167|156795007|FG000|Open-label Titration Phase|Adverse Event|81|||
48711956|NCT01675167|156795008|FG001|Open-label Titration Phase|Adverse Event|0|||
48711957|NCT01675167|156795009|FG002|Open-label Titration Phase|Adverse Event|0|||
48711958|NCT01675167|156795007|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
48711959|NCT01675167|156795008|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
48711960|NCT01675167|156795009|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
48711961|NCT01675167|156795007|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
48492233|NCT02468557|155995671|FG000|Overall Study|Adverse Event|1|||
48492234|NCT02468557|155995671|FG000|Overall Study|Death|1|||
48492235|NCT02468557|155995671|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
48492236|NCT02468557|155995671|FG000|Overall Study|All Enrolled but Never Dosed|4|||
48492237|NCT00447603|155995675|FG000|Screening|Withdrawal by Subject|1|||
48492238|NCT00447603|155995676|FG001|Screening|Withdrawal by Subject|0|||
48492239|NCT00447603|155995677|FG002|Screening|Withdrawal by Subject|0|||
48492240|NCT00447603|155995675|FG000|Screening|Protocol Violation|1|||
48492241|NCT00447603|155995676|FG001|Screening|Protocol Violation|0|||
48492242|NCT00447603|155995677|FG002|Screening|Protocol Violation|0|||
48492243|NCT00447603|155995675|FG000|Screening|Screen Failure|4|||
48492244|NCT00447603|155995676|FG001|Screening|Screen Failure|0|||
48492245|NCT00447603|155995677|FG002|Screening|Screen Failure|0|||
48492246|NCT00447603|155995675|FG000|Screening|Study Terminated by Sponsor|15|||
48492247|NCT00447603|155995676|FG001|Screening|Study Terminated by Sponsor|0|||
48492248|NCT00447603|155995677|FG002|Screening|Study Terminated by Sponsor|0|||
48492249|NCT00447603|155995675|FG000|Filter Period|Adverse Event|0|||
48492250|NCT00447603|155995676|FG001|Filter Period|Adverse Event|0|||
48492251|NCT00447603|155995677|FG002|Filter Period|Adverse Event|1|||
48492252|NCT00447603|155995675|FG000|Filter Period|Screen Failure|0|||
48492253|NCT00447603|155995676|FG001|Filter Period|Screen Failure|3|||
48492254|NCT00447603|155995677|FG002|Filter Period|Screen Failure|4|||
48492255|NCT00447603|155995675|FG000|Filter Period|Study terminated by Sponsor|0|||
48492256|NCT00447603|155995676|FG001|Filter Period|Study terminated by Sponsor|1|||
48492257|NCT00447603|155995677|FG002|Filter Period|Study terminated by Sponsor|10|||
48492258|NCT02410252|155995678|FG000|Overall Study|Withdrawal by Subject|4|||
48492259|NCT02410252|155995678|FG000|Overall Study|Physician Decision|2|||
48492260|NCT04132232|155995679|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
48492261|NCT04132232|155995680|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
48492262|NCT04132232|155995679|FG000|Overall Study|Lost to Follow-up|6|||
48492263|NCT04132232|155995680|FG001|Overall Study|Lost to Follow-up|7|||
48492264|NCT01313728|155995681|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
48492265|NCT02041494|155995698|FG000|Overall Study|Death|1|||
48492266|NCT02041494|155995699|FG001|Overall Study|Death|3|||
48492267|NCT02041494|155995698|FG000|Overall Study|Lost to Follow-up|2|||
48492268|NCT02041494|155995699|FG001|Overall Study|Lost to Follow-up|6|||
48492269|NCT02041494|155995698|FG000|Overall Study|study terminated|16|||
48492270|NCT02041494|155995699|FG001|Overall Study|study terminated|11|||
48492271|NCT03433001|155995700|FG000|Overall Study|Lack of Efficacy|109|||
48492272|NCT03433001|155995700|FG000|Overall Study|Adverse Event|69|||
48492273|NCT03433001|155995700|FG000|Overall Study|Withdrawal by Subject|10|||
48492274|NCT03433001|155995700|FG000|Overall Study|Death|12|||
48492275|NCT03433001|155995700|FG000|Overall Study|Lost to Follow-up|4|||
48492276|NCT03433001|155995700|FG000|Overall Study|Other|25|||
48492277|NCT00993616|155995701|FG000|Overall Study|No tumor at entry|1|||
48492278|NCT00993616|155995701|FG000|Overall Study|Never treated|1|||
48492279|NCT03507439|155995702|FG000|Overall Study|Other|2|||
48711962|NCT01675167|156795008|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
48492280|NCT03507439|155995703|FG001|Overall Study|Other|1|||
48492281|NCT03507439|155995702|FG000|Overall Study|Withdrawal by Subject|1|||
48492282|NCT03507439|155995703|FG001|Overall Study|Withdrawal by Subject|0|||
48711963|NCT01675167|156795009|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
48492283|NCT03507439|155995702|FG000|Overall Study|Death|1|||
48711964|NCT01675167|156795007|FG000|Open-label Titration Phase|Protocol Violation|43|||
48711965|NCT01675167|156795008|FG001|Open-label Titration Phase|Protocol Violation|0|||
48711966|NCT01675167|156795009|FG002|Open-label Titration Phase|Protocol Violation|0|||
48711967|NCT01675167|156795007|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
48711968|NCT01675167|156795008|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
48711969|NCT01675167|156795009|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
48711970|NCT01675167|156795007|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
48711971|NCT01675167|156795008|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
48711972|NCT01675167|156795009|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
48711973|NCT01675167|156795007|FG000|Open-label Titration Phase|Other|55|||
48711974|NCT01675167|156795008|FG001|Open-label Titration Phase|Other|0|||
48711975|NCT01675167|156795009|FG002|Open-label Titration Phase|Other|0|||
48711976|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
48711977|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
48711978|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
48711979|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48711980|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
48711981|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
48711982|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Adverse Event|0|||
48810337|NCT02914184|157146330|FG001|Overall Study|Migrated/moved from the study area|1|||
48810338|NCT02914184|157146331|FG002|Overall Study|Migrated/moved from the study area|2|||
48810339|NCT02914184|157146332|FG003|Overall Study|Migrated/moved from the study area|1|||
48810340|NCT00409786|157146335|FG000|Overall Study|Withdrawal by Subject|3|||
48810341|NCT03075904|157146338|FG000|Overall Study|Physician Decision|3|||
48810342|NCT03075904|157146338|FG000|Overall Study|Need for Medication not Permitted|1|||
48810343|NCT00519896|157146339|FG000|Overall Study|Protocol Violation|1|||
48810344|NCT00519896|157146339|FG000|Overall Study|Adverse Event|1|||
48810345|NCT03327402|157146340|FG000|Overall Study|Withdrawal by Subject|1|||
48810346|NCT03327402|157146340|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
48810347|NCT02367716|157146348|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
48810348|NCT01473381|157146349|FG000|Overall Study|Adverse Event|8|||
48810349|NCT01473381|157146350|FG001|Overall Study|Adverse Event|20|||
48810350|NCT01473381|157146351|FG002|Overall Study|Adverse Event|25|||
48810351|NCT01473381|157146352|FG003|Overall Study|Adverse Event|17|||
48810352|NCT01473381|157146349|FG000|Overall Study|Insufficient Therapeutic Response|10|||
48810353|NCT01473381|157146350|FG001|Overall Study|Insufficient Therapeutic Response|1|||
48810354|NCT01473381|157146351|FG002|Overall Study|Insufficient Therapeutic Response|2|||
48810355|NCT01473381|157146352|FG003|Overall Study|Insufficient Therapeutic Response|3|||
48810356|NCT01473381|157146349|FG000|Overall Study|Protocol Violation|17|||
48810357|NCT01473381|157146350|FG001|Overall Study|Protocol Violation|23|||
48810358|NCT01473381|157146351|FG002|Overall Study|Protocol Violation|19|||
48810359|NCT01473381|157146352|FG003|Overall Study|Protocol Violation|17|||
48810360|NCT01473381|157146349|FG000|Overall Study|Withdrawal of Consent|20|||
48810361|NCT01473381|157146350|FG001|Overall Study|Withdrawal of Consent|21|||
48810362|NCT01473381|157146351|FG002|Overall Study|Withdrawal of Consent|20|||
48810363|NCT01473381|157146352|FG003|Overall Study|Withdrawal of Consent|26|||
48810364|NCT01473381|157146349|FG000|Overall Study|Lost to Follow-up|25|||
48810365|NCT01473381|157146350|FG001|Overall Study|Lost to Follow-up|28|||
48810366|NCT01473381|157146351|FG002|Overall Study|Lost to Follow-up|35|||
48810367|NCT01473381|157146352|FG003|Overall Study|Lost to Follow-up|23|||
48810368|NCT01473381|157146349|FG000|Overall Study|Other Reasons|0|||
48810369|NCT01473381|157146350|FG001|Overall Study|Other Reasons|0|||
48810370|NCT01473381|157146351|FG002|Overall Study|Other Reasons|1|||
48492284|NCT03507439|155995703|FG001|Overall Study|Death|1|||
48492285|NCT00289458|155995704|FG000|Overall Study|Death|1|||
48492286|NCT00289458|155995705|FG001|Overall Study|Death|0|||
48711983|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Adverse Event|5|||
48711984|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Adverse Event|13|||
48711985|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
48711986|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
48711987|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
48810371|NCT01473381|157146352|FG003|Overall Study|Other Reasons|3|||
48810372|NCT04741802|157146353|FG000|Overall Study|Death|1|||
48810373|NCT04741802|157146353|FG000|Overall Study|Lost to Follow-up|11|||
48810374|NCT01616771|157146354|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
48810375|NCT00988221|157146358|FG000|Part I|Adverse Event|0|||
48810376|NCT00988221|157146359|FG001|Part I|Adverse Event|1|||
48810377|NCT00988221|157146360|FG002|Part I|Adverse Event|2|||
48810378|NCT00988221|157146361|FG003|Part I|Adverse Event|0|||
48810379|NCT00988221|157146358|FG000|Part I|Insufficient Therapeutic Response|4|||
48810380|NCT00988221|157146359|FG001|Part I|Insufficient Therapeutic Response|6|||
48810381|NCT00988221|157146360|FG002|Part I|Insufficient Therapeutic Response|5|||
48810382|NCT00988221|157146361|FG003|Part I|Insufficient Therapeutic Response|0|||
48810383|NCT00988221|157146358|FG000|Part I|Refused Treatment|0|||
48810384|NCT00988221|157146359|FG001|Part I|Refused Treatment|2|||
48810385|NCT00988221|157146360|FG002|Part I|Refused Treatment|1|||
48810386|NCT00988221|157146361|FG003|Part I|Refused Treatment|0|||
48810387|NCT00988221|157146358|FG000|Part I|Lost to Follow-up|0|||
48810388|NCT00988221|157146359|FG001|Part I|Lost to Follow-up|1|||
48810389|NCT00988221|157146360|FG002|Part I|Lost to Follow-up|0|||
48810390|NCT00988221|157146361|FG003|Part I|Lost to Follow-up|0|||
48810391|NCT00988221|157146358|FG000|Part II|Adverse Event|1|||
48492287|NCT00289458|155995706|FG002|Overall Study|Death|0|||
48492288|NCT00289458|155995704|FG000|Overall Study|Physician Decision|3|||
48492289|NCT00289458|155995705|FG001|Overall Study|Physician Decision|4|||
48492290|NCT00289458|155995706|FG002|Overall Study|Physician Decision|2|||
48810392|NCT00988221|157146359|FG001|Part II|Adverse Event|0|||
48810393|NCT00988221|157146360|FG002|Part II|Adverse Event|0|||
48492291|NCT00289458|155995704|FG000|Overall Study|Withdrawal by Subject|2|||
48810394|NCT00988221|157146361|FG003|Part II|Adverse Event|1|||
48810395|NCT00988221|157146358|FG000|Part II|Withdrawal by Subject|0|||
48810396|NCT00988221|157146359|FG001|Part II|Withdrawal by Subject|0|||
48492292|NCT00289458|155995705|FG001|Overall Study|Withdrawal by Subject|2|||
48492293|NCT00289458|155995706|FG002|Overall Study|Withdrawal by Subject|4|||
48492294|NCT01007916|155995707|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
48492295|NCT01007916|155995708|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
48492296|NCT01007916|155995707|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
48492297|NCT01007916|155995708|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
48492298|NCT04228302|155995709|FG000|Overall Study|Adverse Event|0|||
48492299|NCT04228302|155995710|FG001|Overall Study|Adverse Event|0|||
48810397|NCT00988221|157146360|FG002|Part II|Withdrawal by Subject|2|||
48810398|NCT00988221|157146361|FG003|Part II|Withdrawal by Subject|2|||
48810399|NCT00988221|157146358|FG000|Part II|Reason not Specified|0|||
48810400|NCT00988221|157146359|FG001|Part II|Reason not Specified|0|||
48810401|NCT00988221|157146360|FG002|Part II|Reason not Specified|1|||
48810402|NCT00988221|157146361|FG003|Part II|Reason not Specified|0|||
48810403|NCT00988221|157146358|FG000|Part III|Adverse Event|1|||
48810404|NCT00988221|157146359|FG001|Part III|Adverse Event|0|||
48810405|NCT00988221|157146360|FG002|Part III|Adverse Event|1|||
48810406|NCT00988221|157146361|FG003|Part III|Adverse Event|0|||
48810407|NCT00988221|157146358|FG000|Part III|Insufficient Therapeutic Response|0|||
48492300|NCT04228302|155995711|FG002|Overall Study|Adverse Event|0|||
48492301|NCT04228302|155995712|FG003|Overall Study|Adverse Event|0|||
48492302|NCT04228302|155995713|FG004|Overall Study|Adverse Event|1|||
48492303|NCT04228302|155995714|FG005|Overall Study|Adverse Event|0|||
48810408|NCT00988221|157146359|FG001|Part III|Insufficient Therapeutic Response|1|||
48810409|NCT00988221|157146360|FG002|Part III|Insufficient Therapeutic Response|1|||
48810410|NCT00988221|157146361|FG003|Part III|Insufficient Therapeutic Response|0|||
48810411|NCT00988221|157146358|FG000|Part III|Refused Treatment|0|||
48810412|NCT00988221|157146359|FG001|Part III|Refused Treatment|0|||
48810413|NCT00988221|157146360|FG002|Part III|Refused Treatment|1|||
48810414|NCT00988221|157146361|FG003|Part III|Refused Treatment|0|||
48810415|NCT02086552|157146364|FG000|Overall Study|Withdrawal by Subject|1|||
48810416|NCT02091739|157146367|FG000|MP: 16 Weeks|Adverse Event|1|||
48810417|NCT02091739|157146368|FG001|MP: 16 Weeks|Adverse Event|1|||
48810418|NCT02091739|157146369|FG002|MP: 16 Weeks|Adverse Event|1|||
48810419|NCT02091739|157146370|FG003|MP: 16 Weeks|Adverse Event|0|||
48810420|NCT02091739|157146371|FG004|MP: 16 Weeks|Adverse Event|0|||
48810421|NCT02091739|157146367|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
48810422|NCT02091739|157146368|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
48810423|NCT02091739|157146369|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
48810424|NCT02091739|157146370|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
48810425|NCT02091739|157146371|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
48810426|NCT02091739|157146367|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
48810427|NCT02091739|157146368|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
48810428|NCT02091739|157146369|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
48810429|NCT02091739|157146370|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
48810430|NCT02091739|157146371|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
48810431|NCT02091739|157146367|FG000|EP: 48 Weeks|Other|0|||
48810432|NCT02091739|157146368|FG001|EP: 48 Weeks|Other|0|||
48810433|NCT02091739|157146369|FG002|EP: 48 Weeks|Other|0|||
48810434|NCT02091739|157146370|FG003|EP: 48 Weeks|Other|1|||
48810435|NCT02091739|157146371|FG004|EP: 48 Weeks|Other|0|||
48810436|NCT02091739|157146367|FG000|EP: 48 Weeks|Death|0|||
48810437|NCT02091739|157146368|FG001|EP: 48 Weeks|Death|0|||
48810438|NCT02091739|157146369|FG002|EP: 48 Weeks|Death|0|||
48810439|NCT02091739|157146370|FG003|EP: 48 Weeks|Death|3|||
48810440|NCT02091739|157146371|FG004|EP: 48 Weeks|Death|2|||
48810441|NCT02091739|157146367|FG000|EP: 48 Weeks|Adverse Event|0|||
48810442|NCT02091739|157146368|FG001|EP: 48 Weeks|Adverse Event|0|||
48492304|NCT01162499|155995726|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
48492305|NCT01162499|155995727|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
48492306|NCT01590433|155995728|FG000|Overall Study|Lost to Follow-up|20|||
48492307|NCT01590433|155995729|FG001|Overall Study|Lost to Follow-up|8|||
48492308|NCT01590433|155995728|FG000|Overall Study|Withdrawal by Subject|21|||
48492309|NCT01590433|155995729|FG001|Overall Study|Withdrawal by Subject|11|||
48492310|NCT01590433|155995728|FG000|Overall Study|Adverse Event|11|||
48492311|NCT01590433|155995729|FG001|Overall Study|Adverse Event|3|||
48492312|NCT01907737|155995734|FG000|Overall Study|Withdrawal by Subject|1|||
48492313|NCT00814658|155995737|FG000|Overall Study|Lost to Follow-up|0|||
48492314|NCT00814658|155995738|FG001|Overall Study|Lost to Follow-up|1|||
48492315|NCT00814658|155995737|FG000|Overall Study|Physician Decision|1|||
48492316|NCT00814658|155995738|FG001|Overall Study|Physician Decision|0|||
48492317|NCT00814658|155995737|FG000|Overall Study|Adverse Event|3|||
48492318|NCT00814658|155995738|FG001|Overall Study|Adverse Event|3|||
48492319|NCT01326026|155995745|FG000|Overall Study|Adverse Event|4|||
48492320|NCT01326026|155995746|FG001|Overall Study|Adverse Event|3|||
48492321|NCT01326026|155995745|FG000|Overall Study|Withdrawal Criteria|5|||
48492322|NCT01326026|155995746|FG001|Overall Study|Withdrawal Criteria|7|||
48492323|NCT01326026|155995745|FG000|Overall Study|Other|3|||
48492324|NCT01326026|155995746|FG001|Overall Study|Other|3|||
48492325|NCT02087046|155995750|FG000|Overall Study|Adverse Event|4|||
48492326|NCT02087046|155995750|FG000|Overall Study|Death|1|||
48492327|NCT02087046|155995750|FG000|Overall Study|Lost to Follow-up|3|||
48492328|NCT02087046|155995750|FG000|Overall Study|Withdrawal by Subject|2|||
48492329|NCT02087046|155995750|FG000|Overall Study|Physician Decision|1|||
48492330|NCT01618266|155995751|FG000|Overall Study|Lost to Follow-up|9|||
48492331|NCT01618266|155995751|FG000|Overall Study|Treatment satisfaction|10|||
48492332|NCT01618266|155995751|FG000|Overall Study|Other reasons|11|||
48597619|NCT02213380|156383549|FG000|Per-protocol Analysis|Protocol Violation|32|||
48810443|NCT02091739|157146369|FG002|EP: 48 Weeks|Adverse Event|0|||
48810444|NCT02091739|157146370|FG003|EP: 48 Weeks|Adverse Event|2|||
48810445|NCT02091739|157146371|FG004|EP: 48 Weeks|Adverse Event|6|||
48810446|NCT02091739|157146367|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
48810447|NCT02091739|157146368|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
48810448|NCT02091739|157146369|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
48810449|NCT02091739|157146370|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
48810450|NCT02091739|157146371|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
48810451|NCT00192023|157146373|FG000|Period III - Double-Blind|Adverse Event|3|||
48810452|NCT00192023|157146374|FG001|Period III - Double-Blind|Adverse Event|0|||
48810453|NCT00192023|157146373|FG000|Period III - Double-Blind|Physician Decision|2|||
48810454|NCT00192023|157146374|FG001|Period III - Double-Blind|Physician Decision|0|||
48810455|NCT00192023|157146373|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
48810456|NCT00192023|157146374|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
48810457|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
48492333|NCT01618266|155995751|FG000|Overall Study|Lack of Efficacy|23|||
48492334|NCT01618266|155995751|FG000|Overall Study|Protocol Violation|43|||
48492335|NCT00891293|155995752|FG000|Overall Study|Adverse Event|2|||
48492336|NCT00891293|155995752|FG000|Overall Study|Protocol Violation|2|||
48711988|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48711989|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
48810458|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
48810459|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
48810460|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
48810461|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
48810462|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
48810463|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
48810464|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
48810465|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
48810466|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
48810467|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
48810468|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
48810469|NCT00192023|157146373|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
48810470|NCT00192023|157146374|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
48810471|NCT00251927|157146378|FG000|Overall Study|Adverse Event|3|||
48810472|NCT00251927|157146379|FG001|Overall Study|Adverse Event|15|||
48810473|NCT00251927|157146378|FG000|Overall Study|Lack of Efficacy|22|||
48810474|NCT00251927|157146379|FG001|Overall Study|Lack of Efficacy|16|||
48810475|NCT00251927|157146378|FG000|Overall Study|Lost to Follow-up|22|||
48810476|NCT00251927|157146379|FG001|Overall Study|Lost to Follow-up|8|||
48810477|NCT00251927|157146378|FG000|Overall Study|Protocol Violation|1|||
48810478|NCT00251927|157146379|FG001|Overall Study|Protocol Violation|2|||
48810479|NCT00251927|157146378|FG000|Overall Study|Pregnancy|2|||
48810480|NCT00251927|157146379|FG001|Overall Study|Pregnancy|0|||
48810481|NCT00251927|157146378|FG000|Overall Study|Withdrawal by Subject|40|||
48810482|NCT00251927|157146379|FG001|Overall Study|Withdrawal by Subject|25|||
48810483|NCT00251927|157146378|FG000|Overall Study|Study-specific discont. achieved|13|||
48810484|NCT00251927|157146379|FG001|Overall Study|Study-specific discont. achieved|2|||
48810485|NCT00251927|157146378|FG000|Overall Study|Study procedure non-compliance|5|||
48810486|NCT00251927|157146379|FG001|Overall Study|Study procedure non-compliance|6|||
48810487|NCT00245856|157146384|FG000|Period Two|Withdrawal by Subject|0|||
48810488|NCT00245856|157146385|FG001|Period Two|Withdrawal by Subject|1|||
48810489|NCT02357810|157146386|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
48810490|NCT02357810|157146386|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
48810491|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Adverse Event|5|||
48810492|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
48810493|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
48810494|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
48810495|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Death|1|||
48810496|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Physician Decision|1|||
48810497|NCT02357810|157146386|FG000|Reached 12 Weeks Response|Other|1|||
48810498|NCT02357810|157146386|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
48810499|NCT02357810|157146386|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
48810500|NCT02357810|157146386|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
48492337|NCT00891293|155995752|FG000|Overall Study|Laboratory abnormality|4|||
48492338|NCT00891293|155995752|FG000|Overall Study|Lost to Follow-up|7|||
48492339|NCT00891293|155995752|FG000|Overall Study|Subject withdrew consent|7|||
48492340|NCT00891293|155995752|FG000|Overall Study|Sponsor termination|62|||
48492341|NCT01754259|155995759|FG000|Overall Study|Withdrawal by Subject|2|||
48492342|NCT01754259|155995760|FG001|Overall Study|Withdrawal by Subject|4|||
48492343|NCT01754259|155995759|FG000|Overall Study|Adverse Event|3|||
48711990|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
48711991|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
48711992|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
48711993|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
48711994|NCT01675167|156795007|FG000|Double-blind Treatment Phase|Other|0|||
48810501|NCT02357810|157146386|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
48810502|NCT02357810|157146386|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
48810503|NCT02357810|157146386|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
48810504|NCT00572624|157146387|FG000|Overall Study|Lost to Follow-up|10|||
48810505|NCT00572624|157146388|FG001|Overall Study|Lost to Follow-up|4|||
48492344|NCT01754259|155995760|FG001|Overall Study|Adverse Event|1|||
48492345|NCT01754259|155995759|FG000|Overall Study|Lost to Follow-up|0|||
48810506|NCT00572624|157146387|FG000|Overall Study|Wanted to do a different diet program|1|||
48810507|NCT00572624|157146388|FG001|Overall Study|Wanted to do a different diet program|0|||
48810508|NCT00572624|157146387|FG000|Overall Study|Medication change|1|||
48810509|NCT00572624|157146388|FG001|Overall Study|Medication change|0|||
48810510|NCT00572624|157146387|FG000|Overall Study|Started a new job-- no time for study|1|||
48810511|NCT00572624|157146388|FG001|Overall Study|Started a new job-- no time for study|0|||
48810512|NCT00572624|157146387|FG000|Overall Study|Admitted to being a smoker|1|||
48810513|NCT00572624|157146388|FG001|Overall Study|Admitted to being a smoker|0|||
48810514|NCT00572624|157146387|FG000|Overall Study|Refused to do the stress test|1|||
48810515|NCT00572624|157146388|FG001|Overall Study|Refused to do the stress test|0|||
48810516|NCT00572624|157146387|FG000|Overall Study|Problem with vascular access|1|||
48810517|NCT00572624|157146388|FG001|Overall Study|Problem with vascular access|0|||
48810518|NCT00572624|157146387|FG000|Overall Study|Health issues unrelated to the study|1|||
48810519|NCT00572624|157146388|FG001|Overall Study|Health issues unrelated to the study|0|||
48810520|NCT04844918|157146389|FG000|Overall Study|Adverse Event|7|||
48810521|NCT04844918|157146390|FG001|Overall Study|Adverse Event|8|||
48810522|NCT04844918|157146391|FG002|Overall Study|Adverse Event|5|||
48810523|NCT04844918|157146389|FG000|Overall Study|Physician Decision|0|||
48810524|NCT04844918|157146390|FG001|Overall Study|Physician Decision|1|||
48810525|NCT04844918|157146391|FG002|Overall Study|Physician Decision|0|||
48810526|NCT04844918|157146389|FG000|Overall Study|Withdrawal by Subject|6|||
48810527|NCT04844918|157146390|FG001|Overall Study|Withdrawal by Subject|3|||
48810528|NCT04844918|157146391|FG002|Overall Study|Withdrawal by Subject|3|||
48810529|NCT04844918|157146389|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
48810530|NCT04844918|157146390|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
48810531|NCT04844918|157146391|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
48810532|NCT00779584|157146392|FG000|Overall Study|Protocol Violation|0|||
48810533|NCT00779584|157146393|FG001|Overall Study|Protocol Violation|0|||
48810534|NCT00779584|157146394|FG002|Overall Study|Protocol Violation|0|||
48810535|NCT00779584|157146395|FG003|Overall Study|Protocol Violation|0|||
48810536|NCT00779584|157146396|FG004|Overall Study|Protocol Violation|0|||
48810537|NCT00779584|157146397|FG005|Overall Study|Protocol Violation|1|||
48810538|NCT00779584|157146398|FG006|Overall Study|Protocol Violation|0|||
48810539|NCT00779584|157146399|FG007|Overall Study|Protocol Violation|0|||
48810540|NCT00779584|157146400|FG008|Overall Study|Protocol Violation|0|||
48810541|NCT00779584|157146392|FG000|Overall Study|Withdrawal by Subject|1|||
48810542|NCT00779584|157146393|FG001|Overall Study|Withdrawal by Subject|1|||
48810543|NCT00779584|157146394|FG002|Overall Study|Withdrawal by Subject|2|||
48810544|NCT00779584|157146395|FG003|Overall Study|Withdrawal by Subject|0|||
48810545|NCT00779584|157146396|FG004|Overall Study|Withdrawal by Subject|0|||
48810546|NCT00779584|157146397|FG005|Overall Study|Withdrawal by Subject|2|||
48810547|NCT00779584|157146398|FG006|Overall Study|Withdrawal by Subject|1|||
48810548|NCT00779584|157146399|FG007|Overall Study|Withdrawal by Subject|0|||
48810549|NCT00779584|157146400|FG008|Overall Study|Withdrawal by Subject|0|||
48810550|NCT00779584|157146392|FG000|Overall Study|Lost to Follow-up|0|||
48810551|NCT00779584|157146393|FG001|Overall Study|Lost to Follow-up|0|||
48810552|NCT00779584|157146394|FG002|Overall Study|Lost to Follow-up|0|||
48810553|NCT00779584|157146395|FG003|Overall Study|Lost to Follow-up|0|||
48810554|NCT00779584|157146396|FG004|Overall Study|Lost to Follow-up|1|||
48810555|NCT00779584|157146397|FG005|Overall Study|Lost to Follow-up|0|||
48810556|NCT00779584|157146398|FG006|Overall Study|Lost to Follow-up|0|||
48810557|NCT00779584|157146399|FG007|Overall Study|Lost to Follow-up|0|||
48810558|NCT00779584|157146400|FG008|Overall Study|Lost to Follow-up|0|||
48810559|NCT00779584|157146392|FG000|Overall Study|Progression of Disease|0|||
48810560|NCT00779584|157146393|FG001|Overall Study|Progression of Disease|1|||
48810561|NCT00779584|157146394|FG002|Overall Study|Progression of Disease|2|||
48810562|NCT00779584|157146395|FG003|Overall Study|Progression of Disease|6|||
48492346|NCT01754259|155995760|FG001|Overall Study|Lost to Follow-up|1|||
48492347|NCT00814320|155995763|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
48492348|NCT00814320|155995764|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
48810563|NCT00779584|157146396|FG004|Overall Study|Progression of Disease|5|||
48810564|NCT00779584|157146397|FG005|Overall Study|Progression of Disease|1|||
48492349|NCT00814320|155995763|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
48810565|NCT00779584|157146398|FG006|Overall Study|Progression of Disease|4|||
48810566|NCT00779584|157146399|FG007|Overall Study|Progression of Disease|2|||
48810567|NCT00779584|157146400|FG008|Overall Study|Progression of Disease|1|||
48810568|NCT00779584|157146392|FG000|Overall Study|Adverse Event|1|||
48810569|NCT00779584|157146393|FG001|Overall Study|Adverse Event|0|||
48810570|NCT00779584|157146394|FG002|Overall Study|Adverse Event|2|||
48810571|NCT00779584|157146395|FG003|Overall Study|Adverse Event|0|||
48810572|NCT00779584|157146396|FG004|Overall Study|Adverse Event|0|||
48810573|NCT00779584|157146397|FG005|Overall Study|Adverse Event|0|||
48810574|NCT00779584|157146398|FG006|Overall Study|Adverse Event|2|||
48810575|NCT00779584|157146399|FG007|Overall Study|Adverse Event|1|||
48810576|NCT00779584|157146400|FG008|Overall Study|Adverse Event|1|||
48492350|NCT00814320|155995764|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
48492351|NCT00814320|155995763|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
48492352|NCT00814320|155995764|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
48492353|NCT00814320|155995763|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
48492354|NCT00814320|155995764|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
48492355|NCT00814320|155995763|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
48492356|NCT00814320|155995764|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
48492357|NCT00814320|155995763|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
48492358|NCT00814320|155995764|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
48492359|NCT00814320|155995763|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
48492360|NCT00814320|155995764|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
48492361|NCT00814320|155995763|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
48492362|NCT00814320|155995764|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
48492363|NCT00814320|155995763|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
48711995|NCT01675167|156795008|FG001|Double-blind Treatment Phase|Other|7|||
48711996|NCT01675167|156795009|FG002|Double-blind Treatment Phase|Other|5|||
48711997|NCT01525225|156795011|FG000|Enrollment|No longer met study criteria|1|||
48492364|NCT00814320|155995764|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
48492365|NCT00814320|155995763|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
48492366|NCT00814320|155995764|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
48492367|NCT00673790|155995769|FG000|Overall Study|Adverse Event|23|||
48492368|NCT00673790|155995770|FG001|Overall Study|Adverse Event|14|||
48492369|NCT00673790|155995771|FG002|Overall Study|Adverse Event|2|||
48492370|NCT00673790|155995769|FG000|Overall Study|Lack of Efficacy|2|||
48492371|NCT00673790|155995770|FG001|Overall Study|Lack of Efficacy|2|||
48492372|NCT00673790|155995771|FG002|Overall Study|Lack of Efficacy|2|||
48492373|NCT00673790|155995769|FG000|Overall Study|Protocol Violation|6|||
48492374|NCT00673790|155995770|FG001|Overall Study|Protocol Violation|9|||
48492375|NCT00673790|155995771|FG002|Overall Study|Protocol Violation|1|||
48492376|NCT00673790|155995769|FG000|Overall Study|Withdrawal by Subject|7|||
48711998|NCT01525225|156795011|FG000|Enrollment|Other|1|||
48711999|NCT00881868|156795013|FG000|Overall Study|Adverse Event|0|||
48712000|NCT00881868|156795014|FG001|Overall Study|Adverse Event|1|||
48712001|NCT00881868|156795013|FG000|Overall Study|Lost to Follow-up|2|||
48712002|NCT00881868|156795014|FG001|Overall Study|Lost to Follow-up|1|||
48712003|NCT00881868|156795013|FG000|Overall Study|Physician Decision|4|||
48712004|NCT00881868|156795014|FG001|Overall Study|Physician Decision|0|||
48712005|NCT00881868|156795013|FG000|Overall Study|Protocol Violation|2|||
48712006|NCT00881868|156795014|FG001|Overall Study|Protocol Violation|0|||
48712007|NCT02537015|156795015|FG000|Overall Study|Adverse Event|3|||
48712008|NCT02537015|156795015|FG000|Overall Study|Withdrawal by Subject|2|||
48712009|NCT02537015|156795015|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48712010|NCT01006291|156796987|FG000|Overall Study|Adverse Event|2|||
48712011|NCT01006291|156796988|FG001|Overall Study|Adverse Event|1|||
48712012|NCT01006291|156796989|FG002|Overall Study|Adverse Event|2|||
48712013|NCT01006291|156796987|FG000|Overall Study|Lack of Efficacy|2|||
48712014|NCT01006291|156796988|FG001|Overall Study|Lack of Efficacy|2|||
48712015|NCT01006291|156796989|FG002|Overall Study|Lack of Efficacy|1|||
48712016|NCT01006291|156796987|FG000|Overall Study|Protocol Violation|3|||
48712017|NCT01006291|156796988|FG001|Overall Study|Protocol Violation|3|||
48712018|NCT01006291|156796989|FG002|Overall Study|Protocol Violation|3|||
48712019|NCT01006291|156796987|FG000|Overall Study|Withdrawal criteria|5|||
48712020|NCT01006291|156796988|FG001|Overall Study|Withdrawal criteria|4|||
48712021|NCT01006291|156796989|FG002|Overall Study|Withdrawal criteria|4|||
48712022|NCT01006291|156796987|FG000|Overall Study|Other|14|||
48712023|NCT01006291|156796988|FG001|Overall Study|Other|14|||
48712024|NCT01006291|156796989|FG002|Overall Study|Other|17|||
48712025|NCT02105662|156796990|FG000|Overall Study|Lost to Follow-up|5|||
48712026|NCT02105662|156796990|FG000|Overall Study|Withdrawal by Subject|1|||
48712027|NCT02605122|156796991|FG000|Overall Study|Withdrawal by Subject|4|||
48712028|NCT02605122|156796992|FG001|Overall Study|Withdrawal by Subject|1|||
48712029|NCT02605122|156796991|FG000|Overall Study|Lost to Follow-up|1|||
48712030|NCT02605122|156796992|FG001|Overall Study|Lost to Follow-up|1|||
48712031|NCT01657461|156796997|FG000|Overall Study|Death|9|||
48712032|NCT01657461|156796998|FG001|Overall Study|Death|12|||
48712033|NCT01657461|156796997|FG000|Overall Study|Lost to Follow-up|0|||
48712034|NCT01657461|156796998|FG001|Overall Study|Lost to Follow-up|3|||
48712035|NCT01657461|156796997|FG000|Overall Study|Physician Decision|0|||
48712036|NCT01657461|156796998|FG001|Overall Study|Physician Decision|2|||
48712037|NCT01657461|156796997|FG000|Overall Study|Withdrawal by Subject|1|||
48712038|NCT01657461|156796998|FG001|Overall Study|Withdrawal by Subject|3|||
48492377|NCT00673790|155995770|FG001|Overall Study|Withdrawal by Subject|4|||
48492378|NCT00673790|155995771|FG002|Overall Study|Withdrawal by Subject|1|||
48492379|NCT00673790|155995769|FG000|Overall Study|Lost to Follow-up|6|||
48712039|NCT03079102|156796999|FG000|Overall Study|Physician Decision|0|||
48712040|NCT03079102|156797000|FG001|Overall Study|Physician Decision|1|||
48810577|NCT00779584|157146392|FG000|Overall Study|Symptomatic Deterioration|1|||
48810578|NCT00779584|157146393|FG001|Overall Study|Symptomatic Deterioration|1|||
48810579|NCT00779584|157146394|FG002|Overall Study|Symptomatic Deterioration|1|||
48810580|NCT00779584|157146395|FG003|Overall Study|Symptomatic Deterioration|0|||
48810581|NCT00779584|157146396|FG004|Overall Study|Symptomatic Deterioration|0|||
48810582|NCT00779584|157146397|FG005|Overall Study|Symptomatic Deterioration|1|||
48810583|NCT00779584|157146398|FG006|Overall Study|Symptomatic Deterioration|1|||
48492380|NCT00673790|155995770|FG001|Overall Study|Lost to Follow-up|6|||
48492381|NCT00673790|155995771|FG002|Overall Study|Lost to Follow-up|5|||
48492382|NCT00673790|155995769|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
48492383|NCT00673790|155995770|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
48492384|NCT00673790|155995771|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
48492385|NCT00673790|155995769|FG000|Overall Study|Poor compliance|1|||
48492386|NCT00673790|155995770|FG001|Overall Study|Poor compliance|0|||
48492387|NCT00673790|155995771|FG002|Overall Study|Poor compliance|0|||
48492388|NCT00673790|155995769|FG000|Overall Study|Participated in two Nebivolol studies|0|||
48492389|NCT00673790|155995770|FG001|Overall Study|Participated in two Nebivolol studies|0|||
48492390|NCT00673790|155995771|FG002|Overall Study|Participated in two Nebivolol studies|1|||
48492391|NCT00673790|155995769|FG000|Overall Study|Unconfirmed pregnancy|0|||
48492392|NCT00673790|155995770|FG001|Overall Study|Unconfirmed pregnancy|1|||
48492393|NCT00673790|155995771|FG002|Overall Study|Unconfirmed pregnancy|0|||
48492394|NCT00673790|155995769|FG000|Overall Study|Randomization criteria not met|0|||
48492395|NCT00673790|155995770|FG001|Overall Study|Randomization criteria not met|1|||
48492396|NCT00673790|155995771|FG002|Overall Study|Randomization criteria not met|0|||
48597620|NCT02213380|156383550|FG001|Per-protocol Analysis|Protocol Violation|36|||
48810584|NCT00779584|157146399|FG007|Overall Study|Symptomatic Deterioration|0|||
48492397|NCT00306384|155995772|FG000|Overall Study|Adverse Event|103|||
48492398|NCT00306384|155995773|FG001|Overall Study|Adverse Event|87|||
48810585|NCT00779584|157146400|FG008|Overall Study|Symptomatic Deterioration|0|||
48810586|NCT00779584|157146392|FG000|Overall Study|Ongoing in Study|0|||
48712041|NCT00843284|156797002|FG000|Overall Study|Adverse Event|39|||
48712042|NCT00843284|156797002|FG000|Overall Study|Lack of Efficacy|5|||
48712043|NCT00843284|156797002|FG000|Overall Study|Lost to Follow-up|11|||
48712044|NCT00843284|156797002|FG000|Overall Study|Other|10|||
48712045|NCT00843284|156797002|FG000|Overall Study|Withdrawal by Subject|4|||
48712046|NCT00843284|156797002|FG000|Overall Study|Death|3|||
48712047|NCT03773796|156797003|FG000|Overall Study|Adverse Event|1|||
48712048|NCT03773796|156797003|FG000|Overall Study|Withdrawal by Subject|1|||
48712049|NCT03773796|156797003|FG000|Overall Study|Lack of Efficacy|1|||
48712050|NCT00122980|156797008|FG000|Overall Study|Death|0|||
48712051|NCT00122980|156797009|FG001|Overall Study|Death|1|||
48712052|NCT00122980|156797008|FG000|Overall Study|Physician Decision|2|||
48712053|NCT00122980|156797009|FG001|Overall Study|Physician Decision|0|||
48712054|NCT00122980|156797008|FG000|Overall Study|Protocol Violation|5|||
48712055|NCT00122980|156797009|FG001|Overall Study|Protocol Violation|1|||
48712056|NCT00122980|156797008|FG000|Overall Study|Withdrawal by Subject|2|||
48712057|NCT00122980|156797009|FG001|Overall Study|Withdrawal by Subject|3|||
48712058|NCT00122980|156797008|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
48712059|NCT00122980|156797009|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
48712060|NCT00122980|156797008|FG000|Overall Study|Study termination|27|||
48712061|NCT00122980|156797009|FG001|Overall Study|Study termination|35|||
48712062|NCT02175199|156797010|FG000|Overall Study|Withdrawal by Subject|1|||
48712063|NCT02175199|156797011|FG001|Overall Study|Withdrawal by Subject|5|||
48712064|NCT02175199|156797010|FG000|Overall Study|Randomized in Error|1|||
48712065|NCT02175199|156797011|FG001|Overall Study|Randomized in Error|0|||
48712066|NCT02175199|156797010|FG000|Overall Study|Sponsor Decision|1|||
48712067|NCT02175199|156797011|FG001|Overall Study|Sponsor Decision|0|||
48712068|NCT00854113|156797014|FG000|Overall Study|Adverse Event|0|||
48712069|NCT00854113|156797015|FG001|Overall Study|Adverse Event|0|||
48712070|NCT00854113|156797016|FG002|Overall Study|Adverse Event|0|||
48712071|NCT00854113|156797017|FG003|Overall Study|Adverse Event|0|||
48712072|NCT00854113|156797018|FG004|Overall Study|Adverse Event|0|||
48712073|NCT00854113|156797019|FG005|Overall Study|Adverse Event|0|||
48712074|NCT00854113|156797020|FG006|Overall Study|Adverse Event|0|||
48712075|NCT00854113|156797021|FG007|Overall Study|Adverse Event|2|||
48712076|NCT00854113|156797022|FG008|Overall Study|Adverse Event|0|||
48712077|NCT00854113|156797023|FG009|Overall Study|Adverse Event|0|||
48712078|NCT00854113|156797024|FG010|Overall Study|Adverse Event|0|||
48712079|NCT00854113|156797014|FG000|Overall Study|Withdrawal by Subject|0|||
48712080|NCT00854113|156797015|FG001|Overall Study|Withdrawal by Subject|0|||
48712081|NCT00854113|156797016|FG002|Overall Study|Withdrawal by Subject|0|||
48712082|NCT00854113|156797017|FG003|Overall Study|Withdrawal by Subject|0|||
48712083|NCT00854113|156797018|FG004|Overall Study|Withdrawal by Subject|0|||
48712084|NCT00854113|156797019|FG005|Overall Study|Withdrawal by Subject|0|||
48712085|NCT00854113|156797020|FG006|Overall Study|Withdrawal by Subject|0|||
48597621|NCT00707057|156383552|FG000|Overall Study|Withdrawal by Subject|8|||
48712086|NCT00854113|156797021|FG007|Overall Study|Withdrawal by Subject|1|||
48712087|NCT00854113|156797022|FG008|Overall Study|Withdrawal by Subject|1|||
48712088|NCT00854113|156797023|FG009|Overall Study|Withdrawal by Subject|0|||
48712089|NCT00854113|156797024|FG010|Overall Study|Withdrawal by Subject|0|||
48712090|NCT02260180|156797025|FG000|Overall Study|Adverse Event|2|||
48712091|NCT02260180|156797026|FG001|Overall Study|Adverse Event|0|||
48712092|NCT02260180|156797027|FG002|Overall Study|Adverse Event|1|||
48712093|NCT01675544|156797036|FG000|Overall Study|Withdrawal by Subject|2|||
48712094|NCT00904033|156797041|FG000|Overall Study|Withdrawal by Subject|1|||
48712095|NCT00904033|156797042|FG001|Overall Study|Withdrawal by Subject|1|||
48712096|NCT00904033|156797043|FG002|Overall Study|Withdrawal by Subject|0|||
48712097|NCT00904033|156797044|FG003|Overall Study|Withdrawal by Subject|0|||
48712098|NCT00904033|156797041|FG000|Overall Study|Physician Decision|0|||
48712099|NCT00904033|156797042|FG001|Overall Study|Physician Decision|0|||
48712100|NCT00904033|156797043|FG002|Overall Study|Physician Decision|1|||
48712101|NCT00904033|156797044|FG003|Overall Study|Physician Decision|0|||
48712102|NCT00904033|156797041|FG000|Overall Study|Unable to obtain final blood draw|0|||
48712103|NCT00904033|156797042|FG001|Overall Study|Unable to obtain final blood draw|0|||
48712104|NCT00904033|156797043|FG002|Overall Study|Unable to obtain final blood draw|0|||
48435466|NCT02175771|155782474|FG004|Treatment Period|Noncompliance|0|||
48435467|NCT02175771|155782475|FG005|Treatment Period|Noncompliance|0|||
48435468|NCT02175771|155782476|FG006|Treatment Period|Noncompliance|0|||
48435469|NCT02175771|155782477|FG007|Treatment Period|Noncompliance|0|||
48435470|NCT02175771|155782478|FG008|Treatment Period|Noncompliance|1|||
48435471|NCT02175771|155782470|FG000|Treatment Period|Protocol Violation|0|||
48435472|NCT02175771|155782471|FG001|Treatment Period|Protocol Violation|0|||
48435473|NCT02175771|155782472|FG002|Treatment Period|Protocol Violation|0|||
48435474|NCT02175771|155782473|FG003|Treatment Period|Protocol Violation|0|||
48435475|NCT02175771|155782474|FG004|Treatment Period|Protocol Violation|0|||
48435476|NCT02175771|155782475|FG005|Treatment Period|Protocol Violation|0|||
48435477|NCT02175771|155782476|FG006|Treatment Period|Protocol Violation|0|||
48435478|NCT02175771|155782477|FG007|Treatment Period|Protocol Violation|1|||
48492399|NCT00306384|155995774|FG002|Overall Study|Adverse Event|40|||
48492400|NCT00306384|155995772|FG000|Overall Study|Major protocol deviation|43|||
48492401|NCT00306384|155995773|FG001|Overall Study|Major protocol deviation|51|||
48492402|NCT00306384|155995774|FG002|Overall Study|Major protocol deviation|18|||
48492403|NCT00306384|155995772|FG000|Overall Study|Lost to Follow-up|57|||
48712105|NCT00904033|156797044|FG003|Overall Study|Unable to obtain final blood draw|2|||
48712106|NCT02600819|156797045|FG000|GEN Phase|Adverse Event|2|||
48712107|NCT02600819|156797046|FG001|GEN Phase|Adverse Event|0|||
48712108|NCT02600819|156797045|FG000|GEN Phase|Death|2|||
48712109|NCT02600819|156797046|FG001|GEN Phase|Death|0|||
48712110|NCT02600819|156797045|FG000|GEN Phase|Investigator's Discretion|4|||
48712111|NCT02600819|156797046|FG001|GEN Phase|Investigator's Discretion|0|||
48712112|NCT02600819|156797045|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
48712113|NCT02600819|156797046|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
48712114|NCT02600819|156797045|FG000|GEN Phase|Withdrew Consent|5|||
48712115|NCT02600819|156797046|FG001|GEN Phase|Withdrew Consent|0|||
48712116|NCT02600819|156797045|FG000|GEN Phase|Lost to Follow-up|2|||
48712117|NCT02600819|156797046|FG001|GEN Phase|Lost to Follow-up|0|||
48810587|NCT00779584|157146393|FG001|Overall Study|Ongoing in Study|0|||
48810588|NCT00779584|157146394|FG002|Overall Study|Ongoing in Study|0|||
48810589|NCT00779584|157146395|FG003|Overall Study|Ongoing in Study|0|||
48810590|NCT00779584|157146396|FG004|Overall Study|Ongoing in Study|1|||
48810591|NCT00779584|157146397|FG005|Overall Study|Ongoing in Study|1|||
48810592|NCT00779584|157146398|FG006|Overall Study|Ongoing in Study|0|||
48810593|NCT00779584|157146399|FG007|Overall Study|Ongoing in Study|0|||
48810594|NCT00779584|157146400|FG008|Overall Study|Ongoing in Study|0|||
48810595|NCT00130793|157146403|FG000|Overall Study|Lost to Follow-up|1|||
48810596|NCT00130793|157146404|FG001|Overall Study|Lost to Follow-up|4|||
48810597|NCT00130793|157146403|FG000|Overall Study|Withdrew consent|2|||
48810598|NCT00130793|157146404|FG001|Overall Study|Withdrew consent|0|||
48810599|NCT01650519|157146407|FG000|Overall Study|Withdrawal by Subject|1|||
48810600|NCT01650519|157146408|FG001|Overall Study|Withdrawal by Subject|0|||
48712118|NCT01754727|156797047|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
48712119|NCT02736890|156797048|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
48712120|NCT02736890|156797049|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
48810601|NCT02667886|157146409|FG000|Dose Escalation (Part A)|Adverse Event|1|||
48492404|NCT00306384|155995773|FG001|Overall Study|Lost to Follow-up|41|||
48810602|NCT02667886|157146410|FG001|Dose Escalation (Part A)|Adverse Event|3|||
48492405|NCT00306384|155995774|FG002|Overall Study|Lost to Follow-up|35|||
48810603|NCT02667886|157146411|FG002|Dose Escalation (Part A)|Adverse Event|1|||
48810604|NCT02667886|157146412|FG003|Dose Escalation (Part A)|Adverse Event|0|||
48810605|NCT02667886|157146413|FG004|Dose Escalation (Part A)|Adverse Event|0|||
48810606|NCT02667886|157146409|FG000|Dose Escalation (Part A)|Disease Progression|1|||
48810607|NCT02667886|157146410|FG001|Dose Escalation (Part A)|Disease Progression|4|||
48810608|NCT02667886|157146411|FG002|Dose Escalation (Part A)|Disease Progression|3|||
48810609|NCT02667886|157146412|FG003|Dose Escalation (Part A)|Disease Progression|0|||
48810610|NCT02667886|157146413|FG004|Dose Escalation (Part A)|Disease Progression|0|||
48810611|NCT02667886|157146409|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
48810612|NCT02667886|157146410|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
48810613|NCT02667886|157146411|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
48810614|NCT02667886|157146412|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
48810615|NCT02667886|157146413|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
48810616|NCT02667886|157146409|FG000|Dose Expansion (Part B)|Adverse Event|0|||
48810617|NCT02667886|157146410|FG001|Dose Expansion (Part B)|Adverse Event|0|||
48810618|NCT02667886|157146411|FG002|Dose Expansion (Part B)|Adverse Event|0|||
48810619|NCT02667886|157146412|FG003|Dose Expansion (Part B)|Adverse Event|9|||
48810620|NCT02667886|157146413|FG004|Dose Expansion (Part B)|Adverse Event|0|||
48810621|NCT02667886|157146409|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
48810622|NCT02667886|157146410|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
48810623|NCT02667886|157146411|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
48810624|NCT02667886|157146412|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
48810625|NCT02667886|157146413|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
48810626|NCT02667886|157146409|FG000|Dose Expansion (Part B)|Disease Progression|0|||
48810627|NCT02667886|157146410|FG001|Dose Expansion (Part B)|Disease Progression|0|||
48810628|NCT02667886|157146411|FG002|Dose Expansion (Part B)|Disease Progression|0|||
48810629|NCT02667886|157146412|FG003|Dose Expansion (Part B)|Disease Progression|38|||
48810630|NCT02667886|157146413|FG004|Dose Expansion (Part B)|Disease Progression|0|||
48810631|NCT02667886|157146409|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
48810632|NCT02667886|157146410|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
48810633|NCT02667886|157146411|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
48810634|NCT02667886|157146412|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
48810635|NCT02667886|157146413|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
48810636|NCT02667886|157146409|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
48810637|NCT02667886|157146410|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
48810638|NCT02667886|157146411|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
48810639|NCT02667886|157146412|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
48810640|NCT02667886|157146413|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
48810641|NCT02667886|157146409|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
48810642|NCT02667886|157146410|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
48810643|NCT02667886|157146411|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
48810644|NCT02667886|157146412|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
48810645|NCT02667886|157146413|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
48810646|NCT00747123|157146414|FG000|Overall Study|Investigator's request|0|||
48810647|NCT00747123|157146415|FG001|Overall Study|Investigator's request|0|||
48810648|NCT00747123|157146416|FG002|Overall Study|Investigator's request|1|||
48810649|NCT00747123|157146417|FG003|Overall Study|Investigator's request|0|||
48810650|NCT00747123|157146414|FG000|Overall Study|Withdrew consent|0|||
48810651|NCT00747123|157146415|FG001|Overall Study|Withdrew consent|1|||
48810652|NCT00747123|157146416|FG002|Overall Study|Withdrew consent|0|||
48597622|NCT00707057|156383553|FG001|Overall Study|Withdrawal by Subject|3|||
48597623|NCT00707057|156383552|FG000|Overall Study|Dosed incorrectly|0|||
48712121|NCT02736890|156797048|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
48712122|NCT02736890|156797049|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
48712123|NCT02249832|156797052|FG000|Overall Study|Withdrawal by Subject|3|||
48712124|NCT02249832|156797052|FG000|Overall Study|Lost to Follow-up|10|||
48712125|NCT02230670|156797059|FG000|Overall Study|Adverse Event|1|||
48712126|NCT02230670|156797060|FG001|Overall Study|Adverse Event|2|||
48712127|NCT02230670|156797059|FG000|Overall Study|Withdrawal by Subject|2|||
48712128|NCT02230670|156797060|FG001|Overall Study|Withdrawal by Subject|2|||
48712129|NCT02230670|156797059|FG000|Overall Study|Physician Decision|0|||
48712130|NCT02230670|156797060|FG001|Overall Study|Physician Decision|1|||
48712131|NCT02230670|156797059|FG000|Overall Study|Protocol Violation|0|||
48712132|NCT02230670|156797060|FG001|Overall Study|Protocol Violation|1|||
48712133|NCT02230670|156797059|FG000|Overall Study|Progression to Child-Pugh C|1|||
48712134|NCT02230670|156797060|FG001|Overall Study|Progression to Child-Pugh C|2|||
48712135|NCT04849559|156797066|FG000|Overall Study|Withdrawal by Subject|2|||
48712136|NCT04849559|156797067|FG001|Overall Study|Withdrawal by Subject|1|||
48712137|NCT01262989|156797069|FG000|Period 1|Lost to Follow-up|1|||
48712138|NCT01262989|156797070|FG001|Period 1|Lost to Follow-up|1|||
48712139|NCT01262989|156797069|FG000|Period 1|Intercurrent disease|0|||
48712140|NCT01262989|156797070|FG001|Period 1|Intercurrent disease|1|||
48712141|NCT01262989|156797069|FG000|Period 1|Positive answer for exclusion criteria|0|||
48712142|NCT01262989|156797070|FG001|Period 1|Positive answer for exclusion criteria|1|||
48712143|NCT01262989|156797069|FG000|Period 2|Intercurrent disease|0|||
48712144|NCT01262989|156797070|FG001|Period 2|Intercurrent disease|1|||
48712145|NCT01068600|156797071|FG000|Overall Study|Withdrawal by Subject|5|||
48712146|NCT01068600|156797072|FG001|Overall Study|Withdrawal by Subject|6|||
48712147|NCT01068600|156797071|FG000|Overall Study|Adverse Event|3|||
48712148|NCT01068600|156797072|FG001|Overall Study|Adverse Event|3|||
48712149|NCT01068600|156797071|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48712150|NCT01068600|156797072|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48712151|NCT01068600|156797071|FG000|Overall Study|Lost to Follow-up|1|||
48712152|NCT01068600|156797072|FG001|Overall Study|Lost to Follow-up|2|||
48712153|NCT01068600|156797071|FG000|Overall Study|Protocol deviation|1|||
48712154|NCT01068600|156797072|FG001|Overall Study|Protocol deviation|1|||
48712155|NCT01068600|156797071|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48712156|NCT01068600|156797072|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48712157|NCT01068600|156797071|FG000|Overall Study|Administrative problems|0|||
48712158|NCT01068600|156797072|FG001|Overall Study|Administrative problems|1|||
48712159|NCT02644109|156797073|FG000|Overall Study|Adverse Event|0|||
48712160|NCT02644109|156797074|FG001|Overall Study|Adverse Event|4|||
48712161|NCT01802073|156797075|FG000|Overall Study|Lost to Follow-up|0|||
48712162|NCT01802073|156797076|FG001|Overall Study|Lost to Follow-up|1|||
48712163|NCT01802073|156797075|FG000|Overall Study|Non-compliant|4|||
48712164|NCT01802073|156797076|FG001|Overall Study|Non-compliant|2|||
48712165|NCT01802073|156797075|FG000|Overall Study|Withdrawal by Subject|1|||
48712166|NCT01802073|156797076|FG001|Overall Study|Withdrawal by Subject|1|||
48712167|NCT01802073|156797075|FG000|Overall Study|Physician Decision|0|||
48712168|NCT01802073|156797076|FG001|Overall Study|Physician Decision|7|||
48712169|NCT04075734|156797077|FG000|Overall Study|Lost to Follow-up|1|||
48712170|NCT04075734|156797078|FG001|Overall Study|Lost to Follow-up|1|||
48712171|NCT04075734|156797079|FG002|Overall Study|Lost to Follow-up|0|||
48712172|NCT04075734|156797077|FG000|Overall Study|Withdrawal by Subject|3|||
48712173|NCT04075734|156797078|FG001|Overall Study|Withdrawal by Subject|0|||
48712174|NCT04075734|156797079|FG002|Overall Study|Withdrawal by Subject|0|||
48712175|NCT00459186|156797080|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
48712176|NCT00459186|156797080|FG000|PET Imaging and Assessment|Adverse Event|3|||
48712177|NCT01598129|156797081|FG000|Overall Study|Disease progression|6|||
48712178|NCT01598129|156797081|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
48712179|NCT01598129|156797081|FG000|Overall Study|Withdrawal by Subject|1|||
48712180|NCT01942733|156797083|FG000|Overall Study|Lost to Follow-up|1|||
48712181|NCT01942733|156797083|FG000|Overall Study|Non-compliance with IMP|1|||
48712182|NCT01942733|156797083|FG000|Overall Study|Administrative|1|||
48712183|NCT00634101|156797084|FG000|Overall Study|Study Terminated|3|||
48712184|NCT00634101|156797085|FG001|Overall Study|Study Terminated|3|||
48712185|NCT00634101|156797084|FG000|Overall Study|Lost to Follow-up|2|||
48712186|NCT00634101|156797085|FG001|Overall Study|Lost to Follow-up|0|||
48712187|NCT04074161|156797087|FG000|Overall Study|Withdrawal by Subject|2|||
48712188|NCT04074161|156797088|FG001|Overall Study|Withdrawal by Subject|4|||
48712189|NCT04074161|156797089|FG002|Overall Study|Withdrawal by Subject|1|||
48712190|NCT04074161|156797087|FG000|Overall Study|Lost to Follow-up|4|||
48597624|NCT00707057|156383553|FG001|Overall Study|Dosed incorrectly|1|||
48712191|NCT04074161|156797088|FG001|Overall Study|Lost to Follow-up|5|||
48712192|NCT04074161|156797089|FG002|Overall Study|Lost to Follow-up|3|||
48712193|NCT01018810|156797092|FG000|Overall Study|Withdrawal by Subject|0|||
48712194|NCT01018810|156797093|FG001|Overall Study|Withdrawal by Subject|1|||
48492406|NCT00306384|155995772|FG000|Overall Study|Voluntary withdrawal|199|||
48492407|NCT00306384|155995773|FG001|Overall Study|Voluntary withdrawal|187|||
48492408|NCT00306384|155995774|FG002|Overall Study|Voluntary withdrawal|91|||
48492409|NCT00306384|155995772|FG000|Overall Study|Study termination|1|||
48492410|NCT00306384|155995773|FG001|Overall Study|Study termination|0|||
48492411|NCT00306384|155995774|FG002|Overall Study|Study termination|1|||
48492412|NCT00306384|155995772|FG000|Overall Study|Pregnancy|3|||
48492413|NCT00306384|155995773|FG001|Overall Study|Pregnancy|1|||
48492414|NCT00306384|155995774|FG002|Overall Study|Pregnancy|1|||
48492415|NCT00306384|155995772|FG000|Overall Study|Lack of Efficacy|26|||
48492416|NCT00306384|155995773|FG001|Overall Study|Lack of Efficacy|40|||
48492417|NCT00306384|155995774|FG002|Overall Study|Lack of Efficacy|38|||
48492418|NCT00306384|155995772|FG000|Overall Study|Investigator discretion|28|||
48492419|NCT00306384|155995773|FG001|Overall Study|Investigator discretion|31|||
48492420|NCT00306384|155995774|FG002|Overall Study|Investigator discretion|21|||
48492421|NCT00306384|155995772|FG000|Overall Study|Other|80|||
48492422|NCT00306384|155995773|FG001|Overall Study|Other|70|||
48492423|NCT00306384|155995774|FG002|Overall Study|Other|32|||
48492424|NCT00306384|155995772|FG000|Overall Study|Site closure|2|||
48492425|NCT00306384|155995773|FG001|Overall Study|Site closure|0|||
48492426|NCT00306384|155995774|FG002|Overall Study|Site closure|0|||
48492427|NCT00717756|155995775|FG000|Overall Study|Withdrawal by Subject|1|||
48492428|NCT01748890|155995776|FG000|Overall Study|Insufficient recruitment for analysis|4|||
48492429|NCT02666430|155995777|FG000|Period 1|Lost to Follow-up|1|||
48492430|NCT02666430|155995778|FG001|Period 1|Lost to Follow-up|0|||
48492431|NCT02666430|155995777|FG000|Period 1|Adverse Event|0|||
48492432|NCT02666430|155995778|FG001|Period 1|Adverse Event|1|||
48492433|NCT02666430|155995777|FG000|Period 2|Withdrawal by Subject|1|||
48492434|NCT02666430|155995778|FG001|Period 2|Withdrawal by Subject|4|||
48492435|NCT02666430|155995777|FG000|Period 3|Lost to Follow-up|1|||
48492436|NCT02666430|155995778|FG001|Period 3|Lost to Follow-up|0|||
48492437|NCT01835145|155995780|FG000|Overall Study|Ineligible prior to treatment|1|||
48492438|NCT01835145|155995781|FG001|Overall Study|Ineligible prior to treatment|0|||
48492439|NCT00860028|155995783|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
48492440|NCT00860028|155995784|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
48492441|NCT01890707|155995788|FG000|Overall Study|Lost to Follow-up|1|||
48492442|NCT01890707|155995789|FG001|Overall Study|Lost to Follow-up|1|||
48492443|NCT00385541|155995791|FG000|Overall Study|severe pain, clinician requested unblind|0|||
48492444|NCT00385541|155995792|FG001|Overall Study|severe pain, clinician requested unblind|1|||
48492445|NCT02688608|155995793|FG000|Overall Study|Lost to Follow-up|1|||
48492446|NCT01497938|155995794|FG000|Overall Study|Adverse Event|0|||
48492447|NCT01497938|155995795|FG001|Overall Study|Adverse Event|1|||
48492448|NCT01497938|155995794|FG000|Overall Study|Physician Decision|0|||
48492449|NCT01497938|155995795|FG001|Overall Study|Physician Decision|1|||
48492450|NCT01497938|155995794|FG000|Overall Study|Withdrawal by Subject|4|||
48492451|NCT01497938|155995795|FG001|Overall Study|Withdrawal by Subject|0|||
48492452|NCT01497938|155995794|FG000|Overall Study|Device Violation|1|||
48492453|NCT01497938|155995795|FG001|Overall Study|Device Violation|0|||
48492454|NCT00982410|155997468|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
48712195|NCT01018810|156797094|FG002|Overall Study|Withdrawal by Subject|0|||
48712196|NCT01018810|156797095|FG003|Overall Study|Withdrawal by Subject|0|||
48712197|NCT01018810|156797096|FG004|Overall Study|Withdrawal by Subject|0|||
48712198|NCT01018810|156797092|FG000|Overall Study|Sponsor Decision|2|||
48712199|NCT01018810|156797093|FG001|Overall Study|Sponsor Decision|0|||
48712200|NCT01018810|156797094|FG002|Overall Study|Sponsor Decision|1|||
48712201|NCT01018810|156797095|FG003|Overall Study|Sponsor Decision|1|||
48712202|NCT01018810|156797096|FG004|Overall Study|Sponsor Decision|1|||
48712203|NCT03672097|156797097|FG000|Period 1|Withdrawal by Subject|2|||
48712204|NCT03672097|156797097|FG000|Period 1|Adverse Event|1|||
48712205|NCT03672097|156797097|FG000|Period 1|Did not receive treatment|1|||
48712206|NCT03672097|156797097|FG000|Period 2|Withdrawal by Subject|3|||
48712207|NCT03672097|156797097|FG000|Period 2|Other|1|||
48712208|NCT00324961|156797100|FG000|Overall Study|Adverse Event|5|||
48712209|NCT00324961|156797100|FG000|Overall Study|Consent Withdrawn|11|||
48712210|NCT00324961|156797100|FG000|Overall Study|Lost to Follow-up|22|||
48712211|NCT00324961|156797100|FG000|Overall Study|Protocol Violation|3|||
48712212|NCT00324961|156797100|FG000|Overall Study|Other|2|||
48712213|NCT00223080|156797101|FG000|Overall Study|Withdrawal by Subject|253|||
48712214|NCT00223080|156797102|FG001|Overall Study|Withdrawal by Subject|232|||
48712215|NCT00223080|156797101|FG000|Overall Study|Required contraindicated med|0|||
48492455|NCT00982410|155997469|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
48712216|NCT00223080|156797102|FG001|Overall Study|Required contraindicated med|1|||
48492456|NCT00982410|155997468|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
48492457|NCT00982410|155997469|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
48492458|NCT00982410|155997468|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
48492459|NCT00982410|155997469|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
48492460|NCT00982410|155997468|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
48810653|NCT00747123|157146417|FG003|Overall Study|Withdrew consent|0|||
48810654|NCT00747123|157146414|FG000|Overall Study|Adverse Event|0|||
48810655|NCT00747123|157146415|FG001|Overall Study|Adverse Event|1|||
48810656|NCT00747123|157146416|FG002|Overall Study|Adverse Event|0|||
48810657|NCT00747123|157146417|FG003|Overall Study|Adverse Event|1|||
48810658|NCT04186403|157146418|FG000|Overall Study|Adverse Event|1|||
48810659|NCT04186403|157146419|FG001|Overall Study|Adverse Event|8|||
48810660|NCT04186403|157146418|FG000|Overall Study|Lost to Follow-up|7|||
48810661|NCT04186403|157146419|FG001|Overall Study|Lost to Follow-up|3|||
48810662|NCT04186403|157146418|FG000|Overall Study|Physician Decision|1|||
48810663|NCT04186403|157146419|FG001|Overall Study|Physician Decision|0|||
48810664|NCT04186403|157146418|FG000|Overall Study|Withdrawal by Subject|7|||
48810665|NCT04186403|157146419|FG001|Overall Study|Withdrawal by Subject|8|||
48810666|NCT04186403|157146418|FG000|Overall Study|Other: Not Related to Covid-19|3|||
48810667|NCT04186403|157146419|FG001|Overall Study|Other: Not Related to Covid-19|0|||
48810668|NCT02696902|157146420|FG000|Overall Study|Lost to Follow-up|0|||
48810669|NCT02696902|157146421|FG001|Overall Study|Lost to Follow-up|1|||
48810670|NCT02696902|157146422|FG002|Overall Study|Lost to Follow-up|1|||
48810671|NCT02696902|157146420|FG000|Overall Study|Withdrawal by Subject|0|||
48810672|NCT02696902|157146421|FG001|Overall Study|Withdrawal by Subject|0|||
48810673|NCT02696902|157146422|FG002|Overall Study|Withdrawal by Subject|1|||
48810674|NCT02696902|157146420|FG000|Overall Study|Death|19|||
48810675|NCT02696902|157146421|FG001|Overall Study|Death|3|||
48810676|NCT02696902|157146422|FG002|Overall Study|Death|24|||
48810677|NCT02696902|157146420|FG000|Overall Study|Participant not fit post-randomization|0|||
48492461|NCT00982410|155997469|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
48492462|NCT00982410|155997468|FG000|6-month Follow-up Assessment|participant no transportation|1|||
48810678|NCT02696902|157146421|FG001|Overall Study|Participant not fit post-randomization|0|||
48810679|NCT02696902|157146422|FG002|Overall Study|Participant not fit post-randomization|1|||
48492463|NCT00982410|155997469|FG001|6-month Follow-up Assessment|participant no transportation|0|||
48492464|NCT00982410|155997468|FG000|6-month Follow-up Assessment|incarceration|0|||
48492465|NCT00982410|155997469|FG001|6-month Follow-up Assessment|incarceration|2|||
48492466|NCT00982410|155997468|FG000|6-month Follow-up Assessment|patent surgery|0|||
48492467|NCT00982410|155997469|FG001|6-month Follow-up Assessment|patent surgery|1|||
48492468|NCT00982410|155997468|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
48492469|NCT00982410|155997469|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
48492470|NCT00982410|155997468|FG000|12-month Follow-up Assessment|Death|0|||
48492471|NCT00982410|155997469|FG001|12-month Follow-up Assessment|Death|2|||
48492472|NCT00982410|155997468|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
48492473|NCT00982410|155997469|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
48492474|NCT00982410|155997468|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
48492475|NCT00982410|155997469|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
48492476|NCT00982410|155997468|FG000|12-month Follow-up Assessment|incarceration|2|||
48492477|NCT00982410|155997469|FG001|12-month Follow-up Assessment|incarceration|1|||
48492478|NCT00982410|155997468|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
48492479|NCT00982410|155997469|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
48492480|NCT03322462|155997472|FG000|Overall Study|Technical difficulties|2|||
48492481|NCT03322462|155997472|FG000|Overall Study|Other|1|||
48492482|NCT01393990|155997473|FG000|Overall Study|Adverse Event|0|||
48492483|NCT01393990|155997474|FG001|Overall Study|Adverse Event|0|||
48492484|NCT01393990|155997475|FG002|Overall Study|Adverse Event|0|||
48492485|NCT01393990|155997476|FG003|Overall Study|Adverse Event|0|||
48492486|NCT01393990|155997477|FG004|Overall Study|Adverse Event|0|||
48492487|NCT01393990|155997478|FG005|Overall Study|Adverse Event|0|||
48492488|NCT01393990|155997479|FG006|Overall Study|Adverse Event|0|||
48492489|NCT01393990|155997480|FG007|Overall Study|Adverse Event|0|||
48492490|NCT01393990|155997481|FG008|Overall Study|Adverse Event|0|||
48492491|NCT01393990|155997482|FG009|Overall Study|Adverse Event|0|||
48492492|NCT01393990|155997483|FG010|Overall Study|Adverse Event|0|||
48492493|NCT01393990|155997484|FG011|Overall Study|Adverse Event|0|||
48492494|NCT01393990|155997485|FG012|Overall Study|Adverse Event|0|||
48492495|NCT01393990|155997486|FG013|Overall Study|Adverse Event|0|||
48492496|NCT01393990|155997487|FG014|Overall Study|Adverse Event|1|||
48492497|NCT01393990|155997488|FG015|Overall Study|Adverse Event|1|||
48597625|NCT01025284|156383554|FG000|Overall Study|Investigator Decision|0|||
48810680|NCT02696902|157146420|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
48492498|NCT01393990|155997489|FG016|Overall Study|Adverse Event|0|||
48492499|NCT01393990|155997490|FG017|Overall Study|Adverse Event|0|||
48597626|NCT01025284|156383555|FG001|Overall Study|Investigator Decision|1|||
48597627|NCT01025284|156383556|FG002|Overall Study|Investigator Decision|0|||
48810681|NCT02696902|157146421|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
48810682|NCT02696902|157146422|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
48492500|NCT01393990|155997473|FG000|Overall Study|Progressive Disease|1|||
48492501|NCT01393990|155997474|FG001|Overall Study|Progressive Disease|0|||
48492502|NCT01393990|155997475|FG002|Overall Study|Progressive Disease|0|||
48492503|NCT01393990|155997476|FG003|Overall Study|Progressive Disease|1|||
48492504|NCT01393990|155997477|FG004|Overall Study|Progressive Disease|1|||
48492505|NCT01393990|155997478|FG005|Overall Study|Progressive Disease|1|||
48492506|NCT01393990|155997479|FG006|Overall Study|Progressive Disease|1|||
48492507|NCT01393990|155997480|FG007|Overall Study|Progressive Disease|1|||
48492508|NCT01393990|155997481|FG008|Overall Study|Progressive Disease|3|||
48492509|NCT01393990|155997482|FG009|Overall Study|Progressive Disease|1|||
48712217|NCT00223080|156797101|FG000|Overall Study|Non-compliant|7|||
48712218|NCT00223080|156797102|FG001|Overall Study|Non-compliant|7|||
48712219|NCT00223080|156797101|FG000|Overall Study|Moved from study area|37|||
48712220|NCT00223080|156797102|FG001|Overall Study|Moved from study area|47|||
48712221|NCT00223080|156797101|FG000|Overall Study|Lost to Follow-up|259|||
48712222|NCT00223080|156797102|FG001|Overall Study|Lost to Follow-up|284|||
48712223|NCT00223080|156797101|FG000|Overall Study|Death|85|||
48712224|NCT00223080|156797102|FG001|Overall Study|Death|74|||
48712225|NCT00223080|156797101|FG000|Overall Study|Other|14|||
48712226|NCT00223080|156797102|FG001|Overall Study|Other|11|||
48712227|NCT00223080|156797101|FG000|Overall Study|Reason not provided|141|||
48712228|NCT00223080|156797102|FG001|Overall Study|Reason not provided|140|||
48712229|NCT00223080|156797101|FG000|Overall Study|Adverse Event|0|||
48712230|NCT00223080|156797102|FG001|Overall Study|Adverse Event|1|||
48712231|NCT01763996|156797103|FG000|Treatment Period 2|Adverse Event|0|||
48712232|NCT01763996|156797104|FG001|Treatment Period 2|Adverse Event|1|||
48712233|NCT01616693|156797105|FG000|Evaluated for Safety|Physician Decision|1|||
48712234|NCT01616693|156797106|FG001|Evaluated for Safety|Physician Decision|0|||
48712235|NCT01616693|156797107|FG002|Evaluated for Safety|Physician Decision|1|||
48712236|NCT01616693|156797108|FG003|Evaluated for Safety|Physician Decision|0|||
48712237|NCT01616693|156797105|FG000|Received Both Vaccines|Adverse Event|2|||
48712238|NCT01616693|156797106|FG001|Received Both Vaccines|Adverse Event|0|||
48492510|NCT01393990|155997483|FG010|Overall Study|Progressive Disease|0|||
48492511|NCT01393990|155997484|FG011|Overall Study|Progressive Disease|0|||
48492512|NCT01393990|155997485|FG012|Overall Study|Progressive Disease|0|||
48712239|NCT01616693|156797107|FG002|Received Both Vaccines|Adverse Event|0|||
48712240|NCT01616693|156797108|FG003|Received Both Vaccines|Adverse Event|0|||
48712241|NCT01616693|156797105|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
48712242|NCT01616693|156797106|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
48712243|NCT01616693|156797107|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
48712244|NCT01616693|156797108|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
48712245|NCT01616693|156797105|FG000|Received Both Vaccines|Lost to Follow-up|4|||
48712246|NCT01616693|156797106|FG001|Received Both Vaccines|Lost to Follow-up|3|||
48712247|NCT01616693|156797107|FG002|Received Both Vaccines|Lost to Follow-up|4|||
48712248|NCT01616693|156797108|FG003|Received Both Vaccines|Lost to Follow-up|4|||
48712249|NCT01616693|156797105|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
48712250|NCT01616693|156797106|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
48712251|NCT01616693|156797107|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
48712252|NCT01616693|156797108|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
48712253|NCT03116152|156797109|FG000|Overall Study|Disease Progression|49|||
48712254|NCT03116152|156797110|FG001|Overall Study|Disease Progression|47|||
48712255|NCT03116152|156797109|FG000|Overall Study|Death|5|||
48712256|NCT03116152|156797110|FG001|Overall Study|Death|2|||
48712257|NCT03116152|156797109|FG000|Overall Study|Adverse Event|21|||
48712258|NCT03116152|156797110|FG001|Overall Study|Adverse Event|7|||
48712259|NCT03116152|156797109|FG000|Overall Study|Protocol Violation|2|||
48712260|NCT03116152|156797110|FG001|Overall Study|Protocol Violation|2|||
48712261|NCT03116152|156797109|FG000|Overall Study|Withdrawal by Subject|0|||
48712262|NCT03116152|156797110|FG001|Overall Study|Withdrawal by Subject|1|||
48712263|NCT03116152|156797109|FG000|Overall Study|Physician Decision|3|||
48712264|NCT03116152|156797110|FG001|Overall Study|Physician Decision|2|||
48712265|NCT03116152|156797109|FG000|Overall Study|other|11|||
48712266|NCT03116152|156797110|FG001|Overall Study|other|34|||
48712267|NCT02791763|156797111|FG000|Overall Study|Protocol Violation|0|||
48712268|NCT02791763|156797112|FG001|Overall Study|Protocol Violation|0|||
48712269|NCT02791763|156797113|FG002|Overall Study|Protocol Violation|1|||
48712270|NCT02791763|156797111|FG000|Overall Study|Withdrawal by Subject|5|||
48712271|NCT02791763|156797112|FG001|Overall Study|Withdrawal by Subject|1|||
48712272|NCT02791763|156797113|FG002|Overall Study|Withdrawal by Subject|0|||
48712273|NCT02791763|156797111|FG000|Overall Study|Physician Decision|0|||
48712274|NCT02791763|156797112|FG001|Overall Study|Physician Decision|1|||
48712275|NCT02791763|156797113|FG002|Overall Study|Physician Decision|0|||
48712276|NCT02791763|156797111|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
48712277|NCT02791763|156797112|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
48712278|NCT02791763|156797113|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
48712279|NCT02791763|156797111|FG000|Overall Study|Cancer event|1|||
48712280|NCT02791763|156797112|FG001|Overall Study|Cancer event|3|||
48712281|NCT02791763|156797113|FG002|Overall Study|Cancer event|0|||
48712282|NCT02791763|156797111|FG000|Overall Study|Participant had renal transplant|3|||
48712283|NCT02791763|156797112|FG001|Overall Study|Participant had renal transplant|0|||
48712284|NCT02791763|156797113|FG002|Overall Study|Participant had renal transplant|0|||
48712285|NCT02791763|156797111|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
48712286|NCT02791763|156797112|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
48712287|NCT02791763|156797113|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
48712288|NCT02791763|156797111|FG000|Overall Study|Adverse Event|12|||
48712289|NCT02791763|156797112|FG001|Overall Study|Adverse Event|13|||
48712290|NCT02791763|156797113|FG002|Overall Study|Adverse Event|7|||
48712291|NCT00711477|156797121|FG000|Overall Study|Adverse Event|3|||
48712292|NCT00711477|156797122|FG001|Overall Study|Adverse Event|1|||
48712293|NCT00711477|156797121|FG000|Overall Study|Lost to Follow-up|0|||
48712294|NCT00711477|156797122|FG001|Overall Study|Lost to Follow-up|1|||
48712295|NCT00711477|156797121|FG000|Overall Study|Noncompliance|0|||
48712296|NCT00711477|156797122|FG001|Overall Study|Noncompliance|1|||
48712297|NCT01456897|156797123|FG000|Overall Study|Adverse Event|19|||
48712298|NCT01456897|156797124|FG001|Overall Study|Adverse Event|22|||
48712299|NCT01456897|156797123|FG000|Overall Study|Protocol Violation|3|||
48712300|NCT01456897|156797124|FG001|Overall Study|Protocol Violation|4|||
48712301|NCT01456897|156797123|FG000|Overall Study|Physician Decision|5|||
48712302|NCT01456897|156797124|FG001|Overall Study|Physician Decision|3|||
48712303|NCT01456897|156797123|FG000|Overall Study|Withdrawal by Subject|44|||
48712304|NCT01456897|156797124|FG001|Overall Study|Withdrawal by Subject|17|||
48712305|NCT01456897|156797123|FG000|Overall Study|Lack of Efficacy|4|||
48712306|NCT01456897|156797124|FG001|Overall Study|Lack of Efficacy|11|||
48712307|NCT02032238|156797128|FG000|Overall Study|Lost to Follow-up|2|||
48712308|NCT02032238|156797129|FG001|Overall Study|Lost to Follow-up|0|||
48712309|NCT00743106|156797130|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
48712310|NCT00743106|156797131|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
48712311|NCT01765218|156797133|FG000|Overall Study|Protocol Violation|1|||
48712312|NCT01765218|156797134|FG001|Overall Study|Protocol Violation|2|||
48712313|NCT01309282|156797135|FG000|Overall Study|Lost to Follow-up|1|||
48712314|NCT01761240|156797138|FG000|Overall Study|Progressive disease:radiology assessment|3|||
48712315|NCT01761240|156797139|FG001|Overall Study|Progressive disease:radiology assessment|3|||
48810683|NCT02696902|157146420|FG000|Overall Study|Principal investigator's decision|1|||
48810684|NCT02696902|157146421|FG001|Overall Study|Principal investigator's decision|0|||
48810685|NCT02696902|157146422|FG002|Overall Study|Principal investigator's decision|0|||
48810686|NCT02696902|157146420|FG000|Overall Study|Sponsor's decision|1|||
48810687|NCT02696902|157146421|FG001|Overall Study|Sponsor's decision|0|||
48810688|NCT02696902|157146422|FG002|Overall Study|Sponsor's decision|0|||
48810689|NCT02696902|157146420|FG000|Overall Study|Transferred to other hospital|1|||
48810690|NCT02696902|157146421|FG001|Overall Study|Transferred to other hospital|0|||
48810691|NCT02696902|157146422|FG002|Overall Study|Transferred to other hospital|0|||
48810692|NCT01857622|157146425|FG000|Overall Study|Adverse Event|5|||
48810693|NCT01857622|157146426|FG001|Overall Study|Adverse Event|0|||
48810694|NCT01857622|157146427|FG002|Overall Study|Adverse Event|2|||
48810695|NCT01857622|157146425|FG000|Overall Study|Physician Decision|1|||
48810696|NCT01857622|157146426|FG001|Overall Study|Physician Decision|0|||
48810697|NCT01857622|157146427|FG002|Overall Study|Physician Decision|0|||
48810698|NCT01857622|157146425|FG000|Overall Study|Protocol Violation|4|||
48810699|NCT01857622|157146426|FG001|Overall Study|Protocol Violation|1|||
48810700|NCT01857622|157146427|FG002|Overall Study|Protocol Violation|0|||
48810701|NCT01857622|157146425|FG000|Overall Study|Withdrawal by Subject|1|||
48810702|NCT01857622|157146426|FG001|Overall Study|Withdrawal by Subject|0|||
48810703|NCT01857622|157146427|FG002|Overall Study|Withdrawal by Subject|0|||
48810704|NCT02875834|157146433|FG000|Open-label Phase|Withdrawal by Subject|3|||
48810705|NCT02875834|157146434|FG001|Open-label Phase|Withdrawal by Subject|0|||
48810706|NCT02875834|157146435|FG002|Open-label Phase|Withdrawal by Subject|0|||
48810707|NCT02875834|157146436|FG003|Open-label Phase|Withdrawal by Subject|0|||
48810708|NCT02875834|157146433|FG000|Open-label Phase|(Not collected)|4|||
48810709|NCT02875834|157146434|FG001|Open-label Phase|(Not collected)|0|||
48810710|NCT02875834|157146435|FG002|Open-label Phase|(Not collected)|0|||
48810711|NCT02875834|157146436|FG003|Open-label Phase|(Not collected)|0|||
48810712|NCT02875834|157146433|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
48810713|NCT02875834|157146434|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
48810714|NCT02875834|157146435|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
48810715|NCT02875834|157146436|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
48810716|NCT02875834|157146433|FG000|Randomized Treatment Phase|Protocol Violation|0|||
48810717|NCT02875834|157146434|FG001|Randomized Treatment Phase|Protocol Violation|2|||
48810718|NCT02875834|157146435|FG002|Randomized Treatment Phase|Protocol Violation|0|||
48810719|NCT02875834|157146436|FG003|Randomized Treatment Phase|Protocol Violation|0|||
48810720|NCT02875834|157146433|FG000|Randomized Treatment Phase|(Not collected)|0|||
48810721|NCT02875834|157146434|FG001|Randomized Treatment Phase|(Not collected)|9|||
48810722|NCT02875834|157146435|FG002|Randomized Treatment Phase|(Not collected)|10|||
48810723|NCT02875834|157146436|FG003|Randomized Treatment Phase|(Not collected)|9|||
48810724|NCT04318093|157146437|FG000|Overall Study|Adverse Event|2|||
48810725|NCT04318093|157146438|FG001|Overall Study|Adverse Event|2|||
48810726|NCT04318093|157146437|FG000|Overall Study|Participant withdrew consent|1|||
48810727|NCT04318093|157146438|FG001|Overall Study|Participant withdrew consent|0|||
48810728|NCT04318093|157146437|FG000|Overall Study|Other reasons|0|||
48810729|NCT04318093|157146438|FG001|Overall Study|Other reasons|1|||
48810730|NCT02998021|157146442|FG000|Overall Study|Withdrawal by Subject|3|||
48810731|NCT02998021|157146443|FG001|Overall Study|Withdrawal by Subject|1|||
48810732|NCT02998021|157146442|FG000|Overall Study|unsafe home|0|||
48810733|NCT02998021|157146443|FG001|Overall Study|unsafe home|1|||
48810734|NCT03342053|157146444|FG000|Overall Study|Adverse Event|2|||
48810735|NCT03342053|157146445|FG001|Overall Study|Adverse Event|0|||
48810736|NCT03342053|157146444|FG000|Overall Study|Withdrawal by Subject|0|||
48810737|NCT03342053|157146445|FG001|Overall Study|Withdrawal by Subject|1|||
48810738|NCT01254890|157146447|FG000|Overall Study|Ineligible|0|||
48810739|NCT01254890|157146448|FG001|Overall Study|Ineligible|3|||
48810740|NCT01254890|157146447|FG000|Overall Study|Withdrawal by Subject|1|||
48810741|NCT01254890|157146448|FG001|Overall Study|Withdrawal by Subject|2|||
48810742|NCT01254890|157146447|FG000|Overall Study|Disease Progression|0|||
48810743|NCT01254890|157146448|FG001|Overall Study|Disease Progression|5|||
48810744|NCT02044458|157146449|FG000|Overall Study|Protocol Violation|3|||
48810745|NCT02044458|157146450|FG001|Overall Study|Protocol Violation|8|||
48810746|NCT01216293|157146451|FG000|Main Study|Adverse Event|1|||
48492513|NCT01393990|155997486|FG013|Overall Study|Progressive Disease|1|||
48492514|NCT01393990|155997487|FG014|Overall Study|Progressive Disease|6|||
48492515|NCT01393990|155997488|FG015|Overall Study|Progressive Disease|1|||
48492516|NCT01393990|155997489|FG016|Overall Study|Progressive Disease|0|||
48492517|NCT01393990|155997490|FG017|Overall Study|Progressive Disease|0|||
48492518|NCT01393990|155997473|FG000|Overall Study|Death|0|||
48492519|NCT01393990|155997474|FG001|Overall Study|Death|0|||
48492520|NCT01393990|155997475|FG002|Overall Study|Death|0|||
48492521|NCT01393990|155997476|FG003|Overall Study|Death|0|||
48492522|NCT01393990|155997477|FG004|Overall Study|Death|1|||
48492523|NCT01393990|155997478|FG005|Overall Study|Death|0|||
48492524|NCT01393990|155997479|FG006|Overall Study|Death|0|||
48492525|NCT01393990|155997480|FG007|Overall Study|Death|0|||
48492526|NCT01393990|155997481|FG008|Overall Study|Death|0|||
48492527|NCT01393990|155997482|FG009|Overall Study|Death|0|||
48492528|NCT01393990|155997483|FG010|Overall Study|Death|0|||
48492529|NCT01393990|155997484|FG011|Overall Study|Death|0|||
48492530|NCT01393990|155997485|FG012|Overall Study|Death|0|||
48492531|NCT01393990|155997486|FG013|Overall Study|Death|1|||
48492532|NCT01393990|155997487|FG014|Overall Study|Death|1|||
48492533|NCT01393990|155997488|FG015|Overall Study|Death|0|||
48492534|NCT01393990|155997489|FG016|Overall Study|Death|0|||
48492535|NCT01393990|155997490|FG017|Overall Study|Death|0|||
48492536|NCT01393990|155997473|FG000|Overall Study|Withdrawal by Subject|0|||
48492537|NCT01393990|155997474|FG001|Overall Study|Withdrawal by Subject|0|||
48492538|NCT01393990|155997475|FG002|Overall Study|Withdrawal by Subject|0|||
48492539|NCT01393990|155997476|FG003|Overall Study|Withdrawal by Subject|0|||
48492540|NCT01393990|155997477|FG004|Overall Study|Withdrawal by Subject|0|||
48492541|NCT01393990|155997478|FG005|Overall Study|Withdrawal by Subject|0|||
48492542|NCT01393990|155997479|FG006|Overall Study|Withdrawal by Subject|0|||
48492543|NCT01393990|155997480|FG007|Overall Study|Withdrawal by Subject|0|||
48492544|NCT01393990|155997481|FG008|Overall Study|Withdrawal by Subject|0|||
48492545|NCT01393990|155997482|FG009|Overall Study|Withdrawal by Subject|0|||
48492546|NCT01393990|155997483|FG010|Overall Study|Withdrawal by Subject|0|||
48492547|NCT01393990|155997484|FG011|Overall Study|Withdrawal by Subject|0|||
48492548|NCT01393990|155997485|FG012|Overall Study|Withdrawal by Subject|0|||
48492549|NCT01393990|155997486|FG013|Overall Study|Withdrawal by Subject|0|||
48492550|NCT01393990|155997487|FG014|Overall Study|Withdrawal by Subject|1|||
48492551|NCT01393990|155997488|FG015|Overall Study|Withdrawal by Subject|1|||
48492552|NCT01393990|155997489|FG016|Overall Study|Withdrawal by Subject|0|||
48492553|NCT01393990|155997490|FG017|Overall Study|Withdrawal by Subject|0|||
48492554|NCT02919475|155997491|FG000|Overall Study|Adverse Event|3|||
48492555|NCT02919475|155997492|FG001|Overall Study|Adverse Event|3|||
48492556|NCT02919475|155997493|FG002|Overall Study|Adverse Event|3|||
48492557|NCT02919475|155997494|FG003|Overall Study|Adverse Event|9|||
48492558|NCT02919475|155997495|FG004|Overall Study|Adverse Event|2|||
48492559|NCT02919475|155997491|FG000|Overall Study|Death|0|||
48492560|NCT02919475|155997492|FG001|Overall Study|Death|1|||
48492561|NCT02919475|155997493|FG002|Overall Study|Death|0|||
48492562|NCT02919475|155997494|FG003|Overall Study|Death|0|||
48492563|NCT02919475|155997495|FG004|Overall Study|Death|0|||
48492564|NCT02919475|155997491|FG000|Overall Study|Lost to Follow-up|0|||
48492565|NCT02919475|155997492|FG001|Overall Study|Lost to Follow-up|0|||
48492566|NCT02919475|155997493|FG002|Overall Study|Lost to Follow-up|0|||
48492567|NCT02919475|155997494|FG003|Overall Study|Lost to Follow-up|1|||
48492568|NCT02919475|155997495|FG004|Overall Study|Lost to Follow-up|0|||
48492569|NCT02919475|155997491|FG000|Overall Study|Withdrawal by Subject|2|||
48492570|NCT02919475|155997492|FG001|Overall Study|Withdrawal by Subject|3|||
48810747|NCT01216293|157146452|FG001|Main Study|Adverse Event|4|||
48810748|NCT01216293|157146453|FG002|Main Study|Adverse Event|2|||
48492571|NCT02919475|155997493|FG002|Overall Study|Withdrawal by Subject|1|||
48810749|NCT01216293|157146451|FG000|Main Study|Major Protocol Deviation|1|||
48492572|NCT02919475|155997494|FG003|Overall Study|Withdrawal by Subject|2|||
48492573|NCT02919475|155997495|FG004|Overall Study|Withdrawal by Subject|2|||
48492574|NCT02919475|155997491|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
48492575|NCT02919475|155997492|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
48492576|NCT02919475|155997493|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
48492577|NCT02919475|155997494|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
48492578|NCT02919475|155997495|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48492579|NCT04014959|155997498|FG000|Baseline MRI and Assessments|Physician Decision|2|||
48492580|NCT04014959|155997498|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
48492581|NCT04014959|155997498|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
48492582|NCT00827827|155997501|FG000|Overall Study|Lost to Follow-up|3|||
48810750|NCT01216293|157146452|FG001|Main Study|Major Protocol Deviation|0|||
48810751|NCT01216293|157146453|FG002|Main Study|Major Protocol Deviation|1|||
48492583|NCT00827827|155997502|FG001|Overall Study|Lost to Follow-up|0|||
48492584|NCT00827827|155997501|FG000|Overall Study|Fall at home- hospitalization|1|||
48810752|NCT01216293|157146451|FG000|Main Study|Lost to Follow-up|3|||
48810753|NCT01216293|157146452|FG001|Main Study|Lost to Follow-up|1|||
48810754|NCT01216293|157146453|FG002|Main Study|Lost to Follow-up|0|||
48810755|NCT01216293|157146451|FG000|Main Study|Voluntary Withdrawal|2|||
48810756|NCT01216293|157146452|FG001|Main Study|Voluntary Withdrawal|2|||
48810757|NCT01216293|157146453|FG002|Main Study|Voluntary Withdrawal|2|||
48810758|NCT01216293|157146451|FG000|Main Study|Other Reason Not Specified|0|||
48810759|NCT01216293|157146452|FG001|Main Study|Other Reason Not Specified|1|||
48810760|NCT01216293|157146453|FG002|Main Study|Other Reason Not Specified|1|||
48810761|NCT01216293|157146451|FG000|Main Study|Randomized, Not Treated|1|||
48810762|NCT01216293|157146452|FG001|Main Study|Randomized, Not Treated|0|||
48810763|NCT01216293|157146453|FG002|Main Study|Randomized, Not Treated|0|||
48810764|NCT01216293|157146451|FG000|Calcium Absorption Substudy|Adverse Event|0|||
48810765|NCT01216293|157146452|FG001|Calcium Absorption Substudy|Adverse Event|2|||
48810766|NCT01216293|157146453|FG002|Calcium Absorption Substudy|Adverse Event|0|||
48810767|NCT01216293|157146451|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
48810768|NCT01216293|157146452|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
48810769|NCT01216293|157146453|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
48810770|NCT01216293|157146451|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
48810771|NCT01216293|157146452|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
48810772|NCT01216293|157146453|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
48810773|NCT01493960|157148094|FG000|Overall Study|Adverse Event|0|||
48810774|NCT01493960|157148095|FG001|Overall Study|Adverse Event|1|||
48810775|NCT01493960|157148094|FG000|Overall Study|Lack of Efficacy|15|||
48810776|NCT01493960|157148095|FG001|Overall Study|Lack of Efficacy|9|||
48810777|NCT01493960|157148094|FG000|Overall Study|Protocol Violation|3|||
48810778|NCT01493960|157148095|FG001|Overall Study|Protocol Violation|0|||
48810779|NCT01493960|157148094|FG000|Overall Study|Withdrawal by Subject|10|||
48810780|NCT01493960|157148095|FG001|Overall Study|Withdrawal by Subject|4|||
48810781|NCT01493960|157148094|FG000|Overall Study|Non-specified|4|||
48810782|NCT01493960|157148095|FG001|Overall Study|Non-specified|4|||
48810783|NCT01679236|157148096|FG000|Overall Study|Lost to Follow-up|15|||
48810784|NCT01679236|157148097|FG001|Overall Study|Lost to Follow-up|15|||
48810785|NCT01590771|157148098|FG000|Overall Study|Other Protocol Specified Criteria|5|||
48810786|NCT01590771|157148099|FG001|Overall Study|Other Protocol Specified Criteria|14|||
48810787|NCT01590771|157148098|FG000|Overall Study|Withdrawal by Subject|8|||
48810788|NCT01590771|157148099|FG001|Overall Study|Withdrawal by Subject|15|||
48810789|NCT01590771|157148098|FG000|Overall Study|Protocol Violation|1|||
48810790|NCT01590771|157148099|FG001|Overall Study|Protocol Violation|2|||
48810791|NCT01590771|157148098|FG000|Overall Study|Lost to Follow-up|1|||
48810792|NCT01590771|157148099|FG001|Overall Study|Lost to Follow-up|1|||
48810793|NCT01590771|157148098|FG000|Overall Study|Lack of Efficacy|1|||
48810794|NCT01590771|157148099|FG001|Overall Study|Lack of Efficacy|0|||
48810795|NCT01590771|157148098|FG000|Overall Study|Adverse Event|3|||
48712316|NCT01761240|156797140|FG002|Overall Study|Progressive disease:radiology assessment|0|||
48712317|NCT01761240|156797141|FG003|Overall Study|Progressive disease:radiology assessment|0|||
48712318|NCT01761240|156797142|FG004|Overall Study|Progressive disease:radiology assessment|0|||
48712319|NCT01761240|156797138|FG000|Overall Study|Progressive disease:clinical assessment|0|||
48712320|NCT01761240|156797139|FG001|Overall Study|Progressive disease:clinical assessment|0|||
48712321|NCT01761240|156797140|FG002|Overall Study|Progressive disease:clinical assessment|3|||
48810796|NCT01590771|157148099|FG001|Overall Study|Adverse Event|7|||
48810797|NCT01806740|157148107|FG000|Overall Study|Withdrawal by Subject|4|||
48810798|NCT01806740|157148107|FG000|Overall Study|Physician Decision|1|||
48712322|NCT01761240|156797141|FG003|Overall Study|Progressive disease:clinical assessment|1|||
48810799|NCT01806740|157148107|FG000|Overall Study|Patient's refusal of treatment|1|||
48810800|NCT00957931|157148109|FG000|Overall Study|Death|4|||
48810801|NCT03462706|157148110|FG000|Overall Study|Polyp was pedunculated|1|||
48810802|NCT03462706|157148111|FG001|Overall Study|Polyp was pedunculated|0|||
48810803|NCT03462706|157148112|FG002|Overall Study|Polyp was pedunculated|1|||
48810804|NCT03462706|157148113|FG003|Overall Study|Polyp was pedunculated|0|||
48810805|NCT03462706|157148110|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
48810806|NCT03462706|157148111|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
48810807|NCT03462706|157148112|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
48810808|NCT03462706|157148113|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
48810809|NCT04651114|157148118|FG000|Overall Study|Withdrawal by Subject|8|||
48435556|NCT02940626|155782514|FG001|Overall Study|Death|32|||
48435557|NCT02940626|155782513|FG000|Overall Study|Lost to Follow-up|5|||
48435558|NCT02940626|155782514|FG001|Overall Study|Lost to Follow-up|2|||
48435559|NCT02940626|155782513|FG000|Overall Study|Withdrawal by Subject|1|||
48435560|NCT02940626|155782514|FG001|Overall Study|Withdrawal by Subject|0|||
48435561|NCT02940626|155782513|FG000|Overall Study|Transfer to Hospice Care|1|||
48435562|NCT02940626|155782514|FG001|Overall Study|Transfer to Hospice Care|0|||
48435563|NCT02940626|155782513|FG000|Overall Study|Prohibited Concomitant Medication|0|||
48435564|NCT02940626|155782514|FG001|Overall Study|Prohibited Concomitant Medication|1|||
48492585|NCT00827827|155997502|FG001|Overall Study|Fall at home- hospitalization|0|||
48492586|NCT00827827|155997501|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
48492587|NCT00827827|155997502|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
48492588|NCT00827827|155997501|FG000|Overall Study|Gout|1|||
48492589|NCT00827827|155997502|FG001|Overall Study|Gout|0|||
48492590|NCT00827827|155997501|FG000|Overall Study|Transportation issues|1|||
48492591|NCT00827827|155997502|FG001|Overall Study|Transportation issues|0|||
48492592|NCT00827827|155997501|FG000|Overall Study|Burned with water at home|1|||
48492593|NCT00827827|155997502|FG001|Overall Study|Burned with water at home|0|||
48492594|NCT00658320|155997503|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
48492595|NCT00658320|155997504|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
48492596|NCT00658320|155997503|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
48492597|NCT00658320|155997504|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
48492598|NCT00658320|155997503|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
48492599|NCT00658320|155997504|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
48492600|NCT00658320|155997503|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
48492601|NCT00658320|155997504|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
48492602|NCT00685919|155997508|FG000|Overall Study|Withdrawal by Subject|0|||
48492603|NCT00685919|155997509|FG001|Overall Study|Withdrawal by Subject|0|||
48492604|NCT00685919|155997510|FG002|Overall Study|Withdrawal by Subject|1|||
48492605|NCT00685919|155997511|FG003|Overall Study|Withdrawal by Subject|0|||
48492606|NCT00685919|155997508|FG000|Overall Study|Physician Decision|1|||
48492607|NCT00685919|155997509|FG001|Overall Study|Physician Decision|0|||
48492608|NCT00685919|155997510|FG002|Overall Study|Physician Decision|0|||
48492609|NCT00685919|155997511|FG003|Overall Study|Physician Decision|0|||
48492610|NCT02742090|155997512|FG000|Overall Study|Adverse Event|10|||
48492611|NCT02742090|155997512|FG000|Overall Study|Death|3|||
48492612|NCT02742090|155997512|FG000|Overall Study|Disease Progression|25|||
48492613|NCT02742090|155997512|FG000|Overall Study|Investigator's Decision|1|||
48492614|NCT02742090|155997512|FG000|Overall Study|Lost to Follow-up|1|||
48492615|NCT02742090|155997512|FG000|Overall Study|Non-compliance with Study|1|||
48492616|NCT02742090|155997512|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
48492617|NCT02742090|155997512|FG000|Overall Study|Withdrawal by Subject|4|||
48492618|NCT02742090|155997512|FG000|Overall Study|Reason Not Specified|1|||
48492619|NCT02732561|155997513|FG000|Overall Study|Lost to Follow-up|1|||
48492620|NCT02732561|155997514|FG001|Overall Study|Lost to Follow-up|1|||
48492621|NCT02732561|155997513|FG000|Overall Study|Withdrawal by Subject|1|||
48492622|NCT02732561|155997514|FG001|Overall Study|Withdrawal by Subject|0|||
48492623|NCT00832078|155997515|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
48492624|NCT00832078|155997516|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
48492625|NCT00832078|155997515|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
48492626|NCT00832078|155997516|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
48492627|NCT02058628|155997517|FG000|Overall Study|Adverse Event|1|||
48492628|NCT02058628|155997518|FG001|Overall Study|Adverse Event|0|||
48492629|NCT02058628|155997517|FG000|Overall Study|Withdrawal by Subject|2|||
48492630|NCT02058628|155997518|FG001|Overall Study|Withdrawal by Subject|2|||
48492631|NCT02058628|155997517|FG000|Overall Study|Lost to Follow-up|2|||
48492632|NCT02058628|155997518|FG001|Overall Study|Lost to Follow-up|4|||
48492633|NCT02058628|155997517|FG000|Overall Study|Not in time schedule|0|||
48492634|NCT02058628|155997518|FG001|Overall Study|Not in time schedule|1|||
48492635|NCT02058628|155997517|FG000|Overall Study|The visit date was not in timeline|0|||
48492636|NCT02058628|155997518|FG001|Overall Study|The visit date was not in timeline|1|||
48492637|NCT02058628|155997517|FG000|Overall Study|A lot of time for study for participant|1|||
48492638|NCT02058628|155997518|FG001|Overall Study|A lot of time for study for participant|0|||
48492639|NCT02058628|155997517|FG000|Overall Study|Non compliance|1|||
48492640|NCT02058628|155997518|FG001|Overall Study|Non compliance|0|||
48492641|NCT01165684|155997538|FG000|Overall Study|Adverse Event|1|||
48492642|NCT01165684|155997539|FG001|Overall Study|Adverse Event|1|||
48492643|NCT01165684|155997538|FG000|Overall Study|Lack of Efficacy|2|||
48492644|NCT01165684|155997539|FG001|Overall Study|Lack of Efficacy|1|||
48492645|NCT01165684|155997538|FG000|Overall Study|Protocol Violation|7|||
48492646|NCT01165684|155997539|FG001|Overall Study|Protocol Violation|15|||
48712323|NCT01761240|156797142|FG004|Overall Study|Progressive disease:clinical assessment|0|||
48492647|NCT01165684|155997538|FG000|Overall Study|Withdrawal Criteria|2|||
48492648|NCT01165684|155997539|FG001|Overall Study|Withdrawal Criteria|13|||
48492649|NCT01165684|155997538|FG000|Overall Study|Unclassified|16|||
48712324|NCT01761240|156797138|FG000|Overall Study|Withdrawal by Subject|0|||
48492650|NCT01165684|155997539|FG001|Overall Study|Unclassified|22|||
48492651|NCT03347695|155997540|FG000|Overall Study|Death|0|||
48492652|NCT03347695|155997541|FG001|Overall Study|Death|4|||
48492653|NCT03347695|155997540|FG000|Overall Study|Lost to Follow-up|0|||
48492654|NCT03347695|155997541|FG001|Overall Study|Lost to Follow-up|1|||
48492655|NCT00614055|155997542|FG000|Overall Study|Adverse Event|1|||
48492656|NCT00614055|155997543|FG001|Overall Study|Adverse Event|0|||
48712325|NCT01761240|156797139|FG001|Overall Study|Withdrawal by Subject|0|||
48810810|NCT00235443|157148121|FG000|Overall Study|Adverse Event|4|||
48810811|NCT00235443|157148122|FG001|Overall Study|Adverse Event|12|||
48810812|NCT00235443|157148123|FG002|Overall Study|Adverse Event|17|||
48810813|NCT00235443|157148124|FG003|Overall Study|Adverse Event|44|||
48810814|NCT00235443|157148125|FG004|Overall Study|Adverse Event|10|||
48810815|NCT00235443|157148126|FG005|Overall Study|Adverse Event|15|||
48810816|NCT00235443|157148121|FG000|Overall Study|Lack of Efficacy|0|||
48810817|NCT00235443|157148122|FG001|Overall Study|Lack of Efficacy|1|||
48810818|NCT00235443|157148123|FG002|Overall Study|Lack of Efficacy|5|||
48810819|NCT00235443|157148124|FG003|Overall Study|Lack of Efficacy|12|||
48810820|NCT00235443|157148125|FG004|Overall Study|Lack of Efficacy|2|||
48810821|NCT00235443|157148126|FG005|Overall Study|Lack of Efficacy|9|||
48810822|NCT00235443|157148121|FG000|Overall Study|Withdrawal by Subject|3|||
48712326|NCT01761240|156797140|FG002|Overall Study|Withdrawal by Subject|0|||
48712327|NCT01761240|156797141|FG003|Overall Study|Withdrawal by Subject|3|||
48712328|NCT01761240|156797142|FG004|Overall Study|Withdrawal by Subject|1|||
48712329|NCT01761240|156797138|FG000|Overall Study|Adverse Event|0|||
48712330|NCT01761240|156797139|FG001|Overall Study|Adverse Event|0|||
48712331|NCT01761240|156797140|FG002|Overall Study|Adverse Event|0|||
48712332|NCT01761240|156797141|FG003|Overall Study|Adverse Event|1|||
48712333|NCT01761240|156797142|FG004|Overall Study|Adverse Event|6|||
48712334|NCT01761240|156797138|FG000|Overall Study|Death|0|||
48712335|NCT01761240|156797139|FG001|Overall Study|Death|1|||
48712336|NCT01761240|156797140|FG002|Overall Study|Death|1|||
48712337|NCT01761240|156797141|FG003|Overall Study|Death|2|||
48712338|NCT01761240|156797142|FG004|Overall Study|Death|1|||
48712339|NCT01761240|156797138|FG000|Overall Study|Non-compliance|0|||
48712340|NCT01761240|156797139|FG001|Overall Study|Non-compliance|0|||
48712341|NCT01761240|156797140|FG002|Overall Study|Non-compliance|1|||
48712342|NCT01761240|156797141|FG003|Overall Study|Non-compliance|0|||
48712343|NCT01761240|156797142|FG004|Overall Study|Non-compliance|0|||
48712344|NCT02762370|156797143|FG000|Overall Study|Protocol Violation|1|||
48712345|NCT02762370|156797144|FG001|Overall Study|Protocol Violation|0|||
48712346|NCT00509145|156797145|FG000|Overall Study|Death|0|||
48712347|NCT00509145|156797146|FG001|Overall Study|Death|2|||
48712348|NCT00509145|156797145|FG000|Overall Study|Adverse Event|42|||
48712349|NCT00509145|156797146|FG001|Overall Study|Adverse Event|28|||
48712350|NCT00509145|156797145|FG000|Overall Study|Withdrawal by Subject|32|||
48712351|NCT00509145|156797146|FG001|Overall Study|Withdrawal by Subject|38|||
48712352|NCT00509145|156797145|FG000|Overall Study|Physician Decision|11|||
48712353|NCT00509145|156797146|FG001|Overall Study|Physician Decision|14|||
48712354|NCT00509145|156797145|FG000|Overall Study|Protocol Violation|1|||
48712355|NCT00509145|156797146|FG001|Overall Study|Protocol Violation|6|||
48712356|NCT00509145|156797145|FG000|Overall Study|Pregnancy|3|||
48810823|NCT00235443|157148122|FG001|Overall Study|Withdrawal by Subject|9|||
48810824|NCT00235443|157148123|FG002|Overall Study|Withdrawal by Subject|25|||
48810825|NCT00235443|157148124|FG003|Overall Study|Withdrawal by Subject|24|||
48810826|NCT00235443|157148125|FG004|Overall Study|Withdrawal by Subject|10|||
48810827|NCT00235443|157148126|FG005|Overall Study|Withdrawal by Subject|12|||
48810828|NCT00235443|157148121|FG000|Overall Study|Lost to Follow-up|0|||
48810829|NCT00235443|157148122|FG001|Overall Study|Lost to Follow-up|8|||
48810830|NCT00235443|157148123|FG002|Overall Study|Lost to Follow-up|6|||
48810831|NCT00235443|157148124|FG003|Overall Study|Lost to Follow-up|6|||
48810832|NCT00235443|157148125|FG004|Overall Study|Lost to Follow-up|4|||
48810833|NCT00235443|157148126|FG005|Overall Study|Lost to Follow-up|3|||
48810834|NCT00235443|157148121|FG000|Overall Study|Unsatisfactory compliance|0|||
48810835|NCT00235443|157148122|FG001|Overall Study|Unsatisfactory compliance|2|||
48810836|NCT00235443|157148123|FG002|Overall Study|Unsatisfactory compliance|3|||
48712357|NCT00509145|156797146|FG001|Overall Study|Pregnancy|8|||
48810837|NCT00235443|157148124|FG003|Overall Study|Unsatisfactory compliance|4|||
48492657|NCT00614055|155997544|FG002|Overall Study|Adverse Event|0|||
48492658|NCT00614055|155997542|FG000|Overall Study|Protocol Violation|2|||
48492659|NCT00614055|155997543|FG001|Overall Study|Protocol Violation|2|||
48712358|NCT00509145|156797145|FG000|Overall Study|Lost to Follow-up|6|||
48712359|NCT00509145|156797146|FG001|Overall Study|Lost to Follow-up|5|||
48712360|NCT00509145|156797145|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
48712361|NCT00509145|156797146|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
48810838|NCT00235443|157148125|FG004|Overall Study|Unsatisfactory compliance|1|||
48810839|NCT00235443|157148126|FG005|Overall Study|Unsatisfactory compliance|0|||
48810840|NCT00235443|157148121|FG000|Overall Study|Other reasons for premature termination|1|||
48810841|NCT00235443|157148122|FG001|Overall Study|Other reasons for premature termination|6|||
48712362|NCT00509145|156797145|FG000|Overall Study|Other|6|||
48712363|NCT00509145|156797146|FG001|Overall Study|Other|6|||
48712364|NCT00246740|156797147|FG000|Initial Enrollment|Death|1|||
48712365|NCT00246740|156797148|FG001|Initial Enrollment|Death|0|||
48712366|NCT00246740|156797147|FG000|Initial Enrollment|Additional surgery scheduled|0|||
48712367|NCT00246740|156797148|FG001|Initial Enrollment|Additional surgery scheduled|2|||
48810842|NCT00235443|157148123|FG002|Overall Study|Other reasons for premature termination|6|||
48712368|NCT00246740|156797147|FG000|Initial Enrollment|Surgery schedule change|4|||
48712369|NCT00246740|156797148|FG001|Initial Enrollment|Surgery schedule change|4|||
48712370|NCT00246740|156797147|FG000|Initial Enrollment|Other|1|||
48712371|NCT00246740|156797148|FG001|Initial Enrollment|Other|2|||
48712372|NCT00101452|156797149|FG000|Overall Study|Adverse Event|2|||
48712373|NCT00101452|156797150|FG001|Overall Study|Adverse Event|0|||
48810843|NCT00235443|157148124|FG003|Overall Study|Other reasons for premature termination|7|||
48712374|NCT00101452|156797151|FG002|Overall Study|Adverse Event|1|||
48712375|NCT00101452|156797149|FG000|Overall Study|Lost to Follow-up|13|||
48712376|NCT00101452|156797150|FG001|Overall Study|Lost to Follow-up|8|||
48712377|NCT00101452|156797151|FG002|Overall Study|Lost to Follow-up|14|||
48810844|NCT00235443|157148125|FG004|Overall Study|Other reasons for premature termination|3|||
48810845|NCT00235443|157148126|FG005|Overall Study|Other reasons for premature termination|6|||
48810846|NCT03661996|157148134|FG000|Overall Study|Adverse Event|0|||
48810847|NCT03661996|157148135|FG001|Overall Study|Adverse Event|0|||
48810848|NCT03661996|157148136|FG002|Overall Study|Adverse Event|1|||
48810849|NCT03661996|157148137|FG003|Overall Study|Adverse Event|1|||
48712378|NCT00101452|156797149|FG000|Overall Study|Withdrawal by Subject|10|||
48712379|NCT00101452|156797150|FG001|Overall Study|Withdrawal by Subject|14|||
48712380|NCT00101452|156797151|FG002|Overall Study|Withdrawal by Subject|9|||
48712381|NCT00101452|156797149|FG000|Overall Study|Baseline Fail|2|||
48712382|NCT00101452|156797150|FG001|Overall Study|Baseline Fail|1|||
48712383|NCT00101452|156797151|FG002|Overall Study|Baseline Fail|2|||
48712384|NCT00101452|156797149|FG000|Overall Study|Physician Decision|0|||
48712385|NCT00101452|156797150|FG001|Overall Study|Physician Decision|3|||
48712386|NCT00101452|156797151|FG002|Overall Study|Physician Decision|2|||
48712387|NCT00101452|156797149|FG000|Overall Study|Protocol Violation|2|||
48712388|NCT00101452|156797150|FG001|Overall Study|Protocol Violation|1|||
48712389|NCT00101452|156797151|FG002|Overall Study|Protocol Violation|3|||
48712390|NCT00101452|156797149|FG000|Overall Study|Other|15|||
48712391|NCT00101452|156797150|FG001|Overall Study|Other|16|||
48712392|NCT00101452|156797151|FG002|Overall Study|Other|12|||
48712393|NCT02969655|156797152|FG000|Overall Study|Withdrawal by Subject|3|||
48712394|NCT02969655|156797153|FG001|Overall Study|Withdrawal by Subject|2|||
48712395|NCT02969655|156797152|FG000|Overall Study|Physician Decision|4|||
48712396|NCT02969655|156797153|FG001|Overall Study|Physician Decision|3|||
48712397|NCT02969655|156797152|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
48712398|NCT02969655|156797153|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
48712399|NCT02969655|156797152|FG000|Overall Study|Adverse Event|10|||
48712400|NCT02969655|156797153|FG001|Overall Study|Adverse Event|8|||
48712401|NCT00929643|156797154|FG000|Overall Study|Protocol Violation|2|||
48712402|NCT00702715|156799298|FG000|Overall Study|Lost to Follow-up|1|||
48712403|NCT00702715|156799299|FG001|Overall Study|Lost to Follow-up|0|||
48712404|NCT02741518|156799308|FG000|Overall Study|Withdrawal by Subject|1|||
48712405|NCT02741518|156799309|FG001|Overall Study|Withdrawal by Subject|1|||
48712406|NCT02160899|156799310|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
48712407|NCT02160899|156799311|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
48712408|NCT02160899|156799312|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
48712409|NCT02160899|156799313|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
48712410|NCT02160899|156799314|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
48712411|NCT02160899|156799315|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
48712412|NCT01715857|156799318|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
48712413|NCT00499616|156799320|FG000|Overall Study|Death|1|||
48810850|NCT03661996|157148138|FG004|Overall Study|Adverse Event|0|||
48810851|NCT03661996|157148134|FG000|Overall Study|Lost to Follow-up|5|||
48712414|NCT00499616|156799321|FG001|Overall Study|Death|5|||
48712415|NCT00499616|156799322|FG002|Overall Study|Death|3|||
48712416|NCT00499616|156799323|FG003|Overall Study|Death|1|||
48712417|NCT00499616|156799320|FG000|Overall Study|Lack of Efficacy|5|||
48712418|NCT00499616|156799321|FG001|Overall Study|Lack of Efficacy|0|||
48810852|NCT03661996|157148135|FG001|Overall Study|Lost to Follow-up|1|||
48712419|NCT00499616|156799322|FG002|Overall Study|Lack of Efficacy|19|||
48712420|NCT00499616|156799323|FG003|Overall Study|Lack of Efficacy|0|||
48712421|NCT00499616|156799320|FG000|Overall Study|Lost to Follow-up|0|||
48712422|NCT00499616|156799321|FG001|Overall Study|Lost to Follow-up|0|||
48712423|NCT00499616|156799322|FG002|Overall Study|Lost to Follow-up|1|||
48712424|NCT00499616|156799323|FG003|Overall Study|Lost to Follow-up|0|||
48435565|NCT00916370|155782515|FG000|Overall Study|Death|3|||
48712425|NCT00499616|156799320|FG000|Overall Study|Physician Decision|6|||
48712426|NCT00499616|156799321|FG001|Overall Study|Physician Decision|16|||
48712427|NCT00499616|156799322|FG002|Overall Study|Physician Decision|9|||
48712428|NCT00499616|156799323|FG003|Overall Study|Physician Decision|0|||
48712429|NCT00499616|156799320|FG000|Overall Study|Withdrawal by Subject|1|||
48712430|NCT00499616|156799321|FG001|Overall Study|Withdrawal by Subject|0|||
48712431|NCT00499616|156799322|FG002|Overall Study|Withdrawal by Subject|1|||
48712432|NCT00499616|156799323|FG003|Overall Study|Withdrawal by Subject|0|||
48810853|NCT03661996|157148136|FG002|Overall Study|Lost to Follow-up|2|||
48810854|NCT03661996|157148137|FG003|Overall Study|Lost to Follow-up|2|||
48810855|NCT03661996|157148138|FG004|Overall Study|Lost to Follow-up|6|||
48810856|NCT03661996|157148134|FG000|Overall Study|Physician Decision|1|||
48810857|NCT03661996|157148135|FG001|Overall Study|Physician Decision|1|||
48810858|NCT03661996|157148136|FG002|Overall Study|Physician Decision|1|||
48810859|NCT03661996|157148137|FG003|Overall Study|Physician Decision|2|||
48810860|NCT03661996|157148138|FG004|Overall Study|Physician Decision|0|||
48810861|NCT03661996|157148134|FG000|Overall Study|Protocol Violation|0|||
48712433|NCT00499616|156799320|FG000|Overall Study|Ineligible|1|||
48712434|NCT00499616|156799321|FG001|Overall Study|Ineligible|2|||
48712435|NCT00499616|156799322|FG002|Overall Study|Ineligible|0|||
48712436|NCT00499616|156799323|FG003|Overall Study|Ineligible|15|||
48712437|NCT00499616|156799320|FG000|Overall Study|Not evaluable|0|||
48712438|NCT00499616|156799321|FG001|Overall Study|Not evaluable|0|||
48712439|NCT00499616|156799322|FG002|Overall Study|Not evaluable|0|||
48712440|NCT00499616|156799323|FG003|Overall Study|Not evaluable|41|||
48712441|NCT00499616|156799320|FG000|Overall Study|Patient/Parent Refusal|1|||
48712442|NCT00499616|156799321|FG001|Overall Study|Patient/Parent Refusal|5|||
48712443|NCT00499616|156799322|FG002|Overall Study|Patient/Parent Refusal|3|||
48712444|NCT00499616|156799323|FG003|Overall Study|Patient/Parent Refusal|0|||
48712445|NCT00942994|156799324|FG000|Overall Study|Adverse Event|7|||
48712446|NCT00942994|156799325|FG001|Overall Study|Adverse Event|4|||
48712447|NCT00942994|156799324|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48712448|NCT00942994|156799325|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48712449|NCT00942994|156799324|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48712450|NCT00942994|156799325|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48712451|NCT00942994|156799324|FG000|Overall Study|Patient withdrew consent|5|||
48712452|NCT00942994|156799325|FG001|Overall Study|Patient withdrew consent|8|||
48712453|NCT00942994|156799324|FG000|Overall Study|Lost to Follow-up|1|||
48712454|NCT00942994|156799325|FG001|Overall Study|Lost to Follow-up|4|||
48810862|NCT03661996|157148135|FG001|Overall Study|Protocol Violation|0|||
48810863|NCT03661996|157148136|FG002|Overall Study|Protocol Violation|0|||
48810864|NCT03661996|157148137|FG003|Overall Study|Protocol Violation|0|||
48810865|NCT03661996|157148138|FG004|Overall Study|Protocol Violation|1|||
48810866|NCT03661996|157148134|FG000|Overall Study|Withdrawal by Subject|3|||
48810867|NCT03661996|157148135|FG001|Overall Study|Withdrawal by Subject|5|||
48810868|NCT03661996|157148136|FG002|Overall Study|Withdrawal by Subject|1|||
48810869|NCT03661996|157148137|FG003|Overall Study|Withdrawal by Subject|7|||
48810870|NCT03661996|157148138|FG004|Overall Study|Withdrawal by Subject|7|||
48810871|NCT03661996|157148134|FG000|Overall Study|Sponsors Decision|2|||
48810872|NCT03661996|157148135|FG001|Overall Study|Sponsors Decision|0|||
48810873|NCT03661996|157148136|FG002|Overall Study|Sponsors Decision|0|||
48712455|NCT00942994|156799324|FG000|Overall Study|Protocol deviation|1|||
48712456|NCT00942994|156799325|FG001|Overall Study|Protocol deviation|2|||
48712457|NCT00243269|156799326|FG000|Overall Study|Protocol Violation|2|||
48492660|NCT00614055|155997544|FG002|Overall Study|Protocol Violation|1|||
48492661|NCT00614055|155997542|FG000|Overall Study|Lack of Efficacy|0|||
48492662|NCT00614055|155997543|FG001|Overall Study|Lack of Efficacy|0|||
48492663|NCT00614055|155997544|FG002|Overall Study|Lack of Efficacy|2|||
48492664|NCT00614055|155997542|FG000|Overall Study|Unclassified|1|||
48492665|NCT00614055|155997543|FG001|Overall Study|Unclassified|4|||
48492666|NCT00614055|155997544|FG002|Overall Study|Unclassified|2|||
48492667|NCT02884206|155997547|FG000|Valsartan Run-in Period|Death|1|||
48492668|NCT02884206|155997548|FG001|Valsartan Run-in Period|Death|0|||
48492669|NCT02884206|155997549|FG002|Valsartan Run-in Period|Death|0|||
48492670|NCT02884206|155997547|FG000|Valsartan Run-in Period|Adverse Event|31|||
48492671|NCT02884206|155997548|FG001|Valsartan Run-in Period|Adverse Event|0|||
48492672|NCT02884206|155997549|FG002|Valsartan Run-in Period|Adverse Event|0|||
48492673|NCT02884206|155997547|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
48492674|NCT02884206|155997548|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
48492675|NCT02884206|155997549|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
48492676|NCT02884206|155997547|FG000|Valsartan Run-in Period|Protocol deviation|4|||
48492677|NCT02884206|155997548|FG001|Valsartan Run-in Period|Protocol deviation|0|||
48712458|NCT00243269|156799327|FG001|Overall Study|Protocol Violation|1|||
48810874|NCT03661996|157148137|FG003|Overall Study|Sponsors Decision|0|||
48810875|NCT03661996|157148138|FG004|Overall Study|Sponsors Decision|0|||
48810876|NCT03661996|157148134|FG000|Overall Study|Other|1|||
48810877|NCT03661996|157148135|FG001|Overall Study|Other|1|||
48810878|NCT03661996|157148136|FG002|Overall Study|Other|1|||
48810879|NCT03661996|157148137|FG003|Overall Study|Other|1|||
48810880|NCT03661996|157148138|FG004|Overall Study|Other|0|||
48712459|NCT00243269|156799328|FG002|Overall Study|Protocol Violation|0|||
48712460|NCT00243269|156799329|FG003|Overall Study|Protocol Violation|1|||
48712461|NCT00243269|156799326|FG000|Overall Study|Lost to Follow-up|1|||
48712462|NCT00243269|156799327|FG001|Overall Study|Lost to Follow-up|0|||
48712463|NCT00243269|156799328|FG002|Overall Study|Lost to Follow-up|1|||
48712464|NCT00243269|156799329|FG003|Overall Study|Lost to Follow-up|3|||
48712465|NCT03052400|156799330|FG000|Overall Study|Lost to Follow-up|1|||
48712466|NCT03052400|156799331|FG001|Overall Study|Lost to Follow-up|0|||
48712467|NCT03052400|156799330|FG000|Overall Study|Withdrawal by Subject|0|||
48712468|NCT03052400|156799331|FG001|Overall Study|Withdrawal by Subject|1|||
48712469|NCT02314637|156799332|FG000|Overall Study|Adverse Event|4|||
48712470|NCT02314637|156799333|FG001|Overall Study|Adverse Event|8|||
48712471|NCT02314637|156799332|FG000|Overall Study|Lack of Efficacy|1|||
48712472|NCT02314637|156799333|FG001|Overall Study|Lack of Efficacy|0|||
48712473|NCT02314637|156799332|FG000|Overall Study|Physician Decision|5|||
48712474|NCT02314637|156799333|FG001|Overall Study|Physician Decision|2|||
48712475|NCT02314637|156799332|FG000|Overall Study|Withdrawal by Subject|5|||
48712476|NCT02314637|156799333|FG001|Overall Study|Withdrawal by Subject|4|||
48712477|NCT02314637|156799332|FG000|Overall Study|Other Reason|1|||
48712478|NCT02314637|156799333|FG001|Overall Study|Other Reason|0|||
48712479|NCT04027608|156799334|FG000|Overall Study|Withdrawal by Subject|13|||
48712480|NCT04027608|156799335|FG001|Overall Study|Withdrawal by Subject|2|||
48712481|NCT04027608|156799334|FG000|Overall Study|Protocol Violation|2|||
48712482|NCT04027608|156799335|FG001|Overall Study|Protocol Violation|1|||
48712483|NCT04027608|156799334|FG000|Overall Study|Physician Decision|1|||
48712484|NCT04027608|156799335|FG001|Overall Study|Physician Decision|0|||
48712485|NCT04027608|156799334|FG000|Overall Study|Lost to Follow-up|20|||
48712486|NCT04027608|156799335|FG001|Overall Study|Lost to Follow-up|4|||
48712487|NCT01396447|156799336|FG000|Overall Study|Did Not Receive Treatment|3|||
48712488|NCT01396447|156799337|FG001|Overall Study|Did Not Receive Treatment|2|||
48492678|NCT02884206|155997549|FG002|Valsartan Run-in Period|Protocol deviation|0|||
48492679|NCT02884206|155997547|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
48492680|NCT02884206|155997548|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
48492681|NCT02884206|155997549|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
48492682|NCT02884206|155997547|FG000|Valsartan Run-in Period|Physician Decision|1|||
48492683|NCT02884206|155997548|FG001|Valsartan Run-in Period|Physician Decision|0|||
48492684|NCT02884206|155997549|FG002|Valsartan Run-in Period|Physician Decision|0|||
48492685|NCT02884206|155997547|FG000|LCZ696 Run-in Period|Adverse Event|38|||
48492686|NCT02884206|155997548|FG001|LCZ696 Run-in Period|Adverse Event|0|||
48492687|NCT02884206|155997549|FG002|LCZ696 Run-in Period|Adverse Event|0|||
48492688|NCT02884206|155997547|FG000|LCZ696 Run-in Period|Death|2|||
48492689|NCT02884206|155997548|FG001|LCZ696 Run-in Period|Death|0|||
48597628|NCT01025284|156383554|FG000|Overall Study|Withdrawal by Subject|0|||
48597629|NCT01025284|156383555|FG001|Overall Study|Withdrawal by Subject|1|||
48810881|NCT03321513|157148139|FG000|Overall Study|Death|11|||
48810882|NCT03321513|157148140|FG001|Overall Study|Death|5|||
48810883|NCT03321513|157148139|FG000|Overall Study|Withdrawal by Subject|5|||
48810884|NCT03321513|157148140|FG001|Overall Study|Withdrawal by Subject|10|||
48810885|NCT03321513|157148139|FG000|Overall Study|Lost to Follow-up|10|||
48810886|NCT03321513|157148140|FG001|Overall Study|Lost to Follow-up|11|||
48810887|NCT01190215|157148142|FG000|Up to Month 6|Lost to Follow-up|2|||
48810888|NCT01190215|157148143|FG001|Up to Month 6|Lost to Follow-up|0|||
48810889|NCT01478113|157148156|FG000|Overall Study|Withdrawal by Subject|0|||
48810890|NCT01478113|157148157|FG001|Overall Study|Withdrawal by Subject|1|||
48810891|NCT01478113|157148156|FG000|Overall Study|Physician Decision|1|||
48810892|NCT01478113|157148157|FG001|Overall Study|Physician Decision|0|||
48810893|NCT00423293|157148158|FG000|Overall Study|Ineligible / No protocol treatment|11|||
48810894|NCT04399551|157148163|FG000|Overall Study|Adverse Event|15|||
48810895|NCT04399551|157148163|FG000|Overall Study|Withdrawal by Subject|6|||
48810896|NCT04399551|157148163|FG000|Overall Study|Physician Decision|3|||
48810897|NCT04399551|157148163|FG000|Overall Study|Lost to Follow-up|2|||
48810898|NCT04399551|157148163|FG000|Overall Study|Protocol Deviation|2|||
48810899|NCT01014975|157148164|FG000|Overall Study|Withdrawal by Subject|1|||
48810900|NCT01014975|157148165|FG001|Overall Study|Withdrawal by Subject|0|||
48810901|NCT01014975|157148166|FG002|Overall Study|Withdrawal by Subject|1|||
48810902|NCT01014975|157148164|FG000|Overall Study|Death|3|||
48810903|NCT01014975|157148165|FG001|Overall Study|Death|3|||
48810904|NCT01014975|157148166|FG002|Overall Study|Death|4|||
48810905|NCT01014975|157148164|FG000|Overall Study|Lost to Follow-up|0|||
48810906|NCT01014975|157148165|FG001|Overall Study|Lost to Follow-up|0|||
48810907|NCT01014975|157148166|FG002|Overall Study|Lost to Follow-up|1|||
48810908|NCT00633932|157148168|FG000|Overall Study|Adverse Event|1|||
48810909|NCT00633932|157148169|FG001|Overall Study|Adverse Event|3|||
48810910|NCT00633932|157148170|FG002|Overall Study|Adverse Event|4|||
48810911|NCT00633932|157148168|FG000|Overall Study|Withdrawal by Subject|3|||
48810912|NCT00633932|157148169|FG001|Overall Study|Withdrawal by Subject|9|||
48810913|NCT00633932|157148170|FG002|Overall Study|Withdrawal by Subject|1|||
48810914|NCT00633932|157148168|FG000|Overall Study|Lost to Follow-up|1|||
48810915|NCT00633932|157148169|FG001|Overall Study|Lost to Follow-up|0|||
48810916|NCT00633932|157148170|FG002|Overall Study|Lost to Follow-up|2|||
48810917|NCT00633932|157148168|FG000|Overall Study|Protocol Violation|5|||
48810918|NCT00633932|157148169|FG001|Overall Study|Protocol Violation|2|||
48810919|NCT00633932|157148170|FG002|Overall Study|Protocol Violation|3|||
48810920|NCT00633932|157148168|FG000|Overall Study|Physician Decision|0|||
48810921|NCT00633932|157148169|FG001|Overall Study|Physician Decision|0|||
48810922|NCT00633932|157148170|FG002|Overall Study|Physician Decision|1|||
48810923|NCT00633932|157148168|FG000|Overall Study|Doctor's judgement|1|||
48810924|NCT00633932|157148169|FG001|Overall Study|Doctor's judgement|0|||
48810925|NCT00633932|157148170|FG002|Overall Study|Doctor's judgement|0|||
48810926|NCT00633932|157148168|FG000|Overall Study|Moved Away|1|||
48810927|NCT00633932|157148169|FG001|Overall Study|Moved Away|0|||
48810928|NCT00633932|157148170|FG002|Overall Study|Moved Away|0|||
48810929|NCT00067990|157148171|FG000|Overall Study|Death|5|||
48492690|NCT02884206|155997549|FG002|LCZ696 Run-in Period|Death|0|||
48492691|NCT02884206|155997547|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
48492692|NCT02884206|155997548|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
48492693|NCT02884206|155997549|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
48597630|NCT01025284|156383556|FG002|Overall Study|Withdrawal by Subject|0|||
48810930|NCT00067990|157148172|FG001|Overall Study|Death|7|||
48810931|NCT00067990|157148171|FG000|Overall Study|ESRD, Non IF/TA|1|||
48810932|NCT00067990|157148172|FG001|Overall Study|ESRD, Non IF/TA|3|||
48810933|NCT00067990|157148171|FG000|Overall Study|Withdrawal by Subject|4|||
48810934|NCT00067990|157148172|FG001|Overall Study|Withdrawal by Subject|12|||
48810935|NCT01112514|157148175|FG000|Overall Study|Lost to Follow-up|1|||
48810936|NCT02961881|157148176|FG000|Overall Study|Adverse Event|1|||
48810937|NCT02961881|157148177|FG001|Overall Study|Adverse Event|2|||
48810938|NCT02961881|157148178|FG002|Overall Study|Adverse Event|2|||
48810939|NCT02961881|157148179|FG003|Overall Study|Adverse Event|0|||
48810940|NCT02961881|157148180|FG004|Overall Study|Adverse Event|1|||
48810941|NCT02961881|157148176|FG000|Overall Study|Participant request|0|||
48810942|NCT02961881|157148177|FG001|Overall Study|Participant request|2|||
48810943|NCT02961881|157148178|FG002|Overall Study|Participant request|0|||
48810944|NCT02961881|157148179|FG003|Overall Study|Participant request|0|||
48810945|NCT02961881|157148180|FG004|Overall Study|Participant request|0|||
48810946|NCT02961881|157148176|FG000|Overall Study|Disease progression|1|||
48810947|NCT02961881|157148177|FG001|Overall Study|Disease progression|0|||
48810948|NCT02961881|157148178|FG002|Overall Study|Disease progression|1|||
48810949|NCT02961881|157148179|FG003|Overall Study|Disease progression|0|||
48810950|NCT02961881|157148180|FG004|Overall Study|Disease progression|0|||
48810951|NCT01118455|157148181|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
48810952|NCT01118455|157148182|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
48810953|NCT02176421|157148183|FG000|Overall Study|Lost to Follow-up|4|||
48810954|NCT02176421|157148183|FG000|Overall Study|Adverse Event|1|||
48810955|NCT03430063|157148184|FG000|Overall Study|Adverse Event|0|||
48810956|NCT03430063|157148185|FG001|Overall Study|Adverse Event|1|||
48810957|NCT03430063|157148186|FG002|Overall Study|Adverse Event|0|||
48810958|NCT03430063|157148184|FG000|Overall Study|Death|3|||
48810959|NCT03430063|157148185|FG001|Overall Study|Death|2|||
48810960|NCT03430063|157148186|FG002|Overall Study|Death|3|||
48810961|NCT03430063|157148184|FG000|Overall Study|Lost to Follow-up|0|||
48810962|NCT03430063|157148185|FG001|Overall Study|Lost to Follow-up|1|||
48810963|NCT03430063|157148186|FG002|Overall Study|Lost to Follow-up|0|||
48810964|NCT03430063|157148184|FG000|Overall Study|Withdrawal by Subject|0|||
48810965|NCT03430063|157148185|FG001|Overall Study|Withdrawal by Subject|0|||
48810966|NCT03430063|157148186|FG002|Overall Study|Withdrawal by Subject|1|||
48810967|NCT03430063|157148184|FG000|Overall Study|Withdrawal of consent|3|||
48810968|NCT03430063|157148185|FG001|Overall Study|Withdrawal of consent|1|||
48810969|NCT03430063|157148186|FG002|Overall Study|Withdrawal of consent|2|||
48810970|NCT03430063|157148184|FG000|Overall Study|Progressive disease|1|||
48810971|NCT03430063|157148185|FG001|Overall Study|Progressive disease|2|||
48810972|NCT03430063|157148186|FG002|Overall Study|Progressive disease|1|||
48810973|NCT03430063|157148184|FG000|Overall Study|Other un-specified|1|||
48810974|NCT03430063|157148185|FG001|Overall Study|Other un-specified|1|||
48810975|NCT03430063|157148186|FG002|Overall Study|Other un-specified|0|||
48810976|NCT03430063|157148184|FG000|Overall Study|Randomized, but never treated|0|||
48810977|NCT03430063|157148185|FG001|Overall Study|Randomized, but never treated|0|||
48810978|NCT03430063|157148186|FG002|Overall Study|Randomized, but never treated|1|||
48810979|NCT02396537|157148187|FG000|Overall Study|Protocol Violation|0|||
48810980|NCT02396537|157148188|FG001|Overall Study|Protocol Violation|1|||
48810981|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
48810982|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
48810983|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Adverse Event|2|||
48810984|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Adverse Event|5|||
48810985|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
48810986|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
48810987|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
48810988|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
48810989|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Randomized by error|0|||
48810990|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Randomized by error|5|||
48810991|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
48810992|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
48810993|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
48810994|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
48810995|NCT02948959|157148193|FG000|52 Weeks Treatment Period|Change of residence location|0|||
48810996|NCT02948959|157148194|FG001|52 Weeks Treatment Period|Change of residence location|1|||
48810997|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
48810998|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
48810999|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
48811000|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
48811001|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
48811002|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
48811003|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
48811004|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
48492694|NCT02884206|155997547|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
48811005|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
48811006|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
48811007|NCT02948959|157148193|FG000|12 Weeks Follow-up Period|Study site closure|1|||
48811008|NCT02948959|157148194|FG001|12 Weeks Follow-up Period|Study site closure|0|||
48811009|NCT02291432|157148195|FG000|Overall Study|Withdrawal by Subject|2|||
48811010|NCT01932294|157148196|FG000|Overall Study|Death|43|||
48811011|NCT01932294|157148196|FG000|Overall Study|Lost to Follow-up|8|||
48811012|NCT01932294|157148196|FG000|Overall Study|VAD Implantation|20|||
48492695|NCT02884206|155997548|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
48492696|NCT02884206|155997549|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
48492697|NCT02884206|155997547|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
48492698|NCT02884206|155997548|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
48811013|NCT01932294|157148196|FG000|Overall Study|Heart Transplantation|16|||
48811014|NCT01932294|157148196|FG000|Overall Study|Transferred to other hospitals|12|||
48811015|NCT03377790|157148198|FG000|Overall Study|Withdrawal by Subject|1|||
48811016|NCT03377790|157148199|FG001|Overall Study|Withdrawal by Subject|0|||
48492699|NCT02884206|155997549|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
48492700|NCT02884206|155997547|FG000|LCZ696 Run-in Period|Physician Decision|1|||
48492701|NCT02884206|155997548|FG001|LCZ696 Run-in Period|Physician Decision|0|||
48492702|NCT02884206|155997549|FG002|LCZ696 Run-in Period|Physician Decision|0|||
48492703|NCT02884206|155997547|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
48492704|NCT02884206|155997548|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
48492705|NCT02884206|155997549|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
48492706|NCT02884206|155997547|FG000|Double-Blind Period|Death|0|||
48492707|NCT02884206|155997548|FG001|Double-Blind Period|Death|28|||
48492708|NCT02884206|155997549|FG002|Double-Blind Period|Death|39|||
48492709|NCT02884206|155997547|FG000|Double-Blind Period|Patient/guardian decision|0|||
48492710|NCT02884206|155997548|FG001|Double-Blind Period|Patient/guardian decision|10|||
48492711|NCT02884206|155997549|FG002|Double-Blind Period|Patient/guardian decision|13|||
48492712|NCT02884206|155997547|FG000|Double-Blind Period|Lost to Follow-up|0|||
48492713|NCT02884206|155997548|FG001|Double-Blind Period|Lost to Follow-up|4|||
48492714|NCT02884206|155997549|FG002|Double-Blind Period|Lost to Follow-up|4|||
48492715|NCT02884206|155997547|FG000|Double-Blind Period|Physician Decision|0|||
48492716|NCT02884206|155997548|FG001|Double-Blind Period|Physician Decision|2|||
48492717|NCT02884206|155997549|FG002|Double-Blind Period|Physician Decision|0|||
48811017|NCT03377790|157148198|FG000|Overall Study|Adverse Event|1|||
48811018|NCT03377790|157148199|FG001|Overall Study|Adverse Event|0|||
48811019|NCT03377790|157148198|FG000|Overall Study|Lost to Follow-up|0|||
48811020|NCT03377790|157148199|FG001|Overall Study|Lost to Follow-up|2|||
48811021|NCT03377790|157148198|FG000|Overall Study|Randomized but not treated|1|||
48811022|NCT03377790|157148199|FG001|Overall Study|Randomized but not treated|0|||
48811023|NCT03377790|157148198|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
48811024|NCT03377790|157148199|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
48811025|NCT02145078|157148200|FG000|Overall Study|Death|1|||
48811026|NCT02145078|157148200|FG000|Overall Study|Reason not given|3|||
48811027|NCT02632786|157148201|FG000|Overall Study|Adverse Event|2|||
48811028|NCT02632786|157148202|FG001|Overall Study|Adverse Event|1|||
48811029|NCT02632786|157148201|FG000|Overall Study|Death|3|||
48811030|NCT02632786|157148202|FG001|Overall Study|Death|2|||
48811031|NCT02632786|157148201|FG000|Overall Study|Physician Decision|5|||
48811032|NCT02632786|157148202|FG001|Overall Study|Physician Decision|4|||
48811033|NCT02632786|157148201|FG000|Overall Study|Withdrawal by Subject|1|||
48811034|NCT02632786|157148202|FG001|Overall Study|Withdrawal by Subject|0|||
48811035|NCT00597714|157148203|FG000|Overall Study|Death|56|||
48811036|NCT00597714|157148204|FG001|Overall Study|Death|46|||
48811037|NCT00597714|157148205|FG002|Overall Study|Death|0|||
48811038|NCT00597714|157148203|FG000|Overall Study|Recipient death|0|||
48811039|NCT00597714|157148204|FG001|Overall Study|Recipient death|0|||
48811040|NCT00597714|157148205|FG002|Overall Study|Recipient death|10|||
48811041|NCT00810082|157148206|FG000|Overall Study|Lost to Follow-up|0|||
48811042|NCT00810082|157148207|FG001|Overall Study|Lost to Follow-up|4|||
48811043|NCT03810313|157148208|FG000|Overall Study|Study terminated by sponsor|164|||
48492718|NCT02884206|155997547|FG000|Double-Blind Period|Adverse Event|0|||
48492719|NCT02884206|155997548|FG001|Double-Blind Period|Adverse Event|0|||
48492720|NCT02884206|155997549|FG002|Double-Blind Period|Adverse Event|3|||
48492721|NCT02884206|155997547|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
48492722|NCT02884206|155997548|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
48811044|NCT03810313|157148209|FG001|Overall Study|Study terminated by sponsor|159|||
48811045|NCT03810313|157148208|FG000|Overall Study|Subject decision|10|||
48811046|NCT03810313|157148209|FG001|Overall Study|Subject decision|11|||
48492723|NCT02884206|155997549|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
48597631|NCT01000974|156383557|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
48811047|NCT03810313|157148208|FG000|Overall Study|Lost to Follow-up|3|||
48811048|NCT03810313|157148209|FG001|Overall Study|Lost to Follow-up|3|||
48811049|NCT03810313|157148208|FG000|Overall Study|Adverse Event|2|||
48811050|NCT03810313|157148209|FG001|Overall Study|Adverse Event|1|||
48811051|NCT03810313|157148208|FG000|Overall Study|Death|2|||
48811052|NCT03810313|157148209|FG001|Overall Study|Death|1|||
48811053|NCT03810313|157148208|FG000|Overall Study|Physician Decision|0|||
48811054|NCT03810313|157148209|FG001|Overall Study|Physician Decision|1|||
48811055|NCT00152763|157148210|FG000|Overall Study|Death|4|||
48811056|NCT00152763|157148211|FG001|Overall Study|Death|1|||
48811057|NCT00152763|157148212|FG002|Overall Study|Death|2|||
48811058|NCT00152763|157148213|FG003|Overall Study|Death|1|||
48811059|NCT00152763|157148210|FG000|Overall Study|Lost to Follow-up|6|||
48811060|NCT00152763|157148211|FG001|Overall Study|Lost to Follow-up|4|||
48811061|NCT00152763|157148212|FG002|Overall Study|Lost to Follow-up|2|||
48811062|NCT00152763|157148213|FG003|Overall Study|Lost to Follow-up|13|||
48811063|NCT01965158|157148214|FG000|Overall Study|Adverse Event|14|||
48811064|NCT01965158|157148215|FG001|Overall Study|Adverse Event|5|||
48435566|NCT00916370|155782516|FG001|Overall Study|Death|1|||
48435567|NCT00916370|155782515|FG000|Overall Study|Withdrawal by Subject|2|||
48435568|NCT00916370|155782516|FG001|Overall Study|Withdrawal by Subject|0|||
48435569|NCT00916370|155782515|FG000|Overall Study|Physician Decision|0|||
48492724|NCT00671879|155997556|FG000|Overall Study|Withdrawal by Subject|0|||
48492725|NCT00671879|155997557|FG001|Overall Study|Withdrawal by Subject|4|||
48492726|NCT00671879|155997558|FG002|Overall Study|Withdrawal by Subject|6|||
48492727|NCT04633837|155997578|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
48492728|NCT04633837|155997579|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
48492729|NCT01886300|155997580|FG000|Overall Study|Trial terminated by sponsor|16|||
48492730|NCT04527471|155997583|FG000|Overall Study|Adverse Event|1|||
48492731|NCT04527471|155997584|FG001|Overall Study|Adverse Event|0|||
48492732|NCT04527471|155997583|FG000|Overall Study|Lost to Follow-up|1|||
48492733|NCT04527471|155997584|FG001|Overall Study|Lost to Follow-up|0|||
48492734|NCT00947427|155997592|FG000|Overall Study|Withdrawal by Subject|1|||
48492735|NCT00947427|155997593|FG001|Overall Study|Withdrawal by Subject|3|||
48492736|NCT00947427|155997592|FG000|Overall Study|Protocol Violation|0|||
48492737|NCT00947427|155997593|FG001|Overall Study|Protocol Violation|1|||
48492738|NCT00112489|155997596|FG000|Overall Study|Refused further treatment|8|||
48492739|NCT00112489|155997596|FG000|Overall Study|Adverse Event|12|||
48492740|NCT00112489|155997596|FG000|Overall Study|Death|2|||
48492741|NCT00112489|155997596|FG000|Overall Study|Other, Not Specified|9|||
48492742|NCT00112489|155997596|FG000|Overall Study|Patient never treated|2|||
48811065|NCT01965158|157148214|FG000|Overall Study|Withdrawal by Subject|16|||
48811066|NCT01965158|157148215|FG001|Overall Study|Withdrawal by Subject|24|||
48811067|NCT01965158|157148214|FG000|Overall Study|Lost to Follow-up|7|||
48811068|NCT01965158|157148215|FG001|Overall Study|Lost to Follow-up|5|||
48811069|NCT01965158|157148214|FG000|Overall Study|Protocol Violation|1|||
48811070|NCT01965158|157148215|FG001|Overall Study|Protocol Violation|1|||
48811071|NCT01965158|157148214|FG000|Overall Study|Other - Miscellaneous|3|||
48811072|NCT01965158|157148215|FG001|Overall Study|Other - Miscellaneous|0|||
48811073|NCT00301080|157148217|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
48811074|NCT00301080|157148218|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
48811075|NCT00301080|157148219|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
48811076|NCT00301080|157148220|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
48811077|NCT00301080|157148221|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
48492743|NCT00112489|155997596|FG000|Overall Study|Ineligible|7|||
48492744|NCT01612000|155997597|FG000|Overall Study|Lost to Follow-up|6|||
48492745|NCT01612000|155997598|FG001|Overall Study|Lost to Follow-up|4|||
48492746|NCT01612000|155997599|FG002|Overall Study|Lost to Follow-up|4|||
48492747|NCT01612000|155997600|FG003|Overall Study|Lost to Follow-up|8|||
48492748|NCT01612000|155997597|FG000|Overall Study|Physician Decision|0|||
48492749|NCT01612000|155997598|FG001|Overall Study|Physician Decision|0|||
48492750|NCT01612000|155997599|FG002|Overall Study|Physician Decision|1|||
48492751|NCT01612000|155997600|FG003|Overall Study|Physician Decision|0|||
48492752|NCT01612000|155997597|FG000|Overall Study|Withdrawal by Subject|3|||
48492753|NCT01612000|155997598|FG001|Overall Study|Withdrawal by Subject|1|||
48492754|NCT01612000|155997599|FG002|Overall Study|Withdrawal by Subject|2|||
48492755|NCT01612000|155997600|FG003|Overall Study|Withdrawal by Subject|2|||
48492756|NCT01107535|155997601|FG000|Overall Study|Death|5|||
48492757|NCT01214603|155997611|FG000|Overall Study|Adverse Event|0|||
48492758|NCT01214603|155997612|FG001|Overall Study|Adverse Event|0|||
48492759|NCT01214603|155997613|FG002|Overall Study|Adverse Event|1|||
48492760|NCT01214603|155997611|FG000|Overall Study|Death|1|||
48492761|NCT01214603|155997612|FG001|Overall Study|Death|0|||
48492762|NCT01214603|155997613|FG002|Overall Study|Death|0|||
48492763|NCT01214603|155997611|FG000|Overall Study|Progressive Disease|4|||
48492764|NCT01214603|155997612|FG001|Overall Study|Progressive Disease|1|||
48492765|NCT01214603|155997613|FG002|Overall Study|Progressive Disease|3|||
48492766|NCT00384033|155997614|FG000|Overall Study|Adverse Event|10|||
48492767|NCT00384033|155997615|FG001|Overall Study|Adverse Event|8|||
48492768|NCT00384033|155997616|FG002|Overall Study|Adverse Event|11|||
48492769|NCT00384033|155997617|FG003|Overall Study|Adverse Event|20|||
48492770|NCT00384033|155997614|FG000|Overall Study|Failed to return|1|||
48492771|NCT00384033|155997615|FG001|Overall Study|Failed to return|3|||
48492772|NCT00384033|155997616|FG002|Overall Study|Failed to return|2|||
48492773|NCT00384033|155997617|FG003|Overall Study|Failed to return|2|||
48811078|NCT01234649|157148223|FG000|Overall Study|Withdrawal by Subject|32|||
48811079|NCT01234649|157148224|FG001|Overall Study|Withdrawal by Subject|26|||
48492774|NCT00384033|155997614|FG000|Overall Study|Physician Decision|1|||
48492775|NCT00384033|155997615|FG001|Overall Study|Physician Decision|0|||
48492776|NCT00384033|155997616|FG002|Overall Study|Physician Decision|0|||
48492777|NCT00384033|155997617|FG003|Overall Study|Physician Decision|0|||
48492778|NCT00384033|155997614|FG000|Overall Study|Lost to Follow-up|6|||
48492779|NCT00384033|155997615|FG001|Overall Study|Lost to Follow-up|12|||
48492780|NCT00384033|155997616|FG002|Overall Study|Lost to Follow-up|7|||
48811080|NCT01234649|157148223|FG000|Overall Study|Pregnancy|6|||
48811081|NCT01234649|157148224|FG001|Overall Study|Pregnancy|6|||
48811082|NCT01234649|157148223|FG000|Overall Study|intolerant to side effects|4|||
48492781|NCT00384033|155997617|FG003|Overall Study|Lost to Follow-up|7|||
48492782|NCT00384033|155997614|FG000|Overall Study|Other|2|||
48492783|NCT00384033|155997615|FG001|Overall Study|Other|0|||
48811083|NCT01234649|157148224|FG001|Overall Study|intolerant to side effects|3|||
48811084|NCT01234649|157148223|FG000|Overall Study|Allergic reaction|1|||
48811085|NCT01234649|157148224|FG001|Overall Study|Allergic reaction|0|||
48811086|NCT01234649|157148223|FG000|Overall Study|Lack of Efficacy|0|||
48811087|NCT01234649|157148224|FG001|Overall Study|Lack of Efficacy|3|||
48811088|NCT01088529|157148225|FG000|Overall Study|Did not receive study treatment|0|||
48811089|NCT01088529|157148226|FG001|Overall Study|Did not receive study treatment|1|||
48811090|NCT03560245|157148227|FG000|Overall Study|Withdrawal by Subject|3|||
48811091|NCT03560245|157148228|FG001|Overall Study|Withdrawal by Subject|2|||
48811092|NCT03560245|157148227|FG000|Overall Study|Adverse Event|1|||
48811093|NCT03560245|157148228|FG001|Overall Study|Adverse Event|1|||
48811094|NCT03560245|157148227|FG000|Overall Study|Protocol Violation|1|||
48811095|NCT03560245|157148228|FG001|Overall Study|Protocol Violation|0|||
48811096|NCT03560245|157148227|FG000|Overall Study|Death|0|||
48811097|NCT03560245|157148228|FG001|Overall Study|Death|1|||
48811098|NCT03560245|157148227|FG000|Overall Study|Lost to Follow-up|0|||
48811099|NCT03560245|157148228|FG001|Overall Study|Lost to Follow-up|1|||
48811100|NCT03560245|157148227|FG000|Overall Study|Physician Decision|0|||
48811101|NCT03560245|157148228|FG001|Overall Study|Physician Decision|1|||
48811102|NCT03560245|157148227|FG000|Overall Study|Other|0|||
48811103|NCT03560245|157148228|FG001|Overall Study|Other|1|||
48811104|NCT00195715|157148236|FG000|Overall Study|Adverse Event|122|||
48811105|NCT00195715|157148236|FG000|Overall Study|Withdrawal by Subject|58|||
48811106|NCT00195715|157148236|FG000|Overall Study|Lost to Follow-up|27|||
48811107|NCT00195715|157148236|FG000|Overall Study|Protocol Violation|13|||
48811108|NCT00195715|157148236|FG000|Overall Study|Lack of Efficacy|93|||
48811109|NCT00195715|157148236|FG000|Overall Study|Pregnancy|14|||
48811110|NCT00195715|157148236|FG000|Overall Study|Investigative site closure|8|||
48811111|NCT00195715|157148236|FG000|Overall Study|Subject moved/relocated|7|||
48811112|NCT00195715|157148236|FG000|Overall Study|Subject non-compliance|6|||
48811113|NCT00195715|157148236|FG000|Overall Study|Subject started commercial Humira|5|||
48811114|NCT00195715|157148236|FG000|Overall Study|Subject choice|3|||
48811115|NCT00195715|157148236|FG000|Overall Study|Loss of response/no improvement|3|||
48811116|NCT00195715|157148236|FG000|Overall Study|Sponsor stopped study|1|||
48811117|NCT00195715|157148236|FG000|Overall Study|Administrative reasons|2|||
48811118|NCT00195715|157148236|FG000|Overall Study|Investigator's decision|2|||
48811119|NCT00195715|157148236|FG000|Overall Study|Subject wants to get pregnant|4|||
48811120|NCT00195715|157148236|FG000|Overall Study|Use of prohibited medication|2|||
48811121|NCT00195715|157148236|FG000|Overall Study|Planned surgery|2|||
48811122|NCT00195715|157148236|FG000|Overall Study|Increased infection rate|1|||
48811123|NCT00195715|157148236|FG000|Overall Study|Ineligible|1|||
48811124|NCT00195715|157148236|FG000|Overall Study|Colonic stricture|1|||
48811125|NCT00195715|157148236|FG000|Overall Study|Sponsor discontinued trial|1|||
48811126|NCT00195715|157148236|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
48811127|NCT00547911|157148242|FG000|Overall Study|Adverse Event|0|||
48811128|NCT00547911|157148243|FG001|Overall Study|Adverse Event|0|||
48811129|NCT00547911|157148244|FG002|Overall Study|Adverse Event|0|||
48811130|NCT00547911|157148245|FG003|Overall Study|Adverse Event|1|||
48811131|NCT00547911|157148246|FG004|Overall Study|Adverse Event|0|||
48811132|NCT00547911|157148247|FG005|Overall Study|Adverse Event|0|||
48811133|NCT03363659|157148248|FG000|Overall Study|Adverse Event|1|||
48811134|NCT03363659|157148248|FG000|Overall Study|Screen fail|1|||
48811135|NCT03363659|157148248|FG000|Overall Study|Withdrawal by Subject|1|||
48811136|NCT03075501|157149862|FG000|Overall Study|Scheduling difficulties|15|||
48811137|NCT03075501|157149863|FG001|Overall Study|Scheduling difficulties|9|||
48811138|NCT04567693|157149864|FG000|Overall Study|Death|0|||
48811139|NCT04567693|157149865|FG001|Overall Study|Death|0|||
48811140|NCT04567693|157149866|FG002|Overall Study|Death|2|||
48811141|NCT04567693|157149864|FG000|Overall Study|Lost to Follow-up|1|||
48811142|NCT04567693|157149865|FG001|Overall Study|Lost to Follow-up|0|||
48811143|NCT04567693|157149866|FG002|Overall Study|Lost to Follow-up|2|||
48811144|NCT04567693|157149864|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
48492784|NCT00384033|155997616|FG002|Overall Study|Other|0|||
48811145|NCT04567693|157149865|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
48811146|NCT04567693|157149866|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
48811147|NCT02959671|157149867|FG000|Overall Study|Adverse Event|2|||
48811148|NCT02959671|157149867|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
48492785|NCT00384033|155997617|FG003|Overall Study|Other|0|||
48811149|NCT01027364|157149881|FG000|Overall Study|Adverse Event|1|||
48811150|NCT01027364|157149882|FG001|Overall Study|Adverse Event|0|||
48811151|NCT01027364|157149883|FG002|Overall Study|Adverse Event|1|||
48811152|NCT01027364|157149884|FG003|Overall Study|Adverse Event|0|||
48811153|NCT01027364|157149881|FG000|Overall Study|Lost to Follow-up|1|||
48811154|NCT01027364|157149882|FG001|Overall Study|Lost to Follow-up|0|||
48492786|NCT00384033|155997614|FG000|Overall Study|Protocol Violation|5|||
48811155|NCT01027364|157149883|FG002|Overall Study|Lost to Follow-up|0|||
48811156|NCT01027364|157149884|FG003|Overall Study|Lost to Follow-up|0|||
48492787|NCT00384033|155997615|FG001|Overall Study|Protocol Violation|0|||
48811157|NCT01027364|157149881|FG000|Overall Study|Protocol Violation|1|||
48811158|NCT01027364|157149882|FG001|Overall Study|Protocol Violation|0|||
48811159|NCT01027364|157149883|FG002|Overall Study|Protocol Violation|0|||
48811160|NCT01027364|157149884|FG003|Overall Study|Protocol Violation|1|||
48811161|NCT01027364|157149881|FG000|Overall Study|Withdrawal by Subject|1|||
48811162|NCT01027364|157149882|FG001|Overall Study|Withdrawal by Subject|2|||
48811163|NCT01027364|157149883|FG002|Overall Study|Withdrawal by Subject|0|||
48811164|NCT01027364|157149884|FG003|Overall Study|Withdrawal by Subject|0|||
48811165|NCT04076020|157149886|FG000|Overall Study|Death|4|||
48811166|NCT04076020|157149887|FG001|Overall Study|Death|6|||
48811167|NCT04076020|157149886|FG000|Overall Study|Withdrawal by Subject|12|||
48811168|NCT04076020|157149887|FG001|Overall Study|Withdrawal by Subject|8|||
48811169|NCT00562978|157149891|FG000|Overall Study|Patient had imaging dose only|1|||
48811170|NCT00562978|157149892|FG001|Overall Study|Patient had imaging dose only|11|||
48811171|NCT00152971|157149893|FG000|Overall Study|Adverse Event|12|||
48811172|NCT00152971|157149894|FG001|Overall Study|Adverse Event|10|||
48811173|NCT00152971|157149895|FG002|Overall Study|Adverse Event|9|||
48811174|NCT00152971|157149893|FG000|Overall Study|Protocol Violation|10|||
48811175|NCT00152971|157149894|FG001|Overall Study|Protocol Violation|11|||
48811176|NCT00152971|157149895|FG002|Overall Study|Protocol Violation|8|||
48811177|NCT00152971|157149893|FG000|Overall Study|Lost to Follow-up|17|||
48811178|NCT00152971|157149894|FG001|Overall Study|Lost to Follow-up|14|||
48811179|NCT00152971|157149895|FG002|Overall Study|Lost to Follow-up|13|||
48811180|NCT00152971|157149893|FG000|Overall Study|Withdrawal by Subject|9|||
48811181|NCT00152971|157149894|FG001|Overall Study|Withdrawal by Subject|8|||
48811182|NCT00152971|157149895|FG002|Overall Study|Withdrawal by Subject|14|||
48811183|NCT00152971|157149893|FG000|Overall Study|Other|3|||
48811184|NCT00152971|157149894|FG001|Overall Study|Other|5|||
48811185|NCT00152971|157149895|FG002|Overall Study|Other|5|||
48811186|NCT00152971|157149893|FG000|Treatment|Adverse Event|49|||
48811187|NCT00152971|157149894|FG001|Treatment|Adverse Event|40|||
48811188|NCT00152971|157149895|FG002|Treatment|Adverse Event|54|||
48811189|NCT00152971|157149893|FG000|Treatment|Protocol Violation|8|||
48811190|NCT00152971|157149894|FG001|Treatment|Protocol Violation|6|||
48811191|NCT00152971|157149895|FG002|Treatment|Protocol Violation|10|||
48811192|NCT00152971|157149893|FG000|Treatment|Lost to Follow-up|1|||
48811193|NCT00152971|157149894|FG001|Treatment|Lost to Follow-up|2|||
48811194|NCT00152971|157149895|FG002|Treatment|Lost to Follow-up|1|||
48811195|NCT00152971|157149893|FG000|Treatment|Withdrawal by Subject|4|||
48811196|NCT00152971|157149894|FG001|Treatment|Withdrawal by Subject|4|||
48811197|NCT00152971|157149895|FG002|Treatment|Withdrawal by Subject|5|||
48811198|NCT00152971|157149893|FG000|Treatment|Other|9|||
48811199|NCT00152971|157149894|FG001|Treatment|Other|11|||
48811200|NCT00152971|157149895|FG002|Treatment|Other|10|||
48811201|NCT00545363|157149896|FG000|Overall Study|Adverse Event|6|||
48811202|NCT00545363|157149897|FG001|Overall Study|Adverse Event|7|||
48811203|NCT00545363|157149896|FG000|Overall Study|Withdrawal by Subject|6|||
48811204|NCT00545363|157149897|FG001|Overall Study|Withdrawal by Subject|5|||
48811205|NCT00545363|157149896|FG000|Overall Study|Non-compliance|3|||
48811206|NCT00545363|157149897|FG001|Overall Study|Non-compliance|1|||
48811207|NCT00545363|157149896|FG000|Overall Study|Did not meet entry criteria|1|||
48811208|NCT00545363|157149897|FG001|Overall Study|Did not meet entry criteria|1|||
48811209|NCT00545363|157149896|FG000|Overall Study|Lost to Follow-up|2|||
48811210|NCT00545363|157149897|FG001|Overall Study|Lost to Follow-up|0|||
48811211|NCT00545363|157149896|FG000|Overall Study|Other|1|||
48811212|NCT00545363|157149897|FG001|Overall Study|Other|1|||
48811213|NCT02001974|157149898|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
48811214|NCT02001974|157149899|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
48811215|NCT02001974|157149900|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
48811216|NCT02001974|157149898|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
48811217|NCT02001974|157149899|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
48811218|NCT02001974|157149900|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
48811219|NCT02001974|157149898|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
48811220|NCT02001974|157149899|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
48811221|NCT02001974|157149900|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
48811222|NCT02001974|157149898|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
48811223|NCT02001974|157149899|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
48811224|NCT02001974|157149900|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
48811225|NCT01306201|157149901|FG000|Overall Study|Arrhythmia|4|||
48811226|NCT01306201|157149901|FG000|Overall Study|Files could not be processed|3|||
48811227|NCT01306201|157149901|FG000|Overall Study|Files unreadable|3|||
48811228|NCT02597933|157149904|FG000|Overall Study|Withdrawal by Subject|7|||
48811229|NCT02597933|157149905|FG001|Overall Study|Withdrawal by Subject|5|||
48811230|NCT02597933|157149904|FG000|Overall Study|Protocol Violation|2|||
48811231|NCT02597933|157149905|FG001|Overall Study|Protocol Violation|2|||
48811232|NCT02597933|157149904|FG000|Overall Study|Adverse Event|20|||
48811233|NCT02597933|157149905|FG001|Overall Study|Adverse Event|28|||
48811234|NCT02597933|157149904|FG000|Overall Study|Not treated|2|||
48811235|NCT02597933|157149905|FG001|Overall Study|Not treated|2|||
48811236|NCT02597933|157149904|FG000|Overall Study|Other than stated above|7|||
48811237|NCT02597933|157149905|FG001|Overall Study|Other than stated above|14|||
48811238|NCT01107743|157149922|FG000|Overall Study|Protocol Violation|46|||
48811239|NCT01225822|157149925|FG000|Overall Study|Adverse Event|13|||
48811240|NCT01225822|157149926|FG001|Overall Study|Adverse Event|31|||
48811241|NCT01225822|157149927|FG002|Overall Study|Adverse Event|18|||
48811242|NCT01225822|157149928|FG003|Overall Study|Adverse Event|23|||
48811243|NCT01225822|157149929|FG004|Overall Study|Adverse Event|14|||
48811244|NCT01225822|157149925|FG000|Overall Study|Protocol Violation|6|||
48811245|NCT01225822|157149926|FG001|Overall Study|Protocol Violation|8|||
48811246|NCT01225822|157149927|FG002|Overall Study|Protocol Violation|6|||
48811247|NCT01225822|157149928|FG003|Overall Study|Protocol Violation|7|||
48811248|NCT01225822|157149929|FG004|Overall Study|Protocol Violation|4|||
48811249|NCT01225822|157149925|FG000|Overall Study|Lost to Follow-up|0|||
48811250|NCT01225822|157149926|FG001|Overall Study|Lost to Follow-up|0|||
48811251|NCT01225822|157149927|FG002|Overall Study|Lost to Follow-up|0|||
48811252|NCT01225822|157149928|FG003|Overall Study|Lost to Follow-up|1|||
48811253|NCT01225822|157149929|FG004|Overall Study|Lost to Follow-up|0|||
48811254|NCT01225822|157149925|FG000|Overall Study|Withdrawal by Subject|6|||
48811255|NCT01225822|157149926|FG001|Overall Study|Withdrawal by Subject|7|||
48811256|NCT01225822|157149927|FG002|Overall Study|Withdrawal by Subject|7|||
48811257|NCT01225822|157149928|FG003|Overall Study|Withdrawal by Subject|11|||
48811258|NCT01225822|157149929|FG004|Overall Study|Withdrawal by Subject|6|||
48811259|NCT01225822|157149925|FG000|Overall Study|Other|13|||
48811260|NCT01225822|157149926|FG001|Overall Study|Other|10|||
48811261|NCT01225822|157149927|FG002|Overall Study|Other|7|||
48811262|NCT01225822|157149928|FG003|Overall Study|Other|10|||
48811263|NCT01225822|157149929|FG004|Overall Study|Other|7|||
48811264|NCT00630058|157149930|FG000|Overall Study|Adverse Event|1|||
48811265|NCT00630058|157149931|FG001|Overall Study|Adverse Event|1|||
48811266|NCT00630058|157149930|FG000|Overall Study|Withdrawal by Subject|0|||
48811267|NCT00630058|157149931|FG001|Overall Study|Withdrawal by Subject|1|||
48811268|NCT00630058|157149930|FG000|Overall Study|stopping criteria|3|||
48811269|NCT00630058|157149931|FG001|Overall Study|stopping criteria|2|||
48811270|NCT01597505|157149932|FG000|Overall Study|Physician Decision|5|||
48811271|NCT01597505|157149933|FG001|Overall Study|Physician Decision|0|||
48811272|NCT01597505|157149932|FG000|Overall Study|Adverse Event|19|||
48811273|NCT01597505|157149933|FG001|Overall Study|Adverse Event|7|||
48492788|NCT00384033|155997616|FG002|Overall Study|Protocol Violation|5|||
48811274|NCT01597505|157149932|FG000|Overall Study|Lost to Follow-up|4|||
48811275|NCT01597505|157149933|FG001|Overall Study|Lost to Follow-up|2|||
48811276|NCT01597505|157149932|FG000|Overall Study|Withdrawal by Subject|10|||
48811277|NCT01597505|157149933|FG001|Overall Study|Withdrawal by Subject|18|||
48811278|NCT01597505|157149932|FG000|Overall Study|Other|5|||
48811279|NCT01597505|157149933|FG001|Overall Study|Other|6|||
48811280|NCT01597505|157149932|FG000|Overall Study|Missing|1|||
48811281|NCT01597505|157149933|FG001|Overall Study|Missing|0|||
48811282|NCT03856996|157149936|FG000|Overall Study|Withdrawal by Subject|1|||
48811283|NCT03856996|157149937|FG001|Overall Study|Withdrawal by Subject|0|||
48811284|NCT03856996|157149936|FG000|Overall Study|Lost to Follow-up|0|||
48811285|NCT03856996|157149937|FG001|Overall Study|Lost to Follow-up|1|||
48811286|NCT03856996|157149936|FG000|Overall Study|Adverse Event|1|||
48811287|NCT03856996|157149937|FG001|Overall Study|Adverse Event|1|||
48492789|NCT00384033|155997617|FG003|Overall Study|Protocol Violation|6|||
48811288|NCT03856996|157149936|FG000|Overall Study|Other|1|||
48811289|NCT03856996|157149937|FG001|Overall Study|Other|0|||
48811290|NCT01290822|157149938|FG000|Overall Study|Withdrawal by Subject|1|||
48492790|NCT00384033|155997614|FG000|Overall Study|Withdrawal by Subject|6|||
48811291|NCT01290822|157149938|FG000|Overall Study|Physician Decision|10|||
48811292|NCT01003639|157149939|FG000|Overall Study|Lost to Follow-up|6|||
48492791|NCT00384033|155997615|FG001|Overall Study|Withdrawal by Subject|2|||
48492792|NCT00384033|155997616|FG002|Overall Study|Withdrawal by Subject|5|||
48492793|NCT00384033|155997617|FG003|Overall Study|Withdrawal by Subject|2|||
48492794|NCT00384033|155997614|FG000|Overall Study|Lack of Efficacy|7|||
48492795|NCT00384033|155997615|FG001|Overall Study|Lack of Efficacy|3|||
48492796|NCT00384033|155997616|FG002|Overall Study|Lack of Efficacy|3|||
48492797|NCT00384033|155997617|FG003|Overall Study|Lack of Efficacy|1|||
48492798|NCT00384033|155997614|FG000|Overall Study|Randomized but not treated|3|||
48492799|NCT00384033|155997615|FG001|Overall Study|Randomized but not treated|7|||
48492800|NCT00384033|155997616|FG002|Overall Study|Randomized but not treated|10|||
48492801|NCT00384033|155997617|FG003|Overall Study|Randomized but not treated|2|||
48492802|NCT02444533|155997618|FG000|Overall Study|Not able to complete forms|0|||
48492803|NCT02444533|155997619|FG001|Overall Study|Not able to complete forms|2|||
48492804|NCT02444533|155997618|FG000|Overall Study|Only gave post-procedure complications|2|||
48492805|NCT02444533|155997619|FG001|Overall Study|Only gave post-procedure complications|2|||
48492806|NCT03349333|155997620|FG000|Overall Study|Progression of Disease|36|||
48492807|NCT03349333|155997620|FG000|Overall Study|Adverse Event|11|||
48492808|NCT03349333|155997620|FG000|Overall Study|Other|6|||
48492809|NCT03349333|155997620|FG000|Overall Study|Withdrawal by Subject|5|||
48492810|NCT03349333|155997620|FG000|Overall Study|Conditions interfere with participation|2|||
48492811|NCT03349333|155997620|FG000|Overall Study|Physician Decision|2|||
48492812|NCT03349333|155997620|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
48492813|NCT03349333|155997620|FG000|Overall Study|Patients in treatment less than 24 month|8|||
48492814|NCT01388647|155997621|FG000|Overall Study|Adverse Event|1|||
48492815|NCT01388647|155997622|FG001|Overall Study|Adverse Event|2|||
48492816|NCT01141283|155997623|FG000|Overall Study|Adverse Event|56|||
48492817|NCT01141283|155997623|FG000|Overall Study|Lost to Follow-up|4|||
48492818|NCT01141283|155997623|FG000|Overall Study|Withdrawal by Subject|14|||
48492819|NCT01141283|155997623|FG000|Overall Study|Administrative|4|||
48492820|NCT01141283|155997623|FG000|Overall Study|Lack of Efficacy|10|||
48492821|NCT00490061|155997624|FG000|Overall Study|Physician Decision|1|||
48492822|NCT01155583|155997625|FG000|Phase I|Screen failure - did not start treatment|0|||
48492823|NCT01155583|155997626|FG001|Phase I|Screen failure - did not start treatment|0|||
48492824|NCT01155583|155997627|FG002|Phase I|Screen failure - did not start treatment|0|||
48492825|NCT01155583|155997628|FG003|Phase I|Screen failure - did not start treatment|0|||
48492826|NCT01155583|155997629|FG004|Phase I|Screen failure - did not start treatment|1|||
48492827|NCT01155583|155997630|FG005|Phase I|Screen failure - did not start treatment|0|||
48492828|NCT01155583|155997631|FG006|Phase I|Screen failure - did not start treatment|0|||
48492829|NCT01155583|155997632|FG007|Phase I|Screen failure - did not start treatment|2|||
48492830|NCT01155583|155997633|FG008|Phase I|Screen failure - did not start treatment|0|||
48492831|NCT01155583|155997625|FG000|Phase I|Withdrawal by Subject|0|||
48492832|NCT01155583|155997626|FG001|Phase I|Withdrawal by Subject|0|||
48492833|NCT01155583|155997627|FG002|Phase I|Withdrawal by Subject|0|||
48492834|NCT01155583|155997628|FG003|Phase I|Withdrawal by Subject|0|||
48492835|NCT01155583|155997629|FG004|Phase I|Withdrawal by Subject|0|||
48492836|NCT01155583|155997630|FG005|Phase I|Withdrawal by Subject|0|||
48492837|NCT01155583|155997631|FG006|Phase I|Withdrawal by Subject|0|||
48492838|NCT01155583|155997632|FG007|Phase I|Withdrawal by Subject|1|||
48492839|NCT01155583|155997633|FG008|Phase I|Withdrawal by Subject|0|||
48492840|NCT02473510|155997637|FG000|Overall Study|Lost to Follow-up|1|||
48492841|NCT02473510|155997638|FG001|Overall Study|Lost to Follow-up|2|||
48492842|NCT01937364|155997641|FG000|Overall Study|Adverse Event|2|||
48492843|NCT01937364|155997642|FG001|Overall Study|Adverse Event|1|||
48492844|NCT04104646|155997648|FG000|Overall Study|Withdrawal by Subject|1|||
48492845|NCT04104646|155997649|FG001|Overall Study|Withdrawal by Subject|1|||
48492846|NCT04104646|155997648|FG000|Overall Study|Lost to Follow-up|1|||
48811293|NCT01003639|157149940|FG001|Overall Study|Lost to Follow-up|9|||
48811294|NCT01003639|157149939|FG000|Overall Study|Withdrawal by Subject|9|||
48811295|NCT01003639|157149940|FG001|Overall Study|Withdrawal by Subject|5|||
48811296|NCT01003639|157149939|FG000|Overall Study|Lack of Efficacy|1|||
48811297|NCT01003639|157149940|FG001|Overall Study|Lack of Efficacy|6|||
48811298|NCT01003639|157149939|FG000|Overall Study|Adverse Event|0|||
48811299|NCT01003639|157149940|FG001|Overall Study|Adverse Event|1|||
48811300|NCT01003639|157149939|FG000|Overall Study|Protocol Violation|0|||
48811301|NCT01003639|157149940|FG001|Overall Study|Protocol Violation|1|||
48811302|NCT01003639|157149939|FG000|Overall Study|Physician Decision|1|||
48811303|NCT01003639|157149940|FG001|Overall Study|Physician Decision|0|||
48811304|NCT05284019|157149941|FG000|Overall Study|Study terminated|2|||
48811305|NCT05284019|157149942|FG001|Overall Study|Study terminated|2|||
48811306|NCT05284019|157149943|FG002|Overall Study|Study terminated|2|||
48811307|NCT05284019|157149944|FG003|Overall Study|Study terminated|5|||
48811308|NCT05284019|157149945|FG004|Overall Study|Study terminated|15|||
48811309|NCT05284019|157149941|FG000|Overall Study|Withdrawal by Subject|0|||
48811310|NCT05284019|157149942|FG001|Overall Study|Withdrawal by Subject|0|||
48811311|NCT05284019|157149943|FG002|Overall Study|Withdrawal by Subject|0|||
48811312|NCT05284019|157149944|FG003|Overall Study|Withdrawal by Subject|1|||
48811313|NCT05284019|157149945|FG004|Overall Study|Withdrawal by Subject|1|||
48811314|NCT05284019|157149941|FG000|Overall Study|Lost to Follow-up|1|||
48811315|NCT05284019|157149942|FG001|Overall Study|Lost to Follow-up|0|||
48811316|NCT05284019|157149943|FG002|Overall Study|Lost to Follow-up|0|||
48811317|NCT05284019|157149944|FG003|Overall Study|Lost to Follow-up|2|||
48811318|NCT05284019|157149945|FG004|Overall Study|Lost to Follow-up|1|||
48811319|NCT00089895|157149947|FG000|Overall Study|Consent Withdrawn|11|||
48811320|NCT00089895|157149948|FG001|Overall Study|Consent Withdrawn|14|||
48811321|NCT00089895|157149947|FG000|Overall Study|Technical reason|7|||
48811322|NCT00089895|157149948|FG001|Overall Study|Technical reason|2|||
48811323|NCT00089895|157149947|FG000|Overall Study|Surgery|0|||
48811324|NCT00089895|157149948|FG001|Overall Study|Surgery|1|||
48811325|NCT00089895|157149947|FG000|Overall Study|Bleeding|0|||
48811326|NCT00089895|157149948|FG001|Overall Study|Bleeding|2|||
48811327|NCT00089895|157149947|FG000|Overall Study|Physician Decision|3|||
48811328|NCT00089895|157149948|FG001|Overall Study|Physician Decision|7|||
48811329|NCT00089895|157149947|FG000|Overall Study|Exclusion criteria met|6|||
48811330|NCT00089895|157149948|FG001|Overall Study|Exclusion criteria met|6|||
48811331|NCT00089895|157149947|FG000|Overall Study|Not otherwise specified|4|||
48811332|NCT00089895|157149948|FG001|Overall Study|Not otherwise specified|8|||
48811333|NCT00089895|157149947|FG000|Overall Study|Missing|4|||
48811334|NCT00089895|157149948|FG001|Overall Study|Missing|2|||
48811335|NCT05033080|157149953|FG000|Overall Study|Adverse Event|4|||
48811336|NCT05033080|157149954|FG001|Overall Study|Adverse Event|4|||
48811337|NCT05033080|157149953|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
48811338|NCT05033080|157149954|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
48811339|NCT05033080|157149953|FG000|Overall Study|Lost to Follow-up|1|||
48811340|NCT05033080|157149954|FG001|Overall Study|Lost to Follow-up|0|||
48811341|NCT05033080|157149953|FG000|Overall Study|Other non-compliance|0|||
48811342|NCT05033080|157149954|FG001|Overall Study|Other non-compliance|1|||
48811343|NCT05033080|157149953|FG000|Overall Study|Physician Decision|0|||
48811344|NCT05033080|157149954|FG001|Overall Study|Physician Decision|1|||
48811345|NCT05033080|157149953|FG000|Overall Study|Other|1|||
48811346|NCT05033080|157149954|FG001|Overall Study|Other|1|||
48811347|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
48811348|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
48811349|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
48811350|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
48811351|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
48811352|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
48811353|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
48811354|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
48811355|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
48811356|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
48811357|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
48811358|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
48811359|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811360|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811361|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811362|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811363|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
48811364|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
48811365|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
48811366|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
48811367|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
48811368|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
48811369|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
48811370|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
48811371|NCT02778399|157149955|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
48811372|NCT02778399|157149956|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
48811373|NCT02778399|157149957|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
48811374|NCT02778399|157149958|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
48811375|NCT02778399|157149959|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
48811376|NCT02778399|157149960|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
48811377|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
48811378|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
48811379|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
48811380|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
48811381|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
48811382|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
48811383|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
48811384|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
48811385|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
48811386|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
48811387|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
48811388|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
48811389|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811390|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
48811391|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811392|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811393|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811394|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
48811395|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
48811396|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
48811397|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
48811398|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
48811399|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
48811400|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
48811401|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
48811402|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
48811403|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
48811404|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
48811405|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
48811406|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
48811407|NCT02778399|157149955|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
48811408|NCT02778399|157149956|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
48811409|NCT02778399|157149957|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
48811410|NCT02778399|157149958|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
48811411|NCT02778399|157149959|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
48811412|NCT02778399|157149960|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
48811413|NCT00882921|157149961|FG000|Overall Study|Death|2|||
48811414|NCT00882921|157149961|FG000|Overall Study|Other|3|||
48811415|NCT00882921|157149961|FG000|Overall Study|Lost to Follow-up|2|||
48811416|NCT00882921|157149961|FG000|Overall Study|Termination By Investigator|3|||
48811417|NCT00882921|157149961|FG000|Overall Study|Withdrawal Of Consent|1|||
48811418|NCT02138747|157149967|FG000|Treatment Period 1|Adverse Event|10|||
48811419|NCT02138747|157149968|FG001|Treatment Period 1|Adverse Event|14|||
48811420|NCT02138747|157149969|FG002|Treatment Period 1|Adverse Event|2|||
48811421|NCT02138747|157149970|FG003|Treatment Period 1|Adverse Event|1|||
48811422|NCT02138747|157149967|FG000|Treatment Period 1|Lost to Follow-up|0|||
48811423|NCT02138747|157149968|FG001|Treatment Period 1|Lost to Follow-up|1|||
48811424|NCT02138747|157149969|FG002|Treatment Period 1|Lost to Follow-up|1|||
48811425|NCT02138747|157149970|FG003|Treatment Period 1|Lost to Follow-up|0|||
48811426|NCT02138747|157149967|FG000|Treatment Period 1|Protocol Violation|0|||
48811427|NCT02138747|157149968|FG001|Treatment Period 1|Protocol Violation|2|||
48811428|NCT02138747|157149969|FG002|Treatment Period 1|Protocol Violation|0|||
48811429|NCT02138747|157149970|FG003|Treatment Period 1|Protocol Violation|0|||
48492847|NCT04104646|155997649|FG001|Overall Study|Lost to Follow-up|0|||
48492848|NCT04104646|155997648|FG000|Overall Study|Physician Decision|2|||
48492849|NCT04104646|155997649|FG001|Overall Study|Physician Decision|0|||
48597632|NCT01000974|156383558|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
48492850|NCT01185288|155997650|FG000|Overall Study|Adverse Event|7|||
48597633|NCT01000974|156383559|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
48597634|NCT01000974|156383557|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
48597635|NCT01000974|156383558|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
48597636|NCT01000974|156383559|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
48597637|NCT01000974|156383557|FG000|Primary Vaccination Phase|Protocol Violation|40|||
48597638|NCT01000974|156383558|FG001|Primary Vaccination Phase|Protocol Violation|3|||
48597639|NCT01000974|156383559|FG002|Primary Vaccination Phase|Protocol Violation|2|||
48597640|NCT01000974|156383557|FG000|Primary Vaccination Phase|Adverse Event|14|||
48597641|NCT01000974|156383558|FG001|Primary Vaccination Phase|Adverse Event|2|||
48597642|NCT01000974|156383559|FG002|Primary Vaccination Phase|Adverse Event|2|||
48597643|NCT01000974|156383557|FG000|Primary Vaccination Phase|Other|4|||
48597644|NCT01000974|156383558|FG001|Primary Vaccination Phase|Other|9|||
48597645|NCT01000974|156383559|FG002|Primary Vaccination Phase|Other|12|||
48597646|NCT01000974|156383557|FG000|Booster Vaccination Phase|Protocol Violation|0|||
48597647|NCT01000974|156383558|FG001|Booster Vaccination Phase|Protocol Violation|0|||
48597648|NCT01000974|156383559|FG002|Booster Vaccination Phase|Protocol Violation|2|||
48597649|NCT01000974|156383557|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
48597650|NCT01000974|156383558|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
48597651|NCT01000974|156383559|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
48597652|NCT01000974|156383557|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
48597653|NCT01000974|156383558|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
48597654|NCT01000974|156383559|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
48597655|NCT01000974|156383557|FG000|Booster Vaccination Phase|Other|24|||
48597656|NCT01000974|156383558|FG001|Booster Vaccination Phase|Other|6|||
48597657|NCT01000974|156383559|FG002|Booster Vaccination Phase|Other|4|||
48597658|NCT01738919|156383561|FG000|Overall Study|Lost to Follow-up|1|||
48597659|NCT01738919|156383562|FG001|Overall Study|Lost to Follow-up|0|||
48597660|NCT01738919|156383561|FG000|Overall Study|Immigrated|0|||
48597661|NCT01738919|156383562|FG001|Overall Study|Immigrated|1|||
48597662|NCT01738919|156383561|FG000|Overall Study|Withdrawal by Subject|0|||
48597663|NCT01738919|156383562|FG001|Overall Study|Withdrawal by Subject|1|||
48597664|NCT01738919|156383561|FG000|Overall Study|Not treated in accordance to guidelines|0|||
48597665|NCT01738919|156383562|FG001|Overall Study|Not treated in accordance to guidelines|1|||
48597666|NCT04131712|156383569|FG000|Overall Study|COVID related|0|||
48597667|NCT04131712|156383570|FG001|Overall Study|COVID related|0|||
48597668|NCT04131712|156383571|FG002|Overall Study|COVID related|2|||
48597669|NCT04131712|156383572|FG003|Overall Study|COVID related|0|||
48597670|NCT04131712|156383569|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
48597671|NCT04131712|156383570|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
48597672|NCT04131712|156383571|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
48597673|NCT04131712|156383572|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
48597674|NCT02090283|156383573|FG000|Overall Study|Withdrawal by Subject|6|||
48597675|NCT02090283|156383574|FG001|Overall Study|Withdrawal by Subject|6|||
48597676|NCT02090283|156383575|FG002|Overall Study|Withdrawal by Subject|6|||
48597677|NCT02090283|156383573|FG000|Overall Study|Sponsor Terminated Study|6|||
48597678|NCT02090283|156383574|FG001|Overall Study|Sponsor Terminated Study|6|||
48597679|NCT02090283|156383575|FG002|Overall Study|Sponsor Terminated Study|1|||
48597680|NCT02090283|156383573|FG000|Overall Study|Lost to Follow-up|2|||
48597681|NCT02090283|156383574|FG001|Overall Study|Lost to Follow-up|2|||
48597682|NCT02090283|156383575|FG002|Overall Study|Lost to Follow-up|3|||
48597683|NCT02090283|156383573|FG000|Overall Study|Adverse Event|1|||
48597684|NCT02090283|156383574|FG001|Overall Study|Adverse Event|1|||
48597685|NCT02090283|156383575|FG002|Overall Study|Adverse Event|0|||
48597686|NCT02090283|156383573|FG000|Overall Study|Protocol Violation|2|||
48597687|NCT02090283|156383574|FG001|Overall Study|Protocol Violation|0|||
48811430|NCT02138747|157149967|FG000|Treatment Period 1|Withdrawal by Subject|8|||
48597688|NCT02090283|156383575|FG002|Overall Study|Protocol Violation|0|||
48597689|NCT02259400|156383576|FG000|Overall Study|Death|0|||
48597690|NCT02259400|156383577|FG001|Overall Study|Death|2|||
48597691|NCT00206427|156383578|FG000|Overall Study|Adverse Event|2|||
48597692|NCT03872843|156383579|FG000|Overall Study|Lost to Follow-up|5|||
48597693|NCT03872843|156383580|FG001|Overall Study|Lost to Follow-up|7|||
48597694|NCT02824224|156383581|FG000|Overall Study|Discontinued, IUS expulsion|0|||
48597695|NCT02824224|156383582|FG001|Overall Study|Discontinued, IUS expulsion|1|||
48597696|NCT02824224|156383581|FG000|Overall Study|Did not show up for allocation visit|2|||
48597697|NCT02824224|156383582|FG001|Overall Study|Did not show up for allocation visit|0|||
48597698|NCT02683239|156383583|FG000|Overall Study|Protocol Violation|35|||
48597699|NCT02683239|156383584|FG001|Overall Study|Protocol Violation|23|||
48597700|NCT02683239|156383585|FG002|Overall Study|Protocol Violation|26|||
48597701|NCT02683239|156383586|FG003|Overall Study|Protocol Violation|4|||
48811431|NCT02138747|157149968|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48597702|NCT02683239|156383587|FG004|Overall Study|Protocol Violation|35|||
48597703|NCT02683239|156383588|FG005|Overall Study|Protocol Violation|4|||
48597704|NCT02683239|156383589|FG006|Overall Study|Protocol Violation|5|||
48597705|NCT02683239|156383583|FG000|Overall Study|Adverse Event|64|||
48597706|NCT02683239|156383584|FG001|Overall Study|Adverse Event|39|||
48597707|NCT02683239|156383585|FG002|Overall Study|Adverse Event|42|||
48597708|NCT02683239|156383586|FG003|Overall Study|Adverse Event|16|||
48597709|NCT02683239|156383587|FG004|Overall Study|Adverse Event|189|||
48597710|NCT02683239|156383588|FG005|Overall Study|Adverse Event|9|||
48597711|NCT02683239|156383589|FG006|Overall Study|Adverse Event|9|||
48597712|NCT02683239|156383583|FG000|Overall Study|Physician Decision|38|||
48597713|NCT02683239|156383584|FG001|Overall Study|Physician Decision|19|||
48597714|NCT02683239|156383585|FG002|Overall Study|Physician Decision|14|||
48597715|NCT02683239|156383586|FG003|Overall Study|Physician Decision|73|||
48597716|NCT02683239|156383587|FG004|Overall Study|Physician Decision|143|||
48597717|NCT02683239|156383588|FG005|Overall Study|Physician Decision|14|||
48597718|NCT02683239|156383589|FG006|Overall Study|Physician Decision|15|||
48597719|NCT02683239|156383583|FG000|Overall Study|Withdrawal by Subject|187|||
48597720|NCT02683239|156383584|FG001|Overall Study|Withdrawal by Subject|99|||
48597721|NCT02683239|156383585|FG002|Overall Study|Withdrawal by Subject|91|||
48597722|NCT02683239|156383586|FG003|Overall Study|Withdrawal by Subject|18|||
48597723|NCT02683239|156383587|FG004|Overall Study|Withdrawal by Subject|248|||
48597724|NCT02683239|156383588|FG005|Overall Study|Withdrawal by Subject|22|||
48597725|NCT02683239|156383589|FG006|Overall Study|Withdrawal by Subject|28|||
48597726|NCT02683239|156383583|FG000|Overall Study|Lost to Follow-up|77|||
48597727|NCT02683239|156383584|FG001|Overall Study|Lost to Follow-up|24|||
48597728|NCT02683239|156383585|FG002|Overall Study|Lost to Follow-up|25|||
48597729|NCT02683239|156383586|FG003|Overall Study|Lost to Follow-up|7|||
48597730|NCT02683239|156383587|FG004|Overall Study|Lost to Follow-up|88|||
48597731|NCT02683239|156383588|FG005|Overall Study|Lost to Follow-up|8|||
48597732|NCT02683239|156383589|FG006|Overall Study|Lost to Follow-up|11|||
48597733|NCT02683239|156383583|FG000|Overall Study|Death|9|||
48597734|NCT02683239|156383584|FG001|Overall Study|Death|5|||
48597735|NCT02683239|156383585|FG002|Overall Study|Death|8|||
48597736|NCT02683239|156383586|FG003|Overall Study|Death|0|||
48597737|NCT02683239|156383587|FG004|Overall Study|Death|12|||
48597738|NCT02683239|156383588|FG005|Overall Study|Death|1|||
48597739|NCT02683239|156383589|FG006|Overall Study|Death|0|||
48597740|NCT02683239|156383583|FG000|Overall Study|Lack of Efficacy|50|||
48597741|NCT02683239|156383584|FG001|Overall Study|Lack of Efficacy|23|||
48597742|NCT02683239|156383585|FG002|Overall Study|Lack of Efficacy|12|||
48597743|NCT02683239|156383586|FG003|Overall Study|Lack of Efficacy|2|||
48597744|NCT02683239|156383587|FG004|Overall Study|Lack of Efficacy|29|||
48597745|NCT02683239|156383588|FG005|Overall Study|Lack of Efficacy|2|||
48597746|NCT02683239|156383589|FG006|Overall Study|Lack of Efficacy|3|||
48597747|NCT02683239|156383583|FG000|Overall Study|Missing data|0|||
48597748|NCT02683239|156383584|FG001|Overall Study|Missing data|1|||
48597749|NCT02683239|156383585|FG002|Overall Study|Missing data|1|||
48597750|NCT02683239|156383586|FG003|Overall Study|Missing data|0|||
48811432|NCT02138747|157149969|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48811433|NCT02138747|157149970|FG003|Treatment Period 1|Withdrawal by Subject|3|||
48811434|NCT02138747|157149967|FG000|Treatment Period 1|Other - Miscellaneous|2|||
48811435|NCT02138747|157149968|FG001|Treatment Period 1|Other - Miscellaneous|4|||
48811436|NCT02138747|157149969|FG002|Treatment Period 1|Other - Miscellaneous|0|||
48811437|NCT02138747|157149970|FG003|Treatment Period 1|Other - Miscellaneous|0|||
48811438|NCT02138747|157149967|FG000|Treatment Period 2|Adverse Event|6|||
48811439|NCT02138747|157149968|FG001|Treatment Period 2|Adverse Event|3|||
48811440|NCT02138747|157149969|FG002|Treatment Period 2|Adverse Event|1|||
48811441|NCT02138747|157149970|FG003|Treatment Period 2|Adverse Event|1|||
48811442|NCT02138747|157149967|FG000|Treatment Period 2|Lost to Follow-up|2|||
48811443|NCT02138747|157149968|FG001|Treatment Period 2|Lost to Follow-up|0|||
48597751|NCT02683239|156383587|FG004|Overall Study|Missing data|1|||
48597752|NCT02683239|156383588|FG005|Overall Study|Missing data|0|||
48597753|NCT02683239|156383589|FG006|Overall Study|Missing data|0|||
48597754|NCT00856999|156383590|FG000|Overall Study|Withdrawal by Subject|5|||
48597755|NCT04547140|156383591|FG000|Overall Study|Adverse Event|0|||
48597756|NCT04547140|156383592|FG001|Overall Study|Adverse Event|1|||
48811444|NCT02138747|157149969|FG002|Treatment Period 2|Lost to Follow-up|0|||
48597757|NCT04547140|156383591|FG000|Overall Study|Withdrawal by Subject|0|||
48811445|NCT02138747|157149970|FG003|Treatment Period 2|Lost to Follow-up|0|||
48811446|NCT02138747|157149967|FG000|Treatment Period 2|Protocol Violation|1|||
48811447|NCT02138747|157149968|FG001|Treatment Period 2|Protocol Violation|0|||
48597758|NCT04547140|156383592|FG001|Overall Study|Withdrawal by Subject|1|||
48597759|NCT04547140|156383591|FG000|Overall Study|Lost to Follow-up|3|||
48597760|NCT04547140|156383592|FG001|Overall Study|Lost to Follow-up|1|||
48597761|NCT04547140|156383591|FG000|Overall Study|Death|2|||
48597762|NCT04547140|156383592|FG001|Overall Study|Death|1|||
48597763|NCT04547140|156383591|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
48597764|NCT04547140|156383592|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
48597765|NCT04547140|156383591|FG000|Overall Study|Pregnancy|1|||
48597766|NCT04547140|156383592|FG001|Overall Study|Pregnancy|0|||
48597767|NCT04547140|156383591|FG000|Overall Study|Reason Not Specified|4|||
48597768|NCT04547140|156383592|FG001|Overall Study|Reason Not Specified|1|||
48811448|NCT02138747|157149969|FG002|Treatment Period 2|Protocol Violation|0|||
48811449|NCT02138747|157149970|FG003|Treatment Period 2|Protocol Violation|0|||
48811450|NCT02138747|157149967|FG000|Treatment Period 2|Withdrawal by Subject|5|||
48811451|NCT02138747|157149968|FG001|Treatment Period 2|Withdrawal by Subject|4|||
48811452|NCT02138747|157149969|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48811453|NCT02138747|157149970|FG003|Treatment Period 2|Withdrawal by Subject|2|||
48811454|NCT02138747|157149967|FG000|Treatment Period 2|Other - Miscellaneous|3|||
48811455|NCT02138747|157149968|FG001|Treatment Period 2|Other - Miscellaneous|0|||
48811456|NCT02138747|157149969|FG002|Treatment Period 2|Other - Miscellaneous|0|||
48811457|NCT02138747|157149970|FG003|Treatment Period 2|Other - Miscellaneous|0|||
48811458|NCT02611830|157149972|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
48811459|NCT02611830|157149973|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
48811460|NCT02611830|157149974|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
48811461|NCT02611830|157149975|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
48811462|NCT02611830|157149972|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
48811463|NCT02611830|157149973|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
48492851|NCT01185288|155997651|FG001|Overall Study|Adverse Event|6|||
48492852|NCT01185288|155997650|FG000|Overall Study|Withdrawal by Subject|6|||
48492853|NCT01185288|155997651|FG001|Overall Study|Withdrawal by Subject|4|||
48492854|NCT01185288|155997650|FG000|Overall Study|Lost to Follow-up|2|||
48492855|NCT01185288|155997651|FG001|Overall Study|Lost to Follow-up|5|||
48492856|NCT01185288|155997650|FG000|Overall Study|Lack of Efficacy|2|||
48492857|NCT01185288|155997651|FG001|Overall Study|Lack of Efficacy|0|||
48492858|NCT01185288|155997650|FG000|Overall Study|Investigator discretion|1|||
48492859|NCT01185288|155997651|FG001|Overall Study|Investigator discretion|0|||
48492860|NCT01185288|155997650|FG000|Overall Study|Did not meet inclusion criteria|1|||
48492861|NCT01185288|155997651|FG001|Overall Study|Did not meet inclusion criteria|0|||
48492862|NCT01185288|155997650|FG000|Overall Study|Noncompliance|0|||
48492863|NCT01185288|155997651|FG001|Overall Study|Noncompliance|1|||
48492864|NCT03276975|155997652|FG000|Overall Study|Withdrawal by Subject|1|||
48492865|NCT03276975|155997653|FG001|Overall Study|Withdrawal by Subject|0|||
48492866|NCT01626859|155997656|FG000|Overall Study|Adverse Event|1|||
48492867|NCT01626859|155997657|FG001|Overall Study|Adverse Event|3|||
48492868|NCT01626859|155997658|FG002|Overall Study|Adverse Event|2|||
48492869|NCT01626859|155997656|FG000|Overall Study|Physician Decision|0|||
48492870|NCT01626859|155997657|FG001|Overall Study|Physician Decision|1|||
48492871|NCT01626859|155997658|FG002|Overall Study|Physician Decision|0|||
48492872|NCT01626859|155997656|FG000|Overall Study|Withdrawal by Subject|1|||
48492873|NCT01626859|155997657|FG001|Overall Study|Withdrawal by Subject|4|||
48492874|NCT01626859|155997658|FG002|Overall Study|Withdrawal by Subject|2|||
48492875|NCT01446913|155997659|FG000|Overall Study|Significant illness|1|||
48492876|NCT01446913|155997660|FG001|Overall Study|Significant illness|1|||
48492877|NCT01446913|155997661|FG002|Overall Study|Significant illness|1|||
48492878|NCT01446913|155997659|FG000|Overall Study|Withdrawal by Subject|5|||
48811464|NCT02611830|157149974|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
48811465|NCT02611830|157149975|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
48492879|NCT01446913|155997660|FG001|Overall Study|Withdrawal by Subject|3|||
48492880|NCT01446913|155997661|FG002|Overall Study|Withdrawal by Subject|5|||
48492881|NCT01446913|155997659|FG000|Overall Study|Physician Decision|0|||
48492882|NCT01446913|155997660|FG001|Overall Study|Physician Decision|0|||
48492883|NCT01446913|155997661|FG002|Overall Study|Physician Decision|2|||
48492884|NCT01446913|155997659|FG000|Overall Study|Lost to Follow-up|3|||
48492885|NCT01446913|155997660|FG001|Overall Study|Lost to Follow-up|5|||
48492886|NCT01446913|155997661|FG002|Overall Study|Lost to Follow-up|3|||
48811466|NCT02611830|157149972|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
48492887|NCT03443869|155997662|FG000|Overall Study|Death|3|||
48492888|NCT03443869|155997663|FG001|Overall Study|Death|3|||
48492889|NCT03443869|155997662|FG000|Overall Study|Withdrawal by Subject|34|||
48811467|NCT02611830|157149973|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
48811468|NCT02611830|157149974|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
48811469|NCT02611830|157149975|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
48811470|NCT02611830|157149972|FG000|OL Induction Phase|Lack of Efficacy|9|||
48811471|NCT02611830|157149973|FG001|OL Induction Phase|Lack of Efficacy|0|||
48811472|NCT02611830|157149974|FG002|OL Induction Phase|Lack of Efficacy|0|||
48811473|NCT02611830|157149975|FG003|OL Induction Phase|Lack of Efficacy|0|||
48811474|NCT02611830|157149972|FG000|OL Induction Phase|Reason not specified|3|||
48811475|NCT02611830|157149973|FG001|OL Induction Phase|Reason not specified|0|||
48811476|NCT02611830|157149974|FG002|OL Induction Phase|Reason not specified|0|||
48811477|NCT02611830|157149975|FG003|OL Induction Phase|Reason not specified|0|||
48811478|NCT02611830|157149972|FG000|Maintenance Phase|Lack of Efficacy|0|||
48492890|NCT03443869|155997663|FG001|Overall Study|Withdrawal by Subject|22|||
48492891|NCT03443869|155997662|FG000|Overall Study|Lost to Follow-up|1|||
48492892|NCT03443869|155997663|FG001|Overall Study|Lost to Follow-up|2|||
48492893|NCT03443869|155997662|FG000|Overall Study|Physician Decision|3|||
48492894|NCT03443869|155997663|FG001|Overall Study|Physician Decision|3|||
48492895|NCT03443869|155997662|FG000|Overall Study|Other|4|||
48811479|NCT02611830|157149973|FG001|Maintenance Phase|Lack of Efficacy|29|||
48811480|NCT02611830|157149974|FG002|Maintenance Phase|Lack of Efficacy|18|||
48811481|NCT02611830|157149975|FG003|Maintenance Phase|Lack of Efficacy|6|||
48811482|NCT02611830|157149972|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48811483|NCT02611830|157149973|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
48811484|NCT02611830|157149974|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
48811485|NCT02611830|157149975|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
48492896|NCT03443869|155997663|FG001|Overall Study|Other|4|||
48492897|NCT00423800|155997664|FG000|Overall Study|Protocol Violation|0|||
48811486|NCT02611830|157149972|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
48811487|NCT02611830|157149973|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
48811488|NCT02611830|157149974|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
48811489|NCT02611830|157149975|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
48811490|NCT02611830|157149972|FG000|Maintenance Phase|Lost to Follow-up|0|||
48811491|NCT02611830|157149973|FG001|Maintenance Phase|Lost to Follow-up|0|||
48811492|NCT02611830|157149974|FG002|Maintenance Phase|Lost to Follow-up|0|||
48811493|NCT02611830|157149975|FG003|Maintenance Phase|Lost to Follow-up|1|||
48811494|NCT02611830|157149972|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
48811495|NCT02611830|157149973|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
48811496|NCT02611830|157149974|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
48811497|NCT02611830|157149975|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
48811498|NCT02611830|157149972|FG000|Maintenance Phase|Pregnancy|0|||
48811499|NCT02611830|157149973|FG001|Maintenance Phase|Pregnancy|0|||
48811500|NCT02611830|157149974|FG002|Maintenance Phase|Pregnancy|1|||
48811501|NCT02611830|157149975|FG003|Maintenance Phase|Pregnancy|0|||
48811502|NCT02611830|157149972|FG000|Maintenance Phase|Reason not specified|0|||
48811503|NCT02611830|157149973|FG001|Maintenance Phase|Reason not specified|1|||
48811504|NCT02611830|157149974|FG002|Maintenance Phase|Reason not specified|4|||
48712489|NCT01396447|156799338|FG002|Overall Study|Did Not Receive Treatment|1|||
48712490|NCT01396447|156799339|FG003|Overall Study|Did Not Receive Treatment|0|||
48712491|NCT01396447|156799336|FG000|Overall Study|Adverse Event|15|||
48712492|NCT01396447|156799337|FG001|Overall Study|Adverse Event|12|||
48712493|NCT01396447|156799338|FG002|Overall Study|Adverse Event|12|||
48712494|NCT01396447|156799339|FG003|Overall Study|Adverse Event|17|||
48712495|NCT01396447|156799336|FG000|Overall Study|Insufficient Therapeutic Response|5|||
48712496|NCT01396447|156799337|FG001|Overall Study|Insufficient Therapeutic Response|5|||
48712497|NCT01396447|156799338|FG002|Overall Study|Insufficient Therapeutic Response|2|||
48712498|NCT01396447|156799339|FG003|Overall Study|Insufficient Therapeutic Response|4|||
48712499|NCT01396447|156799336|FG000|Overall Study|Protocol Violation|5|||
48811505|NCT02611830|157149975|FG003|Maintenance Phase|Reason not specified|0|||
48811506|NCT02120664|157149977|FG000|Overall Study|Withdrawal by Subject|0|||
48811507|NCT02120664|157149978|FG001|Overall Study|Withdrawal by Subject|0|||
48811508|NCT02120664|157149979|FG002|Overall Study|Withdrawal by Subject|0|||
48811509|NCT02120664|157149980|FG003|Overall Study|Withdrawal by Subject|1|||
48811510|NCT02120664|157149981|FG004|Overall Study|Withdrawal by Subject|0|||
48811511|NCT02223754|157149982|FG000|Period 1|Adverse Event|1|||
48811512|NCT02223754|157149983|FG001|Period 1|Adverse Event|0|||
48811513|NCT02223754|157149982|FG000|Period 1|Lost to Follow-up|0|||
48811514|NCT02223754|157149983|FG001|Period 1|Lost to Follow-up|1|||
48492898|NCT00423800|155997665|FG001|Overall Study|Protocol Violation|1|||
48492899|NCT01533428|155997668|FG000|Overall Study|Adverse Event|0|||
48492900|NCT01533428|155997669|FG001|Overall Study|Adverse Event|1|||
48492901|NCT01533428|155997668|FG000|Overall Study|Lost to Follow-up|2|||
48712500|NCT01396447|156799337|FG001|Overall Study|Protocol Violation|2|||
48712501|NCT01396447|156799338|FG002|Overall Study|Protocol Violation|3|||
48712502|NCT01396447|156799339|FG003|Overall Study|Protocol Violation|7|||
48811515|NCT02223754|157149982|FG000|Period 1|Protocol Violation|2|||
48811516|NCT02223754|157149983|FG001|Period 1|Protocol Violation|4|||
48811517|NCT02223754|157149982|FG000|Period 1|Withdrawal by Subject|0|||
48811518|NCT02223754|157149983|FG001|Period 1|Withdrawal by Subject|4|||
48811519|NCT02223754|157149982|FG000|Period 1|Test Article No Longer Available|1|||
48811520|NCT02223754|157149983|FG001|Period 1|Test Article No Longer Available|5|||
48811521|NCT02223754|157149982|FG000|Period 1|Unsatisfactory Visual Response|0|||
48712503|NCT01396447|156799336|FG000|Overall Study|Withdrawal of Consent|11|||
48811522|NCT02223754|157149983|FG001|Period 1|Unsatisfactory Visual Response|1|||
48597769|NCT01093586|156383593|FG000|Overall Study|Failed to engraft|3|||
48597770|NCT01711983|156383594|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
48597771|NCT01711983|156383594|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
48597772|NCT01711983|156383594|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
48597773|NCT01711983|156383594|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
48597774|NCT02438280|156383595|FG000|Overall Study|Physician Decision|1|||
48597775|NCT02438280|156383596|FG001|Overall Study|Physician Decision|0|||
48597776|NCT02620787|156383597|FG000|Overall Study|Adverse Event|1|||
48597777|NCT02620787|156383598|FG001|Overall Study|Adverse Event|0|||
48712504|NCT01396447|156799337|FG001|Overall Study|Withdrawal of Consent|9|||
48712505|NCT01396447|156799338|FG002|Overall Study|Withdrawal of Consent|4|||
48712506|NCT01396447|156799339|FG003|Overall Study|Withdrawal of Consent|15|||
48712507|NCT01396447|156799336|FG000|Overall Study|Lost to Follow-up|4|||
48712508|NCT01396447|156799337|FG001|Overall Study|Lost to Follow-up|8|||
48712509|NCT01396447|156799338|FG002|Overall Study|Lost to Follow-up|7|||
48712510|NCT01396447|156799339|FG003|Overall Study|Lost to Follow-up|9|||
48712511|NCT01396447|156799336|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48712512|NCT01396447|156799337|FG001|Overall Study|Other Miscellaneous Reasons|2|||
48712513|NCT01396447|156799338|FG002|Overall Study|Other Miscellaneous Reasons|1|||
48712514|NCT01396447|156799339|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48712515|NCT00796978|156799340|FG000|Overall Study|Cardiac adverse event|5|||
48712516|NCT00796978|156799340|FG000|Overall Study|Adverse Event|4|||
48712517|NCT00796978|156799340|FG000|Overall Study|Withdrawal by Subject|3|||
48712518|NCT01237899|156799341|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
48712519|NCT01237899|156799342|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
48712520|NCT01237899|156799343|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
48712521|NCT01237899|156799344|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
48712522|NCT01237899|156799345|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
48712523|NCT01237899|156799346|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
48712524|NCT01237899|156799347|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
48712525|NCT01237899|156799348|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
48712526|NCT01237899|156799349|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
48712527|NCT01237899|156799350|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
48712528|NCT01237899|156799351|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
48712529|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
48712530|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
48712531|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
48712532|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
48712533|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
48712534|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
48712535|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
48712536|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
48712537|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
48712538|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
48712539|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
48712540|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
48712541|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
48712542|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
48712543|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
48811523|NCT02223754|157149982|FG000|Period 2|Adverse Event|0|||
48811524|NCT02223754|157149983|FG001|Period 2|Adverse Event|1|||
48811525|NCT02223754|157149982|FG000|Period 2|Protocol Violation|1|||
48811526|NCT02223754|157149983|FG001|Period 2|Protocol Violation|0|||
48811527|NCT02223754|157149982|FG000|Period 2|Lens Discomfort|1|||
48811528|NCT02223754|157149983|FG001|Period 2|Lens Discomfort|1|||
48811529|NCT02223754|157149982|FG000|Period 2|Lost to Follow-up|1|||
48492902|NCT01533428|155997669|FG001|Overall Study|Lost to Follow-up|1|||
48492903|NCT01533428|155997668|FG000|Overall Study|Withdrawal by Subject|7|||
48492904|NCT01533428|155997669|FG001|Overall Study|Withdrawal by Subject|6|||
48492905|NCT02739984|155997672|FG000|Overall Study|Sponsor Decision|1|||
48492906|NCT02739984|155997673|FG001|Overall Study|Sponsor Decision|0|||
48492907|NCT02739984|155997672|FG000|Overall Study|Withdrawal by Subject|1|||
48492908|NCT02739984|155997673|FG001|Overall Study|Withdrawal by Subject|1|||
48492909|NCT02739984|155997672|FG000|Overall Study|Death|0|||
48492910|NCT02739984|155997673|FG001|Overall Study|Death|1|||
48492911|NCT02739984|155997672|FG000|Overall Study|Lost to Follow-up|3|||
48492912|NCT02739984|155997673|FG001|Overall Study|Lost to Follow-up|0|||
48492913|NCT01736553|155997678|FG000|Overall Study|Death|12|||
48492914|NCT01736553|155997679|FG001|Overall Study|Death|0|||
48492915|NCT01736553|155997678|FG000|Overall Study|Withdrawal by Subject|5|||
48492916|NCT01736553|155997679|FG001|Overall Study|Withdrawal by Subject|2|||
48492917|NCT01736553|155997678|FG000|Overall Study|Lost to Follow-up|2|||
48492918|NCT01736553|155997679|FG001|Overall Study|Lost to Follow-up|2|||
48492919|NCT01896297|155997680|FG000|Overall Study|Died in post treatment phase|1|||
48492920|NCT02004847|155999195|FG000|Overall Study|Protocol Violation|1|||
48712544|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
48712545|NCT02834793|156799352|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
48712546|NCT02834793|156799353|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
48712547|NCT02834793|156799354|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
48712548|NCT02834793|156799355|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
48712549|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
48712550|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
48712551|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
48712552|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
48712553|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
48712554|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
48712555|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
48712556|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
48712557|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
48712558|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
48712559|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
48712560|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
48712561|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
48712562|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
48712563|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
48712564|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
48712565|NCT02834793|156799352|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
48712566|NCT02834793|156799353|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
48712567|NCT02834793|156799354|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
48712568|NCT02834793|156799355|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
48712569|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
48712570|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
48712571|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
48712572|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
48811530|NCT02223754|157149983|FG001|Period 2|Lost to Follow-up|0|||
48811531|NCT02223754|157149982|FG000|Period 2|Test Article No Longer Available|0|||
48811532|NCT02223754|157149983|FG001|Period 2|Test Article No Longer Available|1|||
48811533|NCT02058290|157149984|FG000|Overall Study|Protocol Violation|2|||
48811534|NCT02058290|157149985|FG001|Overall Study|Protocol Violation|1|||
48811535|NCT02058290|157149984|FG000|Overall Study|Physician Decision|1|||
48811536|NCT02058290|157149985|FG001|Overall Study|Physician Decision|0|||
48811537|NCT02058290|157149984|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
48811538|NCT02058290|157149985|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
48492921|NCT02004847|155999196|FG001|Overall Study|Protocol Violation|1|||
48492922|NCT02034799|155999199|FG000|Overall Study|Withdrawal by Subject|0|||
48492923|NCT02034799|155999200|FG001|Overall Study|Withdrawal by Subject|2|||
48492924|NCT02034799|155999199|FG000|Overall Study|Lost to Follow-up|0|||
48492925|NCT02034799|155999200|FG001|Overall Study|Lost to Follow-up|1|||
48492926|NCT02034799|155999199|FG000|Overall Study|Death|2|||
48492927|NCT02034799|155999200|FG001|Overall Study|Death|1|||
48492928|NCT00275028|155999203|FG000|Overall Study|Withdrew consent before treatment began|1|||
48492929|NCT00275028|155999203|FG000|Overall Study|Withdrawal by Subject|5|||
48492930|NCT00275028|155999203|FG000|Overall Study|Adverse Event|9|||
48492931|NCT00275028|155999203|FG000|Overall Study|Progressive Disease|30|||
48492932|NCT00275028|155999203|FG000|Overall Study|Physician Decision|2|||
48492933|NCT00387712|155999207|FG000|Overall Study|Physician Decision|6|||
48492934|NCT00387712|155999208|FG001|Overall Study|Physician Decision|4|||
48492935|NCT00387712|155999207|FG000|Overall Study|Lost to Follow-up|17|||
48492936|NCT00387712|155999208|FG001|Overall Study|Lost to Follow-up|20|||
48492937|NCT00387712|155999207|FG000|Overall Study|Withdrawal by Subject|6|||
48492938|NCT00387712|155999208|FG001|Overall Study|Withdrawal by Subject|12|||
48492939|NCT01299038|155999209|FG000|Overall Study|Withdrawal by Subject|1|||
48492940|NCT01299038|155999210|FG001|Overall Study|Withdrawal by Subject|0|||
48492941|NCT00322556|155999211|FG000|Overall Study|Adverse Event|1|||
48492942|NCT00322556|155999211|FG000|Overall Study|Withdrawal by Subject|1|||
48492943|NCT00322556|155999211|FG000|Overall Study|Lost to Follow-up|3|||
48492944|NCT00322556|155999211|FG000|Overall Study|Other Reason|7|||
48492945|NCT01767597|155999214|FG000|Overall Study|Incomplete intervention|3|||
48492946|NCT01767597|155999215|FG001|Overall Study|Incomplete intervention|1|||
48492947|NCT01767597|155999214|FG000|Overall Study|Withdrawal by Subject|1|||
48492948|NCT01767597|155999215|FG001|Overall Study|Withdrawal by Subject|0|||
48492949|NCT03355742|155999216|FG000|Overall Study|Lost to Follow-up|4|||
48492950|NCT03355742|155999216|FG000|Overall Study|Withdrawal by Subject|29|||
48492951|NCT03355742|155999216|FG000|Overall Study|Physician Decision|6|||
48811539|NCT02058290|157149984|FG000|Overall Study|Withdrawal by Subject|0|||
48811540|NCT02058290|157149985|FG001|Overall Study|Withdrawal by Subject|1|||
48811541|NCT02906202|157149986|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
48811542|NCT01302938|157150005|FG000|Overall Study|Withdrawal by Subject|1|||
48811543|NCT01302938|157150006|FG001|Overall Study|Withdrawal by Subject|0|||
48811544|NCT01302938|157150005|FG000|Overall Study|Adverse Event|1|||
48492952|NCT03355742|155999216|FG000|Overall Study|Death|55|||
48597778|NCT02620787|156383597|FG000|Overall Study|Eligibility Criteria Not Met|1|||
48811545|NCT01302938|157150006|FG001|Overall Study|Adverse Event|0|||
48811546|NCT01233609|157150007|FG000|Overall Study|Death|1|||
48811547|NCT01233609|157150008|FG001|Overall Study|Death|0|||
48811548|NCT01233609|157150007|FG000|Overall Study|Lost to Follow-up|3|||
48811549|NCT01233609|157150008|FG001|Overall Study|Lost to Follow-up|1|||
48492953|NCT03355742|155999216|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
48492954|NCT02961920|155999217|FG000|Overall Study|did not achive stydy protocol schedule|1|||
48492955|NCT02961920|155999218|FG001|Overall Study|did not achive stydy protocol schedule|1|||
48492956|NCT00836927|155999219|FG000|Overall Study|Progressive disease|2|||
48811550|NCT01233609|157150007|FG000|Overall Study|Adverse Event|2|||
48811551|NCT01233609|157150008|FG001|Overall Study|Adverse Event|1|||
48492957|NCT00836927|155999220|FG001|Overall Study|Progressive disease|0|||
48492958|NCT00836927|155999221|FG002|Overall Study|Progressive disease|0|||
48492959|NCT00836927|155999222|FG003|Overall Study|Progressive disease|1|||
48492960|NCT00836927|155999223|FG004|Overall Study|Progressive disease|1|||
48492961|NCT00836927|155999219|FG000|Overall Study|Withdrawal by Subject|1|||
48492962|NCT00836927|155999220|FG001|Overall Study|Withdrawal by Subject|0|||
48492963|NCT00836927|155999221|FG002|Overall Study|Withdrawal by Subject|0|||
48492964|NCT00836927|155999222|FG003|Overall Study|Withdrawal by Subject|0|||
48492965|NCT00836927|155999223|FG004|Overall Study|Withdrawal by Subject|0|||
48712573|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
48492966|NCT01772368|155999224|FG000|Overall Study|Adverse Event|1|||
48492967|NCT01772368|155999224|FG000|Overall Study|Withdrawal by Subject|3|||
48492968|NCT01772368|155999224|FG000|Overall Study|Protocol Violation|2|||
48492969|NCT01772368|155999224|FG000|Overall Study|Other|1|||
48492970|NCT01452529|155999226|FG000|Run-in Period|Adverse Event|96|||
48492971|NCT01452529|155999227|FG001|Run-in Period|Adverse Event|0|||
48492972|NCT01452529|155999228|FG002|Run-in Period|Adverse Event|0|||
48492973|NCT01452529|155999226|FG000|Run-in Period|Withdrawal by Subject|49|||
48492974|NCT01452529|155999227|FG001|Run-in Period|Withdrawal by Subject|0|||
48492975|NCT01452529|155999228|FG002|Run-in Period|Withdrawal by Subject|0|||
48492976|NCT01452529|155999226|FG000|Run-in Period|Lost to Follow-up|19|||
48492977|NCT01452529|155999227|FG001|Run-in Period|Lost to Follow-up|0|||
48492978|NCT01452529|155999228|FG002|Run-in Period|Lost to Follow-up|0|||
48492979|NCT01452529|155999226|FG000|Run-in Period|Lack of Efficacy|46|||
48492980|NCT01452529|155999227|FG001|Run-in Period|Lack of Efficacy|0|||
48492981|NCT01452529|155999228|FG002|Run-in Period|Lack of Efficacy|0|||
48492982|NCT01452529|155999226|FG000|Run-in Period|Confirmed or suspected diversion|23|||
48492983|NCT01452529|155999227|FG001|Run-in Period|Confirmed or suspected diversion|0|||
48492984|NCT01452529|155999228|FG002|Run-in Period|Confirmed or suspected diversion|0|||
48492985|NCT01452529|155999226|FG000|Run-in Period|Administrative|21|||
48492986|NCT01452529|155999227|FG001|Run-in Period|Administrative|0|||
48492987|NCT01452529|155999228|FG002|Run-in Period|Administrative|0|||
48492988|NCT01452529|155999226|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
48492989|NCT01452529|155999227|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
48492990|NCT01452529|155999228|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
48492991|NCT01452529|155999226|FG000|Double-blind (DB) Period|Adverse Event|0|||
48492992|NCT01452529|155999227|FG001|Double-blind (DB) Period|Adverse Event|18|||
48492993|NCT01452529|155999228|FG002|Double-blind (DB) Period|Adverse Event|11|||
48492994|NCT01452529|155999226|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
48492995|NCT01452529|155999227|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
48492996|NCT01452529|155999228|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
48492997|NCT01452529|155999226|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
48492998|NCT01452529|155999227|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
48492999|NCT01452529|155999228|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
48493000|NCT01452529|155999226|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
48493001|NCT01452529|155999227|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
48493002|NCT01452529|155999228|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
48493003|NCT01452529|155999226|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
48493004|NCT01452529|155999227|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
48493005|NCT01452529|155999228|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
48493006|NCT01452529|155999226|FG000|Double-blind (DB) Period|Administrative|0|||
48493007|NCT01452529|155999227|FG001|Double-blind (DB) Period|Administrative|11|||
48493008|NCT01452529|155999228|FG002|Double-blind (DB) Period|Administrative|7|||
48493009|NCT00901628|155999232|FG000|Overall Study|disconnection of catheter|4|||
48493010|NCT00901628|155999233|FG001|Overall Study|disconnection of catheter|8|||
48712574|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
48712575|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
48712576|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
48712577|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
48712578|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
48712579|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
48712580|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
48712581|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
48493011|NCT00901628|155999232|FG000|Overall Study|disconnection of drain|0|||
48493012|NCT00901628|155999233|FG001|Overall Study|disconnection of drain|1|||
48493013|NCT00901628|155999232|FG000|Overall Study|peroneal nerve palsy|0|||
48493014|NCT00901628|155999233|FG001|Overall Study|peroneal nerve palsy|1|||
48493015|NCT00608205|155999234|FG000|Overall Study|Adverse Event|3|||
48493016|NCT00608205|155999235|FG001|Overall Study|Adverse Event|2|||
48493017|NCT00608205|155999234|FG000|Overall Study|Patient non-compliant|0|||
48493018|NCT00608205|155999235|FG001|Overall Study|Patient non-compliant|1|||
48493019|NCT02668783|155999237|FG000|Overall Study|Pregnancy|0|||
48493020|NCT02668783|155999238|FG001|Overall Study|Pregnancy|1|||
48493021|NCT02668783|155999237|FG000|Overall Study|Protocol Violation|2|||
48493022|NCT02668783|155999238|FG001|Overall Study|Protocol Violation|1|||
48493023|NCT02668783|155999237|FG000|Overall Study|Study terminated by sponsor|9|||
48493024|NCT02668783|155999238|FG001|Overall Study|Study terminated by sponsor|10|||
48493025|NCT02668783|155999237|FG000|Overall Study|Subject moved|1|||
48493026|NCT02668783|155999238|FG001|Overall Study|Subject moved|0|||
48493027|NCT02668783|155999237|FG000|Overall Study|Withdrawal by Subject|1|||
48493028|NCT02668783|155999238|FG001|Overall Study|Withdrawal by Subject|0|||
48493029|NCT02008721|155999241|FG000|Overall Study|Withdrawal by Subject|5|||
48493030|NCT02008721|155999242|FG001|Overall Study|Withdrawal by Subject|1|||
48493031|NCT02008721|155999241|FG000|Overall Study|Death|4|||
48493032|NCT02008721|155999242|FG001|Overall Study|Death|2|||
48493033|NCT02008721|155999241|FG000|Overall Study|Adverse Event|3|||
48493034|NCT02008721|155999242|FG001|Overall Study|Adverse Event|5|||
48493035|NCT02008721|155999241|FG000|Overall Study|Protocol Violation|3|||
48493036|NCT02008721|155999242|FG001|Overall Study|Protocol Violation|2|||
48493037|NCT01797120|155999243|FG000|Overall Study|Disesae progression|37|||
48493038|NCT01797120|155999244|FG001|Overall Study|Disesae progression|49|||
48493039|NCT01797120|155999243|FG000|Overall Study|Adverse Event|13|||
48493040|NCT01797120|155999244|FG001|Overall Study|Adverse Event|5|||
48493041|NCT01797120|155999243|FG000|Overall Study|Withdrawal by Subject|6|||
48493042|NCT01797120|155999244|FG001|Overall Study|Withdrawal by Subject|6|||
48493043|NCT01797120|155999243|FG000|Overall Study|Symptomatic progression|2|||
48493044|NCT01797120|155999244|FG001|Overall Study|Symptomatic progression|1|||
48493045|NCT01797120|155999243|FG000|Overall Study|Non-compliance|1|||
48493046|NCT01797120|155999244|FG001|Overall Study|Non-compliance|0|||
48597779|NCT02620787|156383598|FG001|Overall Study|Eligibility Criteria Not Met|0|||
48712582|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
48712583|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
48712584|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
48712585|NCT02834793|156799352|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
48712586|NCT02834793|156799353|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
48712587|NCT02834793|156799354|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
48712588|NCT02834793|156799355|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
48712589|NCT00771953|156799356|FG000|Overall Study|Adverse Event|5|||
48712590|NCT00771953|156799357|FG001|Overall Study|Adverse Event|3|||
48712591|NCT00771953|156799356|FG000|Overall Study|Death|2|||
48712592|NCT00771953|156799357|FG001|Overall Study|Death|2|||
48712593|NCT00771953|156799356|FG000|Overall Study|Progression before active Tx|1|||
48712594|NCT00771953|156799357|FG001|Overall Study|Progression before active Tx|2|||
48712595|NCT00771953|156799356|FG000|Overall Study|Sponsor decision|1|||
48712596|NCT00771953|156799357|FG001|Overall Study|Sponsor decision|0|||
48712597|NCT00771953|156799356|FG000|Overall Study|Other complicating disease|1|||
48712598|NCT00771953|156799357|FG001|Overall Study|Other complicating disease|0|||
48712599|NCT00771953|156799356|FG000|Overall Study|Withdrawal by Subject|0|||
48712600|NCT00771953|156799357|FG001|Overall Study|Withdrawal by Subject|3|||
48712601|NCT01086358|156799358|FG000|First Intervention|Lost to Follow-up|9|||
48712602|NCT01086358|156799359|FG001|First Intervention|Lost to Follow-up|4|||
48712603|NCT01086358|156799358|FG000|First Intervention|Withdrawal by Subject|0|||
48712604|NCT01086358|156799359|FG001|First Intervention|Withdrawal by Subject|1|||
48712605|NCT01086358|156799358|FG000|Second Intervention|Lost to Follow-up|4|||
48712606|NCT01086358|156799359|FG001|Second Intervention|Lost to Follow-up|4|||
48712607|NCT00578292|156799360|FG000|Overall Study|Death|1|||
48493047|NCT01797120|155999243|FG000|Overall Study|Physician Decision|3|||
48493048|NCT01797120|155999244|FG001|Overall Study|Physician Decision|0|||
48493049|NCT01797120|155999243|FG000|Overall Study|still on treatment|2|||
48493050|NCT01797120|155999244|FG001|Overall Study|still on treatment|4|||
48712608|NCT00578292|156799360|FG000|Overall Study|Graft failure|2|||
48712609|NCT00947193|156799363|FG000|Overall Study|Lost to Follow-up|1|||
48712610|NCT00947193|156799364|FG001|Overall Study|Lost to Follow-up|0|||
48712611|NCT00947193|156799363|FG000|Overall Study|Withdrawal by Subject|1|||
48712612|NCT00947193|156799364|FG001|Overall Study|Withdrawal by Subject|0|||
48811552|NCT01233609|157150007|FG000|Overall Study|Withdrawal by Subject|3|||
48811553|NCT01233609|157150008|FG001|Overall Study|Withdrawal by Subject|0|||
48811554|NCT00735644|157150009|FG000|Overall Study|Did not receive study vaccine|0|||
48811555|NCT00735644|157150010|FG001|Overall Study|Did not receive study vaccine|1|||
48811556|NCT00735644|157150011|FG002|Overall Study|Did not receive study vaccine|0|||
48811557|NCT00735644|157150012|FG003|Overall Study|Did not receive study vaccine|0|||
48811558|NCT00735644|157150013|FG004|Overall Study|Did not receive study vaccine|0|||
48811559|NCT00735644|157150009|FG000|Overall Study|Withdrawal by Subject|0|||
48811560|NCT00735644|157150010|FG001|Overall Study|Withdrawal by Subject|1|||
48811561|NCT00735644|157150011|FG002|Overall Study|Withdrawal by Subject|1|||
48811562|NCT00735644|157150012|FG003|Overall Study|Withdrawal by Subject|1|||
48811563|NCT00735644|157150013|FG004|Overall Study|Withdrawal by Subject|0|||
48811564|NCT01734434|157150015|FG000|Overall Study|Death Infant|3|||
48811565|NCT01734434|157150016|FG001|Overall Study|Death Infant|1|||
48811566|NCT01734434|157150017|FG002|Overall Study|Death Infant|17|||
48811567|NCT01734434|157150018|FG003|Overall Study|Death Infant|5|||
48811568|NCT01734434|157150015|FG000|Overall Study|Lost to Follow-up|2|||
48493051|NCT01797120|155999243|FG000|Overall Study|never start protocol therapy|2|||
48493052|NCT01797120|155999244|FG001|Overall Study|never start protocol therapy|0|||
48493053|NCT01003886|155999246|FG000|Overall Study|Lack of Efficacy|5|||
48493054|NCT01003886|155999246|FG000|Overall Study|Lost to Follow-up|169|||
48493055|NCT01003886|155999246|FG000|Overall Study|Withdrawal by Subject|39|||
48493056|NCT01003886|155999246|FG000|Overall Study|Other|14|||
48493057|NCT01003886|155999246|FG000|Overall Study|Adverse Event|3|||
48493058|NCT01165996|155999247|FG000|Overall Study|Death|1|||
48493059|NCT01165996|155999247|FG000|Overall Study|Physician Decision|1|||
48493060|NCT00419926|155999249|FG000|Overall Study|Withdrawal by Subject|7|||
48493061|NCT00419926|155999250|FG001|Overall Study|Withdrawal by Subject|3|||
48493062|NCT00419926|155999249|FG000|Overall Study|Administrative Problem|4|||
48712613|NCT00947193|156799363|FG000|Overall Study|Factor VIII >1%|1|||
48712614|NCT00947193|156799364|FG001|Overall Study|Factor VIII >1%|0|||
48712615|NCT04364984|156799367|FG000|Overall Study|Death|2|||
48712616|NCT04364984|156799368|FG001|Overall Study|Death|2|||
48712617|NCT04364984|156799369|FG002|Overall Study|Death|0|||
48712618|NCT02105961|156799370|FG000|Overall Study|Adverse Event|18|||
48712619|NCT02105961|156799371|FG001|Overall Study|Adverse Event|7|||
48712620|NCT02105961|156799372|FG002|Overall Study|Adverse Event|13|||
48712621|NCT02105961|156799370|FG000|Overall Study|Lack of Efficacy|3|||
48712622|NCT02105961|156799371|FG001|Overall Study|Lack of Efficacy|0|||
48712623|NCT02105961|156799372|FG002|Overall Study|Lack of Efficacy|3|||
48712624|NCT02105961|156799370|FG000|Overall Study|Lost to Follow-up|2|||
48712625|NCT02105961|156799371|FG001|Overall Study|Lost to Follow-up|0|||
48712626|NCT02105961|156799372|FG002|Overall Study|Lost to Follow-up|1|||
48712627|NCT02105961|156799370|FG000|Overall Study|Physician Decision|3|||
48712628|NCT02105961|156799371|FG001|Overall Study|Physician Decision|3|||
48712629|NCT02105961|156799372|FG002|Overall Study|Physician Decision|2|||
48712630|NCT02105961|156799370|FG000|Overall Study|Withdrawal by Subject|15|||
48712631|NCT02105961|156799371|FG001|Overall Study|Withdrawal by Subject|7|||
48712632|NCT02105961|156799372|FG002|Overall Study|Withdrawal by Subject|11|||
48712633|NCT03196349|156799373|FG000|Overall Study|Did not receive study drug|0|||
48712634|NCT03196349|156799374|FG001|Overall Study|Did not receive study drug|1|||
48712635|NCT03196349|156799375|FG002|Overall Study|Did not receive study drug|2|||
48712636|NCT03196349|156799373|FG000|Overall Study|No data entered|2|||
48712637|NCT03196349|156799374|FG001|Overall Study|No data entered|4|||
48712638|NCT03196349|156799375|FG002|Overall Study|No data entered|0|||
48712639|NCT03196349|156799373|FG000|Overall Study|Study Terminated early|15|||
48712640|NCT03196349|156799374|FG001|Overall Study|Study Terminated early|9|||
48712641|NCT03196349|156799375|FG002|Overall Study|Study Terminated early|11|||
48712642|NCT02722304|156799376|FG000|Overall Study|Study Terminated by Sponsor|1|||
48712643|NCT02722304|156799377|FG001|Overall Study|Study Terminated by Sponsor|0|||
48493063|NCT00419926|155999250|FG001|Overall Study|Administrative Problem|4|||
48493064|NCT00419926|155999249|FG000|Overall Study|Lost to Follow-up|1|||
48493065|NCT00419926|155999250|FG001|Overall Study|Lost to Follow-up|2|||
48493066|NCT00419926|155999249|FG000|Overall Study|Death|2|||
48712644|NCT02722304|156799378|FG002|Overall Study|Study Terminated by Sponsor|2|||
48712645|NCT02722304|156799379|FG003|Overall Study|Study Terminated by Sponsor|1|||
48712646|NCT02722304|156799380|FG004|Overall Study|Study Terminated by Sponsor|1|||
48712647|NCT02722304|156799376|FG000|Overall Study|Other|0|||
48712648|NCT02722304|156799377|FG001|Overall Study|Other|0|||
48712649|NCT02722304|156799378|FG002|Overall Study|Other|0|||
48811569|NCT01734434|157150016|FG001|Overall Study|Lost to Follow-up|9|||
48811570|NCT01734434|157150017|FG002|Overall Study|Lost to Follow-up|67|||
48811571|NCT01734434|157150018|FG003|Overall Study|Lost to Follow-up|11|||
48811572|NCT01734434|157150015|FG000|Overall Study|No Live Birth|1|||
48811573|NCT01734434|157150016|FG001|Overall Study|No Live Birth|2|||
48493067|NCT00419926|155999250|FG001|Overall Study|Death|1|||
48712650|NCT02722304|156799379|FG003|Overall Study|Other|1|||
48712651|NCT02722304|156799380|FG004|Overall Study|Other|1|||
48493068|NCT02354586|155999252|FG000|Overall Study|Death|230|||
48493069|NCT02354586|155999252|FG000|Overall Study|Withdrawal by Subject|59|||
48493070|NCT02354586|155999252|FG000|Overall Study|Lost to Follow-up|11|||
48493071|NCT02354586|155999252|FG000|Overall Study|Sponsor decision|51|||
48493072|NCT02354586|155999252|FG000|Overall Study|Site closure|2|||
48493073|NCT02354586|155999252|FG000|Overall Study|Intercurrent illness|1|||
48493074|NCT02354586|155999252|FG000|Overall Study|Protocol Violation|3|||
48493075|NCT02354586|155999252|FG000|Overall Study|Physician Decision|13|||
48493076|NCT02354586|155999252|FG000|Overall Study|Lack of Efficacy|86|||
48493077|NCT02354586|155999252|FG000|Overall Study|Adverse Event|7|||
48493078|NCT03870997|155999254|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
48493079|NCT03870997|155999255|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
48493080|NCT03870997|155999256|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
48493081|NCT03870997|155999257|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
48493082|NCT03870997|155999258|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
48493083|NCT03870997|155999259|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
48493084|NCT02419313|155999260|FG000|First Intervention|Lost to Follow-up|2|||
48493085|NCT02419313|155999261|FG001|First Intervention|Lost to Follow-up|0|||
48493086|NCT02419313|155999260|FG000|Second Intervention|Lost to Follow-up|1|||
48493087|NCT02419313|155999261|FG001|Second Intervention|Lost to Follow-up|0|||
48493088|NCT01338636|155999262|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
48493089|NCT03567057|155999264|FG000|Overall Study|Adverse Event|56|||
48493090|NCT03567057|155999265|FG001|Overall Study|Adverse Event|53|||
48493091|NCT03567057|155999266|FG002|Overall Study|Adverse Event|28|||
48493092|NCT03567057|155999264|FG000|Overall Study|Withdrawal by Subject|22|||
48493093|NCT03567057|155999265|FG001|Overall Study|Withdrawal by Subject|24|||
48493094|NCT03567057|155999266|FG002|Overall Study|Withdrawal by Subject|13|||
48493095|NCT03567057|155999264|FG000|Overall Study|Lost to Follow-up|3|||
48493096|NCT03567057|155999265|FG001|Overall Study|Lost to Follow-up|5|||
48493097|NCT03567057|155999266|FG002|Overall Study|Lost to Follow-up|2|||
48493098|NCT03567057|155999264|FG000|Overall Study|COVID-19 pandemic|4|||
48493099|NCT03567057|155999265|FG001|Overall Study|COVID-19 pandemic|3|||
48493100|NCT03567057|155999266|FG002|Overall Study|COVID-19 pandemic|0|||
48493101|NCT03567057|155999264|FG000|Overall Study|Non-compliance with study drug|4|||
48493102|NCT03567057|155999265|FG001|Overall Study|Non-compliance with study drug|2|||
48493103|NCT03567057|155999266|FG002|Overall Study|Non-compliance with study drug|0|||
48493104|NCT03567057|155999264|FG000|Overall Study|Lack of Efficacy|3|||
48493105|NCT03567057|155999265|FG001|Overall Study|Lack of Efficacy|0|||
48493106|NCT03567057|155999266|FG002|Overall Study|Lack of Efficacy|1|||
48493107|NCT03567057|155999264|FG000|Overall Study|Death|1|||
48493108|NCT03567057|155999265|FG001|Overall Study|Death|0|||
48493109|NCT03567057|155999266|FG002|Overall Study|Death|0|||
48493110|NCT03567057|155999264|FG000|Overall Study|Physician Decision|1|||
48493111|NCT03567057|155999265|FG001|Overall Study|Physician Decision|0|||
48493112|NCT03567057|155999266|FG002|Overall Study|Physician Decision|0|||
48493113|NCT03567057|155999264|FG000|Overall Study|Unstable medical condition|1|||
48493114|NCT03567057|155999265|FG001|Overall Study|Unstable medical condition|0|||
48493115|NCT03567057|155999266|FG002|Overall Study|Unstable medical condition|0|||
48493116|NCT03567057|155999264|FG000|Overall Study|Medical history event|0|||
48493117|NCT03567057|155999265|FG001|Overall Study|Medical history event|0|||
48493118|NCT03567057|155999266|FG002|Overall Study|Medical history event|1|||
48493119|NCT03567057|155999264|FG000|Overall Study|Other|0|||
48493120|NCT03567057|155999265|FG001|Overall Study|Other|0|||
48493121|NCT03567057|155999266|FG002|Overall Study|Other|1|||
48493122|NCT01006707|155999267|FG000|Study Session 1|Lost to Follow-up|2|||
48493123|NCT01006707|155999268|FG001|Study Session 1|Lost to Follow-up|0|||
48493124|NCT01006707|155999269|FG002|Study Session 1|Lost to Follow-up|0|||
48493125|NCT01006707|155999267|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
48493126|NCT01006707|155999268|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
48493127|NCT01006707|155999269|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
48493128|NCT01507896|155999270|FG000|Overall Study|Withdrawal by Subject|1|||
48493129|NCT01507896|155999270|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
48597780|NCT02864407|156383604|FG000|Overall Study|Protocol Violation|3|||
48712652|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
48597781|NCT02864407|156383604|FG000|Overall Study|Lost to Follow-up|115|||
48597782|NCT02864407|156383604|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
48712653|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
48712654|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
48493130|NCT02985151|155999271|FG000|Original Randomization|Withdrawal by Subject|0|||
48493131|NCT02985151|155999272|FG001|Original Randomization|Withdrawal by Subject|1|||
48493132|NCT00886483|155999275|FG000|Overall Study|Lost to Follow-up|0|||
48493133|NCT00886483|155999276|FG001|Overall Study|Lost to Follow-up|1|||
48493134|NCT00886483|155999275|FG000|Overall Study|Pursue medications|1|||
48493135|NCT00886483|155999276|FG001|Overall Study|Pursue medications|2|||
48493136|NCT00886483|155999275|FG000|Overall Study|Distance to center, poor grades|1|||
48597783|NCT02864407|156383604|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
48493137|NCT00886483|155999276|FG001|Overall Study|Distance to center, poor grades|0|||
48493138|NCT00760383|155999277|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
48493139|NCT00760383|155999278|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
48493140|NCT01821625|155999280|FG000|Overall Study|Withdrawal by Subject|2|||
48493141|NCT01821625|155999280|FG000|Overall Study|Lack of Efficacy|2|||
48493142|NCT01821625|155999280|FG000|Overall Study|Adverse Event|1|||
48493143|NCT01821625|155999280|FG000|Overall Study|Medical contraindication|1|||
48493144|NCT02015793|155999283|FG000|Overall Study|Adverse Event|3|||
48493145|NCT02015793|155999284|FG001|Overall Study|Adverse Event|3|||
48493146|NCT02015793|155999283|FG000|Overall Study|Withdrawal by Subject|1|||
48493147|NCT02015793|155999284|FG001|Overall Study|Withdrawal by Subject|1|||
48493148|NCT00686036|155999285|FG000|Overall Study|Adverse Event|3|||
48493149|NCT00686036|155999286|FG001|Overall Study|Adverse Event|0|||
48493150|NCT00686036|155999285|FG000|Overall Study|Withdrawal by Subject|3|||
48493151|NCT00686036|155999286|FG001|Overall Study|Withdrawal by Subject|1|||
48493152|NCT00686036|155999285|FG000|Overall Study|Study terminated by AstraZeneca|2|||
48493153|NCT00686036|155999286|FG001|Overall Study|Study terminated by AstraZeneca|1|||
48493154|NCT00686036|155999285|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
48493155|NCT00686036|155999286|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
48493156|NCT00686036|155999285|FG000|Overall Study|Other reasons not identified|0|||
48493157|NCT00686036|155999286|FG001|Overall Study|Other reasons not identified|4|||
48493158|NCT00753714|155999288|FG000|Overall Study|Lack of Efficacy|21|||
48493159|NCT00753714|155999289|FG001|Overall Study|Lack of Efficacy|34|||
48493160|NCT00753714|155999288|FG000|Overall Study|Adverse Event|26|||
48493161|NCT00753714|155999289|FG001|Overall Study|Adverse Event|18|||
48493162|NCT00753714|155999288|FG000|Overall Study|Protocol Violation|1|||
48493163|NCT00753714|155999289|FG001|Overall Study|Protocol Violation|0|||
48493164|NCT00753714|155999288|FG000|Overall Study|Lost to Follow-up|0|||
48493165|NCT00753714|155999289|FG001|Overall Study|Lost to Follow-up|1|||
48493166|NCT00753714|155999288|FG000|Overall Study|Withdrawal by Subject|2|||
48493167|NCT00753714|155999289|FG001|Overall Study|Withdrawal by Subject|1|||
48493168|NCT00753714|155999288|FG000|Overall Study|Death|3|||
48493169|NCT00753714|155999289|FG001|Overall Study|Death|3|||
48493170|NCT00753714|155999288|FG000|Overall Study|Other|7|||
48493171|NCT00753714|155999289|FG001|Overall Study|Other|5|||
48493172|NCT01868009|155999294|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
48493173|NCT01868009|155999295|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
48493174|NCT01868009|155999294|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
48493175|NCT01868009|155999295|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
48493176|NCT01868009|155999294|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
48493177|NCT01868009|155999295|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
48493178|NCT02669264|155999296|FG000|Overall Study|Death|5|||
48493179|NCT02669264|155999297|FG001|Overall Study|Death|5|||
48493180|NCT02669264|155999298|FG002|Overall Study|Death|3|||
48493181|NCT02669264|155999299|FG003|Overall Study|Death|3|||
48493182|NCT02669264|155999300|FG004|Overall Study|Death|3|||
48493183|NCT02669264|155999301|FG005|Overall Study|Death|6|||
48493184|NCT02669264|155999302|FG006|Overall Study|Death|3|||
48493185|NCT02669264|155999296|FG000|Overall Study|Withdrawal by Subject|0|||
48493186|NCT02669264|155999297|FG001|Overall Study|Withdrawal by Subject|1|||
48493187|NCT02669264|155999298|FG002|Overall Study|Withdrawal by Subject|0|||
48493188|NCT02669264|155999299|FG003|Overall Study|Withdrawal by Subject|0|||
48493189|NCT02669264|155999300|FG004|Overall Study|Withdrawal by Subject|1|||
48493190|NCT02669264|155999301|FG005|Overall Study|Withdrawal by Subject|0|||
48493191|NCT02669264|155999302|FG006|Overall Study|Withdrawal by Subject|0|||
48493192|NCT02669264|155999296|FG000|Overall Study|Lost to Follow-up|0|||
48493193|NCT02669264|155999297|FG001|Overall Study|Lost to Follow-up|0|||
48493194|NCT02669264|155999298|FG002|Overall Study|Lost to Follow-up|0|||
48493195|NCT02669264|155999299|FG003|Overall Study|Lost to Follow-up|0|||
48493196|NCT02669264|155999300|FG004|Overall Study|Lost to Follow-up|1|||
48493197|NCT02669264|155999301|FG005|Overall Study|Lost to Follow-up|0|||
48493198|NCT02669264|155999302|FG006|Overall Study|Lost to Follow-up|0|||
48493199|NCT02669264|155999296|FG000|Overall Study|Miscellaneous|0|||
48493200|NCT02669264|155999297|FG001|Overall Study|Miscellaneous|0|||
48493201|NCT02669264|155999298|FG002|Overall Study|Miscellaneous|0|||
48712655|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
48712656|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
48811574|NCT01734434|157150017|FG002|Overall Study|No Live Birth|32|||
48493202|NCT02669264|155999299|FG003|Overall Study|Miscellaneous|0|||
48493203|NCT02669264|155999300|FG004|Overall Study|Miscellaneous|0|||
48493204|NCT02669264|155999301|FG005|Overall Study|Miscellaneous|0|||
48493205|NCT02669264|155999302|FG006|Overall Study|Miscellaneous|2|||
48493206|NCT01361126|155999303|FG000|Overall Study|Sponsor decision|0|||
48493207|NCT01361126|155999304|FG001|Overall Study|Sponsor decision|2|||
48493208|NCT03529955|155999305|FG000|Overall Study|Adverse Event|1|||
48493209|NCT03529955|155999305|FG000|Overall Study|Lack of Efficacy|1|||
48493210|NCT02199509|155999306|FG000|Overall Study|Suicidal Ideation|0|||
48493211|NCT02199509|155999307|FG001|Overall Study|Suicidal Ideation|1|||
48493212|NCT02199509|155999306|FG000|Overall Study|Misunderstood titration schedule|1|||
48493213|NCT02199509|155999307|FG001|Overall Study|Misunderstood titration schedule|0|||
48493214|NCT01618305|155999309|FG000|Overall Study|Death|0|||
48493215|NCT01618305|155999310|FG001|Overall Study|Death|1|||
48493216|NCT01618305|155999309|FG000|Overall Study|Lost to Follow-up|11|||
48493217|NCT01618305|155999310|FG001|Overall Study|Lost to Follow-up|7|||
48493218|NCT01618305|155999309|FG000|Overall Study|Protocol Violation|1|||
48493219|NCT01618305|155999310|FG001|Overall Study|Protocol Violation|0|||
48493220|NCT01618305|155999309|FG000|Overall Study|Withdrawal by Subject|3|||
48493221|NCT01618305|155999310|FG001|Overall Study|Withdrawal by Subject|2|||
48493222|NCT03384745|155999311|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
48493223|NCT03384745|155999312|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
48493224|NCT03384745|155999313|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
48493225|NCT03384745|155999314|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
48493226|NCT03384745|155999315|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
48493227|NCT03384745|155999316|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
48493228|NCT03384745|155999311|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
48493229|NCT03384745|155999312|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
48493230|NCT03384745|155999313|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
48493231|NCT03384745|155999314|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
48493232|NCT03384745|155999315|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
48493233|NCT03384745|155999316|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
48493234|NCT03384745|155999311|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
48493235|NCT03384745|155999312|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
48493236|NCT03384745|155999313|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
48493237|NCT03384745|155999314|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
48493238|NCT03384745|155999315|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
48493239|NCT03384745|155999316|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
48493240|NCT03384745|155999311|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
48493241|NCT03384745|155999312|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
48493242|NCT03384745|155999313|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
48493243|NCT03384745|155999314|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
48493244|NCT03384745|155999315|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
48493245|NCT03384745|155999316|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
48493246|NCT03384745|155999311|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
48493247|NCT03384745|155999312|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
48493248|NCT03384745|155999313|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
48493249|NCT03384745|155999314|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
48493250|NCT03384745|155999315|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
48493251|NCT03384745|155999316|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
48493252|NCT03384745|155999311|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
48493253|NCT03384745|155999312|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
48493254|NCT03384745|155999313|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
48493255|NCT03384745|155999314|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
48493256|NCT03384745|155999315|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
48493257|NCT03384745|155999316|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
48493258|NCT03384745|155999311|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
48493259|NCT03384745|155999312|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
48493260|NCT03384745|155999313|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
48493261|NCT03384745|155999314|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
48811575|NCT01734434|157150018|FG003|Overall Study|No Live Birth|6|||
48811576|NCT01734434|157150015|FG000|Overall Study|Withdrawal by Subject|4|||
48811577|NCT01734434|157150016|FG001|Overall Study|Withdrawal by Subject|0|||
48811578|NCT01734434|157150017|FG002|Overall Study|Withdrawal by Subject|8|||
48811579|NCT01734434|157150018|FG003|Overall Study|Withdrawal by Subject|1|||
48811580|NCT01734434|157150015|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
48811581|NCT01734434|157150016|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
48811582|NCT01734434|157150017|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
48811583|NCT01734434|157150018|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
48811584|NCT01734434|157150015|FG000|Overall Study|Subject Not Reachable|0|||
48811585|NCT01734434|157150016|FG001|Overall Study|Subject Not Reachable|0|||
48493262|NCT03384745|155999315|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
48811586|NCT01734434|157150017|FG002|Overall Study|Subject Not Reachable|1|||
48811587|NCT01734434|157150018|FG003|Overall Study|Subject Not Reachable|0|||
48811588|NCT01734434|157150015|FG000|Overall Study|Treatment Defaulter|0|||
48493263|NCT03384745|155999316|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
48811589|NCT01734434|157150016|FG001|Overall Study|Treatment Defaulter|0|||
48811590|NCT01734434|157150017|FG002|Overall Study|Treatment Defaulter|1|||
48811591|NCT01734434|157150018|FG003|Overall Study|Treatment Defaulter|0|||
48811592|NCT01734434|157150015|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
48811593|NCT01734434|157150016|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
48811594|NCT01734434|157150017|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
48811595|NCT01734434|157150018|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
48811596|NCT01734434|157150015|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
48811597|NCT01734434|157150016|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
48811598|NCT01734434|157150017|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
48811599|NCT01734434|157150018|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
48811600|NCT00871351|157152006|FG000|Overall Study|Withdrawal by Subject|1|||
48811601|NCT00871351|157152007|FG001|Overall Study|Withdrawal by Subject|0|||
48811602|NCT00871351|157152008|FG002|Overall Study|Withdrawal by Subject|0|||
48811603|NCT00871351|157152006|FG000|Overall Study|Adverse Event|3|||
48811604|NCT00871351|157152007|FG001|Overall Study|Adverse Event|1|||
48811605|NCT00871351|157152008|FG002|Overall Study|Adverse Event|0|||
48811606|NCT01289041|157152009|FG000|Overall Study|Adverse Event|24|||
48811607|NCT01289041|157152009|FG000|Overall Study|Physician Decision|1|||
48811608|NCT01289041|157152009|FG000|Overall Study|Progressive Disease|41|||
48811609|NCT01289041|157152009|FG000|Overall Study|Withdrawal by Subject|3|||
48811610|NCT01289041|157152009|FG000|Overall Study|Death|1|||
48811611|NCT01486758|157152010|FG000|Overall Study|Lost to Follow-up|0|||
48811612|NCT01486758|157152011|FG001|Overall Study|Lost to Follow-up|1|||
48811613|NCT02494921|157152019|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
48811614|NCT02494921|157152020|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
48811615|NCT02494921|157152021|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
48811616|NCT02494921|157152022|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
48493264|NCT03384745|155999311|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
48493265|NCT03384745|155999312|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
48493266|NCT03384745|155999313|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
48493267|NCT03384745|155999314|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
48493268|NCT03384745|155999315|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
48493269|NCT03384745|155999316|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
48811617|NCT02494921|157152023|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
48811618|NCT02494921|157152019|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
48811619|NCT02494921|157152020|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
48811620|NCT02494921|157152021|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
48811621|NCT02494921|157152022|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
48493270|NCT03384745|155999311|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
48493271|NCT03384745|155999312|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
48493272|NCT03384745|155999313|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
48493273|NCT03384745|155999314|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
48493274|NCT03384745|155999315|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
48493275|NCT03384745|155999316|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
48493276|NCT03384745|155999311|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
48493277|NCT03384745|155999312|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
48493278|NCT03384745|155999313|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
48493279|NCT03384745|155999314|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
48493280|NCT03384745|155999315|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
48493281|NCT03384745|155999316|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
48493282|NCT03384745|155999311|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
48493283|NCT03384745|155999312|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
48493284|NCT03384745|155999313|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
48597784|NCT02864407|156383604|FG000|Overall Study|Consent prior to the contract date|1|||
48597785|NCT03283930|156383605|FG000|Overall Study|Scheduling conflict|8|||
48597786|NCT03283930|156383606|FG001|Overall Study|Scheduling conflict|10|||
48493285|NCT03384745|155999314|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
48493286|NCT03384745|155999315|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
48493287|NCT03384745|155999316|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
48493288|NCT01346410|155999321|FG000|Overall Study|Death|1|||
48493289|NCT02576990|155999322|FG000|Overall Study|Death|29|||
48493290|NCT02576990|155999323|FG001|Overall Study|Death|18|||
48493291|NCT02576990|155999322|FG000|Overall Study|Physician Decision|1|||
48493292|NCT02576990|155999323|FG001|Overall Study|Physician Decision|0|||
48493293|NCT02576990|155999322|FG000|Overall Study|Screen failure|2|||
48597787|NCT03283930|156383605|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
48493294|NCT02576990|155999323|FG001|Overall Study|Screen failure|0|||
48493295|NCT02576990|155999322|FG000|Overall Study|Sponsor's decision|24|||
48493296|NCT02576990|155999323|FG001|Overall Study|Sponsor's decision|4|||
48493297|NCT02576990|155999322|FG000|Overall Study|Withdrawal by Subject|0|||
48493298|NCT02576990|155999323|FG001|Overall Study|Withdrawal by Subject|2|||
48493299|NCT03118739|155999324|FG000|Overall Study|Physician Decision|0|||
48597788|NCT03283930|156383606|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
48597789|NCT03283930|156383605|FG000|Overall Study|Technical software issue|2|||
48712657|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
48712658|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
48712659|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
48712660|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
48712661|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
48712662|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
48712663|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
48712664|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
48712665|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
48712666|NCT04173494|156799381|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
48712667|NCT04173494|156799382|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
48712668|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
48712669|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
48712670|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
48811622|NCT02494921|157152023|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
48811623|NCT02494921|157152019|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
48493300|NCT03118739|155999325|FG001|Overall Study|Physician Decision|1|||
48493301|NCT03118739|155999324|FG000|Overall Study|Withdrawal by Subject|5|||
48493302|NCT03118739|155999325|FG001|Overall Study|Withdrawal by Subject|3|||
48493303|NCT03118739|155999324|FG000|Overall Study|Lost to Follow-up|2|||
48493304|NCT03118739|155999325|FG001|Overall Study|Lost to Follow-up|0|||
48493305|NCT01893138|155999326|FG000|Double-Blind Period|Withdrawal by Subject|1|||
48493306|NCT01893138|155999327|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48493307|NCT01893138|155999326|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
48493308|NCT01893138|155999327|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
48493309|NCT01893138|155999326|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
48493310|NCT01893138|155999327|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
48493311|NCT01893138|155999326|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
48493312|NCT01893138|155999327|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
48493313|NCT01893138|155999326|FG000|Open Label - Unblinded Period|Adverse Event|1|||
48493314|NCT01893138|155999327|FG001|Open Label - Unblinded Period|Adverse Event|0|||
48493315|NCT00331630|156000494|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
48493316|NCT00331630|156000494|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
48493317|NCT00331630|156000494|FG000|Follow up for 5 Years|Death|5|||
48493318|NCT00331630|156000494|FG000|Follow up for 5 Years|Data collection was stopped|24|||
48493319|NCT03551730|156000499|FG000|Overall Study|Adverse Event|1|||
48493320|NCT03551730|156000500|FG001|Overall Study|Adverse Event|0|||
48493321|NCT03551730|156000501|FG002|Overall Study|Adverse Event|0|||
48493322|NCT03551730|156000502|FG003|Overall Study|Adverse Event|0|||
48493323|NCT01506323|156000505|FG000|Overall Study|Lost to Follow-up|5|||
48493324|NCT01506323|156000506|FG001|Overall Study|Lost to Follow-up|4|||
48493325|NCT01506323|156000505|FG000|Overall Study|Withdrawal by Subject|4|||
48493326|NCT01506323|156000506|FG001|Overall Study|Withdrawal by Subject|4|||
48493327|NCT01506323|156000505|FG000|Overall Study|Lack of Efficacy|1|||
48493328|NCT01506323|156000506|FG001|Overall Study|Lack of Efficacy|3|||
48493329|NCT01506323|156000505|FG000|Overall Study|Moved out of area|5|||
48493330|NCT01506323|156000506|FG001|Overall Study|Moved out of area|2|||
48493331|NCT01506323|156000505|FG000|Overall Study|Schedule or Transportation conflict|8|||
48493332|NCT01506323|156000506|FG001|Overall Study|Schedule or Transportation conflict|0|||
48493333|NCT01506323|156000505|FG000|Overall Study|Started another treatment|1|||
48712671|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
48811624|NCT02494921|157152020|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
48811625|NCT02494921|157152021|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
48811626|NCT02494921|157152022|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
48493334|NCT01506323|156000506|FG001|Overall Study|Started another treatment|0|||
48493335|NCT02192905|156000512|FG000|Overall Study|Lost to Follow-up|1|||
48493336|NCT04467697|156000513|FG000|Overall Study|Adverse Event|2|||
48493337|NCT04467697|156000513|FG000|Overall Study|Lost to Follow-up|6|||
48493338|NCT04467697|156000513|FG000|Overall Study|Withdrawal by Subject|9|||
48493339|NCT04467697|156000513|FG000|Overall Study|Protocol Violation|3|||
48493340|NCT03907280|156000514|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
48493341|NCT03907280|156000515|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
48493342|NCT03907280|156000516|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
48597790|NCT03283930|156383606|FG001|Overall Study|Technical software issue|2|||
48597791|NCT02824627|156383607|FG000|Overall Study|Adverse Event|1|||
48597792|NCT02824627|156383608|FG001|Overall Study|Adverse Event|2|||
48597793|NCT02824627|156383607|FG000|Overall Study|Lost to Follow-up|2|||
48597794|NCT02824627|156383608|FG001|Overall Study|Lost to Follow-up|1|||
48597795|NCT05502302|156383609|FG000|Overall Study|Lost to Follow-up|6|||
48597796|NCT05502302|156383609|FG000|Overall Study|Death|2|||
48597797|NCT02710084|156383610|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
48493343|NCT00909727|156000517|FG000|Overall Study|Adverse Event|1|||
48493344|NCT00909727|156000518|FG001|Overall Study|Adverse Event|0|||
48493345|NCT00909727|156000517|FG000|Overall Study|Wrong Genotype|1|||
48712672|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
48712673|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
48712674|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
48712675|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
48712676|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
48712677|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
48712678|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
48712679|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
48712680|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
48712681|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
48712682|NCT04173494|156799381|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
48493346|NCT00909727|156000518|FG001|Overall Study|Wrong Genotype|0|||
48493347|NCT00909727|156000517|FG000|Overall Study|Withdrawal of Consent|1|||
48493348|NCT00909727|156000518|FG001|Overall Study|Withdrawal of Consent|0|||
48493349|NCT00909727|156000517|FG000|Overall Study|Prohibited Medication|1|||
48493350|NCT00909727|156000518|FG001|Overall Study|Prohibited Medication|0|||
48493351|NCT01909466|156000521|FG000|Overall Study|Lost to Follow-up|5|||
48493352|NCT01909466|156000522|FG001|Overall Study|Lost to Follow-up|7|||
48493353|NCT01909466|156000521|FG000|Overall Study|Adverse Event|3|||
48493354|NCT01909466|156000522|FG001|Overall Study|Adverse Event|4|||
48493355|NCT01909466|156000521|FG000|Overall Study|Met Withdrawal Criteria|0|||
48493356|NCT01909466|156000522|FG001|Overall Study|Met Withdrawal Criteria|3|||
48493357|NCT01909466|156000521|FG000|Overall Study|Physician Decision|2|||
48493358|NCT01909466|156000522|FG001|Overall Study|Physician Decision|0|||
48493359|NCT01909466|156000521|FG000|Overall Study|Withdrawal by Subject|11|||
48493360|NCT01909466|156000522|FG001|Overall Study|Withdrawal by Subject|9|||
48493361|NCT01909466|156000521|FG000|Overall Study|Lack of Efficacy|1|||
48493362|NCT01909466|156000522|FG001|Overall Study|Lack of Efficacy|0|||
48493363|NCT04480463|156000523|FG000|Overall Study|Death|0|||
48493364|NCT04480463|156000524|FG001|Overall Study|Death|1|||
48493365|NCT04480463|156000523|FG000|Overall Study|Adverse Event|6|||
48493366|NCT04480463|156000524|FG001|Overall Study|Adverse Event|8|||
48493367|NCT04480463|156000523|FG000|Overall Study|Lost to Follow-up|3|||
48493368|NCT04480463|156000524|FG001|Overall Study|Lost to Follow-up|2|||
48493369|NCT04480463|156000523|FG000|Overall Study|Physician Decision|2|||
48493370|NCT04480463|156000524|FG001|Overall Study|Physician Decision|5|||
48493371|NCT04480463|156000523|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
48493372|NCT04480463|156000524|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
48712683|NCT04173494|156799382|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
48712684|NCT00635219|156799383|FG000|Overall Study|Adverse Event|12|||
48712685|NCT00635219|156799384|FG001|Overall Study|Adverse Event|10|||
48712686|NCT00635219|156799385|FG002|Overall Study|Adverse Event|18|||
48493373|NCT04480463|156000523|FG000|Overall Study|Protocol Violation|2|||
48493374|NCT04480463|156000524|FG001|Overall Study|Protocol Violation|1|||
48493375|NCT04480463|156000523|FG000|Overall Study|Withdrawal by Subject|6|||
48493376|NCT04480463|156000524|FG001|Overall Study|Withdrawal by Subject|7|||
48597798|NCT02710084|156383611|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
48597799|NCT03839394|156383612|FG000|Overall Study|Lost to Follow-up|6|||
48597800|NCT03839394|156383613|FG001|Overall Study|Lost to Follow-up|8|||
48712687|NCT00635219|156799386|FG003|Overall Study|Adverse Event|15|||
48712688|NCT00635219|156799387|FG004|Overall Study|Adverse Event|19|||
48493377|NCT04480463|156000523|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
48493378|NCT04480463|156000524|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
48493379|NCT04480463|156000523|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
48493380|NCT04480463|156000524|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
48493381|NCT04480463|156000523|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
48493382|NCT04480463|156000524|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
48493383|NCT04480463|156000523|FG000|Overall Study|Other|6|||
48493384|NCT04480463|156000524|FG001|Overall Study|Other|4|||
48493385|NCT00444795|156000526|FG000|Overall Study|Not Treated|1|||
48493386|NCT00444795|156000526|FG000|Overall Study|Treated Prior to the Contract Date|2|||
48493387|NCT01793610|156000527|FG000|Overall Study|Withdrawal by Subject|1|||
48493388|NCT01793610|156000528|FG001|Overall Study|Withdrawal by Subject|0|||
48493389|NCT01793610|156000529|FG002|Overall Study|Withdrawal by Subject|1|||
48493390|NCT02231710|156000530|FG000|Overall Study|Physician Decision|1|||
48493391|NCT01339910|156000531|FG000|Overall Study|Withdrawal by Subject|1|||
48493392|NCT01339910|156000532|FG001|Overall Study|Withdrawal by Subject|0|||
48493393|NCT01339910|156000531|FG000|Overall Study|Physician Decision|1|||
48712689|NCT00635219|156799383|FG000|Overall Study|Lack of Efficacy|5|||
48712690|NCT00635219|156799384|FG001|Overall Study|Lack of Efficacy|6|||
48712691|NCT00635219|156799385|FG002|Overall Study|Lack of Efficacy|3|||
48712692|NCT00635219|156799386|FG003|Overall Study|Lack of Efficacy|4|||
48712693|NCT00635219|156799387|FG004|Overall Study|Lack of Efficacy|6|||
48712694|NCT00635219|156799383|FG000|Overall Study|Non-compliance With Study Product|0|||
48712695|NCT00635219|156799384|FG001|Overall Study|Non-compliance With Study Product|0|||
48712696|NCT00635219|156799385|FG002|Overall Study|Non-compliance With Study Product|0|||
48712697|NCT00635219|156799386|FG003|Overall Study|Non-compliance With Study Product|2|||
48712698|NCT00635219|156799387|FG004|Overall Study|Non-compliance With Study Product|1|||
48712699|NCT00635219|156799383|FG000|Overall Study|Protocol Violation|0|||
48712700|NCT00635219|156799384|FG001|Overall Study|Protocol Violation|2|||
48493394|NCT01339910|156000532|FG001|Overall Study|Physician Decision|0|||
48712701|NCT00635219|156799385|FG002|Overall Study|Protocol Violation|3|||
48712702|NCT00635219|156799386|FG003|Overall Study|Protocol Violation|2|||
48811627|NCT02494921|157152023|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
48811628|NCT01984424|157152024|FG000|Overall Study|Withdrawal by Subject|3|||
48811629|NCT01984424|157152025|FG001|Overall Study|Withdrawal by Subject|5|||
48811630|NCT01984424|157152024|FG000|Overall Study|Sponsor Decision|0|||
48811631|NCT01984424|157152025|FG001|Overall Study|Sponsor Decision|1|||
48811632|NCT01984424|157152024|FG000|Overall Study|Lost to Follow-up|0|||
48811633|NCT01984424|157152025|FG001|Overall Study|Lost to Follow-up|1|||
48811634|NCT01250119|157152028|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
48811635|NCT01250119|157152029|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
48811636|NCT01250119|157152028|FG000|Diagnostic Phase|Participants Not Tested|44|||
48811637|NCT01250119|157152029|FG001|Diagnostic Phase|Participants Not Tested|0|||
48811638|NCT01250119|157152028|FG000|Treatment Phase|Progressive Disease|0|||
48811639|NCT01250119|157152029|FG001|Treatment Phase|Progressive Disease|32|||
48811640|NCT01250119|157152028|FG000|Treatment Phase|Death|0|||
48811641|NCT01250119|157152029|FG001|Treatment Phase|Death|2|||
48811642|NCT01250119|157152028|FG000|Treatment Phase|Withdrawal by Subject|0|||
48811643|NCT01250119|157152029|FG001|Treatment Phase|Withdrawal by Subject|1|||
48493395|NCT01339910|156000531|FG000|Overall Study|Disease relapse|1|||
48493396|NCT01339910|156000532|FG001|Overall Study|Disease relapse|4|||
48493397|NCT00988169|156000533|FG000|Overall Study|Withdrawal by Subject|1|||
48493398|NCT01399723|156000534|FG000|Overall Study|Lost to Follow-up|0|||
48712703|NCT00635219|156799387|FG004|Overall Study|Protocol Violation|4|||
48712704|NCT00635219|156799383|FG000|Overall Study|Withdrawal of Consent|8|||
48712705|NCT00635219|156799384|FG001|Overall Study|Withdrawal of Consent|6|||
48712706|NCT00635219|156799385|FG002|Overall Study|Withdrawal of Consent|8|||
48811644|NCT01250119|157152028|FG000|Treatment Phase|Adverse Event|0|||
48811645|NCT01250119|157152029|FG001|Treatment Phase|Adverse Event|2|||
48811646|NCT01250119|157152028|FG000|Treatment Phase|Unknown reason|0|||
48811647|NCT01250119|157152029|FG001|Treatment Phase|Unknown reason|4|||
48811648|NCT00871403|157152032|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
48811649|NCT00871403|157152033|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
48811650|NCT00871403|157152034|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
48493399|NCT01399723|156000535|FG001|Overall Study|Lost to Follow-up|1|||
48493400|NCT00704418|156000536|FG000|Overall Study|Withdrawal by Subject|2|||
48712707|NCT00635219|156799386|FG003|Overall Study|Withdrawal of Consent|11|||
48712708|NCT00635219|156799387|FG004|Overall Study|Withdrawal of Consent|8|||
48712709|NCT00635219|156799383|FG000|Overall Study|Lost to Follow-up|0|||
48493401|NCT00704418|156000537|FG001|Overall Study|Withdrawal by Subject|0|||
48712710|NCT00635219|156799384|FG001|Overall Study|Lost to Follow-up|0|||
48493402|NCT00704418|156000536|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
48493403|NCT00704418|156000537|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
48493404|NCT02322879|156000539|FG000|First Intervention|Physician Decision|1|||
48712711|NCT00635219|156799385|FG002|Overall Study|Lost to Follow-up|2|||
48712712|NCT00635219|156799386|FG003|Overall Study|Lost to Follow-up|0|||
48712713|NCT00635219|156799387|FG004|Overall Study|Lost to Follow-up|3|||
48712714|NCT00635219|156799383|FG000|Overall Study|Administrative or Other Reasons|0|||
48712715|NCT00635219|156799384|FG001|Overall Study|Administrative or Other Reasons|1|||
48712716|NCT00635219|156799385|FG002|Overall Study|Administrative or Other Reasons|1|||
48712717|NCT00635219|156799386|FG003|Overall Study|Administrative or Other Reasons|0|||
48712718|NCT00635219|156799387|FG004|Overall Study|Administrative or Other Reasons|1|||
48712719|NCT02147561|156799388|FG000|Overall Study|Lost to Follow-up|3|||
48712720|NCT02147561|156799388|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
48712721|NCT01191762|156799389|FG000|Overall Study|Adverse Event|1|||
48712722|NCT01191762|156799390|FG001|Overall Study|Adverse Event|0|||
48712723|NCT00441064|156799391|FG000|Overall Study|Adverse Event|1|||
48712724|NCT00441064|156799392|FG001|Overall Study|Adverse Event|0|||
48712725|NCT00441064|156799391|FG000|Overall Study|Abnormal laboratory values|0|||
48712726|NCT00441064|156799392|FG001|Overall Study|Abnormal laboratory values|2|||
48712727|NCT00441064|156799391|FG000|Overall Study|Abnormal test procedure results|0|||
48712728|NCT00441064|156799392|FG001|Overall Study|Abnormal test procedure results|1|||
48712729|NCT00441064|156799391|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48712730|NCT00441064|156799392|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48712731|NCT00441064|156799391|FG000|Overall Study|Protocol Deviation|3|||
48712732|NCT00441064|156799392|FG001|Overall Study|Protocol Deviation|2|||
48712733|NCT00441064|156799391|FG000|Overall Study|Patient withdrew consent|5|||
48712734|NCT00441064|156799392|FG001|Overall Study|Patient withdrew consent|2|||
48712735|NCT04195893|156799393|FG000|Second Intervention|Withdrawal by Subject|1|||
48712736|NCT04195893|156799394|FG001|Second Intervention|Withdrawal by Subject|0|||
48712737|NCT01738646|156799397|FG000|Overall Study|Still Receiving Treatment|2|||
48712738|NCT03023813|156799398|FG000|Overall Study|Lost to Follow-up|1|||
48712739|NCT03023813|156799399|FG001|Overall Study|Lost to Follow-up|2|||
48712740|NCT03023813|156799400|FG002|Overall Study|Lost to Follow-up|0|||
48712741|NCT00393861|156799401|FG000|Overall Study|Adverse Event|2|||
48712742|NCT00393861|156799401|FG000|Overall Study|Disease Progression|24|||
48712743|NCT01727024|156799402|FG000|Period 1|Lost to Follow-up|1|||
48712744|NCT01727024|156799403|FG001|Period 1|Lost to Follow-up|1|||
48712745|NCT01727024|156799402|FG000|Period 1|Withdrawal by Subject|2|||
48712746|NCT01727024|156799403|FG001|Period 1|Withdrawal by Subject|3|||
48712747|NCT00139477|156799404|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
48712748|NCT00139477|156799405|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
48712749|NCT00139477|156799404|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
48712750|NCT00139477|156799405|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
48712751|NCT00139477|156799404|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
48712752|NCT00139477|156799405|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
48712753|NCT00139477|156799404|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
48712754|NCT00139477|156799405|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
48712755|NCT00139477|156799404|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
48712756|NCT00139477|156799405|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
48712757|NCT00139477|156799404|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
48712758|NCT00139477|156799405|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
48712759|NCT00139477|156799404|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
48712760|NCT00139477|156799405|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
48493405|NCT02322879|156000540|FG001|First Intervention|Physician Decision|0|||
48493406|NCT00295854|156000543|FG000|Overall Study|Adverse Event|7|||
48493407|NCT00295854|156000544|FG001|Overall Study|Adverse Event|7|||
48493408|NCT00295854|156000545|FG002|Overall Study|Adverse Event|6|||
48493409|NCT00295854|156000543|FG000|Overall Study|Protocol Violation|1|||
48493410|NCT00295854|156000544|FG001|Overall Study|Protocol Violation|1|||
48493411|NCT00295854|156000545|FG002|Overall Study|Protocol Violation|1|||
48493412|NCT00295854|156000543|FG000|Overall Study|Lost to Follow-up|2|||
48493413|NCT00295854|156000544|FG001|Overall Study|Lost to Follow-up|0|||
48493414|NCT00295854|156000545|FG002|Overall Study|Lost to Follow-up|1|||
48493415|NCT00295854|156000543|FG000|Overall Study|Withdrawal by Subject|3|||
48493416|NCT00295854|156000544|FG001|Overall Study|Withdrawal by Subject|7|||
48493417|NCT00295854|156000545|FG002|Overall Study|Withdrawal by Subject|4|||
48493418|NCT00295854|156000543|FG000|Overall Study|did not continue to meet criteria|1|||
48493419|NCT00295854|156000544|FG001|Overall Study|did not continue to meet criteria|1|||
48712761|NCT02267317|156799406|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
48712762|NCT02267317|156799407|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48493420|NCT00295854|156000545|FG002|Overall Study|did not continue to meet criteria|2|||
48493421|NCT00295854|156000543|FG000|Overall Study|required a prohibited medication|1|||
48493422|NCT00295854|156000544|FG001|Overall Study|required a prohibited medication|0|||
48493423|NCT00295854|156000545|FG002|Overall Study|required a prohibited medication|0|||
48493424|NCT00295854|156000543|FG000|Overall Study|Other|3|||
48493425|NCT00295854|156000544|FG001|Overall Study|Other|5|||
48493426|NCT00295854|156000545|FG002|Overall Study|Other|1|||
48493427|NCT00672620|156000546|FG000|Overall Study|Adverse Event|7|||
48493428|NCT00672620|156000547|FG001|Overall Study|Adverse Event|7|||
48493429|NCT00672620|156000548|FG002|Overall Study|Adverse Event|12|||
48493430|NCT00672620|156000549|FG003|Overall Study|Adverse Event|17|||
48712763|NCT02267317|156799408|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48493431|NCT00672620|156000546|FG000|Overall Study|Lack of Efficacy|1|||
48493432|NCT00672620|156000547|FG001|Overall Study|Lack of Efficacy|2|||
48493433|NCT00672620|156000548|FG002|Overall Study|Lack of Efficacy|2|||
48493434|NCT00672620|156000549|FG003|Overall Study|Lack of Efficacy|0|||
48493435|NCT00672620|156000546|FG000|Overall Study|Noncompliance with Study Drug|3|||
48493436|NCT00672620|156000547|FG001|Overall Study|Noncompliance with Study Drug|4|||
48493437|NCT00672620|156000548|FG002|Overall Study|Noncompliance with Study Drug|0|||
48493438|NCT00672620|156000549|FG003|Overall Study|Noncompliance with Study Drug|2|||
48493439|NCT00672620|156000546|FG000|Overall Study|Protocol Deviations|5|||
48493440|NCT00672620|156000547|FG001|Overall Study|Protocol Deviations|7|||
48493441|NCT00672620|156000548|FG002|Overall Study|Protocol Deviations|2|||
48493442|NCT00672620|156000549|FG003|Overall Study|Protocol Deviations|5|||
48493443|NCT00672620|156000546|FG000|Overall Study|Withdrawal of Consent|6|||
48493444|NCT00672620|156000547|FG001|Overall Study|Withdrawal of Consent|12|||
48493445|NCT00672620|156000548|FG002|Overall Study|Withdrawal of Consent|5|||
48493446|NCT00672620|156000549|FG003|Overall Study|Withdrawal of Consent|6|||
48493447|NCT00672620|156000546|FG000|Overall Study|Lost to Follow-up|8|||
48493448|NCT00672620|156000547|FG001|Overall Study|Lost to Follow-up|19|||
48493449|NCT00672620|156000548|FG002|Overall Study|Lost to Follow-up|8|||
48493450|NCT00672620|156000549|FG003|Overall Study|Lost to Follow-up|11|||
48493451|NCT00672620|156000546|FG000|Overall Study|Reason not Specified|3|||
48493452|NCT00672620|156000547|FG001|Overall Study|Reason not Specified|3|||
48493453|NCT00672620|156000548|FG002|Overall Study|Reason not Specified|2|||
48493454|NCT00672620|156000549|FG003|Overall Study|Reason not Specified|1|||
48493455|NCT00772577|156000550|FG000|Overall Study|Adverse Event|6|||
48493456|NCT00772577|156000551|FG001|Overall Study|Adverse Event|3|||
48493457|NCT00772577|156000550|FG000|Overall Study|Abnormal laboratory values|0|||
48493458|NCT00772577|156000551|FG001|Overall Study|Abnormal laboratory values|1|||
48493459|NCT00772577|156000550|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48493460|NCT00772577|156000551|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48712764|NCT02267317|156799409|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48712765|NCT02267317|156799410|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48712766|NCT02267317|156799411|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
48712767|NCT02267317|156799406|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
48712768|NCT02267317|156799407|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712769|NCT02267317|156799408|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712770|NCT02267317|156799409|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712771|NCT02267317|156799410|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712772|NCT02267317|156799411|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
48712773|NCT05194579|156799412|FG000|Overall Study|Lost to Follow-up|2|||
48712774|NCT05194579|156799413|FG001|Overall Study|Lost to Follow-up|3|||
48712775|NCT05194579|156799412|FG000|Overall Study|Withdrawal by Subject|3|||
48712776|NCT05194579|156799413|FG001|Overall Study|Withdrawal by Subject|4|||
48712777|NCT05194579|156799412|FG000|Overall Study|Refused further study procedures|0|||
48712778|NCT05194579|156799413|FG001|Overall Study|Refused further study procedures|1|||
48712779|NCT05194579|156799412|FG000|Overall Study|Protocol deviation|1|||
48493461|NCT00772577|156000550|FG000|Overall Study|Patient withdrew consent|8|||
48493462|NCT00772577|156000551|FG001|Overall Study|Patient withdrew consent|5|||
48712780|NCT05194579|156799413|FG001|Overall Study|Protocol deviation|0|||
48712781|NCT03554486|156799418|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
48712782|NCT03554486|156799419|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
48493463|NCT00772577|156000550|FG000|Overall Study|Lost to Follow-up|4|||
48712783|NCT03554486|156799420|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
48712784|NCT03554486|156799418|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
48811651|NCT00871403|157152032|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
48493464|NCT00772577|156000551|FG001|Overall Study|Lost to Follow-up|3|||
48811652|NCT00871403|157152033|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
48811653|NCT00871403|157152034|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
48493465|NCT00772577|156000550|FG000|Overall Study|Administrative problems|2|||
48493466|NCT00772577|156000551|FG001|Overall Study|Administrative problems|1|||
48493467|NCT00772577|156000550|FG000|Overall Study|Protocol Deviation|3|||
48493468|NCT00772577|156000551|FG001|Overall Study|Protocol Deviation|2|||
48493469|NCT00952484|156000566|FG000|Overall Study|Withdrawal by Subject|0|||
48493470|NCT00952484|156000567|FG001|Overall Study|Withdrawal by Subject|1|||
48493471|NCT00952484|156000568|FG002|Overall Study|Withdrawal by Subject|0|||
48597801|NCT03839394|156383612|FG000|Overall Study|Withdrawal by Subject|0|||
48597802|NCT03839394|156383613|FG001|Overall Study|Withdrawal by Subject|2|||
48597803|NCT00101868|156383614|FG000|Overall Study|Death|10|||
48597804|NCT00101868|156383615|FG001|Overall Study|Death|10|||
48597805|NCT00101868|156383614|FG000|Overall Study|Withdrawal by Subject|8|||
48712785|NCT03554486|156799419|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
48712786|NCT03554486|156799420|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
48811654|NCT00871403|157152032|FG000|Combination Treatment Phase|Adverse Event|0|||
48811655|NCT00871403|157152033|FG001|Combination Treatment Phase|Adverse Event|17|||
48811656|NCT00871403|157152034|FG002|Combination Treatment Phase|Adverse Event|2|||
48811657|NCT00871403|157152032|FG000|Combination Treatment Phase|Disease Progression|0|||
48493472|NCT02750306|156000578|FG000|Overall Study|Withdrawal by Subject|5|||
48493473|NCT02750306|156000579|FG001|Overall Study|Withdrawal by Subject|2|||
48493474|NCT02750306|156000578|FG000|Overall Study|Protocol Violation|1|||
48493475|NCT02750306|156000579|FG001|Overall Study|Protocol Violation|0|||
48493476|NCT00585351|156000582|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
48493477|NCT00585351|156000583|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
48493478|NCT00585351|156000584|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
48493479|NCT00585351|156000585|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
48493480|NCT00585351|156000586|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
48493481|NCT00585351|156000587|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
48493482|NCT00585351|156000588|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
48493483|NCT00585351|156000589|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
48493484|NCT00585351|156000582|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
48493485|NCT00585351|156000583|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
48493486|NCT00585351|156000584|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
48597806|NCT00101868|156383615|FG001|Overall Study|Withdrawal by Subject|9|||
48597807|NCT00101868|156383614|FG000|Overall Study|Protocol Violation|3|||
48597808|NCT00101868|156383615|FG001|Overall Study|Protocol Violation|0|||
48712787|NCT03554486|156799418|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48712788|NCT03554486|156799419|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
48712789|NCT03554486|156799420|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
48712790|NCT02640508|156799423|FG000|Overall Study|Death|19|||
48712791|NCT02640508|156799423|FG000|Overall Study|Withdrawal by Subject|8|||
48712792|NCT02640508|156799423|FG000|Overall Study|Physician Decision|1|||
48712793|NCT02640508|156799423|FG000|Overall Study|Lost to Follow-up|1|||
48712794|NCT04343235|156799424|FG000|Overall Study|Lost to Follow-up|3|||
48712795|NCT04343235|156799425|FG001|Overall Study|Lost to Follow-up|2|||
48712796|NCT00280748|156799426|FG000|Overall Study|Decline in performance|3|||
48712797|NCT00280748|156799426|FG000|Overall Study|Extra-cranial disease progression|1|||
48712798|NCT00029146|156799427|FG000|Overall Study|Lost to Follow-up|2|||
48712799|NCT00029146|156799428|FG001|Overall Study|Lost to Follow-up|1|||
48493487|NCT00585351|156000585|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
48493488|NCT00585351|156000586|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
48493489|NCT00585351|156000587|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
48493490|NCT00585351|156000588|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
48493491|NCT00585351|156000589|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
48597809|NCT00101868|156383614|FG000|Overall Study|Lost to Follow-up|8|||
48493492|NCT00585351|156000582|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
48493493|NCT00585351|156000583|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
48493494|NCT00585351|156000584|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
48493495|NCT00585351|156000585|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
48493496|NCT00585351|156000586|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
48493497|NCT00585351|156000587|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
48493498|NCT00585351|156000588|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
48493499|NCT00585351|156000589|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
48493500|NCT00585351|156000582|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
48493501|NCT00585351|156000583|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
48493502|NCT00585351|156000584|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
48493503|NCT00585351|156000585|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
48493504|NCT00585351|156000586|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
48493505|NCT00585351|156000587|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
48493506|NCT00585351|156000588|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
48493507|NCT00585351|156000589|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
48493508|NCT00585351|156000582|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
48493509|NCT00585351|156000583|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
48493510|NCT00585351|156000584|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
48493511|NCT00585351|156000585|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
48493512|NCT00585351|156000586|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
48493513|NCT00585351|156000587|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
48493514|NCT00585351|156000588|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
48493515|NCT00585351|156000589|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
48493516|NCT00585351|156000582|FG000|Enrollment Period (Intervention)|Death|0|||
48493517|NCT00585351|156000583|FG001|Enrollment Period (Intervention)|Death|0|||
48493518|NCT00585351|156000584|FG002|Enrollment Period (Intervention)|Death|0|||
48493519|NCT00585351|156000585|FG003|Enrollment Period (Intervention)|Death|0|||
48493520|NCT00585351|156000586|FG004|Enrollment Period (Intervention)|Death|1|||
48493521|NCT00585351|156000587|FG005|Enrollment Period (Intervention)|Death|0|||
48493522|NCT00585351|156000588|FG006|Enrollment Period (Intervention)|Death|1|||
48493523|NCT00585351|156000589|FG007|Enrollment Period (Intervention)|Death|0|||
48493524|NCT00585351|156000582|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
48493525|NCT00585351|156000583|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
48493526|NCT00585351|156000584|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
48493527|NCT00585351|156000585|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
48712800|NCT02878798|156799432|FG000|Overall Study|Withdrawal by Subject|5|||
48712801|NCT02878798|156799433|FG001|Overall Study|Withdrawal by Subject|4|||
48712802|NCT02878798|156799432|FG000|Overall Study|Lost to Follow-up|2|||
48712803|NCT02878798|156799433|FG001|Overall Study|Lost to Follow-up|2|||
48712804|NCT02878798|156799432|FG000|Overall Study|Protocol Violation|0|||
48712805|NCT02878798|156799433|FG001|Overall Study|Protocol Violation|1|||
48712806|NCT04556383|156799434|FG000|PCP|Lack of Efficacy|28|||
48712807|NCT04556383|156799435|FG001|PCP|Lack of Efficacy|23|||
48712808|NCT04556383|156799436|FG002|PCP|Lack of Efficacy|23|||
48712809|NCT04556383|156799437|FG003|PCP|Lack of Efficacy|0|||
48712810|NCT04556383|156799434|FG000|PCP|Study terminated by sponsor|15|||
48712811|NCT04556383|156799435|FG001|PCP|Study terminated by sponsor|13|||
48712812|NCT04556383|156799436|FG002|PCP|Study terminated by sponsor|16|||
48712813|NCT04556383|156799437|FG003|PCP|Study terminated by sponsor|0|||
48712814|NCT04556383|156799434|FG000|PCP|Withdrawal by Subject|8|||
48712815|NCT04556383|156799435|FG001|PCP|Withdrawal by Subject|6|||
48712816|NCT04556383|156799436|FG002|PCP|Withdrawal by Subject|6|||
48712817|NCT04556383|156799437|FG003|PCP|Withdrawal by Subject|0|||
48712818|NCT04556383|156799434|FG000|PCP|Adverse Event|1|||
48712819|NCT04556383|156799435|FG001|PCP|Adverse Event|7|||
48712820|NCT04556383|156799436|FG002|PCP|Adverse Event|7|||
48712821|NCT04556383|156799437|FG003|PCP|Adverse Event|0|||
48712822|NCT04556383|156799434|FG000|PCP|Other, Not Specified|1|||
48712823|NCT04556383|156799435|FG001|PCP|Other, Not Specified|2|||
48712824|NCT04556383|156799436|FG002|PCP|Other, Not Specified|1|||
48712825|NCT04556383|156799437|FG003|PCP|Other, Not Specified|0|||
48712826|NCT04556383|156799434|FG000|PCP|Protocol Violation|1|||
48712827|NCT04556383|156799435|FG001|PCP|Protocol Violation|0|||
48712828|NCT04556383|156799436|FG002|PCP|Protocol Violation|1|||
48712829|NCT04556383|156799437|FG003|PCP|Protocol Violation|0|||
48712830|NCT04556383|156799434|FG000|PCP|Lost to Follow-up|1|||
48712831|NCT04556383|156799435|FG001|PCP|Lost to Follow-up|0|||
48712832|NCT04556383|156799436|FG002|PCP|Lost to Follow-up|0|||
48712833|NCT04556383|156799437|FG003|PCP|Lost to Follow-up|0|||
48712834|NCT04556383|156799434|FG000|PCP|Physician Decision|0|||
48712835|NCT04556383|156799435|FG001|PCP|Physician Decision|1|||
48712836|NCT04556383|156799436|FG002|PCP|Physician Decision|0|||
48493528|NCT00585351|156000586|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
48493529|NCT00585351|156000587|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
48493530|NCT00585351|156000588|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
48493531|NCT00585351|156000589|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
48493532|NCT00927810|156000594|FG000|Overall Study|Withdrawal by Subject|0|||
48811658|NCT00871403|157152033|FG001|Combination Treatment Phase|Disease Progression|8|||
48811659|NCT00871403|157152034|FG002|Combination Treatment Phase|Disease Progression|5|||
48811660|NCT00871403|157152032|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
48811661|NCT00871403|157152033|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
48811662|NCT00871403|157152034|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
48811663|NCT00871403|157152032|FG000|Combination Treatment Phase|Physician Decision|0|||
48811664|NCT00871403|157152033|FG001|Combination Treatment Phase|Physician Decision|1|||
48811665|NCT00871403|157152034|FG002|Combination Treatment Phase|Physician Decision|3|||
48811666|NCT00871403|157152032|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
48811667|NCT00871403|157152033|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
48811668|NCT00871403|157152034|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
48811669|NCT00871403|157152032|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
48811670|NCT00871403|157152033|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
48811671|NCT00871403|157152034|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
48811672|NCT01588990|157152042|FG000|Phase A|Withdrawal by Subject|5|||
48811673|NCT01588990|157152042|FG000|Phase A|Physician Decision|11|||
48811674|NCT01588990|157152042|FG000|Phase A|Other|14|||
48811675|NCT01588990|157152042|FG000|Phase A|Lost to Follow-up|1|||
48493533|NCT00927810|156000595|FG001|Overall Study|Withdrawal by Subject|3|||
48493534|NCT00927810|156000596|FG002|Overall Study|Withdrawal by Subject|0|||
48493535|NCT00927810|156000597|FG003|Overall Study|Withdrawal by Subject|1|||
48493536|NCT00927810|156000594|FG000|Overall Study|Lost to Follow-up|0|||
48493537|NCT00927810|156000595|FG001|Overall Study|Lost to Follow-up|2|||
48493538|NCT00927810|156000596|FG002|Overall Study|Lost to Follow-up|1|||
48493539|NCT00927810|156000597|FG003|Overall Study|Lost to Follow-up|1|||
48493540|NCT00927810|156000594|FG000|Overall Study|Death|0|||
48493541|NCT00927810|156000595|FG001|Overall Study|Death|2|||
48811676|NCT01588990|157152042|FG000|Phase A|Death|5|||
48811677|NCT01588990|157152042|FG000|Phase A|Adverse Event|28|||
48811678|NCT01588990|157152042|FG000|Phase A|Still on therapy at end of study|6|||
48493542|NCT00927810|156000596|FG002|Overall Study|Death|0|||
48493543|NCT00927810|156000597|FG003|Overall Study|Death|0|||
48493544|NCT00927810|156000594|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48493545|NCT00927810|156000595|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48811679|NCT01588990|157152042|FG000|Phase B|Adverse Event|2|||
48493546|NCT00927810|156000596|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48493547|NCT00927810|156000597|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48493548|NCT00798889|156000598|FG000|Overall Study|Adverse Event|53|||
48493549|NCT00798889|156000598|FG000|Overall Study|Protocol Violation|2|||
48493550|NCT00798889|156000598|FG000|Overall Study|Withdrawal by Subject|31|||
48493551|NCT00798889|156000598|FG000|Overall Study|Lost to Follow-up|1|||
48493552|NCT00798889|156000598|FG000|Overall Study|Lack of Efficacy|213|||
48493553|NCT00798889|156000598|FG000|Overall Study|Decision of Sponsor|11|||
48493554|NCT00798889|156000598|FG000|Overall Study|Enrolled, Not treated|3|||
48493555|NCT00278512|156000614|FG000|Overall Study|Death|1|||
48493556|NCT00278512|156000615|FG001|Overall Study|Death|0|||
48493557|NCT01620177|156000618|FG000|Overall Study|Failure at Screening Visit|43|||
48493558|NCT01620177|156000618|FG000|Overall Study|Withdrawal by Subject|26|||
48493559|NCT01620177|156000618|FG000|Overall Study|Lost to Follow-up|7|||
48493560|NCT01620177|156000618|FG000|Overall Study|Physician Decision|2|||
48493561|NCT01620177|156000618|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
48493562|NCT02153736|156000625|FG000|Overall Study|Lost to Follow-up|1|||
48493563|NCT02153736|156000626|FG001|Overall Study|Lost to Follow-up|0|||
48493564|NCT02153736|156000625|FG000|Overall Study|Medical status change made ineligible|1|||
48493565|NCT02153736|156000626|FG001|Overall Study|Medical status change made ineligible|0|||
48493566|NCT02153736|156000625|FG000|Overall Study|Death|0|||
48493567|NCT02153736|156000626|FG001|Overall Study|Death|1|||
48493568|NCT02153736|156000625|FG000|Overall Study|Withdrawal by Subject|0|||
48493569|NCT02153736|156000626|FG001|Overall Study|Withdrawal by Subject|1|||
48493570|NCT03775681|156000627|FG000|Overall Study|Physician Decision|3|||
48493571|NCT03283709|156000628|FG000|Overall Study|trial terminated|0|||
48493572|NCT03283709|156000629|FG001|Overall Study|trial terminated|1|||
48493573|NCT00969332|156000632|FG000|Overall Study|Physician Decision|8|||
48493574|NCT00969332|156000632|FG000|Overall Study|Withdrawal by Subject|3|||
48811680|NCT01588990|157152042|FG000|Phase B|Still on therapy at end of study|5|||
48811681|NCT01588990|157152042|FG000|Phase B|Withdrawal by Subject|3|||
48811682|NCT01588990|157152042|FG000|Phase B|Physician Decision|4|||
48811683|NCT01588990|157152042|FG000|Phase B|Other|2|||
48811694|NCT00569803|157152047|FG000|Overall Study|Lost to Follow-up|1|||
48811695|NCT00569803|157152048|FG001|Overall Study|Lost to Follow-up|0|||
48811696|NCT00569803|157152049|FG002|Overall Study|Lost to Follow-up|0|||
48811697|NCT00569803|157152050|FG003|Overall Study|Lost to Follow-up|0|||
48811698|NCT00569803|157152051|FG004|Overall Study|Lost to Follow-up|0|||
48811699|NCT00569803|157152052|FG005|Overall Study|Lost to Follow-up|0|||
48811700|NCT00569803|157152053|FG006|Overall Study|Lost to Follow-up|0|||
48811701|NCT00569803|157152054|FG007|Overall Study|Lost to Follow-up|0|||
48811702|NCT00569803|157152047|FG000|Overall Study|injection syringe leaked during dosing|0|||
48811703|NCT00569803|157152048|FG001|Overall Study|injection syringe leaked during dosing|0|||
48811704|NCT00569803|157152049|FG002|Overall Study|injection syringe leaked during dosing|0|||
48811705|NCT00569803|157152050|FG003|Overall Study|injection syringe leaked during dosing|1|||
48811706|NCT00569803|157152051|FG004|Overall Study|injection syringe leaked during dosing|0|||
48811707|NCT00569803|157152052|FG005|Overall Study|injection syringe leaked during dosing|0|||
48811708|NCT00569803|157152053|FG006|Overall Study|injection syringe leaked during dosing|0|||
48811709|NCT00569803|157152054|FG007|Overall Study|injection syringe leaked during dosing|0|||
48811710|NCT00569803|157152047|FG000|Overall Study|Withdrawal by Subject|0|||
48493575|NCT00582309|156000633|FG000|Overall Study|Protocol Violation|0|||
48493576|NCT00582309|156000634|FG001|Overall Study|Protocol Violation|0|||
48493577|NCT00582309|156000635|FG002|Overall Study|Protocol Violation|2|||
48493578|NCT01565083|156000638|FG000|Overall Study|Withdrawal by Subject|6|||
48811711|NCT00569803|157152048|FG001|Overall Study|Withdrawal by Subject|0|||
48811712|NCT00569803|157152049|FG002|Overall Study|Withdrawal by Subject|0|||
48811713|NCT00569803|157152050|FG003|Overall Study|Withdrawal by Subject|0|||
48493579|NCT01565083|156000639|FG001|Overall Study|Withdrawal by Subject|4|||
48493580|NCT01565083|156000638|FG000|Overall Study|Lost to Follow-up|2|||
48811714|NCT00569803|157152051|FG004|Overall Study|Withdrawal by Subject|0|||
48493581|NCT01565083|156000639|FG001|Overall Study|Lost to Follow-up|7|||
48493582|NCT01565083|156000638|FG000|Overall Study|Death|22|||
48493583|NCT01565083|156000639|FG001|Overall Study|Death|23|||
48811715|NCT00569803|157152052|FG005|Overall Study|Withdrawal by Subject|0|||
48493584|NCT01565083|156000638|FG000|Overall Study|Other|3|||
48811716|NCT00569803|157152053|FG006|Overall Study|Withdrawal by Subject|0|||
48811717|NCT00569803|157152054|FG007|Overall Study|Withdrawal by Subject|1|||
48493585|NCT01565083|156000639|FG001|Overall Study|Other|5|||
48493586|NCT02708277|156000640|FG000|Overall Study|Lost to Follow-up|7|||
48493587|NCT02708277|156000641|FG001|Overall Study|Lost to Follow-up|4|||
48493588|NCT00996736|156000642|FG000|Overall Study|Death|1|||
48493589|NCT00996736|156000643|FG001|Overall Study|Death|1|||
48493590|NCT00996736|156000642|FG000|Overall Study|Lost to Follow-up|15|||
48493591|NCT00996736|156000643|FG001|Overall Study|Lost to Follow-up|14|||
48493592|NCT00996736|156000642|FG000|Overall Study|Visit not within 3-month window|5|||
48493593|NCT00996736|156000643|FG001|Overall Study|Visit not within 3-month window|3|||
48493594|NCT00720798|156002158|FG000|Overall Study|Adverse Event|304|||
48493595|NCT00720798|156002158|FG000|Overall Study|Death|39|||
48493596|NCT00720798|156002158|FG000|Overall Study|Insufficient Therapeutic Response|129|||
48493597|NCT00720798|156002158|FG000|Overall Study|Protocol Violation|4|||
48493598|NCT00720798|156002158|FG000|Overall Study|Refused Treatment|151|||
48493599|NCT00720798|156002158|FG000|Overall Study|Failure to Return|46|||
48493600|NCT00720798|156002158|FG000|Overall Study|Reason not Specified|83|||
48493601|NCT01628120|156002162|FG000|Overall Study|Withdrawal by Subject|7|||
48493602|NCT01628120|156002162|FG000|Overall Study|Adverse Event|12|||
48493603|NCT01628120|156002162|FG000|Overall Study|Lost to Follow-up|1|||
48493604|NCT01628120|156002162|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
48493605|NCT01628120|156002162|FG000|Overall Study|Non-compliant with Study Procedures|1|||
48493606|NCT01628120|156002162|FG000|Overall Study|Not Treated|3|||
48493607|NCT01628120|156002162|FG000|Overall Study|Sponsor Decision|5|||
48493608|NCT01628120|156002162|FG000|Overall Study|Switched Dialysis Method|2|||
48493609|NCT01628120|156002162|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
48493610|NCT01628120|156002162|FG000|Overall Study|Moved or Relocated|5|||
48493611|NCT01628120|156002162|FG000|Overall Study|Kidney Transplant|2|||
48493612|NCT01628120|156002162|FG000|Overall Study|Use of Standard of Care|1|||
48493613|NCT02891200|156002180|FG000|Overall Study|Lost to Follow-up|31|||
48493614|NCT02891200|156002181|FG001|Overall Study|Lost to Follow-up|36|||
48493615|NCT02891200|156002180|FG000|Overall Study|Death|10|||
48712837|NCT04556383|156799437|FG003|PCP|Physician Decision|0|||
48712838|NCT04556383|156799434|FG000|PCP|Site terminated by sponsor|0|||
48493616|NCT02891200|156002181|FG001|Overall Study|Death|9|||
48493617|NCT02891200|156002180|FG000|Overall Study|Withdrawal by Subject|1|||
48493618|NCT02891200|156002181|FG001|Overall Study|Withdrawal by Subject|4|||
48493619|NCT02232074|156002186|FG000|Overall Study|Withdrawal by Subject|5|||
48493620|NCT02232074|156002187|FG001|Overall Study|Withdrawal by Subject|3|||
48493621|NCT02232074|156002186|FG000|Overall Study|No legal concerns at baseline|36|||
48493622|NCT02232074|156002187|FG001|Overall Study|No legal concerns at baseline|41|||
48493623|NCT02232074|156002186|FG000|Overall Study|deemed ineligible|0|||
48493624|NCT02232074|156002187|FG001|Overall Study|deemed ineligible|1|||
48493625|NCT05751629|156002188|FG000|Overall Study|Withdrawal by Subject|6|||
48493626|NCT05751629|156002188|FG000|Overall Study|Death|25|||
48493627|NCT05751629|156002188|FG000|Overall Study|Study Site Closed|9|||
48493628|NCT05751629|156002188|FG000|Overall Study|Physician Decision|1|||
48493629|NCT01927757|156002190|FG000|Overall Study|Withdrawal by Subject|14|||
48493630|NCT01927757|156002190|FG000|Overall Study|Lost to Follow-up|2|||
48493631|NCT01927757|156002190|FG000|Overall Study|Decision by Sponsor|2|||
48493632|NCT01927757|156002190|FG000|Overall Study|Other|1|||
48493633|NCT01927757|156002190|FG000|Overall Study|Ethical Reasons|4|||
48493634|NCT04583579|156002191|FG000|Overall Study|Lost to Follow-up|4|||
48493635|NCT01691859|156002192|FG000|Overall Study|Adverse Event|19|||
48493636|NCT01691859|156002192|FG000|Overall Study|Lack of Efficacy|11|||
48493637|NCT01691859|156002192|FG000|Overall Study|Protocol Violation|4|||
48493638|NCT01691859|156002192|FG000|Overall Study|Product commercially available|221|||
48493639|NCT01691859|156002192|FG000|Overall Study|Study closed/terminated|50|||
48493640|NCT01691859|156002192|FG000|Overall Study|Lost to Follow-up|5|||
48493641|NCT01691859|156002192|FG000|Overall Study|Physician Decision|6|||
48712839|NCT04556383|156799435|FG001|PCP|Site terminated by sponsor|1|||
48712840|NCT04556383|156799436|FG002|PCP|Site terminated by sponsor|0|||
48712841|NCT04556383|156799437|FG003|PCP|Site terminated by sponsor|0|||
48712842|NCT04556383|156799434|FG000|OLE|Study terminated by sponsor|0|||
48712843|NCT04556383|156799435|FG001|OLE|Study terminated by sponsor|0|||
48712844|NCT04556383|156799436|FG002|OLE|Study terminated by sponsor|0|||
48712845|NCT04556383|156799437|FG003|OLE|Study terminated by sponsor|68|||
48493642|NCT01691859|156002192|FG000|Overall Study|Withdrawal by Subject|31|||
48493643|NCT04820842|156002193|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
48493644|NCT04820842|156002194|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
48493645|NCT04820842|156002195|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
48493646|NCT04820842|156002196|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
48493647|NCT04820842|156002197|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
48493648|NCT04820842|156002198|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
48493649|NCT04820842|156002199|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
48493650|NCT04820842|156002193|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
48493651|NCT04820842|156002194|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
48712846|NCT04556383|156799434|FG000|OLE|Withdrawal by Subject|0|||
48493652|NCT04820842|156002195|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
48493653|NCT04820842|156002196|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48597810|NCT00101868|156383615|FG001|Overall Study|Lost to Follow-up|13|||
48597811|NCT01619878|156383616|FG000|6 Week Follow-up Phase|Adverse Event|1|||
48597812|NCT01619878|156383616|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
48597813|NCT01619878|156383616|FG000|Follow-up at 12 Months of Age|Death|2|||
48597814|NCT02106351|156383617|FG000|Treatment Cycle 1|Adverse Event|2|||
48597815|NCT02106351|156383618|FG001|Treatment Cycle 1|Adverse Event|0|||
48597816|NCT02106351|156383619|FG002|Treatment Cycle 1|Adverse Event|0|||
48597817|NCT02106351|156383617|FG000|Treatment Cycle 1|Consent withdrawn|1|||
48597818|NCT02106351|156383618|FG001|Treatment Cycle 1|Consent withdrawn|0|||
48597819|NCT02106351|156383619|FG002|Treatment Cycle 1|Consent withdrawn|2|||
48597820|NCT02106351|156383617|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
48597821|NCT02106351|156383618|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
48597822|NCT02106351|156383619|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
48597823|NCT02106351|156383617|FG000|Treatment Cycle 1|Other|0|||
48597824|NCT02106351|156383618|FG001|Treatment Cycle 1|Other|3|||
48597825|NCT02106351|156383619|FG002|Treatment Cycle 1|Other|1|||
48597826|NCT02106351|156383617|FG000|Treatment Cycle 1|Randomised but not treated|1|||
48597827|NCT02106351|156383618|FG001|Treatment Cycle 1|Randomised but not treated|0|||
48493654|NCT04820842|156002197|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48493655|NCT04820842|156002198|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48493656|NCT04820842|156002199|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48493657|NCT04820842|156002193|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48493658|NCT04820842|156002194|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
48493659|NCT04820842|156002195|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48493660|NCT04820842|156002196|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48493661|NCT04820842|156002197|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48493662|NCT04820842|156002198|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48493663|NCT04820842|156002199|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
48493664|NCT04820842|156002193|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48493665|NCT04820842|156002194|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48493666|NCT04820842|156002195|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48493667|NCT04820842|156002196|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
48493668|NCT04820842|156002197|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48493669|NCT04820842|156002198|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
48493670|NCT04820842|156002199|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
48493671|NCT04081337|156002200|FG000|Overall Study|Adverse Event|0|||
48493672|NCT04081337|156002201|FG001|Overall Study|Adverse Event|1|||
48493673|NCT04081337|156002200|FG000|Overall Study|Withdrawal by Subject|2|||
48493674|NCT04081337|156002201|FG001|Overall Study|Withdrawal by Subject|0|||
48493675|NCT04081337|156002200|FG000|Overall Study|Physician Decision|1|||
48493676|NCT04081337|156002201|FG001|Overall Study|Physician Decision|2|||
48493677|NCT04081337|156002200|FG000|Overall Study|Lost to Follow-up|1|||
48493678|NCT04081337|156002201|FG001|Overall Study|Lost to Follow-up|0|||
48493679|NCT01296932|156002202|FG000|Overall Study|Dose limiting toxicity|0|||
48493680|NCT01296932|156002203|FG001|Overall Study|Dose limiting toxicity|0|||
48493681|NCT01296932|156002204|FG002|Overall Study|Dose limiting toxicity|0|||
48493682|NCT01296932|156002205|FG003|Overall Study|Dose limiting toxicity|0|||
48493683|NCT01296932|156002206|FG004|Overall Study|Dose limiting toxicity|0|||
48493684|NCT01296932|156002207|FG005|Overall Study|Dose limiting toxicity|0|||
48493685|NCT01296932|156002208|FG006|Overall Study|Dose limiting toxicity|1|||
48493686|NCT01296932|156002209|FG007|Overall Study|Dose limiting toxicity|0|||
48493687|NCT01296932|156002210|FG008|Overall Study|Dose limiting toxicity|1|||
48493688|NCT01296932|156002202|FG000|Overall Study|Progressive disease|2|||
48493689|NCT01296932|156002203|FG001|Overall Study|Progressive disease|0|||
48493690|NCT01296932|156002204|FG002|Overall Study|Progressive disease|1|||
48493691|NCT01296932|156002205|FG003|Overall Study|Progressive disease|1|||
48597828|NCT02106351|156383619|FG002|Treatment Cycle 1|Randomised but not treated|1|||
48597829|NCT02106351|156383617|FG000|Treatment Cycle 2|Adverse Event|0|||
48597830|NCT02106351|156383618|FG001|Treatment Cycle 2|Adverse Event|2|||
48597831|NCT02106351|156383619|FG002|Treatment Cycle 2|Adverse Event|0|||
48597832|NCT02106351|156383617|FG000|Treatment Cycle 2|Consent withdrawn|0|||
48597833|NCT02106351|156383618|FG001|Treatment Cycle 2|Consent withdrawn|1|||
48597834|NCT02106351|156383619|FG002|Treatment Cycle 2|Consent withdrawn|1|||
48597835|NCT02106351|156383617|FG000|Treatment Cycle 2|Other|0|||
48597836|NCT02106351|156383618|FG001|Treatment Cycle 2|Other|2|||
48597837|NCT02106351|156383619|FG002|Treatment Cycle 2|Other|2|||
48597838|NCT02106351|156383617|FG000|Treatment Cycle 3|Adverse Event|0|||
48597839|NCT02106351|156383618|FG001|Treatment Cycle 3|Adverse Event|1|||
48597840|NCT02106351|156383619|FG002|Treatment Cycle 3|Adverse Event|0|||
48597841|NCT02106351|156383617|FG000|Treatment Cycle 3|Consent withdrawn|0|||
48597842|NCT02106351|156383618|FG001|Treatment Cycle 3|Consent withdrawn|0|||
48597843|NCT02106351|156383619|FG002|Treatment Cycle 3|Consent withdrawn|2|||
48597844|NCT02106351|156383617|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
48597845|NCT02106351|156383618|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
48597846|NCT02106351|156383619|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
48597847|NCT02106351|156383617|FG000|Treatment Cycle 3|Other|0|||
48597848|NCT02106351|156383618|FG001|Treatment Cycle 3|Other|2|||
48712847|NCT04556383|156799435|FG001|OLE|Withdrawal by Subject|0|||
48712848|NCT04556383|156799436|FG002|OLE|Withdrawal by Subject|0|||
48493692|NCT01296932|156002206|FG004|Overall Study|Progressive disease|2|||
48493693|NCT01296932|156002207|FG005|Overall Study|Progressive disease|3|||
48493694|NCT01296932|156002208|FG006|Overall Study|Progressive disease|1|||
48493695|NCT01296932|156002209|FG007|Overall Study|Progressive disease|0|||
48493696|NCT01296932|156002210|FG008|Overall Study|Progressive disease|0|||
48493697|NCT01296932|156002202|FG000|Overall Study|Withdrawal by Subject|0|||
48493698|NCT01296932|156002203|FG001|Overall Study|Withdrawal by Subject|0|||
48493699|NCT01296932|156002204|FG002|Overall Study|Withdrawal by Subject|1|||
48493700|NCT01296932|156002205|FG003|Overall Study|Withdrawal by Subject|1|||
48493701|NCT01296932|156002206|FG004|Overall Study|Withdrawal by Subject|0|||
48493702|NCT01296932|156002207|FG005|Overall Study|Withdrawal by Subject|0|||
48493703|NCT01296932|156002208|FG006|Overall Study|Withdrawal by Subject|3|||
48493704|NCT01296932|156002209|FG007|Overall Study|Withdrawal by Subject|0|||
48493705|NCT01296932|156002210|FG008|Overall Study|Withdrawal by Subject|0|||
48493706|NCT01296932|156002202|FG000|Overall Study|Adverse Event|1|||
48493707|NCT01296932|156002203|FG001|Overall Study|Adverse Event|1|||
48493708|NCT01296932|156002204|FG002|Overall Study|Adverse Event|1|||
48493709|NCT01296932|156002205|FG003|Overall Study|Adverse Event|2|||
48493710|NCT01296932|156002206|FG004|Overall Study|Adverse Event|1|||
48493711|NCT01296932|156002207|FG005|Overall Study|Adverse Event|0|||
48493712|NCT01296932|156002208|FG006|Overall Study|Adverse Event|0|||
48493713|NCT01296932|156002209|FG007|Overall Study|Adverse Event|0|||
48493714|NCT01296932|156002210|FG008|Overall Study|Adverse Event|1|||
48493715|NCT01296932|156002202|FG000|Overall Study|Investigator decision|0|||
48493716|NCT01296932|156002203|FG001|Overall Study|Investigator decision|1|||
48493717|NCT01296932|156002204|FG002|Overall Study|Investigator decision|0|||
48493718|NCT01296932|156002205|FG003|Overall Study|Investigator decision|1|||
48493719|NCT01296932|156002206|FG004|Overall Study|Investigator decision|0|||
48493720|NCT01296932|156002207|FG005|Overall Study|Investigator decision|0|||
48493721|NCT01296932|156002208|FG006|Overall Study|Investigator decision|1|||
48493722|NCT01296932|156002209|FG007|Overall Study|Investigator decision|0|||
48493723|NCT01296932|156002210|FG008|Overall Study|Investigator decision|1|||
48493724|NCT01296932|156002202|FG000|Overall Study|No clinical benefit anymore|0|||
48493725|NCT01296932|156002203|FG001|Overall Study|No clinical benefit anymore|1|||
48493726|NCT01296932|156002204|FG002|Overall Study|No clinical benefit anymore|0|||
48493727|NCT01296932|156002205|FG003|Overall Study|No clinical benefit anymore|0|||
48493728|NCT01296932|156002206|FG004|Overall Study|No clinical benefit anymore|0|||
48493729|NCT01296932|156002207|FG005|Overall Study|No clinical benefit anymore|0|||
48597849|NCT02106351|156383619|FG002|Treatment Cycle 3|Other|3|||
48597850|NCT02106351|156383617|FG000|Treatment Cycle 4|Consent withdrawn|0|||
48712849|NCT04556383|156799437|FG003|OLE|Withdrawal by Subject|10|||
48712850|NCT04556383|156799434|FG000|OLE|Lack of Efficacy|0|||
48712851|NCT04556383|156799435|FG001|OLE|Lack of Efficacy|0|||
48712852|NCT04556383|156799436|FG002|OLE|Lack of Efficacy|0|||
48712853|NCT04556383|156799437|FG003|OLE|Lack of Efficacy|7|||
48712854|NCT04556383|156799434|FG000|OLE|Adverse Event|0|||
48712855|NCT04556383|156799435|FG001|OLE|Adverse Event|0|||
48712856|NCT04556383|156799436|FG002|OLE|Adverse Event|0|||
48712857|NCT04556383|156799437|FG003|OLE|Adverse Event|2|||
48712858|NCT04556383|156799434|FG000|OLE|Other, Not Specified|0|||
48712859|NCT04556383|156799435|FG001|OLE|Other, Not Specified|0|||
48712860|NCT04556383|156799436|FG002|OLE|Other, Not Specified|0|||
48712861|NCT04556383|156799437|FG003|OLE|Other, Not Specified|2|||
48712862|NCT04556383|156799434|FG000|OLE|Death|0|||
48712863|NCT04556383|156799435|FG001|OLE|Death|0|||
48712864|NCT04556383|156799436|FG002|OLE|Death|0|||
48712865|NCT04556383|156799437|FG003|OLE|Death|1|||
48712866|NCT04556383|156799434|FG000|OLE|Lost to Follow-up|0|||
48493730|NCT01296932|156002208|FG006|Overall Study|No clinical benefit anymore|0|||
48493731|NCT01296932|156002209|FG007|Overall Study|No clinical benefit anymore|0|||
48493732|NCT01296932|156002210|FG008|Overall Study|No clinical benefit anymore|0|||
48712867|NCT04556383|156799435|FG001|OLE|Lost to Follow-up|0|||
48712868|NCT04556383|156799436|FG002|OLE|Lost to Follow-up|0|||
48712869|NCT04556383|156799437|FG003|OLE|Lost to Follow-up|1|||
48712870|NCT01387542|156799438|FG000|Overall Study|Adverse Event|3|||
48712871|NCT01387542|156799438|FG000|Overall Study|Withdrawal by Subject|1|||
48493733|NCT01296932|156002202|FG000|Overall Study|Physician Decision|0|||
48493734|NCT01296932|156002203|FG001|Overall Study|Physician Decision|0|||
48493735|NCT01296932|156002204|FG002|Overall Study|Physician Decision|1|||
48493736|NCT01296932|156002205|FG003|Overall Study|Physician Decision|0|||
48493737|NCT01296932|156002206|FG004|Overall Study|Physician Decision|0|||
48493738|NCT01296932|156002207|FG005|Overall Study|Physician Decision|0|||
48493739|NCT01296932|156002208|FG006|Overall Study|Physician Decision|0|||
48493740|NCT01296932|156002209|FG007|Overall Study|Physician Decision|0|||
48493741|NCT01296932|156002210|FG008|Overall Study|Physician Decision|0|||
48493742|NCT01296932|156002202|FG000|Overall Study|IV problems, administration not possible|0|||
48493743|NCT01296932|156002203|FG001|Overall Study|IV problems, administration not possible|0|||
48493744|NCT01296932|156002204|FG002|Overall Study|IV problems, administration not possible|1|||
48493745|NCT01296932|156002205|FG003|Overall Study|IV problems, administration not possible|0|||
48493746|NCT01296932|156002206|FG004|Overall Study|IV problems, administration not possible|0|||
48493747|NCT01296932|156002207|FG005|Overall Study|IV problems, administration not possible|0|||
48493748|NCT01296932|156002208|FG006|Overall Study|IV problems, administration not possible|0|||
48493749|NCT01296932|156002209|FG007|Overall Study|IV problems, administration not possible|0|||
48493750|NCT01296932|156002210|FG008|Overall Study|IV problems, administration not possible|0|||
48493751|NCT01296932|156002202|FG000|Overall Study|per protocol|0|||
48493752|NCT01296932|156002203|FG001|Overall Study|per protocol|0|||
48493753|NCT01296932|156002204|FG002|Overall Study|per protocol|1|||
48493754|NCT01296932|156002205|FG003|Overall Study|per protocol|1|||
48493755|NCT01296932|156002206|FG004|Overall Study|per protocol|0|||
48493756|NCT01296932|156002207|FG005|Overall Study|per protocol|0|||
48493757|NCT01296932|156002208|FG006|Overall Study|per protocol|0|||
48493758|NCT01296932|156002209|FG007|Overall Study|per protocol|0|||
48493759|NCT01296932|156002210|FG008|Overall Study|per protocol|0|||
48493760|NCT01296932|156002202|FG000|Overall Study|Low benefit and too many side effects|0|||
48493761|NCT01296932|156002203|FG001|Overall Study|Low benefit and too many side effects|0|||
48493762|NCT01296932|156002204|FG002|Overall Study|Low benefit and too many side effects|0|||
48493763|NCT01296932|156002205|FG003|Overall Study|Low benefit and too many side effects|0|||
48493764|NCT01296932|156002206|FG004|Overall Study|Low benefit and too many side effects|0|||
48493765|NCT01296932|156002207|FG005|Overall Study|Low benefit and too many side effects|0|||
48493766|NCT01296932|156002208|FG006|Overall Study|Low benefit and too many side effects|0|||
48493767|NCT01296932|156002209|FG007|Overall Study|Low benefit and too many side effects|1|||
48493768|NCT01296932|156002210|FG008|Overall Study|Low benefit and too many side effects|0|||
48493769|NCT01296932|156002202|FG000|Overall Study|No adequate treatment response|0|||
48712872|NCT01387542|156799438|FG000|Overall Study|Changed diagnosis|1|||
48712873|NCT01387542|156799438|FG000|Overall Study|Insufficient response|1|||
48712874|NCT01387542|156799438|FG000|Overall Study|Non-compliant|1|||
48712875|NCT01387542|156799438|FG000|Overall Study|Lost to Follow-up|1|||
48712876|NCT02720042|156799439|FG000|Overall Study|Death|3|||
48712877|NCT02720042|156799439|FG000|Overall Study|Lost to Follow-up|4|||
48712878|NCT02720042|156799439|FG000|Overall Study|Withdrawal by Subject|1|||
48712879|NCT02720042|156799439|FG000|Overall Study|Physician Decision|3|||
48712880|NCT02720042|156799439|FG000|Overall Study|Phasix Mesh explanted|1|||
48712881|NCT02720042|156799439|FG000|Overall Study|unable due to non-study-related illness|3|||
48712882|NCT01994889|156799440|FG000|Overall Study|Adverse Event|5|||
48712883|NCT01994889|156799441|FG001|Overall Study|Adverse Event|12|||
48712884|NCT01994889|156799442|FG002|Overall Study|Adverse Event|11|||
48712885|NCT01994889|156799440|FG000|Overall Study|Cardiac Device Implantation|0|||
48712886|NCT01994889|156799441|FG001|Overall Study|Cardiac Device Implantation|2|||
48712887|NCT01994889|156799442|FG002|Overall Study|Cardiac Device Implantation|0|||
48712888|NCT01994889|156799440|FG000|Overall Study|Organ Transplantation|1|||
48712889|NCT01994889|156799441|FG001|Overall Study|Organ Transplantation|5|||
48712890|NCT01994889|156799442|FG002|Overall Study|Organ Transplantation|5|||
48712891|NCT01994889|156799440|FG000|Overall Study|No longer willing to participate|8|||
48712892|NCT01994889|156799441|FG001|Overall Study|No longer willing to participate|17|||
48712893|NCT01994889|156799442|FG002|Overall Study|No longer willing to participate|37|||
48712894|NCT01994889|156799440|FG000|Overall Study|Lost to Follow-up|0|||
48712895|NCT01994889|156799441|FG001|Overall Study|Lost to Follow-up|1|||
48712896|NCT01994889|156799442|FG002|Overall Study|Lost to Follow-up|0|||
48712897|NCT01994889|156799440|FG000|Overall Study|Protocol Violation|0|||
48712898|NCT01994889|156799441|FG001|Overall Study|Protocol Violation|1|||
48712899|NCT01994889|156799442|FG002|Overall Study|Protocol Violation|1|||
48712900|NCT01994889|156799440|FG000|Overall Study|Death|14|||
48712901|NCT01994889|156799441|FG001|Overall Study|Death|25|||
48712902|NCT01994889|156799442|FG002|Overall Study|Death|38|||
48712903|NCT00335764|156799443|FG000|Overall Study|wrong histology|1|||
48712904|NCT00335764|156799444|FG001|Overall Study|wrong histology|0|||
48712905|NCT00335764|156799445|FG002|Overall Study|wrong histology|0|||
48712906|NCT00335764|156799446|FG003|Overall Study|wrong histology|0|||
48712907|NCT00335764|156799447|FG004|Overall Study|wrong histology|1|||
48712908|NCT01388985|156799452|FG000|Overall Study|Death|0|||
48712909|NCT01388985|156799453|FG001|Overall Study|Death|1|||
48712910|NCT01388985|156799452|FG000|Overall Study|Lost to Follow-up|30|||
48712911|NCT01388985|156799453|FG001|Overall Study|Lost to Follow-up|30|||
48712912|NCT01388985|156799452|FG000|Overall Study|Withdrawal by Subject|13|||
48712913|NCT01388985|156799453|FG001|Overall Study|Withdrawal by Subject|4|||
48712914|NCT01388985|156799452|FG000|Overall Study|Subject unavailable|1|||
48712915|NCT01388985|156799453|FG001|Overall Study|Subject unavailable|1|||
48712916|NCT01388985|156799452|FG000|Overall Study|Other (no reason)|0|||
48712917|NCT01388985|156799453|FG001|Overall Study|Other (no reason)|1|||
48712918|NCT01388985|156799452|FG000|Overall Study|Error of nurse|5|||
48712919|NCT01388985|156799453|FG001|Overall Study|Error of nurse|1|||
48712920|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
48712921|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
48712922|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
48712923|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
48712924|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
48712925|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
48493770|NCT01296932|156002203|FG001|Overall Study|No adequate treatment response|0|||
48493771|NCT01296932|156002204|FG002|Overall Study|No adequate treatment response|0|||
48712926|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
48712927|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
48712928|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
48712929|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
48493772|NCT01296932|156002205|FG003|Overall Study|No adequate treatment response|0|||
48493773|NCT01296932|156002206|FG004|Overall Study|No adequate treatment response|0|||
48493774|NCT01296932|156002207|FG005|Overall Study|No adequate treatment response|0|||
48493775|NCT01296932|156002208|FG006|Overall Study|No adequate treatment response|0|||
48493776|NCT01296932|156002209|FG007|Overall Study|No adequate treatment response|1|||
48493777|NCT01296932|156002210|FG008|Overall Study|No adequate treatment response|0|||
48493778|NCT01296932|156002202|FG000|Overall Study|Dosage already reduced, AE still present|0|||
48493779|NCT01296932|156002203|FG001|Overall Study|Dosage already reduced, AE still present|0|||
48493780|NCT01296932|156002204|FG002|Overall Study|Dosage already reduced, AE still present|0|||
48493781|NCT01296932|156002205|FG003|Overall Study|Dosage already reduced, AE still present|0|||
48712930|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
48712931|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
48712932|NCT03158285|156799454|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
48712933|NCT03158285|156799455|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
48493782|NCT01296932|156002206|FG004|Overall Study|Dosage already reduced, AE still present|0|||
48493783|NCT01296932|156002207|FG005|Overall Study|Dosage already reduced, AE still present|0|||
48493784|NCT01296932|156002208|FG006|Overall Study|Dosage already reduced, AE still present|0|||
48493785|NCT01296932|156002209|FG007|Overall Study|Dosage already reduced, AE still present|0|||
48493786|NCT01296932|156002210|FG008|Overall Study|Dosage already reduced, AE still present|1|||
48493787|NCT03211156|156002217|FG000|Overall Study|Withdrawal by Subject|0|||
48493788|NCT03211156|156002218|FG001|Overall Study|Withdrawal by Subject|2|||
48493789|NCT03211156|156002217|FG000|Overall Study|Lost to Follow-up|1|||
48493790|NCT03211156|156002218|FG001|Overall Study|Lost to Follow-up|1|||
48493791|NCT03211156|156002217|FG000|Overall Study|Adverse Event|1|||
48493792|NCT03211156|156002218|FG001|Overall Study|Adverse Event|0|||
48493793|NCT01579474|156002219|FG000|Overall Study|Adverse Event|1|||
48493794|NCT01579474|156002220|FG001|Overall Study|Adverse Event|13|||
48493795|NCT01579474|156002221|FG002|Overall Study|Adverse Event|2|||
48493796|NCT01579474|156002222|FG003|Overall Study|Adverse Event|0|||
48493797|NCT01579474|156002223|FG004|Overall Study|Adverse Event|0|||
48493798|NCT01579474|156002224|FG005|Overall Study|Adverse Event|1|||
48493799|NCT01579474|156002219|FG000|Overall Study|Lack of Efficacy|1|||
48493800|NCT01579474|156002220|FG001|Overall Study|Lack of Efficacy|0|||
48493801|NCT01579474|156002221|FG002|Overall Study|Lack of Efficacy|0|||
48493802|NCT01579474|156002222|FG003|Overall Study|Lack of Efficacy|0|||
48597851|NCT02106351|156383618|FG001|Treatment Cycle 4|Consent withdrawn|0|||
48597852|NCT02106351|156383619|FG002|Treatment Cycle 4|Consent withdrawn|2|||
48597853|NCT02106351|156383617|FG000|Treatment Cycle 4|Other|0|||
48597854|NCT02106351|156383618|FG001|Treatment Cycle 4|Other|1|||
48597855|NCT02106351|156383619|FG002|Treatment Cycle 4|Other|0|||
48597856|NCT01801111|156383620|FG000|Overall Study|Adverse Event|12|||
48597857|NCT01801111|156383620|FG000|Overall Study|Death|8|||
48597858|NCT01801111|156383620|FG000|Overall Study|Physician Decision|5|||
48597859|NCT01801111|156383620|FG000|Overall Study|Other|1|||
48597860|NCT01801111|156383620|FG000|Overall Study|Withdrawal by Subject|4|||
48712934|NCT03158285|156799456|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
48712935|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
48712936|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
48712937|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
48712938|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
48712939|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
48712940|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
48712941|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
48712942|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
48712943|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
48712944|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
48712945|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
48712946|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
48712947|NCT03158285|156799454|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
48712948|NCT03158285|156799455|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
48712949|NCT03158285|156799456|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
48712950|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
48712951|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
48712952|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
48712953|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
48712954|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
48712955|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
48712956|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
48712957|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
48712958|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
48712959|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
48712960|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
48712961|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
48712962|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Death|1|||
48712963|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Death|0|||
48712964|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Death|0|||
48712965|NCT03158285|156799454|FG000|Active Treatment Period: Week 52-100|Other|4|||
48712966|NCT03158285|156799455|FG001|Active Treatment Period: Week 52-100|Other|1|||
48712967|NCT03158285|156799456|FG002|Active Treatment Period: Week 52-100|Other|0|||
48493803|NCT01579474|156002223|FG004|Overall Study|Lack of Efficacy|1|||
48493804|NCT01579474|156002224|FG005|Overall Study|Lack of Efficacy|0|||
48493805|NCT01579474|156002219|FG000|Overall Study|Withdrawal by Subject|1|||
48493806|NCT01579474|156002220|FG001|Overall Study|Withdrawal by Subject|0|||
48597861|NCT01801111|156383620|FG000|Overall Study|Study Terminated by Sponsor|27|||
48597862|NCT01801111|156383620|FG000|Overall Study|Progressive Disease|81|||
48597863|NCT03284853|156383621|FG000|Overall Study|Adverse Event|40|||
48712968|NCT00402740|156799461|FG000|Overall Study|Withdrawal by Subject|18|||
48712969|NCT00402740|156799461|FG000|Overall Study|Death|50|||
48712970|NCT00402740|156799461|FG000|Overall Study|Lost to Follow-up|6|||
48712971|NCT00402740|156799461|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
48712972|NCT00402740|156799461|FG000|Overall Study|Subject disposition unknown.|1|||
48712973|NCT01700387|156799465|FG000|Overall Study|Withdrawal by Subject|1|||
48712974|NCT01700387|156799466|FG001|Overall Study|Withdrawal by Subject|2|||
48712975|NCT01700387|156799465|FG000|Overall Study|Adverse Event|1|||
48712976|NCT01700387|156799466|FG001|Overall Study|Adverse Event|1|||
48712977|NCT01700387|156799465|FG000|Overall Study|Lost to Follow-up|2|||
48712978|NCT01700387|156799466|FG001|Overall Study|Lost to Follow-up|1|||
48712979|NCT02034409|156799467|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
48712980|NCT02034409|156799468|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
48712981|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
48712982|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
48712983|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
48712984|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
48712985|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
48712986|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
48712987|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
48712988|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
48712989|NCT02034409|156799467|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
48712990|NCT02034409|156799468|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
48712991|NCT01306929|156799469|FG000|Overall Study|Withdrawal by Subject|23|||
48712992|NCT01306929|156799469|FG000|Overall Study|Adverse Event|21|||
48712993|NCT01306929|156799469|FG000|Overall Study|Physician Decision|13|||
48712994|NCT01306929|156799469|FG000|Overall Study|Death|8|||
48712995|NCT01306929|156799469|FG000|Overall Study|Withdrawal by parent/guardian|5|||
48712996|NCT01306929|156799469|FG000|Overall Study|Protocol Violation|3|||
48712997|NCT01306929|156799469|FG000|Overall Study|Non-compliance with study drug|2|||
48712998|NCT01306929|156799469|FG000|Overall Study|Lost to Follow-up|2|||
48712999|NCT01306929|156799469|FG000|Overall Study|Various|17|||
48713000|NCT01870076|156799470|FG000|Overall Study|Withdrawal by Subject|1|||
48713001|NCT01870076|156799471|FG001|Overall Study|Withdrawal by Subject|0|||
48713002|NCT01870076|156799472|FG002|Overall Study|Withdrawal by Subject|1|||
48713003|NCT01870076|156799473|FG003|Overall Study|Withdrawal by Subject|0|||
48713004|NCT04463069|156799475|FG000|Overall Study|Withdrawal by Subject|2|||
48713005|NCT04463069|156799476|FG001|Overall Study|Withdrawal by Subject|10|||
48713006|NCT04463069|156799475|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
48713007|NCT04463069|156799476|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
48713008|NCT00831493|156799477|FG000|Overall Study|Intractable nausea and vomiting|1|||
48713009|NCT00534599|156799478|FG000|Overall Study|Adverse Event|25|||
48713010|NCT00534599|156799479|FG001|Overall Study|Adverse Event|4|||
48713011|NCT00534599|156799478|FG000|Overall Study|Incorrect enrollment|2|||
48713012|NCT00534599|156799479|FG001|Overall Study|Incorrect enrollment|1|||
48713013|NCT00534599|156799478|FG000|Overall Study|Mis-randomization|2|||
48713014|NCT00534599|156799479|FG001|Overall Study|Mis-randomization|2|||
48713015|NCT00534599|156799478|FG000|Overall Study|Developed study-specific d/c criteria|5|||
48713016|NCT00534599|156799479|FG001|Overall Study|Developed study-specific d/c criteria|0|||
48713017|NCT00534599|156799478|FG000|Overall Study|Lack of Efficacy|0|||
48713018|NCT00534599|156799479|FG001|Overall Study|Lack of Efficacy|1|||
48713019|NCT00534599|156799478|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
48713020|NCT00534599|156799479|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
48713021|NCT00534599|156799478|FG000|Overall Study|Protocol Violation|1|||
48713022|NCT00534599|156799479|FG001|Overall Study|Protocol Violation|3|||
48713023|NCT00534599|156799478|FG000|Overall Study|Lost to Follow-up|11|||
48713024|NCT00534599|156799479|FG001|Overall Study|Lost to Follow-up|14|||
48435570|NCT00916370|155782516|FG001|Overall Study|Physician Decision|1|||
48435571|NCT02938585|155782518|FG000|Overall Study|Withdrawal by parent or guardian|0|||
48435572|NCT02938585|155782519|FG001|Overall Study|Withdrawal by parent or guardian|1|||
48435573|NCT02938585|155782520|FG002|Overall Study|Withdrawal by parent or guardian|0|||
48435574|NCT02938585|155782521|FG003|Overall Study|Withdrawal by parent or guardian|0|||
48435575|NCT02938585|155782518|FG000|Overall Study|Withdrawal by Subject|0|||
48435576|NCT02938585|155782519|FG001|Overall Study|Withdrawal by Subject|0|||
48435577|NCT02938585|155782520|FG002|Overall Study|Withdrawal by Subject|0|||
48435578|NCT02938585|155782521|FG003|Overall Study|Withdrawal by Subject|5|||
48435579|NCT02504268|155783722|FG000|Overall Study|Adverse Event|18|||
48435580|NCT02504268|155783723|FG001|Overall Study|Adverse Event|8|||
48435581|NCT02504268|155783724|FG002|Overall Study|Adverse Event|14|||
48435582|NCT02504268|155783725|FG003|Overall Study|Adverse Event|0|||
48435583|NCT02504268|155783726|FG004|Overall Study|Adverse Event|0|||
48435584|NCT02504268|155783727|FG005|Overall Study|Adverse Event|0|||
48811718|NCT01993823|157152055|FG000|Overall Study|Requested by the patient|6|||
48811719|NCT01993823|157152056|FG001|Overall Study|Requested by the patient|11|||
48811720|NCT01993823|157152055|FG000|Overall Study|Protocol Violation|0|||
48811721|NCT01993823|157152056|FG001|Overall Study|Protocol Violation|1|||
48811722|NCT01993823|157152055|FG000|Overall Study|Lost to Follow-up|1|||
48811723|NCT01993823|157152056|FG001|Overall Study|Lost to Follow-up|4|||
48811724|NCT03321006|157152062|FG000|Overall Study|Death|1|||
48811725|NCT03321006|157152063|FG001|Overall Study|Death|0|||
48811726|NCT03321006|157152062|FG000|Overall Study|Lack of Efficacy|1|||
48811727|NCT03321006|157152063|FG001|Overall Study|Lack of Efficacy|0|||
48811728|NCT00708305|157152069|FG000|Period 1|Protocol Violation|1|||
48811729|NCT00708305|157152070|FG001|Period 1|Protocol Violation|0|||
48811730|NCT00708305|157152071|FG002|Period 1|Protocol Violation|1|||
48811731|NCT00708305|157152072|FG003|Period 1|Protocol Violation|0|||
48811732|NCT00708305|157152069|FG000|Period 1|Other Reason|0|||
48811733|NCT00708305|157152070|FG001|Period 1|Other Reason|0|||
48811734|NCT00708305|157152071|FG002|Period 1|Other Reason|0|||
48811735|NCT00708305|157152072|FG003|Period 1|Other Reason|2|||
48811736|NCT00708305|157152069|FG000|Period 2|Lost to Follow-up|0|||
48811737|NCT00708305|157152070|FG001|Period 2|Lost to Follow-up|1|||
48811738|NCT00708305|157152071|FG002|Period 2|Lost to Follow-up|0|||
48811739|NCT00708305|157152072|FG003|Period 2|Lost to Follow-up|0|||
48811740|NCT00708305|157152069|FG000|Period 2|Protocol Violation|0|||
48811741|NCT00708305|157152070|FG001|Period 2|Protocol Violation|1|||
48811742|NCT00708305|157152071|FG002|Period 2|Protocol Violation|0|||
48811743|NCT00708305|157152072|FG003|Period 2|Protocol Violation|0|||
48811744|NCT00708305|157152069|FG000|Period 2|Other Reason|1|||
48811745|NCT00708305|157152070|FG001|Period 2|Other Reason|0|||
48811746|NCT00708305|157152071|FG002|Period 2|Other Reason|0|||
48811747|NCT00708305|157152072|FG003|Period 2|Other Reason|1|||
48811748|NCT00708305|157152069|FG000|Period 3|Protocol Violation|0|||
48811749|NCT00708305|157152070|FG001|Period 3|Protocol Violation|2|||
48811750|NCT00708305|157152071|FG002|Period 3|Protocol Violation|0|||
48811751|NCT00708305|157152072|FG003|Period 3|Protocol Violation|0|||
48811752|NCT00708305|157152069|FG000|Period 3|Other Reason|1|||
48811753|NCT00708305|157152070|FG001|Period 3|Other Reason|0|||
48811754|NCT00708305|157152071|FG002|Period 3|Other Reason|0|||
48811755|NCT00708305|157152072|FG003|Period 3|Other Reason|0|||
48811756|NCT02823964|157152079|FG000|Overall Study|Adverse Event|2|||
48811757|NCT02823964|157152079|FG000|Overall Study|Physician Decision|1|||
48811758|NCT02823964|157152079|FG000|Overall Study|Lack of Efficacy|1|||
48811759|NCT02823964|157152079|FG000|Overall Study|Withdrawal by Subject|1|||
48811760|NCT04498247|157152082|FG000|Overall Study|Lost to Follow-up|0|||
48811761|NCT04498247|157152083|FG001|Overall Study|Lost to Follow-up|0|||
48811762|NCT04498247|157152084|FG002|Overall Study|Lost to Follow-up|0|||
48811763|NCT04498247|157152085|FG003|Overall Study|Lost to Follow-up|1|||
48811764|NCT04498247|157152086|FG004|Overall Study|Lost to Follow-up|0|||
48811765|NCT04498247|157152087|FG005|Overall Study|Lost to Follow-up|0|||
48811766|NCT04498247|157152088|FG006|Overall Study|Lost to Follow-up|0|||
48811767|NCT04498247|157152089|FG007|Overall Study|Lost to Follow-up|0|||
48811768|NCT04498247|157152082|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
48811769|NCT04498247|157152083|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811770|NCT04498247|157152084|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811771|NCT04498247|157152085|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811772|NCT04498247|157152086|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811773|NCT04498247|157152087|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811774|NCT04498247|157152088|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811775|NCT04498247|157152089|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
48811776|NCT04498247|157152082|FG000|Overall Study|Withdrawal by Subject|0|||
48811777|NCT04498247|157152083|FG001|Overall Study|Withdrawal by Subject|8|||
48811778|NCT04498247|157152084|FG002|Overall Study|Withdrawal by Subject|0|||
48811779|NCT04498247|157152085|FG003|Overall Study|Withdrawal by Subject|7|||
48811780|NCT04498247|157152086|FG004|Overall Study|Withdrawal by Subject|0|||
48811781|NCT04498247|157152087|FG005|Overall Study|Withdrawal by Subject|0|||
48811782|NCT04498247|157152088|FG006|Overall Study|Withdrawal by Subject|1|||
48811783|NCT04498247|157152089|FG007|Overall Study|Withdrawal by Subject|0|||
48811784|NCT04498247|157152082|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811785|NCT04498247|157152083|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
48811786|NCT04498247|157152084|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811787|NCT04498247|157152085|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
48811788|NCT04498247|157152086|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811789|NCT04498247|157152087|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811790|NCT04498247|157152088|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
48811791|NCT04498247|157152089|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
48811792|NCT03469349|157152090|FG000|Overall Study|Withdrawal by Subject|1|||
48811793|NCT03469349|157152091|FG001|Overall Study|Withdrawal by Subject|3|||
48811794|NCT03469349|157152090|FG000|Overall Study|Progressive Disease|0|||
48811795|NCT03469349|157152091|FG001|Overall Study|Progressive Disease|1|||
48811796|NCT03469349|157152090|FG000|Overall Study|Lost to Follow-up|2|||
48811797|NCT03469349|157152091|FG001|Overall Study|Lost to Follow-up|2|||
48811798|NCT03469349|157152090|FG000|Overall Study|Adverse Event|2|||
48811799|NCT03469349|157152091|FG001|Overall Study|Adverse Event|4|||
48811800|NCT02247804|157152093|FG000|Treatment Period 1|Adverse Event|9|||
48811801|NCT02247804|157152094|FG001|Treatment Period 1|Adverse Event|2|||
48493807|NCT01579474|156002221|FG002|Overall Study|Withdrawal by Subject|0|||
48493808|NCT01579474|156002222|FG003|Overall Study|Withdrawal by Subject|0|||
48811802|NCT02247804|157152095|FG002|Treatment Period 1|Adverse Event|0|||
48811803|NCT02247804|157152093|FG000|Treatment Period 1|Lack of Efficacy|0|||
48811804|NCT02247804|157152094|FG001|Treatment Period 1|Lack of Efficacy|0|||
48493809|NCT01579474|156002223|FG004|Overall Study|Withdrawal by Subject|0|||
48811805|NCT02247804|157152095|FG002|Treatment Period 1|Lack of Efficacy|2|||
48811806|NCT02247804|157152093|FG000|Treatment Period 1|Lost to Follow-up|1|||
48811807|NCT02247804|157152094|FG001|Treatment Period 1|Lost to Follow-up|0|||
48811808|NCT02247804|157152095|FG002|Treatment Period 1|Lost to Follow-up|2|||
48811809|NCT02247804|157152093|FG000|Treatment Period 1|Personal Reasons|7|||
48811810|NCT02247804|157152094|FG001|Treatment Period 1|Personal Reasons|1|||
48811811|NCT02247804|157152095|FG002|Treatment Period 1|Personal Reasons|2|||
48811812|NCT02247804|157152093|FG000|Treatment Period 1|Protocol Deviation|0|||
48811813|NCT02247804|157152094|FG001|Treatment Period 1|Protocol Deviation|0|||
48811814|NCT02247804|157152095|FG002|Treatment Period 1|Protocol Deviation|1|||
48811815|NCT02247804|157152093|FG000|Treatment Period 1|Randomized but not Treated|5|||
48811816|NCT02247804|157152094|FG001|Treatment Period 1|Randomized but not Treated|1|||
48811817|NCT02247804|157152095|FG002|Treatment Period 1|Randomized but not Treated|1|||
48811818|NCT02247804|157152093|FG000|Treatment Period 2|Adverse Event|6|||
48811819|NCT02247804|157152094|FG001|Treatment Period 2|Adverse Event|3|||
48811820|NCT02247804|157152095|FG002|Treatment Period 2|Adverse Event|3|||
48811821|NCT02247804|157152093|FG000|Treatment Period 2|Lack of Efficacy|0|||
48811822|NCT02247804|157152094|FG001|Treatment Period 2|Lack of Efficacy|0|||
48811823|NCT02247804|157152095|FG002|Treatment Period 2|Lack of Efficacy|1|||
48713025|NCT00534599|156799478|FG000|Overall Study|Withdrawal by Subject|4|||
48811824|NCT02247804|157152093|FG000|Treatment Period 2|Lost to Follow-up|0|||
48713026|NCT00534599|156799479|FG001|Overall Study|Withdrawal by Subject|6|||
48713027|NCT00534599|156799478|FG000|Overall Study|Other|7|||
48713028|NCT00534599|156799479|FG001|Overall Study|Other|0|||
48713029|NCT01124864|156801303|FG000|Overall Study|Follow up phase competed as per protocol|18|||
48713030|NCT01124864|156801304|FG001|Overall Study|Follow up phase competed as per protocol|22|||
48713031|NCT01124864|156801305|FG002|Overall Study|Follow up phase competed as per protocol|24|||
48713032|NCT01124864|156801306|FG003|Overall Study|Follow up phase competed as per protocol|18|||
48713033|NCT01124864|156801307|FG004|Overall Study|Follow up phase competed as per protocol|26|||
48713034|NCT01124864|156801308|FG005|Overall Study|Follow up phase competed as per protocol|2|||
48713035|NCT01124864|156801303|FG000|Overall Study|Death|6|||
48713036|NCT01124864|156801304|FG001|Overall Study|Death|9|||
48713037|NCT01124864|156801305|FG002|Overall Study|Death|6|||
48713038|NCT01124864|156801306|FG003|Overall Study|Death|2|||
48713039|NCT01124864|156801307|FG004|Overall Study|Death|1|||
48713040|NCT01124864|156801308|FG005|Overall Study|Death|0|||
48713041|NCT01124864|156801303|FG000|Overall Study|Withdrawal by Subject|2|||
48713042|NCT01124864|156801304|FG001|Overall Study|Withdrawal by Subject|3|||
48713043|NCT01124864|156801305|FG002|Overall Study|Withdrawal by Subject|4|||
48713044|NCT01124864|156801306|FG003|Overall Study|Withdrawal by Subject|0|||
48713045|NCT01124864|156801307|FG004|Overall Study|Withdrawal by Subject|2|||
48713046|NCT01124864|156801308|FG005|Overall Study|Withdrawal by Subject|1|||
48713047|NCT01124864|156801303|FG000|Overall Study|Lost to Follow-up|1|||
48713048|NCT01124864|156801304|FG001|Overall Study|Lost to Follow-up|1|||
48713049|NCT01124864|156801305|FG002|Overall Study|Lost to Follow-up|0|||
48713050|NCT01124864|156801306|FG003|Overall Study|Lost to Follow-up|1|||
48713051|NCT01124864|156801307|FG004|Overall Study|Lost to Follow-up|0|||
48713052|NCT01124864|156801308|FG005|Overall Study|Lost to Follow-up|0|||
48713053|NCT01124864|156801303|FG000|Overall Study|Protocol Violation|1|||
48713054|NCT01124864|156801304|FG001|Overall Study|Protocol Violation|0|||
48713055|NCT01124864|156801305|FG002|Overall Study|Protocol Violation|0|||
48713056|NCT01124864|156801306|FG003|Overall Study|Protocol Violation|0|||
48713057|NCT01124864|156801307|FG004|Overall Study|Protocol Violation|1|||
48713058|NCT01124864|156801308|FG005|Overall Study|Protocol Violation|0|||
48713059|NCT01243242|156801309|FG000|Overall Study|Adverse Event|1|||
48713060|NCT01243242|156801310|FG001|Overall Study|Adverse Event|1|||
48713061|NCT01243242|156801309|FG000|Overall Study|Withdrawal by Subject|1|||
48713062|NCT01243242|156801310|FG001|Overall Study|Withdrawal by Subject|1|||
48713063|NCT01243242|156801309|FG000|Overall Study|Physician Decision|0|||
48713064|NCT01243242|156801310|FG001|Overall Study|Physician Decision|1|||
48713065|NCT01243242|156801309|FG000|Overall Study|sponsor decision|0|||
48713066|NCT01243242|156801310|FG001|Overall Study|sponsor decision|1|||
48713067|NCT01243242|156801309|FG000|Overall Study|non compliance|1|||
48713068|NCT01243242|156801310|FG001|Overall Study|non compliance|0|||
48713069|NCT00552188|156801313|FG000|Overall Study|Adverse Event|0|||
48713070|NCT00552188|156801314|FG001|Overall Study|Adverse Event|2|||
48713071|NCT00552188|156801313|FG000|Overall Study|Lost to Follow-up|2|||
48713072|NCT00552188|156801314|FG001|Overall Study|Lost to Follow-up|1|||
48713073|NCT00552188|156801313|FG000|Overall Study|Withdrawal of consent|0|||
48713074|NCT00552188|156801314|FG001|Overall Study|Withdrawal of consent|1|||
48713075|NCT00552188|156801313|FG000|Overall Study|Subject returned to home country|0|||
48713076|NCT00552188|156801314|FG001|Overall Study|Subject returned to home country|1|||
48713077|NCT01874340|156801326|FG000|Overall Study|Study terminated by Sponsor|6|||
48713078|NCT01874340|156801327|FG001|Overall Study|Study terminated by Sponsor|8|||
48713079|NCT01874340|156801328|FG002|Overall Study|Study terminated by Sponsor|8|||
48713080|NCT01874340|156801329|FG003|Overall Study|Study terminated by Sponsor|4|||
48713081|NCT01874340|156801326|FG000|Overall Study|Withdrawal by Subject|0|||
48713082|NCT01874340|156801327|FG001|Overall Study|Withdrawal by Subject|0|||
48811825|NCT02247804|157152094|FG001|Treatment Period 2|Lost to Follow-up|1|||
48713083|NCT01874340|156801328|FG002|Overall Study|Withdrawal by Subject|0|||
48713084|NCT01874340|156801329|FG003|Overall Study|Withdrawal by Subject|1|||
48811826|NCT02247804|157152095|FG002|Treatment Period 2|Lost to Follow-up|1|||
48811827|NCT02247804|157152093|FG000|Treatment Period 2|Personal Reasons|2|||
48811828|NCT02247804|157152094|FG001|Treatment Period 2|Personal Reasons|1|||
48811829|NCT02247804|157152095|FG002|Treatment Period 2|Personal Reasons|1|||
48811830|NCT02247804|157152093|FG000|Treatment Period 2|Reason not Specified|0|||
48811831|NCT02247804|157152094|FG001|Treatment Period 2|Reason not Specified|0|||
48811832|NCT02247804|157152095|FG002|Treatment Period 2|Reason not Specified|2|||
48811833|NCT02247804|157152093|FG000|Treatment Period 3|Adverse Event|4|||
48811834|NCT02247804|157152094|FG001|Treatment Period 3|Adverse Event|3|||
48811835|NCT02247804|157152095|FG002|Treatment Period 3|Adverse Event|3|||
48811836|NCT02247804|157152093|FG000|Treatment Period 3|Lack of Efficacy|0|||
48811837|NCT02247804|157152094|FG001|Treatment Period 3|Lack of Efficacy|1|||
48811838|NCT02247804|157152095|FG002|Treatment Period 3|Lack of Efficacy|0|||
48811839|NCT02247804|157152093|FG000|Treatment Period 3|Lost to Follow-up|1|||
48811840|NCT02247804|157152094|FG001|Treatment Period 3|Lost to Follow-up|2|||
48811841|NCT02247804|157152095|FG002|Treatment Period 3|Lost to Follow-up|2|||
48811842|NCT02247804|157152093|FG000|Treatment Period 3|Personal Reasons|4|||
48811843|NCT02247804|157152094|FG001|Treatment Period 3|Personal Reasons|3|||
48811844|NCT02247804|157152095|FG002|Treatment Period 3|Personal Reasons|2|||
48811845|NCT02247804|157152093|FG000|Treatment Period 3|Reason not Specified|2|||
48811846|NCT02247804|157152094|FG001|Treatment Period 3|Reason not Specified|1|||
48811847|NCT02247804|157152095|FG002|Treatment Period 3|Reason not Specified|3|||
48811848|NCT00390455|157152098|FG000|Overall Study|Adverse Event|17|||
48811849|NCT00390455|157152099|FG001|Overall Study|Adverse Event|3|||
48811850|NCT00390455|157152098|FG000|Overall Study|Withdrawal by Subject|8|||
48811851|NCT00390455|157152099|FG001|Overall Study|Withdrawal by Subject|8|||
48811852|NCT00390455|157152098|FG000|Overall Study|Alternate Treatment|0|||
48811853|NCT00390455|157152099|FG001|Overall Study|Alternate Treatment|1|||
48811854|NCT00390455|157152098|FG000|Overall Study|Other Medical Reasons|7|||
48811855|NCT00390455|157152099|FG001|Overall Study|Other Medical Reasons|11|||
48811856|NCT02917265|157152100|FG000|Overall Study|Physician Decision|1|||
48811857|NCT02917265|157152101|FG001|Overall Study|Physician Decision|0|||
48811858|NCT02917265|157152100|FG000|Overall Study|Withdrawal by Subject|1|||
48811859|NCT02917265|157152101|FG001|Overall Study|Withdrawal by Subject|0|||
48811860|NCT03447730|157152102|FG000|Overall Study|Adverse Event|0|||
48493810|NCT01579474|156002224|FG005|Overall Study|Withdrawal by Subject|0|||
48493811|NCT02637076|156002225|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
48493812|NCT02637076|156002226|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
48493813|NCT02637076|156002225|FG000|Overall Study|Withdrawal by Subject|0|||
48493814|NCT02637076|156002226|FG001|Overall Study|Withdrawal by Subject|4|||
48493815|NCT01567306|156002231|FG000|Overall Study|Protocol Violation|2|||
48493816|NCT01567306|156002232|FG001|Overall Study|Protocol Violation|2|||
48493817|NCT01567306|156002233|FG002|Overall Study|Protocol Violation|0|||
48493818|NCT01567306|156002234|FG003|Overall Study|Protocol Violation|3|||
48493819|NCT01567306|156002235|FG004|Overall Study|Protocol Violation|1|||
48811861|NCT03447730|157152103|FG001|Overall Study|Adverse Event|2|||
48811862|NCT03447730|157152104|FG002|Overall Study|Adverse Event|0|||
48811863|NCT01275196|157152107|FG000|Overall Study|Adverse Event|3|||
48811864|NCT01275196|157152108|FG001|Overall Study|Adverse Event|5|||
48811865|NCT01275196|157152107|FG000|Overall Study|Withdrawal by Subject|4|||
48493820|NCT01567306|156002236|FG005|Overall Study|Protocol Violation|1|||
48811866|NCT01275196|157152108|FG001|Overall Study|Withdrawal by Subject|5|||
48811867|NCT01275196|157152107|FG000|Overall Study|Lost to Follow-up|1|||
48713085|NCT02934503|156801330|FG000|Overall Study|progression of disease|3|||
48713086|NCT02934503|156801330|FG000|Overall Study|Withdrawal by Subject|1|||
48713087|NCT00555061|156801331|FG000|Overall Study|Adverse Event|3|||
48713088|NCT00555061|156801331|FG000|Overall Study|Protocol Violation|1|||
48713089|NCT00555061|156801331|FG000|Overall Study|Lost to Follow-up|2|||
48811868|NCT01275196|157152108|FG001|Overall Study|Lost to Follow-up|0|||
48811869|NCT01275196|157152107|FG000|Overall Study|Disease Progression|6|||
48811870|NCT01275196|157152108|FG001|Overall Study|Disease Progression|5|||
48811871|NCT01275196|157152107|FG000|Overall Study|Protocol Violation|1|||
48811872|NCT01275196|157152108|FG001|Overall Study|Protocol Violation|0|||
48811873|NCT01275196|157152107|FG000|Overall Study|Suboptimal response/treatment failure|5|||
48811874|NCT01275196|157152108|FG001|Overall Study|Suboptimal response/treatment failure|6|||
48811875|NCT01248962|157152109|FG000|Overall Study|Withdrawal by Subject|1|||
48811876|NCT01248962|157152110|FG001|Overall Study|Withdrawal by Subject|1|||
48811877|NCT01248962|157152109|FG000|Overall Study|Adverse Event|2|||
48811878|NCT01248962|157152110|FG001|Overall Study|Adverse Event|1|||
48811879|NCT01248962|157152109|FG000|Overall Study|Complete Response after 4 Cycles|1|||
48811880|NCT01248962|157152110|FG001|Overall Study|Complete Response after 4 Cycles|0|||
48811881|NCT01248962|157152109|FG000|Overall Study|Complete Response after 3 Cycles|0|||
48811882|NCT01248962|157152110|FG001|Overall Study|Complete Response after 3 Cycles|1|||
48811883|NCT01248962|157152109|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
48811884|NCT01248962|157152110|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
48811885|NCT02572817|157152114|FG000|Overall Study|Death|6|||
48811886|NCT02572817|157152115|FG001|Overall Study|Death|3|||
48713090|NCT00555061|156801331|FG000|Overall Study|Withdrawal by Subject|2|||
48713091|NCT00555061|156801331|FG000|Overall Study|Participant enrolled, but never treated|1|||
48713092|NCT03926611|156801335|FG000|Overall Study|Adverse Event|0|||
48713093|NCT03926611|156801336|FG001|Overall Study|Adverse Event|0|||
48713094|NCT03926611|156801337|FG002|Overall Study|Adverse Event|0|||
48713095|NCT03926611|156801338|FG003|Overall Study|Adverse Event|3|||
48713096|NCT03926611|156801339|FG004|Overall Study|Adverse Event|1|||
48713097|NCT03926611|156801340|FG005|Overall Study|Adverse Event|3|||
48713098|NCT03926611|156801341|FG006|Overall Study|Adverse Event|0|||
48811887|NCT02572817|157152114|FG000|Overall Study|Lost to Follow-up|3|||
48811888|NCT02572817|157152115|FG001|Overall Study|Lost to Follow-up|3|||
48811889|NCT00258440|157152123|FG000|Overall Study|Withdrawal by Subject|0|||
48811890|NCT00258440|157152124|FG001|Overall Study|Withdrawal by Subject|0|||
48811891|NCT00258440|157152125|FG002|Overall Study|Withdrawal by Subject|1|||
48811892|NCT00979602|157152126|FG000|Overall Study|Serious Adverse Event|5|||
48811893|NCT00979602|157152127|FG001|Overall Study|Serious Adverse Event|3|||
48811894|NCT00979602|157152126|FG000|Overall Study|Protocol Violation|3|||
48811895|NCT00979602|157152127|FG001|Overall Study|Protocol Violation|0|||
48811896|NCT00979602|157152126|FG000|Overall Study|Withdrawal by Subject|31|||
48811897|NCT00979602|157152127|FG001|Overall Study|Withdrawal by Subject|25|||
48811898|NCT00979602|157152126|FG000|Overall Study|Lost to Follow-up|100|||
48811899|NCT00979602|157152127|FG001|Overall Study|Lost to Follow-up|96|||
48811900|NCT00979602|157152126|FG000|Overall Study|Migrated/moved from study area|3|||
48811901|NCT00979602|157152127|FG001|Overall Study|Migrated/moved from study area|6|||
48811902|NCT00979602|157152126|FG000|Overall Study|Others|3|||
48811903|NCT00979602|157152127|FG001|Overall Study|Others|3|||
48811904|NCT01719237|157152131|FG000|Overall Study|Physician Decision|0|||
48811905|NCT01719237|157152132|FG001|Overall Study|Physician Decision|1|||
48811906|NCT03820323|157152133|FG000|Overall Study|Lost to Follow-up|2|||
48811907|NCT03820323|157152134|FG001|Overall Study|Lost to Follow-up|1|||
48811908|NCT03820323|157152133|FG000|Overall Study|Missed 12-month visit|22|||
48811909|NCT03820323|157152134|FG001|Overall Study|Missed 12-month visit|14|||
48811910|NCT03820323|157152133|FG000|Overall Study|Death|2|||
48811911|NCT03820323|157152134|FG001|Overall Study|Death|1|||
48811912|NCT03820323|157152133|FG000|Overall Study|Transferred out|13|||
48811913|NCT03820323|157152134|FG001|Overall Study|Transferred out|11|||
48811914|NCT03820323|157152133|FG000|Overall Study|Terminated|0|||
48811915|NCT03820323|157152134|FG001|Overall Study|Terminated|3|||
48811916|NCT03820323|157152133|FG000|Overall Study|Withdrawal by Subject|1|||
48811917|NCT03820323|157152134|FG001|Overall Study|Withdrawal by Subject|6|||
48811918|NCT01844115|157152135|FG000|Overall Study|Adverse Event|4|||
48811919|NCT01844115|157152136|FG001|Overall Study|Adverse Event|22|||
48713099|NCT03926611|156801335|FG000|Overall Study|Lack of Efficacy|1|||
48811920|NCT01844115|157152135|FG000|Overall Study|Lack of Efficacy|1|||
48811921|NCT01844115|157152136|FG001|Overall Study|Lack of Efficacy|4|||
48811922|NCT01844115|157152135|FG000|Overall Study|Protocol Violation|12|||
48811923|NCT01844115|157152136|FG001|Overall Study|Protocol Violation|10|||
48811924|NCT01844115|157152135|FG000|Overall Study|Withdrawal by Subject|11|||
48811925|NCT01844115|157152136|FG001|Overall Study|Withdrawal by Subject|11|||
48811926|NCT01844115|157152135|FG000|Overall Study|Lost to Follow-up|11|||
48811927|NCT01844115|157152136|FG001|Overall Study|Lost to Follow-up|10|||
48811928|NCT01844115|157152135|FG000|Overall Study|Pregnancy|0|||
48811929|NCT01844115|157152136|FG001|Overall Study|Pregnancy|1|||
48811930|NCT00366301|157152139|FG000|Overall Study|Lost to Follow-up|4|||
48811931|NCT00366301|157152140|FG001|Overall Study|Lost to Follow-up|4|||
48811932|NCT00366301|157152141|FG002|Overall Study|Lost to Follow-up|3|||
48811933|NCT00366301|157152142|FG003|Overall Study|Lost to Follow-up|7|||
48811934|NCT00366301|157152139|FG000|Overall Study|Withdrawal by Subject|4|||
48811935|NCT00366301|157152140|FG001|Overall Study|Withdrawal by Subject|2|||
48811936|NCT00366301|157152141|FG002|Overall Study|Withdrawal by Subject|1|||
48811937|NCT00366301|157152142|FG003|Overall Study|Withdrawal by Subject|1|||
48811938|NCT00579982|157152147|FG000|Overall Study|Adverse Event|4|||
48811939|NCT00579982|157152147|FG000|Overall Study|Protocol Violation|4|||
48811940|NCT04091360|157152148|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811941|NCT04091360|157152149|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811942|NCT04091360|157152150|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811943|NCT04091360|157152151|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811944|NCT04091360|157152152|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811945|NCT04091360|157152153|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811946|NCT04091360|157152154|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48493821|NCT01567306|156002231|FG000|Overall Study|Change site living|1|||
48493822|NCT01567306|156002232|FG001|Overall Study|Change site living|0|||
48493823|NCT01567306|156002233|FG002|Overall Study|Change site living|0|||
48493824|NCT01567306|156002234|FG003|Overall Study|Change site living|0|||
48493825|NCT01567306|156002235|FG004|Overall Study|Change site living|0|||
48493826|NCT01567306|156002236|FG005|Overall Study|Change site living|0|||
48493827|NCT01567306|156002231|FG000|Overall Study|Adverse Event|0|||
48493828|NCT01567306|156002232|FG001|Overall Study|Adverse Event|0|||
48493829|NCT01567306|156002233|FG002|Overall Study|Adverse Event|0|||
48493830|NCT01567306|156002234|FG003|Overall Study|Adverse Event|2|||
48493831|NCT01567306|156002235|FG004|Overall Study|Adverse Event|4|||
48493832|NCT01567306|156002236|FG005|Overall Study|Adverse Event|1|||
48493833|NCT01567306|156002231|FG000|Overall Study|Lost to Follow-up|0|||
48493834|NCT01567306|156002232|FG001|Overall Study|Lost to Follow-up|0|||
48493835|NCT01567306|156002233|FG002|Overall Study|Lost to Follow-up|0|||
48493836|NCT01567306|156002234|FG003|Overall Study|Lost to Follow-up|0|||
48811947|NCT04091360|157152155|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
48811948|NCT04091360|157152156|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
48811949|NCT04091360|157152157|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
48811950|NCT04091360|157152148|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811951|NCT04091360|157152149|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811952|NCT04091360|157152150|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811953|NCT04091360|157152151|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811954|NCT04091360|157152152|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811955|NCT04091360|157152153|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811956|NCT04091360|157152154|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
48811957|NCT04091360|157152155|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
48811958|NCT04091360|157152156|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811959|NCT04091360|157152157|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
48811960|NCT04091360|157152148|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811961|NCT04091360|157152149|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811962|NCT04091360|157152150|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811963|NCT04091360|157152151|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811964|NCT04091360|157152152|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811965|NCT04091360|157152153|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811966|NCT04091360|157152154|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
48811967|NCT04091360|157152155|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48811968|NCT04091360|157152156|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
48493837|NCT01567306|156002235|FG004|Overall Study|Lost to Follow-up|2|||
48493838|NCT01567306|156002236|FG005|Overall Study|Lost to Follow-up|0|||
48493839|NCT01567306|156002231|FG000|Overall Study|Withdrawal by Subject|0|||
48493840|NCT01567306|156002232|FG001|Overall Study|Withdrawal by Subject|0|||
48493841|NCT01567306|156002233|FG002|Overall Study|Withdrawal by Subject|0|||
48493842|NCT01567306|156002234|FG003|Overall Study|Withdrawal by Subject|0|||
48597864|NCT03284853|156383622|FG001|Overall Study|Adverse Event|4|||
48597865|NCT03284853|156383621|FG000|Overall Study|Withdrawal by Subject|5|||
48597866|NCT03284853|156383622|FG001|Overall Study|Withdrawal by Subject|1|||
48597867|NCT03284853|156383621|FG000|Overall Study|Lost to Follow-up|1|||
48597868|NCT03284853|156383622|FG001|Overall Study|Lost to Follow-up|0|||
48597869|NCT03284853|156383621|FG000|Overall Study|Lack of Efficacy|1|||
48597870|NCT03284853|156383622|FG001|Overall Study|Lack of Efficacy|0|||
48597871|NCT03284853|156383621|FG000|Overall Study|Disallowed Concurrent Medication|1|||
48597872|NCT03284853|156383622|FG001|Overall Study|Disallowed Concurrent Medication|1|||
48597873|NCT03284853|156383621|FG000|Overall Study|Protocol Violation|3|||
48597874|NCT03284853|156383622|FG001|Overall Study|Protocol Violation|3|||
48597875|NCT03284853|156383621|FG000|Overall Study|Death|0|||
48597876|NCT03284853|156383622|FG001|Overall Study|Death|1|||
48597877|NCT03284853|156383621|FG000|Overall Study|Other - Reason not reported in CSR|4|||
48597878|NCT03284853|156383622|FG001|Overall Study|Other - Reason not reported in CSR|3|||
48493843|NCT01567306|156002235|FG004|Overall Study|Withdrawal by Subject|0|||
48493844|NCT01567306|156002236|FG005|Overall Study|Withdrawal by Subject|1|||
48493845|NCT02688400|156002241|FG000|Overall Study|Protocol Violation|2|||
48493846|NCT02688400|156002242|FG001|Overall Study|Protocol Violation|5|||
48493847|NCT02688400|156002241|FG000|Overall Study|Lack of Efficacy|7|||
48493848|NCT02688400|156002242|FG001|Overall Study|Lack of Efficacy|7|||
48493849|NCT02688400|156002241|FG000|Overall Study|Adverse Event|21|||
48493850|NCT02688400|156002242|FG001|Overall Study|Adverse Event|12|||
48493851|NCT02688400|156002241|FG000|Overall Study|Withdrawal by Subject|15|||
48493852|NCT02688400|156002242|FG001|Overall Study|Withdrawal by Subject|13|||
48493853|NCT02688400|156002241|FG000|Overall Study|No study medication intake|1|||
48493854|NCT02688400|156002242|FG001|Overall Study|No study medication intake|4|||
48493855|NCT02688400|156002241|FG000|Overall Study|Lost to Follow-up|0|||
48493856|NCT02688400|156002242|FG001|Overall Study|Lost to Follow-up|3|||
48493857|NCT02207621|156002246|FG000|Overall Study|Adverse Event|71|||
48493858|NCT02207621|156002247|FG001|Overall Study|Adverse Event|15|||
48493859|NCT02207621|156002248|FG002|Overall Study|Adverse Event|132|||
48493860|NCT02207621|156002246|FG000|Overall Study|Withdrawal by Subject|9|||
48493861|NCT02207621|156002247|FG001|Overall Study|Withdrawal by Subject|9|||
48493862|NCT02207621|156002248|FG002|Overall Study|Withdrawal by Subject|13|||
48493863|NCT02207621|156002246|FG000|Overall Study|Non-Compliant|3|||
48493864|NCT02207621|156002247|FG001|Overall Study|Non-Compliant|3|||
48493865|NCT02207621|156002248|FG002|Overall Study|Non-Compliant|1|||
48493866|NCT02207621|156002246|FG000|Overall Study|Lost to Follow-up|1|||
48493867|NCT02207621|156002247|FG001|Overall Study|Lost to Follow-up|0|||
48493868|NCT02207621|156002248|FG002|Overall Study|Lost to Follow-up|3|||
48493869|NCT02207621|156002246|FG000|Overall Study|Lack of Efficacy|10|||
48493870|NCT02207621|156002247|FG001|Overall Study|Lack of Efficacy|2|||
48493871|NCT02207621|156002248|FG002|Overall Study|Lack of Efficacy|4|||
48493872|NCT02207621|156002246|FG000|Overall Study|Disallowed Concurrent Medication|2|||
48493873|NCT02207621|156002247|FG001|Overall Study|Disallowed Concurrent Medication|5|||
48493874|NCT02207621|156002248|FG002|Overall Study|Disallowed Concurrent Medication|2|||
48493875|NCT02207621|156002246|FG000|Overall Study|Physician Decision|1|||
48493876|NCT02207621|156002247|FG001|Overall Study|Physician Decision|2|||
48493877|NCT02207621|156002248|FG002|Overall Study|Physician Decision|2|||
48493878|NCT02207621|156002246|FG000|Overall Study|Protocol Violation|4|||
48493879|NCT02207621|156002247|FG001|Overall Study|Protocol Violation|10|||
48493880|NCT02207621|156002248|FG002|Overall Study|Protocol Violation|6|||
48493881|NCT02207621|156002246|FG000|Overall Study|Death|2|||
48493882|NCT02207621|156002247|FG001|Overall Study|Death|0|||
48493883|NCT02207621|156002248|FG002|Overall Study|Death|0|||
48493884|NCT02207621|156002246|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
48597879|NCT01419535|156383623|FG000|Overall Study|could not maintain iv line|1|||
48493885|NCT02207621|156002247|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
48493886|NCT02207621|156002248|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
48493887|NCT02204371|156002250|FG000|Overall Study|Adverse Event|1|||
48597880|NCT01419535|156383624|FG001|Overall Study|could not maintain iv line|1|||
48493888|NCT01894984|156002251|FG000|Overall Study|Other|314|||
48493889|NCT01894984|156002252|FG001|Overall Study|Other|175|||
48493890|NCT00524459|156002253|FG000|Overall Study|Withdrawal by Subject|1|||
48493891|NCT00524459|156002253|FG000|Overall Study|Other|1|||
48493892|NCT02866175|156002254|FG000|Overall Study|Adverse Event|56|||
48493893|NCT02866175|156002255|FG001|Overall Study|Adverse Event|54|||
48493894|NCT02866175|156002254|FG000|Overall Study|Withdrawal by Subject|31|||
48493895|NCT02866175|156002255|FG001|Overall Study|Withdrawal by Subject|52|||
48493896|NCT02866175|156002254|FG000|Overall Study|Death|30|||
48493897|NCT02866175|156002255|FG001|Overall Study|Death|23|||
48493898|NCT02866175|156002254|FG000|Overall Study|Other|7|||
48493899|NCT02866175|156002255|FG001|Overall Study|Other|14|||
48493900|NCT02866175|156002254|FG000|Overall Study|Progressive disease|1|||
48493901|NCT02866175|156002255|FG001|Overall Study|Progressive disease|1|||
48597881|NCT01419535|156383623|FG000|Overall Study|Withdrawal by Subject|0|||
48597882|NCT01419535|156383624|FG001|Overall Study|Withdrawal by Subject|1|||
48597883|NCT02489448|156385146|FG000|Overall Study|Death|3|||
48597884|NCT02489448|156385146|FG000|Overall Study|Withdrawal by Subject|2|||
48597885|NCT03335813|156385152|FG000|Overall Study|Withdrawal by Subject|1|||
48597886|NCT02750332|156385159|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48597887|NCT02750332|156385160|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48597888|NCT03498313|156385168|FG000|Experimental Period 1|Adverse Event|1|||
48597889|NCT03498313|156385169|FG001|Experimental Period 1|Adverse Event|0|||
48597890|NCT03498313|156385170|FG002|Experimental Period 1|Adverse Event|0|||
48493902|NCT02866175|156002254|FG000|Overall Study|Lost to Follow-up|2|||
48493903|NCT02866175|156002255|FG001|Overall Study|Lost to Follow-up|0|||
48811969|NCT04091360|157152157|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
48811970|NCT00119262|157152159|FG000|Overall Study|Lack of Efficacy|0|||
48811971|NCT00119262|157152160|FG001|Overall Study|Lack of Efficacy|3|||
48811972|NCT00119262|157152159|FG000|Overall Study|Withdrawal by Subject|12|||
48811973|NCT00119262|157152160|FG001|Overall Study|Withdrawal by Subject|11|||
48811974|NCT00119262|157152159|FG000|Overall Study|Adverse Event|33|||
48493904|NCT02866175|156002254|FG000|Overall Study|Lack of Efficacy|0|||
48493905|NCT02866175|156002255|FG001|Overall Study|Lack of Efficacy|1|||
48493906|NCT02866175|156002254|FG000|Overall Study|Physician Decision|3|||
48493907|NCT02866175|156002255|FG001|Overall Study|Physician Decision|15|||
48493908|NCT02866175|156002254|FG000|Overall Study|Did not receive treatment|5|||
48493909|NCT02866175|156002255|FG001|Overall Study|Did not receive treatment|15|||
48493910|NCT00729859|156002256|FG000|Overall Study|Adverse Event|0|||
48493911|NCT00729859|156002257|FG001|Overall Study|Adverse Event|1|||
48493912|NCT00729859|156002258|FG002|Overall Study|Adverse Event|0|||
48493913|NCT00729859|156002256|FG000|Overall Study|Withdrawal by Subject|0|||
48493914|NCT00729859|156002257|FG001|Overall Study|Withdrawal by Subject|1|||
48493915|NCT00729859|156002258|FG002|Overall Study|Withdrawal by Subject|0|||
48493916|NCT00290745|156002261|FG000|Overall Study|Withdrawal by Subject|4|||
48493917|NCT00290745|156002261|FG000|Overall Study|Physician Decision|2|||
48493918|NCT00290745|156002261|FG000|Overall Study|Surgery after 3 months for progression|3|||
48493919|NCT00290745|156002261|FG000|Overall Study|Baseline MRI not available|3|||
48493920|NCT01842958|156002262|FG000|Overall Study|Lost to Follow-up|1|||
48493921|NCT01842958|156002263|FG001|Overall Study|Lost to Follow-up|1|||
48493922|NCT00626925|156002264|FG000|Overall Study|Lost to Follow-up|1|||
48493923|NCT00626925|156002265|FG001|Overall Study|Lost to Follow-up|2|||
48493924|NCT00626925|156002264|FG000|Overall Study|relapse|1|||
48493925|NCT00626925|156002265|FG001|Overall Study|relapse|0|||
48493926|NCT00626925|156002264|FG000|Overall Study|Adverse effect|6|||
48493927|NCT00626925|156002265|FG001|Overall Study|Adverse effect|2|||
48493928|NCT00626925|156002264|FG000|Overall Study|Lack of Efficacy|1|||
48493929|NCT00626925|156002265|FG001|Overall Study|Lack of Efficacy|4|||
48493930|NCT00626925|156002264|FG000|Overall Study|Time constraints|3|||
48493931|NCT00626925|156002265|FG001|Overall Study|Time constraints|1|||
48493932|NCT01829477|156002266|FG000|Overall Study|Study Terminated by Sponsor|15|||
48493933|NCT01829477|156002267|FG001|Overall Study|Study Terminated by Sponsor|15|||
48597891|NCT03498313|156385171|FG003|Experimental Period 1|Adverse Event|1|||
48713100|NCT03926611|156801336|FG001|Overall Study|Lack of Efficacy|2|||
48713101|NCT03926611|156801337|FG002|Overall Study|Lack of Efficacy|0|||
48713102|NCT03926611|156801338|FG003|Overall Study|Lack of Efficacy|0|||
48713103|NCT03926611|156801339|FG004|Overall Study|Lack of Efficacy|1|||
48713104|NCT03926611|156801340|FG005|Overall Study|Lack of Efficacy|0|||
48713105|NCT03926611|156801341|FG006|Overall Study|Lack of Efficacy|1|||
48713106|NCT03926611|156801335|FG000|Overall Study|Physician Decision|0|||
48713107|NCT03926611|156801336|FG001|Overall Study|Physician Decision|0|||
48713108|NCT03926611|156801337|FG002|Overall Study|Physician Decision|0|||
48713109|NCT03926611|156801338|FG003|Overall Study|Physician Decision|0|||
48713110|NCT03926611|156801339|FG004|Overall Study|Physician Decision|0|||
48713111|NCT03926611|156801340|FG005|Overall Study|Physician Decision|1|||
48713112|NCT03926611|156801341|FG006|Overall Study|Physician Decision|0|||
48713113|NCT03926611|156801335|FG000|Overall Study|Protocol Violation|1|||
48811975|NCT00119262|157152160|FG001|Overall Study|Adverse Event|35|||
48811976|NCT00119262|157152159|FG000|Overall Study|other disease|0|||
48811977|NCT00119262|157152160|FG001|Overall Study|other disease|2|||
48493934|NCT01829477|156002266|FG000|Overall Study|Withdrawal by Subject|1|||
48493935|NCT01829477|156002267|FG001|Overall Study|Withdrawal by Subject|0|||
48493936|NCT01215942|156002269|FG000|Treatment Period|Adverse Event|15|||
48713114|NCT03926611|156801336|FG001|Overall Study|Protocol Violation|0|||
48493937|NCT01215942|156002270|FG001|Treatment Period|Adverse Event|26|||
48493938|NCT01215942|156002269|FG000|Treatment Period|Death|2|||
48493939|NCT01215942|156002270|FG001|Treatment Period|Death|4|||
48493940|NCT01215942|156002269|FG000|Treatment Period|Lack of Efficacy|23|||
48493941|NCT01215942|156002270|FG001|Treatment Period|Lack of Efficacy|62|||
48493942|NCT01215942|156002269|FG000|Treatment Period|Lost to Follow-up|3|||
48597892|NCT03498313|156385172|FG004|Experimental Period 1|Adverse Event|0|||
48713115|NCT03926611|156801337|FG002|Overall Study|Protocol Violation|0|||
48493943|NCT01215942|156002270|FG001|Treatment Period|Lost to Follow-up|4|||
48597893|NCT03498313|156385173|FG005|Experimental Period 1|Adverse Event|0|||
48713116|NCT03926611|156801338|FG003|Overall Study|Protocol Violation|1|||
48811978|NCT00119262|157152159|FG000|Overall Study|ineligble|1|||
48713117|NCT03926611|156801339|FG004|Overall Study|Protocol Violation|1|||
48713118|NCT03926611|156801340|FG005|Overall Study|Protocol Violation|1|||
48435585|NCT02504268|155783728|FG006|Overall Study|Adverse Event|0|||
48435586|NCT02504268|155783729|FG007|Overall Study|Adverse Event|0|||
48435587|NCT02504268|155783730|FG008|Overall Study|Adverse Event|0|||
48435588|NCT02504268|155783722|FG000|Overall Study|Withdrawal of Consent|11|||
48435589|NCT02504268|155783723|FG001|Overall Study|Withdrawal of Consent|10|||
48435590|NCT02504268|155783724|FG002|Overall Study|Withdrawal of Consent|3|||
48435591|NCT02504268|155783725|FG003|Overall Study|Withdrawal of Consent|0|||
48435592|NCT02504268|155783726|FG004|Overall Study|Withdrawal of Consent|0|||
48435593|NCT02504268|155783727|FG005|Overall Study|Withdrawal of Consent|0|||
48435594|NCT02504268|155783728|FG006|Overall Study|Withdrawal of Consent|0|||
48435595|NCT02504268|155783729|FG007|Overall Study|Withdrawal of Consent|0|||
48435596|NCT02504268|155783730|FG008|Overall Study|Withdrawal of Consent|0|||
48435597|NCT02504268|155783722|FG000|Overall Study|Pregnancy|2|||
48435598|NCT02504268|155783723|FG001|Overall Study|Pregnancy|0|||
48435599|NCT02504268|155783724|FG002|Overall Study|Pregnancy|0|||
48435600|NCT02504268|155783725|FG003|Overall Study|Pregnancy|0|||
48435601|NCT02504268|155783726|FG004|Overall Study|Pregnancy|0|||
48435602|NCT02504268|155783727|FG005|Overall Study|Pregnancy|0|||
48435603|NCT02504268|155783728|FG006|Overall Study|Pregnancy|0|||
48435604|NCT02504268|155783729|FG007|Overall Study|Pregnancy|0|||
48435605|NCT02504268|155783730|FG008|Overall Study|Pregnancy|0|||
48435606|NCT02504268|155783722|FG000|Overall Study|Lost to Follow-up|3|||
48435607|NCT02504268|155783723|FG001|Overall Study|Lost to Follow-up|6|||
48435608|NCT02504268|155783724|FG002|Overall Study|Lost to Follow-up|4|||
48435609|NCT02504268|155783725|FG003|Overall Study|Lost to Follow-up|0|||
48435610|NCT02504268|155783726|FG004|Overall Study|Lost to Follow-up|0|||
48435611|NCT02504268|155783727|FG005|Overall Study|Lost to Follow-up|0|||
48435612|NCT02504268|155783728|FG006|Overall Study|Lost to Follow-up|0|||
48435613|NCT02504268|155783729|FG007|Overall Study|Lost to Follow-up|0|||
48435614|NCT02504268|155783730|FG008|Overall Study|Lost to Follow-up|0|||
48435615|NCT02504268|155783722|FG000|Overall Study|Death|1|||
48435616|NCT02504268|155783723|FG001|Overall Study|Death|1|||
48435617|NCT02504268|155783724|FG002|Overall Study|Death|0|||
48435618|NCT02504268|155783725|FG003|Overall Study|Death|0|||
48435619|NCT02504268|155783726|FG004|Overall Study|Death|0|||
48435620|NCT02504268|155783727|FG005|Overall Study|Death|0|||
48435621|NCT02504268|155783728|FG006|Overall Study|Death|0|||
48435622|NCT02504268|155783729|FG007|Overall Study|Death|0|||
48435623|NCT02504268|155783730|FG008|Overall Study|Death|0|||
48435624|NCT02504268|155783722|FG000|Overall Study|Subject Request to Discontinue|11|||
48435625|NCT02504268|155783723|FG001|Overall Study|Subject Request to Discontinue|3|||
48435626|NCT02504268|155783724|FG002|Overall Study|Subject Request to Discontinue|6|||
48435627|NCT02504268|155783725|FG003|Overall Study|Subject Request to Discontinue|0|||
48435628|NCT02504268|155783726|FG004|Overall Study|Subject Request to Discontinue|0|||
48435629|NCT02504268|155783727|FG005|Overall Study|Subject Request to Discontinue|0|||
48435630|NCT02504268|155783728|FG006|Overall Study|Subject Request to Discontinue|0|||
48435631|NCT02504268|155783729|FG007|Overall Study|Subject Request to Discontinue|0|||
48435632|NCT02504268|155783730|FG008|Overall Study|Subject Request to Discontinue|0|||
48435633|NCT02504268|155783722|FG000|Overall Study|No Longer Meets Study Criteria|2|||
48435634|NCT02504268|155783723|FG001|Overall Study|No Longer Meets Study Criteria|3|||
48435635|NCT02504268|155783724|FG002|Overall Study|No Longer Meets Study Criteria|0|||
48435636|NCT02504268|155783725|FG003|Overall Study|No Longer Meets Study Criteria|0|||
48435637|NCT02504268|155783726|FG004|Overall Study|No Longer Meets Study Criteria|0|||
48435638|NCT02504268|155783727|FG005|Overall Study|No Longer Meets Study Criteria|0|||
48435639|NCT02504268|155783728|FG006|Overall Study|No Longer Meets Study Criteria|0|||
48435640|NCT02504268|155783729|FG007|Overall Study|No Longer Meets Study Criteria|0|||
48435641|NCT02504268|155783730|FG008|Overall Study|No Longer Meets Study Criteria|0|||
48435642|NCT02504268|155783722|FG000|Overall Study|Lack of Efficacy|11|||
48435643|NCT02504268|155783723|FG001|Overall Study|Lack of Efficacy|35|||
48435644|NCT02504268|155783724|FG002|Overall Study|Lack of Efficacy|9|||
48435645|NCT02504268|155783725|FG003|Overall Study|Lack of Efficacy|0|||
48435646|NCT02504268|155783726|FG004|Overall Study|Lack of Efficacy|0|||
48435647|NCT02504268|155783727|FG005|Overall Study|Lack of Efficacy|0|||
48435648|NCT02504268|155783728|FG006|Overall Study|Lack of Efficacy|0|||
48435649|NCT02504268|155783729|FG007|Overall Study|Lack of Efficacy|0|||
48435650|NCT02504268|155783730|FG008|Overall Study|Lack of Efficacy|0|||
48435651|NCT02504268|155783722|FG000|Overall Study|Poor/Non-Compliance|3|||
48435652|NCT02504268|155783723|FG001|Overall Study|Poor/Non-Compliance|2|||
48435653|NCT02504268|155783724|FG002|Overall Study|Poor/Non-Compliance|3|||
48435654|NCT02504268|155783725|FG003|Overall Study|Poor/Non-Compliance|0|||
48435655|NCT02504268|155783726|FG004|Overall Study|Poor/Non-Compliance|0|||
48435656|NCT02504268|155783727|FG005|Overall Study|Poor/Non-Compliance|0|||
48435657|NCT02504268|155783728|FG006|Overall Study|Poor/Non-Compliance|0|||
48435658|NCT02504268|155783729|FG007|Overall Study|Poor/Non-Compliance|0|||
48811979|NCT00119262|157152160|FG001|Overall Study|ineligble|2|||
48811980|NCT00119262|157152159|FG000|Overall Study|others|0|||
48811981|NCT00119262|157152160|FG001|Overall Study|others|5|||
48811982|NCT01258660|157152161|FG000|Overall Study|Adverse Event|2|||
48811983|NCT01258660|157152162|FG001|Overall Study|Adverse Event|4|||
48811984|NCT01258660|157152161|FG000|Overall Study|Withdrawal by Subject|3|||
48811985|NCT01258660|157152162|FG001|Overall Study|Withdrawal by Subject|0|||
48811986|NCT01258660|157152161|FG000|Overall Study|due to relocation|2|||
48811987|NCT01258660|157152162|FG001|Overall Study|due to relocation|0|||
48811988|NCT01258660|157152161|FG000|Overall Study|Protocol Violation|0|||
48811989|NCT01258660|157152162|FG001|Overall Study|Protocol Violation|1|||
48811990|NCT01258660|157152161|FG000|Overall Study|Invalid for primary analysis data set|4|||
48811991|NCT01258660|157152162|FG001|Overall Study|Invalid for primary analysis data set|6|||
48811992|NCT03853317|157152163|FG000|Overall Study|Progressive Disease|5|||
48811993|NCT03853317|157152163|FG000|Overall Study|Adverse Event|1|||
48811994|NCT03853317|157152163|FG000|Overall Study|Death|1|||
48811995|NCT03853317|157152163|FG000|Overall Study|other event|2|||
48811996|NCT00406419|157152168|FG000|Overall Study|Death|3|||
48811997|NCT00406419|157152169|FG001|Overall Study|Death|1|||
48811998|NCT00406419|157152170|FG002|Overall Study|Death|4|||
48811999|NCT00406419|157152168|FG000|Overall Study|Protocol Violation|6|||
48812000|NCT00406419|157152169|FG001|Overall Study|Protocol Violation|2|||
48812001|NCT00406419|157152170|FG002|Overall Study|Protocol Violation|5|||
48493944|NCT01215942|156002269|FG000|Treatment Period|Withdrawal by Subject|17|||
48812002|NCT00406419|157152168|FG000|Overall Study|Study Terminated by Sponsor|260|||
48493945|NCT01215942|156002270|FG001|Treatment Period|Withdrawal by Subject|40|||
48493946|NCT01215942|156002269|FG000|Treatment Period|Physician Decision|5|||
48493947|NCT01215942|156002270|FG001|Treatment Period|Physician Decision|5|||
48493948|NCT01215942|156002269|FG000|Treatment Period|Protocol Violation|0|||
48493949|NCT01215942|156002270|FG001|Treatment Period|Protocol Violation|1|||
48493950|NCT01215942|156002269|FG000|Treatment Period|Sponsor Decision|349|||
48493951|NCT01215942|156002270|FG001|Treatment Period|Sponsor Decision|530|||
48493952|NCT01215942|156002269|FG000|Post-Treatment Follow-Up Period|Death|0|||
48493953|NCT01215942|156002270|FG001|Post-Treatment Follow-Up Period|Death|1|||
48493954|NCT01215942|156002269|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
48812003|NCT00406419|157152169|FG001|Overall Study|Study Terminated by Sponsor|288|||
48812004|NCT00406419|157152170|FG002|Overall Study|Study Terminated by Sponsor|282|||
48812005|NCT00406419|157152168|FG000|Overall Study|Withdrawal by Subject|17|||
48493955|NCT01215942|156002270|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
48493956|NCT01215942|156002269|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
48493957|NCT01215942|156002270|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
48493958|NCT01215942|156002269|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
48493959|NCT01215942|156002270|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
48493960|NCT01215942|156002269|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
48493961|NCT01215942|156002270|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
48493962|NCT01498484|156002273|FG000|Overall Study|Death|6|||
48493963|NCT01498484|156002274|FG001|Overall Study|Death|3|||
48493964|NCT01498484|156002275|FG002|Overall Study|Death|1|||
48493965|NCT01498484|156002276|FG003|Overall Study|Death|1|||
48493966|NCT01498484|156002277|FG004|Overall Study|Death|0|||
48493967|NCT01498484|156002278|FG005|Overall Study|Death|0|||
48493968|NCT01498484|156002279|FG006|Overall Study|Death|10|||
48493969|NCT01498484|156002280|FG007|Overall Study|Death|1|||
48493970|NCT01498484|156002281|FG008|Overall Study|Death|0|||
48493971|NCT01498484|156002273|FG000|Overall Study|Physician Decision|3|||
48493972|NCT01498484|156002274|FG001|Overall Study|Physician Decision|2|||
48493973|NCT01498484|156002275|FG002|Overall Study|Physician Decision|1|||
48493974|NCT01498484|156002276|FG003|Overall Study|Physician Decision|1|||
48493975|NCT01498484|156002277|FG004|Overall Study|Physician Decision|0|||
48493976|NCT01498484|156002278|FG005|Overall Study|Physician Decision|0|||
48493977|NCT01498484|156002279|FG006|Overall Study|Physician Decision|8|||
48493978|NCT01498484|156002280|FG007|Overall Study|Physician Decision|13|||
48493979|NCT01498484|156002281|FG008|Overall Study|Physician Decision|1|||
48493980|NCT01498484|156002273|FG000|Overall Study|Adverse Event|0|||
48493981|NCT01498484|156002274|FG001|Overall Study|Adverse Event|0|||
48493982|NCT01498484|156002275|FG002|Overall Study|Adverse Event|0|||
48493983|NCT01498484|156002276|FG003|Overall Study|Adverse Event|0|||
48493984|NCT01498484|156002277|FG004|Overall Study|Adverse Event|0|||
48493985|NCT01498484|156002278|FG005|Overall Study|Adverse Event|1|||
48493986|NCT01498484|156002279|FG006|Overall Study|Adverse Event|0|||
48493987|NCT01498484|156002280|FG007|Overall Study|Adverse Event|0|||
48493988|NCT01498484|156002281|FG008|Overall Study|Adverse Event|0|||
48493989|NCT01498484|156002273|FG000|Overall Study|Withdrawal by Subject|0|||
48493990|NCT01498484|156002274|FG001|Overall Study|Withdrawal by Subject|0|||
48493991|NCT01498484|156002275|FG002|Overall Study|Withdrawal by Subject|0|||
48493992|NCT01498484|156002276|FG003|Overall Study|Withdrawal by Subject|1|||
48493993|NCT01498484|156002277|FG004|Overall Study|Withdrawal by Subject|0|||
48493994|NCT01498484|156002278|FG005|Overall Study|Withdrawal by Subject|0|||
48493995|NCT01498484|156002279|FG006|Overall Study|Withdrawal by Subject|1|||
48493996|NCT01498484|156002280|FG007|Overall Study|Withdrawal by Subject|0|||
48493997|NCT01498484|156002281|FG008|Overall Study|Withdrawal by Subject|0|||
48493998|NCT01498484|156002273|FG000|Overall Study|Other|5|||
48493999|NCT01498484|156002274|FG001|Overall Study|Other|2|||
48494000|NCT01498484|156002275|FG002|Overall Study|Other|0|||
48494001|NCT01498484|156002276|FG003|Overall Study|Other|0|||
48494002|NCT01498484|156002277|FG004|Overall Study|Other|1|||
48494003|NCT01498484|156002278|FG005|Overall Study|Other|0|||
48494004|NCT01498484|156002279|FG006|Overall Study|Other|3|||
48494005|NCT01498484|156002280|FG007|Overall Study|Other|0|||
48494006|NCT01498484|156002281|FG008|Overall Study|Other|1|||
48494007|NCT02607800|156002282|FG000|Overall Study|Lost to Follow-up|7|||
48494008|NCT02607800|156002283|FG001|Overall Study|Lost to Follow-up|10|||
48494009|NCT02607800|156002282|FG000|Overall Study|Withdrew Consent|2|||
48494010|NCT02607800|156002283|FG001|Overall Study|Withdrew Consent|0|||
48494011|NCT02607800|156002282|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
48494012|NCT02607800|156002283|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
48494013|NCT01656889|156002284|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
48494014|NCT01656889|156002285|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
48494015|NCT01656889|156002284|FG000|Treatment Period, 12 Weeks|Death|0|||
48494016|NCT01656889|156002285|FG001|Treatment Period, 12 Weeks|Death|1|||
48494017|NCT01656889|156002284|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
48494018|NCT01656889|156002285|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
48494019|NCT01656889|156002284|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
48494020|NCT01656889|156002285|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
48494021|NCT01656889|156002284|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
48494022|NCT01656889|156002285|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
48713119|NCT03926611|156801341|FG006|Overall Study|Protocol Violation|1|||
48494023|NCT01656889|156002284|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
48494024|NCT01656889|156002285|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
48494025|NCT01656889|156002284|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
48494026|NCT01656889|156002285|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
48494027|NCT01656889|156002284|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
48494028|NCT01656889|156002285|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
48494029|NCT01656889|156002284|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
48494030|NCT01656889|156002285|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
48713120|NCT03926611|156801335|FG000|Overall Study|Technical problems|0|||
48713121|NCT03926611|156801336|FG001|Overall Study|Technical problems|0|||
48713122|NCT03926611|156801337|FG002|Overall Study|Technical problems|0|||
48713123|NCT03926611|156801338|FG003|Overall Study|Technical problems|0|||
48713124|NCT03926611|156801339|FG004|Overall Study|Technical problems|0|||
48713125|NCT03926611|156801340|FG005|Overall Study|Technical problems|1|||
48713126|NCT03926611|156801341|FG006|Overall Study|Technical problems|0|||
48713127|NCT03926611|156801335|FG000|Overall Study|Withdrawal by Subject|1|||
48713128|NCT03926611|156801336|FG001|Overall Study|Withdrawal by Subject|1|||
48713129|NCT03926611|156801337|FG002|Overall Study|Withdrawal by Subject|1|||
48713130|NCT03926611|156801338|FG003|Overall Study|Withdrawal by Subject|0|||
48713131|NCT03926611|156801339|FG004|Overall Study|Withdrawal by Subject|0|||
48713132|NCT03926611|156801340|FG005|Overall Study|Withdrawal by Subject|1|||
48713133|NCT03926611|156801341|FG006|Overall Study|Withdrawal by Subject|3|||
48713134|NCT03926611|156801335|FG000|Overall Study|Covid-19 pandemic|0|||
48713135|NCT03926611|156801336|FG001|Overall Study|Covid-19 pandemic|0|||
48713136|NCT03926611|156801337|FG002|Overall Study|Covid-19 pandemic|1|||
48713137|NCT03926611|156801338|FG003|Overall Study|Covid-19 pandemic|0|||
48713138|NCT03926611|156801339|FG004|Overall Study|Covid-19 pandemic|1|||
48713139|NCT03926611|156801340|FG005|Overall Study|Covid-19 pandemic|2|||
48713140|NCT03926611|156801341|FG006|Overall Study|Covid-19 pandemic|0|||
48713141|NCT03539549|156801342|FG000|Overall Study|Adverse Event|12|||
48713142|NCT03539549|156801342|FG000|Overall Study|Lost to Follow-up|1|||
48713143|NCT03539549|156801342|FG000|Overall Study|Death|2|||
48713144|NCT03539549|156801342|FG000|Overall Study|Progressive Disease|1|||
48713145|NCT03539549|156801342|FG000|Overall Study|Reason not Specified|1|||
48713146|NCT04050202|156801343|FG000|Overall Study|Lost to Follow-up|2|||
48713147|NCT00481091|156801344|FG000|Overall Study|Withdrawal by Subject|0|||
48713148|NCT00481091|156801345|FG001|Overall Study|Withdrawal by Subject|1|||
48713149|NCT00481091|156801346|FG002|Overall Study|Withdrawal by Subject|1|||
48713150|NCT00481091|156801347|FG003|Overall Study|Withdrawal by Subject|0|||
48713151|NCT00481091|156801348|FG004|Overall Study|Withdrawal by Subject|0|||
48713152|NCT00481091|156801349|FG005|Overall Study|Withdrawal by Subject|0|||
48713153|NCT00481091|156801350|FG006|Overall Study|Withdrawal by Subject|0|||
48713154|NCT00481091|156801351|FG007|Overall Study|Withdrawal by Subject|0|||
48713155|NCT00481091|156801352|FG008|Overall Study|Withdrawal by Subject|1|||
48713156|NCT00481091|156801353|FG009|Overall Study|Withdrawal by Subject|6|||
48713157|NCT00481091|156801344|FG000|Overall Study|Other, Not Specified|0|||
48713158|NCT00481091|156801345|FG001|Overall Study|Other, Not Specified|1|||
48494031|NCT01656889|156002284|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
48494032|NCT01656889|156002285|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
48713159|NCT00481091|156801346|FG002|Overall Study|Other, Not Specified|1|||
48713160|NCT00481091|156801347|FG003|Overall Study|Other, Not Specified|0|||
48713161|NCT00481091|156801348|FG004|Overall Study|Other, Not Specified|0|||
48713162|NCT00481091|156801349|FG005|Overall Study|Other, Not Specified|1|||
48713163|NCT00481091|156801350|FG006|Overall Study|Other, Not Specified|0|||
48713164|NCT00481091|156801351|FG007|Overall Study|Other, Not Specified|0|||
48713165|NCT00481091|156801352|FG008|Overall Study|Other, Not Specified|0|||
48713166|NCT00481091|156801353|FG009|Overall Study|Other, Not Specified|4|||
48713167|NCT00481091|156801344|FG000|Overall Study|Adverse Event|1|||
48713168|NCT00481091|156801345|FG001|Overall Study|Adverse Event|2|||
48713169|NCT00481091|156801346|FG002|Overall Study|Adverse Event|0|||
48713170|NCT00481091|156801347|FG003|Overall Study|Adverse Event|1|||
48713171|NCT00481091|156801348|FG004|Overall Study|Adverse Event|1|||
48713172|NCT00481091|156801349|FG005|Overall Study|Adverse Event|1|||
48713173|NCT00481091|156801350|FG006|Overall Study|Adverse Event|2|||
48713174|NCT00481091|156801351|FG007|Overall Study|Adverse Event|1|||
48713175|NCT00481091|156801352|FG008|Overall Study|Adverse Event|1|||
48713176|NCT00481091|156801353|FG009|Overall Study|Adverse Event|6|||
48713177|NCT00481091|156801344|FG000|Overall Study|Progressive disease clinical|0|||
48713178|NCT00481091|156801345|FG001|Overall Study|Progressive disease clinical|0|||
48713179|NCT00481091|156801346|FG002|Overall Study|Progressive disease clinical|0|||
48713180|NCT00481091|156801347|FG003|Overall Study|Progressive disease clinical|0|||
48812006|NCT00406419|157152169|FG001|Overall Study|Withdrawal by Subject|24|||
48812007|NCT00406419|157152170|FG002|Overall Study|Withdrawal by Subject|26|||
48812008|NCT00406419|157152168|FG000|Overall Study|Lack of Efficacy|12|||
48812009|NCT00406419|157152169|FG001|Overall Study|Lack of Efficacy|1|||
48812010|NCT00406419|157152170|FG002|Overall Study|Lack of Efficacy|6|||
48494033|NCT04000009|156002286|FG000|Overall Study|Adverse Event|13|||
48494034|NCT04000009|156002286|FG000|Overall Study|Lack of Efficacy|7|||
48494035|NCT04000009|156002286|FG000|Overall Study|Lost to Follow-up|8|||
48713181|NCT00481091|156801348|FG004|Overall Study|Progressive disease clinical|0|||
48713182|NCT00481091|156801349|FG005|Overall Study|Progressive disease clinical|0|||
48713183|NCT00481091|156801350|FG006|Overall Study|Progressive disease clinical|0|||
48713184|NCT00481091|156801351|FG007|Overall Study|Progressive disease clinical|0|||
48713185|NCT00481091|156801352|FG008|Overall Study|Progressive disease clinical|1|||
48713186|NCT00481091|156801353|FG009|Overall Study|Progressive disease clinical|7|||
48812011|NCT00406419|157152168|FG000|Overall Study|Non-Compliance with Study Drug|5|||
48713187|NCT00481091|156801344|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
48494036|NCT04000009|156002286|FG000|Overall Study|Noncompliance with study drug|4|||
48494037|NCT04000009|156002286|FG000|Overall Study|Physician Decision|1|||
48494038|NCT04000009|156002286|FG000|Overall Study|Use of prohibited medication|3|||
48812012|NCT00406419|157152169|FG001|Overall Study|Non-Compliance with Study Drug|6|||
48812013|NCT00406419|157152170|FG002|Overall Study|Non-Compliance with Study Drug|3|||
48812014|NCT00406419|157152168|FG000|Overall Study|Adverse Event|10|||
48812015|NCT00406419|157152169|FG001|Overall Study|Adverse Event|12|||
48713188|NCT00481091|156801345|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
48713189|NCT00481091|156801346|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713190|NCT00481091|156801347|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713191|NCT00481091|156801348|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713192|NCT00481091|156801349|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
48713193|NCT00481091|156801350|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713194|NCT00481091|156801351|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713195|NCT00481091|156801352|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48812016|NCT00406419|157152170|FG002|Overall Study|Adverse Event|16|||
48812017|NCT00406419|157152168|FG000|Overall Study|Lost to Follow-up|11|||
48812018|NCT00406419|157152169|FG001|Overall Study|Lost to Follow-up|10|||
48812019|NCT00406419|157152170|FG002|Overall Study|Lost to Follow-up|5|||
48812020|NCT02366936|157152171|FG000|Overall Study|Withdrawal by Subject|2|||
48812021|NCT02366936|157152171|FG000|Overall Study|Lost to Follow-up|4|||
48812022|NCT02366936|157152171|FG000|Overall Study|Physician Decision|2|||
48812023|NCT00098254|157152172|FG000|Overall Study|Adverse Event|2|||
48812024|NCT00098254|157152172|FG000|Overall Study|Death|1|||
48812025|NCT00308737|157152173|FG000|Overall Study|Adverse Event|104|||
48812026|NCT00308737|157152174|FG001|Overall Study|Adverse Event|9|||
48713196|NCT00481091|156801353|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
48713197|NCT00481091|156801344|FG000|Overall Study|Progressive disease other|1|||
48713198|NCT00481091|156801345|FG001|Overall Study|Progressive disease other|1|||
48713199|NCT00481091|156801346|FG002|Overall Study|Progressive disease other|0|||
48713200|NCT00481091|156801347|FG003|Overall Study|Progressive disease other|1|||
48713201|NCT00481091|156801348|FG004|Overall Study|Progressive disease other|1|||
48713202|NCT00481091|156801349|FG005|Overall Study|Progressive disease other|1|||
48713203|NCT00481091|156801350|FG006|Overall Study|Progressive disease other|0|||
48713204|NCT00481091|156801351|FG007|Overall Study|Progressive disease other|2|||
48713205|NCT00481091|156801352|FG008|Overall Study|Progressive disease other|0|||
48713206|NCT00481091|156801353|FG009|Overall Study|Progressive disease other|0|||
48713207|NCT00481091|156801344|FG000|Overall Study|No reason given|0|||
48713208|NCT00481091|156801345|FG001|Overall Study|No reason given|0|||
48812027|NCT00308737|157152175|FG002|Overall Study|Adverse Event|0|||
48494039|NCT04000009|156002286|FG000|Overall Study|Pregnancy|1|||
48812028|NCT00308737|157152173|FG000|Overall Study|Death|4|||
48812029|NCT00308737|157152174|FG001|Overall Study|Death|3|||
48494040|NCT04000009|156002286|FG000|Overall Study|Withdrawal by Subject|22|||
48812030|NCT00308737|157152175|FG002|Overall Study|Death|0|||
48812031|NCT00308737|157152173|FG000|Overall Study|Lost to Follow-up|56|||
48812032|NCT00308737|157152174|FG001|Overall Study|Lost to Follow-up|80|||
48494041|NCT04000009|156002286|FG000|Overall Study|Study terminated by sponsor|98|||
48494042|NCT04000009|156002286|FG000|Overall Study|Not further specified|8|||
48494043|NCT00679783|156002287|FG000|Overall Study|Adverse Event|0|||
48494044|NCT00679783|156002288|FG001|Overall Study|Adverse Event|0|||
48494045|NCT00679783|156002289|FG002|Overall Study|Adverse Event|0|||
48494046|NCT00679783|156002290|FG003|Overall Study|Adverse Event|3|||
48494047|NCT00679783|156002291|FG004|Overall Study|Adverse Event|0|||
48494048|NCT00679783|156002292|FG005|Overall Study|Adverse Event|0|||
48494049|NCT00679783|156002293|FG006|Overall Study|Adverse Event|1|||
48494050|NCT00679783|156002287|FG000|Overall Study|Lack of Efficacy|0|||
48494051|NCT00679783|156002288|FG001|Overall Study|Lack of Efficacy|1|||
48494052|NCT00679783|156002289|FG002|Overall Study|Lack of Efficacy|0|||
48494053|NCT00679783|156002290|FG003|Overall Study|Lack of Efficacy|2|||
48494054|NCT00679783|156002291|FG004|Overall Study|Lack of Efficacy|0|||
48494055|NCT00679783|156002292|FG005|Overall Study|Lack of Efficacy|0|||
48494056|NCT00679783|156002293|FG006|Overall Study|Lack of Efficacy|0|||
48494057|NCT00679783|156002287|FG000|Overall Study|Withdrawal by Subject|0|||
48494058|NCT00679783|156002288|FG001|Overall Study|Withdrawal by Subject|0|||
48494059|NCT00679783|156002289|FG002|Overall Study|Withdrawal by Subject|1|||
48494060|NCT00679783|156002290|FG003|Overall Study|Withdrawal by Subject|1|||
48494061|NCT00679783|156002291|FG004|Overall Study|Withdrawal by Subject|0|||
48494062|NCT00679783|156002292|FG005|Overall Study|Withdrawal by Subject|0|||
48494063|NCT00679783|156002293|FG006|Overall Study|Withdrawal by Subject|0|||
48494064|NCT00679783|156002287|FG000|Overall Study|Not Captured|0|||
48494065|NCT00679783|156002288|FG001|Overall Study|Not Captured|0|||
48494066|NCT00679783|156002289|FG002|Overall Study|Not Captured|0|||
48494067|NCT00679783|156002290|FG003|Overall Study|Not Captured|5|||
48494068|NCT00679783|156002291|FG004|Overall Study|Not Captured|0|||
48494069|NCT00679783|156002292|FG005|Overall Study|Not Captured|0|||
48494070|NCT00679783|156002293|FG006|Overall Study|Not Captured|0|||
48494071|NCT00679783|156002287|FG000|Overall Study|Ongoing at data cut-off|2|||
48494072|NCT00679783|156002288|FG001|Overall Study|Ongoing at data cut-off|2|||
48494073|NCT00679783|156002289|FG002|Overall Study|Ongoing at data cut-off|0|||
48494074|NCT00679783|156002290|FG003|Overall Study|Ongoing at data cut-off|9|||
48494075|NCT00679783|156002291|FG004|Overall Study|Ongoing at data cut-off|1|||
48494076|NCT00679783|156002292|FG005|Overall Study|Ongoing at data cut-off|0|||
48494077|NCT00679783|156002293|FG006|Overall Study|Ongoing at data cut-off|0|||
48494078|NCT00720122|156002294|FG000|Overall Study|Lost to Follow-up|1|||
48494079|NCT00720122|156002294|FG000|Overall Study|Physician Decision|1|||
48494080|NCT00720122|156002294|FG000|Overall Study|Withdrawal by Subject|7|||
48494081|NCT01364870|156002295|FG000|Overall Study|Withdrawal by Subject|13|||
48597894|NCT03498313|156385168|FG000|Experimental Period 1|Withdrawal by Subject|0|||
48597895|NCT03498313|156385169|FG001|Experimental Period 1|Withdrawal by Subject|1|||
48597896|NCT03498313|156385170|FG002|Experimental Period 1|Withdrawal by Subject|0|||
48713209|NCT00481091|156801346|FG002|Overall Study|No reason given|1|||
48713210|NCT00481091|156801347|FG003|Overall Study|No reason given|1|||
48713211|NCT00481091|156801348|FG004|Overall Study|No reason given|1|||
48713212|NCT00481091|156801349|FG005|Overall Study|No reason given|0|||
48713213|NCT00481091|156801350|FG006|Overall Study|No reason given|1|||
48713214|NCT00481091|156801351|FG007|Overall Study|No reason given|1|||
48713215|NCT00481091|156801352|FG008|Overall Study|No reason given|1|||
48713216|NCT00481091|156801353|FG009|Overall Study|No reason given|4|||
48713217|NCT00475306|156801354|FG000|Overall Study|Protocol Violation|1|||
48713218|NCT00475306|156801355|FG001|Overall Study|Protocol Violation|1|||
48713219|NCT00475306|156801356|FG002|Overall Study|Protocol Violation|0|||
48713220|NCT00475306|156801357|FG003|Overall Study|Protocol Violation|1|||
48713221|NCT02405442|156801359|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
48713222|NCT02405442|156801360|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
48713223|NCT02405442|156801361|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
48713224|NCT02405442|156801362|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
48713225|NCT02405442|156801359|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
48713226|NCT02405442|156801360|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
48713227|NCT02405442|156801361|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
48713228|NCT02405442|156801362|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
48713229|NCT02405442|156801359|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
48713230|NCT02405442|156801360|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
48713231|NCT02405442|156801361|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
48713232|NCT02405442|156801362|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
48713233|NCT02405442|156801359|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
48713234|NCT02405442|156801360|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
48713235|NCT02405442|156801361|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
48713236|NCT02405442|156801362|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
48713237|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
48713238|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
48494082|NCT01364870|156002296|FG001|Overall Study|Withdrawal by Subject|24|||
48494083|NCT01364870|156002297|FG002|Overall Study|Withdrawal by Subject|10|||
48812033|NCT00308737|157152175|FG002|Overall Study|Lost to Follow-up|5|||
48812034|NCT00308737|157152173|FG000|Overall Study|Physician Decision|15|||
48812035|NCT00308737|157152174|FG001|Overall Study|Physician Decision|2|||
48812036|NCT00308737|157152175|FG002|Overall Study|Physician Decision|1|||
48812037|NCT00308737|157152173|FG000|Overall Study|Protocol Violation|34|||
48812038|NCT00308737|157152174|FG001|Overall Study|Protocol Violation|9|||
48812039|NCT00308737|157152175|FG002|Overall Study|Protocol Violation|5|||
48812040|NCT00308737|157152173|FG000|Overall Study|Withdrawal by Subject|218|||
48812041|NCT00308737|157152174|FG001|Overall Study|Withdrawal by Subject|166|||
48812042|NCT00308737|157152175|FG002|Overall Study|Withdrawal by Subject|18|||
48494084|NCT01364870|156002295|FG000|Overall Study|Adverse Event|8|||
48812043|NCT00308737|157152173|FG000|Overall Study|Various|32|||
48812044|NCT00308737|157152174|FG001|Overall Study|Various|20|||
48812045|NCT00308737|157152175|FG002|Overall Study|Various|8|||
48494085|NCT01364870|156002296|FG001|Overall Study|Adverse Event|6|||
48494086|NCT01364870|156002297|FG002|Overall Study|Adverse Event|4|||
48494087|NCT01364870|156002295|FG000|Overall Study|Protocol Violation|1|||
48494088|NCT01364870|156002296|FG001|Overall Study|Protocol Violation|0|||
48494089|NCT01364870|156002297|FG002|Overall Study|Protocol Violation|0|||
48494090|NCT01873859|156002298|FG000|Overall Study|Withdrawal by Subject|0|||
48494091|NCT01873859|156002299|FG001|Overall Study|Withdrawal by Subject|4|||
48494092|NCT03072459|156002301|FG000|Overall Study|Device revised/removed|1|||
48494093|NCT03072459|156002301|FG000|Overall Study|Subject not able to return|1|||
48494094|NCT02456909|156002304|FG000|Overall Study|Did not receive allocated intervention|24|||
48494095|NCT02456909|156002305|FG001|Overall Study|Did not receive allocated intervention|26|||
48494096|NCT02456909|156002304|FG000|Overall Study|Did not complete the primary outcome|0|||
48494097|NCT02456909|156002305|FG001|Overall Study|Did not complete the primary outcome|1|||
48812046|NCT00924469|157152176|FG000|Overall Study|Adverse Event|2|||
48812047|NCT00924469|157152177|FG001|Overall Study|Adverse Event|0|||
48812048|NCT00924469|157152176|FG000|Overall Study|Withdrawal by Subject|0|||
48812049|NCT00924469|157152177|FG001|Overall Study|Withdrawal by Subject|1|||
48812050|NCT00924469|157152176|FG000|Overall Study|Lost to Follow-up|0|||
48812051|NCT00924469|157152177|FG001|Overall Study|Lost to Follow-up|1|||
48713239|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
48713240|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
48713241|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
48713242|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
48713243|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
48713244|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
48713245|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
48713246|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
48713247|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
48713248|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
48713249|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
48713250|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
48713251|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
48713252|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
48713253|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
48713254|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
48713255|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
48713256|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
48713257|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
48713258|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
48713259|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
48713260|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
48713261|NCT02405442|156801359|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
48713262|NCT02405442|156801360|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
48713263|NCT02405442|156801361|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
48713264|NCT02405442|156801362|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
48713265|NCT02405442|156801359|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
48713266|NCT02405442|156801360|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
48713267|NCT02405442|156801361|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
48713268|NCT02405442|156801362|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
48713269|NCT02405442|156801359|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
48713270|NCT02405442|156801360|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
48713271|NCT02405442|156801361|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
48713272|NCT02405442|156801362|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
48713273|NCT02405442|156801359|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
48713274|NCT02405442|156801360|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
48713275|NCT02405442|156801361|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
48713276|NCT02405442|156801362|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
48713277|NCT01311024|156801364|FG000|Overall Study|Protocol Violation|35|||
48713278|NCT01311024|156801365|FG001|Overall Study|Protocol Violation|22|||
48713279|NCT02194985|156801366|FG000|Overall Study|Adverse Event|1|||
48713280|NCT02194985|156801366|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
48713281|NCT02194985|156801366|FG000|Overall Study|Physician Decision|4|||
48713282|NCT02194985|156801366|FG000|Overall Study|Lost to Follow-up|1|||
48713283|NCT02194985|156801366|FG000|Overall Study|Withdrawal by Subject|2|||
48713284|NCT00918736|156801369|FG000|Overall Study|Withdrawal by Subject|4|||
48713285|NCT03642132|156801370|FG000|Chemotherapy Period|Adverse Event|1|||
48713286|NCT03642132|156801371|FG001|Chemotherapy Period|Adverse Event|1|||
48713287|NCT03642132|156801372|FG002|Chemotherapy Period|Adverse Event|0|||
48713288|NCT03642132|156801370|FG000|Chemotherapy Period|Physician's decision|4|||
48713289|NCT03642132|156801371|FG001|Chemotherapy Period|Physician's decision|1|||
48713290|NCT03642132|156801372|FG002|Chemotherapy Period|Physician's decision|0|||
48713291|NCT03642132|156801370|FG000|Chemotherapy Period|Progressive disease|0|||
48713292|NCT03642132|156801371|FG001|Chemotherapy Period|Progressive disease|0|||
48812052|NCT02340520|157152180|FG000|Overall Study|Lost to Follow-up|1|||
48812053|NCT02340520|157152180|FG000|Overall Study|Patient did not take drug as specified|1|||
48812054|NCT02340520|157152180|FG000|Overall Study|Withdrawal by Subject|1|||
48812055|NCT04078035|157152181|FG000|Session 2|Lost to Follow-up|3|||
48812056|NCT04078035|157152182|FG001|Session 2|Lost to Follow-up|1|||
48812057|NCT04078035|157152181|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
48812058|NCT04078035|157152182|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
48812059|NCT01263106|157152190|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
48494098|NCT00929708|156002306|FG000|Overall Study|Protocol Violation|2|||
48494099|NCT00929708|156002307|FG001|Overall Study|Protocol Violation|1|||
48494100|NCT00929708|156002308|FG002|Overall Study|Protocol Violation|1|||
48494101|NCT00929708|156002309|FG003|Overall Study|Protocol Violation|1|||
48494102|NCT00929708|156002310|FG004|Overall Study|Protocol Violation|1|||
48494103|NCT00929708|156002306|FG000|Overall Study|Withdrawal by Subject|2|||
48494104|NCT00929708|156002307|FG001|Overall Study|Withdrawal by Subject|0|||
48494105|NCT00929708|156002308|FG002|Overall Study|Withdrawal by Subject|0|||
48494106|NCT00929708|156002309|FG003|Overall Study|Withdrawal by Subject|2|||
48494107|NCT00929708|156002310|FG004|Overall Study|Withdrawal by Subject|1|||
48494108|NCT00929708|156002306|FG000|Overall Study|Adverse Event|0|||
48494109|NCT00929708|156002307|FG001|Overall Study|Adverse Event|0|||
48494110|NCT00929708|156002308|FG002|Overall Study|Adverse Event|0|||
48494111|NCT00929708|156002309|FG003|Overall Study|Adverse Event|0|||
48494112|NCT00929708|156002310|FG004|Overall Study|Adverse Event|3|||
48494113|NCT00929708|156002306|FG000|Overall Study|Physician Decision|0|||
48494114|NCT00929708|156002307|FG001|Overall Study|Physician Decision|2|||
48494115|NCT00929708|156002308|FG002|Overall Study|Physician Decision|2|||
48494116|NCT00929708|156002309|FG003|Overall Study|Physician Decision|2|||
48494117|NCT00929708|156002310|FG004|Overall Study|Physician Decision|1|||
48494118|NCT00929708|156002306|FG000|Overall Study|Lost to Follow-up|0|||
48494119|NCT00929708|156002307|FG001|Overall Study|Lost to Follow-up|0|||
48494120|NCT00929708|156002308|FG002|Overall Study|Lost to Follow-up|0|||
48494121|NCT00929708|156002309|FG003|Overall Study|Lost to Follow-up|1|||
48494122|NCT00929708|156002310|FG004|Overall Study|Lost to Follow-up|0|||
48494123|NCT02154529|156002311|FG000|Overall Study|Death|1|||
48494124|NCT02154529|156002312|FG001|Overall Study|Death|1|||
48494125|NCT02154529|156002313|FG002|Overall Study|Death|5|||
48494126|NCT02154529|156002314|FG003|Overall Study|Death|1|||
48494127|NCT02154529|156002311|FG000|Overall Study|Termination of study by sponsor|2|||
48494128|NCT02154529|156002312|FG001|Overall Study|Termination of study by sponsor|2|||
48494129|NCT02154529|156002313|FG002|Overall Study|Termination of study by sponsor|3|||
48494130|NCT02154529|156002314|FG003|Overall Study|Termination of study by sponsor|1|||
48494131|NCT02154529|156002311|FG000|Overall Study|Lost to Follow-up|1|||
48713293|NCT03642132|156801372|FG002|Chemotherapy Period|Progressive disease|1|||
48713294|NCT03642132|156801370|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
48713295|NCT03642132|156801371|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
48713296|NCT03642132|156801372|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
48713297|NCT03642132|156801370|FG000|Chemotherapy Period|Other|1|||
48713298|NCT03642132|156801371|FG001|Chemotherapy Period|Other|0|||
48713299|NCT03642132|156801372|FG002|Chemotherapy Period|Other|2|||
48713300|NCT03642132|156801370|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
48713301|NCT03642132|156801371|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
48713302|NCT03642132|156801372|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
48713303|NCT03642132|156801370|FG000|Maintenance Period|Adverse Event|1|||
48713304|NCT03642132|156801371|FG001|Maintenance Period|Adverse Event|2|||
48713305|NCT03642132|156801372|FG002|Maintenance Period|Adverse Event|0|||
48713306|NCT03642132|156801370|FG000|Maintenance Period|Non-compliance with study drug|0|||
48713307|NCT03642132|156801371|FG001|Maintenance Period|Non-compliance with study drug|0|||
48713308|NCT03642132|156801372|FG002|Maintenance Period|Non-compliance with study drug|1|||
48713309|NCT03642132|156801370|FG000|Maintenance Period|Physician's decision|2|||
48713310|NCT03642132|156801371|FG001|Maintenance Period|Physician's decision|2|||
48713311|NCT03642132|156801372|FG002|Maintenance Period|Physician's decision|2|||
48713312|NCT03642132|156801370|FG000|Maintenance Period|Progressive disease|9|||
48713313|NCT03642132|156801371|FG001|Maintenance Period|Progressive disease|3|||
48713314|NCT03642132|156801372|FG002|Maintenance Period|Progressive disease|6|||
48713315|NCT03642132|156801370|FG000|Maintenance Period|Other|0|||
48713316|NCT03642132|156801371|FG001|Maintenance Period|Other|0|||
48713317|NCT03642132|156801372|FG002|Maintenance Period|Other|3|||
48713318|NCT03642132|156801370|FG000|Maintenance Period|Withdrawal by Subject|1|||
48713319|NCT03642132|156801371|FG001|Maintenance Period|Withdrawal by Subject|1|||
48713320|NCT03642132|156801372|FG002|Maintenance Period|Withdrawal by Subject|2|||
48713321|NCT03642132|156801370|FG000|Follow-up Period|Other|0|||
48713322|NCT03642132|156801371|FG001|Follow-up Period|Other|0|||
48713323|NCT03642132|156801372|FG002|Follow-up Period|Other|1|||
48713324|NCT03642132|156801370|FG000|Follow-up Period|Withdrawal by Subject|1|||
48713325|NCT03642132|156801371|FG001|Follow-up Period|Withdrawal by Subject|2|||
48713326|NCT03642132|156801372|FG002|Follow-up Period|Withdrawal by Subject|0|||
48713327|NCT03642132|156801370|FG000|Follow-up Period|Study terminated by sponsor|1|||
48713328|NCT03642132|156801371|FG001|Follow-up Period|Study terminated by sponsor|0|||
48494132|NCT02154529|156002312|FG001|Overall Study|Lost to Follow-up|0|||
48494133|NCT02154529|156002313|FG002|Overall Study|Lost to Follow-up|0|||
48494134|NCT02154529|156002314|FG003|Overall Study|Lost to Follow-up|0|||
48494135|NCT00365352|156002315|FG000|Overall Study|Adverse Event|6|||
48494136|NCT00365352|156002316|FG001|Overall Study|Adverse Event|7|||
48494137|NCT00365352|156002317|FG002|Overall Study|Adverse Event|8|||
48494138|NCT00365352|156002315|FG000|Overall Study|Participant Withdrew Consent|8|||
48494139|NCT00365352|156002316|FG001|Overall Study|Participant Withdrew Consent|3|||
48494140|NCT00365352|156002317|FG002|Overall Study|Participant Withdrew Consent|4|||
48494141|NCT00365352|156002315|FG000|Overall Study|Lack of Efficacy|3|||
48494142|NCT00365352|156002316|FG001|Overall Study|Lack of Efficacy|0|||
48494143|NCT00365352|156002317|FG002|Overall Study|Lack of Efficacy|0|||
48494144|NCT00365352|156002315|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
48494145|NCT00365352|156002316|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
48494146|NCT00365352|156002317|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
48494147|NCT00365352|156002315|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
48494148|NCT00365352|156002316|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
48494149|NCT00365352|156002317|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
48494150|NCT00365352|156002315|FG000|Overall Study|Lost to Follow-up|1|||
48494151|NCT00365352|156002316|FG001|Overall Study|Lost to Follow-up|1|||
48494152|NCT00365352|156002317|FG002|Overall Study|Lost to Follow-up|0|||
48494153|NCT00365352|156002315|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
48494154|NCT00365352|156002316|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
48494155|NCT00365352|156002317|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
48494156|NCT00433381|156003909|FG000|Overall Study|Ineligible / no protocol treatment|3|||
48494157|NCT00433381|156003910|FG001|Overall Study|Ineligible / no protocol treatment|3|||
48494158|NCT00598559|156003911|FG000|Overall Study|Adverse Event|11|||
48494159|NCT00598559|156003912|FG001|Overall Study|Adverse Event|7|||
48494160|NCT00598559|156003913|FG002|Overall Study|Adverse Event|0|||
48494161|NCT00598559|156003911|FG000|Overall Study|Withdrawal by Subject|2|||
48494162|NCT00598559|156003912|FG001|Overall Study|Withdrawal by Subject|2|||
48494163|NCT00598559|156003913|FG002|Overall Study|Withdrawal by Subject|0|||
48494164|NCT00598559|156003911|FG000|Overall Study|Protocol Non-compliance|1|||
48494165|NCT00598559|156003912|FG001|Overall Study|Protocol Non-compliance|0|||
48494166|NCT00598559|156003913|FG002|Overall Study|Protocol Non-compliance|0|||
48494167|NCT00598559|156003911|FG000|Overall Study|Early discharge from hospital|9|||
48494168|NCT00598559|156003912|FG001|Overall Study|Early discharge from hospital|12|||
48494169|NCT00598559|156003913|FG002|Overall Study|Early discharge from hospital|3|||
48494170|NCT00598559|156003911|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
48494171|NCT00598559|156003912|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
48494172|NCT00598559|156003913|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
48494173|NCT02806232|156003914|FG000|Overall Study|Lost to Follow-up|1|||
48494174|NCT02806232|156003915|FG001|Overall Study|Lost to Follow-up|2|||
48494175|NCT02806232|156003916|FG002|Overall Study|Lost to Follow-up|1|||
48494176|NCT02806232|156003917|FG003|Overall Study|Lost to Follow-up|0|||
48494177|NCT02806232|156003918|FG004|Overall Study|Lost to Follow-up|0|||
48494178|NCT02806232|156003919|FG005|Overall Study|Lost to Follow-up|1|||
48494179|NCT02806232|156003920|FG006|Overall Study|Lost to Follow-up|0|||
48812060|NCT01263106|157152191|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
48812061|NCT02009696|157152194|FG000|Overall Study|Withdrawal by Subject|2|||
48812062|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
48812063|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
48812064|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
48812065|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
48812066|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
48812067|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
48812068|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Death|0|||
48812069|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Death|1|||
48812070|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Adverse Event|11|||
48812071|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Adverse Event|11|||
48812072|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
48812073|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
48494180|NCT02806232|156003921|FG007|Overall Study|Lost to Follow-up|0|||
48494181|NCT02806232|156003922|FG008|Overall Study|Lost to Follow-up|0|||
48494182|NCT02806232|156003914|FG000|Overall Study|Withdrawal by Subject|0|||
48494183|NCT02806232|156003915|FG001|Overall Study|Withdrawal by Subject|2|||
48494184|NCT02806232|156003916|FG002|Overall Study|Withdrawal by Subject|0|||
48494185|NCT02806232|156003917|FG003|Overall Study|Withdrawal by Subject|0|||
48494186|NCT02806232|156003918|FG004|Overall Study|Withdrawal by Subject|2|||
48494187|NCT02806232|156003919|FG005|Overall Study|Withdrawal by Subject|1|||
48494188|NCT02806232|156003920|FG006|Overall Study|Withdrawal by Subject|0|||
48494189|NCT02806232|156003921|FG007|Overall Study|Withdrawal by Subject|0|||
48494190|NCT02806232|156003922|FG008|Overall Study|Withdrawal by Subject|0|||
48494191|NCT01059071|156003923|FG000|Overall Study|Lack of Efficacy|1|||
48494192|NCT01059071|156003924|FG001|Overall Study|Lack of Efficacy|4|||
48494193|NCT01059071|156003925|FG002|Overall Study|Lack of Efficacy|2|||
48494194|NCT01059071|156003926|FG003|Overall Study|Lack of Efficacy|3|||
48494195|NCT01059071|156003923|FG000|Overall Study|Withdrawal by Subject|1|||
48494196|NCT01059071|156003924|FG001|Overall Study|Withdrawal by Subject|0|||
48494197|NCT01059071|156003925|FG002|Overall Study|Withdrawal by Subject|0|||
48812074|NCT02936037|157153461|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48812075|NCT02936037|157153462|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48812076|NCT02936037|157153461|FG000|Open Label Extension|Adverse Event|0|||
48812077|NCT02936037|157153462|FG001|Open Label Extension|Adverse Event|3|||
48812078|NCT02936037|157153461|FG000|Open Label Extension|Other|0|||
48812079|NCT02936037|157153462|FG001|Open Label Extension|Other|3|||
48812080|NCT02936037|157153461|FG000|Open Label Extension|Withdrawal by Subject|0|||
48812081|NCT02936037|157153462|FG001|Open Label Extension|Withdrawal by Subject|4|||
48812082|NCT01862991|157153463|FG000|Overall Study|Lost to Follow-up|2|||
48812083|NCT01862991|157153464|FG001|Overall Study|Lost to Follow-up|1|||
48812084|NCT01862991|157153465|FG002|Overall Study|Lost to Follow-up|1|||
48812085|NCT01862991|157153463|FG000|Overall Study|Protocol Violation|1|||
48812086|NCT01862991|157153464|FG001|Overall Study|Protocol Violation|0|||
48812087|NCT01862991|157153465|FG002|Overall Study|Protocol Violation|0|||
48812088|NCT00453310|157153469|FG000|Overall Study|Progression of Disease|10|||
48812089|NCT04666922|157153470|FG000|Overall Study|Withdrawal by Subject|1|||
48812090|NCT04666922|157153471|FG001|Overall Study|Withdrawal by Subject|0|||
48812091|NCT04666922|157153472|FG002|Overall Study|Withdrawal by Subject|0|||
48812092|NCT04666922|157153473|FG003|Overall Study|Withdrawal by Subject|0|||
48812093|NCT04666922|157153474|FG004|Overall Study|Withdrawal by Subject|0|||
48812094|NCT04666922|157153475|FG005|Overall Study|Withdrawal by Subject|0|||
48812095|NCT04666922|157153476|FG006|Overall Study|Withdrawal by Subject|0|||
48812096|NCT00857805|157153480|FG000|Overall Study|Withdrawal by Subject|1|||
48812097|NCT00857805|157153481|FG001|Overall Study|Withdrawal by Subject|1|||
48812098|NCT04105972|157153483|FG000|Overall Study|Adverse Event|2|||
48812099|NCT04105972|157153484|FG001|Overall Study|Adverse Event|1|||
48812100|NCT02305381|157153485|FG000|Overall Study|Unclassified|5|||
48812101|NCT02305381|157153486|FG001|Overall Study|Unclassified|5|||
48494198|NCT01059071|156003926|FG003|Overall Study|Withdrawal by Subject|2|||
48713329|NCT03642132|156801372|FG002|Follow-up Period|Study terminated by sponsor|1|||
48713330|NCT03642132|156801370|FG000|Follow-up Period|Lack of Efficacy|1|||
48713331|NCT03642132|156801371|FG001|Follow-up Period|Lack of Efficacy|0|||
48713332|NCT03642132|156801372|FG002|Follow-up Period|Lack of Efficacy|0|||
48713333|NCT03642132|156801370|FG000|Follow-up Period|Death|1|||
48713334|NCT03642132|156801371|FG001|Follow-up Period|Death|0|||
48713335|NCT03642132|156801372|FG002|Follow-up Period|Death|2|||
48713336|NCT03642132|156801370|FG000|Follow-up Period|Adverse Event|1|||
48713337|NCT03642132|156801371|FG001|Follow-up Period|Adverse Event|0|||
48713338|NCT03642132|156801372|FG002|Follow-up Period|Adverse Event|0|||
48713339|NCT03801031|156801377|FG000|Overall Study|Lost to Follow-up|1|||
48713340|NCT03801031|156801378|FG001|Overall Study|Lost to Follow-up|0|||
48713341|NCT03801031|156801377|FG000|Overall Study|Unable to comply|1|||
48713342|NCT03801031|156801378|FG001|Overall Study|Unable to comply|0|||
48713343|NCT03801031|156801377|FG000|Overall Study|Withdrawal by Subject|0|||
48713344|NCT03801031|156801378|FG001|Overall Study|Withdrawal by Subject|1|||
48713345|NCT02948088|156801379|FG000|Overall Study|Lost to Follow-up|8|||
48713346|NCT02948088|156801379|FG000|Overall Study|Death|1|||
48713347|NCT02948088|156801379|FG000|Overall Study|Withdrawal by Subject|4|||
48713348|NCT02948088|156801379|FG000|Overall Study|Other|2|||
48713349|NCT03337490|156801383|FG000|Overall Study|Withdrawal by Subject|1|||
48713350|NCT03337490|156801384|FG001|Overall Study|Withdrawal by Subject|0|||
48713351|NCT03337490|156801385|FG002|Overall Study|Withdrawal by Subject|0|||
48713352|NCT03337490|156801383|FG000|Overall Study|Lack of Efficacy|10|||
48713353|NCT03337490|156801384|FG001|Overall Study|Lack of Efficacy|12|||
48713354|NCT03337490|156801385|FG002|Overall Study|Lack of Efficacy|35|||
48713355|NCT03337490|156801383|FG000|Overall Study|Physician Decision|0|||
48713356|NCT03337490|156801384|FG001|Overall Study|Physician Decision|1|||
48713357|NCT03337490|156801385|FG002|Overall Study|Physician Decision|0|||
48713358|NCT03337490|156801383|FG000|Overall Study|Lost to Follow-up|0|||
48713359|NCT03337490|156801384|FG001|Overall Study|Lost to Follow-up|1|||
48713360|NCT03337490|156801385|FG002|Overall Study|Lost to Follow-up|0|||
48713361|NCT01776307|156801386|FG000|Overall Study|Not dosed|0|||
48713362|NCT01776307|156801387|FG001|Overall Study|Not dosed|0|||
48713363|NCT01776307|156801388|FG002|Overall Study|Not dosed|1|||
48713364|NCT00573144|156801389|FG000|Overall Study|Withdrawal by Subject|2|||
48713365|NCT00573144|156801390|FG001|Overall Study|Withdrawal by Subject|3|||
48713366|NCT04450381|156801391|FG000|Overall Study|Protocol Violation|4|||
48812102|NCT02305381|157153487|FG002|Overall Study|Unclassified|7|||
48812103|NCT00553202|157153495|FG000|Overall Study|Death|16|||
48812104|NCT00553202|157153495|FG000|Overall Study|Lost to Follow-up|1|||
48812105|NCT00553202|157153495|FG000|Overall Study|Physician Decision|28|||
48812106|NCT00553202|157153495|FG000|Overall Study|Withdrawal by Subject|1|||
48812107|NCT00553202|157153495|FG000|Overall Study|No donor identified|16|||
48812108|NCT00553202|157153495|FG000|Overall Study|Fails to meet organ function|6|||
48812109|NCT00077636|157153496|FG000|Overall Study|Refused Treatment|9|||
48812110|NCT00077636|157153497|FG001|Overall Study|Refused Treatment|31|||
48812111|NCT00077636|157153496|FG000|Overall Study|Admin|3|||
48812112|NCT00077636|157153497|FG001|Overall Study|Admin|3|||
48812113|NCT00077636|157153496|FG000|Overall Study|Withdrawal by Subject|2|||
48812114|NCT00077636|157153497|FG001|Overall Study|Withdrawal by Subject|2|||
48812115|NCT00077636|157153496|FG000|Overall Study|Adverse Event|17|||
48812116|NCT00077636|157153497|FG001|Overall Study|Adverse Event|34|||
48812117|NCT00077636|157153496|FG000|Overall Study|Protocol Violation|0|||
48812118|NCT00077636|157153497|FG001|Overall Study|Protocol Violation|2|||
48812119|NCT00077636|157153496|FG000|Overall Study|Lost to Follow-up|10|||
48812120|NCT00077636|157153497|FG001|Overall Study|Lost to Follow-up|18|||
48812121|NCT00077636|157153496|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
48812122|NCT00077636|157153497|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
48812123|NCT01923896|157153502|FG000|Overall Study|Adverse Event|1|||
48812124|NCT01923896|157153503|FG001|Overall Study|Adverse Event|0|||
48812125|NCT00474929|157153508|FG000|Overall Study|Withdrawal by Subject|0|||
48812126|NCT00474929|157153509|FG001|Overall Study|Withdrawal by Subject|1|||
48812127|NCT00474929|157153510|FG002|Overall Study|Withdrawal by Subject|0|||
48812128|NCT00474929|157153511|FG003|Overall Study|Withdrawal by Subject|0|||
48812129|NCT00474929|157153512|FG004|Overall Study|Withdrawal by Subject|0|||
48812130|NCT00474929|157153508|FG000|Overall Study|Unrelated medical condition|0|||
48812131|NCT00474929|157153509|FG001|Overall Study|Unrelated medical condition|0|||
48812132|NCT00474929|157153510|FG002|Overall Study|Unrelated medical condition|1|||
48812133|NCT00474929|157153511|FG003|Overall Study|Unrelated medical condition|0|||
48812134|NCT00474929|157153512|FG004|Overall Study|Unrelated medical condition|0|||
48812135|NCT00474929|157153508|FG000|Overall Study|Physician Decision|0|||
48812136|NCT00474929|157153509|FG001|Overall Study|Physician Decision|0|||
48812137|NCT00474929|157153510|FG002|Overall Study|Physician Decision|1|||
48812138|NCT00474929|157153511|FG003|Overall Study|Physician Decision|2|||
48812139|NCT00474929|157153512|FG004|Overall Study|Physician Decision|0|||
48812140|NCT00068380|157153513|FG000|Overall Study|Withdrawal by Subject|3|||
48812141|NCT00068380|157153513|FG000|Overall Study|Adverse Event|2|||
48812142|NCT01976364|157153514|FG000|Main Study (36 Months)|Adverse Event|63|||
48812143|NCT01976364|157153515|FG001|Main Study (36 Months)|Adverse Event|0|||
48812144|NCT01976364|157153516|FG002|Main Study (36 Months)|Adverse Event|0|||
48812145|NCT01976364|157153514|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
48812146|NCT01976364|157153515|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
48812147|NCT01976364|157153516|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
48812148|NCT01976364|157153514|FG000|Main Study (36 Months)|Other|13|||
48812149|NCT01976364|157153515|FG001|Main Study (36 Months)|Other|0|||
48812150|NCT01976364|157153516|FG002|Main Study (36 Months)|Other|0|||
48812151|NCT01976364|157153514|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
48812152|NCT01976364|157153515|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
48812153|NCT01976364|157153516|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
48812154|NCT01976364|157153514|FG000|Main Study (36 Months)|Medication error|1|||
48812155|NCT01976364|157153515|FG001|Main Study (36 Months)|Medication error|0|||
48812156|NCT01976364|157153516|FG002|Main Study (36 Months)|Medication error|0|||
48812157|NCT01976364|157153514|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
48812158|NCT01976364|157153515|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
48812159|NCT01976364|157153516|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
48812160|NCT01976364|157153514|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
48812161|NCT01976364|157153515|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
48812162|NCT01976364|157153516|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
48812163|NCT01976364|157153514|FG000|Main Study (36 Months)|Protocol Violation|13|||
48812164|NCT01976364|157153515|FG001|Main Study (36 Months)|Protocol Violation|0|||
48812165|NCT01976364|157153516|FG002|Main Study (36 Months)|Protocol Violation|0|||
48812166|NCT01976364|157153514|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
48812167|NCT01976364|157153515|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
48812168|NCT01976364|157153516|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
48812169|NCT01976364|157153514|FG000|Main Study (36 Months)|Death|5|||
48812170|NCT01976364|157153515|FG001|Main Study (36 Months)|Death|0|||
48812171|NCT01976364|157153516|FG002|Main Study (36 Months)|Death|0|||
48812172|NCT01976364|157153514|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
48812173|NCT01976364|157153515|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
48812174|NCT01976364|157153516|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
48812175|NCT01976364|157153514|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
48812176|NCT01976364|157153515|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
48812177|NCT01976364|157153516|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
48494199|NCT01059071|156003923|FG000|Overall Study|Physician Decision|0|||
48494200|NCT01059071|156003924|FG001|Overall Study|Physician Decision|0|||
48812178|NCT01976364|157153514|FG000|Sub-study (12 Months)|Protocol Violation|0|||
48713367|NCT04450381|156801391|FG000|Overall Study|Wrong device setting|2|||
48713368|NCT01090323|156801392|FG000|Overall Study|Adverse Event|12|||
48713369|NCT01090323|156801393|FG001|Overall Study|Adverse Event|2|||
48494201|NCT01059071|156003925|FG002|Overall Study|Physician Decision|0|||
48494202|NCT01059071|156003926|FG003|Overall Study|Physician Decision|1|||
48494203|NCT03922477|156003928|FG000|Overall Study|Death|9|||
48494204|NCT03922477|156003928|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
48494205|NCT03922477|156003928|FG000|Overall Study|Physician Decision|1|||
48494206|NCT03922477|156003928|FG000|Overall Study|Withdrawal by Subject|2|||
48494207|NCT00278200|156003929|FG000|Overall Study|Death|1|||
48713370|NCT01090323|156801392|FG000|Overall Study|Abnormal Lab Values|3|||
48713371|NCT01090323|156801393|FG001|Overall Study|Abnormal Lab Values|1|||
48713372|NCT01090323|156801392|FG000|Overall Study|Abnormal Test Procedure Results|2|||
48713373|NCT01090323|156801393|FG001|Overall Study|Abnormal Test Procedure Results|0|||
48713374|NCT01090323|156801392|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48713375|NCT01090323|156801393|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48713376|NCT01090323|156801392|FG000|Overall Study|Condition no longer requires drug|5|||
48713377|NCT01090323|156801393|FG001|Overall Study|Condition no longer requires drug|4|||
48713378|NCT01090323|156801392|FG000|Overall Study|Protocol Violation|2|||
48713379|NCT01090323|156801393|FG001|Overall Study|Protocol Violation|1|||
48713380|NCT01090323|156801392|FG000|Overall Study|Withdrew consent|33|||
48713381|NCT01090323|156801393|FG001|Overall Study|Withdrew consent|11|||
48713382|NCT01090323|156801392|FG000|Overall Study|Lost to Follow-up|11|||
48713383|NCT01090323|156801393|FG001|Overall Study|Lost to Follow-up|6|||
48713384|NCT01090323|156801392|FG000|Overall Study|Administrative problems|6|||
48713385|NCT01090323|156801393|FG001|Overall Study|Administrative problems|4|||
48713386|NCT01090323|156801392|FG000|Overall Study|Death|1|||
48713387|NCT01090323|156801393|FG001|Overall Study|Death|2|||
48713388|NCT01090323|156801392|FG000|Overall Study|Stopped end of core|7|||
48713389|NCT01090323|156801393|FG001|Overall Study|Stopped end of core|0|||
48713390|NCT01090323|156801392|FG000|Overall Study|Stopped end of extension 1#|3|||
48713391|NCT01090323|156801393|FG001|Overall Study|Stopped end of extension 1#|1|||
48713392|NCT01864005|156801394|FG000|Overall Study|Protocol Violation|0|||
48713393|NCT01864005|156801395|FG001|Overall Study|Protocol Violation|1|||
48812179|NCT01976364|157153515|FG001|Sub-study (12 Months)|Protocol Violation|1|||
48713394|NCT01864005|156801394|FG000|Overall Study|Withdrawal by Subject|0|||
48713395|NCT01864005|156801395|FG001|Overall Study|Withdrawal by Subject|1|||
48713396|NCT01864005|156801394|FG000|Overall Study|Incorrect enrolment|1|||
48713397|NCT01864005|156801395|FG001|Overall Study|Incorrect enrolment|0|||
48713398|NCT01864005|156801394|FG000|Overall Study|Disease need|1|||
48713399|NCT01864005|156801395|FG001|Overall Study|Disease need|1|||
48713400|NCT01864005|156801394|FG000|Overall Study|Need GP IIb/IIIa|1|||
48713401|NCT01864005|156801395|FG001|Overall Study|Need GP IIb/IIIa|3|||
48713402|NCT00763698|156801398|FG000|Overall Study|Unsuccessful Implant|5|||
48713403|NCT00763698|156801398|FG000|Overall Study|Death|4|||
48713404|NCT00763698|156801398|FG000|Overall Study|Withdrawal by Subject|1|||
48713405|NCT00344487|156801399|FG000|Overall Study|immunologic failure|1|||
48713406|NCT02059291|156801400|FG000|Epoch 2|Lack of Efficacy|0|||
48713407|NCT02059291|156801401|FG001|Epoch 2|Lack of Efficacy|0|||
48713408|NCT02059291|156801402|FG002|Epoch 2|Lack of Efficacy|0|||
48713409|NCT02059291|156801403|FG003|Epoch 2|Lack of Efficacy|1|||
48713410|NCT02059291|156801404|FG004|Epoch 2|Lack of Efficacy|0|||
48713411|NCT02059291|156801405|FG005|Epoch 2|Lack of Efficacy|1|||
48713412|NCT02059291|156801406|FG006|Epoch 2|Lack of Efficacy|0|||
48713413|NCT02059291|156801407|FG007|Epoch 2|Lack of Efficacy|0|||
48812180|NCT01976364|157153516|FG002|Sub-study (12 Months)|Protocol Violation|1|||
48435659|NCT02504268|155783730|FG008|Overall Study|Poor/Non-Compliance|0|||
48435660|NCT02504268|155783722|FG000|Overall Study|Not Disclosed|1|||
48435661|NCT02504268|155783723|FG001|Overall Study|Not Disclosed|0|||
48435662|NCT02504268|155783724|FG002|Overall Study|Not Disclosed|2|||
48435663|NCT02504268|155783725|FG003|Overall Study|Not Disclosed|0|||
48435664|NCT02504268|155783726|FG004|Overall Study|Not Disclosed|0|||
48435665|NCT02504268|155783727|FG005|Overall Study|Not Disclosed|0|||
48435666|NCT02504268|155783728|FG006|Overall Study|Not Disclosed|0|||
48435667|NCT02504268|155783729|FG007|Overall Study|Not Disclosed|0|||
48435668|NCT02504268|155783730|FG008|Overall Study|Not Disclosed|0|||
48435669|NCT03025217|155783731|FG000|Overall Study|Pregnancy|1|||
48435670|NCT03025217|155783731|FG000|Overall Study|Lost to Follow-up|1|||
48435671|NCT03025217|155783731|FG000|Overall Study|Not eligible, poor English|2|||
48435672|NCT01958125|155783732|FG000|Overall Study|Missing diary data|2|||
48435673|NCT01958125|155783733|FG001|Overall Study|Missing diary data|6|||
48435674|NCT01958125|155783732|FG000|Overall Study|No headache attacks|0|||
48435675|NCT01958125|155783733|FG001|Overall Study|No headache attacks|2|||
48435676|NCT00987623|155783738|FG000|Overall Study|Lost to Follow-up|2|||
48435677|NCT00987623|155783739|FG001|Overall Study|Lost to Follow-up|1|||
48435678|NCT00987623|155783738|FG000|Overall Study|Time/job conflict|2|||
48435679|NCT00987623|155783739|FG001|Overall Study|Time/job conflict|0|||
48435680|NCT00987623|155783738|FG000|Overall Study|Discomfort|1|||
48435681|NCT00987623|155783739|FG001|Overall Study|Discomfort|0|||
48435682|NCT00987623|155783738|FG000|Overall Study|Biomicroscopy|0|||
48435683|NCT00987623|155783739|FG001|Overall Study|Biomicroscopy|1|||
48494208|NCT00278200|156003930|FG001|Overall Study|Death|3|||
48494209|NCT00278200|156003929|FG000|Overall Study|Physician Decision|0|||
48494210|NCT00278200|156003930|FG001|Overall Study|Physician Decision|1|||
48494211|NCT00673361|156003932|FG000|Overall Study|Screen Failure|2|||
48494212|NCT00829413|156003933|FG000|Overall Study|No study drug admimnistered|13|||
48494213|NCT00829413|156003933|FG000|Overall Study|Training Patients|67|||
48494214|NCT00829413|156003933|FG000|Overall Study|No truth standard procedure available|9|||
48494215|NCT00829413|156003933|FG000|Overall Study|Technically inadequate truth standard|2|||
48494216|NCT00829413|156003933|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
48713414|NCT02059291|156801408|FG008|Epoch 2|Lack of Efficacy|0|||
48713415|NCT02059291|156801409|FG009|Epoch 2|Lack of Efficacy|0|||
48713416|NCT02059291|156801410|FG010|Epoch 2|Lack of Efficacy|0|||
48494217|NCT01464827|156003934|FG000|Overall Study|Adverse Event|0|||
48494218|NCT01464827|156003935|FG001|Overall Study|Adverse Event|0|||
48713417|NCT02059291|156801411|FG011|Epoch 2|Lack of Efficacy|0|||
48713418|NCT02059291|156801412|FG012|Epoch 2|Lack of Efficacy|0|||
48713419|NCT02059291|156801413|FG013|Epoch 2|Lack of Efficacy|0|||
48713420|NCT02059291|156801414|FG014|Epoch 2|Lack of Efficacy|0|||
48812181|NCT01976364|157153514|FG000|Sub-study (12 Months)|Adverse Event|0|||
48812182|NCT01976364|157153515|FG001|Sub-study (12 Months)|Adverse Event|4|||
48812183|NCT01976364|157153516|FG002|Sub-study (12 Months)|Adverse Event|3|||
48812184|NCT03239873|157153517|FG000|Overall Study|Lost to Follow-up|15|||
48812185|NCT03239873|157153518|FG001|Overall Study|Lost to Follow-up|16|||
48812186|NCT03239873|157153517|FG000|Overall Study|Physician Decision|1|||
48812187|NCT03239873|157153518|FG001|Overall Study|Physician Decision|0|||
48812188|NCT03239873|157153517|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
48812189|NCT03239873|157153518|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
48812190|NCT03239873|157153517|FG000|Overall Study|Withdrawal by Subject|2|||
48812191|NCT03239873|157153518|FG001|Overall Study|Withdrawal by Subject|0|||
48812192|NCT03239873|157153517|FG000|Overall Study|Contraindication to study medication|1|||
48812193|NCT03239873|157153518|FG001|Overall Study|Contraindication to study medication|0|||
48812194|NCT03239873|157153517|FG000|Overall Study|Protocol Violation|1|||
48812195|NCT03239873|157153518|FG001|Overall Study|Protocol Violation|0|||
48812196|NCT02960763|157153519|FG000|Step 1|Withdrawal by Subject|10|||
48812197|NCT02960763|157153520|FG001|Step 1|Withdrawal by Subject|8|||
48812198|NCT02960763|157153521|FG002|Step 1|Withdrawal by Subject|13|||
48812199|NCT02960763|157153522|FG003|Step 1|Withdrawal by Subject|0|||
48812200|NCT02960763|157153523|FG004|Step 1|Withdrawal by Subject|0|||
48812201|NCT02960763|157153519|FG000|Step 1|Lost to Follow-up|7|||
48812202|NCT02960763|157153520|FG001|Step 1|Lost to Follow-up|9|||
48812203|NCT02960763|157153521|FG002|Step 1|Lost to Follow-up|12|||
48812204|NCT02960763|157153522|FG003|Step 1|Lost to Follow-up|0|||
48812205|NCT02960763|157153523|FG004|Step 1|Lost to Follow-up|0|||
48812206|NCT02960763|157153519|FG000|Step 1|Death|1|||
48812207|NCT02960763|157153520|FG001|Step 1|Death|1|||
48812208|NCT02960763|157153521|FG002|Step 1|Death|1|||
48812209|NCT02960763|157153522|FG003|Step 1|Death|0|||
48494219|NCT01464827|156003936|FG002|Overall Study|Adverse Event|0|||
48494220|NCT01464827|156003937|FG003|Overall Study|Adverse Event|0|||
48494221|NCT01464827|156003938|FG004|Overall Study|Adverse Event|0|||
48494222|NCT01464827|156003939|FG005|Overall Study|Adverse Event|0|||
48494223|NCT01464827|156003940|FG006|Overall Study|Adverse Event|0|||
48494224|NCT01464827|156003941|FG007|Overall Study|Adverse Event|0|||
48494225|NCT01464827|156003942|FG008|Overall Study|Adverse Event|0|||
48494226|NCT01464827|156003943|FG009|Overall Study|Adverse Event|0|||
48812210|NCT02960763|157153523|FG004|Step 1|Death|0|||
48812211|NCT02960763|157153519|FG000|Step 1|Investigator discretion|1|||
48494227|NCT01464827|156003944|FG010|Overall Study|Adverse Event|0|||
48494228|NCT01464827|156003945|FG011|Overall Study|Adverse Event|0|||
48812212|NCT02960763|157153520|FG001|Step 1|Investigator discretion|0|||
48812213|NCT02960763|157153521|FG002|Step 1|Investigator discretion|1|||
48812214|NCT02960763|157153522|FG003|Step 1|Investigator discretion|0|||
48713421|NCT02059291|156801415|FG015|Epoch 2|Lack of Efficacy|0|||
48713422|NCT02059291|156801416|FG016|Epoch 2|Lack of Efficacy|0|||
48812215|NCT02960763|157153523|FG004|Step 1|Investigator discretion|0|||
48713423|NCT02059291|156801417|FG017|Epoch 2|Lack of Efficacy|0|||
48812216|NCT02960763|157153519|FG000|Step 1|Other|0|||
48812217|NCT02960763|157153520|FG001|Step 1|Other|0|||
48713424|NCT02059291|156801418|FG018|Epoch 2|Lack of Efficacy|0|||
48494229|NCT01464827|156003946|FG012|Overall Study|Adverse Event|1|||
48494230|NCT01464827|156003947|FG013|Overall Study|Adverse Event|0|||
48494231|NCT01464827|156003934|FG000|Overall Study|Withdrawal by Subject|1|||
48494232|NCT01464827|156003935|FG001|Overall Study|Withdrawal by Subject|0|||
48494233|NCT01464827|156003936|FG002|Overall Study|Withdrawal by Subject|0|||
48494234|NCT01464827|156003937|FG003|Overall Study|Withdrawal by Subject|0|||
48494235|NCT01464827|156003938|FG004|Overall Study|Withdrawal by Subject|1|||
48713425|NCT02059291|156801419|FG019|Epoch 2|Lack of Efficacy|0|||
48713426|NCT02059291|156801420|FG020|Epoch 2|Lack of Efficacy|0|||
48713427|NCT02059291|156801421|FG021|Epoch 2|Lack of Efficacy|0|||
48713428|NCT02059291|156801422|FG022|Epoch 2|Lack of Efficacy|0|||
48713429|NCT02059291|156801423|FG023|Epoch 2|Lack of Efficacy|0|||
48713430|NCT02059291|156801424|FG024|Epoch 2|Lack of Efficacy|0|||
48713431|NCT02059291|156801400|FG000|Epoch 2|Adverse Event|0|||
48713432|NCT02059291|156801401|FG001|Epoch 2|Adverse Event|0|||
48713433|NCT02059291|156801402|FG002|Epoch 2|Adverse Event|1|||
48713434|NCT02059291|156801403|FG003|Epoch 2|Adverse Event|1|||
48713435|NCT02059291|156801404|FG004|Epoch 2|Adverse Event|0|||
48713436|NCT02059291|156801405|FG005|Epoch 2|Adverse Event|0|||
48713437|NCT02059291|156801406|FG006|Epoch 2|Adverse Event|0|||
48713438|NCT02059291|156801407|FG007|Epoch 2|Adverse Event|1|||
48713439|NCT02059291|156801408|FG008|Epoch 2|Adverse Event|1|||
48713440|NCT02059291|156801409|FG009|Epoch 2|Adverse Event|0|||
48713441|NCT02059291|156801410|FG010|Epoch 2|Adverse Event|0|||
48713442|NCT02059291|156801411|FG011|Epoch 2|Adverse Event|0|||
48713443|NCT02059291|156801412|FG012|Epoch 2|Adverse Event|0|||
48713444|NCT02059291|156801413|FG013|Epoch 2|Adverse Event|0|||
48713445|NCT02059291|156801414|FG014|Epoch 2|Adverse Event|0|||
48713446|NCT02059291|156801415|FG015|Epoch 2|Adverse Event|0|||
48713447|NCT02059291|156801416|FG016|Epoch 2|Adverse Event|0|||
48713448|NCT02059291|156801417|FG017|Epoch 2|Adverse Event|0|||
48713449|NCT02059291|156801418|FG018|Epoch 2|Adverse Event|0|||
48713450|NCT02059291|156801419|FG019|Epoch 2|Adverse Event|0|||
48713451|NCT02059291|156801420|FG020|Epoch 2|Adverse Event|0|||
48713452|NCT02059291|156801421|FG021|Epoch 2|Adverse Event|0|||
48713453|NCT02059291|156801422|FG022|Epoch 2|Adverse Event|0|||
48713454|NCT02059291|156801423|FG023|Epoch 2|Adverse Event|0|||
48713455|NCT02059291|156801424|FG024|Epoch 2|Adverse Event|0|||
48713456|NCT02059291|156801400|FG000|Epoch 2|Withdrawal by Subject|0|||
48713457|NCT02059291|156801401|FG001|Epoch 2|Withdrawal by Subject|1|||
48713458|NCT02059291|156801402|FG002|Epoch 2|Withdrawal by Subject|0|||
48713459|NCT02059291|156801403|FG003|Epoch 2|Withdrawal by Subject|0|||
48713460|NCT02059291|156801404|FG004|Epoch 2|Withdrawal by Subject|0|||
48713461|NCT02059291|156801405|FG005|Epoch 2|Withdrawal by Subject|1|||
48713462|NCT02059291|156801406|FG006|Epoch 2|Withdrawal by Subject|0|||
48713463|NCT02059291|156801407|FG007|Epoch 2|Withdrawal by Subject|0|||
48713464|NCT02059291|156801408|FG008|Epoch 2|Withdrawal by Subject|1|||
48713465|NCT02059291|156801409|FG009|Epoch 2|Withdrawal by Subject|0|||
48713466|NCT02059291|156801410|FG010|Epoch 2|Withdrawal by Subject|0|||
48713467|NCT02059291|156801411|FG011|Epoch 2|Withdrawal by Subject|0|||
48713468|NCT02059291|156801412|FG012|Epoch 2|Withdrawal by Subject|0|||
48713469|NCT02059291|156801413|FG013|Epoch 2|Withdrawal by Subject|0|||
48713470|NCT02059291|156801414|FG014|Epoch 2|Withdrawal by Subject|0|||
48713471|NCT02059291|156801415|FG015|Epoch 2|Withdrawal by Subject|0|||
48713472|NCT02059291|156801416|FG016|Epoch 2|Withdrawal by Subject|0|||
48713473|NCT02059291|156801417|FG017|Epoch 2|Withdrawal by Subject|0|||
48713474|NCT02059291|156801418|FG018|Epoch 2|Withdrawal by Subject|0|||
48713475|NCT02059291|156801419|FG019|Epoch 2|Withdrawal by Subject|0|||
48494236|NCT01464827|156003939|FG005|Overall Study|Withdrawal by Subject|0|||
48494237|NCT01464827|156003940|FG006|Overall Study|Withdrawal by Subject|0|||
48494238|NCT01464827|156003941|FG007|Overall Study|Withdrawal by Subject|1|||
48494239|NCT01464827|156003942|FG008|Overall Study|Withdrawal by Subject|0|||
48494240|NCT01464827|156003943|FG009|Overall Study|Withdrawal by Subject|0|||
48494241|NCT01464827|156003944|FG010|Overall Study|Withdrawal by Subject|0|||
48494242|NCT01464827|156003945|FG011|Overall Study|Withdrawal by Subject|0|||
48494243|NCT01464827|156003946|FG012|Overall Study|Withdrawal by Subject|0|||
48494244|NCT01464827|156003947|FG013|Overall Study|Withdrawal by Subject|0|||
48494245|NCT01464827|156003934|FG000|Overall Study|Lost to Follow-up|0|||
48494246|NCT01464827|156003935|FG001|Overall Study|Lost to Follow-up|2|||
48494247|NCT01464827|156003936|FG002|Overall Study|Lost to Follow-up|0|||
48494248|NCT01464827|156003937|FG003|Overall Study|Lost to Follow-up|2|||
48494249|NCT01464827|156003938|FG004|Overall Study|Lost to Follow-up|3|||
48494250|NCT01464827|156003939|FG005|Overall Study|Lost to Follow-up|1|||
48494251|NCT01464827|156003940|FG006|Overall Study|Lost to Follow-up|2|||
48494252|NCT01464827|156003941|FG007|Overall Study|Lost to Follow-up|2|||
48494253|NCT01464827|156003942|FG008|Overall Study|Lost to Follow-up|0|||
48713476|NCT02059291|156801420|FG020|Epoch 2|Withdrawal by Subject|0|||
48494254|NCT01464827|156003943|FG009|Overall Study|Lost to Follow-up|0|||
48713477|NCT02059291|156801421|FG021|Epoch 2|Withdrawal by Subject|0|||
48713478|NCT02059291|156801422|FG022|Epoch 2|Withdrawal by Subject|0|||
48713479|NCT02059291|156801423|FG023|Epoch 2|Withdrawal by Subject|0|||
48713480|NCT02059291|156801424|FG024|Epoch 2|Withdrawal by Subject|0|||
48494255|NCT01464827|156003944|FG010|Overall Study|Lost to Follow-up|0|||
48494256|NCT01464827|156003945|FG011|Overall Study|Lost to Follow-up|1|||
48494257|NCT01464827|156003946|FG012|Overall Study|Lost to Follow-up|0|||
48494258|NCT01464827|156003947|FG013|Overall Study|Lost to Follow-up|1|||
48494259|NCT01464827|156003934|FG000|Overall Study|Other|2|||
48494260|NCT01464827|156003935|FG001|Overall Study|Other|3|||
48494261|NCT01464827|156003936|FG002|Overall Study|Other|0|||
48494262|NCT01464827|156003937|FG003|Overall Study|Other|2|||
48494263|NCT01464827|156003938|FG004|Overall Study|Other|3|||
48494264|NCT01464827|156003939|FG005|Overall Study|Other|0|||
48494265|NCT01464827|156003940|FG006|Overall Study|Other|1|||
48494266|NCT01464827|156003941|FG007|Overall Study|Other|0|||
48494267|NCT01464827|156003942|FG008|Overall Study|Other|3|||
48494268|NCT01464827|156003943|FG009|Overall Study|Other|1|||
48494269|NCT01464827|156003944|FG010|Overall Study|Other|2|||
48494270|NCT01464827|156003945|FG011|Overall Study|Other|0|||
48494271|NCT01464827|156003946|FG012|Overall Study|Other|1|||
48494272|NCT01464827|156003947|FG013|Overall Study|Other|0|||
48494273|NCT01464827|156003934|FG000|Overall Study|Not Treated|0|||
48494274|NCT01464827|156003935|FG001|Overall Study|Not Treated|2|||
48494275|NCT01464827|156003936|FG002|Overall Study|Not Treated|0|||
48494276|NCT01464827|156003937|FG003|Overall Study|Not Treated|0|||
48494277|NCT01464827|156003938|FG004|Overall Study|Not Treated|1|||
48494278|NCT01464827|156003939|FG005|Overall Study|Not Treated|0|||
48494279|NCT01464827|156003940|FG006|Overall Study|Not Treated|1|||
48494280|NCT01464827|156003941|FG007|Overall Study|Not Treated|0|||
48494281|NCT01464827|156003942|FG008|Overall Study|Not Treated|0|||
48494282|NCT01464827|156003943|FG009|Overall Study|Not Treated|2|||
48494283|NCT01464827|156003944|FG010|Overall Study|Not Treated|0|||
48494284|NCT01464827|156003945|FG011|Overall Study|Not Treated|1|||
48494285|NCT01464827|156003946|FG012|Overall Study|Not Treated|0|||
48494286|NCT01464827|156003947|FG013|Overall Study|Not Treated|2|||
48494287|NCT04272775|156003949|FG000|Overall Study|Study Terminated by Sponsor|1|||
48494288|NCT04272775|156003950|FG001|Overall Study|Study Terminated by Sponsor|0|||
48494289|NCT04272775|156003949|FG000|Overall Study|Protocol Violation|0|||
48494290|NCT04272775|156003950|FG001|Overall Study|Protocol Violation|1|||
48494291|NCT04272775|156003949|FG000|Overall Study|Symptomatic Deterioration|1|||
48494292|NCT04272775|156003950|FG001|Overall Study|Symptomatic Deterioration|1|||
48494293|NCT04272775|156003949|FG000|Overall Study|Withdrawal by Subject|1|||
48494294|NCT04272775|156003950|FG001|Overall Study|Withdrawal by Subject|2|||
48494295|NCT04272775|156003949|FG000|Overall Study|Adverse Event|1|||
48494296|NCT04272775|156003950|FG001|Overall Study|Adverse Event|2|||
48494297|NCT04272775|156003949|FG000|Overall Study|Progressive Disease|3|||
48494298|NCT04272775|156003950|FG001|Overall Study|Progressive Disease|1|||
48494299|NCT00249821|156003959|FG000|Overall Study|Technical problem|0|||
48494300|NCT00249821|156003960|FG001|Overall Study|Technical problem|1|||
48494301|NCT03222141|156003967|FG000|Overall Study|Death|15|||
48494302|NCT03222141|156003967|FG000|Overall Study|Lost to Follow-up|3|||
48494303|NCT03532009|156003968|FG000|Overall Study|Other|1|||
48494304|NCT03532009|156003969|FG001|Overall Study|Other|1|||
48494305|NCT03532009|156003968|FG000|Overall Study|Death|1|||
48494306|NCT03532009|156003969|FG001|Overall Study|Death|1|||
48494307|NCT03532009|156003968|FG000|Overall Study|Withdrawal by Patient|0|||
48494308|NCT03532009|156003969|FG001|Overall Study|Withdrawal by Patient|2|||
48494309|NCT02737306|156003974|FG000|Overall Study|Adverse Event|3|||
48494310|NCT02737306|156003975|FG001|Overall Study|Adverse Event|0|||
48494311|NCT02737306|156003974|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
48494312|NCT02737306|156003975|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
48494313|NCT01966042|156003978|FG000|Overall Study|Death|2|||
48494314|NCT00625807|156003979|FG000|Overall Study|schedule conflict|2|||
48494315|NCT00625807|156003980|FG001|Overall Study|schedule conflict|8|||
48494316|NCT03361423|156003983|FG000|Overall Study|Withdrawal by Subject|4|||
48494317|NCT03361423|156003984|FG001|Overall Study|Withdrawal by Subject|3|||
48494318|NCT03361423|156003983|FG000|Overall Study|Did not treat|19|||
48494319|NCT03361423|156003984|FG001|Overall Study|Did not treat|18|||
48494320|NCT03361423|156003983|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
48494321|NCT03361423|156003984|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
48494322|NCT03361423|156003983|FG000|Overall Study|Missing data|4|||
48494323|NCT03361423|156003984|FG001|Overall Study|Missing data|1|||
48494324|NCT03267264|156003985|FG000|Overall Study|Withdrawal by Subject|1|||
48494325|NCT03267264|156003986|FG001|Overall Study|Withdrawal by Subject|0|||
48494326|NCT03267264|156003987|FG002|Overall Study|Withdrawal by Subject|2|||
48494327|NCT03267264|156003988|FG003|Overall Study|Withdrawal by Subject|4|||
48597897|NCT03498313|156385171|FG003|Experimental Period 1|Withdrawal by Subject|0|||
48597898|NCT03498313|156385172|FG004|Experimental Period 1|Withdrawal by Subject|0|||
48597899|NCT03498313|156385173|FG005|Experimental Period 1|Withdrawal by Subject|0|||
48597900|NCT03498313|156385168|FG000|Washout Period 1|Anovulation|1|||
48597901|NCT03498313|156385169|FG001|Washout Period 1|Anovulation|0|||
48597902|NCT03498313|156385170|FG002|Washout Period 1|Anovulation|0|||
48597903|NCT03498313|156385171|FG003|Washout Period 1|Anovulation|0|||
48597904|NCT03498313|156385172|FG004|Washout Period 1|Anovulation|0|||
48597905|NCT03498313|156385173|FG005|Washout Period 1|Anovulation|0|||
48597906|NCT03498313|156385168|FG000|Washout Period 1|Withdrawal by Subject|0|||
48713481|NCT02059291|156801400|FG000|Epoch 3|Physician Decision|0|||
48713482|NCT02059291|156801401|FG001|Epoch 3|Physician Decision|0|||
48713483|NCT02059291|156801402|FG002|Epoch 3|Physician Decision|0|||
48713484|NCT02059291|156801403|FG003|Epoch 3|Physician Decision|0|||
48713485|NCT02059291|156801404|FG004|Epoch 3|Physician Decision|0|||
48713486|NCT02059291|156801405|FG005|Epoch 3|Physician Decision|0|||
48713487|NCT02059291|156801406|FG006|Epoch 3|Physician Decision|0|||
48713488|NCT02059291|156801407|FG007|Epoch 3|Physician Decision|0|||
48494328|NCT02315898|156003989|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
48494329|NCT02315898|156003990|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
48494330|NCT02315898|156003991|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
48494331|NCT02315898|156003992|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
48494332|NCT04543136|156003993|FG000|Overall Study|Withdrawal by Subject|0|||
48494333|NCT04543136|156003994|FG001|Overall Study|Withdrawal by Subject|1|||
48494334|NCT04543136|156003995|FG002|Overall Study|Withdrawal by Subject|0|||
48494335|NCT04543136|156003996|FG003|Overall Study|Withdrawal by Subject|1|||
48494336|NCT04543136|156003997|FG004|Overall Study|Withdrawal by Subject|0|||
48494337|NCT04543136|156003998|FG005|Overall Study|Withdrawal by Subject|0|||
48494338|NCT00617461|156003999|FG000|First Treatment Intervention Period|Adverse Event|2|||
48494339|NCT00617461|156004000|FG001|First Treatment Intervention Period|Adverse Event|0|||
48494340|NCT00617461|156003999|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
48494341|NCT00617461|156004000|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
48597907|NCT03498313|156385169|FG001|Washout Period 1|Withdrawal by Subject|3|||
48597908|NCT03498313|156385170|FG002|Washout Period 1|Withdrawal by Subject|0|||
48597909|NCT03498313|156385171|FG003|Washout Period 1|Withdrawal by Subject|1|||
48713489|NCT02059291|156801408|FG008|Epoch 3|Physician Decision|0|||
48713490|NCT02059291|156801409|FG009|Epoch 3|Physician Decision|0|||
48713491|NCT02059291|156801410|FG010|Epoch 3|Physician Decision|0|||
48713492|NCT02059291|156801411|FG011|Epoch 3|Physician Decision|0|||
48713493|NCT02059291|156801412|FG012|Epoch 3|Physician Decision|0|||
48713494|NCT02059291|156801413|FG013|Epoch 3|Physician Decision|1|||
48713495|NCT02059291|156801414|FG014|Epoch 3|Physician Decision|0|||
48713496|NCT02059291|156801415|FG015|Epoch 3|Physician Decision|1|||
48713497|NCT02059291|156801416|FG016|Epoch 3|Physician Decision|0|||
48713498|NCT02059291|156801417|FG017|Epoch 3|Physician Decision|0|||
48713499|NCT02059291|156801418|FG018|Epoch 3|Physician Decision|0|||
48713500|NCT02059291|156801419|FG019|Epoch 3|Physician Decision|0|||
48713501|NCT02059291|156801420|FG020|Epoch 3|Physician Decision|0|||
48713502|NCT02059291|156801421|FG021|Epoch 3|Physician Decision|0|||
48713503|NCT02059291|156801422|FG022|Epoch 3|Physician Decision|0|||
48713504|NCT02059291|156801423|FG023|Epoch 3|Physician Decision|0|||
48713505|NCT02059291|156801424|FG024|Epoch 3|Physician Decision|0|||
48713506|NCT02059291|156801400|FG000|Epoch 3|Adverse Event|0|||
48713507|NCT02059291|156801401|FG001|Epoch 3|Adverse Event|0|||
48713508|NCT02059291|156801402|FG002|Epoch 3|Adverse Event|0|||
48713509|NCT02059291|156801403|FG003|Epoch 3|Adverse Event|0|||
48713510|NCT02059291|156801404|FG004|Epoch 3|Adverse Event|0|||
48713511|NCT02059291|156801405|FG005|Epoch 3|Adverse Event|0|||
48713512|NCT02059291|156801406|FG006|Epoch 3|Adverse Event|0|||
48713513|NCT02059291|156801407|FG007|Epoch 3|Adverse Event|0|||
48713514|NCT02059291|156801408|FG008|Epoch 3|Adverse Event|0|||
48713515|NCT02059291|156801409|FG009|Epoch 3|Adverse Event|0|||
48713516|NCT02059291|156801410|FG010|Epoch 3|Adverse Event|0|||
48713517|NCT02059291|156801411|FG011|Epoch 3|Adverse Event|0|||
48713518|NCT02059291|156801412|FG012|Epoch 3|Adverse Event|0|||
48713519|NCT02059291|156801413|FG013|Epoch 3|Adverse Event|0|||
48713520|NCT02059291|156801414|FG014|Epoch 3|Adverse Event|0|||
48435684|NCT00987623|155783738|FG000|Overall Study|Influenza|0|||
48435685|NCT00987623|155783739|FG001|Overall Study|Influenza|1|||
48435686|NCT00668200|155783740|FG000|Overall Study|Withdrawal by Subject|2|||
48435687|NCT00668200|155783740|FG000|Overall Study|Lost to Follow-up|1|||
48435688|NCT03806179|155783741|FG000|Overall Study|Progressive disease|0|||
48435689|NCT03806179|155783742|FG001|Overall Study|Progressive disease|2|||
48435690|NCT01603641|155783743|FG000|Overall Study|Did not Receive Treatment|3|||
48435691|NCT01603641|155783743|FG000|Overall Study|Adverse Event|1|||
48435692|NCT01603641|155783743|FG000|Overall Study|Lack of Efficacy|1|||
48435693|NCT01603641|155783743|FG000|Overall Study|Lost to Follow-up|6|||
48435694|NCT01603641|155783743|FG000|Overall Study|Personal Reasons|18|||
48435695|NCT01603641|155783743|FG000|Overall Study|Other Miscellaneous Reasons|6|||
48435696|NCT01151579|155783746|FG000|Overall Study|Physician Decision|3|||
48435697|NCT01151579|155783747|FG001|Overall Study|Physician Decision|1|||
48435698|NCT01151579|155783746|FG000|Overall Study|Withdrawal by Subject|3|||
48435699|NCT01151579|155783747|FG001|Overall Study|Withdrawal by Subject|2|||
48435700|NCT01151579|155783746|FG000|Overall Study|Not meet inclusion criteria|6|||
48435701|NCT01151579|155783747|FG001|Overall Study|Not meet inclusion criteria|4|||
48435702|NCT01276457|155783748|FG000|Core Study|Adverse Event|6|||
48435703|NCT01276457|155783749|FG001|Core Study|Adverse Event|3|||
48435704|NCT01276457|155783748|FG000|Core Study|Lost to Follow-up|1|||
48435705|NCT01276457|155783749|FG001|Core Study|Lost to Follow-up|2|||
48435706|NCT01276457|155783748|FG000|Core Study|Administrative problems|1|||
48435707|NCT01276457|155783749|FG001|Core Study|Administrative problems|1|||
48435708|NCT01276457|155783748|FG000|Core Study|Death|2|||
48435709|NCT01276457|155783749|FG001|Core Study|Death|2|||
48435710|NCT01276457|155783748|FG000|Core Study|Lack of Efficacy|3|||
48435711|NCT01276457|155783749|FG001|Core Study|Lack of Efficacy|12|||
48435712|NCT01276457|155783748|FG000|Extension Study|Lost to Follow-up|3|||
48435713|NCT01276457|155783749|FG001|Extension Study|Lost to Follow-up|0|||
48435714|NCT01276457|155783748|FG000|Extension Study|Death|0|||
48435715|NCT01276457|155783749|FG001|Extension Study|Death|1|||
48435716|NCT01276457|155783748|FG000|Extension Study|Lack of Efficacy|3|||
48435717|NCT01276457|155783749|FG001|Extension Study|Lack of Efficacy|1|||
48435718|NCT01952730|155783752|FG000|Overall Study|FDA shut down core lab used by study|1|||
48435719|NCT00608530|155783753|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
48435720|NCT00608530|155783754|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
48435721|NCT00608530|155783755|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
48435722|NCT00608530|155783756|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
48435723|NCT00608530|155783753|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
48435724|NCT00608530|155783754|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
48435725|NCT00608530|155783755|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
48435726|NCT00608530|155783756|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
48435727|NCT00608530|155783753|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
48435728|NCT00608530|155783754|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
48435729|NCT00608530|155783755|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
48435730|NCT00608530|155783756|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
48435731|NCT00608530|155783753|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
48435732|NCT00608530|155783754|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
48435733|NCT00608530|155783755|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
48435734|NCT00608530|155783756|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
48435735|NCT00608530|155783753|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
48435736|NCT00608530|155783754|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
48435737|NCT00608530|155783755|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
48597910|NCT03498313|156385172|FG004|Washout Period 1|Withdrawal by Subject|0|||
48597911|NCT03498313|156385173|FG005|Washout Period 1|Withdrawal by Subject|1|||
48597912|NCT03498313|156385168|FG000|Experimental Period 2|Adverse Event|0|||
48597913|NCT03498313|156385169|FG001|Experimental Period 2|Adverse Event|0|||
48597914|NCT03498313|156385170|FG002|Experimental Period 2|Adverse Event|0|||
48597915|NCT03498313|156385171|FG003|Experimental Period 2|Adverse Event|0|||
48597916|NCT03498313|156385172|FG004|Experimental Period 2|Adverse Event|1|||
48597917|NCT03498313|156385173|FG005|Experimental Period 2|Adverse Event|2|||
48713521|NCT02059291|156801415|FG015|Epoch 3|Adverse Event|1|||
48713522|NCT02059291|156801416|FG016|Epoch 3|Adverse Event|0|||
48713523|NCT02059291|156801417|FG017|Epoch 3|Adverse Event|0|||
48713524|NCT02059291|156801418|FG018|Epoch 3|Adverse Event|0|||
48713525|NCT02059291|156801419|FG019|Epoch 3|Adverse Event|0|||
48713526|NCT02059291|156801420|FG020|Epoch 3|Adverse Event|0|||
48713527|NCT02059291|156801421|FG021|Epoch 3|Adverse Event|0|||
48494342|NCT00617461|156003999|FG000|First Treatment Intervention Period|Protocol Violation|2|||
48494343|NCT00617461|156004000|FG001|First Treatment Intervention Period|Protocol Violation|1|||
48494344|NCT00617461|156003999|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
48494345|NCT00617461|156004000|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
48494346|NCT00617461|156003999|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
48494347|NCT00617461|156004000|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
48494348|NCT00617461|156003999|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
48494349|NCT00617461|156004000|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
48494350|NCT00617461|156003999|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
48494351|NCT00617461|156004000|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
48494352|NCT00617461|156003999|FG000|Second Treatment Intervention Period|Adverse Event|0|||
48494353|NCT00617461|156004000|FG001|Second Treatment Intervention Period|Adverse Event|1|||
48494354|NCT00617461|156003999|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
48494355|NCT00617461|156004000|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
48494356|NCT00617461|156003999|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
48494357|NCT00617461|156004000|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
48494358|NCT00617461|156003999|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
48494359|NCT00617461|156004000|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
48494360|NCT00198029|156004003|FG000|Overall Study|Withdrawal by Subject|4|||
48494361|NCT00358826|156004004|FG000|Core Study|Adverse Event|1|||
48494362|NCT00358826|156004005|FG001|Core Study|Adverse Event|3|||
48494363|NCT00358826|156004006|FG002|Core Study|Adverse Event|1|||
48494364|NCT00358826|156004007|FG003|Core Study|Adverse Event|1|||
48494365|NCT00358826|156004008|FG004|Core Study|Adverse Event|0|||
48494366|NCT00358826|156004009|FG005|Core Study|Adverse Event|0|||
48494367|NCT00358826|156004010|FG006|Core Study|Adverse Event|0|||
48494368|NCT00358826|156004011|FG007|Core Study|Adverse Event|0|||
48494369|NCT00358826|156004004|FG000|Core Study|Withdrawal by Subject|2|||
48494370|NCT00358826|156004005|FG001|Core Study|Withdrawal by Subject|2|||
48494371|NCT00358826|156004006|FG002|Core Study|Withdrawal by Subject|0|||
48494372|NCT00358826|156004007|FG003|Core Study|Withdrawal by Subject|0|||
48494373|NCT00358826|156004008|FG004|Core Study|Withdrawal by Subject|0|||
48494374|NCT00358826|156004009|FG005|Core Study|Withdrawal by Subject|0|||
48494375|NCT00358826|156004010|FG006|Core Study|Withdrawal by Subject|0|||
48494376|NCT00358826|156004011|FG007|Core Study|Withdrawal by Subject|0|||
48494377|NCT00358826|156004004|FG000|Core Study|Lost to Follow-up|0|||
48494378|NCT00358826|156004005|FG001|Core Study|Lost to Follow-up|0|||
48494379|NCT00358826|156004006|FG002|Core Study|Lost to Follow-up|0|||
48494380|NCT00358826|156004007|FG003|Core Study|Lost to Follow-up|1|||
48494381|NCT00358826|156004008|FG004|Core Study|Lost to Follow-up|0|||
48494382|NCT00358826|156004009|FG005|Core Study|Lost to Follow-up|0|||
48494383|NCT00358826|156004010|FG006|Core Study|Lost to Follow-up|0|||
48494384|NCT00358826|156004011|FG007|Core Study|Lost to Follow-up|0|||
48494385|NCT00358826|156004004|FG000|Core Study|Physician Decision|0|||
48494386|NCT00358826|156004005|FG001|Core Study|Physician Decision|0|||
48494387|NCT00358826|156004006|FG002|Core Study|Physician Decision|1|||
48494388|NCT00358826|156004007|FG003|Core Study|Physician Decision|0|||
48494389|NCT00358826|156004008|FG004|Core Study|Physician Decision|0|||
48494390|NCT00358826|156004009|FG005|Core Study|Physician Decision|0|||
48494391|NCT00358826|156004010|FG006|Core Study|Physician Decision|0|||
48494392|NCT00358826|156004011|FG007|Core Study|Physician Decision|0|||
48494393|NCT00358826|156004004|FG000|MDCT Substudy|Adverse Event|0|||
48494394|NCT00358826|156004005|FG001|MDCT Substudy|Adverse Event|0|||
48713528|NCT02059291|156801422|FG022|Epoch 3|Adverse Event|0|||
48494395|NCT00358826|156004006|FG002|MDCT Substudy|Adverse Event|0|||
48494396|NCT00358826|156004007|FG003|MDCT Substudy|Adverse Event|0|||
48494397|NCT00358826|156004008|FG004|MDCT Substudy|Adverse Event|1|||
48494398|NCT00358826|156004009|FG005|MDCT Substudy|Adverse Event|0|||
48713529|NCT02059291|156801423|FG023|Epoch 3|Adverse Event|0|||
48713530|NCT02059291|156801424|FG024|Epoch 3|Adverse Event|0|||
48713531|NCT02059291|156801400|FG000|Epoch 3|Lack of Efficacy|0|||
48713532|NCT02059291|156801401|FG001|Epoch 3|Lack of Efficacy|0|||
48713533|NCT02059291|156801402|FG002|Epoch 3|Lack of Efficacy|0|||
48713534|NCT02059291|156801403|FG003|Epoch 3|Lack of Efficacy|0|||
48713535|NCT02059291|156801404|FG004|Epoch 3|Lack of Efficacy|0|||
48713536|NCT02059291|156801405|FG005|Epoch 3|Lack of Efficacy|0|||
48713537|NCT02059291|156801406|FG006|Epoch 3|Lack of Efficacy|0|||
48713538|NCT02059291|156801407|FG007|Epoch 3|Lack of Efficacy|0|||
48713539|NCT02059291|156801408|FG008|Epoch 3|Lack of Efficacy|0|||
48713540|NCT02059291|156801409|FG009|Epoch 3|Lack of Efficacy|0|||
48713541|NCT02059291|156801410|FG010|Epoch 3|Lack of Efficacy|0|||
48713542|NCT02059291|156801411|FG011|Epoch 3|Lack of Efficacy|0|||
48713543|NCT02059291|156801412|FG012|Epoch 3|Lack of Efficacy|0|||
48713544|NCT02059291|156801413|FG013|Epoch 3|Lack of Efficacy|0|||
48713545|NCT02059291|156801414|FG014|Epoch 3|Lack of Efficacy|0|||
48713546|NCT02059291|156801415|FG015|Epoch 3|Lack of Efficacy|3|||
48812218|NCT02960763|157153521|FG002|Step 1|Other|1|||
48812219|NCT02960763|157153522|FG003|Step 1|Other|0|||
48812220|NCT02960763|157153523|FG004|Step 1|Other|0|||
48812221|NCT02960763|157153519|FG000|Step 2|Withdrawal by Subject|0|||
48812222|NCT02960763|157153520|FG001|Step 2|Withdrawal by Subject|0|||
48812223|NCT02960763|157153521|FG002|Step 2|Withdrawal by Subject|0|||
48812224|NCT02960763|157153522|FG003|Step 2|Withdrawal by Subject|7|||
48812225|NCT02960763|157153523|FG004|Step 2|Withdrawal by Subject|3|||
48812226|NCT02960763|157153519|FG000|Step 2|Lost to Follow-up|0|||
48812227|NCT02960763|157153520|FG001|Step 2|Lost to Follow-up|0|||
48812228|NCT02960763|157153521|FG002|Step 2|Lost to Follow-up|0|||
48812229|NCT02960763|157153522|FG003|Step 2|Lost to Follow-up|4|||
48812230|NCT02960763|157153523|FG004|Step 2|Lost to Follow-up|1|||
48812231|NCT02960763|157153519|FG000|Step 2|Investigator discretion|0|||
48812232|NCT02960763|157153520|FG001|Step 2|Investigator discretion|0|||
48812233|NCT02960763|157153521|FG002|Step 2|Investigator discretion|0|||
48812234|NCT02960763|157153522|FG003|Step 2|Investigator discretion|0|||
48812235|NCT02960763|157153523|FG004|Step 2|Investigator discretion|1|||
48812236|NCT00674323|157153524|FG000|Overall Study|Adverse Event|0|||
48812237|NCT00674323|157153525|FG001|Overall Study|Adverse Event|1|||
48812238|NCT00674323|157153526|FG002|Overall Study|Adverse Event|0|||
48812239|NCT00674323|157153524|FG000|Overall Study|Protocol Violation|1|||
48812240|NCT00674323|157153525|FG001|Overall Study|Protocol Violation|0|||
48812241|NCT00674323|157153526|FG002|Overall Study|Protocol Violation|0|||
48812242|NCT01868035|157153527|FG000|Overall Study|Lost to Follow-up|3|||
48812243|NCT01868035|157153527|FG000|Overall Study|Withdrawal by Subject|1|||
48812244|NCT01868035|157153527|FG000|Overall Study|Progressive Disease|2|||
48812245|NCT01868035|157153527|FG000|Overall Study|Non-compliance|1|||
48812246|NCT02318719|157153528|FG000|Double-blind Phase|Adverse Event|7|||
48812247|NCT02318719|157153529|FG001|Double-blind Phase|Adverse Event|6|||
48812248|NCT02318719|157153530|FG002|Double-blind Phase|Adverse Event|12|||
48812249|NCT02318719|157153531|FG003|Double-blind Phase|Adverse Event|4|||
48812250|NCT02318719|157153532|FG004|Double-blind Phase|Adverse Event|0|||
48812251|NCT02318719|157153528|FG000|Double-blind Phase|Lack of Efficacy|5|||
48812252|NCT02318719|157153529|FG001|Double-blind Phase|Lack of Efficacy|0|||
48812253|NCT02318719|157153530|FG002|Double-blind Phase|Lack of Efficacy|1|||
48812254|NCT02318719|157153531|FG003|Double-blind Phase|Lack of Efficacy|1|||
48812255|NCT02318719|157153532|FG004|Double-blind Phase|Lack of Efficacy|0|||
48494399|NCT00358826|156004010|FG006|MDCT Substudy|Adverse Event|0|||
48494400|NCT00358826|156004011|FG007|MDCT Substudy|Adverse Event|0|||
48494401|NCT00358826|156004004|FG000|MDCT Substudy|Lost to Follow-up|0|||
48494402|NCT00358826|156004005|FG001|MDCT Substudy|Lost to Follow-up|0|||
48494403|NCT00358826|156004006|FG002|MDCT Substudy|Lost to Follow-up|0|||
48494404|NCT00358826|156004007|FG003|MDCT Substudy|Lost to Follow-up|0|||
48494405|NCT00358826|156004008|FG004|MDCT Substudy|Lost to Follow-up|0|||
48494406|NCT00358826|156004009|FG005|MDCT Substudy|Lost to Follow-up|1|||
48713547|NCT02059291|156801416|FG016|Epoch 3|Lack of Efficacy|0|||
48713548|NCT02059291|156801417|FG017|Epoch 3|Lack of Efficacy|0|||
48713549|NCT02059291|156801418|FG018|Epoch 3|Lack of Efficacy|0|||
48713550|NCT02059291|156801419|FG019|Epoch 3|Lack of Efficacy|0|||
48713551|NCT02059291|156801420|FG020|Epoch 3|Lack of Efficacy|0|||
48713552|NCT02059291|156801421|FG021|Epoch 3|Lack of Efficacy|0|||
48713553|NCT02059291|156801422|FG022|Epoch 3|Lack of Efficacy|0|||
48713554|NCT02059291|156801423|FG023|Epoch 3|Lack of Efficacy|0|||
48812256|NCT02318719|157153528|FG000|Double-blind Phase|Protocol Violation|0|||
48812257|NCT02318719|157153529|FG001|Double-blind Phase|Protocol Violation|1|||
48812258|NCT02318719|157153530|FG002|Double-blind Phase|Protocol Violation|3|||
48812259|NCT02318719|157153531|FG003|Double-blind Phase|Protocol Violation|0|||
48812260|NCT02318719|157153532|FG004|Double-blind Phase|Protocol Violation|0|||
48812261|NCT02318719|157153528|FG000|Double-blind Phase|Withdrawal by Subject|25|||
48812262|NCT02318719|157153529|FG001|Double-blind Phase|Withdrawal by Subject|7|||
48812263|NCT02318719|157153530|FG002|Double-blind Phase|Withdrawal by Subject|9|||
48812264|NCT02318719|157153531|FG003|Double-blind Phase|Withdrawal by Subject|10|||
48812265|NCT02318719|157153532|FG004|Double-blind Phase|Withdrawal by Subject|0|||
48812266|NCT02318719|157153528|FG000|Double-blind Phase|Other|1|||
48812267|NCT02318719|157153529|FG001|Double-blind Phase|Other|2|||
48812268|NCT02318719|157153530|FG002|Double-blind Phase|Other|0|||
48812269|NCT02318719|157153531|FG003|Double-blind Phase|Other|0|||
48812270|NCT02318719|157153532|FG004|Double-blind Phase|Other|0|||
48812271|NCT02318719|157153528|FG000|Open-label Extension Phase|Adverse Event|0|||
48812272|NCT02318719|157153529|FG001|Open-label Extension Phase|Adverse Event|0|||
48812273|NCT02318719|157153530|FG002|Open-label Extension Phase|Adverse Event|0|||
48812274|NCT02318719|157153531|FG003|Open-label Extension Phase|Adverse Event|0|||
48812275|NCT02318719|157153532|FG004|Open-label Extension Phase|Adverse Event|15|||
48812276|NCT02318719|157153528|FG000|Open-label Extension Phase|Death|0|||
48812277|NCT02318719|157153529|FG001|Open-label Extension Phase|Death|0|||
48812278|NCT02318719|157153530|FG002|Open-label Extension Phase|Death|0|||
48812279|NCT02318719|157153531|FG003|Open-label Extension Phase|Death|0|||
48812280|NCT02318719|157153532|FG004|Open-label Extension Phase|Death|1|||
48812281|NCT02318719|157153528|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
48812282|NCT02318719|157153529|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
48812283|NCT02318719|157153530|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
48812284|NCT02318719|157153531|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
48812285|NCT02318719|157153532|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
48812286|NCT02318719|157153528|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
48812287|NCT02318719|157153529|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
48812288|NCT02318719|157153530|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
48812289|NCT02318719|157153531|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
48812290|NCT02318719|157153532|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
48812291|NCT02318719|157153528|FG000|Open-label Extension Phase|Other|0|||
48812292|NCT02318719|157153529|FG001|Open-label Extension Phase|Other|0|||
48812293|NCT02318719|157153530|FG002|Open-label Extension Phase|Other|0|||
48812294|NCT02318719|157153531|FG003|Open-label Extension Phase|Other|0|||
48812295|NCT02318719|157153532|FG004|Open-label Extension Phase|Other|7|||
48812296|NCT03249376|157153542|FG000|Overall Study|Adverse Event|11|||
48812297|NCT03249376|157153543|FG001|Overall Study|Adverse Event|5|||
48812298|NCT03249376|157153542|FG000|Overall Study|Lack of Efficacy|2|||
48812299|NCT03249376|157153543|FG001|Overall Study|Lack of Efficacy|4|||
48812300|NCT03249376|157153542|FG000|Overall Study|Protocol Violation|3|||
48812301|NCT03249376|157153543|FG001|Overall Study|Protocol Violation|2|||
48812302|NCT03249376|157153542|FG000|Overall Study|Physician Decision|0|||
48812303|NCT03249376|157153543|FG001|Overall Study|Physician Decision|2|||
48812304|NCT03249376|157153542|FG000|Overall Study|Withdrawal by Subject|3|||
48812305|NCT03249376|157153543|FG001|Overall Study|Withdrawal by Subject|9|||
48812306|NCT03249376|157153542|FG000|Overall Study|LTFU|2|||
48812307|NCT03249376|157153543|FG001|Overall Study|LTFU|1|||
48812308|NCT01827254|157153545|FG000|Overall Study|Death|10|||
48812309|NCT01827254|157153545|FG000|Overall Study|Case report form not completed|4|||
48494407|NCT00358826|156004010|FG006|MDCT Substudy|Lost to Follow-up|0|||
48494408|NCT00358826|156004011|FG007|MDCT Substudy|Lost to Follow-up|0|||
48494409|NCT00358826|156004004|FG000|MDCT Substudy|Withdrawal by Subject|0|||
48494410|NCT00358826|156004005|FG001|MDCT Substudy|Withdrawal by Subject|0|||
48494411|NCT00358826|156004006|FG002|MDCT Substudy|Withdrawal by Subject|0|||
48494412|NCT00358826|156004007|FG003|MDCT Substudy|Withdrawal by Subject|0|||
48494413|NCT00358826|156004008|FG004|MDCT Substudy|Withdrawal by Subject|0|||
48494414|NCT00358826|156004009|FG005|MDCT Substudy|Withdrawal by Subject|1|||
48494415|NCT00358826|156004010|FG006|MDCT Substudy|Withdrawal by Subject|0|||
48494416|NCT00358826|156004011|FG007|MDCT Substudy|Withdrawal by Subject|0|||
48494417|NCT04117607|156004012|FG000|Overall Study|Early Termination|0|||
48494418|NCT04117607|156004013|FG001|Overall Study|Early Termination|1|||
48494419|NCT04117607|156004014|FG002|Overall Study|Early Termination|0|||
48494420|NCT04117607|156004015|FG003|Overall Study|Early Termination|0|||
48494421|NCT04117607|156004016|FG004|Overall Study|Early Termination|0|||
48494422|NCT04117607|156004017|FG005|Overall Study|Early Termination|0|||
48494423|NCT04117607|156004018|FG006|Overall Study|Early Termination|1|||
48494424|NCT04117607|156004019|FG007|Overall Study|Early Termination|0|||
48494425|NCT04117607|156004020|FG008|Overall Study|Early Termination|0|||
48812310|NCT01827254|157153545|FG000|Overall Study|Invalidated centre|3|||
48812311|NCT01827254|157153545|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
48812312|NCT01827254|157153545|FG000|Overall Study|Did not complete re-challenge|1|||
48812313|NCT01827254|157153545|FG000|Overall Study|Disease progression|36|||
48812314|NCT01827254|157153545|FG000|Overall Study|Intolerance to treatment|4|||
48812315|NCT01512745|157153550|FG000|Overall Study|Adverse Event|22|||
48812316|NCT01512745|157153551|FG001|Overall Study|Adverse Event|3|||
48812317|NCT01512745|157153550|FG000|Overall Study|Death|9|||
48812318|NCT01512745|157153551|FG001|Overall Study|Death|13|||
48812319|NCT01512745|157153550|FG000|Overall Study|Withdrawal by Subject|2|||
48812320|NCT01512745|157153551|FG001|Overall Study|Withdrawal by Subject|2|||
48812321|NCT01512745|157153550|FG000|Overall Study|Lost to Follow-up|4|||
48494426|NCT04117607|156004021|FG009|Overall Study|Early Termination|0|||
48494427|NCT04117607|156004022|FG010|Overall Study|Early Termination|0|||
48494428|NCT04117607|156004023|FG011|Overall Study|Early Termination|0|||
48494429|NCT04117607|156004024|FG012|Overall Study|Early Termination|0|||
48494430|NCT04117607|156004025|FG013|Overall Study|Early Termination|0|||
48494431|NCT02427607|156004031|FG000|Overall Study|Withdrawal by Subject|1|||
48494432|NCT01485536|156004034|FG000|Overall Study|Withdrawal by Subject|3|||
48494433|NCT01485536|156004034|FG000|Overall Study|Adverse Event|1|||
48494434|NCT05200858|156004035|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
48494435|NCT05200858|156004036|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
48494436|NCT05200858|156004037|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
48494437|NCT05200858|156004038|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
48494438|NCT00264810|156004041|FG000|Baseline|Withdrawal by Subject|10|||
48494439|NCT00264810|156004042|FG001|Baseline|Withdrawal by Subject|10|||
48494440|NCT00264810|156004041|FG000|Baseline|Physician Decision|7|||
48494441|NCT00264810|156004042|FG001|Baseline|Physician Decision|8|||
48494442|NCT00264810|156004041|FG000|Baseline|Subject Compliance Failure|3|||
48494443|NCT00264810|156004042|FG001|Baseline|Subject Compliance Failure|3|||
48494444|NCT00264810|156004041|FG000|Baseline|Insufficient Seizure Frequency|2|||
48494445|NCT00264810|156004042|FG001|Baseline|Insufficient Seizure Frequency|2|||
48494446|NCT00264810|156004041|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
48494447|NCT00264810|156004042|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
48494448|NCT00264810|156004041|FG000|Baseline|Other|0|||
48494449|NCT00264810|156004042|FG001|Baseline|Other|1|||
48494450|NCT00264810|156004041|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
48494451|NCT00264810|156004042|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
48494452|NCT00264810|156004041|FG000|Stimulation Optimization Period|Death|0|||
48494453|NCT00264810|156004042|FG001|Stimulation Optimization Period|Death|1|||
48494454|NCT00264810|156004041|FG000|Blinded Evaluation Period|Explant due to infection|1|||
48713555|NCT02059291|156801424|FG024|Epoch 3|Lack of Efficacy|0|||
48713556|NCT02059291|156801400|FG000|Epoch 3|Withdrawal by Subject|0|||
48713557|NCT02059291|156801401|FG001|Epoch 3|Withdrawal by Subject|0|||
48713558|NCT02059291|156801402|FG002|Epoch 3|Withdrawal by Subject|0|||
48713559|NCT02059291|156801403|FG003|Epoch 3|Withdrawal by Subject|0|||
48713560|NCT02059291|156801404|FG004|Epoch 3|Withdrawal by Subject|0|||
48713561|NCT02059291|156801405|FG005|Epoch 3|Withdrawal by Subject|0|||
48713562|NCT02059291|156801406|FG006|Epoch 3|Withdrawal by Subject|0|||
48713563|NCT02059291|156801407|FG007|Epoch 3|Withdrawal by Subject|0|||
48713564|NCT02059291|156801408|FG008|Epoch 3|Withdrawal by Subject|0|||
48713565|NCT02059291|156801409|FG009|Epoch 3|Withdrawal by Subject|0|||
48713566|NCT02059291|156801410|FG010|Epoch 3|Withdrawal by Subject|0|||
48713567|NCT02059291|156801411|FG011|Epoch 3|Withdrawal by Subject|0|||
48713568|NCT02059291|156801412|FG012|Epoch 3|Withdrawal by Subject|0|||
48713569|NCT02059291|156801413|FG013|Epoch 3|Withdrawal by Subject|0|||
48713570|NCT02059291|156801414|FG014|Epoch 3|Withdrawal by Subject|0|||
48713571|NCT02059291|156801415|FG015|Epoch 3|Withdrawal by Subject|1|||
48713572|NCT02059291|156801416|FG016|Epoch 3|Withdrawal by Subject|0|||
48713573|NCT02059291|156801417|FG017|Epoch 3|Withdrawal by Subject|0|||
48713574|NCT02059291|156801418|FG018|Epoch 3|Withdrawal by Subject|0|||
48713575|NCT02059291|156801419|FG019|Epoch 3|Withdrawal by Subject|0|||
48713576|NCT02059291|156801420|FG020|Epoch 3|Withdrawal by Subject|0|||
48713577|NCT02059291|156801421|FG021|Epoch 3|Withdrawal by Subject|0|||
48713578|NCT02059291|156801422|FG022|Epoch 3|Withdrawal by Subject|0|||
48713579|NCT02059291|156801423|FG023|Epoch 3|Withdrawal by Subject|0|||
48713580|NCT02059291|156801424|FG024|Epoch 3|Withdrawal by Subject|0|||
48713581|NCT02059291|156801400|FG000|Epoch 4|Adverse Event|0|||
48713582|NCT02059291|156801401|FG001|Epoch 4|Adverse Event|0|||
48713583|NCT02059291|156801402|FG002|Epoch 4|Adverse Event|0|||
48713584|NCT02059291|156801403|FG003|Epoch 4|Adverse Event|0|||
48713585|NCT02059291|156801404|FG004|Epoch 4|Adverse Event|0|||
48713586|NCT02059291|156801405|FG005|Epoch 4|Adverse Event|0|||
48713587|NCT02059291|156801406|FG006|Epoch 4|Adverse Event|0|||
48713588|NCT02059291|156801407|FG007|Epoch 4|Adverse Event|0|||
48713589|NCT02059291|156801408|FG008|Epoch 4|Adverse Event|0|||
48713590|NCT02059291|156801409|FG009|Epoch 4|Adverse Event|0|||
48713591|NCT02059291|156801410|FG010|Epoch 4|Adverse Event|0|||
48713592|NCT02059291|156801411|FG011|Epoch 4|Adverse Event|0|||
48713593|NCT02059291|156801412|FG012|Epoch 4|Adverse Event|0|||
48713594|NCT02059291|156801413|FG013|Epoch 4|Adverse Event|0|||
48713595|NCT02059291|156801414|FG014|Epoch 4|Adverse Event|0|||
48713596|NCT02059291|156801415|FG015|Epoch 4|Adverse Event|0|||
48713597|NCT02059291|156801416|FG016|Epoch 4|Adverse Event|1|||
48713598|NCT02059291|156801417|FG017|Epoch 4|Adverse Event|0|||
48713599|NCT02059291|156801418|FG018|Epoch 4|Adverse Event|0|||
48713600|NCT02059291|156801419|FG019|Epoch 4|Adverse Event|0|||
48713601|NCT02059291|156801420|FG020|Epoch 4|Adverse Event|0|||
48494455|NCT00264810|156004042|FG001|Blinded Evaluation Period|Explant due to infection|1|||
48713602|NCT02059291|156801421|FG021|Epoch 4|Adverse Event|0|||
48713603|NCT02059291|156801422|FG022|Epoch 4|Adverse Event|1|||
48713604|NCT02059291|156801423|FG023|Epoch 4|Adverse Event|0|||
48494456|NCT00264810|156004041|FG000|Open Label Evaluation Period|Explant due to infection|1|||
48494457|NCT00264810|156004042|FG001|Open Label Evaluation Period|Explant due to infection|1|||
48494458|NCT00264810|156004041|FG000|Open Label Evaluation Period|Death|3|||
48494459|NCT00264810|156004042|FG001|Open Label Evaluation Period|Death|2|||
48494460|NCT00264810|156004041|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
48494461|NCT00264810|156004042|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
48494462|NCT01347710|156004043|FG000|Overall Study|Withdrawal by Subject|2|||
48494463|NCT01347710|156004043|FG000|Overall Study|Adverse Event|4|||
48494464|NCT01347710|156004043|FG000|Overall Study|Angio or SPECT not completed|18|||
48494465|NCT01347710|156004043|FG000|Overall Study|issue with vitals prior to dosing|1|||
48494466|NCT01347710|156004043|FG000|Overall Study|Lost to Follow-up|1|||
48494467|NCT01347710|156004043|FG000|Overall Study|Physician Decision|2|||
48494468|NCT01347710|156004043|FG000|Overall Study|Other|3|||
48713605|NCT02059291|156801424|FG024|Epoch 4|Adverse Event|0|||
48494469|NCT03850509|156004044|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
48494470|NCT03850509|156004045|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
48494471|NCT00329602|156004046|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
48494472|NCT00329602|156004047|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
48494473|NCT00329602|156004048|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
48494474|NCT00329602|156004046|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
48494475|NCT00329602|156004047|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
48494476|NCT00329602|156004048|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
48494477|NCT00329602|156004046|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
48494478|NCT00329602|156004047|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
48494479|NCT00329602|156004048|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
48494480|NCT00329602|156004046|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
48494481|NCT00329602|156004047|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
48494482|NCT00329602|156004048|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
48494483|NCT00329602|156004046|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
48494484|NCT00329602|156004047|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
48494485|NCT00329602|156004048|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
48494486|NCT00329602|156004046|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
48494487|NCT00329602|156004047|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
48494488|NCT00329602|156004048|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
48494489|NCT01867242|156004053|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
48494490|NCT01867242|156004054|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
48494491|NCT01867242|156004055|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
48494492|NCT02275364|156004056|FG000|Period 1|Withdrawal by Subject|1|||
48494493|NCT02275364|156004057|FG001|Period 1|Withdrawal by Subject|0|||
48494494|NCT02275364|156004056|FG000|Period 1|Other reason|1|||
48494495|NCT02275364|156004057|FG001|Period 1|Other reason|0|||
48494496|NCT03504852|156004058|FG000|Overall Study|Withdrawal of informed consent|2|||
48494497|NCT03504852|156004059|FG001|Overall Study|Withdrawal of informed consent|1|||
48494498|NCT03504852|156004060|FG002|Overall Study|Withdrawal of informed consent|0|||
48494499|NCT03504852|156004058|FG000|Overall Study|Withdrawal by Subject|5|||
48494500|NCT03504852|156004059|FG001|Overall Study|Withdrawal by Subject|5|||
48494501|NCT03504852|156004060|FG002|Overall Study|Withdrawal by Subject|1|||
48494502|NCT03504852|156004058|FG000|Overall Study|Lost to Follow-up|4|||
48494503|NCT03504852|156004059|FG001|Overall Study|Lost to Follow-up|1|||
48494504|NCT03504852|156004060|FG002|Overall Study|Lost to Follow-up|0|||
48494505|NCT03504852|156004058|FG000|Overall Study|New therapy for study indication|1|||
48494506|NCT03504852|156004059|FG001|Overall Study|New therapy for study indication|0|||
48494507|NCT03504852|156004060|FG002|Overall Study|New therapy for study indication|0|||
48713606|NCT02059291|156801400|FG000|Epoch 4|Pregnancy|0|||
48713607|NCT02059291|156801401|FG001|Epoch 4|Pregnancy|0|||
48713608|NCT02059291|156801402|FG002|Epoch 4|Pregnancy|0|||
48713609|NCT02059291|156801403|FG003|Epoch 4|Pregnancy|0|||
48713610|NCT02059291|156801404|FG004|Epoch 4|Pregnancy|0|||
48713611|NCT02059291|156801405|FG005|Epoch 4|Pregnancy|0|||
48713612|NCT02059291|156801406|FG006|Epoch 4|Pregnancy|0|||
48713613|NCT02059291|156801407|FG007|Epoch 4|Pregnancy|0|||
48713614|NCT02059291|156801408|FG008|Epoch 4|Pregnancy|0|||
48713615|NCT02059291|156801409|FG009|Epoch 4|Pregnancy|0|||
48713616|NCT02059291|156801410|FG010|Epoch 4|Pregnancy|0|||
48713617|NCT02059291|156801411|FG011|Epoch 4|Pregnancy|0|||
48713618|NCT02059291|156801412|FG012|Epoch 4|Pregnancy|0|||
48713619|NCT02059291|156801413|FG013|Epoch 4|Pregnancy|0|||
48713620|NCT02059291|156801414|FG014|Epoch 4|Pregnancy|0|||
48494508|NCT03504852|156004058|FG000|Overall Study|Lack of Efficacy|1|||
48494509|NCT03504852|156004059|FG001|Overall Study|Lack of Efficacy|2|||
48713621|NCT02059291|156801415|FG015|Epoch 4|Pregnancy|0|||
48713622|NCT02059291|156801416|FG016|Epoch 4|Pregnancy|1|||
48713623|NCT02059291|156801417|FG017|Epoch 4|Pregnancy|0|||
48713624|NCT02059291|156801418|FG018|Epoch 4|Pregnancy|0|||
48713625|NCT02059291|156801419|FG019|Epoch 4|Pregnancy|0|||
48713626|NCT02059291|156801420|FG020|Epoch 4|Pregnancy|0|||
48494510|NCT03504852|156004060|FG002|Overall Study|Lack of Efficacy|0|||
48494511|NCT03504852|156004058|FG000|Overall Study|Death|0|||
48494512|NCT03504852|156004059|FG001|Overall Study|Death|1|||
48494513|NCT03504852|156004060|FG002|Overall Study|Death|0|||
48494514|NCT03504852|156004058|FG000|Overall Study|Adverse Event|4|||
48494515|NCT03504852|156004059|FG001|Overall Study|Adverse Event|8|||
48494516|NCT03504852|156004060|FG002|Overall Study|Adverse Event|2|||
48494517|NCT01066052|156004061|FG000|Overall Study|Enrolled But Not Treated|3|||
48494518|NCT01066052|156004062|FG001|Overall Study|Enrolled But Not Treated|0|||
48494519|NCT02220907|156004063|FG000|Overall Study|Adverse Event|7|||
48494520|NCT02220907|156004063|FG000|Overall Study|Physician Decision|1|||
48494521|NCT02220907|156004063|FG000|Overall Study|Withdrawal by Subject|2|||
48494522|NCT02220907|156004063|FG000|Overall Study|Conflict with the stopping criteria|1|||
48494523|NCT02729896|156004068|FG000|Overall Study|Death|0|||
48494524|NCT02729896|156004069|FG001|Overall Study|Death|2|||
48494525|NCT02729896|156004070|FG002|Overall Study|Death|13|||
48494526|NCT02729896|156004068|FG000|Overall Study|Lost to Follow-up|0|||
48494527|NCT02729896|156004069|FG001|Overall Study|Lost to Follow-up|2|||
48494528|NCT02729896|156004070|FG002|Overall Study|Lost to Follow-up|3|||
48494529|NCT02729896|156004068|FG000|Overall Study|Other|0|||
48494530|NCT02729896|156004069|FG001|Overall Study|Other|2|||
48494531|NCT02729896|156004070|FG002|Overall Study|Other|0|||
48494532|NCT02729896|156004068|FG000|Overall Study|Physician Decision|1|||
48494533|NCT02729896|156004069|FG001|Overall Study|Physician Decision|2|||
48494534|NCT02729896|156004070|FG002|Overall Study|Physician Decision|3|||
48494535|NCT02729896|156004068|FG000|Overall Study|Progressive Disease|0|||
48494536|NCT02729896|156004069|FG001|Overall Study|Progressive Disease|1|||
48494537|NCT02729896|156004070|FG002|Overall Study|Progressive Disease|0|||
48494538|NCT02729896|156004068|FG000|Overall Study|Withdrawal by Subject|1|||
48494539|NCT02729896|156004069|FG001|Overall Study|Withdrawal by Subject|0|||
48494540|NCT02729896|156004070|FG002|Overall Study|Withdrawal by Subject|3|||
48494541|NCT01046253|156004071|FG000|Second Intervention|Adverse Event|0|||
48494542|NCT01046253|156004072|FG001|Second Intervention|Adverse Event|1|||
48494543|NCT01046253|156004071|FG000|Second Intervention|Protocol Violation|0|||
48494544|NCT01046253|156004072|FG001|Second Intervention|Protocol Violation|1|||
48494545|NCT01058421|156004076|FG000|1 Month Outcomes|Death|10|||
48494546|NCT01058421|156004077|FG001|1 Month Outcomes|Death|6|||
48494547|NCT01058421|156004076|FG000|1 Month Outcomes|Lost to Follow-up|8|||
48494548|NCT01058421|156004077|FG001|1 Month Outcomes|Lost to Follow-up|7|||
48494549|NCT01058421|156004076|FG000|1 Month Outcomes|Remained in Hospital|5|||
48494550|NCT01058421|156004077|FG001|1 Month Outcomes|Remained in Hospital|12|||
48494551|NCT01058421|156004076|FG000|1 Month Outcomes|Remained in Other Facility|16|||
48494552|NCT01058421|156004077|FG001|1 Month Outcomes|Remained in Other Facility|17|||
48494553|NCT01058421|156004076|FG000|3 Month Outcomes|Death|3|||
48713627|NCT02059291|156801421|FG021|Epoch 4|Pregnancy|0|||
48812322|NCT01512745|157153551|FG001|Overall Study|Lost to Follow-up|0|||
48812323|NCT01512745|157153550|FG000|Overall Study|Lack of Efficacy|2|||
48812324|NCT01512745|157153551|FG001|Overall Study|Lack of Efficacy|2|||
48494554|NCT01058421|156004077|FG001|3 Month Outcomes|Death|5|||
48494555|NCT01058421|156004076|FG000|3 Month Outcomes|Lost to Follow-up|12|||
48494556|NCT01058421|156004077|FG001|3 Month Outcomes|Lost to Follow-up|11|||
48713628|NCT02059291|156801422|FG022|Epoch 4|Pregnancy|0|||
48713629|NCT02059291|156801423|FG023|Epoch 4|Pregnancy|0|||
48713630|NCT02059291|156801424|FG024|Epoch 4|Pregnancy|0|||
48713631|NCT02059291|156801400|FG000|Epoch 4|Withdrawal by Subject|0|||
48713632|NCT02059291|156801401|FG001|Epoch 4|Withdrawal by Subject|0|||
48713633|NCT02059291|156801402|FG002|Epoch 4|Withdrawal by Subject|0|||
48713634|NCT02059291|156801403|FG003|Epoch 4|Withdrawal by Subject|0|||
48713635|NCT02059291|156801404|FG004|Epoch 4|Withdrawal by Subject|0|||
48713636|NCT02059291|156801405|FG005|Epoch 4|Withdrawal by Subject|0|||
48713637|NCT02059291|156801406|FG006|Epoch 4|Withdrawal by Subject|0|||
48713638|NCT02059291|156801407|FG007|Epoch 4|Withdrawal by Subject|0|||
48494557|NCT01058421|156004076|FG000|3 Month Outcomes|Remained in Hospital|0|||
48494558|NCT01058421|156004077|FG001|3 Month Outcomes|Remained in Hospital|2|||
48494559|NCT01058421|156004076|FG000|3 Month Outcomes|Remained in Other Facility|5|||
48494560|NCT01058421|156004077|FG001|3 Month Outcomes|Remained in Other Facility|8|||
48494561|NCT01058421|156004076|FG000|6 Month Outcomes|Death|2|||
48494562|NCT01058421|156004077|FG001|6 Month Outcomes|Death|2|||
48494563|NCT01058421|156004076|FG000|6 Month Outcomes|Lost to Follow-up|16|||
48713639|NCT02059291|156801408|FG008|Epoch 4|Withdrawal by Subject|0|||
48713640|NCT02059291|156801409|FG009|Epoch 4|Withdrawal by Subject|0|||
48812325|NCT01512745|157153550|FG000|Overall Study|Protocol Violation|1|||
48494564|NCT01058421|156004077|FG001|6 Month Outcomes|Lost to Follow-up|21|||
48494565|NCT01058421|156004076|FG000|6 Month Outcomes|Remained in Other Facility|1|||
48494566|NCT01058421|156004077|FG001|6 Month Outcomes|Remained in Other Facility|3|||
48494567|NCT03982433|156004078|FG000|Overall Study|Lost to Follow-up|1|||
48494576|NCT02093689|156004081|FG000|Overall Study|Physician Decision|4|||
48494577|NCT02093689|156004082|FG001|Overall Study|Physician Decision|0|||
48494578|NCT02093689|156004083|FG002|Overall Study|Physician Decision|0|||
48494579|NCT01048333|156004084|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
48494580|NCT01048333|156004085|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
48494581|NCT01048333|156004086|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
48494582|NCT01048333|156004087|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
48494583|NCT01048333|156004088|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
48494584|NCT01048333|156004089|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
48494585|NCT03008460|156004090|FG000|Overall Study|Protocol deviation|0|||
48494586|NCT03008460|156004091|FG001|Overall Study|Protocol deviation|2|||
48494587|NCT03008460|156004090|FG000|Overall Study|Study drug not dispensed|0|||
48494588|NCT03008460|156004091|FG001|Overall Study|Study drug not dispensed|1|||
48494589|NCT03008460|156004090|FG000|Overall Study|Adverse Event|0|||
48494590|NCT03008460|156004091|FG001|Overall Study|Adverse Event|1|||
48494591|NCT03008460|156004090|FG000|Overall Study|Withdrawal by Subject|5|||
48494592|NCT03008460|156004091|FG001|Overall Study|Withdrawal by Subject|6|||
48494593|NCT03008460|156004090|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
48494594|NCT03008460|156004091|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
48494595|NCT03008460|156004090|FG000|Overall Study|End of study visit outside permitted time window|0|||
48494596|NCT03008460|156004091|FG001|Overall Study|End of study visit outside permitted time window|1|||
48494597|NCT03008460|156004090|FG000|Overall Study|Lost to Follow-up|1|||
48494598|NCT03008460|156004091|FG001|Overall Study|Lost to Follow-up|3|||
48494599|NCT04947579|156004092|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
48494600|NCT04947579|156004093|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
48494601|NCT04947579|156004094|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
48494602|NCT04947579|156004095|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
48494603|NCT04947579|156004096|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
48494604|NCT04947579|156004097|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
48494605|NCT04947579|156004092|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
48494606|NCT04947579|156004093|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
48494607|NCT04947579|156004094|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
48494608|NCT04947579|156004095|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
48494609|NCT04947579|156004096|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
48494610|NCT04947579|156004097|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
48494611|NCT04947579|156004092|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
48494612|NCT04947579|156004093|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
48494613|NCT04947579|156004094|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
48494614|NCT04947579|156004095|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
48494615|NCT04947579|156004096|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
48494616|NCT04947579|156004097|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
48494617|NCT04947579|156004092|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
48494618|NCT04947579|156004093|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
48494619|NCT04947579|156004094|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
48494620|NCT04947579|156004095|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
48494621|NCT04947579|156004096|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
48494622|NCT04947579|156004097|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
48494623|NCT04947579|156004092|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
48494624|NCT04947579|156004093|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
48713641|NCT02059291|156801410|FG010|Epoch 4|Withdrawal by Subject|0|||
48713642|NCT02059291|156801411|FG011|Epoch 4|Withdrawal by Subject|0|||
48713643|NCT02059291|156801412|FG012|Epoch 4|Withdrawal by Subject|0|||
48713644|NCT02059291|156801413|FG013|Epoch 4|Withdrawal by Subject|0|||
48713645|NCT02059291|156801414|FG014|Epoch 4|Withdrawal by Subject|0|||
48713646|NCT02059291|156801415|FG015|Epoch 4|Withdrawal by Subject|0|||
48713647|NCT02059291|156801416|FG016|Epoch 4|Withdrawal by Subject|0|||
48713648|NCT02059291|156801417|FG017|Epoch 4|Withdrawal by Subject|0|||
48713649|NCT02059291|156801418|FG018|Epoch 4|Withdrawal by Subject|0|||
48812326|NCT01512745|157153551|FG001|Overall Study|Protocol Violation|0|||
48713650|NCT02059291|156801419|FG019|Epoch 4|Withdrawal by Subject|0|||
48713651|NCT02059291|156801420|FG020|Epoch 4|Withdrawal by Subject|1|||
48494625|NCT04947579|156004094|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
48494626|NCT04947579|156004095|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
48494627|NCT04947579|156004096|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
48713652|NCT02059291|156801421|FG021|Epoch 4|Withdrawal by Subject|0|||
48713653|NCT02059291|156801422|FG022|Epoch 4|Withdrawal by Subject|0|||
48713654|NCT02059291|156801423|FG023|Epoch 4|Withdrawal by Subject|0|||
48713655|NCT02059291|156801424|FG024|Epoch 4|Withdrawal by Subject|0|||
48713656|NCT02059291|156801400|FG000|Epoch 4|Lack of Efficacy|0|||
48713657|NCT02059291|156801401|FG001|Epoch 4|Lack of Efficacy|0|||
48713658|NCT02059291|156801402|FG002|Epoch 4|Lack of Efficacy|0|||
48713659|NCT02059291|156801403|FG003|Epoch 4|Lack of Efficacy|0|||
48713660|NCT02059291|156801404|FG004|Epoch 4|Lack of Efficacy|0|||
48713661|NCT02059291|156801405|FG005|Epoch 4|Lack of Efficacy|0|||
48713662|NCT02059291|156801406|FG006|Epoch 4|Lack of Efficacy|0|||
48713663|NCT02059291|156801407|FG007|Epoch 4|Lack of Efficacy|0|||
48713664|NCT02059291|156801408|FG008|Epoch 4|Lack of Efficacy|0|||
48713665|NCT02059291|156801409|FG009|Epoch 4|Lack of Efficacy|0|||
48713666|NCT02059291|156801410|FG010|Epoch 4|Lack of Efficacy|0|||
48713667|NCT02059291|156801411|FG011|Epoch 4|Lack of Efficacy|0|||
48713668|NCT02059291|156801412|FG012|Epoch 4|Lack of Efficacy|0|||
48713669|NCT02059291|156801413|FG013|Epoch 4|Lack of Efficacy|0|||
48713670|NCT02059291|156801414|FG014|Epoch 4|Lack of Efficacy|0|||
48713671|NCT02059291|156801415|FG015|Epoch 4|Lack of Efficacy|0|||
48713672|NCT02059291|156801416|FG016|Epoch 4|Lack of Efficacy|0|||
48713673|NCT02059291|156801417|FG017|Epoch 4|Lack of Efficacy|0|||
48713674|NCT02059291|156801418|FG018|Epoch 4|Lack of Efficacy|0|||
48713675|NCT02059291|156801419|FG019|Epoch 4|Lack of Efficacy|0|||
48713676|NCT02059291|156801420|FG020|Epoch 4|Lack of Efficacy|0|||
48713677|NCT02059291|156801421|FG021|Epoch 4|Lack of Efficacy|0|||
48713678|NCT02059291|156801422|FG022|Epoch 4|Lack of Efficacy|0|||
48713679|NCT02059291|156801423|FG023|Epoch 4|Lack of Efficacy|1|||
48713680|NCT02059291|156801424|FG024|Epoch 4|Lack of Efficacy|0|||
48713681|NCT01433289|156801426|FG000|Overall Study|Pregnancy|0|||
48713682|NCT01433289|156801427|FG001|Overall Study|Pregnancy|1|||
48713683|NCT01433289|156801428|FG002|Overall Study|Pregnancy|0|||
48713684|NCT01433289|156801429|FG003|Overall Study|Pregnancy|0|||
48713685|NCT00452361|156801432|FG000|Overall Study|Adverse Event|8|||
48713686|NCT00452361|156801433|FG001|Overall Study|Adverse Event|0|||
48713687|NCT00452361|156801432|FG000|Overall Study|Withdrawal by Subject|0|||
48713688|NCT00452361|156801433|FG001|Overall Study|Withdrawal by Subject|1|||
48713689|NCT00452361|156801432|FG000|Overall Study|Premature termination|13|||
48713690|NCT00452361|156801433|FG001|Overall Study|Premature termination|9|||
48713691|NCT03179605|156801434|FG000|Overall Study|Withdrawal by Subject|1|||
48713692|NCT01014910|156801435|FG000|Overall Study|Withdrawal by Subject|0|||
48713693|NCT01014910|156801436|FG001|Overall Study|Withdrawal by Subject|2|||
48713694|NCT02445794|156801437|FG000|Overall Study|Adverse Event|0|||
48713695|NCT02445794|156801438|FG001|Overall Study|Adverse Event|0|||
48713696|NCT02445794|156801439|FG002|Overall Study|Adverse Event|2|||
48713697|NCT02445794|156801440|FG003|Overall Study|Adverse Event|0|||
48713698|NCT01516034|156801443|FG000|Overall Study|Physician Decision|1|||
48713699|NCT01516034|156801443|FG000|Overall Study|Lack of Efficacy|7|||
48713700|NCT01818752|156801444|FG000|Overall Study|Adverse Event|64|||
48494628|NCT04947579|156004097|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
48494629|NCT04947579|156004092|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
48494630|NCT04947579|156004093|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
48494631|NCT04947579|156004094|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
48494632|NCT04947579|156004095|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
48494633|NCT04947579|156004096|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
48494634|NCT04947579|156004097|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
48494635|NCT04947579|156004092|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
48494636|NCT04947579|156004093|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
48494637|NCT04947579|156004094|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
48494638|NCT04947579|156004095|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
48494639|NCT04947579|156004096|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
48494640|NCT04947579|156004097|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
48494641|NCT04947579|156004092|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
48494642|NCT04947579|156004093|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
48494643|NCT04947579|156004094|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
48494644|NCT04947579|156004095|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
48494645|NCT04947579|156004096|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
48494646|NCT04947579|156004097|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
48494647|NCT04947579|156004092|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
48494648|NCT04947579|156004093|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
48494649|NCT04947579|156004094|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
48494650|NCT04947579|156004095|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
48494651|NCT04947579|156004096|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
48494652|NCT04947579|156004097|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
48494653|NCT04947579|156004092|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
48494654|NCT04947579|156004093|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
48494655|NCT04947579|156004094|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
48494656|NCT04947579|156004095|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
48597918|NCT03498313|156385168|FG000|Washout Period 2|Physician Decision|1|||
48597919|NCT03498313|156385169|FG001|Washout Period 2|Physician Decision|0|||
48713701|NCT01818752|156801445|FG001|Overall Study|Adverse Event|74|||
48713702|NCT01818752|156801444|FG000|Overall Study|Death|14|||
48713703|NCT01818752|156801445|FG001|Overall Study|Death|18|||
48713704|NCT01818752|156801444|FG000|Overall Study|Non-compliance|16|||
48713705|NCT01818752|156801445|FG001|Overall Study|Non-compliance|20|||
48713706|NCT01818752|156801444|FG000|Overall Study|Withdrawal by Subject|15|||
48713707|NCT01818752|156801445|FG001|Overall Study|Withdrawal by Subject|14|||
48713708|NCT01818752|156801444|FG000|Overall Study|Physician Decision|9|||
48713709|NCT01818752|156801445|FG001|Overall Study|Physician Decision|8|||
48713710|NCT01818752|156801444|FG000|Overall Study|Disease Progression|54|||
48713711|NCT01818752|156801445|FG001|Overall Study|Disease Progression|48|||
48713712|NCT01818752|156801444|FG000|Overall Study|Other|7|||
48713713|NCT01818752|156801445|FG001|Overall Study|Other|8|||
48713714|NCT01818752|156801444|FG000|Overall Study|Continuing Treatment|1|||
48713715|NCT01818752|156801445|FG001|Overall Study|Continuing Treatment|4|||
48713716|NCT01818752|156801444|FG000|Overall Study|Randomized but not Dosed|7|||
48713717|NCT01818752|156801445|FG001|Overall Study|Randomized but not Dosed|4|||
48713718|NCT01324141|156801446|FG000|Overall Study|Declined to participate before treatment started|1|||
48713719|NCT01324141|156801446|FG000|Overall Study|Disease progression on study|1|||
48713720|NCT04629066|156801449|FG000|Overall Study|Lost to Follow-up|3|||
48713721|NCT04629066|156801450|FG001|Overall Study|Lost to Follow-up|2|||
48713722|NCT00978757|156801452|FG000|Overall Study|Physician Decision|1|||
48494657|NCT04947579|156004096|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
48494658|NCT04947579|156004097|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
48494659|NCT04947579|156004092|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
48494660|NCT04947579|156004093|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
48494661|NCT04947579|156004094|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
48494662|NCT04947579|156004095|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
48494663|NCT04947579|156004096|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
48494664|NCT04947579|156004097|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
48494665|NCT02768298|156004100|FG000|Overall Study|Adverse Event|1|||
48494666|NCT02768298|156004101|FG001|Overall Study|Adverse Event|4|||
48494667|NCT02768298|156004100|FG000|Overall Study|Death|2|||
48494668|NCT02768298|156004101|FG001|Overall Study|Death|1|||
48494669|NCT02768298|156004100|FG000|Overall Study|Non-compliance with study treatment|0|||
48494670|NCT02768298|156004101|FG001|Overall Study|Non-compliance with study treatment|1|||
48494671|NCT02768298|156004100|FG000|Overall Study|Subject/guardian decision|1|||
48494672|NCT02768298|156004101|FG001|Overall Study|Subject/guardian decision|0|||
48494673|NCT02768298|156004100|FG000|Overall Study|Withdrawal of informed consent|0|||
48494674|NCT02768298|156004101|FG001|Overall Study|Withdrawal of informed consent|1|||
48494675|NCT00906347|156005709|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
48494676|NCT00906347|156005710|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
48494677|NCT00906347|156005709|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
48494678|NCT00906347|156005710|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
48494679|NCT00906347|156005709|FG000|Received Study Drug|Refused study drug|1|||
48494680|NCT00906347|156005710|FG001|Received Study Drug|Refused study drug|0|||
48494681|NCT00906347|156005709|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
48494682|NCT00906347|156005710|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
48494683|NCT00759148|156005711|FG000|Overall Study|Adverse Event|1|||
48494684|NCT00759148|156005712|FG001|Overall Study|Adverse Event|6|||
48494685|NCT00759148|156005711|FG000|Overall Study|Withdrawal by Subject|3|||
48494686|NCT00759148|156005712|FG001|Overall Study|Withdrawal by Subject|7|||
48494687|NCT00759148|156005711|FG000|Overall Study|Lost to Follow-up|3|||
48494688|NCT00759148|156005712|FG001|Overall Study|Lost to Follow-up|9|||
48494689|NCT00759148|156005711|FG000|Overall Study|Treatment Failure|6|||
48494690|NCT00759148|156005712|FG001|Overall Study|Treatment Failure|10|||
48494691|NCT00759148|156005711|FG000|Overall Study|Reason not given|1|||
48494692|NCT00759148|156005712|FG001|Overall Study|Reason not given|0|||
48494693|NCT03381248|156005713|FG000|0-6 Months|Withdrawal by Subject|4|||
48494694|NCT03381248|156005714|FG001|0-6 Months|Withdrawal by Subject|1|||
48494695|NCT03381248|156005713|FG000|0-6 Months|Lost to Follow-up|3|||
48494696|NCT03381248|156005714|FG001|0-6 Months|Lost to Follow-up|2|||
48713723|NCT00978757|156801453|FG001|Overall Study|Physician Decision|3|||
48713724|NCT03288142|156801454|FG000|Overall Study|Lost to Follow-up|22|||
48713725|NCT03288142|156801455|FG001|Overall Study|Lost to Follow-up|15|||
48713726|NCT00715910|156801458|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
48713727|NCT00715910|156801459|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
48713728|NCT00715910|156801460|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
48713729|NCT00715910|156801461|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
48713730|NCT00715910|156801462|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
48713731|NCT00715910|156801463|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
48713732|NCT00715910|156801458|FG000|Booster and ESFU Phase|Other|0|||
48713733|NCT00715910|156801459|FG001|Booster and ESFU Phase|Other|0|||
48713734|NCT00715910|156801460|FG002|Booster and ESFU Phase|Other|0|||
48713735|NCT00715910|156801461|FG003|Booster and ESFU Phase|Other|5|||
48713736|NCT00715910|156801462|FG004|Booster and ESFU Phase|Other|1|||
48713737|NCT00715910|156801463|FG005|Booster and ESFU Phase|Other|0|||
48713738|NCT00531427|156801465|FG000|Overall Study|Withdrawal by Subject|7|||
48494697|NCT03381248|156005713|FG000|0-6 Months|Lack of Efficacy|1|||
48494698|NCT03381248|156005714|FG001|0-6 Months|Lack of Efficacy|0|||
48494699|NCT03381248|156005713|FG000|0-6 Months|Adverse Event|1|||
48713739|NCT00531427|156801466|FG001|Overall Study|Withdrawal by Subject|13|||
48494700|NCT03381248|156005714|FG001|0-6 Months|Adverse Event|0|||
48494701|NCT03381248|156005713|FG000|0-6 Months|Protocol Violation|2|||
48494702|NCT03381248|156005714|FG001|0-6 Months|Protocol Violation|1|||
48494703|NCT03381248|156005713|FG000|0-6 Months|Physician Decision|1|||
48494704|NCT03381248|156005714|FG001|0-6 Months|Physician Decision|0|||
48494705|NCT03381248|156005713|FG000|0-6 Months|Planning another procedure|1|||
48494706|NCT03381248|156005714|FG001|0-6 Months|Planning another procedure|2|||
48494707|NCT03381248|156005713|FG000|6-12 Months|Withdrawal by Subject|1|||
48494708|NCT03381248|156005714|FG001|6-12 Months|Withdrawal by Subject|3|||
48494709|NCT03381248|156005713|FG000|6-12 Months|Lost to Follow-up|0|||
48494710|NCT03381248|156005714|FG001|6-12 Months|Lost to Follow-up|2|||
48494711|NCT03381248|156005713|FG000|6-12 Months|Protocol Violation|3|||
48494712|NCT03381248|156005714|FG001|6-12 Months|Protocol Violation|2|||
48494713|NCT03381248|156005713|FG000|6-12 Months|Planning another procedure|6|||
48494714|NCT03381248|156005714|FG001|6-12 Months|Planning another procedure|2|||
48494715|NCT03381248|156005713|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
48494716|NCT03381248|156005714|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
48494717|NCT03381248|156005713|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
48494718|NCT03381248|156005714|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
48494719|NCT03381248|156005713|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
48494720|NCT03381248|156005714|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
48494721|NCT00130520|156005715|FG000|Overall Study|Adverse Event|11|||
48494722|NCT00130520|156005715|FG000|Overall Study|Death|1|||
48494723|NCT00130520|156005715|FG000|Overall Study|Physician Decision|1|||
48494724|NCT00130520|156005715|FG000|Overall Study|Withdrawal by Subject|1|||
48494725|NCT00130520|156005715|FG000|Overall Study|Disease Progression|23|||
48494726|NCT00130520|156005715|FG000|Overall Study|Protocol non-compliance|1|||
48494727|NCT00130520|156005715|FG000|Overall Study|Did not meet re-treatment criteria|1|||
48494728|NCT02965820|156005716|FG000|Period 2, Second 30 Days|Adverse Event|1|||
48494729|NCT02965820|156005717|FG001|Period 2, Second 30 Days|Adverse Event|1|||
48494730|NCT02295774|156005723|FG000|Overall Study|Physician Decision|1|||
48494731|NCT02295774|156005723|FG000|Overall Study|Withdrawal by Subject|2|||
48494732|NCT03487796|156005724|FG000|Overall Study|Lost to Follow-up|18|||
48494733|NCT03487796|156005725|FG001|Overall Study|Lost to Follow-up|6|||
48494734|NCT01075763|156005726|FG000|Overall Study|Lost to Follow-up|2|||
48494735|NCT01075763|156005727|FG001|Overall Study|Lost to Follow-up|1|||
48494736|NCT01075763|156005726|FG000|Overall Study|Lack of Efficacy|0|||
48494737|NCT01075763|156005727|FG001|Overall Study|Lack of Efficacy|1|||
48494738|NCT01075763|156005726|FG000|Overall Study|Withdrawal by Subject|2|||
48494739|NCT01075763|156005727|FG001|Overall Study|Withdrawal by Subject|2|||
48494740|NCT00586521|156005728|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
48494741|NCT02710071|156005738|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
48494742|NCT02710071|156005739|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
48494743|NCT02710071|156005738|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
48494744|NCT02710071|156005739|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
48494745|NCT00124020|156005740|FG000|Overall Study|Death|67|||
48713740|NCT00531427|156801465|FG000|Overall Study|Adverse Event|44|||
48812327|NCT00936221|157153552|FG000|Overall Study|Withdrawal by Subject|1|||
48812328|NCT00936221|157153553|FG001|Overall Study|Withdrawal by Subject|1|||
48812329|NCT00758160|157153554|FG000|Overall Study|No Longer Requires Study Medication|4|||
48812330|NCT00758160|157153554|FG000|Overall Study|Administration Problems|3|||
48812331|NCT00758160|157153554|FG000|Overall Study|Adverse Event|15|||
48812332|NCT00758160|157153554|FG000|Overall Study|Lack of Efficacy|10|||
48812333|NCT00758160|157153554|FG000|Overall Study|Lost to Follow-up|14|||
48812334|NCT00758160|157153554|FG000|Overall Study|Protocol Violation|12|||
48812335|NCT00758160|157153554|FG000|Overall Study|Withdrawal by Subject|8|||
48812336|NCT01380990|157153555|FG000|Overall Study|Treatment Failure|1|||
48812337|NCT01380990|157153556|FG001|Overall Study|Treatment Failure|0|||
48812338|NCT01380990|157153555|FG000|Overall Study|Death|0|||
48494746|NCT00124020|156005741|FG001|Overall Study|Death|71|||
48494747|NCT00124020|156005740|FG000|Overall Study|Withdrawal by Subject|13|||
48494748|NCT00124020|156005741|FG001|Overall Study|Withdrawal by Subject|11|||
48494749|NCT00124020|156005740|FG000|Overall Study|Lost to Follow-up|5|||
48494750|NCT00124020|156005741|FG001|Overall Study|Lost to Follow-up|8|||
48494751|NCT00124020|156005740|FG000|Overall Study|Other|1|||
48713741|NCT00531427|156801466|FG001|Overall Study|Adverse Event|30|||
48713742|NCT00531427|156801465|FG000|Overall Study|Lost to Follow-up|4|||
48713743|NCT00531427|156801466|FG001|Overall Study|Lost to Follow-up|3|||
48713744|NCT00531427|156801465|FG000|Overall Study|Lack of Efficacy|14|||
48713745|NCT00531427|156801466|FG001|Overall Study|Lack of Efficacy|39|||
48713746|NCT00531427|156801465|FG000|Overall Study|Administrative|4|||
48713747|NCT00531427|156801466|FG001|Overall Study|Administrative|9|||
48713748|NCT03073733|156801467|FG000|Overall Study|Lost to Follow-up|1|||
48713749|NCT03073733|156801468|FG001|Overall Study|Lost to Follow-up|0|||
48713750|NCT03073733|156801469|FG002|Overall Study|Lost to Follow-up|0|||
48812339|NCT01380990|157153556|FG001|Overall Study|Death|1|||
48812340|NCT02153359|157153557|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
48494752|NCT00124020|156005741|FG001|Overall Study|Other|1|||
48494753|NCT00124020|156005740|FG000|Overall Study|Transfer to another hospital|2|||
48494754|NCT00124020|156005741|FG001|Overall Study|Transfer to another hospital|0|||
48494755|NCT03731182|156005744|FG000|Overall Study|Lost to Follow-up|2|||
48494756|NCT03731182|156005745|FG001|Overall Study|Lost to Follow-up|0|||
48494757|NCT03731182|156005744|FG000|Overall Study|Physician Decision|1|||
48494758|NCT03731182|156005745|FG001|Overall Study|Physician Decision|0|||
48494759|NCT03731182|156005744|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
48494760|NCT03731182|156005745|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
48494761|NCT02637557|156005746|FG000|Overall Study|Adverse Event|3|||
48494762|NCT02637557|156005747|FG001|Overall Study|Adverse Event|1|||
48494763|NCT02637557|156005748|FG002|Overall Study|Adverse Event|3|||
48494764|NCT02637557|156005749|FG003|Overall Study|Adverse Event|3|||
48494765|NCT02637557|156005746|FG000|Overall Study|Lost to Follow-up|1|||
48494766|NCT02637557|156005747|FG001|Overall Study|Lost to Follow-up|1|||
48494767|NCT02637557|156005748|FG002|Overall Study|Lost to Follow-up|0|||
48494768|NCT02637557|156005749|FG003|Overall Study|Lost to Follow-up|1|||
48494769|NCT02637557|156005746|FG000|Overall Study|Physician Decision|1|||
48494770|NCT02637557|156005747|FG001|Overall Study|Physician Decision|0|||
48494771|NCT02637557|156005748|FG002|Overall Study|Physician Decision|0|||
48812341|NCT02153359|157153558|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
48494772|NCT02637557|156005749|FG003|Overall Study|Physician Decision|0|||
48494773|NCT02637557|156005746|FG000|Overall Study|Protocol Violation|2|||
48494774|NCT02637557|156005747|FG001|Overall Study|Protocol Violation|0|||
48812342|NCT01964521|157153559|FG000|Overall Study|Lost to Follow-up|4|||
48812343|NCT01108510|157153563|FG000|Overall Study|Randomized but Not Treated|5|||
48812344|NCT01108510|157153564|FG001|Overall Study|Randomized but Not Treated|1|||
48812345|NCT01108510|157153563|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
48812346|NCT01108510|157153564|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
48812347|NCT01108510|157153563|FG000|Overall Study|Adverse Event|26|||
48494775|NCT02637557|156005748|FG002|Overall Study|Protocol Violation|2|||
48494776|NCT02637557|156005749|FG003|Overall Study|Protocol Violation|1|||
48494777|NCT02637557|156005746|FG000|Overall Study|Withdrawal by Subject|1|||
48494778|NCT02637557|156005747|FG001|Overall Study|Withdrawal by Subject|3|||
48494779|NCT02637557|156005748|FG002|Overall Study|Withdrawal by Subject|4|||
48494780|NCT02637557|156005749|FG003|Overall Study|Withdrawal by Subject|2|||
48812348|NCT01108510|157153564|FG001|Overall Study|Adverse Event|19|||
48812349|NCT01108510|157153563|FG000|Overall Study|Lost to Follow-up|20|||
48494781|NCT00268346|156005750|FG000|Overall Study|Adverse Event|0|||
48494782|NCT00268346|156005751|FG001|Overall Study|Adverse Event|1|||
48494783|NCT00268346|156005750|FG000|Overall Study|Death|0|||
48494784|NCT00268346|156005751|FG001|Overall Study|Death|1|||
48494785|NCT00268346|156005750|FG000|Overall Study|Withdrawal by Subject|0|||
48812350|NCT01108510|157153564|FG001|Overall Study|Lost to Follow-up|17|||
48494786|NCT00268346|156005751|FG001|Overall Study|Withdrawal by Subject|1|||
48494787|NCT00613574|156005752|FG000|Overall Study|Adverse Event|3|||
48494788|NCT00613574|156005752|FG000|Overall Study|Lost to Follow-up|2|||
48494789|NCT00613574|156005752|FG000|Overall Study|Other|1|||
48494790|NCT04604184|156005759|FG000|Overall Study|Adverse Event|5|||
48494791|NCT04604184|156005760|FG001|Overall Study|Adverse Event|5|||
48494792|NCT04604184|156005759|FG000|Overall Study|Death|2|||
48494793|NCT04604184|156005760|FG001|Overall Study|Death|1|||
48494794|NCT04604184|156005759|FG000|Overall Study|Withdrawal by Subject|1|||
48494795|NCT04604184|156005760|FG001|Overall Study|Withdrawal by Subject|3|||
48494796|NCT04604184|156005759|FG000|Overall Study|Not treated|2|||
48494797|NCT04604184|156005760|FG001|Overall Study|Not treated|2|||
48494798|NCT04604184|156005759|FG000|Overall Study|Due to sponsor decision|9|||
48494799|NCT04604184|156005760|FG001|Overall Study|Due to sponsor decision|7|||
48494800|NCT04604184|156005759|FG000|Overall Study|Physician Decision|0|||
48494801|NCT04604184|156005760|FG001|Overall Study|Physician Decision|1|||
48494802|NCT04604184|156005759|FG000|Overall Study|Transfer to healthcare|1|||
48494803|NCT04604184|156005760|FG001|Overall Study|Transfer to healthcare|0|||
48494804|NCT01751412|156005761|FG000|Overall Study|Disease Progression Before Treatment|1|||
48494805|NCT01673009|156005764|FG000|Overall Study|Physician Decision|5|||
48494806|NCT01673009|156005764|FG000|Overall Study|Withdrawal by Subject|8|||
48494807|NCT01844583|156005765|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
48494808|NCT01844583|156005766|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
48494809|NCT02043366|156005769|FG000|Overall Study|Lost to Follow-up|2|||
48494810|NCT02043366|156005770|FG001|Overall Study|Lost to Follow-up|2|||
48494811|NCT02043366|156005771|FG002|Overall Study|Lost to Follow-up|2|||
48494812|NCT02043366|156005772|FG003|Overall Study|Lost to Follow-up|2|||
48494813|NCT02043366|156005773|FG004|Overall Study|Lost to Follow-up|2|||
48494814|NCT02043366|156005774|FG005|Overall Study|Lost to Follow-up|2|||
48494815|NCT00449072|156005780|FG000|Overall Study|Adverse Event|3|||
48494816|NCT00449072|156005781|FG001|Overall Study|Adverse Event|1|||
48494817|NCT00449072|156005780|FG000|Overall Study|Protocol Violation|14|||
48494818|NCT00449072|156005781|FG001|Overall Study|Protocol Violation|12|||
48812351|NCT01108510|157153563|FG000|Overall Study|Withdrew Consent|21|||
48812352|NCT01108510|157153564|FG001|Overall Study|Withdrew Consent|15|||
48812353|NCT01108510|157153563|FG000|Overall Study|Investigator's Discretion|12|||
48812354|NCT01108510|157153564|FG001|Overall Study|Investigator's Discretion|10|||
48812355|NCT01108510|157153563|FG000|Overall Study|Participant Noncompliance|5|||
48812356|NCT01108510|157153564|FG001|Overall Study|Participant Noncompliance|7|||
48812357|NCT01108510|157153563|FG000|Overall Study|Lack of Efficacy|3|||
48812358|NCT01108510|157153564|FG001|Overall Study|Lack of Efficacy|0|||
48812359|NCT01108510|157153563|FG000|Overall Study|Pregnancy|0|||
48812360|NCT01108510|157153564|FG001|Overall Study|Pregnancy|3|||
48812361|NCT01108510|157153563|FG000|Overall Study|Death|1|||
48812362|NCT01108510|157153564|FG001|Overall Study|Death|1|||
48812363|NCT01284140|157153565|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
48812364|NCT01284140|157153566|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
48812365|NCT01284140|157153565|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
48812366|NCT01284140|157153566|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
48812367|NCT01463293|157153567|FG000|Overall Study|Lost to Follow-up|1|||
48812368|NCT01463293|157153568|FG001|Overall Study|Lost to Follow-up|4|||
48812369|NCT01463293|157153569|FG002|Overall Study|Lost to Follow-up|5|||
48812370|NCT01463293|157153567|FG000|Overall Study|Adverse Event|1|||
48812371|NCT01463293|157153568|FG001|Overall Study|Adverse Event|2|||
48812372|NCT01463293|157153569|FG002|Overall Study|Adverse Event|0|||
48812373|NCT01463293|157153567|FG000|Overall Study|Withdrawal by Subject|4|||
48812374|NCT01463293|157153568|FG001|Overall Study|Withdrawal by Subject|10|||
48812375|NCT01463293|157153569|FG002|Overall Study|Withdrawal by Subject|5|||
48812376|NCT01463293|157153567|FG000|Overall Study|Other|0|||
48812377|NCT01463293|157153568|FG001|Overall Study|Other|0|||
48812378|NCT01463293|157153569|FG002|Overall Study|Other|2|||
48812379|NCT02796963|157153570|FG000|Overall Study|Lost to Follow-up|89|||
48812380|NCT02796963|157153571|FG001|Overall Study|Lost to Follow-up|76|||
48812381|NCT02796963|157153572|FG002|Overall Study|Lost to Follow-up|69|||
48812382|NCT02796963|157153573|FG003|Overall Study|Lost to Follow-up|72|||
48812383|NCT00210119|157153574|FG000|Overall Study|Protocol Violation|1|||
48812384|NCT00210119|157153574|FG000|Overall Study|Withdrawal by Subject|1|||
48494819|NCT00449072|156005780|FG000|Overall Study|Lost to Follow-up|5|||
48494820|NCT00449072|156005781|FG001|Overall Study|Lost to Follow-up|7|||
48494821|NCT00449072|156005780|FG000|Overall Study|Withdrawal by Subject|11|||
48494822|NCT00449072|156005781|FG001|Overall Study|Withdrawal by Subject|8|||
48494823|NCT00449072|156005780|FG000|Overall Study|Lack of Efficacy|1|||
48494824|NCT00449072|156005781|FG001|Overall Study|Lack of Efficacy|1|||
48494825|NCT00449072|156005780|FG000|Overall Study|Physician Decision|1|||
48812385|NCT04192630|157153575|FG000|Overall Study|Discontinued before surgery|2|||
48812386|NCT04192630|157153576|FG001|Overall Study|Discontinued before surgery|0|||
48812387|NCT04192630|157153575|FG000|Overall Study|Discontinued after surgery|5|||
48812388|NCT04192630|157153576|FG001|Overall Study|Discontinued after surgery|3|||
48494826|NCT00449072|156005781|FG001|Overall Study|Physician Decision|0|||
48494827|NCT00449072|156005780|FG000|Overall Study|Not treated|0|||
48494828|NCT00449072|156005781|FG001|Overall Study|Not treated|1|||
48494829|NCT00449072|156005780|FG000|Overall Study|Excluded medication|0|||
48494830|NCT00449072|156005781|FG001|Overall Study|Excluded medication|2|||
48494831|NCT00449072|156005780|FG000|Overall Study|Non-compliance|2|||
48494832|NCT00449072|156005781|FG001|Overall Study|Non-compliance|5|||
48494833|NCT00449072|156005780|FG000|Overall Study|Sponsor decision|1|||
48494834|NCT00449072|156005781|FG001|Overall Study|Sponsor decision|3|||
48494835|NCT00449072|156005780|FG000|Overall Study|Relocation|3|||
48494836|NCT00449072|156005781|FG001|Overall Study|Relocation|2|||
48494837|NCT00429923|156005782|FG000|Overall Study|Adverse Event|0|||
48494838|NCT00429923|156005783|FG001|Overall Study|Adverse Event|2|||
48494839|NCT00429923|156005784|FG002|Overall Study|Adverse Event|3|||
48494840|NCT00429923|156005782|FG000|Overall Study|Lack of Efficacy|4|||
48494841|NCT00429923|156005783|FG001|Overall Study|Lack of Efficacy|1|||
48494842|NCT00429923|156005784|FG002|Overall Study|Lack of Efficacy|33|||
48597920|NCT03498313|156385170|FG002|Washout Period 2|Physician Decision|0|||
48597921|NCT03498313|156385171|FG003|Washout Period 2|Physician Decision|1|||
48713751|NCT03073733|156801467|FG000|Overall Study|Physician Decision|0|||
48713752|NCT03073733|156801468|FG001|Overall Study|Physician Decision|1|||
48494843|NCT00429923|156005782|FG000|Overall Study|Lost to Follow-up|0|||
48494844|NCT00429923|156005783|FG001|Overall Study|Lost to Follow-up|0|||
48494845|NCT00429923|156005784|FG002|Overall Study|Lost to Follow-up|2|||
48494846|NCT00429923|156005782|FG000|Overall Study|Withdrew Consent|1|||
48494847|NCT00429923|156005783|FG001|Overall Study|Withdrew Consent|0|||
48494848|NCT00429923|156005784|FG002|Overall Study|Withdrew Consent|1|||
48494849|NCT00429923|156005782|FG000|Overall Study|Early Termination|0|||
48494850|NCT00429923|156005783|FG001|Overall Study|Early Termination|1|||
48494851|NCT00429923|156005784|FG002|Overall Study|Early Termination|0|||
48494852|NCT00865709|156005785|FG000|Treatment|Adverse Event|9|||
48494853|NCT00865709|156005786|FG001|Treatment|Adverse Event|6|||
48494854|NCT00865709|156005785|FG000|Treatment|Withdrawal by Subject|10|||
48494855|NCT00865709|156005786|FG001|Treatment|Withdrawal by Subject|7|||
48494856|NCT00865709|156005785|FG000|Treatment|Physician Decision|3|||
48494857|NCT00865709|156005786|FG001|Treatment|Physician Decision|2|||
48713753|NCT03073733|156801469|FG002|Overall Study|Physician Decision|0|||
48713754|NCT03073733|156801467|FG000|Overall Study|Withdrawal by Subject|0|||
48713755|NCT03073733|156801468|FG001|Overall Study|Withdrawal by Subject|0|||
48713756|NCT03073733|156801469|FG002|Overall Study|Withdrawal by Subject|1|||
48713757|NCT01338298|156801470|FG000|Overall Study|Withdrawal by Subject|1|||
48713758|NCT01338298|156801471|FG001|Overall Study|Withdrawal by Subject|1|||
48713759|NCT01338298|156801470|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
48713760|NCT01338298|156801471|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
48713761|NCT01338298|156801470|FG000|Overall Study|Administrative error|0|||
48713762|NCT01338298|156801471|FG001|Overall Study|Administrative error|1|||
48713763|NCT01338298|156801470|FG000|Overall Study|Positive symptom worsening|1|||
48713764|NCT01338298|156801471|FG001|Overall Study|Positive symptom worsening|0|||
48713765|NCT01338298|156801470|FG000|Overall Study|Depressive symptoms and nausea|1|||
48713766|NCT01338298|156801471|FG001|Overall Study|Depressive symptoms and nausea|0|||
48713767|NCT01338298|156801470|FG000|Overall Study|Non-adherence|1|||
48713768|NCT01338298|156801471|FG001|Overall Study|Non-adherence|0|||
48713769|NCT04359901|156801473|FG000|Overall Study|Withdrawal by Subject|0|||
48713770|NCT04359901|156801474|FG001|Overall Study|Withdrawal by Subject|1|||
48713771|NCT04359901|156801473|FG000|Overall Study|Death|6|||
48713772|NCT04359901|156801474|FG001|Overall Study|Death|2|||
48713773|NCT02872285|156801475|FG000|Overall Study|Withdrawal by Subject|2|||
48713774|NCT02872285|156801476|FG001|Overall Study|Withdrawal by Subject|0|||
48713775|NCT02872285|156801475|FG000|Overall Study|Lost to Follow-up|2|||
48713776|NCT02872285|156801476|FG001|Overall Study|Lost to Follow-up|2|||
48713777|NCT02872285|156801475|FG000|Overall Study|Discontinued due to back surgery|1|||
48713778|NCT02872285|156801476|FG001|Overall Study|Discontinued due to back surgery|0|||
48713779|NCT01112306|156801482|FG000|Overall Study|Death|175|||
48713780|NCT01112306|156801482|FG000|Overall Study|Lost to Follow-up|9|||
48713781|NCT01112306|156801482|FG000|Overall Study|Withdrawal by Subject|31|||
48713782|NCT01112306|156801482|FG000|Overall Study|Other|70|||
48713783|NCT03976648|156801483|FG000|Overall Study|Adverse Event|0|||
48713784|NCT03976648|156801484|FG001|Overall Study|Adverse Event|2|||
48713785|NCT03976648|156801483|FG000|Overall Study|Study terminated by sponsor|21|||
48713786|NCT03976648|156801484|FG001|Overall Study|Study terminated by sponsor|8|||
48713787|NCT01182844|156801487|FG000|Overall Study|Withdrawal by Subject|0|||
48713788|NCT01182844|156801488|FG001|Overall Study|Withdrawal by Subject|2|||
48713789|NCT00960570|156801489|FG000|21 Day Washout Period|Adverse Event|1|||
48713790|NCT00960570|156801489|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
48713791|NCT00960570|156801489|FG000|1 Day Period Between Dosing|Adverse Event|2|||
48713792|NCT00960570|156801489|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
48494858|NCT00865709|156005785|FG000|Treatment|Surgery|8|||
48494859|NCT00865709|156005786|FG001|Treatment|Surgery|3|||
48494860|NCT01595009|156005789|FG000|Core|Patients completed per protocol|85|||
48713793|NCT01451437|156801492|FG000|Overall Study|Adverse Event|0|||
48812389|NCT01193582|157153577|FG000|Vaccination Series|Withdrawal by Subject|11|||
48812390|NCT01193582|157153578|FG001|Vaccination Series|Withdrawal by Subject|13|||
48812391|NCT01193582|157153579|FG002|Vaccination Series|Withdrawal by Subject|8|||
48812392|NCT01193582|157153580|FG003|Vaccination Series|Withdrawal by Subject|3|||
48812393|NCT01193582|157153577|FG000|12 Month Follow-up|Death|0|||
48812394|NCT01193582|157153578|FG001|12 Month Follow-up|Death|0|||
48812395|NCT01193582|157153579|FG002|12 Month Follow-up|Death|1|||
48812396|NCT01193582|157153580|FG003|12 Month Follow-up|Death|0|||
48597922|NCT03498313|156385172|FG004|Washout Period 2|Physician Decision|0|||
48713794|NCT01451437|156801493|FG001|Overall Study|Adverse Event|0|||
48713795|NCT01451437|156801494|FG002|Overall Study|Adverse Event|0|||
48713796|NCT01451437|156801495|FG003|Overall Study|Adverse Event|0|||
48713797|NCT01451437|156801496|FG004|Overall Study|Adverse Event|0|||
48713798|NCT01451437|156801497|FG005|Overall Study|Adverse Event|1|||
48713799|NCT01451437|156801498|FG006|Overall Study|Adverse Event|1|||
48812397|NCT01193582|157153577|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
48812398|NCT01193582|157153578|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
48812399|NCT01193582|157153579|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
48812400|NCT01193582|157153580|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
48812401|NCT01617005|157153581|FG000|Overall Study|Pregnancy|1|||
48812402|NCT01617005|157153581|FG000|Overall Study|Lack of motivation for treatment|1|||
48812403|NCT01320735|157153582|FG000|Overall Study|Adverse Event|3|||
48812404|NCT01320735|157153582|FG000|Overall Study|Withdrawal by Subject|3|||
48713800|NCT01451437|156801499|FG007|Overall Study|Adverse Event|2|||
48494861|NCT01595009|156005790|FG001|Core|Patients completed per protocol|44|||
48494862|NCT01595009|156005791|FG002|Core|Patients completed per protocol|0|||
48494863|NCT01595009|156005792|FG003|Core|Patients completed per protocol|0|||
48494864|NCT01595009|156005789|FG000|Core|Adverse Event|19|||
48494865|NCT01595009|156005790|FG001|Core|Adverse Event|23|||
48494866|NCT01595009|156005791|FG002|Core|Adverse Event|0|||
48494867|NCT01595009|156005792|FG003|Core|Adverse Event|0|||
48494868|NCT01595009|156005789|FG000|Core|Disease progression|14|||
48494869|NCT01595009|156005790|FG001|Core|Disease progression|26|||
48494870|NCT01595009|156005791|FG002|Core|Disease progression|0|||
48494871|NCT01595009|156005792|FG003|Core|Disease progression|0|||
48494872|NCT01595009|156005789|FG000|Core|Withdrawal by Subject|4|||
48494873|NCT01595009|156005790|FG001|Core|Withdrawal by Subject|17|||
48494874|NCT01595009|156005791|FG002|Core|Withdrawal by Subject|0|||
48494875|NCT01595009|156005792|FG003|Core|Withdrawal by Subject|0|||
48494876|NCT01595009|156005789|FG000|Core|Death|3|||
48494877|NCT01595009|156005790|FG001|Core|Death|6|||
48494878|NCT01595009|156005791|FG002|Core|Death|0|||
48494879|NCT01595009|156005792|FG003|Core|Death|0|||
48494880|NCT01595009|156005789|FG000|Core|Lost to Follow-up|1|||
48494881|NCT01595009|156005790|FG001|Core|Lost to Follow-up|2|||
48494882|NCT01595009|156005791|FG002|Core|Lost to Follow-up|0|||
48494883|NCT01595009|156005792|FG003|Core|Lost to Follow-up|0|||
48494884|NCT01595009|156005789|FG000|Core|Protocol deviation|0|||
48597923|NCT03498313|156385173|FG005|Washout Period 2|Physician Decision|1|||
48597924|NCT03498313|156385168|FG000|Washout Period 2|Withdrawal by Subject|3|||
48597925|NCT03498313|156385169|FG001|Washout Period 2|Withdrawal by Subject|2|||
48597926|NCT03498313|156385170|FG002|Washout Period 2|Withdrawal by Subject|0|||
48597927|NCT03498313|156385171|FG003|Washout Period 2|Withdrawal by Subject|0|||
48597928|NCT03498313|156385172|FG004|Washout Period 2|Withdrawal by Subject|2|||
48597929|NCT03498313|156385173|FG005|Washout Period 2|Withdrawal by Subject|0|||
48494885|NCT01595009|156005790|FG001|Core|Protocol deviation|1|||
48494886|NCT01595009|156005791|FG002|Core|Protocol deviation|0|||
48494887|NCT01595009|156005792|FG003|Core|Protocol deviation|0|||
48494888|NCT01595009|156005789|FG000|Core|Administrative problems|0|||
48494889|NCT01595009|156005790|FG001|Core|Administrative problems|1|||
48494890|NCT01595009|156005791|FG002|Core|Administrative problems|0|||
48494891|NCT01595009|156005792|FG003|Core|Administrative problems|0|||
48494892|NCT01595009|156005789|FG000|Extension|Administrative problems|0|||
48494893|NCT01595009|156005790|FG001|Extension|Administrative problems|0|||
48494894|NCT01595009|156005791|FG002|Extension|Administrative problems|0|||
48494895|NCT01595009|156005792|FG003|Extension|Administrative problems|1|||
48494896|NCT01595009|156005789|FG000|Extension|Patients completed per protocol|0|||
48494897|NCT01595009|156005790|FG001|Extension|Patients completed per protocol|0|||
48494898|NCT01595009|156005791|FG002|Extension|Patients completed per protocol|0|||
48494899|NCT01595009|156005792|FG003|Extension|Patients completed per protocol|2|||
48597930|NCT03498313|156385168|FG000|Washout Period 2|Anovulation|0|||
48597931|NCT03498313|156385169|FG001|Washout Period 2|Anovulation|0|||
48597932|NCT03498313|156385170|FG002|Washout Period 2|Anovulation|0|||
48597933|NCT03498313|156385171|FG003|Washout Period 2|Anovulation|0|||
48597934|NCT03498313|156385172|FG004|Washout Period 2|Anovulation|0|||
48597935|NCT03498313|156385173|FG005|Washout Period 2|Anovulation|1|||
48597936|NCT00522548|156385177|FG000|Overall Study|Adverse Event|2|||
48597937|NCT00522548|156385178|FG001|Overall Study|Adverse Event|2|||
48597938|NCT00522548|156385177|FG000|Overall Study|Withdrawal by Subject|0|||
48597939|NCT00522548|156385178|FG001|Overall Study|Withdrawal by Subject|2|||
48597940|NCT02035553|156385183|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
48597941|NCT02035553|156385184|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
48597942|NCT02035553|156385183|FG000|Overall Study|Adverse Event|10|||
48597943|NCT02035553|156385184|FG001|Overall Study|Adverse Event|6|||
48494900|NCT01595009|156005789|FG000|Extension|Disease progression|0|||
48597944|NCT02035553|156385183|FG000|Overall Study|Physician Decision|3|||
48597945|NCT02035553|156385184|FG001|Overall Study|Physician Decision|2|||
48597946|NCT02035553|156385183|FG000|Overall Study|Lack of Efficacy|1|||
48597947|NCT02035553|156385184|FG001|Overall Study|Lack of Efficacy|1|||
48597948|NCT02035553|156385183|FG000|Overall Study|Withdrawal by Subject|4|||
48597949|NCT02035553|156385184|FG001|Overall Study|Withdrawal by Subject|7|||
48713801|NCT01451437|156801500|FG008|Overall Study|Adverse Event|1|||
48713802|NCT01451437|156801492|FG000|Overall Study|Physician Decision|1|||
48494901|NCT01595009|156005790|FG001|Extension|Disease progression|0|||
48494902|NCT01595009|156005791|FG002|Extension|Disease progression|4|||
48494903|NCT01595009|156005792|FG003|Extension|Disease progression|7|||
48494904|NCT01595009|156005789|FG000|Extension|Adverse Event|0|||
48494905|NCT01595009|156005790|FG001|Extension|Adverse Event|0|||
48494906|NCT01595009|156005791|FG002|Extension|Adverse Event|0|||
48494907|NCT01595009|156005792|FG003|Extension|Adverse Event|1|||
48494908|NCT04956666|156005793|FG000|Overall Study|Adverse Event|18|||
48494909|NCT04956666|156005793|FG000|Overall Study|Physician Decision|5|||
48494910|NCT02623829|156005794|FG000|Overall Study|Lost to Follow-up|1|||
48494911|NCT02623829|156005795|FG001|Overall Study|Lost to Follow-up|1|||
48494912|NCT00192296|156005798|FG000|Overall Study|Withdrawal by Subject|0|||
48812405|NCT01320735|157153582|FG000|Overall Study|Lost to Follow-up|13|||
48494913|NCT00192296|156005799|FG001|Overall Study|Withdrawal by Subject|1|||
48494914|NCT00192296|156005800|FG002|Overall Study|Withdrawal by Subject|0|||
48494915|NCT00192296|156005801|FG003|Overall Study|Withdrawal by Subject|0|||
48494916|NCT00783796|156005803|FG000|Overall Study|Did not receive any stent|4|||
48494917|NCT00783796|156005803|FG000|Overall Study|Received non-XIENCE V stent|1|||
48494918|NCT00783796|156005803|FG000|Overall Study|Received commercial XIENCE V stent|1|||
48494919|NCT03465891|156005806|FG000|Overall Study|Withdrawal by Subject|0|||
48494920|NCT03465891|156005807|FG001|Overall Study|Withdrawal by Subject|1|||
48494921|NCT03465891|156005806|FG000|Overall Study|Disease progression|1|||
48494922|NCT03465891|156005807|FG001|Overall Study|Disease progression|0|||
48494923|NCT02497781|156005808|FG000|Overall Study|Withdrawal by Subject|2|||
48494924|NCT02497781|156005809|FG001|Overall Study|Withdrawal by Subject|0|||
48494925|NCT02497781|156005808|FG000|Overall Study|Lack of Efficacy|0|||
48494926|NCT02497781|156005809|FG001|Overall Study|Lack of Efficacy|1|||
48494927|NCT02497781|156005808|FG000|Overall Study|Randomised but not treated|1|||
48494928|NCT02497781|156005809|FG001|Overall Study|Randomised but not treated|1|||
48494929|NCT02497781|156005808|FG000|Overall Study|Lost to Follow-up|1|||
48494930|NCT02497781|156005809|FG001|Overall Study|Lost to Follow-up|1|||
48494931|NCT04128007|156005810|FG000|Overall Study|Withdrawal by Subject|9|||
48494932|NCT04128007|156005811|FG001|Overall Study|Withdrawal by Subject|6|||
48494933|NCT04128007|156005810|FG000|Overall Study|Protocol Violation|1|||
48494934|NCT04128007|156005811|FG001|Overall Study|Protocol Violation|0|||
48494935|NCT04128007|156005810|FG000|Overall Study|Lost to Follow-up|8|||
48494936|NCT04128007|156005811|FG001|Overall Study|Lost to Follow-up|7|||
48494937|NCT04128007|156005810|FG000|Overall Study|Adverse Event|5|||
48494938|NCT04128007|156005811|FG001|Overall Study|Adverse Event|2|||
48494939|NCT04128007|156005810|FG000|Overall Study|Not reported|0|||
48494940|NCT04128007|156005811|FG001|Overall Study|Not reported|2|||
48494941|NCT00319956|156005812|FG000|Overall Study|Death|20|||
48494942|NCT00319956|156005813|FG001|Overall Study|Death|24|||
48494943|NCT00788957|156005814|FG000|Part 1|Death|8|||
48494944|NCT00788957|156005815|FG001|Part 1|Death|0|||
48494945|NCT00788957|156005816|FG002|Part 1|Death|0|||
48494946|NCT00788957|156005817|FG003|Part 1|Death|0|||
48494947|NCT00788957|156005818|FG004|Part 1|Death|0|||
48494948|NCT00788957|156005819|FG005|Part 1|Death|0|||
48494949|NCT00788957|156005814|FG000|Part 1|Lost to Follow-up|1|||
48494950|NCT00788957|156005815|FG001|Part 1|Lost to Follow-up|0|||
48494951|NCT00788957|156005816|FG002|Part 1|Lost to Follow-up|0|||
48494952|NCT00788957|156005817|FG003|Part 1|Lost to Follow-up|0|||
48494953|NCT00788957|156005818|FG004|Part 1|Lost to Follow-up|0|||
48494954|NCT00788957|156005819|FG005|Part 1|Lost to Follow-up|0|||
48494955|NCT00788957|156005814|FG000|Part 2|Withdrawal by Subject|0|||
48494956|NCT00788957|156005815|FG001|Part 2|Withdrawal by Subject|9|||
48494957|NCT00788957|156005816|FG002|Part 2|Withdrawal by Subject|5|||
48494958|NCT00788957|156005817|FG003|Part 2|Withdrawal by Subject|3|||
48494959|NCT00788957|156005818|FG004|Part 2|Withdrawal by Subject|0|||
48494960|NCT00788957|156005819|FG005|Part 2|Withdrawal by Subject|0|||
48494961|NCT00788957|156005814|FG000|Part 2|Death|0|||
48494962|NCT00788957|156005815|FG001|Part 2|Death|32|||
48494963|NCT00788957|156005816|FG002|Part 2|Death|35|||
48494964|NCT00788957|156005817|FG003|Part 2|Death|37|||
48494965|NCT00788957|156005818|FG004|Part 2|Death|0|||
48494966|NCT00788957|156005819|FG005|Part 2|Death|0|||
48494967|NCT00788957|156005814|FG000|Part 2|Lost to Follow-up|0|||
48494968|NCT00788957|156005815|FG001|Part 2|Lost to Follow-up|0|||
48494969|NCT00788957|156005816|FG002|Part 2|Lost to Follow-up|3|||
48494970|NCT00788957|156005817|FG003|Part 2|Lost to Follow-up|0|||
48494971|NCT00788957|156005818|FG004|Part 2|Lost to Follow-up|0|||
48494972|NCT00788957|156005819|FG005|Part 2|Lost to Follow-up|0|||
48494973|NCT00788957|156005814|FG000|Part 2|On-study at time of data cut-off|0|||
48494974|NCT00788957|156005815|FG001|Part 2|On-study at time of data cut-off|1|||
48494975|NCT00788957|156005816|FG002|Part 2|On-study at time of data cut-off|1|||
48494976|NCT00788957|156005817|FG003|Part 2|On-study at time of data cut-off|1|||
48494977|NCT00788957|156005818|FG004|Part 2|On-study at time of data cut-off|0|||
48494978|NCT00788957|156005819|FG005|Part 2|On-study at time of data cut-off|0|||
48494979|NCT00788957|156005814|FG000|Part 3|Withdrawal by Subject|0|||
48494980|NCT00788957|156005815|FG001|Part 3|Withdrawal by Subject|0|||
48494981|NCT00788957|156005816|FG002|Part 3|Withdrawal by Subject|0|||
48494982|NCT00788957|156005817|FG003|Part 3|Withdrawal by Subject|0|||
48494983|NCT00788957|156005818|FG004|Part 3|Withdrawal by Subject|0|||
48494984|NCT00788957|156005819|FG005|Part 3|Withdrawal by Subject|2|||
48494985|NCT00788957|156005814|FG000|Part 3|Death|0|||
48494986|NCT00788957|156005815|FG001|Part 3|Death|0|||
48494987|NCT00788957|156005816|FG002|Part 3|Death|0|||
48494988|NCT00788957|156005817|FG003|Part 3|Death|0|||
48494989|NCT00788957|156005818|FG004|Part 3|Death|8|||
48494990|NCT00788957|156005819|FG005|Part 3|Death|8|||
48494991|NCT00788957|156005814|FG000|Part 3|On-study at time of data cut-off|0|||
48494992|NCT00788957|156005815|FG001|Part 3|On-study at time of data cut-off|0|||
48494993|NCT00788957|156005816|FG002|Part 3|On-study at time of data cut-off|0|||
48494994|NCT00788957|156005817|FG003|Part 3|On-study at time of data cut-off|0|||
48494995|NCT00788957|156005818|FG004|Part 3|On-study at time of data cut-off|1|||
48494996|NCT00788957|156005819|FG005|Part 3|On-study at time of data cut-off|0|||
48494997|NCT02568384|156005821|FG000|Overall Study|Mobile devices incompatible with App|2|||
48494998|NCT00796510|156005822|FG000|Overall Study|Death|1|||
48494999|NCT00796510|156005823|FG001|Overall Study|Death|0|||
48495000|NCT00796510|156005822|FG000|Overall Study|Study Terminated|2|||
48495001|NCT00796510|156005823|FG001|Overall Study|Study Terminated|0|||
48495002|NCT00203307|156005824|FG000|First Intervention|Adverse Event|2|||
48495003|NCT00203307|156005825|FG001|First Intervention|Adverse Event|0|||
48495004|NCT01734772|156005826|FG000|Overall Study|Adverse Event|1|||
48495005|NCT01734772|156005827|FG001|Overall Study|Adverse Event|2|||
48495006|NCT01734772|156005826|FG000|Overall Study|Withdrawal by Subject|0|||
48495007|NCT01734772|156005827|FG001|Overall Study|Withdrawal by Subject|1|||
48495008|NCT02579096|156005831|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
48495009|NCT02579096|156005832|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
48495010|NCT02579096|156005831|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
48495011|NCT02579096|156005832|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
48495012|NCT02579096|156005831|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
48495013|NCT02579096|156005832|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
48495014|NCT02579096|156005831|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
48495015|NCT02579096|156005832|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
48495016|NCT02579096|156005831|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
48495017|NCT02579096|156005832|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
48495018|NCT02579096|156005831|FG000|Phase 2, Weeks 25 - 48|Death|2|||
48495019|NCT02579096|156005832|FG001|Phase 2, Weeks 25 - 48|Death|4|||
48495020|NCT02579096|156005831|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
48495021|NCT02579096|156005832|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
48495022|NCT02579096|156005831|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
48495023|NCT02579096|156005832|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
48495024|NCT02579096|156005831|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
48495025|NCT02579096|156005832|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
48495026|NCT02579096|156005831|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
48495027|NCT02579096|156005832|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
48495028|NCT02579096|156005831|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
48495029|NCT02579096|156005832|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
48495030|NCT02579096|156005831|FG000|Phase 3, Weeks 49 - 72|Death|3|||
48495031|NCT02579096|156005832|FG001|Phase 3, Weeks 49 - 72|Death|2|||
48495032|NCT02579096|156005831|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
48495033|NCT02579096|156005832|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
48495034|NCT02579096|156005831|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
48495035|NCT02579096|156005832|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
48495036|NCT02579096|156005831|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
48495037|NCT02579096|156005832|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
48495038|NCT02579096|156005831|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
48495039|NCT02579096|156005832|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
48495040|NCT02579096|156005831|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
48495041|NCT02579096|156005832|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
48495042|NCT02579096|156005831|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
48495043|NCT02579096|156005832|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
48495044|NCT00522457|156005833|FG000|Overall Study|Due to disease progression|16|||
48495045|NCT00522457|156005833|FG000|Overall Study|Adverse Event|2|||
48495046|NCT00601484|156005838|FG000|Overall Study|Adverse Event|0|||
48495047|NCT00601484|156005839|FG001|Overall Study|Adverse Event|1|||
48495048|NCT00601484|156005838|FG000|Overall Study|Lost to Follow-up|4|||
48495049|NCT00601484|156005839|FG001|Overall Study|Lost to Follow-up|3|||
48495050|NCT00601484|156005838|FG000|Overall Study|Lack of Efficacy|0|||
48495051|NCT00601484|156005839|FG001|Overall Study|Lack of Efficacy|2|||
48495052|NCT00601484|156005838|FG000|Overall Study|Withdrawal by Subject|1|||
48495053|NCT00601484|156005839|FG001|Overall Study|Withdrawal by Subject|1|||
48495054|NCT00601484|156005838|FG000|Overall Study|Randomized, but not treated|0|||
48495055|NCT00601484|156005839|FG001|Overall Study|Randomized, but not treated|1|||
48495056|NCT01475474|156005840|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
48495057|NCT01475474|156005840|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
48495058|NCT02343120|156005841|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
48495059|NCT02343120|156005842|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
48495060|NCT02343120|156005843|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
48495061|NCT02343120|156005844|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
48495062|NCT02343120|156005845|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
48495063|NCT02343120|156005841|FG000|Part 1: Dose Escalation|Death|1|||
48495064|NCT02343120|156005842|FG001|Part 1: Dose Escalation|Death|2|||
48495065|NCT02343120|156005843|FG002|Part 1: Dose Escalation|Death|2|||
48495066|NCT02343120|156005844|FG003|Part 1: Dose Escalation|Death|2|||
48495067|NCT02343120|156005845|FG004|Part 1: Dose Escalation|Death|1|||
48495068|NCT02343120|156005841|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
48495069|NCT02343120|156005842|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
48495070|NCT02343120|156005843|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
48495071|NCT02343120|156005844|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
48495072|NCT02343120|156005845|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
48495073|NCT02343120|156005841|FG000|Part 2: Expansion|Sponsor decision|0|||
48597950|NCT02035553|156385183|FG000|Overall Study|Non-compliance with Study Drug|0|||
48597951|NCT02035553|156385184|FG001|Overall Study|Non-compliance with Study Drug|1|||
48495074|NCT02343120|156005842|FG001|Part 2: Expansion|Sponsor decision|0|||
48495075|NCT02343120|156005843|FG002|Part 2: Expansion|Sponsor decision|0|||
48495076|NCT02343120|156005844|FG003|Part 2: Expansion|Sponsor decision|165|||
48495077|NCT02343120|156005845|FG004|Part 2: Expansion|Sponsor decision|67|||
48495078|NCT02343120|156005841|FG000|Part 2: Expansion|Death|0|||
48495079|NCT02343120|156005842|FG001|Part 2: Expansion|Death|0|||
48495080|NCT02343120|156005843|FG002|Part 2: Expansion|Death|0|||
48495081|NCT02343120|156005844|FG003|Part 2: Expansion|Death|74|||
48495082|NCT02343120|156005845|FG004|Part 2: Expansion|Death|17|||
48495083|NCT02343120|156005841|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
48495084|NCT02343120|156005842|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
48495085|NCT02343120|156005843|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
48495086|NCT02343120|156005844|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
48495087|NCT02343120|156005845|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
48495088|NCT02343120|156005841|FG000|Part 2: Expansion|Lost to Follow-up|0|||
48495089|NCT02343120|156005842|FG001|Part 2: Expansion|Lost to Follow-up|0|||
48495090|NCT02343120|156005843|FG002|Part 2: Expansion|Lost to Follow-up|0|||
48495091|NCT02343120|156005844|FG003|Part 2: Expansion|Lost to Follow-up|5|||
48495092|NCT02343120|156005845|FG004|Part 2: Expansion|Lost to Follow-up|2|||
48495093|NCT02343120|156005841|FG000|Part 2: Expansion|Other|0|||
48495094|NCT02343120|156005842|FG001|Part 2: Expansion|Other|0|||
48495095|NCT02343120|156005843|FG002|Part 2: Expansion|Other|0|||
48495096|NCT02343120|156005844|FG003|Part 2: Expansion|Other|1|||
48495097|NCT02343120|156005845|FG004|Part 2: Expansion|Other|5|||
48495098|NCT02343120|156005841|FG000|Part 2: Expansion|Adverse Event|0|||
48495099|NCT02343120|156005842|FG001|Part 2: Expansion|Adverse Event|0|||
48495100|NCT02343120|156005843|FG002|Part 2: Expansion|Adverse Event|0|||
48495101|NCT02343120|156005844|FG003|Part 2: Expansion|Adverse Event|1|||
48495102|NCT02343120|156005845|FG004|Part 2: Expansion|Adverse Event|1|||
48495103|NCT02928848|156005847|FG000|Arm 2|Withdrawal by Subject|1|||
48495104|NCT02928848|156005848|FG001|Arm 2|Withdrawal by Subject|0|||
48495105|NCT00663871|156005851|FG000|Overall Study|Lost to Follow-up|5|||
48495106|NCT00663871|156005852|FG001|Overall Study|Lost to Follow-up|5|||
48495107|NCT00663871|156005851|FG000|Overall Study|Withdrawal by Subject|5|||
48495108|NCT00663871|156005852|FG001|Overall Study|Withdrawal by Subject|2|||
48495109|NCT00743197|156005855|FG000|Overall Study|Study terminated due to departure of PI.|1|||
48495110|NCT00743197|156005856|FG001|Overall Study|Study terminated due to departure of PI.|2|||
48495111|NCT01133821|156007777|FG000|Overall Study|Lost to Follow-up|8|||
48495112|NCT01133821|156007778|FG001|Overall Study|Lost to Follow-up|11|||
48495113|NCT01133821|156007777|FG000|Overall Study|Withdrawal by Subject|8|||
48495114|NCT01133821|156007778|FG001|Overall Study|Withdrawal by Subject|3|||
48597952|NCT02035553|156385183|FG000|Overall Study|Lost to Follow-up|0|||
48495115|NCT01133821|156007777|FG000|Overall Study|preferred other treatment|1|||
48495116|NCT01133821|156007778|FG001|Overall Study|preferred other treatment|1|||
48495117|NCT01133821|156007777|FG000|Overall Study|Protocol Violation|0|||
48495118|NCT01133821|156007778|FG001|Overall Study|Protocol Violation|1|||
48495119|NCT01133821|156007777|FG000|Overall Study|Refused participation|1|||
48495120|NCT01133821|156007778|FG001|Overall Study|Refused participation|3|||
48495121|NCT04588259|156007779|FG000|Run-in Period|Run-in failure|0|||
48495122|NCT04588259|156007780|FG001|Run-in Period|Run-in failure|23|||
48495123|NCT04588259|156007779|FG000|Run-in Period|Withdrawn before randomisation|0|||
48495124|NCT04588259|156007780|FG001|Run-in Period|Withdrawn before randomisation|8|||
48495125|NCT04588259|156007779|FG000|Treatment Period|Withdrawal by Subject|6|||
48495126|NCT04588259|156007780|FG001|Treatment Period|Withdrawal by Subject|6|||
48495127|NCT00434161|156007783|FG000|Overall Study|Adverse Event|5|||
48495128|NCT00434161|156007784|FG001|Overall Study|Adverse Event|1|||
48495129|NCT00434161|156007785|FG002|Overall Study|Adverse Event|4|||
48495130|NCT00434161|156007783|FG000|Overall Study|Lost to Follow-up|0|||
48495131|NCT00434161|156007784|FG001|Overall Study|Lost to Follow-up|1|||
48495132|NCT00434161|156007785|FG002|Overall Study|Lost to Follow-up|0|||
48495133|NCT00434161|156007783|FG000|Overall Study|Death|1|||
48495134|NCT00434161|156007784|FG001|Overall Study|Death|0|||
48495135|NCT00434161|156007785|FG002|Overall Study|Death|1|||
48495136|NCT00434161|156007783|FG000|Overall Study|Non-Compliance|1|||
48495137|NCT00434161|156007784|FG001|Overall Study|Non-Compliance|1|||
48495138|NCT00434161|156007785|FG002|Overall Study|Non-Compliance|0|||
48495139|NCT00434161|156007783|FG000|Overall Study|Withdrawal by Subject|2|||
48495140|NCT00434161|156007784|FG001|Overall Study|Withdrawal by Subject|0|||
48495141|NCT00434161|156007785|FG002|Overall Study|Withdrawal by Subject|3|||
48495142|NCT00434161|156007783|FG000|Overall Study|Logistical error study assessments|1|||
48495143|NCT00434161|156007784|FG001|Overall Study|Logistical error study assessments|0|||
48495144|NCT00434161|156007785|FG002|Overall Study|Logistical error study assessments|3|||
48495145|NCT03342898|156007790|FG000|Overall Study|Adverse Event|3|||
48495146|NCT03342898|156007791|FG001|Overall Study|Adverse Event|1|||
48495147|NCT03342898|156007792|FG002|Overall Study|Adverse Event|0|||
48495148|NCT03342898|156007790|FG000|Overall Study|Lost to Follow-up|44|||
48495149|NCT03342898|156007791|FG001|Overall Study|Lost to Follow-up|40|||
48495150|NCT03342898|156007792|FG002|Overall Study|Lost to Follow-up|42|||
48495151|NCT03342898|156007790|FG000|Overall Study|Withdrawal of Consent|5|||
48495152|NCT03342898|156007791|FG001|Overall Study|Withdrawal of Consent|9|||
48495153|NCT03342898|156007792|FG002|Overall Study|Withdrawal of Consent|11|||
48495154|NCT03342898|156007790|FG000|Overall Study|Death|0|||
48495155|NCT03342898|156007791|FG001|Overall Study|Death|1|||
48495156|NCT03342898|156007792|FG002|Overall Study|Death|1|||
48495157|NCT03342898|156007790|FG000|Overall Study|Reason not Specified|2|||
48495158|NCT03342898|156007791|FG001|Overall Study|Reason not Specified|2|||
48495159|NCT03342898|156007792|FG002|Overall Study|Reason not Specified|0|||
48495160|NCT01387282|156007793|FG000|Overall Study|Death|47|||
48495161|NCT01387282|156007794|FG001|Overall Study|Death|16|||
48495162|NCT01387282|156007793|FG000|Overall Study|Other|5|||
48495163|NCT01387282|156007794|FG001|Overall Study|Other|1|||
48495164|NCT01387282|156007793|FG000|Overall Study|Unrelated AE|6|||
48495165|NCT01387282|156007794|FG001|Overall Study|Unrelated AE|4|||
48495166|NCT01387282|156007793|FG000|Overall Study|Withdrawal by patient|33|||
48495167|NCT01387282|156007794|FG001|Overall Study|Withdrawal by patient|23|||
48495168|NCT01387282|156007793|FG000|Overall Study|Study drug-related AE|2|||
48495169|NCT01387282|156007794|FG001|Overall Study|Study drug-related AE|2|||
48495170|NCT01387282|156007793|FG000|Overall Study|Lost to Follow-up|4|||
48495171|NCT01387282|156007794|FG001|Overall Study|Lost to Follow-up|1|||
48812406|NCT01320735|157153582|FG000|Overall Study|Administrative Reason|6|||
48495172|NCT02507375|156007795|FG000|Overall Study|Progressive Disease|4|||
48495173|NCT02507375|156007796|FG001|Overall Study|Progressive Disease|5|||
48812407|NCT01320735|157153582|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
48812408|NCT01320735|157153582|FG000|Overall Study|Protocol Violation|1|||
48812409|NCT01320735|157153582|FG000|Overall Study|Other|1|||
48812410|NCT01320735|157153582|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
48812411|NCT01320735|157153582|FG000|Overall Study|Investigator Unable to be Contacted|17|||
48812412|NCT03632434|157153583|FG000|Overall Study|Withdrawal by Subject|2|||
48812413|NCT00544544|157153586|FG000|Overall Study|Withdrawal by Subject|1|||
48812414|NCT00544544|157153586|FG000|Overall Study|Adverse Event|1|||
48812415|NCT00544544|157153586|FG000|Overall Study|Lost to Follow-up|1|||
48812416|NCT01051063|157153590|FG000|Overall Study|Death|2|||
48812417|NCT01051063|157153591|FG001|Overall Study|Death|2|||
48812418|NCT01051063|157153590|FG000|Overall Study|Withdrawal by Subject|1|||
48812419|NCT01051063|157153591|FG001|Overall Study|Withdrawal by Subject|1|||
48812420|NCT01051063|157153590|FG000|Overall Study|Termination of the study|5|||
48812421|NCT01051063|157153591|FG001|Overall Study|Termination of the study|0|||
48495174|NCT02507375|156007795|FG000|Overall Study|Death|0|||
48495175|NCT02507375|156007796|FG001|Overall Study|Death|1|||
48495176|NCT02507375|156007795|FG000|Overall Study|Refused treatment|0|||
48495177|NCT02507375|156007796|FG001|Overall Study|Refused treatment|1|||
48495178|NCT02507375|156007795|FG000|Overall Study|Adverse Event|0|||
48495179|NCT02507375|156007796|FG001|Overall Study|Adverse Event|1|||
48495180|NCT01625377|156007797|FG000|Overall Study|Death|1|||
48495181|NCT01625377|156007798|FG001|Overall Study|Death|1|||
48495182|NCT01625377|156007797|FG000|Overall Study|Administrative Problem|1|||
48812422|NCT01051063|157153590|FG000|Overall Study|Moved from the study site area|1|||
48812423|NCT01051063|157153591|FG001|Overall Study|Moved from the study site area|0|||
48812424|NCT01051063|157153590|FG000|Overall Study|Other|1|||
48495183|NCT01625377|156007798|FG001|Overall Study|Administrative Problem|1|||
48495184|NCT01625377|156007797|FG000|Overall Study|Protocol Violation|0|||
48495185|NCT01625377|156007798|FG001|Overall Study|Protocol Violation|3|||
48713803|NCT01451437|156801493|FG001|Overall Study|Physician Decision|1|||
48713804|NCT01451437|156801494|FG002|Overall Study|Physician Decision|2|||
48713805|NCT01451437|156801495|FG003|Overall Study|Physician Decision|0|||
48713806|NCT01451437|156801496|FG004|Overall Study|Physician Decision|0|||
48713807|NCT01451437|156801497|FG005|Overall Study|Physician Decision|0|||
48713808|NCT01451437|156801498|FG006|Overall Study|Physician Decision|0|||
48713809|NCT01451437|156801499|FG007|Overall Study|Physician Decision|0|||
48713810|NCT01451437|156801500|FG008|Overall Study|Physician Decision|0|||
48713811|NCT01451437|156801492|FG000|Overall Study|Disease Progression|0|||
48713812|NCT01451437|156801493|FG001|Overall Study|Disease Progression|0|||
48713813|NCT01451437|156801494|FG002|Overall Study|Disease Progression|1|||
48713814|NCT01451437|156801495|FG003|Overall Study|Disease Progression|1|||
48713815|NCT01451437|156801496|FG004|Overall Study|Disease Progression|3|||
48812425|NCT01051063|157153591|FG001|Overall Study|Other|0|||
48812426|NCT01051063|157153590|FG000|Overall Study|Lost to Follow-up|0|||
48812427|NCT01051063|157153591|FG001|Overall Study|Lost to Follow-up|1|||
48812428|NCT00519636|157153592|FG000|Treatment Period 1|Adverse Event|1|||
48812429|NCT00519636|157153593|FG001|Treatment Period 1|Adverse Event|0|||
48812430|NCT00519636|157153594|FG002|Treatment Period 1|Adverse Event|1|||
48812431|NCT00519636|157153595|FG003|Treatment Period 1|Adverse Event|0|||
48812432|NCT00519636|157153592|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
48812433|NCT00519636|157153593|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
48812434|NCT00519636|157153594|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
48812435|NCT00519636|157153595|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
48713816|NCT01451437|156801497|FG005|Overall Study|Disease Progression|2|||
48713817|NCT01451437|156801498|FG006|Overall Study|Disease Progression|3|||
48812436|NCT00519636|157153592|FG000|Washout Period|Adverse Event|2|||
48812437|NCT00519636|157153593|FG001|Washout Period|Adverse Event|1|||
48812438|NCT00519636|157153594|FG002|Washout Period|Adverse Event|1|||
48713818|NCT01451437|156801499|FG007|Overall Study|Disease Progression|1|||
48713819|NCT01451437|156801500|FG008|Overall Study|Disease Progression|3|||
48713820|NCT01451437|156801492|FG000|Overall Study|Protocol Violation|0|||
48495186|NCT01625377|156007797|FG000|Overall Study|Adverse Event|3|||
48495187|NCT01625377|156007798|FG001|Overall Study|Adverse Event|16|||
48495188|NCT01625377|156007797|FG000|Overall Study|Graft loss|1|||
48495189|NCT01625377|156007798|FG001|Overall Study|Graft loss|0|||
48713821|NCT01451437|156801493|FG001|Overall Study|Protocol Violation|0|||
48713822|NCT01451437|156801494|FG002|Overall Study|Protocol Violation|0|||
48713823|NCT01451437|156801495|FG003|Overall Study|Protocol Violation|0|||
48713824|NCT01451437|156801496|FG004|Overall Study|Protocol Violation|0|||
48713825|NCT01451437|156801497|FG005|Overall Study|Protocol Violation|0|||
48713826|NCT01451437|156801498|FG006|Overall Study|Protocol Violation|1|||
48713827|NCT01451437|156801499|FG007|Overall Study|Protocol Violation|0|||
48713828|NCT01451437|156801500|FG008|Overall Study|Protocol Violation|0|||
48713829|NCT01451437|156801492|FG000|Overall Study|Withdrawal by Subject|0|||
48713830|NCT01451437|156801493|FG001|Overall Study|Withdrawal by Subject|0|||
48713831|NCT01451437|156801494|FG002|Overall Study|Withdrawal by Subject|0|||
48713832|NCT01451437|156801495|FG003|Overall Study|Withdrawal by Subject|0|||
48713833|NCT01451437|156801496|FG004|Overall Study|Withdrawal by Subject|1|||
48713834|NCT01451437|156801497|FG005|Overall Study|Withdrawal by Subject|0|||
48713835|NCT01451437|156801498|FG006|Overall Study|Withdrawal by Subject|1|||
48713836|NCT01451437|156801499|FG007|Overall Study|Withdrawal by Subject|0|||
48713837|NCT01451437|156801500|FG008|Overall Study|Withdrawal by Subject|0|||
48713838|NCT02529553|156801503|FG000|Overall Study|Progressive Disease|1|||
48713839|NCT02529553|156801504|FG001|Overall Study|Progressive Disease|0|||
48713840|NCT02529553|156801505|FG002|Overall Study|Progressive Disease|1|||
48713841|NCT02529553|156801506|FG003|Overall Study|Progressive Disease|3|||
48713842|NCT02529553|156801507|FG004|Overall Study|Progressive Disease|2|||
48713843|NCT02529553|156801508|FG005|Overall Study|Progressive Disease|3|||
48713844|NCT02529553|156801509|FG006|Overall Study|Progressive Disease|3|||
48713845|NCT02529553|156801510|FG007|Overall Study|Progressive Disease|5|||
48713846|NCT02529553|156801511|FG008|Overall Study|Progressive Disease|3|||
48713847|NCT02529553|156801503|FG000|Overall Study|Physician Decision|0|||
48713848|NCT02529553|156801504|FG001|Overall Study|Physician Decision|1|||
48713849|NCT02529553|156801505|FG002|Overall Study|Physician Decision|0|||
48713850|NCT02529553|156801506|FG003|Overall Study|Physician Decision|0|||
48713851|NCT02529553|156801507|FG004|Overall Study|Physician Decision|1|||
48713852|NCT02529553|156801508|FG005|Overall Study|Physician Decision|0|||
48713853|NCT02529553|156801509|FG006|Overall Study|Physician Decision|0|||
48713854|NCT02529553|156801510|FG007|Overall Study|Physician Decision|0|||
48713855|NCT02529553|156801511|FG008|Overall Study|Physician Decision|0|||
48713856|NCT02529553|156801503|FG000|Overall Study|Withdrawal by Subject|0|||
48713857|NCT02529553|156801504|FG001|Overall Study|Withdrawal by Subject|0|||
48713858|NCT02529553|156801505|FG002|Overall Study|Withdrawal by Subject|0|||
48713859|NCT02529553|156801506|FG003|Overall Study|Withdrawal by Subject|0|||
48495190|NCT01625377|156007797|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48713860|NCT02529553|156801507|FG004|Overall Study|Withdrawal by Subject|0|||
48713861|NCT02529553|156801508|FG005|Overall Study|Withdrawal by Subject|1|||
48713862|NCT02529553|156801509|FG006|Overall Study|Withdrawal by Subject|0|||
48713863|NCT02529553|156801510|FG007|Overall Study|Withdrawal by Subject|1|||
48495191|NCT01625377|156007798|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48495192|NCT01625377|156007797|FG000|Overall Study|Abnormal laboratory values|1|||
48812439|NCT00519636|157153595|FG003|Washout Period|Adverse Event|0|||
48812440|NCT00519636|157153592|FG000|Washout Period|Lost to Follow-up|1|||
48812441|NCT00519636|157153593|FG001|Washout Period|Lost to Follow-up|0|||
48812442|NCT00519636|157153594|FG002|Washout Period|Lost to Follow-up|0|||
48812443|NCT00519636|157153595|FG003|Washout Period|Lost to Follow-up|0|||
48812444|NCT00519636|157153592|FG000|Washout Period|Protocol Violation|0|||
48812445|NCT00519636|157153593|FG001|Washout Period|Protocol Violation|0|||
48812446|NCT00519636|157153594|FG002|Washout Period|Protocol Violation|1|||
48812447|NCT00519636|157153595|FG003|Washout Period|Protocol Violation|2|||
48812448|NCT00519636|157153592|FG000|Washout Period|Withdrawal by Subject|1|||
48812449|NCT00519636|157153593|FG001|Washout Period|Withdrawal by Subject|0|||
48812450|NCT00519636|157153594|FG002|Washout Period|Withdrawal by Subject|1|||
48812451|NCT00519636|157153595|FG003|Washout Period|Withdrawal by Subject|0|||
48812452|NCT00519636|157153592|FG000|Washout Period|Failed to meet continuation criteria|14|||
48812453|NCT00519636|157153593|FG001|Washout Period|Failed to meet continuation criteria|11|||
48812454|NCT00519636|157153594|FG002|Washout Period|Failed to meet continuation criteria|9|||
48812455|NCT00519636|157153595|FG003|Washout Period|Failed to meet continuation criteria|3|||
48812456|NCT00519636|157153592|FG000|Washout Period|Out of pollen area > 48 hours|1|||
48812457|NCT00519636|157153593|FG001|Washout Period|Out of pollen area > 48 hours|0|||
48812458|NCT00519636|157153594|FG002|Washout Period|Out of pollen area > 48 hours|0|||
48812459|NCT00519636|157153595|FG003|Washout Period|Out of pollen area > 48 hours|0|||
48812460|NCT00519636|157153592|FG000|Washout Period|Participating in study at another site|1|||
48812461|NCT00519636|157153593|FG001|Washout Period|Participating in study at another site|0|||
48812462|NCT00519636|157153594|FG002|Washout Period|Participating in study at another site|0|||
48812463|NCT00519636|157153595|FG003|Washout Period|Participating in study at another site|0|||
48812464|NCT00519636|157153592|FG000|Washout Period|Non-compliant|0|||
48812465|NCT00519636|157153593|FG001|Washout Period|Non-compliant|1|||
48812466|NCT00519636|157153594|FG002|Washout Period|Non-compliant|0|||
48812467|NCT00519636|157153595|FG003|Washout Period|Non-compliant|0|||
48812468|NCT00519636|157153592|FG000|Washout Period|Per doctors request|0|||
48812469|NCT00519636|157153593|FG001|Washout Period|Per doctors request|1|||
48812470|NCT00519636|157153594|FG002|Washout Period|Per doctors request|0|||
48812471|NCT00519636|157153595|FG003|Washout Period|Per doctors request|0|||
48812472|NCT00519636|157153592|FG000|Washout Period|Subject randomized in error|0|||
48812473|NCT00519636|157153593|FG001|Washout Period|Subject randomized in error|0|||
48812474|NCT00519636|157153594|FG002|Washout Period|Subject randomized in error|1|||
48812475|NCT00519636|157153595|FG003|Washout Period|Subject randomized in error|0|||
48812476|NCT00519636|157153592|FG000|Washout Period|Prohibited medications|0|||
48812477|NCT00519636|157153593|FG001|Washout Period|Prohibited medications|0|||
48812478|NCT00519636|157153594|FG002|Washout Period|Prohibited medications|1|||
48812479|NCT00519636|157153595|FG003|Washout Period|Prohibited medications|0|||
48812480|NCT00519636|157153592|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
48812481|NCT00519636|157153593|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
48812482|NCT00519636|157153594|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
48812483|NCT00519636|157153595|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
48812484|NCT00519636|157153592|FG000|Treatment Period 2|Subject randomized in error|0|||
48812485|NCT00519636|157153593|FG001|Treatment Period 2|Subject randomized in error|1|||
48812486|NCT00519636|157153594|FG002|Treatment Period 2|Subject randomized in error|0|||
48812487|NCT00519636|157153595|FG003|Treatment Period 2|Subject randomized in error|0|||
48812488|NCT00519636|157153592|FG000|Treatment Period 2|Per doctors request|0|||
48812489|NCT00519636|157153593|FG001|Treatment Period 2|Per doctors request|0|||
48812490|NCT00519636|157153594|FG002|Treatment Period 2|Per doctors request|1|||
48812491|NCT00519636|157153595|FG003|Treatment Period 2|Per doctors request|0|||
48812492|NCT00519636|157153592|FG000|Treatment Period 2|Subject misrandomized|0|||
48812493|NCT00519636|157153593|FG001|Treatment Period 2|Subject misrandomized|0|||
48812494|NCT00519636|157153594|FG002|Treatment Period 2|Subject misrandomized|0|||
48812495|NCT00519636|157153595|FG003|Treatment Period 2|Subject misrandomized|1|||
48812496|NCT00519636|157153592|FG000|Post Study Period|Subject randomized in error|0|||
48812497|NCT00519636|157153593|FG001|Post Study Period|Subject randomized in error|0|||
48812498|NCT00519636|157153594|FG002|Post Study Period|Subject randomized in error|0|||
48812499|NCT00519636|157153595|FG003|Post Study Period|Subject randomized in error|1|||
48812500|NCT02388074|157153596|FG000|Overall Study|Lost in Transit|2|||
48812501|NCT02388074|157153596|FG000|Overall Study|Sample Not Returned|1|||
48812502|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
48495193|NCT01625377|156007798|FG001|Overall Study|Abnormal laboratory values|0|||
48812503|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
48812504|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
48495194|NCT00294723|156007801|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
48495195|NCT00294723|156007802|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
48812505|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
48812506|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
48495196|NCT00294723|156007803|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
48812507|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
48812508|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
48812509|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
48812510|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
48812511|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
48812512|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
48812513|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
48812514|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
48812515|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
48812516|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
48812517|NCT02023879|157153598|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
48812518|NCT02023879|157153599|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
48812519|NCT02023879|157153600|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
48812520|NCT02023879|157153598|FG000|Extension Open Label Treatment|Adverse Event|1|||
48812521|NCT02023879|157153599|FG001|Extension Open Label Treatment|Adverse Event|7|||
48812522|NCT02023879|157153600|FG002|Extension Open Label Treatment|Adverse Event|3|||
48812523|NCT02023879|157153598|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
48812524|NCT02023879|157153599|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
48812525|NCT02023879|157153600|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
48812526|NCT02023879|157153598|FG000|Extension Open Label Treatment|Participant moved|1|||
48812527|NCT02023879|157153599|FG001|Extension Open Label Treatment|Participant moved|2|||
48812528|NCT02023879|157153600|FG002|Extension Open Label Treatment|Participant moved|0|||
48812529|NCT02023879|157153598|FG000|Extension Open Label Treatment|Other than specified above|2|||
48812530|NCT02023879|157153599|FG001|Extension Open Label Treatment|Other than specified above|7|||
48812531|NCT02023879|157153600|FG002|Extension Open Label Treatment|Other than specified above|2|||
48812532|NCT03857841|157153601|FG000|Overall Study|Death|1|||
48812533|NCT03857841|157153602|FG001|Overall Study|Death|0|||
48812534|NCT03857841|157153603|FG002|Overall Study|Death|0|||
48812535|NCT03857841|157153604|FG003|Overall Study|Death|0|||
48812536|NCT03857841|157153601|FG000|Overall Study|Study Terminated by Sponsor|1|||
48812537|NCT03857841|157153602|FG001|Overall Study|Study Terminated by Sponsor|0|||
48812538|NCT03857841|157153603|FG002|Overall Study|Study Terminated by Sponsor|0|||
48812539|NCT03857841|157153604|FG003|Overall Study|Study Terminated by Sponsor|0|||
48812540|NCT01671748|157153605|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
48812541|NCT01671748|157153606|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
48812542|NCT01671748|157153605|FG000|4 Week run-in Phase|Adverse Event|1|||
48812543|NCT01671748|157153606|FG001|4 Week run-in Phase|Adverse Event|0|||
48812544|NCT01671748|157153605|FG000|4 Week run-in Phase|Not eligible|9|||
48812545|NCT01671748|157153606|FG001|4 Week run-in Phase|Not eligible|0|||
48812546|NCT04249336|157155365|FG000|Overall Study|Lost to Follow-up|3|||
48812547|NCT04249336|157155366|FG001|Overall Study|Lost to Follow-up|3|||
48812548|NCT04249336|157155367|FG002|Overall Study|Lost to Follow-up|3|||
48812549|NCT04249336|157155368|FG003|Overall Study|Lost to Follow-up|3|||
48812550|NCT03029247|157155370|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
48812551|NCT03029247|157155371|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
48812552|NCT03029247|157155370|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
48812553|NCT03029247|157155371|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
48812554|NCT03029247|157155370|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
48812555|NCT03029247|157155371|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
48812556|NCT03029247|157155370|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
48597953|NCT02035553|156385184|FG001|Overall Study|Lost to Follow-up|1|||
48597954|NCT02035553|156385183|FG000|Overall Study|Other Reason|0|||
48597955|NCT02035553|156385184|FG001|Overall Study|Other Reason|4|||
48597956|NCT00169104|156385185|FG000|Overall Study|Withdrawal by Subject|2|||
48597957|NCT00169104|156385186|FG001|Overall Study|Withdrawal by Subject|0|||
48597958|NCT00169104|156385185|FG000|Overall Study|Protocol Violation|0|||
48597959|NCT00169104|156385186|FG001|Overall Study|Protocol Violation|1|||
48597960|NCT00169104|156385185|FG000|Overall Study|Physician Decision|0|||
48597961|NCT00169104|156385186|FG001|Overall Study|Physician Decision|1|||
48597962|NCT01854697|156385187|FG000|Overall Study|Adverse Event|1|||
48597963|NCT01854697|156385188|FG001|Overall Study|Adverse Event|0|||
48597964|NCT01854697|156385189|FG002|Overall Study|Adverse Event|0|||
48597965|NCT01854697|156385190|FG003|Overall Study|Adverse Event|0|||
48597966|NCT01854697|156385191|FG004|Overall Study|Adverse Event|1|||
48597967|NCT01854697|156385187|FG000|Overall Study|Lost to Follow-up|4|||
48597968|NCT01854697|156385188|FG001|Overall Study|Lost to Follow-up|1|||
48597969|NCT01854697|156385189|FG002|Overall Study|Lost to Follow-up|1|||
48597970|NCT01854697|156385190|FG003|Overall Study|Lost to Follow-up|2|||
48597971|NCT01854697|156385191|FG004|Overall Study|Lost to Follow-up|0|||
48597972|NCT01854697|156385187|FG000|Overall Study|To enter another AbbVie study|1|||
48597973|NCT01854697|156385188|FG001|Overall Study|To enter another AbbVie study|0|||
48597974|NCT01854697|156385189|FG002|Overall Study|To enter another AbbVie study|0|||
48597975|NCT01854697|156385190|FG003|Overall Study|To enter another AbbVie study|0|||
48597976|NCT01854697|156385191|FG004|Overall Study|To enter another AbbVie study|1|||
48597977|NCT01854697|156385187|FG000|Overall Study|Withdrew Consent|0|||
48597978|NCT01854697|156385188|FG001|Overall Study|Withdrew Consent|1|||
48597979|NCT01854697|156385189|FG002|Overall Study|Withdrew Consent|0|||
48597980|NCT01854697|156385190|FG003|Overall Study|Withdrew Consent|1|||
48597981|NCT01854697|156385191|FG004|Overall Study|Withdrew Consent|0|||
48597982|NCT01854697|156385187|FG000|Overall Study|Other|0|||
48812557|NCT03029247|157155371|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
48597983|NCT01854697|156385188|FG001|Overall Study|Other|1|||
48597984|NCT01854697|156385189|FG002|Overall Study|Other|1|||
48597985|NCT01854697|156385190|FG003|Overall Study|Other|0|||
48597986|NCT01854697|156385191|FG004|Overall Study|Other|0|||
48597987|NCT01178125|156385195|FG000|Overall Study|Lost to Follow-up|397|||
48597988|NCT01178125|156385195|FG000|Overall Study|Adverse Event|244|||
48597989|NCT01178125|156385195|FG000|Overall Study|Withdrawal by Subject|209|||
48597990|NCT01178125|156385195|FG000|Overall Study|Noncompliance|184|||
48597991|NCT01178125|156385195|FG000|Overall Study|Pregnancy|55|||
48713864|NCT02529553|156801511|FG008|Overall Study|Withdrawal by Subject|0|||
48713865|NCT01808092|156801514|FG000|Overall Study|Death|39|||
48713866|NCT01808092|156801515|FG001|Overall Study|Death|29|||
48713867|NCT01808092|156801514|FG000|Overall Study|Lost to Follow-up|3|||
48713868|NCT01808092|156801515|FG001|Overall Study|Lost to Follow-up|7|||
48713869|NCT01808092|156801514|FG000|Overall Study|Withdrawal by Subject|9|||
48713870|NCT01808092|156801515|FG001|Overall Study|Withdrawal by Subject|4|||
48713871|NCT01808092|156801514|FG000|Overall Study|Other Eligibility criteria|3|||
48713872|NCT01808092|156801515|FG001|Overall Study|Other Eligibility criteria|5|||
48713873|NCT03207763|156803072|FG000|Overall Study|Lost to Follow-up|1|||
48713874|NCT03207763|156803073|FG001|Overall Study|Lost to Follow-up|0|||
48713875|NCT03844945|156803074|FG000|Overall Study|Adverse Event|1|||
48713876|NCT03844945|156803075|FG001|Overall Study|Adverse Event|1|||
48713877|NCT03844945|156803076|FG002|Overall Study|Adverse Event|4|||
48713878|NCT03844945|156803077|FG003|Overall Study|Adverse Event|0|||
48713879|NCT03844945|156803074|FG000|Overall Study|Withdrawal by Subject|0|||
48713880|NCT03844945|156803075|FG001|Overall Study|Withdrawal by Subject|0|||
48713881|NCT03844945|156803076|FG002|Overall Study|Withdrawal by Subject|1|||
48713882|NCT03844945|156803077|FG003|Overall Study|Withdrawal by Subject|0|||
48713883|NCT03844945|156803074|FG000|Overall Study|Lack of Efficacy|0|||
48713884|NCT03844945|156803075|FG001|Overall Study|Lack of Efficacy|0|||
48713885|NCT03844945|156803076|FG002|Overall Study|Lack of Efficacy|0|||
48713886|NCT03844945|156803077|FG003|Overall Study|Lack of Efficacy|1|||
48713887|NCT02565784|156803078|FG000|First Treatment|Adverse Event|1|||
48713888|NCT02565784|156803078|FG000|First Treatment|Withdrawal by Subject|1|||
48713889|NCT02565784|156803078|FG000|Second Treatment|Withdrawal by Subject|2|||
48713890|NCT00476008|156803080|FG000|Overall Study|Adverse Event|4|||
48713891|NCT00476008|156803081|FG001|Overall Study|Adverse Event|4|||
48713892|NCT00476008|156803080|FG000|Overall Study|Placebo concerns|2|||
48713893|NCT00476008|156803081|FG001|Overall Study|Placebo concerns|2|||
48713894|NCT00476008|156803080|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
48713895|NCT00476008|156803081|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
48713896|NCT00476008|156803080|FG000|Overall Study|Withdrawal by Subject|0|||
48713897|NCT00476008|156803081|FG001|Overall Study|Withdrawal by Subject|1|||
48713898|NCT00476008|156803080|FG000|Overall Study|Death|1|||
48713899|NCT00476008|156803081|FG001|Overall Study|Death|0|||
48713900|NCT00375609|156803082|FG000|Overall Study|Did not receive treatment|1|||
48713901|NCT00375609|156803083|FG001|Overall Study|Did not receive treatment|0|||
48713902|NCT00375609|156803084|FG002|Overall Study|Did not receive treatment|0|||
48713903|NCT00375609|156803082|FG000|Overall Study|Adverse Event|0|||
48713904|NCT00375609|156803083|FG001|Overall Study|Adverse Event|3|||
48713905|NCT00375609|156803084|FG002|Overall Study|Adverse Event|0|||
48713906|NCT00375609|156803082|FG000|Overall Study|Lost to Follow-up|1|||
48713907|NCT00375609|156803083|FG001|Overall Study|Lost to Follow-up|0|||
48713908|NCT00375609|156803084|FG002|Overall Study|Lost to Follow-up|0|||
48713909|NCT00375609|156803082|FG000|Overall Study|Physician Decision|0|||
48713910|NCT00375609|156803083|FG001|Overall Study|Physician Decision|0|||
48713911|NCT00375609|156803084|FG002|Overall Study|Physician Decision|1|||
48713912|NCT00375609|156803082|FG000|Overall Study|Withdrawal by Subject|1|||
48713913|NCT00375609|156803083|FG001|Overall Study|Withdrawal by Subject|4|||
48713914|NCT00375609|156803084|FG002|Overall Study|Withdrawal by Subject|0|||
48713915|NCT00375609|156803082|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
48713916|NCT00375609|156803083|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
48713917|NCT00375609|156803084|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
48713918|NCT03860818|156803085|FG000|Overall Study|Death|144|||
48713919|NCT03860818|156803086|FG001|Overall Study|Death|195|||
48713920|NCT03860818|156803085|FG000|Overall Study|Graft Loss|32|||
48713921|NCT03860818|156803086|FG001|Overall Study|Graft Loss|45|||
48812558|NCT02593305|157155374|FG000|Post 1|Comparison only group. No intervention.|0|||
48812559|NCT02593305|157155375|FG001|Post 1|Comparison only group. No intervention.|0|||
48812560|NCT02593305|157155376|FG002|Post 1|Comparison only group. No intervention.|10|||
48812561|NCT02757521|157155377|FG000|Overall Study|Adverse Event|1|||
48812562|NCT02757521|157155378|FG001|Overall Study|Adverse Event|0|||
48812563|NCT01317875|157155379|FG000|Overall Study|Other|0|||
48713922|NCT03126344|156803087|FG000|Overall Study|Lost to Follow-up|0|||
48713923|NCT03126344|156803088|FG001|Overall Study|Lost to Follow-up|0|||
48713924|NCT03126344|156803089|FG002|Overall Study|Lost to Follow-up|5|||
48713925|NCT02078960|156803091|FG000|Treatment Period|Other|0|||
48713926|NCT02078960|156803092|FG001|Treatment Period|Other|0|||
48713927|NCT02078960|156803093|FG002|Treatment Period|Other|1|||
48713928|NCT02078960|156803091|FG000|Treatment Period|Lack of Efficacy|0|||
48713929|NCT02078960|156803092|FG001|Treatment Period|Lack of Efficacy|1|||
48713930|NCT02078960|156803093|FG002|Treatment Period|Lack of Efficacy|0|||
48713931|NCT02078960|156803091|FG000|Treatment Period|Disease progression - accelerated phase|0|||
48713932|NCT02078960|156803092|FG001|Treatment Period|Disease progression - accelerated phase|1|||
48713933|NCT02078960|156803093|FG002|Treatment Period|Disease progression - accelerated phase|0|||
48812564|NCT01317875|157155380|FG001|Overall Study|Other|0|||
48713934|NCT02078960|156803091|FG000|Treatment Period|Disease progression - blast phase|1|||
48713935|NCT02078960|156803092|FG001|Treatment Period|Disease progression - blast phase|0|||
48713936|NCT02078960|156803093|FG002|Treatment Period|Disease progression - blast phase|0|||
48713937|NCT02078960|156803091|FG000|Treatment Period|Withdrawal by Subject|0|||
48713938|NCT02078960|156803092|FG001|Treatment Period|Withdrawal by Subject|1|||
48713939|NCT02078960|156803093|FG002|Treatment Period|Withdrawal by Subject|1|||
48713940|NCT02078960|156803091|FG000|Treatment Period|Adverse Event|1|||
48597992|NCT01178125|156385195|FG000|Overall Study|Other Reason|39|||
48597993|NCT01178125|156385195|FG000|Overall Study|Sponsor Decision|28|||
48597994|NCT01178125|156385195|FG000|Overall Study|Protocol Violation|17|||
48597995|NCT01178125|156385195|FG000|Overall Study|Investigator Decision|5|||
48597996|NCT00715299|156385196|FG000|Overall Study|Withdrawal by Subject|1|||
48597997|NCT00715299|156385196|FG000|Overall Study|Adverse Event|3|||
48597998|NCT00715299|156385196|FG000|Overall Study|failed the pre-screen exercise test|2|||
48597999|NCT01004978|156385197|FG000|Overall Study|Disease progression|31|||
48598000|NCT01004978|156385198|FG001|Overall Study|Disease progression|48|||
48598001|NCT01004978|156385197|FG000|Overall Study|Adverse Event|42|||
48598002|NCT01004978|156385198|FG001|Overall Study|Adverse Event|22|||
48598003|NCT01004978|156385197|FG000|Overall Study|Death|3|||
48598004|NCT01004978|156385198|FG001|Overall Study|Death|2|||
48598005|NCT01004978|156385197|FG000|Overall Study|Withdrawal by Subject|16|||
48598006|NCT01004978|156385198|FG001|Overall Study|Withdrawal by Subject|16|||
48598007|NCT01004978|156385197|FG000|Overall Study|Alternative therapy|4|||
48598008|NCT01004978|156385198|FG001|Overall Study|Alternative therapy|8|||
48598009|NCT01004978|156385197|FG000|Overall Study|Physician Decision|6|||
48598010|NCT01004978|156385198|FG001|Overall Study|Physician Decision|3|||
48598011|NCT01004978|156385197|FG000|Overall Study|Other complicating disease|2|||
48598012|NCT01004978|156385198|FG001|Overall Study|Other complicating disease|2|||
48598013|NCT01004978|156385197|FG000|Overall Study|Protocol Violation|2|||
48598014|NCT01004978|156385198|FG001|Overall Study|Protocol Violation|3|||
48598015|NCT01004978|156385197|FG000|Overall Study|Non-compliance|3|||
48598016|NCT01004978|156385198|FG001|Overall Study|Non-compliance|2|||
48598017|NCT01004978|156385197|FG000|Overall Study|Ineligible|1|||
48598018|NCT01004978|156385198|FG001|Overall Study|Ineligible|0|||
48598019|NCT01004978|156385197|FG000|Overall Study|Unblinded|0|||
48598020|NCT01004978|156385198|FG001|Overall Study|Unblinded|1|||
48598021|NCT01004978|156385197|FG000|Overall Study|Performance status worsening|0|||
48598022|NCT01004978|156385198|FG001|Overall Study|Performance status worsening|1|||
48598023|NCT01004978|156385197|FG000|Overall Study|Never started treatment|8|||
48598024|NCT01004978|156385198|FG001|Overall Study|Never started treatment|9|||
48598025|NCT02326272|156385199|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598026|NCT02326272|156385200|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
48598027|NCT02326272|156385201|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
48598028|NCT02326272|156385202|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598029|NCT02326272|156385203|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598030|NCT02326272|156385204|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48713941|NCT02078960|156803092|FG001|Treatment Period|Adverse Event|0|||
48713942|NCT02078960|156803093|FG002|Treatment Period|Adverse Event|0|||
48713943|NCT02078960|156803091|FG000|Treatment Period|Death|0|||
48713944|NCT02078960|156803092|FG001|Treatment Period|Death|0|||
48713945|NCT02078960|156803093|FG002|Treatment Period|Death|1|||
48713946|NCT02078960|156803091|FG000|Follow-up Period|Death|2|||
48713947|NCT02078960|156803092|FG001|Follow-up Period|Death|0|||
48713948|NCT02078960|156803093|FG002|Follow-up Period|Death|0|||
48713949|NCT02078960|156803091|FG000|Follow-up Period|Lost to Follow-up|0|||
48713950|NCT02078960|156803092|FG001|Follow-up Period|Lost to Follow-up|1|||
48713951|NCT02078960|156803093|FG002|Follow-up Period|Lost to Follow-up|0|||
48713952|NCT00874939|156803099|FG000|Overall Study|Study terminated|4|||
48713953|NCT04657666|156803100|FG000|Period 1|Withdrawal of participant consent|2|||
48713954|NCT04657666|156803101|FG001|Period 1|Withdrawal of participant consent|1|||
48713955|NCT04657666|156803100|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
48713956|NCT04657666|156803101|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
48713957|NCT04657666|156803100|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
48713958|NCT04657666|156803101|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
48713959|NCT04657666|156803100|FG000|Period 2|Other|2|||
48713960|NCT04657666|156803101|FG001|Period 2|Other|0|||
48713961|NCT04657666|156803100|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
48713962|NCT04657666|156803101|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
48713963|NCT00606905|156803102|FG000|Overall Study|No Pregnancy|9|||
48713964|NCT00606905|156803103|FG001|Overall Study|No Pregnancy|6|||
48713965|NCT00606905|156803102|FG000|Overall Study|Non-Index Pregnancy|1|||
48713966|NCT00606905|156803103|FG001|Overall Study|Non-Index Pregnancy|4|||
48713967|NCT00606905|156803102|FG000|Overall Study|Withdrew|5|||
48713968|NCT00606905|156803103|FG001|Overall Study|Withdrew|5|||
48713969|NCT00790088|156803109|FG000|Overall Study|Protocol Violation|11|||
48713970|NCT00790088|156803109|FG000|Overall Study|Withdrawal by Subject|17|||
48598031|NCT02326272|156385205|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598032|NCT02326272|156385206|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48713971|NCT00790088|156803109|FG000|Overall Study|Lost to Follow-up|7|||
48713972|NCT00790088|156803109|FG000|Overall Study|Physician Decision|4|||
48713973|NCT01386970|156803110|FG000|Overall Study|Withdrawal by Subject|0|||
48713974|NCT01386970|156803111|FG001|Overall Study|Withdrawal by Subject|1|||
48713975|NCT01386970|156803110|FG000|Overall Study|Adverse Event|4|||
48713976|NCT01386970|156803111|FG001|Overall Study|Adverse Event|1|||
48713977|NCT01049009|156803112|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
48713978|NCT01049009|156803113|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
48713979|NCT01049009|156803112|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48713980|NCT01049009|156803113|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48713981|NCT01049009|156803112|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
48713982|NCT01049009|156803113|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
48713983|NCT01049009|156803112|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
48713984|NCT01049009|156803113|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
48713985|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
48713986|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
48713987|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
48713988|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
48713989|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
48713990|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
48713991|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
48713992|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
48713993|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
48713994|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
48713995|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Death|0|||
48713996|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Death|0|||
48713997|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Death|0|||
48713998|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Death|0|||
48713999|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Death|0|||
48714000|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Death|0|||
48714001|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Death|0|||
48714002|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Death|0|||
48714003|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Death|1|||
48714004|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Death|0|||
48714005|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
48714006|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714007|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
48714008|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714009|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714010|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714011|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714012|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714013|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
48714014|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
48714015|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714016|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714017|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714018|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714019|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
48714020|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714021|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714022|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
48714023|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
48714024|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
48714025|NCT02036970|156803114|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714026|NCT02036970|156803115|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714027|NCT02036970|156803116|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714028|NCT02036970|156803117|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
48714029|NCT02036970|156803118|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714030|NCT02036970|156803119|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714031|NCT02036970|156803120|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714032|NCT02036970|156803121|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714033|NCT02036970|156803122|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714034|NCT02036970|156803123|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
48714035|NCT02036970|156803114|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
48495197|NCT00294723|156007801|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
48495198|NCT00294723|156007802|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
48714036|NCT02036970|156803115|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
48714037|NCT02036970|156803116|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
48714038|NCT02036970|156803117|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
48495199|NCT00294723|156007803|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
48495200|NCT00294723|156007801|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
48714039|NCT02036970|156803118|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
48714040|NCT02036970|156803119|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
48714041|NCT02036970|156803120|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
48714042|NCT02036970|156803121|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
48714043|NCT02036970|156803122|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
48714044|NCT02036970|156803123|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
48714045|NCT02036970|156803114|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714046|NCT02036970|156803115|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714047|NCT02036970|156803116|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714048|NCT02036970|156803117|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714049|NCT02036970|156803118|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714050|NCT02036970|156803119|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714051|NCT02036970|156803120|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
48598033|NCT02326272|156385207|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598034|NCT02326272|156385208|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598035|NCT02326272|156385209|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598036|NCT02326272|156385210|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598037|NCT02326272|156385211|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598038|NCT02326272|156385212|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598039|NCT02326272|156385213|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48598040|NCT02326272|156385199|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
48714052|NCT02036970|156803121|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
48714053|NCT02036970|156803122|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714054|NCT02036970|156803123|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
48714055|NCT02036970|156803114|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714056|NCT02036970|156803115|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
48714057|NCT02036970|156803116|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
48714058|NCT02036970|156803117|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714059|NCT02036970|156803118|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714060|NCT02036970|156803119|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714061|NCT02036970|156803120|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714062|NCT02036970|156803121|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714063|NCT02036970|156803122|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
48714064|NCT02036970|156803123|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
48714065|NCT02036970|156803114|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714066|NCT02036970|156803115|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
48714067|NCT02036970|156803116|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
48714068|NCT02036970|156803117|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
48714069|NCT02036970|156803118|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714070|NCT02036970|156803119|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714071|NCT02036970|156803120|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714072|NCT02036970|156803121|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714073|NCT02036970|156803122|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
48714074|NCT02036970|156803123|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
48714075|NCT00640224|156803124|FG000|Overall Study|Lost to Follow-up|5|||
48714076|NCT00640224|156803125|FG001|Overall Study|Lost to Follow-up|2|||
48714077|NCT00640224|156803126|FG002|Overall Study|Lost to Follow-up|0|||
48714078|NCT00640224|156803127|FG003|Overall Study|Lost to Follow-up|0|||
48714079|NCT00640224|156803124|FG000|Overall Study|Withdrawal by Subject|1|||
48714080|NCT00640224|156803125|FG001|Overall Study|Withdrawal by Subject|0|||
48714081|NCT00640224|156803126|FG002|Overall Study|Withdrawal by Subject|0|||
48714082|NCT00640224|156803127|FG003|Overall Study|Withdrawal by Subject|0|||
48714083|NCT00640224|156803124|FG000|Overall Study|Headaches|0|||
48714084|NCT00640224|156803125|FG001|Overall Study|Headaches|1|||
48714085|NCT00640224|156803126|FG002|Overall Study|Headaches|0|||
48714086|NCT00640224|156803127|FG003|Overall Study|Headaches|0|||
48714087|NCT01667419|156803130|FG000|Overall Study|Reason Not Specified|1|||
48714088|NCT01667419|156803131|FG001|Overall Study|Reason Not Specified|0|||
48714089|NCT01667419|156803132|FG002|Overall Study|Reason Not Specified|0|||
48714090|NCT01667419|156803133|FG003|Overall Study|Reason Not Specified|0|||
48714091|NCT01667419|156803130|FG000|Overall Study|Withdrawal by Subject|16|||
48714092|NCT01667419|156803131|FG001|Overall Study|Withdrawal by Subject|8|||
48714093|NCT01667419|156803132|FG002|Overall Study|Withdrawal by Subject|9|||
48714094|NCT01667419|156803133|FG003|Overall Study|Withdrawal by Subject|8|||
48714095|NCT01667419|156803130|FG000|Overall Study|Non-compliance|0|||
48714096|NCT01667419|156803131|FG001|Overall Study|Non-compliance|0|||
48714097|NCT01667419|156803132|FG002|Overall Study|Non-compliance|0|||
48325476|NCT00371345|155389105|FG000|Overall Study|Participant Withdrew Consent|0|||
48598041|NCT02326272|156385200|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
48598042|NCT02326272|156385201|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48714098|NCT01667419|156803133|FG003|Overall Study|Non-compliance|1|||
48714099|NCT01667419|156803130|FG000|Overall Study|Protocol Violation|1|||
48714100|NCT01667419|156803131|FG001|Overall Study|Protocol Violation|0|||
48714101|NCT01667419|156803132|FG002|Overall Study|Protocol Violation|0|||
48714102|NCT01667419|156803133|FG003|Overall Study|Protocol Violation|0|||
48714103|NCT01667419|156803130|FG000|Overall Study|Lost to Follow-up|7|||
48714104|NCT01667419|156803131|FG001|Overall Study|Lost to Follow-up|6|||
48714105|NCT01667419|156803132|FG002|Overall Study|Lost to Follow-up|2|||
48714106|NCT01667419|156803133|FG003|Overall Study|Lost to Follow-up|4|||
48714107|NCT01667419|156803130|FG000|Overall Study|Death|18|||
48714108|NCT01667419|156803131|FG001|Overall Study|Death|33|||
48714109|NCT01667419|156803132|FG002|Overall Study|Death|25|||
48714110|NCT01667419|156803133|FG003|Overall Study|Death|26|||
48495201|NCT00294723|156007802|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
48495202|NCT00294723|156007803|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
48495203|NCT00294723|156007801|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
48495204|NCT00294723|156007802|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
48714111|NCT00926029|156803134|FG000|Overall Study|Lost to Follow-up|2|||
48714112|NCT00926029|156803135|FG001|Overall Study|Lost to Follow-up|1|||
48714113|NCT00926029|156803136|FG002|Overall Study|Lost to Follow-up|1|||
48495205|NCT00294723|156007803|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
48495206|NCT00294723|156007801|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
48495207|NCT00294723|156007802|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
48495208|NCT00294723|156007803|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
48495209|NCT00294723|156007801|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
48495210|NCT00294723|156007802|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
48495211|NCT00294723|156007803|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
48495212|NCT00294723|156007801|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
48495213|NCT00294723|156007802|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
48495214|NCT00294723|156007803|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
48495215|NCT00294723|156007801|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
48495216|NCT00294723|156007802|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
48495217|NCT00294723|156007803|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
48495218|NCT00294723|156007801|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
48495219|NCT00294723|156007802|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
48495220|NCT00294723|156007803|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
48495221|NCT00294723|156007801|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
48495222|NCT00294723|156007802|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
48495223|NCT00294723|156007803|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
48495224|NCT00294723|156007801|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
48495225|NCT00294723|156007802|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
48495226|NCT00294723|156007803|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
48495227|NCT00294723|156007801|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
48495228|NCT00294723|156007802|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
48495229|NCT00294723|156007803|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
48495230|NCT03692676|156007804|FG000|Overall Study|exclude patients with prior use|4424|||
48495231|NCT03692676|156007805|FG001|Overall Study|exclude patients with prior use|24726|||
48495232|NCT03692676|156007806|FG002|Overall Study|exclude patients with prior use|0|||
48495233|NCT03692676|156007807|FG003|Overall Study|exclude patients with prior use|0|||
48495234|NCT03692676|156007804|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
48495235|NCT03692676|156007805|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
48495236|NCT03692676|156007806|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
48495237|NCT03692676|156007807|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
48495238|NCT03692676|156007804|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
48495239|NCT03692676|156007805|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
48495240|NCT03692676|156007806|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
48495241|NCT03692676|156007807|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
48495242|NCT03692676|156007804|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
48495243|NCT03692676|156007805|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
48495244|NCT03692676|156007806|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
48495245|NCT03692676|156007807|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
48714114|NCT03615040|156803142|FG000|Overall Study|Withdrawal by Subject|2|||
48714115|NCT03615040|156803143|FG001|Overall Study|Withdrawal by Subject|1|||
48714116|NCT03615040|156803142|FG000|Overall Study|Physician Decision|2|||
48495246|NCT03692676|156007804|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
48495247|NCT03692676|156007805|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
48495248|NCT03692676|156007806|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
48714117|NCT03615040|156803143|FG001|Overall Study|Physician Decision|2|||
48714118|NCT03615040|156803142|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
48812565|NCT01317875|157155381|FG002|Overall Study|Other|1|||
48812566|NCT01317875|157155382|FG003|Overall Study|Other|0|||
48812567|NCT01317875|157155383|FG004|Overall Study|Other|0|||
48812568|NCT01317875|157155384|FG005|Overall Study|Other|0|||
48812569|NCT01317875|157155385|FG006|Overall Study|Other|0|||
48812570|NCT01317875|157155386|FG007|Overall Study|Other|0|||
48812571|NCT01317875|157155387|FG008|Overall Study|Other|0|||
48812572|NCT01317875|157155388|FG009|Overall Study|Other|0|||
48812573|NCT01317875|157155379|FG000|Overall Study|Noncompliance with study drug|0|||
48812574|NCT01317875|157155380|FG001|Overall Study|Noncompliance with study drug|0|||
48812575|NCT01317875|157155381|FG002|Overall Study|Noncompliance with study drug|1|||
48812576|NCT01317875|157155382|FG003|Overall Study|Noncompliance with study drug|0|||
48812577|NCT01317875|157155383|FG004|Overall Study|Noncompliance with study drug|0|||
48812578|NCT01317875|157155384|FG005|Overall Study|Noncompliance with study drug|0|||
48812579|NCT01317875|157155385|FG006|Overall Study|Noncompliance with study drug|0|||
48812580|NCT01317875|157155386|FG007|Overall Study|Noncompliance with study drug|0|||
48812581|NCT01317875|157155387|FG008|Overall Study|Noncompliance with study drug|0|||
48812582|NCT01317875|157155388|FG009|Overall Study|Noncompliance with study drug|0|||
48812583|NCT01317875|157155379|FG000|Overall Study|Progressive Disease|1|||
48812584|NCT01317875|157155380|FG001|Overall Study|Progressive Disease|0|||
48812585|NCT01317875|157155381|FG002|Overall Study|Progressive Disease|2|||
48812586|NCT01317875|157155382|FG003|Overall Study|Progressive Disease|0|||
48812587|NCT01317875|157155383|FG004|Overall Study|Progressive Disease|1|||
48812588|NCT01317875|157155384|FG005|Overall Study|Progressive Disease|0|||
48812589|NCT01317875|157155385|FG006|Overall Study|Progressive Disease|0|||
48812590|NCT01317875|157155386|FG007|Overall Study|Progressive Disease|1|||
48812591|NCT01317875|157155387|FG008|Overall Study|Progressive Disease|0|||
48812592|NCT01317875|157155388|FG009|Overall Study|Progressive Disease|0|||
48812593|NCT01317875|157155379|FG000|Overall Study|Withdrawal by Subject|0|||
48812594|NCT01317875|157155380|FG001|Overall Study|Withdrawal by Subject|0|||
48812595|NCT01317875|157155381|FG002|Overall Study|Withdrawal by Subject|0|||
48812596|NCT01317875|157155382|FG003|Overall Study|Withdrawal by Subject|0|||
48812597|NCT01317875|157155383|FG004|Overall Study|Withdrawal by Subject|1|||
48812598|NCT01317875|157155384|FG005|Overall Study|Withdrawal by Subject|0|||
48812599|NCT01317875|157155385|FG006|Overall Study|Withdrawal by Subject|0|||
48812600|NCT01317875|157155386|FG007|Overall Study|Withdrawal by Subject|3|||
48812601|NCT01317875|157155387|FG008|Overall Study|Withdrawal by Subject|0|||
48812602|NCT01317875|157155388|FG009|Overall Study|Withdrawal by Subject|0|||
48812603|NCT01317875|157155379|FG000|Overall Study|Physician Decision|0|||
48812604|NCT01317875|157155380|FG001|Overall Study|Physician Decision|1|||
48812605|NCT01317875|157155381|FG002|Overall Study|Physician Decision|1|||
48812606|NCT01317875|157155382|FG003|Overall Study|Physician Decision|0|||
48812607|NCT01317875|157155383|FG004|Overall Study|Physician Decision|2|||
48812608|NCT01317875|157155384|FG005|Overall Study|Physician Decision|0|||
48812609|NCT01317875|157155385|FG006|Overall Study|Physician Decision|0|||
48812610|NCT01317875|157155386|FG007|Overall Study|Physician Decision|2|||
48812611|NCT01317875|157155387|FG008|Overall Study|Physician Decision|0|||
48812612|NCT01317875|157155388|FG009|Overall Study|Physician Decision|0|||
48812613|NCT01317875|157155379|FG000|Overall Study|Death|0|||
48812614|NCT01317875|157155380|FG001|Overall Study|Death|0|||
48812615|NCT01317875|157155381|FG002|Overall Study|Death|2|||
48812616|NCT01317875|157155382|FG003|Overall Study|Death|1|||
48812617|NCT01317875|157155383|FG004|Overall Study|Death|0|||
48812618|NCT01317875|157155384|FG005|Overall Study|Death|1|||
48812619|NCT01317875|157155385|FG006|Overall Study|Death|0|||
48812620|NCT01317875|157155386|FG007|Overall Study|Death|4|||
48812621|NCT01317875|157155387|FG008|Overall Study|Death|0|||
48435814|NCT01934192|155783803|FG003|Overall Study|Physician Decision|0|||
48435815|NCT01737840|155783805|FG000|Overall Study|Diagnosed with an other pathology|2|||
48435816|NCT01737840|155783806|FG001|Overall Study|Diagnosed with an other pathology|2|||
48435817|NCT03011034|155783807|FG000|Overall Study|Adverse Event|1|||
48435818|NCT03011034|155783808|FG001|Overall Study|Adverse Event|0|||
48435819|NCT01189435|155783809|FG000|Overall Study|Withdrawal by Subject|1|||
48435820|NCT01189435|155783809|FG000|Overall Study|Physician Decision|1|||
48435821|NCT02357849|155783812|FG000|Overall Study|Withdrawal by Subject|2|||
48435822|NCT02357849|155783813|FG001|Overall Study|Withdrawal by Subject|3|||
48435823|NCT00403559|155783816|FG000|Overall Study|Adverse Event|0|||
48435824|NCT00403559|155783817|FG001|Overall Study|Adverse Event|1|||
48435825|NCT00403559|155783816|FG000|Overall Study|Lost to Follow-up|3|||
48812622|NCT01317875|157155388|FG009|Overall Study|Death|0|||
48812623|NCT01317875|157155379|FG000|Overall Study|Adverse Event|2|||
48812624|NCT01317875|157155380|FG001|Overall Study|Adverse Event|1|||
48812625|NCT01317875|157155381|FG002|Overall Study|Adverse Event|2|||
48812626|NCT01317875|157155382|FG003|Overall Study|Adverse Event|1|||
48812627|NCT01317875|157155383|FG004|Overall Study|Adverse Event|5|||
48812628|NCT01317875|157155384|FG005|Overall Study|Adverse Event|1|||
48812629|NCT01317875|157155385|FG006|Overall Study|Adverse Event|2|||
48812630|NCT01317875|157155386|FG007|Overall Study|Adverse Event|5|||
48812631|NCT01317875|157155387|FG008|Overall Study|Adverse Event|0|||
48812632|NCT01317875|157155388|FG009|Overall Study|Adverse Event|0|||
48812633|NCT02670538|157155389|FG000|Overall Study|Withdrawal of Consent|8|||
48812634|NCT02670538|157155390|FG001|Overall Study|Withdrawal of Consent|6|||
48812635|NCT02670538|157155391|FG002|Overall Study|Withdrawal of Consent|5|||
48812636|NCT02670538|157155389|FG000|Overall Study|Lost to Follow-up|8|||
48714119|NCT03615040|156803143|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
48714120|NCT03615040|156803142|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
48714121|NCT03615040|156803143|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
48714122|NCT03615040|156803142|FG000|Overall Study|Death|0|||
48714123|NCT03615040|156803143|FG001|Overall Study|Death|2|||
48714124|NCT01689532|156803144|FG000|Overall Study|Adverse Event|9|||
48714125|NCT01689532|156803145|FG001|Overall Study|Adverse Event|5|||
48714126|NCT01689532|156803144|FG000|Overall Study|Lack of Efficacy|2|||
48714127|NCT01689532|156803145|FG001|Overall Study|Lack of Efficacy|2|||
48714128|NCT01689532|156803144|FG000|Overall Study|Withdrawal by Subject|1|||
48714129|NCT01689532|156803145|FG001|Overall Study|Withdrawal by Subject|2|||
48714130|NCT01689532|156803144|FG000|Overall Study|Physician Decision|2|||
48435826|NCT00403559|155783817|FG001|Overall Study|Lost to Follow-up|3|||
48435827|NCT00403559|155783816|FG000|Overall Study|Withdrawal by Subject|1|||
48812637|NCT02670538|157155390|FG001|Overall Study|Lost to Follow-up|12|||
48812638|NCT02670538|157155391|FG002|Overall Study|Lost to Follow-up|7|||
48812639|NCT02670538|157155389|FG000|Overall Study|Adverse Event|5|||
48812640|NCT02670538|157155390|FG001|Overall Study|Adverse Event|5|||
48598043|NCT02326272|156385202|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598044|NCT02326272|156385203|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598045|NCT02326272|156385204|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598046|NCT02326272|156385205|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598047|NCT02326272|156385206|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598048|NCT02326272|156385207|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598049|NCT02326272|156385208|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48812641|NCT02670538|157155391|FG002|Overall Study|Adverse Event|11|||
48812642|NCT02670538|157155389|FG000|Overall Study|Lack of Efficacy|7|||
48812643|NCT02670538|157155390|FG001|Overall Study|Lack of Efficacy|1|||
48812644|NCT02670538|157155391|FG002|Overall Study|Lack of Efficacy|2|||
48812645|NCT02670538|157155389|FG000|Overall Study|Protocol Violation|3|||
48812646|NCT02670538|157155390|FG001|Overall Study|Protocol Violation|4|||
48812647|NCT02670538|157155391|FG002|Overall Study|Protocol Violation|1|||
48812648|NCT02670538|157155389|FG000|Overall Study|Noncompliance with Study Drug|1|||
48812649|NCT02670538|157155390|FG001|Overall Study|Noncompliance with Study Drug|3|||
48812650|NCT02670538|157155391|FG002|Overall Study|Noncompliance with Study Drug|2|||
48812651|NCT02670538|157155389|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48812652|NCT02670538|157155390|FG001|Overall Study|Other Miscellaneous Reasons|1|||
48812653|NCT02670538|157155391|FG002|Overall Study|Other Miscellaneous Reasons|2|||
48812654|NCT02887989|157155392|FG000|Overall Study|Withdrawal by Subject|8|||
48812655|NCT02887989|157155393|FG001|Overall Study|Withdrawal by Subject|11|||
48812656|NCT02887989|157155392|FG000|Overall Study|Death|1|||
48812657|NCT02887989|157155393|FG001|Overall Study|Death|0|||
48812658|NCT00358150|157155399|FG000|Overall Study|Adverse Event|3|||
48598050|NCT02326272|156385209|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598051|NCT02326272|156385210|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598052|NCT02326272|156385211|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48812659|NCT00358150|157155399|FG000|Overall Study|Withdrawal by Subject|1|||
48598053|NCT02326272|156385212|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48598054|NCT02326272|156385213|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48812660|NCT00358150|157155399|FG000|Overall Study|Undefined|3|||
48812661|NCT03119610|157155402|FG000|Overall Study|Adverse Event|1|||
48812662|NCT03119610|157155403|FG001|Overall Study|Adverse Event|0|||
48812663|NCT03119610|157155402|FG000|Overall Study|Lost to Follow-up|0|||
48812664|NCT03119610|157155403|FG001|Overall Study|Lost to Follow-up|1|||
48495249|NCT03692676|156007807|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
48495250|NCT03692676|156007804|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
48495251|NCT03692676|156007805|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
48495252|NCT03692676|156007806|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
48495253|NCT03692676|156007807|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
48495254|NCT03692676|156007804|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
48495255|NCT03692676|156007805|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
48495256|NCT03692676|156007806|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
48495257|NCT03692676|156007807|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
48495258|NCT03692676|156007804|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
48495259|NCT03692676|156007805|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
48495260|NCT03692676|156007806|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
48495261|NCT03692676|156007807|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
48495262|NCT03692676|156007804|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
48495263|NCT03692676|156007805|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
48495264|NCT03692676|156007806|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
48495265|NCT03692676|156007807|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
48495266|NCT03692676|156007804|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
48495267|NCT03692676|156007805|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
48495268|NCT03692676|156007806|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
48495269|NCT03692676|156007807|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
48495270|NCT03692676|156007804|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
48495271|NCT03692676|156007805|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
48495272|NCT03692676|156007806|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
48495273|NCT03692676|156007807|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
48495274|NCT03692676|156007804|FG000|Overall Study|Other|0|||
48495275|NCT03692676|156007805|FG001|Overall Study|Other|805|||
48495276|NCT03692676|156007806|FG002|Overall Study|Other|758|||
48495277|NCT03692676|156007807|FG003|Overall Study|Other|277|||
48495278|NCT03692676|156007804|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
48495279|NCT03692676|156007805|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
48495280|NCT03692676|156007806|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
48495281|NCT03692676|156007807|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
48495282|NCT02736227|156007808|FG000|Overall Study|Withdrawal by Subject|0|||
48495283|NCT02736227|156007809|FG001|Overall Study|Withdrawal by Subject|0|||
48495284|NCT02736227|156007810|FG002|Overall Study|Withdrawal by Subject|1|||
48495285|NCT02736227|156007808|FG000|Overall Study|Physician Decision|0|||
48495286|NCT02736227|156007809|FG001|Overall Study|Physician Decision|0|||
48495287|NCT02736227|156007810|FG002|Overall Study|Physician Decision|5|||
48495288|NCT02736227|156007808|FG000|Overall Study|Non Compliant|0|||
48495289|NCT02736227|156007809|FG001|Overall Study|Non Compliant|0|||
48495290|NCT02736227|156007810|FG002|Overall Study|Non Compliant|2|||
48495291|NCT00752791|156007811|FG000|Overall Study|Adverse Event|7|||
48714131|NCT01689532|156803145|FG001|Overall Study|Physician Decision|0|||
48714132|NCT01363349|156803146|FG000|Overall Study|Adverse Event|6|||
48598055|NCT02326272|156385199|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
48598056|NCT02326272|156385200|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
48598057|NCT02326272|156385201|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
48598058|NCT02326272|156385202|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598059|NCT02326272|156385203|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598060|NCT02326272|156385204|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598061|NCT02326272|156385205|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598062|NCT02326272|156385206|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598063|NCT02326272|156385207|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598064|NCT02326272|156385208|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598065|NCT02326272|156385209|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598066|NCT02326272|156385210|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598067|NCT02326272|156385211|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598068|NCT02326272|156385212|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598069|NCT02326272|156385213|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48598070|NCT02326272|156385199|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598071|NCT02326272|156385200|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598072|NCT02326272|156385201|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
48598073|NCT02326272|156385202|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598074|NCT02326272|156385203|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598075|NCT02326272|156385204|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598076|NCT02326272|156385205|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598077|NCT02326272|156385206|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598078|NCT02326272|156385207|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598079|NCT02326272|156385208|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598080|NCT02326272|156385209|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598081|NCT02326272|156385210|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598082|NCT02326272|156385211|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598083|NCT02326272|156385212|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48598084|NCT02326272|156385213|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
48714133|NCT01363349|156803147|FG001|Overall Study|Adverse Event|7|||
48714134|NCT01363349|156803146|FG000|Overall Study|Lack of Efficacy|3|||
48714135|NCT01363349|156803147|FG001|Overall Study|Lack of Efficacy|10|||
48714136|NCT01363349|156803146|FG000|Overall Study|Non compliance/Protocol deviations|2|||
48714137|NCT01363349|156803147|FG001|Overall Study|Non compliance/Protocol deviations|2|||
48495292|NCT00752791|156007811|FG000|Overall Study|Withdrawal by Subject|1|||
48495293|NCT00752791|156007811|FG000|Overall Study|Physician Decision|1|||
48495294|NCT00752791|156007811|FG000|Overall Study|Death|1|||
48495295|NCT00752791|156007811|FG000|Overall Study|Renal transplant|3|||
48495296|NCT00752791|156007811|FG000|Overall Study|Switched to hemodialysis|2|||
48598085|NCT02326272|156385199|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598086|NCT02326272|156385200|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48714138|NCT01363349|156803146|FG000|Overall Study|Withdrawal by Subject|14|||
48495297|NCT00752791|156007811|FG000|Overall Study|Protocol deviation|1|||
48495298|NCT04161144|156007812|FG000|Overall Study|Withdrawal by Subject|0|||
48495299|NCT04161144|156007813|FG001|Overall Study|Withdrawal by Subject|1|||
48495300|NCT04161144|156007812|FG000|Overall Study|Protocol Violation|1|||
48495301|NCT04161144|156007813|FG001|Overall Study|Protocol Violation|0|||
48495302|NCT01054599|156007821|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
48495303|NCT01054599|156007822|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
48495304|NCT01054599|156007821|FG000|Overall Study|Protocol Violation|1|||
48495305|NCT01054599|156007822|FG001|Overall Study|Protocol Violation|0|||
48495306|NCT01054599|156007821|FG000|Overall Study|Spells/seizure-like episodes|1|||
48495307|NCT01054599|156007822|FG001|Overall Study|Spells/seizure-like episodes|1|||
48495308|NCT01054599|156007821|FG000|Overall Study|Timing/scheduling difficulties|1|||
48495309|NCT01054599|156007822|FG001|Overall Study|Timing/scheduling difficulties|1|||
48495310|NCT01054599|156007821|FG000|Overall Study|Visual impairment, WTAR <80|0|||
48495311|NCT01054599|156007822|FG001|Overall Study|Visual impairment, WTAR <80|1|||
48495312|NCT01054599|156007821|FG000|Overall Study|Lost to Follow-up|0|||
48495313|NCT01054599|156007822|FG001|Overall Study|Lost to Follow-up|2|||
48495314|NCT01054599|156007821|FG000|Overall Study|Adverse Event|0|||
48495315|NCT01054599|156007822|FG001|Overall Study|Adverse Event|1|||
48495316|NCT01054599|156007821|FG000|Overall Study|Withdrawal by Subject|0|||
48495317|NCT01054599|156007822|FG001|Overall Study|Withdrawal by Subject|1|||
48495318|NCT05431153|156007825|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48598087|NCT02326272|156385201|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
48598088|NCT02326272|156385202|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598089|NCT02326272|156385203|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48714139|NCT01363349|156803147|FG001|Overall Study|Withdrawal by Subject|6|||
48495319|NCT05431153|156007826|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48495320|NCT05431153|156007827|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48495321|NCT05431153|156007828|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48495322|NCT05431153|156007829|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
48495323|NCT05431153|156007830|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48495324|NCT02374918|156007834|FG000|Overall Study|Protocol Violation|2|||
48495325|NCT02374918|156007835|FG001|Overall Study|Protocol Violation|0|||
48495326|NCT02374918|156007836|FG002|Overall Study|Protocol Violation|2|||
48495327|NCT02374918|156007837|FG003|Overall Study|Protocol Violation|1|||
48495328|NCT02374918|156007834|FG000|Overall Study|Withdrawal by Subject|1|||
48495329|NCT02374918|156007835|FG001|Overall Study|Withdrawal by Subject|1|||
48495330|NCT02374918|156007836|FG002|Overall Study|Withdrawal by Subject|1|||
48495331|NCT02374918|156007837|FG003|Overall Study|Withdrawal by Subject|0|||
48495332|NCT02374918|156007834|FG000|Overall Study|Lack of Efficacy|0|||
48495333|NCT02374918|156007835|FG001|Overall Study|Lack of Efficacy|0|||
48495334|NCT02374918|156007836|FG002|Overall Study|Lack of Efficacy|1|||
48495335|NCT02374918|156007837|FG003|Overall Study|Lack of Efficacy|1|||
48495336|NCT01957488|156007838|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
48495337|NCT01957488|156007839|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
48495338|NCT01957488|156007840|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
48495339|NCT01957488|156007841|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
48495340|NCT01957488|156007842|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
48495341|NCT01957488|156007843|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
48495342|NCT01957488|156007838|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
48495343|NCT01957488|156007839|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
48495344|NCT01957488|156007840|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
48495345|NCT01957488|156007841|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
48495346|NCT01957488|156007842|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
48495347|NCT01957488|156007843|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
48495348|NCT01957488|156007838|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
48495349|NCT01957488|156007839|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
48495350|NCT01957488|156007840|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
48495351|NCT01957488|156007841|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
48495352|NCT01957488|156007842|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
48495353|NCT01957488|156007843|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
48495354|NCT01957488|156007838|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48495355|NCT01957488|156007839|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48495356|NCT01957488|156007840|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
48495357|NCT01957488|156007841|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
48495358|NCT01957488|156007842|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
48495359|NCT01957488|156007843|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
48495360|NCT01957488|156007838|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
48495361|NCT01957488|156007839|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
48495362|NCT01957488|156007840|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
48495363|NCT01957488|156007841|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
48495364|NCT01957488|156007842|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
48495365|NCT01957488|156007843|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
48495366|NCT01957488|156007838|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
48495367|NCT01957488|156007839|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
48495368|NCT01957488|156007840|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
48714140|NCT01363349|156803146|FG000|Overall Study|Lost to Follow-up|5|||
48714141|NCT01363349|156803147|FG001|Overall Study|Lost to Follow-up|6|||
48714142|NCT01363349|156803146|FG000|Overall Study|Not reported|36|||
48714143|NCT01363349|156803147|FG001|Overall Study|Not reported|37|||
48714144|NCT01363349|156803146|FG000|Overall Study|missing|1|||
48714145|NCT01363349|156803147|FG001|Overall Study|missing|2|||
48714146|NCT01958489|156803148|FG000|Period 2|Adverse Event|0|||
48714147|NCT01958489|156803149|FG001|Period 2|Adverse Event|1|||
48714148|NCT03462511|156803150|FG000|Overall Study|Withdrawal by Subject|2|||
48714149|NCT03462511|156803151|FG001|Overall Study|Withdrawal by Subject|3|||
48714150|NCT03890666|156803152|FG000|Overall Study|Withdrawal by Subject|0|||
48714151|NCT03890666|156803153|FG001|Overall Study|Withdrawal by Subject|1|||
48714152|NCT03890666|156803152|FG000|Overall Study|Protocol deviation|1|||
48714153|NCT03890666|156803153|FG001|Overall Study|Protocol deviation|4|||
48714154|NCT03890666|156803152|FG000|Overall Study|Lost to Follow-up|2|||
48714155|NCT03890666|156803153|FG001|Overall Study|Lost to Follow-up|5|||
48714156|NCT03890666|156803152|FG000|Overall Study|Other than specified|1|||
48714157|NCT03890666|156803153|FG001|Overall Study|Other than specified|8|||
48714158|NCT03595228|156803154|FG000|Overall Study|Death|2|||
48714159|NCT03595228|156803154|FG000|Overall Study|Lack of Efficacy|13|||
48714160|NCT03595228|156803154|FG000|Overall Study|Withdrawal by Subject|3|||
48714161|NCT03595228|156803154|FG000|Overall Study|Withdrawal by Sponsor|1|||
48714162|NCT01639729|156803155|FG000|Overall Study|Withdrawal by Subject|1|||
48714163|NCT01639729|156803156|FG001|Overall Study|Withdrawal by Subject|0|||
48714164|NCT01639729|156803157|FG002|Overall Study|Withdrawal by Subject|1|||
48495369|NCT01957488|156007841|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
48714165|NCT01639729|156803158|FG003|Overall Study|Withdrawal by Subject|1|||
48714166|NCT01639729|156803159|FG004|Overall Study|Withdrawal by Subject|0|||
48714167|NCT01639729|156803160|FG005|Overall Study|Withdrawal by Subject|0|||
48714168|NCT00200356|156803161|FG000|Overall Study|Lack of Efficacy|3|||
48714169|NCT00200356|156803162|FG001|Overall Study|Lack of Efficacy|3|||
48714170|NCT00200356|156803161|FG000|Overall Study|Protocol Violation|4|||
48714171|NCT00200356|156803162|FG001|Overall Study|Protocol Violation|4|||
48714172|NCT00200356|156803161|FG000|Overall Study|Nontreatment|1|||
48714173|NCT00200356|156803162|FG001|Overall Study|Nontreatment|0|||
48714174|NCT02238067|156803164|FG000|Overall Study|Not completed survey at Month 6|45|||
48714175|NCT00862641|156803173|FG000|Overall Study|Randomized, but drug not received|1|||
48714176|NCT00862641|156803174|FG001|Overall Study|Randomized, but drug not received|4|||
48714177|NCT00862641|156803175|FG002|Overall Study|Randomized, but drug not received|1|||
48714178|NCT00862641|156803176|FG003|Overall Study|Randomized, but drug not received|4|||
48714179|NCT01419197|156803178|FG000|Overall Study|Death|247|||
48714180|NCT01419197|156803179|FG001|Overall Study|Death|122|||
48495370|NCT01957488|156007842|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
48495371|NCT01957488|156007843|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
48495372|NCT01957488|156007838|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
48495373|NCT01957488|156007839|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
48495374|NCT01957488|156007840|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
48495375|NCT01957488|156007841|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
48495376|NCT01957488|156007842|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
48495377|NCT01957488|156007843|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
48495378|NCT01957488|156007838|FG000|Test Period 2 (2 Weeks)|Other|1|||
48495379|NCT01957488|156007839|FG001|Test Period 2 (2 Weeks)|Other|0|||
48495380|NCT01957488|156007840|FG002|Test Period 2 (2 Weeks)|Other|0|||
48495381|NCT01957488|156007841|FG003|Test Period 2 (2 Weeks)|Other|0|||
48495382|NCT01957488|156007842|FG004|Test Period 2 (2 Weeks)|Other|0|||
48495383|NCT01957488|156007843|FG005|Test Period 2 (2 Weeks)|Other|0|||
48495384|NCT01957488|156007838|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
48495385|NCT01957488|156007839|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
48495386|NCT01957488|156007840|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
48495387|NCT01957488|156007841|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
48495388|NCT01957488|156007842|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
48495389|NCT01957488|156007843|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
48495390|NCT01957488|156007838|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
48495391|NCT01957488|156007839|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
48495392|NCT01957488|156007840|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
48495393|NCT01957488|156007841|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
48495394|NCT01957488|156007842|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
48495395|NCT01957488|156007843|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
48495396|NCT01957488|156007838|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
48495397|NCT01957488|156007839|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
48495398|NCT01957488|156007840|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
48495399|NCT01957488|156007841|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
48495400|NCT01957488|156007842|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
48495401|NCT01957488|156007843|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
48495402|NCT01957488|156007838|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
48495403|NCT01957488|156007839|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
48495404|NCT01957488|156007840|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
48495405|NCT01957488|156007841|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
48714181|NCT01419197|156803178|FG000|Overall Study|Physician Decision|4|||
48495406|NCT01957488|156007842|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
48714182|NCT01419197|156803179|FG001|Overall Study|Physician Decision|4|||
48495407|NCT01957488|156007843|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
48495408|NCT01957488|156007838|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
48495409|NCT01957488|156007839|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
48495410|NCT01957488|156007840|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
48495411|NCT01957488|156007841|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
48495412|NCT01957488|156007842|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
48495413|NCT01957488|156007843|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
48495414|NCT02752776|156007844|FG000|Overall Study|Adverse Event|15|||
48495415|NCT02752776|156007845|FG001|Overall Study|Adverse Event|23|||
48495416|NCT02752776|156007846|FG002|Overall Study|Adverse Event|11|||
48495417|NCT02752776|156007844|FG000|Overall Study|Lack of Efficacy|2|||
48495418|NCT02752776|156007845|FG001|Overall Study|Lack of Efficacy|6|||
48495419|NCT02752776|156007846|FG002|Overall Study|Lack of Efficacy|14|||
48495420|NCT02752776|156007844|FG000|Overall Study|Lost to Follow-up|11|||
48495421|NCT02752776|156007845|FG001|Overall Study|Lost to Follow-up|12|||
48495422|NCT02752776|156007846|FG002|Overall Study|Lost to Follow-up|4|||
48495423|NCT02752776|156007844|FG000|Overall Study|Non-compliance with study treatment|0|||
48495424|NCT02752776|156007845|FG001|Overall Study|Non-compliance with study treatment|0|||
48495425|NCT02752776|156007846|FG002|Overall Study|Non-compliance with study treatment|1|||
48495426|NCT02752776|156007844|FG000|Overall Study|Physician Decision|2|||
48495427|NCT02752776|156007845|FG001|Overall Study|Physician Decision|6|||
48495428|NCT02752776|156007846|FG002|Overall Study|Physician Decision|2|||
48495429|NCT02752776|156007844|FG000|Overall Study|Pregnancy|1|||
48495430|NCT02752776|156007845|FG001|Overall Study|Pregnancy|6|||
48495431|NCT02752776|156007846|FG002|Overall Study|Pregnancy|3|||
48495432|NCT02752776|156007844|FG000|Overall Study|Protocol Violation|10|||
48495433|NCT02752776|156007845|FG001|Overall Study|Protocol Violation|13|||
48495434|NCT02752776|156007846|FG002|Overall Study|Protocol Violation|6|||
48495435|NCT02752776|156007844|FG000|Overall Study|Subject/guardian decision|8|||
48495436|NCT02752776|156007845|FG001|Overall Study|Subject/guardian decision|6|||
48495437|NCT02752776|156007846|FG002|Overall Study|Subject/guardian decision|4|||
48495438|NCT02752776|156007844|FG000|Overall Study|Death|0|||
48495439|NCT02752776|156007845|FG001|Overall Study|Death|0|||
48495440|NCT02752776|156007846|FG002|Overall Study|Death|1|||
48495441|NCT02752776|156007844|FG000|Overall Study|Withdrawal by Subject|3|||
48495442|NCT02752776|156007845|FG001|Overall Study|Withdrawal by Subject|4|||
48495443|NCT02752776|156007846|FG002|Overall Study|Withdrawal by Subject|2|||
48495444|NCT01336894|156007847|FG000|Follow-up|Study terminated prematurely|2|||
48495445|NCT01336894|156007848|FG001|Follow-up|Study terminated prematurely|7|||
48495446|NCT01001169|156007849|FG000|Overall Study|Withdrawal by Subject|2|||
48495447|NCT01001169|156007850|FG001|Overall Study|Withdrawal by Subject|1|||
48495448|NCT02224391|156007851|FG000|Overall Study|Lost to Follow-up|26|||
48598090|NCT02326272|156385204|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598091|NCT02326272|156385205|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598092|NCT02326272|156385206|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598093|NCT02326272|156385207|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598094|NCT02326272|156385208|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598095|NCT02326272|156385209|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598096|NCT02326272|156385210|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598097|NCT02326272|156385211|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598098|NCT02326272|156385212|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598099|NCT02326272|156385213|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
48598100|NCT02326272|156385199|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598101|NCT02326272|156385200|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598102|NCT02326272|156385201|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
48598103|NCT02326272|156385202|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598104|NCT02326272|156385203|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48714183|NCT01419197|156803178|FG000|Overall Study|Non-compliance|3|||
48495449|NCT02224391|156007852|FG001|Overall Study|Lost to Follow-up|19|||
48495450|NCT02224391|156007851|FG000|Overall Study|Withdrawal by Subject|6|||
48495451|NCT02224391|156007852|FG001|Overall Study|Withdrawal by Subject|5|||
48495452|NCT02492958|156007853|FG000|Overall Study|Withdrawal by Subject|0|||
48495453|NCT02492958|156007854|FG001|Overall Study|Withdrawal by Subject|0|||
48495454|NCT02492958|156007855|FG002|Overall Study|Withdrawal by Subject|1|||
48495455|NCT02492958|156007856|FG003|Overall Study|Withdrawal by Subject|0|||
48495456|NCT02492958|156007853|FG000|Overall Study|Adverse Event|1|||
48495457|NCT02492958|156007854|FG001|Overall Study|Adverse Event|0|||
48495458|NCT02492958|156007855|FG002|Overall Study|Adverse Event|1|||
48495459|NCT02492958|156007856|FG003|Overall Study|Adverse Event|0|||
48495460|NCT01193608|156007857|FG000|Overall Study|Other|0|||
48495461|NCT01193608|156007858|FG001|Overall Study|Other|1|||
48495462|NCT01193608|156007859|FG002|Overall Study|Other|0|||
48495463|NCT01193608|156007860|FG003|Overall Study|Other|0|||
48495464|NCT01193608|156007861|FG004|Overall Study|Other|0|||
48495465|NCT01193608|156007862|FG005|Overall Study|Other|0|||
48495466|NCT01193608|156007857|FG000|Overall Study|Withdrawal by Subject|0|||
48495467|NCT01193608|156007858|FG001|Overall Study|Withdrawal by Subject|1|||
48495468|NCT01193608|156007859|FG002|Overall Study|Withdrawal by Subject|2|||
48495469|NCT01193608|156007860|FG003|Overall Study|Withdrawal by Subject|3|||
48495470|NCT01193608|156007861|FG004|Overall Study|Withdrawal by Subject|3|||
48495471|NCT01193608|156007862|FG005|Overall Study|Withdrawal by Subject|0|||
48495472|NCT01193608|156007857|FG000|Overall Study|Lost to Follow-up|0|||
48495473|NCT01193608|156007858|FG001|Overall Study|Lost to Follow-up|0|||
48495474|NCT01193608|156007859|FG002|Overall Study|Lost to Follow-up|0|||
48495475|NCT01193608|156007860|FG003|Overall Study|Lost to Follow-up|0|||
48495476|NCT01193608|156007861|FG004|Overall Study|Lost to Follow-up|1|||
48495477|NCT01193608|156007862|FG005|Overall Study|Lost to Follow-up|2|||
48495478|NCT01193608|156007857|FG000|Overall Study|Adverse Event|0|||
48495479|NCT01193608|156007858|FG001|Overall Study|Adverse Event|0|||
48495480|NCT01193608|156007859|FG002|Overall Study|Adverse Event|0|||
48495481|NCT01193608|156007860|FG003|Overall Study|Adverse Event|0|||
48495482|NCT01193608|156007861|FG004|Overall Study|Adverse Event|1|||
48495483|NCT01193608|156007862|FG005|Overall Study|Adverse Event|0|||
48495484|NCT01047345|156007863|FG000|Base Study|Adverse Event|3|||
48495485|NCT01047345|156007864|FG001|Base Study|Adverse Event|0|||
48495486|NCT01047345|156007865|FG002|Base Study|Adverse Event|0|||
48495487|NCT01047345|156007863|FG000|Base Study|Lost to Follow-up|4|||
48495488|NCT01047345|156007864|FG001|Base Study|Lost to Follow-up|1|||
48495489|NCT01047345|156007865|FG002|Base Study|Lost to Follow-up|0|||
48495490|NCT01047345|156007863|FG000|Base Study|Protocol Violation|3|||
48495491|NCT01047345|156007864|FG001|Base Study|Protocol Violation|1|||
48495492|NCT01047345|156007865|FG002|Base Study|Protocol Violation|0|||
48495493|NCT01047345|156007863|FG000|Base Study|Withdrawal by Subject|12|||
48495494|NCT01047345|156007864|FG001|Base Study|Withdrawal by Subject|4|||
48495495|NCT01047345|156007865|FG002|Base Study|Withdrawal by Subject|0|||
48495496|NCT01047345|156007863|FG000|Extension|Withdrawal by Subject|0|||
48495497|NCT01047345|156007864|FG001|Extension|Withdrawal by Subject|0|||
48495498|NCT01047345|156007865|FG002|Extension|Withdrawal by Subject|1|||
48495499|NCT01047345|156007863|FG000|Extension|Lost to Follow-up|0|||
48495500|NCT01047345|156007864|FG001|Extension|Lost to Follow-up|0|||
48495501|NCT01047345|156007865|FG002|Extension|Lost to Follow-up|5|||
48495502|NCT01816477|156007868|FG000|Overall Study|Withdrawal by Subject|13|||
48495503|NCT01816477|156007869|FG001|Overall Study|Withdrawal by Subject|1|||
48495504|NCT01816477|156007868|FG000|Overall Study|Unable to tolerate catheter placement|3|||
48495505|NCT01816477|156007869|FG001|Overall Study|Unable to tolerate catheter placement|0|||
48495506|NCT02001558|156007873|FG000|Overall Study|Lost to Follow-up|8|||
48495507|NCT02001558|156007874|FG001|Overall Study|Lost to Follow-up|14|||
48495508|NCT02978326|156007878|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
48495509|NCT02978326|156007879|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
48495510|NCT02978326|156007880|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
48495511|NCT02978326|156007878|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
48495512|NCT02978326|156007879|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
48495513|NCT02978326|156007880|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
48495514|NCT02978326|156007878|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
48495515|NCT02978326|156007879|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
48495516|NCT02978326|156007880|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
48495517|NCT02978326|156007878|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
48495518|NCT02978326|156007879|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
48495519|NCT02978326|156007880|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
48495520|NCT01709383|156007881|FG000|Overall Study|Lost to Follow-up|1|||
48495521|NCT01709383|156007882|FG001|Overall Study|Lost to Follow-up|0|||
48495522|NCT03402893|156007883|FG000|Overall Study|Withdrawal by Subject|1|||
48495523|NCT01411995|156007884|FG000|Overall Study|Failed IUD insertion|0|||
48495524|NCT01411995|156007885|FG001|Overall Study|Failed IUD insertion|1|||
48495525|NCT02545998|156007886|FG000|Overall Study|Lost to Follow-up|12|||
48495526|NCT02545998|156007887|FG001|Overall Study|Lost to Follow-up|3|||
48495527|NCT02545998|156007886|FG000|Overall Study|Withdrawal by Subject|3|||
48495528|NCT02545998|156007887|FG001|Overall Study|Withdrawal by Subject|2|||
48598105|NCT02326272|156385204|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48495529|NCT02486796|156007888|FG000|Overall Study|Withdrawal by Subject|1|||
48495530|NCT02486796|156007889|FG001|Overall Study|Withdrawal by Subject|1|||
48598106|NCT02326272|156385205|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598107|NCT02326272|156385206|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48495531|NCT02486796|156007888|FG000|Overall Study|Physician Decision|1|||
48495532|NCT02486796|156007889|FG001|Overall Study|Physician Decision|0|||
48495533|NCT03387098|156007890|FG000|Overall Study|progressive disease|1|||
48495534|NCT03387098|156007890|FG000|Overall Study|Withdrawal by Subject|2|||
48495535|NCT03387098|156007890|FG000|Overall Study|study terminated by sponsor|1|||
48495536|NCT00662129|156007891|FG000|Overall Study|Protocol Violation|1|||
48495537|NCT00662129|156007891|FG000|Overall Study|Cancel prior to beginning treatment|1|||
48495538|NCT00662129|156007891|FG000|Overall Study|Ineligible|1|||
48495539|NCT02292238|156007896|FG000|Overall Study|Protocol Violation|1|||
48495540|NCT02292238|156007897|FG001|Overall Study|Protocol Violation|2|||
48495541|NCT02292238|156007896|FG000|Overall Study|Withdrawal by Subject|2|||
48598108|NCT02326272|156385207|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598109|NCT02326272|156385208|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598110|NCT02326272|156385209|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598111|NCT02326272|156385210|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598112|NCT02326272|156385211|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598113|NCT02326272|156385212|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598114|NCT02326272|156385213|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
48598115|NCT02326272|156385199|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598116|NCT02326272|156385200|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598117|NCT02326272|156385201|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
48598118|NCT02326272|156385202|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598119|NCT02326272|156385203|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598120|NCT02326272|156385204|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598121|NCT02326272|156385205|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598122|NCT02326272|156385206|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598123|NCT02326272|156385207|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598124|NCT02326272|156385208|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598125|NCT02326272|156385209|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598126|NCT02326272|156385210|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598127|NCT02326272|156385211|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598128|NCT02326272|156385212|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598129|NCT02326272|156385213|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
48598130|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48495542|NCT02292238|156007897|FG001|Overall Study|Withdrawal by Subject|1|||
48495543|NCT02292238|156007896|FG000|Overall Study|Lost to Follow-up|1|||
48495544|NCT02292238|156007897|FG001|Overall Study|Lost to Follow-up|0|||
48495545|NCT02292238|156007896|FG000|Overall Study|Physician Decision|0|||
48495546|NCT02292238|156007897|FG001|Overall Study|Physician Decision|1|||
48495547|NCT02277769|156007898|FG000|Overall Study|Protocol Violation|3|||
48495548|NCT02277769|156007899|FG001|Overall Study|Protocol Violation|3|||
48495549|NCT02277769|156007900|FG002|Overall Study|Protocol Violation|5|||
48495550|NCT02277769|156007898|FG000|Overall Study|Lack of Efficacy|17|||
48495551|NCT02277769|156007899|FG001|Overall Study|Lack of Efficacy|0|||
48495552|NCT02277769|156007900|FG002|Overall Study|Lack of Efficacy|4|||
48495553|NCT02277769|156007898|FG000|Overall Study|Adverse Event|14|||
48495554|NCT02277769|156007899|FG001|Overall Study|Adverse Event|2|||
48495555|NCT02277769|156007900|FG002|Overall Study|Adverse Event|4|||
48495556|NCT02277769|156007898|FG000|Overall Study|Other than specified above|12|||
48495557|NCT02277769|156007899|FG001|Overall Study|Other than specified above|8|||
48495558|NCT02277769|156007900|FG002|Overall Study|Other than specified above|5|||
48495559|NCT01789320|156007902|FG000|Overall Study|Re-enrolled into study|1|||
48812665|NCT01003184|157155404|FG000|Overall Study|Adverse Event|12|||
48812666|NCT01003184|157155405|FG001|Overall Study|Adverse Event|5|||
48812667|NCT01003184|157155404|FG000|Overall Study|Lost to Follow-up|1|||
48812668|NCT01003184|157155405|FG001|Overall Study|Lost to Follow-up|0|||
48812669|NCT01003184|157155404|FG000|Overall Study|Loss of glucose control|1|||
48812670|NCT01003184|157155405|FG001|Overall Study|Loss of glucose control|1|||
48812671|NCT01003184|157155404|FG000|Overall Study|Protocol Violation|3|||
48812672|NCT01003184|157155405|FG001|Overall Study|Protocol Violation|0|||
48812673|NCT01003184|157155404|FG000|Overall Study|Withdrawal by Subject|1|||
48812674|NCT01003184|157155405|FG001|Overall Study|Withdrawal by Subject|6|||
48812675|NCT01003184|157155404|FG000|Overall Study|Physician Decision|1|||
48812676|NCT01003184|157155405|FG001|Overall Study|Physician Decision|0|||
48812677|NCT02765490|157155406|FG000|Overall Study|Lost to Follow-up|1|||
48812678|NCT02765490|157155407|FG001|Overall Study|Lost to Follow-up|1|||
48812679|NCT02765490|157155406|FG000|Overall Study|Other|0|||
48812680|NCT02765490|157155407|FG001|Overall Study|Other|1|||
48812681|NCT02765490|157155406|FG000|Overall Study|Death|0|||
48812682|NCT02765490|157155407|FG001|Overall Study|Death|1|||
48812683|NCT03662997|157155408|FG000|Overall Study|Adverse Event|0|||
48812684|NCT03662997|157155409|FG001|Overall Study|Adverse Event|2|||
48495560|NCT01789320|156007902|FG000|Overall Study|Lost to Follow-up|1|||
48495561|NCT00491504|156007903|FG000|Overall Study|Adverse Event|0|||
48495562|NCT00491504|156007904|FG001|Overall Study|Adverse Event|1|||
48495563|NCT00491504|156007905|FG002|Overall Study|Adverse Event|0|||
48495564|NCT00491504|156007906|FG003|Overall Study|Adverse Event|0|||
48495565|NCT00491504|156007903|FG000|Overall Study|Withdrawal by Subject|0|||
48495566|NCT00491504|156007904|FG001|Overall Study|Withdrawal by Subject|0|||
48495567|NCT00491504|156007905|FG002|Overall Study|Withdrawal by Subject|1|||
48495568|NCT00491504|156007906|FG003|Overall Study|Withdrawal by Subject|2|||
48812685|NCT03662997|157155410|FG002|Overall Study|Adverse Event|0|||
48812686|NCT03662997|157155411|FG003|Overall Study|Adverse Event|0|||
48495569|NCT00491504|156007903|FG000|Overall Study|Protocol Violation|0|||
48812687|NCT01865617|157155412|FG000|Overall Study|Death|27|||
48812688|NCT01865617|157155413|FG001|Overall Study|Death|3|||
48812689|NCT01865617|157155414|FG002|Overall Study|Death|1|||
48812690|NCT01865617|157155415|FG003|Overall Study|Death|1|||
48812691|NCT01865617|157155416|FG004|Overall Study|Death|5|||
48812692|NCT01865617|157155417|FG005|Overall Study|Death|1|||
48495570|NCT00491504|156007904|FG001|Overall Study|Protocol Violation|0|||
48495571|NCT00491504|156007905|FG002|Overall Study|Protocol Violation|3|||
48495572|NCT00491504|156007906|FG003|Overall Study|Protocol Violation|2|||
48812693|NCT01865617|157155418|FG006|Overall Study|Death|11|||
48812694|NCT01865617|157155419|FG007|Overall Study|Death|1|||
48812695|NCT01865617|157155420|FG008|Overall Study|Death|11|||
48812696|NCT01865617|157155421|FG009|Overall Study|Death|3|||
48812697|NCT01865617|157155422|FG010|Overall Study|Death|32|||
48812698|NCT01865617|157155423|FG011|Overall Study|Death|6|||
48812699|NCT01865617|157155424|FG012|Overall Study|Death|13|||
48812700|NCT01865617|157155412|FG000|Overall Study|Lost to Follow-up|2|||
48812701|NCT01865617|157155413|FG001|Overall Study|Lost to Follow-up|0|||
48812702|NCT01865617|157155414|FG002|Overall Study|Lost to Follow-up|0|||
48812703|NCT01865617|157155415|FG003|Overall Study|Lost to Follow-up|0|||
48812704|NCT01865617|157155416|FG004|Overall Study|Lost to Follow-up|0|||
48812705|NCT01865617|157155417|FG005|Overall Study|Lost to Follow-up|0|||
48812706|NCT01865617|157155418|FG006|Overall Study|Lost to Follow-up|0|||
48812707|NCT01865617|157155419|FG007|Overall Study|Lost to Follow-up|0|||
48495573|NCT00745095|156007907|FG000|Overall Study|Declined to participate|1|||
48495574|NCT00745095|156007908|FG001|Overall Study|Declined to participate|0|||
48812708|NCT01865617|157155420|FG008|Overall Study|Lost to Follow-up|0|||
48812709|NCT01865617|157155421|FG009|Overall Study|Lost to Follow-up|0|||
48812710|NCT01865617|157155422|FG010|Overall Study|Lost to Follow-up|0|||
48812711|NCT01865617|157155423|FG011|Overall Study|Lost to Follow-up|0|||
48812712|NCT01865617|157155424|FG012|Overall Study|Lost to Follow-up|0|||
48495575|NCT00745095|156007909|FG002|Overall Study|Declined to participate|0|||
48812713|NCT01865617|157155412|FG000|Overall Study|Withdrawal by Subject|1|||
48812714|NCT01865617|157155413|FG001|Overall Study|Withdrawal by Subject|0|||
48812715|NCT01865617|157155414|FG002|Overall Study|Withdrawal by Subject|0|||
48812716|NCT01865617|157155415|FG003|Overall Study|Withdrawal by Subject|0|||
48812717|NCT01865617|157155416|FG004|Overall Study|Withdrawal by Subject|0|||
48812718|NCT01865617|157155417|FG005|Overall Study|Withdrawal by Subject|0|||
48812719|NCT01865617|157155418|FG006|Overall Study|Withdrawal by Subject|0|||
48812720|NCT01865617|157155419|FG007|Overall Study|Withdrawal by Subject|0|||
48812721|NCT01865617|157155420|FG008|Overall Study|Withdrawal by Subject|0|||
48812722|NCT01865617|157155421|FG009|Overall Study|Withdrawal by Subject|0|||
48812723|NCT01865617|157155422|FG010|Overall Study|Withdrawal by Subject|0|||
48812724|NCT01865617|157155423|FG011|Overall Study|Withdrawal by Subject|0|||
48812725|NCT01865617|157155424|FG012|Overall Study|Withdrawal by Subject|0|||
48812726|NCT01865617|157155412|FG000|Overall Study|Patient proceeded to new therapy|0|||
48812727|NCT01865617|157155413|FG001|Overall Study|Patient proceeded to new therapy|0|||
48812728|NCT01865617|157155414|FG002|Overall Study|Patient proceeded to new therapy|0|||
48812729|NCT01865617|157155415|FG003|Overall Study|Patient proceeded to new therapy|0|||
48812730|NCT01865617|157155416|FG004|Overall Study|Patient proceeded to new therapy|2|||
48812731|NCT01865617|157155417|FG005|Overall Study|Patient proceeded to new therapy|0|||
48812732|NCT01865617|157155418|FG006|Overall Study|Patient proceeded to new therapy|0|||
48812733|NCT01865617|157155419|FG007|Overall Study|Patient proceeded to new therapy|0|||
48812734|NCT01865617|157155420|FG008|Overall Study|Patient proceeded to new therapy|0|||
48812735|NCT01865617|157155421|FG009|Overall Study|Patient proceeded to new therapy|0|||
48812736|NCT01865617|157155422|FG010|Overall Study|Patient proceeded to new therapy|0|||
48812737|NCT01865617|157155423|FG011|Overall Study|Patient proceeded to new therapy|0|||
48812738|NCT01865617|157155424|FG012|Overall Study|Patient proceeded to new therapy|0|||
48812739|NCT01865617|157155412|FG000|Overall Study|Other|0|||
48812740|NCT01865617|157155413|FG001|Overall Study|Other|0|||
48812741|NCT01865617|157155414|FG002|Overall Study|Other|0|||
48812742|NCT01865617|157155415|FG003|Overall Study|Other|0|||
48812743|NCT01865617|157155416|FG004|Overall Study|Other|0|||
48812744|NCT01865617|157155417|FG005|Overall Study|Other|0|||
48812745|NCT01865617|157155418|FG006|Overall Study|Other|1|||
48812746|NCT01865617|157155419|FG007|Overall Study|Other|0|||
48812747|NCT01865617|157155420|FG008|Overall Study|Other|0|||
48812748|NCT01865617|157155421|FG009|Overall Study|Other|0|||
48812749|NCT01865617|157155422|FG010|Overall Study|Other|0|||
48812750|NCT01865617|157155423|FG011|Overall Study|Other|0|||
48812751|NCT01865617|157155424|FG012|Overall Study|Other|0|||
48812752|NCT02500979|157155425|FG000|Period 1|Hyperglycemia|1|||
48812753|NCT02500979|157155426|FG001|Period 1|Hyperglycemia|0|||
48812754|NCT02500979|157155425|FG000|Period 1|Severe non-compliance to protocol|0|||
48812755|NCT02500979|157155426|FG001|Period 1|Severe non-compliance to protocol|1|||
48812756|NCT02500979|157155425|FG000|Period 1|Adverse Event|1|||
48812757|NCT02500979|157155426|FG001|Period 1|Adverse Event|0|||
48812758|NCT02500979|157155425|FG000|Period 1|Subject decision|2|||
48812759|NCT02500979|157155426|FG001|Period 1|Subject decision|0|||
48812760|NCT02500979|157155425|FG000|Period 2|Change in risk|1|||
48812761|NCT02500979|157155426|FG001|Period 2|Change in risk|0|||
48812762|NCT00675506|157155428|FG000|Overall Study|Lost to Follow-up|1|||
48812763|NCT00675506|157155429|FG001|Overall Study|Lost to Follow-up|5|||
48812764|NCT00675506|157155428|FG000|Overall Study|Lost interest|3|||
48812765|NCT00675506|157155429|FG001|Overall Study|Lost interest|5|||
48812766|NCT00675506|157155428|FG000|Overall Study|Elevated fasting glucose|2|||
48812767|NCT00675506|157155429|FG001|Overall Study|Elevated fasting glucose|1|||
48812768|NCT00675506|157155428|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
48812769|NCT00675506|157155429|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
48812770|NCT00675506|157155428|FG000|Overall Study|Elevated IGF-1|2|||
48812771|NCT00675506|157155429|FG001|Overall Study|Elevated IGF-1|0|||
48812772|NCT00675506|157155428|FG000|Overall Study|Hypersensitivity Reaction|1|||
48812773|NCT00675506|157155429|FG001|Overall Study|Hypersensitivity Reaction|0|||
48812774|NCT00675506|157155428|FG000|Overall Study|Disclosed history of cancer|1|||
48812775|NCT00675506|157155429|FG001|Overall Study|Disclosed history of cancer|0|||
48812776|NCT00675506|157155428|FG000|Overall Study|Declined participation|1|||
48812777|NCT00675506|157155429|FG001|Overall Study|Declined participation|0|||
48812778|NCT00675506|157155428|FG000|Overall Study|Schedule conflict|0|||
48812779|NCT00675506|157155429|FG001|Overall Study|Schedule conflict|1|||
48812780|NCT03292146|157155430|FG000|Baseline to 12 Months|Relocation|1|||
48812781|NCT03292146|157155431|FG001|Baseline to 12 Months|Relocation|0|||
48812782|NCT03292146|157155430|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
48812783|NCT03292146|157155431|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
48812784|NCT03292146|157155430|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
48495576|NCT00745095|156007910|FG003|Overall Study|Declined to participate|0|||
48495577|NCT00745095|156007911|FG004|Overall Study|Declined to participate|92|||
48495578|NCT00745095|156007912|FG005|Overall Study|Declined to participate|95|||
48495579|NCT00745095|156007907|FG000|Overall Study|Ineligible due to GFR criteria|0|||
48495580|NCT00745095|156007908|FG001|Overall Study|Ineligible due to GFR criteria|2|||
48495581|NCT00745095|156007909|FG002|Overall Study|Ineligible due to GFR criteria|3|||
48495582|NCT00745095|156007910|FG003|Overall Study|Ineligible due to GFR criteria|3|||
48495583|NCT00745095|156007911|FG004|Overall Study|Ineligible due to GFR criteria|30|||
48495584|NCT00745095|156007912|FG005|Overall Study|Ineligible due to GFR criteria|28|||
48495585|NCT02041702|156007924|FG000|Overall Study|Lost to Follow-up|1|||
48495586|NCT02041702|156007925|FG001|Overall Study|Lost to Follow-up|6|||
48495587|NCT02041702|156007924|FG000|Overall Study|Death|4|||
48495588|NCT02041702|156007925|FG001|Overall Study|Death|0|||
48495589|NCT02041702|156007924|FG000|Overall Study|Withdrawal by Subject|4|||
48495590|NCT02041702|156007925|FG001|Overall Study|Withdrawal by Subject|3|||
48495591|NCT02041702|156007924|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
48495592|NCT02041702|156007925|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
48495593|NCT02041702|156007924|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
48495594|NCT02041702|156007925|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
48495595|NCT03977584|156007927|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
48495596|NCT03977584|156007928|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
48495597|NCT03977584|156007929|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
48495598|NCT01766778|156007930|FG000|Overall Study|Adverse Event|4|||
48495599|NCT01766778|156007931|FG001|Overall Study|Adverse Event|4|||
48495600|NCT01766778|156007930|FG000|Overall Study|Withdrawal by Subject|1|||
48495601|NCT01766778|156007931|FG001|Overall Study|Withdrawal by Subject|0|||
48495602|NCT01104662|156007932|FG000|Overall Study|Adverse Event|2|||
48495603|NCT01104662|156007933|FG001|Overall Study|Adverse Event|2|||
48495604|NCT01104662|156007934|FG002|Overall Study|Adverse Event|0|||
48495605|NCT01104662|156007935|FG003|Overall Study|Adverse Event|1|||
48495606|NCT01104662|156007936|FG004|Overall Study|Adverse Event|1|||
48495607|NCT01104662|156007937|FG005|Overall Study|Adverse Event|1|||
48495608|NCT01104662|156007938|FG006|Overall Study|Adverse Event|0|||
48495609|NCT01104662|156007939|FG007|Overall Study|Adverse Event|0|||
48495610|NCT01104662|156007932|FG000|Overall Study|Clinical Failure|1|||
48495611|NCT01104662|156007933|FG001|Overall Study|Clinical Failure|0|||
48495612|NCT01104662|156007934|FG002|Overall Study|Clinical Failure|0|||
48495613|NCT01104662|156007935|FG003|Overall Study|Clinical Failure|0|||
48495614|NCT01104662|156007936|FG004|Overall Study|Clinical Failure|0|||
48495615|NCT01104662|156007937|FG005|Overall Study|Clinical Failure|1|||
48495616|NCT01104662|156007938|FG006|Overall Study|Clinical Failure|0|||
48495617|NCT01104662|156007939|FG007|Overall Study|Clinical Failure|0|||
48714184|NCT01419197|156803179|FG001|Overall Study|Non-compliance|1|||
48714185|NCT01419197|156803178|FG000|Overall Study|Withdrawal by Subject|33|||
48714186|NCT01419197|156803179|FG001|Overall Study|Withdrawal by Subject|32|||
48714187|NCT01419197|156803178|FG000|Overall Study|Study Completed by Sponsor|103|||
48714188|NCT01419197|156803179|FG001|Overall Study|Study Completed by Sponsor|34|||
48714189|NCT01419197|156803178|FG000|Overall Study|Reason Not Specified|0|||
48714190|NCT01419197|156803179|FG001|Overall Study|Reason Not Specified|1|||
48714191|NCT01419197|156803178|FG000|Overall Study|Lost to Follow-up|14|||
48714192|NCT01419197|156803179|FG001|Overall Study|Lost to Follow-up|4|||
48714193|NCT00653939|156803180|FG000|Overall Study|Adverse Event|1|||
48812785|NCT03292146|157155431|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
48812786|NCT03292146|157155430|FG000|12 Months to 24 Months|Planning pregnancy|2|||
48812787|NCT03292146|157155431|FG001|12 Months to 24 Months|Planning pregnancy|2|||
48812788|NCT03292146|157155430|FG000|12 Months to 24 Months|Personal reasons|1|||
48812789|NCT03292146|157155431|FG001|12 Months to 24 Months|Personal reasons|0|||
48812790|NCT03292146|157155430|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
48812791|NCT03292146|157155431|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
48812792|NCT01613027|157155436|FG000|Overall Study|Lost to Follow-up|5|||
48812793|NCT01613027|157155436|FG000|Overall Study|Switched Physician|1|||
48812794|NCT01613027|157155436|FG000|Overall Study|Lack of Efficacy|1|||
48812795|NCT01613027|157155436|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
48812796|NCT00993317|157155437|FG000|Overall Study|Adverse Event|2|||
48495618|NCT01104662|156007932|FG000|Overall Study|Participant left investigator's care|1|||
48495619|NCT01104662|156007933|FG001|Overall Study|Participant left investigator's care|1|||
48495620|NCT01104662|156007934|FG002|Overall Study|Participant left investigator's care|0|||
48495621|NCT01104662|156007935|FG003|Overall Study|Participant left investigator's care|0|||
48495622|NCT01104662|156007936|FG004|Overall Study|Participant left investigator's care|0|||
48495623|NCT01104662|156007937|FG005|Overall Study|Participant left investigator's care|0|||
48495624|NCT01104662|156007938|FG006|Overall Study|Participant left investigator's care|0|||
48495625|NCT01104662|156007939|FG007|Overall Study|Participant left investigator's care|0|||
48495626|NCT01104662|156007932|FG000|Overall Study|Reason not specified|3|||
48495627|NCT01104662|156007933|FG001|Overall Study|Reason not specified|3|||
48495628|NCT01104662|156007934|FG002|Overall Study|Reason not specified|0|||
48495629|NCT01104662|156007935|FG003|Overall Study|Reason not specified|0|||
48495630|NCT01104662|156007936|FG004|Overall Study|Reason not specified|0|||
48495631|NCT01104662|156007937|FG005|Overall Study|Reason not specified|1|||
48495632|NCT01104662|156007938|FG006|Overall Study|Reason not specified|0|||
48495633|NCT01104662|156007939|FG007|Overall Study|Reason not specified|0|||
48495634|NCT01104662|156007932|FG000|Overall Study|Randomized but not treated|3|||
48495635|NCT01104662|156007933|FG001|Overall Study|Randomized but not treated|4|||
48495636|NCT01104662|156007934|FG002|Overall Study|Randomized but not treated|1|||
48495637|NCT01104662|156007935|FG003|Overall Study|Randomized but not treated|0|||
48495638|NCT01104662|156007936|FG004|Overall Study|Randomized but not treated|0|||
48495639|NCT01104662|156007937|FG005|Overall Study|Randomized but not treated|1|||
48495640|NCT01104662|156007938|FG006|Overall Study|Randomized but not treated|0|||
48495641|NCT01104662|156007939|FG007|Overall Study|Randomized but not treated|0|||
48495642|NCT01478620|156007940|FG000|Overall Study|Lost to Follow-up|6|||
48495643|NCT00475020|156007941|FG000|Overall Study|Physician Decision|3|||
48495644|NCT00475020|156007941|FG000|Overall Study|Insurance Denial|1|||
48495645|NCT00475020|156007941|FG000|Overall Study|Donor not able to donate the last minute|1|||
48495646|NCT02514174|156007942|FG000|Overall Study|Patient refused to continue medication|1|||
48495647|NCT02514174|156007942|FG000|Overall Study|Adverse Event|2|||
48495648|NCT02514174|156007942|FG000|Overall Study|Study closed by sponsor|9|||
48495649|NCT02514174|156007942|FG000|Overall Study|Progressive disease|11|||
48495650|NCT02514174|156007942|FG000|Overall Study|Treatment change|1|||
48495651|NCT02514174|156007942|FG000|Overall Study|Treated off study with Afatinib.|1|||
48495652|NCT02346201|156007947|FG000|Overall Study|Adverse Event|3|||
48495653|NCT02346201|156007948|FG001|Overall Study|Adverse Event|2|||
48495654|NCT02346201|156007947|FG000|Overall Study|Lost to Follow-up|1|||
48495655|NCT02346201|156007948|FG001|Overall Study|Lost to Follow-up|0|||
48714194|NCT00653939|156803181|FG001|Overall Study|Adverse Event|3|||
48714195|NCT00653939|156803180|FG000|Overall Study|Withdrawal by Subject|3|||
48714196|NCT00653939|156803181|FG001|Overall Study|Withdrawal by Subject|3|||
48714197|NCT00653939|156803180|FG000|Overall Study|Physician Decision|4|||
48714198|NCT00653939|156803181|FG001|Overall Study|Physician Decision|0|||
48714199|NCT00653939|156803180|FG000|Overall Study|Disease Progression|2|||
48714200|NCT00653939|156803181|FG001|Overall Study|Disease Progression|3|||
48714201|NCT00653939|156803180|FG000|Overall Study|Other|2|||
48714202|NCT00653939|156803181|FG001|Overall Study|Other|6|||
48714203|NCT01396057|156803182|FG000|Overall Study|Adverse Event|2|||
48714204|NCT01396057|156803183|FG001|Overall Study|Adverse Event|6|||
48714205|NCT01396057|156803182|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48714206|NCT01396057|156803183|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
48714207|NCT01396057|156803182|FG000|Overall Study|Protocol deviation|4|||
48714208|NCT01396057|156803183|FG001|Overall Study|Protocol deviation|4|||
48714209|NCT01396057|156803182|FG000|Overall Study|Consent withdrawn|3|||
48714210|NCT01396057|156803183|FG001|Overall Study|Consent withdrawn|2|||
48714211|NCT00636363|156803185|FG000|Overall Study|Conjunctivitis|0|||
48714212|NCT00636363|156803186|FG001|Overall Study|Conjunctivitis|0|||
48714213|NCT00636363|156803187|FG002|Overall Study|Conjunctivitis|1|||
48714214|NCT00636363|156803185|FG000|Overall Study|Adverse Event|0|||
48714215|NCT00636363|156803186|FG001|Overall Study|Adverse Event|0|||
48714216|NCT00636363|156803187|FG002|Overall Study|Adverse Event|1|||
48714217|NCT00636363|156803185|FG000|Overall Study|Positive slit lamp finding|0|||
48714218|NCT00636363|156803186|FG001|Overall Study|Positive slit lamp finding|2|||
48714219|NCT00636363|156803187|FG002|Overall Study|Positive slit lamp finding|1|||
48714220|NCT00636363|156803185|FG000|Overall Study|Study related symptoms/complaints|8|||
48714221|NCT00636363|156803186|FG001|Overall Study|Study related symptoms/complaints|7|||
48714222|NCT00636363|156803187|FG002|Overall Study|Study related symptoms/complaints|4|||
48495656|NCT02346201|156007947|FG000|Overall Study|Withdrawal by Subject|6|||
48495657|NCT02346201|156007948|FG001|Overall Study|Withdrawal by Subject|3|||
48495658|NCT02346201|156007947|FG000|Overall Study|Unavailable for future follow-up|0|||
48714223|NCT00636363|156803185|FG000|Overall Study|Met ineligibility criteria|0|||
48714224|NCT00636363|156803186|FG001|Overall Study|Met ineligibility criteria|0|||
48714225|NCT00636363|156803187|FG002|Overall Study|Met ineligibility criteria|3|||
48495659|NCT02346201|156007948|FG001|Overall Study|Unavailable for future follow-up|1|||
48495660|NCT02346201|156007947|FG000|Overall Study|Physician Decision|0|||
48495661|NCT02346201|156007948|FG001|Overall Study|Physician Decision|1|||
48495662|NCT02346201|156007947|FG000|Overall Study|Missed final visit|0|||
48495663|NCT02346201|156007948|FG001|Overall Study|Missed final visit|2|||
48495664|NCT02130466|156007949|FG000|Overall Study|Death|4|||
48495665|NCT02130466|156007950|FG001|Overall Study|Death|1|||
48495666|NCT02130466|156007951|FG002|Overall Study|Death|1|||
48495667|NCT02130466|156007952|FG003|Overall Study|Death|3|||
48495668|NCT02130466|156007953|FG004|Overall Study|Death|2|||
48812797|NCT00993317|157155438|FG001|Overall Study|Adverse Event|4|||
48812798|NCT00993317|157155437|FG000|Overall Study|Lack of Efficacy|18|||
48495669|NCT02130466|156007954|FG005|Overall Study|Death|30|||
48495670|NCT02130466|156007955|FG006|Overall Study|Death|45|||
48812799|NCT00993317|157155438|FG001|Overall Study|Lack of Efficacy|18|||
48812800|NCT00993317|157155437|FG000|Overall Study|Withdrawal by Subject|0|||
48812801|NCT00993317|157155438|FG001|Overall Study|Withdrawal by Subject|2|||
48812802|NCT00993317|157155437|FG000|Overall Study|Investigator's opinion|0|||
48812803|NCT00993317|157155438|FG001|Overall Study|Investigator's opinion|1|||
48812804|NCT00993317|157155437|FG000|Overall Study|Early study termination at the site|1|||
48495671|NCT02130466|156007956|FG007|Overall Study|Death|2|||
48495672|NCT02130466|156007957|FG008|Overall Study|Death|3|||
48495673|NCT02130466|156007958|FG009|Overall Study|Death|4|||
48495674|NCT02130466|156007959|FG010|Overall Study|Death|5|||
48495675|NCT02130466|156007960|FG011|Overall Study|Death|3|||
48495676|NCT02130466|156007961|FG012|Overall Study|Death|11|||
48495677|NCT02130466|156007962|FG013|Overall Study|Death|7|||
48495678|NCT02130466|156007949|FG000|Overall Study|Lost to Follow-up|1|||
48495679|NCT02130466|156007950|FG001|Overall Study|Lost to Follow-up|0|||
48495680|NCT02130466|156007951|FG002|Overall Study|Lost to Follow-up|0|||
48495681|NCT02130466|156007952|FG003|Overall Study|Lost to Follow-up|0|||
48495682|NCT02130466|156007953|FG004|Overall Study|Lost to Follow-up|0|||
48495683|NCT02130466|156007954|FG005|Overall Study|Lost to Follow-up|1|||
48495684|NCT02130466|156007955|FG006|Overall Study|Lost to Follow-up|0|||
48495685|NCT02130466|156007956|FG007|Overall Study|Lost to Follow-up|0|||
48495686|NCT02130466|156007957|FG008|Overall Study|Lost to Follow-up|0|||
48495687|NCT02130466|156007958|FG009|Overall Study|Lost to Follow-up|0|||
48495688|NCT02130466|156007959|FG010|Overall Study|Lost to Follow-up|0|||
48495689|NCT02130466|156007960|FG011|Overall Study|Lost to Follow-up|0|||
48495690|NCT02130466|156007961|FG012|Overall Study|Lost to Follow-up|1|||
48495691|NCT02130466|156007962|FG013|Overall Study|Lost to Follow-up|0|||
48495692|NCT02130466|156007949|FG000|Overall Study|Physician Decision|0|||
48495693|NCT02130466|156007950|FG001|Overall Study|Physician Decision|0|||
48495694|NCT02130466|156007951|FG002|Overall Study|Physician Decision|0|||
48495695|NCT02130466|156007952|FG003|Overall Study|Physician Decision|0|||
48495696|NCT02130466|156007953|FG004|Overall Study|Physician Decision|0|||
48495697|NCT02130466|156007954|FG005|Overall Study|Physician Decision|1|||
48598131|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48598132|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48812805|NCT00993317|157155438|FG001|Overall Study|Early study termination at the site|0|||
48812806|NCT00672958|157155439|FG000|Overall Study|Adverse Event|11|||
48812807|NCT00672958|157155440|FG001|Overall Study|Adverse Event|9|||
48812808|NCT00672958|157155439|FG000|Overall Study|Lack of Efficacy|6|||
48812809|NCT00672958|157155440|FG001|Overall Study|Lack of Efficacy|11|||
48812810|NCT00672958|157155439|FG000|Overall Study|Non-compliance with study drug|2|||
48812811|NCT00672958|157155440|FG001|Overall Study|Non-compliance with study drug|3|||
48812812|NCT00672958|157155439|FG000|Overall Study|Protocol deviations|11|||
48812813|NCT00672958|157155440|FG001|Overall Study|Protocol deviations|5|||
48495698|NCT02130466|156007955|FG006|Overall Study|Physician Decision|1|||
48495699|NCT02130466|156007956|FG007|Overall Study|Physician Decision|0|||
48495700|NCT02130466|156007957|FG008|Overall Study|Physician Decision|0|||
48812814|NCT00672958|157155439|FG000|Overall Study|Voluntary withdrawal|12|||
48495701|NCT02130466|156007958|FG009|Overall Study|Physician Decision|0|||
48495702|NCT02130466|156007959|FG010|Overall Study|Physician Decision|0|||
48495703|NCT02130466|156007960|FG011|Overall Study|Physician Decision|0|||
48495704|NCT02130466|156007961|FG012|Overall Study|Physician Decision|0|||
48495705|NCT02130466|156007962|FG013|Overall Study|Physician Decision|0|||
48495706|NCT02130466|156007949|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
48495707|NCT02130466|156007950|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
48495708|NCT02130466|156007951|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
48495709|NCT02130466|156007952|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
48495710|NCT02130466|156007953|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
48495711|NCT02130466|156007954|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
48495712|NCT02130466|156007955|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
48495713|NCT02130466|156007956|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
48495714|NCT02130466|156007957|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
48495715|NCT02130466|156007958|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
48495716|NCT02130466|156007959|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
48495717|NCT02130466|156007960|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
48495718|NCT02130466|156007961|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
48495719|NCT02130466|156007962|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
48495720|NCT02130466|156007949|FG000|Overall Study|Withdrawal by Subject|1|||
48495721|NCT02130466|156007950|FG001|Overall Study|Withdrawal by Subject|0|||
48495722|NCT02130466|156007951|FG002|Overall Study|Withdrawal by Subject|0|||
48495723|NCT02130466|156007952|FG003|Overall Study|Withdrawal by Subject|0|||
48495724|NCT02130466|156007953|FG004|Overall Study|Withdrawal by Subject|0|||
48495725|NCT02130466|156007954|FG005|Overall Study|Withdrawal by Subject|1|||
48495726|NCT02130466|156007955|FG006|Overall Study|Withdrawal by Subject|0|||
48714226|NCT00636363|156803185|FG000|Overall Study|Missed > 1 visit|0|||
48714227|NCT00636363|156803186|FG001|Overall Study|Missed > 1 visit|1|||
48714228|NCT00636363|156803187|FG002|Overall Study|Missed > 1 visit|3|||
48714229|NCT00636363|156803185|FG000|Overall Study|Lack of motivation|1|||
48714230|NCT00636363|156803186|FG001|Overall Study|Lack of motivation|0|||
48714231|NCT00636363|156803187|FG002|Overall Study|Lack of motivation|1|||
48714232|NCT00636363|156803185|FG000|Overall Study|Protocol Violation|0|||
48714233|NCT00636363|156803186|FG001|Overall Study|Protocol Violation|3|||
48714234|NCT00636363|156803187|FG002|Overall Study|Protocol Violation|0|||
48714235|NCT00636363|156803185|FG000|Overall Study|Lost to Follow-up|3|||
48714236|NCT00636363|156803186|FG001|Overall Study|Lost to Follow-up|4|||
48714237|NCT00636363|156803187|FG002|Overall Study|Lost to Follow-up|2|||
48714238|NCT00636363|156803185|FG000|Overall Study|Withdrawal by Subject|1|||
48714239|NCT00636363|156803186|FG001|Overall Study|Withdrawal by Subject|3|||
48714240|NCT00636363|156803187|FG002|Overall Study|Withdrawal by Subject|2|||
48714241|NCT00796991|156803191|FG000|Overall Study|Adverse Event|0|||
48714242|NCT00796991|156803192|FG001|Overall Study|Adverse Event|0|||
48714243|NCT00796991|156803193|FG002|Overall Study|Adverse Event|1|||
48714244|NCT00796991|156803191|FG000|Overall Study|Death|2|||
48714245|NCT00796991|156803192|FG001|Overall Study|Death|0|||
48714246|NCT00796991|156803193|FG002|Overall Study|Death|0|||
48714247|NCT00796991|156803191|FG000|Overall Study|Disease Progression|10|||
48714248|NCT00796991|156803192|FG001|Overall Study|Disease Progression|9|||
48714249|NCT00796991|156803193|FG002|Overall Study|Disease Progression|7|||
48714250|NCT00796991|156803191|FG000|Overall Study|Study Drug Toxicity|3|||
48714251|NCT00796991|156803192|FG001|Overall Study|Study Drug Toxicity|3|||
48714252|NCT00796991|156803193|FG002|Overall Study|Study Drug Toxicity|5|||
48714253|NCT00796991|156803191|FG000|Overall Study|Withdrawal by Subject|0|||
48714254|NCT00796991|156803192|FG001|Overall Study|Withdrawal by Subject|0|||
48714255|NCT00796991|156803193|FG002|Overall Study|Withdrawal by Subject|1|||
48714256|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
48714257|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
48714258|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
48714259|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
48714260|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
48714261|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
48714262|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
48714263|NCT00946985|156803194|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
48714264|NCT00946985|156803194|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
48714265|NCT00899392|156803195|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
48714266|NCT00899392|156803196|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
48714267|NCT03753789|156803197|FG000|Overall Study|Withdrawal by Subject|2|||
48714268|NCT00171834|156803198|FG000|Overall Study|Adverse Event|2|||
48714269|NCT00171834|156803199|FG001|Overall Study|Adverse Event|1|||
48714270|NCT00171834|156803200|FG002|Overall Study|Adverse Event|3|||
48714271|NCT00171834|156803201|FG003|Overall Study|Adverse Event|2|||
48714272|NCT00171834|156803202|FG004|Overall Study|Adverse Event|2|||
48714273|NCT00171834|156803203|FG005|Overall Study|Adverse Event|15|||
48714274|NCT00171834|156803204|FG006|Overall Study|Adverse Event|1|||
48714275|NCT00171834|156803198|FG000|Overall Study|Withdrawal by Subject|0|||
48495727|NCT02130466|156007956|FG007|Overall Study|Withdrawal by Subject|0|||
48495728|NCT02130466|156007957|FG008|Overall Study|Withdrawal by Subject|1|||
48812815|NCT00672958|157155440|FG001|Overall Study|Voluntary withdrawal|8|||
48495729|NCT02130466|156007958|FG009|Overall Study|Withdrawal by Subject|0|||
48495730|NCT02130466|156007959|FG010|Overall Study|Withdrawal by Subject|0|||
48495731|NCT02130466|156007960|FG011|Overall Study|Withdrawal by Subject|0|||
48495732|NCT02130466|156007961|FG012|Overall Study|Withdrawal by Subject|0|||
48714276|NCT00171834|156803199|FG001|Overall Study|Withdrawal by Subject|2|||
48714277|NCT00171834|156803200|FG002|Overall Study|Withdrawal by Subject|0|||
48495733|NCT02130466|156007962|FG013|Overall Study|Withdrawal by Subject|0|||
48495734|NCT03997448|156009709|FG000|Study Treatment|Disease Progression|1|||
48495735|NCT03997448|156009709|FG000|Study Treatment|Symptomatic Deterioration|1|||
48495736|NCT03997448|156009709|FG000|Follow up|Death|2|||
48495737|NCT03997448|156009709|FG000|Follow up|study terminated|1|||
48495738|NCT04582266|156009712|FG000|Overall Study|Lost to Follow-up|7|||
48495739|NCT04582266|156009713|FG001|Overall Study|Lost to Follow-up|5|||
48495740|NCT04582266|156009712|FG000|Overall Study|Withdrawal by Subject|1|||
48495741|NCT04582266|156009713|FG001|Overall Study|Withdrawal by Subject|0|||
48495742|NCT04582266|156009712|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
48495743|NCT04582266|156009713|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
48495744|NCT01341639|156009714|FG000|Infant Series|Protocol Violation|1|||
48495745|NCT01341639|156009715|FG001|Infant Series|Protocol Violation|0|||
48495746|NCT01341639|156009714|FG000|Infant Series|Not Vaccinated|0|||
48495747|NCT01341639|156009715|FG001|Infant Series|Not Vaccinated|1|||
48495748|NCT01341639|156009714|FG000|Infant Series|Adverse Event|0|||
48495749|NCT01341639|156009715|FG001|Infant Series|Adverse Event|5|||
48495750|NCT01341639|156009714|FG000|Infant Series|Withdrawal by Subject|11|||
48495751|NCT01341639|156009715|FG001|Infant Series|Withdrawal by Subject|8|||
48495752|NCT01341639|156009714|FG000|Infant Series|Lost to Follow-up|0|||
48495753|NCT01341639|156009715|FG001|Infant Series|Lost to Follow-up|2|||
48495754|NCT01341639|156009714|FG000|Infant Series|Site 0048 Participants|17|||
48495755|NCT01341639|156009715|FG001|Infant Series|Site 0048 Participants|16|||
48495756|NCT01341639|156009714|FG000|Interim Period|Withdrawal by Subject|6|||
48495757|NCT01341639|156009715|FG001|Interim Period|Withdrawal by Subject|7|||
48495758|NCT01341639|156009714|FG000|Interim Period|Lost to Follow-up|2|||
48495759|NCT01341639|156009715|FG001|Interim Period|Lost to Follow-up|0|||
48495760|NCT01341639|156009714|FG000|Interim Period|Physician Decision|0|||
48495761|NCT01341639|156009715|FG001|Interim Period|Physician Decision|1|||
48495762|NCT01341639|156009714|FG000|Interim Period|Protocol Violation|0|||
48714278|NCT00171834|156803201|FG003|Overall Study|Withdrawal by Subject|1|||
48714279|NCT00171834|156803202|FG004|Overall Study|Withdrawal by Subject|1|||
48714280|NCT00171834|156803203|FG005|Overall Study|Withdrawal by Subject|1|||
48714281|NCT00171834|156803204|FG006|Overall Study|Withdrawal by Subject|0|||
48714282|NCT00171834|156803198|FG000|Overall Study|Death from study indication|0|||
48812816|NCT00672958|157155439|FG000|Overall Study|Lost to Follow-up|22|||
48812817|NCT00672958|157155440|FG001|Overall Study|Lost to Follow-up|17|||
48495763|NCT01341639|156009715|FG001|Interim Period|Protocol Violation|1|||
48495764|NCT01341639|156009714|FG000|Post-Treatment|Withdrawal by Subject|0|||
48714283|NCT00171834|156803199|FG001|Overall Study|Death from study indication|1|||
48495765|NCT01341639|156009715|FG001|Post-Treatment|Withdrawal by Subject|1|||
48495766|NCT01341639|156009714|FG000|Post-Treatment|Adverse Event|0|||
48495767|NCT01341639|156009715|FG001|Post-Treatment|Adverse Event|2|||
48495768|NCT03083483|156009717|FG000|Overall Study|Adverse Event|1|||
48495769|NCT03083483|156009718|FG001|Overall Study|Adverse Event|1|||
48495770|NCT03083483|156009719|FG002|Overall Study|Adverse Event|1|||
48495771|NCT03083483|156009717|FG000|Overall Study|Lost to Follow-up|2|||
48495772|NCT03083483|156009718|FG001|Overall Study|Lost to Follow-up|1|||
48495773|NCT03083483|156009719|FG002|Overall Study|Lost to Follow-up|1|||
48714284|NCT00171834|156803200|FG002|Overall Study|Death from study indication|0|||
48714285|NCT00171834|156803201|FG003|Overall Study|Death from study indication|0|||
48714286|NCT00171834|156803202|FG004|Overall Study|Death from study indication|1|||
48714287|NCT00171834|156803203|FG005|Overall Study|Death from study indication|0|||
48714288|NCT00171834|156803204|FG006|Overall Study|Death from study indication|0|||
48714289|NCT00171834|156803198|FG000|Overall Study|Disease Progression|4|||
48714290|NCT00171834|156803199|FG001|Overall Study|Disease Progression|8|||
48714291|NCT00171834|156803200|FG002|Overall Study|Disease Progression|8|||
48495774|NCT03083483|156009717|FG000|Overall Study|technological issues|1|||
48714292|NCT00171834|156803201|FG003|Overall Study|Disease Progression|9|||
48714293|NCT00171834|156803202|FG004|Overall Study|Disease Progression|2|||
48495775|NCT03083483|156009718|FG001|Overall Study|technological issues|0|||
48714294|NCT00171834|156803203|FG005|Overall Study|Disease Progression|18|||
48714295|NCT00171834|156803204|FG006|Overall Study|Disease Progression|3|||
48714296|NCT00171834|156803198|FG000|Overall Study|Treatment Duration Completed|0|||
48714297|NCT00171834|156803199|FG001|Overall Study|Treatment Duration Completed|0|||
48714298|NCT00171834|156803200|FG002|Overall Study|Treatment Duration Completed|1|||
48495776|NCT03083483|156009719|FG002|Overall Study|technological issues|1|||
48495777|NCT00738673|156009725|FG000|Overall Study|Adverse Event|1|||
48495778|NCT00738673|156009726|FG001|Overall Study|Adverse Event|0|||
48495779|NCT00738673|156009725|FG000|Overall Study|Lack of Efficacy|19|||
48714299|NCT00171834|156803201|FG003|Overall Study|Treatment Duration Completed|0|||
48714300|NCT00171834|156803202|FG004|Overall Study|Treatment Duration Completed|2|||
48714301|NCT00171834|156803203|FG005|Overall Study|Treatment Duration Completed|1|||
48495780|NCT00738673|156009726|FG001|Overall Study|Lack of Efficacy|8|||
48495781|NCT00738673|156009725|FG000|Overall Study|Protocol Violation|1|||
48495782|NCT00738673|156009726|FG001|Overall Study|Protocol Violation|2|||
48495783|NCT00738673|156009725|FG000|Overall Study|Withdrawal by Subject|3|||
48495784|NCT00738673|156009726|FG001|Overall Study|Withdrawal by Subject|1|||
48495785|NCT01799590|156009728|FG000|Overall Study|Adverse Event|13|||
48495786|NCT01799590|156009729|FG001|Overall Study|Adverse Event|7|||
48495787|NCT01799590|156009730|FG002|Overall Study|Adverse Event|5|||
48495788|NCT01799590|156009728|FG000|Overall Study|Pregnancy|2|||
48495789|NCT01799590|156009729|FG001|Overall Study|Pregnancy|0|||
48495790|NCT01799590|156009730|FG002|Overall Study|Pregnancy|0|||
48495791|NCT01799590|156009728|FG000|Overall Study|Lack of Efficacy|3|||
48495792|NCT01799590|156009729|FG001|Overall Study|Lack of Efficacy|1|||
48495793|NCT01799590|156009730|FG002|Overall Study|Lack of Efficacy|3|||
48495794|NCT01799590|156009728|FG000|Overall Study|Participants convenience|4|||
48495795|NCT01799590|156009729|FG001|Overall Study|Participants convenience|4|||
48495796|NCT01799590|156009730|FG002|Overall Study|Participants convenience|2|||
48495797|NCT01799590|156009728|FG000|Overall Study|Aggravation of complications|0|||
48495798|NCT01799590|156009729|FG001|Overall Study|Aggravation of complications|1|||
48495799|NCT01799590|156009730|FG002|Overall Study|Aggravation of complications|1|||
48495800|NCT01799590|156009728|FG000|Overall Study|Using drugs with restricted days of use|0|||
48495801|NCT01799590|156009729|FG001|Overall Study|Using drugs with restricted days of use|3|||
48495802|NCT01799590|156009730|FG002|Overall Study|Using drugs with restricted days of use|2|||
48495803|NCT01799590|156009728|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
48495804|NCT01799590|156009729|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
48495805|NCT01799590|156009730|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
48495806|NCT01799590|156009728|FG000|Overall Study|Other|3|||
48495807|NCT01799590|156009729|FG001|Overall Study|Other|0|||
48495808|NCT01799590|156009730|FG002|Overall Study|Other|1|||
48495809|NCT02006706|156009731|FG000|Overall Study|Lost to Follow-up|1|||
48495810|NCT00582036|156009732|FG000|Overall Study|Withdrawal by Subject|0|||
48495811|NCT00582036|156009733|FG001|Overall Study|Withdrawal by Subject|1|||
48495812|NCT05487456|156009734|FG000|Overall Study|Withdrawal by Subject|0|||
48495813|NCT05487456|156009735|FG001|Overall Study|Withdrawal by Subject|0|||
48495814|NCT05487456|156009736|FG002|Overall Study|Withdrawal by Subject|1|||
48495815|NCT05487456|156009737|FG003|Overall Study|Withdrawal by Subject|0|||
48495816|NCT03734237|156009738|FG000|Overall Study|Lost to Follow-up|1|||
48495817|NCT03734237|156009739|FG001|Overall Study|Lost to Follow-up|3|||
48495818|NCT03734237|156009740|FG002|Overall Study|Lost to Follow-up|0|||
48495819|NCT03734237|156009738|FG000|Overall Study|Withdrawal by Subject|7|||
48495820|NCT03734237|156009739|FG001|Overall Study|Withdrawal by Subject|9|||
48495821|NCT03734237|156009740|FG002|Overall Study|Withdrawal by Subject|10|||
48495822|NCT02711956|156009741|FG000|Overall Study|Adverse Event|0|||
48495823|NCT02711956|156009742|FG001|Overall Study|Adverse Event|0|||
48495824|NCT02711956|156009743|FG002|Overall Study|Adverse Event|0|||
48495825|NCT02711956|156009744|FG003|Overall Study|Adverse Event|1|||
48495826|NCT02711956|156009745|FG004|Overall Study|Adverse Event|2|||
48495827|NCT02711956|156009746|FG005|Overall Study|Adverse Event|0|||
48495828|NCT02711956|156009747|FG006|Overall Study|Adverse Event|0|||
48495829|NCT02711956|156009748|FG007|Overall Study|Adverse Event|1|||
48495830|NCT02711956|156009749|FG008|Overall Study|Adverse Event|1|||
48495831|NCT02711956|156009750|FG009|Overall Study|Adverse Event|1|||
48495832|NCT02711956|156009751|FG010|Overall Study|Adverse Event|1|||
48495833|NCT02711956|156009752|FG011|Overall Study|Adverse Event|0|||
48495834|NCT02711956|156009753|FG012|Overall Study|Adverse Event|0|||
48495835|NCT02711956|156009754|FG013|Overall Study|Adverse Event|0|||
48495836|NCT02711956|156009755|FG014|Overall Study|Adverse Event|2|||
48495837|NCT02711956|156009741|FG000|Overall Study|Physician Decision|0|||
48495838|NCT02711956|156009742|FG001|Overall Study|Physician Decision|0|||
48495839|NCT02711956|156009743|FG002|Overall Study|Physician Decision|0|||
48495840|NCT02711956|156009744|FG003|Overall Study|Physician Decision|2|||
48495841|NCT02711956|156009745|FG004|Overall Study|Physician Decision|0|||
48495842|NCT02711956|156009746|FG005|Overall Study|Physician Decision|0|||
48714302|NCT00171834|156803204|FG006|Overall Study|Treatment Duration Completed|0|||
48495843|NCT02711956|156009747|FG006|Overall Study|Physician Decision|0|||
48714303|NCT02873429|156803207|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
48495844|NCT02711956|156009748|FG007|Overall Study|Physician Decision|0|||
48495845|NCT02711956|156009749|FG008|Overall Study|Physician Decision|0|||
48714304|NCT02873429|156803208|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
48495846|NCT02711956|156009750|FG009|Overall Study|Physician Decision|0|||
48495847|NCT02711956|156009751|FG010|Overall Study|Physician Decision|0|||
48495848|NCT02711956|156009752|FG011|Overall Study|Physician Decision|0|||
48495849|NCT02711956|156009753|FG012|Overall Study|Physician Decision|0|||
48495850|NCT02711956|156009754|FG013|Overall Study|Physician Decision|0|||
48495851|NCT02711956|156009755|FG014|Overall Study|Physician Decision|0|||
48495852|NCT02711956|156009741|FG000|Overall Study|Withdrawal by Subject|0|||
48495853|NCT02711956|156009742|FG001|Overall Study|Withdrawal by Subject|0|||
48495854|NCT02711956|156009743|FG002|Overall Study|Withdrawal by Subject|0|||
48495855|NCT02711956|156009744|FG003|Overall Study|Withdrawal by Subject|0|||
48495856|NCT02711956|156009745|FG004|Overall Study|Withdrawal by Subject|0|||
48495857|NCT02711956|156009746|FG005|Overall Study|Withdrawal by Subject|0|||
48495858|NCT02711956|156009747|FG006|Overall Study|Withdrawal by Subject|1|||
48495859|NCT02711956|156009748|FG007|Overall Study|Withdrawal by Subject|0|||
48495860|NCT02711956|156009749|FG008|Overall Study|Withdrawal by Subject|0|||
48495861|NCT02711956|156009750|FG009|Overall Study|Withdrawal by Subject|0|||
48495862|NCT02711956|156009751|FG010|Overall Study|Withdrawal by Subject|0|||
48495863|NCT02711956|156009752|FG011|Overall Study|Withdrawal by Subject|1|||
48495864|NCT02711956|156009753|FG012|Overall Study|Withdrawal by Subject|6|||
48495865|NCT02711956|156009754|FG013|Overall Study|Withdrawal by Subject|0|||
48495866|NCT02711956|156009755|FG014|Overall Study|Withdrawal by Subject|1|||
48495867|NCT02711956|156009741|FG000|Overall Study|Clinical progression|1|||
48495868|NCT02711956|156009742|FG001|Overall Study|Clinical progression|0|||
48495869|NCT02711956|156009743|FG002|Overall Study|Clinical progression|0|||
48495870|NCT02711956|156009744|FG003|Overall Study|Clinical progression|0|||
48495871|NCT02711956|156009745|FG004|Overall Study|Clinical progression|0|||
48495872|NCT02711956|156009746|FG005|Overall Study|Clinical progression|0|||
48495873|NCT02711956|156009747|FG006|Overall Study|Clinical progression|1|||
48714305|NCT02873429|156803207|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
48714306|NCT02873429|156803208|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
48714307|NCT02873429|156803207|FG000|16 Weeks|Lost to Follow-up|3|||
48714308|NCT02873429|156803208|FG001|16 Weeks|Lost to Follow-up|0|||
48714309|NCT00612807|156803209|FG000|Overall Study|Withdrawal by Subject|2|||
48714310|NCT00612807|156803210|FG001|Overall Study|Withdrawal by Subject|0|||
48714311|NCT00145977|156803211|FG000|Overall Study|Lack of Efficacy|0|||
48714312|NCT00145977|156803212|FG001|Overall Study|Lack of Efficacy|4|||
48714313|NCT00145977|156803211|FG000|Overall Study|Lost to Follow-up|1|||
48714314|NCT00145977|156803212|FG001|Overall Study|Lost to Follow-up|0|||
48714315|NCT00145977|156803211|FG000|Overall Study|Withdrawal by Subject|1|||
48714316|NCT00145977|156803212|FG001|Overall Study|Withdrawal by Subject|0|||
48714317|NCT01057589|156803215|FG000|Overall Study|Disease Progression|35|||
48714318|NCT01057589|156803215|FG000|Overall Study|Adverse Event|10|||
48714319|NCT01057589|156803215|FG000|Overall Study|Physician Decision|8|||
48714320|NCT01057589|156803215|FG000|Overall Study|Withdrawal by Subject|3|||
48714321|NCT01057589|156803215|FG000|Overall Study|Sponsor Decision|1|||
48714322|NCT01057589|156803215|FG000|Overall Study|Death|8|||
48714323|NCT01057589|156803215|FG000|Overall Study|Lost to Follow-up|1|||
48812818|NCT00672958|157155439|FG000|Overall Study|Reason not specified|0|||
48812819|NCT00672958|157155440|FG001|Overall Study|Reason not specified|3|||
48812820|NCT04422639|157155443|FG000|Overall Study|Death|1|||
48495874|NCT02711956|156009748|FG007|Overall Study|Clinical progression|0|||
48495875|NCT02711956|156009749|FG008|Overall Study|Clinical progression|1|||
48495876|NCT02711956|156009750|FG009|Overall Study|Clinical progression|0|||
48495877|NCT02711956|156009751|FG010|Overall Study|Clinical progression|0|||
48598133|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48598134|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
48598135|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
48598136|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
48598137|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
48598138|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
48598139|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48598140|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48598141|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48495878|NCT02711956|156009752|FG011|Overall Study|Clinical progression|2|||
48495879|NCT02711956|156009753|FG012|Overall Study|Clinical progression|4|||
48495880|NCT02711956|156009754|FG013|Overall Study|Clinical progression|1|||
48495881|NCT02711956|156009755|FG014|Overall Study|Clinical progression|1|||
48714324|NCT00243841|156803216|FG000|Overall Study|Physician Decision|0|||
48714325|NCT00243841|156803217|FG001|Overall Study|Physician Decision|0|||
48495882|NCT02711956|156009741|FG000|Overall Study|Radiographic progression|1|||
48495883|NCT02711956|156009742|FG001|Overall Study|Radiographic progression|1|||
48495884|NCT02711956|156009743|FG002|Overall Study|Radiographic progression|2|||
48714326|NCT00243841|156803218|FG002|Overall Study|Physician Decision|1|||
48714327|NCT00243841|156803219|FG003|Overall Study|Physician Decision|0|||
48714328|NCT00243841|156803220|FG004|Overall Study|Physician Decision|0|||
48714329|NCT00243841|156803221|FG005|Overall Study|Physician Decision|2|||
48714330|NCT01981551|156803222|FG000|Overall Study|Refused further treatment|8|||
48714331|NCT01981551|156803222|FG000|Overall Study|Adverse Event|1|||
48714332|NCT01217307|156804815|FG000|Overall Study|Withdrawal by Subject|0|||
48714333|NCT01217307|156804816|FG001|Overall Study|Withdrawal by Subject|1|||
48714334|NCT01868542|156804817|FG000|Overall Study|Protocol Violation|0|||
48714335|NCT01868542|156804818|FG001|Overall Study|Protocol Violation|1|||
48714336|NCT01868542|156804817|FG000|Overall Study|Unclassified|0|||
48714337|NCT01868542|156804818|FG001|Overall Study|Unclassified|1|||
48714338|NCT02923921|156804821|FG000|Overall Study|Sponsor Decision|39|||
48714339|NCT02923921|156804822|FG001|Overall Study|Sponsor Decision|38|||
48714340|NCT02923921|156804821|FG000|Overall Study|Lost to Follow-up|1|||
48714341|NCT02923921|156804822|FG001|Overall Study|Lost to Follow-up|0|||
48714342|NCT02923921|156804821|FG000|Overall Study|Withdrawal by Subject|6|||
48714343|NCT02923921|156804822|FG001|Overall Study|Withdrawal by Subject|13|||
48714344|NCT02923921|156804821|FG000|Overall Study|Unknown, Not Collected|7|||
48714345|NCT02923921|156804822|FG001|Overall Study|Unknown, Not Collected|6|||
48714346|NCT03805659|156804823|FG000|Overall Study|Withdrawal by Subject|0|||
48714347|NCT03805659|156804824|FG001|Overall Study|Withdrawal by Subject|1|||
48714348|NCT01761162|156804825|FG000|Overall Study|Withdrawal by Subject|3|||
48714349|NCT02687191|156804826|FG000|Overall Study|Death|0|||
48714350|NCT02687191|156804827|FG001|Overall Study|Death|1|||
48714351|NCT02687191|156804828|FG002|Overall Study|Death|1|||
48714352|NCT02687191|156804829|FG003|Overall Study|Death|0|||
48714353|NCT02687191|156804830|FG004|Overall Study|Death|1|||
48714354|NCT02687191|156804831|FG005|Overall Study|Death|1|||
48714355|NCT02687191|156804826|FG000|Overall Study|Withdrawal by Subject|0|||
48714356|NCT02687191|156804827|FG001|Overall Study|Withdrawal by Subject|0|||
48714357|NCT02687191|156804828|FG002|Overall Study|Withdrawal by Subject|0|||
48714358|NCT02687191|156804829|FG003|Overall Study|Withdrawal by Subject|1|||
48714359|NCT02687191|156804830|FG004|Overall Study|Withdrawal by Subject|0|||
48714360|NCT02687191|156804831|FG005|Overall Study|Withdrawal by Subject|0|||
48714361|NCT00545272|156804838|FG000|Overall Study|Protocol deviation|0|||
48714362|NCT00545272|156804839|FG001|Overall Study|Protocol deviation|1|||
48714363|NCT00545272|156804840|FG002|Overall Study|Protocol deviation|0|||
48714364|NCT00545272|156804841|FG003|Overall Study|Protocol deviation|1|||
48714365|NCT00545272|156804842|FG004|Overall Study|Protocol deviation|0|||
48714366|NCT00545272|156804843|FG005|Overall Study|Protocol deviation|1|||
48714367|NCT00545272|156804838|FG000|Overall Study|Adverse Event|0|||
48714368|NCT00545272|156804839|FG001|Overall Study|Adverse Event|0|||
48714369|NCT00545272|156804840|FG002|Overall Study|Adverse Event|1|||
48714370|NCT00545272|156804841|FG003|Overall Study|Adverse Event|0|||
48714371|NCT00545272|156804842|FG004|Overall Study|Adverse Event|0|||
48714372|NCT00545272|156804843|FG005|Overall Study|Adverse Event|1|||
48714373|NCT00545272|156804838|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48714374|NCT00545272|156804839|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48714375|NCT00545272|156804840|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48714376|NCT00545272|156804841|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48714377|NCT00545272|156804842|FG004|Overall Study|Abnormal laboratory value(s)|0|||
48714378|NCT00545272|156804843|FG005|Overall Study|Abnormal laboratory value(s)|1|||
48714379|NCT00545272|156804838|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48714380|NCT00545272|156804839|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48714381|NCT00545272|156804840|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48714382|NCT00545272|156804841|FG003|Overall Study|Abnormal test procedure result(s)|0|||
48598142|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48598143|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48598144|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48598145|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598146|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598147|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598148|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598149|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598150|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
48598151|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
48714383|NCT00545272|156804842|FG004|Overall Study|Abnormal test procedure result(s)|1|||
48714384|NCT00545272|156804843|FG005|Overall Study|Abnormal test procedure result(s)|0|||
48714385|NCT00545272|156804838|FG000|Overall Study|Lost to Follow-up|0|||
48714386|NCT00545272|156804839|FG001|Overall Study|Lost to Follow-up|0|||
48714387|NCT00545272|156804840|FG002|Overall Study|Lost to Follow-up|0|||
48714388|NCT00545272|156804841|FG003|Overall Study|Lost to Follow-up|0|||
48714389|NCT00545272|156804842|FG004|Overall Study|Lost to Follow-up|1|||
48714390|NCT00545272|156804843|FG005|Overall Study|Lost to Follow-up|0|||
48714391|NCT00724867|156804846|FG000|Overall Study|Adverse Event|25|||
48714392|NCT00724867|156804846|FG000|Overall Study|Lack of Efficacy|14|||
48714393|NCT00724867|156804846|FG000|Overall Study|Lost to Follow-up|12|||
48714394|NCT00724867|156804846|FG000|Overall Study|Non-compliance with study drug|6|||
48714395|NCT00724867|156804846|FG000|Overall Study|Physician Decision|17|||
48714396|NCT00724867|156804846|FG000|Overall Study|Protocol Violation|1|||
48714397|NCT00724867|156804846|FG000|Overall Study|Withdrawal by Subject|31|||
48714398|NCT00724867|156804846|FG000|Overall Study|Sponsor decision to end study|14|||
48714399|NCT00724867|156804846|FG000|Overall Study|Subject incarcerated|1|||
48714400|NCT00724867|156804846|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
48435905|NCT00547378|155783847|FG002|Randomized Cohort|Other reasons|0|||
48435906|NCT00547378|155783845|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
48435907|NCT00547378|155783846|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
48714401|NCT00724867|156804846|FG000|Overall Study|Subject moved out of state|1|||
48714402|NCT00724867|156804846|FG000|Overall Study|Elected to exit due to site closure|2|||
48714403|NCT02864862|156804854|FG000|Overall Study|Lost to Follow-up|1|||
48714404|NCT02864862|156804855|FG001|Overall Study|Lost to Follow-up|0|||
48714405|NCT02864862|156804856|FG002|Overall Study|Lost to Follow-up|1|||
48714406|NCT02864862|156804854|FG000|Overall Study|Protocol Violation|0|||
48714407|NCT02864862|156804855|FG001|Overall Study|Protocol Violation|0|||
48714408|NCT02864862|156804856|FG002|Overall Study|Protocol Violation|1|||
48714409|NCT00615901|156804857|FG000|Overall Study|Withdrawal by Subject|2|||
48714410|NCT00615901|156804857|FG000|Overall Study|Adverse Event|7|||
48714411|NCT01523275|156804858|FG000|Overall Study|Lost to Follow-up|1|||
48714412|NCT01523275|156804859|FG001|Overall Study|Lost to Follow-up|2|||
48714413|NCT01523275|156804858|FG000|Overall Study|Withdrawal by Subject|1|||
48714414|NCT01523275|156804859|FG001|Overall Study|Withdrawal by Subject|0|||
48714415|NCT03263702|156804860|FG000|Overall Study|Lost to Follow-up|2|||
48714416|NCT03263702|156804861|FG001|Overall Study|Lost to Follow-up|2|||
48714417|NCT03263702|156804860|FG000|Overall Study|Withdrawal by Subject|1|||
48714418|NCT03263702|156804861|FG001|Overall Study|Withdrawal by Subject|2|||
48714419|NCT01250496|156804865|FG000|Overall Study|Study terminated|124|||
48714420|NCT01250496|156804866|FG001|Overall Study|Study terminated|124|||
48714421|NCT01589653|156804869|FG000|Overall Study|Protocol Violation|3|||
48714422|NCT01589653|156804870|FG001|Overall Study|Protocol Violation|1|||
48714423|NCT01589653|156804869|FG000|Overall Study|Withdrawal criteria|4|||
48714424|NCT01589653|156804870|FG001|Overall Study|Withdrawal criteria|7|||
48714425|NCT01589653|156804869|FG000|Overall Study|Unclassified|0|||
48714426|NCT01589653|156804870|FG001|Overall Study|Unclassified|3|||
48714427|NCT01536067|156804871|FG000|Overall Study|Disease Progression|1|||
48714428|NCT00668733|156804872|FG000|Overall Study|Lost to Follow-up|2|||
48714429|NCT00668733|156804873|FG001|Overall Study|Lost to Follow-up|3|||
48714430|NCT00668733|156804872|FG000|Overall Study|Withdrawal by Subject|0|||
48714431|NCT00668733|156804873|FG001|Overall Study|Withdrawal by Subject|4|||
48714432|NCT00905645|156804874|FG000|Overall Study|Death (not device related)|10|||
48714433|NCT00905645|156804875|FG001|Overall Study|Death (not device related)|4|||
48714434|NCT00905645|156804876|FG002|Overall Study|Death (not device related)|15|||
48714435|NCT00905645|156804877|FG003|Overall Study|Death (not device related)|8|||
48714436|NCT00905645|156804874|FG000|Overall Study|Explantation of study device(s)|78|||
48714437|NCT00905645|156804875|FG001|Overall Study|Explantation of study device(s)|47|||
48812821|NCT04422639|157155444|FG001|Overall Study|Death|0|||
48435908|NCT00547378|155783847|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
48435909|NCT00547378|155783845|FG000|All Implanted Cohort|Adverse Event|4|||
48435910|NCT00547378|155783846|FG001|All Implanted Cohort|Adverse Event|10|||
48495885|NCT02711956|156009744|FG003|Overall Study|Radiographic progression|0|||
48812822|NCT04422639|157155443|FG000|Overall Study|study closed prior to completion of FU visits|0|||
48812823|NCT04422639|157155444|FG001|Overall Study|study closed prior to completion of FU visits|2|||
48812824|NCT01348776|157155445|FG000|Overall Study|Lost to Follow-up|3|||
48812825|NCT01913639|157155448|FG000|Overall Study|Not Eligible|3|||
48812826|NCT02491892|157155450|FG000|Overall Study|Adverse Event|1|||
48812827|NCT02491892|157155451|FG001|Overall Study|Adverse Event|1|||
48812828|NCT02491892|157155450|FG000|Overall Study|Death|1|||
48812829|NCT02491892|157155451|FG001|Overall Study|Death|1|||
48812830|NCT02491892|157155450|FG000|Overall Study|Lack of Efficacy|37|||
48812831|NCT02491892|157155451|FG001|Overall Study|Lack of Efficacy|36|||
48812832|NCT02491892|157155450|FG000|Overall Study|Refused Treatment|1|||
48812833|NCT02491892|157155451|FG001|Overall Study|Refused Treatment|0|||
48812834|NCT02491892|157155450|FG000|Overall Study|Lost to Follow-up|1|||
48812835|NCT02491892|157155451|FG001|Overall Study|Lost to Follow-up|0|||
48812836|NCT01231503|157155456|FG000|Overall Study|Adverse Event|0|||
48812837|NCT01231503|157155457|FG001|Overall Study|Adverse Event|0|||
48812838|NCT01231503|157155458|FG002|Overall Study|Adverse Event|0|||
48812839|NCT01231503|157155459|FG003|Overall Study|Adverse Event|0|||
48812840|NCT01231503|157155460|FG004|Overall Study|Adverse Event|0|||
48812841|NCT01231503|157155461|FG005|Overall Study|Adverse Event|1|||
48812842|NCT01231503|157155462|FG006|Overall Study|Adverse Event|0|||
48812843|NCT01231503|157155463|FG007|Overall Study|Adverse Event|0|||
48812844|NCT01231503|157155456|FG000|Overall Study|Adverse event, serious fatal|0|||
48812845|NCT01231503|157155457|FG001|Overall Study|Adverse event, serious fatal|0|||
48812846|NCT01231503|157155458|FG002|Overall Study|Adverse event, serious fatal|1|||
48812847|NCT01231503|157155459|FG003|Overall Study|Adverse event, serious fatal|1|||
48812848|NCT01231503|157155460|FG004|Overall Study|Adverse event, serious fatal|0|||
48812849|NCT01231503|157155461|FG005|Overall Study|Adverse event, serious fatal|1|||
48812850|NCT01231503|157155462|FG006|Overall Study|Adverse event, serious fatal|0|||
48812851|NCT01231503|157155463|FG007|Overall Study|Adverse event, serious fatal|0|||
48812852|NCT01231503|157155456|FG000|Overall Study|Withdrawal by Subject|6|||
48812853|NCT01231503|157155457|FG001|Overall Study|Withdrawal by Subject|3|||
48812854|NCT01231503|157155458|FG002|Overall Study|Withdrawal by Subject|3|||
48812855|NCT01231503|157155459|FG003|Overall Study|Withdrawal by Subject|1|||
48812856|NCT01231503|157155460|FG004|Overall Study|Withdrawal by Subject|3|||
48812857|NCT01231503|157155461|FG005|Overall Study|Withdrawal by Subject|5|||
48812858|NCT01231503|157155462|FG006|Overall Study|Withdrawal by Subject|1|||
48812859|NCT01231503|157155463|FG007|Overall Study|Withdrawal by Subject|2|||
48812860|NCT01231503|157155456|FG000|Overall Study|Lost to Follow-up|8|||
48812861|NCT01231503|157155457|FG001|Overall Study|Lost to Follow-up|10|||
48812862|NCT01231503|157155458|FG002|Overall Study|Lost to Follow-up|8|||
48812863|NCT01231503|157155459|FG003|Overall Study|Lost to Follow-up|5|||
48812864|NCT01231503|157155460|FG004|Overall Study|Lost to Follow-up|7|||
48812865|NCT01231503|157155461|FG005|Overall Study|Lost to Follow-up|9|||
48812866|NCT01231503|157155462|FG006|Overall Study|Lost to Follow-up|6|||
48812867|NCT01231503|157155463|FG007|Overall Study|Lost to Follow-up|6|||
48812868|NCT01231503|157155456|FG000|Overall Study|Protocol Violation|0|||
48812869|NCT01231503|157155457|FG001|Overall Study|Protocol Violation|0|||
48812870|NCT01231503|157155458|FG002|Overall Study|Protocol Violation|0|||
48812871|NCT01231503|157155459|FG003|Overall Study|Protocol Violation|1|||
48812872|NCT01231503|157155460|FG004|Overall Study|Protocol Violation|0|||
48812873|NCT01231503|157155461|FG005|Overall Study|Protocol Violation|0|||
48812874|NCT01231503|157155462|FG006|Overall Study|Protocol Violation|0|||
48812875|NCT01231503|157155463|FG007|Overall Study|Protocol Violation|0|||
48812876|NCT01586338|157155464|FG000|Overall Study|Adverse Event|3|||
48812877|NCT01586338|157155464|FG000|Overall Study|Lost to Follow-up|1|||
48812878|NCT01586338|157155464|FG000|Overall Study|Withdrawal by participant|3|||
48812879|NCT01586338|157155464|FG000|Overall Study|Other|1|||
48812880|NCT00284089|157155467|FG000|Multiple Dose Phase|Adverse Event|1|||
48812881|NCT00284089|157155468|FG001|Multiple Dose Phase|Adverse Event|0|||
48812882|NCT00284089|157155469|FG002|Multiple Dose Phase|Adverse Event|1|||
48812883|NCT00284089|157155470|FG003|Multiple Dose Phase|Adverse Event|1|||
48812884|NCT00284089|157155467|FG000|Multiple Dose Phase|Protocol Violation|0|||
48812885|NCT00284089|157155468|FG001|Multiple Dose Phase|Protocol Violation|0|||
48495886|NCT02711956|156009745|FG004|Overall Study|Radiographic progression|1|||
48495887|NCT02711956|156009746|FG005|Overall Study|Radiographic progression|0|||
48495888|NCT02711956|156009747|FG006|Overall Study|Radiographic progression|0|||
48812886|NCT00284089|157155469|FG002|Multiple Dose Phase|Protocol Violation|1|||
48812887|NCT00284089|157155470|FG003|Multiple Dose Phase|Protocol Violation|0|||
48812888|NCT00284089|157155467|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
48812889|NCT00284089|157155468|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
48812890|NCT00284089|157155469|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
48812891|NCT00284089|157155470|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
48812892|NCT00284089|157155467|FG000|Multiple Dose Phase|Death|0|||
48812893|NCT00284089|157155468|FG001|Multiple Dose Phase|Death|0|||
48812894|NCT00284089|157155469|FG002|Multiple Dose Phase|Death|1|||
48812895|NCT00284089|157155470|FG003|Multiple Dose Phase|Death|1|||
48812896|NCT00284089|157155467|FG000|Extension Phase|Adverse Event|0|||
48812897|NCT00284089|157155468|FG001|Extension Phase|Adverse Event|0|||
48812898|NCT00284089|157155469|FG002|Extension Phase|Adverse Event|2|||
48812899|NCT00284089|157155470|FG003|Extension Phase|Adverse Event|2|||
48812900|NCT00284089|157155467|FG000|Extension Phase|condition no longer requires study drug|2|||
48812901|NCT00284089|157155468|FG001|Extension Phase|condition no longer requires study drug|0|||
48495889|NCT02711956|156009748|FG007|Overall Study|Radiographic progression|0|||
48812902|NCT00284089|157155469|FG002|Extension Phase|condition no longer requires study drug|2|||
48812903|NCT00284089|157155470|FG003|Extension Phase|condition no longer requires study drug|7|||
48812904|NCT00284089|157155467|FG000|Extension Phase|Protocol Violation|0|||
48812905|NCT00284089|157155468|FG001|Extension Phase|Protocol Violation|0|||
48812906|NCT00284089|157155469|FG002|Extension Phase|Protocol Violation|1|||
48812907|NCT00284089|157155470|FG003|Extension Phase|Protocol Violation|0|||
48812908|NCT00284089|157155467|FG000|Extension Phase|Withdrawal by Subject|0|||
48812909|NCT00284089|157155468|FG001|Extension Phase|Withdrawal by Subject|0|||
48812910|NCT00284089|157155469|FG002|Extension Phase|Withdrawal by Subject|1|||
48812911|NCT00284089|157155470|FG003|Extension Phase|Withdrawal by Subject|3|||
48812912|NCT00453102|157155471|FG000|Overall Study|Withdrawal by Subject|2|||
48812913|NCT03051659|157155472|FG000|Treatment Period|Withdrawal by Subject|0|||
48812914|NCT03051659|157155473|FG001|Treatment Period|Withdrawal by Subject|2|||
48812915|NCT03051659|157155472|FG000|Survival Follow-up|Lost to Follow-up|23|||
48495890|NCT02711956|156009749|FG008|Overall Study|Radiographic progression|2|||
48495891|NCT02711956|156009750|FG009|Overall Study|Radiographic progression|1|||
48495892|NCT02711956|156009751|FG010|Overall Study|Radiographic progression|0|||
48495893|NCT02711956|156009752|FG011|Overall Study|Radiographic progression|5|||
48495894|NCT02711956|156009753|FG012|Overall Study|Radiographic progression|3|||
48495895|NCT02711956|156009754|FG013|Overall Study|Radiographic progression|0|||
48495896|NCT02711956|156009755|FG014|Overall Study|Radiographic progression|1|||
48495897|NCT02711956|156009741|FG000|Overall Study|PSA progression with clinical progression|0|||
48495898|NCT02711956|156009742|FG001|Overall Study|PSA progression with clinical progression|0|||
48495899|NCT02711956|156009743|FG002|Overall Study|PSA progression with clinical progression|0|||
48495900|NCT02711956|156009744|FG003|Overall Study|PSA progression with clinical progression|0|||
48495901|NCT02711956|156009745|FG004|Overall Study|PSA progression with clinical progression|1|||
48495902|NCT02711956|156009746|FG005|Overall Study|PSA progression with clinical progression|0|||
48495903|NCT02711956|156009747|FG006|Overall Study|PSA progression with clinical progression|0|||
48495904|NCT02711956|156009748|FG007|Overall Study|PSA progression with clinical progression|0|||
48495905|NCT02711956|156009749|FG008|Overall Study|PSA progression with clinical progression|0|||
48495906|NCT02711956|156009750|FG009|Overall Study|PSA progression with clinical progression|0|||
48495907|NCT02711956|156009751|FG010|Overall Study|PSA progression with clinical progression|0|||
48495908|NCT02711956|156009752|FG011|Overall Study|PSA progression with clinical progression|0|||
48495909|NCT02711956|156009753|FG012|Overall Study|PSA progression with clinical progression|1|||
48495910|NCT02711956|156009754|FG013|Overall Study|PSA progression with clinical progression|1|||
48495911|NCT02711956|156009755|FG014|Overall Study|PSA progression with clinical progression|0|||
48495912|NCT02711956|156009741|FG000|Overall Study|PSA progression with radiographic progression|0|||
48812916|NCT03051659|157155473|FG001|Survival Follow-up|Lost to Follow-up|22|||
48812917|NCT04362137|157155474|FG000|Overall Study|Death|9|||
48812918|NCT04362137|157155475|FG001|Overall Study|Death|3|||
48812919|NCT04362137|157155474|FG000|Overall Study|Patient decision|6|||
48812920|NCT04362137|157155475|FG001|Overall Study|Patient decision|3|||
48812921|NCT04362137|157155474|FG000|Overall Study|Adverse Event|1|||
48812922|NCT04362137|157155475|FG001|Overall Study|Adverse Event|0|||
48495913|NCT02711956|156009742|FG001|Overall Study|PSA progression with radiographic progression|1|||
48495914|NCT02711956|156009743|FG002|Overall Study|PSA progression with radiographic progression|0|||
48495915|NCT02711956|156009744|FG003|Overall Study|PSA progression with radiographic progression|0|||
48495916|NCT02711956|156009745|FG004|Overall Study|PSA progression with radiographic progression|0|||
48812923|NCT04362137|157155474|FG000|Overall Study|Lost to Follow-up|1|||
48812924|NCT04362137|157155475|FG001|Overall Study|Lost to Follow-up|0|||
48812925|NCT04362137|157155474|FG000|Overall Study|Protocol deviation|1|||
48812926|NCT04362137|157155475|FG001|Overall Study|Protocol deviation|0|||
48812927|NCT02066532|157155476|FG000|Phase II|Withdrawal by Subject|1|||
48812928|NCT02066532|157155477|FG001|Phase II|Withdrawal by Subject|0|||
48812929|NCT02066532|157155478|FG002|Phase II|Withdrawal by Subject|0|||
48812930|NCT02066532|157155479|FG003|Phase II|Withdrawal by Subject|0|||
48812931|NCT02040090|157155480|FG000|Overall Study|Adverse Event|2|||
48812932|NCT02040090|157155481|FG001|Overall Study|Adverse Event|0|||
48812933|NCT02040090|157155480|FG000|Overall Study|Physician Decision|1|||
48812934|NCT02040090|157155481|FG001|Overall Study|Physician Decision|0|||
48812935|NCT02040090|157155480|FG000|Overall Study|Withdrawal by Subject|0|||
48812936|NCT02040090|157155481|FG001|Overall Study|Withdrawal by Subject|1|||
48812937|NCT02040090|157155480|FG000|Overall Study|Lost to Follow-up|0|||
48495917|NCT02711956|156009746|FG005|Overall Study|PSA progression with radiographic progression|2|||
48495918|NCT02711956|156009747|FG006|Overall Study|PSA progression with radiographic progression|2|||
48495919|NCT02711956|156009748|FG007|Overall Study|PSA progression with radiographic progression|1|||
48495920|NCT02711956|156009749|FG008|Overall Study|PSA progression with radiographic progression|0|||
48598152|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598153|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
48812938|NCT02040090|157155481|FG001|Overall Study|Lost to Follow-up|1|||
48812939|NCT02258464|157155486|FG000|Overall Study|Progressive disease (PD)|9|||
48812940|NCT02258464|157155487|FG001|Overall Study|Progressive disease (PD)|17|||
48812941|NCT02258464|157155486|FG000|Overall Study|Study drug never administered|1|||
48812942|NCT02258464|157155487|FG001|Overall Study|Study drug never administered|1|||
48812943|NCT02258464|157155486|FG000|Overall Study|AE not related to clinical PD|1|||
48812944|NCT02258464|157155487|FG001|Overall Study|AE not related to clinical PD|3|||
48812945|NCT02258464|157155486|FG000|Overall Study|Withdrawal by Subject|5|||
48812946|NCT02258464|157155487|FG001|Overall Study|Withdrawal by Subject|4|||
48812947|NCT02258464|157155486|FG000|Overall Study|AE related to clinical PD|1|||
48812948|NCT02258464|157155487|FG001|Overall Study|AE related to clinical PD|0|||
48495921|NCT02711956|156009750|FG009|Overall Study|PSA progression with radiographic progression|1|||
48495922|NCT02711956|156009751|FG010|Overall Study|PSA progression with radiographic progression|0|||
48495923|NCT02711956|156009752|FG011|Overall Study|PSA progression with radiographic progression|1|||
48495924|NCT02711956|156009753|FG012|Overall Study|PSA progression with radiographic progression|2|||
48495925|NCT02711956|156009754|FG013|Overall Study|PSA progression with radiographic progression|3|||
48495926|NCT02711956|156009755|FG014|Overall Study|PSA progression with radiographic progression|3|||
48495927|NCT03294538|156009759|FG000|Overall Study|Adverse Event|0|||
48495928|NCT03294538|156009760|FG001|Overall Study|Adverse Event|1|||
48495929|NCT03294538|156009761|FG002|Overall Study|Adverse Event|1|||
48495930|NCT03294538|156009759|FG000|Overall Study|Lost to Follow-up|1|||
48495931|NCT03294538|156009760|FG001|Overall Study|Lost to Follow-up|0|||
48495932|NCT03294538|156009761|FG002|Overall Study|Lost to Follow-up|0|||
48495933|NCT03294538|156009759|FG000|Overall Study|Outside of Visit Window|4|||
48495934|NCT03294538|156009760|FG001|Overall Study|Outside of Visit Window|4|||
48495935|NCT03294538|156009761|FG002|Overall Study|Outside of Visit Window|1|||
48812949|NCT00932646|157155488|FG000|Overall Study|Adverse Event|2|||
48812950|NCT00932646|157155489|FG001|Overall Study|Adverse Event|1|||
48812951|NCT00932646|157155490|FG002|Overall Study|Adverse Event|1|||
48812952|NCT00932646|157155491|FG003|Overall Study|Adverse Event|1|||
48812953|NCT00932646|157155488|FG000|Overall Study|Lost to Follow-up|2|||
48812954|NCT00932646|157155489|FG001|Overall Study|Lost to Follow-up|1|||
48812955|NCT00932646|157155490|FG002|Overall Study|Lost to Follow-up|0|||
48812956|NCT00932646|157155491|FG003|Overall Study|Lost to Follow-up|0|||
48812957|NCT00932646|157155488|FG000|Overall Study|Withdrawal by Subject|1|||
48812958|NCT00932646|157155489|FG001|Overall Study|Withdrawal by Subject|1|||
48812959|NCT00932646|157155490|FG002|Overall Study|Withdrawal by Subject|3|||
48812960|NCT00932646|157155491|FG003|Overall Study|Withdrawal by Subject|0|||
48812961|NCT04170296|157155492|FG000|Overall Study|Adverse Event|1|||
48812962|NCT04170296|157155493|FG001|Overall Study|Adverse Event|0|||
48812963|NCT04170296|157155492|FG000|Overall Study|Withdrawal by Subject|3|||
48812964|NCT04170296|157155493|FG001|Overall Study|Withdrawal by Subject|2|||
48812965|NCT04170296|157155492|FG000|Overall Study|Lost to Follow-up|4|||
48812966|NCT04170296|157155493|FG001|Overall Study|Lost to Follow-up|2|||
48812967|NCT04278417|157155499|FG000|Overall Study|Withdrawal by Subject|13|||
48812968|NCT04278417|157155500|FG001|Overall Study|Withdrawal by Subject|12|||
48812969|NCT04278417|157155499|FG000|Overall Study|Progressive disease|0|||
48812970|NCT04278417|157155500|FG001|Overall Study|Progressive disease|1|||
48812971|NCT04278417|157155499|FG000|Overall Study|Physician Decision|2|||
48812972|NCT04278417|157155500|FG001|Overall Study|Physician Decision|1|||
48812973|NCT04278417|157155499|FG000|Overall Study|Lost to Follow-up|7|||
48812974|NCT04278417|157155500|FG001|Overall Study|Lost to Follow-up|8|||
48812975|NCT04278417|157155499|FG000|Overall Study|Death|6|||
48812976|NCT04278417|157155500|FG001|Overall Study|Death|3|||
48812977|NCT04278417|157155499|FG000|Overall Study|Adverse Event|2|||
48812978|NCT04278417|157155500|FG001|Overall Study|Adverse Event|4|||
48812979|NCT04278417|157155499|FG000|Overall Study|Ongoing, did not complete Week 54|31|||
48812980|NCT04278417|157155500|FG001|Overall Study|Ongoing, did not complete Week 54|27|||
48812981|NCT03406702|157155501|FG000|Overall Study|Missed Day 27 Dosing|1|||
48812982|NCT01291225|157155505|FG000|Overall Study|Lost to Follow-up|85|||
48812983|NCT01291225|157155506|FG001|Overall Study|Lost to Follow-up|39|||
48812984|NCT01267253|157155507|FG000|Overall Study|Ineligible - required test not done|1|||
48812985|NCT01267253|157155507|FG000|Overall Study|Inevaluable-never received study treatme|2|||
48812986|NCT00147225|157155508|FG000|Overall Study|Withdrawal by Subject|1|||
48812987|NCT00147225|157155509|FG001|Overall Study|Withdrawal by Subject|0|||
48812988|NCT00147225|157155510|FG002|Overall Study|Withdrawal by Subject|1|||
48812989|NCT00147225|157155511|FG003|Overall Study|Withdrawal by Subject|0|||
48812990|NCT00147225|157155512|FG004|Overall Study|Withdrawal by Subject|0|||
48812991|NCT00147225|157155513|FG005|Overall Study|Withdrawal by Subject|1|||
48812992|NCT00147225|157155508|FG000|Overall Study|Adverse Event|0|||
48812993|NCT00147225|157155509|FG001|Overall Study|Adverse Event|0|||
48812994|NCT00147225|157155510|FG002|Overall Study|Adverse Event|1|||
48812995|NCT00147225|157155511|FG003|Overall Study|Adverse Event|1|||
48812996|NCT00147225|157155512|FG004|Overall Study|Adverse Event|0|||
48812997|NCT00147225|157155513|FG005|Overall Study|Adverse Event|0|||
48812998|NCT00147225|157155508|FG000|Overall Study|Screen Failure|0|||
48812999|NCT00147225|157155509|FG001|Overall Study|Screen Failure|0|||
48813000|NCT00147225|157155510|FG002|Overall Study|Screen Failure|0|||
48813001|NCT00147225|157155511|FG003|Overall Study|Screen Failure|0|||
48813002|NCT00147225|157155512|FG004|Overall Study|Screen Failure|1|||
48813003|NCT00147225|157155513|FG005|Overall Study|Screen Failure|0|||
48813004|NCT00147225|157155508|FG000|Overall Study|Chemotherapy Changed|0|||
48813005|NCT00147225|157155509|FG001|Overall Study|Chemotherapy Changed|0|||
48813006|NCT00147225|157155510|FG002|Overall Study|Chemotherapy Changed|0|||
48813007|NCT00147225|157155511|FG003|Overall Study|Chemotherapy Changed|0|||
48813008|NCT00147225|157155512|FG004|Overall Study|Chemotherapy Changed|0|||
48813009|NCT00147225|157155513|FG005|Overall Study|Chemotherapy Changed|1|||
48813010|NCT00514046|157155520|FG000|Overall Study|transferred to another protocol|2|||
48813011|NCT00514046|157155521|FG001|Overall Study|transferred to another protocol|1|||
48813012|NCT00514046|157155522|FG002|Overall Study|transferred to another protocol|3|||
48813013|NCT00514046|157155523|FG003|Overall Study|transferred to another protocol|0|||
48813014|NCT00514046|157155524|FG004|Overall Study|transferred to another protocol|1|||
48813015|NCT00514046|157155525|FG005|Overall Study|transferred to another protocol|0|||
48813016|NCT00514046|157155526|FG006|Overall Study|transferred to another protocol|0|||
48813017|NCT00514046|157155527|FG007|Overall Study|transferred to another protocol|0|||
48813018|NCT00514046|157155528|FG008|Overall Study|transferred to another protocol|0|||
48813019|NCT00514046|157155520|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
48813020|NCT00514046|157155521|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
48813021|NCT00514046|157155522|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
48813022|NCT00514046|157155523|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
48813023|NCT00514046|157155524|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
48813024|NCT00514046|157155525|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
48813025|NCT00514046|157155526|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
48813026|NCT00514046|157155527|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
48813027|NCT00514046|157155528|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
48813028|NCT00514046|157155520|FG000|Overall Study|Disease progression on study|0|||
48813029|NCT00514046|157155521|FG001|Overall Study|Disease progression on study|0|||
48813030|NCT00514046|157155522|FG002|Overall Study|Disease progression on study|2|||
48813031|NCT00514046|157155523|FG003|Overall Study|Disease progression on study|0|||
48813032|NCT00514046|157155524|FG004|Overall Study|Disease progression on study|0|||
48813033|NCT00514046|157155525|FG005|Overall Study|Disease progression on study|1|||
48813034|NCT00514046|157155526|FG006|Overall Study|Disease progression on study|0|||
48813035|NCT00514046|157155527|FG007|Overall Study|Disease progression on study|0|||
48813036|NCT00514046|157155528|FG008|Overall Study|Disease progression on study|0|||
48813037|NCT03077620|157155529|FG000|Overall Study|Unable to place lumbar catheter|1|||
48813038|NCT03077620|157155530|FG001|Overall Study|Unable to place lumbar catheter|0|||
48813039|NCT03077620|157155531|FG002|Overall Study|Unable to place lumbar catheter|1|||
48813040|NCT03077620|157155532|FG003|Overall Study|Unable to place lumbar catheter|0|||
48813041|NCT03077620|157155529|FG000|Overall Study|Withdrawal by Subject|0|||
48813042|NCT03077620|157155530|FG001|Overall Study|Withdrawal by Subject|1|||
48813043|NCT03077620|157155531|FG002|Overall Study|Withdrawal by Subject|0|||
48813044|NCT03077620|157155532|FG003|Overall Study|Withdrawal by Subject|0|||
48813045|NCT03077620|157155529|FG000|Overall Study|Physician Decision|0|||
48813046|NCT03077620|157155530|FG001|Overall Study|Physician Decision|0|||
48813047|NCT03077620|157155531|FG002|Overall Study|Physician Decision|1|||
48813048|NCT03077620|157155532|FG003|Overall Study|Physician Decision|0|||
48813049|NCT02468934|157155533|FG000|Overall Study|Withdrawal by Subject|4|||
48813050|NCT02468934|157155533|FG000|Overall Study|Screen Failure|3|||
48813051|NCT00976703|157157345|FG000|Overall Study|Physician Decision|1|||
48813052|NCT00976703|157157346|FG001|Overall Study|Physician Decision|1|||
48813053|NCT00976703|157157345|FG000|Overall Study|ineligible for study|2|||
48813054|NCT00976703|157157346|FG001|Overall Study|ineligible for study|2|||
48813055|NCT01785628|157157351|FG000|Overall Study|Lost to Follow-up|2|||
48813056|NCT01785628|157157352|FG001|Overall Study|Lost to Follow-up|3|||
48813057|NCT00767104|157157353|FG000|Overall Study|Lost to Follow-up|1|||
48813058|NCT00767104|157157354|FG001|Overall Study|Lost to Follow-up|2|||
48813059|NCT00840996|157157355|FG000|Overall Study|Withdrawal by Subject|1|||
48813060|NCT00840996|157157356|FG001|Overall Study|Withdrawal by Subject|0|||
48813061|NCT04022889|157157357|FG000|Stage 1: Period 1|Adverse Event|1|||
48813062|NCT04022889|157157358|FG001|Stage 1: Period 1|Adverse Event|0|||
48813063|NCT04022889|157157359|FG002|Stage 1: Period 1|Adverse Event|0|||
48813064|NCT04022889|157157357|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
48813065|NCT04022889|157157358|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
48813066|NCT04022889|157157359|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
48813067|NCT04022889|157157357|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
48813068|NCT04022889|157157358|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
48813069|NCT04022889|157157359|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
48813070|NCT04022889|157157357|FG000|Stage 2|Screen Failure|0|||
48813071|NCT04022889|157157358|FG001|Stage 2|Screen Failure|0|||
48598154|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
48598155|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48813072|NCT04022889|157157359|FG002|Stage 2|Screen Failure|3|||
48813073|NCT04022889|157157357|FG000|Stage 2|Ineligible for apheresis donation|0|||
48813074|NCT04022889|157157358|FG001|Stage 2|Ineligible for apheresis donation|0|||
48813075|NCT04022889|157157359|FG002|Stage 2|Ineligible for apheresis donation|2|||
48598156|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598157|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598158|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598159|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48598160|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598161|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598162|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598163|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598164|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598165|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
48598166|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598167|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
48598168|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598169|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598170|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48714438|NCT00905645|156804876|FG002|Overall Study|Explantation of study device(s)|28|||
48714439|NCT00905645|156804877|FG003|Overall Study|Explantation of study device(s)|21|||
48714440|NCT00905645|156804874|FG000|Overall Study|Subject Request|41|||
48714441|NCT00905645|156804875|FG001|Overall Study|Subject Request|17|||
48714442|NCT00905645|156804876|FG002|Overall Study|Subject Request|13|||
48714443|NCT00905645|156804877|FG003|Overall Study|Subject Request|11|||
48714444|NCT00905645|156804874|FG000|Overall Study|Lost to Follow-up|299|||
48714445|NCT00905645|156804875|FG001|Overall Study|Lost to Follow-up|103|||
48714446|NCT00905645|156804876|FG002|Overall Study|Lost to Follow-up|51|||
48714447|NCT00905645|156804877|FG003|Overall Study|Lost to Follow-up|12|||
48714448|NCT01731938|156804879|FG000|Preliminary Part I|Withdrawal by Subject|2|||
48714449|NCT01731938|156804880|FG001|Preliminary Part I|Withdrawal by Subject|2|||
48714450|NCT01731938|156804879|FG000|Preliminary Part I|Physician Decision|1|||
48714451|NCT01731938|156804880|FG001|Preliminary Part I|Physician Decision|0|||
48495936|NCT00958256|156009768|FG000|Overall Study|Adverse Event|3|||
48495937|NCT02322047|156009770|FG000|Overall Study|Physician Decision|1|||
48495938|NCT02322047|156009771|FG001|Overall Study|Physician Decision|0|||
48495939|NCT02322047|156009772|FG002|Overall Study|Physician Decision|0|||
48495940|NCT02322047|156009773|FG003|Overall Study|Physician Decision|0|||
48495941|NCT02322047|156009770|FG000|Overall Study|Withdrawal by Subject|1|||
48495942|NCT02322047|156009771|FG001|Overall Study|Withdrawal by Subject|0|||
48495943|NCT02322047|156009772|FG002|Overall Study|Withdrawal by Subject|0|||
48495944|NCT02322047|156009773|FG003|Overall Study|Withdrawal by Subject|1|||
48495945|NCT02322047|156009770|FG000|Overall Study|Adverse Event|0|||
48495946|NCT02322047|156009771|FG001|Overall Study|Adverse Event|1|||
48495947|NCT02322047|156009772|FG002|Overall Study|Adverse Event|0|||
48495948|NCT02322047|156009773|FG003|Overall Study|Adverse Event|0|||
48495949|NCT02322047|156009770|FG000|Overall Study|Lost to Follow-up|0|||
48495950|NCT02322047|156009771|FG001|Overall Study|Lost to Follow-up|0|||
48495951|NCT02322047|156009772|FG002|Overall Study|Lost to Follow-up|1|||
48495952|NCT02322047|156009773|FG003|Overall Study|Lost to Follow-up|1|||
48495953|NCT03036579|156009774|FG000|2 Years|Lost to Follow-up|1|||
48495954|NCT03036579|156009775|FG001|2 Years|Lost to Follow-up|0|||
48495955|NCT03036579|156009774|FG000|3 Years|Lost to Follow-up|0|||
48598171|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598172|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598173|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598174|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48598175|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598176|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598177|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598178|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48598179|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598180|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
48598181|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48598182|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48598183|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598184|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48598185|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598186|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598187|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598188|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598189|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48598190|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598191|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598192|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598193|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598194|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598195|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598196|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598197|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
48598198|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598199|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598200|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598201|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598202|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598203|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598204|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
48598205|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598206|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48714452|NCT01731938|156804879|FG000|Preliminary Part I|Lost to Follow-up|0|||
48714453|NCT01731938|156804880|FG001|Preliminary Part I|Lost to Follow-up|3|||
48714454|NCT01731938|156804879|FG000|Preliminary Part I|Missed Week 6 visit|0|||
48714455|NCT01731938|156804880|FG001|Preliminary Part I|Missed Week 6 visit|3|||
48495956|NCT03036579|156009775|FG001|3 Years|Lost to Follow-up|1|||
48495957|NCT02848599|156009776|FG000|Overall Study|Protocol Violation|7|||
48495958|NCT02848599|156009777|FG001|Overall Study|Protocol Violation|9|||
48495959|NCT01769378|156009778|FG000|Overall Study|Adverse Event|10|||
48495960|NCT01769378|156009779|FG001|Overall Study|Adverse Event|0|||
48495961|NCT01769378|156009778|FG000|Overall Study|Entry criteria not met|1|||
48495962|NCT01769378|156009779|FG001|Overall Study|Entry criteria not met|0|||
48495963|NCT01769378|156009778|FG000|Overall Study|Protocol Violation|1|||
48495964|NCT01769378|156009779|FG001|Overall Study|Protocol Violation|1|||
48495965|NCT01769378|156009778|FG000|Overall Study|Withdrawal by Subject|10|||
48495966|NCT01769378|156009779|FG001|Overall Study|Withdrawal by Subject|3|||
48495967|NCT01769378|156009778|FG000|Overall Study|Sponsor Decision|1|||
48495968|NCT01769378|156009779|FG001|Overall Study|Sponsor Decision|0|||
48495969|NCT01769378|156009778|FG000|Overall Study|Lost to Follow-up|2|||
48495970|NCT01769378|156009779|FG001|Overall Study|Lost to Follow-up|0|||
48495971|NCT03519256|156009780|FG000|Overall Study|Disease recurrence|4|||
48598207|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598208|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598209|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598210|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598211|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
48598212|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48714456|NCT01731938|156804879|FG000|Primary Part II|Withdrawal by Subject|5|||
48714457|NCT01731938|156804880|FG001|Primary Part II|Withdrawal by Subject|4|||
48714458|NCT01731938|156804879|FG000|Primary Part II|Lost to Follow-up|4|||
48714459|NCT01731938|156804880|FG001|Primary Part II|Lost to Follow-up|5|||
48714460|NCT01731938|156804879|FG000|Primary Part II|Death|2|||
48714461|NCT01731938|156804880|FG001|Primary Part II|Death|1|||
48714462|NCT01731938|156804879|FG000|Primary Part II|Missed Week 6 visit|2|||
48714463|NCT01731938|156804880|FG001|Primary Part II|Missed Week 6 visit|3|||
48714464|NCT01155011|156804882|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
48714465|NCT01155011|156804883|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
48714466|NCT01155011|156804882|FG000|Baseline to 6 Months|investigator decision, moved|4|||
48714467|NCT01155011|156804883|FG001|Baseline to 6 Months|investigator decision, moved|5|||
48714468|NCT01155011|156804882|FG000|Baseline to 6 Months|Death|0|||
48714469|NCT01155011|156804883|FG001|Baseline to 6 Months|Death|1|||
48714470|NCT01155011|156804882|FG000|6 to 12 Months|Withdrawal by Subject|8|||
48714471|NCT01155011|156804883|FG001|6 to 12 Months|Withdrawal by Subject|5|||
48714472|NCT01155011|156804882|FG000|6 to 12 Months|Death|1|||
48714473|NCT01155011|156804883|FG001|6 to 12 Months|Death|5|||
48714474|NCT01087736|156804884|FG000|Overall Study|Lost to Follow-up|1|||
48714475|NCT01087736|156804885|FG001|Overall Study|Lost to Follow-up|0|||
48714476|NCT01087736|156804884|FG000|Overall Study|Death|0|||
48714477|NCT01087736|156804885|FG001|Overall Study|Death|1|||
48714478|NCT01087736|156804884|FG000|Overall Study|Withdrawal by Subject|0|||
48714479|NCT01087736|156804885|FG001|Overall Study|Withdrawal by Subject|1|||
48714480|NCT03083990|156804886|FG000|Overall Study|Adverse Event|1|||
48714481|NCT03083990|156804887|FG001|Overall Study|Adverse Event|0|||
48495972|NCT03519256|156009781|FG001|Overall Study|Disease recurrence|4|||
48495973|NCT03519256|156009782|FG002|Overall Study|Disease recurrence|5|||
48598213|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48714482|NCT01509053|156804888|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
48714483|NCT01509053|156804888|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
48714484|NCT01509053|156804888|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
48714485|NCT01509053|156804888|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
48714486|NCT01509053|156804888|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
48495974|NCT03519256|156009783|FG003|Overall Study|Disease recurrence|2|||
48495975|NCT03519256|156009780|FG000|Overall Study|Study drug toxicity|0|||
48598214|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48813076|NCT04022889|157157357|FG000|Stage 2|Adverse Event|0|||
48714487|NCT01509053|156804888|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
48714488|NCT00776919|156804890|FG000|Overall Study|Withdrawal by Subject|16|||
48714489|NCT00776919|156804891|FG001|Overall Study|Withdrawal by Subject|14|||
48714490|NCT00776919|156804892|FG002|Overall Study|Withdrawal by Subject|15|||
48714491|NCT00776919|156804893|FG003|Overall Study|Withdrawal by Subject|26|||
48714492|NCT00776919|156804890|FG000|Overall Study|Lost to Follow-up|8|||
48714493|NCT00776919|156804891|FG001|Overall Study|Lost to Follow-up|12|||
48714494|NCT00776919|156804892|FG002|Overall Study|Lost to Follow-up|11|||
48714495|NCT00776919|156804893|FG003|Overall Study|Lost to Follow-up|8|||
48714496|NCT00776919|156804890|FG000|Overall Study|Adverse Event|1|||
48714497|NCT00776919|156804891|FG001|Overall Study|Adverse Event|0|||
48714498|NCT00776919|156804892|FG002|Overall Study|Adverse Event|2|||
48714499|NCT00776919|156804893|FG003|Overall Study|Adverse Event|2|||
48714500|NCT00776919|156804890|FG000|Overall Study|Protocol Violation|1|||
48714501|NCT00776919|156804891|FG001|Overall Study|Protocol Violation|2|||
48714502|NCT00776919|156804892|FG002|Overall Study|Protocol Violation|0|||
48714503|NCT00776919|156804893|FG003|Overall Study|Protocol Violation|1|||
48714504|NCT00776919|156804890|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
48714505|NCT00776919|156804891|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
48714506|NCT00776919|156804892|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
48714507|NCT00776919|156804893|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
48714508|NCT00441116|156804894|FG000|Overall Study|Adverse Event|1|||
48714509|NCT00441116|156804895|FG001|Overall Study|Adverse Event|1|||
48714510|NCT00441116|156804894|FG000|Overall Study|Withdrawal by Subject|1|||
48714511|NCT00441116|156804895|FG001|Overall Study|Withdrawal by Subject|0|||
48714512|NCT00441116|156804894|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
48714513|NCT00441116|156804895|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
48714514|NCT00275340|156804896|FG000|Overall Study|Lost to Follow-up|2|||
48714515|NCT00275340|156804897|FG001|Overall Study|Lost to Follow-up|4|||
48714516|NCT01950013|156804898|FG000|Overall Study|Withdrawal by Subject|0|||
48714517|NCT01950013|156804899|FG001|Overall Study|Withdrawal by Subject|2|||
48714518|NCT01950013|156804900|FG002|Overall Study|Withdrawal by Subject|0|||
48714519|NCT02509117|156804905|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714520|NCT02509117|156804906|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
48714521|NCT02509117|156804907|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714522|NCT02509117|156804908|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714523|NCT02509117|156804909|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714524|NCT02509117|156804910|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714525|NCT02509117|156804911|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714526|NCT02509117|156804912|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714527|NCT02509117|156804913|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714528|NCT02509117|156804914|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
48714529|NCT02509117|156804905|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714530|NCT02509117|156804906|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714531|NCT02509117|156804907|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714532|NCT02509117|156804908|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714533|NCT02509117|156804909|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714534|NCT02509117|156804910|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714535|NCT02509117|156804911|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714536|NCT02509117|156804912|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714537|NCT02509117|156804913|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
48714538|NCT02509117|156804914|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
48714539|NCT02509117|156804905|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48714540|NCT02509117|156804906|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48813077|NCT04022889|157157358|FG001|Stage 2|Adverse Event|0|||
48813078|NCT04022889|157157359|FG002|Stage 2|Adverse Event|2|||
48813079|NCT04022889|157157357|FG000|Stage 2|Protocol Violation|0|||
48813080|NCT04022889|157157358|FG001|Stage 2|Protocol Violation|0|||
48813081|NCT04022889|157157359|FG002|Stage 2|Protocol Violation|1|||
48813082|NCT04022889|157157357|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
48813083|NCT04022889|157157358|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
48813084|NCT04022889|157157359|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
48714541|NCT02509117|156804907|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48714542|NCT02509117|156804908|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48813085|NCT02248961|157157360|FG000|Overall Study|Adverse Event|1|||
48813086|NCT02248961|157157361|FG001|Overall Study|Adverse Event|0|||
48714543|NCT02509117|156804909|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48813087|NCT02248961|157157360|FG000|Overall Study|Withdrawal by Subject|1|||
48813088|NCT02248961|157157361|FG001|Overall Study|Withdrawal by Subject|2|||
48495976|NCT03519256|156009781|FG001|Overall Study|Study drug toxicity|2|||
48495977|NCT03519256|156009782|FG002|Overall Study|Study drug toxicity|5|||
48495978|NCT03519256|156009783|FG003|Overall Study|Study drug toxicity|2|||
48495979|NCT03519256|156009780|FG000|Overall Study|Adverse event unrelated to study drug|0|||
48495980|NCT03519256|156009781|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48495981|NCT03519256|156009782|FG002|Overall Study|Adverse event unrelated to study drug|1|||
48495982|NCT03519256|156009783|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48495983|NCT03519256|156009780|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48495984|NCT03519256|156009781|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48495985|NCT03519256|156009782|FG002|Overall Study|Participant request to discontinue study treatment|0|||
48495986|NCT03519256|156009783|FG003|Overall Study|Participant request to discontinue study treatment|2|||
48495987|NCT03519256|156009780|FG000|Overall Study|Other reasons|0|||
48495988|NCT03519256|156009781|FG001|Overall Study|Other reasons|0|||
48495989|NCT03519256|156009782|FG002|Overall Study|Other reasons|2|||
48495990|NCT03519256|156009783|FG003|Overall Study|Other reasons|0|||
48495991|NCT03519256|156009780|FG000|Overall Study|Disease progression|6|||
48495992|NCT03519256|156009781|FG001|Overall Study|Disease progression|3|||
48495993|NCT03519256|156009782|FG002|Overall Study|Disease progression|2|||
48495994|NCT03519256|156009783|FG003|Overall Study|Disease progression|1|||
48495995|NCT03519256|156009780|FG000|Overall Study|Lost to Follow-up|0|||
48495996|NCT03519256|156009781|FG001|Overall Study|Lost to Follow-up|1|||
48495997|NCT03519256|156009782|FG002|Overall Study|Lost to Follow-up|0|||
48495998|NCT03519256|156009783|FG003|Overall Study|Lost to Follow-up|0|||
48495999|NCT04828161|156009784|FG000|Overall Study|Withdrawal by Subject|0|||
48496000|NCT04828161|156009785|FG001|Overall Study|Withdrawal by Subject|3|||
48496001|NCT04828161|156009786|FG002|Overall Study|Withdrawal by Subject|3|||
48496002|NCT04828161|156009787|FG003|Overall Study|Withdrawal by Subject|4|||
48496003|NCT04828161|156009784|FG000|Overall Study|Lost to Follow-up|1|||
48496004|NCT04828161|156009785|FG001|Overall Study|Lost to Follow-up|4|||
48496005|NCT04828161|156009786|FG002|Overall Study|Lost to Follow-up|2|||
48813089|NCT02248961|157157360|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
48813090|NCT02248961|157157361|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
48813091|NCT01900054|157157364|FG000|Overall Study|Physician Decision|1|||
48813092|NCT01900054|157157364|FG000|Overall Study|Withdrawal by Subject|1|||
48813093|NCT03285295|157157365|FG000|Alinity s HBsAg|Protocol Violation|11|||
48813094|NCT03285295|157157366|FG001|Alinity s HBsAg|Protocol Violation|0|||
48813095|NCT03285295|157157367|FG002|Alinity s HBsAg|Protocol Violation|0|||
48813096|NCT03285295|157157368|FG003|Alinity s HBsAg|Protocol Violation|0|||
48813097|NCT03285295|157157369|FG004|Alinity s HBsAg|Protocol Violation|0|||
48813098|NCT03285295|157157365|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
48813099|NCT03285295|157157366|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
48813100|NCT03285295|157157367|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
48813101|NCT03285295|157157368|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
48813102|NCT03285295|157157369|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
48813103|NCT03285295|157157365|FG000|Alinity s HBsAg|No Results Generated|74|||
48813104|NCT03285295|157157366|FG001|Alinity s HBsAg|No Results Generated|6|||
48813105|NCT03285295|157157367|FG002|Alinity s HBsAg|No Results Generated|0|||
48813106|NCT03285295|157157368|FG003|Alinity s HBsAg|No Results Generated|0|||
48813107|NCT03285295|157157369|FG004|Alinity s HBsAg|No Results Generated|0|||
48813108|NCT03285295|157157365|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
48496006|NCT04828161|156009787|FG003|Overall Study|Lost to Follow-up|2|||
48496007|NCT04828161|156009784|FG000|Overall Study|Other|2|||
48496008|NCT04828161|156009785|FG001|Overall Study|Other|0|||
48496009|NCT04828161|156009786|FG002|Overall Study|Other|2|||
48496010|NCT04828161|156009787|FG003|Overall Study|Other|0|||
48496011|NCT04828161|156009784|FG000|Overall Study|Death|0|||
48496012|NCT04828161|156009785|FG001|Overall Study|Death|0|||
48496013|NCT04828161|156009786|FG002|Overall Study|Death|0|||
48496014|NCT04828161|156009787|FG003|Overall Study|Death|2|||
48813109|NCT03285295|157157366|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
48813110|NCT03285295|157157367|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
48813111|NCT03285295|157157368|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
48496015|NCT02352337|156009788|FG000|Overall Study|Patients never treated|4|||
48496016|NCT02352337|156009789|FG001|Overall Study|Patients never treated|1|||
48496017|NCT02352337|156009790|FG002|Overall Study|Patients never treated|2|||
48496018|NCT00601354|156009791|FG000|Overall Study|Lost to Follow-up|4|||
48496019|NCT00601354|156009792|FG001|Overall Study|Lost to Follow-up|5|||
48496020|NCT03175120|156009795|FG000|Overall Study|Adverse Event|2|||
48496021|NCT03175120|156009796|FG001|Overall Study|Adverse Event|2|||
48496022|NCT03175120|156009795|FG000|Overall Study|Protocol Violation|5|||
48496023|NCT03175120|156009796|FG001|Overall Study|Protocol Violation|2|||
48496024|NCT03175120|156009795|FG000|Overall Study|Lost to Follow-up|1|||
48496025|NCT03175120|156009796|FG001|Overall Study|Lost to Follow-up|0|||
48496026|NCT03175120|156009795|FG000|Overall Study|Withdrawal by Subject|2|||
48496027|NCT03175120|156009796|FG001|Overall Study|Withdrawal by Subject|5|||
48496028|NCT03175120|156009795|FG000|Overall Study|Other|2|||
48496029|NCT03175120|156009796|FG001|Overall Study|Other|3|||
48496030|NCT00922974|156009797|FG000|Phase II Component|Protocol Violation|2|||
48496031|NCT00922974|156009798|FG001|Phase II Component|Protocol Violation|0|||
48496032|NCT00922974|156009797|FG000|Phase II Component|Not evaluable for treatment review|5|||
48496033|NCT00922974|156009798|FG001|Phase II Component|Not evaluable for treatment review|0|||
48496034|NCT00922974|156009797|FG000|Phase III Component|Protocol Violation|8|||
48496035|NCT00922974|156009798|FG001|Phase III Component|Protocol Violation|6|||
48496036|NCT04120194|156009799|FG000|Overall Study|Lost to Follow-up|11|||
48496037|NCT04120194|156009800|FG001|Overall Study|Lost to Follow-up|8|||
48496038|NCT04120194|156009799|FG000|Overall Study|Adverse Event|4|||
48714544|NCT02509117|156804910|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48496039|NCT04120194|156009800|FG001|Overall Study|Adverse Event|5|||
48714545|NCT02509117|156804911|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48714546|NCT02509117|156804912|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48714547|NCT02509117|156804913|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
48496040|NCT04120194|156009799|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
48496041|NCT04120194|156009800|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
48496042|NCT04120194|156009799|FG000|Overall Study|Miscellaneous|4|||
48496043|NCT04120194|156009800|FG001|Overall Study|Miscellaneous|5|||
48714548|NCT02509117|156804914|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
48714549|NCT00145119|156804915|FG000|Overall Study|Death|45|||
48714550|NCT00832624|156804916|FG000|Overall Study|Study Terminated|10|||
48714551|NCT02636361|156804917|FG000|Period 4|Physician Decision|0|||
48714552|NCT02636361|156804918|FG001|Period 4|Physician Decision|0|||
48714553|NCT02636361|156804919|FG002|Period 4|Physician Decision|0|||
48714554|NCT02636361|156804920|FG003|Period 4|Physician Decision|1|||
48714555|NCT02636361|156804921|FG004|Period 4|Physician Decision|0|||
48714556|NCT02466659|156804922|FG000|Overall Study|Lost to Follow-up|5|||
48714557|NCT02466659|156804923|FG001|Overall Study|Lost to Follow-up|2|||
48714558|NCT03425253|156804924|FG000|Overall Study|Adverse Event|2|||
48714559|NCT03425253|156804924|FG000|Overall Study|Lost to Follow-up|3|||
48714560|NCT03425253|156804924|FG000|Overall Study|Withdrew Consent|6|||
48714561|NCT03425253|156804924|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
48714562|NCT01590758|156804925|FG000|Overall Study|Withdrawal by Subject|0|||
48714563|NCT01590758|156804926|FG001|Overall Study|Withdrawal by Subject|3|||
48714564|NCT01590758|156804925|FG000|Overall Study|Physician Decision|1|||
48714565|NCT01590758|156804926|FG001|Overall Study|Physician Decision|2|||
48714566|NCT01590758|156804925|FG000|Overall Study|Lost to Follow-up|4|||
48714567|NCT01590758|156804926|FG001|Overall Study|Lost to Follow-up|2|||
48714568|NCT02717832|156804927|FG000|Overall Study|Inability to place IV|3|||
48714569|NCT00096356|156804928|FG000|Overall Study|Adverse Event|11|||
48714570|NCT00096356|156804929|FG001|Overall Study|Adverse Event|9|||
48714571|NCT00096356|156804928|FG000|Overall Study|Physician Decision|5|||
48714572|NCT00096356|156804929|FG001|Overall Study|Physician Decision|3|||
48496044|NCT01090765|156009801|FG000|Overall Study|Patient withdrew consent|0|||
48496045|NCT01090765|156009802|FG001|Overall Study|Patient withdrew consent|0|||
48496046|NCT01090765|156009803|FG002|Overall Study|Patient withdrew consent|0|||
48714573|NCT00096356|156804928|FG000|Overall Study|Withdrawal by Subject|17|||
48714574|NCT00096356|156804929|FG001|Overall Study|Withdrawal by Subject|23|||
48714575|NCT00096356|156804928|FG000|Overall Study|Lack of Efficacy|1|||
48813112|NCT03285295|157157369|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
48813113|NCT03285295|157157365|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
48813114|NCT03285295|157157366|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
48813115|NCT03285295|157157367|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
48813116|NCT03285295|157157368|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
48813117|NCT03285295|157157369|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
48813118|NCT03285295|157157365|FG000|Alinity s HTLV I/II|No Results Generated|70|||
48813119|NCT03285295|157157366|FG001|Alinity s HTLV I/II|No Results Generated|0|||
48496047|NCT01090765|156009804|FG003|Overall Study|Patient withdrew consent|0|||
48496048|NCT01090765|156009805|FG004|Overall Study|Patient withdrew consent|1|||
48496049|NCT01090765|156009806|FG005|Overall Study|Patient withdrew consent|1|||
48496050|NCT01090765|156009801|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
48496051|NCT01090765|156009802|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
48496052|NCT01090765|156009803|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
48496053|NCT01090765|156009804|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
48496054|NCT01090765|156009805|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
48496055|NCT01090765|156009806|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
48496056|NCT01090765|156009801|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
48496057|NCT01090765|156009802|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
48496058|NCT01090765|156009803|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
48496059|NCT01090765|156009804|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
48496060|NCT01090765|156009805|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
48496061|NCT01090765|156009806|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
48496062|NCT01977092|156009809|FG000|Overall Study|Death|3|||
48496063|NCT01977092|156009810|FG001|Overall Study|Death|4|||
48496064|NCT01977092|156009809|FG000|Overall Study|Lost to Follow-up|23|||
48496065|NCT01977092|156009810|FG001|Overall Study|Lost to Follow-up|14|||
48496066|NCT01977092|156009809|FG000|Overall Study|Withdrawal by Subject|2|||
48496067|NCT01977092|156009810|FG001|Overall Study|Withdrawal by Subject|1|||
48496068|NCT01977092|156009809|FG000|Overall Study|In prison|3|||
48496069|NCT01977092|156009810|FG001|Overall Study|In prison|11|||
48496070|NCT03038113|156009811|FG000|Overall Study|Withdrawal by Subject|0|||
48813120|NCT03285295|157157367|FG002|Alinity s HTLV I/II|No Results Generated|0|||
48813121|NCT03285295|157157368|FG003|Alinity s HTLV I/II|No Results Generated|0|||
48813122|NCT03285295|157157369|FG004|Alinity s HTLV I/II|No Results Generated|0|||
48496071|NCT03038113|156009812|FG001|Overall Study|Withdrawal by Subject|0|||
48496072|NCT03038113|156009813|FG002|Overall Study|Withdrawal by Subject|1|||
48496073|NCT03038113|156009814|FG003|Overall Study|Withdrawal by Subject|0|||
48496074|NCT03038113|156009815|FG004|Overall Study|Withdrawal by Subject|0|||
48496075|NCT03038113|156009816|FG005|Overall Study|Withdrawal by Subject|0|||
48496076|NCT03038113|156009817|FG006|Overall Study|Withdrawal by Subject|0|||
48813123|NCT03285295|157157365|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
48813124|NCT03285295|157157366|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
48813125|NCT03285295|157157367|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
48813126|NCT03285295|157157368|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
48813127|NCT03285295|157157369|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
48813128|NCT03285295|157157365|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
48813129|NCT03285295|157157366|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
48813130|NCT03285295|157157367|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
48813131|NCT03285295|157157368|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
48813132|NCT03285295|157157369|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
48813133|NCT03285295|157157365|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
48813134|NCT03285295|157157366|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
48813135|NCT03285295|157157367|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
48813136|NCT03285295|157157368|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
48813137|NCT03285295|157157369|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
48813138|NCT03285295|157157365|FG000|Alinity s Anti-HCV|No Results Generated|71|||
48813139|NCT03285295|157157366|FG001|Alinity s Anti-HCV|No Results Generated|0|||
48813140|NCT03285295|157157367|FG002|Alinity s Anti-HCV|No Results Generated|0|||
48813141|NCT03285295|157157368|FG003|Alinity s Anti-HCV|No Results Generated|0|||
48813142|NCT03285295|157157369|FG004|Alinity s Anti-HCV|No Results Generated|0|||
48813143|NCT03285295|157157365|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
48813144|NCT03285295|157157366|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
48813145|NCT03285295|157157367|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
48813146|NCT03285295|157157368|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
48813147|NCT03285295|157157369|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
48813148|NCT03285295|157157365|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
48813149|NCT03285295|157157366|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
48813150|NCT03285295|157157367|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
48813151|NCT03285295|157157368|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
48813152|NCT03285295|157157369|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
48496077|NCT03038113|156009818|FG007|Overall Study|Withdrawal by Subject|0|||
48496078|NCT03038113|156009819|FG008|Overall Study|Withdrawal by Subject|0|||
48496079|NCT03038113|156009820|FG009|Overall Study|Withdrawal by Subject|0|||
48496080|NCT03038113|156009821|FG010|Overall Study|Withdrawal by Subject|0|||
48496081|NCT03038113|156009822|FG011|Overall Study|Withdrawal by Subject|0|||
48813153|NCT03285295|157157365|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
48496082|NCT03038113|156009823|FG012|Overall Study|Withdrawal by Subject|0|||
48496083|NCT03038113|156009824|FG013|Overall Study|Withdrawal by Subject|1|||
48496084|NCT03038113|156009811|FG000|Overall Study|Lost to Follow-up|0|||
48496085|NCT03038113|156009812|FG001|Overall Study|Lost to Follow-up|0|||
48496086|NCT03038113|156009813|FG002|Overall Study|Lost to Follow-up|0|||
48813154|NCT03285295|157157366|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
48813155|NCT03285295|157157367|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
48813156|NCT03285295|157157368|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
48813157|NCT03285295|157157369|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
48813158|NCT03285295|157157365|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
48813159|NCT03285295|157157366|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
48813160|NCT03285295|157157367|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
48813161|NCT03285295|157157368|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
48813162|NCT03285295|157157369|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
48813163|NCT03285295|157157365|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
48813164|NCT03285295|157157366|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
48813165|NCT03285295|157157367|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
48813166|NCT03285295|157157368|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
48813167|NCT03285295|157157369|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
48813168|NCT03285295|157157365|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
48813169|NCT03285295|157157366|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
48813170|NCT03285295|157157367|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
48813171|NCT03285295|157157368|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
48813172|NCT03285295|157157369|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
48813173|NCT03285295|157157365|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
48813174|NCT03285295|157157366|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
48813175|NCT03285295|157157367|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
48813176|NCT03285295|157157368|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
48813177|NCT03285295|157157369|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
48813178|NCT03285295|157157365|FG000|Alinity s Anti-HBc|No Results Generated|70|||
48813179|NCT03285295|157157366|FG001|Alinity s Anti-HBc|No Results Generated|0|||
48813180|NCT03285295|157157367|FG002|Alinity s Anti-HBc|No Results Generated|0|||
48496087|NCT03038113|156009814|FG003|Overall Study|Lost to Follow-up|0|||
48496088|NCT03038113|156009815|FG004|Overall Study|Lost to Follow-up|0|||
48496089|NCT03038113|156009816|FG005|Overall Study|Lost to Follow-up|0|||
48496090|NCT03038113|156009817|FG006|Overall Study|Lost to Follow-up|1|||
48496091|NCT03038113|156009818|FG007|Overall Study|Lost to Follow-up|0|||
48496092|NCT03038113|156009819|FG008|Overall Study|Lost to Follow-up|0|||
48496093|NCT03038113|156009820|FG009|Overall Study|Lost to Follow-up|0|||
48496094|NCT03038113|156009821|FG010|Overall Study|Lost to Follow-up|0|||
48496095|NCT03038113|156009822|FG011|Overall Study|Lost to Follow-up|0|||
48496096|NCT03038113|156009823|FG012|Overall Study|Lost to Follow-up|0|||
48496097|NCT03038113|156009824|FG013|Overall Study|Lost to Follow-up|0|||
48496098|NCT02623959|156009830|FG000|Overall Study|Progression|0|||
48496099|NCT02623959|156009831|FG001|Overall Study|Progression|1|||
48496100|NCT01787825|156009836|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
48496101|NCT01787825|156009837|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
48496102|NCT01787825|156009836|FG000|Overall Study|Data Not Analyzable|5|||
48496103|NCT01787825|156009837|FG001|Overall Study|Data Not Analyzable|1|||
48496104|NCT00536575|156009846|FG000|Overall Study|Withdrawal by Subject|1|||
48496105|NCT00536575|156009846|FG000|Overall Study|Death|1|||
48496106|NCT00623103|156009848|FG000|Overall Study|Adverse Event|70|||
48496107|NCT00623103|156009849|FG001|Overall Study|Adverse Event|60|||
48496108|NCT00623103|156009848|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48496109|NCT00623103|156009849|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
48496110|NCT00623103|156009848|FG000|Overall Study|Withdrawal by Subject|18|||
48496111|NCT00623103|156009849|FG001|Overall Study|Withdrawal by Subject|24|||
48496112|NCT00623103|156009848|FG000|Overall Study|Lost to Follow-up|4|||
48496113|NCT00623103|156009849|FG001|Overall Study|Lost to Follow-up|1|||
48496114|NCT00623103|156009848|FG000|Overall Study|Administrative problems|2|||
48496115|NCT00623103|156009849|FG001|Overall Study|Administrative problems|4|||
48496116|NCT00623103|156009848|FG000|Overall Study|Death|11|||
48813181|NCT03285295|157157368|FG003|Alinity s Anti-HBc|No Results Generated|0|||
48813182|NCT03285295|157157369|FG004|Alinity s Anti-HBc|No Results Generated|0|||
48813183|NCT03285295|157157365|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
48813184|NCT03285295|157157366|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
48496117|NCT00623103|156009849|FG001|Overall Study|Death|11|||
48496118|NCT00623103|156009848|FG000|Overall Study|Protocol deviation|2|||
48496119|NCT00623103|156009849|FG001|Overall Study|Protocol deviation|1|||
48496120|NCT05034731|156009853|FG000|Overall Study|Screen fail|1|||
48496121|NCT05034731|156009854|FG001|Overall Study|Screen fail|1|||
48496122|NCT03522948|156009855|FG000|Overall Study|Lost to Follow-up|1|||
48496123|NCT03937466|156009856|FG000|Overall Study|not eligbile after the 2-week diary|9|||
48496124|NCT03937466|156009856|FG000|Overall Study|never returned their diary|6|||
48496125|NCT03937466|156009856|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
48496126|NCT03937466|156009856|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
48496127|NCT00622908|156009858|FG000|Overall Study|Protocol Violation|1|||
48496128|NCT00622908|156009859|FG001|Overall Study|Protocol Violation|0|||
48496129|NCT00622908|156009858|FG000|Overall Study|Adverse Event|0|||
48496130|NCT00622908|156009859|FG001|Overall Study|Adverse Event|1|||
48496131|NCT00622908|156009858|FG000|Overall Study|Lack of Efficacy|1|||
48496132|NCT00622908|156009859|FG001|Overall Study|Lack of Efficacy|7|||
48496133|NCT00622908|156009858|FG000|Overall Study|Lost to Follow-up|1|||
48496134|NCT00622908|156009859|FG001|Overall Study|Lost to Follow-up|0|||
48496135|NCT00622908|156009858|FG000|Overall Study|Refusal|0|||
48496136|NCT00622908|156009859|FG001|Overall Study|Refusal|1|||
48496137|NCT00622908|156009858|FG000|Overall Study|Termination by study sponser|0|||
48496138|NCT00622908|156009859|FG001|Overall Study|Termination by study sponser|1|||
48496139|NCT02158936|156009860|FG000|Overall Study|Study closed/ terminated|57|||
48496140|NCT02158936|156009861|FG001|Overall Study|Study closed/ terminated|77|||
48496141|NCT02158936|156009860|FG000|Overall Study|Azacitidine tx discontinued|53|||
48496142|NCT02158936|156009861|FG001|Overall Study|Azacitidine tx discontinued|46|||
48496143|NCT02158936|156009860|FG000|Overall Study|Adverse Event|39|||
48598215|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598216|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598217|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598218|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598219|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48598220|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48496144|NCT02158936|156009861|FG001|Overall Study|Adverse Event|24|||
48496145|NCT02158936|156009860|FG000|Overall Study|Withdrawal by Subject|15|||
48496146|NCT02158936|156009861|FG001|Overall Study|Withdrawal by Subject|16|||
48496147|NCT02158936|156009860|FG000|Overall Study|Physician Decision|15|||
48496148|NCT02158936|156009861|FG001|Overall Study|Physician Decision|13|||
48496149|NCT02158936|156009860|FG000|Overall Study|Lost to Follow-up|0|||
48496150|NCT02158936|156009861|FG001|Overall Study|Lost to Follow-up|1|||
48496151|NCT01802879|156009862|FG000|Overall Study|Administrative problems|2|||
48496152|NCT01802879|156009862|FG000|Overall Study|Disease progression|6|||
48496153|NCT00113490|156009866|FG000|Overall Study|Withdrawal by Subject|1|||
48496154|NCT00113490|156009867|FG001|Overall Study|Withdrawal by Subject|3|||
48496155|NCT00113490|156009866|FG000|Overall Study|Lost to Follow-up|1|||
48496156|NCT00113490|156009867|FG001|Overall Study|Lost to Follow-up|0|||
48496157|NCT02236130|156009868|FG000|Overall Study|Lost to Follow-up|7|||
48496158|NCT02236130|156009869|FG001|Overall Study|Lost to Follow-up|12|||
48496159|NCT00819247|156009874|FG000|Overall Study|Adverse Event|0|||
48496160|NCT00819247|156009875|FG001|Overall Study|Adverse Event|5|||
48496161|NCT00819247|156009876|FG002|Overall Study|Adverse Event|3|||
48496162|NCT00819247|156009874|FG000|Overall Study|Insufficient testosterone response|5|||
48496163|NCT00819247|156009875|FG001|Overall Study|Insufficient testosterone response|8|||
48496164|NCT00819247|156009876|FG002|Overall Study|Insufficient testosterone response|10|||
48496165|NCT00819247|156009874|FG000|Overall Study|Withdrawal by Subject|1|||
48496166|NCT00819247|156009875|FG001|Overall Study|Withdrawal by Subject|0|||
48496167|NCT00819247|156009876|FG002|Overall Study|Withdrawal by Subject|0|||
48496168|NCT00819247|156009874|FG000|Overall Study|Protocol Violation|1|||
48598221|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48598222|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48496169|NCT00819247|156009875|FG001|Overall Study|Protocol Violation|0|||
48496170|NCT00819247|156009876|FG002|Overall Study|Protocol Violation|1|||
48496171|NCT00819247|156009874|FG000|Overall Study|Mistakenly withdrawn|0|||
48496172|NCT00819247|156009875|FG001|Overall Study|Mistakenly withdrawn|1|||
48496173|NCT00819247|156009876|FG002|Overall Study|Mistakenly withdrawn|0|||
48496174|NCT00819247|156009874|FG000|Overall Study|Bad prostate-specific antigen response|3|||
48496175|NCT00819247|156009875|FG001|Overall Study|Bad prostate-specific antigen response|2|||
48496176|NCT00819247|156009876|FG002|Overall Study|Bad prostate-specific antigen response|0|||
48598223|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48813185|NCT03285295|157157367|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
48496177|NCT00819247|156009874|FG000|Overall Study|Other|1|||
48496178|NCT00819247|156009875|FG001|Overall Study|Other|0|||
48496179|NCT00819247|156009876|FG002|Overall Study|Other|0|||
48496180|NCT00108732|156009877|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
48496181|NCT00108732|156009877|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
48496182|NCT00108732|156009877|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
48496183|NCT00108732|156009877|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
48496184|NCT00108732|156009877|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
48496185|NCT00108732|156009877|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
48496186|NCT00108732|156009877|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
48496187|NCT02187042|156009878|FG000|Overall Study|Death|1|||
48496188|NCT02187042|156009879|FG001|Overall Study|Death|1|||
48496189|NCT02187042|156009878|FG000|Overall Study|Toxicity|6|||
48496190|NCT02187042|156009879|FG001|Overall Study|Toxicity|5|||
48496191|NCT02187042|156009878|FG000|Overall Study|Participant choice|1|||
48496192|NCT02187042|156009879|FG001|Overall Study|Participant choice|0|||
48496193|NCT02187042|156009878|FG000|Overall Study|Doctor choice|1|||
48496194|NCT02187042|156009879|FG001|Overall Study|Doctor choice|0|||
48496195|NCT02187042|156009878|FG000|Overall Study|Progressive disease|4|||
48496196|NCT02187042|156009879|FG001|Overall Study|Progressive disease|8|||
48496197|NCT02040766|156009880|FG000|Overall Study|Adverse Event|1|||
48496198|NCT02040766|156009881|FG001|Overall Study|Adverse Event|1|||
48496199|NCT02040766|156009882|FG002|Overall Study|Adverse Event|1|||
48496200|NCT02040766|156009883|FG003|Overall Study|Adverse Event|0|||
48496201|NCT02040766|156009884|FG004|Overall Study|Adverse Event|2|||
48496202|NCT02040766|156009880|FG000|Overall Study|Withdrawal by Subject|4|||
48496203|NCT02040766|156009881|FG001|Overall Study|Withdrawal by Subject|3|||
48496204|NCT02040766|156009882|FG002|Overall Study|Withdrawal by Subject|2|||
48496205|NCT02040766|156009883|FG003|Overall Study|Withdrawal by Subject|3|||
48496206|NCT02040766|156009884|FG004|Overall Study|Withdrawal by Subject|2|||
48496207|NCT02040766|156009880|FG000|Overall Study|Non-compliance|0|||
48813186|NCT03285295|157157368|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
48496208|NCT02040766|156009881|FG001|Overall Study|Non-compliance|1|||
48813187|NCT03285295|157157369|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
48813188|NCT03285295|157157365|FG000|Alinity s Chagas|Protocol Violation|76|||
48496209|NCT02040766|156009882|FG002|Overall Study|Non-compliance|0|||
48496210|NCT02040766|156009883|FG003|Overall Study|Non-compliance|0|||
48813189|NCT03285295|157157366|FG001|Alinity s Chagas|Protocol Violation|0|||
48813190|NCT03285295|157157367|FG002|Alinity s Chagas|Protocol Violation|0|||
48813191|NCT03285295|157157368|FG003|Alinity s Chagas|Protocol Violation|0|||
48813192|NCT03285295|157157369|FG004|Alinity s Chagas|Protocol Violation|0|||
48813193|NCT03285295|157157365|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
48813194|NCT03285295|157157366|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
48813195|NCT03285295|157157367|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
48813196|NCT03285295|157157368|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
48813197|NCT03285295|157157369|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
48496211|NCT02040766|156009884|FG004|Overall Study|Non-compliance|0|||
48496212|NCT02040766|156009880|FG000|Overall Study|Protocol Violation|2|||
48496213|NCT02040766|156009881|FG001|Overall Study|Protocol Violation|1|||
48496214|NCT02040766|156009882|FG002|Overall Study|Protocol Violation|2|||
48496215|NCT02040766|156009883|FG003|Overall Study|Protocol Violation|3|||
48496216|NCT02040766|156009884|FG004|Overall Study|Protocol Violation|0|||
48496217|NCT02040766|156009880|FG000|Overall Study|Lost to Follow-up|4|||
48496218|NCT02040766|156009881|FG001|Overall Study|Lost to Follow-up|1|||
48813198|NCT03285295|157157365|FG000|Alinity s Chagas|No Results Generated|105|||
48813199|NCT03285295|157157366|FG001|Alinity s Chagas|No Results Generated|0|||
48496219|NCT02040766|156009882|FG002|Overall Study|Lost to Follow-up|3|||
48496220|NCT02040766|156009883|FG003|Overall Study|Lost to Follow-up|1|||
48496221|NCT02040766|156009884|FG004|Overall Study|Lost to Follow-up|4|||
48496222|NCT02040766|156009880|FG000|Overall Study|Not reported|1|||
48496223|NCT02040766|156009881|FG001|Overall Study|Not reported|0|||
48496224|NCT02040766|156009882|FG002|Overall Study|Not reported|0|||
48496225|NCT02040766|156009883|FG003|Overall Study|Not reported|0|||
48496226|NCT02040766|156009884|FG004|Overall Study|Not reported|0|||
48496227|NCT02040766|156009880|FG000|Overall Study|Lack of Efficacy|6|||
48496228|NCT02040766|156009881|FG001|Overall Study|Lack of Efficacy|3|||
48496229|NCT02040766|156009882|FG002|Overall Study|Lack of Efficacy|4|||
48496230|NCT02040766|156009883|FG003|Overall Study|Lack of Efficacy|6|||
48496231|NCT02040766|156009884|FG004|Overall Study|Lack of Efficacy|5|||
48496232|NCT01946165|156009885|FG000|Overall Study|Physician Decision|2|||
48496233|NCT01946165|156009886|FG001|Overall Study|Physician Decision|0|||
48496234|NCT01946165|156009885|FG000|Overall Study|Withdrawal by Subject|0|||
48496235|NCT01946165|156009886|FG001|Overall Study|Withdrawal by Subject|2|||
48496236|NCT00462982|156009892|FG000|Overall Study|Adverse Event|1|||
48496237|NCT00462982|156009892|FG000|Overall Study|Patient Not Treated|2|||
48496238|NCT02801877|156009893|FG000|Overall Study|Lost to Follow-up|1|||
48496239|NCT02801877|156009894|FG001|Overall Study|Lost to Follow-up|1|||
48496240|NCT02801877|156009895|FG002|Overall Study|Lost to Follow-up|2|||
48496241|NCT02801877|156009896|FG003|Overall Study|Lost to Follow-up|0|||
48496242|NCT02801877|156009893|FG000|Overall Study|Never Started Treatment|2|||
48496243|NCT02801877|156009894|FG001|Overall Study|Never Started Treatment|0|||
48714576|NCT00096356|156804929|FG001|Overall Study|Lack of Efficacy|0|||
48496244|NCT02801877|156009895|FG002|Overall Study|Never Started Treatment|4|||
48714577|NCT00096356|156804928|FG000|Overall Study|multiple reasons|10|||
48714578|NCT00096356|156804929|FG001|Overall Study|multiple reasons|18|||
48714579|NCT02560025|156804930|FG000|Overall Study|Ineligible after consent/ registration|3|||
48714580|NCT01755026|156804934|FG000|Overall Study|Adverse Event|1|||
48714581|NCT01755026|156804935|FG001|Overall Study|Adverse Event|0|||
48714582|NCT01755026|156804934|FG000|Overall Study|Withdrawal by Subject|1|||
48714583|NCT01755026|156804935|FG001|Overall Study|Withdrawal by Subject|1|||
48714584|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
48496245|NCT02801877|156009896|FG003|Overall Study|Never Started Treatment|0|||
48496246|NCT05188521|156012107|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
48496247|NCT05188521|156012108|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
48496248|NCT00458302|156012109|FG000|Overall Study|Adverse Event|4|||
48496249|NCT00458302|156012110|FG001|Overall Study|Adverse Event|14|||
48496250|NCT00458302|156012109|FG000|Overall Study|Pregnancy|2|||
48496251|NCT00458302|156012110|FG001|Overall Study|Pregnancy|1|||
48496252|NCT00458302|156012109|FG000|Overall Study|Protocol Violation|0|||
48496253|NCT00458302|156012110|FG001|Overall Study|Protocol Violation|2|||
48496254|NCT00458302|156012109|FG000|Overall Study|Withdrawal by Subject|6|||
48496255|NCT00458302|156012110|FG001|Overall Study|Withdrawal by Subject|4|||
48496256|NCT00458302|156012109|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
48714585|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
48496257|NCT00458302|156012110|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
48496258|NCT00458302|156012109|FG000|Overall Study|Study Termination By Sponsor|1|||
48496259|NCT00458302|156012110|FG001|Overall Study|Study Termination By Sponsor|0|||
48496260|NCT00458302|156012109|FG000|Overall Study|Lost to Follow-up|2|||
48496261|NCT00458302|156012110|FG001|Overall Study|Lost to Follow-up|0|||
48496262|NCT00458302|156012109|FG000|Overall Study|Other|4|||
48496263|NCT00458302|156012110|FG001|Overall Study|Other|2|||
48496264|NCT01621490|156012113|FG000|Overall Study|Subject no longer meets study criteria|0|||
48496265|NCT01621490|156012114|FG001|Overall Study|Subject no longer meets study criteria|0|||
48496266|NCT01621490|156012115|FG002|Overall Study|Subject no longer meets study criteria|0|||
48496267|NCT01621490|156012116|FG003|Overall Study|Subject no longer meets study criteria|0|||
48496268|NCT01621490|156012117|FG004|Overall Study|Subject no longer meets study criteria|1|||
48496269|NCT01621490|156012118|FG005|Overall Study|Subject no longer meets study criteria|0|||
48496270|NCT01621490|156012119|FG006|Overall Study|Subject no longer meets study criteria|0|||
48496271|NCT01621490|156012120|FG007|Overall Study|Subject no longer meets study criteria|0|||
48496272|NCT01621490|156012121|FG008|Overall Study|Subject no longer meets study criteria|0|||
48496273|NCT01621490|156012122|FG009|Overall Study|Subject no longer meets study criteria|0|||
48496274|NCT01621490|156012123|FG010|Overall Study|Subject no longer meets study criteria|0|||
48496275|NCT01621490|156012113|FG000|Overall Study|Maximum clinical benefit|3|||
48496276|NCT01621490|156012114|FG001|Overall Study|Maximum clinical benefit|2|||
48496277|NCT01621490|156012115|FG002|Overall Study|Maximum clinical benefit|0|||
48496278|NCT01621490|156012116|FG003|Overall Study|Maximum clinical benefit|0|||
48714586|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
48714587|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
48496279|NCT01621490|156012117|FG004|Overall Study|Maximum clinical benefit|0|||
48496280|NCT01621490|156012118|FG005|Overall Study|Maximum clinical benefit|0|||
48496281|NCT01621490|156012119|FG006|Overall Study|Maximum clinical benefit|1|||
48714588|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
48714589|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
48714590|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
48714591|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
48714592|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
48714593|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
48714594|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
48714595|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
48714596|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
48714597|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
48714598|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
48714599|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
48714600|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
48714601|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
48714602|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
48714603|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
48714604|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
48714605|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
48714606|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
48714607|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
48714608|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
48714609|NCT00095147|156804936|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
48714610|NCT00095147|156804937|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
48714611|NCT00095147|156804938|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
48714612|NCT00095147|156804939|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
48714613|NCT00095147|156804940|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
48496282|NCT01621490|156012120|FG007|Overall Study|Maximum clinical benefit|2|||
48714614|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
48714615|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
48714616|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
48714617|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
48714618|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
48714619|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
48714620|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
48714621|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
48714622|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
48714623|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
48714624|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
48714625|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
48714626|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
48714627|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
48714628|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
48714629|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
48714630|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
48714631|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
48714632|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
48714633|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
48714634|NCT00095147|156804936|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
48714635|NCT00095147|156804937|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
48496283|NCT01621490|156012121|FG008|Overall Study|Maximum clinical benefit|2|||
48496284|NCT01621490|156012122|FG009|Overall Study|Maximum clinical benefit|0|||
48496285|NCT01621490|156012123|FG010|Overall Study|Maximum clinical benefit|0|||
48496286|NCT01621490|156012113|FG000|Overall Study|Withdrawal by Subject|1|||
48496287|NCT01621490|156012114|FG001|Overall Study|Withdrawal by Subject|0|||
48496288|NCT01621490|156012115|FG002|Overall Study|Withdrawal by Subject|0|||
48496289|NCT01621490|156012116|FG003|Overall Study|Withdrawal by Subject|0|||
48496290|NCT01621490|156012117|FG004|Overall Study|Withdrawal by Subject|0|||
48714636|NCT00095147|156804938|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
48714637|NCT00095147|156804939|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
48714638|NCT00095147|156804940|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
48714639|NCT00095147|156804936|FG000|Long-term Extension Period|Death|0|||
48714640|NCT00095147|156804937|FG001|Long-term Extension Period|Death|0|||
48714641|NCT00095147|156804938|FG002|Long-term Extension Period|Death|0|||
48714642|NCT00095147|156804939|FG003|Long-term Extension Period|Death|0|||
48496291|NCT01621490|156012118|FG005|Overall Study|Withdrawal by Subject|1|||
48496292|NCT01621490|156012119|FG006|Overall Study|Withdrawal by Subject|0|||
48496293|NCT01621490|156012120|FG007|Overall Study|Withdrawal by Subject|0|||
48496294|NCT01621490|156012121|FG008|Overall Study|Withdrawal by Subject|0|||
48496295|NCT01621490|156012122|FG009|Overall Study|Withdrawal by Subject|0|||
48496296|NCT01621490|156012123|FG010|Overall Study|Withdrawal by Subject|0|||
48496297|NCT01621490|156012113|FG000|Overall Study|Subject request to discontinue study|1|||
48496298|NCT01621490|156012114|FG001|Overall Study|Subject request to discontinue study|3|||
48496299|NCT01621490|156012115|FG002|Overall Study|Subject request to discontinue study|1|||
48496300|NCT01621490|156012116|FG003|Overall Study|Subject request to discontinue study|1|||
48496301|NCT01621490|156012117|FG004|Overall Study|Subject request to discontinue study|0|||
48496302|NCT01621490|156012118|FG005|Overall Study|Subject request to discontinue study|2|||
48714643|NCT00095147|156804940|FG004|Long-term Extension Period|Death|3|||
48496303|NCT01621490|156012119|FG006|Overall Study|Subject request to discontinue study|1|||
48714644|NCT00095147|156804936|FG000|Long-term Extension Period|Adverse Event|0|||
48496304|NCT01621490|156012120|FG007|Overall Study|Subject request to discontinue study|0|||
48496305|NCT01621490|156012121|FG008|Overall Study|Subject request to discontinue study|1|||
48714645|NCT00095147|156804937|FG001|Long-term Extension Period|Adverse Event|0|||
48714646|NCT00095147|156804938|FG002|Long-term Extension Period|Adverse Event|0|||
48714647|NCT00095147|156804939|FG003|Long-term Extension Period|Adverse Event|0|||
48714648|NCT00095147|156804940|FG004|Long-term Extension Period|Adverse Event|11|||
48496306|NCT01621490|156012122|FG009|Overall Study|Subject request to discontinue study|0|||
48496307|NCT01621490|156012123|FG010|Overall Study|Subject request to discontinue study|0|||
48496308|NCT01621490|156012113|FG000|Overall Study|Adverse event unrelated to study drug|1|||
48496309|NCT01621490|156012114|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48496310|NCT01621490|156012115|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48496311|NCT01621490|156012116|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48496312|NCT01621490|156012117|FG004|Overall Study|Adverse event unrelated to study drug|0|||
48496313|NCT01621490|156012118|FG005|Overall Study|Adverse event unrelated to study drug|0|||
48496314|NCT01621490|156012119|FG006|Overall Study|Adverse event unrelated to study drug|0|||
48496315|NCT01621490|156012120|FG007|Overall Study|Adverse event unrelated to study drug|2|||
48496316|NCT01621490|156012121|FG008|Overall Study|Adverse event unrelated to study drug|0|||
48496317|NCT01621490|156012122|FG009|Overall Study|Adverse event unrelated to study drug|0|||
48714649|NCT00095147|156804936|FG000|Long-term Extension Period|Lack of Efficacy|0|||
48714650|NCT00095147|156804937|FG001|Long-term Extension Period|Lack of Efficacy|0|||
48714651|NCT00095147|156804938|FG002|Long-term Extension Period|Lack of Efficacy|0|||
48714652|NCT00095147|156804939|FG003|Long-term Extension Period|Lack of Efficacy|0|||
48714653|NCT00095147|156804940|FG004|Long-term Extension Period|Lack of Efficacy|9|||
48714654|NCT00095147|156804936|FG000|Long-term Extension Period|Lost to Follow-up|0|||
48714655|NCT00095147|156804937|FG001|Long-term Extension Period|Lost to Follow-up|0|||
48714656|NCT00095147|156804938|FG002|Long-term Extension Period|Lost to Follow-up|0|||
48714657|NCT00095147|156804939|FG003|Long-term Extension Period|Lost to Follow-up|0|||
48714658|NCT00095147|156804940|FG004|Long-term Extension Period|Lost to Follow-up|6|||
48813200|NCT03285295|157157367|FG002|Alinity s Chagas|No Results Generated|0|||
48813201|NCT03285295|157157368|FG003|Alinity s Chagas|No Results Generated|0|||
48496318|NCT01621490|156012123|FG010|Overall Study|Adverse event unrelated to study drug|0|||
48496319|NCT01621490|156012113|FG000|Overall Study|Disease progression|27|||
48496320|NCT01621490|156012114|FG001|Overall Study|Disease progression|28|||
48496321|NCT01621490|156012115|FG002|Overall Study|Disease progression|1|||
48496322|NCT01621490|156012116|FG003|Overall Study|Disease progression|5|||
48598224|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48714659|NCT00095147|156804936|FG000|Long-term Extension Period|Withdrawal of consent|0|||
48714660|NCT00095147|156804937|FG001|Long-term Extension Period|Withdrawal of consent|0|||
48714661|NCT00095147|156804938|FG002|Long-term Extension Period|Withdrawal of consent|0|||
48714662|NCT00095147|156804939|FG003|Long-term Extension Period|Withdrawal of consent|0|||
48714663|NCT00095147|156804940|FG004|Long-term Extension Period|Withdrawal of consent|12|||
48714664|NCT00095147|156804936|FG000|Long-term Extension Period|Pregnancy|0|||
48714665|NCT00095147|156804937|FG001|Long-term Extension Period|Pregnancy|0|||
48714666|NCT00095147|156804938|FG002|Long-term Extension Period|Pregnancy|0|||
48714667|NCT00095147|156804939|FG003|Long-term Extension Period|Pregnancy|0|||
48714668|NCT00095147|156804940|FG004|Long-term Extension Period|Pregnancy|1|||
48714669|NCT00095147|156804936|FG000|Long-term Extension Period|No longer meets study criteria|0|||
48813202|NCT03285295|157157369|FG004|Alinity s Chagas|No Results Generated|0|||
48496323|NCT01621490|156012117|FG004|Overall Study|Disease progression|3|||
48496324|NCT01621490|156012118|FG005|Overall Study|Disease progression|8|||
48496325|NCT01621490|156012119|FG006|Overall Study|Disease progression|7|||
48496326|NCT01621490|156012120|FG007|Overall Study|Disease progression|1|||
48496327|NCT01621490|156012121|FG008|Overall Study|Disease progression|4|||
48496328|NCT01621490|156012122|FG009|Overall Study|Disease progression|1|||
48496329|NCT01621490|156012123|FG010|Overall Study|Disease progression|1|||
48496330|NCT01621490|156012113|FG000|Overall Study|Study drug toxicity|1|||
48496331|NCT01621490|156012114|FG001|Overall Study|Study drug toxicity|4|||
48496332|NCT01621490|156012115|FG002|Overall Study|Study drug toxicity|5|||
48496333|NCT01621490|156012116|FG003|Overall Study|Study drug toxicity|3|||
48496334|NCT01621490|156012117|FG004|Overall Study|Study drug toxicity|1|||
48496335|NCT01621490|156012118|FG005|Overall Study|Study drug toxicity|10|||
48496336|NCT01621490|156012119|FG006|Overall Study|Study drug toxicity|1|||
48496337|NCT01621490|156012120|FG007|Overall Study|Study drug toxicity|4|||
48496338|NCT01621490|156012121|FG008|Overall Study|Study drug toxicity|1|||
48714670|NCT00095147|156804937|FG001|Long-term Extension Period|No longer meets study criteria|0|||
48714671|NCT00095147|156804938|FG002|Long-term Extension Period|No longer meets study criteria|0|||
48714672|NCT00095147|156804939|FG003|Long-term Extension Period|No longer meets study criteria|0|||
48714673|NCT00095147|156804940|FG004|Long-term Extension Period|No longer meets study criteria|1|||
48714674|NCT00095147|156804936|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
48714675|NCT00095147|156804937|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
48714676|NCT00095147|156804938|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
48714677|NCT00095147|156804939|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
48714678|NCT00095147|156804940|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
48714679|NCT00095147|156804936|FG000|Long-term Extension Period|Leaving country|0|||
48714680|NCT00095147|156804937|FG001|Long-term Extension Period|Leaving country|0|||
48714681|NCT00095147|156804938|FG002|Long-term Extension Period|Leaving country|0|||
48714682|NCT00095147|156804939|FG003|Long-term Extension Period|Leaving country|0|||
48714683|NCT00095147|156804940|FG004|Long-term Extension Period|Leaving country|1|||
48714684|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
48714685|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
48714686|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
48813203|NCT03285295|157157365|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
48496339|NCT01621490|156012122|FG009|Overall Study|Study drug toxicity|0|||
48496340|NCT01621490|156012123|FG010|Overall Study|Study drug toxicity|0|||
48496341|NCT01621490|156012113|FG000|Overall Study|Death|0|||
48496342|NCT01621490|156012114|FG001|Overall Study|Death|0|||
48496343|NCT01621490|156012115|FG002|Overall Study|Death|0|||
48496344|NCT01621490|156012116|FG003|Overall Study|Death|0|||
48496345|NCT01621490|156012117|FG004|Overall Study|Death|0|||
48496346|NCT01621490|156012118|FG005|Overall Study|Death|0|||
48496347|NCT01621490|156012119|FG006|Overall Study|Death|0|||
48496348|NCT01621490|156012120|FG007|Overall Study|Death|0|||
48496349|NCT01621490|156012121|FG008|Overall Study|Death|1|||
48496350|NCT01621490|156012122|FG009|Overall Study|Death|0|||
48496351|NCT01621490|156012123|FG010|Overall Study|Death|0|||
48496352|NCT01621490|156012113|FG000|Overall Study|Other reasons|7|||
48496353|NCT01621490|156012114|FG001|Overall Study|Other reasons|6|||
48496354|NCT01621490|156012115|FG002|Overall Study|Other reasons|4|||
48496355|NCT01621490|156012116|FG003|Overall Study|Other reasons|1|||
48496356|NCT01621490|156012117|FG004|Overall Study|Other reasons|1|||
48496357|NCT01621490|156012118|FG005|Overall Study|Other reasons|3|||
48496358|NCT01621490|156012119|FG006|Overall Study|Other reasons|1|||
48496359|NCT01621490|156012120|FG007|Overall Study|Other reasons|1|||
48496360|NCT01621490|156012121|FG008|Overall Study|Other reasons|1|||
48496361|NCT01621490|156012122|FG009|Overall Study|Other reasons|0|||
48813204|NCT03285295|157157366|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
48813205|NCT03285295|157157367|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
48813206|NCT03285295|157157368|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
48813207|NCT03285295|157157369|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
48813208|NCT02746575|157157370|FG000|Overall Study|Surgery cancelled or time chaned|13|||
48496362|NCT01621490|156012123|FG010|Overall Study|Other reasons|0|||
48496363|NCT00506753|156012124|FG000|Overall Study|Lost to Follow-up|21|||
48598225|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48598226|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48496364|NCT00506753|156012125|FG001|Overall Study|Lost to Follow-up|15|||
48496365|NCT00125359|156012127|FG000|Overall Study|Death|4|||
48496366|NCT00125359|156012127|FG000|Overall Study|Adverse Event|5|||
48496367|NCT00125359|156012127|FG000|Overall Study|Physician Decision|14|||
48496368|NCT02224456|156012134|FG000|Overall Study|Lack of Efficacy|1|||
48598227|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48598228|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
48496369|NCT02224456|156012134|FG000|Overall Study|Lost to Follow-up|15|||
48496370|NCT02224456|156012134|FG000|Overall Study|Withdrawal by Subject|9|||
48496371|NCT02224456|156012134|FG000|Overall Study|Physician Decision|3|||
48813209|NCT02746575|157157370|FG000|Overall Study|Received epidural|10|||
48813210|NCT02746575|157157370|FG000|Overall Study|Withdrawal by Subject|3|||
48813211|NCT02746575|157157370|FG000|Overall Study|Bradycardia/hypotension|9|||
48714687|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
48496372|NCT02224456|156012134|FG000|Overall Study|Death|2|||
48496373|NCT02224456|156012134|FG000|Overall Study|Pregnancy|4|||
48496374|NCT02224456|156012134|FG000|Overall Study|Protocol Violation|1|||
48496375|NCT02224456|156012134|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
48496376|NCT00678392|156012135|FG000|Overall Study|Adverse Event|0|||
48496377|NCT00678392|156012136|FG001|Overall Study|Adverse Event|6|||
48496378|NCT00678392|156012135|FG000|Overall Study|Death|280|||
48496379|NCT00678392|156012136|FG001|Overall Study|Death|269|||
48496380|NCT00678392|156012135|FG000|Overall Study|Lost to Follow-up|15|||
48496381|NCT00678392|156012136|FG001|Overall Study|Lost to Follow-up|13|||
48496382|NCT00678392|156012135|FG000|Overall Study|Objective Progression or Relapse|3|||
48496383|NCT00678392|156012136|FG001|Overall Study|Objective Progression or Relapse|8|||
48496384|NCT00678392|156012135|FG000|Overall Study|Sponsor's Decision|1|||
48496385|NCT00678392|156012136|FG001|Overall Study|Sponsor's Decision|2|||
48496386|NCT00678392|156012135|FG000|Overall Study|Withdrawal by Subject|4|||
48598229|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48496387|NCT00678392|156012136|FG001|Overall Study|Withdrawal by Subject|4|||
48598230|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48598231|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48598232|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48598233|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48598234|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
48598235|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598236|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48714688|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
48714689|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
48714690|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
48714691|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
48714692|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
48714693|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
48714694|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
48714695|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
48714696|NCT01087788|156804941|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
48714697|NCT01087788|156804942|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
48714698|NCT01087788|156804943|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
48714699|NCT01087788|156804941|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
48714700|NCT01087788|156804942|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
48714701|NCT01087788|156804943|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
48714702|NCT01087788|156804941|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
48714703|NCT01087788|156804942|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
48714704|NCT01087788|156804943|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
48714705|NCT01087788|156804941|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
48714706|NCT01087788|156804942|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
48714707|NCT01087788|156804943|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
48714708|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
48714709|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
48496388|NCT00678392|156012135|FG000|Overall Study|Randomized But Not Treated|2|||
48598237|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598238|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598239|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598240|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
48598241|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
48598242|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
48598243|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
48598244|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598245|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598246|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598247|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598248|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48598249|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48714710|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
48714711|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
48714712|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
48714713|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
48714714|NCT01087788|156804941|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
48714715|NCT01087788|156804942|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
48714716|NCT01087788|156804943|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
48714717|NCT01087788|156804941|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
48714718|NCT01087788|156804942|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
48714719|NCT01087788|156804943|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
48714720|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
48714721|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
48714722|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
48714723|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
48813212|NCT02746575|157157370|FG000|Overall Study|Study paused|8|||
48813213|NCT02746575|157157370|FG000|Overall Study|put on beta-blocker|3|||
48813214|NCT02746575|157157370|FG000|Overall Study|type of surgery|1|||
48813215|NCT02746575|157157370|FG000|Overall Study|typ of surgery|1|||
48813216|NCT02746575|157157370|FG000|Overall Study|PI unavailable|1|||
48813217|NCT02746575|157157370|FG000|Overall Study|Unknown history of CVA|1|||
48813218|NCT02762981|157157375|FG000|Overall Study|Adverse Event|2|||
48813219|NCT02762981|157157376|FG001|Overall Study|Adverse Event|3|||
48714724|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
48714725|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
48714726|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
48714727|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
48714728|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
48714729|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
48714730|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
48714731|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
48714732|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
48714733|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
48813220|NCT02762981|157157377|FG002|Overall Study|Adverse Event|1|||
48813221|NCT02762981|157157378|FG003|Overall Study|Adverse Event|1|||
48813222|NCT02762981|157157379|FG004|Overall Study|Adverse Event|3|||
48813223|NCT02762981|157157375|FG000|Overall Study|Physician Decision|0|||
48813224|NCT02762981|157157376|FG001|Overall Study|Physician Decision|1|||
48813225|NCT02762981|157157377|FG002|Overall Study|Physician Decision|0|||
48813226|NCT02762981|157157378|FG003|Overall Study|Physician Decision|0|||
48813227|NCT02762981|157157379|FG004|Overall Study|Physician Decision|1|||
48813228|NCT02762981|157157375|FG000|Overall Study|Disease progression|11|||
48813229|NCT02762981|157157376|FG001|Overall Study|Disease progression|23|||
48813230|NCT02762981|157157377|FG002|Overall Study|Disease progression|4|||
48496389|NCT00678392|156012136|FG001|Overall Study|Randomized But Not Treated|7|||
48496390|NCT00678392|156012135|FG000|Overall Study|Other|56|||
48496391|NCT00678392|156012136|FG001|Overall Study|Other|53|||
48496392|NCT01958281|156012139|FG000|Overall Study|Lack of Efficacy|5|||
48496393|NCT01958281|156012140|FG001|Overall Study|Lack of Efficacy|2|||
48496394|NCT01958281|156012141|FG002|Overall Study|Lack of Efficacy|0|||
48496395|NCT01958281|156012139|FG000|Overall Study|Adverse Event|0|||
48496396|NCT01958281|156012140|FG001|Overall Study|Adverse Event|2|||
48496397|NCT01958281|156012141|FG002|Overall Study|Adverse Event|0|||
48496398|NCT01958281|156012139|FG000|Overall Study|Withdrew Consent|1|||
48496399|NCT01958281|156012140|FG001|Overall Study|Withdrew Consent|0|||
48496400|NCT01958281|156012141|FG002|Overall Study|Withdrew Consent|0|||
48496401|NCT04635423|156012142|FG000|Overall Study|Ongoing|493|||
48496402|NCT04635423|156012143|FG001|Overall Study|Ongoing|501|||
48496403|NCT04635423|156012142|FG000|Overall Study|Withdrawal by Subject|36|||
48714734|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
48714735|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
48714736|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
48714737|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
48714738|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
48496404|NCT04635423|156012143|FG001|Overall Study|Withdrawal by Subject|29|||
48496405|NCT02784106|156012144|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
48496406|NCT02784106|156012145|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
48496407|NCT02784106|156012146|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48714739|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
48714740|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
48714741|NCT01087788|156804941|FG000|24-weeks Dose-blind Period|Patient moved|0|||
48714742|NCT01087788|156804942|FG001|24-weeks Dose-blind Period|Patient moved|0|||
48714743|NCT01087788|156804943|FG002|24-weeks Dose-blind Period|Patient moved|1|||
48714744|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
48714745|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
48714746|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
48714747|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
48714748|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
48714749|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
48714750|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
48714751|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
48714752|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
48714753|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
48714754|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
48714755|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
48714756|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
48714757|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
48714758|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
48714759|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
48714760|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
48714761|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
48714762|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
48714763|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
48714764|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
48714765|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
48714766|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
48714767|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
48714768|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
48714769|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
48714770|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
48714771|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
48714772|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
48714773|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
48714774|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
48714775|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
48714776|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
48714777|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
48714778|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
48714779|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
48714780|NCT01087788|156804941|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
48714781|NCT01087788|156804942|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
48714782|NCT01087788|156804943|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
48714783|NCT00934843|156804944|FG000|Overall Study|Protocol Violation|0|||
48714784|NCT00934843|156804945|FG001|Overall Study|Protocol Violation|1|||
48714785|NCT00160667|156804946|FG000|Overall Study|Adverse Event|3|||
48714786|NCT00160667|156804947|FG001|Overall Study|Adverse Event|1|||
48714787|NCT00160667|156804948|FG002|Overall Study|Adverse Event|4|||
48714788|NCT00160667|156804946|FG000|Overall Study|Withdrawal by Subject|2|||
48714789|NCT00160667|156804947|FG001|Overall Study|Withdrawal by Subject|0|||
48714790|NCT00160667|156804948|FG002|Overall Study|Withdrawal by Subject|1|||
48714791|NCT00160667|156804946|FG000|Overall Study|Lack of Efficacy|0|||
48714792|NCT00160667|156804947|FG001|Overall Study|Lack of Efficacy|1|||
48714793|NCT00160667|156804948|FG002|Overall Study|Lack of Efficacy|0|||
48714794|NCT00160667|156804946|FG000|Overall Study|Protocol Violation|0|||
48714795|NCT00160667|156804947|FG001|Overall Study|Protocol Violation|1|||
48714796|NCT00160667|156804948|FG002|Overall Study|Protocol Violation|0|||
48714797|NCT00160667|156804946|FG000|Overall Study|Patient decision|0|||
48714798|NCT00160667|156804947|FG001|Overall Study|Patient decision|0|||
48714799|NCT00160667|156804948|FG002|Overall Study|Patient decision|1|||
48714800|NCT01144299|156804951|FG000|Overall Study|Lost to Follow-up|1|||
48714801|NCT01144299|156804952|FG001|Overall Study|Lost to Follow-up|0|||
48714802|NCT01144299|156804951|FG000|Overall Study|Withdrawal by Subject|1|||
48714803|NCT01144299|156804952|FG001|Overall Study|Withdrawal by Subject|0|||
48714804|NCT03041129|156804956|FG000|Overall Study|Withdrawal by Subject|2|||
48714805|NCT03041129|156804957|FG001|Overall Study|Withdrawal by Subject|0|||
48714806|NCT03041129|156804958|FG002|Overall Study|Withdrawal by Subject|0|||
48714807|NCT03041129|156804959|FG003|Overall Study|Withdrawal by Subject|0|||
48714808|NCT01947855|156804960|FG000|Overall Study|Withdrawal by Subject|1|||
48714809|NCT01947855|156804961|FG001|Overall Study|Withdrawal by Subject|0|||
48714810|NCT01947855|156804962|FG002|Overall Study|Withdrawal by Subject|0|||
48714811|NCT02282293|156804963|FG000|Overall Study|Lost to Follow-up|2|||
48714812|NCT02282293|156804964|FG001|Overall Study|Lost to Follow-up|2|||
48714813|NCT02282293|156804963|FG000|Overall Study|Unable to comply with study procedures|1|||
48714814|NCT02282293|156804964|FG001|Overall Study|Unable to comply with study procedures|0|||
48714815|NCT02282293|156804963|FG000|Overall Study|Moved out of study area|0|||
48714816|NCT02282293|156804964|FG001|Overall Study|Moved out of study area|1|||
48714817|NCT03720652|156804965|FG000|Overall Study|Withdrawal by Subject|2|||
48714818|NCT03720652|156804966|FG001|Overall Study|Withdrawal by Subject|7|||
48714819|NCT03720652|156804965|FG000|Overall Study|Lost to Follow-up|0|||
48714820|NCT03720652|156804966|FG001|Overall Study|Lost to Follow-up|4|||
48714821|NCT01395524|156806515|FG000|Overall Study|Non-compliance with study schedule|1|||
48714822|NCT01395524|156806516|FG001|Overall Study|Non-compliance with study schedule|0|||
48714823|NCT01395524|156806517|FG002|Overall Study|Non-compliance with study schedule|1|||
48714824|NCT01395524|156806515|FG000|Overall Study|Lost to Follow-up|3|||
48714825|NCT01395524|156806516|FG001|Overall Study|Lost to Follow-up|1|||
48714826|NCT01395524|156806517|FG002|Overall Study|Lost to Follow-up|1|||
48714827|NCT01395524|156806515|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
48714828|NCT01395524|156806516|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
48714829|NCT01395524|156806517|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
48714830|NCT01395524|156806515|FG000|Overall Study|Severe noncompliance with protocol|1|||
48714831|NCT01395524|156806516|FG001|Overall Study|Severe noncompliance with protocol|0|||
48714832|NCT01395524|156806517|FG002|Overall Study|Severe noncompliance with protocol|0|||
48813231|NCT02762981|157157378|FG003|Overall Study|Disease progression|10|||
48813232|NCT02762981|157157379|FG004|Overall Study|Disease progression|1|||
48813233|NCT02762981|157157375|FG000|Overall Study|Enrolled not treated|1|||
48813234|NCT02762981|157157376|FG001|Overall Study|Enrolled not treated|5|||
48813235|NCT02762981|157157377|FG002|Overall Study|Enrolled not treated|0|||
48813236|NCT02762981|157157378|FG003|Overall Study|Enrolled not treated|2|||
48813237|NCT02762981|157157379|FG004|Overall Study|Enrolled not treated|0|||
48813238|NCT02762981|157157375|FG000|Overall Study|Other|2|||
48813239|NCT02762981|157157376|FG001|Overall Study|Other|3|||
48813240|NCT02762981|157157377|FG002|Overall Study|Other|1|||
48813241|NCT02762981|157157378|FG003|Overall Study|Other|0|||
48813242|NCT02762981|157157379|FG004|Overall Study|Other|0|||
48813243|NCT02762981|157157375|FG000|Overall Study|Missing|1|||
48813244|NCT02762981|157157376|FG001|Overall Study|Missing|0|||
48813245|NCT02762981|157157377|FG002|Overall Study|Missing|0|||
48813246|NCT02762981|157157378|FG003|Overall Study|Missing|0|||
48813247|NCT02762981|157157379|FG004|Overall Study|Missing|0|||
48813248|NCT02762981|157157375|FG000|Overall Study|Withdrawal by Subject|0|||
48813249|NCT02762981|157157376|FG001|Overall Study|Withdrawal by Subject|5|||
48813250|NCT02762981|157157377|FG002|Overall Study|Withdrawal by Subject|1|||
48813251|NCT02762981|157157378|FG003|Overall Study|Withdrawal by Subject|3|||
48813252|NCT02762981|157157379|FG004|Overall Study|Withdrawal by Subject|0|||
48813253|NCT01382940|157157382|FG000|Overall Study|Adverse Event|19|||
48714833|NCT01395524|156806515|FG000|Overall Study|Adverse Event|4|||
48714834|NCT01395524|156806516|FG001|Overall Study|Adverse Event|4|||
48714835|NCT01395524|156806517|FG002|Overall Study|Adverse Event|3|||
48714836|NCT01395524|156806515|FG000|Overall Study|Death|1|||
48714837|NCT01395524|156806516|FG001|Overall Study|Death|0|||
48714838|NCT01395524|156806517|FG002|Overall Study|Death|0|||
48714839|NCT01395524|156806515|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
48714840|NCT01395524|156806516|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48714841|NCT01395524|156806517|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48714842|NCT01395524|156806515|FG000|Overall Study|Withdrawal by Subject|4|||
48714843|NCT01395524|156806516|FG001|Overall Study|Withdrawal by Subject|8|||
48714844|NCT01395524|156806517|FG002|Overall Study|Withdrawal by Subject|8|||
48714845|NCT01395524|156806515|FG000|Overall Study|Did not receive treatment|1|||
48714846|NCT01395524|156806516|FG001|Overall Study|Did not receive treatment|1|||
48714847|NCT01395524|156806517|FG002|Overall Study|Did not receive treatment|3|||
48813254|NCT01382940|157157382|FG000|Overall Study|Lost to Follow-up|4|||
48813255|NCT01382940|157157382|FG000|Overall Study|Physician Decision|7|||
48813256|NCT01382940|157157382|FG000|Overall Study|Withdrawal by Subject|23|||
48813257|NCT01382940|157157382|FG000|Overall Study|Protocol Violation|20|||
48813258|NCT01242176|157157383|FG000|Washout Period of 7 Days|Adverse Event|0|||
48813259|NCT01242176|157157384|FG001|Washout Period of 7 Days|Adverse Event|2|||
48813260|NCT01242176|157157383|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
48496408|NCT02784106|156012147|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48496409|NCT02784106|156012144|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
48496410|NCT02784106|156012145|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
48496411|NCT02784106|156012146|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48496412|NCT02784106|156012147|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48496413|NCT02784106|156012144|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
48496414|NCT02784106|156012145|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
48496415|NCT02784106|156012146|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
48496416|NCT02784106|156012147|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
48496417|NCT02784106|156012144|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
48496418|NCT02784106|156012145|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
48496419|NCT02784106|156012146|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
48496420|NCT02784106|156012147|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
48496421|NCT02784106|156012144|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
48496422|NCT02784106|156012145|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
48496423|NCT02784106|156012146|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
48496424|NCT02784106|156012147|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
48496425|NCT02784106|156012144|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
48496426|NCT02784106|156012145|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
48496427|NCT02784106|156012146|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
48496428|NCT02784106|156012147|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
48496429|NCT03341507|156012148|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
48598250|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48714848|NCT01395524|156806515|FG000|Overall Study|Subject had spinal surgery|0|||
48714849|NCT01395524|156806516|FG001|Overall Study|Subject had spinal surgery|0|||
48714850|NCT01395524|156806517|FG002|Overall Study|Subject had spinal surgery|1|||
48714851|NCT01596062|156806518|FG000|Overall Study|Adverse Event|1|||
48714852|NCT01596062|156806519|FG001|Overall Study|Adverse Event|0|||
48714853|NCT01596062|156806520|FG002|Overall Study|Adverse Event|2|||
48714854|NCT01596062|156806518|FG000|Overall Study|Lack of Efficacy|0|||
48714855|NCT01596062|156806519|FG001|Overall Study|Lack of Efficacy|0|||
48714856|NCT01596062|156806520|FG002|Overall Study|Lack of Efficacy|1|||
48714857|NCT03137069|156806523|FG000|Overall Study|Withdrawal by Subject|1|||
48714858|NCT03137069|156806524|FG001|Overall Study|Withdrawal by Subject|2|||
48714859|NCT03137069|156806525|FG002|Overall Study|Withdrawal by Subject|2|||
48714860|NCT03137069|156806526|FG003|Overall Study|Withdrawal by Subject|2|||
48714861|NCT03137069|156806527|FG004|Overall Study|Withdrawal by Subject|0|||
48714862|NCT03137069|156806528|FG005|Overall Study|Withdrawal by Subject|0|||
48714863|NCT03137069|156806523|FG000|Overall Study|Adverse Event|0|||
48714864|NCT03137069|156806524|FG001|Overall Study|Adverse Event|3|||
48714865|NCT03137069|156806525|FG002|Overall Study|Adverse Event|1|||
48714866|NCT03137069|156806526|FG003|Overall Study|Adverse Event|1|||
48714867|NCT03137069|156806527|FG004|Overall Study|Adverse Event|0|||
48714868|NCT03137069|156806528|FG005|Overall Study|Adverse Event|1|||
48714869|NCT03137069|156806523|FG000|Overall Study|Protocol Violation|0|||
48714870|NCT03137069|156806524|FG001|Overall Study|Protocol Violation|1|||
48714871|NCT03137069|156806525|FG002|Overall Study|Protocol Violation|0|||
48714872|NCT03137069|156806526|FG003|Overall Study|Protocol Violation|1|||
48714873|NCT03137069|156806527|FG004|Overall Study|Protocol Violation|1|||
48714874|NCT03137069|156806528|FG005|Overall Study|Protocol Violation|1|||
48714875|NCT03137069|156806523|FG000|Overall Study|Physician Decision|0|||
48714876|NCT03137069|156806524|FG001|Overall Study|Physician Decision|0|||
48714877|NCT03137069|156806525|FG002|Overall Study|Physician Decision|0|||
48714878|NCT03137069|156806526|FG003|Overall Study|Physician Decision|1|||
48714879|NCT03137069|156806527|FG004|Overall Study|Physician Decision|0|||
48714880|NCT03137069|156806528|FG005|Overall Study|Physician Decision|0|||
48714881|NCT03137069|156806523|FG000|Overall Study|Study Terminated by Sponsor|0|||
48714882|NCT03137069|156806524|FG001|Overall Study|Study Terminated by Sponsor|0|||
48714883|NCT03137069|156806525|FG002|Overall Study|Study Terminated by Sponsor|0|||
48714884|NCT03137069|156806526|FG003|Overall Study|Study Terminated by Sponsor|0|||
48714885|NCT03137069|156806527|FG004|Overall Study|Study Terminated by Sponsor|1|||
48714886|NCT03137069|156806528|FG005|Overall Study|Study Terminated by Sponsor|0|||
48714887|NCT03137069|156806523|FG000|Overall Study|Data Entry Error|0|||
48714888|NCT03137069|156806524|FG001|Overall Study|Data Entry Error|0|||
48714889|NCT03137069|156806525|FG002|Overall Study|Data Entry Error|0|||
48714890|NCT03137069|156806526|FG003|Overall Study|Data Entry Error|1|||
48714891|NCT03137069|156806527|FG004|Overall Study|Data Entry Error|0|||
48714892|NCT03137069|156806528|FG005|Overall Study|Data Entry Error|0|||
48714893|NCT00943072|156806533|FG000|Overall Study|Adverse Event|0|||
48714894|NCT00943072|156806534|FG001|Overall Study|Adverse Event|3|||
48714895|NCT00943072|156806533|FG000|Overall Study|Death|0|||
48714896|NCT00943072|156806534|FG001|Overall Study|Death|2|||
48813261|NCT01242176|157157384|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
48813262|NCT00976482|157157388|FG000|Overall Study|Death|208|||
48813263|NCT00976482|157157388|FG000|Overall Study|Withdrawal by Subject|45|||
48813264|NCT00976482|157157388|FG000|Overall Study|Center terminated|1|||
48813265|NCT00976482|157157388|FG000|Overall Study|Protocol Violation|5|||
48813266|NCT03548064|157157389|FG000|Overall Study|Withdrawal by Subject|0|||
48813267|NCT03548064|157157390|FG001|Overall Study|Withdrawal by Subject|0|||
48813268|NCT03548064|157157391|FG002|Overall Study|Withdrawal by Subject|0|||
48813269|NCT03548064|157157392|FG003|Overall Study|Withdrawal by Subject|1|||
48813270|NCT03548064|157157393|FG004|Overall Study|Withdrawal by Subject|0|||
48813271|NCT03548064|157157394|FG005|Overall Study|Withdrawal by Subject|0|||
48813272|NCT03548064|157157395|FG006|Overall Study|Withdrawal by Subject|0|||
48813273|NCT03548064|157157396|FG007|Overall Study|Withdrawal by Subject|0|||
48813274|NCT03548064|157157389|FG000|Overall Study|Lost to Follow-up|0|||
48813275|NCT03548064|157157390|FG001|Overall Study|Lost to Follow-up|0|||
48813276|NCT03548064|157157391|FG002|Overall Study|Lost to Follow-up|0|||
48813277|NCT03548064|157157392|FG003|Overall Study|Lost to Follow-up|0|||
48813278|NCT03548064|157157393|FG004|Overall Study|Lost to Follow-up|2|||
48813279|NCT03548064|157157394|FG005|Overall Study|Lost to Follow-up|0|||
48813280|NCT03548064|157157395|FG006|Overall Study|Lost to Follow-up|0|||
48813281|NCT03548064|157157396|FG007|Overall Study|Lost to Follow-up|0|||
48813282|NCT03548064|157157389|FG000|Overall Study|Covid-19 Pandemic|0|||
48813283|NCT03548064|157157390|FG001|Overall Study|Covid-19 Pandemic|0|||
48813284|NCT03548064|157157391|FG002|Overall Study|Covid-19 Pandemic|0|||
48813285|NCT03548064|157157392|FG003|Overall Study|Covid-19 Pandemic|0|||
48813286|NCT03548064|157157393|FG004|Overall Study|Covid-19 Pandemic|10|||
48813287|NCT03548064|157157394|FG005|Overall Study|Covid-19 Pandemic|3|||
48813288|NCT03548064|157157395|FG006|Overall Study|Covid-19 Pandemic|0|||
48813289|NCT03548064|157157396|FG007|Overall Study|Covid-19 Pandemic|0|||
48813290|NCT04867785|157157397|FG000|Overall Study|Adverse Event|1|||
48813291|NCT04867785|157157398|FG001|Overall Study|Adverse Event|0|||
48813292|NCT04867785|157157399|FG002|Overall Study|Adverse Event|1|||
48813293|NCT04867785|157157400|FG003|Overall Study|Adverse Event|0|||
48813294|NCT04867785|157157401|FG004|Overall Study|Adverse Event|0|||
48813295|NCT04867785|157157402|FG005|Overall Study|Adverse Event|0|||
48813296|NCT04867785|157157403|FG006|Overall Study|Adverse Event|0|||
48813297|NCT04867785|157157404|FG007|Overall Study|Adverse Event|2|||
48813298|NCT04867785|157157397|FG000|Overall Study|Lost to Follow-up|4|||
48813299|NCT04867785|157157398|FG001|Overall Study|Lost to Follow-up|4|||
48813300|NCT04867785|157157399|FG002|Overall Study|Lost to Follow-up|3|||
48813301|NCT04867785|157157400|FG003|Overall Study|Lost to Follow-up|2|||
48813302|NCT04867785|157157401|FG004|Overall Study|Lost to Follow-up|0|||
48813303|NCT04867785|157157402|FG005|Overall Study|Lost to Follow-up|1|||
48813304|NCT04867785|157157403|FG006|Overall Study|Lost to Follow-up|0|||
48813305|NCT04867785|157157404|FG007|Overall Study|Lost to Follow-up|1|||
48496430|NCT00135707|156012149|FG000|Overall Study|Lost to Follow-up|94|||
48714897|NCT00943072|156806533|FG000|Overall Study|Withdrawal by Subject|3|||
48714898|NCT00943072|156806534|FG001|Overall Study|Withdrawal by Subject|1|||
48714899|NCT00943072|156806533|FG000|Overall Study|Protocol Violation|0|||
48714900|NCT00943072|156806534|FG001|Overall Study|Protocol Violation|1|||
48714901|NCT00943072|156806533|FG000|Overall Study|Lost to Follow-up|1|||
48714902|NCT00943072|156806534|FG001|Overall Study|Lost to Follow-up|2|||
48714903|NCT00943072|156806533|FG000|Overall Study|Lack of Efficacy|0|||
48714904|NCT00943072|156806534|FG001|Overall Study|Lack of Efficacy|4|||
48714905|NCT00943072|156806533|FG000|Overall Study|Other|1|||
48714906|NCT00943072|156806534|FG001|Overall Study|Other|1|||
48714907|NCT01349049|156806535|FG000|Overall Study|Disease progression|3|||
48714908|NCT01349049|156806536|FG001|Overall Study|Disease progression|5|||
48714909|NCT01349049|156806537|FG002|Overall Study|Disease progression|3|||
48714910|NCT01349049|156806538|FG003|Overall Study|Disease progression|2|||
48714911|NCT01349049|156806539|FG004|Overall Study|Disease progression|2|||
48714912|NCT01349049|156806540|FG005|Overall Study|Disease progression|2|||
48813306|NCT04867785|157157397|FG000|Overall Study|Withdrawal by Subject|6|||
48813307|NCT04867785|157157398|FG001|Overall Study|Withdrawal by Subject|2|||
48813308|NCT04867785|157157399|FG002|Overall Study|Withdrawal by Subject|2|||
48813309|NCT04867785|157157400|FG003|Overall Study|Withdrawal by Subject|1|||
48714913|NCT01349049|156806541|FG006|Overall Study|Disease progression|3|||
48714914|NCT01349049|156806542|FG007|Overall Study|Disease progression|2|||
48813310|NCT04867785|157157401|FG004|Overall Study|Withdrawal by Subject|2|||
48813311|NCT04867785|157157402|FG005|Overall Study|Withdrawal by Subject|0|||
48813312|NCT04867785|157157403|FG006|Overall Study|Withdrawal by Subject|2|||
48813313|NCT04867785|157157404|FG007|Overall Study|Withdrawal by Subject|5|||
48813314|NCT04867785|157157397|FG000|Overall Study|Physician Decision|0|||
48813315|NCT04867785|157157398|FG001|Overall Study|Physician Decision|0|||
48813316|NCT04867785|157157399|FG002|Overall Study|Physician Decision|0|||
48813317|NCT04867785|157157400|FG003|Overall Study|Physician Decision|0|||
48714915|NCT01349049|156806543|FG008|Overall Study|Disease progression|33|||
48813318|NCT04867785|157157401|FG004|Overall Study|Physician Decision|0|||
48813319|NCT04867785|157157402|FG005|Overall Study|Physician Decision|0|||
48813320|NCT04867785|157157403|FG006|Overall Study|Physician Decision|0|||
48496431|NCT00135707|156012150|FG001|Overall Study|Lost to Follow-up|89|||
48496432|NCT00135707|156012149|FG000|Overall Study|Withdrawal by Subject|0|||
48496433|NCT00135707|156012150|FG001|Overall Study|Withdrawal by Subject|1|||
48496434|NCT00135707|156012149|FG000|Overall Study|Institutional review board request|1|||
48496435|NCT00135707|156012150|FG001|Overall Study|Institutional review board request|0|||
48496436|NCT03093454|156012154|FG000|Overall Study|Withdrawal by Subject|1|||
48496437|NCT03093454|156012155|FG001|Overall Study|Withdrawal by Subject|1|||
48496438|NCT03093454|156012154|FG000|Overall Study|Scheduling conflict|3|||
48496439|NCT03093454|156012155|FG001|Overall Study|Scheduling conflict|1|||
48496440|NCT03093454|156012154|FG000|Overall Study|Physician Decision|2|||
48496441|NCT03093454|156012155|FG001|Overall Study|Physician Decision|1|||
48496442|NCT00421174|156012158|FG000|Overall Study|Withdrawal by Subject|0|||
48496443|NCT00421174|156012159|FG001|Overall Study|Withdrawal by Subject|1|||
48496444|NCT00421174|156012158|FG000|Overall Study|Ineligible due to infection|2|||
48496445|NCT00421174|156012159|FG001|Overall Study|Ineligible due to infection|0|||
48496446|NCT01829464|156012160|FG000|Overall Study|Adverse Event|1|||
48496447|NCT01829464|156012161|FG001|Overall Study|Adverse Event|0|||
48496448|NCT01829464|156012162|FG002|Overall Study|Adverse Event|0|||
48496449|NCT01829464|156012160|FG000|Overall Study|Lost to Follow-up|0|||
48496450|NCT01829464|156012161|FG001|Overall Study|Lost to Follow-up|0|||
48496451|NCT01829464|156012162|FG002|Overall Study|Lost to Follow-up|1|||
48496452|NCT01829464|156012160|FG000|Overall Study|Withdrawal by Subject|2|||
48496453|NCT01829464|156012161|FG001|Overall Study|Withdrawal by Subject|0|||
48496454|NCT01829464|156012162|FG002|Overall Study|Withdrawal by Subject|0|||
48496455|NCT01829464|156012160|FG000|Overall Study|Study terminated by sponsor|25|||
48496456|NCT01829464|156012161|FG001|Overall Study|Study terminated by sponsor|28|||
48496457|NCT01829464|156012162|FG002|Overall Study|Study terminated by sponsor|25|||
48496458|NCT01829464|156012160|FG000|Overall Study|Lack of Efficacy|0|||
48496459|NCT01829464|156012161|FG001|Overall Study|Lack of Efficacy|1|||
48496460|NCT01829464|156012162|FG002|Overall Study|Lack of Efficacy|0|||
48496461|NCT00992407|156012167|FG000|Overall Study|Protocol Violation|2|||
48496462|NCT00992407|156012168|FG001|Overall Study|Protocol Violation|1|||
48496463|NCT00992407|156012167|FG000|Overall Study|Lost to Follow-up|3|||
48496464|NCT00992407|156012168|FG001|Overall Study|Lost to Follow-up|3|||
48496465|NCT00992407|156012167|FG000|Overall Study|Adverse Event|3|||
48496466|NCT00992407|156012168|FG001|Overall Study|Adverse Event|2|||
48496467|NCT00992407|156012167|FG000|Overall Study|protocol Violation & Adverse events|2|||
48496468|NCT00992407|156012168|FG001|Overall Study|protocol Violation & Adverse events|4|||
48496469|NCT00992407|156012167|FG000|Overall Study|Other|2|||
48496470|NCT00992407|156012168|FG001|Overall Study|Other|0|||
48496471|NCT00992407|156012167|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
48496472|NCT00992407|156012168|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
48496473|NCT00992407|156012167|FG000|Overall Study|Study medication not administered|17|||
48496474|NCT00992407|156012168|FG001|Overall Study|Study medication not administered|13|||
48496475|NCT00989261|156012173|FG000|Overall Study|Still in follow up|12|||
48496476|NCT00989261|156012174|FG001|Overall Study|Still in follow up|21|||
48496477|NCT00989261|156012173|FG000|Overall Study|Withdrawal by Subject|0|||
48496478|NCT00989261|156012174|FG001|Overall Study|Withdrawal by Subject|1|||
48496479|NCT00989261|156012173|FG000|Overall Study|Lost to Follow-up|3|||
48496480|NCT00989261|156012174|FG001|Overall Study|Lost to Follow-up|0|||
48496481|NCT01521559|156012177|FG000|Overall Study|Adverse Event|0|||
48496482|NCT01521559|156012178|FG001|Overall Study|Adverse Event|4|||
48496483|NCT01521559|156012177|FG000|Overall Study|Death|1|||
48496484|NCT01521559|156012178|FG001|Overall Study|Death|0|||
48496485|NCT01521559|156012177|FG000|Overall Study|Withdrawal by Subject|9|||
48496486|NCT01521559|156012178|FG001|Overall Study|Withdrawal by Subject|11|||
48496487|NCT01521559|156012177|FG000|Overall Study|Lost to Follow-up|3|||
48496488|NCT01521559|156012178|FG001|Overall Study|Lost to Follow-up|1|||
48496489|NCT01521559|156012177|FG000|Overall Study|Protocol Violation|1|||
48813321|NCT04867785|157157404|FG007|Overall Study|Physician Decision|1|||
48813322|NCT04867785|157157397|FG000|Overall Study|Inadvertent Enrollment|0|||
48813323|NCT04867785|157157398|FG001|Overall Study|Inadvertent Enrollment|0|||
48813324|NCT04867785|157157399|FG002|Overall Study|Inadvertent Enrollment|0|||
48813325|NCT04867785|157157400|FG003|Overall Study|Inadvertent Enrollment|1|||
48813326|NCT04867785|157157401|FG004|Overall Study|Inadvertent Enrollment|1|||
48813327|NCT04867785|157157402|FG005|Overall Study|Inadvertent Enrollment|0|||
48813328|NCT04867785|157157403|FG006|Overall Study|Inadvertent Enrollment|0|||
48813329|NCT04867785|157157404|FG007|Overall Study|Inadvertent Enrollment|1|||
48813330|NCT04867785|157157397|FG000|Overall Study|Eligibility Criteria Not Met|0|||
48496490|NCT01521559|156012178|FG001|Overall Study|Protocol Violation|0|||
48496491|NCT01521559|156012177|FG000|Overall Study|Other|1|||
48496492|NCT01521559|156012178|FG001|Overall Study|Other|2|||
48813331|NCT04867785|157157398|FG001|Overall Study|Eligibility Criteria Not Met|0|||
48813332|NCT04867785|157157399|FG002|Overall Study|Eligibility Criteria Not Met|0|||
48496493|NCT02336737|156012179|FG000|Overall Study|Withdrawal by Subject|5|||
48496494|NCT02336737|156012179|FG000|Overall Study|Physician Decision|8|||
48496495|NCT00810368|156012182|FG000|Overall Study|Lost to Follow-up|4|||
48496496|NCT00810368|156012183|FG001|Overall Study|Lost to Follow-up|2|||
48496497|NCT00810368|156012182|FG000|Overall Study|Lack of Efficacy|2|||
48496498|NCT00810368|156012183|FG001|Overall Study|Lack of Efficacy|0|||
48496499|NCT03305055|156012184|FG000|Overall Study|Withdrawal by Subject|0|||
48496500|NCT03305055|156012185|FG001|Overall Study|Withdrawal by Subject|1|||
48496501|NCT03305055|156012184|FG000|Overall Study|Adverse Event|1|||
48496502|NCT03305055|156012185|FG001|Overall Study|Adverse Event|1|||
48496503|NCT00084084|156012186|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
48496504|NCT00084084|156012186|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
48496505|NCT00266409|156012187|FG000|Overall Study|Lack of Efficacy|2|||
48496506|NCT00266409|156012188|FG001|Overall Study|Lack of Efficacy|6|||
48496507|NCT00266409|156012189|FG002|Overall Study|Lack of Efficacy|1|||
48496508|NCT00266409|156012190|FG003|Overall Study|Lack of Efficacy|2|||
48496509|NCT00266409|156012187|FG000|Overall Study|Adverse Event|7|||
48496510|NCT00266409|156012188|FG001|Overall Study|Adverse Event|2|||
48496511|NCT00266409|156012189|FG002|Overall Study|Adverse Event|1|||
48496512|NCT00266409|156012190|FG003|Overall Study|Adverse Event|1|||
48496513|NCT00266409|156012187|FG000|Overall Study|Lost to Follow-up|18|||
48496514|NCT00266409|156012188|FG001|Overall Study|Lost to Follow-up|21|||
48496515|NCT00266409|156012189|FG002|Overall Study|Lost to Follow-up|6|||
48496516|NCT00266409|156012190|FG003|Overall Study|Lost to Follow-up|8|||
48496517|NCT00266409|156012187|FG000|Overall Study|Withdrawal by Subject|6|||
48496518|NCT00266409|156012188|FG001|Overall Study|Withdrawal by Subject|10|||
48496519|NCT00266409|156012189|FG002|Overall Study|Withdrawal by Subject|3|||
48496520|NCT00266409|156012190|FG003|Overall Study|Withdrawal by Subject|9|||
48496521|NCT00266409|156012187|FG000|Overall Study|Protocol Violation|5|||
48496522|NCT00266409|156012188|FG001|Overall Study|Protocol Violation|3|||
48496523|NCT00266409|156012189|FG002|Overall Study|Protocol Violation|4|||
48496524|NCT00266409|156012190|FG003|Overall Study|Protocol Violation|2|||
48496525|NCT00266409|156012187|FG000|Overall Study|Other|7|||
48496526|NCT00266409|156012188|FG001|Overall Study|Other|4|||
48496527|NCT00266409|156012189|FG002|Overall Study|Other|2|||
48496528|NCT00266409|156012190|FG003|Overall Study|Other|0|||
48496529|NCT00712010|156012193|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
48496530|NCT02162758|156012194|FG000|Overall Study|Study termination|0|||
48496531|NCT02162758|156012195|FG001|Overall Study|Study termination|1|||
48496532|NCT04471935|156012196|FG000|Overall Study|Withdrawal by Subject|1|||
48496533|NCT04471935|156012196|FG000|Overall Study|Deemed ineligible to participate|1|||
48496534|NCT02116803|156012199|FG000|Overall Study|Adverse Event|2|||
48496535|NCT02116803|156012200|FG001|Overall Study|Adverse Event|1|||
48496536|NCT02116803|156012199|FG000|Overall Study|Physician Decision|1|||
48496537|NCT02116803|156012200|FG001|Overall Study|Physician Decision|0|||
48496538|NCT02116803|156012199|FG000|Overall Study|Progressive disease|4|||
48496539|NCT02116803|156012200|FG001|Overall Study|Progressive disease|0|||
48496540|NCT02116803|156012199|FG000|Overall Study|Study terminated by sponsor|2|||
48496541|NCT02116803|156012200|FG001|Overall Study|Study terminated by sponsor|1|||
48496542|NCT02116803|156012199|FG000|Overall Study|Death|1|||
48496543|NCT02116803|156012200|FG001|Overall Study|Death|0|||
48496544|NCT01766921|156012203|FG000|Overall Study|Administrative Reason|5|||
48496545|NCT01766921|156012204|FG001|Overall Study|Administrative Reason|5|||
48496546|NCT01766921|156012203|FG000|Overall Study|Death|1|||
48496547|NCT01766921|156012204|FG001|Overall Study|Death|1|||
48496548|NCT01766921|156012203|FG000|Overall Study|Lost to Follow-up|1|||
48496549|NCT01766921|156012204|FG001|Overall Study|Lost to Follow-up|3|||
48496550|NCT01766921|156012203|FG000|Overall Study|Unclassified|2|||
48496551|NCT01766921|156012204|FG001|Overall Study|Unclassified|2|||
48496552|NCT01766921|156012203|FG000|Overall Study|Protocol Violation|1|||
48496553|NCT01766921|156012204|FG001|Overall Study|Protocol Violation|1|||
48496554|NCT01766921|156012203|FG000|Overall Study|Withdrawal by Subject|14|||
48496555|NCT01766921|156012204|FG001|Overall Study|Withdrawal by Subject|5|||
48598251|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598252|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598253|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598254|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48630154|NCT02723955|156504845|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
48496556|NCT00818623|156012205|FG000|Overall Study|Adverse Event|1|||
48496557|NCT00818623|156012206|FG001|Overall Study|Adverse Event|0|||
48496558|NCT00818623|156012207|FG002|Overall Study|Adverse Event|1|||
48496559|NCT00818623|156012208|FG003|Overall Study|Adverse Event|0|||
48496560|NCT00818623|156012209|FG004|Overall Study|Adverse Event|0|||
48496561|NCT00818623|156012210|FG005|Overall Study|Adverse Event|1|||
48496562|NCT00818623|156012211|FG006|Overall Study|Adverse Event|0|||
48496563|NCT00818623|156012212|FG007|Overall Study|Adverse Event|0|||
48496564|NCT00818623|156012205|FG000|Overall Study|Bad prostate specific antigen response|0|||
48496565|NCT00818623|156012206|FG001|Overall Study|Bad prostate specific antigen response|3|||
48496566|NCT00818623|156012207|FG002|Overall Study|Bad prostate specific antigen response|2|||
48496567|NCT00818623|156012208|FG003|Overall Study|Bad prostate specific antigen response|5|||
48496568|NCT00818623|156012209|FG004|Overall Study|Bad prostate specific antigen response|0|||
48496569|NCT00818623|156012210|FG005|Overall Study|Bad prostate specific antigen response|1|||
48496570|NCT00818623|156012211|FG006|Overall Study|Bad prostate specific antigen response|0|||
48496571|NCT00818623|156012212|FG007|Overall Study|Bad prostate specific antigen response|0|||
48496572|NCT00818623|156012205|FG000|Overall Study|Withdrawal by Subject|0|||
48496573|NCT00818623|156012206|FG001|Overall Study|Withdrawal by Subject|1|||
48496574|NCT00818623|156012207|FG002|Overall Study|Withdrawal by Subject|1|||
48496575|NCT00818623|156012208|FG003|Overall Study|Withdrawal by Subject|0|||
48496576|NCT00818623|156012209|FG004|Overall Study|Withdrawal by Subject|0|||
48496577|NCT00818623|156012210|FG005|Overall Study|Withdrawal by Subject|1|||
48496578|NCT00818623|156012211|FG006|Overall Study|Withdrawal by Subject|1|||
48598255|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
48813333|NCT04867785|157157400|FG003|Overall Study|Eligibility Criteria Not Met|0|||
48813334|NCT04867785|157157401|FG004|Overall Study|Eligibility Criteria Not Met|0|||
48813335|NCT04867785|157157402|FG005|Overall Study|Eligibility Criteria Not Met|0|||
48813336|NCT04867785|157157403|FG006|Overall Study|Eligibility Criteria Not Met|0|||
48813337|NCT04867785|157157404|FG007|Overall Study|Eligibility Criteria Not Met|1|||
48813338|NCT02802319|157157417|FG000|Overall Study|Physician Decision|2|||
48813339|NCT02802319|157157418|FG001|Overall Study|Physician Decision|1|||
48813340|NCT02802319|157157417|FG000|Overall Study|Lost to Follow-up|0|||
48813341|NCT02802319|157157418|FG001|Overall Study|Lost to Follow-up|4|||
48813342|NCT00592319|157157421|FG000|Overall Study|Lost to Follow-up|0|||
48813343|NCT00592319|157157422|FG001|Overall Study|Lost to Follow-up|3|||
48813344|NCT02254421|157157427|FG000|Overall Study|Randomized but Not Treated|1|||
48813345|NCT02254421|157157428|FG001|Overall Study|Randomized but Not Treated|0|||
48813346|NCT02254421|157157427|FG000|Overall Study|Death|0|||
48813347|NCT02254421|157157428|FG001|Overall Study|Death|2|||
48813348|NCT02254421|157157427|FG000|Overall Study|Withdrew Consent|1|||
48813349|NCT02254421|157157428|FG001|Overall Study|Withdrew Consent|1|||
48813350|NCT01024959|157157429|FG000|Overall Study|ineligible|12|||
48813351|NCT01024959|157157429|FG000|Overall Study|results not evaluable|12|||
48813352|NCT01024959|157157429|FG000|Overall Study|missing results required for analysis|17|||
48813353|NCT01973491|157157430|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
48813354|NCT01973491|157157430|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
48813355|NCT01973491|157157430|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
48813356|NCT01863043|157157434|FG000|Overall Study|Death|6|||
48813357|NCT01863043|157157435|FG001|Overall Study|Death|1|||
48813358|NCT01863043|157157434|FG000|Overall Study|Withdrawal by Subject|0|||
48813359|NCT01863043|157157435|FG001|Overall Study|Withdrawal by Subject|2|||
48813360|NCT01863043|157157434|FG000|Overall Study|Adverse Event|7|||
48813361|NCT01863043|157157435|FG001|Overall Study|Adverse Event|8|||
48813362|NCT01863043|157157434|FG000|Overall Study|exclusion criteria found after enrollment|0|||
48813363|NCT01863043|157157435|FG001|Overall Study|exclusion criteria found after enrollment|1|||
48813364|NCT00313911|157157436|FG000|Overall Study|Serious adverse event|6|||
48813365|NCT00313911|157157437|FG001|Overall Study|Serious adverse event|1|||
48813366|NCT00313911|157157436|FG000|Overall Study|Adverse Event|2|||
48813367|NCT00313911|157157437|FG001|Overall Study|Adverse Event|3|||
48813368|NCT00313911|157157436|FG000|Overall Study|Protocol Violation|19|||
48813369|NCT00313911|157157437|FG001|Overall Study|Protocol Violation|10|||
48813370|NCT00313911|157157436|FG000|Overall Study|Lost to Follow-up|27|||
48813371|NCT00313911|157157437|FG001|Overall Study|Lost to Follow-up|14|||
48813372|NCT00313911|157157436|FG000|Overall Study|Withdrawal by Subject|39|||
48813373|NCT00313911|157157437|FG001|Overall Study|Withdrawal by Subject|12|||
48813374|NCT00313911|157157436|FG000|Overall Study|Did not meet age criteria|1|||
48813375|NCT00313911|157157437|FG001|Overall Study|Did not meet age criteria|1|||
48813376|NCT00636792|157157438|FG000|Overall Study|Adverse Event|16|||
48813377|NCT00636792|157157438|FG000|Overall Study|Physician Decision|7|||
48813378|NCT00636792|157157438|FG000|Overall Study|Progressive Disease|4|||
48813379|NCT00636792|157157438|FG000|Overall Study|Withdrawal by Subject|3|||
48813380|NCT00636792|157157438|FG000|Overall Study|Other|3|||
48813381|NCT01912781|157157439|FG000|Overall Study|Withdrawal by Subject|2|||
48813382|NCT01912781|157157440|FG001|Overall Study|Withdrawal by Subject|0|||
48813383|NCT01928225|157157443|FG000|Overall Study|Pregnancy|1|||
48813384|NCT01928225|157157444|FG001|Overall Study|Pregnancy|0|||
48813385|NCT01928225|157157443|FG000|Overall Study|basaloid cervical cancer|1|||
48813386|NCT01928225|157157444|FG001|Overall Study|basaloid cervical cancer|0|||
48813387|NCT01928225|157157443|FG000|Overall Study|Lost to Follow-up|1|||
48813388|NCT01928225|157157444|FG001|Overall Study|Lost to Follow-up|3|||
48813389|NCT03154359|157157445|FG000|Overall Study|Adverse Event|1|||
48813390|NCT03154359|157157445|FG000|Overall Study|Lack of Efficacy|2|||
48496579|NCT00818623|156012212|FG007|Overall Study|Withdrawal by Subject|1|||
48496580|NCT00818623|156012205|FG000|Overall Study|Protocol Violation|1|||
48496581|NCT00818623|156012206|FG001|Overall Study|Protocol Violation|0|||
48813391|NCT03154359|157157445|FG000|Overall Study|Lost to Follow-up|3|||
48813392|NCT03154359|157157445|FG000|Overall Study|Physician Decision|3|||
48813393|NCT03154359|157157445|FG000|Overall Study|Protocol Violation|4|||
48496582|NCT00818623|156012207|FG002|Overall Study|Protocol Violation|0|||
48496583|NCT00818623|156012208|FG003|Overall Study|Protocol Violation|0|||
48496584|NCT00818623|156012209|FG004|Overall Study|Protocol Violation|1|||
48496585|NCT00818623|156012210|FG005|Overall Study|Protocol Violation|0|||
48496586|NCT00818623|156012211|FG006|Overall Study|Protocol Violation|1|||
48496587|NCT00818623|156012212|FG007|Overall Study|Protocol Violation|0|||
48496588|NCT00818623|156012205|FG000|Overall Study|Need of additional treatment|0|||
48496589|NCT00818623|156012206|FG001|Overall Study|Need of additional treatment|0|||
48496590|NCT00818623|156012207|FG002|Overall Study|Need of additional treatment|0|||
48496591|NCT00818623|156012208|FG003|Overall Study|Need of additional treatment|0|||
48496592|NCT00818623|156012209|FG004|Overall Study|Need of additional treatment|1|||
48496593|NCT00818623|156012210|FG005|Overall Study|Need of additional treatment|0|||
48496594|NCT00818623|156012211|FG006|Overall Study|Need of additional treatment|0|||
48496595|NCT00818623|156012212|FG007|Overall Study|Need of additional treatment|0|||
48496596|NCT00818623|156012205|FG000|Overall Study|Lack of trial drug at site|0|||
48496597|NCT00818623|156012206|FG001|Overall Study|Lack of trial drug at site|0|||
48496598|NCT00818623|156012207|FG002|Overall Study|Lack of trial drug at site|0|||
48496599|NCT00818623|156012208|FG003|Overall Study|Lack of trial drug at site|0|||
48496600|NCT00818623|156012209|FG004|Overall Study|Lack of trial drug at site|2|||
48496601|NCT00818623|156012210|FG005|Overall Study|Lack of trial drug at site|0|||
48496602|NCT00818623|156012211|FG006|Overall Study|Lack of trial drug at site|1|||
48496603|NCT00818623|156012212|FG007|Overall Study|Lack of trial drug at site|0|||
48496604|NCT00818623|156012205|FG000|Overall Study|Disease progression|0|||
48496605|NCT00818623|156012206|FG001|Overall Study|Disease progression|0|||
48496606|NCT00818623|156012207|FG002|Overall Study|Disease progression|0|||
48496607|NCT00818623|156012208|FG003|Overall Study|Disease progression|0|||
48496608|NCT00818623|156012209|FG004|Overall Study|Disease progression|0|||
48496609|NCT00818623|156012210|FG005|Overall Study|Disease progression|0|||
48496610|NCT00818623|156012211|FG006|Overall Study|Disease progression|1|||
48496611|NCT00818623|156012212|FG007|Overall Study|Disease progression|0|||
48496612|NCT02974114|156012213|FG000|Overall Study|Other (Not specified)|0|||
48496613|NCT02974114|156012214|FG001|Overall Study|Other (Not specified)|1|||
48496614|NCT02974114|156012215|FG002|Overall Study|Other (Not specified)|2|||
48496615|NCT01249664|156012216|FG000|Overall Study|Withdrawal by Subject|5|||
48714916|NCT01349049|156806535|FG000|Overall Study|Adverse Event|0|||
48714917|NCT01349049|156806536|FG001|Overall Study|Adverse Event|1|||
48714918|NCT01349049|156806537|FG002|Overall Study|Adverse Event|0|||
48714919|NCT01349049|156806538|FG003|Overall Study|Adverse Event|0|||
48714920|NCT01349049|156806539|FG004|Overall Study|Adverse Event|0|||
48714921|NCT01349049|156806540|FG005|Overall Study|Adverse Event|3|||
48714922|NCT01349049|156806541|FG006|Overall Study|Adverse Event|1|||
48714923|NCT01349049|156806542|FG007|Overall Study|Adverse Event|0|||
48714924|NCT01349049|156806543|FG008|Overall Study|Adverse Event|4|||
48714925|NCT01349049|156806535|FG000|Overall Study|Physician Decision|0|||
48714926|NCT01349049|156806536|FG001|Overall Study|Physician Decision|1|||
48714927|NCT01349049|156806537|FG002|Overall Study|Physician Decision|0|||
48714928|NCT01349049|156806538|FG003|Overall Study|Physician Decision|0|||
48714929|NCT01349049|156806539|FG004|Overall Study|Physician Decision|0|||
48714930|NCT01349049|156806540|FG005|Overall Study|Physician Decision|0|||
48714931|NCT01349049|156806541|FG006|Overall Study|Physician Decision|0|||
48714932|NCT01349049|156806542|FG007|Overall Study|Physician Decision|0|||
48714933|NCT01349049|156806543|FG008|Overall Study|Physician Decision|2|||
48714934|NCT01349049|156806535|FG000|Overall Study|Protocol Violation|0|||
48714935|NCT01349049|156806536|FG001|Overall Study|Protocol Violation|0|||
48714936|NCT01349049|156806537|FG002|Overall Study|Protocol Violation|0|||
48714937|NCT01349049|156806538|FG003|Overall Study|Protocol Violation|0|||
48714938|NCT01349049|156806539|FG004|Overall Study|Protocol Violation|0|||
48714939|NCT01349049|156806540|FG005|Overall Study|Protocol Violation|0|||
48714940|NCT01349049|156806541|FG006|Overall Study|Protocol Violation|0|||
48714941|NCT01349049|156806542|FG007|Overall Study|Protocol Violation|0|||
48714942|NCT01349049|156806543|FG008|Overall Study|Protocol Violation|1|||
48714943|NCT01349049|156806535|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
48714944|NCT01349049|156806536|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
48714945|NCT01349049|156806537|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
48714946|NCT01349049|156806538|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
48496616|NCT01249664|156012217|FG001|Overall Study|Withdrawal by Subject|0|||
48496617|NCT01249664|156012216|FG000|Overall Study|Adverse Event|1|||
48496618|NCT01249664|156012217|FG001|Overall Study|Adverse Event|0|||
48496619|NCT01400113|156012218|FG000|Overall Study|Withdrawal by Subject|1|||
48496620|NCT01400113|156012219|FG001|Overall Study|Withdrawal by Subject|1|||
48496621|NCT00950807|156012221|FG000|Treatment Period 1|Lack of Efficacy|1|||
48496622|NCT00950807|156012222|FG001|Treatment Period 1|Lack of Efficacy|0|||
48496623|NCT00950807|156012223|FG002|Treatment Period 1|Lack of Efficacy|0|||
48714947|NCT01349049|156806539|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
48714948|NCT01349049|156806540|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
48714949|NCT01349049|156806541|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
48496624|NCT00950807|156012224|FG003|Treatment Period 1|Lack of Efficacy|0|||
48496625|NCT00950807|156012225|FG004|Treatment Period 1|Lack of Efficacy|0|||
48714950|NCT01349049|156806542|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
48496626|NCT00950807|156012226|FG005|Treatment Period 1|Lack of Efficacy|1|||
48496627|NCT00950807|156012227|FG006|Treatment Period 1|Lack of Efficacy|0|||
48496628|NCT00950807|156012228|FG007|Treatment Period 1|Lack of Efficacy|0|||
48496629|NCT00950807|156012229|FG008|Treatment Period 1|Lack of Efficacy|0|||
48496630|NCT00950807|156012230|FG009|Treatment Period 1|Lack of Efficacy|0|||
48496631|NCT00950807|156012221|FG000|Treatment Period 1|Protocol Violation|1|||
48496632|NCT00950807|156012222|FG001|Treatment Period 1|Protocol Violation|0|||
48496633|NCT00950807|156012223|FG002|Treatment Period 1|Protocol Violation|0|||
48496634|NCT00950807|156012224|FG003|Treatment Period 1|Protocol Violation|0|||
48714951|NCT01349049|156806543|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
48714952|NCT01349049|156806535|FG000|Overall Study|Other|0|||
48714953|NCT01349049|156806536|FG001|Overall Study|Other|0|||
48714954|NCT01349049|156806537|FG002|Overall Study|Other|0|||
48714955|NCT01349049|156806538|FG003|Overall Study|Other|0|||
48714956|NCT01349049|156806539|FG004|Overall Study|Other|0|||
48714957|NCT01349049|156806540|FG005|Overall Study|Other|1|||
48714958|NCT01349049|156806541|FG006|Overall Study|Other|0|||
48813394|NCT03154359|157157445|FG000|Overall Study|Withdrawal by Subject|5|||
48496635|NCT00950807|156012225|FG004|Treatment Period 1|Protocol Violation|0|||
48496636|NCT00950807|156012226|FG005|Treatment Period 1|Protocol Violation|0|||
48496637|NCT00950807|156012227|FG006|Treatment Period 1|Protocol Violation|0|||
48496638|NCT00950807|156012228|FG007|Treatment Period 1|Protocol Violation|0|||
48496639|NCT00950807|156012229|FG008|Treatment Period 1|Protocol Violation|0|||
48496640|NCT00950807|156012230|FG009|Treatment Period 1|Protocol Violation|0|||
48496641|NCT00950807|156012221|FG000|Treatment Period 1|Lost to Follow-up|0|||
48496642|NCT00950807|156012222|FG001|Treatment Period 1|Lost to Follow-up|0|||
48496643|NCT00950807|156012223|FG002|Treatment Period 1|Lost to Follow-up|1|||
48496644|NCT00950807|156012224|FG003|Treatment Period 1|Lost to Follow-up|0|||
48496645|NCT00950807|156012225|FG004|Treatment Period 1|Lost to Follow-up|0|||
48496646|NCT00950807|156012226|FG005|Treatment Period 1|Lost to Follow-up|0|||
48496647|NCT00950807|156012227|FG006|Treatment Period 1|Lost to Follow-up|0|||
48496648|NCT00950807|156012228|FG007|Treatment Period 1|Lost to Follow-up|0|||
48496649|NCT00950807|156012229|FG008|Treatment Period 1|Lost to Follow-up|0|||
48496650|NCT00950807|156012230|FG009|Treatment Period 1|Lost to Follow-up|0|||
48598256|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598257|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598258|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598259|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598260|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598261|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598262|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598263|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598264|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
48598265|NCT02326272|156385199|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598266|NCT02326272|156385200|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598267|NCT02326272|156385201|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598268|NCT02326272|156385202|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598269|NCT02326272|156385203|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598270|NCT02326272|156385204|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598271|NCT02326272|156385205|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
48714959|NCT01349049|156806542|FG007|Overall Study|Other|0|||
48714960|NCT01349049|156806543|FG008|Overall Study|Other|4|||
48598272|NCT02326272|156385206|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598273|NCT02326272|156385207|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598274|NCT02326272|156385208|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598275|NCT02326272|156385209|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598276|NCT02326272|156385210|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598277|NCT02326272|156385211|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598278|NCT02326272|156385212|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598279|NCT02326272|156385213|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
48598280|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
48598281|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
48598282|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
48598283|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
48598284|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
48598285|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
48598286|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
48598287|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
48598288|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
48598289|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
48598290|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
48598291|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
48598292|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
48598293|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
48598294|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
48598295|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598296|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598297|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598298|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598299|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598300|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598301|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598302|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598303|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598304|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598305|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
48598306|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
48598307|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
48598308|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48598309|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
48598310|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598311|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598312|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598313|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598314|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598315|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598316|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598317|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598318|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598319|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598320|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
48598321|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598322|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
48598323|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598324|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48598325|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598326|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598327|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598328|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48714961|NCT01349049|156806535|FG000|Overall Study|Death|0|||
48714962|NCT01349049|156806536|FG001|Overall Study|Death|0|||
48714963|NCT01349049|156806537|FG002|Overall Study|Death|0|||
48714964|NCT01349049|156806538|FG003|Overall Study|Death|0|||
48598329|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598330|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48714965|NCT01349049|156806539|FG004|Overall Study|Death|0|||
48714966|NCT01349049|156806540|FG005|Overall Study|Death|0|||
48714967|NCT01349049|156806541|FG006|Overall Study|Death|0|||
48714968|NCT01349049|156806542|FG007|Overall Study|Death|1|||
48714969|NCT01349049|156806543|FG008|Overall Study|Death|5|||
48496651|NCT00950807|156012221|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48496652|NCT00950807|156012222|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48496653|NCT00950807|156012223|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48496654|NCT00950807|156012224|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48496655|NCT00950807|156012225|FG004|Treatment Period 1|Withdrawal by Subject|1|||
48496656|NCT00950807|156012226|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48496657|NCT00950807|156012227|FG006|Treatment Period 1|Withdrawal by Subject|0|||
48496658|NCT00950807|156012228|FG007|Treatment Period 1|Withdrawal by Subject|0|||
48496659|NCT00950807|156012229|FG008|Treatment Period 1|Withdrawal by Subject|1|||
48496660|NCT00950807|156012230|FG009|Treatment Period 1|Withdrawal by Subject|0|||
48496661|NCT00950807|156012221|FG000|Treatment Period 1|Adverse Event|0|||
48496662|NCT00950807|156012222|FG001|Treatment Period 1|Adverse Event|0|||
48496663|NCT00950807|156012223|FG002|Treatment Period 1|Adverse Event|0|||
48496664|NCT00950807|156012224|FG003|Treatment Period 1|Adverse Event|0|||
48496665|NCT00950807|156012225|FG004|Treatment Period 1|Adverse Event|0|||
48496666|NCT00950807|156012226|FG005|Treatment Period 1|Adverse Event|1|||
48496667|NCT00950807|156012227|FG006|Treatment Period 1|Adverse Event|0|||
48496668|NCT00950807|156012228|FG007|Treatment Period 1|Adverse Event|0|||
48496669|NCT00950807|156012229|FG008|Treatment Period 1|Adverse Event|0|||
48496670|NCT00950807|156012230|FG009|Treatment Period 1|Adverse Event|0|||
48496671|NCT00950807|156012221|FG000|Washout Period 1|Lack of Efficacy|0|||
48496672|NCT00950807|156012222|FG001|Washout Period 1|Lack of Efficacy|0|||
48496673|NCT00950807|156012223|FG002|Washout Period 1|Lack of Efficacy|0|||
48496674|NCT00950807|156012224|FG003|Washout Period 1|Lack of Efficacy|0|||
48496675|NCT00950807|156012225|FG004|Washout Period 1|Lack of Efficacy|0|||
48496676|NCT00950807|156012226|FG005|Washout Period 1|Lack of Efficacy|0|||
48496677|NCT00950807|156012227|FG006|Washout Period 1|Lack of Efficacy|1|||
48496678|NCT00950807|156012228|FG007|Washout Period 1|Lack of Efficacy|0|||
48496679|NCT00950807|156012229|FG008|Washout Period 1|Lack of Efficacy|0|||
48496680|NCT00950807|156012230|FG009|Washout Period 1|Lack of Efficacy|0|||
48496681|NCT00950807|156012221|FG000|Washout Period 1|Withdrawal by Subject|0|||
48496682|NCT00950807|156012222|FG001|Washout Period 1|Withdrawal by Subject|0|||
48496683|NCT00950807|156012223|FG002|Washout Period 1|Withdrawal by Subject|0|||
48496684|NCT00950807|156012224|FG003|Washout Period 1|Withdrawal by Subject|0|||
48496685|NCT00950807|156012225|FG004|Washout Period 1|Withdrawal by Subject|0|||
48496686|NCT00950807|156012226|FG005|Washout Period 1|Withdrawal by Subject|0|||
48496687|NCT00950807|156012227|FG006|Washout Period 1|Withdrawal by Subject|0|||
48496688|NCT00950807|156012228|FG007|Washout Period 1|Withdrawal by Subject|0|||
48496689|NCT00950807|156012229|FG008|Washout Period 1|Withdrawal by Subject|1|||
48496690|NCT00950807|156012230|FG009|Washout Period 1|Withdrawal by Subject|0|||
48496691|NCT00950807|156012221|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
48496692|NCT00950807|156012222|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
48496693|NCT00950807|156012223|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
48496694|NCT00950807|156012224|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
48496695|NCT00950807|156012225|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
48496696|NCT00950807|156012226|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
48496697|NCT00950807|156012227|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
48496698|NCT00950807|156012228|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
48496699|NCT00950807|156012229|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
48496700|NCT00950807|156012230|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
48496701|NCT00950807|156012221|FG000|Washout Period 1|Adverse Event|2|||
48496702|NCT00950807|156012222|FG001|Washout Period 1|Adverse Event|0|||
48496703|NCT00950807|156012223|FG002|Washout Period 1|Adverse Event|0|||
48496704|NCT00950807|156012224|FG003|Washout Period 1|Adverse Event|1|||
48496705|NCT00950807|156012225|FG004|Washout Period 1|Adverse Event|1|||
48496706|NCT00950807|156012226|FG005|Washout Period 1|Adverse Event|0|||
48496707|NCT00950807|156012227|FG006|Washout Period 1|Adverse Event|0|||
48496708|NCT00950807|156012228|FG007|Washout Period 1|Adverse Event|0|||
48496709|NCT00950807|156012229|FG008|Washout Period 1|Adverse Event|0|||
48496710|NCT00950807|156012230|FG009|Washout Period 1|Adverse Event|0|||
48496711|NCT00950807|156012221|FG000|Treatment Period 2|Lack of Efficacy|1|||
48496712|NCT00950807|156012222|FG001|Treatment Period 2|Lack of Efficacy|0|||
48496713|NCT00950807|156012223|FG002|Treatment Period 2|Lack of Efficacy|0|||
48714970|NCT01349049|156806535|FG000|Overall Study|Non-compliance|0|||
48714971|NCT01349049|156806536|FG001|Overall Study|Non-compliance|0|||
48496714|NCT00950807|156012224|FG003|Treatment Period 2|Lack of Efficacy|0|||
48496715|NCT00950807|156012225|FG004|Treatment Period 2|Lack of Efficacy|0|||
48496716|NCT00950807|156012226|FG005|Treatment Period 2|Lack of Efficacy|0|||
48496717|NCT00950807|156012227|FG006|Treatment Period 2|Lack of Efficacy|0|||
48496718|NCT00950807|156012228|FG007|Treatment Period 2|Lack of Efficacy|0|||
48714972|NCT01349049|156806537|FG002|Overall Study|Non-compliance|0|||
48714973|NCT01349049|156806538|FG003|Overall Study|Non-compliance|1|||
48496719|NCT00950807|156012229|FG008|Treatment Period 2|Lack of Efficacy|0|||
48496720|NCT00950807|156012230|FG009|Treatment Period 2|Lack of Efficacy|0|||
48496721|NCT00950807|156012221|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48496722|NCT00950807|156012222|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48496723|NCT00950807|156012223|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48496724|NCT00950807|156012224|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48496725|NCT00950807|156012225|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48496726|NCT00950807|156012226|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48496727|NCT00950807|156012227|FG006|Treatment Period 2|Withdrawal by Subject|1|||
48496728|NCT00950807|156012228|FG007|Treatment Period 2|Withdrawal by Subject|2|||
48496729|NCT00950807|156012229|FG008|Treatment Period 2|Withdrawal by Subject|0|||
48496730|NCT00950807|156012230|FG009|Treatment Period 2|Withdrawal by Subject|0|||
48496731|NCT00950807|156012221|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
48496732|NCT00950807|156012222|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496733|NCT00950807|156012223|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496734|NCT00950807|156012224|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496735|NCT00950807|156012225|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496736|NCT00950807|156012226|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496737|NCT00950807|156012227|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496738|NCT00950807|156012228|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496739|NCT00950807|156012229|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496740|NCT00950807|156012230|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48496741|NCT00950807|156012221|FG000|Treatment Period 2|Adverse Event|0|||
48496742|NCT00950807|156012222|FG001|Treatment Period 2|Adverse Event|1|||
48496743|NCT00950807|156012223|FG002|Treatment Period 2|Adverse Event|0|||
48496744|NCT00950807|156012224|FG003|Treatment Period 2|Adverse Event|1|||
48496745|NCT00950807|156012225|FG004|Treatment Period 2|Adverse Event|0|||
48496746|NCT00950807|156012226|FG005|Treatment Period 2|Adverse Event|1|||
48496747|NCT00950807|156012227|FG006|Treatment Period 2|Adverse Event|0|||
48496748|NCT00950807|156012228|FG007|Treatment Period 2|Adverse Event|1|||
48496749|NCT00950807|156012229|FG008|Treatment Period 2|Adverse Event|0|||
48496750|NCT00950807|156012230|FG009|Treatment Period 2|Adverse Event|0|||
48496751|NCT00950807|156012221|FG000|Washout Period 2|Lack of Efficacy|1|||
48496752|NCT00950807|156012222|FG001|Washout Period 2|Lack of Efficacy|0|||
48496753|NCT00950807|156012223|FG002|Washout Period 2|Lack of Efficacy|0|||
48496754|NCT00950807|156012224|FG003|Washout Period 2|Lack of Efficacy|0|||
48496755|NCT00950807|156012225|FG004|Washout Period 2|Lack of Efficacy|0|||
48496756|NCT00950807|156012226|FG005|Washout Period 2|Lack of Efficacy|0|||
48496757|NCT00950807|156012227|FG006|Washout Period 2|Lack of Efficacy|0|||
48496758|NCT00950807|156012228|FG007|Washout Period 2|Lack of Efficacy|0|||
48496759|NCT00950807|156012229|FG008|Washout Period 2|Lack of Efficacy|0|||
48496760|NCT00950807|156012230|FG009|Washout Period 2|Lack of Efficacy|0|||
48496761|NCT00950807|156012221|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
48496762|NCT00950807|156012222|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
48496763|NCT00950807|156012223|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
48496764|NCT00950807|156012224|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
48496765|NCT00950807|156012225|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
48496766|NCT00950807|156012226|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
48496767|NCT00950807|156012227|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
48496768|NCT00950807|156012228|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
48496769|NCT00950807|156012229|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
48496770|NCT00950807|156012230|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
48496771|NCT00950807|156012221|FG000|Washout Period 2|Adverse Event|3|||
48496772|NCT00950807|156012222|FG001|Washout Period 2|Adverse Event|0|||
48496773|NCT00950807|156012223|FG002|Washout Period 2|Adverse Event|0|||
48496774|NCT00950807|156012224|FG003|Washout Period 2|Adverse Event|1|||
48496775|NCT00950807|156012225|FG004|Washout Period 2|Adverse Event|0|||
48496776|NCT00950807|156012226|FG005|Washout Period 2|Adverse Event|0|||
48496777|NCT00950807|156012227|FG006|Washout Period 2|Adverse Event|0|||
48496778|NCT00950807|156012228|FG007|Washout Period 2|Adverse Event|0|||
48496779|NCT00950807|156012229|FG008|Washout Period 2|Adverse Event|0|||
48496780|NCT00950807|156012230|FG009|Washout Period 2|Adverse Event|0|||
48496781|NCT00950807|156012221|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48496782|NCT00950807|156012222|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48813395|NCT03154359|157157445|FG000|Overall Study|Disruption of study due to COVID-19|4|||
48496783|NCT00950807|156012223|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48496784|NCT00950807|156012224|FG003|Treatment Period 3|Withdrawal by Subject|0|||
48496785|NCT00950807|156012225|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48496786|NCT00950807|156012226|FG005|Treatment Period 3|Withdrawal by Subject|0|||
48496787|NCT00950807|156012227|FG006|Treatment Period 3|Withdrawal by Subject|0|||
48496788|NCT00950807|156012228|FG007|Treatment Period 3|Withdrawal by Subject|0|||
48496789|NCT00950807|156012229|FG008|Treatment Period 3|Withdrawal by Subject|0|||
48598331|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48496790|NCT00950807|156012230|FG009|Treatment Period 3|Withdrawal by Subject|1|||
48496791|NCT00950807|156012221|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
48496792|NCT00950807|156012222|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48714974|NCT01349049|156806539|FG004|Overall Study|Non-compliance|0|||
48714975|NCT01349049|156806540|FG005|Overall Study|Non-compliance|0|||
48598332|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598333|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598334|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598335|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598336|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
48598337|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598338|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598339|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48598340|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598341|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598342|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598343|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598344|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598345|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598346|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598347|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598348|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598349|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598350|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
48598351|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598352|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
48598353|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48598354|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
48598355|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598356|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598357|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598358|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598359|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598360|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598361|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598362|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598363|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598364|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598365|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598366|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
48598367|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598368|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48598369|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
48598370|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598371|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598372|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598373|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598374|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598375|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598376|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598377|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598378|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598379|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598380|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598381|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
48598382|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
48598383|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48598384|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
48598385|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598386|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48714976|NCT01349049|156806541|FG006|Overall Study|Non-compliance|0|||
48714977|NCT01349049|156806542|FG007|Overall Study|Non-compliance|0|||
48714978|NCT01349049|156806543|FG008|Overall Study|Non-compliance|0|||
48714979|NCT01349049|156806535|FG000|Overall Study|Withdrawal by Subject|0|||
48714980|NCT01349049|156806536|FG001|Overall Study|Withdrawal by Subject|0|||
48714981|NCT01349049|156806537|FG002|Overall Study|Withdrawal by Subject|0|||
48598387|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598388|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598389|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598390|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598391|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598392|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598393|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48813396|NCT01454830|157157446|FG000|Overall Study|Withdrawal by Subject|4|||
48813397|NCT01454830|157157447|FG001|Overall Study|Withdrawal by Subject|4|||
48813398|NCT01454830|157157446|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
48813399|NCT01454830|157157447|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
48813400|NCT01454830|157157446|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
48813401|NCT01454830|157157447|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
48813402|NCT01454830|157157446|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
48813403|NCT01454830|157157447|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
48813404|NCT01454830|157157446|FG000|Overall Study|Withdrawal - no polysomnography|3|||
48598394|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48714982|NCT01349049|156806538|FG003|Overall Study|Withdrawal by Subject|0|||
48714983|NCT01349049|156806539|FG004|Overall Study|Withdrawal by Subject|0|||
48714984|NCT01349049|156806540|FG005|Overall Study|Withdrawal by Subject|0|||
48714985|NCT01349049|156806541|FG006|Overall Study|Withdrawal by Subject|0|||
48714986|NCT01349049|156806542|FG007|Overall Study|Withdrawal by Subject|0|||
48714987|NCT01349049|156806543|FG008|Overall Study|Withdrawal by Subject|6|||
48714988|NCT04129151|156806546|FG000|Overall Study|Adverse Event|1|||
48714989|NCT04129151|156806546|FG000|Overall Study|Disease Progression|7|||
48714990|NCT04129151|156806546|FG000|Overall Study|Study closure|1|||
48714991|NCT01643772|156806547|FG000|Overall Study|Protocol Violation|0|||
48714992|NCT01643772|156806548|FG001|Overall Study|Protocol Violation|0|||
48714993|NCT01643772|156806549|FG002|Overall Study|Protocol Violation|0|||
48714994|NCT01643772|156806550|FG003|Overall Study|Protocol Violation|1|||
48714995|NCT01643772|156806547|FG000|Overall Study|Adverse Event|0|||
48714996|NCT01643772|156806548|FG001|Overall Study|Adverse Event|0|||
48714997|NCT01643772|156806549|FG002|Overall Study|Adverse Event|0|||
48714998|NCT01643772|156806550|FG003|Overall Study|Adverse Event|1|||
48714999|NCT01754402|156806551|FG000|Overall Study|Death|0|||
48715000|NCT01754402|156806552|FG001|Overall Study|Death|0|||
48715001|NCT01754402|156806553|FG002|Overall Study|Death|1|||
48715002|NCT01754402|156806551|FG000|Overall Study|Adverse Event|2|||
48715003|NCT01754402|156806552|FG001|Overall Study|Adverse Event|2|||
48715004|NCT01754402|156806553|FG002|Overall Study|Adverse Event|1|||
48715005|NCT01754402|156806551|FG000|Overall Study|Withdrawal by Subject|0|||
48715006|NCT01754402|156806552|FG001|Overall Study|Withdrawal by Subject|0|||
48715007|NCT01754402|156806553|FG002|Overall Study|Withdrawal by Subject|1|||
48715008|NCT01754402|156806551|FG000|Overall Study|Lack of Efficacy|0|||
48715009|NCT01754402|156806552|FG001|Overall Study|Lack of Efficacy|0|||
48715010|NCT01754402|156806553|FG002|Overall Study|Lack of Efficacy|1|||
48715011|NCT01282463|156806554|FG000|Overall Study|Lost to Follow-up|1|||
48715012|NCT01282463|156806555|FG001|Overall Study|Lost to Follow-up|0|||
48715013|NCT01282463|156806556|FG002|Overall Study|Lost to Follow-up|0|||
48715014|NCT01282463|156806554|FG000|Overall Study|Withdrawal by Subject|6|||
48715015|NCT01282463|156806555|FG001|Overall Study|Withdrawal by Subject|2|||
48715016|NCT01282463|156806556|FG002|Overall Study|Withdrawal by Subject|3|||
48715017|NCT01282463|156806554|FG000|Overall Study|"Never Treated Death"|0|||
48598395|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598396|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
48715018|NCT01282463|156806555|FG001|Overall Study|"Never Treated Death"|1|||
48715019|NCT01282463|156806556|FG002|Overall Study|"Never Treated Death"|0|||
48715020|NCT01282463|156806554|FG000|Overall Study|"Never Treated PD"|0|||
48715021|NCT01282463|156806555|FG001|Overall Study|"Never Treated PD"|1|||
48715022|NCT01282463|156806556|FG002|Overall Study|"Never Treated PD"|0|||
48715023|NCT01282463|156806554|FG000|Overall Study|Protocol Violation|0|||
48715024|NCT01282463|156806555|FG001|Overall Study|Protocol Violation|0|||
48715025|NCT01282463|156806556|FG002|Overall Study|Protocol Violation|1|||
48715026|NCT01282463|156806554|FG000|Overall Study|Physician Decision|1|||
48715027|NCT01282463|156806555|FG001|Overall Study|Physician Decision|0|||
48715028|NCT01282463|156806556|FG002|Overall Study|Physician Decision|0|||
48715029|NCT01788358|156806558|FG000|Overall Study|Other|11|||
48715030|NCT01788358|156806558|FG000|Overall Study|Logistical difficulties|1|||
48813405|NCT01454830|157157447|FG001|Overall Study|Withdrawal - no polysomnography|2|||
48715031|NCT01788358|156806558|FG000|Overall Study|Lost to Follow-up|5|||
48715032|NCT01788358|156806558|FG000|Overall Study|Protocol Violation|3|||
48715033|NCT01788358|156806558|FG000|Overall Study|Withdrawal by Subject|26|||
48715034|NCT01788358|156806558|FG000|Overall Study|Lack of Efficacy|1|||
48715035|NCT01788358|156806558|FG000|Overall Study|Adverse Event|51|||
48715036|NCT01357850|156806561|FG000|Overall Study|Lost to Follow-up|1|||
48715037|NCT01357850|156806562|FG001|Overall Study|Lost to Follow-up|0|||
48715038|NCT01357850|156806563|FG002|Overall Study|Lost to Follow-up|0|||
48715039|NCT01357850|156806564|FG003|Overall Study|Lost to Follow-up|0|||
48715040|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
48715041|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
48715042|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
48715043|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
48715044|NCT00490529|156806565|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
48715045|NCT00490529|156806565|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
48715046|NCT00792571|156806566|FG000|Overall Study|Death|1|||
48715047|NCT00792571|156806566|FG000|Overall Study|Adverse Event|4|||
48715048|NCT00792571|156806566|FG000|Overall Study|Withdrawal by Subject|1|||
48715049|NCT00792571|156806566|FG000|Overall Study|Other|4|||
48715050|NCT02338882|156806567|FG000|Overall Study|Death|1|||
48715051|NCT02338882|156806568|FG001|Overall Study|Death|0|||
48715052|NCT02338882|156806567|FG000|Overall Study|Lost to Follow-up|6|||
48715053|NCT02338882|156806568|FG001|Overall Study|Lost to Follow-up|3|||
48715054|NCT00505778|156806569|FG000|Overall Study|Adverse Event|2|||
48715055|NCT00505778|156806570|FG001|Overall Study|Adverse Event|7|||
48715056|NCT00505778|156806569|FG000|Overall Study|Physician Decision|8|||
48715057|NCT00505778|156806570|FG001|Overall Study|Physician Decision|14|||
48715058|NCT00505778|156806569|FG000|Overall Study|Lost to Follow-up|17|||
48715059|NCT00505778|156806570|FG001|Overall Study|Lost to Follow-up|23|||
48715060|NCT00505778|156806569|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
48715061|NCT00505778|156806570|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
48715062|NCT00505778|156806569|FG000|Overall Study|Protocol Violation|7|||
48715063|NCT00505778|156806570|FG001|Overall Study|Protocol Violation|9|||
48715064|NCT00505778|156806569|FG000|Overall Study|Withdrawal by Subject|29|||
48715065|NCT00505778|156806570|FG001|Overall Study|Withdrawal by Subject|14|||
48715066|NCT00505778|156806569|FG000|Overall Study|Relapse|65|||
48715067|NCT00505778|156806570|FG001|Overall Study|Relapse|65|||
48715068|NCT00505778|156806569|FG000|Overall Study|Took No Study Drug|2|||
48715069|NCT00505778|156806570|FG001|Overall Study|Took No Study Drug|2|||
48715070|NCT01343693|156806573|FG000|Overall Study|Lost to Follow-up|9|||
48715071|NCT02891070|156806574|FG000|Overall Study|Adverse Event|1|||
48715072|NCT02891070|156806575|FG001|Overall Study|Adverse Event|0|||
48715073|NCT02891070|156806574|FG000|Overall Study|Physician Decision|0|||
48715074|NCT02891070|156806575|FG001|Overall Study|Physician Decision|1|||
48715075|NCT02891070|156806574|FG000|Overall Study|Lost to Follow-up|4|||
48715076|NCT02891070|156806575|FG001|Overall Study|Lost to Follow-up|4|||
48715077|NCT02891070|156806574|FG000|Overall Study|Other|1|||
48715078|NCT02891070|156806575|FG001|Overall Study|Other|0|||
48715079|NCT02891070|156806574|FG000|Overall Study|Protocol Violation|0|||
48715080|NCT02891070|156806575|FG001|Overall Study|Protocol Violation|1|||
48715081|NCT02891070|156806574|FG000|Overall Study|Withdrawal by Subject|1|||
48715082|NCT02891070|156806575|FG001|Overall Study|Withdrawal by Subject|2|||
48715083|NCT02891070|156806574|FG000|Overall Study|Death|3|||
48715084|NCT02891070|156806575|FG001|Overall Study|Death|0|||
48715085|NCT04881942|156806576|FG000|Overall Study|Adverse Event|0|||
48715086|NCT04881942|156806577|FG001|Overall Study|Adverse Event|0|||
48715087|NCT04881942|156806578|FG002|Overall Study|Adverse Event|0|||
48715088|NCT04881942|156806579|FG003|Overall Study|Adverse Event|0|||
48715089|NCT04881942|156806580|FG004|Overall Study|Adverse Event|1|||
48715090|NCT04881942|156806576|FG000|Overall Study|Alternates|0|||
48715091|NCT04881942|156806577|FG001|Overall Study|Alternates|0|||
48715092|NCT04881942|156806578|FG002|Overall Study|Alternates|0|||
48715093|NCT04881942|156806579|FG003|Overall Study|Alternates|0|||
48715094|NCT04881942|156806580|FG004|Overall Study|Alternates|2|||
48715095|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
48715096|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
48715097|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Adverse Event|7|||
48715098|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Adverse Event|6|||
48715099|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
48715100|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
48715101|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Physician Decision|4|||
48715102|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Physician Decision|4|||
48715103|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
48715104|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
48715105|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
48715106|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
48715107|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
48715108|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
48715109|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Non-compliance|1|||
48715110|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Non-compliance|0|||
48715111|NCT00470834|156806583|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
48715112|NCT00470834|156806584|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
48715113|NCT00470834|156806583|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
48715114|NCT00470834|156806584|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
48715115|NCT00470834|156806583|FG000|Extension Period (24 Months)|Adverse Event|3|||
48715116|NCT00470834|156806584|FG001|Extension Period (24 Months)|Adverse Event|4|||
48715117|NCT00470834|156806583|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
48715118|NCT00470834|156806584|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
48715119|NCT00470834|156806583|FG000|Extension Period (24 Months)|Physician Decision|4|||
48715120|NCT00470834|156806584|FG001|Extension Period (24 Months)|Physician Decision|3|||
48715121|NCT00470834|156806583|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
48715122|NCT00470834|156806584|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
48715123|NCT00470834|156806583|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
48715124|NCT00470834|156806584|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
48715125|NCT00470834|156806583|FG000|Extension Period (24 Months)|Non-compliance|0|||
48496793|NCT00950807|156012223|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48496794|NCT00950807|156012224|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48715126|NCT00470834|156806584|FG001|Extension Period (24 Months)|Non-compliance|1|||
48715127|NCT00470834|156806583|FG000|Extension Period (24 Months)|Disease Progression|0|||
48715128|NCT00470834|156806584|FG001|Extension Period (24 Months)|Disease Progression|1|||
48715129|NCT02925338|156806585|FG000|Overall Study|Death|0|||
48715130|NCT02925338|156806586|FG001|Overall Study|Death|2|||
48715131|NCT02925338|156806587|FG002|Overall Study|Death|1|||
48715132|NCT02925338|156806588|FG003|Overall Study|Death|0|||
48715133|NCT02925338|156806589|FG004|Overall Study|Death|0|||
48715134|NCT02925338|156806585|FG000|Overall Study|Lost to Follow-up|30|||
48715135|NCT02925338|156806586|FG001|Overall Study|Lost to Follow-up|10|||
48715136|NCT02925338|156806587|FG002|Overall Study|Lost to Follow-up|1|||
48715137|NCT02925338|156806588|FG003|Overall Study|Lost to Follow-up|16|||
48715138|NCT02925338|156806589|FG004|Overall Study|Lost to Follow-up|3|||
48715139|NCT02925338|156806585|FG000|Overall Study|Withdrawal by Subject|3|||
48715140|NCT02925338|156806586|FG001|Overall Study|Withdrawal by Subject|0|||
48715141|NCT02925338|156806587|FG002|Overall Study|Withdrawal by Subject|3|||
48715142|NCT02925338|156806588|FG003|Overall Study|Withdrawal by Subject|2|||
48715143|NCT02925338|156806589|FG004|Overall Study|Withdrawal by Subject|2|||
48715144|NCT02925338|156806585|FG000|Overall Study|Missing|38|||
48715145|NCT02925338|156806586|FG001|Overall Study|Missing|27|||
48715146|NCT02925338|156806587|FG002|Overall Study|Missing|0|||
48496795|NCT00950807|156012225|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48496796|NCT00950807|156012226|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48496797|NCT00950807|156012227|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48496798|NCT00950807|156012228|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
48496799|NCT00950807|156012229|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48496800|NCT00950807|156012230|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48496801|NCT00950807|156012221|FG000|Treatment Period 3|Adverse Event|0|||
48496802|NCT00950807|156012222|FG001|Treatment Period 3|Adverse Event|0|||
48813406|NCT01533714|157157448|FG000|Overall Study|Adverse Event|0|||
48813407|NCT01533714|157157449|FG001|Overall Study|Adverse Event|1|||
48813408|NCT01533714|157157450|FG002|Overall Study|Adverse Event|2|||
48813409|NCT01533714|157157451|FG003|Overall Study|Adverse Event|2|||
48715147|NCT02925338|156806588|FG003|Overall Study|Missing|3|||
48715148|NCT02925338|156806589|FG004|Overall Study|Missing|2|||
48496803|NCT00950807|156012223|FG002|Treatment Period 3|Adverse Event|0|||
48715149|NCT02925338|156806585|FG000|Overall Study|Participant's Decision|11|||
48715150|NCT02925338|156806586|FG001|Overall Study|Participant's Decision|7|||
48715151|NCT02925338|156806587|FG002|Overall Study|Participant's Decision|3|||
48715152|NCT02925338|156806588|FG003|Overall Study|Participant's Decision|8|||
48715153|NCT02925338|156806589|FG004|Overall Study|Participant's Decision|1|||
48715154|NCT02925338|156806585|FG000|Overall Study|Treatment Discontinuation|144|||
48715155|NCT02925338|156806586|FG001|Overall Study|Treatment Discontinuation|65|||
48813410|NCT01533714|157157452|FG004|Overall Study|Adverse Event|2|||
48813411|NCT01533714|157157453|FG005|Overall Study|Adverse Event|1|||
48496804|NCT00950807|156012224|FG003|Treatment Period 3|Adverse Event|0|||
48715156|NCT02925338|156806587|FG002|Overall Study|Treatment Discontinuation|56|||
48715157|NCT02925338|156806588|FG003|Overall Study|Treatment Discontinuation|131|||
48715158|NCT02925338|156806589|FG004|Overall Study|Treatment Discontinuation|22|||
48715159|NCT00146848|156806593|FG000|Pre-randomization|Death|19|||
48715160|NCT00146848|156806594|FG001|Pre-randomization|Death|0|||
48715161|NCT00146848|156806595|FG002|Pre-randomization|Death|0|||
48813412|NCT01533714|157157448|FG000|Overall Study|Lack of Efficacy|0|||
48813413|NCT01533714|157157449|FG001|Overall Study|Lack of Efficacy|0|||
48715162|NCT00146848|156806593|FG000|Pre-randomization|Lost to Follow-up|70|||
48715163|NCT00146848|156806594|FG001|Pre-randomization|Lost to Follow-up|0|||
48715164|NCT00146848|156806595|FG002|Pre-randomization|Lost to Follow-up|0|||
48715165|NCT00146848|156806593|FG000|Pre-randomization|Physician Decision|8|||
48715166|NCT00146848|156806594|FG001|Pre-randomization|Physician Decision|0|||
48715167|NCT00146848|156806595|FG002|Pre-randomization|Physician Decision|0|||
48715168|NCT00146848|156806593|FG000|Pre-randomization|Protocol Violation|172|||
48715169|NCT00146848|156806594|FG001|Pre-randomization|Protocol Violation|0|||
48715170|NCT00146848|156806595|FG002|Pre-randomization|Protocol Violation|0|||
48715171|NCT00146848|156806593|FG000|Pre-randomization|Withdrawal by Subject|40|||
48715172|NCT00146848|156806594|FG001|Pre-randomization|Withdrawal by Subject|0|||
48715173|NCT00146848|156806595|FG002|Pre-randomization|Withdrawal by Subject|0|||
48715174|NCT00146848|156806593|FG000|Post-randomization|Lost to Follow-up|12|||
48715175|NCT00146848|156806594|FG001|Post-randomization|Lost to Follow-up|15|||
48715176|NCT00146848|156806595|FG002|Post-randomization|Lost to Follow-up|12|||
48715177|NCT00146848|156806593|FG000|Post-randomization|Withdrawn|26|||
48715178|NCT00146848|156806594|FG001|Post-randomization|Withdrawn|32|||
48715179|NCT00146848|156806595|FG002|Post-randomization|Withdrawn|27|||
48715180|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
48715181|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
48715182|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
48715183|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
48715184|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
48715185|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
48715186|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
48715187|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
48715188|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
48715189|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
48715190|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
48715191|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
48715192|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
48715193|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
48715194|NCT00612105|156806596|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
48715195|NCT00612105|156806597|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
48715196|NCT00612105|156806596|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
48715197|NCT00612105|156806597|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
48715198|NCT00612105|156806596|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
48715199|NCT00612105|156806597|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
48715200|NCT00612105|156806596|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
48715201|NCT00612105|156806597|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
48715202|NCT00612105|156806596|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
48715203|NCT00612105|156806597|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
48715204|NCT00475982|156806598|FG000|Overall Study|surgery rescheduled|7|||
48715205|NCT00475982|156806599|FG001|Overall Study|surgery rescheduled|3|||
48715206|NCT01105767|156806600|FG000|Overall Study|Lost to Follow-up|1160|||
48715207|NCT01105767|156806601|FG001|Overall Study|Lost to Follow-up|1614|||
48715208|NCT01105767|156806602|FG002|Overall Study|Lost to Follow-up|1184|||
48715209|NCT00783198|156806606|FG000|Overall Study|Adverse Event|15|||
48715210|NCT00783198|156806607|FG001|Overall Study|Adverse Event|19|||
48715211|NCT00783198|156806608|FG002|Overall Study|Adverse Event|3|||
48715212|NCT00783198|156806606|FG000|Overall Study|Lost to Follow-up|11|||
48715213|NCT00783198|156806607|FG001|Overall Study|Lost to Follow-up|1|||
48715214|NCT00783198|156806608|FG002|Overall Study|Lost to Follow-up|7|||
48715215|NCT00783198|156806606|FG000|Overall Study|Withdrawal by Subject|22|||
48715216|NCT00783198|156806607|FG001|Overall Study|Withdrawal by Subject|14|||
48715217|NCT00783198|156806608|FG002|Overall Study|Withdrawal by Subject|20|||
48715218|NCT00783198|156806606|FG000|Overall Study|Noncompliance with protocol|7|||
48715219|NCT00783198|156806607|FG001|Overall Study|Noncompliance with protocol|7|||
48715220|NCT00783198|156806608|FG002|Overall Study|Noncompliance with protocol|10|||
48715221|NCT00783198|156806606|FG000|Overall Study|Did not meet protocol eligibility|0|||
48715222|NCT00783198|156806607|FG001|Overall Study|Did not meet protocol eligibility|1|||
48715223|NCT00783198|156806608|FG002|Overall Study|Did not meet protocol eligibility|0|||
48496805|NCT00950807|156012225|FG004|Treatment Period 3|Adverse Event|0|||
48715224|NCT00783198|156806606|FG000|Overall Study|Administrative|2|||
48715225|NCT00783198|156806607|FG001|Overall Study|Administrative|1|||
48715226|NCT00783198|156806608|FG002|Overall Study|Administrative|2|||
48715227|NCT00228553|156806614|FG000|Overall Study|Adverse Event|112|||
48715228|NCT00228553|156806614|FG000|Overall Study|Lack of Efficacy|34|||
48715229|NCT00228553|156806614|FG000|Overall Study|Lost to Follow-up|67|||
48715230|NCT00228553|156806614|FG000|Overall Study|Physician Decision|48|||
48715231|NCT00228553|156806614|FG000|Overall Study|Protocol Violation|6|||
48496806|NCT00950807|156012226|FG005|Treatment Period 3|Adverse Event|0|||
48496807|NCT00950807|156012227|FG006|Treatment Period 3|Adverse Event|1|||
48496808|NCT00950807|156012228|FG007|Treatment Period 3|Adverse Event|0|||
48496809|NCT00950807|156012229|FG008|Treatment Period 3|Adverse Event|0|||
48496810|NCT00950807|156012230|FG009|Treatment Period 3|Adverse Event|0|||
48496811|NCT00619385|156012231|FG000|Overall Study|Adverse Event|0|||
48496812|NCT00619385|156012232|FG001|Overall Study|Adverse Event|0|||
48496813|NCT00619385|156012233|FG002|Overall Study|Adverse Event|3|||
48496814|NCT00619385|156012231|FG000|Overall Study|Other|1|||
48496815|NCT00619385|156012232|FG001|Overall Study|Other|2|||
48496816|NCT00619385|156012233|FG002|Overall Study|Other|1|||
48496817|NCT04591626|156012239|FG000|Overall Study|Adverse Event|4|||
48496818|NCT04591626|156012240|FG001|Overall Study|Adverse Event|0|||
48496819|NCT04591626|156012239|FG000|Overall Study|Withdrawal by Subject|5|||
48496820|NCT04591626|156012240|FG001|Overall Study|Withdrawal by Subject|3|||
48496821|NCT04591626|156012239|FG000|Overall Study|Physician Decision|0|||
48496822|NCT04591626|156012240|FG001|Overall Study|Physician Decision|1|||
48715232|NCT00228553|156806614|FG000|Overall Study|Withdrawal by Subject|115|||
48813414|NCT01533714|157157450|FG002|Overall Study|Lack of Efficacy|0|||
48813415|NCT01533714|157157451|FG003|Overall Study|Lack of Efficacy|0|||
48813416|NCT01533714|157157452|FG004|Overall Study|Lack of Efficacy|0|||
48813417|NCT01533714|157157453|FG005|Overall Study|Lack of Efficacy|1|||
48813418|NCT01533714|157157448|FG000|Overall Study|Withdrawal by Subject|0|||
48813419|NCT01533714|157157449|FG001|Overall Study|Withdrawal by Subject|1|||
48813420|NCT01533714|157157450|FG002|Overall Study|Withdrawal by Subject|0|||
48496823|NCT04591626|156012239|FG000|Overall Study|Death|0|||
48496824|NCT04591626|156012240|FG001|Overall Study|Death|1|||
48496825|NCT04591626|156012239|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48496826|NCT04591626|156012240|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48496827|NCT01922349|156012242|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
48496828|NCT01922349|156012243|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
48496829|NCT01922349|156012244|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
48715233|NCT00228553|156806614|FG000|Overall Study|Pregnancy|2|||
48715234|NCT00228553|156806614|FG000|Overall Study|Miscellaneous|46|||
48813421|NCT01533714|157157451|FG003|Overall Study|Withdrawal by Subject|1|||
48813422|NCT01533714|157157452|FG004|Overall Study|Withdrawal by Subject|1|||
48813423|NCT01533714|157157453|FG005|Overall Study|Withdrawal by Subject|0|||
48496830|NCT01922349|156012245|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
48496831|NCT02097121|156012246|FG000|Overall Study|Other, not specified|4|||
48496832|NCT02097121|156012247|FG001|Overall Study|Other, not specified|2|||
48496833|NCT02097121|156012248|FG002|Overall Study|Other, not specified|3|||
48496834|NCT02097121|156012246|FG000|Overall Study|Lack of Efficacy|2|||
48496835|NCT02097121|156012247|FG001|Overall Study|Lack of Efficacy|1|||
48496836|NCT02097121|156012248|FG002|Overall Study|Lack of Efficacy|3|||
48496837|NCT02097121|156012246|FG000|Overall Study|Withdrawal by Subject|0|||
48496838|NCT02097121|156012247|FG001|Overall Study|Withdrawal by Subject|1|||
48496839|NCT02097121|156012248|FG002|Overall Study|Withdrawal by Subject|2|||
48496840|NCT02097121|156012246|FG000|Overall Study|Adverse Event|0|||
48496841|NCT02097121|156012247|FG001|Overall Study|Adverse Event|1|||
48496842|NCT02097121|156012248|FG002|Overall Study|Adverse Event|0|||
48496843|NCT02097121|156012246|FG000|Overall Study|Lost to Follow-up|1|||
48496844|NCT02097121|156012247|FG001|Overall Study|Lost to Follow-up|1|||
48496845|NCT02097121|156012248|FG002|Overall Study|Lost to Follow-up|2|||
48496846|NCT02097290|156012249|FG000|Overall Study|Death|6|||
48496847|NCT02097290|156012249|FG000|Overall Study|Total Withdrawals|3|||
48496848|NCT02097290|156012249|FG000|Overall Study|Attempt|8|||
48496849|NCT00661505|156012250|FG000|Overall Study|Adverse Event|3|||
48496850|NCT00661505|156012250|FG000|Overall Study|Protocol Violation|14|||
48496851|NCT00661505|156012250|FG000|Overall Study|Withdrawal by Subject|8|||
48496852|NCT00661505|156012250|FG000|Overall Study|Lost to Follow-up|3|||
48496853|NCT00661505|156012250|FG000|Overall Study|Other|2|||
48496854|NCT04534283|156012251|FG000|Overall Study|Physician Decision|2|||
48496855|NCT04534283|156012251|FG000|Overall Study|Withdrawal by Subject|1|||
48496856|NCT04534283|156012251|FG000|Overall Study|Disease Progression|12|||
48496857|NCT04534283|156012251|FG000|Overall Study|Adverse Event|1|||
48496858|NCT01575054|156012255|FG000|Overall Study|Other Reasons|5|||
48496859|NCT01575054|156012256|FG001|Overall Study|Other Reasons|3|||
48496860|NCT01575054|156012255|FG000|Overall Study|Protocol Violation|2|||
48496861|NCT01575054|156012256|FG001|Overall Study|Protocol Violation|1|||
48496862|NCT01575054|156012255|FG000|Overall Study|Personal Reasons|10|||
48496863|NCT01575054|156012256|FG001|Overall Study|Personal Reasons|11|||
48496864|NCT01575054|156012255|FG000|Overall Study|Lost to Follow-up|3|||
48496865|NCT01575054|156012256|FG001|Overall Study|Lost to Follow-up|3|||
48496866|NCT01575054|156012255|FG000|Overall Study|Adverse Event|9|||
48496867|NCT01575054|156012256|FG001|Overall Study|Adverse Event|8|||
48496868|NCT02888171|156012257|FG000|Overall Study|Lost to Follow-up|2|||
48496869|NCT02888171|156012258|FG001|Overall Study|Lost to Follow-up|1|||
48496870|NCT02888171|156012257|FG000|Overall Study|Withdrawal by Subject|3|||
48496871|NCT02888171|156012258|FG001|Overall Study|Withdrawal by Subject|2|||
48496872|NCT02888171|156012257|FG000|Overall Study|Adverse Event|0|||
48496873|NCT02888171|156012258|FG001|Overall Study|Adverse Event|1|||
48496874|NCT02178709|156014404|FG000|Overall Study|Adverse Event|5|||
48496875|NCT02178709|156014404|FG000|Overall Study|Death|2|||
48496876|NCT02178709|156014404|FG000|Overall Study|Withdrawal by Subject|2|||
48496877|NCT02178709|156014404|FG000|Overall Study|Physician Decision|2|||
48496878|NCT02178709|156014404|FG000|Overall Study|Disease Progression|5|||
48496879|NCT02946385|156014405|FG000|Overall Study|Lost to Follow-up|0|||
48496880|NCT02946385|156014406|FG001|Overall Study|Lost to Follow-up|0|||
48496881|NCT02946385|156014407|FG002|Overall Study|Lost to Follow-up|3|||
48496882|NCT02946385|156014408|FG003|Overall Study|Lost to Follow-up|0|||
48496883|NCT02946385|156014409|FG004|Overall Study|Lost to Follow-up|2|||
48496884|NCT02946385|156014410|FG005|Overall Study|Lost to Follow-up|1|||
48496885|NCT01241461|156014411|FG000|Overall Study|Progressive Disease|3|||
48496886|NCT01241461|156014412|FG001|Overall Study|Progressive Disease|6|||
48496887|NCT01144663|156014413|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
48496888|NCT01144663|156014414|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
48496889|NCT01144663|156014415|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
48496890|NCT01144663|156014416|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
48496891|NCT01144663|156014413|FG000|Primary Vaccination Phase|Adverse Event|1|||
48496892|NCT01144663|156014414|FG001|Primary Vaccination Phase|Adverse Event|0|||
48496893|NCT01144663|156014415|FG002|Primary Vaccination Phase|Adverse Event|0|||
48496894|NCT01144663|156014416|FG003|Primary Vaccination Phase|Adverse Event|1|||
48496895|NCT01144663|156014413|FG000|Primary Vaccination Phase|Protocol Violation|2|||
48496896|NCT01144663|156014414|FG001|Primary Vaccination Phase|Protocol Violation|0|||
48715235|NCT00539188|156806617|FG000|Overall Study|Withdrawal by Subject|1|||
48496897|NCT01144663|156014415|FG002|Primary Vaccination Phase|Protocol Violation|1|||
48496898|NCT01144663|156014416|FG003|Primary Vaccination Phase|Protocol Violation|0|||
48496899|NCT01144663|156014413|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
48496900|NCT01144663|156014414|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
48496901|NCT01144663|156014415|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
48496902|NCT01144663|156014416|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
48496903|NCT01144663|156014413|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
48715236|NCT00539188|156806618|FG001|Overall Study|Withdrawal by Subject|0|||
48715237|NCT00539188|156806617|FG000|Overall Study|Lost to Follow-up|2|||
48715238|NCT00539188|156806618|FG001|Overall Study|Lost to Follow-up|1|||
48496904|NCT01144663|156014414|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
48496905|NCT01144663|156014415|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
48496906|NCT01144663|156014416|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
48496907|NCT01144663|156014413|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
48496908|NCT01144663|156014414|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
48496909|NCT01144663|156014415|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
48496910|NCT01144663|156014416|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
48496911|NCT01144663|156014413|FG000|Primary Vaccination Phase|Other|0|||
48496912|NCT01144663|156014414|FG001|Primary Vaccination Phase|Other|1|||
48496913|NCT01144663|156014415|FG002|Primary Vaccination Phase|Other|0|||
48496914|NCT01144663|156014416|FG003|Primary Vaccination Phase|Other|2|||
48496915|NCT01144663|156014413|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
48496916|NCT01144663|156014414|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
48496917|NCT01144663|156014415|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
48496918|NCT01144663|156014416|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
48496919|NCT01144663|156014413|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
48496920|NCT01144663|156014414|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
48496921|NCT01144663|156014415|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
48496922|NCT01144663|156014416|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
48496923|NCT01144663|156014413|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
48496924|NCT01144663|156014414|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
48496925|NCT01144663|156014415|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
48496926|NCT01144663|156014416|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
48715239|NCT01233232|156806619|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
48715240|NCT01233232|156806620|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
48715241|NCT01233232|156806621|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
48496927|NCT01144663|156014413|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
48496928|NCT01144663|156014414|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
48496929|NCT01144663|156014415|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
48496930|NCT01144663|156014416|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
48496931|NCT01144663|156014413|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
48496932|NCT01144663|156014414|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
48496933|NCT01144663|156014415|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
48496934|NCT01144663|156014416|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
48496935|NCT01144663|156014413|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
48715242|NCT01536392|156806627|FG000|Overall Study|Adverse Event|2|||
48715243|NCT01536392|156806628|FG001|Overall Study|Adverse Event|2|||
48715244|NCT01536392|156806627|FG000|Overall Study|Physician Decision|2|||
48715245|NCT01536392|156806628|FG001|Overall Study|Physician Decision|3|||
48715246|NCT01536392|156806627|FG000|Overall Study|Withdrawal by Subject|3|||
48715247|NCT01536392|156806628|FG001|Overall Study|Withdrawal by Subject|6|||
48715248|NCT01536392|156806627|FG000|Overall Study|Non Compliance|3|||
48715249|NCT01536392|156806628|FG001|Overall Study|Non Compliance|4|||
48715250|NCT01536392|156806627|FG000|Overall Study|Completed therapy early|3|||
48715251|NCT01536392|156806628|FG001|Overall Study|Completed therapy early|0|||
48715252|NCT03113136|156806630|FG000|Overall Study|Lost to Follow-up|22|||
48715253|NCT03113136|156806631|FG001|Overall Study|Lost to Follow-up|47|||
48715254|NCT03113136|156806632|FG002|Overall Study|Lost to Follow-up|54|||
48715255|NCT03113136|156806630|FG000|Overall Study|Withdrawal by Subject|4|||
48715256|NCT03113136|156806631|FG001|Overall Study|Withdrawal by Subject|13|||
48715257|NCT03113136|156806632|FG002|Overall Study|Withdrawal by Subject|14|||
48715258|NCT03113136|156806630|FG000|Overall Study|Ineligible|0|||
48715259|NCT03113136|156806631|FG001|Overall Study|Ineligible|2|||
48715260|NCT03113136|156806632|FG002|Overall Study|Ineligible|1|||
48715261|NCT03113136|156806630|FG000|Overall Study|Study Team Decision|1|||
48715262|NCT03113136|156806631|FG001|Overall Study|Study Team Decision|4|||
48715263|NCT03113136|156806632|FG002|Overall Study|Study Team Decision|0|||
48715264|NCT04345367|156806633|FG000|Overall Study|Other|3|||
48715265|NCT04345367|156806634|FG001|Overall Study|Other|4|||
48496936|NCT01144663|156014414|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
48496937|NCT01144663|156014415|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
48496938|NCT01144663|156014416|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
48496939|NCT02524379|156014426|FG000|Overall Study|Death|1|||
48496940|NCT01367275|156014427|FG000|Overall Study|Ineligible|1|||
48496941|NCT01367275|156014427|FG000|Overall Study|Disease Progression|2|||
48496942|NCT00721409|156014431|FG000|Overall Study|Global deterioration of health status|2|||
48496943|NCT00721409|156014432|FG001|Overall Study|Global deterioration of health status|6|||
48715266|NCT04345367|156806633|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
48715267|NCT04345367|156806634|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
48715268|NCT04345367|156806633|FG000|Overall Study|Withdrawal by Subject|11|||
48715269|NCT04345367|156806634|FG001|Overall Study|Withdrawal by Subject|11|||
48715270|NCT04345367|156806633|FG000|Overall Study|Protocol Violation|4|||
48496944|NCT00721409|156014433|FG002|Overall Study|Global deterioration of health status|3|||
48496945|NCT00721409|156014431|FG000|Overall Study|Death|0|||
48496946|NCT00721409|156014432|FG001|Overall Study|Death|1|||
48496947|NCT00721409|156014433|FG002|Overall Study|Death|0|||
48496948|NCT00721409|156014431|FG000|Overall Study|Randomized not Treated|0|||
48496949|NCT00721409|156014432|FG001|Overall Study|Randomized not Treated|1|||
48496950|NCT00721409|156014433|FG002|Overall Study|Randomized not Treated|4|||
48715271|NCT04345367|156806634|FG001|Overall Study|Protocol Violation|3|||
48715272|NCT04345367|156806633|FG000|Overall Study|Lost to Follow-up|2|||
48715273|NCT04345367|156806634|FG001|Overall Study|Lost to Follow-up|4|||
48715274|NCT04345367|156806633|FG000|Overall Study|Lack of Efficacy|2|||
48496951|NCT00721409|156014431|FG000|Overall Study|Reason not specified|1|||
48496952|NCT00721409|156014432|FG001|Overall Study|Reason not specified|0|||
48496953|NCT00721409|156014433|FG002|Overall Study|Reason not specified|2|||
48715275|NCT04345367|156806634|FG001|Overall Study|Lack of Efficacy|0|||
48715276|NCT04345367|156806633|FG000|Overall Study|Death|2|||
48715277|NCT04345367|156806634|FG001|Overall Study|Death|0|||
48715278|NCT04345367|156806633|FG000|Overall Study|Adverse Event|10|||
48715279|NCT04345367|156806634|FG001|Overall Study|Adverse Event|9|||
48715280|NCT01578850|156806635|FG000|Period 1|Insufficient Clinical Response|1|||
48715281|NCT01578850|156806636|FG001|Period 1|Insufficient Clinical Response|0|||
48715282|NCT01578850|156806637|FG002|Period 1|Insufficient Clinical Response|0|||
48715283|NCT01578850|156806635|FG000|Period 1|Adverse Event|11|||
48715284|NCT01578850|156806636|FG001|Period 1|Adverse Event|0|||
48715285|NCT01578850|156806637|FG002|Period 1|Adverse Event|0|||
48715286|NCT01578850|156806635|FG000|Period 1|Death|1|||
48715287|NCT01578850|156806636|FG001|Period 1|Death|0|||
48715288|NCT01578850|156806637|FG002|Period 1|Death|0|||
48715289|NCT01578850|156806635|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
48715290|NCT01578850|156806636|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
48715291|NCT01578850|156806637|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
48715292|NCT01578850|156806635|FG000|Period 1|Withdrawal by Subject|9|||
48715293|NCT01578850|156806636|FG001|Period 1|Withdrawal by Subject|0|||
48715294|NCT01578850|156806637|FG002|Period 1|Withdrawal by Subject|0|||
48496954|NCT00721409|156014431|FG000|Overall Study|Adverse Event|0|||
48496955|NCT00721409|156014432|FG001|Overall Study|Adverse Event|13|||
48496956|NCT00721409|156014433|FG002|Overall Study|Adverse Event|2|||
48496957|NCT00721409|156014431|FG000|Overall Study|Lost to Follow-up|0|||
48496958|NCT00721409|156014432|FG001|Overall Study|Lost to Follow-up|0|||
48496959|NCT00721409|156014433|FG002|Overall Study|Lost to Follow-up|1|||
48496960|NCT00721409|156014431|FG000|Overall Study|Withdrawal by Subject|1|||
48496961|NCT00721409|156014432|FG001|Overall Study|Withdrawal by Subject|6|||
48496962|NCT00721409|156014433|FG002|Overall Study|Withdrawal by Subject|5|||
48496963|NCT00721409|156014431|FG000|Overall Study|Objective progression or relapse|8|||
48496964|NCT00721409|156014432|FG001|Overall Study|Objective progression or relapse|55|||
48496965|NCT00721409|156014433|FG002|Overall Study|Objective progression or relapse|62|||
48496966|NCT00368966|156014434|FG000|Infant Series|Withdrawal by Subject|11|||
48496967|NCT00368966|156014435|FG001|Infant Series|Withdrawal by Subject|6|||
48496968|NCT00368966|156014434|FG000|Infant Series|Protocol Violation|2|||
48496969|NCT00368966|156014435|FG001|Infant Series|Protocol Violation|1|||
48496970|NCT00368966|156014434|FG000|Infant Series|Lost to Follow-up|2|||
48496971|NCT00368966|156014435|FG001|Infant Series|Lost to Follow-up|0|||
48496972|NCT00368966|156014434|FG000|Infant Series|Randomization error|0|||
48496973|NCT00368966|156014435|FG001|Infant Series|Randomization error|1|||
48496974|NCT00368966|156014434|FG000|Infant Series|Failed to meet eligibility criteria|0|||
48496975|NCT00368966|156014435|FG001|Infant Series|Failed to meet eligibility criteria|1|||
48496976|NCT00368966|156014434|FG000|Infant Series|Adverse Event|0|||
48496977|NCT00368966|156014435|FG001|Infant Series|Adverse Event|1|||
48496978|NCT00368966|156014434|FG000|Infant Series|Failed to return|1|||
48496979|NCT00368966|156014435|FG001|Infant Series|Failed to return|0|||
48496980|NCT00368966|156014434|FG000|After Infant|Failed to return|3|||
48496981|NCT00368966|156014435|FG001|After Infant|Failed to return|1|||
48496982|NCT00368966|156014434|FG000|After Infant|Adverse Event|1|||
48496983|NCT00368966|156014435|FG001|After Infant|Adverse Event|2|||
48496984|NCT00368966|156014434|FG000|After Infant|Withdrawal by Subject|1|||
48496985|NCT00368966|156014435|FG001|After Infant|Withdrawal by Subject|1|||
48496986|NCT00368966|156014434|FG000|After Infant|Death|1|||
48496987|NCT00368966|156014435|FG001|After Infant|Death|0|||
48496988|NCT00368966|156014434|FG000|After Infant|Lost to Follow-up|0|||
48715295|NCT01578850|156806635|FG000|Period 1|Study Terminated by Sponsor|3|||
48715296|NCT01578850|156806636|FG001|Period 1|Study Terminated by Sponsor|0|||
48715297|NCT01578850|156806637|FG002|Period 1|Study Terminated by Sponsor|0|||
48496989|NCT00368966|156014435|FG001|After Infant|Lost to Follow-up|1|||
48496990|NCT00368966|156014434|FG000|Toddler Dose|Withdrawal by Subject|1|||
48715298|NCT01578850|156806635|FG000|Period 2|Insufficient Clinical Response|0|||
48715299|NCT01578850|156806636|FG001|Period 2|Insufficient Clinical Response|1|||
48715300|NCT01578850|156806637|FG002|Period 2|Insufficient Clinical Response|0|||
48715301|NCT01578850|156806635|FG000|Period 2|Adverse Event|0|||
48715302|NCT01578850|156806636|FG001|Period 2|Adverse Event|3|||
48496991|NCT00368966|156014435|FG001|Toddler Dose|Withdrawal by Subject|1|||
48496992|NCT00368966|156014434|FG000|Toddler Dose|Lost to Follow-up|0|||
48496993|NCT00368966|156014435|FG001|Toddler Dose|Lost to Follow-up|2|||
48496994|NCT01901055|156014440|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
48496995|NCT01901055|156014441|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
48496996|NCT01901055|156014440|FG000|Randomization But Not Titrated|Physician Decision|0|||
48496997|NCT01901055|156014441|FG001|Randomization But Not Titrated|Physician Decision|1|||
48496998|NCT01901055|156014440|FG000|Started Protocol to Week 6|Physician Decision|2|||
48496999|NCT01901055|156014441|FG001|Started Protocol to Week 6|Physician Decision|1|||
48497000|NCT01901055|156014440|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
48497001|NCT01901055|156014441|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
48497002|NCT01901055|156014440|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
48497003|NCT01901055|156014441|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
48497004|NCT01901055|156014440|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
48497005|NCT01901055|156014441|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
48497006|NCT01901055|156014440|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
48497007|NCT01901055|156014441|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
48497008|NCT01901055|156014440|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
48497009|NCT01901055|156014441|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
48497010|NCT01901055|156014440|FG000|Week 24|Withdrawal by Subject|13|||
48497011|NCT01901055|156014441|FG001|Week 24|Withdrawal by Subject|19|||
48497012|NCT01901055|156014440|FG000|Week 24|Physician Decision|1|||
48497013|NCT01901055|156014441|FG001|Week 24|Physician Decision|0|||
48497014|NCT01901055|156014440|FG000|Week 36|Withdrawal by Subject|0|||
48497015|NCT01901055|156014441|FG001|Week 36|Withdrawal by Subject|5|||
48497016|NCT00454636|156014444|FG000|Overall Study|Adverse Event|10|||
48497017|NCT00454636|156014445|FG001|Overall Study|Adverse Event|6|||
48497018|NCT00454636|156014446|FG002|Overall Study|Adverse Event|9|||
48497019|NCT00454636|156014447|FG003|Overall Study|Adverse Event|15|||
48497020|NCT00454636|156014444|FG000|Overall Study|Disease Progression|11|||
48497021|NCT00454636|156014445|FG001|Overall Study|Disease Progression|12|||
48497022|NCT00454636|156014446|FG002|Overall Study|Disease Progression|4|||
48497023|NCT00454636|156014447|FG003|Overall Study|Disease Progression|11|||
48497024|NCT00454636|156014444|FG000|Overall Study|Protocol Violation|3|||
48497025|NCT00454636|156014445|FG001|Overall Study|Protocol Violation|2|||
48497026|NCT00454636|156014446|FG002|Overall Study|Protocol Violation|3|||
48497027|NCT00454636|156014447|FG003|Overall Study|Protocol Violation|3|||
48497028|NCT00454636|156014444|FG000|Overall Study|Death|6|||
48497029|NCT00454636|156014445|FG001|Overall Study|Death|1|||
48497030|NCT00454636|156014446|FG002|Overall Study|Death|1|||
48715303|NCT01578850|156806637|FG002|Period 2|Adverse Event|6|||
48715304|NCT01578850|156806635|FG000|Period 2|Lost to Follow-up|0|||
48715305|NCT01578850|156806636|FG001|Period 2|Lost to Follow-up|1|||
48715306|NCT01578850|156806637|FG002|Period 2|Lost to Follow-up|2|||
48715307|NCT01578850|156806635|FG000|Period 2|Withdrawal by Subject|0|||
48715308|NCT01578850|156806636|FG001|Period 2|Withdrawal by Subject|2|||
48715309|NCT01578850|156806637|FG002|Period 2|Withdrawal by Subject|2|||
48497031|NCT00454636|156014447|FG003|Overall Study|Death|1|||
48497032|NCT00454636|156014444|FG000|Overall Study|Patient refusal|1|||
48497033|NCT00454636|156014445|FG001|Overall Study|Patient refusal|1|||
48715310|NCT01578850|156806635|FG000|Period 2|Study Terminated by Sponsor|0|||
48715311|NCT01578850|156806636|FG001|Period 2|Study Terminated by Sponsor|5|||
48715312|NCT01578850|156806637|FG002|Period 2|Study Terminated by Sponsor|4|||
48715313|NCT01578850|156806635|FG000|Period 2|Unspecified Reasons|0|||
48715314|NCT01578850|156806636|FG001|Period 2|Unspecified Reasons|1|||
48715315|NCT01578850|156806637|FG002|Period 2|Unspecified Reasons|0|||
48715316|NCT02756806|156806639|FG000|Overall Study|Study terminated early|5|||
48715317|NCT00750152|156806640|FG000|Overall Study|Adverse Event|2|||
48715318|NCT00750152|156806641|FG001|Overall Study|Adverse Event|1|||
48715319|NCT00750152|156806640|FG000|Overall Study|Lost to Follow-up|8|||
48715320|NCT00750152|156806641|FG001|Overall Study|Lost to Follow-up|13|||
48715321|NCT00750152|156806640|FG000|Overall Study|Withdrawal by Subject|3|||
48715322|NCT00750152|156806641|FG001|Overall Study|Withdrawal by Subject|3|||
48715323|NCT00750152|156806640|FG000|Overall Study|Physician Decision|1|||
48715324|NCT00750152|156806641|FG001|Overall Study|Physician Decision|1|||
48715325|NCT00750152|156806640|FG000|Overall Study|Non-compliance|0|||
48497034|NCT00454636|156014446|FG002|Overall Study|Patient refusal|3|||
48497035|NCT00454636|156014447|FG003|Overall Study|Patient refusal|2|||
48497036|NCT00454636|156014444|FG000|Overall Study|Lost to Follow-up|0|||
48497037|NCT00454636|156014445|FG001|Overall Study|Lost to Follow-up|1|||
48497038|NCT00454636|156014446|FG002|Overall Study|Lost to Follow-up|0|||
48497039|NCT00454636|156014447|FG003|Overall Study|Lost to Follow-up|0|||
48497040|NCT02536378|156014448|FG000|Overall Study|Physician Decision|0|||
48715326|NCT00750152|156806641|FG001|Overall Study|Non-compliance|1|||
48715327|NCT00750152|156806640|FG000|Overall Study|Termination by sponsor|1|||
48715328|NCT00750152|156806641|FG001|Overall Study|Termination by sponsor|0|||
48715329|NCT00750152|156806640|FG000|Overall Study|Other|7|||
48715330|NCT00750152|156806641|FG001|Overall Study|Other|8|||
48715331|NCT01008423|156806642|FG000|Overall Study|Adverse Event|13|||
48715332|NCT01008423|156806643|FG001|Overall Study|Adverse Event|6|||
48715333|NCT01008423|156806642|FG000|Overall Study|Withdrawal by Subject|4|||
48715334|NCT01008423|156806643|FG001|Overall Study|Withdrawal by Subject|7|||
48715335|NCT01008423|156806642|FG000|Overall Study|Lost to Follow-up|0|||
48715336|NCT01008423|156806643|FG001|Overall Study|Lost to Follow-up|2|||
48715337|NCT01008423|156806642|FG000|Overall Study|Low Cortisol|0|||
48715338|NCT01008423|156806643|FG001|Overall Study|Low Cortisol|1|||
48715339|NCT01008423|156806642|FG000|Overall Study|Lack of Efficacy|0|||
48715340|NCT01008423|156806643|FG001|Overall Study|Lack of Efficacy|5|||
48715341|NCT01008423|156806642|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
48715342|NCT01008423|156806643|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
48715343|NCT01008423|156806642|FG000|Overall Study|Personal Conflict|1|||
48715344|NCT01008423|156806643|FG001|Overall Study|Personal Conflict|0|||
48715345|NCT01008423|156806642|FG000|Overall Study|Other|0|||
48715346|NCT01008423|156806643|FG001|Overall Study|Other|1|||
48715347|NCT01214395|156806644|FG000|Overall Study|All patients had infection|5|||
48715348|NCT02365233|156806646|FG000|Overall Study|IRB withheld the data|1|||
48715349|NCT02365233|156806647|FG001|Overall Study|IRB withheld the data|2|||
48715350|NCT02365233|156806648|FG002|Overall Study|IRB withheld the data|2|||
48715351|NCT02270944|156806649|FG000|Overall Study|Lost to Follow-up|9|||
48715352|NCT02270944|156806650|FG001|Overall Study|Lost to Follow-up|4|||
48715353|NCT02270944|156806649|FG000|Overall Study|Withdrawal by Subject|2|||
48715354|NCT02270944|156806650|FG001|Overall Study|Withdrawal by Subject|1|||
48715355|NCT01030666|156806651|FG000|Overall Study|Lost to Follow-up|3|||
48715356|NCT01030666|156806652|FG001|Overall Study|Lost to Follow-up|2|||
48715357|NCT01700439|156806659|FG000|Overall Study|Lost to Follow-up|47|||
48715358|NCT01700439|156806659|FG000|Overall Study|Withdrawal by Subject|183|||
48715359|NCT01700439|156806659|FG000|Overall Study|Death|186|||
48715360|NCT01865552|156808213|FG000|Period 1|Adverse Event|1|||
48715361|NCT01865552|156808214|FG001|Period 1|Adverse Event|0|||
48715362|NCT01865552|156808215|FG002|Period 1|Adverse Event|0|||
48715363|NCT01865552|156808216|FG003|Period 1|Adverse Event|1|||
48715364|NCT01865552|156808217|FG004|Period 1|Adverse Event|1|||
48715365|NCT01865552|156808218|FG005|Period 1|Adverse Event|1|||
48715366|NCT01865552|156808213|FG000|Period 1|Pathological lab|0|||
48715367|NCT01865552|156808214|FG001|Period 1|Pathological lab|0|||
48715368|NCT01865552|156808215|FG002|Period 1|Pathological lab|0|||
48715369|NCT01865552|156808216|FG003|Period 1|Pathological lab|0|||
48715370|NCT01865552|156808217|FG004|Period 1|Pathological lab|1|||
48715371|NCT01865552|156808218|FG005|Period 1|Pathological lab|0|||
48715372|NCT01865552|156808213|FG000|Period 1|Other|0|||
48715373|NCT01865552|156808214|FG001|Period 1|Other|0|||
48715374|NCT01865552|156808215|FG002|Period 1|Other|0|||
48715375|NCT01865552|156808216|FG003|Period 1|Other|0|||
48715376|NCT01865552|156808217|FG004|Period 1|Other|1|||
48715377|NCT01865552|156808218|FG005|Period 1|Other|0|||
48497041|NCT02536378|156014449|FG001|Overall Study|Physician Decision|2|||
48497042|NCT02536378|156014448|FG000|Overall Study|Withdrawal by Subject|0|||
48497043|NCT02536378|156014449|FG001|Overall Study|Withdrawal by Subject|1|||
48497044|NCT02536378|156014448|FG000|Overall Study|Death|1|||
48497045|NCT02536378|156014449|FG001|Overall Study|Death|2|||
48497046|NCT02536378|156014448|FG000|Overall Study|Patient refused further follow up|6|||
48497047|NCT02536378|156014449|FG001|Overall Study|Patient refused further follow up|2|||
48497048|NCT03019965|156014452|FG000|Overall Study|Withdrawal by Subject|1|||
48497049|NCT03019965|156014453|FG001|Overall Study|Withdrawal by Subject|0|||
48497050|NCT03019965|156014452|FG000|Overall Study|Protocol Violation|1|||
48497051|NCT03019965|156014453|FG001|Overall Study|Protocol Violation|3|||
48497052|NCT03019965|156014452|FG000|Overall Study|viral or fungal infection|3|||
48497053|NCT03019965|156014453|FG001|Overall Study|viral or fungal infection|4|||
48497054|NCT03019965|156014452|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
48497055|NCT03019965|156014453|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
48497056|NCT03019965|156014452|FG000|Overall Study|Physician Decision|1|||
48497057|NCT03019965|156014453|FG001|Overall Study|Physician Decision|1|||
48497058|NCT01659567|156014454|FG000|Overall Study|Lack of Efficacy|22|||
48497059|NCT01659567|156014454|FG000|Overall Study|Switched to Pegferon|6|||
48497060|NCT01659567|156014454|FG000|Overall Study|Adverse Event|12|||
48497061|NCT01659567|156014454|FG000|Overall Study|Good result at early stage of treatment|5|||
48715378|NCT01256294|156808223|FG000|Overall Study|Adverse Event|1|||
48715379|NCT01256294|156808224|FG001|Overall Study|Adverse Event|0|||
48715380|NCT01256294|156808223|FG000|Overall Study|Withdrawal by Subject|1|||
48715381|NCT01256294|156808224|FG001|Overall Study|Withdrawal by Subject|1|||
48715382|NCT01256294|156808223|FG000|Overall Study|Protocol deviation|2|||
48715383|NCT01256294|156808224|FG001|Overall Study|Protocol deviation|1|||
48715384|NCT04681352|156808225|FG000|Overall Study|Lost to Follow-up|2|||
48715385|NCT04681352|156808225|FG000|Overall Study|Withdrawal by Subject|22|||
48715386|NCT01193257|156808228|FG000|Overall Study|Death|202|||
48715387|NCT01193257|156808229|FG001|Overall Study|Death|391|||
48813424|NCT01533714|157157448|FG000|Overall Study|Exclusion criteria|0|||
48715388|NCT01193257|156808228|FG000|Overall Study|Study termination by sponsor|0|||
48715389|NCT01193257|156808229|FG001|Overall Study|Study termination by sponsor|3|||
48715390|NCT01193257|156808228|FG000|Overall Study|Withdrawal by Subject|26|||
48715391|NCT01193257|156808229|FG001|Overall Study|Withdrawal by Subject|86|||
48715392|NCT01193257|156808228|FG000|Overall Study|Lost to Follow-up|2|||
48715393|NCT01193257|156808229|FG001|Overall Study|Lost to Follow-up|3|||
48715394|NCT01193257|156808228|FG000|Overall Study|Unblinded due to futility|135|||
48715395|NCT01193257|156808229|FG001|Overall Study|Unblinded due to futility|251|||
48715396|NCT02156271|156808230|FG000|Overall Study|Physician Decision|4|||
48715397|NCT02156271|156808231|FG001|Overall Study|Physician Decision|3|||
48715398|NCT02123251|156808232|FG000|Overall Study|Death|1|||
48715399|NCT02123251|156808233|FG001|Overall Study|Death|1|||
48497062|NCT01659567|156014454|FG000|Overall Study|Withdrawal by Subject|64|||
48497063|NCT01659567|156014454|FG000|Overall Study|Progression of the main disease|1|||
48715400|NCT02123251|156808232|FG000|Overall Study|Withdrawal by Subject|0|||
48715401|NCT02123251|156808233|FG001|Overall Study|Withdrawal by Subject|3|||
48715402|NCT02123251|156808232|FG000|Overall Study|Lost Medicaid eligibility|29|||
48715403|NCT02123251|156808233|FG001|Overall Study|Lost Medicaid eligibility|22|||
48715404|NCT02123251|156808232|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
48715405|NCT02123251|156808233|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
48715406|NCT00724711|156808234|FG000|Overall Study|Adverse Event|7|||
48715407|NCT00724711|156808235|FG001|Overall Study|Adverse Event|3|||
48715408|NCT00724711|156808234|FG000|Overall Study|Pregnancy|0|||
48715409|NCT00724711|156808235|FG001|Overall Study|Pregnancy|1|||
48715410|NCT00724711|156808234|FG000|Overall Study|Lack of Efficacy|0|||
48715411|NCT00724711|156808235|FG001|Overall Study|Lack of Efficacy|1|||
48715412|NCT00724711|156808234|FG000|Overall Study|Physician Decision|0|||
48715413|NCT00724711|156808235|FG001|Overall Study|Physician Decision|3|||
48715414|NCT00724711|156808234|FG000|Overall Study|Withdrawal by Subject|5|||
48715415|NCT00724711|156808235|FG001|Overall Study|Withdrawal by Subject|4|||
48715416|NCT00724711|156808234|FG000|Overall Study|Lost to Follow-up|4|||
48715417|NCT00724711|156808235|FG001|Overall Study|Lost to Follow-up|5|||
48715418|NCT00724711|156808234|FG000|Overall Study|Protocol Violation|1|||
48715419|NCT00724711|156808235|FG001|Overall Study|Protocol Violation|0|||
48715420|NCT01168219|156808236|FG000|Overall Study|off study before starting treatment|2|||
48715421|NCT01168219|156808236|FG000|Overall Study|withdrew before transplant|1|||
48715422|NCT01168219|156808236|FG000|Overall Study|ineligible due to CML|2|||
48715423|NCT03254108|156808237|FG000|Overall Study|Adverse Event|0|||
48715424|NCT03254108|156808238|FG001|Overall Study|Adverse Event|2|||
48715425|NCT03254108|156808239|FG002|Overall Study|Adverse Event|0|||
48715426|NCT03254108|156808240|FG003|Overall Study|Adverse Event|1|||
48715427|NCT03254108|156808241|FG004|Overall Study|Adverse Event|1|||
48715428|NCT03254108|156808237|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
48715429|NCT03254108|156808238|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
48813425|NCT01533714|157157449|FG001|Overall Study|Exclusion criteria|1|||
48813426|NCT01533714|157157450|FG002|Overall Study|Exclusion criteria|0|||
48813427|NCT01533714|157157451|FG003|Overall Study|Exclusion criteria|0|||
48813428|NCT01533714|157157452|FG004|Overall Study|Exclusion criteria|0|||
48813429|NCT01533714|157157453|FG005|Overall Study|Exclusion criteria|0|||
48813430|NCT01533714|157157448|FG000|Overall Study|Positive for purified protein derivative|0|||
48813431|NCT01533714|157157449|FG001|Overall Study|Positive for purified protein derivative|0|||
48813432|NCT01533714|157157450|FG002|Overall Study|Positive for purified protein derivative|1|||
48813433|NCT01533714|157157451|FG003|Overall Study|Positive for purified protein derivative|0|||
48813434|NCT01533714|157157452|FG004|Overall Study|Positive for purified protein derivative|1|||
48813435|NCT01533714|157157453|FG005|Overall Study|Positive for purified protein derivative|0|||
48813436|NCT01533714|157157448|FG000|Overall Study|Withdrawal criteria|0|||
48497064|NCT01659567|156014454|FG000|Overall Study|Other|13|||
48497065|NCT03213210|156014457|FG000|Overall Study|Lost to Follow-up|2|||
48715430|NCT03254108|156808239|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
48715431|NCT03254108|156808240|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
48813437|NCT01533714|157157449|FG001|Overall Study|Withdrawal criteria|0|||
48813438|NCT01533714|157157450|FG002|Overall Study|Withdrawal criteria|1|||
48813439|NCT01533714|157157451|FG003|Overall Study|Withdrawal criteria|0|||
48813440|NCT01533714|157157452|FG004|Overall Study|Withdrawal criteria|3|||
48813441|NCT01533714|157157453|FG005|Overall Study|Withdrawal criteria|1|||
48497066|NCT03213210|156014457|FG000|Overall Study|Study termination|3|||
48497067|NCT01179919|156014465|FG000|Overall Study|Protocol Violation|1|||
48715432|NCT03254108|156808241|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
48813442|NCT01533714|157157448|FG000|Overall Study|Ineligibility reason|0|||
48497068|NCT01179919|156014465|FG000|Overall Study|Adverse Event|1|||
48715433|NCT00095940|156808244|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
48715434|NCT00095940|156808245|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
48813443|NCT01533714|157157449|FG001|Overall Study|Ineligibility reason|0|||
48813444|NCT01533714|157157450|FG002|Overall Study|Ineligibility reason|0|||
48813445|NCT01533714|157157451|FG003|Overall Study|Ineligibility reason|1|||
48497069|NCT01915732|156014471|FG000|Overall Study|Withdrawal by Subject|18|||
48497070|NCT01915732|156014472|FG001|Overall Study|Withdrawal by Subject|18|||
48497071|NCT01915732|156014471|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
48497072|NCT01915732|156014472|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
48497073|NCT01915732|156014471|FG000|Overall Study|Adverse Event|12|||
48497074|NCT01915732|156014472|FG001|Overall Study|Adverse Event|4|||
48497075|NCT01915732|156014471|FG000|Overall Study|Protocol Violation|5|||
48497076|NCT01915732|156014472|FG001|Overall Study|Protocol Violation|5|||
48497077|NCT01915732|156014471|FG000|Overall Study|Lack of Efficacy|6|||
48497078|NCT01915732|156014472|FG001|Overall Study|Lack of Efficacy|11|||
48497079|NCT01915732|156014471|FG000|Overall Study|Lost to Follow-up|22|||
48497080|NCT01915732|156014472|FG001|Overall Study|Lost to Follow-up|26|||
48497081|NCT01915732|156014471|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
48497082|NCT01915732|156014472|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
48497083|NCT01915732|156014471|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
48813446|NCT01533714|157157452|FG004|Overall Study|Ineligibility reason|0|||
48813447|NCT01533714|157157453|FG005|Overall Study|Ineligibility reason|0|||
48813448|NCT00839917|157157454|FG000|Overall Study|Lost to Follow-up|1|||
48813449|NCT00839917|157157455|FG001|Overall Study|Lost to Follow-up|0|||
48813450|NCT00839917|157157454|FG000|Overall Study|Did not receive vaccine|0|||
48813451|NCT00839917|157157455|FG001|Overall Study|Did not receive vaccine|1|||
48813452|NCT03525574|157157456|FG000|Overall Study|Adverse Event|15|||
48497084|NCT01915732|156014472|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
48497085|NCT01915732|156014471|FG000|Overall Study|Drug Release Error|1|||
48497086|NCT01915732|156014472|FG001|Overall Study|Drug Release Error|0|||
48497087|NCT01915732|156014471|FG000|Overall Study|Recovered|1|||
48715435|NCT00095940|156808246|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
48715436|NCT00095940|156808247|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
48715437|NCT00095940|156808248|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
48715438|NCT00095940|156808249|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
48715439|NCT00095940|156808250|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
48715440|NCT00095940|156808251|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
48715441|NCT00095940|156808252|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
48715442|NCT00095940|156808244|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
48715443|NCT00095940|156808245|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
48715444|NCT00095940|156808246|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
48715445|NCT00095940|156808247|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715446|NCT00095940|156808248|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715447|NCT00095940|156808249|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715448|NCT00095940|156808250|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715449|NCT00095940|156808251|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
48715450|NCT00095940|156808252|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
48715451|NCT00095940|156808244|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715452|NCT00095940|156808245|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715453|NCT00095940|156808246|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715454|NCT00095940|156808247|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715455|NCT00095940|156808248|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715456|NCT00095940|156808249|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715457|NCT00095940|156808250|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715458|NCT00095940|156808251|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
48715459|NCT00095940|156808252|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
48715460|NCT04491604|156808253|FG000|Overall Study|Withdrawal by Subject|3|||
48715461|NCT01175083|156808254|FG000|Primary Epoch|Withdrawal by Subject|0|||
48715462|NCT01175083|156808255|FG001|Primary Epoch|Withdrawal by Subject|0|||
48497088|NCT01915732|156014472|FG001|Overall Study|Recovered|0|||
48497089|NCT01915732|156014471|FG000|Overall Study|Pregnancy|1|||
48497090|NCT01915732|156014472|FG001|Overall Study|Pregnancy|0|||
48497091|NCT01915732|156014471|FG000|Overall Study|Poor Perceived Efficacy|1|||
48497092|NCT01915732|156014472|FG001|Overall Study|Poor Perceived Efficacy|0|||
48497093|NCT01915732|156014471|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
48715463|NCT01175083|156808256|FG002|Primary Epoch|Withdrawal by Subject|0|||
48715464|NCT01175083|156808257|FG003|Primary Epoch|Withdrawal by Subject|0|||
48715465|NCT01175083|156808258|FG004|Primary Epoch|Withdrawal by Subject|0|||
48715466|NCT01175083|156808259|FG005|Primary Epoch|Withdrawal by Subject|2|||
48813453|NCT03525574|157157457|FG001|Overall Study|Adverse Event|0|||
48813454|NCT03525574|157157456|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
48813455|NCT03525574|157157457|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
48813456|NCT03525574|157157456|FG000|Overall Study|Lost to Follow-up|4|||
48813457|NCT03525574|157157457|FG001|Overall Study|Lost to Follow-up|0|||
48813458|NCT03525574|157157456|FG000|Overall Study|Commercial drug is Available for participant|48|||
48813459|NCT03525574|157157457|FG001|Overall Study|Commercial drug is Available for participant|0|||
48813460|NCT03525574|157157456|FG000|Overall Study|Death|1|||
48813461|NCT03525574|157157457|FG001|Overall Study|Death|0|||
48813462|NCT03525574|157157456|FG000|Overall Study|Other non-compliance|2|||
48813463|NCT03525574|157157457|FG001|Overall Study|Other non-compliance|0|||
48813464|NCT03525574|157157456|FG000|Overall Study|Physician Decision|6|||
48813465|NCT03525574|157157457|FG001|Overall Study|Physician Decision|0|||
48813466|NCT03525574|157157456|FG000|Overall Study|Other|58|||
48813467|NCT03525574|157157457|FG001|Overall Study|Other|0|||
48813468|NCT03525574|157157456|FG000|Overall Study|Enrolled but never dosed|1|||
48813469|NCT03525574|157157457|FG001|Overall Study|Enrolled but never dosed|0|||
48813470|NCT03525574|157157456|FG000|Overall Study|Not enrolled in 105 study|0|||
48813471|NCT03525574|157157457|FG001|Overall Study|Not enrolled in 105 study|3|||
48813472|NCT03354637|157157458|FG000|Double-blind Period|Protocol Violation|2|||
48813473|NCT03354637|157157459|FG001|Double-blind Period|Protocol Violation|0|||
48813474|NCT03354637|157157460|FG002|Double-blind Period|Protocol Violation|0|||
48813475|NCT03354637|157157458|FG000|Double-blind Period|Adverse Event|1|||
48813476|NCT03354637|157157459|FG001|Double-blind Period|Adverse Event|2|||
48813477|NCT03354637|157157460|FG002|Double-blind Period|Adverse Event|0|||
48813478|NCT03354637|157157458|FG000|Double-blind Period|Lost to Follow-up|3|||
48813479|NCT03354637|157157459|FG001|Double-blind Period|Lost to Follow-up|4|||
48813480|NCT03354637|157157460|FG002|Double-blind Period|Lost to Follow-up|3|||
48813481|NCT03354637|157157458|FG000|Double-blind Period|Withdrawal by Subject|10|||
48813482|NCT03354637|157157459|FG001|Double-blind Period|Withdrawal by Subject|6|||
48813483|NCT03354637|157157460|FG002|Double-blind Period|Withdrawal by Subject|4|||
48813484|NCT03354637|157157458|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
48813485|NCT03354637|157157459|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
48813486|NCT03354637|157157460|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
48813487|NCT03354637|157157458|FG000|Open Label Extension|Adverse Event|0|||
48813488|NCT03354637|157157459|FG001|Open Label Extension|Adverse Event|0|||
48813489|NCT03354637|157157460|FG002|Open Label Extension|Adverse Event|1|||
48813490|NCT03354637|157157458|FG000|Open Label Extension|Lost to Follow-up|0|||
48813491|NCT03354637|157157459|FG001|Open Label Extension|Lost to Follow-up|0|||
48813492|NCT03354637|157157460|FG002|Open Label Extension|Lost to Follow-up|2|||
48813493|NCT03354637|157157458|FG000|Open Label Extension|Withdrawal by Subject|0|||
48813494|NCT03354637|157157459|FG001|Open Label Extension|Withdrawal by Subject|0|||
48813495|NCT03354637|157157460|FG002|Open Label Extension|Withdrawal by Subject|5|||
48497094|NCT01915732|156014472|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
48497095|NCT01915732|156014471|FG000|Overall Study|Got Well|0|||
48497096|NCT01915732|156014472|FG001|Overall Study|Got Well|1|||
48497097|NCT01915732|156014471|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
48497098|NCT01915732|156014472|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
48715467|NCT01175083|156808254|FG000|Primary Epoch|Lost to Follow-up|0|||
48715468|NCT01175083|156808255|FG001|Primary Epoch|Lost to Follow-up|0|||
48715469|NCT01175083|156808256|FG002|Primary Epoch|Lost to Follow-up|0|||
48715470|NCT01175083|156808257|FG003|Primary Epoch|Lost to Follow-up|0|||
48715471|NCT01175083|156808258|FG004|Primary Epoch|Lost to Follow-up|0|||
48715472|NCT01175083|156808259|FG005|Primary Epoch|Lost to Follow-up|1|||
48715473|NCT01175083|156808254|FG000|Booster Epoch|Death|0|||
48715474|NCT01175083|156808255|FG001|Booster Epoch|Death|0|||
48715475|NCT01175083|156808256|FG002|Booster Epoch|Death|1|||
48715476|NCT01175083|156808257|FG003|Booster Epoch|Death|0|||
48715477|NCT01175083|156808258|FG004|Booster Epoch|Death|0|||
48715478|NCT01175083|156808259|FG005|Booster Epoch|Death|0|||
48715479|NCT01175083|156808254|FG000|Booster Epoch|Withdrawal by Subject|0|||
48715480|NCT01175083|156808255|FG001|Booster Epoch|Withdrawal by Subject|0|||
48813496|NCT03354637|157157458|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
48497099|NCT01915732|156014471|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
48497100|NCT01915732|156014472|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
48497101|NCT01915732|156014471|FG000|Overall Study|Job Transfer|0|||
48497102|NCT01915732|156014472|FG001|Overall Study|Job Transfer|1|||
48497103|NCT01915732|156014471|FG000|Overall Study|Improper Facial Procedure|0|||
48497104|NCT01915732|156014472|FG001|Overall Study|Improper Facial Procedure|1|||
48497105|NCT01915732|156014471|FG000|Overall Study|Poor Conscious Effect|0|||
48715481|NCT01175083|156808256|FG002|Booster Epoch|Withdrawal by Subject|0|||
48715482|NCT01175083|156808257|FG003|Booster Epoch|Withdrawal by Subject|1|||
48715483|NCT01175083|156808258|FG004|Booster Epoch|Withdrawal by Subject|0|||
48715484|NCT01175083|156808259|FG005|Booster Epoch|Withdrawal by Subject|0|||
48715485|NCT02386189|156808271|FG000|Overall Study|Lost to Follow-up|2|||
48813497|NCT03354637|157157459|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
48813498|NCT03354637|157157460|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
48813499|NCT03354637|157157458|FG000|Open Label Extension|Subject Noncompliance|0|||
48715486|NCT02386189|156808272|FG001|Overall Study|Lost to Follow-up|3|||
48715487|NCT02386189|156808271|FG000|Overall Study|Withdrawal by Subject|1|||
48715488|NCT02386189|156808272|FG001|Overall Study|Withdrawal by Subject|0|||
48715489|NCT02386189|156808271|FG000|Overall Study|Death|1|||
48715490|NCT02386189|156808272|FG001|Overall Study|Death|0|||
48715491|NCT01256190|156808275|FG000|Overall Study|Lost to Follow-up|2|||
48715492|NCT01256190|156808276|FG001|Overall Study|Lost to Follow-up|0|||
48715493|NCT02364336|156808277|FG000|Overall Study|Adverse Event|0|||
48497106|NCT01915732|156014472|FG001|Overall Study|Poor Conscious Effect|1|||
48497107|NCT02518685|156014473|FG000|Overall Study|Adverse Event|29|||
48497108|NCT02518685|156014474|FG001|Overall Study|Adverse Event|1|||
48497109|NCT02518685|156014473|FG000|Overall Study|Withdrawal by Subject|10|||
48497110|NCT02518685|156014474|FG001|Overall Study|Withdrawal by Subject|3|||
48497111|NCT02518685|156014473|FG000|Overall Study|relocation, study fatigue|7|||
48497112|NCT02518685|156014474|FG001|Overall Study|relocation, study fatigue|2|||
48497113|NCT02518685|156014473|FG000|Overall Study|Pregnancy|1|||
48497114|NCT02518685|156014474|FG001|Overall Study|Pregnancy|0|||
48497115|NCT02518685|156014473|FG000|Overall Study|Physician Decision|1|||
48497116|NCT02518685|156014474|FG001|Overall Study|Physician Decision|0|||
48497117|NCT02518685|156014473|FG000|Overall Study|Lost to Follow-up|1|||
48497118|NCT02518685|156014474|FG001|Overall Study|Lost to Follow-up|4|||
48497119|NCT00282256|156014475|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
48497120|NCT00282256|156014475|FG000|Extension Treatment Period|Adverse Event|2|||
48497121|NCT00806156|156014476|FG000|Overall Study|Death|35|||
48497122|NCT00806156|156014477|FG001|Overall Study|Death|95|||
48497123|NCT00806156|156014476|FG000|Overall Study|Did not meet eligibility criteria|1|||
48497124|NCT00806156|156014477|FG001|Overall Study|Did not meet eligibility criteria|0|||
48497125|NCT00806156|156014476|FG000|Overall Study|Study terminated by Sponsor|2|||
48497126|NCT00806156|156014477|FG001|Overall Study|Study terminated by Sponsor|40|||
48497127|NCT00806156|156014476|FG000|Overall Study|Consent withdrawn by subject|1|||
48497128|NCT00806156|156014477|FG001|Overall Study|Consent withdrawn by subject|3|||
48497129|NCT00806156|156014476|FG000|Overall Study|Lost to Follow-up|0|||
48497130|NCT00806156|156014477|FG001|Overall Study|Lost to Follow-up|1|||
48497131|NCT00698685|156014478|FG000|Overall Study|Sister withdrew as donor|1|||
48497132|NCT00698685|156014478|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
48497133|NCT01325207|156014479|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
48497134|NCT01325207|156014480|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
48497135|NCT01325207|156014481|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
48497136|NCT01325207|156014482|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
48715494|NCT02364336|156808278|FG001|Overall Study|Adverse Event|1|||
48715495|NCT00859456|156808283|FG000|Overall Study|Adverse Event|3|||
48813500|NCT03354637|157157459|FG001|Open Label Extension|Subject Noncompliance|0|||
48813501|NCT03354637|157157460|FG002|Open Label Extension|Subject Noncompliance|1|||
48813502|NCT03354637|157157458|FG000|Open Label Extension|Lack of Efficacy|0|||
48813503|NCT03354637|157157459|FG001|Open Label Extension|Lack of Efficacy|0|||
48813504|NCT03354637|157157460|FG002|Open Label Extension|Lack of Efficacy|1|||
48813505|NCT03354637|157157458|FG000|Open Label Extension|Physician Decision|0|||
48813506|NCT03354637|157157459|FG001|Open Label Extension|Physician Decision|0|||
48813507|NCT03354637|157157460|FG002|Open Label Extension|Physician Decision|1|||
48813508|NCT00584805|157157461|FG000|Overall Study|No longer at risk of exposure|39|||
48813509|NCT00584805|157157461|FG000|Overall Study|Relocation|36|||
48813510|NCT00584805|157157461|FG000|Overall Study|Withdrawal by Subject|18|||
48813511|NCT00584805|157157461|FG000|Overall Study|Non-compliance|1|||
48813512|NCT00584805|157157461|FG000|Overall Study|Lost to follow up|3|||
48813513|NCT00584805|157157461|FG000|Overall Study|Screen failures|2|||
48813514|NCT01763788|157157462|FG000|Overall Study|Lost to Follow-up|0|||
48813515|NCT01763788|157157463|FG001|Overall Study|Lost to Follow-up|0|||
48813516|NCT01763788|157157464|FG002|Overall Study|Lost to Follow-up|1|||
48813517|NCT01763788|157157465|FG003|Overall Study|Lost to Follow-up|0|||
48813518|NCT03893825|157157468|FG000|Overall Study|Death|2|||
48813519|NCT03893825|157157469|FG001|Overall Study|Death|1|||
48813520|NCT03893825|157157468|FG000|Overall Study|Adverse Event|0|||
48813521|NCT03893825|157157469|FG001|Overall Study|Adverse Event|2|||
48813522|NCT03893825|157157468|FG000|Overall Study|Withdrawal by Subject|19|||
48813523|NCT03893825|157157469|FG001|Overall Study|Withdrawal by Subject|21|||
48497137|NCT01325207|156014483|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
48497138|NCT01325207|156014484|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
48497139|NCT01325207|156014479|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
48497140|NCT01325207|156014480|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
48715496|NCT00859456|156808283|FG000|Overall Study|Progressive disease|2|||
48715497|NCT00859456|156808283|FG000|Overall Study|Non-compliance|3|||
48715498|NCT03085914|156808285|FG000|Overall Study|Death|6|||
48715499|NCT03085914|156808286|FG001|Overall Study|Death|6|||
48715500|NCT03085914|156808287|FG002|Overall Study|Death|4|||
48497141|NCT01325207|156014481|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
48497142|NCT01325207|156014482|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
48497143|NCT01325207|156014483|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
48497144|NCT01325207|156014484|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
48497145|NCT01325207|156014479|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
48497146|NCT01325207|156014480|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
48497147|NCT01325207|156014481|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
48497148|NCT01325207|156014482|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
48497149|NCT01325207|156014483|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
48497150|NCT01325207|156014484|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
48497151|NCT01325207|156014479|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
48497152|NCT01325207|156014480|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
48497153|NCT01325207|156014481|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
48497154|NCT01325207|156014482|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
48497155|NCT01325207|156014483|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
48497156|NCT01325207|156014484|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
48497157|NCT01325207|156014479|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
48715501|NCT03085914|156808288|FG003|Overall Study|Death|1|||
48715502|NCT03085914|156808289|FG004|Overall Study|Death|5|||
48715503|NCT03085914|156808290|FG005|Overall Study|Death|2|||
48715504|NCT03085914|156808291|FG006|Overall Study|Death|2|||
48715505|NCT03085914|156808285|FG000|Overall Study|Withdrawal by Subject|1|||
48715506|NCT03085914|156808286|FG001|Overall Study|Withdrawal by Subject|1|||
48715507|NCT03085914|156808287|FG002|Overall Study|Withdrawal by Subject|2|||
48715508|NCT03085914|156808288|FG003|Overall Study|Withdrawal by Subject|2|||
48715509|NCT03085914|156808289|FG004|Overall Study|Withdrawal by Subject|2|||
48715510|NCT03085914|156808290|FG005|Overall Study|Withdrawal by Subject|0|||
48715511|NCT03085914|156808291|FG006|Overall Study|Withdrawal by Subject|1|||
48813524|NCT03893825|157157468|FG000|Overall Study|Protocol deviation|1|||
48715512|NCT03085914|156808285|FG000|Overall Study|Lost to Follow-up|0|||
48715513|NCT03085914|156808286|FG001|Overall Study|Lost to Follow-up|0|||
48715514|NCT03085914|156808287|FG002|Overall Study|Lost to Follow-up|1|||
48715515|NCT03085914|156808288|FG003|Overall Study|Lost to Follow-up|0|||
48715516|NCT03085914|156808289|FG004|Overall Study|Lost to Follow-up|0|||
48715517|NCT03085914|156808290|FG005|Overall Study|Lost to Follow-up|1|||
48715518|NCT03085914|156808291|FG006|Overall Study|Lost to Follow-up|1|||
48715519|NCT03085914|156808285|FG000|Overall Study|Reason was not specified,|2|||
48715520|NCT03085914|156808286|FG001|Overall Study|Reason was not specified,|2|||
48715521|NCT03085914|156808287|FG002|Overall Study|Reason was not specified,|2|||
48715522|NCT03085914|156808288|FG003|Overall Study|Reason was not specified,|3|||
48715523|NCT03085914|156808289|FG004|Overall Study|Reason was not specified,|3|||
48715524|NCT03085914|156808290|FG005|Overall Study|Reason was not specified,|3|||
48715525|NCT03085914|156808291|FG006|Overall Study|Reason was not specified,|6|||
48715526|NCT03085914|156808285|FG000|Overall Study|Progressive Disease|0|||
48715527|NCT03085914|156808286|FG001|Overall Study|Progressive Disease|0|||
48715528|NCT03085914|156808287|FG002|Overall Study|Progressive Disease|2|||
48715529|NCT03085914|156808288|FG003|Overall Study|Progressive Disease|2|||
48715530|NCT03085914|156808289|FG004|Overall Study|Progressive Disease|1|||
48715531|NCT03085914|156808290|FG005|Overall Study|Progressive Disease|1|||
48715532|NCT03085914|156808291|FG006|Overall Study|Progressive Disease|1|||
48715533|NCT03085914|156808285|FG000|Overall Study|Study Terminated by the Sponsor|0|||
48715534|NCT03085914|156808286|FG001|Overall Study|Study Terminated by the Sponsor|0|||
48497158|NCT01325207|156014480|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
48715535|NCT03085914|156808287|FG002|Overall Study|Study Terminated by the Sponsor|0|||
48813525|NCT03893825|157157469|FG001|Overall Study|Protocol deviation|0|||
48813526|NCT03893825|157157468|FG000|Overall Study|Lost to Follow-up|10|||
48813527|NCT03893825|157157469|FG001|Overall Study|Lost to Follow-up|10|||
48813528|NCT03893825|157157468|FG000|Overall Study|Other than specified|7|||
48813529|NCT03893825|157157469|FG001|Overall Study|Other than specified|6|||
48813530|NCT04161807|157157470|FG000|Overall Study|Withdrawal by Subject|2|||
48813531|NCT04161807|157157470|FG000|Overall Study|Performed only 1 treatment|2|||
48813532|NCT02306265|157157479|FG000|Overall Study|Withdrawal by Subject|1|||
48813533|NCT02207374|157157480|FG000|Overall Study|Withdrawal by Subject|5|||
48813534|NCT02207374|157157481|FG001|Overall Study|Withdrawal by Subject|9|||
48813535|NCT02207374|157157482|FG002|Overall Study|Withdrawal by Subject|4|||
48813536|NCT02207374|157157480|FG000|Overall Study|Death|1|||
48813537|NCT02207374|157157481|FG001|Overall Study|Death|0|||
48813538|NCT02207374|157157482|FG002|Overall Study|Death|1|||
48813539|NCT02207374|157157480|FG000|Overall Study|Missing follow-up information|0|||
48813540|NCT02207374|157157481|FG001|Overall Study|Missing follow-up information|1|||
48497159|NCT01325207|156014481|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
48715536|NCT03085914|156808288|FG003|Overall Study|Study Terminated by the Sponsor|1|||
48715537|NCT03085914|156808289|FG004|Overall Study|Study Terminated by the Sponsor|2|||
48715538|NCT03085914|156808290|FG005|Overall Study|Study Terminated by the Sponsor|1|||
48813541|NCT02207374|157157482|FG002|Overall Study|Missing follow-up information|1|||
48813542|NCT00785538|157157483|FG000|Treatment Period|Adverse Event|1|||
48813543|NCT00785538|157157484|FG001|Treatment Period|Adverse Event|2|||
48813544|NCT00785538|157157485|FG002|Treatment Period|Adverse Event|2|||
48813545|NCT00785538|157157486|FG003|Treatment Period|Adverse Event|0|||
48813546|NCT00785538|157157483|FG000|Treatment Period|Withdrawal by Subject|0|||
48715539|NCT03085914|156808291|FG006|Overall Study|Study Terminated by the Sponsor|0|||
48715540|NCT01478048|156808292|FG000|Overall Study|Disease Progression|52|||
48715541|NCT01478048|156808293|FG001|Overall Study|Disease Progression|35|||
48715542|NCT01478048|156808292|FG000|Overall Study|study drug toxicity|11|||
48715543|NCT01478048|156808293|FG001|Overall Study|study drug toxicity|14|||
48715544|NCT01478048|156808292|FG000|Overall Study|Adverse Event|2|||
48715545|NCT01478048|156808293|FG001|Overall Study|Adverse Event|11|||
48715546|NCT01478048|156808292|FG000|Overall Study|subject request to discontinue treatment|3|||
48715547|NCT01478048|156808293|FG001|Overall Study|subject request to discontinue treatment|5|||
48715548|NCT01478048|156808292|FG000|Overall Study|Withdrawal by Subject|2|||
48715549|NCT01478048|156808293|FG001|Overall Study|Withdrawal by Subject|5|||
48715550|NCT01478048|156808292|FG000|Overall Study|non-specified|6|||
48715551|NCT01478048|156808293|FG001|Overall Study|non-specified|4|||
48715552|NCT01478048|156808292|FG000|Overall Study|poor/non-compliance|0|||
48715553|NCT01478048|156808293|FG001|Overall Study|poor/non-compliance|1|||
48715554|NCT01478048|156808292|FG000|Overall Study|no longer meets study criteria|1|||
48715555|NCT01478048|156808293|FG001|Overall Study|no longer meets study criteria|0|||
48715556|NCT00647270|156808295|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
48813547|NCT00785538|157157484|FG001|Treatment Period|Withdrawal by Subject|0|||
48813548|NCT00785538|157157485|FG002|Treatment Period|Withdrawal by Subject|0|||
48813549|NCT00785538|157157486|FG003|Treatment Period|Withdrawal by Subject|1|||
48813550|NCT02494206|157157487|FG000|Overall Study|Adverse Event|1|||
48813551|NCT02494206|157157487|FG000|Overall Study|Disease Progression|1|||
48813552|NCT02584855|157157494|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
48813553|NCT02584855|157157495|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
48813554|NCT02584855|157157496|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
48813555|NCT02584855|157157497|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
48813556|NCT02584855|157157498|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
48813557|NCT02584855|157157499|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
48813558|NCT02584855|157157494|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
48813559|NCT02584855|157157495|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813560|NCT02584855|157157496|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813561|NCT02584855|157157497|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813562|NCT02584855|157157498|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813563|NCT02584855|157157499|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
48813564|NCT02584855|157157494|FG000|Open-Label Treatment Period|Adverse Event|14|||
48813565|NCT02584855|157157495|FG001|Open-Label Treatment Period|Adverse Event|0|||
48813566|NCT02584855|157157496|FG002|Open-Label Treatment Period|Adverse Event|0|||
48813567|NCT02584855|157157497|FG003|Open-Label Treatment Period|Adverse Event|0|||
48813568|NCT02584855|157157498|FG004|Open-Label Treatment Period|Adverse Event|0|||
48813569|NCT02584855|157157499|FG005|Open-Label Treatment Period|Adverse Event|0|||
48813570|NCT02584855|157157494|FG000|Open-Label Treatment Period|Death|2|||
48813571|NCT02584855|157157495|FG001|Open-Label Treatment Period|Death|0|||
48813572|NCT02584855|157157496|FG002|Open-Label Treatment Period|Death|0|||
48813573|NCT02584855|157157497|FG003|Open-Label Treatment Period|Death|0|||
48813574|NCT02584855|157157498|FG004|Open-Label Treatment Period|Death|0|||
48813575|NCT02584855|157157499|FG005|Open-Label Treatment Period|Death|0|||
48813576|NCT02584855|157157494|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
48813577|NCT02584855|157157495|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
48813578|NCT02584855|157157496|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
48813579|NCT02584855|157157497|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
48813580|NCT02584855|157157498|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
48813581|NCT02584855|157157499|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
48813582|NCT02584855|157157494|FG000|Open-Label Treatment Period|Protocol Violation|1|||
48813583|NCT02584855|157157495|FG001|Open-Label Treatment Period|Protocol Violation|0|||
48813584|NCT02584855|157157496|FG002|Open-Label Treatment Period|Protocol Violation|0|||
48813585|NCT02584855|157157497|FG003|Open-Label Treatment Period|Protocol Violation|0|||
48813586|NCT02584855|157157498|FG004|Open-Label Treatment Period|Protocol Violation|0|||
48813587|NCT02584855|157157499|FG005|Open-Label Treatment Period|Protocol Violation|0|||
48813588|NCT02584855|157157494|FG000|Open-Label Treatment Period|No PI Available|2|||
48813589|NCT02584855|157157495|FG001|Open-Label Treatment Period|No PI Available|0|||
48715557|NCT00647270|156808296|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
48715558|NCT00647270|156808297|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
48715559|NCT00647270|156808295|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
48715560|NCT00647270|156808296|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
48813590|NCT02584855|157157496|FG002|Open-Label Treatment Period|No PI Available|0|||
48813591|NCT02584855|157157497|FG003|Open-Label Treatment Period|No PI Available|0|||
48813592|NCT02584855|157157498|FG004|Open-Label Treatment Period|No PI Available|0|||
48813593|NCT02584855|157157499|FG005|Open-Label Treatment Period|No PI Available|0|||
48715561|NCT00647270|156808297|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
48715562|NCT00647270|156808295|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
48715563|NCT00647270|156808296|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
48715564|NCT00647270|156808297|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
48715565|NCT00647270|156808295|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
48715566|NCT00647270|156808296|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
48715567|NCT00647270|156808297|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
48715568|NCT00647270|156808295|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
48715569|NCT00647270|156808296|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
48715570|NCT00647270|156808297|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
48715571|NCT00647270|156808295|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
48715572|NCT00647270|156808296|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
48715573|NCT00647270|156808297|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
48715574|NCT00647270|156808295|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
48715575|NCT00647270|156808296|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
48715576|NCT00647270|156808297|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
48715577|NCT05277337|156808300|FG000|Overall Study|Lost to Follow-up|2|||
48715578|NCT05277337|156808301|FG001|Overall Study|Lost to Follow-up|0|||
48715579|NCT05277337|156808300|FG000|Overall Study|Withdrawal by Subject|1|||
48715580|NCT05277337|156808301|FG001|Overall Study|Withdrawal by Subject|0|||
48715581|NCT00357760|156808302|FG000|Overall Study|Disease progression|44|||
48715582|NCT00357760|156808303|FG001|Overall Study|Disease progression|17|||
48715583|NCT00357760|156808302|FG000|Overall Study|Adverse Event|10|||
48715584|NCT00357760|156808303|FG001|Overall Study|Adverse Event|7|||
48715585|NCT00357760|156808302|FG000|Overall Study|Death|0|||
48715586|NCT00357760|156808303|FG001|Overall Study|Death|3|||
48715587|NCT00357760|156808302|FG000|Overall Study|Alternative therapy|1|||
48715588|NCT00357760|156808303|FG001|Overall Study|Alternative therapy|0|||
48715589|NCT00357760|156808302|FG000|Overall Study|Withdrawal by Subject|0|||
48715590|NCT00357760|156808303|FG001|Overall Study|Withdrawal by Subject|2|||
48715591|NCT00357760|156808302|FG000|Overall Study|Never started treatment|2|||
48715592|NCT00357760|156808303|FG001|Overall Study|Never started treatment|1|||
48715593|NCT00357760|156808302|FG000|Overall Study|Ineligible|0|||
48715594|NCT00357760|156808303|FG001|Overall Study|Ineligible|2|||
48715595|NCT00357760|156808302|FG000|Overall Study|Physician Decision|2|||
48715596|NCT00357760|156808303|FG001|Overall Study|Physician Decision|1|||
48715597|NCT00357760|156808302|FG000|Overall Study|Protocol Violation|0|||
48715598|NCT00357760|156808303|FG001|Overall Study|Protocol Violation|1|||
48715599|NCT00357760|156808302|FG000|Overall Study|To receive hospice care|0|||
48715600|NCT00357760|156808303|FG001|Overall Study|To receive hospice care|1|||
48715601|NCT00984620|156808304|FG000|Overall Study|Adverse Event|5|||
48715602|NCT00984620|156808305|FG001|Overall Study|Adverse Event|5|||
48715603|NCT00984620|156808304|FG000|Overall Study|Lost to Follow-up|1|||
48715604|NCT00984620|156808305|FG001|Overall Study|Lost to Follow-up|1|||
48715605|NCT00984620|156808304|FG000|Overall Study|Withdrawal by Subject|0|||
48715606|NCT00984620|156808305|FG001|Overall Study|Withdrawal by Subject|2|||
48715607|NCT00984620|156808304|FG000|Overall Study|reason other than listed above|0|||
48715608|NCT00984620|156808305|FG001|Overall Study|reason other than listed above|4|||
48715609|NCT01853839|156808306|FG000|Overall Study|Violated inclusion criteria|2|||
48715610|NCT01853839|156808306|FG000|Overall Study|Not meet ITT population definition|58|||
48715611|NCT01853839|156808306|FG000|Overall Study|End of treatment visit too early|33|||
48715612|NCT01853839|156808306|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
48715613|NCT02709538|156808308|FG000|Overall Study|Adverse Event|13|||
48715614|NCT02709538|156808309|FG001|Overall Study|Adverse Event|2|||
48715615|NCT02709538|156808310|FG002|Overall Study|Adverse Event|3|||
48715616|NCT02709538|156808308|FG000|Overall Study|Lack of Efficacy|1|||
48715617|NCT02709538|156808309|FG001|Overall Study|Lack of Efficacy|0|||
48715618|NCT02709538|156808310|FG002|Overall Study|Lack of Efficacy|0|||
48715619|NCT02709538|156808308|FG000|Overall Study|Lost to Follow-up|24|||
48715620|NCT02709538|156808309|FG001|Overall Study|Lost to Follow-up|8|||
48715621|NCT02709538|156808310|FG002|Overall Study|Lost to Follow-up|4|||
48715622|NCT02709538|156808308|FG000|Overall Study|Physician Decision|1|||
48715623|NCT02709538|156808309|FG001|Overall Study|Physician Decision|0|||
48715624|NCT02709538|156808310|FG002|Overall Study|Physician Decision|0|||
48715625|NCT02709538|156808308|FG000|Overall Study|Withdrawal by Subject|40|||
48715626|NCT02709538|156808309|FG001|Overall Study|Withdrawal by Subject|7|||
48715627|NCT02709538|156808310|FG002|Overall Study|Withdrawal by Subject|4|||
48715628|NCT02709538|156808308|FG000|Overall Study|Non-compliance with study procedures|5|||
48715629|NCT02709538|156808309|FG001|Overall Study|Non-compliance with study procedures|0|||
48715630|NCT02709538|156808310|FG002|Overall Study|Non-compliance with study procedures|0|||
48715631|NCT02709538|156808308|FG000|Overall Study|Non-compliance with study drug|2|||
48715632|NCT02709538|156808309|FG001|Overall Study|Non-compliance with study drug|0|||
48715633|NCT02709538|156808310|FG002|Overall Study|Non-compliance with study drug|0|||
48715634|NCT02709538|156808308|FG000|Overall Study|Protocol deviation|10|||
48715635|NCT02709538|156808309|FG001|Overall Study|Protocol deviation|4|||
48715636|NCT02709538|156808310|FG002|Overall Study|Protocol deviation|4|||
48715637|NCT02709538|156808308|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
48715638|NCT02709538|156808309|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
48715639|NCT02709538|156808310|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
48715640|NCT02709538|156808308|FG000|Overall Study|Other|16|||
48715641|NCT02709538|156808309|FG001|Overall Study|Other|7|||
48715642|NCT02709538|156808310|FG002|Overall Study|Other|5|||
48715643|NCT00835211|156808311|FG000|First Intervention|Withdrawal by Subject|0|||
48715644|NCT00835211|156808312|FG001|First Intervention|Withdrawal by Subject|1|||
48715645|NCT00835211|156808311|FG000|Washout: 7 Days|Adverse Event|2|||
48715646|NCT00835211|156808312|FG001|Washout: 7 Days|Adverse Event|1|||
48813594|NCT02584855|157157494|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
48813595|NCT02584855|157157495|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
48813596|NCT02584855|157157496|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
48813597|NCT02584855|157157497|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
48813598|NCT02584855|157157498|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
48813599|NCT02584855|157157499|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
48813600|NCT02584855|157157494|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48715647|NCT00835211|156808311|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
48715648|NCT00835211|156808312|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
48715649|NCT02343549|156808313|FG000|Overall Study|Death|11|||
48715650|NCT02343549|156808313|FG000|Overall Study|Withdrawal by Subject|2|||
48715651|NCT02160041|156808315|FG000|Overall Study|Adverse Event|11|||
48715652|NCT02160041|156808315|FG000|Overall Study|Death|2|||
48715653|NCT02160041|156808315|FG000|Overall Study|disease progression|57|||
48715654|NCT02160041|156808315|FG000|Overall Study|Protocol Violation|1|||
48715655|NCT02160041|156808315|FG000|Overall Study|non-compliance with study|1|||
48715656|NCT02160041|156808315|FG000|Overall Study|Physician Decision|3|||
48715657|NCT02160041|156808315|FG000|Overall Study|Withdrawal by Subject|8|||
48715658|NCT02160041|156808315|FG000|Overall Study|study terminated by by sponsor|1|||
48715659|NCT00638183|156808316|FG000|Overall Study|Adverse Event|23|||
48715660|NCT00638183|156808316|FG000|Overall Study|Lack of Efficacy|14|||
48715661|NCT00638183|156808316|FG000|Overall Study|Physician Decision|9|||
48715662|NCT00638183|156808316|FG000|Overall Study|Lost to Follow-up|46|||
48715663|NCT00638183|156808316|FG000|Overall Study|Other reason not defined above|27|||
48715664|NCT00271505|156808317|FG000|Overall Study|Screen Failure|3|||
48715665|NCT00271505|156808317|FG000|Overall Study|Adverse Event|1|||
48715666|NCT00271505|156808317|FG000|Overall Study|Death|1|||
48715667|NCT01546623|156808320|FG000|Overall Study|Adverse Event|2|||
48715668|NCT01546623|156808321|FG001|Overall Study|Adverse Event|3|||
48715669|NCT01546623|156808320|FG000|Overall Study|Major Protocol Deviation|1|||
48715670|NCT01546623|156808321|FG001|Overall Study|Major Protocol Deviation|1|||
48715671|NCT01546623|156808320|FG000|Overall Study|High Prostate specific antigen|2|||
48715672|NCT01546623|156808321|FG001|Overall Study|High Prostate specific antigen|1|||
48715673|NCT01546623|156808320|FG000|Overall Study|Did Not Receive Study Drug|1|||
48715674|NCT01546623|156808321|FG001|Overall Study|Did Not Receive Study Drug|1|||
48715675|NCT03567343|156808323|FG000|Overall Study|Lost to Follow-up|2|||
48715676|NCT03567343|156808324|FG001|Overall Study|Lost to Follow-up|1|||
48715677|NCT03567343|156808323|FG000|Overall Study|No longer eligible|2|||
48715678|NCT03567343|156808324|FG001|Overall Study|No longer eligible|1|||
48715679|NCT03567343|156808323|FG000|Overall Study|Adverse Event|1|||
48715680|NCT03567343|156808324|FG001|Overall Study|Adverse Event|0|||
48715681|NCT03567343|156808323|FG000|Overall Study|Protocol Violation|1|||
48715682|NCT03567343|156808324|FG001|Overall Study|Protocol Violation|1|||
48715683|NCT04784442|156808325|FG000|Overall Study|Adverse Event|1|||
48715684|NCT04784442|156808326|FG001|Overall Study|Adverse Event|0|||
48715685|NCT04784442|156808327|FG002|Overall Study|Adverse Event|2|||
48813601|NCT02584855|157157495|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48813602|NCT02584855|157157496|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
48813603|NCT02584855|157157497|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48813604|NCT02584855|157157498|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48813605|NCT02584855|157157499|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
48813606|NCT02584855|157157494|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
48813607|NCT02584855|157157495|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
48715686|NCT04784442|156808328|FG003|Overall Study|Adverse Event|1|||
48715687|NCT04784442|156808325|FG000|Overall Study|Protocol Violation|1|||
48715688|NCT04784442|156808326|FG001|Overall Study|Protocol Violation|0|||
48436138|NCT00617409|155785801|FG002|Overall Study|Adverse Event|3|||
48715689|NCT04784442|156808327|FG002|Overall Study|Protocol Violation|0|||
48715690|NCT04784442|156808328|FG003|Overall Study|Protocol Violation|0|||
48715691|NCT04784442|156808325|FG000|Overall Study|Non-compliance with study drug|1|||
48715692|NCT04784442|156808326|FG001|Overall Study|Non-compliance with study drug|0|||
48715693|NCT04784442|156808327|FG002|Overall Study|Non-compliance with study drug|0|||
48715694|NCT04784442|156808328|FG003|Overall Study|Non-compliance with study drug|0|||
48813608|NCT02584855|157157496|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
48715695|NCT01510769|156808329|FG000|Overall Study|Adverse Event|7|||
48715696|NCT01510769|156808330|FG001|Overall Study|Adverse Event|6|||
48715697|NCT01510769|156808331|FG002|Overall Study|Adverse Event|4|||
48715698|NCT01510769|156808329|FG000|Overall Study|Gout Flare|0|||
48715699|NCT01510769|156808330|FG001|Overall Study|Gout Flare|3|||
48715700|NCT01510769|156808331|FG002|Overall Study|Gout Flare|1|||
48715701|NCT01510769|156808329|FG000|Overall Study|Protocol Violation|11|||
48715702|NCT01510769|156808330|FG001|Overall Study|Protocol Violation|10|||
48715703|NCT01510769|156808331|FG002|Overall Study|Protocol Violation|9|||
48715704|NCT01510769|156808329|FG000|Overall Study|Lost to Follow-up|5|||
48715705|NCT01510769|156808330|FG001|Overall Study|Lost to Follow-up|1|||
48715706|NCT01510769|156808331|FG002|Overall Study|Lost to Follow-up|5|||
48715707|NCT01510769|156808329|FG000|Overall Study|Withdrawal by Subject|3|||
48715708|NCT01510769|156808330|FG001|Overall Study|Withdrawal by Subject|4|||
48715709|NCT01510769|156808331|FG002|Overall Study|Withdrawal by Subject|3|||
48715710|NCT01510769|156808329|FG000|Overall Study|Death|1|||
48715711|NCT01510769|156808330|FG001|Overall Study|Death|1|||
48715712|NCT01510769|156808331|FG002|Overall Study|Death|0|||
48715713|NCT02874144|156808335|FG000|Overall Study|Lost to Follow-up|3|||
48715714|NCT02874144|156808336|FG001|Overall Study|Lost to Follow-up|5|||
48715715|NCT00934440|156808337|FG000|Overall Study|Lost to Follow-up|1|||
48715716|NCT02547363|156808340|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
48715717|NCT02547363|156808341|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
48715718|NCT02547363|156808340|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
48715719|NCT02547363|156808341|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
48715720|NCT02547363|156808340|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
48715721|NCT02547363|156808341|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
48715722|NCT02547363|156808340|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
48715723|NCT02547363|156808341|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
48715724|NCT02547363|156808340|FG000|12-month Follow-up|Withdrawal by Subject|4|||
48715725|NCT02547363|156808341|FG001|12-month Follow-up|Withdrawal by Subject|3|||
48715726|NCT02547363|156808340|FG000|12-month Follow-up|Lost to Follow-up|4|||
48715727|NCT02547363|156808341|FG001|12-month Follow-up|Lost to Follow-up|1|||
48715728|NCT02547363|156808340|FG000|12-month Follow-up|Lack of Efficacy|1|||
48715729|NCT02547363|156808341|FG001|12-month Follow-up|Lack of Efficacy|1|||
48715730|NCT02547363|156808340|FG000|12-month Follow-up|Other|1|||
48715731|NCT02547363|156808341|FG001|12-month Follow-up|Other|0|||
48715732|NCT01159431|156808345|FG000|Overall Study|Adverse Event|1|||
48715733|NCT01159431|156808346|FG001|Overall Study|Adverse Event|2|||
48715734|NCT01159431|156808345|FG000|Overall Study|non-compliance|1|||
48715735|NCT01159431|156808346|FG001|Overall Study|non-compliance|1|||
48715736|NCT01159431|156808345|FG000|Overall Study|Lack of Efficacy|0|||
48715737|NCT01159431|156808346|FG001|Overall Study|Lack of Efficacy|3|||
48715738|NCT01454778|156808347|FG000|Overall Study|Lost to Follow-up|2|||
48715739|NCT01454778|156808347|FG000|Overall Study|Death|1|||
48715740|NCT01097005|156808348|FG000|Overall Study|Case Report Form not collected|18|||
48715741|NCT01097005|156808348|FG000|Overall Study|Subjects cannot visit the hospital|1|||
48715742|NCT01097005|156808348|FG000|Overall Study|Poor medication compliance|1|||
48715743|NCT01097005|156808348|FG000|Overall Study|No examination data available|244|||
48715744|NCT01097005|156808348|FG000|Overall Study|Deviation from exclusion criteria|37|||
48715745|NCT01097005|156808348|FG000|Overall Study|Adverse Event|14|||
48715746|NCT01097005|156808348|FG000|Overall Study|Discontinuance by complication|50|||
48715747|NCT02654717|156808349|FG000|Overall Study|Adverse Event|2|||
48715748|NCT02654717|156808350|FG001|Overall Study|Adverse Event|2|||
48715749|NCT02654717|156808349|FG000|Overall Study|Protocol Violation|1|||
48715750|NCT02654717|156808350|FG001|Overall Study|Protocol Violation|2|||
48715751|NCT02654717|156808349|FG000|Overall Study|Withdrawal by Subject|0|||
48715752|NCT02654717|156808350|FG001|Overall Study|Withdrawal by Subject|1|||
48715753|NCT02654717|156808349|FG000|Overall Study|Non-permitted medication|3|||
48715754|NCT02654717|156808350|FG001|Overall Study|Non-permitted medication|0|||
48715755|NCT02102204|156809939|FG000|Overall Study|Withdrawal by Subject|137|||
48715756|NCT02102204|156809939|FG000|Overall Study|Death|92|||
48715757|NCT02102204|156809939|FG000|Overall Study|Lost to Follow-up|65|||
48715758|NCT02102204|156809939|FG000|Overall Study|Sponsor Decision|5|||
48715759|NCT02102204|156809939|FG000|Overall Study|Ongoing|5|||
48715760|NCT03254459|156809945|FG000|Overall Study|Adverse Event|7|||
48715761|NCT03254459|156809946|FG001|Overall Study|Adverse Event|20|||
48715762|NCT03254459|156809945|FG000|Overall Study|Withdrawal by Subject Consent|3|||
48715763|NCT03254459|156809946|FG001|Overall Study|Withdrawal by Subject Consent|1|||
48715764|NCT03254459|156809945|FG000|Overall Study|Lost to Follow-up|0|||
48715765|NCT03254459|156809946|FG001|Overall Study|Lost to Follow-up|1|||
48715766|NCT03254459|156809945|FG000|Overall Study|Miscellaneous|0|||
48715767|NCT03254459|156809946|FG001|Overall Study|Miscellaneous|1|||
48715768|NCT01139008|156809949|FG000|Overall Study|Withdrawal by Subject|5|||
48715769|NCT01139008|156809949|FG000|Overall Study|Non-compliant, lost product|1|||
48715770|NCT02785770|156809950|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
48715771|NCT02785770|156809951|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
48715772|NCT02785770|156809952|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
48715773|NCT02785770|156809953|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
48715774|NCT02785770|156809950|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
48715775|NCT02785770|156809951|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
48715776|NCT02785770|156809952|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
48715777|NCT02785770|156809953|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
48715778|NCT02785770|156809950|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
48715779|NCT02785770|156809951|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
48715780|NCT02785770|156809952|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
48715781|NCT02785770|156809953|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
48715782|NCT04518995|156809963|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
48715783|NCT04518995|156809964|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
48715784|NCT04518995|156809965|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
48715785|NCT04518995|156809963|FG000|Overall Study|Lack of Efficacy|2|||
48715786|NCT04518995|156809964|FG001|Overall Study|Lack of Efficacy|1|||
48715787|NCT04518995|156809965|FG002|Overall Study|Lack of Efficacy|0|||
48715788|NCT04518995|156809963|FG000|Overall Study|Non-compliance With Study Drug|0|||
48715789|NCT04518995|156809964|FG001|Overall Study|Non-compliance With Study Drug|3|||
48715790|NCT04518995|156809965|FG002|Overall Study|Non-compliance With Study Drug|2|||
48715791|NCT04518995|156809963|FG000|Overall Study|Pregnancy|0|||
48715792|NCT04518995|156809964|FG001|Overall Study|Pregnancy|0|||
48715793|NCT04518995|156809965|FG002|Overall Study|Pregnancy|1|||
48715794|NCT04518995|156809963|FG000|Overall Study|Protocol Violation|2|||
48715795|NCT04518995|156809964|FG001|Overall Study|Protocol Violation|0|||
48715796|NCT04518995|156809965|FG002|Overall Study|Protocol Violation|1|||
48715797|NCT04518995|156809963|FG000|Overall Study|Reason not Specified|4|||
48715798|NCT04518995|156809964|FG001|Overall Study|Reason not Specified|11|||
48715799|NCT04518995|156809965|FG002|Overall Study|Reason not Specified|2|||
48715800|NCT04518995|156809963|FG000|Overall Study|Lost to Follow-up|1|||
48715801|NCT04518995|156809964|FG001|Overall Study|Lost to Follow-up|10|||
48715802|NCT04518995|156809965|FG002|Overall Study|Lost to Follow-up|6|||
48715803|NCT02248675|156809966|FG000|Overall Study|Lost to Follow-up|3|||
48715804|NCT02248675|156809967|FG001|Overall Study|Lost to Follow-up|1|||
48715805|NCT02704143|156809968|FG000|Overall Study|disease progression|10|||
48715806|NCT01235598|156809969|FG000|Overall Study|Adverse Event|0|||
48715807|NCT01235598|156809970|FG001|Overall Study|Adverse Event|3|||
48715808|NCT01235598|156809969|FG000|Overall Study|Lack of Efficacy|0|||
48715809|NCT01235598|156809970|FG001|Overall Study|Lack of Efficacy|1|||
48715810|NCT01235598|156809969|FG000|Overall Study|Withdrawal by Subject|1|||
48715811|NCT01235598|156809970|FG001|Overall Study|Withdrawal by Subject|0|||
48715812|NCT00689117|156809974|FG000|Overall Study|Adverse Event|6|||
48715813|NCT00689117|156809975|FG001|Overall Study|Adverse Event|0|||
48715814|NCT00689117|156809976|FG002|Overall Study|Adverse Event|5|||
48715815|NCT00689117|156809977|FG003|Overall Study|Adverse Event|0|||
48715816|NCT00689117|156809974|FG000|Overall Study|Lost to Follow-up|26|||
48715817|NCT00689117|156809975|FG001|Overall Study|Lost to Follow-up|19|||
48715818|NCT00689117|156809976|FG002|Overall Study|Lost to Follow-up|17|||
48715819|NCT00689117|156809977|FG003|Overall Study|Lost to Follow-up|11|||
48715820|NCT00689117|156809974|FG000|Overall Study|Lack of Efficacy|1|||
48715821|NCT00689117|156809975|FG001|Overall Study|Lack of Efficacy|2|||
48715822|NCT00689117|156809976|FG002|Overall Study|Lack of Efficacy|2|||
48715823|NCT00689117|156809977|FG003|Overall Study|Lack of Efficacy|2|||
48715824|NCT00689117|156809974|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
48715825|NCT00689117|156809975|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
48715826|NCT00689117|156809976|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
48715827|NCT00689117|156809977|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
48715828|NCT00689117|156809974|FG000|Overall Study|Withdrawal by Subject|19|||
48715829|NCT00689117|156809975|FG001|Overall Study|Withdrawal by Subject|18|||
48715830|NCT00689117|156809976|FG002|Overall Study|Withdrawal by Subject|26|||
48715831|NCT00689117|156809977|FG003|Overall Study|Withdrawal by Subject|13|||
48715832|NCT00689117|156809974|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
48497160|NCT01325207|156014482|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
48497161|NCT01325207|156014483|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
48715833|NCT00689117|156809975|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
48715834|NCT00689117|156809976|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
48497162|NCT01325207|156014484|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
48497163|NCT01325207|156014479|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
48497164|NCT01325207|156014480|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
48497165|NCT01325207|156014481|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
48497166|NCT01325207|156014482|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
48715835|NCT00689117|156809977|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
48715836|NCT00689117|156809974|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
48715837|NCT00689117|156809975|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
48715838|NCT00689117|156809976|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48715839|NCT00689117|156809977|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48715840|NCT00689117|156809974|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
48715841|NCT00689117|156809975|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
48715842|NCT00689117|156809976|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
48715843|NCT00689117|156809977|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
48715844|NCT00689117|156809974|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
48715845|NCT00689117|156809975|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
48715846|NCT00689117|156809976|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
48715847|NCT00689117|156809977|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
48715848|NCT00689117|156809974|FG000|Overall Study|Use of Prohibitive Medication|2|||
48715849|NCT00689117|156809975|FG001|Overall Study|Use of Prohibitive Medication|1|||
48715850|NCT00689117|156809976|FG002|Overall Study|Use of Prohibitive Medication|3|||
48715851|NCT00689117|156809977|FG003|Overall Study|Use of Prohibitive Medication|0|||
48715852|NCT00689117|156809974|FG000|Overall Study|Pregnancy|0|||
48715853|NCT00689117|156809975|FG001|Overall Study|Pregnancy|2|||
48715854|NCT00689117|156809976|FG002|Overall Study|Pregnancy|0|||
48715855|NCT00689117|156809977|FG003|Overall Study|Pregnancy|2|||
48715856|NCT00689117|156809974|FG000|Overall Study|Incarceration|2|||
48715857|NCT00689117|156809975|FG001|Overall Study|Incarceration|0|||
48715858|NCT00689117|156809976|FG002|Overall Study|Incarceration|0|||
48715859|NCT00689117|156809977|FG003|Overall Study|Incarceration|0|||
48715860|NCT00689117|156809974|FG000|Overall Study|Fear of Birth Defects|0|||
48715861|NCT00689117|156809975|FG001|Overall Study|Fear of Birth Defects|0|||
48715862|NCT00689117|156809976|FG002|Overall Study|Fear of Birth Defects|1|||
48715863|NCT00689117|156809977|FG003|Overall Study|Fear of Birth Defects|0|||
48715864|NCT00689117|156809974|FG000|Overall Study|Transportation|1|||
48715865|NCT00689117|156809975|FG001|Overall Study|Transportation|0|||
48715866|NCT00689117|156809976|FG002|Overall Study|Transportation|0|||
48813609|NCT02584855|157157497|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
48598397|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598398|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598399|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
48598400|NCT02326272|156385199|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598401|NCT02326272|156385200|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598402|NCT02326272|156385201|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598403|NCT02326272|156385202|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598404|NCT02326272|156385203|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598405|NCT02326272|156385204|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598406|NCT02326272|156385205|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598407|NCT02326272|156385206|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598408|NCT02326272|156385207|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598409|NCT02326272|156385208|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598410|NCT02326272|156385209|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598411|NCT02326272|156385210|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598412|NCT02326272|156385211|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
48598413|NCT02326272|156385212|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598414|NCT02326272|156385213|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
48598415|NCT01265394|156385220|FG000|Overall Study|Subjects withdrawn|37|||
48598416|NCT00735943|156385221|FG000|Overall Study|Lost to Follow-up|1|||
48598417|NCT00735943|156385221|FG000|Overall Study|Adverse Event|1|||
48598418|NCT02595502|156385231|FG000|Period 1|Adverse Event|0|||
48598419|NCT02595502|156385232|FG001|Period 1|Adverse Event|1|||
48598420|NCT02595502|156385231|FG000|Period 1|Withdrawal by Subject|1|||
48598421|NCT02595502|156385232|FG001|Period 1|Withdrawal by Subject|0|||
48598422|NCT02595502|156385231|FG000|Period 1|Lost to Follow-up|0|||
48598423|NCT02595502|156385232|FG001|Period 1|Lost to Follow-up|1|||
48715867|NCT00689117|156809977|FG003|Overall Study|Transportation|0|||
48715868|NCT00689117|156809974|FG000|Overall Study|Patient Withdrew from Study|0|||
48715869|NCT00689117|156809975|FG001|Overall Study|Patient Withdrew from Study|0|||
48715870|NCT00689117|156809976|FG002|Overall Study|Patient Withdrew from Study|0|||
48598424|NCT02595502|156385231|FG000|Period 2|Adverse Event|1|||
48598425|NCT02595502|156385232|FG001|Period 2|Adverse Event|1|||
48598426|NCT02595502|156385231|FG000|Period 2|Received incorrect lens at Period 1|0|||
48598427|NCT02595502|156385232|FG001|Period 2|Received incorrect lens at Period 1|1|||
48598428|NCT02595502|156385231|FG000|Period 3|Protocol Violation|0|||
48598429|NCT02595502|156385232|FG001|Period 3|Protocol Violation|1|||
48715871|NCT00689117|156809977|FG003|Overall Study|Patient Withdrew from Study|1|||
48715872|NCT00689117|156809974|FG000|Overall Study|Personal Reason|0|||
48715873|NCT00689117|156809975|FG001|Overall Study|Personal Reason|1|||
48715874|NCT00689117|156809976|FG002|Overall Study|Personal Reason|0|||
48715875|NCT00689117|156809977|FG003|Overall Study|Personal Reason|0|||
48715876|NCT00689117|156809974|FG000|Overall Study|Dispensing Error|0|||
48715877|NCT00689117|156809975|FG001|Overall Study|Dispensing Error|1|||
48715878|NCT00689117|156809976|FG002|Overall Study|Dispensing Error|0|||
48715879|NCT00689117|156809977|FG003|Overall Study|Dispensing Error|0|||
48715880|NCT00444678|156809980|FG000|Overall Study|Toxicity|11|||
48715881|NCT00444678|156809980|FG000|Overall Study|Disease Progression|12|||
48715882|NCT00444678|156809980|FG000|Overall Study|Death|3|||
48715883|NCT00444678|156809980|FG000|Overall Study|Physician Decision|3|||
48715884|NCT00444678|156809980|FG000|Overall Study|Withdrawal by Subject|2|||
48715885|NCT00003590|156809981|FG000|Overall Study|Ineligible Patient|1|||
48715886|NCT00003590|156809981|FG000|Overall Study|Adverse Event|7|||
48715887|NCT00003590|156809981|FG000|Overall Study|Withdrawal by Subject|1|||
48715888|NCT00003590|156809981|FG000|Overall Study|Lack of Efficacy|11|||
48715889|NCT00003590|156809981|FG000|Overall Study|Death|1|||
48715890|NCT00003590|156809981|FG000|Overall Study|Physician Decision|1|||
48715891|NCT03319745|156809984|FG000|Overall Study|Death|1|||
48715892|NCT03319745|156809984|FG000|Overall Study|Toxicity Precluding Surgery|1|||
48715893|NCT02855541|156809986|FG000|Overall Study|Change in health status|2|||
48715894|NCT02855541|156809986|FG000|Overall Study|Withdrawal by Subject|2|||
48715895|NCT01242813|156809987|FG000|Overall Study|Lost to Follow-up|2|||
48715896|NCT03135119|156809988|FG000|Overall Study|Lost to Follow-up|2|||
48715897|NCT03135119|156809989|FG001|Overall Study|Lost to Follow-up|0|||
48715898|NCT03135119|156809988|FG000|Overall Study|Physician Decision|1|||
48715899|NCT03135119|156809989|FG001|Overall Study|Physician Decision|1|||
48715900|NCT03135119|156809988|FG000|Overall Study|COVID-19 Shutdown|2|||
48715901|NCT03135119|156809989|FG001|Overall Study|COVID-19 Shutdown|2|||
48715902|NCT00361634|156809995|FG000|Overall Study|Lost to Follow-up|1|||
48715903|NCT00361634|156809995|FG000|Overall Study|Withdrawal by Subject|1|||
48715904|NCT01561898|156809996|FG000|Overall Study|Withdrawal by Subject|0|||
48715905|NCT01561898|156809997|FG001|Overall Study|Withdrawal by Subject|8|||
48715906|NCT01561898|156809998|FG002|Overall Study|Withdrawal by Subject|12|||
48715907|NCT01561898|156809999|FG003|Overall Study|Withdrawal by Subject|5|||
48715908|NCT01561898|156809996|FG000|Overall Study|Lack of Efficacy|0|||
48715909|NCT01561898|156809997|FG001|Overall Study|Lack of Efficacy|8|||
48715910|NCT01561898|156809998|FG002|Overall Study|Lack of Efficacy|10|||
48715911|NCT01561898|156809999|FG003|Overall Study|Lack of Efficacy|5|||
48715912|NCT01561898|156809996|FG000|Overall Study|Worsening of complications|0|||
48715913|NCT01561898|156809997|FG001|Overall Study|Worsening of complications|1|||
48715914|NCT01561898|156809998|FG002|Overall Study|Worsening of complications|0|||
48715915|NCT01561898|156809999|FG003|Overall Study|Worsening of complications|0|||
48715916|NCT01561898|156809996|FG000|Overall Study|Lost to Follow-up|0|||
48715917|NCT01561898|156809997|FG001|Overall Study|Lost to Follow-up|0|||
48715918|NCT01561898|156809998|FG002|Overall Study|Lost to Follow-up|1|||
48715919|NCT01561898|156809999|FG003|Overall Study|Lost to Follow-up|0|||
48715920|NCT01561898|156809996|FG000|Overall Study|Adverse Event|1|||
48715921|NCT01561898|156809997|FG001|Overall Study|Adverse Event|19|||
48715922|NCT01561898|156809998|FG002|Overall Study|Adverse Event|14|||
48715923|NCT01561898|156809999|FG003|Overall Study|Adverse Event|9|||
48715924|NCT01561898|156809996|FG000|Overall Study|Physician Decision|1|||
48715925|NCT01561898|156809997|FG001|Overall Study|Physician Decision|5|||
48715926|NCT01561898|156809998|FG002|Overall Study|Physician Decision|7|||
48715927|NCT01561898|156809999|FG003|Overall Study|Physician Decision|1|||
48715928|NCT00505076|156810000|FG000|Overall Study|Adverse Event|1|||
48715929|NCT00505076|156810001|FG001|Overall Study|Adverse Event|0|||
48715930|NCT00505076|156810002|FG002|Overall Study|Adverse Event|1|||
48715931|NCT00505076|156810000|FG000|Overall Study|Protocol Violation|2|||
48715932|NCT00505076|156810001|FG001|Overall Study|Protocol Violation|1|||
48715933|NCT00505076|156810002|FG002|Overall Study|Protocol Violation|2|||
48715934|NCT00505076|156810000|FG000|Overall Study|Withdrawal by Subject|0|||
48715935|NCT00505076|156810001|FG001|Overall Study|Withdrawal by Subject|1|||
48497167|NCT01325207|156014483|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
48497168|NCT01325207|156014484|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
48715936|NCT00505076|156810002|FG002|Overall Study|Withdrawal by Subject|2|||
48715937|NCT00591318|156810005|FG000|Overall Study|Lack of Efficacy|2|||
48715938|NCT00591318|156810006|FG001|Overall Study|Lack of Efficacy|0|||
48715939|NCT00591318|156810005|FG000|Overall Study|Adverse Event|2|||
48715940|NCT00591318|156810006|FG001|Overall Study|Adverse Event|0|||
48715941|NCT04493892|156810014|FG000|Overall Study|Withdrawal by Subject|15|||
48715942|NCT00233454|156810019|FG000|Overall Study|Death|6|||
48715943|NCT03595618|156810020|FG000|Overall Study|Adverse Event|16|||
48715944|NCT03595618|156810021|FG001|Overall Study|Adverse Event|17|||
48715945|NCT03595618|156810022|FG002|Overall Study|Adverse Event|20|||
48715946|NCT03595618|156810023|FG003|Overall Study|Adverse Event|8|||
48715947|NCT03595618|156810020|FG000|Overall Study|Withdrawal by Subject|12|||
48715948|NCT03595618|156810021|FG001|Overall Study|Withdrawal by Subject|14|||
48715949|NCT03595618|156810022|FG002|Overall Study|Withdrawal by Subject|14|||
48715950|NCT03595618|156810023|FG003|Overall Study|Withdrawal by Subject|10|||
48715951|NCT03595618|156810020|FG000|Overall Study|Lost to Follow-up|6|||
48715952|NCT03595618|156810021|FG001|Overall Study|Lost to Follow-up|4|||
48715953|NCT03595618|156810022|FG002|Overall Study|Lost to Follow-up|5|||
48715954|NCT03595618|156810023|FG003|Overall Study|Lost to Follow-up|6|||
48813610|NCT02584855|157157498|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
48497169|NCT01325207|156014479|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
48497170|NCT01325207|156014480|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
48497171|NCT01325207|156014481|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
48497172|NCT01325207|156014482|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
48497173|NCT01325207|156014483|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
48497174|NCT01325207|156014484|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
48497175|NCT00602030|156014485|FG000|Lead-in Phase|Disease Progression|2|||
48497176|NCT00602030|156014486|FG001|Lead-in Phase|Disease Progression|3|||
48497177|NCT00602030|156014487|FG002|Lead-in Phase|Disease Progression|0|||
48497178|NCT00602030|156014488|FG003|Lead-in Phase|Disease Progression|0|||
48715955|NCT03595618|156810020|FG000|Overall Study|Protocol Violation|2|||
48715956|NCT03595618|156810021|FG001|Overall Study|Protocol Violation|0|||
48715957|NCT03595618|156810022|FG002|Overall Study|Protocol Violation|6|||
48715958|NCT03595618|156810023|FG003|Overall Study|Protocol Violation|2|||
48715959|NCT03595618|156810020|FG000|Overall Study|Physician Decision|0|||
48715960|NCT03595618|156810021|FG001|Overall Study|Physician Decision|0|||
48715961|NCT03595618|156810022|FG002|Overall Study|Physician Decision|1|||
48715962|NCT03595618|156810023|FG003|Overall Study|Physician Decision|2|||
48715963|NCT03595618|156810020|FG000|Overall Study|Miscellaneous|7|||
48715964|NCT03595618|156810021|FG001|Overall Study|Miscellaneous|5|||
48497179|NCT00602030|156014489|FG004|Lead-in Phase|Disease Progression|0|||
48497180|NCT00602030|156014485|FG000|Lead-in Phase|Adverse Event|0|||
48497181|NCT00602030|156014486|FG001|Lead-in Phase|Adverse Event|2|||
48497182|NCT00602030|156014487|FG002|Lead-in Phase|Adverse Event|0|||
48497183|NCT00602030|156014488|FG003|Lead-in Phase|Adverse Event|0|||
48497184|NCT00602030|156014489|FG004|Lead-in Phase|Adverse Event|0|||
48497185|NCT00602030|156014485|FG000|Double-blind Phase|Disease progression|0|||
48497186|NCT00602030|156014486|FG001|Double-blind Phase|Disease progression|0|||
48813611|NCT02584855|157157499|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
48813612|NCT02584855|157157494|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813613|NCT02584855|157157495|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
48813614|NCT02584855|157157496|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813615|NCT02584855|157157497|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813616|NCT02584855|157157498|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813617|NCT02584855|157157499|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
48813618|NCT02584855|157157494|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813619|NCT02584855|157157495|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
48813620|NCT02584855|157157496|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813621|NCT02584855|157157497|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813622|NCT02584855|157157498|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813623|NCT02584855|157157499|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
48813624|NCT02584855|157157494|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813625|NCT02584855|157157495|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813626|NCT02584855|157157496|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813627|NCT02584855|157157497|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813628|NCT02584855|157157498|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
48813629|NCT02584855|157157499|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
48813630|NCT02584855|157157494|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
48813631|NCT02584855|157157495|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
48813632|NCT02584855|157157496|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
48813633|NCT02584855|157157497|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
48813634|NCT02584855|157157498|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
48813635|NCT02584855|157157499|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
48813636|NCT02550873|157157500|FG000|Randomized Double Blind|Adverse Event|3|||
48813637|NCT02550873|157157501|FG001|Randomized Double Blind|Adverse Event|1|||
48813638|NCT02550873|157157502|FG002|Randomized Double Blind|Adverse Event|0|||
48813639|NCT02550873|157157500|FG000|Randomized Double Blind|Disease progression|1|||
48813640|NCT02550873|157157501|FG001|Randomized Double Blind|Disease progression|1|||
48715965|NCT03595618|156810022|FG002|Overall Study|Miscellaneous|10|||
48715966|NCT03595618|156810023|FG003|Overall Study|Miscellaneous|6|||
48715967|NCT00006409|156810028|FG000|Baseline|Protocol Violation|48|||
48813641|NCT02550873|157157502|FG002|Randomized Double Blind|Disease progression|0|||
48497187|NCT00602030|156014487|FG002|Double-blind Phase|Disease progression|33|||
48497188|NCT00602030|156014488|FG003|Double-blind Phase|Disease progression|30|||
48497189|NCT00602030|156014489|FG004|Double-blind Phase|Disease progression|0|||
48715968|NCT00006409|156810029|FG001|Baseline|Protocol Violation|70|||
48715969|NCT00006409|156810030|FG002|Baseline|Protocol Violation|0|||
48497190|NCT00602030|156014485|FG000|Double-blind Phase|Adverse Event|0|||
48715970|NCT00006409|156810031|FG003|Baseline|Protocol Violation|0|||
48715971|NCT00006409|156810032|FG004|Baseline|Protocol Violation|0|||
48715972|NCT00006409|156810033|FG005|Baseline|Protocol Violation|0|||
48715973|NCT00006409|156810028|FG000|Post-2 Year Intervention|Protocol Violation|0|||
48715974|NCT00006409|156810029|FG001|Post-2 Year Intervention|Protocol Violation|0|||
48715975|NCT00006409|156810030|FG002|Post-2 Year Intervention|Protocol Violation|251|||
48715976|NCT00006409|156810031|FG003|Post-2 Year Intervention|Protocol Violation|168|||
48715977|NCT00006409|156810032|FG004|Post-2 Year Intervention|Protocol Violation|0|||
48715978|NCT00006409|156810033|FG005|Post-2 Year Intervention|Protocol Violation|0|||
48715979|NCT00006409|156810028|FG000|Post-3 Year Intervention|Protocol Violation|0|||
48715980|NCT00006409|156810029|FG001|Post-3 Year Intervention|Protocol Violation|0|||
48715981|NCT00006409|156810030|FG002|Post-3 Year Intervention|Protocol Violation|0|||
48715982|NCT00006409|156810031|FG003|Post-3 Year Intervention|Protocol Violation|0|||
48715983|NCT00006409|156810032|FG004|Post-3 Year Intervention|Protocol Violation|62|||
48715984|NCT00006409|156810033|FG005|Post-3 Year Intervention|Protocol Violation|62|||
48715985|NCT03180619|156810034|FG000|Overall Study|Withdrew Consent|5|||
48715986|NCT03180619|156810035|FG001|Overall Study|Withdrew Consent|0|||
48715987|NCT03180619|156810036|FG002|Overall Study|Withdrew Consent|2|||
48715988|NCT03180619|156810034|FG000|Overall Study|Death|2|||
48715989|NCT03180619|156810035|FG001|Overall Study|Death|1|||
48715990|NCT03180619|156810036|FG002|Overall Study|Death|2|||
48715991|NCT03180619|156810034|FG000|Overall Study|Adverse Event|2|||
48715992|NCT03180619|156810035|FG001|Overall Study|Adverse Event|0|||
48715993|NCT03180619|156810036|FG002|Overall Study|Adverse Event|1|||
48715994|NCT03180619|156810034|FG000|Overall Study|Investigator's discretion|2|||
48715995|NCT03180619|156810035|FG001|Overall Study|Investigator's discretion|0|||
48715996|NCT03180619|156810036|FG002|Overall Study|Investigator's discretion|1|||
48715997|NCT01270802|156810037|FG000|Overall Study|Withdrawal by Subject|1|||
48715998|NCT01270802|156810038|FG001|Overall Study|Withdrawal by Subject|0|||
48715999|NCT01270802|156810037|FG000|Overall Study|Adverse Event|1|||
48716000|NCT01270802|156810038|FG001|Overall Study|Adverse Event|0|||
48716001|NCT01270802|156810037|FG000|Overall Study|Lost to Follow-up|0|||
48716002|NCT01270802|156810038|FG001|Overall Study|Lost to Follow-up|1|||
48716003|NCT03077087|156810041|FG000|Overall Study|Physician Decision|2|||
48716004|NCT04620798|156810042|FG000|Overall Study|Lost to Follow-up|126|||
48716005|NCT04620798|156810043|FG001|Overall Study|Lost to Follow-up|138|||
48716006|NCT01587898|156810047|FG000|Overall Study|Adverse Event|1|||
48716007|NCT01587898|156810048|FG001|Overall Study|Adverse Event|1|||
48716008|NCT01587898|156810049|FG002|Overall Study|Adverse Event|0|||
48716009|NCT01587898|156810050|FG003|Overall Study|Adverse Event|0|||
48716010|NCT01587898|156810047|FG000|Overall Study|Protocol Violation|0|||
48716011|NCT01587898|156810048|FG001|Overall Study|Protocol Violation|2|||
48716012|NCT01587898|156810049|FG002|Overall Study|Protocol Violation|1|||
48716013|NCT01587898|156810050|FG003|Overall Study|Protocol Violation|1|||
48716014|NCT01587898|156810047|FG000|Overall Study|Lost to Follow-up|0|||
48716015|NCT01587898|156810048|FG001|Overall Study|Lost to Follow-up|0|||
48716016|NCT01587898|156810049|FG002|Overall Study|Lost to Follow-up|0|||
48716017|NCT01587898|156810050|FG003|Overall Study|Lost to Follow-up|1|||
48716018|NCT01587898|156810047|FG000|Overall Study|Withdrawal by Subject|2|||
48716019|NCT01587898|156810048|FG001|Overall Study|Withdrawal by Subject|1|||
48716020|NCT01587898|156810049|FG002|Overall Study|Withdrawal by Subject|0|||
48716021|NCT01587898|156810050|FG003|Overall Study|Withdrawal by Subject|0|||
48716022|NCT01587898|156810047|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
48716023|NCT01587898|156810048|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
48716024|NCT01587898|156810049|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
48716025|NCT01587898|156810050|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
48716026|NCT01788215|156810054|FG000|Overall Study|Withdrawal by Subject|0|||
48716027|NCT01788215|156810055|FG001|Overall Study|Withdrawal by Subject|1|||
48716028|NCT01788215|156810054|FG000|Overall Study|Lost to Follow-up|2|||
48716029|NCT01788215|156810055|FG001|Overall Study|Lost to Follow-up|0|||
48716030|NCT01738477|156810056|FG000|Overall Study|Lost to Follow-up|1|||
48716031|NCT01738477|156810057|FG001|Overall Study|Lost to Follow-up|4|||
48716032|NCT02365480|156810060|FG000|Overall Study|Withdrawal by Subject|2|||
48716033|NCT02365480|156810061|FG001|Overall Study|Withdrawal by Subject|0|||
48716034|NCT01915303|156810062|FG000|Core Phase|Adverse Event|7|||
48716035|NCT01915303|156810062|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
48716036|NCT01915303|156810062|FG000|Core Phase|Death|2|||
48716037|NCT01915303|156810062|FG000|Core Phase|Protocol Violation|2|||
48716038|NCT01915303|156810062|FG000|Core Phase|Abnormal lab value|1|||
48716039|NCT01915303|156810062|FG000|Core Phase|Withdrawal by Subject|1|||
48716040|NCT01915303|156810062|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
48716041|NCT01915303|156810062|FG000|Extension Phase|Withdrawal by Subject|4|||
48716042|NCT01915303|156810062|FG000|Extension Phase|Adverse Event|3|||
48716043|NCT01915303|156810062|FG000|Extension Phase|Death|1|||
48716044|NCT01915303|156810062|FG000|Extension Phase|Protocol Violation|1|||
48716045|NCT01136785|156810066|FG000|Overall Study|Protocol Violation|2|||
48716046|NCT01136785|156810067|FG001|Overall Study|Protocol Violation|1|||
48716047|NCT00744042|156810068|FG000|Overall Study|Withdrawal by Subject|1|||
48716048|NCT01181986|156810071|FG000|Phase 1|Lost to Follow-up|0|||
48813642|NCT02550873|157157500|FG000|Open Label Extension|Study ongoing|0|||
48813643|NCT02550873|157157501|FG001|Open Label Extension|Study ongoing|0|||
48813644|NCT02550873|157157502|FG002|Open Label Extension|Study ongoing|111|||
48813645|NCT00895843|157157504|FG000|Overall Study|Protocol Violation|12|||
48813646|NCT00895843|157157505|FG001|Overall Study|Protocol Violation|12|||
48813647|NCT02285595|157157511|FG000|Overall Study|Lost to Follow-up|14|||
48813648|NCT02285595|157157511|FG000|Overall Study|Withdrawal by Subject|1|||
48813649|NCT01960790|157157512|FG000|Overall Study|Survey forms could not be recovered|3|||
48813650|NCT01960790|157157512|FG000|Overall Study|Treat with Humira outside survey period|3|||
48813651|NCT01960790|157157512|FG000|Overall Study|Transferred to another hospital|4|||
48813652|NCT01960790|157157512|FG000|Overall Study|Unevaluable for safety|1|||
48813653|NCT01987830|157157515|FG000|Overall Study|Never received baseline scan|1|||
48813654|NCT01794117|157157516|FG000|Overall Study|Adverse Event|1|||
48813655|NCT01794117|157157517|FG001|Overall Study|Adverse Event|0|||
48813656|NCT01794117|157157518|FG002|Overall Study|Adverse Event|0|||
48813657|NCT01794117|157157519|FG003|Overall Study|Adverse Event|0|||
48813658|NCT01794117|157157516|FG000|Overall Study|Participant noncompliance|0|||
48598430|NCT02595502|156385231|FG000|Period 3|Lost to Follow-up|1|||
48598431|NCT02595502|156385232|FG001|Period 3|Lost to Follow-up|0|||
48598432|NCT02595502|156385231|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
48598433|NCT02595502|156385232|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
48813659|NCT01794117|157157517|FG001|Overall Study|Participant noncompliance|1|||
48813660|NCT01794117|157157518|FG002|Overall Study|Participant noncompliance|0|||
48813661|NCT01794117|157157519|FG003|Overall Study|Participant noncompliance|0|||
48813662|NCT01794117|157157516|FG000|Overall Study|Refused further treatment|0|||
48813663|NCT01794117|157157517|FG001|Overall Study|Refused further treatment|2|||
48813664|NCT01794117|157157518|FG002|Overall Study|Refused further treatment|0|||
48598434|NCT01029262|156385233|FG000|Overall Study|Adverse Event|9|||
48598435|NCT01029262|156385234|FG001|Overall Study|Adverse Event|52|||
48598436|NCT01029262|156385233|FG000|Overall Study|Lack of therapeutic effect|57|||
48813665|NCT01794117|157157519|FG003|Overall Study|Refused further treatment|0|||
48813666|NCT00180713|157157523|FG000|Overall Study|Withdrawal by Subject|2|||
48813667|NCT00180713|157157524|FG001|Overall Study|Withdrawal by Subject|0|||
48813668|NCT00180713|157157523|FG000|Overall Study|Adverse Event|3|||
48813669|NCT00180713|157157524|FG001|Overall Study|Adverse Event|3|||
48813670|NCT00556374|157157525|FG000|Overall Study|Withdrawal by Subject|235|||
48813671|NCT00556374|157157526|FG001|Overall Study|Withdrawal by Subject|205|||
48813672|NCT00556374|157157525|FG000|Overall Study|Death|158|||
48813673|NCT00556374|157157526|FG001|Overall Study|Death|127|||
48813674|NCT00556374|157157525|FG000|Overall Study|Lost to Follow-up|24|||
48813675|NCT00556374|157157526|FG001|Overall Study|Lost to Follow-up|17|||
48813676|NCT00556374|157157525|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
48813677|NCT00556374|157157526|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
48813678|NCT00847301|157157527|FG000|Overall Study|Adverse Event|35|||
48813679|NCT00847301|157157527|FG000|Overall Study|Switch to other anticoagulants|16|||
48813680|NCT00847301|157157527|FG000|Overall Study|Lost to Follow-up|1|||
48813681|NCT00847301|157157527|FG000|Overall Study|No prescription after hospital discharge|1|||
48813682|NCT00847301|157157527|FG000|Overall Study|Other reason not defined above|1|||
48813683|NCT00845871|157157528|FG000|Assessment Period|Adverse Event|2|||
48598437|NCT01029262|156385234|FG001|Overall Study|Lack of therapeutic effect|76|||
48598438|NCT01029262|156385233|FG000|Overall Study|Withdrawal by Subject|10|||
48598439|NCT01029262|156385234|FG001|Overall Study|Withdrawal by Subject|17|||
48598440|NCT01029262|156385233|FG000|Overall Study|Protocol Violation|2|||
48598441|NCT01029262|156385234|FG001|Overall Study|Protocol Violation|3|||
48813684|NCT00845871|157157528|FG000|Assessment Period|Abnormal laboratory values|1|||
48813685|NCT00845871|157157528|FG000|Assessment Period|Abnormal test procedure results|1|||
48813686|NCT00845871|157157528|FG000|Assessment Period|Patient withdrew consent|3|||
48813687|NCT01816763|157159916|FG000|Overall Study|The main reason for an incomplete survey|4|||
48813688|NCT01816763|157159917|FG001|Overall Study|The main reason for an incomplete survey|15|||
48813689|NCT01816763|157159918|FG002|Overall Study|The main reason for an incomplete survey|11|||
48813690|NCT02769065|157159924|FG000|Overall Study|Voluntary Withdrawal|1|||
48598442|NCT01029262|156385233|FG000|Overall Study|Miscellaneous|1|||
48598443|NCT01029262|156385234|FG001|Overall Study|Miscellaneous|9|||
48598444|NCT01029262|156385233|FG000|Overall Study|Death|0|||
48598445|NCT01029262|156385234|FG001|Overall Study|Death|3|||
48598446|NCT03410992|156385237|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598447|NCT03410992|156385238|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
48598448|NCT03410992|156385239|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598449|NCT03410992|156385240|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598450|NCT03410992|156385241|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598451|NCT03410992|156385242|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598452|NCT03410992|156385243|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598453|NCT03410992|156385244|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598454|NCT03410992|156385245|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48716049|NCT01181986|156810072|FG001|Phase 1|Lost to Follow-up|1|||
48716050|NCT01181986|156810073|FG002|Phase 1|Lost to Follow-up|1|||
48716051|NCT01181986|156810071|FG000|Phase 1|Adverse Event|0|||
48716052|NCT01181986|156810072|FG001|Phase 1|Adverse Event|0|||
48716053|NCT01181986|156810073|FG002|Phase 1|Adverse Event|1|||
48716054|NCT01181986|156810071|FG000|Phase 1|Protocol Violation|1|||
48716055|NCT01181986|156810072|FG001|Phase 1|Protocol Violation|0|||
48716056|NCT01181986|156810073|FG002|Phase 1|Protocol Violation|0|||
48716057|NCT01181986|156810071|FG000|Phase 2|Adverse Event|0|||
48716058|NCT01181986|156810072|FG001|Phase 2|Adverse Event|3|||
48716059|NCT01181986|156810073|FG002|Phase 2|Adverse Event|0|||
48716060|NCT01181986|156810071|FG000|Phase 2|Medical condition|0|||
48716061|NCT01181986|156810072|FG001|Phase 2|Medical condition|1|||
48716062|NCT01181986|156810073|FG002|Phase 2|Medical condition|0|||
48716063|NCT00348881|156810074|FG000|Overall Study|Lost to Follow-up|12|||
48716064|NCT00348881|156810075|FG001|Overall Study|Lost to Follow-up|6|||
48716065|NCT00348881|156810074|FG000|Overall Study|Withdrawal by Subject|3|||
48813691|NCT02769065|157159925|FG001|Overall Study|Voluntary Withdrawal|0|||
48813692|NCT02769065|157159926|FG002|Overall Study|Voluntary Withdrawal|0|||
48813693|NCT02769065|157159927|FG003|Overall Study|Voluntary Withdrawal|0|||
48813694|NCT02769065|157159928|FG004|Overall Study|Voluntary Withdrawal|0|||
48813695|NCT02769065|157159929|FG005|Overall Study|Voluntary Withdrawal|0|||
48813696|NCT02769065|157159930|FG006|Overall Study|Voluntary Withdrawal|0|||
48813697|NCT02769065|157159931|FG007|Overall Study|Voluntary Withdrawal|0|||
48813698|NCT02769065|157159932|FG008|Overall Study|Voluntary Withdrawal|0|||
48716066|NCT00348881|156810075|FG001|Overall Study|Withdrawal by Subject|4|||
48716067|NCT00348881|156810074|FG000|Overall Study|Adverse Event|2|||
48716068|NCT00348881|156810075|FG001|Overall Study|Adverse Event|0|||
48716069|NCT00348881|156810074|FG000|Overall Study|Serious Adverse Event|0|||
48716070|NCT00348881|156810075|FG001|Overall Study|Serious Adverse Event|2|||
48716071|NCT03255083|156810081|FG000|Overall Study|Clinical progression|1|||
48716072|NCT03255083|156810082|FG001|Overall Study|Clinical progression|0|||
48716073|NCT03255083|156810083|FG002|Overall Study|Clinical progression|0|||
48716074|NCT03255083|156810084|FG003|Overall Study|Clinical progression|0|||
48716075|NCT03255083|156810081|FG000|Overall Study|Adverse Event|0|||
48716076|NCT03255083|156810082|FG001|Overall Study|Adverse Event|1|||
48716077|NCT03255083|156810083|FG002|Overall Study|Adverse Event|0|||
48716078|NCT03255083|156810084|FG003|Overall Study|Adverse Event|0|||
48716079|NCT03255083|156810081|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
48716080|NCT03255083|156810082|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
48716081|NCT03255083|156810083|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
48716082|NCT03255083|156810084|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
48716083|NCT03255083|156810081|FG000|Overall Study|Withdrawal by Subject|1|||
48716084|NCT03255083|156810082|FG001|Overall Study|Withdrawal by Subject|1|||
48716085|NCT03255083|156810083|FG002|Overall Study|Withdrawal by Subject|1|||
48716086|NCT03255083|156810084|FG003|Overall Study|Withdrawal by Subject|0|||
48716087|NCT02051933|156811178|FG000|Overall Study|Physician Decision|0|||
48716088|NCT02051933|156811179|FG001|Overall Study|Physician Decision|1|||
48716089|NCT00798759|156811180|FG000|Overall Study|Adverse Event|3|||
48716090|NCT00798759|156811181|FG001|Overall Study|Adverse Event|3|||
48716091|NCT00798759|156811180|FG000|Overall Study|Lost to Follow-up|1|||
48716092|NCT00798759|156811181|FG001|Overall Study|Lost to Follow-up|1|||
48716093|NCT00798759|156811180|FG000|Overall Study|Protocol Violation|4|||
48497191|NCT00602030|156014486|FG001|Double-blind Phase|Adverse Event|0|||
48497192|NCT00602030|156014487|FG002|Double-blind Phase|Adverse Event|9|||
48497193|NCT00602030|156014488|FG003|Double-blind Phase|Adverse Event|18|||
48497194|NCT00602030|156014489|FG004|Double-blind Phase|Adverse Event|0|||
48813699|NCT02769065|157159933|FG009|Overall Study|Voluntary Withdrawal|0|||
48813700|NCT02769065|157159934|FG010|Overall Study|Voluntary Withdrawal|0|||
48497195|NCT00602030|156014485|FG000|Double-blind Phase|Consent withdrawal|0|||
48497196|NCT00602030|156014486|FG001|Double-blind Phase|Consent withdrawal|0|||
48497197|NCT00602030|156014487|FG002|Double-blind Phase|Consent withdrawal|4|||
48497198|NCT00602030|156014488|FG003|Double-blind Phase|Consent withdrawal|3|||
48497199|NCT00602030|156014489|FG004|Double-blind Phase|Consent withdrawal|0|||
48497200|NCT00602030|156014485|FG000|Double-blind Phase|Death|0|||
48497201|NCT00602030|156014486|FG001|Double-blind Phase|Death|0|||
48716094|NCT00798759|156811181|FG001|Overall Study|Protocol Violation|8|||
48716095|NCT00798759|156811180|FG000|Overall Study|Other|0|||
48813701|NCT02769065|157159935|FG011|Overall Study|Voluntary Withdrawal|0|||
48716096|NCT00798759|156811181|FG001|Overall Study|Other|1|||
48716097|NCT00109590|156811183|FG000|Overall Study|Lost to Follow-up|1|||
48716098|NCT00109590|156811184|FG001|Overall Study|Lost to Follow-up|0|||
48716099|NCT00109590|156811185|FG002|Overall Study|Lost to Follow-up|1|||
48813702|NCT02769065|157159936|FG012|Overall Study|Voluntary Withdrawal|0|||
48497202|NCT00602030|156014487|FG002|Double-blind Phase|Death|3|||
48497203|NCT00602030|156014488|FG003|Double-blind Phase|Death|3|||
48497204|NCT00602030|156014489|FG004|Double-blind Phase|Death|0|||
48716100|NCT00109590|156811183|FG000|Overall Study|Never Started Treatment|1|||
48716101|NCT00109590|156811184|FG001|Overall Study|Never Started Treatment|2|||
48813703|NCT02769065|157159937|FG013|Overall Study|Voluntary Withdrawal|0|||
48813704|NCT02769065|157159938|FG014|Overall Study|Voluntary Withdrawal|0|||
48813705|NCT02769065|157159939|FG015|Overall Study|Voluntary Withdrawal|0|||
48813706|NCT02769065|157159940|FG016|Overall Study|Voluntary Withdrawal|0|||
48813707|NCT02769065|157159941|FG017|Overall Study|Voluntary Withdrawal|0|||
48813708|NCT02769065|157159942|FG018|Overall Study|Voluntary Withdrawal|0|||
48813709|NCT02769065|157159943|FG019|Overall Study|Voluntary Withdrawal|0|||
48813710|NCT02769065|157159944|FG020|Overall Study|Voluntary Withdrawal|0|||
48813711|NCT02769065|157159945|FG021|Overall Study|Voluntary Withdrawal|0|||
48813712|NCT02769065|157159946|FG022|Overall Study|Voluntary Withdrawal|0|||
48813713|NCT02769065|157159947|FG023|Overall Study|Voluntary Withdrawal|0|||
48813714|NCT02769065|157159948|FG024|Overall Study|Voluntary Withdrawal|0|||
48813715|NCT02769065|157159949|FG025|Overall Study|Voluntary Withdrawal|0|||
48813716|NCT02769065|157159950|FG026|Overall Study|Voluntary Withdrawal|0|||
48813717|NCT02769065|157159951|FG027|Overall Study|Voluntary Withdrawal|0|||
48813718|NCT02769065|157159952|FG028|Overall Study|Voluntary Withdrawal|0|||
48813719|NCT02769065|157159953|FG029|Overall Study|Voluntary Withdrawal|0|||
48813720|NCT02769065|157159924|FG000|Overall Study|Reason Not Specified|0|||
48813721|NCT02769065|157159925|FG001|Overall Study|Reason Not Specified|0|||
48813722|NCT02769065|157159926|FG002|Overall Study|Reason Not Specified|0|||
48813723|NCT02769065|157159927|FG003|Overall Study|Reason Not Specified|0|||
48813724|NCT02769065|157159928|FG004|Overall Study|Reason Not Specified|0|||
48813725|NCT02769065|157159929|FG005|Overall Study|Reason Not Specified|0|||
48813726|NCT02769065|157159930|FG006|Overall Study|Reason Not Specified|1|||
48813727|NCT02769065|157159931|FG007|Overall Study|Reason Not Specified|0|||
48813728|NCT02769065|157159932|FG008|Overall Study|Reason Not Specified|0|||
48813729|NCT02769065|157159933|FG009|Overall Study|Reason Not Specified|0|||
48813730|NCT02769065|157159934|FG010|Overall Study|Reason Not Specified|0|||
48813731|NCT02769065|157159935|FG011|Overall Study|Reason Not Specified|0|||
48813732|NCT02769065|157159936|FG012|Overall Study|Reason Not Specified|0|||
48813733|NCT02769065|157159937|FG013|Overall Study|Reason Not Specified|0|||
48813734|NCT02769065|157159938|FG014|Overall Study|Reason Not Specified|0|||
48813735|NCT02769065|157159939|FG015|Overall Study|Reason Not Specified|0|||
48813736|NCT02769065|157159940|FG016|Overall Study|Reason Not Specified|0|||
48813737|NCT02769065|157159941|FG017|Overall Study|Reason Not Specified|0|||
48813738|NCT02769065|157159942|FG018|Overall Study|Reason Not Specified|0|||
48813739|NCT02769065|157159943|FG019|Overall Study|Reason Not Specified|0|||
48497205|NCT00602030|156014485|FG000|Double-blind Phase|Administrative decision|0|||
48497206|NCT00602030|156014486|FG001|Double-blind Phase|Administrative decision|0|||
48497207|NCT00602030|156014487|FG002|Double-blind Phase|Administrative decision|0|||
48497208|NCT00602030|156014488|FG003|Double-blind Phase|Administrative decision|2|||
48497209|NCT00602030|156014489|FG004|Double-blind Phase|Administrative decision|0|||
48497210|NCT00602030|156014485|FG000|Double-blind Phase|Ineligibility|0|||
48497211|NCT00602030|156014486|FG001|Double-blind Phase|Ineligibility|0|||
48497212|NCT00602030|156014487|FG002|Double-blind Phase|Ineligibility|0|||
48497213|NCT00602030|156014488|FG003|Double-blind Phase|Ineligibility|1|||
48716102|NCT00109590|156811185|FG002|Overall Study|Never Started Treatment|3|||
48716103|NCT01221285|156811186|FG000|Overall Study|Withdrawal by Subject|1|||
48716104|NCT00588861|156811190|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
48716105|NCT00588861|156811191|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
48716106|NCT00588861|156811190|FG000|6 Months|Patients did not return for follow-up|98|||
48716107|NCT00588861|156811191|FG001|6 Months|Patients did not return for follow-up|73|||
48716108|NCT00588861|156811190|FG000|1 Year|Patients did not return for follow-up|89|||
48716109|NCT00588861|156811191|FG001|1 Year|Patients did not return for follow-up|82|||
48813740|NCT02769065|157159944|FG020|Overall Study|Reason Not Specified|0|||
48813741|NCT02769065|157159945|FG021|Overall Study|Reason Not Specified|0|||
48813742|NCT02769065|157159946|FG022|Overall Study|Reason Not Specified|0|||
48813743|NCT02769065|157159947|FG023|Overall Study|Reason Not Specified|0|||
48813744|NCT02769065|157159948|FG024|Overall Study|Reason Not Specified|0|||
48813745|NCT02769065|157159949|FG025|Overall Study|Reason Not Specified|0|||
48813746|NCT02769065|157159950|FG026|Overall Study|Reason Not Specified|0|||
48813747|NCT02769065|157159951|FG027|Overall Study|Reason Not Specified|0|||
48813748|NCT02769065|157159952|FG028|Overall Study|Reason Not Specified|0|||
48716110|NCT00588861|156811190|FG000|2 Years|Patients did not return for follow-up|92|||
48716111|NCT00588861|156811191|FG001|2 Years|Patients did not return for follow-up|87|||
48497214|NCT00602030|156014489|FG004|Double-blind Phase|Ineligibility|0|||
48716112|NCT00588861|156811190|FG000|4 Years|Patients did not return for follow-up|91|||
48716113|NCT00588861|156811191|FG001|4 Years|Patients did not return for follow-up|103|||
48497215|NCT00602030|156014485|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
48497216|NCT00602030|156014486|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
48813749|NCT02769065|157159953|FG029|Overall Study|Reason Not Specified|0|||
48813750|NCT02769065|157159924|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813751|NCT02769065|157159925|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813752|NCT02769065|157159926|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
48497217|NCT00602030|156014487|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
48497218|NCT00602030|156014488|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
48497219|NCT00602030|156014489|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
48497220|NCT00602030|156014485|FG000|Double-blind Phase|Reason not specified|0|||
48497221|NCT00602030|156014486|FG001|Double-blind Phase|Reason not specified|0|||
48497222|NCT00602030|156014487|FG002|Double-blind Phase|Reason not specified|4|||
48497223|NCT00602030|156014488|FG003|Double-blind Phase|Reason not specified|2|||
48497224|NCT00602030|156014489|FG004|Double-blind Phase|Reason not specified|0|||
48497225|NCT00602030|156014485|FG000|Crossover Phase|Disease Progression|0|||
48497226|NCT00602030|156014486|FG001|Crossover Phase|Disease Progression|0|||
48813753|NCT02769065|157159927|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813754|NCT02769065|157159928|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813755|NCT02769065|157159929|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813756|NCT02769065|157159930|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813757|NCT02769065|157159931|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
48497227|NCT00602030|156014487|FG002|Crossover Phase|Disease Progression|0|||
48497228|NCT00602030|156014488|FG003|Crossover Phase|Disease Progression|0|||
48497229|NCT00602030|156014489|FG004|Crossover Phase|Disease Progression|11|||
48497230|NCT00602030|156014485|FG000|Crossover Phase|Adverse Event|0|||
48497231|NCT00602030|156014486|FG001|Crossover Phase|Adverse Event|0|||
48497232|NCT00602030|156014487|FG002|Crossover Phase|Adverse Event|0|||
48716114|NCT00588861|156811190|FG000|6 Years|Patients did not return for follow-up|104|||
48716115|NCT00588861|156811191|FG001|6 Years|Patients did not return for follow-up|109|||
48716116|NCT00588861|156811190|FG000|8 Years|Patients did not return for follow-up|105|||
48716117|NCT00588861|156811191|FG001|8 Years|Patients did not return for follow-up|114|||
48716118|NCT00588861|156811190|FG000|10 Years|Incomplete due to study termination|107|||
48716119|NCT00588861|156811191|FG001|10 Years|Incomplete due to study termination|114|||
48716120|NCT02730195|156811192|FG000|Overall Study|Withdrawal by Subject|1|||
48716121|NCT01368562|156811193|FG000|Overall Study|Adverse Event|1|||
48716122|NCT01368562|156811193|FG000|Overall Study|Disease progression|1|||
48497233|NCT00602030|156014488|FG003|Crossover Phase|Adverse Event|0|||
48497234|NCT00602030|156014489|FG004|Crossover Phase|Adverse Event|3|||
48497235|NCT00602030|156014485|FG000|Crossover Phase|Consent withdrawal|0|||
48497236|NCT00602030|156014486|FG001|Crossover Phase|Consent withdrawal|0|||
48497237|NCT00602030|156014487|FG002|Crossover Phase|Consent withdrawal|0|||
48497238|NCT00602030|156014488|FG003|Crossover Phase|Consent withdrawal|0|||
48497239|NCT00602030|156014489|FG004|Crossover Phase|Consent withdrawal|2|||
48497240|NCT00708422|156014490|FG000|Overall Study|Adverse Event|3|||
48497241|NCT00708422|156014491|FG001|Overall Study|Adverse Event|1|||
48497242|NCT00708422|156014490|FG000|Overall Study|Withdrawal by Subject|1|||
48497243|NCT00708422|156014491|FG001|Overall Study|Withdrawal by Subject|0|||
48497244|NCT01254409|156014492|FG000|Overall Study|Adverse Event|0|||
48497245|NCT01254409|156014493|FG001|Overall Study|Adverse Event|1|||
48497246|NCT01254409|156014494|FG002|Overall Study|Adverse Event|0|||
48497247|NCT01254409|156014495|FG003|Overall Study|Adverse Event|0|||
48497248|NCT00299156|156014500|FG000|Period 2 (Randomized)|Screen Failure|0|||
48497249|NCT00299156|156014501|FG001|Period 2 (Randomized)|Screen Failure|1|||
48716123|NCT01368562|156811193|FG000|Overall Study|Lost to Follow-up|1|||
48716124|NCT01368562|156811193|FG000|Overall Study|Death|6|||
48716125|NCT01368562|156811193|FG000|Overall Study|Unresponsive to treatment|5|||
48716126|NCT01368562|156811193|FG000|Overall Study|Other|3|||
48813758|NCT02769065|157159932|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813759|NCT02769065|157159933|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813760|NCT02769065|157159934|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
48813761|NCT02769065|157159935|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813762|NCT02769065|157159936|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813763|NCT02769065|157159937|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813764|NCT02769065|157159938|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813765|NCT02769065|157159939|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813766|NCT02769065|157159940|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813767|NCT02769065|157159941|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813768|NCT02769065|157159942|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813769|NCT02769065|157159943|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813770|NCT02769065|157159944|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813771|NCT02769065|157159945|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813772|NCT02769065|157159946|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813773|NCT02769065|157159947|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813774|NCT02769065|157159948|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813775|NCT02769065|157159949|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
48497250|NCT00299156|156014502|FG002|Period 2 (Randomized)|Screen Failure|0|||
48497251|NCT00635154|156014504|FG000|Overall Study|Alternative Treatment|8|||
48497252|NCT00635154|156014504|FG000|Overall Study|Other|4|||
48716127|NCT01368562|156811193|FG000|Overall Study|Other than specified|2|||
48813776|NCT02769065|157159950|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
48497253|NCT00635154|156014504|FG000|Overall Study|Still on treatment|21|||
48497254|NCT03980483|156014505|FG000|Overall Study|Adverse Event|13|||
48497255|NCT03980483|156014506|FG001|Overall Study|Adverse Event|29|||
48497256|NCT03980483|156014507|FG002|Overall Study|Adverse Event|11|||
48497257|NCT03980483|156014508|FG003|Overall Study|Adverse Event|2|||
48497258|NCT03980483|156014509|FG004|Overall Study|Adverse Event|2|||
48497259|NCT03980483|156014510|FG005|Overall Study|Adverse Event|2|||
48497260|NCT03980483|156014505|FG000|Overall Study|Lack of Efficacy|7|||
48497261|NCT03980483|156014506|FG001|Overall Study|Lack of Efficacy|6|||
48497262|NCT03980483|156014507|FG002|Overall Study|Lack of Efficacy|0|||
48497263|NCT03980483|156014508|FG003|Overall Study|Lack of Efficacy|3|||
48497264|NCT03980483|156014509|FG004|Overall Study|Lack of Efficacy|1|||
48497265|NCT03980483|156014510|FG005|Overall Study|Lack of Efficacy|1|||
48497266|NCT03980483|156014505|FG000|Overall Study|Lost to Follow-up|2|||
48497267|NCT03980483|156014506|FG001|Overall Study|Lost to Follow-up|4|||
48497268|NCT03980483|156014507|FG002|Overall Study|Lost to Follow-up|2|||
48497269|NCT03980483|156014508|FG003|Overall Study|Lost to Follow-up|1|||
48497270|NCT03980483|156014509|FG004|Overall Study|Lost to Follow-up|2|||
48497271|NCT03980483|156014510|FG005|Overall Study|Lost to Follow-up|0|||
48497272|NCT03980483|156014505|FG000|Overall Study|Protocol Violation|4|||
48497273|NCT03980483|156014506|FG001|Overall Study|Protocol Violation|2|||
48598455|NCT03410992|156385246|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598456|NCT03410992|156385247|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
48598457|NCT03410992|156385237|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
48598458|NCT03410992|156385238|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
48598459|NCT03410992|156385239|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48598460|NCT03410992|156385240|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48598461|NCT03410992|156385241|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48598462|NCT03410992|156385242|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48598463|NCT03410992|156385243|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48716128|NCT01325337|156811194|FG000|Overall Study|Adverse Event|0|||
48716129|NCT01325337|156811195|FG001|Overall Study|Adverse Event|2|||
48716130|NCT01325337|156811196|FG002|Overall Study|Adverse Event|2|||
48716131|NCT01325337|156811197|FG003|Overall Study|Adverse Event|1|||
48716132|NCT01325337|156811198|FG004|Overall Study|Adverse Event|2|||
48716133|NCT01325337|156811194|FG000|Overall Study|Lost to Follow-up|2|||
48716134|NCT01325337|156811195|FG001|Overall Study|Lost to Follow-up|2|||
48716135|NCT01325337|156811196|FG002|Overall Study|Lost to Follow-up|2|||
48716136|NCT01325337|156811197|FG003|Overall Study|Lost to Follow-up|1|||
48716137|NCT01325337|156811198|FG004|Overall Study|Lost to Follow-up|2|||
48716138|NCT01325337|156811194|FG000|Overall Study|Personal Reasons|2|||
48716139|NCT01325337|156811195|FG001|Overall Study|Personal Reasons|5|||
48716140|NCT01325337|156811196|FG002|Overall Study|Personal Reasons|4|||
48716141|NCT01325337|156811197|FG003|Overall Study|Personal Reasons|8|||
48716142|NCT01325337|156811198|FG004|Overall Study|Personal Reasons|3|||
48716143|NCT01325337|156811194|FG000|Overall Study|Withdrawal by Subject|1|||
48716144|NCT01325337|156811195|FG001|Overall Study|Withdrawal by Subject|0|||
48716145|NCT01325337|156811196|FG002|Overall Study|Withdrawal by Subject|1|||
48716146|NCT01325337|156811197|FG003|Overall Study|Withdrawal by Subject|0|||
48716147|NCT01325337|156811198|FG004|Overall Study|Withdrawal by Subject|1|||
48716148|NCT02881567|156811199|FG000|Overall Study|Adverse Event|1|||
48716149|NCT02881567|156811199|FG000|Overall Study|Lost to Follow-up|3|||
48436139|NCT00617409|155785799|FG000|Overall Study|Disease Progression|8|||
48436140|NCT00617409|155785800|FG001|Overall Study|Disease Progression|8|||
48436141|NCT00617409|155785801|FG002|Overall Study|Disease Progression|18|||
48436142|NCT00617409|155785799|FG000|Overall Study|Death|3|||
48436143|NCT00617409|155785800|FG001|Overall Study|Death|5|||
48436144|NCT00617409|155785801|FG002|Overall Study|Death|4|||
48436145|NCT00617409|155785799|FG000|Overall Study|Alternative Therapy|1|||
48436146|NCT00617409|155785800|FG001|Overall Study|Alternative Therapy|2|||
48436147|NCT00617409|155785801|FG002|Overall Study|Alternative Therapy|0|||
48436148|NCT04032171|155785802|FG000|Overall Study|Study Termination|1|||
48436149|NCT04032171|155785803|FG001|Overall Study|Study Termination|0|||
48436150|NCT02841787|155785815|FG000|Overall Study|Lost to Follow-up|1|||
48436151|NCT02841787|155785816|FG001|Overall Study|Lost to Follow-up|0|||
48436152|NCT02841787|155785817|FG002|Overall Study|Lost to Follow-up|0|||
48436153|NCT02841787|155785815|FG000|Overall Study|Symptoms dropped below threshold|1|||
48436154|NCT02841787|155785816|FG001|Overall Study|Symptoms dropped below threshold|0|||
48436155|NCT02841787|155785817|FG002|Overall Study|Symptoms dropped below threshold|0|||
48436156|NCT02841787|155785815|FG000|Overall Study|Withdrawal by Subject|1|||
48436157|NCT02841787|155785816|FG001|Overall Study|Withdrawal by Subject|4|||
48436158|NCT02841787|155785817|FG002|Overall Study|Withdrawal by Subject|0|||
48436159|NCT03491553|155785818|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
48436160|NCT03491553|155785819|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
48436161|NCT03491553|155785820|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
48436162|NCT03491553|155785821|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
48436163|NCT03491553|155785822|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
48813777|NCT02769065|157159951|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
48497274|NCT03980483|156014507|FG002|Overall Study|Protocol Violation|1|||
48497275|NCT03980483|156014508|FG003|Overall Study|Protocol Violation|1|||
48497276|NCT03980483|156014509|FG004|Overall Study|Protocol Violation|0|||
48497277|NCT03980483|156014510|FG005|Overall Study|Protocol Violation|0|||
48497278|NCT03980483|156014505|FG000|Overall Study|Physician Decision|14|||
48497279|NCT03980483|156014506|FG001|Overall Study|Physician Decision|10|||
48497280|NCT03980483|156014507|FG002|Overall Study|Physician Decision|7|||
48497281|NCT03980483|156014508|FG003|Overall Study|Physician Decision|4|||
48497282|NCT03980483|156014509|FG004|Overall Study|Physician Decision|4|||
48497283|NCT03980483|156014510|FG005|Overall Study|Physician Decision|2|||
48497284|NCT03980483|156014505|FG000|Overall Study|Withdrawal by Subject|38|||
48497285|NCT03980483|156014506|FG001|Overall Study|Withdrawal by Subject|21|||
48497286|NCT03980483|156014507|FG002|Overall Study|Withdrawal by Subject|15|||
48497287|NCT03980483|156014508|FG003|Overall Study|Withdrawal by Subject|5|||
48497288|NCT03980483|156014509|FG004|Overall Study|Withdrawal by Subject|3|||
48497289|NCT03980483|156014510|FG005|Overall Study|Withdrawal by Subject|4|||
48497290|NCT03980483|156014505|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
48813778|NCT02769065|157159952|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813779|NCT02769065|157159953|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
48813780|NCT00429494|157159960|FG000|Overall Study|Withdrawal by Subject|9|||
48813781|NCT00429494|157159960|FG000|Overall Study|Death|6|||
48813782|NCT00975221|157159961|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
48813783|NCT00975221|157159962|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
48813784|NCT00975221|157159961|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
48813785|NCT00975221|157159962|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
48813786|NCT00975221|157159961|FG000|Titration Phase (Weeks 1-12)|Other|0|||
48497291|NCT03980483|156014506|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
48497292|NCT03980483|156014507|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
48497293|NCT03980483|156014508|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
48497294|NCT03980483|156014509|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
48497295|NCT03980483|156014510|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
48497296|NCT03980483|156014505|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
48497297|NCT03980483|156014506|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
48497298|NCT03980483|156014507|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
48497299|NCT03980483|156014508|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
48497300|NCT03980483|156014509|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
48497301|NCT03980483|156014510|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
48813787|NCT00975221|157159962|FG001|Titration Phase (Weeks 1-12)|Other|1|||
48813788|NCT00975221|157159961|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
48813789|NCT00975221|157159962|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
48813790|NCT00975221|157159961|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
48813791|NCT00975221|157159962|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
48813792|NCT00975221|157159961|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
48813793|NCT00975221|157159962|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
48813794|NCT03935217|157159965|FG000|Overall Study|Adverse Event|1|||
48813795|NCT03935217|157159966|FG001|Overall Study|Adverse Event|0|||
48813796|NCT03935217|157159965|FG000|Overall Study|Lost to Follow-up|0|||
48813797|NCT03935217|157159966|FG001|Overall Study|Lost to Follow-up|1|||
48813798|NCT03935217|157159965|FG000|Overall Study|Withdrawal by Subject|0|||
48813799|NCT03935217|157159966|FG001|Overall Study|Withdrawal by Subject|2|||
48813800|NCT01992549|157159967|FG000|Overall Study|Lost to Follow-up|2|||
48813801|NCT01992549|157159967|FG000|Overall Study|Serious Adverse Event|1|||
48813802|NCT01992549|157159967|FG000|Overall Study|Product Switch to Extend Half Life|1|||
48813803|NCT02791490|157159968|FG000|Overall Study|Lost to Follow-up|1|||
48813804|NCT02791490|157159969|FG001|Overall Study|Lost to Follow-up|2|||
48813805|NCT02791490|157159968|FG000|Overall Study|Withdrawal by Subject|2|||
48813806|NCT02791490|157159969|FG001|Overall Study|Withdrawal by Subject|6|||
48813807|NCT01912222|157159971|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
48813808|NCT01912222|157159972|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
48813809|NCT01912222|157159973|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
48813810|NCT01912222|157159971|FG000|Part B: Treatment Period|Progressive disease|10|||
48813811|NCT01912222|157159972|FG001|Part B: Treatment Period|Progressive disease|12|||
48813812|NCT01912222|157159973|FG002|Part B: Treatment Period|Progressive disease|15|||
48813813|NCT01912222|157159971|FG000|Part B: Treatment Period|Adverse Event|1|||
48813814|NCT01912222|157159972|FG001|Part B: Treatment Period|Adverse Event|2|||
48497302|NCT03980483|156014505|FG000|Overall Study|Other|0|||
48497303|NCT03980483|156014506|FG001|Overall Study|Other|1|||
48497304|NCT03980483|156014507|FG002|Overall Study|Other|0|||
48497305|NCT03980483|156014508|FG003|Overall Study|Other|0|||
48497306|NCT03980483|156014509|FG004|Overall Study|Other|0|||
48497307|NCT03980483|156014510|FG005|Overall Study|Other|0|||
48497308|NCT01225146|156014513|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
48813815|NCT01912222|157159973|FG002|Part B: Treatment Period|Adverse Event|3|||
48813816|NCT01912222|157159971|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
48813817|NCT01912222|157159972|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
48813818|NCT01912222|157159973|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
48813819|NCT00154063|157159974|FG000|Overall Study|Adverse Event|4|||
48813820|NCT00154063|157159975|FG001|Overall Study|Adverse Event|8|||
48813821|NCT00154063|157159974|FG000|Overall Study|Protocol Violation|1|||
48813822|NCT00154063|157159975|FG001|Overall Study|Protocol Violation|1|||
48813823|NCT00154063|157159974|FG000|Overall Study|Investigator or Sponsor Request|0|||
48813824|NCT00154063|157159975|FG001|Overall Study|Investigator or Sponsor Request|1|||
48497309|NCT01225146|156014514|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
48716150|NCT02881567|156811199|FG000|Overall Study|Consent withdrawn|1|||
48716151|NCT02881567|156811199|FG000|Overall Study|Investigator decision|1|||
48716152|NCT02881567|156811199|FG000|Overall Study|Study terminated by sponsor|9|||
48716153|NCT02881567|156811199|FG000|Overall Study|Reason not Specified|3|||
48716154|NCT01012219|156811200|FG000|Period 1|Withdrawal by Subject|1|||
48716155|NCT01012219|156811200|FG000|Period 2|Withdrawal by Subject|1|||
48716156|NCT02894502|156811201|FG000|Baseline|Withdrawal by Subject|24|||
48716157|NCT02894502|156811202|FG001|Baseline|Withdrawal by Subject|31|||
48716158|NCT02894502|156811203|FG002|Baseline|Withdrawal by Subject|36|||
48716159|NCT02894502|156811201|FG000|Baseline|Death|3|||
48716160|NCT02894502|156811202|FG001|Baseline|Death|1|||
48716161|NCT02894502|156811203|FG002|Baseline|Death|9|||
48716162|NCT02894502|156811201|FG000|First Follow up|Withdrawal by Subject|32|||
48716163|NCT02894502|156811202|FG001|First Follow up|Withdrawal by Subject|29|||
48716164|NCT02894502|156811203|FG002|First Follow up|Withdrawal by Subject|37|||
48716165|NCT02894502|156811201|FG000|First Follow up|Death|2|||
48716166|NCT02894502|156811202|FG001|First Follow up|Death|2|||
48716167|NCT02894502|156811203|FG002|First Follow up|Death|3|||
48716168|NCT02894502|156811201|FG000|Second Follow up|Withdrawal by Subject|13|||
48716169|NCT02894502|156811202|FG001|Second Follow up|Withdrawal by Subject|15|||
48716170|NCT02894502|156811203|FG002|Second Follow up|Withdrawal by Subject|13|||
48716171|NCT02894502|156811201|FG000|Second Follow up|Death|2|||
48716172|NCT02894502|156811202|FG001|Second Follow up|Death|3|||
48716173|NCT02894502|156811203|FG002|Second Follow up|Death|1|||
48716174|NCT02894502|156811201|FG000|Third Follow up|Withdrawal by Subject|5|||
48716175|NCT02894502|156811202|FG001|Third Follow up|Withdrawal by Subject|6|||
48716176|NCT02894502|156811203|FG002|Third Follow up|Withdrawal by Subject|3|||
48716177|NCT02894502|156811201|FG000|Third Follow up|Death|1|||
48716178|NCT02894502|156811202|FG001|Third Follow up|Death|1|||
48716179|NCT02894502|156811203|FG002|Third Follow up|Death|0|||
48716180|NCT02870933|156811209|FG000|Overall Study|Death|2|||
48716181|NCT02870933|156811210|FG001|Overall Study|Death|1|||
48716182|NCT02870933|156811209|FG000|Overall Study|Withdrawal by Subject|0|||
48716183|NCT02870933|156811210|FG001|Overall Study|Withdrawal by Subject|1|||
48716184|NCT01206322|156811211|FG000|Overall Study|Adverse Event|0|||
48716185|NCT01206322|156811212|FG001|Overall Study|Adverse Event|0|||
48716186|NCT01206322|156811213|FG002|Overall Study|Adverse Event|0|||
48716187|NCT01206322|156811214|FG003|Overall Study|Adverse Event|1|||
48716188|NCT01425463|156811215|FG000|Overall Study|Adverse Event|5|||
48716189|NCT01425463|156811216|FG001|Overall Study|Adverse Event|7|||
48716190|NCT01425463|156811215|FG000|Overall Study|Lack of Efficacy|1|||
48716191|NCT01425463|156811216|FG001|Overall Study|Lack of Efficacy|1|||
48716192|NCT01425463|156811215|FG000|Overall Study|Protocol Violation|2|||
48716193|NCT01425463|156811216|FG001|Overall Study|Protocol Violation|2|||
48716194|NCT01425463|156811215|FG000|Overall Study|Lost to Follow-up|5|||
48716195|NCT01425463|156811216|FG001|Overall Study|Lost to Follow-up|2|||
48716196|NCT01425463|156811215|FG000|Overall Study|Withdrawal by Subject|7|||
48716197|NCT01425463|156811216|FG001|Overall Study|Withdrawal by Subject|5|||
48716198|NCT01425463|156811215|FG000|Overall Study|Unknown Reason|4|||
48716199|NCT01425463|156811216|FG001|Overall Study|Unknown Reason|7|||
48716200|NCT04931888|156811217|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
48716201|NCT04931888|156811218|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
48716202|NCT04931888|156811219|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
48716203|NCT04931888|156811220|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
48716204|NCT01317550|156811221|FG000|Overall Study|Withdrawal by Subject|1|||
48497310|NCT04799158|156014515|FG000|Run-In Period|Adverse Event|6|||
48497311|NCT04799158|156014516|FG001|Run-In Period|Adverse Event|0|||
48497312|NCT04799158|156014517|FG002|Run-In Period|Adverse Event|0|||
48497313|NCT04799158|156014518|FG003|Run-In Period|Adverse Event|0|||
48497314|NCT04799158|156014519|FG004|Run-In Period|Adverse Event|0|||
48497315|NCT04799158|156014515|FG000|Run-In Period|Lost to Follow-up|4|||
48497316|NCT04799158|156014516|FG001|Run-In Period|Lost to Follow-up|0|||
48716205|NCT01317550|156811222|FG001|Overall Study|Withdrawal by Subject|0|||
48716206|NCT01317550|156811223|FG002|Overall Study|Withdrawal by Subject|0|||
48813825|NCT00154063|157159974|FG000|Overall Study|Withdrawal by Subject|4|||
48497317|NCT04799158|156014517|FG002|Run-In Period|Lost to Follow-up|0|||
48497318|NCT04799158|156014518|FG003|Run-In Period|Lost to Follow-up|0|||
48497319|NCT04799158|156014519|FG004|Run-In Period|Lost to Follow-up|0|||
48497320|NCT04799158|156014515|FG000|Run-In Period|Significant Protocol Deviation|1|||
48497321|NCT04799158|156014516|FG001|Run-In Period|Significant Protocol Deviation|0|||
48497322|NCT04799158|156014517|FG002|Run-In Period|Significant Protocol Deviation|0|||
48497323|NCT04799158|156014518|FG003|Run-In Period|Significant Protocol Deviation|0|||
48497324|NCT04799158|156014519|FG004|Run-In Period|Significant Protocol Deviation|0|||
48497325|NCT04799158|156014515|FG000|Run-In Period|Withdrawal by Subject|11|||
48813826|NCT00154063|157159975|FG001|Overall Study|Withdrawal by Subject|9|||
48813827|NCT00154063|157159974|FG000|Overall Study|Other|3|||
48497326|NCT04799158|156014516|FG001|Run-In Period|Withdrawal by Subject|0|||
48497327|NCT04799158|156014517|FG002|Run-In Period|Withdrawal by Subject|0|||
48497328|NCT04799158|156014518|FG003|Run-In Period|Withdrawal by Subject|0|||
48497329|NCT04799158|156014519|FG004|Run-In Period|Withdrawal by Subject|0|||
48497330|NCT04799158|156014515|FG000|Run-In Period|Miscellaneous|3|||
48497331|NCT04799158|156014516|FG001|Run-In Period|Miscellaneous|0|||
48497332|NCT04799158|156014517|FG002|Run-In Period|Miscellaneous|0|||
48497333|NCT04799158|156014518|FG003|Run-In Period|Miscellaneous|0|||
48497334|NCT04799158|156014519|FG004|Run-In Period|Miscellaneous|0|||
48497335|NCT04799158|156014515|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
48497336|NCT04799158|156014516|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
48497337|NCT04799158|156014517|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
48497338|NCT04799158|156014518|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
48497339|NCT04799158|156014519|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
48497340|NCT04799158|156014515|FG000|On-Demand Treatment Period|Adverse Event|0|||
48497341|NCT04799158|156014516|FG001|On-Demand Treatment Period|Adverse Event|1|||
48497342|NCT04799158|156014517|FG002|On-Demand Treatment Period|Adverse Event|0|||
48497343|NCT04799158|156014518|FG003|On-Demand Treatment Period|Adverse Event|0|||
48497344|NCT04799158|156014519|FG004|On-Demand Treatment Period|Adverse Event|1|||
48497345|NCT04799158|156014515|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
48813828|NCT00154063|157159975|FG001|Overall Study|Other|3|||
48813829|NCT00962585|157159976|FG000|Overall Study|Adverse Event|0|||
48813830|NCT00962585|157159977|FG001|Overall Study|Adverse Event|2|||
48813831|NCT00962585|157159978|FG002|Overall Study|Adverse Event|1|||
48813832|NCT00962585|157159979|FG003|Overall Study|Adverse Event|0|||
48813833|NCT00962585|157159976|FG000|Overall Study|Lost to Follow-up|3|||
48813834|NCT00962585|157159977|FG001|Overall Study|Lost to Follow-up|0|||
48813835|NCT00962585|157159978|FG002|Overall Study|Lost to Follow-up|1|||
48813836|NCT00962585|157159979|FG003|Overall Study|Lost to Follow-up|0|||
48813837|NCT00962585|157159976|FG000|Overall Study|Protocol Violation|0|||
48813838|NCT00962585|157159977|FG001|Overall Study|Protocol Violation|0|||
48813839|NCT00962585|157159978|FG002|Overall Study|Protocol Violation|1|||
48813840|NCT00962585|157159979|FG003|Overall Study|Protocol Violation|0|||
48813841|NCT00962585|157159976|FG000|Overall Study|Withdrawal by Subject|1|||
48813842|NCT00962585|157159977|FG001|Overall Study|Withdrawal by Subject|0|||
48813843|NCT00962585|157159978|FG002|Overall Study|Withdrawal by Subject|0|||
48497346|NCT04799158|156014516|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
48497347|NCT04799158|156014517|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
48497348|NCT04799158|156014518|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
48497349|NCT04799158|156014519|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
48497350|NCT04799158|156014515|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
48497351|NCT04799158|156014516|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
48497352|NCT04799158|156014517|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
48497353|NCT04799158|156014518|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
48497354|NCT04799158|156014519|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
48497355|NCT04799158|156014515|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
48497356|NCT04799158|156014516|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
48497357|NCT04799158|156014517|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
48497358|NCT04799158|156014518|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
48497359|NCT04799158|156014519|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
48497360|NCT04799158|156014515|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
48497361|NCT04799158|156014516|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
48497362|NCT04799158|156014517|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
48497363|NCT04799158|156014518|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
48497364|NCT04799158|156014519|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
48497365|NCT04799158|156014515|FG000|On-Demand Treatment Period|Miscellaneous|0|||
48497366|NCT04799158|156014516|FG001|On-Demand Treatment Period|Miscellaneous|0|||
48497367|NCT04799158|156014517|FG002|On-Demand Treatment Period|Miscellaneous|0|||
48497368|NCT04799158|156014518|FG003|On-Demand Treatment Period|Miscellaneous|0|||
48497369|NCT04799158|156014519|FG004|On-Demand Treatment Period|Miscellaneous|1|||
48497370|NCT02974153|156014520|FG000|Overall Study|Adverse Event|6|||
48813844|NCT00962585|157159979|FG003|Overall Study|Withdrawal by Subject|0|||
48813845|NCT00962585|157159976|FG000|Overall Study|Withdrew Consent|2|||
48813846|NCT00962585|157159977|FG001|Overall Study|Withdrew Consent|0|||
48813847|NCT00962585|157159978|FG002|Overall Study|Withdrew Consent|0|||
48497371|NCT02974153|156014521|FG001|Overall Study|Adverse Event|0|||
48497372|NCT02974153|156014522|FG002|Overall Study|Adverse Event|1|||
48497373|NCT02974153|156014520|FG000|Overall Study|Lack of Efficacy|6|||
48497374|NCT02974153|156014521|FG001|Overall Study|Lack of Efficacy|5|||
48497375|NCT02974153|156014522|FG002|Overall Study|Lack of Efficacy|10|||
48497376|NCT02974153|156014520|FG000|Overall Study|Lost to Follow-up|9|||
48497377|NCT02974153|156014521|FG001|Overall Study|Lost to Follow-up|10|||
48497378|NCT02974153|156014522|FG002|Overall Study|Lost to Follow-up|17|||
48497379|NCT02974153|156014520|FG000|Overall Study|Physician Decision|0|||
48497380|NCT02974153|156014521|FG001|Overall Study|Physician Decision|2|||
48497381|NCT02974153|156014522|FG002|Overall Study|Physician Decision|1|||
48497382|NCT02974153|156014520|FG000|Overall Study|Withdrawal by Subject|9|||
48497383|NCT02974153|156014521|FG001|Overall Study|Withdrawal by Subject|16|||
48497384|NCT02974153|156014522|FG002|Overall Study|Withdrawal by Subject|11|||
48497385|NCT02974153|156014520|FG000|Overall Study|Study Burden|8|||
48497386|NCT02974153|156014521|FG001|Overall Study|Study Burden|7|||
48497387|NCT02974153|156014522|FG002|Overall Study|Study Burden|3|||
48497388|NCT02974153|156014520|FG000|Overall Study|Other|14|||
48497389|NCT02974153|156014521|FG001|Overall Study|Other|8|||
48497390|NCT02974153|156014522|FG002|Overall Study|Other|7|||
48497391|NCT01202747|156014524|FG000|Overall Study|Withdrawal by Subject|1|||
48497392|NCT02603952|156014528|FG000|Overall Study|Withdrawal by Subject|1|||
48497393|NCT02603952|156014529|FG001|Overall Study|Withdrawal by Subject|0|||
48497394|NCT02603952|156014530|FG002|Overall Study|Withdrawal by Subject|0|||
48497395|NCT02603952|156014531|FG003|Overall Study|Withdrawal by Subject|0|||
48497396|NCT02603952|156014528|FG000|Overall Study|Received oseltamivir by error|0|||
48497397|NCT02603952|156014529|FG001|Overall Study|Received oseltamivir by error|0|||
48497398|NCT02603952|156014530|FG002|Overall Study|Received oseltamivir by error|0|||
48497399|NCT02603952|156014531|FG003|Overall Study|Received oseltamivir by error|1|||
48497400|NCT01611090|156014535|FG000|Randomized Period|Lost to Follow-up|8|||
48497401|NCT01611090|156014536|FG001|Randomized Period|Lost to Follow-up|3|||
48497402|NCT01611090|156014537|FG002|Randomized Period|Lost to Follow-up|0|||
48813848|NCT00962585|157159979|FG003|Overall Study|Withdrew Consent|0|||
48497403|NCT01611090|156014535|FG000|Randomized Period|Withdrawal by Subject|22|||
48497404|NCT01611090|156014536|FG001|Randomized Period|Withdrawal by Subject|26|||
48497405|NCT01611090|156014537|FG002|Randomized Period|Withdrawal by Subject|0|||
48813849|NCT01987596|157159980|FG000|Overall Study|Physician Decision|1|||
48813850|NCT01987596|157159981|FG001|Overall Study|Physician Decision|0|||
48813851|NCT01987596|157159980|FG000|Overall Study|Progressive Disease; missing all period|0|||
48813852|NCT01987596|157159981|FG001|Overall Study|Progressive Disease; missing all period|1|||
48813853|NCT02341456|157159988|FG000|Overall Study|Disease progression|2|||
48813854|NCT02341456|157159989|FG001|Overall Study|Disease progression|3|||
48813855|NCT02341456|157159990|FG002|Overall Study|Disease progression|1|||
48813856|NCT02341456|157159988|FG000|Overall Study|Death|1|||
48813857|NCT02341456|157159989|FG001|Overall Study|Death|1|||
48813858|NCT02341456|157159990|FG002|Overall Study|Death|1|||
48813859|NCT02341456|157159988|FG000|Overall Study|Withdrawal by Subject|0|||
48813860|NCT02341456|157159989|FG001|Overall Study|Withdrawal by Subject|1|||
48813861|NCT02341456|157159990|FG002|Overall Study|Withdrawal by Subject|1|||
48813862|NCT02341456|157159988|FG000|Overall Study|Moved to local access programme.|0|||
48813863|NCT02341456|157159989|FG001|Overall Study|Moved to local access programme.|1|||
48813864|NCT02341456|157159990|FG002|Overall Study|Moved to local access programme.|1|||
48813865|NCT02341456|157159988|FG000|Overall Study|Physician Decision|1|||
48813866|NCT02341456|157159989|FG001|Overall Study|Physician Decision|0|||
48813867|NCT02341456|157159990|FG002|Overall Study|Physician Decision|0|||
48813868|NCT01077362|157159991|FG000|Overall Study|Lack of Efficacy|13|||
48813869|NCT01077362|157159992|FG001|Overall Study|Lack of Efficacy|8|||
48813870|NCT01077362|157159993|FG002|Overall Study|Lack of Efficacy|10|||
48813871|NCT01077362|157159991|FG000|Overall Study|Lost to Follow-up|1|||
48813872|NCT01077362|157159992|FG001|Overall Study|Lost to Follow-up|0|||
48813873|NCT01077362|157159993|FG002|Overall Study|Lost to Follow-up|3|||
48813874|NCT01077362|157159991|FG000|Overall Study|Adverse Event|12|||
48813875|NCT01077362|157159992|FG001|Overall Study|Adverse Event|7|||
48813876|NCT01077362|157159993|FG002|Overall Study|Adverse Event|4|||
48813877|NCT01077362|157159991|FG000|Overall Study|Withdrawal by Subject|5|||
48813878|NCT01077362|157159992|FG001|Overall Study|Withdrawal by Subject|3|||
48813879|NCT01077362|157159993|FG002|Overall Study|Withdrawal by Subject|5|||
48813880|NCT01077362|157159991|FG000|Overall Study|Other|0|||
48813881|NCT01077362|157159992|FG001|Overall Study|Other|1|||
48813882|NCT01077362|157159993|FG002|Overall Study|Other|2|||
48813883|NCT00791921|157159994|FG000|Overall Study|Protocol planed|24|||
48813884|NCT00791921|157159995|FG001|Overall Study|Protocol planed|88|||
48813885|NCT00791921|157159994|FG000|Overall Study|Withdrawal by Subject|1|||
48813886|NCT00791921|157159995|FG001|Overall Study|Withdrawal by Subject|2|||
48497406|NCT01611090|156014535|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
48497407|NCT01611090|156014536|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
48497408|NCT01611090|156014537|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
48497409|NCT01611090|156014535|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
48598464|NCT03410992|156385244|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48598465|NCT03410992|156385245|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48497410|NCT01611090|156014536|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
48497411|NCT01611090|156014537|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
48497412|NCT02672553|156014538|FG000|Overall Study|Death|3|||
48497413|NCT02672553|156014539|FG001|Overall Study|Death|5|||
48497414|NCT02672553|156014538|FG000|Overall Study|Valve Explant|1|||
48497415|NCT02672553|156014539|FG001|Overall Study|Valve Explant|0|||
48497416|NCT02672553|156014538|FG000|Overall Study|Conversion to Commercial Valve|3|||
48497417|NCT02672553|156014539|FG001|Overall Study|Conversion to Commercial Valve|0|||
48497418|NCT02672553|156014538|FG000|Overall Study|Withdrawal by Subject|3|||
48497419|NCT02672553|156014539|FG001|Overall Study|Withdrawal by Subject|3|||
48497420|NCT02672553|156014538|FG000|Overall Study|Intraoperative screen failure|2|||
48497421|NCT02672553|156014539|FG001|Overall Study|Intraoperative screen failure|0|||
48497422|NCT01004172|156014540|FG000|Overall Study|Progressive Disease in CNS Only|16|||
48497423|NCT01004172|156014540|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
48497424|NCT01004172|156014540|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
48497425|NCT01004172|156014540|FG000|Overall Study|Adverse Event|1|||
48497426|NCT01004172|156014540|FG000|Overall Study|Physician Decision|1|||
48497427|NCT01004172|156014540|FG000|Overall Study|Symptomatic Deterioration|2|||
48497428|NCT01606306|156014541|FG000|Overall Study|Lack of Efficacy|2|||
48497429|NCT01606306|156014542|FG001|Overall Study|Lack of Efficacy|1|||
48497430|NCT01606306|156014543|FG002|Overall Study|Lack of Efficacy|4|||
48497431|NCT01606306|156014544|FG003|Overall Study|Lack of Efficacy|4|||
48497432|NCT01606306|156014545|FG004|Overall Study|Lack of Efficacy|1|||
48497433|NCT01606306|156014546|FG005|Overall Study|Lack of Efficacy|2|||
48598466|NCT03410992|156385246|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48598467|NCT03410992|156385247|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
48598468|NCT03410992|156385237|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
48598469|NCT03410992|156385238|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
48598470|NCT03410992|156385239|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48598471|NCT03410992|156385240|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48497434|NCT01606306|156014541|FG000|Overall Study|Adverse Event|1|||
48497435|NCT01606306|156014542|FG001|Overall Study|Adverse Event|0|||
48497436|NCT01606306|156014543|FG002|Overall Study|Adverse Event|1|||
48497437|NCT01606306|156014544|FG003|Overall Study|Adverse Event|1|||
48497438|NCT01606306|156014545|FG004|Overall Study|Adverse Event|2|||
48497439|NCT01606306|156014546|FG005|Overall Study|Adverse Event|0|||
48598472|NCT03410992|156385241|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48598473|NCT03410992|156385242|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48598474|NCT03410992|156385243|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48716207|NCT01317550|156811224|FG003|Overall Study|Withdrawal by Subject|0|||
48497440|NCT01606306|156014541|FG000|Overall Study|Lost to Follow-up|7|||
48497441|NCT01606306|156014542|FG001|Overall Study|Lost to Follow-up|4|||
48497442|NCT01606306|156014543|FG002|Overall Study|Lost to Follow-up|5|||
48497443|NCT01606306|156014544|FG003|Overall Study|Lost to Follow-up|4|||
48497444|NCT01606306|156014545|FG004|Overall Study|Lost to Follow-up|3|||
48497445|NCT01606306|156014546|FG005|Overall Study|Lost to Follow-up|5|||
48497446|NCT01606306|156014541|FG000|Overall Study|Withdrawal by Subject|4|||
48497447|NCT01606306|156014542|FG001|Overall Study|Withdrawal by Subject|3|||
48497448|NCT01606306|156014543|FG002|Overall Study|Withdrawal by Subject|4|||
48497449|NCT01606306|156014544|FG003|Overall Study|Withdrawal by Subject|4|||
48497450|NCT01606306|156014545|FG004|Overall Study|Withdrawal by Subject|5|||
48497451|NCT01606306|156014546|FG005|Overall Study|Withdrawal by Subject|4|||
48497452|NCT01606306|156014541|FG000|Overall Study|Physician Decision|1|||
48497453|NCT01606306|156014542|FG001|Overall Study|Physician Decision|2|||
48497454|NCT01606306|156014543|FG002|Overall Study|Physician Decision|0|||
48497455|NCT01606306|156014544|FG003|Overall Study|Physician Decision|0|||
48497456|NCT01606306|156014545|FG004|Overall Study|Physician Decision|0|||
48497457|NCT01606306|156014546|FG005|Overall Study|Physician Decision|0|||
48497458|NCT03066999|156014547|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
48497459|NCT03066999|156014548|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
48497460|NCT00661999|156014549|FG000|Overall Study|Adverse Event|11|||
48497461|NCT00661999|156014550|FG001|Overall Study|Adverse Event|5|||
48716208|NCT01317550|156811221|FG000|Overall Study|Lack of compliance study med|1|||
48813887|NCT00791921|157159994|FG000|Overall Study|Adverse Event|8|||
48497462|NCT00661999|156014551|FG002|Overall Study|Adverse Event|8|||
48497463|NCT00661999|156014549|FG000|Overall Study|Death|8|||
48497464|NCT00661999|156014550|FG001|Overall Study|Death|6|||
48497465|NCT00661999|156014551|FG002|Overall Study|Death|3|||
48497466|NCT00661999|156014549|FG000|Overall Study|Other Reasons|5|||
48497467|NCT00661999|156014550|FG001|Overall Study|Other Reasons|12|||
48497468|NCT00661999|156014551|FG002|Overall Study|Other Reasons|23|||
48497469|NCT00661999|156014549|FG000|Overall Study|Withdrawal by Subject|30|||
48497470|NCT00661999|156014550|FG001|Overall Study|Withdrawal by Subject|23|||
48497471|NCT00661999|156014551|FG002|Overall Study|Withdrawal by Subject|14|||
48497472|NCT00661999|156014549|FG000|Overall Study|Alternative Treatment|1|||
48497473|NCT00661999|156014550|FG001|Overall Study|Alternative Treatment|0|||
48497474|NCT00661999|156014551|FG002|Overall Study|Alternative Treatment|0|||
48716209|NCT01317550|156811222|FG001|Overall Study|Lack of compliance study med|0|||
48716210|NCT01317550|156811223|FG002|Overall Study|Lack of compliance study med|0|||
48716211|NCT01317550|156811224|FG003|Overall Study|Lack of compliance study med|0|||
48716212|NCT03032380|156811226|FG000|Overall Study|Adverse Event|0|||
48716213|NCT03032380|156811227|FG001|Overall Study|Adverse Event|1|||
48716214|NCT03032380|156811226|FG000|Overall Study|Lack of Efficacy|1|||
48716215|NCT03032380|156811227|FG001|Overall Study|Lack of Efficacy|0|||
48716216|NCT03032380|156811226|FG000|Overall Study|Withdrawal by Subject|2|||
48716217|NCT03032380|156811227|FG001|Overall Study|Withdrawal by Subject|3|||
48716218|NCT03032380|156811226|FG000|Overall Study|Recovery|0|||
48716219|NCT03032380|156811227|FG001|Overall Study|Recovery|1|||
48716220|NCT03032380|156811226|FG000|Overall Study|Death|39|||
48716221|NCT03032380|156811227|FG001|Overall Study|Death|34|||
48716222|NCT03032380|156811226|FG000|Overall Study|Other - Miscellaneous|0|||
48716223|NCT03032380|156811227|FG001|Overall Study|Other - Miscellaneous|1|||
48716224|NCT00294762|156811228|FG000|Overall Study|Did not receive study treatment|3|||
48716225|NCT00294762|156811229|FG001|Overall Study|Did not receive study treatment|3|||
48716226|NCT04093024|156811232|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
48716227|NCT04093024|156811233|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
48716228|NCT04093024|156811232|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
48716229|NCT04093024|156811233|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
48716230|NCT04093024|156811232|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
48716231|NCT04093024|156811233|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
48716232|NCT04093024|156811232|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
48716233|NCT04093024|156811233|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
48813888|NCT00791921|157159995|FG001|Overall Study|Adverse Event|2|||
48813889|NCT00791921|157159994|FG000|Overall Study|Lack of Efficacy|0|||
48813890|NCT00791921|157159995|FG001|Overall Study|Lack of Efficacy|2|||
48813891|NCT00791921|157159994|FG000|Overall Study|Lack of study drug administration|1|||
48813892|NCT00791921|157159995|FG001|Overall Study|Lack of study drug administration|1|||
48813893|NCT00791921|157159994|FG000|Overall Study|Reason other than those above|0|||
48813894|NCT00791921|157159995|FG001|Overall Study|Reason other than those above|1|||
48813895|NCT00557622|157160005|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
48813896|NCT00557622|157160006|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
48813897|NCT00557622|157160005|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
48813898|NCT00557622|157160006|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
48813899|NCT00557622|157160005|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
48716234|NCT00701662|156811234|FG000|Overall Study|Lack of Efficacy|1|||
48813900|NCT00557622|157160006|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
48813901|NCT01539863|157160007|FG000|Overall Study|Lost to Follow-up|5|||
48813902|NCT01539863|157160008|FG001|Overall Study|Lost to Follow-up|4|||
48813903|NCT01468922|157160014|FG000|Overall Study|Screening failure|0|||
48813904|NCT01468922|157160015|FG001|Overall Study|Screening failure|0|||
48813905|NCT01468922|157160016|FG002|Overall Study|Screening failure|0|||
48813906|NCT01468922|157160017|FG003|Overall Study|Screening failure|0|||
48813907|NCT01468922|157160018|FG004|Overall Study|Screening failure|0|||
48813908|NCT01468922|157160019|FG005|Overall Study|Screening failure|0|||
48813909|NCT01468922|157160020|FG006|Overall Study|Screening failure|0|||
48716235|NCT01541397|156811235|FG000|Overall Study|Study ended prior to data collection|4|||
48716236|NCT01541397|156811236|FG001|Overall Study|Study ended prior to data collection|2|||
48716237|NCT02577887|156811237|FG000|Overall Study|Death|93|||
48813910|NCT01468922|157160021|FG007|Overall Study|Screening failure|0|||
48813911|NCT01468922|157160022|FG008|Overall Study|Screening failure|1|||
48813912|NCT01468922|157160014|FG000|Overall Study|Per patient choice|1|||
48497475|NCT00661999|156014549|FG000|Overall Study|Other Medical Problems|4|||
48497476|NCT00661999|156014550|FG001|Overall Study|Other Medical Problems|4|||
48497477|NCT00661999|156014551|FG002|Overall Study|Other Medical Problems|9|||
48497478|NCT00182091|156014556|FG000|Overall Study|Withdrawal by Subject|1|||
48497479|NCT00182091|156014557|FG001|Overall Study|Withdrawal by Subject|0|||
48497480|NCT00182091|156014558|FG002|Overall Study|Withdrawal by Subject|0|||
48497481|NCT00182091|156014559|FG003|Overall Study|Withdrawal by Subject|0|||
48497482|NCT04094870|156014562|FG000|Overall Study|Lost to Follow-up|1|||
48497483|NCT04094870|156014563|FG001|Overall Study|Lost to Follow-up|1|||
48497484|NCT01691248|156014564|FG000|Overall Study|Protocol Violation|43|||
48497485|NCT01691248|156014565|FG001|Overall Study|Protocol Violation|27|||
48497486|NCT01691248|156014564|FG000|Overall Study|Adverse Event|24|||
48716238|NCT02577887|156811237|FG000|Overall Study|Protocol Violation|125|||
48716239|NCT02577887|156811237|FG000|Overall Study|Withdrawal by Subject|80|||
48497487|NCT01691248|156014565|FG001|Overall Study|Adverse Event|22|||
48497488|NCT01691248|156014564|FG000|Overall Study|Withdrawal by Subject|20|||
48497489|NCT01691248|156014565|FG001|Overall Study|Withdrawal by Subject|18|||
48497490|NCT01691248|156014564|FG000|Overall Study|Confirmed CDAD|14|||
48497491|NCT01691248|156014565|FG001|Overall Study|Confirmed CDAD|31|||
48497492|NCT01691248|156014564|FG000|Overall Study|Lost to Follow-up|2|||
48497493|NCT01691248|156014565|FG001|Overall Study|Lost to Follow-up|5|||
48497494|NCT01691248|156014564|FG000|Overall Study|Reason not provided|4|||
48497495|NCT01691248|156014565|FG001|Overall Study|Reason not provided|4|||
48497496|NCT01691248|156014564|FG000|Overall Study|Not Treated|4|||
48497497|NCT01691248|156014565|FG001|Overall Study|Not Treated|7|||
48497498|NCT01569152|156014567|FG000|Phase IIa, Period 1|Early Escape|5|||
48497499|NCT01569152|156014568|FG001|Phase IIa, Period 1|Early Escape|22|||
48497500|NCT01569152|156014569|FG002|Phase IIa, Period 1|Early Escape|0|||
48497501|NCT01569152|156014567|FG000|Phase IIa, Period 1|Adverse Event|4|||
48497502|NCT01569152|156014568|FG001|Phase IIa, Period 1|Adverse Event|0|||
48497503|NCT01569152|156014569|FG002|Phase IIa, Period 1|Adverse Event|0|||
48497504|NCT01569152|156014567|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
48497505|NCT01569152|156014568|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
48497506|NCT01569152|156014569|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
48497507|NCT01569152|156014567|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
48716240|NCT00388583|156811245|FG000|Overall Study|Protocol Violation|1|||
48716241|NCT00388583|156811246|FG001|Overall Study|Protocol Violation|0|||
48716242|NCT00388583|156811245|FG000|Overall Study|Withdrawal by Subject|3|||
48716243|NCT00388583|156811246|FG001|Overall Study|Withdrawal by Subject|3|||
48716244|NCT00388583|156811245|FG000|Overall Study|Serious Adverse Event|2|||
48716245|NCT00388583|156811246|FG001|Overall Study|Serious Adverse Event|0|||
48716246|NCT00388583|156811245|FG000|Overall Study|Did not receive vaccine|0|||
48716247|NCT00388583|156811246|FG001|Overall Study|Did not receive vaccine|1|||
48716248|NCT02366091|156811247|FG000|Overall Study|Withdrawal by Subject|3|||
48716249|NCT02366091|156811248|FG001|Overall Study|Withdrawal by Subject|7|||
48716250|NCT02366091|156811249|FG002|Overall Study|Withdrawal by Subject|3|||
48716251|NCT02366091|156811250|FG003|Overall Study|Withdrawal by Subject|1|||
48716252|NCT02500056|156811251|FG000|Overall Study|Lost to Follow-up|3|||
48716253|NCT02500056|156811252|FG001|Overall Study|Lost to Follow-up|7|||
48716254|NCT02500056|156811251|FG000|Overall Study|Recurrence|1|||
48716255|NCT02500056|156811252|FG001|Overall Study|Recurrence|0|||
48716256|NCT02500056|156811251|FG000|Overall Study|Death|3|||
48716257|NCT02500056|156811252|FG001|Overall Study|Death|1|||
48716258|NCT02925416|156811253|FG000|Overall Study|Adverse Event|2|||
48716259|NCT02925416|156811254|FG001|Overall Study|Adverse Event|0|||
48716260|NCT01290796|156811264|FG000|Overall Study|Lost to Follow-up|21|||
48716261|NCT01290796|156811264|FG000|Overall Study|Withdrawal by Subject|4|||
48716262|NCT01290796|156811264|FG000|Overall Study|Physician Decision|2|||
48716263|NCT01290796|156811264|FG000|Overall Study|Secondary Surgical Intervention|2|||
48716264|NCT01290796|156811264|FG000|Overall Study|Withdrawal by Sponsor|1|||
48716265|NCT03087617|156811265|FG000|Overall Study|Lost to Follow-up|32|||
48716266|NCT03087617|156811266|FG001|Overall Study|Lost to Follow-up|30|||
48716267|NCT03087617|156811267|FG002|Overall Study|Lost to Follow-up|30|||
48716268|NCT03087617|156811268|FG003|Overall Study|Lost to Follow-up|39|||
48716269|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716270|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716271|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716272|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716273|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716274|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
48716275|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
48716276|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48716277|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48813913|NCT01468922|157160015|FG001|Overall Study|Per patient choice|0|||
48716278|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
48716279|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48716280|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48716281|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48813914|NCT01468922|157160016|FG002|Overall Study|Per patient choice|0|||
48813915|NCT01468922|157160017|FG003|Overall Study|Per patient choice|0|||
48813916|NCT01468922|157160018|FG004|Overall Study|Per patient choice|0|||
48813917|NCT01468922|157160019|FG005|Overall Study|Per patient choice|0|||
48813918|NCT01468922|157160020|FG006|Overall Study|Per patient choice|0|||
48813919|NCT01468922|157160021|FG007|Overall Study|Per patient choice|0|||
48813920|NCT01468922|157160022|FG008|Overall Study|Per patient choice|0|||
48813921|NCT01468922|157160014|FG000|Overall Study|Switched to alternative treatment|1|||
48813922|NCT01468922|157160015|FG001|Overall Study|Switched to alternative treatment|0|||
48497508|NCT01569152|156014568|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
48497509|NCT01569152|156014569|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
48497510|NCT01569152|156014567|FG000|Phase IIa, Period 1|Protocol Violation|0|||
48497511|NCT01569152|156014568|FG001|Phase IIa, Period 1|Protocol Violation|1|||
48716282|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
48497512|NCT01569152|156014569|FG002|Phase IIa, Period 1|Protocol Violation|0|||
48497513|NCT01569152|156014567|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
48497514|NCT01569152|156014568|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
48497515|NCT01569152|156014569|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
48497516|NCT01569152|156014567|FG000|Safety Extension, Period 3|Adverse Event|0|||
48497517|NCT01569152|156014568|FG001|Safety Extension, Period 3|Adverse Event|0|||
48497518|NCT01569152|156014569|FG002|Safety Extension, Period 3|Adverse Event|4|||
48497519|NCT01569152|156014567|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
48497520|NCT01569152|156014568|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
48497521|NCT01569152|156014569|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
48497522|NCT01569152|156014567|FG000|Safety Extension, Period 3|Physician Decision|0|||
48497523|NCT01569152|156014568|FG001|Safety Extension, Period 3|Physician Decision|0|||
48497524|NCT01569152|156014569|FG002|Safety Extension, Period 3|Physician Decision|2|||
48497525|NCT01569152|156014567|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
48497526|NCT01569152|156014568|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
48813923|NCT01468922|157160016|FG002|Overall Study|Switched to alternative treatment|0|||
48813924|NCT01468922|157160017|FG003|Overall Study|Switched to alternative treatment|0|||
48813925|NCT01468922|157160018|FG004|Overall Study|Switched to alternative treatment|1|||
48813926|NCT01468922|157160019|FG005|Overall Study|Switched to alternative treatment|0|||
48813927|NCT01468922|157160020|FG006|Overall Study|Switched to alternative treatment|0|||
48813928|NCT01468922|157160021|FG007|Overall Study|Switched to alternative treatment|0|||
48813929|NCT01468922|157160022|FG008|Overall Study|Switched to alternative treatment|0|||
48813930|NCT01468922|157160014|FG000|Overall Study|Enrolled on new protocol|0|||
48813931|NCT01468922|157160015|FG001|Overall Study|Enrolled on new protocol|0|||
48813932|NCT01468922|157160016|FG002|Overall Study|Enrolled on new protocol|0|||
48813933|NCT01468922|157160017|FG003|Overall Study|Enrolled on new protocol|0|||
48813934|NCT01468922|157160018|FG004|Overall Study|Enrolled on new protocol|1|||
48813935|NCT01468922|157160019|FG005|Overall Study|Enrolled on new protocol|0|||
48813936|NCT01468922|157160020|FG006|Overall Study|Enrolled on new protocol|0|||
48813937|NCT01468922|157160021|FG007|Overall Study|Enrolled on new protocol|0|||
48813938|NCT01468922|157160022|FG008|Overall Study|Enrolled on new protocol|0|||
48813939|NCT01468922|157160014|FG000|Overall Study|Adverse Event|0|||
48813940|NCT01468922|157160015|FG001|Overall Study|Adverse Event|0|||
48813941|NCT01468922|157160016|FG002|Overall Study|Adverse Event|0|||
48813942|NCT01468922|157160017|FG003|Overall Study|Adverse Event|0|||
48813943|NCT01468922|157160018|FG004|Overall Study|Adverse Event|0|||
48813944|NCT01468922|157160019|FG005|Overall Study|Adverse Event|0|||
48716283|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
48813945|NCT01468922|157160020|FG006|Overall Study|Adverse Event|0|||
48813946|NCT01468922|157160021|FG007|Overall Study|Adverse Event|1|||
48813947|NCT01468922|157160022|FG008|Overall Study|Adverse Event|0|||
48813948|NCT01468922|157160014|FG000|Overall Study|Infection of blood|0|||
48813949|NCT01468922|157160015|FG001|Overall Study|Infection of blood|0|||
48813950|NCT01468922|157160016|FG002|Overall Study|Infection of blood|0|||
48813951|NCT01468922|157160017|FG003|Overall Study|Infection of blood|0|||
48813952|NCT01468922|157160018|FG004|Overall Study|Infection of blood|0|||
48716284|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716285|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716286|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716287|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716288|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716289|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
48716290|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
48716291|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
48716292|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
48716293|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
48716294|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
48716295|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
48716296|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
48716297|NCT00065429|156811272|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
48716298|NCT00065429|156811273|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
48716299|NCT00065429|156811274|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
48716300|NCT00065429|156811275|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
48497527|NCT01569152|156014569|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
48497528|NCT02070744|156014570|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
48716301|NCT00065429|156811276|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
48716302|NCT00065429|156811277|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
48813953|NCT01468922|157160019|FG005|Overall Study|Infection of blood|0|||
48813954|NCT01468922|157160020|FG006|Overall Study|Infection of blood|0|||
48813955|NCT01468922|157160021|FG007|Overall Study|Infection of blood|1|||
48813956|NCT01468922|157160022|FG008|Overall Study|Infection of blood|0|||
48813957|NCT01468922|157160014|FG000|Overall Study|Patient choice - surgery|0|||
48497529|NCT02070744|156014571|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
48497530|NCT02070744|156014572|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
48497531|NCT02070744|156014573|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
48497532|NCT02070744|156014574|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
48497533|NCT02070744|156014570|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
48716303|NCT00065429|156811278|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
48716304|NCT00065429|156811272|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716305|NCT00065429|156811273|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716306|NCT00065429|156811274|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716307|NCT00065429|156811275|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716308|NCT00065429|156811276|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
48716309|NCT00065429|156811277|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716310|NCT00065429|156811278|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
48716311|NCT00065429|156811272|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716312|NCT00065429|156811273|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716313|NCT00065429|156811274|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716314|NCT00065429|156811275|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716315|NCT00065429|156811276|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
48716316|NCT00065429|156811277|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716317|NCT00065429|156811278|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
48716318|NCT00502203|156811279|FG000|Overall Study|Inevaluable|1|||
48716319|NCT00548184|156811280|FG000|Overall Study|Adverse Event|3|||
48716320|NCT00548184|156811280|FG000|Overall Study|took other drug|1|||
48716321|NCT00548184|156811280|FG000|Overall Study|Found Her2 negative|1|||
48716322|NCT00796523|156811281|FG000|Overall Study|Lost to Follow-up|9|||
48716323|NCT00796523|156811282|FG001|Overall Study|Lost to Follow-up|7|||
48716324|NCT03060551|156811283|FG000|Overall Study|Withdrawal by Subject|1|||
48716325|NCT03060551|156811283|FG000|Overall Study|Adverse Event|1|||
48813958|NCT01468922|157160015|FG001|Overall Study|Patient choice - surgery|0|||
48813959|NCT01468922|157160016|FG002|Overall Study|Patient choice - surgery|0|||
48813960|NCT01468922|157160017|FG003|Overall Study|Patient choice - surgery|0|||
48813961|NCT01468922|157160018|FG004|Overall Study|Patient choice - surgery|0|||
48813962|NCT01468922|157160019|FG005|Overall Study|Patient choice - surgery|0|||
48813963|NCT01468922|157160020|FG006|Overall Study|Patient choice - surgery|0|||
48813964|NCT01468922|157160021|FG007|Overall Study|Patient choice - surgery|1|||
48813965|NCT01468922|157160022|FG008|Overall Study|Patient choice - surgery|0|||
48813966|NCT01468922|157160014|FG000|Overall Study|Refused further treatment|0|||
48813967|NCT01468922|157160015|FG001|Overall Study|Refused further treatment|0|||
48813968|NCT01468922|157160016|FG002|Overall Study|Refused further treatment|0|||
48813969|NCT01468922|157160017|FG003|Overall Study|Refused further treatment|0|||
48813970|NCT01468922|157160018|FG004|Overall Study|Refused further treatment|0|||
48813971|NCT01468922|157160019|FG005|Overall Study|Refused further treatment|0|||
48813972|NCT01468922|157160020|FG006|Overall Study|Refused further treatment|0|||
48813973|NCT01468922|157160021|FG007|Overall Study|Refused further treatment|1|||
48813974|NCT01468922|157160022|FG008|Overall Study|Refused further treatment|0|||
48813975|NCT04848662|157160023|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
48813976|NCT04848662|157160024|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
48813977|NCT02226172|157160027|FG000|Overall Study|Participant refused further follow-up|4|||
48813978|NCT02226172|157160027|FG000|Overall Study|Other|5|||
48813979|NCT02226172|157160027|FG000|Overall Study|Death|1|||
48813980|NCT02226172|157160027|FG000|Overall Study|Study terminated by sponsor|1|||
48813981|NCT02226172|157160027|FG000|Overall Study|Adverse Event|6|||
48716326|NCT02929498|156811284|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
48716327|NCT02929498|156811285|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
48716328|NCT02929498|156811286|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
48716329|NCT02929498|156811284|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
48716330|NCT02929498|156811285|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
48716331|NCT02929498|156811286|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
48716332|NCT00870584|156811289|FG000|Overall Study|Adverse Event|3|||
48716333|NCT00870584|156811290|FG001|Overall Study|Adverse Event|3|||
48716334|NCT00870584|156811289|FG000|Overall Study|Withdrawal by Subject|6|||
48716335|NCT00870584|156811290|FG001|Overall Study|Withdrawal by Subject|7|||
48716336|NCT00870584|156811289|FG000|Overall Study|Lost to Follow-up|5|||
48716337|NCT00870584|156811290|FG001|Overall Study|Lost to Follow-up|1|||
48716338|NCT00870584|156811289|FG000|Overall Study|Protocol Deviation|2|||
48716339|NCT00870584|156811290|FG001|Overall Study|Protocol Deviation|2|||
48813982|NCT01729728|157160028|FG000|Overall Study|Adverse Event|0|||
48813983|NCT01729728|157160029|FG001|Overall Study|Adverse Event|6|||
48716340|NCT01028300|156811291|FG000|Overall Study|Study Terminated|4|||
48716341|NCT02730793|156811295|FG000|Overall Study|Physician Decision|0|||
48716342|NCT02730793|156811296|FG001|Overall Study|Physician Decision|1|||
48716343|NCT02730793|156811295|FG000|Overall Study|Withdrawal by Subject|0|||
48716344|NCT02730793|156811296|FG001|Overall Study|Withdrawal by Subject|1|||
48716345|NCT01284491|156811297|FG000|Overall Study|Study termination|13|||
48813984|NCT01729728|157160030|FG002|Overall Study|Adverse Event|0|||
48813985|NCT01729728|157160028|FG000|Overall Study|Protocol Violation|1|||
48813986|NCT01729728|157160029|FG001|Overall Study|Protocol Violation|0|||
48497534|NCT02070744|156014571|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
48716346|NCT01978938|156811301|FG000|Overall Study|Lost to Follow-up|12|||
48716347|NCT01978938|156811302|FG001|Overall Study|Lost to Follow-up|6|||
48716348|NCT01978938|156811301|FG000|Overall Study|Withdrawal by Subject|8|||
48716349|NCT01978938|156811302|FG001|Overall Study|Withdrawal by Subject|4|||
48716350|NCT01978938|156811301|FG000|Overall Study|Adverse Event, non-fatal|2|||
48716351|NCT01978938|156811302|FG001|Overall Study|Adverse Event, non-fatal|1|||
48716352|NCT01978938|156811301|FG000|Overall Study|Participant noncompliance|1|||
48716353|NCT01978938|156811302|FG001|Overall Study|Participant noncompliance|1|||
48716354|NCT01978938|156811301|FG000|Overall Study|Did not meet inclusion criteria|0|||
48716355|NCT01978938|156811302|FG001|Overall Study|Did not meet inclusion criteria|1|||
48716356|NCT01978938|156811301|FG000|Overall Study|Previously scheduled procedure|0|||
48716357|NCT01978938|156811302|FG001|Overall Study|Previously scheduled procedure|1|||
48716358|NCT02520089|156811309|FG000|Overall Study|Lost to Follow-up|3|||
48716359|NCT02520089|156811310|FG001|Overall Study|Lost to Follow-up|4|||
48716360|NCT03658876|156813475|FG000|Overall Study|Protocol Violation|3|||
48716361|NCT03658876|156813476|FG001|Overall Study|Protocol Violation|2|||
48497535|NCT02070744|156014572|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
48497536|NCT02070744|156014573|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
48497537|NCT02070744|156014574|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
48497538|NCT02070744|156014570|FG000|OLE Phase (48 Weeks)|Other|0|||
48497539|NCT02070744|156014571|FG001|OLE Phase (48 Weeks)|Other|0|||
48497540|NCT02070744|156014572|FG002|OLE Phase (48 Weeks)|Other|0|||
48497541|NCT02070744|156014573|FG003|OLE Phase (48 Weeks)|Other|0|||
48497542|NCT02070744|156014574|FG004|OLE Phase (48 Weeks)|Other|1|||
48497543|NCT01513551|156016081|FG000|Overall Study|Death|0|||
48497544|NCT01513551|156016082|FG001|Overall Study|Death|1|||
48497545|NCT01513551|156016083|FG002|Overall Study|Death|0|||
48497546|NCT01513551|156016081|FG000|Overall Study|Lost to Follow-up|3|||
48716362|NCT03658876|156813475|FG000|Overall Study|Withdrawal by Subject|2|||
48716363|NCT03658876|156813476|FG001|Overall Study|Withdrawal by Subject|0|||
48716364|NCT03658876|156813475|FG000|Overall Study|Death|0|||
48716365|NCT03658876|156813476|FG001|Overall Study|Death|1|||
48716366|NCT03658876|156813475|FG000|Overall Study|Intercurrent illness|6|||
48716367|NCT03658876|156813476|FG001|Overall Study|Intercurrent illness|4|||
48497547|NCT01513551|156016082|FG001|Overall Study|Lost to Follow-up|5|||
48497548|NCT01513551|156016083|FG002|Overall Study|Lost to Follow-up|2|||
48497549|NCT01513551|156016081|FG000|Overall Study|Withdrawal by Subject|1|||
48497550|NCT01513551|156016082|FG001|Overall Study|Withdrawal by Subject|0|||
48497551|NCT01513551|156016083|FG002|Overall Study|Withdrawal by Subject|2|||
48497552|NCT01513551|156016081|FG000|Overall Study|Randomized but not vaccinated|0|||
48497553|NCT01513551|156016082|FG001|Overall Study|Randomized but not vaccinated|0|||
48497554|NCT01513551|156016083|FG002|Overall Study|Randomized but not vaccinated|1|||
48497555|NCT01267266|156016084|FG000|Enrollment Phase|Withdrawal by Subject|2|||
48497556|NCT01267266|156016085|FG001|Enrollment Phase|Withdrawal by Subject|0|||
48497557|NCT01267266|156016084|FG000|Lead-in Phase|Lack of Efficacy|20|||
48497558|NCT01267266|156016085|FG001|Lead-in Phase|Lack of Efficacy|0|||
48497559|NCT01267266|156016084|FG000|Lead-in Phase|Adverse Event|2|||
48497560|NCT01267266|156016085|FG001|Lead-in Phase|Adverse Event|0|||
48497561|NCT01267266|156016084|FG000|Lead-in Phase|Withdrawal by Subject|1|||
48497562|NCT01267266|156016085|FG001|Lead-in Phase|Withdrawal by Subject|0|||
48716368|NCT03658876|156813475|FG000|Overall Study|Transplantation/other operation|1|||
48716369|NCT03658876|156813476|FG001|Overall Study|Transplantation/other operation|5|||
48716370|NCT03751657|156813477|FG000|Overall Study|Physician Decision|0|||
48716371|NCT03751657|156813478|FG001|Overall Study|Physician Decision|1|||
48716372|NCT03751657|156813477|FG000|Overall Study|Withdrawal by Subject|1|||
48716373|NCT03751657|156813478|FG001|Overall Study|Withdrawal by Subject|1|||
48716374|NCT03751657|156813477|FG000|Overall Study|Lost to Follow-up|2|||
48716375|NCT03751657|156813478|FG001|Overall Study|Lost to Follow-up|1|||
48716376|NCT02255435|156813479|FG000|Overall Study|Patient's Limited Time Availability|0|||
48716377|NCT02255435|156813480|FG001|Overall Study|Patient's Limited Time Availability|0|||
48716378|NCT02255435|156813481|FG002|Overall Study|Patient's Limited Time Availability|0|||
48813987|NCT01729728|157160030|FG002|Overall Study|Protocol Violation|1|||
48716379|NCT02255435|156813482|FG003|Overall Study|Patient's Limited Time Availability|0|||
48716380|NCT02255435|156813483|FG004|Overall Study|Patient's Limited Time Availability|0|||
48716381|NCT02255435|156813484|FG005|Overall Study|Patient's Limited Time Availability|0|||
48716382|NCT02255435|156813485|FG006|Overall Study|Patient's Limited Time Availability|0|||
48716383|NCT02255435|156813486|FG007|Overall Study|Patient's Limited Time Availability|1|||
48716384|NCT02255435|156813487|FG008|Overall Study|Patient's Limited Time Availability|0|||
48813988|NCT01536145|157160036|FG000|Overall Study|Progressive disease|3|||
48813989|NCT01536145|157160037|FG001|Overall Study|Progressive disease|4|||
48497563|NCT01379781|156016086|FG000|Overall Study|Lost to Follow-up|11|||
48497564|NCT01379781|156016087|FG001|Overall Study|Lost to Follow-up|8|||
48497565|NCT02247479|156016088|FG000|Overall Study|Adverse Event|8|||
48497566|NCT02247479|156016089|FG001|Overall Study|Adverse Event|9|||
48497567|NCT02247479|156016090|FG002|Overall Study|Adverse Event|8|||
48813990|NCT01536145|157160038|FG002|Overall Study|Progressive disease|1|||
48813991|NCT01536145|157160039|FG003|Overall Study|Progressive disease|2|||
48813992|NCT01536145|157160040|FG004|Overall Study|Progressive disease|1|||
48813993|NCT01536145|157160041|FG005|Overall Study|Progressive disease|2|||
48813994|NCT01536145|157160042|FG006|Overall Study|Progressive disease|1|||
48813995|NCT01536145|157160043|FG007|Overall Study|Progressive disease|2|||
48813996|NCT01536145|157160044|FG008|Overall Study|Progressive disease|1|||
48813997|NCT01536145|157160045|FG009|Overall Study|Progressive disease|3|||
48813998|NCT01536145|157160046|FG010|Overall Study|Progressive disease|3|||
48813999|NCT01536145|157160036|FG000|Overall Study|Withdrawal by Subject|0|||
48814000|NCT01536145|157160037|FG001|Overall Study|Withdrawal by Subject|0|||
48814001|NCT01536145|157160038|FG002|Overall Study|Withdrawal by Subject|1|||
48814002|NCT01536145|157160039|FG003|Overall Study|Withdrawal by Subject|0|||
48814003|NCT01536145|157160040|FG004|Overall Study|Withdrawal by Subject|0|||
48814004|NCT01536145|157160041|FG005|Overall Study|Withdrawal by Subject|1|||
48814005|NCT01536145|157160042|FG006|Overall Study|Withdrawal by Subject|0|||
48814006|NCT01536145|157160043|FG007|Overall Study|Withdrawal by Subject|0|||
48814007|NCT01536145|157160044|FG008|Overall Study|Withdrawal by Subject|2|||
48814008|NCT01536145|157160045|FG009|Overall Study|Withdrawal by Subject|0|||
48814009|NCT01536145|157160046|FG010|Overall Study|Withdrawal by Subject|2|||
48814010|NCT01536145|157160036|FG000|Overall Study|Other|0|||
48716385|NCT02255435|156813488|FG009|Overall Study|Patient's Limited Time Availability|0|||
48716386|NCT02255435|156813479|FG000|Overall Study|Withdrawal by Subject|0|||
48716387|NCT02255435|156813480|FG001|Overall Study|Withdrawal by Subject|0|||
48716388|NCT02255435|156813481|FG002|Overall Study|Withdrawal by Subject|0|||
48716389|NCT02255435|156813482|FG003|Overall Study|Withdrawal by Subject|0|||
48716390|NCT02255435|156813483|FG004|Overall Study|Withdrawal by Subject|0|||
48716391|NCT02255435|156813484|FG005|Overall Study|Withdrawal by Subject|0|||
48716392|NCT02255435|156813485|FG006|Overall Study|Withdrawal by Subject|0|||
48716393|NCT02255435|156813486|FG007|Overall Study|Withdrawal by Subject|0|||
48716394|NCT02255435|156813487|FG008|Overall Study|Withdrawal by Subject|1|||
48716395|NCT02255435|156813488|FG009|Overall Study|Withdrawal by Subject|4|||
48716396|NCT02255435|156813479|FG000|Overall Study|Administrative reasons|0|||
48716397|NCT02255435|156813480|FG001|Overall Study|Administrative reasons|0|||
48716398|NCT02255435|156813481|FG002|Overall Study|Administrative reasons|0|||
48716399|NCT02255435|156813482|FG003|Overall Study|Administrative reasons|0|||
48716400|NCT02255435|156813483|FG004|Overall Study|Administrative reasons|0|||
48716401|NCT02255435|156813484|FG005|Overall Study|Administrative reasons|0|||
48716402|NCT02255435|156813485|FG006|Overall Study|Administrative reasons|0|||
48716403|NCT02255435|156813486|FG007|Overall Study|Administrative reasons|0|||
48716404|NCT02255435|156813487|FG008|Overall Study|Administrative reasons|0|||
48716405|NCT02255435|156813488|FG009|Overall Study|Administrative reasons|2|||
48716406|NCT01239992|156813489|FG000|Overall Study|Withdrawal by Subject|2|||
48716407|NCT02810444|156813490|FG000|Overall Study|Screen Failures|14|||
48716408|NCT02810444|156813490|FG000|Overall Study|Withdrawal by Subject|4|||
48716409|NCT02810444|156813490|FG000|Overall Study|Adverse Event|3|||
48716410|NCT02880956|156813502|FG000|Overall Study|Adverse Event|3|||
48716411|NCT02880956|156813503|FG001|Overall Study|Adverse Event|6|||
48716412|NCT02880956|156813504|FG002|Overall Study|Adverse Event|5|||
48716413|NCT02880956|156813505|FG003|Overall Study|Adverse Event|4|||
48716414|NCT02880956|156813502|FG000|Overall Study|Withdrawal by Subject|9|||
48716415|NCT02880956|156813503|FG001|Overall Study|Withdrawal by Subject|4|||
48716416|NCT02880956|156813504|FG002|Overall Study|Withdrawal by Subject|6|||
48716417|NCT02880956|156813505|FG003|Overall Study|Withdrawal by Subject|11|||
48716418|NCT02880956|156813502|FG000|Overall Study|Lost to Follow-up|0|||
48716419|NCT02880956|156813503|FG001|Overall Study|Lost to Follow-up|1|||
48716420|NCT02880956|156813504|FG002|Overall Study|Lost to Follow-up|0|||
48716421|NCT02880956|156813505|FG003|Overall Study|Lost to Follow-up|0|||
48716422|NCT02880956|156813502|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
48716423|NCT02880956|156813503|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
48716424|NCT02880956|156813504|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
48716425|NCT02880956|156813505|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
48716426|NCT02880956|156813502|FG000|Overall Study|Other, Not Specified|4|||
48716427|NCT02880956|156813503|FG001|Overall Study|Other, Not Specified|2|||
48716428|NCT02880956|156813504|FG002|Overall Study|Other, Not Specified|0|||
48814011|NCT01536145|157160037|FG001|Overall Study|Other|0|||
48814012|NCT01536145|157160038|FG002|Overall Study|Other|0|||
48814013|NCT01536145|157160039|FG003|Overall Study|Other|0|||
48814014|NCT01536145|157160040|FG004|Overall Study|Other|1|||
48716429|NCT02880956|156813505|FG003|Overall Study|Other, Not Specified|3|||
48716430|NCT00363545|156813506|FG000|Overall Study|Serious Adverse Event|0|||
48716431|NCT00363545|156813507|FG001|Overall Study|Serious Adverse Event|1|||
48716432|NCT00363545|156813506|FG000|Overall Study|Withdrawal by Subject|12|||
48716433|NCT00363545|156813507|FG001|Overall Study|Withdrawal by Subject|15|||
48814015|NCT01536145|157160041|FG005|Overall Study|Other|0|||
48814016|NCT01536145|157160042|FG006|Overall Study|Other|0|||
48814017|NCT01536145|157160043|FG007|Overall Study|Other|0|||
48814018|NCT01536145|157160044|FG008|Overall Study|Other|0|||
48716434|NCT00363545|156813506|FG000|Overall Study|Migrated/moved from study area|3|||
48716435|NCT00363545|156813507|FG001|Overall Study|Migrated/moved from study area|6|||
48716436|NCT00363545|156813506|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
48716437|NCT00363545|156813507|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
48716438|NCT00363545|156813506|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
48716439|NCT00363545|156813507|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
48814019|NCT01536145|157160045|FG009|Overall Study|Other|3|||
48814020|NCT01536145|157160046|FG010|Overall Study|Other|2|||
48814021|NCT01536145|157160036|FG000|Overall Study|Death|0|||
48814022|NCT01536145|157160037|FG001|Overall Study|Death|0|||
48814023|NCT01536145|157160038|FG002|Overall Study|Death|0|||
48814024|NCT01536145|157160039|FG003|Overall Study|Death|0|||
48814025|NCT01536145|157160040|FG004|Overall Study|Death|0|||
48814026|NCT01536145|157160041|FG005|Overall Study|Death|0|||
48814027|NCT01536145|157160042|FG006|Overall Study|Death|1|||
48814028|NCT01536145|157160043|FG007|Overall Study|Death|0|||
48814029|NCT01536145|157160044|FG008|Overall Study|Death|0|||
48814030|NCT01536145|157160045|FG009|Overall Study|Death|0|||
48814031|NCT01536145|157160046|FG010|Overall Study|Death|0|||
48814032|NCT01536145|157160036|FG000|Overall Study|Adverse Event|0|||
48814033|NCT01536145|157160037|FG001|Overall Study|Adverse Event|0|||
48814034|NCT01536145|157160038|FG002|Overall Study|Adverse Event|0|||
48814035|NCT01536145|157160039|FG003|Overall Study|Adverse Event|0|||
48814036|NCT01536145|157160040|FG004|Overall Study|Adverse Event|0|||
48814037|NCT01536145|157160041|FG005|Overall Study|Adverse Event|0|||
48814038|NCT01536145|157160042|FG006|Overall Study|Adverse Event|0|||
48814039|NCT01536145|157160043|FG007|Overall Study|Adverse Event|2|||
48814040|NCT01536145|157160044|FG008|Overall Study|Adverse Event|0|||
48814041|NCT01536145|157160045|FG009|Overall Study|Adverse Event|0|||
48814042|NCT01536145|157160046|FG010|Overall Study|Adverse Event|3|||
48716440|NCT00363545|156813506|FG000|Overall Study|Others|1|||
48497568|NCT02247479|156016088|FG000|Overall Study|Death|5|||
48497569|NCT02247479|156016089|FG001|Overall Study|Death|4|||
48497570|NCT02247479|156016090|FG002|Overall Study|Death|6|||
48497571|NCT02247479|156016088|FG000|Overall Study|Lost to Follow-up|3|||
48497572|NCT02247479|156016089|FG001|Overall Study|Lost to Follow-up|3|||
48814043|NCT03151395|157160047|FG000|Overall Study|Adverse Event|2|||
48814044|NCT03151395|157160047|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
48814045|NCT03151395|157160047|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
48814046|NCT03151395|157160047|FG000|Overall Study|Unspecified reason|4|||
48814047|NCT04827134|157160051|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
48814048|NCT04827134|157160052|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
48814049|NCT04827134|157160053|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
48814050|NCT04827134|157160054|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
48814051|NCT03125941|157160056|FG000|Overall Study|did not receive intervention|1|||
48497573|NCT02247479|156016090|FG002|Overall Study|Lost to Follow-up|1|||
48497574|NCT02247479|156016088|FG000|Overall Study|Non-compliance|0|||
48497575|NCT02247479|156016089|FG001|Overall Study|Non-compliance|0|||
48716441|NCT00363545|156813507|FG001|Overall Study|Others|0|||
48716442|NCT00966875|156813511|FG000|Part A|Adverse Event|2|||
48716443|NCT00966875|156813512|FG001|Part A|Adverse Event|1|||
48716444|NCT00966875|156813513|FG002|Part A|Adverse Event|0|||
48716445|NCT00966875|156813514|FG003|Part A|Adverse Event|1|||
48497576|NCT02247479|156016090|FG002|Overall Study|Non-compliance|1|||
48497577|NCT02247479|156016088|FG000|Overall Study|Withdrawal by Subject|25|||
48497578|NCT02247479|156016089|FG001|Overall Study|Withdrawal by Subject|29|||
48497579|NCT02247479|156016090|FG002|Overall Study|Withdrawal by Subject|24|||
48497580|NCT02247479|156016088|FG000|Overall Study|Study Terminated by Sponsor|98|||
48497581|NCT02247479|156016089|FG001|Overall Study|Study Terminated by Sponsor|88|||
48716446|NCT00966875|156813515|FG004|Part A|Adverse Event|0|||
48716447|NCT00966875|156813516|FG005|Part A|Adverse Event|1|||
48716448|NCT00966875|156813517|FG006|Part A|Adverse Event|0|||
48716449|NCT00966875|156813518|FG007|Part A|Adverse Event|3|||
48716450|NCT00966875|156813519|FG008|Part A|Adverse Event|3|||
48716451|NCT00966875|156813511|FG000|Part A|Entry Criteria|0|||
48716452|NCT00966875|156813512|FG001|Part A|Entry Criteria|0|||
48716453|NCT00966875|156813513|FG002|Part A|Entry Criteria|0|||
48497582|NCT02247479|156016090|FG002|Overall Study|Study Terminated by Sponsor|94|||
48716454|NCT00966875|156813514|FG003|Part A|Entry Criteria|0|||
48716455|NCT00966875|156813515|FG004|Part A|Entry Criteria|0|||
48814052|NCT03125941|157160057|FG001|Overall Study|did not receive intervention|2|||
48814053|NCT00734214|157160058|FG000|Overall Study|Withdrawal by Subject|3|||
48814054|NCT00734214|157160059|FG001|Overall Study|Withdrawal by Subject|4|||
48814055|NCT00734214|157160058|FG000|Overall Study|MD withdrawal|1|||
48814056|NCT00734214|157160059|FG001|Overall Study|MD withdrawal|0|||
48814057|NCT01630590|157160062|FG000|Overall Study|Adverse Event|9|||
48814058|NCT01630590|157160062|FG000|Overall Study|Lack of Efficacy|37|||
48814059|NCT01630590|157160062|FG000|Overall Study|Withdrawal by Subject|4|||
48497583|NCT02247479|156016088|FG000|Overall Study|Physician Decision|1|||
48497584|NCT02247479|156016089|FG001|Overall Study|Physician Decision|0|||
48814060|NCT01630590|157160062|FG000|Overall Study|2nd primary tumor|2|||
48814061|NCT01630590|157160062|FG000|Overall Study|Automobile accident|1|||
48814062|NCT01630590|157160062|FG000|Overall Study|Maximum benefit|4|||
48814063|NCT01551303|157160063|FG000|Overall Study|failed awareness check on vision test|4|||
48814064|NCT01551303|157160064|FG001|Overall Study|failed awareness check on vision test|7|||
48814065|NCT00211237|157160068|FG000|Baseline|Withdrew|1|||
48814066|NCT00211237|157160069|FG001|Baseline|Withdrew|3|||
48814067|NCT00211237|157160070|FG002|Baseline|Withdrew|0|||
48814068|NCT00211237|157160068|FG000|Baseline|Refused random assignment|1|||
48814069|NCT00211237|157160069|FG001|Baseline|Refused random assignment|0|||
48814070|NCT00211237|157160070|FG002|Baseline|Refused random assignment|0|||
48814071|NCT00211237|157160068|FG000|1 Month|Death|2|||
48814072|NCT00211237|157160069|FG001|1 Month|Death|1|||
48814073|NCT00211237|157160070|FG002|1 Month|Death|0|||
48814074|NCT00211237|157160068|FG000|1 Month|Lost to Follow-up|0|||
48814075|NCT00211237|157160069|FG001|1 Month|Lost to Follow-up|2|||
48814076|NCT00211237|157160070|FG002|1 Month|Lost to Follow-up|0|||
48814077|NCT00211237|157160068|FG000|1 Month|Withdrew|0|||
48814078|NCT00211237|157160069|FG001|1 Month|Withdrew|4|||
48814079|NCT00211237|157160070|FG002|1 Month|Withdrew|0|||
48814080|NCT00211237|157160068|FG000|1 Month|Additional surgery needed|1|||
48814081|NCT00211237|157160069|FG001|1 Month|Additional surgery needed|0|||
48814082|NCT00211237|157160070|FG002|1 Month|Additional surgery needed|0|||
48814083|NCT00211237|157160068|FG000|1 Month|Non-medical problem|0|||
48814084|NCT00211237|157160069|FG001|1 Month|Non-medical problem|2|||
48814085|NCT00211237|157160070|FG002|1 Month|Non-medical problem|0|||
48814086|NCT00211237|157160068|FG000|3 Months|Death|7|||
48814087|NCT00211237|157160069|FG001|3 Months|Death|3|||
48814088|NCT00211237|157160070|FG002|3 Months|Death|0|||
48814089|NCT00211237|157160068|FG000|3 Months|Could not comply with protocol|1|||
48814090|NCT00211237|157160069|FG001|3 Months|Could not comply with protocol|0|||
48814091|NCT00211237|157160070|FG002|3 Months|Could not comply with protocol|0|||
48814092|NCT00211237|157160068|FG000|3 Months|Withdrew|0|||
48814093|NCT00211237|157160069|FG001|3 Months|Withdrew|1|||
48814094|NCT00211237|157160070|FG002|3 Months|Withdrew|0|||
48814095|NCT00211237|157160068|FG000|3 Months|Non-medical problem|0|||
48814096|NCT00211237|157160069|FG001|3 Months|Non-medical problem|0|||
48814097|NCT00211237|157160070|FG002|3 Months|Non-medical problem|1|||
48814098|NCT00211237|157160068|FG000|6 Months|Death|6|||
48814099|NCT00211237|157160069|FG001|6 Months|Death|0|||
48814100|NCT00211237|157160070|FG002|6 Months|Death|3|||
48814101|NCT00211237|157160068|FG000|6 Months|Lost to Follow-up|2|||
48716456|NCT00966875|156813516|FG005|Part A|Entry Criteria|2|||
48716457|NCT00966875|156813517|FG006|Part A|Entry Criteria|0|||
48716458|NCT00966875|156813518|FG007|Part A|Entry Criteria|0|||
48716459|NCT00966875|156813519|FG008|Part A|Entry Criteria|0|||
48716460|NCT00966875|156813511|FG000|Part A|Lack of Efficacy|0|||
48716461|NCT00966875|156813512|FG001|Part A|Lack of Efficacy|1|||
48716462|NCT00966875|156813513|FG002|Part A|Lack of Efficacy|0|||
48716463|NCT00966875|156813514|FG003|Part A|Lack of Efficacy|0|||
48716464|NCT00966875|156813515|FG004|Part A|Lack of Efficacy|0|||
48716465|NCT00966875|156813516|FG005|Part A|Lack of Efficacy|0|||
48716466|NCT00966875|156813517|FG006|Part A|Lack of Efficacy|4|||
48716467|NCT00966875|156813518|FG007|Part A|Lack of Efficacy|0|||
48716468|NCT00966875|156813519|FG008|Part A|Lack of Efficacy|0|||
48716469|NCT00966875|156813511|FG000|Part A|Lost to Follow-up|2|||
48716470|NCT00966875|156813512|FG001|Part A|Lost to Follow-up|0|||
48716471|NCT00966875|156813513|FG002|Part A|Lost to Follow-up|0|||
48716472|NCT00966875|156813514|FG003|Part A|Lost to Follow-up|0|||
48716473|NCT00966875|156813515|FG004|Part A|Lost to Follow-up|0|||
48716474|NCT00966875|156813516|FG005|Part A|Lost to Follow-up|1|||
48497585|NCT02247479|156016090|FG002|Overall Study|Physician Decision|2|||
48497586|NCT02247479|156016088|FG000|Overall Study|Unspecified Reason|2|||
48497587|NCT02247479|156016089|FG001|Overall Study|Unspecified Reason|5|||
48497588|NCT02247479|156016090|FG002|Overall Study|Unspecified Reason|2|||
48814102|NCT00211237|157160069|FG001|6 Months|Lost to Follow-up|0|||
48716475|NCT00966875|156813517|FG006|Part A|Lost to Follow-up|0|||
48814103|NCT00211237|157160070|FG002|6 Months|Lost to Follow-up|0|||
48814104|NCT00211237|157160068|FG000|6 Months|Could not comply with protocol|0|||
48814105|NCT00211237|157160069|FG001|6 Months|Could not comply with protocol|2|||
48814106|NCT00211237|157160070|FG002|6 Months|Could not comply with protocol|0|||
48716476|NCT00966875|156813518|FG007|Part A|Lost to Follow-up|0|||
48814107|NCT00211237|157160068|FG000|12 Months|Death|8|||
48814108|NCT00211237|157160069|FG001|12 Months|Death|2|||
48814109|NCT00211237|157160070|FG002|12 Months|Death|3|||
48814110|NCT00211237|157160068|FG000|12 Months|Lost to Follow-up|1|||
48716477|NCT00966875|156813519|FG008|Part A|Lost to Follow-up|0|||
48716478|NCT00966875|156813511|FG000|Part A|Parent/Caregiver Decision|0|||
48716479|NCT00966875|156813512|FG001|Part A|Parent/Caregiver Decision|0|||
48716480|NCT00966875|156813513|FG002|Part A|Parent/Caregiver Decision|0|||
48716481|NCT00966875|156813514|FG003|Part A|Parent/Caregiver Decision|1|||
48814111|NCT00211237|157160069|FG001|12 Months|Lost to Follow-up|0|||
48814112|NCT00211237|157160070|FG002|12 Months|Lost to Follow-up|1|||
48814113|NCT00211237|157160068|FG000|12 Months|Withdrew|0|||
48814114|NCT00211237|157160069|FG001|12 Months|Withdrew|0|||
48814115|NCT00211237|157160070|FG002|12 Months|Withdrew|1|||
48814116|NCT00211237|157160068|FG000|12 Months|unrelated medical problem|0|||
48814117|NCT00211237|157160069|FG001|12 Months|unrelated medical problem|0|||
48814118|NCT00211237|157160070|FG002|12 Months|unrelated medical problem|1|||
48814119|NCT01464255|157160075|FG000|Overall Study|unresolve corneal staining|0|||
48814120|NCT01464255|157160076|FG001|Overall Study|unresolve corneal staining|1|||
48814121|NCT02743793|157160083|FG000|Overall Study|Death|1|||
48814122|NCT02743793|157160084|FG001|Overall Study|Death|1|||
48814123|NCT02743793|157160083|FG000|Overall Study|Withdrawal by Subject|0|||
48814124|NCT02743793|157160084|FG001|Overall Study|Withdrawal by Subject|1|||
48814125|NCT02743793|157160083|FG000|Overall Study|Screen Failure|4|||
48814126|NCT02743793|157160084|FG001|Overall Study|Screen Failure|0|||
48814127|NCT02743793|157160083|FG000|Overall Study|No Primary Care Physician|0|||
48814128|NCT02743793|157160084|FG001|Overall Study|No Primary Care Physician|1|||
48814129|NCT02743793|157160083|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
48814130|NCT02743793|157160084|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
48814131|NCT02743793|157160083|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
48814132|NCT02743793|157160084|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
48814133|NCT04276090|157160088|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
48814134|NCT04276090|157160089|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
48814135|NCT01951092|157160093|FG000|Overall Study|Lost to Follow-up|10|||
48814136|NCT01951092|157160093|FG000|Overall Study|Incarceration|1|||
48814137|NCT01951092|157160093|FG000|Overall Study|Transfer of Care|1|||
48814138|NCT03714022|157160097|FG000|Overall Study|Adverse Event|1|||
48814139|NCT03714022|157160098|FG001|Overall Study|Adverse Event|0|||
48814140|NCT03714022|157160097|FG000|Overall Study|Consent withdrawal|0|||
48814141|NCT03714022|157160098|FG001|Overall Study|Consent withdrawal|1|||
48497589|NCT02927847|156016091|FG000|Overall Study|Lost to Follow-up|1|||
48497590|NCT02927847|156016092|FG001|Overall Study|Lost to Follow-up|0|||
48497591|NCT02927847|156016091|FG000|Overall Study|Withdrawal by Subject|4|||
48497592|NCT02927847|156016092|FG001|Overall Study|Withdrawal by Subject|2|||
48497593|NCT02927847|156016091|FG000|Overall Study|PI withdrawn due to missed visits|1|||
48497594|NCT02927847|156016092|FG001|Overall Study|PI withdrawn due to missed visits|1|||
48497595|NCT01290263|156016097|FG000|Overall Study|Adverse Event|0|||
48497596|NCT01290263|156016098|FG001|Overall Study|Adverse Event|0|||
48497597|NCT01290263|156016099|FG002|Overall Study|Adverse Event|0|||
48497598|NCT01290263|156016100|FG003|Overall Study|Adverse Event|1|||
48497599|NCT01290263|156016101|FG004|Overall Study|Adverse Event|1|||
48497600|NCT01290263|156016097|FG000|Overall Study|Lack of Efficacy|8|||
48497601|NCT01290263|156016098|FG001|Overall Study|Lack of Efficacy|2|||
48497602|NCT01290263|156016099|FG002|Overall Study|Lack of Efficacy|7|||
48497603|NCT01290263|156016100|FG003|Overall Study|Lack of Efficacy|24|||
48497604|NCT01290263|156016101|FG004|Overall Study|Lack of Efficacy|33|||
48497605|NCT01290263|156016097|FG000|Overall Study|Withdrawal by Subject|3|||
48497606|NCT01290263|156016098|FG001|Overall Study|Withdrawal by Subject|1|||
48497607|NCT01290263|156016099|FG002|Overall Study|Withdrawal by Subject|0|||
48497608|NCT01290263|156016100|FG003|Overall Study|Withdrawal by Subject|1|||
48497609|NCT01290263|156016101|FG004|Overall Study|Withdrawal by Subject|2|||
48497610|NCT01290263|156016097|FG000|Overall Study|Participant Non-Compliance|0|||
48497611|NCT01290263|156016098|FG001|Overall Study|Participant Non-Compliance|0|||
48497612|NCT01290263|156016099|FG002|Overall Study|Participant Non-Compliance|0|||
48497613|NCT01290263|156016100|FG003|Overall Study|Participant Non-Compliance|1|||
48497614|NCT01290263|156016101|FG004|Overall Study|Participant Non-Compliance|1|||
48497615|NCT05346055|156016102|FG000|Overall Study|Withdrawal by Subject|1|||
48497616|NCT05346055|156016102|FG000|Overall Study|Protocol Violation|1|||
48814142|NCT03714022|157160097|FG000|Overall Study|Lost to Follow-up|3|||
48814143|NCT03714022|157160098|FG001|Overall Study|Lost to Follow-up|2|||
48814144|NCT01018563|157160101|FG000|Overall Study|Termination of the study by Sponsor|2|||
48814145|NCT01018563|157160102|FG001|Overall Study|Termination of the study by Sponsor|1|||
48814146|NCT02294474|157160103|FG000|Overall Study|Adverse Event|7|||
48814147|NCT02294474|157160104|FG001|Overall Study|Adverse Event|7|||
48814148|NCT02294474|157160103|FG000|Overall Study|Lack of Efficacy|2|||
48497617|NCT05346055|156016102|FG000|Overall Study|Therapist decision|1|||
48814149|NCT02294474|157160104|FG001|Overall Study|Lack of Efficacy|1|||
48814150|NCT02294474|157160103|FG000|Overall Study|Protocol Violation|4|||
48814151|NCT02294474|157160104|FG001|Overall Study|Protocol Violation|2|||
48814152|NCT02294474|157160103|FG000|Overall Study|Other than specified above|12|||
48814153|NCT02294474|157160104|FG001|Overall Study|Other than specified above|12|||
48814154|NCT00309608|157160105|FG000|Overall Study|Adverse Event|1|||
48814155|NCT00309608|157160106|FG001|Overall Study|Adverse Event|5|||
48497618|NCT00718159|156016105|FG000|Overall Study|Progressive Disease|3|||
48497619|NCT00718159|156016106|FG001|Overall Study|Progressive Disease|3|||
48814156|NCT00309608|157160107|FG002|Overall Study|Adverse Event|3|||
48814157|NCT00309608|157160108|FG003|Overall Study|Adverse Event|2|||
48814158|NCT00309608|157160109|FG004|Overall Study|Adverse Event|3|||
48814159|NCT00309608|157160105|FG000|Overall Study|Protocol Violation|2|||
48497620|NCT00718159|156016107|FG002|Overall Study|Progressive Disease|2|||
48814160|NCT00309608|157160106|FG001|Overall Study|Protocol Violation|0|||
48814161|NCT00309608|157160107|FG002|Overall Study|Protocol Violation|0|||
48814162|NCT00309608|157160108|FG003|Overall Study|Protocol Violation|0|||
48814163|NCT00309608|157160109|FG004|Overall Study|Protocol Violation|0|||
48814164|NCT00309608|157160105|FG000|Overall Study|Lost to Follow-up|0|||
48814165|NCT00309608|157160106|FG001|Overall Study|Lost to Follow-up|0|||
48814166|NCT00309608|157160107|FG002|Overall Study|Lost to Follow-up|2|||
48814167|NCT00309608|157160108|FG003|Overall Study|Lost to Follow-up|0|||
48814168|NCT00309608|157160109|FG004|Overall Study|Lost to Follow-up|1|||
48814169|NCT00309608|157160105|FG000|Overall Study|Withdrawal by Subject|1|||
48814170|NCT00309608|157160106|FG001|Overall Study|Withdrawal by Subject|4|||
48814171|NCT00309608|157160107|FG002|Overall Study|Withdrawal by Subject|2|||
48814172|NCT00309608|157160108|FG003|Overall Study|Withdrawal by Subject|0|||
48814173|NCT00309608|157160109|FG004|Overall Study|Withdrawal by Subject|0|||
48814174|NCT00309608|157160105|FG000|Overall Study|Other incl. Lack of efficacy|10|||
48814175|NCT00309608|157160106|FG001|Overall Study|Other incl. Lack of efficacy|4|||
48814176|NCT00309608|157160107|FG002|Overall Study|Other incl. Lack of efficacy|3|||
48814177|NCT00309608|157160108|FG003|Overall Study|Other incl. Lack of efficacy|4|||
48814178|NCT00309608|157160109|FG004|Overall Study|Other incl. Lack of efficacy|0|||
48814179|NCT00641186|157160112|FG000|Overall Study|Adverse Event|3|||
48814180|NCT02684903|157160119|FG000|Overall Study|COVID-19 shutdown of lab|4|||
48814181|NCT02684903|157160120|FG001|Overall Study|COVID-19 shutdown of lab|6|||
48814182|NCT02684903|157160119|FG000|Overall Study|Lost to Follow-up|31|||
48814183|NCT02684903|157160120|FG001|Overall Study|Lost to Follow-up|41|||
48814184|NCT00904150|157160121|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
48814185|NCT00904150|157160122|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
48814186|NCT00904150|157160121|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
48814187|NCT00904150|157160122|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
48814188|NCT04880161|157160123|FG000|Overall Study|Withdrawal by Subject|1|||
48814189|NCT04880161|157160124|FG001|Overall Study|Withdrawal by Subject|0|||
48814190|NCT04880161|157160123|FG000|Overall Study|Lack of Compliance|1|||
48814191|NCT04880161|157160124|FG001|Overall Study|Lack of Compliance|1|||
48814192|NCT04880161|157160123|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
48814193|NCT04880161|157160124|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
48814194|NCT04880161|157160123|FG000|Overall Study|Screen Failure|0|||
48814195|NCT04880161|157160124|FG001|Overall Study|Screen Failure|1|||
48814196|NCT01354106|157160125|FG000|Overall Study|Withdrawal by Subject|2|||
48814197|NCT00798174|157161730|FG000|Overall Study|inability to implant azygos coil|3|||
48814198|NCT00798174|157161731|FG001|Overall Study|inability to implant azygos coil|3|||
48814199|NCT00798174|157161730|FG000|Overall Study|Inability to sedate for DFT testing|1|||
48814200|NCT00798174|157161731|FG001|Overall Study|Inability to sedate for DFT testing|0|||
48814201|NCT00917267|157161739|FG000|Overall Study|Adverse Event|15|||
48814202|NCT00917267|157161740|FG001|Overall Study|Adverse Event|36|||
48814203|NCT00917267|157161739|FG000|Overall Study|Physician Decision|2|||
48814204|NCT00917267|157161740|FG001|Overall Study|Physician Decision|4|||
48814205|NCT00917267|157161739|FG000|Overall Study|Protocol Violation|9|||
48814206|NCT00917267|157161740|FG001|Overall Study|Protocol Violation|18|||
48814207|NCT00917267|157161739|FG000|Overall Study|Withdrawal by Subject|5|||
48814208|NCT00917267|157161740|FG001|Overall Study|Withdrawal by Subject|12|||
48814209|NCT00917267|157161739|FG000|Overall Study|Lost to follow up|0|||
48814210|NCT00917267|157161740|FG001|Overall Study|Lost to follow up|2|||
48814211|NCT00917267|157161739|FG000|Overall Study|Entry Criteria Not Met|1|||
48814212|NCT00917267|157161740|FG001|Overall Study|Entry Criteria Not Met|0|||
48814213|NCT00917267|157161739|FG000|Overall Study|Sponsor Decision|5|||
48814214|NCT00917267|157161740|FG001|Overall Study|Sponsor Decision|5|||
48814215|NCT00917267|157161739|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
48814216|NCT00917267|157161740|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
48814217|NCT00432835|157161745|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
48814218|NCT00432835|157161746|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
48814219|NCT02045433|157161747|FG000|Overall Study|Withdrawal by Subject|1|||
48814220|NCT00594906|157161748|FG000|Overall Study|Physician Decision|1|||
48814221|NCT00594906|157161749|FG001|Overall Study|Physician Decision|0|||
48814222|NCT00594906|157161748|FG000|Overall Study|Physician Decision|0|||
48814223|NCT00594906|157161749|FG001|Overall Study|Physician Decision|1|||
48814224|NCT00594906|157161748|FG000|Overall Study|Death|0|||
48814225|NCT00594906|157161749|FG001|Overall Study|Death|1|||
48436392|NCT00618449|155785887|FG000|Overall Study|Lost to Follow-up|98|||
48814226|NCT00451217|157161751|FG000|Overall Study|Lost to Follow-up|0|||
48814227|NCT00451217|157161752|FG001|Overall Study|Lost to Follow-up|1|||
48814228|NCT00451217|157161753|FG002|Overall Study|Lost to Follow-up|1|||
48814229|NCT00451217|157161754|FG003|Overall Study|Lost to Follow-up|1|||
48814230|NCT00451217|157161751|FG000|Overall Study|Withdrawal by Subject|1|||
48814231|NCT00451217|157161752|FG001|Overall Study|Withdrawal by Subject|0|||
48814232|NCT00451217|157161753|FG002|Overall Study|Withdrawal by Subject|0|||
48814233|NCT00451217|157161754|FG003|Overall Study|Withdrawal by Subject|0|||
48814234|NCT00451217|157161751|FG000|Overall Study|Not Treated|1|||
48814235|NCT00451217|157161752|FG001|Overall Study|Not Treated|1|||
48814236|NCT00451217|157161753|FG002|Overall Study|Not Treated|3|||
48814237|NCT00451217|157161754|FG003|Overall Study|Not Treated|4|||
48814238|NCT00867490|157161756|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
48814239|NCT00867490|157161756|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
48814240|NCT00867490|157161756|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
48814241|NCT00867490|157161756|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
48814242|NCT00867490|157161756|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
48814243|NCT01129336|157161757|FG000|Overall Study|Protocol Violation|1|||
48814244|NCT01129336|157161758|FG001|Overall Study|Protocol Violation|0|||
48814245|NCT01129336|157161757|FG000|Overall Study|Disease Progression|1|||
48814246|NCT01129336|157161758|FG001|Overall Study|Disease Progression|4|||
48814247|NCT01129336|157161757|FG000|Overall Study|Lost to Follow-up|1|||
48814248|NCT01129336|157161758|FG001|Overall Study|Lost to Follow-up|0|||
48814249|NCT01129336|157161757|FG000|Overall Study|Withdrawal by Subject|7|||
48814250|NCT01129336|157161758|FG001|Overall Study|Withdrawal by Subject|4|||
48814251|NCT01129336|157161757|FG000|Overall Study|Adverse Event|0|||
48814252|NCT01129336|157161758|FG001|Overall Study|Adverse Event|1|||
48814253|NCT01129336|157161757|FG000|Overall Study|Missing Study Completion Status|2|||
48814254|NCT01129336|157161758|FG001|Overall Study|Missing Study Completion Status|3|||
48814255|NCT01129336|157161757|FG000|Overall Study|Death|0|||
48814256|NCT01129336|157161758|FG001|Overall Study|Death|4|||
48814257|NCT01950273|157161761|FG000|Overall Study|Protocol Violation|1|||
48814258|NCT01950273|157161762|FG001|Overall Study|Protocol Violation|0|||
48814259|NCT01950273|157161761|FG000|Overall Study|Withdrawal by Subject|2|||
48814260|NCT01950273|157161762|FG001|Overall Study|Withdrawal by Subject|0|||
48814261|NCT01950273|157161761|FG000|Overall Study|Other not defined above|1|||
48814262|NCT01950273|157161762|FG001|Overall Study|Other not defined above|0|||
48814263|NCT01254565|157161763|FG000|Overall Study|Non-compliance to Study Procedures|0|||
48814264|NCT01254565|157161764|FG001|Overall Study|Non-compliance to Study Procedures|0|||
48814265|NCT01254565|157161765|FG002|Overall Study|Non-compliance to Study Procedures|0|||
48814266|NCT01254565|157161766|FG003|Overall Study|Non-compliance to Study Procedures|0|||
48814267|NCT01254565|157161767|FG004|Overall Study|Non-compliance to Study Procedures|1|||
48814268|NCT01254565|157161768|FG005|Overall Study|Non-compliance to Study Procedures|0|||
48814269|NCT01254565|157161763|FG000|Overall Study|Did not Receive Treatment|1|||
48814270|NCT01254565|157161764|FG001|Overall Study|Did not Receive Treatment|1|||
48814271|NCT01254565|157161765|FG002|Overall Study|Did not Receive Treatment|0|||
48814272|NCT01254565|157161766|FG003|Overall Study|Did not Receive Treatment|0|||
48814273|NCT01254565|157161767|FG004|Overall Study|Did not Receive Treatment|3|||
48814274|NCT01254565|157161768|FG005|Overall Study|Did not Receive Treatment|4|||
48814275|NCT01254565|157161763|FG000|Overall Study|Other|0|||
48814276|NCT01254565|157161764|FG001|Overall Study|Other|0|||
48814277|NCT01254565|157161765|FG002|Overall Study|Other|0|||
48814278|NCT01254565|157161766|FG003|Overall Study|Other|1|||
48814279|NCT01254565|157161767|FG004|Overall Study|Other|0|||
48814280|NCT01254565|157161768|FG005|Overall Study|Other|0|||
48814281|NCT00472186|157161769|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
48814282|NCT00472186|157161770|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
48814283|NCT01235975|157161773|FG000|Overall Study|Serious Adverse Event|0|||
48814284|NCT01235975|157161774|FG001|Overall Study|Serious Adverse Event|1|||
48814285|NCT01235975|157161773|FG000|Overall Study|Withdrawal by Subject|8|||
48814286|NCT01235975|157161774|FG001|Overall Study|Withdrawal by Subject|2|||
48814287|NCT01235975|157161773|FG000|Overall Study|Migrated/moved from study area|2|||
48814288|NCT01235975|157161774|FG001|Overall Study|Migrated/moved from study area|1|||
48814289|NCT01235975|157161773|FG000|Overall Study|Lost to Follow-up|7|||
48814290|NCT01235975|157161774|FG001|Overall Study|Lost to Follow-up|3|||
48497621|NCT00718159|156016108|FG003|Overall Study|Progressive Disease|0|||
48497622|NCT00718159|156016109|FG004|Overall Study|Progressive Disease|6|||
48497623|NCT00718159|156016110|FG005|Overall Study|Progressive Disease|0|||
48497624|NCT00718159|156016111|FG006|Overall Study|Progressive Disease|0|||
48497625|NCT00718159|156016105|FG000|Overall Study|Death due to Adverse Event|0|||
48497626|NCT00718159|156016106|FG001|Overall Study|Death due to Adverse Event|0|||
48497627|NCT00718159|156016107|FG002|Overall Study|Death due to Adverse Event|0|||
48497628|NCT00718159|156016108|FG003|Overall Study|Death due to Adverse Event|2|||
48497629|NCT00718159|156016109|FG004|Overall Study|Death due to Adverse Event|2|||
48497630|NCT00718159|156016110|FG005|Overall Study|Death due to Adverse Event|0|||
48497631|NCT00718159|156016111|FG006|Overall Study|Death due to Adverse Event|0|||
48497632|NCT00718159|156016105|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
48814291|NCT01622348|157161775|FG000|Overall Study|Withdrawal by Subject|1|||
48814292|NCT01622348|157161776|FG001|Overall Study|Withdrawal by Subject|0|||
48814293|NCT01622348|157161777|FG002|Overall Study|Withdrawal by Subject|1|||
48814294|NCT04397523|157161778|FG000|Overall Study|Lost to Follow-up|3|||
48814295|NCT04397523|157161778|FG000|Overall Study|Transfer from/to other hospital|8|||
48814296|NCT00951509|157161787|FG000|Overall Study|Withdrawal by Subject|2|||
48814297|NCT01830881|157161788|FG000|Overall Study|Changed decision to have an abortion|0|||
48814298|NCT01830881|157161789|FG001|Overall Study|Changed decision to have an abortion|1|||
48814299|NCT02038764|157161792|FG000|Overall Study|Adverse Event|0|||
48814300|NCT02038764|157161793|FG001|Overall Study|Adverse Event|0|||
48814301|NCT02038764|157161794|FG002|Overall Study|Adverse Event|1|||
48814302|NCT02038764|157161795|FG003|Overall Study|Adverse Event|0|||
48814303|NCT02038764|157161796|FG004|Overall Study|Adverse Event|0|||
48814304|NCT02038764|157161792|FG000|Overall Study|Lost to Follow-up|0|||
48814305|NCT02038764|157161793|FG001|Overall Study|Lost to Follow-up|1|||
48814306|NCT02038764|157161794|FG002|Overall Study|Lost to Follow-up|0|||
48814307|NCT02038764|157161795|FG003|Overall Study|Lost to Follow-up|0|||
48814308|NCT02038764|157161796|FG004|Overall Study|Lost to Follow-up|0|||
48814309|NCT02038764|157161792|FG000|Overall Study|Withdrawal by Subject|0|||
48814310|NCT02038764|157161793|FG001|Overall Study|Withdrawal by Subject|0|||
48814311|NCT02038764|157161794|FG002|Overall Study|Withdrawal by Subject|0|||
48814312|NCT02038764|157161795|FG003|Overall Study|Withdrawal by Subject|0|||
48814313|NCT02038764|157161796|FG004|Overall Study|Withdrawal by Subject|1|||
48814314|NCT02038764|157161792|FG000|Overall Study|Other|1|||
48814315|NCT02038764|157161793|FG001|Overall Study|Other|0|||
48814316|NCT02038764|157161794|FG002|Overall Study|Other|1|||
48814317|NCT02038764|157161795|FG003|Overall Study|Other|0|||
48814318|NCT02038764|157161796|FG004|Overall Study|Other|0|||
48814319|NCT00582491|157161797|FG000|Overall Study|Withdrawal by Subject|1|||
48814320|NCT00582491|157161798|FG001|Overall Study|Withdrawal by Subject|0|||
48814321|NCT01775930|157161809|FG000|Overall Study|Futility stopping boundary met|1|||
48814322|NCT02471404|157161820|FG000|Overall Study|Adverse Event|7|||
48814323|NCT02471404|157161821|FG001|Overall Study|Adverse Event|1|||
48814324|NCT02471404|157161822|FG002|Overall Study|Adverse Event|2|||
48814325|NCT02471404|157161820|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
48814326|NCT02471404|157161821|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
48814327|NCT02471404|157161822|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
48814328|NCT02471404|157161820|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
48814329|NCT02471404|157161821|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
48814330|NCT02471404|157161822|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
48814331|NCT02471404|157161820|FG000|Overall Study|Lost to Follow-up|1|||
48814332|NCT02471404|157161821|FG001|Overall Study|Lost to Follow-up|1|||
48814333|NCT02471404|157161822|FG002|Overall Study|Lost to Follow-up|3|||
48814334|NCT02471404|157161820|FG000|Overall Study|Protocol Violation|1|||
48814335|NCT02471404|157161821|FG001|Overall Study|Protocol Violation|0|||
48814336|NCT02471404|157161822|FG002|Overall Study|Protocol Violation|0|||
48814337|NCT02471404|157161820|FG000|Overall Study|Withdrawal by Subject|8|||
48814338|NCT02471404|157161821|FG001|Overall Study|Withdrawal by Subject|4|||
48814339|NCT02471404|157161822|FG002|Overall Study|Withdrawal by Subject|5|||
48814340|NCT02471404|157161820|FG000|Overall Study|Other reasons not specified|10|||
48814341|NCT02471404|157161821|FG001|Overall Study|Other reasons not specified|7|||
48814342|NCT02471404|157161822|FG002|Overall Study|Other reasons not specified|12|||
48814343|NCT01927731|157161823|FG000|Overall Study|Graft Failure|1|||
48814344|NCT01927731|157161824|FG001|Overall Study|Graft Failure|2|||
48814345|NCT01927731|157161823|FG000|Overall Study|Physician Decision|2|||
48814346|NCT01927731|157161824|FG001|Overall Study|Physician Decision|3|||
48814347|NCT01927731|157161823|FG000|Overall Study|Withdrawal by Subject|0|||
48814348|NCT01927731|157161824|FG001|Overall Study|Withdrawal by Subject|2|||
48814349|NCT01927731|157161823|FG000|Overall Study|Death|0|||
48814350|NCT01927731|157161824|FG001|Overall Study|Death|3|||
48814351|NCT00305864|157161825|FG000|Overall Study|Ineligible / No protocol treatment|0|||
48814352|NCT00305864|157161826|FG001|Overall Study|Ineligible / No protocol treatment|1|||
48814353|NCT00305864|157161827|FG002|Overall Study|Ineligible / No protocol treatment|1|||
48814354|NCT00305864|157161828|FG003|Overall Study|Ineligible / No protocol treatment|13|||
48814355|NCT01734850|157161829|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
48497633|NCT00718159|156016106|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
48497634|NCT00718159|156016107|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
48497635|NCT00718159|156016108|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
48497636|NCT00718159|156016109|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
48497637|NCT00718159|156016110|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
48497638|NCT00718159|156016111|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
48497639|NCT00718159|156016105|FG000|Overall Study|Investigator Decision|0|||
48497640|NCT00718159|156016106|FG001|Overall Study|Investigator Decision|0|||
48497641|NCT00718159|156016107|FG002|Overall Study|Investigator Decision|0|||
48814356|NCT01734850|157161830|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
48814357|NCT01734850|157161831|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
48814358|NCT01734850|157161829|FG000|Overall Study|Not infused due to manufacturing failure|0|||
48814359|NCT01734850|157161830|FG001|Overall Study|Not infused due to manufacturing failure|0|||
48814360|NCT01734850|157161831|FG002|Overall Study|Not infused due to manufacturing failure|1|||
48814361|NCT03881059|157161832|FG000|Treatment Period - Part A|Adverse Event|1|||
48814362|NCT03881059|157161833|FG001|Treatment Period - Part A|Adverse Event|3|||
48814363|NCT03881059|157161834|FG002|Treatment Period - Part A|Adverse Event|4|||
48814364|NCT03881059|157161832|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
48814365|NCT03881059|157161833|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
48814366|NCT03881059|157161834|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
48814367|NCT03881059|157161832|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
48814368|NCT03881059|157161833|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
48814369|NCT03881059|157161834|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
48814370|NCT03881059|157161832|FG000|Treatment Period - Part A|Other reasons|2|||
48814371|NCT03881059|157161833|FG001|Treatment Period - Part A|Other reasons|1|||
48814372|NCT03881059|157161834|FG002|Treatment Period - Part A|Other reasons|0|||
48814373|NCT03881059|157161832|FG000|Treatment Period - Part B|Adverse Event|0|||
48814374|NCT03881059|157161833|FG001|Treatment Period - Part B|Adverse Event|0|||
48814375|NCT03881059|157161834|FG002|Treatment Period - Part B|Adverse Event|3|||
48814376|NCT03881059|157161832|FG000|Treatment Period - Part B|Death|0|||
48814377|NCT03881059|157161833|FG001|Treatment Period - Part B|Death|1|||
48814378|NCT03881059|157161834|FG002|Treatment Period - Part B|Death|1|||
48814379|NCT03881059|157161832|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
48814380|NCT03881059|157161833|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
48814381|NCT03881059|157161834|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
48814382|NCT03881059|157161832|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
48814383|NCT03881059|157161833|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
48814384|NCT03881059|157161834|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
48814385|NCT03881059|157161832|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
48814386|NCT03881059|157161833|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
48814387|NCT03881059|157161834|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
48814388|NCT03881059|157161832|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
48814389|NCT03881059|157161833|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
48814390|NCT03881059|157161834|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
48814391|NCT03881059|157161832|FG000|Treatment Period - Part B|Other reasons|4|||
48814392|NCT03881059|157161833|FG001|Treatment Period - Part B|Other reasons|3|||
48814393|NCT03881059|157161834|FG002|Treatment Period - Part B|Other reasons|3|||
48814394|NCT02204293|157161835|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
48814395|NCT02204293|157161836|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
48814396|NCT02204293|157161837|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
48814397|NCT02204293|157161838|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
48814398|NCT02204293|157161839|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
48814399|NCT02204293|157161840|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
48814400|NCT02204293|157161835|FG000|Core Study Part I|Adverse Event|1|||
48814401|NCT02204293|157161836|FG001|Core Study Part I|Adverse Event|0|||
48814402|NCT02204293|157161837|FG002|Core Study Part I|Adverse Event|0|||
48814403|NCT02204293|157161838|FG003|Core Study Part I|Adverse Event|0|||
48814404|NCT02204293|157161839|FG004|Core Study Part I|Adverse Event|0|||
48814405|NCT02204293|157161840|FG005|Core Study Part I|Adverse Event|0|||
48814406|NCT02204293|157161835|FG000|Core Study Part I|Physician Decision|0|||
48814407|NCT02204293|157161836|FG001|Core Study Part I|Physician Decision|3|||
48814408|NCT02204293|157161837|FG002|Core Study Part I|Physician Decision|0|||
48814409|NCT02204293|157161838|FG003|Core Study Part I|Physician Decision|0|||
48814410|NCT02204293|157161839|FG004|Core Study Part I|Physician Decision|0|||
48814411|NCT02204293|157161840|FG005|Core Study Part I|Physician Decision|0|||
48814412|NCT02204293|157161835|FG000|LTE Phase|Study Suspended|0|||
48814413|NCT02204293|157161836|FG001|LTE Phase|Study Suspended|0|||
48814414|NCT02204293|157161837|FG002|LTE Phase|Study Suspended|0|||
48814415|NCT02204293|157161838|FG003|LTE Phase|Study Suspended|0|||
48814416|NCT02204293|157161839|FG004|LTE Phase|Study Suspended|0|||
48814417|NCT02204293|157161840|FG005|LTE Phase|Study Suspended|7|||
48814418|NCT00661258|157161841|FG000|Overall Study|Death|1|||
48814419|NCT00661258|157161842|FG001|Overall Study|Death|0|||
48814420|NCT00661258|157161841|FG000|Overall Study|caught by police and in detox center|2|||
48814421|NCT00661258|157161842|FG001|Overall Study|caught by police and in detox center|1|||
48814422|NCT01146574|157161843|FG000|Overall Study|Death|0|||
48814423|NCT01146574|157161844|FG001|Overall Study|Death|1|||
48814424|NCT01146574|157161845|FG002|Overall Study|Death|1|||
48814425|NCT01146574|157161846|FG003|Overall Study|Death|0|||
48814426|NCT01146574|157161847|FG004|Overall Study|Death|0|||
48814427|NCT01146574|157161848|FG005|Overall Study|Death|0|||
48814428|NCT01146574|157161849|FG006|Overall Study|Death|0|||
48814429|NCT01146574|157161843|FG000|Overall Study|Other reasons|0|||
48814430|NCT01146574|157161844|FG001|Overall Study|Other reasons|0|||
48497642|NCT00718159|156016108|FG003|Overall Study|Investigator Decision|0|||
48497643|NCT00718159|156016109|FG004|Overall Study|Investigator Decision|0|||
48497644|NCT00718159|156016110|FG005|Overall Study|Investigator Decision|1|||
48497645|NCT00718159|156016111|FG006|Overall Study|Investigator Decision|1|||
48497646|NCT04700449|156016114|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
48497647|NCT04700449|156016115|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
48497648|NCT04700449|156016116|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
48814431|NCT01146574|157161845|FG002|Overall Study|Other reasons|3|||
48497649|NCT04700449|156016117|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
48716482|NCT00966875|156813515|FG004|Part A|Parent/Caregiver Decision|0|||
48716483|NCT00966875|156813516|FG005|Part A|Parent/Caregiver Decision|0|||
48716484|NCT00966875|156813517|FG006|Part A|Parent/Caregiver Decision|0|||
48716485|NCT00966875|156813518|FG007|Part A|Parent/Caregiver Decision|0|||
48716486|NCT00966875|156813519|FG008|Part A|Parent/Caregiver Decision|0|||
48716487|NCT00966875|156813511|FG000|Part A|Physician Decision|0|||
48716488|NCT00966875|156813512|FG001|Part A|Physician Decision|0|||
48716489|NCT00966875|156813513|FG002|Part A|Physician Decision|0|||
48716490|NCT00966875|156813514|FG003|Part A|Physician Decision|0|||
48716491|NCT00966875|156813515|FG004|Part A|Physician Decision|1|||
48716492|NCT00966875|156813516|FG005|Part A|Physician Decision|0|||
48716493|NCT00966875|156813517|FG006|Part A|Physician Decision|1|||
48716494|NCT00966875|156813518|FG007|Part A|Physician Decision|0|||
48716495|NCT00966875|156813519|FG008|Part A|Physician Decision|2|||
48716496|NCT00966875|156813511|FG000|Part A|Sponsor Decision|0|||
48716497|NCT00966875|156813512|FG001|Part A|Sponsor Decision|0|||
48716498|NCT00966875|156813513|FG002|Part A|Sponsor Decision|1|||
48716499|NCT00966875|156813514|FG003|Part A|Sponsor Decision|0|||
48716500|NCT00966875|156813515|FG004|Part A|Sponsor Decision|1|||
48716501|NCT00966875|156813516|FG005|Part A|Sponsor Decision|0|||
48716502|NCT00966875|156813517|FG006|Part A|Sponsor Decision|0|||
48716503|NCT00966875|156813518|FG007|Part A|Sponsor Decision|2|||
48716504|NCT00966875|156813519|FG008|Part A|Sponsor Decision|1|||
48716505|NCT00966875|156813511|FG000|Part A|Withdrawal by Subject|2|||
48716506|NCT00966875|156813512|FG001|Part A|Withdrawal by Subject|2|||
48716507|NCT00966875|156813513|FG002|Part A|Withdrawal by Subject|1|||
48716508|NCT00966875|156813514|FG003|Part A|Withdrawal by Subject|1|||
48716509|NCT00966875|156813515|FG004|Part A|Withdrawal by Subject|3|||
48716510|NCT00966875|156813516|FG005|Part A|Withdrawal by Subject|0|||
48716511|NCT00966875|156813517|FG006|Part A|Withdrawal by Subject|5|||
48716512|NCT00966875|156813518|FG007|Part A|Withdrawal by Subject|1|||
48716513|NCT00966875|156813519|FG008|Part A|Withdrawal by Subject|1|||
48716514|NCT00966875|156813511|FG000|Part A|Protocol Violation|0|||
48716515|NCT00966875|156813512|FG001|Part A|Protocol Violation|0|||
48716516|NCT00966875|156813513|FG002|Part A|Protocol Violation|0|||
48716517|NCT00966875|156813514|FG003|Part A|Protocol Violation|0|||
48716518|NCT00966875|156813515|FG004|Part A|Protocol Violation|0|||
48716519|NCT00966875|156813516|FG005|Part A|Protocol Violation|0|||
48716520|NCT00966875|156813517|FG006|Part A|Protocol Violation|2|||
48716521|NCT00966875|156813518|FG007|Part A|Protocol Violation|1|||
48716522|NCT00966875|156813519|FG008|Part A|Protocol Violation|1|||
48716523|NCT00966875|156813511|FG000|Part B|Adverse Event|0|||
48716524|NCT00966875|156813512|FG001|Part B|Adverse Event|1|||
48716525|NCT00966875|156813513|FG002|Part B|Adverse Event|1|||
48716526|NCT00966875|156813514|FG003|Part B|Adverse Event|0|||
48716527|NCT00966875|156813515|FG004|Part B|Adverse Event|1|||
48716528|NCT00966875|156813516|FG005|Part B|Adverse Event|0|||
48716529|NCT00966875|156813517|FG006|Part B|Adverse Event|5|||
48716530|NCT00966875|156813518|FG007|Part B|Adverse Event|2|||
48716531|NCT00966875|156813519|FG008|Part B|Adverse Event|2|||
48716532|NCT00966875|156813511|FG000|Part B|Death|0|||
48716533|NCT00966875|156813512|FG001|Part B|Death|0|||
48716534|NCT00966875|156813513|FG002|Part B|Death|1|||
48716535|NCT00966875|156813514|FG003|Part B|Death|0|||
48716536|NCT00966875|156813515|FG004|Part B|Death|0|||
48716537|NCT00966875|156813516|FG005|Part B|Death|0|||
48716538|NCT00966875|156813517|FG006|Part B|Death|0|||
48716539|NCT00966875|156813518|FG007|Part B|Death|1|||
48716540|NCT00966875|156813519|FG008|Part B|Death|0|||
48716541|NCT00966875|156813511|FG000|Part B|Lack of Efficacy|2|||
48716542|NCT00966875|156813512|FG001|Part B|Lack of Efficacy|1|||
48716543|NCT00966875|156813513|FG002|Part B|Lack of Efficacy|1|||
48716544|NCT00966875|156813514|FG003|Part B|Lack of Efficacy|1|||
48497650|NCT04700449|156016114|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
48716545|NCT00966875|156813515|FG004|Part B|Lack of Efficacy|2|||
48716546|NCT00966875|156813516|FG005|Part B|Lack of Efficacy|3|||
48716547|NCT00966875|156813517|FG006|Part B|Lack of Efficacy|12|||
48716548|NCT00966875|156813518|FG007|Part B|Lack of Efficacy|9|||
48716549|NCT00966875|156813519|FG008|Part B|Lack of Efficacy|6|||
48716550|NCT00966875|156813511|FG000|Part B|Lost to Follow-up|0|||
48716551|NCT00966875|156813512|FG001|Part B|Lost to Follow-up|0|||
48716552|NCT00966875|156813513|FG002|Part B|Lost to Follow-up|0|||
48716553|NCT00966875|156813514|FG003|Part B|Lost to Follow-up|1|||
48716554|NCT00966875|156813515|FG004|Part B|Lost to Follow-up|0|||
48497651|NCT04700449|156016115|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
48716555|NCT00966875|156813516|FG005|Part B|Lost to Follow-up|0|||
48716556|NCT00966875|156813517|FG006|Part B|Lost to Follow-up|0|||
48716557|NCT00966875|156813518|FG007|Part B|Lost to Follow-up|0|||
48716558|NCT00966875|156813519|FG008|Part B|Lost to Follow-up|1|||
48716559|NCT00966875|156813511|FG000|Part B|Physician Decision|0|||
48716560|NCT00966875|156813512|FG001|Part B|Physician Decision|0|||
48716561|NCT00966875|156813513|FG002|Part B|Physician Decision|1|||
48716562|NCT00966875|156813514|FG003|Part B|Physician Decision|0|||
48716563|NCT00966875|156813515|FG004|Part B|Physician Decision|2|||
48716564|NCT00966875|156813516|FG005|Part B|Physician Decision|1|||
48716565|NCT00966875|156813517|FG006|Part B|Physician Decision|0|||
48716566|NCT00966875|156813518|FG007|Part B|Physician Decision|0|||
48814432|NCT01146574|157161846|FG003|Overall Study|Other reasons|0|||
48814433|NCT01146574|157161847|FG004|Overall Study|Other reasons|0|||
48814434|NCT01146574|157161848|FG005|Overall Study|Other reasons|0|||
48814435|NCT01146574|157161849|FG006|Overall Study|Other reasons|0|||
48814436|NCT01146574|157161843|FG000|Overall Study|Kidney transplant|0|||
48814437|NCT01146574|157161844|FG001|Overall Study|Kidney transplant|0|||
48814438|NCT01146574|157161845|FG002|Overall Study|Kidney transplant|1|||
48814439|NCT01146574|157161846|FG003|Overall Study|Kidney transplant|1|||
48814440|NCT01146574|157161847|FG004|Overall Study|Kidney transplant|0|||
48814441|NCT01146574|157161848|FG005|Overall Study|Kidney transplant|0|||
48814442|NCT01146574|157161849|FG006|Overall Study|Kidney transplant|0|||
48814443|NCT01146574|157161843|FG000|Overall Study|Withdrew consent|0|||
48814444|NCT01146574|157161844|FG001|Overall Study|Withdrew consent|0|||
48814445|NCT01146574|157161845|FG002|Overall Study|Withdrew consent|1|||
48814446|NCT01146574|157161846|FG003|Overall Study|Withdrew consent|1|||
48814447|NCT01146574|157161847|FG004|Overall Study|Withdrew consent|2|||
48814448|NCT01146574|157161848|FG005|Overall Study|Withdrew consent|1|||
48814449|NCT01146574|157161849|FG006|Overall Study|Withdrew consent|1|||
48814450|NCT02293837|157161850|FG000|Overall Study|Lost to Follow-up|0|||
48814451|NCT02293837|157161851|FG001|Overall Study|Lost to Follow-up|2|||
48814452|NCT02293837|157161852|FG002|Overall Study|Lost to Follow-up|1|||
48814453|NCT02293837|157161853|FG003|Overall Study|Lost to Follow-up|0|||
48814454|NCT02293837|157161850|FG000|Overall Study|Withdrawal by Subject|2|||
48814455|NCT02293837|157161851|FG001|Overall Study|Withdrawal by Subject|1|||
48814456|NCT02293837|157161852|FG002|Overall Study|Withdrawal by Subject|2|||
48814457|NCT02293837|157161853|FG003|Overall Study|Withdrawal by Subject|1|||
48814458|NCT02293837|157161850|FG000|Overall Study|COVID-19 Related|1|||
48814459|NCT02293837|157161851|FG001|Overall Study|COVID-19 Related|1|||
48814460|NCT02293837|157161852|FG002|Overall Study|COVID-19 Related|0|||
48814461|NCT02293837|157161853|FG003|Overall Study|COVID-19 Related|0|||
48814462|NCT02293837|157161850|FG000|Overall Study|Participant ill and could not be infused|0|||
48814463|NCT02293837|157161851|FG001|Overall Study|Participant ill and could not be infused|0|||
48814464|NCT02293837|157161852|FG002|Overall Study|Participant ill and could not be infused|1|||
48814465|NCT02293837|157161853|FG003|Overall Study|Participant ill and could not be infused|0|||
48497652|NCT04700449|156016116|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
48497653|NCT04700449|156016117|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
48716567|NCT00966875|156813519|FG008|Part B|Physician Decision|2|||
48716568|NCT00966875|156813511|FG000|Part B|Sponsor Decision|1|||
48716569|NCT00966875|156813512|FG001|Part B|Sponsor Decision|0|||
48716570|NCT00966875|156813513|FG002|Part B|Sponsor Decision|0|||
48716571|NCT00966875|156813514|FG003|Part B|Sponsor Decision|0|||
48716572|NCT00966875|156813515|FG004|Part B|Sponsor Decision|0|||
48716573|NCT00966875|156813516|FG005|Part B|Sponsor Decision|1|||
48716574|NCT00966875|156813517|FG006|Part B|Sponsor Decision|0|||
48716575|NCT00966875|156813518|FG007|Part B|Sponsor Decision|2|||
48716576|NCT00966875|156813519|FG008|Part B|Sponsor Decision|1|||
48716577|NCT00966875|156813511|FG000|Part B|Withdrawal by Subject|2|||
48716578|NCT00966875|156813512|FG001|Part B|Withdrawal by Subject|1|||
48716579|NCT00966875|156813513|FG002|Part B|Withdrawal by Subject|2|||
48716580|NCT00966875|156813514|FG003|Part B|Withdrawal by Subject|1|||
48716581|NCT00966875|156813515|FG004|Part B|Withdrawal by Subject|2|||
48716582|NCT00966875|156813516|FG005|Part B|Withdrawal by Subject|1|||
48716583|NCT00966875|156813517|FG006|Part B|Withdrawal by Subject|4|||
48716584|NCT00966875|156813518|FG007|Part B|Withdrawal by Subject|5|||
48716585|NCT00966875|156813519|FG008|Part B|Withdrawal by Subject|5|||
48716586|NCT00966875|156813511|FG000|Part B|Entry Criteria|0|||
48716587|NCT00966875|156813512|FG001|Part B|Entry Criteria|0|||
48716588|NCT00966875|156813513|FG002|Part B|Entry Criteria|0|||
48716589|NCT00966875|156813514|FG003|Part B|Entry Criteria|0|||
48716590|NCT00966875|156813515|FG004|Part B|Entry Criteria|0|||
48716591|NCT00966875|156813516|FG005|Part B|Entry Criteria|0|||
48716592|NCT00966875|156813517|FG006|Part B|Entry Criteria|1|||
48716593|NCT00966875|156813518|FG007|Part B|Entry Criteria|0|||
48716594|NCT00966875|156813519|FG008|Part B|Entry Criteria|1|||
48716595|NCT01625260|156813520|FG000|Overall Study|Adverse Event|3|||
48814466|NCT00786474|157161854|FG000|Overall Study|Death|5|||
48814467|NCT00786474|157161855|FG001|Overall Study|Death|4|||
48814468|NCT00786474|157161854|FG000|Overall Study|Withdrawal by Subject|23|||
48814469|NCT00786474|157161855|FG001|Overall Study|Withdrawal by Subject|31|||
48716596|NCT01625260|156813521|FG001|Overall Study|Adverse Event|0|||
48716597|NCT01625260|156813520|FG000|Overall Study|Study Terminated by Investigator|2|||
48716598|NCT01625260|156813521|FG001|Overall Study|Study Terminated by Investigator|0|||
48716599|NCT01625260|156813520|FG000|Overall Study|Disease Progression|2|||
48716600|NCT01625260|156813521|FG001|Overall Study|Disease Progression|0|||
48716601|NCT01625260|156813520|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
48716602|NCT01625260|156813521|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
48716603|NCT02123472|156813522|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
48814470|NCT00786474|157161854|FG000|Overall Study|Lost to Follow-up|3|||
48814471|NCT00786474|157161855|FG001|Overall Study|Lost to Follow-up|3|||
48814472|NCT00786474|157161854|FG000|Overall Study|Physician Decision|2|||
48497654|NCT04700449|156016114|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
48814473|NCT00786474|157161855|FG001|Overall Study|Physician Decision|1|||
48814474|NCT00786474|157161854|FG000|Overall Study|Other|4|||
48814475|NCT00786474|157161855|FG001|Overall Study|Other|4|||
48814476|NCT00849680|157161856|FG000|Overall Study|Adverse Event|0|||
48814477|NCT00849680|157161857|FG001|Overall Study|Adverse Event|0|||
48814478|NCT00849680|157161858|FG002|Overall Study|Adverse Event|0|||
48814479|NCT00849680|157161859|FG003|Overall Study|Adverse Event|0|||
48814480|NCT00849680|157161860|FG004|Overall Study|Adverse Event|0|||
48814481|NCT00849680|157161861|FG005|Overall Study|Adverse Event|0|||
48814482|NCT00849680|157161862|FG006|Overall Study|Adverse Event|2|||
48814483|NCT00849680|157161863|FG007|Overall Study|Adverse Event|0|||
48814484|NCT00849680|157161856|FG000|Overall Study|Lost to Follow-up|7|||
48814485|NCT00849680|157161857|FG001|Overall Study|Lost to Follow-up|3|||
48814486|NCT00849680|157161858|FG002|Overall Study|Lost to Follow-up|12|||
48814487|NCT00849680|157161859|FG003|Overall Study|Lost to Follow-up|11|||
48814488|NCT00849680|157161860|FG004|Overall Study|Lost to Follow-up|8|||
48814489|NCT00849680|157161861|FG005|Overall Study|Lost to Follow-up|11|||
48814490|NCT00849680|157161862|FG006|Overall Study|Lost to Follow-up|12|||
48814491|NCT00849680|157161863|FG007|Overall Study|Lost to Follow-up|5|||
48814492|NCT00849680|157161856|FG000|Overall Study|Subject moved|1|||
48814493|NCT00849680|157161857|FG001|Overall Study|Subject moved|0|||
48814494|NCT00849680|157161858|FG002|Overall Study|Subject moved|3|||
48814495|NCT00849680|157161859|FG003|Overall Study|Subject moved|1|||
48814496|NCT00849680|157161860|FG004|Overall Study|Subject moved|0|||
48814497|NCT00849680|157161861|FG005|Overall Study|Subject moved|2|||
48814498|NCT00849680|157161862|FG006|Overall Study|Subject moved|2|||
48814499|NCT00849680|157161863|FG007|Overall Study|Subject moved|2|||
48814500|NCT00849680|157161856|FG000|Overall Study|Withdrawal by Subject|2|||
48814501|NCT00849680|157161857|FG001|Overall Study|Withdrawal by Subject|0|||
48814502|NCT00849680|157161858|FG002|Overall Study|Withdrawal by Subject|0|||
48814503|NCT00849680|157161859|FG003|Overall Study|Withdrawal by Subject|2|||
48814504|NCT00849680|157161860|FG004|Overall Study|Withdrawal by Subject|2|||
48814505|NCT00849680|157161861|FG005|Overall Study|Withdrawal by Subject|2|||
48497655|NCT04700449|156016115|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
48497656|NCT04700449|156016116|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
48814506|NCT00849680|157161862|FG006|Overall Study|Withdrawal by Subject|1|||
48814507|NCT00849680|157161863|FG007|Overall Study|Withdrawal by Subject|1|||
48814508|NCT00849680|157161856|FG000|Overall Study|Subject unable to comply with protocol|1|||
48814509|NCT00849680|157161857|FG001|Overall Study|Subject unable to comply with protocol|0|||
48814510|NCT00849680|157161858|FG002|Overall Study|Subject unable to comply with protocol|0|||
48814511|NCT00849680|157161859|FG003|Overall Study|Subject unable to comply with protocol|0|||
48814512|NCT00849680|157161860|FG004|Overall Study|Subject unable to comply with protocol|0|||
48814513|NCT00849680|157161861|FG005|Overall Study|Subject unable to comply with protocol|0|||
48814514|NCT00849680|157161862|FG006|Overall Study|Subject unable to comply with protocol|0|||
48814515|NCT00849680|157161863|FG007|Overall Study|Subject unable to comply with protocol|0|||
48814516|NCT01265823|157161871|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
48814517|NCT01265823|157161871|FG000|Overall Study|Failure to Return|4|||
48814518|NCT01265823|157161871|FG000|Overall Study|Protocol Violation|1|||
48814519|NCT01265823|157161871|FG000|Overall Study|Participant Request|1|||
48814520|NCT04320615|157161872|FG000|Overall Study|Withdrawal by Subject|4|||
48814521|NCT04320615|157161873|FG001|Overall Study|Withdrawal by Subject|10|||
48814522|NCT04320615|157161872|FG000|Overall Study|Physician Decision|2|||
48814523|NCT04320615|157161873|FG001|Overall Study|Physician Decision|0|||
48814524|NCT04320615|157161872|FG000|Overall Study|Other|2|||
48814525|NCT04320615|157161873|FG001|Overall Study|Other|0|||
48814526|NCT04320615|157161872|FG000|Overall Study|Lost to Follow-up|5|||
48814527|NCT04320615|157161873|FG001|Overall Study|Lost to Follow-up|23|||
48814528|NCT04320615|157161872|FG000|Overall Study|Death|35|||
48497657|NCT04700449|156016117|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
48497658|NCT04700449|156016114|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
48497659|NCT04700449|156016115|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
48497660|NCT04700449|156016116|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
48497661|NCT04700449|156016117|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
48497662|NCT04700449|156016114|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
48497663|NCT04700449|156016115|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
48497664|NCT04700449|156016116|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
48814529|NCT04320615|157161873|FG001|Overall Study|Death|71|||
48814530|NCT01213173|157161884|FG000|Overall Study|Protocol Violation|2|||
48814531|NCT01213173|157161885|FG001|Overall Study|Protocol Violation|0|||
48814532|NCT01213173|157161884|FG000|Overall Study|Adverse Event|4|||
48814533|NCT01213173|157161885|FG001|Overall Study|Adverse Event|8|||
48814534|NCT01213173|157161884|FG000|Overall Study|Withdrawal by Subject|5|||
48814535|NCT01213173|157161885|FG001|Overall Study|Withdrawal by Subject|5|||
48814536|NCT01213173|157161884|FG000|Overall Study|Incorrect Enrollment|1|||
48814537|NCT01213173|157161885|FG001|Overall Study|Incorrect Enrollment|3|||
48814538|NCT00581113|157163500|FG000|Overall Study|Withdrawal by Subject|0|||
48814539|NCT00581113|157163501|FG001|Overall Study|Withdrawal by Subject|1|||
48814540|NCT04781647|157163512|FG000|Overall Study|Study terminated by Sponsor|11|||
48814541|NCT04781647|157163513|FG001|Overall Study|Study terminated by Sponsor|9|||
48814542|NCT04781647|157163514|FG002|Overall Study|Study terminated by Sponsor|9|||
48814543|NCT04781647|157163512|FG000|Overall Study|Withdrawal by Subject|1|||
48814544|NCT04781647|157163513|FG001|Overall Study|Withdrawal by Subject|2|||
48814545|NCT04781647|157163514|FG002|Overall Study|Withdrawal by Subject|0|||
48814546|NCT04781647|157163512|FG000|Overall Study|Adverse Event|0|||
48814547|NCT04781647|157163513|FG001|Overall Study|Adverse Event|1|||
48814548|NCT04781647|157163514|FG002|Overall Study|Adverse Event|1|||
48814549|NCT04781647|157163512|FG000|Overall Study|Protocol Violation|1|||
48814550|NCT04781647|157163513|FG001|Overall Study|Protocol Violation|0|||
48814551|NCT04781647|157163514|FG002|Overall Study|Protocol Violation|0|||
48814552|NCT04781647|157163512|FG000|Overall Study|Pregnancy|0|||
48814553|NCT04781647|157163513|FG001|Overall Study|Pregnancy|0|||
48716604|NCT02123472|156813523|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
48716605|NCT03560518|156813524|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
48716606|NCT03560518|156813525|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
48716607|NCT03560518|156813526|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
48716608|NCT03560518|156813524|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
48716609|NCT03560518|156813525|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
48716610|NCT03560518|156813526|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
48716611|NCT03560518|156813524|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48716612|NCT03560518|156813525|FG001|Double Blind Treatment Period|Protocol Violation|2|||
48716613|NCT03560518|156813526|FG002|Double Blind Treatment Period|Protocol Violation|0|||
48716614|NCT03560518|156813524|FG000|Double Blind Treatment Period|Pregnancy|0|||
48716615|NCT03560518|156813525|FG001|Double Blind Treatment Period|Pregnancy|2|||
48716616|NCT03560518|156813526|FG002|Double Blind Treatment Period|Pregnancy|0|||
48716617|NCT03560518|156813524|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
48716618|NCT03560518|156813525|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
48716619|NCT03560518|156813526|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
48716620|NCT03560518|156813524|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
48716621|NCT03560518|156813525|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
48716622|NCT03560518|156813526|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
48716623|NCT03560518|156813524|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
48716624|NCT03560518|156813525|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
48716625|NCT03560518|156813526|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
48716626|NCT03560518|156813524|FG000|Double Blind Treatment Period|Adverse Event|0|||
48716627|NCT03560518|156813525|FG001|Double Blind Treatment Period|Adverse Event|3|||
48716628|NCT03560518|156813526|FG002|Double Blind Treatment Period|Adverse Event|1|||
48716629|NCT01128621|156813527|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
48716630|NCT01128621|156813528|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
48716631|NCT02745145|156813529|FG000|Overall Study|Adverse Event|1|||
48716632|NCT02745145|156813530|FG001|Overall Study|Adverse Event|0|||
48716633|NCT02745145|156813531|FG002|Overall Study|Adverse Event|0|||
48716634|NCT02745145|156813529|FG000|Overall Study|Death|0|||
48716635|NCT02745145|156813530|FG001|Overall Study|Death|1|||
48716636|NCT02745145|156813531|FG002|Overall Study|Death|0|||
48716637|NCT02745145|156813529|FG000|Overall Study|Progressive disease|0|||
48716638|NCT02745145|156813530|FG001|Overall Study|Progressive disease|0|||
48716639|NCT02745145|156813531|FG002|Overall Study|Progressive disease|1|||
48716640|NCT02745145|156813529|FG000|Overall Study|Withdrew consent|1|||
48716641|NCT02745145|156813530|FG001|Overall Study|Withdrew consent|1|||
48716642|NCT02745145|156813531|FG002|Overall Study|Withdrew consent|1|||
48716643|NCT02745145|156813529|FG000|Overall Study|Study Termination|8|||
48716644|NCT02745145|156813530|FG001|Overall Study|Study Termination|3|||
48716645|NCT02745145|156813531|FG002|Overall Study|Study Termination|7|||
48716646|NCT00796445|156813532|FG000|Overall Study|Protocol Violation|5|||
48716647|NCT00796445|156813533|FG001|Overall Study|Protocol Violation|3|||
48814554|NCT04781647|157163514|FG002|Overall Study|Pregnancy|1|||
48814555|NCT04781647|157163512|FG000|Overall Study|Virology rebounded|1|||
48497665|NCT04700449|156016117|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
48814556|NCT04781647|157163513|FG001|Overall Study|Virology rebounded|0|||
48497666|NCT04700449|156016114|FG000|Stage 1: Double-Blind Period|Other|0|||
48497667|NCT04700449|156016115|FG001|Stage 1: Double-Blind Period|Other|0|||
48814557|NCT04781647|157163514|FG002|Overall Study|Virology rebounded|0|||
48716648|NCT00796445|156813532|FG000|Overall Study|Adverse event, serious fatal|10|||
48716649|NCT00796445|156813533|FG001|Overall Study|Adverse event, serious fatal|5|||
48716650|NCT00796445|156813532|FG000|Overall Study|Adverse event, non-fatal|4|||
48814558|NCT00649389|157163515|FG000|Overall Study|Adverse Event|22|||
48814559|NCT00649389|157163516|FG001|Overall Study|Adverse Event|46|||
48497668|NCT04700449|156016116|FG002|Stage 1: Double-Blind Period|Other|1|||
48497669|NCT04700449|156016117|FG003|Stage 1: Double-Blind Period|Other|0|||
48497670|NCT04700449|156016114|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
48716651|NCT00796445|156813533|FG001|Overall Study|Adverse event, non-fatal|0|||
48716652|NCT00796445|156813532|FG000|Overall Study|Disease progression/recurrence|537|||
48716653|NCT00796445|156813533|FG001|Overall Study|Disease progression/recurrence|268|||
48716654|NCT00796445|156813532|FG000|Overall Study|Other|10|||
48716655|NCT00796445|156813533|FG001|Overall Study|Other|7|||
48716656|NCT00796445|156813532|FG000|Overall Study|Withdrawal by Subject|18|||
48716657|NCT00796445|156813533|FG001|Overall Study|Withdrawal by Subject|9|||
48716658|NCT00796445|156813532|FG000|Overall Study|Invalid Informed Consent Form|1|||
48716659|NCT00796445|156813533|FG001|Overall Study|Invalid Informed Consent Form|0|||
48716660|NCT00913458|156813534|FG000|Phase 1|Non-Responder|54|||
48716661|NCT00913458|156813535|FG001|Phase 1|Non-Responder|0|||
48716662|NCT00913458|156813536|FG002|Phase 1|Non-Responder|0|||
48716663|NCT00913458|156813537|FG003|Phase 1|Non-Responder|0|||
48716664|NCT00913458|156813538|FG004|Phase 1|Non-Responder|0|||
48716665|NCT00913458|156813539|FG005|Phase 1|Non-Responder|0|||
48716666|NCT00913458|156813540|FG006|Phase 1|Non-Responder|0|||
48716667|NCT00913458|156813534|FG000|Phase 1|Subject Request|17|||
48716668|NCT00913458|156813535|FG001|Phase 1|Subject Request|0|||
48497671|NCT04700449|156016115|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
48497672|NCT04700449|156016116|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
48497673|NCT04700449|156016117|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
48497674|NCT04700449|156016114|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
48497675|NCT04700449|156016115|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
48497676|NCT04700449|156016116|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
48497677|NCT04700449|156016117|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
48497678|NCT04700449|156016114|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
48497679|NCT04700449|156016115|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
48497680|NCT04700449|156016116|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
48497681|NCT04700449|156016117|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
48497682|NCT04700449|156016114|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
48497683|NCT04700449|156016115|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
48497684|NCT04700449|156016116|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
48497685|NCT04700449|156016117|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
48716669|NCT00913458|156813536|FG002|Phase 1|Subject Request|0|||
48716670|NCT00913458|156813537|FG003|Phase 1|Subject Request|0|||
48716671|NCT00913458|156813538|FG004|Phase 1|Subject Request|0|||
48716672|NCT00913458|156813539|FG005|Phase 1|Subject Request|0|||
48716673|NCT00913458|156813540|FG006|Phase 1|Subject Request|0|||
48716674|NCT00913458|156813534|FG000|Phase 1|Adverse Event|20|||
48716675|NCT00913458|156813535|FG001|Phase 1|Adverse Event|0|||
48716676|NCT00913458|156813536|FG002|Phase 1|Adverse Event|0|||
48716677|NCT00913458|156813537|FG003|Phase 1|Adverse Event|0|||
48716678|NCT00913458|156813538|FG004|Phase 1|Adverse Event|0|||
48716679|NCT00913458|156813539|FG005|Phase 1|Adverse Event|0|||
48716680|NCT00913458|156813540|FG006|Phase 1|Adverse Event|0|||
48716681|NCT00913458|156813534|FG000|Phase 1|Lost to Follow-up|2|||
48716682|NCT00913458|156813535|FG001|Phase 1|Lost to Follow-up|0|||
48716683|NCT00913458|156813536|FG002|Phase 1|Lost to Follow-up|0|||
48716684|NCT00913458|156813537|FG003|Phase 1|Lost to Follow-up|0|||
48716685|NCT00913458|156813538|FG004|Phase 1|Lost to Follow-up|0|||
48716686|NCT00913458|156813539|FG005|Phase 1|Lost to Follow-up|0|||
48716687|NCT00913458|156813540|FG006|Phase 1|Lost to Follow-up|0|||
48497686|NCT04700449|156016114|FG000|Stage 2 Sub-study 1|Other|1|||
48497687|NCT04700449|156016115|FG001|Stage 2 Sub-study 1|Other|2|||
48497688|NCT04700449|156016116|FG002|Stage 2 Sub-study 1|Other|0|||
48497689|NCT04700449|156016117|FG003|Stage 2 Sub-study 1|Other|0|||
48497690|NCT04700449|156016114|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
48497691|NCT04700449|156016115|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
48497692|NCT04700449|156016116|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
48497693|NCT04700449|156016117|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
48497694|NCT04700449|156016114|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
48497695|NCT04700449|156016115|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
48497696|NCT04700449|156016116|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
48497697|NCT04700449|156016117|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
48497698|NCT04700449|156016114|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
48497699|NCT04700449|156016115|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
48716688|NCT00913458|156813534|FG000|Phase 1|Protocol Violation|10|||
48716689|NCT00913458|156813535|FG001|Phase 1|Protocol Violation|0|||
48716690|NCT00913458|156813536|FG002|Phase 1|Protocol Violation|0|||
48716691|NCT00913458|156813537|FG003|Phase 1|Protocol Violation|0|||
48716692|NCT00913458|156813538|FG004|Phase 1|Protocol Violation|0|||
48716693|NCT00913458|156813539|FG005|Phase 1|Protocol Violation|0|||
48716694|NCT00913458|156813540|FG006|Phase 1|Protocol Violation|0|||
48716695|NCT00913458|156813534|FG000|Phase 1|Sponsor|2|||
48497700|NCT04700449|156016116|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
48497701|NCT04700449|156016117|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
48497702|NCT04700449|156016114|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
48497703|NCT04700449|156016115|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
48716696|NCT00913458|156813535|FG001|Phase 1|Sponsor|0|||
48716697|NCT00913458|156813536|FG002|Phase 1|Sponsor|0|||
48716698|NCT00913458|156813537|FG003|Phase 1|Sponsor|0|||
48716699|NCT00913458|156813538|FG004|Phase 1|Sponsor|0|||
48497704|NCT04700449|156016116|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
48497705|NCT04700449|156016117|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
48497706|NCT04700449|156016114|FG000|Stage 2 Sub-study 2|Other|0|||
48497707|NCT04700449|156016115|FG001|Stage 2 Sub-study 2|Other|0|||
48497708|NCT04700449|156016116|FG002|Stage 2 Sub-study 2|Other|0|||
48497709|NCT04700449|156016117|FG003|Stage 2 Sub-study 2|Other|5|||
48497710|NCT03738332|156016118|FG000|Overall Study|Withdrawal by Subject|1|||
48497711|NCT00502775|156016119|FG000|Overall Study|Adverse Event|1|||
48497712|NCT00502775|156016120|FG001|Overall Study|Adverse Event|2|||
48497713|NCT00502775|156016121|FG002|Overall Study|Adverse Event|1|||
48497714|NCT00502775|156016119|FG000|Overall Study|Protocol Violation|1|||
48497715|NCT00502775|156016120|FG001|Overall Study|Protocol Violation|5|||
48497716|NCT00502775|156016121|FG002|Overall Study|Protocol Violation|2|||
48497717|NCT00502775|156016119|FG000|Overall Study|Withdrawal by Subject|1|||
48497718|NCT00502775|156016120|FG001|Overall Study|Withdrawal by Subject|1|||
48497719|NCT00502775|156016121|FG002|Overall Study|Withdrawal by Subject|2|||
48497720|NCT00502775|156016119|FG000|Overall Study|Sponsor Terminated Study|1|||
48497721|NCT00502775|156016120|FG001|Overall Study|Sponsor Terminated Study|0|||
48497722|NCT00502775|156016121|FG002|Overall Study|Sponsor Terminated Study|1|||
48497723|NCT00502775|156016119|FG000|Overall Study|Non-compliance with eDiary|4|||
48497724|NCT00502775|156016120|FG001|Overall Study|Non-compliance with eDiary|1|||
48497725|NCT00502775|156016121|FG002|Overall Study|Non-compliance with eDiary|1|||
48497726|NCT00502775|156016119|FG000|Overall Study|Subject unable to swallow capsule|1|||
48497727|NCT00502775|156016120|FG001|Overall Study|Subject unable to swallow capsule|0|||
48497728|NCT00502775|156016121|FG002|Overall Study|Subject unable to swallow capsule|1|||
48497729|NCT00502775|156016119|FG000|Overall Study|Logpad compliance <80%|1|||
48497730|NCT00502775|156016120|FG001|Overall Study|Logpad compliance <80%|0|||
48497731|NCT00502775|156016121|FG002|Overall Study|Logpad compliance <80%|0|||
48497732|NCT00502775|156016119|FG000|Overall Study|Randomized in error|0|||
48497733|NCT00502775|156016120|FG001|Overall Study|Randomized in error|1|||
48497734|NCT00502775|156016121|FG002|Overall Study|Randomized in error|1|||
48497735|NCT00502775|156016119|FG000|Overall Study|Non-compliance|0|||
48497736|NCT00502775|156016120|FG001|Overall Study|Non-compliance|2|||
48497737|NCT00502775|156016121|FG002|Overall Study|Non-compliance|2|||
48497738|NCT00502775|156016119|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
48497739|NCT00502775|156016120|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
48497740|NCT00502775|156016121|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
48497741|NCT00502775|156016119|FG000|Overall Study|Declining pollen counts|0|||
48497742|NCT00502775|156016120|FG001|Overall Study|Declining pollen counts|1|||
48497743|NCT00502775|156016121|FG002|Overall Study|Declining pollen counts|1|||
48497744|NCT00502775|156016119|FG000|Overall Study|Subject in jail|0|||
48497745|NCT00502775|156016120|FG001|Overall Study|Subject in jail|1|||
48497746|NCT00502775|156016121|FG002|Overall Study|Subject in jail|0|||
48497747|NCT00502775|156016119|FG000|Overall Study|Subject took disallowed drug|0|||
48497748|NCT00502775|156016120|FG001|Overall Study|Subject took disallowed drug|0|||
48497749|NCT00502775|156016121|FG002|Overall Study|Subject took disallowed drug|1|||
48497750|NCT00553540|156016126|FG000|Overall Study|discharged after first visit|2|||
48497751|NCT00553540|156016127|FG001|Overall Study|discharged after first visit|5|||
48497752|NCT00576901|156016128|FG000|Overall Study|Withdrawal by Subject|1|||
48497753|NCT00576901|156016128|FG000|Overall Study|Disease course|1|||
48497754|NCT00576901|156016128|FG000|Overall Study|Protocol Violation|1|||
48497755|NCT01755858|156016131|FG000|Overall Study|Adverse Event|1|||
48497756|NCT01755858|156016132|FG001|Overall Study|Adverse Event|1|||
48497757|NCT02396381|156016133|FG000|Overall Study|Adverse Event|3|||
48497758|NCT02396381|156016134|FG001|Overall Study|Adverse Event|2|||
48497759|NCT02396381|156016133|FG000|Overall Study|Withdrawal by Subject|33|||
48497760|NCT02396381|156016134|FG001|Overall Study|Withdrawal by Subject|24|||
48497761|NCT02396381|156016133|FG000|Overall Study|Lost to Follow-up|49|||
48497762|NCT02396381|156016134|FG001|Overall Study|Lost to Follow-up|31|||
48497763|NCT02396381|156016133|FG000|Overall Study|Protocol Violation|1|||
48497764|NCT02396381|156016134|FG001|Overall Study|Protocol Violation|0|||
48598475|NCT03410992|156385244|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48598476|NCT03410992|156385245|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48716700|NCT00913458|156813539|FG005|Phase 1|Sponsor|0|||
48497765|NCT02396381|156016133|FG000|Overall Study|Site terminated by sponsor|7|||
48497766|NCT02396381|156016134|FG001|Overall Study|Site terminated by sponsor|8|||
48497767|NCT02396381|156016133|FG000|Overall Study|Physician Decision|5|||
48716701|NCT00913458|156813540|FG006|Phase 1|Sponsor|0|||
48716702|NCT00913458|156813534|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
48497768|NCT02396381|156016134|FG001|Overall Study|Physician Decision|5|||
48497769|NCT02396381|156016133|FG000|Overall Study|Pregnancy|2|||
48716703|NCT00913458|156813535|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
48497770|NCT02396381|156016134|FG001|Overall Study|Pregnancy|0|||
48497771|NCT02396381|156016133|FG000|Overall Study|Non-compliance with study procedures|1|||
48497772|NCT02396381|156016134|FG001|Overall Study|Non-compliance with study procedures|0|||
48497773|NCT02396381|156016133|FG000|Overall Study|Moved out of town/state|1|||
48497774|NCT02396381|156016134|FG001|Overall Study|Moved out of town/state|3|||
48497775|NCT02396381|156016133|FG000|Overall Study|Could not complete visit|1|||
48497776|NCT02396381|156016134|FG001|Overall Study|Could not complete visit|0|||
48497777|NCT02396381|156016133|FG000|Overall Study|Possible conflict of interest|1|||
48497778|NCT02396381|156016134|FG001|Overall Study|Possible conflict of interest|0|||
48497779|NCT02396381|156016133|FG000|Overall Study|Randomization/Screening Error|3|||
48497780|NCT02396381|156016134|FG001|Overall Study|Randomization/Screening Error|1|||
48497781|NCT00265759|156016135|FG000|Overall Study|Withdrawal by Subject|0|||
48497782|NCT00265759|156016136|FG001|Overall Study|Withdrawal by Subject|1|||
48497783|NCT00265759|156016137|FG002|Overall Study|Withdrawal by Subject|2|||
48497784|NCT00265759|156016138|FG003|Overall Study|Withdrawal by Subject|2|||
48497785|NCT00265759|156016135|FG000|Overall Study|Cancel|0|||
48497786|NCT00265759|156016136|FG001|Overall Study|Cancel|0|||
48497787|NCT00265759|156016137|FG002|Overall Study|Cancel|0|||
48497788|NCT00265759|156016138|FG003|Overall Study|Cancel|3|||
48497789|NCT00265759|156016135|FG000|Overall Study|Ineligible|0|||
48497790|NCT00265759|156016136|FG001|Overall Study|Ineligible|0|||
48598477|NCT03410992|156385246|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48598478|NCT03410992|156385247|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
48497791|NCT00265759|156016137|FG002|Overall Study|Ineligible|0|||
48598479|NCT03410992|156385237|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
48598480|NCT03410992|156385238|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598481|NCT03410992|156385239|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598482|NCT03410992|156385240|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598483|NCT03410992|156385241|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598484|NCT03410992|156385242|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598485|NCT03410992|156385243|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598486|NCT03410992|156385244|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598487|NCT03410992|156385245|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598488|NCT03410992|156385246|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48598489|NCT03410992|156385247|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
48716704|NCT00913458|156813536|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
48716705|NCT00913458|156813537|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
48716706|NCT00913458|156813538|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
48716707|NCT00913458|156813539|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
48716708|NCT00913458|156813540|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
48716709|NCT00913458|156813534|FG000|Phase 2|Non-Responder|0|||
48716710|NCT00913458|156813535|FG001|Phase 2|Non-Responder|5|||
48716711|NCT00913458|156813536|FG002|Phase 2|Non-Responder|7|||
48716712|NCT00913458|156813537|FG003|Phase 2|Non-Responder|12|||
48716713|NCT00913458|156813538|FG004|Phase 2|Non-Responder|0|||
48716714|NCT00913458|156813539|FG005|Phase 2|Non-Responder|0|||
48716715|NCT00913458|156813540|FG006|Phase 2|Non-Responder|0|||
48716716|NCT00913458|156813534|FG000|Phase 2|Subject Request|0|||
48716717|NCT00913458|156813535|FG001|Phase 2|Subject Request|0|||
48716718|NCT00913458|156813536|FG002|Phase 2|Subject Request|1|||
48716719|NCT00913458|156813537|FG003|Phase 2|Subject Request|2|||
48716720|NCT00913458|156813538|FG004|Phase 2|Subject Request|0|||
48716721|NCT00913458|156813539|FG005|Phase 2|Subject Request|0|||
48497792|NCT00265759|156016138|FG003|Overall Study|Ineligible|1|||
48497793|NCT00265759|156016135|FG000|Overall Study|Bilateral disease|0|||
48497794|NCT00265759|156016136|FG001|Overall Study|Bilateral disease|0|||
48497795|NCT00265759|156016137|FG002|Overall Study|Bilateral disease|0|||
48716722|NCT00913458|156813540|FG006|Phase 2|Subject Request|0|||
48716723|NCT00913458|156813534|FG000|Phase 2|Adverse Event|0|||
48497796|NCT00265759|156016138|FG003|Overall Study|Bilateral disease|2|||
48497797|NCT00265759|156016135|FG000|Overall Study|Discontinued due to intolerability|0|||
48497798|NCT00265759|156016136|FG001|Overall Study|Discontinued due to intolerability|0|||
48497799|NCT00265759|156016137|FG002|Overall Study|Discontinued due to intolerability|0|||
48497800|NCT00265759|156016138|FG003|Overall Study|Discontinued due to intolerability|1|||
48497801|NCT02309099|156016143|FG000|Overall Study|Adverse Event|2|||
48497802|NCT02309099|156016144|FG001|Overall Study|Adverse Event|0|||
48497803|NCT02016300|156016145|FG000|Overall Study|Lost to Follow-up|0|||
48497804|NCT02016300|156016146|FG001|Overall Study|Lost to Follow-up|3|||
48497805|NCT00356200|156016147|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
48497806|NCT00356200|156016148|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
48497807|NCT00356200|156016147|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
48497808|NCT00356200|156016148|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
48497809|NCT00635778|156016149|FG000|Overall Study|Adverse Event|1|||
48497810|NCT00635778|156016150|FG001|Overall Study|Adverse Event|0|||
48497811|NCT00635778|156016151|FG002|Overall Study|Adverse Event|0|||
48716724|NCT00913458|156813535|FG001|Phase 2|Adverse Event|3|||
48716725|NCT00913458|156813536|FG002|Phase 2|Adverse Event|0|||
48716726|NCT00913458|156813537|FG003|Phase 2|Adverse Event|1|||
48716727|NCT00913458|156813538|FG004|Phase 2|Adverse Event|0|||
48814560|NCT00649389|157163517|FG002|Overall Study|Adverse Event|38|||
48497812|NCT00635778|156016152|FG003|Overall Study|Adverse Event|3|||
48716728|NCT00913458|156813539|FG005|Phase 2|Adverse Event|0|||
48716729|NCT00913458|156813540|FG006|Phase 2|Adverse Event|0|||
48497813|NCT00635778|156016153|FG004|Overall Study|Adverse Event|3|||
48497814|NCT00635778|156016154|FG005|Overall Study|Adverse Event|6|||
48497815|NCT00635778|156016155|FG006|Overall Study|Adverse Event|1|||
48497816|NCT00635778|156016149|FG000|Overall Study|Withdrawal by Subject|0|||
48598490|NCT03410992|156385237|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
48716730|NCT00913458|156813534|FG000|Phase 2|Lost to Follow-up|0|||
48716731|NCT00913458|156813535|FG001|Phase 2|Lost to Follow-up|0|||
48814561|NCT00649389|157163518|FG003|Overall Study|Adverse Event|48|||
48814562|NCT00649389|157163515|FG000|Overall Study|Lost to Follow-up|15|||
48814563|NCT00649389|157163516|FG001|Overall Study|Lost to Follow-up|17|||
48814564|NCT00649389|157163517|FG002|Overall Study|Lost to Follow-up|21|||
48814565|NCT00649389|157163518|FG003|Overall Study|Lost to Follow-up|26|||
48814566|NCT00649389|157163515|FG000|Overall Study|Protocol Violation|11|||
48814567|NCT00649389|157163516|FG001|Overall Study|Protocol Violation|13|||
48814568|NCT00649389|157163517|FG002|Overall Study|Protocol Violation|9|||
48814569|NCT00649389|157163518|FG003|Overall Study|Protocol Violation|8|||
48814570|NCT00649389|157163515|FG000|Overall Study|Withdrawal by Subject|20|||
48814571|NCT00649389|157163516|FG001|Overall Study|Withdrawal by Subject|21|||
48814572|NCT00649389|157163517|FG002|Overall Study|Withdrawal by Subject|19|||
48814573|NCT00649389|157163518|FG003|Overall Study|Withdrawal by Subject|23|||
48814574|NCT00649389|157163515|FG000|Overall Study|Other|3|||
48814575|NCT00649389|157163516|FG001|Overall Study|Other|9|||
48814576|NCT00649389|157163517|FG002|Overall Study|Other|1|||
48814577|NCT00649389|157163518|FG003|Overall Study|Other|6|||
48814578|NCT01186328|157163519|FG000|Overall Study|Death|1|||
48814579|NCT01186328|157163520|FG001|Overall Study|Death|0|||
48814580|NCT01186328|157163521|FG002|Overall Study|Death|0|||
48814581|NCT04424290|157163524|FG000|Overall Study|Not treated|0|||
48814582|NCT04424290|157163525|FG001|Overall Study|Not treated|0|||
48814583|NCT04424290|157163526|FG002|Overall Study|Not treated|1|||
48814584|NCT04424290|157163527|FG003|Overall Study|Not treated|0|||
48716732|NCT00913458|156813536|FG002|Phase 2|Lost to Follow-up|0|||
48716733|NCT00913458|156813537|FG003|Phase 2|Lost to Follow-up|1|||
48716734|NCT00913458|156813538|FG004|Phase 2|Lost to Follow-up|0|||
48716735|NCT00913458|156813539|FG005|Phase 2|Lost to Follow-up|0|||
48716736|NCT00913458|156813540|FG006|Phase 2|Lost to Follow-up|0|||
48716737|NCT00913458|156813534|FG000|Phase 2|Protocol Violation|0|||
48716738|NCT00913458|156813535|FG001|Phase 2|Protocol Violation|2|||
48716739|NCT00913458|156813536|FG002|Phase 2|Protocol Violation|0|||
48716740|NCT00913458|156813537|FG003|Phase 2|Protocol Violation|0|||
48716741|NCT00913458|156813538|FG004|Phase 2|Protocol Violation|0|||
48716742|NCT00913458|156813539|FG005|Phase 2|Protocol Violation|0|||
48716743|NCT00913458|156813540|FG006|Phase 2|Protocol Violation|0|||
48716744|NCT00913458|156813534|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
48716745|NCT00913458|156813535|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
48716746|NCT00913458|156813536|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
48716747|NCT00913458|156813537|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
48716748|NCT00913458|156813538|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
48716749|NCT00913458|156813539|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
48716750|NCT00913458|156813540|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
48497817|NCT00635778|156016150|FG001|Overall Study|Withdrawal by Subject|0|||
48497818|NCT00635778|156016151|FG002|Overall Study|Withdrawal by Subject|0|||
48598491|NCT03410992|156385238|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
48598492|NCT03410992|156385239|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48598493|NCT03410992|156385240|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48598494|NCT03410992|156385241|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48598495|NCT03410992|156385242|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48598496|NCT03410992|156385243|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48598497|NCT03410992|156385244|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48598498|NCT03410992|156385245|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48598499|NCT03410992|156385246|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48497819|NCT00635778|156016152|FG003|Overall Study|Withdrawal by Subject|1|||
48497820|NCT00635778|156016153|FG004|Overall Study|Withdrawal by Subject|0|||
48598500|NCT03410992|156385247|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
48598501|NCT03410992|156385237|FG000|Week 16 Assessment|Incorrect escapers|0|||
48598502|NCT03410992|156385238|FG001|Week 16 Assessment|Incorrect escapers|6|||
48716751|NCT00913458|156813534|FG000|Phase 3|Adverse Event|0|||
48716752|NCT00913458|156813535|FG001|Phase 3|Adverse Event|0|||
48716753|NCT00913458|156813536|FG002|Phase 3|Adverse Event|0|||
48814585|NCT04424290|157163528|FG004|Overall Study|Not treated|1|||
48497821|NCT00635778|156016154|FG005|Overall Study|Withdrawal by Subject|1|||
48716754|NCT00913458|156813537|FG003|Phase 3|Adverse Event|0|||
48716755|NCT00913458|156813538|FG004|Phase 3|Adverse Event|5|||
48716756|NCT00913458|156813539|FG005|Phase 3|Adverse Event|4|||
48716757|NCT00913458|156813540|FG006|Phase 3|Adverse Event|1|||
48716758|NCT00913458|156813534|FG000|Phase 3|Lost to Follow-up|0|||
48814586|NCT04424290|157163524|FG000|Overall Study|Adverse Event|0|||
48814587|NCT04424290|157163525|FG001|Overall Study|Adverse Event|0|||
48716759|NCT00913458|156813535|FG001|Phase 3|Lost to Follow-up|0|||
48716760|NCT00913458|156813536|FG002|Phase 3|Lost to Follow-up|0|||
48716761|NCT00913458|156813537|FG003|Phase 3|Lost to Follow-up|0|||
48716762|NCT00913458|156813538|FG004|Phase 3|Lost to Follow-up|2|||
48716763|NCT00913458|156813539|FG005|Phase 3|Lost to Follow-up|0|||
48716764|NCT00913458|156813540|FG006|Phase 3|Lost to Follow-up|0|||
48716765|NCT00913458|156813534|FG000|Phase 3|Non-Responder|0|||
48716766|NCT00913458|156813535|FG001|Phase 3|Non-Responder|0|||
48716767|NCT00913458|156813536|FG002|Phase 3|Non-Responder|0|||
48716768|NCT00913458|156813537|FG003|Phase 3|Non-Responder|0|||
48716769|NCT00913458|156813538|FG004|Phase 3|Non-Responder|0|||
48716770|NCT00913458|156813539|FG005|Phase 3|Non-Responder|1|||
48716771|NCT00913458|156813540|FG006|Phase 3|Non-Responder|3|||
48716772|NCT00913458|156813534|FG000|Phase 3|Withdrawal by Subject|0|||
48716773|NCT00913458|156813535|FG001|Phase 3|Withdrawal by Subject|0|||
48716774|NCT00913458|156813536|FG002|Phase 3|Withdrawal by Subject|0|||
48716775|NCT00913458|156813537|FG003|Phase 3|Withdrawal by Subject|0|||
48716776|NCT00913458|156813538|FG004|Phase 3|Withdrawal by Subject|1|||
48716777|NCT00913458|156813539|FG005|Phase 3|Withdrawal by Subject|2|||
48716778|NCT00913458|156813540|FG006|Phase 3|Withdrawal by Subject|0|||
48716779|NCT00913458|156813534|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
48716780|NCT00913458|156813535|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
48716781|NCT00913458|156813536|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
48716782|NCT00913458|156813537|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
48716783|NCT00913458|156813538|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
48716784|NCT00913458|156813539|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
48716785|NCT00913458|156813540|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
48716786|NCT02338232|156813541|FG000|Overall Study|Screen Failure|3|||
48716787|NCT02338232|156813541|FG000|Overall Study|Withdrawal by Subject|6|||
48716788|NCT02338232|156813541|FG000|Overall Study|Adverse Event|2|||
48716789|NCT00992589|156813542|FG000|Open-Label Phase|Adverse Event|4|||
48716790|NCT00992589|156813543|FG001|Open-Label Phase|Adverse Event|0|||
48716791|NCT00992589|156813544|FG002|Open-Label Phase|Adverse Event|0|||
48716792|NCT00992589|156813545|FG003|Open-Label Phase|Adverse Event|0|||
48716793|NCT00992589|156813542|FG000|Open-Label Phase|Withdrawal by Subject|20|||
48716794|NCT00992589|156813543|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48716795|NCT00992589|156813544|FG002|Open-Label Phase|Withdrawal by Subject|0|||
48716796|NCT00992589|156813545|FG003|Open-Label Phase|Withdrawal by Subject|0|||
48716797|NCT00992589|156813542|FG000|Open-Label Phase|Lost to Follow-up|1|||
48716798|NCT00992589|156813543|FG001|Open-Label Phase|Lost to Follow-up|0|||
48716799|NCT00992589|156813544|FG002|Open-Label Phase|Lost to Follow-up|0|||
48716800|NCT00992589|156813545|FG003|Open-Label Phase|Lost to Follow-up|0|||
48716801|NCT00992589|156813542|FG000|Open-Label Phase|Protocol Violation|3|||
48716802|NCT00992589|156813543|FG001|Open-Label Phase|Protocol Violation|0|||
48716803|NCT00992589|156813544|FG002|Open-Label Phase|Protocol Violation|0|||
48716804|NCT00992589|156813545|FG003|Open-Label Phase|Protocol Violation|0|||
48716805|NCT00992589|156813542|FG000|Open-Label Phase|Physician Decision|4|||
48716806|NCT00992589|156813543|FG001|Open-Label Phase|Physician Decision|0|||
48716807|NCT00992589|156813544|FG002|Open-Label Phase|Physician Decision|0|||
48716808|NCT00992589|156813545|FG003|Open-Label Phase|Physician Decision|0|||
48716809|NCT00992589|156813542|FG000|Open-Label Phase|Other|45|||
48716810|NCT00992589|156813543|FG001|Open-Label Phase|Other|0|||
48716811|NCT00992589|156813544|FG002|Open-Label Phase|Other|0|||
48716812|NCT00992589|156813545|FG003|Open-Label Phase|Other|0|||
48716813|NCT00992589|156813542|FG000|Double-Blind Phase|Adverse Event|0|||
48716814|NCT00992589|156813543|FG001|Double-Blind Phase|Adverse Event|6|||
48716815|NCT00992589|156813544|FG002|Double-Blind Phase|Adverse Event|2|||
48716816|NCT00992589|156813545|FG003|Double-Blind Phase|Adverse Event|3|||
48716817|NCT00992589|156813542|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
48716818|NCT00992589|156813543|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
48716819|NCT00992589|156813544|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
48716820|NCT00992589|156813545|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
48716821|NCT00992589|156813542|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48716822|NCT00992589|156813543|FG001|Double-Blind Phase|Lost to Follow-up|0|||
48716823|NCT00992589|156813544|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48716824|NCT00992589|156813545|FG003|Double-Blind Phase|Lost to Follow-up|2|||
48716825|NCT00992589|156813542|FG000|Double-Blind Phase|Other|0|||
48716826|NCT00992589|156813543|FG001|Double-Blind Phase|Other|1|||
48716827|NCT00992589|156813544|FG002|Double-Blind Phase|Other|6|||
48716828|NCT00992589|156813545|FG003|Double-Blind Phase|Other|3|||
48716829|NCT03232333|156813546|FG000|Overall Study|Infection or Osteomyelitis|9|||
48716830|NCT03232333|156813546|FG000|Overall Study|Lost to Follow-up|4|||
48716831|NCT03232333|156813546|FG000|Overall Study|Withdrawal by Subject|2|||
48716832|NCT00422084|156813547|FG000|Overall Study|Adverse Event|21|||
48716833|NCT00422084|156813548|FG001|Overall Study|Adverse Event|7|||
48716834|NCT00422084|156813547|FG000|Overall Study|Withdrawal by Subject|12|||
48716835|NCT00422084|156813548|FG001|Overall Study|Withdrawal by Subject|9|||
48716836|NCT00422084|156813547|FG000|Overall Study|Lost to Follow-up|14|||
48716837|NCT00422084|156813548|FG001|Overall Study|Lost to Follow-up|9|||
48716838|NCT00422084|156813547|FG000|Overall Study|Protocol Violation|4|||
48716839|NCT00422084|156813548|FG001|Overall Study|Protocol Violation|1|||
48716840|NCT00422084|156813547|FG000|Overall Study|Lack of Efficacy|40|||
48716841|NCT00422084|156813548|FG001|Overall Study|Lack of Efficacy|42|||
48716842|NCT00422084|156813547|FG000|Overall Study|P. vivax infection|3|||
48716843|NCT00422084|156813548|FG001|Overall Study|P. vivax infection|6|||
48716844|NCT00422084|156813547|FG000|Overall Study|Cyesis|1|||
48716845|NCT00422084|156813548|FG001|Overall Study|Cyesis|0|||
48716846|NCT00422084|156813547|FG000|Overall Study|Withdrawn from study accidentally|1|||
48716847|NCT00422084|156813548|FG001|Overall Study|Withdrawn from study accidentally|0|||
48716848|NCT00422084|156813547|FG000|Overall Study|Non-compliance|1|||
48716849|NCT00422084|156813548|FG001|Overall Study|Non-compliance|0|||
48716850|NCT00422084|156813547|FG000|Overall Study|Re-location|0|||
48716851|NCT00422084|156813548|FG001|Overall Study|Re-location|1|||
48716852|NCT00422084|156813547|FG000|Overall Study|Not defined|1|||
48716853|NCT00422084|156813548|FG001|Overall Study|Not defined|1|||
48716854|NCT00662532|156813556|FG000|Overall Study|Adverse Event|0|||
48716855|NCT00662532|156813557|FG001|Overall Study|Adverse Event|1|||
48716856|NCT00662532|156813556|FG000|Overall Study|Lost to Follow-up|0|||
48716857|NCT00662532|156813557|FG001|Overall Study|Lost to Follow-up|1|||
48716858|NCT02184572|156813558|FG000|Overall Study|Lost to Follow-up|29|||
48716859|NCT02184572|156813559|FG001|Overall Study|Lost to Follow-up|21|||
48716860|NCT02184572|156813558|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
48716861|NCT02184572|156813559|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
48598503|NCT03410992|156385239|FG002|Week 16 Assessment|Incorrect escapers|0|||
48598504|NCT03410992|156385240|FG003|Week 16 Assessment|Incorrect escapers|0|||
48598505|NCT03410992|156385241|FG004|Week 16 Assessment|Incorrect escapers|0|||
48598506|NCT03410992|156385242|FG005|Week 16 Assessment|Incorrect escapers|0|||
48598507|NCT03410992|156385243|FG006|Week 16 Assessment|Incorrect escapers|0|||
48598508|NCT03410992|156385244|FG007|Week 16 Assessment|Incorrect escapers|0|||
48598509|NCT03410992|156385245|FG008|Week 16 Assessment|Incorrect escapers|0|||
48598510|NCT03410992|156385246|FG009|Week 16 Assessment|Incorrect escapers|0|||
48598511|NCT03410992|156385247|FG010|Week 16 Assessment|Incorrect escapers|0|||
48598512|NCT03410992|156385237|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598513|NCT03410992|156385238|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598514|NCT03410992|156385239|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598515|NCT03410992|156385240|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
48598516|NCT03410992|156385241|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
48716862|NCT02184572|156813558|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
48716863|NCT02184572|156813559|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
48716864|NCT02184572|156813558|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
48716865|NCT02184572|156813559|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
48716866|NCT02184572|156813558|FG000|Overall Study|Traveling Outside The Country|1|||
48598517|NCT03410992|156385242|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598518|NCT03410992|156385243|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598519|NCT03410992|156385244|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598520|NCT03410992|156385245|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598521|NCT03410992|156385246|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598522|NCT03410992|156385247|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
48598523|NCT03410992|156385237|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
48598524|NCT03410992|156385238|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
48598525|NCT03410992|156385239|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
48598526|NCT03410992|156385240|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
48598527|NCT03410992|156385241|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
48598528|NCT03410992|156385242|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
48598529|NCT03410992|156385243|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
48598530|NCT03410992|156385244|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
48598531|NCT03410992|156385245|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
48598532|NCT03410992|156385246|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
48598533|NCT03410992|156385247|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
48598534|NCT03410992|156385237|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598535|NCT03410992|156385238|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598536|NCT03410992|156385239|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598537|NCT03410992|156385240|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598538|NCT03410992|156385241|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48716867|NCT02184572|156813559|FG001|Overall Study|Traveling Outside The Country|0|||
48716868|NCT02184572|156813558|FG000|Overall Study|Withdrawal by Subject|14|||
48716869|NCT02184572|156813559|FG001|Overall Study|Withdrawal by Subject|9|||
48716870|NCT02350764|156813563|FG000|Overall Study|Adverse Event|4|||
48716871|NCT02350764|156813563|FG000|Overall Study|Death|3|||
48716872|NCT02350764|156813563|FG000|Overall Study|Physician Decision|2|||
48716873|NCT02350764|156813563|FG000|Overall Study|Withdrawal by Subject|2|||
48497822|NCT00635778|156016155|FG006|Overall Study|Withdrawal by Subject|1|||
48497823|NCT00635778|156016149|FG000|Overall Study|Progressive disease|0|||
48497824|NCT00635778|156016150|FG001|Overall Study|Progressive disease|3|||
48497825|NCT00635778|156016151|FG002|Overall Study|Progressive disease|3|||
48497826|NCT00635778|156016152|FG003|Overall Study|Progressive disease|4|||
48497827|NCT00635778|156016153|FG004|Overall Study|Progressive disease|5|||
48497828|NCT00635778|156016154|FG005|Overall Study|Progressive disease|14|||
48497829|NCT00635778|156016155|FG006|Overall Study|Progressive disease|4|||
48497830|NCT02398188|156016156|FG000|Overall Study|Adverse Event|2|||
48497831|NCT02398188|156016157|FG001|Overall Study|Adverse Event|3|||
48497832|NCT02398188|156016156|FG000|Overall Study|Lost to Follow-up|5|||
48497833|NCT02398188|156016157|FG001|Overall Study|Lost to Follow-up|0|||
48497834|NCT02398188|156016156|FG000|Overall Study|Non-compliance|4|||
48497835|NCT02398188|156016157|FG001|Overall Study|Non-compliance|4|||
48497836|NCT02398188|156016156|FG000|Overall Study|Protocol Violation|6|||
48716874|NCT02743611|156813564|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
48716875|NCT02743611|156813565|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
48716876|NCT02743611|156813566|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
48716877|NCT02743611|156813567|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
48716878|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
48716879|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
48716880|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
48716881|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
48716882|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
48716883|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
48716884|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48716885|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
48716886|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
48716887|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48716888|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48716889|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48716890|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
48716891|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
48716892|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
48716893|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
48716894|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
48716895|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
48716896|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
48716897|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716898|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716899|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716900|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716901|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
48716902|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
48716903|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
48716904|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
48716905|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
48716906|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
48716907|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
48716908|NCT00600119|156813568|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
48716909|NCT00600119|156813569|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
48716910|NCT00600119|156813570|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
48716911|NCT00600119|156813571|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
48716912|NCT00600119|156813572|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
48716913|NCT00600119|156813573|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
48716914|NCT00600119|156813568|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
48716915|NCT00600119|156813569|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
48716916|NCT00600119|156813570|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48716917|NCT00600119|156813571|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
48716918|NCT00600119|156813572|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
48716919|NCT00600119|156813573|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
48497837|NCT02398188|156016157|FG001|Overall Study|Protocol Violation|10|||
48497838|NCT02398188|156016156|FG000|Overall Study|Sponsor Decision|2|||
48497839|NCT02398188|156016157|FG001|Overall Study|Sponsor Decision|1|||
48497840|NCT02398188|156016156|FG000|Overall Study|Pregnancy|1|||
48497841|NCT02398188|156016157|FG001|Overall Study|Pregnancy|0|||
48497842|NCT02398188|156016156|FG000|Overall Study|Withdrawal by Subject|7|||
48716920|NCT00600119|156813568|FG000|Double-blind Treatment Period|Other|0|||
48716921|NCT00600119|156813569|FG001|Double-blind Treatment Period|Other|0|||
48716922|NCT00600119|156813570|FG002|Double-blind Treatment Period|Other|0|||
48716923|NCT00600119|156813571|FG003|Double-blind Treatment Period|Other|0|||
48716924|NCT00600119|156813572|FG004|Double-blind Treatment Period|Other|2|||
48716925|NCT00600119|156813573|FG005|Double-blind Treatment Period|Other|1|||
48716926|NCT00600119|156813568|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
48716927|NCT00600119|156813569|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
48716928|NCT00600119|156813570|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
48716929|NCT00600119|156813571|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
48716930|NCT00600119|156813572|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
48716931|NCT00600119|156813573|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
48716932|NCT00600119|156813568|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716933|NCT00600119|156813569|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
48716934|NCT00600119|156813570|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716935|NCT00600119|156813571|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716936|NCT00600119|156813572|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716937|NCT00600119|156813573|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
48716938|NCT00600119|156813568|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
48716939|NCT00600119|156813569|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
48716940|NCT00600119|156813570|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
48716941|NCT00600119|156813571|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
48716942|NCT00600119|156813572|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
48716943|NCT00600119|156813573|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
48716944|NCT00600119|156813568|FG000|Double-blind Treatment Period|Physician Decision|2|||
48716945|NCT00600119|156813569|FG001|Double-blind Treatment Period|Physician Decision|0|||
48716946|NCT00600119|156813570|FG002|Double-blind Treatment Period|Physician Decision|0|||
48716947|NCT00600119|156813571|FG003|Double-blind Treatment Period|Physician Decision|0|||
48716948|NCT00600119|156813572|FG004|Double-blind Treatment Period|Physician Decision|0|||
48716949|NCT00600119|156813573|FG005|Double-blind Treatment Period|Physician Decision|0|||
48716950|NCT00600119|156813568|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48716951|NCT00600119|156813569|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
48716952|NCT00600119|156813570|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
48716953|NCT00600119|156813571|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
48716954|NCT00600119|156813572|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
48716955|NCT00600119|156813573|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
48716956|NCT00600119|156813568|FG000|Double-blind Treatment Period|Adverse Event|1|||
48716957|NCT00600119|156813569|FG001|Double-blind Treatment Period|Adverse Event|1|||
48716958|NCT00600119|156813570|FG002|Double-blind Treatment Period|Adverse Event|0|||
48716959|NCT00600119|156813571|FG003|Double-blind Treatment Period|Adverse Event|1|||
48716960|NCT00600119|156813572|FG004|Double-blind Treatment Period|Adverse Event|2|||
48716961|NCT00600119|156813573|FG005|Double-blind Treatment Period|Adverse Event|10|||
48716962|NCT00600119|156813568|FG000|Follow-up Period|Adverse Event|0|||
48716963|NCT00600119|156813569|FG001|Follow-up Period|Adverse Event|0|||
48716964|NCT00600119|156813570|FG002|Follow-up Period|Adverse Event|0|||
48716965|NCT00600119|156813571|FG003|Follow-up Period|Adverse Event|0|||
48716966|NCT00600119|156813572|FG004|Follow-up Period|Adverse Event|0|||
48716967|NCT00600119|156813573|FG005|Follow-up Period|Adverse Event|1|||
48716968|NCT00600119|156813568|FG000|Follow-up Period|Other|1|||
48716969|NCT00600119|156813569|FG001|Follow-up Period|Other|0|||
48716970|NCT00600119|156813570|FG002|Follow-up Period|Other|0|||
48716971|NCT00600119|156813571|FG003|Follow-up Period|Other|0|||
48716972|NCT00600119|156813572|FG004|Follow-up Period|Other|0|||
48716973|NCT00600119|156813573|FG005|Follow-up Period|Other|0|||
48716974|NCT03051620|156813574|FG000|Overall Study|Lost to Follow-up|6|||
48716975|NCT03051620|156813574|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
48716976|NCT01989468|156813575|FG000|Overall Study|Adverse Event|10|||
48716977|NCT01989468|156813576|FG001|Overall Study|Adverse Event|15|||
48716978|NCT01989468|156813577|FG002|Overall Study|Adverse Event|4|||
48716979|NCT01989468|156813578|FG003|Overall Study|Adverse Event|5|||
48716980|NCT01989468|156813579|FG004|Overall Study|Adverse Event|4|||
48716981|NCT01989468|156813575|FG000|Overall Study|Lack of Efficacy|11|||
48716982|NCT01989468|156813576|FG001|Overall Study|Lack of Efficacy|11|||
48716983|NCT01989468|156813577|FG002|Overall Study|Lack of Efficacy|7|||
48716984|NCT01989468|156813578|FG003|Overall Study|Lack of Efficacy|4|||
48716985|NCT01989468|156813579|FG004|Overall Study|Lack of Efficacy|2|||
48716986|NCT01989468|156813575|FG000|Overall Study|Lost to Follow-up|5|||
48716987|NCT01989468|156813576|FG001|Overall Study|Lost to Follow-up|2|||
48716988|NCT01989468|156813577|FG002|Overall Study|Lost to Follow-up|0|||
48716989|NCT01989468|156813578|FG003|Overall Study|Lost to Follow-up|1|||
48716990|NCT01989468|156813579|FG004|Overall Study|Lost to Follow-up|1|||
48716991|NCT01989468|156813575|FG000|Overall Study|Physician Decision|4|||
48716992|NCT01989468|156813576|FG001|Overall Study|Physician Decision|1|||
48716993|NCT01989468|156813577|FG002|Overall Study|Physician Decision|0|||
48716994|NCT01989468|156813578|FG003|Overall Study|Physician Decision|1|||
48716995|NCT01989468|156813579|FG004|Overall Study|Physician Decision|0|||
48716996|NCT01989468|156813575|FG000|Overall Study|Pregnancy|0|||
48716997|NCT01989468|156813576|FG001|Overall Study|Pregnancy|1|||
48716998|NCT01989468|156813577|FG002|Overall Study|Pregnancy|0|||
48716999|NCT01989468|156813578|FG003|Overall Study|Pregnancy|0|||
48717000|NCT01989468|156813579|FG004|Overall Study|Pregnancy|0|||
48717001|NCT01989468|156813575|FG000|Overall Study|Technical Problems|3|||
48717002|NCT01989468|156813576|FG001|Overall Study|Technical Problems|1|||
48717003|NCT01989468|156813577|FG002|Overall Study|Technical Problems|3|||
48717004|NCT01989468|156813578|FG003|Overall Study|Technical Problems|1|||
48717005|NCT01989468|156813579|FG004|Overall Study|Technical Problems|0|||
48717006|NCT01989468|156813575|FG000|Overall Study|Subject Guardian Decision|11|||
48717007|NCT01989468|156813576|FG001|Overall Study|Subject Guardian Decision|6|||
48717008|NCT01989468|156813577|FG002|Overall Study|Subject Guardian Decision|4|||
48717009|NCT01989468|156813578|FG003|Overall Study|Subject Guardian Decision|4|||
48717010|NCT01989468|156813579|FG004|Overall Study|Subject Guardian Decision|1|||
48717011|NCT01989468|156813575|FG000|Overall Study|Death|3|||
48717012|NCT01989468|156813576|FG001|Overall Study|Death|0|||
48717013|NCT01989468|156813577|FG002|Overall Study|Death|1|||
48717014|NCT01989468|156813578|FG003|Overall Study|Death|0|||
48717015|NCT01989468|156813579|FG004|Overall Study|Death|0|||
48717016|NCT01989208|156813585|FG000|200 mg (7 Days)|Protocol Violation|0|||
48717017|NCT01989208|156813586|FG001|200 mg (7 Days)|Protocol Violation|1|||
48717018|NCT02395172|156813587|FG000|Overall Study|Participants randomized but not treated|3|||
48717019|NCT02395172|156813588|FG001|Overall Study|Participants randomized but not treated|31|||
48717020|NCT00717236|156813589|FG000|Double-Blind Period|Adverse Event|33|||
48717021|NCT00717236|156813590|FG001|Double-Blind Period|Adverse Event|6|||
48717022|NCT00717236|156813589|FG000|Double-Blind Period|Lack of Efficacy|6|||
48717023|NCT00717236|156813590|FG001|Double-Blind Period|Lack of Efficacy|6|||
48717024|NCT00717236|156813589|FG000|Double-Blind Period|Lost to Follow-up|3|||
48717025|NCT00717236|156813590|FG001|Double-Blind Period|Lost to Follow-up|5|||
48717026|NCT00717236|156813589|FG000|Double-Blind Period|Withdrawal by Subject|10|||
48717027|NCT00717236|156813590|FG001|Double-Blind Period|Withdrawal by Subject|2|||
48717028|NCT00717236|156813589|FG000|Double-Blind Period|Loss of efficacy|3|||
48717029|NCT00717236|156813590|FG001|Double-Blind Period|Loss of efficacy|0|||
48717030|NCT00717236|156813589|FG000|Double-Blind Period|Other: Death|1|||
48717031|NCT00717236|156813590|FG001|Double-Blind Period|Other: Death|0|||
48717032|NCT00717236|156813589|FG000|Double-Blind Period|Other: Pregnancy|1|||
48717033|NCT00717236|156813590|FG001|Double-Blind Period|Other: Pregnancy|0|||
48717034|NCT00717236|156813589|FG000|Double-Blind Period|Other: Protocol Violation|2|||
48814588|NCT04424290|157163526|FG002|Overall Study|Adverse Event|0|||
48814589|NCT04424290|157163527|FG003|Overall Study|Adverse Event|2|||
48814590|NCT04424290|157163528|FG004|Overall Study|Adverse Event|0|||
48814591|NCT04424290|157163524|FG000|Overall Study|Withdrawal by Subject|0|||
48717035|NCT00717236|156813590|FG001|Double-Blind Period|Other: Protocol Violation|0|||
48717036|NCT00717236|156813589|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
48814592|NCT04424290|157163525|FG001|Overall Study|Withdrawal by Subject|0|||
48814593|NCT04424290|157163526|FG002|Overall Study|Withdrawal by Subject|0|||
48814594|NCT04424290|157163527|FG003|Overall Study|Withdrawal by Subject|0|||
48814595|NCT04424290|157163528|FG004|Overall Study|Withdrawal by Subject|1|||
48814596|NCT04424290|157163524|FG000|Overall Study|Other than listed|0|||
48814597|NCT04424290|157163525|FG001|Overall Study|Other than listed|0|||
48814598|NCT04424290|157163526|FG002|Overall Study|Other than listed|0|||
48814599|NCT04424290|157163527|FG003|Overall Study|Other than listed|1|||
48814600|NCT04424290|157163528|FG004|Overall Study|Other than listed|0|||
48814601|NCT03015116|157163529|FG000|Overall Study|Lost to Follow-up|3|||
48814602|NCT03015116|157163530|FG001|Overall Study|Lost to Follow-up|0|||
48814603|NCT03015116|157163531|FG002|Overall Study|Lost to Follow-up|2|||
48436393|NCT00618449|155785888|FG001|Overall Study|Lost to Follow-up|110|||
48436394|NCT05127421|155785889|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
48436395|NCT05127421|155785890|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
48436396|NCT05127421|155785891|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
48436397|NCT05127421|155785892|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
48436398|NCT05127421|155785889|FG000|4-Week Double-Blind Period|Physician Decision|1|||
48436399|NCT05127421|155785890|FG001|4-Week Double-Blind Period|Physician Decision|0|||
48436400|NCT05127421|155785891|FG002|4-Week Double-Blind Period|Physician Decision|0|||
48436401|NCT05127421|155785892|FG003|4-Week Double-Blind Period|Physician Decision|0|||
48436402|NCT05127421|155785889|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
48436403|NCT05127421|155785890|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
48436404|NCT05127421|155785891|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
48436405|NCT05127421|155785892|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
48436406|NCT05127421|155785889|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
48436407|NCT05127421|155785890|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
48598539|NCT03410992|156385242|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
48598540|NCT03410992|156385243|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598541|NCT03410992|156385244|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598542|NCT03410992|156385245|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598543|NCT03410992|156385246|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598544|NCT03410992|156385247|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
48598545|NCT03410992|156385237|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48598546|NCT03410992|156385238|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48598547|NCT03410992|156385239|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48598548|NCT03410992|156385240|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
48497843|NCT02398188|156016157|FG001|Overall Study|Withdrawal by Subject|16|||
48497844|NCT00782509|156016158|FG000|Overall Study|Adverse Event|20|||
48497845|NCT00782509|156016159|FG001|Overall Study|Adverse Event|10|||
48497846|NCT00782509|156016160|FG002|Overall Study|Adverse Event|20|||
48497847|NCT00782509|156016158|FG000|Overall Study|Lost to Follow-up|1|||
48497848|NCT00782509|156016159|FG001|Overall Study|Lost to Follow-up|2|||
48497849|NCT00782509|156016160|FG002|Overall Study|Lost to Follow-up|3|||
48497850|NCT00782509|156016158|FG000|Overall Study|Withdrawal by Subject|3|||
48497851|NCT00782509|156016159|FG001|Overall Study|Withdrawal by Subject|5|||
48497852|NCT00782509|156016160|FG002|Overall Study|Withdrawal by Subject|8|||
48497853|NCT00782509|156016158|FG000|Overall Study|Non compliance with protocol|2|||
48497854|NCT00782509|156016159|FG001|Overall Study|Non compliance with protocol|0|||
48497855|NCT00782509|156016160|FG002|Overall Study|Non compliance with protocol|0|||
48497856|NCT00782509|156016158|FG000|Overall Study|Other reasons not stated above|5|||
48717037|NCT00717236|156813590|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
48717038|NCT00717236|156813589|FG000|Double-Blind Period|Other: Site withdrew|2|||
48717039|NCT00717236|156813590|FG001|Double-Blind Period|Other: Site withdrew|0|||
48717040|NCT00717236|156813589|FG000|Double-Blind Period|Other: Screening failure|1|||
48717041|NCT00717236|156813590|FG001|Double-Blind Period|Other: Screening failure|0|||
48717042|NCT00717236|156813589|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
48814604|NCT03015116|157163529|FG000|Overall Study|Withdrawal by Subject|3|||
48814605|NCT03015116|157163530|FG001|Overall Study|Withdrawal by Subject|1|||
48497857|NCT00782509|156016159|FG001|Overall Study|Other reasons not stated above|2|||
48497858|NCT00782509|156016160|FG002|Overall Study|Other reasons not stated above|3|||
48497859|NCT00782509|156016158|FG000|Overall Study|Lack of Efficacy|10|||
48497860|NCT00782509|156016159|FG001|Overall Study|Lack of Efficacy|5|||
48497861|NCT00782509|156016160|FG002|Overall Study|Lack of Efficacy|2|||
48497862|NCT01884025|156016161|FG000|Overall Study|Lost to Follow-up|3|||
48497863|NCT01884025|156016162|FG001|Overall Study|Lost to Follow-up|4|||
48497864|NCT01890915|156016174|FG000|Overall Study|Adverse Event|1|||
48497865|NCT01890915|156016175|FG001|Overall Study|Adverse Event|0|||
48497866|NCT01890915|156016174|FG000|Overall Study|Protocol Violation|2|||
48497867|NCT01890915|156016175|FG001|Overall Study|Protocol Violation|0|||
48497868|NCT01890915|156016174|FG000|Overall Study|Equipment Malfunction|0|||
48497869|NCT01890915|156016175|FG001|Overall Study|Equipment Malfunction|1|||
48497870|NCT01974895|156016176|FG000|Overall Study|Protocol Violation|1|||
48497871|NCT01974895|156016177|FG001|Overall Study|Protocol Violation|0|||
48497872|NCT01974895|156016176|FG000|Overall Study|Lost to Follow-up|4|||
48497873|NCT01974895|156016177|FG001|Overall Study|Lost to Follow-up|6|||
48497874|NCT01974895|156016176|FG000|Overall Study|Withdrawal by Subject|0|||
48497875|NCT01974895|156016177|FG001|Overall Study|Withdrawal by Subject|1|||
48497876|NCT01974895|156016176|FG000|Overall Study|Other (Missed Visit)|1|||
48497877|NCT01974895|156016177|FG001|Overall Study|Other (Missed Visit)|0|||
48497878|NCT01974895|156016176|FG000|Overall Study|Other (Reason unknown)|9|||
48497879|NCT01974895|156016177|FG001|Overall Study|Other (Reason unknown)|8|||
48497880|NCT02448771|156016182|FG000|Overall Study|Disease Progression|30|||
48497881|NCT02448771|156016182|FG000|Overall Study|Unacceptable Toxicity|1|||
48497882|NCT02448771|156016182|FG000|Overall Study|Physician Decision|3|||
48497883|NCT02448771|156016182|FG000|Overall Study|Started new therapy|2|||
48598549|NCT03410992|156385241|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
48717043|NCT00717236|156813590|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
48717044|NCT00717236|156813589|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
48717045|NCT00717236|156813590|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
48717046|NCT00717236|156813589|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
48497884|NCT02540356|156016183|FG000|Overall Study|Terminated due to disease progression|1|||
48717047|NCT00717236|156813590|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
48717048|NCT00717236|156813589|FG000|Double-Blind Period|Other: History of cancer|1|||
48497885|NCT02540356|156016184|FG001|Overall Study|Terminated due to disease progression|0|||
48497886|NCT02114697|156016185|FG000|Overall Study|Study terminated|5|||
48497887|NCT02114697|156016186|FG001|Overall Study|Study terminated|4|||
48497888|NCT02795104|156016187|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
48497889|NCT02795104|156016188|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
48717049|NCT00717236|156813590|FG001|Double-Blind Period|Other: History of cancer|0|||
48717050|NCT00717236|156813589|FG000|Double-Blind Period|Other: Sponsor request|1|||
48717051|NCT00717236|156813590|FG001|Double-Blind Period|Other: Sponsor request|0|||
48717052|NCT00717236|156813589|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
48717053|NCT00717236|156813590|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
48717054|NCT00717236|156813589|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
48717055|NCT00717236|156813590|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
48717056|NCT00717236|156813589|FG000|Double-Blind Period|Other: Subject moved|1|||
48814606|NCT03015116|157163531|FG002|Overall Study|Withdrawal by Subject|0|||
48814607|NCT03015116|157163529|FG000|Overall Study|Subject has New Medical Status|1|||
48814608|NCT03015116|157163530|FG001|Overall Study|Subject has New Medical Status|0|||
48814609|NCT03015116|157163531|FG002|Overall Study|Subject has New Medical Status|0|||
48814610|NCT03015116|157163529|FG000|Overall Study|Physician Decision|0|||
48814611|NCT03015116|157163530|FG001|Overall Study|Physician Decision|1|||
48814612|NCT03015116|157163531|FG002|Overall Study|Physician Decision|0|||
48814613|NCT01267825|157163532|FG000|Overall Study|study terminated. no data collected.|1|||
48814614|NCT01267825|157163533|FG001|Overall Study|study terminated. no data collected.|0|||
48814615|NCT00358215|157163536|FG000|Overall Study|Ineligibility determined|4|||
48814616|NCT00358215|157163537|FG001|Overall Study|Ineligibility determined|3|||
48814617|NCT00358215|157163536|FG000|Overall Study|Adverse Event|83|||
48814618|NCT00358215|157163537|FG001|Overall Study|Adverse Event|65|||
48814619|NCT00358215|157163536|FG000|Overall Study|Withdrawal by Subject|111|||
48814620|NCT00358215|157163537|FG001|Overall Study|Withdrawal by Subject|102|||
48814621|NCT00358215|157163536|FG000|Overall Study|Participant request|65|||
48814622|NCT00358215|157163537|FG001|Overall Study|Participant request|64|||
48814623|NCT00358215|157163536|FG000|Overall Study|Physician Decision|47|||
48814624|NCT00358215|157163537|FG001|Overall Study|Physician Decision|39|||
48497890|NCT02795104|156016189|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
48497891|NCT02795104|156016187|FG000|Overall Study|Withdrawal by Subject|0|||
48717057|NCT00717236|156813590|FG001|Double-Blind Period|Other: Subject moved|1|||
48717058|NCT00717236|156813589|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
48717059|NCT00717236|156813590|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
48717060|NCT00717236|156813589|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
48717061|NCT00717236|156813590|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
48717062|NCT00717236|156813589|FG000|Double-Blind Period|Other: Transportation problems|0|||
48717063|NCT00717236|156813590|FG001|Double-Blind Period|Other: Transportation problems|1|||
48717064|NCT00717236|156813589|FG000|Double-Blind Period|Other: Investigator Decision|0|||
48717065|NCT00717236|156813590|FG001|Double-Blind Period|Other: Investigator Decision|1|||
48717066|NCT00717236|156813589|FG000|Open-Label Period|Adverse Event|29|||
48717067|NCT00717236|156813590|FG001|Open-Label Period|Adverse Event|4|||
48717068|NCT00717236|156813589|FG000|Open-Label Period|Lack of Efficacy|30|||
48717069|NCT00717236|156813590|FG001|Open-Label Period|Lack of Efficacy|8|||
48717070|NCT00717236|156813589|FG000|Open-Label Period|Lost to Follow-up|28|||
48717071|NCT00717236|156813590|FG001|Open-Label Period|Lost to Follow-up|4|||
48717072|NCT00717236|156813589|FG000|Open-Label Period|Withdrawal by Subject|20|||
48717073|NCT00717236|156813590|FG001|Open-Label Period|Withdrawal by Subject|2|||
48814625|NCT00358215|157163536|FG000|Overall Study|Lost to Follow-up|16|||
48497892|NCT02795104|156016188|FG001|Overall Study|Withdrawal by Subject|2|||
48497893|NCT02795104|156016189|FG002|Overall Study|Withdrawal by Subject|0|||
48497894|NCT02795104|156016187|FG000|Overall Study|Lost to Follow-up|0|||
48497895|NCT02795104|156016188|FG001|Overall Study|Lost to Follow-up|0|||
48497896|NCT02795104|156016189|FG002|Overall Study|Lost to Follow-up|1|||
48497897|NCT00995553|156016190|FG000|Overall Study|Withdrawal by Subject|2|||
48497898|NCT00995553|156016191|FG001|Overall Study|Withdrawal by Subject|6|||
48497899|NCT01089647|156016192|FG000|Overall Study|Lost to Follow-up|2|||
48497900|NCT01089647|156016193|FG001|Overall Study|Lost to Follow-up|2|||
48497901|NCT01089647|156016192|FG000|Overall Study|Withdrawal by Subject|2|||
48497902|NCT01089647|156016193|FG001|Overall Study|Withdrawal by Subject|1|||
48497903|NCT01089647|156016192|FG000|Overall Study|Adverse Event|0|||
48497904|NCT01089647|156016193|FG001|Overall Study|Adverse Event|1|||
48497905|NCT00777829|156016197|FG000|Overall Study|Withdrawal by Subject|0|||
48497906|NCT00777829|156016198|FG001|Overall Study|Withdrawal by Subject|2|||
48497907|NCT00918567|156016201|FG000|Overall Study|Lack of Efficacy|3|||
48497908|NCT00918567|156016202|FG001|Overall Study|Lack of Efficacy|1|||
48497909|NCT00918567|156016201|FG000|Overall Study|Withdrawal by Subject|1|||
48497910|NCT00918567|156016202|FG001|Overall Study|Withdrawal by Subject|1|||
48497911|NCT00918567|156016201|FG000|Overall Study|Adverse Event|1|||
48497912|NCT00918567|156016202|FG001|Overall Study|Adverse Event|0|||
48497913|NCT00970281|156016205|FG000|Overall Study|Lack of Efficacy|1|||
48814626|NCT00358215|157163537|FG001|Overall Study|Lost to Follow-up|22|||
48814627|NCT00358215|157163536|FG000|Overall Study|Death|265|||
48814628|NCT00358215|157163537|FG001|Overall Study|Death|281|||
48814629|NCT00358215|157163536|FG000|Overall Study|Protocol Violation|64|||
48497914|NCT00970281|156016206|FG001|Overall Study|Lack of Efficacy|14|||
48814630|NCT00358215|157163537|FG001|Overall Study|Protocol Violation|59|||
48497915|NCT00970281|156016205|FG000|Overall Study|Withdrawal by Subject|0|||
48497916|NCT00970281|156016206|FG001|Overall Study|Withdrawal by Subject|1|||
48717074|NCT00717236|156813589|FG000|Open-Label Period|Loss of Efficacy|6|||
48814631|NCT00358215|157163536|FG000|Overall Study|Pregnancy|1|||
48814632|NCT00358215|157163537|FG001|Overall Study|Pregnancy|0|||
48814633|NCT00358215|157163536|FG000|Overall Study|Other|21|||
48814634|NCT00358215|157163537|FG001|Overall Study|Other|14|||
48814635|NCT00358215|157163536|FG000|Overall Study|Did not receive investigational product|2|||
48814636|NCT00358215|157163537|FG001|Overall Study|Did not receive investigational product|3|||
48814637|NCT00744237|157163538|FG000|Overall Study|Lack of Efficacy|1|||
48814638|NCT00744237|157163539|FG001|Overall Study|Lack of Efficacy|1|||
48814639|NCT00744237|157163540|FG002|Overall Study|Lack of Efficacy|0|||
48814640|NCT00744237|157163538|FG000|Overall Study|Withdrawal by Subject|9|||
48814641|NCT00744237|157163539|FG001|Overall Study|Withdrawal by Subject|5|||
48814642|NCT00744237|157163540|FG002|Overall Study|Withdrawal by Subject|3|||
48814643|NCT00744237|157163538|FG000|Overall Study|Lost to Follow-up|1|||
48717075|NCT00717236|156813590|FG001|Open-Label Period|Loss of Efficacy|1|||
48717076|NCT00717236|156813589|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
48814644|NCT00744237|157163539|FG001|Overall Study|Lost to Follow-up|1|||
48814645|NCT00744237|157163540|FG002|Overall Study|Lost to Follow-up|1|||
48814646|NCT00744237|157163538|FG000|Overall Study|Protocol Violation|3|||
48814647|NCT00744237|157163539|FG001|Overall Study|Protocol Violation|4|||
48814648|NCT00744237|157163540|FG002|Overall Study|Protocol Violation|3|||
48814649|NCT00744237|157163538|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
48814650|NCT00744237|157163539|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
48814651|NCT00744237|157163540|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
48814652|NCT00744237|157163538|FG000|Overall Study|Dosing Error|1|||
48814653|NCT00744237|157163539|FG001|Overall Study|Dosing Error|0|||
48814654|NCT00744237|157163540|FG002|Overall Study|Dosing Error|1|||
48814655|NCT00744237|157163538|FG000|Overall Study|Study Drug Error|1|||
48814656|NCT00744237|157163539|FG001|Overall Study|Study Drug Error|0|||
48814657|NCT00744237|157163540|FG002|Overall Study|Study Drug Error|0|||
48814658|NCT00744237|157163538|FG000|Overall Study|Prohibited Concomitant Medication|0|||
48814659|NCT00744237|157163539|FG001|Overall Study|Prohibited Concomitant Medication|0|||
48814660|NCT00744237|157163540|FG002|Overall Study|Prohibited Concomitant Medication|1|||
48814661|NCT00744237|157163538|FG000|Overall Study|Poor Compliance|0|||
48814662|NCT00744237|157163539|FG001|Overall Study|Poor Compliance|2|||
48717077|NCT00717236|156813590|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
48717078|NCT00717236|156813589|FG000|Open-Label Period|Other: Lack of Compliance|1|||
48717079|NCT00717236|156813590|FG001|Open-Label Period|Other: Lack of Compliance|1|||
48717080|NCT00717236|156813589|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
48717081|NCT00717236|156813590|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
48717082|NCT00717236|156813589|FG000|Open-Label Period|Other: Moved|1|||
48717083|NCT00717236|156813590|FG001|Open-Label Period|Other: Moved|0|||
48717084|NCT00717236|156813589|FG000|Open-Label Period|Other: Investigator Decision|1|||
48717085|NCT00717236|156813590|FG001|Open-Label Period|Other: Investigator Decision|0|||
48717086|NCT00717236|156813589|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
48717087|NCT00717236|156813590|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
48717088|NCT00717236|156813589|FG000|Open-Label Period|Other: Sponsor Request|3|||
48717089|NCT00717236|156813590|FG001|Open-Label Period|Other: Sponsor Request|0|||
48717090|NCT00717236|156813589|FG000|Open-Label Period|Other: Cataract Surgery|1|||
48717091|NCT00717236|156813590|FG001|Open-Label Period|Other: Cataract Surgery|0|||
48717092|NCT00717236|156813589|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
48717093|NCT00717236|156813590|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
48717094|NCT00717236|156813589|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
48717095|NCT00717236|156813590|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
48717096|NCT00717236|156813589|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
48717097|NCT00717236|156813590|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
48717098|NCT02410343|156813598|FG000|Core Period (24 Weeks)|Adverse Event|1|||
48717099|NCT02410343|156813599|FG001|Core Period (24 Weeks)|Adverse Event|0|||
48717100|NCT02410343|156813598|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
48717101|NCT02410343|156813599|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
48717102|NCT02410343|156813598|FG000|Extension Period (12 Months)|Adverse Event|1|||
48814663|NCT00744237|157163540|FG002|Overall Study|Poor Compliance|0|||
48814664|NCT00744237|157163538|FG000|Overall Study|Administrative. Site Closed|1|||
48814665|NCT00744237|157163539|FG001|Overall Study|Administrative. Site Closed|1|||
48814666|NCT00744237|157163540|FG002|Overall Study|Administrative. Site Closed|1|||
48814667|NCT00744237|157163538|FG000|Overall Study|Adverse Event|9|||
48814668|NCT00744237|157163539|FG001|Overall Study|Adverse Event|13|||
48814669|NCT00744237|157163540|FG002|Overall Study|Adverse Event|5|||
48814670|NCT02609659|157163543|FG000|Overall Study|Adverse Event|1|||
48814671|NCT02609659|157163543|FG000|Overall Study|Lost to Follow-up|6|||
48814672|NCT02609659|157163543|FG000|Overall Study|Other|1|||
48814673|NCT02032173|157163544|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
48814674|NCT01004250|157163545|FG000|Induction Therapy Period|Adverse Event|10|||
48814675|NCT01004250|157163545|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
48814676|NCT01004250|157163545|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
48814677|NCT01004250|157163545|FG000|Induction Therapy Period|Physician Decision|2|||
48814678|NCT01004250|157163545|FG000|Maintenance Therapy Period|Adverse Event|15|||
48814679|NCT01004250|157163545|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
48814680|NCT01004250|157163545|FG000|Maintenance Therapy Period|Protocol Violation|1|||
48630155|NCT02723955|156504846|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
48630156|NCT02723955|156504847|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
48630157|NCT02723955|156504848|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
48630158|NCT02723955|156504849|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
48630159|NCT02723955|156504850|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
48630160|NCT02723955|156504851|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
48630161|NCT02723955|156504852|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
48630162|NCT02723955|156504853|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
48630163|NCT02723955|156504854|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
48630164|NCT02723955|156504855|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
48630165|NCT00833703|156504858|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
48630166|NCT00833703|156504859|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
48630167|NCT01661595|156504860|FG000|Phase 1: Week 0-4|Adverse Event|1|||
48630168|NCT01661595|156504861|FG001|Phase 1: Week 0-4|Adverse Event|0|||
48630169|NCT01661595|156504862|FG002|Phase 1: Week 0-4|Adverse Event|0|||
48630170|NCT01661595|156504863|FG003|Phase 1: Week 0-4|Adverse Event|0|||
48630171|NCT01661595|156504860|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
48630172|NCT01661595|156504861|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
48630173|NCT01661595|156504862|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
48630174|NCT01661595|156504863|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
48630175|NCT03033784|156504865|FG000|Overall Study|Anxiety related to MRI scanner|0|||
48630176|NCT03033784|156504866|FG001|Overall Study|Anxiety related to MRI scanner|1|||
48630177|NCT03033784|156504867|FG002|Overall Study|Anxiety related to MRI scanner|0|||
48630178|NCT03033784|156504868|FG003|Overall Study|Anxiety related to MRI scanner|0|||
48630179|NCT03033784|156504869|FG004|Overall Study|Anxiety related to MRI scanner|0|||
48630180|NCT03033784|156504870|FG005|Overall Study|Anxiety related to MRI scanner|0|||
48630181|NCT03033784|156504871|FG006|Overall Study|Anxiety related to MRI scanner|0|||
48630182|NCT03033784|156504872|FG007|Overall Study|Anxiety related to MRI scanner|0|||
48630183|NCT03033784|156504873|FG008|Overall Study|Anxiety related to MRI scanner|0|||
48630184|NCT03033784|156504874|FG009|Overall Study|Anxiety related to MRI scanner|0|||
48630185|NCT03033784|156504875|FG010|Overall Study|Anxiety related to MRI scanner|0|||
48630186|NCT03033784|156504876|FG011|Overall Study|Anxiety related to MRI scanner|0|||
48630187|NCT03033784|156504877|FG012|Overall Study|Anxiety related to MRI scanner|0|||
48630188|NCT03033784|156504865|FG000|Overall Study|Withdrawal by Subject|0|||
48630189|NCT03033784|156504866|FG001|Overall Study|Withdrawal by Subject|0|||
48630190|NCT03033784|156504867|FG002|Overall Study|Withdrawal by Subject|0|||
48630191|NCT03033784|156504868|FG003|Overall Study|Withdrawal by Subject|0|||
48630192|NCT03033784|156504869|FG004|Overall Study|Withdrawal by Subject|0|||
48630193|NCT03033784|156504870|FG005|Overall Study|Withdrawal by Subject|0|||
48630194|NCT03033784|156504871|FG006|Overall Study|Withdrawal by Subject|0|||
48630195|NCT03033784|156504872|FG007|Overall Study|Withdrawal by Subject|0|||
48630196|NCT03033784|156504873|FG008|Overall Study|Withdrawal by Subject|0|||
48630197|NCT03033784|156504874|FG009|Overall Study|Withdrawal by Subject|0|||
48630198|NCT03033784|156504875|FG010|Overall Study|Withdrawal by Subject|0|||
48630199|NCT03033784|156504876|FG011|Overall Study|Withdrawal by Subject|0|||
48630200|NCT03033784|156504877|FG012|Overall Study|Withdrawal by Subject|2|||
48630201|NCT00668642|156504888|FG000|First Off-cycle|Cancer progression|1|||
48630202|NCT00668642|156504889|FG001|First Off-cycle|Cancer progression|0|||
48630203|NCT00668642|156504888|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
48630204|NCT00668642|156504889|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
48630205|NCT00836706|156504890|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
48630206|NCT00836706|156504891|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
48630207|NCT01537432|156504892|FG000|Overall Study|Lost to Follow-up|3|||
48630208|NCT01537432|156504893|FG001|Overall Study|Lost to Follow-up|1|||
48630209|NCT01537432|156504892|FG000|Overall Study|Withdrawal by Subject|0|||
48630210|NCT01537432|156504893|FG001|Overall Study|Withdrawal by Subject|1|||
48630211|NCT01537432|156504892|FG000|Overall Study|Administrative problems|1|||
48630212|NCT01537432|156504893|FG001|Overall Study|Administrative problems|0|||
48630213|NCT01537432|156504892|FG000|Overall Study|Adverse Event|1|||
48630214|NCT01537432|156504893|FG001|Overall Study|Adverse Event|0|||
48630215|NCT01537432|156504892|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48630216|NCT01537432|156504893|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48717103|NCT02410343|156813599|FG001|Extension Period (12 Months)|Adverse Event|0|||
48717104|NCT02410343|156813598|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
48717105|NCT02410343|156813599|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
48717106|NCT00119678|156813601|FG000|Double-blind Treatment Period|Death|1|||
48717107|NCT00119678|156813602|FG001|Double-blind Treatment Period|Death|0|||
48717108|NCT00119678|156813601|FG000|Double-blind Treatment Period|Adverse Event|7|||
48717109|NCT00119678|156813602|FG001|Double-blind Treatment Period|Adverse Event|1|||
48717110|NCT00119678|156813601|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
48717111|NCT00119678|156813602|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
48717112|NCT00119678|156813601|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
48717113|NCT00119678|156813602|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
48717114|NCT00119678|156813601|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
48717115|NCT00119678|156813602|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
48717116|NCT00119678|156813601|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
48717117|NCT00119678|156813602|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
48717118|NCT00119678|156813601|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
48717119|NCT00119678|156813602|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
48717120|NCT00119678|156813601|FG000|Double-blind Treatment Period|Pregnancy|0|||
48717121|NCT00119678|156813602|FG001|Double-blind Treatment Period|Pregnancy|2|||
48717122|NCT00119678|156813601|FG000|Double-blind Treatment Period|Not treated|1|||
48717123|NCT00119678|156813602|FG001|Double-blind Treatment Period|Not treated|2|||
48717124|NCT00119678|156813601|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
48717125|NCT00119678|156813602|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
48717126|NCT00119678|156813601|FG000|Open-label Treatment Period|Death|1|||
48717127|NCT00119678|156813602|FG001|Open-label Treatment Period|Death|0|||
48717128|NCT00119678|156813601|FG000|Open-label Treatment Period|Adverse Event|3|||
48717129|NCT00119678|156813602|FG001|Open-label Treatment Period|Adverse Event|0|||
48717130|NCT00119678|156813601|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
48717131|NCT00119678|156813602|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
48717132|NCT00119678|156813601|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
48717133|NCT00119678|156813602|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
48717134|NCT00119678|156813601|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
48717135|NCT00119678|156813602|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
48717136|NCT00119678|156813601|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
48717137|NCT00119678|156813602|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
48717138|NCT00119678|156813601|FG000|Open-label Treatment Period|Pregnancy|1|||
48717139|NCT00119678|156813602|FG001|Open-label Treatment Period|Pregnancy|0|||
48717140|NCT00119678|156813601|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
48717141|NCT00119678|156813602|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
48717142|NCT00486811|156813605|FG000|Overall Study|Adverse Event|28|||
48717143|NCT00486811|156813606|FG001|Overall Study|Adverse Event|60|||
48717144|NCT00486811|156813607|FG002|Overall Study|Adverse Event|135|||
48717145|NCT00486811|156813605|FG000|Overall Study|Lack of Efficacy|34|||
48717146|NCT00486811|156813606|FG001|Overall Study|Lack of Efficacy|14|||
48717147|NCT00486811|156813607|FG002|Overall Study|Lack of Efficacy|7|||
48717148|NCT00486811|156813605|FG000|Overall Study|Lost to Follow-up|4|||
48717149|NCT00486811|156813606|FG001|Overall Study|Lost to Follow-up|6|||
48717150|NCT00486811|156813607|FG002|Overall Study|Lost to Follow-up|4|||
48717151|NCT00486811|156813605|FG000|Overall Study|Withdrawal by Subject|33|||
48717152|NCT00486811|156813606|FG001|Overall Study|Withdrawal by Subject|44|||
48717153|NCT00486811|156813607|FG002|Overall Study|Withdrawal by Subject|58|||
48717154|NCT00486811|156813605|FG000|Overall Study|Study drug non-compliant|5|||
48717155|NCT00486811|156813606|FG001|Overall Study|Study drug non-compliant|6|||
48717156|NCT00486811|156813607|FG002|Overall Study|Study drug non-compliant|3|||
48717157|NCT00486811|156813605|FG000|Overall Study|All other|18|||
48717158|NCT00486811|156813606|FG001|Overall Study|All other|11|||
48717159|NCT00486811|156813607|FG002|Overall Study|All other|7|||
48717160|NCT00834080|156813608|FG000|Overall Study|Adverse Event|7|||
48717161|NCT00834080|156813608|FG000|Overall Study|Lost to Follow-up|7|||
48717162|NCT00834080|156813608|FG000|Overall Study|Withdrawal by Subject|5|||
48717163|NCT00834080|156813608|FG000|Overall Study|Other - Pregnancy|1|||
48717164|NCT00834080|156813608|FG000|Overall Study|Other - False positive tests of the UDS|1|||
48717165|NCT00834080|156813608|FG000|Overall Study|Physician Decision|1|||
48814681|NCT01004250|157163545|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
48717166|NCT00834080|156813608|FG000|Overall Study|Subject Relocated|1|||
48717167|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
48717168|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48717169|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48717170|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
48717171|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
48814682|NCT01004250|157163545|FG000|Maintenance Therapy Period|Physician Decision|4|||
48814683|NCT01004250|157163545|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
48814684|NCT01383993|157163547|FG000|Overall Study|Adverse Event|1|||
48814685|NCT01383993|157163548|FG001|Overall Study|Adverse Event|1|||
48497917|NCT00970281|156016205|FG000|Overall Study|Physician Decision|1|||
48497918|NCT00970281|156016206|FG001|Overall Study|Physician Decision|1|||
48717172|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
48717173|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
48717174|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
48717175|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
48717176|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
48717177|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
48717178|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
48717179|NCT01642615|156813613|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
48717180|NCT01642615|156813614|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
48717181|NCT01642615|156813615|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
48717182|NCT01642615|156813613|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
48717183|NCT01642615|156813614|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
48717184|NCT01642615|156813615|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
48717185|NCT01642615|156813613|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
48717186|NCT01642615|156813614|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
48717187|NCT01642615|156813615|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
48717188|NCT01642615|156813613|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48717189|NCT01642615|156813614|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
48717190|NCT01642615|156813615|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
48717191|NCT01642615|156813613|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
48717192|NCT01642615|156813614|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
48717193|NCT01642615|156813615|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
48717194|NCT00439738|156813616|FG000|Overall Study|Withdrawal by Subject|16|||
48717195|NCT00439738|156813617|FG001|Overall Study|Withdrawal by Subject|13|||
48717196|NCT00439738|156813616|FG000|Overall Study|Adverse Event|6|||
48717197|NCT00439738|156813617|FG001|Overall Study|Adverse Event|4|||
48717198|NCT00439738|156813616|FG000|Overall Study|Lost to Follow-up|5|||
48717199|NCT00439738|156813617|FG001|Overall Study|Lost to Follow-up|6|||
48717200|NCT00439738|156813616|FG000|Overall Study|Protocol Violation|6|||
48717201|NCT00439738|156813617|FG001|Overall Study|Protocol Violation|3|||
48717202|NCT00439738|156813616|FG000|Overall Study|Lack of Efficacy|2|||
48717203|NCT00439738|156813617|FG001|Overall Study|Lack of Efficacy|2|||
48717204|NCT00439738|156813616|FG000|Overall Study|Abnormal Lab Values|1|||
48717205|NCT00439738|156813617|FG001|Overall Study|Abnormal Lab Values|0|||
48717206|NCT01457352|156813618|FG000|Period 1|Adverse Event|2|||
48717207|NCT01457352|156813619|FG001|Period 1|Adverse Event|0|||
48717208|NCT01457352|156813618|FG000|Period 1|Withdrawal by Subject|2|||
48717209|NCT01457352|156813619|FG001|Period 1|Withdrawal by Subject|0|||
48717210|NCT01457352|156813618|FG000|Period 1|Physician Decision|2|||
48717211|NCT01457352|156813619|FG001|Period 1|Physician Decision|0|||
48717212|NCT01457352|156813618|FG000|Period 1|MS related disease progression|1|||
48717213|NCT01457352|156813619|FG001|Period 1|MS related disease progression|0|||
48717214|NCT01457352|156813618|FG000|Period 1|Withdrawn|1|||
48717215|NCT01457352|156813619|FG001|Period 1|Withdrawn|0|||
48717216|NCT01457352|156813618|FG000|Period 1|withdrew per sponsor|1|||
48717217|NCT01457352|156813619|FG001|Period 1|withdrew per sponsor|0|||
48717218|NCT01457352|156813618|FG000|Period 1|Protocol Violation|4|||
48717219|NCT01457352|156813619|FG001|Period 1|Protocol Violation|0|||
48717220|NCT01457352|156813618|FG000|Period 1|Did not meet eligibility criteria|3|||
48717221|NCT01457352|156813619|FG001|Period 1|Did not meet eligibility criteria|0|||
48717222|NCT01457352|156813618|FG000|Period 2|Withdrawal by Subject|23|||
48717223|NCT01457352|156813619|FG001|Period 2|Withdrawal by Subject|0|||
48717224|NCT01457352|156813618|FG000|Period 2|Adverse Event|22|||
48717225|NCT01457352|156813619|FG001|Period 2|Adverse Event|0|||
48717226|NCT01457352|156813618|FG000|Period 2|no analysis|10|||
48717227|NCT01457352|156813619|FG001|Period 2|no analysis|0|||
48497919|NCT00510510|156016209|FG000|Overall Study|Adverse Event|4|||
48717228|NCT01457352|156813618|FG000|Period 2|Lack of Efficacy|8|||
48717229|NCT01457352|156813619|FG001|Period 2|Lack of Efficacy|0|||
48717230|NCT01457352|156813618|FG000|Period 2|Protocol Violation|4|||
48717231|NCT01457352|156813619|FG001|Period 2|Protocol Violation|0|||
48717232|NCT01457352|156813618|FG000|Period 2|Sponsor's withdrawal|7|||
48717233|NCT01457352|156813619|FG001|Period 2|Sponsor's withdrawal|0|||
48717234|NCT01457352|156813618|FG000|Period 2|Lost to Follow-up|1|||
48717235|NCT01457352|156813619|FG001|Period 2|Lost to Follow-up|0|||
48717236|NCT01457352|156813618|FG000|Period 2|dose change|1|||
48717237|NCT01457352|156813619|FG001|Period 2|dose change|0|||
48717238|NCT01457352|156813618|FG000|Period 2|Physician Decision|1|||
48814686|NCT01383993|157163549|FG002|Overall Study|Adverse Event|0|||
48717239|NCT01457352|156813619|FG001|Period 2|Physician Decision|0|||
48814687|NCT01383993|157163547|FG000|Overall Study|Withdrawal by Subject|0|||
48717240|NCT01457352|156813618|FG000|Period 2|Did not meet eligibility criteria|3|||
48717241|NCT01457352|156813619|FG001|Period 2|Did not meet eligibility criteria|0|||
48717242|NCT01457352|156813618|FG000|Period 3|Adverse Event|1|||
48717243|NCT01457352|156813619|FG001|Period 3|Adverse Event|1|||
48717244|NCT01457352|156813618|FG000|Period 3|Withdrawal by Subject|0|||
48717245|NCT01457352|156813619|FG001|Period 3|Withdrawal by Subject|2|||
48717246|NCT01457352|156813618|FG000|Period 3|incorrect treatment|0|||
48717247|NCT01457352|156813619|FG001|Period 3|incorrect treatment|1|||
48717248|NCT01457352|156813618|FG000|Period 3|Sponsor's withdrawal|0|||
48717249|NCT01457352|156813619|FG001|Period 3|Sponsor's withdrawal|1|||
48717250|NCT02576145|156813620|FG000|Overall Study|Adverse Event|1|||
48717251|NCT02576145|156813621|FG001|Overall Study|Adverse Event|0|||
48717252|NCT02576145|156813620|FG000|Overall Study|Withdrawal by Subject|1|||
48814688|NCT01383993|157163548|FG001|Overall Study|Withdrawal by Subject|0|||
48814689|NCT01383993|157163549|FG002|Overall Study|Withdrawal by Subject|1|||
48814690|NCT01383993|157163547|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
48814691|NCT01383993|157163548|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
48814692|NCT01383993|157163549|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
48814693|NCT00312858|157163550|FG000|Overall Study|Adverse Event|0|||
48814694|NCT00312858|157163551|FG001|Overall Study|Adverse Event|1|||
48814695|NCT00312858|157163550|FG000|Overall Study|Lost to Follow-up|25|||
48814696|NCT00312858|157163551|FG001|Overall Study|Lost to Follow-up|42|||
48814697|NCT00312858|157163550|FG000|Overall Study|Protocol Violation|3|||
48814698|NCT00312858|157163551|FG001|Overall Study|Protocol Violation|8|||
48497920|NCT00510510|156016210|FG001|Overall Study|Adverse Event|3|||
48497921|NCT00510510|156016211|FG002|Overall Study|Adverse Event|6|||
48497922|NCT00510510|156016209|FG000|Overall Study|Lack of Efficacy|0|||
48497923|NCT00510510|156016210|FG001|Overall Study|Lack of Efficacy|1|||
48497924|NCT00510510|156016211|FG002|Overall Study|Lack of Efficacy|1|||
48497925|NCT00510510|156016209|FG000|Overall Study|Subjects no longer requires study drug|0|||
48497926|NCT00510510|156016210|FG001|Overall Study|Subjects no longer requires study drug|0|||
48497927|NCT00510510|156016211|FG002|Overall Study|Subjects no longer requires study drug|2|||
48497928|NCT00510510|156016209|FG000|Overall Study|Withdrawal by Subject|1|||
48497929|NCT00510510|156016210|FG001|Overall Study|Withdrawal by Subject|2|||
48497930|NCT00510510|156016211|FG002|Overall Study|Withdrawal by Subject|3|||
48497931|NCT00510510|156016209|FG000|Overall Study|Lost to Follow-up|0|||
48497932|NCT00510510|156016210|FG001|Overall Study|Lost to Follow-up|0|||
48497933|NCT00510510|156016211|FG002|Overall Study|Lost to Follow-up|1|||
48497934|NCT00510510|156016209|FG000|Overall Study|Protocol Violation|0|||
48497935|NCT00510510|156016210|FG001|Overall Study|Protocol Violation|3|||
48497936|NCT00510510|156016211|FG002|Overall Study|Protocol Violation|4|||
48497937|NCT03295721|156016212|FG000|Overall Study|Adverse Event|1|||
48497938|NCT03295721|156016213|FG001|Overall Study|Adverse Event|0|||
48497939|NCT03295721|156016214|FG002|Overall Study|Adverse Event|0|||
48497940|NCT03295721|156016212|FG000|Overall Study|Lost to Follow-up|1|||
48497941|NCT03295721|156016213|FG001|Overall Study|Lost to Follow-up|1|||
48497942|NCT03295721|156016214|FG002|Overall Study|Lost to Follow-up|1|||
48497943|NCT03295721|156016212|FG000|Overall Study|Withdrawal by Subject|1|||
48497944|NCT03295721|156016213|FG001|Overall Study|Withdrawal by Subject|0|||
48497945|NCT03295721|156016214|FG002|Overall Study|Withdrawal by Subject|1|||
48497946|NCT03295721|156016212|FG000|Overall Study|Death|0|||
48497947|NCT03295721|156016213|FG001|Overall Study|Death|0|||
48497948|NCT03295721|156016214|FG002|Overall Study|Death|1|||
48497949|NCT00408902|156016215|FG000|Overall Study|Lack of Efficacy|7|||
48497950|NCT00408902|156016215|FG000|Overall Study|Adverse Event|3|||
48497951|NCT02994056|156016216|FG000|Overall Study|Death|8|||
48497952|NCT02994056|156016216|FG000|Overall Study|Withdrew Consent|1|||
48497953|NCT02534493|156016217|FG000|Overall Study|Lost to Follow-up|1|||
48497954|NCT02534493|156016217|FG000|Overall Study|Withdrawal by Subject|1|||
48497955|NCT01937390|156016218|FG000|Overall Study|Death|2|||
48717253|NCT02576145|156813621|FG001|Overall Study|Withdrawal by Subject|0|||
48717254|NCT02576145|156813620|FG000|Overall Study|Acute rejection|1|||
48717255|NCT02576145|156813621|FG001|Overall Study|Acute rejection|0|||
48717256|NCT02576145|156813620|FG000|Overall Study|Tetanus Titers Decreased|0|||
48814699|NCT00312858|157163550|FG000|Overall Study|Withdraw by Participant|20|||
48814700|NCT00312858|157163551|FG001|Overall Study|Withdraw by Participant|20|||
48814701|NCT00312858|157163550|FG000|Overall Study|Participant Moved|11|||
48814702|NCT00312858|157163551|FG001|Overall Study|Participant Moved|10|||
48814703|NCT00312858|157163550|FG000|Overall Study|Other|9|||
48814704|NCT00312858|157163551|FG001|Overall Study|Other|12|||
48497956|NCT01937390|156016218|FG000|Overall Study|Lost to Follow-up|7|||
48497957|NCT01937390|156016218|FG000|Overall Study|Withdrawal by Subject|5|||
48497958|NCT01937390|156016218|FG000|Overall Study|Fail to return|21|||
48717257|NCT02576145|156813621|FG001|Overall Study|Tetanus Titers Decreased|1|||
48717258|NCT02660138|156813622|FG000|Overall Study|Adverse Event|0|||
48717259|NCT02660138|156813623|FG001|Overall Study|Adverse Event|3|||
48814705|NCT00422799|157163553|FG000|Overall Study|Withdrawal by Subject|6|||
48497959|NCT00922779|156016221|FG000|Overall Study|Adverse Event|67|||
48717260|NCT02660138|156813624|FG002|Overall Study|Adverse Event|2|||
48497960|NCT00922779|156016221|FG000|Overall Study|Pregnancy|7|||
48497961|NCT00922779|156016221|FG000|Overall Study|Withdrawal by Subject|308|||
48717261|NCT02660138|156813622|FG000|Overall Study|Lack of Efficacy|1|||
48497962|NCT00922779|156016221|FG000|Overall Study|Lost to Follow-up|44|||
48497963|NCT00922779|156016221|FG000|Overall Study|Other|27|||
48497964|NCT00922779|156016221|FG000|Overall Study|Missing|1874|||
48497965|NCT03144687|156016224|FG000|Overall Study|Death|0|||
48497966|NCT03144687|156016225|FG001|Overall Study|Death|2|||
48497967|NCT03144687|156016224|FG000|Overall Study|Lost to Follow-up|0|||
48497968|NCT03144687|156016225|FG001|Overall Study|Lost to Follow-up|1|||
48497969|NCT03144687|156016224|FG000|Overall Study|Physician Decision|0|||
48497970|NCT03144687|156016225|FG001|Overall Study|Physician Decision|1|||
48497971|NCT03144687|156016224|FG000|Overall Study|Withdrawal by Subject|1|||
48497972|NCT03144687|156016225|FG001|Overall Study|Withdrawal by Subject|3|||
48497973|NCT03144687|156016224|FG000|Overall Study|Not Reported|2|||
48497974|NCT03144687|156016225|FG001|Overall Study|Not Reported|0|||
48497975|NCT04529109|156016226|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
48497976|NCT04529109|156016227|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
48497977|NCT03708211|156016228|FG000|Overall Study|Progressive Disease|10|||
48497978|NCT03708211|156016229|FG001|Overall Study|Progressive Disease|7|||
48497979|NCT03708211|156016228|FG000|Overall Study|Withdrawal by Subject|0|||
48497980|NCT03708211|156016229|FG001|Overall Study|Withdrawal by Subject|1|||
48497981|NCT03708211|156016228|FG000|Overall Study|Other|2|||
48497982|NCT03708211|156016229|FG001|Overall Study|Other|0|||
48497983|NCT00175019|156017878|FG000|Overall Study|Adverse Event|54|||
48497984|NCT00175019|156017879|FG001|Overall Study|Adverse Event|22|||
48497985|NCT00175019|156017880|FG002|Overall Study|Adverse Event|2|||
48497986|NCT00175019|156017878|FG000|Overall Study|Protocol Violation|6|||
48497987|NCT00175019|156017879|FG001|Overall Study|Protocol Violation|3|||
48497988|NCT00175019|156017880|FG002|Overall Study|Protocol Violation|3|||
48497989|NCT00175019|156017878|FG000|Overall Study|Lost to Follow-up|42|||
48497990|NCT00175019|156017879|FG001|Overall Study|Lost to Follow-up|39|||
48497991|NCT00175019|156017880|FG002|Overall Study|Lost to Follow-up|9|||
48497992|NCT00175019|156017878|FG000|Overall Study|Did not continue under Amendment 4|1|||
48497993|NCT00175019|156017879|FG001|Overall Study|Did not continue under Amendment 4|1|||
48497994|NCT00175019|156017880|FG002|Overall Study|Did not continue under Amendment 4|2|||
48497995|NCT00175019|156017878|FG000|Overall Study|Personal Reason(s)|39|||
48598550|NCT03410992|156385242|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
48598551|NCT03410992|156385243|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48814706|NCT00422799|157163553|FG000|Overall Study|Adverse Event|7|||
48814707|NCT02406261|157163554|FG000|Period 1|Lost to Follow-up|2|||
48814708|NCT02406261|157163555|FG001|Period 1|Lost to Follow-up|0|||
48814709|NCT02406261|157163554|FG000|Period 1|Adverse Event|1|||
48814710|NCT02406261|157163555|FG001|Period 1|Adverse Event|0|||
48814711|NCT02406261|157163554|FG000|Period 2|Physician Decision|0|||
48814712|NCT02406261|157163555|FG001|Period 2|Physician Decision|1|||
48814713|NCT02406261|157163554|FG000|Period 2|Protocol Violation|0|||
48717262|NCT02660138|156813623|FG001|Overall Study|Lack of Efficacy|2|||
48717263|NCT02660138|156813624|FG002|Overall Study|Lack of Efficacy|1|||
48717264|NCT02660138|156813622|FG000|Overall Study|Withdrawal by Subject|7|||
48717265|NCT02660138|156813623|FG001|Overall Study|Withdrawal by Subject|6|||
48717266|NCT02660138|156813624|FG002|Overall Study|Withdrawal by Subject|6|||
48717267|NCT02660138|156813622|FG000|Overall Study|Lost to Follow-up|4|||
48717268|NCT02660138|156813623|FG001|Overall Study|Lost to Follow-up|4|||
48717269|NCT02660138|156813624|FG002|Overall Study|Lost to Follow-up|1|||
48717270|NCT02660138|156813622|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
48717271|NCT02660138|156813623|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
48717272|NCT02660138|156813624|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
48717273|NCT02660138|156813622|FG000|Overall Study|Other|1|||
48717274|NCT02660138|156813623|FG001|Overall Study|Other|1|||
48717275|NCT02660138|156813624|FG002|Overall Study|Other|0|||
48717276|NCT02660138|156813622|FG000|Overall Study|Not treated|0|||
48717277|NCT02660138|156813623|FG001|Overall Study|Not treated|1|||
48717278|NCT02660138|156813624|FG002|Overall Study|Not treated|0|||
48717279|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
48717280|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
48717281|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
48717282|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
48814714|NCT02406261|157163555|FG001|Period 2|Protocol Violation|1|||
48814715|NCT02406261|157163554|FG000|Period 2|Withdrawal by Subject|0|||
48497996|NCT00175019|156017879|FG001|Overall Study|Personal Reason(s)|31|||
48497997|NCT00175019|156017880|FG002|Overall Study|Personal Reason(s)|8|||
48497998|NCT00175019|156017878|FG000|Overall Study|Therapeutic Failure|10|||
48497999|NCT00175019|156017879|FG001|Overall Study|Therapeutic Failure|38|||
48717283|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
48717284|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48717285|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48814716|NCT02406261|157163555|FG001|Period 2|Withdrawal by Subject|1|||
48498000|NCT00175019|156017880|FG002|Overall Study|Therapeutic Failure|22|||
48498001|NCT00175019|156017878|FG000|Overall Study|Gout Flare|2|||
48498002|NCT00175019|156017879|FG001|Overall Study|Gout Flare|3|||
48498003|NCT00175019|156017880|FG002|Overall Study|Gout Flare|0|||
48498004|NCT00175019|156017878|FG000|Overall Study|Reason Not Specified|40|||
48498005|NCT00175019|156017879|FG001|Overall Study|Reason Not Specified|34|||
48498006|NCT00175019|156017880|FG002|Overall Study|Reason Not Specified|11|||
48498007|NCT02324465|156017891|FG000|Overall Study|device failure|0|||
48498008|NCT02324465|156017892|FG001|Overall Study|device failure|1|||
48498009|NCT02270736|156017893|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
48498010|NCT02270736|156017894|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
48498011|NCT02270736|156017895|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
48498012|NCT02270736|156017896|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
48498013|NCT02270736|156017897|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
48498014|NCT02270736|156017893|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
48498015|NCT02270736|156017894|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
48498016|NCT02270736|156017895|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
48814717|NCT01394250|157163556|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
48814718|NCT01394250|157163557|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
48814719|NCT01394250|157163556|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
48814720|NCT01394250|157163557|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
48814721|NCT03000673|157163560|FG000|Overall Study|Withdrawal by Subject|1|||
48814722|NCT03000673|157163561|FG001|Overall Study|Withdrawal by Subject|0|||
48814723|NCT03000673|157163562|FG002|Overall Study|Withdrawal by Subject|0|||
48814724|NCT03000673|157163563|FG003|Overall Study|Withdrawal by Subject|0|||
48814725|NCT02374593|157163564|FG000|Overall Study|non-compliant|2|||
48498017|NCT02270736|156017896|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
48498018|NCT02270736|156017897|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
48498019|NCT02270736|156017893|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
48498020|NCT02270736|156017894|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
48498021|NCT02270736|156017895|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
48498022|NCT02270736|156017896|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
48498023|NCT02270736|156017897|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
48498024|NCT02270736|156017893|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
48498025|NCT02270736|156017894|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
48498026|NCT02270736|156017895|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
48498027|NCT02270736|156017896|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
48630217|NCT02276040|156504896|FG000|Overall Study|Physician Decision|15|||
48630218|NCT00505687|156504897|FG000|Overall Study|Important protocol violation|2|||
48630219|NCT00505687|156504897|FG000|Overall Study|Lack of Efficacy|15|||
48630220|NCT00505687|156504897|FG000|Overall Study|Adverse Event|48|||
48630221|NCT00505687|156504897|FG000|Overall Study|Subject withdrew consent|15|||
48630222|NCT00505687|156504897|FG000|Overall Study|Lost to Follow-up|1|||
48630223|NCT00505687|156504897|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
48630224|NCT00505687|156504897|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
48630225|NCT00505687|156504897|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
48630226|NCT00505687|156504897|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
48630227|NCT00505687|156504897|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
48630228|NCT00505687|156504897|FG000|Overall Study|Other: Disease Progression|1|||
48630229|NCT00505687|156504897|FG000|Overall Study|Other: As Per Sponsor|8|||
48630230|NCT00567502|156504898|FG000|Overall Study|Lost to Follow-up|91|||
48630231|NCT00567502|156504899|FG001|Overall Study|Lost to Follow-up|14|||
48630232|NCT00567502|156504900|FG002|Overall Study|Lost to Follow-up|351|||
48630233|NCT00567502|156504901|FG003|Overall Study|Lost to Follow-up|2|||
48630234|NCT00567502|156504898|FG000|Overall Study|Death|65|||
48630235|NCT00567502|156504899|FG001|Overall Study|Death|16|||
48630236|NCT00567502|156504900|FG002|Overall Study|Death|360|||
48630237|NCT00567502|156504901|FG003|Overall Study|Death|5|||
48630238|NCT00567502|156504898|FG000|Overall Study|Other|64|||
48630239|NCT00567502|156504899|FG001|Overall Study|Other|2|||
48630240|NCT00567502|156504900|FG002|Overall Study|Other|134|||
48630241|NCT00567502|156504901|FG003|Overall Study|Other|6|||
48630242|NCT00567502|156504898|FG000|Overall Study|Participant request|12|||
48630243|NCT00567502|156504899|FG001|Overall Study|Participant request|1|||
48630244|NCT00567502|156504900|FG002|Overall Study|Participant request|33|||
48630245|NCT00567502|156504901|FG003|Overall Study|Participant request|1|||
48630246|NCT00567502|156504898|FG000|Overall Study|Sponsor request|9|||
48630247|NCT00567502|156504899|FG001|Overall Study|Sponsor request|0|||
48630248|NCT00567502|156504900|FG002|Overall Study|Sponsor request|30|||
48630249|NCT00567502|156504901|FG003|Overall Study|Sponsor request|1|||
48630250|NCT00567502|156504898|FG000|Overall Study|Never Initiated Treatment|0|||
48630251|NCT00567502|156504899|FG001|Overall Study|Never Initiated Treatment|0|||
48630252|NCT00567502|156504900|FG002|Overall Study|Never Initiated Treatment|0|||
48630253|NCT00567502|156504901|FG003|Overall Study|Never Initiated Treatment|72|||
48498028|NCT02270736|156017897|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
48498029|NCT02270736|156017893|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
48498030|NCT02270736|156017894|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
48498031|NCT02270736|156017895|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
48498032|NCT02270736|156017896|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
48498033|NCT02270736|156017897|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
48498034|NCT02270736|156017893|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
48498035|NCT02270736|156017894|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
48498036|NCT02270736|156017895|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
48498037|NCT02270736|156017896|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
48717286|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48717287|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48717288|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
48717289|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717290|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717291|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717292|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717293|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
48717294|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717295|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48498038|NCT02270736|156017897|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
48498039|NCT02270736|156017893|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
48498040|NCT02270736|156017894|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
48498041|NCT02270736|156017895|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
48498042|NCT02270736|156017896|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
48498043|NCT02270736|156017897|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
48498044|NCT02270736|156017893|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
48498045|NCT02270736|156017894|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
48498046|NCT02270736|156017895|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
48498047|NCT02270736|156017896|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
48498048|NCT02270736|156017897|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
48498049|NCT02270736|156017893|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
48498050|NCT02270736|156017894|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
48498051|NCT02270736|156017895|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
48498052|NCT02270736|156017896|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
48498053|NCT02270736|156017897|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
48498054|NCT01631864|156017898|FG000|Overall Study|Withdrawal by Subject|0|||
48498055|NCT01631864|156017899|FG001|Overall Study|Withdrawal by Subject|1|||
48717296|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717297|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717298|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
48717299|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
48717300|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717301|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717302|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717303|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
48717304|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717305|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717306|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48498056|NCT01631864|156017898|FG000|Overall Study|Adverse Event|2|||
48498057|NCT01631864|156017899|FG001|Overall Study|Adverse Event|3|||
48498058|NCT03823300|156017915|FG000|Overall Study|Withdrawal by Subject|16|||
48498059|NCT03823300|156017916|FG001|Overall Study|Withdrawal by Subject|22|||
48498060|NCT03823300|156017915|FG000|Overall Study|Death|10|||
48498061|NCT03823300|156017916|FG001|Overall Study|Death|14|||
48498062|NCT03823300|156017915|FG000|Overall Study|Adverse Event|3|||
48498063|NCT03823300|156017916|FG001|Overall Study|Adverse Event|5|||
48498064|NCT03823300|156017915|FG000|Overall Study|Physician Decision|1|||
48498065|NCT03823300|156017916|FG001|Overall Study|Physician Decision|7|||
48717307|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717308|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
48717309|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717310|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717311|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
48717312|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717313|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
48717314|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717315|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48498066|NCT03823300|156017915|FG000|Overall Study|Lost to Follow-up|1|||
48498067|NCT03823300|156017916|FG001|Overall Study|Lost to Follow-up|3|||
48498068|NCT03823300|156017915|FG000|Overall Study|Protocol Violation|1|||
48498069|NCT03823300|156017916|FG001|Overall Study|Protocol Violation|1|||
48498070|NCT03823300|156017915|FG000|Overall Study|Lack of Efficacy|1|||
48498071|NCT03823300|156017916|FG001|Overall Study|Lack of Efficacy|1|||
48498072|NCT03823300|156017915|FG000|Overall Study|Not Eligible|0|||
48498073|NCT03823300|156017916|FG001|Overall Study|Not Eligible|1|||
48498074|NCT03823300|156017915|FG000|Overall Study|Other|1|||
48498075|NCT03823300|156017916|FG001|Overall Study|Other|0|||
48498076|NCT04041570|156017917|FG000|Overall Study|Moved from Area|0|||
48498077|NCT04041570|156017918|FG001|Overall Study|Moved from Area|2|||
48498078|NCT01180244|156017919|FG000|Overall Study|Lack of Efficacy|0|||
48498079|NCT01180244|156017920|FG001|Overall Study|Lack of Efficacy|7|||
48598552|NCT03410992|156385244|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48598553|NCT03410992|156385245|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48598554|NCT03410992|156385246|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48598555|NCT03410992|156385247|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
48598556|NCT03410992|156385237|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598557|NCT03410992|156385238|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598558|NCT03410992|156385239|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598559|NCT03410992|156385240|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598560|NCT03410992|156385241|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598561|NCT03410992|156385242|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598562|NCT03410992|156385243|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598563|NCT03410992|156385244|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
48598564|NCT03410992|156385245|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598565|NCT03410992|156385246|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598566|NCT03410992|156385247|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
48598567|NCT03410992|156385237|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48598568|NCT03410992|156385238|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48498080|NCT01180244|156017919|FG000|Overall Study|Physician Decision|3|||
48498081|NCT01180244|156017920|FG001|Overall Study|Physician Decision|0|||
48498082|NCT01180244|156017919|FG000|Overall Study|Adverse Event|1|||
48498083|NCT01180244|156017920|FG001|Overall Study|Adverse Event|0|||
48498084|NCT01180244|156017919|FG000|Overall Study|Withdrawal by Subject|0|||
48498085|NCT01180244|156017920|FG001|Overall Study|Withdrawal by Subject|1|||
48498086|NCT01180244|156017919|FG000|Overall Study|Protocol Violation|1|||
48498087|NCT01180244|156017920|FG001|Overall Study|Protocol Violation|0|||
48498088|NCT01180244|156017919|FG000|Overall Study|Lost to Follow-up|1|||
48498089|NCT01180244|156017920|FG001|Overall Study|Lost to Follow-up|0|||
48598569|NCT03410992|156385239|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48598570|NCT03410992|156385240|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48598571|NCT03410992|156385241|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48598572|NCT03410992|156385242|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48598573|NCT03410992|156385243|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48598574|NCT03410992|156385244|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48717316|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717317|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717318|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
48717319|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717320|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717321|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48498090|NCT00662025|156017933|FG000|Overall Study|Objective progression or relapse|51|||
48498091|NCT00662025|156017933|FG000|Overall Study|Adverse Event|7|||
48498092|NCT00662025|156017933|FG000|Overall Study|Withdrawal by Subject|1|||
48498093|NCT00662025|156017933|FG000|Overall Study|Results of other clinical study|2|||
48498094|NCT00662025|156017933|FG000|Overall Study|Target lesion cannot be evaluated|1|||
48717322|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717323|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
48717324|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717325|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717326|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717327|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48498095|NCT00662025|156017933|FG000|Overall Study|Domestic circumstances|1|||
48498096|NCT00525590|156017941|FG000|Overall Study|Adverse Event|3|||
48598575|NCT03410992|156385245|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
48598576|NCT03410992|156385246|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48598577|NCT03410992|156385247|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
48598578|NCT02260817|156385248|FG000|Overall Study|Lost to Follow-up|0|||
48598579|NCT02260817|156385249|FG001|Overall Study|Lost to Follow-up|14|||
48598580|NCT02260817|156385248|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
48717328|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
48717329|NCT01185353|156813627|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
48498097|NCT00525590|156017941|FG000|Overall Study|Physician Decision|3|||
48498098|NCT00525590|156017941|FG000|Overall Study|Withdrawal by Subject|16|||
48598581|NCT02260817|156385249|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
48598582|NCT02260817|156385248|FG000|Overall Study|Observation, no biopsy|0|||
48598583|NCT02260817|156385249|FG001|Overall Study|Observation, no biopsy|1|||
48598584|NCT02260817|156385248|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
48598585|NCT02260817|156385249|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
48598586|NCT02260817|156385248|FG000|Overall Study|Protocol Violation|0|||
48598587|NCT02260817|156385249|FG001|Overall Study|Protocol Violation|14|||
48598588|NCT04435808|156385250|FG000|Overall Study|Study stopped by DSMB|0|||
48598589|NCT04435808|156385251|FG001|Overall Study|Study stopped by DSMB|1|||
48598590|NCT02896569|156385252|FG000|Overall Study|Lost to Follow-up|2|||
48598591|NCT02896569|156385253|FG001|Overall Study|Lost to Follow-up|1|||
48598592|NCT02896569|156385252|FG000|Overall Study|Physician Decision|1|||
48598593|NCT02896569|156385253|FG001|Overall Study|Physician Decision|3|||
48598594|NCT02896569|156385252|FG000|Overall Study|Adverse Event|0|||
48598595|NCT02896569|156385253|FG001|Overall Study|Adverse Event|1|||
48598596|NCT02896569|156385252|FG000|Overall Study|Withdrawal by Subject|1|||
48598597|NCT02896569|156385253|FG001|Overall Study|Withdrawal by Subject|0|||
48598598|NCT03075267|156385255|FG000|Overall Study|Protocol Violation|1|||
48598599|NCT03075267|156385256|FG001|Overall Study|Protocol Violation|0|||
48598600|NCT03075267|156385257|FG002|Overall Study|Protocol Violation|0|||
48717330|NCT01185353|156813628|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717331|NCT01185353|156813629|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717332|NCT01185353|156813630|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717333|NCT01185353|156813631|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
48717334|NCT01185353|156813632|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717335|NCT01185353|156813633|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717336|NCT01185353|156813634|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717337|NCT01185353|156813635|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717338|NCT01185353|156813636|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
48717339|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717340|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717341|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
48717342|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717343|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717344|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
48717345|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717346|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717347|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717348|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
48717349|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717350|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
48717351|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717352|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
48717353|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717354|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717355|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717356|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717357|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717358|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
48717359|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717360|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717361|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717362|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
48717363|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717364|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717365|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
48717366|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717367|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48598601|NCT00527826|156385259|FG000|Overall Study|Adverse Event|10|||
48598602|NCT00527826|156385260|FG001|Overall Study|Adverse Event|10|||
48598603|NCT00527826|156385259|FG000|Overall Study|Lost to Follow-up|3|||
48598604|NCT00527826|156385260|FG001|Overall Study|Lost to Follow-up|2|||
48598605|NCT00527826|156385259|FG000|Overall Study|Withdrawal by Subject|5|||
48598606|NCT00527826|156385260|FG001|Overall Study|Withdrawal by Subject|8|||
48598607|NCT00527826|156385259|FG000|Overall Study|Inclusion Criteria Not Met|3|||
48598608|NCT00527826|156385260|FG001|Overall Study|Inclusion Criteria Not Met|3|||
48717368|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
48717369|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48717370|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48717371|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
48717372|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
48717373|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48598609|NCT00527826|156385259|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
48498099|NCT00525590|156017941|FG000|Overall Study|Lost to Follow-up|1|||
48498100|NCT00525590|156017941|FG000|Overall Study|Death|9|||
48498101|NCT00525590|156017941|FG000|Overall Study|Other|13|||
48498102|NCT01025037|156017945|FG000|Overall Study|Adverse Event|3|||
48498103|NCT01025037|156017945|FG000|Overall Study|Lost to Follow-up|7|||
48498104|NCT01025037|156017945|FG000|Overall Study|Withdrawal by Subject|1|||
48498105|NCT00337571|156017946|FG000|Overall Study|Lack of Efficacy|3|||
48498106|NCT00337571|156017947|FG001|Overall Study|Lack of Efficacy|0|||
48498107|NCT00337571|156017948|FG002|Overall Study|Lack of Efficacy|0|||
48498108|NCT00337571|156017949|FG003|Overall Study|Lack of Efficacy|0|||
48498109|NCT00337571|156017946|FG000|Overall Study|Adverse Event|4|||
48498110|NCT00337571|156017947|FG001|Overall Study|Adverse Event|5|||
48498111|NCT00337571|156017948|FG002|Overall Study|Adverse Event|8|||
48498112|NCT00337571|156017949|FG003|Overall Study|Adverse Event|4|||
48814726|NCT02374593|157163565|FG001|Overall Study|non-compliant|0|||
48814727|NCT01425632|157163566|FG000|Overall Study|Adverse Event|0|||
48814728|NCT01425632|157163567|FG001|Overall Study|Adverse Event|1|||
48814729|NCT01425632|157163568|FG002|Overall Study|Adverse Event|1|||
48814730|NCT01425632|157163566|FG000|Overall Study|Physician Decision|1|||
48814731|NCT01425632|157163567|FG001|Overall Study|Physician Decision|0|||
48717374|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
48717375|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
48717376|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48717377|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48598610|NCT00527826|156385260|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
48598611|NCT00527826|156385259|FG000|Overall Study|Additional Intake of Viani forte|0|||
48598612|NCT00527826|156385260|FG001|Overall Study|Additional Intake of Viani forte|1|||
48598613|NCT00527826|156385259|FG000|Overall Study|Participant moved away|0|||
48598614|NCT00527826|156385260|FG001|Overall Study|Participant moved away|1|||
48598615|NCT00810069|156385261|FG000|Lead-in Period I|Adverse Event|43|||
48498113|NCT00337571|156017946|FG000|Overall Study|Withdrawal by Subject|2|||
48498114|NCT00337571|156017947|FG001|Overall Study|Withdrawal by Subject|2|||
48498115|NCT00337571|156017948|FG002|Overall Study|Withdrawal by Subject|1|||
48498116|NCT00337571|156017949|FG003|Overall Study|Withdrawal by Subject|0|||
48598616|NCT00810069|156385262|FG001|Lead-in Period I|Adverse Event|0|||
48598617|NCT00810069|156385263|FG002|Lead-in Period I|Adverse Event|0|||
48598618|NCT00810069|156385261|FG000|Lead-in Period I|Lack of Efficacy|1|||
48598619|NCT00810069|156385262|FG001|Lead-in Period I|Lack of Efficacy|0|||
48717378|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
48717379|NCT01185353|156813627|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717380|NCT01185353|156813628|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48814732|NCT01425632|157163568|FG002|Overall Study|Physician Decision|0|||
48814733|NCT01425632|157163566|FG000|Overall Study|Protocol Violation|0|||
48814734|NCT01425632|157163567|FG001|Overall Study|Protocol Violation|0|||
48814735|NCT01425632|157163568|FG002|Overall Study|Protocol Violation|2|||
48814736|NCT01425632|157163566|FG000|Overall Study|Withdrawal by Subject|0|||
48717381|NCT01185353|156813629|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717382|NCT01185353|156813630|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717383|NCT01185353|156813631|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717384|NCT01185353|156813632|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717385|NCT01185353|156813633|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
48717386|NCT01185353|156813634|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717387|NCT01185353|156813635|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717388|NCT01185353|156813636|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
48717389|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717390|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48814737|NCT01425632|157163567|FG001|Overall Study|Withdrawal by Subject|0|||
48814738|NCT01425632|157163568|FG002|Overall Study|Withdrawal by Subject|1|||
48814739|NCT02443103|157163574|FG000|Overall Study|Adverse Event|2|||
48814740|NCT02443103|157163574|FG000|Overall Study|Noncompliance|1|||
48498117|NCT00337571|156017946|FG000|Overall Study|Lost to Follow-up|3|||
48814741|NCT01751113|157163580|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
48498118|NCT00337571|156017947|FG001|Overall Study|Lost to Follow-up|1|||
48598620|NCT00810069|156385263|FG002|Lead-in Period I|Lack of Efficacy|0|||
48498119|NCT00337571|156017948|FG002|Overall Study|Lost to Follow-up|0|||
48598621|NCT00810069|156385261|FG000|Lead-in Period I|Lost to Follow-up|19|||
48598622|NCT00810069|156385262|FG001|Lead-in Period I|Lost to Follow-up|0|||
48598623|NCT00810069|156385263|FG002|Lead-in Period I|Lost to Follow-up|0|||
48598624|NCT00810069|156385261|FG000|Lead-in Period I|Physician Decision|1|||
48598625|NCT00810069|156385262|FG001|Lead-in Period I|Physician Decision|0|||
48717391|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48814742|NCT01751113|157163581|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
48498120|NCT00337571|156017949|FG003|Overall Study|Lost to Follow-up|1|||
48498121|NCT00337571|156017946|FG000|Overall Study|Poor/noncompliance|1|||
48717392|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717393|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717394|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717395|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
48717396|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
48717397|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
48717398|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
48717399|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717400|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717401|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717402|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717403|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717404|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717405|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
48717406|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
48717407|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
48717408|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
48717409|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717410|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717411|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48498122|NCT00337571|156017947|FG001|Overall Study|Poor/noncompliance|1|||
48498123|NCT00337571|156017948|FG002|Overall Study|Poor/noncompliance|1|||
48498124|NCT00337571|156017949|FG003|Overall Study|Poor/noncompliance|1|||
48498125|NCT00337571|156017946|FG000|Overall Study|No longer met study criteria|1|||
48498126|NCT00337571|156017947|FG001|Overall Study|No longer met study criteria|0|||
48498127|NCT00337571|156017948|FG002|Overall Study|No longer met study criteria|0|||
48498128|NCT00337571|156017949|FG003|Overall Study|No longer met study criteria|0|||
48498129|NCT00337571|156017946|FG000|Overall Study|High Potassium level|0|||
48498130|NCT00337571|156017947|FG001|Overall Study|High Potassium level|0|||
48498131|NCT00337571|156017948|FG002|Overall Study|High Potassium level|0|||
48498132|NCT00337571|156017949|FG003|Overall Study|High Potassium level|1|||
48498133|NCT01399736|156017951|FG000|Overall Study|Withdrawal by Subject|4|||
48498134|NCT01399736|156017952|FG001|Overall Study|Withdrawal by Subject|2|||
48498135|NCT01399736|156017951|FG000|Overall Study|Lost to Follow-up|0|||
48498136|NCT01399736|156017952|FG001|Overall Study|Lost to Follow-up|2|||
48498137|NCT03500484|156017953|FG000|Overall Study|Adverse Event|2|||
48498138|NCT03500484|156017954|FG001|Overall Study|Adverse Event|0|||
48498139|NCT03500484|156017953|FG000|Overall Study|Physician Decision|1|||
48498140|NCT03500484|156017954|FG001|Overall Study|Physician Decision|0|||
48498141|NCT03500484|156017953|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
48498142|NCT03500484|156017954|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
48498143|NCT01166568|156017955|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
48498144|NCT01166568|156017956|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
48498145|NCT01166568|156017957|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
48498146|NCT01166568|156017955|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
48498147|NCT01166568|156017956|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
48498148|NCT01166568|156017957|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
48498149|NCT01166568|156017955|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
48498150|NCT01166568|156017956|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
48498151|NCT01166568|156017957|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
48498152|NCT01508936|156017958|FG000|Overall Study|Adverse Event|11|||
48498153|NCT01508936|156017959|FG001|Overall Study|Adverse Event|32|||
48498154|NCT01508936|156017958|FG000|Overall Study|Lack of Efficacy|0|||
48498155|NCT01508936|156017959|FG001|Overall Study|Lack of Efficacy|1|||
48498156|NCT01508936|156017958|FG000|Overall Study|Withdrawal by Subject|4|||
48498157|NCT01508936|156017959|FG001|Overall Study|Withdrawal by Subject|18|||
48498158|NCT01508936|156017958|FG000|Overall Study|Protocol Violation|2|||
48498159|NCT01508936|156017959|FG001|Overall Study|Protocol Violation|3|||
48498160|NCT01508936|156017958|FG000|Overall Study|Lost to Follow-up|2|||
48498161|NCT01508936|156017959|FG001|Overall Study|Lost to Follow-up|9|||
48498162|NCT01508936|156017958|FG000|Overall Study|Other|0|||
48498163|NCT01508936|156017959|FG001|Overall Study|Other|5|||
48498164|NCT01508936|156017958|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
48498165|NCT01508936|156017959|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
48598626|NCT00810069|156385263|FG002|Lead-in Period I|Physician Decision|0|||
48717412|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717413|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717414|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48498166|NCT01531205|156017960|FG000|Overall Study|Did not proceed to surgery|1|||
48498167|NCT00948675|156017961|FG000|Overall Study|Lost to Follow-up|1|||
48498168|NCT00948675|156017962|FG001|Overall Study|Lost to Follow-up|0|||
48498169|NCT03335371|156017963|FG000|Overall Study|Lost to Follow-up|0|||
48717415|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
48717416|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
48717417|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
48717418|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
48717419|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717420|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717421|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717422|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717423|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717424|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717425|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717426|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717427|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
48717428|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
48717429|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Death|0|||
48717430|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Death|0|||
48717431|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Death|0|||
48717432|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Death|0|||
48717433|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Death|0|||
48717434|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Death|0|||
48717435|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Death|0|||
48717436|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Death|0|||
48717437|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Death|0|||
48717438|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Death|1|||
48717439|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717440|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717441|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717442|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717443|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717444|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717445|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717446|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717447|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
48717448|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
48717449|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717450|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717451|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717452|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717453|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48814743|NCT01751113|157163582|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
48814744|NCT01751113|157163583|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
48814745|NCT01751113|157163584|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
48814746|NCT01751113|157163585|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
48498170|NCT03335371|156017964|FG001|Overall Study|Lost to Follow-up|0|||
48814747|NCT01751113|157163580|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48814748|NCT01751113|157163581|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48814749|NCT01751113|157163582|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48814750|NCT01751113|157163583|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48498171|NCT03335371|156017965|FG002|Overall Study|Lost to Follow-up|0|||
48498172|NCT03335371|156017966|FG003|Overall Study|Lost to Follow-up|0|||
48498173|NCT03335371|156017967|FG004|Overall Study|Lost to Follow-up|1|||
48498174|NCT03335371|156017963|FG000|Overall Study|Withdrawal by Subject|0|||
48498175|NCT03335371|156017964|FG001|Overall Study|Withdrawal by Subject|0|||
48498176|NCT03335371|156017965|FG002|Overall Study|Withdrawal by Subject|0|||
48498177|NCT03335371|156017966|FG003|Overall Study|Withdrawal by Subject|0|||
48717454|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48814751|NCT01751113|157163584|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
48814752|NCT01751113|157163585|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
48814753|NCT01115491|157163587|FG000|Overall Study|Death|22|||
48814754|NCT01115491|157163587|FG000|Overall Study|Adverse Event|3|||
48814755|NCT01115491|157163587|FG000|Overall Study|Lost to Follow-up|3|||
48814756|NCT01115491|157163587|FG000|Overall Study|Withdrawal by Subject|1|||
48814757|NCT01115491|157163587|FG000|Overall Study|Physician Decision|1|||
48814758|NCT00363896|157163588|FG000|Overall Study|Withdrawal by Subject|29|||
48814759|NCT00363896|157163589|FG001|Overall Study|Withdrawal by Subject|16|||
48717455|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717456|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717457|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
48717458|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
48814760|NCT00363896|157163588|FG000|Overall Study|Adverse Event|24|||
48498178|NCT03335371|156017967|FG004|Overall Study|Withdrawal by Subject|1|||
48498179|NCT03335371|156017963|FG000|Overall Study|Randomization Error|0|||
48717459|NCT01185353|156813627|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717460|NCT01185353|156813628|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717461|NCT01185353|156813629|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717462|NCT01185353|156813630|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717463|NCT01185353|156813631|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717464|NCT01185353|156813632|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717465|NCT01185353|156813633|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717466|NCT01185353|156813634|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717467|NCT01185353|156813635|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
48717468|NCT01185353|156813636|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
48717469|NCT01185353|156813627|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717470|NCT01185353|156813628|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717471|NCT01185353|156813629|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48814761|NCT00363896|157163589|FG001|Overall Study|Adverse Event|13|||
48814762|NCT00363896|157163588|FG000|Overall Study|COPD exacerbation|13|||
48814763|NCT00363896|157163589|FG001|Overall Study|COPD exacerbation|7|||
48598627|NCT00810069|156385261|FG000|Lead-in Period I|Protocol Violation|1|||
48814764|NCT00363896|157163588|FG000|Overall Study|Lack of Efficacy|12|||
48814765|NCT00363896|157163589|FG001|Overall Study|Lack of Efficacy|8|||
48498180|NCT03335371|156017964|FG001|Overall Study|Randomization Error|0|||
48498181|NCT03335371|156017965|FG002|Overall Study|Randomization Error|1|||
48498182|NCT03335371|156017966|FG003|Overall Study|Randomization Error|0|||
48498183|NCT03335371|156017967|FG004|Overall Study|Randomization Error|0|||
48498184|NCT00684671|156017972|FG000|Overall Study|Adverse Event|1|||
48498185|NCT00684671|156017973|FG001|Overall Study|Adverse Event|0|||
48498186|NCT00684671|156017974|FG002|Overall Study|Adverse Event|0|||
48498187|NCT00684671|156017972|FG000|Overall Study|Lost to Follow-up|1|||
48498188|NCT00684671|156017973|FG001|Overall Study|Lost to Follow-up|0|||
48498189|NCT00684671|156017974|FG002|Overall Study|Lost to Follow-up|0|||
48498190|NCT00684671|156017972|FG000|Overall Study|Alcoholic dependance|1|||
48498191|NCT00684671|156017973|FG001|Overall Study|Alcoholic dependance|0|||
48498192|NCT00684671|156017974|FG002|Overall Study|Alcoholic dependance|0|||
48498193|NCT04276883|156017976|FG000|Overall Study|Withdrawal by Subject|2|||
48498194|NCT04276883|156017977|FG001|Overall Study|Withdrawal by Subject|3|||
48498195|NCT04276883|156017978|FG002|Overall Study|Withdrawal by Subject|6|||
48498196|NCT04276883|156017976|FG000|Overall Study|Lost to Follow-up|1|||
48498197|NCT04276883|156017977|FG001|Overall Study|Lost to Follow-up|3|||
48498198|NCT04276883|156017978|FG002|Overall Study|Lost to Follow-up|0|||
48498199|NCT04276883|156017976|FG000|Overall Study|Adverse Event|0|||
48498200|NCT04276883|156017977|FG001|Overall Study|Adverse Event|1|||
48498201|NCT04276883|156017978|FG002|Overall Study|Adverse Event|0|||
48498202|NCT04276883|156017976|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
48498203|NCT04276883|156017977|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
48498204|NCT04276883|156017978|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
48498205|NCT00958243|156017997|FG000|Overall Study|Withdrawal by Subject|0|||
48498206|NCT00958243|156017998|FG001|Overall Study|Withdrawal by Subject|1|||
48498207|NCT00958243|156017999|FG002|Overall Study|Withdrawal by Subject|3|||
48498208|NCT00958243|156018000|FG003|Overall Study|Withdrawal by Subject|1|||
48498209|NCT00958243|156018001|FG004|Overall Study|Withdrawal by Subject|1|||
48498210|NCT00958243|156018002|FG005|Overall Study|Withdrawal by Subject|5|||
48498211|NCT00958243|156017997|FG000|Overall Study|Lost to Follow-up|2|||
48498212|NCT00958243|156017998|FG001|Overall Study|Lost to Follow-up|5|||
48498213|NCT00958243|156017999|FG002|Overall Study|Lost to Follow-up|11|||
48498214|NCT00958243|156018000|FG003|Overall Study|Lost to Follow-up|2|||
48498215|NCT00958243|156018001|FG004|Overall Study|Lost to Follow-up|8|||
48498216|NCT00958243|156018002|FG005|Overall Study|Lost to Follow-up|5|||
48498217|NCT00117949|156018011|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
48498218|NCT00117949|156018012|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
48498219|NCT00117949|156018013|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
48498220|NCT00117949|156018014|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
48498221|NCT00117949|156018011|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
48498222|NCT00117949|156018012|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
48498223|NCT00117949|156018013|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
48498224|NCT00117949|156018014|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
48498225|NCT00117949|156018011|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
48498226|NCT00117949|156018012|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
48717472|NCT01185353|156813630|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48814766|NCT00363896|157163588|FG000|Overall Study|Protocol Violation|6|||
48498227|NCT00117949|156018013|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
48498228|NCT00117949|156018014|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
48498229|NCT00117949|156018011|FG000|Overall Study|PSA increase >=10ng/mL|0|||
48498230|NCT00117949|156018012|FG001|Overall Study|PSA increase >=10ng/mL|1|||
48498231|NCT00117949|156018013|FG002|Overall Study|PSA increase >=10ng/mL|1|||
48498232|NCT00117949|156018014|FG003|Overall Study|PSA increase >=10ng/mL|0|||
48498233|NCT00117949|156018011|FG000|Overall Study|PSA reduction <=50%|0|||
48814767|NCT00363896|157163589|FG001|Overall Study|Protocol Violation|1|||
48814768|NCT00363896|157163588|FG000|Overall Study|Lost to Follow-up|3|||
48814769|NCT00363896|157163589|FG001|Overall Study|Lost to Follow-up|0|||
48814770|NCT00363896|157163588|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
48814771|NCT00363896|157163589|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
48814772|NCT00363896|157163588|FG000|Overall Study|Other|1|||
48814773|NCT00363896|157163589|FG001|Overall Study|Other|2|||
48814774|NCT01651936|157163590|FG000|Base Study|Adverse Event|3|||
48814775|NCT01651936|157163591|FG001|Base Study|Adverse Event|0|||
48814776|NCT01651936|157163592|FG002|Base Study|Adverse Event|0|||
48814777|NCT01651936|157163590|FG000|Base Study|Withdrawal by Subject|1|||
48814778|NCT01651936|157163591|FG001|Base Study|Withdrawal by Subject|1|||
48814779|NCT01651936|157163592|FG002|Base Study|Withdrawal by Subject|0|||
48814780|NCT01651936|157163590|FG000|Base Study|Early Escape|2|||
48814781|NCT01651936|157163591|FG001|Base Study|Early Escape|8|||
48814782|NCT01651936|157163592|FG002|Base Study|Early Escape|0|||
48814783|NCT01651936|157163590|FG000|Base Study|Study terminated by sponsor|21|||
48814784|NCT01651936|157163591|FG001|Base Study|Study terminated by sponsor|16|||
48814785|NCT01651936|157163592|FG002|Base Study|Study terminated by sponsor|0|||
48814786|NCT01651936|157163590|FG000|Extension Study|Lack of Efficacy|0|||
48814787|NCT01651936|157163591|FG001|Extension Study|Lack of Efficacy|0|||
48814788|NCT01651936|157163592|FG002|Extension Study|Lack of Efficacy|1|||
48814789|NCT01651936|157163590|FG000|Extension Study|Study terminated by sponsor|0|||
48814790|NCT01651936|157163591|FG001|Extension Study|Study terminated by sponsor|0|||
48814791|NCT01651936|157163592|FG002|Extension Study|Study terminated by sponsor|13|||
48814792|NCT01799720|157163599|FG000|Overall Study|Withdrawal by Subject|3|||
48814793|NCT01799720|157163600|FG001|Overall Study|Withdrawal by Subject|0|||
48814794|NCT01799720|157163601|FG002|Overall Study|Withdrawal by Subject|0|||
48814795|NCT01799720|157163599|FG000|Overall Study|Protocol Violation|0|||
48814796|NCT01799720|157163600|FG001|Overall Study|Protocol Violation|1|||
48814797|NCT01799720|157163601|FG002|Overall Study|Protocol Violation|0|||
48814798|NCT01799720|157163599|FG000|Overall Study|Pregnancy|0|||
48814799|NCT01799720|157163600|FG001|Overall Study|Pregnancy|0|||
48814800|NCT01799720|157163601|FG002|Overall Study|Pregnancy|1|||
48498234|NCT00117949|156018012|FG001|Overall Study|PSA reduction <=50%|2|||
48498235|NCT00117949|156018013|FG002|Overall Study|PSA reduction <=50%|2|||
48498236|NCT00117949|156018014|FG003|Overall Study|PSA reduction <=50%|4|||
48498237|NCT00117949|156018011|FG000|Overall Study|Hepatic abnormalities|0|||
48498238|NCT00117949|156018012|FG001|Overall Study|Hepatic abnormalities|1|||
48498239|NCT00117949|156018013|FG002|Overall Study|Hepatic abnormalities|0|||
48498240|NCT00117949|156018014|FG003|Overall Study|Hepatic abnormalities|1|||
48498241|NCT01226797|156018015|FG000|Overall Study|Adverse Event|1|||
48498242|NCT01226797|156018016|FG001|Overall Study|Adverse Event|0|||
48630254|NCT00573768|156504902|FG000|Overall Study|Adverse Event|1|||
48630255|NCT00573768|156504903|FG001|Overall Study|Adverse Event|1|||
48630256|NCT00573768|156504904|FG002|Overall Study|Adverse Event|2|||
48630257|NCT00573768|156504902|FG000|Overall Study|Protocol Violation|1|||
48630258|NCT00573768|156504903|FG001|Overall Study|Protocol Violation|0|||
48630259|NCT00573768|156504904|FG002|Overall Study|Protocol Violation|1|||
48630260|NCT00573768|156504902|FG000|Overall Study|Withdrawal by Subject|0|||
48630261|NCT00573768|156504903|FG001|Overall Study|Withdrawal by Subject|1|||
48630262|NCT00573768|156504904|FG002|Overall Study|Withdrawal by Subject|0|||
48630263|NCT00573768|156504902|FG000|Overall Study|Lost to Follow-up|0|||
48630264|NCT00573768|156504903|FG001|Overall Study|Lost to Follow-up|0|||
48630265|NCT00573768|156504904|FG002|Overall Study|Lost to Follow-up|1|||
48630266|NCT00160563|156504905|FG000|Overall Study|Adverse Event|1|||
48630267|NCT00160563|156504906|FG001|Overall Study|Adverse Event|1|||
48630268|NCT00160563|156504907|FG002|Overall Study|Adverse Event|1|||
48630269|NCT00160563|156504905|FG000|Overall Study|Lost to Follow-up|1|||
48630270|NCT00160563|156504906|FG001|Overall Study|Lost to Follow-up|1|||
48630271|NCT00160563|156504907|FG002|Overall Study|Lost to Follow-up|2|||
48630272|NCT00160563|156504905|FG000|Overall Study|Protocol Violation|0|||
48630273|NCT00160563|156504906|FG001|Overall Study|Protocol Violation|0|||
48630274|NCT00160563|156504907|FG002|Overall Study|Protocol Violation|3|||
48630275|NCT00160563|156504905|FG000|Overall Study|Withdrawal by Subject|1|||
48630276|NCT00160563|156504906|FG001|Overall Study|Withdrawal by Subject|2|||
48630277|NCT00160563|156504907|FG002|Overall Study|Withdrawal by Subject|3|||
48630278|NCT00160563|156504905|FG000|Overall Study|Other (listed in the study report)|48|||
48630279|NCT00160563|156504906|FG001|Overall Study|Other (listed in the study report)|40|||
48630280|NCT00160563|156504907|FG002|Overall Study|Other (listed in the study report)|81|||
48630281|NCT00160563|156504905|FG000|Overall Study|Missing reason|0|||
48630282|NCT00160563|156504906|FG001|Overall Study|Missing reason|1|||
48630283|NCT00160563|156504907|FG002|Overall Study|Missing reason|0|||
48630284|NCT00867334|156504909|FG000|Overall Study|Withdrawal by Subject|0|||
48630285|NCT00867334|156504910|FG001|Overall Study|Withdrawal by Subject|1|||
48630286|NCT00867334|156504909|FG000|Overall Study|Withdrawal by Subject|1|||
48630287|NCT00867334|156504910|FG001|Overall Study|Withdrawal by Subject|0|||
48630288|NCT00867334|156504909|FG000|Overall Study|Withdrawal by Subject|1|||
48717473|NCT01185353|156813631|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717474|NCT01185353|156813632|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717475|NCT01185353|156813633|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717476|NCT01185353|156813634|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
48717477|NCT01185353|156813635|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
48717478|NCT01185353|156813636|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
48717479|NCT01185353|156813627|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717480|NCT01185353|156813628|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717481|NCT01185353|156813629|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717482|NCT01185353|156813630|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717483|NCT01185353|156813631|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717484|NCT01185353|156813632|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717485|NCT01185353|156813633|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
48717486|NCT01185353|156813634|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
48717487|NCT01185353|156813635|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
48717488|NCT01185353|156813636|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
48717489|NCT01185353|156813627|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717490|NCT01185353|156813628|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717491|NCT01185353|156813629|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717492|NCT01185353|156813630|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717493|NCT01185353|156813631|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717494|NCT01185353|156813632|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717495|NCT01185353|156813633|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717496|NCT01185353|156813634|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
48717497|NCT01185353|156813635|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
48717498|NCT01185353|156813636|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
48717499|NCT02081859|156813637|FG000|Overall Study|No fertilization|2|||
48717500|NCT02081859|156813638|FG001|Overall Study|No fertilization|2|||
48717501|NCT02081859|156813637|FG000|Overall Study|No sperm|1|||
48717502|NCT02081859|156813638|FG001|Overall Study|No sperm|0|||
48717503|NCT02081859|156813637|FG000|Overall Study|Unanticipated freeze all cycle|2|||
48717504|NCT02081859|156813638|FG001|Overall Study|Unanticipated freeze all cycle|6|||
48717505|NCT02081859|156813637|FG000|Overall Study|< 4 embryos|27|||
48717506|NCT02081859|156813638|FG001|Overall Study|< 4 embryos|23|||
48717507|NCT02081859|156813637|FG000|Overall Study|Other reasons|2|||
48717508|NCT02081859|156813638|FG001|Overall Study|Other reasons|0|||
48717509|NCT01576159|156813645|FG000|Overall Study|Withdrawal by Subject|0|||
48717510|NCT01576159|156813646|FG001|Overall Study|Withdrawal by Subject|1|||
48717511|NCT01576159|156813647|FG002|Overall Study|Withdrawal by Subject|0|||
48717512|NCT01576159|156813648|FG003|Overall Study|Withdrawal by Subject|0|||
48717513|NCT01576159|156813645|FG000|Overall Study|Physician Decision|0|||
48717514|NCT01576159|156813646|FG001|Overall Study|Physician Decision|0|||
48717515|NCT01576159|156813647|FG002|Overall Study|Physician Decision|1|||
48717516|NCT01576159|156813648|FG003|Overall Study|Physician Decision|0|||
48717517|NCT01576159|156813645|FG000|Overall Study|Lost to Follow-up|0|||
48717518|NCT01576159|156813646|FG001|Overall Study|Lost to Follow-up|0|||
48717519|NCT01576159|156813647|FG002|Overall Study|Lost to Follow-up|0|||
48717520|NCT01576159|156813648|FG003|Overall Study|Lost to Follow-up|1|||
48717521|NCT01576159|156813645|FG000|Overall Study|Protocol Violation|1|||
48717522|NCT01576159|156813646|FG001|Overall Study|Protocol Violation|0|||
48717523|NCT01576159|156813647|FG002|Overall Study|Protocol Violation|0|||
48717524|NCT01576159|156813648|FG003|Overall Study|Protocol Violation|0|||
48717525|NCT01155167|156813655|FG000|Overall Study|Insufficient ultrasound data|2|||
48717526|NCT01155167|156813656|FG001|Overall Study|Insufficient ultrasound data|0|||
48717527|NCT01155167|156813655|FG000|Overall Study|Access site changed to femoral artery|1|||
48717528|NCT01155167|156813656|FG001|Overall Study|Access site changed to femoral artery|0|||
48717529|NCT01964755|156815021|FG000|Overall Study|Death|2|||
48717530|NCT03598114|156815022|FG000|Overall Study|Staff turnover/left the program|3|||
48717531|NCT03598114|156815023|FG001|Overall Study|Staff turnover/left the program|39|||
48717532|NCT01332799|156815025|FG000|Overall Study|Insufficient funding|10|||
48717533|NCT01332799|156815026|FG001|Overall Study|Insufficient funding|10|||
48717534|NCT03179202|156815027|FG000|Overall Study|Screen Failure|67|||
48717535|NCT03179202|156815027|FG000|Overall Study|Subject Lost to Follow Up|12|||
48717536|NCT03179202|156815027|FG000|Overall Study|Withdrawal by Subject|7|||
48717537|NCT03179202|156815027|FG000|Overall Study|Adverse Event|3|||
48717538|NCT03179202|156815027|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
48717539|NCT03179202|156815027|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
48717540|NCT01120782|156815028|FG000|Overall Study|Test article shipping error|11|||
48717541|NCT03255629|156815029|FG000|Overall Study|Adverse Event|1|||
48717542|NCT03255629|156815030|FG001|Overall Study|Adverse Event|0|||
48717543|NCT03255629|156815029|FG000|Overall Study|did not experience hypoglycemia|2|||
48717544|NCT03255629|156815030|FG001|Overall Study|did not experience hypoglycemia|1|||
48717545|NCT00910624|156815031|FG000|Treatment Phase|Adverse Event|2|||
48717546|NCT00910624|156815032|FG001|Treatment Phase|Adverse Event|6|||
48717547|NCT00910624|156815033|FG002|Treatment Phase|Adverse Event|6|||
48717548|NCT00910624|156815034|FG003|Treatment Phase|Adverse Event|0|||
48717549|NCT00910624|156815031|FG000|Treatment Phase|Treatment Failure|23|||
48717550|NCT00910624|156815032|FG001|Treatment Phase|Treatment Failure|10|||
48717551|NCT00910624|156815033|FG002|Treatment Phase|Treatment Failure|0|||
48717552|NCT00910624|156815034|FG003|Treatment Phase|Treatment Failure|0|||
48717553|NCT00910624|156815031|FG000|Treatment Phase|Lost to Follow-up|0|||
48717554|NCT00910624|156815032|FG001|Treatment Phase|Lost to Follow-up|0|||
48717555|NCT00910624|156815033|FG002|Treatment Phase|Lost to Follow-up|1|||
48717556|NCT00910624|156815034|FG003|Treatment Phase|Lost to Follow-up|0|||
48717557|NCT00910624|156815031|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
48717558|NCT00910624|156815032|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
48717559|NCT00910624|156815033|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
48717560|NCT00910624|156815034|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
48717561|NCT00910624|156815031|FG000|Treatment Phase|Withdrawal by Subject|2|||
48717562|NCT00910624|156815032|FG001|Treatment Phase|Withdrawal by Subject|1|||
48717563|NCT00910624|156815033|FG002|Treatment Phase|Withdrawal by Subject|0|||
48717564|NCT00910624|156815034|FG003|Treatment Phase|Withdrawal by Subject|0|||
48717565|NCT00910624|156815031|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
48717566|NCT00910624|156815032|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
48717567|NCT00910624|156815033|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
48717568|NCT00910624|156815034|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
48717569|NCT00910624|156815031|FG000|Follow-Up Phase|Adverse Event|0|||
48717570|NCT00910624|156815032|FG001|Follow-Up Phase|Adverse Event|0|||
48717571|NCT00910624|156815033|FG002|Follow-Up Phase|Adverse Event|1|||
48498243|NCT01226797|156018015|FG000|Overall Study|No longer willing to participate|1|||
48498244|NCT01226797|156018016|FG001|Overall Study|No longer willing to participate|0|||
48498245|NCT01226797|156018015|FG000|Overall Study|Protocol Violation|0|||
48498246|NCT01226797|156018016|FG001|Overall Study|Protocol Violation|1|||
48498247|NCT02799602|156018017|FG000|Overall Study|Protocol Violation|1|||
48498248|NCT02799602|156018018|FG001|Overall Study|Protocol Violation|0|||
48498249|NCT02799602|156018017|FG000|Overall Study|Physician Decision|5|||
48498250|NCT02799602|156018018|FG001|Overall Study|Physician Decision|6|||
48498251|NCT02799602|156018017|FG000|Overall Study|Lost to Follow-up|4|||
48498252|NCT02799602|156018018|FG001|Overall Study|Lost to Follow-up|2|||
48498253|NCT02799602|156018017|FG000|Overall Study|Additional primary malignancy|11|||
48498254|NCT02799602|156018018|FG001|Overall Study|Additional primary malignancy|6|||
48498255|NCT02799602|156018017|FG000|Overall Study|Non-compliance with study drug|14|||
48498256|NCT02799602|156018018|FG001|Overall Study|Non-compliance with study drug|12|||
48717572|NCT00910624|156815034|FG003|Follow-Up Phase|Adverse Event|0|||
48717573|NCT00910624|156815031|FG000|Follow-Up Phase|Lost to Follow-up|3|||
48717574|NCT00910624|156815032|FG001|Follow-Up Phase|Lost to Follow-up|1|||
48717575|NCT00910624|156815033|FG002|Follow-Up Phase|Lost to Follow-up|2|||
48717576|NCT00910624|156815034|FG003|Follow-Up Phase|Lost to Follow-up|0|||
48717577|NCT00910624|156815031|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
48717578|NCT00910624|156815032|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
48717579|NCT00910624|156815033|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
48717580|NCT00910624|156815034|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
48717581|NCT00910624|156815031|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
48717582|NCT00910624|156815032|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
48717583|NCT00910624|156815033|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
48717584|NCT00910624|156815034|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
48717585|NCT00910624|156815031|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
48717586|NCT00910624|156815032|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
48717587|NCT00910624|156815033|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
48717588|NCT00910624|156815034|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
48717589|NCT00910624|156815031|FG000|Follow-Up Phase|Administrative|0|||
48717590|NCT00910624|156815032|FG001|Follow-Up Phase|Administrative|1|||
48498257|NCT02799602|156018017|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
48498258|NCT02799602|156018018|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
48498259|NCT02799602|156018017|FG000|Overall Study|Withdrawal by Subject|26|||
48717591|NCT00910624|156815033|FG002|Follow-Up Phase|Administrative|1|||
48717592|NCT00910624|156815034|FG003|Follow-Up Phase|Administrative|0|||
48717593|NCT03005873|156815035|FG000|Overall Study|Prohibited medication use post radnomization|1|||
48717594|NCT03005873|156815036|FG001|Overall Study|Prohibited medication use post radnomization|1|||
48717595|NCT03005873|156815037|FG002|Overall Study|Prohibited medication use post radnomization|1|||
48717596|NCT03005873|156815035|FG000|Overall Study|Withdrew consent|0|||
48717597|NCT03005873|156815036|FG001|Overall Study|Withdrew consent|1|||
48717598|NCT03005873|156815037|FG002|Overall Study|Withdrew consent|2|||
48717599|NCT03005873|156815035|FG000|Overall Study|Lost to Follow-up|0|||
48717600|NCT03005873|156815036|FG001|Overall Study|Lost to Follow-up|1|||
48717601|NCT03005873|156815037|FG002|Overall Study|Lost to Follow-up|0|||
48717602|NCT03005873|156815035|FG000|Overall Study|Ineligible post randomization|0|||
48498260|NCT02799602|156018018|FG001|Overall Study|Withdrawal by Subject|40|||
48717603|NCT03005873|156815036|FG001|Overall Study|Ineligible post randomization|0|||
48717604|NCT03005873|156815037|FG002|Overall Study|Ineligible post randomization|1|||
48717605|NCT00097981|156815038|FG000|Overall Study|Adverse Event|31|||
48717606|NCT00097981|156815039|FG001|Overall Study|Adverse Event|44|||
48717607|NCT00097981|156815038|FG000|Overall Study|Withdrawal by Subject|10|||
48717608|NCT00097981|156815039|FG001|Overall Study|Withdrawal by Subject|8|||
48814801|NCT02838628|157163603|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
48498261|NCT02799602|156018017|FG000|Overall Study|Progressive disease - clinical progression|131|||
48498262|NCT02799602|156018018|FG001|Overall Study|Progressive disease - clinical progression|276|||
48717609|NCT00097981|156815038|FG000|Overall Study|Protocol Violation|1|||
48717610|NCT00097981|156815039|FG001|Overall Study|Protocol Violation|1|||
48814802|NCT02838628|157163604|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
48814803|NCT02838628|157163603|FG000|Recurrence Follow-up Period|Adverse Event|1|||
48814804|NCT02838628|157163604|FG001|Recurrence Follow-up Period|Adverse Event|0|||
48814805|NCT02838628|157163603|FG000|Recurrence Follow-up Period|Non-compliance|0|||
48814806|NCT02838628|157163604|FG001|Recurrence Follow-up Period|Non-compliance|1|||
48814807|NCT02838628|157163603|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
48814808|NCT02838628|157163604|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
48814809|NCT02838628|157163603|FG000|Recurrence Follow-up Period|Other un-specified|1|||
48814810|NCT02838628|157163604|FG001|Recurrence Follow-up Period|Other un-specified|1|||
48814811|NCT03567993|157163609|FG000|Overall Study|Lost to Follow-up|4|||
48814812|NCT03567993|157163610|FG001|Overall Study|Lost to Follow-up|2|||
48814813|NCT03567993|157163609|FG000|Overall Study|Death|1|||
48814814|NCT03567993|157163610|FG001|Overall Study|Death|1|||
48814815|NCT03567993|157163609|FG000|Overall Study|Withdrawal by Subject|1|||
48814816|NCT03567993|157163610|FG001|Overall Study|Withdrawal by Subject|0|||
48814817|NCT01368211|157163614|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
48814818|NCT01368211|157163615|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
48814819|NCT03990363|157163616|FG000|Overall Study|Withdrawal by Subject|10|||
48814820|NCT03990363|157163617|FG001|Overall Study|Withdrawal by Subject|9|||
48814821|NCT03990363|157163618|FG002|Overall Study|Withdrawal by Subject|18|||
48814822|NCT03990363|157163619|FG003|Overall Study|Withdrawal by Subject|11|||
48814823|NCT03990363|157163620|FG004|Overall Study|Withdrawal by Subject|9|||
48814824|NCT03990363|157163616|FG000|Overall Study|Physician Decision|1|||
48814825|NCT03990363|157163617|FG001|Overall Study|Physician Decision|0|||
48814826|NCT03990363|157163618|FG002|Overall Study|Physician Decision|0|||
48814827|NCT03990363|157163619|FG003|Overall Study|Physician Decision|0|||
48814828|NCT03990363|157163620|FG004|Overall Study|Physician Decision|0|||
48814829|NCT03990363|157163616|FG000|Overall Study|Adverse Event|1|||
48814830|NCT03990363|157163617|FG001|Overall Study|Adverse Event|3|||
48814831|NCT03990363|157163618|FG002|Overall Study|Adverse Event|2|||
48814832|NCT03990363|157163619|FG003|Overall Study|Adverse Event|2|||
48814833|NCT03990363|157163620|FG004|Overall Study|Adverse Event|0|||
48814834|NCT03990363|157163616|FG000|Overall Study|Death|14|||
48814835|NCT03990363|157163617|FG001|Overall Study|Death|8|||
48814836|NCT03990363|157163618|FG002|Overall Study|Death|14|||
48814837|NCT03990363|157163619|FG003|Overall Study|Death|10|||
48814838|NCT03990363|157163620|FG004|Overall Study|Death|11|||
48814839|NCT03990363|157163616|FG000|Overall Study|Failure to meet randomization criteria|0|||
48814840|NCT03990363|157163617|FG001|Overall Study|Failure to meet randomization criteria|1|||
48814841|NCT03990363|157163618|FG002|Overall Study|Failure to meet randomization criteria|1|||
48814842|NCT03990363|157163619|FG003|Overall Study|Failure to meet randomization criteria|0|||
48498263|NCT02799602|156018017|FG000|Overall Study|Progressive disease - radiological progression|90|||
48498264|NCT02799602|156018018|FG001|Overall Study|Progressive disease - radiological progression|133|||
48498265|NCT02799602|156018017|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
48498266|NCT02799602|156018018|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
48498267|NCT02799602|156018017|FG000|Overall Study|Death|9|||
48498268|NCT02799602|156018018|FG001|Overall Study|Death|5|||
48498269|NCT02799602|156018017|FG000|Overall Study|Other|287|||
48498270|NCT02799602|156018018|FG001|Overall Study|Other|118|||
48498271|NCT02799602|156018017|FG000|Overall Study|Study drug never administered|0|||
48498272|NCT02799602|156018018|FG001|Overall Study|Study drug never administered|3|||
48498273|NCT00577460|156018019|FG000|Overall Study|Adverse Event|11|||
48498274|NCT00577460|156018020|FG001|Overall Study|Adverse Event|7|||
48498275|NCT00577460|156018021|FG002|Overall Study|Adverse Event|14|||
48498276|NCT00577460|156018019|FG000|Overall Study|Protocol Violation|0|||
48717611|NCT00097981|156815038|FG000|Overall Study|Death|2|||
48814843|NCT03990363|157163620|FG004|Overall Study|Failure to meet randomization criteria|0|||
48814844|NCT03990363|157163616|FG000|Overall Study|Lost to Follow-up|0|||
48814845|NCT03990363|157163617|FG001|Overall Study|Lost to Follow-up|0|||
48814846|NCT03990363|157163618|FG002|Overall Study|Lost to Follow-up|0|||
48814847|NCT03990363|157163619|FG003|Overall Study|Lost to Follow-up|1|||
48814848|NCT03990363|157163620|FG004|Overall Study|Lost to Follow-up|2|||
48717612|NCT00097981|156815039|FG001|Overall Study|Death|4|||
48717613|NCT00097981|156815038|FG000|Overall Study|Physician Decision|7|||
48814849|NCT03990363|157163616|FG000|Overall Study|Non-compliance with study drug|2|||
48814850|NCT03990363|157163617|FG001|Overall Study|Non-compliance with study drug|1|||
48814851|NCT03990363|157163618|FG002|Overall Study|Non-compliance with study drug|2|||
48814852|NCT03990363|157163619|FG003|Overall Study|Non-compliance with study drug|0|||
48814853|NCT03990363|157163620|FG004|Overall Study|Non-compliance with study drug|0|||
48498277|NCT00577460|156018020|FG001|Overall Study|Protocol Violation|1|||
48498278|NCT00577460|156018021|FG002|Overall Study|Protocol Violation|1|||
48498279|NCT00577460|156018019|FG000|Overall Study|Lost to Follow-up|0|||
48498280|NCT00577460|156018020|FG001|Overall Study|Lost to Follow-up|3|||
48498281|NCT00577460|156018021|FG002|Overall Study|Lost to Follow-up|4|||
48498282|NCT00577460|156018019|FG000|Overall Study|Withdrawal by Subject|5|||
48498283|NCT00577460|156018020|FG001|Overall Study|Withdrawal by Subject|5|||
48498284|NCT00577460|156018021|FG002|Overall Study|Withdrawal by Subject|6|||
48498285|NCT00577460|156018019|FG000|Overall Study|Other|0|||
48498286|NCT00577460|156018020|FG001|Overall Study|Other|3|||
48498287|NCT00577460|156018021|FG002|Overall Study|Other|2|||
48498288|NCT03730103|156018022|FG000|Overall Study|Did not meet inclusion criteria|0|||
48498289|NCT03730103|156018023|FG001|Overall Study|Did not meet inclusion criteria|5|||
48498290|NCT00162123|156018024|FG000|Overall Study|Disease progression|27|||
48498291|NCT00162123|156018025|FG001|Overall Study|Disease progression|19|||
48498292|NCT00162123|156018026|FG002|Overall Study|Disease progression|10|||
48498293|NCT00162123|156018027|FG003|Overall Study|Disease progression|4|||
48498294|NCT00162123|156018028|FG004|Overall Study|Disease progression|8|||
48498295|NCT00162123|156018029|FG005|Overall Study|Disease progression|3|||
48498296|NCT00162123|156018030|FG006|Overall Study|Disease progression|1|||
48498297|NCT00162123|156018031|FG007|Overall Study|Disease progression|0|||
48498298|NCT00162123|156018024|FG000|Overall Study|Study drug toxicity|6|||
48498299|NCT00162123|156018025|FG001|Overall Study|Study drug toxicity|1|||
48498300|NCT00162123|156018026|FG002|Overall Study|Study drug toxicity|5|||
48498301|NCT00162123|156018027|FG003|Overall Study|Study drug toxicity|0|||
48498302|NCT00162123|156018028|FG004|Overall Study|Study drug toxicity|4|||
48498303|NCT00162123|156018029|FG005|Overall Study|Study drug toxicity|1|||
48498304|NCT00162123|156018030|FG006|Overall Study|Study drug toxicity|1|||
48498305|NCT00162123|156018031|FG007|Overall Study|Study drug toxicity|0|||
48498306|NCT00162123|156018024|FG000|Overall Study|Death|3|||
48498307|NCT00162123|156018025|FG001|Overall Study|Death|3|||
48717614|NCT00097981|156815039|FG001|Overall Study|Physician Decision|1|||
48717615|NCT00097981|156815038|FG000|Overall Study|Disease Progression|8|||
48717616|NCT00097981|156815039|FG001|Overall Study|Disease Progression|2|||
48717617|NCT00097981|156815038|FG000|Overall Study|Transplant planned|28|||
48717618|NCT00097981|156815039|FG001|Overall Study|Transplant planned|27|||
48717619|NCT00097981|156815038|FG000|Overall Study|Other|19|||
48717620|NCT00097981|156815039|FG001|Overall Study|Other|13|||
48717621|NCT01767142|156815040|FG000|Overall Study|Lost to Follow-up|3|||
48717622|NCT02471612|156815041|FG000|Overall Study|Lost to Follow-up|2|||
48717623|NCT02082340|156815042|FG000|Overall Study|Lost to Follow-up|1|||
48717624|NCT02082340|156815043|FG001|Overall Study|Lost to Follow-up|1|||
48717625|NCT05315908|156815046|FG000|Overall Study|Lost to Follow-up|4477|||
48717626|NCT05315908|156815047|FG001|Overall Study|Lost to Follow-up|4606|||
48717627|NCT01883453|156815048|FG000|Overall Study|No episode of common cold|25|||
48717628|NCT01883453|156815049|FG001|Overall Study|No episode of common cold|23|||
48717629|NCT01024309|156815054|FG000|Overall Study|Physician Decision|4|||
48717630|NCT01024309|156815055|FG001|Overall Study|Physician Decision|0|||
48717631|NCT01024309|156815054|FG000|Overall Study|Withdrawal by Subject|4|||
48717632|NCT01024309|156815055|FG001|Overall Study|Withdrawal by Subject|4|||
48717633|NCT02208063|156815056|FG000|Overall Study|Death|3|||
48717634|NCT02208063|156815057|FG001|Overall Study|Death|5|||
48717635|NCT02208063|156815056|FG000|Overall Study|Not Specified in report|3|||
48717636|NCT02208063|156815057|FG001|Overall Study|Not Specified in report|4|||
48717637|NCT02208063|156815056|FG000|Overall Study|Withdrawal by Subject|5|||
48717638|NCT02208063|156815057|FG001|Overall Study|Withdrawal by Subject|2|||
48717639|NCT02208063|156815056|FG000|Overall Study|Lost to Follow-up|1|||
48717640|NCT02208063|156815057|FG001|Overall Study|Lost to Follow-up|0|||
48717641|NCT01105065|156815058|FG000|Overall Study|Adverse Event|5|||
48717642|NCT01105065|156815058|FG000|Overall Study|Technical Problems|1|||
48717643|NCT01395784|156815059|FG000|Overall Study|Lost to Follow-up|7|||
48498308|NCT00162123|156018026|FG002|Overall Study|Death|1|||
48498309|NCT00162123|156018027|FG003|Overall Study|Death|1|||
48717644|NCT01395784|156815059|FG000|Overall Study|Withdrawal by Subject|3|||
48717645|NCT01395784|156815059|FG000|Overall Study|Physician Decision|5|||
48717646|NCT00329849|156815060|FG000|Overall Study|Withdrawal by Subject|6|||
48717647|NCT00329849|156815061|FG001|Overall Study|Withdrawal by Subject|4|||
48717648|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
48717649|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
48717650|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
48717651|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
48498310|NCT00162123|156018028|FG004|Overall Study|Death|1|||
48498311|NCT00162123|156018029|FG005|Overall Study|Death|1|||
48498312|NCT00162123|156018030|FG006|Overall Study|Death|0|||
48498313|NCT00162123|156018031|FG007|Overall Study|Death|0|||
48498314|NCT00162123|156018024|FG000|Overall Study|Withdrawal by Subject|2|||
48498315|NCT00162123|156018025|FG001|Overall Study|Withdrawal by Subject|0|||
48498316|NCT00162123|156018026|FG002|Overall Study|Withdrawal by Subject|2|||
48498317|NCT00162123|156018027|FG003|Overall Study|Withdrawal by Subject|1|||
48498318|NCT00162123|156018028|FG004|Overall Study|Withdrawal by Subject|1|||
48814854|NCT03990363|157163616|FG000|Overall Study|Study terminated by sponsor|0|||
48814855|NCT03990363|157163617|FG001|Overall Study|Study terminated by sponsor|1|||
48814856|NCT03990363|157163618|FG002|Overall Study|Study terminated by sponsor|0|||
48814857|NCT03990363|157163619|FG003|Overall Study|Study terminated by sponsor|0|||
48814858|NCT03990363|157163620|FG004|Overall Study|Study terminated by sponsor|0|||
48814859|NCT03990363|157163616|FG000|Overall Study|Site terminated by sponsor|2|||
48814860|NCT03990363|157163617|FG001|Overall Study|Site terminated by sponsor|1|||
48814861|NCT03990363|157163618|FG002|Overall Study|Site terminated by sponsor|2|||
48814862|NCT03990363|157163619|FG003|Overall Study|Site terminated by sponsor|0|||
48814863|NCT03990363|157163620|FG004|Overall Study|Site terminated by sponsor|2|||
48814864|NCT03990363|157163616|FG000|Overall Study|Not categorized|5|||
48814865|NCT03990363|157163617|FG001|Overall Study|Not categorized|5|||
48814866|NCT03990363|157163618|FG002|Overall Study|Not categorized|3|||
48814867|NCT03990363|157163619|FG003|Overall Study|Not categorized|2|||
48814868|NCT03990363|157163620|FG004|Overall Study|Not categorized|2|||
48814869|NCT03225846|157163633|FG000|Overall Study|Adverse Event|0|||
48814870|NCT03225846|157163634|FG001|Overall Study|Adverse Event|0|||
48498319|NCT00162123|156018029|FG005|Overall Study|Withdrawal by Subject|2|||
48498320|NCT00162123|156018030|FG006|Overall Study|Withdrawal by Subject|1|||
48498321|NCT00162123|156018031|FG007|Overall Study|Withdrawal by Subject|0|||
48498322|NCT00162123|156018024|FG000|Overall Study|Deterioration without progression|2|||
48717652|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
48717653|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
48717654|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
48717655|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
48717656|NCT00435045|156815062|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
48717657|NCT00435045|156815063|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
48717658|NCT00435045|156815062|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
48717659|NCT00435045|156815063|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
48717660|NCT00435045|156815062|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
48717661|NCT00435045|156815063|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
48717662|NCT00435045|156815062|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
48717663|NCT00435045|156815063|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
48717664|NCT00435045|156815062|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
48717665|NCT00435045|156815063|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
48717666|NCT00435045|156815062|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
48717667|NCT00435045|156815063|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
48717668|NCT00435045|156815062|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
48717669|NCT00435045|156815063|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
48717670|NCT01782469|156815065|FG000|Overall Study|Lost to Follow-up|1|||
48717671|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
48717672|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
48717673|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
48717674|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
48717675|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
48717676|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
48717677|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
48717678|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
48717679|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
48717680|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
48717681|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
48717682|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
48717683|NCT00322621|156815066|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
48717684|NCT00322621|156815067|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
48717685|NCT00322621|156815068|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
48717686|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
48717687|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
48717688|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
48717689|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
48717690|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
48717691|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
48717692|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
48717693|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
48717694|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
48717695|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
48717696|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
48717697|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
48717698|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
48717699|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
48717700|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
48717701|NCT00322621|156815066|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
48717702|NCT00322621|156815067|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
48717703|NCT00322621|156815068|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
48717704|NCT01038869|156815071|FG000|Overall Study|Withdrawal by Subject|1|||
48717705|NCT01038869|156815071|FG000|Overall Study|Lost to Follow-up|6|||
48717706|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
48717707|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
48717708|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
48717709|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
48717710|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
48717711|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
48717712|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
48717713|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
48717714|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
48717715|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
48717716|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
48717717|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
48717718|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48717719|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48717720|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48717721|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48717722|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48717723|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48717724|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
48717725|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
48717726|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
48717727|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
48717728|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
48717729|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
48717730|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
48717731|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48717732|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48717733|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48717734|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48717735|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48717736|NCT01328444|156815074|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48717737|NCT01328444|156815075|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
48717738|NCT01328444|156815076|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48717739|NCT01328444|156815077|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
48717740|NCT01328444|156815078|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48717741|NCT01328444|156815079|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48717742|NCT01328444|156815074|FG000|Washout Period (14 Days)|Adverse Event|1|||
48717743|NCT01328444|156815075|FG001|Washout Period (14 Days)|Adverse Event|1|||
48717744|NCT01328444|156815076|FG002|Washout Period (14 Days)|Adverse Event|0|||
48717745|NCT01328444|156815077|FG003|Washout Period (14 Days)|Adverse Event|1|||
48717746|NCT01328444|156815078|FG004|Washout Period (14 Days)|Adverse Event|1|||
48717747|NCT01328444|156815079|FG005|Washout Period (14 Days)|Adverse Event|2|||
48814871|NCT03225846|157163635|FG002|Overall Study|Adverse Event|0|||
48814872|NCT03225846|157163636|FG003|Overall Study|Adverse Event|0|||
48814873|NCT03225846|157163637|FG004|Overall Study|Adverse Event|0|||
48814874|NCT03225846|157163638|FG005|Overall Study|Adverse Event|0|||
48814875|NCT03225846|157163639|FG006|Overall Study|Adverse Event|6|||
48814876|NCT03225846|157163633|FG000|Overall Study|Withdrawal by Subject|0|||
48814877|NCT03225846|157163634|FG001|Overall Study|Withdrawal by Subject|1|||
48814878|NCT03225846|157163635|FG002|Overall Study|Withdrawal by Subject|0|||
48814879|NCT03225846|157163636|FG003|Overall Study|Withdrawal by Subject|0|||
48814880|NCT03225846|157163637|FG004|Overall Study|Withdrawal by Subject|0|||
48814881|NCT03225846|157163638|FG005|Overall Study|Withdrawal by Subject|0|||
48814882|NCT03225846|157163639|FG006|Overall Study|Withdrawal by Subject|0|||
48717748|NCT01328444|156815074|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
48717749|NCT01328444|156815075|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
48717750|NCT01328444|156815076|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
48717751|NCT01328444|156815077|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
48814883|NCT03225846|157163633|FG000|Overall Study|Death|0|||
48717752|NCT01328444|156815078|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
48717753|NCT01328444|156815079|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
48717754|NCT01328444|156815074|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717755|NCT01328444|156815075|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717756|NCT01328444|156815076|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717757|NCT01328444|156815077|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717758|NCT01328444|156815078|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
48717759|NCT01328444|156815079|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
48717760|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
48717761|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48717762|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48717763|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48717764|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48717765|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48717766|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
48717767|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
48717768|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
48498323|NCT00162123|156018025|FG001|Overall Study|Deterioration without progression|2|||
48498324|NCT00162123|156018026|FG002|Overall Study|Deterioration without progression|3|||
48498325|NCT00162123|156018027|FG003|Overall Study|Deterioration without progression|0|||
48498326|NCT00162123|156018028|FG004|Overall Study|Deterioration without progression|1|||
48498327|NCT00162123|156018029|FG005|Overall Study|Deterioration without progression|0|||
48498328|NCT00162123|156018030|FG006|Overall Study|Deterioration without progression|0|||
48498329|NCT00162123|156018031|FG007|Overall Study|Deterioration without progression|0|||
48498330|NCT00162123|156018024|FG000|Overall Study|Adverse Event|1|||
48498331|NCT00162123|156018025|FG001|Overall Study|Adverse Event|2|||
48498332|NCT00162123|156018026|FG002|Overall Study|Adverse Event|0|||
48498333|NCT00162123|156018027|FG003|Overall Study|Adverse Event|2|||
48498334|NCT00162123|156018028|FG004|Overall Study|Adverse Event|1|||
48498335|NCT00162123|156018029|FG005|Overall Study|Adverse Event|0|||
48498336|NCT00162123|156018030|FG006|Overall Study|Adverse Event|0|||
48498337|NCT00162123|156018031|FG007|Overall Study|Adverse Event|0|||
48498338|NCT00162123|156018024|FG000|Overall Study|Not specified (before treatment)|2|||
48498339|NCT00162123|156018025|FG001|Overall Study|Not specified (before treatment)|0|||
48498340|NCT00162123|156018026|FG002|Overall Study|Not specified (before treatment)|0|||
48498341|NCT00162123|156018027|FG003|Overall Study|Not specified (before treatment)|0|||
48498342|NCT00162123|156018028|FG004|Overall Study|Not specified (before treatment)|12|||
48498343|NCT00162123|156018029|FG005|Overall Study|Not specified (before treatment)|1|||
48498344|NCT00162123|156018030|FG006|Overall Study|Not specified (before treatment)|0|||
48498345|NCT00162123|156018031|FG007|Overall Study|Not specified (before treatment)|0|||
48498346|NCT00162123|156018024|FG000|Overall Study|Not specified (after start of treatment)|0|||
48498347|NCT00162123|156018025|FG001|Overall Study|Not specified (after start of treatment)|0|||
48498348|NCT00162123|156018026|FG002|Overall Study|Not specified (after start of treatment)|0|||
48498349|NCT00162123|156018027|FG003|Overall Study|Not specified (after start of treatment)|0|||
48498350|NCT00162123|156018028|FG004|Overall Study|Not specified (after start of treatment)|3|||
48498351|NCT00162123|156018029|FG005|Overall Study|Not specified (after start of treatment)|0|||
48498352|NCT00162123|156018030|FG006|Overall Study|Not specified (after start of treatment)|0|||
48498353|NCT00162123|156018031|FG007|Overall Study|Not specified (after start of treatment)|0|||
48498354|NCT00162123|156018024|FG000|Overall Study|Physician Decision|1|||
48498355|NCT00162123|156018025|FG001|Overall Study|Physician Decision|2|||
48498356|NCT00162123|156018026|FG002|Overall Study|Physician Decision|0|||
48498357|NCT00162123|156018027|FG003|Overall Study|Physician Decision|0|||
48498358|NCT00162123|156018028|FG004|Overall Study|Physician Decision|0|||
48498359|NCT00162123|156018029|FG005|Overall Study|Physician Decision|1|||
48498360|NCT00162123|156018030|FG006|Overall Study|Physician Decision|1|||
48498361|NCT00162123|156018031|FG007|Overall Study|Physician Decision|0|||
48498362|NCT00162123|156018024|FG000|Overall Study|Tumor assessment only (not treated)|0|||
48498363|NCT00162123|156018025|FG001|Overall Study|Tumor assessment only (not treated)|0|||
48498364|NCT00162123|156018026|FG002|Overall Study|Tumor assessment only (not treated)|0|||
48498365|NCT00162123|156018027|FG003|Overall Study|Tumor assessment only (not treated)|0|||
48498366|NCT00162123|156018028|FG004|Overall Study|Tumor assessment only (not treated)|0|||
48498367|NCT00162123|156018029|FG005|Overall Study|Tumor assessment only (not treated)|0|||
48717769|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
48717770|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
48717771|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
48498368|NCT00162123|156018030|FG006|Overall Study|Tumor assessment only (not treated)|0|||
48498369|NCT00162123|156018031|FG007|Overall Study|Tumor assessment only (not treated)|1|||
48498370|NCT00162123|156018024|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
48498371|NCT00162123|156018025|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
48498372|NCT00162123|156018026|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
48498373|NCT00162123|156018027|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
48717772|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
48717773|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
48717774|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
48717775|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
48717776|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
48717777|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
48717778|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
48717779|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
48717780|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
48717781|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
48717782|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
48717783|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
48717784|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48717785|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48717786|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48717787|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48717788|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48717789|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
48717790|NCT01328444|156815074|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48717791|NCT01328444|156815075|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48717792|NCT01328444|156815076|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48717793|NCT01328444|156815077|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48717794|NCT01328444|156815078|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48717795|NCT01328444|156815079|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48717796|NCT03531632|156815080|FG000|Overall Study|Adverse Event|0|||
48717797|NCT03531632|156815081|FG001|Overall Study|Adverse Event|0|||
48717798|NCT03531632|156815082|FG002|Overall Study|Adverse Event|1|||
48717799|NCT03531632|156815080|FG000|Overall Study|Death|4|||
48498374|NCT00162123|156018028|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
48717800|NCT03531632|156815081|FG001|Overall Study|Death|0|||
48717801|NCT03531632|156815082|FG002|Overall Study|Death|14|||
48717802|NCT03531632|156815080|FG000|Overall Study|Study Terminated|1|||
48717803|NCT03531632|156815081|FG001|Overall Study|Study Terminated|3|||
48717804|NCT03531632|156815082|FG002|Overall Study|Study Terminated|11|||
48717805|NCT00729469|156815083|FG000|Overall Study|Adverse Event|14|||
48717806|NCT00729469|156815084|FG001|Overall Study|Adverse Event|25|||
48717807|NCT00729469|156815083|FG000|Overall Study|Lost to Follow-up|9|||
48717808|NCT00729469|156815084|FG001|Overall Study|Lost to Follow-up|9|||
48717809|NCT00729469|156815083|FG000|Overall Study|Protocol Violation|2|||
48717810|NCT00729469|156815084|FG001|Overall Study|Protocol Violation|1|||
48717811|NCT00729469|156815083|FG000|Overall Study|Withdrawal by Subject|19|||
48717812|NCT00729469|156815084|FG001|Overall Study|Withdrawal by Subject|8|||
48717813|NCT00729469|156815083|FG000|Overall Study|Other-Not mentioned|9|||
48717814|NCT00729469|156815084|FG001|Overall Study|Other-Not mentioned|4|||
48717815|NCT00393510|156815085|FG000|Overall Study|Physician Decision|3|||
48717816|NCT00393510|156815086|FG001|Overall Study|Physician Decision|9|||
48717817|NCT02674204|156815090|FG000|Overall Study|Adverse Event|1|||
48498375|NCT00162123|156018029|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
48498376|NCT00162123|156018030|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
48498377|NCT00162123|156018031|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
48498378|NCT02626949|156018032|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
48498379|NCT02626949|156018033|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
48498380|NCT02626949|156018032|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
48498381|NCT02626949|156018033|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
48498382|NCT02626949|156018032|FG000|Enrolled|Lost to Follow-up|7|||
48498383|NCT02626949|156018033|FG001|Enrolled|Lost to Follow-up|6|||
48498384|NCT02626949|156018032|FG000|Enrolled|Withdrawal by Subject|3|||
48498385|NCT02626949|156018033|FG001|Enrolled|Withdrawal by Subject|2|||
48498386|NCT00950872|156018038|FG000|Overall Study|Withdrawal by Subject|1|||
48498387|NCT00950872|156018038|FG000|Overall Study|Did not have surgery|2|||
48498388|NCT03561883|156018044|FG000|Overall Study|Adverse Event|10|||
48498389|NCT03561883|156018045|FG001|Overall Study|Adverse Event|13|||
48717818|NCT02674204|156815091|FG001|Overall Study|Adverse Event|0|||
48717819|NCT00773838|156815099|FG000|Overall Study|Adverse Event|29|||
48717820|NCT00773838|156815099|FG000|Overall Study|Lost to Follow-up|1|||
48717821|NCT00773838|156815099|FG000|Overall Study|Physician Decision|8|||
48717822|NCT00773838|156815099|FG000|Overall Study|Progressive Disease|82|||
48717823|NCT00773838|156815099|FG000|Overall Study|Protocol Violation|2|||
48717824|NCT00773838|156815099|FG000|Overall Study|Withdrawal by Subject|21|||
48717825|NCT00392379|156815100|FG000|Overall Study|Withdrawal by Subject|17|||
48717826|NCT00392379|156815101|FG001|Overall Study|Withdrawal by Subject|28|||
48717827|NCT00392379|156815100|FG000|Overall Study|Lost to Follow-up|4|||
48498390|NCT03561883|156018044|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48498391|NCT03561883|156018045|FG001|Overall Study|Non-Compliance With Study Drug|2|||
48498392|NCT03561883|156018044|FG000|Overall Study|Protocol Violation|2|||
48498393|NCT03561883|156018045|FG001|Overall Study|Protocol Violation|3|||
48498394|NCT03561883|156018044|FG000|Overall Study|Withdrawal by Subject|14|||
48717828|NCT00392379|156815101|FG001|Overall Study|Lost to Follow-up|9|||
48717829|NCT00392379|156815100|FG000|Overall Study|Adverse Event|1|||
48717830|NCT00392379|156815101|FG001|Overall Study|Adverse Event|1|||
48717831|NCT00308581|156815102|FG000|Induction Phase|Adverse Event|0|||
48717832|NCT00308581|156815103|FG001|Induction Phase|Adverse Event|0|||
48717833|NCT00308581|156815104|FG002|Induction Phase|Adverse Event|37|||
48717834|NCT00308581|156815102|FG000|Induction Phase|Lack of Efficacy|0|||
48717835|NCT00308581|156815103|FG001|Induction Phase|Lack of Efficacy|0|||
48717836|NCT00308581|156815104|FG002|Induction Phase|Lack of Efficacy|121|||
48717837|NCT00308581|156815102|FG000|Induction Phase|Withdrawal by Subject|0|||
48717838|NCT00308581|156815103|FG001|Induction Phase|Withdrawal by Subject|0|||
48717839|NCT00308581|156815104|FG002|Induction Phase|Withdrawal by Subject|5|||
48717840|NCT00308581|156815102|FG000|Induction Phase|Unknown reason|0|||
48717841|NCT00308581|156815103|FG001|Induction Phase|Unknown reason|0|||
48717842|NCT00308581|156815104|FG002|Induction Phase|Unknown reason|3|||
48717843|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Adverse Event|10|||
48717844|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Adverse Event|17|||
48717845|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Adverse Event|0|||
48717846|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
48717847|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
48717848|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
48717849|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
48717850|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
48717851|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
48717852|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
48717853|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
48717854|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
48717855|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
48717856|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
48717857|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
48717858|NCT00308581|156815102|FG000|Randomized Maintenance Phase|Unknown reason|3|||
48717859|NCT00308581|156815103|FG001|Randomized Maintenance Phase|Unknown reason|0|||
48717860|NCT00308581|156815104|FG002|Randomized Maintenance Phase|Unknown reason|0|||
48717861|NCT01699867|156815113|FG000|Overall Study|Screening Failure|3|||
48717862|NCT02342418|156815114|FG000|Overall Study|Adverse Event|0|||
48717863|NCT02342418|156815115|FG001|Overall Study|Adverse Event|1|||
48717864|NCT04255394|156815116|FG000|Overall Study|Death|35|||
48717865|NCT04255394|156815117|FG001|Overall Study|Death|25|||
48717866|NCT04255394|156815116|FG000|Overall Study|Device removed|2|||
48717867|NCT04255394|156815117|FG001|Overall Study|Device removed|10|||
48717868|NCT04255394|156815116|FG000|Overall Study|Withdrawal by Subject|9|||
48717869|NCT04255394|156815117|FG001|Overall Study|Withdrawal by Subject|8|||
48717870|NCT04255394|156815116|FG000|Overall Study|Screen Failure/Not treated|12|||
48717871|NCT04255394|156815117|FG001|Overall Study|Screen Failure/Not treated|8|||
48717872|NCT04255394|156815116|FG000|Overall Study|Lost to Follow-up|123|||
48814884|NCT03225846|157163634|FG001|Overall Study|Death|1|||
48814885|NCT03225846|157163635|FG002|Overall Study|Death|0|||
48814886|NCT03225846|157163636|FG003|Overall Study|Death|0|||
48498395|NCT03561883|156018045|FG001|Overall Study|Withdrawal by Subject|6|||
48498396|NCT03561883|156018044|FG000|Overall Study|Lost to Follow-up|2|||
48498397|NCT03561883|156018045|FG001|Overall Study|Lost to Follow-up|6|||
48498398|NCT03561883|156018044|FG000|Overall Study|Study Terminated by Sponsor|12|||
48498399|NCT03561883|156018045|FG001|Overall Study|Study Terminated by Sponsor|11|||
48498400|NCT03561883|156018044|FG000|Overall Study|Physician Decision|1|||
48498401|NCT03561883|156018045|FG001|Overall Study|Physician Decision|0|||
48814887|NCT03225846|157163637|FG004|Overall Study|Death|0|||
48814888|NCT03225846|157163638|FG005|Overall Study|Death|0|||
48814889|NCT03225846|157163639|FG006|Overall Study|Death|0|||
48498402|NCT03561883|156018044|FG000|Overall Study|Randomized by Mistake|1|||
48498403|NCT03561883|156018045|FG001|Overall Study|Randomized by Mistake|0|||
48717873|NCT04255394|156815117|FG001|Overall Study|Lost to Follow-up|265|||
48717874|NCT04255394|156815116|FG000|Overall Study|Adverse Event|1|||
48717875|NCT04255394|156815117|FG001|Overall Study|Adverse Event|3|||
48717876|NCT00725842|156815118|FG000|Overall Study|Lost to Follow-up|19|||
48717877|NCT00725842|156815118|FG000|Overall Study|Death|1|||
48717878|NCT00725842|156815118|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
48717879|NCT00725842|156815118|FG000|Overall Study|Consent date prior to study start date|5|||
48717880|NCT00725842|156815118|FG000|Overall Study|Inclusion criterion not met|1|||
48717881|NCT00725842|156815118|FG000|Overall Study|No Visit 1 data|1|||
48814890|NCT03225846|157163633|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
48717882|NCT01806662|156815119|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
48717883|NCT01806662|156815120|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
48717884|NCT01806662|156815119|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
48717885|NCT01806662|156815120|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
48717886|NCT01806662|156815119|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
48717887|NCT01806662|156815120|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
48717888|NCT01806662|156815119|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
48717889|NCT01806662|156815120|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
48717890|NCT01375075|156815121|FG000|Overall Study|Adverse Event|0|||
48717891|NCT01375075|156815122|FG001|Overall Study|Adverse Event|0|||
48717892|NCT01375075|156815123|FG002|Overall Study|Adverse Event|3|||
48717893|NCT01375075|156815124|FG003|Overall Study|Adverse Event|1|||
48717894|NCT01375075|156815125|FG004|Overall Study|Adverse Event|0|||
48717895|NCT01375075|156815126|FG005|Overall Study|Adverse Event|1|||
48717896|NCT01375075|156815121|FG000|Overall Study|Entry Criterion Not Met|1|||
48717897|NCT01375075|156815122|FG001|Overall Study|Entry Criterion Not Met|0|||
48717898|NCT01375075|156815123|FG002|Overall Study|Entry Criterion Not Met|0|||
48717899|NCT01375075|156815124|FG003|Overall Study|Entry Criterion Not Met|0|||
48717900|NCT01375075|156815125|FG004|Overall Study|Entry Criterion Not Met|0|||
48717901|NCT01375075|156815126|FG005|Overall Study|Entry Criterion Not Met|1|||
48717902|NCT01375075|156815121|FG000|Overall Study|Withdrawal by Subject|0|||
48717903|NCT01375075|156815122|FG001|Overall Study|Withdrawal by Subject|1|||
48717904|NCT01375075|156815123|FG002|Overall Study|Withdrawal by Subject|0|||
48717905|NCT01375075|156815124|FG003|Overall Study|Withdrawal by Subject|0|||
48717906|NCT01375075|156815125|FG004|Overall Study|Withdrawal by Subject|0|||
48717907|NCT01375075|156815126|FG005|Overall Study|Withdrawal by Subject|1|||
48717908|NCT00311584|156815127|FG000|Overall Study|Death|1|||
48717909|NCT00311584|156815128|FG001|Overall Study|Death|0|||
48717910|NCT00311584|156815127|FG000|Overall Study|Lack of Efficacy|12|||
48717911|NCT00311584|156815128|FG001|Overall Study|Lack of Efficacy|15|||
48717912|NCT00311584|156815127|FG000|Overall Study|Physician Decision|4|||
48717913|NCT00311584|156815128|FG001|Overall Study|Physician Decision|5|||
48717914|NCT00311584|156815127|FG000|Overall Study|Withdrawal by Subject|1|||
48717915|NCT00311584|156815128|FG001|Overall Study|Withdrawal by Subject|1|||
48717916|NCT00311584|156815127|FG000|Overall Study|ineligible|2|||
48717917|NCT00311584|156815128|FG001|Overall Study|ineligible|2|||
48717918|NCT00835731|156815134|FG000|Overall Study|Withdrawal by Subject|1|||
48717919|NCT00835731|156815135|FG001|Overall Study|Withdrawal by Subject|0|||
48717920|NCT00835731|156815134|FG000|Overall Study|Physician Decision|1|||
48717921|NCT00835731|156815135|FG001|Overall Study|Physician Decision|1|||
48717922|NCT02216812|156815139|FG000|Overall Study|Lost to Follow-up|10|||
48717923|NCT02216812|156815140|FG001|Overall Study|Lost to Follow-up|5|||
48717924|NCT00129311|156815142|FG000|Overall Study|Withdrawal by Subject|12|||
48717925|NCT00129311|156815143|FG001|Overall Study|Withdrawal by Subject|19|||
48717926|NCT02207946|156815145|FG000|Overall Study|Lost to Follow-up|1|||
48717927|NCT02207946|156815146|FG001|Overall Study|Lost to Follow-up|0|||
48717928|NCT02207946|156815145|FG000|Overall Study|Adverse Event|0|||
48717929|NCT02207946|156815146|FG001|Overall Study|Adverse Event|1|||
48717930|NCT00167778|156815147|FG000|Overall Study|Withdrawal by Subject|1|||
48717931|NCT00734747|156815151|FG000|SRS Procedure|No staples placed|3|||
48717932|NCT00734747|156815151|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
48717933|NCT00853970|156815154|FG000|Overall Study|Withdrawal by Subject|2|||
48717934|NCT00853970|156815155|FG001|Overall Study|Withdrawal by Subject|1|||
48717935|NCT00853970|156815154|FG000|Overall Study|Cancelled surgery|4|||
48717936|NCT00853970|156815155|FG001|Overall Study|Cancelled surgery|2|||
48498404|NCT03561883|156018044|FG000|Overall Study|Other, Not Specified|3|||
48498405|NCT03561883|156018045|FG001|Overall Study|Other, Not Specified|2|||
48498406|NCT03184441|156018051|FG000|Overall Study|Withdrawal by Subject|1|||
48498407|NCT03125200|156018054|FG000|Overall Study|Study Termination|0|||
48498408|NCT03125200|156018055|FG001|Overall Study|Study Termination|0|||
48498409|NCT03125200|156018056|FG002|Overall Study|Study Termination|0|||
48498410|NCT03125200|156018057|FG003|Overall Study|Study Termination|1|||
48498411|NCT03125200|156018058|FG004|Overall Study|Study Termination|1|||
48498412|NCT03125200|156018059|FG005|Overall Study|Study Termination|2|||
48498413|NCT03125200|156018060|FG006|Overall Study|Study Termination|1|||
48717937|NCT00130247|156816603|FG000|Overall Study|Pregnancy|1|||
48717938|NCT00130247|156816604|FG001|Overall Study|Pregnancy|0|||
48717939|NCT00130247|156816603|FG000|Overall Study|Post-randomization exclusion|1|||
48717940|NCT00130247|156816604|FG001|Overall Study|Post-randomization exclusion|2|||
48717941|NCT00130247|156816603|FG000|Overall Study|Not compliant with DOT|0|||
48717942|NCT00130247|156816604|FG001|Overall Study|Not compliant with DOT|2|||
48717943|NCT01794338|156816605|FG000|Overall Study|Death|2|||
48717944|NCT01794338|156816606|FG001|Overall Study|Death|0|||
48717945|NCT01794338|156816605|FG000|Overall Study|Lost to Follow-up|6|||
48717946|NCT01794338|156816606|FG001|Overall Study|Lost to Follow-up|9|||
48717947|NCT04473235|156816607|FG000|Overall Study|Lost to Follow-up|6|||
48598628|NCT00810069|156385262|FG001|Lead-in Period I|Protocol Violation|0|||
48598629|NCT00810069|156385263|FG002|Lead-in Period I|Protocol Violation|0|||
48598630|NCT00810069|156385261|FG000|Lead-in Period I|Withdrawal by Subject|46|||
48598631|NCT00810069|156385262|FG001|Lead-in Period I|Withdrawal by Subject|0|||
48598632|NCT00810069|156385263|FG002|Lead-in Period I|Withdrawal by Subject|0|||
48814891|NCT03225846|157163634|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
48598633|NCT00810069|156385261|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
48598634|NCT00810069|156385262|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
48598635|NCT00810069|156385263|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
48598636|NCT00810069|156385261|FG000|Lead-in Period I|Randomization criteria not met|158|||
48598637|NCT00810069|156385262|FG001|Lead-in Period I|Randomization criteria not met|0|||
48598638|NCT00810069|156385263|FG002|Lead-in Period I|Randomization criteria not met|0|||
48598639|NCT00810069|156385261|FG000|Double-Blind Period II|Adverse Event|0|||
48598640|NCT00810069|156385262|FG001|Double-Blind Period II|Adverse Event|9|||
48598641|NCT00810069|156385263|FG002|Double-Blind Period II|Adverse Event|8|||
48598642|NCT00810069|156385261|FG000|Double-Blind Period II|Lack of Efficacy|0|||
48598643|NCT00810069|156385262|FG001|Double-Blind Period II|Lack of Efficacy|7|||
48598644|NCT00810069|156385263|FG002|Double-Blind Period II|Lack of Efficacy|12|||
48598645|NCT00810069|156385261|FG000|Double-Blind Period II|Lost to Follow-up|0|||
48598646|NCT00810069|156385262|FG001|Double-Blind Period II|Lost to Follow-up|9|||
48598647|NCT00810069|156385263|FG002|Double-Blind Period II|Lost to Follow-up|9|||
48598648|NCT00810069|156385261|FG000|Double-Blind Period II|Physician Decision|0|||
48598649|NCT00810069|156385262|FG001|Double-Blind Period II|Physician Decision|0|||
48598650|NCT00810069|156385263|FG002|Double-Blind Period II|Physician Decision|1|||
48598651|NCT00810069|156385261|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
48598652|NCT00810069|156385262|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
48598653|NCT00810069|156385263|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
48598654|NCT00810069|156385261|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
48598655|NCT00810069|156385262|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
48598656|NCT00810069|156385263|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
48598657|NCT00810069|156385261|FG000|Double-Blind Period II|Clinical relapse|0|||
48598658|NCT00810069|156385262|FG001|Double-Blind Period II|Clinical relapse|3|||
48598659|NCT00810069|156385263|FG002|Double-Blind Period II|Clinical relapse|0|||
48598660|NCT00810069|156385261|FG000|Double-Blind Period II|Protocol Violation|0|||
48598661|NCT00810069|156385262|FG001|Double-Blind Period II|Protocol Violation|7|||
48598662|NCT00810069|156385263|FG002|Double-Blind Period II|Protocol Violation|6|||
48598663|NCT03143101|156385264|FG000|Overall Study|Withdrawal by Subject|0|||
48598664|NCT03143101|156385265|FG001|Overall Study|Withdrawal by Subject|1|||
48598665|NCT03143101|156385266|FG002|Overall Study|Withdrawal by Subject|0|||
48598666|NCT03143101|156385264|FG000|Overall Study|Lost to Follow-up|2|||
48598667|NCT03143101|156385265|FG001|Overall Study|Lost to Follow-up|2|||
48436560|NCT04402008|155787454|FG003|Overall Study|Other|0|||
48436561|NCT04402008|155787455|FG004|Overall Study|Other|0|||
48436562|NCT04402008|155787456|FG005|Overall Study|Other|0|||
48436563|NCT04402008|155787457|FG006|Overall Study|Other|5|||
48436564|NCT00937560|155787463|FG000|Initial Treatment|Death|6|||
48436565|NCT00937560|155787463|FG000|Initial Treatment|Withdraw consent|3|||
48436566|NCT00937560|155787463|FG000|Initial Treatment|Adverse Event|1|||
48436567|NCT00937560|155787463|FG000|Initial Treatment|Lost to Follow-up|1|||
48436568|NCT00937560|155787463|FG000|Initial Treatment|No end of study page|10|||
48436569|NCT00937560|155787463|FG000|Maintenance Treatment|Death|12|||
48436570|NCT00937560|155787463|FG000|Maintenance Treatment|Withdraw consent|5|||
48436571|NCT00937560|155787463|FG000|Maintenance Treatment|According to protocol|1|||
48436572|NCT01774344|155787464|FG000|Overall Study|Withdrawal by Subject|3|||
48436573|NCT01774344|155787465|FG001|Overall Study|Withdrawal by Subject|10|||
48436574|NCT01774344|155787464|FG000|Overall Study|Protocol Violation|0|||
48436575|NCT01774344|155787465|FG001|Overall Study|Protocol Violation|1|||
48436576|NCT01774344|155787464|FG000|Overall Study|Lost to Follow-up|4|||
48436577|NCT01774344|155787465|FG001|Overall Study|Lost to Follow-up|10|||
48436578|NCT01774344|155787464|FG000|Overall Study|End of survival follow-up not available|2|||
48436579|NCT01774344|155787465|FG001|Overall Study|End of survival follow-up not available|2|||
48436580|NCT01774344|155787464|FG000|Overall Study|Data collection finished|4|||
48436581|NCT01774344|155787465|FG001|Overall Study|Data collection finished|14|||
48436582|NCT01774344|155787464|FG000|Overall Study|Other|0|||
48436583|NCT01774344|155787465|FG001|Overall Study|Other|1|||
48436584|NCT01774344|155787464|FG000|Overall Study|Did not enter Survival Follow up|49|||
48436585|NCT01774344|155787465|FG001|Overall Study|Did not enter Survival Follow up|83|||
48436586|NCT04550221|155787469|FG000|Overall Study|Lost to Follow-up|0|||
48436587|NCT04550221|155787470|FG001|Overall Study|Lost to Follow-up|4|||
48436588|NCT04550221|155787469|FG000|Overall Study|Withdrawn|3|||
48436589|NCT04550221|155787470|FG001|Overall Study|Withdrawn|0|||
48436590|NCT04550221|155787469|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
48436591|NCT04550221|155787470|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
48436592|NCT01089582|155787475|FG000|Overall Study|Death|2|||
48717948|NCT04473235|156816608|FG001|Overall Study|Lost to Follow-up|5|||
48717949|NCT04473235|156816607|FG000|Overall Study|Declined continuation|2|||
48717950|NCT04473235|156816608|FG001|Overall Study|Declined continuation|0|||
48717951|NCT04473235|156816607|FG000|Overall Study|Physician Decision|1|||
48717952|NCT04473235|156816608|FG001|Overall Study|Physician Decision|1|||
48717953|NCT04473235|156816607|FG000|Overall Study|Protocol Violation|10|||
48717954|NCT04473235|156816608|FG001|Overall Study|Protocol Violation|6|||
48717955|NCT02522624|156816609|FG000|Overall Study|Technical failure|1|||
48717956|NCT02522624|156816610|FG001|Overall Study|Technical failure|0|||
48717957|NCT01771809|156816618|FG000|Overall Study|Adverse Event|4|||
48717958|NCT01771809|156816619|FG001|Overall Study|Adverse Event|12|||
48717959|NCT01771809|156816618|FG000|Overall Study|Protocol Violation|0|||
48717960|NCT01771809|156816619|FG001|Overall Study|Protocol Violation|1|||
48717961|NCT01771809|156816618|FG000|Overall Study|Withdrawal by Subject|34|||
48717962|NCT01771809|156816619|FG001|Overall Study|Withdrawal by Subject|42|||
48717963|NCT01771809|156816618|FG000|Overall Study|Lost to Follow-up|1|||
48717964|NCT01771809|156816619|FG001|Overall Study|Lost to Follow-up|3|||
48717965|NCT01771809|156816618|FG000|Overall Study|Other (Insufficient clinical response)|22|||
48717966|NCT01771809|156816619|FG001|Overall Study|Other (Insufficient clinical response)|20|||
48717967|NCT01771809|156816618|FG000|Overall Study|Death|1|||
48717968|NCT01771809|156816619|FG001|Overall Study|Death|0|||
48717969|NCT01771809|156816618|FG000|Overall Study|Other (other)|9|||
48717970|NCT01771809|156816619|FG001|Overall Study|Other (other)|5|||
48717971|NCT01106092|156816620|FG000|Overall Study|Withdrawal by Subject|0|||
48717972|NCT01106092|156816621|FG001|Overall Study|Withdrawal by Subject|0|||
48717973|NCT01106092|156816622|FG002|Overall Study|Withdrawal by Subject|0|||
48717974|NCT01106092|156816623|FG003|Overall Study|Withdrawal by Subject|1|||
48717975|NCT00727441|156816624|FG000|Overall Study|Disease Progression|11|||
48717976|NCT00727441|156816625|FG001|Overall Study|Disease Progression|14|||
48717977|NCT00727441|156816626|FG002|Overall Study|Disease Progression|17|||
48717978|NCT00727441|156816624|FG000|Overall Study|Eligibility|7|||
48717979|NCT00727441|156816625|FG001|Overall Study|Eligibility|5|||
48717980|NCT00727441|156816626|FG002|Overall Study|Eligibility|7|||
48717981|NCT00727441|156816624|FG000|Overall Study|Death|0|||
48717982|NCT00727441|156816625|FG001|Overall Study|Death|1|||
48717983|NCT00727441|156816626|FG002|Overall Study|Death|1|||
48717984|NCT00727441|156816624|FG000|Overall Study|Physician Decision|0|||
48717985|NCT00727441|156816625|FG001|Overall Study|Physician Decision|1|||
48717986|NCT00727441|156816626|FG002|Overall Study|Physician Decision|0|||
48717987|NCT00727441|156816624|FG000|Overall Study|Withdrawal by Subject|0|||
48717988|NCT00727441|156816625|FG001|Overall Study|Withdrawal by Subject|1|||
48717989|NCT00727441|156816626|FG002|Overall Study|Withdrawal by Subject|0|||
48717990|NCT00220779|156816627|FG000|Overall Study|Adverse Event|1|||
48717991|NCT00220779|156816628|FG001|Overall Study|Adverse Event|0|||
48717992|NCT00220779|156816629|FG002|Overall Study|Adverse Event|0|||
48717993|NCT00220779|156816627|FG000|Overall Study|Withdrawal by Subject|1|||
48717994|NCT00220779|156816628|FG001|Overall Study|Withdrawal by Subject|4|||
48436593|NCT01089582|155787475|FG000|Overall Study|Adverse Event|15|||
48436594|NCT01089582|155787475|FG000|Overall Study|Lost to Follow-up|8|||
48436595|NCT01089582|155787475|FG000|Overall Study|Other|4|||
48436596|NCT01089582|155787475|FG000|Overall Study|Withdrawal by Subject|1|||
48436597|NCT02232087|155787476|FG000|Overall Study|Withdrawal by Subject|2|||
48436598|NCT02232087|155787477|FG001|Overall Study|Withdrawal by Subject|0|||
48436599|NCT02232087|155787478|FG002|Overall Study|Withdrawal by Subject|0|||
48436600|NCT02232087|155787479|FG003|Overall Study|Withdrawal by Subject|0|||
48436601|NCT02232087|155787480|FG004|Overall Study|Withdrawal by Subject|0|||
48436602|NCT02232087|155787481|FG005|Overall Study|Withdrawal by Subject|1|||
48436603|NCT02232087|155787476|FG000|Overall Study|poor inhalation technique|0|||
48436604|NCT02232087|155787477|FG001|Overall Study|poor inhalation technique|1|||
48436605|NCT02232087|155787478|FG002|Overall Study|poor inhalation technique|0|||
48436606|NCT02232087|155787479|FG003|Overall Study|poor inhalation technique|0|||
48436607|NCT02232087|155787480|FG004|Overall Study|poor inhalation technique|0|||
48436608|NCT02232087|155787481|FG005|Overall Study|poor inhalation technique|2|||
48436609|NCT02232087|155787476|FG000|Overall Study|protocol stop criteria|0|||
48436610|NCT02232087|155787477|FG001|Overall Study|protocol stop criteria|1|||
48436611|NCT02232087|155787478|FG002|Overall Study|protocol stop criteria|0|||
48436612|NCT02232087|155787479|FG003|Overall Study|protocol stop criteria|1|||
48436613|NCT02232087|155787480|FG004|Overall Study|protocol stop criteria|0|||
48436614|NCT02232087|155787481|FG005|Overall Study|protocol stop criteria|0|||
48436615|NCT02232087|155787476|FG000|Overall Study|Adverse Event|0|||
48436616|NCT02232087|155787477|FG001|Overall Study|Adverse Event|0|||
48436617|NCT02232087|155787478|FG002|Overall Study|Adverse Event|0|||
48436618|NCT02232087|155787479|FG003|Overall Study|Adverse Event|0|||
48436619|NCT02232087|155787480|FG004|Overall Study|Adverse Event|1|||
48436620|NCT02232087|155787481|FG005|Overall Study|Adverse Event|0|||
48436621|NCT00779324|155787482|FG000|Overall Study|Lost to Follow-up|2|||
48436622|NCT00779324|155787483|FG001|Overall Study|Lost to Follow-up|1|||
48436623|NCT00779324|155787482|FG000|Overall Study|Withdrawal by Subject|4|||
48498414|NCT03125200|156018054|FG000|Overall Study|Clinical Progression|0|||
48598668|NCT03143101|156385266|FG002|Overall Study|Lost to Follow-up|0|||
48717995|NCT00220779|156816629|FG002|Overall Study|Withdrawal by Subject|1|||
48717996|NCT00220779|156816627|FG000|Overall Study|Non-compliance|1|||
48717997|NCT00220779|156816628|FG001|Overall Study|Non-compliance|0|||
48717998|NCT00220779|156816629|FG002|Overall Study|Non-compliance|0|||
48717999|NCT00220779|156816627|FG000|Overall Study|Too time consuming|1|||
48718000|NCT00220779|156816628|FG001|Overall Study|Too time consuming|0|||
48718001|NCT00220779|156816629|FG002|Overall Study|Too time consuming|0|||
48718002|NCT00220779|156816627|FG000|Overall Study|Pregnancy|0|||
48718003|NCT00220779|156816628|FG001|Overall Study|Pregnancy|0|||
48718004|NCT00220779|156816629|FG002|Overall Study|Pregnancy|2|||
48718005|NCT00220779|156816627|FG000|Overall Study|Lack of Efficacy|3|||
48718006|NCT00220779|156816628|FG001|Overall Study|Lack of Efficacy|0|||
48718007|NCT00220779|156816629|FG002|Overall Study|Lack of Efficacy|1|||
48718008|NCT02184455|156816630|FG000|Overall Study|Lost to Follow-up|1|||
48718009|NCT00281658|156816631|FG000|Randomized Phase|Adverse Event|0|||
48718010|NCT00281658|156816632|FG001|Randomized Phase|Adverse Event|2|||
48718011|NCT00281658|156816633|FG002|Randomized Phase|Adverse Event|0|||
48718012|NCT00281658|156816634|FG003|Randomized Phase|Adverse Event|0|||
48718013|NCT00281658|156816631|FG000|Randomized Phase|Lost to Follow-up|34|||
48718014|NCT00281658|156816632|FG001|Randomized Phase|Lost to Follow-up|27|||
48718015|NCT00281658|156816633|FG002|Randomized Phase|Lost to Follow-up|0|||
48718016|NCT00281658|156816634|FG003|Randomized Phase|Lost to Follow-up|0|||
48718017|NCT00281658|156816631|FG000|Randomized Phase|Withdrawal by Subject|8|||
48718018|NCT00281658|156816632|FG001|Randomized Phase|Withdrawal by Subject|7|||
48718019|NCT00281658|156816633|FG002|Randomized Phase|Withdrawal by Subject|0|||
48718020|NCT00281658|156816634|FG003|Randomized Phase|Withdrawal by Subject|0|||
48498415|NCT03125200|156018055|FG001|Overall Study|Clinical Progression|0|||
48498416|NCT03125200|156018056|FG002|Overall Study|Clinical Progression|0|||
48498417|NCT03125200|156018057|FG003|Overall Study|Clinical Progression|1|||
48498418|NCT03125200|156018058|FG004|Overall Study|Clinical Progression|0|||
48498419|NCT03125200|156018059|FG005|Overall Study|Clinical Progression|1|||
48498420|NCT03125200|156018060|FG006|Overall Study|Clinical Progression|0|||
48498421|NCT03125200|156018054|FG000|Overall Study|Progressive Disease|2|||
48498422|NCT03125200|156018055|FG001|Overall Study|Progressive Disease|1|||
48498423|NCT03125200|156018056|FG002|Overall Study|Progressive Disease|2|||
48498424|NCT03125200|156018057|FG003|Overall Study|Progressive Disease|1|||
48498425|NCT03125200|156018058|FG004|Overall Study|Progressive Disease|2|||
48498426|NCT03125200|156018059|FG005|Overall Study|Progressive Disease|0|||
48498427|NCT03125200|156018060|FG006|Overall Study|Progressive Disease|1|||
48498428|NCT03125200|156018054|FG000|Overall Study|Lack of Efficacy|0|||
48498429|NCT03125200|156018055|FG001|Overall Study|Lack of Efficacy|0|||
48498430|NCT03125200|156018056|FG002|Overall Study|Lack of Efficacy|0|||
48498431|NCT03125200|156018057|FG003|Overall Study|Lack of Efficacy|1|||
48498432|NCT03125200|156018058|FG004|Overall Study|Lack of Efficacy|0|||
48498433|NCT03125200|156018059|FG005|Overall Study|Lack of Efficacy|0|||
48498434|NCT03125200|156018060|FG006|Overall Study|Lack of Efficacy|0|||
48498435|NCT03125200|156018054|FG000|Overall Study|Toxicity|0|||
48498436|NCT03125200|156018055|FG001|Overall Study|Toxicity|0|||
48498437|NCT03125200|156018056|FG002|Overall Study|Toxicity|0|||
48498438|NCT03125200|156018057|FG003|Overall Study|Toxicity|1|||
48498439|NCT03125200|156018058|FG004|Overall Study|Toxicity|0|||
48498440|NCT03125200|156018059|FG005|Overall Study|Toxicity|0|||
48498441|NCT03125200|156018060|FG006|Overall Study|Toxicity|0|||
48498442|NCT03125200|156018054|FG000|Overall Study|Consent Withdrawn by Subject|0|||
48498443|NCT03125200|156018055|FG001|Overall Study|Consent Withdrawn by Subject|1|||
48498444|NCT03125200|156018056|FG002|Overall Study|Consent Withdrawn by Subject|0|||
48498445|NCT03125200|156018057|FG003|Overall Study|Consent Withdrawn by Subject|0|||
48498446|NCT03125200|156018058|FG004|Overall Study|Consent Withdrawn by Subject|1|||
48498447|NCT03125200|156018059|FG005|Overall Study|Consent Withdrawn by Subject|0|||
48498448|NCT03125200|156018060|FG006|Overall Study|Consent Withdrawn by Subject|1|||
48498449|NCT03544138|156018062|FG000|Overall Study|Lost to Follow-up|29|||
48498450|NCT00368277|156020121|FG000|Overall Study|Adverse Event|33|||
48498451|NCT00368277|156020122|FG001|Overall Study|Adverse Event|49|||
48498452|NCT00368277|156020121|FG000|Overall Study|Death|2|||
48498453|NCT00368277|156020122|FG001|Overall Study|Death|1|||
48498454|NCT00368277|156020121|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
48498455|NCT00368277|156020122|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
48498456|NCT00368277|156020121|FG000|Overall Study|Protocol deviation|7|||
48598669|NCT00227539|156385269|FG000|Overall Study|Protocol Violation|1|||
48718021|NCT00281658|156816631|FG000|Randomized Phase|Study closed/terminated|1|||
48718022|NCT00281658|156816632|FG001|Randomized Phase|Study closed/terminated|1|||
48498457|NCT00368277|156020122|FG001|Overall Study|Protocol deviation|0|||
48498458|NCT00368277|156020121|FG000|Overall Study|Patient withdrew consent|32|||
48718023|NCT00281658|156816633|FG002|Randomized Phase|Study closed/terminated|0|||
48718024|NCT00281658|156816634|FG003|Randomized Phase|Study closed/terminated|0|||
48718025|NCT00281658|156816631|FG000|Randomized Phase|Disease progression|36|||
48718026|NCT00281658|156816632|FG001|Randomized Phase|Disease progression|27|||
48718027|NCT00281658|156816633|FG002|Randomized Phase|Disease progression|0|||
48718028|NCT00281658|156816634|FG003|Randomized Phase|Disease progression|0|||
48718029|NCT00281658|156816631|FG000|Randomized Phase|Physician Decision|1|||
48718030|NCT00281658|156816632|FG001|Randomized Phase|Physician Decision|1|||
48718031|NCT00281658|156816633|FG002|Randomized Phase|Physician Decision|0|||
48718032|NCT00281658|156816634|FG003|Randomized Phase|Physician Decision|0|||
48718033|NCT00281658|156816631|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
48718034|NCT00281658|156816632|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
48718035|NCT00281658|156816633|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
48718036|NCT00281658|156816634|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
48718037|NCT00281658|156816631|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
48718038|NCT00281658|156816632|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
48718039|NCT00281658|156816633|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
48718040|NCT00281658|156816634|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
48718041|NCT00281658|156816631|FG000|Randomized Phase|Treatment ongoing|1|||
48718042|NCT00281658|156816632|FG001|Randomized Phase|Treatment ongoing|0|||
48718043|NCT00281658|156816633|FG002|Randomized Phase|Treatment ongoing|0|||
48718044|NCT00281658|156816634|FG003|Randomized Phase|Treatment ongoing|0|||
48718045|NCT00281658|156816631|FG000|Open Label Phase|Adverse Event|0|||
48718046|NCT00281658|156816632|FG001|Open Label Phase|Adverse Event|0|||
48718047|NCT00281658|156816633|FG002|Open Label Phase|Adverse Event|1|||
48718048|NCT00281658|156816634|FG003|Open Label Phase|Adverse Event|0|||
48718049|NCT00281658|156816631|FG000|Open Label Phase|Lost to Follow-up|0|||
48718050|NCT00281658|156816632|FG001|Open Label Phase|Lost to Follow-up|0|||
48718051|NCT00281658|156816633|FG002|Open Label Phase|Lost to Follow-up|16|||
48718052|NCT00281658|156816634|FG003|Open Label Phase|Lost to Follow-up|2|||
48718053|NCT00281658|156816631|FG000|Open Label Phase|Withdrawal by Subject|0|||
48718054|NCT00281658|156816632|FG001|Open Label Phase|Withdrawal by Subject|0|||
48718055|NCT00281658|156816633|FG002|Open Label Phase|Withdrawal by Subject|3|||
48718056|NCT00281658|156816634|FG003|Open Label Phase|Withdrawal by Subject|2|||
48718057|NCT00281658|156816631|FG000|Open Label Phase|Disease progression|0|||
48718058|NCT00281658|156816632|FG001|Open Label Phase|Disease progression|0|||
48718059|NCT00281658|156816633|FG002|Open Label Phase|Disease progression|18|||
48718060|NCT00281658|156816634|FG003|Open Label Phase|Disease progression|0|||
48718061|NCT00281658|156816631|FG000|Open Label Phase|Physician Decision|0|||
48718062|NCT00281658|156816632|FG001|Open Label Phase|Physician Decision|0|||
48718063|NCT00281658|156816633|FG002|Open Label Phase|Physician Decision|1|||
48718064|NCT00281658|156816634|FG003|Open Label Phase|Physician Decision|0|||
48718065|NCT00281658|156816631|FG000|Open Label Phase|Relocation of patient|0|||
48718066|NCT00281658|156816632|FG001|Open Label Phase|Relocation of patient|0|||
48718067|NCT00281658|156816633|FG002|Open Label Phase|Relocation of patient|1|||
48718068|NCT00281658|156816634|FG003|Open Label Phase|Relocation of patient|0|||
48718069|NCT00281658|156816631|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
48718070|NCT00281658|156816632|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
48718071|NCT00281658|156816633|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
48718072|NCT00281658|156816634|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
48718073|NCT02551991|156816635|FG000|Overall Study|Death|5|||
48718074|NCT02551991|156816636|FG001|Overall Study|Death|7|||
48718075|NCT02551991|156816637|FG002|Overall Study|Death|8|||
48718076|NCT02551991|156816638|FG003|Overall Study|Death|7|||
48718077|NCT02551991|156816639|FG004|Overall Study|Death|17|||
48718078|NCT02551991|156816635|FG000|Overall Study|Withdrawal by Subject|1|||
48718079|NCT02551991|156816636|FG001|Overall Study|Withdrawal by Subject|0|||
48718080|NCT02551991|156816637|FG002|Overall Study|Withdrawal by Subject|0|||
48718081|NCT02551991|156816638|FG003|Overall Study|Withdrawal by Subject|0|||
48718082|NCT02551991|156816639|FG004|Overall Study|Withdrawal by Subject|2|||
48718083|NCT02551991|156816635|FG000|Overall Study|Lost to Follow-up|0|||
48718084|NCT02551991|156816636|FG001|Overall Study|Lost to Follow-up|0|||
48718085|NCT02551991|156816637|FG002|Overall Study|Lost to Follow-up|1|||
48718086|NCT02551991|156816638|FG003|Overall Study|Lost to Follow-up|0|||
48718087|NCT02551991|156816639|FG004|Overall Study|Lost to Follow-up|0|||
48718088|NCT02551991|156816635|FG000|Overall Study|Sponsor Decision|1|||
48814892|NCT03225846|157163635|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
48718089|NCT02551991|156816636|FG001|Overall Study|Sponsor Decision|0|||
48718090|NCT02551991|156816637|FG002|Overall Study|Sponsor Decision|1|||
48718091|NCT02551991|156816638|FG003|Overall Study|Sponsor Decision|0|||
48718092|NCT02551991|156816639|FG004|Overall Study|Sponsor Decision|5|||
48718093|NCT02551991|156816635|FG000|Overall Study|Other|0|||
48718094|NCT02551991|156816636|FG001|Overall Study|Other|0|||
48718095|NCT02551991|156816637|FG002|Overall Study|Other|0|||
48718096|NCT02551991|156816638|FG003|Overall Study|Other|0|||
48718097|NCT02551991|156816639|FG004|Overall Study|Other|1|||
48718098|NCT02151773|156816640|FG000|Overall Study|Protocol Deviation|64|||
48718099|NCT00395343|156816641|FG000|Overall Study|Adverse Event|13|||
48718100|NCT00395343|156816642|FG001|Overall Study|Adverse Event|5|||
48718101|NCT00395343|156816641|FG000|Overall Study|Lack of Efficacy|0|||
48718102|NCT00395343|156816642|FG001|Overall Study|Lack of Efficacy|1|||
48718103|NCT00395343|156816641|FG000|Overall Study|Lost to Follow-up|4|||
48718104|NCT00395343|156816642|FG001|Overall Study|Lost to Follow-up|4|||
48718105|NCT00395343|156816641|FG000|Overall Study|Physician Decision|2|||
48718106|NCT00395343|156816642|FG001|Overall Study|Physician Decision|4|||
48718107|NCT00395343|156816641|FG000|Overall Study|Protocol Violation|6|||
48718108|NCT00395343|156816642|FG001|Overall Study|Protocol Violation|8|||
48718109|NCT00395343|156816641|FG000|Overall Study|Withdrawal by Subject|11|||
48718110|NCT00395343|156816642|FG001|Overall Study|Withdrawal by Subject|12|||
48718111|NCT00395343|156816641|FG000|Overall Study|Other|5|||
48718112|NCT00395343|156816642|FG001|Overall Study|Other|2|||
48718113|NCT00265148|156816643|FG000|Overall Study|Adverse Event|2|||
48718114|NCT00265148|156816644|FG001|Overall Study|Adverse Event|2|||
48718115|NCT00265148|156816643|FG000|Overall Study|Lack of Efficacy|0|||
48718116|NCT00265148|156816644|FG001|Overall Study|Lack of Efficacy|2|||
48718117|NCT00265148|156816643|FG000|Overall Study|Protocol Violation|3|||
48718118|NCT00265148|156816644|FG001|Overall Study|Protocol Violation|2|||
48814893|NCT03225846|157163636|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
48814894|NCT03225846|157163637|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
48814895|NCT03225846|157163638|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
48814896|NCT03225846|157163639|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
48814897|NCT03225846|157163633|FG000|Overall Study|Patient decision|0|||
48814898|NCT03225846|157163634|FG001|Overall Study|Patient decision|0|||
48814899|NCT03225846|157163635|FG002|Overall Study|Patient decision|0|||
48814900|NCT03225846|157163636|FG003|Overall Study|Patient decision|0|||
48814901|NCT03225846|157163637|FG004|Overall Study|Patient decision|0|||
48814902|NCT03225846|157163638|FG005|Overall Study|Patient decision|0|||
48814903|NCT03225846|157163639|FG006|Overall Study|Patient decision|1|||
48814904|NCT02855164|157163640|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814905|NCT02855164|157163641|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814906|NCT02855164|157163642|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
48814907|NCT02855164|157163643|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
48814908|NCT02855164|157163644|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
48814909|NCT02855164|157163645|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814910|NCT02855164|157163646|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48814911|NCT02855164|157163647|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
48598670|NCT00991289|156385270|FG000|Overall Study|Adverse Event|1|||
48598671|NCT00991289|156385270|FG000|Overall Study|Physician Decision|2|||
48598672|NCT00991289|156385270|FG000|Overall Study|Withdrawal by Subject|3|||
48598673|NCT00991289|156385270|FG000|Overall Study|Lost to Follow-up|4|||
48814912|NCT02855164|157163640|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
48814913|NCT02855164|157163641|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
48814914|NCT02855164|157163642|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
48814915|NCT02855164|157163643|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
48814916|NCT02855164|157163644|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
48598674|NCT00991289|156385270|FG000|Overall Study|Protocol Violation|2|||
48598675|NCT01166750|156385273|FG000|Overall Study|Lost to Follow-up|1|||
48598676|NCT01166750|156385274|FG001|Overall Study|Lost to Follow-up|0|||
48598677|NCT04552132|156385277|FG000|Overall Study|Lost to Follow-up|4|||
48598678|NCT04552132|156385278|FG001|Overall Study|Lost to Follow-up|3|||
48598679|NCT04552132|156385277|FG000|Overall Study|Protocol Violation|1|||
48598680|NCT04552132|156385278|FG001|Overall Study|Protocol Violation|0|||
48598681|NCT00792909|156385279|FG000|Overall Study|Withdrawal by Subject|0|||
48598682|NCT00792909|156385280|FG001|Overall Study|Withdrawal by Subject|1|||
48598683|NCT00792909|156385281|FG002|Overall Study|Withdrawal by Subject|0|||
48598684|NCT03293394|156385282|FG000|Follow-up (6 Months)|Adverse Event|4|||
48598685|NCT03293394|156385283|FG001|Follow-up (6 Months)|Adverse Event|2|||
48598686|NCT00385918|156385284|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
48598687|NCT00385918|156385285|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
48598688|NCT00385918|156385286|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
48718119|NCT00265148|156816643|FG000|Overall Study|Lost to Follow-up|0|||
48718120|NCT00265148|156816644|FG001|Overall Study|Lost to Follow-up|1|||
48814917|NCT02855164|157163645|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
48436768|NCT00077610|155787511|FG002|Overall Study|Financial issues|0|||
48598689|NCT00385918|156385284|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
48598690|NCT00385918|156385285|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
48718121|NCT00265148|156816643|FG000|Overall Study|Withdrawal by Subject|2|||
48718122|NCT00265148|156816644|FG001|Overall Study|Withdrawal by Subject|1|||
48718123|NCT00265148|156816643|FG000|Overall Study|Physician Decision|1|||
48718124|NCT00265148|156816644|FG001|Overall Study|Physician Decision|0|||
48718125|NCT00265148|156816643|FG000|Overall Study|Increasing frailty|0|||
48718126|NCT00265148|156816644|FG001|Overall Study|Increasing frailty|1|||
48814918|NCT02855164|157163646|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
48814919|NCT02855164|157163647|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
48598691|NCT00385918|156385286|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
48598692|NCT00385918|156385284|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
48598693|NCT00385918|156385285|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
48598694|NCT00385918|156385286|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
48598695|NCT00385918|156385284|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
48598696|NCT00385918|156385285|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
48598697|NCT00385918|156385286|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
48598698|NCT00385918|156385284|FG000|Intervention Phase After Randomization|Physician Decision|1|||
48598699|NCT00385918|156385285|FG001|Intervention Phase After Randomization|Physician Decision|0|||
48598700|NCT00385918|156385286|FG002|Intervention Phase After Randomization|Physician Decision|0|||
48598701|NCT00385918|156385284|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
48598702|NCT00385918|156385285|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
48598703|NCT00385918|156385286|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
48598704|NCT00196105|156385287|FG000|Overall Study|Lost to Follow-up|4|||
48598705|NCT00196105|156385288|FG001|Overall Study|Lost to Follow-up|5|||
48598706|NCT00196105|156385289|FG002|Overall Study|Lost to Follow-up|7|||
48598707|NCT03421379|156385290|FG000|Period 1|Withdrawal by Subject|0|||
48598708|NCT03421379|156385291|FG001|Period 1|Withdrawal by Subject|1|||
48598709|NCT03421379|156385290|FG000|Period 1|Physician Decision|1|||
48598710|NCT03421379|156385291|FG001|Period 1|Physician Decision|1|||
48598711|NCT03421379|156385290|FG000|Period 1|Did not receive treatment|1|||
48598712|NCT03421379|156385291|FG001|Period 1|Did not receive treatment|2|||
48598713|NCT04978337|156385292|FG000|Overall Study|Withdrawal by Subject|0|||
48598714|NCT04978337|156385293|FG001|Overall Study|Withdrawal by Subject|1|||
48598715|NCT04346199|156385297|FG000|Overall Study|Death|8|||
48498459|NCT00368277|156020122|FG001|Overall Study|Patient withdrew consent|28|||
48498460|NCT00368277|156020121|FG000|Overall Study|Lost to Follow-up|8|||
48498461|NCT00368277|156020122|FG001|Overall Study|Lost to Follow-up|6|||
48498462|NCT01132118|156020123|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
48498463|NCT01132118|156020124|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
48598716|NCT04346199|156385298|FG001|Overall Study|Death|9|||
48598717|NCT04346199|156385297|FG000|Overall Study|Lost to Follow-up|0|||
48598718|NCT04346199|156385298|FG001|Overall Study|Lost to Follow-up|1|||
48498464|NCT01132118|156020123|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
48598719|NCT04346199|156385297|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
48598720|NCT04346199|156385298|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
48598721|NCT04346199|156385297|FG000|Overall Study|Withdrawal by Subject|5|||
48598722|NCT04346199|156385298|FG001|Overall Study|Withdrawal by Subject|1|||
48598723|NCT03797898|156385300|FG000|Overall Study|Lost to Follow-up|60|||
48598724|NCT03797898|156385301|FG001|Overall Study|Lost to Follow-up|69|||
48598725|NCT03797898|156385300|FG000|Overall Study|Withdrawal by Subject|9|||
48598726|NCT03797898|156385301|FG001|Overall Study|Withdrawal by Subject|7|||
48598727|NCT03797898|156385300|FG000|Overall Study|Became ineligible|5|||
48598728|NCT03797898|156385301|FG001|Overall Study|Became ineligible|2|||
48598729|NCT01151345|156385302|FG000|First Intervention Period|Protocol Violation|0|||
48598730|NCT01151345|156385303|FG001|First Intervention Period|Protocol Violation|1|||
48598731|NCT03066830|156385304|FG000|Overall Study|At the Participant's own Request|16|||
48598732|NCT03066830|156385305|FG001|Overall Study|At the Participant's own Request|17|||
48718127|NCT00265148|156816643|FG000|Overall Study|Subject chose to change of the dose|1|||
48718128|NCT00265148|156816644|FG001|Overall Study|Subject chose to change of the dose|0|||
48718129|NCT01410357|156816645|FG000|Overall Study|Death|2|||
48718130|NCT01410357|156816646|FG001|Overall Study|Death|1|||
48718131|NCT01410357|156816645|FG000|Overall Study|Withdrawal by Subject|1|||
48718132|NCT01410357|156816646|FG001|Overall Study|Withdrawal by Subject|2|||
48718133|NCT01410357|156816645|FG000|Overall Study|Lost to Follow-up|23|||
48718134|NCT01410357|156816646|FG001|Overall Study|Lost to Follow-up|21|||
48718135|NCT00945906|156816648|FG000|Overall Study|Withdrawal by Subject|1|||
48718136|NCT00945906|156816648|FG000|Overall Study|Did not want to return for last visit|2|||
48718137|NCT00945906|156816648|FG000|Overall Study|Unable to return for last visit|2|||
48718138|NCT00945906|156816648|FG000|Overall Study|Moved to another country|2|||
48718139|NCT01022398|156816650|FG000|Overall Study|Study terminated|2|||
48718140|NCT01022398|156816651|FG001|Overall Study|Study terminated|2|||
48718141|NCT03565367|156816652|FG000|Overall Study|No scan due to technical issues|4|||
48718142|NCT03565367|156816653|FG001|Overall Study|No scan due to technical issues|0|||
48718143|NCT01104376|156816654|FG000|Overall Study|Withdrawal by Subject|15|||
48718144|NCT01104376|156816654|FG000|Overall Study|Consented but excluded after labs|13|||
48814920|NCT02855164|157163640|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
48498465|NCT01132118|156020124|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
48498466|NCT01132118|156020123|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
48718145|NCT02160002|156816656|FG000|Overall Study|Withdrawal by Subject|2|||
48718146|NCT02160002|156816657|FG001|Overall Study|Withdrawal by Subject|1|||
48598733|NCT03066830|156385304|FG000|Overall Study|Other|3|||
48598734|NCT03066830|156385305|FG001|Overall Study|Other|0|||
48598735|NCT03066830|156385304|FG000|Overall Study|Poor Compliance to Protocol|1|||
48598736|NCT03066830|156385305|FG001|Overall Study|Poor Compliance to Protocol|0|||
48598737|NCT03066830|156385304|FG000|Overall Study|Adverse Event|2|||
48598738|NCT03066830|156385305|FG001|Overall Study|Adverse Event|2|||
48598739|NCT03066830|156385304|FG000|Overall Study|Lost to Follow-up|11|||
48598740|NCT03066830|156385305|FG001|Overall Study|Lost to Follow-up|3|||
48598741|NCT02686164|156385310|FG000|Overall Study|Adverse Event|1|||
48598742|NCT02686164|156385310|FG000|Overall Study|Withdrawal of consent|1|||
48598743|NCT02686164|156385310|FG000|Overall Study|Clinical progression|1|||
48598744|NCT04378569|156387848|FG000|Overall Study|Adverse Event|0|||
48598745|NCT04378569|156387849|FG001|Overall Study|Adverse Event|0|||
48598746|NCT04378569|156387850|FG002|Overall Study|Adverse Event|2|||
48598747|NCT04378569|156387851|FG003|Overall Study|Adverse Event|0|||
48598748|NCT04378569|156387852|FG004|Overall Study|Adverse Event|3|||
48598749|NCT04378569|156387853|FG005|Overall Study|Adverse Event|3|||
48598750|NCT04378569|156387848|FG000|Overall Study|Lost to Follow-up|0|||
48598751|NCT04378569|156387849|FG001|Overall Study|Lost to Follow-up|3|||
48598752|NCT04378569|156387850|FG002|Overall Study|Lost to Follow-up|1|||
48598753|NCT04378569|156387851|FG003|Overall Study|Lost to Follow-up|0|||
48598754|NCT04378569|156387852|FG004|Overall Study|Lost to Follow-up|1|||
48598755|NCT04378569|156387853|FG005|Overall Study|Lost to Follow-up|1|||
48598756|NCT04378569|156387848|FG000|Overall Study|Protocol Violation|0|||
48598757|NCT04378569|156387849|FG001|Overall Study|Protocol Violation|0|||
48598758|NCT04378569|156387850|FG002|Overall Study|Protocol Violation|0|||
48598759|NCT04378569|156387851|FG003|Overall Study|Protocol Violation|0|||
48598760|NCT04378569|156387852|FG004|Overall Study|Protocol Violation|0|||
48598761|NCT04378569|156387853|FG005|Overall Study|Protocol Violation|1|||
48598762|NCT04378569|156387848|FG000|Overall Study|Withdrawal by Subject|0|||
48598763|NCT04378569|156387849|FG001|Overall Study|Withdrawal by Subject|6|||
48598764|NCT04378569|156387850|FG002|Overall Study|Withdrawal by Subject|7|||
48598765|NCT04378569|156387851|FG003|Overall Study|Withdrawal by Subject|4|||
48598766|NCT04378569|156387852|FG004|Overall Study|Withdrawal by Subject|5|||
48598767|NCT04378569|156387853|FG005|Overall Study|Withdrawal by Subject|4|||
48718147|NCT00869778|156816671|FG000|Overall Study|Adverse Event|2|||
48718148|NCT00869778|156816672|FG001|Overall Study|Adverse Event|0|||
48718149|NCT00869778|156816673|FG002|Overall Study|Adverse Event|0|||
48718150|NCT00869778|156816671|FG000|Overall Study|Withdrawal by Subject|3|||
48718151|NCT00869778|156816672|FG001|Overall Study|Withdrawal by Subject|4|||
48718152|NCT00869778|156816673|FG002|Overall Study|Withdrawal by Subject|5|||
48718153|NCT00869778|156816671|FG000|Overall Study|Pregnancy|1|||
48814921|NCT02855164|157163641|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
48814922|NCT02855164|157163642|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
48814923|NCT02855164|157163643|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
48718154|NCT00869778|156816672|FG001|Overall Study|Pregnancy|0|||
48718155|NCT00869778|156816673|FG002|Overall Study|Pregnancy|0|||
48718156|NCT00869778|156816671|FG000|Overall Study|Protocol Violation|5|||
48718157|NCT00869778|156816672|FG001|Overall Study|Protocol Violation|3|||
48718158|NCT00869778|156816673|FG002|Overall Study|Protocol Violation|5|||
48718159|NCT00869778|156816671|FG000|Overall Study|Unblinding|1|||
48718160|NCT00869778|156816672|FG001|Overall Study|Unblinding|0|||
48718161|NCT00869778|156816673|FG002|Overall Study|Unblinding|0|||
48718162|NCT01403948|156816674|FG000|Overall Study|Progressive disease|0|||
48718163|NCT01403948|156816675|FG001|Overall Study|Progressive disease|2|||
48718164|NCT01403948|156816676|FG002|Overall Study|Progressive disease|2|||
48718165|NCT01403948|156816677|FG003|Overall Study|Progressive disease|4|||
48718166|NCT01403948|156816678|FG004|Overall Study|Progressive disease|2|||
48814924|NCT02855164|157163644|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
48814925|NCT02855164|157163645|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
48814926|NCT02855164|157163646|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
48814927|NCT02855164|157163647|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
48598768|NCT04378569|156387848|FG000|Overall Study|Lack of response|0|||
48598769|NCT04378569|156387849|FG001|Overall Study|Lack of response|0|||
48598770|NCT04378569|156387850|FG002|Overall Study|Lack of response|1|||
48598771|NCT04378569|156387851|FG003|Overall Study|Lack of response|0|||
48598772|NCT04378569|156387852|FG004|Overall Study|Lack of response|1|||
48598773|NCT04378569|156387853|FG005|Overall Study|Lack of response|1|||
48598774|NCT01844817|156387854|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
48718167|NCT01403948|156816679|FG005|Overall Study|Progressive disease|6|||
48718168|NCT01403948|156816680|FG006|Overall Study|Progressive disease|2|||
48718169|NCT01403948|156816681|FG007|Overall Study|Progressive disease|4|||
48598775|NCT01844817|156387855|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
48598776|NCT01844817|156387854|FG000|Treatment|Progressive Disease|27|||
48718170|NCT01403948|156816682|FG008|Overall Study|Progressive disease|5|||
48718171|NCT01403948|156816683|FG009|Overall Study|Progressive disease|5|||
48718172|NCT01403948|156816674|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
48814928|NCT02855164|157163640|FG000|Part C (Randomized Set)|Adverse Event|0|||
48814929|NCT02855164|157163641|FG001|Part C (Randomized Set)|Adverse Event|0|||
48814930|NCT02855164|157163642|FG002|Part C (Randomized Set)|Adverse Event|0|||
48814931|NCT02855164|157163643|FG003|Part C (Randomized Set)|Adverse Event|0|||
48814932|NCT02855164|157163644|FG004|Part C (Randomized Set)|Adverse Event|0|||
48814933|NCT02855164|157163645|FG005|Part C (Randomized Set)|Adverse Event|5|||
48814934|NCT02855164|157163646|FG006|Part C (Randomized Set)|Adverse Event|9|||
48814935|NCT02855164|157163647|FG007|Part C (Randomized Set)|Adverse Event|2|||
48598777|NCT01844817|156387855|FG001|Treatment|Progressive Disease|36|||
48598778|NCT01844817|156387854|FG000|Treatment|Adverse Event|17|||
48598779|NCT01844817|156387855|FG001|Treatment|Adverse Event|9|||
48814936|NCT02855164|157163640|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
48814937|NCT02855164|157163641|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
48814938|NCT02855164|157163642|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
48814939|NCT02855164|157163643|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
48814940|NCT02855164|157163644|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
48814941|NCT02855164|157163645|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
48814942|NCT02855164|157163646|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
48814943|NCT02855164|157163647|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
48814944|NCT02855164|157163640|FG000|Part C (Randomized Set)|Physician Decision|0|||
48814945|NCT02855164|157163641|FG001|Part C (Randomized Set)|Physician Decision|0|||
48814946|NCT02855164|157163642|FG002|Part C (Randomized Set)|Physician Decision|0|||
48814947|NCT02855164|157163643|FG003|Part C (Randomized Set)|Physician Decision|0|||
48814948|NCT02855164|157163644|FG004|Part C (Randomized Set)|Physician Decision|0|||
48814949|NCT02855164|157163645|FG005|Part C (Randomized Set)|Physician Decision|1|||
48814950|NCT02855164|157163646|FG006|Part C (Randomized Set)|Physician Decision|0|||
48814951|NCT02855164|157163647|FG007|Part C (Randomized Set)|Physician Decision|1|||
48814952|NCT02855164|157163640|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
48814953|NCT02855164|157163641|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
48814954|NCT02855164|157163642|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
48718173|NCT01403948|156816675|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718174|NCT01403948|156816676|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718175|NCT01403948|156816677|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
48598780|NCT01844817|156387854|FG000|Treatment|Withdrawal by Subject|10|||
48598781|NCT01844817|156387855|FG001|Treatment|Withdrawal by Subject|6|||
48598782|NCT01844817|156387854|FG000|Treatment|Death|10|||
48598783|NCT01844817|156387855|FG001|Treatment|Death|8|||
48598784|NCT01844817|156387854|FG000|Treatment|Lost to Follow-up|0|||
48598785|NCT01844817|156387855|FG001|Treatment|Lost to Follow-up|1|||
48598786|NCT01844817|156387854|FG000|Treatment|Other|0|||
48598787|NCT01844817|156387855|FG001|Treatment|Other|3|||
48598788|NCT00762762|156387856|FG000|Overall Study|Did not return for appointments|6|||
48598789|NCT00762762|156387857|FG001|Overall Study|Did not return for appointments|8|||
48598790|NCT02250300|156387858|FG000|Expansion Phase|Death|6|||
48598791|NCT02250300|156387859|FG001|Expansion Phase|Death|7|||
48598792|NCT02250300|156387860|FG002|Expansion Phase|Death|0|||
48598793|NCT02250300|156387861|FG003|Expansion Phase|Death|0|||
48598794|NCT03512353|156387862|FG000|Overall Study|Sponsor Decision|3|||
48598795|NCT03512353|156387862|FG000|Overall Study|Death|1|||
48718176|NCT01403948|156816678|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
48814955|NCT02855164|157163643|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
48718177|NCT01403948|156816679|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718178|NCT01403948|156816680|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
48718179|NCT01403948|156816681|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718180|NCT01403948|156816682|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
48718181|NCT01403948|156816683|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
48718182|NCT01403948|156816674|FG000|Overall Study|Lost to Follow-up|0|||
48718183|NCT01403948|156816675|FG001|Overall Study|Lost to Follow-up|0|||
48718184|NCT01403948|156816676|FG002|Overall Study|Lost to Follow-up|0|||
48718185|NCT01403948|156816677|FG003|Overall Study|Lost to Follow-up|0|||
48718186|NCT01403948|156816678|FG004|Overall Study|Lost to Follow-up|0|||
48718187|NCT01403948|156816679|FG005|Overall Study|Lost to Follow-up|0|||
48718188|NCT01403948|156816680|FG006|Overall Study|Lost to Follow-up|0|||
48718189|NCT01403948|156816681|FG007|Overall Study|Lost to Follow-up|0|||
48718190|NCT01403948|156816682|FG008|Overall Study|Lost to Follow-up|0|||
48718191|NCT01403948|156816683|FG009|Overall Study|Lost to Follow-up|1|||
48814956|NCT02855164|157163644|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
48814957|NCT02855164|157163645|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
48814958|NCT02855164|157163646|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
48598796|NCT02171429|156387863|FG000|Overall Study|Other|0|||
48598797|NCT02171429|156387864|FG001|Overall Study|Other|1|||
48598798|NCT02171429|156387865|FG002|Overall Study|Other|1|||
48718192|NCT01403948|156816674|FG000|Overall Study|Refused cont. medication|0|||
48718193|NCT01403948|156816675|FG001|Overall Study|Refused cont. medication|0|||
48718194|NCT01403948|156816676|FG002|Overall Study|Refused cont. medication|0|||
48718195|NCT01403948|156816677|FG003|Overall Study|Refused cont. medication|0|||
48598799|NCT02171429|156387863|FG000|Overall Study|Non-Compliance|0|||
48598800|NCT02171429|156387864|FG001|Overall Study|Non-Compliance|0|||
48718196|NCT01403948|156816678|FG004|Overall Study|Refused cont. medication|1|||
48718197|NCT01403948|156816679|FG005|Overall Study|Refused cont. medication|0|||
48718198|NCT01403948|156816680|FG006|Overall Study|Refused cont. medication|0|||
48718199|NCT01403948|156816681|FG007|Overall Study|Refused cont. medication|0|||
48718200|NCT01403948|156816682|FG008|Overall Study|Refused cont. medication|0|||
48718201|NCT01403948|156816683|FG009|Overall Study|Refused cont. medication|1|||
48718202|NCT01403948|156816674|FG000|Overall Study|other than above|1|||
48718203|NCT01403948|156816675|FG001|Overall Study|other than above|2|||
48718204|NCT01403948|156816676|FG002|Overall Study|other than above|1|||
48718205|NCT01403948|156816677|FG003|Overall Study|other than above|0|||
48718206|NCT01403948|156816678|FG004|Overall Study|other than above|1|||
48718207|NCT01403948|156816679|FG005|Overall Study|other than above|1|||
48718208|NCT01403948|156816680|FG006|Overall Study|other than above|2|||
48718209|NCT01403948|156816681|FG007|Overall Study|other than above|0|||
48718210|NCT01403948|156816682|FG008|Overall Study|other than above|0|||
48718211|NCT01403948|156816683|FG009|Overall Study|other than above|0|||
48718212|NCT03459690|156816690|FG000|Overall Study|Lost to Follow-up|0|||
48718213|NCT03459690|156816691|FG001|Overall Study|Lost to Follow-up|1|||
48718214|NCT03459690|156816690|FG000|Overall Study|Withdrawal by Subject|1|||
48718215|NCT03459690|156816691|FG001|Overall Study|Withdrawal by Subject|1|||
48718216|NCT00910299|156816697|FG000|Overall Study|Withdrawal by Subject|16|||
48718217|NCT00910299|156816698|FG001|Overall Study|Withdrawal by Subject|13|||
48718218|NCT00910299|156816697|FG000|Overall Study|Sponsor Decision|58|||
48718219|NCT00910299|156816698|FG001|Overall Study|Sponsor Decision|60|||
48718220|NCT00910299|156816697|FG000|Overall Study|Didn't receive any study drug|2|||
48718221|NCT00910299|156816698|FG001|Overall Study|Didn't receive any study drug|1|||
48498467|NCT01132118|156020124|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
48498468|NCT01644890|156020125|FG000|Overall Study|Adverse Event|7|||
48498469|NCT01644890|156020126|FG001|Overall Study|Adverse Event|20|||
48498470|NCT01644890|156020125|FG000|Overall Study|Death|1|||
48498471|NCT01644890|156020126|FG001|Overall Study|Death|3|||
48498472|NCT01644890|156020125|FG000|Overall Study|Physician Decision|3|||
48498473|NCT01644890|156020126|FG001|Overall Study|Physician Decision|9|||
48498474|NCT01644890|156020125|FG000|Overall Study|Protocol Violation|6|||
48498475|NCT01644890|156020126|FG001|Overall Study|Protocol Violation|7|||
48498476|NCT01644890|156020125|FG000|Overall Study|Withdrawal by Subject|19|||
48498477|NCT01644890|156020126|FG001|Overall Study|Withdrawal by Subject|27|||
48498478|NCT01644890|156020125|FG000|Overall Study|Progression Disease|160|||
48498479|NCT01644890|156020126|FG001|Overall Study|Progression Disease|131|||
48498480|NCT01644890|156020125|FG000|Overall Study|Clinical Progression|6|||
48498481|NCT01644890|156020126|FG001|Overall Study|Clinical Progression|6|||
48498482|NCT01644890|156020125|FG000|Overall Study|> 28 days since last dose of study drug|6|||
48498483|NCT01644890|156020126|FG001|Overall Study|> 28 days since last dose of study drug|3|||
48498484|NCT01644890|156020125|FG000|Overall Study|Other|8|||
48498485|NCT01644890|156020126|FG001|Overall Study|Other|9|||
48498486|NCT02785913|156020127|FG000|Overall Study|Adverse Event|5|||
48498487|NCT02785913|156020127|FG000|Overall Study|Death|2|||
48498488|NCT02785913|156020127|FG000|Overall Study|Progression|18|||
48498489|NCT02785913|156020127|FG000|Overall Study|Not protocol specified|1|||
48498490|NCT01335477|156020128|FG000|Overall Study|Adverse Event|30|||
48498491|NCT01335477|156020129|FG001|Overall Study|Adverse Event|42|||
48498492|NCT01335477|156020128|FG000|Overall Study|Non compliant with protocol|0|||
48498493|NCT01335477|156020129|FG001|Overall Study|Non compliant with protocol|2|||
48498494|NCT01335477|156020128|FG000|Overall Study|Lost to Follow-up|1|||
48498495|NCT01335477|156020129|FG001|Overall Study|Lost to Follow-up|2|||
48498496|NCT01335477|156020128|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
48498497|NCT01335477|156020129|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
48498498|NCT01335477|156020128|FG000|Overall Study|Not treated|1|||
48498499|NCT01335477|156020129|FG001|Overall Study|Not treated|2|||
48498500|NCT01335477|156020128|FG000|Overall Study|Reason other than those stated above|2|||
48498501|NCT01335477|156020129|FG001|Overall Study|Reason other than those stated above|2|||
48498502|NCT01060670|156020135|FG000|Run In|screen failure|0|||
48498503|NCT01060670|156020136|FG001|Run In|screen failure|238|||
48498504|NCT02841709|156020137|FG000|5th Intervention|Adverse Event|2|||
48498505|NCT02841709|156020138|FG001|5th Intervention|Adverse Event|0|||
48498506|NCT02841709|156020139|FG002|5th Intervention|Adverse Event|0|||
48498507|NCT02841709|156020140|FG003|5th Intervention|Adverse Event|0|||
48498508|NCT02841709|156020141|FG004|5th Intervention|Adverse Event|2|||
48498509|NCT01929109|156020142|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
48718222|NCT03704636|156816707|FG000|Overall Study|Inadequate Venous Flow|3|||
48718223|NCT00313781|156816708|FG000|Before Crossover|Death|22|||
48718224|NCT00313781|156816709|FG001|Before Crossover|Death|8|||
48498510|NCT01929109|156020143|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
48718225|NCT00313781|156816710|FG002|Before Crossover|Death|0|||
48718226|NCT00313781|156816708|FG000|Before Crossover|Lost to Follow-up|0|||
48718227|NCT00313781|156816709|FG001|Before Crossover|Lost to Follow-up|3|||
48718228|NCT00313781|156816710|FG002|Before Crossover|Lost to Follow-up|0|||
48718229|NCT00313781|156816708|FG000|Before Crossover|Withdrawal by Subject|3|||
48598801|NCT02171429|156387865|FG002|Overall Study|Non-Compliance|1|||
48598802|NCT02171429|156387863|FG000|Overall Study|Physician Decision|0|||
48598803|NCT02171429|156387864|FG001|Overall Study|Physician Decision|0|||
48598804|NCT02171429|156387865|FG002|Overall Study|Physician Decision|1|||
48598805|NCT02171429|156387863|FG000|Overall Study|Withdrawal by Subject|1|||
48598806|NCT02171429|156387864|FG001|Overall Study|Withdrawal by Subject|1|||
48598807|NCT02171429|156387865|FG002|Overall Study|Withdrawal by Subject|1|||
48598808|NCT02171429|156387863|FG000|Overall Study|Lost to Follow-up|0|||
48598809|NCT02171429|156387864|FG001|Overall Study|Lost to Follow-up|1|||
48598810|NCT02171429|156387865|FG002|Overall Study|Lost to Follow-up|0|||
48598811|NCT02171429|156387863|FG000|Overall Study|Death|0|||
48598812|NCT02171429|156387864|FG001|Overall Study|Death|0|||
48598813|NCT02171429|156387865|FG002|Overall Study|Death|1|||
48598814|NCT00493012|156387868|FG000|Overall Study|Lost to Follow-up|18|||
48598815|NCT00493012|156387869|FG001|Overall Study|Lost to Follow-up|17|||
48598816|NCT01519817|156387870|FG000|Overall Study|Withdrawal by Subject|1|||
48598817|NCT01519817|156387871|FG001|Overall Study|Withdrawal by Subject|0|||
48598818|NCT01519817|156387872|FG002|Overall Study|Withdrawal by Subject|0|||
48814959|NCT02855164|157163647|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
48814960|NCT01544582|157163648|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
48718230|NCT00313781|156816709|FG001|Before Crossover|Withdrawal by Subject|1|||
48718231|NCT00313781|156816710|FG002|Before Crossover|Withdrawal by Subject|0|||
48718232|NCT00313781|156816708|FG000|Before Crossover|Other|45|||
48718233|NCT00313781|156816709|FG001|Before Crossover|Other|30|||
48718234|NCT00313781|156816710|FG002|Before Crossover|Other|0|||
48718235|NCT00313781|156816708|FG000|Before Crossover|Crossover|0|||
48718236|NCT00313781|156816709|FG001|Before Crossover|Crossover|37|||
48718237|NCT00313781|156816710|FG002|Before Crossover|Crossover|0|||
48718238|NCT00313781|156816708|FG000|Before Crossover|Randomized, not treated|5|||
48718239|NCT00313781|156816709|FG001|Before Crossover|Randomized, not treated|0|||
48718240|NCT00313781|156816710|FG002|Before Crossover|Randomized, not treated|0|||
48718241|NCT00313781|156816708|FG000|After Crossover|Death|0|||
48718242|NCT00313781|156816709|FG001|After Crossover|Death|0|||
48718243|NCT00313781|156816710|FG002|After Crossover|Death|6|||
48718244|NCT00313781|156816708|FG000|After Crossover|Withdrawal by Subject|0|||
48718245|NCT00313781|156816709|FG001|After Crossover|Withdrawal by Subject|0|||
48718246|NCT00313781|156816710|FG002|After Crossover|Withdrawal by Subject|3|||
48718247|NCT00313781|156816708|FG000|After Crossover|Other|0|||
48718248|NCT00313781|156816709|FG001|After Crossover|Other|0|||
48718249|NCT00313781|156816710|FG002|After Crossover|Other|18|||
48718250|NCT03148691|156816711|FG000|Overall Study|Protocol Violation|1|||
48718251|NCT03148691|156816712|FG001|Overall Study|Protocol Violation|2|||
48718252|NCT03148691|156816713|FG002|Overall Study|Protocol Violation|7|||
48718253|NCT03148691|156816711|FG000|Overall Study|Lost to Follow-up|0|||
48718254|NCT03148691|156816712|FG001|Overall Study|Lost to Follow-up|0|||
48718255|NCT03148691|156816713|FG002|Overall Study|Lost to Follow-up|1|||
48814961|NCT01544582|157163649|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
48814962|NCT01544582|157163650|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
48814963|NCT01544582|157163651|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
48814964|NCT01544582|157163648|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
48814965|NCT01544582|157163649|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
48814966|NCT01544582|157163650|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
48814967|NCT01544582|157163651|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
48814968|NCT01544582|157163648|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
48598819|NCT01519817|156387873|FG003|Overall Study|Withdrawal by Subject|0|||
48598820|NCT01519817|156387870|FG000|Overall Study|Off study due to infection|0|||
48718256|NCT03148691|156816711|FG000|Overall Study|Other|1|||
48814969|NCT01544582|157163649|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
48814970|NCT01544582|157163650|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
48814971|NCT01544582|157163651|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
48598821|NCT01519817|156387871|FG001|Overall Study|Off study due to infection|0|||
48598822|NCT01519817|156387872|FG002|Overall Study|Off study due to infection|0|||
48598823|NCT01519817|156387873|FG003|Overall Study|Off study due to infection|1|||
48718257|NCT03148691|156816712|FG001|Overall Study|Other|0|||
48718258|NCT03148691|156816713|FG002|Overall Study|Other|0|||
48718259|NCT03148691|156816711|FG000|Overall Study|Withdrawal by Subject|1|||
48718260|NCT03148691|156816712|FG001|Overall Study|Withdrawal by Subject|0|||
48718261|NCT03148691|156816713|FG002|Overall Study|Withdrawal by Subject|0|||
48718262|NCT02437110|156816714|FG000|Screening|Lost to Follow-up|3|||
48718263|NCT02437110|156816714|FG000|Screening|Physician Decision|1|||
48718264|NCT02437110|156816714|FG000|ART|Adverse Event|3|||
48598824|NCT00305227|156387874|FG000|Overall Study|Lost to Follow-up|7|||
48598825|NCT00305227|156387875|FG001|Overall Study|Lost to Follow-up|6|||
48598826|NCT01704755|156387876|FG000|Overall Study|Adverse Event|4|||
48598827|NCT01704755|156387877|FG001|Overall Study|Adverse Event|1|||
48598828|NCT01704755|156387876|FG000|Overall Study|Lost to Follow-up|3|||
48718265|NCT02437110|156816714|FG000|ART|Protocol Violation|3|||
48718266|NCT02437110|156816714|FG000|ART|Withdrawal by Subject|4|||
48598829|NCT01704755|156387877|FG001|Overall Study|Lost to Follow-up|4|||
48598830|NCT01704755|156387876|FG000|Overall Study|Withdrew consent|1|||
48598831|NCT01704755|156387877|FG001|Overall Study|Withdrew consent|1|||
48598832|NCT01704755|156387876|FG000|Overall Study|Other (not specified)|3|||
48598833|NCT01704755|156387877|FG001|Overall Study|Other (not specified)|1|||
48598834|NCT01704755|156387876|FG000|Overall Study|Withdrew consent and personal issues|1|||
48598835|NCT01704755|156387877|FG001|Overall Study|Withdrew consent and personal issues|0|||
48598836|NCT00281697|156387878|FG000|Overall Study|> 60 days since last dose of study drug|4|||
48598837|NCT00281697|156387879|FG001|Overall Study|> 60 days since last dose of study drug|4|||
48598838|NCT00281697|156387878|FG000|Overall Study|Adverse Event|54|||
48598839|NCT00281697|156387879|FG001|Overall Study|Adverse Event|15|||
48598840|NCT00281697|156387878|FG000|Overall Study|Death|8|||
48598841|NCT00281697|156387879|FG001|Overall Study|Death|3|||
48598842|NCT00281697|156387878|FG000|Overall Study|Disease progression|279|||
48598843|NCT00281697|156387879|FG001|Overall Study|Disease progression|149|||
48598844|NCT00281697|156387878|FG000|Overall Study|Other|5|||
48718267|NCT02437110|156816714|FG000|ART|Lost to follow-up prior to start of intervention|1|||
48718268|NCT02437110|156816714|FG000|ART|Physician decision prior to start of intervention|2|||
48718269|NCT02437110|156816714|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
48718270|NCT02437110|156816714|FG000|Post-ART|Lost to Follow-up|3|||
48718271|NCT02437110|156816714|FG000|Post-ART|Protocol Violation|4|||
48718272|NCT02437110|156816714|FG000|Post-ART|Withdrawal by Subject|3|||
48718273|NCT04525885|156816715|FG000|Overall Study|Screen Failure|1|||
48718274|NCT04525885|156816716|FG001|Overall Study|Screen Failure|0|||
48718275|NCT04525885|156816717|FG002|Overall Study|Screen Failure|0|||
48718276|NCT04525885|156816715|FG000|Overall Study|Withdrawal by Subject|14|||
48718277|NCT04525885|156816716|FG001|Overall Study|Withdrawal by Subject|6|||
48718278|NCT04525885|156816717|FG002|Overall Study|Withdrawal by Subject|20|||
48718279|NCT04525885|156816715|FG000|Overall Study|Physician Decision|1|||
48718280|NCT04525885|156816716|FG001|Overall Study|Physician Decision|0|||
48718281|NCT04525885|156816717|FG002|Overall Study|Physician Decision|1|||
48718282|NCT03836001|156816725|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
48718283|NCT03836001|156816726|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
48718284|NCT03836001|156816727|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
48718285|NCT03836001|156816725|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
48718286|NCT03836001|156816726|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
48718287|NCT03836001|156816727|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
48718288|NCT03836001|156816725|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
48718289|NCT03836001|156816726|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
48718290|NCT03836001|156816727|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
48718291|NCT03836001|156816725|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
48718292|NCT03836001|156816726|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
48718293|NCT03836001|156816727|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
48718294|NCT00534313|156816728|FG000|Short-term Period|Adverse Event|1|||
48718295|NCT00534313|156816729|FG001|Short-term Period|Adverse Event|2|||
48718296|NCT00534313|156816730|FG002|Short-term Period|Adverse Event|1|||
48718297|NCT00534313|156816731|FG003|Short-term Period|Adverse Event|3|||
48718298|NCT00534313|156816728|FG000|Short-term Period|Lack of Efficacy|3|||
48718299|NCT00534313|156816729|FG001|Short-term Period|Lack of Efficacy|4|||
48498511|NCT01929109|156020144|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
48498512|NCT01929109|156020145|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
48498513|NCT01929109|156020146|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
48498514|NCT02228382|156020147|FG000|Overall Study|Death|5|||
48498515|NCT02228382|156020148|FG001|Overall Study|Death|7|||
48498516|NCT02228382|156020149|FG002|Overall Study|Death|5|||
48498517|NCT02228382|156020150|FG003|Overall Study|Death|0|||
48498518|NCT02228382|156020151|FG004|Overall Study|Death|2|||
48498519|NCT02228382|156020147|FG000|Overall Study|Participant refused further follow-up|0|||
48498520|NCT02228382|156020148|FG001|Overall Study|Participant refused further follow-up|0|||
48498521|NCT02228382|156020149|FG002|Overall Study|Participant refused further follow-up|1|||
48498522|NCT02228382|156020150|FG003|Overall Study|Participant refused further follow-up|0|||
48498523|NCT02228382|156020151|FG004|Overall Study|Participant refused further follow-up|0|||
48498524|NCT02228382|156020147|FG000|Overall Study|Study terminated by sponsor|3|||
48498525|NCT02228382|156020148|FG001|Overall Study|Study terminated by sponsor|5|||
48498526|NCT02228382|156020149|FG002|Overall Study|Study terminated by sponsor|7|||
48598845|NCT00281697|156387879|FG001|Overall Study|Other|6|||
48718300|NCT00534313|156816730|FG002|Short-term Period|Lack of Efficacy|0|||
48718301|NCT00534313|156816731|FG003|Short-term Period|Lack of Efficacy|3|||
48718302|NCT00534313|156816728|FG000|Short-term Period|Participant not meeting study criteria|0|||
48598846|NCT00281697|156387878|FG000|Overall Study|Physician's decision to withdraw|15|||
48598847|NCT00281697|156387879|FG001|Overall Study|Physician's decision to withdraw|12|||
48598848|NCT00281697|156387878|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
48598849|NCT00281697|156387879|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
48498527|NCT02228382|156020150|FG003|Overall Study|Study terminated by sponsor|0|||
48498528|NCT02228382|156020151|FG004|Overall Study|Study terminated by sponsor|0|||
48498529|NCT02228382|156020147|FG000|Overall Study|Lost to Follow-up|0|||
48498530|NCT02228382|156020148|FG001|Overall Study|Lost to Follow-up|0|||
48498531|NCT02228382|156020149|FG002|Overall Study|Lost to Follow-up|3|||
48498532|NCT02228382|156020150|FG003|Overall Study|Lost to Follow-up|1|||
48498533|NCT02228382|156020151|FG004|Overall Study|Lost to Follow-up|0|||
48498534|NCT02228382|156020147|FG000|Overall Study|Withdrawal by Subject|0|||
48498535|NCT02228382|156020148|FG001|Overall Study|Withdrawal by Subject|3|||
48498536|NCT02228382|156020149|FG002|Overall Study|Withdrawal by Subject|2|||
48498537|NCT02228382|156020150|FG003|Overall Study|Withdrawal by Subject|1|||
48498538|NCT02228382|156020151|FG004|Overall Study|Withdrawal by Subject|0|||
48498539|NCT02228382|156020147|FG000|Overall Study|Other|2|||
48498540|NCT02228382|156020148|FG001|Overall Study|Other|3|||
48498541|NCT02228382|156020149|FG002|Overall Study|Other|3|||
48498542|NCT02228382|156020150|FG003|Overall Study|Other|0|||
48498543|NCT02228382|156020151|FG004|Overall Study|Other|0|||
48498544|NCT01238848|156020153|FG000|Overall Study|Physician Decision|13|||
48498545|NCT01238848|156020154|FG001|Overall Study|Physician Decision|5|||
48498546|NCT00275002|156020158|FG000|Overall Study|Death|1|||
48498547|NCT00275002|156020159|FG001|Overall Study|Death|0|||
48498548|NCT00275002|156020158|FG000|Overall Study|Disease progression|21|||
48498549|NCT00275002|156020159|FG001|Overall Study|Disease progression|15|||
48498550|NCT00275002|156020158|FG000|Overall Study|Adverse Event|0|||
48498551|NCT00275002|156020159|FG001|Overall Study|Adverse Event|1|||
48498552|NCT03882047|156020160|FG000|Overall Study|Adverse Event|0|||
48498553|NCT03882047|156020161|FG001|Overall Study|Adverse Event|2|||
48498554|NCT03882047|156020162|FG002|Overall Study|Adverse Event|2|||
48498555|NCT03882047|156020160|FG000|Overall Study|Treatment Failure|3|||
48498556|NCT03882047|156020161|FG001|Overall Study|Treatment Failure|3|||
48498557|NCT03882047|156020162|FG002|Overall Study|Treatment Failure|12|||
48498558|NCT03882047|156020160|FG000|Overall Study|Lost to Follow-up|0|||
48498559|NCT03882047|156020161|FG001|Overall Study|Lost to Follow-up|1|||
48498560|NCT03882047|156020162|FG002|Overall Study|Lost to Follow-up|0|||
48498561|NCT03882047|156020160|FG000|Overall Study|Did Not Wish to Continue|1|||
48498562|NCT03882047|156020161|FG001|Overall Study|Did Not Wish to Continue|4|||
48498563|NCT03882047|156020162|FG002|Overall Study|Did Not Wish to Continue|1|||
48498564|NCT03882047|156020160|FG000|Overall Study|Noncompliance With Protocol|2|||
48498565|NCT03882047|156020161|FG001|Overall Study|Noncompliance With Protocol|0|||
48498566|NCT03882047|156020162|FG002|Overall Study|Noncompliance With Protocol|0|||
48498567|NCT03882047|156020160|FG000|Overall Study|Did Not Meet Eligibility|0|||
48498568|NCT03882047|156020161|FG001|Overall Study|Did Not Meet Eligibility|0|||
48498569|NCT03882047|156020162|FG002|Overall Study|Did Not Meet Eligibility|1|||
48498570|NCT00812253|156020164|FG000|Overall Study|Withdrawal by Subject|3|||
48498571|NCT00812253|156020165|FG001|Overall Study|Withdrawal by Subject|2|||
48498572|NCT00812253|156020164|FG000|Overall Study|Protocol Violation|1|||
48498573|NCT00812253|156020165|FG001|Overall Study|Protocol Violation|1|||
48498574|NCT00812253|156020164|FG000|Overall Study|Lost to Follow-up|2|||
48498575|NCT00812253|156020165|FG001|Overall Study|Lost to Follow-up|0|||
48498576|NCT02918162|156020167|FG000|Overall Study|Withdrawal by Subject|1|||
48498577|NCT02918162|156020167|FG000|Overall Study|Omental Disease|1|||
48498578|NCT01545076|156020168|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
48498579|NCT01545076|156020169|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
48498580|NCT01545076|156020170|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
48498581|NCT01545076|156020171|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
48498582|NCT01545076|156020172|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
48498583|NCT01545076|156020168|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
48498584|NCT01545076|156020169|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
48498585|NCT01545076|156020170|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
48498586|NCT01545076|156020171|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
48498587|NCT01545076|156020172|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
48498588|NCT01545076|156020168|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
48498589|NCT01545076|156020169|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
48498590|NCT01545076|156020170|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
48498591|NCT01545076|156020171|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
48498592|NCT01545076|156020172|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
48498593|NCT01545076|156020168|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
48498594|NCT01545076|156020169|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
48498595|NCT01545076|156020170|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
48498596|NCT01545076|156020171|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
48498597|NCT01545076|156020172|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
48498598|NCT01545076|156020168|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
48498599|NCT01545076|156020169|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
48498600|NCT01545076|156020170|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
48498601|NCT01545076|156020171|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
48498602|NCT01545076|156020172|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
48498603|NCT01545076|156020168|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
48498604|NCT01545076|156020169|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
48498605|NCT01545076|156020170|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
48498606|NCT01545076|156020171|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
48498607|NCT01545076|156020172|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
48498608|NCT01545076|156020168|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
48498609|NCT01545076|156020169|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
48498610|NCT01545076|156020170|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
48498611|NCT01545076|156020171|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
48498612|NCT01545076|156020172|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
48498613|NCT01545076|156020168|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
48498614|NCT01545076|156020169|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
48498615|NCT01545076|156020170|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
48498616|NCT01545076|156020171|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
48498617|NCT01545076|156020172|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
48498618|NCT01545076|156020168|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
48498619|NCT01545076|156020169|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
48498620|NCT01545076|156020170|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
48498621|NCT01545076|156020171|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
48498622|NCT01545076|156020172|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
48498623|NCT00379340|156020173|FG000|Overall Study|Death|0|||
48498624|NCT00379340|156020174|FG001|Overall Study|Death|0|||
48498625|NCT00379340|156020175|FG002|Overall Study|Death|0|||
48498626|NCT00379340|156020176|FG003|Overall Study|Death|2|||
48498627|NCT00379340|156020177|FG004|Overall Study|Death|0|||
48498628|NCT00379340|156020173|FG000|Overall Study|Lack of Efficacy|6|||
48498629|NCT00379340|156020174|FG001|Overall Study|Lack of Efficacy|1|||
48498630|NCT00379340|156020175|FG002|Overall Study|Lack of Efficacy|0|||
48498631|NCT00379340|156020176|FG003|Overall Study|Lack of Efficacy|4|||
48498632|NCT00379340|156020177|FG004|Overall Study|Lack of Efficacy|3|||
48498633|NCT00379340|156020173|FG000|Overall Study|Physician Decision|6|||
48498634|NCT00379340|156020174|FG001|Overall Study|Physician Decision|2|||
48498635|NCT00379340|156020175|FG002|Overall Study|Physician Decision|1|||
48498636|NCT00379340|156020176|FG003|Overall Study|Physician Decision|2|||
48498637|NCT00379340|156020177|FG004|Overall Study|Physician Decision|3|||
48498638|NCT00379340|156020173|FG000|Overall Study|Withdrawal by Subject|0|||
48498639|NCT00379340|156020174|FG001|Overall Study|Withdrawal by Subject|0|||
48498640|NCT00379340|156020175|FG002|Overall Study|Withdrawal by Subject|0|||
48498641|NCT00379340|156020176|FG003|Overall Study|Withdrawal by Subject|1|||
48498642|NCT00379340|156020177|FG004|Overall Study|Withdrawal by Subject|0|||
48498643|NCT00379340|156020173|FG000|Overall Study|Refusal of further protocol therapy|1|||
48498644|NCT00379340|156020174|FG001|Overall Study|Refusal of further protocol therapy|0|||
48498645|NCT00379340|156020175|FG002|Overall Study|Refusal of further protocol therapy|1|||
48814972|NCT01544582|157163648|FG000|Analysis Population|Physician Decision|0|||
48814973|NCT01544582|157163649|FG001|Analysis Population|Physician Decision|13|||
48814974|NCT01544582|157163650|FG002|Analysis Population|Physician Decision|10|||
48814975|NCT01544582|157163651|FG003|Analysis Population|Physician Decision|9|||
48814976|NCT01544582|157163648|FG000|Analysis Population|Safety Reason|0|||
48814977|NCT01544582|157163649|FG001|Analysis Population|Safety Reason|33|||
48814978|NCT01544582|157163650|FG002|Analysis Population|Safety Reason|31|||
48814979|NCT01544582|157163651|FG003|Analysis Population|Safety Reason|8|||
48814980|NCT01544582|157163648|FG000|Analysis Population|Effectiveness Reason|0|||
48814981|NCT01544582|157163649|FG001|Analysis Population|Effectiveness Reason|48|||
48814982|NCT01544582|157163650|FG002|Analysis Population|Effectiveness Reason|29|||
48814983|NCT01544582|157163651|FG003|Analysis Population|Effectiveness Reason|12|||
48814984|NCT01544582|157163648|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
48814985|NCT01544582|157163649|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
48814986|NCT01544582|157163650|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
48498646|NCT00379340|156020176|FG003|Overall Study|Refusal of further protocol therapy|1|||
48498647|NCT00379340|156020177|FG004|Overall Study|Refusal of further protocol therapy|7|||
48498648|NCT00379340|156020173|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
48814987|NCT01544582|157163651|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
48814988|NCT01544582|157163648|FG000|Analysis Population|Lost to Follow-up|0|||
48814989|NCT01544582|157163649|FG001|Analysis Population|Lost to Follow-up|6|||
48814990|NCT01544582|157163650|FG002|Analysis Population|Lost to Follow-up|6|||
48814991|NCT01544582|157163651|FG003|Analysis Population|Lost to Follow-up|5|||
48814992|NCT01544582|157163648|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
48814993|NCT01544582|157163649|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
48814994|NCT01544582|157163650|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
48498649|NCT00379340|156020174|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
48498650|NCT00379340|156020175|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
48498651|NCT00379340|156020176|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
48498652|NCT00379340|156020177|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
48498653|NCT00379340|156020173|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
48498654|NCT00379340|156020174|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
48498655|NCT00379340|156020175|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
48498656|NCT00379340|156020176|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
48498657|NCT00379340|156020177|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
48498658|NCT00395226|156020179|FG000|Overall Study|Adverse Event|4|||
48498659|NCT00395226|156020180|FG001|Overall Study|Adverse Event|3|||
48498660|NCT00395226|156020179|FG000|Overall Study|Withdrawal by Subject|0|||
48498661|NCT00395226|156020180|FG001|Overall Study|Withdrawal by Subject|1|||
48498662|NCT00395226|156020179|FG000|Overall Study|Lost to Follow-up|0|||
48498663|NCT00395226|156020180|FG001|Overall Study|Lost to Follow-up|1|||
48498664|NCT02563522|156020181|FG000|Overall Study|Adverse Event|2|||
48498665|NCT02563522|156020182|FG001|Overall Study|Adverse Event|3|||
48498666|NCT02563522|156020181|FG000|Overall Study|Lost to Follow-up|1|||
48498667|NCT02563522|156020182|FG001|Overall Study|Lost to Follow-up|0|||
48498668|NCT02563522|156020181|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
48498669|NCT02563522|156020182|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
48498670|NCT01259869|156020183|FG000|Overall Study|Duplicated registration|1|||
48498671|NCT00576381|156020184|FG000|Overall Study|Reoperation|3|||
48498672|NCT00576381|156020184|FG000|Overall Study|Adverse Event|4|||
48498673|NCT02518113|156020185|FG000|Overall Study|Adverse Event|1|||
48498674|NCT02518113|156020186|FG001|Overall Study|Adverse Event|0|||
48498675|NCT02518113|156020187|FG002|Overall Study|Adverse Event|1|||
48498676|NCT02518113|156020188|FG003|Overall Study|Adverse Event|0|||
48498677|NCT02518113|156020185|FG000|Overall Study|Death|1|||
48498678|NCT02518113|156020186|FG001|Overall Study|Death|2|||
48498679|NCT02518113|156020187|FG002|Overall Study|Death|0|||
48498680|NCT02518113|156020188|FG003|Overall Study|Death|0|||
48498681|NCT02518113|156020185|FG000|Overall Study|Physician Decision|0|||
48498682|NCT02518113|156020186|FG001|Overall Study|Physician Decision|1|||
48498683|NCT02518113|156020187|FG002|Overall Study|Physician Decision|0|||
48718303|NCT00534313|156816729|FG001|Short-term Period|Participant not meeting study criteria|0|||
48718304|NCT00534313|156816730|FG002|Short-term Period|Participant not meeting study criteria|0|||
48718305|NCT00534313|156816731|FG003|Short-term Period|Participant not meeting study criteria|1|||
48718306|NCT00534313|156816728|FG000|Short-term Period|Participant withdrew consent|2|||
48718307|NCT00534313|156816729|FG001|Short-term Period|Participant withdrew consent|0|||
48718308|NCT00534313|156816730|FG002|Short-term Period|Participant withdrew consent|0|||
48718309|NCT00534313|156816731|FG003|Short-term Period|Participant withdrew consent|2|||
48718310|NCT00534313|156816728|FG000|Short-term Period|Pregnancy|0|||
48718311|NCT00534313|156816729|FG001|Short-term Period|Pregnancy|0|||
48718312|NCT00534313|156816730|FG002|Short-term Period|Pregnancy|1|||
48718313|NCT00534313|156816731|FG003|Short-term Period|Pregnancy|0|||
48718314|NCT00534313|156816728|FG000|Long-term Period|Adverse Event|2|||
48718315|NCT00534313|156816729|FG001|Long-term Period|Adverse Event|1|||
48718316|NCT00534313|156816730|FG002|Long-term Period|Adverse Event|0|||
48718317|NCT00534313|156816731|FG003|Long-term Period|Adverse Event|1|||
48718318|NCT00534313|156816728|FG000|Long-term Period|Lack of Efficacy|14|||
48718319|NCT00534313|156816729|FG001|Long-term Period|Lack of Efficacy|10|||
48718320|NCT00534313|156816730|FG002|Long-term Period|Lack of Efficacy|14|||
48718321|NCT00534313|156816731|FG003|Long-term Period|Lack of Efficacy|12|||
48718322|NCT00534313|156816728|FG000|Long-term Period|Lost to Follow-up|1|||
48718323|NCT00534313|156816729|FG001|Long-term Period|Lost to Follow-up|2|||
48718324|NCT00534313|156816730|FG002|Long-term Period|Lost to Follow-up|0|||
48718325|NCT00534313|156816731|FG003|Long-term Period|Lost to Follow-up|0|||
48718326|NCT00534313|156816728|FG000|Long-term Period|Withdrawal by Subject|2|||
48718327|NCT00534313|156816729|FG001|Long-term Period|Withdrawal by Subject|2|||
48718328|NCT00534313|156816730|FG002|Long-term Period|Withdrawal by Subject|0|||
48718329|NCT00534313|156816731|FG003|Long-term Period|Withdrawal by Subject|0|||
48718330|NCT00534313|156816728|FG000|Long-term Period|No longer meets study criteria|0|||
48718331|NCT00534313|156816729|FG001|Long-term Period|No longer meets study criteria|1|||
48718332|NCT00534313|156816730|FG002|Long-term Period|No longer meets study criteria|0|||
48718333|NCT00534313|156816731|FG003|Long-term Period|No longer meets study criteria|0|||
48718334|NCT00534313|156816728|FG000|Long-term Period|Poor compliance/noncompliance|0|||
48718335|NCT00534313|156816729|FG001|Long-term Period|Poor compliance/noncompliance|1|||
48718336|NCT00534313|156816730|FG002|Long-term Period|Poor compliance/noncompliance|1|||
48718337|NCT00534313|156816731|FG003|Long-term Period|Poor compliance/noncompliance|0|||
48498684|NCT02518113|156020188|FG003|Overall Study|Physician Decision|0|||
48718338|NCT00534313|156816728|FG000|Long-term Period|Administrative reason by sponsor|17|||
48718339|NCT00534313|156816729|FG001|Long-term Period|Administrative reason by sponsor|15|||
48718340|NCT00534313|156816730|FG002|Long-term Period|Administrative reason by sponsor|26|||
48718341|NCT00534313|156816731|FG003|Long-term Period|Administrative reason by sponsor|18|||
48498685|NCT02518113|156020185|FG000|Overall Study|Progressive Disease|1|||
48498686|NCT02518113|156020186|FG001|Overall Study|Progressive Disease|2|||
48718342|NCT00534313|156816728|FG000|Long-term Period|Other|1|||
48718343|NCT00534313|156816729|FG001|Long-term Period|Other|2|||
48718344|NCT00534313|156816730|FG002|Long-term Period|Other|2|||
48718345|NCT00534313|156816731|FG003|Long-term Period|Other|2|||
48718346|NCT00995566|156816736|FG000|Overall Study|Adverse Event|2|||
48718347|NCT00995566|156816736|FG000|Overall Study|Early study termination|52|||
48718348|NCT00483756|156816739|FG000|Overall Study|Death|2|||
48718349|NCT00483756|156816740|FG001|Overall Study|Death|0|||
48718350|NCT00483756|156816741|FG002|Overall Study|Death|1|||
48718351|NCT00483756|156816739|FG000|Overall Study|Adverse Event|19|||
48718352|NCT00483756|156816740|FG001|Overall Study|Adverse Event|38|||
48718353|NCT00483756|156816741|FG002|Overall Study|Adverse Event|40|||
48718354|NCT00483756|156816739|FG000|Overall Study|Lack of Efficacy|1|||
48718355|NCT00483756|156816740|FG001|Overall Study|Lack of Efficacy|0|||
48498687|NCT02518113|156020187|FG002|Overall Study|Progressive Disease|3|||
48498688|NCT02518113|156020188|FG003|Overall Study|Progressive Disease|0|||
48498689|NCT00797108|156020189|FG000|Overall Study|Adverse Event|1|||
48498690|NCT00797108|156020190|FG001|Overall Study|Adverse Event|0|||
48718356|NCT00483756|156816741|FG002|Overall Study|Lack of Efficacy|0|||
48498691|NCT00797108|156020191|FG002|Overall Study|Adverse Event|3|||
48498692|NCT00797108|156020189|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
48498693|NCT00797108|156020190|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
48498694|NCT00797108|156020191|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
48498695|NCT00797108|156020189|FG000|Overall Study|Global Deterioration of Health Status|0|||
48498696|NCT00797108|156020190|FG001|Overall Study|Global Deterioration of Health Status|1|||
48498697|NCT00797108|156020191|FG002|Overall Study|Global Deterioration of Health Status|0|||
48498698|NCT00797108|156020189|FG000|Overall Study|Lack of Efficacy|1|||
48498699|NCT00797108|156020190|FG001|Overall Study|Lack of Efficacy|0|||
48498700|NCT00797108|156020191|FG002|Overall Study|Lack of Efficacy|1|||
48498701|NCT00797108|156020189|FG000|Overall Study|Other|0|||
48498702|NCT00797108|156020190|FG001|Overall Study|Other|0|||
48498703|NCT00797108|156020191|FG002|Overall Study|Other|2|||
48498704|NCT00797108|156020189|FG000|Overall Study|Randomized but not Treated|2|||
48498705|NCT00797108|156020190|FG001|Overall Study|Randomized but not Treated|0|||
48498706|NCT00797108|156020191|FG002|Overall Study|Randomized but not Treated|0|||
48498707|NCT00287118|156020192|FG000|Overall Study|Adverse Event|30|||
48498708|NCT00287118|156020192|FG000|Overall Study|Death|1|||
48498709|NCT00287118|156020192|FG000|Overall Study|Lack of Efficacy|11|||
48498710|NCT00287118|156020192|FG000|Overall Study|Lost to Follow-up|1|||
48498711|NCT00287118|156020192|FG000|Overall Study|Protocol Violation|2|||
48498712|NCT00287118|156020192|FG000|Overall Study|Other|7|||
48498713|NCT00669864|156020193|FG000|Overall Study|Lost to Follow-up|2|||
48498714|NCT00669864|156020193|FG000|Overall Study|Protocol Violation|2|||
48498715|NCT00669864|156020193|FG000|Overall Study|Withdrawal by Subject|3|||
48498716|NCT00669864|156020193|FG000|Overall Study|Other|2|||
48498717|NCT00262600|156020194|FG000|Overall Study|Lost to Follow-up|17|||
48498718|NCT00262600|156020195|FG001|Overall Study|Lost to Follow-up|31|||
48498719|NCT00262600|156020196|FG002|Overall Study|Lost to Follow-up|41|||
48718357|NCT00483756|156816739|FG000|Overall Study|Lost to Follow-up|3|||
48718358|NCT00483756|156816740|FG001|Overall Study|Lost to Follow-up|1|||
48718359|NCT00483756|156816741|FG002|Overall Study|Lost to Follow-up|0|||
48718360|NCT00483756|156816739|FG000|Overall Study|Withdrawal by Subject|5|||
48718361|NCT00483756|156816740|FG001|Overall Study|Withdrawal by Subject|3|||
48718362|NCT00483756|156816741|FG002|Overall Study|Withdrawal by Subject|4|||
48718363|NCT00483756|156816739|FG000|Overall Study|Other|2|||
48718364|NCT00483756|156816740|FG001|Overall Study|Other|4|||
48718365|NCT00483756|156816741|FG002|Overall Study|Other|3|||
48718366|NCT00483756|156816739|FG000|Overall Study|Randomized, Not Treated|1|||
48498720|NCT00262600|156020194|FG000|Overall Study|Withdrawal by Subject|128|||
48498721|NCT00262600|156020195|FG001|Overall Study|Withdrawal by Subject|145|||
48498722|NCT00262600|156020196|FG002|Overall Study|Withdrawal by Subject|139|||
48498723|NCT00262600|156020194|FG000|Overall Study|Not Treated|32|||
48498724|NCT00262600|156020195|FG001|Overall Study|Not Treated|17|||
48718367|NCT00483756|156816740|FG001|Overall Study|Randomized, Not Treated|4|||
48718368|NCT00483756|156816741|FG002|Overall Study|Randomized, Not Treated|4|||
48718369|NCT00545129|156816758|FG000|Overall Study|Lack of Efficacy|2|||
48498725|NCT00262600|156020196|FG002|Overall Study|Not Treated|24|||
48718370|NCT00545129|156816759|FG001|Overall Study|Lack of Efficacy|5|||
48718371|NCT00545129|156816758|FG000|Overall Study|Death|2|||
48718372|NCT00545129|156816759|FG001|Overall Study|Death|1|||
48718373|NCT00545129|156816758|FG000|Overall Study|Adverse Event|1|||
48718374|NCT00545129|156816759|FG001|Overall Study|Adverse Event|1|||
48718375|NCT00545129|156816758|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
48498726|NCT00262600|156020194|FG000|Overall Study|Other|58|||
48498727|NCT00262600|156020195|FG001|Overall Study|Other|59|||
48498728|NCT00262600|156020196|FG002|Overall Study|Other|62|||
48498729|NCT03209570|156020197|FG000|Overall Study|Death|1|||
48498730|NCT03209570|156020198|FG001|Overall Study|Death|0|||
48718376|NCT00545129|156816759|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
48718377|NCT00545129|156816758|FG000|Overall Study|Other|3|||
48718378|NCT00545129|156816759|FG001|Overall Study|Other|3|||
48498731|NCT03209570|156020197|FG000|Overall Study|Incomplete Data|8|||
48498732|NCT03209570|156020198|FG001|Overall Study|Incomplete Data|10|||
48498733|NCT03209570|156020197|FG000|Overall Study|Protocol Violation|1|||
48498734|NCT03209570|156020198|FG001|Overall Study|Protocol Violation|0|||
48498735|NCT03209570|156020197|FG000|Overall Study|Withdrawal by Subject|0|||
48498736|NCT03209570|156020198|FG001|Overall Study|Withdrawal by Subject|3|||
48498737|NCT01031537|156020199|FG000|Overall Study|medical reasons not related to study|3|||
48498738|NCT01031537|156020199|FG000|Overall Study|Lack of Efficacy|1|||
48498739|NCT01031537|156020199|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
48498740|NCT01031537|156020199|FG000|Overall Study|moved, met exclusion criteria|10|||
48498741|NCT01031537|156020199|FG000|Overall Study|Withdrawal by Subject|5|||
48498742|NCT01031537|156020199|FG000|Overall Study|PI removal, no longer met eligibility|12|||
48498743|NCT04471207|156020202|FG000|Overall Study|Lost to Follow-up|4|||
48498744|NCT04471207|156020203|FG001|Overall Study|Lost to Follow-up|1|||
48498745|NCT04471207|156020202|FG000|Overall Study|Medication Contraindication|0|||
48498746|NCT04471207|156020203|FG001|Overall Study|Medication Contraindication|1|||
48498747|NCT04471207|156020202|FG000|Overall Study|Loss of Interest|2|||
48498748|NCT04471207|156020203|FG001|Overall Study|Loss of Interest|1|||
48498749|NCT04471207|156020202|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
48498750|NCT04471207|156020203|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
48498751|NCT04471207|156020202|FG000|Overall Study|Scheduling Conflicts|3|||
48498752|NCT04471207|156020203|FG001|Overall Study|Scheduling Conflicts|1|||
48498753|NCT04471207|156020202|FG000|Overall Study|Physician Decision|1|||
48498754|NCT04471207|156020203|FG001|Overall Study|Physician Decision|0|||
48498755|NCT04471207|156020202|FG000|Overall Study|Unwilling to Use System|0|||
48598850|NCT00281697|156387878|FG000|Overall Study|Did not receive study drug|3|||
48598851|NCT00281697|156387879|FG001|Overall Study|Did not receive study drug|2|||
48598852|NCT00667563|156387880|FG000|Overall Study|Protocol Violation|24|||
48598853|NCT05133323|156387881|FG000|Overall Study|Lack of Efficacy|0|||
48598854|NCT05133323|156387882|FG001|Overall Study|Lack of Efficacy|0|||
48598855|NCT05133323|156387883|FG002|Overall Study|Lack of Efficacy|1|||
48598856|NCT05133323|156387881|FG000|Overall Study|Withdrawal by Subject|2|||
48598857|NCT05133323|156387882|FG001|Overall Study|Withdrawal by Subject|1|||
48598858|NCT05133323|156387883|FG002|Overall Study|Withdrawal by Subject|0|||
48598859|NCT00113295|156387884|FG000|Overall Study|Adverse Event|4|||
48598860|NCT00113295|156387885|FG001|Overall Study|Adverse Event|1|||
48598861|NCT00113295|156387884|FG000|Overall Study|Unrelated Medical Illness|1|||
48598862|NCT00113295|156387885|FG001|Overall Study|Unrelated Medical Illness|0|||
48598863|NCT03130959|156387888|FG000|Overall Study|Disease progression|19|||
48598864|NCT03130959|156387889|FG001|Overall Study|Disease progression|7|||
48598865|NCT03130959|156387890|FG002|Overall Study|Disease progression|12|||
48598866|NCT03130959|156387891|FG003|Overall Study|Disease progression|7|||
48598867|NCT03130959|156387892|FG004|Overall Study|Disease progression|12|||
48598868|NCT03130959|156387893|FG005|Overall Study|Disease progression|3|||
48598869|NCT03130959|156387894|FG006|Overall Study|Disease progression|6|||
48598870|NCT03130959|156387895|FG007|Overall Study|Disease progression|3|||
48598871|NCT03130959|156387896|FG008|Overall Study|Disease progression|15|||
48598872|NCT03130959|156387897|FG009|Overall Study|Disease progression|8|||
48598873|NCT03130959|156387888|FG000|Overall Study|Study drug toxicity|2|||
48598874|NCT03130959|156387889|FG001|Overall Study|Study drug toxicity|2|||
48598875|NCT03130959|156387890|FG002|Overall Study|Study drug toxicity|1|||
48814995|NCT01544582|157163651|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
48814996|NCT01544582|157163648|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
48814997|NCT01544582|157163649|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
48814998|NCT01544582|157163650|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
48814999|NCT01544582|157163651|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
48815000|NCT01544582|157163648|FG000|Analysis Population|Intolerance|0|||
48815001|NCT01544582|157163649|FG001|Analysis Population|Intolerance|1|||
48815002|NCT01544582|157163650|FG002|Analysis Population|Intolerance|0|||
48815003|NCT01544582|157163651|FG003|Analysis Population|Intolerance|0|||
48815004|NCT01544582|157163648|FG000|Analysis Population|Liver Transplantation|0|||
48498756|NCT04471207|156020203|FG001|Overall Study|Unwilling to Use System|1|||
48498757|NCT02655237|156020204|FG000|Overall Study|Adverse Event|10|||
48498758|NCT02655237|156020205|FG001|Overall Study|Adverse Event|7|||
48498759|NCT02655237|156020204|FG000|Overall Study|Protocol Deviation|2|||
48598876|NCT03130959|156387891|FG003|Overall Study|Study drug toxicity|2|||
48598877|NCT03130959|156387892|FG004|Overall Study|Study drug toxicity|1|||
48598878|NCT03130959|156387893|FG005|Overall Study|Study drug toxicity|1|||
48598879|NCT03130959|156387894|FG006|Overall Study|Study drug toxicity|3|||
48598880|NCT03130959|156387895|FG007|Overall Study|Study drug toxicity|0|||
48598881|NCT03130959|156387896|FG008|Overall Study|Study drug toxicity|3|||
48598882|NCT03130959|156387897|FG009|Overall Study|Study drug toxicity|3|||
48598883|NCT03130959|156387888|FG000|Overall Study|Other reasons|0|||
48598884|NCT03130959|156387889|FG001|Overall Study|Other reasons|0|||
48598885|NCT03130959|156387890|FG002|Overall Study|Other reasons|0|||
48598886|NCT03130959|156387891|FG003|Overall Study|Other reasons|0|||
48598887|NCT03130959|156387892|FG004|Overall Study|Other reasons|0|||
48598888|NCT03130959|156387893|FG005|Overall Study|Other reasons|1|||
48598889|NCT03130959|156387894|FG006|Overall Study|Other reasons|1|||
48598890|NCT03130959|156387895|FG007|Overall Study|Other reasons|0|||
48598891|NCT03130959|156387896|FG008|Overall Study|Other reasons|0|||
48498760|NCT02655237|156020205|FG001|Overall Study|Protocol Deviation|0|||
48498761|NCT02655237|156020204|FG000|Overall Study|Withdrawal by Participant|1|||
48498762|NCT02655237|156020205|FG001|Overall Study|Withdrawal by Participant|2|||
48498763|NCT02655237|156020204|FG000|Overall Study|Lack of Efficacy|0|||
48498764|NCT02655237|156020205|FG001|Overall Study|Lack of Efficacy|1|||
48498765|NCT02655237|156020204|FG000|Overall Study|Recovery Leading to Surgery|2|||
48498766|NCT02655237|156020205|FG001|Overall Study|Recovery Leading to Surgery|1|||
48498767|NCT02655237|156020204|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
48498768|NCT02655237|156020205|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
48498769|NCT02655237|156020204|FG000|Overall Study|Randomized but Not Treated|1|||
48498770|NCT02655237|156020205|FG001|Overall Study|Randomized but Not Treated|0|||
48498771|NCT02132247|156020215|FG000|Overall Study|Protocol Violation|1|||
48498772|NCT02132247|156020216|FG001|Overall Study|Protocol Violation|0|||
48598892|NCT03130959|156387897|FG009|Overall Study|Other reasons|0|||
48598893|NCT03130959|156387888|FG000|Overall Study|Subject request to discontinue therapy|0|||
48598894|NCT03130959|156387889|FG001|Overall Study|Subject request to discontinue therapy|0|||
48598895|NCT03130959|156387890|FG002|Overall Study|Subject request to discontinue therapy|1|||
48598896|NCT03130959|156387891|FG003|Overall Study|Subject request to discontinue therapy|1|||
48598897|NCT03130959|156387892|FG004|Overall Study|Subject request to discontinue therapy|0|||
48598898|NCT03130959|156387893|FG005|Overall Study|Subject request to discontinue therapy|0|||
48598899|NCT03130959|156387894|FG006|Overall Study|Subject request to discontinue therapy|1|||
48598900|NCT03130959|156387895|FG007|Overall Study|Subject request to discontinue therapy|1|||
48598901|NCT03130959|156387896|FG008|Overall Study|Subject request to discontinue therapy|0|||
48598902|NCT03130959|156387897|FG009|Overall Study|Subject request to discontinue therapy|0|||
48598903|NCT03130959|156387888|FG000|Overall Study|Not reported|0|||
48598904|NCT03130959|156387889|FG001|Overall Study|Not reported|0|||
48598905|NCT03130959|156387890|FG002|Overall Study|Not reported|0|||
48598906|NCT03130959|156387891|FG003|Overall Study|Not reported|1|||
48815005|NCT01544582|157163649|FG001|Analysis Population|Liver Transplantation|0|||
48498773|NCT00561730|156020217|FG000|Overall Study|Adverse Event|2|||
48498774|NCT00561730|156020217|FG000|Overall Study|Handling of the drug|1|||
48498775|NCT00561730|156020217|FG000|Overall Study|Lost to Follow-up|5|||
48498776|NCT00561730|156020217|FG000|Overall Study|Not specified reasons|1|||
48498777|NCT00376220|156020220|FG000|Overall Study|Lost to Follow-up|7|||
48498778|NCT00376220|156020221|FG001|Overall Study|Lost to Follow-up|10|||
48498779|NCT00376220|156020220|FG000|Overall Study|Withdrawal by Subject|3|||
48498780|NCT00376220|156020221|FG001|Overall Study|Withdrawal by Subject|2|||
48498781|NCT00220701|156020222|FG000|Overall Study|Lost to Follow-up|5|||
48498782|NCT00220701|156020223|FG001|Overall Study|Lost to Follow-up|4|||
48498783|NCT00723554|156020224|FG000|Overall Study|Adverse Event|12|||
48498784|NCT00723554|156020224|FG000|Overall Study|Investigator's judgement|5|||
48498785|NCT00723554|156020224|FG000|Overall Study|Inhaled medication other than iloprost|4|||
48498786|NCT00723554|156020224|FG000|Overall Study|Withdrawal of consent|3|||
48498787|NCT00723554|156020224|FG000|Overall Study|Other|3|||
48498788|NCT00723554|156020224|FG000|Overall Study|Lost to Follow-up|1|||
48498789|NCT00723554|156020224|FG000|Overall Study|Non-compliance|1|||
48498790|NCT00436007|156020231|FG000|Overall Study|Withdrawal by Subject|5|||
48498791|NCT00436007|156020232|FG001|Overall Study|Withdrawal by Subject|3|||
48498792|NCT00436007|156020233|FG002|Overall Study|Withdrawal by Subject|4|||
48498793|NCT00436007|156020231|FG000|Overall Study|Lost to Follow-up|14|||
48498794|NCT00436007|156020232|FG001|Overall Study|Lost to Follow-up|10|||
48498795|NCT00436007|156020233|FG002|Overall Study|Lost to Follow-up|13|||
48498796|NCT00436007|156020231|FG000|Overall Study|Physician Decision|0|||
48498797|NCT00436007|156020232|FG001|Overall Study|Physician Decision|0|||
48498798|NCT00436007|156020233|FG002|Overall Study|Physician Decision|2|||
48498799|NCT00436007|156020231|FG000|Overall Study|Death|0|||
48498800|NCT00436007|156020232|FG001|Overall Study|Death|1|||
48498801|NCT00436007|156020233|FG002|Overall Study|Death|3|||
48498802|NCT00436007|156020231|FG000|Overall Study|Other|0|||
48498803|NCT00436007|156020232|FG001|Overall Study|Other|0|||
48498804|NCT00436007|156020233|FG002|Overall Study|Other|1|||
48498805|NCT03331042|156020235|FG000|Overall Study|Protocol Violation|1|||
48498806|NCT03331042|156020236|FG001|Overall Study|Protocol Violation|0|||
48498807|NCT03331042|156020237|FG002|Overall Study|Protocol Violation|0|||
48498808|NCT03331042|156020238|FG003|Overall Study|Protocol Violation|0|||
48498809|NCT03331042|156020235|FG000|Overall Study|Physician Decision|0|||
48498810|NCT03331042|156020236|FG001|Overall Study|Physician Decision|0|||
48498811|NCT03331042|156020237|FG002|Overall Study|Physician Decision|1|||
48498812|NCT03331042|156020238|FG003|Overall Study|Physician Decision|0|||
48498813|NCT03331042|156020235|FG000|Overall Study|Lost to Follow-up|0|||
48498814|NCT03331042|156020236|FG001|Overall Study|Lost to Follow-up|0|||
48598907|NCT03130959|156387892|FG004|Overall Study|Not reported|0|||
48598908|NCT03130959|156387893|FG005|Overall Study|Not reported|1|||
48598909|NCT03130959|156387894|FG006|Overall Study|Not reported|0|||
48598910|NCT03130959|156387895|FG007|Overall Study|Not reported|0|||
48598911|NCT03130959|156387896|FG008|Overall Study|Not reported|0|||
48598912|NCT03130959|156387897|FG009|Overall Study|Not reported|1|||
48598913|NCT03130959|156387888|FG000|Overall Study|Adverse Event unrelated to drug|0|||
48598914|NCT03130959|156387889|FG001|Overall Study|Adverse Event unrelated to drug|0|||
48598915|NCT03130959|156387890|FG002|Overall Study|Adverse Event unrelated to drug|1|||
48598916|NCT03130959|156387891|FG003|Overall Study|Adverse Event unrelated to drug|1|||
48598917|NCT03130959|156387892|FG004|Overall Study|Adverse Event unrelated to drug|1|||
48598918|NCT03130959|156387893|FG005|Overall Study|Adverse Event unrelated to drug|0|||
48598919|NCT03130959|156387894|FG006|Overall Study|Adverse Event unrelated to drug|1|||
48598920|NCT03130959|156387895|FG007|Overall Study|Adverse Event unrelated to drug|0|||
48598921|NCT03130959|156387896|FG008|Overall Study|Adverse Event unrelated to drug|1|||
48598922|NCT03130959|156387897|FG009|Overall Study|Adverse Event unrelated to drug|1|||
48598923|NCT03130959|156387888|FG000|Overall Study|Participant withdrew consent|0|||
48598924|NCT03130959|156387889|FG001|Overall Study|Participant withdrew consent|1|||
48598925|NCT03130959|156387890|FG002|Overall Study|Participant withdrew consent|0|||
48598926|NCT03130959|156387891|FG003|Overall Study|Participant withdrew consent|2|||
48598927|NCT03130959|156387892|FG004|Overall Study|Participant withdrew consent|1|||
48598928|NCT03130959|156387893|FG005|Overall Study|Participant withdrew consent|0|||
48598929|NCT03130959|156387894|FG006|Overall Study|Participant withdrew consent|0|||
48598930|NCT03130959|156387895|FG007|Overall Study|Participant withdrew consent|0|||
48598931|NCT03130959|156387896|FG008|Overall Study|Participant withdrew consent|0|||
48598932|NCT03130959|156387897|FG009|Overall Study|Participant withdrew consent|2|||
48598933|NCT03130959|156387888|FG000|Overall Study|Administrative reason by sponsor|1|||
48598934|NCT03130959|156387889|FG001|Overall Study|Administrative reason by sponsor|0|||
48598935|NCT03130959|156387890|FG002|Overall Study|Administrative reason by sponsor|1|||
48498815|NCT03331042|156020237|FG002|Overall Study|Lost to Follow-up|0|||
48498816|NCT03331042|156020238|FG003|Overall Study|Lost to Follow-up|1|||
48498817|NCT01475838|156020239|FG000|Randomized Phase|Randomized but Not Treated|0|||
48498818|NCT01475838|156020240|FG001|Randomized Phase|Randomized but Not Treated|5|||
48498819|NCT01475838|156020239|FG000|Randomized Phase|Adverse Event|6|||
48498820|NCT01475838|156020240|FG001|Randomized Phase|Adverse Event|1|||
48598936|NCT03130959|156387891|FG003|Overall Study|Administrative reason by sponsor|0|||
48598937|NCT03130959|156387892|FG004|Overall Study|Administrative reason by sponsor|0|||
48598938|NCT03130959|156387893|FG005|Overall Study|Administrative reason by sponsor|0|||
48598939|NCT03130959|156387894|FG006|Overall Study|Administrative reason by sponsor|0|||
48598940|NCT03130959|156387895|FG007|Overall Study|Administrative reason by sponsor|0|||
48598941|NCT03130959|156387896|FG008|Overall Study|Administrative reason by sponsor|0|||
48598942|NCT03130959|156387897|FG009|Overall Study|Administrative reason by sponsor|0|||
48598943|NCT03130959|156387888|FG000|Overall Study|Lost to Follow-up|1|||
48598944|NCT03130959|156387889|FG001|Overall Study|Lost to Follow-up|0|||
48598945|NCT03130959|156387890|FG002|Overall Study|Lost to Follow-up|0|||
48598946|NCT03130959|156387891|FG003|Overall Study|Lost to Follow-up|0|||
48498821|NCT01475838|156020239|FG000|Randomized Phase|Pregnancy|0|||
48498822|NCT01475838|156020240|FG001|Randomized Phase|Pregnancy|1|||
48598947|NCT03130959|156387892|FG004|Overall Study|Lost to Follow-up|0|||
48598948|NCT03130959|156387893|FG005|Overall Study|Lost to Follow-up|0|||
48598949|NCT03130959|156387894|FG006|Overall Study|Lost to Follow-up|0|||
48598950|NCT03130959|156387895|FG007|Overall Study|Lost to Follow-up|0|||
48598951|NCT03130959|156387896|FG008|Overall Study|Lost to Follow-up|0|||
48598952|NCT03130959|156387897|FG009|Overall Study|Lost to Follow-up|0|||
48598953|NCT00666211|156387898|FG000|Overall Study|Withdrawal by Subject|10|||
48598954|NCT00666211|156387899|FG001|Overall Study|Withdrawal by Subject|13|||
48598955|NCT00666211|156387898|FG000|Overall Study|went off medication, no more pain|1|||
48598956|NCT00666211|156387899|FG001|Overall Study|went off medication, no more pain|0|||
48598957|NCT00666211|156387898|FG000|Overall Study|patient non-compliant|6|||
48498823|NCT01475838|156020239|FG000|Randomized Phase|Investigators Discretion|1|||
48498824|NCT01475838|156020240|FG001|Randomized Phase|Investigators Discretion|2|||
48498825|NCT01475838|156020239|FG000|Randomized Phase|Withdrew Consent|10|||
48498826|NCT01475838|156020240|FG001|Randomized Phase|Withdrew Consent|14|||
48498827|NCT01475838|156020239|FG000|Randomized Phase|Lost to Follow-up|3|||
48498828|NCT01475838|156020240|FG001|Randomized Phase|Lost to Follow-up|4|||
48498829|NCT01475838|156020239|FG000|Randomized Phase|Participant Noncompliance|1|||
48498830|NCT01475838|156020240|FG001|Randomized Phase|Participant Noncompliance|5|||
48498831|NCT01475838|156020239|FG000|Randomized Phase|Protocol Violation|9|||
48598958|NCT00666211|156387899|FG001|Overall Study|patient non-compliant|6|||
48598959|NCT00666211|156387898|FG000|Overall Study|disease progression|1|||
48598960|NCT00666211|156387899|FG001|Overall Study|disease progression|8|||
48498832|NCT01475838|156020240|FG001|Randomized Phase|Protocol Violation|4|||
48598961|NCT00666211|156387898|FG000|Overall Study|Lost to Follow-up|2|||
48598962|NCT00666211|156387899|FG001|Overall Study|Lost to Follow-up|0|||
48598963|NCT00666211|156387898|FG000|Overall Study|toxicity|0|||
48498833|NCT01475838|156020239|FG000|Extension Phase|Participant Noncompliance|1|||
48498834|NCT01475838|156020240|FG001|Extension Phase|Participant Noncompliance|0|||
48498835|NCT01694485|156020241|FG000|Overall Study|Withdrawal by Subject|20|||
48498836|NCT01694485|156020242|FG001|Overall Study|Withdrawal by Subject|6|||
48498837|NCT01694485|156020243|FG002|Overall Study|Withdrawal by Subject|7|||
48498838|NCT01694485|156020244|FG003|Overall Study|Withdrawal by Subject|25|||
48498839|NCT01694485|156020245|FG004|Overall Study|Withdrawal by Subject|18|||
48498840|NCT01694485|156020241|FG000|Overall Study|Sponsor Decision|3|||
48498841|NCT01694485|156020242|FG001|Overall Study|Sponsor Decision|0|||
48498842|NCT01694485|156020243|FG002|Overall Study|Sponsor Decision|0|||
48498843|NCT01694485|156020244|FG003|Overall Study|Sponsor Decision|2|||
48498844|NCT01694485|156020245|FG004|Overall Study|Sponsor Decision|0|||
48498845|NCT01694485|156020241|FG000|Overall Study|Lost to Follow-up|9|||
48498846|NCT01694485|156020242|FG001|Overall Study|Lost to Follow-up|1|||
48498847|NCT01694485|156020243|FG002|Overall Study|Lost to Follow-up|6|||
48498848|NCT01694485|156020244|FG003|Overall Study|Lost to Follow-up|10|||
48498849|NCT01694485|156020245|FG004|Overall Study|Lost to Follow-up|7|||
48498850|NCT01694485|156020241|FG000|Overall Study|Death|1|||
48498851|NCT01694485|156020242|FG001|Overall Study|Death|0|||
48498852|NCT01694485|156020243|FG002|Overall Study|Death|0|||
48498853|NCT01694485|156020244|FG003|Overall Study|Death|1|||
48498854|NCT01694485|156020245|FG004|Overall Study|Death|0|||
48498855|NCT02907203|156020246|FG000|Overall Study|Death|1|||
48498856|NCT02907203|156020246|FG000|Overall Study|Lost to Follow-up|3|||
48498857|NCT02907203|156020246|FG000|Overall Study|Withdrawal by Subject|3|||
48498858|NCT02907203|156020246|FG000|Overall Study|Surgical bypass|1|||
48498859|NCT01513148|156020252|FG000|Overall Study|Protocol Violation|2|||
48498860|NCT01513148|156020253|FG001|Overall Study|Protocol Violation|2|||
48498861|NCT01654380|156020257|FG000|Part B, Period 1|Physician Decision|0|||
48498862|NCT01654380|156020258|FG001|Part B, Period 1|Physician Decision|0|||
48498863|NCT01654380|156020259|FG002|Part B, Period 1|Physician Decision|1|||
48498864|NCT01654380|156020260|FG003|Part B, Period 1|Physician Decision|0|||
48498865|NCT00424489|156020261|FG000|Overall Study|Death|3|||
48498866|NCT01984242|156020262|FG000|Overall Study|Death|52|||
48498867|NCT01984242|156020263|FG001|Overall Study|Death|50|||
48498868|NCT01984242|156020264|FG002|Overall Study|Death|52|||
48498869|NCT01984242|156020262|FG000|Overall Study|Withdrawal by Subject|5|||
48498870|NCT01984242|156020263|FG001|Overall Study|Withdrawal by Subject|3|||
48498871|NCT01984242|156020264|FG002|Overall Study|Withdrawal by Subject|10|||
48498872|NCT01984242|156020262|FG000|Overall Study|Physician Decision|0|||
48498873|NCT01984242|156020263|FG001|Overall Study|Physician Decision|0|||
48498874|NCT01984242|156020264|FG002|Overall Study|Physician Decision|1|||
48498875|NCT01984242|156020262|FG000|Overall Study|Lost to Follow-up|4|||
48498876|NCT01984242|156020263|FG001|Overall Study|Lost to Follow-up|0|||
48498877|NCT01984242|156020264|FG002|Overall Study|Lost to Follow-up|3|||
48498878|NCT01984242|156020262|FG000|Overall Study|Sponsor Decision|1|||
48498879|NCT01984242|156020263|FG001|Overall Study|Sponsor Decision|0|||
48498880|NCT01984242|156020264|FG002|Overall Study|Sponsor Decision|0|||
48498881|NCT01984242|156020262|FG000|Overall Study|Non-Compliance|1|||
48498882|NCT01984242|156020263|FG001|Overall Study|Non-Compliance|0|||
48498883|NCT01984242|156020264|FG002|Overall Study|Non-Compliance|0|||
48498884|NCT01984242|156020262|FG000|Overall Study|Study terminated by Sponsor|38|||
48498885|NCT01984242|156020263|FG001|Overall Study|Study terminated by Sponsor|50|||
48498886|NCT01984242|156020264|FG002|Overall Study|Study terminated by Sponsor|34|||
48498887|NCT01984242|156020262|FG000|Overall Study|Disease Progression|0|||
48498888|NCT01984242|156020263|FG001|Overall Study|Disease Progression|0|||
48498889|NCT01984242|156020264|FG002|Overall Study|Disease Progression|1|||
48498890|NCT01479439|156020268|FG000|Overall Study|Adverse Event|1|||
48498891|NCT01479439|156020269|FG001|Overall Study|Adverse Event|0|||
48498892|NCT01479439|156020270|FG002|Overall Study|Adverse Event|0|||
48498893|NCT01479439|156020268|FG000|Overall Study|Lost to Follow-up|0|||
48498894|NCT01479439|156020269|FG001|Overall Study|Lost to Follow-up|1|||
48498895|NCT01479439|156020270|FG002|Overall Study|Lost to Follow-up|0|||
48498896|NCT01479439|156020268|FG000|Overall Study|Protocol Violation|0|||
48498897|NCT01479439|156020269|FG001|Overall Study|Protocol Violation|0|||
48498898|NCT01479439|156020270|FG002|Overall Study|Protocol Violation|2|||
48498899|NCT02003183|156020271|FG000|Overall Study|Lost to Follow-up|0|||
48498900|NCT02003183|156020272|FG001|Overall Study|Lost to Follow-up|2|||
48498901|NCT01139164|156020275|FG000|Overall Study|Withdrawn prior to study start|0|||
48498902|NCT01139164|156020276|FG001|Overall Study|Withdrawn prior to study start|2|||
48498903|NCT01139164|156020277|FG002|Overall Study|Withdrawn prior to study start|0|||
48498904|NCT00878995|156020278|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
48498905|NCT00878995|156020279|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
48598964|NCT00666211|156387899|FG001|Overall Study|toxicity|2|||
48598965|NCT00666211|156387898|FG000|Overall Study|hospital admission|0|||
48498906|NCT01030965|156020286|FG000|Overall Study|Lack of Efficacy|3|||
48498907|NCT01030965|156020287|FG001|Overall Study|Lack of Efficacy|2|||
48498908|NCT01030965|156020288|FG002|Overall Study|Lack of Efficacy|0|||
48498909|NCT01030965|156020289|FG003|Overall Study|Lack of Efficacy|3|||
48498910|NCT01030965|156020286|FG000|Overall Study|Protocol Violation|1|||
48498911|NCT01030965|156020287|FG001|Overall Study|Protocol Violation|1|||
48498912|NCT01030965|156020288|FG002|Overall Study|Protocol Violation|1|||
48498913|NCT01030965|156020289|FG003|Overall Study|Protocol Violation|1|||
48498914|NCT01030965|156020286|FG000|Overall Study|Adverse Event|0|||
48498915|NCT01030965|156020287|FG001|Overall Study|Adverse Event|1|||
48498916|NCT01030965|156020288|FG002|Overall Study|Adverse Event|2|||
48498917|NCT01030965|156020289|FG003|Overall Study|Adverse Event|1|||
48498918|NCT01030965|156020286|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
48498919|NCT01030965|156020287|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
48498920|NCT01030965|156020288|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
48498921|NCT01030965|156020289|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
48498922|NCT01030965|156020286|FG000|Overall Study|Withdrawal by Subject|0|||
48498923|NCT01030965|156020287|FG001|Overall Study|Withdrawal by Subject|1|||
48498924|NCT01030965|156020288|FG002|Overall Study|Withdrawal by Subject|0|||
48498925|NCT01030965|156020289|FG003|Overall Study|Withdrawal by Subject|2|||
48498926|NCT02339909|156020296|FG000|Overall Study|Became ineligible after randomisation|89|||
48498927|NCT02339909|156020297|FG001|Overall Study|Became ineligible after randomisation|63|||
48498928|NCT02339909|156020298|FG002|Overall Study|Became ineligible after randomisation|71|||
48498929|NCT03481309|156020301|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
48498930|NCT03481309|156020302|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
48498931|NCT03481309|156020303|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
48498932|NCT03481309|156020304|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
48598966|NCT00666211|156387899|FG001|Overall Study|hospital admission|5|||
48598967|NCT00666211|156387898|FG000|Overall Study|Death|0|||
48598968|NCT00666211|156387899|FG001|Overall Study|Death|2|||
48598969|NCT00666211|156387898|FG000|Overall Study|off tx for other complicating disease|0|||
48598970|NCT00666211|156387899|FG001|Overall Study|off tx for other complicating disease|1|||
48598971|NCT00666211|156387898|FG000|Overall Study|Physician Decision|0|||
48598972|NCT00666211|156387899|FG001|Overall Study|Physician Decision|1|||
48598973|NCT03280056|156387900|FG000|Overall Study|Withdrawal by Subject|12|||
48598974|NCT03280056|156387901|FG001|Overall Study|Withdrawal by Subject|14|||
48598975|NCT03280056|156387900|FG000|Overall Study|Death|9|||
48598976|NCT03280056|156387901|FG001|Overall Study|Death|2|||
48598977|NCT03280056|156387900|FG000|Overall Study|Adverse Event|1|||
48598978|NCT03280056|156387901|FG001|Overall Study|Adverse Event|3|||
48598979|NCT03280056|156387900|FG000|Overall Study|Lost to Follow-up|1|||
48598980|NCT03280056|156387901|FG001|Overall Study|Lost to Follow-up|1|||
48598981|NCT03280056|156387900|FG000|Overall Study|Physician Decision|0|||
48598982|NCT03280056|156387901|FG001|Overall Study|Physician Decision|1|||
48598983|NCT03280056|156387900|FG000|Overall Study|Early Discontinuation|1|||
48598984|NCT03280056|156387901|FG001|Overall Study|Early Discontinuation|0|||
48598985|NCT01869777|156387907|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
48598986|NCT00130689|156387912|FG000|Overall Study|Progressive Disease|29|||
48598987|NCT00130689|156387912|FG000|Overall Study|Death|1|||
48598988|NCT00130689|156387912|FG000|Overall Study|Clinical Deterioration|4|||
48598989|NCT00130689|156387912|FG000|Overall Study|Withdrawal by Subject|3|||
48598990|NCT00130689|156387912|FG000|Overall Study|Ineligible|6|||
48598991|NCT00766597|156387913|FG000|Overall Study|Unexpected closure of study|4|||
48598992|NCT00766597|156387913|FG000|Overall Study|Without CCR5-tropic virus|5|||
48598993|NCT02829047|156387916|FG000|Overall Study|Withdrawal by Subject|1|||
48598994|NCT03318003|156387917|FG000|Overall Study|Withdrawal by Subject|1|||
48598995|NCT03318003|156387918|FG001|Overall Study|Withdrawal by Subject|1|||
48598996|NCT03318003|156387917|FG000|Overall Study|fetal loss|0|||
48598997|NCT03318003|156387918|FG001|Overall Study|fetal loss|1|||
48598998|NCT02907463|156387920|FG000|Overall Study|Lost to Follow-up|17|||
48598999|NCT02907463|156387920|FG000|Overall Study|Death|10|||
48599000|NCT02907463|156387920|FG000|Overall Study|Withdrawal by Subject|4|||
48599001|NCT02907463|156387920|FG000|Overall Study|MIS Approach was not used|2|||
48599002|NCT02907463|156387920|FG000|Overall Study|Not Implanted with Study Device|2|||
48599003|NCT02907463|156387920|FG000|Overall Study|Device Explanted|1|||
48599004|NCT02907463|156387920|FG000|Overall Study|Missing Exit Form|1|||
48815006|NCT01544582|157163650|FG002|Analysis Population|Liver Transplantation|1|||
48815007|NCT01544582|157163651|FG003|Analysis Population|Liver Transplantation|0|||
48815008|NCT01544582|157163648|FG000|Analysis Population|No Social Insurance|0|||
48599005|NCT04878055|156387921|FG000|Overall Study|Patient transferred in another department|0|||
48599006|NCT04878055|156387922|FG001|Overall Study|Patient transferred in another department|2|||
48815009|NCT01544582|157163649|FG001|Analysis Population|No Social Insurance|0|||
48815010|NCT01544582|157163650|FG002|Analysis Population|No Social Insurance|1|||
48599007|NCT04878055|156387921|FG000|Overall Study|Physician Decision|1|||
48815011|NCT01544582|157163651|FG003|Analysis Population|No Social Insurance|0|||
48498933|NCT03481309|156020305|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
48498934|NCT03481309|156020306|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
48498935|NCT00154102|156020307|FG000|Overall Study|investigational study phase ongoing|7|||
48498936|NCT00154102|156020308|FG001|Overall Study|investigational study phase ongoing|2|||
48498937|NCT01471522|156020310|FG000|Overall Study|Withdrawal by Subject|28|||
48599008|NCT04878055|156387922|FG001|Overall Study|Physician Decision|1|||
48599009|NCT04878055|156387921|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
48599010|NCT04878055|156387922|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
48599011|NCT04878055|156387921|FG000|Overall Study|Adverse Event|12|||
48599012|NCT04878055|156387922|FG001|Overall Study|Adverse Event|7|||
48599013|NCT04878055|156387921|FG000|Overall Study|Other|5|||
48718379|NCT04605991|156818353|FG000|Overall Study|Adverse Event|5|||
48718380|NCT04605991|156818353|FG000|Overall Study|Lack of Efficacy|1|||
48718381|NCT04605991|156818353|FG000|Overall Study|Lost to Follow-up|8|||
48718382|NCT04605991|156818353|FG000|Overall Study|Physician Decision|4|||
48718383|NCT04605991|156818353|FG000|Overall Study|Withdrawal by Subject|14|||
48718384|NCT04605991|156818353|FG000|Overall Study|Non-compliance with study|1|||
48718385|NCT02168387|156818354|FG000|Overall Study|Planned exubation|6|||
48718386|NCT02168387|156818355|FG001|Overall Study|Planned exubation|3|||
48718387|NCT02168387|156818354|FG000|Overall Study|Death|1|||
48718388|NCT02168387|156818355|FG001|Overall Study|Death|0|||
48718389|NCT03700684|156818358|FG000|Overall Study|COVID-19|0|||
48718390|NCT03700684|156818359|FG001|Overall Study|COVID-19|0|||
48599014|NCT04878055|156387922|FG001|Overall Study|Other|0|||
48599015|NCT04878055|156387921|FG000|Overall Study|Withdrawal by Subject|7|||
48599016|NCT04878055|156387922|FG001|Overall Study|Withdrawal by Subject|3|||
48599017|NCT04878055|156387921|FG000|Overall Study|Lost to Follow-up|10|||
48599018|NCT04878055|156387922|FG001|Overall Study|Lost to Follow-up|1|||
48599019|NCT01968811|156387923|FG000|Overall Study|Protocol Violation|4|||
48599020|NCT01968811|156387923|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
48599021|NCT01247350|156387924|FG000|Overall Study|Adverse Event|0|||
48599022|NCT01247350|156387925|FG001|Overall Study|Adverse Event|0|||
48599023|NCT01247350|156387926|FG002|Overall Study|Adverse Event|1|||
48599024|NCT01247350|156387927|FG003|Overall Study|Adverse Event|0|||
48599025|NCT01247350|156387928|FG004|Overall Study|Adverse Event|0|||
48599026|NCT01247350|156387924|FG000|Overall Study|Withdrawal by Subject|0|||
48599027|NCT01247350|156387925|FG001|Overall Study|Withdrawal by Subject|0|||
48599028|NCT01247350|156387926|FG002|Overall Study|Withdrawal by Subject|0|||
48599029|NCT01247350|156387927|FG003|Overall Study|Withdrawal by Subject|1|||
48599030|NCT01247350|156387928|FG004|Overall Study|Withdrawal by Subject|0|||
48599031|NCT01247350|156387924|FG000|Overall Study|Entry criteria not met|0|||
48599032|NCT01247350|156387925|FG001|Overall Study|Entry criteria not met|0|||
48599033|NCT01247350|156387926|FG002|Overall Study|Entry criteria not met|0|||
48599034|NCT01247350|156387927|FG003|Overall Study|Entry criteria not met|0|||
48599035|NCT01247350|156387928|FG004|Overall Study|Entry criteria not met|1|||
48599036|NCT01896193|156387933|FG000|Overall Study|Lack of Efficacy|20|||
48599037|NCT01896193|156387934|FG001|Overall Study|Lack of Efficacy|11|||
48599038|NCT01896193|156387933|FG000|Overall Study|Protocol Violation|0|||
48599039|NCT01896193|156387934|FG001|Overall Study|Protocol Violation|1|||
48599040|NCT01896193|156387933|FG000|Overall Study|Withdrew Consent|1|||
48599041|NCT01896193|156387934|FG001|Overall Study|Withdrew Consent|0|||
48599042|NCT01932697|156387935|FG000|Overall Study|Received a different amount of tx|1|||
48599043|NCT01932697|156387936|FG001|Overall Study|Received a different amount of tx|0|||
48599044|NCT01932697|156387935|FG000|Overall Study|Ineligible|1|||
48599045|NCT01932697|156387936|FG001|Overall Study|Ineligible|0|||
48599046|NCT00809445|156387944|FG000|1 Month Follow-up|Lost contact|1|||
48599047|NCT00809445|156387945|FG001|1 Month Follow-up|Lost contact|2|||
48599048|NCT00809445|156387946|FG002|1 Month Follow-up|Lost contact|1|||
48599049|NCT00809445|156387944|FG000|1 Month Follow-up|Withdrew consent|1|||
48599050|NCT00809445|156387945|FG001|1 Month Follow-up|Withdrew consent|1|||
48599051|NCT00809445|156387946|FG002|1 Month Follow-up|Withdrew consent|1|||
48599052|NCT00809445|156387944|FG000|1 Month Follow-up|Death|0|||
48599053|NCT00809445|156387945|FG001|1 Month Follow-up|Death|1|||
48599054|NCT00809445|156387946|FG002|1 Month Follow-up|Death|1|||
48599055|NCT00809445|156387944|FG000|1 Month Follow-up|Incarcerated|0|||
48718391|NCT03700684|156818360|FG002|Overall Study|COVID-19|2|||
48718392|NCT01713933|156818372|FG000|Overall Study|Lost to Follow-up|2|||
48599056|NCT00809445|156387945|FG001|1 Month Follow-up|Incarcerated|0|||
48599057|NCT00809445|156387946|FG002|1 Month Follow-up|Incarcerated|1|||
48718393|NCT01713933|156818372|FG000|Overall Study|Withdrawal by Subject|3|||
48718394|NCT01713933|156818372|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
48718395|NCT00859638|156818375|FG000|Overall Study|Lost to Follow-up|6|||
48718396|NCT00859638|156818376|FG001|Overall Study|Lost to Follow-up|1|||
48718397|NCT00859638|156818375|FG000|Overall Study|Withdrawal by Subject|3|||
48718398|NCT00859638|156818376|FG001|Overall Study|Withdrawal by Subject|2|||
48599058|NCT00809445|156387944|FG000|6 Month Follow-up|Lost contact|16|||
48599059|NCT00809445|156387945|FG001|6 Month Follow-up|Lost contact|14|||
48599060|NCT00809445|156387946|FG002|6 Month Follow-up|Lost contact|14|||
48599061|NCT00809445|156387944|FG000|6 Month Follow-up|Death|2|||
48599062|NCT00809445|156387945|FG001|6 Month Follow-up|Death|1|||
48599063|NCT00809445|156387946|FG002|6 Month Follow-up|Death|1|||
48599064|NCT00809445|156387944|FG000|6 Month Follow-up|Incarcerated|6|||
48718399|NCT00859638|156818375|FG000|Overall Study|Ill health|1|||
48718400|NCT00859638|156818376|FG001|Overall Study|Ill health|1|||
48498938|NCT01471522|156020311|FG001|Overall Study|Withdrawal by Subject|22|||
48498939|NCT01471522|156020310|FG000|Overall Study|Lost to Follow-up|36|||
48498940|NCT01471522|156020311|FG001|Overall Study|Lost to Follow-up|26|||
48498941|NCT03717064|156022328|FG000|Period 2|Adverse Event|1|||
48498942|NCT00313703|156022329|FG000|Overall Study|Lost to Follow-up|11|||
48498943|NCT00313703|156022330|FG001|Overall Study|Lost to Follow-up|2|||
48498944|NCT00313703|156022331|FG002|Overall Study|Lost to Follow-up|5|||
48498945|NCT00313703|156022332|FG003|Overall Study|Lost to Follow-up|12|||
48498946|NCT01298570|156022333|FG000|Overall Study|Disease progression, relapse during acti|64|||
48498947|NCT01298570|156022334|FG001|Overall Study|Disease progression, relapse during acti|40|||
48498948|NCT01298570|156022333|FG000|Overall Study|Adverse Event|20|||
48498949|NCT01298570|156022334|FG001|Overall Study|Adverse Event|2|||
48498950|NCT01298570|156022333|FG000|Overall Study|Withdrawal by Subject|21|||
48498951|NCT01298570|156022334|FG001|Overall Study|Withdrawal by Subject|6|||
48498952|NCT01298570|156022333|FG000|Overall Study|Treatment delay > 4 weeks|4|||
48599065|NCT00809445|156387945|FG001|6 Month Follow-up|Incarcerated|8|||
48599066|NCT00809445|156387946|FG002|6 Month Follow-up|Incarcerated|8|||
48599067|NCT00809445|156387944|FG000|6 Month Follow-up|Withdrew consent|0|||
48599068|NCT00809445|156387945|FG001|6 Month Follow-up|Withdrew consent|0|||
48599069|NCT00809445|156387946|FG002|6 Month Follow-up|Withdrew consent|1|||
48599070|NCT03874013|156387947|FG000|Overall Study|Adverse Event|0|||
48599071|NCT03874013|156387948|FG001|Overall Study|Adverse Event|1|||
48599072|NCT01096160|156387949|FG000|Overall Study|Adverse Event|0|||
48599073|NCT01096160|156387950|FG001|Overall Study|Adverse Event|0|||
48599074|NCT01096160|156387951|FG002|Overall Study|Adverse Event|1|||
48599075|NCT01096160|156387952|FG003|Overall Study|Adverse Event|0|||
48599076|NCT01096160|156387953|FG004|Overall Study|Adverse Event|0|||
48599077|NCT01096160|156387954|FG005|Overall Study|Adverse Event|0|||
48599078|NCT01096160|156387955|FG006|Overall Study|Adverse Event|0|||
48599079|NCT01096160|156387956|FG007|Overall Study|Adverse Event|0|||
48599080|NCT01096160|156387957|FG008|Overall Study|Adverse Event|0|||
48599081|NCT01096160|156387958|FG009|Overall Study|Adverse Event|1|||
48599082|NCT01096160|156387949|FG000|Overall Study|Met stopping criteria per protocol|0|||
48599083|NCT01096160|156387950|FG001|Overall Study|Met stopping criteria per protocol|0|||
48599084|NCT01096160|156387951|FG002|Overall Study|Met stopping criteria per protocol|0|||
48599085|NCT01096160|156387952|FG003|Overall Study|Met stopping criteria per protocol|0|||
48599086|NCT01096160|156387953|FG004|Overall Study|Met stopping criteria per protocol|1|||
48599087|NCT01096160|156387954|FG005|Overall Study|Met stopping criteria per protocol|0|||
48599088|NCT01096160|156387955|FG006|Overall Study|Met stopping criteria per protocol|2|||
48599089|NCT01096160|156387956|FG007|Overall Study|Met stopping criteria per protocol|0|||
48599090|NCT01096160|156387957|FG008|Overall Study|Met stopping criteria per protocol|2|||
48599091|NCT01096160|156387958|FG009|Overall Study|Met stopping criteria per protocol|0|||
48599092|NCT00627497|156387959|FG000|Overall Study|Lost to Follow-up|1|||
48599093|NCT00627497|156387960|FG001|Overall Study|Lost to Follow-up|1|||
48599094|NCT00627497|156387961|FG002|Overall Study|Lost to Follow-up|0|||
48599095|NCT00627497|156387962|FG003|Overall Study|Lost to Follow-up|0|||
48599096|NCT00705757|156387963|FG000|Overall Study|Lack of Efficacy|5|||
48599097|NCT00705757|156387964|FG001|Overall Study|Lack of Efficacy|1|||
48599098|NCT00705757|156387965|FG002|Overall Study|Lack of Efficacy|3|||
48599099|NCT00705757|156387963|FG000|Overall Study|Lost to Follow-up|7|||
48599100|NCT00705757|156387964|FG001|Overall Study|Lost to Follow-up|6|||
48599101|NCT00705757|156387965|FG002|Overall Study|Lost to Follow-up|6|||
48599102|NCT00705757|156387963|FG000|Overall Study|Withdrawal by Subject|1|||
48599103|NCT00705757|156387964|FG001|Overall Study|Withdrawal by Subject|1|||
48599104|NCT00705757|156387965|FG002|Overall Study|Withdrawal by Subject|2|||
48599105|NCT01272908|156387968|FG000|Initial Treatment Period|Adverse Event|1|||
48599106|NCT01272908|156387968|FG000|Initial Treatment Period|Lack of Efficacy|5|||
48599107|NCT01272908|156387968|FG000|Initial Treatment Period|Protocol Violation|1|||
48599108|NCT01272908|156387968|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
48599109|NCT01272908|156387968|FG000|Re-Treatment Period|Adverse Event|2|||
48599110|NCT01272908|156387968|FG000|Re-Treatment Period|Lack of Efficacy|3|||
48599111|NCT01272908|156387968|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
48599112|NCT01038687|156387975|FG000|Overall Study|Adverse Event|0|||
48599113|NCT01038687|156387976|FG001|Overall Study|Adverse Event|2|||
48599114|NCT01038687|156387977|FG002|Overall Study|Adverse Event|1|||
48599115|NCT05227118|156387978|FG000|Overall Study|Adverse Event|0|||
48599116|NCT05227118|156387979|FG001|Overall Study|Adverse Event|0|||
48599117|NCT05227118|156387980|FG002|Overall Study|Adverse Event|1|||
48599118|NCT05227118|156387981|FG003|Overall Study|Adverse Event|0|||
48599119|NCT05227118|156387978|FG000|Overall Study|Withdrawal by Subject|0|||
48599120|NCT05227118|156387979|FG001|Overall Study|Withdrawal by Subject|0|||
48599121|NCT05227118|156387980|FG002|Overall Study|Withdrawal by Subject|2|||
48498953|NCT01298570|156022334|FG001|Overall Study|Treatment delay > 4 weeks|5|||
48498954|NCT01298570|156022333|FG000|Overall Study|Physician Decision|4|||
48498955|NCT01298570|156022334|FG001|Overall Study|Physician Decision|2|||
48498956|NCT01298570|156022333|FG000|Overall Study|Other complicating disease|2|||
48599122|NCT05227118|156387981|FG003|Overall Study|Withdrawal by Subject|0|||
48718401|NCT01009840|156818378|FG000|Overall Study|Lost to Follow-up|1|||
48718402|NCT01009840|156818378|FG000|Overall Study|Adverse Event|4|||
48718403|NCT01009840|156818378|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
48718404|NCT01009840|156818378|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
48718405|NCT01009840|156818378|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
48718406|NCT04022733|156818379|FG000|Overall Study|conversion to open surgery|3|||
48718407|NCT04022733|156818380|FG001|Overall Study|conversion to open surgery|2|||
48718408|NCT04022733|156818379|FG000|Overall Study|bradycardia|0|||
48718409|NCT04022733|156818380|FG001|Overall Study|bradycardia|1|||
48718410|NCT00797966|156818384|FG000|Phase A|Lost to Follow-up|0|||
48599123|NCT01435759|156387982|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
48599124|NCT01435759|156387983|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
48599125|NCT01435759|156387984|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
48599126|NCT01435759|156387985|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
48599127|NCT01435759|156387986|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
48599128|NCT01435759|156387987|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
48599129|NCT01435759|156387982|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
48599130|NCT01435759|156387983|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
48599131|NCT01435759|156387984|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
48599132|NCT01435759|156387985|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
48718411|NCT00797966|156818385|FG001|Phase A|Lost to Follow-up|0|||
48718412|NCT00797966|156818386|FG002|Phase A|Lost to Follow-up|0|||
48718413|NCT00797966|156818387|FG003|Phase A|Lost to Follow-up|0|||
48718414|NCT00797966|156818388|FG004|Phase A|Lost to Follow-up|33|||
48718415|NCT00797966|156818389|FG005|Phase A|Lost to Follow-up|0|||
48718416|NCT00797966|156818384|FG000|Phase A|Adverse Event|0|||
48718417|NCT00797966|156818385|FG001|Phase A|Adverse Event|0|||
48718418|NCT00797966|156818386|FG002|Phase A|Adverse Event|0|||
48718419|NCT00797966|156818387|FG003|Phase A|Adverse Event|0|||
48718420|NCT00797966|156818388|FG004|Phase A|Adverse Event|46|||
48718421|NCT00797966|156818389|FG005|Phase A|Adverse Event|0|||
48718422|NCT00797966|156818384|FG000|Phase A|Met withdrawal criteria|0|||
48718423|NCT00797966|156818385|FG001|Phase A|Met withdrawal criteria|0|||
48718424|NCT00797966|156818386|FG002|Phase A|Met withdrawal criteria|0|||
48718425|NCT00797966|156818387|FG003|Phase A|Met withdrawal criteria|0|||
48718426|NCT00797966|156818388|FG004|Phase A|Met withdrawal criteria|4|||
48718427|NCT00797966|156818389|FG005|Phase A|Met withdrawal criteria|0|||
48718428|NCT00797966|156818384|FG000|Phase A|Physician Decision|0|||
48718429|NCT00797966|156818385|FG001|Phase A|Physician Decision|0|||
48718430|NCT00797966|156818386|FG002|Phase A|Physician Decision|0|||
48718431|NCT00797966|156818387|FG003|Phase A|Physician Decision|0|||
48718432|NCT00797966|156818388|FG004|Phase A|Physician Decision|13|||
48718433|NCT00797966|156818389|FG005|Phase A|Physician Decision|0|||
48718434|NCT00797966|156818384|FG000|Phase A|Withdrawal by Subject|0|||
48718435|NCT00797966|156818385|FG001|Phase A|Withdrawal by Subject|0|||
48718436|NCT00797966|156818386|FG002|Phase A|Withdrawal by Subject|0|||
48718437|NCT00797966|156818387|FG003|Phase A|Withdrawal by Subject|0|||
48718438|NCT00797966|156818388|FG004|Phase A|Withdrawal by Subject|33|||
48718439|NCT00797966|156818389|FG005|Phase A|Withdrawal by Subject|0|||
48718440|NCT00797966|156818384|FG000|Phase A|Protocol deviation|0|||
48718441|NCT00797966|156818385|FG001|Phase A|Protocol deviation|0|||
48718442|NCT00797966|156818386|FG002|Phase A|Protocol deviation|0|||
48718443|NCT00797966|156818387|FG003|Phase A|Protocol deviation|0|||
48718444|NCT00797966|156818388|FG004|Phase A|Protocol deviation|56|||
48718445|NCT00797966|156818389|FG005|Phase A|Protocol deviation|0|||
48718446|NCT00797966|156818384|FG000|Phase B|Lost to Follow-up|0|||
48599133|NCT01435759|156387986|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
48599134|NCT01435759|156387987|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
48599135|NCT01435759|156387982|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
48599136|NCT01435759|156387983|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48718447|NCT00797966|156818385|FG001|Phase B|Lost to Follow-up|1|||
48718448|NCT00797966|156818386|FG002|Phase B|Lost to Follow-up|3|||
48718449|NCT00797966|156818387|FG003|Phase B|Lost to Follow-up|0|||
48718450|NCT00797966|156818388|FG004|Phase B|Lost to Follow-up|0|||
48718451|NCT00797966|156818389|FG005|Phase B|Lost to Follow-up|0|||
48718452|NCT00797966|156818384|FG000|Phase B|Adverse Event|2|||
48718453|NCT00797966|156818385|FG001|Phase B|Adverse Event|1|||
48718454|NCT00797966|156818386|FG002|Phase B|Adverse Event|3|||
48599137|NCT01435759|156387984|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48599138|NCT01435759|156387985|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48718455|NCT00797966|156818387|FG003|Phase B|Adverse Event|1|||
48718456|NCT00797966|156818388|FG004|Phase B|Adverse Event|0|||
48718457|NCT00797966|156818389|FG005|Phase B|Adverse Event|0|||
48718458|NCT00797966|156818384|FG000|Phase B|Met Withdrawal Criteria|3|||
48718459|NCT00797966|156818385|FG001|Phase B|Met Withdrawal Criteria|3|||
48718460|NCT00797966|156818386|FG002|Phase B|Met Withdrawal Criteria|6|||
48718461|NCT00797966|156818387|FG003|Phase B|Met Withdrawal Criteria|1|||
48718462|NCT00797966|156818388|FG004|Phase B|Met Withdrawal Criteria|0|||
48718463|NCT00797966|156818389|FG005|Phase B|Met Withdrawal Criteria|0|||
48599139|NCT01435759|156387986|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48599140|NCT01435759|156387987|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
48599141|NCT01435759|156387982|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
48599142|NCT01435759|156387983|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48599143|NCT01435759|156387984|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48599144|NCT01435759|156387985|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48599145|NCT01435759|156387986|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48599146|NCT01435759|156387987|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
48599147|NCT01435759|156387982|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
48599148|NCT01435759|156387983|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48599149|NCT01435759|156387984|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48599150|NCT01435759|156387985|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48599151|NCT01435759|156387986|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48599152|NCT01435759|156387987|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48498957|NCT01298570|156022334|FG001|Overall Study|Other complicating disease|1|||
48498958|NCT01298570|156022333|FG000|Overall Study|Surgery|2|||
48599153|NCT01435759|156387982|FG000|Antidepressant Lead-in Phase|Other|119|||
48599154|NCT01435759|156387983|FG001|Antidepressant Lead-in Phase|Other|0|||
48599155|NCT01435759|156387984|FG002|Antidepressant Lead-in Phase|Other|0|||
48599156|NCT01435759|156387985|FG003|Antidepressant Lead-in Phase|Other|0|||
48599157|NCT01435759|156387986|FG004|Antidepressant Lead-in Phase|Other|0|||
48599158|NCT01435759|156387987|FG005|Antidepressant Lead-in Phase|Other|0|||
48599159|NCT01435759|156387982|FG000|Double-blind Phase|Adverse Event|7|||
48599160|NCT01435759|156387983|FG001|Double-blind Phase|Adverse Event|0|||
48599161|NCT01435759|156387984|FG002|Double-blind Phase|Adverse Event|1|||
48599162|NCT01435759|156387985|FG003|Double-blind Phase|Adverse Event|1|||
48599163|NCT01435759|156387986|FG004|Double-blind Phase|Adverse Event|1|||
48599164|NCT01435759|156387987|FG005|Double-blind Phase|Adverse Event|3|||
48599165|NCT01435759|156387982|FG000|Double-blind Phase|Protocol Violation|2|||
48599166|NCT01435759|156387983|FG001|Double-blind Phase|Protocol Violation|0|||
48599167|NCT01435759|156387984|FG002|Double-blind Phase|Protocol Violation|1|||
48599168|NCT01435759|156387985|FG003|Double-blind Phase|Protocol Violation|2|||
48599169|NCT01435759|156387986|FG004|Double-blind Phase|Protocol Violation|0|||
48599170|NCT01435759|156387987|FG005|Double-blind Phase|Protocol Violation|1|||
48599171|NCT01435759|156387982|FG000|Double-blind Phase|Withdrawal by Subject|17|||
48498959|NCT01298570|156022334|FG001|Overall Study|Surgery|1|||
48498960|NCT01298570|156022333|FG000|Overall Study|Symptomatic progression/deterioration|3|||
48498961|NCT01298570|156022334|FG001|Overall Study|Symptomatic progression/deterioration|2|||
48498962|NCT01298570|156022333|FG000|Overall Study|Death|0|||
48498963|NCT01298570|156022334|FG001|Overall Study|Death|1|||
48498964|NCT01298570|156022333|FG000|Overall Study|Ineligibility|0|||
48498965|NCT01298570|156022334|FG001|Overall Study|Ineligibility|1|||
48599172|NCT01435759|156387983|FG001|Double-blind Phase|Withdrawal by Subject|4|||
48599173|NCT01435759|156387984|FG002|Double-blind Phase|Withdrawal by Subject|3|||
48599174|NCT01435759|156387985|FG003|Double-blind Phase|Withdrawal by Subject|4|||
48599175|NCT01435759|156387986|FG004|Double-blind Phase|Withdrawal by Subject|2|||
48599176|NCT01435759|156387987|FG005|Double-blind Phase|Withdrawal by Subject|2|||
48599177|NCT01435759|156387982|FG000|Double-blind Phase|Lost to Follow-up|31|||
48599178|NCT01435759|156387983|FG001|Double-blind Phase|Lost to Follow-up|1|||
48599179|NCT01435759|156387984|FG002|Double-blind Phase|Lost to Follow-up|2|||
48599180|NCT01435759|156387985|FG003|Double-blind Phase|Lost to Follow-up|0|||
48599181|NCT01435759|156387986|FG004|Double-blind Phase|Lost to Follow-up|3|||
48599182|NCT01435759|156387987|FG005|Double-blind Phase|Lost to Follow-up|3|||
48599183|NCT01435759|156387982|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
48599184|NCT01435759|156387983|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
48599185|NCT01435759|156387984|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
48599186|NCT01435759|156387985|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
48599187|NCT01435759|156387986|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
48599188|NCT01435759|156387987|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
48718464|NCT00797966|156818384|FG000|Phase B|Physician Decision|1|||
48718465|NCT00797966|156818385|FG001|Phase B|Physician Decision|0|||
48718466|NCT00797966|156818386|FG002|Phase B|Physician Decision|3|||
48718467|NCT00797966|156818387|FG003|Phase B|Physician Decision|1|||
48718468|NCT00797966|156818388|FG004|Phase B|Physician Decision|0|||
48718469|NCT00797966|156818389|FG005|Phase B|Physician Decision|0|||
48718470|NCT00797966|156818384|FG000|Phase B|Withdrawal by Subject|1|||
48718471|NCT00797966|156818385|FG001|Phase B|Withdrawal by Subject|4|||
48718472|NCT00797966|156818386|FG002|Phase B|Withdrawal by Subject|3|||
48718473|NCT00797966|156818387|FG003|Phase B|Withdrawal by Subject|3|||
48718474|NCT00797966|156818388|FG004|Phase B|Withdrawal by Subject|0|||
48718475|NCT00797966|156818389|FG005|Phase B|Withdrawal by Subject|0|||
48498966|NCT01648166|156022345|FG000|Overall Study|inadequate toenail samples|53|||
48718476|NCT00797966|156818384|FG000|Phase B|Protocol Deviation|4|||
48718477|NCT00797966|156818385|FG001|Phase B|Protocol Deviation|8|||
48498967|NCT01648166|156022346|FG001|Overall Study|inadequate toenail samples|100|||
48498968|NCT02564263|156022363|FG000|Overall Study|Adverse Event|31|||
48498969|NCT02564263|156022364|FG001|Overall Study|Adverse Event|29|||
48498970|NCT02564263|156022363|FG000|Overall Study|Death|270|||
48498971|NCT02564263|156022364|FG001|Overall Study|Death|262|||
48498972|NCT02564263|156022363|FG000|Overall Study|Withdrawal by Subject|4|||
48498973|NCT02564263|156022364|FG001|Overall Study|Withdrawal by Subject|19|||
48498974|NCT02564263|156022363|FG000|Overall Study|Sponsor's decision|9|||
48498975|NCT02564263|156022364|FG001|Overall Study|Sponsor's decision|4|||
48498976|NCT00520741|156022365|FG000|Overall Study|Adverse Event|16|||
48498977|NCT00520741|156022366|FG001|Overall Study|Adverse Event|56|||
48498978|NCT00520741|156022365|FG000|Overall Study|Lack of Efficacy|11|||
48498979|NCT00520741|156022366|FG001|Overall Study|Lack of Efficacy|30|||
48498980|NCT00520741|156022365|FG000|Overall Study|Withdrawal by Subject|0|||
48599189|NCT01435759|156387982|FG000|Double-blind Phase|Other|8|||
48599190|NCT01435759|156387983|FG001|Double-blind Phase|Other|2|||
48599191|NCT01435759|156387984|FG002|Double-blind Phase|Other|0|||
48718478|NCT00797966|156818386|FG002|Phase B|Protocol Deviation|2|||
48718479|NCT00797966|156818387|FG003|Phase B|Protocol Deviation|6|||
48718480|NCT00797966|156818388|FG004|Phase B|Protocol Deviation|0|||
48718481|NCT00797966|156818389|FG005|Phase B|Protocol Deviation|0|||
48718482|NCT00797966|156818384|FG000|Phase B|Lack of Efficacy|0|||
48718483|NCT00797966|156818385|FG001|Phase B|Lack of Efficacy|1|||
48718484|NCT00797966|156818386|FG002|Phase B|Lack of Efficacy|1|||
48718485|NCT00797966|156818387|FG003|Phase B|Lack of Efficacy|4|||
48718486|NCT00797966|156818388|FG004|Phase B|Lack of Efficacy|0|||
48718487|NCT00797966|156818389|FG005|Phase B|Lack of Efficacy|0|||
48718488|NCT00797966|156818384|FG000|Phase A+|Lost to Follow-up|0|||
48718489|NCT00797966|156818385|FG001|Phase A+|Lost to Follow-up|0|||
48718490|NCT00797966|156818386|FG002|Phase A+|Lost to Follow-up|0|||
48718491|NCT00797966|156818387|FG003|Phase A+|Lost to Follow-up|0|||
48718492|NCT00797966|156818388|FG004|Phase A+|Lost to Follow-up|0|||
48718493|NCT00797966|156818389|FG005|Phase A+|Lost to Follow-up|9|||
48718494|NCT00797966|156818384|FG000|Phase A+|Met withdrawal criteria|0|||
48718495|NCT00797966|156818385|FG001|Phase A+|Met withdrawal criteria|0|||
48718496|NCT00797966|156818386|FG002|Phase A+|Met withdrawal criteria|0|||
48718497|NCT00797966|156818387|FG003|Phase A+|Met withdrawal criteria|0|||
48718498|NCT00797966|156818388|FG004|Phase A+|Met withdrawal criteria|0|||
48718499|NCT00797966|156818389|FG005|Phase A+|Met withdrawal criteria|5|||
48718500|NCT00797966|156818384|FG000|Phase A+|Withdrawal by Subject|0|||
48718501|NCT00797966|156818385|FG001|Phase A+|Withdrawal by Subject|0|||
48718502|NCT00797966|156818386|FG002|Phase A+|Withdrawal by Subject|0|||
48718503|NCT00797966|156818387|FG003|Phase A+|Withdrawal by Subject|0|||
48718504|NCT00797966|156818388|FG004|Phase A+|Withdrawal by Subject|0|||
48718505|NCT00797966|156818389|FG005|Phase A+|Withdrawal by Subject|6|||
48718506|NCT00797966|156818384|FG000|Phase A+|Adverse Event|0|||
48718507|NCT00797966|156818385|FG001|Phase A+|Adverse Event|0|||
48718508|NCT00797966|156818386|FG002|Phase A+|Adverse Event|0|||
48718509|NCT00797966|156818387|FG003|Phase A+|Adverse Event|0|||
48718510|NCT00797966|156818388|FG004|Phase A+|Adverse Event|0|||
48718511|NCT00797966|156818389|FG005|Phase A+|Adverse Event|4|||
48718512|NCT00797966|156818384|FG000|Phase A+|Protocol deviation|0|||
48718513|NCT00797966|156818385|FG001|Phase A+|Protocol deviation|0|||
48718514|NCT00797966|156818386|FG002|Phase A+|Protocol deviation|0|||
48718515|NCT00797966|156818387|FG003|Phase A+|Protocol deviation|0|||
48718516|NCT00797966|156818388|FG004|Phase A+|Protocol deviation|0|||
48718517|NCT00797966|156818389|FG005|Phase A+|Protocol deviation|4|||
48718518|NCT04644315|156818390|FG000|Overall Study|Subject withdrawal of consent|1|||
48718519|NCT03874429|156818391|FG000|Overall Study|Adverse Event|2|||
48718520|NCT03874429|156818392|FG001|Overall Study|Adverse Event|2|||
48718521|NCT03874429|156818391|FG000|Overall Study|Lack of Efficacy|0|||
48718522|NCT03874429|156818392|FG001|Overall Study|Lack of Efficacy|1|||
48718523|NCT03874429|156818391|FG000|Overall Study|Covid-19 pandemic|4|||
48718524|NCT03874429|156818392|FG001|Overall Study|Covid-19 pandemic|2|||
48718525|NCT00331552|156818393|FG000|Period 3: Phase II|Neurological Symptoms|1|||
48498981|NCT00520741|156022366|FG001|Overall Study|Withdrawal by Subject|11|||
48718526|NCT00331552|156818394|FG001|Period 3: Phase II|Neurological Symptoms|0|||
48718527|NCT00331552|156818393|FG000|Period 3: Phase II|Severe Nausea|1|||
48718528|NCT00331552|156818394|FG001|Period 3: Phase II|Severe Nausea|0|||
48718529|NCT02937584|156818395|FG000|Period 1|Adverse Event|1|||
48718530|NCT02937584|156818396|FG001|Period 1|Adverse Event|2|||
48718531|NCT02937584|156818395|FG000|Washout|Adverse Event|0|||
48718532|NCT02937584|156818396|FG001|Washout|Adverse Event|1|||
48718533|NCT04224688|156818400|FG000|Overall Study|Withdrawal by Subject|1|||
48718534|NCT04224688|156818401|FG001|Overall Study|Withdrawal by Subject|3|||
48718535|NCT04224688|156818400|FG000|Overall Study|Lack of Efficacy|1|||
48718536|NCT04224688|156818401|FG001|Overall Study|Lack of Efficacy|1|||
48718537|NCT04224688|156818400|FG000|Overall Study|Adverse event, not fatal|0|||
48718538|NCT04224688|156818401|FG001|Overall Study|Adverse event, not fatal|2|||
48718539|NCT04224688|156818400|FG000|Overall Study|COVID-19|0|||
48718540|NCT04224688|156818401|FG001|Overall Study|COVID-19|1|||
48718541|NCT00329901|156818404|FG000|Overall Study|Withdrawal by Subject|4|||
48718542|NCT00329901|156818405|FG001|Overall Study|Withdrawal by Subject|3|||
48718543|NCT00329901|156818406|FG002|Overall Study|Withdrawal by Subject|2|||
48718544|NCT00329901|156818404|FG000|Overall Study|Lost to Follow-up|2|||
48718545|NCT00329901|156818405|FG001|Overall Study|Lost to Follow-up|0|||
48718546|NCT00329901|156818406|FG002|Overall Study|Lost to Follow-up|1|||
48718547|NCT00329901|156818404|FG000|Overall Study|Protocol Violation|1|||
48718548|NCT00329901|156818405|FG001|Overall Study|Protocol Violation|0|||
48718549|NCT00329901|156818406|FG002|Overall Study|Protocol Violation|1|||
48718550|NCT00329901|156818404|FG000|Overall Study|Unable to classify|2|||
48718551|NCT00329901|156818405|FG001|Overall Study|Unable to classify|2|||
48718552|NCT00329901|156818406|FG002|Overall Study|Unable to classify|0|||
48718553|NCT01215916|156818407|FG000|Overall Study|Progressive Disease|0|||
48718554|NCT01215916|156818408|FG001|Overall Study|Progressive Disease|2|||
48718555|NCT01215916|156818409|FG002|Overall Study|Progressive Disease|1|||
48718556|NCT01215916|156818410|FG003|Overall Study|Progressive Disease|2|||
48718557|NCT01215916|156818411|FG004|Overall Study|Progressive Disease|5|||
48718558|NCT01215916|156818412|FG005|Overall Study|Progressive Disease|4|||
48718559|NCT01215916|156818413|FG006|Overall Study|Progressive Disease|5|||
48718560|NCT01215916|156818414|FG007|Overall Study|Progressive Disease|3|||
48718561|NCT01215916|156818415|FG008|Overall Study|Progressive Disease|1|||
48718562|NCT01215916|156818407|FG000|Overall Study|Adverse Event|1|||
48718563|NCT01215916|156818408|FG001|Overall Study|Adverse Event|1|||
48815012|NCT01544582|157163648|FG000|Analysis Population|Poor Adherence|0|||
48815013|NCT01544582|157163649|FG001|Analysis Population|Poor Adherence|0|||
48815014|NCT01544582|157163650|FG002|Analysis Population|Poor Adherence|1|||
48815015|NCT01544582|157163651|FG003|Analysis Population|Poor Adherence|0|||
48815016|NCT01544582|157163648|FG000|Analysis Population|Poor Participant Compliance|0|||
48815017|NCT01544582|157163649|FG001|Analysis Population|Poor Participant Compliance|1|||
48815018|NCT01544582|157163650|FG002|Analysis Population|Poor Participant Compliance|0|||
48815019|NCT01544582|157163651|FG003|Analysis Population|Poor Participant Compliance|0|||
48815020|NCT01544582|157163648|FG000|Analysis Population|Programmed Surgery|0|||
48815021|NCT01544582|157163649|FG001|Analysis Population|Programmed Surgery|1|||
48815022|NCT01544582|157163650|FG002|Analysis Population|Programmed Surgery|0|||
48815023|NCT01544582|157163651|FG003|Analysis Population|Programmed Surgery|0|||
48815024|NCT01544582|157163648|FG000|Analysis Population|Participant in Jail|0|||
48498982|NCT00520741|156022365|FG000|Overall Study|Protocol Violation|2|||
48498983|NCT00520741|156022366|FG001|Overall Study|Protocol Violation|15|||
48718564|NCT01215916|156818409|FG002|Overall Study|Adverse Event|0|||
48718565|NCT01215916|156818410|FG003|Overall Study|Adverse Event|1|||
48718566|NCT01215916|156818411|FG004|Overall Study|Adverse Event|0|||
48718567|NCT01215916|156818412|FG005|Overall Study|Adverse Event|0|||
48718568|NCT01215916|156818413|FG006|Overall Study|Adverse Event|3|||
48718569|NCT01215916|156818414|FG007|Overall Study|Adverse Event|0|||
48718570|NCT01215916|156818415|FG008|Overall Study|Adverse Event|0|||
48718571|NCT01215916|156818407|FG000|Overall Study|Withdrawal by Subject|0|||
48718572|NCT01215916|156818408|FG001|Overall Study|Withdrawal by Subject|1|||
48718573|NCT01215916|156818409|FG002|Overall Study|Withdrawal by Subject|1|||
48718574|NCT01215916|156818410|FG003|Overall Study|Withdrawal by Subject|2|||
48718575|NCT01215916|156818411|FG004|Overall Study|Withdrawal by Subject|0|||
48718576|NCT01215916|156818412|FG005|Overall Study|Withdrawal by Subject|0|||
48718577|NCT01215916|156818413|FG006|Overall Study|Withdrawal by Subject|1|||
48718578|NCT01215916|156818414|FG007|Overall Study|Withdrawal by Subject|0|||
48718579|NCT01215916|156818415|FG008|Overall Study|Withdrawal by Subject|0|||
48718580|NCT01215916|156818407|FG000|Overall Study|Death|0|||
48718581|NCT01215916|156818408|FG001|Overall Study|Death|1|||
48498984|NCT00520741|156022365|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
48498985|NCT00520741|156022366|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
48498986|NCT00520741|156022365|FG000|Overall Study|Lost to Follow-up|4|||
48498987|NCT00520741|156022366|FG001|Overall Study|Lost to Follow-up|4|||
48498988|NCT00520741|156022365|FG000|Overall Study|Other reasons for premature termination|0|||
48498989|NCT00520741|156022366|FG001|Overall Study|Other reasons for premature termination|6|||
48498990|NCT03679741|156022367|FG000|Period 1|No longer meet eligibility criteria|1|||
48718582|NCT01215916|156818409|FG002|Overall Study|Death|0|||
48718583|NCT01215916|156818410|FG003|Overall Study|Death|0|||
48718584|NCT01215916|156818411|FG004|Overall Study|Death|1|||
48718585|NCT01215916|156818412|FG005|Overall Study|Death|0|||
48718586|NCT01215916|156818413|FG006|Overall Study|Death|0|||
48718587|NCT01215916|156818414|FG007|Overall Study|Death|0|||
48815025|NCT01544582|157163649|FG001|Analysis Population|Participant in Jail|0|||
48718588|NCT01215916|156818415|FG008|Overall Study|Death|1|||
48718589|NCT01215916|156818407|FG000|Overall Study|Physician Decision|0|||
48718590|NCT01215916|156818408|FG001|Overall Study|Physician Decision|0|||
48718591|NCT01215916|156818409|FG002|Overall Study|Physician Decision|1|||
48718592|NCT01215916|156818410|FG003|Overall Study|Physician Decision|1|||
48718593|NCT01215916|156818411|FG004|Overall Study|Physician Decision|0|||
48718594|NCT01215916|156818412|FG005|Overall Study|Physician Decision|0|||
48718595|NCT01215916|156818413|FG006|Overall Study|Physician Decision|0|||
48718596|NCT01215916|156818414|FG007|Overall Study|Physician Decision|0|||
48718597|NCT01215916|156818415|FG008|Overall Study|Physician Decision|0|||
48718598|NCT00934648|156818418|FG000|Overall Study|Failure to return|8|||
48718599|NCT00934648|156818418|FG000|Overall Study|Withdrawal by Subject|1|||
48718600|NCT01253811|156818419|FG000|Overall Study|Withdrawal criteria|1|||
48718601|NCT02788279|156818420|FG000|Overall Study|Death|62|||
48718602|NCT02788279|156818421|FG001|Overall Study|Death|136|||
48718603|NCT02788279|156818422|FG002|Overall Study|Death|72|||
48718604|NCT02788279|156818420|FG000|Overall Study|Withdrawal by Subject|10|||
48718605|NCT02788279|156818421|FG001|Overall Study|Withdrawal by Subject|15|||
48718606|NCT02788279|156818422|FG002|Overall Study|Withdrawal by Subject|5|||
48718607|NCT02788279|156818420|FG000|Overall Study|Lost to Follow-up|0|||
48718608|NCT02788279|156818421|FG001|Overall Study|Lost to Follow-up|3|||
48718609|NCT02788279|156818422|FG002|Overall Study|Lost to Follow-up|2|||
48718610|NCT02788279|156818420|FG000|Overall Study|Sponsor decision|18|||
48718611|NCT02788279|156818421|FG001|Overall Study|Sponsor decision|29|||
48718612|NCT02788279|156818422|FG002|Overall Study|Sponsor decision|11|||
48718613|NCT05028361|156818423|FG000|Overall Study|Withdrawal by Subject|1|||
48718614|NCT05028361|156818424|FG001|Overall Study|Withdrawal by Subject|0|||
48718615|NCT00779259|156818427|FG000|Quinine Alone|Adverse Event|2|||
48718616|NCT00711516|156818431|FG000|Overall Study|Adverse Event|1|||
48718617|NCT00711516|156818432|FG001|Overall Study|Adverse Event|1|||
48718618|NCT00711516|156818431|FG000|Overall Study|Withdrawal by Subject|0|||
48718619|NCT00711516|156818432|FG001|Overall Study|Withdrawal by Subject|1|||
48718620|NCT00711516|156818431|FG000|Overall Study|Protocol Violation|0|||
48718621|NCT00711516|156818432|FG001|Overall Study|Protocol Violation|1|||
48718622|NCT01565343|156818433|FG000|Overall Study|Administrative decision/technical issues|1|||
48718623|NCT01565343|156818434|FG001|Overall Study|Administrative decision/technical issues|0|||
48718624|NCT01565343|156818435|FG002|Overall Study|Administrative decision/technical issues|0|||
48718625|NCT03339297|156818436|FG000|Overall Study|Relapse of Hematologic Disease|1|||
48718626|NCT03339297|156818437|FG001|Overall Study|Relapse of Hematologic Disease|0|||
48718627|NCT03339297|156818436|FG000|Overall Study|Death|10|||
48718628|NCT03339297|156818437|FG001|Overall Study|Death|7|||
48718629|NCT03339297|156818436|FG000|Overall Study|Hepatic Candidosis|1|||
48718630|NCT03339297|156818437|FG001|Overall Study|Hepatic Candidosis|0|||
48718631|NCT03339297|156818436|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
48718632|NCT03339297|156818437|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
48718633|NCT03339297|156818436|FG000|Overall Study|Consent Withdrawn by Participant|3|||
48718634|NCT03339297|156818437|FG001|Overall Study|Consent Withdrawn by Participant|3|||
48718635|NCT03339297|156818436|FG000|Overall Study|Disease Relapse|2|||
48718636|NCT03339297|156818437|FG001|Overall Study|Disease Relapse|0|||
48718637|NCT03339297|156818436|FG000|Overall Study|Physician Decision|1|||
48718638|NCT03339297|156818437|FG001|Overall Study|Physician Decision|1|||
48718639|NCT03339297|156818436|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
48718640|NCT03339297|156818437|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
48718641|NCT03339297|156818436|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
48718642|NCT03339297|156818437|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
48718643|NCT03339297|156818436|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
48718644|NCT03339297|156818437|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
48718645|NCT03339297|156818436|FG000|Overall Study|Adverse Event, Non-fatal|1|||
48718646|NCT03339297|156818437|FG001|Overall Study|Adverse Event, Non-fatal|0|||
48718647|NCT03339297|156818436|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
48718648|NCT03339297|156818437|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
48718649|NCT03339297|156818436|FG000|Overall Study|Patient Was Not Eligible|1|||
48718650|NCT03339297|156818437|FG001|Overall Study|Patient Was Not Eligible|0|||
48718651|NCT02586506|156818438|FG000|Overall Study|Protocol Violation|6|||
48718652|NCT02586506|156818438|FG000|Overall Study|Lost to Follow-up|1|||
48718653|NCT02586506|156818438|FG000|Overall Study|Other Reason|2|||
48718654|NCT01566214|156818439|FG000|Overall Study|Lost to Follow-up|3|||
48718655|NCT01566214|156818440|FG001|Overall Study|Lost to Follow-up|0|||
48718656|NCT02536404|156818446|FG000|Overall Study|Adverse Event|5|||
48718657|NCT02536404|156818447|FG001|Overall Study|Adverse Event|0|||
48718658|NCT02536404|156818446|FG000|Overall Study|Withdrawal by Subject|4|||
48718659|NCT02536404|156818447|FG001|Overall Study|Withdrawal by Subject|1|||
48718660|NCT02536404|156818446|FG000|Overall Study|Physician Decision|10|||
48718661|NCT02536404|156818447|FG001|Overall Study|Physician Decision|0|||
48718662|NCT02536404|156818446|FG000|Overall Study|Sponsor decision|1|||
48718663|NCT02536404|156818447|FG001|Overall Study|Sponsor decision|0|||
48718664|NCT01431638|156818450|FG000|Overall Study|Adverse Event|1|||
48718665|NCT01431638|156818451|FG001|Overall Study|Adverse Event|3|||
48718666|NCT01431638|156818452|FG002|Overall Study|Adverse Event|1|||
48718667|NCT01431638|156818450|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48718668|NCT01431638|156818451|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48718669|NCT01431638|156818452|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
48718670|NCT01431638|156818450|FG000|Overall Study|Participants condition no longer requires study drug|0|||
48718671|NCT01431638|156818451|FG001|Overall Study|Participants condition no longer requires study drug|1|||
48718672|NCT01431638|156818452|FG002|Overall Study|Participants condition no longer requires study drug|0|||
48718673|NCT01431638|156818450|FG000|Overall Study|Participant withdrew consent|14|||
48815026|NCT01544582|157163650|FG002|Analysis Population|Participant in Jail|1|||
48815027|NCT01544582|157163651|FG003|Analysis Population|Participant in Jail|0|||
48815028|NCT01644474|157163655|FG000|Overall Study|Poor compliance to protocol|1|||
48815029|NCT01644474|157163656|FG001|Overall Study|Poor compliance to protocol|0|||
48815030|NCT01644474|157163655|FG000|Overall Study|Consent withdrawn by participant|0|||
48815031|NCT01644474|157163656|FG001|Overall Study|Consent withdrawn by participant|1|||
48815032|NCT01644474|157163655|FG000|Overall Study|Participant moved|0|||
48815033|NCT01644474|157163656|FG001|Overall Study|Participant moved|1|||
48815034|NCT01644474|157163655|FG000|Overall Study|Adverse Event|4|||
48815035|NCT01644474|157163656|FG001|Overall Study|Adverse Event|5|||
48815036|NCT01644474|157163655|FG000|Overall Study|Site scheduling error|1|||
48815037|NCT01644474|157163656|FG001|Overall Study|Site scheduling error|1|||
48815038|NCT01644474|157163655|FG000|Overall Study|Protocol Violation|1|||
48815039|NCT01644474|157163656|FG001|Overall Study|Protocol Violation|0|||
48815040|NCT03317379|157163660|FG000|Overall Study|Lost to Follow-up|0|||
48718674|NCT01431638|156818451|FG001|Overall Study|Participant withdrew consent|5|||
48718675|NCT01431638|156818452|FG002|Overall Study|Participant withdrew consent|8|||
48718676|NCT01431638|156818450|FG000|Overall Study|Lost to Follow-up|7|||
48718677|NCT01431638|156818451|FG001|Overall Study|Lost to Follow-up|9|||
48718678|NCT01431638|156818452|FG002|Overall Study|Lost to Follow-up|7|||
48718679|NCT01431638|156818450|FG000|Overall Study|Administrative problems|1|||
48718680|NCT01431638|156818451|FG001|Overall Study|Administrative problems|4|||
48718681|NCT01431638|156818452|FG002|Overall Study|Administrative problems|6|||
48718682|NCT01431638|156818450|FG000|Overall Study|Death|1|||
48718683|NCT01431638|156818451|FG001|Overall Study|Death|0|||
48718684|NCT01431638|156818452|FG002|Overall Study|Death|0|||
48718685|NCT01431638|156818450|FG000|Overall Study|Protocol deviation|1|||
48718686|NCT01431638|156818451|FG001|Overall Study|Protocol deviation|1|||
48718687|NCT01431638|156818452|FG002|Overall Study|Protocol deviation|4|||
48718688|NCT01431638|156818450|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
48718689|NCT01431638|156818451|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
48718690|NCT01431638|156818452|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
48718691|NCT00899353|156818453|FG000|Overall Study|Adverse Event|2|||
48718692|NCT00899353|156818453|FG000|Overall Study|Lost to Follow-up|1|||
48718693|NCT00899353|156818453|FG000|Overall Study|Withdrawal by Subject|2|||
48718694|NCT02395302|156818459|FG000|Overall Study|Screen Failure|3|||
48718695|NCT02395302|156818459|FG000|Overall Study|Run In Failure|7|||
48718696|NCT02395302|156818459|FG000|Overall Study|Withdrawal by Subject|2|||
48718697|NCT02395302|156818459|FG000|Overall Study|Physician Decision|2|||
48718698|NCT04268823|156818460|FG000|Overall Study|Adverse Event|1|||
48815041|NCT03317379|157163661|FG001|Overall Study|Lost to Follow-up|3|||
48498991|NCT03679741|156022368|FG001|Period 1|No longer meet eligibility criteria|0|||
48498992|NCT03679741|156022367|FG000|Period 1|Lost to Follow-up|0|||
48815042|NCT03317379|157163662|FG002|Overall Study|Lost to Follow-up|2|||
48815043|NCT05886777|157163665|FG000|Overall Study|Lost to Follow-up|1|||
48815044|NCT05886777|157163666|FG001|Overall Study|Lost to Follow-up|0|||
48815045|NCT05886777|157163667|FG002|Overall Study|Lost to Follow-up|2|||
48815046|NCT05886777|157163668|FG003|Overall Study|Lost to Follow-up|1|||
48815047|NCT05886777|157163669|FG004|Overall Study|Lost to Follow-up|0|||
48815048|NCT05886777|157163670|FG005|Overall Study|Lost to Follow-up|2|||
48815049|NCT05886777|157163671|FG006|Overall Study|Lost to Follow-up|0|||
48815050|NCT05886777|157163665|FG000|Overall Study|Other|0|||
48815051|NCT05886777|157163666|FG001|Overall Study|Other|2|||
48815052|NCT05886777|157163667|FG002|Overall Study|Other|1|||
48815053|NCT05886777|157163668|FG003|Overall Study|Other|0|||
48815054|NCT05886777|157163669|FG004|Overall Study|Other|0|||
48498993|NCT03679741|156022368|FG001|Period 1|Lost to Follow-up|1|||
48498994|NCT03679741|156022367|FG000|Period 1|Adverse Event|1|||
48498995|NCT03679741|156022368|FG001|Period 1|Adverse Event|1|||
48498996|NCT03679741|156022367|FG000|Period 1|Withdrawal by Subject|0|||
48498997|NCT03679741|156022368|FG001|Period 1|Withdrawal by Subject|1|||
48498998|NCT03679741|156022367|FG000|Period 2|Adverse Event|2|||
48498999|NCT03679741|156022368|FG001|Period 2|Adverse Event|1|||
48499000|NCT03679741|156022367|FG000|Period 2|Withdrawal by Subject|1|||
48499001|NCT03679741|156022368|FG001|Period 2|Withdrawal by Subject|1|||
48499002|NCT03311646|156022369|FG000|Overall Study|Physician Decision|1|||
48499003|NCT03311646|156022369|FG000|Overall Study|Withdrawal by Subject|5|||
48499004|NCT03311646|156022369|FG000|Overall Study|Lost to Follow-up|5|||
48499005|NCT03311646|156022369|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
48499006|NCT00527423|156022370|FG000|Overall Study|Protocol Violation|1|||
48718699|NCT04268823|156818461|FG001|Overall Study|Adverse Event|0|||
48718700|NCT04268823|156818460|FG000|Overall Study|Participant Decision|1|||
48718701|NCT04268823|156818461|FG001|Overall Study|Participant Decision|0|||
48815055|NCT05886777|157163670|FG005|Overall Study|Other|0|||
48815056|NCT05886777|157163671|FG006|Overall Study|Other|0|||
48599192|NCT01435759|156387985|FG003|Double-blind Phase|Other|2|||
48599193|NCT01435759|156387986|FG004|Double-blind Phase|Other|0|||
48718702|NCT04604132|156818462|FG000|Overall Study|Adverse Event|2|||
48718703|NCT04604132|156818463|FG001|Overall Study|Adverse Event|0|||
48815057|NCT05886777|157163665|FG000|Overall Study|Withdrawal by Subject|1|||
48815058|NCT05886777|157163666|FG001|Overall Study|Withdrawal by Subject|0|||
48815059|NCT05886777|157163667|FG002|Overall Study|Withdrawal by Subject|1|||
48815060|NCT05886777|157163668|FG003|Overall Study|Withdrawal by Subject|4|||
48815061|NCT05886777|157163669|FG004|Overall Study|Withdrawal by Subject|3|||
48815062|NCT05886777|157163670|FG005|Overall Study|Withdrawal by Subject|1|||
48815063|NCT05886777|157163671|FG006|Overall Study|Withdrawal by Subject|1|||
48815064|NCT05886777|157163665|FG000|Overall Study|Protocol Violation|0|||
48815065|NCT05886777|157163666|FG001|Overall Study|Protocol Violation|0|||
48815066|NCT05886777|157163667|FG002|Overall Study|Protocol Violation|1|||
48815067|NCT05886777|157163668|FG003|Overall Study|Protocol Violation|0|||
48815068|NCT05886777|157163669|FG004|Overall Study|Protocol Violation|0|||
48718704|NCT04604132|156818464|FG002|Overall Study|Adverse Event|0|||
48718705|NCT04604132|156818465|FG003|Overall Study|Adverse Event|1|||
48499007|NCT00527423|156022370|FG000|Overall Study|Adverse Event|5|||
48499008|NCT00527423|156022370|FG000|Overall Study|Physician Decision|4|||
48599194|NCT01435759|156387987|FG005|Double-blind Phase|Other|0|||
48599195|NCT03113968|156387988|FG000|Overall Study|Withdrawal by Subject|31|||
48599196|NCT03113968|156387989|FG001|Overall Study|Withdrawal by Subject|4|||
48599197|NCT00784719|156387994|FG000|Overall Study|Adverse Event|0|||
48599198|NCT00784719|156387995|FG001|Overall Study|Adverse Event|2|||
48599199|NCT00784719|156387996|FG002|Overall Study|Adverse Event|0|||
48599200|NCT00784719|156387997|FG003|Overall Study|Adverse Event|0|||
48599201|NCT00784719|156387998|FG004|Overall Study|Adverse Event|1|||
48499009|NCT00527423|156022370|FG000|Overall Study|Withdrawal by Subject|10|||
48499010|NCT00527423|156022370|FG000|Overall Study|Lost to Follow-up|4|||
48499011|NCT00527423|156022370|FG000|Overall Study|OTHER|4|||
48499012|NCT00527423|156022370|FG000|Overall Study|Death|9|||
48499013|NCT03702621|156022371|FG000|Overall Study|Physician Decision|6|||
48499014|NCT03702621|156022372|FG001|Overall Study|Physician Decision|6|||
48499015|NCT00883090|156022377|FG000|Overall Study|Sponsor's decision|1|||
48499016|NCT00883090|156022377|FG000|Overall Study|Withdrawal by Subject|1|||
48499017|NCT03194464|156022378|FG000|Overall Study|data not usable|2|||
48499018|NCT03103100|156022379|FG000|Overall Study|Adverse Event|1|||
48499019|NCT03103100|156022380|FG001|Overall Study|Adverse Event|0|||
48499020|NCT03103100|156022381|FG002|Overall Study|Adverse Event|0|||
48499021|NCT03103100|156022379|FG000|Overall Study|Physician Decision|1|||
48499022|NCT03103100|156022380|FG001|Overall Study|Physician Decision|0|||
48499023|NCT03103100|156022381|FG002|Overall Study|Physician Decision|2|||
48499024|NCT00531206|156022382|FG000|Overall Study|Adverse Event related|5|||
48499025|NCT00531206|156022382|FG000|Overall Study|Lack of Efficacy|2|||
48499026|NCT00531206|156022382|FG000|Overall Study|Lost to Follow-up|5|||
48499027|NCT00531206|156022382|FG000|Overall Study|including non-related adverse events|8|||
48499028|NCT01000337|156022386|FG000|Overall Study|Lost to Follow-up|4|||
48499029|NCT01000337|156022387|FG001|Overall Study|Lost to Follow-up|3|||
48499030|NCT01492361|156022394|FG000|Overall Study|Withdrawal by Subject|281|||
48499031|NCT01492361|156022395|FG001|Overall Study|Withdrawal by Subject|297|||
48499032|NCT01492361|156022394|FG000|Overall Study|Physician Decision|12|||
48499033|NCT01492361|156022395|FG001|Overall Study|Physician Decision|12|||
48499034|NCT01492361|156022394|FG000|Overall Study|Lost to Follow-up|6|||
48499035|NCT01492361|156022395|FG001|Overall Study|Lost to Follow-up|13|||
48499036|NCT01492361|156022394|FG000|Overall Study|Other than specified above|106|||
48499037|NCT01492361|156022395|FG001|Overall Study|Other than specified above|138|||
48499038|NCT02750761|156022396|FG000|Overall Study|Lost to Follow-up|0|||
48499039|NCT02750761|156022397|FG001|Overall Study|Lost to Follow-up|0|||
48718706|NCT04604132|156818466|FG004|Overall Study|Adverse Event|2|||
48718707|NCT04604132|156818462|FG000|Overall Study|Study terminated by sponsor|0|||
48718708|NCT04604132|156818463|FG001|Overall Study|Study terminated by sponsor|0|||
48718709|NCT04604132|156818464|FG002|Overall Study|Study terminated by sponsor|0|||
48499040|NCT02750761|156022398|FG002|Overall Study|Lost to Follow-up|1|||
48499041|NCT02750761|156022399|FG003|Overall Study|Lost to Follow-up|0|||
48499042|NCT02750761|156022400|FG004|Overall Study|Lost to Follow-up|0|||
48718710|NCT04604132|156818465|FG003|Overall Study|Study terminated by sponsor|0|||
48815069|NCT05886777|157163670|FG005|Overall Study|Protocol Violation|0|||
48499043|NCT02750761|156022401|FG005|Overall Study|Lost to Follow-up|0|||
48499044|NCT03527745|156022402|FG000|Overall Study|Lost to Follow-up|3|||
48499045|NCT03527745|156022403|FG001|Overall Study|Lost to Follow-up|6|||
48499046|NCT03527745|156022404|FG002|Overall Study|Lost to Follow-up|7|||
48499047|NCT03527745|156022405|FG003|Overall Study|Lost to Follow-up|9|||
48499048|NCT03527745|156022406|FG004|Overall Study|Lost to Follow-up|0|||
48599202|NCT00784719|156387999|FG005|Overall Study|Adverse Event|1|||
48599203|NCT00784719|156388000|FG006|Overall Study|Adverse Event|1|||
48599204|NCT00784719|156387994|FG000|Overall Study|Lost to Follow-up|0|||
48599205|NCT00784719|156387995|FG001|Overall Study|Lost to Follow-up|0|||
48499049|NCT03527745|156022407|FG005|Overall Study|Lost to Follow-up|2|||
48815070|NCT05886777|157163671|FG006|Overall Study|Protocol Violation|0|||
48599206|NCT00784719|156387996|FG002|Overall Study|Lost to Follow-up|0|||
48599207|NCT00784719|156387997|FG003|Overall Study|Lost to Follow-up|0|||
48599208|NCT00784719|156387998|FG004|Overall Study|Lost to Follow-up|1|||
48599209|NCT00784719|156387999|FG005|Overall Study|Lost to Follow-up|1|||
48599210|NCT00784719|156388000|FG006|Overall Study|Lost to Follow-up|0|||
48599211|NCT00784719|156387994|FG000|Overall Study|Other|2|||
48599212|NCT00784719|156387995|FG001|Overall Study|Other|1|||
48499050|NCT03527745|156022408|FG006|Overall Study|Lost to Follow-up|3|||
48499051|NCT03527745|156022409|FG007|Overall Study|Lost to Follow-up|2|||
48499052|NCT03527745|156022410|FG008|Overall Study|Lost to Follow-up|3|||
48499053|NCT03527745|156022411|FG009|Overall Study|Lost to Follow-up|2|||
48499054|NCT03527745|156022412|FG010|Overall Study|Lost to Follow-up|1|||
48499055|NCT03527745|156022413|FG011|Overall Study|Lost to Follow-up|1|||
48499056|NCT03527745|156022414|FG012|Overall Study|Lost to Follow-up|0|||
48499057|NCT03527745|156022415|FG013|Overall Study|Lost to Follow-up|0|||
48499058|NCT03527745|156022416|FG014|Overall Study|Lost to Follow-up|0|||
48499059|NCT03527745|156022417|FG015|Overall Study|Lost to Follow-up|0|||
48499060|NCT03527745|156022418|FG016|Overall Study|Lost to Follow-up|1|||
48499061|NCT03527745|156022419|FG017|Overall Study|Lost to Follow-up|0|||
48499062|NCT03527745|156022420|FG018|Overall Study|Lost to Follow-up|0|||
48499063|NCT03527745|156022421|FG019|Overall Study|Lost to Follow-up|1|||
48499064|NCT03527745|156022422|FG020|Overall Study|Lost to Follow-up|1|||
48499065|NCT03527745|156022423|FG021|Overall Study|Lost to Follow-up|5|||
48499066|NCT03527745|156022424|FG022|Overall Study|Lost to Follow-up|6|||
48499067|NCT03527745|156022425|FG023|Overall Study|Lost to Follow-up|8|||
48499068|NCT03527745|156022426|FG024|Overall Study|Lost to Follow-up|1|||
48499069|NCT03527745|156022427|FG025|Overall Study|Lost to Follow-up|3|||
48499070|NCT02906709|156022428|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
48499071|NCT02906709|156022429|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
48499072|NCT02906709|156022428|FG000|Phase A (Week 0 to Week 16)|Death|0|||
48499073|NCT02906709|156022429|FG001|Phase A (Week 0 to Week 16)|Death|1|||
48499074|NCT02906709|156022428|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
48499075|NCT02906709|156022429|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
48499076|NCT02906709|156022428|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
48499077|NCT02906709|156022429|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
48499078|NCT01860976|156022430|FG000|Blinded Treatment|Adverse Event|1|||
48499079|NCT01860976|156022431|FG001|Blinded Treatment|Adverse Event|3|||
48499080|NCT01860976|156022430|FG000|Blinded Treatment|Lack of Efficacy|5|||
48499081|NCT01860976|156022431|FG001|Blinded Treatment|Lack of Efficacy|12|||
48499082|NCT01860976|156022430|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
48499083|NCT01860976|156022431|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
48499084|NCT01860976|156022430|FG000|Blinded Treatment|Withdrawal by Subject|3|||
48499085|NCT01860976|156022431|FG001|Blinded Treatment|Withdrawal by Subject|5|||
48499086|NCT01860976|156022430|FG000|Blinded Treatment|Subject no longer met criteria|1|||
48499087|NCT01860976|156022431|FG001|Blinded Treatment|Subject no longer met criteria|0|||
48499088|NCT01860976|156022430|FG000|Blinded Treatment|Entered Open-Label in error|0|||
48499089|NCT01860976|156022431|FG001|Blinded Treatment|Entered Open-Label in error|1|||
48499090|NCT01860976|156022430|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
48499091|NCT01860976|156022431|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
48499092|NCT01860976|156022430|FG000|Open-Label|Adverse Event|2|||
48499093|NCT01860976|156022431|FG001|Open-Label|Adverse Event|4|||
48499094|NCT01860976|156022430|FG000|Open-Label|Lack of Efficacy|16|||
48499095|NCT01860976|156022431|FG001|Open-Label|Lack of Efficacy|8|||
48499096|NCT01860976|156022430|FG000|Open-Label|Lost to Follow-up|1|||
48499097|NCT01860976|156022431|FG001|Open-Label|Lost to Follow-up|2|||
48499098|NCT01860976|156022430|FG000|Open-Label|Subject request discontinue treatment|4|||
48499099|NCT01860976|156022431|FG001|Open-Label|Subject request discontinue treatment|3|||
48499100|NCT01860976|156022430|FG000|Open-Label|Withdrawal by Subject|4|||
48499101|NCT01860976|156022431|FG001|Open-Label|Withdrawal by Subject|1|||
48499102|NCT01860976|156022430|FG000|Open-Label|Other Reasons|1|||
48499103|NCT01860976|156022431|FG001|Open-Label|Other Reasons|1|||
48499104|NCT01860976|156022430|FG000|Long Term Extension|Adverse Event|4|||
48499105|NCT01860976|156022431|FG001|Long Term Extension|Adverse Event|0|||
48499106|NCT01860976|156022430|FG000|Long Term Extension|Lack of Efficacy|2|||
48499107|NCT01860976|156022431|FG001|Long Term Extension|Lack of Efficacy|0|||
48499108|NCT01860976|156022430|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
48499109|NCT01860976|156022431|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
48599213|NCT00784719|156387996|FG002|Overall Study|Other|1|||
48599214|NCT00784719|156387997|FG003|Overall Study|Other|0|||
48599215|NCT00784719|156387998|FG004|Overall Study|Other|2|||
48499110|NCT01860976|156022430|FG000|Long Term Extension|Lost to Follow-up|2|||
48499111|NCT01860976|156022431|FG001|Long Term Extension|Lost to Follow-up|0|||
48499112|NCT01860976|156022430|FG000|Long Term Extension|subject withdrew consent|7|||
48499113|NCT01860976|156022431|FG001|Long Term Extension|subject withdrew consent|0|||
48499114|NCT02227862|156022432|FG000|Overall Study|Protocol Violation|7|||
48499115|NCT02227862|156022433|FG001|Overall Study|Protocol Violation|9|||
48499116|NCT02227862|156022432|FG000|Overall Study|Other|0|||
48499117|NCT02227862|156022433|FG001|Overall Study|Other|2|||
48499118|NCT02227862|156022432|FG000|Overall Study|Adverse Event|4|||
48499119|NCT02227862|156022433|FG001|Overall Study|Adverse Event|3|||
48499120|NCT02227862|156022432|FG000|Overall Study|Withdrawal by Subject|7|||
48499121|NCT02227862|156022433|FG001|Overall Study|Withdrawal by Subject|6|||
48499122|NCT02227862|156022432|FG000|Overall Study|Lost to Follow-up|1|||
48499123|NCT02227862|156022433|FG001|Overall Study|Lost to Follow-up|2|||
48499124|NCT00755326|156022434|FG000|Overall Study|Lost to Follow-up|2|||
48499125|NCT00755326|156022435|FG001|Overall Study|Lost to Follow-up|3|||
48499126|NCT02402166|156022443|FG000|Overall Study|Adverse Event|2|||
48499127|NCT02402166|156022443|FG000|Overall Study|Withdrawal by Subject|2|||
48499128|NCT02402166|156022443|FG000|Overall Study|Lost to Follow-up|1|||
48499129|NCT01439165|156022444|FG000|Overall Study|Protocol Violation|3|||
48499130|NCT01439165|156022445|FG001|Overall Study|Protocol Violation|0|||
48499131|NCT01439165|156022444|FG000|Overall Study|Lost to Follow-up|11|||
48499132|NCT01439165|156022445|FG001|Overall Study|Lost to Follow-up|1|||
48499133|NCT01439165|156022444|FG000|Overall Study|Withdrawal by Subject|7|||
48499134|NCT01439165|156022445|FG001|Overall Study|Withdrawal by Subject|1|||
48499135|NCT02428699|156022451|FG000|Washout Period 1|Screen Failure|1|||
48499136|NCT02428699|156022452|FG001|Washout Period 1|Screen Failure|2|||
48499137|NCT00728949|156022453|FG000|Overall Study|Adverse Event|8|||
48499138|NCT00728949|156022454|FG001|Overall Study|Adverse Event|0|||
48499139|NCT00728949|156022453|FG000|Overall Study|Withdrawal by Subject|2|||
48499140|NCT00728949|156022454|FG001|Overall Study|Withdrawal by Subject|2|||
48499141|NCT00728949|156022453|FG000|Overall Study|Abnormal Lab Results|0|||
48499142|NCT00728949|156022454|FG001|Overall Study|Abnormal Lab Results|2|||
48499143|NCT00728949|156022453|FG000|Overall Study|On treatment at cutoff date|1|||
48499144|NCT00728949|156022454|FG001|Overall Study|On treatment at cutoff date|0|||
48499145|NCT01996033|156022455|FG000|Overall Study|Death|1|||
48499146|NCT01996033|156022455|FG000|Overall Study|Physician Decision|1|||
48499147|NCT01996033|156022455|FG000|Overall Study|Withdrawal by Subject|4|||
48499148|NCT01996033|156022455|FG000|Overall Study|Lost to Follow-up|3|||
48499149|NCT01506947|156022456|FG000|Overall Study|Lost to Follow-up|7|||
48499150|NCT01506947|156022456|FG000|Overall Study|Adverse Event|5|||
48499151|NCT01506947|156022456|FG000|Overall Study|Death|1|||
48499152|NCT01506947|156022456|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
48499153|NCT03583606|156022457|FG000|Overall Study|Lost to Follow-up|0|||
48499154|NCT03583606|156022458|FG001|Overall Study|Lost to Follow-up|1|||
48499155|NCT03583606|156022459|FG002|Overall Study|Lost to Follow-up|0|||
48499156|NCT03583606|156022457|FG000|Overall Study|Ineligible at baseline|1|||
48499157|NCT03583606|156022458|FG001|Overall Study|Ineligible at baseline|0|||
48499158|NCT03583606|156022459|FG002|Overall Study|Ineligible at baseline|0|||
48499159|NCT02143102|156022463|FG000|Overall Study|Lost to Follow-up|11|||
48499160|NCT02143102|156022464|FG001|Overall Study|Lost to Follow-up|0|||
48499161|NCT02674334|156022466|FG000|Overall Study|Lost to Follow-up|5|||
48499162|NCT02674334|156022467|FG001|Overall Study|Lost to Follow-up|3|||
48499163|NCT02674334|156022466|FG000|Overall Study|participant difficulty breathing|1|||
48499164|NCT02674334|156022467|FG001|Overall Study|participant difficulty breathing|0|||
48499165|NCT02674334|156022466|FG000|Overall Study|NIRS not recording|1|||
48499166|NCT02674334|156022467|FG001|Overall Study|NIRS not recording|0|||
48499167|NCT01432171|156022468|FG000|Overall Study|Death|1|||
48499168|NCT01432171|156022469|FG001|Overall Study|Death|2|||
48499169|NCT01432171|156022468|FG000|Overall Study|Lost to Follow-up|6|||
48499170|NCT01432171|156022469|FG001|Overall Study|Lost to Follow-up|5|||
48499171|NCT01432171|156022468|FG000|Overall Study|Withdrawal by Subject|3|||
48499172|NCT01432171|156022469|FG001|Overall Study|Withdrawal by Subject|1|||
48499173|NCT01432171|156022468|FG000|Overall Study|Noncompliance|2|||
48499174|NCT01432171|156022469|FG001|Overall Study|Noncompliance|3|||
48499175|NCT01432171|156022468|FG000|Overall Study|Insurance denial trial coverage|1|||
48499176|NCT01432171|156022469|FG001|Overall Study|Insurance denial trial coverage|0|||
48499177|NCT01432171|156022468|FG000|Overall Study|Patient moved to palliative care|1|||
48499178|NCT01432171|156022469|FG001|Overall Study|Patient moved to palliative care|0|||
48499179|NCT01939197|156022472|FG000|Overall Study|Withdrawal by Subject|1|||
48499180|NCT01939197|156022473|FG001|Overall Study|Withdrawal by Subject|0|||
48499181|NCT01939197|156022474|FG002|Overall Study|Withdrawal by Subject|0|||
48499182|NCT01939197|156022475|FG003|Overall Study|Withdrawal by Subject|0|||
48499183|NCT01939197|156022476|FG004|Overall Study|Withdrawal by Subject|1|||
48499184|NCT01939197|156022477|FG005|Overall Study|Withdrawal by Subject|0|||
48499185|NCT01939197|156022478|FG006|Overall Study|Withdrawal by Subject|0|||
48599216|NCT00784719|156387999|FG005|Overall Study|Other|1|||
48499186|NCT01939197|156022472|FG000|Overall Study|Lost to Follow-up|0|||
48499187|NCT01939197|156022473|FG001|Overall Study|Lost to Follow-up|1|||
48499188|NCT01939197|156022474|FG002|Overall Study|Lost to Follow-up|0|||
48499189|NCT01939197|156022475|FG003|Overall Study|Lost to Follow-up|1|||
48499190|NCT01939197|156022476|FG004|Overall Study|Lost to Follow-up|3|||
48499191|NCT01939197|156022477|FG005|Overall Study|Lost to Follow-up|1|||
48499192|NCT01939197|156022478|FG006|Overall Study|Lost to Follow-up|2|||
48499193|NCT02660242|156022482|FG000|Glucose Tabs|Lost to Follow-up|1|||
48718711|NCT04604132|156818466|FG004|Overall Study|Study terminated by sponsor|1|||
48718712|NCT04604132|156818462|FG000|Overall Study|Progressive disease: Clinical progression|0|||
48718713|NCT04604132|156818463|FG001|Overall Study|Progressive disease: Clinical progression|0|||
48718714|NCT04604132|156818464|FG002|Overall Study|Progressive disease: Clinical progression|1|||
48718715|NCT04604132|156818465|FG003|Overall Study|Progressive disease: Clinical progression|0|||
48718716|NCT04604132|156818466|FG004|Overall Study|Progressive disease: Clinical progression|0|||
48718717|NCT04604132|156818462|FG000|Overall Study|Progressive disease: Radiological progression|8|||
48718718|NCT04604132|156818463|FG001|Overall Study|Progressive disease: Radiological progression|7|||
48718719|NCT04604132|156818464|FG002|Overall Study|Progressive disease: Radiological progression|10|||
48718720|NCT04604132|156818465|FG003|Overall Study|Progressive disease: Radiological progression|4|||
48718721|NCT04604132|156818466|FG004|Overall Study|Progressive disease: Radiological progression|3|||
48718722|NCT04604132|156818462|FG000|Overall Study|Death|3|||
48718723|NCT04604132|156818463|FG001|Overall Study|Death|1|||
48718724|NCT04604132|156818464|FG002|Overall Study|Death|2|||
48718725|NCT04604132|156818465|FG003|Overall Study|Death|1|||
48718726|NCT04604132|156818466|FG004|Overall Study|Death|0|||
48718727|NCT00952380|156818467|FG000|Overall Study|Other|0|||
48718728|NCT00952380|156818468|FG001|Overall Study|Other|0|||
48718729|NCT00952380|156818469|FG002|Overall Study|Other|0|||
48718730|NCT00952380|156818470|FG003|Overall Study|Other|0|||
48499194|NCT02660242|156022482|FG000|Glucagon Injection|Lost to Follow-up|1|||
48499195|NCT00623779|156022487|FG000|Overall Study|Adverse Event|1|||
48499196|NCT00623779|156022488|FG001|Overall Study|Adverse Event|3|||
48499197|NCT00623779|156022489|FG002|Overall Study|Adverse Event|0|||
48499198|NCT00623779|156022487|FG000|Overall Study|Criteria from CSR|2|||
48718731|NCT00952380|156818471|FG004|Overall Study|Other|1|||
48718732|NCT00952380|156818467|FG000|Overall Study|Withdrawal by Subject|0|||
48718733|NCT00952380|156818468|FG001|Overall Study|Withdrawal by Subject|0|||
48718734|NCT00952380|156818469|FG002|Overall Study|Withdrawal by Subject|1|||
48718735|NCT00952380|156818470|FG003|Overall Study|Withdrawal by Subject|0|||
48718736|NCT00952380|156818471|FG004|Overall Study|Withdrawal by Subject|2|||
48718737|NCT00952380|156818467|FG000|Overall Study|Adverse Event|0|||
48718738|NCT00952380|156818468|FG001|Overall Study|Adverse Event|1|||
48718739|NCT00952380|156818469|FG002|Overall Study|Adverse Event|0|||
48718740|NCT00952380|156818470|FG003|Overall Study|Adverse Event|0|||
48718741|NCT00952380|156818471|FG004|Overall Study|Adverse Event|3|||
48718742|NCT00952380|156818467|FG000|Overall Study|Physician Decision|0|||
48718743|NCT00952380|156818468|FG001|Overall Study|Physician Decision|0|||
48718744|NCT00952380|156818469|FG002|Overall Study|Physician Decision|1|||
48718745|NCT00952380|156818470|FG003|Overall Study|Physician Decision|2|||
48718746|NCT00952380|156818471|FG004|Overall Study|Physician Decision|0|||
48718747|NCT00952380|156818467|FG000|Overall Study|Non-compliant to protocol|0|||
48718748|NCT00952380|156818468|FG001|Overall Study|Non-compliant to protocol|0|||
48718749|NCT00952380|156818469|FG002|Overall Study|Non-compliant to protocol|0|||
48718750|NCT00952380|156818470|FG003|Overall Study|Non-compliant to protocol|1|||
48718751|NCT00952380|156818471|FG004|Overall Study|Non-compliant to protocol|0|||
48718752|NCT00510653|156818477|FG000|Overall Study|Withdrawal by Subject|8|||
48718753|NCT00510653|156818477|FG000|Overall Study|Monetary|3|||
48718754|NCT01075191|156818478|FG000|Overall Study|Death|1|||
48718755|NCT01075191|156818478|FG000|Overall Study|Intensification|3|||
48718756|NCT01075191|156818478|FG000|Overall Study|Co-morbidities|1|||
48815071|NCT05886777|157163665|FG000|Overall Study|No longer met eligibility criteria|0|||
48815072|NCT05886777|157163666|FG001|Overall Study|No longer met eligibility criteria|1|||
48815073|NCT05886777|157163667|FG002|Overall Study|No longer met eligibility criteria|0|||
48499199|NCT00623779|156022488|FG001|Overall Study|Criteria from CSR|0|||
48499200|NCT00623779|156022489|FG002|Overall Study|Criteria from CSR|1|||
48499201|NCT03661528|156022490|FG000|Overall Study|Death|1|||
48718757|NCT01075191|156818478|FG000|Overall Study|Adverse Event|4|||
48499202|NCT03661528|156022491|FG001|Overall Study|Death|0|||
48499203|NCT03661528|156022490|FG000|Overall Study|Physician Decision|3|||
48499204|NCT03661528|156022491|FG001|Overall Study|Physician Decision|1|||
48499205|NCT03661528|156022490|FG000|Overall Study|Other than Specified|5|||
48499206|NCT03661528|156022491|FG001|Overall Study|Other than Specified|2|||
48499207|NCT03661528|156022490|FG000|Overall Study|Withdrawal by Subject|5|||
48499208|NCT03661528|156022491|FG001|Overall Study|Withdrawal by Subject|3|||
48499209|NCT03661528|156022490|FG000|Overall Study|Disease Progression|8|||
48499210|NCT03661528|156022491|FG001|Overall Study|Disease Progression|13|||
48499211|NCT03661528|156022490|FG000|Overall Study|Adverse Event|61|||
48499212|NCT03661528|156022491|FG001|Overall Study|Adverse Event|55|||
48499213|NCT00796822|156022492|FG000|Overall Study|Lost to Follow-up|2|||
48499214|NCT00796822|156022493|FG001|Overall Study|Lost to Follow-up|0|||
48499215|NCT00796822|156022492|FG000|Overall Study|Adverse Event|1|||
48499216|NCT00796822|156022493|FG001|Overall Study|Adverse Event|0|||
48499217|NCT01941030|156022496|FG000|Overall Study|Death|3|||
48499218|NCT01941030|156022497|FG001|Overall Study|Death|2|||
48499219|NCT01941030|156022496|FG000|Overall Study|Lost to Follow-up|6|||
48499220|NCT01941030|156022497|FG001|Overall Study|Lost to Follow-up|5|||
48499221|NCT01941030|156022496|FG000|Overall Study|Withdrawal by Subject|4|||
48599217|NCT00784719|156388000|FG006|Overall Study|Other|3|||
48599218|NCT00784719|156387994|FG000|Overall Study|Withdrawal by Subject|1|||
48599219|NCT00784719|156387995|FG001|Overall Study|Withdrawal by Subject|0|||
48599220|NCT00784719|156387996|FG002|Overall Study|Withdrawal by Subject|0|||
48599221|NCT00784719|156387997|FG003|Overall Study|Withdrawal by Subject|0|||
48599222|NCT00784719|156387998|FG004|Overall Study|Withdrawal by Subject|2|||
48599223|NCT00784719|156387999|FG005|Overall Study|Withdrawal by Subject|0|||
48599224|NCT00784719|156388000|FG006|Overall Study|Withdrawal by Subject|1|||
48599225|NCT04157088|156388001|FG000|Overall Study|Study terminated by sponsor|23|||
48599226|NCT04157088|156388001|FG000|Overall Study|Withdrawal by Subject|4|||
48599227|NCT04157088|156388001|FG000|Overall Study|Lost to Follow-up|2|||
48718758|NCT01075191|156818478|FG000|Overall Study|Noncompliance|3|||
48718759|NCT01075191|156818478|FG000|Overall Study|Therapy Break|3|||
48718760|NCT01075191|156818478|FG000|Overall Study|Patient's Wish|2|||
48718761|NCT01075191|156818478|FG000|Overall Study|Unknown Reasons|1|||
48718762|NCT00436501|156818479|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
48718763|NCT00436501|156818480|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
48718764|NCT00436501|156818479|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
48718765|NCT00436501|156818480|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
48718766|NCT00495040|156818482|FG000|Overall Study|Withdrawal by Subject|3|||
48718767|NCT01892384|156818486|FG000|Overall Study|Withdrawal by Subject|1|||
48718768|NCT01892384|156818487|FG001|Overall Study|Withdrawal by Subject|1|||
48718769|NCT01892384|156818488|FG002|Overall Study|Withdrawal by Subject|0|||
48718770|NCT01892384|156818489|FG003|Overall Study|Withdrawal by Subject|0|||
48718771|NCT02518464|156818490|FG000|Overall Study|Adverse Event|2|||
48718772|NCT01829243|156818491|FG000|First Intervention|Screen Failure|4|||
48718773|NCT01829243|156818492|FG001|First Intervention|Screen Failure|2|||
48599228|NCT04157088|156388001|FG000|Overall Study|Death|1|||
48718774|NCT00608569|156818493|FG000|Overall Study|Death|4|||
48718775|NCT00608569|156818494|FG001|Overall Study|Death|3|||
48718776|NCT00608569|156818493|FG000|Overall Study|Lost to Follow-up|4|||
48718777|NCT00608569|156818494|FG001|Overall Study|Lost to Follow-up|5|||
48718778|NCT00608569|156818493|FG000|Overall Study|Withdrawal by Subject|1|||
48718779|NCT00608569|156818494|FG001|Overall Study|Withdrawal by Subject|0|||
48718780|NCT00608569|156818493|FG000|Overall Study|Adverse Event|1|||
48718781|NCT00608569|156818494|FG001|Overall Study|Adverse Event|0|||
48499222|NCT01941030|156022497|FG001|Overall Study|Withdrawal by Subject|6|||
48499223|NCT04646109|156022498|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
48499224|NCT04646109|156022499|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
48499225|NCT01001208|156022500|FG000|Overall Study|Adverse Event|10|||
48499226|NCT01001208|156022501|FG001|Overall Study|Adverse Event|5|||
48499227|NCT01001208|156022500|FG000|Overall Study|Lost to Follow-up|5|||
48499228|NCT01001208|156022501|FG001|Overall Study|Lost to Follow-up|9|||
48499229|NCT01001208|156022500|FG000|Overall Study|Physician Decision|1|||
48499230|NCT01001208|156022501|FG001|Overall Study|Physician Decision|0|||
48499231|NCT01001208|156022500|FG000|Overall Study|Withdrawal by Subject|4|||
48718782|NCT00608569|156818493|FG000|Overall Study|Unable to adhere with study requirements|0|||
48718783|NCT00608569|156818494|FG001|Overall Study|Unable to adhere with study requirements|1|||
48718784|NCT00053898|156818495|FG000|Overall Study|No follow-up data from any source|9|||
48718785|NCT00053898|156818496|FG001|Overall Study|No follow-up data from any source|12|||
48718786|NCT00053898|156818495|FG000|Overall Study|Follow-up from telephone contact only|5|||
48718787|NCT00053898|156818496|FG001|Overall Study|Follow-up from telephone contact only|1|||
48718788|NCT00906971|156818499|FG000|Overall Study|Withdrawal by Subject|8|||
48718789|NCT00906971|156818500|FG001|Overall Study|Withdrawal by Subject|2|||
48718790|NCT00906971|156818499|FG000|Overall Study|Lost to Follow-up|0|||
48718791|NCT00906971|156818500|FG001|Overall Study|Lost to Follow-up|1|||
48499232|NCT01001208|156022501|FG001|Overall Study|Withdrawal by Subject|5|||
48718792|NCT00821509|156818501|FG000|Overall Study|Withdrawal by Subject|12|||
48718793|NCT00821509|156818502|FG001|Overall Study|Withdrawal by Subject|11|||
48718794|NCT00821509|156818503|FG002|Overall Study|Withdrawal by Subject|34|||
48718795|NCT03678870|156818504|FG000|Overall Study|prescribed non- protocol medications|10|||
48718796|NCT03678870|156818505|FG001|Overall Study|prescribed non- protocol medications|6|||
48718797|NCT03678870|156818504|FG000|Overall Study|Lost to Follow-up|3|||
48718798|NCT03678870|156818505|FG001|Overall Study|Lost to Follow-up|2|||
48718799|NCT03104816|156818507|FG000|Overall Study|Lack of Efficacy|0|||
48718800|NCT03104816|156818508|FG001|Overall Study|Lack of Efficacy|2|||
48718801|NCT03104816|156818509|FG002|Overall Study|Lack of Efficacy|0|||
48718802|NCT03104816|156818507|FG000|Overall Study|Protocol Violation|2|||
48718803|NCT03104816|156818508|FG001|Overall Study|Protocol Violation|0|||
48499233|NCT01001208|156022500|FG000|Overall Study|Ineligibility Determined|4|||
48718804|NCT03104816|156818509|FG002|Overall Study|Protocol Violation|2|||
48718805|NCT00807573|156818514|FG000|Overall Study|Withdrawal by Subject|1|||
48599229|NCT01951417|156388002|FG000|Overall Study|Withdrawal by Subject|1|||
48599230|NCT01951417|156388002|FG000|Overall Study|Protocol Violation|2|||
48599231|NCT01951417|156388002|FG000|Overall Study|Lost to Follow-up|6|||
48599232|NCT04010461|156388003|FG000|Overall Study|COVID based withdrawal|5|||
48718806|NCT00807573|156818514|FG000|Overall Study|Adverse Event|1|||
48718807|NCT04054947|156818515|FG000|Overall Study|Withdrawal by Subject|1|||
48718808|NCT04054947|156818516|FG001|Overall Study|Withdrawal by Subject|0|||
48718809|NCT04054947|156818515|FG000|Overall Study|Lost to Follow-up|2|||
48718810|NCT04054947|156818516|FG001|Overall Study|Lost to Follow-up|5|||
48718811|NCT03353740|156818521|FG000|Overall Study|Images for these participants not viable|52|||
48718812|NCT01888432|156821211|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
48718813|NCT01888432|156821212|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
48718814|NCT01888432|156821211|FG000|12-month Analysis (FAS)|Physician Decision|1|||
48718815|NCT01888432|156821212|FG001|12-month Analysis (FAS)|Physician Decision|1|||
48718816|NCT01888432|156821211|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
48718817|NCT01888432|156821212|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
48718818|NCT01888432|156821211|FG000|12-month Analysis (FAS)|Death|4|||
48718819|NCT01888432|156821212|FG001|12-month Analysis (FAS)|Death|3|||
48718820|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Graft loss|0|||
48718821|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Graft loss|1|||
48718822|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
48718823|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
48718824|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Physician Decision|2|||
48718825|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Physician Decision|4|||
48718826|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
48718827|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
48718828|NCT01888432|156821211|FG000|24-month Analysis (FAS)|Death|8|||
48718829|NCT01888432|156821212|FG001|24-month Analysis (FAS)|Death|4|||
48718830|NCT01888432|156821211|FG000|36-month Analysis (Extension)|Death|1|||
48718831|NCT01888432|156821212|FG001|36-month Analysis (Extension)|Death|0|||
48718832|NCT00336856|156821214|FG000|Overall Study|Withdrawal by Subject|3|||
48718833|NCT00336856|156821214|FG000|Overall Study|Found ineligible at time of analysis|1|||
48718834|NCT02043899|156821215|FG000|Overall Study|Adverse Event|3|||
48718835|NCT02043899|156821215|FG000|Overall Study|Physician Decision|1|||
48718836|NCT02043899|156821215|FG000|Overall Study|Withdrawal by Subject|2|||
48718837|NCT02043899|156821215|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
48718838|NCT02043899|156821215|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
48718839|NCT02043899|156821215|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
48718840|NCT02043899|156821215|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
48718841|NCT02043899|156821215|FG000|Overall Study|Treatment delayed|1|||
48718842|NCT01954927|156821217|FG000|Overall Study|Withdrawal by Subject|3|||
48718843|NCT01954927|156821218|FG001|Overall Study|Withdrawal by Subject|1|||
48718844|NCT03320824|156821219|FG000|Overall Study|Withdrawal by Subject|8|||
48718845|NCT03320824|156821220|FG001|Overall Study|Withdrawal by Subject|1|||
48718846|NCT03320824|156821219|FG000|Overall Study|Lost to Follow-up|10|||
48718847|NCT03320824|156821220|FG001|Overall Study|Lost to Follow-up|1|||
48718848|NCT03320824|156821219|FG000|Overall Study|moved out of state|0|||
48718849|NCT03320824|156821220|FG001|Overall Study|moved out of state|1|||
48718850|NCT03320824|156821219|FG000|Overall Study|could not complete final visit|0|||
48718851|NCT03320824|156821220|FG001|Overall Study|could not complete final visit|1|||
48718852|NCT00955305|156821221|FG000|Overall Study|Disease progression|39|||
48718853|NCT00955305|156821222|FG001|Overall Study|Disease progression|41|||
48815074|NCT05886777|157163668|FG003|Overall Study|No longer met eligibility criteria|0|||
48815075|NCT05886777|157163669|FG004|Overall Study|No longer met eligibility criteria|0|||
48815076|NCT05886777|157163670|FG005|Overall Study|No longer met eligibility criteria|0|||
48815077|NCT05886777|157163671|FG006|Overall Study|No longer met eligibility criteria|0|||
48815078|NCT01591460|157165680|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
48815079|NCT01591460|157165680|FG000|Overall Study|Futility Rule (Week 12)|7|||
48815080|NCT01591460|157165680|FG000|Overall Study|Futility Rule (Week 24)|3|||
48815081|NCT01591460|157165680|FG000|Overall Study|Rebound or Breakthrough|3|||
48815082|NCT01591460|157165680|FG000|Overall Study|Treatment Discontinued by Error|1|||
48815083|NCT01591460|157165680|FG000|Overall Study|Lost to Follow-up|1|||
48499234|NCT01001208|156022501|FG001|Overall Study|Ineligibility Determined|2|||
48499235|NCT01001208|156022500|FG000|Overall Study|Noncompliance|4|||
48499236|NCT01001208|156022501|FG001|Overall Study|Noncompliance|7|||
48499237|NCT01001208|156022500|FG000|Overall Study|Disease Progression|0|||
48499238|NCT01001208|156022501|FG001|Overall Study|Disease Progression|3|||
48499239|NCT01001208|156022500|FG000|Overall Study|Other|0|||
48499240|NCT01001208|156022501|FG001|Overall Study|Other|2|||
48499241|NCT01417078|156022505|FG000|Overall Study|Withdrawal by Subject|1|||
48499242|NCT01469546|156022512|FG000|Received 5 mg Dose|Adverse Event|13|||
48499243|NCT01469546|156022512|FG000|Received 5 mg Dose|Death|2|||
48499244|NCT01469546|156022512|FG000|Received 5 mg Dose|Protocol Violation|2|||
48499245|NCT01469546|156022512|FG000|Received 5 mg Dose|Progressive Disease|3|||
48499246|NCT01469546|156022512|FG000|Received 5 mg Dose|Physician Decision|3|||
48499247|NCT00094302|156024317|FG000|Overall Study|Lost to Follow-up|43|||
48499248|NCT00094302|156024318|FG001|Overall Study|Lost to Follow-up|41|||
48499249|NCT00094302|156024317|FG000|Overall Study|Physician Decision|5|||
48718854|NCT00955305|156821221|FG000|Overall Study|Adverse Event|22|||
48718855|NCT00955305|156821222|FG001|Overall Study|Adverse Event|22|||
48718856|NCT00955305|156821221|FG000|Overall Study|Death|2|||
48718857|NCT00955305|156821222|FG001|Overall Study|Death|1|||
48718858|NCT00955305|156821221|FG000|Overall Study|Withdrawal by Subject|5|||
48718859|NCT00955305|156821222|FG001|Overall Study|Withdrawal by Subject|4|||
48718860|NCT00955305|156821221|FG000|Overall Study|Alternative therapy|4|||
48718861|NCT00955305|156821222|FG001|Overall Study|Alternative therapy|0|||
48718862|NCT00955305|156821221|FG000|Overall Study|Other complicating disease|2|||
48718863|NCT00955305|156821222|FG001|Overall Study|Other complicating disease|4|||
48718864|NCT00955305|156821221|FG000|Overall Study|Physician Decision|1|||
48718865|NCT00955305|156821222|FG001|Overall Study|Physician Decision|0|||
48718866|NCT00955305|156821221|FG000|Overall Study|Continued presence of residual disease|0|||
48718867|NCT00955305|156821222|FG001|Overall Study|Continued presence of residual disease|1|||
48718868|NCT00955305|156821221|FG000|Overall Study|Functional decline|2|||
48718869|NCT00955305|156821222|FG001|Overall Study|Functional decline|0|||
48718870|NCT00955305|156821221|FG000|Overall Study|Maximum response achieved|0|||
48718871|NCT00955305|156821222|FG001|Overall Study|Maximum response achieved|1|||
48718872|NCT00955305|156821221|FG000|Overall Study|Lost to Follow-up|0|||
48718873|NCT00955305|156821222|FG001|Overall Study|Lost to Follow-up|1|||
48718874|NCT00955305|156821221|FG000|Overall Study|No off-treatment reason submitted|1|||
48718875|NCT00955305|156821222|FG001|Overall Study|No off-treatment reason submitted|0|||
48718876|NCT00955305|156821221|FG000|Overall Study|Never started protocol treatment|5|||
48718877|NCT00955305|156821222|FG001|Overall Study|Never started protocol treatment|5|||
48718878|NCT00955305|156821221|FG000|Overall Study|Ineligible|5|||
48718879|NCT00955305|156821222|FG001|Overall Study|Ineligible|7|||
48718880|NCT01945710|156821223|FG000|Overall Study|Progressive Disease|5|||
48718881|NCT01945710|156821224|FG001|Overall Study|Progressive Disease|4|||
48718882|NCT01945710|156821225|FG002|Overall Study|Progressive Disease|3|||
48718883|NCT01945710|156821226|FG003|Overall Study|Progressive Disease|2|||
48718884|NCT01945710|156821227|FG004|Overall Study|Progressive Disease|7|||
48718885|NCT01945710|156821228|FG005|Overall Study|Progressive Disease|3|||
48718886|NCT01945710|156821229|FG006|Overall Study|Progressive Disease|19|||
48718887|NCT01945710|156821223|FG000|Overall Study|Adverse Event|0|||
48718888|NCT01945710|156821224|FG001|Overall Study|Adverse Event|1|||
48718889|NCT01945710|156821225|FG002|Overall Study|Adverse Event|0|||
48718890|NCT01945710|156821226|FG003|Overall Study|Adverse Event|0|||
48718891|NCT01945710|156821227|FG004|Overall Study|Adverse Event|0|||
48718892|NCT01945710|156821228|FG005|Overall Study|Adverse Event|0|||
48718893|NCT01945710|156821229|FG006|Overall Study|Adverse Event|0|||
48718894|NCT01945710|156821223|FG000|Overall Study|Other|2|||
48718895|NCT01945710|156821224|FG001|Overall Study|Other|0|||
48718896|NCT01945710|156821225|FG002|Overall Study|Other|3|||
48718897|NCT01945710|156821226|FG003|Overall Study|Other|1|||
48718898|NCT01945710|156821227|FG004|Overall Study|Other|1|||
48718899|NCT01945710|156821228|FG005|Overall Study|Other|0|||
48718900|NCT01945710|156821229|FG006|Overall Study|Other|4|||
48718901|NCT01945710|156821223|FG000|Overall Study|Withdrawal by Subject|0|||
48815084|NCT01591460|157165680|FG000|Overall Study|Noncompliance|1|||
48815085|NCT01591460|157165680|FG000|Overall Study|Participant Refusal|3|||
48815086|NCT01591460|157165680|FG000|Overall Study|Withdrawal by Subject|1|||
48815087|NCT01591460|157165680|FG000|Overall Study|Protocol Violation|1|||
48499250|NCT00094302|156024318|FG001|Overall Study|Physician Decision|8|||
48499251|NCT00094302|156024317|FG000|Overall Study|Withdrawal by Subject|103|||
48499252|NCT00094302|156024318|FG001|Overall Study|Withdrawal by Subject|111|||
48499253|NCT00094302|156024317|FG000|Overall Study|Death|266|||
48499254|NCT00094302|156024318|FG001|Overall Study|Death|246|||
48499255|NCT01941095|156024321|FG000|Overall Study|Insufficient therapeutic response|13|||
48499256|NCT01941095|156024321|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
48499257|NCT01941095|156024321|FG000|Overall Study|Adverse Event|11|||
48718902|NCT01945710|156821224|FG001|Overall Study|Withdrawal by Subject|1|||
48718903|NCT01945710|156821225|FG002|Overall Study|Withdrawal by Subject|1|||
48718904|NCT01945710|156821226|FG003|Overall Study|Withdrawal by Subject|0|||
48718905|NCT01945710|156821227|FG004|Overall Study|Withdrawal by Subject|1|||
48718906|NCT01945710|156821228|FG005|Overall Study|Withdrawal by Subject|0|||
48718907|NCT01945710|156821229|FG006|Overall Study|Withdrawal by Subject|0|||
48718908|NCT03472547|156821230|FG000|Overall Study|Withdrawal by Subject|30|||
48718909|NCT02434471|156821231|FG000|Overall Study|Physician Decision|9|||
48718910|NCT00843778|156821232|FG000|Overall Study|Adverse Event|15|||
48718911|NCT00843778|156821232|FG000|Overall Study|Lack of Efficacy|14|||
48718912|NCT00843778|156821232|FG000|Overall Study|Loss of efficacy|2|||
48718913|NCT00843778|156821232|FG000|Overall Study|Withdrawal by Subject|4|||
48718914|NCT02600871|156821233|FG000|Overall Study|Lost to Follow-up|13|||
48718915|NCT02600871|156821234|FG001|Overall Study|Lost to Follow-up|10|||
48718916|NCT02848729|156821242|FG000|Overall Study|Withdrawal by Subject|1|||
48718917|NCT02848729|156821243|FG001|Overall Study|Withdrawal by Subject|0|||
48815088|NCT02310126|157165681|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
48718918|NCT02848729|156821242|FG000|Overall Study|Emesis|15|||
48718919|NCT02848729|156821243|FG001|Overall Study|Emesis|11|||
48718920|NCT01998984|156821244|FG000|Overall Study|Adverse Event|0|||
48718921|NCT01998984|156821245|FG001|Overall Study|Adverse Event|0|||
48718922|NCT01998984|156821246|FG002|Overall Study|Adverse Event|0|||
48718923|NCT01998984|156821247|FG003|Overall Study|Adverse Event|1|||
48718924|NCT01998984|156821244|FG000|Overall Study|Lost to Follow-up|0|||
48718925|NCT01998984|156821245|FG001|Overall Study|Lost to Follow-up|1|||
48718926|NCT01998984|156821246|FG002|Overall Study|Lost to Follow-up|0|||
48718927|NCT01998984|156821247|FG003|Overall Study|Lost to Follow-up|1|||
48718928|NCT01998984|156821244|FG000|Overall Study|Withdrawal by Subject|0|||
48718929|NCT01998984|156821245|FG001|Overall Study|Withdrawal by Subject|0|||
48718930|NCT01998984|156821246|FG002|Overall Study|Withdrawal by Subject|1|||
48718931|NCT01998984|156821247|FG003|Overall Study|Withdrawal by Subject|0|||
48718932|NCT01998984|156821244|FG000|Overall Study|Other|0|||
48718933|NCT01998984|156821245|FG001|Overall Study|Other|0|||
48718934|NCT01998984|156821246|FG002|Overall Study|Other|0|||
48718935|NCT01998984|156821247|FG003|Overall Study|Other|1|||
48718936|NCT04966910|156821248|FG000|Baseline|Participant did not complete measure|0|||
48718937|NCT04966910|156821249|FG001|Baseline|Participant did not complete measure|0|||
48718938|NCT04966910|156821250|FG002|Baseline|Participant did not complete measure|1|||
48718939|NCT04966910|156821251|FG003|Baseline|Participant did not complete measure|0|||
48718940|NCT04966910|156821248|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
48718941|NCT04966910|156821249|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
48718942|NCT04966910|156821250|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
48718943|NCT04966910|156821251|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
48718944|NCT04966910|156821248|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
48718945|NCT04966910|156821249|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
48718946|NCT04966910|156821250|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
48718947|NCT04966910|156821251|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
48718948|NCT04966910|156821248|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
48718949|NCT04966910|156821249|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
48718950|NCT04966910|156821250|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
48718951|NCT04966910|156821251|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
48718952|NCT02617485|156821253|FG000|Treatment and Observation Period|Adverse Event|9|||
48718953|NCT02617485|156821254|FG001|Treatment and Observation Period|Adverse Event|1|||
48718954|NCT02617485|156821253|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
48718955|NCT02617485|156821254|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
48718956|NCT02617485|156821253|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
48718957|NCT02617485|156821254|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
48718958|NCT02617485|156821253|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
48718959|NCT02617485|156821254|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
48718960|NCT02617485|156821253|FG000|Treatment and Observation Period|Physician Decision|0|||
48718961|NCT02617485|156821254|FG001|Treatment and Observation Period|Physician Decision|1|||
48718962|NCT02617485|156821253|FG000|Follow-up Period|Adverse Event|1|||
48718963|NCT02617485|156821254|FG001|Follow-up Period|Adverse Event|0|||
48718964|NCT02617485|156821253|FG000|Follow-up Period|Withdrawal by Subject|1|||
48718965|NCT02617485|156821254|FG001|Follow-up Period|Withdrawal by Subject|0|||
48718966|NCT02617485|156821253|FG000|Follow-up Period|Disease progression|2|||
48718967|NCT02617485|156821254|FG001|Follow-up Period|Disease progression|1|||
48718968|NCT02617485|156821253|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
48718969|NCT02617485|156821254|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
48718970|NCT02617485|156821253|FG000|Follow-up Period|Patient needed radiotherapy|9|||
48718971|NCT02617485|156821254|FG001|Follow-up Period|Patient needed radiotherapy|5|||
48499258|NCT01941095|156024321|FG000|Overall Study|Physician Decision|3|||
48499259|NCT01941095|156024321|FG000|Overall Study|Withdrawal by Subject|17|||
48499260|NCT01941095|156024321|FG000|Overall Study|Lost to Follow-up|10|||
48499261|NCT02532764|156024323|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
48499262|NCT02532764|156024324|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
48499263|NCT02532764|156024325|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
48499264|NCT02532764|156024326|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
48499265|NCT02532764|156024327|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
48499266|NCT02532764|156024328|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
48499267|NCT02532764|156024329|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
48499268|NCT02532764|156024330|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
48499269|NCT02532764|156024331|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
48499270|NCT02532764|156024332|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
48499271|NCT00920140|156024333|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
48499272|NCT00920140|156024334|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
48499273|NCT00920140|156024335|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
48499274|NCT00920140|156024336|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
48599233|NCT04010461|156388003|FG000|Overall Study|Withdrawal by Subject|5|||
48718972|NCT02617485|156821253|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
48815089|NCT02310126|157165682|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
48599234|NCT04010461|156388003|FG000|Overall Study|Adverse Event|1|||
48599235|NCT04010461|156388003|FG000|Overall Study|No Motor Threshold obtainable|1|||
48599236|NCT04010461|156388003|FG000|Overall Study|Physician Decision|1|||
48599237|NCT04058028|156388004|FG000|Overall Study|Withdrawal of Consent from Study|12|||
48599238|NCT04058028|156388005|FG001|Overall Study|Withdrawal of Consent from Study|8|||
48599239|NCT04058028|156388006|FG002|Overall Study|Withdrawal of Consent from Study|6|||
48599240|NCT04058028|156388007|FG003|Overall Study|Withdrawal of Consent from Study|7|||
48599241|NCT04058028|156388004|FG000|Overall Study|Decision by Sponsor|13|||
48599242|NCT04058028|156388005|FG001|Overall Study|Decision by Sponsor|4|||
48599243|NCT04058028|156388006|FG002|Overall Study|Decision by Sponsor|1|||
48599244|NCT04058028|156388007|FG003|Overall Study|Decision by Sponsor|35|||
48599245|NCT04058028|156388004|FG000|Overall Study|Lost to Follow-up|1|||
48599246|NCT04058028|156388005|FG001|Overall Study|Lost to Follow-up|1|||
48599247|NCT04058028|156388006|FG002|Overall Study|Lost to Follow-up|1|||
48599248|NCT04058028|156388007|FG003|Overall Study|Lost to Follow-up|0|||
48718973|NCT02617485|156821254|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
48718974|NCT00409331|156821255|FG000|Overall Study|Physician Decision|1|||
48718975|NCT03680742|156821264|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
48718976|NCT00003472|156821268|FG000|Overall Study|Not evaluable|3|||
48718977|NCT02527200|156821269|FG000|Overall Study|Withdrawal by Subject|3|||
48718978|NCT02527200|156821270|FG001|Overall Study|Withdrawal by Subject|2|||
48718979|NCT02527200|156821271|FG002|Overall Study|Withdrawal by Subject|1|||
48718980|NCT02527200|156821272|FG003|Overall Study|Withdrawal by Subject|0|||
48718981|NCT02527200|156821269|FG000|Overall Study|Unclassified|0|||
48718982|NCT02527200|156821270|FG001|Overall Study|Unclassified|1|||
48718983|NCT02527200|156821271|FG002|Overall Study|Unclassified|0|||
48718984|NCT02527200|156821272|FG003|Overall Study|Unclassified|0|||
48718985|NCT02527200|156821269|FG000|Overall Study|Lost to Follow-up|0|||
48718986|NCT02527200|156821270|FG001|Overall Study|Lost to Follow-up|0|||
48718987|NCT02527200|156821271|FG002|Overall Study|Lost to Follow-up|1|||
48718988|NCT02527200|156821272|FG003|Overall Study|Lost to Follow-up|0|||
48718989|NCT00883688|156821286|FG000|Overall Study|Ineligible|2|||
48718990|NCT01909791|156821289|FG000|Overall Study|Death|9|||
48718991|NCT01909791|156821290|FG001|Overall Study|Death|8|||
48718992|NCT01909791|156821291|FG002|Overall Study|Death|4|||
48815090|NCT02310126|157165681|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
48815091|NCT02310126|157165682|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
48815092|NCT02533258|157165689|FG000|Overall Study|Adverse Event|1|||
48815093|NCT02533258|157165689|FG000|Overall Study|Death|2|||
48599249|NCT04058028|156388004|FG000|Overall Study|Death|0|||
48599250|NCT04058028|156388005|FG001|Overall Study|Death|1|||
48599251|NCT04058028|156388006|FG002|Overall Study|Death|0|||
48599252|NCT04058028|156388007|FG003|Overall Study|Death|0|||
48599253|NCT01598610|156388008|FG000|Overall Study|Adverse Event|1|||
48599254|NCT00571662|156388012|FG000|Overall Study|Withdrawal by Subject|2|||
48599255|NCT00571662|156388012|FG000|Overall Study|psychiatric instability|1|||
48599256|NCT00571662|156388012|FG000|Overall Study|Adverse Event|5|||
48599257|NCT00402727|156388016|FG000|Overall Study|Adverse Event|10|||
48599258|NCT00402727|156388017|FG001|Overall Study|Adverse Event|6|||
48599259|NCT00402727|156388016|FG000|Overall Study|Death|1|||
48599260|NCT00402727|156388017|FG001|Overall Study|Death|0|||
48599261|NCT00402727|156388016|FG000|Overall Study|Lack of Efficacy|1|||
48599262|NCT00402727|156388017|FG001|Overall Study|Lack of Efficacy|3|||
48599263|NCT00402727|156388016|FG000|Overall Study|Lost to Follow-up|24|||
48599264|NCT00402727|156388017|FG001|Overall Study|Lost to Follow-up|11|||
48599265|NCT00402727|156388016|FG000|Overall Study|Physician Decision|1|||
48599266|NCT00402727|156388017|FG001|Overall Study|Physician Decision|1|||
48599267|NCT00402727|156388016|FG000|Overall Study|Protocol Violation|0|||
48599268|NCT00402727|156388017|FG001|Overall Study|Protocol Violation|4|||
48718993|NCT01909791|156821289|FG000|Overall Study|Withdrawal by Subject|5|||
48718994|NCT01909791|156821290|FG001|Overall Study|Withdrawal by Subject|9|||
48718995|NCT01909791|156821291|FG002|Overall Study|Withdrawal by Subject|13|||
48718996|NCT01909791|156821289|FG000|Overall Study|Lost to Follow-up|5|||
48718997|NCT01909791|156821290|FG001|Overall Study|Lost to Follow-up|11|||
48815094|NCT02533258|157165689|FG000|Overall Study|Other|1|||
48815095|NCT02533258|157165689|FG000|Overall Study|Economic factor|1|||
48599269|NCT00402727|156388016|FG000|Overall Study|Withdrawal by Subject|3|||
48599270|NCT00402727|156388017|FG001|Overall Study|Withdrawal by Subject|7|||
48599271|NCT00402727|156388016|FG000|Overall Study|supply problems|2|||
48599272|NCT00402727|156388017|FG001|Overall Study|supply problems|1|||
48599273|NCT00402727|156388016|FG000|Overall Study|non-compliance|0|||
48599274|NCT00402727|156388017|FG001|Overall Study|non-compliance|1|||
48599275|NCT02573259|156388018|FG000|Overall Study|Death|1|||
48599276|NCT02573259|156388019|FG001|Overall Study|Death|6|||
48599277|NCT02573259|156388020|FG002|Overall Study|Death|5|||
48599278|NCT02573259|156388021|FG003|Overall Study|Death|6|||
48599279|NCT02573259|156388022|FG004|Overall Study|Death|9|||
48599280|NCT02573259|156388023|FG005|Overall Study|Death|32|||
48718998|NCT01909791|156821291|FG002|Overall Study|Lost to Follow-up|10|||
48599281|NCT02573259|156388024|FG006|Overall Study|Death|21|||
48599282|NCT02573259|156388018|FG000|Overall Study|Lost to Follow-up|0|||
48599283|NCT02573259|156388019|FG001|Overall Study|Lost to Follow-up|0|||
48599284|NCT02573259|156388020|FG002|Overall Study|Lost to Follow-up|0|||
48599285|NCT02573259|156388021|FG003|Overall Study|Lost to Follow-up|0|||
48599286|NCT02573259|156388022|FG004|Overall Study|Lost to Follow-up|0|||
48599287|NCT02573259|156388023|FG005|Overall Study|Lost to Follow-up|2|||
48718999|NCT01909791|156821289|FG000|Overall Study|Missed Visit|2|||
48719000|NCT01909791|156821290|FG001|Overall Study|Missed Visit|0|||
48719001|NCT01909791|156821291|FG002|Overall Study|Missed Visit|1|||
48719002|NCT02984943|156821294|FG000|Overall Study|Withdrawal by Subject|3|||
48719003|NCT02984943|156821294|FG000|Overall Study|Physician Decision|1|||
48719004|NCT03316911|156821300|FG000|Overall Study|Lost to Follow-up|33|||
48719005|NCT03316911|156821301|FG001|Overall Study|Lost to Follow-up|29|||
48719006|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
48499275|NCT00920140|156024337|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
48499276|NCT00920140|156024333|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
48499277|NCT00920140|156024334|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
48499278|NCT00920140|156024335|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
48499279|NCT00920140|156024336|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
48719007|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
48719008|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
48719009|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
48719010|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
48719011|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
48499280|NCT00920140|156024337|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
48499281|NCT00920140|156024333|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
48499282|NCT00920140|156024334|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
48499283|NCT00920140|156024335|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
48499284|NCT00920140|156024336|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
48815096|NCT02533258|157165689|FG000|Overall Study|Progression of pleural effusion|1|||
48815097|NCT02533258|157165689|FG000|Overall Study|Lack of Efficacy|2|||
48815098|NCT01009047|157165690|FG000|Overall Study|Adverse Event|5|||
48815099|NCT01009047|157165691|FG001|Overall Study|Adverse Event|0|||
48815100|NCT01009047|157165690|FG000|Overall Study|Lost to Follow-up|0|||
48815101|NCT01009047|157165691|FG001|Overall Study|Lost to Follow-up|2|||
48815102|NCT01009047|157165690|FG000|Overall Study|Lack of Efficacy|4|||
48815103|NCT01009047|157165691|FG001|Overall Study|Lack of Efficacy|11|||
48815104|NCT01009047|157165690|FG000|Overall Study|Withdrawal by consent|16|||
48815105|NCT01009047|157165691|FG001|Overall Study|Withdrawal by consent|11|||
48499285|NCT00920140|156024337|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
48499286|NCT00920140|156024333|FG000|Phase 2|Adverse Event|0|||
48499287|NCT00920140|156024334|FG001|Phase 2|Adverse Event|0|||
48499288|NCT00920140|156024335|FG002|Phase 2|Adverse Event|14|||
48499289|NCT00920140|156024336|FG003|Phase 2|Adverse Event|2|||
48499290|NCT00920140|156024337|FG004|Phase 2|Adverse Event|3|||
48499291|NCT00920140|156024333|FG000|Phase 2|Lack of Efficacy|0|||
48499292|NCT00920140|156024334|FG001|Phase 2|Lack of Efficacy|0|||
48499293|NCT00920140|156024335|FG002|Phase 2|Lack of Efficacy|29|||
48499294|NCT00920140|156024336|FG003|Phase 2|Lack of Efficacy|14|||
48499295|NCT00920140|156024337|FG004|Phase 2|Lack of Efficacy|5|||
48499296|NCT00920140|156024333|FG000|Phase 2|Lost to Follow-up|0|||
48499297|NCT00920140|156024334|FG001|Phase 2|Lost to Follow-up|0|||
48499298|NCT00920140|156024335|FG002|Phase 2|Lost to Follow-up|0|||
48499299|NCT00920140|156024336|FG003|Phase 2|Lost to Follow-up|1|||
48599288|NCT02573259|156388024|FG006|Overall Study|Lost to Follow-up|1|||
48599289|NCT02573259|156388018|FG000|Overall Study|Participant refused further follow-up|0|||
48599290|NCT02573259|156388019|FG001|Overall Study|Participant refused further follow-up|2|||
48719012|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
48815106|NCT01009047|157165690|FG000|Overall Study|Other|3|||
48815107|NCT01009047|157165691|FG001|Overall Study|Other|2|||
48815108|NCT02982720|157165694|FG000|Overall Study|Adverse Event|3|||
48499300|NCT00920140|156024337|FG004|Phase 2|Lost to Follow-up|0|||
48499301|NCT00920140|156024333|FG000|Phase 2|Physician Decision|0|||
48499302|NCT00920140|156024334|FG001|Phase 2|Physician Decision|0|||
48499303|NCT00920140|156024335|FG002|Phase 2|Physician Decision|3|||
48499304|NCT00920140|156024336|FG003|Phase 2|Physician Decision|3|||
48499305|NCT00920140|156024337|FG004|Phase 2|Physician Decision|2|||
48499306|NCT00920140|156024333|FG000|Phase 2|Withdrawal by Subject|0|||
48719013|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
48599291|NCT02573259|156388020|FG002|Overall Study|Participant refused further follow-up|1|||
48599292|NCT02573259|156388021|FG003|Overall Study|Participant refused further follow-up|0|||
48815109|NCT02982720|157165694|FG000|Overall Study|Death|1|||
48815110|NCT03875911|157165697|FG000|Overall Study|Lost to Follow-up|3|||
48815111|NCT03875911|157165698|FG001|Overall Study|Lost to Follow-up|6|||
48815112|NCT03875911|157165699|FG002|Overall Study|Lost to Follow-up|2|||
48499307|NCT00920140|156024334|FG001|Phase 2|Withdrawal by Subject|0|||
48499308|NCT00920140|156024335|FG002|Phase 2|Withdrawal by Subject|4|||
48815113|NCT03875911|157165697|FG000|Overall Study|Surgery cancelled|1|||
48815114|NCT03875911|157165698|FG001|Overall Study|Surgery cancelled|0|||
48815115|NCT03875911|157165699|FG002|Overall Study|Surgery cancelled|1|||
48815116|NCT03875911|157165697|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
48815117|NCT03875911|157165698|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
48815118|NCT03875911|157165699|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
48815119|NCT01388530|157165700|FG000|Overall Study|Lost to Follow-up|5|||
48815120|NCT02065570|157165703|FG000|Induction Study|Adverse Event|5|||
48815121|NCT02065570|157165704|FG001|Induction Study|Adverse Event|12|||
48815122|NCT02065570|157165705|FG002|Induction Study|Adverse Event|0|||
48499309|NCT00920140|156024336|FG003|Phase 2|Withdrawal by Subject|2|||
48499310|NCT00920140|156024337|FG004|Phase 2|Withdrawal by Subject|1|||
48499311|NCT01265784|156024340|FG000|Overall Study|Lost to Follow-up|5|||
48499312|NCT01265784|156024341|FG001|Overall Study|Lost to Follow-up|3|||
48499313|NCT01265784|156024342|FG002|Overall Study|Lost to Follow-up|2|||
48499314|NCT01265784|156024340|FG000|Overall Study|Withdrawal by Subject|0|||
48815123|NCT02065570|157165706|FG003|Induction Study|Adverse Event|0|||
48815124|NCT02065570|157165703|FG000|Induction Study|Withdrawal by Subject|2|||
48815125|NCT02065570|157165704|FG001|Induction Study|Withdrawal by Subject|3|||
48815126|NCT02065570|157165705|FG002|Induction Study|Withdrawal by Subject|0|||
48815127|NCT02065570|157165706|FG003|Induction Study|Withdrawal by Subject|0|||
48815128|NCT02065570|157165703|FG000|Induction Study|Lost to Follow-up|1|||
48815129|NCT02065570|157165704|FG001|Induction Study|Lost to Follow-up|1|||
48815130|NCT02065570|157165705|FG002|Induction Study|Lost to Follow-up|0|||
48815131|NCT02065570|157165706|FG003|Induction Study|Lost to Follow-up|0|||
48815132|NCT02065570|157165703|FG000|Induction Study|Other, Not Specified|6|||
48815133|NCT02065570|157165704|FG001|Induction Study|Other, Not Specified|5|||
48815134|NCT02065570|157165705|FG002|Induction Study|Other, Not Specified|0|||
48815135|NCT02065570|157165706|FG003|Induction Study|Other, Not Specified|0|||
48815136|NCT02065570|157165703|FG000|Maintenance Study|Adverse Event|0|||
48815137|NCT02065570|157165704|FG001|Maintenance Study|Adverse Event|0|||
48499315|NCT01265784|156024341|FG001|Overall Study|Withdrawal by Subject|5|||
48815138|NCT02065570|157165705|FG002|Maintenance Study|Adverse Event|8|||
48499316|NCT01265784|156024342|FG002|Overall Study|Withdrawal by Subject|0|||
48499317|NCT01265784|156024340|FG000|Overall Study|Physician Decision|1|||
48499318|NCT01265784|156024341|FG001|Overall Study|Physician Decision|0|||
48499319|NCT01265784|156024342|FG002|Overall Study|Physician Decision|1|||
48499320|NCT01265784|156024340|FG000|Overall Study|Adverse Event|1|||
48499321|NCT01265784|156024341|FG001|Overall Study|Adverse Event|0|||
48499322|NCT01265784|156024342|FG002|Overall Study|Adverse Event|0|||
48499323|NCT01265784|156024340|FG000|Overall Study|Death|3|||
48499324|NCT01265784|156024341|FG001|Overall Study|Death|0|||
48499325|NCT01265784|156024342|FG002|Overall Study|Death|0|||
48499326|NCT01265784|156024340|FG000|Overall Study|Protocol Violation|2|||
48499327|NCT01265784|156024341|FG001|Overall Study|Protocol Violation|0|||
48499328|NCT01265784|156024342|FG002|Overall Study|Protocol Violation|0|||
48499329|NCT01265784|156024340|FG000|Overall Study|Incorrectly Randomized|0|||
48499330|NCT01265784|156024341|FG001|Overall Study|Incorrectly Randomized|0|||
48499331|NCT01265784|156024342|FG002|Overall Study|Incorrectly Randomized|1|||
48499332|NCT00680121|156024345|FG000|Overall Study|Lost to Follow-up|27|||
48499333|NCT00680121|156024346|FG001|Overall Study|Lost to Follow-up|23|||
48499334|NCT03444038|156024347|FG000|Overall Study|Adverse Event|12|||
48499335|NCT03444038|156024347|FG000|Overall Study|Withdrawal by Subject|7|||
48499336|NCT03444038|156024347|FG000|Overall Study|Lost to Follow-up|1|||
48499337|NCT03444038|156024347|FG000|Overall Study|Physician Decision|2|||
48499338|NCT03444038|156024347|FG000|Overall Study|Lack of Efficacy|7|||
48499339|NCT01124149|156024348|FG000|Acute Phase|Withdrawal by Subject|22|||
48499340|NCT01124149|156024348|FG000|Acute Phase|Adverse Event|21|||
48499341|NCT01124149|156024348|FG000|Acute Phase|Lack of Efficacy|17|||
48499342|NCT01124149|156024348|FG000|Acute Phase|Protocol Violation|14|||
48499343|NCT01124149|156024348|FG000|Acute Phase|Lost to Follow-up|2|||
48499344|NCT01124149|156024348|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
48499345|NCT01124149|156024348|FG000|Acute Phase|Sponsor request|1|||
48815139|NCT02065570|157165706|FG003|Maintenance Study|Adverse Event|8|||
48815140|NCT02065570|157165703|FG000|Maintenance Study|Withdrawal by Subject|0|||
48815141|NCT02065570|157165704|FG001|Maintenance Study|Withdrawal by Subject|0|||
48815142|NCT02065570|157165705|FG002|Maintenance Study|Withdrawal by Subject|1|||
48499346|NCT01124149|156024348|FG000|Acute Phase|UC symptoms not ameliorated|1|||
48499347|NCT01124149|156024348|FG000|Acute Phase|Non-compliance|1|||
48499348|NCT01124149|156024348|FG000|Acute Phase|Low hemoglobin|1|||
48499349|NCT01124149|156024348|FG000|Acute Phase|Travelling to another country|1|||
48499350|NCT01124149|156024348|FG000|Acute Phase|Sponsor decision|1|||
48499351|NCT01124149|156024348|FG000|Maintenance Phase|Lack of Efficacy|40|||
48499352|NCT01124149|156024348|FG000|Maintenance Phase|Adverse Event|24|||
48499353|NCT01124149|156024348|FG000|Maintenance Phase|Lost to Follow-up|15|||
48499354|NCT01124149|156024348|FG000|Maintenance Phase|Withdrawal by Subject|10|||
48499355|NCT01124149|156024348|FG000|Maintenance Phase|Protocol Violation|5|||
48499356|NCT01124149|156024348|FG000|Maintenance Phase|Coordinator error|1|||
48815143|NCT02065570|157165706|FG003|Maintenance Study|Withdrawal by Subject|4|||
48815144|NCT02065570|157165703|FG000|Maintenance Study|Lost to Follow-up|0|||
48815145|NCT02065570|157165704|FG001|Maintenance Study|Lost to Follow-up|0|||
48815146|NCT02065570|157165705|FG002|Maintenance Study|Lost to Follow-up|2|||
48815147|NCT02065570|157165706|FG003|Maintenance Study|Lost to Follow-up|2|||
48815148|NCT02065570|157165703|FG000|Maintenance Study|Other, Not Specified|0|||
48815149|NCT02065570|157165704|FG001|Maintenance Study|Other, Not Specified|0|||
48815150|NCT02065570|157165705|FG002|Maintenance Study|Other, Not Specified|11|||
48815151|NCT02065570|157165706|FG003|Maintenance Study|Other, Not Specified|5|||
48815152|NCT01868074|157165710|FG000|Overall Study|Lost to Follow-up|3|||
48815153|NCT01868074|157165711|FG001|Overall Study|Lost to Follow-up|2|||
48815154|NCT01868074|157165710|FG000|Overall Study|Withdrawal by Subject|4|||
48815155|NCT01868074|157165711|FG001|Overall Study|Withdrawal by Subject|2|||
48815156|NCT03770273|157165712|FG000|Overall Study|Adverse Event|2|||
48815157|NCT03770273|157165713|FG001|Overall Study|Adverse Event|0|||
48815158|NCT03770273|157165712|FG000|Overall Study|Lost to Follow-up|1|||
48815159|NCT03770273|157165713|FG001|Overall Study|Lost to Follow-up|1|||
48815160|NCT03306043|157165714|FG000|Overall Study|Adverse Event|1|||
48815161|NCT03306043|157165714|FG000|Overall Study|Lost to Follow-up|1|||
48815162|NCT03306043|157165714|FG000|Overall Study|Withdrawal by Subject|2|||
48815163|NCT02087150|157165715|FG000|Overall Study|Death|0|||
48815164|NCT02087150|157165716|FG001|Overall Study|Death|1|||
48815165|NCT02087150|157165717|FG002|Overall Study|Death|0|||
48815166|NCT02087150|157165715|FG000|Overall Study|Lost to Follow-up|6|||
48815167|NCT02087150|157165716|FG001|Overall Study|Lost to Follow-up|13|||
48815168|NCT02087150|157165717|FG002|Overall Study|Lost to Follow-up|7|||
48815169|NCT02087150|157165715|FG000|Overall Study|Withdrawal by Subject|2|||
48815170|NCT02087150|157165716|FG001|Overall Study|Withdrawal by Subject|5|||
48499357|NCT01124149|156024348|FG000|Maintenance Phase|Non-compliance|1|||
48499358|NCT00977106|156024349|FG000|Overall Study|Adverse Event|5|||
48499359|NCT00977106|156024350|FG001|Overall Study|Adverse Event|6|||
48499360|NCT00977106|156024349|FG000|Overall Study|Withdrawal by Subject|2|||
48499361|NCT00977106|156024350|FG001|Overall Study|Withdrawal by Subject|2|||
48499362|NCT00977106|156024349|FG000|Overall Study|Lack of Efficacy|2|||
48499363|NCT00977106|156024350|FG001|Overall Study|Lack of Efficacy|2|||
48499364|NCT00977106|156024349|FG000|Overall Study|Protocol Violation|0|||
48499365|NCT00977106|156024350|FG001|Overall Study|Protocol Violation|1|||
48499366|NCT00977106|156024349|FG000|Overall Study|Other|1|||
48499367|NCT00977106|156024350|FG001|Overall Study|Other|0|||
48499368|NCT01644500|156024355|FG000|Overall Study|Adverse Event|6|||
48499369|NCT01644500|156024356|FG001|Overall Study|Adverse Event|1|||
48499370|NCT01644500|156024357|FG002|Overall Study|Adverse Event|2|||
48499371|NCT01644500|156024355|FG000|Overall Study|Death|0|||
48499372|NCT01644500|156024356|FG001|Overall Study|Death|1|||
48499373|NCT01644500|156024357|FG002|Overall Study|Death|0|||
48499374|NCT01644500|156024355|FG000|Overall Study|Lost to Follow-up|3|||
48499375|NCT01644500|156024356|FG001|Overall Study|Lost to Follow-up|8|||
48499376|NCT01644500|156024357|FG002|Overall Study|Lost to Follow-up|0|||
48499377|NCT01644500|156024355|FG000|Overall Study|Protocol Violation|1|||
48499378|NCT01644500|156024356|FG001|Overall Study|Protocol Violation|1|||
48499379|NCT01644500|156024357|FG002|Overall Study|Protocol Violation|0|||
48499380|NCT01644500|156024355|FG000|Overall Study|Withdrawal by Subject|11|||
48499381|NCT01644500|156024356|FG001|Overall Study|Withdrawal by Subject|12|||
48499382|NCT01644500|156024357|FG002|Overall Study|Withdrawal by Subject|12|||
48499383|NCT01644500|156024355|FG000|Overall Study|Physician Decision|1|||
48499384|NCT01644500|156024356|FG001|Overall Study|Physician Decision|1|||
48499385|NCT01644500|156024357|FG002|Overall Study|Physician Decision|1|||
48499386|NCT00634907|156024359|FG000|Overall Study|Withdrawal by Subject|3|||
48499387|NCT00634907|156024360|FG001|Overall Study|Withdrawal by Subject|0|||
48499388|NCT00634907|156024359|FG000|Overall Study|Physician Decision|3|||
48499389|NCT00634907|156024360|FG001|Overall Study|Physician Decision|9|||
48499390|NCT00634907|156024359|FG000|Overall Study|Withdrawal by Subject|11|||
48499391|NCT00634907|156024360|FG001|Overall Study|Withdrawal by Subject|8|||
48499392|NCT02153398|156024361|FG000|Overall Study|Withdrawal by Subject|1|||
48499393|NCT02153398|156024362|FG001|Overall Study|Withdrawal by Subject|0|||
48499394|NCT02153398|156024363|FG002|Overall Study|Withdrawal by Subject|0|||
48499395|NCT02153398|156024364|FG003|Overall Study|Withdrawal by Subject|0|||
48499396|NCT02153398|156024365|FG004|Overall Study|Withdrawal by Subject|0|||
48499397|NCT02153398|156024361|FG000|Overall Study|Adverse Event|0|||
48499398|NCT02153398|156024362|FG001|Overall Study|Adverse Event|0|||
48499399|NCT02153398|156024363|FG002|Overall Study|Adverse Event|1|||
48499400|NCT02153398|156024364|FG003|Overall Study|Adverse Event|1|||
48499401|NCT02153398|156024365|FG004|Overall Study|Adverse Event|0|||
48499402|NCT02863575|156024366|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
48815171|NCT02087150|157165717|FG002|Overall Study|Withdrawal by Subject|3|||
48815172|NCT02087150|157165715|FG000|Overall Study|Physician Decision|0|||
48815173|NCT02087150|157165716|FG001|Overall Study|Physician Decision|1|||
48815174|NCT02087150|157165717|FG002|Overall Study|Physician Decision|0|||
48815175|NCT02087150|157165715|FG000|Overall Study|Procedure not done|1|||
48719014|NCT04740905|156821302|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
48719015|NCT04740905|156821303|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
48719016|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
48719017|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
48719018|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
48719019|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
48815176|NCT02087150|157165716|FG001|Overall Study|Procedure not done|13|||
48815177|NCT02087150|157165717|FG002|Overall Study|Procedure not done|0|||
48815178|NCT02087150|157165715|FG000|Overall Study|F/U not completed w/in study window|0|||
48815179|NCT02087150|157165716|FG001|Overall Study|F/U not completed w/in study window|0|||
48719020|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
48719021|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
48719022|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
48719023|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
48815180|NCT02087150|157165717|FG002|Overall Study|F/U not completed w/in study window|1|||
48815181|NCT02087150|157165715|FG000|Overall Study|Other|1|||
48815182|NCT02087150|157165716|FG001|Overall Study|Other|0|||
48815183|NCT02087150|157165717|FG002|Overall Study|Other|0|||
48815184|NCT02087150|157165715|FG000|Overall Study|Pt moved out of town|0|||
48815185|NCT02087150|157165716|FG001|Overall Study|Pt moved out of town|1|||
48815186|NCT02087150|157165717|FG002|Overall Study|Pt moved out of town|0|||
48815187|NCT00393094|157165719|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
48815188|NCT00393094|157165719|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
48815189|NCT02019602|157165720|FG000|Screening Period|Ineligibility|4|||
48815190|NCT02019602|157165721|FG001|Screening Period|Ineligibility|0|||
48815191|NCT02019602|157165720|FG000|Screening Period|Adverse Event|1|||
48815192|NCT02019602|157165721|FG001|Screening Period|Adverse Event|0|||
48815193|NCT01448044|157165722|FG000|Treatment Period|Adverse Event|4|||
48815194|NCT01448044|157165723|FG001|Treatment Period|Adverse Event|3|||
48815195|NCT01448044|157165722|FG000|Treatment Period|Lack of Efficacy|5|||
48815196|NCT01448044|157165723|FG001|Treatment Period|Lack of Efficacy|12|||
48815197|NCT01448044|157165722|FG000|Treatment Period|Subject requested discontinue study drug|1|||
48815198|NCT01448044|157165723|FG001|Treatment Period|Subject requested discontinue study drug|0|||
48815199|NCT01448044|157165722|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
48815200|NCT01448044|157165723|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
48815201|NCT01448044|157165722|FG000|Treatment Period|Participant does not meet study criteria|1|||
48815202|NCT01448044|157165723|FG001|Treatment Period|Participant does not meet study criteria|0|||
48815203|NCT01448044|157165722|FG000|Treatment Period|Lost to Follow-up|2|||
48815204|NCT01448044|157165723|FG001|Treatment Period|Lost to Follow-up|1|||
48815205|NCT01448044|157165722|FG000|Treatment Period|Other reason|2|||
48815206|NCT01448044|157165723|FG001|Treatment Period|Other reason|0|||
48815207|NCT01448044|157165722|FG000|Follow Up Period|Withdrawal by Subject|1|||
48815208|NCT01448044|157165723|FG001|Follow Up Period|Withdrawal by Subject|1|||
48815209|NCT01448044|157165722|FG000|Follow Up Period|Lost to Follow-up|6|||
48815210|NCT01448044|157165723|FG001|Follow Up Period|Lost to Follow-up|2|||
48815211|NCT01448044|157165722|FG000|Follow Up Period|Other|5|||
48815212|NCT01448044|157165723|FG001|Follow Up Period|Other|11|||
48815213|NCT02372058|157165725|FG000|Overall Study|Withdrawal by Subject|3|||
48499403|NCT02863575|156024367|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
48499404|NCT02863575|156024368|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
48499405|NCT02863575|156024366|FG000|Overall Study|Withdrawal by Subject|0|||
48499406|NCT02863575|156024367|FG001|Overall Study|Withdrawal by Subject|1|||
48499407|NCT02863575|156024368|FG002|Overall Study|Withdrawal by Subject|1|||
48499408|NCT02863575|156024366|FG000|Overall Study|Adverse Event|0|||
48499409|NCT02863575|156024367|FG001|Overall Study|Adverse Event|1|||
48499410|NCT02863575|156024368|FG002|Overall Study|Adverse Event|0|||
48499411|NCT00322491|156024370|FG000|Overall Study|Adverse Event|1|||
48499412|NCT00322491|156024371|FG001|Overall Study|Adverse Event|0|||
48499413|NCT00322491|156024370|FG000|Overall Study|Death|1|||
48499414|NCT00322491|156024371|FG001|Overall Study|Death|2|||
48499415|NCT03831048|156024372|FG000|Overall Study|Protocol Violation|9|||
48499416|NCT03831048|156024373|FG001|Overall Study|Protocol Violation|3|||
48499417|NCT03831048|156024372|FG000|Overall Study|Death|4|||
48499418|NCT03831048|156024373|FG001|Overall Study|Death|9|||
48499419|NCT03831048|156024372|FG000|Overall Study|Re-transplant|0|||
48499420|NCT03831048|156024373|FG001|Overall Study|Re-transplant|2|||
48499421|NCT03831048|156024372|FG000|Overall Study|Protocol violation and death|1|||
48815214|NCT02788006|157165726|FG000|Overall Study|Patient not treated|1|||
48815215|NCT02397460|157165728|FG000|Treatment Period 2|Adverse Event|0|||
48815216|NCT02397460|157165729|FG001|Treatment Period 2|Adverse Event|0|||
48815217|NCT02397460|157165730|FG002|Treatment Period 2|Adverse Event|0|||
48815218|NCT02397460|157165731|FG003|Treatment Period 2|Adverse Event|0|||
48815219|NCT02397460|157165732|FG004|Treatment Period 2|Adverse Event|0|||
48815220|NCT02397460|157165733|FG005|Treatment Period 2|Adverse Event|0|||
48815221|NCT02397460|157165734|FG006|Treatment Period 2|Adverse Event|0|||
48815222|NCT02397460|157165735|FG007|Treatment Period 2|Adverse Event|1|||
48499422|NCT03831048|156024373|FG001|Overall Study|Protocol violation and death|1|||
48499423|NCT01400425|156024380|FG000|Overall Study|Withdrawal by Subject|10|||
48815223|NCT02397460|157165728|FG000|Treatment Period 4|Adverse Event|0|||
48815224|NCT02397460|157165729|FG001|Treatment Period 4|Adverse Event|1|||
48815225|NCT02397460|157165730|FG002|Treatment Period 4|Adverse Event|0|||
48815226|NCT02397460|157165731|FG003|Treatment Period 4|Adverse Event|0|||
48815227|NCT02397460|157165732|FG004|Treatment Period 4|Adverse Event|0|||
48815228|NCT02397460|157165733|FG005|Treatment Period 4|Adverse Event|0|||
48815229|NCT02397460|157165734|FG006|Treatment Period 4|Adverse Event|0|||
48815230|NCT02397460|157165735|FG007|Treatment Period 4|Adverse Event|0|||
48815231|NCT02397460|157165728|FG000|Treatment Period 4|Physician Decision|0|||
48815232|NCT02397460|157165729|FG001|Treatment Period 4|Physician Decision|0|||
48815233|NCT02397460|157165730|FG002|Treatment Period 4|Physician Decision|0|||
48815234|NCT02397460|157165731|FG003|Treatment Period 4|Physician Decision|0|||
48499424|NCT00688064|156024382|FG000|Overall Study|Protocol Violation|0|||
48499425|NCT00688064|156024383|FG001|Overall Study|Protocol Violation|1|||
48499426|NCT00688064|156024382|FG000|Overall Study|Adverse Event|2|||
48499427|NCT00688064|156024383|FG001|Overall Study|Adverse Event|4|||
48499428|NCT00688064|156024382|FG000|Overall Study|Withdrawal by Subject|7|||
48499429|NCT00688064|156024383|FG001|Overall Study|Withdrawal by Subject|7|||
48499430|NCT00688064|156024382|FG000|Overall Study|Lost to Follow-up|10|||
48499431|NCT00688064|156024383|FG001|Overall Study|Lost to Follow-up|10|||
48499432|NCT00688064|156024382|FG000|Overall Study|Lack of Efficacy|0|||
48499433|NCT00688064|156024383|FG001|Overall Study|Lack of Efficacy|1|||
48499434|NCT00688064|156024382|FG000|Overall Study|Pregnancy|1|||
48499435|NCT00688064|156024383|FG001|Overall Study|Pregnancy|0|||
48499436|NCT00688064|156024382|FG000|Overall Study|Any other reasons|1|||
48719024|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
48719025|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
48719026|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
48719027|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
48719028|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
48719029|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
48719030|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
48719031|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
48719032|NCT04740905|156821302|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
48719033|NCT04740905|156821303|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
48719034|NCT01073462|156821304|FG000|Overall Study|Death|14|||
48719035|NCT01073462|156821304|FG000|Overall Study|Kidney transplant|10|||
48719036|NCT01073462|156821304|FG000|Overall Study|Low parathyroid hormone levels|8|||
48719037|NCT01073462|156821304|FG000|Overall Study|Serious adverse event|2|||
48719038|NCT01073462|156821304|FG000|Overall Study|Lost to Follow-up|7|||
48719039|NCT01433250|156821309|FG000|Overall Study|Protocol Violation|0|||
48719040|NCT01433250|156821310|FG001|Overall Study|Protocol Violation|1|||
48719041|NCT01433250|156821309|FG000|Overall Study|Withdrawal by Subject|3|||
48719042|NCT01433250|156821310|FG001|Overall Study|Withdrawal by Subject|2|||
48719043|NCT01261780|156821314|FG000|Overall Study|Withdrawal by Subject|1|||
48719044|NCT01261780|156821315|FG001|Overall Study|Withdrawal by Subject|0|||
48719045|NCT01261780|156821314|FG000|Overall Study|Event not related to subject|1|||
48719046|NCT01261780|156821315|FG001|Overall Study|Event not related to subject|2|||
48719047|NCT01239732|156821316|FG000|Overall Study|Termination of study per protocol|667|||
48719048|NCT01239732|156821316|FG000|Overall Study|Death|226|||
48719049|NCT01239732|156821316|FG000|Overall Study|Withdrawal by Subject|87|||
48719050|NCT01239732|156821316|FG000|Overall Study|Adverse Event|6|||
48719051|NCT01239732|156821316|FG000|Overall Study|Protocol Violation|3|||
48719052|NCT01239732|156821316|FG000|Overall Study|Participant non compliance|5|||
48719053|NCT01239732|156821316|FG000|Overall Study|Study termination by sponsor|2|||
48719054|NCT01239732|156821316|FG000|Overall Study|Investigator's decision|4|||
48719055|NCT01239732|156821316|FG000|Overall Study|Treatment failure|2|||
48719056|NCT01239732|156821316|FG000|Overall Study|Other|19|||
48719057|NCT02431260|156821317|FG000|Overall Study|Subject Decision|0|||
48719058|NCT02431260|156821318|FG001|Overall Study|Subject Decision|1|||
48719059|NCT02431260|156821319|FG002|Overall Study|Subject Decision|1|||
48719060|NCT02431260|156821320|FG003|Overall Study|Subject Decision|0|||
48719061|NCT02431260|156821321|FG004|Overall Study|Subject Decision|0|||
48719062|NCT02431260|156821322|FG005|Overall Study|Subject Decision|0|||
48719063|NCT02431260|156821323|FG006|Overall Study|Subject Decision|0|||
48719064|NCT02431260|156821324|FG007|Overall Study|Subject Decision|0|||
48719065|NCT02431260|156821325|FG008|Overall Study|Subject Decision|1|||
48719066|NCT02431260|156821326|FG009|Overall Study|Subject Decision|1|||
48719067|NCT02431260|156821327|FG010|Overall Study|Subject Decision|0|||
48719068|NCT02431260|156821328|FG011|Overall Study|Subject Decision|1|||
48719069|NCT02431260|156821329|FG012|Overall Study|Subject Decision|0|||
48719070|NCT02431260|156821330|FG013|Overall Study|Subject Decision|0|||
48719071|NCT02431260|156821317|FG000|Overall Study|Death|4|||
48719072|NCT02431260|156821318|FG001|Overall Study|Death|4|||
48719073|NCT02431260|156821319|FG002|Overall Study|Death|3|||
48719074|NCT02431260|156821320|FG003|Overall Study|Death|4|||
48719075|NCT02431260|156821321|FG004|Overall Study|Death|2|||
48815235|NCT02397460|157165732|FG004|Treatment Period 4|Physician Decision|1|||
48815236|NCT02397460|157165733|FG005|Treatment Period 4|Physician Decision|0|||
48815237|NCT02397460|157165734|FG006|Treatment Period 4|Physician Decision|0|||
48815238|NCT02397460|157165735|FG007|Treatment Period 4|Physician Decision|0|||
48815239|NCT01349660|157165740|FG000|Overall Study|Still Receiving Study Treatment|0|||
48815240|NCT01349660|157165741|FG001|Overall Study|Still Receiving Study Treatment|0|||
48815241|NCT01349660|157165742|FG002|Overall Study|Still Receiving Study Treatment|1|||
48815242|NCT01349660|157165740|FG000|Overall Study|Disease Progression|2|||
48815243|NCT01349660|157165741|FG001|Overall Study|Disease Progression|4|||
48719076|NCT02431260|156821322|FG005|Overall Study|Death|2|||
48719077|NCT02431260|156821323|FG006|Overall Study|Death|3|||
48719078|NCT02431260|156821324|FG007|Overall Study|Death|1|||
48719079|NCT02431260|156821325|FG008|Overall Study|Death|6|||
48719080|NCT02431260|156821326|FG009|Overall Study|Death|6|||
48499437|NCT00688064|156024383|FG001|Overall Study|Any other reasons|3|||
48815244|NCT01349660|157165742|FG002|Overall Study|Disease Progression|50|||
48815245|NCT01349660|157165740|FG000|Overall Study|Adverse Event|1|||
48815246|NCT01349660|157165741|FG001|Overall Study|Adverse Event|1|||
48815247|NCT01349660|157165742|FG002|Overall Study|Adverse Event|12|||
48815248|NCT01349660|157165740|FG000|Overall Study|Withdrawal by Subject|2|||
48815249|NCT01349660|157165741|FG001|Overall Study|Withdrawal by Subject|0|||
48499438|NCT00560235|156024386|FG000|Phase 1|Discontinued|8|||
48499439|NCT00560235|156024387|FG001|Phase 1|Discontinued|0|||
48499440|NCT00560235|156024388|FG002|Phase 1|Discontinued|0|||
48499441|NCT00560235|156024386|FG000|Phase 1B|Discontinued|0|||
48499442|NCT00560235|156024387|FG001|Phase 1B|Discontinued|19|||
48499443|NCT00560235|156024388|FG002|Phase 1B|Discontinued|0|||
48499444|NCT00560235|156024386|FG000|Phase 2|Discontinued|0|||
48499445|NCT00560235|156024387|FG001|Phase 2|Discontinued|0|||
48499446|NCT00560235|156024388|FG002|Phase 2|Discontinued|96|||
48499447|NCT00560235|156024386|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
48499448|NCT00560235|156024387|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
48499449|NCT00560235|156024388|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
48499450|NCT00620763|156024389|FG000|Period: First Intervention|Withdrawal by Subject|0|||
48499451|NCT00620763|156024390|FG001|Period: First Intervention|Withdrawal by Subject|2|||
48499452|NCT00620763|156024389|FG000|Period: First Intervention|Protocol Violation|0|||
48499453|NCT00620763|156024390|FG001|Period: First Intervention|Protocol Violation|3|||
48499454|NCT00620763|156024389|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
48499455|NCT00620763|156024390|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
48499456|NCT01658943|156024394|FG000|Overall Study|Adverse Event|6|||
48499457|NCT01658943|156024395|FG001|Overall Study|Adverse Event|13|||
48499458|NCT01658943|156024394|FG000|Overall Study|Withdrawal by Subject|9|||
48499459|NCT01658943|156024395|FG001|Overall Study|Withdrawal by Subject|2|||
48499460|NCT01658943|156024394|FG000|Overall Study|Progression/Relapse|39|||
48499461|NCT01658943|156024395|FG001|Overall Study|Progression/Relapse|40|||
48499462|NCT01658943|156024394|FG000|Overall Study|Death|4|||
48499463|NCT01658943|156024395|FG001|Overall Study|Death|2|||
48499464|NCT01658943|156024394|FG000|Overall Study|not protocol specified|4|||
48499465|NCT01658943|156024395|FG001|Overall Study|not protocol specified|1|||
48499466|NCT01658943|156024394|FG000|Overall Study|Not eligible|7|||
48499467|NCT01658943|156024395|FG001|Overall Study|Not eligible|9|||
48499468|NCT01658943|156024394|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
48499469|NCT01658943|156024395|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
48499470|NCT02458638|156024396|FG000|Overall Study|Death|309|||
48499471|NCT02458638|156024396|FG000|Overall Study|End of Cohort/End of Study|67|||
48499472|NCT02458638|156024396|FG000|Overall Study|Lost to Follow-up|31|||
48499473|NCT02458638|156024396|FG000|Overall Study|Other Reasons|4|||
48499474|NCT02458638|156024396|FG000|Overall Study|Physician Decision|1|||
48499475|NCT02458638|156024396|FG000|Overall Study|Withdrawal by Subject|47|||
48499476|NCT01725451|156024406|FG000|Period 1|Withdrawal by Subject|1|||
48499477|NCT01725451|156024407|FG001|Period 1|Withdrawal by Subject|0|||
48499478|NCT01725451|156024408|FG002|Period 1|Withdrawal by Subject|0|||
48499479|NCT01725451|156024409|FG003|Period 1|Withdrawal by Subject|0|||
48499480|NCT01725451|156024406|FG000|Washout From Period 3|Protocol Violation|0|||
48499481|NCT01725451|156024407|FG001|Washout From Period 3|Protocol Violation|0|||
48719081|NCT02431260|156821327|FG010|Overall Study|Death|3|||
48499482|NCT01725451|156024408|FG002|Washout From Period 3|Protocol Violation|1|||
48499483|NCT01725451|156024409|FG003|Washout From Period 3|Protocol Violation|0|||
48499484|NCT01725451|156024406|FG000|Washout From Period 3|Adverse Event|0|||
48499485|NCT01725451|156024407|FG001|Washout From Period 3|Adverse Event|1|||
48499486|NCT01725451|156024408|FG002|Washout From Period 3|Adverse Event|0|||
48719082|NCT02431260|156821328|FG011|Overall Study|Death|2|||
48499487|NCT01725451|156024409|FG003|Washout From Period 3|Adverse Event|0|||
48499488|NCT01725451|156024406|FG000|Period 4|Adverse Event|0|||
48719083|NCT02431260|156821329|FG012|Overall Study|Death|5|||
48719084|NCT02431260|156821330|FG013|Overall Study|Death|1|||
48719085|NCT02431260|156821317|FG000|Overall Study|Lost to Follow-up|0|||
48719086|NCT02431260|156821318|FG001|Overall Study|Lost to Follow-up|0|||
48719087|NCT02431260|156821319|FG002|Overall Study|Lost to Follow-up|0|||
48719088|NCT02431260|156821320|FG003|Overall Study|Lost to Follow-up|0|||
48719089|NCT02431260|156821321|FG004|Overall Study|Lost to Follow-up|0|||
48719090|NCT02431260|156821322|FG005|Overall Study|Lost to Follow-up|1|||
48719091|NCT02431260|156821323|FG006|Overall Study|Lost to Follow-up|0|||
48719092|NCT02431260|156821324|FG007|Overall Study|Lost to Follow-up|0|||
48719093|NCT02431260|156821325|FG008|Overall Study|Lost to Follow-up|0|||
48719094|NCT02431260|156821326|FG009|Overall Study|Lost to Follow-up|0|||
48719095|NCT02431260|156821327|FG010|Overall Study|Lost to Follow-up|0|||
48719096|NCT02431260|156821328|FG011|Overall Study|Lost to Follow-up|0|||
48719097|NCT02431260|156821329|FG012|Overall Study|Lost to Follow-up|0|||
48719098|NCT02431260|156821330|FG013|Overall Study|Lost to Follow-up|0|||
48719099|NCT02431260|156821317|FG000|Overall Study|Study Terminated by the Sponsor|0|||
48719100|NCT02431260|156821318|FG001|Overall Study|Study Terminated by the Sponsor|0|||
48719101|NCT02431260|156821319|FG002|Overall Study|Study Terminated by the Sponsor|2|||
48719102|NCT02431260|156821320|FG003|Overall Study|Study Terminated by the Sponsor|1|||
48719103|NCT02431260|156821321|FG004|Overall Study|Study Terminated by the Sponsor|1|||
48719104|NCT02431260|156821322|FG005|Overall Study|Study Terminated by the Sponsor|0|||
48815250|NCT01349660|157165742|FG002|Overall Study|Withdrawal by Subject|9|||
48815251|NCT01349660|157165740|FG000|Overall Study|Death|1|||
48815252|NCT01349660|157165741|FG001|Overall Study|Death|1|||
48815253|NCT01349660|157165742|FG002|Overall Study|Death|0|||
48815254|NCT01349660|157165740|FG000|Overall Study|Non-Permitted Interventions|0|||
48815255|NCT01349660|157165741|FG001|Overall Study|Non-Permitted Interventions|0|||
48719105|NCT02431260|156821323|FG006|Overall Study|Study Terminated by the Sponsor|1|||
48719106|NCT02431260|156821324|FG007|Overall Study|Study Terminated by the Sponsor|2|||
48719107|NCT02431260|156821325|FG008|Overall Study|Study Terminated by the Sponsor|1|||
48719108|NCT02431260|156821326|FG009|Overall Study|Study Terminated by the Sponsor|1|||
48499489|NCT01725451|156024407|FG001|Period 4|Adverse Event|0|||
48499490|NCT01725451|156024408|FG002|Period 4|Adverse Event|1|||
48499491|NCT01725451|156024409|FG003|Period 4|Adverse Event|0|||
48499492|NCT01345019|156024410|FG000|Blinded Treatment Phase|Death|147|||
48499493|NCT01345019|156024411|FG001|Blinded Treatment Phase|Death|137|||
48499494|NCT01345019|156024410|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
48499495|NCT01345019|156024411|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
48499496|NCT01345019|156024410|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
48499497|NCT01345019|156024411|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
48499498|NCT01345019|156024410|FG000|Blinded Treatment Phase|Disease Progression|12|||
48499499|NCT01345019|156024411|FG001|Blinded Treatment Phase|Disease Progression|10|||
48499500|NCT01345019|156024410|FG000|Blinded Treatment Phase|Adverse Event|6|||
48499501|NCT01345019|156024411|FG001|Blinded Treatment Phase|Adverse Event|13|||
48499502|NCT01345019|156024410|FG000|Blinded Treatment Phase|Administrative Decision|10|||
48499503|NCT01345019|156024411|FG001|Blinded Treatment Phase|Administrative Decision|8|||
48499504|NCT01345019|156024410|FG000|Blinded Treatment Phase|Noncompliance|5|||
48499505|NCT01345019|156024411|FG001|Blinded Treatment Phase|Noncompliance|3|||
48499506|NCT01345019|156024410|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
48499507|NCT01345019|156024411|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
48499508|NCT01345019|156024410|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
48499509|NCT01345019|156024411|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
48499510|NCT01345019|156024410|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
48499511|NCT01345019|156024411|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
48599293|NCT02573259|156388022|FG004|Overall Study|Participant refused further follow-up|3|||
48599294|NCT02573259|156388023|FG005|Overall Study|Participant refused further follow-up|20|||
48599295|NCT02573259|156388024|FG006|Overall Study|Participant refused further follow-up|7|||
48599296|NCT02573259|156388018|FG000|Overall Study|Other|0|||
48599297|NCT02573259|156388019|FG001|Overall Study|Other|0|||
48599298|NCT02573259|156388020|FG002|Overall Study|Other|0|||
48599299|NCT02573259|156388021|FG003|Overall Study|Other|0|||
48719109|NCT02431260|156821327|FG010|Overall Study|Study Terminated by the Sponsor|1|||
48815256|NCT01349660|157165742|FG002|Overall Study|Non-Permitted Interventions|2|||
48815257|NCT01349660|157165740|FG000|Overall Study|Study Compliance|0|||
48719110|NCT02431260|156821328|FG011|Overall Study|Study Terminated by the Sponsor|0|||
48499512|NCT01345019|156024410|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
48599300|NCT02573259|156388022|FG004|Overall Study|Other|1|||
48599301|NCT02573259|156388023|FG005|Overall Study|Other|4|||
48719111|NCT02431260|156821329|FG012|Overall Study|Study Terminated by the Sponsor|4|||
48719112|NCT02431260|156821330|FG013|Overall Study|Study Terminated by the Sponsor|0|||
48719113|NCT02431260|156821317|FG000|Overall Study|Physician Decision|0|||
48719114|NCT02431260|156821318|FG001|Overall Study|Physician Decision|0|||
48719115|NCT02431260|156821319|FG002|Overall Study|Physician Decision|0|||
48815258|NCT01349660|157165741|FG001|Overall Study|Study Compliance|0|||
48815259|NCT01349660|157165742|FG002|Overall Study|Study Compliance|1|||
48499513|NCT01345019|156024411|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
48499514|NCT01345019|156024410|FG000|Open Label Treatment Phase|Death|49|||
48719116|NCT02431260|156821320|FG003|Overall Study|Physician Decision|0|||
48719117|NCT02431260|156821321|FG004|Overall Study|Physician Decision|0|||
48719118|NCT02431260|156821322|FG005|Overall Study|Physician Decision|1|||
48719119|NCT02431260|156821323|FG006|Overall Study|Physician Decision|0|||
48719120|NCT02431260|156821324|FG007|Overall Study|Physician Decision|0|||
48719121|NCT02431260|156821325|FG008|Overall Study|Physician Decision|0|||
48719122|NCT02431260|156821326|FG009|Overall Study|Physician Decision|0|||
48719123|NCT02431260|156821327|FG010|Overall Study|Physician Decision|0|||
48719124|NCT02431260|156821328|FG011|Overall Study|Physician Decision|0|||
48719125|NCT02431260|156821329|FG012|Overall Study|Physician Decision|0|||
48719126|NCT02431260|156821330|FG013|Overall Study|Physician Decision|0|||
48719127|NCT02431260|156821317|FG000|Overall Study|Other Unspecified|0|||
48719128|NCT02431260|156821318|FG001|Overall Study|Other Unspecified|0|||
48719129|NCT02431260|156821319|FG002|Overall Study|Other Unspecified|0|||
48719130|NCT02431260|156821320|FG003|Overall Study|Other Unspecified|0|||
48719131|NCT02431260|156821321|FG004|Overall Study|Other Unspecified|0|||
48719132|NCT02431260|156821322|FG005|Overall Study|Other Unspecified|0|||
48719133|NCT02431260|156821323|FG006|Overall Study|Other Unspecified|0|||
48719134|NCT02431260|156821324|FG007|Overall Study|Other Unspecified|0|||
48719135|NCT02431260|156821325|FG008|Overall Study|Other Unspecified|0|||
48719136|NCT02431260|156821326|FG009|Overall Study|Other Unspecified|0|||
48719137|NCT02431260|156821327|FG010|Overall Study|Other Unspecified|0|||
48719138|NCT02431260|156821328|FG011|Overall Study|Other Unspecified|1|||
48719139|NCT02431260|156821329|FG012|Overall Study|Other Unspecified|1|||
48719140|NCT02431260|156821330|FG013|Overall Study|Other Unspecified|0|||
48719141|NCT00321646|156821331|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
48719142|NCT00321646|156821331|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
48719143|NCT00321646|156821331|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
48719144|NCT01381562|156821337|FG000|Overall Study|Adverse Event|0|||
48719145|NCT01381562|156821338|FG001|Overall Study|Adverse Event|1|||
48719146|NCT01381562|156821339|FG002|Overall Study|Adverse Event|0|||
48815260|NCT01349660|157165740|FG000|Overall Study|Declining Performance Status|0|||
48815261|NCT01349660|157165741|FG001|Overall Study|Declining Performance Status|0|||
48815262|NCT01349660|157165742|FG002|Overall Study|Declining Performance Status|1|||
48815263|NCT01563978|157165751|FG000|Overall Study|Physician Decision|1|||
48815264|NCT01563978|157165752|FG001|Overall Study|Physician Decision|0|||
48499515|NCT01345019|156024411|FG001|Open Label Treatment Phase|Death|48|||
48499516|NCT01345019|156024410|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
48499517|NCT01345019|156024411|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
48499518|NCT01345019|156024410|FG000|Open Label Treatment Phase|Adverse Event|30|||
48499519|NCT01345019|156024411|FG001|Open Label Treatment Phase|Adverse Event|51|||
48499520|NCT01345019|156024410|FG000|Open Label Treatment Phase|Administrative Decision|30|||
48499521|NCT01345019|156024411|FG001|Open Label Treatment Phase|Administrative Decision|15|||
48499522|NCT01345019|156024410|FG000|Open Label Treatment Phase|Disease Progression|17|||
48499523|NCT01345019|156024411|FG001|Open Label Treatment Phase|Disease Progression|18|||
48499524|NCT01345019|156024410|FG000|Open Label Treatment Phase|Noncompliance|5|||
48499525|NCT01345019|156024411|FG001|Open Label Treatment Phase|Noncompliance|4|||
48499526|NCT01345019|156024410|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
48499527|NCT01345019|156024411|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
48499528|NCT01345019|156024410|FG000|Open Label Treatment Phase|Pregnancy|1|||
48499529|NCT01345019|156024411|FG001|Open Label Treatment Phase|Pregnancy|0|||
48499530|NCT01345019|156024410|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
48499531|NCT01345019|156024411|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
48499532|NCT01345019|156024410|FG000|Open Label Treatment Phase|Protocol Violation|0|||
48499533|NCT01345019|156024411|FG001|Open Label Treatment Phase|Protocol Violation|1|||
48499534|NCT02636907|156024412|FG000|Autoinjector Assessment Period|Adverse Event|2|||
48499535|NCT02636907|156024412|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
48499536|NCT02636907|156024412|FG000|Extension Phase|Adverse Event|2|||
48499537|NCT02636907|156024412|FG000|Extension Phase|Withdrawal by Subject|4|||
48499538|NCT02636907|156024412|FG000|Extension Phase|Physician Decision|1|||
48499539|NCT02636907|156024412|FG000|Extension Phase|Lost to Follow-up|2|||
48499540|NCT02636907|156024412|FG000|Extension Phase|Lack of Efficacy|1|||
48499541|NCT03164772|156024413|FG000|Overall Study|Death|4|||
48499542|NCT03164772|156024414|FG001|Overall Study|Death|2|||
48499543|NCT03164772|156024413|FG000|Overall Study|Adverse Event|1|||
48499544|NCT03164772|156024414|FG001|Overall Study|Adverse Event|4|||
48499545|NCT03164772|156024413|FG000|Overall Study|Progressive Disease|11|||
48499546|NCT03164772|156024414|FG001|Overall Study|Progressive Disease|21|||
48499547|NCT03164772|156024413|FG000|Overall Study|Physician Decision|2|||
48719147|NCT01642732|156821340|FG000|Overall Study|Withdrawal by Subject|1|||
48719148|NCT03400956|156821341|FG000|Treatment Period 1|Adverse Event|0|||
48815265|NCT01563978|157165751|FG000|Overall Study|Lost to Follow-up|1|||
48499548|NCT03164772|156024414|FG001|Overall Study|Physician Decision|0|||
48499549|NCT03164772|156024413|FG000|Overall Study|Withdrawal by Subject|0|||
48719149|NCT03400956|156821342|FG001|Treatment Period 1|Adverse Event|1|||
48719150|NCT03400956|156821343|FG002|Treatment Period 1|Adverse Event|0|||
48719151|NCT03400956|156821341|FG000|Treatment Period 1|Lost to Follow-up|0|||
48719152|NCT03400956|156821342|FG001|Treatment Period 1|Lost to Follow-up|0|||
48719153|NCT03400956|156821343|FG002|Treatment Period 1|Lost to Follow-up|1|||
48719154|NCT03400956|156821341|FG000|Treatment Period 1|Protocol Violation|0|||
48719155|NCT03400956|156821342|FG001|Treatment Period 1|Protocol Violation|2|||
48719156|NCT03400956|156821343|FG002|Treatment Period 1|Protocol Violation|0|||
48719157|NCT03400956|156821341|FG000|Treatment Period 1|Study terminated by sponsor|3|||
48719158|NCT03400956|156821342|FG001|Treatment Period 1|Study terminated by sponsor|1|||
48719159|NCT03400956|156821343|FG002|Treatment Period 1|Study terminated by sponsor|1|||
48719160|NCT03400956|156821341|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48719161|NCT03400956|156821342|FG001|Treatment Period 1|Withdrawal by Subject|2|||
48599302|NCT02573259|156388024|FG006|Overall Study|Other|5|||
48599303|NCT01628848|156388025|FG000|Overall Study|Adverse Event|9|||
48599304|NCT01628848|156388026|FG001|Overall Study|Adverse Event|7|||
48599305|NCT01628848|156388025|FG000|Overall Study|Lack of Efficacy|0|||
48719162|NCT03400956|156821343|FG002|Treatment Period 1|Withdrawal by Subject|4|||
48719163|NCT03400956|156821341|FG000|Treatment Period 1|Other|1|||
48719164|NCT03400956|156821342|FG001|Treatment Period 1|Other|2|||
48719165|NCT03400956|156821343|FG002|Treatment Period 1|Other|3|||
48719166|NCT03400956|156821341|FG000|Post-treatment Period 1|Adverse Event|0|||
48719167|NCT03400956|156821342|FG001|Post-treatment Period 1|Adverse Event|0|||
48599306|NCT01628848|156388026|FG001|Overall Study|Lack of Efficacy|4|||
48599307|NCT01628848|156388025|FG000|Overall Study|Withdrawal by Subject|0|||
48599308|NCT01628848|156388026|FG001|Overall Study|Withdrawal by Subject|2|||
48599309|NCT01628848|156388025|FG000|Overall Study|Physician Decision|3|||
48599310|NCT01628848|156388026|FG001|Overall Study|Physician Decision|1|||
48599311|NCT01405898|156388029|FG000|Overall Study|Withdrawal by Subject|2|||
48599312|NCT01405898|156388030|FG001|Overall Study|Withdrawal by Subject|2|||
48599313|NCT02283658|156388031|FG000|Overall Study|Withdrawal by Subject|1|||
48599314|NCT01789047|156388033|FG000|Overall Study|Adverse Event|3|||
48599315|NCT01789047|156388034|FG001|Overall Study|Adverse Event|2|||
48599316|NCT01789047|156388033|FG000|Overall Study|Withdrawal by Subject|1|||
48599317|NCT01789047|156388034|FG001|Overall Study|Withdrawal by Subject|2|||
48599318|NCT01839916|156388035|FG000|Overall Study|Death|9|||
48599319|NCT01839916|156388035|FG000|Overall Study|Physician Decision|17|||
48599320|NCT01839916|156388035|FG000|Overall Study|Relapse|12|||
48599321|NCT01839916|156388035|FG000|Overall Study|GVHD|2|||
48599322|NCT01839916|156388035|FG000|Overall Study|Graft Failure|1|||
48599323|NCT00964028|156388036|FG000|Overall Study|Withdrawal by Subject|0|||
48599324|NCT00964028|156388037|FG001|Overall Study|Withdrawal by Subject|1|||
48599325|NCT02104895|156388038|FG000|Overall Study|Withdrawal by Subject|0|||
48599326|NCT02104895|156388039|FG001|Overall Study|Withdrawal by Subject|14|||
48599327|NCT00369343|156388042|FG000|Double-blind Phase|Adverse Event|19|||
48599328|NCT00369343|156388043|FG001|Double-blind Phase|Adverse Event|4|||
48599329|NCT00369343|156388042|FG000|Double-blind Phase|Failed to return|2|||
48599330|NCT00369343|156388043|FG001|Double-blind Phase|Failed to return|0|||
48599331|NCT00369343|156388042|FG000|Double-blind Phase|Lost to Follow-up|9|||
48599332|NCT00369343|156388043|FG001|Double-blind Phase|Lost to Follow-up|2|||
48599333|NCT00369343|156388042|FG000|Double-blind Phase|Protocol Violation|2|||
48599334|NCT00369343|156388043|FG001|Double-blind Phase|Protocol Violation|0|||
48599335|NCT00369343|156388042|FG000|Double-blind Phase|Withdrawal by Subject|8|||
48599336|NCT00369343|156388043|FG001|Double-blind Phase|Withdrawal by Subject|6|||
48599337|NCT00369343|156388042|FG000|Double-blind Phase|Lack of Efficacy|0|||
48599338|NCT00369343|156388043|FG001|Double-blind Phase|Lack of Efficacy|4|||
48599339|NCT00369343|156388042|FG000|Double-blind Phase|Protocol deviation|4|||
48599340|NCT00369343|156388043|FG001|Double-blind Phase|Protocol deviation|0|||
48599341|NCT00369343|156388042|FG000|Open-label Phase|Adverse Event|19|||
48599342|NCT00369343|156388043|FG001|Open-label Phase|Adverse Event|7|||
48599343|NCT00369343|156388042|FG000|Open-label Phase|Failed to return|4|||
48599344|NCT00369343|156388043|FG001|Open-label Phase|Failed to return|0|||
48599345|NCT00369343|156388042|FG000|Open-label Phase|Physician Decision|2|||
48599346|NCT00369343|156388043|FG001|Open-label Phase|Physician Decision|0|||
48599347|NCT00369343|156388042|FG000|Open-label Phase|Lost to Follow-up|5|||
48719168|NCT03400956|156821343|FG002|Post-treatment Period 1|Adverse Event|1|||
48719169|NCT03400956|156821341|FG000|Post-treatment Period 1|Physician Decision|2|||
48599348|NCT00369343|156388043|FG001|Open-label Phase|Lost to Follow-up|3|||
48599349|NCT00369343|156388042|FG000|Open-label Phase|inadvertently reported study completers|3|||
48599350|NCT00369343|156388043|FG001|Open-label Phase|inadvertently reported study completers|2|||
48599351|NCT00369343|156388042|FG000|Open-label Phase|Protocol Violation|1|||
48719170|NCT03400956|156821342|FG001|Post-treatment Period 1|Physician Decision|3|||
48599352|NCT00369343|156388043|FG001|Open-label Phase|Protocol Violation|3|||
48599353|NCT00369343|156388042|FG000|Open-label Phase|Withdrawal by Subject|15|||
48599354|NCT00369343|156388043|FG001|Open-label Phase|Withdrawal by Subject|6|||
48599355|NCT00369343|156388042|FG000|Open-label Phase|Lack of Efficacy|4|||
48599356|NCT00369343|156388043|FG001|Open-label Phase|Lack of Efficacy|3|||
48599357|NCT00369343|156388042|FG000|Open-label Phase|Lack of continuance tolerability|3|||
48719171|NCT03400956|156821343|FG002|Post-treatment Period 1|Physician Decision|0|||
48719172|NCT03400956|156821341|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
48599358|NCT00369343|156388043|FG001|Open-label Phase|Lack of continuance tolerability|4|||
48599359|NCT00369343|156388042|FG000|Open-label Phase|did not take study drug|1|||
48499550|NCT03164772|156024414|FG001|Overall Study|Withdrawal by Subject|4|||
48599360|NCT00369343|156388043|FG001|Open-label Phase|did not take study drug|2|||
48599361|NCT04001803|156388044|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
48599362|NCT04001803|156388044|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
48599363|NCT04001803|156388044|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
48599364|NCT04001803|156388044|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
48599365|NCT04001803|156388044|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
48599366|NCT04001803|156388044|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
48599367|NCT04001803|156388044|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
48599368|NCT04001803|156388044|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
48599369|NCT04001803|156388044|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
48599370|NCT04001803|156388044|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
48599371|NCT01971567|156389680|FG000|Overall Study|Withdrawal by Subject|3|||
48599372|NCT01971567|156389681|FG001|Overall Study|Withdrawal by Subject|2|||
48599373|NCT01971567|156389680|FG000|Overall Study|Lost to Follow-up|1|||
48599374|NCT01971567|156389681|FG001|Overall Study|Lost to Follow-up|0|||
48599375|NCT01239394|156389682|FG000|Overall Study|Adverse Event|1|||
48599376|NCT01697800|156389683|FG000|Overall Study|Death|0|||
48599377|NCT01697800|156389684|FG001|Overall Study|Death|1|||
48499551|NCT01029353|156024418|FG000|Overall Study|Lost to Follow-up|4|||
48499552|NCT01029353|156024419|FG001|Overall Study|Lost to Follow-up|5|||
48499553|NCT01029353|156024420|FG002|Overall Study|Lost to Follow-up|5|||
48499554|NCT01029353|156024421|FG003|Overall Study|Lost to Follow-up|4|||
48499555|NCT01029353|156024418|FG000|Overall Study|Consent Withdrawn|2|||
48499556|NCT01029353|156024419|FG001|Overall Study|Consent Withdrawn|0|||
48499557|NCT01029353|156024420|FG002|Overall Study|Consent Withdrawn|0|||
48599378|NCT04771013|156389688|FG000|Overall Study|Withdrawal by Subject|2|||
48599379|NCT04771013|156389689|FG001|Overall Study|Withdrawal by Subject|0|||
48599380|NCT04771013|156389688|FG000|Overall Study|Death|0|||
48599381|NCT04771013|156389689|FG001|Overall Study|Death|5|||
48599382|NCT04771013|156389688|FG000|Overall Study|Referred to another hospital before day 20|0|||
48719173|NCT03400956|156821342|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
48719174|NCT03400956|156821343|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
48719175|NCT03400956|156821341|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
48499558|NCT01029353|156024421|FG003|Overall Study|Consent Withdrawn|0|||
48499559|NCT01029353|156024418|FG000|Overall Study|Primary Outcome Indeterminate|1|||
48499560|NCT01029353|156024419|FG001|Overall Study|Primary Outcome Indeterminate|3|||
48499561|NCT01029353|156024420|FG002|Overall Study|Primary Outcome Indeterminate|2|||
48499562|NCT01029353|156024421|FG003|Overall Study|Primary Outcome Indeterminate|0|||
48499563|NCT00497796|156024426|FG000|Overall Study|Adverse event (not related)|9|||
48499564|NCT00497796|156024427|FG001|Overall Study|Adverse event (not related)|9|||
48499565|NCT00497796|156024426|FG000|Overall Study|Adverse event (related)|5|||
48499566|NCT00497796|156024427|FG001|Overall Study|Adverse event (related)|4|||
48499567|NCT00497796|156024426|FG000|Overall Study|CMV infection or disease treatment|30|||
48499568|NCT00497796|156024427|FG001|Overall Study|CMV infection or disease treatment|4|||
48499569|NCT00497796|156024426|FG000|Overall Study|Consent withdrawn|10|||
48499570|NCT00497796|156024427|FG001|Overall Study|Consent withdrawn|3|||
48499571|NCT00497796|156024426|FG000|Overall Study|Investigator/sponsor discretion|31|||
48499572|NCT00497796|156024427|FG001|Overall Study|Investigator/sponsor discretion|34|||
48499573|NCT00497796|156024426|FG000|Overall Study|Lost to Follow-up|0|||
48499574|NCT00497796|156024427|FG001|Overall Study|Lost to Follow-up|1|||
48499575|NCT00497796|156024426|FG000|Overall Study|Not applicable (randomized not treated)|0|||
48499576|NCT00497796|156024427|FG001|Overall Study|Not applicable (randomized not treated)|4|||
48499577|NCT00220337|156024428|FG000|Overall Study|Adverse Event|70|||
48499578|NCT00220337|156024428|FG000|Overall Study|Lack of Efficacy|17|||
48499579|NCT00220337|156024428|FG000|Overall Study|Withdrawal by Subject|68|||
48499580|NCT00220337|156024428|FG000|Overall Study|Protocol Violation|2|||
48499581|NCT00220337|156024428|FG000|Overall Study|Lost to Follow-up|5|||
48499582|NCT00220337|156024428|FG000|Overall Study|Other|12|||
48499583|NCT00220337|156024428|FG000|Overall Study|Unsatisfactory compliance|5|||
48499584|NCT01199861|156024429|FG000|Overall Study|Administrative problems|1|||
48499585|NCT01199861|156024430|FG001|Overall Study|Administrative problems|0|||
48499586|NCT01199861|156024429|FG000|Overall Study|Adverse Event|1|||
48499587|NCT01199861|156024430|FG001|Overall Study|Adverse Event|0|||
48499588|NCT02979353|156024434|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
48499589|NCT02979353|156024435|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
48499590|NCT02979353|156024434|FG000|Overall Study|Withdrawal by Subject|16|||
48499591|NCT02979353|156024435|FG001|Overall Study|Withdrawal by Subject|12|||
48499592|NCT02979353|156024434|FG000|Overall Study|Death|10|||
48499593|NCT02979353|156024435|FG001|Overall Study|Death|11|||
48499594|NCT02979353|156024434|FG000|Overall Study|Transfer to Hospice Care|19|||
48499595|NCT02979353|156024435|FG001|Overall Study|Transfer to Hospice Care|14|||
48719176|NCT03400956|156821342|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
48719177|NCT03400956|156821343|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
48719178|NCT03400956|156821341|FG000|Post-treatment Period 1|Other|4|||
48719179|NCT03400956|156821342|FG001|Post-treatment Period 1|Other|3|||
48719180|NCT03400956|156821343|FG002|Post-treatment Period 1|Other|4|||
48719181|NCT03400956|156821341|FG000|Treatment Period 2|Adverse Event|2|||
48719182|NCT03400956|156821342|FG001|Treatment Period 2|Adverse Event|1|||
48719183|NCT03400956|156821343|FG002|Treatment Period 2|Adverse Event|1|||
48719184|NCT03400956|156821341|FG000|Treatment Period 2|Lost to Follow-up|1|||
48719185|NCT03400956|156821342|FG001|Treatment Period 2|Lost to Follow-up|1|||
48719186|NCT03400956|156821343|FG002|Treatment Period 2|Lost to Follow-up|0|||
48719187|NCT03400956|156821341|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48719188|NCT03400956|156821342|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48719189|NCT03400956|156821343|FG002|Treatment Period 2|Withdrawal by Subject|3|||
48719190|NCT03400956|156821341|FG000|Treatment Period 2|Other|1|||
48719191|NCT03400956|156821342|FG001|Treatment Period 2|Other|1|||
48719192|NCT03400956|156821343|FG002|Treatment Period 2|Other|0|||
48719193|NCT03400956|156821341|FG000|Follow-up Period|Withdrawal by Subject|0|||
48719194|NCT03400956|156821342|FG001|Follow-up Period|Withdrawal by Subject|0|||
48719195|NCT03400956|156821343|FG002|Follow-up Period|Withdrawal by Subject|1|||
48719196|NCT03400956|156821341|FG000|Follow-up Period|Other|0|||
48719197|NCT03400956|156821342|FG001|Follow-up Period|Other|0|||
48719198|NCT03400956|156821343|FG002|Follow-up Period|Other|1|||
48719199|NCT00043550|156821344|FG000|Overall Study|Withdrawal by Subject|22|||
48719200|NCT00043550|156821345|FG001|Overall Study|Withdrawal by Subject|12|||
48719201|NCT00043550|156821346|FG002|Overall Study|Withdrawal by Subject|20|||
48719202|NCT01917656|156821347|FG000|Overall Study|Adverse Event|11|||
48719203|NCT01917656|156821348|FG001|Overall Study|Adverse Event|0|||
48719204|NCT01917656|156821347|FG000|Overall Study|Withdrawal criteria|8|||
48719205|NCT01917656|156821348|FG001|Overall Study|Withdrawal criteria|14|||
48719206|NCT01917656|156821347|FG000|Overall Study|Unclassified|0|||
48719207|NCT01917656|156821348|FG001|Overall Study|Unclassified|3|||
48719208|NCT01917656|156821347|FG000|Overall Study|Withdrawal by Subject|4|||
48719209|NCT01917656|156821348|FG001|Overall Study|Withdrawal by Subject|3|||
48719210|NCT01917656|156821347|FG000|Overall Study|Lost to Follow-up|3|||
48719211|NCT01917656|156821348|FG001|Overall Study|Lost to Follow-up|4|||
48719212|NCT02015221|156821349|FG000|Overall Study|Withdrawal by Subject|8|||
48719213|NCT02015221|156821350|FG001|Overall Study|Withdrawal by Subject|6|||
48719214|NCT02015221|156821349|FG000|Overall Study|Lost to Follow-up|1|||
48599383|NCT04771013|156389689|FG001|Overall Study|Referred to another hospital before day 20|1|||
48599384|NCT01255904|156389690|FG000|Overall Study|Physician Decision|1|||
48599385|NCT01255904|156389691|FG001|Overall Study|Physician Decision|4|||
48599386|NCT02915159|156389700|FG000|Overall Study|Participant no longer meets criteria|2|||
48599387|NCT02915159|156389701|FG001|Overall Study|Participant no longer meets criteria|0|||
48599388|NCT02915159|156389700|FG000|Overall Study|poor/non-compliance|1|||
48719215|NCT02015221|156821350|FG001|Overall Study|Lost to Follow-up|0|||
48719216|NCT03579602|156821351|FG000|Overall Study|Subject unable to receive study drug|0|||
48719217|NCT03579602|156821352|FG001|Overall Study|Subject unable to receive study drug|2|||
48719218|NCT03579602|156821351|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
48719219|NCT03579602|156821352|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
48719220|NCT03149848|156821366|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
48719221|NCT03149848|156821366|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
48719222|NCT01924429|156821368|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
48719223|NCT01924429|156821369|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
48719224|NCT00217464|156821370|FG000|Overall Study|Progression|15|||
48719225|NCT00217464|156821370|FG000|Overall Study|Other|2|||
48719226|NCT01227629|156821371|FG000|Overall Study|Adverse Event|2|||
48719227|NCT01227629|156821372|FG001|Overall Study|Adverse Event|2|||
48719228|NCT01227629|156821373|FG002|Overall Study|Adverse Event|1|||
48719229|NCT01227629|156821374|FG003|Overall Study|Adverse Event|6|||
48719230|NCT01227629|156821375|FG004|Overall Study|Adverse Event|1|||
48719231|NCT01227629|156821376|FG005|Overall Study|Adverse Event|1|||
48719232|NCT01227629|156821377|FG006|Overall Study|Adverse Event|6|||
48719233|NCT01227629|156821378|FG007|Overall Study|Adverse Event|6|||
48719234|NCT01227629|156821379|FG008|Overall Study|Adverse Event|4|||
48815266|NCT01563978|157165752|FG001|Overall Study|Lost to Follow-up|0|||
48599389|NCT02915159|156389701|FG001|Overall Study|poor/non-compliance|0|||
48599390|NCT02915159|156389700|FG000|Overall Study|Participant withdrew consent|5|||
48719235|NCT01227629|156821380|FG009|Overall Study|Adverse Event|0|||
48719236|NCT01227629|156821371|FG000|Overall Study|Protocol Violation|0|||
48719237|NCT01227629|156821372|FG001|Overall Study|Protocol Violation|0|||
48719238|NCT01227629|156821373|FG002|Overall Study|Protocol Violation|0|||
48719239|NCT01227629|156821374|FG003|Overall Study|Protocol Violation|1|||
48719240|NCT01227629|156821375|FG004|Overall Study|Protocol Violation|0|||
48719241|NCT01227629|156821376|FG005|Overall Study|Protocol Violation|0|||
48719242|NCT01227629|156821377|FG006|Overall Study|Protocol Violation|0|||
48719243|NCT01227629|156821378|FG007|Overall Study|Protocol Violation|0|||
48719244|NCT01227629|156821379|FG008|Overall Study|Protocol Violation|0|||
48719245|NCT01227629|156821380|FG009|Overall Study|Protocol Violation|0|||
48719246|NCT01227629|156821371|FG000|Overall Study|Lost to Follow-up|0|||
48719247|NCT01227629|156821372|FG001|Overall Study|Lost to Follow-up|0|||
48719248|NCT01227629|156821373|FG002|Overall Study|Lost to Follow-up|0|||
48719249|NCT01227629|156821374|FG003|Overall Study|Lost to Follow-up|0|||
48719250|NCT01227629|156821375|FG004|Overall Study|Lost to Follow-up|1|||
48719251|NCT01227629|156821376|FG005|Overall Study|Lost to Follow-up|0|||
48499596|NCT02979353|156024434|FG000|Overall Study|Lost to Follow-up|1|||
48719252|NCT01227629|156821377|FG006|Overall Study|Lost to Follow-up|0|||
48719253|NCT01227629|156821378|FG007|Overall Study|Lost to Follow-up|0|||
48719254|NCT01227629|156821379|FG008|Overall Study|Lost to Follow-up|0|||
48719255|NCT01227629|156821380|FG009|Overall Study|Lost to Follow-up|0|||
48719256|NCT01227629|156821371|FG000|Overall Study|Withdrawal by Subject|0|||
48719257|NCT01227629|156821372|FG001|Overall Study|Withdrawal by Subject|0|||
48719258|NCT01227629|156821373|FG002|Overall Study|Withdrawal by Subject|0|||
48719259|NCT01227629|156821374|FG003|Overall Study|Withdrawal by Subject|0|||
48719260|NCT01227629|156821375|FG004|Overall Study|Withdrawal by Subject|0|||
48719261|NCT01227629|156821376|FG005|Overall Study|Withdrawal by Subject|0|||
48499597|NCT02979353|156024435|FG001|Overall Study|Lost to Follow-up|5|||
48499598|NCT03309956|156024440|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
48499599|NCT04025879|156024441|FG000|Randomization|Participant withdrew consent|0|||
48499600|NCT04025879|156024442|FG001|Randomization|Participant withdrew consent|1|||
48499601|NCT04025879|156024441|FG000|Randomization|Participant no longer met study criteria|1|||
48499602|NCT04025879|156024442|FG001|Randomization|Participant no longer met study criteria|1|||
48499603|NCT04025879|156024441|FG000|Treatment|Ongoing treatment|10|||
48499604|NCT04025879|156024442|FG001|Treatment|Ongoing treatment|8|||
48499605|NCT04025879|156024441|FG000|Treatment|Disease progression/recurrence|36|||
48499606|NCT04025879|156024442|FG001|Treatment|Disease progression/recurrence|72|||
48499607|NCT04025879|156024441|FG000|Treatment|Study drug toxicity|36|||
48499608|NCT04025879|156024442|FG001|Treatment|Study drug toxicity|13|||
48499609|NCT04025879|156024441|FG000|Treatment|Death|2|||
48499610|NCT04025879|156024442|FG001|Treatment|Death|0|||
48499611|NCT04025879|156024441|FG000|Treatment|Adverse event unrelated to study drug|21|||
48499612|NCT04025879|156024442|FG001|Treatment|Adverse event unrelated to study drug|14|||
48499613|NCT04025879|156024441|FG000|Treatment|Participant request to discontinue study treatment|16|||
48499614|NCT04025879|156024442|FG001|Treatment|Participant request to discontinue study treatment|8|||
48499615|NCT04025879|156024441|FG000|Treatment|Participant withdrew consent|1|||
48499616|NCT04025879|156024442|FG001|Treatment|Participant withdrew consent|3|||
48499617|NCT04025879|156024441|FG000|Treatment|Participant no longer meets study criteria|3|||
48499618|NCT04025879|156024442|FG001|Treatment|Participant no longer meets study criteria|2|||
48499619|NCT04025879|156024441|FG000|Treatment|Lost to Follow-up|1|||
48499620|NCT04025879|156024442|FG001|Treatment|Lost to Follow-up|0|||
48499621|NCT04025879|156024441|FG000|Treatment|Other reasons|15|||
48499622|NCT04025879|156024442|FG001|Treatment|Other reasons|17|||
48499623|NCT04025879|156024441|FG000|Treatment|Administrative reason by sponsor|0|||
48499624|NCT04025879|156024442|FG001|Treatment|Administrative reason by sponsor|1|||
48499625|NCT04025879|156024441|FG000|Treatment|Not reported|2|||
48499626|NCT04025879|156024442|FG001|Treatment|Not reported|0|||
48499627|NCT02170688|156024443|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
48499628|NCT02170688|156024444|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
48499629|NCT02170688|156024445|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
48499630|NCT02170688|156024446|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
48499631|NCT02170688|156024447|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
48499632|NCT02170688|156024443|FG000|Overall Study|Full dose not received|0|||
48499633|NCT02170688|156024444|FG001|Overall Study|Full dose not received|1|||
48499634|NCT02170688|156024445|FG002|Overall Study|Full dose not received|0|||
48499635|NCT02170688|156024446|FG003|Overall Study|Full dose not received|0|||
48499636|NCT02170688|156024447|FG004|Overall Study|Full dose not received|0|||
48499637|NCT02170688|156024443|FG000|Overall Study|Physician Decision|0|||
48499638|NCT02170688|156024444|FG001|Overall Study|Physician Decision|0|||
48499639|NCT02170688|156024445|FG002|Overall Study|Physician Decision|1|||
48499640|NCT02170688|156024446|FG003|Overall Study|Physician Decision|0|||
48499641|NCT02170688|156024447|FG004|Overall Study|Physician Decision|0|||
48499642|NCT03329027|156026048|FG000|Overall Study|Lost to Follow-up|1|||
48499643|NCT03329027|156026049|FG001|Overall Study|Lost to Follow-up|0|||
48499644|NCT03329027|156026050|FG002|Overall Study|Lost to Follow-up|1|||
48499645|NCT03329027|156026048|FG000|Overall Study|Protocol Violation|9|||
48499646|NCT03329027|156026049|FG001|Overall Study|Protocol Violation|5|||
48499647|NCT03329027|156026050|FG002|Overall Study|Protocol Violation|7|||
48499648|NCT00076102|156026051|FG000|Overall Study|Clinical progression|1|||
48499649|NCT00076102|156026051|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
48719262|NCT01227629|156821377|FG006|Overall Study|Withdrawal by Subject|2|||
48719263|NCT01227629|156821378|FG007|Overall Study|Withdrawal by Subject|0|||
48719264|NCT01227629|156821379|FG008|Overall Study|Withdrawal by Subject|0|||
48719265|NCT01227629|156821380|FG009|Overall Study|Withdrawal by Subject|1|||
48599391|NCT02915159|156389701|FG001|Overall Study|Participant withdrew consent|1|||
48599392|NCT02915159|156389700|FG000|Overall Study|Request to discontinue treatment|1|||
48599393|NCT02915159|156389701|FG001|Overall Study|Request to discontinue treatment|2|||
48599394|NCT02915159|156389700|FG000|Overall Study|Adverse Event|2|||
48599395|NCT02915159|156389701|FG001|Overall Study|Adverse Event|2|||
48599396|NCT02915159|156389700|FG000|Overall Study|Lack of Efficacy|0|||
48599397|NCT02915159|156389701|FG001|Overall Study|Lack of Efficacy|3|||
48599398|NCT00003483|156389708|FG000|Overall Study|Not evaluable|1|||
48599399|NCT00873730|156389709|FG000|Overall Study|Protocol Deviation|5|||
48599400|NCT00873730|156389710|FG001|Overall Study|Protocol Deviation|2|||
48599401|NCT00873730|156389709|FG000|Overall Study|Adverse Event|0|||
48599402|NCT00873730|156389710|FG001|Overall Study|Adverse Event|2|||
48499650|NCT00076102|156026051|FG000|Overall Study|plexiform neurofibroma surgery|1|||
48499651|NCT00076102|156026051|FG000|Overall Study|refusal of further therapy|2|||
48499652|NCT01210001|156026054|FG000|Overall Study|Not treated|1|||
48499653|NCT01210001|156026055|FG001|Overall Study|Not treated|0|||
48599403|NCT00873730|156389709|FG000|Overall Study|Withdrawal by Subject|0|||
48599404|NCT00873730|156389710|FG001|Overall Study|Withdrawal by Subject|1|||
48599405|NCT00873730|156389709|FG000|Overall Study|Sponsor decision|1|||
48599406|NCT00873730|156389710|FG001|Overall Study|Sponsor decision|0|||
48719266|NCT01227629|156821371|FG000|Overall Study|Other|0|||
48719267|NCT01227629|156821372|FG001|Overall Study|Other|0|||
48719268|NCT01227629|156821373|FG002|Overall Study|Other|0|||
48719269|NCT01227629|156821374|FG003|Overall Study|Other|1|||
48719270|NCT01227629|156821375|FG004|Overall Study|Other|0|||
48719271|NCT01227629|156821376|FG005|Overall Study|Other|0|||
48719272|NCT01227629|156821377|FG006|Overall Study|Other|0|||
48719273|NCT01227629|156821378|FG007|Overall Study|Other|0|||
48719274|NCT01227629|156821379|FG008|Overall Study|Other|2|||
48719275|NCT01227629|156821380|FG009|Overall Study|Other|1|||
48719276|NCT02545543|156821381|FG000|Overall Study|Lost to Follow-up|67|||
48719277|NCT02545543|156821382|FG001|Overall Study|Lost to Follow-up|25|||
48719278|NCT02545543|156821381|FG000|Overall Study|Physician Decision|3|||
48719279|NCT02545543|156821382|FG001|Overall Study|Physician Decision|0|||
48719280|NCT02545543|156821381|FG000|Overall Study|Withdrawal by Subject|9|||
48719281|NCT02545543|156821382|FG001|Overall Study|Withdrawal by Subject|8|||
48719282|NCT02545543|156821381|FG000|Overall Study|Noncomplaince|1|||
48719283|NCT02545543|156821382|FG001|Overall Study|Noncomplaince|0|||
48499654|NCT01210001|156026056|FG002|Overall Study|Not treated|0|||
48499655|NCT01210001|156026054|FG000|Overall Study|Adverse Event|4|||
48499656|NCT01210001|156026055|FG001|Overall Study|Adverse Event|2|||
48499657|NCT01210001|156026056|FG002|Overall Study|Adverse Event|5|||
48499658|NCT01210001|156026054|FG000|Overall Study|Non compliant with protocol|2|||
48499659|NCT01210001|156026055|FG001|Overall Study|Non compliant with protocol|2|||
48499660|NCT01210001|156026056|FG002|Overall Study|Non compliant with protocol|3|||
48499661|NCT01210001|156026054|FG000|Overall Study|Lost to Follow-up|4|||
48499662|NCT01210001|156026055|FG001|Overall Study|Lost to Follow-up|3|||
48499663|NCT01210001|156026056|FG002|Overall Study|Lost to Follow-up|2|||
48499664|NCT01210001|156026054|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
48499665|NCT01210001|156026055|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
48499666|NCT01210001|156026056|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
48499667|NCT01210001|156026054|FG000|Overall Study|Other reason not defined above|2|||
48499668|NCT01210001|156026055|FG001|Overall Study|Other reason not defined above|2|||
48499669|NCT01210001|156026056|FG002|Overall Study|Other reason not defined above|1|||
48499670|NCT02207231|156026062|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
48499671|NCT02207231|156026063|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
48499672|NCT02207231|156026064|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
48499673|NCT02207231|156026065|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
48499674|NCT02207231|156026062|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
48599407|NCT04613739|156389711|FG000|Overall Study|Lost to Follow-up|6|||
48599408|NCT04613739|156389712|FG001|Overall Study|Lost to Follow-up|9|||
48599409|NCT04613739|156389711|FG000|Overall Study|potentially duplicative/fraudulent|1|||
48599410|NCT04613739|156389712|FG001|Overall Study|potentially duplicative/fraudulent|3|||
48599411|NCT03373760|156389713|FG000|Overall Study|Adverse Event|8|||
48599412|NCT03373760|156389713|FG000|Overall Study|Disease Progression|46|||
48599413|NCT03373760|156389713|FG000|Overall Study|Death|4|||
48599414|NCT00357877|156389719|FG000|Overall Study|Death|2|||
48719284|NCT02545543|156821381|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
48499675|NCT02207231|156026063|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
48499676|NCT02207231|156026064|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
48499677|NCT02207231|156026065|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
48499678|NCT02207231|156026062|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
48719285|NCT02545543|156821382|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
48719286|NCT00523367|156821383|FG000|Overall Study|19 screen failures|19|||
48719287|NCT00523367|156821383|FG000|Overall Study|4 Withdrawn by PI|4|||
48719288|NCT03387111|156822876|FG000|Overall Study|Progressive Disease|3|||
48719289|NCT03387111|156822876|FG000|Overall Study|Other|1|||
48499679|NCT02207231|156026063|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
48499680|NCT02207231|156026064|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
48599415|NCT00357877|156389720|FG001|Overall Study|Death|1|||
48599416|NCT00357877|156389719|FG000|Overall Study|Lost to Follow-up|20|||
48815267|NCT01563978|157165751|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
48815268|NCT01563978|157165752|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
48815269|NCT01563978|157165751|FG000|Overall Study|Adverse Event|1|||
48815270|NCT01563978|157165752|FG001|Overall Study|Adverse Event|2|||
48815271|NCT05764239|157165753|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
48815272|NCT05764239|157165753|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
48815273|NCT05764239|157165753|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
48815274|NCT05764239|157165753|FG000|DEP (Part 1)|Adverse Event|1|||
48599417|NCT00357877|156389720|FG001|Overall Study|Lost to Follow-up|23|||
48599418|NCT00357877|156389719|FG000|Overall Study|Withdrawal by Subject|3|||
48599419|NCT00357877|156389720|FG001|Overall Study|Withdrawal by Subject|3|||
48599420|NCT00357877|156389719|FG000|Overall Study|Administrative withdrawal|1|||
48599421|NCT00357877|156389720|FG001|Overall Study|Administrative withdrawal|1|||
48599422|NCT00357877|156389719|FG000|Overall Study|Other|0|||
48599423|NCT00357877|156389720|FG001|Overall Study|Other|2|||
48815275|NCT05764239|157165753|FG000|DEP (Part 1)|Lost to Follow-up|1|||
48815276|NCT05764239|157165753|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
48815277|NCT05764239|157165753|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
48815278|NCT05764239|157165753|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
48815279|NCT05764239|157165753|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
48815280|NCT00729690|157165754|FG000|Overall Study|IT Catheter Malfunction|0|||
48815281|NCT00729690|157165755|FG001|Overall Study|IT Catheter Malfunction|2|||
48815282|NCT00729690|157165756|FG002|Overall Study|IT Catheter Malfunction|2|||
48815283|NCT05593211|157165758|FG000|Overall Study|Withdrawal by Subject|1|||
48815284|NCT00996580|157165762|FG000|Overall Study|Adverse Event|466|||
48815285|NCT00996580|157165762|FG000|Overall Study|Lost to Follow-up|480|||
48815286|NCT00996580|157165762|FG000|Overall Study|Noncompliance with the protocol|137|||
48815287|NCT00996580|157165762|FG000|Overall Study|Physician Decision|5|||
48815288|NCT00996580|157165762|FG000|Overall Study|Pregnancy|68|||
48815289|NCT00996580|157165762|FG000|Overall Study|Protocol Violation|16|||
48815290|NCT00996580|157165762|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
48815291|NCT00996580|157165762|FG000|Overall Study|Withdrawal by Subject|217|||
48815292|NCT00996580|157165762|FG000|Overall Study|Other|29|||
48815293|NCT04248465|157165765|FG000|Randomized-Controlled Period|Death|12|||
48815294|NCT04248465|157165766|FG001|Randomized-Controlled Period|Death|5|||
48815295|NCT04248465|157165765|FG000|Randomized-Controlled Period|Adverse Event|2|||
48815296|NCT04248465|157165766|FG001|Randomized-Controlled Period|Adverse Event|0|||
48499681|NCT02207231|156026065|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
48499682|NCT02207231|156026062|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
48499683|NCT02207231|156026063|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
48499684|NCT02207231|156026064|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
48499685|NCT02207231|156026065|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
48499686|NCT02207231|156026062|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
48499687|NCT02207231|156026063|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
48499688|NCT02207231|156026064|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
48499689|NCT02207231|156026065|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
48499690|NCT02207231|156026062|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
48499691|NCT02207231|156026063|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
48499692|NCT02207231|156026064|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
48499693|NCT02207231|156026065|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
48499694|NCT02207231|156026062|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
48499695|NCT02207231|156026063|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
48499696|NCT02207231|156026064|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
48499697|NCT02207231|156026065|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
48499698|NCT02207231|156026062|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
48599424|NCT01051557|156389721|FG000|Overall Study|Physician Decision|1|||
48599425|NCT01051557|156389722|FG001|Overall Study|Physician Decision|0|||
48599426|NCT01051557|156389723|FG002|Overall Study|Physician Decision|0|||
48599427|NCT01051557|156389724|FG003|Overall Study|Physician Decision|0|||
48599428|NCT01051557|156389725|FG004|Overall Study|Physician Decision|0|||
48599429|NCT01051557|156389726|FG005|Overall Study|Physician Decision|0|||
48599430|NCT01051557|156389727|FG006|Overall Study|Physician Decision|0|||
48815297|NCT04248465|157165765|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
48815298|NCT04248465|157165766|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
48815299|NCT04248465|157165765|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
48815300|NCT04248465|157165766|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
48815301|NCT04248465|157165765|FG000|Randomized-Controlled Period|Physician Decision|1|||
48815302|NCT04248465|157165766|FG001|Randomized-Controlled Period|Physician Decision|1|||
48599431|NCT01051557|156389721|FG000|Overall Study|disease progression|3|||
48599432|NCT01051557|156389722|FG001|Overall Study|disease progression|3|||
48599433|NCT01051557|156389723|FG002|Overall Study|disease progression|5|||
48599434|NCT01051557|156389724|FG003|Overall Study|disease progression|2|||
48599435|NCT01051557|156389725|FG004|Overall Study|disease progression|4|||
48599436|NCT01051557|156389726|FG005|Overall Study|disease progression|3|||
48719290|NCT00535288|156822889|FG000|Overall Study|Adverse Event|20|||
48719291|NCT00535288|156822890|FG001|Overall Study|Adverse Event|19|||
48719292|NCT00535288|156822891|FG002|Overall Study|Adverse Event|25|||
48719293|NCT00535288|156822892|FG003|Overall Study|Adverse Event|20|||
48719294|NCT00535288|156822893|FG004|Overall Study|Adverse Event|30|||
48719295|NCT00535288|156822889|FG000|Overall Study|Lost to Follow-up|0|||
48719296|NCT00535288|156822890|FG001|Overall Study|Lost to Follow-up|3|||
48719297|NCT00535288|156822891|FG002|Overall Study|Lost to Follow-up|0|||
48719298|NCT00535288|156822892|FG003|Overall Study|Lost to Follow-up|0|||
48719299|NCT00535288|156822893|FG004|Overall Study|Lost to Follow-up|0|||
48719300|NCT00535288|156822889|FG000|Overall Study|Lack of Efficacy|26|||
48719301|NCT00535288|156822890|FG001|Overall Study|Lack of Efficacy|3|||
48719302|NCT00535288|156822891|FG002|Overall Study|Lack of Efficacy|4|||
48719303|NCT00535288|156822892|FG003|Overall Study|Lack of Efficacy|4|||
48719304|NCT00535288|156822893|FG004|Overall Study|Lack of Efficacy|7|||
48719305|NCT00535288|156822889|FG000|Overall Study|Unwilling to cooperate|6|||
48719306|NCT00535288|156822890|FG001|Overall Study|Unwilling to cooperate|6|||
48719307|NCT00535288|156822891|FG002|Overall Study|Unwilling to cooperate|3|||
48719308|NCT00535288|156822892|FG003|Overall Study|Unwilling to cooperate|3|||
48719309|NCT00535288|156822893|FG004|Overall Study|Unwilling to cooperate|4|||
48719310|NCT00535288|156822889|FG000|Overall Study|Other|2|||
48719311|NCT00535288|156822890|FG001|Overall Study|Other|1|||
48719312|NCT00535288|156822891|FG002|Overall Study|Other|1|||
48719313|NCT00535288|156822892|FG003|Overall Study|Other|2|||
48719314|NCT00535288|156822893|FG004|Overall Study|Other|1|||
48719315|NCT00369629|156822894|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
48719316|NCT00369629|156822895|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
48719317|NCT00369629|156822896|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
48719318|NCT00369629|156822897|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
48719319|NCT00369629|156822894|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
48719320|NCT00369629|156822895|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
48719321|NCT00369629|156822896|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
48719322|NCT00369629|156822897|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
48719323|NCT00369629|156822894|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
48719324|NCT00369629|156822895|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
48719325|NCT00369629|156822896|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
48719326|NCT00369629|156822897|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
48719327|NCT00369629|156822894|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
48719328|NCT00369629|156822895|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
48719329|NCT00369629|156822896|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
48719330|NCT00369629|156822897|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
48719331|NCT00369629|156822894|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
48719332|NCT00369629|156822895|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
48719333|NCT00369629|156822896|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
48719334|NCT00369629|156822897|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
48719335|NCT00369629|156822894|FG000|Completed 4 More Cycles|Progressive disease|2|||
48719336|NCT00369629|156822895|FG001|Completed 4 More Cycles|Progressive disease|1|||
48719337|NCT00369629|156822896|FG002|Completed 4 More Cycles|Progressive disease|2|||
48719338|NCT00369629|156822897|FG003|Completed 4 More Cycles|Progressive disease|0|||
48719339|NCT00369629|156822894|FG000|Follow up for 1 Year|Death|2|||
48599437|NCT01051557|156389727|FG006|Overall Study|disease progression|1|||
48599438|NCT01051557|156389721|FG000|Overall Study|Withdrawal by Subject|0|||
48599439|NCT01051557|156389722|FG001|Overall Study|Withdrawal by Subject|0|||
48719340|NCT00369629|156822895|FG001|Follow up for 1 Year|Death|1|||
48719341|NCT00369629|156822896|FG002|Follow up for 1 Year|Death|1|||
48719342|NCT00369629|156822897|FG003|Follow up for 1 Year|Death|0|||
48719343|NCT00369629|156822894|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
48719344|NCT00369629|156822895|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
48719345|NCT00369629|156822896|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
48719346|NCT00369629|156822897|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
48719347|NCT00369629|156822894|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
48719348|NCT00369629|156822895|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
48719349|NCT00369629|156822896|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
48599440|NCT01051557|156389723|FG002|Overall Study|Withdrawal by Subject|1|||
48599441|NCT01051557|156389724|FG003|Overall Study|Withdrawal by Subject|0|||
48599442|NCT01051557|156389725|FG004|Overall Study|Withdrawal by Subject|2|||
48815303|NCT04248465|157165765|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
48599443|NCT01051557|156389726|FG005|Overall Study|Withdrawal by Subject|0|||
48599444|NCT01051557|156389727|FG006|Overall Study|Withdrawal by Subject|1|||
48599445|NCT01051557|156389721|FG000|Overall Study|Adverse Event|0|||
48599446|NCT01051557|156389722|FG001|Overall Study|Adverse Event|0|||
48599447|NCT01051557|156389723|FG002|Overall Study|Adverse Event|0|||
48599448|NCT01051557|156389724|FG003|Overall Study|Adverse Event|1|||
48719350|NCT00369629|156822897|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
48719351|NCT01129583|156822898|FG000|Overall Study|Death|1|||
48719352|NCT01129583|156822899|FG001|Overall Study|Death|0|||
48719353|NCT01129583|156822898|FG000|Overall Study|Lost to Follow-up|1|||
48719354|NCT01129583|156822899|FG001|Overall Study|Lost to Follow-up|1|||
48719355|NCT01129583|156822898|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
48719356|NCT01129583|156822899|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
48719357|NCT01604278|156822900|FG000|Overall Study|Lack of Efficacy|0|||
48719358|NCT01604278|156822901|FG001|Overall Study|Lack of Efficacy|1|||
48719359|NCT01604278|156822900|FG000|Overall Study|Lost to Follow-up|1|||
48719360|NCT01604278|156822901|FG001|Overall Study|Lost to Follow-up|0|||
48719361|NCT01604278|156822900|FG000|Overall Study|Administrative problems|2|||
48499699|NCT02207231|156026063|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
48499700|NCT02207231|156026064|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
48499701|NCT02207231|156026065|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
48499702|NCT02207231|156026062|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
48499703|NCT02207231|156026063|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
48499704|NCT02207231|156026064|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
48499705|NCT02207231|156026065|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
48499706|NCT02207231|156026062|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
48499707|NCT02207231|156026063|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
48499708|NCT02207231|156026064|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
48499709|NCT02207231|156026065|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
48499710|NCT02207231|156026062|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
48499711|NCT02207231|156026063|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
48499712|NCT02207231|156026064|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
48499713|NCT02207231|156026065|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
48499714|NCT02207231|156026062|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
48499715|NCT02207231|156026063|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
48499716|NCT02207231|156026064|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
48499717|NCT02207231|156026065|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
48499718|NCT02207231|156026062|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
48499719|NCT02207231|156026063|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
48499720|NCT02207231|156026064|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
48499721|NCT02207231|156026065|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
48499722|NCT02207231|156026062|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
48499723|NCT02207231|156026063|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
48499724|NCT02207231|156026064|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
48499725|NCT02207231|156026065|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
48499726|NCT02207231|156026062|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
48499727|NCT02207231|156026063|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
48499728|NCT02207231|156026064|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
48499729|NCT02207231|156026065|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
48499730|NCT02207231|156026062|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
48499731|NCT02207231|156026063|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
48499732|NCT02207231|156026064|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
48499733|NCT02207231|156026065|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
48499734|NCT02207231|156026062|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
48499735|NCT02207231|156026063|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
48499736|NCT02207231|156026064|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
48499737|NCT02207231|156026065|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
48499738|NCT02207231|156026062|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
48499739|NCT02207231|156026063|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
48499740|NCT02207231|156026064|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
48499741|NCT02207231|156026065|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
48499742|NCT02207231|156026062|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
48599449|NCT01051557|156389725|FG004|Overall Study|Adverse Event|1|||
48599450|NCT01051557|156389726|FG005|Overall Study|Adverse Event|3|||
48719362|NCT01604278|156822901|FG001|Overall Study|Administrative problems|1|||
48815304|NCT04248465|157165766|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
48499743|NCT02207231|156026063|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
48499744|NCT02207231|156026064|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
48499745|NCT02207231|156026065|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
48719363|NCT01604278|156822900|FG000|Overall Study|Withdrawal by Subject|3|||
48719364|NCT01604278|156822901|FG001|Overall Study|Withdrawal by Subject|3|||
48719365|NCT01604278|156822900|FG000|Overall Study|Adverse Event|3|||
48719366|NCT01604278|156822901|FG001|Overall Study|Adverse Event|5|||
48719367|NCT01604278|156822900|FG000|Overall Study|Protocol Deviation|5|||
48719368|NCT01604278|156822901|FG001|Overall Study|Protocol Deviation|3|||
48719369|NCT03390101|156822905|FG000|Weeks 0-12|Withdrawal by Subject|0|||
48719370|NCT03390101|156822906|FG001|Weeks 0-12|Withdrawal by Subject|1|||
48719371|NCT03390101|156822907|FG002|Weeks 0-12|Withdrawal by Subject|1|||
48719372|NCT03390101|156822905|FG000|Weeks 0-12|Lost to Follow-up|0|||
48719373|NCT03390101|156822906|FG001|Weeks 0-12|Lost to Follow-up|1|||
48719374|NCT03390101|156822907|FG002|Weeks 0-12|Lost to Follow-up|0|||
48719375|NCT03390101|156822905|FG000|Weeks 12-54|Withdrawal by Subject|0|||
48719376|NCT03390101|156822906|FG001|Weeks 12-54|Withdrawal by Subject|3|||
48719377|NCT03390101|156822907|FG002|Weeks 12-54|Withdrawal by Subject|1|||
48719378|NCT03390101|156822905|FG000|Weeks 12-54|Pregnancy|1|||
48719379|NCT03390101|156822906|FG001|Weeks 12-54|Pregnancy|0|||
48719380|NCT03390101|156822907|FG002|Weeks 12-54|Pregnancy|0|||
48719381|NCT03390101|156822905|FG000|Weeks 12-54|Adverse Event|2|||
48719382|NCT03390101|156822906|FG001|Weeks 12-54|Adverse Event|1|||
48719383|NCT03390101|156822907|FG002|Weeks 12-54|Adverse Event|1|||
48499746|NCT02207231|156026062|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
48499747|NCT02207231|156026063|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
48499748|NCT02207231|156026064|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
48499749|NCT02207231|156026065|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
48499750|NCT02207231|156026062|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
48499751|NCT02207231|156026063|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
48499752|NCT02207231|156026064|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
48499753|NCT02207231|156026065|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
48499754|NCT04015232|156026070|FG000|Overall Study|Withdrawal by Subject|7|||
48499755|NCT04015232|156026071|FG001|Overall Study|Withdrawal by Subject|4|||
48499756|NCT04015232|156026070|FG000|Overall Study|Protocol Violation|1|||
48499757|NCT04015232|156026071|FG001|Overall Study|Protocol Violation|0|||
48499758|NCT04015232|156026070|FG000|Overall Study|Medical Grounds|3|||
48499759|NCT04015232|156026071|FG001|Overall Study|Medical Grounds|3|||
48499760|NCT03127137|156026073|FG000|Overall Study|Requested sedation after consent|1|||
48499761|NCT03127137|156026074|FG001|Overall Study|Requested sedation after consent|0|||
48499762|NCT03127137|156026073|FG000|Overall Study|Malfunction in electronic data collection|1|||
48499763|NCT03127137|156026074|FG001|Overall Study|Malfunction in electronic data collection|0|||
48499764|NCT03127137|156026073|FG000|Overall Study|Post procedure testing could not be obtained|0|||
48499765|NCT03127137|156026074|FG001|Overall Study|Post procedure testing could not be obtained|1|||
48499766|NCT02433678|156026075|FG000|Overall Study|Lost to Follow-up|1|||
48499767|NCT02433678|156026076|FG001|Overall Study|Lost to Follow-up|2|||
48499768|NCT03787680|156026084|FG000|Overall Study|Physician Decision|2|||
48499769|NCT03787680|156026085|FG001|Overall Study|Physician Decision|3|||
48499770|NCT03787680|156026084|FG000|Overall Study|Adverse Event|7|||
48499771|NCT03787680|156026085|FG001|Overall Study|Adverse Event|3|||
48499772|NCT03787680|156026084|FG000|Overall Study|Withdrawal by Subject|2|||
48499773|NCT03787680|156026085|FG001|Overall Study|Withdrawal by Subject|1|||
48499774|NCT00995410|156026088|FG000|Overall Study|Adverse Event|51|||
48499775|NCT00995410|156026088|FG000|Overall Study|Withdrawal by Subject|7|||
48499776|NCT00995410|156026088|FG000|Overall Study|Lost to Follow-up|2|||
48499777|NCT00995410|156026088|FG000|Overall Study|Misc|28|||
48499778|NCT01700621|156026089|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
48719384|NCT01511055|156822909|FG000|Overall Study|Withdrawal by Subject|6|||
48719385|NCT01122264|156822910|FG000|Overall Study|Adverse Event|6|||
48719386|NCT01122264|156822911|FG001|Overall Study|Adverse Event|5|||
48719387|NCT01122264|156822912|FG002|Overall Study|Adverse Event|7|||
48719388|NCT01122264|156822910|FG000|Overall Study|Death|1|||
48719389|NCT01122264|156822911|FG001|Overall Study|Death|0|||
48719390|NCT01122264|156822912|FG002|Overall Study|Death|0|||
48719391|NCT01122264|156822910|FG000|Overall Study|Lost to Follow-up|5|||
48719392|NCT01122264|156822911|FG001|Overall Study|Lost to Follow-up|9|||
48719393|NCT01122264|156822912|FG002|Overall Study|Lost to Follow-up|13|||
48719394|NCT01122264|156822910|FG000|Overall Study|Entry Criteria Not Met|1|||
48719395|NCT01122264|156822911|FG001|Overall Study|Entry Criteria Not Met|0|||
48719396|NCT01122264|156822912|FG002|Overall Study|Entry Criteria Not Met|0|||
48719397|NCT01122264|156822910|FG000|Overall Study|Protocol Violation|7|||
48719398|NCT01122264|156822911|FG001|Overall Study|Protocol Violation|7|||
48719399|NCT01122264|156822912|FG002|Overall Study|Protocol Violation|9|||
48719400|NCT01122264|156822910|FG000|Overall Study|Withdrawal by Subject|6|||
48719401|NCT01122264|156822911|FG001|Overall Study|Withdrawal by Subject|6|||
48719402|NCT01122264|156822912|FG002|Overall Study|Withdrawal by Subject|16|||
48499779|NCT01700621|156026090|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
48499780|NCT01700621|156026089|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
48719403|NCT01122264|156822910|FG000|Overall Study|Physician Decision|3|||
48719404|NCT01122264|156822911|FG001|Overall Study|Physician Decision|1|||
48719405|NCT01122264|156822912|FG002|Overall Study|Physician Decision|1|||
48499781|NCT01700621|156026090|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
48499782|NCT01700621|156026089|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
48719406|NCT01122264|156822910|FG000|Overall Study|Lack of Efficacy|3|||
48719407|NCT01122264|156822911|FG001|Overall Study|Lack of Efficacy|1|||
48719408|NCT01122264|156822912|FG002|Overall Study|Lack of Efficacy|1|||
48719409|NCT04585009|156822915|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
48719410|NCT04585009|156822916|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719411|NCT04585009|156822917|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719412|NCT04585009|156822918|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719413|NCT04585009|156822919|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719414|NCT04585009|156822920|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719415|NCT04585009|156822921|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719416|NCT04585009|156822922|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719417|NCT04585009|156822923|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719418|NCT04585009|156822924|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719419|NCT04585009|156822925|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719420|NCT04585009|156822926|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
48719421|NCT04585009|156822915|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
48719422|NCT04585009|156822916|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719423|NCT04585009|156822917|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719424|NCT04585009|156822918|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719425|NCT04585009|156822919|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719426|NCT04585009|156822920|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719427|NCT04585009|156822921|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719428|NCT04585009|156822922|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719429|NCT04585009|156822923|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719430|NCT04585009|156822924|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719431|NCT04585009|156822925|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719432|NCT04585009|156822926|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
48719433|NCT04585009|156822915|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719434|NCT04585009|156822916|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719435|NCT04585009|156822917|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719436|NCT04585009|156822918|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719437|NCT04585009|156822919|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719438|NCT04585009|156822920|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719439|NCT04585009|156822921|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719440|NCT04585009|156822922|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
48719441|NCT04585009|156822923|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719442|NCT04585009|156822924|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719443|NCT04585009|156822925|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719444|NCT04585009|156822926|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
48719445|NCT04585009|156822915|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719446|NCT04585009|156822916|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719447|NCT04585009|156822917|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719448|NCT04585009|156822918|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719449|NCT04585009|156822919|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
48719450|NCT04585009|156822920|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719451|NCT04585009|156822921|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719452|NCT04585009|156822922|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719453|NCT04585009|156822923|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719454|NCT04585009|156822924|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719455|NCT04585009|156822925|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719456|NCT04585009|156822926|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
48719457|NCT04585009|156822915|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719458|NCT04585009|156822916|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719459|NCT04585009|156822917|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719460|NCT04585009|156822918|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719461|NCT04585009|156822919|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719462|NCT04585009|156822920|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719463|NCT04585009|156822921|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719464|NCT04585009|156822922|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48815305|NCT04248465|157165765|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
48499783|NCT01700621|156026090|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
48499784|NCT00543309|156026091|FG000|Overall Study|Physician Decision|0|||
48499785|NCT00543309|156026092|FG001|Overall Study|Physician Decision|1|||
48499786|NCT00543309|156026093|FG002|Overall Study|Physician Decision|0|||
48499787|NCT03552757|156026100|FG000|Overall Study|Withdrawal by Subject|10|||
48499788|NCT03552757|156026101|FG001|Overall Study|Withdrawal by Subject|5|||
48499789|NCT03552757|156026102|FG002|Overall Study|Withdrawal by Subject|12|||
48499790|NCT03552757|156026100|FG000|Overall Study|Lost to Follow-up|2|||
48499791|NCT03552757|156026101|FG001|Overall Study|Lost to Follow-up|7|||
48499792|NCT03552757|156026102|FG002|Overall Study|Lost to Follow-up|7|||
48499793|NCT03552757|156026100|FG000|Overall Study|Death|1|||
48499794|NCT03552757|156026101|FG001|Overall Study|Death|1|||
48599451|NCT01051557|156389727|FG006|Overall Study|Adverse Event|4|||
48599452|NCT02169505|156389728|FG000|Overall Study|Withdrawal by Subject|1|||
48599453|NCT01266824|156389729|FG000|Overall Study|Study terminated prior to completion|2|||
48815306|NCT04248465|157165766|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
48499795|NCT03552757|156026102|FG002|Overall Study|Death|1|||
48499796|NCT00449150|156026103|FG000|Overall Study|Adverse Event|11|||
48499797|NCT00449150|156026104|FG001|Overall Study|Adverse Event|18|||
48499798|NCT00449150|156026105|FG002|Overall Study|Adverse Event|9|||
48499799|NCT00449150|156026103|FG000|Overall Study|Lack of Efficacy|1|||
48499800|NCT00449150|156026104|FG001|Overall Study|Lack of Efficacy|2|||
48499801|NCT00449150|156026105|FG002|Overall Study|Lack of Efficacy|2|||
48499802|NCT00449150|156026103|FG000|Overall Study|Other|16|||
48499803|NCT00449150|156026104|FG001|Overall Study|Other|13|||
48499804|NCT00449150|156026105|FG002|Overall Study|Other|14|||
48499805|NCT00449150|156026103|FG000|Overall Study|Withdrawal by Subject|17|||
48499806|NCT00449150|156026104|FG001|Overall Study|Withdrawal by Subject|18|||
48499807|NCT00449150|156026105|FG002|Overall Study|Withdrawal by Subject|21|||
48499808|NCT00449150|156026103|FG000|Overall Study|Protocol Violation|1|||
48499809|NCT00449150|156026104|FG001|Overall Study|Protocol Violation|2|||
48499810|NCT00449150|156026105|FG002|Overall Study|Protocol Violation|1|||
48499811|NCT04652453|156026106|FG000|Overall Study|Death|8|||
48499812|NCT04652453|156026107|FG001|Overall Study|Death|2|||
48499813|NCT04652453|156026108|FG002|Overall Study|Death|0|||
48499814|NCT04652453|156026106|FG000|Overall Study|Hospice|5|||
48499815|NCT04652453|156026107|FG001|Overall Study|Hospice|5|||
48499816|NCT04652453|156026108|FG002|Overall Study|Hospice|0|||
48499817|NCT04652453|156026106|FG000|Overall Study|Withdrawal by Subject|2|||
48499818|NCT04652453|156026107|FG001|Overall Study|Withdrawal by Subject|0|||
48499819|NCT04652453|156026108|FG002|Overall Study|Withdrawal by Subject|0|||
48499820|NCT00984295|156026115|FG000|Overall Study|Lost to Follow-up|31|||
48499821|NCT00984295|156026116|FG001|Overall Study|Lost to Follow-up|12|||
48499822|NCT00984295|156026117|FG002|Overall Study|Lost to Follow-up|13|||
48499823|NCT00984295|156026115|FG000|Overall Study|Protocol Violation|2|||
48499824|NCT00984295|156026116|FG001|Overall Study|Protocol Violation|1|||
48499825|NCT00984295|156026117|FG002|Overall Study|Protocol Violation|4|||
48499826|NCT00984295|156026115|FG000|Overall Study|Withdrawal by Subject|18|||
48499827|NCT00984295|156026116|FG001|Overall Study|Withdrawal by Subject|9|||
48499828|NCT00984295|156026117|FG002|Overall Study|Withdrawal by Subject|12|||
48499829|NCT00984295|156026115|FG000|Overall Study|CAE - discontinued test vaccine|0|||
48499830|NCT00984295|156026116|FG001|Overall Study|CAE - discontinued test vaccine|1|||
48499831|NCT00984295|156026117|FG002|Overall Study|CAE - discontinued test vaccine|3|||
48499832|NCT00984295|156026115|FG000|Overall Study|Missed one or more blood samplings|3|||
48499833|NCT00984295|156026116|FG001|Overall Study|Missed one or more blood samplings|7|||
48499834|NCT00984295|156026117|FG002|Overall Study|Missed one or more blood samplings|2|||
48499835|NCT00984295|156026115|FG000|Overall Study|Incomplete safety follow-up|11|||
48499836|NCT00984295|156026116|FG001|Overall Study|Incomplete safety follow-up|2|||
48499837|NCT00984295|156026117|FG002|Overall Study|Incomplete safety follow-up|3|||
48499838|NCT00770510|156026118|FG000|Overall Study|Lost to Follow-up|2|||
48499839|NCT00770510|156026118|FG000|Overall Study|Pregnancy|1|||
48499840|NCT00770510|156026118|FG000|Overall Study|Withdrawal by Subject|2|||
48499841|NCT00881621|156026120|FG000|Overall Study|Physician Decision|34|||
48815307|NCT04248465|157165765|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
48499842|NCT00727571|156026123|FG000|Overall Study|Ineligibility determined|1|||
48499843|NCT00727571|156026124|FG001|Overall Study|Ineligibility determined|1|||
48499844|NCT00727571|156026125|FG002|Overall Study|Ineligibility determined|1|||
48499845|NCT00727571|156026126|FG003|Overall Study|Ineligibility determined|0|||
48499846|NCT00727571|156026123|FG000|Overall Study|Death|0|||
48499847|NCT00727571|156026124|FG001|Overall Study|Death|19|||
48499848|NCT00727571|156026125|FG002|Overall Study|Death|5|||
48499849|NCT00727571|156026126|FG003|Overall Study|Death|1|||
48815308|NCT04248465|157165766|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
48499850|NCT00727571|156026123|FG000|Overall Study|Physician Decision|0|||
48499851|NCT00727571|156026124|FG001|Overall Study|Physician Decision|5|||
48499852|NCT00727571|156026125|FG002|Overall Study|Physician Decision|0|||
48499853|NCT00727571|156026126|FG003|Overall Study|Physician Decision|0|||
48499854|NCT00727571|156026123|FG000|Overall Study|Withdrawal by Subject|0|||
48499855|NCT00727571|156026124|FG001|Overall Study|Withdrawal by Subject|10|||
48499856|NCT00727571|156026125|FG002|Overall Study|Withdrawal by Subject|11|||
48499857|NCT00727571|156026126|FG003|Overall Study|Withdrawal by Subject|0|||
48719465|NCT04585009|156822923|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719466|NCT04585009|156822924|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
48719467|NCT04585009|156822925|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719468|NCT04585009|156822926|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
48719469|NCT04585009|156822915|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719470|NCT04585009|156822916|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719471|NCT04585009|156822917|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719472|NCT04585009|156822918|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719473|NCT04585009|156822919|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719474|NCT04585009|156822920|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719475|NCT04585009|156822921|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719476|NCT04585009|156822922|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719477|NCT04585009|156822923|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719478|NCT04585009|156822924|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719479|NCT04585009|156822925|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
48719480|NCT04585009|156822926|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
48719481|NCT04140227|156822927|FG000|Overall Study|Withdrawal by Subject|26|||
48719482|NCT04140227|156822927|FG000|Overall Study|Lost to Follow-up|8|||
48719483|NCT04140227|156822927|FG000|Overall Study|Adverse Event|8|||
48719484|NCT04140227|156822927|FG000|Overall Study|Death|1|||
48719485|NCT04140227|156822927|FG000|Overall Study|Other|3|||
48719486|NCT04140227|156822927|FG000|Overall Study|Protocol Violation|2|||
48719487|NCT00412373|156822928|FG000|Overall Study|Adverse Event|8|||
48719488|NCT00412373|156822929|FG001|Overall Study|Adverse Event|13|||
48719489|NCT00412373|156822928|FG000|Overall Study|Lack of Efficacy|16|||
48719490|NCT00412373|156822929|FG001|Overall Study|Lack of Efficacy|22|||
48719491|NCT00412373|156822928|FG000|Overall Study|Lost to Follow-up|7|||
48719492|NCT00412373|156822929|FG001|Overall Study|Lost to Follow-up|13|||
48719493|NCT00412373|156822928|FG000|Overall Study|Withdrawal by Subject|8|||
48719494|NCT00412373|156822929|FG001|Overall Study|Withdrawal by Subject|27|||
48719495|NCT00412373|156822928|FG000|Overall Study|Other|2|||
48719496|NCT00412373|156822929|FG001|Overall Study|Other|2|||
48719497|NCT02969408|156822930|FG000|Overall Study|Adverse Event|2|||
48719498|NCT02969408|156822930|FG000|Overall Study|Withdrawal by Subject|8|||
48719499|NCT02969408|156822930|FG000|Overall Study|Lost to Follow-up|4|||
48719500|NCT02969408|156822930|FG000|Overall Study|Protocol Violation|1|||
48719501|NCT02969408|156822930|FG000|Overall Study|Other than specified|1|||
48719502|NCT00538785|156822931|FG000|Overall Study|Death|9|||
48719503|NCT00538785|156822932|FG001|Overall Study|Death|10|||
48719504|NCT00538785|156822931|FG000|Overall Study|Withdrawal of consent|9|||
48719505|NCT00538785|156822932|FG001|Overall Study|Withdrawal of consent|7|||
48719506|NCT00538785|156822931|FG000|Overall Study|Lost to Follow-up|1|||
48719507|NCT00538785|156822932|FG001|Overall Study|Lost to Follow-up|0|||
48719508|NCT00422513|156822937|FG000|Overall Study|Lack of Efficacy|4|||
48719509|NCT00422513|156822938|FG001|Overall Study|Lack of Efficacy|5|||
48719510|NCT00422513|156822937|FG000|Overall Study|Protocol Violation|23|||
48719511|NCT00422513|156822938|FG001|Overall Study|Protocol Violation|7|||
48719512|NCT00422513|156822937|FG000|Overall Study|Refused Treatment|4|||
48719513|NCT00422513|156822938|FG001|Overall Study|Refused Treatment|2|||
48719514|NCT00422513|156822937|FG000|Overall Study|Withdrawal by Subject|2|||
48719515|NCT00422513|156822938|FG001|Overall Study|Withdrawal by Subject|1|||
48719516|NCT00422513|156822937|FG000|Overall Study|early termination of the study|67|||
48815309|NCT00064025|157165767|FG000|Overall Study|Ineligible|4|||
48815310|NCT00064025|157165767|FG000|Overall Study|Inevaluable|3|||
48815311|NCT02036515|157165768|FG000|Overall Study|Adverse Event|1|||
48815312|NCT02036515|157165769|FG001|Overall Study|Adverse Event|1|||
48815313|NCT02036515|157165770|FG002|Overall Study|Adverse Event|2|||
48815314|NCT02036515|157165768|FG000|Overall Study|Lost to Follow-up|0|||
48815315|NCT02036515|157165769|FG001|Overall Study|Lost to Follow-up|2|||
48815316|NCT02036515|157165770|FG002|Overall Study|Lost to Follow-up|0|||
48815317|NCT02036515|157165768|FG000|Overall Study|Non-compliance with study drug|0|||
48815318|NCT02036515|157165769|FG001|Overall Study|Non-compliance with study drug|0|||
48719517|NCT00422513|156822938|FG001|Overall Study|early termination of the study|80|||
48719518|NCT00422513|156822937|FG000|Overall Study|Adverse Event|4|||
48719519|NCT00422513|156822938|FG001|Overall Study|Adverse Event|4|||
48719520|NCT00422513|156822937|FG000|Overall Study|Death|3|||
48719521|NCT00422513|156822938|FG001|Overall Study|Death|7|||
48719522|NCT01252667|156822943|FG000|Overall Study|Transplant aborted post-conditioning|0|||
48719523|NCT01252667|156822944|FG001|Overall Study|Transplant aborted post-conditioning|0|||
48719524|NCT01252667|156822945|FG002|Overall Study|Transplant aborted post-conditioning|0|||
48719525|NCT01252667|156822946|FG003|Overall Study|Transplant aborted post-conditioning|0|||
48719526|NCT01252667|156822947|FG004|Overall Study|Transplant aborted post-conditioning|0|||
48719527|NCT01252667|156822948|FG005|Overall Study|Transplant aborted post-conditioning|1|||
48719528|NCT00833417|156822949|FG000|Overall Study|Adverse Event|5|||
48719529|NCT00833417|156822950|FG001|Overall Study|Adverse Event|16|||
48719530|NCT00833417|156822949|FG000|Overall Study|Death|1|||
48719531|NCT00833417|156822950|FG001|Overall Study|Death|3|||
48719532|NCT00833417|156822949|FG000|Overall Study|Lost to Follow-up|1|||
48719533|NCT00833417|156822950|FG001|Overall Study|Lost to Follow-up|2|||
48719534|NCT00833417|156822949|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
48719535|NCT00833417|156822950|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
48719536|NCT00833417|156822949|FG000|Overall Study|Patient Decision to Withdraw|4|||
48719537|NCT00833417|156822950|FG001|Overall Study|Patient Decision to Withdraw|23|||
48719538|NCT00833417|156822949|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
48719539|NCT00833417|156822950|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
48719540|NCT00833417|156822949|FG000|Overall Study|Disease Progression|18|||
48499858|NCT00727571|156026123|FG000|Overall Study|Subject Non Compliance|0|||
48499859|NCT00727571|156026124|FG001|Overall Study|Subject Non Compliance|6|||
48499860|NCT00727571|156026125|FG002|Overall Study|Subject Non Compliance|0|||
48499861|NCT00727571|156026126|FG003|Overall Study|Subject Non Compliance|4|||
48499862|NCT00727571|156026123|FG000|Overall Study|Dismissed from nursing home|0|||
48499863|NCT00727571|156026124|FG001|Overall Study|Dismissed from nursing home|9|||
48719541|NCT00833417|156822950|FG001|Overall Study|Disease Progression|17|||
48719542|NCT00833417|156822949|FG000|Overall Study|Reason Not Specified|0|||
48719543|NCT00833417|156822950|FG001|Overall Study|Reason Not Specified|1|||
48719544|NCT01836276|156822951|FG000|Overall Study|Lost to Follow-up|28|||
48719545|NCT01836276|156822952|FG001|Overall Study|Lost to Follow-up|51|||
48719546|NCT01445548|156822953|FG000|Overall Study|Adverse Event|1|||
48719547|NCT00864916|156822956|FG000|Overall Study|Lost to Follow-up|4|||
48719548|NCT00864916|156822957|FG001|Overall Study|Lost to Follow-up|4|||
48719549|NCT00864916|156822956|FG000|Overall Study|Protocol Violation|1|||
48719550|NCT00864916|156822957|FG001|Overall Study|Protocol Violation|0|||
48719551|NCT00864916|156822956|FG000|Overall Study|Withdrawal by Subject|1|||
48719552|NCT00864916|156822957|FG001|Overall Study|Withdrawal by Subject|0|||
48719553|NCT00958438|156822958|FG000|Overall Study|Protocol Violation|3|||
48719554|NCT00958438|156822959|FG001|Overall Study|Protocol Violation|2|||
48719555|NCT00958438|156822960|FG002|Overall Study|Protocol Violation|2|||
48719556|NCT00958438|156822958|FG000|Overall Study|Withdrawal by Subject|4|||
48719557|NCT00958438|156822959|FG001|Overall Study|Withdrawal by Subject|2|||
48719558|NCT00958438|156822960|FG002|Overall Study|Withdrawal by Subject|1|||
48719559|NCT00958438|156822958|FG000|Overall Study|Adverse Event|0|||
48719560|NCT00958438|156822959|FG001|Overall Study|Adverse Event|3|||
48719561|NCT00958438|156822960|FG002|Overall Study|Adverse Event|0|||
48719562|NCT00958438|156822958|FG000|Overall Study|Physician Decision|1|||
48719563|NCT00958438|156822959|FG001|Overall Study|Physician Decision|0|||
48719564|NCT00958438|156822960|FG002|Overall Study|Physician Decision|1|||
48719565|NCT00958438|156822958|FG000|Overall Study|Other than specified above|2|||
48815319|NCT02036515|157165770|FG002|Overall Study|Non-compliance with study drug|2|||
48815320|NCT02036515|157165768|FG000|Overall Study|Screen failure|0|||
48815321|NCT02036515|157165769|FG001|Overall Study|Screen failure|2|||
48815322|NCT02036515|157165770|FG002|Overall Study|Screen failure|0|||
48815323|NCT02036515|157165768|FG000|Overall Study|Withdrawal by Subject|4|||
48815324|NCT02036515|157165769|FG001|Overall Study|Withdrawal by Subject|7|||
48815325|NCT02036515|157165770|FG002|Overall Study|Withdrawal by Subject|9|||
48815326|NCT02036515|157165768|FG000|Overall Study|Hyperglycemia|0|||
48815327|NCT02036515|157165769|FG001|Overall Study|Hyperglycemia|0|||
48815328|NCT02036515|157165770|FG002|Overall Study|Hyperglycemia|1|||
48719566|NCT00958438|156822959|FG001|Overall Study|Other than specified above|3|||
48719567|NCT00958438|156822960|FG002|Overall Study|Other than specified above|2|||
48815329|NCT03621982|157165771|FG000|Overall Study|Withdrawal by Subject|1|||
48815330|NCT03621982|157165772|FG001|Overall Study|Withdrawal by Subject|0|||
48815331|NCT03621982|157165773|FG002|Overall Study|Withdrawal by Subject|0|||
48815332|NCT03621982|157165774|FG003|Overall Study|Withdrawal by Subject|1|||
48815333|NCT03621982|157165775|FG004|Overall Study|Withdrawal by Subject|0|||
48815334|NCT03621982|157165776|FG005|Overall Study|Withdrawal by Subject|1|||
48499864|NCT00727571|156026125|FG002|Overall Study|Dismissed from nursing home|5|||
48719568|NCT02122783|156822961|FG000|Overall Study|Adverse Event|0|||
48719569|NCT02122783|156822962|FG001|Overall Study|Adverse Event|1|||
48719570|NCT01101308|156822967|FG000|Period 1|Adverse Event|2|||
48719571|NCT01101308|156822968|FG001|Period 1|Adverse Event|1|||
48719572|NCT01101308|156822967|FG000|Period 1|Positive for cotinine|1|||
48719573|NCT01101308|156822968|FG001|Period 1|Positive for cotinine|0|||
48719574|NCT00653432|156822969|FG000|Overall Study|Adverse Event|4|||
48719575|NCT00653432|156822970|FG001|Overall Study|Adverse Event|1|||
48719576|NCT00653432|156822969|FG000|Overall Study|Withdrawal by Subject|4|||
48719577|NCT00653432|156822970|FG001|Overall Study|Withdrawal by Subject|5|||
48719578|NCT00653432|156822969|FG000|Overall Study|Lost to Follow-up|7|||
48719579|NCT00653432|156822970|FG001|Overall Study|Lost to Follow-up|6|||
48719580|NCT00653432|156822969|FG000|Overall Study|Use/Need of Con Therapy|2|||
48719581|NCT00653432|156822970|FG001|Overall Study|Use/Need of Con Therapy|1|||
48719582|NCT00653432|156822969|FG000|Overall Study|Other - Reason Not Provided|5|||
48719583|NCT00653432|156822970|FG001|Overall Study|Other - Reason Not Provided|3|||
48719584|NCT00686634|156822972|FG000|Overall Study|Protocol Violation|6|||
48719585|NCT00567255|156822973|FG000|Overall Study|Adverse Event|241|||
48719586|NCT00567255|156822974|FG001|Overall Study|Adverse Event|68|||
48719587|NCT00567255|156822973|FG000|Overall Study|Lost to Follow-up|77|||
48719588|NCT00567255|156822974|FG001|Overall Study|Lost to Follow-up|48|||
48719589|NCT00567255|156822973|FG000|Overall Study|Withdrawal by Subject|75|||
48719590|NCT00567255|156822974|FG001|Overall Study|Withdrawal by Subject|56|||
48719591|NCT00567255|156822973|FG000|Overall Study|Lack of Efficacy|19|||
48719592|NCT00567255|156822974|FG001|Overall Study|Lack of Efficacy|33|||
48719593|NCT00567255|156822973|FG000|Overall Study|Protocol Violation|20|||
48719594|NCT00567255|156822974|FG001|Overall Study|Protocol Violation|8|||
48719595|NCT00567255|156822973|FG000|Overall Study|Pregnancy|6|||
48719596|NCT00567255|156822974|FG001|Overall Study|Pregnancy|0|||
48719597|NCT00567255|156822973|FG000|Overall Study|Drug noncompliance,moved,other|25|||
48719598|NCT00567255|156822974|FG001|Overall Study|Drug noncompliance,moved,other|15|||
48719599|NCT02282345|156822978|FG000|Overall Study|Progression|0|||
48719600|NCT02282345|156822979|FG001|Overall Study|Progression|1|||
48719601|NCT02296138|156822981|FG000|Overall Study|Adverse Event|348|||
48719602|NCT02296138|156822982|FG001|Overall Study|Adverse Event|259|||
48719603|NCT02296138|156822981|FG000|Overall Study|Lack of Efficacy|59|||
48719604|NCT02296138|156822982|FG001|Overall Study|Lack of Efficacy|37|||
48719605|NCT02296138|156822981|FG000|Overall Study|Protocol Violation|35|||
48719606|NCT02296138|156822982|FG001|Overall Study|Protocol Violation|36|||
48719607|NCT02296138|156822981|FG000|Overall Study|Lost to Follow-up|9|||
48719608|NCT02296138|156822982|FG001|Overall Study|Lost to Follow-up|12|||
48719609|NCT02296138|156822981|FG000|Overall Study|Withdrawal by Subject|184|||
48719610|NCT02296138|156822982|FG001|Overall Study|Withdrawal by Subject|131|||
48719611|NCT02296138|156822981|FG000|Overall Study|Not Treated|1|||
48719612|NCT02296138|156822982|FG001|Overall Study|Not Treated|1|||
48719613|NCT02296138|156822981|FG000|Overall Study|Patients with data irregularities|10|||
48719614|NCT02296138|156822982|FG001|Overall Study|Patients with data irregularities|11|||
48719615|NCT02296138|156822981|FG000|Overall Study|Other than specified|15|||
48719616|NCT02296138|156822982|FG001|Overall Study|Other than specified|13|||
48719617|NCT02353143|156822983|FG000|Overall Study|Withdrawal by Subject|1|||
48719618|NCT02353143|156822984|FG001|Overall Study|Withdrawal by Subject|0|||
48815335|NCT03621982|157165777|FG006|Overall Study|Withdrawal by Subject|1|||
48815336|NCT03621982|157165778|FG007|Overall Study|Withdrawal by Subject|0|||
48815337|NCT03621982|157165779|FG008|Overall Study|Withdrawal by Subject|1|||
48719619|NCT02353143|156822985|FG002|Overall Study|Withdrawal by Subject|0|||
48719620|NCT02353143|156822986|FG003|Overall Study|Withdrawal by Subject|0|||
48815338|NCT03621982|157165780|FG009|Overall Study|Withdrawal by Subject|0|||
48815339|NCT03621982|157165781|FG010|Overall Study|Withdrawal by Subject|2|||
48815340|NCT03621982|157165782|FG011|Overall Study|Withdrawal by Subject|1|||
48815341|NCT03621982|157165783|FG012|Overall Study|Withdrawal by Subject|2|||
48815342|NCT03621982|157165784|FG013|Overall Study|Withdrawal by Subject|2|||
48815343|NCT03621982|157165771|FG000|Overall Study|Investigator/Sponsor decision|0|||
48815344|NCT03621982|157165772|FG001|Overall Study|Investigator/Sponsor decision|0|||
48815345|NCT03621982|157165773|FG002|Overall Study|Investigator/Sponsor decision|0|||
48815346|NCT03621982|157165774|FG003|Overall Study|Investigator/Sponsor decision|0|||
48815347|NCT03621982|157165775|FG004|Overall Study|Investigator/Sponsor decision|0|||
48815348|NCT03621982|157165776|FG005|Overall Study|Investigator/Sponsor decision|0|||
48815349|NCT03621982|157165777|FG006|Overall Study|Investigator/Sponsor decision|0|||
48815350|NCT03621982|157165778|FG007|Overall Study|Investigator/Sponsor decision|0|||
48815351|NCT03621982|157165779|FG008|Overall Study|Investigator/Sponsor decision|0|||
48815352|NCT03621982|157165780|FG009|Overall Study|Investigator/Sponsor decision|0|||
48815353|NCT03621982|157165781|FG010|Overall Study|Investigator/Sponsor decision|0|||
48815354|NCT03621982|157165782|FG011|Overall Study|Investigator/Sponsor decision|4|||
48815355|NCT03621982|157165783|FG012|Overall Study|Investigator/Sponsor decision|0|||
48815356|NCT03621982|157165784|FG013|Overall Study|Investigator/Sponsor decision|2|||
48719621|NCT02353143|156822987|FG004|Overall Study|Withdrawal by Subject|1|||
48719622|NCT02353143|156822988|FG005|Overall Study|Withdrawal by Subject|0|||
48719623|NCT02353143|156822989|FG006|Overall Study|Withdrawal by Subject|0|||
48719624|NCT02353143|156822990|FG007|Overall Study|Withdrawal by Subject|1|||
48719625|NCT02353143|156822991|FG008|Overall Study|Withdrawal by Subject|1|||
48815357|NCT03621982|157165771|FG000|Overall Study|Death|2|||
48815358|NCT03621982|157165772|FG001|Overall Study|Death|4|||
48815359|NCT03621982|157165773|FG002|Overall Study|Death|4|||
48815360|NCT03621982|157165774|FG003|Overall Study|Death|3|||
48815361|NCT03621982|157165775|FG004|Overall Study|Death|8|||
48815362|NCT03621982|157165776|FG005|Overall Study|Death|4|||
48719626|NCT02353143|156822983|FG000|Overall Study|Lack of Efficacy|2|||
48719627|NCT02353143|156822984|FG001|Overall Study|Lack of Efficacy|1|||
48719628|NCT02353143|156822985|FG002|Overall Study|Lack of Efficacy|2|||
48719629|NCT02353143|156822986|FG003|Overall Study|Lack of Efficacy|4|||
48719630|NCT02353143|156822987|FG004|Overall Study|Lack of Efficacy|13|||
48719631|NCT02353143|156822988|FG005|Overall Study|Lack of Efficacy|2|||
48719632|NCT02353143|156822989|FG006|Overall Study|Lack of Efficacy|2|||
48719633|NCT02353143|156822990|FG007|Overall Study|Lack of Efficacy|2|||
48719634|NCT02353143|156822991|FG008|Overall Study|Lack of Efficacy|1|||
48719635|NCT02353143|156822983|FG000|Overall Study|reason not specified|1|||
48719636|NCT02353143|156822984|FG001|Overall Study|reason not specified|2|||
48719637|NCT02353143|156822985|FG002|Overall Study|reason not specified|0|||
48719638|NCT02353143|156822986|FG003|Overall Study|reason not specified|0|||
48719639|NCT02353143|156822987|FG004|Overall Study|reason not specified|6|||
48719640|NCT02353143|156822988|FG005|Overall Study|reason not specified|1|||
48599454|NCT01266824|156389730|FG001|Overall Study|Study terminated prior to completion|3|||
48599455|NCT00509899|156389731|FG000|Overall Study|Progressive disease|1|||
48599456|NCT00509899|156389732|FG001|Overall Study|Progressive disease|3|||
48599457|NCT00509899|156389733|FG002|Overall Study|Progressive disease|5|||
48599458|NCT00509899|156389734|FG003|Overall Study|Progressive disease|1|||
48599459|NCT00509899|156389735|FG004|Overall Study|Progressive disease|0|||
48599460|NCT00509899|156389736|FG005|Overall Study|Progressive disease|1|||
48599461|NCT00509899|156389737|FG006|Overall Study|Progressive disease|0|||
48599462|NCT00509899|156389738|FG007|Overall Study|Progressive disease|0|||
48599463|NCT00509899|156389731|FG000|Overall Study|Unacceptable Toxicity|1|||
48599464|NCT00509899|156389732|FG001|Overall Study|Unacceptable Toxicity|0|||
48599465|NCT00509899|156389733|FG002|Overall Study|Unacceptable Toxicity|0|||
48599466|NCT00509899|156389734|FG003|Overall Study|Unacceptable Toxicity|2|||
48599467|NCT00509899|156389735|FG004|Overall Study|Unacceptable Toxicity|0|||
48599468|NCT00509899|156389736|FG005|Overall Study|Unacceptable Toxicity|0|||
48599469|NCT00509899|156389737|FG006|Overall Study|Unacceptable Toxicity|0|||
48599470|NCT00509899|156389738|FG007|Overall Study|Unacceptable Toxicity|0|||
48599471|NCT00509899|156389731|FG000|Overall Study|Withdrawal by Subject|6|||
48599472|NCT00509899|156389732|FG001|Overall Study|Withdrawal by Subject|2|||
48599473|NCT00509899|156389733|FG002|Overall Study|Withdrawal by Subject|3|||
48599474|NCT00509899|156389734|FG003|Overall Study|Withdrawal by Subject|0|||
48599475|NCT00509899|156389735|FG004|Overall Study|Withdrawal by Subject|3|||
48599476|NCT00509899|156389736|FG005|Overall Study|Withdrawal by Subject|2|||
48599477|NCT00509899|156389737|FG006|Overall Study|Withdrawal by Subject|0|||
48599478|NCT00509899|156389738|FG007|Overall Study|Withdrawal by Subject|0|||
48599479|NCT00509899|156389731|FG000|Overall Study|Physician Decision|4|||
48599480|NCT00509899|156389732|FG001|Overall Study|Physician Decision|2|||
48599481|NCT00509899|156389733|FG002|Overall Study|Physician Decision|7|||
48599482|NCT00509899|156389734|FG003|Overall Study|Physician Decision|0|||
48599483|NCT00509899|156389735|FG004|Overall Study|Physician Decision|1|||
48599484|NCT00509899|156389736|FG005|Overall Study|Physician Decision|4|||
48599485|NCT00509899|156389737|FG006|Overall Study|Physician Decision|0|||
48599486|NCT00509899|156389738|FG007|Overall Study|Physician Decision|0|||
48599487|NCT00509899|156389731|FG000|Overall Study|Intercurrent Illness|1|||
48599488|NCT00509899|156389732|FG001|Overall Study|Intercurrent Illness|0|||
48815363|NCT03621982|157165777|FG006|Overall Study|Death|6|||
48815364|NCT03621982|157165778|FG007|Overall Study|Death|3|||
48815365|NCT03621982|157165779|FG008|Overall Study|Death|0|||
48815366|NCT03621982|157165780|FG009|Overall Study|Death|3|||
48815367|NCT03621982|157165781|FG010|Overall Study|Death|8|||
48815368|NCT03621982|157165782|FG011|Overall Study|Death|4|||
48815369|NCT03621982|157165783|FG012|Overall Study|Death|2|||
48815370|NCT03621982|157165784|FG013|Overall Study|Death|2|||
48815371|NCT03621982|157165771|FG000|Overall Study|Lost to Follow-up|0|||
48815372|NCT03621982|157165772|FG001|Overall Study|Lost to Follow-up|0|||
48815373|NCT03621982|157165773|FG002|Overall Study|Lost to Follow-up|1|||
48815374|NCT03621982|157165774|FG003|Overall Study|Lost to Follow-up|0|||
48815375|NCT03621982|157165775|FG004|Overall Study|Lost to Follow-up|0|||
48815376|NCT03621982|157165776|FG005|Overall Study|Lost to Follow-up|0|||
48815377|NCT03621982|157165777|FG006|Overall Study|Lost to Follow-up|1|||
48815378|NCT03621982|157165778|FG007|Overall Study|Lost to Follow-up|0|||
48815379|NCT03621982|157165779|FG008|Overall Study|Lost to Follow-up|0|||
48815380|NCT03621982|157165780|FG009|Overall Study|Lost to Follow-up|1|||
48815381|NCT03621982|157165781|FG010|Overall Study|Lost to Follow-up|0|||
48815382|NCT03621982|157165782|FG011|Overall Study|Lost to Follow-up|0|||
48719641|NCT02353143|156822989|FG006|Overall Study|reason not specified|0|||
48719642|NCT02353143|156822990|FG007|Overall Study|reason not specified|3|||
48815383|NCT03621982|157165783|FG012|Overall Study|Lost to Follow-up|0|||
48815384|NCT03621982|157165784|FG013|Overall Study|Lost to Follow-up|0|||
48599489|NCT00509899|156389733|FG002|Overall Study|Intercurrent Illness|0|||
48599490|NCT00509899|156389734|FG003|Overall Study|Intercurrent Illness|1|||
48599491|NCT00509899|156389735|FG004|Overall Study|Intercurrent Illness|0|||
48815385|NCT01342887|157165785|FG000|Overall Study|Death|2|||
48815386|NCT00127413|157165786|FG000|Overall Study|Lost to Follow-up|6|||
48815387|NCT00127413|157165787|FG001|Overall Study|Lost to Follow-up|4|||
48599492|NCT00509899|156389736|FG005|Overall Study|Intercurrent Illness|1|||
48599493|NCT00509899|156389737|FG006|Overall Study|Intercurrent Illness|0|||
48719643|NCT02353143|156822991|FG008|Overall Study|reason not specified|1|||
48719644|NCT02353143|156822983|FG000|Overall Study|Physician Decision|0|||
48815388|NCT00127413|157165788|FG002|Overall Study|Lost to Follow-up|8|||
48815389|NCT00127413|157165789|FG003|Overall Study|Lost to Follow-up|2|||
48815390|NCT00663962|157165790|FG000|Overall Study|somnolence|1|||
48815391|NCT00663962|157165791|FG001|Overall Study|somnolence|0|||
48719645|NCT02353143|156822984|FG001|Overall Study|Physician Decision|4|||
48719646|NCT02353143|156822985|FG002|Overall Study|Physician Decision|2|||
48719647|NCT02353143|156822986|FG003|Overall Study|Physician Decision|3|||
48719648|NCT02353143|156822987|FG004|Overall Study|Physician Decision|4|||
48719649|NCT02353143|156822988|FG005|Overall Study|Physician Decision|0|||
48719650|NCT02353143|156822989|FG006|Overall Study|Physician Decision|1|||
48719651|NCT02353143|156822990|FG007|Overall Study|Physician Decision|2|||
48815392|NCT05221749|157165794|FG000|Overall Study|Lost to Follow-up|2|||
48815393|NCT05221749|157165795|FG001|Overall Study|Lost to Follow-up|3|||
48815394|NCT02404493|157165796|FG000|Overall Study|Adverse Event|1|||
48815395|NCT02404493|157165797|FG001|Overall Study|Adverse Event|1|||
48815396|NCT01700348|157165798|FG000|Overall Study|Withdrawal by Subject|22|||
48815397|NCT01700348|157165798|FG000|Overall Study|Lost to Follow-up|1|||
48815398|NCT04140890|157165799|FG000|Overall Study|Withdrawal by Subject|0|||
48815399|NCT04140890|157165800|FG001|Overall Study|Withdrawal by Subject|1|||
48815400|NCT02102464|157165801|FG000|Randomized Study|Withdrawal by Subject|0|||
48719652|NCT02353143|156822991|FG008|Overall Study|Physician Decision|0|||
48719653|NCT02353143|156822983|FG000|Overall Study|Adverse Event|0|||
48719654|NCT02353143|156822984|FG001|Overall Study|Adverse Event|0|||
48719655|NCT02353143|156822985|FG002|Overall Study|Adverse Event|1|||
48719656|NCT02353143|156822986|FG003|Overall Study|Adverse Event|0|||
48719657|NCT02353143|156822987|FG004|Overall Study|Adverse Event|1|||
48719658|NCT02353143|156822988|FG005|Overall Study|Adverse Event|1|||
48719659|NCT02353143|156822989|FG006|Overall Study|Adverse Event|0|||
48719660|NCT02353143|156822990|FG007|Overall Study|Adverse Event|0|||
48719661|NCT02353143|156822991|FG008|Overall Study|Adverse Event|0|||
48719662|NCT02353143|156822983|FG000|Overall Study|patient receiving other treatment for AML|0|||
48719663|NCT02353143|156822984|FG001|Overall Study|patient receiving other treatment for AML|0|||
48719664|NCT02353143|156822985|FG002|Overall Study|patient receiving other treatment for AML|1|||
48719665|NCT02353143|156822986|FG003|Overall Study|patient receiving other treatment for AML|0|||
48719666|NCT02353143|156822987|FG004|Overall Study|patient receiving other treatment for AML|0|||
48719667|NCT02353143|156822988|FG005|Overall Study|patient receiving other treatment for AML|0|||
48719668|NCT02353143|156822989|FG006|Overall Study|patient receiving other treatment for AML|0|||
48719669|NCT02353143|156822990|FG007|Overall Study|patient receiving other treatment for AML|0|||
48719670|NCT02353143|156822991|FG008|Overall Study|patient receiving other treatment for AML|0|||
48719671|NCT02353143|156822983|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
48815401|NCT02102464|157165802|FG001|Randomized Study|Withdrawal by Subject|1|||
48815402|NCT02102464|157165803|FG002|Randomized Study|Withdrawal by Subject|0|||
48815403|NCT01778062|157165804|FG000|Overall Study|Adverse Event|1|||
48815404|NCT01778062|157165805|FG001|Overall Study|Adverse Event|3|||
48815405|NCT01778062|157165804|FG000|Overall Study|Consent Withdrawal|1|||
48599494|NCT00509899|156389738|FG007|Overall Study|Intercurrent Illness|0|||
48599495|NCT00509899|156389731|FG000|Overall Study|Death|2|||
48599496|NCT00509899|156389732|FG001|Overall Study|Death|2|||
48599497|NCT00509899|156389733|FG002|Overall Study|Death|3|||
48599498|NCT00509899|156389734|FG003|Overall Study|Death|0|||
48599499|NCT00509899|156389735|FG004|Overall Study|Death|1|||
48599500|NCT00509899|156389736|FG005|Overall Study|Death|1|||
48599501|NCT00509899|156389737|FG006|Overall Study|Death|1|||
48599502|NCT00509899|156389738|FG007|Overall Study|Death|1|||
48599503|NCT00509899|156389731|FG000|Overall Study|Lack of Efficacy|1|||
48599504|NCT00509899|156389732|FG001|Overall Study|Lack of Efficacy|0|||
48599505|NCT00509899|156389733|FG002|Overall Study|Lack of Efficacy|2|||
48599506|NCT00509899|156389734|FG003|Overall Study|Lack of Efficacy|0|||
48599507|NCT00509899|156389735|FG004|Overall Study|Lack of Efficacy|0|||
48599508|NCT00509899|156389736|FG005|Overall Study|Lack of Efficacy|1|||
48599509|NCT00509899|156389737|FG006|Overall Study|Lack of Efficacy|0|||
48599510|NCT00509899|156389738|FG007|Overall Study|Lack of Efficacy|0|||
48599511|NCT01716663|156389748|FG000|Overall Study|Withdrawn prior to procedure|4|||
48599512|NCT01716663|156389748|FG000|Overall Study|Treated with non-study catheter|2|||
48599513|NCT01059773|156389752|FG000|Overall Study|Adverse Event|2|||
48599514|NCT01059773|156389753|FG001|Overall Study|Adverse Event|2|||
48599515|NCT01059773|156389752|FG000|Overall Study|Withdrawal by Subject|1|||
48599516|NCT01059773|156389753|FG001|Overall Study|Withdrawal by Subject|5|||
48599517|NCT01059773|156389752|FG000|Overall Study|Lost to Follow-up|1|||
48599518|NCT01059773|156389753|FG001|Overall Study|Lost to Follow-up|1|||
48719672|NCT02353143|156822984|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
48719673|NCT02353143|156822985|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
48719674|NCT02353143|156822986|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
48719675|NCT02353143|156822987|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
48719676|NCT02353143|156822988|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
48719677|NCT02353143|156822989|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
48719678|NCT02353143|156822990|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
48719679|NCT02353143|156822991|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
48719680|NCT04136444|156822992|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
48719681|NCT04136444|156822993|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
48599519|NCT01059773|156389752|FG000|Overall Study|Pregnancy|1|||
48599520|NCT01059773|156389753|FG001|Overall Study|Pregnancy|1|||
48599521|NCT01059773|156389752|FG000|Overall Study|Protocol Violation|6|||
48599522|NCT01059773|156389753|FG001|Overall Study|Protocol Violation|2|||
48599523|NCT01059773|156389752|FG000|Overall Study|Physician Decision|5|||
48599524|NCT01059773|156389753|FG001|Overall Study|Physician Decision|4|||
48599525|NCT01059773|156389752|FG000|Overall Study|Lack of Efficacy|3|||
48599526|NCT01059773|156389753|FG001|Overall Study|Lack of Efficacy|3|||
48599527|NCT01059773|156389752|FG000|Overall Study|Death|0|||
48599528|NCT01059773|156389753|FG001|Overall Study|Death|1|||
48599529|NCT01059773|156389752|FG000|Overall Study|Malignancy including squamous cell skin|0|||
48599530|NCT01059773|156389753|FG001|Overall Study|Malignancy including squamous cell skin|1|||
48599531|NCT01059773|156389752|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
48599532|NCT01059773|156389753|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
48599533|NCT01059773|156389752|FG000|Overall Study|Other|1|||
48599534|NCT01059773|156389753|FG001|Overall Study|Other|3|||
48599535|NCT00872521|156389756|FG000|Completed PAD Induction|Patient choice|0|||
48599536|NCT00872521|156389757|FG001|Completed PAD Induction|Patient choice|1|||
48599537|NCT00872521|156389758|FG002|Completed PAD Induction|Patient choice|0|||
48599538|NCT00872521|156389756|FG000|Completed PAD Induction|Disease progression|0|||
48599539|NCT00872521|156389757|FG001|Completed PAD Induction|Disease progression|2|||
48599540|NCT00872521|156389758|FG002|Completed PAD Induction|Disease progression|0|||
48599541|NCT00872521|156389756|FG000|Completed PAD Induction|Adverse Event|4|||
48599542|NCT00872521|156389757|FG001|Completed PAD Induction|Adverse Event|0|||
48599543|NCT00872521|156389758|FG002|Completed PAD Induction|Adverse Event|0|||
48599544|NCT00872521|156389756|FG000|Completed PAD Induction|Death|1|||
48599545|NCT00872521|156389757|FG001|Completed PAD Induction|Death|1|||
48599546|NCT00872521|156389758|FG002|Completed PAD Induction|Death|0|||
48719682|NCT01029405|156822998|FG000|Overall Study|Withdrawal by Subject|0|||
48719683|NCT01029405|156822999|FG001|Overall Study|Withdrawal by Subject|1|||
48719684|NCT01029405|156823000|FG002|Overall Study|Withdrawal by Subject|2|||
48599547|NCT00872521|156389756|FG000|Primary Endpoint Analysis|Other|1|||
48599548|NCT00872521|156389757|FG001|Primary Endpoint Analysis|Other|2|||
48599549|NCT00872521|156389758|FG002|Primary Endpoint Analysis|Other|0|||
48599550|NCT00872521|156389756|FG000|Primary Endpoint Analysis|Patient choice|0|||
48599551|NCT00872521|156389757|FG001|Primary Endpoint Analysis|Patient choice|1|||
48599552|NCT00872521|156389758|FG002|Primary Endpoint Analysis|Patient choice|0|||
48599553|NCT00872521|156389756|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
48599554|NCT00872521|156389757|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
48599555|NCT00872521|156389758|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
48599556|NCT00872521|156389756|FG000|Primary Endpoint Analysis|Patient response missing|0|||
48599557|NCT00872521|156389757|FG001|Primary Endpoint Analysis|Patient response missing|0|||
48599558|NCT00872521|156389758|FG002|Primary Endpoint Analysis|Patient response missing|1|||
48599559|NCT00872521|156389756|FG000|Completed 3-month Follow up|Other|0|||
48599560|NCT00872521|156389757|FG001|Completed 3-month Follow up|Other|2|||
48599561|NCT00872521|156389758|FG002|Completed 3-month Follow up|Other|0|||
48599562|NCT00872521|156389756|FG000|Completed 3-month Follow up|Physician Decision|0|||
48599563|NCT00872521|156389757|FG001|Completed 3-month Follow up|Physician Decision|1|||
48599564|NCT00872521|156389758|FG002|Completed 3-month Follow up|Physician Decision|0|||
48499865|NCT00727571|156026126|FG003|Overall Study|Dismissed from nursing home|0|||
48499866|NCT00727571|156026123|FG000|Overall Study|Hospitalization|0|||
48499867|NCT00727571|156026124|FG001|Overall Study|Hospitalization|1|||
48499868|NCT00727571|156026125|FG002|Overall Study|Hospitalization|0|||
48499869|NCT00727571|156026126|FG003|Overall Study|Hospitalization|1|||
48499870|NCT00727571|156026123|FG000|Overall Study|AE not leading to hospitalization|0|||
48499871|NCT00727571|156026124|FG001|Overall Study|AE not leading to hospitalization|0|||
48499872|NCT00727571|156026125|FG002|Overall Study|AE not leading to hospitalization|2|||
48499873|NCT00727571|156026126|FG003|Overall Study|AE not leading to hospitalization|0|||
48499874|NCT00727571|156026123|FG000|Overall Study|Other|0|||
48499875|NCT00727571|156026124|FG001|Overall Study|Other|4|||
48499876|NCT00727571|156026125|FG002|Overall Study|Other|6|||
48499877|NCT00727571|156026126|FG003|Overall Study|Other|0|||
48499878|NCT01706926|156026129|FG000|Overall Study|Lost to Follow-up|0|||
48499879|NCT01706926|156026130|FG001|Overall Study|Lost to Follow-up|0|||
48499880|NCT01706926|156026131|FG002|Overall Study|Lost to Follow-up|1|||
48499881|NCT01706926|156026132|FG003|Overall Study|Lost to Follow-up|0|||
48499882|NCT01706926|156026129|FG000|Overall Study|Withdrawal by Subject|2|||
48499883|NCT01706926|156026130|FG001|Overall Study|Withdrawal by Subject|0|||
48499884|NCT01706926|156026131|FG002|Overall Study|Withdrawal by Subject|1|||
48499885|NCT01706926|156026132|FG003|Overall Study|Withdrawal by Subject|2|||
48499886|NCT01706926|156026129|FG000|Overall Study|Other|4|||
48499887|NCT01706926|156026130|FG001|Overall Study|Other|4|||
48499888|NCT01706926|156026131|FG002|Overall Study|Other|4|||
48599565|NCT00872521|156389756|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
48599566|NCT00872521|156389757|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
48499889|NCT01706926|156026132|FG003|Overall Study|Other|3|||
48599567|NCT00872521|156389758|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
48599568|NCT01468454|156389770|FG000|Overall Study|Did not have surgery after PET|9|||
48599569|NCT03299101|156389771|FG000|Overall Study|Lost to Follow-up|1|||
48599570|NCT03299101|156389771|FG000|Overall Study|Withdrawal by Subject|5|||
48599571|NCT03299101|156389771|FG000|Overall Study|Surgery was changed|3|||
48599572|NCT03299101|156389771|FG000|Overall Study|Not enough time to complete prehab|1|||
48599573|NCT01462630|156389774|FG000|Overall Study|Did not initiate therapy|3|||
48599574|NCT01462630|156389774|FG000|Overall Study|Death|1|||
48599575|NCT01462630|156389774|FG000|Overall Study|Protocol Violation|2|||
48599576|NCT01462630|156389774|FG000|Overall Study|Adverse Event|1|||
48599577|NCT03193047|156389775|FG000|Overall Study|Physician Decision|1|||
48499890|NCT00762086|156026133|FG000|Overall Study|Adverse Event|2|||
48499891|NCT00762086|156026134|FG001|Overall Study|Adverse Event|0|||
48499892|NCT00762086|156026133|FG000|Overall Study|Lost to Follow-up|0|||
48599578|NCT03193047|156389776|FG001|Overall Study|Physician Decision|0|||
48599579|NCT03193047|156389775|FG000|Overall Study|Participant Left State|1|||
48599580|NCT03193047|156389776|FG001|Overall Study|Participant Left State|0|||
48599581|NCT02131064|156389777|FG000|Overall Study|Death|5|||
48599582|NCT02131064|156389778|FG001|Overall Study|Death|6|||
48599583|NCT02131064|156389777|FG000|Overall Study|Lost to Follow-up|4|||
48599584|NCT02131064|156389778|FG001|Overall Study|Lost to Follow-up|8|||
48599585|NCT02131064|156389777|FG000|Overall Study|Withdrawal by Subject|14|||
48599586|NCT02131064|156389778|FG001|Overall Study|Withdrawal by Subject|18|||
48599587|NCT02131064|156389777|FG000|Overall Study|Other|2|||
48599588|NCT02131064|156389778|FG001|Overall Study|Other|2|||
48599589|NCT00379899|156389781|FG000|Overall Study|Adverse Event|7|||
48599590|NCT00379899|156389782|FG001|Overall Study|Adverse Event|3|||
48599591|NCT00379899|156389781|FG000|Overall Study|Death|10|||
48599592|NCT00379899|156389782|FG001|Overall Study|Death|10|||
48599593|NCT00379899|156389781|FG000|Overall Study|Lost to Follow-up|2|||
48599594|NCT00379899|156389782|FG001|Overall Study|Lost to Follow-up|4|||
48599595|NCT00379899|156389781|FG000|Overall Study|Physician Decision|3|||
48599596|NCT00379899|156389782|FG001|Overall Study|Physician Decision|4|||
48599597|NCT00379899|156389781|FG000|Overall Study|Withdrawal by Subject|5|||
48499893|NCT00762086|156026134|FG001|Overall Study|Lost to Follow-up|2|||
48499894|NCT00762086|156026133|FG000|Overall Study|Non compliance|1|||
48499895|NCT00762086|156026134|FG001|Overall Study|Non compliance|0|||
48499896|NCT00762086|156026133|FG000|Overall Study|Withdrawal by Subject|2|||
48599598|NCT00379899|156389782|FG001|Overall Study|Withdrawal by Subject|5|||
48599599|NCT00379899|156389781|FG000|Overall Study|Ineligibility determined|0|||
48719685|NCT01029405|156823001|FG003|Overall Study|Withdrawal by Subject|0|||
48499897|NCT00762086|156026134|FG001|Overall Study|Withdrawal by Subject|2|||
48499898|NCT00762086|156026133|FG000|Overall Study|Ineligible to participate in the study|1|||
48499899|NCT00762086|156026134|FG001|Overall Study|Ineligible to participate in the study|0|||
48499900|NCT01287013|156026135|FG000|Overall Study|Non-evaluable|3|||
48499901|NCT01287013|156026136|FG001|Overall Study|Non-evaluable|5|||
48719686|NCT01029405|156822998|FG000|Overall Study|Protocol Violation|0|||
48719687|NCT01029405|156822999|FG001|Overall Study|Protocol Violation|0|||
48719688|NCT01029405|156823000|FG002|Overall Study|Protocol Violation|0|||
48719689|NCT01029405|156823001|FG003|Overall Study|Protocol Violation|1|||
48719690|NCT01029405|156822998|FG000|Overall Study|Adverse Event|0|||
48719691|NCT01029405|156822999|FG001|Overall Study|Adverse Event|0|||
48719692|NCT01029405|156823000|FG002|Overall Study|Adverse Event|1|||
48719693|NCT01029405|156823001|FG003|Overall Study|Adverse Event|1|||
48719694|NCT01029405|156822998|FG000|Overall Study|Lost to Follow-up|2|||
48719695|NCT01029405|156822999|FG001|Overall Study|Lost to Follow-up|1|||
48719696|NCT01029405|156823000|FG002|Overall Study|Lost to Follow-up|1|||
48719697|NCT01029405|156823001|FG003|Overall Study|Lost to Follow-up|2|||
48719698|NCT01029405|156822998|FG000|Overall Study|Other|0|||
48719699|NCT01029405|156822999|FG001|Overall Study|Other|1|||
48719700|NCT01029405|156823000|FG002|Overall Study|Other|0|||
48719701|NCT01029405|156823001|FG003|Overall Study|Other|1|||
48719702|NCT02946931|156823002|FG000|Overall Study|Did not require collection of CRFs|588|||
48719703|NCT02946931|156823002|FG000|Overall Study|Other than listed|37|||
48719704|NCT02946931|156823002|FG000|Overall Study|Discharge from hospital|118|||
48719705|NCT02946931|156823002|FG000|Overall Study|Adverse Event|81|||
48719706|NCT02946931|156823002|FG000|Overall Study|CRFs not valid|1|||
48719707|NCT02946931|156823002|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
48719708|NCT00561977|156823003|FG000|Overall Study|Withdrawal by Subject|0|||
48719709|NCT00561977|156823004|FG001|Overall Study|Withdrawal by Subject|2|||
48719710|NCT00561977|156823005|FG002|Overall Study|Withdrawal by Subject|1|||
48599600|NCT00379899|156389782|FG001|Overall Study|Ineligibility determined|1|||
48599601|NCT00379899|156389781|FG000|Overall Study|Noncompliance|1|||
48599602|NCT00379899|156389782|FG001|Overall Study|Noncompliance|1|||
48719711|NCT00561977|156823003|FG000|Overall Study|Pregnancy|0|||
48719712|NCT00561977|156823004|FG001|Overall Study|Pregnancy|1|||
48719713|NCT00561977|156823005|FG002|Overall Study|Pregnancy|1|||
48719714|NCT00732940|156823008|FG000|Overall Study|Withdrawal by Subject|1|||
48719715|NCT00732940|156823009|FG001|Overall Study|Withdrawal by Subject|2|||
48719716|NCT00732940|156823008|FG000|Overall Study|Adverse Event|0|||
48719717|NCT00732940|156823009|FG001|Overall Study|Adverse Event|1|||
48719718|NCT00732940|156823008|FG000|Overall Study|Lost to Follow-up|1|||
48719719|NCT00732940|156823009|FG001|Overall Study|Lost to Follow-up|0|||
48719720|NCT00509262|156823010|FG000|Overall Study|Adverse Event|16|||
48719721|NCT00509262|156823011|FG001|Overall Study|Adverse Event|18|||
48719722|NCT00509262|156823010|FG000|Overall Study|Other|2|||
48719723|NCT00509262|156823011|FG001|Overall Study|Other|2|||
48719724|NCT00509262|156823010|FG000|Overall Study|Lack of Efficacy|1|||
48719725|NCT00509262|156823011|FG001|Overall Study|Lack of Efficacy|0|||
48719726|NCT00509262|156823010|FG000|Overall Study|Lost to Follow-up|1|||
48719727|NCT00509262|156823011|FG001|Overall Study|Lost to Follow-up|6|||
48719728|NCT00509262|156823010|FG000|Overall Study|Physician Decision|1|||
48719729|NCT00509262|156823011|FG001|Overall Study|Physician Decision|3|||
48719730|NCT00509262|156823010|FG000|Overall Study|Protocol Violation|2|||
48719731|NCT00509262|156823011|FG001|Overall Study|Protocol Violation|2|||
48815406|NCT01778062|157165805|FG001|Overall Study|Consent Withdrawal|5|||
48815407|NCT01778062|157165804|FG000|Overall Study|major protocol deviation|4|||
48815408|NCT01778062|157165805|FG001|Overall Study|major protocol deviation|3|||
48815409|NCT00003458|157165809|FG000|Overall Study|Not evaluable|4|||
48815410|NCT02133924|157165810|FG000|Overall Study|Death|38|||
48815411|NCT02133924|157165810|FG000|Overall Study|Physician Decision|1|||
48719732|NCT00509262|156823010|FG000|Overall Study|Withdrawal by Subject|24|||
48719733|NCT00509262|156823011|FG001|Overall Study|Withdrawal by Subject|11|||
48719734|NCT03709576|156823014|FG000|Overall Study|progression prior to enrollment|1|||
48719735|NCT00621621|156823019|FG000|Overall Study|Subjects were exited at EP study|30|||
48719736|NCT00621621|156823020|FG001|Overall Study|Subjects were exited at EP study|0|||
48719737|NCT01226121|156823023|FG000|Overall Study|Lost to Follow-up|2|||
48719738|NCT01226121|156823024|FG001|Overall Study|Lost to Follow-up|0|||
48719739|NCT01226121|156823025|FG002|Overall Study|Lost to Follow-up|1|||
48719740|NCT00169442|156823026|FG000|Overall Study|Withdrawal by Subject|0|||
48719741|NCT00169442|156823027|FG001|Overall Study|Withdrawal by Subject|0|||
48719742|NCT00169442|156823028|FG002|Overall Study|Withdrawal by Subject|1|||
48719743|NCT00169442|156823029|FG003|Overall Study|Withdrawal by Subject|0|||
48719744|NCT00169442|156823030|FG004|Overall Study|Withdrawal by Subject|0|||
48719745|NCT00169442|156823031|FG005|Overall Study|Withdrawal by Subject|0|||
48719746|NCT00169442|156823026|FG000|Overall Study|Migrated/moved from study area|0|||
48719747|NCT00169442|156823027|FG001|Overall Study|Migrated/moved from study area|0|||
48719748|NCT00169442|156823028|FG002|Overall Study|Migrated/moved from study area|0|||
48719749|NCT00169442|156823029|FG003|Overall Study|Migrated/moved from study area|0|||
48719750|NCT00169442|156823030|FG004|Overall Study|Migrated/moved from study area|0|||
48719751|NCT00169442|156823031|FG005|Overall Study|Migrated/moved from study area|2|||
48719752|NCT00169442|156823026|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48719753|NCT00169442|156823027|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48719754|NCT00169442|156823028|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48815412|NCT02133924|157165810|FG000|Overall Study|Withdrawal by Subject|3|||
48815413|NCT04039503|157165817|FG000|Overall Study|Adverse Event|3|||
48499902|NCT01287013|156026137|FG002|Overall Study|Non-evaluable|21|||
48499903|NCT03830164|156026138|FG000|Overall Study|Adverse Event|0|||
48499904|NCT03830164|156026139|FG001|Overall Study|Adverse Event|2|||
48499905|NCT03830164|156026140|FG002|Overall Study|Adverse Event|0|||
48499906|NCT03830164|156026138|FG000|Overall Study|Lack of Efficacy|1|||
48499907|NCT03830164|156026139|FG001|Overall Study|Lack of Efficacy|5|||
48499908|NCT03830164|156026140|FG002|Overall Study|Lack of Efficacy|0|||
48499909|NCT03830164|156026138|FG000|Overall Study|Lost to Follow-up|0|||
48499910|NCT03830164|156026139|FG001|Overall Study|Lost to Follow-up|1|||
48499911|NCT03830164|156026140|FG002|Overall Study|Lost to Follow-up|0|||
48499912|NCT03830164|156026138|FG000|Overall Study|Withdrawal by Subject|1|||
48499913|NCT03830164|156026139|FG001|Overall Study|Withdrawal by Subject|0|||
48499914|NCT03830164|156026140|FG002|Overall Study|Withdrawal by Subject|0|||
48499915|NCT04099888|156026141|FG000|Overall Study|Study terminated by sponsor|9|||
48499916|NCT04099888|156026142|FG001|Overall Study|Study terminated by sponsor|11|||
48499917|NCT04099888|156026141|FG000|Overall Study|Lost to Follow-up|1|||
48499918|NCT04099888|156026142|FG001|Overall Study|Lost to Follow-up|1|||
48499919|NCT04099888|156026141|FG000|Overall Study|Withdrawal by Subject|5|||
48719755|NCT00169442|156823029|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48719756|NCT00169442|156823030|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
48719757|NCT00169442|156823031|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48719758|NCT00169442|156823026|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48719759|NCT00169442|156823027|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
48719760|NCT00169442|156823028|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48719761|NCT00169442|156823029|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48719762|NCT00169442|156823030|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48719763|NCT00169442|156823031|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
48815414|NCT04039503|157165818|FG001|Overall Study|Adverse Event|0|||
48815415|NCT04039503|157165819|FG002|Overall Study|Adverse Event|2|||
48719764|NCT00811642|156823040|FG000|Overall Study|Adverse Event|3|||
48719765|NCT00811642|156823040|FG000|Overall Study|Protocol Violation|1|||
48719766|NCT00811642|156823040|FG000|Overall Study|Death|2|||
48719767|NCT00811642|156823040|FG000|Overall Study|Withdrawal by Subject|7|||
48719768|NCT00811642|156823040|FG000|Overall Study|Cumulative use of antifungal agent|2|||
48719769|NCT01246466|156824793|FG000|Overall Study|Death|1|||
48719770|NCT01246466|156824793|FG000|Overall Study|Withdrawal by Subject|1|||
48719771|NCT02446171|156824800|FG000|Overall Study|Withdrawal by Subject|0|||
48719772|NCT02446171|156824801|FG001|Overall Study|Withdrawal by Subject|0|||
48719773|NCT02446171|156824802|FG002|Overall Study|Withdrawal by Subject|2|||
48719774|NCT02446171|156824803|FG003|Overall Study|Withdrawal by Subject|0|||
48719775|NCT01027273|156824805|FG000|Overall Study|Lost to Follow-up|57|||
48719776|NCT01027273|156824806|FG001|Overall Study|Lost to Follow-up|31|||
48719777|NCT01027273|156824805|FG000|Overall Study|Death|2|||
48719778|NCT01027273|156824806|FG001|Overall Study|Death|2|||
48719779|NCT03745820|156824811|FG000|Overall Study|Adverse Event|0|||
48719780|NCT03745820|156824812|FG001|Overall Study|Adverse Event|3|||
48719781|NCT03745820|156824813|FG002|Overall Study|Adverse Event|2|||
48719782|NCT03745820|156824811|FG000|Overall Study|Non-Compliance with Study Drug|4|||
48719783|NCT03745820|156824812|FG001|Overall Study|Non-Compliance with Study Drug|3|||
48719784|NCT03745820|156824813|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48719785|NCT03745820|156824811|FG000|Overall Study|Withdrawal by Subject|4|||
48719786|NCT03745820|156824812|FG001|Overall Study|Withdrawal by Subject|4|||
48719787|NCT03745820|156824813|FG002|Overall Study|Withdrawal by Subject|4|||
48719788|NCT03745820|156824811|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
48719789|NCT03745820|156824812|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
48719790|NCT03745820|156824813|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
48719791|NCT03745820|156824811|FG000|Overall Study|Lost to Follow-up|2|||
48719792|NCT03745820|156824812|FG001|Overall Study|Lost to Follow-up|0|||
48719793|NCT03745820|156824813|FG002|Overall Study|Lost to Follow-up|3|||
48719794|NCT03745820|156824811|FG000|Overall Study|Reason not Specified|2|||
48719795|NCT03745820|156824812|FG001|Overall Study|Reason not Specified|4|||
48719796|NCT03745820|156824813|FG002|Overall Study|Reason not Specified|1|||
48719797|NCT00669409|156824814|FG000|Part 2|Withdrawal by Subject|0|||
48719798|NCT00669409|156824815|FG001|Part 2|Withdrawal by Subject|0|||
48719799|NCT00669409|156824816|FG002|Part 2|Withdrawal by Subject|0|||
48719800|NCT00669409|156824817|FG003|Part 2|Withdrawal by Subject|0|||
48719801|NCT00669409|156824818|FG004|Part 2|Withdrawal by Subject|0|||
48719802|NCT00669409|156824819|FG005|Part 2|Withdrawal by Subject|0|||
48719803|NCT00669409|156824820|FG006|Part 2|Withdrawal by Subject|0|||
48719804|NCT00669409|156824821|FG007|Part 2|Withdrawal by Subject|0|||
48719805|NCT00669409|156824822|FG008|Part 2|Withdrawal by Subject|0|||
48719806|NCT00669409|156824823|FG009|Part 2|Withdrawal by Subject|1|||
48719807|NCT00669409|156824824|FG010|Part 2|Withdrawal by Subject|0|||
48719808|NCT02052414|156824827|FG000|Overall Study|Adverse Event|12|||
48719809|NCT02052414|156824827|FG000|Overall Study|Lack of Efficacy|2|||
48719810|NCT02052414|156824827|FG000|Overall Study|Withdrawal by Subject|3|||
48719811|NCT01489111|156824828|FG000|Overall Study|Withdrawal criterion|1|||
48719812|NCT00813943|156824830|FG000|Overall Study|Ongoing at cut-off date|5|||
48719813|NCT00813943|156824831|FG001|Overall Study|Ongoing at cut-off date|5|||
48719814|NCT00813943|156824832|FG002|Overall Study|Ongoing at cut-off date|3|||
48719815|NCT01463007|156824836|FG000|Overall Study|Physician Decision|1|||
48499920|NCT04099888|156026142|FG001|Overall Study|Withdrawal by Subject|6|||
48499921|NCT04099888|156026141|FG000|Overall Study|Death|5|||
48499922|NCT04099888|156026142|FG001|Overall Study|Death|2|||
48499923|NCT04099888|156026141|FG000|Overall Study|Other|1|||
48499924|NCT04099888|156026142|FG001|Overall Study|Other|0|||
48499925|NCT04538170|156026145|FG000|Overall Study|Withdrawal by Subject|104|||
48499926|NCT04538170|156026146|FG001|Overall Study|Withdrawal by Subject|210|||
48499927|NCT01074554|156026147|FG000|Overall Study|Adverse Event|3|||
48499928|NCT01074554|156026148|FG001|Overall Study|Adverse Event|3|||
48499929|NCT01074554|156026147|FG000|Overall Study|Lost to Follow-up|0|||
48499930|NCT01074554|156026148|FG001|Overall Study|Lost to Follow-up|1|||
48499931|NCT05150964|156026149|FG000|Overall Study|Lost to Follow-up|2|||
48499932|NCT01273181|156026150|FG000|Phase I, Dose 1|Study termination|1|||
48499933|NCT01273181|156026151|FG001|Phase I, Dose 1|Study termination|0|||
48499934|NCT01273181|156026152|FG002|Phase I, Dose 1|Study termination|0|||
48499935|NCT01273181|156026153|FG003|Phase I, Dose 1|Study termination|0|||
48499936|NCT01273181|156026150|FG000|Phase I, Dose 2|Death during treatment|0|||
48499937|NCT01273181|156026151|FG001|Phase I, Dose 2|Death during treatment|1|||
48719816|NCT01095094|156824842|FG000|Overall Study|Withdrawal by Subject|1|||
48719817|NCT01095094|156824842|FG000|Overall Study|Death|1|||
48719818|NCT01095094|156824842|FG000|Overall Study|Physician Decision|1|||
48719819|NCT03467152|156824843|FG000|Overall Study|Adverse Event|4|||
48719820|NCT03467152|156824844|FG001|Overall Study|Adverse Event|5|||
48499938|NCT01273181|156026152|FG002|Phase I, Dose 2|Death during treatment|0|||
48499939|NCT01273181|156026153|FG003|Phase I, Dose 2|Death during treatment|0|||
48719821|NCT03467152|156824845|FG002|Overall Study|Adverse Event|0|||
48815416|NCT04039503|157165820|FG003|Overall Study|Adverse Event|0|||
48815417|NCT04039503|157165817|FG000|Overall Study|Lost to Follow-up|0|||
48815418|NCT04039503|157165818|FG001|Overall Study|Lost to Follow-up|0|||
48815419|NCT04039503|157165819|FG002|Overall Study|Lost to Follow-up|1|||
48815420|NCT04039503|157165820|FG003|Overall Study|Lost to Follow-up|0|||
48815421|NCT04039503|157165817|FG000|Overall Study|Protocol Violation|0|||
48815422|NCT04039503|157165818|FG001|Overall Study|Protocol Violation|1|||
48815423|NCT04039503|157165819|FG002|Overall Study|Protocol Violation|2|||
48815424|NCT04039503|157165820|FG003|Overall Study|Protocol Violation|1|||
48815425|NCT04039503|157165817|FG000|Overall Study|Withdrawal by Subject|4|||
48815426|NCT04039503|157165818|FG001|Overall Study|Withdrawal by Subject|3|||
48815427|NCT04039503|157165819|FG002|Overall Study|Withdrawal by Subject|5|||
48815428|NCT04039503|157165820|FG003|Overall Study|Withdrawal by Subject|2|||
48815429|NCT03387514|157165821|FG000|Overall Study|Withdrawal by Subject|2|||
48815430|NCT03387514|157165821|FG000|Overall Study|Physician Decision|1|||
48815431|NCT03387514|157165821|FG000|Overall Study|Lost to Follow-up|2|||
48815432|NCT00245011|157165822|FG000|Overall Study|Lack of Efficacy|1|||
48815433|NCT03040687|157165823|FG000|Overall Study|Withdrawal by Subject|1|||
48815434|NCT03040687|157165824|FG001|Overall Study|Withdrawal by Subject|0|||
48815435|NCT03040687|157165825|FG002|Overall Study|Withdrawal by Subject|0|||
48815436|NCT02846558|157165826|FG000|Overall Study|Adverse Event|1|||
48815437|NCT02846558|157165827|FG001|Overall Study|Adverse Event|0|||
48815438|NCT02846558|157165828|FG002|Overall Study|Adverse Event|0|||
48815439|NCT02846558|157165829|FG003|Overall Study|Adverse Event|0|||
48815440|NCT02846558|157165826|FG000|Overall Study|Withdrawal by Subject|5|||
48815441|NCT02846558|157165827|FG001|Overall Study|Withdrawal by Subject|4|||
48815442|NCT02846558|157165828|FG002|Overall Study|Withdrawal by Subject|2|||
48815443|NCT02846558|157165829|FG003|Overall Study|Withdrawal by Subject|2|||
48815444|NCT02846558|157165826|FG000|Overall Study|Lost to Follow-up|2|||
48815445|NCT02846558|157165827|FG001|Overall Study|Lost to Follow-up|0|||
48815446|NCT02846558|157165828|FG002|Overall Study|Lost to Follow-up|0|||
48815447|NCT02846558|157165829|FG003|Overall Study|Lost to Follow-up|0|||
48815448|NCT04157686|157165830|FG000|Overall Study|Adverse Event|1|||
48815449|NCT04157686|157165831|FG001|Overall Study|Adverse Event|0|||
48815450|NCT04157686|157165832|FG002|Overall Study|Adverse Event|1|||
48815451|NCT04157686|157165833|FG003|Overall Study|Adverse Event|0|||
48815452|NCT04157686|157165834|FG004|Overall Study|Adverse Event|1|||
48815453|NCT04157686|157165835|FG005|Overall Study|Adverse Event|0|||
48815454|NCT04157686|157165836|FG006|Overall Study|Adverse Event|0|||
48815455|NCT04157686|157165837|FG007|Overall Study|Adverse Event|0|||
48815456|NCT04157686|157165830|FG000|Overall Study|Pregnancy|0|||
48815457|NCT04157686|157165831|FG001|Overall Study|Pregnancy|1|||
48815458|NCT04157686|157165832|FG002|Overall Study|Pregnancy|3|||
48815459|NCT04157686|157165833|FG003|Overall Study|Pregnancy|0|||
48815460|NCT04157686|157165834|FG004|Overall Study|Pregnancy|0|||
48815461|NCT04157686|157165835|FG005|Overall Study|Pregnancy|0|||
48815462|NCT04157686|157165836|FG006|Overall Study|Pregnancy|3|||
48815463|NCT04157686|157165837|FG007|Overall Study|Pregnancy|0|||
48815464|NCT04157686|157165830|FG000|Overall Study|Lost to Follow-up|1|||
48815465|NCT04157686|157165831|FG001|Overall Study|Lost to Follow-up|2|||
48499940|NCT01273181|156026150|FG000|Phase 2, Dose 1|Study termination|0|||
48499941|NCT01273181|156026151|FG001|Phase 2, Dose 1|Study termination|0|||
48499942|NCT01273181|156026152|FG002|Phase 2, Dose 1|Study termination|1|||
48499943|NCT01273181|156026153|FG003|Phase 2, Dose 1|Study termination|0|||
48499944|NCT01273181|156026150|FG000|Phase 2, Dose 2|Death during treatment|0|||
48499945|NCT01273181|156026151|FG001|Phase 2, Dose 2|Death during treatment|0|||
48499946|NCT01273181|156026152|FG002|Phase 2, Dose 2|Death during treatment|0|||
48499947|NCT01273181|156026153|FG003|Phase 2, Dose 2|Death during treatment|1|||
48499948|NCT03361228|156026170|FG000|Overall Study|Other|1|||
48499949|NCT03361228|156026171|FG001|Overall Study|Other|1|||
48499950|NCT03361228|156026170|FG000|Overall Study|Death|3|||
48499951|NCT03361228|156026171|FG001|Overall Study|Death|0|||
48499952|NCT02016170|156026172|FG000|Overall Study|Adverse Event|1|||
48499953|NCT02016170|156026173|FG001|Overall Study|Adverse Event|1|||
48499954|NCT02016170|156026174|FG002|Overall Study|Adverse Event|0|||
48499955|NCT02016170|156026172|FG000|Overall Study|Protocol Violation|1|||
48815466|NCT04157686|157165832|FG002|Overall Study|Lost to Follow-up|8|||
48815467|NCT04157686|157165833|FG003|Overall Study|Lost to Follow-up|6|||
48815468|NCT04157686|157165834|FG004|Overall Study|Lost to Follow-up|6|||
48815469|NCT04157686|157165835|FG005|Overall Study|Lost to Follow-up|3|||
48815470|NCT04157686|157165836|FG006|Overall Study|Lost to Follow-up|7|||
48815471|NCT04157686|157165837|FG007|Overall Study|Lost to Follow-up|9|||
48815472|NCT04157686|157165830|FG000|Overall Study|Lack of Efficacy|0|||
48815473|NCT04157686|157165831|FG001|Overall Study|Lack of Efficacy|0|||
48815474|NCT04157686|157165832|FG002|Overall Study|Lack of Efficacy|0|||
48815475|NCT04157686|157165833|FG003|Overall Study|Lack of Efficacy|0|||
48499956|NCT02016170|156026173|FG001|Overall Study|Protocol Violation|0|||
48499957|NCT02016170|156026174|FG002|Overall Study|Protocol Violation|0|||
48499958|NCT02930005|156026180|FG000|Overall Study|Lost to Follow-up|1|||
48815476|NCT04157686|157165834|FG004|Overall Study|Lack of Efficacy|0|||
48815477|NCT04157686|157165835|FG005|Overall Study|Lack of Efficacy|2|||
48719822|NCT03467152|156824843|FG000|Overall Study|Subject Choice|1|||
48719823|NCT03467152|156824844|FG001|Overall Study|Subject Choice|3|||
48719824|NCT03467152|156824845|FG002|Overall Study|Subject Choice|0|||
48719825|NCT03467152|156824843|FG000|Overall Study|Lost to Follow-up|1|||
48719826|NCT03467152|156824844|FG001|Overall Study|Lost to Follow-up|0|||
48719827|NCT03467152|156824845|FG002|Overall Study|Lost to Follow-up|0|||
48719828|NCT03467152|156824843|FG000|Overall Study|Withdrawal by Subject|4|||
48719829|NCT03467152|156824844|FG001|Overall Study|Withdrawal by Subject|2|||
48719830|NCT03467152|156824845|FG002|Overall Study|Withdrawal by Subject|0|||
48719831|NCT03467152|156824843|FG000|Overall Study|Others|3|||
48719832|NCT03467152|156824844|FG001|Overall Study|Others|0|||
48719833|NCT03467152|156824845|FG002|Overall Study|Others|0|||
48719834|NCT03467152|156824843|FG000|Overall Study|Not treated|3|||
48719835|NCT03467152|156824844|FG001|Overall Study|Not treated|1|||
48719836|NCT03467152|156824845|FG002|Overall Study|Not treated|6|||
48719837|NCT01236547|156824846|FG000|Overall Study|Protocol Violation|0|||
48719838|NCT01236547|156824847|FG001|Overall Study|Protocol Violation|1|||
48719839|NCT01236547|156824848|FG002|Overall Study|Protocol Violation|1|||
48719840|NCT01236547|156824849|FG003|Overall Study|Protocol Violation|6|||
48719841|NCT01236547|156824850|FG004|Overall Study|Protocol Violation|12|||
48719842|NCT04250077|156824851|FG000|Overall Study|Withdrawal by Subject|0|||
48719843|NCT04250077|156824852|FG001|Overall Study|Withdrawal by Subject|1|||
48719844|NCT04250077|156824853|FG002|Overall Study|Withdrawal by Subject|0|||
48719845|NCT04250077|156824851|FG000|Overall Study|Lost to Follow-up|2|||
48719846|NCT04250077|156824852|FG001|Overall Study|Lost to Follow-up|3|||
48719847|NCT04250077|156824853|FG002|Overall Study|Lost to Follow-up|0|||
48719848|NCT00528970|156824854|FG000|Overall Study|Adverse Event|6|||
48719849|NCT00528970|156824855|FG001|Overall Study|Adverse Event|8|||
48719850|NCT00528970|156824856|FG002|Overall Study|Adverse Event|5|||
48719851|NCT00528970|156824854|FG000|Overall Study|Lost to Follow-up|0|||
48719852|NCT00528970|156824855|FG001|Overall Study|Lost to Follow-up|0|||
48719853|NCT00528970|156824856|FG002|Overall Study|Lost to Follow-up|1|||
48719854|NCT00528970|156824854|FG000|Overall Study|Other than specified|2|||
48719855|NCT00528970|156824855|FG001|Overall Study|Other than specified|3|||
48719856|NCT00528970|156824856|FG002|Overall Study|Other than specified|3|||
48719857|NCT00528970|156824854|FG000|Overall Study|Protocol Violation|2|||
48719858|NCT00528970|156824855|FG001|Overall Study|Protocol Violation|1|||
48719859|NCT00528970|156824856|FG002|Overall Study|Protocol Violation|4|||
48719860|NCT00528970|156824854|FG000|Overall Study|Lack of Efficacy|0|||
48719861|NCT00528970|156824855|FG001|Overall Study|Lack of Efficacy|0|||
48719862|NCT00528970|156824856|FG002|Overall Study|Lack of Efficacy|1|||
48719863|NCT00528970|156824854|FG000|Overall Study|Withdrawal by Subject|4|||
48719864|NCT00528970|156824855|FG001|Overall Study|Withdrawal by Subject|3|||
48719865|NCT00528970|156824856|FG002|Overall Study|Withdrawal by Subject|5|||
48719866|NCT00528970|156824854|FG000|Overall Study|Randomized but not treated|0|||
48719867|NCT00528970|156824855|FG001|Overall Study|Randomized but not treated|0|||
48719868|NCT00528970|156824856|FG002|Overall Study|Randomized but not treated|1|||
48719869|NCT01002820|156824858|FG000|Overall Study|Adverse Event|1|||
48719870|NCT01002820|156824858|FG000|Overall Study|Withdrawal by Subject|2|||
48719871|NCT01002820|156824858|FG000|Overall Study|Lack of Efficacy|1|||
48719872|NCT03859973|156824862|FG000|Overall Study|Other reason than listed|3|||
48719873|NCT03859973|156824863|FG001|Overall Study|Other reason than listed|2|||
48719874|NCT03859973|156824862|FG000|Overall Study|COVID-19 related, not due to AE|3|||
48719875|NCT03859973|156824863|FG001|Overall Study|COVID-19 related, not due to AE|4|||
48719876|NCT03859973|156824862|FG000|Overall Study|Withdrawal by Subject|8|||
48719877|NCT03859973|156824863|FG001|Overall Study|Withdrawal by Subject|9|||
48719878|NCT03859973|156824862|FG000|Overall Study|Lost to Follow-up|2|||
48719879|NCT03859973|156824863|FG001|Overall Study|Lost to Follow-up|3|||
48719880|NCT03859973|156824862|FG000|Overall Study|Protocol Violation|1|||
48719881|NCT03859973|156824863|FG001|Overall Study|Protocol Violation|3|||
48719882|NCT03859973|156824862|FG000|Overall Study|Adverse Event|3|||
48719883|NCT03859973|156824863|FG001|Overall Study|Adverse Event|5|||
48719884|NCT01369329|156824866|FG000|Overall Study|Withdrawal by Subject|8|||
48719885|NCT01369329|156824867|FG001|Overall Study|Withdrawal by Subject|6|||
48719886|NCT01369329|156824868|FG002|Overall Study|Withdrawal by Subject|10|||
48719887|NCT01369329|156824866|FG000|Overall Study|Lost to Follow-up|2|||
48719888|NCT01369329|156824867|FG001|Overall Study|Lost to Follow-up|2|||
48719889|NCT01369329|156824868|FG002|Overall Study|Lost to Follow-up|2|||
48719890|NCT01369329|156824866|FG000|Overall Study|Other|2|||
48719891|NCT01369329|156824867|FG001|Overall Study|Other|3|||
48719892|NCT01369329|156824868|FG002|Overall Study|Other|2|||
48719893|NCT03206788|156824869|FG000|Overall Study|Withdrawal by Subject|0|||
48719894|NCT03206788|156824870|FG001|Overall Study|Withdrawal by Subject|1|||
48719895|NCT03206788|156824869|FG000|Overall Study|Adverse Event|0|||
48719896|NCT03206788|156824870|FG001|Overall Study|Adverse Event|1|||
48719897|NCT03206788|156824869|FG000|Overall Study|Physician Decision|0|||
48719898|NCT03206788|156824870|FG001|Overall Study|Physician Decision|1|||
48719899|NCT03330002|156824871|FG000|Overall Study|Lost to Follow-up|15|||
48719900|NCT03330002|156824871|FG000|Overall Study|Death|7|||
48815478|NCT04157686|157165836|FG006|Overall Study|Lack of Efficacy|0|||
48499959|NCT02930005|156026181|FG001|Overall Study|Lost to Follow-up|5|||
48499960|NCT05067647|156026182|FG000|Overall Study|Lost to Follow-up|1|||
48499961|NCT01759290|156026183|FG000|Overall Study|Subjects withdrawn consent|5|||
48499962|NCT01759290|156026183|FG000|Overall Study|Physician Decision|2|||
48499963|NCT01759290|156026183|FG000|Overall Study|Death|17|||
48499964|NCT01759290|156026183|FG000|Overall Study|Lost to Follow-up|53|||
48499965|NCT01759290|156026183|FG000|Overall Study|Unknown reason|4|||
48499966|NCT03897088|156026186|FG000|Overall Study|Withdrawal by Subject|12|||
48499967|NCT03897088|156026187|FG001|Overall Study|Withdrawal by Subject|12|||
48499968|NCT03897088|156026186|FG000|Overall Study|Lost to Follow-up|7|||
48499969|NCT03897088|156026187|FG001|Overall Study|Lost to Follow-up|15|||
48499970|NCT03897088|156026186|FG000|Overall Study|Sponsor Decision|1|||
48499971|NCT03897088|156026187|FG001|Overall Study|Sponsor Decision|2|||
48499972|NCT03897088|156026186|FG000|Overall Study|COVID-19|2|||
48499973|NCT03897088|156026187|FG001|Overall Study|COVID-19|0|||
48499974|NCT03897088|156026186|FG000|Overall Study|Other|3|||
48499975|NCT03897088|156026187|FG001|Overall Study|Other|0|||
48499976|NCT03897088|156026186|FG000|Overall Study|Non-compliance with Study Drug|1|||
48499977|NCT03897088|156026187|FG001|Overall Study|Non-compliance with Study Drug|1|||
48499978|NCT03897088|156026186|FG000|Overall Study|Pregnancy|0|||
48499979|NCT03897088|156026187|FG001|Overall Study|Pregnancy|1|||
48499980|NCT02079532|156026193|FG000|Overall Study|Adverse Event|7|||
48499981|NCT02079532|156026193|FG000|Overall Study|Additional or changed therapy|2|||
48499982|NCT02079532|156026193|FG000|Overall Study|Lack of Efficacy|9|||
48499983|NCT02079532|156026193|FG000|Overall Study|Protocol Violation|3|||
48499984|NCT02079532|156026193|FG000|Overall Study|Withdrawal by Subject|1|||
48499985|NCT02079532|156026193|FG000|Overall Study|Administrative problems|1|||
48499986|NCT02079532|156026193|FG000|Overall Study|Inclusion into ReFIRST|3|||
48499987|NCT02079532|156026193|FG000|Overall Study|Other|3|||
48499988|NCT02920996|156026194|FG000|Overall Study|Adverse Event|8|||
48499989|NCT02920996|156026195|FG001|Overall Study|Adverse Event|0|||
48499990|NCT02920996|156026194|FG000|Overall Study|Physician Decision|1|||
48499991|NCT02920996|156026195|FG001|Overall Study|Physician Decision|0|||
48499992|NCT02920996|156026194|FG000|Overall Study|Death|1|||
48499993|NCT02920996|156026195|FG001|Overall Study|Death|0|||
48499994|NCT02920996|156026194|FG000|Overall Study|Missing|1|||
48499995|NCT02920996|156026195|FG001|Overall Study|Missing|0|||
48499996|NCT02920996|156026194|FG000|Overall Study|Subject Non-Compliance|1|||
48499997|NCT02920996|156026195|FG001|Overall Study|Subject Non-Compliance|0|||
48499998|NCT02682602|156026196|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
48499999|NCT02682602|156026197|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
48500000|NCT02682602|156026196|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
48500001|NCT02682602|156026197|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
48500002|NCT04849988|156028004|FG000|Overall Study|Lack of Efficacy|3|||
48500003|NCT04849988|156028005|FG001|Overall Study|Lack of Efficacy|4|||
48500004|NCT04849988|156028006|FG002|Overall Study|Lack of Efficacy|1|||
48500005|NCT04849988|156028007|FG003|Overall Study|Lack of Efficacy|4|||
48500006|NCT04849988|156028004|FG000|Overall Study|Other reasons|1|||
48500007|NCT04849988|156028005|FG001|Overall Study|Other reasons|2|||
48500008|NCT04849988|156028006|FG002|Overall Study|Other reasons|2|||
48719901|NCT00917644|156824876|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
48719902|NCT00917644|156824877|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
48719903|NCT00917644|156824876|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
48719904|NCT00917644|156824877|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
48719905|NCT00917644|156824876|FG000|Period 2: Second Intervention|family emergency|1|||
48719906|NCT00917644|156824877|FG001|Period 2: Second Intervention|family emergency|0|||
48719907|NCT02142387|156824878|FG000|Overall Study|<19 years old|49|||
48719908|NCT02142387|156824879|FG001|Overall Study|<19 years old|326|||
48719909|NCT02142387|156824878|FG000|Overall Study|non-cardiac etiology|504|||
48719910|NCT02142387|156824879|FG001|Overall Study|non-cardiac etiology|3431|||
48719911|NCT02142387|156824878|FG000|Overall Study|CPR not performed|74|||
48719912|NCT02142387|156824879|FG001|Overall Study|CPR not performed|473|||
48719913|NCT02142387|156824878|FG000|Overall Study|witnessed by paramedic|139|||
48719914|NCT02142387|156824879|FG001|Overall Study|witnessed by paramedic|917|||
48719915|NCT02142387|156824878|FG000|Overall Study|incomplete data|1|||
48719916|NCT02142387|156824879|FG001|Overall Study|incomplete data|9|||
48719917|NCT02142387|156824878|FG000|Overall Study|occurred not at home|298|||
48719918|NCT02142387|156824879|FG001|Overall Study|occurred not at home|2474|||
48719919|NCT03996369|156824881|FG000|Overall Study|Protocol deviation|1|||
48719920|NCT03996369|156824882|FG001|Overall Study|Protocol deviation|1|||
48719921|NCT03996369|156824881|FG000|Overall Study|Physician Decision|4|||
48719922|NCT03996369|156824882|FG001|Overall Study|Physician Decision|2|||
48719923|NCT03996369|156824881|FG000|Overall Study|Participant decision|0|||
48719924|NCT03996369|156824882|FG001|Overall Study|Participant decision|1|||
48719925|NCT03996369|156824881|FG000|Overall Study|Lack of Efficacy|4|||
48719926|NCT03996369|156824882|FG001|Overall Study|Lack of Efficacy|0|||
48500009|NCT04849988|156028007|FG003|Overall Study|Other reasons|1|||
48500010|NCT02173704|156028019|FG000|Overall Study|Adverse Event|1|||
48719927|NCT03996369|156824881|FG000|Overall Study|Adverse Event|9|||
48719928|NCT03996369|156824882|FG001|Overall Study|Adverse Event|0|||
48719929|NCT03996369|156824881|FG000|Overall Study|Withdrawal by Subject|6|||
48719930|NCT03996369|156824882|FG001|Overall Study|Withdrawal by Subject|8|||
48719931|NCT03996369|156824881|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
48719932|NCT03996369|156824882|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
48719933|NCT03996369|156824881|FG000|Overall Study|Lost to Follow-up|0|||
48719934|NCT03996369|156824882|FG001|Overall Study|Lost to Follow-up|1|||
48815479|NCT04157686|157165837|FG007|Overall Study|Lack of Efficacy|1|||
48815480|NCT04157686|157165830|FG000|Overall Study|Withdrawal by Subject|10|||
48815481|NCT04157686|157165831|FG001|Overall Study|Withdrawal by Subject|10|||
48815482|NCT04157686|157165832|FG002|Overall Study|Withdrawal by Subject|12|||
48815483|NCT04157686|157165833|FG003|Overall Study|Withdrawal by Subject|20|||
48815484|NCT04157686|157165834|FG004|Overall Study|Withdrawal by Subject|12|||
48815485|NCT04157686|157165835|FG005|Overall Study|Withdrawal by Subject|11|||
48815486|NCT04157686|157165836|FG006|Overall Study|Withdrawal by Subject|18|||
48815487|NCT04157686|157165837|FG007|Overall Study|Withdrawal by Subject|24|||
48815488|NCT04157686|157165830|FG000|Overall Study|Physician Decision|0|||
48815489|NCT04157686|157165831|FG001|Overall Study|Physician Decision|0|||
48815490|NCT04157686|157165832|FG002|Overall Study|Physician Decision|1|||
48815491|NCT04157686|157165833|FG003|Overall Study|Physician Decision|0|||
48815492|NCT04157686|157165834|FG004|Overall Study|Physician Decision|1|||
48815493|NCT04157686|157165835|FG005|Overall Study|Physician Decision|0|||
48815494|NCT04157686|157165836|FG006|Overall Study|Physician Decision|3|||
48815495|NCT04157686|157165837|FG007|Overall Study|Physician Decision|0|||
48815496|NCT04157686|157165830|FG000|Overall Study|Death|0|||
48815497|NCT04157686|157165831|FG001|Overall Study|Death|0|||
48815498|NCT04157686|157165832|FG002|Overall Study|Death|0|||
48815499|NCT04157686|157165833|FG003|Overall Study|Death|2|||
48815500|NCT04157686|157165834|FG004|Overall Study|Death|0|||
48815501|NCT04157686|157165835|FG005|Overall Study|Death|0|||
48815502|NCT04157686|157165836|FG006|Overall Study|Death|0|||
48815503|NCT04157686|157165837|FG007|Overall Study|Death|0|||
48815504|NCT04157686|157165830|FG000|Overall Study|Protocol Violation|0|||
48815505|NCT04157686|157165831|FG001|Overall Study|Protocol Violation|0|||
48815506|NCT04157686|157165832|FG002|Overall Study|Protocol Violation|0|||
48815507|NCT04157686|157165833|FG003|Overall Study|Protocol Violation|0|||
48815508|NCT04157686|157165834|FG004|Overall Study|Protocol Violation|1|||
48815509|NCT04157686|157165835|FG005|Overall Study|Protocol Violation|0|||
48815510|NCT04157686|157165836|FG006|Overall Study|Protocol Violation|0|||
48719935|NCT01579812|156824883|FG000|Overall Study|Ineligible after treatment start|40|||
48719936|NCT01579812|156824883|FG000|Overall Study|Patient choice|3|||
48719937|NCT01579812|156824883|FG000|Overall Study|Noncompliance|3|||
48719938|NCT01579812|156824883|FG000|Overall Study|Withdrawal by Subject|6|||
48719939|NCT01743001|156824885|FG000|Overall Study|Physician Decision|1|||
48719940|NCT01743001|156824886|FG001|Overall Study|Physician Decision|0|||
48719941|NCT01743001|156824885|FG000|Overall Study|Pregnancy|1|||
48719942|NCT01743001|156824886|FG001|Overall Study|Pregnancy|0|||
48719943|NCT01743001|156824885|FG000|Overall Study|Death|1|||
48719944|NCT01743001|156824886|FG001|Overall Study|Death|0|||
48719945|NCT02683746|156824887|FG000|Overall Study|Adverse Event|3|||
48719946|NCT02683746|156824888|FG001|Overall Study|Adverse Event|2|||
48719947|NCT02683746|156824887|FG000|Overall Study|Lost to Follow-up|5|||
48719948|NCT02683746|156824888|FG001|Overall Study|Lost to Follow-up|6|||
48719949|NCT02683746|156824887|FG000|Overall Study|Withdrawal by Subject|6|||
48719950|NCT02683746|156824888|FG001|Overall Study|Withdrawal by Subject|5|||
48719951|NCT02683746|156824887|FG000|Overall Study|Physician Decision|2|||
48719952|NCT02683746|156824888|FG001|Overall Study|Physician Decision|1|||
48719953|NCT04987944|156824893|FG000|Overall Study|Adverse Event|0|||
48719954|NCT04987944|156824894|FG001|Overall Study|Adverse Event|1|||
48719955|NCT04987944|156824893|FG000|Overall Study|Withdrawal by Subject|0|||
48719956|NCT04987944|156824894|FG001|Overall Study|Withdrawal by Subject|1|||
48719957|NCT02108262|156824895|FG000|Overall Study|Non-compliance|0|||
48719958|NCT02108262|156824896|FG001|Overall Study|Non-compliance|2|||
48719959|NCT02108262|156824897|FG002|Overall Study|Non-compliance|1|||
48719960|NCT02108262|156824898|FG003|Overall Study|Non-compliance|1|||
48815511|NCT04157686|157165837|FG007|Overall Study|Protocol Violation|0|||
48815512|NCT04157686|157165830|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
48815513|NCT04157686|157165831|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
48815514|NCT04157686|157165832|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
48815515|NCT04157686|157165833|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
48719961|NCT02108262|156824895|FG000|Overall Study|Randomized by error/screen failure|0|||
48719962|NCT02108262|156824896|FG001|Overall Study|Randomized by error/screen failure|0|||
48719963|NCT02108262|156824897|FG002|Overall Study|Randomized by error/screen failure|1|||
48719964|NCT02108262|156824898|FG003|Overall Study|Randomized by error/screen failure|0|||
48815516|NCT04157686|157165834|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
48815517|NCT04157686|157165835|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
48815518|NCT04157686|157165836|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
48500011|NCT02173704|156028020|FG001|Overall Study|Adverse Event|0|||
48500012|NCT02173704|156028019|FG000|Overall Study|Lost to Follow-up|1|||
48500013|NCT02173704|156028020|FG001|Overall Study|Lost to Follow-up|0|||
48500014|NCT02173704|156028019|FG000|Overall Study|Other|1|||
48500015|NCT02173704|156028020|FG001|Overall Study|Other|0|||
48500016|NCT02173704|156028019|FG000|Overall Study|Protocol Violation|1|||
48500017|NCT02173704|156028020|FG001|Overall Study|Protocol Violation|0|||
48500018|NCT02173704|156028019|FG000|Overall Study|Withdrawal by Subject|9|||
48500019|NCT02173704|156028020|FG001|Overall Study|Withdrawal by Subject|4|||
48500020|NCT01717976|156028025|FG000|Overall Study|Protocol Violation|0|||
48500021|NCT01717976|156028026|FG001|Overall Study|Protocol Violation|1|||
48500022|NCT00048568|156028027|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
48500023|NCT00048568|156028028|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
48500024|NCT00048568|156028029|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
48500025|NCT00048568|156028027|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
48500026|NCT00048568|156028028|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
48500027|NCT00048568|156028029|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
48500028|NCT00048568|156028027|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
48500029|NCT00048568|156028028|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
48500030|NCT00048568|156028029|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
48500031|NCT00048568|156028027|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
48500032|NCT00048568|156028028|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
48500033|NCT00048568|156028029|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
48500034|NCT00048568|156028027|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
48500035|NCT00048568|156028028|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
48500036|NCT00048568|156028029|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
48500037|NCT00048568|156028027|FG000|Double-Blind Period Days 170 to 365|Death|1|||
48500038|NCT00048568|156028028|FG001|Double-Blind Period Days 170 to 365|Death|1|||
48500039|NCT00048568|156028029|FG002|Double-Blind Period Days 170 to 365|Death|0|||
48500040|NCT00048568|156028027|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
48500041|NCT00048568|156028028|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
48719965|NCT02108262|156824895|FG000|Overall Study|Distance to center|0|||
48500042|NCT00048568|156028029|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
48500043|NCT00048568|156028027|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
48719966|NCT02108262|156824896|FG001|Overall Study|Distance to center|1|||
48719967|NCT02108262|156824897|FG002|Overall Study|Distance to center|1|||
48719968|NCT02108262|156824898|FG003|Overall Study|Distance to center|0|||
48719969|NCT02108262|156824895|FG000|Overall Study|Adverse Event|0|||
48719970|NCT02108262|156824896|FG001|Overall Study|Adverse Event|11|||
48719971|NCT02108262|156824897|FG002|Overall Study|Adverse Event|6|||
48719972|NCT02108262|156824898|FG003|Overall Study|Adverse Event|12|||
48719973|NCT02108262|156824895|FG000|Overall Study|Death|0|||
48719974|NCT02108262|156824896|FG001|Overall Study|Death|2|||
48719975|NCT02108262|156824897|FG002|Overall Study|Death|2|||
48719976|NCT02108262|156824898|FG003|Overall Study|Death|1|||
48719977|NCT02108262|156824895|FG000|Overall Study|Lost to Follow-up|0|||
48719978|NCT02108262|156824896|FG001|Overall Study|Lost to Follow-up|0|||
48719979|NCT02108262|156824897|FG002|Overall Study|Lost to Follow-up|1|||
48719980|NCT02108262|156824898|FG003|Overall Study|Lost to Follow-up|0|||
48719981|NCT02108262|156824895|FG000|Overall Study|Physician Decision|0|||
48719982|NCT02108262|156824896|FG001|Overall Study|Physician Decision|0|||
48719983|NCT02108262|156824897|FG002|Overall Study|Physician Decision|2|||
48719984|NCT02108262|156824898|FG003|Overall Study|Physician Decision|0|||
48719985|NCT02108262|156824895|FG000|Overall Study|Withdrawal by Subject|0|||
48719986|NCT02108262|156824896|FG001|Overall Study|Withdrawal by Subject|7|||
48719987|NCT02108262|156824897|FG002|Overall Study|Withdrawal by Subject|3|||
48719988|NCT02108262|156824898|FG003|Overall Study|Withdrawal by Subject|4|||
48719989|NCT02108262|156824895|FG000|Overall Study|Due to key hepatic values|0|||
48719990|NCT02108262|156824896|FG001|Overall Study|Due to key hepatic values|1|||
48719991|NCT02108262|156824897|FG002|Overall Study|Due to key hepatic values|0|||
48719992|NCT02108262|156824898|FG003|Overall Study|Due to key hepatic values|0|||
48719993|NCT02108262|156824895|FG000|Overall Study|Unable to contact patient|0|||
48719994|NCT02108262|156824896|FG001|Overall Study|Unable to contact patient|3|||
48719995|NCT02108262|156824897|FG002|Overall Study|Unable to contact patient|1|||
48719996|NCT02108262|156824898|FG003|Overall Study|Unable to contact patient|2|||
48719997|NCT02108262|156824895|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
48719998|NCT02108262|156824896|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
48719999|NCT02108262|156824897|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
48720000|NCT02108262|156824898|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
48720001|NCT02108262|156824895|FG000|Overall Study|Patient did not want another infusion|0|||
48720002|NCT02108262|156824896|FG001|Overall Study|Patient did not want another infusion|3|||
48500044|NCT00048568|156028028|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
48500045|NCT00048568|156028029|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
48720003|NCT02108262|156824897|FG002|Overall Study|Patient did not want another infusion|3|||
48815519|NCT04157686|157165837|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
48815520|NCT04445155|157165838|FG000|Overall Study|Lost to Follow-up|11|||
48815521|NCT04445155|157165839|FG001|Overall Study|Lost to Follow-up|2|||
48815522|NCT04445155|157165840|FG002|Overall Study|Lost to Follow-up|3|||
48815523|NCT04445155|157165841|FG003|Overall Study|Lost to Follow-up|0|||
48815524|NCT04445155|157165838|FG000|Overall Study|Withdrawal by Subject|8|||
48815525|NCT04445155|157165839|FG001|Overall Study|Withdrawal by Subject|0|||
48720004|NCT02108262|156824898|FG003|Overall Study|Patient did not want another infusion|2|||
48720005|NCT02108262|156824895|FG000|Overall Study|Vacation|0|||
48500046|NCT00048568|156028027|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
48500047|NCT00048568|156028028|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
48500048|NCT00048568|156028029|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
48500049|NCT00048568|156028027|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
48500050|NCT00048568|156028028|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
48500051|NCT00048568|156028029|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
48500052|NCT00048568|156028027|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
48720006|NCT02108262|156824896|FG001|Overall Study|Vacation|1|||
48720007|NCT02108262|156824897|FG002|Overall Study|Vacation|0|||
48720008|NCT02108262|156824898|FG003|Overall Study|Vacation|0|||
48720009|NCT02108262|156824895|FG000|Overall Study|Patient decision|0|||
48720010|NCT02108262|156824896|FG001|Overall Study|Patient decision|7|||
48720011|NCT02108262|156824897|FG002|Overall Study|Patient decision|9|||
48815526|NCT04445155|157165840|FG002|Overall Study|Withdrawal by Subject|0|||
48815527|NCT04445155|157165841|FG003|Overall Study|Withdrawal by Subject|0|||
48815528|NCT04445155|157165838|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
48815529|NCT04445155|157165839|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
48815530|NCT04445155|157165840|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
48815531|NCT04445155|157165841|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
48815532|NCT04445155|157165838|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
48815533|NCT04445155|157165839|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
48815534|NCT04445155|157165840|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
48815535|NCT04445155|157165841|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
48815536|NCT00810641|157165842|FG000|Overall Study|Withdrawal by Subject|0|||
48720012|NCT02108262|156824898|FG003|Overall Study|Patient decision|14|||
48720013|NCT02108262|156824895|FG000|Overall Study|Missed IV due to pharmacy error|0|||
48720014|NCT02108262|156824896|FG001|Overall Study|Missed IV due to pharmacy error|0|||
48720015|NCT02108262|156824897|FG002|Overall Study|Missed IV due to pharmacy error|1|||
48720016|NCT02108262|156824898|FG003|Overall Study|Missed IV due to pharmacy error|0|||
48720017|NCT02692651|156824899|FG000|Study Treatment|Death|7|||
48720018|NCT02692651|156824900|FG001|Study Treatment|Death|3|||
48720019|NCT02692651|156824899|FG000|Study Treatment|comfort care|1|||
48720020|NCT02692651|156824900|FG001|Study Treatment|comfort care|1|||
48720021|NCT02692651|156824899|FG000|Study Treatment|Protocol violation per treating team preference|8|||
48720022|NCT02692651|156824900|FG001|Study Treatment|Protocol violation per treating team preference|6|||
48720023|NCT02692651|156824899|FG000|Post Study Treatment Follow-up|Death|4|||
48720024|NCT02692651|156824900|FG001|Post Study Treatment Follow-up|Death|4|||
48720025|NCT02239120|156824901|FG000|Overall Study|Death|56|||
48720026|NCT02239120|156824902|FG001|Overall Study|Death|58|||
48720027|NCT02239120|156824901|FG000|Overall Study|Lost to Follow-up|19|||
48720028|NCT02239120|156824902|FG001|Overall Study|Lost to Follow-up|14|||
48720029|NCT02213133|156824903|FG000|Overall Study|Participant discontinued study therapy|2|||
48720030|NCT02213133|156824904|FG001|Overall Study|Participant discontinued study therapy|0|||
48720031|NCT02213133|156824905|FG002|Overall Study|Participant discontinued study therapy|0|||
48720032|NCT02213133|156824903|FG000|Overall Study|Participant withdrew informed consent|2|||
48720033|NCT02213133|156824904|FG001|Overall Study|Participant withdrew informed consent|1|||
48720034|NCT02213133|156824905|FG002|Overall Study|Participant withdrew informed consent|2|||
48720035|NCT02213133|156824903|FG000|Overall Study|Disease progression|11|||
48720036|NCT02213133|156824904|FG001|Overall Study|Disease progression|2|||
48720037|NCT02213133|156824905|FG002|Overall Study|Disease progression|0|||
48720038|NCT02213133|156824903|FG000|Overall Study|Adverse Event (AE)|1|||
48815537|NCT00810641|157165843|FG001|Overall Study|Withdrawal by Subject|1|||
48815538|NCT00810641|157165844|FG002|Overall Study|Withdrawal by Subject|2|||
48720039|NCT02213133|156824904|FG001|Overall Study|Adverse Event (AE)|0|||
48720040|NCT02213133|156824905|FG002|Overall Study|Adverse Event (AE)|0|||
48815539|NCT02325713|157165851|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815540|NCT02325713|157165852|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48720041|NCT02213133|156824903|FG000|Overall Study|Death|16|||
48720042|NCT02213133|156824904|FG001|Overall Study|Death|2|||
48720043|NCT02213133|156824905|FG002|Overall Study|Death|1|||
48720044|NCT02213133|156824903|FG000|Overall Study|Other|5|||
48720045|NCT02213133|156824904|FG001|Overall Study|Other|0|||
48815541|NCT02325713|157165853|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48500053|NCT00048568|156028028|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
48599603|NCT00379899|156389781|FG000|Overall Study|Parathyroidectomy|0|||
48599604|NCT00379899|156389782|FG001|Overall Study|Parathyroidectomy|2|||
48599605|NCT00379899|156389781|FG000|Overall Study|Renal transplantation|5|||
48599606|NCT00379899|156389782|FG001|Overall Study|Renal transplantation|4|||
48599607|NCT00379899|156389781|FG000|Overall Study|Coronary artery bypass graft|1|||
48599608|NCT00379899|156389782|FG001|Overall Study|Coronary artery bypass graft|1|||
48599609|NCT00379899|156389781|FG000|Overall Study|Other protocol-specified criteria|3|||
48599610|NCT00379899|156389782|FG001|Overall Study|Other protocol-specified criteria|4|||
48599611|NCT00379899|156389781|FG000|Overall Study|Other|3|||
48599612|NCT00379899|156389782|FG001|Overall Study|Other|1|||
48599613|NCT01747499|156389785|FG000|Overall Study|Steroid refractory aGvHD|1|||
48599614|NCT01747499|156389786|FG001|Overall Study|Steroid refractory aGvHD|0|||
48599615|NCT01747499|156389787|FG002|Overall Study|Steroid refractory aGvHD|0|||
48599616|NCT01747499|156389788|FG003|Overall Study|Steroid refractory aGvHD|1|||
48599617|NCT01747499|156389789|FG004|Overall Study|Steroid refractory aGvHD|4|||
48599618|NCT01747499|156389785|FG000|Overall Study|Physician Decision|0|||
48599619|NCT01747499|156389786|FG001|Overall Study|Physician Decision|1|||
48599620|NCT01747499|156389787|FG002|Overall Study|Physician Decision|0|||
48599621|NCT01747499|156389788|FG003|Overall Study|Physician Decision|0|||
48599622|NCT01747499|156389789|FG004|Overall Study|Physician Decision|2|||
48599623|NCT01747499|156389785|FG000|Overall Study|Death|0|||
48599624|NCT01747499|156389786|FG001|Overall Study|Death|0|||
48599625|NCT01747499|156389787|FG002|Overall Study|Death|0|||
48599626|NCT01747499|156389788|FG003|Overall Study|Death|1|||
48599627|NCT01747499|156389789|FG004|Overall Study|Death|1|||
48599628|NCT01747499|156389785|FG000|Overall Study|Withdrawal by Subject|0|||
48599629|NCT01747499|156389786|FG001|Overall Study|Withdrawal by Subject|0|||
48599630|NCT01747499|156389787|FG002|Overall Study|Withdrawal by Subject|0|||
48599631|NCT01747499|156389788|FG003|Overall Study|Withdrawal by Subject|0|||
48599632|NCT01747499|156389789|FG004|Overall Study|Withdrawal by Subject|6|||
48599633|NCT01747499|156389785|FG000|Overall Study|Developed AML and death|0|||
48500054|NCT00048568|156028029|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
48500055|NCT00048568|156028027|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
48500056|NCT00048568|156028028|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
48500057|NCT00048568|156028029|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
48500058|NCT00048568|156028027|FG000|Open-Label Period|Death|0|||
48500059|NCT00048568|156028028|FG001|Open-Label Period|Death|0|||
48500060|NCT00048568|156028029|FG002|Open-Label Period|Death|13|||
48500061|NCT00048568|156028027|FG000|Open-Label Period|Adverse Event|0|||
48500062|NCT00048568|156028028|FG001|Open-Label Period|Adverse Event|0|||
48500063|NCT00048568|156028029|FG002|Open-Label Period|Adverse Event|49|||
48500064|NCT00048568|156028027|FG000|Open-Label Period|Lack of Efficacy|0|||
48500065|NCT00048568|156028028|FG001|Open-Label Period|Lack of Efficacy|0|||
48500066|NCT00048568|156028029|FG002|Open-Label Period|Lack of Efficacy|32|||
48500067|NCT00048568|156028027|FG000|Open-Label Period|Withdrawal by Subject|0|||
48500068|NCT00048568|156028028|FG001|Open-Label Period|Withdrawal by Subject|0|||
48500069|NCT00048568|156028029|FG002|Open-Label Period|Withdrawal by Subject|26|||
48500070|NCT00048568|156028027|FG000|Open-Label Period|Pregnancy|0|||
48500071|NCT00048568|156028028|FG001|Open-Label Period|Pregnancy|0|||
48500072|NCT00048568|156028029|FG002|Open-Label Period|Pregnancy|5|||
48500073|NCT00048568|156028027|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
48500074|NCT00048568|156028028|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
48500075|NCT00048568|156028029|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
48500076|NCT00048568|156028027|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
48500077|NCT00048568|156028028|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
48500078|NCT00048568|156028029|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
48500079|NCT00048568|156028027|FG000|Open-Label Period|Unknown Reasons|0|||
48500080|NCT00048568|156028028|FG001|Open-Label Period|Unknown Reasons|0|||
48500081|NCT00048568|156028029|FG002|Open-Label Period|Unknown Reasons|25|||
48500082|NCT00048568|156028027|FG000|Open-Label Period|Lost to Follow-up|0|||
48500083|NCT00048568|156028028|FG001|Open-Label Period|Lost to Follow-up|0|||
48500084|NCT00048568|156028029|FG002|Open-Label Period|Lost to Follow-up|7|||
48500085|NCT00720096|156028030|FG000|Overall Study|Withdrawal by Subject|0|||
48500086|NCT00720096|156028031|FG001|Overall Study|Withdrawal by Subject|2|||
48500087|NCT00001849|156028033|FG000|Overall Study|Death|4|||
48500088|NCT00001849|156028033|FG000|Overall Study|Lost to Follow-up|2|||
48599634|NCT01747499|156389786|FG001|Overall Study|Developed AML and death|0|||
48599635|NCT01747499|156389787|FG002|Overall Study|Developed AML and death|0|||
48599636|NCT01747499|156389788|FG003|Overall Study|Developed AML and death|0|||
48815542|NCT02325713|157165854|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48500089|NCT00001849|156028033|FG000|Overall Study|Withdrawal by Subject|2|||
48599637|NCT01747499|156389789|FG004|Overall Study|Developed AML and death|1|||
48599638|NCT01747499|156389785|FG000|Overall Study|Determined not to be eligible|0|||
48720046|NCT02213133|156824905|FG002|Overall Study|Other|0|||
48720047|NCT01925989|156824906|FG000|Period 1|Sponsor Decision|1|||
48720048|NCT01925989|156824907|FG001|Period 1|Sponsor Decision|1|||
48720049|NCT01925989|156824908|FG002|Period 1|Sponsor Decision|0|||
48720050|NCT01925989|156824906|FG000|Period 1|Withdrawal by Subject|0|||
48720051|NCT01925989|156824907|FG001|Period 1|Withdrawal by Subject|1|||
48720052|NCT01925989|156824908|FG002|Period 1|Withdrawal by Subject|0|||
48720053|NCT00770146|156824911|FG000|Treatment Period|Withdrawal by Subject|6|||
48720054|NCT00770146|156824912|FG001|Treatment Period|Withdrawal by Subject|13|||
48720055|NCT00770146|156824911|FG000|Treatment Period|Adverse Event|2|||
48720056|NCT00770146|156824912|FG001|Treatment Period|Adverse Event|26|||
48720057|NCT00770146|156824911|FG000|Treatment Period|Other|1|||
48720058|NCT00770146|156824912|FG001|Treatment Period|Other|5|||
48720059|NCT00770146|156824911|FG000|Treatment Period|Protocol non-compliance|0|||
48720060|NCT00770146|156824912|FG001|Treatment Period|Protocol non-compliance|1|||
48720061|NCT00770146|156824911|FG000|Follow-up Period|Withdrawal by Subject|7|||
48720062|NCT00770146|156824912|FG001|Follow-up Period|Withdrawal by Subject|13|||
48720063|NCT00770146|156824911|FG000|Follow-up Period|Adverse Event|0|||
48720064|NCT00770146|156824912|FG001|Follow-up Period|Adverse Event|2|||
48720065|NCT00770146|156824911|FG000|Follow-up Period|Other|4|||
48720066|NCT00770146|156824912|FG001|Follow-up Period|Other|5|||
48720067|NCT04658940|156824916|FG000|Overall Study|Withdrawal by Subject|1|||
48720068|NCT01853618|156824917|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
48720069|NCT01853618|156824918|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
48720070|NCT01853618|156824919|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
48720071|NCT01853618|156824920|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
48720072|NCT01853618|156824921|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
48720073|NCT01853618|156824917|FG000|Overall Study|Progressive disease|1|||
48720074|NCT01853618|156824918|FG001|Overall Study|Progressive disease|1|||
48720075|NCT01853618|156824919|FG002|Overall Study|Progressive disease|1|||
48720076|NCT01853618|156824920|FG003|Overall Study|Progressive disease|1|||
48720077|NCT01853618|156824921|FG004|Overall Study|Progressive disease|2|||
48720078|NCT01853618|156824917|FG000|Overall Study|Physician Decision|0|||
48720079|NCT01853618|156824918|FG001|Overall Study|Physician Decision|1|||
48720080|NCT01853618|156824919|FG002|Overall Study|Physician Decision|1|||
48720081|NCT01853618|156824920|FG003|Overall Study|Physician Decision|0|||
48720082|NCT01853618|156824921|FG004|Overall Study|Physician Decision|0|||
48720083|NCT01853618|156824917|FG000|Overall Study|Refused further treatment|0|||
48720084|NCT01853618|156824918|FG001|Overall Study|Refused further treatment|0|||
48720085|NCT01853618|156824919|FG002|Overall Study|Refused further treatment|0|||
48720086|NCT01853618|156824920|FG003|Overall Study|Refused further treatment|0|||
48720087|NCT01853618|156824921|FG004|Overall Study|Refused further treatment|1|||
48720088|NCT00938886|156824922|FG000|Overall Study|Death|0|||
48720089|NCT00938886|156824923|FG001|Overall Study|Death|1|||
48720090|NCT00938886|156824922|FG000|Overall Study|Withdrawal by Subject|4|||
48599639|NCT01747499|156389786|FG001|Overall Study|Determined not to be eligible|0|||
48599640|NCT01747499|156389787|FG002|Overall Study|Determined not to be eligible|0|||
48599641|NCT01747499|156389788|FG003|Overall Study|Determined not to be eligible|0|||
48720091|NCT00938886|156824923|FG001|Overall Study|Withdrawal by Subject|7|||
48720092|NCT00938886|156824922|FG000|Overall Study|Lost to Follow-up|3|||
48720093|NCT00938886|156824923|FG001|Overall Study|Lost to Follow-up|2|||
48720094|NCT02009384|156824926|FG000|Overall Study|Death|2|||
48720095|NCT00710762|156824927|FG000|Overall Study|Progressive disease|27|||
48720096|NCT00710762|156824928|FG001|Overall Study|Progressive disease|30|||
48720097|NCT00710762|156824927|FG000|Overall Study|Adverse Event other disease worsening|2|||
48720098|NCT00710762|156824928|FG001|Overall Study|Adverse Event other disease worsening|1|||
48720099|NCT00710762|156824927|FG000|Overall Study|Other Adverse Event|7|||
48720100|NCT00710762|156824928|FG001|Overall Study|Other Adverse Event|7|||
48720101|NCT00710762|156824927|FG000|Overall Study|Lost to Follow-up|1|||
48436844|NCT00171314|155787534|FG001|Overall Study|Lost to Follow-up|3|||
48436845|NCT00171314|155787533|FG000|Overall Study|Death|2|||
48436846|NCT00171314|155787534|FG001|Overall Study|Death|1|||
48436847|NCT00077376|155787537|FG000|Overall Study|Adverse Event|8|||
48436848|NCT00077376|155787537|FG000|Overall Study|Withdrawal by Subject|2|||
48436849|NCT00077376|155787537|FG000|Overall Study|Death|1|||
48436850|NCT00077376|155787537|FG000|Overall Study|Physician Decision|1|||
48436851|NCT00077376|155787537|FG000|Overall Study|Alternative therapy|5|||
48436852|NCT00077376|155787537|FG000|Overall Study|Complicating disease|1|||
48436853|NCT00077376|155787537|FG000|Overall Study|Still on treatment|1|||
48436854|NCT00077376|155787537|FG000|Overall Study|Symptomatic deterioration|1|||
48436855|NCT00077376|155787537|FG000|Overall Study|Surgery|1|||
48436856|NCT00077376|155787537|FG000|Overall Study|Insurance ran out|1|||
48436857|NCT00417976|155787541|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
48436858|NCT00417976|155787541|FG000|Overall Study|Treatment -related toxicity|2|||
48436859|NCT04348591|155787542|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
48436860|NCT04348591|155787543|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
48436861|NCT04348591|155787542|FG000|Imaging Session (120 Min)|Physician Decision|0|||
48500090|NCT00001849|156028033|FG000|Overall Study|tumor remained occult|6|||
48500091|NCT00442936|156028034|FG000|Overall Study|Protocol Violation|1|||
48500092|NCT00442936|156028035|FG001|Overall Study|Protocol Violation|0|||
48500093|NCT00442936|156028036|FG002|Overall Study|Protocol Violation|1|||
48500094|NCT00442936|156028037|FG003|Overall Study|Protocol Violation|1|||
48500095|NCT02319148|156028039|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
48500096|NCT02319148|156028040|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
48500097|NCT02319148|156028041|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
48500098|NCT02319148|156028042|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
48500099|NCT02319148|156028039|FG000|Second Intervention Period|No longer willing to participate|0|||
48500100|NCT02319148|156028040|FG001|Second Intervention Period|No longer willing to participate|1|||
48500101|NCT02319148|156028041|FG002|Second Intervention Period|No longer willing to participate|0|||
48500102|NCT02319148|156028042|FG003|Second Intervention Period|No longer willing to participate|0|||
48500103|NCT02319148|156028039|FG000|Second Intervention Period|Other|0|||
48500104|NCT02319148|156028040|FG001|Second Intervention Period|Other|0|||
48500105|NCT02319148|156028041|FG002|Second Intervention Period|Other|0|||
48500106|NCT02319148|156028042|FG003|Second Intervention Period|Other|1|||
48500107|NCT04109222|156028043|FG000|Overall Study|Adverse Event|1|||
48500108|NCT04109222|156028044|FG001|Overall Study|Adverse Event|0|||
48500109|NCT04109222|156028045|FG002|Overall Study|Adverse Event|0|||
48500110|NCT01574248|156028046|FG000|Overall Study|Withdrawal by Subject|2|||
48720102|NCT00710762|156824928|FG001|Overall Study|Lost to Follow-up|0|||
48720103|NCT00710762|156824927|FG000|Overall Study|Reason other than listed above|2|||
48720104|NCT00710762|156824928|FG001|Overall Study|Reason other than listed above|2|||
48720105|NCT03011892|156824931|FG000|Double Blind (DB) Period|Adverse Event|0|||
48720106|NCT03011892|156824932|FG001|Double Blind (DB) Period|Adverse Event|1|||
48720107|NCT03011892|156824933|FG002|Double Blind (DB) Period|Adverse Event|1|||
48720108|NCT03011892|156824934|FG003|Double Blind (DB) Period|Adverse Event|0|||
48720109|NCT03011892|156824935|FG004|Double Blind (DB) Period|Adverse Event|0|||
48815543|NCT02325713|157165855|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815544|NCT02325713|157165856|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815545|NCT02325713|157165857|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815546|NCT02325713|157165858|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815547|NCT02325713|157165859|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815548|NCT02325713|157165860|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815549|NCT02325713|157165861|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
48815550|NCT02325713|157165862|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815551|NCT02325713|157165863|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815552|NCT02325713|157165864|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815553|NCT02325713|157165865|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815554|NCT02325713|157165866|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
48815555|NCT02325713|157165851|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
48815556|NCT02325713|157165852|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815557|NCT02325713|157165853|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815558|NCT02325713|157165854|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815559|NCT02325713|157165855|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815560|NCT02325713|157165856|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815561|NCT02325713|157165857|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815562|NCT02325713|157165858|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815563|NCT02325713|157165859|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815564|NCT02325713|157165860|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815565|NCT02325713|157165861|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815566|NCT02325713|157165862|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815567|NCT02325713|157165863|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815568|NCT02325713|157165864|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815569|NCT02325713|157165865|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48815570|NCT02325713|157165866|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
48500111|NCT01574248|156028047|FG001|Overall Study|Withdrawal by Subject|0|||
48500112|NCT01574248|156028046|FG000|Overall Study|Missing primary endpoint data|1|||
48500113|NCT01574248|156028047|FG001|Overall Study|Missing primary endpoint data|0|||
48500114|NCT01424722|156028048|FG000|Overall Study|Sponsor terminated investigation|2258|||
48500115|NCT01781286|156028053|FG000|Overall Study|Lost to Follow-up|0|||
48500116|NCT01781286|156028054|FG001|Overall Study|Lost to Follow-up|0|||
48500117|NCT01781286|156028055|FG002|Overall Study|Lost to Follow-up|0|||
48500118|NCT01781286|156028056|FG003|Overall Study|Lost to Follow-up|0|||
48500119|NCT01781286|156028057|FG004|Overall Study|Lost to Follow-up|0|||
48500120|NCT01781286|156028058|FG005|Overall Study|Lost to Follow-up|1|||
48500121|NCT01781286|156028053|FG000|Overall Study|Time Constraints|2|||
48599642|NCT01747499|156389789|FG004|Overall Study|Determined not to be eligible|1|||
48815571|NCT02325713|157165851|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815572|NCT02325713|157165852|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815573|NCT02325713|157165853|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815574|NCT02325713|157165854|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815575|NCT02325713|157165855|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815576|NCT02325713|157165856|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815577|NCT02325713|157165857|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815578|NCT02325713|157165858|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815579|NCT02325713|157165859|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815580|NCT02325713|157165860|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
48815581|NCT02325713|157165861|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815582|NCT02325713|157165862|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815583|NCT02325713|157165863|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815584|NCT02325713|157165864|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815585|NCT02325713|157165865|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815586|NCT02325713|157165866|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
48815587|NCT05035654|157165867|FG000|Overall Study|Physician Decision|0|||
48815588|NCT05035654|157165868|FG001|Overall Study|Physician Decision|1|||
48815589|NCT05035654|157165869|FG002|Overall Study|Physician Decision|0|||
48815590|NCT05035654|157165867|FG000|Overall Study|Adverse Event|0|||
48815591|NCT05035654|157165868|FG001|Overall Study|Adverse Event|1|||
48815592|NCT05035654|157165869|FG002|Overall Study|Adverse Event|0|||
48815593|NCT05035654|157165867|FG000|Overall Study|Withdrawal by Subject|0|||
48815594|NCT05035654|157165868|FG001|Overall Study|Withdrawal by Subject|0|||
48815595|NCT05035654|157165869|FG002|Overall Study|Withdrawal by Subject|4|||
48815596|NCT05035654|157165867|FG000|Overall Study|Bilateral Dislodgement|1|||
48815597|NCT05035654|157165868|FG001|Overall Study|Bilateral Dislodgement|0|||
48815598|NCT05035654|157165869|FG002|Overall Study|Bilateral Dislodgement|0|||
48815599|NCT02353832|157165870|FG000|Overall Study|Ineligible after enrollment|1|||
48815600|NCT02353832|157165870|FG000|Overall Study|Lost to Follow-up|1|||
48815601|NCT03864926|157167330|FG000|Overall Study|Death|0|||
48815602|NCT03864926|157167331|FG001|Overall Study|Death|2|||
48599643|NCT01676701|156389790|FG000|Overall Study|Protocol Violation|1|||
48599644|NCT01676701|156389791|FG001|Overall Study|Protocol Violation|0|||
48720110|NCT03011892|156824936|FG005|Double Blind (DB) Period|Adverse Event|0|||
48720111|NCT03011892|156824937|FG006|Double Blind (DB) Period|Adverse Event|0|||
48720112|NCT03011892|156824938|FG007|Double Blind (DB) Period|Adverse Event|0|||
48720113|NCT03011892|156824939|FG008|Double Blind (DB) Period|Adverse Event|0|||
48720114|NCT03011892|156824940|FG009|Double Blind (DB) Period|Adverse Event|0|||
48720115|NCT03011892|156824941|FG010|Double Blind (DB) Period|Adverse Event|0|||
48720116|NCT03011892|156824942|FG011|Double Blind (DB) Period|Adverse Event|0|||
48720117|NCT03011892|156824931|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
48720118|NCT03011892|156824932|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
48720119|NCT03011892|156824933|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
48720120|NCT03011892|156824934|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
48720121|NCT03011892|156824935|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
48720122|NCT03011892|156824936|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
48720123|NCT03011892|156824937|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
48720124|NCT03011892|156824938|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
48720125|NCT03011892|156824939|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
48720126|NCT03011892|156824940|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
48720127|NCT03011892|156824941|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
48720128|NCT03011892|156824942|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
48720129|NCT03011892|156824931|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
48720130|NCT03011892|156824932|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
48720131|NCT03011892|156824933|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
48720132|NCT03011892|156824934|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
48720133|NCT03011892|156824935|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
48720134|NCT03011892|156824936|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
48720135|NCT03011892|156824937|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
48720136|NCT03011892|156824938|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
48720137|NCT03011892|156824939|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
48720138|NCT03011892|156824940|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
48720139|NCT03011892|156824941|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
48720140|NCT03011892|156824942|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
48720141|NCT03011892|156824931|FG000|Double Blind (DB) Period|Other|1|||
48720142|NCT03011892|156824932|FG001|Double Blind (DB) Period|Other|1|||
48720143|NCT03011892|156824933|FG002|Double Blind (DB) Period|Other|1|||
48720144|NCT03011892|156824934|FG003|Double Blind (DB) Period|Other|0|||
48720145|NCT03011892|156824935|FG004|Double Blind (DB) Period|Other|1|||
48815603|NCT03017235|157167332|FG000|Overall Study|Withdrawal by Subject|4|||
48815604|NCT03017235|157167333|FG001|Overall Study|Withdrawal by Subject|3|||
48815605|NCT03017235|157167332|FG000|Overall Study|Lost to Follow-up|2|||
48815606|NCT03017235|157167333|FG001|Overall Study|Lost to Follow-up|7|||
48815607|NCT03017235|157167332|FG000|Overall Study|Adverse Event|0|||
48599645|NCT01676701|156389790|FG000|Overall Study|Sponsor Decision|3|||
48720146|NCT03011892|156824936|FG005|Double Blind (DB) Period|Other|0|||
48720147|NCT03011892|156824937|FG006|Double Blind (DB) Period|Other|0|||
48720148|NCT03011892|156824938|FG007|Double Blind (DB) Period|Other|0|||
48720149|NCT03011892|156824939|FG008|Double Blind (DB) Period|Other|0|||
48720150|NCT03011892|156824940|FG009|Double Blind (DB) Period|Other|0|||
48720151|NCT03011892|156824941|FG010|Double Blind (DB) Period|Other|0|||
48720152|NCT03011892|156824942|FG011|Double Blind (DB) Period|Other|0|||
48720153|NCT03011892|156824931|FG000|Double Blind (DB) Period|Physician Decision|1|||
48720154|NCT03011892|156824932|FG001|Double Blind (DB) Period|Physician Decision|0|||
48720155|NCT03011892|156824933|FG002|Double Blind (DB) Period|Physician Decision|1|||
48720156|NCT03011892|156824934|FG003|Double Blind (DB) Period|Physician Decision|0|||
48720157|NCT03011892|156824935|FG004|Double Blind (DB) Period|Physician Decision|0|||
48720158|NCT03011892|156824936|FG005|Double Blind (DB) Period|Physician Decision|0|||
48720159|NCT03011892|156824937|FG006|Double Blind (DB) Period|Physician Decision|0|||
48720160|NCT03011892|156824938|FG007|Double Blind (DB) Period|Physician Decision|0|||
48720161|NCT03011892|156824939|FG008|Double Blind (DB) Period|Physician Decision|0|||
48720162|NCT03011892|156824940|FG009|Double Blind (DB) Period|Physician Decision|0|||
48720163|NCT03011892|156824941|FG010|Double Blind (DB) Period|Physician Decision|0|||
48720164|NCT03011892|156824942|FG011|Double Blind (DB) Period|Physician Decision|0|||
48720165|NCT03011892|156824931|FG000|Double Blind (DB) Period|Pregnancy|0|||
48720166|NCT03011892|156824932|FG001|Double Blind (DB) Period|Pregnancy|0|||
48720167|NCT03011892|156824933|FG002|Double Blind (DB) Period|Pregnancy|0|||
48720168|NCT03011892|156824934|FG003|Double Blind (DB) Period|Pregnancy|0|||
48720169|NCT03011892|156824935|FG004|Double Blind (DB) Period|Pregnancy|1|||
48720170|NCT03011892|156824936|FG005|Double Blind (DB) Period|Pregnancy|0|||
48720171|NCT03011892|156824937|FG006|Double Blind (DB) Period|Pregnancy|0|||
48720172|NCT03011892|156824938|FG007|Double Blind (DB) Period|Pregnancy|0|||
48720173|NCT03011892|156824939|FG008|Double Blind (DB) Period|Pregnancy|0|||
48720174|NCT03011892|156824940|FG009|Double Blind (DB) Period|Pregnancy|0|||
48720175|NCT03011892|156824941|FG010|Double Blind (DB) Period|Pregnancy|0|||
48720176|NCT03011892|156824942|FG011|Double Blind (DB) Period|Pregnancy|0|||
48720177|NCT03011892|156824931|FG000|Double Blind (DB) Period|Protocol Violation|1|||
48720178|NCT03011892|156824932|FG001|Double Blind (DB) Period|Protocol Violation|0|||
48720179|NCT03011892|156824933|FG002|Double Blind (DB) Period|Protocol Violation|0|||
48720180|NCT03011892|156824934|FG003|Double Blind (DB) Period|Protocol Violation|0|||
48720181|NCT03011892|156824935|FG004|Double Blind (DB) Period|Protocol Violation|0|||
48720182|NCT03011892|156824936|FG005|Double Blind (DB) Period|Protocol Violation|0|||
48720183|NCT03011892|156824937|FG006|Double Blind (DB) Period|Protocol Violation|0|||
48720184|NCT03011892|156824938|FG007|Double Blind (DB) Period|Protocol Violation|0|||
48720185|NCT03011892|156824939|FG008|Double Blind (DB) Period|Protocol Violation|0|||
48720186|NCT03011892|156824940|FG009|Double Blind (DB) Period|Protocol Violation|0|||
48720187|NCT03011892|156824941|FG010|Double Blind (DB) Period|Protocol Violation|0|||
48720188|NCT03011892|156824942|FG011|Double Blind (DB) Period|Protocol Violation|0|||
48720189|NCT03011892|156824931|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
48720190|NCT03011892|156824932|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
48720191|NCT03011892|156824933|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
48720192|NCT03011892|156824934|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
48720193|NCT03011892|156824935|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
48720194|NCT03011892|156824936|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
48720195|NCT03011892|156824937|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720196|NCT03011892|156824938|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720197|NCT03011892|156824939|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720198|NCT03011892|156824940|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720199|NCT03011892|156824941|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
48720200|NCT03011892|156824942|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
48500122|NCT01781286|156028054|FG001|Overall Study|Time Constraints|0|||
48500123|NCT01781286|156028055|FG002|Overall Study|Time Constraints|2|||
48500124|NCT01781286|156028056|FG003|Overall Study|Time Constraints|0|||
48720201|NCT03011892|156824931|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
48500125|NCT01781286|156028057|FG004|Overall Study|Time Constraints|0|||
48500126|NCT01781286|156028058|FG005|Overall Study|Time Constraints|0|||
48500127|NCT01781286|156028053|FG000|Overall Study|Noncompliance|0|||
48500128|NCT01781286|156028054|FG001|Overall Study|Noncompliance|0|||
48500129|NCT01781286|156028055|FG002|Overall Study|Noncompliance|0|||
48500130|NCT01781286|156028056|FG003|Overall Study|Noncompliance|1|||
48500131|NCT01781286|156028057|FG004|Overall Study|Noncompliance|0|||
48500132|NCT01781286|156028058|FG005|Overall Study|Noncompliance|0|||
48500133|NCT03594123|156028059|FG000|Overall Study|Lost to Follow-up|0|||
48500134|NCT03594123|156028060|FG001|Overall Study|Lost to Follow-up|1|||
48500135|NCT03594123|156028059|FG000|Overall Study|Adverse Event|8|||
48599646|NCT01676701|156389791|FG001|Overall Study|Sponsor Decision|4|||
48500136|NCT03594123|156028060|FG001|Overall Study|Adverse Event|5|||
48500137|NCT03594123|156028059|FG000|Overall Study|Site Terminated by Sponsor|4|||
48720202|NCT03011892|156824932|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
48720203|NCT03011892|156824933|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
48720204|NCT03011892|156824934|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
48720205|NCT03011892|156824935|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
48720206|NCT03011892|156824936|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
48720207|NCT03011892|156824937|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
48720208|NCT03011892|156824938|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
48720209|NCT03011892|156824939|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
48720210|NCT03011892|156824940|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
48720211|NCT03011892|156824941|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
48720212|NCT03011892|156824942|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
48720213|NCT03011892|156824931|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
48720214|NCT03011892|156824932|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
48720215|NCT03011892|156824933|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
48720216|NCT03011892|156824934|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
48720217|NCT03011892|156824935|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
48720218|NCT03011892|156824936|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
48720219|NCT03011892|156824937|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
48720220|NCT03011892|156824938|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
48720221|NCT03011892|156824939|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
48500138|NCT03594123|156028060|FG001|Overall Study|Site Terminated by Sponsor|1|||
48500139|NCT03594123|156028059|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
48500140|NCT03594123|156028060|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
48500141|NCT03594123|156028059|FG000|Overall Study|Lack of Efficacy|1|||
48500142|NCT03594123|156028060|FG001|Overall Study|Lack of Efficacy|0|||
48500143|NCT03594123|156028059|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
48500144|NCT03594123|156028060|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
48500145|NCT01315249|156028061|FG000|Overall Study|Adverse Event|22|||
48500146|NCT01315249|156028062|FG001|Overall Study|Adverse Event|26|||
48500147|NCT01315249|156028061|FG000|Overall Study|Withdrawal by Subject|11|||
48500148|NCT01315249|156028062|FG001|Overall Study|Withdrawal by Subject|10|||
48500149|NCT01315249|156028061|FG000|Overall Study|Protocol Violation|8|||
48500150|NCT01315249|156028062|FG001|Overall Study|Protocol Violation|5|||
48500151|NCT01315249|156028061|FG000|Overall Study|Abnormal test results|1|||
48500152|NCT01315249|156028062|FG001|Overall Study|Abnormal test results|2|||
48500153|NCT01315249|156028061|FG000|Overall Study|Administrative problems|1|||
48500154|NCT01315249|156028062|FG001|Overall Study|Administrative problems|0|||
48500155|NCT01315249|156028061|FG000|Overall Study|inability to use device|1|||
48500156|NCT01315249|156028062|FG001|Overall Study|inability to use device|0|||
48500157|NCT01315249|156028061|FG000|Overall Study|Lack of Efficacy|0|||
48500158|NCT01315249|156028062|FG001|Overall Study|Lack of Efficacy|1|||
48500159|NCT01315249|156028061|FG000|Overall Study|Lost to Follow-up|0|||
48500160|NCT01315249|156028062|FG001|Overall Study|Lost to Follow-up|2|||
48500161|NCT01315249|156028061|FG000|Overall Study|Death|0|||
48500162|NCT01315249|156028062|FG001|Overall Study|Death|1|||
48500163|NCT02483975|156028065|FG000|Overall Study|Adverse Event|0|||
48500164|NCT02483975|156028066|FG001|Overall Study|Adverse Event|1|||
48500165|NCT02483975|156028065|FG000|Overall Study|Lost to Follow-up|0|||
48500166|NCT02483975|156028066|FG001|Overall Study|Lost to Follow-up|1|||
48500167|NCT02483975|156028065|FG000|Overall Study|Physician Decision|2|||
48500168|NCT02483975|156028066|FG001|Overall Study|Physician Decision|0|||
48500169|NCT03365375|156028067|FG000|Overall Study|Withdrawal by Subject|0|||
48500170|NCT03365375|156028068|FG001|Overall Study|Withdrawal by Subject|1|||
48500171|NCT03365375|156028067|FG000|Overall Study|Lost to Follow-up|0|||
48500172|NCT03365375|156028068|FG001|Overall Study|Lost to Follow-up|4|||
48500173|NCT01087970|156028069|FG000|Overall Study|Protocol Violation|2|||
48500174|NCT03655106|156028070|FG000|Overall Study|Withdrawal by Subject|3|||
48500175|NCT03655106|156028071|FG001|Overall Study|Withdrawal by Subject|2|||
48500176|NCT03655106|156028070|FG000|Overall Study|Lost to Follow-up|2|||
48500177|NCT03655106|156028071|FG001|Overall Study|Lost to Follow-up|1|||
48500178|NCT03655106|156028070|FG000|Overall Study|Duplicate Enrollment|1|||
48500179|NCT03655106|156028071|FG001|Overall Study|Duplicate Enrollment|1|||
48720222|NCT03011892|156824940|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
48720223|NCT03011892|156824941|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
48720224|NCT03011892|156824942|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
48815608|NCT03017235|157167333|FG001|Overall Study|Adverse Event|1|||
48500180|NCT03655106|156028070|FG000|Overall Study|Protocol Violation|3|||
48500181|NCT03655106|156028071|FG001|Overall Study|Protocol Violation|0|||
48500182|NCT00818883|156028072|FG000|Overall Study|Adverse Event|28|||
48500183|NCT00818883|156028073|FG001|Overall Study|Adverse Event|19|||
48500184|NCT00818883|156028072|FG000|Overall Study|Protocol Violation|2|||
48500185|NCT00818883|156028073|FG001|Overall Study|Protocol Violation|2|||
48500186|NCT00818883|156028072|FG000|Overall Study|Lost to Follow-up|3|||
48500187|NCT00818883|156028073|FG001|Overall Study|Lost to Follow-up|2|||
48500188|NCT00818883|156028072|FG000|Overall Study|Withdrawal by Subject|16|||
48500189|NCT00818883|156028073|FG001|Overall Study|Withdrawal by Subject|14|||
48599647|NCT03771963|156389794|FG000|Overall Study|Lost to Follow-up|22|||
48599648|NCT03771963|156389794|FG000|Overall Study|Withdrawal of Consent|10|||
48599649|NCT00753675|156389803|FG000|Overall Study|other reason|11|||
48599650|NCT00753675|156389804|FG001|Overall Study|other reason|12|||
48599651|NCT00753675|156389805|FG002|Overall Study|other reason|13|||
48599652|NCT00753675|156389803|FG000|Overall Study|Death|1|||
48599653|NCT00753675|156389804|FG001|Overall Study|Death|2|||
48599654|NCT00753675|156389805|FG002|Overall Study|Death|4|||
48599655|NCT00753675|156389803|FG000|Overall Study|Adverse Event|11|||
48599656|NCT00753675|156389804|FG001|Overall Study|Adverse Event|9|||
48599657|NCT00753675|156389805|FG002|Overall Study|Adverse Event|4|||
48599658|NCT00753675|156389803|FG000|Overall Study|Objective progression of disease|35|||
48599659|NCT00753675|156389804|FG001|Overall Study|Objective progression of disease|35|||
48599660|NCT00753675|156389805|FG002|Overall Study|Objective progression of disease|35|||
48599661|NCT00753675|156389803|FG000|Overall Study|Withdrawal by Subject|0|||
48599662|NCT00753675|156389804|FG001|Overall Study|Withdrawal by Subject|1|||
48599663|NCT00753675|156389805|FG002|Overall Study|Withdrawal by Subject|0|||
48599664|NCT00753675|156389803|FG000|Overall Study|Lost to Follow-up|1|||
48599665|NCT00753675|156389804|FG001|Overall Study|Lost to Follow-up|0|||
48599666|NCT00753675|156389805|FG002|Overall Study|Lost to Follow-up|0|||
48599667|NCT02895347|156389811|FG000|Overall Study|Withdrawal by Subject|3|||
48599668|NCT02895347|156389812|FG001|Overall Study|Withdrawal by Subject|1|||
48599669|NCT04794751|156389813|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
48599670|NCT04794751|156389814|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
48599671|NCT04794751|156389813|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
48599672|NCT04794751|156389814|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
48599673|NCT04794751|156389813|FG000|Period 1|Protocol Violation|0|||
48599674|NCT04794751|156389814|FG001|Period 1|Protocol Violation|2|||
48599675|NCT04794751|156389813|FG000|Period 1|Withdrawal by Subject|0|||
48599676|NCT04794751|156389814|FG001|Period 1|Withdrawal by Subject|1|||
48599677|NCT04794751|156389813|FG000|Period 2|Withdrawal by Subject|0|||
48599678|NCT04794751|156389814|FG001|Period 2|Withdrawal by Subject|1|||
48599679|NCT04794751|156389813|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
48599680|NCT04794751|156389814|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
48599681|NCT04794751|156389813|FG000|Period 2|Protocol Violation|1|||
48599682|NCT04794751|156389814|FG001|Period 2|Protocol Violation|0|||
48599683|NCT01526785|156389815|FG000|Overall Study|Study Terminated by Sponsor|8|||
48599684|NCT01526785|156389815|FG000|Overall Study|Death|2|||
48599685|NCT01526785|156389815|FG000|Overall Study|Physician Decision|1|||
48599686|NCT01526785|156389815|FG000|Overall Study|Withdrawal by Subject|2|||
48599687|NCT01945944|156389816|FG000|Overall Study|Adverse Event|0|||
48599688|NCT01945944|156389817|FG001|Overall Study|Adverse Event|2|||
48599689|NCT01945944|156389816|FG000|Overall Study|Physician Decision|1|||
48599690|NCT01945944|156389817|FG001|Overall Study|Physician Decision|0|||
48599691|NCT01945944|156389816|FG000|Overall Study|Withdrawal by Subject|0|||
48599692|NCT01945944|156389817|FG001|Overall Study|Withdrawal by Subject|1|||
48599693|NCT02346877|156389818|FG000|Overall Study|Adverse Event|1|||
48599694|NCT02346877|156389819|FG001|Overall Study|Adverse Event|0|||
48599695|NCT02346877|156389818|FG000|Overall Study|Administrative Decision|1|||
48720225|NCT03011892|156824931|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
48599696|NCT02346877|156389819|FG001|Overall Study|Administrative Decision|0|||
48599697|NCT02346877|156389818|FG000|Overall Study|Sponsor Decision|12|||
48599698|NCT02346877|156389819|FG001|Overall Study|Sponsor Decision|0|||
48599699|NCT02346877|156389818|FG000|Overall Study|Missing|5|||
48599700|NCT02346877|156389819|FG001|Overall Study|Missing|0|||
48599701|NCT00807365|156389820|FG000|Overall Study|Study Terminated|5|||
48599702|NCT03810456|156389821|FG000|Treatment|Urgent Family Matters|3|||
48599703|NCT03810456|156389822|FG001|Treatment|Urgent Family Matters|0|||
48599704|NCT03810456|156389823|FG002|Treatment|Urgent Family Matters|0|||
48599705|NCT03810456|156389821|FG000|Treatment|Scheduling Conflicts|0|||
48599706|NCT03810456|156389822|FG001|Treatment|Scheduling Conflicts|11|||
48720226|NCT03011892|156824932|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
48720227|NCT03011892|156824933|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
48720228|NCT03011892|156824934|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
48720229|NCT03011892|156824935|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
48720230|NCT03011892|156824936|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
48720231|NCT03011892|156824937|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
48720232|NCT03011892|156824938|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
48720233|NCT03011892|156824939|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
48720234|NCT03011892|156824940|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
48720235|NCT03011892|156824941|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
48599707|NCT03810456|156389823|FG002|Treatment|Scheduling Conflicts|0|||
48599708|NCT03810456|156389821|FG000|Treatment|No Longer Interested|0|||
48599709|NCT03810456|156389822|FG001|Treatment|No Longer Interested|12|||
48599710|NCT03810456|156389823|FG002|Treatment|No Longer Interested|0|||
48599711|NCT03810456|156389821|FG000|Treatment|Transportation Issues|0|||
48599712|NCT03810456|156389822|FG001|Treatment|Transportation Issues|1|||
48500190|NCT00818883|156028072|FG000|Overall Study|Lack of Efficacy|0|||
48500191|NCT00818883|156028073|FG001|Overall Study|Lack of Efficacy|2|||
48500192|NCT00818883|156028072|FG000|Overall Study|Other|2|||
48500193|NCT00818883|156028073|FG001|Overall Study|Other|7|||
48500194|NCT02166697|156028074|FG000|Overall Study|Protocol Violation|347|||
48500195|NCT03227445|156028078|FG000|Period 1 (28 Days)|Adverse Event|1|||
48815609|NCT03017235|157167332|FG000|Overall Study|Protocol Violation|2|||
48815610|NCT03017235|157167333|FG001|Overall Study|Protocol Violation|1|||
48500196|NCT03227445|156028079|FG001|Period 1 (28 Days)|Adverse Event|2|||
48500197|NCT03227445|156028080|FG002|Period 1 (28 Days)|Adverse Event|0|||
48500198|NCT03227445|156028081|FG003|Period 1 (28 Days)|Adverse Event|1|||
48500199|NCT03227445|156028078|FG000|Period 1 (28 Days)|Protocol Violation|1|||
48500200|NCT03227445|156028079|FG001|Period 1 (28 Days)|Protocol Violation|0|||
48500201|NCT03227445|156028080|FG002|Period 1 (28 Days)|Protocol Violation|0|||
48500202|NCT03227445|156028081|FG003|Period 1 (28 Days)|Protocol Violation|0|||
48500203|NCT03227445|156028078|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
48500204|NCT03227445|156028079|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
48500205|NCT03227445|156028080|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
48500206|NCT03227445|156028081|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
48500207|NCT03227445|156028078|FG000|Period 2 (28 Days)|Adverse Event|1|||
48500208|NCT03227445|156028079|FG001|Period 2 (28 Days)|Adverse Event|0|||
48500209|NCT03227445|156028080|FG002|Period 2 (28 Days)|Adverse Event|2|||
48815611|NCT03017235|157167332|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
48815612|NCT03017235|157167333|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
48815613|NCT01818141|157167335|FG000|Overall Study|Withdrawal by Subject|2|||
48815614|NCT01818141|157167336|FG001|Overall Study|Withdrawal by Subject|0|||
48815615|NCT01818141|157167335|FG000|Overall Study|No baseline C.diff colonies|1|||
48815616|NCT01818141|157167336|FG001|Overall Study|No baseline C.diff colonies|1|||
48815617|NCT01818141|157167335|FG000|Overall Study|Lost to Follow-up|0|||
48815618|NCT01818141|157167336|FG001|Overall Study|Lost to Follow-up|2|||
48815619|NCT03518658|157167337|FG000|Overall Study|Other|51|||
48815620|NCT03518658|157167338|FG001|Overall Study|Other|0|||
48815621|NCT04213989|157167339|FG000|Overall Study|Withdrawal by Subject|3|||
48815622|NCT04213989|157167340|FG001|Overall Study|Withdrawal by Subject|2|||
48815623|NCT04213989|157167339|FG000|Overall Study|Physician Decision|1|||
48815624|NCT04213989|157167340|FG001|Overall Study|Physician Decision|0|||
48815625|NCT04213989|157167339|FG000|Overall Study|Lost to Follow-up|0|||
48815626|NCT04213989|157167340|FG001|Overall Study|Lost to Follow-up|4|||
48815627|NCT01087723|157167345|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
48815628|NCT01087723|157167346|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
48815629|NCT01087723|157167345|FG000|Overall Study|Withdrawal by Subject|10|||
48815630|NCT01087723|157167346|FG001|Overall Study|Withdrawal by Subject|13|||
48815631|NCT01087723|157167345|FG000|Overall Study|Physician Decision|2|||
48815632|NCT01087723|157167346|FG001|Overall Study|Physician Decision|0|||
48815633|NCT01087723|157167345|FG000|Overall Study|Lost to Follow-up|1|||
48815634|NCT01087723|157167346|FG001|Overall Study|Lost to Follow-up|4|||
48815635|NCT01087723|157167345|FG000|Overall Study|Reason Not Specified|1|||
48815636|NCT01087723|157167346|FG001|Overall Study|Reason Not Specified|2|||
48815637|NCT03638635|157167347|FG000|Initial Hospitalization|Study terminated prematurely|0|||
48815638|NCT03638635|157167348|FG001|Initial Hospitalization|Study terminated prematurely|1|||
48815639|NCT03638635|157167347|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
48815640|NCT03638635|157167348|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
48815641|NCT03638635|157167347|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
48815642|NCT03638635|157167348|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
48815643|NCT02091869|157167357|FG000|Overall Study|Withdrawal by Subject|0|||
48815644|NCT02091869|157167358|FG001|Overall Study|Withdrawal by Subject|3|||
48815645|NCT00627042|157167366|FG000|Overall Study|Withdrawal by Subject|2|||
48815646|NCT04747275|157167367|FG000|Overall Study|Study terminated|0|||
48815647|NCT04747275|157167368|FG001|Overall Study|Study terminated|1|||
48815648|NCT04537897|157167369|FG000|Overall Study|Other than listed|0|||
48815649|NCT04537897|157167370|FG001|Overall Study|Other than listed|0|||
48815650|NCT04537897|157167371|FG002|Overall Study|Other than listed|0|||
48815651|NCT04537897|157167372|FG003|Overall Study|Other than listed|0|||
48815652|NCT04537897|157167373|FG004|Overall Study|Other than listed|0|||
48815653|NCT04537897|157167374|FG005|Overall Study|Other than listed|0|||
48815654|NCT04537897|157167375|FG006|Overall Study|Other than listed|1|||
48815655|NCT04537897|157167376|FG007|Overall Study|Other than listed|0|||
48815656|NCT04537897|157167377|FG008|Overall Study|Other than listed|0|||
48815657|NCT04537897|157167369|FG000|Overall Study|Adverse Event|0|||
48815658|NCT04537897|157167370|FG001|Overall Study|Adverse Event|0|||
48815659|NCT04537897|157167371|FG002|Overall Study|Adverse Event|0|||
48815660|NCT04537897|157167372|FG003|Overall Study|Adverse Event|1|||
48500210|NCT03227445|156028081|FG003|Period 2 (28 Days)|Adverse Event|1|||
48500211|NCT03227445|156028078|FG000|Period 2 (28 Days)|Protocol Violation|0|||
48500212|NCT03227445|156028079|FG001|Period 2 (28 Days)|Protocol Violation|0|||
48500213|NCT03227445|156028080|FG002|Period 2 (28 Days)|Protocol Violation|0|||
48815661|NCT04537897|157167373|FG004|Overall Study|Adverse Event|0|||
48720236|NCT03011892|156824942|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
48720237|NCT03011892|156824931|FG000|Open Label (OL) Period|Reason not specified|0|||
48720238|NCT03011892|156824932|FG001|Open Label (OL) Period|Reason not specified|0|||
48720239|NCT03011892|156824933|FG002|Open Label (OL) Period|Reason not specified|0|||
48720240|NCT03011892|156824934|FG003|Open Label (OL) Period|Reason not specified|0|||
48720241|NCT03011892|156824935|FG004|Open Label (OL) Period|Reason not specified|0|||
48720242|NCT03011892|156824936|FG005|Open Label (OL) Period|Reason not specified|0|||
48720243|NCT03011892|156824937|FG006|Open Label (OL) Period|Reason not specified|0|||
48720244|NCT03011892|156824938|FG007|Open Label (OL) Period|Reason not specified|1|||
48720245|NCT03011892|156824939|FG008|Open Label (OL) Period|Reason not specified|0|||
48720246|NCT03011892|156824940|FG009|Open Label (OL) Period|Reason not specified|0|||
48720247|NCT03011892|156824941|FG010|Open Label (OL) Period|Reason not specified|0|||
48720248|NCT03011892|156824942|FG011|Open Label (OL) Period|Reason not specified|0|||
48720249|NCT01470989|156824943|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
48815662|NCT04537897|157167374|FG005|Overall Study|Adverse Event|0|||
48815663|NCT04537897|157167375|FG006|Overall Study|Adverse Event|0|||
48815664|NCT04537897|157167376|FG007|Overall Study|Adverse Event|0|||
48815665|NCT04537897|157167377|FG008|Overall Study|Adverse Event|0|||
48815666|NCT04537897|157167369|FG000|Overall Study|Withdrawal by Subject|0|||
48815667|NCT04537897|157167370|FG001|Overall Study|Withdrawal by Subject|1|||
48815668|NCT04537897|157167371|FG002|Overall Study|Withdrawal by Subject|0|||
48815669|NCT04537897|157167372|FG003|Overall Study|Withdrawal by Subject|0|||
48815670|NCT04537897|157167373|FG004|Overall Study|Withdrawal by Subject|0|||
48815671|NCT04537897|157167374|FG005|Overall Study|Withdrawal by Subject|0|||
48720250|NCT01470989|156824944|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
48720251|NCT01470989|156824943|FG000|Overall Study|Adverse Event|2|||
48720252|NCT01470989|156824944|FG001|Overall Study|Adverse Event|5|||
48720253|NCT01470989|156824943|FG000|Overall Study|Abnormal laboratory value|1|||
48720254|NCT01470989|156824944|FG001|Overall Study|Abnormal laboratory value|1|||
48720255|NCT01470989|156824943|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48720256|NCT01470989|156824944|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
48720257|NCT01470989|156824943|FG000|Overall Study|Withdrawal by Subject|19|||
48720258|NCT01470989|156824944|FG001|Overall Study|Withdrawal by Subject|17|||
48720259|NCT01470989|156824943|FG000|Overall Study|Lost to Follow-up|18|||
48720260|NCT01470989|156824944|FG001|Overall Study|Lost to Follow-up|13|||
48720261|NCT01470989|156824943|FG000|Overall Study|Administrative problems|2|||
48815672|NCT04537897|157167375|FG006|Overall Study|Withdrawal by Subject|0|||
48815673|NCT04537897|157167376|FG007|Overall Study|Withdrawal by Subject|0|||
48815674|NCT04537897|157167377|FG008|Overall Study|Withdrawal by Subject|0|||
48815675|NCT01130883|157167378|FG000|Overall Study|Patient Noncompliance|6|||
48815676|NCT01130883|157167378|FG000|Overall Study|Reason Unknown|1|||
48815677|NCT01130883|157167378|FG000|Overall Study|Adverse Event|3|||
48720262|NCT01470989|156824944|FG001|Overall Study|Administrative problems|4|||
48720263|NCT01470989|156824943|FG000|Overall Study|Death|2|||
48720264|NCT01470989|156824944|FG001|Overall Study|Death|2|||
48720265|NCT01470989|156824943|FG000|Overall Study|Protocol deviation|1|||
48720266|NCT01470989|156824944|FG001|Overall Study|Protocol deviation|2|||
48742997|NCT01086033|156910453|FG000|Overall Study|AE and Lack of Efficacy|4|||
48742998|NCT01086033|156910453|FG000|Overall Study|Death|1|||
48742999|NCT01086033|156910453|FG000|Overall Study|AE and Lost to Follow-up|1|||
48743000|NCT01086033|156910453|FG000|Overall Study|AE and Other Reason|1|||
48743001|NCT01086033|156910453|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
48743002|NCT01921387|156910454|FG000|Overall Study|Adverse Event|1|||
48743003|NCT03727230|156910455|FG000|Overall Study|Lost to Follow-up|12|||
48743004|NCT02763462|156910456|FG000|Overall Study|Protocol Violation|6|||
48743005|NCT03600818|156910457|FG000|Overall Study|Adverse Event|4|||
48743006|NCT03600818|156910458|FG001|Overall Study|Adverse Event|7|||
48743007|NCT03600818|156910457|FG000|Overall Study|Lack of Efficacy|9|||
48815678|NCT04466618|157167384|FG000|Overall Study|Withdrawal by Subject|0|||
48815679|NCT04466618|157167385|FG001|Overall Study|Withdrawal by Subject|1|||
48437101|NCT03987919|155789560|FG001|Overall Study|Pregnancy|0|||
48437102|NCT03987919|155789561|FG002|Overall Study|Pregnancy|1|||
48437103|NCT03987919|155789562|FG003|Overall Study|Pregnancy|1|||
48437104|NCT03987919|155789559|FG000|Overall Study|Protocol Violation|0|||
48437105|NCT03987919|155789560|FG001|Overall Study|Protocol Violation|1|||
48437106|NCT03987919|155789561|FG002|Overall Study|Protocol Violation|0|||
48437107|NCT03987919|155789562|FG003|Overall Study|Protocol Violation|0|||
48437108|NCT03987919|155789559|FG000|Overall Study|Site terminated by Sponsor|0|||
48437109|NCT03987919|155789560|FG001|Overall Study|Site terminated by Sponsor|0|||
48437110|NCT03987919|155789561|FG002|Overall Study|Site terminated by Sponsor|0|||
48437111|NCT03987919|155789562|FG003|Overall Study|Site terminated by Sponsor|1|||
48437112|NCT03987919|155789559|FG000|Overall Study|Withdrawal by Subject|7|||
48437113|NCT03987919|155789560|FG001|Overall Study|Withdrawal by Subject|7|||
48437114|NCT03987919|155789561|FG002|Overall Study|Withdrawal by Subject|8|||
48437115|NCT03987919|155789562|FG003|Overall Study|Withdrawal by Subject|4|||
48720267|NCT03860935|156826571|FG000|Overall Study|Withdrawal of Consent|15|||
48720268|NCT03860935|156826572|FG001|Overall Study|Withdrawal of Consent|6|||
48720269|NCT03860935|156826571|FG000|Overall Study|Death|75|||
48720270|NCT03860935|156826572|FG001|Overall Study|Death|51|||
48720271|NCT02661178|156826573|FG000|Part 1|Protocol Violation|1|||
48720272|NCT02661178|156826574|FG001|Part 1|Protocol Violation|0|||
48720273|NCT02661178|156826575|FG002|Part 1|Protocol Violation|0|||
48720274|NCT02661178|156826576|FG003|Part 1|Protocol Violation|0|||
48720275|NCT02661178|156826577|FG004|Part 1|Protocol Violation|0|||
48720276|NCT02661178|156826578|FG005|Part 1|Protocol Violation|0|||
48720277|NCT02661178|156826579|FG006|Part 1|Protocol Violation|0|||
48720278|NCT02661178|156826580|FG007|Part 1|Protocol Violation|0|||
48720279|NCT02661178|156826581|FG008|Part 1|Protocol Violation|0|||
48720280|NCT02661178|156826582|FG009|Part 1|Protocol Violation|0|||
48720281|NCT02661178|156826583|FG010|Part 1|Protocol Violation|0|||
48720282|NCT02661178|156826584|FG011|Part 1|Protocol Violation|0|||
48720283|NCT02661178|156826585|FG012|Part 1|Protocol Violation|0|||
48720284|NCT02661178|156826586|FG013|Part 1|Protocol Violation|0|||
48720285|NCT02661178|156826587|FG014|Part 1|Protocol Violation|0|||
48720286|NCT01437995|156826589|FG000|Overall Study|Lost to Follow-up|11|||
48720287|NCT01437995|156826590|FG001|Overall Study|Lost to Follow-up|18|||
48720288|NCT01437995|156826591|FG002|Overall Study|Lost to Follow-up|20|||
48720289|NCT00704522|156826594|FG000|Overall Study|Lack of Efficacy|65|||
48500214|NCT03227445|156028081|FG003|Period 2 (28 Days)|Protocol Violation|1|||
48720290|NCT00704522|156826595|FG001|Overall Study|Lack of Efficacy|17|||
48720291|NCT00704522|156826594|FG000|Overall Study|Failure to appear again at hospital|56|||
48720292|NCT00704522|156826595|FG001|Overall Study|Failure to appear again at hospital|10|||
48720293|NCT00704522|156826594|FG000|Overall Study|Withdrawal by Subject|17|||
48720294|NCT00704522|156826595|FG001|Overall Study|Withdrawal by Subject|8|||
48720295|NCT00704522|156826594|FG000|Overall Study|Adverse Event|9|||
48720296|NCT00704522|156826595|FG001|Overall Study|Adverse Event|1|||
48720297|NCT00704522|156826594|FG000|Overall Study|Undefined causes|9|||
48720298|NCT00704522|156826595|FG001|Overall Study|Undefined causes|7|||
48720299|NCT00704522|156826594|FG000|Overall Study|No information on therapy end|27|||
48720300|NCT00704522|156826595|FG001|Overall Study|No information on therapy end|2|||
48720301|NCT00775203|156826596|FG000|Overall Study|Adverse Event|25|||
48720302|NCT00775203|156826597|FG001|Overall Study|Adverse Event|6|||
48720303|NCT00775203|156826596|FG000|Overall Study|Lack of Efficacy|8|||
48720304|NCT00775203|156826597|FG001|Overall Study|Lack of Efficacy|9|||
48720305|NCT00775203|156826596|FG000|Overall Study|Withdrawal by Subject|11|||
48720306|NCT00775203|156826597|FG001|Overall Study|Withdrawal by Subject|9|||
48720307|NCT00775203|156826596|FG000|Overall Study|Lost to Follow-up|11|||
48720308|NCT00775203|156826597|FG001|Overall Study|Lost to Follow-up|15|||
48720309|NCT00775203|156826596|FG000|Overall Study|Administrative reason|2|||
48720310|NCT00775203|156826597|FG001|Overall Study|Administrative reason|0|||
48720311|NCT00775203|156826596|FG000|Overall Study|Noncompliance|4|||
48720312|NCT00775203|156826597|FG001|Overall Study|Noncompliance|2|||
48720313|NCT00775203|156826596|FG000|Overall Study|Protocol Violation|0|||
48720314|NCT00775203|156826597|FG001|Overall Study|Protocol Violation|1|||
48720315|NCT00775203|156826596|FG000|Overall Study|Entered other study|1|||
48720316|NCT00775203|156826597|FG001|Overall Study|Entered other study|0|||
48720317|NCT00775203|156826596|FG000|Overall Study|Physician Decision|0|||
48720318|NCT00775203|156826597|FG001|Overall Study|Physician Decision|1|||
48720319|NCT05458011|156826598|FG000|DB Period (12 Weeks)|Adverse Event|2|||
48720320|NCT05458011|156826599|FG001|DB Period (12 Weeks)|Adverse Event|1|||
48720321|NCT05458011|156826600|FG002|DB Period (12 Weeks)|Adverse Event|1|||
48720322|NCT05458011|156826598|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
48720323|NCT05458011|156826599|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
48720324|NCT05458011|156826600|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
48500215|NCT03227445|156028078|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
48500216|NCT03227445|156028079|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
48500217|NCT03227445|156028080|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
48720325|NCT05458011|156826598|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
48720326|NCT05458011|156826599|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
48720327|NCT05458011|156826600|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
48720328|NCT05458011|156826598|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
48720329|NCT05458011|156826599|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
48720330|NCT05458011|156826600|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
48500218|NCT03227445|156028081|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
48720331|NCT05458011|156826598|FG000|OL Period (12 Weeks)|Adverse Event|1|||
48720332|NCT05458011|156826599|FG001|OL Period (12 Weeks)|Adverse Event|2|||
48720333|NCT05458011|156826600|FG002|OL Period (12 Weeks)|Adverse Event|1|||
48500219|NCT00264797|156028082|FG000|Overall Study|Withdrawal by Subject|11|||
48720334|NCT05458011|156826598|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
48720335|NCT05458011|156826599|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
48720336|NCT05458011|156826600|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
48720337|NCT01129024|156826602|FG000|Overall Study|Physician Decision|5|||
48720338|NCT01129024|156826602|FG000|Overall Study|Study Terminated by Sponsor|8|||
48720339|NCT01129024|156826602|FG000|Overall Study|Withdrawal by Subject|2|||
48720340|NCT01129024|156826602|FG000|Overall Study|Lack of Efficacy|3|||
48720341|NCT01129024|156826602|FG000|Overall Study|Needed a Platelet Transfusion|1|||
48720342|NCT00713310|156826604|FG000|Overall Study|Adverse Event|5|||
48720343|NCT00713310|156826605|FG001|Overall Study|Adverse Event|2|||
48720344|NCT00713310|156826604|FG000|Overall Study|Lack of Efficacy|0|||
48720345|NCT00713310|156826605|FG001|Overall Study|Lack of Efficacy|2|||
48720346|NCT00713310|156826604|FG000|Overall Study|Withdrawal by Subject|0|||
48720347|NCT00713310|156826605|FG001|Overall Study|Withdrawal by Subject|2|||
48720348|NCT03726996|156826607|FG000|Overall Study|Parent's decision|2|||
48720349|NCT03726996|156826607|FG000|Overall Study|Study early termination|2|||
48720350|NCT03499964|156826618|FG000|Overall Study|Lack of Efficacy|6|||
48720351|NCT03499964|156826619|FG001|Overall Study|Lack of Efficacy|26|||
48720352|NCT03499964|156826618|FG000|Overall Study|Adverse Event|1|||
48720353|NCT03499964|156826619|FG001|Overall Study|Adverse Event|0|||
48720354|NCT03499964|156826618|FG000|Overall Study|Death|1|||
48720355|NCT03499964|156826619|FG001|Overall Study|Death|0|||
48720356|NCT03499964|156826618|FG000|Overall Study|Withdrawal by Subject|2|||
48720357|NCT03499964|156826619|FG001|Overall Study|Withdrawal by Subject|1|||
48720358|NCT03499964|156826618|FG000|Overall Study|Lost to Follow-up|1|||
48720359|NCT03499964|156826619|FG001|Overall Study|Lost to Follow-up|0|||
48720360|NCT01673282|156826622|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
48720361|NCT01673282|156826623|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
48720362|NCT01673282|156826622|FG000|Overall Study|Lack of Efficacy|9|||
48720363|NCT01673282|156826623|FG001|Overall Study|Lack of Efficacy|2|||
48720364|NCT01673282|156826622|FG000|Overall Study|Lost to Follow-up|11|||
48720365|NCT01673282|156826623|FG001|Overall Study|Lost to Follow-up|10|||
48720366|NCT01673282|156826622|FG000|Overall Study|Withdrawal by Subject|3|||
48720367|NCT01673282|156826623|FG001|Overall Study|Withdrawal by Subject|3|||
48720368|NCT01673282|156826622|FG000|Overall Study|Other|1|||
48720369|NCT01673282|156826623|FG001|Overall Study|Other|6|||
48720370|NCT01534182|156826625|FG000|Overall Study|Administrative problems|1|||
48720371|NCT01534182|156826626|FG001|Overall Study|Administrative problems|0|||
48720372|NCT01534182|156826625|FG000|Overall Study|Withdrawal by Subject|4|||
48720373|NCT01534182|156826626|FG001|Overall Study|Withdrawal by Subject|7|||
48720374|NCT01534182|156826625|FG000|Overall Study|Adverse Event|7|||
48720375|NCT01534182|156826626|FG001|Overall Study|Adverse Event|3|||
48720376|NCT01323920|156826627|FG000|Overall Study|Death|5|||
48720377|NCT01323920|156826627|FG000|Overall Study|Withdrawal by Subject|1|||
48720378|NCT00816023|156826628|FG000|Overall Study|Lost to Follow-up|1|||
48720379|NCT00816023|156826629|FG001|Overall Study|Lost to Follow-up|1|||
48720380|NCT00816023|156826630|FG002|Overall Study|Lost to Follow-up|0|||
48720381|NCT00816023|156826631|FG003|Overall Study|Lost to Follow-up|0|||
48720382|NCT00816023|156826628|FG000|Overall Study|Withdrawal by Subject|1|||
48720383|NCT00816023|156826629|FG001|Overall Study|Withdrawal by Subject|0|||
48720384|NCT00816023|156826630|FG002|Overall Study|Withdrawal by Subject|0|||
48720385|NCT00816023|156826631|FG003|Overall Study|Withdrawal by Subject|0|||
48720386|NCT00816023|156826628|FG000|Overall Study|Physician Decision|0|||
48720387|NCT00816023|156826629|FG001|Overall Study|Physician Decision|0|||
48720388|NCT00816023|156826630|FG002|Overall Study|Physician Decision|1|||
48720389|NCT00816023|156826631|FG003|Overall Study|Physician Decision|0|||
48720390|NCT00816023|156826628|FG000|Overall Study|assessments complete prior to window|1|||
48815680|NCT04789577|157167392|FG000|Overall Study|Withdrawal by Subject|1|||
48815681|NCT04789577|157167393|FG001|Overall Study|Withdrawal by Subject|1|||
48815682|NCT04789577|157167394|FG002|Overall Study|Withdrawal by Subject|1|||
48815683|NCT04789577|157167395|FG003|Overall Study|Withdrawal by Subject|3|||
48815684|NCT04789577|157167396|FG004|Overall Study|Withdrawal by Subject|1|||
48815685|NCT04789577|157167397|FG005|Overall Study|Withdrawal by Subject|7|||
48815686|NCT04789577|157167398|FG006|Overall Study|Withdrawal by Subject|1|||
48815687|NCT04789577|157167392|FG000|Overall Study|Lost to Follow-up|7|||
48815688|NCT04789577|157167393|FG001|Overall Study|Lost to Follow-up|12|||
48720391|NCT00816023|156826629|FG001|Overall Study|assessments complete prior to window|1|||
48720392|NCT00816023|156826630|FG002|Overall Study|assessments complete prior to window|2|||
48720393|NCT00816023|156826631|FG003|Overall Study|assessments complete prior to window|1|||
48720394|NCT00816023|156826628|FG000|Overall Study|Randomized Not Treated|6|||
48720395|NCT00816023|156826629|FG001|Overall Study|Randomized Not Treated|4|||
48720396|NCT00816023|156826630|FG002|Overall Study|Randomized Not Treated|6|||
48720397|NCT00816023|156826631|FG003|Overall Study|Randomized Not Treated|11|||
48720398|NCT01224782|156826639|FG000|Overall Study|Lost to Follow-up|177|||
48720399|NCT01224782|156826639|FG000|Overall Study|Withdrawal by Subject|16|||
48720400|NCT01224782|156826639|FG000|Overall Study|Death|14|||
48720401|NCT01224782|156826639|FG000|Overall Study|Improvement|13|||
48720402|NCT01224782|156826639|FG000|Overall Study|Adverse Event|12|||
48720403|NCT01224782|156826639|FG000|Overall Study|Adverse Reaction|11|||
48720404|NCT01224782|156826639|FG000|Overall Study|Noncompliance|10|||
48720405|NCT01224782|156826639|FG000|Overall Study|Other|4|||
48720406|NCT01224782|156826639|FG000|Overall Study|Start of Dialysis|3|||
48815689|NCT04789577|157167394|FG002|Overall Study|Lost to Follow-up|7|||
48815690|NCT04789577|157167395|FG003|Overall Study|Lost to Follow-up|10|||
48815691|NCT04789577|157167396|FG004|Overall Study|Lost to Follow-up|8|||
48815692|NCT04789577|157167397|FG005|Overall Study|Lost to Follow-up|6|||
48815693|NCT04789577|157167398|FG006|Overall Study|Lost to Follow-up|10|||
48815694|NCT04789577|157167392|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
48815695|NCT04789577|157167393|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
48815696|NCT04789577|157167394|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
48815697|NCT04789577|157167395|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
48815698|NCT04789577|157167396|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
48815699|NCT04789577|157167397|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
48815700|NCT04789577|157167398|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
48815701|NCT04789577|157167392|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
48815702|NCT04789577|157167393|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
48815703|NCT04789577|157167394|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
48815704|NCT04789577|157167395|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
48815705|NCT04789577|157167396|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
48815706|NCT04789577|157167397|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
48815707|NCT04789577|157167398|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
48815708|NCT02222896|157167404|FG000|Abdomen|Did not qualify|34|||
48815709|NCT02222896|157167405|FG001|Abdomen|Did not qualify|10|||
48815710|NCT02222896|157167406|FG002|Abdomen|Did not qualify|32|||
48815711|NCT02222896|157167404|FG000|Groin|Did not qualify|43|||
48815712|NCT02222896|157167405|FG001|Groin|Did not qualify|9|||
48815713|NCT02222896|157167406|FG002|Groin|Did not qualify|40|||
48815714|NCT02111213|157167408|FG000|Overall Study|Withdrawal by Subject|3|||
48815715|NCT02111213|157167409|FG001|Overall Study|Withdrawal by Subject|2|||
48815716|NCT02111213|157167408|FG000|Overall Study|Lost to Follow-up|3|||
48815717|NCT02111213|157167409|FG001|Overall Study|Lost to Follow-up|4|||
48815718|NCT03537261|157167414|FG000|Overall Study|Lost to Follow-up|4|||
48815719|NCT03537261|157167415|FG001|Overall Study|Lost to Follow-up|5|||
48815720|NCT03537261|157167414|FG000|Overall Study|Withdrawal by Subject|4|||
48815721|NCT03537261|157167415|FG001|Overall Study|Withdrawal by Subject|6|||
48815722|NCT03537261|157167414|FG000|Overall Study|Did not return study questionnaires|0|||
48815723|NCT03537261|157167415|FG001|Overall Study|Did not return study questionnaires|1|||
48815724|NCT03237013|157167417|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
48720407|NCT01224782|156826639|FG000|Overall Study|Change of Treatment|1|||
48815725|NCT03237013|157167418|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
48815726|NCT03237013|157167419|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
48815727|NCT00287469|157167422|FG000|Overall Study|serious adverse event|1|||
48815728|NCT00287469|157167423|FG001|Overall Study|serious adverse event|6|||
48720408|NCT01224782|156826639|FG000|Overall Study|Financial Reasons|1|||
48720409|NCT01224782|156826639|FG000|Overall Study|Deterioration|1|||
48720410|NCT01224782|156826639|FG000|Overall Study|Transplantation|1|||
48720411|NCT01203852|156826644|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
48720412|NCT01203852|156826644|FG000|Washout 2 Weeks|Physician Decision|46|||
48720413|NCT01238588|156826645|FG000|Overall Study|Withdrawal by Subject|1|||
48720414|NCT01238588|156826645|FG000|Overall Study|Physician Decision|2|||
48720415|NCT01903252|156826646|FG000|Double-Blind Induction|Adverse Event|20|||
48720416|NCT01903252|156826647|FG001|Double-Blind Induction|Adverse Event|18|||
48720417|NCT01903252|156826648|FG002|Double-Blind Induction|Adverse Event|0|||
48720418|NCT01903252|156826649|FG003|Double-Blind Induction|Adverse Event|0|||
48720419|NCT01903252|156826650|FG004|Double-Blind Induction|Adverse Event|0|||
48720420|NCT01903252|156826651|FG005|Double-Blind Induction|Adverse Event|0|||
48815729|NCT00287469|157167422|FG000|Overall Study|Adverse Event|1|||
48815730|NCT00287469|157167423|FG001|Overall Study|Adverse Event|1|||
48815731|NCT00287469|157167422|FG000|Overall Study|moved from area|144|||
48815732|NCT00287469|157167423|FG001|Overall Study|moved from area|138|||
48815733|NCT00287469|157167422|FG000|Overall Study|Lost to Follow-up|74|||
48815734|NCT00287469|157167423|FG001|Overall Study|Lost to Follow-up|69|||
48815735|NCT00967018|157167424|FG000|Overall Study|Adverse Event|2|||
48815736|NCT00967018|157167424|FG000|Overall Study|Physician Decision|7|||
48815737|NCT00967018|157167424|FG000|Overall Study|Lost to Follow-up|2|||
48720421|NCT01903252|156826646|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
48720422|NCT01903252|156826647|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
48437481|NCT02796391|155789617|FG002|Overall Study|COVID|5|||
48720423|NCT01903252|156826648|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
48437482|NCT02796391|155789618|FG003|Overall Study|COVID|5|||
48437483|NCT02796391|155789619|FG004|Overall Study|COVID|2|||
48437484|NCT02796391|155789620|FG005|Overall Study|COVID|4|||
48437485|NCT02796391|155789615|FG000|Overall Study|Participant did not like study cigarettes|0|||
48437486|NCT02796391|155789616|FG001|Overall Study|Participant did not like study cigarettes|0|||
48437487|NCT02796391|155789617|FG002|Overall Study|Participant did not like study cigarettes|3|||
48437488|NCT02796391|155789618|FG003|Overall Study|Participant did not like study cigarettes|0|||
48437489|NCT02796391|155789619|FG004|Overall Study|Participant did not like study cigarettes|0|||
48437490|NCT02796391|155789620|FG005|Overall Study|Participant did not like study cigarettes|0|||
48720424|NCT01903252|156826649|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
48720425|NCT01903252|156826650|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
48720426|NCT01903252|156826651|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
48720427|NCT01903252|156826646|FG000|Double-Blind Induction|Physician Decision|2|||
48720428|NCT01903252|156826647|FG001|Double-Blind Induction|Physician Decision|3|||
48720429|NCT01903252|156826648|FG002|Double-Blind Induction|Physician Decision|0|||
48720430|NCT01903252|156826649|FG003|Double-Blind Induction|Physician Decision|0|||
48720431|NCT01903252|156826650|FG004|Double-Blind Induction|Physician Decision|0|||
48720432|NCT01903252|156826651|FG005|Double-Blind Induction|Physician Decision|0|||
48720433|NCT01903252|156826646|FG000|Double-Blind Induction|non-compliance,|7|||
48720434|NCT01903252|156826647|FG001|Double-Blind Induction|non-compliance,|7|||
48720435|NCT01903252|156826648|FG002|Double-Blind Induction|non-compliance,|0|||
48720436|NCT01903252|156826649|FG003|Double-Blind Induction|non-compliance,|0|||
48720437|NCT01903252|156826650|FG004|Double-Blind Induction|non-compliance,|0|||
48720438|NCT01903252|156826651|FG005|Double-Blind Induction|non-compliance,|0|||
48720439|NCT01903252|156826646|FG000|Extended Induction, Open-Label|Adverse Event|0|||
48720440|NCT01903252|156826647|FG001|Extended Induction, Open-Label|Adverse Event|0|||
48720441|NCT01903252|156826648|FG002|Extended Induction, Open-Label|Adverse Event|17|||
48720442|NCT01903252|156826649|FG003|Extended Induction, Open-Label|Adverse Event|0|||
48720443|NCT01903252|156826650|FG004|Extended Induction, Open-Label|Adverse Event|0|||
48720444|NCT01903252|156826651|FG005|Extended Induction, Open-Label|Adverse Event|0|||
48720445|NCT01903252|156826646|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720446|NCT01903252|156826647|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720447|NCT01903252|156826648|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
48720448|NCT01903252|156826649|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720449|NCT01903252|156826650|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720450|NCT01903252|156826651|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
48720451|NCT01903252|156826646|FG000|Extended Induction, Open-Label|Physician Decision|0|||
48720452|NCT01903252|156826647|FG001|Extended Induction, Open-Label|Physician Decision|0|||
48720453|NCT01903252|156826648|FG002|Extended Induction, Open-Label|Physician Decision|1|||
48720454|NCT01903252|156826649|FG003|Extended Induction, Open-Label|Physician Decision|0|||
48720455|NCT01903252|156826650|FG004|Extended Induction, Open-Label|Physician Decision|0|||
48720456|NCT01903252|156826651|FG005|Extended Induction, Open-Label|Physician Decision|0|||
48720457|NCT01903252|156826646|FG000|Maintenance, Open-Label|Adverse Event|0|||
48720458|NCT01903252|156826647|FG001|Maintenance, Open-Label|Adverse Event|0|||
48720459|NCT01903252|156826648|FG002|Maintenance, Open-Label|Adverse Event|0|||
48720460|NCT01903252|156826649|FG003|Maintenance, Open-Label|Adverse Event|3|||
48720461|NCT01903252|156826650|FG004|Maintenance, Open-Label|Adverse Event|9|||
48720462|NCT01903252|156826651|FG005|Maintenance, Open-Label|Adverse Event|14|||
48720463|NCT01903252|156826646|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
48720464|NCT01903252|156826647|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
48720465|NCT01903252|156826648|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
48720466|NCT01903252|156826649|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
48720467|NCT01903252|156826650|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
48720468|NCT01903252|156826651|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
48720469|NCT01903252|156826646|FG000|Maintenance, Open-Label|Other|0|||
48720470|NCT01903252|156826647|FG001|Maintenance, Open-Label|Other|0|||
48720471|NCT01903252|156826648|FG002|Maintenance, Open-Label|Other|0|||
48720472|NCT01903252|156826649|FG003|Maintenance, Open-Label|Other|2|||
48720473|NCT01903252|156826650|FG004|Maintenance, Open-Label|Other|6|||
48720474|NCT01903252|156826651|FG005|Maintenance, Open-Label|Other|2|||
48720475|NCT00852371|156826652|FG000|Overall Study|Lost to Follow-up|2|||
48720476|NCT00852371|156826653|FG001|Overall Study|Lost to Follow-up|3|||
48720477|NCT00852371|156826654|FG002|Overall Study|Lost to Follow-up|4|||
48815738|NCT00967018|157167424|FG000|Overall Study|Withdrawal by Subject|1|||
48815739|NCT00967018|157167424|FG000|Overall Study|Miscellaneous Reasons|9|||
48815740|NCT04642469|157167427|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
48815741|NCT04642469|157167428|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
48815742|NCT04642469|157167427|FG000|Overall Study|Death|1|||
48815743|NCT04642469|157167428|FG001|Overall Study|Death|2|||
48815744|NCT04642469|157167427|FG000|Overall Study|Study/site closed following amendment 1|11|||
48815745|NCT04642469|157167428|FG001|Overall Study|Study/site closed following amendment 1|11|||
48815746|NCT04642469|157167427|FG000|Overall Study|Other|1|||
48720478|NCT00852371|156826655|FG003|Overall Study|Lost to Follow-up|2|||
48720479|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
48720480|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
48720481|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
48720482|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
48720483|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
48720484|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
48815747|NCT04642469|157167428|FG001|Overall Study|Other|1|||
48500220|NCT00264797|156028083|FG001|Overall Study|Withdrawal by Subject|11|||
48720485|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
48720486|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
48720487|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
48720488|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
48720489|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
48720490|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
48720491|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
48720492|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
48720493|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
48720494|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
48720495|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
48720496|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
48720497|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
48720498|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
48720499|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
48720500|NCT01227824|156826659|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
48720501|NCT01227824|156826660|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
48720502|NCT01227824|156826661|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
48743008|NCT03600818|156910458|FG001|Overall Study|Lack of Efficacy|4|||
48743009|NCT03600818|156910457|FG000|Overall Study|Withdrawal by Subject|4|||
48743010|NCT03600818|156910458|FG001|Overall Study|Withdrawal by Subject|3|||
48743011|NCT03600818|156910457|FG000|Overall Study|Other-unspecified|5|||
48743012|NCT03600818|156910458|FG001|Overall Study|Other-unspecified|3|||
48743013|NCT03600818|156910457|FG000|Overall Study|Randomized and not treated|0|||
48743014|NCT03600818|156910458|FG001|Overall Study|Randomized and not treated|1|||
48743015|NCT04930965|156910459|FG000|Overall Study|Lost to Follow-up|7|||
48743016|NCT04930965|156910460|FG001|Overall Study|Lost to Follow-up|5|||
48743017|NCT03478930|156910461|FG000|Overall Study|Adverse Event|0|||
48743018|NCT03478930|156910462|FG001|Overall Study|Adverse Event|1|||
48743019|NCT03478930|156910461|FG000|Overall Study|Lack of Efficacy|3|||
48743020|NCT03478930|156910462|FG001|Overall Study|Lack of Efficacy|3|||
48743021|NCT03478930|156910461|FG000|Overall Study|Withdrawal by Subject|6|||
48743022|NCT03478930|156910462|FG001|Overall Study|Withdrawal by Subject|5|||
48743023|NCT02590003|156910480|FG000|Overall Study|Death|1|||
48743024|NCT02590003|156910481|FG001|Overall Study|Death|2|||
48743025|NCT01091974|156910482|FG000|Overall Study|Did not start intervention|3|||
48743026|NCT01091974|156910483|FG001|Overall Study|Did not start intervention|1|||
48743027|NCT01091974|156910484|FG002|Overall Study|Did not start intervention|3|||
48743028|NCT01091974|156910485|FG003|Overall Study|Did not start intervention|1|||
48743029|NCT01091974|156910482|FG000|Overall Study|resumed sleep medication|0|||
48743030|NCT01091974|156910483|FG001|Overall Study|resumed sleep medication|0|||
48743031|NCT01091974|156910484|FG002|Overall Study|resumed sleep medication|1|||
48743032|NCT01091974|156910485|FG003|Overall Study|resumed sleep medication|2|||
48743033|NCT01091974|156910482|FG000|Overall Study|Withdrawal by Subject|1|||
48743034|NCT01091974|156910483|FG001|Overall Study|Withdrawal by Subject|3|||
48743035|NCT01091974|156910484|FG002|Overall Study|Withdrawal by Subject|2|||
48743036|NCT01091974|156910485|FG003|Overall Study|Withdrawal by Subject|2|||
48743037|NCT01091974|156910482|FG000|Overall Study|side-effects|1|||
48743038|NCT01091974|156910483|FG001|Overall Study|side-effects|1|||
48743039|NCT01091974|156910484|FG002|Overall Study|side-effects|0|||
48743040|NCT01091974|156910485|FG003|Overall Study|side-effects|2|||
48743041|NCT00555971|156910486|FG000|Overall Study|Adverse Event|1|||
48743042|NCT00555971|156910487|FG001|Overall Study|Adverse Event|1|||
48743043|NCT03334539|156910491|FG000|Overall Study|Adverse Event|3|||
48743044|NCT03334539|156910492|FG001|Overall Study|Adverse Event|5|||
48743045|NCT03334539|156910493|FG002|Overall Study|Adverse Event|0|||
48743046|NCT03334539|156910491|FG000|Overall Study|Withdrawal by Subject|0|||
48743047|NCT03334539|156910492|FG001|Overall Study|Withdrawal by Subject|1|||
48743048|NCT03334539|156910493|FG002|Overall Study|Withdrawal by Subject|1|||
48743049|NCT03334539|156910491|FG000|Overall Study|Administrative Reasons|1|||
48743050|NCT03334539|156910492|FG001|Overall Study|Administrative Reasons|0|||
48743051|NCT03334539|156910493|FG002|Overall Study|Administrative Reasons|0|||
48743052|NCT03334539|156910491|FG000|Overall Study|Hypertension Not Controlled|0|||
48743053|NCT03334539|156910492|FG001|Overall Study|Hypertension Not Controlled|1|||
48743054|NCT03334539|156910493|FG002|Overall Study|Hypertension Not Controlled|0|||
48743055|NCT00968201|156910494|FG000|Base Study - (Period II)|Adverse Event|8|||
48743056|NCT00968201|156910495|FG001|Base Study - (Period II)|Adverse Event|0|||
48743057|NCT00968201|156910496|FG002|Base Study - (Period II)|Adverse Event|16|||
48743058|NCT00968201|156910494|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
48720503|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
48720504|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
48720505|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
48720506|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
48720507|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
48720508|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
48720509|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
48720510|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
48720511|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
48720512|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
48720513|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
48720514|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
48720515|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
48720516|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
48720517|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
48720518|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
48720519|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
48720520|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
48720521|NCT01227824|156826659|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
48720522|NCT01227824|156826660|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
48720523|NCT01227824|156826661|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
48720524|NCT02694757|156826663|FG000|Overall Study|Lack of Efficacy|3|||
48720525|NCT00783302|156826666|FG000|Overall Study|Lost to Follow-up|17|||
48720526|NCT00783302|156826666|FG000|Overall Study|Technical Problems|11|||
48720527|NCT00783302|156826666|FG000|Overall Study|Protocol Violation|3|||
48720528|NCT00783302|156826666|FG000|Overall Study|Physician Decision|1|||
48720529|NCT00783302|156826666|FG000|Overall Study|Withdrawal by Subject|3|||
48720530|NCT03562767|156826670|FG000|Overall Study|Physician Decision|2|||
48720531|NCT03562767|156826671|FG001|Overall Study|Physician Decision|0|||
48720532|NCT03562767|156826672|FG002|Overall Study|Physician Decision|0|||
48720533|NCT03562767|156826670|FG000|Overall Study|Logistic Reason|1|||
48720534|NCT03562767|156826671|FG001|Overall Study|Logistic Reason|3|||
48720535|NCT03562767|156826672|FG002|Overall Study|Logistic Reason|0|||
48720536|NCT01589770|156826673|FG000|Overall Study|EGFR <60ml/min|6|||
48720537|NCT01589770|156826674|FG001|Overall Study|EGFR <60ml/min|4|||
48720538|NCT01589770|156826673|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
48720539|NCT01589770|156826674|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
48720540|NCT02048241|156826675|FG000|Overall Study|Withdrawal by Subject|0|||
48720541|NCT02048241|156826676|FG001|Overall Study|Withdrawal by Subject|1|||
48720542|NCT00402233|156826677|FG000|Overall Study|Adverse Event|1|||
48720543|NCT00402233|156826678|FG001|Overall Study|Adverse Event|7|||
48720544|NCT00402233|156826679|FG002|Overall Study|Adverse Event|9|||
48720545|NCT00402233|156826680|FG003|Overall Study|Adverse Event|9|||
48720546|NCT00402233|156826677|FG000|Overall Study|Protocol Violation|0|||
48500221|NCT00264797|156028082|FG000|Overall Study|Lost to Follow-up|9|||
48500222|NCT00264797|156028083|FG001|Overall Study|Lost to Follow-up|17|||
48720547|NCT00402233|156826678|FG001|Overall Study|Protocol Violation|1|||
48720548|NCT00402233|156826679|FG002|Overall Study|Protocol Violation|0|||
48720549|NCT00402233|156826680|FG003|Overall Study|Protocol Violation|0|||
48720550|NCT00402233|156826677|FG000|Overall Study|Withdrawal by Subject|2|||
48720551|NCT00402233|156826678|FG001|Overall Study|Withdrawal by Subject|1|||
48720552|NCT00402233|156826679|FG002|Overall Study|Withdrawal by Subject|2|||
48720553|NCT00402233|156826680|FG003|Overall Study|Withdrawal by Subject|2|||
48720554|NCT00402233|156826677|FG000|Overall Study|Worsening of disease under study|2|||
48720555|NCT00402233|156826678|FG001|Overall Study|Worsening of disease under study|0|||
48720556|NCT00402233|156826679|FG002|Overall Study|Worsening of disease under study|0|||
48720557|NCT00402233|156826680|FG003|Overall Study|Worsening of disease under study|0|||
48720558|NCT00402233|156826677|FG000|Overall Study|Worsening of other pre-existing disease|0|||
48720559|NCT00402233|156826678|FG001|Overall Study|Worsening of other pre-existing disease|1|||
48720560|NCT00402233|156826679|FG002|Overall Study|Worsening of other pre-existing disease|0|||
48720561|NCT00402233|156826680|FG003|Overall Study|Worsening of other pre-existing disease|0|||
48720562|NCT00927940|156826681|FG000|Overall Study|Death|1|||
48720563|NCT03007888|156826682|FG000|First Intervention (14 Days)|Adverse Event|1|||
48720564|NCT03007888|156826683|FG001|First Intervention (14 Days)|Adverse Event|0|||
48720565|NCT01658813|156826686|FG000|Overall Study|Disease progression|3|||
48720566|NCT02285062|156826692|FG000|Pre-Treatment Period|Protocol Violation|0|||
48720567|NCT02285062|156826693|FG001|Pre-Treatment Period|Protocol Violation|2|||
48720568|NCT02285062|156826692|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
48720569|NCT02285062|156826693|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
48720570|NCT01715129|156826694|FG000|Overall Study|Adverse Event, fatal|1|||
48500223|NCT00264797|156028082|FG000|Overall Study|Moved from area|3|||
48720571|NCT01715129|156826694|FG000|Overall Study|Lack of Efficacy|3|||
48720572|NCT01715129|156826694|FG000|Overall Study|Protocol Violation|1|||
48720573|NCT01715129|156826694|FG000|Overall Study|Consent Withdrawn|2|||
48720574|NCT01715129|156826694|FG000|Overall Study|Lost to Follow-up|1|||
48720575|NCT01715129|156826694|FG000|Overall Study|Other|1|||
48720576|NCT01101191|156826697|FG000|Period 1|Withdrawal by Subject|1|||
48720577|NCT01101191|156826698|FG001|Period 1|Withdrawal by Subject|0|||
48720578|NCT01101191|156826697|FG000|Period 1|Adverse Event|1|||
48720579|NCT01101191|156826698|FG001|Period 1|Adverse Event|2|||
48720580|NCT03044574|156826699|FG000|Overall Study|Lost to Follow-up|37|||
48720581|NCT03044574|156826700|FG001|Overall Study|Lost to Follow-up|45|||
48720582|NCT00890045|156826701|FG000|Overall Study|Death|0|||
48720583|NCT00890045|156826702|FG001|Overall Study|Death|1|||
48720584|NCT00890045|156826701|FG000|Overall Study|Did not receive HeRO Graft|0|||
48720585|NCT00890045|156826702|FG001|Overall Study|Did not receive HeRO Graft|2|||
48720586|NCT00890045|156826701|FG000|Overall Study|Lost to Follow-up|5|||
48720587|NCT00890045|156826702|FG001|Overall Study|Lost to Follow-up|7|||
48720588|NCT03985878|156826715|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
48720589|NCT03985878|156826715|FG000|Overall Study|Study Terminated by Sponsor|12|||
48720590|NCT03985878|156826715|FG000|Overall Study|Withdrawal by Subject|1|||
48720591|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
48720592|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
48720593|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
48720594|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
48720595|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
48720596|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
48720597|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
48500224|NCT00264797|156028083|FG001|Overall Study|Moved from area|1|||
48500225|NCT00264797|156028082|FG000|Overall Study|Practical Problems|2|||
48500226|NCT00264797|156028083|FG001|Overall Study|Practical Problems|3|||
48500227|NCT00264797|156028082|FG000|Overall Study|Incarceration|4|||
48500228|NCT00264797|156028083|FG001|Overall Study|Incarceration|5|||
48500229|NCT00264797|156028082|FG000|Overall Study|Pressure/advice from Outsiders|1|||
48500230|NCT00264797|156028083|FG001|Overall Study|Pressure/advice from Outsiders|1|||
48500231|NCT00264797|156028082|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
48500232|NCT00264797|156028083|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
48500233|NCT00264797|156028082|FG000|Overall Study|Other|3|||
48815748|NCT04642469|157167427|FG000|Overall Study|Withdrawal by Subject|1|||
48815749|NCT04642469|157167428|FG001|Overall Study|Withdrawal by Subject|0|||
48815750|NCT03050398|157167429|FG000|Overall Study|Study terminated by sponsor|8|||
48815751|NCT02733042|157167430|FG000|Overall Study|Adverse Event|1|||
48815752|NCT02733042|157167431|FG001|Overall Study|Adverse Event|0|||
48815753|NCT02733042|157167432|FG002|Overall Study|Adverse Event|1|||
48815754|NCT02733042|157167433|FG003|Overall Study|Adverse Event|1|||
48815755|NCT02733042|157167434|FG004|Overall Study|Adverse Event|0|||
48815756|NCT02733042|157167435|FG005|Overall Study|Adverse Event|0|||
48815757|NCT02733042|157167436|FG006|Overall Study|Adverse Event|0|||
48815758|NCT02733042|157167437|FG007|Overall Study|Adverse Event|0|||
48815759|NCT02733042|157167438|FG008|Overall Study|Adverse Event|0|||
48815760|NCT02733042|157167439|FG009|Overall Study|Adverse Event|0|||
48815761|NCT02733042|157167440|FG010|Overall Study|Adverse Event|2|||
48815762|NCT02733042|157167441|FG011|Overall Study|Adverse Event|2|||
48815763|NCT02733042|157167442|FG012|Overall Study|Adverse Event|0|||
48815764|NCT02733042|157167443|FG013|Overall Study|Adverse Event|2|||
48815765|NCT02733042|157167444|FG014|Overall Study|Adverse Event|0|||
48815766|NCT02733042|157167445|FG015|Overall Study|Adverse Event|0|||
48815767|NCT02733042|157167446|FG016|Overall Study|Adverse Event|0|||
48815768|NCT02733042|157167447|FG017|Overall Study|Adverse Event|1|||
48815769|NCT02733042|157167448|FG018|Overall Study|Adverse Event|0|||
48815770|NCT02733042|157167430|FG000|Overall Study|Progressive Disease|2|||
48815771|NCT02733042|157167431|FG001|Overall Study|Progressive Disease|1|||
48720598|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
48720599|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
48720600|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
48500234|NCT00264797|156028083|FG001|Overall Study|Other|4|||
48720601|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
48720602|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
48500235|NCT00048048|156028084|FG000|Core Treatment|Withdrawal by Subject|0|||
48720603|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
48815772|NCT02733042|157167432|FG002|Overall Study|Progressive Disease|3|||
48815773|NCT02733042|157167433|FG003|Overall Study|Progressive Disease|1|||
48815774|NCT02733042|157167434|FG004|Overall Study|Progressive Disease|2|||
48720604|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
48815775|NCT02733042|157167435|FG005|Overall Study|Progressive Disease|3|||
48815776|NCT02733042|157167436|FG006|Overall Study|Progressive Disease|0|||
48720605|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
48815777|NCT02733042|157167437|FG007|Overall Study|Progressive Disease|3|||
48815778|NCT02733042|157167438|FG008|Overall Study|Progressive Disease|3|||
48500236|NCT00048048|156028085|FG001|Core Treatment|Withdrawal by Subject|0|||
48500237|NCT00048048|156028086|FG002|Core Treatment|Withdrawal by Subject|1|||
48500238|NCT00048048|156028087|FG003|Core Treatment|Withdrawal by Subject|0|||
48500239|NCT00048048|156028088|FG004|Core Treatment|Withdrawal by Subject|0|||
48500240|NCT00048048|156028089|FG005|Core Treatment|Withdrawal by Subject|0|||
48500241|NCT00048048|156028090|FG006|Core Treatment|Withdrawal by Subject|0|||
48500242|NCT00048048|156028091|FG007|Core Treatment|Withdrawal by Subject|0|||
48500243|NCT00048048|156028092|FG008|Core Treatment|Withdrawal by Subject|0|||
48500244|NCT00048048|156028093|FG009|Core Treatment|Withdrawal by Subject|0|||
48500245|NCT00048048|156028094|FG010|Core Treatment|Withdrawal by Subject|0|||
48500246|NCT00048048|156028095|FG011|Core Treatment|Withdrawal by Subject|0|||
48500247|NCT00048048|156028084|FG000|Core Treatment|Adverse Event|0|||
48500248|NCT00048048|156028085|FG001|Core Treatment|Adverse Event|0|||
48720606|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
48720607|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
48720608|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
48720609|NCT00591578|156826716|FG000|Double-Blind Treatment Phase|Other|4|||
48720610|NCT00591578|156826717|FG001|Double-Blind Treatment Phase|Other|9|||
48720611|NCT00591578|156826718|FG002|Double-Blind Treatment Phase|Other|4|||
48720612|NCT00591578|156826716|FG000|Open-Label Extension Phase|Adverse Event|3|||
48720613|NCT00591578|156826717|FG001|Open-Label Extension Phase|Adverse Event|5|||
48720614|NCT00591578|156826718|FG002|Open-Label Extension Phase|Adverse Event|0|||
48720615|NCT00591578|156826716|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
48720616|NCT00591578|156826717|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
48720617|NCT00591578|156826718|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
48720618|NCT00591578|156826716|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
48720619|NCT00591578|156826717|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
48720620|NCT00591578|156826718|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
48720621|NCT00591578|156826716|FG000|Open-Label Extension Phase|Other|1|||
48720622|NCT00591578|156826717|FG001|Open-Label Extension Phase|Other|0|||
48720623|NCT00591578|156826718|FG002|Open-Label Extension Phase|Other|0|||
48720624|NCT04738318|156826719|FG000|Overall Study|Protocol Violation|1|||
48720625|NCT04738318|156826720|FG001|Overall Study|Protocol Violation|0|||
48720626|NCT02119676|156826723|FG000|Overall Study|Adverse Event|9|||
48500249|NCT00048048|156028086|FG002|Core Treatment|Adverse Event|0|||
48500250|NCT00048048|156028087|FG003|Core Treatment|Adverse Event|0|||
48500251|NCT00048048|156028088|FG004|Core Treatment|Adverse Event|0|||
48500252|NCT00048048|156028089|FG005|Core Treatment|Adverse Event|0|||
48500253|NCT00048048|156028090|FG006|Core Treatment|Adverse Event|0|||
48500254|NCT00048048|156028091|FG007|Core Treatment|Adverse Event|1|||
48500255|NCT00048048|156028092|FG008|Core Treatment|Adverse Event|0|||
48500256|NCT00048048|156028093|FG009|Core Treatment|Adverse Event|0|||
48500257|NCT00048048|156028094|FG010|Core Treatment|Adverse Event|0|||
48500258|NCT00048048|156028095|FG011|Core Treatment|Adverse Event|0|||
48720627|NCT02119676|156826724|FG001|Overall Study|Adverse Event|17|||
48720628|NCT02119676|156826725|FG002|Overall Study|Adverse Event|10|||
48720629|NCT02119676|156826726|FG003|Overall Study|Adverse Event|10|||
48720630|NCT02119676|156826723|FG000|Overall Study|Disease progression|53|||
48720631|NCT02119676|156826724|FG001|Overall Study|Disease progression|55|||
48720632|NCT02119676|156826725|FG002|Overall Study|Disease progression|68|||
48720633|NCT02119676|156826726|FG003|Overall Study|Disease progression|73|||
48720634|NCT02119676|156826723|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
48720635|NCT02119676|156826724|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
48720636|NCT02119676|156826725|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
48720637|NCT02119676|156826726|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
48720638|NCT02119676|156826723|FG000|Overall Study|Physician Decision|4|||
48720639|NCT02119676|156826724|FG001|Overall Study|Physician Decision|2|||
48720640|NCT02119676|156826725|FG002|Overall Study|Physician Decision|3|||
48720641|NCT02119676|156826726|FG003|Overall Study|Physician Decision|2|||
48720642|NCT02119676|156826723|FG000|Overall Study|Death|9|||
48720643|NCT02119676|156826724|FG001|Overall Study|Death|3|||
48720644|NCT02119676|156826725|FG002|Overall Study|Death|2|||
48720645|NCT02119676|156826726|FG003|Overall Study|Death|1|||
48720646|NCT02119676|156826723|FG000|Overall Study|Noncompliance|0|||
48720647|NCT02119676|156826724|FG001|Overall Study|Noncompliance|1|||
48720648|NCT02119676|156826725|FG002|Overall Study|Noncompliance|0|||
48720649|NCT02119676|156826726|FG003|Overall Study|Noncompliance|0|||
48720650|NCT02119676|156826723|FG000|Overall Study|Lost to Follow-up|0|||
48720651|NCT02119676|156826724|FG001|Overall Study|Lost to Follow-up|0|||
48500259|NCT00048048|156028084|FG000|Extension Year 1|Early withdrawals|0|||
48500260|NCT00048048|156028085|FG001|Extension Year 1|Early withdrawals|0|||
48500261|NCT00048048|156028086|FG002|Extension Year 1|Early withdrawals|0|||
48500262|NCT00048048|156028087|FG003|Extension Year 1|Early withdrawals|0|||
48500263|NCT00048048|156028088|FG004|Extension Year 1|Early withdrawals|0|||
48720652|NCT02119676|156826725|FG002|Overall Study|Lost to Follow-up|1|||
48720653|NCT02119676|156826726|FG003|Overall Study|Lost to Follow-up|0|||
48720654|NCT02119676|156826723|FG000|Overall Study|Protocol deviation|0|||
48720655|NCT02119676|156826724|FG001|Overall Study|Protocol deviation|0|||
48720656|NCT02119676|156826725|FG002|Overall Study|Protocol deviation|1|||
48720657|NCT02119676|156826726|FG003|Overall Study|Protocol deviation|0|||
48720658|NCT02119676|156826723|FG000|Overall Study|Other, unspecified|2|||
48720659|NCT02119676|156826724|FG001|Overall Study|Other, unspecified|1|||
48720660|NCT02119676|156826725|FG002|Overall Study|Other, unspecified|3|||
48720661|NCT02119676|156826726|FG003|Overall Study|Other, unspecified|4|||
48720662|NCT02119676|156826723|FG000|Overall Study|Did not receive study med|2|||
48720663|NCT02119676|156826724|FG001|Overall Study|Did not receive study med|2|||
48720664|NCT02119676|156826725|FG002|Overall Study|Did not receive study med|4|||
48720665|NCT02119676|156826726|FG003|Overall Study|Did not receive study med|5|||
48720666|NCT01426789|156826729|FG000|Part 1|Protocol deviation|0|||
48720667|NCT01426789|156826730|FG001|Part 1|Protocol deviation|1|||
48720668|NCT01426789|156826731|FG002|Part 1|Protocol deviation|0|||
48720669|NCT01426789|156826732|FG003|Part 1|Protocol deviation|0|||
48720670|NCT01426789|156826733|FG004|Part 1|Protocol deviation|0|||
48815779|NCT02733042|157167439|FG009|Overall Study|Progressive Disease|2|||
48815780|NCT02733042|157167440|FG010|Overall Study|Progressive Disease|2|||
48815781|NCT02733042|157167441|FG011|Overall Study|Progressive Disease|2|||
48815782|NCT02733042|157167442|FG012|Overall Study|Progressive Disease|8|||
48815783|NCT02733042|157167443|FG013|Overall Study|Progressive Disease|1|||
48815784|NCT02733042|157167444|FG014|Overall Study|Progressive Disease|4|||
48815785|NCT02733042|157167445|FG015|Overall Study|Progressive Disease|7|||
48815786|NCT02733042|157167446|FG016|Overall Study|Progressive Disease|2|||
48815787|NCT02733042|157167447|FG017|Overall Study|Progressive Disease|3|||
48815788|NCT02733042|157167448|FG018|Overall Study|Progressive Disease|4|||
48815789|NCT02733042|157167430|FG000|Overall Study|Withdrawal by Subject|0|||
48815790|NCT02733042|157167431|FG001|Overall Study|Withdrawal by Subject|1|||
48815791|NCT02733042|157167432|FG002|Overall Study|Withdrawal by Subject|2|||
48815792|NCT02733042|157167433|FG003|Overall Study|Withdrawal by Subject|1|||
48815793|NCT02733042|157167434|FG004|Overall Study|Withdrawal by Subject|1|||
48815794|NCT02733042|157167435|FG005|Overall Study|Withdrawal by Subject|0|||
48815795|NCT02733042|157167436|FG006|Overall Study|Withdrawal by Subject|0|||
48815796|NCT02733042|157167437|FG007|Overall Study|Withdrawal by Subject|0|||
48815797|NCT02733042|157167438|FG008|Overall Study|Withdrawal by Subject|1|||
48815798|NCT02733042|157167439|FG009|Overall Study|Withdrawal by Subject|1|||
48815799|NCT02733042|157167440|FG010|Overall Study|Withdrawal by Subject|0|||
48815800|NCT02733042|157167441|FG011|Overall Study|Withdrawal by Subject|2|||
48815801|NCT02733042|157167442|FG012|Overall Study|Withdrawal by Subject|1|||
48815802|NCT02733042|157167443|FG013|Overall Study|Withdrawal by Subject|1|||
48815803|NCT02733042|157167444|FG014|Overall Study|Withdrawal by Subject|0|||
48815804|NCT02733042|157167445|FG015|Overall Study|Withdrawal by Subject|0|||
48815805|NCT02733042|157167446|FG016|Overall Study|Withdrawal by Subject|0|||
48815806|NCT02733042|157167447|FG017|Overall Study|Withdrawal by Subject|0|||
48815807|NCT02733042|157167448|FG018|Overall Study|Withdrawal by Subject|0|||
48815808|NCT02733042|157167430|FG000|Overall Study|Other Reasons|0|||
48815809|NCT02733042|157167431|FG001|Overall Study|Other Reasons|0|||
48815810|NCT02733042|157167432|FG002|Overall Study|Other Reasons|1|||
48815811|NCT02733042|157167433|FG003|Overall Study|Other Reasons|0|||
48815812|NCT02733042|157167434|FG004|Overall Study|Other Reasons|0|||
48815813|NCT02733042|157167435|FG005|Overall Study|Other Reasons|0|||
48815814|NCT02733042|157167436|FG006|Overall Study|Other Reasons|0|||
48815815|NCT02733042|157167437|FG007|Overall Study|Other Reasons|0|||
48815816|NCT02733042|157167438|FG008|Overall Study|Other Reasons|0|||
48815817|NCT02733042|157167439|FG009|Overall Study|Other Reasons|1|||
48815818|NCT02733042|157167440|FG010|Overall Study|Other Reasons|1|||
48815819|NCT02733042|157167441|FG011|Overall Study|Other Reasons|0|||
48815820|NCT02733042|157167442|FG012|Overall Study|Other Reasons|0|||
48815821|NCT02733042|157167443|FG013|Overall Study|Other Reasons|0|||
48815822|NCT02733042|157167444|FG014|Overall Study|Other Reasons|0|||
48815823|NCT02733042|157167445|FG015|Overall Study|Other Reasons|1|||
48815824|NCT02733042|157167446|FG016|Overall Study|Other Reasons|0|||
48815825|NCT02733042|157167447|FG017|Overall Study|Other Reasons|1|||
48815826|NCT02733042|157167448|FG018|Overall Study|Other Reasons|0|||
48500264|NCT00048048|156028089|FG005|Extension Year 1|Early withdrawals|0|||
48500265|NCT00048048|156028090|FG006|Extension Year 1|Early withdrawals|0|||
48720671|NCT01426789|156826734|FG005|Part 1|Protocol deviation|0|||
48720672|NCT01426789|156826729|FG000|Part 1|Lost to Follow-up|1|||
48815827|NCT02733042|157167430|FG000|Overall Study|Death|0|||
48720673|NCT01426789|156826730|FG001|Part 1|Lost to Follow-up|2|||
48720674|NCT01426789|156826731|FG002|Part 1|Lost to Follow-up|0|||
48720675|NCT01426789|156826732|FG003|Part 1|Lost to Follow-up|0|||
48720676|NCT01426789|156826733|FG004|Part 1|Lost to Follow-up|0|||
48720677|NCT01426789|156826734|FG005|Part 1|Lost to Follow-up|0|||
48815828|NCT02733042|157167431|FG001|Overall Study|Death|0|||
48815829|NCT02733042|157167432|FG002|Overall Study|Death|0|||
48815830|NCT02733042|157167433|FG003|Overall Study|Death|0|||
48815831|NCT02733042|157167434|FG004|Overall Study|Death|0|||
48815832|NCT02733042|157167435|FG005|Overall Study|Death|0|||
48815833|NCT02733042|157167436|FG006|Overall Study|Death|1|||
48720678|NCT01426789|156826729|FG000|Part 1|Lack of Efficacy|2|||
48720679|NCT01426789|156826730|FG001|Part 1|Lack of Efficacy|1|||
48720680|NCT01426789|156826731|FG002|Part 1|Lack of Efficacy|0|||
48720681|NCT01426789|156826732|FG003|Part 1|Lack of Efficacy|0|||
48720682|NCT01426789|156826733|FG004|Part 1|Lack of Efficacy|0|||
48720683|NCT01426789|156826734|FG005|Part 1|Lack of Efficacy|0|||
48720684|NCT01426789|156826729|FG000|Part 1|Adverse Event|3|||
48720685|NCT01426789|156826730|FG001|Part 1|Adverse Event|0|||
48720686|NCT01426789|156826731|FG002|Part 1|Adverse Event|0|||
48720687|NCT01426789|156826732|FG003|Part 1|Adverse Event|0|||
48720688|NCT01426789|156826733|FG004|Part 1|Adverse Event|0|||
48720689|NCT01426789|156826734|FG005|Part 1|Adverse Event|0|||
48500266|NCT00048048|156028091|FG007|Extension Year 1|Early withdrawals|0|||
48500267|NCT00048048|156028092|FG008|Extension Year 1|Early withdrawals|0|||
48500268|NCT00048048|156028093|FG009|Extension Year 1|Early withdrawals|2|||
48500269|NCT00048048|156028094|FG010|Extension Year 1|Early withdrawals|2|||
48500270|NCT00048048|156028095|FG011|Extension Year 1|Early withdrawals|4|||
48500271|NCT00048048|156028084|FG000|Extension Year 2|Early withdrawals|0|||
48500272|NCT00048048|156028085|FG001|Extension Year 2|Early withdrawals|0|||
48500273|NCT00048048|156028086|FG002|Extension Year 2|Early withdrawals|0|||
48500274|NCT00048048|156028087|FG003|Extension Year 2|Early withdrawals|0|||
48500275|NCT00048048|156028088|FG004|Extension Year 2|Early withdrawals|0|||
48500276|NCT00048048|156028089|FG005|Extension Year 2|Early withdrawals|0|||
48500277|NCT00048048|156028090|FG006|Extension Year 2|Early withdrawals|0|||
48500278|NCT00048048|156028091|FG007|Extension Year 2|Early withdrawals|0|||
48500279|NCT00048048|156028092|FG008|Extension Year 2|Early withdrawals|0|||
48815834|NCT02733042|157167437|FG007|Overall Study|Death|0|||
48815835|NCT02733042|157167438|FG008|Overall Study|Death|1|||
48815836|NCT02733042|157167439|FG009|Overall Study|Death|0|||
48815837|NCT02733042|157167440|FG010|Overall Study|Death|1|||
48815838|NCT02733042|157167441|FG011|Overall Study|Death|0|||
48815839|NCT02733042|157167442|FG012|Overall Study|Death|0|||
48815840|NCT02733042|157167443|FG013|Overall Study|Death|0|||
48815841|NCT02733042|157167444|FG014|Overall Study|Death|1|||
48815842|NCT02733042|157167445|FG015|Overall Study|Death|2|||
48815843|NCT02733042|157167446|FG016|Overall Study|Death|0|||
48815844|NCT02733042|157167447|FG017|Overall Study|Death|0|||
48815845|NCT02733042|157167448|FG018|Overall Study|Death|0|||
48500280|NCT00048048|156028093|FG009|Extension Year 2|Early withdrawals|0|||
48500281|NCT00048048|156028094|FG010|Extension Year 2|Early withdrawals|4|||
48815846|NCT03688711|157167451|FG000|Overall Study|Withdrawal by Subject|0|||
48815847|NCT03688711|157167452|FG001|Overall Study|Withdrawal by Subject|1|||
48815848|NCT00873093|157167453|FG000|Overall Study|Adverse Event|0|||
48815849|NCT00873093|157167454|FG001|Overall Study|Adverse Event|2|||
48815850|NCT00873093|157167455|FG002|Overall Study|Adverse Event|0|||
48815851|NCT00873093|157167456|FG003|Overall Study|Adverse Event|0|||
48815852|NCT00873093|157167457|FG004|Overall Study|Adverse Event|0|||
48815853|NCT00873093|157167453|FG000|Overall Study|Death|0|||
48815854|NCT00873093|157167454|FG001|Overall Study|Death|3|||
48815855|NCT00873093|157167455|FG002|Overall Study|Death|2|||
48815856|NCT00873093|157167456|FG003|Overall Study|Death|0|||
48815857|NCT00873093|157167457|FG004|Overall Study|Death|0|||
48815858|NCT00873093|157167453|FG000|Overall Study|Physician Decision|0|||
48815859|NCT00873093|157167454|FG001|Overall Study|Physician Decision|17|||
48815860|NCT00873093|157167455|FG002|Overall Study|Physician Decision|10|||
48815861|NCT00873093|157167456|FG003|Overall Study|Physician Decision|10|||
48815862|NCT00873093|157167457|FG004|Overall Study|Physician Decision|2|||
48500282|NCT00048048|156028095|FG011|Extension Year 2|Early withdrawals|2|||
48720690|NCT01426789|156826729|FG000|Part 2|Protocol deviation|0|||
48720691|NCT01426789|156826730|FG001|Part 2|Protocol deviation|0|||
48720692|NCT01426789|156826731|FG002|Part 2|Protocol deviation|1|||
48720693|NCT01426789|156826732|FG003|Part 2|Protocol deviation|0|||
48815863|NCT00873093|157167453|FG000|Overall Study|Withdrawal by Subject|1|||
48815864|NCT00873093|157167454|FG001|Overall Study|Withdrawal by Subject|4|||
48815865|NCT00873093|157167455|FG002|Overall Study|Withdrawal by Subject|4|||
48815866|NCT00873093|157167456|FG003|Overall Study|Withdrawal by Subject|0|||
48500283|NCT03992196|156028096|FG000|Enrollment|lost to follow-up prior dosing|1|||
48500284|NCT03992196|156028097|FG001|Enrollment|lost to follow-up prior dosing|0|||
48500285|NCT03992196|156028098|FG002|Enrollment|lost to follow-up prior dosing|0|||
48500286|NCT03992196|156028096|FG000|Treatment|Protocol Violation|0|||
48720694|NCT01426789|156826733|FG004|Part 2|Protocol deviation|0|||
48720695|NCT01426789|156826734|FG005|Part 2|Protocol deviation|0|||
48720696|NCT01426789|156826729|FG000|Part 2|Death|0|||
48815867|NCT00873093|157167457|FG004|Overall Study|Withdrawal by Subject|0|||
48815868|NCT00873093|157167453|FG000|Overall Study|Ineligible|0|||
48815869|NCT00873093|157167454|FG001|Overall Study|Ineligible|1|||
48815870|NCT00873093|157167455|FG002|Overall Study|Ineligible|0|||
48815871|NCT00873093|157167456|FG003|Overall Study|Ineligible|1|||
48815872|NCT00873093|157167457|FG004|Overall Study|Ineligible|0|||
48815873|NCT01556763|157167465|FG000|Overall Study|Withdrawal by Subject|0|||
48815874|NCT01556763|157167466|FG001|Overall Study|Withdrawal by Subject|1|||
48815875|NCT01556763|157167467|FG002|Overall Study|Withdrawal by Subject|0|||
48815876|NCT02243631|157168508|FG000|Overall Study|no synovial fluid on second aspirate|0|||
48815877|NCT02243631|157168509|FG001|Overall Study|no synovial fluid on second aspirate|1|||
48815878|NCT02105636|157168514|FG000|Pre-Treatment|Disease Progression|1|||
48815879|NCT02105636|157168515|FG001|Pre-Treatment|Disease Progression|0|||
48815880|NCT02105636|157168514|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
48815881|NCT02105636|157168515|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
48815882|NCT02105636|157168514|FG000|Pre-Treatment|Participant withdrew consent|0|||
48815883|NCT02105636|157168515|FG001|Pre-Treatment|Participant withdrew consent|6|||
48815884|NCT02105636|157168514|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
48815885|NCT02105636|157168515|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
48815886|NCT02105636|157168514|FG000|Treatment|Study Drug Toxicity|14|||
48815887|NCT02105636|157168515|FG001|Treatment|Study Drug Toxicity|10|||
48815888|NCT02105636|157168514|FG000|Treatment|Adverse event unrelated to study drug|19|||
48815889|NCT02105636|157168515|FG001|Treatment|Adverse event unrelated to study drug|3|||
48815890|NCT02105636|157168514|FG000|Treatment|Participant request to discontinue study treatment|8|||
48815891|NCT02105636|157168515|FG001|Treatment|Participant request to discontinue study treatment|6|||
48815892|NCT02105636|157168514|FG000|Treatment|Participant withdrew consent|5|||
48815893|NCT02105636|157168515|FG001|Treatment|Participant withdrew consent|1|||
48815894|NCT02105636|157168514|FG000|Treatment|Lost to Follow-up|1|||
48815895|NCT02105636|157168515|FG001|Treatment|Lost to Follow-up|0|||
48815896|NCT02105636|157168514|FG000|Treatment|Maximum Clinical Benefit|1|||
48815897|NCT02105636|157168515|FG001|Treatment|Maximum Clinical Benefit|3|||
48815898|NCT02105636|157168514|FG000|Treatment|Poor/Non-compliance|0|||
48815899|NCT02105636|157168515|FG001|Treatment|Poor/Non-compliance|1|||
48815900|NCT02105636|157168514|FG000|Treatment|Participant no longer meets study criteria|1|||
48815901|NCT02105636|157168515|FG001|Treatment|Participant no longer meets study criteria|0|||
48815902|NCT02105636|157168514|FG000|Treatment|Other reasons|1|||
48815903|NCT02105636|157168515|FG001|Treatment|Other reasons|0|||
48815904|NCT02105636|157168514|FG000|Treatment|Disease Progression|185|||
48815905|NCT02105636|157168515|FG001|Treatment|Disease Progression|87|||
48815906|NCT03722264|157168517|FG000|Overall Study|Physician Decision|3|||
48815907|NCT01995357|157168518|FG000|Period 5|Lack of Efficacy|1|||
48815908|NCT01995357|157168519|FG001|Period 5|Lack of Efficacy|0|||
48815909|NCT01995357|157168520|FG002|Period 5|Lack of Efficacy|0|||
48815910|NCT01995357|157168521|FG003|Period 5|Lack of Efficacy|0|||
48815911|NCT01995357|157168522|FG004|Period 5|Lack of Efficacy|0|||
48815912|NCT01995357|157168523|FG005|Period 5|Lack of Efficacy|0|||
48815913|NCT01995357|157168518|FG000|Period 5|Adverse Event|1|||
48815914|NCT01995357|157168519|FG001|Period 5|Adverse Event|0|||
48815915|NCT01995357|157168520|FG002|Period 5|Adverse Event|1|||
48815916|NCT01995357|157168521|FG003|Period 5|Adverse Event|0|||
48815917|NCT01995357|157168522|FG004|Period 5|Adverse Event|0|||
48815918|NCT01995357|157168523|FG005|Period 5|Adverse Event|0|||
48815919|NCT01807221|157168524|FG000|Overall Study|Progressive disease|1|||
48815920|NCT01807221|157168525|FG001|Overall Study|Progressive disease|0|||
48815921|NCT01807221|157168526|FG002|Overall Study|Progressive disease|1|||
48815922|NCT01807221|157168527|FG003|Overall Study|Progressive disease|0|||
48815923|NCT01807221|157168528|FG004|Overall Study|Progressive disease|0|||
48815924|NCT01807221|157168529|FG005|Overall Study|Progressive disease|0|||
48815925|NCT01807221|157168524|FG000|Overall Study|Death|7|||
48815926|NCT01807221|157168525|FG001|Overall Study|Death|9|||
48815927|NCT01807221|157168526|FG002|Overall Study|Death|4|||
48815928|NCT01807221|157168527|FG003|Overall Study|Death|2|||
48815929|NCT01807221|157168528|FG004|Overall Study|Death|1|||
48815930|NCT01807221|157168529|FG005|Overall Study|Death|6|||
48815931|NCT01807221|157168524|FG000|Overall Study|Physician Decision|2|||
48815932|NCT01807221|157168525|FG001|Overall Study|Physician Decision|1|||
48815933|NCT01807221|157168526|FG002|Overall Study|Physician Decision|0|||
48815934|NCT01807221|157168527|FG003|Overall Study|Physician Decision|0|||
48815935|NCT01807221|157168528|FG004|Overall Study|Physician Decision|0|||
48815936|NCT01807221|157168529|FG005|Overall Study|Physician Decision|0|||
48815937|NCT01807221|157168524|FG000|Overall Study|Adverse Event|33|||
48815938|NCT01807221|157168525|FG001|Overall Study|Adverse Event|22|||
48815939|NCT01807221|157168526|FG002|Overall Study|Adverse Event|26|||
48815940|NCT01807221|157168527|FG003|Overall Study|Adverse Event|25|||
48815941|NCT01807221|157168528|FG004|Overall Study|Adverse Event|18|||
48815942|NCT01807221|157168529|FG005|Overall Study|Adverse Event|21|||
48815943|NCT01807221|157168524|FG000|Overall Study|Protocol Violation|0|||
48815944|NCT01807221|157168525|FG001|Overall Study|Protocol Violation|2|||
48815945|NCT01807221|157168526|FG002|Overall Study|Protocol Violation|1|||
48815946|NCT01807221|157168527|FG003|Overall Study|Protocol Violation|2|||
48815947|NCT01807221|157168528|FG004|Overall Study|Protocol Violation|0|||
48815948|NCT01807221|157168529|FG005|Overall Study|Protocol Violation|1|||
48815949|NCT01807221|157168524|FG000|Overall Study|Non-compliance|1|||
48815950|NCT01807221|157168525|FG001|Overall Study|Non-compliance|2|||
48815951|NCT01807221|157168526|FG002|Overall Study|Non-compliance|0|||
48815952|NCT01807221|157168527|FG003|Overall Study|Non-compliance|1|||
48815953|NCT01807221|157168528|FG004|Overall Study|Non-compliance|0|||
48815954|NCT01807221|157168529|FG005|Overall Study|Non-compliance|0|||
48500287|NCT03992196|156028097|FG001|Treatment|Protocol Violation|0|||
48500288|NCT03992196|156028098|FG002|Treatment|Protocol Violation|1|||
48500289|NCT03992196|156028096|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
48815955|NCT01807221|157168524|FG000|Overall Study|Logistical difficulties|0|||
48815956|NCT01807221|157168525|FG001|Overall Study|Logistical difficulties|1|||
48815957|NCT01807221|157168526|FG002|Overall Study|Logistical difficulties|0|||
48815958|NCT01807221|157168527|FG003|Overall Study|Logistical difficulties|0|||
48815959|NCT01807221|157168528|FG004|Overall Study|Logistical difficulties|1|||
48815960|NCT01807221|157168529|FG005|Overall Study|Logistical difficulties|0|||
48815961|NCT01807221|157168524|FG000|Overall Study|Withdrawal by Subject|33|||
48815962|NCT01807221|157168525|FG001|Overall Study|Withdrawal by Subject|15|||
48815963|NCT01807221|157168526|FG002|Overall Study|Withdrawal by Subject|8|||
48815964|NCT01807221|157168527|FG003|Overall Study|Withdrawal by Subject|14|||
48815965|NCT01807221|157168528|FG004|Overall Study|Withdrawal by Subject|16|||
48815966|NCT01807221|157168529|FG005|Overall Study|Withdrawal by Subject|13|||
48815967|NCT01807221|157168524|FG000|Overall Study|Sponsor decision|2|||
48815968|NCT01807221|157168525|FG001|Overall Study|Sponsor decision|0|||
48815969|NCT01807221|157168526|FG002|Overall Study|Sponsor decision|1|||
48815970|NCT01807221|157168527|FG003|Overall Study|Sponsor decision|1|||
48815971|NCT01807221|157168528|FG004|Overall Study|Sponsor decision|0|||
48815972|NCT01807221|157168529|FG005|Overall Study|Sponsor decision|0|||
48815973|NCT01807221|157168524|FG000|Overall Study|Lost to Follow-up|1|||
48500290|NCT03992196|156028097|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
48500291|NCT03992196|156028098|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
48500292|NCT03992196|156028096|FG000|Treatment|Withdrawal due to non-compliance|0|||
48500293|NCT03992196|156028097|FG001|Treatment|Withdrawal due to non-compliance|0|||
48815974|NCT01807221|157168525|FG001|Overall Study|Lost to Follow-up|0|||
48815975|NCT01807221|157168526|FG002|Overall Study|Lost to Follow-up|2|||
48500294|NCT03992196|156028098|FG002|Treatment|Withdrawal due to non-compliance|1|||
48500295|NCT03992196|156028096|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
48500296|NCT03992196|156028097|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
48500297|NCT03992196|156028098|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
48500298|NCT03992196|156028096|FG000|Treatment|Withdrawal by parent/guardian|0|||
48500299|NCT03992196|156028097|FG001|Treatment|Withdrawal by parent/guardian|0|||
48500300|NCT03992196|156028098|FG002|Treatment|Withdrawal by parent/guardian|2|||
48500301|NCT02684578|156028101|FG000|Overall Study|Withdrawal by Subject|10|||
48500302|NCT02684578|156028102|FG001|Overall Study|Withdrawal by Subject|7|||
48500303|NCT02684578|156028101|FG000|Overall Study|Lost to Follow-up|0|||
48500304|NCT02684578|156028102|FG001|Overall Study|Lost to Follow-up|3|||
48500305|NCT02684578|156028101|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
48500306|NCT02684578|156028102|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
48500307|NCT02684578|156028101|FG000|Overall Study|Missing follow-up data|0|||
48500308|NCT02684578|156028102|FG001|Overall Study|Missing follow-up data|1|||
48500309|NCT01505530|156028104|FG000|Overall Study|Progressive Disease|19|||
48500310|NCT01505530|156028105|FG001|Overall Study|Progressive Disease|17|||
48500311|NCT01505530|156028106|FG002|Overall Study|Progressive Disease|18|||
48500312|NCT01505530|156028104|FG000|Overall Study|Adverse Event|1|||
48500313|NCT01505530|156028105|FG001|Overall Study|Adverse Event|1|||
48500314|NCT01505530|156028106|FG002|Overall Study|Adverse Event|0|||
48500315|NCT01505530|156028104|FG000|Overall Study|Withdrawal by Subject|7|||
48500316|NCT01505530|156028105|FG001|Overall Study|Withdrawal by Subject|8|||
48500317|NCT01505530|156028106|FG002|Overall Study|Withdrawal by Subject|6|||
48500318|NCT01505530|156028104|FG000|Overall Study|Physician Decision|6|||
48500319|NCT01505530|156028105|FG001|Overall Study|Physician Decision|2|||
48500320|NCT01505530|156028106|FG002|Overall Study|Physician Decision|5|||
48500321|NCT01505530|156028104|FG000|Overall Study|Sponsor Decision|1|||
48500322|NCT01505530|156028105|FG001|Overall Study|Sponsor Decision|8|||
48500323|NCT01505530|156028106|FG002|Overall Study|Sponsor Decision|7|||
48500324|NCT01505530|156028104|FG000|Overall Study|Death|7|||
48500325|NCT01505530|156028105|FG001|Overall Study|Death|6|||
48500326|NCT01505530|156028106|FG002|Overall Study|Death|5|||
48500327|NCT01505530|156028104|FG000|Overall Study|entry criteria not met|0|||
48500328|NCT01505530|156028105|FG001|Overall Study|entry criteria not met|1|||
48500329|NCT01505530|156028106|FG002|Overall Study|entry criteria not met|0|||
48500330|NCT02388763|156028107|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
48500331|NCT02388763|156028108|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
48500332|NCT02388763|156028107|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
48500333|NCT02388763|156028108|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
48500334|NCT00365300|156028115|FG000|Open-label Phase|Adverse Event|4|||
48500335|NCT00365300|156028116|FG001|Open-label Phase|Adverse Event|0|||
48500336|NCT00365300|156028115|FG000|Open-label Phase|Failed to Return|1|||
48500337|NCT00365300|156028116|FG001|Open-label Phase|Failed to Return|0|||
48720697|NCT01426789|156826730|FG001|Part 2|Death|0|||
48720698|NCT01426789|156826731|FG002|Part 2|Death|1|||
48720699|NCT01426789|156826732|FG003|Part 2|Death|0|||
48720700|NCT01426789|156826733|FG004|Part 2|Death|1|||
48720701|NCT01426789|156826734|FG005|Part 2|Death|0|||
48720702|NCT01426789|156826729|FG000|Part 2|Administrative problems|0|||
48720703|NCT01426789|156826730|FG001|Part 2|Administrative problems|0|||
48720704|NCT01426789|156826731|FG002|Part 2|Administrative problems|2|||
48720705|NCT01426789|156826732|FG003|Part 2|Administrative problems|0|||
48720706|NCT01426789|156826733|FG004|Part 2|Administrative problems|1|||
48720707|NCT01426789|156826734|FG005|Part 2|Administrative problems|0|||
48720708|NCT01426789|156826729|FG000|Part 2|Lost to Follow-up|0|||
48720709|NCT01426789|156826730|FG001|Part 2|Lost to Follow-up|0|||
48720710|NCT01426789|156826731|FG002|Part 2|Lost to Follow-up|4|||
48720711|NCT01426789|156826732|FG003|Part 2|Lost to Follow-up|0|||
48720712|NCT01426789|156826733|FG004|Part 2|Lost to Follow-up|1|||
48720713|NCT01426789|156826734|FG005|Part 2|Lost to Follow-up|0|||
48720714|NCT01426789|156826729|FG000|Part 2|Withdrawal by Subject|0|||
48720715|NCT01426789|156826730|FG001|Part 2|Withdrawal by Subject|0|||
48720716|NCT01426789|156826731|FG002|Part 2|Withdrawal by Subject|0|||
48720717|NCT01426789|156826732|FG003|Part 2|Withdrawal by Subject|1|||
48720718|NCT01426789|156826733|FG004|Part 2|Withdrawal by Subject|2|||
48720719|NCT01426789|156826734|FG005|Part 2|Withdrawal by Subject|0|||
48720720|NCT01426789|156826729|FG000|Part 2|Lack of Efficacy|0|||
48720721|NCT01426789|156826730|FG001|Part 2|Lack of Efficacy|0|||
48720722|NCT01426789|156826731|FG002|Part 2|Lack of Efficacy|5|||
48720723|NCT01426789|156826732|FG003|Part 2|Lack of Efficacy|0|||
48720724|NCT01426789|156826733|FG004|Part 2|Lack of Efficacy|2|||
48720725|NCT01426789|156826734|FG005|Part 2|Lack of Efficacy|0|||
48720726|NCT01426789|156826729|FG000|Part 2|Adverse Event|0|||
48720727|NCT01426789|156826730|FG001|Part 2|Adverse Event|0|||
48720728|NCT01426789|156826731|FG002|Part 2|Adverse Event|2|||
48720729|NCT01426789|156826732|FG003|Part 2|Adverse Event|0|||
48720730|NCT01426789|156826733|FG004|Part 2|Adverse Event|1|||
48720731|NCT01426789|156826734|FG005|Part 2|Adverse Event|0|||
48720732|NCT00362180|156828362|FG000|Treated Period|Withdrawal by Subject|1|||
48720733|NCT00362180|156828363|FG001|Treated Period|Withdrawal by Subject|0|||
48720734|NCT00362180|156828364|FG002|Treated Period|Withdrawal by Subject|0|||
48720735|NCT00362180|156828365|FG003|Treated Period|Withdrawal by Subject|0|||
48720736|NCT00362180|156828366|FG004|Treated Period|Withdrawal by Subject|0|||
48720737|NCT00362180|156828367|FG005|Treated Period|Withdrawal by Subject|0|||
48720738|NCT00362180|156828368|FG006|Treated Period|Withdrawal by Subject|0|||
48720739|NCT00362180|156828369|FG007|Treated Period|Withdrawal by Subject|0|||
48720740|NCT00362180|156828370|FG008|Treated Period|Withdrawal by Subject|0|||
48720741|NCT00362180|156828362|FG000|Treated Period|Adverse Event|0|||
48720742|NCT00362180|156828363|FG001|Treated Period|Adverse Event|0|||
48720743|NCT00362180|156828364|FG002|Treated Period|Adverse Event|0|||
48720744|NCT00362180|156828365|FG003|Treated Period|Adverse Event|0|||
48720745|NCT00362180|156828366|FG004|Treated Period|Adverse Event|0|||
48720746|NCT00362180|156828367|FG005|Treated Period|Adverse Event|1|||
48720747|NCT00362180|156828368|FG006|Treated Period|Adverse Event|0|||
48720748|NCT00362180|156828369|FG007|Treated Period|Adverse Event|1|||
48720749|NCT00362180|156828370|FG008|Treated Period|Adverse Event|0|||
48720750|NCT03821844|156828371|FG000|Overall Study|Death|37|||
48720751|NCT03821844|156828372|FG001|Overall Study|Death|31|||
48720752|NCT03821844|156828371|FG000|Overall Study|Discharged|10|||
48720753|NCT03821844|156828372|FG001|Overall Study|Discharged|14|||
48720754|NCT03821844|156828371|FG000|Overall Study|Not present in facility at followup|2|||
48720755|NCT03821844|156828372|FG001|Overall Study|Not present in facility at followup|3|||
48720756|NCT00745849|156828377|FG000|First Intervention|Withdrawal by Subject|0|||
48720757|NCT00745849|156828378|FG001|First Intervention|Withdrawal by Subject|1|||
48720758|NCT00745849|156828377|FG000|First Intervention|Lost to Follow-up|1|||
48720759|NCT00745849|156828378|FG001|First Intervention|Lost to Follow-up|1|||
48720760|NCT00745849|156828377|FG000|Second Intervention|Lost to Follow-up|2|||
48720761|NCT00745849|156828378|FG001|Second Intervention|Lost to Follow-up|1|||
48720762|NCT02656680|156828379|FG000|Overall Study|Lost to Follow-up|0|||
48720763|NCT02656680|156828380|FG001|Overall Study|Lost to Follow-up|1|||
48720764|NCT02656680|156828381|FG002|Overall Study|Lost to Follow-up|7|||
48720765|NCT01143389|156828382|FG000|Overall Study|Lost to Follow-up|26|||
48720766|NCT01143389|156828383|FG001|Overall Study|Lost to Follow-up|25|||
48720767|NCT04839562|156828384|FG000|Overall Study|Withdrawal by Subject|0|||
48720768|NCT04839562|156828385|FG001|Overall Study|Withdrawal by Subject|1|||
48720769|NCT04839562|156828384|FG000|Overall Study|Physician Decision|0|||
48720770|NCT04839562|156828385|FG001|Overall Study|Physician Decision|1|||
48720771|NCT03338959|156828386|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
48720772|NCT03338959|156828386|FG000|Overall Study|Physician Decision|1|||
48720773|NCT01904773|156828387|FG000|Screen|Screen failure|3|||
48720774|NCT01904773|156828388|FG001|Screen|Screen failure|0|||
48720775|NCT01904773|156828389|FG002|Screen|Screen failure|0|||
48720776|NCT01904773|156828390|FG003|Screen|Screen failure|0|||
48720777|NCT01904773|156828391|FG004|Screen|Screen failure|0|||
48720778|NCT01904773|156828392|FG005|Screen|Screen failure|0|||
48500338|NCT00365300|156028115|FG000|Open-label Phase|Physician Decision|1|||
48500339|NCT00365300|156028116|FG001|Open-label Phase|Physician Decision|0|||
48500340|NCT00365300|156028115|FG000|Open-label Phase|Noncompliance|9|||
48500341|NCT00365300|156028116|FG001|Open-label Phase|Noncompliance|0|||
48500342|NCT00365300|156028115|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
48500343|NCT00365300|156028116|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
48500344|NCT00365300|156028115|FG000|Open-label Phase|Protocol Violation|1|||
48500345|NCT00365300|156028116|FG001|Open-label Phase|Protocol Violation|0|||
48500346|NCT00365300|156028115|FG000|Open-label Phase|Lack of Efficacy|1|||
48500347|NCT00365300|156028116|FG001|Open-label Phase|Lack of Efficacy|0|||
48500348|NCT00365300|156028115|FG000|Open-label Phase|Patient skipped open label phase|1|||
48500349|NCT00365300|156028116|FG001|Open-label Phase|Patient skipped open label phase|0|||
48500350|NCT00365300|156028115|FG000|Double-blind Phase|Failed to return|1|||
48500351|NCT00365300|156028116|FG001|Double-blind Phase|Failed to return|0|||
48500352|NCT00365300|156028115|FG000|Double-blind Phase|Noncompliance|1|||
48500353|NCT00365300|156028116|FG001|Double-blind Phase|Noncompliance|1|||
48500354|NCT00365300|156028115|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48500355|NCT00365300|156028116|FG001|Double-blind Phase|Withdrawal by Subject|1|||
48500356|NCT00365300|156028115|FG000|Double-blind Phase|Protocol Violation|3|||
48500357|NCT00365300|156028116|FG001|Double-blind Phase|Protocol Violation|1|||
48500358|NCT00365300|156028115|FG000|Double-blind Phase|Lack of Efficacy|6|||
48500359|NCT00365300|156028116|FG001|Double-blind Phase|Lack of Efficacy|6|||
48500360|NCT01991470|156028117|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
48500361|NCT01991470|156028117|FG000|Enlite 1 Period|Adverse Event|1|||
48599713|NCT03810456|156389823|FG002|Treatment|Transportation Issues|0|||
48599714|NCT03810456|156389821|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
48599715|NCT03810456|156389822|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
48720779|NCT01904773|156828393|FG006|Screen|Screen failure|0|||
48720780|NCT01904773|156828394|FG007|Screen|Screen failure|0|||
48720781|NCT01904773|156828395|FG008|Screen|Screen failure|0|||
48720782|NCT01904773|156828387|FG000|Screen|Withdrawal by Subject|1|||
48720783|NCT01904773|156828388|FG001|Screen|Withdrawal by Subject|0|||
48720784|NCT01904773|156828389|FG002|Screen|Withdrawal by Subject|0|||
48720785|NCT01904773|156828390|FG003|Screen|Withdrawal by Subject|0|||
48720786|NCT01904773|156828391|FG004|Screen|Withdrawal by Subject|0|||
48720787|NCT01904773|156828392|FG005|Screen|Withdrawal by Subject|0|||
48720788|NCT01904773|156828393|FG006|Screen|Withdrawal by Subject|0|||
48720789|NCT01904773|156828394|FG007|Screen|Withdrawal by Subject|0|||
48720790|NCT01904773|156828395|FG008|Screen|Withdrawal by Subject|0|||
48720791|NCT01904773|156828387|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
48720792|NCT01904773|156828388|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720793|NCT01904773|156828389|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720794|NCT01904773|156828390|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720795|NCT01904773|156828391|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720796|NCT01904773|156828392|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720797|NCT01904773|156828393|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720798|NCT01904773|156828394|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720799|NCT01904773|156828395|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
48720800|NCT01904773|156828387|FG000|First Intervention|Adverse Event|0|||
48720801|NCT01904773|156828388|FG001|First Intervention|Adverse Event|0|||
48720802|NCT01904773|156828389|FG002|First Intervention|Adverse Event|0|||
48720803|NCT01904773|156828390|FG003|First Intervention|Adverse Event|0|||
48720804|NCT01904773|156828391|FG004|First Intervention|Adverse Event|0|||
48720805|NCT01904773|156828392|FG005|First Intervention|Adverse Event|0|||
48720806|NCT01904773|156828393|FG006|First Intervention|Adverse Event|1|||
48720807|NCT01904773|156828394|FG007|First Intervention|Adverse Event|0|||
48720808|NCT01904773|156828395|FG008|First Intervention|Adverse Event|0|||
48720809|NCT01904773|156828387|FG000|Placebo Washout First Intervention|Condition worsened|0|||
48720810|NCT01904773|156828388|FG001|Placebo Washout First Intervention|Condition worsened|1|||
48720811|NCT01904773|156828389|FG002|Placebo Washout First Intervention|Condition worsened|0|||
48720812|NCT01904773|156828390|FG003|Placebo Washout First Intervention|Condition worsened|0|||
48720813|NCT01904773|156828391|FG004|Placebo Washout First Intervention|Condition worsened|0|||
48720814|NCT01904773|156828392|FG005|Placebo Washout First Intervention|Condition worsened|0|||
48720815|NCT01904773|156828393|FG006|Placebo Washout First Intervention|Condition worsened|0|||
48720816|NCT01904773|156828394|FG007|Placebo Washout First Intervention|Condition worsened|0|||
48720817|NCT01904773|156828395|FG008|Placebo Washout First Intervention|Condition worsened|0|||
48720818|NCT01904773|156828387|FG000|Fifth Intervention|Adverse Event|0|||
48720819|NCT01904773|156828388|FG001|Fifth Intervention|Adverse Event|0|||
48720820|NCT01904773|156828389|FG002|Fifth Intervention|Adverse Event|0|||
48720821|NCT01904773|156828390|FG003|Fifth Intervention|Adverse Event|0|||
48720822|NCT01904773|156828391|FG004|Fifth Intervention|Adverse Event|0|||
48720823|NCT01904773|156828392|FG005|Fifth Intervention|Adverse Event|0|||
48720824|NCT01904773|156828393|FG006|Fifth Intervention|Adverse Event|0|||
48720825|NCT01904773|156828394|FG007|Fifth Intervention|Adverse Event|1|||
48720826|NCT01904773|156828395|FG008|Fifth Intervention|Adverse Event|0|||
48500362|NCT01991470|156028117|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
48720827|NCT01904773|156828387|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720828|NCT01904773|156828388|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
48720829|NCT01904773|156828389|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720830|NCT01904773|156828390|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720831|NCT01904773|156828391|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720832|NCT01904773|156828392|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720833|NCT01904773|156828393|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720834|NCT01904773|156828394|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720835|NCT01904773|156828395|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
48720836|NCT02276027|156828404|FG000|Overall Study|Death|1|||
48815976|NCT01807221|157168527|FG003|Overall Study|Lost to Follow-up|1|||
48815977|NCT01807221|157168528|FG004|Overall Study|Lost to Follow-up|0|||
48815978|NCT01807221|157168529|FG005|Overall Study|Lost to Follow-up|0|||
48720837|NCT02276027|156828405|FG001|Overall Study|Death|0|||
48720838|NCT02276027|156828406|FG002|Overall Study|Death|0|||
48720839|NCT02276027|156828407|FG003|Overall Study|Death|2|||
48815979|NCT03545113|157168530|FG000|Overall Study|Surgery Cancelled|1|||
48815980|NCT03545113|157168531|FG001|Overall Study|Surgery Cancelled|0|||
48815981|NCT03545113|157168530|FG000|Overall Study|Death|1|||
48815982|NCT03545113|157168531|FG001|Overall Study|Death|0|||
48815983|NCT03545113|157168530|FG000|Overall Study|Adverse Event|2|||
48815984|NCT03545113|157168531|FG001|Overall Study|Adverse Event|0|||
48815985|NCT03545113|157168530|FG000|Overall Study|Received different surgery|1|||
48815986|NCT03545113|157168531|FG001|Overall Study|Received different surgery|0|||
48815987|NCT00502996|157168544|FG000|Overall Study|Lost to Follow-up|9|||
48815988|NCT00502996|157168544|FG000|Overall Study|Protocol Violation|2|||
48815989|NCT00502996|157168544|FG000|Overall Study|Treatment failure|25|||
48815990|NCT00502996|157168544|FG000|Overall Study|Withdrawal Informed Consent|6|||
48815991|NCT00502996|157168544|FG000|Overall Study|Adverse Event|2|||
48815992|NCT00439179|157168545|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
48815993|NCT00439179|157168546|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
48815994|NCT00439179|157168547|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
48815995|NCT00439179|157168548|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
48815996|NCT00170573|157168555|FG000|Overall Study|Violation of inclusion criteria|13|||
48815997|NCT01375114|157168560|FG000|Overall Study|Lost to Follow-up|1|||
48815998|NCT01375114|157168561|FG001|Overall Study|Lost to Follow-up|0|||
48815999|NCT01375114|157168562|FG002|Overall Study|Lost to Follow-up|1|||
48816000|NCT01375114|157168560|FG000|Overall Study|Disease Progression|3|||
48816001|NCT01375114|157168561|FG001|Overall Study|Disease Progression|2|||
48816002|NCT01375114|157168562|FG002|Overall Study|Disease Progression|2|||
48816003|NCT01375114|157168560|FG000|Overall Study|Patient Changed Mind|0|||
48816004|NCT01375114|157168561|FG001|Overall Study|Patient Changed Mind|0|||
48816005|NCT01375114|157168562|FG002|Overall Study|Patient Changed Mind|2|||
48816006|NCT01375114|157168560|FG000|Overall Study|Pruritus|0|||
48816007|NCT01375114|157168561|FG001|Overall Study|Pruritus|0|||
48816008|NCT01375114|157168562|FG002|Overall Study|Pruritus|1|||
48816009|NCT01375114|157168560|FG000|Overall Study|Restlessness|0|||
48816010|NCT01375114|157168561|FG001|Overall Study|Restlessness|0|||
48816011|NCT01375114|157168562|FG002|Overall Study|Restlessness|1|||
48816012|NCT01375114|157168560|FG000|Overall Study|Diarrhea|0|||
48816013|NCT01375114|157168561|FG001|Overall Study|Diarrhea|0|||
48816014|NCT01375114|157168562|FG002|Overall Study|Diarrhea|1|||
48816015|NCT01375114|157168560|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
48816016|NCT01375114|157168561|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
48816017|NCT01375114|157168562|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
48816018|NCT01375114|157168560|FG000|Overall Study|Nausea|0|||
48816019|NCT01375114|157168561|FG001|Overall Study|Nausea|1|||
48816020|NCT01375114|157168562|FG002|Overall Study|Nausea|0|||
48816021|NCT01375114|157168560|FG000|Overall Study|Increased AST/ALT|0|||
48720840|NCT02276027|156828404|FG000|Overall Study|Physician Decision|0|||
48816022|NCT01375114|157168561|FG001|Overall Study|Increased AST/ALT|1|||
48816023|NCT01375114|157168562|FG002|Overall Study|Increased AST/ALT|0|||
48816024|NCT01375114|157168560|FG000|Overall Study|Vaginal Hemorrhage|0|||
48816025|NCT01375114|157168561|FG001|Overall Study|Vaginal Hemorrhage|1|||
48500363|NCT01991470|156028117|FG000|Enlite 3 Period|Lost to Follow-up|1|||
48500364|NCT01991470|156028117|FG000|Enlite 3 Period|Physician Decision|2|||
48720841|NCT02276027|156828405|FG001|Overall Study|Physician Decision|0|||
48720842|NCT02276027|156828406|FG002|Overall Study|Physician Decision|0|||
48720843|NCT02276027|156828407|FG003|Overall Study|Physician Decision|1|||
48816026|NCT01375114|157168562|FG002|Overall Study|Vaginal Hemorrhage|0|||
48816027|NCT01375114|157168560|FG000|Overall Study|Family problem|0|||
48816028|NCT01375114|157168561|FG001|Overall Study|Family problem|1|||
48816029|NCT01375114|157168562|FG002|Overall Study|Family problem|0|||
48816030|NCT01375114|157168560|FG000|Overall Study|Protocol Violation|2|||
48816031|NCT01375114|157168561|FG001|Overall Study|Protocol Violation|0|||
48816032|NCT01375114|157168562|FG002|Overall Study|Protocol Violation|0|||
48720844|NCT02276027|156828404|FG000|Overall Study|Progressive disease|1|||
48720845|NCT02276027|156828405|FG001|Overall Study|Progressive disease|13|||
48720846|NCT02276027|156828406|FG002|Overall Study|Progressive disease|12|||
48720847|NCT02276027|156828407|FG003|Overall Study|Progressive disease|14|||
48720848|NCT02276027|156828404|FG000|Overall Study|Subject/guardian decision|0|||
48720849|NCT02276027|156828405|FG001|Overall Study|Subject/guardian decision|1|||
48720850|NCT02276027|156828406|FG002|Overall Study|Subject/guardian decision|0|||
48720851|NCT02276027|156828407|FG003|Overall Study|Subject/guardian decision|3|||
48720852|NCT02276027|156828404|FG000|Overall Study|Adverse Event|0|||
48720853|NCT02276027|156828405|FG001|Overall Study|Adverse Event|2|||
48720854|NCT02276027|156828406|FG002|Overall Study|Adverse Event|8|||
48720855|NCT02276027|156828407|FG003|Overall Study|Adverse Event|2|||
48720856|NCT00791076|156828410|FG000|Overall Study|Study was terminated,PI left institution|8|||
48720857|NCT00877773|156828411|FG000|Overall Study|Disease Progression|44|||
48720858|NCT05510232|156828418|FG000|Overall Study|Withdrawal by Subject|2|||
48720859|NCT05510232|156828419|FG001|Overall Study|Withdrawal by Subject|7|||
48720860|NCT05510232|156828420|FG002|Overall Study|Withdrawal by Subject|6|||
48720861|NCT01659554|156828422|FG000|Overall Study|Study Termination|4|||
48720862|NCT01328366|156828423|FG000|Overall Study|Death|1|||
48720863|NCT01328366|156828423|FG000|Overall Study|Withdrawal by Subject|2|||
48720864|NCT01328366|156828423|FG000|Overall Study|Lost to Follow-up|7|||
48720865|NCT02882152|156828424|FG000|Overall Study|Lost to Follow-up|1|||
48720866|NCT02882152|156828425|FG001|Overall Study|Lost to Follow-up|0|||
48720867|NCT03739242|156828428|FG000|Overall Study|Withdrawal by Subject|1|||
48720868|NCT03739242|156828429|FG001|Overall Study|Withdrawal by Subject|1|||
48720869|NCT03739242|156828428|FG000|Overall Study|Protocol Violation|0|||
48720870|NCT03739242|156828429|FG001|Overall Study|Protocol Violation|1|||
48720871|NCT00923364|156828436|FG000|Overall Study|Death|3|||
48720872|NCT00923364|156828437|FG001|Overall Study|Death|0|||
48720873|NCT00923364|156828436|FG000|Overall Study|Did not go to transplant|1|||
48720874|NCT00923364|156828437|FG001|Overall Study|Did not go to transplant|0|||
48720875|NCT02230527|156828438|FG000|Overall Study|Withdrawal by Subject|1|||
48720876|NCT02230527|156828439|FG001|Overall Study|Withdrawal by Subject|1|||
48720877|NCT02230527|156828438|FG000|Overall Study|Death|1|||
48720878|NCT02230527|156828439|FG001|Overall Study|Death|0|||
48720879|NCT02230527|156828438|FG000|Overall Study|Lost to Follow-up|2|||
48720880|NCT02230527|156828439|FG001|Overall Study|Lost to Follow-up|1|||
48720881|NCT02230527|156828438|FG000|Overall Study|Other|1|||
48720882|NCT02230527|156828439|FG001|Overall Study|Other|0|||
48720883|NCT04461600|156828440|FG000|Overall Study|Death|6|||
48720884|NCT04461600|156828441|FG001|Overall Study|Death|5|||
48720885|NCT04461600|156828440|FG000|Overall Study|Withdrawal by Subject|0|||
48720886|NCT04461600|156828441|FG001|Overall Study|Withdrawal by Subject|1|||
48720887|NCT02279407|156828442|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
48720888|NCT02279407|156828443|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
48720889|NCT02279407|156828444|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
48720890|NCT02279407|156828445|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
48720891|NCT02279407|156828442|FG000|Overall Study|Withdrawal by Subject|1|||
48720892|NCT02279407|156828443|FG001|Overall Study|Withdrawal by Subject|0|||
48720893|NCT02279407|156828444|FG002|Overall Study|Withdrawal by Subject|1|||
48720894|NCT02279407|156828445|FG003|Overall Study|Withdrawal by Subject|1|||
48720895|NCT02279407|156828442|FG000|Overall Study|Adverse Event|1|||
48720896|NCT02279407|156828443|FG001|Overall Study|Adverse Event|1|||
48720897|NCT02279407|156828444|FG002|Overall Study|Adverse Event|2|||
48720898|NCT02279407|156828445|FG003|Overall Study|Adverse Event|0|||
48720899|NCT00275821|156828446|FG000|Overall Study|Adverse Event|4|||
48720900|NCT00275821|156828447|FG001|Overall Study|Adverse Event|12|||
48720901|NCT00275821|156828448|FG002|Overall Study|Adverse Event|5|||
48720902|NCT00275821|156828446|FG000|Overall Study|Administrative problems|3|||
48720903|NCT00275821|156828447|FG001|Overall Study|Administrative problems|4|||
48720904|NCT00275821|156828448|FG002|Overall Study|Administrative problems|4|||
48720905|NCT00275821|156828446|FG000|Overall Study|Withdrawal by Subject|0|||
48720906|NCT00275821|156828447|FG001|Overall Study|Withdrawal by Subject|2|||
48720907|NCT00275821|156828448|FG002|Overall Study|Withdrawal by Subject|1|||
48720908|NCT00275821|156828446|FG000|Overall Study|Lost to Follow-up|0|||
48720909|NCT00275821|156828447|FG001|Overall Study|Lost to Follow-up|1|||
48720910|NCT00275821|156828448|FG002|Overall Study|Lost to Follow-up|1|||
48720911|NCT00275821|156828446|FG000|Overall Study|Death|0|||
48720912|NCT00275821|156828447|FG001|Overall Study|Death|2|||
48720913|NCT00275821|156828448|FG002|Overall Study|Death|1|||
48720914|NCT00275821|156828446|FG000|Overall Study|Lack of Efficacy|2|||
48720915|NCT00275821|156828447|FG001|Overall Study|Lack of Efficacy|1|||
48720916|NCT00275821|156828448|FG002|Overall Study|Lack of Efficacy|0|||
48720917|NCT00275821|156828446|FG000|Overall Study|Protocol Violation|5|||
48720918|NCT00275821|156828447|FG001|Overall Study|Protocol Violation|1|||
48720919|NCT00275821|156828448|FG002|Overall Study|Protocol Violation|0|||
48720920|NCT00045942|156828449|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
48720921|NCT00045942|156828450|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48816033|NCT01208415|157168563|FG000|Overall Study|Death|1|||
48816034|NCT01208415|157168563|FG000|Overall Study|Lost to Follow-up|2|||
48816035|NCT01208415|157168563|FG000|Overall Study|Withdrawal by Subject|3|||
48816036|NCT01208415|157168563|FG000|Overall Study|Device not placed|1|||
48816037|NCT01208415|157168563|FG000|Overall Study|Still be eligible for follow-up|33|||
48816038|NCT02878213|157168564|FG000|Overall Study|Withdrawal by Subject|2|||
48816039|NCT02878213|157168564|FG000|Overall Study|Adverse Event|1|||
48816040|NCT03619174|157168577|FG000|Overall Study|Lost to Follow-up|3|||
48816041|NCT03619174|157168578|FG001|Overall Study|Lost to Follow-up|0|||
48816042|NCT03619174|157168577|FG000|Overall Study|Withdrawal by Subject|4|||
48816043|NCT03619174|157168578|FG001|Overall Study|Withdrawal by Subject|3|||
48816044|NCT03619174|157168577|FG000|Overall Study|Pregnancy|1|||
48816045|NCT03619174|157168578|FG001|Overall Study|Pregnancy|1|||
48816046|NCT03619174|157168577|FG000|Overall Study|Discomfort during treatment|1|||
48816047|NCT03619174|157168578|FG001|Overall Study|Discomfort during treatment|0|||
48816048|NCT03486899|157168579|FG000|Overall Study|Lost to Follow-up|4|||
48816049|NCT03486899|157168580|FG001|Overall Study|Lost to Follow-up|1|||
48816050|NCT03486899|157168581|FG002|Overall Study|Lost to Follow-up|4|||
48816051|NCT03486899|157168582|FG003|Overall Study|Lost to Follow-up|3|||
48816052|NCT03486899|157168579|FG000|Overall Study|Death|1|||
48816053|NCT03486899|157168580|FG001|Overall Study|Death|0|||
48816054|NCT03486899|157168581|FG002|Overall Study|Death|0|||
48816055|NCT03486899|157168582|FG003|Overall Study|Death|1|||
48816056|NCT03486899|157168579|FG000|Overall Study|Adverse Event|0|||
48816057|NCT03486899|157168580|FG001|Overall Study|Adverse Event|2|||
48816058|NCT03486899|157168581|FG002|Overall Study|Adverse Event|0|||
48816059|NCT03486899|157168582|FG003|Overall Study|Adverse Event|2|||
48816060|NCT03486899|157168579|FG000|Overall Study|Withdrawal by Subject|3|||
48816061|NCT03486899|157168580|FG001|Overall Study|Withdrawal by Subject|7|||
48816062|NCT03486899|157168581|FG002|Overall Study|Withdrawal by Subject|4|||
48816063|NCT03486899|157168582|FG003|Overall Study|Withdrawal by Subject|3|||
48816064|NCT03486899|157168579|FG000|Overall Study|Other Reasons|0|||
48816065|NCT03486899|157168580|FG001|Overall Study|Other Reasons|1|||
48816066|NCT03486899|157168581|FG002|Overall Study|Other Reasons|0|||
48816067|NCT03486899|157168582|FG003|Overall Study|Other Reasons|1|||
48816068|NCT01818700|157168583|FG000|Overall Study|Adverse Event|67|||
48816069|NCT01818700|157168583|FG000|Overall Study|Lack of Efficacy|2|||
48816070|NCT01818700|157168583|FG000|Overall Study|Lost to Follow-up|5|||
48816071|NCT01818700|157168583|FG000|Overall Study|Withdrawal by Subject|27|||
48816072|NCT01818700|157168583|FG000|Overall Study|Protocol Violation|2|||
48816073|NCT01818700|157168583|FG000|Overall Study|Other|1|||
48816074|NCT02213055|157168584|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
48816075|NCT02213055|157168585|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
48720922|NCT00045942|156828451|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720923|NCT00045942|156828452|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720924|NCT00045942|156828453|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720925|NCT00045942|156828454|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720926|NCT00045942|156828455|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720927|NCT00045942|156828456|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720928|NCT00045942|156828457|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
48720929|NCT00045942|156828449|FG000|PKC412A2104 (Core)|Adverse Event|5|||
48720930|NCT00045942|156828450|FG001|PKC412A2104 (Core)|Adverse Event|0|||
48720931|NCT00045942|156828451|FG002|PKC412A2104 (Core)|Adverse Event|0|||
48720932|NCT00045942|156828452|FG003|PKC412A2104 (Core)|Adverse Event|0|||
48720933|NCT00045942|156828453|FG004|PKC412A2104 (Core)|Adverse Event|0|||
48720934|NCT00045942|156828454|FG005|PKC412A2104 (Core)|Adverse Event|0|||
48720935|NCT00045942|156828455|FG006|PKC412A2104 (Core)|Adverse Event|0|||
48720936|NCT00045942|156828456|FG007|PKC412A2104 (Core)|Adverse Event|0|||
48720937|NCT00045942|156828457|FG008|PKC412A2104 (Core)|Adverse Event|0|||
48720938|NCT00045942|156828449|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
48720939|NCT00045942|156828450|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720940|NCT00045942|156828451|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720941|NCT00045942|156828452|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720942|NCT00045942|156828453|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720943|NCT00045942|156828454|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720944|NCT00045942|156828455|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720945|NCT00045942|156828456|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720946|NCT00045942|156828457|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
48720947|NCT00045942|156828449|FG000|PKC412A2104 (Core)|Death|1|||
48720948|NCT00045942|156828450|FG001|PKC412A2104 (Core)|Death|0|||
48720949|NCT00045942|156828451|FG002|PKC412A2104 (Core)|Death|0|||
48720950|NCT00045942|156828452|FG003|PKC412A2104 (Core)|Death|0|||
48720951|NCT00045942|156828453|FG004|PKC412A2104 (Core)|Death|0|||
48720952|NCT00045942|156828454|FG005|PKC412A2104 (Core)|Death|0|||
48816076|NCT02213055|157168584|FG000|Overall Study|Protocol was not Followed during Study|1|||
48816077|NCT02213055|157168585|FG001|Overall Study|Protocol was not Followed during Study|0|||
48816078|NCT02213055|157168584|FG000|Overall Study|Documentation Issue at Enrollment|1|||
48816079|NCT02213055|157168585|FG001|Overall Study|Documentation Issue at Enrollment|0|||
48816080|NCT02213055|157168584|FG000|Overall Study|Documentation Issue during Study|10|||
48816081|NCT02213055|157168585|FG001|Overall Study|Documentation Issue during Study|0|||
48816082|NCT02213055|157168584|FG000|Overall Study|Did not have Live Lice|8|||
48816083|NCT02213055|157168585|FG001|Overall Study|Did not have Live Lice|0|||
48816084|NCT02213055|157168584|FG000|Overall Study|Had another Treatment during the Study|3|||
48816085|NCT02213055|157168585|FG001|Overall Study|Had another Treatment during the Study|0|||
48816086|NCT02213055|157168584|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
48816087|NCT02213055|157168585|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
48816088|NCT02213055|157168584|FG000|Overall Study|Did not Return to School|5|||
48816089|NCT02213055|157168585|FG001|Overall Study|Did not Return to School|0|||
48816090|NCT03257995|157168588|FG000|Overall Study|Adverse Event|0|||
48816091|NCT03257995|157168589|FG001|Overall Study|Adverse Event|1|||
48816092|NCT03257995|157168590|FG002|Overall Study|Adverse Event|0|||
48816093|NCT03257995|157168591|FG003|Overall Study|Adverse Event|0|||
48816094|NCT03257995|157168592|FG004|Overall Study|Adverse Event|0|||
48816095|NCT03257995|157168593|FG005|Overall Study|Adverse Event|0|||
48816096|NCT03257995|157168588|FG000|Overall Study|Protocol deviation|0|||
48816097|NCT03257995|157168589|FG001|Overall Study|Protocol deviation|0|||
48816098|NCT03257995|157168590|FG002|Overall Study|Protocol deviation|0|||
48816099|NCT03257995|157168591|FG003|Overall Study|Protocol deviation|0|||
48816100|NCT03257995|157168592|FG004|Overall Study|Protocol deviation|0|||
48816101|NCT03257995|157168593|FG005|Overall Study|Protocol deviation|2|||
48816102|NCT01544114|157168594|FG000|Overall Study|Withdrawal by Subject|0|||
48816103|NCT01544114|157168595|FG001|Overall Study|Withdrawal by Subject|0|||
48816104|NCT01544114|157168596|FG002|Overall Study|Withdrawal by Subject|3|||
48816105|NCT01544114|157168594|FG000|Overall Study|Lost to Follow-up|0|||
48816106|NCT01544114|157168595|FG001|Overall Study|Lost to Follow-up|2|||
48816107|NCT01544114|157168596|FG002|Overall Study|Lost to Follow-up|0|||
48816108|NCT01544114|157168594|FG000|Overall Study|Adverse Event|1|||
48816109|NCT01544114|157168595|FG001|Overall Study|Adverse Event|1|||
48816110|NCT01544114|157168596|FG002|Overall Study|Adverse Event|2|||
48816111|NCT01544114|157168594|FG000|Overall Study|Protocol Violation|0|||
48816112|NCT01544114|157168595|FG001|Overall Study|Protocol Violation|1|||
48816113|NCT01544114|157168596|FG002|Overall Study|Protocol Violation|0|||
48816114|NCT02723591|157168599|FG000|Overall Study|Adverse Event|48|||
48816115|NCT02723591|157168600|FG001|Overall Study|Adverse Event|40|||
48816116|NCT02723591|157168599|FG000|Overall Study|Death|2|||
48816117|NCT02723591|157168600|FG001|Overall Study|Death|2|||
48816118|NCT02723591|157168599|FG000|Overall Study|Lack of Efficacy|4|||
48816119|NCT02723591|157168600|FG001|Overall Study|Lack of Efficacy|3|||
48816120|NCT02723591|157168599|FG000|Overall Study|Lost to Follow-up|1|||
48816121|NCT02723591|157168600|FG001|Overall Study|Lost to Follow-up|7|||
48816122|NCT02723591|157168599|FG000|Overall Study|Protocol Violation|20|||
48816123|NCT02723591|157168600|FG001|Overall Study|Protocol Violation|23|||
48816124|NCT02723591|157168599|FG000|Overall Study|Withdrawal by Subject|4|||
48816125|NCT02723591|157168600|FG001|Overall Study|Withdrawal by Subject|8|||
48816126|NCT02723591|157168599|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
48816127|NCT02723591|157168600|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
48816128|NCT02723591|157168599|FG000|Overall Study|Miscellaneous|5|||
48816129|NCT02723591|157168600|FG001|Overall Study|Miscellaneous|6|||
48816130|NCT01680458|157168607|FG000|Overall Study|Protocol Violation|3|||
48500365|NCT01991470|156028117|FG000|Enlite 3 Period|Physician Decision|8|||
48720953|NCT00045942|156828455|FG006|PKC412A2104 (Core)|Death|0|||
48500366|NCT01991470|156028117|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
48500367|NCT00243932|156028118|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
48720954|NCT00045942|156828456|FG007|PKC412A2104 (Core)|Death|0|||
48720955|NCT00045942|156828457|FG008|PKC412A2104 (Core)|Death|0|||
48720956|NCT00045942|156828449|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
48720957|NCT00045942|156828450|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
48720958|NCT00045942|156828451|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
48720959|NCT00045942|156828452|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
48500368|NCT00243932|156028119|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
48720960|NCT00045942|156828453|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
48720961|NCT00045942|156828454|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
48720962|NCT00045942|156828455|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
48720963|NCT00045942|156828456|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
48816131|NCT01923428|157168608|FG000|Overall Study|Adverse Event|8|||
48816132|NCT01923428|157168609|FG001|Overall Study|Adverse Event|6|||
48816133|NCT01923428|157168610|FG002|Overall Study|Adverse Event|3|||
48816134|NCT01923428|157168611|FG003|Overall Study|Adverse Event|3|||
48816135|NCT01923428|157168608|FG000|Overall Study|Withdrawal by Subject|5|||
48816136|NCT01923428|157168609|FG001|Overall Study|Withdrawal by Subject|3|||
48500369|NCT00243932|156028120|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
48720964|NCT00045942|156828457|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
48816137|NCT01923428|157168610|FG002|Overall Study|Withdrawal by Subject|0|||
48816138|NCT01923428|157168611|FG003|Overall Study|Withdrawal by Subject|4|||
48816139|NCT01923428|157168608|FG000|Overall Study|Lost to Follow-up|2|||
48816140|NCT01923428|157168609|FG001|Overall Study|Lost to Follow-up|1|||
48500370|NCT02194998|156028123|FG000|On-HCV Treatment|Did not pick up study medication|0|||
48500371|NCT02194998|156028124|FG001|On-HCV Treatment|Did not pick up study medication|1|||
48500372|NCT02194998|156028125|FG002|On-HCV Treatment|Did not pick up study medication|0|||
48720965|NCT00045942|156828449|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
48720966|NCT00045942|156828450|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
48500373|NCT02194998|156028126|FG003|On-HCV Treatment|Did not pick up study medication|0|||
48500374|NCT02194998|156028123|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
48500375|NCT02194998|156028124|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
48500376|NCT02194998|156028125|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
48500377|NCT02194998|156028126|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
48500378|NCT03657160|156028129|FG000|Overall Study|Adverse Event|5|||
48500379|NCT03657160|156028130|FG001|Overall Study|Adverse Event|6|||
48720967|NCT00045942|156828451|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
48720968|NCT00045942|156828452|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
48720969|NCT00045942|156828453|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
48720970|NCT00045942|156828454|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
48720971|NCT00045942|156828455|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
48720972|NCT00045942|156828456|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
48720973|NCT00045942|156828457|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
48816141|NCT01923428|157168610|FG002|Overall Study|Lost to Follow-up|5|||
48816142|NCT01923428|157168611|FG003|Overall Study|Lost to Follow-up|0|||
48816143|NCT01923428|157168608|FG000|Overall Study|Protocol Violation|3|||
48816144|NCT01923428|157168609|FG001|Overall Study|Protocol Violation|0|||
48816145|NCT01923428|157168610|FG002|Overall Study|Protocol Violation|2|||
48816146|NCT01923428|157168611|FG003|Overall Study|Protocol Violation|1|||
48816147|NCT01923428|157168608|FG000|Overall Study|Non Compliance to treatment|1|||
48816148|NCT01923428|157168609|FG001|Overall Study|Non Compliance to treatment|2|||
48816149|NCT01923428|157168610|FG002|Overall Study|Non Compliance to treatment|0|||
48816150|NCT01923428|157168611|FG003|Overall Study|Non Compliance to treatment|1|||
48816151|NCT01923428|157168608|FG000|Overall Study|Lack of Efficacy|0|||
48816152|NCT01923428|157168609|FG001|Overall Study|Lack of Efficacy|0|||
48816153|NCT01923428|157168610|FG002|Overall Study|Lack of Efficacy|1|||
48816154|NCT01923428|157168611|FG003|Overall Study|Lack of Efficacy|1|||
48816155|NCT02337478|157168612|FG000|Overall Study|Lack of Efficacy|5|||
48816156|NCT00653263|157168613|FG000|Overall Study|Withdrawal by Subject|1|||
48816157|NCT00653263|157168613|FG000|Overall Study|Physician Decision|1|||
48816158|NCT01449721|157168617|FG000|Overall Study|Physician Decision|0|||
48816159|NCT01449721|157168618|FG001|Overall Study|Physician Decision|1|||
48816160|NCT01449721|157168617|FG000|Overall Study|Physician Decision|0|||
48816161|NCT01449721|157168618|FG001|Overall Study|Physician Decision|1|||
48816162|NCT03873246|157168622|FG000|Overall Study|Adverse Event|1|||
48816163|NCT03873246|157168623|FG001|Overall Study|Adverse Event|3|||
48816164|NCT03873246|157168624|FG002|Overall Study|Adverse Event|3|||
48816165|NCT03873246|157168622|FG000|Overall Study|Lost to Follow-up|4|||
48816166|NCT03873246|157168623|FG001|Overall Study|Lost to Follow-up|4|||
48816167|NCT03873246|157168624|FG002|Overall Study|Lost to Follow-up|5|||
48816168|NCT03873246|157168622|FG000|Overall Study|Protocol Violation|0|||
48816169|NCT03873246|157168623|FG001|Overall Study|Protocol Violation|1|||
48816170|NCT03873246|157168624|FG002|Overall Study|Protocol Violation|0|||
48720974|NCT00045942|156828449|FG000|PKC412A2104E1|Lack of Efficacy|0|||
48720975|NCT00045942|156828450|FG001|PKC412A2104E1|Lack of Efficacy|11|||
48720976|NCT00045942|156828451|FG002|PKC412A2104E1|Lack of Efficacy|11|||
48720977|NCT00045942|156828452|FG003|PKC412A2104E1|Lack of Efficacy|23|||
48720978|NCT00045942|156828453|FG004|PKC412A2104E1|Lack of Efficacy|17|||
48720979|NCT00045942|156828454|FG005|PKC412A2104E1|Lack of Efficacy|0|||
48720980|NCT00045942|156828455|FG006|PKC412A2104E1|Lack of Efficacy|0|||
48720981|NCT00045942|156828456|FG007|PKC412A2104E1|Lack of Efficacy|0|||
48720982|NCT00045942|156828457|FG008|PKC412A2104E1|Lack of Efficacy|0|||
48720983|NCT00045942|156828449|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
48720984|NCT00045942|156828450|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
48720985|NCT00045942|156828451|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
48816171|NCT03873246|157168622|FG000|Overall Study|Withdrawal by Subject|0|||
48816172|NCT03873246|157168623|FG001|Overall Study|Withdrawal by Subject|4|||
48816173|NCT03873246|157168624|FG002|Overall Study|Withdrawal by Subject|1|||
48500380|NCT03657160|156028129|FG000|Overall Study|Protocol Deviation|3|||
48816174|NCT01857323|157168625|FG000|Overall Study|Adverse Event|1|||
48816175|NCT01857323|157168625|FG000|Overall Study|Withdrawal by Subject|3|||
48816176|NCT01857323|157168625|FG000|Overall Study|Non-compliance|1|||
48816177|NCT01857323|157168625|FG000|Overall Study|Protocol Violation|6|||
48816178|NCT01857323|157168625|FG000|Overall Study|Lost to Follow-up|1|||
48816179|NCT01857323|157168625|FG000|Overall Study|Other|4|||
48816180|NCT01857323|157168625|FG000|Overall Study|Did not complete 180 doses|48|||
48500381|NCT03657160|156028130|FG001|Overall Study|Protocol Deviation|0|||
48720986|NCT00045942|156828452|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
48720987|NCT00045942|156828453|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
48816181|NCT02593539|157170372|FG000|Overall Study|Adverse Event|1|||
48816182|NCT04838626|157170378|FG000|Overall Study|Adverse Event|2|||
48500382|NCT03657160|156028129|FG000|Overall Study|Withdrawal by Subject|18|||
48500383|NCT03657160|156028130|FG001|Overall Study|Withdrawal by Subject|16|||
48500384|NCT03657160|156028129|FG000|Overall Study|Site Termination|1|||
48500385|NCT03657160|156028130|FG001|Overall Study|Site Termination|0|||
48500386|NCT03657160|156028129|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
48500387|NCT03657160|156028130|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
48720988|NCT00045942|156828454|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
48720989|NCT00045942|156828455|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
48720990|NCT00045942|156828456|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
48720991|NCT00045942|156828457|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
48720992|NCT00045942|156828449|FG000|PKC412A2104E1|Adverse Event|0|||
48720993|NCT00045942|156828450|FG001|PKC412A2104E1|Adverse Event|1|||
48720994|NCT00045942|156828451|FG002|PKC412A2104E1|Adverse Event|1|||
48720995|NCT00045942|156828452|FG003|PKC412A2104E1|Adverse Event|3|||
48720996|NCT00045942|156828453|FG004|PKC412A2104E1|Adverse Event|6|||
48720997|NCT00045942|156828454|FG005|PKC412A2104E1|Adverse Event|0|||
48720998|NCT00045942|156828455|FG006|PKC412A2104E1|Adverse Event|0|||
48720999|NCT00045942|156828456|FG007|PKC412A2104E1|Adverse Event|0|||
48721000|NCT00045942|156828457|FG008|PKC412A2104E1|Adverse Event|0|||
48500388|NCT03657160|156028129|FG000|Overall Study|Death|33|||
48500389|NCT03657160|156028130|FG001|Overall Study|Death|26|||
48500390|NCT03657160|156028129|FG000|Overall Study|Death (COVID-19-Related)|1|||
48500391|NCT03657160|156028130|FG001|Overall Study|Death (COVID-19-Related)|0|||
48500392|NCT03657160|156028129|FG000|Overall Study|Reason Not Specified|5|||
48500393|NCT03657160|156028130|FG001|Overall Study|Reason Not Specified|5|||
48500394|NCT03657160|156028129|FG000|Overall Study|Other (COVID-19-Related)|0|||
48500395|NCT03657160|156028130|FG001|Overall Study|Other (COVID-19-Related)|1|||
48500396|NCT00302952|156028137|FG000|Overall Study|Physician Decision|1|||
48721001|NCT00045942|156828449|FG000|PKC412A2104E1|Death|0|||
48500397|NCT00302952|156028138|FG001|Overall Study|Physician Decision|1|||
48500398|NCT00302952|156028137|FG000|Overall Study|Withdrawal by Subject|2|||
48721002|NCT00045942|156828450|FG001|PKC412A2104E1|Death|4|||
48721003|NCT00045942|156828451|FG002|PKC412A2104E1|Death|1|||
48500399|NCT00302952|156028138|FG001|Overall Study|Withdrawal by Subject|3|||
48500400|NCT00302952|156028137|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
48500401|NCT00302952|156028138|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
48500402|NCT01936948|156028139|FG000|Overall Study|no 30-day follow-up data|0|||
48500403|NCT01936948|156028140|FG001|Overall Study|no 30-day follow-up data|3|||
48500404|NCT01936948|156028141|FG002|Overall Study|no 30-day follow-up data|3|||
48500405|NCT01936948|156028142|FG003|Overall Study|no 30-day follow-up data|3|||
48500406|NCT02365207|156028143|FG000|Overall Study|Withdrawal by Subject|1|||
48500407|NCT02365207|156028143|FG000|Overall Study|Physician Decision|1|||
48500408|NCT00626548|156028149|FG000|Overall Study|Adverse Event|164|||
48500409|NCT00626548|156028150|FG001|Overall Study|Adverse Event|44|||
48500410|NCT00626548|156028149|FG000|Overall Study|Withdrawal by Subject|42|||
48500411|NCT00626548|156028150|FG001|Overall Study|Withdrawal by Subject|46|||
48500412|NCT00626548|156028149|FG000|Overall Study|Protocol Violation|4|||
48500413|NCT00626548|156028150|FG001|Overall Study|Protocol Violation|11|||
48500414|NCT00626548|156028149|FG000|Overall Study|Lost to Follow-up|2|||
48500415|NCT00626548|156028150|FG001|Overall Study|Lost to Follow-up|2|||
48500416|NCT00626548|156028149|FG000|Overall Study|Other termination reason|493|||
48500417|NCT00626548|156028150|FG001|Overall Study|Other termination reason|613|||
48500418|NCT00406848|156028151|FG000|Overall Study|Withdrawal by Subject|27|||
48500419|NCT00406848|156028152|FG001|Overall Study|Withdrawal by Subject|22|||
48500420|NCT00406848|156028151|FG000|Overall Study|Adverse Event|38|||
48500421|NCT00406848|156028152|FG001|Overall Study|Adverse Event|7|||
48500422|NCT00406848|156028151|FG000|Overall Study|Lack of Efficacy|9|||
48500423|NCT00406848|156028152|FG001|Overall Study|Lack of Efficacy|14|||
48500424|NCT00406848|156028151|FG000|Overall Study|Protocol Violation|10|||
48500425|NCT00406848|156028152|FG001|Overall Study|Protocol Violation|6|||
48500426|NCT00406848|156028151|FG000|Overall Study|Lost to Follow-up|6|||
48500427|NCT00406848|156028152|FG001|Overall Study|Lost to Follow-up|2|||
48500428|NCT00406848|156028151|FG000|Overall Study|Physician Decision|2|||
48500429|NCT00406848|156028152|FG001|Overall Study|Physician Decision|2|||
48500430|NCT00406848|156028151|FG000|Overall Study|Sponsor Decision|1|||
48500431|NCT00406848|156028152|FG001|Overall Study|Sponsor Decision|1|||
48500432|NCT00048581|156028153|FG000|Double-Blind Period|Adverse Event|9|||
48500433|NCT00048581|156028154|FG001|Double-Blind Period|Adverse Event|5|||
48500434|NCT00048581|156028155|FG002|Double-Blind Period|Adverse Event|0|||
48721004|NCT00045942|156828452|FG003|PKC412A2104E1|Death|1|||
48721005|NCT00045942|156828453|FG004|PKC412A2104E1|Death|1|||
48721006|NCT00045942|156828454|FG005|PKC412A2104E1|Death|0|||
48721007|NCT00045942|156828455|FG006|PKC412A2104E1|Death|0|||
48721008|NCT00045942|156828456|FG007|PKC412A2104E1|Death|0|||
48721009|NCT00045942|156828457|FG008|PKC412A2104E1|Death|0|||
48721010|NCT00045942|156828449|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721011|NCT00045942|156828450|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721012|NCT00045942|156828451|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
48721013|NCT00045942|156828452|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
48721014|NCT00045942|156828453|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48599716|NCT03810456|156389823|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
48599717|NCT03810456|156389821|FG000|1 Month Follow-Up|Relocated to Different State|1|||
48599718|NCT03810456|156389822|FG001|1 Month Follow-Up|Relocated to Different State|0|||
48721015|NCT00045942|156828454|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721016|NCT00045942|156828455|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721017|NCT00045942|156828456|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721018|NCT00045942|156828457|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
48721019|NCT00045942|156828449|FG000|PKC412A2104E2|Lost to Follow-up|0|||
48721020|NCT00045942|156828450|FG001|PKC412A2104E2|Lost to Follow-up|0|||
48721021|NCT00045942|156828451|FG002|PKC412A2104E2|Lost to Follow-up|0|||
48721022|NCT00045942|156828452|FG003|PKC412A2104E2|Lost to Follow-up|0|||
48721023|NCT00045942|156828453|FG004|PKC412A2104E2|Lost to Follow-up|0|||
48721024|NCT00045942|156828454|FG005|PKC412A2104E2|Lost to Follow-up|0|||
48721025|NCT00045942|156828455|FG006|PKC412A2104E2|Lost to Follow-up|0|||
48721026|NCT00045942|156828456|FG007|PKC412A2104E2|Lost to Follow-up|3|||
48721027|NCT00045942|156828457|FG008|PKC412A2104E2|Lost to Follow-up|0|||
48721028|NCT00045942|156828449|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
48721029|NCT00045942|156828450|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
48721030|NCT00045942|156828451|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
48721031|NCT00045942|156828452|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
48721032|NCT00045942|156828453|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
48721033|NCT00045942|156828454|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
48721034|NCT00045942|156828455|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
48721035|NCT00045942|156828456|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
48721036|NCT00045942|156828457|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
48721037|NCT00045942|156828449|FG000|PKC412A2104E2|Lack of Efficacy|0|||
48721038|NCT00045942|156828450|FG001|PKC412A2104E2|Lack of Efficacy|0|||
48721039|NCT00045942|156828451|FG002|PKC412A2104E2|Lack of Efficacy|0|||
48721040|NCT00045942|156828452|FG003|PKC412A2104E2|Lack of Efficacy|0|||
48721041|NCT00045942|156828453|FG004|PKC412A2104E2|Lack of Efficacy|0|||
48721042|NCT00045942|156828454|FG005|PKC412A2104E2|Lack of Efficacy|3|||
48721043|NCT00045942|156828455|FG006|PKC412A2104E2|Lack of Efficacy|2|||
48721044|NCT00045942|156828456|FG007|PKC412A2104E2|Lack of Efficacy|2|||
48721045|NCT00045942|156828457|FG008|PKC412A2104E2|Lack of Efficacy|6|||
48721046|NCT00045942|156828449|FG000|PKC412A2104E2|Adverse Event|0|||
48721047|NCT00045942|156828450|FG001|PKC412A2104E2|Adverse Event|0|||
48721048|NCT00045942|156828451|FG002|PKC412A2104E2|Adverse Event|0|||
48721049|NCT00045942|156828452|FG003|PKC412A2104E2|Adverse Event|0|||
48721050|NCT00045942|156828453|FG004|PKC412A2104E2|Adverse Event|0|||
48721051|NCT00045942|156828454|FG005|PKC412A2104E2|Adverse Event|4|||
48721052|NCT00045942|156828455|FG006|PKC412A2104E2|Adverse Event|3|||
48721053|NCT00045942|156828456|FG007|PKC412A2104E2|Adverse Event|1|||
48721054|NCT00045942|156828457|FG008|PKC412A2104E2|Adverse Event|0|||
48721055|NCT00045942|156828449|FG000|PKC412A2104E2|Death|0|||
48721056|NCT00045942|156828450|FG001|PKC412A2104E2|Death|0|||
48721057|NCT00045942|156828451|FG002|PKC412A2104E2|Death|0|||
48721058|NCT00045942|156828452|FG003|PKC412A2104E2|Death|0|||
48721059|NCT00045942|156828453|FG004|PKC412A2104E2|Death|0|||
48721060|NCT00045942|156828454|FG005|PKC412A2104E2|Death|1|||
48721061|NCT00045942|156828455|FG006|PKC412A2104E2|Death|2|||
48721062|NCT00045942|156828456|FG007|PKC412A2104E2|Death|0|||
48721063|NCT00045942|156828457|FG008|PKC412A2104E2|Death|0|||
48721064|NCT03774823|156828458|FG000|Overall Study|Withdrawal by Subject|1|||
48721065|NCT03774823|156828459|FG001|Overall Study|Withdrawal by Subject|1|||
48721066|NCT04905498|156828466|FG000|Overall Study|Lost to Follow-up|0|||
48721067|NCT04905498|156828467|FG001|Overall Study|Lost to Follow-up|2|||
48721068|NCT04905498|156828466|FG000|Overall Study|COVID lockdown|1|||
48500435|NCT00048581|156028153|FG000|Double-Blind Period|Lack of Efficacy|14|||
48500436|NCT00048581|156028154|FG001|Double-Blind Period|Lack of Efficacy|27|||
48500437|NCT00048581|156028155|FG002|Double-Blind Period|Lack of Efficacy|0|||
48500438|NCT00048581|156028153|FG000|Double-Blind Period|Lost to Follow-up|5|||
48500439|NCT00048581|156028154|FG001|Double-Blind Period|Lost to Follow-up|0|||
48500440|NCT00048581|156028155|FG002|Double-Blind Period|Lost to Follow-up|0|||
48500441|NCT00048581|156028153|FG000|Double-Blind Period|Withdrawal by Subject|5|||
48500442|NCT00048581|156028154|FG001|Double-Blind Period|Withdrawal by Subject|2|||
48500443|NCT00048581|156028155|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48500444|NCT00048581|156028153|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
48500445|NCT00048581|156028154|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
48500446|NCT00048581|156028155|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
48500447|NCT00048581|156028153|FG000|Double-Blind Period|Investigator Decision|1|||
48500448|NCT00048581|156028154|FG001|Double-Blind Period|Investigator Decision|0|||
48599719|NCT03810456|156389823|FG002|1 Month Follow-Up|Relocated to Different State|1|||
48721069|NCT04905498|156828467|FG001|Overall Study|COVID lockdown|0|||
48721070|NCT00409175|156828468|FG000|Overall Study|Adverse Event|4|||
48721071|NCT00409175|156828469|FG001|Overall Study|Adverse Event|3|||
48721072|NCT00409175|156828468|FG000|Overall Study|Withdrawal by Subject|1|||
48816183|NCT04838626|157170378|FG000|Overall Study|Physician Decision|6|||
48816184|NCT04838626|157170378|FG000|Overall Study|Protocol Violation|3|||
48816185|NCT04838626|157170378|FG000|Overall Study|Withdrawal by Subject|9|||
48816186|NCT04838626|157170378|FG000|Overall Study|Technical Problems|2|||
48816187|NCT00854295|157170381|FG000|Overall Study|Death|7|||
48816188|NCT00854295|157170382|FG001|Overall Study|Death|0|||
48816189|NCT00854295|157170383|FG002|Overall Study|Death|1|||
48816190|NCT00854295|157170384|FG003|Overall Study|Death|1|||
48816191|NCT00854295|157170381|FG000|Overall Study|Adverse Event|6|||
48816192|NCT00854295|157170382|FG001|Overall Study|Adverse Event|1|||
48816193|NCT00854295|157170383|FG002|Overall Study|Adverse Event|1|||
48816194|NCT00854295|157170384|FG003|Overall Study|Adverse Event|3|||
48816195|NCT00854295|157170381|FG000|Overall Study|Lost to Follow-up|18|||
48816196|NCT00854295|157170382|FG001|Overall Study|Lost to Follow-up|5|||
48816197|NCT00854295|157170383|FG002|Overall Study|Lost to Follow-up|21|||
48816198|NCT00854295|157170384|FG003|Overall Study|Lost to Follow-up|21|||
48816199|NCT00854295|157170381|FG000|Overall Study|Physician Decision|10|||
48816200|NCT00854295|157170382|FG001|Overall Study|Physician Decision|0|||
48816201|NCT00854295|157170383|FG002|Overall Study|Physician Decision|0|||
48816202|NCT00854295|157170384|FG003|Overall Study|Physician Decision|0|||
48816203|NCT00709592|157170385|FG000|Overall Study|Unable to proceed to transplant|0|||
48816204|NCT00709592|157170386|FG001|Overall Study|Unable to proceed to transplant|1|||
48816205|NCT02726399|157170387|FG000|Overall Study|Participant Non-Compliance|1|||
48816206|NCT02726399|157170387|FG000|Overall Study|Adverse Event|2|||
48816207|NCT02726399|157170387|FG000|Overall Study|Progression of disease|4|||
48816208|NCT01254305|157170388|FG000|Overall Study|Adverse Event|6|||
48816209|NCT01254305|157170389|FG001|Overall Study|Adverse Event|3|||
48816210|NCT01254305|157170390|FG002|Overall Study|Adverse Event|2|||
48816211|NCT01254305|157170388|FG000|Overall Study|Lack of Efficacy|1|||
48816212|NCT01254305|157170389|FG001|Overall Study|Lack of Efficacy|0|||
48816213|NCT01254305|157170390|FG002|Overall Study|Lack of Efficacy|1|||
48816214|NCT01254305|157170388|FG000|Overall Study|Protocol Violation|1|||
48816215|NCT01254305|157170389|FG001|Overall Study|Protocol Violation|7|||
48816216|NCT01254305|157170390|FG002|Overall Study|Protocol Violation|3|||
48816217|NCT01254305|157170388|FG000|Overall Study|Withdrawal by Subject|4|||
48816218|NCT01254305|157170389|FG001|Overall Study|Withdrawal by Subject|2|||
48816219|NCT01254305|157170390|FG002|Overall Study|Withdrawal by Subject|4|||
48721073|NCT00409175|156828469|FG001|Overall Study|Withdrawal by Subject|2|||
48721074|NCT00409175|156828468|FG000|Overall Study|Negative genotype|0|||
48721075|NCT00409175|156828469|FG001|Overall Study|Negative genotype|1|||
48721076|NCT00409175|156828468|FG000|Overall Study|Liver transplantation|13|||
48721077|NCT00409175|156828469|FG001|Overall Study|Liver transplantation|13|||
48721078|NCT00282464|156828470|FG000|Overall Study|Adverse Event|26|||
48721079|NCT00282464|156828471|FG001|Overall Study|Adverse Event|20|||
48721080|NCT00282464|156828470|FG000|Overall Study|Lack of Efficacy|8|||
48721081|NCT00282464|156828471|FG001|Overall Study|Lack of Efficacy|8|||
48721082|NCT00282464|156828470|FG000|Overall Study|Lost to Follow-up|10|||
48721083|NCT00282464|156828471|FG001|Overall Study|Lost to Follow-up|10|||
48721084|NCT00282464|156828470|FG000|Overall Study|Withdrawal by Subject|24|||
48721085|NCT00282464|156828471|FG001|Overall Study|Withdrawal by Subject|10|||
48721086|NCT00282464|156828470|FG000|Overall Study|laboratory abnormality|1|||
48721087|NCT00282464|156828471|FG001|Overall Study|laboratory abnormality|2|||
48721088|NCT00282464|156828470|FG000|Overall Study|Protocol Violation|0|||
48721089|NCT00282464|156828471|FG001|Overall Study|Protocol Violation|7|||
48721090|NCT00282464|156828470|FG000|Overall Study|Patient moved|1|||
48721091|NCT00282464|156828471|FG001|Overall Study|Patient moved|0|||
48721092|NCT00282464|156828470|FG000|Overall Study|patient non-compliant|3|||
48721093|NCT00282464|156828471|FG001|Overall Study|patient non-compliant|0|||
48721094|NCT00282464|156828470|FG000|Overall Study|patient no show|0|||
48721095|NCT00282464|156828471|FG001|Overall Study|patient no show|1|||
48721096|NCT00282464|156828470|FG000|Overall Study|patient incarcerated|0|||
48721097|NCT00282464|156828471|FG001|Overall Study|patient incarcerated|1|||
48721098|NCT00282464|156828470|FG000|Overall Study|family crisis|0|||
48721099|NCT00282464|156828471|FG001|Overall Study|family crisis|1|||
48721100|NCT00282464|156828470|FG000|Overall Study|dispensed wrong kit|0|||
48721101|NCT00282464|156828471|FG001|Overall Study|dispensed wrong kit|1|||
48721102|NCT00282464|156828470|FG000|Overall Study|dropped due to missed visits|0|||
48721103|NCT00282464|156828471|FG001|Overall Study|dropped due to missed visits|1|||
48816220|NCT01254305|157170388|FG000|Overall Study|Lost to Follow-up|10|||
48816221|NCT01254305|157170389|FG001|Overall Study|Lost to Follow-up|6|||
48816222|NCT01254305|157170390|FG002|Overall Study|Lost to Follow-up|5|||
48816223|NCT01254305|157170388|FG000|Overall Study|Other Reasons|0|||
48816224|NCT01254305|157170389|FG001|Overall Study|Other Reasons|0|||
48816225|NCT01254305|157170390|FG002|Overall Study|Other Reasons|2|||
48721104|NCT05463198|156828472|FG000|Overall Study|Withdrawal by Subject|19|||
48816226|NCT05033743|157170391|FG000|Overall Study|Lost to Follow-up|1|||
48816227|NCT05033743|157170391|FG000|Overall Study|Protocol Violation|2|||
48816228|NCT05033743|157170391|FG000|Overall Study|Withdrawal by Subject|1|||
48500449|NCT00048581|156028155|FG002|Double-Blind Period|Investigator Decision|0|||
48500450|NCT00048581|156028153|FG000|Open-Label Period|Death|0|||
48500451|NCT00048581|156028154|FG001|Open-Label Period|Death|0|||
48500452|NCT00048581|156028155|FG002|Open-Label Period|Death|4|||
48816229|NCT01592695|157170407|FG000|Overall Study|Lost to Follow-up|8|||
48816230|NCT01592695|157170408|FG001|Overall Study|Lost to Follow-up|4|||
48816231|NCT02564055|157170409|FG000|Overall Study|Adverse Event|1|||
48816232|NCT02564055|157170410|FG001|Overall Study|Adverse Event|0|||
48816233|NCT02564055|157170411|FG002|Overall Study|Adverse Event|4|||
48816234|NCT02564055|157170412|FG003|Overall Study|Adverse Event|1|||
48816235|NCT02564055|157170413|FG004|Overall Study|Adverse Event|4|||
48816236|NCT02564055|157170414|FG005|Overall Study|Adverse Event|1|||
48816237|NCT02564055|157170409|FG000|Overall Study|Protocol Violation|1|||
48816238|NCT02564055|157170410|FG001|Overall Study|Protocol Violation|0|||
48816239|NCT02564055|157170411|FG002|Overall Study|Protocol Violation|0|||
48816240|NCT02564055|157170412|FG003|Overall Study|Protocol Violation|0|||
48816241|NCT02564055|157170413|FG004|Overall Study|Protocol Violation|0|||
48816242|NCT02564055|157170414|FG005|Overall Study|Protocol Violation|0|||
48816243|NCT02564055|157170409|FG000|Overall Study|Reached stopping criteria|0|||
48816244|NCT02564055|157170410|FG001|Overall Study|Reached stopping criteria|0|||
48816245|NCT02564055|157170411|FG002|Overall Study|Reached stopping criteria|0|||
48816246|NCT02564055|157170412|FG003|Overall Study|Reached stopping criteria|0|||
48816247|NCT02564055|157170413|FG004|Overall Study|Reached stopping criteria|0|||
48816248|NCT02564055|157170414|FG005|Overall Study|Reached stopping criteria|1|||
48816249|NCT02564055|157170409|FG000|Overall Study|Lost to Follow-up|0|||
48816250|NCT02564055|157170410|FG001|Overall Study|Lost to Follow-up|1|||
48816251|NCT02564055|157170411|FG002|Overall Study|Lost to Follow-up|4|||
48500453|NCT00048581|156028153|FG000|Open-Label Period|Adverse Event|0|||
48500454|NCT00048581|156028154|FG001|Open-Label Period|Adverse Event|0|||
48500455|NCT00048581|156028155|FG002|Open-Label Period|Adverse Event|37|||
48500456|NCT00048581|156028153|FG000|Open-Label Period|Lack of Efficacy|0|||
48500457|NCT00048581|156028154|FG001|Open-Label Period|Lack of Efficacy|0|||
48500458|NCT00048581|156028155|FG002|Open-Label Period|Lack of Efficacy|69|||
48500459|NCT00048581|156028153|FG000|Open-Label Period|Lost to Follow-up|0|||
48500460|NCT00048581|156028154|FG001|Open-Label Period|Lost to Follow-up|0|||
48500461|NCT00048581|156028155|FG002|Open-Label Period|Lost to Follow-up|14|||
48500462|NCT00048581|156028153|FG000|Open-Label Period|Withdrawal by Subject|0|||
48500463|NCT00048581|156028154|FG001|Open-Label Period|Withdrawal by Subject|0|||
48500464|NCT00048581|156028155|FG002|Open-Label Period|Withdrawal by Subject|20|||
48500465|NCT00048581|156028153|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
48500466|NCT00048581|156028154|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
48500467|NCT00048581|156028155|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
48500468|NCT00048581|156028153|FG000|Open-Label Period|Poor/Non-compliance|0|||
48500469|NCT00048581|156028154|FG001|Open-Label Period|Poor/Non-compliance|0|||
48500470|NCT00048581|156028155|FG002|Open-Label Period|Poor/Non-compliance|5|||
48500471|NCT00048581|156028153|FG000|Open-Label Period|Pregnancy|0|||
48500472|NCT00048581|156028154|FG001|Open-Label Period|Pregnancy|0|||
48500473|NCT00048581|156028155|FG002|Open-Label Period|Pregnancy|7|||
48500474|NCT00048581|156028153|FG000|Open-Label Period|Study Site Closure|0|||
48500475|NCT00048581|156028154|FG001|Open-Label Period|Study Site Closure|0|||
48500476|NCT00048581|156028155|FG002|Open-Label Period|Study Site Closure|2|||
48500477|NCT00048581|156028153|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
48500478|NCT00048581|156028154|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
48500479|NCT00048581|156028155|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
48500480|NCT00048581|156028153|FG000|Open-Label Period|Problem With Transportation To Site|0|||
48500481|NCT00048581|156028154|FG001|Open-Label Period|Problem With Transportation To Site|0|||
48500482|NCT00048581|156028155|FG002|Open-Label Period|Problem With Transportation To Site|1|||
48500483|NCT00048581|156028153|FG000|Open-Label Period|Primary Investigator Retired|0|||
48500484|NCT00048581|156028154|FG001|Open-Label Period|Primary Investigator Retired|0|||
48500485|NCT00048581|156028155|FG002|Open-Label Period|Primary Investigator Retired|2|||
48500486|NCT00048581|156028153|FG000|Open-Label Period|Study Ended By Sponsor|0|||
48500487|NCT00048581|156028154|FG001|Open-Label Period|Study Ended By Sponsor|0|||
48816252|NCT02564055|157170412|FG003|Overall Study|Lost to Follow-up|2|||
48816253|NCT02564055|157170413|FG004|Overall Study|Lost to Follow-up|1|||
48816254|NCT02564055|157170414|FG005|Overall Study|Lost to Follow-up|0|||
48599720|NCT03810456|156389821|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
48816255|NCT02564055|157170409|FG000|Overall Study|Physician Decision|0|||
48816256|NCT02564055|157170410|FG001|Overall Study|Physician Decision|0|||
48816257|NCT02564055|157170411|FG002|Overall Study|Physician Decision|1|||
48816258|NCT02564055|157170412|FG003|Overall Study|Physician Decision|0|||
48816259|NCT02564055|157170413|FG004|Overall Study|Physician Decision|0|||
48500488|NCT00048581|156028155|FG002|Open-Label Period|Study Ended By Sponsor|1|||
48500489|NCT00870870|156028162|FG000|Overall Study|Withdrawal by Subject|0|||
48500490|NCT00870870|156028163|FG001|Overall Study|Withdrawal by Subject|1|||
48500491|NCT00870870|156028164|FG002|Overall Study|Withdrawal by Subject|1|||
48816260|NCT02564055|157170414|FG005|Overall Study|Physician Decision|0|||
48816261|NCT02564055|157170409|FG000|Overall Study|Withdrawal by Subject|4|||
48816262|NCT02564055|157170410|FG001|Overall Study|Withdrawal by Subject|4|||
48816263|NCT02564055|157170411|FG002|Overall Study|Withdrawal by Subject|3|||
48816264|NCT02564055|157170412|FG003|Overall Study|Withdrawal by Subject|3|||
48816265|NCT02564055|157170413|FG004|Overall Study|Withdrawal by Subject|10|||
48500492|NCT00870870|156028165|FG003|Overall Study|Withdrawal by Subject|3|||
48721105|NCT05463198|156828472|FG000|Overall Study|Procedure Notes Missing|18|||
48721106|NCT02815280|156828475|FG000|Double-Blind Phase|Adverse Event|1|||
48721107|NCT02815280|156828476|FG001|Double-Blind Phase|Adverse Event|1|||
48721108|NCT02815280|156828475|FG000|Double-Blind Phase|Lost to Follow-up|10|||
48721109|NCT02815280|156828476|FG001|Double-Blind Phase|Lost to Follow-up|9|||
48721110|NCT02815280|156828475|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
48721111|NCT02815280|156828476|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
48721112|NCT02815280|156828475|FG000|Double-Blind Phase|Protocol Violation|2|||
48721113|NCT02815280|156828476|FG001|Double-Blind Phase|Protocol Violation|2|||
48721114|NCT02815280|156828475|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
48721115|NCT02815280|156828476|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
48721116|NCT02815280|156828475|FG000|Open-Label Phase|Adverse Event|2|||
48721117|NCT02815280|156828476|FG001|Open-Label Phase|Adverse Event|3|||
48721118|NCT02815280|156828475|FG000|Open-Label Phase|Lost to Follow-up|18|||
48721119|NCT02815280|156828476|FG001|Open-Label Phase|Lost to Follow-up|9|||
48721120|NCT02815280|156828475|FG000|Open-Label Phase|Withdrawal by Subject|33|||
48721121|NCT02815280|156828476|FG001|Open-Label Phase|Withdrawal by Subject|18|||
48721122|NCT02815280|156828475|FG000|Open-Label Phase|Protocol Violation|3|||
48721123|NCT02815280|156828476|FG001|Open-Label Phase|Protocol Violation|0|||
48721124|NCT02815280|156828475|FG000|Open-Label Phase|Administrative|26|||
48721125|NCT02815280|156828476|FG001|Open-Label Phase|Administrative|12|||
48721126|NCT02815280|156828475|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
48721127|NCT02815280|156828476|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
48721128|NCT02158364|156828488|FG000|Overall Study|Case report forms uncollected|10|||
48721129|NCT02158364|156828488|FG000|Overall Study|Protocol Deviation|50|||
48721130|NCT02412488|156828489|FG000|Overall Study|Lost to Follow-up|10|||
48721131|NCT02412488|156828489|FG000|Overall Study|Withdrawal by Subject|5|||
48721132|NCT02412488|156828489|FG000|Overall Study|Physician Decision|1|||
48721133|NCT02412488|156828489|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
48721134|NCT02412488|156828489|FG000|Overall Study|Reveal LINQ explant|1|||
48721135|NCT04381988|156828490|FG000|Overall Study|The study was terminated|4|||
48721136|NCT04381988|156828491|FG001|Overall Study|The study was terminated|0|||
48721137|NCT02915874|156828492|FG000|Overall Study|Lost to Follow-up|5|||
48721138|NCT02915874|156828493|FG001|Overall Study|Lost to Follow-up|4|||
48721139|NCT02915874|156828492|FG000|Overall Study|Withdrawal by Subject|1|||
48721140|NCT02915874|156828493|FG001|Overall Study|Withdrawal by Subject|1|||
48721141|NCT02915874|156828492|FG000|Overall Study|Started New Anxiety Medication|0|||
48721142|NCT02915874|156828493|FG001|Overall Study|Started New Anxiety Medication|1|||
48721143|NCT02195011|156828494|FG000|Overall Study|Adverse Event|4|||
48721144|NCT02195011|156828495|FG001|Overall Study|Adverse Event|0|||
48721145|NCT02195011|156828494|FG000|Overall Study|Progressive Disease|18|||
48721146|NCT02195011|156828495|FG001|Overall Study|Progressive Disease|1|||
48721147|NCT02195011|156828494|FG000|Overall Study|Withdrawal by Subject|3|||
48721148|NCT02195011|156828495|FG001|Overall Study|Withdrawal by Subject|0|||
48721149|NCT00674154|156828496|FG000|Overall Study|Withdrawal by Subject|3|||
48721150|NCT00674154|156828497|FG001|Overall Study|Withdrawal by Subject|1|||
48721151|NCT00674154|156828496|FG000|Overall Study|Did not want parathyroidectomy|0|||
48721152|NCT00674154|156828497|FG001|Overall Study|Did not want parathyroidectomy|2|||
48721153|NCT01107379|156828498|FG000|Overall Study|Withdrawal by Subject|18|||
48721154|NCT01107379|156828498|FG000|Overall Study|Lost to Follow-up|3|||
48721155|NCT05093790|156828501|FG000|Overall Study|Failure to meet continuation criteria|0|||
48721156|NCT05093790|156828502|FG001|Overall Study|Failure to meet continuation criteria|0|||
48721157|NCT05093790|156828503|FG002|Overall Study|Failure to meet continuation criteria|1|||
48721158|NCT05093790|156828504|FG003|Overall Study|Failure to meet continuation criteria|0|||
48721159|NCT05093790|156828501|FG000|Overall Study|Adverse Event|1|||
48721160|NCT05093790|156828502|FG001|Overall Study|Adverse Event|0|||
48721161|NCT05093790|156828503|FG002|Overall Study|Adverse Event|0|||
48721162|NCT05093790|156828504|FG003|Overall Study|Adverse Event|0|||
48721163|NCT00548405|156828505|FG000|Overall Study|Adverse Event|6|||
48721164|NCT00548405|156828506|FG001|Overall Study|Adverse Event|2|||
48721165|NCT00548405|156828507|FG002|Overall Study|Adverse Event|0|||
48721166|NCT00548405|156828505|FG000|Overall Study|Lack of Efficacy|6|||
48721167|NCT00548405|156828506|FG001|Overall Study|Lack of Efficacy|0|||
48721168|NCT00548405|156828507|FG002|Overall Study|Lack of Efficacy|0|||
48721169|NCT00548405|156828505|FG000|Overall Study|Physician Decision|3|||
48500493|NCT00870870|156028162|FG000|Overall Study|Adverse Event|0|||
48500494|NCT00870870|156028163|FG001|Overall Study|Adverse Event|0|||
48721170|NCT00548405|156828506|FG001|Overall Study|Physician Decision|4|||
48816266|NCT02564055|157170414|FG005|Overall Study|Withdrawal by Subject|10|||
48816267|NCT01804816|157170421|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
48816268|NCT01804816|157170421|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
48816269|NCT00474175|157170422|FG000|Overall Study|Lack of Efficacy|0|||
48816270|NCT00474175|157170423|FG001|Overall Study|Lack of Efficacy|0|||
48816271|NCT00474175|157170424|FG002|Overall Study|Lack of Efficacy|1|||
48816272|NCT00474175|157170422|FG000|Overall Study|Withdrawal by Subject|0|||
48500495|NCT00870870|156028164|FG002|Overall Study|Adverse Event|2|||
48721171|NCT00548405|156828507|FG002|Overall Study|Physician Decision|1|||
48721172|NCT00548405|156828505|FG000|Overall Study|Pregnancy|1|||
48721173|NCT00548405|156828506|FG001|Overall Study|Pregnancy|0|||
48721174|NCT00548405|156828507|FG002|Overall Study|Pregnancy|0|||
48721175|NCT00548405|156828505|FG000|Overall Study|Protocol Violation|1|||
48721176|NCT00548405|156828506|FG001|Overall Study|Protocol Violation|0|||
48721177|NCT00548405|156828507|FG002|Overall Study|Protocol Violation|0|||
48721178|NCT00548405|156828505|FG000|Overall Study|Withdrawal by Subject|36|||
48721179|NCT00548405|156828506|FG001|Overall Study|Withdrawal by Subject|12|||
48721180|NCT00548405|156828507|FG002|Overall Study|Withdrawal by Subject|5|||
48721181|NCT00548405|156828505|FG000|Overall Study|Lost to Follow-up|1|||
48721182|NCT00548405|156828506|FG001|Overall Study|Lost to Follow-up|1|||
48721183|NCT00548405|156828507|FG002|Overall Study|Lost to Follow-up|2|||
48721184|NCT00548405|156828505|FG000|Overall Study|Death|0|||
48721185|NCT00548405|156828506|FG001|Overall Study|Death|1|||
48721186|NCT00548405|156828507|FG002|Overall Study|Death|1|||
48721187|NCT00548405|156828505|FG000|Overall Study|Sponsor decision|1|||
48721188|NCT00548405|156828506|FG001|Overall Study|Sponsor decision|0|||
48721189|NCT00548405|156828507|FG002|Overall Study|Sponsor decision|0|||
48721190|NCT00548405|156828505|FG000|Overall Study|Randomized but not treated|1|||
48721191|NCT00548405|156828506|FG001|Overall Study|Randomized but not treated|0|||
48721192|NCT00548405|156828507|FG002|Overall Study|Randomized but not treated|0|||
48721193|NCT01609478|156828509|FG000|Overall Study|Adverse Event|3|||
48721194|NCT01609478|156828510|FG001|Overall Study|Adverse Event|1|||
48721195|NCT01609478|156828511|FG002|Overall Study|Adverse Event|5|||
48721196|NCT01609478|156828509|FG000|Overall Study|Protocol Deviation|0|||
48721197|NCT01609478|156828510|FG001|Overall Study|Protocol Deviation|1|||
48721198|NCT01609478|156828511|FG002|Overall Study|Protocol Deviation|1|||
48721199|NCT01609478|156828509|FG000|Overall Study|Non-Compliance with study treatment|1|||
48721200|NCT01609478|156828510|FG001|Overall Study|Non-Compliance with study treatment|0|||
48721201|NCT01609478|156828511|FG002|Overall Study|Non-Compliance with study treatment|0|||
48721202|NCT01609478|156828509|FG000|Overall Study|Physician Decision|1|||
48721203|NCT01609478|156828510|FG001|Overall Study|Physician Decision|0|||
48721204|NCT01609478|156828511|FG002|Overall Study|Physician Decision|1|||
48721205|NCT01609478|156828509|FG000|Overall Study|Withdrawal by Subject|2|||
48721206|NCT01609478|156828510|FG001|Overall Study|Withdrawal by Subject|0|||
48721207|NCT01609478|156828511|FG002|Overall Study|Withdrawal by Subject|2|||
48721208|NCT00459056|156828512|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
48721209|NCT00459056|156828513|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
48721210|NCT02793622|156828514|FG000|Overall Study|Lost to Follow-up|31|||
48721211|NCT02793622|156828515|FG001|Overall Study|Lost to Follow-up|19|||
48721212|NCT02793622|156828514|FG000|Overall Study|Withdrawal by Subject|21|||
48721213|NCT02793622|156828515|FG001|Overall Study|Withdrawal by Subject|17|||
48721214|NCT02793622|156828514|FG000|Overall Study|Adverse Event|0|||
48721215|NCT02793622|156828515|FG001|Overall Study|Adverse Event|1|||
48721216|NCT02793622|156828514|FG000|Overall Study|Protocol Violation|1|||
48721217|NCT02793622|156828515|FG001|Overall Study|Protocol Violation|5|||
48721218|NCT00492063|156828516|FG000|Overall Study|Death|0|||
48721219|NCT00492063|156828517|FG001|Overall Study|Death|0|||
48721220|NCT00492063|156828518|FG002|Overall Study|Death|1|||
48721221|NCT00492063|156828519|FG003|Overall Study|Death|2|||
48721222|NCT00492063|156828516|FG000|Overall Study|Withdrawal by Subject|4|||
48721223|NCT00492063|156828517|FG001|Overall Study|Withdrawal by Subject|3|||
48721224|NCT00492063|156828518|FG002|Overall Study|Withdrawal by Subject|5|||
48721225|NCT00492063|156828519|FG003|Overall Study|Withdrawal by Subject|4|||
48721226|NCT00492063|156828516|FG000|Overall Study|Lost to Follow-up|6|||
48721227|NCT00492063|156828517|FG001|Overall Study|Lost to Follow-up|11|||
48721228|NCT00492063|156828518|FG002|Overall Study|Lost to Follow-up|5|||
48721229|NCT00492063|156828519|FG003|Overall Study|Lost to Follow-up|3|||
48721230|NCT00492063|156828516|FG000|Overall Study|Protocol Violation|0|||
48721231|NCT00492063|156828517|FG001|Overall Study|Protocol Violation|0|||
48721232|NCT00492063|156828518|FG002|Overall Study|Protocol Violation|0|||
48721233|NCT00492063|156828519|FG003|Overall Study|Protocol Violation|1|||
48721234|NCT00592774|156828522|FG000|Overall Study|Adverse Event|5|||
48816273|NCT00474175|157170423|FG001|Overall Study|Withdrawal by Subject|1|||
48816274|NCT00474175|157170424|FG002|Overall Study|Withdrawal by Subject|1|||
48500496|NCT00870870|156028165|FG003|Overall Study|Adverse Event|2|||
48721235|NCT00592774|156828523|FG001|Overall Study|Adverse Event|19|||
48721236|NCT00592774|156828524|FG002|Overall Study|Adverse Event|2|||
48721237|NCT00592774|156828525|FG003|Overall Study|Adverse Event|14|||
48721238|NCT00592774|156828526|FG004|Overall Study|Adverse Event|8|||
48816275|NCT00474175|157170422|FG000|Overall Study|Ineligible|1|||
48816276|NCT00474175|157170423|FG001|Overall Study|Ineligible|3|||
48816277|NCT00474175|157170424|FG002|Overall Study|Ineligible|1|||
48816278|NCT00474175|157170422|FG000|Overall Study|Protocol Violation|0|||
48816279|NCT00474175|157170423|FG001|Overall Study|Protocol Violation|2|||
48721239|NCT00592774|156828522|FG000|Overall Study|Protocol Violation|0|||
48816280|NCT00474175|157170424|FG002|Overall Study|Protocol Violation|1|||
48816281|NCT00474175|157170422|FG000|Overall Study|Administrative|0|||
48816282|NCT00474175|157170423|FG001|Overall Study|Administrative|1|||
48816283|NCT00474175|157170424|FG002|Overall Study|Administrative|0|||
48816284|NCT00919893|157170427|FG000|Overall Study|Protocol Violation|19|||
48816285|NCT00919893|157170428|FG001|Overall Study|Protocol Violation|9|||
48816286|NCT00197028|157170429|FG000|Overall Study|Adverse Event|2|||
48816287|NCT00197028|157170430|FG001|Overall Study|Adverse Event|2|||
48816288|NCT00197028|157170429|FG000|Overall Study|Protocol Violation|2|||
48816289|NCT00197028|157170430|FG001|Overall Study|Protocol Violation|1|||
48816290|NCT00197028|157170429|FG000|Overall Study|Withdrawal by Subject|8|||
48816291|NCT00197028|157170430|FG001|Overall Study|Withdrawal by Subject|12|||
48816292|NCT00197028|157170429|FG000|Overall Study|Lost to Follow-up|1|||
48816293|NCT00197028|157170430|FG001|Overall Study|Lost to Follow-up|0|||
48816294|NCT00197028|157170429|FG000|Overall Study|Other|3|||
48816295|NCT00197028|157170430|FG001|Overall Study|Other|6|||
48816296|NCT02287610|157170431|FG000|Overall Study|Lost to Follow-up|3|||
48816297|NCT02287610|157170431|FG000|Overall Study|Withdrawal by Subject|8|||
48816298|NCT02287610|157170431|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
48816299|NCT02080520|157170432|FG000|Overall Study|Self-reported symptoms|5|||
48816300|NCT02080520|157170433|FG001|Overall Study|Self-reported symptoms|6|||
48816301|NCT02080520|157170432|FG000|Overall Study|Unable to contact|2|||
48816302|NCT02080520|157170433|FG001|Overall Study|Unable to contact|1|||
48816303|NCT02080520|157170432|FG000|Overall Study|Initiated aspirin|2|||
48816304|NCT02080520|157170433|FG001|Overall Study|Initiated aspirin|0|||
48816305|NCT02080520|157170432|FG000|Overall Study|Atrial fibrillation|1|||
48816306|NCT02080520|157170433|FG001|Overall Study|Atrial fibrillation|1|||
48816307|NCT02080520|157170432|FG000|Overall Study|Cancer|1|||
48816308|NCT02080520|157170433|FG001|Overall Study|Cancer|2|||
48816309|NCT02080520|157170432|FG000|Overall Study|Not interested in study|1|||
48816310|NCT02080520|157170433|FG001|Overall Study|Not interested in study|3|||
48816311|NCT02080520|157170432|FG000|Overall Study|Too busy|1|||
48816312|NCT02080520|157170433|FG001|Overall Study|Too busy|1|||
48816313|NCT02080520|157170432|FG000|Overall Study|Work-related injury|1|||
48816314|NCT02080520|157170433|FG001|Overall Study|Work-related injury|0|||
48816315|NCT02080520|157170432|FG000|Overall Study|Personal reasons|0|||
48816316|NCT02080520|157170433|FG001|Overall Study|Personal reasons|3|||
48816317|NCT00794820|157170434|FG000|Overall Study|Adverse Event|11|||
48816318|NCT00794820|157170434|FG000|Overall Study|Secondary Malignancies|2|||
48816319|NCT00794820|157170434|FG000|Overall Study|Resistant Disease|2|||
48816320|NCT00794820|157170434|FG000|Overall Study|Ineligible/Screen Failure|1|||
48816321|NCT00432679|157170440|FG000|Overall Study|Adverse Event|2|||
48816322|NCT00432679|157170441|FG001|Overall Study|Adverse Event|1|||
48816323|NCT00432679|157170440|FG000|Overall Study|Withdrawal by Subject|3|||
48816324|NCT00432679|157170441|FG001|Overall Study|Withdrawal by Subject|2|||
48816325|NCT01923389|157170446|FG000|Overall Study|Protocol Violation|1|||
48816326|NCT01923389|157170447|FG001|Overall Study|Protocol Violation|0|||
48816327|NCT04267614|157170451|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
48500497|NCT00841100|156028166|FG000|Phase 1 (28 Days)|Adverse Event|1|||
48721240|NCT00592774|156828523|FG001|Overall Study|Protocol Violation|1|||
48721241|NCT00592774|156828524|FG002|Overall Study|Protocol Violation|0|||
48721242|NCT00592774|156828525|FG003|Overall Study|Protocol Violation|0|||
48721243|NCT00592774|156828526|FG004|Overall Study|Protocol Violation|1|||
48721244|NCT00592774|156828522|FG000|Overall Study|Withdrawal by Subject|3|||
48721245|NCT00592774|156828523|FG001|Overall Study|Withdrawal by Subject|7|||
48721246|NCT00592774|156828524|FG002|Overall Study|Withdrawal by Subject|0|||
48721247|NCT00592774|156828525|FG003|Overall Study|Withdrawal by Subject|0|||
48721248|NCT00592774|156828526|FG004|Overall Study|Withdrawal by Subject|0|||
48721249|NCT00592774|156828522|FG000|Overall Study|Lack of Efficacy|3|||
48816328|NCT04267614|157170451|FG000|Overall Study|Lost to Follow-up|115|||
48816329|NCT00088205|157170452|FG000|Overall Study|Adverse Event|4|||
48816330|NCT00088205|157170452|FG000|Overall Study|Progressive Disease|51|||
48816331|NCT00088205|157170452|FG000|Overall Study|Physician Decision|1|||
48816332|NCT00088205|157170452|FG000|Overall Study|Death Due to Study Disease|4|||
48500498|NCT00841100|156028166|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
48500499|NCT03420300|156028167|FG000|Overall Study|Death|2|||
48816333|NCT00988351|157170453|FG000|Overall Study|Withdrawal by Subject|8|||
48816334|NCT00988351|157170454|FG001|Overall Study|Withdrawal by Subject|0|||
48816335|NCT00988351|157170453|FG000|Overall Study|Lost to Follow-up|6|||
48816336|NCT00988351|157170454|FG001|Overall Study|Lost to Follow-up|9|||
48816337|NCT00988351|157170453|FG000|Overall Study|not using CPAP|5|||
48816338|NCT00988351|157170454|FG001|Overall Study|not using CPAP|3|||
48816339|NCT01364727|157170455|FG000|Overall Study|Not Eligible|2|||
48816340|NCT01310868|157170459|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
48816341|NCT01558674|157170460|FG000|Part 1|Study Terminated by Sponsor|10|||
48816342|NCT01558674|157170461|FG001|Part 1|Study Terminated by Sponsor|0|||
48816343|NCT01558674|157170460|FG000|Part 1|Withdrawal by Subject|1|||
48816344|NCT01558674|157170461|FG001|Part 1|Withdrawal by Subject|0|||
48816345|NCT04297241|157170464|FG000|Overall Study|Withdrawal by Subject|1|||
48816346|NCT04297241|157170464|FG000|Overall Study|Adverse Event|1|||
48816347|NCT04297241|157170464|FG000|Overall Study|Physician Decision|3|||
48816348|NCT02411591|157170465|FG000|Overall Study|Adverse Event|0|||
48816349|NCT02411591|157170466|FG001|Overall Study|Adverse Event|4|||
48816350|NCT02411591|157170467|FG002|Overall Study|Adverse Event|2|||
48816351|NCT02411591|157170465|FG000|Overall Study|Withdrawal by Subject|0|||
48816352|NCT02411591|157170466|FG001|Overall Study|Withdrawal by Subject|3|||
48816353|NCT02411591|157170467|FG002|Overall Study|Withdrawal by Subject|0|||
48816354|NCT02411591|157170465|FG000|Overall Study|Physician Decision|0|||
48816355|NCT02411591|157170466|FG001|Overall Study|Physician Decision|3|||
48816356|NCT02411591|157170467|FG002|Overall Study|Physician Decision|1|||
48816357|NCT03044353|157170468|FG000|Overall Study|Adverse Event|0|||
48816358|NCT03044353|157170469|FG001|Overall Study|Adverse Event|1|||
48816359|NCT03044353|157170470|FG002|Overall Study|Adverse Event|0|||
48816360|NCT02141659|157170471|FG000|Overall Study|Major Protocol Deviation|0|||
48816361|NCT02141659|157170472|FG001|Overall Study|Major Protocol Deviation|1|||
48816362|NCT02141659|157170473|FG002|Overall Study|Major Protocol Deviation|0|||
48816363|NCT02141659|157170474|FG003|Overall Study|Major Protocol Deviation|0|||
48816364|NCT02141659|157170475|FG004|Overall Study|Major Protocol Deviation|0|||
48816365|NCT02141659|157170476|FG005|Overall Study|Major Protocol Deviation|0|||
48816366|NCT02141659|157170471|FG000|Overall Study|Lack of Efficacy|0|||
48816367|NCT02141659|157170472|FG001|Overall Study|Lack of Efficacy|0|||
48816368|NCT02141659|157170473|FG002|Overall Study|Lack of Efficacy|0|||
48816369|NCT02141659|157170474|FG003|Overall Study|Lack of Efficacy|0|||
48816370|NCT02141659|157170475|FG004|Overall Study|Lack of Efficacy|0|||
48816371|NCT02141659|157170476|FG005|Overall Study|Lack of Efficacy|1|||
48816372|NCT02141659|157170471|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
48816373|NCT02141659|157170472|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
48816374|NCT02141659|157170473|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
48816375|NCT02141659|157170474|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
48816376|NCT02141659|157170475|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
48816377|NCT02141659|157170476|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
48816378|NCT02954575|157170477|FG000|Overall Study|Withdrawal by Subject|2|||
48816379|NCT02954575|157170477|FG000|Overall Study|Adverse Event|1|||
48816380|NCT03358329|157170479|FG000|Overall Study|Lost to Follow-up|2|||
48816381|NCT03358329|157170479|FG000|Overall Study|Withdrawal by Subject|2|||
48816382|NCT01313923|157170480|FG000|Overall Study|Physician Decision|3|||
48816383|NCT02836613|157170483|FG000|Overall Study|Accidental drowning|1|||
48816384|NCT02836613|157170484|FG001|Overall Study|Accidental drowning|0|||
48816385|NCT02836613|157170483|FG000|Overall Study|Lost to Follow-up|0|||
48816386|NCT02836613|157170484|FG001|Overall Study|Lost to Follow-up|1|||
48816387|NCT02836613|157170483|FG000|Overall Study|Withdrawal by Subject|0|||
48816388|NCT02836613|157170484|FG001|Overall Study|Withdrawal by Subject|2|||
48816389|NCT03824938|157170485|FG000|Overall Study|Withdrawal by Subject|2|||
48816390|NCT03824938|157170486|FG001|Overall Study|Withdrawal by Subject|1|||
48816391|NCT03824938|157170487|FG002|Overall Study|Withdrawal by Subject|0|||
48816392|NCT03824938|157170488|FG003|Overall Study|Withdrawal by Subject|2|||
48816393|NCT03824938|157170489|FG004|Overall Study|Withdrawal by Subject|0|||
48816394|NCT03824938|157170490|FG005|Overall Study|Withdrawal by Subject|1|||
48816395|NCT03824938|157170485|FG000|Overall Study|Lost to Follow-up|0|||
48816396|NCT03824938|157170486|FG001|Overall Study|Lost to Follow-up|1|||
48816397|NCT03824938|157170487|FG002|Overall Study|Lost to Follow-up|0|||
48816398|NCT03824938|157170488|FG003|Overall Study|Lost to Follow-up|0|||
48816399|NCT03824938|157170489|FG004|Overall Study|Lost to Follow-up|1|||
48816400|NCT03824938|157170490|FG005|Overall Study|Lost to Follow-up|0|||
48816401|NCT01990300|157170491|FG000|Overall Study|Case Report Forms Uncollected|89|||
48816402|NCT01990300|157170491|FG000|Overall Study|Protocol Deviation|53|||
48816403|NCT00065468|157170494|FG000|Overall Study|Death|172|||
48816404|NCT00065468|157170495|FG001|Overall Study|Death|169|||
48500500|NCT02658084|156028172|FG000|Overall Study|Withdrawal by Subject|1|||
48816405|NCT00065468|157170496|FG002|Overall Study|Death|171|||
48816406|NCT00065468|157170494|FG000|Overall Study|Withdrawal by Subject|3|||
48816407|NCT00065468|157170495|FG001|Overall Study|Withdrawal by Subject|4|||
48500501|NCT02658084|156028173|FG001|Overall Study|Withdrawal by Subject|0|||
48500502|NCT02658084|156028172|FG000|Overall Study|Study Termination|1|||
48816408|NCT00065468|157170496|FG002|Overall Study|Withdrawal by Subject|5|||
48816409|NCT00065468|157170494|FG000|Overall Study|Lost to Follow-up|5|||
48816410|NCT00065468|157170495|FG001|Overall Study|Lost to Follow-up|3|||
48816411|NCT00065468|157170496|FG002|Overall Study|Lost to Follow-up|2|||
48816412|NCT00065468|157170494|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
48816413|NCT00065468|157170495|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
48816414|NCT00065468|157170496|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
48816415|NCT00065468|157170494|FG000|Overall Study|Disease progression|0|||
48816416|NCT00065468|157170495|FG001|Overall Study|Disease progression|0|||
48816417|NCT00065468|157170496|FG002|Overall Study|Disease progression|1|||
48816418|NCT00065468|157170494|FG000|Overall Study|Other|14|||
48816419|NCT00065468|157170495|FG001|Overall Study|Other|24|||
48816420|NCT00065468|157170496|FG002|Overall Study|Other|18|||
48816421|NCT01225835|157170497|FG000|Overall Study|Completed protocol|2|||
48816422|NCT01225835|157170498|FG001|Overall Study|Completed protocol|1|||
48816423|NCT01225835|157170497|FG000|Overall Study|Did not meet hCG criterion|2|||
48816424|NCT01225835|157170498|FG001|Overall Study|Did not meet hCG criterion|0|||
48816425|NCT01225835|157170497|FG000|Overall Study|Adverse Event|2|||
48816426|NCT01225835|157170498|FG001|Overall Study|Adverse Event|1|||
48816427|NCT01225835|157170497|FG000|Overall Study|Other|1|||
48816428|NCT01225835|157170498|FG001|Overall Study|Other|1|||
48816429|NCT03443323|157170499|FG000|Overall Study|Lost to Follow-up|2|||
48816430|NCT03443323|157170500|FG001|Overall Study|Lost to Follow-up|2|||
48816431|NCT03443323|157170499|FG000|Overall Study|PI withdrawal|1|||
48816432|NCT03443323|157170500|FG001|Overall Study|PI withdrawal|0|||
48816433|NCT02589392|157170501|FG000|Overall Study|Adverse Event|1|||
48816434|NCT02589392|157170502|FG001|Overall Study|Adverse Event|1|||
48816435|NCT02589392|157170501|FG000|Overall Study|Withdrawal by Subject|1|||
48816436|NCT02589392|157170502|FG001|Overall Study|Withdrawal by Subject|2|||
48816437|NCT02589392|157170501|FG000|Overall Study|Protocol Violation|1|||
48816438|NCT02589392|157170502|FG001|Overall Study|Protocol Violation|1|||
48816439|NCT02589392|157170501|FG000|Overall Study|Lost to Follow-up|2|||
48816440|NCT02589392|157170502|FG001|Overall Study|Lost to Follow-up|2|||
48816441|NCT02589392|157170501|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
48816442|NCT02589392|157170502|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
48816443|NCT04927364|157170508|FG000|Overall Study|Withdrawal by Subject|3|||
48816444|NCT04927364|157170508|FG000|Overall Study|Unable to complete preassessment MRI|1|||
48816445|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
48816446|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
48816447|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
48816448|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
48816449|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
48816450|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
48816451|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
48599721|NCT03810456|156389822|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
48816452|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Death|0|||
48816453|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Death|1|||
48816454|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Death|0|||
48816455|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Death|0|||
48816456|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Death|0|||
48816457|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Death|0|||
48816458|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Death|0|||
48816459|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
48816460|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816461|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816462|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816463|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816464|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816465|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
48816466|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816467|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
48816468|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816469|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816470|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48721250|NCT00592774|156828523|FG001|Overall Study|Lack of Efficacy|3|||
48721251|NCT00592774|156828524|FG002|Overall Study|Lack of Efficacy|0|||
48721252|NCT00592774|156828525|FG003|Overall Study|Lack of Efficacy|0|||
48721253|NCT00592774|156828526|FG004|Overall Study|Lack of Efficacy|2|||
48721254|NCT00592774|156828522|FG000|Overall Study|Physician Decision|0|||
48721255|NCT00592774|156828523|FG001|Overall Study|Physician Decision|1|||
48721256|NCT00592774|156828524|FG002|Overall Study|Physician Decision|1|||
48721257|NCT00592774|156828525|FG003|Overall Study|Physician Decision|0|||
48721258|NCT00592774|156828526|FG004|Overall Study|Physician Decision|1|||
48816471|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816472|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
48816473|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Other|1|||
48816474|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Other|0|||
48816475|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Other|0|||
48816476|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Other|0|||
48816477|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Other|0|||
48816478|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Other|0|||
48816479|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Other|0|||
48500503|NCT02658084|156028173|FG001|Overall Study|Study Termination|0|||
48500504|NCT04149964|156028176|FG000|Overall Study|Lost to Follow-up|19|||
48816480|NCT04585815|157170514|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
48816481|NCT04585815|157170515|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
48816482|NCT04585815|157170516|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816483|NCT04585815|157170517|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816484|NCT04585815|157170518|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816485|NCT04585815|157170519|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816486|NCT04585815|157170520|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
48816487|NCT04585815|157170514|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816488|NCT04585815|157170515|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
48816489|NCT04585815|157170516|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816490|NCT04585815|157170517|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816491|NCT04585815|157170518|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816492|NCT04585815|157170519|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816493|NCT04585815|157170520|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
48816494|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
48816495|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
48816496|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
48816497|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
48816498|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
48816499|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
48816500|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
48816501|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Death|0|||
48816502|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Death|0|||
48816503|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Death|0|||
48816504|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Death|1|||
48816505|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Death|0|||
48816506|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Death|0|||
48816507|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Death|0|||
48816508|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816509|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816510|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816511|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
48816512|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816513|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
48816514|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
48816515|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816516|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816517|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816518|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
48816519|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816520|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816521|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
48816522|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48721259|NCT00592774|156828522|FG000|Overall Study|Other|0|||
48721260|NCT00592774|156828523|FG001|Overall Study|Other|1|||
48721261|NCT00592774|156828524|FG002|Overall Study|Other|1|||
48721262|NCT00592774|156828525|FG003|Overall Study|Other|0|||
48721263|NCT00592774|156828526|FG004|Overall Study|Other|2|||
48721264|NCT00278915|156828527|FG000|Overall Study|Disease progression|1|||
48721265|NCT00586664|156828528|FG000|Overall Study|Withdrawal by Subject|3|||
48721266|NCT00586664|156828529|FG001|Overall Study|Withdrawal by Subject|7|||
48816523|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48816524|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48816525|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48816526|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48500505|NCT04149964|156028177|FG001|Overall Study|Lost to Follow-up|18|||
48721267|NCT00586664|156828530|FG002|Overall Study|Withdrawal by Subject|1|||
48599722|NCT03810456|156389823|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
48599723|NCT03810456|156389821|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
48599724|NCT03810456|156389822|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
48599725|NCT03810456|156389823|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
48599726|NCT03810456|156389821|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
48599727|NCT03810456|156389822|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
48599728|NCT03810456|156389823|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
48721268|NCT00586664|156828528|FG000|Overall Study|Exclusion criteria met|2|||
48721269|NCT00586664|156828529|FG001|Overall Study|Exclusion criteria met|0|||
48721270|NCT00586664|156828530|FG002|Overall Study|Exclusion criteria met|0|||
48721271|NCT01037088|156828535|FG000|Overall Study|Withdrawal by Subject|3|||
48721272|NCT01585584|156828546|FG000|Overall Study|Lack of Efficacy|1|||
48721273|NCT01585584|156828546|FG000|Overall Study|Withdrawal by Subject|1|||
48599729|NCT03810456|156389821|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
48721274|NCT01585584|156828546|FG000|Overall Study|Physician Decision|2|||
48721275|NCT00527488|156828547|FG000|Overall Study|Withdrawn prior to dosing|0|||
48721276|NCT00527488|156828548|FG001|Overall Study|Withdrawn prior to dosing|1|||
48721277|NCT00527488|156828549|FG002|Overall Study|Withdrawn prior to dosing|1|||
48721278|NCT00527488|156828550|FG003|Overall Study|Withdrawn prior to dosing|0|||
48721279|NCT00266864|156828551|FG000|Overall Study|Lost to Follow-up|4|||
48721280|NCT00266864|156828552|FG001|Overall Study|Lost to Follow-up|1|||
48721281|NCT00266864|156828551|FG000|Overall Study|Withdrawal by Subject|1|||
48721282|NCT00266864|156828552|FG001|Overall Study|Withdrawal by Subject|1|||
48721283|NCT01330017|156829955|FG000|Overall Study|Adverse Event|0|||
48721284|NCT01330017|156829956|FG001|Overall Study|Adverse Event|1|||
48721285|NCT01330017|156829957|FG002|Overall Study|Adverse Event|1|||
48721286|NCT01330017|156829958|FG003|Overall Study|Adverse Event|4|||
48599730|NCT03810456|156389822|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
48599731|NCT03810456|156389823|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
48721287|NCT01330017|156829959|FG004|Overall Study|Adverse Event|0|||
48721288|NCT01330017|156829955|FG000|Overall Study|Withdrawal by Subject|0|||
48721289|NCT01330017|156829956|FG001|Overall Study|Withdrawal by Subject|0|||
48721290|NCT01330017|156829957|FG002|Overall Study|Withdrawal by Subject|1|||
48721291|NCT01330017|156829958|FG003|Overall Study|Withdrawal by Subject|0|||
48721292|NCT01330017|156829959|FG004|Overall Study|Withdrawal by Subject|1|||
48721293|NCT01330017|156829955|FG000|Overall Study|Lost to Follow-up|0|||
48721294|NCT01330017|156829956|FG001|Overall Study|Lost to Follow-up|0|||
48721295|NCT01330017|156829957|FG002|Overall Study|Lost to Follow-up|1|||
48721296|NCT01330017|156829958|FG003|Overall Study|Lost to Follow-up|0|||
48721297|NCT01330017|156829959|FG004|Overall Study|Lost to Follow-up|0|||
48721298|NCT01330017|156829955|FG000|Overall Study|Protocol Violation|0|||
48721299|NCT01330017|156829956|FG001|Overall Study|Protocol Violation|0|||
48721300|NCT01330017|156829957|FG002|Overall Study|Protocol Violation|0|||
48721301|NCT01330017|156829958|FG003|Overall Study|Protocol Violation|1|||
48721302|NCT01330017|156829959|FG004|Overall Study|Protocol Violation|0|||
48721303|NCT01330017|156829955|FG000|Overall Study|Unknown Reason|5|||
48721304|NCT01330017|156829956|FG001|Overall Study|Unknown Reason|3|||
48721305|NCT01330017|156829957|FG002|Overall Study|Unknown Reason|5|||
48721306|NCT01330017|156829958|FG003|Overall Study|Unknown Reason|7|||
48721307|NCT01330017|156829959|FG004|Overall Study|Unknown Reason|2|||
48721308|NCT00814333|156829960|FG000|Enrollment|Lost to Follow-up|1|||
48721309|NCT00814333|156829961|FG001|Enrollment|Lost to Follow-up|0|||
48721310|NCT00830869|156829962|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
48721311|NCT00830869|156829963|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
48721312|NCT00830869|156829964|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
48721313|NCT00830869|156829965|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
48721314|NCT00830869|156829966|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
48721315|NCT00830869|156829967|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
48721316|NCT00830869|156829968|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
48721317|NCT00830869|156829969|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
48721318|NCT00830869|156829970|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
48721319|NCT00830869|156829971|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
48721320|NCT00830869|156829972|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
48721321|NCT00830869|156829973|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
48721322|NCT00830869|156829962|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
48721323|NCT00830869|156829963|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
48721324|NCT00830869|156829964|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
48721325|NCT00830869|156829965|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
48721326|NCT00830869|156829966|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
48721327|NCT00830869|156829967|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
48721328|NCT00830869|156829968|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
48721329|NCT00830869|156829969|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
48721330|NCT00830869|156829970|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
48721331|NCT00830869|156829971|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
48721332|NCT00830869|156829972|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
48721333|NCT00830869|156829973|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
48721334|NCT00830869|156829962|FG000|Period 1: Part 1|Adverse Event|0|||
48721335|NCT00830869|156829963|FG001|Period 1: Part 1|Adverse Event|0|||
48721336|NCT00830869|156829964|FG002|Period 1: Part 1|Adverse Event|0|||
48721337|NCT00830869|156829965|FG003|Period 1: Part 1|Adverse Event|0|||
48721338|NCT00830869|156829966|FG004|Period 1: Part 1|Adverse Event|0|||
48721339|NCT00830869|156829967|FG005|Period 1: Part 1|Adverse Event|1|||
48816527|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
48816528|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
48816529|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
48816530|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
48816531|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
48816532|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
48816533|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
48816534|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
48816535|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
48816536|NCT04585815|157170514|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
48816537|NCT04585815|157170515|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
48816538|NCT04585815|157170516|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
48816539|NCT04585815|157170517|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
48816540|NCT04585815|157170518|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
48816541|NCT04585815|157170519|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
48816542|NCT04585815|157170520|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
48816543|NCT04585815|157170514|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
48816544|NCT04585815|157170515|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
48816545|NCT04585815|157170516|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
48816546|NCT04585815|157170517|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
48816547|NCT04585815|157170518|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
48816548|NCT04585815|157170519|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
48816549|NCT04585815|157170520|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
48816550|NCT04585815|157170514|FG000|Sub-study B- Follow-up Phase|Death|0|||
48816551|NCT04585815|157170515|FG001|Sub-study B- Follow-up Phase|Death|0|||
48816552|NCT04585815|157170516|FG002|Sub-study B- Follow-up Phase|Death|1|||
48816553|NCT04585815|157170517|FG003|Sub-study B- Follow-up Phase|Death|3|||
48816554|NCT04585815|157170518|FG004|Sub-study B- Follow-up Phase|Death|0|||
48816555|NCT04585815|157170519|FG005|Sub-study B- Follow-up Phase|Death|0|||
48816556|NCT04585815|157170520|FG006|Sub-study B- Follow-up Phase|Death|1|||
48816557|NCT02262260|157170521|FG000|Overall Study|Adverse Event|4|||
48816558|NCT02262260|157170522|FG001|Overall Study|Adverse Event|1|||
48816559|NCT02262260|157170521|FG000|Overall Study|Withdrawal of consent|4|||
48816560|NCT02262260|157170522|FG001|Overall Study|Withdrawal of consent|2|||
48816561|NCT02262260|157170521|FG000|Overall Study|Lost to Follow-up|1|||
48816562|NCT02262260|157170522|FG001|Overall Study|Lost to Follow-up|2|||
48816563|NCT02262260|157170521|FG000|Overall Study|Protocol deviation|2|||
48816564|NCT02262260|157170522|FG001|Overall Study|Protocol deviation|5|||
48816565|NCT02169219|157170523|FG000|Overall Study|Lack of Efficacy|6|||
48816566|NCT04158648|157170525|FG000|Overall Study|Ongoing in the Study|69|||
48816567|NCT04158648|157170525|FG000|Overall Study|Withdrawal by Subject|4|||
48816568|NCT00924560|157170526|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
48816569|NCT00924560|157170527|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
48816570|NCT00924560|157170528|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
48500506|NCT01411332|156028178|FG000|Enrollment|Protocol Violation|0|||
48500507|NCT01411332|156028179|FG001|Enrollment|Protocol Violation|1|||
48500508|NCT01411332|156028178|FG000|Enrollment|Withdrawal by Subject|0|||
48500509|NCT01411332|156028179|FG001|Enrollment|Withdrawal by Subject|1|||
48500510|NCT01411332|156028178|FG000|Treatment|Lost to Follow-up|1|||
48500511|NCT01411332|156028179|FG001|Treatment|Lost to Follow-up|0|||
48500512|NCT00679367|156028180|FG000|Overall Study|Adverse Event|7|||
48500513|NCT00679367|156028180|FG000|Overall Study|inability to swallow oral drugs|1|||
48500514|NCT00679367|156028180|FG000|Overall Study|Lack of Efficacy|3|||
48500515|NCT00679367|156028180|FG000|Overall Study|Withdrawal by Subject|1|||
48500516|NCT02761980|156029360|FG000|Overall Study|Adverse Event|4|||
48500517|NCT02761980|156029361|FG001|Overall Study|Adverse Event|6|||
48500518|NCT02761980|156029362|FG002|Overall Study|Adverse Event|5|||
48500519|NCT02761980|156029363|FG003|Overall Study|Adverse Event|6|||
48500520|NCT02761980|156029360|FG000|Overall Study|Withdrawal by Subject|0|||
48500521|NCT02761980|156029361|FG001|Overall Study|Withdrawal by Subject|1|||
48500522|NCT02761980|156029362|FG002|Overall Study|Withdrawal by Subject|0|||
48500523|NCT02761980|156029363|FG003|Overall Study|Withdrawal by Subject|0|||
48500524|NCT02761980|156029360|FG000|Overall Study|Other|0|||
48500525|NCT02761980|156029361|FG001|Overall Study|Other|0|||
48500526|NCT02761980|156029362|FG002|Overall Study|Other|1|||
48721340|NCT00830869|156829968|FG006|Period 1: Part 1|Adverse Event|1|||
48500527|NCT02761980|156029363|FG003|Overall Study|Other|0|||
48721341|NCT00830869|156829969|FG007|Period 1: Part 1|Adverse Event|0|||
48721342|NCT00830869|156829970|FG008|Period 1: Part 1|Adverse Event|0|||
48721343|NCT00830869|156829971|FG009|Period 1: Part 1|Adverse Event|0|||
48721344|NCT00830869|156829972|FG010|Period 1: Part 1|Adverse Event|0|||
48721345|NCT00830869|156829973|FG011|Period 1: Part 1|Adverse Event|0|||
48721346|NCT00830869|156829962|FG000|Period 1: Part 1|Progressive disease|1|||
48721347|NCT00830869|156829963|FG001|Period 1: Part 1|Progressive disease|0|||
48721348|NCT00830869|156829964|FG002|Period 1: Part 1|Progressive disease|1|||
48721349|NCT00830869|156829965|FG003|Period 1: Part 1|Progressive disease|6|||
48721350|NCT00830869|156829966|FG004|Period 1: Part 1|Progressive disease|4|||
48721351|NCT00830869|156829967|FG005|Period 1: Part 1|Progressive disease|4|||
48721352|NCT00830869|156829968|FG006|Period 1: Part 1|Progressive disease|1|||
48721353|NCT00830869|156829969|FG007|Period 1: Part 1|Progressive disease|0|||
48721354|NCT00830869|156829970|FG008|Period 1: Part 1|Progressive disease|0|||
48721355|NCT00830869|156829971|FG009|Period 1: Part 1|Progressive disease|0|||
48721356|NCT00830869|156829972|FG010|Period 1: Part 1|Progressive disease|0|||
48721357|NCT00830869|156829973|FG011|Period 1: Part 1|Progressive disease|0|||
48721358|NCT00830869|156829962|FG000|Period 2: Part 2|Protocol Violation|0|||
48721359|NCT00830869|156829963|FG001|Period 2: Part 2|Protocol Violation|0|||
48721360|NCT00830869|156829964|FG002|Period 2: Part 2|Protocol Violation|0|||
48816571|NCT00924560|157170526|FG000|Overall Study|Non Compliance with the Protocol|20|||
48816572|NCT00924560|157170527|FG001|Overall Study|Non Compliance with the Protocol|15|||
48816573|NCT00924560|157170528|FG002|Overall Study|Non Compliance with the Protocol|4|||
48816574|NCT00924560|157170526|FG000|Overall Study|Physician Decision|2|||
48816575|NCT00924560|157170527|FG001|Overall Study|Physician Decision|3|||
48816576|NCT00924560|157170528|FG002|Overall Study|Physician Decision|4|||
48816577|NCT00924560|157170526|FG000|Overall Study|Withdrawal by Subject|50|||
48816578|NCT00924560|157170527|FG001|Overall Study|Withdrawal by Subject|44|||
48816579|NCT00924560|157170528|FG002|Overall Study|Withdrawal by Subject|18|||
48816580|NCT00924560|157170526|FG000|Overall Study|Adverse Event|39|||
48816581|NCT00924560|157170527|FG001|Overall Study|Adverse Event|33|||
48816582|NCT00924560|157170528|FG002|Overall Study|Adverse Event|0|||
48816583|NCT00924560|157170526|FG000|Overall Study|Pregnancy|5|||
48816584|NCT00924560|157170527|FG001|Overall Study|Pregnancy|7|||
48816585|NCT00924560|157170528|FG002|Overall Study|Pregnancy|1|||
48816586|NCT00924560|157170526|FG000|Overall Study|Lost to Follow-up|78|||
48816587|NCT00924560|157170527|FG001|Overall Study|Lost to Follow-up|94|||
48816588|NCT00924560|157170528|FG002|Overall Study|Lost to Follow-up|45|||
48816589|NCT00924560|157170526|FG000|Overall Study|Miscellaneous Reasons|13|||
48816590|NCT00924560|157170527|FG001|Overall Study|Miscellaneous Reasons|10|||
48816591|NCT00924560|157170528|FG002|Overall Study|Miscellaneous Reasons|10|||
48816592|NCT04426006|157170529|FG000|Inclusion|Protocol Violation|1|||
48816593|NCT04426006|157170529|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
48816594|NCT04426006|157170529|FG000|Inclusion|Blood sample at inclusion not done|1|||
48816595|NCT04426006|157170529|FG000|3 Months|Lost to Follow-up|17|||
48816596|NCT04426006|157170529|FG000|12 Months|Lost to Follow-up|38|||
48816597|NCT00550173|157170533|FG000|Overall Study|Death|45|||
48816598|NCT00550173|157170534|FG001|Overall Study|Death|38|||
48721361|NCT00830869|156829965|FG003|Period 2: Part 2|Protocol Violation|0|||
48721362|NCT00830869|156829966|FG004|Period 2: Part 2|Protocol Violation|0|||
48721363|NCT00830869|156829967|FG005|Period 2: Part 2|Protocol Violation|0|||
48721364|NCT00830869|156829968|FG006|Period 2: Part 2|Protocol Violation|0|||
48721365|NCT00830869|156829969|FG007|Period 2: Part 2|Protocol Violation|1|||
48721366|NCT00830869|156829970|FG008|Period 2: Part 2|Protocol Violation|0|||
48721367|NCT00830869|156829971|FG009|Period 2: Part 2|Protocol Violation|1|||
48721368|NCT00830869|156829972|FG010|Period 2: Part 2|Protocol Violation|0|||
48721369|NCT00830869|156829973|FG011|Period 2: Part 2|Protocol Violation|0|||
48816599|NCT00550173|157170535|FG002|Overall Study|Death|50|||
48721370|NCT00830869|156829962|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
48721371|NCT00830869|156829963|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
48721372|NCT00830869|156829964|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
48721373|NCT00830869|156829965|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
48721374|NCT00830869|156829966|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
48721375|NCT00830869|156829967|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
48721376|NCT00830869|156829968|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
48721377|NCT00830869|156829969|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
48721378|NCT00830869|156829970|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
48721379|NCT00830869|156829971|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
48721380|NCT00830869|156829972|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
48721381|NCT00830869|156829973|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
48721382|NCT00830869|156829962|FG000|Period 2: Part 2|Adverse Event|0|||
48816600|NCT00550173|157170533|FG000|Overall Study|Physician Decision|1|||
48816601|NCT00550173|157170534|FG001|Overall Study|Physician Decision|2|||
48721383|NCT00830869|156829963|FG001|Period 2: Part 2|Adverse Event|0|||
48721384|NCT00830869|156829964|FG002|Period 2: Part 2|Adverse Event|0|||
48721385|NCT00830869|156829965|FG003|Period 2: Part 2|Adverse Event|0|||
48816602|NCT00550173|157170535|FG002|Overall Study|Physician Decision|2|||
48816603|NCT00550173|157170533|FG000|Overall Study|Withdrawal by Subject|9|||
48816604|NCT00550173|157170534|FG001|Overall Study|Withdrawal by Subject|12|||
48816605|NCT00550173|157170535|FG002|Overall Study|Withdrawal by Subject|17|||
48816606|NCT00550173|157170533|FG000|Overall Study|Sponsor Decision|13|||
48816607|NCT00550173|157170534|FG001|Overall Study|Sponsor Decision|7|||
48816608|NCT00550173|157170535|FG002|Overall Study|Sponsor Decision|1|||
48816609|NCT00550173|157170533|FG000|Overall Study|Lost to Follow-up|4|||
48816610|NCT00550173|157170534|FG001|Overall Study|Lost to Follow-up|4|||
48816611|NCT00550173|157170535|FG002|Overall Study|Lost to Follow-up|3|||
48816612|NCT00097370|157170536|FG000|Stage 1|Adverse Event|3|||
48816613|NCT00097370|157170536|FG000|Stage 1|Withdrawal by Subject|1|||
48816614|NCT00097370|157170536|FG000|Stage 1|Lack of Efficacy|2|||
48816615|NCT00097370|157170536|FG000|Stage 2|Adverse Event|5|||
48816616|NCT00097370|157170536|FG000|Stage 2|Withdrawal by Subject|1|||
48816617|NCT00097370|157170536|FG000|Stage 2|Lack of Efficacy|3|||
48816618|NCT00097370|157170536|FG000|Stage 2|Pregnancy|1|||
48816619|NCT00097370|157170536|FG000|Stage 2|Sponsor Terminated Study|2|||
48816620|NCT00097370|157170536|FG000|Stage 2|Lost to Follow-up|1|||
48816621|NCT00097370|157170536|FG000|Stage 3|Adverse Event|2|||
48816622|NCT00097370|157170536|FG000|Stage 3|Withdrawal by Subject|3|||
48816623|NCT00097370|157170536|FG000|Stage 3|Lack of Efficacy|1|||
48816624|NCT00097370|157170536|FG000|Stage 3|Sponsor Terminated Study|52|||
48816625|NCT00097370|157170536|FG000|Stage 3|Lost to Follow-up|1|||
48816626|NCT00802659|157171997|FG000|Overall Study|Physician Decision|0|||
48816627|NCT00802659|157171998|FG001|Overall Study|Physician Decision|1|||
48816628|NCT00802659|157171999|FG002|Overall Study|Physician Decision|0|||
48816629|NCT00802659|157172000|FG003|Overall Study|Physician Decision|0|||
48816630|NCT00289770|157172002|FG000|Year 15|Withdrawal by Subject|1|||
48816631|NCT00737061|157172003|FG000|Waiting Period|Lost to Follow-up|6|||
48816632|NCT00737061|157172003|FG000|Waiting Period|Withdrawal by Subject|1|||
48816633|NCT00737061|157172003|FG000|Waiting Period|Bilateral placement failure|34|||
48816634|NCT00737061|157172003|FG000|Waiting Period|Deemed patent following HSG|26|||
48816635|NCT00737061|157172003|FG000|Waiting Period|Alternative contraception failure|3|||
48816636|NCT00737061|157172003|FG000|Waiting Period|Elected surgical tubal ligation|5|||
48816637|NCT00737061|157172003|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
48816638|NCT00737061|157172003|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
48816639|NCT00737061|157172003|FG000|1 Year Wearing Period|Discontinued reilance|3|||
48816640|NCT00737061|157172003|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
48816641|NCT02761629|157172004|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
48816642|NCT02761629|157172005|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
48816643|NCT02761629|157172004|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48816644|NCT02761629|157172005|FG001|Overall Study|Insufficient Therapeutic Response|7|||
48816645|NCT02761629|157172004|FG000|Overall Study|Failure to Return|2|||
48816646|NCT02761629|157172005|FG001|Overall Study|Failure to Return|4|||
48816647|NCT02761629|157172004|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
48816648|NCT02761629|157172005|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
48816649|NCT02761629|157172004|FG000|Overall Study|Protocol Violation|2|||
48816650|NCT02761629|157172005|FG001|Overall Study|Protocol Violation|2|||
48816651|NCT02761629|157172004|FG000|Overall Study|Withdrawal by Subject|0|||
48816652|NCT02761629|157172005|FG001|Overall Study|Withdrawal by Subject|3|||
48816653|NCT02761629|157172004|FG000|Overall Study|Other|0|||
48816654|NCT02761629|157172005|FG001|Overall Study|Other|2|||
48816655|NCT02761629|157172004|FG000|Overall Study|Lost to Follow-up|4|||
48816656|NCT02761629|157172005|FG001|Overall Study|Lost to Follow-up|1|||
48816657|NCT02761629|157172004|FG000|Overall Study|Randomized But Not Treated|8|||
48816658|NCT02761629|157172005|FG001|Overall Study|Randomized But Not Treated|4|||
48816659|NCT04581824|157172006|FG000|Overall Study|Ongoing|75|||
48816660|NCT04581824|157172007|FG001|Overall Study|Ongoing|69|||
48816661|NCT04581824|157172006|FG000|Overall Study|Withdrawal by Subject|3|||
48816662|NCT04581824|157172007|FG001|Overall Study|Withdrawal by Subject|5|||
48816663|NCT04581824|157172006|FG000|Overall Study|Lost to Follow-up|1|||
48816664|NCT04581824|157172007|FG001|Overall Study|Lost to Follow-up|0|||
48816665|NCT04716881|157172010|FG000|Overall Study|Adverse Event|1|||
48816666|NCT04716881|157172010|FG000|Overall Study|Lost to Follow-up|1|||
48816667|NCT04147260|157172011|FG000|Overall Study|Adverse Event|1|||
48816668|NCT04147260|157172012|FG001|Overall Study|Adverse Event|0|||
48816669|NCT04147260|157172013|FG002|Overall Study|Adverse Event|1|||
48816670|NCT04147260|157172014|FG003|Overall Study|Adverse Event|2|||
48816671|NCT04147260|157172015|FG004|Overall Study|Adverse Event|0|||
48816672|NCT04147260|157172011|FG000|Overall Study|Withdrawal by Subject|0|||
48816673|NCT04147260|157172012|FG001|Overall Study|Withdrawal by Subject|0|||
48816674|NCT04147260|157172013|FG002|Overall Study|Withdrawal by Subject|1|||
48816675|NCT04147260|157172014|FG003|Overall Study|Withdrawal by Subject|1|||
48816676|NCT04147260|157172015|FG004|Overall Study|Withdrawal by Subject|0|||
48816677|NCT01555021|157172016|FG000|Overall Study|Lost to Follow-up|1|||
48816678|NCT01555021|157172017|FG001|Overall Study|Lost to Follow-up|2|||
48816679|NCT01266993|157172026|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
48816680|NCT01266993|157172027|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
48816681|NCT01266993|157172026|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
48721386|NCT00830869|156829966|FG004|Period 2: Part 2|Adverse Event|0|||
48721387|NCT00830869|156829967|FG005|Period 2: Part 2|Adverse Event|0|||
48721388|NCT00830869|156829968|FG006|Period 2: Part 2|Adverse Event|0|||
48721389|NCT00830869|156829969|FG007|Period 2: Part 2|Adverse Event|4|||
48721390|NCT00830869|156829970|FG008|Period 2: Part 2|Adverse Event|3|||
48721391|NCT00830869|156829971|FG009|Period 2: Part 2|Adverse Event|2|||
48721392|NCT00830869|156829972|FG010|Period 2: Part 2|Adverse Event|2|||
48721393|NCT00830869|156829973|FG011|Period 2: Part 2|Adverse Event|0|||
48721394|NCT00830869|156829962|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
48721395|NCT00830869|156829963|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
48721396|NCT00830869|156829964|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
48721397|NCT00830869|156829965|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
48500528|NCT00788125|156029364|FG000|Overall Study|Death|6|||
48500529|NCT04565990|156029365|FG000|Overall Study|Death|5|||
48500530|NCT04565990|156029365|FG000|Overall Study|Lost to Follow-up|1|||
48500531|NCT04565990|156029365|FG000|Overall Study|Withdrawal by Subject|1|||
48500532|NCT01052116|156029368|FG000|Overall Study|Lost to Follow-up|11|||
48500533|NCT01052116|156029369|FG001|Overall Study|Lost to Follow-up|17|||
48500534|NCT01052116|156029368|FG000|Overall Study|Withdrawal by Subject|3|||
48500535|NCT01052116|156029369|FG001|Overall Study|Withdrawal by Subject|6|||
48500536|NCT01052116|156029368|FG000|Overall Study|Spirometry not performed|0|||
48500537|NCT01052116|156029369|FG001|Overall Study|Spirometry not performed|4|||
48500538|NCT00101582|156029377|FG000|Overall Study|Ineligibility determined|0|||
48500539|NCT00101582|156029378|FG001|Overall Study|Ineligibility determined|1|||
48500540|NCT00101582|156029377|FG000|Overall Study|Adverse Event|1|||
48500541|NCT00101582|156029378|FG001|Overall Study|Adverse Event|4|||
48500542|NCT00101582|156029377|FG000|Overall Study|Withdrawal by Subject|6|||
48500543|NCT00101582|156029378|FG001|Overall Study|Withdrawal by Subject|4|||
48500544|NCT00101582|156029377|FG000|Overall Study|Physician Decision|1|||
48500545|NCT00101582|156029378|FG001|Overall Study|Physician Decision|0|||
48500546|NCT00101582|156029377|FG000|Overall Study|Death|3|||
48500547|NCT00101582|156029378|FG001|Overall Study|Death|5|||
48500548|NCT00101582|156029377|FG000|Overall Study|Other|0|||
48500549|NCT00101582|156029378|FG001|Overall Study|Other|1|||
48500550|NCT00056160|156029379|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
48500551|NCT00056160|156029380|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
48500552|NCT00056160|156029379|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
48500553|NCT00056160|156029380|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
48500554|NCT00056160|156029379|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
48500555|NCT00056160|156029380|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
48500556|NCT00056160|156029379|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
48500557|NCT00056160|156029380|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
48500558|NCT00056160|156029379|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
48500559|NCT00056160|156029380|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
48500560|NCT00056160|156029379|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
48500561|NCT00056160|156029380|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
48500562|NCT00056160|156029379|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
48500563|NCT00056160|156029380|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
48500564|NCT00056160|156029379|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
48500565|NCT00056160|156029380|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
48500566|NCT00056160|156029379|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
48500567|NCT00056160|156029380|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
48500568|NCT00056160|156029379|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
48500569|NCT00056160|156029380|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
48500570|NCT00056160|156029379|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
48500571|NCT00056160|156029380|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
48500572|NCT00056160|156029379|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
48500573|NCT00056160|156029380|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
48500574|NCT00056160|156029379|FG000|Final Follow-up|Transferred into expanded access study.|3|||
48500575|NCT00056160|156029380|FG001|Final Follow-up|Transferred into expanded access study.|0|||
48500576|NCT00056160|156029379|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
48500577|NCT00056160|156029380|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
48500578|NCT00056160|156029379|FG000|Final Follow-up|Adverse Event|1|||
48721398|NCT00830869|156829966|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
48721399|NCT00830869|156829967|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
48721400|NCT00830869|156829968|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
48721401|NCT00830869|156829969|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
48500579|NCT00056160|156029380|FG001|Final Follow-up|Adverse Event|0|||
48500580|NCT01402908|156029388|FG000|Overall Study|Withdrawal by Subject|30|||
48721402|NCT00830869|156829970|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
48721403|NCT00830869|156829971|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
48721404|NCT00830869|156829972|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
48721405|NCT00830869|156829973|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
48500581|NCT01402908|156029389|FG001|Overall Study|Withdrawal by Subject|17|||
48816682|NCT01266993|157172027|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
48816683|NCT03285113|157172030|FG000|Overall Study|Unable to implant leads|2|||
48816684|NCT03382600|157172031|FG000|Overall Study|Adverse Event|3|||
48816685|NCT03382600|157172032|FG001|Overall Study|Adverse Event|3|||
48500582|NCT01402908|156029388|FG000|Overall Study|Lost to Follow-up|3|||
48816686|NCT03382600|157172031|FG000|Overall Study|Clinical Disease Progression|2|||
48816687|NCT03382600|157172032|FG001|Overall Study|Clinical Disease Progression|4|||
48816688|NCT03382600|157172031|FG000|Overall Study|Radiological Progression|40|||
48816689|NCT03382600|157172032|FG001|Overall Study|Radiological Progression|31|||
48816690|NCT03382600|157172031|FG000|Overall Study|Withdrawal by Subject|0|||
48816691|NCT03382600|157172032|FG001|Overall Study|Withdrawal by Subject|1|||
48816692|NCT03382600|157172031|FG000|Overall Study|Other|9|||
48816693|NCT03382600|157172032|FG001|Overall Study|Other|7|||
48816694|NCT01000376|157172033|FG000|Cycle 1 Day 1|Adverse Event|1|||
48816695|NCT01000376|157172034|FG001|Cycle 1 Day 1|Adverse Event|0|||
48816696|NCT01000376|157172033|FG000|Cycle 1 Day 1|Progressive Disease|1|||
48816697|NCT01000376|157172034|FG001|Cycle 1 Day 1|Progressive Disease|0|||
48816698|NCT00507026|157172035|FG000|Overall Study|Lack of Efficacy|6|||
48816699|NCT00507026|157172036|FG001|Overall Study|Lack of Efficacy|4|||
48816700|NCT00507026|157172037|FG002|Overall Study|Lack of Efficacy|21|||
48816701|NCT00507026|157172035|FG000|Overall Study|Withdrawal by Subject|2|||
48816702|NCT00507026|157172036|FG001|Overall Study|Withdrawal by Subject|0|||
48816703|NCT00507026|157172037|FG002|Overall Study|Withdrawal by Subject|0|||
48816704|NCT00507026|157172035|FG000|Overall Study|Investigator Decision|1|||
48816705|NCT00507026|157172036|FG001|Overall Study|Investigator Decision|0|||
48816706|NCT00507026|157172037|FG002|Overall Study|Investigator Decision|0|||
48816707|NCT00507026|157172035|FG000|Overall Study|Adverse Event|2|||
48816708|NCT00507026|157172036|FG001|Overall Study|Adverse Event|0|||
48816709|NCT00507026|157172037|FG002|Overall Study|Adverse Event|0|||
48816710|NCT00507026|157172035|FG000|Overall Study|Protocol Violation|1|||
48816711|NCT00507026|157172036|FG001|Overall Study|Protocol Violation|0|||
48816712|NCT00507026|157172037|FG002|Overall Study|Protocol Violation|0|||
48816713|NCT00507026|157172035|FG000|Overall Study|Other|1|||
48816714|NCT00507026|157172036|FG001|Overall Study|Other|0|||
48816715|NCT00507026|157172037|FG002|Overall Study|Other|0|||
48816716|NCT01058863|157172038|FG000|Overall Study|Lost to Follow-up|1|||
48816717|NCT01058863|157172038|FG000|Overall Study|Withdrawal by Subject|1|||
48816718|NCT01058863|157172038|FG000|Overall Study|Sponsor requested withdrawal|1|||
48816719|NCT01058863|157172038|FG000|Overall Study|Randomized in error|1|||
48816720|NCT02269943|157172040|FG000|Treatment Period|Death|0|||
48816721|NCT02269943|157172041|FG001|Treatment Period|Death|1|||
48500583|NCT01402908|156029389|FG001|Overall Study|Lost to Follow-up|1|||
48500584|NCT01402908|156029388|FG000|Overall Study|Physician Decision|1|||
48721406|NCT00830869|156829962|FG000|Period 2: Part 2|Progressive disease|0|||
48721407|NCT00830869|156829963|FG001|Period 2: Part 2|Progressive disease|0|||
48721408|NCT00830869|156829964|FG002|Period 2: Part 2|Progressive disease|0|||
48721409|NCT00830869|156829965|FG003|Period 2: Part 2|Progressive disease|0|||
48721410|NCT00830869|156829966|FG004|Period 2: Part 2|Progressive disease|0|||
48721411|NCT00830869|156829967|FG005|Period 2: Part 2|Progressive disease|0|||
48721412|NCT00830869|156829968|FG006|Period 2: Part 2|Progressive disease|0|||
48721413|NCT00830869|156829969|FG007|Period 2: Part 2|Progressive disease|14|||
48721414|NCT00830869|156829970|FG008|Period 2: Part 2|Progressive disease|11|||
48721415|NCT00830869|156829971|FG009|Period 2: Part 2|Progressive disease|12|||
48721416|NCT00830869|156829972|FG010|Period 2: Part 2|Progressive disease|8|||
48721417|NCT00830869|156829973|FG011|Period 2: Part 2|Progressive disease|15|||
48721418|NCT00830869|156829962|FG000|Period 2: Part 2|Other|0|||
48721419|NCT00830869|156829963|FG001|Period 2: Part 2|Other|0|||
48721420|NCT00830869|156829964|FG002|Period 2: Part 2|Other|0|||
48721421|NCT00830869|156829965|FG003|Period 2: Part 2|Other|0|||
48721422|NCT00830869|156829966|FG004|Period 2: Part 2|Other|0|||
48721423|NCT00830869|156829967|FG005|Period 2: Part 2|Other|0|||
48721424|NCT00830869|156829968|FG006|Period 2: Part 2|Other|0|||
48721425|NCT00830869|156829969|FG007|Period 2: Part 2|Other|0|||
48721426|NCT00830869|156829970|FG008|Period 2: Part 2|Other|0|||
48721427|NCT00830869|156829971|FG009|Period 2: Part 2|Other|1|||
48721428|NCT00830869|156829972|FG010|Period 2: Part 2|Other|0|||
48721429|NCT00830869|156829973|FG011|Period 2: Part 2|Other|0|||
48816722|NCT02269943|157172040|FG000|Treatment Period|Adverse Event|1|||
48816723|NCT02269943|157172041|FG001|Treatment Period|Adverse Event|10|||
48816724|NCT02269943|157172040|FG000|Treatment Period|Progressive Disease|5|||
48816725|NCT02269943|157172041|FG001|Treatment Period|Progressive Disease|17|||
48816726|NCT02269943|157172040|FG000|Treatment Period|Symptomatic Deterioration|0|||
48500585|NCT01402908|156029389|FG001|Overall Study|Physician Decision|0|||
48721430|NCT00617669|156829974|FG000|Overall Study|Withdrawal by Subject|71|||
48721431|NCT00617669|156829975|FG001|Overall Study|Withdrawal by Subject|77|||
48721432|NCT00617669|156829974|FG000|Overall Study|Lost to Follow-up|3|||
48721433|NCT00617669|156829975|FG001|Overall Study|Lost to Follow-up|2|||
48816727|NCT02269943|157172041|FG001|Treatment Period|Symptomatic Deterioration|2|||
48500586|NCT01919190|156029391|FG000|Overall Study|Intra-op findings, etc.|3|||
48500587|NCT01919190|156029392|FG001|Overall Study|Intra-op findings, etc.|0|||
48500588|NCT01739790|156029393|FG000|Overall Study|Early Trial Termination|2|||
48500589|NCT01739790|156029394|FG001|Overall Study|Early Trial Termination|4|||
48500590|NCT00444145|156029395|FG000|Overall Study|Withdrawal by Subject|2|||
48500591|NCT00444145|156029395|FG000|Overall Study|Lost to Follow-up|1|||
48500592|NCT00444145|156029395|FG000|Overall Study|non-compliant|11|||
48500593|NCT00444145|156029395|FG000|Overall Study|Screen Failures|5|||
48500594|NCT01153984|156029407|FG000|Overall Study|Withdrawal by Subject|1|||
48500595|NCT01153984|156029407|FG000|Overall Study|Adverse Event|1|||
48500596|NCT02896361|156029408|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
48500597|NCT02896361|156029409|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
48500598|NCT02896361|156029410|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
48500599|NCT02896361|156029408|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
48500600|NCT02896361|156029409|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
48500601|NCT02896361|156029410|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
48500602|NCT01458405|156029418|FG000|Phase 1 (up to 12 Months)|Other|0|||
48500603|NCT01458405|156029419|FG001|Phase 1 (up to 12 Months)|Other|1|||
48500604|NCT01458405|156029420|FG002|Phase 1 (up to 12 Months)|Other|0|||
48500605|NCT01458405|156029421|FG003|Phase 1 (up to 12 Months)|Other|0|||
48500606|NCT01458405|156029418|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
48500607|NCT01458405|156029419|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
48500608|NCT01458405|156029420|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
48500609|NCT01458405|156029421|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
48500610|NCT01458405|156029418|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
48721434|NCT00617669|156829974|FG000|Overall Study|Adverse Event|87|||
48721435|NCT00617669|156829975|FG001|Overall Study|Adverse Event|76|||
48721436|NCT00617669|156829974|FG000|Overall Study|Protocol Violation|2|||
48721437|NCT00617669|156829975|FG001|Overall Study|Protocol Violation|3|||
48721438|NCT00617669|156829974|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
48721439|NCT00617669|156829975|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
48721440|NCT00617669|156829974|FG000|Overall Study|Patients randomized but not treated|2|||
48721441|NCT00617669|156829975|FG001|Overall Study|Patients randomized but not treated|3|||
48721442|NCT00507728|156829976|FG000|Randomization to Month 3|Lost to Follow-up|15|||
48721443|NCT00507728|156829977|FG001|Randomization to Month 3|Lost to Follow-up|14|||
48721444|NCT00507728|156829978|FG002|Randomization to Month 3|Lost to Follow-up|20|||
48721445|NCT00507728|156829976|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
48721446|NCT00507728|156829977|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
48721447|NCT00507728|156829978|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
48721448|NCT04590248|156829979|FG000|Overall Study|Lost to Follow-up|1|||
48721449|NCT04590248|156829979|FG000|Overall Study|Withdrawal by Subject|16|||
48721450|NCT04590248|156829979|FG000|Overall Study|Other|2|||
48721451|NCT02292784|156829980|FG000|Overall Study|Lost to Follow-up|1|||
48721452|NCT02292784|156829981|FG001|Overall Study|Lost to Follow-up|17|||
48721453|NCT02292784|156829982|FG002|Overall Study|Lost to Follow-up|18|||
48721454|NCT02292784|156829980|FG000|Overall Study|Withdrawal by Subject|0|||
48721455|NCT02292784|156829981|FG001|Overall Study|Withdrawal by Subject|3|||
48721456|NCT02292784|156829982|FG002|Overall Study|Withdrawal by Subject|3|||
48721457|NCT00348933|156829983|FG000|Overall Study|Withdrawal by Subject|10|||
48721458|NCT00348933|156829983|FG000|Overall Study|Lost to Follow-up|6|||
48721459|NCT00348933|156829983|FG000|Overall Study|Protocol Violation|2|||
48721460|NCT00348933|156829983|FG000|Overall Study|Adverse Event|7|||
48721461|NCT05347147|156829990|FG000|Overall Study|Lost to Follow-up|0|||
48721462|NCT05347147|156829991|FG001|Overall Study|Lost to Follow-up|1|||
48721463|NCT05347147|156829990|FG000|Overall Study|Sponsor request|3|||
48721464|NCT05347147|156829991|FG001|Overall Study|Sponsor request|3|||
48721465|NCT05347147|156829990|FG000|Overall Study|Study termination|2|||
48721466|NCT05347147|156829991|FG001|Overall Study|Study termination|1|||
48721467|NCT01350544|156829992|FG000|Overall Study|Administrative Withdrawal|0|||
48721468|NCT01350544|156829993|FG001|Overall Study|Administrative Withdrawal|1|||
48721469|NCT01350544|156829992|FG000|Overall Study|Death|1|||
48721470|NCT01350544|156829993|FG001|Overall Study|Death|2|||
48721471|NCT01350544|156829992|FG000|Overall Study|Moved out of LA County|2|||
48721472|NCT01350544|156829993|FG001|Overall Study|Moved out of LA County|2|||
48721473|NCT01350544|156829992|FG000|Overall Study|Medical Issues|1|||
48721474|NCT01350544|156829993|FG001|Overall Study|Medical Issues|1|||
48721475|NCT01350544|156829992|FG000|Overall Study|Withdrawal by Subject|0|||
48721476|NCT01350544|156829993|FG001|Overall Study|Withdrawal by Subject|1|||
48721477|NCT01350544|156829992|FG000|Overall Study|Incarceration|1|||
48721478|NCT01350544|156829993|FG001|Overall Study|Incarceration|0|||
48721479|NCT01350544|156829992|FG000|Overall Study|Lost to Follow-up|18|||
48721480|NCT01350544|156829993|FG001|Overall Study|Lost to Follow-up|15|||
48721481|NCT01444092|156829994|FG000|Overall Study|Adverse Event|8|||
48721482|NCT01444092|156829994|FG000|Overall Study|Protocol Violation|1|||
48816728|NCT02269943|157172040|FG000|Follow-Up Survival Period|Death|3|||
48816729|NCT02269943|157172041|FG001|Follow-Up Survival Period|Death|16|||
48816730|NCT02269943|157172040|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
48816731|NCT02269943|157172041|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
48816732|NCT02269943|157172040|FG000|Follow-Up Survival Period|Alive|2|||
48816733|NCT02269943|157172041|FG001|Follow-Up Survival Period|Alive|8|||
48816734|NCT03541642|157172042|FG000|Overall Study|Withdrawal by Subject|1|||
48816735|NCT03541642|157172043|FG001|Overall Study|Withdrawal by Subject|2|||
48816736|NCT03541642|157172042|FG000|Overall Study|Lost to Follow-up|16|||
48816737|NCT03541642|157172043|FG001|Overall Study|Lost to Follow-up|12|||
48816738|NCT03541642|157172042|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
48816739|NCT03541642|157172043|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
48816740|NCT00598481|157172044|FG000|Treatment|Physician Decision|1|||
48816741|NCT01083160|157172045|FG000|Overall Study|Adverse Event|1|||
48816742|NCT00972179|157172046|FG000|Overall Study|Noncompliance|1|||
48816743|NCT00972179|157172047|FG001|Overall Study|Noncompliance|0|||
48816744|NCT00972179|157172048|FG002|Overall Study|Noncompliance|0|||
48816745|NCT00972179|157172049|FG003|Overall Study|Noncompliance|0|||
48816746|NCT00972179|157172050|FG004|Overall Study|Noncompliance|1|||
48816747|NCT00972179|157172051|FG005|Overall Study|Noncompliance|0|||
48816748|NCT00972179|157172052|FG006|Overall Study|Noncompliance|1|||
48816749|NCT00972179|157172046|FG000|Overall Study|Withdrawal by Subject|0|||
48816750|NCT00972179|157172047|FG001|Overall Study|Withdrawal by Subject|3|||
48816751|NCT00972179|157172048|FG002|Overall Study|Withdrawal by Subject|0|||
48816752|NCT00972179|157172049|FG003|Overall Study|Withdrawal by Subject|1|||
48816753|NCT00972179|157172050|FG004|Overall Study|Withdrawal by Subject|0|||
48816754|NCT00972179|157172051|FG005|Overall Study|Withdrawal by Subject|0|||
48816755|NCT00972179|157172052|FG006|Overall Study|Withdrawal by Subject|2|||
48816756|NCT00972179|157172046|FG000|Overall Study|Administrative Decision|0|||
48816757|NCT00972179|157172047|FG001|Overall Study|Administrative Decision|0|||
48816758|NCT00972179|157172048|FG002|Overall Study|Administrative Decision|0|||
48816759|NCT00972179|157172049|FG003|Overall Study|Administrative Decision|0|||
48816760|NCT00972179|157172050|FG004|Overall Study|Administrative Decision|1|||
48816761|NCT00972179|157172051|FG005|Overall Study|Administrative Decision|0|||
48816762|NCT00972179|157172052|FG006|Overall Study|Administrative Decision|0|||
48816763|NCT00972179|157172046|FG000|Overall Study|Lost to Follow-up|0|||
48816764|NCT00972179|157172047|FG001|Overall Study|Lost to Follow-up|0|||
48816765|NCT00972179|157172048|FG002|Overall Study|Lost to Follow-up|1|||
48816766|NCT00972179|157172049|FG003|Overall Study|Lost to Follow-up|0|||
48816767|NCT00972179|157172050|FG004|Overall Study|Lost to Follow-up|0|||
48816768|NCT00972179|157172051|FG005|Overall Study|Lost to Follow-up|3|||
48816769|NCT00972179|157172052|FG006|Overall Study|Lost to Follow-up|1|||
48816770|NCT03232138|157172055|FG000|Overall Study|Physician Decision|1|||
48816771|NCT03232138|157172056|FG001|Overall Study|Physician Decision|0|||
48816772|NCT03232138|157172055|FG000|Overall Study|Adverse Event|2|||
48816773|NCT03232138|157172056|FG001|Overall Study|Adverse Event|0|||
48816774|NCT03232138|157172055|FG000|Overall Study|Withdrawal by Subject|1|||
48816775|NCT03232138|157172056|FG001|Overall Study|Withdrawal by Subject|2|||
48816776|NCT01163149|157172059|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
48816777|NCT01163149|157172060|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
48816778|NCT01163149|157172061|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
48816779|NCT01163149|157172059|FG000|Extension Treatment Period|Adverse Event|0|||
48816780|NCT01163149|157172060|FG001|Extension Treatment Period|Adverse Event|1|||
48816781|NCT01163149|157172061|FG002|Extension Treatment Period|Adverse Event|0|||
48816782|NCT01163149|157172059|FG000|Extension Treatment Period|Noncompliance|0|||
48816783|NCT01163149|157172060|FG001|Extension Treatment Period|Noncompliance|0|||
48816784|NCT01163149|157172061|FG002|Extension Treatment Period|Noncompliance|1|||
48816785|NCT01932996|157172062|FG000|Overall Study|Protocol Violation|2|||
48816786|NCT01932996|157172063|FG001|Overall Study|Protocol Violation|0|||
48816787|NCT03008122|157172065|FG000|Overall Study|Physician Decision|3|||
48816788|NCT03008122|157172066|FG001|Overall Study|Physician Decision|2|||
48816789|NCT03008122|157172067|FG002|Overall Study|Physician Decision|0|||
48816790|NCT03008122|157172065|FG000|Overall Study|Withdrawal by Subject|1|||
48816791|NCT03008122|157172066|FG001|Overall Study|Withdrawal by Subject|3|||
48816792|NCT03008122|157172067|FG002|Overall Study|Withdrawal by Subject|0|||
48816793|NCT03008122|157172065|FG000|Overall Study|Lost to Follow-up|4|||
48816794|NCT03008122|157172066|FG001|Overall Study|Lost to Follow-up|8|||
48816795|NCT03008122|157172067|FG002|Overall Study|Lost to Follow-up|3|||
48816796|NCT03008122|157172065|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
48816797|NCT03008122|157172066|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
48816798|NCT03008122|157172067|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
48816799|NCT03008122|157172065|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
48816800|NCT03008122|157172066|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
48816801|NCT03008122|157172067|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
48816802|NCT03008122|157172065|FG000|Overall Study|Death|0|||
48816803|NCT03008122|157172066|FG001|Overall Study|Death|0|||
48500611|NCT01458405|156029419|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
48500612|NCT01458405|156029420|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
48500613|NCT01458405|156029421|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
48500614|NCT01458405|156029418|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
48500615|NCT01458405|156029419|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
48500616|NCT01458405|156029420|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
48500617|NCT01458405|156029421|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
48500618|NCT02192099|156029428|FG000|Overall Study|Adverse Event|1|||
48500619|NCT02192099|156029428|FG000|Overall Study|Lost to Follow-up|2|||
48500620|NCT02192099|156029428|FG000|Overall Study|Physician Decision|1|||
48500621|NCT02192099|156029428|FG000|Overall Study|Pregnancy|1|||
48500622|NCT02192099|156029428|FG000|Overall Study|Protocol Violation|8|||
48500623|NCT02192099|156029428|FG000|Overall Study|Study Terminated by Sponsor|32|||
48500624|NCT02192099|156029428|FG000|Overall Study|Withdrawal by Subject|11|||
48500625|NCT02192099|156029428|FG000|Overall Study|Miscellaneous Reasons|5|||
48500626|NCT02796664|156029431|FG000|Overall Study|Withdrawal by Subject|0|||
48500627|NCT02796664|156029432|FG001|Overall Study|Withdrawal by Subject|3|||
48500628|NCT02796664|156029431|FG000|Overall Study|Noncompliance|1|||
48500629|NCT02796664|156029432|FG001|Overall Study|Noncompliance|1|||
48500630|NCT02796664|156029431|FG000|Overall Study|Death|0|||
48500631|NCT02796664|156029432|FG001|Overall Study|Death|1|||
48500632|NCT01045096|156029433|FG000|Overall Study|Withdrawal by Subject|2|||
48500633|NCT01045096|156029434|FG001|Overall Study|Withdrawal by Subject|0|||
48500634|NCT01045096|156029435|FG002|Overall Study|Withdrawal by Subject|0|||
48500635|NCT01045096|156029433|FG000|Overall Study|Other|1|||
48500636|NCT01045096|156029434|FG001|Overall Study|Other|0|||
48500637|NCT01045096|156029435|FG002|Overall Study|Other|0|||
48500638|NCT02731157|156029440|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
48721483|NCT01444092|156829994|FG000|Overall Study|Withdrawal by Subject|1|||
48721484|NCT01444092|156829994|FG000|Overall Study|Other Eligibility criteria|7|||
48500639|NCT02465567|156029441|FG000|Overall Study|Adverse Event|118|||
48500640|NCT02465567|156029442|FG001|Overall Study|Adverse Event|113|||
48500641|NCT02465567|156029443|FG002|Overall Study|Adverse Event|147|||
48500642|NCT02465567|156029444|FG003|Overall Study|Adverse Event|138|||
48500643|NCT02465567|156029441|FG000|Overall Study|Lack of Efficacy|103|||
48721485|NCT03188042|156829995|FG000|Overall Study|Withdrawal by Subject|1|||
48721486|NCT03188042|156829996|FG001|Overall Study|Withdrawal by Subject|1|||
48721487|NCT00870103|156829997|FG000|Overall Study|Physician Decision|2|||
48721488|NCT00870103|156829997|FG000|Overall Study|Lost to Follow-up|2|||
48721489|NCT01122394|156830004|FG000|Overall Study|Withdrawal by Subject|1|||
48721490|NCT01122394|156830005|FG001|Overall Study|Withdrawal by Subject|1|||
48721491|NCT01122394|156830004|FG000|Overall Study|Lost to Follow-up|2|||
48721492|NCT01122394|156830005|FG001|Overall Study|Lost to Follow-up|2|||
48721493|NCT01122394|156830004|FG000|Overall Study|Adverse Event|0|||
48721494|NCT01122394|156830005|FG001|Overall Study|Adverse Event|1|||
48721495|NCT01343823|156830006|FG000|Overall Study|Study Terminated|1|||
48721496|NCT01343823|156830007|FG001|Overall Study|Study Terminated|0|||
48721497|NCT01343823|156830008|FG002|Overall Study|Study Terminated|0|||
48721498|NCT01343823|156830009|FG003|Overall Study|Study Terminated|1|||
48721499|NCT01343823|156830006|FG000|Overall Study|Withdrawal by Subject|1|||
48721500|NCT01343823|156830007|FG001|Overall Study|Withdrawal by Subject|0|||
48721501|NCT01343823|156830008|FG002|Overall Study|Withdrawal by Subject|0|||
48721502|NCT01343823|156830009|FG003|Overall Study|Withdrawal by Subject|0|||
48721503|NCT01752036|156830011|FG000|Overall Study|Death|2|||
48721504|NCT04173663|156830012|FG000|Overall Study|Withdrawal by Subject|1|||
48721505|NCT04173663|156830013|FG001|Overall Study|Withdrawal by Subject|6|||
48721506|NCT04173663|156830012|FG000|Overall Study|Lost to Follow-up|17|||
48721507|NCT04173663|156830013|FG001|Overall Study|Lost to Follow-up|24|||
48721508|NCT03474107|156830014|FG000|Overall Study|Adverse Event|42|||
48721509|NCT03474107|156830015|FG001|Overall Study|Adverse Event|46|||
48721510|NCT03474107|156830014|FG000|Overall Study|Death|2|||
48721511|NCT03474107|156830015|FG001|Overall Study|Death|2|||
48721512|NCT03474107|156830014|FG000|Overall Study|Lost to Follow-up|0|||
48721513|NCT03474107|156830015|FG001|Overall Study|Lost to Follow-up|1|||
48721514|NCT03474107|156830014|FG000|Overall Study|Progressive Disease|177|||
48721515|NCT03474107|156830015|FG001|Overall Study|Progressive Disease|180|||
48721516|NCT03474107|156830014|FG000|Overall Study|Protocol Violation|1|||
48721517|NCT03474107|156830015|FG001|Overall Study|Protocol Violation|1|||
48721518|NCT03474107|156830014|FG000|Overall Study|Withdrawal by Subject|15|||
48721519|NCT03474107|156830015|FG001|Overall Study|Withdrawal by Subject|27|||
48721520|NCT03474107|156830014|FG000|Overall Study|Physician Decision|7|||
48721521|NCT03474107|156830015|FG001|Overall Study|Physician Decision|22|||
48500644|NCT02465567|156029442|FG001|Overall Study|Lack of Efficacy|102|||
48500645|NCT02465567|156029443|FG002|Overall Study|Lack of Efficacy|171|||
48500646|NCT02465567|156029444|FG003|Overall Study|Lack of Efficacy|135|||
48721522|NCT03474107|156830014|FG000|Overall Study|Miscellaneous|1|||
48721523|NCT03474107|156830015|FG001|Overall Study|Miscellaneous|6|||
48721524|NCT05070429|156830017|FG000|Overall Study|Death|0|||
48721525|NCT05070429|156830018|FG001|Overall Study|Death|4|||
48721526|NCT05070429|156830017|FG000|Overall Study|Withdrawal by Subject|2|||
48816804|NCT03008122|157172067|FG002|Overall Study|Death|1|||
48816805|NCT01848834|157172068|FG000|Overall Study|Adverse Event|3|||
48816806|NCT01848834|157172069|FG001|Overall Study|Adverse Event|11|||
48816807|NCT01848834|157172070|FG002|Overall Study|Adverse Event|3|||
48816808|NCT01848834|157172071|FG003|Overall Study|Adverse Event|5|||
48500647|NCT02465567|156029441|FG000|Overall Study|Withdrawal by Subject|104|||
48500648|NCT02465567|156029442|FG001|Overall Study|Withdrawal by Subject|94|||
48500649|NCT02465567|156029443|FG002|Overall Study|Withdrawal by Subject|123|||
48721527|NCT05070429|156830018|FG001|Overall Study|Withdrawal by Subject|1|||
48721528|NCT05070429|156830017|FG000|Overall Study|Other|15|||
48721529|NCT05070429|156830018|FG001|Overall Study|Other|5|||
48721530|NCT03780400|156830025|FG000|Overall Study|Lost to Follow-up|5|||
48721531|NCT03780400|156830025|FG000|Overall Study|Withdrawal by Subject|2|||
48721532|NCT04559529|156830035|FG000|First Intervention (1 Day)|Adverse Event|0|||
48721533|NCT04559529|156830036|FG001|First Intervention (1 Day)|Adverse Event|0|||
48721534|NCT04559529|156830037|FG002|First Intervention (1 Day)|Adverse Event|0|||
48721535|NCT04559529|156830038|FG003|First Intervention (1 Day)|Adverse Event|1|||
48721536|NCT04559529|156830035|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
48721537|NCT04559529|156830036|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
48721538|NCT04559529|156830037|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
48721539|NCT04559529|156830038|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
48721540|NCT04559529|156830035|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
48721541|NCT04559529|156830036|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
48721542|NCT04559529|156830037|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
48721543|NCT04559529|156830038|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
48721544|NCT00484185|156830040|FG000|Overall Study|Lost to Follow-up|44|||
48721545|NCT00484185|156830040|FG000|Overall Study|Other|20|||
48721546|NCT00484185|156830040|FG000|Overall Study|Randomized but not treated|5|||
48721547|NCT00484185|156830040|FG000|Overall Study|Death|2|||
48721548|NCT05615935|156830042|FG000|Overall Study|Lost to Follow-up|1|||
48721549|NCT05615935|156830043|FG001|Overall Study|Lost to Follow-up|1|||
48721550|NCT01092832|156830044|FG000|Overall Study|Other|1|||
48721551|NCT01092832|156830045|FG001|Overall Study|Other|0|||
48721552|NCT02635646|156830054|FG000|Overall Study|Lost to Follow-up|24|||
48721553|NCT02635646|156830055|FG001|Overall Study|Lost to Follow-up|25|||
48721554|NCT02635646|156830054|FG000|Overall Study|Pregnancy|1|||
48721555|NCT02635646|156830055|FG001|Overall Study|Pregnancy|1|||
48721556|NCT03189381|156830064|FG000|Overall Study|Death|1|||
48721557|NCT03189381|156830065|FG001|Overall Study|Death|0|||
48721558|NCT00251004|156830066|FG000|Overall Study|Withdrawal by Subject|23|||
48721559|NCT00251004|156830067|FG001|Overall Study|Withdrawal by Subject|16|||
48721560|NCT00251004|156830068|FG002|Overall Study|Withdrawal by Subject|14|||
48721561|NCT00251004|156830066|FG000|Overall Study|Death|9|||
48721562|NCT00251004|156830067|FG001|Overall Study|Death|10|||
48721563|NCT00251004|156830068|FG002|Overall Study|Death|8|||
48721564|NCT00251004|156830066|FG000|Overall Study|Lost to Follow-up|1|||
48721565|NCT00251004|156830067|FG001|Overall Study|Lost to Follow-up|2|||
48721566|NCT00251004|156830068|FG002|Overall Study|Lost to Follow-up|1|||
48721567|NCT00251004|156830066|FG000|Overall Study|Graft Loss|12|||
48721568|NCT00251004|156830067|FG001|Overall Study|Graft Loss|13|||
48721569|NCT00251004|156830068|FG002|Overall Study|Graft Loss|8|||
48721570|NCT01077375|156830069|FG000|Overall Study|Adverse Event|2|||
48721571|NCT01077375|156830070|FG001|Overall Study|Adverse Event|15|||
48721572|NCT01077375|156830069|FG000|Overall Study|Lack of Efficacy|6|||
48721573|NCT01077375|156830070|FG001|Overall Study|Lack of Efficacy|8|||
48721574|NCT01077375|156830069|FG000|Overall Study|Withdrawal by Subject|0|||
48721575|NCT01077375|156830070|FG001|Overall Study|Withdrawal by Subject|6|||
48721576|NCT01077375|156830069|FG000|Overall Study|Lost to Follow-up|2|||
48721577|NCT01077375|156830070|FG001|Overall Study|Lost to Follow-up|5|||
48721578|NCT01077375|156830069|FG000|Overall Study|Other Reason|0|||
48721579|NCT01077375|156830070|FG001|Overall Study|Other Reason|1|||
48721580|NCT01244490|156830071|FG000|Overall Study|Lack of Efficacy|14|||
48721581|NCT01244490|156830072|FG001|Overall Study|Lack of Efficacy|5|||
48816809|NCT01848834|157172072|FG004|Overall Study|Adverse Event|9|||
48816810|NCT01848834|157172068|FG000|Overall Study|Death|2|||
48816811|NCT01848834|157172069|FG001|Overall Study|Death|11|||
48500650|NCT02465567|156029444|FG003|Overall Study|Withdrawal by Subject|130|||
48721582|NCT01244490|156830073|FG002|Overall Study|Lack of Efficacy|5|||
48721583|NCT01244490|156830071|FG000|Overall Study|Withdrawal by Subject|4|||
48721584|NCT01244490|156830072|FG001|Overall Study|Withdrawal by Subject|4|||
48721585|NCT01244490|156830073|FG002|Overall Study|Withdrawal by Subject|9|||
48721586|NCT01244490|156830071|FG000|Overall Study|Adverse Event|1|||
48721587|NCT01244490|156830072|FG001|Overall Study|Adverse Event|9|||
48721588|NCT01244490|156830073|FG002|Overall Study|Adverse Event|5|||
48721589|NCT01244490|156830071|FG000|Overall Study|Lost to Follow-up|0|||
48721590|NCT01244490|156830072|FG001|Overall Study|Lost to Follow-up|6|||
48721591|NCT01244490|156830073|FG002|Overall Study|Lost to Follow-up|3|||
48816812|NCT01848834|157172070|FG002|Overall Study|Death|1|||
48816813|NCT01848834|157172071|FG003|Overall Study|Death|8|||
48721592|NCT01244490|156830071|FG000|Overall Study|Other|0|||
48721593|NCT01244490|156830072|FG001|Overall Study|Other|0|||
48816814|NCT01848834|157172072|FG004|Overall Study|Death|27|||
48816815|NCT01848834|157172068|FG000|Overall Study|Excluded Medication|5|||
48816816|NCT01848834|157172069|FG001|Overall Study|Excluded Medication|4|||
48816817|NCT01848834|157172070|FG002|Overall Study|Excluded Medication|3|||
48816818|NCT01848834|157172071|FG003|Overall Study|Excluded Medication|6|||
48816819|NCT01848834|157172072|FG004|Overall Study|Excluded Medication|6|||
48816820|NCT01848834|157172068|FG000|Overall Study|Lost to Follow-up|5|||
48816821|NCT01848834|157172069|FG001|Overall Study|Lost to Follow-up|5|||
48816822|NCT01848834|157172070|FG002|Overall Study|Lost to Follow-up|3|||
48816823|NCT01848834|157172071|FG003|Overall Study|Lost to Follow-up|0|||
48816824|NCT01848834|157172072|FG004|Overall Study|Lost to Follow-up|3|||
48721594|NCT01244490|156830073|FG002|Overall Study|Other|1|||
48721595|NCT04719832|156830078|FG000|Overall Study|Adverse Event|2|||
48721596|NCT04719832|156830079|FG001|Overall Study|Adverse Event|0|||
48721597|NCT04719832|156830078|FG000|Overall Study|Lack of Efficacy|2|||
48721598|NCT04719832|156830079|FG001|Overall Study|Lack of Efficacy|4|||
48721599|NCT04719832|156830078|FG000|Overall Study|Lost to Follow-up|0|||
48721600|NCT04719832|156830079|FG001|Overall Study|Lost to Follow-up|2|||
48721601|NCT04719832|156830078|FG000|Overall Study|Physician Decision|0|||
48721602|NCT04719832|156830079|FG001|Overall Study|Physician Decision|1|||
48721603|NCT04719832|156830078|FG000|Overall Study|Pregnancy|1|||
48721604|NCT04719832|156830079|FG001|Overall Study|Pregnancy|1|||
48721605|NCT04719832|156830078|FG000|Overall Study|Withdrawal by Subject|5|||
48721606|NCT04719832|156830079|FG001|Overall Study|Withdrawal by Subject|5|||
48721607|NCT04719832|156830078|FG000|Overall Study|Randomized, not treated|0|||
48721608|NCT04719832|156830079|FG001|Overall Study|Randomized, not treated|2|||
48721609|NCT04719832|156830078|FG000|Overall Study|GCP violations|4|||
48721610|NCT04719832|156830079|FG001|Overall Study|GCP violations|7|||
48721611|NCT01343901|156830080|FG000|Overall Study|Death|85|||
48721612|NCT01343901|156830080|FG000|Overall Study|Physician Decision|4|||
48721613|NCT01343901|156830080|FG000|Overall Study|Lost to Follow-up|12|||
48721614|NCT01343901|156830080|FG000|Overall Study|Management by another medical team|11|||
48721615|NCT01343901|156830080|FG000|Overall Study|Participant decision|1|||
48721616|NCT02232880|156830081|FG000|Overall Study|study stopped prior to randomization|1|||
48721617|NCT01958827|156830082|FG000|Overall Study|Adverse Event|3|||
48721618|NCT01958827|156830082|FG000|Overall Study|Lack of Efficacy|6|||
48721619|NCT01958827|156830082|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
48721620|NCT00604214|156830083|FG000|Baseline to Day 28|Death|223|||
48721621|NCT00604214|156830084|FG001|Baseline to Day 28|Death|202|||
48721622|NCT00604214|156830083|FG000|Baseline to Day 28|Lost to Follow-up|2|||
48721623|NCT00604214|156830084|FG001|Baseline to Day 28|Lost to Follow-up|4|||
48721624|NCT00604214|156830083|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
48721625|NCT00604214|156830084|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
48721626|NCT00604214|156830083|FG000|Day 29 to Day 90|Death|64|||
48721627|NCT00604214|156830084|FG001|Day 29 to Day 90|Death|67|||
48816825|NCT01848834|157172068|FG000|Overall Study|Physician Decision|1|||
48721628|NCT00604214|156830083|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
48721629|NCT00604214|156830084|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
48721630|NCT00604214|156830083|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
48721631|NCT00604214|156830084|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
48721632|NCT00604214|156830083|FG000|Day 91 to Day 180|Death|19|||
48721633|NCT00604214|156830084|FG001|Day 91 to Day 180|Death|23|||
48721634|NCT00604214|156830083|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
48721635|NCT00604214|156830084|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
48721636|NCT00604214|156830083|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
48721637|NCT00604214|156830084|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
48721638|NCT03505710|156830085|FG000|Overall Study|Progressive Disease|22|||
48721639|NCT03505710|156830086|FG001|Overall Study|Progressive Disease|9|||
48721640|NCT03505710|156830087|FG002|Overall Study|Progressive Disease|34|||
48721641|NCT03505710|156830085|FG000|Overall Study|Clinical Progression|6|||
48721642|NCT03505710|156830086|FG001|Overall Study|Clinical Progression|6|||
48721643|NCT03505710|156830087|FG002|Overall Study|Clinical Progression|3|||
48816826|NCT01848834|157172069|FG001|Overall Study|Physician Decision|3|||
48816827|NCT01848834|157172070|FG002|Overall Study|Physician Decision|4|||
48500651|NCT02465567|156029441|FG000|Overall Study|Physician Decision|23|||
48721644|NCT03505710|156830085|FG000|Overall Study|Adverse Event|12|||
48721645|NCT03505710|156830086|FG001|Overall Study|Adverse Event|5|||
48500652|NCT02465567|156029442|FG001|Overall Study|Physician Decision|33|||
48721646|NCT03505710|156830087|FG002|Overall Study|Adverse Event|27|||
48721647|NCT03505710|156830085|FG000|Overall Study|Withdrawal by Subject|1|||
48721648|NCT03505710|156830086|FG001|Overall Study|Withdrawal by Subject|3|||
48721649|NCT03505710|156830087|FG002|Overall Study|Withdrawal by Subject|3|||
48721650|NCT03505710|156830085|FG000|Overall Study|Physician Decision|1|||
48721651|NCT03505710|156830086|FG001|Overall Study|Physician Decision|0|||
48721652|NCT03505710|156830087|FG002|Overall Study|Physician Decision|2|||
48816828|NCT01848834|157172071|FG003|Overall Study|Physician Decision|0|||
48816829|NCT01848834|157172072|FG004|Overall Study|Physician Decision|11|||
48721653|NCT03505710|156830085|FG000|Overall Study|Death|4|||
48721654|NCT03505710|156830086|FG001|Overall Study|Death|3|||
48721655|NCT03505710|156830087|FG002|Overall Study|Death|6|||
48721656|NCT03505710|156830085|FG000|Overall Study|Other Reasons|1|||
48721657|NCT03505710|156830086|FG001|Overall Study|Other Reasons|1|||
48721658|NCT03505710|156830087|FG002|Overall Study|Other Reasons|1|||
48721659|NCT00817479|156830088|FG000|Overall Study|Physician Decision|1|||
48721660|NCT00817479|156830089|FG001|Overall Study|Physician Decision|1|||
48500653|NCT02465567|156029443|FG002|Overall Study|Physician Decision|38|||
48500654|NCT02465567|156029444|FG003|Overall Study|Physician Decision|28|||
48816830|NCT01848834|157172068|FG000|Overall Study|Protocol Violation|0|||
48500655|NCT02465567|156029441|FG000|Overall Study|Major Protocol Deviation|24|||
48500656|NCT02465567|156029442|FG001|Overall Study|Major Protocol Deviation|26|||
48500657|NCT02465567|156029443|FG002|Overall Study|Major Protocol Deviation|22|||
48500658|NCT02465567|156029444|FG003|Overall Study|Major Protocol Deviation|25|||
48721661|NCT00282347|156830090|FG000|Treatment Period|Death|2|||
48721662|NCT00282347|156830091|FG001|Treatment Period|Death|0|||
48721663|NCT00282347|156830090|FG000|Treatment Period|Lost to Follow-up|2|||
48721664|NCT00282347|156830091|FG001|Treatment Period|Lost to Follow-up|5|||
48721665|NCT00282347|156830090|FG000|Treatment Period|Withdrawal by Subject|1|||
48721666|NCT00282347|156830091|FG001|Treatment Period|Withdrawal by Subject|3|||
48721667|NCT00282347|156830090|FG000|Treatment Period|Physician Decision|0|||
48721668|NCT00282347|156830091|FG001|Treatment Period|Physician Decision|1|||
48721669|NCT00282347|156830090|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
48721670|NCT00282347|156830091|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
48721671|NCT00282347|156830090|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
48721672|NCT00282347|156830091|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
48721673|NCT00282347|156830090|FG000|Safety Follow-up Period|Physician Decision|1|||
48721674|NCT00282347|156830091|FG001|Safety Follow-up Period|Physician Decision|1|||
48721675|NCT00282347|156830090|FG000|Safety Follow-up Period|Protocol Deviation|0|||
48721676|NCT00282347|156830091|FG001|Safety Follow-up Period|Protocol Deviation|2|||
48721677|NCT00282347|156830090|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
48721678|NCT00282347|156830091|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
48721679|NCT00282347|156830090|FG000|B Cell Follow-up Period|Physician Decision|1|||
48816831|NCT01848834|157172069|FG001|Overall Study|Protocol Violation|0|||
48816832|NCT01848834|157172070|FG002|Overall Study|Protocol Violation|0|||
48816833|NCT01848834|157172071|FG003|Overall Study|Protocol Violation|0|||
48816834|NCT01848834|157172072|FG004|Overall Study|Protocol Violation|1|||
48816835|NCT01848834|157172068|FG000|Overall Study|Sponsor Decision|1|||
48816836|NCT01848834|157172069|FG001|Overall Study|Sponsor Decision|1|||
48816837|NCT01848834|157172070|FG002|Overall Study|Sponsor Decision|0|||
48816838|NCT01848834|157172071|FG003|Overall Study|Sponsor Decision|1|||
48816839|NCT01848834|157172072|FG004|Overall Study|Sponsor Decision|1|||
48816840|NCT01848834|157172068|FG000|Overall Study|Withdrawal by Subject|2|||
48816841|NCT01848834|157172069|FG001|Overall Study|Withdrawal by Subject|13|||
48816842|NCT01848834|157172070|FG002|Overall Study|Withdrawal by Subject|10|||
48816843|NCT01848834|157172071|FG003|Overall Study|Withdrawal by Subject|6|||
48816844|NCT01848834|157172072|FG004|Overall Study|Withdrawal by Subject|36|||
48816845|NCT01406717|157172073|FG000|Overall Study|Subject non-compliance|4|||
48816846|NCT01406717|157172074|FG001|Overall Study|Subject non-compliance|3|||
48816847|NCT01406717|157172073|FG000|Overall Study|Protocol Violation|5|||
48816848|NCT01406717|157172074|FG001|Overall Study|Protocol Violation|1|||
48816849|NCT01406717|157172073|FG000|Overall Study|Lost to Follow-up|14|||
48816850|NCT01406717|157172074|FG001|Overall Study|Lost to Follow-up|8|||
48816851|NCT01406717|157172073|FG000|Overall Study|Withdrawal by Subject|19|||
48816852|NCT01406717|157172074|FG001|Overall Study|Withdrawal by Subject|15|||
48816853|NCT01406717|157172073|FG000|Overall Study|Adverse Event|1|||
48816854|NCT01406717|157172074|FG001|Overall Study|Adverse Event|2|||
48816855|NCT01406717|157172073|FG000|Overall Study|Lack of Efficacy|0|||
48816856|NCT01406717|157172074|FG001|Overall Study|Lack of Efficacy|1|||
48500659|NCT02465567|156029441|FG000|Overall Study|Lost to Follow-up|25|||
48721680|NCT00282347|156830091|FG001|B Cell Follow-up Period|Physician Decision|0|||
48721681|NCT00282347|156830090|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
48721682|NCT00282347|156830091|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
48721683|NCT02125604|156830092|FG000|Overall Study|Other|4|||
48816857|NCT01406717|157172073|FG000|Overall Study|Non-completion of visit activity|0|||
48816858|NCT01406717|157172074|FG001|Overall Study|Non-completion of visit activity|1|||
48816859|NCT00655551|157172075|FG000|All Periods Combined|Adverse Event|0|||
48816860|NCT00655551|157172076|FG001|All Periods Combined|Adverse Event|3|||
48816861|NCT00655551|157172077|FG002|All Periods Combined|Adverse Event|4|||
48816862|NCT00655551|157172075|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
48500660|NCT02465567|156029442|FG001|Overall Study|Lost to Follow-up|21|||
48721684|NCT02125604|156830092|FG000|Overall Study|Investigator Decision|1|||
48721685|NCT02125604|156830092|FG000|Overall Study|Lost to Follow-up|2|||
48721686|NCT02125604|156830092|FG000|Overall Study|Consent Withdrawn|4|||
48816863|NCT00655551|157172076|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
48816864|NCT00655551|157172077|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
48816865|NCT00655551|157172075|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
48816866|NCT00655551|157172076|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
48816867|NCT00655551|157172077|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
48816868|NCT00655551|157172075|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
48816869|NCT00655551|157172076|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
48816870|NCT00655551|157172077|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
48816871|NCT00238420|157172078|FG000|Overall Study|Protocol Violation|1|||
48816872|NCT00238420|157172079|FG001|Overall Study|Protocol Violation|1|||
48816873|NCT02218489|157172082|FG000|Overall Study|Withdrawal by Subject|4|||
48816874|NCT02218489|157172083|FG001|Overall Study|Withdrawal by Subject|3|||
48816875|NCT02218489|157172082|FG000|Overall Study|Lost to Follow-up|1|||
48816876|NCT02218489|157172083|FG001|Overall Study|Lost to Follow-up|0|||
48816877|NCT02753530|157172084|FG000|Overall Study|Adverse Event|7|||
48816878|NCT02753530|157172085|FG001|Overall Study|Adverse Event|1|||
48816879|NCT02753530|157172084|FG000|Overall Study|Death|0|||
48816880|NCT02753530|157172085|FG001|Overall Study|Death|1|||
48816881|NCT02753530|157172084|FG000|Overall Study|Physician Decision|0|||
48816882|NCT02753530|157172085|FG001|Overall Study|Physician Decision|1|||
48816883|NCT02753530|157172084|FG000|Overall Study|Protocol Violation|1|||
48816884|NCT02753530|157172085|FG001|Overall Study|Protocol Violation|0|||
48816885|NCT02753530|157172084|FG000|Overall Study|Withdrawal by Subject|4|||
48816886|NCT02753530|157172085|FG001|Overall Study|Withdrawal by Subject|3|||
48816887|NCT03958630|157172086|FG000|Overall Study|Withdrawal by Subject|0|||
48816888|NCT03958630|157172087|FG001|Overall Study|Withdrawal by Subject|0|||
48816889|NCT03958630|157172088|FG002|Overall Study|Withdrawal by Subject|1|||
48816890|NCT03958630|157172086|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
48816891|NCT03958630|157172087|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
48816892|NCT03958630|157172088|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
48816893|NCT01824472|157172089|FG000|Overall Study|Lost to Follow-up|0|||
48816894|NCT01824472|157172090|FG001|Overall Study|Lost to Follow-up|0|||
48816895|NCT01824472|157172091|FG002|Overall Study|Lost to Follow-up|1|||
48816896|NCT01824472|157172089|FG000|Overall Study|Withdrawal by Subject|1|||
48816897|NCT01824472|157172090|FG001|Overall Study|Withdrawal by Subject|5|||
48816898|NCT01824472|157172091|FG002|Overall Study|Withdrawal by Subject|3|||
48816899|NCT01824472|157172089|FG000|Overall Study|Ineligible post randomization&screening|0|||
48816900|NCT01824472|157172090|FG001|Overall Study|Ineligible post randomization&screening|2|||
48816901|NCT01824472|157172091|FG002|Overall Study|Ineligible post randomization&screening|0|||
48816902|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
48816903|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
48816904|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
48816905|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
48816906|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
48816907|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
48816908|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
48816909|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
48816910|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
48816911|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
48816912|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
48816913|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
48816914|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
48816915|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
48816916|NCT01815736|157172092|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
48816917|NCT01815736|157172093|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
48816918|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
48721687|NCT02125604|156830092|FG000|Overall Study|Adverse Event|20|||
48721688|NCT01006603|156830093|FG000|Overall Study|Withdrawal by Subject|17|||
48721689|NCT01006603|156830094|FG001|Overall Study|Withdrawal by Subject|19|||
48721690|NCT01006603|156830093|FG000|Overall Study|Lost to Follow-up|0|||
48721691|NCT01006603|156830094|FG001|Overall Study|Lost to Follow-up|1|||
48721692|NCT01006603|156830093|FG000|Overall Study|Safety reason|1|||
48721693|NCT01006603|156830094|FG001|Overall Study|Safety reason|1|||
48721694|NCT01006603|156830093|FG000|Overall Study|Protocol Violation|1|||
48721695|NCT01006603|156830094|FG001|Overall Study|Protocol Violation|3|||
48721696|NCT01006603|156830093|FG000|Overall Study|Incorrect enrolment|0|||
48721697|NCT01006603|156830094|FG001|Overall Study|Incorrect enrolment|2|||
48816919|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
48721698|NCT01006603|156830093|FG000|Overall Study|Adverse Event|15|||
48721699|NCT01006603|156830094|FG001|Overall Study|Adverse Event|7|||
48721700|NCT01006603|156830093|FG000|Overall Study|Death|1|||
48721701|NCT01006603|156830094|FG001|Overall Study|Death|1|||
48500661|NCT02465567|156029443|FG002|Overall Study|Lost to Follow-up|19|||
48500662|NCT02465567|156029444|FG003|Overall Study|Lost to Follow-up|15|||
48500663|NCT02465567|156029441|FG000|Overall Study|Protocol Specified Criteria|20|||
48500664|NCT02465567|156029442|FG001|Overall Study|Protocol Specified Criteria|10|||
48500665|NCT02465567|156029443|FG002|Overall Study|Protocol Specified Criteria|9|||
48500666|NCT02465567|156029444|FG003|Overall Study|Protocol Specified Criteria|12|||
48500667|NCT02465567|156029441|FG000|Overall Study|Administrative Reasons|12|||
48500668|NCT02465567|156029442|FG001|Overall Study|Administrative Reasons|9|||
48500669|NCT02465567|156029443|FG002|Overall Study|Administrative Reasons|11|||
48500670|NCT02465567|156029444|FG003|Overall Study|Administrative Reasons|5|||
48500671|NCT02465567|156029441|FG000|Overall Study|Randomized but not treated|1|||
48500672|NCT02465567|156029442|FG001|Overall Study|Randomized but not treated|5|||
48500673|NCT02465567|156029443|FG002|Overall Study|Randomized but not treated|4|||
48500674|NCT02465567|156029444|FG003|Overall Study|Randomized but not treated|5|||
48500675|NCT02465567|156029441|FG000|Overall Study|enrolled in >1 studies|18|||
48500676|NCT02465567|156029442|FG001|Overall Study|enrolled in >1 studies|11|||
48500677|NCT02465567|156029443|FG002|Overall Study|enrolled in >1 studies|19|||
48500678|NCT02465567|156029444|FG003|Overall Study|enrolled in >1 studies|15|||
48816920|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
48816921|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
48816922|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
48816923|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
48816924|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
48816925|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
48816926|NCT01815736|157172092|FG000|Extension Treatment Phase- After Week 96|Death|1|||
48816927|NCT01815736|157172093|FG001|Extension Treatment Phase- After Week 96|Death|0|||
48816928|NCT01163747|157172094|FG000|Overall Study|Adverse Event|0|||
48816929|NCT01163747|157172095|FG001|Overall Study|Adverse Event|5|||
48816930|NCT01163747|157172094|FG000|Overall Study|Insufficient Therapeutic Response|0|||
48721702|NCT01006603|156830093|FG000|Overall Study|Study specific discontinuation criteria|33|||
48721703|NCT01006603|156830094|FG001|Overall Study|Study specific discontinuation criteria|34|||
48721704|NCT01006603|156830093|FG000|Overall Study|Other|3|||
48721705|NCT01006603|156830094|FG001|Overall Study|Other|7|||
48721706|NCT01974765|156831218|FG000|Overall Study|Withdrawal by Subject|1|||
48721707|NCT01974765|156831218|FG000|Overall Study|Death|1|||
48721708|NCT01974765|156831218|FG000|Overall Study|Adverse Event|2|||
48721709|NCT02519855|156831219|FG000|Overall Study|Adverse Event|0|||
48721710|NCT02519855|156831220|FG001|Overall Study|Adverse Event|1|||
48721711|NCT02519855|156831219|FG000|Overall Study|Lost to Follow-up|3|||
48721712|NCT02519855|156831220|FG001|Overall Study|Lost to Follow-up|3|||
48721713|NCT03699475|156831224|FG000|Overall Study|Death|1|||
48721714|NCT03055377|156831236|FG000|Treatment Phase|Lost to Follow-up|28|||
48721715|NCT03055377|156831237|FG001|Treatment Phase|Lost to Follow-up|24|||
48721716|NCT03055377|156831236|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
48816931|NCT01163747|157172095|FG001|Overall Study|Insufficient Therapeutic Response|1|||
48816932|NCT01163747|157172094|FG000|Overall Study|Protocol Violation|0|||
48816933|NCT01163747|157172095|FG001|Overall Study|Protocol Violation|1|||
48816934|NCT01163747|157172094|FG000|Overall Study|Refused Treatment|6|||
48816935|NCT01163747|157172095|FG001|Overall Study|Refused Treatment|4|||
48816936|NCT00604786|157172096|FG000|Overall Study|Lost to Follow-up|2|||
48816937|NCT00604786|157172097|FG001|Overall Study|Lost to Follow-up|0|||
48816938|NCT02698436|157172101|FG000|Overall Study|Adverse Event|1|||
48500679|NCT02465567|156029441|FG000|Overall Study|missing PI Signature|1|||
48500680|NCT02465567|156029442|FG001|Overall Study|missing PI Signature|0|||
48721717|NCT03055377|156831237|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
48721718|NCT03560739|156831238|FG000|Overall Study|Adverse Event|0|||
48816939|NCT02698436|157172102|FG001|Overall Study|Adverse Event|0|||
48500681|NCT02465567|156029443|FG002|Overall Study|missing PI Signature|0|||
48500682|NCT02465567|156029444|FG003|Overall Study|missing PI Signature|0|||
48500683|NCT00337077|156029451|FG000|Overall Study|Progressive disease|25|||
48500684|NCT00337077|156029452|FG001|Overall Study|Progressive disease|37|||
48500685|NCT00337077|156029453|FG002|Overall Study|Progressive disease|19|||
48500686|NCT00337077|156029451|FG000|Overall Study|Adverse Event|7|||
48721719|NCT03560739|156831239|FG001|Overall Study|Adverse Event|1|||
48721720|NCT03560739|156831240|FG002|Overall Study|Adverse Event|0|||
48721721|NCT03560739|156831241|FG003|Overall Study|Adverse Event|0|||
48721722|NCT00636987|156831244|FG000|Overall Study|Death|44|||
48721723|NCT00636987|156831244|FG000|Overall Study|Explanted|13|||
48721724|NCT00636987|156831244|FG000|Overall Study|Lost to Follow-up|63|||
48721725|NCT00636987|156831244|FG000|Overall Study|5 year visit window not complete|69|||
48721726|NCT03192891|156831245|FG000|Overall Study|Lost to Follow-up|55|||
48816940|NCT02698436|157172101|FG000|Overall Study|Withdrawal by Subject|3|||
48816941|NCT02698436|157172102|FG001|Overall Study|Withdrawal by Subject|3|||
48500687|NCT00337077|156029452|FG001|Overall Study|Adverse Event|7|||
48500688|NCT00337077|156029453|FG002|Overall Study|Adverse Event|1|||
48500689|NCT00337077|156029451|FG000|Overall Study|Death|0|||
48500690|NCT00337077|156029452|FG001|Overall Study|Death|1|||
48500691|NCT00337077|156029453|FG002|Overall Study|Death|0|||
48500692|NCT00337077|156029451|FG000|Overall Study|Withdrawal by Subject|7|||
48500693|NCT00337077|156029452|FG001|Overall Study|Withdrawal by Subject|2|||
48500694|NCT00337077|156029453|FG002|Overall Study|Withdrawal by Subject|2|||
48500695|NCT00337077|156029451|FG000|Overall Study|Alternative therapy|1|||
48500696|NCT00337077|156029452|FG001|Overall Study|Alternative therapy|0|||
48500697|NCT00337077|156029453|FG002|Overall Study|Alternative therapy|0|||
48599732|NCT03810456|156389821|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
48721727|NCT05406921|156831246|FG000|Overall Study|Withdrawal by Subject|25|||
48721728|NCT05406921|156831247|FG001|Overall Study|Withdrawal by Subject|0|||
48721729|NCT05406921|156831248|FG002|Overall Study|Withdrawal by Subject|25|||
48721730|NCT05406921|156831246|FG000|Overall Study|Protocol Violation|0|||
48721731|NCT05406921|156831247|FG001|Overall Study|Protocol Violation|12|||
48721732|NCT05406921|156831248|FG002|Overall Study|Protocol Violation|0|||
48721733|NCT00075270|156831249|FG000|Overall Study|Withdrawal by Subject|28|||
48721734|NCT00075270|156831250|FG001|Overall Study|Withdrawal by Subject|21|||
48721735|NCT00075270|156831249|FG000|Overall Study|Lost to Follow-up|25|||
48721736|NCT00075270|156831250|FG001|Overall Study|Lost to Follow-up|28|||
48721737|NCT00075270|156831249|FG000|Overall Study|Protocol Violation|0|||
48721738|NCT00075270|156831250|FG001|Overall Study|Protocol Violation|2|||
48721739|NCT00075270|156831249|FG000|Overall Study|Death|198|||
48721740|NCT00075270|156831250|FG001|Overall Study|Death|215|||
48721741|NCT00075270|156831249|FG000|Overall Study|Other/Unknown|9|||
48721742|NCT00075270|156831250|FG001|Overall Study|Other/Unknown|5|||
48721743|NCT00075270|156831249|FG000|Overall Study|Missing|26|||
48721744|NCT00075270|156831250|FG001|Overall Study|Missing|13|||
48721745|NCT00246571|156831251|FG000|Overall Study|Adverse Event|7|||
48721746|NCT00246571|156831252|FG001|Overall Study|Adverse Event|0|||
48721747|NCT00246571|156831251|FG000|Overall Study|Protocol Violation|0|||
48721748|NCT00246571|156831252|FG001|Overall Study|Protocol Violation|1|||
48721749|NCT00246571|156831251|FG000|Overall Study|Withdrawal by Subject|2|||
48721750|NCT00246571|156831252|FG001|Overall Study|Withdrawal by Subject|3|||
48721751|NCT00246571|156831251|FG000|Overall Study|Lack of Efficacy|84|||
48721752|NCT00246571|156831252|FG001|Overall Study|Lack of Efficacy|21|||
48721753|NCT00246571|156831251|FG000|Overall Study|Death|17|||
48721754|NCT00246571|156831252|FG001|Overall Study|Death|3|||
48721755|NCT00246571|156831251|FG000|Overall Study|Sponsor|0|||
48721756|NCT00246571|156831252|FG001|Overall Study|Sponsor|1|||
48721757|NCT00246571|156831251|FG000|Overall Study|Did not meet entrance criteria|2|||
48721758|NCT00246571|156831252|FG001|Overall Study|Did not meet entrance criteria|1|||
48721759|NCT00246571|156831251|FG000|Overall Study|Laboratory abnormalities|1|||
48721760|NCT00246571|156831252|FG001|Overall Study|Laboratory abnormalities|0|||
48721761|NCT00246571|156831251|FG000|Overall Study|Crossover participants|0|||
48721762|NCT00246571|156831252|FG001|Overall Study|Crossover participants|74|||
48721763|NCT03924986|156831254|FG000|Overall Study|Death|57|||
48721764|NCT03924986|156831255|FG001|Overall Study|Death|66|||
48721765|NCT03924986|156831254|FG000|Overall Study|Study Concluded by Sponsor|51|||
48721766|NCT03924986|156831255|FG001|Overall Study|Study Concluded by Sponsor|41|||
48721767|NCT03924986|156831254|FG000|Overall Study|Withdrawal by Subject|15|||
48721768|NCT03924986|156831255|FG001|Overall Study|Withdrawal by Subject|20|||
48721769|NCT03924986|156831254|FG000|Overall Study|Lost to Follow-up|7|||
48721770|NCT03924986|156831255|FG001|Overall Study|Lost to Follow-up|5|||
48721771|NCT03924986|156831254|FG000|Overall Study|Miscellaneous|1|||
48721772|NCT03924986|156831255|FG001|Overall Study|Miscellaneous|0|||
48721773|NCT03920111|156831259|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
48721774|NCT03920111|156831260|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
48721775|NCT03920111|156831261|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
48721776|NCT01133990|156831262|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
48721777|NCT01133990|156831263|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721778|NCT01133990|156831264|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721779|NCT01133990|156831265|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721780|NCT01133990|156831266|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721781|NCT01133990|156831267|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
48721782|NCT01133990|156831262|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
48721783|NCT01133990|156831263|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721784|NCT01133990|156831264|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721785|NCT01133990|156831265|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721786|NCT01133990|156831266|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721787|NCT01133990|156831267|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
48721788|NCT01133990|156831262|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
48721789|NCT01133990|156831263|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48721790|NCT01133990|156831264|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48721791|NCT01133990|156831265|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48816942|NCT02698436|157172101|FG000|Overall Study|Lost to Follow-up|2|||
48500698|NCT00337077|156029451|FG000|Overall Study|Physician Decision|1|||
48500699|NCT00337077|156029452|FG001|Overall Study|Physician Decision|4|||
48816943|NCT02698436|157172102|FG001|Overall Study|Lost to Follow-up|4|||
48816944|NCT02698436|157172101|FG000|Overall Study|Non-compliance with study regimen|1|||
48816945|NCT02698436|157172102|FG001|Overall Study|Non-compliance with study regimen|0|||
48816946|NCT04163991|157172103|FG000|Overall Study|Adverse Event|0|||
48816947|NCT04163991|157172104|FG001|Overall Study|Adverse Event|0|||
48816948|NCT04163991|157172105|FG002|Overall Study|Adverse Event|0|||
48816949|NCT04163991|157172106|FG003|Overall Study|Adverse Event|1|||
48816950|NCT04163991|157172107|FG004|Overall Study|Adverse Event|0|||
48500700|NCT00337077|156029453|FG002|Overall Study|Physician Decision|2|||
48500701|NCT00337077|156029451|FG000|Overall Study|Never started treatment|1|||
48500702|NCT00337077|156029452|FG001|Overall Study|Never started treatment|1|||
48816951|NCT04163991|157172103|FG000|Overall Study|Death|0|||
48816952|NCT04163991|157172104|FG001|Overall Study|Death|0|||
48816953|NCT04163991|157172105|FG002|Overall Study|Death|1|||
48816954|NCT04163991|157172106|FG003|Overall Study|Death|0|||
48816955|NCT04163991|157172107|FG004|Overall Study|Death|0|||
48816956|NCT04163991|157172103|FG000|Overall Study|Lost to Follow-up|0|||
48816957|NCT04163991|157172104|FG001|Overall Study|Lost to Follow-up|1|||
48816958|NCT04163991|157172105|FG002|Overall Study|Lost to Follow-up|0|||
48500703|NCT00337077|156029453|FG002|Overall Study|Never started treatment|0|||
48599733|NCT03810456|156389822|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
48500704|NCT00337077|156029451|FG000|Overall Study|Ineligible|1|||
48500705|NCT00337077|156029452|FG001|Overall Study|Ineligible|1|||
48500706|NCT00337077|156029453|FG002|Overall Study|Ineligible|1|||
48500707|NCT00944697|156029454|FG000|Overall Study|Withdrawal by Subject|1|||
48500708|NCT00944697|156029455|FG001|Overall Study|Withdrawal by Subject|1|||
48500709|NCT00944697|156029454|FG000|Overall Study|Adverse Event|0|||
48500710|NCT00944697|156029455|FG001|Overall Study|Adverse Event|3|||
48500711|NCT00944697|156029454|FG000|Overall Study|Administrative|1|||
48500712|NCT00944697|156029455|FG001|Overall Study|Administrative|1|||
48500713|NCT04091971|156029457|FG000|Overall Study|Withdrawal by Subject|1|||
48500714|NCT04091971|156029457|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
48500715|NCT04091971|156029457|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
48500716|NCT00472290|156029458|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
48500717|NCT00472290|156029458|FG000|Overall Study|Protocol Specified Criteria|7|||
48500718|NCT00472290|156029458|FG000|Overall Study|Administrative Decision|37|||
48500719|NCT00472290|156029458|FG000|Overall Study|Death|3|||
48500720|NCT00472290|156029458|FG000|Overall Study|Lost to Follow-up|1|||
48500721|NCT00472290|156029458|FG000|Overall Study|Lack of Efficacy|1|||
48500722|NCT00472290|156029458|FG000|Overall Study|Disease Progression|4|||
48500723|NCT00472290|156029458|FG000|Overall Study|Withdrawal by Subject|5|||
48500724|NCT00472290|156029458|FG000|Overall Study|Adverse Event|6|||
48500725|NCT00472290|156029458|FG000|Overall Study|Requirement for alternative therapy|7|||
48500726|NCT00193609|156029459|FG000|Overall Study|Lack of Efficacy|2|||
48500727|NCT00193609|156029459|FG000|Overall Study|Adverse Event|2|||
48500728|NCT01722877|156029466|FG000|Overall Study|Death|1|||
48500729|NCT01722877|156029466|FG000|Overall Study|Lost to Follow-up|1|||
48599734|NCT03810456|156389823|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
48599735|NCT01128400|156391454|FG000|Overall Study|Lost to Follow-up|1|||
48721792|NCT01133990|156831266|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48721793|NCT01133990|156831267|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
48721794|NCT01133990|156831262|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
48721795|NCT01133990|156831263|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48721796|NCT01133990|156831264|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48721797|NCT01133990|156831265|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48500730|NCT03693430|156029467|FG000|Overall Study|Lost to Follow-up|3|||
48500731|NCT03693430|156029468|FG001|Overall Study|Lost to Follow-up|14|||
48721798|NCT01133990|156831266|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48721799|NCT01133990|156831267|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
48721800|NCT01185301|156831268|FG000|Overall Study|Adverse Event|3|||
48721801|NCT01185301|156831269|FG001|Overall Study|Adverse Event|0|||
48721802|NCT01185301|156831270|FG002|Overall Study|Adverse Event|2|||
48721803|NCT01185301|156831271|FG003|Overall Study|Adverse Event|3|||
48721804|NCT01185301|156831268|FG000|Overall Study|Withdrawal by Subject|7|||
48500732|NCT03693430|156029467|FG000|Overall Study|Death|1|||
48500733|NCT03693430|156029468|FG001|Overall Study|Death|0|||
48599736|NCT01128400|156391455|FG001|Overall Study|Lost to Follow-up|0|||
48721805|NCT01185301|156831269|FG001|Overall Study|Withdrawal by Subject|5|||
48721806|NCT01185301|156831270|FG002|Overall Study|Withdrawal by Subject|2|||
48816959|NCT04163991|157172106|FG003|Overall Study|Lost to Follow-up|0|||
48816960|NCT04163991|157172107|FG004|Overall Study|Lost to Follow-up|0|||
48500734|NCT03693430|156029467|FG000|Overall Study|Withdrawal by Subject|0|||
48500735|NCT03693430|156029468|FG001|Overall Study|Withdrawal by Subject|4|||
48500736|NCT03338972|156029469|FG000|Overall Study|Death|1|||
48500737|NCT03338972|156029470|FG001|Overall Study|Death|1|||
48500738|NCT03338972|156029471|FG002|Overall Study|Death|0|||
48500739|NCT03338972|156029472|FG003|Overall Study|Death|0|||
48816961|NCT04163991|157172103|FG000|Overall Study|Withdrawal by Subject|1|||
48500740|NCT03338972|156029469|FG000|Overall Study|Withdrawal by Subject|1|||
48500741|NCT03338972|156029470|FG001|Overall Study|Withdrawal by Subject|0|||
48721807|NCT01185301|156831271|FG003|Overall Study|Withdrawal by Subject|3|||
48721808|NCT01185301|156831268|FG000|Overall Study|Lost to Follow-up|2|||
48721809|NCT01185301|156831269|FG001|Overall Study|Lost to Follow-up|0|||
48721810|NCT01185301|156831270|FG002|Overall Study|Lost to Follow-up|0|||
48721811|NCT01185301|156831271|FG003|Overall Study|Lost to Follow-up|1|||
48721812|NCT01185301|156831268|FG000|Overall Study|Other Reason|3|||
48721813|NCT01185301|156831269|FG001|Overall Study|Other Reason|2|||
48721814|NCT01185301|156831270|FG002|Overall Study|Other Reason|2|||
48721815|NCT01185301|156831271|FG003|Overall Study|Other Reason|2|||
48500742|NCT03338972|156029471|FG002|Overall Study|Withdrawal by Subject|0|||
48500743|NCT03338972|156029472|FG003|Overall Study|Withdrawal by Subject|0|||
48500744|NCT01355081|156029475|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
48500745|NCT01355081|156029476|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
48500746|NCT01355081|156029477|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
48500747|NCT01355081|156029475|FG000|Overall Study|Major Protocol Deviation|0|||
48500748|NCT01355081|156029476|FG001|Overall Study|Major Protocol Deviation|1|||
48500749|NCT01355081|156029477|FG002|Overall Study|Major Protocol Deviation|0|||
48500750|NCT01355081|156029475|FG000|Overall Study|Lost to Follow-up|0|||
48500751|NCT01355081|156029476|FG001|Overall Study|Lost to Follow-up|0|||
48500752|NCT01355081|156029477|FG002|Overall Study|Lost to Follow-up|1|||
48500753|NCT01355081|156029475|FG000|Overall Study|Withdrawal of Consent|2|||
48500754|NCT01355081|156029476|FG001|Overall Study|Withdrawal of Consent|3|||
48500755|NCT01355081|156029477|FG002|Overall Study|Withdrawal of Consent|3|||
48500756|NCT01355081|156029475|FG000|Overall Study|Lack of Efficacy|2|||
48500757|NCT01355081|156029476|FG001|Overall Study|Lack of Efficacy|1|||
48500758|NCT01355081|156029477|FG002|Overall Study|Lack of Efficacy|1|||
48500759|NCT01355081|156029475|FG000|Overall Study|Non Compliance with Study Medication|0|||
48500760|NCT01355081|156029476|FG001|Overall Study|Non Compliance with Study Medication|1|||
48500761|NCT01355081|156029477|FG002|Overall Study|Non Compliance with Study Medication|0|||
48500762|NCT02480764|156029478|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
48500763|NCT02480764|156029479|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
48500764|NCT02480764|156029480|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
48500765|NCT02480764|156029478|FG000|Overall Study|Major Protocol Deviation|1|||
48500766|NCT02480764|156029479|FG001|Overall Study|Major Protocol Deviation|4|||
48500767|NCT02480764|156029480|FG002|Overall Study|Major Protocol Deviation|3|||
48500768|NCT02480764|156029478|FG000|Overall Study|Lost to Follow-up|0|||
48500769|NCT02480764|156029479|FG001|Overall Study|Lost to Follow-up|1|||
48500770|NCT02480764|156029480|FG002|Overall Study|Lost to Follow-up|2|||
48500771|NCT02480764|156029478|FG000|Overall Study|Voluntary Withdrawal|6|||
48500772|NCT02480764|156029479|FG001|Overall Study|Voluntary Withdrawal|5|||
48500773|NCT02480764|156029480|FG002|Overall Study|Voluntary Withdrawal|10|||
48500774|NCT02480764|156029478|FG000|Overall Study|Lack of Efficacy|0|||
48500775|NCT02480764|156029479|FG001|Overall Study|Lack of Efficacy|3|||
48500776|NCT02480764|156029480|FG002|Overall Study|Lack of Efficacy|3|||
48500777|NCT02480764|156029478|FG000|Overall Study|Reason not Specified|0|||
48500778|NCT02480764|156029479|FG001|Overall Study|Reason not Specified|1|||
48500779|NCT02480764|156029480|FG002|Overall Study|Reason not Specified|0|||
48500780|NCT01706536|156029481|FG000|Overall Study|Withdrawal by Subject|1|||
48500781|NCT01706536|156029482|FG001|Overall Study|Withdrawal by Subject|0|||
48500782|NCT01706536|156029483|FG002|Overall Study|Withdrawal by Subject|1|||
48500783|NCT01706536|156029484|FG003|Overall Study|Withdrawal by Subject|0|||
48500784|NCT01706536|156029485|FG004|Overall Study|Withdrawal by Subject|0|||
48500785|NCT01706536|156029481|FG000|Overall Study|Adverse Event|2|||
48500786|NCT01706536|156029482|FG001|Overall Study|Adverse Event|3|||
48500787|NCT01706536|156029483|FG002|Overall Study|Adverse Event|4|||
48500788|NCT01706536|156029484|FG003|Overall Study|Adverse Event|3|||
48500789|NCT01706536|156029485|FG004|Overall Study|Adverse Event|2|||
48500790|NCT01706536|156029481|FG000|Overall Study|Lack of Efficacy|1|||
48500791|NCT01706536|156029482|FG001|Overall Study|Lack of Efficacy|0|||
48500792|NCT01706536|156029483|FG002|Overall Study|Lack of Efficacy|0|||
48500793|NCT01706536|156029484|FG003|Overall Study|Lack of Efficacy|1|||
48500794|NCT01706536|156029485|FG004|Overall Study|Lack of Efficacy|0|||
48500795|NCT01706536|156029481|FG000|Overall Study|non compliance|0|||
48500796|NCT01706536|156029482|FG001|Overall Study|non compliance|1|||
48500797|NCT01706536|156029483|FG002|Overall Study|non compliance|0|||
48500798|NCT01706536|156029484|FG003|Overall Study|non compliance|0|||
48500799|NCT01706536|156029485|FG004|Overall Study|non compliance|0|||
48500800|NCT03629249|156029487|FG000|Overall Study|Study terminated by sponsor|197|||
48500801|NCT03629249|156029488|FG001|Overall Study|Study terminated by sponsor|197|||
48500802|NCT03629249|156029489|FG002|Overall Study|Study terminated by sponsor|194|||
48500803|NCT03629249|156029487|FG000|Overall Study|Protocol deviation|0|||
48721816|NCT02047318|156831272|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
48721817|NCT02047318|156831272|FG000|Core Study Period|Adverse Event|1|||
48500804|NCT03629249|156029488|FG001|Overall Study|Protocol deviation|2|||
48500805|NCT03629249|156029489|FG002|Overall Study|Protocol deviation|5|||
48721818|NCT02047318|156831272|FG000|Core Study Period|Withdrawal by caregiver|3|||
48816962|NCT04163991|157172104|FG001|Overall Study|Withdrawal by Subject|1|||
48816963|NCT04163991|157172105|FG002|Overall Study|Withdrawal by Subject|3|||
48816964|NCT04163991|157172106|FG003|Overall Study|Withdrawal by Subject|1|||
48816965|NCT04163991|157172107|FG004|Overall Study|Withdrawal by Subject|1|||
48816966|NCT04163991|157172103|FG000|Overall Study|Other, Not Specified|0|||
48816967|NCT04163991|157172104|FG001|Overall Study|Other, Not Specified|1|||
48816968|NCT04163991|157172105|FG002|Overall Study|Other, Not Specified|1|||
48816969|NCT04163991|157172106|FG003|Overall Study|Other, Not Specified|1|||
48816970|NCT04163991|157172107|FG004|Overall Study|Other, Not Specified|0|||
48816971|NCT03390036|157173558|FG000|Overall Study|Lost to Follow-up|1|||
48816972|NCT03390036|157173559|FG001|Overall Study|Lost to Follow-up|0|||
48816973|NCT03390036|157173560|FG002|Overall Study|Lost to Follow-up|0|||
48816974|NCT03390036|157173558|FG000|Overall Study|Lack of Efficacy|1|||
48500806|NCT03629249|156029487|FG000|Overall Study|Subject decision|1|||
48500807|NCT03629249|156029488|FG001|Overall Study|Subject decision|1|||
48721819|NCT02047318|156831272|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
48721820|NCT00924781|156831273|FG000|Overall Study|Study terminated by sponsor|12|||
48721821|NCT00924781|156831274|FG001|Overall Study|Study terminated by sponsor|10|||
48721822|NCT02095132|156831276|FG000|Overall Study|Adverse Event|0|||
48721823|NCT02095132|156831277|FG001|Overall Study|Adverse Event|0|||
48721824|NCT02095132|156831278|FG002|Overall Study|Adverse Event|0|||
48721825|NCT02095132|156831279|FG003|Overall Study|Adverse Event|0|||
48721826|NCT02095132|156831280|FG004|Overall Study|Adverse Event|1|||
48721827|NCT02095132|156831281|FG005|Overall Study|Adverse Event|0|||
48721828|NCT02095132|156831282|FG006|Overall Study|Adverse Event|1|||
48721829|NCT02095132|156831283|FG007|Overall Study|Adverse Event|0|||
48721830|NCT02095132|156831284|FG008|Overall Study|Adverse Event|0|||
48721831|NCT02095132|156831276|FG000|Overall Study|Death|0|||
48721832|NCT02095132|156831277|FG001|Overall Study|Death|0|||
48721833|NCT02095132|156831278|FG002|Overall Study|Death|0|||
48721834|NCT02095132|156831279|FG003|Overall Study|Death|0|||
48721835|NCT02095132|156831280|FG004|Overall Study|Death|0|||
48721836|NCT02095132|156831281|FG005|Overall Study|Death|0|||
48721837|NCT02095132|156831282|FG006|Overall Study|Death|1|||
48721838|NCT02095132|156831283|FG007|Overall Study|Death|0|||
48721839|NCT02095132|156831284|FG008|Overall Study|Death|0|||
48721840|NCT02095132|156831276|FG000|Overall Study|Lack of Efficacy|3|||
48721841|NCT02095132|156831277|FG001|Overall Study|Lack of Efficacy|5|||
48500808|NCT03629249|156029489|FG002|Overall Study|Subject decision|3|||
48500809|NCT03629249|156029487|FG000|Overall Study|Adverse Event|1|||
48500810|NCT03629249|156029488|FG001|Overall Study|Adverse Event|1|||
48500811|NCT03629249|156029489|FG002|Overall Study|Adverse Event|0|||
48500812|NCT03629249|156029487|FG000|Overall Study|Death|1|||
48500813|NCT03629249|156029488|FG001|Overall Study|Death|0|||
48500814|NCT03629249|156029489|FG002|Overall Study|Death|0|||
48500815|NCT03629249|156029487|FG000|Overall Study|Physician Decision|1|||
48500816|NCT03629249|156029488|FG001|Overall Study|Physician Decision|0|||
48500817|NCT03629249|156029489|FG002|Overall Study|Physician Decision|0|||
48500818|NCT01697696|156029494|FG000|Overall Study|Study terminated by sponsor|0|||
48500819|NCT01697696|156029495|FG001|Overall Study|Study terminated by sponsor|3|||
48500820|NCT01697696|156029494|FG000|Overall Study|Protocol deviation|1|||
48500821|NCT01697696|156029495|FG001|Overall Study|Protocol deviation|0|||
48500822|NCT01697696|156029494|FG000|Overall Study|Physician Decision|1|||
48500823|NCT01697696|156029495|FG001|Overall Study|Physician Decision|0|||
48500824|NCT01697696|156029494|FG000|Overall Study|Death|4|||
48500825|NCT01697696|156029495|FG001|Overall Study|Death|2|||
48500826|NCT01697696|156029494|FG000|Overall Study|Lost to Follow-up|10|||
48500827|NCT01697696|156029495|FG001|Overall Study|Lost to Follow-up|7|||
48500828|NCT01697696|156029494|FG000|Overall Study|Subject/guardian decision|31|||
48500829|NCT01697696|156029495|FG001|Overall Study|Subject/guardian decision|35|||
48500830|NCT01402947|156029496|FG000|First Intervention|Adverse Event|0|||
48721842|NCT02095132|156831278|FG002|Overall Study|Lack of Efficacy|2|||
48721843|NCT02095132|156831279|FG003|Overall Study|Lack of Efficacy|8|||
48721844|NCT02095132|156831280|FG004|Overall Study|Lack of Efficacy|3|||
48500831|NCT01402947|156029497|FG001|First Intervention|Adverse Event|1|||
48500832|NCT05593965|156029498|FG000|1st Intervention (1 Day)|Technical error|1|||
48500833|NCT05593965|156029499|FG001|1st Intervention (1 Day)|Technical error|0|||
48500834|NCT00591630|156029500|FG000|Overall Study|Death|0|||
48500835|NCT00591630|156029501|FG001|Overall Study|Death|0|||
48500836|NCT00591630|156029502|FG002|Overall Study|Death|1|||
48500837|NCT00591630|156029503|FG003|Overall Study|Death|0|||
48500838|NCT02146430|156030868|FG000|Overall Study|Protocol Violation|5|||
48721845|NCT02095132|156831281|FG005|Overall Study|Lack of Efficacy|6|||
48721846|NCT02095132|156831282|FG006|Overall Study|Lack of Efficacy|10|||
48816975|NCT03390036|157173559|FG001|Overall Study|Lack of Efficacy|0|||
48816976|NCT03390036|157173560|FG002|Overall Study|Lack of Efficacy|0|||
48816977|NCT00373295|157173561|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48816978|NCT00373295|157173562|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
48816979|NCT00373295|157173563|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48816980|NCT00373295|157173564|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48816981|NCT00373295|157173565|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
48816982|NCT00373295|157173566|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48500839|NCT02146430|156030869|FG001|Overall Study|Protocol Violation|4|||
48500840|NCT02146430|156030870|FG002|Overall Study|Protocol Violation|8|||
48500841|NCT02146430|156030871|FG003|Overall Study|Protocol Violation|6|||
48500842|NCT02146430|156030868|FG000|Overall Study|Lack of Efficacy|13|||
48500843|NCT02146430|156030869|FG001|Overall Study|Lack of Efficacy|11|||
48816983|NCT05107401|157173567|FG000|Overall Study|Lost to Follow-up|13|||
48816984|NCT05107401|157173568|FG001|Overall Study|Lost to Follow-up|12|||
48816985|NCT00605319|157173571|FG000|Overall Study|Adverse Event|6|||
48816986|NCT01683994|157173589|FG000|Overall Study|Withdrawal by Subject|1|||
48816987|NCT01683994|157173590|FG001|Overall Study|Withdrawal by Subject|0|||
48816988|NCT01683994|157173591|FG002|Overall Study|Withdrawal by Subject|0|||
48816989|NCT01683994|157173592|FG003|Overall Study|Withdrawal by Subject|1|||
48816990|NCT01683994|157173593|FG004|Overall Study|Withdrawal by Subject|0|||
48816991|NCT01683994|157173589|FG000|Overall Study|Intercurrent illness|0|||
48816992|NCT01683994|157173590|FG001|Overall Study|Intercurrent illness|0|||
48816993|NCT01683994|157173591|FG002|Overall Study|Intercurrent illness|0|||
48816994|NCT01683994|157173592|FG003|Overall Study|Intercurrent illness|2|||
48721847|NCT02095132|156831283|FG007|Overall Study|Lack of Efficacy|9|||
48721848|NCT02095132|156831284|FG008|Overall Study|Lack of Efficacy|8|||
48721849|NCT02095132|156831276|FG000|Overall Study|Physician Decision|1|||
48721850|NCT02095132|156831277|FG001|Overall Study|Physician Decision|0|||
48721851|NCT02095132|156831278|FG002|Overall Study|Physician Decision|0|||
48721852|NCT02095132|156831279|FG003|Overall Study|Physician Decision|0|||
48721853|NCT02095132|156831280|FG004|Overall Study|Physician Decision|0|||
48721854|NCT02095132|156831281|FG005|Overall Study|Physician Decision|0|||
48721855|NCT02095132|156831282|FG006|Overall Study|Physician Decision|1|||
48721856|NCT02095132|156831283|FG007|Overall Study|Physician Decision|0|||
48721857|NCT02095132|156831284|FG008|Overall Study|Physician Decision|2|||
48721858|NCT02095132|156831276|FG000|Overall Study|Withdrawal by Subject|0|||
48721859|NCT02095132|156831277|FG001|Overall Study|Withdrawal by Subject|0|||
48721860|NCT02095132|156831278|FG002|Overall Study|Withdrawal by Subject|2|||
48721861|NCT02095132|156831279|FG003|Overall Study|Withdrawal by Subject|2|||
48721862|NCT02095132|156831280|FG004|Overall Study|Withdrawal by Subject|3|||
48721863|NCT02095132|156831281|FG005|Overall Study|Withdrawal by Subject|0|||
48721864|NCT02095132|156831282|FG006|Overall Study|Withdrawal by Subject|5|||
48721865|NCT02095132|156831283|FG007|Overall Study|Withdrawal by Subject|0|||
48721866|NCT02095132|156831284|FG008|Overall Study|Withdrawal by Subject|0|||
48721867|NCT02554279|156831291|FG000|Overall Study|Adverse Event|2|||
48721868|NCT02554279|156831292|FG001|Overall Study|Adverse Event|5|||
48721869|NCT02554279|156831291|FG000|Overall Study|Lost to Follow-up|3|||
48721870|NCT02554279|156831292|FG001|Overall Study|Lost to Follow-up|2|||
48721871|NCT02554279|156831291|FG000|Overall Study|Withdrawal by Subject|6|||
48721872|NCT02554279|156831292|FG001|Overall Study|Withdrawal by Subject|4|||
48721873|NCT02554279|156831291|FG000|Overall Study|Protocol Violation|2|||
48721874|NCT02554279|156831292|FG001|Overall Study|Protocol Violation|1|||
48721875|NCT02554279|156831291|FG000|Overall Study|Other reason|19|||
48721876|NCT02554279|156831292|FG001|Overall Study|Other reason|6|||
48721877|NCT02496676|156831299|FG000|Phase 1 - Period 1|Adverse Event|0|||
48721878|NCT02496676|156831300|FG001|Phase 1 - Period 1|Adverse Event|1|||
48721879|NCT02496676|156831299|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
48721880|NCT02496676|156831300|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
48721881|NCT01119937|156831301|FG000|Overall Study|Adverse Event|11|||
48721882|NCT01119937|156831302|FG001|Overall Study|Adverse Event|5|||
48721883|NCT01119937|156831301|FG000|Overall Study|Protocol deviation|3|||
48721884|NCT01119937|156831302|FG001|Overall Study|Protocol deviation|1|||
48816995|NCT01683994|157173593|FG004|Overall Study|Intercurrent illness|1|||
48816996|NCT01500226|157173595|FG000|Overall Study|Adverse Event|31|||
48816997|NCT01500226|157173596|FG001|Overall Study|Adverse Event|38|||
48500844|NCT02146430|156030870|FG002|Overall Study|Lack of Efficacy|8|||
48500845|NCT02146430|156030871|FG003|Overall Study|Lack of Efficacy|5|||
48500846|NCT02146430|156030868|FG000|Overall Study|Adverse Event|20|||
48500847|NCT02146430|156030869|FG001|Overall Study|Adverse Event|40|||
48500848|NCT02146430|156030870|FG002|Overall Study|Adverse Event|32|||
48721885|NCT01119937|156831301|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
48721886|NCT01119937|156831302|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48721887|NCT01119937|156831301|FG000|Overall Study|Withdrawal by Subject|2|||
48721888|NCT01119937|156831302|FG001|Overall Study|Withdrawal by Subject|1|||
48721889|NCT02025556|156831303|FG000|Overall Study|Adverse Event|0|||
48721890|NCT02025556|156831304|FG001|Overall Study|Adverse Event|4|||
48721891|NCT02025556|156831305|FG002|Overall Study|Adverse Event|2|||
48721892|NCT02025556|156831303|FG000|Overall Study|Lack of Efficacy|2|||
48721893|NCT02025556|156831304|FG001|Overall Study|Lack of Efficacy|1|||
48721894|NCT02025556|156831305|FG002|Overall Study|Lack of Efficacy|0|||
48816998|NCT01500226|157173595|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
48500849|NCT02146430|156030871|FG003|Overall Study|Adverse Event|49|||
48500850|NCT02146430|156030868|FG000|Overall Study|Reason missing or not reported|2|||
48500851|NCT02146430|156030869|FG001|Overall Study|Reason missing or not reported|3|||
48500852|NCT02146430|156030870|FG002|Overall Study|Reason missing or not reported|4|||
48500853|NCT02146430|156030871|FG003|Overall Study|Reason missing or not reported|5|||
48500854|NCT02146430|156030868|FG000|Overall Study|Withdrawal by Subject|27|||
48500855|NCT02146430|156030869|FG001|Overall Study|Withdrawal by Subject|29|||
48500856|NCT02146430|156030870|FG002|Overall Study|Withdrawal by Subject|30|||
48500857|NCT02146430|156030871|FG003|Overall Study|Withdrawal by Subject|34|||
48500858|NCT01469364|156030872|FG000|Overall Study|Adverse Event|1|||
48500859|NCT01469364|156030872|FG000|Overall Study|Withdrawal by Subject|1|||
48500860|NCT06066541|156030873|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
48500861|NCT06066541|156030874|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
48500862|NCT06066541|156030875|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
48500863|NCT06066541|156030876|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
48500864|NCT06066541|156030877|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
48500865|NCT06066541|156030878|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
48500866|NCT06066541|156030879|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
48500867|NCT06066541|156030873|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
48500868|NCT06066541|156030874|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
48500869|NCT06066541|156030875|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
48500870|NCT06066541|156030876|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
48500871|NCT06066541|156030877|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
48500872|NCT06066541|156030878|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
48500873|NCT06066541|156030879|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
48500874|NCT02581345|156030880|FG000|Part 1: up to Week 16|Adverse Event|3|||
48500875|NCT02581345|156030881|FG001|Part 1: up to Week 16|Adverse Event|8|||
48500876|NCT02581345|156030882|FG002|Part 1: up to Week 16|Adverse Event|0|||
48500877|NCT02581345|156030883|FG003|Part 1: up to Week 16|Adverse Event|0|||
48500878|NCT02581345|156030880|FG000|Part 1: up to Week 16|Physician Decision|2|||
48500879|NCT02581345|156030881|FG001|Part 1: up to Week 16|Physician Decision|4|||
48500880|NCT02581345|156030882|FG002|Part 1: up to Week 16|Physician Decision|0|||
48500881|NCT02581345|156030883|FG003|Part 1: up to Week 16|Physician Decision|0|||
48500882|NCT02581345|156030880|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
48500883|NCT02581345|156030881|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
48500884|NCT02581345|156030882|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
48500885|NCT02581345|156030883|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
48500886|NCT02581345|156030880|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
48500887|NCT02581345|156030881|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
48500888|NCT02581345|156030882|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
48500889|NCT02581345|156030883|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
48500890|NCT02581345|156030880|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
48500891|NCT02581345|156030881|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
48500892|NCT02581345|156030882|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
48500893|NCT02581345|156030883|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
48500894|NCT02581345|156030880|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
48500895|NCT02581345|156030881|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
48500896|NCT02581345|156030882|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
48500897|NCT02581345|156030883|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
48500898|NCT02581345|156030880|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
48500899|NCT02581345|156030881|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
48500900|NCT02581345|156030882|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
48500901|NCT02581345|156030883|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
48500902|NCT02581345|156030880|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
48500903|NCT02581345|156030881|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
48500904|NCT02581345|156030882|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
48500905|NCT02581345|156030883|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
48500906|NCT02581345|156030880|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
48500907|NCT02581345|156030881|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
48500908|NCT02581345|156030882|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
48500909|NCT02581345|156030883|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
48500910|NCT02581345|156030880|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
48721895|NCT02025556|156831303|FG000|Overall Study|Protocol Violation|2|||
48500911|NCT02581345|156030881|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
48500912|NCT02581345|156030882|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
48500913|NCT02581345|156030883|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
48500914|NCT02581345|156030880|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
48500915|NCT02581345|156030881|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
48721896|NCT02025556|156831304|FG001|Overall Study|Protocol Violation|1|||
48500916|NCT02581345|156030882|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
48500917|NCT02581345|156030883|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
48721897|NCT02025556|156831305|FG002|Overall Study|Protocol Violation|0|||
48721898|NCT02025556|156831303|FG000|Overall Study|Withdrawal by Subject|0|||
48721899|NCT02025556|156831304|FG001|Overall Study|Withdrawal by Subject|3|||
48721900|NCT02025556|156831305|FG002|Overall Study|Withdrawal by Subject|6|||
48721901|NCT02025556|156831303|FG000|Overall Study|Lost to Follow-up|2|||
48721902|NCT02025556|156831304|FG001|Overall Study|Lost to Follow-up|4|||
48500918|NCT02581345|156030880|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
48500919|NCT02581345|156030881|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
48721903|NCT02025556|156831305|FG002|Overall Study|Lost to Follow-up|0|||
48721904|NCT02025556|156831303|FG000|Overall Study|Reason not reported|0|||
48721905|NCT02025556|156831304|FG001|Overall Study|Reason not reported|0|||
48721906|NCT02025556|156831305|FG002|Overall Study|Reason not reported|1|||
48721907|NCT03946670|156831306|FG000|Overall Study|Progressive Disease|26|||
48500920|NCT02581345|156030882|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
48500921|NCT02581345|156030883|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
48500922|NCT01893905|156030884|FG000|Overall Study|Withdrawal by Subject|1|||
48500923|NCT01893905|156030885|FG001|Overall Study|Withdrawal by Subject|0|||
48500924|NCT01893905|156030884|FG000|Overall Study|Adverse Event|9|||
48721908|NCT03946670|156831307|FG001|Overall Study|Progressive Disease|23|||
48721909|NCT03946670|156831306|FG000|Overall Study|Adverse Event|7|||
48721910|NCT03946670|156831307|FG001|Overall Study|Adverse Event|9|||
48721911|NCT03946670|156831306|FG000|Overall Study|Death|5|||
48721912|NCT03946670|156831307|FG001|Overall Study|Death|6|||
48721913|NCT03946670|156831306|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
48721914|NCT03946670|156831307|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
48721915|NCT03946670|156831306|FG000|Overall Study|Subject Decision|4|||
48721916|NCT03946670|156831307|FG001|Overall Study|Subject Decision|4|||
48721917|NCT03946670|156831306|FG000|Overall Study|Physician Decision|3|||
48721918|NCT03946670|156831307|FG001|Overall Study|Physician Decision|3|||
48721919|NCT03946670|156831306|FG000|Overall Study|New Therapy for Study Indication|1|||
48721920|NCT03946670|156831307|FG001|Overall Study|New Therapy for Study Indication|0|||
48721921|NCT03946670|156831306|FG000|Overall Study|Not treated|1|||
48721922|NCT03946670|156831307|FG001|Overall Study|Not treated|1|||
48721923|NCT02112045|156831308|FG000|Overall Study|Withdrawal by Subject|1|||
48721924|NCT02112045|156831309|FG001|Overall Study|Withdrawal by Subject|0|||
48721925|NCT01960907|156831310|FG000|Overall Study|Death|4|||
48721926|NCT01960907|156831311|FG001|Overall Study|Death|3|||
48721927|NCT01960907|156831310|FG000|Overall Study|Withdrawal by Subject|32|||
48721928|NCT01960907|156831311|FG001|Overall Study|Withdrawal by Subject|42|||
48721929|NCT00913692|156831317|FG000|Screening (4 Months)|Physician Decision|3|||
48500925|NCT01893905|156030885|FG001|Overall Study|Adverse Event|3|||
48500926|NCT01893905|156030884|FG000|Overall Study|Lack of Efficacy|5|||
48500927|NCT01893905|156030885|FG001|Overall Study|Lack of Efficacy|7|||
48500928|NCT01893905|156030884|FG000|Overall Study|Lost to Follow-up|1|||
48500929|NCT01893905|156030885|FG001|Overall Study|Lost to Follow-up|0|||
48500930|NCT01893905|156030884|FG000|Overall Study|Protocol Violation|6|||
48500931|NCT01893905|156030885|FG001|Overall Study|Protocol Violation|1|||
48500932|NCT01893905|156030884|FG000|Overall Study|Lack of adherence to treatment|2|||
48500933|NCT01893905|156030885|FG001|Overall Study|Lack of adherence to treatment|0|||
48500934|NCT01893905|156030884|FG000|Overall Study|Other reason|1|||
48500935|NCT01893905|156030885|FG001|Overall Study|Other reason|3|||
48500936|NCT03289039|156030886|FG000|Overall Study|Withdrawal by Subject|0|||
48500937|NCT03289039|156030887|FG001|Overall Study|Withdrawal by Subject|1|||
48500938|NCT03289039|156030886|FG000|Overall Study|Became ineligible prior to treatment start|0|||
48500939|NCT03289039|156030887|FG001|Overall Study|Became ineligible prior to treatment start|1|||
48500940|NCT03289039|156030886|FG000|Overall Study|progressed before treatment start|1|||
48721930|NCT00913692|156831317|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
48721931|NCT00913692|156831317|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
48721932|NCT00266877|156831320|FG000|Overall Study|Death|1|||
48721933|NCT00266877|156831321|FG001|Overall Study|Death|1|||
48500941|NCT03289039|156030887|FG001|Overall Study|progressed before treatment start|0|||
48500942|NCT01768858|156030888|FG000|Overall Study|Lost to Follow-up|9|||
48500943|NCT01768858|156030888|FG000|Overall Study|Lack of Efficacy|8|||
48500944|NCT01768858|156030888|FG000|Overall Study|Serious Adverse Event|1|||
48721934|NCT00266877|156831322|FG002|Overall Study|Death|1|||
48500945|NCT01768858|156030888|FG000|Overall Study|Participant moved to Germany|1|||
48500946|NCT01768858|156030888|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
48500947|NCT01768858|156030888|FG000|Overall Study|Exanthema|1|||
48599737|NCT01128400|156391456|FG002|Overall Study|Lost to Follow-up|1|||
48721935|NCT00266877|156831320|FG000|Overall Study|Adverse Event|6|||
48721936|NCT00266877|156831321|FG001|Overall Study|Adverse Event|4|||
48721937|NCT00266877|156831322|FG002|Overall Study|Adverse Event|1|||
48721938|NCT00266877|156831320|FG000|Overall Study|Physician Decision|2|||
48721939|NCT00266877|156831321|FG001|Overall Study|Physician Decision|1|||
48721940|NCT00266877|156831322|FG002|Overall Study|Physician Decision|1|||
48721941|NCT00266877|156831320|FG000|Overall Study|Withdrawal by Subject|3|||
48721942|NCT00266877|156831321|FG001|Overall Study|Withdrawal by Subject|1|||
48721943|NCT00266877|156831322|FG002|Overall Study|Withdrawal by Subject|1|||
48721944|NCT00266877|156831320|FG000|Overall Study|Disease Progression|72|||
48721945|NCT00266877|156831321|FG001|Overall Study|Disease Progression|37|||
48500948|NCT01768858|156030888|FG000|Overall Study|Withdrawal by Subject|1|||
48500949|NCT01374919|156030891|FG000|Overall Study|Withdrawal by Subject|2|||
48500950|NCT03312530|156030892|FG000|Overall Study|Death|5|||
48500951|NCT03312530|156030893|FG001|Overall Study|Death|5|||
48500952|NCT03312530|156030894|FG002|Overall Study|Death|4|||
48500953|NCT03312530|156030895|FG003|Overall Study|Death|10|||
48500954|NCT03312530|156030896|FG004|Overall Study|Death|8|||
48500955|NCT03312530|156030892|FG000|Overall Study|Lost to Follow-up|0|||
48721946|NCT00266877|156831322|FG002|Overall Study|Disease Progression|23|||
48721947|NCT00266877|156831320|FG000|Overall Study|Symptomatic Deterioration|6|||
48721948|NCT00266877|156831321|FG001|Overall Study|Symptomatic Deterioration|3|||
48721949|NCT00266877|156831322|FG002|Overall Study|Symptomatic Deterioration|1|||
48721950|NCT00266877|156831320|FG000|Overall Study|Hospitalization|1|||
48721951|NCT00266877|156831321|FG001|Overall Study|Hospitalization|0|||
48721952|NCT00266877|156831322|FG002|Overall Study|Hospitalization|0|||
48721953|NCT00266877|156831320|FG000|Overall Study|Concomitant Radiotherapy|0|||
48721954|NCT00266877|156831321|FG001|Overall Study|Concomitant Radiotherapy|1|||
48721955|NCT00266877|156831322|FG002|Overall Study|Concomitant Radiotherapy|0|||
48721956|NCT03945175|156831323|FG000|Overall Study|Did not meet inclusion criteria|31|||
48721957|NCT03945175|156831323|FG000|Overall Study|Withdrew consent|2|||
48721958|NCT03945175|156831323|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
48721959|NCT03945175|156831323|FG000|Overall Study|Early termination during Mydayis treatment|1|||
48721960|NCT01089361|156831325|FG000|Overall Study|Death|1|||
48721961|NCT01089361|156831326|FG001|Overall Study|Death|0|||
48721962|NCT01606878|156831327|FG000|Overall Study|Adverse Event|1|||
48721963|NCT01606878|156831328|FG001|Overall Study|Adverse Event|1|||
48721964|NCT01606878|156831329|FG002|Overall Study|Adverse Event|0|||
48721965|NCT01606878|156831330|FG003|Overall Study|Adverse Event|0|||
48721966|NCT01606878|156831331|FG004|Overall Study|Adverse Event|0|||
48721967|NCT01606878|156831332|FG005|Overall Study|Adverse Event|0|||
48721968|NCT01606878|156831333|FG006|Overall Study|Adverse Event|1|||
48721969|NCT01606878|156831334|FG007|Overall Study|Adverse Event|0|||
48721970|NCT01606878|156831335|FG008|Overall Study|Adverse Event|1|||
48721971|NCT01606878|156831336|FG009|Overall Study|Adverse Event|3|||
48721972|NCT01606878|156831337|FG010|Overall Study|Adverse Event|0|||
48721973|NCT01606878|156831327|FG000|Overall Study|Lack of Efficacy|1|||
48721974|NCT01606878|156831328|FG001|Overall Study|Lack of Efficacy|1|||
48816999|NCT01500226|157173596|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
48817000|NCT01500226|157173595|FG000|Overall Study|Withdrawal by Subject|93|||
48817001|NCT01500226|157173596|FG001|Overall Study|Withdrawal by Subject|96|||
48817002|NCT01500226|157173595|FG000|Overall Study|Death|12|||
48817003|NCT01500226|157173596|FG001|Overall Study|Death|4|||
48817004|NCT01500226|157173595|FG000|Overall Study|Disease Progression|16|||
48721975|NCT01606878|156831329|FG002|Overall Study|Lack of Efficacy|1|||
48721976|NCT01606878|156831330|FG003|Overall Study|Lack of Efficacy|2|||
48721977|NCT01606878|156831331|FG004|Overall Study|Lack of Efficacy|1|||
48721978|NCT01606878|156831332|FG005|Overall Study|Lack of Efficacy|2|||
48721979|NCT01606878|156831333|FG006|Overall Study|Lack of Efficacy|1|||
48721980|NCT01606878|156831334|FG007|Overall Study|Lack of Efficacy|2|||
48721981|NCT01606878|156831335|FG008|Overall Study|Lack of Efficacy|2|||
48721982|NCT01606878|156831336|FG009|Overall Study|Lack of Efficacy|0|||
48721983|NCT01606878|156831337|FG010|Overall Study|Lack of Efficacy|1|||
48721984|NCT01606878|156831327|FG000|Overall Study|Physician Decision|1|||
48721985|NCT01606878|156831328|FG001|Overall Study|Physician Decision|0|||
48721986|NCT01606878|156831329|FG002|Overall Study|Physician Decision|2|||
48721987|NCT01606878|156831330|FG003|Overall Study|Physician Decision|1|||
48817005|NCT01500226|157173596|FG001|Overall Study|Disease Progression|14|||
48817006|NCT01500226|157173595|FG000|Overall Study|Protocol Violation|53|||
48500956|NCT03312530|156030893|FG001|Overall Study|Lost to Follow-up|0|||
48721988|NCT01606878|156831331|FG004|Overall Study|Physician Decision|1|||
48721989|NCT01606878|156831332|FG005|Overall Study|Physician Decision|1|||
48721990|NCT01606878|156831333|FG006|Overall Study|Physician Decision|2|||
48721991|NCT01606878|156831334|FG007|Overall Study|Physician Decision|0|||
48721992|NCT01606878|156831335|FG008|Overall Study|Physician Decision|1|||
48721993|NCT01606878|156831336|FG009|Overall Study|Physician Decision|0|||
48721994|NCT01606878|156831337|FG010|Overall Study|Physician Decision|0|||
48721995|NCT01606878|156831327|FG000|Overall Study|Withdrawal by Subject|3|||
48721996|NCT01606878|156831328|FG001|Overall Study|Withdrawal by Subject|2|||
48721997|NCT01606878|156831329|FG002|Overall Study|Withdrawal by Subject|2|||
48721998|NCT01606878|156831330|FG003|Overall Study|Withdrawal by Subject|0|||
48721999|NCT01606878|156831331|FG004|Overall Study|Withdrawal by Subject|1|||
48500957|NCT03312530|156030894|FG002|Overall Study|Lost to Follow-up|0|||
48500958|NCT03312530|156030895|FG003|Overall Study|Lost to Follow-up|1|||
48817007|NCT01500226|157173596|FG001|Overall Study|Protocol Violation|39|||
48817008|NCT01500226|157173595|FG000|Overall Study|Physician Decision|17|||
48817009|NCT01500226|157173596|FG001|Overall Study|Physician Decision|15|||
48817010|NCT01500226|157173595|FG000|Overall Study|Lack of Efficacy|14|||
48817011|NCT01500226|157173596|FG001|Overall Study|Lack of Efficacy|30|||
48817012|NCT01500226|157173595|FG000|Overall Study|Lost to Follow-up|9|||
48817013|NCT01500226|157173596|FG001|Overall Study|Lost to Follow-up|5|||
48722000|NCT01606878|156831332|FG005|Overall Study|Withdrawal by Subject|1|||
48722001|NCT01606878|156831333|FG006|Overall Study|Withdrawal by Subject|2|||
48722002|NCT01606878|156831334|FG007|Overall Study|Withdrawal by Subject|1|||
48722003|NCT01606878|156831335|FG008|Overall Study|Withdrawal by Subject|2|||
48722004|NCT01606878|156831336|FG009|Overall Study|Withdrawal by Subject|0|||
48722005|NCT01606878|156831337|FG010|Overall Study|Withdrawal by Subject|2|||
48722006|NCT00727532|156831338|FG000|Overall Study|Adverse Event|1|||
48722007|NCT00727532|156831338|FG000|Overall Study|Withdrawal by Subject|1|||
48722008|NCT02839265|156831343|FG000|Overall Study|Screen Failure|2|||
48722009|NCT02839265|156831343|FG000|Overall Study|Death|1|||
48722010|NCT02839265|156831343|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
48722011|NCT03858517|156831344|FG000|Overall Study|Adverse Event|1|||
48722012|NCT03858517|156831344|FG000|Overall Study|Lost to Follow-up|1|||
48722013|NCT03858517|156831344|FG000|Overall Study|removed for being incarcerated|1|||
48722014|NCT03858517|156831344|FG000|Overall Study|Sponsor Closure|48|||
48722015|NCT01031836|156832578|FG000|Stage I|Adverse Event|1|||
48722016|NCT01031836|156832579|FG001|Stage I|Adverse Event|1|||
48599738|NCT01128400|156391454|FG000|Overall Study|Screening failure|1|||
48599739|NCT01128400|156391455|FG001|Overall Study|Screening failure|0|||
48722017|NCT01031836|156832580|FG002|Stage I|Adverse Event|0|||
48722018|NCT01031836|156832581|FG003|Stage I|Adverse Event|0|||
48722019|NCT01031836|156832582|FG004|Stage I|Adverse Event|0|||
48817014|NCT01500226|157173595|FG000|Overall Study|Other Reasons|19|||
48817015|NCT01500226|157173596|FG001|Overall Study|Other Reasons|16|||
48817016|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
48817017|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
48817018|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
48817019|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
48817020|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
48817021|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
48817022|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
48817023|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
48817024|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
48817025|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
48817026|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
48817027|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
48817028|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
48817029|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
48500959|NCT03312530|156030896|FG004|Overall Study|Lost to Follow-up|0|||
48500960|NCT03312530|156030892|FG000|Overall Study|Participant in another sponsor study.|0|||
48500961|NCT03312530|156030893|FG001|Overall Study|Participant in another sponsor study.|0|||
48500962|NCT03312530|156030894|FG002|Overall Study|Participant in another sponsor study.|0|||
48500963|NCT03312530|156030895|FG003|Overall Study|Participant in another sponsor study.|1|||
48500964|NCT03312530|156030896|FG004|Overall Study|Participant in another sponsor study.|0|||
48500965|NCT03312530|156030892|FG000|Overall Study|Study terminated by sponsor|1|||
48500966|NCT03312530|156030893|FG001|Overall Study|Study terminated by sponsor|0|||
48500967|NCT03312530|156030894|FG002|Overall Study|Study terminated by sponsor|2|||
48599740|NCT01128400|156391456|FG002|Overall Study|Screening failure|0|||
48599741|NCT01128400|156391454|FG000|Overall Study|were not invited to participate on taste|0|||
48599742|NCT01128400|156391455|FG001|Overall Study|were not invited to participate on taste|0|||
48599743|NCT01128400|156391456|FG002|Overall Study|were not invited to participate on taste|15|||
48599744|NCT01128400|156391454|FG000|Overall Study|Excluded due to sinus problems|0|||
48599745|NCT01128400|156391455|FG001|Overall Study|Excluded due to sinus problems|1|||
48599746|NCT01128400|156391456|FG002|Overall Study|Excluded due to sinus problems|0|||
48599747|NCT00803712|156391459|FG000|Overall Study|Noncompliance|3|||
48722020|NCT01031836|156832583|FG005|Stage I|Adverse Event|0|||
48722021|NCT01031836|156832578|FG000|Stage I|Other|0|||
48722022|NCT01031836|156832579|FG001|Stage I|Other|1|||
48722023|NCT01031836|156832580|FG002|Stage I|Other|0|||
48722024|NCT01031836|156832581|FG003|Stage I|Other|0|||
48722025|NCT01031836|156832582|FG004|Stage I|Other|0|||
48500968|NCT03312530|156030895|FG003|Overall Study|Study terminated by sponsor|3|||
48599748|NCT00803712|156391460|FG001|Overall Study|Noncompliance|0|||
48722026|NCT01031836|156832583|FG005|Stage I|Other|1|||
48722027|NCT01031836|156832578|FG000|Stage II|Adverse Event|0|||
48722028|NCT01031836|156832579|FG001|Stage II|Adverse Event|0|||
48722029|NCT01031836|156832580|FG002|Stage II|Adverse Event|2|||
48817030|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
48817031|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
48817032|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
48817033|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
48817034|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
48817035|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
48817036|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
48817037|NCT02718417|157173601|FG000|Chemotherapy Phase (CP)|Other|2|||
48817038|NCT02718417|157173602|FG001|Chemotherapy Phase (CP)|Other|0|||
48817039|NCT02718417|157173603|FG002|Chemotherapy Phase (CP)|Other|1|||
48817040|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Adverse Event|21|||
48817041|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Adverse Event|26|||
48817042|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Adverse Event|0|||
48817043|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
48817044|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
48817045|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
48817046|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
48817047|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
48817048|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
48817049|NCT02718417|157173601|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
48817050|NCT02718417|157173602|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
48817051|NCT02718417|157173603|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
48817052|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Physician's decision|6|||
48817053|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Physician's decision|7|||
48817054|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Physician's decision|0|||
48817055|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Progressive disease|100|||
48817056|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Progressive disease|88|||
48817057|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Progressive disease|0|||
48817058|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Other|2|||
48817059|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Other|1|||
48817060|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Other|0|||
48817061|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
48817062|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
48817063|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
48817064|NCT02718417|157173601|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
48817065|NCT02718417|157173602|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
48817066|NCT02718417|157173603|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
48817067|NCT02718417|157173601|FG000|Observation Phase (OP)|Adverse Event|0|||
48817068|NCT02718417|157173602|FG001|Observation Phase (OP)|Adverse Event|0|||
48817069|NCT02718417|157173603|FG002|Observation Phase (OP)|Adverse Event|1|||
48817070|NCT02718417|157173601|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
48817071|NCT02718417|157173602|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
48817072|NCT02718417|157173603|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
48817073|NCT02718417|157173601|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
48817074|NCT02718417|157173602|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
48817075|NCT02718417|157173603|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
48817076|NCT02718417|157173601|FG000|Observation Phase (OP)|Physician Decision|0|||
48817077|NCT02718417|157173602|FG001|Observation Phase (OP)|Physician Decision|0|||
48817078|NCT02718417|157173603|FG002|Observation Phase (OP)|Physician Decision|9|||
48817079|NCT02718417|157173601|FG000|Observation Phase (OP)|Progressive disease|0|||
48817080|NCT02718417|157173602|FG001|Observation Phase (OP)|Progressive disease|0|||
48817081|NCT02718417|157173603|FG002|Observation Phase (OP)|Progressive disease|92|||
48817082|NCT02718417|157173601|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
48817083|NCT02718417|157173602|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
48817084|NCT02718417|157173603|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
48817085|NCT02718417|157173601|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
48722030|NCT01031836|156832581|FG003|Stage II|Adverse Event|2|||
48722031|NCT01031836|156832582|FG004|Stage II|Adverse Event|1|||
48722032|NCT01031836|156832583|FG005|Stage II|Adverse Event|1|||
48722033|NCT01031836|156832578|FG000|Stage II|Other|2|||
48722034|NCT01031836|156832579|FG001|Stage II|Other|0|||
48722035|NCT01031836|156832580|FG002|Stage II|Other|0|||
48722036|NCT01031836|156832581|FG003|Stage II|Other|1|||
48722037|NCT01031836|156832582|FG004|Stage II|Other|1|||
48722038|NCT01031836|156832583|FG005|Stage II|Other|0|||
48722039|NCT01925131|156832584|FG000|Overall Study|Death|0|||
48722040|NCT01925131|156832585|FG001|Overall Study|Death|0|||
48817086|NCT02718417|157173602|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
48722041|NCT01925131|156832586|FG002|Overall Study|Death|1|||
48722042|NCT01925131|156832587|FG003|Overall Study|Death|0|||
48817087|NCT02718417|157173603|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
48817088|NCT02718417|157173601|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
48722043|NCT01925131|156832588|FG004|Overall Study|Death|0|||
48722044|NCT01925131|156832589|FG005|Overall Study|Death|0|||
48817089|NCT02718417|157173602|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
48817090|NCT02718417|157173603|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
48817091|NCT02718417|157173601|FG000|Observation Phase (OP)|Other|0|||
48817092|NCT02718417|157173602|FG001|Observation Phase (OP)|Other|0|||
48817093|NCT02718417|157173603|FG002|Observation Phase (OP)|Other|7|||
48817094|NCT02718417|157173601|FG000|Follow-up Phase|Adverse Event|3|||
48817095|NCT02718417|157173602|FG001|Follow-up Phase|Adverse Event|1|||
48817096|NCT02718417|157173603|FG002|Follow-up Phase|Adverse Event|1|||
48817097|NCT02718417|157173601|FG000|Follow-up Phase|Other|4|||
48817098|NCT02718417|157173602|FG001|Follow-up Phase|Other|6|||
48817099|NCT02718417|157173603|FG002|Follow-up Phase|Other|4|||
48817100|NCT02718417|157173601|FG000|Follow-up Phase|Withdrawal by Subject|19|||
48817101|NCT02718417|157173602|FG001|Follow-up Phase|Withdrawal by Subject|17|||
48817102|NCT02718417|157173603|FG002|Follow-up Phase|Withdrawal by Subject|5|||
48817103|NCT02718417|157173601|FG000|Follow-up Phase|Study terminated by sponsor|100|||
48817104|NCT02718417|157173602|FG001|Follow-up Phase|Study terminated by sponsor|138|||
48817105|NCT02718417|157173603|FG002|Follow-up Phase|Study terminated by sponsor|6|||
48817106|NCT02718417|157173601|FG000|Follow-up Phase|Lost to Follow-up|2|||
48817107|NCT02718417|157173602|FG001|Follow-up Phase|Lost to Follow-up|3|||
48817108|NCT02718417|157173603|FG002|Follow-up Phase|Lost to Follow-up|0|||
48817109|NCT02718417|157173601|FG000|Follow-up Phase|Death leading to discontinuation|7|||
48817110|NCT02718417|157173602|FG001|Follow-up Phase|Death leading to discontinuation|7|||
48817111|NCT02718417|157173603|FG002|Follow-up Phase|Death leading to discontinuation|3|||
48817112|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
48817113|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
48817114|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
48817115|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
48817116|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
48817117|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
48817118|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
48817119|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
48817120|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
48817121|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
48817122|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
48817123|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
48817124|NCT02718417|157173601|FG000|Long-term Follow-up Phase|Other|0|||
48817125|NCT02718417|157173602|FG001|Long-term Follow-up Phase|Other|2|||
48817126|NCT02718417|157173603|FG002|Long-term Follow-up Phase|Other|0|||
48817127|NCT02163447|157173611|FG000|Overall Study|Withdrawal by Subject|2|||
48817128|NCT02163447|157173612|FG001|Overall Study|Withdrawal by Subject|0|||
48817129|NCT02163447|157173613|FG002|Overall Study|Withdrawal by Subject|1|||
48817130|NCT02163447|157173611|FG000|Overall Study|Lost to Follow-up|1|||
48817131|NCT02163447|157173612|FG001|Overall Study|Lost to Follow-up|3|||
48817132|NCT02163447|157173613|FG002|Overall Study|Lost to Follow-up|0|||
48817133|NCT02163447|157173611|FG000|Overall Study|Moved out of study area|2|||
48817134|NCT02163447|157173612|FG001|Overall Study|Moved out of study area|3|||
48817135|NCT02163447|157173613|FG002|Overall Study|Moved out of study area|2|||
48817136|NCT02163447|157173611|FG000|Overall Study|Became HIV infected at time of delivery|1|||
48817137|NCT02163447|157173612|FG001|Overall Study|Became HIV infected at time of delivery|0|||
48817138|NCT02163447|157173613|FG002|Overall Study|Became HIV infected at time of delivery|0|||
48817139|NCT03268590|157173620|FG000|Overall Study|Previously unknown exclusion criteria|1|||
48817140|NCT02771210|157173625|FG000|Period 1|Adverse Event|5|||
48817141|NCT02771210|157173626|FG001|Period 1|Adverse Event|3|||
48817142|NCT02771210|157173625|FG000|Period 1|Lack of Efficacy|3|||
48817143|NCT02771210|157173626|FG001|Period 1|Lack of Efficacy|6|||
48817144|NCT02771210|157173625|FG000|Period 1|Lost to Follow-up|2|||
48817145|NCT02771210|157173626|FG001|Period 1|Lost to Follow-up|0|||
48500969|NCT03312530|156030896|FG004|Overall Study|Study terminated by sponsor|7|||
48500970|NCT03312530|156030892|FG000|Overall Study|Withdrawal by Subject|0|||
48500971|NCT03312530|156030893|FG001|Overall Study|Withdrawal by Subject|1|||
48817146|NCT02771210|157173625|FG000|Period 1|Physician Decision|0|||
48500972|NCT03312530|156030894|FG002|Overall Study|Withdrawal by Subject|0|||
48817147|NCT02771210|157173626|FG001|Period 1|Physician Decision|1|||
48817148|NCT02771210|157173625|FG000|Period 1|Withdrawal by Subject|0|||
48817149|NCT02771210|157173626|FG001|Period 1|Withdrawal by Subject|3|||
48817150|NCT02771210|157173625|FG000|Period 1|Withdrawal of informed consent|1|||
48817151|NCT02771210|157173626|FG001|Period 1|Withdrawal of informed consent|5|||
48817152|NCT02771210|157173625|FG000|Period 2|Adverse Event|1|||
48817153|NCT02771210|157173626|FG001|Period 2|Adverse Event|0|||
48817154|NCT02771210|157173625|FG000|Period 2|Lack of Efficacy|0|||
48817155|NCT02771210|157173626|FG001|Period 2|Lack of Efficacy|1|||
48817156|NCT02771210|157173625|FG000|Period 2|Withdrawal by Subject|1|||
48817157|NCT02771210|157173626|FG001|Period 2|Withdrawal by Subject|0|||
48817158|NCT02771210|157173625|FG000|Period 2|Withdrawal of informed consent|0|||
48500973|NCT03312530|156030895|FG003|Overall Study|Withdrawal by Subject|0|||
48817159|NCT02771210|157173626|FG001|Period 2|Withdrawal of informed consent|2|||
48817160|NCT00478608|157173627|FG000|Overall Study|Adverse Event|1|||
48817161|NCT00478608|157173627|FG000|Overall Study|Serious Adverse Event|14|||
48817162|NCT00478608|157173627|FG000|Overall Study|Withdrawal by Subject|2|||
48817163|NCT00478608|157173627|FG000|Overall Study|Protocol Violation|3|||
48817164|NCT01349907|157173629|FG000|Overall Study|Adverse Event|37|||
48500974|NCT03312530|156030896|FG004|Overall Study|Withdrawal by Subject|0|||
48500975|NCT03312530|156030892|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
48500976|NCT03312530|156030893|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
48500977|NCT03312530|156030894|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
48500978|NCT03312530|156030895|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
48500979|NCT03312530|156030896|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
48500980|NCT02819843|156030897|FG000|Overall Study|Disease progression before RT|0|||
48500981|NCT02819843|156030898|FG001|Overall Study|Disease progression before RT|1|||
48500982|NCT00366899|156030899|FG000|Infant Series|Withdrawal by Subject|4|||
48500983|NCT00366899|156030900|FG001|Infant Series|Withdrawal by Subject|7|||
48500984|NCT00366899|156030899|FG000|Infant Series|Protocol Violation|2|||
48500985|NCT00366899|156030900|FG001|Infant Series|Protocol Violation|1|||
48500986|NCT00366899|156030899|FG000|Infant Series|Failed to return|1|||
48500987|NCT00366899|156030900|FG001|Infant Series|Failed to return|1|||
48500988|NCT00366899|156030899|FG000|Infant Series|Lost to Follow-up|0|||
48500989|NCT00366899|156030900|FG001|Infant Series|Lost to Follow-up|2|||
48500990|NCT00366899|156030899|FG000|Infant Series|Adverse Event|0|||
48500991|NCT00366899|156030900|FG001|Infant Series|Adverse Event|1|||
48500992|NCT00366899|156030899|FG000|Infant Series|Physician Decision|1|||
48500993|NCT00366899|156030900|FG001|Infant Series|Physician Decision|0|||
48500994|NCT00366899|156030899|FG000|Infant Series|Randomized but not consented|1|||
48500995|NCT00366899|156030900|FG001|Infant Series|Randomized but not consented|0|||
48500996|NCT00366899|156030899|FG000|After Infant Series|Lost to Follow-up|4|||
48500997|NCT00366899|156030900|FG001|After Infant Series|Lost to Follow-up|3|||
48500998|NCT00366899|156030899|FG000|After Infant Series|Withdrawal by Subject|1|||
48500999|NCT00366899|156030900|FG001|After Infant Series|Withdrawal by Subject|4|||
48501000|NCT00366899|156030899|FG000|After Infant Series|Adverse Event|1|||
48501001|NCT00366899|156030900|FG001|After Infant Series|Adverse Event|2|||
48501002|NCT00366899|156030899|FG000|After Infant Series|Protocol Violation|1|||
48501003|NCT00366899|156030900|FG001|After Infant Series|Protocol Violation|0|||
48501004|NCT00366899|156030899|FG000|Toddler Dose|Withdrawal by Subject|1|||
48501005|NCT00366899|156030900|FG001|Toddler Dose|Withdrawal by Subject|1|||
48501006|NCT00366899|156030899|FG000|Toddler Dose|Protocol Violation|1|||
48501007|NCT00366899|156030900|FG001|Toddler Dose|Protocol Violation|0|||
48501008|NCT01619800|156030901|FG000|Overall Study|study terminated|2|||
48501009|NCT01619800|156030902|FG001|Overall Study|study terminated|0|||
48501010|NCT00755196|156030910|FG000|Overall Study|Lost to Follow-up|1|||
48501011|NCT00755196|156030910|FG000|Overall Study|Lack of Efficiency|1|||
48501012|NCT02720510|156030913|FG000|Overall Study|Study Terminated by the sponsor|2|||
48501013|NCT02720510|156030914|FG001|Overall Study|Study Terminated by the sponsor|0|||
48501014|NCT02720510|156030913|FG000|Overall Study|Adverse Event|0|||
48501015|NCT02720510|156030914|FG001|Overall Study|Adverse Event|1|||
48501016|NCT02720510|156030913|FG000|Overall Study|Physician Decision|1|||
48501017|NCT02720510|156030914|FG001|Overall Study|Physician Decision|2|||
48501018|NCT01604850|156030915|FG000|Overall Study|Enrolled but never treated|0|||
48501019|NCT01604850|156030916|FG001|Overall Study|Enrolled but never treated|1|||
48501020|NCT01604850|156030915|FG000|Overall Study|Efficacy Failure|50|||
48501021|NCT01604850|156030916|FG001|Overall Study|Efficacy Failure|29|||
48501022|NCT01604850|156030915|FG000|Overall Study|Lost to Follow-up|1|||
48501023|NCT01604850|156030916|FG001|Overall Study|Lost to Follow-up|0|||
48501024|NCT01604850|156030915|FG000|Overall Study|Subject withdrew consent|1|||
48501025|NCT01604850|156030916|FG001|Overall Study|Subject withdrew consent|0|||
48501026|NCT02460159|156030917|FG000|Overall Study|Adverse Event|4|||
48501027|NCT02460159|156030918|FG001|Overall Study|Adverse Event|1|||
48501028|NCT02460159|156030917|FG000|Overall Study|Withdrawal by Subject|2|||
48501029|NCT02460159|156030918|FG001|Overall Study|Withdrawal by Subject|0|||
48501030|NCT00973700|156030919|FG000|Overall Study|Withdrawal by Subject|2|||
48501031|NCT00973700|156030920|FG001|Overall Study|Withdrawal by Subject|2|||
48501032|NCT00973700|156030921|FG002|Overall Study|Withdrawal by Subject|8|||
48501033|NCT00973700|156030922|FG003|Overall Study|Withdrawal by Subject|4|||
48501034|NCT00973700|156030923|FG004|Overall Study|Withdrawal by Subject|4|||
48501035|NCT00973700|156030919|FG000|Overall Study|Lost to Follow-up|5|||
48501036|NCT00973700|156030920|FG001|Overall Study|Lost to Follow-up|0|||
48501037|NCT00973700|156030921|FG002|Overall Study|Lost to Follow-up|1|||
48501038|NCT00973700|156030922|FG003|Overall Study|Lost to Follow-up|8|||
48599749|NCT00803712|156391459|FG000|Overall Study|Adverse Event|5|||
48599750|NCT00803712|156391460|FG001|Overall Study|Adverse Event|0|||
48817165|NCT01349907|157173630|FG001|Overall Study|Adverse Event|11|||
48501039|NCT00973700|156030923|FG004|Overall Study|Lost to Follow-up|5|||
48501040|NCT00973700|156030919|FG000|Overall Study|Inappropriate enrolment|0|||
48501041|NCT00973700|156030920|FG001|Overall Study|Inappropriate enrolment|0|||
48817166|NCT01349907|157173629|FG000|Overall Study|Treatment failure|13|||
48817167|NCT01349907|157173630|FG001|Overall Study|Treatment failure|4|||
48501042|NCT00973700|156030921|FG002|Overall Study|Inappropriate enrolment|0|||
48501043|NCT00973700|156030922|FG003|Overall Study|Inappropriate enrolment|4|||
48817168|NCT01349907|157173629|FG000|Overall Study|Lost to Follow-up|25|||
48817169|NCT01349907|157173630|FG001|Overall Study|Lost to Follow-up|6|||
48817170|NCT01349907|157173629|FG000|Overall Study|Withdrawal by Subject|30|||
48817171|NCT01349907|157173630|FG001|Overall Study|Withdrawal by Subject|8|||
48817172|NCT01349907|157173629|FG000|Overall Study|Protocol Violation|33|||
48817173|NCT01349907|157173630|FG001|Overall Study|Protocol Violation|13|||
48722045|NCT01925131|156832584|FG000|Overall Study|Progression/Relapse|1|||
48722046|NCT01925131|156832585|FG001|Overall Study|Progression/Relapse|1|||
48722047|NCT01925131|156832586|FG002|Overall Study|Progression/Relapse|4|||
48722048|NCT01925131|156832587|FG003|Overall Study|Progression/Relapse|0|||
48722049|NCT01925131|156832588|FG004|Overall Study|Progression/Relapse|0|||
48722050|NCT01925131|156832589|FG005|Overall Study|Progression/Relapse|1|||
48722051|NCT01925131|156832584|FG000|Overall Study|Patient Refusal|1|||
48722052|NCT01925131|156832585|FG001|Overall Study|Patient Refusal|0|||
48722053|NCT01925131|156832586|FG002|Overall Study|Patient Refusal|0|||
48722054|NCT01925131|156832587|FG003|Overall Study|Patient Refusal|0|||
48722055|NCT01925131|156832588|FG004|Overall Study|Patient Refusal|0|||
48722056|NCT01925131|156832589|FG005|Overall Study|Patient Refusal|0|||
48722057|NCT01925131|156832584|FG000|Overall Study|Adverse Event|0|||
48722058|NCT01925131|156832585|FG001|Overall Study|Adverse Event|0|||
48722059|NCT01925131|156832586|FG002|Overall Study|Adverse Event|2|||
48722060|NCT01925131|156832587|FG003|Overall Study|Adverse Event|0|||
48722061|NCT01925131|156832588|FG004|Overall Study|Adverse Event|1|||
48722062|NCT01925131|156832589|FG005|Overall Study|Adverse Event|3|||
48722063|NCT01925131|156832584|FG000|Overall Study|Other - Not Protocol Specified|3|||
48722064|NCT01925131|156832585|FG001|Overall Study|Other - Not Protocol Specified|1|||
48722065|NCT01925131|156832586|FG002|Overall Study|Other - Not Protocol Specified|2|||
48722066|NCT01925131|156832587|FG003|Overall Study|Other - Not Protocol Specified|5|||
48722067|NCT01925131|156832588|FG004|Overall Study|Other - Not Protocol Specified|10|||
48722068|NCT01925131|156832589|FG005|Overall Study|Other - Not Protocol Specified|6|||
48722069|NCT01696929|156832590|FG000|Overall Study|Physician Decision|1|||
48722070|NCT03811093|156832593|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
48722071|NCT03811093|156832594|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
48722072|NCT03811093|156832593|FG000|Overall Study|Unable to measure body fat percentage|2|||
48722073|NCT03811093|156832594|FG001|Overall Study|Unable to measure body fat percentage|0|||
48722074|NCT01673347|156832595|FG000|Overall Study|failure of allograft|7|||
48722075|NCT02186301|156832596|FG000|Overall Study|Progressive Disease|7|||
48722076|NCT02186301|156832597|FG001|Overall Study|Progressive Disease|22|||
48722077|NCT02186301|156832598|FG002|Overall Study|Progressive Disease|27|||
48722078|NCT02186301|156832596|FG000|Overall Study|Adverse Event|5|||
48722079|NCT02186301|156832597|FG001|Overall Study|Adverse Event|5|||
48722080|NCT02186301|156832598|FG002|Overall Study|Adverse Event|5|||
48722081|NCT02186301|156832596|FG000|Overall Study|Death|1|||
48722082|NCT02186301|156832597|FG001|Overall Study|Death|0|||
48722083|NCT02186301|156832598|FG002|Overall Study|Death|0|||
48817174|NCT01349907|157173629|FG000|Overall Study|Administrative|1|||
48817175|NCT01349907|157173630|FG001|Overall Study|Administrative|1|||
48817176|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
48817177|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
48722084|NCT02186301|156832596|FG000|Overall Study|Withdrawal by Subject|5|||
48722085|NCT02186301|156832597|FG001|Overall Study|Withdrawal by Subject|1|||
48722086|NCT02186301|156832598|FG002|Overall Study|Withdrawal by Subject|3|||
48722087|NCT02186301|156832596|FG000|Overall Study|Physician Decision|1|||
48722088|NCT02186301|156832597|FG001|Overall Study|Physician Decision|0|||
48722089|NCT02186301|156832598|FG002|Overall Study|Physician Decision|1|||
48722090|NCT02186301|156832596|FG000|Overall Study|Study Terminated by Sponsor|1|||
48722091|NCT02186301|156832597|FG001|Overall Study|Study Terminated by Sponsor|0|||
48722092|NCT02186301|156832598|FG002|Overall Study|Study Terminated by Sponsor|11|||
48722093|NCT02186301|156832596|FG000|Overall Study|Protocol Deviation|0|||
48722094|NCT02186301|156832597|FG001|Overall Study|Protocol Deviation|2|||
48501044|NCT00973700|156030923|FG004|Overall Study|Inappropriate enrolment|0|||
48501045|NCT00973700|156030919|FG000|Overall Study|Unable to Classify|0|||
48722095|NCT02186301|156832598|FG002|Overall Study|Protocol Deviation|0|||
48501046|NCT00973700|156030920|FG001|Overall Study|Unable to Classify|0|||
48722096|NCT02186301|156832596|FG000|Overall Study|Missing|0|||
48722097|NCT02186301|156832597|FG001|Overall Study|Missing|0|||
48722098|NCT02186301|156832598|FG002|Overall Study|Missing|2|||
48722099|NCT02186301|156832596|FG000|Overall Study|Other|0|||
48817178|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
48501047|NCT00973700|156030921|FG002|Overall Study|Unable to Classify|1|||
48722100|NCT02186301|156832597|FG001|Overall Study|Other|0|||
48501048|NCT00973700|156030922|FG003|Overall Study|Unable to Classify|2|||
48501049|NCT00973700|156030923|FG004|Overall Study|Unable to Classify|1|||
48501050|NCT01703832|156030924|FG000|Overall Study|Withdrawal by Subject|1|||
48501051|NCT01703832|156030925|FG001|Overall Study|Withdrawal by Subject|0|||
48501052|NCT02849652|156030944|FG000|Overall Study|Lost to Follow-up|104|||
48501053|NCT02849652|156030945|FG001|Overall Study|Lost to Follow-up|35|||
48501054|NCT02849652|156030946|FG002|Overall Study|Lost to Follow-up|116|||
48501055|NCT02849652|156030947|FG003|Overall Study|Lost to Follow-up|22|||
48501056|NCT02849652|156030944|FG000|Overall Study|Withdrawal by Subject|10|||
48501057|NCT02849652|156030945|FG001|Overall Study|Withdrawal by Subject|2|||
48501058|NCT02849652|156030946|FG002|Overall Study|Withdrawal by Subject|8|||
48501059|NCT02849652|156030947|FG003|Overall Study|Withdrawal by Subject|4|||
48501060|NCT03247556|156030948|FG000|Overall Study|Adverse Event|1|||
48501061|NCT03247556|156030949|FG001|Overall Study|Adverse Event|4|||
48501062|NCT03247556|156030950|FG002|Overall Study|Adverse Event|5|||
48501063|NCT03247556|156030948|FG000|Overall Study|Lost to Follow-up|5|||
48501064|NCT03247556|156030949|FG001|Overall Study|Lost to Follow-up|5|||
48501065|NCT03247556|156030950|FG002|Overall Study|Lost to Follow-up|4|||
48501066|NCT03247556|156030948|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
48501067|NCT03247556|156030949|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
48501068|NCT03247556|156030950|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
48501069|NCT03247556|156030948|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
48501070|NCT03247556|156030949|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
48501071|NCT03247556|156030950|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
48501072|NCT03247556|156030948|FG000|Overall Study|Protocol Violation|2|||
48501073|NCT03247556|156030949|FG001|Overall Study|Protocol Violation|0|||
48501074|NCT03247556|156030950|FG002|Overall Study|Protocol Violation|1|||
48501075|NCT03247556|156030948|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
48501076|NCT03247556|156030949|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
48501077|NCT03247556|156030950|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
48501078|NCT00760266|156030953|FG000|Overall Study|Adverse Event|13|||
48501079|NCT00760266|156030954|FG001|Overall Study|Adverse Event|7|||
48501080|NCT00760266|156030953|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48501081|NCT00760266|156030954|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48501082|NCT00760266|156030953|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48501083|NCT00760266|156030954|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48501084|NCT00760266|156030953|FG000|Overall Study|Lack of Efficacy|2|||
48501085|NCT00760266|156030954|FG001|Overall Study|Lack of Efficacy|2|||
48501086|NCT00760266|156030953|FG000|Overall Study|Protocol deviation|2|||
48501087|NCT00760266|156030954|FG001|Overall Study|Protocol deviation|4|||
48501088|NCT00760266|156030953|FG000|Overall Study|Patient withdrew consent|3|||
48501089|NCT00760266|156030954|FG001|Overall Study|Patient withdrew consent|3|||
48501090|NCT00760266|156030953|FG000|Overall Study|Lost to Follow-up|2|||
48501091|NCT00760266|156030954|FG001|Overall Study|Lost to Follow-up|1|||
48501092|NCT00760266|156030953|FG000|Overall Study|Administrative Problems|0|||
48501093|NCT00760266|156030954|FG001|Overall Study|Administrative Problems|1|||
48501094|NCT01856309|156030964|FG000|Overall Study|Death|4|||
48722101|NCT02186301|156832598|FG002|Overall Study|Other|1|||
48722102|NCT03086967|156832599|FG000|Overall Study|Screen Failure|2|||
48722103|NCT03086967|156832600|FG001|Overall Study|Screen Failure|2|||
48722104|NCT04732494|156832601|FG000|Overall Study|Death|39|||
48722105|NCT04732494|156832602|FG001|Overall Study|Death|36|||
48722106|NCT04732494|156832601|FG000|Overall Study|Study Closed by Sponsor|20|||
48722107|NCT04732494|156832602|FG001|Overall Study|Study Closed by Sponsor|15|||
48722108|NCT04732494|156832601|FG000|Overall Study|Withdrawal by Subject|2|||
48722109|NCT04732494|156832602|FG001|Overall Study|Withdrawal by Subject|7|||
48722110|NCT04732494|156832601|FG000|Overall Study|Lost to Follow-up|1|||
48722111|NCT04732494|156832602|FG001|Overall Study|Lost to Follow-up|5|||
48722112|NCT01268579|156832606|FG000|Overall Study|Adverse Event|1|||
48722113|NCT01268579|156832606|FG000|Overall Study|Withdrawal by Subject|2|||
48722114|NCT00475423|156832607|FG000|Overall Study|Protocol Violation|5|||
48722115|NCT00475423|156832607|FG000|Overall Study|Adverse Event|4|||
48722116|NCT00475423|156832607|FG000|Overall Study|Withdrawal by Subject|6|||
48722117|NCT00475423|156832607|FG000|Overall Study|Lack of Efficacy|8|||
48722118|NCT00475423|156832607|FG000|Overall Study|Death|1|||
48722119|NCT00475423|156832607|FG000|Overall Study|Reason not specified|1|||
48722120|NCT00475423|156832607|FG000|Overall Study|Lost to Follow-up|7|||
48722121|NCT00868517|156832610|FG000|Overall Study|Withdrawal by Subject|3|||
48722122|NCT00868517|156832611|FG001|Overall Study|Withdrawal by Subject|3|||
48722123|NCT00868517|156832612|FG002|Overall Study|Withdrawal by Subject|2|||
48722124|NCT00868517|156832610|FG000|Overall Study|Protocol Violation|1|||
48722125|NCT00868517|156832611|FG001|Overall Study|Protocol Violation|1|||
48722126|NCT00868517|156832612|FG002|Overall Study|Protocol Violation|0|||
48722127|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
48722128|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
48722129|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
48722130|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
48817179|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
48722131|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
48817180|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48817181|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
48817182|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48817183|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48817184|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
48817185|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
48817186|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
48817187|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
48817188|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
48817189|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
48817190|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
48817191|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
48817192|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
48817193|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
48817194|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
48817195|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
48817196|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
48817197|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
48817198|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
48817199|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
48817200|NCT03230864|157173633|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
48817201|NCT03230864|157173634|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
48817202|NCT03230864|157173635|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
48817203|NCT03230864|157173636|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
48817204|NCT03230864|157173633|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
48817205|NCT03230864|157173634|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
48817206|NCT03230864|157173635|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
48817207|NCT03230864|157173636|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
48722132|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
48437571|NCT01996748|155789675|FG001|Overall Study|Personal reason|0|||
48722133|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
48722134|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
48722135|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
48722136|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
48722137|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
48722138|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
48722139|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
48722140|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
48722141|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
48722142|NCT00274924|156832614|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
48722143|NCT00274924|156832615|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
48722144|NCT00274924|156832616|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
48722145|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
48722146|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
48722147|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
48722148|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
48722149|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
48722150|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
48722151|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
48722152|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
48722153|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
48722154|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
48722155|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
48722156|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
48722157|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
48722158|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
48722159|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
48722160|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
48722161|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
48722162|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
48437572|NCT01996748|155789674|FG000|Overall Study|Physician Decision|2|||
48437573|NCT01996748|155789675|FG001|Overall Study|Physician Decision|0|||
48437574|NCT01996748|155789674|FG000|Overall Study|Adverse Event|1|||
48501095|NCT01856309|156030965|FG001|Overall Study|Death|6|||
48501096|NCT01856309|156030966|FG002|Overall Study|Death|11|||
48501097|NCT01856309|156030967|FG003|Overall Study|Death|6|||
48501098|NCT01856309|156030964|FG000|Overall Study|Lost to Follow-up|6|||
48501099|NCT01856309|156030965|FG001|Overall Study|Lost to Follow-up|2|||
48501100|NCT01856309|156030966|FG002|Overall Study|Lost to Follow-up|4|||
48501101|NCT01856309|156030967|FG003|Overall Study|Lost to Follow-up|8|||
48501102|NCT01856309|156030964|FG000|Overall Study|Withdrawal by Subject|11|||
48501103|NCT01856309|156030965|FG001|Overall Study|Withdrawal by Subject|13|||
48501104|NCT01856309|156030966|FG002|Overall Study|Withdrawal by Subject|28|||
48501105|NCT01856309|156030967|FG003|Overall Study|Withdrawal by Subject|26|||
48501106|NCT01856309|156030964|FG000|Overall Study|Other|227|||
48501107|NCT01856309|156030965|FG001|Overall Study|Other|225|||
48501108|NCT01856309|156030966|FG002|Overall Study|Other|447|||
48501109|NCT01856309|156030967|FG003|Overall Study|Other|469|||
48501110|NCT01856309|156030964|FG000|Overall Study|Lack of Efficacy|14|||
48501111|NCT01856309|156030965|FG001|Overall Study|Lack of Efficacy|9|||
48501112|NCT01856309|156030966|FG002|Overall Study|Lack of Efficacy|40|||
48501113|NCT01856309|156030967|FG003|Overall Study|Lack of Efficacy|25|||
48501114|NCT01856309|156030964|FG000|Overall Study|Adverse Event|31|||
48501115|NCT01856309|156030965|FG001|Overall Study|Adverse Event|31|||
48501116|NCT01856309|156030966|FG002|Overall Study|Adverse Event|55|||
48501117|NCT01856309|156030967|FG003|Overall Study|Adverse Event|65|||
48501118|NCT01856309|156030964|FG000|Overall Study|Pregnancy|0|||
48722163|NCT00274924|156832614|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
48722164|NCT00274924|156832615|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
48722165|NCT00274924|156832616|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
48722166|NCT00740051|156832617|FG000|Overall Study|Lack of Efficacy|2|||
48722167|NCT00740051|156832618|FG001|Overall Study|Lack of Efficacy|5|||
48722168|NCT00740051|156832617|FG000|Overall Study|Adverse Event|1|||
48722169|NCT00740051|156832618|FG001|Overall Study|Adverse Event|4|||
48722170|NCT00740051|156832617|FG000|Overall Study|Protocol Violation|2|||
48722171|NCT00740051|156832618|FG001|Overall Study|Protocol Violation|6|||
48722172|NCT00740051|156832617|FG000|Overall Study|Lost to Follow-up|3|||
48722173|NCT00740051|156832618|FG001|Overall Study|Lost to Follow-up|8|||
48722174|NCT00740051|156832617|FG000|Overall Study|Withdrawal by Subject|6|||
48722175|NCT00740051|156832618|FG001|Overall Study|Withdrawal by Subject|8|||
48722176|NCT00740051|156832617|FG000|Overall Study|Other reason (not specified)|4|||
48722177|NCT00740051|156832618|FG001|Overall Study|Other reason (not specified)|1|||
48722178|NCT00991952|156832619|FG000|Overall Study|Adverse Event|0|||
48722179|NCT00991952|156832620|FG001|Overall Study|Adverse Event|1|||
48722180|NCT04717492|156832621|FG000|Overall Study|Withdrawal by Subject|2|||
48722181|NCT04717492|156832622|FG001|Overall Study|Withdrawal by Subject|13|||
48722182|NCT04717492|156832621|FG000|Overall Study|Lost to Follow-up|2|||
48722183|NCT04717492|156832622|FG001|Overall Study|Lost to Follow-up|9|||
48817208|NCT03230864|157173633|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48817209|NCT03230864|157173634|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48817210|NCT03230864|157173635|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
48817211|NCT03230864|157173636|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
48817212|NCT03230864|157173633|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
48817213|NCT03230864|157173634|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
48501119|NCT01856309|156030965|FG001|Overall Study|Pregnancy|0|||
48501120|NCT01856309|156030966|FG002|Overall Study|Pregnancy|0|||
48501121|NCT01856309|156030967|FG003|Overall Study|Pregnancy|1|||
48501122|NCT01856309|156030964|FG000|Overall Study|Physician Decision|6|||
48501123|NCT01856309|156030965|FG001|Overall Study|Physician Decision|1|||
48722184|NCT03452527|156832625|FG000|Overall Study|Withdrawal by Subject|1|||
48722185|NCT03452527|156832626|FG001|Overall Study|Withdrawal by Subject|1|||
48722186|NCT03452527|156832625|FG000|Overall Study|Study Terminated|2|||
48501124|NCT01856309|156030966|FG002|Overall Study|Physician Decision|6|||
48501125|NCT01856309|156030967|FG003|Overall Study|Physician Decision|8|||
48501126|NCT01856309|156030964|FG000|Overall Study|Noncompliance With Study Drug|0|||
48501127|NCT01856309|156030965|FG001|Overall Study|Noncompliance With Study Drug|1|||
48501128|NCT01856309|156030966|FG002|Overall Study|Noncompliance With Study Drug|4|||
48501129|NCT01856309|156030967|FG003|Overall Study|Noncompliance With Study Drug|1|||
48722187|NCT03452527|156832626|FG001|Overall Study|Study Terminated|3|||
48722188|NCT01001299|156832629|FG000|Overall Study|Insufficient Therapeutic Response|20|||
48722189|NCT01001299|156832629|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
48722190|NCT01001299|156832629|FG000|Overall Study|Death|1|||
48722191|NCT01001299|156832629|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
48722192|NCT01001299|156832629|FG000|Overall Study|Withdrew Consent|1|||
48722193|NCT02486627|156832630|FG000|Overall Study|Death|1|||
48501130|NCT00832377|156030970|FG000|Overall Study|Protocol Violation|1|||
48501131|NCT01617668|156030972|FG000|Overall Study|Adverse Event|7|||
48501132|NCT01617668|156030973|FG001|Overall Study|Adverse Event|0|||
48501133|NCT01617668|156030974|FG002|Overall Study|Adverse Event|12|||
48501134|NCT01617668|156030975|FG003|Overall Study|Adverse Event|5|||
48722194|NCT02486627|156832631|FG001|Overall Study|Death|0|||
48722195|NCT02486627|156832630|FG000|Overall Study|Other Unspecified|0|||
48722196|NCT02486627|156832631|FG001|Overall Study|Other Unspecified|2|||
48722197|NCT02486627|156832630|FG000|Overall Study|Consent Withdrawn by Participant|4|||
48722198|NCT02486627|156832631|FG001|Overall Study|Consent Withdrawn by Participant|3|||
48722199|NCT02486627|156832630|FG000|Overall Study|Significant Participant Noncompliance|1|||
48722200|NCT02486627|156832631|FG001|Overall Study|Significant Participant Noncompliance|1|||
48722201|NCT02486627|156832630|FG000|Overall Study|Lost to Follow-up|1|||
48722202|NCT02486627|156832631|FG001|Overall Study|Lost to Follow-up|3|||
48722203|NCT01933932|156832632|FG000|Overall Study|Death|173|||
48722204|NCT01933932|156832633|FG001|Overall Study|Death|163|||
48722205|NCT01933932|156832632|FG000|Overall Study|Withdrawal by Subject|11|||
48722206|NCT01933932|156832633|FG001|Overall Study|Withdrawal by Subject|14|||
48722207|NCT01933932|156832632|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48722208|NCT01933932|156832633|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48722209|NCT04683744|156832634|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
48722210|NCT04683744|156832635|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
48722211|NCT04683744|156832636|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
48722212|NCT02217527|156832637|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
48722213|NCT02217527|156832638|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
48722214|NCT02217527|156832637|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
48722215|NCT02217527|156832638|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
48722216|NCT05869383|156832639|FG000|Overall Study|Withdrawal by Subject|2|||
48722217|NCT05869383|156832640|FG001|Overall Study|Withdrawal by Subject|0|||
48722218|NCT02650921|156832647|FG000|Overall Study|Withdrawal by Subject|4|||
48722219|NCT02650921|156832647|FG000|Overall Study|Lost to Follow-up|2|||
48722220|NCT02650921|156832647|FG000|Overall Study|Adverse Event|1|||
48722221|NCT02650921|156832647|FG000|Overall Study|Due to Medical Condition|1|||
48722222|NCT02522871|156832648|FG000|Overall Study|Protocol Violation|1|||
48722223|NCT02522871|156832649|FG001|Overall Study|Protocol Violation|4|||
48722224|NCT02522871|156832648|FG000|Overall Study|Treated without randomization|1|||
48722225|NCT02522871|156832649|FG001|Overall Study|Treated without randomization|0|||
48722226|NCT02522871|156832648|FG000|Overall Study|Death|9|||
48722227|NCT02522871|156832649|FG001|Overall Study|Death|9|||
48722228|NCT02522871|156832648|FG000|Overall Study|Died in operating room prior to transplant|0|||
48722229|NCT02522871|156832649|FG001|Overall Study|Died in operating room prior to transplant|1|||
48722230|NCT02068768|156832650|FG000|Overall Study|Lost to Follow-up|5|||
48722231|NCT02068768|156832650|FG000|Overall Study|Early Termination by Sponsor|2|||
48722232|NCT02674854|156832651|FG000|Overall Study|Adverse Event|17|||
48722233|NCT02674854|156832652|FG001|Overall Study|Adverse Event|15|||
48722234|NCT02674854|156832653|FG002|Overall Study|Adverse Event|5|||
48722235|NCT02674854|156832651|FG000|Overall Study|Withdrawal by Subject|1|||
48722236|NCT02674854|156832652|FG001|Overall Study|Withdrawal by Subject|5|||
48722237|NCT02674854|156832653|FG002|Overall Study|Withdrawal by Subject|4|||
48722238|NCT02674854|156832651|FG000|Overall Study|No-compliant subject|1|||
48722239|NCT02674854|156832652|FG001|Overall Study|No-compliant subject|0|||
48722240|NCT02674854|156832653|FG002|Overall Study|No-compliant subject|1|||
48722241|NCT02674854|156832651|FG000|Overall Study|Lost to Follow-up|1|||
48817214|NCT03230864|157173635|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
48817215|NCT03230864|157173636|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
48817216|NCT00109928|157173645|FG000|Overall Study|Adverse Event|2|||
48817217|NCT00109928|157173645|FG000|Overall Study|Progression|6|||
48817218|NCT00109928|157173645|FG000|Overall Study|Death|2|||
48817219|NCT00109928|157173645|FG000|Overall Study|not protocol specified|2|||
48817220|NCT00109928|157173645|FG000|Overall Study|not eligible|1|||
48817221|NCT01196104|157173646|FG000|Overall Study|Lost to Follow-up|1|||
48817222|NCT01196104|157173647|FG001|Overall Study|Lost to Follow-up|0|||
48817223|NCT01196104|157173646|FG000|Overall Study|Physician Decision|0|||
48817224|NCT01196104|157173647|FG001|Overall Study|Physician Decision|1|||
48817225|NCT01196104|157173646|FG000|Overall Study|Withdrawal by Subject|3|||
48817226|NCT01196104|157173647|FG001|Overall Study|Withdrawal by Subject|3|||
48817227|NCT01196104|157173646|FG000|Overall Study|Various|0|||
48722242|NCT02674854|156832652|FG001|Overall Study|Lost to Follow-up|0|||
48722243|NCT02674854|156832653|FG002|Overall Study|Lost to Follow-up|2|||
48722244|NCT02674854|156832651|FG000|Overall Study|Lack of Efficacy|0|||
48722245|NCT02674854|156832652|FG001|Overall Study|Lack of Efficacy|3|||
48722246|NCT02674854|156832653|FG002|Overall Study|Lack of Efficacy|0|||
48722247|NCT02674854|156832651|FG000|Overall Study|Disallowed Concurrent Medication|2|||
48722248|NCT02674854|156832652|FG001|Overall Study|Disallowed Concurrent Medication|2|||
48722249|NCT02674854|156832653|FG002|Overall Study|Disallowed Concurrent Medication|0|||
48817228|NCT01196104|157173647|FG001|Overall Study|Various|1|||
48817229|NCT00610675|157173648|FG000|Overall Study|Untreated|4|||
48722250|NCT02674854|156832651|FG000|Overall Study|Protocol Violation|1|||
48722251|NCT02674854|156832652|FG001|Overall Study|Protocol Violation|1|||
48722252|NCT02674854|156832653|FG002|Overall Study|Protocol Violation|2|||
48722253|NCT02674854|156832651|FG000|Overall Study|Death|0|||
48722254|NCT02674854|156832652|FG001|Overall Study|Death|1|||
48722255|NCT02674854|156832653|FG002|Overall Study|Death|0|||
48722256|NCT02674854|156832651|FG000|Overall Study|Subject missed V6.2|1|||
48722257|NCT02674854|156832652|FG001|Overall Study|Subject missed V6.2|0|||
48722258|NCT02674854|156832653|FG002|Overall Study|Subject missed V6.2|0|||
48722259|NCT01185834|156832654|FG000|Overall Study|Lost to Follow-up|2|||
48722260|NCT01185834|156832654|FG000|Overall Study|Discomfort|4|||
48722261|NCT01185834|156832654|FG000|Overall Study|Biomicroscopy|4|||
48722262|NCT01185834|156832654|FG000|Overall Study|Time/Job Conflict|2|||
48722263|NCT01185834|156832654|FG000|Overall Study|Early exit - Site error|2|||
48722264|NCT00887744|156832655|FG000|Overall Study|Adverse Event|3|||
48722265|NCT00887744|156832655|FG000|Overall Study|Death|1|||
48722266|NCT00887744|156832655|FG000|Overall Study|Lost to Follow-up|3|||
48722267|NCT00887744|156832655|FG000|Overall Study|Withdrawal by Subject|18|||
48722268|NCT00887744|156832655|FG000|Overall Study|Various reasons|9|||
48722269|NCT00393042|156832658|FG000|First Intervention|Withdrawal by Subject|1|||
48722270|NCT00393042|156832659|FG001|First Intervention|Withdrawal by Subject|2|||
48722271|NCT00393042|156832658|FG000|First Intervention|Lost to Follow-up|3|||
48722272|NCT00393042|156832659|FG001|First Intervention|Lost to Follow-up|3|||
48722273|NCT00393042|156832658|FG000|First Intervention|Protocol Violation|1|||
48722274|NCT00393042|156832659|FG001|First Intervention|Protocol Violation|0|||
48722275|NCT00393042|156832658|FG000|First Intervention|Adverse Event|0|||
48722276|NCT00393042|156832659|FG001|First Intervention|Adverse Event|1|||
48722277|NCT00393042|156832658|FG000|Second Intervetion|Adverse Event|0|||
48722278|NCT00393042|156832659|FG001|Second Intervetion|Adverse Event|3|||
48722279|NCT00393042|156832658|FG000|Second Intervetion|Withdrawal by Subject|0|||
48722280|NCT00393042|156832659|FG001|Second Intervetion|Withdrawal by Subject|2|||
48722281|NCT00393042|156832658|FG000|Second Intervetion|Lack of Efficacy|1|||
48722282|NCT00393042|156832659|FG001|Second Intervetion|Lack of Efficacy|0|||
48722283|NCT00393042|156832658|FG000|Second Intervetion|Lost to Follow-up|0|||
48722284|NCT00393042|156832659|FG001|Second Intervetion|Lost to Follow-up|2|||
48722285|NCT00393042|156832658|FG000|Second Intervetion|Protocol Violation|1|||
48722286|NCT00393042|156832659|FG001|Second Intervetion|Protocol Violation|1|||
48722287|NCT02312687|156832660|FG000|Overall Study|Other, Not Specified|1|||
48722288|NCT02632838|156832661|FG000|Overall Study|Withdrawal by Subject|3|||
48722289|NCT02632838|156832662|FG001|Overall Study|Withdrawal by Subject|0|||
48722290|NCT02632838|156832661|FG000|Overall Study|Lost to Follow-up|0|||
48722291|NCT02632838|156832662|FG001|Overall Study|Lost to Follow-up|2|||
48722292|NCT01894568|156832663|FG000|Overall Study|Adverse Event|2|||
48722293|NCT01894568|156832664|FG001|Overall Study|Adverse Event|3|||
48722294|NCT01894568|156832663|FG000|Overall Study|Protocol required discontinuation|2|||
48722295|NCT01894568|156832664|FG001|Overall Study|Protocol required discontinuation|1|||
48722296|NCT01894568|156832663|FG000|Overall Study|Withdrawal by Subject|5|||
48722297|NCT01894568|156832664|FG001|Overall Study|Withdrawal by Subject|5|||
48722298|NCT01894568|156832663|FG000|Overall Study|Physician Decision|1|||
48722299|NCT01894568|156832664|FG001|Overall Study|Physician Decision|0|||
48722300|NCT01894568|156832663|FG000|Overall Study|Lost to Follow-up|0|||
48722301|NCT01894568|156832664|FG001|Overall Study|Lost to Follow-up|1|||
48722302|NCT03899259|156832665|FG000|Overall Study|Adverse Event|5|||
48722303|NCT03899259|156832666|FG001|Overall Study|Adverse Event|4|||
48722304|NCT03899259|156832667|FG002|Overall Study|Adverse Event|6|||
48722305|NCT03899259|156832665|FG000|Overall Study|Lack of Efficacy|5|||
48722306|NCT03899259|156832666|FG001|Overall Study|Lack of Efficacy|0|||
48722307|NCT03899259|156832667|FG002|Overall Study|Lack of Efficacy|2|||
48722308|NCT03899259|156832665|FG000|Overall Study|Pregnancy|3|||
48722309|NCT03899259|156832666|FG001|Overall Study|Pregnancy|0|||
48722310|NCT03899259|156832667|FG002|Overall Study|Pregnancy|1|||
48722311|NCT03899259|156832665|FG000|Overall Study|Physician Decision|0|||
48722312|NCT03899259|156832666|FG001|Overall Study|Physician Decision|1|||
48722313|NCT03899259|156832667|FG002|Overall Study|Physician Decision|0|||
48722314|NCT03899259|156832665|FG000|Overall Study|Protocol Deviation|1|||
48722315|NCT03899259|156832666|FG001|Overall Study|Protocol Deviation|1|||
48722316|NCT03899259|156832667|FG002|Overall Study|Protocol Deviation|1|||
48722317|NCT03899259|156832665|FG000|Overall Study|Withdrawal by Subject|8|||
48722318|NCT03899259|156832666|FG001|Overall Study|Withdrawal by Subject|10|||
48722319|NCT03899259|156832667|FG002|Overall Study|Withdrawal by Subject|12|||
48722320|NCT03899259|156832665|FG000|Overall Study|Lost to Follow-up|5|||
48722321|NCT03899259|156832666|FG001|Overall Study|Lost to Follow-up|6|||
48722322|NCT03899259|156832667|FG002|Overall Study|Lost to Follow-up|2|||
48722323|NCT03899259|156832665|FG000|Overall Study|Lack of Adherence|1|||
48722324|NCT03899259|156832666|FG001|Overall Study|Lack of Adherence|0|||
48722325|NCT03899259|156832667|FG002|Overall Study|Lack of Adherence|0|||
48722326|NCT03899259|156832665|FG000|Overall Study|Screen Failure|1|||
48722327|NCT03899259|156832666|FG001|Overall Study|Screen Failure|0|||
48722328|NCT03899259|156832667|FG002|Overall Study|Screen Failure|0|||
48722329|NCT03899259|156832665|FG000|Overall Study|Ongoing Study Participation|127|||
48722330|NCT03899259|156832666|FG001|Overall Study|Ongoing Study Participation|134|||
48722331|NCT03899259|156832667|FG002|Overall Study|Ongoing Study Participation|210|||
48722332|NCT02589795|156832669|FG000|Overall Study|Lost to Follow-up|1|||
48722333|NCT02589795|156832670|FG001|Overall Study|Lost to Follow-up|0|||
48722334|NCT02589795|156832671|FG002|Overall Study|Lost to Follow-up|0|||
48722335|NCT02589795|156832669|FG000|Overall Study|Withdrawal by Subject|0|||
48722336|NCT02589795|156832670|FG001|Overall Study|Withdrawal by Subject|0|||
48722337|NCT02589795|156832671|FG002|Overall Study|Withdrawal by Subject|2|||
48722338|NCT02589795|156832669|FG000|Overall Study|Protocol Violation|0|||
48722339|NCT02589795|156832670|FG001|Overall Study|Protocol Violation|0|||
48722340|NCT02589795|156832671|FG002|Overall Study|Protocol Violation|1|||
48722341|NCT03473548|156832672|FG000|Overall Study|Did not attempt HST testing|3|||
48722342|NCT03473548|156832673|FG001|Overall Study|Did not attempt HST testing|0|||
48722343|NCT01307020|156832674|FG000|Overall Study|Lost to Follow-up|0|||
48722344|NCT01307020|156832675|FG001|Overall Study|Lost to Follow-up|0|||
48722345|NCT01307020|156832676|FG002|Overall Study|Lost to Follow-up|1|||
48722346|NCT01307020|156832677|FG003|Overall Study|Lost to Follow-up|1|||
48722347|NCT01307020|156832678|FG004|Overall Study|Lost to Follow-up|0|||
48722348|NCT01307020|156832679|FG005|Overall Study|Lost to Follow-up|0|||
48722349|NCT01307020|156832680|FG006|Overall Study|Lost to Follow-up|1|||
48722350|NCT01307020|156832681|FG007|Overall Study|Lost to Follow-up|0|||
48722351|NCT01307020|156832682|FG008|Overall Study|Lost to Follow-up|0|||
48722352|NCT01307020|156832683|FG009|Overall Study|Lost to Follow-up|0|||
48722353|NCT01307020|156832674|FG000|Overall Study|Electronic data capture failure|0|||
48722354|NCT01307020|156832675|FG001|Overall Study|Electronic data capture failure|1|||
48722355|NCT01307020|156832676|FG002|Overall Study|Electronic data capture failure|0|||
48722356|NCT01307020|156832677|FG003|Overall Study|Electronic data capture failure|0|||
48722357|NCT01307020|156832678|FG004|Overall Study|Electronic data capture failure|0|||
48722358|NCT01307020|156832679|FG005|Overall Study|Electronic data capture failure|0|||
48722359|NCT01307020|156832680|FG006|Overall Study|Electronic data capture failure|0|||
48722360|NCT01307020|156832681|FG007|Overall Study|Electronic data capture failure|0|||
48722361|NCT01307020|156832682|FG008|Overall Study|Electronic data capture failure|0|||
48722362|NCT01307020|156832683|FG009|Overall Study|Electronic data capture failure|0|||
48722363|NCT03911843|156832684|FG000|Overall Study|Adverse Event|2|||
48722364|NCT03911843|156832685|FG001|Overall Study|Adverse Event|0|||
48722365|NCT03911843|156832684|FG000|Overall Study|Protocol Violation|2|||
48722366|NCT03911843|156832685|FG001|Overall Study|Protocol Violation|0|||
48722367|NCT03911843|156832684|FG000|Overall Study|Lost to Follow-up|0|||
48722368|NCT03911843|156832685|FG001|Overall Study|Lost to Follow-up|1|||
48722369|NCT00829933|156832686|FG000|Overall Study|Adverse Event|2|||
48722370|NCT00829933|156832687|FG001|Overall Study|Adverse Event|3|||
48722371|NCT00829933|156832688|FG002|Overall Study|Adverse Event|2|||
48722372|NCT00829933|156832689|FG003|Overall Study|Adverse Event|1|||
48722373|NCT00829933|156832686|FG000|Overall Study|Death|0|||
48722374|NCT00829933|156832687|FG001|Overall Study|Death|0|||
48722375|NCT00829933|156832688|FG002|Overall Study|Death|1|||
48722376|NCT00829933|156832689|FG003|Overall Study|Death|1|||
48722377|NCT00829933|156832686|FG000|Overall Study|Lack of Efficacy|0|||
48722378|NCT00829933|156832687|FG001|Overall Study|Lack of Efficacy|1|||
48722379|NCT00829933|156832688|FG002|Overall Study|Lack of Efficacy|0|||
48722380|NCT00829933|156832689|FG003|Overall Study|Lack of Efficacy|0|||
48722381|NCT00829933|156832686|FG000|Overall Study|Physician Decision|5|||
48722382|NCT00829933|156832687|FG001|Overall Study|Physician Decision|7|||
48722383|NCT00829933|156832688|FG002|Overall Study|Physician Decision|8|||
48722384|NCT00829933|156832689|FG003|Overall Study|Physician Decision|1|||
48722385|NCT00829933|156832686|FG000|Overall Study|Pregnancy|0|||
48722386|NCT00829933|156832687|FG001|Overall Study|Pregnancy|0|||
48722387|NCT00829933|156832688|FG002|Overall Study|Pregnancy|0|||
48722388|NCT00829933|156832689|FG003|Overall Study|Pregnancy|2|||
48722389|NCT00829933|156832686|FG000|Overall Study|Protocol Violation|2|||
48722390|NCT00829933|156832687|FG001|Overall Study|Protocol Violation|1|||
48722391|NCT00829933|156832688|FG002|Overall Study|Protocol Violation|0|||
48722392|NCT00829933|156832689|FG003|Overall Study|Protocol Violation|0|||
48722393|NCT00829933|156832686|FG000|Overall Study|withdrew before treatment started|5|||
48501135|NCT01617668|156030972|FG000|Overall Study|Physician Decision|1|||
48501136|NCT01617668|156030973|FG001|Overall Study|Physician Decision|2|||
48722394|NCT00829933|156832687|FG001|Overall Study|withdrew before treatment started|1|||
48722395|NCT00829933|156832688|FG002|Overall Study|withdrew before treatment started|2|||
48722396|NCT00829933|156832689|FG003|Overall Study|withdrew before treatment started|9|||
48722397|NCT05093842|156832695|FG000|Overall Study|Pregnancy loss|1|||
48722398|NCT05093842|156832696|FG001|Overall Study|Pregnancy loss|1|||
48722399|NCT05093842|156832695|FG000|Overall Study|Lost to Follow-up|6|||
48722400|NCT05093842|156832696|FG001|Overall Study|Lost to Follow-up|0|||
48722401|NCT05093842|156832695|FG000|Overall Study|Physician Decision|0|||
48722402|NCT05093842|156832696|FG001|Overall Study|Physician Decision|1|||
48722403|NCT00993044|156832709|FG000|Irinotecan 50 mg|Physician Decision|1|||
48722404|NCT04560179|156832715|FG000|Overall Study|Physician Decision|1|||
48722405|NCT04560179|156832716|FG001|Overall Study|Physician Decision|0|||
48501137|NCT01617668|156030974|FG002|Overall Study|Physician Decision|3|||
48722406|NCT04560179|156832717|FG002|Overall Study|Physician Decision|0|||
48722407|NCT04560179|156832718|FG003|Overall Study|Physician Decision|0|||
48817230|NCT00610675|157173648|FG000|Overall Study|Adverse Event|67|||
48817231|NCT00610675|157173648|FG000|Overall Study|Insufficient Effect|31|||
48817232|NCT00610675|157173648|FG000|Overall Study|Withdrawal by Subject|28|||
48817233|NCT00610675|157173648|FG000|Overall Study|Reasons unrelated to trial|27|||
48817234|NCT00610675|157173648|FG000|Overall Study|Lack of Compliance|7|||
48817235|NCT00610675|157173648|FG000|Overall Study|Lost to Follow-up|31|||
48817236|NCT00610675|157173648|FG000|Overall Study|Other reason (not specified)|25|||
48817237|NCT01734382|157173649|FG000|Part 1|Adverse Event|2|||
48501138|NCT01617668|156030975|FG003|Overall Study|Physician Decision|0|||
48501139|NCT01617668|156030972|FG000|Overall Study|Progressive Disease|4|||
48501140|NCT01617668|156030973|FG001|Overall Study|Progressive Disease|4|||
48501141|NCT01617668|156030974|FG002|Overall Study|Progressive Disease|6|||
48501142|NCT01617668|156030975|FG003|Overall Study|Progressive Disease|9|||
48501143|NCT01617668|156030972|FG000|Overall Study|Subject/guardian decision|1|||
48501144|NCT01617668|156030973|FG001|Overall Study|Subject/guardian decision|3|||
48501145|NCT01617668|156030974|FG002|Overall Study|Subject/guardian decision|2|||
48501146|NCT01617668|156030975|FG003|Overall Study|Subject/guardian decision|1|||
48501147|NCT02017964|156030976|FG000|Overall Study|Patient deemed ineligible|1|||
48501148|NCT01038856|156030980|FG000|Overall Study|Adverse Event|2|||
48501149|NCT01492400|156030981|FG000|Overall Study|Miscellaneous Reasons|2|||
48501150|NCT01492400|156030982|FG001|Overall Study|Miscellaneous Reasons|3|||
48501151|NCT01492400|156030981|FG000|Overall Study|Personal Reasons|0|||
48501152|NCT01492400|156030982|FG001|Overall Study|Personal Reasons|5|||
48501153|NCT01492400|156030981|FG000|Overall Study|Lost to Follow-up|3|||
48501154|NCT01492400|156030982|FG001|Overall Study|Lost to Follow-up|1|||
48501155|NCT01492400|156030981|FG000|Overall Study|Pregnancy|0|||
48501156|NCT01492400|156030982|FG001|Overall Study|Pregnancy|1|||
48501157|NCT01492400|156030981|FG000|Overall Study|Lack of Efficacy|1|||
48501158|NCT01492400|156030982|FG001|Overall Study|Lack of Efficacy|1|||
48501159|NCT01492400|156030981|FG000|Overall Study|Adverse Event|10|||
48501160|NCT01492400|156030982|FG001|Overall Study|Adverse Event|5|||
48501161|NCT00604500|156030983|FG000|Overall Study|Adverse Event|2|||
48501162|NCT00604500|156030983|FG000|Overall Study|Protocol Violation|2|||
48501163|NCT00604500|156030983|FG000|Overall Study|Treatment Failure|1|||
48501164|NCT00604500|156030983|FG000|Overall Study|Withdrawal by Subject|4|||
48501165|NCT00604500|156030983|FG000|Overall Study|Administrative|1|||
48501166|NCT00604500|156030983|FG000|Overall Study|Did not meet protocol eligibility|1|||
48501167|NCT00659607|156030986|FG000|Overall Study|No blood pressure recorded|147|||
48501168|NCT00659607|156030986|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
48501169|NCT00659607|156030986|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
48501170|NCT00659607|156030986|FG000|Overall Study|No recorded efficacy data|15|||
48501171|NCT00659607|156030986|FG000|Overall Study|Inconsistent BP measuring date|2|||
48501172|NCT03364647|156030990|FG000|Overall Study|Withdrawal by Subject|3|||
48501173|NCT03364647|156030991|FG001|Overall Study|Withdrawal by Subject|1|||
48501174|NCT04292223|156030995|FG000|Overall Study|Adverse Event|1|||
48501175|NCT04292223|156030995|FG000|Overall Study|Lost to Follow-up|1|||
48501176|NCT04292223|156030995|FG000|Overall Study|Noncompliance with study drug|2|||
48501177|NCT04292223|156030995|FG000|Overall Study|Patient moved out of the state|1|||
48501178|NCT02899338|156030996|FG000|Overall Study|Adverse Event|1|||
48501179|NCT02899338|156030997|FG001|Overall Study|Adverse Event|2|||
48501180|NCT02899338|156030996|FG000|Overall Study|Withdrawal by Subject|2|||
48501181|NCT02899338|156030997|FG001|Overall Study|Withdrawal by Subject|0|||
48501182|NCT01406795|156031001|FG000|Overall Study|Withdrawal by Subject|1|||
48501183|NCT05090683|156031002|FG000|Overall Study|Lost to Follow-up|10|||
48501184|NCT05090683|156031003|FG001|Overall Study|Lost to Follow-up|2|||
48501185|NCT05090683|156031002|FG000|Overall Study|Withdrawal by Subject|15|||
48501186|NCT05090683|156031003|FG001|Overall Study|Withdrawal by Subject|0|||
48501187|NCT03482882|156031005|FG000|Overall Study|Adverse Event|3|||
48501188|NCT03482882|156031005|FG000|Overall Study|Lost to Follow-up|1|||
48501189|NCT03482882|156031005|FG000|Overall Study|Protocol Violation|2|||
48817238|NCT01734382|157173650|FG001|Part 1|Adverse Event|0|||
48817239|NCT01734382|157173651|FG002|Part 1|Adverse Event|0|||
48817240|NCT01734382|157173649|FG000|Part 2|Adverse Event|0|||
48817241|NCT01734382|157173650|FG001|Part 2|Adverse Event|0|||
48501190|NCT03482882|156031005|FG000|Overall Study|Not further specified|1|||
48599751|NCT00803712|156391459|FG000|Overall Study|Death|8|||
48599752|NCT00803712|156391460|FG001|Overall Study|Death|7|||
48501191|NCT02216071|156031008|FG000|Overall Study|Withdrawal by Subject|7|||
48501192|NCT02216071|156031009|FG001|Overall Study|Withdrawal by Subject|2|||
48501193|NCT02216071|156031008|FG000|Overall Study|Lost to Follow-up|3|||
48599753|NCT00803712|156391459|FG000|Overall Study|Lost to Follow-up|3|||
48817242|NCT01734382|157173651|FG002|Part 2|Adverse Event|1|||
48817243|NCT01734382|157173649|FG000|Part 2|Lack of Efficacy|0|||
48501194|NCT02216071|156031009|FG001|Overall Study|Lost to Follow-up|3|||
48501195|NCT02216071|156031008|FG000|Overall Study|Protocol Violation|3|||
48501196|NCT02216071|156031009|FG001|Overall Study|Protocol Violation|5|||
48501197|NCT02216071|156031008|FG000|Overall Study|Other|2|||
48501198|NCT02216071|156031009|FG001|Overall Study|Other|2|||
48817244|NCT01734382|157173650|FG001|Part 2|Lack of Efficacy|1|||
48722408|NCT04560179|156832719|FG004|Overall Study|Physician Decision|0|||
48722409|NCT04560179|156832715|FG000|Overall Study|Adverse Event|0|||
48722410|NCT04560179|156832716|FG001|Overall Study|Adverse Event|0|||
48722411|NCT04560179|156832717|FG002|Overall Study|Adverse Event|0|||
48722412|NCT04560179|156832718|FG003|Overall Study|Adverse Event|1|||
48722413|NCT04560179|156832719|FG004|Overall Study|Adverse Event|0|||
48722414|NCT04649047|156832720|FG000|Overall Study|Withdrawal by Subject|3|||
48722415|NCT04236141|156834557|FG000|Overall Study|Death|18|||
48501199|NCT03500692|156031012|FG000|Overall Study|Death|163|||
48817245|NCT01734382|157173651|FG002|Part 2|Lack of Efficacy|1|||
48722416|NCT04236141|156834558|FG001|Overall Study|Death|10|||
48722417|NCT04236141|156834557|FG000|Overall Study|Withdrawal by Participant|1|||
48722418|NCT04236141|156834558|FG001|Overall Study|Withdrawal by Participant|0|||
48722419|NCT04236141|156834557|FG000|Overall Study|Reason not Specified|1|||
48722420|NCT04236141|156834558|FG001|Overall Study|Reason not Specified|0|||
48817246|NCT01734382|157173649|FG000|Part 2|Other|0|||
48817247|NCT01734382|157173650|FG001|Part 2|Other|0|||
48817248|NCT01734382|157173651|FG002|Part 2|Other|1|||
48817249|NCT01734382|157173649|FG000|Part 2|Physician Decision|0|||
48817250|NCT01734382|157173650|FG001|Part 2|Physician Decision|0|||
48501200|NCT03500692|156031012|FG000|Overall Study|Lost to Follow-up|75|||
48722421|NCT04236141|156834557|FG000|Overall Study|Study terminated by Sponsor|8|||
48722422|NCT04236141|156834558|FG001|Overall Study|Study terminated by Sponsor|4|||
48722423|NCT03865316|156834559|FG000|Overall Study|Procedure Cancelled|4|||
48722424|NCT03865316|156834559|FG000|Overall Study|Equipment failure|4|||
48722425|NCT01948193|156834564|FG000|Overall Study|Serious event|2|||
48722426|NCT01948193|156834564|FG000|Overall Study|Lost to Follow-up|7|||
48722427|NCT01258998|156834565|FG000|Overall Study|Ineligible|1|||
48722428|NCT00002931|156834568|FG000|Overall Study|rapidly progressing disease during|2|||
48722429|NCT03224598|156834572|FG000|Overall Study|Lost to Follow-up|0|||
48722430|NCT03224598|156834573|FG001|Overall Study|Lost to Follow-up|2|||
48722431|NCT03224598|156834574|FG002|Overall Study|Lost to Follow-up|0|||
48722432|NCT03224598|156834572|FG000|Overall Study|Other|0|||
48722433|NCT03224598|156834573|FG001|Overall Study|Other|1|||
48722434|NCT03224598|156834574|FG002|Overall Study|Other|0|||
48817251|NCT01734382|157173651|FG002|Part 2|Physician Decision|3|||
48817252|NCT01734382|157173649|FG000|Part 2|Protocol Violation|0|||
48817253|NCT01734382|157173650|FG001|Part 2|Protocol Violation|1|||
48817254|NCT01734382|157173651|FG002|Part 2|Protocol Violation|0|||
48817255|NCT01734382|157173649|FG000|Part 2|Withdrawal by Subject|0|||
48817256|NCT01734382|157173650|FG001|Part 2|Withdrawal by Subject|0|||
48817257|NCT01734382|157173651|FG002|Part 2|Withdrawal by Subject|1|||
48817258|NCT01439711|157173654|FG000|Overall Study|Ineligible|13|||
48817259|NCT01439711|157173654|FG000|Overall Study|Cancel|3|||
48817260|NCT01439711|157173654|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
48817261|NCT01439711|157173654|FG000|Overall Study|Adverse Event|5|||
48501201|NCT03500692|156031012|FG000|Overall Study|Termination Reasons|3|||
48501202|NCT02305758|156031013|FG000|Overall Study|Death|27|||
48501203|NCT02305758|156031014|FG001|Overall Study|Death|27|||
48722435|NCT02907892|156834578|FG000|Overall Study|Lost to Follow-up|27|||
48722436|NCT02907892|156834579|FG001|Overall Study|Lost to Follow-up|40|||
48722437|NCT04531462|156834580|FG000|Overall Study|Withdrawal by Subject|3|||
48722438|NCT04531462|156834581|FG001|Overall Study|Withdrawal by Subject|1|||
48722439|NCT04531462|156834580|FG000|Overall Study|Adverse Event|3|||
48722440|NCT04531462|156834581|FG001|Overall Study|Adverse Event|3|||
48722441|NCT01264081|156834582|FG000|Participants Screened|Screening failures|30|||
48501204|NCT02305758|156031013|FG000|Overall Study|Withdrew consent|9|||
48501205|NCT02305758|156031014|FG001|Overall Study|Withdrew consent|2|||
48501206|NCT02305758|156031013|FG000|Overall Study|Lost to Follow-up|6|||
48501207|NCT02305758|156031014|FG001|Overall Study|Lost to Follow-up|1|||
48722442|NCT01264081|156834582|FG000|Started Treatment|Withdrawal by Subject|1|||
48722443|NCT01264081|156834582|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
48722444|NCT00134784|156834585|FG000|Overall Study|Withdrawal by Subject|2|||
48722445|NCT00134784|156834586|FG001|Overall Study|Withdrawal by Subject|2|||
48722446|NCT00134784|156834587|FG002|Overall Study|Withdrawal by Subject|2|||
48722447|NCT00134784|156834588|FG003|Overall Study|Withdrawal by Subject|1|||
48722448|NCT00137839|156834592|FG000|Overall Study|Adverse Event|7|||
48722449|NCT00137839|156834592|FG000|Overall Study|Physician Decision|7|||
48817262|NCT01439711|157173654|FG000|Overall Study|Withdrawal by Subject|3|||
48817263|NCT01439711|157173654|FG000|Overall Study|Progression During Active Tx|3|||
48501208|NCT02305758|156031013|FG000|Overall Study|Study Terminated by Sponsor|21|||
48722450|NCT00137839|156834592|FG000|Overall Study|Death|8|||
48722451|NCT00137839|156834592|FG000|Overall Study|Disease Progression|60|||
48722452|NCT00137839|156834592|FG000|Overall Study|Not Start Treatment|1|||
48722453|NCT00137839|156834592|FG000|Overall Study|Prolonged Treatment Delay|1|||
48722454|NCT03234881|156834593|FG000|Overall Study|Lost to Follow-up|9|||
48722455|NCT03234881|156834594|FG001|Overall Study|Lost to Follow-up|3|||
48817264|NCT01439711|157173654|FG000|Overall Study|Noncompliance|3|||
48599754|NCT00803712|156391460|FG001|Overall Study|Lost to Follow-up|1|||
48817265|NCT01439711|157173654|FG000|Overall Study|No MRI|9|||
48817266|NCT00209027|157173655|FG000|Overall Study|study terminated|10|||
48722456|NCT01011478|156834597|FG000|Overall Study|No follow up data|12|||
48722457|NCT01011478|156834598|FG001|Overall Study|No follow up data|7|||
48501209|NCT02305758|156031014|FG001|Overall Study|Study Terminated by Sponsor|34|||
48501210|NCT02305758|156031013|FG000|Overall Study|Other, not specified|2|||
48501211|NCT02305758|156031014|FG001|Overall Study|Other, not specified|1|||
48501212|NCT00824265|156031015|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
48501213|NCT00824265|156031016|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
48501214|NCT00824265|156031015|FG000|Treatment Phase|Protocol Violation|1|||
48501215|NCT00824265|156031016|FG001|Treatment Phase|Protocol Violation|0|||
48501216|NCT00824265|156031015|FG000|Treatment Phase|Lost to Follow-up|1|||
48501217|NCT00824265|156031016|FG001|Treatment Phase|Lost to Follow-up|1|||
48501218|NCT00824265|156031015|FG000|Treatment Phase|Physician Decision|6|||
48501219|NCT00824265|156031016|FG001|Treatment Phase|Physician Decision|12|||
48501220|NCT00824265|156031015|FG000|Treatment Phase|Withdrawal by Subject|6|||
48501221|NCT00824265|156031016|FG001|Treatment Phase|Withdrawal by Subject|15|||
48501222|NCT00824265|156031015|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
48501223|NCT00824265|156031016|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
48501224|NCT00824265|156031015|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
48722458|NCT00635024|156834602|FG000|Overall Study|Adverse Event|1|||
48722459|NCT04575597|156834603|FG000|Overall Study|Death|0|||
48722460|NCT04575597|156834604|FG001|Overall Study|Death|0|||
48722461|NCT04575597|156834605|FG002|Overall Study|Death|0|||
48722462|NCT04575597|156834606|FG003|Overall Study|Death|1|||
48722463|NCT04575597|156834607|FG004|Overall Study|Death|3|||
48722464|NCT04575597|156834608|FG005|Overall Study|Death|14|||
48722465|NCT04575597|156834603|FG000|Overall Study|Lost to Follow-up|2|||
48722466|NCT04575597|156834604|FG001|Overall Study|Lost to Follow-up|1|||
48722467|NCT04575597|156834605|FG002|Overall Study|Lost to Follow-up|1|||
48722468|NCT04575597|156834606|FG003|Overall Study|Lost to Follow-up|2|||
48722469|NCT04575597|156834607|FG004|Overall Study|Lost to Follow-up|10|||
48722470|NCT04575597|156834608|FG005|Overall Study|Lost to Follow-up|8|||
48722471|NCT04575597|156834603|FG000|Overall Study|Withdrawal by Subject|2|||
48722472|NCT04575597|156834604|FG001|Overall Study|Withdrawal by Subject|2|||
48722473|NCT04575597|156834605|FG002|Overall Study|Withdrawal by Subject|4|||
48722474|NCT04575597|156834606|FG003|Overall Study|Withdrawal by Subject|2|||
48722475|NCT04575597|156834607|FG004|Overall Study|Withdrawal by Subject|25|||
48722476|NCT04575597|156834608|FG005|Overall Study|Withdrawal by Subject|28|||
48722477|NCT04575597|156834603|FG000|Overall Study|Not Recorded|0|||
48722478|NCT04575597|156834604|FG001|Overall Study|Not Recorded|0|||
48722479|NCT04575597|156834605|FG002|Overall Study|Not Recorded|0|||
48722480|NCT04575597|156834606|FG003|Overall Study|Not Recorded|0|||
48722481|NCT04575597|156834607|FG004|Overall Study|Not Recorded|0|||
48722482|NCT04575597|156834608|FG005|Overall Study|Not Recorded|2|||
48722483|NCT04575597|156834603|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48722484|NCT04575597|156834604|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48722485|NCT04575597|156834605|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48722486|NCT04575597|156834606|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48722487|NCT04575597|156834607|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
48722488|NCT04575597|156834608|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
48722489|NCT01653132|156834609|FG000|First Intervention|Protocol Violation|1|||
48722490|NCT01653132|156834610|FG001|First Intervention|Protocol Violation|0|||
48722491|NCT01895361|156834615|FG000|Overall Study|Adverse Event|1|||
48722492|NCT01895361|156834616|FG001|Overall Study|Adverse Event|1|||
48722493|NCT01895361|156834617|FG002|Overall Study|Adverse Event|3|||
48722494|NCT01895361|156834615|FG000|Overall Study|Death|2|||
48722495|NCT01895361|156834616|FG001|Overall Study|Death|1|||
48722496|NCT01895361|156834617|FG002|Overall Study|Death|2|||
48722497|NCT01895361|156834615|FG000|Overall Study|Lost to Follow-up|4|||
48722498|NCT01895361|156834616|FG001|Overall Study|Lost to Follow-up|4|||
48722499|NCT01895361|156834617|FG002|Overall Study|Lost to Follow-up|6|||
48722500|NCT01895361|156834615|FG000|Overall Study|Non-compliance with study|1|||
48722501|NCT01895361|156834616|FG001|Overall Study|Non-compliance with study|3|||
48722502|NCT01895361|156834617|FG002|Overall Study|Non-compliance with study|1|||
48722503|NCT01895361|156834615|FG000|Overall Study|Physician Decision|2|||
48722504|NCT01895361|156834616|FG001|Overall Study|Physician Decision|2|||
48722505|NCT01895361|156834617|FG002|Overall Study|Physician Decision|2|||
48722506|NCT01895361|156834615|FG000|Overall Study|Withdrawal by Subject|7|||
48722507|NCT01895361|156834616|FG001|Overall Study|Withdrawal by Subject|6|||
48722508|NCT01895361|156834617|FG002|Overall Study|Withdrawal by Subject|6|||
48722509|NCT01895361|156834615|FG000|Overall Study|Lack of Efficacy|0|||
48722510|NCT01895361|156834616|FG001|Overall Study|Lack of Efficacy|1|||
48501225|NCT00824265|156031016|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
48722511|NCT01895361|156834617|FG002|Overall Study|Lack of Efficacy|0|||
48722512|NCT01895361|156834615|FG000|Overall Study|Reasons different from categories above|7|||
48722513|NCT01895361|156834616|FG001|Overall Study|Reasons different from categories above|3|||
48722514|NCT01895361|156834617|FG002|Overall Study|Reasons different from categories above|4|||
48501226|NCT03805438|156032823|FG000|Overall Study|Lack of Efficacy|1|||
48501227|NCT03805438|156032823|FG000|Overall Study|Protocol Violation|1|||
48501228|NCT00419770|156032824|FG000|Overall Study|Withdrawal by Subject|5|||
48501229|NCT00419770|156032825|FG001|Overall Study|Withdrawal by Subject|1|||
48501230|NCT01494506|156032826|FG000|Overall Study|Lack of Efficacy|77|||
48501231|NCT01494506|156032827|FG001|Overall Study|Lack of Efficacy|83|||
48501232|NCT01494506|156032828|FG002|Overall Study|Lack of Efficacy|57|||
48501233|NCT01494506|156032826|FG000|Overall Study|Adverse Event|17|||
48501234|NCT01494506|156032827|FG001|Overall Study|Adverse Event|10|||
48501235|NCT01494506|156032828|FG002|Overall Study|Adverse Event|11|||
48501236|NCT01494506|156032826|FG000|Overall Study|Death|9|||
48501237|NCT01494506|156032827|FG001|Overall Study|Death|5|||
48501238|NCT01494506|156032828|FG002|Overall Study|Death|2|||
48501239|NCT01494506|156032826|FG000|Overall Study|Physician Decision|7|||
48501240|NCT01494506|156032827|FG001|Overall Study|Physician Decision|5|||
48501241|NCT01494506|156032828|FG002|Overall Study|Physician Decision|4|||
48501242|NCT01494506|156032826|FG000|Overall Study|Withdrawal by Subject|17|||
48501243|NCT01494506|156032827|FG001|Overall Study|Withdrawal by Subject|20|||
48501244|NCT01494506|156032828|FG002|Overall Study|Withdrawal by Subject|14|||
48599755|NCT00803712|156391459|FG000|Overall Study|Withdrawal by Subject|2|||
48599756|NCT00803712|156391460|FG001|Overall Study|Withdrawal by Subject|4|||
48599757|NCT00803712|156391459|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
48501245|NCT01494506|156032826|FG000|Overall Study|Clinical Deterioration|21|||
48501246|NCT01494506|156032827|FG001|Overall Study|Clinical Deterioration|17|||
48501247|NCT01494506|156032828|FG002|Overall Study|Clinical Deterioration|13|||
48501248|NCT01494506|156032826|FG000|Overall Study|Sponsor Decision|0|||
48501249|NCT01494506|156032827|FG001|Overall Study|Sponsor Decision|0|||
48501250|NCT01494506|156032828|FG002|Overall Study|Sponsor Decision|1|||
48501251|NCT01494506|156032826|FG000|Overall Study|Other|0|||
48501252|NCT01494506|156032827|FG001|Overall Study|Other|3|||
48501253|NCT01494506|156032828|FG002|Overall Study|Other|1|||
48501254|NCT02848326|156032830|FG000|Treatment Period|Adverse Event|5|||
48501255|NCT02848326|156032831|FG001|Treatment Period|Adverse Event|4|||
48501256|NCT02848326|156032832|FG002|Treatment Period|Adverse Event|11|||
48501257|NCT02848326|156032833|FG003|Treatment Period|Adverse Event|6|||
48501258|NCT02848326|156032834|FG004|Treatment Period|Adverse Event|5|||
48501259|NCT02848326|156032835|FG005|Treatment Period|Adverse Event|7|||
48501260|NCT02848326|156032830|FG000|Treatment Period|Withdrawal of Consent|20|||
48501261|NCT02848326|156032831|FG001|Treatment Period|Withdrawal of Consent|6|||
48501262|NCT02848326|156032832|FG002|Treatment Period|Withdrawal of Consent|9|||
48501263|NCT02848326|156032833|FG003|Treatment Period|Withdrawal of Consent|6|||
48501264|NCT02848326|156032834|FG004|Treatment Period|Withdrawal of Consent|9|||
48501265|NCT02848326|156032835|FG005|Treatment Period|Withdrawal of Consent|6|||
48501266|NCT02848326|156032830|FG000|Treatment Period|Lost to Follow-up|5|||
48501267|NCT02848326|156032831|FG001|Treatment Period|Lost to Follow-up|1|||
48501268|NCT02848326|156032832|FG002|Treatment Period|Lost to Follow-up|11|||
48501269|NCT02848326|156032833|FG003|Treatment Period|Lost to Follow-up|7|||
48501270|NCT02848326|156032834|FG004|Treatment Period|Lost to Follow-up|2|||
48501271|NCT02848326|156032835|FG005|Treatment Period|Lost to Follow-up|3|||
48501272|NCT02848326|156032830|FG000|Treatment Period|Pregnancy|0|||
48501273|NCT02848326|156032831|FG001|Treatment Period|Pregnancy|0|||
48501274|NCT02848326|156032832|FG002|Treatment Period|Pregnancy|1|||
48501275|NCT02848326|156032833|FG003|Treatment Period|Pregnancy|1|||
48501276|NCT02848326|156032834|FG004|Treatment Period|Pregnancy|0|||
48599758|NCT00803712|156391460|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
48722515|NCT03490981|156834618|FG000|Overall Study|Lost to Follow-up|1|||
48722516|NCT03490981|156834619|FG001|Overall Study|Lost to Follow-up|2|||
48722517|NCT00812487|156834620|FG000|Overall Study|Lost to Follow-up|2|||
48722518|NCT00812487|156834621|FG001|Overall Study|Lost to Follow-up|0|||
48722519|NCT00812487|156834620|FG000|Overall Study|Withdrawal by Subject|3|||
48722520|NCT00812487|156834621|FG001|Overall Study|Withdrawal by Subject|2|||
48722521|NCT00812487|156834620|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
48722522|NCT00812487|156834621|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
48722523|NCT00812487|156834620|FG000|Overall Study|Protocol Violation|0|||
48722524|NCT00812487|156834621|FG001|Overall Study|Protocol Violation|1|||
48722525|NCT05498701|156834622|FG000|Period 3|Adverse Event|1|||
48722526|NCT05498701|156834623|FG001|Period 3|Adverse Event|0|||
48722527|NCT02129777|156834630|FG000|Double-Blind Period|Adverse Event|0|||
48722528|NCT02129777|156834631|FG001|Double-Blind Period|Adverse Event|0|||
48722529|NCT02129777|156834632|FG002|Double-Blind Period|Adverse Event|0|||
48722530|NCT02129777|156834633|FG003|Double-Blind Period|Adverse Event|0|||
48722531|NCT02129777|156834634|FG004|Double-Blind Period|Adverse Event|1|||
48722532|NCT02129777|156834635|FG005|Double-Blind Period|Adverse Event|0|||
48722533|NCT02129777|156834636|FG006|Double-Blind Period|Adverse Event|0|||
48722534|NCT02129777|156834630|FG000|Double-Blind Period|Lost to Follow-up|1|||
48722535|NCT02129777|156834631|FG001|Double-Blind Period|Lost to Follow-up|1|||
48722536|NCT02129777|156834632|FG002|Double-Blind Period|Lost to Follow-up|1|||
48722537|NCT02129777|156834633|FG003|Double-Blind Period|Lost to Follow-up|2|||
48501277|NCT02848326|156032835|FG005|Treatment Period|Pregnancy|1|||
48501278|NCT02848326|156032830|FG000|Treatment Period|Protocol Violation|4|||
48501279|NCT02848326|156032831|FG001|Treatment Period|Protocol Violation|3|||
48501280|NCT02848326|156032832|FG002|Treatment Period|Protocol Violation|4|||
48501281|NCT02848326|156032833|FG003|Treatment Period|Protocol Violation|2|||
48501282|NCT02848326|156032834|FG004|Treatment Period|Protocol Violation|3|||
48501283|NCT02848326|156032835|FG005|Treatment Period|Protocol Violation|3|||
48501284|NCT02848326|156032830|FG000|Treatment Period|Non-compliance with Study Drug|4|||
48501285|NCT02848326|156032831|FG001|Treatment Period|Non-compliance with Study Drug|0|||
48501286|NCT02848326|156032832|FG002|Treatment Period|Non-compliance with Study Drug|0|||
48501287|NCT02848326|156032833|FG003|Treatment Period|Non-compliance with Study Drug|1|||
48501288|NCT02848326|156032834|FG004|Treatment Period|Non-compliance with Study Drug|0|||
48501289|NCT02848326|156032835|FG005|Treatment Period|Non-compliance with Study Drug|0|||
48501290|NCT02848326|156032830|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
48501291|NCT02848326|156032831|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
48501292|NCT02848326|156032832|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
48501293|NCT02848326|156032833|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
48722538|NCT02129777|156834634|FG004|Double-Blind Period|Lost to Follow-up|0|||
48722539|NCT02129777|156834635|FG005|Double-Blind Period|Lost to Follow-up|0|||
48722540|NCT02129777|156834636|FG006|Double-Blind Period|Lost to Follow-up|0|||
48722541|NCT02129777|156834630|FG000|Double-Blind Period|Withdrawal by Subject|2|||
48722542|NCT02129777|156834631|FG001|Double-Blind Period|Withdrawal by Subject|4|||
48722543|NCT02129777|156834632|FG002|Double-Blind Period|Withdrawal by Subject|3|||
48722544|NCT02129777|156834633|FG003|Double-Blind Period|Withdrawal by Subject|2|||
48722545|NCT02129777|156834634|FG004|Double-Blind Period|Withdrawal by Subject|3|||
48722546|NCT02129777|156834635|FG005|Double-Blind Period|Withdrawal by Subject|0|||
48722547|NCT02129777|156834636|FG006|Double-Blind Period|Withdrawal by Subject|0|||
48722548|NCT02129777|156834630|FG000|Double-Blind Period|Pregnancy|0|||
48722549|NCT02129777|156834631|FG001|Double-Blind Period|Pregnancy|0|||
48722550|NCT02129777|156834632|FG002|Double-Blind Period|Pregnancy|0|||
48722551|NCT02129777|156834633|FG003|Double-Blind Period|Pregnancy|0|||
48722552|NCT02129777|156834634|FG004|Double-Blind Period|Pregnancy|1|||
48722553|NCT02129777|156834635|FG005|Double-Blind Period|Pregnancy|0|||
48722554|NCT02129777|156834636|FG006|Double-Blind Period|Pregnancy|0|||
48722555|NCT02129777|156834630|FG000|Double-Blind Period|Lack of Efficacy|3|||
48722556|NCT02129777|156834631|FG001|Double-Blind Period|Lack of Efficacy|1|||
48722557|NCT02129777|156834632|FG002|Double-Blind Period|Lack of Efficacy|0|||
48722558|NCT02129777|156834633|FG003|Double-Blind Period|Lack of Efficacy|3|||
48722559|NCT02129777|156834634|FG004|Double-Blind Period|Lack of Efficacy|2|||
48722560|NCT02129777|156834635|FG005|Double-Blind Period|Lack of Efficacy|0|||
48722561|NCT02129777|156834636|FG006|Double-Blind Period|Lack of Efficacy|0|||
48722562|NCT02129777|156834630|FG000|Double-Blind Period|Other|1|||
48722563|NCT02129777|156834631|FG001|Double-Blind Period|Other|2|||
48722564|NCT02129777|156834632|FG002|Double-Blind Period|Other|0|||
48722565|NCT02129777|156834633|FG003|Double-Blind Period|Other|0|||
48722566|NCT02129777|156834634|FG004|Double-Blind Period|Other|0|||
48722567|NCT02129777|156834635|FG005|Double-Blind Period|Other|0|||
48722568|NCT02129777|156834636|FG006|Double-Blind Period|Other|0|||
48722569|NCT02129777|156834630|FG000|Open-Label Period|Lack of Efficacy|0|||
48722570|NCT02129777|156834631|FG001|Open-Label Period|Lack of Efficacy|0|||
48722571|NCT02129777|156834632|FG002|Open-Label Period|Lack of Efficacy|0|||
48722572|NCT02129777|156834633|FG003|Open-Label Period|Lack of Efficacy|0|||
48722573|NCT02129777|156834634|FG004|Open-Label Period|Lack of Efficacy|0|||
48722574|NCT02129777|156834635|FG005|Open-Label Period|Lack of Efficacy|0|||
48722575|NCT02129777|156834636|FG006|Open-Label Period|Lack of Efficacy|5|||
48722576|NCT02129777|156834630|FG000|Open-Label Period|Lost to Follow-up|0|||
48722577|NCT02129777|156834631|FG001|Open-Label Period|Lost to Follow-up|0|||
48722578|NCT02129777|156834632|FG002|Open-Label Period|Lost to Follow-up|0|||
48722579|NCT02129777|156834633|FG003|Open-Label Period|Lost to Follow-up|0|||
48501294|NCT02848326|156032834|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
48501295|NCT02848326|156032835|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
48501296|NCT02848326|156032830|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
48501297|NCT02848326|156032831|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
48722580|NCT02129777|156834634|FG004|Open-Label Period|Lost to Follow-up|0|||
48722581|NCT02129777|156834635|FG005|Open-Label Period|Lost to Follow-up|1|||
48722582|NCT02129777|156834636|FG006|Open-Label Period|Lost to Follow-up|1|||
48722583|NCT02129777|156834630|FG000|Open-Label Period|Withdrawal by Subject|0|||
48722584|NCT02129777|156834631|FG001|Open-Label Period|Withdrawal by Subject|0|||
48722585|NCT02129777|156834632|FG002|Open-Label Period|Withdrawal by Subject|0|||
48722586|NCT02129777|156834633|FG003|Open-Label Period|Withdrawal by Subject|0|||
48722587|NCT02129777|156834634|FG004|Open-Label Period|Withdrawal by Subject|0|||
48722588|NCT02129777|156834635|FG005|Open-Label Period|Withdrawal by Subject|1|||
48722589|NCT02129777|156834636|FG006|Open-Label Period|Withdrawal by Subject|3|||
48722590|NCT02129777|156834630|FG000|Open-Label Period|Study Termination|0|||
48722591|NCT02129777|156834631|FG001|Open-Label Period|Study Termination|0|||
48722592|NCT02129777|156834632|FG002|Open-Label Period|Study Termination|0|||
48501298|NCT02848326|156032832|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
48501299|NCT02848326|156032833|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
48501300|NCT02848326|156032834|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
48501301|NCT02848326|156032835|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
48501302|NCT03093324|156032836|FG000|Overall Study|Adverse Event|4|||
48501303|NCT03093324|156032837|FG001|Overall Study|Adverse Event|15|||
48501304|NCT03093324|156032836|FG000|Overall Study|Lost to Follow-up|1|||
48501305|NCT03093324|156032837|FG001|Overall Study|Lost to Follow-up|0|||
48599759|NCT00803712|156391459|FG000|Overall Study|Protocol criteria (other)|0|||
48599760|NCT00803712|156391460|FG001|Overall Study|Protocol criteria (other)|2|||
48599761|NCT00803712|156391459|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
48599762|NCT00803712|156391460|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
48599763|NCT00803712|156391459|FG000|Overall Study|Administrative decision|2|||
48501306|NCT03093324|156032836|FG000|Overall Study|Protocol Deviation|2|||
48501307|NCT03093324|156032837|FG001|Overall Study|Protocol Deviation|2|||
48501308|NCT03093324|156032836|FG000|Overall Study|Withdrawal by Subject|2|||
48501309|NCT03093324|156032837|FG001|Overall Study|Withdrawal by Subject|2|||
48501310|NCT04473963|156032838|FG000|Overall Study|Withdrawal by Subject|1|||
48501311|NCT04473963|156032839|FG001|Overall Study|Withdrawal by Subject|1|||
48501312|NCT04473963|156032840|FG002|Overall Study|Withdrawal by Subject|0|||
48501313|NCT04473963|156032838|FG000|Overall Study|Not inducible in AF|0|||
48501314|NCT04473963|156032839|FG001|Overall Study|Not inducible in AF|0|||
48501315|NCT04473963|156032840|FG002|Overall Study|Not inducible in AF|2|||
48501316|NCT00414466|156032841|FG000|Overall Study|Adverse Event|0|||
48501317|NCT00414466|156032842|FG001|Overall Study|Adverse Event|0|||
48501318|NCT00414466|156032843|FG002|Overall Study|Adverse Event|1|||
48501319|NCT00414466|156032844|FG003|Overall Study|Adverse Event|1|||
48501320|NCT00414466|156032841|FG000|Overall Study|Lack of Efficacy|1|||
48501321|NCT00414466|156032842|FG001|Overall Study|Lack of Efficacy|0|||
48501322|NCT00414466|156032843|FG002|Overall Study|Lack of Efficacy|0|||
48501323|NCT00414466|156032844|FG003|Overall Study|Lack of Efficacy|0|||
48501324|NCT00414466|156032841|FG000|Overall Study|Withdrawn by Sponsor|1|||
48501325|NCT00414466|156032842|FG001|Overall Study|Withdrawn by Sponsor|0|||
48501326|NCT00414466|156032843|FG002|Overall Study|Withdrawn by Sponsor|0|||
48501327|NCT00414466|156032844|FG003|Overall Study|Withdrawn by Sponsor|0|||
48501328|NCT04526210|156032845|FG000|Overall Study|Sponsor decision|7|||
48501329|NCT04526210|156032846|FG001|Overall Study|Sponsor decision|5|||
48501330|NCT04526210|156032845|FG000|Overall Study|Withdrawal by Subject|3|||
48501331|NCT04526210|156032846|FG001|Overall Study|Withdrawal by Subject|2|||
48501332|NCT02999178|156032847|FG000|Overall Study|Adverse Event|85|||
48501333|NCT02999178|156032848|FG001|Overall Study|Adverse Event|62|||
48501334|NCT02999178|156032847|FG000|Overall Study|Protocol Violation|1|||
48501335|NCT02999178|156032848|FG001|Overall Study|Protocol Violation|2|||
48501336|NCT02999178|156032847|FG000|Overall Study|Lost to Follow-up|0|||
48501337|NCT02999178|156032848|FG001|Overall Study|Lost to Follow-up|2|||
48501338|NCT02999178|156032847|FG000|Overall Study|Withdrawal by Subject|21|||
48501339|NCT02999178|156032848|FG001|Overall Study|Withdrawal by Subject|21|||
48501340|NCT02999178|156032847|FG000|Overall Study|Other reason not defined above|7|||
48501341|NCT02999178|156032848|FG001|Overall Study|Other reason not defined above|13|||
48501342|NCT04176965|156032850|FG000|Overall Study|Death|1|||
48501343|NCT04176965|156032851|FG001|Overall Study|Death|2|||
48501344|NCT04176965|156032850|FG000|Overall Study|Lost to Follow-up|10|||
48501345|NCT04176965|156032851|FG001|Overall Study|Lost to Follow-up|2|||
48501346|NCT04176965|156032850|FG000|Overall Study|Withdrawal by Subject|6|||
48501347|NCT04176965|156032851|FG001|Overall Study|Withdrawal by Subject|1|||
48501348|NCT03903146|156032852|FG000|Overall Study|Lost to Follow-up|6|||
48501349|NCT03903146|156032853|FG001|Overall Study|Lost to Follow-up|4|||
48501350|NCT03903146|156032852|FG000|Overall Study|Withdrawal by Subject|0|||
48501351|NCT03903146|156032853|FG001|Overall Study|Withdrawal by Subject|1|||
48501352|NCT01179048|156032854|FG000|Overall Study|Withdrawn - does not allow contact|4|||
48501353|NCT01179048|156032855|FG001|Overall Study|Withdrawn - does not allow contact|8|||
48501354|NCT01179048|156032854|FG000|Overall Study|Lost to Follow-up|8|||
48501355|NCT01179048|156032855|FG001|Overall Study|Lost to Follow-up|9|||
48501356|NCT01179048|156032854|FG000|Overall Study|Alive|127|||
48501357|NCT01179048|156032855|FG001|Overall Study|Alive|142|||
48501358|NCT01900730|156032856|FG000|Overall Study|Withdrawal by Subject|1|||
48501359|NCT01900730|156032857|FG001|Overall Study|Withdrawal by Subject|0|||
48501360|NCT01900730|156032856|FG000|Overall Study|Screen Failure|1|||
48501361|NCT01900730|156032857|FG001|Overall Study|Screen Failure|0|||
48501362|NCT00051025|156032858|FG000|Overall Study|Progressive Disease|1|||
48501363|NCT00051025|156032859|FG001|Overall Study|Progressive Disease|1|||
48501364|NCT00051025|156032858|FG000|Overall Study|Adverse Event|1|||
48501365|NCT00051025|156032859|FG001|Overall Study|Adverse Event|1|||
48501366|NCT00051025|156032858|FG000|Overall Study|Withdrawal by Subject|0|||
48501367|NCT00051025|156032859|FG001|Overall Study|Withdrawal by Subject|1|||
48501368|NCT00051025|156032858|FG000|Overall Study|Death|0|||
48501369|NCT00051025|156032859|FG001|Overall Study|Death|1|||
48501370|NCT00386009|156032862|FG000|Overall Study|Adverse Event|0|||
48501371|NCT00386009|156032863|FG001|Overall Study|Adverse Event|2|||
48501372|NCT00386009|156032862|FG000|Overall Study|Death|1|||
48501373|NCT00386009|156032863|FG001|Overall Study|Death|0|||
48501374|NCT00386009|156032862|FG000|Overall Study|Entry Criteria Not Met|0|||
48501375|NCT00386009|156032863|FG001|Overall Study|Entry Criteria Not Met|2|||
48501376|NCT00386009|156032862|FG000|Overall Study|Lost to Follow-up|1|||
48501377|NCT00386009|156032863|FG001|Overall Study|Lost to Follow-up|1|||
48501378|NCT00386009|156032862|FG000|Overall Study|Protocol Violation|1|||
48501379|NCT00386009|156032863|FG001|Overall Study|Protocol Violation|0|||
48501380|NCT00386009|156032862|FG000|Overall Study|Sponsor Decision|1|||
48501381|NCT00386009|156032863|FG001|Overall Study|Sponsor Decision|1|||
48501382|NCT00386009|156032862|FG000|Overall Study|Withdrawal by Subject|5|||
48501383|NCT00386009|156032863|FG001|Overall Study|Withdrawal by Subject|4|||
48501384|NCT01626079|156032865|FG000|Overall Study|Death|167|||
48501385|NCT01626079|156032866|FG001|Overall Study|Death|192|||
48501386|NCT01626079|156032867|FG002|Overall Study|Death|39|||
48501387|NCT01626079|156032865|FG000|Overall Study|Withdrawal by Subject|23|||
48501388|NCT01626079|156032866|FG001|Overall Study|Withdrawal by Subject|37|||
48501389|NCT01626079|156032867|FG002|Overall Study|Withdrawal by Subject|5|||
48501390|NCT01626079|156032865|FG000|Overall Study|Lost to Follow-up|7|||
48501391|NCT01626079|156032866|FG001|Overall Study|Lost to Follow-up|4|||
48501392|NCT01626079|156032867|FG002|Overall Study|Lost to Follow-up|2|||
48501393|NCT01626079|156032865|FG000|Overall Study|Missed Visits|1|||
48501394|NCT01626079|156032866|FG001|Overall Study|Missed Visits|4|||
48501395|NCT01626079|156032867|FG002|Overall Study|Missed Visits|6|||
48501396|NCT01239121|156032868|FG000|Overall Study|Withdrawal by Subject|2|||
48501397|NCT01239121|156032869|FG001|Overall Study|Withdrawal by Subject|4|||
48501398|NCT01239121|156032870|FG002|Overall Study|Withdrawal by Subject|0|||
48501399|NCT00418184|156032871|FG000|Double-blind Phase|Withdrawal by Subject|22|||
48501400|NCT00418184|156032872|FG001|Double-blind Phase|Withdrawal by Subject|9|||
48501401|NCT00418184|156032871|FG000|Double-blind Phase|Adverse Event|2|||
48501402|NCT00418184|156032872|FG001|Double-blind Phase|Adverse Event|1|||
48501403|NCT00418184|156032871|FG000|Double-blind Phase|Poor compliance|3|||
48501404|NCT00418184|156032872|FG001|Double-blind Phase|Poor compliance|1|||
48501405|NCT04088760|156032873|FG000|Overall Study|Physician Decision|1|||
48501406|NCT00320112|156032877|FG000|Overall Study|Lost to Follow-up|3|||
48501407|NCT00320112|156032878|FG001|Overall Study|Lost to Follow-up|4|||
48501408|NCT00320112|156032877|FG000|Overall Study|Withdrawal by Subject|3|||
48501409|NCT00320112|156032878|FG001|Overall Study|Withdrawal by Subject|0|||
48501410|NCT00320112|156032877|FG000|Overall Study|Death|2|||
48501411|NCT00320112|156032878|FG001|Overall Study|Death|1|||
48501412|NCT01391793|156032879|FG000|Overall Study|Ineligible|3|||
48501413|NCT01391793|156032880|FG001|Overall Study|Ineligible|0|||
48501414|NCT01391793|156032879|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
48501415|NCT01391793|156032880|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
48501416|NCT01391793|156032879|FG000|Overall Study|No DMSA|73|||
48501417|NCT01391793|156032880|FG001|Overall Study|No DMSA|57|||
48501418|NCT00150462|156032881|FG000|Overall Study|Disease Progression or Relapse|3|||
48501419|NCT00150462|156032882|FG001|Overall Study|Disease Progression or Relapse|1|||
48501420|NCT00150462|156032883|FG002|Overall Study|Disease Progression or Relapse|2|||
48501421|NCT00150462|156032884|FG003|Overall Study|Disease Progression or Relapse|1|||
48501422|NCT00150462|156032885|FG004|Overall Study|Disease Progression or Relapse|2|||
48501423|NCT00150462|156032886|FG005|Overall Study|Disease Progression or Relapse|2|||
48501424|NCT00150462|156032887|FG006|Overall Study|Disease Progression or Relapse|3|||
48501425|NCT00150462|156032888|FG007|Overall Study|Disease Progression or Relapse|5|||
48501426|NCT00150462|156032889|FG008|Overall Study|Disease Progression or Relapse|5|||
48501427|NCT00150462|156032890|FG009|Overall Study|Disease Progression or Relapse|3|||
48501428|NCT00150462|156032891|FG010|Overall Study|Disease Progression or Relapse|2|||
48501429|NCT00150462|156032881|FG000|Overall Study|Withdrawal by Subject|0|||
48501430|NCT00150462|156032882|FG001|Overall Study|Withdrawal by Subject|1|||
48501431|NCT00150462|156032883|FG002|Overall Study|Withdrawal by Subject|1|||
48501432|NCT00150462|156032884|FG003|Overall Study|Withdrawal by Subject|0|||
48501433|NCT00150462|156032885|FG004|Overall Study|Withdrawal by Subject|1|||
48501434|NCT00150462|156032886|FG005|Overall Study|Withdrawal by Subject|2|||
48501435|NCT00150462|156032887|FG006|Overall Study|Withdrawal by Subject|0|||
48501436|NCT00150462|156032888|FG007|Overall Study|Withdrawal by Subject|1|||
48501437|NCT00150462|156032889|FG008|Overall Study|Withdrawal by Subject|0|||
48501438|NCT00150462|156032890|FG009|Overall Study|Withdrawal by Subject|1|||
48501439|NCT00150462|156032891|FG010|Overall Study|Withdrawal by Subject|0|||
48501440|NCT00150462|156032881|FG000|Overall Study|Death|0|||
48501441|NCT00150462|156032882|FG001|Overall Study|Death|1|||
48722593|NCT02129777|156834633|FG003|Open-Label Period|Study Termination|0|||
48501442|NCT00150462|156032883|FG002|Overall Study|Death|0|||
48501443|NCT00150462|156032884|FG003|Overall Study|Death|0|||
48501444|NCT00150462|156032885|FG004|Overall Study|Death|0|||
48501445|NCT00150462|156032886|FG005|Overall Study|Death|0|||
48501446|NCT00150462|156032887|FG006|Overall Study|Death|0|||
48501447|NCT00150462|156032888|FG007|Overall Study|Death|0|||
48501448|NCT00150462|156032889|FG008|Overall Study|Death|1|||
48501449|NCT00150462|156032890|FG009|Overall Study|Death|0|||
48501450|NCT00150462|156032891|FG010|Overall Study|Death|0|||
48501451|NCT00150462|156032881|FG000|Overall Study|Adverse Event|0|||
48501452|NCT00150462|156032882|FG001|Overall Study|Adverse Event|0|||
48501453|NCT00150462|156032883|FG002|Overall Study|Adverse Event|0|||
48501454|NCT00150462|156032884|FG003|Overall Study|Adverse Event|1|||
48501455|NCT00150462|156032885|FG004|Overall Study|Adverse Event|0|||
48501456|NCT00150462|156032886|FG005|Overall Study|Adverse Event|0|||
48501457|NCT00150462|156032887|FG006|Overall Study|Adverse Event|0|||
48501458|NCT00150462|156032888|FG007|Overall Study|Adverse Event|2|||
48501459|NCT00150462|156032889|FG008|Overall Study|Adverse Event|0|||
48501460|NCT00150462|156032890|FG009|Overall Study|Adverse Event|1|||
48501461|NCT00150462|156032891|FG010|Overall Study|Adverse Event|0|||
48501462|NCT00150462|156032881|FG000|Overall Study|Physician Decision|0|||
48501463|NCT00150462|156032882|FG001|Overall Study|Physician Decision|0|||
48501464|NCT00150462|156032883|FG002|Overall Study|Physician Decision|1|||
48501465|NCT00150462|156032884|FG003|Overall Study|Physician Decision|1|||
48501466|NCT00150462|156032885|FG004|Overall Study|Physician Decision|0|||
48501467|NCT00150462|156032886|FG005|Overall Study|Physician Decision|0|||
48501468|NCT00150462|156032887|FG006|Overall Study|Physician Decision|0|||
48501469|NCT00150462|156032888|FG007|Overall Study|Physician Decision|0|||
48501470|NCT00150462|156032889|FG008|Overall Study|Physician Decision|0|||
48501471|NCT00150462|156032890|FG009|Overall Study|Physician Decision|0|||
48501472|NCT00150462|156032891|FG010|Overall Study|Physician Decision|0|||
48501473|NCT00150462|156032881|FG000|Overall Study|Other|0|||
48501474|NCT00150462|156032882|FG001|Overall Study|Other|0|||
48501475|NCT00150462|156032883|FG002|Overall Study|Other|0|||
48501476|NCT00150462|156032884|FG003|Overall Study|Other|0|||
48501477|NCT00150462|156032885|FG004|Overall Study|Other|0|||
48501478|NCT00150462|156032886|FG005|Overall Study|Other|0|||
48501479|NCT00150462|156032887|FG006|Overall Study|Other|0|||
48501480|NCT00150462|156032888|FG007|Overall Study|Other|0|||
48501481|NCT00150462|156032889|FG008|Overall Study|Other|0|||
48501482|NCT00150462|156032890|FG009|Overall Study|Other|1|||
48501483|NCT00150462|156032891|FG010|Overall Study|Other|1|||
48501484|NCT00569374|156032894|FG000|Overall Study|Withdrawal by Subject|4|||
48501485|NCT01666730|156032895|FG000|Overall Study|Adverse Event|16|||
48501486|NCT01666730|156032895|FG000|Overall Study|Death|2|||
48501487|NCT01666730|156032895|FG000|Overall Study|Physician Decision|5|||
48501488|NCT01666730|156032895|FG000|Overall Study|Withdrawal by Subject|9|||
48501489|NCT01666730|156032895|FG000|Overall Study|Disease progression/relapse|18|||
48501490|NCT04719390|156032896|FG000|Overall Study|Withdrawal by Subject|1|||
48501491|NCT01874353|156032897|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
48501492|NCT01874353|156032898|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
48501493|NCT01874353|156032899|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
48501494|NCT01874353|156032900|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
48501495|NCT01874353|156032897|FG000|Overall Study|Lost to Follow-up|2|||
48501496|NCT01874353|156032898|FG001|Overall Study|Lost to Follow-up|2|||
48501497|NCT01874353|156032899|FG002|Overall Study|Lost to Follow-up|2|||
48501498|NCT01874353|156032900|FG003|Overall Study|Lost to Follow-up|0|||
48501499|NCT01874353|156032897|FG000|Overall Study|Death|110|||
48501500|NCT01874353|156032898|FG001|Overall Study|Death|60|||
48501501|NCT01874353|156032899|FG002|Overall Study|Death|13|||
48501502|NCT01874353|156032900|FG003|Overall Study|Death|7|||
48501503|NCT01874353|156032897|FG000|Overall Study|Withdrawal by Subject|13|||
48501504|NCT01874353|156032898|FG001|Overall Study|Withdrawal by Subject|11|||
48501505|NCT01874353|156032899|FG002|Overall Study|Withdrawal by Subject|0|||
48501506|NCT01874353|156032900|FG003|Overall Study|Withdrawal by Subject|0|||
48501507|NCT01457053|156032901|FG000|Overall Study|Unable to undergo selected treatment|1|||
48501508|NCT01457053|156032902|FG001|Overall Study|Unable to undergo selected treatment|1|||
48501509|NCT04638153|156032903|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48501510|NCT04638153|156032904|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48501511|NCT04638153|156032905|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48501512|NCT04638153|156032903|FG000|Overall Study|Study terminated by sponsor|4|||
48501513|NCT04638153|156032904|FG001|Overall Study|Study terminated by sponsor|2|||
48501514|NCT04638153|156032905|FG002|Overall Study|Study terminated by sponsor|14|||
48501515|NCT03839940|156032911|FG000|Overall Study|Withdrawal by Subject|3|||
48501516|NCT03839940|156032912|FG001|Overall Study|Withdrawal by Subject|0|||
48599764|NCT00803712|156391460|FG001|Overall Study|Administrative decision|3|||
48501517|NCT03839940|156032911|FG000|Overall Study|Protocol Violation|0|||
48501518|NCT03839940|156032912|FG001|Overall Study|Protocol Violation|1|||
48501519|NCT03839940|156032911|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
48501520|NCT03839940|156032912|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
48501521|NCT00814463|156032914|FG000|Overall Study|Lost to Follow-up|1|||
48501522|NCT03023410|156032915|FG000|Overall Study|study termination|0|||
48501523|NCT03023410|156032916|FG001|Overall Study|study termination|1|||
48501524|NCT01370408|156032917|FG000|Overall Study|treatment failure|9|||
48501525|NCT01434693|156032918|FG000|Overall Study|Adverse Event|1|||
48501526|NCT01434693|156032919|FG001|Overall Study|Adverse Event|0|||
48501527|NCT01434693|156032920|FG002|Overall Study|Adverse Event|0|||
48501528|NCT01434693|156032921|FG003|Overall Study|Adverse Event|0|||
48501529|NCT01434693|156032918|FG000|Overall Study|Withdrawal by Subject|1|||
48501530|NCT01434693|156032919|FG001|Overall Study|Withdrawal by Subject|0|||
48501531|NCT01434693|156032920|FG002|Overall Study|Withdrawal by Subject|1|||
48501532|NCT01434693|156032921|FG003|Overall Study|Withdrawal by Subject|1|||
48501533|NCT01434693|156032918|FG000|Overall Study|Lost to Follow-up|1|||
48501534|NCT01434693|156032919|FG001|Overall Study|Lost to Follow-up|0|||
48501535|NCT01434693|156032920|FG002|Overall Study|Lost to Follow-up|0|||
48501536|NCT01434693|156032921|FG003|Overall Study|Lost to Follow-up|0|||
48501537|NCT00854308|156032923|FG000|Overall Study|Disease progression|42|||
48501538|NCT00854308|156032924|FG001|Overall Study|Disease progression|50|||
48501539|NCT00854308|156032923|FG000|Overall Study|Adverse Event|8|||
48501540|NCT00854308|156032924|FG001|Overall Study|Adverse Event|3|||
48501541|NCT00854308|156032923|FG000|Overall Study|Death|2|||
48501542|NCT00854308|156032924|FG001|Overall Study|Death|5|||
48501543|NCT00854308|156032923|FG000|Overall Study|Physician Decision|6|||
48501544|NCT00854308|156032924|FG001|Overall Study|Physician Decision|6|||
48501545|NCT00854308|156032923|FG000|Overall Study|Withdrawal by Subject|4|||
48501546|NCT00854308|156032924|FG001|Overall Study|Withdrawal by Subject|2|||
48599765|NCT00803712|156391459|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
48599766|NCT00803712|156391460|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
48599767|NCT02699996|156391468|FG000|Overall Study|Withdrawal by Subject|5|||
48599768|NCT02699996|156391469|FG001|Overall Study|Withdrawal by Subject|2|||
48599769|NCT04194489|156391471|FG000|Overall Study|Withdrawal by Subject|5|||
48722594|NCT02129777|156834634|FG004|Open-Label Period|Study Termination|0|||
48722595|NCT02129777|156834635|FG005|Open-Label Period|Study Termination|10|||
48501547|NCT00854308|156032923|FG000|Overall Study|Sponsor's decision to terminate study|0|||
48501548|NCT00854308|156032924|FG001|Overall Study|Sponsor's decision to terminate study|1|||
48501549|NCT02781727|156032927|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
48501550|NCT02781727|156032928|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
48501551|NCT02781727|156032927|FG000|Treatment Period|Withdrawal by Subject|1|||
48501552|NCT02781727|156032928|FG001|Treatment Period|Withdrawal by Subject|0|||
48501553|NCT02781727|156032927|FG000|Treatment Period|Lost to Follow-up|0|||
48501554|NCT02781727|156032928|FG001|Treatment Period|Lost to Follow-up|1|||
48501555|NCT02193178|156032929|FG000|Overall Study|Lost to Follow-up|1|||
48501556|NCT02193178|156032929|FG000|Overall Study|Dry eyes|1|||
48501557|NCT01790568|156032933|FG000|Overall Study|Progression prior to transplant|0|||
48501558|NCT01790568|156032934|FG001|Overall Study|Progression prior to transplant|1|||
48501559|NCT00352690|156032935|FG000|Overall Study|Determined to be ineligible|2|||
48599770|NCT04194489|156391471|FG000|Overall Study|Lost to Follow-up|48|||
48599771|NCT02630563|156391482|FG000|Overall Study|Administrative|1|||
48501560|NCT00352690|156032936|FG001|Overall Study|Determined to be ineligible|0|||
48501561|NCT01059903|156032937|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
48501562|NCT01059903|156032938|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
48501563|NCT03262012|156032939|FG000|Overall Study|Withdrawal by Subject|15|||
48501564|NCT03262012|156032940|FG001|Overall Study|Withdrawal by Subject|13|||
48501565|NCT03262012|156032941|FG002|Overall Study|Withdrawal by Subject|8|||
48722596|NCT02129777|156834636|FG006|Open-Label Period|Study Termination|39|||
48722597|NCT03485495|156834637|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
48501566|NCT03262012|156032942|FG003|Overall Study|Withdrawal by Subject|7|||
48501567|NCT03262012|156032939|FG000|Overall Study|Adverse Event|10|||
48501568|NCT03262012|156032940|FG001|Overall Study|Adverse Event|12|||
48501569|NCT03262012|156032941|FG002|Overall Study|Adverse Event|4|||
48501570|NCT03262012|156032942|FG003|Overall Study|Adverse Event|6|||
48722598|NCT03485495|156834638|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
48722599|NCT00924170|156834639|FG000|Overall Study|Refused further treatment|0|||
48722600|NCT00924170|156834640|FG001|Overall Study|Refused further treatment|1|||
48722601|NCT00924170|156834639|FG000|Overall Study|Physician Decision|0|||
48722602|NCT00924170|156834640|FG001|Overall Study|Physician Decision|1|||
48722603|NCT00924170|156834639|FG000|Overall Study|Progressive disease|3|||
48722604|NCT00924170|156834640|FG001|Overall Study|Progressive disease|6|||
48722605|NCT00924170|156834639|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
48722606|NCT00924170|156834640|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
48722607|NCT00924170|156834639|FG000|Overall Study|Death|1|||
48722608|NCT00924170|156834640|FG001|Overall Study|Death|0|||
48722609|NCT05499377|156834641|FG000|Overall Study|Withdrawal by Subject|2|||
48501571|NCT03262012|156032939|FG000|Overall Study|Physician Decision|2|||
48501572|NCT03262012|156032940|FG001|Overall Study|Physician Decision|5|||
48501573|NCT03262012|156032941|FG002|Overall Study|Physician Decision|1|||
48501574|NCT03262012|156032942|FG003|Overall Study|Physician Decision|0|||
48722610|NCT05499377|156834642|FG001|Overall Study|Withdrawal by Subject|0|||
48722611|NCT05499377|156834641|FG000|Overall Study|Physician Decision|1|||
48722612|NCT05499377|156834642|FG001|Overall Study|Physician Decision|0|||
48501575|NCT03262012|156032939|FG000|Overall Study|Lack of Efficacy|0|||
48501576|NCT03262012|156032940|FG001|Overall Study|Lack of Efficacy|5|||
48501577|NCT03262012|156032941|FG002|Overall Study|Lack of Efficacy|1|||
48501578|NCT03262012|156032942|FG003|Overall Study|Lack of Efficacy|2|||
48501579|NCT03262012|156032939|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
48501580|NCT03262012|156032940|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
48501581|NCT03262012|156032941|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
48501582|NCT03262012|156032942|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
48501583|NCT00463606|156032945|FG000|Overall Study|Adverse Event|21|||
48501584|NCT00463606|156032946|FG001|Overall Study|Adverse Event|18|||
48501585|NCT00463606|156032947|FG002|Overall Study|Adverse Event|11|||
48501586|NCT00463606|156032945|FG000|Overall Study|Withdrawal by Subject|11|||
48501587|NCT00463606|156032946|FG001|Overall Study|Withdrawal by Subject|11|||
48501588|NCT00463606|156032947|FG002|Overall Study|Withdrawal by Subject|5|||
48501589|NCT00463606|156032945|FG000|Overall Study|Lost to Follow-up|2|||
48501590|NCT00463606|156032946|FG001|Overall Study|Lost to Follow-up|2|||
48722613|NCT04776317|156834643|FG000|Overall Study|Physician Decision|0|||
48722614|NCT04776317|156834644|FG001|Overall Study|Physician Decision|1|||
48722615|NCT04776317|156834645|FG002|Overall Study|Physician Decision|0|||
48722616|NCT04776317|156834646|FG003|Overall Study|Physician Decision|0|||
48722617|NCT04776317|156834647|FG004|Overall Study|Physician Decision|0|||
48722618|NCT04776317|156834648|FG005|Overall Study|Physician Decision|0|||
48722619|NCT04776317|156834649|FG006|Overall Study|Physician Decision|0|||
48722620|NCT04776317|156834650|FG007|Overall Study|Physician Decision|0|||
48817267|NCT00209027|157173656|FG001|Overall Study|study terminated|0|||
48817268|NCT05546411|157173657|FG000|Overall Study|Progressive Disease|1|||
48817269|NCT05546411|157173658|FG001|Overall Study|Progressive Disease|0|||
48817270|NCT05546411|157173657|FG000|Overall Study|Adverse Event|0|||
48817271|NCT05546411|157173658|FG001|Overall Study|Adverse Event|1|||
48817272|NCT05546411|157173657|FG000|Overall Study|Metastatic disease|1|||
48817273|NCT05546411|157173658|FG001|Overall Study|Metastatic disease|0|||
48817274|NCT00776100|157173659|FG000|Overall Study|Disease Progression|1|||
48817275|NCT00776100|157173660|FG001|Overall Study|Disease Progression|0|||
48817276|NCT02148718|157173661|FG000|Overall Study|Protocol Violation|26|||
48817277|NCT02148718|157173661|FG000|Overall Study|Discontinued Study Prematurely|5|||
48722621|NCT04776317|156834651|FG008|Overall Study|Physician Decision|0|||
48722622|NCT04776317|156834652|FG009|Overall Study|Physician Decision|0|||
48722623|NCT04776317|156834653|FG010|Overall Study|Physician Decision|0|||
48817278|NCT00003509|157173662|FG000|Overall Study|Not evaluable|5|||
48722624|NCT04776317|156834654|FG011|Overall Study|Physician Decision|0|||
48722625|NCT04776317|156834655|FG012|Overall Study|Physician Decision|0|||
48722626|NCT04776317|156834656|FG013|Overall Study|Physician Decision|0|||
48722627|NCT04776317|156834657|FG014|Overall Study|Physician Decision|0|||
48722628|NCT04776317|156834643|FG000|Overall Study|Protocol Violation|0|||
48722629|NCT04776317|156834644|FG001|Overall Study|Protocol Violation|0|||
48722630|NCT04776317|156834645|FG002|Overall Study|Protocol Violation|1|||
48722631|NCT04776317|156834646|FG003|Overall Study|Protocol Violation|0|||
48722632|NCT04776317|156834647|FG004|Overall Study|Protocol Violation|0|||
48722633|NCT04776317|156834648|FG005|Overall Study|Protocol Violation|0|||
48722634|NCT04776317|156834649|FG006|Overall Study|Protocol Violation|0|||
48722635|NCT04776317|156834650|FG007|Overall Study|Protocol Violation|0|||
48722636|NCT04776317|156834651|FG008|Overall Study|Protocol Violation|0|||
48722637|NCT04776317|156834652|FG009|Overall Study|Protocol Violation|0|||
48722638|NCT04776317|156834653|FG010|Overall Study|Protocol Violation|0|||
48722639|NCT04776317|156834654|FG011|Overall Study|Protocol Violation|0|||
48722640|NCT04776317|156834655|FG012|Overall Study|Protocol Violation|0|||
48722641|NCT04776317|156834656|FG013|Overall Study|Protocol Violation|0|||
48501591|NCT00463606|156032947|FG002|Overall Study|Lost to Follow-up|3|||
48501592|NCT00463606|156032945|FG000|Overall Study|Subject noncompliance|1|||
48817279|NCT02107443|157173663|FG000|Overall Study|Death|42|||
48501593|NCT00463606|156032946|FG001|Overall Study|Subject noncompliance|1|||
48501594|NCT00463606|156032947|FG002|Overall Study|Subject noncompliance|0|||
48501595|NCT00463606|156032945|FG000|Overall Study|Subject moved out of town|1|||
48501596|NCT00463606|156032946|FG001|Overall Study|Subject moved out of town|0|||
48501597|NCT00463606|156032947|FG002|Overall Study|Subject moved out of town|0|||
48501598|NCT00463606|156032945|FG000|Overall Study|Physician Decision|0|||
48501599|NCT00463606|156032946|FG001|Overall Study|Physician Decision|1|||
48501600|NCT00463606|156032947|FG002|Overall Study|Physician Decision|0|||
48501601|NCT00463606|156032945|FG000|Overall Study|Sponsor request|0|||
48501602|NCT00463606|156032946|FG001|Overall Study|Sponsor request|1|||
48501603|NCT00463606|156032947|FG002|Overall Study|Sponsor request|0|||
48501604|NCT00463606|156032945|FG000|Overall Study|Exclusion criteria violation|2|||
48722642|NCT04776317|156834657|FG014|Overall Study|Protocol Violation|0|||
48722643|NCT04776317|156834643|FG000|Overall Study|Withdrawal by Subject|0|||
48722644|NCT04776317|156834644|FG001|Overall Study|Withdrawal by Subject|0|||
48722645|NCT04776317|156834645|FG002|Overall Study|Withdrawal by Subject|0|||
48817280|NCT02107443|157173664|FG001|Overall Study|Death|30|||
48501605|NCT00463606|156032946|FG001|Overall Study|Exclusion criteria violation|0|||
48722646|NCT04776317|156834646|FG003|Overall Study|Withdrawal by Subject|0|||
48722647|NCT04776317|156834647|FG004|Overall Study|Withdrawal by Subject|1|||
48817281|NCT02107443|157173663|FG000|Overall Study|Study Protocol Violation|3|||
48501606|NCT00463606|156032947|FG002|Overall Study|Exclusion criteria violation|0|||
48501607|NCT00463606|156032945|FG000|Overall Study|Coordinator error|1|||
48501608|NCT00463606|156032946|FG001|Overall Study|Coordinator error|0|||
48817282|NCT02107443|157173664|FG001|Overall Study|Study Protocol Violation|1|||
48817283|NCT02107443|157173663|FG000|Overall Study|Registered but Not Eligible|0|||
48817284|NCT02107443|157173664|FG001|Overall Study|Registered but Not Eligible|1|||
48817285|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
48817286|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
48817287|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
48817288|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
48817289|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Changed Mind|2|||
48817290|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Changed Mind|0|||
48817291|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
48817292|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
48817293|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
48817294|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
48817295|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
48817296|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
48817297|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
48817298|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
48817299|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Other Medical|9|||
48817300|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Other Medical|5|||
48817301|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Disease Progression|4|||
48817302|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Disease Progression|2|||
48817303|NCT02107443|157173663|FG000|Overall Study|Withdrawal: Personal Issues|0|||
48817304|NCT02107443|157173664|FG001|Overall Study|Withdrawal: Personal Issues|3|||
48817305|NCT03428815|157173673|FG000|Overall Study|Lost to Follow-up|2|||
48817306|NCT03428815|157173674|FG001|Overall Study|Lost to Follow-up|2|||
48817307|NCT03428815|157173673|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
48817308|NCT03428815|157173674|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
48817309|NCT03428815|157173673|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
48817310|NCT03428815|157173674|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
48817311|NCT00209274|157173675|FG000|Overall Study|Missed visit|3|||
48817312|NCT00209274|157173676|FG001|Overall Study|Missed visit|2|||
48817313|NCT00209274|157173675|FG000|Overall Study|Death|32|||
48817314|NCT00209274|157173676|FG001|Overall Study|Death|15|||
48817315|NCT00209274|157173675|FG000|Overall Study|Withdrawal by Subject|30|||
48817316|NCT00209274|157173676|FG001|Overall Study|Withdrawal by Subject|15|||
48817317|NCT00209274|157173675|FG000|Overall Study|Randomized not treated (RNT)|6|||
48817318|NCT00209274|157173676|FG001|Overall Study|Randomized not treated (RNT)|15|||
48817319|NCT00386308|157175123|FG000|Overall Study|Adverse Event|3|||
48817320|NCT00386308|157175124|FG001|Overall Study|Adverse Event|3|||
48817321|NCT00386308|157175123|FG000|Overall Study|Protocol Violation|2|||
48817322|NCT00386308|157175124|FG001|Overall Study|Protocol Violation|5|||
48817323|NCT00386308|157175123|FG000|Overall Study|Lack of Efficacy|0|||
48817324|NCT00386308|157175124|FG001|Overall Study|Lack of Efficacy|2|||
48817325|NCT00386308|157175123|FG000|Overall Study|Lost to Follow-up|10|||
48501609|NCT00463606|156032947|FG002|Overall Study|Coordinator error|0|||
48501610|NCT00463606|156032945|FG000|Overall Study|Patient randomized in error|1|||
48501611|NCT00463606|156032946|FG001|Overall Study|Patient randomized in error|0|||
48501612|NCT00463606|156032947|FG002|Overall Study|Patient randomized in error|0|||
48501613|NCT00463606|156032945|FG000|Overall Study|Participation in another ABT-335 trial|1|||
48501614|NCT00463606|156032946|FG001|Overall Study|Participation in another ABT-335 trial|0|||
48501615|NCT00463606|156032947|FG002|Overall Study|Participation in another ABT-335 trial|0|||
48501616|NCT00463606|156032945|FG000|Overall Study|Protocol Violation|0|||
48501617|NCT00463606|156032946|FG001|Overall Study|Protocol Violation|0|||
48501618|NCT00463606|156032947|FG002|Overall Study|Protocol Violation|1|||
48501619|NCT01223365|156032949|FG000|Open-label Titration Period|Enrolled but not treated|1|||
48817326|NCT00386308|157175124|FG001|Overall Study|Lost to Follow-up|6|||
48501620|NCT01223365|156032949|FG000|Open-label Titration Period|Adverse Event|23|||
48501621|NCT01223365|156032949|FG000|Open-label Titration Period|Lack of Efficacy|3|||
48501622|NCT01223365|156032949|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
48501623|NCT01223365|156032949|FG000|Open-label Titration Period|Protocol Violation|1|||
48501624|NCT01223365|156032949|FG000|Open-label Titration Period|Lost to Follow-up|2|||
48501625|NCT01223365|156032949|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
48501626|NCT01223365|156032949|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
48501627|NCT01223365|156032949|FG000|Open-label Titration Period|Starting physical therapy|1|||
48817327|NCT00386308|157175123|FG000|Overall Study|Withdrawal by Subject|6|||
48817328|NCT00386308|157175124|FG001|Overall Study|Withdrawal by Subject|2|||
48817329|NCT00386308|157175123|FG000|Overall Study|Other Event|8|||
48817330|NCT00386308|157175124|FG001|Overall Study|Other Event|1|||
48817331|NCT04814186|157175125|FG000|Treatment Phase|Adverse Event|1|||
48817332|NCT04814186|157175125|FG000|Treatment Phase|Death|6|||
48817333|NCT04814186|157175125|FG000|Treatment Phase|Withdrawal by Subject|2|||
48817334|NCT04814186|157175125|FG000|Treatment Phase|Other|1|||
48817335|NCT04814186|157175125|FG000|Follow-Up Phase|Adverse Event|1|||
48817336|NCT04814186|157175125|FG000|Follow-Up Phase|Death|6|||
48817337|NCT04814186|157175125|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
48817338|NCT04814186|157175125|FG000|Follow-Up Phase|Other|1|||
48817339|NCT03122886|157175133|FG000|Overall Study|Withdrawal by Subject|1|||
48817340|NCT03122886|157175134|FG001|Overall Study|Withdrawal by Subject|2|||
48817341|NCT01167179|157175139|FG000|Overall Study|disease recurrence|4|||
48817342|NCT01167179|157175140|FG001|Overall Study|disease recurrence|4|||
48817343|NCT01167179|157175139|FG000|Overall Study|Death|4|||
48817344|NCT01167179|157175140|FG001|Overall Study|Death|10|||
48817345|NCT01167179|157175139|FG000|Overall Study|Withdrawal by Subject|1|||
48817346|NCT01167179|157175140|FG001|Overall Study|Withdrawal by Subject|2|||
48817347|NCT01167179|157175139|FG000|Overall Study|diverse|6|||
48501628|NCT01223365|156032949|FG000|Open-label Treatment Period|Adverse Event|39|||
48501629|NCT01223365|156032949|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
48501630|NCT01223365|156032949|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
48501631|NCT01223365|156032949|FG000|Open-label Treatment Period|Protocol Violation|15|||
48501632|NCT01223365|156032949|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
48501633|NCT01223365|156032949|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
48501634|NCT01223365|156032949|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
48501635|NCT01223365|156032949|FG000|Open-label Treatment Period|Moved out of area|2|||
48501636|NCT01223365|156032949|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
48501637|NCT01223365|156032949|FG000|Open-label Treatment Period|"Out of window"|1|||
48501638|NCT01223365|156032949|FG000|Open-label Treatment Period|Starting physical therapy|1|||
48501639|NCT01223365|156032949|FG000|Open-label Treatment Period|Physician Decision|2|||
48501640|NCT01949662|156032950|FG000|Overall Study|Death|9|||
48501641|NCT01949662|156032951|FG001|Overall Study|Death|7|||
48501642|NCT01949662|156032950|FG000|Overall Study|Discharged before an agitation event|8|||
48501643|NCT01949662|156032951|FG001|Overall Study|Discharged before an agitation event|3|||
48722648|NCT04776317|156834648|FG005|Overall Study|Withdrawal by Subject|0|||
48722649|NCT04776317|156834649|FG006|Overall Study|Withdrawal by Subject|0|||
48501644|NCT01949662|156032950|FG000|Overall Study|Dropped out|1|||
48501645|NCT01949662|156032951|FG001|Overall Study|Dropped out|3|||
48501646|NCT01949662|156032950|FG000|Overall Study|Ineligible|0|||
48501647|NCT01949662|156032951|FG001|Overall Study|Ineligible|1|||
48501648|NCT02637232|156033994|FG000|Overall Study|Lost to Follow-up|42|||
48501649|NCT02637232|156033994|FG000|Overall Study|Adverse Event|11|||
48501650|NCT02637232|156033994|FG000|Overall Study|patient 's decision|2|||
48501651|NCT01781637|156033995|FG000|Overall Study|Adverse Event|1|||
48501652|NCT01781637|156033996|FG001|Overall Study|Adverse Event|0|||
48722650|NCT04776317|156834650|FG007|Overall Study|Withdrawal by Subject|0|||
48722651|NCT04776317|156834651|FG008|Overall Study|Withdrawal by Subject|0|||
48722652|NCT04776317|156834652|FG009|Overall Study|Withdrawal by Subject|0|||
48722653|NCT04776317|156834653|FG010|Overall Study|Withdrawal by Subject|0|||
48722654|NCT04776317|156834654|FG011|Overall Study|Withdrawal by Subject|0|||
48722655|NCT04776317|156834655|FG012|Overall Study|Withdrawal by Subject|0|||
48722656|NCT04776317|156834656|FG013|Overall Study|Withdrawal by Subject|0|||
48722657|NCT04776317|156834657|FG014|Overall Study|Withdrawal by Subject|0|||
48722658|NCT04858451|156834658|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
48722659|NCT04858451|156834659|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722660|NCT04858451|156834660|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722661|NCT04858451|156834661|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722662|NCT04858451|156834662|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722663|NCT04858451|156834663|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48501653|NCT01781637|156033995|FG000|Overall Study|Lack of Efficacy|2|||
48501654|NCT01781637|156033996|FG001|Overall Study|Lack of Efficacy|6|||
48501655|NCT01781637|156033995|FG000|Overall Study|Withdrawal by Subject|1|||
48501656|NCT01781637|156033996|FG001|Overall Study|Withdrawal by Subject|0|||
48501657|NCT00683293|156033997|FG000|Overall Study|Withdrawal by Subject|2|||
48501658|NCT00683293|156033998|FG001|Overall Study|Withdrawal by Subject|3|||
48501659|NCT00090857|156033999|FG000|Overall Study|Lost to Follow-up|0|||
48501660|NCT00090857|156034000|FG001|Overall Study|Lost to Follow-up|1|||
48599772|NCT02239640|156391483|FG000|Overall Study|Withdrawal by Subject|3|||
48501661|NCT00090857|156033999|FG000|Overall Study|Withdrawal by Subject|2|||
48599773|NCT02239640|156391483|FG000|Overall Study|Lost to Follow-up|72|||
48599774|NCT02239640|156391483|FG000|Overall Study|Death|142|||
48599775|NCT02485483|156391486|FG000|Overall Study|Depression at baseline|15|||
48817348|NCT01167179|157175140|FG001|Overall Study|diverse|5|||
48817349|NCT00663117|157175141|FG000|Overall Study|Lack of Efficacy|1|||
48817350|NCT00663117|157175142|FG001|Overall Study|Lack of Efficacy|0|||
48817351|NCT02781506|157175143|FG000|Overall Study|Adverse Event|5|||
48817352|NCT01158378|157175144|FG000|Overall Study|Death|4|||
48817353|NCT01158378|157175145|FG001|Overall Study|Death|5|||
48817354|NCT01158378|157175144|FG000|Overall Study|Lost to Follow-up|2|||
48501662|NCT00090857|156034000|FG001|Overall Study|Withdrawal by Subject|0|||
48501663|NCT00090857|156033999|FG000|Overall Study|Adverse Event|2|||
48501664|NCT00090857|156034000|FG001|Overall Study|Adverse Event|2|||
48817355|NCT01158378|157175145|FG001|Overall Study|Lost to Follow-up|4|||
48817356|NCT01158378|157175144|FG000|Overall Study|Withdrawal by Subject|4|||
48817357|NCT01158378|157175145|FG001|Overall Study|Withdrawal by Subject|0|||
48817358|NCT00311155|157175146|FG000|Overall Study|Adverse Event|21|||
48817359|NCT00311155|157175146|FG000|Overall Study|Withdrawal by Subject|17|||
48817360|NCT00311155|157175146|FG000|Overall Study|Did not meet entry criteria|55|||
48817361|NCT00445601|157175147|FG000|Overall Study|Withdrawal by Subject|11|||
48817362|NCT00445601|157175148|FG001|Overall Study|Withdrawal by Subject|11|||
48817363|NCT00445601|157175147|FG000|Overall Study|TURBT Complication|12|||
48817364|NCT00445601|157175148|FG001|Overall Study|TURBT Complication|8|||
48817365|NCT00445601|157175147|FG000|Overall Study|Incorrect Disease Status|6|||
48817366|NCT00445601|157175148|FG001|Overall Study|Incorrect Disease Status|6|||
48817367|NCT00445601|157175147|FG000|Overall Study|Drug Delivery Issue|2|||
48817368|NCT00445601|157175148|FG001|Overall Study|Drug Delivery Issue|2|||
48817369|NCT00445601|157175147|FG000|Overall Study|Adverse Event|2|||
48817370|NCT00445601|157175148|FG001|Overall Study|Adverse Event|0|||
48501665|NCT05097326|156034002|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
48501666|NCT05097326|156034003|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
48501667|NCT03713281|156034004|FG000|Overall Study|Lens handling difficuluties|2|||
48501668|NCT03713281|156034004|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
48501669|NCT02684344|156034007|FG000|Overall Study|Withdrawal by Subject|0|||
48501670|NCT02684344|156034008|FG001|Overall Study|Withdrawal by Subject|1|||
48501671|NCT01244126|156034009|FG000|Overall Study|Protocol Violation|3|||
48501672|NCT01244126|156034010|FG001|Overall Study|Protocol Violation|3|||
48501673|NCT01244126|156034011|FG002|Overall Study|Protocol Violation|9|||
48501674|NCT02246478|156034014|FG000|Multiple-dose Phase|Protocol Violation|1|||
48501675|NCT02246478|156034015|FG001|Multiple-dose Phase|Protocol Violation|0|||
48501676|NCT02246478|156034016|FG002|Multiple-dose Phase|Protocol Violation|0|||
48722664|NCT04858451|156834664|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722665|NCT04858451|156834665|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722666|NCT04858451|156834666|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
48722667|NCT04858451|156834658|FG000|Part 2|Discontinued|0|||
48722668|NCT04858451|156834659|FG001|Part 2|Discontinued|0|||
48722669|NCT04858451|156834660|FG002|Part 2|Discontinued|0|||
48722670|NCT04858451|156834661|FG003|Part 2|Discontinued|0|||
48722671|NCT04858451|156834662|FG004|Part 2|Discontinued|0|||
48722672|NCT04858451|156834663|FG005|Part 2|Discontinued|0|||
48722673|NCT04858451|156834664|FG006|Part 2|Discontinued|0|||
48722674|NCT04858451|156834665|FG007|Part 2|Discontinued|0|||
48722675|NCT04858451|156834666|FG008|Part 2|Discontinued|63|||
48722676|NCT04992520|156834667|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
48722677|NCT04992520|156834668|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
48722678|NCT04992520|156834669|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
48722679|NCT04992520|156834670|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
48722680|NCT04992520|156834671|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
48722681|NCT04992520|156834672|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
48722682|NCT04992520|156834667|FG000|Part A: First Challenge|Non-compliance|0|||
48722683|NCT04992520|156834668|FG001|Part A: First Challenge|Non-compliance|0|||
48722684|NCT04992520|156834669|FG002|Part A: First Challenge|Non-compliance|0|||
48722685|NCT04992520|156834670|FG003|Part A: First Challenge|Non-compliance|1|||
48722686|NCT04992520|156834671|FG004|Part A: First Challenge|Non-compliance|0|||
48722687|NCT04992520|156834672|FG005|Part A: First Challenge|Non-compliance|0|||
48722688|NCT04992520|156834667|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
48722689|NCT04992520|156834668|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
48722690|NCT04992520|156834669|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
48722691|NCT04992520|156834670|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
48722692|NCT04992520|156834671|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
48722693|NCT04992520|156834672|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
48722694|NCT04992520|156834667|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722695|NCT04992520|156834668|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722696|NCT04992520|156834669|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
48722697|NCT04992520|156834670|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722698|NCT04992520|156834671|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722699|NCT04992520|156834672|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
48722700|NCT01146860|156834673|FG000|Overall Study|Withdrawal by Subject|0|||
48722701|NCT01146860|156834674|FG001|Overall Study|Withdrawal by Subject|1|||
48722702|NCT00718237|156834676|FG000|Overall Study|Adverse Event|1|||
48722703|NCT00718237|156834677|FG001|Overall Study|Adverse Event|3|||
48722704|NCT00718237|156834676|FG000|Overall Study|Lost to Follow-up|2|||
48722705|NCT00718237|156834677|FG001|Overall Study|Lost to Follow-up|2|||
48817371|NCT00445601|157175147|FG000|Overall Study|Death prior to TURBT|0|||
48501677|NCT02246478|156034017|FG003|Multiple-dose Phase|Protocol Violation|1|||
48501678|NCT02732210|156034021|FG000|Overall Study|Site Closed|0|||
48501679|NCT02732210|156034022|FG001|Overall Study|Site Closed|11|||
48501680|NCT02732210|156034021|FG000|Overall Study|Study Ended|13|||
48501681|NCT02732210|156034022|FG001|Overall Study|Study Ended|13|||
48722706|NCT00718237|156834676|FG000|Overall Study|Physician Decision|1|||
48722707|NCT00718237|156834677|FG001|Overall Study|Physician Decision|0|||
48722708|NCT00718237|156834676|FG000|Overall Study|Withdrawal by Subject|9|||
48722709|NCT00718237|156834677|FG001|Overall Study|Withdrawal by Subject|10|||
48722710|NCT03761797|156834678|FG000|Overall Study|Changing hospital|11|||
48722711|NCT03761797|156834678|FG000|Overall Study|Improvement/remission|6|||
48722712|NCT03761797|156834678|FG000|Overall Study|Withdrawal by Subject|19|||
48722713|NCT03761797|156834678|FG000|Overall Study|Lost to Follow-up|33|||
48722714|NCT03761797|156834678|FG000|Overall Study|Adverse Event|37|||
48722715|NCT03761797|156834678|FG000|Overall Study|Case report form (CRF) not collected|5|||
48722716|NCT03761797|156834678|FG000|Overall Study|No patient visit after entry|13|||
48722717|NCT03761797|156834678|FG000|Overall Study|Switch to other diabetes medication|10|||
48722718|NCT03761797|156834678|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
48722719|NCT03761797|156834678|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
48722720|NCT03761797|156834678|FG000|Overall Study|Insufficient effectives|2|||
48722721|NCT03761797|156834678|FG000|Overall Study|Excessive alcohol intake|1|||
48722722|NCT02694718|156834679|FG000|Overall Study|Death|1|||
48722723|NCT02694718|156834679|FG000|Overall Study|Withdrawal by Subject|1|||
48722724|NCT03785964|156834682|FG000|Overall Study|Adverse Event|14|||
48722725|NCT03785964|156834683|FG001|Overall Study|Adverse Event|1|||
48722726|NCT03785964|156834682|FG000|Overall Study|Unqualified Clinical Progression|1|||
48722727|NCT03785964|156834683|FG001|Overall Study|Unqualified Clinical Progression|1|||
48722728|NCT03785964|156834682|FG000|Overall Study|Participant non-compliance|1|||
48722729|NCT03785964|156834683|FG001|Overall Study|Participant non-compliance|1|||
48722730|NCT03785964|156834682|FG000|Overall Study|Not treated|1|||
48722731|NCT03785964|156834683|FG001|Overall Study|Not treated|0|||
48722732|NCT03785964|156834682|FG000|Overall Study|Other reason|5|||
48722733|NCT03785964|156834683|FG001|Overall Study|Other reason|11|||
48722734|NCT03785964|156834682|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
48722735|NCT03785964|156834683|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
48722736|NCT02055365|156836484|FG000|Overall Study|Prematurely Withdrawn|1|||
48722737|NCT00576420|156836485|FG000|Overall Study|Death|0|||
48722738|NCT00576420|156836486|FG001|Overall Study|Death|0|||
48722739|NCT00576420|156836487|FG002|Overall Study|Death|1|||
48722740|NCT01347580|156836493|FG000|Overall Study|Withdrawal by Subject|13|||
48722741|NCT01347580|156836494|FG001|Overall Study|Withdrawal by Subject|23|||
48722742|NCT01347580|156836493|FG000|Overall Study|Death|30|||
48722743|NCT01347580|156836494|FG001|Overall Study|Death|19|||
48722744|NCT01347580|156836493|FG000|Overall Study|Protocol Violation|10|||
48722745|NCT01347580|156836494|FG001|Overall Study|Protocol Violation|7|||
48722746|NCT01347580|156836493|FG000|Overall Study|Lost to Follow-up|3|||
48722747|NCT01347580|156836494|FG001|Overall Study|Lost to Follow-up|1|||
48722748|NCT01347580|156836493|FG000|Overall Study|Had other reason|9|||
48722749|NCT01347580|156836494|FG001|Overall Study|Had other reason|6|||
48722750|NCT02054481|156836495|FG000|Overall Study|Adverse Event|1|||
48722751|NCT02054481|156836496|FG001|Overall Study|Adverse Event|1|||
48722752|NCT02054481|156836497|FG002|Overall Study|Adverse Event|0|||
48722753|NCT02054481|156836498|FG003|Overall Study|Adverse Event|1|||
48722754|NCT02054481|156836495|FG000|Overall Study|Lost to Follow-up|1|||
48722755|NCT02054481|156836496|FG001|Overall Study|Lost to Follow-up|0|||
48722756|NCT02054481|156836497|FG002|Overall Study|Lost to Follow-up|0|||
48722757|NCT02054481|156836498|FG003|Overall Study|Lost to Follow-up|0|||
48722758|NCT02054481|156836495|FG000|Overall Study|Other reason|2|||
48722759|NCT02054481|156836496|FG001|Overall Study|Other reason|1|||
48722760|NCT02054481|156836497|FG002|Overall Study|Other reason|2|||
48722761|NCT02054481|156836498|FG003|Overall Study|Other reason|0|||
48722762|NCT01842633|156836501|FG000|Overall Study|Screen Failure|1|||
48722763|NCT01842633|156836502|FG001|Overall Study|Screen Failure|0|||
48722764|NCT01842633|156836503|FG002|Overall Study|Screen Failure|0|||
48722765|NCT01842633|156836501|FG000|Overall Study|Adverse Event|1|||
48722766|NCT01842633|156836502|FG001|Overall Study|Adverse Event|1|||
48722767|NCT01842633|156836503|FG002|Overall Study|Adverse Event|0|||
48722768|NCT01842633|156836501|FG000|Overall Study|Withdrawal by Subject|0|||
48722769|NCT01842633|156836502|FG001|Overall Study|Withdrawal by Subject|1|||
48722770|NCT01842633|156836503|FG002|Overall Study|Withdrawal by Subject|0|||
48722771|NCT01842633|156836501|FG000|Overall Study|Technical issues|1|||
48722772|NCT01842633|156836502|FG001|Overall Study|Technical issues|0|||
48722773|NCT01842633|156836503|FG002|Overall Study|Technical issues|0|||
48722774|NCT01547780|156836506|FG000|Baseline PET Scan|Physician Decision|1|||
48722775|NCT01547780|156836507|FG001|Baseline PET Scan|Physician Decision|0|||
48722776|NCT01547780|156836508|FG002|Baseline PET Scan|Physician Decision|1|||
48722777|NCT01547780|156836509|FG003|Baseline PET Scan|Physician Decision|0|||
48722778|NCT01547780|156836506|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
48817372|NCT00445601|157175148|FG001|Overall Study|Death prior to TURBT|1|||
48817373|NCT01340482|157175149|FG000|Overall Study|Adverse Event|2|||
48817374|NCT01340482|157175150|FG001|Overall Study|Adverse Event|0|||
48817375|NCT01340482|157175151|FG002|Overall Study|Adverse Event|0|||
48817376|NCT01091428|157175158|FG000|Phase 1|Progressive Disease|24|||
48817377|NCT01091428|157175159|FG001|Phase 1|Progressive Disease|8|||
48817378|NCT01091428|157175160|FG002|Phase 1|Progressive Disease|0|||
48817379|NCT01091428|157175161|FG003|Phase 1|Progressive Disease|0|||
48817380|NCT01091428|157175158|FG000|Phase 1|Symptomatic Deterioration|3|||
48817381|NCT01091428|157175159|FG001|Phase 1|Symptomatic Deterioration|2|||
48817382|NCT01091428|157175160|FG002|Phase 1|Symptomatic Deterioration|0|||
48817383|NCT01091428|157175161|FG003|Phase 1|Symptomatic Deterioration|0|||
48817384|NCT01091428|157175158|FG000|Phase 1|Adverse Event|2|||
48817385|NCT01091428|157175159|FG001|Phase 1|Adverse Event|0|||
48817386|NCT01091428|157175160|FG002|Phase 1|Adverse Event|0|||
48817387|NCT01091428|157175161|FG003|Phase 1|Adverse Event|0|||
48817388|NCT01091428|157175158|FG000|Phase 1|Withdrawal by Subject|7|||
48817389|NCT01091428|157175159|FG001|Phase 1|Withdrawal by Subject|0|||
48817390|NCT01091428|157175160|FG002|Phase 1|Withdrawal by Subject|0|||
48817391|NCT01091428|157175161|FG003|Phase 1|Withdrawal by Subject|0|||
48817392|NCT01091428|157175158|FG000|Phase 1|Reason not specified|0|||
48817393|NCT01091428|157175159|FG001|Phase 1|Reason not specified|1|||
48817394|NCT01091428|157175160|FG002|Phase 1|Reason not specified|0|||
48817395|NCT01091428|157175161|FG003|Phase 1|Reason not specified|0|||
48817396|NCT01091428|157175158|FG000|Phase 1|Single-Patient IND|2|||
48817397|NCT01091428|157175159|FG001|Phase 1|Single-Patient IND|0|||
48817398|NCT01091428|157175160|FG002|Phase 1|Single-Patient IND|0|||
48817399|NCT01091428|157175161|FG003|Phase 1|Single-Patient IND|0|||
48817400|NCT01091428|157175158|FG000|Phase 2|Progressive Disease|0|||
48817401|NCT01091428|157175159|FG001|Phase 2|Progressive Disease|0|||
48817402|NCT01091428|157175160|FG002|Phase 2|Progressive Disease|44|||
48817403|NCT01091428|157175161|FG003|Phase 2|Progressive Disease|46|||
48501682|NCT02732210|156034021|FG000|Overall Study|Withdrawal by Subject|28|||
48501683|NCT02732210|156034022|FG001|Overall Study|Withdrawal by Subject|87|||
48501684|NCT02732210|156034021|FG000|Overall Study|Lost to Follow-up|5|||
48501685|NCT02732210|156034022|FG001|Overall Study|Lost to Follow-up|57|||
48501686|NCT02732210|156034021|FG000|Overall Study|Death|4|||
48501687|NCT02732210|156034022|FG001|Overall Study|Death|15|||
48817404|NCT01091428|157175158|FG000|Phase 2|Symptomatic Deterioration|0|||
48817405|NCT01091428|157175159|FG001|Phase 2|Symptomatic Deterioration|0|||
48817406|NCT01091428|157175160|FG002|Phase 2|Symptomatic Deterioration|1|||
48817407|NCT01091428|157175161|FG003|Phase 2|Symptomatic Deterioration|6|||
48817408|NCT01091428|157175158|FG000|Phase 2|Adverse Event|0|||
48817409|NCT01091428|157175159|FG001|Phase 2|Adverse Event|0|||
48817410|NCT01091428|157175160|FG002|Phase 2|Adverse Event|12|||
48817411|NCT01091428|157175161|FG003|Phase 2|Adverse Event|5|||
48817412|NCT01091428|157175158|FG000|Phase 2|Withdrawal by Subject|0|||
48817413|NCT01091428|157175159|FG001|Phase 2|Withdrawal by Subject|0|||
48817414|NCT01091428|157175160|FG002|Phase 2|Withdrawal by Subject|9|||
48817415|NCT01091428|157175161|FG003|Phase 2|Withdrawal by Subject|8|||
48817416|NCT01091428|157175158|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
48817417|NCT01091428|157175159|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
48817418|NCT01091428|157175160|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
48817419|NCT01091428|157175161|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
48817420|NCT01091428|157175158|FG000|Phase 2|Reason not specified|0|||
48817421|NCT01091428|157175159|FG001|Phase 2|Reason not specified|0|||
48817422|NCT01091428|157175160|FG002|Phase 2|Reason not specified|4|||
48817423|NCT01091428|157175161|FG003|Phase 2|Reason not specified|3|||
48817424|NCT01091428|157175158|FG000|Phase 2|Physician Decision|0|||
48599776|NCT02485483|156391487|FG001|Overall Study|Depression at baseline|0|||
48817425|NCT01091428|157175159|FG001|Phase 2|Physician Decision|0|||
48817426|NCT01091428|157175160|FG002|Phase 2|Physician Decision|2|||
48817427|NCT01091428|157175161|FG003|Phase 2|Physician Decision|0|||
48817428|NCT01282476|157175162|FG000|Overall Study|Death|11|||
48817429|NCT00437125|157175168|FG000|Overall Study|Adverse Event|12|||
48501688|NCT02732210|156034021|FG000|Overall Study|Other|35|||
48817430|NCT00437125|157175168|FG000|Overall Study|Death|1|||
48817431|NCT00437125|157175168|FG000|Overall Study|Clinical Relapse|1|||
48817432|NCT00437125|157175168|FG000|Overall Study|Lack of Efficacy|1|||
48817433|NCT00437125|157175168|FG000|Overall Study|Lost to Follow-up|1|||
48817434|NCT00437125|157175168|FG000|Overall Study|Withdrawal by Subject|13|||
48501689|NCT02732210|156034022|FG001|Overall Study|Other|103|||
48599777|NCT02485483|156391486|FG000|Overall Study|Discontinued after baseline|39|||
48817435|NCT00437125|157175168|FG000|Overall Study|Withdrawal by Caregiver|2|||
48817436|NCT00437125|157175168|FG000|Overall Study|Physician Decision|1|||
48501690|NCT02732210|156034021|FG000|Overall Study|Missing|0|||
48501691|NCT02732210|156034022|FG001|Overall Study|Missing|8|||
48817437|NCT03204695|157175169|FG000|Overall Study|Death|1|||
48817438|NCT03204695|157175169|FG000|Overall Study|Participant was treated with another device|1|||
48501692|NCT03401112|156034023|FG000|Overall Study|Adverse Event|1|||
48817439|NCT03204695|157175169|FG000|Overall Study|Physician Decision|2|||
48501693|NCT03401112|156034024|FG001|Overall Study|Adverse Event|2|||
48501694|NCT03401112|156034025|FG002|Overall Study|Adverse Event|3|||
48501695|NCT03401112|156034026|FG003|Overall Study|Adverse Event|2|||
48501696|NCT03401112|156034027|FG004|Overall Study|Adverse Event|0|||
48501697|NCT03401112|156034023|FG000|Overall Study|Lost to Follow-up|1|||
48501698|NCT03401112|156034024|FG001|Overall Study|Lost to Follow-up|0|||
48501699|NCT03401112|156034025|FG002|Overall Study|Lost to Follow-up|0|||
48501700|NCT03401112|156034026|FG003|Overall Study|Lost to Follow-up|0|||
48501701|NCT03401112|156034027|FG004|Overall Study|Lost to Follow-up|0|||
48501702|NCT03401112|156034023|FG000|Overall Study|Noncompliance|1|||
48501703|NCT03401112|156034024|FG001|Overall Study|Noncompliance|2|||
48501704|NCT03401112|156034025|FG002|Overall Study|Noncompliance|3|||
48501705|NCT03401112|156034026|FG003|Overall Study|Noncompliance|0|||
48501706|NCT03401112|156034027|FG004|Overall Study|Noncompliance|0|||
48501707|NCT03401112|156034023|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
48501708|NCT03401112|156034024|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
48501709|NCT03401112|156034025|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
48501710|NCT03401112|156034026|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
48501711|NCT03401112|156034027|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
48501712|NCT03401112|156034023|FG000|Overall Study|Withdrawal by Subject|0|||
48501713|NCT03401112|156034024|FG001|Overall Study|Withdrawal by Subject|3|||
48501714|NCT03401112|156034025|FG002|Overall Study|Withdrawal by Subject|2|||
48501715|NCT03401112|156034026|FG003|Overall Study|Withdrawal by Subject|1|||
48501716|NCT03401112|156034027|FG004|Overall Study|Withdrawal by Subject|0|||
48501717|NCT03401112|156034023|FG000|Overall Study|Physician Decision|0|||
48501718|NCT03401112|156034024|FG001|Overall Study|Physician Decision|0|||
48501719|NCT03401112|156034025|FG002|Overall Study|Physician Decision|0|||
48501720|NCT03401112|156034026|FG003|Overall Study|Physician Decision|2|||
48501721|NCT03401112|156034027|FG004|Overall Study|Physician Decision|0|||
48501722|NCT03401112|156034023|FG000|Overall Study|Study was Terminated by Sponsor|0|||
48501723|NCT03401112|156034024|FG001|Overall Study|Study was Terminated by Sponsor|0|||
48501724|NCT03401112|156034025|FG002|Overall Study|Study was Terminated by Sponsor|0|||
48501725|NCT03401112|156034026|FG003|Overall Study|Study was Terminated by Sponsor|1|||
48501726|NCT03401112|156034027|FG004|Overall Study|Study was Terminated by Sponsor|0|||
48501727|NCT03401112|156034023|FG000|Overall Study|Day 1 Assessment not Done|1|||
48501728|NCT03401112|156034024|FG001|Overall Study|Day 1 Assessment not Done|0|||
48501729|NCT03401112|156034025|FG002|Overall Study|Day 1 Assessment not Done|0|||
48501730|NCT03401112|156034026|FG003|Overall Study|Day 1 Assessment not Done|0|||
48501731|NCT03401112|156034027|FG004|Overall Study|Day 1 Assessment not Done|0|||
48501732|NCT03401112|156034023|FG000|Overall Study|Not Dosed|0|||
48501733|NCT03401112|156034024|FG001|Overall Study|Not Dosed|0|||
48501734|NCT03401112|156034025|FG002|Overall Study|Not Dosed|1|||
48501735|NCT03401112|156034026|FG003|Overall Study|Not Dosed|0|||
48501736|NCT03401112|156034027|FG004|Overall Study|Not Dosed|0|||
48722779|NCT01547780|156836507|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
48722780|NCT01547780|156836508|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
48722781|NCT01547780|156836509|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
48722782|NCT00895011|156836510|FG000|Overall Study|Withdrawal by Subject|14|||
48722783|NCT00895011|156836511|FG001|Overall Study|Withdrawal by Subject|7|||
48722784|NCT00895011|156836512|FG002|Overall Study|Withdrawal by Subject|2|||
48722785|NCT00895011|156836510|FG000|Overall Study|Lost to Follow-up|5|||
48722786|NCT00895011|156836511|FG001|Overall Study|Lost to Follow-up|4|||
48722787|NCT00895011|156836512|FG002|Overall Study|Lost to Follow-up|1|||
48722788|NCT00895011|156836510|FG000|Overall Study|Protocol Violation|3|||
48722789|NCT00895011|156836511|FG001|Overall Study|Protocol Violation|1|||
48722790|NCT00895011|156836512|FG002|Overall Study|Protocol Violation|3|||
48722791|NCT00895011|156836510|FG000|Overall Study|Adverse Event|1|||
48722792|NCT00895011|156836511|FG001|Overall Study|Adverse Event|2|||
48722793|NCT00895011|156836512|FG002|Overall Study|Adverse Event|2|||
48722794|NCT00895011|156836510|FG000|Overall Study|schedule conflict|1|||
48722795|NCT00895011|156836511|FG001|Overall Study|schedule conflict|0|||
48722796|NCT00895011|156836512|FG002|Overall Study|schedule conflict|0|||
48722797|NCT00959374|156836513|FG000|Overall Study|Withdrawal by Subject|2|||
48722798|NCT00959374|156836513|FG000|Overall Study|Lost to Follow-up|14|||
48722799|NCT00959374|156836513|FG000|Overall Study|Death|1|||
48722800|NCT00959374|156836513|FG000|Overall Study|Protocol Violation|1|||
48722801|NCT00959374|156836513|FG000|Overall Study|Implant Removed/Not Replaced|4|||
48722802|NCT00959374|156836513|FG000|Overall Study|Physician Decision|1|||
48722803|NCT01397825|156836515|FG000|Overall Study|Progressive Disease|10|||
48722804|NCT01397825|156836516|FG001|Overall Study|Progressive Disease|3|||
48722805|NCT01397825|156836517|FG002|Overall Study|Progressive Disease|11|||
48722806|NCT01397825|156836518|FG003|Overall Study|Progressive Disease|1|||
48501737|NCT03401112|156034023|FG000|Overall Study|Missed Clinical Visit|0|||
48501738|NCT03401112|156034024|FG001|Overall Study|Missed Clinical Visit|0|||
48722807|NCT01397825|156836519|FG004|Overall Study|Progressive Disease|0|||
48722808|NCT01397825|156836515|FG000|Overall Study|Symptomatic Deterioration|2|||
48722809|NCT01397825|156836516|FG001|Overall Study|Symptomatic Deterioration|0|||
48722810|NCT01397825|156836517|FG002|Overall Study|Symptomatic Deterioration|4|||
48501739|NCT03401112|156034025|FG002|Overall Study|Missed Clinical Visit|1|||
48501740|NCT03401112|156034026|FG003|Overall Study|Missed Clinical Visit|0|||
48501741|NCT03401112|156034027|FG004|Overall Study|Missed Clinical Visit|0|||
48501742|NCT03401112|156034023|FG000|Overall Study|Missed Doses|0|||
48501743|NCT03401112|156034024|FG001|Overall Study|Missed Doses|0|||
48501744|NCT03401112|156034025|FG002|Overall Study|Missed Doses|1|||
48599778|NCT02485483|156391487|FG001|Overall Study|Discontinued after baseline|0|||
48599779|NCT00929994|156391488|FG000|Overall Study|Withdrawal by Subject|1|||
48599780|NCT00929994|156391488|FG000|Overall Study|medical issue unrelated to intervention|4|||
48599781|NCT00929994|156391488|FG000|Overall Study|employment|1|||
48501745|NCT03401112|156034026|FG003|Overall Study|Missed Doses|0|||
48501746|NCT03401112|156034027|FG004|Overall Study|Missed Doses|0|||
48501747|NCT00925769|156034028|FG000|Overall Study|Major toxicity|1|||
48501748|NCT00925769|156034029|FG001|Overall Study|Major toxicity|0|||
48501749|NCT00925769|156034030|FG002|Overall Study|Major toxicity|1|||
48599782|NCT00268983|156391492|FG000|Overall Study|Death|3|||
48501750|NCT00925769|156034031|FG003|Overall Study|Major toxicity|1|||
48501751|NCT00925769|156034032|FG004|Overall Study|Major toxicity|0|||
48501752|NCT00925769|156034033|FG005|Overall Study|Major toxicity|0|||
48501753|NCT00925769|156034028|FG000|Overall Study|Disease progression|4|||
48501754|NCT00925769|156034029|FG001|Overall Study|Disease progression|5|||
48501755|NCT00925769|156034030|FG002|Overall Study|Disease progression|3|||
48501756|NCT00925769|156034031|FG003|Overall Study|Disease progression|4|||
48501757|NCT00925769|156034032|FG004|Overall Study|Disease progression|2|||
48501758|NCT00925769|156034033|FG005|Overall Study|Disease progression|3|||
48501759|NCT00925769|156034028|FG000|Overall Study|Death|0|||
48501760|NCT00925769|156034029|FG001|Overall Study|Death|0|||
48501761|NCT00925769|156034030|FG002|Overall Study|Death|1|||
48501762|NCT00925769|156034031|FG003|Overall Study|Death|0|||
48501763|NCT00925769|156034032|FG004|Overall Study|Death|0|||
48501764|NCT00925769|156034033|FG005|Overall Study|Death|0|||
48501765|NCT00925769|156034028|FG000|Overall Study|Physician Decision|1|||
48501766|NCT00925769|156034029|FG001|Overall Study|Physician Decision|0|||
48501767|NCT00925769|156034030|FG002|Overall Study|Physician Decision|0|||
48501768|NCT00925769|156034031|FG003|Overall Study|Physician Decision|0|||
48501769|NCT00925769|156034032|FG004|Overall Study|Physician Decision|0|||
48599783|NCT00268983|156391493|FG001|Overall Study|Death|0|||
48599784|NCT00875563|156391494|FG000|Overall Study|Death|4|||
48599785|NCT00875563|156391494|FG000|Overall Study|Withdrawal by Subject|7|||
48599786|NCT00875563|156391494|FG000|Overall Study|No long-term (3-5 year) consent|6|||
48599787|NCT00875563|156391494|FG000|Overall Study|Still be eligible for follow-up|7|||
48599788|NCT00970489|156391495|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
48599789|NCT00970489|156391496|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
48599790|NCT05417412|156391497|FG000|Overall Study|Lost to Follow-up|2|||
48599791|NCT01841970|156391498|FG000|Overall Study|Withdrawal by Subject|1|||
48599792|NCT01841970|156391498|FG000|Overall Study|Physician Decision|2|||
48599793|NCT01841970|156391498|FG000|Overall Study|Lost to Follow-up|8|||
48599794|NCT03478371|156391499|FG000|Overall Study|non-compliance|1|||
48599795|NCT03478371|156391499|FG000|Overall Study|Lost to Follow-up|4|||
48501770|NCT00925769|156034033|FG005|Overall Study|Physician Decision|0|||
48501771|NCT00925769|156034028|FG000|Overall Study|Missing documentation|0|||
48501772|NCT00925769|156034029|FG001|Overall Study|Missing documentation|1|||
48501773|NCT00925769|156034030|FG002|Overall Study|Missing documentation|0|||
48501774|NCT00925769|156034031|FG003|Overall Study|Missing documentation|0|||
48501775|NCT00925769|156034032|FG004|Overall Study|Missing documentation|0|||
48501776|NCT00925769|156034033|FG005|Overall Study|Missing documentation|0|||
48599796|NCT03428100|156391500|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
48599797|NCT03428100|156391501|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599798|NCT03428100|156391502|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
48599799|NCT03428100|156391503|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
48501777|NCT00925769|156034028|FG000|Overall Study|End of study visit not done|0|||
48501778|NCT00925769|156034029|FG001|Overall Study|End of study visit not done|0|||
48501779|NCT00925769|156034030|FG002|Overall Study|End of study visit not done|1|||
48501780|NCT00925769|156034031|FG003|Overall Study|End of study visit not done|0|||
48501781|NCT00925769|156034032|FG004|Overall Study|End of study visit not done|0|||
48501782|NCT00925769|156034033|FG005|Overall Study|End of study visit not done|0|||
48501783|NCT00925769|156034028|FG000|Overall Study|Participant is unable to swallow drug|0|||
48599800|NCT03428100|156391504|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599801|NCT03428100|156391505|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48501784|NCT00925769|156034029|FG001|Overall Study|Participant is unable to swallow drug|0|||
48501785|NCT00925769|156034030|FG002|Overall Study|Participant is unable to swallow drug|0|||
48501786|NCT00925769|156034031|FG003|Overall Study|Participant is unable to swallow drug|1|||
48501787|NCT00925769|156034032|FG004|Overall Study|Participant is unable to swallow drug|0|||
48501788|NCT00925769|156034033|FG005|Overall Study|Participant is unable to swallow drug|0|||
48501789|NCT00925769|156034028|FG000|Overall Study|Adverse Event|0|||
48501790|NCT00925769|156034029|FG001|Overall Study|Adverse Event|0|||
48722811|NCT01397825|156836518|FG003|Overall Study|Symptomatic Deterioration|0|||
48722812|NCT01397825|156836519|FG004|Overall Study|Symptomatic Deterioration|0|||
48722813|NCT01397825|156836515|FG000|Overall Study|Adverse Event|0|||
48722814|NCT01397825|156836516|FG001|Overall Study|Adverse Event|1|||
48722815|NCT01397825|156836517|FG002|Overall Study|Adverse Event|5|||
48722816|NCT01397825|156836518|FG003|Overall Study|Adverse Event|1|||
48722817|NCT01397825|156836519|FG004|Overall Study|Adverse Event|0|||
48722818|NCT01397825|156836515|FG000|Overall Study|Withdrawal by Subject|1|||
48722819|NCT01397825|156836516|FG001|Overall Study|Withdrawal by Subject|0|||
48722820|NCT01397825|156836517|FG002|Overall Study|Withdrawal by Subject|5|||
48722821|NCT01397825|156836518|FG003|Overall Study|Withdrawal by Subject|1|||
48722822|NCT01397825|156836519|FG004|Overall Study|Withdrawal by Subject|0|||
48722823|NCT03332017|156836523|FG000|Overall Study|Lost to Follow-up|1|||
48722824|NCT03332017|156836524|FG001|Overall Study|Lost to Follow-up|2|||
48722825|NCT03332017|156836523|FG000|Overall Study|Death|17|||
48722826|NCT03332017|156836524|FG001|Overall Study|Death|16|||
48722827|NCT03332017|156836523|FG000|Overall Study|Withdrawal by Subject|6|||
48722828|NCT03332017|156836524|FG001|Overall Study|Withdrawal by Subject|14|||
48722829|NCT03332017|156836523|FG000|Overall Study|Other|1|||
48722830|NCT03332017|156836524|FG001|Overall Study|Other|3|||
48722831|NCT03332017|156836523|FG000|Overall Study|Remained in Study (Ongoing)|47|||
48722832|NCT03332017|156836524|FG001|Overall Study|Remained in Study (Ongoing)|110|||
48722833|NCT03436290|156836525|FG000|Overall Study|Post-randomization Exclusion|1|||
48817440|NCT03095599|157175172|FG000|Overall Study|Withdrawal by Subject|1|||
48817441|NCT03095599|157175173|FG001|Overall Study|Withdrawal by Subject|0|||
48817442|NCT03095599|157175172|FG000|Overall Study|Lost to Follow-up|1|||
48817443|NCT03095599|157175173|FG001|Overall Study|Lost to Follow-up|0|||
48817444|NCT03095599|157175172|FG000|Overall Study|Withdrawal prior to vaccination|1|||
48817445|NCT03095599|157175173|FG001|Overall Study|Withdrawal prior to vaccination|0|||
48817446|NCT02391038|157175174|FG000|Overall Study|Progressive disease|3|||
48817447|NCT02391038|157175175|FG001|Overall Study|Progressive disease|3|||
48722834|NCT03436290|156836526|FG001|Overall Study|Post-randomization Exclusion|0|||
48722835|NCT03436290|156836525|FG000|Overall Study|Death|6|||
48817448|NCT02391038|157175176|FG002|Overall Study|Progressive disease|6|||
48722836|NCT03436290|156836526|FG001|Overall Study|Death|0|||
48722837|NCT03436290|156836525|FG000|Overall Study|Withdrawal by Subject|4|||
48722838|NCT03436290|156836526|FG001|Overall Study|Withdrawal by Subject|0|||
48722839|NCT03436290|156836525|FG000|Overall Study|Protocol Violation|30|||
48722840|NCT03436290|156836526|FG001|Overall Study|Protocol Violation|0|||
48722841|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
48722842|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Adverse Event|9|||
48722843|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Death|4|||
48722844|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
48722845|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
48817449|NCT02959138|157175177|FG000|Overall Study|Enrolled but Never Treated|0|||
48817450|NCT02959138|157175178|FG001|Overall Study|Enrolled but Never Treated|1|||
48817451|NCT02959138|157175179|FG002|Overall Study|Enrolled but Never Treated|0|||
48817452|NCT02531295|157175180|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817453|NCT02531295|157175181|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817454|NCT02531295|157175182|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817455|NCT02531295|157175183|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817456|NCT02531295|157175184|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
48817457|NCT02531295|157175185|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
48817458|NCT01811563|157175186|FG000|Overall Study|Lost to Follow-up|5|||
48722846|NCT00159822|156836527|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
48722847|NCT00159822|156836527|FG000|Post-treatment Follow-up Period|Death|1|||
48722848|NCT00159822|156836527|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
48817459|NCT01811563|157175187|FG001|Overall Study|Lost to Follow-up|2|||
48817460|NCT01811563|157175186|FG000|Overall Study|Incorrect Randomization procedure|0|||
48817461|NCT01811563|157175187|FG001|Overall Study|Incorrect Randomization procedure|1|||
48817462|NCT01755689|157175188|FG000|Overall Study|Withdrawal by Subject|1|||
48817463|NCT01755689|157175189|FG001|Overall Study|Withdrawal by Subject|3|||
48722849|NCT00159822|156836527|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
48817464|NCT01755689|157175190|FG002|Overall Study|Withdrawal by Subject|2|||
48817465|NCT01755689|157175191|FG003|Overall Study|Withdrawal by Subject|1|||
48817466|NCT01755689|157175192|FG004|Overall Study|Withdrawal by Subject|1|||
48817467|NCT01755689|157175188|FG000|Overall Study|Migrated/moved from study area|0|||
48817468|NCT01755689|157175189|FG001|Overall Study|Migrated/moved from study area|1|||
48722850|NCT02677324|156836533|FG000|Overall Study|Disease Progression|6|||
48722851|NCT02677324|156836533|FG000|Overall Study|Inability to Swallow pills|1|||
48722852|NCT02677324|156836533|FG000|Overall Study|Non-compliance|1|||
48722853|NCT02677324|156836533|FG000|Overall Study|Lack of Efficacy|1|||
48722854|NCT02677324|156836533|FG000|Overall Study|Medical insurance coverage|1|||
48722855|NCT02677324|156836533|FG000|Overall Study|Adverse Event|1|||
48722856|NCT02677324|156836533|FG000|Overall Study|IgM Myeloma diagnosis|1|||
48722857|NCT05134233|156836534|FG000|Overall Study|Pregnancy|1|||
48722858|NCT05134233|156836534|FG000|Overall Study|MEP value too low|2|||
48722859|NCT05134233|156836534|FG000|Overall Study|Lost to Follow-up|1|||
48722860|NCT04761627|156836535|FG000|Run-in Period|Death|1|||
48722861|NCT04761627|156836536|FG001|Run-in Period|Death|0|||
48722862|NCT04761627|156836537|FG002|Run-in Period|Death|0|||
48722863|NCT04761627|156836535|FG000|Run-in Period|Required alternative therapy|2|||
48722864|NCT04761627|156836536|FG001|Run-in Period|Required alternative therapy|0|||
48722865|NCT04761627|156836537|FG002|Run-in Period|Required alternative therapy|0|||
48722866|NCT04761627|156836535|FG000|Run-in Period|Lost to Follow-up|2|||
48722867|NCT04761627|156836536|FG001|Run-in Period|Lost to Follow-up|0|||
48722868|NCT04761627|156836537|FG002|Run-in Period|Lost to Follow-up|0|||
48722869|NCT04761627|156836535|FG000|Run-in Period|Protocol Violation|3|||
48722870|NCT04761627|156836536|FG001|Run-in Period|Protocol Violation|0|||
48722871|NCT04761627|156836537|FG002|Run-in Period|Protocol Violation|0|||
48722872|NCT04761627|156836535|FG000|Run-in Period|Abnormal liver function|1|||
48722873|NCT04761627|156836536|FG001|Run-in Period|Abnormal liver function|0|||
48722874|NCT04761627|156836537|FG002|Run-in Period|Abnormal liver function|0|||
48722875|NCT04761627|156836535|FG000|Run-in Period|Adverse Event|6|||
48722876|NCT04761627|156836536|FG001|Run-in Period|Adverse Event|0|||
48722877|NCT04761627|156836537|FG002|Run-in Period|Adverse Event|0|||
48722878|NCT04761627|156836535|FG000|Run-in Period|Withdrawal by Subject|7|||
48722879|NCT04761627|156836536|FG001|Run-in Period|Withdrawal by Subject|0|||
48722880|NCT04761627|156836537|FG002|Run-in Period|Withdrawal by Subject|0|||
48722881|NCT04761627|156836535|FG000|Run-in Period|Did not meet PASI 50|15|||
48722882|NCT04761627|156836536|FG001|Run-in Period|Did not meet PASI 50|0|||
48722883|NCT04761627|156836537|FG002|Run-in Period|Did not meet PASI 50|0|||
48722884|NCT04761627|156836535|FG000|Run-in Period|Study site closure|2|||
48722885|NCT04761627|156836536|FG001|Run-in Period|Study site closure|0|||
48722886|NCT04761627|156836537|FG002|Run-in Period|Study site closure|0|||
48722887|NCT04761627|156836535|FG000|Run-in Period|Pregnancy|2|||
48722888|NCT04761627|156836536|FG001|Run-in Period|Pregnancy|0|||
48722889|NCT04761627|156836537|FG002|Run-in Period|Pregnancy|0|||
48722890|NCT04761627|156836535|FG000|Post-randomization Period|Military service|0|||
48722891|NCT04761627|156836536|FG001|Post-randomization Period|Military service|1|||
48722892|NCT04761627|156836537|FG002|Post-randomization Period|Military service|0|||
48722893|NCT04761627|156836535|FG000|Post-randomization Period|Adverse Event|0|||
48722894|NCT04761627|156836536|FG001|Post-randomization Period|Adverse Event|4|||
48722895|NCT04761627|156836537|FG002|Post-randomization Period|Adverse Event|2|||
48722896|NCT04761627|156836535|FG000|Post-randomization Period|Lost to Follow-up|0|||
48722897|NCT04761627|156836536|FG001|Post-randomization Period|Lost to Follow-up|6|||
48722898|NCT04761627|156836537|FG002|Post-randomization Period|Lost to Follow-up|6|||
48722899|NCT04761627|156836535|FG000|Post-randomization Period|Withdrawal by Subject|0|||
48722900|NCT04761627|156836536|FG001|Post-randomization Period|Withdrawal by Subject|7|||
48722901|NCT04761627|156836537|FG002|Post-randomization Period|Withdrawal by Subject|6|||
48722902|NCT04761627|156836535|FG000|Post-randomization Period|Pregnancy|0|||
48722903|NCT04761627|156836536|FG001|Post-randomization Period|Pregnancy|0|||
48722904|NCT04761627|156836537|FG002|Post-randomization Period|Pregnancy|1|||
48722905|NCT04761627|156836535|FG000|Post-randomization Period|Study site closure|0|||
48722906|NCT04761627|156836536|FG001|Post-randomization Period|Study site closure|0|||
48722907|NCT04761627|156836537|FG002|Post-randomization Period|Study site closure|1|||
48722908|NCT04761627|156836535|FG000|Post-randomization Period|Family planning|0|||
48722909|NCT04761627|156836536|FG001|Post-randomization Period|Family planning|1|||
48722910|NCT04761627|156836537|FG002|Post-randomization Period|Family planning|0|||
48722911|NCT00466687|156836540|FG000|Overall Study|Adverse Event|1|||
48722912|NCT00466687|156836540|FG000|Overall Study|Other complicating illness|3|||
48722913|NCT00466687|156836540|FG000|Overall Study|Withdrawal by Subject|1|||
48722914|NCT00466687|156836540|FG000|Overall Study|Disease progression|29|||
48722915|NCT00420641|156836543|FG000|Overall Study|Adverse Event|3|||
48722916|NCT00420641|156836544|FG001|Overall Study|Adverse Event|25|||
48722917|NCT00420641|156836545|FG002|Overall Study|Adverse Event|10|||
48722918|NCT00420641|156836543|FG000|Overall Study|Lost to Follow-up|2|||
48722919|NCT00420641|156836544|FG001|Overall Study|Lost to Follow-up|4|||
48722920|NCT00420641|156836545|FG002|Overall Study|Lost to Follow-up|2|||
48722921|NCT00420641|156836543|FG000|Overall Study|Protocol Violation|8|||
48722922|NCT00420641|156836544|FG001|Overall Study|Protocol Violation|8|||
48722923|NCT00420641|156836545|FG002|Overall Study|Protocol Violation|7|||
48722924|NCT00420641|156836543|FG000|Overall Study|Withdrawal by Subject|15|||
48722925|NCT00420641|156836544|FG001|Overall Study|Withdrawal by Subject|21|||
48722926|NCT00420641|156836545|FG002|Overall Study|Withdrawal by Subject|14|||
48722927|NCT00420641|156836543|FG000|Overall Study|Lack of Efficacy|6|||
48722928|NCT00420641|156836544|FG001|Overall Study|Lack of Efficacy|5|||
48722929|NCT00420641|156836545|FG002|Overall Study|Lack of Efficacy|4|||
48722930|NCT00420641|156836543|FG000|Overall Study|Non-compliance|7|||
48722931|NCT00420641|156836544|FG001|Overall Study|Non-compliance|5|||
48501791|NCT00925769|156034030|FG002|Overall Study|Adverse Event|0|||
48817469|NCT01755689|157175190|FG002|Overall Study|Migrated/moved from study area|1|||
48501792|NCT00925769|156034031|FG003|Overall Study|Adverse Event|0|||
48501793|NCT00925769|156034032|FG004|Overall Study|Adverse Event|1|||
48501794|NCT00925769|156034033|FG005|Overall Study|Adverse Event|0|||
48501795|NCT00686959|156034036|FG000|Overall Study|Participants censored (no death events)|124|||
48501796|NCT00686959|156034037|FG001|Overall Study|Participants censored (no death events)|117|||
48501797|NCT01876706|156034038|FG000|Overall Study|BPH Intervention|9|||
48501798|NCT01876706|156034038|FG000|Overall Study|Lost to Follow-up|7|||
48501799|NCT01876706|156034038|FG000|Overall Study|Withdrawals|6|||
48501800|NCT01876706|156034038|FG000|Overall Study|Death|3|||
48501801|NCT04006171|156034040|FG000|Overall Study|Withdrawal by Subject|8|||
48501802|NCT04006171|156034041|FG001|Overall Study|Withdrawal by Subject|7|||
48501803|NCT04006171|156034040|FG000|Overall Study|missing serum samples|2|||
48501804|NCT04006171|156034041|FG001|Overall Study|missing serum samples|2|||
48599802|NCT03428100|156391506|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48722932|NCT00420641|156836545|FG002|Overall Study|Non-compliance|4|||
48722933|NCT00420641|156836543|FG000|Overall Study|Other|4|||
48722934|NCT00420641|156836544|FG001|Overall Study|Other|4|||
48722935|NCT00420641|156836545|FG002|Overall Study|Other|3|||
48722936|NCT00247611|156836546|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
48722937|NCT00247611|156836547|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
48722938|NCT00247611|156836546|FG000|Baselined|Completed baseline only|9|||
48722939|NCT00247611|156836547|FG001|Baselined|Completed baseline only|8|||
48722940|NCT01878149|156836551|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
48722941|NCT01878149|156836552|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
48722942|NCT04672252|156836553|FG000|Overall Study|Protocol Violation|1|||
48722943|NCT04672252|156836554|FG001|Overall Study|Protocol Violation|0|||
48817470|NCT01755689|157175191|FG003|Overall Study|Migrated/moved from study area|1|||
48817471|NCT01755689|157175192|FG004|Overall Study|Migrated/moved from study area|1|||
48817472|NCT01755689|157175188|FG000|Overall Study|Lost to Follow-up|1|||
48817473|NCT01755689|157175189|FG001|Overall Study|Lost to Follow-up|0|||
48817474|NCT01755689|157175190|FG002|Overall Study|Lost to Follow-up|1|||
48817475|NCT01755689|157175191|FG003|Overall Study|Lost to Follow-up|0|||
48817476|NCT01755689|157175192|FG004|Overall Study|Lost to Follow-up|2|||
48722944|NCT01582854|156836555|FG000|Overall Study|Death|8|||
48722945|NCT01582854|156836556|FG001|Overall Study|Death|5|||
48722946|NCT01582854|156836555|FG000|Overall Study|Adverse Event|2|||
48817477|NCT01755689|157175188|FG000|Overall Study|Pregnancy|1|||
48817478|NCT01755689|157175189|FG001|Overall Study|Pregnancy|1|||
48817479|NCT01755689|157175190|FG002|Overall Study|Pregnancy|2|||
48722947|NCT01582854|156836556|FG001|Overall Study|Adverse Event|3|||
48722948|NCT01582854|156836555|FG000|Overall Study|Withdrawal by Participant|8|||
48722949|NCT01582854|156836556|FG001|Overall Study|Withdrawal by Participant|11|||
48722950|NCT01582854|156836555|FG000|Overall Study|Lost to Follow-up|1|||
48722951|NCT01582854|156836556|FG001|Overall Study|Lost to Follow-up|2|||
48722952|NCT01582854|156836555|FG000|Overall Study|Physician Decision|0|||
48722953|NCT01582854|156836556|FG001|Overall Study|Physician Decision|1|||
48722954|NCT01582854|156836555|FG000|Overall Study|Recurrent Stroke|13|||
48722955|NCT01582854|156836556|FG001|Overall Study|Recurrent Stroke|8|||
48722956|NCT01582854|156836555|FG000|Overall Study|Disallowed Concomitant Medication|3|||
48722957|NCT01582854|156836556|FG001|Overall Study|Disallowed Concomitant Medication|2|||
48722958|NCT01582854|156836555|FG000|Overall Study|Carotid or Neurosurgery|0|||
48722959|NCT01582854|156836556|FG001|Overall Study|Carotid or Neurosurgery|1|||
48722960|NCT01582854|156836555|FG000|Overall Study|General Anaesthesia|0|||
48817480|NCT01755689|157175191|FG003|Overall Study|Pregnancy|4|||
48817481|NCT01755689|157175192|FG004|Overall Study|Pregnancy|2|||
48501805|NCT04006171|156034040|FG000|Overall Study|insufficient sample volume|2|||
48501806|NCT04006171|156034041|FG001|Overall Study|insufficient sample volume|3|||
48501807|NCT02073643|156034042|FG000|Overall Study|Lost to Follow-up|24|||
48501808|NCT01062256|156034046|FG000|Overall Study|Adverse Event|1|||
48501809|NCT01062256|156034047|FG001|Overall Study|Adverse Event|0|||
48501810|NCT01062256|156034048|FG002|Overall Study|Adverse Event|0|||
48501811|NCT01062256|156034046|FG000|Overall Study|Withdrawal by Subject|1|||
48501812|NCT01062256|156034047|FG001|Overall Study|Withdrawal by Subject|1|||
48501813|NCT01062256|156034048|FG002|Overall Study|Withdrawal by Subject|1|||
48722961|NCT01582854|156836556|FG001|Overall Study|General Anaesthesia|1|||
48722962|NCT01582854|156836555|FG000|Overall Study|Other Miscellaneous Reason|1|||
48722963|NCT01582854|156836556|FG001|Overall Study|Other Miscellaneous Reason|0|||
48722964|NCT02241889|156836564|FG000|Overall Study|device issues|0|||
48817482|NCT00329719|157175193|FG000|Overall Study|Lost to Follow-up|0|||
48817483|NCT00329719|157175194|FG001|Overall Study|Lost to Follow-up|0|||
48817484|NCT00329719|157175195|FG002|Overall Study|Lost to Follow-up|0|||
48501814|NCT01062256|156034046|FG000|Overall Study|Ineligible|1|||
48501815|NCT01062256|156034047|FG001|Overall Study|Ineligible|4|||
48501816|NCT01062256|156034048|FG002|Overall Study|Ineligible|3|||
48501817|NCT01062256|156034046|FG000|Overall Study|Administrative|0|||
48501818|NCT01062256|156034047|FG001|Overall Study|Administrative|2|||
48501819|NCT01062256|156034048|FG002|Overall Study|Administrative|0|||
48817485|NCT00329719|157175196|FG003|Overall Study|Lost to Follow-up|1|||
48817486|NCT03918239|157175197|FG000|Overall Study|Lost to Follow-up|3|||
48501820|NCT02780687|156034051|FG000|Overall Study|Adverse Event|1|||
48501821|NCT02780687|156034052|FG001|Overall Study|Adverse Event|1|||
48501822|NCT02780687|156034051|FG000|Overall Study|Withdrawal by Subject|2|||
48501823|NCT02780687|156034052|FG001|Overall Study|Withdrawal by Subject|1|||
48501824|NCT02780687|156034051|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
48501825|NCT02780687|156034052|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
48501826|NCT02780687|156034051|FG000|Overall Study|progressive disease|29|||
48501827|NCT02780687|156034052|FG001|Overall Study|progressive disease|6|||
48501828|NCT01606215|156034056|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
48501829|NCT01606215|156034057|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
48501830|NCT05213390|156034058|FG000|Overall Study|Withdrawal by Subject|2|||
48501831|NCT05213390|156034058|FG000|Overall Study|Lost to Follow-up|12|||
48501832|NCT05213390|156034058|FG000|Overall Study|Protocol Violation|9|||
48501833|NCT03048500|156034062|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
48501834|NCT03048500|156034062|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
48501835|NCT03048500|156034062|FG000|Reached 1st Response/Continued Treatment|Death|1|||
48501836|NCT03048500|156034062|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
48501837|NCT03048500|156034062|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
48501838|NCT03048500|156034062|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
48501839|NCT03048500|156034062|FG000|Follow up for 3 Years|Death|12|||
48501840|NCT01395030|156034065|FG000|Overall Study|Did not complete FCH PET/CT|7|||
48501841|NCT02079766|156034066|FG000|Overall Study|Physician Decision|1|||
48501842|NCT02079766|156034067|FG001|Overall Study|Physician Decision|0|||
48501843|NCT02079766|156034066|FG000|Overall Study|Withdrawal by Subject|1|||
48501844|NCT02079766|156034067|FG001|Overall Study|Withdrawal by Subject|0|||
48501845|NCT01079988|156034068|FG000|Overall Study|Lost to Follow-up|0|||
48501846|NCT01079988|156034069|FG001|Overall Study|Lost to Follow-up|0|||
48501847|NCT01079988|156034070|FG002|Overall Study|Lost to Follow-up|0|||
48501848|NCT01079988|156034071|FG003|Overall Study|Lost to Follow-up|1|||
48501849|NCT01079988|156034072|FG004|Overall Study|Lost to Follow-up|0|||
48501850|NCT01079988|156034068|FG000|Overall Study|Lack of Efficacy|1|||
48501851|NCT01079988|156034069|FG001|Overall Study|Lack of Efficacy|0|||
48501852|NCT01079988|156034070|FG002|Overall Study|Lack of Efficacy|0|||
48501853|NCT01079988|156034071|FG003|Overall Study|Lack of Efficacy|0|||
48501854|NCT01079988|156034072|FG004|Overall Study|Lack of Efficacy|0|||
48501855|NCT01079988|156034068|FG000|Overall Study|Other|0|||
48501856|NCT01079988|156034069|FG001|Overall Study|Other|0|||
48501857|NCT01079988|156034070|FG002|Overall Study|Other|0|||
48501858|NCT01079988|156034071|FG003|Overall Study|Other|2|||
48501859|NCT01079988|156034072|FG004|Overall Study|Other|1|||
48501860|NCT03595657|156034075|FG000|Overall Study|Adverse Event|14|||
48501861|NCT03595657|156034075|FG000|Overall Study|Death|1|||
48501862|NCT03595657|156034075|FG000|Overall Study|Lack of Efficacy|40|||
48501863|NCT03595657|156034075|FG000|Overall Study|Withdrawal by Subject|10|||
48501864|NCT03595657|156034075|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
48501865|NCT03595657|156034075|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
48501866|NCT04625114|156034081|FG000|Overall Study|Adverse Event|3|||
48501867|NCT04625114|156034082|FG001|Overall Study|Adverse Event|1|||
48501868|NCT04625114|156034081|FG000|Overall Study|Withdrawal by Subject|2|||
48501869|NCT04625114|156034082|FG001|Overall Study|Withdrawal by Subject|0|||
48501870|NCT03819049|156034085|FG000|Overall Study|Lost to Follow-up|1|||
48501871|NCT03819049|156034086|FG001|Overall Study|Lost to Follow-up|2|||
48501872|NCT03819049|156034087|FG002|Overall Study|Lost to Follow-up|9|||
48501873|NCT03819049|156034088|FG003|Overall Study|Lost to Follow-up|0|||
48501874|NCT03819049|156034089|FG004|Overall Study|Lost to Follow-up|3|||
48501875|NCT03819049|156034090|FG005|Overall Study|Lost to Follow-up|1|||
48501876|NCT03819049|156034091|FG006|Overall Study|Lost to Follow-up|0|||
48501877|NCT03819049|156034085|FG000|Overall Study|Withdrawal by Subject|0|||
48501878|NCT03819049|156034086|FG001|Overall Study|Withdrawal by Subject|0|||
48501879|NCT03819049|156034087|FG002|Overall Study|Withdrawal by Subject|18|||
48501880|NCT03819049|156034088|FG003|Overall Study|Withdrawal by Subject|0|||
48817487|NCT03918239|157175198|FG001|Overall Study|Lost to Follow-up|1|||
48817488|NCT03918239|157175197|FG000|Overall Study|Pregnancy|0|||
48501881|NCT03819049|156034089|FG004|Overall Study|Withdrawal by Subject|10|||
48501882|NCT03819049|156034090|FG005|Overall Study|Withdrawal by Subject|9|||
48501883|NCT03819049|156034091|FG006|Overall Study|Withdrawal by Subject|1|||
48501884|NCT03819049|156034085|FG000|Overall Study|Ongoing|0|||
48501885|NCT03819049|156034086|FG001|Overall Study|Ongoing|0|||
48501886|NCT03819049|156034087|FG002|Overall Study|Ongoing|75|||
48501887|NCT03819049|156034088|FG003|Overall Study|Ongoing|0|||
48501888|NCT03819049|156034089|FG004|Overall Study|Ongoing|41|||
48501889|NCT03819049|156034090|FG005|Overall Study|Ongoing|0|||
48501890|NCT03819049|156034091|FG006|Overall Study|Ongoing|0|||
48501891|NCT03819049|156034085|FG000|Overall Study|Other|0|||
48501892|NCT03819049|156034086|FG001|Overall Study|Other|0|||
48501893|NCT03819049|156034087|FG002|Overall Study|Other|2|||
48501894|NCT03819049|156034088|FG003|Overall Study|Other|0|||
48501895|NCT03819049|156034089|FG004|Overall Study|Other|0|||
48501896|NCT03819049|156034090|FG005|Overall Study|Other|0|||
48501897|NCT03819049|156034091|FG006|Overall Study|Other|0|||
48501898|NCT03819049|156034085|FG000|Overall Study|Randomized but not vaccinated|0|||
48501899|NCT03819049|156034086|FG001|Overall Study|Randomized but not vaccinated|0|||
48501900|NCT03819049|156034087|FG002|Overall Study|Randomized but not vaccinated|0|||
48501901|NCT03819049|156034088|FG003|Overall Study|Randomized but not vaccinated|1|||
48501902|NCT03819049|156034089|FG004|Overall Study|Randomized but not vaccinated|0|||
48501903|NCT03819049|156034090|FG005|Overall Study|Randomized but not vaccinated|2|||
48501904|NCT03819049|156034091|FG006|Overall Study|Randomized but not vaccinated|1|||
48501905|NCT03819049|156034085|FG000|Overall Study|Physician Decision|0|||
48501906|NCT03819049|156034086|FG001|Overall Study|Physician Decision|0|||
48501907|NCT03819049|156034087|FG002|Overall Study|Physician Decision|0|||
48501908|NCT03819049|156034088|FG003|Overall Study|Physician Decision|0|||
48501909|NCT03819049|156034089|FG004|Overall Study|Physician Decision|0|||
48501910|NCT03819049|156034090|FG005|Overall Study|Physician Decision|0|||
48501911|NCT03819049|156034091|FG006|Overall Study|Physician Decision|1|||
48501912|NCT01044732|156034092|FG000|Overall Study|Lost to Follow-up|2|||
48501913|NCT01044732|156034093|FG001|Overall Study|Lost to Follow-up|1|||
48501914|NCT01044732|156034092|FG000|Overall Study|Physician Decision|5|||
48722965|NCT02241889|156836565|FG001|Overall Study|device issues|0|||
48722966|NCT02241889|156836566|FG002|Overall Study|device issues|1|||
48722967|NCT02241889|156836567|FG003|Overall Study|device issues|0|||
48722968|NCT02241889|156836568|FG004|Overall Study|device issues|0|||
48722969|NCT02241889|156836569|FG005|Overall Study|device issues|0|||
48722970|NCT02241889|156836564|FG000|Overall Study|Withdrawal by Subject|0|||
48722971|NCT02241889|156836565|FG001|Overall Study|Withdrawal by Subject|0|||
48722972|NCT02241889|156836566|FG002|Overall Study|Withdrawal by Subject|0|||
48722973|NCT02241889|156836567|FG003|Overall Study|Withdrawal by Subject|0|||
48722974|NCT02241889|156836568|FG004|Overall Study|Withdrawal by Subject|0|||
48722975|NCT02241889|156836569|FG005|Overall Study|Withdrawal by Subject|1|||
48722976|NCT00722371|156836575|FG000|Overall Study|Adverse Event|6|||
48722977|NCT00722371|156836576|FG001|Overall Study|Adverse Event|13|||
48722978|NCT00722371|156836577|FG002|Overall Study|Adverse Event|9|||
48722979|NCT00722371|156836578|FG003|Overall Study|Adverse Event|10|||
48722980|NCT00722371|156836579|FG004|Overall Study|Adverse Event|6|||
48722981|NCT00722371|156836580|FG005|Overall Study|Adverse Event|8|||
48722982|NCT00722371|156836581|FG006|Overall Study|Adverse Event|4|||
48722983|NCT00722371|156836575|FG000|Overall Study|Contraindication|0|||
48722984|NCT00722371|156836576|FG001|Overall Study|Contraindication|0|||
48722985|NCT00722371|156836577|FG002|Overall Study|Contraindication|1|||
48722986|NCT00722371|156836578|FG003|Overall Study|Contraindication|0|||
48722987|NCT00722371|156836579|FG004|Overall Study|Contraindication|0|||
48722988|NCT00722371|156836580|FG005|Overall Study|Contraindication|0|||
48722989|NCT00722371|156836581|FG006|Overall Study|Contraindication|0|||
48722990|NCT00722371|156836575|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
48722991|NCT00722371|156836576|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
48722992|NCT00722371|156836577|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
48722993|NCT00722371|156836578|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
48722994|NCT00722371|156836579|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
48722995|NCT00722371|156836580|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
48722996|NCT00722371|156836581|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
48722997|NCT00722371|156836575|FG000|Overall Study|Excluded medication|0|||
48722998|NCT00722371|156836576|FG001|Overall Study|Excluded medication|1|||
48722999|NCT00722371|156836577|FG002|Overall Study|Excluded medication|1|||
48723000|NCT00722371|156836578|FG003|Overall Study|Excluded medication|0|||
48723001|NCT00722371|156836579|FG004|Overall Study|Excluded medication|0|||
48501915|NCT01044732|156034093|FG001|Overall Study|Physician Decision|3|||
48501916|NCT01044732|156034092|FG000|Overall Study|Protocol Violation|11|||
48501917|NCT01044732|156034093|FG001|Overall Study|Protocol Violation|12|||
48501918|NCT01044732|156034092|FG000|Overall Study|Withdrawal by Subject|0|||
48501919|NCT01044732|156034093|FG001|Overall Study|Withdrawal by Subject|1|||
48501920|NCT01044732|156034092|FG000|Overall Study|Inadequate bowel preparation|11|||
48501921|NCT01044732|156034093|FG001|Overall Study|Inadequate bowel preparation|17|||
48501922|NCT01044732|156034092|FG000|Overall Study|Inability to reach cecum|5|||
48501923|NCT01044732|156034093|FG001|Overall Study|Inability to reach cecum|2|||
48723002|NCT00722371|156836580|FG005|Overall Study|Excluded medication|0|||
48723003|NCT00722371|156836581|FG006|Overall Study|Excluded medication|1|||
48723004|NCT00722371|156836575|FG000|Overall Study|Hyperglycemia|2|||
48723005|NCT00722371|156836576|FG001|Overall Study|Hyperglycemia|6|||
48723006|NCT00722371|156836577|FG002|Overall Study|Hyperglycemia|4|||
48501924|NCT01044732|156034092|FG000|Overall Study|Technical error or malfunction|15|||
48501925|NCT01044732|156034093|FG001|Overall Study|Technical error or malfunction|14|||
48501926|NCT03492177|156034096|FG000|Overall Study|Adverse Event|1|||
48501927|NCT03492177|156034097|FG001|Overall Study|Adverse Event|0|||
48501928|NCT03492177|156034098|FG002|Overall Study|Adverse Event|0|||
48501929|NCT03492177|156034096|FG000|Overall Study|Death|3|||
48501930|NCT03492177|156034097|FG001|Overall Study|Death|0|||
48501931|NCT03492177|156034098|FG002|Overall Study|Death|3|||
48501932|NCT03492177|156034096|FG000|Overall Study|Lack of Efficacy|1|||
48501933|NCT03492177|156034097|FG001|Overall Study|Lack of Efficacy|2|||
48501934|NCT03492177|156034098|FG002|Overall Study|Lack of Efficacy|0|||
48501935|NCT03492177|156034096|FG000|Overall Study|Other|1|||
48501936|NCT03492177|156034097|FG001|Overall Study|Other|0|||
48501937|NCT03492177|156034098|FG002|Overall Study|Other|0|||
48501938|NCT03492177|156034096|FG000|Overall Study|Ongoing|16|||
48501939|NCT03492177|156034097|FG001|Overall Study|Ongoing|19|||
48501940|NCT03492177|156034098|FG002|Overall Study|Ongoing|17|||
48501941|NCT00694551|156034104|FG000|Overall Study|Disease Progression|1|||
48501942|NCT00694551|156034105|FG001|Overall Study|Disease Progression|0|||
48501943|NCT00694551|156034106|FG002|Overall Study|Disease Progression|1|||
48599803|NCT03428100|156391507|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599804|NCT03428100|156391508|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599805|NCT03428100|156391509|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599806|NCT03428100|156391510|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599807|NCT03428100|156391511|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599808|NCT03428100|156391512|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599809|NCT03428100|156391513|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599810|NCT03428100|156391514|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48501944|NCT02242201|156034113|FG000|Overall Study|preoperative identified neuropathy|2|||
48501945|NCT02242201|156034114|FG001|Overall Study|preoperative identified neuropathy|0|||
48501946|NCT02242201|156034115|FG002|Overall Study|preoperative identified neuropathy|0|||
48501947|NCT02242201|156034113|FG000|Overall Study|planned post-op anticoagulation|1|||
48501948|NCT02242201|156034114|FG001|Overall Study|planned post-op anticoagulation|0|||
48599811|NCT03428100|156391515|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48723007|NCT00722371|156836578|FG003|Overall Study|Hyperglycemia|2|||
48723008|NCT00722371|156836579|FG004|Overall Study|Hyperglycemia|5|||
48723009|NCT00722371|156836580|FG005|Overall Study|Hyperglycemia|1|||
48723010|NCT00722371|156836581|FG006|Overall Study|Hyperglycemia|1|||
48723011|NCT00722371|156836575|FG000|Overall Study|Hypoglycemia|1|||
48723012|NCT00722371|156836576|FG001|Overall Study|Hypoglycemia|0|||
48723013|NCT00722371|156836577|FG002|Overall Study|Hypoglycemia|0|||
48723014|NCT00722371|156836578|FG003|Overall Study|Hypoglycemia|0|||
48723015|NCT00722371|156836579|FG004|Overall Study|Hypoglycemia|0|||
48723016|NCT00722371|156836580|FG005|Overall Study|Hypoglycemia|0|||
48723017|NCT00722371|156836581|FG006|Overall Study|Hypoglycemia|0|||
48723018|NCT00722371|156836575|FG000|Overall Study|Lack of Efficacy|4|||
48723019|NCT00722371|156836576|FG001|Overall Study|Lack of Efficacy|6|||
48723020|NCT00722371|156836577|FG002|Overall Study|Lack of Efficacy|6|||
48723021|NCT00722371|156836578|FG003|Overall Study|Lack of Efficacy|6|||
48723022|NCT00722371|156836579|FG004|Overall Study|Lack of Efficacy|2|||
48723023|NCT00722371|156836580|FG005|Overall Study|Lack of Efficacy|3|||
48723024|NCT00722371|156836581|FG006|Overall Study|Lack of Efficacy|0|||
48723025|NCT00722371|156836575|FG000|Overall Study|Lost to Follow-up|11|||
48723026|NCT00722371|156836576|FG001|Overall Study|Lost to Follow-up|14|||
48723027|NCT00722371|156836577|FG002|Overall Study|Lost to Follow-up|21|||
48723028|NCT00722371|156836578|FG003|Overall Study|Lost to Follow-up|13|||
48723029|NCT00722371|156836579|FG004|Overall Study|Lost to Follow-up|8|||
48723030|NCT00722371|156836580|FG005|Overall Study|Lost to Follow-up|16|||
48723031|NCT00722371|156836581|FG006|Overall Study|Lost to Follow-up|13|||
48723032|NCT00722371|156836575|FG000|Overall Study|Physician Decision|5|||
48723033|NCT00722371|156836576|FG001|Overall Study|Physician Decision|2|||
48723034|NCT00722371|156836577|FG002|Overall Study|Physician Decision|2|||
48723035|NCT00722371|156836578|FG003|Overall Study|Physician Decision|5|||
48723036|NCT00722371|156836579|FG004|Overall Study|Physician Decision|2|||
48723037|NCT00722371|156836580|FG005|Overall Study|Physician Decision|3|||
48723038|NCT00722371|156836581|FG006|Overall Study|Physician Decision|4|||
48723039|NCT00722371|156836575|FG000|Overall Study|Pregnancy|1|||
48723040|NCT00722371|156836576|FG001|Overall Study|Pregnancy|1|||
48723041|NCT00722371|156836577|FG002|Overall Study|Pregnancy|0|||
48723042|NCT00722371|156836578|FG003|Overall Study|Pregnancy|0|||
48723043|NCT00722371|156836579|FG004|Overall Study|Pregnancy|0|||
48723044|NCT00722371|156836580|FG005|Overall Study|Pregnancy|1|||
48723045|NCT00722371|156836581|FG006|Overall Study|Pregnancy|0|||
48501949|NCT02242201|156034115|FG002|Overall Study|planned post-op anticoagulation|0|||
48501950|NCT02242201|156034113|FG000|Overall Study|changed surgical procedure|1|||
48723046|NCT00722371|156836575|FG000|Overall Study|Protocol Violation|6|||
48723047|NCT00722371|156836576|FG001|Overall Study|Protocol Violation|1|||
48723048|NCT00722371|156836577|FG002|Overall Study|Protocol Violation|0|||
48723049|NCT00722371|156836578|FG003|Overall Study|Protocol Violation|1|||
48501951|NCT02242201|156034114|FG001|Overall Study|changed surgical procedure|0|||
48501952|NCT02242201|156034115|FG002|Overall Study|changed surgical procedure|0|||
48501953|NCT02242201|156034113|FG000|Overall Study|postponed surgery|0|||
48501954|NCT02242201|156034114|FG001|Overall Study|postponed surgery|0|||
48501955|NCT02242201|156034115|FG002|Overall Study|postponed surgery|1|||
48501956|NCT02242201|156034113|FG000|Overall Study|preoperative opioid consumption|0|||
48501957|NCT02242201|156034114|FG001|Overall Study|preoperative opioid consumption|1|||
48501958|NCT02242201|156034115|FG002|Overall Study|preoperative opioid consumption|0|||
48501959|NCT01424644|156034116|FG000|Overall Study|Adverse Event|2|||
48501960|NCT01424644|156034117|FG001|Overall Study|Adverse Event|0|||
48501961|NCT01424644|156034116|FG000|Overall Study|Withdrawal by Subject|9|||
48501962|NCT01424644|156034117|FG001|Overall Study|Withdrawal by Subject|12|||
48501963|NCT01424644|156034116|FG000|Overall Study|Lost to Follow-up|16|||
48501964|NCT01424644|156034117|FG001|Overall Study|Lost to Follow-up|12|||
48501965|NCT01424644|156034116|FG000|Overall Study|Protocol Violation|4|||
48501966|NCT01424644|156034117|FG001|Overall Study|Protocol Violation|3|||
48501967|NCT01424644|156034116|FG000|Overall Study|Administrative Reason|1|||
48501968|NCT01424644|156034117|FG001|Overall Study|Administrative Reason|0|||
48501969|NCT01424644|156034116|FG000|Overall Study|Unable to Classify|1|||
48501970|NCT01424644|156034117|FG001|Overall Study|Unable to Classify|0|||
48501971|NCT03480425|156035322|FG000|Overall Study|Force transducer technical failure|1|||
48501972|NCT05113966|156035323|FG000|Overall Study|Death|21|||
48501973|NCT05113966|156035323|FG000|Overall Study|Study Terminated by Sponsor|9|||
48501974|NCT01451762|156035324|FG000|Overall Study|Lost to Follow-up|3|||
48501975|NCT01451762|156035325|FG001|Overall Study|Lost to Follow-up|6|||
48501976|NCT01451762|156035326|FG002|Overall Study|Lost to Follow-up|6|||
48501977|NCT02919683|156035334|FG000|Post-Surgery Follow-Up|Death|2|||
48501978|NCT02919683|156035335|FG001|Post-Surgery Follow-Up|Death|2|||
48501979|NCT02919683|156035334|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
48501980|NCT02919683|156035335|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
48501981|NCT04799899|156035340|FG000|Overall Study|Lost to Follow-up|2|||
48501982|NCT04799899|156035341|FG001|Overall Study|Lost to Follow-up|4|||
48501983|NCT00912288|156035346|FG000|Overall Study|Death|0|||
48501984|NCT00912288|156035347|FG001|Overall Study|Death|1|||
48501985|NCT00912288|156035346|FG000|Overall Study|Adverse Event|1|||
48501986|NCT00912288|156035347|FG001|Overall Study|Adverse Event|1|||
48501987|NCT00912288|156035346|FG000|Overall Study|Lost to Follow-up|1|||
48501988|NCT00912288|156035347|FG001|Overall Study|Lost to Follow-up|0|||
48501989|NCT00912288|156035346|FG000|Overall Study|Protocol Violation|1|||
48501990|NCT00912288|156035347|FG001|Overall Study|Protocol Violation|0|||
48599812|NCT03428100|156391516|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599813|NCT03428100|156391517|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48501991|NCT00912288|156035346|FG000|Overall Study|Withdrawal by Subject|3|||
48501992|NCT00912288|156035347|FG001|Overall Study|Withdrawal by Subject|3|||
48501993|NCT00912288|156035346|FG000|Overall Study|Study terminated by sponsor|34|||
48501994|NCT00912288|156035347|FG001|Overall Study|Study terminated by sponsor|35|||
48501995|NCT00912288|156035346|FG000|Overall Study|Other|1|||
48501996|NCT00912288|156035347|FG001|Overall Study|Other|0|||
48501997|NCT01440283|156035350|FG000|Overall Study|Death|3|||
48501998|NCT01440283|156035350|FG000|Overall Study|Withdrawal by Subject|4|||
48501999|NCT01440283|156035350|FG000|Overall Study|Physician Decision|3|||
48502000|NCT03896789|156035351|FG000|Baseline|Lost to Follow-up|1|||
48502001|NCT03896789|156035352|FG001|Baseline|Lost to Follow-up|2|||
48502002|NCT03896789|156035351|FG000|Baseline|Death|3|||
48502003|NCT03896789|156035352|FG001|Baseline|Death|6|||
48502004|NCT03896789|156035351|FG000|Post-Randomization|Lost to Follow-up|12|||
48502005|NCT03896789|156035352|FG001|Post-Randomization|Lost to Follow-up|11|||
48502006|NCT03896789|156035351|FG000|Post-Randomization|Death|12|||
48502007|NCT03896789|156035352|FG001|Post-Randomization|Death|13|||
48599814|NCT03428100|156391518|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
48599815|NCT03428100|156391500|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
48502008|NCT01449630|156035353|FG000|Period 1|Physician Decision|1|||
48502009|NCT01449630|156035354|FG001|Period 1|Physician Decision|0|||
48502010|NCT01449630|156035355|FG002|Period 1|Physician Decision|0|||
48502011|NCT01449630|156035356|FG003|Period 1|Physician Decision|1|||
48502012|NCT01449630|156035357|FG004|Period 1|Physician Decision|0|||
48599816|NCT03428100|156391501|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
48502013|NCT01449630|156035358|FG005|Period 1|Physician Decision|0|||
48502014|NCT01449630|156035359|FG006|Period 1|Physician Decision|0|||
48502015|NCT01449630|156035360|FG007|Period 1|Physician Decision|0|||
48502016|NCT01449630|156035361|FG008|Period 1|Physician Decision|0|||
48502017|NCT01449630|156035353|FG000|Period 1|Sponsor Decision|0|||
48502018|NCT01449630|156035354|FG001|Period 1|Sponsor Decision|0|||
48502019|NCT01449630|156035355|FG002|Period 1|Sponsor Decision|0|||
48502020|NCT01449630|156035356|FG003|Period 1|Sponsor Decision|0|||
48502021|NCT01449630|156035357|FG004|Period 1|Sponsor Decision|0|||
48502022|NCT01449630|156035358|FG005|Period 1|Sponsor Decision|1|||
48502023|NCT01449630|156035359|FG006|Period 1|Sponsor Decision|0|||
48502024|NCT01449630|156035360|FG007|Period 1|Sponsor Decision|0|||
48502025|NCT01449630|156035361|FG008|Period 1|Sponsor Decision|0|||
48502026|NCT01449630|156035353|FG000|Period 2|Sponsor Decision|0|||
48502027|NCT01449630|156035354|FG001|Period 2|Sponsor Decision|0|||
48502028|NCT01449630|156035355|FG002|Period 2|Sponsor Decision|0|||
48502029|NCT01449630|156035356|FG003|Period 2|Sponsor Decision|0|||
48502030|NCT01449630|156035357|FG004|Period 2|Sponsor Decision|0|||
48502031|NCT01449630|156035358|FG005|Period 2|Sponsor Decision|0|||
48502032|NCT01449630|156035359|FG006|Period 2|Sponsor Decision|1|||
48502033|NCT01449630|156035360|FG007|Period 2|Sponsor Decision|0|||
48502034|NCT01449630|156035361|FG008|Period 2|Sponsor Decision|0|||
48502035|NCT02430870|156035369|FG000|Part 2|Voluntary Withdrawal|0|||
48502036|NCT02430870|156035370|FG001|Part 2|Voluntary Withdrawal|0|||
48502037|NCT02430870|156035371|FG002|Part 2|Voluntary Withdrawal|0|||
48502038|NCT02430870|156035372|FG003|Part 2|Voluntary Withdrawal|0|||
48502039|NCT02430870|156035373|FG004|Part 2|Voluntary Withdrawal|0|||
48502040|NCT02430870|156035374|FG005|Part 2|Voluntary Withdrawal|0|||
48502041|NCT02430870|156035375|FG006|Part 2|Voluntary Withdrawal|1|||
48502042|NCT02430870|156035376|FG007|Part 2|Voluntary Withdrawal|0|||
48502043|NCT02430870|156035369|FG000|Part 2|Other Reason Not Specified|0|||
48502044|NCT02430870|156035370|FG001|Part 2|Other Reason Not Specified|0|||
48502045|NCT02430870|156035371|FG002|Part 2|Other Reason Not Specified|0|||
48502046|NCT02430870|156035372|FG003|Part 2|Other Reason Not Specified|0|||
48502047|NCT02430870|156035373|FG004|Part 2|Other Reason Not Specified|0|||
48502048|NCT02430870|156035374|FG005|Part 2|Other Reason Not Specified|0|||
48502049|NCT02430870|156035375|FG006|Part 2|Other Reason Not Specified|0|||
48502050|NCT02430870|156035376|FG007|Part 2|Other Reason Not Specified|1|||
48502051|NCT03447470|156035377|FG000|Overall Study|Death|0|||
48502052|NCT03447470|156035378|FG001|Overall Study|Death|1|||
48502053|NCT03447470|156035379|FG002|Overall Study|Death|3|||
48502054|NCT03447470|156035380|FG003|Overall Study|Death|0|||
48502055|NCT03447470|156035381|FG004|Overall Study|Death|1|||
48502056|NCT03447470|156035382|FG005|Overall Study|Death|0|||
48502057|NCT03447470|156035383|FG006|Overall Study|Death|3|||
48502058|NCT03447470|156035384|FG007|Overall Study|Death|3|||
48502059|NCT03447470|156035385|FG008|Overall Study|Death|1|||
48502060|NCT03447470|156035377|FG000|Overall Study|Withdrawal by Subject|1|||
48502061|NCT03447470|156035378|FG001|Overall Study|Withdrawal by Subject|0|||
48502062|NCT03447470|156035379|FG002|Overall Study|Withdrawal by Subject|0|||
48502063|NCT03447470|156035380|FG003|Overall Study|Withdrawal by Subject|0|||
48502064|NCT03447470|156035381|FG004|Overall Study|Withdrawal by Subject|1|||
48502065|NCT03447470|156035382|FG005|Overall Study|Withdrawal by Subject|0|||
48502066|NCT03447470|156035383|FG006|Overall Study|Withdrawal by Subject|1|||
48502067|NCT03447470|156035384|FG007|Overall Study|Withdrawal by Subject|1|||
48502068|NCT03447470|156035385|FG008|Overall Study|Withdrawal by Subject|3|||
48502069|NCT03447470|156035377|FG000|Overall Study|Treatment discontinued|3|||
48502070|NCT03447470|156035378|FG001|Overall Study|Treatment discontinued|2|||
48502071|NCT03447470|156035379|FG002|Overall Study|Treatment discontinued|4|||
48502072|NCT03447470|156035380|FG003|Overall Study|Treatment discontinued|6|||
48502073|NCT03447470|156035381|FG004|Overall Study|Treatment discontinued|2|||
48502074|NCT03447470|156035382|FG005|Overall Study|Treatment discontinued|1|||
48502075|NCT03447470|156035383|FG006|Overall Study|Treatment discontinued|2|||
48502076|NCT03447470|156035384|FG007|Overall Study|Treatment discontinued|4|||
48502077|NCT03447470|156035385|FG008|Overall Study|Treatment discontinued|3|||
48502078|NCT03049488|156035386|FG000|Overall Study|Lost to Follow-up|1|||
48502079|NCT03049488|156035387|FG001|Overall Study|Lost to Follow-up|1|||
48502080|NCT03049488|156035388|FG002|Overall Study|Lost to Follow-up|0|||
48502081|NCT03049488|156035389|FG003|Overall Study|Lost to Follow-up|0|||
48502082|NCT03049488|156035390|FG004|Overall Study|Lost to Follow-up|0|||
48502083|NCT03049488|156035391|FG005|Overall Study|Lost to Follow-up|0|||
48502084|NCT03049488|156035386|FG000|Overall Study|Moved from Area|1|||
48502085|NCT03049488|156035387|FG001|Overall Study|Moved from Area|0|||
48502086|NCT03049488|156035388|FG002|Overall Study|Moved from Area|0|||
48502087|NCT03049488|156035389|FG003|Overall Study|Moved from Area|1|||
48502088|NCT03049488|156035390|FG004|Overall Study|Moved from Area|1|||
48502089|NCT03049488|156035391|FG005|Overall Study|Moved from Area|0|||
48502090|NCT03049488|156035386|FG000|Overall Study|Physician Decision|0|||
48502091|NCT03049488|156035387|FG001|Overall Study|Physician Decision|1|||
48502092|NCT03049488|156035388|FG002|Overall Study|Physician Decision|0|||
48502093|NCT03049488|156035389|FG003|Overall Study|Physician Decision|0|||
48502094|NCT03049488|156035390|FG004|Overall Study|Physician Decision|0|||
48502095|NCT03049488|156035391|FG005|Overall Study|Physician Decision|0|||
48502096|NCT03049488|156035386|FG000|Overall Study|Withdrawal by Subject|0|||
48502097|NCT03049488|156035387|FG001|Overall Study|Withdrawal by Subject|0|||
48502098|NCT03049488|156035388|FG002|Overall Study|Withdrawal by Subject|0|||
48502099|NCT03049488|156035389|FG003|Overall Study|Withdrawal by Subject|1|||
48502100|NCT03049488|156035390|FG004|Overall Study|Withdrawal by Subject|1|||
48502101|NCT03049488|156035391|FG005|Overall Study|Withdrawal by Subject|0|||
48502102|NCT02362503|156035392|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
48502103|NCT02362503|156035393|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
48502104|NCT02362503|156035394|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
48502105|NCT02362503|156035392|FG000|Double-blind Period-Up to 8 Days|Death|1|||
48502106|NCT02362503|156035393|FG001|Double-blind Period-Up to 8 Days|Death|0|||
48502107|NCT02362503|156035394|FG002|Double-blind Period-Up to 8 Days|Death|0|||
48502108|NCT02362503|156035392|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
48502109|NCT02362503|156035393|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
48502110|NCT02362503|156035394|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
48502111|NCT02362503|156035392|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
48502112|NCT02362503|156035393|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
48502113|NCT02362503|156035394|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
48502114|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
48502115|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
48502116|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
48502117|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
48502118|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
48502119|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
48502120|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
48502121|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
48502122|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
48502123|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
48502124|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
48502125|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
48502126|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
48502127|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
48502128|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
48502129|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
48502130|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
48502131|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
48502132|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
48502133|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
48502134|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
48502135|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
48502136|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
48502137|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
48502138|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
48502139|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
48502140|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
48502141|NCT02362503|156035392|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
48502142|NCT02362503|156035393|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
48502143|NCT02362503|156035394|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
48502144|NCT04692077|156035395|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
48502145|NCT04044768|156035396|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
48502146|NCT04044768|156035397|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
48502147|NCT05447663|156035401|FG000|Overall Study|Study terminated by Sponsor|5|||
48502148|NCT05447663|156035401|FG000|Overall Study|Death|2|||
48502149|NCT05447663|156035401|FG000|Overall Study|Withdrawal by Subject|1|||
48502150|NCT04338061|156035402|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
48502151|NCT04338061|156035403|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
48502152|NCT04338061|156035402|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
48502153|NCT04338061|156035403|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
48502154|NCT04338061|156035402|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
48502155|NCT04338061|156035403|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
48502156|NCT04338061|156035402|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
48502157|NCT04338061|156035403|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
48502158|NCT04338061|156035402|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
48502159|NCT04338061|156035403|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
48502160|NCT04338061|156035402|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
48502161|NCT04338061|156035403|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
48502162|NCT04338061|156035402|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
48502163|NCT04338061|156035403|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
48502164|NCT04338061|156035402|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
48502165|NCT04338061|156035403|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
48502166|NCT04338061|156035402|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
48502167|NCT04338061|156035403|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
48502168|NCT04338061|156035402|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
48723050|NCT00722371|156836579|FG004|Overall Study|Protocol Violation|4|||
48723051|NCT00722371|156836580|FG005|Overall Study|Protocol Violation|2|||
48723052|NCT00722371|156836581|FG006|Overall Study|Protocol Violation|1|||
48502169|NCT04338061|156035403|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
48502170|NCT04338061|156035402|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
48502171|NCT04338061|156035403|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
48502172|NCT04338061|156035402|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
48817489|NCT03918239|157175198|FG001|Overall Study|Pregnancy|2|||
48817490|NCT03918239|157175197|FG000|Overall Study|Withdrawal by Subject|3|||
48817491|NCT03918239|157175198|FG001|Overall Study|Withdrawal by Subject|3|||
48817492|NCT03918239|157175197|FG000|Overall Study|positive urine drug screening results|4|||
48817493|NCT03918239|157175198|FG001|Overall Study|positive urine drug screening results|1|||
48817494|NCT01681368|157175200|FG000|Overall Study|Refused further treatment|1|||
48502173|NCT04338061|156035403|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
48502174|NCT01698905|156035404|FG000|Overall Study|Adverse Event|4|||
48502175|NCT01698905|156035404|FG000|Overall Study|Physician Decision|2|||
48502176|NCT01698905|156035404|FG000|Overall Study|Pregnancy|1|||
48502177|NCT01698905|156035404|FG000|Overall Study|Protocol Violation|1|||
48502178|NCT01698905|156035404|FG000|Overall Study|Subject/guardian decision|2|||
48817495|NCT01681368|157175200|FG000|Overall Study|Refused further follow up|1|||
48817496|NCT01189890|157175201|FG000|Overall Study|Adverse Event|3|||
48817497|NCT01189890|157175202|FG001|Overall Study|Adverse Event|4|||
48817498|NCT01189890|157175201|FG000|Overall Study|Lack of Efficacy|7|||
48502179|NCT01698905|156035404|FG000|Overall Study|Death|1|||
48502180|NCT04510285|156035407|FG000|Overall Study|Death|1|||
48502181|NCT03929393|156035414|FG000|Overall Study|Death|1|||
48502182|NCT03929393|156035415|FG001|Overall Study|Death|0|||
48502183|NCT03929393|156035414|FG000|Overall Study|Time Commitment|2|||
48502184|NCT03929393|156035415|FG001|Overall Study|Time Commitment|5|||
48502185|NCT03929393|156035414|FG000|Overall Study|Motor Vehicle Accident|0|||
48502186|NCT03929393|156035415|FG001|Overall Study|Motor Vehicle Accident|1|||
48502187|NCT03929393|156035414|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
48502188|NCT03929393|156035415|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
48502189|NCT03929393|156035414|FG000|Overall Study|Other|1|||
48502190|NCT03929393|156035415|FG001|Overall Study|Other|3|||
48502191|NCT00980538|156035416|FG000|Overall Study|Lost to Follow-up|20|||
48502192|NCT00980538|156035416|FG000|Overall Study|Sponsor's Decision|4|||
48502193|NCT00980538|156035416|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
48502194|NCT00980538|156035416|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
48502195|NCT00980538|156035416|FG000|Overall Study|Switch to Commercially Available Medication|25|||
48502196|NCT00980538|156035416|FG000|Overall Study|Participant Non-Compliant|9|||
48502197|NCT00980538|156035416|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
48502198|NCT00980538|156035416|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
48502199|NCT00980538|156035416|FG000|Overall Study|Other|60|||
48502200|NCT00980538|156035416|FG000|Overall Study|Other|1|||
48502201|NCT02272777|156035417|FG000|Overall Study|Adverse Event|0|||
48502202|NCT02272777|156035418|FG001|Overall Study|Adverse Event|1|||
48502203|NCT02272777|156035417|FG000|Overall Study|Withdrawal by Subject|0|||
48502204|NCT02272777|156035418|FG001|Overall Study|Withdrawal by Subject|3|||
48502205|NCT02272777|156035417|FG000|Overall Study|Lost to Follow-up|2|||
48502206|NCT02272777|156035418|FG001|Overall Study|Lost to Follow-up|0|||
48502207|NCT02272777|156035417|FG000|Overall Study|Other|2|||
48502208|NCT02272777|156035418|FG001|Overall Study|Other|0|||
48502209|NCT02066922|156035421|FG000|Overall Study|Adverse Event|1|||
48502210|NCT03020641|156035423|FG000|Overall Study|Lost to Follow-up|0|||
48502211|NCT03020641|156035424|FG001|Overall Study|Lost to Follow-up|1|||
48502212|NCT03020641|156035423|FG000|Overall Study|Converted to open surgery|2|||
48502213|NCT03020641|156035424|FG001|Overall Study|Converted to open surgery|1|||
48502214|NCT03020641|156035423|FG000|Overall Study|for surgery not performed|0|||
48502215|NCT03020641|156035424|FG001|Overall Study|for surgery not performed|1|||
48502216|NCT03978637|156035425|FG000|Overall Study|Death|0|||
48502217|NCT03978637|156035426|FG001|Overall Study|Death|2|||
48502218|NCT03978637|156035427|FG002|Overall Study|Death|2|||
48817499|NCT01189890|157175202|FG001|Overall Study|Lack of Efficacy|2|||
48817500|NCT01189890|157175201|FG000|Overall Study|Lost to Follow-up|1|||
48817501|NCT01189890|157175202|FG001|Overall Study|Lost to Follow-up|7|||
48817502|NCT01189890|157175201|FG000|Overall Study|Protocol Violation|1|||
48502219|NCT03978637|156035428|FG003|Overall Study|Death|0|||
48502220|NCT03978637|156035425|FG000|Overall Study|Withdrawal by Subject|0|||
48502221|NCT03978637|156035426|FG001|Overall Study|Withdrawal by Subject|0|||
48502222|NCT03978637|156035427|FG002|Overall Study|Withdrawal by Subject|1|||
48502223|NCT03978637|156035428|FG003|Overall Study|Withdrawal by Subject|0|||
48502224|NCT03978637|156035425|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
48502225|NCT03978637|156035426|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
48502226|NCT03978637|156035427|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
48502227|NCT03978637|156035428|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
48817503|NCT01189890|157175202|FG001|Overall Study|Protocol Violation|5|||
48817504|NCT01189890|157175201|FG000|Overall Study|Withdrawal by Subject|15|||
48817505|NCT01189890|157175202|FG001|Overall Study|Withdrawal by Subject|11|||
48502228|NCT03773107|156035429|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
48502229|NCT03773107|156035430|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
48502230|NCT03773107|156035431|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
48502231|NCT03773107|156035432|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
48502232|NCT03365882|156036461|FG000|Randomization|Still Receiving Protocol Treatment|2|||
48502233|NCT03365882|156036462|FG001|Randomization|Still Receiving Protocol Treatment|0|||
48502234|NCT03365882|156036461|FG000|Randomization|Adverse Event|1|||
48502235|NCT03365882|156036462|FG001|Randomization|Adverse Event|2|||
48502236|NCT03365882|156036461|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
48502237|NCT03365882|156036462|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
48817506|NCT01189890|157175201|FG000|Overall Study|Non Compliance|0|||
48817507|NCT01189890|157175202|FG001|Overall Study|Non Compliance|1|||
48817508|NCT01189890|157175201|FG000|Overall Study|Physician Decision|5|||
48502238|NCT03365882|156036461|FG000|Randomization|Progression/Relapse|21|||
48502239|NCT03365882|156036462|FG001|Randomization|Progression/Relapse|3|||
48502240|NCT03365882|156036461|FG000|Randomization|Death|1|||
48502241|NCT03365882|156036462|FG001|Randomization|Death|0|||
48502242|NCT03365882|156036461|FG000|Randomization|Other - Not Protocol Specified|1|||
48502243|NCT03365882|156036462|FG001|Randomization|Other - Not Protocol Specified|1|||
48502244|NCT03365882|156036461|FG000|Randomization|Major Protocol Deviation|0|||
48502245|NCT03365882|156036462|FG001|Randomization|Major Protocol Deviation|1|||
48502246|NCT03365882|156036461|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
48502247|NCT03365882|156036462|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
48502248|NCT03365882|156036461|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
48502249|NCT03365882|156036462|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
48502250|NCT03365882|156036461|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
48502251|NCT03365882|156036462|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
48502252|NCT03365882|156036461|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
48502253|NCT03365882|156036462|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
48502254|NCT01704079|156036465|FG000|Overall Study|Withdrawal by Subject|5|||
48502255|NCT01704079|156036466|FG001|Overall Study|Withdrawal by Subject|7|||
48502256|NCT01704079|156036465|FG000|Overall Study|Lost to Follow-up|2|||
48502257|NCT01704079|156036466|FG001|Overall Study|Lost to Follow-up|5|||
48502258|NCT01704079|156036465|FG000|Overall Study|Adverse Event|4|||
48502259|NCT01704079|156036466|FG001|Overall Study|Adverse Event|7|||
48502260|NCT01704079|156036465|FG000|Overall Study|Protocol Violation|1|||
48502261|NCT01704079|156036466|FG001|Overall Study|Protocol Violation|0|||
48502262|NCT01704079|156036465|FG000|Overall Study|Subject noncompliance|2|||
48502263|NCT01704079|156036466|FG001|Overall Study|Subject noncompliance|3|||
48502264|NCT01704079|156036465|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
48502265|NCT01704079|156036466|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
48502266|NCT00630305|156036469|FG000|Overall Study|Withdrawal by Subject|1|||
48502267|NCT00630305|156036469|FG000|Overall Study|Inability to insert contact lens|1|||
48502268|NCT01085045|156036470|FG000|Part A|Withdrawal by Subject|4|||
48502269|NCT01085045|156036470|FG000|Part A|Adverse Event|6|||
48502270|NCT01085045|156036470|FG000|Part A|Protocol Violation|1|||
48502271|NCT01085045|156036470|FG000|Part A|Protocol Specified Criteria|7|||
48502272|NCT01085045|156036470|FG000|Part B|Withdrawal by Subject|2|||
48502273|NCT01085045|156036470|FG000|Part B|Protocol Specified Criteria|6|||
48502274|NCT01085045|156036470|FG000|Part B|Lost to Follow-up|1|||
48502275|NCT01085045|156036470|FG000|Part B|Adverse Event|6|||
48502276|NCT05986565|156036471|FG000|Overall Study|Lost to Follow-up|8|||
48502277|NCT05986565|156036472|FG001|Overall Study|Lost to Follow-up|3|||
48502278|NCT05986565|156036471|FG000|Overall Study|Withdrawal by Subject|0|||
48502279|NCT05986565|156036472|FG001|Overall Study|Withdrawal by Subject|1|||
48502280|NCT04755595|156036475|FG000|Overall Study|Lost to Follow-up|1|||
48502281|NCT02109042|156036483|FG000|Overall Study|Sponsor Decision|15|||
48502282|NCT01511939|156036486|FG000|Overall Study|Withdrawal by Subject|2|||
48502283|NCT01511939|156036487|FG001|Overall Study|Withdrawal by Subject|1|||
48502284|NCT01511939|156036488|FG002|Overall Study|Withdrawal by Subject|0|||
48502285|NCT03203447|156036493|FG000|Overall Study|Withdrawal by Subject|2|||
48502286|NCT03203447|156036494|FG001|Overall Study|Withdrawal by Subject|1|||
48502287|NCT03203447|156036493|FG000|Overall Study|Lost to Follow-up|1|||
48502288|NCT03203447|156036494|FG001|Overall Study|Lost to Follow-up|10|||
48502289|NCT03203447|156036493|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
48502290|NCT03203447|156036494|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
48502291|NCT00324168|156036495|FG000|Overall Study|Lost to Follow-up|19|||
48502292|NCT00324168|156036496|FG001|Overall Study|Lost to Follow-up|18|||
48502293|NCT00324168|156036495|FG000|Overall Study|Death|3|||
48502294|NCT00324168|156036496|FG001|Overall Study|Death|3|||
48502295|NCT00324168|156036495|FG000|Overall Study|Patient did not visit in f/u window|6|||
48502296|NCT00324168|156036496|FG001|Overall Study|Patient did not visit in f/u window|9|||
48817509|NCT01189890|157175202|FG001|Overall Study|Physician Decision|4|||
48599817|NCT03428100|156391502|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
48599818|NCT03428100|156391503|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
48599819|NCT03428100|156391504|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599820|NCT03428100|156391505|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599821|NCT03428100|156391506|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599822|NCT03428100|156391507|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48723053|NCT00722371|156836575|FG000|Overall Study|Withdrawal by Subject|18|||
48723054|NCT00722371|156836576|FG001|Overall Study|Withdrawal by Subject|27|||
48723055|NCT00722371|156836577|FG002|Overall Study|Withdrawal by Subject|19|||
48817510|NCT01189890|157175201|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
48817511|NCT01189890|157175202|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
48817512|NCT03398148|157175203|FG000|Substudy 1 Period 1|Adverse Event|5|||
48817513|NCT03398148|157175204|FG001|Substudy 1 Period 1|Adverse Event|2|||
48817514|NCT03398148|157175205|FG002|Substudy 1 Period 1|Adverse Event|2|||
48817515|NCT03398148|157175206|FG003|Substudy 1 Period 1|Adverse Event|0|||
48817516|NCT03398148|157175207|FG004|Substudy 1 Period 1|Adverse Event|8|||
48817517|NCT03398148|157175208|FG005|Substudy 1 Period 1|Adverse Event|0|||
48817518|NCT03398148|157175209|FG006|Substudy 1 Period 1|Adverse Event|0|||
48599823|NCT03428100|156391508|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599824|NCT03428100|156391509|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599825|NCT03428100|156391510|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48723056|NCT00722371|156836578|FG003|Overall Study|Withdrawal by Subject|23|||
48723057|NCT00722371|156836579|FG004|Overall Study|Withdrawal by Subject|19|||
48723058|NCT00722371|156836580|FG005|Overall Study|Withdrawal by Subject|18|||
48723059|NCT00722371|156836581|FG006|Overall Study|Withdrawal by Subject|26|||
48723060|NCT01423604|156836589|FG000|Safety Run-In|Adverse Event|3|||
48723061|NCT01423604|156836590|FG001|Safety Run-In|Adverse Event|0|||
48723062|NCT01423604|156836589|FG000|Safety Run-In|Death|1|||
48723063|NCT01423604|156836590|FG001|Safety Run-In|Death|0|||
48723064|NCT01423604|156836589|FG000|Safety Run-In|Physician Decision|1|||
48723065|NCT01423604|156836590|FG001|Safety Run-In|Physician Decision|0|||
48723066|NCT01423604|156836589|FG000|Safety Run-In|Disease progression|3|||
48723067|NCT01423604|156836590|FG001|Safety Run-In|Disease progression|0|||
48723068|NCT01423604|156836589|FG000|Safety Run-In|Patient decision|1|||
48723069|NCT01423604|156836590|FG001|Safety Run-In|Patient decision|0|||
48723070|NCT01423604|156836589|FG000|Randomized|Adverse Event|4|||
48723071|NCT01423604|156836590|FG001|Randomized|Adverse Event|10|||
48723072|NCT01423604|156836589|FG000|Randomized|Death|1|||
48723073|NCT01423604|156836590|FG001|Randomized|Death|0|||
48723074|NCT01423604|156836589|FG000|Randomized|Physician Decision|16|||
48723075|NCT01423604|156836590|FG001|Randomized|Physician Decision|13|||
48723076|NCT01423604|156836589|FG000|Randomized|Other - unspecified|37|||
48723077|NCT01423604|156836590|FG001|Randomized|Other - unspecified|31|||
48723078|NCT01423604|156836589|FG000|Randomized|Patient decision|5|||
48723079|NCT01423604|156836590|FG001|Randomized|Patient decision|9|||
48723080|NCT00424255|156836591|FG000|Overall Study|Death|115|||
48723081|NCT00424255|156836592|FG001|Overall Study|Death|111|||
48723082|NCT00424255|156836591|FG000|Overall Study|Lost to Follow-up|26|||
48723083|NCT00424255|156836592|FG001|Overall Study|Lost to Follow-up|20|||
48723084|NCT00424255|156836591|FG000|Overall Study|Protocol Violation|0|||
48723085|NCT00424255|156836592|FG001|Overall Study|Protocol Violation|1|||
48723086|NCT00424255|156836591|FG000|Overall Study|Withdrawal by Subject|34|||
48723087|NCT00424255|156836592|FG001|Overall Study|Withdrawal by Subject|38|||
48723088|NCT00424255|156836591|FG000|Overall Study|Physician Decision|3|||
48723089|NCT00424255|156836592|FG001|Overall Study|Physician Decision|7|||
48723090|NCT00424255|156836591|FG000|Overall Study|Cognitive Disturbance|1|||
48817519|NCT03398148|157175210|FG007|Substudy 1 Period 1|Adverse Event|0|||
48817520|NCT03398148|157175211|FG008|Substudy 1 Period 1|Adverse Event|0|||
48723091|NCT00424255|156836592|FG001|Overall Study|Cognitive Disturbance|0|||
48723092|NCT00424255|156836591|FG000|Overall Study|Non-compliance by Participants|1|||
48723093|NCT00424255|156836592|FG001|Overall Study|Non-compliance by Participants|0|||
48723094|NCT00424255|156836591|FG000|Overall Study|Fatigue|1|||
48723095|NCT00424255|156836592|FG001|Overall Study|Fatigue|0|||
48723096|NCT00424255|156836591|FG000|Overall Study|Disease Progression|0|||
48723097|NCT00424255|156836592|FG001|Overall Study|Disease Progression|2|||
48723098|NCT00424255|156836591|FG000|Overall Study|Sponsor Terminated Study|161|||
48723099|NCT00424255|156836592|FG001|Overall Study|Sponsor Terminated Study|167|||
48723100|NCT00256282|156836593|FG000|Overall Study|Disease progression, relapse during acti|12|||
48723101|NCT00256282|156836593|FG000|Overall Study|Adverse Event|3|||
48723102|NCT00256282|156836593|FG000|Overall Study|Physician Decision|1|||
48723103|NCT00969280|156836594|FG000|Overall Study|Protocol Violation|2|||
48723104|NCT00969280|156836595|FG001|Overall Study|Protocol Violation|1|||
48723105|NCT00969280|156836594|FG000|Overall Study|Withdrawal by Subject|0|||
48723106|NCT00969280|156836595|FG001|Overall Study|Withdrawal by Subject|1|||
48723107|NCT00969280|156836594|FG000|Overall Study|infection of influenza A(H1N1)|0|||
48723108|NCT00969280|156836595|FG001|Overall Study|infection of influenza A(H1N1)|1|||
48723109|NCT02290431|156836596|FG000|Overall Study|Adverse Event|20|||
48502297|NCT01203878|156036497|FG000|Overall Study|Withdrawal by Subject|0|||
48502298|NCT01203878|156036498|FG001|Overall Study|Withdrawal by Subject|0|||
48502299|NCT01203878|156036499|FG002|Overall Study|Withdrawal by Subject|1|||
48599826|NCT03428100|156391511|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599827|NCT03428100|156391512|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599828|NCT03428100|156391513|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599829|NCT03428100|156391514|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599830|NCT03428100|156391515|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599831|NCT03428100|156391516|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599832|NCT03428100|156391517|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599833|NCT03428100|156391518|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
48599834|NCT03428100|156391500|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599835|NCT03428100|156391501|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
48599836|NCT03428100|156391502|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
48599837|NCT03428100|156391503|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599838|NCT03428100|156391504|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599839|NCT03428100|156391505|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599840|NCT03428100|156391506|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599841|NCT03428100|156391507|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48723110|NCT02290431|156836596|FG000|Overall Study|Progressive disease|4|||
48723111|NCT02290431|156836596|FG000|Overall Study|Study terminated by Sponsor|1|||
48723112|NCT02290431|156836596|FG000|Overall Study|Physician Decision|2|||
48723113|NCT03963401|156836597|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
48723114|NCT03963401|156836598|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
48723115|NCT03963401|156836599|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
48723116|NCT03963401|156836600|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
48723117|NCT03963401|156836601|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
48723118|NCT03963401|156836602|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
48723119|NCT03963401|156836597|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
48723120|NCT03963401|156836598|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
48599842|NCT03428100|156391508|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599843|NCT03428100|156391509|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599844|NCT03428100|156391510|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599845|NCT03428100|156391511|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599846|NCT03428100|156391512|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48723121|NCT03963401|156836599|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
48723122|NCT03963401|156836600|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
48723123|NCT03963401|156836601|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
48723124|NCT03963401|156836602|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
48723125|NCT03963401|156836597|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
48723126|NCT03963401|156836598|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
48723127|NCT03963401|156836599|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
48723128|NCT03963401|156836600|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
48723129|NCT03963401|156836601|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
48723130|NCT03963401|156836602|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
48723131|NCT03963401|156836597|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723132|NCT03963401|156836598|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
48723133|NCT03963401|156836599|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723134|NCT03963401|156836600|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723135|NCT03963401|156836601|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723136|NCT03963401|156836602|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
48723137|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
48723138|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
48817521|NCT03398148|157175212|FG009|Substudy 1 Period 1|Adverse Event|0|||
48502300|NCT01203878|156036497|FG000|Overall Study|Adverse Event|0|||
48502301|NCT01203878|156036498|FG001|Overall Study|Adverse Event|0|||
48502302|NCT01203878|156036499|FG002|Overall Study|Adverse Event|2|||
48502303|NCT03652688|156036500|FG000|Baseline|Withdrawal by Subject|0|||
48502304|NCT03652688|156036501|FG001|Baseline|Withdrawal by Subject|3|||
48502305|NCT03652688|156036500|FG000|Follow-up|Lost to Follow-up|56|||
48502306|NCT03652688|156036501|FG001|Follow-up|Lost to Follow-up|54|||
48502307|NCT01735630|156036507|FG000|Overall Study|Adverse Event|8|||
48502308|NCT01735630|156036508|FG001|Overall Study|Adverse Event|7|||
48502309|NCT01735630|156036507|FG000|Overall Study|Lost to Follow-up|1|||
48502310|NCT01735630|156036508|FG001|Overall Study|Lost to Follow-up|0|||
48502311|NCT01735630|156036507|FG000|Overall Study|Physician Decision|0|||
48502312|NCT01735630|156036508|FG001|Overall Study|Physician Decision|1|||
48502313|NCT01735630|156036507|FG000|Overall Study|Sponsor Decision|2|||
48502314|NCT01735630|156036508|FG001|Overall Study|Sponsor Decision|1|||
48723139|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
48723140|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
48723141|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
48817522|NCT03398148|157175213|FG010|Substudy 1 Period 1|Adverse Event|0|||
48817523|NCT03398148|157175214|FG011|Substudy 1 Period 1|Adverse Event|0|||
48817524|NCT03398148|157175215|FG012|Substudy 1 Period 1|Adverse Event|0|||
48817525|NCT03398148|157175216|FG013|Substudy 1 Period 1|Adverse Event|0|||
48817526|NCT03398148|157175217|FG014|Substudy 1 Period 1|Adverse Event|0|||
48817527|NCT03398148|157175203|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
48817528|NCT03398148|157175204|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
48817529|NCT03398148|157175205|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817530|NCT03398148|157175206|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
48817531|NCT03398148|157175207|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
48817532|NCT03398148|157175208|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817533|NCT03398148|157175209|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817534|NCT03398148|157175210|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817535|NCT03398148|157175211|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817536|NCT03398148|157175212|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817537|NCT03398148|157175213|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817538|NCT03398148|157175214|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817539|NCT03398148|157175215|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817540|NCT03398148|157175216|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817541|NCT03398148|157175217|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
48817542|NCT03398148|157175203|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
48817543|NCT03398148|157175204|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
48817544|NCT03398148|157175205|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
48817545|NCT03398148|157175206|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
48817546|NCT03398148|157175207|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
48817547|NCT03398148|157175208|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
48817548|NCT03398148|157175209|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
48817549|NCT03398148|157175210|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
48723142|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
48723143|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
48723144|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
48723145|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
48723146|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
48723147|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
48723148|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
48723149|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723150|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723151|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
48723152|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723153|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723154|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
48723155|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
48723156|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723157|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723158|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723159|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723160|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
48723161|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
48723162|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
48723163|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
48723164|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
48723165|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
48723166|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
48723167|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
48723168|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48723169|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48723170|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48723171|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48817550|NCT03398148|157175211|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
48817551|NCT03398148|157175212|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
48723172|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
48817552|NCT03398148|157175213|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
48817553|NCT03398148|157175214|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
48817554|NCT03398148|157175215|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
48817555|NCT03398148|157175216|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
48817556|NCT03398148|157175217|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
48817557|NCT03398148|157175203|FG000|Substudy 1 Period 1|Other|0|||
48817558|NCT03398148|157175204|FG001|Substudy 1 Period 1|Other|1|||
48817559|NCT03398148|157175205|FG002|Substudy 1 Period 1|Other|0|||
48817560|NCT03398148|157175206|FG003|Substudy 1 Period 1|Other|0|||
48817561|NCT03398148|157175207|FG004|Substudy 1 Period 1|Other|3|||
48817562|NCT03398148|157175208|FG005|Substudy 1 Period 1|Other|0|||
48817563|NCT03398148|157175209|FG006|Substudy 1 Period 1|Other|0|||
48817564|NCT03398148|157175210|FG007|Substudy 1 Period 1|Other|0|||
48817565|NCT03398148|157175211|FG008|Substudy 1 Period 1|Other|0|||
48502315|NCT01735630|156036507|FG000|Overall Study|Withdrawal by Subject|7|||
48502316|NCT01735630|156036508|FG001|Overall Study|Withdrawal by Subject|9|||
48502317|NCT00105196|156036509|FG000|Overall Study|Lack of Efficacy|2|||
48502318|NCT00105196|156036510|FG001|Overall Study|Lack of Efficacy|3|||
48502319|NCT00105196|156036509|FG000|Overall Study|Adverse Event|11|||
48502320|NCT00105196|156036510|FG001|Overall Study|Adverse Event|3|||
48723173|NCT03963401|156836597|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
48723174|NCT03963401|156836598|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
48723175|NCT03963401|156836599|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
48723176|NCT03963401|156836600|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
48723177|NCT03963401|156836601|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
48723178|NCT03963401|156836602|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
48723179|NCT00821327|156836605|FG000|Overall Study|Adverse Event|13|||
48723180|NCT00821327|156836605|FG000|Overall Study|Patient Request|1|||
48723181|NCT00821327|156836605|FG000|Overall Study|Investigator Request|2|||
48723182|NCT00821327|156836605|FG000|Overall Study|Sponsor Request|1|||
48723183|NCT00821327|156836605|FG000|Overall Study|Disease Progression|13|||
48723184|NCT00821327|156836605|FG000|Overall Study|Other/Unknown|5|||
48723185|NCT01514370|156836606|FG000|Overall Study|Protocol Violation|2|||
48723186|NCT01514370|156836607|FG001|Overall Study|Protocol Violation|3|||
48723187|NCT01514370|156836606|FG000|Overall Study|Lost to Follow-up|0|||
48723188|NCT01514370|156836607|FG001|Overall Study|Lost to Follow-up|2|||
48723189|NCT01514370|156836606|FG000|Overall Study|Withdrawal by Subject|2|||
48723190|NCT01514370|156836607|FG001|Overall Study|Withdrawal by Subject|1|||
48723191|NCT01514370|156836606|FG000|Overall Study|Adverse Event|1|||
48723192|NCT01514370|156836607|FG001|Overall Study|Adverse Event|3|||
48723193|NCT01514370|156836606|FG000|Overall Study|Other|6|||
48723194|NCT01514370|156836607|FG001|Overall Study|Other|7|||
48723195|NCT01551420|156836608|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
48723196|NCT01551420|156836609|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
48723197|NCT01551420|156836608|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
48723198|NCT01551420|156836609|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
48723199|NCT01551420|156836608|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
48723200|NCT01551420|156836609|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
48723201|NCT01551420|156836608|FG000|Screened for Part B Eligibility|Declined participation|8|||
48723202|NCT01551420|156836609|FG001|Screened for Part B Eligibility|Declined participation|1|||
48723203|NCT01551420|156836608|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
48723204|NCT01551420|156836609|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
48723205|NCT01551420|156836608|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
48723206|NCT01551420|156836609|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
48723207|NCT01551420|156836608|FG000|Home Use (Part B)|Withdrawal by staff|0|||
48723208|NCT01551420|156836609|FG001|Home Use (Part B)|Withdrawal by staff|1|||
48723209|NCT03612856|156836610|FG000|Pre-dose Period|Physician Decision|0|||
48723210|NCT03612856|156836611|FG001|Pre-dose Period|Physician Decision|1|||
48723211|NCT03612856|156836612|FG002|Pre-dose Period|Physician Decision|1|||
48723212|NCT03612856|156836610|FG000|Pre-dose Period|Withdrawal by Subject|0|||
48723213|NCT03612856|156836611|FG001|Pre-dose Period|Withdrawal by Subject|1|||
48723214|NCT03612856|156836612|FG002|Pre-dose Period|Withdrawal by Subject|0|||
48723215|NCT00219544|156836613|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
48723216|NCT00219544|156836614|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
48723217|NCT00219544|156836613|FG000|Single Blind Treatment Period|Adverse Event|9|||
48723218|NCT00219544|156836614|FG001|Single Blind Treatment Period|Adverse Event|0|||
48723219|NCT00219544|156836613|FG000|Single Blind Treatment Period|Protocol Violation|4|||
48817566|NCT03398148|157175212|FG009|Substudy 1 Period 1|Other|0|||
48817567|NCT03398148|157175213|FG010|Substudy 1 Period 1|Other|0|||
48502321|NCT00105196|156036509|FG000|Overall Study|Withdrawal by Subject|6|||
48723220|NCT00219544|156836614|FG001|Single Blind Treatment Period|Protocol Violation|0|||
48723221|NCT00219544|156836613|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
48723222|NCT00219544|156836614|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
48723223|NCT00219544|156836613|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
48817568|NCT03398148|157175214|FG011|Substudy 1 Period 1|Other|0|||
48502322|NCT00105196|156036510|FG001|Overall Study|Withdrawal by Subject|6|||
48723224|NCT00219544|156836614|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
48817569|NCT03398148|157175215|FG012|Substudy 1 Period 1|Other|0|||
48817570|NCT03398148|157175216|FG013|Substudy 1 Period 1|Other|0|||
48817571|NCT03398148|157175217|FG014|Substudy 1 Period 1|Other|0|||
48817572|NCT03398148|157175203|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817573|NCT03398148|157175204|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817574|NCT03398148|157175205|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
48723225|NCT00219544|156836613|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
48817575|NCT03398148|157175206|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817576|NCT03398148|157175207|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
48817577|NCT03398148|157175208|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817578|NCT03398148|157175209|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817579|NCT03398148|157175210|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817580|NCT03398148|157175211|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817581|NCT03398148|157175212|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817582|NCT03398148|157175213|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817583|NCT03398148|157175214|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817584|NCT03398148|157175215|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817585|NCT03398148|157175216|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817586|NCT03398148|157175217|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
48817587|NCT03398148|157175203|FG000|Substudy 1 Period 2|Adverse Event|0|||
48502323|NCT00105196|156036509|FG000|Overall Study|Lost to Follow-up|3|||
48502324|NCT00105196|156036510|FG001|Overall Study|Lost to Follow-up|2|||
48502325|NCT00105196|156036509|FG000|Overall Study|Poor/noncompliance|3|||
48502326|NCT00105196|156036510|FG001|Overall Study|Poor/noncompliance|4|||
48502327|NCT00105196|156036509|FG000|Overall Study|Protocol Violation|5|||
48502328|NCT00105196|156036510|FG001|Overall Study|Protocol Violation|2|||
48502329|NCT00105196|156036509|FG000|Overall Study|pending surgery|0|||
48502330|NCT00105196|156036510|FG001|Overall Study|pending surgery|1|||
48723226|NCT00219544|156836614|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
48723227|NCT03800654|156836620|FG000|Overall Study|Time constraints|3|||
48723228|NCT03800654|156836621|FG001|Overall Study|Time constraints|3|||
48723229|NCT03800654|156836622|FG002|Overall Study|Time constraints|3|||
48723230|NCT03800654|156836620|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
48723231|NCT03800654|156836621|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
48723232|NCT03800654|156836622|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
48723233|NCT03800654|156836620|FG000|Overall Study|Lost to Follow-up|2|||
48723234|NCT03800654|156836621|FG001|Overall Study|Lost to Follow-up|1|||
48723235|NCT03800654|156836622|FG002|Overall Study|Lost to Follow-up|6|||
48723236|NCT03800654|156836620|FG000|Overall Study|Medical Health Issue|0|||
48723237|NCT03800654|156836621|FG001|Overall Study|Medical Health Issue|0|||
48723238|NCT03800654|156836622|FG002|Overall Study|Medical Health Issue|1|||
48723239|NCT03800654|156836620|FG000|Overall Study|Personal Issues|0|||
48723240|NCT03800654|156836621|FG001|Overall Study|Personal Issues|2|||
48723241|NCT03800654|156836622|FG002|Overall Study|Personal Issues|0|||
48723242|NCT03800654|156836620|FG000|Overall Study|Protocol Violation|0|||
48723243|NCT03800654|156836621|FG001|Overall Study|Protocol Violation|1|||
48723244|NCT03800654|156836622|FG002|Overall Study|Protocol Violation|0|||
48723245|NCT02380690|156836626|FG000|Overall Study|Lost to Follow-up|14|||
48723246|NCT02380690|156836627|FG001|Overall Study|Lost to Follow-up|4|||
48723247|NCT02380690|156836626|FG000|Overall Study|Withdrawal by Subject|20|||
48723248|NCT02380690|156836627|FG001|Overall Study|Withdrawal by Subject|8|||
48723249|NCT01077154|156836628|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
48723250|NCT01077154|156836629|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
48723251|NCT01077154|156836628|FG000|Overall Study|Withdrawal by Subject|369|||
48723252|NCT01077154|156836629|FG001|Overall Study|Withdrawal by Subject|385|||
48723253|NCT01077154|156836628|FG000|Overall Study|Death|215|||
48723254|NCT01077154|156836629|FG001|Overall Study|Death|214|||
48723255|NCT01077154|156836628|FG000|Overall Study|Lost to Follow-up|43|||
48723256|NCT01077154|156836629|FG001|Overall Study|Lost to Follow-up|35|||
48723257|NCT01077154|156836628|FG000|Overall Study|Noncompliance|22|||
48723258|NCT01077154|156836629|FG001|Overall Study|Noncompliance|20|||
48723259|NCT01077154|156836628|FG000|Overall Study|Disease Progression|18|||
48723260|NCT01077154|156836629|FG001|Overall Study|Disease Progression|20|||
48723261|NCT01077154|156836628|FG000|Overall Study|Ineligibility Determined|10|||
48723262|NCT01077154|156836629|FG001|Overall Study|Ineligibility Determined|14|||
48723263|NCT01077154|156836628|FG000|Overall Study|Other|14|||
48723264|NCT01077154|156836629|FG001|Overall Study|Other|11|||
48723265|NCT01077154|156836628|FG000|Overall Study|Adverse Event|9|||
48817588|NCT03398148|157175204|FG001|Substudy 1 Period 2|Adverse Event|0|||
48723266|NCT01077154|156836629|FG001|Overall Study|Adverse Event|9|||
48723267|NCT01077154|156836628|FG000|Overall Study|Administrative Decision|1|||
48723268|NCT01077154|156836629|FG001|Overall Study|Administrative Decision|6|||
48723269|NCT01077154|156836628|FG000|Overall Study|Protocol Deviation|1|||
48723270|NCT01077154|156836629|FG001|Overall Study|Protocol Deviation|0|||
48723271|NCT02829944|156836630|FG000|Overall Study|Physician Decision|0|||
48723272|NCT02829944|156836631|FG001|Overall Study|Physician Decision|1|||
48723273|NCT02829944|156836630|FG000|Overall Study|Screen Failure|2|||
48502331|NCT00105196|156036509|FG000|Overall Study|marijuana use|0|||
48723274|NCT02829944|156836631|FG001|Overall Study|Screen Failure|2|||
48502332|NCT00105196|156036510|FG001|Overall Study|marijuana use|1|||
48502333|NCT00105196|156036509|FG000|Overall Study|Subject became unblinded|0|||
48502334|NCT00105196|156036510|FG001|Overall Study|Subject became unblinded|1|||
48502335|NCT03099538|156036513|FG000|Overall Study|Lack of Efficacy|3|||
48502336|NCT01196052|156036514|FG000|Overall Study|Adverse Event|9|||
48502337|NCT01196052|156036514|FG000|Overall Study|Lost to Follow-up|1|||
48502338|NCT01196052|156036514|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
48502339|NCT01196052|156036514|FG000|Overall Study|Reason not Specified|5|||
48502340|NCT01196052|156036514|FG000|Overall Study|Withdrawal by Subject|6|||
48502341|NCT03603314|156036515|FG000|Overall Study|Lost to Follow-up|0|||
48502342|NCT03603314|156036516|FG001|Overall Study|Lost to Follow-up|3|||
48502343|NCT03603314|156036517|FG002|Overall Study|Lost to Follow-up|0|||
48502344|NCT03603314|156036515|FG000|Overall Study|Protocol Violation|0|||
48502345|NCT03603314|156036516|FG001|Overall Study|Protocol Violation|1|||
48502346|NCT03603314|156036517|FG002|Overall Study|Protocol Violation|0|||
48502347|NCT03603314|156036515|FG000|Overall Study|Adverse Event|2|||
48502348|NCT03603314|156036516|FG001|Overall Study|Adverse Event|0|||
48502349|NCT03603314|156036517|FG002|Overall Study|Adverse Event|0|||
48502350|NCT03603314|156036515|FG000|Overall Study|Physician Decision|1|||
48502351|NCT03603314|156036516|FG001|Overall Study|Physician Decision|1|||
48502352|NCT03603314|156036517|FG002|Overall Study|Physician Decision|0|||
48502353|NCT03603314|156036515|FG000|Overall Study|Withdrawal by Subject|4|||
48502354|NCT03603314|156036516|FG001|Overall Study|Withdrawal by Subject|5|||
48502355|NCT03603314|156036517|FG002|Overall Study|Withdrawal by Subject|3|||
48502356|NCT03603314|156036515|FG000|Overall Study|Other|0|||
48502357|NCT03603314|156036516|FG001|Overall Study|Other|1|||
48502358|NCT03603314|156036517|FG002|Overall Study|Other|0|||
48502359|NCT01784068|156036519|FG000|NTCS Phase|Adverse Event|5|||
48502360|NCT01784068|156036520|FG001|NTCS Phase|Adverse Event|0|||
48502361|NCT01784068|156036519|FG000|NTCS Phase|Physician Decision|2|||
48502362|NCT01784068|156036520|FG001|NTCS Phase|Physician Decision|0|||
48502363|NCT01784068|156036519|FG000|NTCS Phase|Patient/guardian decision|3|||
48502364|NCT01784068|156036520|FG001|NTCS Phase|Patient/guardian decision|0|||
48502365|NCT01784068|156036519|FG000|NTCS Phase|Death|2|||
48502366|NCT01784068|156036520|FG001|NTCS Phase|Death|0|||
48502367|NCT01784068|156036519|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
48502368|NCT01784068|156036520|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
48502369|NCT01784068|156036519|FG000|TFR Phase|Physician Decision|0|||
48502370|NCT01784068|156036520|FG001|TFR Phase|Physician Decision|1|||
48502371|NCT01784068|156036519|FG000|TFR Phase|Patient/guardian decision|0|||
48502372|NCT01784068|156036520|FG001|TFR Phase|Patient/guardian decision|3|||
48502373|NCT01784068|156036519|FG000|TFR Phase|Death|0|||
48817589|NCT03398148|157175205|FG002|Substudy 1 Period 2|Adverse Event|0|||
48817590|NCT03398148|157175206|FG003|Substudy 1 Period 2|Adverse Event|0|||
48817591|NCT03398148|157175207|FG004|Substudy 1 Period 2|Adverse Event|0|||
48817592|NCT03398148|157175208|FG005|Substudy 1 Period 2|Adverse Event|2|||
48817593|NCT03398148|157175209|FG006|Substudy 1 Period 2|Adverse Event|4|||
48817594|NCT03398148|157175210|FG007|Substudy 1 Period 2|Adverse Event|0|||
48817595|NCT03398148|157175211|FG008|Substudy 1 Period 2|Adverse Event|0|||
48817596|NCT03398148|157175212|FG009|Substudy 1 Period 2|Adverse Event|0|||
48817597|NCT03398148|157175213|FG010|Substudy 1 Period 2|Adverse Event|0|||
48817598|NCT03398148|157175214|FG011|Substudy 1 Period 2|Adverse Event|0|||
48817599|NCT03398148|157175215|FG012|Substudy 1 Period 2|Adverse Event|0|||
48502374|NCT01784068|156036520|FG001|TFR Phase|Death|1|||
48502375|NCT01784068|156036519|FG000|TFR Phase|Lack of Efficacy|0|||
48502376|NCT01784068|156036520|FG001|TFR Phase|Lack of Efficacy|88|||
48502377|NCT00248287|156036521|FG000|Overall Study|Adverse Event|11|||
48502378|NCT00248287|156036522|FG001|Overall Study|Adverse Event|10|||
48502379|NCT00248287|156036521|FG000|Overall Study|Death|1|||
48502380|NCT00248287|156036522|FG001|Overall Study|Death|0|||
48502381|NCT00248287|156036521|FG000|Overall Study|Lost to Follow-up|0|||
48502382|NCT00248287|156036522|FG001|Overall Study|Lost to Follow-up|1|||
48502383|NCT00248287|156036521|FG000|Overall Study|Investigator Request|4|||
48502384|NCT00248287|156036522|FG001|Overall Study|Investigator Request|3|||
48502385|NCT00248287|156036521|FG000|Overall Study|Patient Request|5|||
48502386|NCT00248287|156036522|FG001|Overall Study|Patient Request|3|||
48817600|NCT03398148|157175216|FG013|Substudy 1 Period 2|Adverse Event|0|||
48817601|NCT03398148|157175217|FG014|Substudy 1 Period 2|Adverse Event|0|||
48817602|NCT03398148|157175203|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817603|NCT03398148|157175204|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817604|NCT03398148|157175205|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817605|NCT03398148|157175206|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817606|NCT03398148|157175207|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48502387|NCT00248287|156036521|FG000|Overall Study|Other|3|||
48502388|NCT00248287|156036522|FG001|Overall Study|Other|2|||
48502389|NCT05808257|156036523|FG000|Overall Study|Lost to Follow-up|8|||
48502390|NCT05808257|156036524|FG001|Overall Study|Lost to Follow-up|8|||
48502391|NCT04185909|156036525|FG000|Overall Study|Lost to Follow-up|1|||
48502392|NCT03639311|156036526|FG000|Maintenance Phase|Lost to Follow-up|1|||
48817607|NCT03398148|157175208|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48502393|NCT03639311|156036527|FG001|Maintenance Phase|Lost to Follow-up|0|||
48502394|NCT03639311|156036528|FG002|Maintenance Phase|Lost to Follow-up|0|||
48502395|NCT03639311|156036526|FG000|Maintenance Phase|Adverse Event|1|||
48502396|NCT03639311|156036527|FG001|Maintenance Phase|Adverse Event|0|||
48502397|NCT03639311|156036528|FG002|Maintenance Phase|Adverse Event|0|||
48502398|NCT03639311|156036526|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
48502399|NCT03639311|156036527|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
48502400|NCT03639311|156036528|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
48502401|NCT03639311|156036526|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
48502402|NCT03639311|156036527|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
48502403|NCT03639311|156036528|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
48502404|NCT03639311|156036526|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
48502405|NCT03639311|156036527|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
48502406|NCT03639311|156036528|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
48502407|NCT03639311|156036526|FG000|Maintenance Phase|Lack of Efficacy|1|||
48502408|NCT03639311|156036527|FG001|Maintenance Phase|Lack of Efficacy|0|||
48502409|NCT03639311|156036528|FG002|Maintenance Phase|Lack of Efficacy|0|||
48502410|NCT00565448|156036531|FG000|Overall Study|Adverse Event|1|||
48502411|NCT00565448|156036532|FG001|Overall Study|Adverse Event|2|||
48502412|NCT00565448|156036531|FG000|Overall Study|Disease progression|1|||
48502413|NCT00565448|156036532|FG001|Overall Study|Disease progression|0|||
48502414|NCT00565448|156036531|FG000|Overall Study|Withdrawal by Subject|1|||
48502415|NCT00565448|156036532|FG001|Overall Study|Withdrawal by Subject|0|||
48502416|NCT00822926|156036533|FG000|Second Injection Visit|Lost to Follow-up|1|||
48502417|NCT00822926|156036534|FG001|Second Injection Visit|Lost to Follow-up|0|||
48502418|NCT00822926|156036533|FG000|Second Injection Visit|Withdrawal by Subject|0|||
48502419|NCT00822926|156036534|FG001|Second Injection Visit|Withdrawal by Subject|1|||
48502420|NCT00429364|156036537|FG000|Overall Study|Withdrawal by Subject|11|||
48502421|NCT00429364|156036538|FG001|Overall Study|Withdrawal by Subject|5|||
48502422|NCT00429364|156036537|FG000|Overall Study|Physician Decision|4|||
48502423|NCT00429364|156036538|FG001|Overall Study|Physician Decision|2|||
48502424|NCT00429364|156036537|FG000|Overall Study|Lost to Follow-up|7|||
48502425|NCT00429364|156036538|FG001|Overall Study|Lost to Follow-up|6|||
48502426|NCT00429364|156036537|FG000|Overall Study|Death|0|||
48502427|NCT00429364|156036538|FG001|Overall Study|Death|1|||
48502428|NCT00429364|156036537|FG000|Overall Study|Underwent aortic root surgery|10|||
48502429|NCT00429364|156036538|FG001|Overall Study|Underwent aortic root surgery|18|||
48502430|NCT00429364|156036537|FG000|Overall Study|Pregnancy|0|||
48502431|NCT00429364|156036538|FG001|Overall Study|Pregnancy|1|||
48502432|NCT05089734|156036547|FG000|Overall Study|Still on study|122|||
48502433|NCT05089734|156036548|FG001|Overall Study|Still on study|101|||
48502434|NCT05089734|156036547|FG000|Overall Study|Death|161|||
48502435|NCT05089734|156036548|FG001|Overall Study|Death|179|||
48502436|NCT05089734|156036547|FG000|Overall Study|Withdrew consent|11|||
48502437|NCT05089734|156036548|FG001|Overall Study|Withdrew consent|24|||
48502438|NCT05089734|156036547|FG000|Overall Study|Lost to Follow-up|5|||
48502439|NCT05089734|156036548|FG001|Overall Study|Lost to Follow-up|0|||
48502440|NCT03991494|156036549|FG000|Overall Study|Progressive Disease|4|||
48502441|NCT00319735|156036550|FG000|Overall Study|Death|2|||
48502442|NCT04451772|156036554|FG000|Overall Study|Adverse Event|1|||
48502443|NCT04451772|156036555|FG001|Overall Study|Adverse Event|0|||
48502444|NCT04451772|156036556|FG002|Overall Study|Adverse Event|1|||
48502445|NCT04451772|156036557|FG003|Overall Study|Adverse Event|1|||
48502446|NCT04451772|156036558|FG004|Overall Study|Adverse Event|0|||
48502447|NCT04451772|156036559|FG005|Overall Study|Adverse Event|3|||
48502448|NCT04451772|156036554|FG000|Overall Study|Withdrawal by Subject|2|||
48502449|NCT04451772|156036555|FG001|Overall Study|Withdrawal by Subject|7|||
48502450|NCT04451772|156036556|FG002|Overall Study|Withdrawal by Subject|2|||
48502451|NCT04451772|156036557|FG003|Overall Study|Withdrawal by Subject|1|||
48502452|NCT04451772|156036558|FG004|Overall Study|Withdrawal by Subject|1|||
48502453|NCT04451772|156036559|FG005|Overall Study|Withdrawal by Subject|0|||
48502454|NCT04451772|156036554|FG000|Overall Study|Other, not specified|1|||
48502455|NCT04451772|156036555|FG001|Overall Study|Other, not specified|2|||
48502456|NCT04451772|156036556|FG002|Overall Study|Other, not specified|1|||
48502457|NCT04451772|156036557|FG003|Overall Study|Other, not specified|0|||
48502458|NCT04451772|156036558|FG004|Overall Study|Other, not specified|0|||
48502459|NCT04451772|156036559|FG005|Overall Study|Other, not specified|1|||
48502460|NCT04451772|156036554|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
48502461|NCT04451772|156036555|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
48502462|NCT04451772|156036556|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
48502463|NCT04451772|156036557|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
48502464|NCT04451772|156036558|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
48502465|NCT04451772|156036559|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
48502466|NCT00096265|156038319|FG000|Overall Study|Ineligible|1|||
48502467|NCT00096265|156038320|FG001|Overall Study|Ineligible|0|||
48502468|NCT00096265|156038321|FG002|Overall Study|Ineligible|0|||
48502469|NCT00863746|156038322|FG000|Treatment|Not treated|4|||
48502470|NCT00863746|156038323|FG001|Treatment|Not treated|2|||
48502471|NCT00863746|156038322|FG000|Treatment|Adverse Event|41|||
48502472|NCT00863746|156038323|FG001|Treatment|Adverse Event|16|||
48502473|NCT00863746|156038322|FG000|Treatment|non-compliant with study medication|4|||
48502474|NCT00863746|156038323|FG001|Treatment|non-compliant with study medication|0|||
48502475|NCT00863746|156038322|FG000|Treatment|Consent withdrawn|15|||
48502476|NCT00863746|156038323|FG001|Treatment|Consent withdrawn|14|||
48502477|NCT00863746|156038322|FG000|Treatment|Lost to Follow-up|1|||
48502478|NCT00863746|156038323|FG001|Treatment|Lost to Follow-up|0|||
48502479|NCT00863746|156038322|FG000|Treatment|Protocol Violation|5|||
48502480|NCT00863746|156038323|FG001|Treatment|Protocol Violation|3|||
48502481|NCT00863746|156038322|FG000|Treatment|Other|1|||
48502482|NCT00863746|156038323|FG001|Treatment|Other|0|||
48502483|NCT00863746|156038322|FG000|Survival Follow up|Death|244|||
48502484|NCT00863746|156038323|FG001|Survival Follow up|Death|271|||
48502485|NCT00863746|156038322|FG000|Survival Follow up|Lost to Follow-up|2|||
48502486|NCT00863746|156038323|FG001|Survival Follow up|Lost to Follow-up|1|||
48723275|NCT02829944|156836630|FG000|Overall Study|Inadequate Neuraxial Block|1|||
48817608|NCT03398148|157175209|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
48817609|NCT03398148|157175210|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
48817610|NCT03398148|157175211|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817611|NCT03398148|157175212|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817612|NCT03398148|157175213|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817613|NCT03398148|157175214|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817614|NCT03398148|157175215|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817615|NCT03398148|157175216|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817616|NCT03398148|157175217|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
48817617|NCT03398148|157175203|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
48817618|NCT03398148|157175204|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
48817619|NCT03398148|157175205|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
48817620|NCT03398148|157175206|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
48817621|NCT03398148|157175207|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
48817622|NCT03398148|157175208|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
48817623|NCT03398148|157175209|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
48817624|NCT03398148|157175210|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
48817625|NCT03398148|157175211|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
48502487|NCT00863746|156038322|FG000|Survival Follow up|Consent Withdrawn|7|||
48502488|NCT00863746|156038323|FG001|Survival Follow up|Consent Withdrawn|8|||
48502489|NCT02924038|156038324|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
48502490|NCT02924038|156038325|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
48723276|NCT02829944|156836631|FG001|Overall Study|Inadequate Neuraxial Block|1|||
48723277|NCT02829944|156836630|FG000|Overall Study|Withdrawal by Subject|2|||
48723278|NCT02829944|156836631|FG001|Overall Study|Withdrawal by Subject|1|||
48723279|NCT02829944|156836630|FG000|Overall Study|Catheter Displacement|1|||
48723280|NCT02829944|156836631|FG001|Overall Study|Catheter Displacement|0|||
48723281|NCT02829944|156836630|FG000|Overall Study|Catheter broke|0|||
48723282|NCT02829944|156836631|FG001|Overall Study|Catheter broke|1|||
48723283|NCT02829944|156836630|FG000|Overall Study|Staff unavailable|0|||
48723284|NCT02829944|156836631|FG001|Overall Study|Staff unavailable|1|||
48723285|NCT03640559|156836632|FG000|Overall Study|Physician Decision|1|||
48723286|NCT03640559|156836633|FG001|Overall Study|Physician Decision|1|||
48723287|NCT03640559|156836632|FG000|Overall Study|Withdrawal by Subject|1|||
48723288|NCT03640559|156836633|FG001|Overall Study|Withdrawal by Subject|0|||
48723289|NCT01340872|156837906|FG000|Double-blind Phase|Adverse Event|6|||
48723290|NCT01340872|156837907|FG001|Double-blind Phase|Adverse Event|4|||
48723291|NCT01340872|156837908|FG002|Double-blind Phase|Adverse Event|0|||
48723292|NCT01340872|156837909|FG003|Double-blind Phase|Adverse Event|0|||
48723293|NCT01340872|156837906|FG000|Double-blind Phase|Withdrawal by Subject|3|||
48723294|NCT01340872|156837907|FG001|Double-blind Phase|Withdrawal by Subject|5|||
48723295|NCT01340872|156837908|FG002|Double-blind Phase|Withdrawal by Subject|0|||
48723296|NCT01340872|156837909|FG003|Double-blind Phase|Withdrawal by Subject|0|||
48817626|NCT03398148|157175212|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
48817627|NCT03398148|157175213|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
48817628|NCT03398148|157175214|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
48817629|NCT03398148|157175215|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
48817630|NCT03398148|157175216|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
48817631|NCT03398148|157175217|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
48817632|NCT03398148|157175203|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817633|NCT03398148|157175204|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48502491|NCT04072380|156038330|FG000|Overall Study|Adverse Event|4|||
48502492|NCT04072380|156038331|FG001|Overall Study|Adverse Event|6|||
48502493|NCT04072380|156038332|FG002|Overall Study|Adverse Event|0|||
48502494|NCT04072380|156038330|FG000|Overall Study|Withdrawal by Subject|3|||
48502495|NCT04072380|156038331|FG001|Overall Study|Withdrawal by Subject|1|||
48817634|NCT03398148|157175205|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817635|NCT03398148|157175206|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817636|NCT03398148|157175207|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817637|NCT03398148|157175208|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817638|NCT03398148|157175209|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
48817639|NCT03398148|157175210|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48502496|NCT04072380|156038332|FG002|Overall Study|Withdrawal by Subject|1|||
48502497|NCT04072380|156038330|FG000|Overall Study|Physician Decision|2|||
48502498|NCT04072380|156038331|FG001|Overall Study|Physician Decision|0|||
48817640|NCT03398148|157175211|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817641|NCT03398148|157175212|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817642|NCT03398148|157175213|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48502499|NCT04072380|156038332|FG002|Overall Study|Physician Decision|0|||
48502500|NCT04072380|156038330|FG000|Overall Study|Protocol Violation|0|||
48817643|NCT03398148|157175214|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817644|NCT03398148|157175215|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48502501|NCT04072380|156038331|FG001|Overall Study|Protocol Violation|2|||
48502502|NCT04072380|156038332|FG002|Overall Study|Protocol Violation|3|||
48502503|NCT04072380|156038330|FG000|Overall Study|Intercurrent Illness and Others|3|||
48502504|NCT04072380|156038331|FG001|Overall Study|Intercurrent Illness and Others|5|||
48723297|NCT01340872|156837906|FG000|Double-blind Phase|Lost to Follow-up|0|||
48723298|NCT01340872|156837907|FG001|Double-blind Phase|Lost to Follow-up|1|||
48723299|NCT01340872|156837908|FG002|Double-blind Phase|Lost to Follow-up|0|||
48723300|NCT01340872|156837909|FG003|Double-blind Phase|Lost to Follow-up|0|||
48723301|NCT01340872|156837906|FG000|Double-blind Phase|Protocol Violation|0|||
48723302|NCT01340872|156837907|FG001|Double-blind Phase|Protocol Violation|1|||
48723303|NCT01340872|156837908|FG002|Double-blind Phase|Protocol Violation|0|||
48723304|NCT01340872|156837909|FG003|Double-blind Phase|Protocol Violation|0|||
48723305|NCT01340872|156837906|FG000|Open-label Phase|Physician Decision|0|||
48723306|NCT01340872|156837907|FG001|Open-label Phase|Physician Decision|0|||
48723307|NCT01340872|156837908|FG002|Open-label Phase|Physician Decision|2|||
48502505|NCT04072380|156038332|FG002|Overall Study|Intercurrent Illness and Others|6|||
48502506|NCT02087904|156038333|FG000|Overall Study|Did Not Receive Study Drug|0|||
48502507|NCT02087904|156038334|FG001|Overall Study|Did Not Receive Study Drug|0|||
48502508|NCT02087904|156038335|FG002|Overall Study|Did Not Receive Study Drug|2|||
48502509|NCT02087904|156038336|FG003|Overall Study|Did Not Receive Study Drug|1|||
48502510|NCT02087904|156038333|FG000|Overall Study|Adverse Event|8|||
48502511|NCT02087904|156038334|FG001|Overall Study|Adverse Event|4|||
48502512|NCT02087904|156038335|FG002|Overall Study|Adverse Event|4|||
48502513|NCT02087904|156038336|FG003|Overall Study|Adverse Event|12|||
48502514|NCT02087904|156038333|FG000|Overall Study|Lack of Efficacy|3|||
48502515|NCT02087904|156038334|FG001|Overall Study|Lack of Efficacy|6|||
48502516|NCT02087904|156038335|FG002|Overall Study|Lack of Efficacy|3|||
48502517|NCT02087904|156038336|FG003|Overall Study|Lack of Efficacy|2|||
48502518|NCT02087904|156038333|FG000|Overall Study|Other|6|||
48502519|NCT02087904|156038334|FG001|Overall Study|Other|2|||
48502520|NCT02087904|156038335|FG002|Overall Study|Other|4|||
48502521|NCT02087904|156038336|FG003|Overall Study|Other|4|||
48502522|NCT02087904|156038333|FG000|Overall Study|Withdrawal by Subject|8|||
48502523|NCT02087904|156038334|FG001|Overall Study|Withdrawal by Subject|3|||
48502524|NCT02087904|156038335|FG002|Overall Study|Withdrawal by Subject|7|||
48502525|NCT02087904|156038336|FG003|Overall Study|Withdrawal by Subject|4|||
48502526|NCT02087904|156038333|FG000|Overall Study|Lost to Follow-up|0|||
48502527|NCT02087904|156038334|FG001|Overall Study|Lost to Follow-up|4|||
48502528|NCT02087904|156038335|FG002|Overall Study|Lost to Follow-up|2|||
48502529|NCT02087904|156038336|FG003|Overall Study|Lost to Follow-up|2|||
48502530|NCT04585789|156038337|FG000|Overall Study|Withdrawal by Subject|1|||
48502531|NCT04585789|156038338|FG001|Overall Study|Withdrawal by Subject|0|||
48502532|NCT04585789|156038337|FG000|Overall Study|Ongoing|9|||
48502533|NCT04585789|156038338|FG001|Overall Study|Ongoing|10|||
48502534|NCT03945292|156038339|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
48502535|NCT03945292|156038340|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
48502536|NCT03945292|156038341|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
48723308|NCT01340872|156837909|FG003|Open-label Phase|Physician Decision|1|||
48723309|NCT01340872|156837906|FG000|Open-label Phase|Pregnancy|0|||
48723310|NCT01340872|156837907|FG001|Open-label Phase|Pregnancy|0|||
48723311|NCT01340872|156837908|FG002|Open-label Phase|Pregnancy|1|||
48723312|NCT01340872|156837909|FG003|Open-label Phase|Pregnancy|0|||
48817645|NCT03398148|157175216|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817646|NCT03398148|157175217|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817647|NCT03398148|157175203|FG000|Substudy 1 Period 2|Other|0|||
48502537|NCT03945292|156038342|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
48502538|NCT03945292|156038343|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
48502539|NCT03945292|156038344|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
48599847|NCT03428100|156391513|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599848|NCT03428100|156391514|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599849|NCT03428100|156391515|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599850|NCT03428100|156391516|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599851|NCT03428100|156391517|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599852|NCT03428100|156391518|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
48599853|NCT03428100|156391500|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
48599854|NCT03428100|156391501|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599855|NCT03428100|156391502|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599856|NCT03428100|156391503|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599857|NCT03428100|156391504|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599858|NCT03428100|156391505|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599859|NCT03428100|156391506|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599860|NCT03428100|156391507|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599861|NCT03428100|156391508|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599862|NCT03428100|156391509|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599863|NCT03428100|156391510|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599864|NCT03428100|156391511|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599865|NCT03428100|156391512|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599866|NCT03428100|156391513|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599867|NCT03428100|156391514|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599868|NCT03428100|156391515|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599869|NCT03428100|156391516|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599870|NCT03428100|156391517|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599871|NCT03428100|156391518|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
48599872|NCT03428100|156391500|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599873|NCT03428100|156391501|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
48599874|NCT03428100|156391502|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599875|NCT03428100|156391503|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599876|NCT03428100|156391504|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599877|NCT03428100|156391505|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599878|NCT03428100|156391506|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599879|NCT03428100|156391507|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599880|NCT03428100|156391508|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599881|NCT03428100|156391509|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599882|NCT03428100|156391510|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599883|NCT03428100|156391511|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599884|NCT03428100|156391512|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599885|NCT03428100|156391513|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599886|NCT03428100|156391514|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599887|NCT03428100|156391515|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599888|NCT03428100|156391516|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599889|NCT03428100|156391517|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599890|NCT03428100|156391518|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
48599891|NCT03428100|156391500|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599892|NCT03428100|156391501|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599893|NCT03428100|156391502|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599894|NCT03428100|156391503|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599895|NCT03428100|156391504|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599896|NCT03428100|156391505|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
48599897|NCT03428100|156391506|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
48599898|NCT03428100|156391507|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
48599899|NCT03428100|156391508|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
48599900|NCT03428100|156391509|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599901|NCT03428100|156391510|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
48599902|NCT03428100|156391511|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599903|NCT03428100|156391512|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
48599904|NCT03428100|156391513|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
48599905|NCT03428100|156391514|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
48599906|NCT03428100|156391515|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
48599907|NCT03428100|156391516|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
48723313|NCT01340872|156837906|FG000|Open-label Phase|Adverse Event|0|||
48723314|NCT01340872|156837907|FG001|Open-label Phase|Adverse Event|0|||
48502540|NCT03945292|156038345|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
48502541|NCT03945292|156038346|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
48502542|NCT03945292|156038339|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
48502543|NCT03945292|156038340|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
48502544|NCT03945292|156038341|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
48502545|NCT03945292|156038342|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
48502546|NCT03945292|156038343|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
48502547|NCT03945292|156038344|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
48502548|NCT03945292|156038345|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
48502549|NCT03945292|156038346|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
48502550|NCT03945292|156038339|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48502551|NCT03945292|156038340|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48502552|NCT03945292|156038341|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48502553|NCT03945292|156038342|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48502554|NCT03945292|156038343|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48502555|NCT03945292|156038344|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48502556|NCT03945292|156038345|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
48502557|NCT03945292|156038346|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
48502558|NCT03959423|156038348|FG000|Overall Study|Withdrawal by Subject|2|||
48502559|NCT03959423|156038349|FG001|Overall Study|Withdrawal by Subject|3|||
48502560|NCT03959423|156038348|FG000|Overall Study|Physician Decision|0|||
48502561|NCT03959423|156038349|FG001|Overall Study|Physician Decision|1|||
48502562|NCT03959423|156038348|FG000|Overall Study|Lost to Follow-up|1|||
48502563|NCT03959423|156038349|FG001|Overall Study|Lost to Follow-up|0|||
48502564|NCT03959423|156038348|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
48502565|NCT03959423|156038349|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48502566|NCT03473223|156038350|FG000|Overall Study|Lost to Follow-up|1|||
48502567|NCT03473223|156038351|FG001|Overall Study|Lost to Follow-up|1|||
48502568|NCT03473223|156038350|FG000|Overall Study|Withdrawal by Subject|47|||
48502569|NCT03473223|156038351|FG001|Overall Study|Withdrawal by Subject|42|||
48502570|NCT03473223|156038350|FG000|Overall Study|Indirect contact|32|||
48502571|NCT03473223|156038351|FG001|Overall Study|Indirect contact|29|||
48502572|NCT03473223|156038350|FG000|Overall Study|Other (Not specified)|32|||
48502573|NCT03473223|156038351|FG001|Overall Study|Other (Not specified)|20|||
48502574|NCT03524118|156038352|FG000|Overall Study|Lost to Follow-up|0|||
48502575|NCT03524118|156038353|FG001|Overall Study|Lost to Follow-up|0|||
48502576|NCT03524118|156038354|FG002|Overall Study|Lost to Follow-up|0|||
48502577|NCT03524118|156038355|FG003|Overall Study|Lost to Follow-up|0|||
48502578|NCT03524118|156038356|FG004|Overall Study|Lost to Follow-up|1|||
48502579|NCT03524118|156038357|FG005|Overall Study|Lost to Follow-up|0|||
48502580|NCT03524118|156038352|FG000|Overall Study|Other|0|||
48502581|NCT03524118|156038353|FG001|Overall Study|Other|1|||
48502582|NCT03524118|156038354|FG002|Overall Study|Other|0|||
48502583|NCT03524118|156038355|FG003|Overall Study|Other|0|||
48502584|NCT03524118|156038356|FG004|Overall Study|Other|1|||
48502585|NCT03524118|156038357|FG005|Overall Study|Other|1|||
48502586|NCT03524118|156038352|FG000|Overall Study|Physician Decision|0|||
48502587|NCT03524118|156038353|FG001|Overall Study|Physician Decision|0|||
48502588|NCT03524118|156038354|FG002|Overall Study|Physician Decision|0|||
48502589|NCT03524118|156038355|FG003|Overall Study|Physician Decision|0|||
48502590|NCT03524118|156038356|FG004|Overall Study|Physician Decision|1|||
48502591|NCT03524118|156038357|FG005|Overall Study|Physician Decision|0|||
48502592|NCT03524118|156038352|FG000|Overall Study|Protocol Violation|0|||
48502593|NCT03524118|156038353|FG001|Overall Study|Protocol Violation|0|||
48502594|NCT03524118|156038354|FG002|Overall Study|Protocol Violation|1|||
48502595|NCT03524118|156038355|FG003|Overall Study|Protocol Violation|0|||
48502596|NCT03524118|156038356|FG004|Overall Study|Protocol Violation|1|||
48502597|NCT03524118|156038357|FG005|Overall Study|Protocol Violation|0|||
48502598|NCT03524118|156038352|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48502599|NCT03524118|156038353|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48502600|NCT03524118|156038354|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48502601|NCT03524118|156038355|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
48502602|NCT03524118|156038356|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
48502603|NCT03524118|156038357|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
48502604|NCT02353169|156038358|FG000|Overall Study|QTc > 450 msec|1|||
48502605|NCT02353169|156038359|FG001|Overall Study|QTc > 450 msec|1|||
48502606|NCT02353169|156038360|FG002|Overall Study|QTc > 450 msec|1|||
48502607|NCT02353169|156038361|FG003|Overall Study|QTc > 450 msec|1|||
48502608|NCT02353169|156038358|FG000|Overall Study|OR team declined|2|||
48502609|NCT02353169|156038359|FG001|Overall Study|OR team declined|0|||
48502610|NCT02353169|156038360|FG002|Overall Study|OR team declined|0|||
48502611|NCT02353169|156038361|FG003|Overall Study|OR team declined|0|||
48502612|NCT02353169|156038358|FG000|Overall Study|Inhalational induction|0|||
48502613|NCT02353169|156038359|FG001|Overall Study|Inhalational induction|2|||
48502614|NCT02353169|156038360|FG002|Overall Study|Inhalational induction|0|||
48817648|NCT03398148|157175204|FG001|Substudy 1 Period 2|Other|0|||
48817649|NCT03398148|157175205|FG002|Substudy 1 Period 2|Other|0|||
48502615|NCT02353169|156038361|FG003|Overall Study|Inhalational induction|0|||
48502616|NCT02353169|156038358|FG000|Overall Study|ECG data error|0|||
48502617|NCT02353169|156038359|FG001|Overall Study|ECG data error|3|||
48502618|NCT02353169|156038360|FG002|Overall Study|ECG data error|2|||
48502619|NCT02353169|156038361|FG003|Overall Study|ECG data error|2|||
48502620|NCT02353169|156038358|FG000|Overall Study|Pre-op medication|0|||
48502621|NCT02353169|156038359|FG001|Overall Study|Pre-op medication|0|||
48502622|NCT02353169|156038360|FG002|Overall Study|Pre-op medication|1|||
48502623|NCT02353169|156038361|FG003|Overall Study|Pre-op medication|0|||
48502624|NCT04338269|156038362|FG000|Overall Study|Death|86|||
48502625|NCT04338269|156038363|FG001|Overall Study|Death|89|||
48502626|NCT04338269|156038362|FG000|Overall Study|Lost to Follow-up|1|||
48502627|NCT04338269|156038363|FG001|Overall Study|Lost to Follow-up|2|||
48502628|NCT04338269|156038362|FG000|Overall Study|Physician Decision|1|||
48502629|NCT04338269|156038363|FG001|Overall Study|Physician Decision|0|||
48502630|NCT04338269|156038362|FG000|Overall Study|Withdrawal by Subject|14|||
48502631|NCT04338269|156038363|FG001|Overall Study|Withdrawal by Subject|11|||
48502632|NCT00085735|156038364|FG000|Overall Study|Adverse Event|1|||
48502633|NCT00085735|156038365|FG001|Overall Study|Adverse Event|0|||
48502634|NCT00085735|156038366|FG002|Overall Study|Adverse Event|0|||
48502635|NCT00085735|156038367|FG003|Overall Study|Adverse Event|0|||
48502636|NCT00085735|156038368|FG004|Overall Study|Adverse Event|0|||
48502637|NCT00085735|156038369|FG005|Overall Study|Adverse Event|0|||
48502638|NCT00085735|156038364|FG000|Overall Study|Lack of Efficacy|2|||
48502639|NCT00085735|156038365|FG001|Overall Study|Lack of Efficacy|4|||
48502640|NCT00085735|156038366|FG002|Overall Study|Lack of Efficacy|6|||
48502641|NCT00085735|156038367|FG003|Overall Study|Lack of Efficacy|3|||
48502642|NCT00085735|156038368|FG004|Overall Study|Lack of Efficacy|4|||
48502643|NCT00085735|156038369|FG005|Overall Study|Lack of Efficacy|3|||
48502644|NCT00085735|156038364|FG000|Overall Study|Lost to Follow-up|0|||
48502645|NCT00085735|156038365|FG001|Overall Study|Lost to Follow-up|1|||
48502646|NCT00085735|156038366|FG002|Overall Study|Lost to Follow-up|0|||
48502647|NCT00085735|156038367|FG003|Overall Study|Lost to Follow-up|0|||
48502648|NCT00085735|156038368|FG004|Overall Study|Lost to Follow-up|1|||
48502649|NCT00085735|156038369|FG005|Overall Study|Lost to Follow-up|0|||
48502650|NCT00085735|156038364|FG000|Overall Study|Physician Decision|2|||
48502651|NCT00085735|156038365|FG001|Overall Study|Physician Decision|3|||
48502652|NCT00085735|156038366|FG002|Overall Study|Physician Decision|2|||
48502653|NCT00085735|156038367|FG003|Overall Study|Physician Decision|3|||
48502654|NCT00085735|156038368|FG004|Overall Study|Physician Decision|11|||
48502655|NCT00085735|156038369|FG005|Overall Study|Physician Decision|8|||
48502656|NCT00085735|156038364|FG000|Overall Study|Protocol Violation|1|||
48502657|NCT00085735|156038365|FG001|Overall Study|Protocol Violation|0|||
48502658|NCT00085735|156038366|FG002|Overall Study|Protocol Violation|0|||
48502659|NCT00085735|156038367|FG003|Overall Study|Protocol Violation|0|||
48502660|NCT00085735|156038368|FG004|Overall Study|Protocol Violation|0|||
48502661|NCT00085735|156038369|FG005|Overall Study|Protocol Violation|0|||
48502662|NCT00085735|156038364|FG000|Overall Study|Withdrawal by Subject|1|||
48502663|NCT00085735|156038365|FG001|Overall Study|Withdrawal by Subject|0|||
48502664|NCT00085735|156038366|FG002|Overall Study|Withdrawal by Subject|4|||
48502665|NCT00085735|156038367|FG003|Overall Study|Withdrawal by Subject|5|||
48502666|NCT00085735|156038368|FG004|Overall Study|Withdrawal by Subject|7|||
48502667|NCT00085735|156038369|FG005|Overall Study|Withdrawal by Subject|8|||
48502668|NCT00085735|156038364|FG000|Overall Study|Patient ineligible|1|||
48502669|NCT00085735|156038365|FG001|Overall Study|Patient ineligible|0|||
48502670|NCT00085735|156038366|FG002|Overall Study|Patient ineligible|3|||
48502671|NCT00085735|156038367|FG003|Overall Study|Patient ineligible|7|||
48502672|NCT00085735|156038368|FG004|Overall Study|Patient ineligible|17|||
48817650|NCT03398148|157175206|FG003|Substudy 1 Period 2|Other|0|||
48817651|NCT03398148|157175207|FG004|Substudy 1 Period 2|Other|0|||
48502673|NCT00085735|156038369|FG005|Overall Study|Patient ineligible|8|||
48502674|NCT00085735|156038364|FG000|Overall Study|Excess residual disease|2|||
48502675|NCT00085735|156038365|FG001|Overall Study|Excess residual disease|2|||
48502676|NCT00085735|156038366|FG002|Overall Study|Excess residual disease|1|||
48502677|NCT00085735|156038367|FG003|Overall Study|Excess residual disease|1|||
48502678|NCT00085735|156038368|FG004|Overall Study|Excess residual disease|1|||
48502679|NCT00085735|156038369|FG005|Overall Study|Excess residual disease|4|||
48502680|NCT00085735|156038364|FG000|Overall Study|Reason not documented|1|||
48502681|NCT00085735|156038365|FG001|Overall Study|Reason not documented|0|||
48502682|NCT00085735|156038366|FG002|Overall Study|Reason not documented|1|||
48817652|NCT03398148|157175208|FG005|Substudy 1 Period 2|Other|0|||
48502683|NCT00085735|156038367|FG003|Overall Study|Reason not documented|0|||
48502684|NCT00085735|156038368|FG004|Overall Study|Reason not documented|1|||
48502685|NCT00085735|156038369|FG005|Overall Study|Reason not documented|0|||
48502686|NCT00085735|156038364|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
48502687|NCT00085735|156038365|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
48817653|NCT03398148|157175209|FG006|Substudy 1 Period 2|Other|1|||
48817654|NCT03398148|157175210|FG007|Substudy 1 Period 2|Other|0|||
48723315|NCT01340872|156837908|FG002|Open-label Phase|Adverse Event|8|||
48723316|NCT01340872|156837909|FG003|Open-label Phase|Adverse Event|4|||
48723317|NCT01340872|156837906|FG000|Open-label Phase|Withdrawal by Subject|0|||
48723318|NCT01340872|156837907|FG001|Open-label Phase|Withdrawal by Subject|0|||
48723319|NCT01340872|156837908|FG002|Open-label Phase|Withdrawal by Subject|1|||
48723320|NCT01340872|156837909|FG003|Open-label Phase|Withdrawal by Subject|6|||
48723321|NCT01340872|156837906|FG000|Open-label Phase|Worsening of IBD|0|||
48723322|NCT01340872|156837907|FG001|Open-label Phase|Worsening of IBD|0|||
48723323|NCT01340872|156837908|FG002|Open-label Phase|Worsening of IBD|1|||
48723324|NCT01340872|156837909|FG003|Open-label Phase|Worsening of IBD|0|||
48723325|NCT03039621|156837912|FG000|Overall Study|Violation of inclusion criteria|3|||
48723326|NCT03039621|156837913|FG001|Overall Study|Violation of inclusion criteria|2|||
48723327|NCT03039621|156837912|FG000|Overall Study|Non-compliance with protocol requirement|4|||
48723328|NCT03039621|156837913|FG001|Overall Study|Non-compliance with protocol requirement|5|||
48723329|NCT03039621|156837912|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
48723330|NCT03039621|156837913|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
48723331|NCT03039621|156837912|FG000|Overall Study|Violation of non-inclusion criteria|1|||
48723332|NCT03039621|156837913|FG001|Overall Study|Violation of non-inclusion criteria|2|||
48723333|NCT03328182|156837917|FG000|Overall Study|Withdrawal by Subject|1|||
48723334|NCT03328182|156837917|FG000|Overall Study|Protocol Violation|2|||
48723335|NCT03328182|156837917|FG000|Overall Study|No Product Evaluated|1|||
48723336|NCT03274687|156837920|FG000|Overall Study|Protocol Violation|1|||
48723337|NCT03274687|156837921|FG001|Overall Study|Protocol Violation|1|||
48723338|NCT02919969|156837927|FG000|Overall Study|Lack of Efficacy|22|||
48723339|NCT02919969|156837927|FG000|Overall Study|Death|4|||
48723340|NCT02919969|156837927|FG000|Overall Study|Physician Decision|3|||
48723341|NCT02919969|156837927|FG000|Overall Study|Withdrawal by Subject|2|||
48723342|NCT00003830|156837928|FG000|Overall Study|No follow up data|3|||
48723343|NCT00003830|156837929|FG001|Overall Study|No follow up data|0|||
48817655|NCT03398148|157175211|FG008|Substudy 1 Period 2|Other|0|||
48817656|NCT03398148|157175212|FG009|Substudy 1 Period 2|Other|0|||
48817657|NCT03398148|157175213|FG010|Substudy 1 Period 2|Other|0|||
48817658|NCT03398148|157175214|FG011|Substudy 1 Period 2|Other|0|||
48502688|NCT00085735|156038366|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
48502689|NCT00085735|156038367|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
48502690|NCT00085735|156038368|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
48502691|NCT00085735|156038369|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
48723344|NCT00003830|156837928|FG000|Overall Study|Sentinel node positive patients|829|||
48817659|NCT03398148|157175215|FG012|Substudy 1 Period 2|Other|0|||
48817660|NCT03398148|157175216|FG013|Substudy 1 Period 2|Other|0|||
48502692|NCT04567186|156038370|FG000|Period 1|COVID-19 related|1|||
48502693|NCT04567186|156038371|FG001|Period 1|COVID-19 related|0|||
48502694|NCT04567186|156038370|FG000|Period 1|Protocol Violation|0|||
48502695|NCT04567186|156038371|FG001|Period 1|Protocol Violation|1|||
48502696|NCT04567186|156038370|FG000|Period 1|Adverse Event|0|||
48502697|NCT04567186|156038371|FG001|Period 1|Adverse Event|2|||
48502698|NCT04567186|156038370|FG000|Period 2|COVID-19 Related|0|||
48502699|NCT04567186|156038371|FG001|Period 2|COVID-19 Related|1|||
48502700|NCT04567186|156038370|FG000|Period 2|Protocol Violation|0|||
48502701|NCT04567186|156038371|FG001|Period 2|Protocol Violation|1|||
48502702|NCT04567186|156038370|FG000|Period 2|Lost to Follow-up|0|||
48502703|NCT04567186|156038371|FG001|Period 2|Lost to Follow-up|1|||
48502704|NCT04567186|156038370|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
48502705|NCT04567186|156038371|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
48502706|NCT01448057|156038372|FG000|Overall Study|Protocol Violation|3|||
48502707|NCT01448057|156038373|FG001|Overall Study|Protocol Violation|2|||
48502708|NCT01448057|156038372|FG000|Overall Study|Lost to Follow-up|3|||
48502709|NCT01448057|156038373|FG001|Overall Study|Lost to Follow-up|0|||
48502710|NCT01448057|156038372|FG000|Overall Study|Adverse Event|0|||
48502711|NCT01448057|156038373|FG001|Overall Study|Adverse Event|2|||
48502712|NCT01448057|156038372|FG000|Overall Study|Withdrawal by Subject|2|||
48502713|NCT01448057|156038373|FG001|Overall Study|Withdrawal by Subject|0|||
48502714|NCT00440557|156038374|FG000|Overall Study|Withdrawal by Subject|10|||
48502715|NCT00440557|156038375|FG001|Overall Study|Withdrawal by Subject|5|||
48502716|NCT00440557|156038376|FG002|Overall Study|Withdrawal by Subject|11|||
48502717|NCT00440557|156038374|FG000|Overall Study|Lost to Follow-up|1|||
48502718|NCT00440557|156038375|FG001|Overall Study|Lost to Follow-up|2|||
48502719|NCT00440557|156038376|FG002|Overall Study|Lost to Follow-up|6|||
48502720|NCT00440557|156038374|FG000|Overall Study|Adverse Event|3|||
48723345|NCT00003830|156837929|FG001|Overall Study|Sentinel node positive patients|793|||
48723346|NCT00464490|156837930|FG000|Overall Study|Physician Decision|11|||
48723347|NCT00464490|156837931|FG001|Overall Study|Physician Decision|11|||
48723348|NCT00603590|156837932|FG000|Overall Study|Did not attend study clinic|39|||
48817661|NCT03398148|157175217|FG014|Substudy 1 Period 2|Other|0|||
48502721|NCT00440557|156038375|FG001|Overall Study|Adverse Event|3|||
48502722|NCT00440557|156038376|FG002|Overall Study|Adverse Event|5|||
48502723|NCT00440557|156038374|FG000|Overall Study|Death|2|||
48502724|NCT00440557|156038375|FG001|Overall Study|Death|6|||
48723349|NCT00603590|156837933|FG001|Overall Study|Did not attend study clinic|30|||
48723350|NCT00603590|156837932|FG000|Overall Study|Refused blood test|5|||
48723351|NCT00603590|156837933|FG001|Overall Study|Refused blood test|1|||
48817662|NCT03398148|157175203|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817663|NCT03398148|157175204|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817664|NCT03398148|157175205|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817665|NCT03398148|157175206|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817666|NCT03398148|157175207|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817667|NCT03398148|157175208|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817668|NCT03398148|157175209|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
48817669|NCT03398148|157175210|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817670|NCT03398148|157175211|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817671|NCT03398148|157175212|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817672|NCT03398148|157175213|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817673|NCT03398148|157175214|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
48723352|NCT00603590|156837932|FG000|Overall Study|Patient discontinued study drug|22|||
48723353|NCT00603590|156837933|FG001|Overall Study|Patient discontinued study drug|15|||
48723354|NCT00603590|156837932|FG000|Overall Study|Adverse Event|2|||
48723355|NCT00603590|156837933|FG001|Overall Study|Adverse Event|0|||
48723356|NCT00603590|156837932|FG000|Overall Study|Lost to Follow-up|8|||
48723357|NCT00603590|156837933|FG001|Overall Study|Lost to Follow-up|4|||
48817674|NCT03398148|157175215|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
48817675|NCT03398148|157175216|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
48502725|NCT00440557|156038376|FG002|Overall Study|Death|3|||
48502726|NCT00440557|156038374|FG000|Overall Study|Began Dialysis|4|||
48502727|NCT00440557|156038375|FG001|Overall Study|Began Dialysis|1|||
48502728|NCT00440557|156038376|FG002|Overall Study|Began Dialysis|4|||
48502729|NCT00440557|156038374|FG000|Overall Study|Principal Investigator decision|0|||
48502730|NCT00440557|156038375|FG001|Overall Study|Principal Investigator decision|3|||
48502731|NCT00440557|156038376|FG002|Overall Study|Principal Investigator decision|1|||
48502732|NCT00440557|156038374|FG000|Overall Study|Patient moved|1|||
48502733|NCT00440557|156038375|FG001|Overall Study|Patient moved|2|||
48502734|NCT00440557|156038376|FG002|Overall Study|Patient moved|1|||
48502735|NCT00440557|156038374|FG000|Overall Study|Principal Investigator's office closed|3|||
48502736|NCT00440557|156038375|FG001|Overall Study|Principal Investigator's office closed|6|||
48502737|NCT00440557|156038376|FG002|Overall Study|Principal Investigator's office closed|4|||
48723358|NCT00603590|156837932|FG000|Overall Study|Cardiovascular event|0|||
48723359|NCT00603590|156837933|FG001|Overall Study|Cardiovascular event|1|||
48723360|NCT01099709|156837936|FG000|Period 1|Withdrawal by Subject|0|||
48723361|NCT01099709|156837937|FG001|Period 1|Withdrawal by Subject|1|||
48723362|NCT01099709|156837936|FG000|Period 1|Positive cotinine test|0|||
48723363|NCT01099709|156837937|FG001|Period 1|Positive cotinine test|1|||
48723364|NCT01099709|156837936|FG000|Period 1|Adverse Event|1|||
48723365|NCT01099709|156837937|FG001|Period 1|Adverse Event|0|||
48723366|NCT01288976|156837938|FG000|Overall Study|Withdrawal by Subject|58|||
48723367|NCT01288976|156837939|FG001|Overall Study|Withdrawal by Subject|12|||
48723368|NCT01288976|156837940|FG002|Overall Study|Withdrawal by Subject|9|||
48723369|NCT01288976|156837938|FG000|Overall Study|Death|98|||
48723370|NCT01288976|156837939|FG001|Overall Study|Death|6|||
48723371|NCT01288976|156837940|FG002|Overall Study|Death|4|||
48723372|NCT01288976|156837938|FG000|Overall Study|Data unavailable|22|||
48723373|NCT01288976|156837939|FG001|Overall Study|Data unavailable|9|||
48723374|NCT01288976|156837940|FG002|Overall Study|Data unavailable|7|||
48723375|NCT01430754|156837945|FG000|Run-In Phase|Circadian Period Ineligible|24|||
48723376|NCT01430754|156837946|FG001|Run-In Phase|Circadian Period Ineligible|0|||
48723377|NCT01430754|156837945|FG000|Run-In Phase|Protocol Violation|6|||
48723378|NCT01430754|156837946|FG001|Run-In Phase|Protocol Violation|0|||
48723379|NCT01430754|156837945|FG000|Run-In Phase|Adverse Event|2|||
48723380|NCT01430754|156837946|FG001|Run-In Phase|Adverse Event|0|||
48723381|NCT01430754|156837945|FG000|Run-In Phase|Other|2|||
48723382|NCT01430754|156837946|FG001|Run-In Phase|Other|0|||
48723383|NCT01430754|156837945|FG000|Run-In Phase|Withdrawal by Subject|2|||
48502738|NCT00440557|156038374|FG000|Overall Study|Patient transferred to nursing home|0|||
48817676|NCT03398148|157175217|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
48502739|NCT00440557|156038375|FG001|Overall Study|Patient transferred to nursing home|1|||
48502740|NCT00440557|156038376|FG002|Overall Study|Patient transferred to nursing home|0|||
48723384|NCT01430754|156837946|FG001|Run-In Phase|Withdrawal by Subject|0|||
48723385|NCT01430754|156837945|FG000|Run-In Phase|Lost to Follow-up|1|||
48723386|NCT01430754|156837946|FG001|Run-In Phase|Lost to Follow-up|0|||
48817677|NCT03398148|157175203|FG000|Substudy 2 Period 1|Adverse Event|0|||
48723387|NCT04179890|156837947|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
48723388|NCT04179890|156837948|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
48723389|NCT04179890|156837947|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
48723390|NCT04179890|156837948|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
48817678|NCT03398148|157175204|FG001|Substudy 2 Period 1|Adverse Event|0|||
48817679|NCT03398148|157175205|FG002|Substudy 2 Period 1|Adverse Event|0|||
48817680|NCT03398148|157175206|FG003|Substudy 2 Period 1|Adverse Event|0|||
48817681|NCT03398148|157175207|FG004|Substudy 2 Period 1|Adverse Event|0|||
48817682|NCT03398148|157175208|FG005|Substudy 2 Period 1|Adverse Event|0|||
48817683|NCT03398148|157175209|FG006|Substudy 2 Period 1|Adverse Event|0|||
48817684|NCT03398148|157175210|FG007|Substudy 2 Period 1|Adverse Event|0|||
48817685|NCT03398148|157175211|FG008|Substudy 2 Period 1|Adverse Event|0|||
48817686|NCT03398148|157175212|FG009|Substudy 2 Period 1|Adverse Event|12|||
48817687|NCT03398148|157175213|FG010|Substudy 2 Period 1|Adverse Event|2|||
48817688|NCT03398148|157175214|FG011|Substudy 2 Period 1|Adverse Event|0|||
48817689|NCT03398148|157175215|FG012|Substudy 2 Period 1|Adverse Event|0|||
48817690|NCT03398148|157175216|FG013|Substudy 2 Period 1|Adverse Event|0|||
48817691|NCT03398148|157175217|FG014|Substudy 2 Period 1|Adverse Event|0|||
48817692|NCT03398148|157175203|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817693|NCT03398148|157175204|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817694|NCT03398148|157175205|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817695|NCT03398148|157175206|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817696|NCT03398148|157175207|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817697|NCT03398148|157175208|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817698|NCT03398148|157175209|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817699|NCT03398148|157175210|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817700|NCT03398148|157175211|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817701|NCT03398148|157175212|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
48817702|NCT03398148|157175213|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
48723391|NCT04179890|156837947|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
48723392|NCT04179890|156837948|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
48723393|NCT04179890|156837947|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
48723394|NCT04179890|156837948|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
48817703|NCT03398148|157175214|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817704|NCT03398148|157175215|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817705|NCT03398148|157175216|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48817706|NCT03398148|157175217|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
48502741|NCT00440557|156038374|FG000|Overall Study|Patient had surgery|1|||
48502742|NCT00440557|156038375|FG001|Overall Study|Patient had surgery|0|||
48502743|NCT00440557|156038376|FG002|Overall Study|Patient had surgery|0|||
48502744|NCT03553823|156038377|FG000|Overall Study|Physician Decision|0|||
48502745|NCT03553823|156038378|FG001|Overall Study|Physician Decision|1|||
48502746|NCT03450070|156038379|FG000|Overall Study|Withdrawal by Subject|8|||
48502747|NCT00050778|156038380|FG000|Overall Study|Adverse Event|13|||
48502748|NCT00050778|156038381|FG001|Overall Study|Adverse Event|3|||
48502749|NCT00050778|156038382|FG002|Overall Study|Adverse Event|2|||
48723395|NCT04179890|156837947|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
48817707|NCT03398148|157175203|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
48817708|NCT03398148|157175204|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
48817709|NCT03398148|157175205|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
48817710|NCT03398148|157175206|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
48817711|NCT03398148|157175207|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
48817712|NCT03398148|157175208|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
48502750|NCT00050778|156038380|FG000|Overall Study|Death|0|||
48502751|NCT00050778|156038381|FG001|Overall Study|Death|1|||
48502752|NCT00050778|156038382|FG002|Overall Study|Death|1|||
48502753|NCT00050778|156038380|FG000|Overall Study|Lack of Efficacy|16|||
48502754|NCT00050778|156038381|FG001|Overall Study|Lack of Efficacy|2|||
48502755|NCT00050778|156038382|FG002|Overall Study|Lack of Efficacy|2|||
48502756|NCT00050778|156038380|FG000|Overall Study|Lost to Follow-up|0|||
48502757|NCT00050778|156038381|FG001|Overall Study|Lost to Follow-up|2|||
48502758|NCT00050778|156038382|FG002|Overall Study|Lost to Follow-up|4|||
48502759|NCT00050778|156038380|FG000|Overall Study|Physician Decision|3|||
48502760|NCT00050778|156038381|FG001|Overall Study|Physician Decision|0|||
48502761|NCT00050778|156038382|FG002|Overall Study|Physician Decision|2|||
48502762|NCT00050778|156038380|FG000|Overall Study|Protocol Violation|2|||
48502763|NCT00050778|156038381|FG001|Overall Study|Protocol Violation|0|||
48502764|NCT00050778|156038382|FG002|Overall Study|Protocol Violation|1|||
48502765|NCT00050778|156038380|FG000|Overall Study|Withdrawal by Subject|6|||
48817713|NCT03398148|157175209|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
48817714|NCT03398148|157175210|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
48502766|NCT00050778|156038381|FG001|Overall Study|Withdrawal by Subject|8|||
48502767|NCT00050778|156038382|FG002|Overall Study|Withdrawal by Subject|4|||
48502768|NCT00050778|156038380|FG000|Overall Study|Randomized but not treated|4|||
48502769|NCT00050778|156038381|FG001|Overall Study|Randomized but not treated|5|||
48502770|NCT00050778|156038382|FG002|Overall Study|Randomized but not treated|2|||
48502771|NCT00050778|156038380|FG000|Overall Study|Familial and personal reasons|1|||
48502772|NCT00050778|156038381|FG001|Overall Study|Familial and personal reasons|0|||
48817715|NCT03398148|157175211|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
48817716|NCT03398148|157175212|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
48817717|NCT03398148|157175213|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
48817718|NCT03398148|157175214|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
48817719|NCT03398148|157175215|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
48817720|NCT03398148|157175216|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
48817721|NCT03398148|157175217|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
48817722|NCT03398148|157175203|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817723|NCT03398148|157175204|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817724|NCT03398148|157175205|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817725|NCT03398148|157175206|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817726|NCT03398148|157175207|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817727|NCT03398148|157175208|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817728|NCT03398148|157175209|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817729|NCT03398148|157175210|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817730|NCT03398148|157175211|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817731|NCT03398148|157175212|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817732|NCT03398148|157175213|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
48817733|NCT03398148|157175214|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48723396|NCT04179890|156837948|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
48723397|NCT04179890|156837947|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
48817734|NCT03398148|157175215|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817735|NCT03398148|157175216|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817736|NCT03398148|157175217|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
48817737|NCT03398148|157175203|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817738|NCT03398148|157175204|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817739|NCT03398148|157175205|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817740|NCT03398148|157175206|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817741|NCT03398148|157175207|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817742|NCT03398148|157175208|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817743|NCT03398148|157175209|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817744|NCT03398148|157175210|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817745|NCT03398148|157175211|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817746|NCT03398148|157175212|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817747|NCT03398148|157175213|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
48817748|NCT03398148|157175214|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817749|NCT03398148|157175215|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817750|NCT03398148|157175216|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48723398|NCT04179890|156837948|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
48723399|NCT04179890|156837947|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
48723400|NCT04179890|156837948|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
48723401|NCT04179890|156837947|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
48723402|NCT04179890|156837948|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
48723403|NCT04179890|156837947|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
48723404|NCT04179890|156837948|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
48723405|NCT00095238|156837949|FG000|Overall Study|Lack of Efficacy|9|||
48723406|NCT00095238|156837950|FG001|Overall Study|Lack of Efficacy|9|||
48723407|NCT00095238|156837949|FG000|Overall Study|Adverse Event|331|||
48723408|NCT00095238|156837950|FG001|Overall Study|Adverse Event|287|||
48723409|NCT00095238|156837949|FG000|Overall Study|Subject Withdrew Consent|208|||
48723410|NCT00095238|156837950|FG001|Overall Study|Subject Withdrew Consent|223|||
48723411|NCT00095238|156837949|FG000|Overall Study|Death|154|||
48723412|NCT00095238|156837950|FG001|Overall Study|Death|170|||
48723413|NCT00095238|156837949|FG000|Overall Study|Lost to Follow-up|19|||
48817751|NCT03398148|157175217|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
48817752|NCT03398148|157175203|FG000|Substudy 2 Period 1|Other|0|||
48817753|NCT03398148|157175204|FG001|Substudy 2 Period 1|Other|0|||
48502773|NCT00050778|156038382|FG002|Overall Study|Familial and personal reasons|0|||
48502774|NCT00436553|156038396|FG000|Overall Study|Adverse Event|4|||
48502775|NCT00436553|156038397|FG001|Overall Study|Adverse Event|3|||
48817754|NCT03398148|157175205|FG002|Substudy 2 Period 1|Other|0|||
48502776|NCT00436553|156038398|FG002|Overall Study|Adverse Event|4|||
48502777|NCT00436553|156038396|FG000|Overall Study|Death|3|||
48502778|NCT00436553|156038397|FG001|Overall Study|Death|1|||
48502779|NCT00436553|156038398|FG002|Overall Study|Death|3|||
48817755|NCT03398148|157175206|FG003|Substudy 2 Period 1|Other|0|||
48817756|NCT03398148|157175207|FG004|Substudy 2 Period 1|Other|0|||
48502780|NCT00436553|156038396|FG000|Overall Study|Lost to Follow-up|0|||
48502781|NCT00436553|156038397|FG001|Overall Study|Lost to Follow-up|2|||
48817757|NCT03398148|157175208|FG005|Substudy 2 Period 1|Other|0|||
48502782|NCT00436553|156038398|FG002|Overall Study|Lost to Follow-up|0|||
48502783|NCT00436553|156038396|FG000|Overall Study|Protocol Violation|1|||
48817758|NCT03398148|157175209|FG006|Substudy 2 Period 1|Other|0|||
48817759|NCT03398148|157175210|FG007|Substudy 2 Period 1|Other|0|||
48817760|NCT03398148|157175211|FG008|Substudy 2 Period 1|Other|0|||
48817761|NCT03398148|157175212|FG009|Substudy 2 Period 1|Other|4|||
48817762|NCT03398148|157175213|FG010|Substudy 2 Period 1|Other|4|||
48817763|NCT03398148|157175214|FG011|Substudy 2 Period 1|Other|0|||
48817764|NCT03398148|157175215|FG012|Substudy 2 Period 1|Other|0|||
48817765|NCT03398148|157175216|FG013|Substudy 2 Period 1|Other|0|||
48817766|NCT03398148|157175217|FG014|Substudy 2 Period 1|Other|0|||
48817767|NCT03398148|157175203|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817768|NCT03398148|157175204|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817769|NCT03398148|157175205|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817770|NCT03398148|157175206|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817771|NCT03398148|157175207|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817772|NCT03398148|157175208|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817773|NCT03398148|157175209|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817774|NCT03398148|157175210|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817775|NCT03398148|157175211|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817776|NCT03398148|157175212|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817777|NCT03398148|157175213|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
48817778|NCT03398148|157175214|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817779|NCT03398148|157175215|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817780|NCT03398148|157175216|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817781|NCT03398148|157175217|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
48817782|NCT03398148|157175203|FG000|Substudy 2 Period 2|Adverse Event|0|||
48817783|NCT03398148|157175204|FG001|Substudy 2 Period 2|Adverse Event|0|||
48817784|NCT03398148|157175205|FG002|Substudy 2 Period 2|Adverse Event|0|||
48817785|NCT03398148|157175206|FG003|Substudy 2 Period 2|Adverse Event|0|||
48817786|NCT03398148|157175207|FG004|Substudy 2 Period 2|Adverse Event|0|||
48817787|NCT03398148|157175208|FG005|Substudy 2 Period 2|Adverse Event|0|||
48723414|NCT00095238|156837950|FG001|Overall Study|Lost to Follow-up|24|||
48723415|NCT00095238|156837949|FG000|Overall Study|Noncompliance|44|||
48817788|NCT03398148|157175209|FG006|Substudy 2 Period 2|Adverse Event|0|||
48817789|NCT03398148|157175210|FG007|Substudy 2 Period 2|Adverse Event|0|||
48817790|NCT03398148|157175211|FG008|Substudy 2 Period 2|Adverse Event|0|||
48817791|NCT03398148|157175212|FG009|Substudy 2 Period 2|Adverse Event|0|||
48817792|NCT03398148|157175213|FG010|Substudy 2 Period 2|Adverse Event|0|||
48817793|NCT03398148|157175214|FG011|Substudy 2 Period 2|Adverse Event|0|||
48817794|NCT03398148|157175215|FG012|Substudy 2 Period 2|Adverse Event|0|||
48817795|NCT03398148|157175216|FG013|Substudy 2 Period 2|Adverse Event|1|||
48817796|NCT03398148|157175217|FG014|Substudy 2 Period 2|Adverse Event|3|||
48817797|NCT03398148|157175203|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
48817798|NCT03398148|157175204|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
48817799|NCT03398148|157175205|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
48817800|NCT03398148|157175206|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
48817801|NCT03398148|157175207|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
48817802|NCT03398148|157175208|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
48817803|NCT03398148|157175209|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
48817804|NCT03398148|157175210|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
48502784|NCT00436553|156038397|FG001|Overall Study|Protocol Violation|0|||
48502785|NCT00436553|156038398|FG002|Overall Study|Protocol Violation|0|||
48502786|NCT00436553|156038396|FG000|Overall Study|Withdrawal by Subject|5|||
48502787|NCT00436553|156038397|FG001|Overall Study|Withdrawal by Subject|6|||
48502788|NCT00436553|156038398|FG002|Overall Study|Withdrawal by Subject|3|||
48723416|NCT00095238|156837950|FG001|Overall Study|Noncompliance|45|||
48723417|NCT00095238|156837949|FG000|Overall Study|No longer met study criteria|4|||
48723418|NCT00095238|156837950|FG001|Overall Study|No longer met study criteria|5|||
48723419|NCT00095238|156837949|FG000|Overall Study|Study terminated by sponsor|0|||
48723420|NCT00095238|156837950|FG001|Overall Study|Study terminated by sponsor|1|||
48723421|NCT00095238|156837949|FG000|Overall Study|Missing|1|||
48723422|NCT00095238|156837950|FG001|Overall Study|Missing|0|||
48723423|NCT00095238|156837949|FG000|Overall Study|Other Reasons|87|||
48723424|NCT00095238|156837950|FG001|Overall Study|Other Reasons|88|||
48817805|NCT03398148|157175211|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
48817806|NCT03398148|157175212|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
48817807|NCT03398148|157175213|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
48817808|NCT03398148|157175214|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
48817809|NCT03398148|157175215|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
48817810|NCT03398148|157175216|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
48817811|NCT03398148|157175217|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
48723425|NCT03263026|156837953|FG000|Overall Study|Withdrawal by Subject|1|||
48723426|NCT03263026|156837954|FG001|Overall Study|Withdrawal by Subject|0|||
48817812|NCT03398148|157175203|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817813|NCT03398148|157175204|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817814|NCT03398148|157175205|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817815|NCT03398148|157175206|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817816|NCT03398148|157175207|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817817|NCT03398148|157175208|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817818|NCT03398148|157175209|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817819|NCT03398148|157175210|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817820|NCT03398148|157175211|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817821|NCT03398148|157175212|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817822|NCT03398148|157175213|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817823|NCT03398148|157175214|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
48817824|NCT03398148|157175215|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
48817825|NCT03398148|157175216|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
48817826|NCT03398148|157175217|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
48817827|NCT03398148|157175203|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
48817828|NCT03398148|157175204|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
48817829|NCT03398148|157175205|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
48817830|NCT03398148|157175206|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
48817831|NCT03398148|157175207|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
48817832|NCT03398148|157175208|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
48817833|NCT03398148|157175209|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
48817834|NCT03398148|157175210|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
48817835|NCT03398148|157175211|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
48817836|NCT03398148|157175212|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
48817837|NCT03398148|157175213|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
48817838|NCT03398148|157175214|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
48817839|NCT03398148|157175215|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
48817840|NCT03398148|157175216|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
48817841|NCT03398148|157175217|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
48817842|NCT03398148|157175203|FG000|Substudy 2 Period 2|Other|0|||
48817843|NCT03398148|157175204|FG001|Substudy 2 Period 2|Other|0|||
48817844|NCT03398148|157175205|FG002|Substudy 2 Period 2|Other|0|||
48817845|NCT03398148|157175206|FG003|Substudy 2 Period 2|Other|0|||
48817846|NCT03398148|157175207|FG004|Substudy 2 Period 2|Other|0|||
48817847|NCT03398148|157175208|FG005|Substudy 2 Period 2|Other|0|||
48817848|NCT03398148|157175209|FG006|Substudy 2 Period 2|Other|0|||
48817849|NCT03398148|157175210|FG007|Substudy 2 Period 2|Other|0|||
48817850|NCT03398148|157175211|FG008|Substudy 2 Period 2|Other|0|||
48817851|NCT03398148|157175212|FG009|Substudy 2 Period 2|Other|0|||
48817852|NCT03398148|157175213|FG010|Substudy 2 Period 2|Other|0|||
48817853|NCT03398148|157175214|FG011|Substudy 2 Period 2|Other|0|||
48817854|NCT03398148|157175215|FG012|Substudy 2 Period 2|Other|0|||
48817855|NCT03398148|157175216|FG013|Substudy 2 Period 2|Other|1|||
48817856|NCT03398148|157175217|FG014|Substudy 2 Period 2|Other|1|||
48817857|NCT03398148|157175203|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817858|NCT03398148|157175204|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817859|NCT03398148|157175205|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817860|NCT03398148|157175206|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817861|NCT03398148|157175207|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817862|NCT03398148|157175208|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817863|NCT03398148|157175209|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817864|NCT03398148|157175210|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817865|NCT03398148|157175211|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817866|NCT03398148|157175212|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817867|NCT03398148|157175213|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817868|NCT03398148|157175214|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817869|NCT03398148|157175215|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
48817870|NCT03398148|157175216|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
48817871|NCT03398148|157175217|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
48817872|NCT01155388|157175218|FG000|Overall Study|Adverse Event|1|||
48817873|NCT01155388|157175219|FG001|Overall Study|Adverse Event|0|||
48817874|NCT01023308|157175221|FG000|Overall Study|Abnormal test proceedure results|3|||
48817875|NCT01023308|157175222|FG001|Overall Study|Abnormal test proceedure results|8|||
48502789|NCT02468778|156038401|FG000|Overall Study|Death|2|||
48502790|NCT02468778|156038402|FG001|Overall Study|Death|1|||
48502791|NCT02468778|156038403|FG002|Overall Study|Death|0|||
48502792|NCT02468778|156038401|FG000|Overall Study|Lost to Follow-up|1|||
48502793|NCT02468778|156038402|FG001|Overall Study|Lost to Follow-up|2|||
48502794|NCT02468778|156038403|FG002|Overall Study|Lost to Follow-up|2|||
48817876|NCT01023308|157175221|FG000|Overall Study|Administrative problems|2|||
48817877|NCT01023308|157175222|FG001|Overall Study|Administrative problems|1|||
48817878|NCT01023308|157175221|FG000|Overall Study|Adverse Event|130|||
48817879|NCT01023308|157175222|FG001|Overall Study|Adverse Event|66|||
48817880|NCT01023308|157175221|FG000|Overall Study|Death|21|||
48817881|NCT01023308|157175222|FG001|Overall Study|Death|17|||
48817882|NCT01023308|157175221|FG000|Overall Study|Disease progression|82|||
48817883|NCT01023308|157175222|FG001|Overall Study|Disease progression|153|||
48817884|NCT01023308|157175221|FG000|Overall Study|New Cancer therapy|4|||
48502795|NCT02468778|156038401|FG000|Overall Study|Withdrawal by Subject|0|||
48817885|NCT01023308|157175222|FG001|Overall Study|New Cancer therapy|7|||
48817886|NCT01023308|157175221|FG000|Overall Study|Protocol Violation|3|||
48817887|NCT01023308|157175222|FG001|Overall Study|Protocol Violation|4|||
48502796|NCT02468778|156038402|FG001|Overall Study|Withdrawal by Subject|1|||
48817888|NCT01023308|157175221|FG000|Overall Study|Untreated|5|||
48817889|NCT01023308|157175222|FG001|Overall Study|Untreated|5|||
48817890|NCT01023308|157175221|FG000|Overall Study|Lost to Follow-up|1|||
48817891|NCT01023308|157175222|FG001|Overall Study|Lost to Follow-up|0|||
48817892|NCT01023308|157175221|FG000|Overall Study|Withdrawal by Subject|34|||
48817893|NCT01023308|157175222|FG001|Overall Study|Withdrawal by Subject|18|||
48817894|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
48502797|NCT02468778|156038403|FG002|Overall Study|Withdrawal by Subject|1|||
48502798|NCT02206828|156038404|FG000|Overall Study|Lost to Follow-up|7|||
48817895|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
48817896|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
48817897|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
48817898|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
48723427|NCT03263026|156837953|FG000|Overall Study|Death|1|||
48723428|NCT03263026|156837954|FG001|Overall Study|Death|0|||
48723429|NCT03263026|156837953|FG000|Overall Study|Other/ Various|41|||
48502799|NCT06132282|156038410|FG000|Overall Study|Lost to Follow-up|31|||
48502800|NCT05052996|156038411|FG000|Overall Study|Still on study|0|||
48502801|NCT05052996|156038412|FG001|Overall Study|Still on study|0|||
48502802|NCT05052996|156038413|FG002|Overall Study|Still on study|47|||
48502803|NCT05052996|156038414|FG003|Overall Study|Still on study|44|||
48502804|NCT05052996|156038411|FG000|Overall Study|Cohort terminated by sponsor|21|||
48502805|NCT05052996|156038412|FG001|Overall Study|Cohort terminated by sponsor|12|||
48502806|NCT05052996|156038413|FG002|Overall Study|Cohort terminated by sponsor|0|||
48502807|NCT05052996|156038414|FG003|Overall Study|Cohort terminated by sponsor|0|||
48502808|NCT05052996|156038411|FG000|Overall Study|Withdrew consent|1|||
48502809|NCT05052996|156038412|FG001|Overall Study|Withdrew consent|0|||
48502810|NCT05052996|156038413|FG002|Overall Study|Withdrew consent|1|||
48502811|NCT05052996|156038414|FG003|Overall Study|Withdrew consent|2|||
48502812|NCT05052996|156038411|FG000|Overall Study|Lost to Follow-up|1|||
48502813|NCT05052996|156038412|FG001|Overall Study|Lost to Follow-up|0|||
48502814|NCT05052996|156038413|FG002|Overall Study|Lost to Follow-up|0|||
48502815|NCT05052996|156038414|FG003|Overall Study|Lost to Follow-up|2|||
48502816|NCT05052996|156038411|FG000|Overall Study|Adverse Event|0|||
48502817|NCT05052996|156038412|FG001|Overall Study|Adverse Event|0|||
48502818|NCT05052996|156038413|FG002|Overall Study|Adverse Event|2|||
48502819|NCT05052996|156038414|FG003|Overall Study|Adverse Event|0|||
48502820|NCT05052996|156038411|FG000|Overall Study|Randomized but never treated|0|||
48723430|NCT03263026|156837954|FG001|Overall Study|Other/ Various|29|||
48723431|NCT03285763|156837957|FG000|Overall Study|Death|470|||
48723432|NCT03285763|156837957|FG000|Overall Study|Lost to Follow-up|18|||
48817899|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
48817900|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
48817901|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
48817902|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
48502821|NCT05052996|156038412|FG001|Overall Study|Randomized but never treated|0|||
48723433|NCT03285763|156837957|FG000|Overall Study|Physician Decision|2|||
48723434|NCT03285763|156837957|FG000|Overall Study|Study Terminated By Sponsor|79|||
48723435|NCT03285763|156837957|FG000|Overall Study|Withdrawal by Subject|33|||
48723436|NCT01820260|156837958|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723437|NCT01820260|156837959|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723438|NCT01820260|156837960|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723439|NCT01820260|156837961|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723440|NCT01820260|156837962|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723441|NCT01820260|156837963|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723442|NCT01820260|156837964|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
48723443|NCT01820260|156837965|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723444|NCT01820260|156837966|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723445|NCT01820260|156837967|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723446|NCT01820260|156837968|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723447|NCT01820260|156837969|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723448|NCT01820260|156837970|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48723449|NCT01820260|156837971|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
48817903|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
48502822|NCT05052996|156038413|FG002|Overall Study|Randomized but never treated|1|||
48502823|NCT05052996|156038414|FG003|Overall Study|Randomized but never treated|1|||
48502824|NCT05052996|156038411|FG000|Overall Study|Protocol Violation|1|||
48723450|NCT01820260|156837958|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48502825|NCT05052996|156038412|FG001|Overall Study|Protocol Violation|0|||
48502826|NCT05052996|156038413|FG002|Overall Study|Protocol Violation|0|||
48502827|NCT05052996|156038414|FG003|Overall Study|Protocol Violation|0|||
48502828|NCT05672069|156038415|FG000|Overall Study|Implant removal|1|||
48502829|NCT05672069|156038415|FG000|Overall Study|Lost to Follow-up|2|||
48502830|NCT05257486|156038416|FG000|Overall Study|Protocol Violation|3|||
48502831|NCT00857623|156038420|FG000|Overall Study|Adverse Event|5|||
48502832|NCT00857623|156038421|FG001|Overall Study|Adverse Event|2|||
48502833|NCT00857623|156038420|FG000|Overall Study|Study-specific discontinuation criteria|5|||
48502834|NCT00857623|156038421|FG001|Overall Study|Study-specific discontinuation criteria|3|||
48502835|NCT00857623|156038420|FG000|Overall Study|Withdrawal by Subject|2|||
48502836|NCT00857623|156038421|FG001|Overall Study|Withdrawal by Subject|1|||
48502837|NCT00857623|156038420|FG000|Overall Study|Lack of Efficacy|1|||
48502838|NCT00857623|156038421|FG001|Overall Study|Lack of Efficacy|1|||
48502839|NCT00857623|156038420|FG000|Overall Study|Severe non-compliance to protocol|1|||
48502840|NCT00857623|156038421|FG001|Overall Study|Severe non-compliance to protocol|1|||
48502841|NCT00857623|156038420|FG000|Overall Study|Intake of prohibited medication|0|||
48502842|NCT00857623|156038421|FG001|Overall Study|Intake of prohibited medication|1|||
48502843|NCT00857623|156038420|FG000|Overall Study|Positive for HEP C|0|||
48502844|NCT00857623|156038421|FG001|Overall Study|Positive for HEP C|1|||
48502845|NCT03435081|156038422|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
48502846|NCT03435081|156038423|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
48502847|NCT03435081|156038424|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
48502848|NCT03435081|156038422|FG000|Week 0 to Week 16|Adverse Event|2|||
48502849|NCT03435081|156038423|FG001|Week 0 to Week 16|Adverse Event|2|||
48502850|NCT03435081|156038424|FG002|Week 0 to Week 16|Adverse Event|2|||
48502851|NCT03435081|156038422|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
48502852|NCT03435081|156038423|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
48502853|NCT03435081|156038424|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
48502854|NCT03435081|156038422|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
48502855|NCT03435081|156038423|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
48502856|NCT03435081|156038424|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
48502857|NCT03435081|156038422|FG000|Week 0 to Week 16|Pregnancy|1|||
48502858|NCT03435081|156038423|FG001|Week 0 to Week 16|Pregnancy|0|||
48502859|NCT03435081|156038424|FG002|Week 0 to Week 16|Pregnancy|0|||
48502860|NCT03435081|156038422|FG000|Week 0 to Week 16|Non-compliance|1|||
48502861|NCT03435081|156038423|FG001|Week 0 to Week 16|Non-compliance|0|||
48502862|NCT03435081|156038424|FG002|Week 0 to Week 16|Non-compliance|2|||
48502863|NCT03435081|156038422|FG000|Week 0 to Week 16|Inadequate Response|0|||
48502864|NCT03435081|156038423|FG001|Week 0 to Week 16|Inadequate Response|1|||
48502865|NCT03435081|156038424|FG002|Week 0 to Week 16|Inadequate Response|0|||
48502866|NCT03435081|156038422|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
48502867|NCT03435081|156038423|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
48502868|NCT03435081|156038424|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
48502869|NCT03435081|156038422|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
48502870|NCT03435081|156038423|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
48502871|NCT03435081|156038424|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
48502872|NCT03435081|156038422|FG000|Week 16 to Week 104|Adverse Event|1|||
48502873|NCT03435081|156038423|FG001|Week 16 to Week 104|Adverse Event|0|||
48502874|NCT03435081|156038424|FG002|Week 16 to Week 104|Adverse Event|2|||
48502875|NCT03435081|156038422|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
48502876|NCT03435081|156038423|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
48502877|NCT03435081|156038424|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
48502878|NCT03435081|156038422|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
48502879|NCT03435081|156038423|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
48502880|NCT03435081|156038424|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
48502881|NCT03435081|156038422|FG000|Week 16 to Week 104|Non--Compliance|0|||
48502882|NCT03435081|156038423|FG001|Week 16 to Week 104|Non--Compliance|0|||
48502883|NCT03435081|156038424|FG002|Week 16 to Week 104|Non--Compliance|1|||
48502884|NCT05586490|156038425|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
48502885|NCT05586490|156038426|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
48723451|NCT01820260|156837959|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48502886|NCT05586490|156038427|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
48502887|NCT05586490|156038428|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
48502888|NCT05586490|156038429|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
48502889|NCT05586490|156038425|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
48502890|NCT05586490|156038426|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
48502891|NCT05586490|156038427|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
48502892|NCT05586490|156038428|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
48723452|NCT01820260|156837960|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48502893|NCT05586490|156038429|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
48502894|NCT05586490|156038425|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
48502895|NCT05586490|156038426|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
48723453|NCT01820260|156837961|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723454|NCT01820260|156837962|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48502896|NCT05586490|156038427|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
48502897|NCT05586490|156038428|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
48502898|NCT05586490|156038429|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
48502899|NCT04786119|156038430|FG000|Overall Study|Withdrawal by Subject|2|||
48502900|NCT00855738|156038431|FG000|Overall Study|Lost to Follow-up|2|||
48502901|NCT00855738|156038431|FG000|Overall Study|Adverse Event|1|||
48502902|NCT00855738|156038431|FG000|Overall Study|Subject Defaulted|1|||
48502903|NCT00855738|156038431|FG000|Overall Study|Death|1|||
48502904|NCT02323880|156038434|FG000|Overall Study|Adverse Event|2|||
48502905|NCT02323880|156038435|FG001|Overall Study|Adverse Event|0|||
48502906|NCT02323880|156038436|FG002|Overall Study|Adverse Event|1|||
48502907|NCT02323880|156038437|FG003|Overall Study|Adverse Event|1|||
48502908|NCT02323880|156038438|FG004|Overall Study|Adverse Event|1|||
48502909|NCT02323880|156038439|FG005|Overall Study|Adverse Event|0|||
48502910|NCT02323880|156038440|FG006|Overall Study|Adverse Event|1|||
48502911|NCT02323880|156038441|FG007|Overall Study|Adverse Event|0|||
48502912|NCT02323880|156038434|FG000|Overall Study|Death|0|||
48502913|NCT02323880|156038435|FG001|Overall Study|Death|0|||
48502914|NCT02323880|156038436|FG002|Overall Study|Death|0|||
48502915|NCT02323880|156038437|FG003|Overall Study|Death|0|||
48502916|NCT02323880|156038438|FG004|Overall Study|Death|0|||
48502917|NCT02323880|156038439|FG005|Overall Study|Death|1|||
48502918|NCT02323880|156038440|FG006|Overall Study|Death|0|||
48502919|NCT02323880|156038441|FG007|Overall Study|Death|0|||
48502920|NCT02323880|156038434|FG000|Overall Study|Lack of Efficacy|4|||
48502921|NCT02323880|156038435|FG001|Overall Study|Lack of Efficacy|11|||
48502922|NCT02323880|156038436|FG002|Overall Study|Lack of Efficacy|5|||
48502923|NCT02323880|156038437|FG003|Overall Study|Lack of Efficacy|5|||
48502924|NCT02323880|156038438|FG004|Overall Study|Lack of Efficacy|4|||
48502925|NCT02323880|156038439|FG005|Overall Study|Lack of Efficacy|8|||
48502926|NCT02323880|156038440|FG006|Overall Study|Lack of Efficacy|4|||
48502927|NCT02323880|156038441|FG007|Overall Study|Lack of Efficacy|6|||
48502928|NCT02323880|156038434|FG000|Overall Study|Physician Decision|0|||
48502929|NCT02323880|156038435|FG001|Overall Study|Physician Decision|0|||
48502930|NCT02323880|156038436|FG002|Overall Study|Physician Decision|0|||
48502931|NCT02323880|156038437|FG003|Overall Study|Physician Decision|0|||
48502932|NCT02323880|156038438|FG004|Overall Study|Physician Decision|1|||
48502933|NCT02323880|156038439|FG005|Overall Study|Physician Decision|1|||
48502934|NCT02323880|156038440|FG006|Overall Study|Physician Decision|1|||
48502935|NCT02323880|156038441|FG007|Overall Study|Physician Decision|0|||
48502936|NCT02323880|156038434|FG000|Overall Study|Withdrawal by Subject|0|||
48502937|NCT02323880|156038435|FG001|Overall Study|Withdrawal by Subject|2|||
48502938|NCT02323880|156038436|FG002|Overall Study|Withdrawal by Subject|0|||
48502939|NCT02323880|156038437|FG003|Overall Study|Withdrawal by Subject|0|||
48502940|NCT02323880|156038438|FG004|Overall Study|Withdrawal by Subject|0|||
48502941|NCT02323880|156038439|FG005|Overall Study|Withdrawal by Subject|0|||
48502942|NCT02323880|156038440|FG006|Overall Study|Withdrawal by Subject|0|||
48502943|NCT02323880|156038441|FG007|Overall Study|Withdrawal by Subject|0|||
48502944|NCT04218851|156038442|FG000|Overall Study|Death|1|||
48502945|NCT04218851|156038443|FG001|Overall Study|Death|3|||
48502946|NCT00119379|156038444|FG000|Overall Study|Adverse Event|4|||
48502947|NCT00119379|156038445|FG001|Overall Study|Adverse Event|1|||
48502948|NCT04753437|156038458|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48502949|NCT04753437|156038459|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48502950|NCT04753437|156038458|FG000|Overall Study|Liver Function Test Abnormalities|2|||
48502951|NCT04753437|156038459|FG001|Overall Study|Liver Function Test Abnormalities|4|||
48502952|NCT02032888|156038460|FG000|Treatment Period|Poor compliance/noncompliance|1|||
48723455|NCT01820260|156837963|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723456|NCT01820260|156837964|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723457|NCT01820260|156837965|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48502953|NCT02032888|156038461|FG001|Treatment Period|Poor compliance/noncompliance|1|||
48502954|NCT02032888|156038462|FG002|Treatment Period|Poor compliance/noncompliance|0|||
48502955|NCT02032888|156038460|FG000|Treatment Period|Other|1|||
48502956|NCT02032888|156038461|FG001|Treatment Period|Other|1|||
48502957|NCT02032888|156038462|FG002|Treatment Period|Other|0|||
48723458|NCT01820260|156837966|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723459|NCT01820260|156837967|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
48723460|NCT01820260|156837968|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723461|NCT01820260|156837969|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723462|NCT01820260|156837970|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723463|NCT01820260|156837971|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
48723464|NCT04088630|156837972|FG000|Overall Study|Lost to Follow-up|3|||
48723465|NCT04088630|156837973|FG001|Overall Study|Lost to Follow-up|2|||
48723466|NCT04088630|156837974|FG002|Overall Study|Lost to Follow-up|6|||
48723467|NCT04088630|156837972|FG000|Overall Study|Death|3|||
48502958|NCT02032888|156038460|FG000|Follow-up Period|Lost to Follow-up|1|||
48502959|NCT02032888|156038461|FG001|Follow-up Period|Lost to Follow-up|1|||
48502960|NCT02032888|156038462|FG002|Follow-up Period|Lost to Follow-up|0|||
48502961|NCT02032888|156038460|FG000|Follow-up Period|Death|1|||
48502962|NCT02032888|156038461|FG001|Follow-up Period|Death|1|||
48502963|NCT02032888|156038462|FG002|Follow-up Period|Death|0|||
48502964|NCT02032888|156038460|FG000|Follow-up Period|Other|1|||
48502965|NCT02032888|156038461|FG001|Follow-up Period|Other|0|||
48502966|NCT02032888|156038462|FG002|Follow-up Period|Other|0|||
48502967|NCT05275205|156038465|FG000|Overall Study|Adverse Event|1|||
48502968|NCT05275205|156038466|FG001|Overall Study|Adverse Event|2|||
48502969|NCT05275205|156038465|FG000|Overall Study|Physician Decision|1|||
48502970|NCT05275205|156038466|FG001|Overall Study|Physician Decision|1|||
48502971|NCT05275205|156038465|FG000|Overall Study|Withdrawal by Subject|2|||
48502972|NCT05275205|156038466|FG001|Overall Study|Withdrawal by Subject|3|||
48502973|NCT05275205|156038465|FG000|Overall Study|Death|1|||
48502974|NCT05275205|156038466|FG001|Overall Study|Death|0|||
48502975|NCT05275205|156038465|FG000|Overall Study|Patient unable to attend visits|1|||
48502976|NCT05275205|156038466|FG001|Overall Study|Patient unable to attend visits|0|||
48502977|NCT00440297|156038467|FG000|Overall Study|Adverse Event|8|||
48723468|NCT04088630|156837973|FG001|Overall Study|Death|1|||
48817904|NCT01646320|157175223|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
48817905|NCT01646320|157175224|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
48817906|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
48817907|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
48817908|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
48817909|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
48817910|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
48723469|NCT04088630|156837974|FG002|Overall Study|Death|1|||
48723470|NCT04088630|156837972|FG000|Overall Study|Physician Decision|0|||
48723471|NCT04088630|156837973|FG001|Overall Study|Physician Decision|1|||
48723472|NCT04088630|156837974|FG002|Overall Study|Physician Decision|1|||
48723473|NCT01265537|156837975|FG000|Overall Study|Adverse Event|2|||
48723474|NCT01265537|156837976|FG001|Overall Study|Adverse Event|1|||
48723475|NCT01265537|156837975|FG000|Overall Study|Physician Decision|0|||
48723476|NCT01265537|156837976|FG001|Overall Study|Physician Decision|1|||
48723477|NCT01944839|156837977|FG000|Overall Study|Physician Decision|2|||
48723478|NCT01944839|156837978|FG001|Overall Study|Physician Decision|2|||
48723479|NCT01944839|156837977|FG000|Overall Study|Protocol Violation|0|||
48723480|NCT01944839|156837978|FG001|Overall Study|Protocol Violation|1|||
48723481|NCT01944839|156837977|FG000|Overall Study|Adverse Event|10|||
48723482|NCT01944839|156837978|FG001|Overall Study|Adverse Event|5|||
48723483|NCT01944839|156837977|FG000|Overall Study|Withdrawal by Subject|9|||
48723484|NCT01944839|156837978|FG001|Overall Study|Withdrawal by Subject|17|||
48723485|NCT01944839|156837977|FG000|Overall Study|Lost to Follow-up|1|||
48723486|NCT01944839|156837978|FG001|Overall Study|Lost to Follow-up|0|||
48723487|NCT01944839|156837977|FG000|Overall Study|Subject non-compliance|0|||
48723488|NCT01944839|156837978|FG001|Overall Study|Subject non-compliance|3|||
48723489|NCT00627445|156837981|FG000|Overall Study|Adverse Event|3|||
48723490|NCT00627445|156837982|FG001|Overall Study|Adverse Event|3|||
48723491|NCT00627445|156837981|FG000|Overall Study|Lack of Efficacy|0|||
48723492|NCT00627445|156837982|FG001|Overall Study|Lack of Efficacy|1|||
48723493|NCT00627445|156837981|FG000|Overall Study|Other|6|||
48723494|NCT00627445|156837982|FG001|Overall Study|Other|8|||
48723495|NCT04505540|156837983|FG000|Baseline|Protocol Violation|10|||
48723496|NCT04505540|156837983|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
48723497|NCT04505540|156837983|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
48723498|NCT04505540|156837983|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
48723499|NCT04505540|156837983|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
48723500|NCT04505540|156837983|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
48723501|NCT04505540|156837983|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
48723502|NCT04505540|156837983|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
48723503|NCT04505540|156837983|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
48723504|NCT04505540|156837983|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
48723505|NCT04505540|156837983|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
48723506|NCT04505540|156837983|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
48817911|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
48817912|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
48502978|NCT00440297|156038468|FG001|Overall Study|Adverse Event|5|||
48502979|NCT00440297|156038467|FG000|Overall Study|Lost to Follow-up|1|||
48723507|NCT04505540|156837983|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
48723508|NCT00977080|156837984|FG000|Overall Study|Adverse Event|2|||
48502980|NCT00440297|156038468|FG001|Overall Study|Lost to Follow-up|0|||
48502981|NCT00440297|156038467|FG000|Overall Study|Physician Decision|1|||
48502982|NCT00440297|156038468|FG001|Overall Study|Physician Decision|0|||
48723509|NCT00977080|156837985|FG001|Overall Study|Adverse Event|7|||
48723510|NCT00977080|156837986|FG002|Overall Study|Adverse Event|7|||
48723511|NCT00977080|156837987|FG003|Overall Study|Adverse Event|7|||
48723512|NCT00977080|156837984|FG000|Overall Study|Withdrawal by Subject|1|||
48723513|NCT00977080|156837985|FG001|Overall Study|Withdrawal by Subject|5|||
48723514|NCT00977080|156837986|FG002|Overall Study|Withdrawal by Subject|1|||
48723515|NCT00977080|156837987|FG003|Overall Study|Withdrawal by Subject|5|||
48723516|NCT00977080|156837984|FG000|Overall Study|Protocol Violation|7|||
48723517|NCT00977080|156837985|FG001|Overall Study|Protocol Violation|3|||
48723518|NCT00977080|156837986|FG002|Overall Study|Protocol Violation|4|||
48723519|NCT00977080|156837987|FG003|Overall Study|Protocol Violation|3|||
48723520|NCT00977080|156837984|FG000|Overall Study|Noncompliance|0|||
48723521|NCT00977080|156837985|FG001|Overall Study|Noncompliance|2|||
48723522|NCT00977080|156837986|FG002|Overall Study|Noncompliance|1|||
48723523|NCT00977080|156837987|FG003|Overall Study|Noncompliance|0|||
48723524|NCT00977080|156837984|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
48817913|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
48817914|NCT01646320|157175223|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
48817915|NCT01646320|157175224|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
48817916|NCT01155726|157175225|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
48502983|NCT00440297|156038467|FG000|Overall Study|Protocol Violation|11|||
48723525|NCT00977080|156837985|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
48502984|NCT00440297|156038468|FG001|Overall Study|Protocol Violation|7|||
48502985|NCT00440297|156038467|FG000|Overall Study|Withdrawal by Subject|1|||
48502986|NCT00440297|156038468|FG001|Overall Study|Withdrawal by Subject|6|||
48502987|NCT00440297|156038467|FG000|Overall Study|Randomized by mistake|1|||
48502988|NCT00440297|156038468|FG001|Overall Study|Randomized by mistake|0|||
48502989|NCT02024932|156038469|FG000|Overall Study|Adverse Event|2|||
48502990|NCT02024932|156038470|FG001|Overall Study|Adverse Event|3|||
48502991|NCT02024932|156038471|FG002|Overall Study|Adverse Event|0|||
48502992|NCT02024932|156038472|FG003|Overall Study|Adverse Event|0|||
48502993|NCT02024932|156038473|FG004|Overall Study|Adverse Event|2|||
48502994|NCT02024932|156038474|FG005|Overall Study|Adverse Event|0|||
48502995|NCT02024932|156038469|FG000|Overall Study|Abnormal laboratory value|0|||
48502996|NCT02024932|156038470|FG001|Overall Study|Abnormal laboratory value|0|||
48502997|NCT02024932|156038471|FG002|Overall Study|Abnormal laboratory value|0|||
48502998|NCT02024932|156038472|FG003|Overall Study|Abnormal laboratory value|2|||
48502999|NCT02024932|156038473|FG004|Overall Study|Abnormal laboratory value|0|||
48503000|NCT02024932|156038474|FG005|Overall Study|Abnormal laboratory value|0|||
48503001|NCT03567174|156038475|FG000|Overall Study|Death|24|||
48503002|NCT03567174|156038476|FG001|Overall Study|Death|31|||
48503003|NCT03567174|156038475|FG000|Overall Study|Lost to Follow-up|165|||
48503004|NCT03567174|156038476|FG001|Overall Study|Lost to Follow-up|174|||
48503005|NCT02131129|156038477|FG000|Overall Study|Withdrawal by Subject|1|||
48503006|NCT02131129|156038478|FG001|Overall Study|Withdrawal by Subject|0|||
48503007|NCT03538041|156039963|FG000|12-Week Treatment Period|Adverse Event|1|||
48503008|NCT03538041|156039964|FG001|12-Week Treatment Period|Adverse Event|1|||
48503009|NCT03538041|156039963|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
48503010|NCT03538041|156039964|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
48503011|NCT03538041|156039963|FG000|Treatment Extension Period|Adverse Event|4|||
48503012|NCT03538041|156039964|FG001|Treatment Extension Period|Adverse Event|1|||
48503013|NCT03538041|156039963|FG000|Treatment Extension Period|Physician Decision|1|||
48503014|NCT03538041|156039964|FG001|Treatment Extension Period|Physician Decision|1|||
48817917|NCT01155726|157175226|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
48817918|NCT01155726|157175227|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
48817919|NCT01155726|157175228|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
48817920|NCT01017120|157175229|FG000|Overall Study|Adverse Event|9|||
48817921|NCT01017120|157175230|FG001|Overall Study|Adverse Event|0|||
48817922|NCT01017120|157175229|FG000|Overall Study|Lost to Follow-up|13|||
48817923|NCT01017120|157175230|FG001|Overall Study|Lost to Follow-up|11|||
48503015|NCT03538041|156039963|FG000|Treatment Extension Period|Lack of Efficacy|1|||
48503016|NCT03538041|156039964|FG001|Treatment Extension Period|Lack of Efficacy|4|||
48503017|NCT03538041|156039963|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
48503018|NCT03538041|156039964|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
48723526|NCT00977080|156837986|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
48723527|NCT00977080|156837987|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
48503019|NCT03538041|156039963|FG000|Treatment Extension Period|Death|0|||
48503020|NCT03538041|156039964|FG001|Treatment Extension Period|Death|1|||
48503021|NCT03471078|156039965|FG000|Overall Study|Withdrawal by Subject|9|||
48503022|NCT03471078|156039966|FG001|Overall Study|Withdrawal by Subject|1|||
48503023|NCT03471078|156039965|FG000|Overall Study|Adverse Event|4|||
48723528|NCT00977080|156837984|FG000|Overall Study|Required kidney transplantation|1|||
48723529|NCT00977080|156837985|FG001|Overall Study|Required kidney transplantation|3|||
48723530|NCT00977080|156837986|FG002|Overall Study|Required kidney transplantation|3|||
48723531|NCT00977080|156837987|FG003|Overall Study|Required kidney transplantation|1|||
48723532|NCT00977080|156837984|FG000|Overall Study|Travel for family reasons|1|||
48817924|NCT01017120|157175229|FG000|Overall Study|Lack of Efficacy|1|||
48817925|NCT01017120|157175230|FG001|Overall Study|Lack of Efficacy|0|||
48723533|NCT00977080|156837985|FG001|Overall Study|Travel for family reasons|0|||
48723534|NCT00977080|156837986|FG002|Overall Study|Travel for family reasons|0|||
48723535|NCT00977080|156837987|FG003|Overall Study|Travel for family reasons|0|||
48723536|NCT00827931|156837991|FG000|Overall Study|Death|3|||
48723537|NCT00827931|156837992|FG001|Overall Study|Death|5|||
48723538|NCT00827931|156837991|FG000|Overall Study|Adverse Event|1|||
48723539|NCT00827931|156837992|FG001|Overall Study|Adverse Event|0|||
48723540|NCT00827931|156837991|FG000|Overall Study|Lost to Follow-up|1|||
48723541|NCT00827931|156837992|FG001|Overall Study|Lost to Follow-up|0|||
48723542|NCT00827931|156837991|FG000|Overall Study|Withdrawal by Subject|0|||
48723543|NCT00827931|156837992|FG001|Overall Study|Withdrawal by Subject|1|||
48723544|NCT00827931|156837991|FG000|Overall Study|Other|1|||
48723545|NCT00827931|156837992|FG001|Overall Study|Other|0|||
48723546|NCT01120067|156837997|FG000|Overall Study|Lost to Follow-up|3|||
48723547|NCT01120067|156837998|FG001|Overall Study|Lost to Follow-up|1|||
48723548|NCT01120067|156837997|FG000|Overall Study|fail to engage >3 sessions|2|||
48723549|NCT01120067|156837998|FG001|Overall Study|fail to engage >3 sessions|0|||
48723550|NCT01267955|156838001|FG000|Stage 1 (6 Months)|Death|3|||
48723551|NCT01267955|156838001|FG000|Stage 2 (6 Months)|Death|5|||
48723552|NCT01267955|156838001|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
48723553|NCT00870233|156838002|FG000|Overall Study|Withdrawal by Subject|18|||
48723554|NCT00870233|156838002|FG000|Overall Study|Did not undergo laparotomy|3|||
48723555|NCT00870233|156838002|FG000|Overall Study|Incompatible internet browser|2|||
48723556|NCT00870233|156838002|FG000|Overall Study|Death|1|||
48723557|NCT02274038|156838006|FG000|Overall Study|Death|1|||
48723558|NCT01007253|156838013|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
48723559|NCT01007253|156838014|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
48723560|NCT01007253|156838015|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
48723561|NCT01007253|156838016|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
48723562|NCT02751931|156838017|FG000|Overall Study|Adverse Event|3|||
48723563|NCT02751931|156838018|FG001|Overall Study|Adverse Event|0|||
48723564|NCT02751931|156838017|FG000|Overall Study|Other: Miscelleneous|10|||
48723565|NCT02751931|156838018|FG001|Overall Study|Other: Miscelleneous|8|||
48723566|NCT05985980|156838020|FG000|Overall Study|Withdrawal by Subject|1|||
48723567|NCT05985980|156838020|FG000|Overall Study|Withdrawal by Subject|1|||
48723568|NCT05985980|156838020|FG000|Overall Study|Withdrawal by Subject|1|||
48723569|NCT05985980|156838020|FG000|Overall Study|Withdrawal by Subject|1|||
48723570|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
48723571|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
48723572|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
48723573|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
48723574|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
48723575|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
48723576|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
48723577|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
48723578|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
48723579|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
48723580|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
48723581|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
48723582|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
48723583|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48723584|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
48723585|NCT01436162|156838021|FG000|Single-blind Lead-in Phase|Other|107|||
48723586|NCT01436162|156838022|FG001|Single-blind Lead-in Phase|Other|0|||
48723587|NCT01436162|156838023|FG002|Single-blind Lead-in Phase|Other|0|||
48723588|NCT01436162|156838021|FG000|Randomized Phase|Adverse Event|1|||
48723589|NCT01436162|156838022|FG001|Randomized Phase|Adverse Event|5|||
48723590|NCT01436162|156838023|FG002|Randomized Phase|Adverse Event|6|||
48723591|NCT01436162|156838021|FG000|Randomized Phase|Protocol Violation|4|||
48723592|NCT01436162|156838022|FG001|Randomized Phase|Protocol Violation|4|||
48723593|NCT01436162|156838023|FG002|Randomized Phase|Protocol Violation|2|||
48723594|NCT01436162|156838021|FG000|Randomized Phase|Withdrawal by Subject|16|||
48723595|NCT01436162|156838022|FG001|Randomized Phase|Withdrawal by Subject|9|||
48723596|NCT01436162|156838023|FG002|Randomized Phase|Withdrawal by Subject|8|||
48723597|NCT01436162|156838021|FG000|Randomized Phase|Lost to Follow-up|17|||
48723598|NCT01436162|156838022|FG001|Randomized Phase|Lost to Follow-up|5|||
48723599|NCT01436162|156838023|FG002|Randomized Phase|Lost to Follow-up|4|||
48723600|NCT01436162|156838021|FG000|Randomized Phase|Lack of Efficacy|0|||
48723601|NCT01436162|156838022|FG001|Randomized Phase|Lack of Efficacy|1|||
48723602|NCT01436162|156838023|FG002|Randomized Phase|Lack of Efficacy|1|||
48723603|NCT01436162|156838021|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
48723604|NCT01436162|156838022|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
48723605|NCT01436162|156838023|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
48817926|NCT01017120|157175229|FG000|Overall Study|Withdrawal by Subject|39|||
48817927|NCT01017120|157175230|FG001|Overall Study|Withdrawal by Subject|21|||
48723606|NCT01436162|156838021|FG000|Randomized Phase|Other|2|||
48503024|NCT03471078|156039966|FG001|Overall Study|Adverse Event|1|||
48503025|NCT03471078|156039965|FG000|Overall Study|Physician Decision|3|||
48503026|NCT03471078|156039966|FG001|Overall Study|Physician Decision|2|||
48503027|NCT03471078|156039965|FG000|Overall Study|Death|2|||
48503028|NCT03471078|156039966|FG001|Overall Study|Death|0|||
48503029|NCT03471078|156039965|FG000|Overall Study|Other|3|||
48503030|NCT03471078|156039966|FG001|Overall Study|Other|2|||
48503031|NCT00274937|156039979|FG000|Overall Study|Physician Decision|10|||
48503032|NCT00274937|156039979|FG000|Overall Study|Withdrawal by Subject|6|||
48503033|NCT00274937|156039979|FG000|Overall Study|Progressive Disease|4|||
48503034|NCT00860405|156039983|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
48503035|NCT00860405|156039984|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
48503036|NCT00445003|156039985|FG000|Overall Study|Death|1|||
48503037|NCT00445003|156039986|FG001|Overall Study|Death|2|||
48503038|NCT00445003|156039987|FG002|Overall Study|Death|1|||
48503039|NCT00445003|156039985|FG000|Overall Study|Missed Visit|3|||
48503040|NCT00445003|156039986|FG001|Overall Study|Missed Visit|5|||
48503041|NCT00445003|156039987|FG002|Overall Study|Missed Visit|1|||
48503042|NCT00445003|156039985|FG000|Overall Study|Dropped|1|||
48503043|NCT00445003|156039986|FG001|Overall Study|Dropped|3|||
48503044|NCT00445003|156039987|FG002|Overall Study|Dropped|2|||
48503045|NCT02178722|156039988|FG000|Overall Study|Withdrawal by Subject|0|||
48503046|NCT02178722|156039989|FG001|Overall Study|Withdrawal by Subject|0|||
48503047|NCT02178722|156039990|FG002|Overall Study|Withdrawal by Subject|0|||
48503048|NCT02178722|156039991|FG003|Overall Study|Withdrawal by Subject|2|||
48503049|NCT02178722|156039992|FG004|Overall Study|Withdrawal by Subject|33|||
48503050|NCT02178722|156039988|FG000|Overall Study|Death|2|||
48503051|NCT02178722|156039989|FG001|Overall Study|Death|13|||
48503052|NCT02178722|156039990|FG002|Overall Study|Death|12|||
48503053|NCT02178722|156039991|FG003|Overall Study|Death|12|||
48503054|NCT02178722|156039992|FG004|Overall Study|Death|205|||
48503055|NCT02178722|156039988|FG000|Overall Study|Lost to Follow-up|0|||
48503056|NCT02178722|156039989|FG001|Overall Study|Lost to Follow-up|0|||
48503057|NCT02178722|156039990|FG002|Overall Study|Lost to Follow-up|0|||
48503058|NCT02178722|156039991|FG003|Overall Study|Lost to Follow-up|2|||
48503059|NCT02178722|156039992|FG004|Overall Study|Lost to Follow-up|11|||
48503060|NCT02178722|156039988|FG000|Overall Study|Study terminated by Sponsor|2|||
48503061|NCT02178722|156039989|FG001|Overall Study|Study terminated by Sponsor|7|||
48503062|NCT02178722|156039990|FG002|Overall Study|Study terminated by Sponsor|6|||
48503063|NCT02178722|156039991|FG003|Overall Study|Study terminated by Sponsor|4|||
48503064|NCT02178722|156039992|FG004|Overall Study|Study terminated by Sponsor|128|||
48503065|NCT02178722|156039988|FG000|Overall Study|Physician Decision|0|||
48503066|NCT02178722|156039989|FG001|Overall Study|Physician Decision|0|||
48503067|NCT02178722|156039990|FG002|Overall Study|Physician Decision|0|||
48503068|NCT02178722|156039991|FG003|Overall Study|Physician Decision|0|||
48503069|NCT02178722|156039992|FG004|Overall Study|Physician Decision|3|||
48503070|NCT02178722|156039988|FG000|Overall Study|Other|0|||
48503071|NCT02178722|156039989|FG001|Overall Study|Other|0|||
48503072|NCT02178722|156039990|FG002|Overall Study|Other|0|||
48503073|NCT02178722|156039991|FG003|Overall Study|Other|0|||
48503074|NCT02178722|156039992|FG004|Overall Study|Other|2|||
48503075|NCT03025880|156039993|FG000|Overall Study|Adverse Event|1|||
48503076|NCT03025880|156039994|FG001|Overall Study|Adverse Event|0|||
48503077|NCT03025880|156039993|FG000|Overall Study|Death|1|||
48503078|NCT03025880|156039994|FG001|Overall Study|Death|1|||
48503079|NCT03025880|156039993|FG000|Overall Study|Withdrawal by Subject|0|||
48503080|NCT03025880|156039994|FG001|Overall Study|Withdrawal by Subject|1|||
48503081|NCT03025880|156039993|FG000|Overall Study|Physician Decision|0|||
48503082|NCT03025880|156039994|FG001|Overall Study|Physician Decision|1|||
48503083|NCT03025880|156039993|FG000|Overall Study|Progressive Disease|12|||
48503084|NCT03025880|156039994|FG001|Overall Study|Progressive Disease|19|||
48503085|NCT01572948|156039995|FG000|Overall Study|Lost to Follow-up|1|||
48503086|NCT01572948|156039996|FG001|Overall Study|Lost to Follow-up|0|||
48503087|NCT01572948|156039995|FG000|Overall Study|unable to contact|0|||
48503088|NCT01572948|156039996|FG001|Overall Study|unable to contact|1|||
48503089|NCT01389102|156039998|FG000|Overall Study|Adverse Event|1|||
48503090|NCT01389102|156039999|FG001|Overall Study|Adverse Event|3|||
48503091|NCT01389102|156040000|FG002|Overall Study|Adverse Event|2|||
48503092|NCT01389102|156040001|FG003|Overall Study|Adverse Event|2|||
48503093|NCT01389102|156040002|FG004|Overall Study|Adverse Event|2|||
48503094|NCT01389102|156040003|FG005|Overall Study|Adverse Event|2|||
48503095|NCT01389102|156039998|FG000|Overall Study|Hurricane Katrina|4|||
48503096|NCT01389102|156039999|FG001|Overall Study|Hurricane Katrina|2|||
48503097|NCT01389102|156040000|FG002|Overall Study|Hurricane Katrina|3|||
48503098|NCT01389102|156040001|FG003|Overall Study|Hurricane Katrina|0|||
48503099|NCT01389102|156040002|FG004|Overall Study|Hurricane Katrina|3|||
48503100|NCT01389102|156040003|FG005|Overall Study|Hurricane Katrina|1|||
48503101|NCT01389102|156039998|FG000|Overall Study|Lost to Follow-up|4|||
48503102|NCT01389102|156039999|FG001|Overall Study|Lost to Follow-up|1|||
48503103|NCT01389102|156040000|FG002|Overall Study|Lost to Follow-up|1|||
48503104|NCT01389102|156040001|FG003|Overall Study|Lost to Follow-up|2|||
48723607|NCT01436162|156838022|FG001|Randomized Phase|Other|5|||
48723608|NCT01436162|156838023|FG002|Randomized Phase|Other|4|||
48723609|NCT03960463|156840362|FG000|Overall Study|Withdrawal by Subject|2|||
48723610|NCT03960463|156840363|FG001|Overall Study|Withdrawal by Subject|0|||
48723611|NCT02616146|156840366|FG000|Overall Study|Adverse Event|64|||
48723612|NCT02616146|156840367|FG001|Overall Study|Adverse Event|24|||
48723613|NCT02616146|156840366|FG000|Overall Study|Lost to Follow-up|23|||
48723614|NCT02616146|156840367|FG001|Overall Study|Lost to Follow-up|13|||
48723615|NCT02616146|156840366|FG000|Overall Study|Non-compliance with study protocol|2|||
48723616|NCT02616146|156840367|FG001|Overall Study|Non-compliance with study protocol|0|||
48723617|NCT02616146|156840366|FG000|Overall Study|Non-compliance with study drug|4|||
48723618|NCT02616146|156840367|FG001|Overall Study|Non-compliance with study drug|2|||
48723619|NCT02616146|156840366|FG000|Overall Study|Pregnancy|2|||
48723620|NCT02616146|156840367|FG001|Overall Study|Pregnancy|2|||
48723621|NCT02616146|156840366|FG000|Overall Study|Pregnancy wish|3|||
48723622|NCT02616146|156840367|FG001|Overall Study|Pregnancy wish|0|||
48723623|NCT02616146|156840366|FG000|Overall Study|Protocol Violation|6|||
48723624|NCT02616146|156840367|FG001|Overall Study|Protocol Violation|3|||
48723625|NCT02616146|156840366|FG000|Overall Study|Study terminated by sponsor|1372|||
48723626|NCT02616146|156840367|FG001|Overall Study|Study terminated by sponsor|432|||
48723627|NCT02616146|156840366|FG000|Overall Study|Participant moved|4|||
48723628|NCT02616146|156840367|FG001|Overall Study|Participant moved|3|||
48723629|NCT02616146|156840366|FG000|Overall Study|Withdrawal by Subject|30|||
48723630|NCT02616146|156840367|FG001|Overall Study|Withdrawal by Subject|24|||
48723631|NCT02616146|156840366|FG000|Overall Study|Physician Decision|2|||
48723632|NCT02616146|156840367|FG001|Overall Study|Physician Decision|1|||
48723633|NCT01221272|156840368|FG000|Period 1|Adverse Event|2|||
48723634|NCT01221272|156840369|FG001|Period 1|Adverse Event|0|||
48723635|NCT01221272|156840368|FG000|Period 1|Consent Withdrawal|0|||
48723636|NCT01221272|156840369|FG001|Period 1|Consent Withdrawal|1|||
48723637|NCT01221272|156840368|FG000|Period 1|Significant Dosing Noncompliance|0|||
48723638|NCT01221272|156840369|FG001|Period 1|Significant Dosing Noncompliance|1|||
48723639|NCT01221272|156840368|FG000|Period 2|Adverse Event|0|||
48723640|NCT01221272|156840369|FG001|Period 2|Adverse Event|2|||
48723641|NCT02320903|156840372|FG000|Overall Study|Withdrawal by Subject|0|||
48723642|NCT02320903|156840373|FG001|Overall Study|Withdrawal by Subject|9|||
48723643|NCT02320903|156840374|FG002|Overall Study|Withdrawal by Subject|9|||
48723644|NCT02320903|156840372|FG000|Overall Study|Exited therapy; no longer eligible|8|||
48723645|NCT02320903|156840373|FG001|Overall Study|Exited therapy; no longer eligible|2|||
48723646|NCT02320903|156840374|FG002|Overall Study|Exited therapy; no longer eligible|2|||
48723647|NCT02320903|156840372|FG000|Overall Study|Lost to Follow-up|0|||
48723648|NCT02320903|156840373|FG001|Overall Study|Lost to Follow-up|5|||
48723649|NCT02320903|156840374|FG002|Overall Study|Lost to Follow-up|5|||
48723650|NCT00730028|156840375|FG000|Overall Study|Adverse Event|23|||
48723651|NCT00730028|156840376|FG001|Overall Study|Adverse Event|26|||
48723652|NCT00730028|156840377|FG002|Overall Study|Adverse Event|16|||
48723653|NCT00730028|156840378|FG003|Overall Study|Adverse Event|20|||
48723654|NCT00730028|156840379|FG004|Overall Study|Adverse Event|43|||
48723655|NCT00730028|156840375|FG000|Overall Study|Lost to Follow-up|13|||
48723656|NCT00730028|156840376|FG001|Overall Study|Lost to Follow-up|26|||
48723657|NCT00730028|156840377|FG002|Overall Study|Lost to Follow-up|22|||
48723658|NCT00730028|156840378|FG003|Overall Study|Lost to Follow-up|26|||
48723659|NCT00730028|156840379|FG004|Overall Study|Lost to Follow-up|25|||
48723660|NCT00730028|156840375|FG000|Overall Study|Protocol Violation|6|||
48723661|NCT00730028|156840376|FG001|Overall Study|Protocol Violation|1|||
48723662|NCT00730028|156840377|FG002|Overall Study|Protocol Violation|1|||
48723663|NCT00730028|156840378|FG003|Overall Study|Protocol Violation|2|||
48723664|NCT00730028|156840379|FG004|Overall Study|Protocol Violation|0|||
48723665|NCT00730028|156840375|FG000|Overall Study|Withdrawal by Subject|9|||
48723666|NCT00730028|156840376|FG001|Overall Study|Withdrawal by Subject|5|||
48723667|NCT00730028|156840377|FG002|Overall Study|Withdrawal by Subject|4|||
48723668|NCT00730028|156840378|FG003|Overall Study|Withdrawal by Subject|5|||
48723669|NCT00730028|156840379|FG004|Overall Study|Withdrawal by Subject|9|||
48723670|NCT00730028|156840375|FG000|Overall Study|Physician Decision|3|||
48723671|NCT00730028|156840376|FG001|Overall Study|Physician Decision|3|||
48723672|NCT00730028|156840377|FG002|Overall Study|Physician Decision|2|||
48723673|NCT00730028|156840378|FG003|Overall Study|Physician Decision|3|||
48723674|NCT00730028|156840379|FG004|Overall Study|Physician Decision|2|||
48723675|NCT00730028|156840375|FG000|Overall Study|Treatment Failure|5|||
48723676|NCT00730028|156840376|FG001|Overall Study|Treatment Failure|5|||
48723677|NCT00730028|156840377|FG002|Overall Study|Treatment Failure|0|||
48723678|NCT00730028|156840378|FG003|Overall Study|Treatment Failure|0|||
48723679|NCT00730028|156840379|FG004|Overall Study|Treatment Failure|1|||
48723680|NCT00730028|156840375|FG000|Overall Study|Randomization Error|1|||
48723681|NCT00730028|156840376|FG001|Overall Study|Randomization Error|0|||
48723682|NCT00730028|156840377|FG002|Overall Study|Randomization Error|0|||
48723683|NCT00730028|156840378|FG003|Overall Study|Randomization Error|0|||
48723684|NCT00730028|156840379|FG004|Overall Study|Randomization Error|2|||
48723685|NCT01931670|156840385|FG000|Treatment Period|Exclusionary Medication Received|1|||
48723686|NCT01931670|156840386|FG001|Treatment Period|Exclusionary Medication Received|1|||
48723687|NCT01931670|156840387|FG002|Treatment Period|Exclusionary Medication Received|1|||
48723688|NCT01931670|156840385|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
48723689|NCT01931670|156840386|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
48723690|NCT01931670|156840387|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
48723691|NCT01931670|156840385|FG000|Treatment Period|Subject Noncompliant|4|||
48723692|NCT01931670|156840386|FG001|Treatment Period|Subject Noncompliant|9|||
48817928|NCT01017120|157175229|FG000|Overall Study|Pregnancy|1|||
48817929|NCT01017120|157175230|FG001|Overall Study|Pregnancy|1|||
48817930|NCT01017120|157175229|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
48817931|NCT01017120|157175230|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
48817932|NCT01017120|157175229|FG000|Overall Study|Relocated Out of Town|0|||
48817933|NCT01017120|157175230|FG001|Overall Study|Relocated Out of Town|2|||
48817934|NCT01017120|157175229|FG000|Overall Study|Protocol Violation|1|||
48817935|NCT01017120|157175230|FG001|Overall Study|Protocol Violation|0|||
48503105|NCT01389102|156040002|FG004|Overall Study|Lost to Follow-up|4|||
48503106|NCT01389102|156040003|FG005|Overall Study|Lost to Follow-up|1|||
48503107|NCT01389102|156039998|FG000|Overall Study|Protocol Violation|0|||
48503108|NCT01389102|156039999|FG001|Overall Study|Protocol Violation|0|||
48503109|NCT01389102|156040000|FG002|Overall Study|Protocol Violation|3|||
48503110|NCT01389102|156040001|FG003|Overall Study|Protocol Violation|0|||
48503111|NCT01389102|156040002|FG004|Overall Study|Protocol Violation|1|||
48503112|NCT01389102|156040003|FG005|Overall Study|Protocol Violation|1|||
48503113|NCT01389102|156039998|FG000|Overall Study|Withdrawal by Subject|7|||
48503114|NCT01389102|156039999|FG001|Overall Study|Withdrawal by Subject|4|||
48503115|NCT01389102|156040000|FG002|Overall Study|Withdrawal by Subject|9|||
48503116|NCT01389102|156040001|FG003|Overall Study|Withdrawal by Subject|2|||
48503117|NCT01389102|156040002|FG004|Overall Study|Withdrawal by Subject|3|||
48503118|NCT01389102|156040003|FG005|Overall Study|Withdrawal by Subject|3|||
48503119|NCT01389102|156039998|FG000|Overall Study|Subject Traveling Out of Country|0|||
48503120|NCT01389102|156039999|FG001|Overall Study|Subject Traveling Out of Country|0|||
48503121|NCT01389102|156040000|FG002|Overall Study|Subject Traveling Out of Country|0|||
48503122|NCT01389102|156040001|FG003|Overall Study|Subject Traveling Out of Country|1|||
48503123|NCT01389102|156040002|FG004|Overall Study|Subject Traveling Out of Country|0|||
48503124|NCT01389102|156040003|FG005|Overall Study|Subject Traveling Out of Country|0|||
48503125|NCT01389102|156039998|FG000|Overall Study|Subject Moved|2|||
48503126|NCT01389102|156039999|FG001|Overall Study|Subject Moved|0|||
48503127|NCT01389102|156040000|FG002|Overall Study|Subject Moved|1|||
48503128|NCT01389102|156040001|FG003|Overall Study|Subject Moved|0|||
48503129|NCT01389102|156040002|FG004|Overall Study|Subject Moved|0|||
48503130|NCT01389102|156040003|FG005|Overall Study|Subject Moved|0|||
48503131|NCT01389102|156039998|FG000|Overall Study|Unavailable due to husband's illness|0|||
48503132|NCT01389102|156039999|FG001|Overall Study|Unavailable due to husband's illness|1|||
48503133|NCT01389102|156040000|FG002|Overall Study|Unavailable due to husband's illness|0|||
48723693|NCT01931670|156840387|FG002|Treatment Period|Subject Noncompliant|5|||
48723694|NCT01931670|156840385|FG000|Treatment Period|Adverse Event|19|||
48723695|NCT01931670|156840386|FG001|Treatment Period|Adverse Event|8|||
48723696|NCT01931670|156840387|FG002|Treatment Period|Adverse Event|21|||
48723697|NCT01931670|156840385|FG000|Treatment Period|Lack of Efficacy|11|||
48723698|NCT01931670|156840386|FG001|Treatment Period|Lack of Efficacy|2|||
48723699|NCT01931670|156840387|FG002|Treatment Period|Lack of Efficacy|2|||
48723700|NCT01931670|156840385|FG000|Treatment Period|Pregnancy|7|||
48723701|NCT01931670|156840386|FG001|Treatment Period|Pregnancy|2|||
48723702|NCT01931670|156840387|FG002|Treatment Period|Pregnancy|0|||
48723703|NCT01931670|156840385|FG000|Treatment Period|Other|8|||
48817936|NCT01017120|157175229|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
48503134|NCT01389102|156040001|FG003|Overall Study|Unavailable due to husband's illness|0|||
48503135|NCT01389102|156040002|FG004|Overall Study|Unavailable due to husband's illness|0|||
48723704|NCT01931670|156840386|FG001|Treatment Period|Other|7|||
48723705|NCT01931670|156840387|FG002|Treatment Period|Other|2|||
48723706|NCT01931670|156840385|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
48723707|NCT01931670|156840386|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
48723708|NCT01931670|156840387|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
48723709|NCT01931670|156840385|FG000|Treatment Period|Lost to Follow-up|19|||
48723710|NCT01931670|156840386|FG001|Treatment Period|Lost to Follow-up|5|||
48817937|NCT01017120|157175230|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
48503136|NCT01389102|156040003|FG005|Overall Study|Unavailable due to husband's illness|0|||
48503137|NCT01389102|156039998|FG000|Overall Study|Investigator Judgement|0|||
48723711|NCT01931670|156840387|FG002|Treatment Period|Lost to Follow-up|7|||
48723712|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
48723713|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
48723714|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
48503138|NCT01389102|156039999|FG001|Overall Study|Investigator Judgement|1|||
48723715|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
48817938|NCT05038566|157175231|FG000|Overall Study|Technical Difficulties with the Device|0|||
48817939|NCT05038566|157175232|FG001|Overall Study|Technical Difficulties with the Device|1|||
48817940|NCT00806624|157175234|FG000|Overall Study|Adverse Event|2|||
48817941|NCT00806624|157175235|FG001|Overall Study|Adverse Event|8|||
48817942|NCT00806624|157175236|FG002|Overall Study|Adverse Event|0|||
48817943|NCT00806624|157175234|FG000|Overall Study|Death|0|||
48817944|NCT00806624|157175235|FG001|Overall Study|Death|1|||
48817945|NCT00806624|157175236|FG002|Overall Study|Death|1|||
48817946|NCT00806624|157175234|FG000|Overall Study|Lost to Follow-up|1|||
48817947|NCT00806624|157175235|FG001|Overall Study|Lost to Follow-up|0|||
48817948|NCT00806624|157175236|FG002|Overall Study|Lost to Follow-up|1|||
48817949|NCT00806624|157175234|FG000|Overall Study|Withdrawal by Subject|6|||
48817950|NCT00806624|157175235|FG001|Overall Study|Withdrawal by Subject|3|||
48817951|NCT00806624|157175236|FG002|Overall Study|Withdrawal by Subject|3|||
48817952|NCT00806624|157175234|FG000|Overall Study|discontinued before start of treatment|0|||
48817953|NCT00806624|157175235|FG001|Overall Study|discontinued before start of treatment|0|||
48817954|NCT00806624|157175236|FG002|Overall Study|discontinued before start of treatment|1|||
48817955|NCT01702428|157175237|FG000|Overall Study|Adverse Event|2|||
48817956|NCT01702428|157175238|FG001|Overall Study|Adverse Event|0|||
48817957|NCT01702428|157175239|FG002|Overall Study|Adverse Event|0|||
48817958|NCT01702428|157175240|FG003|Overall Study|Adverse Event|0|||
48817959|NCT01702428|157175237|FG000|Overall Study|Lost to Follow-up|33|||
48817960|NCT01702428|157175238|FG001|Overall Study|Lost to Follow-up|41|||
48817961|NCT01702428|157175239|FG002|Overall Study|Lost to Follow-up|37|||
48817962|NCT01702428|157175240|FG003|Overall Study|Lost to Follow-up|44|||
48817963|NCT01702428|157175237|FG000|Overall Study|Parents cannot assist to site|1|||
48817964|NCT01702428|157175238|FG001|Overall Study|Parents cannot assist to site|0|||
48817965|NCT01702428|157175239|FG002|Overall Study|Parents cannot assist to site|1|||
48817966|NCT01702428|157175240|FG003|Overall Study|Parents cannot assist to site|0|||
48817967|NCT01702428|157175237|FG000|Overall Study|Lost Coverage|0|||
48817968|NCT01702428|157175238|FG001|Overall Study|Lost Coverage|0|||
48817969|NCT01702428|157175239|FG002|Overall Study|Lost Coverage|0|||
48817970|NCT01702428|157175240|FG003|Overall Study|Lost Coverage|1|||
48817971|NCT01702428|157175237|FG000|Overall Study|Lost Health Plan|3|||
48817972|NCT01702428|157175238|FG001|Overall Study|Lost Health Plan|5|||
48817973|NCT01702428|157175239|FG002|Overall Study|Lost Health Plan|0|||
48817974|NCT01702428|157175240|FG003|Overall Study|Lost Health Plan|2|||
48817975|NCT01702428|157175237|FG000|Overall Study|Mother transferred care|0|||
48817976|NCT01702428|157175238|FG001|Overall Study|Mother transferred care|1|||
48817977|NCT01702428|157175239|FG002|Overall Study|Mother transferred care|0|||
48817978|NCT01702428|157175240|FG003|Overall Study|Mother transferred care|0|||
48817979|NCT01702428|157175237|FG000|Overall Study|Parents too busy|1|||
48817980|NCT01702428|157175238|FG001|Overall Study|Parents too busy|0|||
48817981|NCT01702428|157175239|FG002|Overall Study|Parents too busy|0|||
48817982|NCT01702428|157175240|FG003|Overall Study|Parents too busy|0|||
48817983|NCT01702428|157175237|FG000|Overall Study|Protocol Violation|3|||
48723716|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
48723717|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
48723718|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
48817984|NCT01702428|157175238|FG001|Overall Study|Protocol Violation|0|||
48723719|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
48723720|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
48723721|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
48723722|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
48723723|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
48723724|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
48723725|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
48723726|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
48723727|NCT01931670|156840385|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
48723728|NCT01931670|156840386|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
48723729|NCT01931670|156840387|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
48723730|NCT00976508|156840389|FG000|Overall Study|Death|7|||
48723731|NCT00976508|156840390|FG001|Overall Study|Death|1|||
48817985|NCT01702428|157175239|FG002|Overall Study|Protocol Violation|1|||
48817986|NCT01702428|157175240|FG003|Overall Study|Protocol Violation|0|||
48817987|NCT01702428|157175237|FG000|Overall Study|Withdrawal by Subject|21|||
48817988|NCT01702428|157175238|FG001|Overall Study|Withdrawal by Subject|23|||
48817989|NCT01702428|157175239|FG002|Overall Study|Withdrawal by Subject|14|||
48437575|NCT01996748|155789675|FG001|Overall Study|Adverse Event|4|||
48437576|NCT01996748|155789674|FG000|Overall Study|Withdrawal by Subject|0|||
48437577|NCT01996748|155789675|FG001|Overall Study|Withdrawal by Subject|1|||
48817990|NCT01702428|157175240|FG003|Overall Study|Withdrawal by Subject|10|||
48817991|NCT01804673|157175241|FG000|Overall Study|Adverse Event|4|||
48817992|NCT01804673|157175241|FG000|Overall Study|Withdrawal by Subject|1|||
48817993|NCT01804673|157175241|FG000|Overall Study|Lack of Efficacy|9|||
48503139|NCT01389102|156040000|FG002|Overall Study|Investigator Judgement|0|||
48503140|NCT01389102|156040001|FG003|Overall Study|Investigator Judgement|0|||
48503141|NCT01389102|156040002|FG004|Overall Study|Investigator Judgement|0|||
48503142|NCT01389102|156040003|FG005|Overall Study|Investigator Judgement|0|||
48503143|NCT00893464|156040004|FG000|Overall Study|Did not complete therapy/experience PD|0|||
48503144|NCT00893464|156040005|FG001|Overall Study|Did not complete therapy/experience PD|0|||
48503145|NCT00893464|156040006|FG002|Overall Study|Did not complete therapy/experience PD|0|||
48503146|NCT00893464|156040007|FG003|Overall Study|Did not complete therapy/experience PD|0|||
48723732|NCT00976508|156840389|FG000|Overall Study|Lost to Follow-up|1|||
48723733|NCT00976508|156840390|FG001|Overall Study|Lost to Follow-up|0|||
48723734|NCT00976508|156840389|FG000|Overall Study|Withdrawal by Subject|1|||
48723735|NCT00976508|156840390|FG001|Overall Study|Withdrawal by Subject|0|||
48723736|NCT00976508|156840389|FG000|Overall Study|Disease Progression|4|||
48723737|NCT00976508|156840390|FG001|Overall Study|Disease Progression|4|||
48723738|NCT00976508|156840389|FG000|Overall Study|Subject Enrolled in Hospice|1|||
48723739|NCT00976508|156840390|FG001|Overall Study|Subject Enrolled in Hospice|0|||
48723740|NCT00976508|156840389|FG000|Overall Study|Terminated by the Sponsor|0|||
48723741|NCT00976508|156840390|FG001|Overall Study|Terminated by the Sponsor|1|||
48723742|NCT01992159|156840391|FG000|Overall Study|Withdrawal by Subject|4|||
48723743|NCT01992159|156840392|FG001|Overall Study|Withdrawal by Subject|7|||
48723744|NCT01992159|156840393|FG002|Overall Study|Withdrawal by Subject|0|||
48723745|NCT01992159|156840394|FG003|Overall Study|Withdrawal by Subject|3|||
48723746|NCT01992159|156840391|FG000|Overall Study|Adverse Event|0|||
48723747|NCT01992159|156840392|FG001|Overall Study|Adverse Event|1|||
48723748|NCT01992159|156840393|FG002|Overall Study|Adverse Event|0|||
48723749|NCT01992159|156840394|FG003|Overall Study|Adverse Event|1|||
48723750|NCT01992159|156840391|FG000|Overall Study|Death|0|||
48723751|NCT01992159|156840392|FG001|Overall Study|Death|0|||
48723752|NCT01992159|156840393|FG002|Overall Study|Death|1|||
48723753|NCT01992159|156840394|FG003|Overall Study|Death|0|||
48723754|NCT05058391|156840395|FG000|Overall Study|Adverse Event|1|||
48723755|NCT02742246|156840396|FG000|Overall Study|Never initiated treatment|5|||
48723756|NCT02742246|156840397|FG001|Overall Study|Never initiated treatment|3|||
48723757|NCT02742246|156840398|FG002|Overall Study|Never initiated treatment|1|||
48723758|NCT02742246|156840396|FG000|Overall Study|dropped out during treatment|7|||
48723759|NCT02742246|156840397|FG001|Overall Study|dropped out during treatment|13|||
48723760|NCT02742246|156840398|FG002|Overall Study|dropped out during treatment|10|||
48723761|NCT02742246|156840396|FG000|Overall Study|Death|1|||
48723762|NCT02742246|156840397|FG001|Overall Study|Death|0|||
48723763|NCT02742246|156840398|FG002|Overall Study|Death|0|||
48723764|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
48723765|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
48723766|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
48723767|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723768|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723769|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723770|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723771|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723772|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723773|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723774|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723775|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723776|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
48723777|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
48723778|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
48723779|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723780|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723781|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723782|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723783|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723784|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723785|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723786|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723787|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723788|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723789|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
48723790|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
48723791|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
48723792|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723793|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48817994|NCT01804673|157175241|FG000|Overall Study|Change to Oral Therapy|37|||
48817995|NCT01804673|157175241|FG000|Overall Study|No Further Therapy Required|84|||
48817996|NCT01804673|157175241|FG000|Overall Study|Use of Prohibited Medication|1|||
48817997|NCT01804673|157175241|FG000|Overall Study|Other|4|||
48817998|NCT03685708|157175250|FG000|Overall Study|Withdrawal by Subject|0|||
48817999|NCT03685708|157175251|FG001|Overall Study|Withdrawal by Subject|0|||
48818000|NCT03685708|157175252|FG002|Overall Study|Withdrawal by Subject|1|||
48503147|NCT00893464|156040008|FG004|Overall Study|Did not complete therapy/experience PD|0|||
48503148|NCT00893464|156040009|FG005|Overall Study|Did not complete therapy/experience PD|0|||
48503149|NCT00893464|156040010|FG006|Overall Study|Did not complete therapy/experience PD|2|||
48503150|NCT00893464|156040011|FG007|Overall Study|Did not complete therapy/experience PD|2|||
48503151|NCT02910037|156040012|FG000|Overall Study|Withdrawal by Subject|4|||
48503152|NCT02910037|156040012|FG000|Overall Study|Lost to Follow-up|6|||
48503153|NCT03560609|156040015|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
48503154|NCT03560609|156040016|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
48503155|NCT00486837|156040026|FG000|Overall Study|Withdrawal by Subject|1|||
48503156|NCT00486837|156040027|FG001|Overall Study|Withdrawal by Subject|0|||
48818001|NCT03685708|157175250|FG000|Overall Study|Screen Fail|0|||
48818002|NCT03685708|157175251|FG001|Overall Study|Screen Fail|1|||
48818003|NCT03685708|157175252|FG002|Overall Study|Screen Fail|1|||
48818004|NCT03685708|157175250|FG000|Overall Study|COVID 19 Pandemic|1|||
48818005|NCT03685708|157175251|FG001|Overall Study|COVID 19 Pandemic|1|||
48818006|NCT03685708|157175252|FG002|Overall Study|COVID 19 Pandemic|6|||
48818007|NCT03685708|157175250|FG000|Overall Study|Disease Progression|0|||
48818008|NCT03685708|157175251|FG001|Overall Study|Disease Progression|0|||
48818009|NCT03685708|157175252|FG002|Overall Study|Disease Progression|1|||
48818010|NCT04006366|157175255|FG000|Overall Study|Withdrawal by Subject|1|||
48818011|NCT04430335|157175256|FG000|Overall Study|Withdrawal by Subject|1|||
48818012|NCT00750893|157175259|FG000|Overall Study|Adverse Event|5|||
48503157|NCT00486837|156040026|FG000|Overall Study|Adverse Event|1|||
48503158|NCT00486837|156040027|FG001|Overall Study|Adverse Event|1|||
48503159|NCT00486837|156040026|FG000|Overall Study|Protocol Violation|4|||
48503160|NCT00486837|156040027|FG001|Overall Study|Protocol Violation|2|||
48503161|NCT00486837|156040026|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
48503162|NCT00486837|156040027|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
48503163|NCT00874237|156040028|FG000|Overall Study|Physician Decision|0|||
48818013|NCT00750893|157175259|FG000|Overall Study|Withdrawal by Subject|10|||
48503164|NCT00874237|156040029|FG001|Overall Study|Physician Decision|1|||
48503165|NCT00874237|156040030|FG002|Overall Study|Physician Decision|0|||
48503166|NCT00874237|156040031|FG003|Overall Study|Physician Decision|0|||
48503167|NCT00874237|156040032|FG004|Overall Study|Physician Decision|0|||
48503168|NCT00874237|156040033|FG005|Overall Study|Physician Decision|0|||
48503169|NCT00874237|156040028|FG000|Overall Study|Withdrawal by Subject|0|||
48503170|NCT00874237|156040029|FG001|Overall Study|Withdrawal by Subject|0|||
48503171|NCT00874237|156040030|FG002|Overall Study|Withdrawal by Subject|1|||
48503172|NCT00874237|156040031|FG003|Overall Study|Withdrawal by Subject|0|||
48503173|NCT00874237|156040032|FG004|Overall Study|Withdrawal by Subject|0|||
48503174|NCT00874237|156040033|FG005|Overall Study|Withdrawal by Subject|0|||
48503175|NCT02728102|156040038|FG000|Overall Study|Death|3|||
48503176|NCT02728102|156040039|FG001|Overall Study|Death|0|||
48503177|NCT02728102|156040040|FG002|Overall Study|Death|1|||
48503178|NCT02728102|156040038|FG000|Overall Study|Withdrawal by Subject|0|||
48503179|NCT02728102|156040039|FG001|Overall Study|Withdrawal by Subject|2|||
48503180|NCT02728102|156040040|FG002|Overall Study|Withdrawal by Subject|3|||
48503181|NCT02728102|156040038|FG000|Overall Study|Physician Decision|1|||
48503182|NCT02728102|156040039|FG001|Overall Study|Physician Decision|1|||
48503183|NCT02728102|156040040|FG002|Overall Study|Physician Decision|0|||
48503184|NCT02728102|156040038|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
48503185|NCT02728102|156040039|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
48503186|NCT02728102|156040040|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
48503187|NCT02728102|156040038|FG000|Overall Study|Covid|0|||
48503188|NCT02728102|156040039|FG001|Overall Study|Covid|0|||
48818014|NCT00750893|157175259|FG000|Overall Study|Lost to Follow-up|510|||
48818015|NCT00750893|157175259|FG000|Overall Study|Other|17|||
48818016|NCT00531011|157176641|FG000|Overall Study|Withdrawal by Subject|2|||
48818017|NCT00531011|157176642|FG001|Overall Study|Withdrawal by Subject|4|||
48503189|NCT02728102|156040040|FG002|Overall Study|Covid|1|||
48503190|NCT04869787|156040041|FG000|Screening|Physician Decision|1|||
48503191|NCT04869787|156040041|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
48503192|NCT00877032|156040043|FG000|Overall Study|Did not meet entrance criteria|0|||
48503193|NCT00877032|156040044|FG001|Overall Study|Did not meet entrance criteria|0|||
48818018|NCT00531011|157176641|FG000|Overall Study|Death|1|||
48818019|NCT00531011|157176642|FG001|Overall Study|Death|0|||
48818020|NCT00531011|157176641|FG000|Overall Study|Lost to Follow-up|1|||
48503194|NCT00877032|156040045|FG002|Overall Study|Did not meet entrance criteria|0|||
48818021|NCT00531011|157176642|FG001|Overall Study|Lost to Follow-up|0|||
48503195|NCT00877032|156040046|FG003|Overall Study|Did not meet entrance criteria|1|||
48503196|NCT00877032|156040047|FG004|Overall Study|Did not meet entrance criteria|0|||
48503197|NCT00877032|156040048|FG005|Overall Study|Did not meet entrance criteria|0|||
48503198|NCT00877032|156040049|FG006|Overall Study|Did not meet entrance criteria|2|||
48503199|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
48503200|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
48503201|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
48503202|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
48503203|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
48503204|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
48503205|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
48503206|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
48503207|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
48503208|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
48503209|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
48503210|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
48503211|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
48503212|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
48503213|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
48503214|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
48503215|NCT03182244|156040053|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
48503216|NCT03182244|156040054|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
48503217|NCT03182244|156040053|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
48503218|NCT03182244|156040054|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
48503219|NCT03182244|156040053|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
48503220|NCT03182244|156040054|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
48503221|NCT03182244|156040053|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
48503222|NCT03182244|156040054|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
48503223|NCT03182244|156040053|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
48503224|NCT03182244|156040054|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
48723794|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723795|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723796|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723797|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723798|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723799|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723800|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723801|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723802|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
48723803|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
48723804|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
48723805|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723806|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723807|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723808|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48818022|NCT00531011|157176641|FG000|Overall Study|Physician Decision|0|||
48818023|NCT00531011|157176642|FG001|Overall Study|Physician Decision|3|||
48818024|NCT02139982|157176643|FG000|Overall Study|Lack of Efficacy|0|||
48818025|NCT02139982|157176644|FG001|Overall Study|Lack of Efficacy|1|||
48818026|NCT02139982|157176645|FG002|Overall Study|Lack of Efficacy|0|||
48818027|NCT02139982|157176646|FG003|Overall Study|Lack of Efficacy|1|||
48818028|NCT02139982|157176647|FG004|Overall Study|Lack of Efficacy|0|||
48818029|NCT02139982|157176648|FG005|Overall Study|Lack of Efficacy|0|||
48818030|NCT02139982|157176649|FG006|Overall Study|Lack of Efficacy|0|||
48818031|NCT02139982|157176650|FG007|Overall Study|Lack of Efficacy|0|||
48818032|NCT02139982|157176651|FG008|Overall Study|Lack of Efficacy|0|||
48818033|NCT02139982|157176652|FG009|Overall Study|Lack of Efficacy|0|||
48818034|NCT00467142|157176653|FG000|Overall Study|Withdrawal by Subject|1|||
48818035|NCT00467142|157176653|FG000|Overall Study|Adverse Event|1|||
48818036|NCT00467142|157176653|FG000|Overall Study|Protocol Violation|1|||
48818037|NCT01619787|157176654|FG000|Overall Study|Lost to Follow-up|5|||
48818038|NCT03029780|157176680|FG000|Overall Study|Disease Progression|20|||
48723809|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48818039|NCT03029780|157176681|FG001|Overall Study|Disease Progression|22|||
48818040|NCT03029780|157176680|FG000|Overall Study|Study Drug Toxicity|15|||
48818041|NCT03029780|157176681|FG001|Overall Study|Study Drug Toxicity|11|||
48818042|NCT03029780|157176680|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
48818043|NCT03029780|157176681|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
48818044|NCT03029780|157176680|FG000|Overall Study|Participant request to discontinue study treatment|4|||
48818045|NCT03029780|157176681|FG001|Overall Study|Participant request to discontinue study treatment|1|||
48818046|NCT03029780|157176680|FG000|Overall Study|Maximum clinical benefit|1|||
48818047|NCT03029780|157176681|FG001|Overall Study|Maximum clinical benefit|0|||
48818048|NCT03029780|157176680|FG000|Overall Study|Participant no longer meets study criteria|0|||
48818049|NCT03029780|157176681|FG001|Overall Study|Participant no longer meets study criteria|1|||
48818050|NCT03029780|157176680|FG000|Overall Study|Other reasons|6|||
48818051|NCT03029780|157176681|FG001|Overall Study|Other reasons|6|||
48818052|NCT03029780|157176680|FG000|Overall Study|Not reported|1|||
48818053|NCT03029780|157176681|FG001|Overall Study|Not reported|1|||
48818054|NCT03029780|157176680|FG000|Overall Study|Death|2|||
48818055|NCT03029780|157176681|FG001|Overall Study|Death|6|||
48818056|NCT04012814|157176685|FG000|Overall Study|Lost to Follow-up|4|||
48818057|NCT04012814|157176685|FG000|Overall Study|Withdrawal by Subject|2|||
48818058|NCT04012814|157176685|FG000|Overall Study|Protocol Violation|1|||
48818059|NCT04012814|157176685|FG000|Overall Study|Adverse Event|1|||
48818060|NCT02942004|157176690|FG000|Overall Study|Withdrawal by Subject|0|||
48818061|NCT02942004|157176691|FG001|Overall Study|Withdrawal by Subject|2|||
48818062|NCT02942004|157176692|FG002|Overall Study|Withdrawal by Subject|3|||
48818063|NCT02942004|157176690|FG000|Overall Study|Lost to Follow-up|1|||
48818064|NCT02942004|157176691|FG001|Overall Study|Lost to Follow-up|1|||
48818065|NCT02942004|157176692|FG002|Overall Study|Lost to Follow-up|2|||
48818066|NCT02942004|157176690|FG000|Overall Study|Randomized but not dosed|3|||
48818067|NCT02942004|157176691|FG001|Overall Study|Randomized but not dosed|9|||
48818068|NCT02942004|157176692|FG002|Overall Study|Randomized but not dosed|4|||
48818069|NCT01544491|157176694|FG000|Overall Study|Withdrawal by Subject|3|||
48818070|NCT01544491|157176695|FG001|Overall Study|Withdrawal by Subject|2|||
48818071|NCT01544491|157176694|FG000|Overall Study|Lost to Follow-up|0|||
48818072|NCT01544491|157176695|FG001|Overall Study|Lost to Follow-up|1|||
48818073|NCT01544491|157176694|FG000|Overall Study|administrative problems|2|||
48818074|NCT01544491|157176695|FG001|Overall Study|administrative problems|0|||
48818075|NCT03653416|157176709|FG000|Overall Study|Protocol Violation|6|||
48818076|NCT03653416|157176710|FG001|Overall Study|Protocol Violation|1|||
48818077|NCT04230980|157176711|FG000|Overall Study|Lost to Follow-up|1|||
48818078|NCT04230980|157176712|FG001|Overall Study|Lost to Follow-up|2|||
48723810|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723811|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723812|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723813|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723814|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723815|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
48723816|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
48723817|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
48818079|NCT04230980|157176711|FG000|Overall Study|Adverse Event|0|||
48818080|NCT04230980|157176712|FG001|Overall Study|Adverse Event|1|||
48818081|NCT01461993|157176715|FG000|Overall Study|Withdrawal by Subject|60|||
48818082|NCT01461993|157176716|FG001|Overall Study|Withdrawal by Subject|53|||
48818083|NCT01461993|157176717|FG002|Overall Study|Withdrawal by Subject|16|||
48818084|NCT01461993|157176715|FG000|Overall Study|Lost to Follow-up|44|||
48818085|NCT01461993|157176716|FG001|Overall Study|Lost to Follow-up|48|||
48818086|NCT01461993|157176717|FG002|Overall Study|Lost to Follow-up|22|||
48818087|NCT01461993|157176715|FG000|Overall Study|Protocol Violation|10|||
48818088|NCT01461993|157176716|FG001|Overall Study|Protocol Violation|9|||
48818089|NCT01461993|157176717|FG002|Overall Study|Protocol Violation|7|||
48818090|NCT01461993|157176715|FG000|Overall Study|Adverse Event|9|||
48723818|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
48723819|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723820|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723821|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723822|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723823|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723824|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723825|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723826|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723827|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723828|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
48723829|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
48723830|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
48723831|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
48723832|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723833|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723834|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723835|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723836|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723837|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723838|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723839|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723840|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723841|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
48723842|NCT01261312|156840401|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
48723843|NCT01261312|156840402|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48503261|NCT02601313|156040061|FG000|Overall Study|Death|2|||
48503262|NCT02601313|156040062|FG001|Overall Study|Death|41|||
48503263|NCT02601313|156040063|FG002|Overall Study|Death|6|||
48503264|NCT02601313|156040061|FG000|Overall Study|Enrolled but never treated|0|||
48503265|NCT02601313|156040062|FG001|Overall Study|Enrolled but never treated|6|||
48503266|NCT02601313|156040063|FG002|Overall Study|Enrolled but never treated|3|||
48503267|NCT02601313|156040061|FG000|Overall Study|Enrolled, did not initiate AC|4|||
48503268|NCT02601313|156040062|FG001|Overall Study|Enrolled, did not initiate AC|0|||
48503269|NCT02601313|156040063|FG002|Overall Study|Enrolled, did not initiate AC|0|||
48503270|NCT02601313|156040061|FG000|Overall Study|Full consent withdrawal|0|||
48503271|NCT02601313|156040062|FG001|Overall Study|Full consent withdrawal|3|||
48503272|NCT02601313|156040063|FG002|Overall Study|Full consent withdrawal|2|||
48503273|NCT02601313|156040061|FG000|Overall Study|Lost to Follow-up|0|||
48503274|NCT02601313|156040062|FG001|Overall Study|Lost to Follow-up|1|||
48503275|NCT02601313|156040063|FG002|Overall Study|Lost to Follow-up|1|||
48503276|NCT01390844|156040067|FG000|Treatment Phase|Adverse Event|12|||
48503277|NCT01390844|156040068|FG001|Treatment Phase|Adverse Event|2|||
48503278|NCT01390844|156040069|FG002|Treatment Phase|Adverse Event|3|||
48503279|NCT01390844|156040070|FG003|Treatment Phase|Adverse Event|2|||
48503280|NCT01390844|156040067|FG000|Treatment Phase|Treatment Failure|23|||
48503281|NCT01390844|156040068|FG001|Treatment Phase|Treatment Failure|25|||
48503282|NCT01390844|156040069|FG002|Treatment Phase|Treatment Failure|10|||
48503283|NCT01390844|156040070|FG003|Treatment Phase|Treatment Failure|13|||
48503284|NCT01390844|156040067|FG000|Treatment Phase|Non-Medical Reasons|5|||
48503285|NCT01390844|156040068|FG001|Treatment Phase|Non-Medical Reasons|1|||
48503286|NCT01390844|156040069|FG002|Treatment Phase|Non-Medical Reasons|8|||
48503287|NCT01390844|156040070|FG003|Treatment Phase|Non-Medical Reasons|1|||
48503288|NCT01390844|156040067|FG000|Treatment Phase|Non-GCP Compliant|0|||
48503289|NCT01390844|156040068|FG001|Treatment Phase|Non-GCP Compliant|0|||
48503290|NCT01390844|156040069|FG002|Treatment Phase|Non-GCP Compliant|10|||
48503291|NCT01390844|156040070|FG003|Treatment Phase|Non-GCP Compliant|3|||
48503292|NCT01390844|156040067|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
48503293|NCT01390844|156040068|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
48503294|NCT01390844|156040069|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
48503295|NCT01390844|156040070|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
48503296|NCT01318499|156040073|FG000|Overall Study|Adverse Event|16|||
48503297|NCT01318499|156040074|FG001|Overall Study|Adverse Event|11|||
48503298|NCT01318499|156040075|FG002|Overall Study|Adverse Event|6|||
48503299|NCT01318499|156040073|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
48503300|NCT01318499|156040074|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
48503301|NCT01318499|156040075|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
48503302|NCT01318499|156040073|FG000|Overall Study|Noncompliance|2|||
48503303|NCT01318499|156040074|FG001|Overall Study|Noncompliance|3|||
48503304|NCT01318499|156040075|FG002|Overall Study|Noncompliance|0|||
48503305|NCT01318499|156040073|FG000|Overall Study|Treatment Failure|19|||
48503306|NCT01318499|156040074|FG001|Overall Study|Treatment Failure|19|||
48503307|NCT01318499|156040075|FG002|Overall Study|Treatment Failure|101|||
48503308|NCT01318499|156040073|FG000|Overall Study|Protocol Violation|2|||
48503309|NCT01318499|156040074|FG001|Overall Study|Protocol Violation|4|||
48503310|NCT01318499|156040075|FG002|Overall Study|Protocol Violation|2|||
48503311|NCT01318499|156040073|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
48503312|NCT01318499|156040074|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
48503313|NCT01318499|156040075|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
48503314|NCT01318499|156040073|FG000|Overall Study|Other|7|||
48503315|NCT01318499|156040074|FG001|Overall Study|Other|10|||
48503316|NCT01318499|156040075|FG002|Overall Study|Other|22|||
48503317|NCT01974141|156040076|FG000|Overall Study|Other Reasons|28|||
48503318|NCT01974141|156040077|FG001|Overall Study|Other Reasons|18|||
48503319|NCT01974141|156040076|FG000|Overall Study|Protocol Violation|2|||
48503320|NCT01974141|156040077|FG001|Overall Study|Protocol Violation|6|||
48503321|NCT01974141|156040076|FG000|Overall Study|Personal Reasons|21|||
48503322|NCT01974141|156040077|FG001|Overall Study|Personal Reasons|20|||
48503323|NCT01974141|156040076|FG000|Overall Study|Lost to Follow-up|38|||
48503324|NCT01974141|156040077|FG001|Overall Study|Lost to Follow-up|29|||
48503325|NCT01974141|156040076|FG000|Overall Study|Pregnancy|3|||
48503326|NCT01974141|156040077|FG001|Overall Study|Pregnancy|3|||
48503327|NCT01974141|156040076|FG000|Overall Study|Lack of Efficacy|0|||
48818091|NCT01461993|157176716|FG001|Overall Study|Adverse Event|11|||
48818092|NCT01461993|157176717|FG002|Overall Study|Adverse Event|3|||
48503328|NCT01974141|156040077|FG001|Overall Study|Lack of Efficacy|1|||
48503329|NCT01974141|156040076|FG000|Overall Study|Adverse Event|4|||
48503330|NCT01974141|156040077|FG001|Overall Study|Adverse Event|5|||
48503331|NCT02719522|156040082|FG000|Overall Study|Implant Failure|4|||
48503332|NCT02719522|156040082|FG000|Overall Study|Death|2|||
48503333|NCT02719522|156040082|FG000|Overall Study|Lost to Follow-up|5|||
48503334|NCT03583333|156040097|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
48503335|NCT03583333|156040098|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
48503336|NCT03583333|156040097|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
48503337|NCT03583333|156040098|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
48503338|NCT03583333|156040097|FG000|Overall Study|Withdrawal by Subject|9|||
48503339|NCT03583333|156040098|FG001|Overall Study|Withdrawal by Subject|5|||
48818093|NCT01461993|157176715|FG000|Overall Study|No longer met eligibility criteria|13|||
48818094|NCT01461993|157176716|FG001|Overall Study|No longer met eligibility criteria|18|||
48818095|NCT01461993|157176717|FG002|Overall Study|No longer met eligibility criteria|10|||
48818096|NCT01461993|157176715|FG000|Overall Study|Did not meet entrance criteria|2|||
48818097|NCT01461993|157176716|FG001|Overall Study|Did not meet entrance criteria|3|||
48818098|NCT01461993|157176717|FG002|Overall Study|Did not meet entrance criteria|0|||
48818099|NCT01461993|157176715|FG000|Overall Study|Other|13|||
48818100|NCT01461993|157176716|FG001|Overall Study|Other|15|||
48818101|NCT01461993|157176717|FG002|Overall Study|Other|6|||
48818102|NCT00680056|157176718|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
48818103|NCT00680056|157176719|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
48818104|NCT00680056|157176718|FG000|Second Intervention|Protocol Violation|3|||
48818105|NCT00680056|157176719|FG001|Second Intervention|Protocol Violation|1|||
48818106|NCT00219141|157176720|FG000|Overall Study|Adverse Event|4|||
48818107|NCT00219141|157176721|FG001|Overall Study|Adverse Event|10|||
48818108|NCT00219141|157176722|FG002|Overall Study|Adverse Event|5|||
48503340|NCT03583333|156040097|FG000|Overall Study|Physician Decision|3|||
48503341|NCT03583333|156040098|FG001|Overall Study|Physician Decision|2|||
48503342|NCT03583333|156040097|FG000|Overall Study|Death|12|||
48503343|NCT03583333|156040098|FG001|Overall Study|Death|7|||
48503344|NCT03536884|156040099|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
48503345|NCT03536884|156040100|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
48503346|NCT03536884|156040101|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503347|NCT03536884|156040102|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503348|NCT03536884|156040103|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503349|NCT03536884|156040104|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48818109|NCT00219141|157176720|FG000|Overall Study|Lack of Efficacy|3|||
48503350|NCT03536884|156040105|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503351|NCT03536884|156040106|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503352|NCT03536884|156040107|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503353|NCT03536884|156040108|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503354|NCT03536884|156040109|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503355|NCT03536884|156040110|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
48503356|NCT03536884|156040099|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503357|NCT03536884|156040100|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
48818110|NCT00219141|157176721|FG001|Overall Study|Lack of Efficacy|2|||
48818111|NCT00219141|157176722|FG002|Overall Study|Lack of Efficacy|0|||
48818112|NCT00219141|157176720|FG000|Overall Study|Administrative problems|0|||
48818113|NCT00219141|157176721|FG001|Overall Study|Administrative problems|1|||
48818114|NCT00219141|157176722|FG002|Overall Study|Administrative problems|0|||
48818115|NCT00219141|157176720|FG000|Overall Study|Lost to Follow-up|2|||
48818116|NCT00219141|157176721|FG001|Overall Study|Lost to Follow-up|4|||
48818117|NCT00219141|157176722|FG002|Overall Study|Lost to Follow-up|1|||
48818118|NCT00219141|157176720|FG000|Overall Study|Protocol Violation|3|||
48818119|NCT00219141|157176721|FG001|Overall Study|Protocol Violation|1|||
48818120|NCT00219141|157176722|FG002|Overall Study|Protocol Violation|1|||
48818121|NCT00219141|157176720|FG000|Overall Study|Withdrawal by Subject|1|||
48818122|NCT00219141|157176721|FG001|Overall Study|Withdrawal by Subject|3|||
48818123|NCT00219141|157176722|FG002|Overall Study|Withdrawal by Subject|5|||
48818124|NCT00219141|157176720|FG000|Overall Study|Condition no longer requires study drug|1|||
48818125|NCT00219141|157176721|FG001|Overall Study|Condition no longer requires study drug|0|||
48818126|NCT00219141|157176722|FG002|Overall Study|Condition no longer requires study drug|0|||
48818127|NCT03055832|157176723|FG000|Week 2|Withdrawal by Subject|1|||
48818128|NCT03055832|157176724|FG001|Week 2|Withdrawal by Subject|0|||
48818129|NCT00479674|157176725|FG000|Overall Study|Adverse Event|18|||
48818130|NCT00479674|157176725|FG000|Overall Study|Withdrawal by Subject|6|||
48818131|NCT00479674|157176725|FG000|Overall Study|Physician Decision|14|||
48818132|NCT00479674|157176725|FG000|Overall Study|none provided|3|||
48818133|NCT02059161|157176727|FG000|Overall Study|Pregnancy|0|||
48818134|NCT02059161|157176728|FG001|Overall Study|Pregnancy|2|||
48818135|NCT02059161|157176727|FG000|Overall Study|Adverse Event|2|||
48818136|NCT02059161|157176728|FG001|Overall Study|Adverse Event|6|||
48818137|NCT02059161|157176727|FG000|Overall Study|Lost to Follow-up|20|||
48818138|NCT02059161|157176728|FG001|Overall Study|Lost to Follow-up|12|||
48818139|NCT02059161|157176727|FG000|Overall Study|Physician Decision|4|||
48818140|NCT02059161|157176728|FG001|Overall Study|Physician Decision|4|||
48818141|NCT02059161|157176727|FG000|Overall Study|Protocol Violation|1|||
48818142|NCT02059161|157176728|FG001|Overall Study|Protocol Violation|1|||
48818143|NCT02059161|157176727|FG000|Overall Study|Withdrawal by Subject|16|||
48818144|NCT02059161|157176728|FG001|Overall Study|Withdrawal by Subject|13|||
48818145|NCT02059161|157176727|FG000|Overall Study|Randomized in error, no study drug|0|||
48818146|NCT02059161|157176728|FG001|Overall Study|Randomized in error, no study drug|1|||
48818147|NCT02059161|157176727|FG000|Overall Study|Non-compliance with study drug|6|||
48818148|NCT02059161|157176728|FG001|Overall Study|Non-compliance with study drug|2|||
48818149|NCT00372528|157176729|FG000|Overall Study|Lack of Efficacy|1|||
48818150|NCT00372528|157176729|FG000|Overall Study|Adverse Event|1|||
48818151|NCT00372528|157176729|FG000|Overall Study|Study Terminated by Sponsor|18|||
48818152|NCT00372528|157176729|FG000|Overall Study|Other|1|||
48818153|NCT04242875|157176730|FG000|Overall Study|Adverse Event|2|||
48818154|NCT01012973|157176731|FG000|Overall Study|Adverse Event|5|||
48818155|NCT01012973|157176732|FG001|Overall Study|Adverse Event|5|||
48818156|NCT01012973|157176731|FG000|Overall Study|Lack of Efficacy|0|||
48818157|NCT01012973|157176732|FG001|Overall Study|Lack of Efficacy|5|||
48818158|NCT01012973|157176731|FG000|Overall Study|Lost to Follow-up|1|||
48818159|NCT01012973|157176732|FG001|Overall Study|Lost to Follow-up|0|||
48818160|NCT01012973|157176731|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
48818161|NCT01012973|157176732|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
48818162|NCT01012973|157176731|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
48818163|NCT01012973|157176732|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
48818164|NCT01012973|157176731|FG000|Overall Study|Protocol Violation|5|||
48818165|NCT01012973|157176732|FG001|Overall Study|Protocol Violation|2|||
48818166|NCT01012973|157176731|FG000|Overall Study|Withdrawal by Subject|4|||
48818167|NCT01012973|157176732|FG001|Overall Study|Withdrawal by Subject|6|||
48818168|NCT00231894|157176733|FG000|Overall Study|Withdrawal by Subject|1|||
48818169|NCT00231894|157176734|FG001|Overall Study|Withdrawal by Subject|1|||
48818170|NCT01024751|157176738|FG000|Enrolled Participants|Ineligible at baseline|3|||
48818171|NCT01024751|157176739|FG001|Enrolled Participants|Ineligible at baseline|4|||
48818172|NCT01024751|157176738|FG000|Eligible Participants|Withdrawal by Subject|0|||
48818173|NCT01024751|157176739|FG001|Eligible Participants|Withdrawal by Subject|1|||
48818174|NCT01024751|157176738|FG000|Eligible Participants|Lost to Follow-up|0|||
48818175|NCT01024751|157176739|FG001|Eligible Participants|Lost to Follow-up|1|||
48818176|NCT01024751|157176738|FG000|Eligible Participants|Ineligible|0|||
48818177|NCT01024751|157176739|FG001|Eligible Participants|Ineligible|1|||
48818178|NCT00577720|157176749|FG000|Overall Study|Adverse Event|2|||
48818179|NCT00577720|157176750|FG001|Overall Study|Adverse Event|1|||
48818180|NCT00577720|157176751|FG002|Overall Study|Adverse Event|0|||
48818181|NCT00577720|157176752|FG003|Overall Study|Adverse Event|4|||
48818182|NCT00577720|157176749|FG000|Overall Study|Lost to Follow-up|0|||
48818183|NCT00577720|157176750|FG001|Overall Study|Lost to Follow-up|0|||
48818184|NCT00577720|157176751|FG002|Overall Study|Lost to Follow-up|1|||
48818185|NCT00577720|157176752|FG003|Overall Study|Lost to Follow-up|0|||
48818186|NCT00577720|157176749|FG000|Overall Study|Protocol Violation|0|||
48818187|NCT00577720|157176750|FG001|Overall Study|Protocol Violation|0|||
48818188|NCT00577720|157176751|FG002|Overall Study|Protocol Violation|0|||
48818189|NCT00577720|157176752|FG003|Overall Study|Protocol Violation|1|||
48818190|NCT00577720|157176749|FG000|Overall Study|Withdrawal by Subject|2|||
48818191|NCT00577720|157176750|FG001|Overall Study|Withdrawal by Subject|0|||
48818192|NCT00577720|157176751|FG002|Overall Study|Withdrawal by Subject|0|||
48818193|NCT00577720|157176752|FG003|Overall Study|Withdrawal by Subject|2|||
48818194|NCT01628510|157176758|FG000|Overall Study|Withdrawal by Subject|0|||
48818195|NCT01628510|157176759|FG001|Overall Study|Withdrawal by Subject|4|||
48818196|NCT01628510|157176758|FG000|Overall Study|Death|3|||
48818197|NCT01628510|157176759|FG001|Overall Study|Death|1|||
48818198|NCT01653847|157176760|FG000|Overall Study|Withdrawal by Subject|1|||
48818199|NCT01653847|157176761|FG001|Overall Study|Withdrawal by Subject|0|||
48818200|NCT04707391|157176762|FG000|Overall Study|Adverse Event|5|||
48818201|NCT04707391|157176763|FG001|Overall Study|Adverse Event|8|||
48818202|NCT04707391|157176762|FG000|Overall Study|Lost to Follow-up|44|||
48818203|NCT04707391|157176763|FG001|Overall Study|Lost to Follow-up|31|||
48818204|NCT04707391|157176762|FG000|Overall Study|Protocol Violation|1|||
48818205|NCT04707391|157176763|FG001|Overall Study|Protocol Violation|5|||
48818206|NCT04707391|157176762|FG000|Overall Study|Withdrawal by Subject|27|||
48818207|NCT04707391|157176763|FG001|Overall Study|Withdrawal by Subject|25|||
48818208|NCT04707391|157176762|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
48818209|NCT04707391|157176763|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
48818210|NCT04707391|157176762|FG000|Overall Study|Other|0|||
48818211|NCT04707391|157176763|FG001|Overall Study|Other|2|||
48818212|NCT00131911|157176764|FG000|Overall Study|Withdrawal by Subject|1|||
48818213|NCT00131911|157176765|FG001|Overall Study|Withdrawal by Subject|0|||
48818214|NCT03519581|157176768|FG000|Overall Study|Lost to Follow-up|3|||
48818215|NCT03519581|157176769|FG001|Overall Study|Lost to Follow-up|2|||
48818216|NCT03519581|157176768|FG000|Overall Study|Adverse Event|5|||
48818217|NCT03519581|157176769|FG001|Overall Study|Adverse Event|2|||
48818218|NCT03519581|157176768|FG000|Overall Study|Withdrawal by Subject|2|||
48818219|NCT03519581|157176769|FG001|Overall Study|Withdrawal by Subject|0|||
48818220|NCT03519581|157176768|FG000|Overall Study|Change to insurance|2|||
48818221|NCT03519581|157176769|FG001|Overall Study|Change to insurance|1|||
48818222|NCT03519581|157176768|FG000|Overall Study|Other|2|||
48818223|NCT03519581|157176769|FG001|Overall Study|Other|4|||
48818224|NCT00388362|157176772|FG000|Enrolled|Ineligible|1|||
48818225|NCT00388362|157176772|FG000|Enrolled|Adverse Event|9|||
48818226|NCT00388362|157176772|FG000|Enrolled|Death|1|||
48818227|NCT00388362|157176772|FG000|Enrolled|Loss insurance|1|||
48818228|NCT00388362|157176772|FG000|Enrolled|Withdrawal by Subject|1|||
48818229|NCT00388362|157176772|FG000|Remained on Study Median of 514 Days|Death|2|||
48818230|NCT02035787|157176773|FG000|Overall Study- 12 Months|Adverse Event|3|||
48818231|NCT02035787|157176774|FG001|Overall Study- 12 Months|Adverse Event|0|||
48818232|NCT02035787|157176773|FG000|Overall Study- 12 Months|Complete response|4|||
48503358|NCT03536884|156040101|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48818233|NCT02035787|157176774|FG001|Overall Study- 12 Months|Complete response|1|||
48818234|NCT02035787|157176773|FG000|Overall Study- 12 Months|Protocol Violation|1|||
48818235|NCT02035787|157176774|FG001|Overall Study- 12 Months|Protocol Violation|1|||
48818236|NCT02323321|157176780|FG000|Overall Study|Re-Transplant|1|||
48818237|NCT02323321|157176780|FG000|Overall Study|Death|12|||
48818238|NCT02577835|157176781|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
48818239|NCT04516967|157176782|FG000|Core Phase|Adverse Event|2|||
48503359|NCT03536884|156040102|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503360|NCT03536884|156040103|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503361|NCT03536884|156040104|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48818240|NCT04516967|157176783|FG001|Core Phase|Adverse Event|1|||
48818241|NCT04516967|157176784|FG002|Core Phase|Adverse Event|0|||
48818242|NCT04516967|157176782|FG000|Core Phase|Physician Decision|1|||
48818243|NCT04516967|157176783|FG001|Core Phase|Physician Decision|1|||
48818244|NCT04516967|157176784|FG002|Core Phase|Physician Decision|0|||
48818245|NCT04516967|157176782|FG000|Core Phase|Lack of Efficacy|7|||
48818246|NCT04516967|157176783|FG001|Core Phase|Lack of Efficacy|18|||
48818247|NCT04516967|157176784|FG002|Core Phase|Lack of Efficacy|0|||
48818248|NCT00686335|157176785|FG000|Run-in Period|Adverse Event|1|||
48818249|NCT00686335|157176785|FG000|Run-in Period|asthma exacerbation|1|||
48818250|NCT00686335|157176785|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
48818251|NCT01822353|157176790|FG000|Overall Study|Adverse Event|1|||
48818252|NCT01822353|157176791|FG001|Overall Study|Adverse Event|3|||
48818253|NCT01822353|157176792|FG002|Overall Study|Adverse Event|1|||
48818254|NCT01822353|157176790|FG000|Overall Study|Pregnancy|0|||
48818255|NCT01822353|157176791|FG001|Overall Study|Pregnancy|1|||
48818256|NCT01822353|157176792|FG002|Overall Study|Pregnancy|0|||
48818257|NCT01822353|157176790|FG000|Overall Study|Withdrawal by Subject|3|||
48818258|NCT01822353|157176791|FG001|Overall Study|Withdrawal by Subject|1|||
48818259|NCT01822353|157176792|FG002|Overall Study|Withdrawal by Subject|0|||
48818260|NCT02320721|157176793|FG000|Overall Study|Adverse Event|6|||
48818261|NCT02320721|157176794|FG001|Overall Study|Adverse Event|6|||
48818262|NCT02320721|157176793|FG000|Overall Study|Lack of Efficacy|2|||
48818263|NCT02320721|157176794|FG001|Overall Study|Lack of Efficacy|0|||
48818264|NCT02320721|157176793|FG000|Overall Study|Poor compliance to protocol|3|||
48818265|NCT02320721|157176794|FG001|Overall Study|Poor compliance to protocol|7|||
48818266|NCT02320721|157176793|FG000|Overall Study|Randomized but not treated|0|||
48818267|NCT02320721|157176794|FG001|Overall Study|Randomized but not treated|1|||
48818268|NCT02320721|157176793|FG000|Overall Study|Hypoglycemia|1|||
48503362|NCT03536884|156040105|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503363|NCT03536884|156040106|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503364|NCT03536884|156040107|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503365|NCT03536884|156040108|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503366|NCT03536884|156040109|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503367|NCT03536884|156040110|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
48503368|NCT03536884|156040099|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
48503369|NCT03536884|156040100|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
48503370|NCT03536884|156040101|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503371|NCT03536884|156040102|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503372|NCT03536884|156040103|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503373|NCT03536884|156040104|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503374|NCT03536884|156040105|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503375|NCT03536884|156040106|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503376|NCT03536884|156040107|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503377|NCT03536884|156040108|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503378|NCT03536884|156040109|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503379|NCT03536884|156040110|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
48503380|NCT03536884|156040099|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503381|NCT03536884|156040100|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
48503382|NCT03536884|156040101|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503383|NCT03536884|156040102|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503384|NCT03536884|156040103|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503385|NCT03536884|156040104|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503386|NCT03536884|156040105|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503387|NCT03536884|156040106|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503388|NCT03536884|156040107|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503389|NCT03536884|156040108|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503390|NCT03536884|156040109|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503391|NCT03536884|156040110|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
48503392|NCT03536884|156040099|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503393|NCT03536884|156040100|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
48503394|NCT03536884|156040101|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503395|NCT03536884|156040102|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503396|NCT03536884|156040103|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503397|NCT03536884|156040104|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503398|NCT03536884|156040105|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503399|NCT03536884|156040106|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503400|NCT03536884|156040107|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48818269|NCT02320721|157176794|FG001|Overall Study|Hypoglycemia|0|||
48818270|NCT02320721|157176793|FG000|Overall Study|Other than specified above|15|||
48818271|NCT02320721|157176794|FG001|Overall Study|Other than specified above|20|||
48818272|NCT04266795|157176810|FG000|Overall Study|Adverse Event|10|||
48818273|NCT04266795|157176811|FG001|Overall Study|Adverse Event|19|||
48818274|NCT04266795|157176810|FG000|Overall Study|Death|7|||
48818275|NCT04266795|157176811|FG001|Overall Study|Death|8|||
48818276|NCT04266795|157176810|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
48503401|NCT03536884|156040108|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503402|NCT03536884|156040109|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503403|NCT03536884|156040110|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
48503404|NCT03536884|156040099|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503405|NCT03536884|156040100|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
48503406|NCT03536884|156040101|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503407|NCT03536884|156040102|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503408|NCT03536884|156040103|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503409|NCT03536884|156040104|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503410|NCT03536884|156040105|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48723844|NCT01261312|156840403|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
48723845|NCT01261312|156840404|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723846|NCT01261312|156840405|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723847|NCT01261312|156840406|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723848|NCT01261312|156840407|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723849|NCT01261312|156840408|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723850|NCT01261312|156840409|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723851|NCT01261312|156840410|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723852|NCT01261312|156840411|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723853|NCT01261312|156840412|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723854|NCT01261312|156840413|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
48723855|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723856|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723857|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723858|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
48723859|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
48599908|NCT03428100|156391517|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599909|NCT03428100|156391518|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
48599910|NCT03428100|156391500|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
48599911|NCT03428100|156391501|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
48599912|NCT03428100|156391502|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
48599913|NCT03428100|156391503|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
48723860|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
48503411|NCT03536884|156040106|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503412|NCT03536884|156040107|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503413|NCT03536884|156040108|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503414|NCT03536884|156040109|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503415|NCT03536884|156040110|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
48503416|NCT03536884|156040099|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503417|NCT03536884|156040100|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503418|NCT03536884|156040101|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
48503419|NCT03536884|156040102|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503420|NCT03536884|156040103|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
48503421|NCT03536884|156040104|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503422|NCT03536884|156040105|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503423|NCT03536884|156040106|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503424|NCT03536884|156040107|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503425|NCT03536884|156040108|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503426|NCT03536884|156040109|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503427|NCT03536884|156040110|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
48503428|NCT03536884|156040099|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503429|NCT03536884|156040100|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503430|NCT03536884|156040101|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
48503431|NCT03536884|156040102|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
48503432|NCT03536884|156040103|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
48503433|NCT03536884|156040104|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503434|NCT03536884|156040105|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503435|NCT03536884|156040106|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503436|NCT03536884|156040107|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503437|NCT03536884|156040108|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503438|NCT03536884|156040109|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503439|NCT03536884|156040110|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
48503440|NCT03536884|156040099|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503441|NCT03536884|156040100|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48723861|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48503442|NCT03536884|156040101|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503443|NCT03536884|156040102|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
48503444|NCT03536884|156040103|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
48599914|NCT03428100|156391504|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
48599915|NCT03428100|156391505|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
48599916|NCT03428100|156391506|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
48599917|NCT03428100|156391507|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
48599918|NCT03428100|156391508|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
48599919|NCT03428100|156391509|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
48818277|NCT04266795|157176811|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
48818278|NCT04266795|157176810|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
48818279|NCT04266795|157176811|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48818280|NCT04266795|157176810|FG000|Overall Study|Progressive Disease|12|||
48818281|NCT04266795|157176811|FG001|Overall Study|Progressive Disease|9|||
48818282|NCT04266795|157176810|FG000|Overall Study|Withdrawal by Patient|5|||
48818283|NCT04266795|157176811|FG001|Overall Study|Withdrawal by Patient|6|||
48818284|NCT04266795|157176810|FG000|Overall Study|Disease Relapse|3|||
48503445|NCT03536884|156040104|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503446|NCT03536884|156040105|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503447|NCT03536884|156040106|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503448|NCT03536884|156040107|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503449|NCT03536884|156040108|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503450|NCT03536884|156040109|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503451|NCT03536884|156040110|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
48503452|NCT03536884|156040099|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48818285|NCT04266795|157176811|FG001|Overall Study|Disease Relapse|6|||
48818286|NCT04266795|157176810|FG000|Overall Study|Reason not Specified|12|||
48818287|NCT04266795|157176811|FG001|Overall Study|Reason not Specified|10|||
48818288|NCT04266795|157176810|FG000|Overall Study|Participants Ongoing on Treatment|25|||
48818289|NCT04266795|157176811|FG001|Overall Study|Participants Ongoing on Treatment|23|||
48818290|NCT02764775|157178433|FG000|Overall Study|Death|1|||
48818291|NCT02764775|157178433|FG000|Overall Study|Lost to Follow-up|2|||
48818292|NCT02764775|157178433|FG000|Overall Study|Withdrawal by Subject|3|||
48818293|NCT00513019|157178437|FG000|Overall Study|Adverse Event|1|||
48818294|NCT00513019|157178438|FG001|Overall Study|Adverse Event|0|||
48818295|NCT00513019|157178437|FG000|Overall Study|Withdrawal by Subject|4|||
48818296|NCT00513019|157178438|FG001|Overall Study|Withdrawal by Subject|5|||
48818297|NCT00777803|157178439|FG000|Overall Study|Lost to Follow-up|12|||
48818298|NCT00777803|157178440|FG001|Overall Study|Lost to Follow-up|5|||
48818299|NCT00777803|157178439|FG000|Overall Study|Adverse Event|1|||
48818300|NCT00777803|157178440|FG001|Overall Study|Adverse Event|0|||
48503453|NCT03536884|156040100|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48503454|NCT03536884|156040101|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
48503455|NCT03536884|156040102|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
48503456|NCT03536884|156040103|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
48503457|NCT03536884|156040104|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48503458|NCT03536884|156040105|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48503459|NCT03536884|156040106|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48503460|NCT03536884|156040107|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48503461|NCT03536884|156040108|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48503462|NCT03536884|156040109|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48503463|NCT03536884|156040110|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
48503464|NCT03536884|156040099|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503465|NCT03536884|156040100|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503466|NCT03536884|156040101|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
48503467|NCT03536884|156040102|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
48503468|NCT03536884|156040103|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
48503469|NCT03536884|156040104|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503470|NCT03536884|156040105|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503471|NCT03536884|156040106|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503472|NCT03536884|156040107|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503473|NCT03536884|156040108|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503474|NCT03536884|156040109|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503475|NCT03536884|156040110|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
48503476|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
48503477|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
48599920|NCT03428100|156391510|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
48818301|NCT00777803|157178439|FG000|Overall Study|Non-compliance|2|||
48818302|NCT00777803|157178440|FG001|Overall Study|Non-compliance|2|||
48818303|NCT02930122|157178442|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
48818304|NCT02930122|157178443|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
48818305|NCT00830947|157178444|FG000|Overall Study|Lost to Follow-up|4|||
48818306|NCT00830947|157178445|FG001|Overall Study|Lost to Follow-up|4|||
48818307|NCT00107380|157178449|FG000|Overall Study|Adverse Event|7|||
48503478|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
48818308|NCT00107380|157178449|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
48818309|NCT00107380|157178449|FG000|Overall Study|Progression/relapse|4|||
48818310|NCT00107380|157178449|FG000|Overall Study|Death|3|||
48818311|NCT00107380|157178449|FG000|Overall Study|Other - not protocol specified|7|||
48818312|NCT00107380|157178449|FG000|Overall Study|Ineligible|2|||
48818313|NCT04129528|157178462|FG000|Overall Study|Adverse Event|1|||
48818314|NCT04129528|157178463|FG001|Overall Study|Adverse Event|0|||
48818315|NCT04129528|157178462|FG000|Overall Study|Physician Decision|1|||
48818316|NCT04129528|157178463|FG001|Overall Study|Physician Decision|1|||
48818317|NCT04129528|157178462|FG000|Overall Study|Withdrawal by Subject|1|||
48818318|NCT04129528|157178463|FG001|Overall Study|Withdrawal by Subject|1|||
48818319|NCT01489020|157178464|FG000|Overall Study|Withdrawal by Subject|1|||
48818320|NCT01489020|157178465|FG001|Overall Study|Withdrawal by Subject|0|||
48503479|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
48503480|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
48818321|NCT01489020|157178466|FG002|Overall Study|Withdrawal by Subject|0|||
48503481|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
48503482|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
48818322|NCT01489020|157178467|FG003|Overall Study|Withdrawal by Subject|0|||
48818323|NCT01489020|157178468|FG004|Overall Study|Withdrawal by Subject|0|||
48818324|NCT01489020|157178469|FG005|Overall Study|Withdrawal by Subject|0|||
48818325|NCT01489020|157178464|FG000|Overall Study|Adverse Event|0|||
48818326|NCT01489020|157178465|FG001|Overall Study|Adverse Event|0|||
48818327|NCT01489020|157178466|FG002|Overall Study|Adverse Event|3|||
48818328|NCT01489020|157178467|FG003|Overall Study|Adverse Event|0|||
48818329|NCT01489020|157178468|FG004|Overall Study|Adverse Event|3|||
48818330|NCT01489020|157178469|FG005|Overall Study|Adverse Event|0|||
48818331|NCT01489020|157178464|FG000|Overall Study|Concomitant disease|0|||
48818332|NCT01489020|157178465|FG001|Overall Study|Concomitant disease|0|||
48818333|NCT01489020|157178466|FG002|Overall Study|Concomitant disease|0|||
48503483|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
48503484|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
48503485|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
48503486|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
48503487|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
48503488|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
48503489|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
48503490|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
48503491|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
48503492|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
48503493|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
48503494|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
48503495|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
48503496|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
48503497|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
48503498|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
48818334|NCT01489020|157178467|FG003|Overall Study|Concomitant disease|0|||
48818335|NCT01489020|157178468|FG004|Overall Study|Concomitant disease|3|||
48818336|NCT01489020|157178469|FG005|Overall Study|Concomitant disease|0|||
48503499|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
48503500|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48503501|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48503502|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48599921|NCT03428100|156391511|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
48599922|NCT03428100|156391512|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
48818337|NCT01781611|157178475|FG000|Overall Study|Adverse Event|4|||
48818338|NCT01781611|157178476|FG001|Overall Study|Adverse Event|0|||
48818339|NCT04905290|157178477|FG000|Overall Study|Adverse Event|4|||
48818340|NCT04905290|157178477|FG000|Overall Study|Death|2|||
48818341|NCT04905290|157178477|FG000|Overall Study|Withdrawal by Subject|4|||
48818342|NCT04905290|157178477|FG000|Overall Study|Physician Decision|2|||
48818343|NCT04905290|157178477|FG000|Overall Study|Lost to Follow-up|2|||
48503503|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48503504|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48599923|NCT03428100|156391513|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
48818344|NCT04905290|157178477|FG000|Overall Study|Screen Failure|2|||
48818345|NCT04905290|157178477|FG000|Overall Study|Unsuccessful Procedure|2|||
48818346|NCT00179010|157178480|FG000|Overall Study|Muscle probe defective|1|||
48503505|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
48503506|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48503507|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
48503508|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48503509|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48503510|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48503511|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
48503512|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503513|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503514|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503515|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503516|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503517|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
48503518|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503519|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
48503520|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
48503521|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503522|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503523|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
48503524|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
48503525|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
48503526|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
48503527|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
48503528|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
48503529|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
48503530|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
48503531|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
48503532|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
48503533|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
48503534|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
48503535|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
48503536|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503537|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503538|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503539|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503540|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503541|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
48503542|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503543|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503544|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503545|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503546|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503547|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
48503548|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503549|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503550|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503551|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503552|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503553|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503554|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
48503555|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503556|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503557|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48584940|NCT00743288|156333717|FG003|Overall Study|Withdrawal by Subject|0|||
48723862|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723863|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723864|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723865|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723866|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723867|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
48723868|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723869|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723870|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723871|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723872|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
48723873|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
48723874|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723875|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48503558|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503559|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
48503560|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503561|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503562|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503563|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503564|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503565|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503566|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
48503567|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503568|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503569|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503570|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503571|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
48503572|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503573|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503574|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503575|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503576|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503577|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
48503578|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503579|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503580|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503581|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503582|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503583|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
48503584|NCT03536884|156040099|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503585|NCT03536884|156040100|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503586|NCT03536884|156040101|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503587|NCT03536884|156040102|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503588|NCT03536884|156040103|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503589|NCT03536884|156040104|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503590|NCT03536884|156040105|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503591|NCT03536884|156040106|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503592|NCT03536884|156040107|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
48503593|NCT03536884|156040108|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503594|NCT03536884|156040109|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503595|NCT03536884|156040110|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
48503596|NCT03536884|156040099|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503597|NCT03536884|156040100|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503598|NCT03536884|156040101|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503599|NCT03536884|156040102|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503600|NCT03536884|156040103|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503601|NCT03536884|156040104|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503602|NCT03536884|156040105|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503603|NCT03536884|156040106|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503604|NCT03536884|156040107|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48503605|NCT03536884|156040108|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
48503606|NCT03536884|156040109|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
48503607|NCT03536884|156040110|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
48503608|NCT03536884|156040099|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48503609|NCT03536884|156040100|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48503610|NCT03536884|156040101|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48503611|NCT03536884|156040102|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48503612|NCT03536884|156040103|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48503613|NCT03536884|156040104|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48503614|NCT03536884|156040105|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48503615|NCT03536884|156040106|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48503616|NCT03536884|156040107|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48599924|NCT03428100|156391514|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
48599925|NCT03428100|156391515|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
48503617|NCT03536884|156040108|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
48503618|NCT03536884|156040109|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
48503619|NCT03536884|156040110|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
48599926|NCT03428100|156391516|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
48599927|NCT03428100|156391517|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
48503620|NCT03536884|156040099|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503621|NCT03536884|156040100|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503622|NCT03536884|156040101|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503623|NCT03536884|156040102|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503624|NCT03536884|156040103|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503625|NCT03536884|156040104|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503626|NCT03536884|156040105|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503627|NCT03536884|156040106|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503628|NCT03536884|156040107|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503629|NCT03536884|156040108|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503630|NCT03536884|156040109|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
48503631|NCT03536884|156040110|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
48503632|NCT03536884|156040099|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503633|NCT03536884|156040100|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503634|NCT03536884|156040101|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503635|NCT03536884|156040102|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503636|NCT03536884|156040103|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503637|NCT03536884|156040104|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503638|NCT03536884|156040105|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503639|NCT03536884|156040106|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503640|NCT03536884|156040107|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503641|NCT03536884|156040108|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503642|NCT03536884|156040109|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
48503643|NCT03536884|156040110|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
48503644|NCT03536884|156040099|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503645|NCT03536884|156040100|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503646|NCT03536884|156040101|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503647|NCT03536884|156040102|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503648|NCT03536884|156040103|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503649|NCT03536884|156040104|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503650|NCT03536884|156040105|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503651|NCT03536884|156040106|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503652|NCT03536884|156040107|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503653|NCT03536884|156040108|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48723876|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723877|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723878|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723879|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723880|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
48723881|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723882|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723883|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723884|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723885|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
48723886|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
48723887|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723888|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723889|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723890|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723891|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723892|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723893|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
48723894|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723895|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723896|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723897|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
48723898|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
48723899|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
48723900|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723901|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723902|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723903|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723904|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723905|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723906|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
48723907|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723908|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723909|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723910|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723911|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48818347|NCT00179010|157178481|FG001|Overall Study|Muscle probe defective|1|||
48818348|NCT00179010|157178480|FG000|Overall Study|Failure to place arterial line|0|||
48818349|NCT00179010|157178481|FG001|Overall Study|Failure to place arterial line|1|||
48818350|NCT00178256|157178485|FG000|Overall Study|Adverse Event|2|||
48818351|NCT00178256|157178486|FG001|Overall Study|Adverse Event|0|||
48818352|NCT00178256|157178487|FG002|Overall Study|Adverse Event|0|||
48818353|NCT00178256|157178488|FG003|Overall Study|Adverse Event|0|||
48818354|NCT00178256|157178485|FG000|Overall Study|Death|0|||
48818355|NCT00178256|157178486|FG001|Overall Study|Death|1|||
48818356|NCT00178256|157178487|FG002|Overall Study|Death|0|||
48818357|NCT00178256|157178488|FG003|Overall Study|Death|1|||
48818358|NCT00178256|157178485|FG000|Overall Study|Cancer progression|2|||
48818359|NCT00178256|157178486|FG001|Overall Study|Cancer progression|0|||
48818360|NCT00178256|157178487|FG002|Overall Study|Cancer progression|0|||
48503654|NCT03536884|156040109|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
48503655|NCT03536884|156040110|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
48503656|NCT00385684|156040111|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
48503657|NCT00385684|156040112|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
48503658|NCT00385684|156040111|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
48503659|NCT00385684|156040112|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
48503660|NCT00385684|156040111|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
48503661|NCT00385684|156040112|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
48503662|NCT03616106|156040113|FG000|Overall Study|Removed by PI|6|||
48503663|NCT03616106|156040114|FG001|Overall Study|Removed by PI|0|||
48503664|NCT03616106|156040113|FG000|Overall Study|Withdrawal by Subject|1|||
48503665|NCT03616106|156040114|FG001|Overall Study|Withdrawal by Subject|1|||
48503666|NCT03616106|156040113|FG000|Overall Study|Lost to Follow-up|7|||
48503667|NCT03616106|156040114|FG001|Overall Study|Lost to Follow-up|0|||
48503668|NCT00939003|156040118|FG000|Double-blind Treatment Period|Adverse Event|1|||
48503669|NCT00939003|156040119|FG001|Double-blind Treatment Period|Adverse Event|1|||
48503670|NCT00939003|156040118|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
48503671|NCT00939003|156040119|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
48503672|NCT00939003|156040118|FG000|Double-blind Treatment Period|Pregnancy|0|||
48503673|NCT00939003|156040119|FG001|Double-blind Treatment Period|Pregnancy|1|||
48503674|NCT00939003|156040118|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
48503675|NCT00939003|156040119|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
48503676|NCT00939003|156040118|FG000|Open-label Treatment Period|Adverse Event|4|||
48503677|NCT00939003|156040119|FG001|Open-label Treatment Period|Adverse Event|8|||
48503678|NCT00939003|156040118|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
48503679|NCT00939003|156040119|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
48503680|NCT00939003|156040118|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
48503681|NCT00939003|156040119|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
48503682|NCT00939003|156040118|FG000|Open-label Treatment Period|Pregnancy|1|||
48503683|NCT00939003|156040119|FG001|Open-label Treatment Period|Pregnancy|1|||
48503684|NCT00939003|156040118|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
48503685|NCT00939003|156040119|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
48503686|NCT00939003|156040118|FG000|Open-label Treatment Period|Site Closure|3|||
48503687|NCT00939003|156040119|FG001|Open-label Treatment Period|Site Closure|4|||
48503688|NCT02865122|156040120|FG000|Overall Study|Adverse Event|1|||
48503689|NCT02865122|156040121|FG001|Overall Study|Adverse Event|0|||
48503690|NCT02865122|156040122|FG002|Overall Study|Adverse Event|0|||
48503691|NCT01651000|156040123|FG000|Overall Study|Adverse Event|2|||
48503692|NCT01651000|156040124|FG001|Overall Study|Adverse Event|8|||
48503693|NCT01651000|156040123|FG000|Overall Study|Lost to Follow-up|3|||
48503694|NCT01651000|156040124|FG001|Overall Study|Lost to Follow-up|2|||
48503695|NCT01651000|156040123|FG000|Overall Study|Protocol Violation|0|||
48503696|NCT01651000|156040124|FG001|Overall Study|Protocol Violation|3|||
48503697|NCT01651000|156040123|FG000|Overall Study|Withdrawal by Subject|2|||
48503698|NCT01651000|156040124|FG001|Overall Study|Withdrawal by Subject|10|||
48503699|NCT01651000|156040123|FG000|Overall Study|Subject noncompliance|0|||
48503700|NCT01651000|156040124|FG001|Overall Study|Subject noncompliance|3|||
48503701|NCT01651000|156040123|FG000|Overall Study|Lack of Efficacy|1|||
48503702|NCT01651000|156040124|FG001|Overall Study|Lack of Efficacy|1|||
48503703|NCT01651000|156040123|FG000|Overall Study|Physician Decision|1|||
48723912|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
48723913|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48503704|NCT01651000|156040124|FG001|Overall Study|Physician Decision|0|||
48503705|NCT01651000|156040123|FG000|Overall Study|Administrative reason|1|||
48503706|NCT01651000|156040124|FG001|Overall Study|Administrative reason|0|||
48503707|NCT01651000|156040123|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
48503708|NCT01651000|156040124|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
48503709|NCT04439539|156041272|FG000|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|1|||
48503710|NCT04439539|156041273|FG001|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|0|||
48723914|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723915|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723916|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723917|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723918|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723919|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
48723920|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723921|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723922|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723923|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
48818361|NCT00178256|157178488|FG003|Overall Study|Cancer progression|1|||
48503711|NCT04439539|156041274|FG002|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|2|||
48503712|NCT04439539|156041272|FG000|Follow-up (FU): FU Week 0 to 48|Ongoing|0|||
48503713|NCT04439539|156041273|FG001|Follow-up (FU): FU Week 0 to 48|Ongoing|5|||
48503714|NCT04439539|156041274|FG002|Follow-up (FU): FU Week 0 to 48|Ongoing|17|||
48503715|NCT04439539|156041272|FG000|Follow-up (FU): FU Week 0 to 48|Other|0|||
48503716|NCT04439539|156041273|FG001|Follow-up (FU): FU Week 0 to 48|Other|1|||
48503717|NCT04439539|156041274|FG002|Follow-up (FU): FU Week 0 to 48|Other|0|||
48503718|NCT01691508|156041275|FG000|Overall Study|Adverse Event|3|||
48503719|NCT01691508|156041276|FG001|Overall Study|Adverse Event|3|||
48503720|NCT01691508|156041275|FG000|Overall Study|Withdrawal by Subject|1|||
48503721|NCT01691508|156041276|FG001|Overall Study|Withdrawal by Subject|0|||
48503722|NCT02127281|156041277|FG000|Overall Study|Lost to Follow-up|1|||
48503723|NCT02127281|156041278|FG001|Overall Study|Lost to Follow-up|0|||
48503724|NCT04885296|156041279|FG000|Period 1|Covid-19 Related|1|||
48503725|NCT04885296|156041280|FG001|Period 1|Covid-19 Related|0|||
48503726|NCT04885296|156041279|FG000|Period 1|Adverse Event|0|||
48503727|NCT04885296|156041280|FG001|Period 1|Adverse Event|1|||
48503728|NCT04885296|156041279|FG000|Period 1|Withdrawal by Subject|1|||
48503729|NCT04885296|156041280|FG001|Period 1|Withdrawal by Subject|1|||
48503730|NCT04885296|156041279|FG000|Period 1|Test Article No Longer Available|1|||
48503731|NCT04885296|156041280|FG001|Period 1|Test Article No Longer Available|0|||
48503732|NCT04885296|156041279|FG000|Period 1|Dispensed Study lens in Error|1|||
48503733|NCT04885296|156041280|FG001|Period 1|Dispensed Study lens in Error|0|||
48503734|NCT04885296|156041279|FG000|Period 1|Lost to Follow-up|1|||
48503735|NCT04885296|156041280|FG001|Period 1|Lost to Follow-up|0|||
48503736|NCT04885296|156041279|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
48503737|NCT04885296|156041280|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
48503738|NCT00862979|156041281|FG000|Overall Study|Adverse Event|6|||
48503739|NCT00862979|156041282|FG001|Overall Study|Adverse Event|3|||
48503740|NCT00862979|156041281|FG000|Overall Study|Protocol Violation|0|||
48503741|NCT00862979|156041282|FG001|Overall Study|Protocol Violation|1|||
48503742|NCT00862979|156041281|FG000|Overall Study|Patient withdrew consent|2|||
48503743|NCT00862979|156041282|FG001|Overall Study|Patient withdrew consent|1|||
48503744|NCT00862979|156041281|FG000|Overall Study|Administrative problems|0|||
48503745|NCT00862979|156041282|FG001|Overall Study|Administrative problems|1|||
48503746|NCT00862979|156041281|FG000|Overall Study|Death|0|||
48503747|NCT00862979|156041282|FG001|Overall Study|Death|1|||
48503748|NCT03100903|156041285|FG000|Overall Study|Withdrawal by Subject|0|||
48503749|NCT03100903|156041286|FG001|Overall Study|Withdrawal by Subject|0|||
48503750|NCT03100903|156041287|FG002|Overall Study|Withdrawal by Subject|1|||
48503751|NCT02189941|156041288|FG000|Overall Study|Non-compliance|0|||
48503752|NCT02189941|156041289|FG001|Overall Study|Non-compliance|0|||
48503753|NCT02189941|156041290|FG002|Overall Study|Non-compliance|1|||
48503754|NCT05551637|156041291|FG000|Overall Study|Lack of Efficacy|0|||
48503755|NCT05551637|156041292|FG001|Overall Study|Lack of Efficacy|6|||
48503756|NCT05551637|156041291|FG000|Overall Study|Lost to Follow-up|1|||
48503757|NCT05551637|156041292|FG001|Overall Study|Lost to Follow-up|1|||
48723924|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
48503758|NCT01682083|156041293|FG000|Overall Study|Lost to Follow-up|11|||
48503759|NCT01682083|156041294|FG001|Overall Study|Lost to Follow-up|18|||
48503760|NCT01682083|156041293|FG000|Overall Study|Withdrawal by Subject|31|||
48503761|NCT01682083|156041294|FG001|Overall Study|Withdrawal by Subject|40|||
48503762|NCT01682083|156041293|FG000|Overall Study|Death|60|||
48503763|NCT01682083|156041294|FG001|Overall Study|Death|93|||
48503764|NCT01682083|156041293|FG000|Overall Study|Physician Decision|5|||
48503765|NCT01682083|156041294|FG001|Overall Study|Physician Decision|4|||
48503766|NCT03817983|156041295|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
48503767|NCT03817983|156041296|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
48818362|NCT04102540|157178491|FG000|Overall Study|Withdrawn by PI|2|||
48818363|NCT04102540|157178491|FG000|Overall Study|Lost to Follow-up|6|||
48818364|NCT04467840|157178492|FG000|Overall Study|Death|35|||
48818365|NCT04467840|157178493|FG001|Overall Study|Death|39|||
48818366|NCT04467840|157178492|FG000|Overall Study|Withdrawal by Subject|8|||
48818367|NCT04467840|157178493|FG001|Overall Study|Withdrawal by Subject|4|||
48818368|NCT04467840|157178492|FG000|Overall Study|Adverse Event|2|||
48818369|NCT04467840|157178493|FG001|Overall Study|Adverse Event|0|||
48818370|NCT04467840|157178492|FG000|Overall Study|Lost to Follow-up|1|||
48818371|NCT04467840|157178493|FG001|Overall Study|Lost to Follow-up|3|||
48818372|NCT04467840|157178492|FG000|Overall Study|Physician Decision|1|||
48818373|NCT04467840|157178493|FG001|Overall Study|Physician Decision|0|||
48818374|NCT04467840|157178492|FG000|Overall Study|Other|1|||
48818375|NCT04467840|157178493|FG001|Overall Study|Other|5|||
48818376|NCT04467840|157178492|FG000|Overall Study|Missing study completion status|3|||
48818377|NCT04467840|157178493|FG001|Overall Study|Missing study completion status|1|||
48818378|NCT00280293|157178494|FG000|Overall Study|Protocol Violation|3|||
48818379|NCT00280293|157178495|FG001|Overall Study|Protocol Violation|0|||
48818380|NCT00280293|157178494|FG000|Overall Study|Physician Decision|5|||
48818381|NCT00280293|157178495|FG001|Overall Study|Physician Decision|4|||
48503768|NCT03817983|156041297|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
48503769|NCT03497897|156041298|FG000|Overall Study|Adverse Event|1|||
48503770|NCT03497897|156041299|FG001|Overall Study|Adverse Event|1|||
48503771|NCT03497897|156041300|FG002|Overall Study|Adverse Event|1|||
48503772|NCT03497897|156041298|FG000|Overall Study|Lost to Follow-up|2|||
48503773|NCT03497897|156041299|FG001|Overall Study|Lost to Follow-up|0|||
48503774|NCT03497897|156041300|FG002|Overall Study|Lost to Follow-up|2|||
48503775|NCT03497897|156041298|FG000|Overall Study|Physician Decision|1|||
48503776|NCT03497897|156041299|FG001|Overall Study|Physician Decision|0|||
48503777|NCT03497897|156041300|FG002|Overall Study|Physician Decision|0|||
48503778|NCT03497897|156041298|FG000|Overall Study|Subject/Guardian Decision|2|||
48503779|NCT03497897|156041299|FG001|Overall Study|Subject/Guardian Decision|1|||
48503780|NCT03497897|156041300|FG002|Overall Study|Subject/Guardian Decision|3|||
48503781|NCT00528606|156041309|FG000|Overall Study|Withdrew consent|4|||
48503782|NCT00528606|156041310|FG001|Overall Study|Withdrew consent|3|||
48503783|NCT00528606|156041309|FG000|Overall Study|Lost to Follow-up|4|||
48503784|NCT00528606|156041310|FG001|Overall Study|Lost to Follow-up|1|||
48503785|NCT00528606|156041309|FG000|Overall Study|Adverse Event|3|||
48503786|NCT00528606|156041310|FG001|Overall Study|Adverse Event|0|||
48503787|NCT00528606|156041309|FG000|Overall Study|Other|2|||
48503788|NCT00528606|156041310|FG001|Overall Study|Other|0|||
48503789|NCT02475954|156041311|FG000|Overall Study|Withdrawal by Subject|2|||
48503790|NCT02475954|156041312|FG001|Overall Study|Withdrawal by Subject|2|||
48503791|NCT02475954|156041311|FG000|Overall Study|Lost to Follow-up|11|||
48503792|NCT02475954|156041312|FG001|Overall Study|Lost to Follow-up|9|||
48503793|NCT02475954|156041311|FG000|Overall Study|Death|1|||
48503794|NCT02475954|156041312|FG001|Overall Study|Death|1|||
48503795|NCT01993030|156041315|FG000|Overall Study|Adverse Event|0|||
48503796|NCT01993030|156041316|FG001|Overall Study|Adverse Event|4|||
48503797|NCT01710657|156041317|FG000|Overall Study|Lost to Follow-up|2|||
48503798|NCT01710657|156041318|FG001|Overall Study|Lost to Follow-up|0|||
48503799|NCT01710657|156041319|FG002|Overall Study|Lost to Follow-up|1|||
48503800|NCT01710657|156041317|FG000|Overall Study|Protocol Violation|2|||
48818382|NCT00280293|157178494|FG000|Overall Study|Lost to Follow-up|14|||
48818383|NCT00280293|157178495|FG001|Overall Study|Lost to Follow-up|12|||
48818384|NCT00280293|157178494|FG000|Overall Study|Withdrawal by Subject|3|||
48503801|NCT01710657|156041318|FG001|Overall Study|Protocol Violation|2|||
48818385|NCT00280293|157178495|FG001|Overall Study|Withdrawal by Subject|5|||
48818386|NCT00280293|157178494|FG000|Overall Study|Incarceration/Legal Reasons|1|||
48818387|NCT00280293|157178495|FG001|Overall Study|Incarceration/Legal Reasons|1|||
48818388|NCT00280293|157178494|FG000|Overall Study|Adverse Event|0|||
48818389|NCT00280293|157178495|FG001|Overall Study|Adverse Event|1|||
48818390|NCT01720797|157178498|FG000|Overall Study|Withdrawal by Subject|3|||
48503802|NCT01710657|156041319|FG002|Overall Study|Protocol Violation|0|||
48503803|NCT01710657|156041317|FG000|Overall Study|Adverse Event|14|||
48503804|NCT01710657|156041318|FG001|Overall Study|Adverse Event|8|||
48818391|NCT01720797|157178499|FG001|Overall Study|Withdrawal by Subject|0|||
48818392|NCT01880554|157178506|FG000|Overall Study|Protocol Violation|14|||
48818393|NCT01880554|157178506|FG000|Overall Study|Simon's design requirements|2|||
48818394|NCT04227340|157178507|FG000|Overall Study|Withdrawal by Subject|3|||
48818395|NCT00570661|157178508|FG000|Overall Study|Disease worsening|5|||
48503805|NCT01710657|156041319|FG002|Overall Study|Adverse Event|28|||
48503806|NCT01710657|156041317|FG000|Overall Study|Withdrawal by Subject|0|||
48503807|NCT01710657|156041318|FG001|Overall Study|Withdrawal by Subject|1|||
48503808|NCT01710657|156041319|FG002|Overall Study|Withdrawal by Subject|2|||
48503809|NCT01710657|156041317|FG000|Overall Study|Lack of Efficacy|0|||
48503810|NCT01710657|156041318|FG001|Overall Study|Lack of Efficacy|1|||
48503811|NCT01710657|156041319|FG002|Overall Study|Lack of Efficacy|1|||
48503812|NCT00620022|156041320|FG000|Treatment Period 1|Adverse Event|4|||
48503813|NCT00620022|156041321|FG001|Treatment Period 1|Adverse Event|6|||
48723925|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
48723926|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723927|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723928|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723929|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723930|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723931|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723932|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
48723933|NCT01261312|156840401|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723934|NCT01261312|156840402|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723935|NCT01261312|156840403|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723936|NCT01261312|156840404|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
48723937|NCT01261312|156840405|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
48723938|NCT01261312|156840406|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
48723939|NCT01261312|156840407|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723940|NCT01261312|156840408|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723941|NCT01261312|156840409|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723942|NCT01261312|156840410|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723943|NCT01261312|156840411|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723944|NCT01261312|156840412|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723945|NCT01261312|156840413|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
48723946|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723947|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723948|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723949|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723950|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723951|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723952|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
48723953|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
48723954|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
48723955|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723956|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723957|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723958|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
48723959|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723960|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723961|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723962|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723963|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723964|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723965|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723966|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
48723967|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
48723968|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723969|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723970|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48723971|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
48818396|NCT00570661|157178508|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
48503814|NCT00620022|156041320|FG000|Treatment Period 1|Subject withdrew consent|1|||
48503815|NCT00620022|156041321|FG001|Treatment Period 1|Subject withdrew consent|0|||
48503816|NCT00620022|156041320|FG000|Treatment Period 2|Adverse Event|2|||
48503817|NCT00620022|156041321|FG001|Treatment Period 2|Adverse Event|2|||
48503818|NCT03340727|156041324|FG000|Overall Study|Death|1|||
48503819|NCT03340727|156041325|FG001|Overall Study|Death|0|||
48503820|NCT03340727|156041324|FG000|Overall Study|Lost to Follow-up|31|||
48503821|NCT03340727|156041325|FG001|Overall Study|Lost to Follow-up|35|||
48503822|NCT03340727|156041324|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
48503823|NCT03340727|156041325|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
48503824|NCT03340727|156041324|FG000|Overall Study|Transferred to another facility|10|||
48503825|NCT03340727|156041325|FG001|Overall Study|Transferred to another facility|7|||
48503826|NCT03340727|156041324|FG000|Overall Study|Withdrawal by Subject|28|||
48503827|NCT03340727|156041325|FG001|Overall Study|Withdrawal by Subject|17|||
48503828|NCT01035060|156041326|FG000|Overall Study|Lost to Follow-up|0|||
48503829|NCT01035060|156041327|FG001|Overall Study|Lost to Follow-up|7|||
48503830|NCT01035060|156041326|FG000|Overall Study|Did not quality after 2nd screening|14|||
48503831|NCT01035060|156041327|FG001|Overall Study|Did not quality after 2nd screening|1|||
48503832|NCT01035060|156041326|FG000|Overall Study|Withdrawal by Subject|8|||
48503833|NCT01035060|156041327|FG001|Overall Study|Withdrawal by Subject|6|||
48723972|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48503834|NCT01035060|156041326|FG000|Overall Study|Physician Decision|2|||
48818397|NCT00570661|157178508|FG000|Overall Study|Adverse Event|1|||
48818398|NCT01076088|157178511|FG000|Overall Study|Adverse Event|1|||
48818399|NCT01076088|157178512|FG001|Overall Study|Adverse Event|6|||
48818400|NCT01076088|157178513|FG002|Overall Study|Adverse Event|3|||
48818401|NCT01076088|157178514|FG003|Overall Study|Adverse Event|2|||
48818402|NCT01076088|157178515|FG004|Overall Study|Adverse Event|3|||
48818403|NCT01076088|157178516|FG005|Overall Study|Adverse Event|3|||
48818404|NCT01076088|157178511|FG000|Overall Study|Lost to Follow-up|1|||
48818405|NCT01076088|157178512|FG001|Overall Study|Lost to Follow-up|1|||
48818406|NCT01076088|157178513|FG002|Overall Study|Lost to Follow-up|0|||
48818407|NCT01076088|157178514|FG003|Overall Study|Lost to Follow-up|1|||
48818408|NCT01076088|157178515|FG004|Overall Study|Lost to Follow-up|1|||
48818409|NCT01076088|157178516|FG005|Overall Study|Lost to Follow-up|2|||
48818410|NCT01076088|157178511|FG000|Overall Study|Non-compliance with study drug|0|||
48818411|NCT01076088|157178512|FG001|Overall Study|Non-compliance with study drug|0|||
48818412|NCT01076088|157178513|FG002|Overall Study|Non-compliance with study drug|0|||
48818413|NCT01076088|157178514|FG003|Overall Study|Non-compliance with study drug|1|||
48818414|NCT01076088|157178515|FG004|Overall Study|Non-compliance with study drug|0|||
48818415|NCT01076088|157178516|FG005|Overall Study|Non-compliance with study drug|0|||
48818416|NCT01076088|157178511|FG000|Overall Study|Physician Decision|1|||
48818417|NCT01076088|157178512|FG001|Overall Study|Physician Decision|3|||
48818418|NCT01076088|157178513|FG002|Overall Study|Physician Decision|0|||
48818419|NCT01076088|157178514|FG003|Overall Study|Physician Decision|1|||
48818420|NCT01076088|157178515|FG004|Overall Study|Physician Decision|1|||
48818421|NCT01076088|157178516|FG005|Overall Study|Physician Decision|0|||
48818422|NCT01076088|157178511|FG000|Overall Study|Withdrawal by Subject|8|||
48818423|NCT01076088|157178512|FG001|Overall Study|Withdrawal by Subject|8|||
48818424|NCT01076088|157178513|FG002|Overall Study|Withdrawal by Subject|14|||
48818425|NCT01076088|157178514|FG003|Overall Study|Withdrawal by Subject|10|||
48818426|NCT01076088|157178515|FG004|Overall Study|Withdrawal by Subject|11|||
48818427|NCT01076088|157178516|FG005|Overall Study|Withdrawal by Subject|17|||
48818428|NCT01076088|157178511|FG000|Overall Study|Other protocol specified criteria|0|||
48818429|NCT01076088|157178512|FG001|Overall Study|Other protocol specified criteria|0|||
48818430|NCT01076088|157178513|FG002|Overall Study|Other protocol specified criteria|0|||
48818431|NCT01076088|157178514|FG003|Overall Study|Other protocol specified criteria|0|||
48818432|NCT01076088|157178515|FG004|Overall Study|Other protocol specified criteria|0|||
48818433|NCT01076088|157178516|FG005|Overall Study|Other protocol specified criteria|1|||
48818434|NCT03053492|157178517|FG000|Overall Study|Adverse Event|1|||
48818435|NCT03053492|157178518|FG001|Overall Study|Adverse Event|1|||
48818436|NCT03053492|157178517|FG000|Overall Study|Withdrawal by Subject|7|||
48818437|NCT03053492|157178518|FG001|Overall Study|Withdrawal by Subject|5|||
48818438|NCT04537949|157178523|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
48818439|NCT04537949|157178524|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
48818440|NCT04537949|157178525|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
48818441|NCT04537949|157178526|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
48818442|NCT04537949|157178527|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
48818443|NCT04537949|157178528|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
48818444|NCT04537949|157178529|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
48818445|NCT04537949|157178530|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
48818446|NCT04537949|157178523|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
48818447|NCT04537949|157178524|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
48818448|NCT04537949|157178525|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
48818449|NCT04537949|157178526|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
48818450|NCT04537949|157178527|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
48818451|NCT04537949|157178528|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
48818452|NCT04537949|157178529|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
48818453|NCT04537949|157178530|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
48818454|NCT04537949|157178523|FG000|Follow-up Phase|Lost to Follow-up|0|||
48723973|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723974|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723975|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723976|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723977|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723978|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
48723979|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
48723980|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
48503835|NCT01035060|156041327|FG001|Overall Study|Physician Decision|0|||
48723981|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48818455|NCT04537949|157178524|FG001|Follow-up Phase|Lost to Follow-up|3|||
48723982|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48818456|NCT04537949|157178525|FG002|Follow-up Phase|Lost to Follow-up|0|||
48818457|NCT04537949|157178526|FG003|Follow-up Phase|Lost to Follow-up|0|||
48818458|NCT04537949|157178527|FG004|Follow-up Phase|Lost to Follow-up|0|||
48818459|NCT04537949|157178528|FG005|Follow-up Phase|Lost to Follow-up|0|||
48818460|NCT04537949|157178529|FG006|Follow-up Phase|Lost to Follow-up|0|||
48818461|NCT04537949|157178530|FG007|Follow-up Phase|Lost to Follow-up|0|||
48818462|NCT04537949|157178523|FG000|Follow-up Phase|personal reasons|0|||
48818463|NCT04537949|157178524|FG001|Follow-up Phase|personal reasons|0|||
48818464|NCT04537949|157178525|FG002|Follow-up Phase|personal reasons|0|||
48818465|NCT04537949|157178526|FG003|Follow-up Phase|personal reasons|1|||
48818466|NCT04537949|157178527|FG004|Follow-up Phase|personal reasons|1|||
48818467|NCT04537949|157178528|FG005|Follow-up Phase|personal reasons|0|||
48818468|NCT04537949|157178529|FG006|Follow-up Phase|personal reasons|0|||
48818469|NCT04537949|157178530|FG007|Follow-up Phase|personal reasons|0|||
48503836|NCT01902173|156041330|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
48503837|NCT01902173|156041331|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
48503838|NCT01902173|156041332|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
48503839|NCT01902173|156041333|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
48503840|NCT01902173|156041334|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
48503841|NCT01902173|156041335|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
48503842|NCT01902173|156041330|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
48503843|NCT01902173|156041331|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
48818470|NCT04537949|157178523|FG000|Follow-up Phase|Withdrawal by Subject|0|||
48818471|NCT04537949|157178524|FG001|Follow-up Phase|Withdrawal by Subject|0|||
48818472|NCT04537949|157178525|FG002|Follow-up Phase|Withdrawal by Subject|0|||
48818473|NCT04537949|157178526|FG003|Follow-up Phase|Withdrawal by Subject|0|||
48818474|NCT04537949|157178527|FG004|Follow-up Phase|Withdrawal by Subject|1|||
48818475|NCT04537949|157178528|FG005|Follow-up Phase|Withdrawal by Subject|0|||
48818476|NCT04537949|157178529|FG006|Follow-up Phase|Withdrawal by Subject|0|||
48818477|NCT04537949|157178530|FG007|Follow-up Phase|Withdrawal by Subject|0|||
48818478|NCT00322374|157178531|FG000|Starting Dose|Physician Decision|2|||
48818479|NCT00322374|157178532|FG001|Starting Dose|Physician Decision|0|||
48818480|NCT00322374|157178533|FG002|Starting Dose|Physician Decision|0|||
48818481|NCT00322374|157178534|FG003|Starting Dose|Physician Decision|0|||
48818482|NCT00322374|157178531|FG000|Starting Dose|Study Drug Toxicity|4|||
48818483|NCT00322374|157178532|FG001|Starting Dose|Study Drug Toxicity|0|||
48818484|NCT00322374|157178533|FG002|Starting Dose|Study Drug Toxicity|0|||
48818485|NCT00322374|157178534|FG003|Starting Dose|Study Drug Toxicity|0|||
48818486|NCT00322374|157178531|FG000|First Escalation|Documented Disease Progression|0|||
48818487|NCT00322374|157178532|FG001|First Escalation|Documented Disease Progression|6|||
48818488|NCT00322374|157178533|FG002|First Escalation|Documented Disease Progression|0|||
48818489|NCT00322374|157178534|FG003|First Escalation|Documented Disease Progression|0|||
48818490|NCT00322374|157178531|FG000|First Escalation|Physician Decision|0|||
48818491|NCT00322374|157178532|FG001|First Escalation|Physician Decision|12|||
48818492|NCT00322374|157178533|FG002|First Escalation|Physician Decision|0|||
48818493|NCT00322374|157178534|FG003|First Escalation|Physician Decision|0|||
48818494|NCT00322374|157178531|FG000|First Escalation|Study Drug Toxicity|0|||
48818495|NCT00322374|157178532|FG001|First Escalation|Study Drug Toxicity|11|||
48818496|NCT00322374|157178533|FG002|First Escalation|Study Drug Toxicity|0|||
48818497|NCT00322374|157178534|FG003|First Escalation|Study Drug Toxicity|0|||
48818498|NCT00322374|157178531|FG000|First Escalation|Participant Request|0|||
48818499|NCT00322374|157178532|FG001|First Escalation|Participant Request|1|||
48818500|NCT00322374|157178533|FG002|First Escalation|Participant Request|0|||
48818501|NCT00322374|157178534|FG003|First Escalation|Participant Request|0|||
48818502|NCT00322374|157178531|FG000|Second Escalation|Physician Decision|0|||
48818503|NCT00322374|157178532|FG001|Second Escalation|Physician Decision|0|||
48818504|NCT00322374|157178533|FG002|Second Escalation|Physician Decision|5|||
48818505|NCT00322374|157178534|FG003|Second Escalation|Physician Decision|0|||
48818506|NCT00322374|157178531|FG000|Second Escalation|Study Drug Toxicity|0|||
48818507|NCT00322374|157178532|FG001|Second Escalation|Study Drug Toxicity|0|||
48818508|NCT00322374|157178533|FG002|Second Escalation|Study Drug Toxicity|1|||
48818509|NCT00322374|157178534|FG003|Second Escalation|Study Drug Toxicity|0|||
48818510|NCT00681187|157178537|FG000|Overall Study|Withdrawal by Subject|1|||
48818511|NCT00681187|157178538|FG001|Overall Study|Withdrawal by Subject|0|||
48818512|NCT00681187|157178537|FG000|Overall Study|Death|0|||
48818513|NCT00681187|157178538|FG001|Overall Study|Death|1|||
48818514|NCT00681187|157178537|FG000|Overall Study|Adverse Event|0|||
48818515|NCT00681187|157178538|FG001|Overall Study|Adverse Event|1|||
48818516|NCT01708187|157178539|FG000|Overall Study|Lost to Follow-up|0|||
48818517|NCT01708187|157178540|FG001|Overall Study|Lost to Follow-up|1|||
48818518|NCT02117544|157178541|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
48818519|NCT02117544|157178542|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
48818520|NCT01991197|157178543|FG000|Overall Study|Lost to Follow-up|1|||
48818521|NCT01991197|157178544|FG001|Overall Study|Lost to Follow-up|1|||
48818522|NCT01991197|157178543|FG000|Overall Study|Physician Decision|0|||
48818523|NCT01991197|157178544|FG001|Overall Study|Physician Decision|2|||
48818524|NCT01991197|157178543|FG000|Overall Study|Withdrawal by Subject|2|||
48818525|NCT01991197|157178544|FG001|Overall Study|Withdrawal by Subject|0|||
48818526|NCT03293485|157178545|FG000|Overall Study|Death|1|||
48818527|NCT03293485|157178545|FG000|Overall Study|Screen Failure|2|||
48818528|NCT03293485|157178545|FG000|Overall Study|Withdrawal by Subject|2|||
48818529|NCT01010217|157178546|FG000|Overall Study|Lost to Follow-up|4|||
48818530|NCT01010217|157178547|FG001|Overall Study|Lost to Follow-up|5|||
48818531|NCT01010217|157178548|FG002|Overall Study|Lost to Follow-up|1|||
48818532|NCT01010217|157178549|FG003|Overall Study|Lost to Follow-up|0|||
48818533|NCT01010217|157178550|FG004|Overall Study|Lost to Follow-up|0|||
48818534|NCT01010217|157178546|FG000|Overall Study|Withdrawal by Subject|1|||
48818535|NCT01010217|157178547|FG001|Overall Study|Withdrawal by Subject|0|||
48818536|NCT01010217|157178548|FG002|Overall Study|Withdrawal by Subject|0|||
48818537|NCT01010217|157178549|FG003|Overall Study|Withdrawal by Subject|0|||
48818538|NCT01010217|157178550|FG004|Overall Study|Withdrawal by Subject|0|||
48818539|NCT01010217|157178546|FG000|Overall Study|Physician Decision|0|||
48818540|NCT01010217|157178547|FG001|Overall Study|Physician Decision|0|||
48818541|NCT01010217|157178548|FG002|Overall Study|Physician Decision|0|||
48818542|NCT01010217|157178549|FG003|Overall Study|Physician Decision|6|||
48818543|NCT01010217|157178550|FG004|Overall Study|Physician Decision|3|||
48818544|NCT01767129|157178551|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
48818545|NCT01767129|157178552|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
48818546|NCT03785340|157178556|FG000|Overall Study|Lost to Follow-up|2|||
48818547|NCT03785340|157178557|FG001|Overall Study|Lost to Follow-up|0|||
48818548|NCT03785340|157178556|FG000|Overall Study|Adverse Event|1|||
48818549|NCT03785340|157178557|FG001|Overall Study|Adverse Event|0|||
48818550|NCT02274662|157178558|FG000|Overall Study|Death|1|||
48818551|NCT02274662|157178558|FG000|Overall Study|Lost to Follow-up|3|||
48818552|NCT05459688|157178561|FG000|Overall Study|Lost to Follow-up|6|||
48818553|NCT05459688|157178561|FG000|Overall Study|Physician Decision|1|||
48818554|NCT05459688|157178561|FG000|Overall Study|Withdrawal by Subject|19|||
48818555|NCT05459688|157178561|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
48818556|NCT04640571|157178562|FG000|Overall Study|Withdrawal by Subject|0|||
48818557|NCT04640571|157178563|FG001|Overall Study|Withdrawal by Subject|0|||
48818558|NCT04640571|157178564|FG002|Overall Study|Withdrawal by Subject|0|||
48818559|NCT04640571|157178565|FG003|Overall Study|Withdrawal by Subject|0|||
48818560|NCT04640571|157178566|FG004|Overall Study|Withdrawal by Subject|0|||
48818561|NCT04640571|157178567|FG005|Overall Study|Withdrawal by Subject|2|||
48818562|NCT02844465|157178573|FG000|Overall Study|Screen Failure|36|||
48818563|NCT02844465|157178573|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
48818564|NCT02844465|157178573|FG000|Overall Study|Withdrawal by Subject|5|||
48818565|NCT02844465|157178573|FG000|Overall Study|Lost to Follow-up|1|||
48818566|NCT02844465|157178573|FG000|Overall Study|Retreatment|1|||
48818567|NCT01828099|157178574|FG000|Treatment Period|Adverse Event|24|||
48818568|NCT01828099|157178575|FG001|Treatment Period|Adverse Event|23|||
48818569|NCT01828099|157178574|FG000|Treatment Period|Death|10|||
48818570|NCT01828099|157178575|FG001|Treatment Period|Death|12|||
48818571|NCT01828099|157178574|FG000|Treatment Period|Lost to Follow-up|2|||
48818572|NCT01828099|157178575|FG001|Treatment Period|Lost to Follow-up|1|||
48818573|NCT01828099|157178574|FG000|Treatment Period|Non-compliance with study treatment|1|||
48818574|NCT01828099|157178575|FG001|Treatment Period|Non-compliance with study treatment|0|||
48818575|NCT01828099|157178574|FG000|Treatment Period|Physician Decision|17|||
48818576|NCT01828099|157178575|FG001|Treatment Period|Physician Decision|16|||
48818577|NCT01828099|157178574|FG000|Treatment Period|Progressive disease|99|||
48818578|NCT01828099|157178575|FG001|Treatment Period|Progressive disease|107|||
48723983|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48818579|NCT01828099|157178574|FG000|Treatment Period|Subject/guardian decision|22|||
48818580|NCT01828099|157178575|FG001|Treatment Period|Subject/guardian decision|26|||
48818581|NCT01828099|157178574|FG000|Treatment Period|Study terminated by Sponsor|13|||
48818582|NCT01828099|157178575|FG001|Treatment Period|Study terminated by Sponsor|1|||
48818583|NCT01828099|157178574|FG000|Treatment Period|Protocol deviation|1|||
48818584|NCT01828099|157178575|FG001|Treatment Period|Protocol deviation|0|||
48818585|NCT01828099|157178574|FG000|Treatment Period|No longer requires treatment|0|||
48818586|NCT01828099|157178575|FG001|Treatment Period|No longer requires treatment|1|||
48723984|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
48723985|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
48723986|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
48723987|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
48723988|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
48723989|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
48723990|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
48723991|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
48723992|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
48818587|NCT01828099|157178574|FG000|Extension-treatment Phase|Adverse Event|0|||
48723993|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
48818588|NCT01828099|157178575|FG001|Extension-treatment Phase|Adverse Event|17|||
48723994|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
48723995|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
48723996|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
48818589|NCT01828099|157178574|FG000|Extension-treatment Phase|Death|0|||
48818590|NCT01828099|157178575|FG001|Extension-treatment Phase|Death|11|||
48818591|NCT01828099|157178574|FG000|Extension-treatment Phase|Physician Decision|0|||
48818592|NCT01828099|157178575|FG001|Extension-treatment Phase|Physician Decision|5|||
48818593|NCT01828099|157178574|FG000|Extension-treatment Phase|Progressive disease|0|||
48818594|NCT01828099|157178575|FG001|Extension-treatment Phase|Progressive disease|54|||
48818595|NCT01828099|157178574|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
48818596|NCT01828099|157178575|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
48818597|NCT01828099|157178574|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
48818598|NCT01828099|157178575|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
48818599|NCT05446870|157178576|FG000|Overall Study|Death|6|||
48818600|NCT05446870|157178577|FG001|Overall Study|Death|2|||
48818601|NCT05446870|157178576|FG000|Overall Study|Lost to Follow-up|0|||
48818602|NCT05446870|157178577|FG001|Overall Study|Lost to Follow-up|1|||
48818603|NCT05446870|157178576|FG000|Overall Study|Physician Decision|27|||
48818604|NCT05446870|157178577|FG001|Overall Study|Physician Decision|25|||
48818605|NCT05446870|157178576|FG000|Overall Study|Withdrawal by Subject|3|||
48503844|NCT01902173|156041332|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
48503845|NCT01902173|156041333|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
48503846|NCT01902173|156041334|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
48503847|NCT01902173|156041335|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
48503848|NCT01902173|156041330|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
48503849|NCT01902173|156041331|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
48503850|NCT01902173|156041332|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
48503851|NCT01902173|156041333|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
48503852|NCT01902173|156041334|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
48503853|NCT01902173|156041335|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
48503854|NCT01902173|156041330|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
48503855|NCT01902173|156041331|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
48503856|NCT01902173|156041332|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
48503857|NCT01902173|156041333|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
48503858|NCT01902173|156041334|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
48503859|NCT01902173|156041335|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
48503860|NCT01902173|156041330|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
48503861|NCT01902173|156041331|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
48503862|NCT01902173|156041332|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
48503863|NCT01902173|156041333|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
48503864|NCT01902173|156041334|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
48503865|NCT01902173|156041335|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
48503866|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
48503867|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
48503868|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
48503869|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
48503870|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
48503871|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
48503872|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
48503873|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
48503874|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
48503875|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
48503876|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
48503877|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
48503878|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
48503879|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
48503880|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
48503881|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
48503882|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
48503883|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
48503884|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
48503885|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
48503886|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
48503887|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
48503888|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
48503889|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
48818606|NCT05446870|157178577|FG001|Overall Study|Withdrawal by Subject|2|||
48818607|NCT05446870|157178576|FG000|Overall Study|Study Ongoing|37|||
48818608|NCT05446870|157178577|FG001|Overall Study|Study Ongoing|43|||
48503890|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
48503891|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
48818609|NCT03030261|157178580|FG000|Overall Study|Still receiving continuation therapy|5|||
48818610|NCT04793464|157178581|FG000|Overall Study|Lost to Follow-up|458|||
48503892|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
48723997|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
48723998|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48723999|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724000|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724001|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724002|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724003|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724004|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
48724005|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
48724006|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
48724007|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724008|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724009|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724010|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
48724011|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724012|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724013|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724014|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724015|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724016|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724017|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
48724018|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
48724019|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
48724020|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724021|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724022|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724023|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
48724024|NCT01261312|156840401|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724025|NCT01261312|156840402|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724026|NCT01261312|156840403|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724027|NCT01261312|156840404|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724028|NCT01261312|156840405|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724029|NCT01261312|156840406|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724030|NCT01261312|156840407|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
48724031|NCT01261312|156840408|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
48724032|NCT01261312|156840409|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
48724033|NCT01261312|156840410|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724034|NCT01261312|156840411|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724035|NCT01261312|156840412|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48724036|NCT01261312|156840413|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
48503893|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
48503894|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
48503895|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
48503896|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
48503897|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
48503898|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
48503899|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
48503900|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
48503901|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
48503902|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
48503903|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
48503904|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
48503905|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
48503906|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
48503907|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
48503908|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
48503909|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
48503910|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
48503911|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
48503912|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
48503913|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
48503914|NCT01902173|156041330|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
48503915|NCT01902173|156041331|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
48503916|NCT01902173|156041332|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
48599928|NCT03428100|156391518|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
48599929|NCT03428100|156391500|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
48599930|NCT03428100|156391501|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
48599931|NCT03428100|156391502|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
48599932|NCT03428100|156391503|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
48599933|NCT03428100|156391504|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
48599934|NCT03428100|156391505|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
48503917|NCT01902173|156041333|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
48818611|NCT04793464|157178582|FG001|Overall Study|Lost to Follow-up|168|||
48818612|NCT04793464|157178583|FG002|Overall Study|Lost to Follow-up|5|||
48818613|NCT04793464|157178581|FG000|Overall Study|Withdrawal by Subject|43|||
48818614|NCT04793464|157178582|FG001|Overall Study|Withdrawal by Subject|15|||
48503918|NCT01902173|156041334|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
48503919|NCT01902173|156041335|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
48503920|NCT00625443|156041341|FG000|Overall Study|Adverse Event|1|||
48503921|NCT00625443|156041342|FG001|Overall Study|Adverse Event|4|||
48503922|NCT00625443|156041343|FG002|Overall Study|Adverse Event|0|||
48503923|NCT00625443|156041341|FG000|Overall Study|Non-compliance with protocol|0|||
48503924|NCT00625443|156041342|FG001|Overall Study|Non-compliance with protocol|1|||
48503925|NCT00625443|156041343|FG002|Overall Study|Non-compliance with protocol|0|||
48503926|NCT00625443|156041341|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
48503927|NCT00625443|156041342|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
48503928|NCT00625443|156041343|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
48503929|NCT00625443|156041341|FG000|Overall Study|Withdrawal by Subject|0|||
48503930|NCT00625443|156041342|FG001|Overall Study|Withdrawal by Subject|1|||
48503931|NCT00625443|156041343|FG002|Overall Study|Withdrawal by Subject|2|||
48503932|NCT00625443|156041341|FG000|Overall Study|Physician Decision|0|||
48503933|NCT00625443|156041342|FG001|Overall Study|Physician Decision|4|||
48503934|NCT00625443|156041343|FG002|Overall Study|Physician Decision|2|||
48503935|NCT00625443|156041341|FG000|Overall Study|Other|0|||
48503936|NCT00625443|156041342|FG001|Overall Study|Other|1|||
48503937|NCT00625443|156041343|FG002|Overall Study|Other|1|||
48503938|NCT03883906|156041344|FG000|Overall Study|Withdrawal by Subject|2|||
48503939|NCT03883906|156041344|FG000|Overall Study|Physician Decision|5|||
48818615|NCT04793464|157178583|FG002|Overall Study|Withdrawal by Subject|0|||
48818616|NCT02234310|157178586|FG000|Overall Study|Physician Decision|1|||
48503940|NCT01185821|156041345|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48503941|NCT01185821|156041346|FG001|Overall Study|Abnormal laboratory value(s)|2|||
48503942|NCT01185821|156041347|FG002|Overall Study|Abnormal laboratory value(s)|1|||
48503943|NCT01185821|156041348|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48503944|NCT01185821|156041349|FG004|Overall Study|Abnormal laboratory value(s)|0|||
48503945|NCT01185821|156041345|FG000|Overall Study|Protocol Violation|0|||
48503946|NCT01185821|156041346|FG001|Overall Study|Protocol Violation|0|||
48503947|NCT01185821|156041347|FG002|Overall Study|Protocol Violation|0|||
48503948|NCT01185821|156041348|FG003|Overall Study|Protocol Violation|1|||
48503949|NCT01185821|156041349|FG004|Overall Study|Protocol Violation|1|||
48503950|NCT01185821|156041345|FG000|Overall Study|Abnormal test procedure result|0|||
48503951|NCT01185821|156041346|FG001|Overall Study|Abnormal test procedure result|0|||
48503952|NCT01185821|156041347|FG002|Overall Study|Abnormal test procedure result|0|||
48503953|NCT01185821|156041348|FG003|Overall Study|Abnormal test procedure result|0|||
48599935|NCT03428100|156391506|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
48599936|NCT03428100|156391507|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
48599937|NCT03428100|156391508|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
48599938|NCT03428100|156391509|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
48599939|NCT03428100|156391510|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
48599940|NCT03428100|156391511|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
48599941|NCT03428100|156391512|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
48818617|NCT02234310|157178586|FG000|Overall Study|Adverse Event|1|||
48818618|NCT02234310|157178586|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
48818619|NCT02234310|157178586|FG000|Overall Study|Withdrawal by Subject|2|||
48818620|NCT02487446|157178587|FG000|Period 1|Physician Decision|0|||
48503954|NCT01185821|156041349|FG004|Overall Study|Abnormal test procedure result|1|||
48503955|NCT01185821|156041345|FG000|Overall Study|Death|0|||
48503956|NCT01185821|156041346|FG001|Overall Study|Death|1|||
48503957|NCT01185821|156041347|FG002|Overall Study|Death|0|||
48818621|NCT02487446|157178588|FG001|Period 1|Physician Decision|1|||
48818622|NCT02487446|157178587|FG000|Period 1|Lack of Efficacy|1|||
48503958|NCT01185821|156041348|FG003|Overall Study|Death|0|||
48503959|NCT01185821|156041349|FG004|Overall Study|Death|0|||
48503960|NCT01185821|156041345|FG000|Overall Study|Condition no longer required study drug|0|||
48503961|NCT01185821|156041346|FG001|Overall Study|Condition no longer required study drug|0|||
48503962|NCT01185821|156041347|FG002|Overall Study|Condition no longer required study drug|0|||
48503963|NCT01185821|156041348|FG003|Overall Study|Condition no longer required study drug|0|||
48503964|NCT01185821|156041349|FG004|Overall Study|Condition no longer required study drug|1|||
48818623|NCT02487446|157178588|FG001|Period 1|Lack of Efficacy|0|||
48818624|NCT02487446|157178587|FG000|Period 1|Protocol deviation|3|||
48818625|NCT02487446|157178588|FG001|Period 1|Protocol deviation|2|||
48818626|NCT02487446|157178587|FG000|Period 1|Lost to Follow-up|2|||
48818627|NCT02487446|157178588|FG001|Period 1|Lost to Follow-up|0|||
48818628|NCT02487446|157178587|FG000|Period 1|Withdrawal by Subject|2|||
48818629|NCT02487446|157178588|FG001|Period 1|Withdrawal by Subject|0|||
48818630|NCT02487446|157178587|FG000|Period 1|Adverse Event|5|||
48818631|NCT02487446|157178588|FG001|Period 1|Adverse Event|5|||
48818632|NCT02487446|157178587|FG000|Washout|Lost to Follow-up|0|||
48818633|NCT02487446|157178588|FG001|Washout|Lost to Follow-up|2|||
48818634|NCT02487446|157178587|FG000|Washout|Withdrawal by Subject|1|||
48818635|NCT02487446|157178588|FG001|Washout|Withdrawal by Subject|4|||
48503965|NCT01185821|156041345|FG000|Overall Study|Adverse Event|2|||
48503966|NCT01185821|156041346|FG001|Overall Study|Adverse Event|3|||
48503967|NCT01185821|156041347|FG002|Overall Study|Adverse Event|1|||
48503968|NCT01185821|156041348|FG003|Overall Study|Adverse Event|2|||
48503969|NCT01185821|156041349|FG004|Overall Study|Adverse Event|5|||
48503970|NCT01185821|156041345|FG000|Overall Study|Lack of Efficacy|0|||
48818636|NCT02487446|157178587|FG000|Washout|Adverse Event|2|||
48818637|NCT02487446|157178588|FG001|Washout|Adverse Event|2|||
48818638|NCT02487446|157178587|FG000|Period 2|Protocol deviation|0|||
48818639|NCT02487446|157178588|FG001|Period 2|Protocol deviation|1|||
48818640|NCT02487446|157178587|FG000|Period 2|Lost to Follow-up|1|||
48818641|NCT02487446|157178588|FG001|Period 2|Lost to Follow-up|1|||
48818642|NCT02487446|157178587|FG000|Period 2|Withdrawal by Subject|1|||
48818643|NCT02487446|157178588|FG001|Period 2|Withdrawal by Subject|1|||
48818644|NCT02487446|157178587|FG000|Period 2|Adverse Event|6|||
48818645|NCT02487446|157178588|FG001|Period 2|Adverse Event|2|||
48818646|NCT00946647|157178589|FG000|Phase 1 Part|Adverse Event|2|||
48818647|NCT00946647|157178590|FG001|Phase 1 Part|Adverse Event|5|||
48818648|NCT00946647|157178591|FG002|Phase 1 Part|Adverse Event|3|||
48818649|NCT00946647|157178592|FG003|Phase 1 Part|Adverse Event|0|||
48818650|NCT00946647|157178593|FG004|Phase 1 Part|Adverse Event|0|||
48818651|NCT00946647|157178589|FG000|Phase 1 Part|Disease progression|3|||
48818652|NCT00946647|157178590|FG001|Phase 1 Part|Disease progression|6|||
48818653|NCT00946647|157178591|FG002|Phase 1 Part|Disease progression|1|||
48818654|NCT00946647|157178592|FG003|Phase 1 Part|Disease progression|0|||
48503971|NCT01185821|156041346|FG001|Overall Study|Lack of Efficacy|0|||
48503972|NCT01185821|156041347|FG002|Overall Study|Lack of Efficacy|3|||
48503973|NCT01185821|156041348|FG003|Overall Study|Lack of Efficacy|0|||
48503974|NCT01185821|156041349|FG004|Overall Study|Lack of Efficacy|9|||
48503975|NCT01185821|156041345|FG000|Overall Study|Withdrawal by Subject|3|||
48503976|NCT01185821|156041346|FG001|Overall Study|Withdrawal by Subject|2|||
48503977|NCT01185821|156041347|FG002|Overall Study|Withdrawal by Subject|2|||
48503978|NCT01185821|156041348|FG003|Overall Study|Withdrawal by Subject|1|||
48503979|NCT01185821|156041349|FG004|Overall Study|Withdrawal by Subject|3|||
48503980|NCT01185821|156041345|FG000|Overall Study|Lost to Follow-up|1|||
48503981|NCT01185821|156041346|FG001|Overall Study|Lost to Follow-up|1|||
48503982|NCT01185821|156041347|FG002|Overall Study|Lost to Follow-up|2|||
48503983|NCT01185821|156041348|FG003|Overall Study|Lost to Follow-up|1|||
48503984|NCT01185821|156041349|FG004|Overall Study|Lost to Follow-up|2|||
48503985|NCT01185821|156041345|FG000|Overall Study|Administrative problems|0|||
48503986|NCT01185821|156041346|FG001|Overall Study|Administrative problems|0|||
48503987|NCT01185821|156041347|FG002|Overall Study|Administrative problems|1|||
48503988|NCT01185821|156041348|FG003|Overall Study|Administrative problems|1|||
48503989|NCT01185821|156041349|FG004|Overall Study|Administrative problems|2|||
48818655|NCT00946647|157178593|FG004|Phase 1 Part|Disease progression|0|||
48818656|NCT00946647|157178589|FG000|Phase 1 Part|Withdrawal by Subject|1|||
48818657|NCT00946647|157178590|FG001|Phase 1 Part|Withdrawal by Subject|4|||
48818658|NCT00946647|157178591|FG002|Phase 1 Part|Withdrawal by Subject|3|||
48503990|NCT01126736|156041350|FG000|Overall Study|Death|2|||
48599942|NCT03428100|156391513|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
48599943|NCT03428100|156391514|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
48818659|NCT00946647|157178592|FG003|Phase 1 Part|Withdrawal by Subject|0|||
48818660|NCT00946647|157178593|FG004|Phase 1 Part|Withdrawal by Subject|0|||
48818661|NCT00946647|157178589|FG000|Phase 1 Part|Abnormal values|0|||
48818662|NCT00946647|157178590|FG001|Phase 1 Part|Abnormal values|2|||
48818663|NCT00946647|157178591|FG002|Phase 1 Part|Abnormal values|0|||
48503991|NCT01126736|156041351|FG001|Overall Study|Death|2|||
48503992|NCT01126736|156041352|FG002|Overall Study|Death|1|||
48503993|NCT01126736|156041353|FG003|Overall Study|Death|19|||
48818664|NCT00946647|157178592|FG003|Phase 1 Part|Abnormal values|0|||
48818665|NCT00946647|157178593|FG004|Phase 1 Part|Abnormal values|0|||
48818666|NCT00946647|157178589|FG000|Phase 1 Part|Reason missing|0|||
48818667|NCT00946647|157178590|FG001|Phase 1 Part|Reason missing|1|||
48818668|NCT00946647|157178591|FG002|Phase 1 Part|Reason missing|0|||
48503994|NCT01126736|156041354|FG004|Overall Study|Death|19|||
48503995|NCT01126736|156041350|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
48818669|NCT00946647|157178592|FG003|Phase 1 Part|Reason missing|0|||
48503996|NCT01126736|156041351|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
48503997|NCT01126736|156041352|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
48503998|NCT01126736|156041353|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
48503999|NCT01126736|156041354|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
48504000|NCT01126736|156041350|FG000|Overall Study|Lost to Follow-up|0|||
48504001|NCT01126736|156041351|FG001|Overall Study|Lost to Follow-up|0|||
48504002|NCT01126736|156041352|FG002|Overall Study|Lost to Follow-up|0|||
48504003|NCT01126736|156041353|FG003|Overall Study|Lost to Follow-up|1|||
48504004|NCT01126736|156041354|FG004|Overall Study|Lost to Follow-up|1|||
48504005|NCT01126736|156041350|FG000|Overall Study|Administrative reasons|0|||
48504006|NCT01126736|156041351|FG001|Overall Study|Administrative reasons|0|||
48504007|NCT01126736|156041352|FG002|Overall Study|Administrative reasons|0|||
48504008|NCT01126736|156041353|FG003|Overall Study|Administrative reasons|0|||
48504009|NCT01126736|156041354|FG004|Overall Study|Administrative reasons|1|||
48504010|NCT01126736|156041350|FG000|Overall Study|Progressive disease|0|||
48504011|NCT01126736|156041351|FG001|Overall Study|Progressive disease|0|||
48504012|NCT01126736|156041352|FG002|Overall Study|Progressive disease|0|||
48724037|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48818670|NCT00946647|157178593|FG004|Phase 1 Part|Reason missing|0|||
48818671|NCT00946647|157178589|FG000|Phase ll Part|Untreated|0|||
48818672|NCT00946647|157178590|FG001|Phase ll Part|Untreated|0|||
48818673|NCT00946647|157178591|FG002|Phase ll Part|Untreated|0|||
48818674|NCT00946647|157178592|FG003|Phase ll Part|Untreated|0|||
48818675|NCT00946647|157178593|FG004|Phase ll Part|Untreated|2|||
48504013|NCT01126736|156041353|FG003|Overall Study|Progressive disease|2|||
48504014|NCT01126736|156041354|FG004|Overall Study|Progressive disease|1|||
48504015|NCT01126736|156041350|FG000|Overall Study|Withdrawal by Subject|0|||
48504016|NCT01126736|156041351|FG001|Overall Study|Withdrawal by Subject|0|||
48504017|NCT01126736|156041352|FG002|Overall Study|Withdrawal by Subject|0|||
48504018|NCT01126736|156041353|FG003|Overall Study|Withdrawal by Subject|1|||
48504019|NCT01126736|156041354|FG004|Overall Study|Withdrawal by Subject|1|||
48504020|NCT01126736|156041350|FG000|Overall Study|Other|2|||
48504021|NCT01126736|156041351|FG001|Overall Study|Other|4|||
48504022|NCT01126736|156041352|FG002|Overall Study|Other|4|||
48818676|NCT00946647|157178589|FG000|Phase ll Part|Adverse Event|0|||
48818677|NCT00946647|157178590|FG001|Phase ll Part|Adverse Event|0|||
48504023|NCT01126736|156041353|FG003|Overall Study|Other|16|||
48724038|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724039|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724040|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724041|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724042|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724043|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724044|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724045|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
48724046|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
48724047|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
48724048|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
48724049|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
48724050|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724051|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724052|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724053|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724054|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724055|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724056|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724057|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724058|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48724059|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
48724060|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
48818678|NCT00946647|157178591|FG002|Phase ll Part|Adverse Event|0|||
48504024|NCT01126736|156041354|FG004|Overall Study|Other|15|||
48818679|NCT00946647|157178592|FG003|Phase ll Part|Adverse Event|10|||
48504025|NCT00389064|156041356|FG000|Overall Study|Adverse Event|11|||
48504026|NCT00389064|156041357|FG001|Overall Study|Adverse Event|3|||
48504027|NCT00389064|156041356|FG000|Overall Study|Lack of Efficacy|3|||
48504028|NCT00389064|156041357|FG001|Overall Study|Lack of Efficacy|14|||
48818680|NCT00946647|157178593|FG004|Phase ll Part|Adverse Event|6|||
48504029|NCT00389064|156041356|FG000|Overall Study|Withdrawal by Subject|17|||
48504030|NCT00389064|156041357|FG001|Overall Study|Withdrawal by Subject|27|||
48504031|NCT00389064|156041356|FG000|Overall Study|Physician Decision|2|||
48818681|NCT00946647|157178589|FG000|Phase ll Part|Withdrawal by Subject|0|||
48504032|NCT00389064|156041357|FG001|Overall Study|Physician Decision|2|||
48818682|NCT00946647|157178590|FG001|Phase ll Part|Withdrawal by Subject|0|||
48818683|NCT00946647|157178591|FG002|Phase ll Part|Withdrawal by Subject|0|||
48818684|NCT00946647|157178592|FG003|Phase ll Part|Withdrawal by Subject|8|||
48818685|NCT00946647|157178593|FG004|Phase ll Part|Withdrawal by Subject|6|||
48818686|NCT00946647|157178589|FG000|Phase ll Part|Administrative problems|0|||
48818687|NCT00946647|157178590|FG001|Phase ll Part|Administrative problems|0|||
48818688|NCT00946647|157178591|FG002|Phase ll Part|Administrative problems|0|||
48818689|NCT00946647|157178592|FG003|Phase ll Part|Administrative problems|3|||
48818690|NCT00946647|157178593|FG004|Phase ll Part|Administrative problems|8|||
48818691|NCT00946647|157178589|FG000|Phase ll Part|Death|0|||
48818692|NCT00946647|157178590|FG001|Phase ll Part|Death|0|||
48818693|NCT00946647|157178591|FG002|Phase ll Part|Death|0|||
48818694|NCT00946647|157178592|FG003|Phase ll Part|Death|7|||
48818695|NCT00946647|157178593|FG004|Phase ll Part|Death|4|||
48818696|NCT00946647|157178589|FG000|Phase ll Part|Disease progression|0|||
48818697|NCT00946647|157178590|FG001|Phase ll Part|Disease progression|0|||
48818698|NCT00946647|157178591|FG002|Phase ll Part|Disease progression|0|||
48818699|NCT00946647|157178592|FG003|Phase ll Part|Disease progression|6|||
48818700|NCT00946647|157178593|FG004|Phase ll Part|Disease progression|14|||
48504033|NCT00389064|156041356|FG000|Overall Study|Lost to Follow-up|1|||
48504034|NCT00389064|156041357|FG001|Overall Study|Lost to Follow-up|2|||
48504035|NCT00389064|156041356|FG000|Overall Study|Protocol Violation|2|||
48724061|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
48504036|NCT00389064|156041357|FG001|Overall Study|Protocol Violation|0|||
48724062|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
48724063|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724064|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724065|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724066|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724067|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724068|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724069|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724070|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724071|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
48724072|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
48724073|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
48724074|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
48724075|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
48724076|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724077|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724078|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724079|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724080|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724081|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724082|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724083|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724084|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
48724085|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
48724086|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
48724087|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
48724088|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
48724089|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724090|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724091|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724092|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724093|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724094|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724095|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724096|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724097|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
48724098|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
48724099|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
48724100|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
48724101|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
48818701|NCT00946647|157178589|FG000|Phase ll Part|Protocol Violation|0|||
48818702|NCT00946647|157178590|FG001|Phase ll Part|Protocol Violation|0|||
48818703|NCT00946647|157178591|FG002|Phase ll Part|Protocol Violation|0|||
48818704|NCT00946647|157178592|FG003|Phase ll Part|Protocol Violation|4|||
48818705|NCT00946647|157178593|FG004|Phase ll Part|Protocol Violation|2|||
48504037|NCT00389064|156041356|FG000|Overall Study|Multiple Reasons|9|||
48504038|NCT00389064|156041357|FG001|Overall Study|Multiple Reasons|11|||
48504039|NCT02015390|156041358|FG000|Overall Study|Lost to Follow-up|1|||
48504040|NCT02015390|156041359|FG001|Overall Study|Lost to Follow-up|0|||
48504041|NCT02015390|156041358|FG000|Overall Study|Adverse Event|0|||
48504042|NCT02015390|156041359|FG001|Overall Study|Adverse Event|3|||
48504043|NCT02015390|156041358|FG000|Overall Study|Physician Decision|0|||
48504044|NCT02015390|156041359|FG001|Overall Study|Physician Decision|1|||
48504045|NCT01358877|156041360|FG000|Overall Study|Death|80|||
48504046|NCT01358877|156041361|FG001|Overall Study|Death|89|||
48504047|NCT01358877|156041360|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
48504048|NCT01358877|156041361|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
48504049|NCT01358877|156041360|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
48504050|NCT01358877|156041361|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
48504051|NCT01358877|156041360|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
48504052|NCT01358877|156041361|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
48504053|NCT01358877|156041360|FG000|Overall Study|Other|142|||
48504054|NCT01358877|156041361|FG001|Overall Study|Other|129|||
48504055|NCT00064753|156041362|FG000|Overall Study|Death|251|||
48504056|NCT00064753|156041363|FG001|Overall Study|Death|242|||
48504057|NCT00064753|156041362|FG000|Overall Study|Withdrawal by Subject|198|||
48504058|NCT00064753|156041363|FG001|Overall Study|Withdrawal by Subject|171|||
48504059|NCT00064753|156041362|FG000|Overall Study|Lost to Follow-up|225|||
48504060|NCT00064753|156041363|FG001|Overall Study|Lost to Follow-up|235|||
48504061|NCT02979327|156041364|FG000|First Intervention|Protocol Violation|1|||
48504062|NCT02979327|156041365|FG001|First Intervention|Protocol Violation|0|||
48504063|NCT02193880|156041366|FG000|Overall Study|patients did not collect enough HPC|3|||
48504064|NCT02924883|156041367|FG000|Overall Study|Death|39|||
48504065|NCT02924883|156041368|FG001|Overall Study|Death|20|||
48504066|NCT02924883|156041367|FG000|Overall Study|Lost to Follow-up|1|||
48504067|NCT02924883|156041368|FG001|Overall Study|Lost to Follow-up|0|||
48504068|NCT02924883|156041367|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
48504069|NCT02924883|156041368|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
48504070|NCT02924883|156041367|FG000|Overall Study|Protocol Violation|1|||
48504071|NCT02924883|156041368|FG001|Overall Study|Protocol Violation|0|||
48504072|NCT02924883|156041367|FG000|Overall Study|Withdrawal by Subject|22|||
48504073|NCT02924883|156041368|FG001|Overall Study|Withdrawal by Subject|16|||
48504074|NCT02924883|156041367|FG000|Overall Study|Progressive Disease|1|||
48504075|NCT02924883|156041368|FG001|Overall Study|Progressive Disease|0|||
48504076|NCT02924883|156041367|FG000|Overall Study|Study Terminated by Sponsor|69|||
48504077|NCT02924883|156041368|FG001|Overall Study|Study Terminated by Sponsor|32|||
48504078|NCT01873586|156041379|FG000|Overall Study|Lost to Follow-up|3|||
48504079|NCT02421952|156041383|FG000|Overall Study|Diary Not Returned|93|||
48504080|NCT02421952|156041383|FG000|Overall Study|Failed seriation task|13|||
48504081|NCT02421952|156041383|FG000|Overall Study|Subject uncooperative for baseline test|2|||
48504082|NCT02421952|156041383|FG000|Overall Study|Surgery cancelled|1|||
48504083|NCT00669942|156041385|FG000|Parts 2 and 3|Adverse Event|0|||
48724102|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724103|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48818706|NCT00946647|157178589|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
48818707|NCT00946647|157178590|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
48818708|NCT00946647|157178591|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
48818709|NCT00946647|157178592|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
48818710|NCT00946647|157178593|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
48818711|NCT00333788|157178594|FG000|Overall Study|Adverse Event|44|||
48504084|NCT00669942|156041386|FG001|Parts 2 and 3|Adverse Event|0|||
48504085|NCT00669942|156041387|FG002|Parts 2 and 3|Adverse Event|0|||
48504086|NCT00669942|156041388|FG003|Parts 2 and 3|Adverse Event|0|||
48504087|NCT00669942|156041389|FG004|Parts 2 and 3|Adverse Event|0|||
48504088|NCT00669942|156041390|FG005|Parts 2 and 3|Adverse Event|0|||
48599944|NCT03428100|156391515|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
48724104|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724105|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724106|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724107|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48724108|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48818712|NCT00333788|157178594|FG000|Overall Study|Lack of Efficacy|80|||
48818713|NCT00333788|157178594|FG000|Overall Study|Lost to Follow-up|2|||
48818714|NCT00333788|157178594|FG000|Overall Study|Withdrawal by Subject|24|||
48504089|NCT00669942|156041391|FG006|Parts 2 and 3|Adverse Event|0|||
48504090|NCT00669942|156041392|FG007|Parts 2 and 3|Adverse Event|2|||
48504091|NCT00669942|156041393|FG008|Parts 2 and 3|Adverse Event|1|||
48504092|NCT00669942|156041394|FG009|Parts 2 and 3|Adverse Event|0|||
48504093|NCT00669942|156041395|FG010|Parts 2 and 3|Adverse Event|0|||
48504094|NCT00669942|156041396|FG011|Parts 2 and 3|Adverse Event|0|||
48504095|NCT00669942|156041385|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
48504096|NCT00669942|156041386|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
48599945|NCT03428100|156391516|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
48599946|NCT03428100|156391517|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
48599947|NCT03428100|156391518|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
48599948|NCT03428100|156391500|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599949|NCT03428100|156391501|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599950|NCT03428100|156391502|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599951|NCT03428100|156391503|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599952|NCT03428100|156391504|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599953|NCT03428100|156391505|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599954|NCT03428100|156391506|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48724109|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48504097|NCT00669942|156041387|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
48504098|NCT00669942|156041388|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
48504099|NCT00669942|156041389|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
48504100|NCT00669942|156041390|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
48504101|NCT00669942|156041391|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
48504102|NCT00669942|156041392|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
48504103|NCT00669942|156041393|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
48504104|NCT00669942|156041394|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
48504105|NCT00669942|156041395|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
48504106|NCT00669942|156041396|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
48504107|NCT00669942|156041385|FG000|Parts 2 and 3|Protocol Violation|0|||
48504108|NCT00669942|156041386|FG001|Parts 2 and 3|Protocol Violation|0|||
48504109|NCT00669942|156041387|FG002|Parts 2 and 3|Protocol Violation|0|||
48504110|NCT00669942|156041388|FG003|Parts 2 and 3|Protocol Violation|0|||
48504111|NCT00669942|156041389|FG004|Parts 2 and 3|Protocol Violation|0|||
48504112|NCT00669942|156041390|FG005|Parts 2 and 3|Protocol Violation|1|||
48504113|NCT00669942|156041391|FG006|Parts 2 and 3|Protocol Violation|0|||
48504114|NCT00669942|156041392|FG007|Parts 2 and 3|Protocol Violation|0|||
48504115|NCT00669942|156041393|FG008|Parts 2 and 3|Protocol Violation|0|||
48504116|NCT00669942|156041394|FG009|Parts 2 and 3|Protocol Violation|0|||
48504117|NCT00669942|156041395|FG010|Parts 2 and 3|Protocol Violation|0|||
48504118|NCT00669942|156041396|FG011|Parts 2 and 3|Protocol Violation|0|||
48504119|NCT00119015|156041397|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
48504120|NCT00119015|156041398|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
48504121|NCT00119015|156041399|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
48504122|NCT02914600|156041400|FG000|Overall Study|Adverse Event|298|||
48504123|NCT02914600|156041401|FG001|Overall Study|Adverse Event|35|||
48504124|NCT02914600|156041402|FG002|Overall Study|Adverse Event|25|||
48504125|NCT02914600|156041400|FG000|Overall Study|Sponsors decision|287|||
48504126|NCT02914600|156041401|FG001|Overall Study|Sponsors decision|41|||
48504127|NCT02914600|156041402|FG002|Overall Study|Sponsors decision|12|||
48504128|NCT02914600|156041400|FG000|Overall Study|Withdrawal by Subject|158|||
48504129|NCT02914600|156041401|FG001|Overall Study|Withdrawal by Subject|20|||
48504130|NCT02914600|156041402|FG002|Overall Study|Withdrawal by Subject|18|||
48504131|NCT02914600|156041400|FG000|Overall Study|Investigators discretion|169|||
48504132|NCT02914600|156041401|FG001|Overall Study|Investigators discretion|14|||
48504133|NCT02914600|156041402|FG002|Overall Study|Investigators discretion|13|||
48504134|NCT02914600|156041400|FG000|Overall Study|Lost to Follow-up|10|||
48504135|NCT02914600|156041401|FG001|Overall Study|Lost to Follow-up|4|||
48504136|NCT02914600|156041402|FG002|Overall Study|Lost to Follow-up|0|||
48504137|NCT02914600|156041400|FG000|Overall Study|Pregnancy|8|||
48504138|NCT02914600|156041401|FG001|Overall Study|Pregnancy|0|||
48504139|NCT02914600|156041402|FG002|Overall Study|Pregnancy|0|||
48504140|NCT02914600|156041400|FG000|Overall Study|Protocol Violation|5|||
48504141|NCT02914600|156041401|FG001|Overall Study|Protocol Violation|3|||
48504142|NCT02914600|156041402|FG002|Overall Study|Protocol Violation|0|||
48504143|NCT02914600|156041400|FG000|Overall Study|Non-compliance with study drug|6|||
48504144|NCT02914600|156041401|FG001|Overall Study|Non-compliance with study drug|1|||
48504145|NCT02914600|156041402|FG002|Overall Study|Non-compliance with study drug|0|||
48504146|NCT02914600|156041400|FG000|Overall Study|Death|3|||
48504147|NCT02914600|156041401|FG001|Overall Study|Death|1|||
48504148|NCT02914600|156041402|FG002|Overall Study|Death|1|||
48599955|NCT03428100|156391507|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
48599956|NCT03428100|156391508|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48504149|NCT02914600|156041400|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
48504150|NCT02914600|156041401|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
48504151|NCT02914600|156041402|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
48504152|NCT02914600|156041400|FG000|Overall Study|Enrolled but not treated|1|||
48504153|NCT02914600|156041401|FG001|Overall Study|Enrolled but not treated|0|||
48724110|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
48504154|NCT02914600|156041402|FG002|Overall Study|Enrolled but not treated|0|||
48504155|NCT00454909|156041403|FG000|Overall Study|Withdrawal by Subject|1|||
48599957|NCT03428100|156391509|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599958|NCT03428100|156391510|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599959|NCT03428100|156391511|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
48599960|NCT03428100|156391512|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
48599961|NCT03428100|156391513|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599962|NCT03428100|156391514|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
48599963|NCT03428100|156391515|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599964|NCT03428100|156391516|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599965|NCT03428100|156391517|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
48599966|NCT03428100|156391518|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
48599967|NCT03428100|156391500|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
48599968|NCT03428100|156391501|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
48599969|NCT03428100|156391502|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
48599970|NCT03428100|156391503|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
48599971|NCT03428100|156391504|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
48599972|NCT03428100|156391505|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
48599973|NCT03428100|156391506|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
48599974|NCT03428100|156391507|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
48599975|NCT03428100|156391508|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
48599976|NCT03428100|156391509|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
48599977|NCT03428100|156391510|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
48599978|NCT03428100|156391511|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
48599979|NCT03428100|156391512|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
48599980|NCT03428100|156391513|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
48599981|NCT03428100|156391514|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
48599982|NCT03428100|156391515|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
48599983|NCT03428100|156391516|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
48599984|NCT03428100|156391517|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
48599985|NCT03428100|156391518|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
48599986|NCT03428100|156391500|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599987|NCT03428100|156391501|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599988|NCT03428100|156391502|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599989|NCT03428100|156391503|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599990|NCT03428100|156391504|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599991|NCT03428100|156391505|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599992|NCT03428100|156391506|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
48599993|NCT03428100|156391507|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599994|NCT03428100|156391508|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599995|NCT03428100|156391509|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599996|NCT03428100|156391510|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599997|NCT03428100|156391511|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599998|NCT03428100|156391512|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48599999|NCT03428100|156391513|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48600000|NCT03428100|156391514|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48600001|NCT03428100|156391515|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48600002|NCT03428100|156391516|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48600003|NCT03428100|156391517|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
48600004|NCT03428100|156391518|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
48600005|NCT03428100|156391500|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
48600006|NCT03428100|156391501|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
48600007|NCT03428100|156391502|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
48600008|NCT03428100|156391503|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
48600009|NCT03428100|156391504|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
48600010|NCT03428100|156391505|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
48600011|NCT03428100|156391506|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
48600012|NCT03428100|156391507|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
48724111|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
48724112|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
48724113|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
48724114|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
48724115|NCT01261312|156840401|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724116|NCT01261312|156840402|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724117|NCT01261312|156840403|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724118|NCT01261312|156840404|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48600013|NCT03428100|156391508|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
48600014|NCT03428100|156391509|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
48600015|NCT03428100|156391510|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
48600016|NCT03428100|156391511|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
48600017|NCT03428100|156391512|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
48600018|NCT03428100|156391513|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
48600019|NCT03428100|156391514|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
48600020|NCT03428100|156391515|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
48600021|NCT03428100|156391516|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
48600022|NCT03428100|156391517|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
48600023|NCT03428100|156391518|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
48600024|NCT03428100|156391500|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48600025|NCT03428100|156391501|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48600026|NCT03428100|156391502|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48600027|NCT03428100|156391503|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48600028|NCT03428100|156391504|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
48600029|NCT03428100|156391505|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48600030|NCT03428100|156391506|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
48600031|NCT03428100|156391507|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
48600032|NCT03428100|156391508|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48600033|NCT03428100|156391509|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
48600034|NCT03428100|156391510|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
48600035|NCT03428100|156391511|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
48600036|NCT03428100|156391512|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
48600037|NCT03428100|156391513|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
48600038|NCT03428100|156391514|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
48600039|NCT03428100|156391515|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48818715|NCT00333788|157178594|FG000|Overall Study|Other: Non-compliance|2|||
48504156|NCT00454909|156041404|FG001|Overall Study|Withdrawal by Subject|0|||
48504157|NCT00454909|156041405|FG002|Overall Study|Withdrawal by Subject|0|||
48504158|NCT00454909|156041403|FG000|Overall Study|Migrated/moved from study area|0|||
48504159|NCT00454909|156041404|FG001|Overall Study|Migrated/moved from study area|0|||
48504160|NCT00454909|156041405|FG002|Overall Study|Migrated/moved from study area|1|||
48504161|NCT00454909|156041403|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
48504162|NCT00454909|156041404|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
48504163|NCT00454909|156041405|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
48504164|NCT00454909|156041403|FG000|Overall Study|Others|1|||
48504165|NCT00454909|156041404|FG001|Overall Study|Others|0|||
48504166|NCT00454909|156041405|FG002|Overall Study|Others|0|||
48504167|NCT03912337|156041406|FG000|Overall Study|Withdrawal of Consent From Study|1|||
48504168|NCT03912337|156041407|FG001|Overall Study|Withdrawal of Consent From Study|0|||
48504169|NCT03912337|156041406|FG000|Overall Study|Lost to Follow-up|1|||
48504170|NCT03912337|156041407|FG001|Overall Study|Lost to Follow-up|1|||
48504171|NCT03752528|156041408|FG000|Part A|Lost to Follow-up|1|||
48504172|NCT03752528|156041408|FG000|Part A|Protocol Violation|1|||
48504173|NCT03752528|156041408|FG000|Part B|Protocol Violation|1|||
48504174|NCT03752528|156041408|FG000|Part B|Study terminated by sponsor|3|||
48504175|NCT02465268|156041409|FG000|Overall Study|Withdrawal by Subject|4|||
48504176|NCT02465268|156041410|FG001|Overall Study|Withdrawal by Subject|3|||
48504177|NCT02465268|156041411|FG002|Overall Study|Withdrawal by Subject|1|||
48504178|NCT02465268|156041409|FG000|Overall Study|Not evaluable per protocol criteria|3|||
48504179|NCT02465268|156041410|FG001|Overall Study|Not evaluable per protocol criteria|2|||
48504180|NCT02465268|156041411|FG002|Overall Study|Not evaluable per protocol criteria|1|||
48504181|NCT02465268|156041409|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
48504182|NCT02465268|156041410|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
48504183|NCT02465268|156041411|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
48504184|NCT02465268|156041409|FG000|Overall Study|Study drug did not pass QA/QC|1|||
48504185|NCT02465268|156041410|FG001|Overall Study|Study drug did not pass QA/QC|0|||
48504186|NCT02465268|156041411|FG002|Overall Study|Study drug did not pass QA/QC|0|||
48504187|NCT02465268|156041409|FG000|Overall Study|Adverse Event|0|||
48504188|NCT02465268|156041410|FG001|Overall Study|Adverse Event|1|||
48504189|NCT02465268|156041411|FG002|Overall Study|Adverse Event|0|||
48504190|NCT02465268|156041409|FG000|Overall Study|Physician Decision|0|||
48504191|NCT02465268|156041410|FG001|Overall Study|Physician Decision|1|||
48504192|NCT02465268|156041411|FG002|Overall Study|Physician Decision|0|||
48504193|NCT03100149|156041414|FG000|Overall Study|Adverse Event|0|||
48504194|NCT03100149|156041415|FG001|Overall Study|Adverse Event|1|||
48504195|NCT03100149|156041416|FG002|Overall Study|Adverse Event|0|||
48600040|NCT03428100|156391516|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
48600041|NCT03428100|156391517|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
48600042|NCT03428100|156391518|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
48600043|NCT02849743|156391519|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
48600044|NCT02849743|156391520|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
48600045|NCT02849743|156391519|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
48600046|NCT02849743|156391520|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
48600047|NCT01656395|156391521|FG000|Overall Study|Adverse Event|1|||
48600048|NCT01656395|156391522|FG001|Overall Study|Adverse Event|14|||
48600049|NCT01656395|156391523|FG002|Overall Study|Adverse Event|5|||
48600050|NCT01656395|156391524|FG003|Overall Study|Adverse Event|4|||
48600051|NCT01656395|156391525|FG004|Overall Study|Adverse Event|5|||
48600052|NCT01656395|156391526|FG005|Overall Study|Adverse Event|7|||
48600053|NCT01656395|156391527|FG006|Overall Study|Adverse Event|0|||
48600054|NCT01656395|156391528|FG007|Overall Study|Adverse Event|0|||
48600055|NCT01656395|156391521|FG000|Overall Study|Lack of Efficacy|1|||
48600056|NCT01656395|156391522|FG001|Overall Study|Lack of Efficacy|8|||
48600057|NCT01656395|156391523|FG002|Overall Study|Lack of Efficacy|6|||
48600058|NCT01656395|156391524|FG003|Overall Study|Lack of Efficacy|1|||
48600059|NCT01656395|156391525|FG004|Overall Study|Lack of Efficacy|1|||
48600060|NCT01656395|156391526|FG005|Overall Study|Lack of Efficacy|6|||
48600061|NCT01656395|156391527|FG006|Overall Study|Lack of Efficacy|0|||
48600062|NCT01656395|156391528|FG007|Overall Study|Lack of Efficacy|0|||
48600063|NCT01656395|156391521|FG000|Overall Study|Lost to Follow-up|1|||
48600064|NCT01656395|156391522|FG001|Overall Study|Lost to Follow-up|0|||
48600065|NCT01656395|156391523|FG002|Overall Study|Lost to Follow-up|0|||
48600066|NCT01656395|156391524|FG003|Overall Study|Lost to Follow-up|0|||
48600067|NCT01656395|156391525|FG004|Overall Study|Lost to Follow-up|0|||
48600068|NCT01656395|156391526|FG005|Overall Study|Lost to Follow-up|0|||
48600069|NCT01656395|156391527|FG006|Overall Study|Lost to Follow-up|0|||
48600070|NCT01656395|156391528|FG007|Overall Study|Lost to Follow-up|0|||
48600071|NCT01656395|156391521|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48600072|NCT01656395|156391522|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48600073|NCT01656395|156391523|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48600074|NCT01656395|156391524|FG003|Overall Study|Non-Compliance with Study Drug|0|||
48600075|NCT01656395|156391525|FG004|Overall Study|Non-Compliance with Study Drug|1|||
48600076|NCT01656395|156391526|FG005|Overall Study|Non-Compliance with Study Drug|1|||
48600077|NCT01656395|156391527|FG006|Overall Study|Non-Compliance with Study Drug|0|||
48600078|NCT01656395|156391528|FG007|Overall Study|Non-Compliance with Study Drug|0|||
48600079|NCT01656395|156391521|FG000|Overall Study|Other|0|||
48724119|NCT01261312|156840405|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724120|NCT01261312|156840406|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48600080|NCT01656395|156391522|FG001|Overall Study|Other|0|||
48600081|NCT01656395|156391523|FG002|Overall Study|Other|1|||
48600082|NCT01656395|156391524|FG003|Overall Study|Other|0|||
48600083|NCT01656395|156391525|FG004|Overall Study|Other|0|||
48600084|NCT01656395|156391526|FG005|Overall Study|Other|1|||
48600085|NCT01656395|156391527|FG006|Overall Study|Other|0|||
48600086|NCT01656395|156391528|FG007|Overall Study|Other|0|||
48724121|NCT01261312|156840407|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724122|NCT01261312|156840408|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724123|NCT01261312|156840409|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
48724124|NCT01261312|156840410|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
48724125|NCT01261312|156840411|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
48724126|NCT01261312|156840412|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
48724127|NCT01261312|156840413|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
48724128|NCT01993836|156840416|FG000|Overall Study|Surgery Cancelled|3|||
48724129|NCT01993836|156840417|FG001|Overall Study|Surgery Cancelled|0|||
48724130|NCT01993836|156840418|FG002|Overall Study|Surgery Cancelled|0|||
48724131|NCT01993836|156840416|FG000|Overall Study|Physician Decision|2|||
48724132|NCT01993836|156840417|FG001|Overall Study|Physician Decision|1|||
48724133|NCT01993836|156840418|FG002|Overall Study|Physician Decision|0|||
48724134|NCT01993836|156840416|FG000|Overall Study|Death|0|||
48724135|NCT01993836|156840417|FG001|Overall Study|Death|2|||
48724136|NCT01993836|156840418|FG002|Overall Study|Death|0|||
48724137|NCT01993836|156840416|FG000|Overall Study|Withdrawal by Subject|12|||
48724138|NCT01993836|156840417|FG001|Overall Study|Withdrawal by Subject|10|||
48724139|NCT01993836|156840418|FG002|Overall Study|Withdrawal by Subject|5|||
48724140|NCT00584740|156840425|FG000|Overall Study|Adverse Event|1|||
48724141|NCT00584740|156840426|FG001|Overall Study|Adverse Event|1|||
48600087|NCT01656395|156391521|FG000|Overall Study|Physician Decision|2|||
48600088|NCT01656395|156391522|FG001|Overall Study|Physician Decision|3|||
48724142|NCT00584740|156840425|FG000|Overall Study|Lack of Efficacy|8|||
48724143|NCT00584740|156840426|FG001|Overall Study|Lack of Efficacy|2|||
48724144|NCT00584740|156840425|FG000|Overall Study|Withdrawal by Subject|3|||
48600089|NCT01656395|156391523|FG002|Overall Study|Physician Decision|3|||
48504196|NCT03100149|156041414|FG000|Overall Study|Participant Moved out of Country|0|||
48504197|NCT03100149|156041415|FG001|Overall Study|Participant Moved out of Country|0|||
48504198|NCT03100149|156041416|FG002|Overall Study|Participant Moved out of Country|1|||
48504199|NCT03100149|156041414|FG000|Overall Study|Withdrawal by Subject|0|||
48504200|NCT03100149|156041415|FG001|Overall Study|Withdrawal by Subject|3|||
48724145|NCT00584740|156840426|FG001|Overall Study|Withdrawal by Subject|2|||
48724146|NCT00584740|156840425|FG000|Overall Study|Lost to Follow-up|0|||
48504201|NCT03100149|156041416|FG002|Overall Study|Withdrawal by Subject|1|||
48504202|NCT04320849|156041417|FG000|Overall Study|Withdrawal by Subject|4|||
48504203|NCT04320849|156041417|FG000|Overall Study|Imaging data unavailable|2|||
48504204|NCT04320849|156041417|FG000|Overall Study|Incomplete imaging|2|||
48504205|NCT03018249|156041418|FG000|Overall Study|Withdrawal by Subject|2|||
48504206|NCT03018249|156041419|FG001|Overall Study|Withdrawal by Subject|2|||
48504207|NCT00727961|156041420|FG000|Overall Study|Lost to Follow-up|1|||
48504208|NCT00727961|156041420|FG000|Overall Study|Adverse Event|4|||
48724147|NCT00584740|156840426|FG001|Overall Study|Lost to Follow-up|1|||
48724148|NCT00582816|156840427|FG000|Overall Study|Engraftment Failure|3|||
48724149|NCT02514473|156840428|FG000|Overall Study|Adverse Event|0|||
48724150|NCT02514473|156840429|FG001|Overall Study|Adverse Event|2|||
48724151|NCT02514473|156840428|FG000|Overall Study|Withdrawal by Subject|2|||
48724152|NCT02514473|156840429|FG001|Overall Study|Withdrawal by Subject|1|||
48504209|NCT00727961|156041420|FG000|Overall Study|Patient's refusal|2|||
48504210|NCT00727961|156041420|FG000|Overall Study|Progression|30|||
48504211|NCT02473640|156042831|FG000|Treatment Period 1|Adverse Event|1|||
48504212|NCT02395822|156042832|FG000|Overall Study|Withdrawal by Subject|1|||
48504213|NCT02395822|156042832|FG000|Overall Study|Death|1|||
48504214|NCT00453362|156042837|FG000|Overall Study|Adverse Event|5|||
48504215|NCT00453362|156042837|FG000|Overall Study|Death|7|||
48504216|NCT00453362|156042837|FG000|Overall Study|Physician Decision|2|||
48504217|NCT00453362|156042837|FG000|Overall Study|Withdrawal by Subject|3|||
48504218|NCT00453362|156042837|FG000|Overall Study|Progression of disease|56|||
48504219|NCT00453362|156042837|FG000|Overall Study|Screening Failure|14|||
48504220|NCT00433147|156042840|FG000|Overall Study|Adverse Event|0|||
48504221|NCT00433147|156042841|FG001|Overall Study|Adverse Event|1|||
48504222|NCT00433147|156042842|FG002|Overall Study|Adverse Event|0|||
48504223|NCT00433147|156042843|FG003|Overall Study|Adverse Event|0|||
48504224|NCT01882647|156042844|FG000|Overall Study|Lost to Follow-up|2|||
48504225|NCT01882647|156042845|FG001|Overall Study|Lost to Follow-up|2|||
48504226|NCT01882647|156042844|FG000|Overall Study|Withdrawal by Subject|0|||
48504227|NCT01882647|156042845|FG001|Overall Study|Withdrawal by Subject|4|||
48504228|NCT02937701|156042846|FG000|Day 1 to Week 22|Adverse Event|11|||
48724153|NCT02514473|156840428|FG000|Overall Study|Lost to Follow-up|0|||
48600090|NCT01656395|156391524|FG003|Overall Study|Physician Decision|2|||
48600091|NCT01656395|156391525|FG004|Overall Study|Physician Decision|3|||
48724154|NCT02514473|156840429|FG001|Overall Study|Lost to Follow-up|1|||
48724155|NCT02514473|156840428|FG000|Overall Study|Other|1|||
48724156|NCT02514473|156840429|FG001|Overall Study|Other|1|||
48724157|NCT02106923|156840430|FG000|Overall Study|Protocol Violation|0|||
48724158|NCT02106923|156840431|FG001|Overall Study|Protocol Violation|0|||
48724159|NCT02106923|156840432|FG002|Overall Study|Protocol Violation|0|||
48818716|NCT00333788|157178594|FG000|Overall Study|Other: Moved|2|||
48818717|NCT00333788|157178594|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
48818718|NCT00333788|157178594|FG000|Overall Study|Other: Investigator decision|1|||
48818719|NCT00333788|157178594|FG000|Overall Study|Other: Quality of life concern|1|||
48818720|NCT00333788|157178594|FG000|Overall Study|Other: Sponsor decision|1|||
48818721|NCT00333788|157178594|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
48818722|NCT00333788|157178594|FG000|Overall Study|Other: Medical monitor decision|1|||
48504229|NCT02937701|156042847|FG001|Day 1 to Week 22|Adverse Event|14|||
48600092|NCT01656395|156391526|FG005|Overall Study|Physician Decision|3|||
48504230|NCT02937701|156042848|FG002|Day 1 to Week 22|Adverse Event|0|||
48504231|NCT02937701|156042849|FG003|Day 1 to Week 22|Adverse Event|0|||
48504232|NCT02937701|156042850|FG004|Day 1 to Week 22|Adverse Event|0|||
48504233|NCT02937701|156042846|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
48504234|NCT02937701|156042847|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
48504235|NCT02937701|156042848|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
48504236|NCT02937701|156042849|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
48600093|NCT01656395|156391527|FG006|Overall Study|Physician Decision|0|||
48724160|NCT02106923|156840433|FG003|Overall Study|Protocol Violation|0|||
48724161|NCT02106923|156840434|FG004|Overall Study|Protocol Violation|0|||
48724162|NCT02106923|156840435|FG005|Overall Study|Protocol Violation|1|||
48504237|NCT02937701|156042850|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
48504238|NCT02937701|156042846|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
48504239|NCT02937701|156042847|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
48818723|NCT00333788|157178594|FG000|Overall Study|Other: Physician decision|1|||
48600094|NCT01656395|156391528|FG007|Overall Study|Physician Decision|0|||
48724163|NCT03222492|156840438|FG000|Overall Study|Withdrawal by Subject|0|||
48724164|NCT03222492|156840439|FG001|Overall Study|Withdrawal by Subject|0|||
48724165|NCT03222492|156840440|FG002|Overall Study|Withdrawal by Subject|1|||
48724166|NCT03222492|156840441|FG003|Overall Study|Withdrawal by Subject|0|||
48724167|NCT03222492|156840438|FG000|Overall Study|COVID-19 related|0|||
48724168|NCT03222492|156840439|FG001|Overall Study|COVID-19 related|0|||
48724169|NCT03222492|156840440|FG002|Overall Study|COVID-19 related|1|||
48724170|NCT03222492|156840441|FG003|Overall Study|COVID-19 related|0|||
48724171|NCT01624870|156840442|FG000|Overall Study|Death|19|||
48724172|NCT01624870|156840442|FG000|Overall Study|Withdrawal by Subject|1|||
48724173|NCT01624870|156840442|FG000|Overall Study|CoreValve not implanted|6|||
48724174|NCT01624870|156840442|FG000|Overall Study|Lost to follow up|1|||
48724175|NCT00984568|156840444|FG000|Overall Study|Withdrawal by Subject|1|||
48724176|NCT00984568|156840445|FG001|Overall Study|Withdrawal by Subject|2|||
48724177|NCT00984568|156840444|FG000|Overall Study|Lack of Efficacy|2|||
48724178|NCT00984568|156840445|FG001|Overall Study|Lack of Efficacy|0|||
48724179|NCT00984568|156840444|FG000|Overall Study|Adverse Event|2|||
48724180|NCT00984568|156840445|FG001|Overall Study|Adverse Event|0|||
48724181|NCT00984568|156840444|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
48724182|NCT00984568|156840445|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
48724183|NCT00984568|156840444|FG000|Overall Study|Lost to Follow-up|0|||
48724184|NCT00984568|156840445|FG001|Overall Study|Lost to Follow-up|1|||
48724185|NCT00984568|156840444|FG000|Overall Study|Opportunistic Infection|1|||
48724186|NCT00984568|156840445|FG001|Overall Study|Opportunistic Infection|0|||
48724187|NCT00984568|156840444|FG000|Overall Study|Unknown Reason|1|||
48724188|NCT00984568|156840445|FG001|Overall Study|Unknown Reason|3|||
48504240|NCT02937701|156042848|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
48504241|NCT02937701|156042849|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
48504242|NCT02937701|156042850|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
48724189|NCT02964507|156840447|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724190|NCT02964507|156840448|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
48724191|NCT02964507|156840449|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
48818724|NCT00333788|157178594|FG000|Overall Study|Other: Signed consent for another study|1|||
48818725|NCT01007552|157178595|FG000|Overall Study|Withdrawal by Subject|1|||
48818726|NCT02507219|157178602|FG000|Overall Study|Physician Decision|1|||
48818727|NCT02507219|157178603|FG001|Overall Study|Physician Decision|0|||
48818728|NCT02507219|157178604|FG002|Overall Study|Physician Decision|0|||
48724192|NCT02964507|156840450|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724193|NCT02964507|156840451|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
48724194|NCT02964507|156840452|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724195|NCT02964507|156840453|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724196|NCT02964507|156840454|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
48724197|NCT02964507|156840447|FG000|Overall Study|Study terminated by Sponsor|9|||
48724198|NCT02964507|156840448|FG001|Overall Study|Study terminated by Sponsor|1|||
48724199|NCT02964507|156840449|FG002|Overall Study|Study terminated by Sponsor|9|||
48724200|NCT02964507|156840450|FG003|Overall Study|Study terminated by Sponsor|3|||
48724201|NCT02964507|156840451|FG004|Overall Study|Study terminated by Sponsor|3|||
48724202|NCT02964507|156840452|FG005|Overall Study|Study terminated by Sponsor|2|||
48724203|NCT02964507|156840453|FG006|Overall Study|Study terminated by Sponsor|0|||
48724204|NCT02964507|156840454|FG007|Overall Study|Study terminated by Sponsor|0|||
48724205|NCT02964507|156840447|FG000|Overall Study|Other|3|||
48818729|NCT02507219|157178605|FG003|Overall Study|Physician Decision|0|||
48818730|NCT02507219|157178606|FG004|Overall Study|Physician Decision|0|||
48818731|NCT02507219|157178607|FG005|Overall Study|Physician Decision|0|||
48724206|NCT02964507|156840448|FG001|Overall Study|Other|0|||
48724207|NCT02964507|156840449|FG002|Overall Study|Other|0|||
48724208|NCT02964507|156840450|FG003|Overall Study|Other|0|||
48504243|NCT02937701|156042846|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
48504244|NCT02937701|156042847|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
48504245|NCT02937701|156042848|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
48504246|NCT02937701|156042849|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
48724209|NCT02964507|156840451|FG004|Overall Study|Other|1|||
48818732|NCT02507219|157178602|FG000|Overall Study|Withdrawal by Subject|0|||
48504247|NCT02937701|156042850|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
48504248|NCT02937701|156042846|FG000|Day 1 to Week 22|Death|1|||
48504249|NCT02937701|156042847|FG001|Day 1 to Week 22|Death|1|||
48504250|NCT02937701|156042848|FG002|Day 1 to Week 22|Death|0|||
48504251|NCT02937701|156042849|FG003|Day 1 to Week 22|Death|0|||
48504252|NCT02937701|156042850|FG004|Day 1 to Week 22|Death|0|||
48724210|NCT02964507|156840452|FG005|Overall Study|Other|0|||
48724211|NCT02964507|156840453|FG006|Overall Study|Other|0|||
48724212|NCT02964507|156840454|FG007|Overall Study|Other|0|||
48724213|NCT02964507|156840447|FG000|Overall Study|Death|11|||
48724214|NCT02964507|156840448|FG001|Overall Study|Death|9|||
48818733|NCT02507219|157178603|FG001|Overall Study|Withdrawal by Subject|0|||
48818734|NCT02507219|157178604|FG002|Overall Study|Withdrawal by Subject|0|||
48504253|NCT02937701|156042846|FG000|Day 1 to Week 22|Protocol Violation|1|||
48504254|NCT02937701|156042847|FG001|Day 1 to Week 22|Protocol Violation|1|||
48818735|NCT02507219|157178605|FG003|Overall Study|Withdrawal by Subject|0|||
48818736|NCT02507219|157178606|FG004|Overall Study|Withdrawal by Subject|1|||
48818737|NCT02507219|157178607|FG005|Overall Study|Withdrawal by Subject|0|||
48818738|NCT02291289|157179826|FG000|Induction Treatment|Withdrawal by Subject|0|||
48818739|NCT02291289|157179827|FG001|Induction Treatment|Withdrawal by Subject|0|||
48818740|NCT02291289|157179828|FG002|Induction Treatment|Withdrawal by Subject|0|||
48818741|NCT02291289|157179829|FG003|Induction Treatment|Withdrawal by Subject|24|||
48818742|NCT02291289|157179830|FG004|Induction Treatment|Withdrawal by Subject|0|||
48818743|NCT02291289|157179831|FG005|Induction Treatment|Withdrawal by Subject|0|||
48818744|NCT02291289|157179832|FG006|Induction Treatment|Withdrawal by Subject|0|||
48818745|NCT02291289|157179833|FG007|Induction Treatment|Withdrawal by Subject|0|||
48818746|NCT02291289|157179834|FG008|Induction Treatment|Withdrawal by Subject|0|||
48818747|NCT02291289|157179835|FG009|Induction Treatment|Withdrawal by Subject|18|||
48818748|NCT02291289|157179836|FG010|Induction Treatment|Withdrawal by Subject|0|||
48818749|NCT02291289|157179837|FG011|Induction Treatment|Withdrawal by Subject|0|||
48818750|NCT02291289|157179838|FG012|Induction Treatment|Withdrawal by Subject|0|||
48818751|NCT02291289|157179826|FG000|Induction Treatment|Adverse Event|0|||
48818752|NCT02291289|157179827|FG001|Induction Treatment|Adverse Event|0|||
48818753|NCT02291289|157179828|FG002|Induction Treatment|Adverse Event|0|||
48818754|NCT02291289|157179829|FG003|Induction Treatment|Adverse Event|3|||
48818755|NCT02291289|157179830|FG004|Induction Treatment|Adverse Event|0|||
48818756|NCT02291289|157179831|FG005|Induction Treatment|Adverse Event|0|||
48818757|NCT02291289|157179832|FG006|Induction Treatment|Adverse Event|0|||
48818758|NCT02291289|157179833|FG007|Induction Treatment|Adverse Event|0|||
48818759|NCT02291289|157179834|FG008|Induction Treatment|Adverse Event|0|||
48818760|NCT02291289|157179835|FG009|Induction Treatment|Adverse Event|1|||
48818761|NCT02291289|157179836|FG010|Induction Treatment|Adverse Event|0|||
48818762|NCT02291289|157179837|FG011|Induction Treatment|Adverse Event|0|||
48818763|NCT02291289|157179838|FG012|Induction Treatment|Adverse Event|0|||
48818764|NCT02291289|157179826|FG000|Induction Treatment|Death|25|||
48818765|NCT02291289|157179827|FG001|Induction Treatment|Death|0|||
48818766|NCT02291289|157179828|FG002|Induction Treatment|Death|0|||
48818767|NCT02291289|157179829|FG003|Induction Treatment|Death|111|||
48818768|NCT02291289|157179830|FG004|Induction Treatment|Death|0|||
48818769|NCT02291289|157179831|FG005|Induction Treatment|Death|0|||
48818770|NCT02291289|157179832|FG006|Induction Treatment|Death|1|||
48818771|NCT02291289|157179833|FG007|Induction Treatment|Death|0|||
48818772|NCT02291289|157179834|FG008|Induction Treatment|Death|0|||
48818773|NCT02291289|157179835|FG009|Induction Treatment|Death|82|||
48818774|NCT02291289|157179836|FG010|Induction Treatment|Death|0|||
48818775|NCT02291289|157179837|FG011|Induction Treatment|Death|0|||
48818776|NCT02291289|157179838|FG012|Induction Treatment|Death|0|||
48818777|NCT02291289|157179826|FG000|Induction Treatment|Lost to Follow-up|1|||
48818778|NCT02291289|157179827|FG001|Induction Treatment|Lost to Follow-up|0|||
48818779|NCT02291289|157179828|FG002|Induction Treatment|Lost to Follow-up|0|||
48818780|NCT02291289|157179829|FG003|Induction Treatment|Lost to Follow-up|12|||
48818781|NCT02291289|157179830|FG004|Induction Treatment|Lost to Follow-up|0|||
48818782|NCT02291289|157179831|FG005|Induction Treatment|Lost to Follow-up|0|||
48818783|NCT02291289|157179832|FG006|Induction Treatment|Lost to Follow-up|0|||
48818784|NCT02291289|157179833|FG007|Induction Treatment|Lost to Follow-up|0|||
48818785|NCT02291289|157179834|FG008|Induction Treatment|Lost to Follow-up|0|||
48818786|NCT02291289|157179835|FG009|Induction Treatment|Lost to Follow-up|9|||
48818787|NCT02291289|157179836|FG010|Induction Treatment|Lost to Follow-up|0|||
48818788|NCT02291289|157179837|FG011|Induction Treatment|Lost to Follow-up|0|||
48818789|NCT02291289|157179838|FG012|Induction Treatment|Lost to Follow-up|0|||
48818790|NCT02291289|157179826|FG000|Induction Treatment|Non-Compliance|0|||
48818791|NCT02291289|157179827|FG001|Induction Treatment|Non-Compliance|0|||
48818792|NCT02291289|157179828|FG002|Induction Treatment|Non-Compliance|0|||
48818793|NCT02291289|157179829|FG003|Induction Treatment|Non-Compliance|1|||
48818794|NCT02291289|157179830|FG004|Induction Treatment|Non-Compliance|0|||
48818795|NCT02291289|157179831|FG005|Induction Treatment|Non-Compliance|0|||
48818796|NCT02291289|157179832|FG006|Induction Treatment|Non-Compliance|0|||
48818797|NCT02291289|157179833|FG007|Induction Treatment|Non-Compliance|0|||
48818798|NCT02291289|157179834|FG008|Induction Treatment|Non-Compliance|0|||
48818799|NCT02291289|157179835|FG009|Induction Treatment|Non-Compliance|1|||
48818800|NCT02291289|157179836|FG010|Induction Treatment|Non-Compliance|0|||
48818801|NCT02291289|157179837|FG011|Induction Treatment|Non-Compliance|0|||
48818802|NCT02291289|157179838|FG012|Induction Treatment|Non-Compliance|0|||
48818803|NCT02291289|157179826|FG000|Induction Treatment|Reason Not Specified|0|||
48818804|NCT02291289|157179827|FG001|Induction Treatment|Reason Not Specified|0|||
48818805|NCT02291289|157179828|FG002|Induction Treatment|Reason Not Specified|0|||
48818806|NCT02291289|157179829|FG003|Induction Treatment|Reason Not Specified|4|||
48818807|NCT02291289|157179830|FG004|Induction Treatment|Reason Not Specified|0|||
48437578|NCT01996748|155789674|FG000|Overall Study|Lost to Follow-up|4|||
48437579|NCT01996748|155789675|FG001|Overall Study|Lost to Follow-up|1|||
48437580|NCT03722784|155789684|FG000|Overall Study|Withdrawal by Subject|1|||
48437581|NCT03722784|155789685|FG001|Overall Study|Withdrawal by Subject|0|||
48437582|NCT03722784|155789684|FG000|Overall Study|Physician Decision|1|||
48818808|NCT02291289|157179831|FG005|Induction Treatment|Reason Not Specified|0|||
48818809|NCT02291289|157179832|FG006|Induction Treatment|Reason Not Specified|0|||
48818810|NCT02291289|157179833|FG007|Induction Treatment|Reason Not Specified|0|||
48818811|NCT02291289|157179834|FG008|Induction Treatment|Reason Not Specified|0|||
48724215|NCT02964507|156840449|FG002|Overall Study|Death|12|||
48818812|NCT02291289|157179835|FG009|Induction Treatment|Reason Not Specified|7|||
48818813|NCT02291289|157179836|FG010|Induction Treatment|Reason Not Specified|0|||
48818814|NCT02291289|157179837|FG011|Induction Treatment|Reason Not Specified|0|||
48818815|NCT02291289|157179838|FG012|Induction Treatment|Reason Not Specified|0|||
48818816|NCT02291289|157179826|FG000|Induction Treatment|Physician Decision|0|||
48818817|NCT02291289|157179827|FG001|Induction Treatment|Physician Decision|0|||
48818818|NCT02291289|157179828|FG002|Induction Treatment|Physician Decision|0|||
48818819|NCT02291289|157179829|FG003|Induction Treatment|Physician Decision|3|||
48818820|NCT02291289|157179830|FG004|Induction Treatment|Physician Decision|0|||
48818821|NCT02291289|157179831|FG005|Induction Treatment|Physician Decision|0|||
48818822|NCT02291289|157179832|FG006|Induction Treatment|Physician Decision|0|||
48818823|NCT02291289|157179833|FG007|Induction Treatment|Physician Decision|0|||
48818824|NCT02291289|157179834|FG008|Induction Treatment|Physician Decision|0|||
48818825|NCT02291289|157179835|FG009|Induction Treatment|Physician Decision|1|||
48818826|NCT02291289|157179836|FG010|Induction Treatment|Physician Decision|0|||
48818827|NCT02291289|157179837|FG011|Induction Treatment|Physician Decision|0|||
48818828|NCT02291289|157179838|FG012|Induction Treatment|Physician Decision|0|||
48818829|NCT02291289|157179826|FG000|Induction Treatment|Protocol Violation|0|||
48818830|NCT02291289|157179827|FG001|Induction Treatment|Protocol Violation|0|||
48818831|NCT02291289|157179828|FG002|Induction Treatment|Protocol Violation|0|||
48818832|NCT02291289|157179829|FG003|Induction Treatment|Protocol Violation|3|||
48818833|NCT02291289|157179830|FG004|Induction Treatment|Protocol Violation|0|||
48818834|NCT02291289|157179831|FG005|Induction Treatment|Protocol Violation|0|||
48818835|NCT02291289|157179832|FG006|Induction Treatment|Protocol Violation|0|||
48818836|NCT02291289|157179833|FG007|Induction Treatment|Protocol Violation|0|||
48818837|NCT02291289|157179834|FG008|Induction Treatment|Protocol Violation|0|||
48818838|NCT02291289|157179835|FG009|Induction Treatment|Protocol Violation|2|||
48818839|NCT02291289|157179836|FG010|Induction Treatment|Protocol Violation|0|||
48818840|NCT02291289|157179837|FG011|Induction Treatment|Protocol Violation|0|||
48818841|NCT02291289|157179838|FG012|Induction Treatment|Protocol Violation|0|||
48818842|NCT02291289|157179826|FG000|Induction Treatment|Missing|4|||
48818843|NCT02291289|157179827|FG001|Induction Treatment|Missing|0|||
48818844|NCT02291289|157179828|FG002|Induction Treatment|Missing|0|||
48818845|NCT02291289|157179829|FG003|Induction Treatment|Missing|14|||
48818846|NCT02291289|157179830|FG004|Induction Treatment|Missing|0|||
48818847|NCT02291289|157179831|FG005|Induction Treatment|Missing|0|||
48818848|NCT02291289|157179832|FG006|Induction Treatment|Missing|0|||
48818849|NCT02291289|157179833|FG007|Induction Treatment|Missing|0|||
48818850|NCT02291289|157179834|FG008|Induction Treatment|Missing|0|||
48818851|NCT02291289|157179835|FG009|Induction Treatment|Missing|54|||
48818852|NCT02291289|157179836|FG010|Induction Treatment|Missing|0|||
48818853|NCT02291289|157179837|FG011|Induction Treatment|Missing|0|||
48818854|NCT02291289|157179838|FG012|Induction Treatment|Missing|0|||
48818855|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818856|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818857|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48724216|NCT02964507|156840450|FG003|Overall Study|Death|2|||
48724217|NCT02964507|156840451|FG004|Overall Study|Death|10|||
48724218|NCT02964507|156840452|FG005|Overall Study|Death|5|||
48724219|NCT02964507|156840453|FG006|Overall Study|Death|0|||
48724220|NCT02964507|156840454|FG007|Overall Study|Death|0|||
48724221|NCT02964507|156840447|FG000|Overall Study|Withdrawal by Subject|1|||
48724222|NCT02964507|156840448|FG001|Overall Study|Withdrawal by Subject|0|||
48724223|NCT02964507|156840449|FG002|Overall Study|Withdrawal by Subject|1|||
48724224|NCT02964507|156840450|FG003|Overall Study|Withdrawal by Subject|1|||
48724225|NCT02964507|156840451|FG004|Overall Study|Withdrawal by Subject|0|||
48724226|NCT02964507|156840452|FG005|Overall Study|Withdrawal by Subject|1|||
48724227|NCT02964507|156840453|FG006|Overall Study|Withdrawal by Subject|0|||
48724228|NCT02964507|156840454|FG007|Overall Study|Withdrawal by Subject|0|||
48724229|NCT02964507|156840447|FG000|Overall Study|Physician Decision|2|||
48724230|NCT02964507|156840448|FG001|Overall Study|Physician Decision|0|||
48724231|NCT02964507|156840449|FG002|Overall Study|Physician Decision|3|||
48724232|NCT02964507|156840450|FG003|Overall Study|Physician Decision|0|||
48724233|NCT02964507|156840451|FG004|Overall Study|Physician Decision|1|||
48600095|NCT01656395|156391521|FG000|Overall Study|Pregnancy|0|||
48724234|NCT02964507|156840452|FG005|Overall Study|Physician Decision|0|||
48818858|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818859|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
48818860|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
48724235|NCT02964507|156840453|FG006|Overall Study|Physician Decision|0|||
48724236|NCT02964507|156840454|FG007|Overall Study|Physician Decision|0|||
48724237|NCT02582684|156840455|FG000|Overall Study|Unable to contact subject/parent|4|||
48818861|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818862|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818863|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818864|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818865|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
48818866|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
48818867|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48818868|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Death|0|||
48818869|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Death|29|||
48818870|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Death|16|||
48818871|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Death|0|||
48818872|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Death|188|||
48818873|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Death|107|||
48818874|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Death|0|||
48818875|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Death|1|||
48818876|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Death|1|||
48818877|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Death|0|||
48818878|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Death|46|||
48818879|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Death|19|||
48818880|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Death|0|||
48818881|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Adverse Event|0|||
48818882|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Adverse Event|0|||
48818883|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Adverse Event|0|||
48818884|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Adverse Event|0|||
48818885|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Adverse Event|1|||
48818886|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Adverse Event|1|||
48818887|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Adverse Event|0|||
48818888|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Adverse Event|0|||
48818889|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Adverse Event|0|||
48818890|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Adverse Event|0|||
48818891|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Adverse Event|0|||
48818892|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Adverse Event|0|||
48818893|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Adverse Event|0|||
48818894|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818895|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
48818896|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818897|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818898|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
48818899|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
48818900|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818901|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
48818902|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818903|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818904|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
48818905|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
48818906|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
48818907|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
48818908|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
48818909|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
48818910|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
48818911|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
48818912|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
48818913|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
48818914|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
48818915|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
48818916|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
48818917|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
48818918|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
48818919|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
48818920|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Physician Decision|0|||
48818921|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Physician Decision|2|||
48818922|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Physician Decision|0|||
48818923|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Physician Decision|0|||
48818924|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Physician Decision|3|||
48818925|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Physician Decision|0|||
48818926|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Physician Decision|0|||
48818927|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Physician Decision|0|||
48818928|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Physician Decision|0|||
48504255|NCT02937701|156042848|FG002|Day 1 to Week 22|Protocol Violation|0|||
48504256|NCT02937701|156042849|FG003|Day 1 to Week 22|Protocol Violation|0|||
48818929|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Physician Decision|0|||
48818930|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Physician Decision|1|||
48818931|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Physician Decision|3|||
48818932|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Physician Decision|0|||
48818933|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Not Treated|0|||
48818934|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Not Treated|0|||
48818935|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Not Treated|2|||
48818936|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Not Treated|0|||
48818937|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Not Treated|0|||
48818938|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Not Treated|0|||
48818939|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Not Treated|0|||
48818940|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Not Treated|0|||
48818941|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Not Treated|0|||
48818942|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Not Treated|0|||
48818943|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Not Treated|0|||
48724238|NCT02582684|156840455|FG000|Overall Study|Subject not able to get to clinic|10|||
48724239|NCT02582684|156840455|FG000|Overall Study|Subject withdrew consent|1|||
48724240|NCT02582684|156840455|FG000|Overall Study|Found to be ineligible after enrollment|2|||
48724241|NCT04074759|156840461|FG000|Overall Study|Withdrawal by Subject|0|||
48724242|NCT04074759|156840462|FG001|Overall Study|Withdrawal by Subject|0|||
48724243|NCT04074759|156840463|FG002|Overall Study|Withdrawal by Subject|0|||
48724244|NCT04074759|156840464|FG003|Overall Study|Withdrawal by Subject|0|||
48724245|NCT04074759|156840465|FG004|Overall Study|Withdrawal by Subject|0|||
48724246|NCT04074759|156840466|FG005|Overall Study|Withdrawal by Subject|2|||
48724247|NCT04074759|156840467|FG006|Overall Study|Withdrawal by Subject|0|||
48724248|NCT04074759|156840468|FG007|Overall Study|Withdrawal by Subject|2|||
48724249|NCT04074759|156840469|FG008|Overall Study|Withdrawal by Subject|1|||
48724250|NCT04074759|156840470|FG009|Overall Study|Withdrawal by Subject|2|||
48724251|NCT04074759|156840471|FG010|Overall Study|Withdrawal by Subject|9|||
48724252|NCT04074759|156840472|FG011|Overall Study|Withdrawal by Subject|2|||
48724253|NCT04074759|156840473|FG012|Overall Study|Withdrawal by Subject|1|||
48724254|NCT04074759|156840474|FG013|Overall Study|Withdrawal by Subject|3|||
48724255|NCT04074759|156840475|FG014|Overall Study|Withdrawal by Subject|2|||
48724256|NCT04074759|156840476|FG015|Overall Study|Withdrawal by Subject|0|||
48724257|NCT04074759|156840477|FG016|Overall Study|Withdrawal by Subject|0|||
48724258|NCT04074759|156840478|FG017|Overall Study|Withdrawal by Subject|3|||
48724259|NCT04074759|156840479|FG018|Overall Study|Withdrawal by Subject|1|||
48724260|NCT04074759|156840461|FG000|Overall Study|Death|1|||
48724261|NCT04074759|156840462|FG001|Overall Study|Death|0|||
48724262|NCT04074759|156840463|FG002|Overall Study|Death|1|||
48724263|NCT04074759|156840464|FG003|Overall Study|Death|1|||
48724264|NCT04074759|156840465|FG004|Overall Study|Death|2|||
48724265|NCT04074759|156840466|FG005|Overall Study|Death|0|||
48724266|NCT04074759|156840467|FG006|Overall Study|Death|1|||
48724267|NCT04074759|156840468|FG007|Overall Study|Death|0|||
48724268|NCT04074759|156840469|FG008|Overall Study|Death|3|||
48724269|NCT04074759|156840470|FG009|Overall Study|Death|2|||
48724270|NCT04074759|156840471|FG010|Overall Study|Death|4|||
48724271|NCT04074759|156840472|FG011|Overall Study|Death|1|||
48724272|NCT04074759|156840473|FG012|Overall Study|Death|0|||
48724273|NCT04074759|156840474|FG013|Overall Study|Death|2|||
48724274|NCT04074759|156840475|FG014|Overall Study|Death|1|||
48724275|NCT04074759|156840476|FG015|Overall Study|Death|0|||
48724276|NCT04074759|156840477|FG016|Overall Study|Death|1|||
48724277|NCT04074759|156840478|FG017|Overall Study|Death|0|||
48724278|NCT04074759|156840479|FG018|Overall Study|Death|1|||
48724279|NCT04074759|156840461|FG000|Overall Study|Lost to Follow-up|0|||
48724280|NCT04074759|156840462|FG001|Overall Study|Lost to Follow-up|0|||
48724281|NCT04074759|156840463|FG002|Overall Study|Lost to Follow-up|0|||
48724282|NCT04074759|156840464|FG003|Overall Study|Lost to Follow-up|0|||
48724283|NCT04074759|156840465|FG004|Overall Study|Lost to Follow-up|0|||
48724284|NCT04074759|156840466|FG005|Overall Study|Lost to Follow-up|0|||
48724285|NCT04074759|156840467|FG006|Overall Study|Lost to Follow-up|0|||
48724286|NCT04074759|156840468|FG007|Overall Study|Lost to Follow-up|0|||
48724287|NCT04074759|156840469|FG008|Overall Study|Lost to Follow-up|0|||
48724288|NCT04074759|156840470|FG009|Overall Study|Lost to Follow-up|0|||
48724289|NCT04074759|156840471|FG010|Overall Study|Lost to Follow-up|1|||
48724290|NCT04074759|156840472|FG011|Overall Study|Lost to Follow-up|0|||
48724291|NCT04074759|156840473|FG012|Overall Study|Lost to Follow-up|0|||
48724292|NCT04074759|156840474|FG013|Overall Study|Lost to Follow-up|0|||
48724293|NCT04074759|156840475|FG014|Overall Study|Lost to Follow-up|0|||
48724294|NCT04074759|156840476|FG015|Overall Study|Lost to Follow-up|0|||
48724295|NCT04074759|156840477|FG016|Overall Study|Lost to Follow-up|1|||
48724296|NCT04074759|156840478|FG017|Overall Study|Lost to Follow-up|0|||
48724297|NCT04074759|156840479|FG018|Overall Study|Lost to Follow-up|1|||
48724298|NCT04074759|156840461|FG000|Overall Study|Other|0|||
48724299|NCT04074759|156840462|FG001|Overall Study|Other|1|||
48724300|NCT04074759|156840463|FG002|Overall Study|Other|1|||
48724301|NCT04074759|156840464|FG003|Overall Study|Other|0|||
48724302|NCT04074759|156840465|FG004|Overall Study|Other|2|||
48724303|NCT04074759|156840466|FG005|Overall Study|Other|1|||
48724304|NCT04074759|156840467|FG006|Overall Study|Other|2|||
48724305|NCT04074759|156840468|FG007|Overall Study|Other|1|||
48818944|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Not Treated|0|||
48818945|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Not Treated|0|||
48818946|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818947|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
48818948|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818949|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818950|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818951|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818952|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818953|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818954|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818955|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818956|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818957|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818958|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
48818959|NCT02291289|157179826|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
48818960|NCT02291289|157179827|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
48818961|NCT02291289|157179828|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
48818962|NCT02291289|157179829|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
48818963|NCT02291289|157179830|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
48818964|NCT02291289|157179831|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
48818965|NCT02291289|157179832|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
48818966|NCT02291289|157179833|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
48818967|NCT02291289|157179834|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
48818968|NCT02291289|157179835|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
48818969|NCT02291289|157179836|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
48818970|NCT02291289|157179837|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
48818971|NCT02291289|157179838|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
48818972|NCT02291289|157179826|FG000|Early Disease Progression|Death|0|||
48818973|NCT02291289|157179827|FG001|Early Disease Progression|Death|0|||
48818974|NCT02291289|157179828|FG002|Early Disease Progression|Death|0|||
48818975|NCT02291289|157179829|FG003|Early Disease Progression|Death|0|||
48818976|NCT02291289|157179830|FG004|Early Disease Progression|Death|0|||
48818977|NCT02291289|157179831|FG005|Early Disease Progression|Death|0|||
48818978|NCT02291289|157179832|FG006|Early Disease Progression|Death|0|||
48724306|NCT04074759|156840469|FG008|Overall Study|Other|1|||
48504257|NCT02937701|156042850|FG004|Day 1 to Week 22|Protocol Violation|0|||
48724307|NCT04074759|156840470|FG009|Overall Study|Other|4|||
48724308|NCT04074759|156840471|FG010|Overall Study|Other|4|||
48724309|NCT04074759|156840472|FG011|Overall Study|Other|2|||
48724310|NCT04074759|156840473|FG012|Overall Study|Other|0|||
48724311|NCT04074759|156840474|FG013|Overall Study|Other|0|||
48724312|NCT04074759|156840475|FG014|Overall Study|Other|0|||
48724313|NCT04074759|156840476|FG015|Overall Study|Other|1|||
48724314|NCT04074759|156840477|FG016|Overall Study|Other|0|||
48818979|NCT02291289|157179833|FG007|Early Disease Progression|Death|0|||
48818980|NCT02291289|157179834|FG008|Early Disease Progression|Death|0|||
48818981|NCT02291289|157179835|FG009|Early Disease Progression|Death|0|||
48818982|NCT02291289|157179836|FG010|Early Disease Progression|Death|0|||
48818983|NCT02291289|157179837|FG011|Early Disease Progression|Death|0|||
48818984|NCT02291289|157179838|FG012|Early Disease Progression|Death|10|||
48818985|NCT02291289|157179826|FG000|Early Disease Progression|Lost to Follow-up|0|||
48818986|NCT02291289|157179827|FG001|Early Disease Progression|Lost to Follow-up|0|||
48818987|NCT02291289|157179828|FG002|Early Disease Progression|Lost to Follow-up|0|||
48818988|NCT02291289|157179829|FG003|Early Disease Progression|Lost to Follow-up|0|||
48818989|NCT02291289|157179830|FG004|Early Disease Progression|Lost to Follow-up|0|||
48504258|NCT02937701|156042846|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
48504259|NCT02937701|156042847|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
48504260|NCT02937701|156042848|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
48818990|NCT02291289|157179831|FG005|Early Disease Progression|Lost to Follow-up|0|||
48818991|NCT02291289|157179832|FG006|Early Disease Progression|Lost to Follow-up|0|||
48504261|NCT02937701|156042849|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
48504262|NCT02937701|156042850|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
48504263|NCT02937701|156042846|FG000|Day 1 to Week 22|Physician Decision|2|||
48504264|NCT02937701|156042847|FG001|Day 1 to Week 22|Physician Decision|0|||
48504265|NCT02937701|156042848|FG002|Day 1 to Week 22|Physician Decision|0|||
48504266|NCT02937701|156042849|FG003|Day 1 to Week 22|Physician Decision|0|||
48504267|NCT02937701|156042850|FG004|Day 1 to Week 22|Physician Decision|0|||
48724315|NCT04074759|156840478|FG017|Overall Study|Other|0|||
48724316|NCT04074759|156840479|FG018|Overall Study|Other|0|||
48724317|NCT04074759|156840461|FG000|Overall Study|Missing end of study status|0|||
48724318|NCT04074759|156840462|FG001|Overall Study|Missing end of study status|0|||
48724319|NCT04074759|156840463|FG002|Overall Study|Missing end of study status|0|||
48724320|NCT04074759|156840464|FG003|Overall Study|Missing end of study status|0|||
48724321|NCT04074759|156840465|FG004|Overall Study|Missing end of study status|0|||
48724322|NCT04074759|156840466|FG005|Overall Study|Missing end of study status|0|||
48724323|NCT04074759|156840467|FG006|Overall Study|Missing end of study status|0|||
48724324|NCT04074759|156840468|FG007|Overall Study|Missing end of study status|0|||
48504268|NCT02937701|156042846|FG000|Day 1 to Week 22|Other|1|||
48504269|NCT02937701|156042847|FG001|Day 1 to Week 22|Other|0|||
48724325|NCT04074759|156840469|FG008|Overall Study|Missing end of study status|0|||
48724326|NCT04074759|156840470|FG009|Overall Study|Missing end of study status|0|||
48724327|NCT04074759|156840471|FG010|Overall Study|Missing end of study status|2|||
48724328|NCT04074759|156840472|FG011|Overall Study|Missing end of study status|0|||
48724329|NCT04074759|156840473|FG012|Overall Study|Missing end of study status|0|||
48724330|NCT04074759|156840474|FG013|Overall Study|Missing end of study status|0|||
48724331|NCT04074759|156840475|FG014|Overall Study|Missing end of study status|0|||
48724332|NCT04074759|156840476|FG015|Overall Study|Missing end of study status|0|||
48724333|NCT04074759|156840477|FG016|Overall Study|Missing end of study status|1|||
48724334|NCT04074759|156840478|FG017|Overall Study|Missing end of study status|0|||
48724335|NCT04074759|156840479|FG018|Overall Study|Missing end of study status|0|||
48724336|NCT00555425|156840480|FG000|Overall Study|Missed Medication > 1 wk|34|||
48724337|NCT00555425|156840481|FG001|Overall Study|Missed Medication > 1 wk|15|||
48724338|NCT00555425|156840480|FG000|Overall Study|Missed 3 physician management visits|1|||
48724339|NCT00555425|156840481|FG001|Overall Study|Missed 3 physician management visits|0|||
48724340|NCT00555425|156840480|FG000|Overall Study|Met criteria for protective transfer|16|||
48724341|NCT00555425|156840481|FG001|Overall Study|Met criteria for protective transfer|3|||
48724342|NCT00555425|156840480|FG000|Overall Study|Became pregnant and transferred care|0|||
48724343|NCT00555425|156840481|FG001|Overall Study|Became pregnant and transferred care|1|||
48724344|NCT01262352|156840482|FG000|Period 1|Illness after randomization|1|||
48724345|NCT01262352|156840483|FG001|Period 1|Illness after randomization|0|||
48724346|NCT01262352|156840482|FG000|Washout|Adverse Event|1|||
48724347|NCT01262352|156840483|FG001|Washout|Adverse Event|1|||
48724348|NCT01262352|156840482|FG000|Washout|Extended Washout|0|||
48724349|NCT01262352|156840483|FG001|Washout|Extended Washout|1|||
48724350|NCT00450385|156840484|FG000|Overall Study|Death|3|||
48724351|NCT00450385|156840484|FG000|Overall Study|Protocol Violation|1|||
48724352|NCT00450385|156840484|FG000|Overall Study|Withdrawal by Subject|2|||
48724353|NCT00450385|156840484|FG000|Overall Study|Lack of Efficacy|2|||
48724354|NCT00450385|156840484|FG000|Overall Study|Adverse Event|1|||
48724355|NCT00450385|156840484|FG000|Overall Study|Physician Decision|1|||
48724356|NCT00450385|156840484|FG000|Overall Study|Other|3|||
48724357|NCT00645788|156840485|FG000|Overall Study|Did not receive study drug|1|||
48724358|NCT00645788|156840486|FG001|Overall Study|Did not receive study drug|1|||
48724359|NCT00645788|156840487|FG002|Overall Study|Did not receive study drug|0|||
48724360|NCT00645788|156840488|FG003|Overall Study|Did not receive study drug|0|||
48724361|NCT00645788|156840485|FG000|Overall Study|Adverse Event|4|||
48724362|NCT00645788|156840486|FG001|Overall Study|Adverse Event|9|||
48724363|NCT00645788|156840487|FG002|Overall Study|Adverse Event|5|||
48724364|NCT00645788|156840488|FG003|Overall Study|Adverse Event|3|||
48724365|NCT00645788|156840485|FG000|Overall Study|Lost to Follow-up|1|||
48724366|NCT00645788|156840486|FG001|Overall Study|Lost to Follow-up|0|||
48724367|NCT00645788|156840487|FG002|Overall Study|Lost to Follow-up|0|||
48724368|NCT00645788|156840488|FG003|Overall Study|Lost to Follow-up|0|||
48724369|NCT00645788|156840485|FG000|Overall Study|Protocol Violation|1|||
48724370|NCT00645788|156840486|FG001|Overall Study|Protocol Violation|0|||
48724371|NCT00645788|156840487|FG002|Overall Study|Protocol Violation|2|||
48724372|NCT00645788|156840488|FG003|Overall Study|Protocol Violation|0|||
48724373|NCT00645788|156840485|FG000|Overall Study|Withdrawal by Subject|0|||
48724374|NCT00645788|156840486|FG001|Overall Study|Withdrawal by Subject|1|||
48724375|NCT00645788|156840487|FG002|Overall Study|Withdrawal by Subject|0|||
48724376|NCT00645788|156840488|FG003|Overall Study|Withdrawal by Subject|2|||
48724377|NCT00645788|156840485|FG000|Overall Study|Pulmonary exacerbation|13|||
48724378|NCT00645788|156840486|FG001|Overall Study|Pulmonary exacerbation|16|||
48504270|NCT02937701|156042848|FG002|Day 1 to Week 22|Other|0|||
48504271|NCT02937701|156042849|FG003|Day 1 to Week 22|Other|0|||
48724379|NCT00645788|156840487|FG002|Overall Study|Pulmonary exacerbation|11|||
48724380|NCT00645788|156840488|FG003|Overall Study|Pulmonary exacerbation|9|||
48724381|NCT00400153|156840489|FG000|Overall Study|AE due to study disease worsening|14|||
48724382|NCT00400153|156840490|FG001|Overall Study|AE due to study disease worsening|19|||
48724383|NCT00400153|156840491|FG002|Overall Study|AE due to study disease worsening|20|||
48724384|NCT00400153|156840489|FG000|Overall Study|AE due to other disease worsening|2|||
48724385|NCT00400153|156840490|FG001|Overall Study|AE due to other disease worsening|1|||
48724386|NCT00400153|156840491|FG002|Overall Study|AE due to other disease worsening|0|||
48724387|NCT00400153|156840489|FG000|Overall Study|AE due to other condition|3|||
48724388|NCT00400153|156840490|FG001|Overall Study|AE due to other condition|14|||
48724389|NCT00400153|156840491|FG002|Overall Study|AE due to other condition|15|||
48724390|NCT00400153|156840489|FG000|Overall Study|Protocol Violation|7|||
48724391|NCT00400153|156840490|FG001|Overall Study|Protocol Violation|4|||
48724392|NCT00400153|156840491|FG002|Overall Study|Protocol Violation|9|||
48818992|NCT02291289|157179833|FG007|Early Disease Progression|Lost to Follow-up|0|||
48818993|NCT02291289|157179834|FG008|Early Disease Progression|Lost to Follow-up|0|||
48818994|NCT02291289|157179835|FG009|Early Disease Progression|Lost to Follow-up|0|||
48818995|NCT02291289|157179836|FG010|Early Disease Progression|Lost to Follow-up|0|||
48818996|NCT02291289|157179837|FG011|Early Disease Progression|Lost to Follow-up|0|||
48818997|NCT02291289|157179838|FG012|Early Disease Progression|Lost to Follow-up|1|||
48818998|NCT03615482|157179839|FG000|Overall Study|Death|1|||
48818999|NCT03615482|157179840|FG001|Overall Study|Death|0|||
48819000|NCT03615482|157179839|FG000|Overall Study|Lost to Follow-up|7|||
48819001|NCT03615482|157179840|FG001|Overall Study|Lost to Follow-up|7|||
48819002|NCT03615482|157179839|FG000|Overall Study|Physician Decision|2|||
48819003|NCT03615482|157179840|FG001|Overall Study|Physician Decision|3|||
48819004|NCT03615482|157179839|FG000|Overall Study|Withdrawal by Subject|7|||
48819005|NCT03615482|157179840|FG001|Overall Study|Withdrawal by Subject|7|||
48819006|NCT00163215|157179841|FG000|Overall Study|Lack of Efficacy|3|||
48819007|NCT00163215|157179841|FG000|Overall Study|Withdrawal by Subject|5|||
48819008|NCT00163215|157179841|FG000|Overall Study|Other|7|||
48819009|NCT00504348|157179842|FG000|Overall Study|Adverse Event|3|||
48819010|NCT00504348|157179842|FG000|Overall Study|Lack of Efficacy|4|||
48819011|NCT00504348|157179842|FG000|Overall Study|Physician Decision|1|||
48819012|NCT00999661|157179846|FG000|Overall Study|Lost to Follow-up|59|||
48819013|NCT00999661|157179846|FG000|Overall Study|Adverse Event|1|||
48819014|NCT00999661|157179846|FG000|Overall Study|Withdrawal by Subject|1|||
48819015|NCT00999661|157179846|FG000|Overall Study|Not meeting eligibility criteria|9|||
48819016|NCT00506285|157179847|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
48819017|NCT00506285|157179848|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
48819018|NCT00506285|157179847|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
48819019|NCT00506285|157179848|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
48819020|NCT00506285|157179847|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
48819021|NCT00506285|157179848|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
48819022|NCT00506285|157179847|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
48819023|NCT00506285|157179848|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
48819024|NCT00506285|157179847|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
48819025|NCT00506285|157179848|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
48819026|NCT01238575|157179849|FG000|Overall Study|Lack of Efficacy|2|||
48819027|NCT01238575|157179850|FG001|Overall Study|Lack of Efficacy|4|||
48819028|NCT01238575|157179849|FG000|Overall Study|Adverse Event|2|||
48819029|NCT01238575|157179850|FG001|Overall Study|Adverse Event|0|||
48819030|NCT00593554|157179851|FG000|Overall Study|Death|1|||
48819031|NCT00593554|157179852|FG001|Overall Study|Death|2|||
48819032|NCT00593554|157179851|FG000|Overall Study|Physician Decision|0|||
48819033|NCT00593554|157179852|FG001|Overall Study|Physician Decision|1|||
48819034|NCT00593554|157179851|FG000|Overall Study|Withdrawal by Subject|1|||
48819035|NCT00593554|157179852|FG001|Overall Study|Withdrawal by Subject|0|||
48819036|NCT00593554|157179851|FG000|Overall Study|Disease Progression|1|||
48819037|NCT00593554|157179852|FG001|Overall Study|Disease Progression|2|||
48819038|NCT04668989|157179859|FG000|First Intervention|Covid-19 related self-isolation|0|||
48819039|NCT04668989|157179860|FG001|First Intervention|Covid-19 related self-isolation|1|||
48819040|NCT04668989|157179859|FG000|Second Intervention|Adverse Event|0|||
48819041|NCT04668989|157179860|FG001|Second Intervention|Adverse Event|1|||
48819042|NCT01375959|157179861|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
48819043|NCT01375959|157179862|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
48819044|NCT01375959|157179861|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
48819045|NCT01375959|157179862|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
48819046|NCT01375959|157179861|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
48819047|NCT01375959|157179862|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
48819048|NCT02206152|157179873|FG000|Pre-Randomization|Withdrawal by Subject|2|||
48819049|NCT02420327|157179875|FG000|Overall Study|Adverse Event|7|||
48819050|NCT02420327|157179875|FG000|Overall Study|Pregnancy|1|||
48819051|NCT02420327|157179875|FG000|Overall Study|Withdrawal by Subject|6|||
48504272|NCT02937701|156042850|FG004|Day 1 to Week 22|Other|0|||
48504273|NCT02937701|156042846|FG000|Week 22 to Week 50|Adverse Event|0|||
48504274|NCT02937701|156042847|FG001|Week 22 to Week 50|Adverse Event|0|||
48504275|NCT02937701|156042848|FG002|Week 22 to Week 50|Adverse Event|10|||
48504276|NCT02937701|156042849|FG003|Week 22 to Week 50|Adverse Event|3|||
48504277|NCT02937701|156042850|FG004|Week 22 to Week 50|Adverse Event|3|||
48504278|NCT02937701|156042846|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
48504279|NCT02937701|156042847|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
48504280|NCT02937701|156042848|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
48600096|NCT01656395|156391522|FG001|Overall Study|Pregnancy|0|||
48819052|NCT02420327|157179875|FG000|Overall Study|Lost to Follow-up|1|||
48819053|NCT02420327|157179875|FG000|Overall Study|Protocol Violation|1|||
48819054|NCT04496167|157179877|FG000|Overall Study|Adverse Event|6|||
48819055|NCT04496167|157179878|FG001|Overall Study|Adverse Event|2|||
48819056|NCT04496167|157179877|FG000|Overall Study|Withdrawal by Subject|7|||
48819057|NCT04496167|157179878|FG001|Overall Study|Withdrawal by Subject|6|||
48819058|NCT04496167|157179877|FG000|Overall Study|Lost to Follow-up|3|||
48819059|NCT04496167|157179878|FG001|Overall Study|Lost to Follow-up|5|||
48819060|NCT04496167|157179877|FG000|Overall Study|Not Treated|1|||
48819061|NCT04496167|157179878|FG001|Overall Study|Not Treated|2|||
48819062|NCT04496167|157179877|FG000|Overall Study|Other Than Specified|1|||
48819063|NCT04496167|157179878|FG001|Overall Study|Other Than Specified|1|||
48819064|NCT00683449|157179879|FG000|Overall Study|Lost to Follow-up|0|||
48819065|NCT00683449|157179880|FG001|Overall Study|Lost to Follow-up|1|||
48819066|NCT00683449|157179881|FG002|Overall Study|Lost to Follow-up|0|||
48819067|NCT00683449|157179882|FG003|Overall Study|Lost to Follow-up|0|||
48819068|NCT00683449|157179883|FG004|Overall Study|Lost to Follow-up|0|||
48819069|NCT02322775|157179885|FG000|Overall Study|Adverse Event|1|||
48819070|NCT02322775|157179886|FG001|Overall Study|Adverse Event|0|||
48819071|NCT02322775|157179885|FG000|Overall Study|Lost to Follow-up|0|||
48819072|NCT02322775|157179886|FG001|Overall Study|Lost to Follow-up|1|||
48819073|NCT02322775|157179885|FG000|Overall Study|Protocol Violation|1|||
48819074|NCT02322775|157179886|FG001|Overall Study|Protocol Violation|0|||
48819075|NCT02322775|157179885|FG000|Overall Study|Withdrawal by Subject|3|||
48819076|NCT02322775|157179886|FG001|Overall Study|Withdrawal by Subject|4|||
48819077|NCT02322775|157179885|FG000|Overall Study|Not willing to perform all FU visits|0|||
48819078|NCT02322775|157179886|FG001|Overall Study|Not willing to perform all FU visits|1|||
48819079|NCT03590743|157179892|FG000|Overall Study|Withdrawal by Subject|0|||
48819080|NCT03590743|157179893|FG001|Overall Study|Withdrawal by Subject|1|||
48819081|NCT01190176|157179894|FG000|Overall Study|Withdrawal by Subject|1|||
48819082|NCT01190176|157179894|FG000|Overall Study|Lost to Follow-up|1|||
48819083|NCT02696226|157179895|FG000|Overall Study|Study terminated - lack of enrollment|1|||
48819084|NCT02696226|157179896|FG001|Overall Study|Study terminated - lack of enrollment|0|||
48819085|NCT02696226|157179897|FG002|Overall Study|Study terminated - lack of enrollment|2|||
48819086|NCT02696226|157179898|FG003|Overall Study|Study terminated - lack of enrollment|0|||
48819087|NCT02909101|157179906|FG000|Overall Study|Lost to Follow-up|1|||
48819088|NCT02909101|157179907|FG001|Overall Study|Lost to Follow-up|1|||
48819089|NCT01836458|157179908|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
48819090|NCT01836458|157179909|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48819091|NCT01836458|157179910|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
48819092|NCT01836458|157179911|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
48819093|NCT01221181|157179916|FG000|Overall Study|Lost to Follow-up|1|||
48819094|NCT02189863|157179917|FG000|First 2 Weeks|Motion Sickness|4|||
48819095|NCT02189863|157179918|FG001|First 2 Weeks|Motion Sickness|2|||
48819096|NCT02427646|157179923|FG000|Overall Study|Lack of Efficacy|2|||
48819097|NCT02427646|157179924|FG001|Overall Study|Lack of Efficacy|3|||
48819098|NCT02427646|157179923|FG000|Overall Study|Physician Decision|1|||
48819099|NCT02427646|157179924|FG001|Overall Study|Physician Decision|4|||
48819100|NCT02427646|157179923|FG000|Overall Study|Protocol Violation|3|||
48819101|NCT02427646|157179924|FG001|Overall Study|Protocol Violation|3|||
48819102|NCT02427646|157179923|FG000|Overall Study|Bothersome hand weakness|2|||
48724393|NCT00400153|156840489|FG000|Overall Study|Lost to Follow-up|2|||
48724394|NCT00400153|156840490|FG001|Overall Study|Lost to Follow-up|1|||
48724395|NCT00400153|156840491|FG002|Overall Study|Lost to Follow-up|4|||
48724396|NCT00400153|156840489|FG000|Overall Study|Withdrawal by Subject|12|||
48724397|NCT00400153|156840490|FG001|Overall Study|Withdrawal by Subject|11|||
48819103|NCT02427646|157179924|FG001|Overall Study|Bothersome hand weakness|4|||
48819104|NCT02990338|157179937|FG000|Overall Study|Randomized and not treated|4|||
48819105|NCT02990338|157179938|FG001|Overall Study|Randomized and not treated|2|||
48819106|NCT02990338|157179937|FG000|Overall Study|Adverse Event|23|||
48724398|NCT00400153|156840491|FG002|Overall Study|Withdrawal by Subject|10|||
48724399|NCT00400153|156840489|FG000|Overall Study|Other reasons - not mentioned above|8|||
48724400|NCT00400153|156840490|FG001|Overall Study|Other reasons - not mentioned above|5|||
48819107|NCT02990338|157179938|FG001|Overall Study|Adverse Event|22|||
48819108|NCT02990338|157179937|FG000|Overall Study|Progressive disease|118|||
48724401|NCT00400153|156840491|FG002|Overall Study|Other reasons - not mentioned above|3|||
48724402|NCT01150474|156840492|FG000|Overall Study|Withdrawal by Subject|5|||
48819109|NCT02990338|157179938|FG001|Overall Study|Progressive disease|107|||
48819110|NCT02990338|157179937|FG000|Overall Study|Poor compliance to protocol|0|||
48819111|NCT02990338|157179938|FG001|Overall Study|Poor compliance to protocol|1|||
48819112|NCT02990338|157179937|FG000|Overall Study|Withdrawal by Subject|6|||
48819113|NCT02990338|157179938|FG001|Overall Study|Withdrawal by Subject|8|||
48819114|NCT02990338|157179937|FG000|Overall Study|Physician's decision|2|||
48819115|NCT02990338|157179938|FG001|Overall Study|Physician's decision|6|||
48819116|NCT02990338|157179937|FG000|Overall Study|Treatment extension study|0|||
48437583|NCT03722784|155789685|FG001|Overall Study|Physician Decision|1|||
48437584|NCT03722784|155789684|FG000|Overall Study|Protocol Violation|0|||
48437585|NCT03722784|155789685|FG001|Overall Study|Protocol Violation|1|||
48437586|NCT03288493|155789686|FG000|Overall Study|Withdrawal by Subject|4|||
48437587|NCT03288493|155789687|FG001|Overall Study|Withdrawal by Subject|0|||
48437588|NCT03288493|155789688|FG002|Overall Study|Withdrawal by Subject|0|||
48437589|NCT03288493|155789689|FG003|Overall Study|Withdrawal by Subject|0|||
48819117|NCT02990338|157179938|FG001|Overall Study|Treatment extension study|6|||
48819118|NCT02990338|157179937|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
48819119|NCT02990338|157179938|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
48819120|NCT02990338|157179937|FG000|Overall Study|Continue with therapy available commercially|0|||
48819121|NCT02990338|157179938|FG001|Overall Study|Continue with therapy available commercially|1|||
48819122|NCT03675737|157179939|FG000|Overall Study|Death|593|||
48819123|NCT03675737|157179940|FG001|Overall Study|Death|660|||
48819124|NCT03675737|157179939|FG000|Overall Study|Lost to Follow-up|1|||
48819125|NCT03675737|157179940|FG001|Overall Study|Lost to Follow-up|5|||
48819126|NCT03675737|157179939|FG000|Overall Study|Physician Decision|1|||
48819127|NCT03675737|157179940|FG001|Overall Study|Physician Decision|0|||
48819128|NCT03675737|157179939|FG000|Overall Study|Withdrawal by Subject|14|||
48819129|NCT03675737|157179940|FG001|Overall Study|Withdrawal by Subject|12|||
48819130|NCT03675737|157179939|FG000|Overall Study|Ongoing in Study|181|||
48819131|NCT03675737|157179940|FG001|Overall Study|Ongoing in Study|112|||
48819132|NCT02169830|157181751|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
48819133|NCT02169830|157181752|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
48819134|NCT02169830|157181753|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
48819135|NCT02169830|157181751|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
48819136|NCT02169830|157181752|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
48819137|NCT02169830|157181753|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
48819138|NCT02169830|157181751|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
48819139|NCT02169830|157181752|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
48819140|NCT02169830|157181753|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
48819141|NCT02169830|157181751|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
48819142|NCT02169830|157181752|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
48819143|NCT02169830|157181753|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
48819144|NCT02169830|157181751|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
48819145|NCT02169830|157181752|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
48819146|NCT02169830|157181753|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
48819147|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
48819148|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
48819149|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
48819150|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
48819151|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
48819152|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
48819153|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
48504281|NCT02937701|156042849|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
48504282|NCT02937701|156042850|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
48504283|NCT02937701|156042846|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
48724403|NCT01150474|156840493|FG001|Overall Study|Withdrawal by Subject|2|||
48819154|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
48819155|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
48819156|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
48819157|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
48819158|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
48819159|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
48819160|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
48819161|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
48819162|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
48819163|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
48819164|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
48819165|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
48819166|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
48724404|NCT01150474|156840492|FG000|Overall Study|Cancer found|1|||
48724405|NCT01150474|156840493|FG001|Overall Study|Cancer found|0|||
48724406|NCT01150474|156840492|FG000|Overall Study|Multiple Studies|0|||
48724407|NCT01150474|156840493|FG001|Overall Study|Multiple Studies|1|||
48724408|NCT01150474|156840492|FG000|Overall Study|Rectotomy|1|||
48724409|NCT01150474|156840493|FG001|Overall Study|Rectotomy|0|||
48724410|NCT01150474|156840492|FG000|Overall Study|Drug did not arrive in time|1|||
48819167|NCT02555371|157181754|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
48819168|NCT02555371|157181755|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
48819169|NCT02555371|157181756|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
48724411|NCT01150474|156840493|FG001|Overall Study|Drug did not arrive in time|0|||
48819170|NCT02555371|157181757|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
48819171|NCT02555371|157181758|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
48819172|NCT02555371|157181754|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
48724412|NCT01150474|156840492|FG000|Overall Study|Drug not administered|1|||
48724413|NCT01150474|156840493|FG001|Overall Study|Drug not administered|0|||
48819173|NCT02555371|157181755|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
48819174|NCT02555371|157181756|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
48819175|NCT02555371|157181757|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
48819176|NCT02555371|157181758|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
48819177|NCT02555371|157181754|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
48819178|NCT02555371|157181755|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
48819179|NCT02555371|157181756|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
48819180|NCT02555371|157181757|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
48819181|NCT02555371|157181758|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
48819182|NCT02555371|157181754|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
48819183|NCT02555371|157181755|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
48819184|NCT02555371|157181756|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
48819185|NCT02555371|157181757|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
48819186|NCT02555371|157181758|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
48819187|NCT02555371|157181754|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
48819188|NCT02555371|157181755|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
48819189|NCT02555371|157181756|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
48819190|NCT02555371|157181757|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
48819191|NCT02555371|157181758|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
48819192|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
48819193|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
48819194|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
48819195|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
48819196|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
48819197|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
48819198|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
48819199|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
48819200|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
48819201|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
48819202|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
48819203|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
48819204|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
48819205|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
48819206|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
48819207|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
48819208|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
48819209|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
48819210|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
48819211|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
48819212|NCT02555371|157181754|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
48819213|NCT02555371|157181755|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
48819214|NCT02555371|157181756|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
48819215|NCT02555371|157181757|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
48819216|NCT02555371|157181758|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
48819217|NCT01853254|157181759|FG000|Overall Study|Abnormal Laboratory Test|1|||
48819218|NCT01853254|157181759|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
48819219|NCT01853254|157181759|FG000|Overall Study|Death|1|||
48819220|NCT01853254|157181759|FG000|Overall Study|Failure to Return|43|||
48819221|NCT01853254|157181759|FG000|Overall Study|Insufficient Therapeutic Response|22|||
48819222|NCT01853254|157181759|FG000|Overall Study|Refusal of Treatment|1|||
48819223|NCT01853254|157181759|FG000|Overall Study|Other Protocol Violation|1|||
48819224|NCT01853254|157181759|FG000|Overall Study|Withdrawal of Consent|16|||
48819225|NCT01853254|157181759|FG000|Overall Study|Administrative/Other|16|||
48819226|NCT00900627|157181760|FG000|Overall Study|Condition under investigation worsened|4|||
48819227|NCT00900627|157181761|FG001|Overall Study|Condition under investigation worsened|0|||
48819228|NCT00900627|157181762|FG002|Overall Study|Condition under investigation worsened|5|||
48819229|NCT00900627|157181763|FG003|Overall Study|Condition under investigation worsened|3|||
48819230|NCT00900627|157181764|FG004|Overall Study|Condition under investigation worsened|0|||
48819231|NCT00900627|157181765|FG005|Overall Study|Condition under investigation worsened|0|||
48819232|NCT00900627|157181760|FG000|Overall Study|Withdrawal by Subject|1|||
48819233|NCT00900627|157181761|FG001|Overall Study|Withdrawal by Subject|0|||
48600097|NCT01656395|156391523|FG002|Overall Study|Pregnancy|1|||
48600098|NCT01656395|156391524|FG003|Overall Study|Pregnancy|0|||
48819234|NCT00900627|157181762|FG002|Overall Study|Withdrawal by Subject|1|||
48819235|NCT00900627|157181763|FG003|Overall Study|Withdrawal by Subject|0|||
48819236|NCT00900627|157181764|FG004|Overall Study|Withdrawal by Subject|1|||
48819237|NCT00900627|157181765|FG005|Overall Study|Withdrawal by Subject|2|||
48819238|NCT00900627|157181760|FG000|Overall Study|Adverse Event|1|||
48819239|NCT00900627|157181761|FG001|Overall Study|Adverse Event|2|||
48819240|NCT00900627|157181762|FG002|Overall Study|Adverse Event|0|||
48819241|NCT00900627|157181763|FG003|Overall Study|Adverse Event|3|||
48819242|NCT00900627|157181764|FG004|Overall Study|Adverse Event|0|||
48819243|NCT00900627|157181765|FG005|Overall Study|Adverse Event|0|||
48819244|NCT00900627|157181760|FG000|Overall Study|Death|0|||
48819245|NCT00900627|157181761|FG001|Overall Study|Death|0|||
48819246|NCT00900627|157181762|FG002|Overall Study|Death|0|||
48819247|NCT00900627|157181763|FG003|Overall Study|Death|0|||
48504284|NCT02937701|156042847|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
48504285|NCT02937701|156042848|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
48504286|NCT02937701|156042849|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
48504287|NCT02937701|156042850|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
48504288|NCT02937701|156042846|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
48504289|NCT02937701|156042847|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
48504290|NCT02937701|156042848|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
48724414|NCT01150474|156840492|FG000|Overall Study|Surgery Changed|1|||
48724415|NCT01150474|156840493|FG001|Overall Study|Surgery Changed|0|||
48724416|NCT03533686|156840494|FG000|Overall Study|Withdrawal by Subject|1|||
48724417|NCT03533686|156840495|FG001|Overall Study|Withdrawal by Subject|0|||
48724418|NCT03533686|156840496|FG002|Overall Study|Withdrawal by Subject|0|||
48724419|NCT03533686|156840497|FG003|Overall Study|Withdrawal by Subject|3|||
48724420|NCT03533686|156840498|FG004|Overall Study|Withdrawal by Subject|5|||
48724421|NCT03533686|156840499|FG005|Overall Study|Withdrawal by Subject|1|||
48724422|NCT03533686|156840494|FG000|Overall Study|Lost to Follow-up|0|||
48724423|NCT03533686|156840495|FG001|Overall Study|Lost to Follow-up|1|||
48724424|NCT03533686|156840496|FG002|Overall Study|Lost to Follow-up|0|||
48724425|NCT03533686|156840497|FG003|Overall Study|Lost to Follow-up|0|||
48724426|NCT03533686|156840498|FG004|Overall Study|Lost to Follow-up|2|||
48724427|NCT03533686|156840499|FG005|Overall Study|Lost to Follow-up|0|||
48724428|NCT03533686|156840494|FG000|Overall Study|Screen Failure|0|||
48724429|NCT03533686|156840495|FG001|Overall Study|Screen Failure|0|||
48724430|NCT03533686|156840496|FG002|Overall Study|Screen Failure|0|||
48724431|NCT03533686|156840497|FG003|Overall Study|Screen Failure|2|||
48724432|NCT03533686|156840498|FG004|Overall Study|Screen Failure|0|||
48724433|NCT03533686|156840499|FG005|Overall Study|Screen Failure|0|||
48724434|NCT01856023|156840500|FG000|Overall Study|Death|1|||
48724435|NCT01856023|156840501|FG001|Overall Study|Death|2|||
48819248|NCT00900627|157181764|FG004|Overall Study|Death|28|||
48819249|NCT00900627|157181765|FG005|Overall Study|Death|24|||
48819250|NCT01625338|157181766|FG000|Overall Study|Enrolled but not Treated|0|||
48819251|NCT01625338|157181767|FG001|Overall Study|Enrolled but not Treated|0|||
48819252|NCT01625338|157181768|FG002|Overall Study|Enrolled but not Treated|1|||
48819253|NCT01625338|157181766|FG000|Overall Study|Efficacy Failure|27|||
48819254|NCT01625338|157181767|FG001|Overall Study|Efficacy Failure|39|||
48819255|NCT01625338|157181768|FG002|Overall Study|Efficacy Failure|31|||
48819256|NCT01625338|157181766|FG000|Overall Study|Lost to Follow-up|3|||
48819257|NCT01625338|157181767|FG001|Overall Study|Lost to Follow-up|3|||
48819258|NCT01625338|157181768|FG002|Overall Study|Lost to Follow-up|2|||
48819259|NCT01625338|157181766|FG000|Overall Study|Investigator Decision|0|||
48819260|NCT01625338|157181767|FG001|Overall Study|Investigator Decision|2|||
48819261|NCT01625338|157181768|FG002|Overall Study|Investigator Decision|1|||
48819262|NCT01625338|157181766|FG000|Overall Study|Subject Withdrew Consent|1|||
48724436|NCT01856023|156840500|FG000|Overall Study|Adverse Event|2|||
48724437|NCT01856023|156840501|FG001|Overall Study|Adverse Event|1|||
48724438|NCT01856023|156840500|FG000|Overall Study|Lack of Efficacy|5|||
48724439|NCT01856023|156840501|FG001|Overall Study|Lack of Efficacy|5|||
48724440|NCT01856023|156840500|FG000|Overall Study|non compliance, study closure|1|||
48724441|NCT01856023|156840501|FG001|Overall Study|non compliance, study closure|3|||
48724442|NCT01856023|156840500|FG000|Overall Study|Withdrawal by Subject|1|||
48724443|NCT01856023|156840501|FG001|Overall Study|Withdrawal by Subject|1|||
48504291|NCT02937701|156042849|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
48504292|NCT02937701|156042850|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
48724444|NCT00384111|156840502|FG000|Overall Study|Disease Progression|3|||
48724445|NCT00384111|156840502|FG000|Overall Study|Adverse Event|1|||
48724446|NCT00384111|156840502|FG000|Overall Study|Investigator Decision|3|||
48724447|NCT00384111|156840502|FG000|Overall Study|Study Terminated by the Sponsor|19|||
48724448|NCT02273739|156840503|FG000|Overall Study|Progression of Disease|3|||
48724449|NCT02273739|156840504|FG001|Overall Study|Progression of Disease|4|||
48819263|NCT01625338|157181767|FG001|Overall Study|Subject Withdrew Consent|0|||
48819264|NCT01625338|157181768|FG002|Overall Study|Subject Withdrew Consent|2|||
48819265|NCT01625338|157181766|FG000|Overall Study|Adverse Event|1|||
48819266|NCT01625338|157181767|FG001|Overall Study|Adverse Event|0|||
48819267|NCT01625338|157181768|FG002|Overall Study|Adverse Event|1|||
48819268|NCT01625338|157181766|FG000|Overall Study|Study Discontinued by Sponsor|0|||
48819269|NCT01625338|157181767|FG001|Overall Study|Study Discontinued by Sponsor|0|||
48504293|NCT02937701|156042846|FG000|Week 22 to Week 50|Physician Decision|0|||
48504294|NCT02937701|156042847|FG001|Week 22 to Week 50|Physician Decision|0|||
48504295|NCT02937701|156042848|FG002|Week 22 to Week 50|Physician Decision|2|||
48504296|NCT02937701|156042849|FG003|Week 22 to Week 50|Physician Decision|0|||
48504297|NCT02937701|156042850|FG004|Week 22 to Week 50|Physician Decision|1|||
48504298|NCT02937701|156042846|FG000|Week 22 to Week 50|Other|0|||
48504299|NCT02937701|156042847|FG001|Week 22 to Week 50|Other|0|||
48724450|NCT02273739|156840505|FG002|Overall Study|Progression of Disease|5|||
48724451|NCT02273739|156840506|FG003|Overall Study|Progression of Disease|2|||
48724452|NCT02273739|156840503|FG000|Overall Study|Death|0|||
48724453|NCT02273739|156840504|FG001|Overall Study|Death|0|||
48724454|NCT02273739|156840505|FG002|Overall Study|Death|0|||
48724455|NCT02273739|156840506|FG003|Overall Study|Death|2|||
48724456|NCT02273739|156840503|FG000|Overall Study|Adverse Event|0|||
48724457|NCT02273739|156840504|FG001|Overall Study|Adverse Event|0|||
48724458|NCT02273739|156840505|FG002|Overall Study|Adverse Event|0|||
48724459|NCT02273739|156840506|FG003|Overall Study|Adverse Event|1|||
48724460|NCT02273739|156840503|FG000|Overall Study|Withdrawal by Subject|0|||
48724461|NCT02273739|156840504|FG001|Overall Study|Withdrawal by Subject|0|||
48724462|NCT02273739|156840505|FG002|Overall Study|Withdrawal by Subject|2|||
48724463|NCT02273739|156840506|FG003|Overall Study|Withdrawal by Subject|1|||
48724464|NCT02273739|156840503|FG000|Overall Study|Physician Decision|0|||
48724465|NCT02273739|156840504|FG001|Overall Study|Physician Decision|0|||
48724466|NCT02273739|156840505|FG002|Overall Study|Physician Decision|0|||
48724467|NCT02273739|156840506|FG003|Overall Study|Physician Decision|1|||
48724468|NCT00327470|156840508|FG000|Overall Study|Randomized, but not treated|0|||
48724469|NCT00327470|156840509|FG001|Overall Study|Randomized, but not treated|2|||
48724470|NCT00327470|156840508|FG000|Overall Study|Adverse Event|9|||
48724471|NCT00327470|156840509|FG001|Overall Study|Adverse Event|14|||
48724472|NCT00327470|156840508|FG000|Overall Study|Lack of Efficacy|7|||
48724473|NCT00327470|156840509|FG001|Overall Study|Lack of Efficacy|19|||
48724474|NCT00327470|156840508|FG000|Overall Study|Other|5|||
48724475|NCT00327470|156840509|FG001|Overall Study|Other|9|||
48724476|NCT00327470|156840508|FG000|Overall Study|Lost to Follow-up|1|||
48724477|NCT00327470|156840509|FG001|Overall Study|Lost to Follow-up|3|||
48724478|NCT00327470|156840508|FG000|Overall Study|Withdrawal by Subject|6|||
48724479|NCT00327470|156840509|FG001|Overall Study|Withdrawal by Subject|12|||
48724480|NCT00327470|156840508|FG000|Overall Study|Death|1|||
48724481|NCT00327470|156840509|FG001|Overall Study|Death|4|||
48724482|NCT00309985|156840512|FG000|Overall Study|Disease progression|12|||
48724483|NCT00309985|156840513|FG001|Overall Study|Disease progression|0|||
48724484|NCT00309985|156840512|FG000|Overall Study|Adverse Event|30|||
48724485|NCT00309985|156840513|FG001|Overall Study|Adverse Event|0|||
48724486|NCT00309985|156840512|FG000|Overall Study|Death|2|||
48724487|NCT00309985|156840513|FG001|Overall Study|Death|0|||
48724488|NCT00309985|156840512|FG000|Overall Study|Withdrawal by Subject|5|||
48724489|NCT00309985|156840513|FG001|Overall Study|Withdrawal by Subject|1|||
48724490|NCT00309985|156840512|FG000|Overall Study|Physician Decision|3|||
48724491|NCT00309985|156840513|FG001|Overall Study|Physician Decision|0|||
48724492|NCT00309985|156840512|FG000|Overall Study|Never started treatment|7|||
48724493|NCT00309985|156840513|FG001|Overall Study|Never started treatment|0|||
48724494|NCT00309985|156840512|FG000|Overall Study|Complicating disease|1|||
48724495|NCT00309985|156840513|FG001|Overall Study|Complicating disease|0|||
48724496|NCT00309985|156840512|FG000|Overall Study|Non-compliance|1|||
48724497|NCT00309985|156840513|FG001|Overall Study|Non-compliance|0|||
48724498|NCT00309985|156840512|FG000|Overall Study|Chemotherapy discontinued only|1|||
48724499|NCT00309985|156840513|FG001|Overall Study|Chemotherapy discontinued only|0|||
48724500|NCT05104463|156840514|FG000|Overall Study|Adverse Event|1|||
48724501|NCT05104463|156840515|FG001|Overall Study|Adverse Event|1|||
48724502|NCT05104463|156840514|FG000|Overall Study|Lost to Follow-up|1|||
48724503|NCT05104463|156840515|FG001|Overall Study|Lost to Follow-up|1|||
48724504|NCT05104463|156840514|FG000|Overall Study|Physician Decision|1|||
48724505|NCT05104463|156840515|FG001|Overall Study|Physician Decision|0|||
48724506|NCT05104463|156840514|FG000|Overall Study|Protocol Violation|0|||
48724507|NCT05104463|156840515|FG001|Overall Study|Protocol Violation|2|||
48724508|NCT05104463|156840514|FG000|Overall Study|Withdrawal by Subject|1|||
48724509|NCT05104463|156840515|FG001|Overall Study|Withdrawal by Subject|1|||
48724510|NCT01876810|156840516|FG000|Overall Study|Physician Decision|0|||
48724511|NCT01876810|156840517|FG001|Overall Study|Physician Decision|1|||
48724512|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
48724513|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
48724514|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
48724515|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
48724516|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
48724517|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
48724518|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
48724519|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
48724520|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
48504300|NCT02937701|156042848|FG002|Week 22 to Week 50|Other|0|||
48504301|NCT02937701|156042849|FG003|Week 22 to Week 50|Other|0|||
48819270|NCT01625338|157181768|FG002|Overall Study|Study Discontinued by Sponsor|1|||
48819271|NCT04421378|157181770|FG000|Overall Study|Adverse Event|2|||
48504302|NCT02937701|156042850|FG004|Week 22 to Week 50|Other|1|||
48504303|NCT03601637|156042851|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
48504304|NCT03601637|156042852|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
48504305|NCT03601637|156042851|FG000|Overall Study|Adverse Event|1|||
48504306|NCT03601637|156042852|FG001|Overall Study|Adverse Event|1|||
48504307|NCT03601637|156042851|FG000|Overall Study|Other|0|||
48504308|NCT03601637|156042852|FG001|Overall Study|Other|1|||
48504309|NCT01387737|156042854|FG000|Overall Study|Adverse Event|20|||
48504310|NCT01387737|156042855|FG001|Overall Study|Adverse Event|30|||
48504311|NCT01387737|156042854|FG000|Overall Study|Lack of Efficacy|1|||
48504312|NCT01387737|156042855|FG001|Overall Study|Lack of Efficacy|0|||
48504313|NCT01387737|156042854|FG000|Overall Study|Physician Decision|3|||
48504314|NCT01387737|156042855|FG001|Overall Study|Physician Decision|10|||
48504315|NCT01387737|156042854|FG000|Overall Study|Withdrawal by Subject|27|||
48504316|NCT01387737|156042855|FG001|Overall Study|Withdrawal by Subject|31|||
48504317|NCT01387737|156042854|FG000|Overall Study|Clearly not eligible for the study|1|||
48504318|NCT01387737|156042855|FG001|Overall Study|Clearly not eligible for the study|3|||
48504319|NCT00723528|156042857|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
48504320|NCT00723528|156042858|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
48504321|NCT00723528|156042859|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
48504322|NCT00723528|156042860|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
48504323|NCT00723528|156042861|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
48504324|NCT00723528|156042862|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
48504325|NCT00723528|156042863|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
48504326|NCT00723528|156042857|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
48504327|NCT00723528|156042858|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
48504328|NCT00723528|156042859|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
48504329|NCT00723528|156042860|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
48504330|NCT00723528|156042861|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
48504331|NCT00723528|156042862|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
48504332|NCT00723528|156042863|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
48504333|NCT00723528|156042857|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
48504334|NCT00723528|156042858|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
48504335|NCT00723528|156042859|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
48504336|NCT00723528|156042860|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
48504337|NCT00723528|156042861|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
48504338|NCT00723528|156042862|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
48504339|NCT00723528|156042863|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
48504340|NCT00723528|156042857|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
48504341|NCT00723528|156042858|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
48504342|NCT00723528|156042859|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
48504343|NCT00723528|156042860|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
48504344|NCT00723528|156042861|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
48504345|NCT00723528|156042862|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
48504346|NCT00723528|156042863|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
48504347|NCT00723528|156042857|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
48504348|NCT00723528|156042858|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
48504349|NCT00723528|156042859|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
48504350|NCT00723528|156042860|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
48819272|NCT04421378|157181771|FG001|Overall Study|Adverse Event|7|||
48504351|NCT00723528|156042861|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
48504352|NCT00723528|156042862|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
48504353|NCT00723528|156042863|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
48504354|NCT00723528|156042857|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
48504355|NCT00723528|156042858|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
48600099|NCT01656395|156391525|FG004|Overall Study|Pregnancy|0|||
48724521|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
48724522|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
48724523|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
48724524|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
48724525|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
48724526|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
48724527|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
48724528|NCT00491556|156840520|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
48504356|NCT00723528|156042859|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
48504357|NCT00723528|156042860|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
48504358|NCT00723528|156042861|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
48504359|NCT00723528|156042862|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
48504360|NCT00723528|156042863|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
48504361|NCT00723528|156042857|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
48724529|NCT00491556|156840521|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
48724530|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
48504362|NCT00723528|156042858|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
48504363|NCT00723528|156042859|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
48504364|NCT00723528|156042860|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
48504365|NCT00723528|156042861|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
48504366|NCT00723528|156042862|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
48504367|NCT00723528|156042863|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
48504368|NCT00723528|156042857|FG000|Period 2: After Controlled Period|Other|0|||
48504369|NCT00723528|156042858|FG001|Period 2: After Controlled Period|Other|0|||
48504370|NCT00723528|156042859|FG002|Period 2: After Controlled Period|Other|0|||
48504371|NCT00723528|156042860|FG003|Period 2: After Controlled Period|Other|0|||
48504372|NCT00723528|156042861|FG004|Period 2: After Controlled Period|Other|1|||
48504373|NCT00723528|156042862|FG005|Period 2: After Controlled Period|Other|4|||
48504374|NCT00723528|156042863|FG006|Period 2: After Controlled Period|Other|0|||
48504375|NCT00723528|156042857|FG000|Period 2: After Controlled Period|Adverse Event|0|||
48504376|NCT00723528|156042858|FG001|Period 2: After Controlled Period|Adverse Event|0|||
48504377|NCT00723528|156042859|FG002|Period 2: After Controlled Period|Adverse Event|0|||
48504378|NCT00723528|156042860|FG003|Period 2: After Controlled Period|Adverse Event|0|||
48504379|NCT00723528|156042861|FG004|Period 2: After Controlled Period|Adverse Event|1|||
48504380|NCT00723528|156042862|FG005|Period 2: After Controlled Period|Adverse Event|0|||
48504381|NCT00723528|156042863|FG006|Period 2: After Controlled Period|Adverse Event|1|||
48504382|NCT00723528|156042857|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
48504383|NCT00723528|156042858|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
48504384|NCT00723528|156042859|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
48504385|NCT00723528|156042860|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
48504386|NCT00723528|156042861|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
48504387|NCT00723528|156042862|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
48504388|NCT00723528|156042863|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
48504389|NCT00723528|156042857|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
48504390|NCT00723528|156042858|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
48504391|NCT00723528|156042859|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
48504392|NCT00723528|156042860|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
48504393|NCT00723528|156042861|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
48504394|NCT00723528|156042862|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
48504395|NCT00723528|156042863|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
48504396|NCT01471093|156042867|FG000|Overall Study|Adverse Event|1|||
48504397|NCT01471093|156042868|FG001|Overall Study|Adverse Event|0|||
48504398|NCT01471093|156042869|FG002|Overall Study|Adverse Event|0|||
48504399|NCT01471093|156042870|FG003|Overall Study|Adverse Event|0|||
48504400|NCT02932878|156042871|FG000|Overall Study|Due to Lab Results|2|||
48504401|NCT02932878|156042872|FG001|Overall Study|Due to Lab Results|1|||
48504402|NCT01776840|156042873|FG000|Overall Study|Lost to Follow-up|4|||
48504403|NCT01776840|156042874|FG001|Overall Study|Lost to Follow-up|4|||
48504404|NCT01776840|156042873|FG000|Overall Study|Withdrawal by Subject|42|||
48504405|NCT01776840|156042874|FG001|Overall Study|Withdrawal by Subject|22|||
48504406|NCT01776840|156042873|FG000|Overall Study|Ongoing|112|||
48504407|NCT01776840|156042874|FG001|Overall Study|Ongoing|129|||
48504408|NCT04477486|156042879|FG000|Overall Study|Death|2|||
48504409|NCT04477486|156042879|FG000|Overall Study|Ongoing at Time of Analysis|11|||
48504410|NCT03136380|156042885|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48504411|NCT03136380|156042886|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
48504412|NCT03136380|156042887|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48504413|NCT03136380|156042888|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48504414|NCT03136380|156042889|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48504415|NCT05341622|156042894|FG000|Overall Study|Death|0|||
48504416|NCT05341622|156042895|FG001|Overall Study|Death|0|||
48504417|NCT05341622|156042896|FG002|Overall Study|Death|0|||
48504418|NCT05341622|156042897|FG003|Overall Study|Death|0|||
48504419|NCT05341622|156042898|FG004|Overall Study|Death|1|||
48504420|NCT05341622|156042899|FG005|Overall Study|Death|0|||
48504421|NCT05341622|156042900|FG006|Overall Study|Death|0|||
48819273|NCT04421378|157181772|FG002|Overall Study|Adverse Event|0|||
48600100|NCT01656395|156391526|FG005|Overall Study|Pregnancy|0|||
48600101|NCT01656395|156391527|FG006|Overall Study|Pregnancy|0|||
48600102|NCT01656395|156391528|FG007|Overall Study|Pregnancy|0|||
48600103|NCT01656395|156391521|FG000|Overall Study|Progressive Disease|0|||
48819274|NCT04421378|157181773|FG003|Overall Study|Adverse Event|1|||
48819275|NCT04421378|157181774|FG004|Overall Study|Adverse Event|0|||
48819276|NCT04421378|157181770|FG000|Overall Study|Physician Decision|1|||
48819277|NCT04421378|157181771|FG001|Overall Study|Physician Decision|2|||
48819278|NCT04421378|157181772|FG002|Overall Study|Physician Decision|0|||
48819279|NCT04421378|157181773|FG003|Overall Study|Physician Decision|0|||
48819280|NCT04421378|157181774|FG004|Overall Study|Physician Decision|0|||
48819281|NCT04421378|157181770|FG000|Overall Study|Progressive Disease|16|||
48819282|NCT04421378|157181771|FG001|Overall Study|Progressive Disease|4|||
48819283|NCT04421378|157181772|FG002|Overall Study|Progressive Disease|18|||
48819284|NCT04421378|157181773|FG003|Overall Study|Progressive Disease|11|||
48819285|NCT04421378|157181774|FG004|Overall Study|Progressive Disease|3|||
48819286|NCT04421378|157181770|FG000|Overall Study|Study Terminated by Sponsor|0|||
48819287|NCT04421378|157181771|FG001|Overall Study|Study Terminated by Sponsor|1|||
48819288|NCT04421378|157181772|FG002|Overall Study|Study Terminated by Sponsor|1|||
48819289|NCT04421378|157181773|FG003|Overall Study|Study Terminated by Sponsor|0|||
48819290|NCT04421378|157181774|FG004|Overall Study|Study Terminated by Sponsor|0|||
48819291|NCT04421378|157181770|FG000|Overall Study|Withdrawal by Subject|3|||
48819292|NCT04421378|157181771|FG001|Overall Study|Withdrawal by Subject|1|||
48819293|NCT04421378|157181772|FG002|Overall Study|Withdrawal by Subject|0|||
48819294|NCT04421378|157181773|FG003|Overall Study|Withdrawal by Subject|2|||
48819295|NCT04421378|157181774|FG004|Overall Study|Withdrawal by Subject|0|||
48819296|NCT04421378|157181770|FG000|Overall Study|Other|1|||
48819297|NCT04421378|157181771|FG001|Overall Study|Other|0|||
48819298|NCT04421378|157181772|FG002|Overall Study|Other|0|||
48819299|NCT04421378|157181773|FG003|Overall Study|Other|0|||
48819300|NCT04421378|157181774|FG004|Overall Study|Other|0|||
48819301|NCT00765362|157181775|FG000|Overall Study|Death|9|||
48819302|NCT00765362|157181775|FG000|Overall Study|Adverse Event|2|||
48819303|NCT00765362|157181775|FG000|Overall Study|Protocol Violation|18|||
48819304|NCT00765362|157181775|FG000|Overall Study|Withdrawal by Subject|13|||
48819305|NCT00765362|157181775|FG000|Overall Study|Lost to Follow-up|95|||
48819306|NCT03019458|157181776|FG000|Overall Study|Death|0|||
48819307|NCT03019458|157181777|FG001|Overall Study|Death|1|||
48819308|NCT03302910|157181785|FG000|Overall Study|Protocol Violation|1|||
48819309|NCT03302910|157181786|FG001|Overall Study|Protocol Violation|0|||
48819310|NCT05862870|157181787|FG000|Overall Study|Lost to Follow-up|3|||
48819311|NCT01477749|157181790|FG000|Overall Study|Physician Decision|4|||
48819312|NCT01567163|157181793|FG000|Overall Study|Progressive Disease|2|||
48819313|NCT01567163|157181793|FG000|Overall Study|Lost to Follow-up|2|||
48819314|NCT03405662|157181796|FG000|Overall Study|COVID-19 restriction|1|||
48819315|NCT03405662|157181797|FG001|Overall Study|COVID-19 restriction|0|||
48819316|NCT03405662|157181796|FG000|Overall Study|unblinding|0|||
48819317|NCT03405662|157181797|FG001|Overall Study|unblinding|1|||
48819318|NCT03405662|157181796|FG000|Overall Study|placement in memory care facility|0|||
48819319|NCT03405662|157181797|FG001|Overall Study|placement in memory care facility|2|||
48819320|NCT01177813|157181798|FG000|Overall Study|Adverse Event|8|||
48819321|NCT01177813|157181799|FG001|Overall Study|Adverse Event|2|||
48819322|NCT01177813|157181800|FG002|Overall Study|Adverse Event|4|||
48819323|NCT01177813|157181801|FG003|Overall Study|Adverse Event|6|||
48504422|NCT05341622|156042901|FG007|Overall Study|Death|1|||
48504423|NCT05341622|156042894|FG000|Overall Study|Invalid Address|0|||
48504424|NCT05341622|156042895|FG001|Overall Study|Invalid Address|1|||
48504425|NCT05341622|156042896|FG002|Overall Study|Invalid Address|0|||
48504426|NCT05341622|156042897|FG003|Overall Study|Invalid Address|0|||
48504427|NCT05341622|156042898|FG004|Overall Study|Invalid Address|0|||
48504428|NCT05341622|156042899|FG005|Overall Study|Invalid Address|0|||
48504429|NCT05341622|156042900|FG006|Overall Study|Invalid Address|0|||
48504430|NCT05341622|156042901|FG007|Overall Study|Invalid Address|0|||
48504431|NCT05341622|156042894|FG000|Overall Study|Ineligible|26|||
48504432|NCT05341622|156042895|FG001|Overall Study|Ineligible|21|||
48819324|NCT01177813|157181802|FG004|Overall Study|Adverse Event|3|||
48819325|NCT01177813|157181798|FG000|Overall Study|Lack of Efficacy|1|||
48819326|NCT01177813|157181799|FG001|Overall Study|Lack of Efficacy|0|||
48819327|NCT01177813|157181800|FG002|Overall Study|Lack of Efficacy|0|||
48819328|NCT01177813|157181801|FG003|Overall Study|Lack of Efficacy|0|||
48819329|NCT01177813|157181802|FG004|Overall Study|Lack of Efficacy|0|||
48819330|NCT01177813|157181798|FG000|Overall Study|Protocol Violation|3|||
48819331|NCT01177813|157181799|FG001|Overall Study|Protocol Violation|2|||
48819332|NCT01177813|157181800|FG002|Overall Study|Protocol Violation|2|||
48819333|NCT01177813|157181801|FG003|Overall Study|Protocol Violation|0|||
48819334|NCT01177813|157181802|FG004|Overall Study|Protocol Violation|1|||
48504433|NCT05341622|156042896|FG002|Overall Study|Ineligible|28|||
48504434|NCT05341622|156042897|FG003|Overall Study|Ineligible|24|||
48504435|NCT05341622|156042898|FG004|Overall Study|Ineligible|29|||
48504436|NCT05341622|156042899|FG005|Overall Study|Ineligible|31|||
48819335|NCT01177813|157181798|FG000|Overall Study|Lost to Follow-up|12|||
48504437|NCT05341622|156042900|FG006|Overall Study|Ineligible|28|||
48504438|NCT05341622|156042901|FG007|Overall Study|Ineligible|26|||
48504439|NCT02935686|156042902|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
48504440|NCT02935686|156042903|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
48504441|NCT02935686|156042904|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
48504442|NCT02935686|156042905|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
48504443|NCT02935686|156042906|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
48504444|NCT02935686|156042902|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
48504445|NCT02935686|156042903|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
48504446|NCT02935686|156042904|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
48504447|NCT02935686|156042905|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
48504448|NCT02935686|156042906|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
48504449|NCT02935686|156042902|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
48504450|NCT02935686|156042903|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
48504451|NCT02935686|156042904|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
48504452|NCT02935686|156042905|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
48504453|NCT02935686|156042906|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
48504454|NCT02935686|156042902|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
48504455|NCT02935686|156042903|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
48504456|NCT02935686|156042904|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
48504457|NCT02935686|156042905|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
48724531|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
48438270|NCT02559206|155792001|FG002|Overall Study|Protocol Violation|1|||
48724532|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
48724533|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
48724534|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
48724535|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
48724536|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
48724537|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
48724538|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
48724539|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
48724540|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
48724541|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
48724542|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
48724543|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
48724544|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
48724545|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
48724546|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
48724547|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
48724548|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
48724549|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
48724550|NCT00491556|156840520|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
48724551|NCT00491556|156840521|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
48724552|NCT02361346|156840522|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724553|NCT02361346|156840523|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724554|NCT02361346|156840524|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
48438271|NCT02559206|155792002|FG003|Overall Study|Protocol Violation|0|||
48438272|NCT02559206|155792003|FG004|Overall Study|Protocol Violation|0|||
48438273|NCT02559206|155792004|FG005|Overall Study|Protocol Violation|2|||
48438274|NCT02559206|155792005|FG006|Overall Study|Protocol Violation|0|||
48438275|NCT02559206|155792006|FG007|Overall Study|Protocol Violation|0|||
48438276|NCT02559206|155791999|FG000|Overall Study|Withdrawal by Subject|3|||
48438277|NCT02559206|155792000|FG001|Overall Study|Withdrawal by Subject|3|||
48438278|NCT02559206|155792001|FG002|Overall Study|Withdrawal by Subject|1|||
48438279|NCT02559206|155792002|FG003|Overall Study|Withdrawal by Subject|3|||
48438280|NCT02559206|155792003|FG004|Overall Study|Withdrawal by Subject|5|||
48438281|NCT02559206|155792004|FG005|Overall Study|Withdrawal by Subject|4|||
48438282|NCT02559206|155792005|FG006|Overall Study|Withdrawal by Subject|1|||
48438283|NCT02559206|155792006|FG007|Overall Study|Withdrawal by Subject|2|||
48438284|NCT02559206|155791999|FG000|Overall Study|Lost to Follow-up|3|||
48438285|NCT02559206|155792000|FG001|Overall Study|Lost to Follow-up|5|||
48438286|NCT02559206|155792001|FG002|Overall Study|Lost to Follow-up|3|||
48438287|NCT02559206|155792002|FG003|Overall Study|Lost to Follow-up|3|||
48438288|NCT02559206|155792003|FG004|Overall Study|Lost to Follow-up|2|||
48438289|NCT02559206|155792004|FG005|Overall Study|Lost to Follow-up|5|||
48438290|NCT02559206|155792005|FG006|Overall Study|Lost to Follow-up|1|||
48438291|NCT02559206|155792006|FG007|Overall Study|Lost to Follow-up|4|||
48438292|NCT02559206|155791999|FG000|Overall Study|Lack of Efficacy|1|||
48438293|NCT02559206|155792000|FG001|Overall Study|Lack of Efficacy|0|||
48438294|NCT02559206|155792001|FG002|Overall Study|Lack of Efficacy|3|||
48504458|NCT02935686|156042906|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
48504459|NCT02935686|156042902|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
48504460|NCT02935686|156042903|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
48504461|NCT02935686|156042904|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
48504462|NCT02935686|156042905|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
48504463|NCT02935686|156042906|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
48504464|NCT02935686|156042902|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
48504465|NCT02935686|156042903|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
48504466|NCT02935686|156042904|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
48504467|NCT02935686|156042905|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
48504468|NCT02935686|156042906|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
48504469|NCT02935686|156042902|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
48504470|NCT02935686|156042903|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
48504471|NCT02935686|156042904|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
48504472|NCT02935686|156042905|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
48504473|NCT02935686|156042906|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
48504474|NCT02935686|156042902|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
48819336|NCT01177813|157181799|FG001|Overall Study|Lost to Follow-up|5|||
48819337|NCT01177813|157181800|FG002|Overall Study|Lost to Follow-up|6|||
48819338|NCT01177813|157181801|FG003|Overall Study|Lost to Follow-up|3|||
48819339|NCT01177813|157181802|FG004|Overall Study|Lost to Follow-up|0|||
48504475|NCT02935686|156042903|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
48504476|NCT02935686|156042904|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
48504477|NCT02935686|156042905|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
48504478|NCT02935686|156042906|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
48504479|NCT02935686|156042902|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
48504480|NCT02935686|156042903|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
48504481|NCT02935686|156042904|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
48504482|NCT02935686|156042905|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
48504483|NCT02935686|156042906|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
48504484|NCT02935686|156042902|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
48504485|NCT02935686|156042903|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
48504486|NCT02935686|156042904|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
48504487|NCT02935686|156042905|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
48504488|NCT02935686|156042906|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
48504489|NCT02935686|156042902|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
48504490|NCT02935686|156042903|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
48504491|NCT02935686|156042904|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
48504492|NCT02935686|156042905|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
48504493|NCT02935686|156042906|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
48504494|NCT01661686|156042909|FG000|Overall Study|Lost to Follow-up|2|||
48504495|NCT01661686|156042910|FG001|Overall Study|Lost to Follow-up|1|||
48504496|NCT01661686|156042909|FG000|Overall Study|did not receive allocated intervention|0|||
48504497|NCT01661686|156042910|FG001|Overall Study|did not receive allocated intervention|1|||
48504498|NCT01720264|156042913|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
48504499|NCT01720264|156042913|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
48504500|NCT01720264|156042913|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
48504501|NCT02472366|156042914|FG000|Overall Study|Lost to Follow-up|1|||
48504502|NCT02472366|156042915|FG001|Overall Study|Lost to Follow-up|0|||
48504503|NCT02419937|156042918|FG000|Overall Study|Lost to Follow-up|1|||
48504504|NCT02419937|156042919|FG001|Overall Study|Lost to Follow-up|0|||
48504505|NCT00813293|156042920|FG000|Overall Study|Intercurrent illness|1|||
48504506|NCT00813293|156042921|FG001|Overall Study|Intercurrent illness|0|||
48504507|NCT00813293|156042920|FG000|Overall Study|Adverse Event|0|||
48504508|NCT00813293|156042921|FG001|Overall Study|Adverse Event|1|||
48504509|NCT01182415|156042922|FG000|Overall Study|Lost to Follow-up|1|||
48504510|NCT01544127|156042923|FG000|Overall Study|Lost to Follow-up|4|||
48504511|NCT01544127|156042924|FG001|Overall Study|Lost to Follow-up|2|||
48504512|NCT01544127|156042925|FG002|Overall Study|Lost to Follow-up|9|||
48504513|NCT01544127|156042923|FG000|Overall Study|Withdrawal by Subject|2|||
48504514|NCT01544127|156042924|FG001|Overall Study|Withdrawal by Subject|2|||
48504515|NCT01544127|156042925|FG002|Overall Study|Withdrawal by Subject|1|||
48504516|NCT01544127|156042923|FG000|Overall Study|Discharged out of catchment area|1|||
48504517|NCT01544127|156042924|FG001|Overall Study|Discharged out of catchment area|1|||
48504518|NCT01544127|156042925|FG002|Overall Study|Discharged out of catchment area|1|||
48504519|NCT01544127|156042923|FG000|Overall Study|Death|1|||
48504520|NCT01544127|156042924|FG001|Overall Study|Death|0|||
48504521|NCT01544127|156042925|FG002|Overall Study|Death|0|||
48504522|NCT01544127|156042923|FG000|Overall Study|Jail or Prison|1|||
48504523|NCT01544127|156042924|FG001|Overall Study|Jail or Prison|1|||
48504524|NCT01544127|156042925|FG002|Overall Study|Jail or Prison|2|||
48819340|NCT01177813|157181798|FG000|Overall Study|Withdrawal by Subject|12|||
48504525|NCT01544127|156042923|FG000|Overall Study|Became Psychotic|1|||
48504526|NCT01544127|156042924|FG001|Overall Study|Became Psychotic|0|||
48504527|NCT01544127|156042925|FG002|Overall Study|Became Psychotic|0|||
48504528|NCT01544127|156042923|FG000|Overall Study|Researcher withdrew|1|||
48504529|NCT01544127|156042924|FG001|Overall Study|Researcher withdrew|0|||
48504530|NCT01544127|156042925|FG002|Overall Study|Researcher withdrew|0|||
48504531|NCT01544127|156042923|FG000|Overall Study|Went active duty|0|||
48504532|NCT01544127|156042924|FG001|Overall Study|Went active duty|0|||
48504533|NCT01544127|156042925|FG002|Overall Study|Went active duty|1|||
48504534|NCT03699020|156042928|FG000|Overall Study|Withdrawal by Subject|3|||
48504535|NCT03699020|156042929|FG001|Overall Study|Withdrawal by Subject|2|||
48504536|NCT00615069|156042930|FG000|Overall Study|Death|10|||
48504537|NCT00615069|156042930|FG000|Overall Study|Physician Decision|2|||
48504538|NCT00615069|156042930|FG000|Overall Study|Withdrawal by Subject|4|||
48504539|NCT01256684|156042931|FG000|Overall Study|Adverse Event|1|||
48504540|NCT01256684|156042932|FG001|Overall Study|Adverse Event|4|||
48504541|NCT01256684|156042933|FG002|Overall Study|Adverse Event|2|||
48504542|NCT01256684|156042931|FG000|Overall Study|Withdrawal by Subject|4|||
48504543|NCT01256684|156042932|FG001|Overall Study|Withdrawal by Subject|0|||
48504544|NCT01256684|156042933|FG002|Overall Study|Withdrawal by Subject|2|||
48504545|NCT01256684|156042931|FG000|Overall Study|Physician Decision|0|||
48504546|NCT01256684|156042932|FG001|Overall Study|Physician Decision|1|||
48504547|NCT01256684|156042933|FG002|Overall Study|Physician Decision|0|||
48504548|NCT01256684|156042931|FG000|Overall Study|Lack of Efficacy|0|||
48504549|NCT01256684|156042932|FG001|Overall Study|Lack of Efficacy|1|||
48504550|NCT01256684|156042933|FG002|Overall Study|Lack of Efficacy|1|||
48504551|NCT01256684|156042931|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
48504552|NCT01256684|156042932|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
48504553|NCT01256684|156042933|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
48504554|NCT02246920|156042936|FG000|Overall Study|Adverse Event|3|||
48504555|NCT02246920|156042937|FG001|Overall Study|Adverse Event|1|||
48504556|NCT02246920|156042938|FG002|Overall Study|Adverse Event|1|||
48504557|NCT02246920|156042936|FG000|Overall Study|Lost to Follow-up|2|||
48504558|NCT02246920|156042937|FG001|Overall Study|Lost to Follow-up|1|||
48504559|NCT02246920|156042938|FG002|Overall Study|Lost to Follow-up|0|||
48504560|NCT02246920|156042936|FG000|Overall Study|Protocol Violation|2|||
48504561|NCT02246920|156042937|FG001|Overall Study|Protocol Violation|5|||
48504562|NCT02246920|156042938|FG002|Overall Study|Protocol Violation|1|||
48504563|NCT02246920|156042936|FG000|Overall Study|Withdrawal by Subject|0|||
48504564|NCT02246920|156042937|FG001|Overall Study|Withdrawal by Subject|0|||
48504565|NCT02246920|156042938|FG002|Overall Study|Withdrawal by Subject|1|||
48504566|NCT00282048|156042940|FG000|Overall Study|Lack of Efficacy|30|||
48504567|NCT00282048|156042940|FG000|Overall Study|Adverse Event|22|||
48504568|NCT00282048|156042940|FG000|Overall Study|Withdrawal by Subject|1|||
48504569|NCT00282048|156042940|FG000|Overall Study|Other|8|||
48504570|NCT00282048|156042940|FG000|Overall Study|Ongoing|1|||
48504571|NCT02107092|156042941|FG000|Overall Study|Miscellaneous|3|||
48504572|NCT02107092|156042941|FG000|Overall Study|Subject compliance|3|||
48504573|NCT02107092|156042941|FG000|Overall Study|Hypo-or hyperkalemia|2|||
48504574|NCT02107092|156042941|FG000|Overall Study|Met ECG withdrawal criteria|3|||
48504575|NCT02107092|156042941|FG000|Overall Study|Physician Decision|3|||
48504576|NCT02107092|156042941|FG000|Overall Study|Lost to Follow-up|2|||
48504577|NCT02107092|156042941|FG000|Overall Study|Withdrawal by Subject|9|||
48504578|NCT02107092|156042941|FG000|Overall Study|Adverse Event|7|||
48504579|NCT02107092|156042941|FG000|Overall Study|Expected progression of CKD|12|||
48504580|NCT03522675|156042942|FG000|Overall Study|Screen fail|1|||
48504581|NCT03522675|156042942|FG000|Overall Study|Non-reactive to histamine|1|||
48504582|NCT02231749|156042943|FG000|Overall Study|Disease progression|229|||
48504583|NCT02231749|156042944|FG001|Overall Study|Disease progression|297|||
48504584|NCT02231749|156042943|FG000|Overall Study|Study Drug Toxicity|134|||
48504585|NCT02231749|156042944|FG001|Overall Study|Study Drug Toxicity|63|||
48600104|NCT01656395|156391522|FG001|Overall Study|Progressive Disease|0|||
48504586|NCT02231749|156042943|FG000|Overall Study|Death|1|||
48504587|NCT02231749|156042944|FG001|Overall Study|Death|1|||
48504588|NCT02231749|156042943|FG000|Overall Study|AE unrelated to Study drug|32|||
48504589|NCT02231749|156042944|FG001|Overall Study|AE unrelated to Study drug|31|||
48504590|NCT02231749|156042943|FG000|Overall Study|Participant's request to discontinue|10|||
48504591|NCT02231749|156042944|FG001|Overall Study|Participant's request to discontinue|21|||
48504592|NCT02231749|156042943|FG000|Overall Study|Participant withdrew Consent|8|||
48504593|NCT02231749|156042944|FG001|Overall Study|Participant withdrew Consent|15|||
48504594|NCT02231749|156042943|FG000|Overall Study|Lost to Follow-up|1|||
48504595|NCT02231749|156042944|FG001|Overall Study|Lost to Follow-up|2|||
48504596|NCT02231749|156042943|FG000|Overall Study|Maximum Clinical Benefit|5|||
48504597|NCT02231749|156042944|FG001|Overall Study|Maximum Clinical Benefit|8|||
48504598|NCT02231749|156042943|FG000|Overall Study|Poor/Non-Compliance|0|||
48504599|NCT02231749|156042944|FG001|Overall Study|Poor/Non-Compliance|3|||
48504600|NCT02231749|156042943|FG000|Overall Study|Pregnancy|1|||
48504601|NCT02231749|156042944|FG001|Overall Study|Pregnancy|0|||
48504602|NCT02231749|156042943|FG000|Overall Study|other|0|||
48724555|NCT02361346|156840525|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
48819341|NCT01177813|157181799|FG001|Overall Study|Withdrawal by Subject|7|||
48819342|NCT01177813|157181800|FG002|Overall Study|Withdrawal by Subject|6|||
48819343|NCT01177813|157181801|FG003|Overall Study|Withdrawal by Subject|5|||
48819344|NCT01177813|157181802|FG004|Overall Study|Withdrawal by Subject|3|||
48819345|NCT01177813|157181798|FG000|Overall Study|Other reason not defined above|5|||
48819346|NCT01177813|157181799|FG001|Overall Study|Other reason not defined above|2|||
48819347|NCT01177813|157181800|FG002|Overall Study|Other reason not defined above|2|||
48819348|NCT01177813|157181801|FG003|Overall Study|Other reason not defined above|3|||
48819349|NCT01177813|157181802|FG004|Overall Study|Other reason not defined above|2|||
48819350|NCT02886728|157181804|FG000|Overall Study|Withdrew Consent|31|||
48819351|NCT02886728|157181805|FG001|Overall Study|Withdrew Consent|13|||
48819352|NCT02886728|157181806|FG002|Overall Study|Withdrew Consent|11|||
48819353|NCT02886728|157181807|FG003|Overall Study|Withdrew Consent|47|||
48819354|NCT02886728|157181804|FG000|Overall Study|Lost to Follow-up|12|||
48819355|NCT02886728|157181805|FG001|Overall Study|Lost to Follow-up|6|||
48819356|NCT02886728|157181806|FG002|Overall Study|Lost to Follow-up|13|||
48724556|NCT02361346|156840526|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724557|NCT02361346|156840527|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724558|NCT02361346|156840528|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724559|NCT02361346|156840529|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724560|NCT02361346|156840530|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
48724561|NCT02361346|156840522|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724562|NCT02361346|156840523|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724563|NCT02361346|156840524|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724564|NCT02361346|156840525|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724565|NCT02361346|156840526|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
48724566|NCT02361346|156840527|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724567|NCT02361346|156840528|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724568|NCT02361346|156840529|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724569|NCT02361346|156840530|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
48724570|NCT02361346|156840522|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
48724571|NCT02361346|156840523|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
48724572|NCT02361346|156840524|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
48724573|NCT02361346|156840525|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
48724574|NCT02361346|156840526|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
48724575|NCT02361346|156840527|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
48724576|NCT02361346|156840528|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
48724577|NCT02361346|156840529|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
48724578|NCT02361346|156840530|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
48724579|NCT02361346|156840522|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724580|NCT02361346|156840523|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724581|NCT02361346|156840524|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724582|NCT02361346|156840525|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724583|NCT02361346|156840526|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724584|NCT02361346|156840527|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724585|NCT02361346|156840528|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724586|NCT02361346|156840529|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
48724587|NCT02361346|156840530|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
48724588|NCT02361346|156840522|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724589|NCT02361346|156840523|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724590|NCT02361346|156840524|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724591|NCT02361346|156840525|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724592|NCT02361346|156840526|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724593|NCT02361346|156840527|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724594|NCT02361346|156840528|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724595|NCT02361346|156840529|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
48724596|NCT02361346|156840530|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
48724597|NCT02361346|156840522|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724598|NCT02361346|156840523|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724599|NCT02361346|156840524|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724600|NCT02361346|156840525|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724601|NCT02361346|156840526|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724602|NCT02361346|156840527|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48819357|NCT02886728|157181807|FG003|Overall Study|Lost to Follow-up|12|||
48819358|NCT02886728|157181804|FG000|Overall Study|Adverse Event|13|||
48819359|NCT02886728|157181805|FG001|Overall Study|Adverse Event|5|||
48819360|NCT02886728|157181806|FG002|Overall Study|Adverse Event|5|||
48504603|NCT02231749|156042944|FG001|Overall Study|other|8|||
48504604|NCT02231749|156042943|FG000|Overall Study|No longer meets Study Criteria|1|||
48504605|NCT02231749|156042944|FG001|Overall Study|No longer meets Study Criteria|0|||
48504606|NCT00184600|156042945|FG000|Overall Study|Adverse Event|9|||
48504607|NCT00184600|156042946|FG001|Overall Study|Adverse Event|0|||
48504608|NCT00184600|156042947|FG002|Overall Study|Adverse Event|5|||
48504609|NCT00184600|156042945|FG000|Overall Study|Death|3|||
48504610|NCT00184600|156042946|FG001|Overall Study|Death|9|||
48504611|NCT00184600|156042947|FG002|Overall Study|Death|7|||
48504612|NCT00184600|156042945|FG000|Overall Study|Lack of Efficacy|3|||
48504613|NCT00184600|156042946|FG001|Overall Study|Lack of Efficacy|1|||
48504614|NCT00184600|156042947|FG002|Overall Study|Lack of Efficacy|3|||
48504615|NCT00184600|156042945|FG000|Overall Study|Lost to Follow-up|4|||
48504616|NCT00184600|156042946|FG001|Overall Study|Lost to Follow-up|6|||
48504617|NCT00184600|156042947|FG002|Overall Study|Lost to Follow-up|1|||
48504618|NCT00184600|156042945|FG000|Overall Study|Protocol Violation|2|||
48504619|NCT00184600|156042946|FG001|Overall Study|Protocol Violation|2|||
48504620|NCT00184600|156042947|FG002|Overall Study|Protocol Violation|3|||
48504621|NCT00184600|156042945|FG000|Overall Study|Withdrawal by Subject|20|||
48504622|NCT00184600|156042946|FG001|Overall Study|Withdrawal by Subject|28|||
48504623|NCT00184600|156042947|FG002|Overall Study|Withdrawal by Subject|12|||
48504624|NCT00184600|156042945|FG000|Overall Study|Unclassified|4|||
48504625|NCT00184600|156042946|FG001|Overall Study|Unclassified|5|||
48504626|NCT00184600|156042947|FG002|Overall Study|Unclassified|3|||
48504627|NCT00707161|156042950|FG000|Overall Study|Physician Decision|6|||
48504628|NCT02674477|156042951|FG000|Overall Study|Protocol Violation|8|||
48504629|NCT02674477|156042952|FG001|Overall Study|Protocol Violation|2|||
48504630|NCT00735904|156042953|FG000|Overall Study|Adverse Event|3|||
48504631|NCT00735904|156042953|FG000|Overall Study|Death|20|||
48504632|NCT00735904|156042953|FG000|Overall Study|Protocol Violation|1|||
48504633|NCT00735904|156042953|FG000|Overall Study|Withdrawal by Subject|1|||
48504634|NCT00735904|156042953|FG000|Overall Study|Study Terminated by Sponsor|5|||
48504635|NCT00735904|156042953|FG000|Overall Study|Other|8|||
48504636|NCT00610363|156042954|FG000|Overall Study|Non-compliance with protocol|0|||
48504637|NCT00610363|156042955|FG001|Overall Study|Non-compliance with protocol|1|||
48504638|NCT00610363|156042954|FG000|Overall Study|Adverse Event|3|||
48504639|NCT00610363|156042955|FG001|Overall Study|Adverse Event|1|||
48504640|NCT00610363|156042954|FG000|Overall Study|Lack of Efficacy|2|||
48504641|NCT00610363|156042955|FG001|Overall Study|Lack of Efficacy|0|||
48504642|NCT00610363|156042954|FG000|Overall Study|Lost to Follow-up|4|||
48504643|NCT00610363|156042955|FG001|Overall Study|Lost to Follow-up|0|||
48504644|NCT00610363|156042954|FG000|Overall Study|Withdrawal by Subject|1|||
48504645|NCT00610363|156042955|FG001|Overall Study|Withdrawal by Subject|0|||
48504646|NCT00610363|156042954|FG000|Overall Study|Other than specified above|1|||
48504647|NCT00610363|156042955|FG001|Overall Study|Other than specified above|1|||
48504648|NCT00336479|156042956|FG000|Overall Study|Adverse Event|8|||
48504649|NCT00336479|156042957|FG001|Overall Study|Adverse Event|11|||
48504650|NCT00336479|156042958|FG002|Overall Study|Adverse Event|18|||
48504651|NCT00336479|156042959|FG003|Overall Study|Adverse Event|4|||
48504652|NCT00336479|156042956|FG000|Overall Study|Noncompliant|1|||
48504653|NCT00336479|156042957|FG001|Overall Study|Noncompliant|7|||
48504654|NCT00336479|156042958|FG002|Overall Study|Noncompliant|3|||
48504655|NCT00336479|156042959|FG003|Overall Study|Noncompliant|0|||
48504656|NCT00336479|156042956|FG000|Overall Study|Physician Decision|2|||
48504657|NCT00336479|156042957|FG001|Overall Study|Physician Decision|3|||
48504658|NCT00336479|156042958|FG002|Overall Study|Physician Decision|1|||
48504659|NCT00336479|156042959|FG003|Overall Study|Physician Decision|0|||
48504660|NCT00336479|156042956|FG000|Overall Study|Lost to Follow-up|3|||
48600105|NCT01656395|156391523|FG002|Overall Study|Progressive Disease|0|||
48600106|NCT01656395|156391524|FG003|Overall Study|Progressive Disease|0|||
48600107|NCT01656395|156391525|FG004|Overall Study|Progressive Disease|0|||
48600108|NCT01656395|156391526|FG005|Overall Study|Progressive Disease|1|||
48600109|NCT01656395|156391527|FG006|Overall Study|Progressive Disease|0|||
48600110|NCT01656395|156391528|FG007|Overall Study|Progressive Disease|0|||
48504661|NCT00336479|156042957|FG001|Overall Study|Lost to Follow-up|2|||
48504662|NCT00336479|156042958|FG002|Overall Study|Lost to Follow-up|0|||
48504663|NCT00336479|156042959|FG003|Overall Study|Lost to Follow-up|0|||
48504664|NCT00336479|156042956|FG000|Overall Study|Withdrawal by Subject|3|||
48504665|NCT00336479|156042957|FG001|Overall Study|Withdrawal by Subject|2|||
48600111|NCT01656395|156391521|FG000|Overall Study|Protocol Violation|6|||
48504666|NCT00336479|156042958|FG002|Overall Study|Withdrawal by Subject|3|||
48504667|NCT00336479|156042959|FG003|Overall Study|Withdrawal by Subject|0|||
48504668|NCT00336479|156042956|FG000|Overall Study|Other|0|||
48504669|NCT00336479|156042957|FG001|Overall Study|Other|0|||
48504670|NCT00336479|156042958|FG002|Overall Study|Other|1|||
48504671|NCT00336479|156042959|FG003|Overall Study|Other|0|||
48504672|NCT00336479|156042956|FG000|Overall Study|Virologic Stopping Rule|20|||
48504673|NCT00336479|156042957|FG001|Overall Study|Virologic Stopping Rule|0|||
48504674|NCT00336479|156042958|FG002|Overall Study|Virologic Stopping Rule|0|||
48504675|NCT00336479|156042959|FG003|Overall Study|Virologic Stopping Rule|0|||
48504676|NCT02008565|156042962|FG000|Overall Study|Protocol Violation|1|||
48504677|NCT02008565|156042963|FG001|Overall Study|Protocol Violation|1|||
48504678|NCT02008565|156042964|FG002|Overall Study|Protocol Violation|2|||
48724603|NCT02361346|156840528|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724604|NCT02361346|156840529|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
48724605|NCT02361346|156840530|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
48724606|NCT03571386|156840531|FG000|Overall Study|scheduling conflict|4|||
48724607|NCT03571386|156840532|FG001|Overall Study|scheduling conflict|0|||
48724608|NCT03571386|156840531|FG000|Overall Study|Withdrawal by Subject|15|||
48724609|NCT03571386|156840532|FG001|Overall Study|Withdrawal by Subject|5|||
48724610|NCT04571515|156840533|FG000|Overall Study|Physician Decision|0|||
48724611|NCT04571515|156840534|FG001|Overall Study|Physician Decision|0|||
48724612|NCT04571515|156840535|FG002|Overall Study|Physician Decision|0|||
48724613|NCT04571515|156840536|FG003|Overall Study|Physician Decision|0|||
48724614|NCT04571515|156840537|FG004|Overall Study|Physician Decision|1|||
48724615|NCT04571515|156840533|FG000|Overall Study|Withdrawal by Subject|0|||
48724616|NCT04571515|156840534|FG001|Overall Study|Withdrawal by Subject|0|||
48724617|NCT04571515|156840535|FG002|Overall Study|Withdrawal by Subject|0|||
48724618|NCT04571515|156840536|FG003|Overall Study|Withdrawal by Subject|0|||
48724619|NCT04571515|156840537|FG004|Overall Study|Withdrawal by Subject|1|||
48724620|NCT04571515|156840533|FG000|Overall Study|insufficient pain|1|||
48724621|NCT04571515|156840534|FG001|Overall Study|insufficient pain|0|||
48724622|NCT04571515|156840535|FG002|Overall Study|insufficient pain|0|||
48724623|NCT04571515|156840536|FG003|Overall Study|insufficient pain|0|||
48724624|NCT04571515|156840537|FG004|Overall Study|insufficient pain|1|||
48724625|NCT03670836|156840545|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
48724626|NCT03670836|156840546|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
48724627|NCT03670836|156840545|FG000|Per Protocol Population (PP)|Physician Decision|9|||
48504679|NCT02008565|156042965|FG003|Overall Study|Protocol Violation|0|||
48504680|NCT02100228|156042966|FG000|Overall Study|Other|19|||
48504681|NCT02100228|156042967|FG001|Overall Study|Other|19|||
48504682|NCT02100228|156042966|FG000|Overall Study|Administrative reason|0|||
48504683|NCT02100228|156042967|FG001|Overall Study|Administrative reason|1|||
48504684|NCT02100228|156042966|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
48504685|NCT02100228|156042967|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
48504686|NCT02100228|156042966|FG000|Overall Study|Non-compliance|0|||
48504687|NCT02100228|156042967|FG001|Overall Study|Non-compliance|3|||
48504688|NCT02100228|156042966|FG000|Overall Study|Lost to Follow-up|0|||
48504689|NCT02100228|156042967|FG001|Overall Study|Lost to Follow-up|1|||
48504690|NCT02100228|156042966|FG000|Overall Study|Withdrawal by Subject|27|||
48504691|NCT02100228|156042967|FG001|Overall Study|Withdrawal by Subject|37|||
48504692|NCT02100228|156042966|FG000|Overall Study|Adverse Event|16|||
48504693|NCT02100228|156042967|FG001|Overall Study|Adverse Event|12|||
48504694|NCT02100228|156042966|FG000|Overall Study|Death|1|||
48504695|NCT02100228|156042967|FG001|Overall Study|Death|1|||
48504696|NCT02605928|156042968|FG000|Overall Study|Model tuning phase|28|||
48504697|NCT02605928|156042968|FG000|Overall Study|Lack of Efficacy|5|||
48504698|NCT04625413|156042969|FG000|Overall Study|Hospice|2|||
48504699|NCT04625413|156042969|FG000|Overall Study|Distress|1|||
48504700|NCT04625413|156042969|FG000|Overall Study|Not feeling well|1|||
48504701|NCT02612337|156042972|FG000|Overall Study|Lack of Efficacy|1|||
48724628|NCT03670836|156840546|FG001|Per Protocol Population (PP)|Physician Decision|10|||
48504702|NCT02612337|156042973|FG001|Overall Study|Lack of Efficacy|0|||
48724629|NCT03670836|156840545|FG000|Per Protocol Population (PP)|Physician Decision|4|||
48724630|NCT03670836|156840546|FG001|Per Protocol Population (PP)|Physician Decision|6|||
48724631|NCT03670836|156840545|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
48724632|NCT03670836|156840546|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
48724633|NCT00718081|156842000|FG000|Overall Study|Adverse Event|0|||
48724634|NCT00718081|156842001|FG001|Overall Study|Adverse Event|1|||
48724635|NCT00718081|156842002|FG002|Overall Study|Adverse Event|0|||
48504703|NCT02612337|156042972|FG000|Overall Study|Withdrawal by Subject|2|||
48504704|NCT02612337|156042973|FG001|Overall Study|Withdrawal by Subject|2|||
48504705|NCT02612337|156042972|FG000|Overall Study|Did not receive study drug|0|||
48724636|NCT00718081|156842000|FG000|Overall Study|Lack of Efficacy|7|||
48724637|NCT00718081|156842001|FG001|Overall Study|Lack of Efficacy|3|||
48724638|NCT00718081|156842002|FG002|Overall Study|Lack of Efficacy|21|||
48724639|NCT03281291|156842004|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
48724640|NCT03281291|156842005|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
48724641|NCT03281291|156842006|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
48724642|NCT03281291|156842007|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
48724643|NCT03281291|156842008|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
48724644|NCT03281291|156842004|FG000|Overall Study|Protocol Deviation|2|||
48724645|NCT03281291|156842005|FG001|Overall Study|Protocol Deviation|0|||
48724646|NCT03281291|156842006|FG002|Overall Study|Protocol Deviation|1|||
48724647|NCT03281291|156842007|FG003|Overall Study|Protocol Deviation|2|||
48724648|NCT03281291|156842008|FG004|Overall Study|Protocol Deviation|1|||
48724649|NCT03281291|156842004|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
48504706|NCT02612337|156042973|FG001|Overall Study|Did not receive study drug|1|||
48504707|NCT02441309|156042974|FG000|Overall Study|Disease progression|2|||
48504708|NCT02441309|156042975|FG001|Overall Study|Disease progression|1|||
48504709|NCT02441309|156042976|FG002|Overall Study|Disease progression|2|||
48504710|NCT02441309|156042974|FG000|Overall Study|Adverse Event|0|||
48819361|NCT02886728|157181807|FG003|Overall Study|Adverse Event|11|||
48819362|NCT02886728|157181804|FG000|Overall Study|Investigator's Discretion|11|||
48819363|NCT02886728|157181805|FG001|Overall Study|Investigator's Discretion|7|||
48819364|NCT02886728|157181806|FG002|Overall Study|Investigator's Discretion|5|||
48504711|NCT02441309|156042975|FG001|Overall Study|Adverse Event|1|||
48504712|NCT02441309|156042976|FG002|Overall Study|Adverse Event|0|||
48504713|NCT02441309|156042974|FG000|Overall Study|Withdrawal by Subject|1|||
48504714|NCT02441309|156042975|FG001|Overall Study|Withdrawal by Subject|0|||
48504715|NCT02441309|156042976|FG002|Overall Study|Withdrawal by Subject|1|||
48504716|NCT00854100|156042977|FG000|Overall Study|Inability to complete the study visits|0|||
48504717|NCT00854100|156042978|FG001|Overall Study|Inability to complete the study visits|0|||
48504718|NCT00854100|156042979|FG002|Overall Study|Inability to complete the study visits|1|||
48504719|NCT00854100|156042977|FG000|Overall Study|Lost to Follow-up|2|||
48504720|NCT00854100|156042978|FG001|Overall Study|Lost to Follow-up|0|||
48504721|NCT00854100|156042979|FG002|Overall Study|Lost to Follow-up|3|||
48504722|NCT00854100|156042977|FG000|Overall Study|Withdrawal by Subject|3|||
48504723|NCT00854100|156042978|FG001|Overall Study|Withdrawal by Subject|1|||
48504724|NCT00854100|156042979|FG002|Overall Study|Withdrawal by Subject|2|||
48504725|NCT00854100|156042977|FG000|Overall Study|Protocol Violation|2|||
48504726|NCT00854100|156042978|FG001|Overall Study|Protocol Violation|4|||
48504727|NCT00854100|156042979|FG002|Overall Study|Protocol Violation|3|||
48504728|NCT00854100|156042977|FG000|Overall Study|Adverse Event|2|||
48504729|NCT00854100|156042978|FG001|Overall Study|Adverse Event|1|||
48504730|NCT00854100|156042979|FG002|Overall Study|Adverse Event|2|||
48504731|NCT01027143|156044438|FG000|Overall Study|Lost to Follow-up|9|||
48504732|NCT01027143|156044439|FG001|Overall Study|Lost to Follow-up|4|||
48504733|NCT00416520|156044441|FG000|Open-label Period|Adverse Event|28|||
48504734|NCT00416520|156044442|FG001|Open-label Period|Adverse Event|10|||
48504735|NCT00416520|156044443|FG002|Open-label Period|Adverse Event|0|||
48504736|NCT00416520|156044444|FG003|Open-label Period|Adverse Event|0|||
48504737|NCT00416520|156044441|FG000|Open-label Period|Death|2|||
48504738|NCT00416520|156044442|FG001|Open-label Period|Death|1|||
48504739|NCT00416520|156044443|FG002|Open-label Period|Death|0|||
48504740|NCT00416520|156044444|FG003|Open-label Period|Death|0|||
48504741|NCT00416520|156044441|FG000|Open-label Period|Lack of Efficacy|8|||
48504742|NCT00416520|156044442|FG001|Open-label Period|Lack of Efficacy|1|||
48504743|NCT00416520|156044443|FG002|Open-label Period|Lack of Efficacy|0|||
48504744|NCT00416520|156044444|FG003|Open-label Period|Lack of Efficacy|0|||
48504745|NCT00416520|156044441|FG000|Open-label Period|Protocol Violation|3|||
48504746|NCT00416520|156044442|FG001|Open-label Period|Protocol Violation|3|||
48504747|NCT00416520|156044443|FG002|Open-label Period|Protocol Violation|0|||
48504748|NCT00416520|156044444|FG003|Open-label Period|Protocol Violation|0|||
48504749|NCT00416520|156044441|FG000|Open-label Period|Withdrawal by Subject|16|||
48504750|NCT00416520|156044442|FG001|Open-label Period|Withdrawal by Subject|5|||
48504751|NCT00416520|156044443|FG002|Open-label Period|Withdrawal by Subject|0|||
48504752|NCT00416520|156044444|FG003|Open-label Period|Withdrawal by Subject|0|||
48504753|NCT00416520|156044441|FG000|Open-label Period|Other Reasons|3|||
48504754|NCT00416520|156044442|FG001|Open-label Period|Other Reasons|12|||
48504755|NCT00416520|156044443|FG002|Open-label Period|Other Reasons|0|||
48504756|NCT00416520|156044444|FG003|Open-label Period|Other Reasons|0|||
48504757|NCT00416520|156044441|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
48504758|NCT00416520|156044442|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
48504759|NCT00416520|156044443|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
48504760|NCT00416520|156044444|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
48504761|NCT00416520|156044441|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
48504762|NCT00416520|156044442|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
48504763|NCT00416520|156044443|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
48504764|NCT00416520|156044444|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
48504765|NCT00416520|156044441|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
48504766|NCT00416520|156044442|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
48504767|NCT00416520|156044443|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
48504768|NCT00416520|156044444|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
48504769|NCT01248247|156044445|FG000|Overall Study|Adverse Event|2|||
48504770|NCT01248247|156044446|FG001|Overall Study|Adverse Event|4|||
48504771|NCT01248247|156044447|FG002|Overall Study|Adverse Event|4|||
48504772|NCT01248247|156044448|FG003|Overall Study|Adverse Event|2|||
48504773|NCT01248247|156044445|FG000|Overall Study|Death|0|||
48504774|NCT01248247|156044446|FG001|Overall Study|Death|1|||
48504775|NCT01248247|156044447|FG002|Overall Study|Death|4|||
48504776|NCT01248247|156044448|FG003|Overall Study|Death|7|||
48504777|NCT01248247|156044445|FG000|Overall Study|Lost to Follow-up|0|||
48600112|NCT01656395|156391522|FG001|Overall Study|Protocol Violation|6|||
48600113|NCT01656395|156391523|FG002|Overall Study|Protocol Violation|9|||
48724650|NCT03281291|156842005|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
48724651|NCT03281291|156842006|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
48504778|NCT01248247|156044446|FG001|Overall Study|Lost to Follow-up|1|||
48504779|NCT01248247|156044447|FG002|Overall Study|Lost to Follow-up|1|||
48504780|NCT01248247|156044448|FG003|Overall Study|Lost to Follow-up|0|||
48504781|NCT01248247|156044445|FG000|Overall Study|Alternative treatment|0|||
48724652|NCT03281291|156842007|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
48724653|NCT03281291|156842008|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
48724654|NCT03281291|156842004|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
48724655|NCT03281291|156842005|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
48724656|NCT03281291|156842006|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
48724657|NCT03281291|156842007|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
48724658|NCT03281291|156842008|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
48600114|NCT01656395|156391524|FG003|Overall Study|Protocol Violation|2|||
48600115|NCT01656395|156391525|FG004|Overall Study|Protocol Violation|4|||
48600116|NCT01656395|156391526|FG005|Overall Study|Protocol Violation|10|||
48600117|NCT01656395|156391527|FG006|Overall Study|Protocol Violation|0|||
48600118|NCT01656395|156391528|FG007|Overall Study|Protocol Violation|0|||
48600119|NCT01656395|156391521|FG000|Overall Study|Screen Failure|2|||
48724659|NCT03281291|156842004|FG000|Overall Study|Lost to Follow-up|10|||
48724660|NCT03281291|156842005|FG001|Overall Study|Lost to Follow-up|10|||
48724661|NCT03281291|156842006|FG002|Overall Study|Lost to Follow-up|4|||
48724662|NCT03281291|156842007|FG003|Overall Study|Lost to Follow-up|6|||
48724663|NCT03281291|156842008|FG004|Overall Study|Lost to Follow-up|10|||
48724664|NCT03281291|156842004|FG000|Overall Study|Other|0|||
48724665|NCT03281291|156842005|FG001|Overall Study|Other|2|||
48724666|NCT03281291|156842006|FG002|Overall Study|Other|0|||
48724667|NCT03281291|156842007|FG003|Overall Study|Other|2|||
48724668|NCT03281291|156842008|FG004|Overall Study|Other|1|||
48724669|NCT04956861|156842009|FG000|Overall Study|Withdrawal by Subject|4|||
48724670|NCT04956861|156842010|FG001|Overall Study|Withdrawal by Subject|4|||
48724671|NCT04956861|156842011|FG002|Overall Study|Withdrawal by Subject|2|||
48724672|NCT04956861|156842009|FG000|Overall Study|Physician Decision|4|||
48724673|NCT04956861|156842010|FG001|Overall Study|Physician Decision|5|||
48724674|NCT04956861|156842011|FG002|Overall Study|Physician Decision|1|||
48819365|NCT02886728|157181807|FG003|Overall Study|Investigator's Discretion|11|||
48819366|NCT02886728|157181804|FG000|Overall Study|Death|3|||
48819367|NCT02886728|157181805|FG001|Overall Study|Death|1|||
48819368|NCT02886728|157181806|FG002|Overall Study|Death|0|||
48819369|NCT02886728|157181807|FG003|Overall Study|Death|0|||
48819370|NCT02886728|157181804|FG000|Overall Study|Protocol Violation|0|||
48819371|NCT02886728|157181805|FG001|Overall Study|Protocol Violation|0|||
48819372|NCT02886728|157181806|FG002|Overall Study|Protocol Violation|0|||
48819373|NCT02886728|157181807|FG003|Overall Study|Protocol Violation|4|||
48819374|NCT02886728|157181804|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48819375|NCT02886728|157181805|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48819376|NCT02886728|157181806|FG002|Overall Study|Non-Compliance with Study Drug|1|||
48504782|NCT01248247|156044446|FG001|Overall Study|Alternative treatment|1|||
48504783|NCT01248247|156044447|FG002|Overall Study|Alternative treatment|0|||
48504784|NCT01248247|156044448|FG003|Overall Study|Alternative treatment|0|||
48504785|NCT01248247|156044445|FG000|Overall Study|Other|2|||
48600120|NCT01656395|156391522|FG001|Overall Study|Screen Failure|1|||
48600121|NCT01656395|156391523|FG002|Overall Study|Screen Failure|7|||
48600122|NCT01656395|156391524|FG003|Overall Study|Screen Failure|1|||
48600123|NCT01656395|156391525|FG004|Overall Study|Screen Failure|0|||
48724675|NCT03355664|156842012|FG000|Overall Study|Adverse Event|1|||
48724676|NCT03355664|156842013|FG001|Overall Study|Adverse Event|2|||
48724677|NCT03355664|156842012|FG000|Overall Study|Lost to Follow-up|11|||
48724678|NCT03355664|156842013|FG001|Overall Study|Lost to Follow-up|7|||
48819377|NCT02886728|157181807|FG003|Overall Study|Non-Compliance with Study Drug|0|||
48819378|NCT02886728|157181804|FG000|Overall Study|Pregnancy|0|||
48600124|NCT01656395|156391526|FG005|Overall Study|Screen Failure|8|||
48724679|NCT03355664|156842012|FG000|Overall Study|Protocol Violation|1|||
48724680|NCT03355664|156842013|FG001|Overall Study|Protocol Violation|2|||
48724681|NCT03355664|156842012|FG000|Overall Study|Withdrawal by Subject|2|||
48724682|NCT03355664|156842013|FG001|Overall Study|Withdrawal by Subject|1|||
48819379|NCT02886728|157181805|FG001|Overall Study|Pregnancy|0|||
48819380|NCT02886728|157181806|FG002|Overall Study|Pregnancy|1|||
48819381|NCT02886728|157181807|FG003|Overall Study|Pregnancy|0|||
48504786|NCT01248247|156044446|FG001|Overall Study|Other|8|||
48504787|NCT01248247|156044447|FG002|Overall Study|Other|8|||
48600125|NCT01656395|156391527|FG006|Overall Study|Screen Failure|0|||
48600126|NCT01656395|156391528|FG007|Overall Study|Screen Failure|0|||
48724683|NCT00290407|156842014|FG000|Overall Study|Physician Decision|2|||
48819382|NCT02886728|157181804|FG000|Overall Study|Randomized but Not Dosed|1|||
48600127|NCT01656395|156391521|FG000|Overall Study|Withdrawal by Subject|3|||
48600128|NCT01656395|156391522|FG001|Overall Study|Withdrawal by Subject|1|||
48600129|NCT01656395|156391523|FG002|Overall Study|Withdrawal by Subject|4|||
48600130|NCT01656395|156391524|FG003|Overall Study|Withdrawal by Subject|2|||
48600131|NCT01656395|156391525|FG004|Overall Study|Withdrawal by Subject|0|||
48600132|NCT01656395|156391526|FG005|Overall Study|Withdrawal by Subject|3|||
48600133|NCT01656395|156391527|FG006|Overall Study|Withdrawal by Subject|0|||
48600134|NCT01656395|156391528|FG007|Overall Study|Withdrawal by Subject|0|||
48600135|NCT02168491|156391529|FG000|Overall Study|Withdrawal by Subject|1|||
48600136|NCT01610037|156391530|FG000|All Patients|Adverse Event|27|||
48600137|NCT01610037|156391531|FG001|All Patients|Adverse Event|22|||
48600138|NCT01610037|156391532|FG002|All Patients|Adverse Event|26|||
48600139|NCT01610037|156391530|FG000|All Patients|Withdrawal by Subject|12|||
48600140|NCT01610037|156391531|FG001|All Patients|Withdrawal by Subject|10|||
48600141|NCT01610037|156391532|FG002|All Patients|Withdrawal by Subject|20|||
48600142|NCT01610037|156391530|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
48600143|NCT01610037|156391531|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
48600144|NCT01610037|156391532|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
48600145|NCT01610037|156391530|FG000|All Patients|Death|4|||
48600146|NCT01610037|156391531|FG001|All Patients|Death|2|||
48600147|NCT01610037|156391532|FG002|All Patients|Death|1|||
48600148|NCT01610037|156391530|FG000|All Patients|Protocol deviation|4|||
48724684|NCT03915860|156842017|FG000|Overall Study|Adverse Event|3|||
48438295|NCT02559206|155792002|FG003|Overall Study|Lack of Efficacy|2|||
48438296|NCT02559206|155792003|FG004|Overall Study|Lack of Efficacy|2|||
48438297|NCT02559206|155792004|FG005|Overall Study|Lack of Efficacy|3|||
48438298|NCT02559206|155792005|FG006|Overall Study|Lack of Efficacy|3|||
48438299|NCT02559206|155792006|FG007|Overall Study|Lack of Efficacy|3|||
48438300|NCT02559206|155791999|FG000|Overall Study|Other Not Specified|0|||
48438301|NCT02559206|155792000|FG001|Overall Study|Other Not Specified|0|||
48438302|NCT02559206|155792001|FG002|Overall Study|Other Not Specified|0|||
48438303|NCT02559206|155792002|FG003|Overall Study|Other Not Specified|1|||
48438304|NCT02559206|155792003|FG004|Overall Study|Other Not Specified|0|||
48438305|NCT02559206|155792004|FG005|Overall Study|Other Not Specified|0|||
48438306|NCT02559206|155792005|FG006|Overall Study|Other Not Specified|0|||
48438307|NCT02559206|155792006|FG007|Overall Study|Other Not Specified|0|||
48438308|NCT01963208|155792007|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
48438309|NCT01963208|155792008|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
48438310|NCT01963208|155792009|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
48438311|NCT01963208|155792010|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
48438312|NCT01963208|155792011|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
48438313|NCT01963208|155792012|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
48438314|NCT01963208|155792007|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
48438315|NCT01963208|155792008|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
48438316|NCT01963208|155792009|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
48438317|NCT01963208|155792010|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
48438318|NCT01963208|155792011|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
48438319|NCT01963208|155792012|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
48438320|NCT01963208|155792007|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48438321|NCT01963208|155792008|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48438322|NCT01963208|155792009|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
48438323|NCT01963208|155792010|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48438324|NCT01963208|155792011|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48438325|NCT01963208|155792012|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
48438326|NCT01963208|155792007|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
48438327|NCT01963208|155792008|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
48438328|NCT01963208|155792009|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
48438329|NCT01963208|155792010|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
48438330|NCT01963208|155792011|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
48438331|NCT01963208|155792012|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
48438332|NCT01963208|155792007|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
48438333|NCT01963208|155792008|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
48438334|NCT01963208|155792009|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
48438335|NCT01963208|155792010|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
48438336|NCT01963208|155792011|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
48438337|NCT01963208|155792012|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
48438338|NCT01963208|155792007|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48438339|NCT01963208|155792008|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48438340|NCT01963208|155792009|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48438341|NCT01963208|155792010|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
48438342|NCT01963208|155792011|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48504788|NCT01248247|156044448|FG003|Overall Study|Other|5|||
48504789|NCT01248247|156044445|FG000|Overall Study|Progression|18|||
48504790|NCT01248247|156044446|FG001|Overall Study|Progression|27|||
48504791|NCT01248247|156044447|FG002|Overall Study|Progression|56|||
48504792|NCT01248247|156044448|FG003|Overall Study|Progression|44|||
48504793|NCT01248247|156044445|FG000|Overall Study|Refuse further treatment|0|||
48504794|NCT01248247|156044446|FG001|Overall Study|Refuse further treatment|0|||
48504795|NCT01248247|156044447|FG002|Overall Study|Refuse further treatment|1|||
48504796|NCT01248247|156044448|FG003|Overall Study|Refuse further treatment|2|||
48504797|NCT01248247|156044445|FG000|Overall Study|Complicating disease|0|||
48504798|NCT01248247|156044446|FG001|Overall Study|Complicating disease|0|||
48504799|NCT01248247|156044447|FG002|Overall Study|Complicating disease|1|||
48504800|NCT01248247|156044448|FG003|Overall Study|Complicating disease|1|||
48504801|NCT03292653|156044449|FG000|Overall Study|Adverse Event|0|||
48504802|NCT03292653|156044450|FG001|Overall Study|Adverse Event|0|||
48504803|NCT03292653|156044451|FG002|Overall Study|Adverse Event|1|||
48504804|NCT03292653|156044449|FG000|Overall Study|Did not Receive Treatment|1|||
48504805|NCT03292653|156044450|FG001|Overall Study|Did not Receive Treatment|0|||
48504806|NCT03292653|156044451|FG002|Overall Study|Did not Receive Treatment|0|||
48504807|NCT04178733|156044452|FG000|Overall Study|Investigator Decision|0|||
48504808|NCT04178733|156044453|FG001|Overall Study|Investigator Decision|0|||
48504809|NCT04178733|156044454|FG002|Overall Study|Investigator Decision|0|||
48504810|NCT04178733|156044455|FG003|Overall Study|Investigator Decision|1|||
48504811|NCT04178733|156044456|FG004|Overall Study|Investigator Decision|2|||
48504812|NCT03785548|156044461|FG000|Overall Study|age > 80|1|||
48504813|NCT03785548|156044462|FG001|Overall Study|age > 80|0|||
48504814|NCT03785548|156044461|FG000|Overall Study|no Postop queries|1|||
48504815|NCT03785548|156044462|FG001|Overall Study|no Postop queries|0|||
48504816|NCT00880568|156044463|FG000|Overall Study|Disease progression|3|||
48504817|NCT00880568|156044464|FG001|Overall Study|Disease progression|3|||
48504818|NCT00880568|156044465|FG002|Overall Study|Disease progression|3|||
48504819|NCT00880568|156044466|FG003|Overall Study|Disease progression|1|||
48504820|NCT00880568|156044467|FG004|Overall Study|Disease progression|3|||
48504821|NCT00880568|156044468|FG005|Overall Study|Disease progression|3|||
48504822|NCT00880568|156044469|FG006|Overall Study|Disease progression|5|||
48504823|NCT00880568|156044470|FG007|Overall Study|Disease progression|0|||
48504824|NCT00880568|156044471|FG008|Overall Study|Disease progression|3|||
48504825|NCT00880568|156044463|FG000|Overall Study|Adverse Event|0|||
48504826|NCT00880568|156044464|FG001|Overall Study|Adverse Event|0|||
48504827|NCT00880568|156044465|FG002|Overall Study|Adverse Event|0|||
48504828|NCT00880568|156044466|FG003|Overall Study|Adverse Event|0|||
48504829|NCT00880568|156044467|FG004|Overall Study|Adverse Event|0|||
48504830|NCT00880568|156044468|FG005|Overall Study|Adverse Event|0|||
48504831|NCT00880568|156044469|FG006|Overall Study|Adverse Event|1|||
48504832|NCT00880568|156044470|FG007|Overall Study|Adverse Event|1|||
48504833|NCT00880568|156044471|FG008|Overall Study|Adverse Event|0|||
48504834|NCT00880568|156044463|FG000|Overall Study|Withdrawal by Subject|0|||
48504835|NCT00880568|156044464|FG001|Overall Study|Withdrawal by Subject|0|||
48504836|NCT00880568|156044465|FG002|Overall Study|Withdrawal by Subject|0|||
48504837|NCT00880568|156044466|FG003|Overall Study|Withdrawal by Subject|0|||
48504838|NCT00880568|156044467|FG004|Overall Study|Withdrawal by Subject|0|||
48504839|NCT00880568|156044468|FG005|Overall Study|Withdrawal by Subject|0|||
48504840|NCT00880568|156044469|FG006|Overall Study|Withdrawal by Subject|0|||
48600149|NCT01610037|156391531|FG001|All Patients|Protocol deviation|3|||
48600150|NCT01610037|156391532|FG002|All Patients|Protocol deviation|3|||
48600151|NCT01610037|156391530|FG000|All Patients|Abnormal laboratory value|1|||
48600152|NCT01610037|156391531|FG001|All Patients|Abnormal laboratory value|1|||
48724685|NCT03915860|156842017|FG000|Overall Study|Withdrawal by Subject|6|||
48724686|NCT03915860|156842017|FG000|Overall Study|Lost to Follow-up|2|||
48724687|NCT03915860|156842017|FG000|Overall Study|Other than specified|3|||
48504841|NCT00880568|156044470|FG007|Overall Study|Withdrawal by Subject|1|||
48600153|NCT01610037|156391532|FG002|All Patients|Abnormal laboratory value|0|||
48504842|NCT00880568|156044471|FG008|Overall Study|Withdrawal by Subject|0|||
48504843|NCT03033576|156044475|FG000|Overall Study|Ineligible|1|||
48504844|NCT03033576|156044476|FG001|Overall Study|Ineligible|1|||
48504845|NCT03033576|156044475|FG000|Overall Study|Adverse Event|4|||
48504846|NCT03033576|156044476|FG001|Overall Study|Adverse Event|20|||
48504847|NCT03033576|156044475|FG000|Overall Study|Progression/relapse|9|||
48504848|NCT03033576|156044476|FG001|Overall Study|Progression/relapse|36|||
48504849|NCT03033576|156044475|FG000|Overall Study|Death|1|||
48724688|NCT00768469|156842018|FG000|Overall Study|Adverse Event|0|||
48504850|NCT03033576|156044476|FG001|Overall Study|Death|1|||
48504851|NCT03033576|156044475|FG000|Overall Study|Patient refusal|1|||
48504852|NCT03033576|156044476|FG001|Overall Study|Patient refusal|6|||
48504853|NCT03033576|156044475|FG000|Overall Study|Other, unspecified reasons|0|||
48504854|NCT03033576|156044476|FG001|Overall Study|Other, unspecified reasons|4|||
48504855|NCT03033576|156044475|FG000|Overall Study|Currently on protocol therapy|0|||
48504856|NCT03033576|156044476|FG001|Overall Study|Currently on protocol therapy|2|||
48600154|NCT01610037|156391530|FG000|All Patients|Administrative problems|1|||
48504857|NCT00849901|156044478|FG000|Acute Treatment Phase|Adverse Event|9|||
48504858|NCT00849901|156044479|FG001|Acute Treatment Phase|Adverse Event|1|||
48504859|NCT00849901|156044480|FG002|Acute Treatment Phase|Adverse Event|3|||
48504860|NCT00849901|156044478|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
48504861|NCT00849901|156044479|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
48504862|NCT00849901|156044480|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
48504863|NCT00849901|156044478|FG000|Acute Treatment Phase|Protocol Violation|0|||
48504864|NCT00849901|156044479|FG001|Acute Treatment Phase|Protocol Violation|2|||
48504865|NCT00849901|156044480|FG002|Acute Treatment Phase|Protocol Violation|1|||
48504866|NCT00849901|156044478|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
48504867|NCT00849901|156044479|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
48504868|NCT00849901|156044480|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
48504869|NCT00849901|156044478|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
48504870|NCT00849901|156044479|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
48504871|NCT00849901|156044480|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
48504872|NCT00849901|156044478|FG000|Acute Treatment Phase|Physician Decision|1|||
48504873|NCT00849901|156044479|FG001|Acute Treatment Phase|Physician Decision|1|||
48504874|NCT00849901|156044480|FG002|Acute Treatment Phase|Physician Decision|1|||
48504875|NCT00849901|156044478|FG000|Acute Treatment Phase|Sponsor Decision|1|||
48504876|NCT00849901|156044479|FG001|Acute Treatment Phase|Sponsor Decision|0|||
48504877|NCT00849901|156044480|FG002|Acute Treatment Phase|Sponsor Decision|0|||
48504878|NCT00849901|156044478|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
48724689|NCT00768469|156842019|FG001|Overall Study|Adverse Event|2|||
48724690|NCT00768469|156842018|FG000|Overall Study|Disease Progression|3|||
48724691|NCT00768469|156842019|FG001|Overall Study|Disease Progression|4|||
48724692|NCT00768469|156842018|FG000|Overall Study|Withdrawal by Subject|0|||
48724693|NCT00768469|156842019|FG001|Overall Study|Withdrawal by Subject|1|||
48724694|NCT03180684|156842022|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
48724695|NCT03180684|156842023|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
48504879|NCT00849901|156044479|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
48504880|NCT00849901|156044480|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
48504881|NCT00849901|156044478|FG000|Extension Phase|Adverse Event|2|||
48504882|NCT00849901|156044479|FG001|Extension Phase|Adverse Event|8|||
48600155|NCT01610037|156391531|FG001|All Patients|Administrative problems|4|||
48600156|NCT01610037|156391532|FG002|All Patients|Administrative problems|4|||
48600157|NCT01610037|156391530|FG000|All Patients|Lost to Follow-up|1|||
48600158|NCT01610037|156391531|FG001|All Patients|Lost to Follow-up|0|||
48600159|NCT01610037|156391532|FG002|All Patients|Lost to Follow-up|0|||
48600160|NCT01610037|156391530|FG000|All Patients|Abnormal test procedure result(s)|0|||
48600161|NCT01610037|156391531|FG001|All Patients|Abnormal test procedure result(s)|1|||
48600162|NCT01610037|156391532|FG002|All Patients|Abnormal test procedure result(s)|3|||
48600163|NCT01610037|156391530|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
48600164|NCT01610037|156391531|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
48600165|NCT01610037|156391532|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
48600166|NCT01610037|156391530|FG000|Treatment and Follow up Period|Death|10|||
48600167|NCT01610037|156391531|FG001|Treatment and Follow up Period|Death|5|||
48600168|NCT01610037|156391532|FG002|Treatment and Follow up Period|Death|4|||
48600169|NCT01610037|156391530|FG000|Treatment and Follow up Period|Administrative problems|1|||
48600170|NCT01610037|156391531|FG001|Treatment and Follow up Period|Administrative problems|3|||
48600171|NCT01610037|156391532|FG002|Treatment and Follow up Period|Administrative problems|2|||
48600172|NCT01610037|156391530|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
48600173|NCT01610037|156391531|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
48600174|NCT01610037|156391532|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
48600175|NCT01048541|156391533|FG000|Overall Study|Withdrawal by Subject|1|||
48724696|NCT03180684|156842022|FG000|Overall Study|Physician Decision|1|||
48724697|NCT03180684|156842023|FG001|Overall Study|Physician Decision|0|||
48724698|NCT03180684|156842022|FG000|Overall Study|Lost to Follow-up|1|||
48724699|NCT03180684|156842023|FG001|Overall Study|Lost to Follow-up|0|||
48724700|NCT03180684|156842022|FG000|Overall Study|Progressive Disease|1|||
48724701|NCT03180684|156842023|FG001|Overall Study|Progressive Disease|0|||
48724702|NCT00136604|156842024|FG000|Overall Study|Lost to Follow-up|1|||
48724703|NCT00136604|156842025|FG001|Overall Study|Lost to Follow-up|0|||
48724704|NCT00136604|156842026|FG002|Overall Study|Lost to Follow-up|0|||
48724705|NCT00136604|156842027|FG003|Overall Study|Lost to Follow-up|0|||
48724706|NCT00136604|156842028|FG004|Overall Study|Lost to Follow-up|1|||
48724707|NCT00136604|156842024|FG000|Overall Study|Migrated/moved from study area|0|||
48724708|NCT00136604|156842025|FG001|Overall Study|Migrated/moved from study area|1|||
48724709|NCT00136604|156842026|FG002|Overall Study|Migrated/moved from study area|0|||
48724710|NCT00136604|156842027|FG003|Overall Study|Migrated/moved from study area|0|||
48724711|NCT00136604|156842028|FG004|Overall Study|Migrated/moved from study area|0|||
48724712|NCT02942576|156842031|FG000|Overall Study|Adverse Event|28|||
48724713|NCT02942576|156842032|FG001|Overall Study|Adverse Event|6|||
48724714|NCT02942576|156842031|FG000|Overall Study|Withdrawal by Subject|7|||
48504883|NCT00849901|156044480|FG002|Extension Phase|Adverse Event|4|||
48724715|NCT02942576|156842032|FG001|Overall Study|Withdrawal by Subject|5|||
48504884|NCT00849901|156044478|FG000|Extension Phase|Lost to Follow-up|3|||
48504885|NCT00849901|156044479|FG001|Extension Phase|Lost to Follow-up|0|||
48504886|NCT00849901|156044480|FG002|Extension Phase|Lost to Follow-up|1|||
48504887|NCT00849901|156044478|FG000|Extension Phase|Protocol Violation|2|||
48504888|NCT00849901|156044479|FG001|Extension Phase|Protocol Violation|2|||
48504889|NCT00849901|156044480|FG002|Extension Phase|Protocol Violation|4|||
48504890|NCT00849901|156044478|FG000|Extension Phase|Withdrawal by Subject|7|||
48504891|NCT00849901|156044479|FG001|Extension Phase|Withdrawal by Subject|6|||
48504892|NCT00849901|156044480|FG002|Extension Phase|Withdrawal by Subject|3|||
48504893|NCT00849901|156044478|FG000|Extension Phase|Parent or Caregiver Decision|10|||
48504894|NCT00849901|156044479|FG001|Extension Phase|Parent or Caregiver Decision|4|||
48504895|NCT00849901|156044480|FG002|Extension Phase|Parent or Caregiver Decision|4|||
48504896|NCT00849901|156044478|FG000|Extension Phase|Physician Decision|1|||
48504897|NCT00849901|156044479|FG001|Extension Phase|Physician Decision|2|||
48504898|NCT00849901|156044480|FG002|Extension Phase|Physician Decision|0|||
48504899|NCT00849901|156044478|FG000|Extension Phase|Lack of Efficacy|2|||
48504900|NCT00849901|156044479|FG001|Extension Phase|Lack of Efficacy|4|||
48504901|NCT00849901|156044480|FG002|Extension Phase|Lack of Efficacy|1|||
48504902|NCT03952143|156044481|FG000|Lead-In Period|Adverse Event|2|||
48504903|NCT03952143|156044482|FG001|Lead-In Period|Adverse Event|0|||
48504904|NCT03952143|156044483|FG002|Lead-In Period|Adverse Event|0|||
48504905|NCT03952143|156044481|FG000|Lead-In Period|Lack of Efficacy|2|||
48724716|NCT02942576|156842031|FG000|Overall Study|Physician Decision|1|||
48504906|NCT03952143|156044482|FG001|Lead-In Period|Lack of Efficacy|0|||
48724717|NCT02942576|156842032|FG001|Overall Study|Physician Decision|4|||
48724718|NCT02942576|156842031|FG000|Overall Study|Other|10|||
48724719|NCT02942576|156842032|FG001|Overall Study|Other|8|||
48504907|NCT03952143|156044483|FG002|Lead-In Period|Lack of Efficacy|0|||
48504908|NCT03952143|156044481|FG000|Lead-In Period|Physician Decision|5|||
48504909|NCT03952143|156044482|FG001|Lead-In Period|Physician Decision|0|||
48504910|NCT03952143|156044483|FG002|Lead-In Period|Physician Decision|0|||
48504911|NCT03952143|156044481|FG000|Lead-In Period|Protocol Violation|5|||
48504912|NCT03952143|156044482|FG001|Lead-In Period|Protocol Violation|0|||
48504913|NCT03952143|156044483|FG002|Lead-In Period|Protocol Violation|0|||
48504914|NCT03952143|156044481|FG000|Lead-In Period|Withdrawal by Subject|19|||
48504915|NCT03952143|156044482|FG001|Lead-In Period|Withdrawal by Subject|0|||
48504916|NCT03952143|156044483|FG002|Lead-In Period|Withdrawal by Subject|0|||
48504917|NCT03952143|156044481|FG000|Treatment Period|Adverse Event|0|||
48504918|NCT03952143|156044482|FG001|Treatment Period|Adverse Event|0|||
48504919|NCT03952143|156044483|FG002|Treatment Period|Adverse Event|1|||
48504920|NCT03952143|156044481|FG000|Treatment Period|Lost to Follow-up|0|||
48504921|NCT03952143|156044482|FG001|Treatment Period|Lost to Follow-up|2|||
48504922|NCT03952143|156044483|FG002|Treatment Period|Lost to Follow-up|0|||
48504923|NCT03952143|156044481|FG000|Treatment Period|Physician Decision|0|||
48504924|NCT03952143|156044482|FG001|Treatment Period|Physician Decision|0|||
48724720|NCT01017575|156842051|FG000|Overall Study|Lack of Efficacy|0|||
48724721|NCT01017575|156842052|FG001|Overall Study|Lack of Efficacy|1|||
48724722|NCT01017575|156842053|FG002|Overall Study|Lack of Efficacy|0|||
48724723|NCT01017575|156842054|FG003|Overall Study|Lack of Efficacy|1|||
48724724|NCT01017575|156842055|FG004|Overall Study|Lack of Efficacy|1|||
48724725|NCT01017575|156842051|FG000|Overall Study|Adverse Event|0|||
48724726|NCT01017575|156842052|FG001|Overall Study|Adverse Event|1|||
48724727|NCT01017575|156842053|FG002|Overall Study|Adverse Event|0|||
48724728|NCT01017575|156842054|FG003|Overall Study|Adverse Event|0|||
48724729|NCT01017575|156842055|FG004|Overall Study|Adverse Event|2|||
48724730|NCT01017575|156842051|FG000|Overall Study|Withdrawal by Subject|1|||
48724731|NCT01017575|156842052|FG001|Overall Study|Withdrawal by Subject|0|||
48724732|NCT01017575|156842053|FG002|Overall Study|Withdrawal by Subject|0|||
48724733|NCT01017575|156842054|FG003|Overall Study|Withdrawal by Subject|0|||
48724734|NCT01017575|156842055|FG004|Overall Study|Withdrawal by Subject|0|||
48724735|NCT03500679|156842056|FG000|Overall Study|Lost to Follow-up|6|||
48724736|NCT03500679|156842057|FG001|Overall Study|Lost to Follow-up|3|||
48724737|NCT03500679|156842056|FG000|Overall Study|Withdrawal by Subject|3|||
48724738|NCT03500679|156842057|FG001|Overall Study|Withdrawal by Subject|0|||
48724739|NCT05446168|156842062|FG000|Overall Study|Physician Decision|0|||
48724740|NCT05446168|156842063|FG001|Overall Study|Physician Decision|1|||
48724741|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
48724742|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
48724743|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
48724744|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
48724745|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
48724746|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
48504925|NCT03952143|156044483|FG002|Treatment Period|Physician Decision|2|||
48504926|NCT03952143|156044481|FG000|Treatment Period|Protocol Violation|0|||
48504927|NCT03952143|156044482|FG001|Treatment Period|Protocol Violation|0|||
48724747|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
48724748|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
48504928|NCT03952143|156044483|FG002|Treatment Period|Protocol Violation|1|||
48504929|NCT03952143|156044481|FG000|Treatment Period|Withdrawal by Subject|0|||
48504930|NCT03952143|156044482|FG001|Treatment Period|Withdrawal by Subject|5|||
48504931|NCT03952143|156044483|FG002|Treatment Period|Withdrawal by Subject|26|||
48504932|NCT03952143|156044481|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
48504933|NCT03952143|156044482|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
48504934|NCT03952143|156044483|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
48504935|NCT03952143|156044481|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
48504936|NCT03952143|156044482|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
48504937|NCT03952143|156044483|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
48504938|NCT01367457|156044484|FG000|Overall Study|Death|2|||
48504939|NCT01367457|156044485|FG001|Overall Study|Death|0|||
48504940|NCT01367457|156044486|FG002|Overall Study|Death|0|||
48504941|NCT01367457|156044484|FG000|Overall Study|Investigator's decision|2|||
48504942|NCT01367457|156044485|FG001|Overall Study|Investigator's decision|0|||
48504943|NCT01367457|156044486|FG002|Overall Study|Investigator's decision|0|||
48504944|NCT01367457|156044484|FG000|Overall Study|Clinical decline (CD)|2|||
48504945|NCT01367457|156044485|FG001|Overall Study|Clinical decline (CD)|0|||
48504946|NCT01367457|156044486|FG002|Overall Study|Clinical decline (CD)|0|||
48504947|NCT01367457|156044484|FG000|Overall Study|Progression and death|8|||
48504948|NCT01367457|156044485|FG001|Overall Study|Progression and death|0|||
48504949|NCT01367457|156044486|FG002|Overall Study|Progression and death|0|||
48504950|NCT01367457|156044484|FG000|Overall Study|Toxicity|16|||
48504951|NCT01367457|156044485|FG001|Overall Study|Toxicity|0|||
48504952|NCT01367457|156044486|FG002|Overall Study|Toxicity|0|||
48504953|NCT01367457|156044484|FG000|Overall Study|Progression|137|||
48504954|NCT01367457|156044485|FG001|Overall Study|Progression|0|||
48504955|NCT01367457|156044486|FG002|Overall Study|Progression|0|||
48504956|NCT01367457|156044484|FG000|Overall Study|Patient asks for rest + slow progression|1|||
48504957|NCT01367457|156044485|FG001|Overall Study|Patient asks for rest + slow progression|0|||
48504958|NCT01367457|156044486|FG002|Overall Study|Patient asks for rest + slow progression|0|||
48504959|NCT01367457|156044484|FG000|Overall Study|Investigator's opinion, stable disease|1|||
48504960|NCT01367457|156044485|FG001|Overall Study|Investigator's opinion, stable disease|0|||
48504961|NCT01367457|156044486|FG002|Overall Study|Investigator's opinion, stable disease|0|||
48504962|NCT01367457|156044484|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
48504963|NCT01367457|156044485|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
48504964|NCT01367457|156044486|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
48504965|NCT01367457|156044484|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
48504966|NCT01367457|156044485|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
48504967|NCT01367457|156044486|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
48504968|NCT01367457|156044484|FG000|Overall Study|low grade toxicities + stable disease|1|||
48504969|NCT01367457|156044485|FG001|Overall Study|low grade toxicities + stable disease|0|||
48504970|NCT01367457|156044486|FG002|Overall Study|low grade toxicities + stable disease|0|||
48504971|NCT01367457|156044484|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
48504972|NCT01367457|156044485|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
48504973|NCT01367457|156044486|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
48504974|NCT01367457|156044484|FG000|Overall Study|Withdrawal by Subject|1|||
48504975|NCT01367457|156044485|FG001|Overall Study|Withdrawal by Subject|0|||
48504976|NCT01367457|156044486|FG002|Overall Study|Withdrawal by Subject|0|||
48504977|NCT01367457|156044484|FG000|Overall Study|CD, associated leukaemia|1|||
48504978|NCT01367457|156044485|FG001|Overall Study|CD, associated leukaemia|0|||
48504979|NCT01367457|156044486|FG002|Overall Study|CD, associated leukaemia|0|||
48504980|NCT01367457|156044484|FG000|Overall Study|Uncontrolled pain|1|||
48504981|NCT01367457|156044485|FG001|Overall Study|Uncontrolled pain|0|||
48504982|NCT01367457|156044486|FG002|Overall Study|Uncontrolled pain|0|||
48504983|NCT01367457|156044484|FG000|Overall Study|Overall status worsens to grade 4|1|||
48504984|NCT01367457|156044485|FG001|Overall Study|Overall status worsens to grade 4|0|||
48504985|NCT01367457|156044486|FG002|Overall Study|Overall status worsens to grade 4|0|||
48504986|NCT01367457|156044484|FG000|Overall Study|Stabilisation + frequent infections|1|||
48504987|NCT01367457|156044485|FG001|Overall Study|Stabilisation + frequent infections|0|||
48504988|NCT01367457|156044486|FG002|Overall Study|Stabilisation + frequent infections|0|||
48504989|NCT01367457|156044484|FG000|Overall Study|No clinical benefit|1|||
48504990|NCT01367457|156044485|FG001|Overall Study|No clinical benefit|0|||
48504991|NCT01367457|156044486|FG002|Overall Study|No clinical benefit|0|||
48819383|NCT02886728|157181805|FG001|Overall Study|Randomized but Not Dosed|0|||
48819384|NCT02886728|157181806|FG002|Overall Study|Randomized but Not Dosed|0|||
48819385|NCT02886728|157181807|FG003|Overall Study|Randomized but Not Dosed|2|||
48504992|NCT01367457|156044484|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
48819386|NCT00884286|157181808|FG000|Overall Study|Progressive disease|21|||
48819387|NCT00884286|157181809|FG001|Overall Study|Progressive disease|28|||
48504993|NCT01367457|156044485|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
48504994|NCT01367457|156044486|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
48819388|NCT00884286|157181808|FG000|Overall Study|Toxicity|4|||
48504995|NCT01367457|156044484|FG000|Overall Study|Overall decline|1|||
48504996|NCT01367457|156044485|FG001|Overall Study|Overall decline|0|||
48504997|NCT01367457|156044486|FG002|Overall Study|Overall decline|0|||
48504998|NCT01367457|156044484|FG000|Overall Study|Rejection of treatment|1|||
48504999|NCT01367457|156044485|FG001|Overall Study|Rejection of treatment|0|||
48505000|NCT01367457|156044486|FG002|Overall Study|Rejection of treatment|0|||
48505001|NCT01367457|156044484|FG000|Overall Study|Lost to Follow-up|1|||
48505002|NCT01367457|156044485|FG001|Overall Study|Lost to Follow-up|0|||
48505003|NCT01367457|156044486|FG002|Overall Study|Lost to Follow-up|0|||
48505004|NCT01367457|156044484|FG000|Overall Study|Death from septic shock|1|||
48505005|NCT01367457|156044485|FG001|Overall Study|Death from septic shock|0|||
48505006|NCT01367457|156044486|FG002|Overall Study|Death from septic shock|0|||
48505007|NCT01367457|156044484|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
48505008|NCT01367457|156044485|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
48505009|NCT01367457|156044486|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
48505010|NCT01367457|156044484|FG000|Overall Study|Patient's Wish|1|||
48505011|NCT01367457|156044485|FG001|Overall Study|Patient's Wish|0|||
48505012|NCT01367457|156044486|FG002|Overall Study|Patient's Wish|0|||
48505013|NCT01367457|156044484|FG000|Overall Study|Palliative. Overall decline|1|||
48600176|NCT01048541|156391534|FG001|Overall Study|Withdrawal by Subject|0|||
48600177|NCT00922116|156391536|FG000|Overall Study|Adverse Event|4|||
48600178|NCT00922116|156391536|FG000|Overall Study|Death|1|||
48600179|NCT00922116|156391536|FG000|Overall Study|Lost to Follow-up|1|||
48600180|NCT00922116|156391536|FG000|Overall Study|Withdrawal by Subject|4|||
48600181|NCT00922116|156391536|FG000|Overall Study|Other|5|||
48600182|NCT02221648|156391542|FG000|Overall Study|Withdrawal by Subject|3|||
48600183|NCT02221648|156391543|FG001|Overall Study|Withdrawal by Subject|3|||
48600184|NCT04613518|156391546|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
48600185|NCT04613518|156391547|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
48600186|NCT04613518|156391548|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
48600187|NCT04613518|156391546|FG000|Double-Blind Treatment Period|Adverse Event|2|||
48600188|NCT04613518|156391547|FG001|Double-Blind Treatment Period|Adverse Event|0|||
48600189|NCT04613518|156391548|FG002|Double-Blind Treatment Period|Adverse Event|1|||
48505014|NCT01367457|156044485|FG001|Overall Study|Palliative. Overall decline|0|||
48505015|NCT01367457|156044486|FG002|Overall Study|Palliative. Overall decline|0|||
48505016|NCT01367457|156044484|FG000|Overall Study|Suspected DP/suspected active infection|1|||
48505017|NCT01367457|156044485|FG001|Overall Study|Suspected DP/suspected active infection|0|||
48505018|NCT01367457|156044486|FG002|Overall Study|Suspected DP/suspected active infection|0|||
48505019|NCT03854227|156044492|FG000|Overall Study|Adverse Event|0|||
48505020|NCT03854227|156044493|FG001|Overall Study|Adverse Event|0|||
48505021|NCT03854227|156044494|FG002|Overall Study|Adverse Event|0|||
48505022|NCT03854227|156044495|FG003|Overall Study|Adverse Event|1|||
48505023|NCT03854227|156044496|FG004|Overall Study|Adverse Event|0|||
48505024|NCT03854227|156044497|FG005|Overall Study|Adverse Event|0|||
48505025|NCT03854227|156044498|FG006|Overall Study|Adverse Event|1|||
48505026|NCT03854227|156044499|FG007|Overall Study|Adverse Event|0|||
48505027|NCT03854227|156044500|FG008|Overall Study|Adverse Event|0|||
48505028|NCT03854227|156044501|FG009|Overall Study|Adverse Event|3|||
48505029|NCT03854227|156044502|FG010|Overall Study|Adverse Event|0|||
48505030|NCT03854227|156044503|FG011|Overall Study|Adverse Event|1|||
48505031|NCT03854227|156044492|FG000|Overall Study|Death|0|||
48505032|NCT03854227|156044493|FG001|Overall Study|Death|0|||
48505033|NCT03854227|156044494|FG002|Overall Study|Death|0|||
48505034|NCT03854227|156044495|FG003|Overall Study|Death|0|||
48505035|NCT03854227|156044496|FG004|Overall Study|Death|0|||
48505036|NCT03854227|156044497|FG005|Overall Study|Death|1|||
48505037|NCT03854227|156044498|FG006|Overall Study|Death|0|||
48505038|NCT03854227|156044499|FG007|Overall Study|Death|0|||
48505039|NCT03854227|156044500|FG008|Overall Study|Death|0|||
48505040|NCT03854227|156044501|FG009|Overall Study|Death|1|||
48505041|NCT03854227|156044502|FG010|Overall Study|Death|0|||
48505042|NCT03854227|156044503|FG011|Overall Study|Death|1|||
48505043|NCT03854227|156044492|FG000|Overall Study|Physician Decision|0|||
48505044|NCT03854227|156044493|FG001|Overall Study|Physician Decision|0|||
48600190|NCT04613518|156391546|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
48600191|NCT04613518|156391547|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
48600192|NCT04613518|156391548|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
48600193|NCT04613518|156391546|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
48505045|NCT03854227|156044494|FG002|Overall Study|Physician Decision|0|||
48505046|NCT03854227|156044495|FG003|Overall Study|Physician Decision|0|||
48505047|NCT03854227|156044496|FG004|Overall Study|Physician Decision|0|||
48505048|NCT03854227|156044497|FG005|Overall Study|Physician Decision|1|||
48505049|NCT03854227|156044498|FG006|Overall Study|Physician Decision|0|||
48724749|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
48505050|NCT03854227|156044499|FG007|Overall Study|Physician Decision|0|||
48505051|NCT03854227|156044500|FG008|Overall Study|Physician Decision|1|||
48505052|NCT03854227|156044501|FG009|Overall Study|Physician Decision|1|||
48600194|NCT04613518|156391547|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
48600195|NCT04613518|156391548|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
48600196|NCT04613518|156391546|FG000|Double-Blind Treatment Period|Other Reasons|2|||
48600197|NCT04613518|156391547|FG001|Double-Blind Treatment Period|Other Reasons|0|||
48724750|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
48724751|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
48505053|NCT03854227|156044502|FG010|Overall Study|Physician Decision|0|||
48505054|NCT03854227|156044503|FG011|Overall Study|Physician Decision|1|||
48505055|NCT03854227|156044492|FG000|Overall Study|Progressive disease|1|||
48505056|NCT03854227|156044493|FG001|Overall Study|Progressive disease|1|||
48505057|NCT03854227|156044494|FG002|Overall Study|Progressive disease|1|||
48505058|NCT03854227|156044495|FG003|Overall Study|Progressive disease|2|||
48505059|NCT03854227|156044496|FG004|Overall Study|Progressive disease|3|||
48505060|NCT03854227|156044497|FG005|Overall Study|Progressive disease|1|||
48505061|NCT03854227|156044498|FG006|Overall Study|Progressive disease|2|||
48505062|NCT03854227|156044499|FG007|Overall Study|Progressive disease|5|||
48505063|NCT03854227|156044500|FG008|Overall Study|Progressive disease|2|||
48505064|NCT03854227|156044501|FG009|Overall Study|Progressive disease|5|||
48505065|NCT03854227|156044502|FG010|Overall Study|Progressive disease|1|||
48505066|NCT03854227|156044503|FG011|Overall Study|Progressive disease|6|||
48505067|NCT03854227|156044492|FG000|Overall Study|Study terminated by sponsor|0|||
48505068|NCT03854227|156044493|FG001|Overall Study|Study terminated by sponsor|0|||
48505069|NCT03854227|156044494|FG002|Overall Study|Study terminated by sponsor|0|||
48505070|NCT03854227|156044495|FG003|Overall Study|Study terminated by sponsor|0|||
48505071|NCT03854227|156044496|FG004|Overall Study|Study terminated by sponsor|0|||
48505072|NCT03854227|156044497|FG005|Overall Study|Study terminated by sponsor|0|||
48505073|NCT03854227|156044498|FG006|Overall Study|Study terminated by sponsor|0|||
48505074|NCT03854227|156044499|FG007|Overall Study|Study terminated by sponsor|0|||
48505075|NCT03854227|156044500|FG008|Overall Study|Study terminated by sponsor|0|||
48505076|NCT03854227|156044501|FG009|Overall Study|Study terminated by sponsor|1|||
48505077|NCT03854227|156044502|FG010|Overall Study|Study terminated by sponsor|0|||
48505078|NCT03854227|156044503|FG011|Overall Study|Study terminated by sponsor|0|||
48505079|NCT03854227|156044492|FG000|Overall Study|Withdrawal by Subject|0|||
48505080|NCT03854227|156044493|FG001|Overall Study|Withdrawal by Subject|0|||
48505081|NCT03854227|156044494|FG002|Overall Study|Withdrawal by Subject|1|||
48505082|NCT03854227|156044495|FG003|Overall Study|Withdrawal by Subject|0|||
48505083|NCT03854227|156044496|FG004|Overall Study|Withdrawal by Subject|0|||
48505084|NCT03854227|156044497|FG005|Overall Study|Withdrawal by Subject|0|||
48505085|NCT03854227|156044498|FG006|Overall Study|Withdrawal by Subject|0|||
48505086|NCT03854227|156044499|FG007|Overall Study|Withdrawal by Subject|0|||
48505087|NCT03854227|156044500|FG008|Overall Study|Withdrawal by Subject|0|||
48505088|NCT03854227|156044501|FG009|Overall Study|Withdrawal by Subject|1|||
48505089|NCT03854227|156044502|FG010|Overall Study|Withdrawal by Subject|1|||
48505090|NCT03854227|156044503|FG011|Overall Study|Withdrawal by Subject|0|||
48505091|NCT03854227|156044492|FG000|Overall Study|Disease relapse|0|||
48505092|NCT03854227|156044493|FG001|Overall Study|Disease relapse|0|||
48505093|NCT03854227|156044494|FG002|Overall Study|Disease relapse|0|||
48505094|NCT03854227|156044495|FG003|Overall Study|Disease relapse|0|||
48505095|NCT03854227|156044496|FG004|Overall Study|Disease relapse|0|||
48505096|NCT03854227|156044497|FG005|Overall Study|Disease relapse|0|||
48505097|NCT03854227|156044498|FG006|Overall Study|Disease relapse|0|||
48505098|NCT03854227|156044499|FG007|Overall Study|Disease relapse|0|||
48505099|NCT03854227|156044500|FG008|Overall Study|Disease relapse|1|||
48505100|NCT03854227|156044501|FG009|Overall Study|Disease relapse|0|||
48505101|NCT03854227|156044502|FG010|Overall Study|Disease relapse|0|||
48505102|NCT03854227|156044503|FG011|Overall Study|Disease relapse|0|||
48505103|NCT03854227|156044492|FG000|Overall Study|Global deterioration of health status|0|||
48505104|NCT03854227|156044493|FG001|Overall Study|Global deterioration of health status|0|||
48505105|NCT03854227|156044494|FG002|Overall Study|Global deterioration of health status|0|||
48505106|NCT03854227|156044495|FG003|Overall Study|Global deterioration of health status|0|||
48505107|NCT03854227|156044496|FG004|Overall Study|Global deterioration of health status|0|||
48505108|NCT03854227|156044497|FG005|Overall Study|Global deterioration of health status|1|||
48505109|NCT03854227|156044498|FG006|Overall Study|Global deterioration of health status|0|||
48600198|NCT04613518|156391548|FG002|Double-Blind Treatment Period|Other Reasons|0|||
48724752|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
48505110|NCT03854227|156044499|FG007|Overall Study|Global deterioration of health status|1|||
48505111|NCT03854227|156044500|FG008|Overall Study|Global deterioration of health status|0|||
48505112|NCT03854227|156044501|FG009|Overall Study|Global deterioration of health status|0|||
48505113|NCT03854227|156044502|FG010|Overall Study|Global deterioration of health status|0|||
48505114|NCT03854227|156044503|FG011|Overall Study|Global deterioration of health status|0|||
48505115|NCT03854227|156044492|FG000|Overall Study|Refused further treatment|0|||
48505116|NCT03854227|156044493|FG001|Overall Study|Refused further treatment|0|||
48505117|NCT03854227|156044494|FG002|Overall Study|Refused further treatment|0|||
48505118|NCT03854227|156044495|FG003|Overall Study|Refused further treatment|0|||
48600199|NCT04613518|156391546|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
48600200|NCT04613518|156391547|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
48600201|NCT04613518|156391548|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
48600202|NCT04613518|156391546|FG000|Open-Label Treatment Period|Adverse Event|1|||
48600203|NCT04613518|156391547|FG001|Open-Label Treatment Period|Adverse Event|0|||
48600204|NCT04613518|156391548|FG002|Open-Label Treatment Period|Adverse Event|3|||
48600205|NCT04613518|156391546|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
48600206|NCT04613518|156391547|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
48600207|NCT04613518|156391548|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
48600208|NCT04613518|156391546|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
48600209|NCT04613518|156391547|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
48505119|NCT03854227|156044496|FG004|Overall Study|Refused further treatment|0|||
48505120|NCT03854227|156044497|FG005|Overall Study|Refused further treatment|0|||
48505121|NCT03854227|156044498|FG006|Overall Study|Refused further treatment|0|||
48505122|NCT03854227|156044499|FG007|Overall Study|Refused further treatment|0|||
48505123|NCT03854227|156044500|FG008|Overall Study|Refused further treatment|0|||
48505124|NCT03854227|156044501|FG009|Overall Study|Refused further treatment|1|||
48505125|NCT03854227|156044502|FG010|Overall Study|Refused further treatment|0|||
48505126|NCT03854227|156044503|FG011|Overall Study|Refused further treatment|1|||
48505127|NCT03854227|156044492|FG000|Overall Study|Other|0|||
48505128|NCT03854227|156044493|FG001|Overall Study|Other|0|||
48505129|NCT03854227|156044494|FG002|Overall Study|Other|0|||
48505130|NCT03854227|156044495|FG003|Overall Study|Other|0|||
48505131|NCT03854227|156044496|FG004|Overall Study|Other|0|||
48505132|NCT03854227|156044497|FG005|Overall Study|Other|0|||
48505133|NCT03854227|156044498|FG006|Overall Study|Other|0|||
48505134|NCT03854227|156044499|FG007|Overall Study|Other|0|||
48505135|NCT03854227|156044500|FG008|Overall Study|Other|1|||
48505136|NCT03854227|156044501|FG009|Overall Study|Other|1|||
48505137|NCT03854227|156044502|FG010|Overall Study|Other|0|||
48505138|NCT03854227|156044503|FG011|Overall Study|Other|0|||
48505139|NCT02996682|156044504|FG000|Overall Study|Death|0|||
48505140|NCT02996682|156044505|FG001|Overall Study|Death|3|||
48505141|NCT01185548|156044507|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
48505142|NCT00537030|156044508|FG000|Overall Study|Physician Decision|2|||
48505143|NCT00537030|156044508|FG000|Overall Study|Withdrawal by Subject|2|||
48505144|NCT00537030|156044508|FG000|Overall Study|≥ Grade 2 allergy|7|||
48505145|NCT00537030|156044508|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
48505146|NCT00537030|156044508|FG000|Overall Study|Ineligible|2|||
48505147|NCT00537030|156044508|FG000|Overall Study|Inevaluable|2|||
48505148|NCT00414765|156044509|FG000|Overall Study|Adverse Event|5|||
48505149|NCT00414765|156044510|FG001|Overall Study|Adverse Event|9|||
48505150|NCT00414765|156044509|FG000|Overall Study|Withdrawal by Subject|1|||
48505151|NCT00414765|156044510|FG001|Overall Study|Withdrawal by Subject|1|||
48505152|NCT00414765|156044509|FG000|Overall Study|Disease Progression|0|||
48505153|NCT00414765|156044510|FG001|Overall Study|Disease Progression|1|||
48505154|NCT02678286|156044511|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
48505155|NCT02678286|156044512|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
48505156|NCT02678286|156044511|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
48505157|NCT02678286|156044512|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
48505158|NCT02678286|156044511|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
48505159|NCT02678286|156044512|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
48505160|NCT02678286|156044511|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
48505161|NCT02678286|156044512|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
48505162|NCT02678286|156044511|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
48505163|NCT02678286|156044512|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
48505164|NCT00086996|156044515|FG000|Overall Study|Adverse Event|29|||
48505165|NCT00086996|156044515|FG000|Overall Study|Death|4|||
48505166|NCT00086996|156044515|FG000|Overall Study|progression/relapse|7|||
48505167|NCT00086996|156044515|FG000|Overall Study|Withdrawal by Subject|13|||
48505168|NCT00086996|156044515|FG000|Overall Study|Other|6|||
48505169|NCT00086996|156044515|FG000|Overall Study|not eligible|5|||
48505170|NCT00259012|156044517|FG000|Overall Study|Adverse Event|0|||
48505171|NCT00259012|156044518|FG001|Overall Study|Adverse Event|1|||
48505172|NCT00259012|156044517|FG000|Overall Study|Withdrawal by Subject|1|||
48505173|NCT00259012|156044518|FG001|Overall Study|Withdrawal by Subject|0|||
48505174|NCT00259012|156044517|FG000|Overall Study|Physician Decision|0|||
48505175|NCT00259012|156044518|FG001|Overall Study|Physician Decision|1|||
48505176|NCT00259012|156044517|FG000|Overall Study|Lost to Follow-up|0|||
48600210|NCT04613518|156391548|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
48505177|NCT00259012|156044518|FG001|Overall Study|Lost to Follow-up|1|||
48505178|NCT00259012|156044517|FG000|Overall Study|Protocol Violation|1|||
48505179|NCT00259012|156044518|FG001|Overall Study|Protocol Violation|1|||
48505180|NCT03204539|156044524|FG000|Overall Study|Loss of funding|0|||
48505181|NCT03204539|156044525|FG001|Overall Study|Loss of funding|1|||
48505182|NCT00585689|156044528|FG000|Overall Study|Received different ABI-007 schedule|3|||
48505183|NCT00585689|156044528|FG000|Overall Study|Adverse Event|1|||
48819389|NCT00884286|157181809|FG001|Overall Study|Toxicity|1|||
48819390|NCT00884286|157181808|FG000|Overall Study|Death|2|||
48819391|NCT00884286|157181809|FG001|Overall Study|Death|2|||
48819392|NCT00884286|157181808|FG000|Overall Study|Physician Decision|1|||
48819393|NCT00884286|157181809|FG001|Overall Study|Physician Decision|0|||
48819394|NCT00884286|157181808|FG000|Overall Study|Septic shock|1|||
48505184|NCT00585689|156044528|FG000|Overall Study|Patient Declined Surgery|1|||
48505185|NCT00585689|156044528|FG000|Overall Study|Patient had unresectable disease|1|||
48505186|NCT00585689|156044528|FG000|Overall Study|Death|1|||
48505187|NCT00984126|156044529|FG000|Overall Study|Protocol Violation|0|||
48505188|NCT00984126|156044530|FG001|Overall Study|Protocol Violation|0|||
48505189|NCT00984126|156044531|FG002|Overall Study|Protocol Violation|1|||
48724753|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
48819395|NCT00884286|157181809|FG001|Overall Study|Septic shock|0|||
48819396|NCT00884286|157181808|FG000|Overall Study|Thrombus in right auricle|1|||
48819397|NCT00884286|157181809|FG001|Overall Study|Thrombus in right auricle|0|||
48505190|NCT00984126|156044532|FG003|Overall Study|Protocol Violation|2|||
48724754|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
48724755|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
48724756|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
48724757|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
48724758|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
48724759|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
48724760|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
48724761|NCT01986933|156842064|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
48724762|NCT01986933|156842065|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
48724763|NCT01986933|156842066|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
48724764|NCT01986933|156842067|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
48724765|NCT01986933|156842068|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
48724766|NCT01986933|156842064|FG000|Active-to-active (Part B)|Adverse Event|0|||
48724767|NCT01986933|156842065|FG001|Active-to-active (Part B)|Adverse Event|2|||
48724768|NCT01986933|156842066|FG002|Active-to-active (Part B)|Adverse Event|0|||
48724769|NCT01986933|156842067|FG003|Active-to-active (Part B)|Adverse Event|1|||
48724770|NCT01986933|156842068|FG004|Active-to-active (Part B)|Adverse Event|3|||
48724771|NCT01986933|156842064|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
48724772|NCT01986933|156842065|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
48724773|NCT01986933|156842066|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
48724774|NCT01986933|156842067|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
48724775|NCT01986933|156842068|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
48724776|NCT01986933|156842064|FG000|Active-to-active (Part B)|Pregnancy|0|||
48724777|NCT01986933|156842065|FG001|Active-to-active (Part B)|Pregnancy|0|||
48724778|NCT01986933|156842066|FG002|Active-to-active (Part B)|Pregnancy|0|||
48724779|NCT01986933|156842067|FG003|Active-to-active (Part B)|Pregnancy|0|||
48724780|NCT01986933|156842068|FG004|Active-to-active (Part B)|Pregnancy|1|||
48724781|NCT01986933|156842064|FG000|Active-to-active (Part B)|Physician Decision|0|||
48724782|NCT01986933|156842065|FG001|Active-to-active (Part B)|Physician Decision|0|||
48724783|NCT01986933|156842066|FG002|Active-to-active (Part B)|Physician Decision|1|||
48724784|NCT01986933|156842067|FG003|Active-to-active (Part B)|Physician Decision|1|||
48724785|NCT01986933|156842068|FG004|Active-to-active (Part B)|Physician Decision|0|||
48724786|NCT01986933|156842064|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
48724787|NCT01986933|156842065|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
48724788|NCT01986933|156842066|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
48724789|NCT01986933|156842067|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
48724790|NCT01986933|156842068|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
48724791|NCT01986933|156842064|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
48724792|NCT01986933|156842065|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
48724793|NCT01986933|156842066|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
48724794|NCT01986933|156842067|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
48724795|NCT01986933|156842068|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
48724796|NCT01986933|156842064|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
48724797|NCT01986933|156842065|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
48724798|NCT01986933|156842066|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
48724799|NCT01986933|156842067|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
48724800|NCT01986933|156842068|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
48724801|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
48724802|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
48819398|NCT00884286|157181808|FG000|Overall Study|Not treated|2|||
48819399|NCT00884286|157181809|FG001|Overall Study|Not treated|1|||
48505191|NCT00984126|156044529|FG000|Overall Study|Adverse Event|0|||
48505192|NCT00984126|156044530|FG001|Overall Study|Adverse Event|0|||
48505193|NCT00984126|156044531|FG002|Overall Study|Adverse Event|0|||
48505194|NCT00984126|156044532|FG003|Overall Study|Adverse Event|2|||
48505195|NCT00984126|156044529|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
48505196|NCT00984126|156044530|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
48505197|NCT00984126|156044531|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
48505198|NCT00984126|156044532|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
48505199|NCT00984126|156044529|FG000|Overall Study|Withdrawal criteria|0|||
48505200|NCT00984126|156044530|FG001|Overall Study|Withdrawal criteria|1|||
48505201|NCT00984126|156044531|FG002|Overall Study|Withdrawal criteria|3|||
48505202|NCT00984126|156044532|FG003|Overall Study|Withdrawal criteria|9|||
48505203|NCT02373098|156044533|FG000|Overall Study|Lost to Follow-up|1|||
48505204|NCT02373098|156044534|FG001|Overall Study|Lost to Follow-up|0|||
48505205|NCT02373098|156044533|FG000|Overall Study|Protocol Violation|3|||
48505206|NCT02373098|156044534|FG001|Overall Study|Protocol Violation|0|||
48505207|NCT02373098|156044533|FG000|Overall Study|Withdrawal by Subject|5|||
48505208|NCT02373098|156044534|FG001|Overall Study|Withdrawal by Subject|0|||
48505209|NCT02373098|156044533|FG000|Overall Study|Adverse Event|3|||
48505210|NCT02373098|156044534|FG001|Overall Study|Adverse Event|0|||
48505211|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Adverse Event|11|||
48505212|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Adverse Event|23|||
48505213|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Adverse Event|29|||
48505214|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Adverse Event|2|||
48505215|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Adverse Event|8|||
48505216|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
48505217|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
48505218|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
48505219|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
48505220|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
48505221|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
48505222|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
48505223|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
48505224|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
48505225|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
48505226|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
48600211|NCT04613518|156391546|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
48724803|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
48724804|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
48505227|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
48505228|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
48505229|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
48505230|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
48600212|NCT04613518|156391547|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
48600213|NCT04613518|156391548|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
48600214|NCT04613518|156391546|FG000|Open-Label Treatment Period|Other reasons|1|||
48600215|NCT04613518|156391547|FG001|Open-Label Treatment Period|Other reasons|0|||
48600216|NCT04613518|156391548|FG002|Open-Label Treatment Period|Other reasons|0|||
48600217|NCT00149396|156391549|FG000|Overall Study|Death|15|||
48724805|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
48724806|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
48724807|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
48724808|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
48724809|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
48724810|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
48724811|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
48819400|NCT00884286|157181808|FG000|Overall Study|Comprised lung carcinoma|0|||
48819401|NCT00884286|157181809|FG001|Overall Study|Comprised lung carcinoma|1|||
48819402|NCT03712098|157181813|FG000|Overall Study|Lost to Follow-up|3|||
48819403|NCT03712098|157181814|FG001|Overall Study|Lost to Follow-up|7|||
48819404|NCT03712098|157181813|FG000|Overall Study|Withdrawal by Subject|9|||
48819405|NCT03712098|157181814|FG001|Overall Study|Withdrawal by Subject|4|||
48505231|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
48505232|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
48505233|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
48505234|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
48505235|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
48505236|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
48600218|NCT00149396|156391549|FG000|Overall Study|Withdrawal by Subject|1|||
48600219|NCT00149396|156391549|FG000|Overall Study|Subject noncompliance|2|||
48600220|NCT00149396|156391549|FG000|Overall Study|other treatment|5|||
48819406|NCT03712098|157181813|FG000|Overall Study|Protocol Violation|2|||
48505237|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
48505238|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
48505239|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
48819407|NCT03712098|157181814|FG001|Overall Study|Protocol Violation|1|||
48505240|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
48505241|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
48505242|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
48505243|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
48505244|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
48505245|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
48505246|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Move|0|||
48505247|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Move|1|||
48505248|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Move|0|||
48505249|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Move|0|||
48505250|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Move|0|||
48505251|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
48505252|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
48505253|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
48505254|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
48505255|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
48505256|NCT00318461|156044537|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
48505257|NCT00318461|156044538|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
48505258|NCT00318461|156044539|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
48505259|NCT00318461|156044540|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
48505260|NCT00318461|156044541|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
48505261|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Work commitment|0|||
48505262|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Work commitment|0|||
48505263|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Work commitment|0|||
48505264|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Work commitment|0|||
48505265|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Work commitment|1|||
48505266|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Investigator decision|0|||
48505267|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Investigator decision|0|||
48505268|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Investigator decision|0|||
48505269|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Investigator decision|0|||
48505270|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Investigator decision|1|||
48505271|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Lack of time|1|||
48505272|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Lack of time|0|||
48505273|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Lack of time|0|||
48505274|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Lack of time|0|||
48505275|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Lack of time|0|||
48724812|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
48724813|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
48724814|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
48724815|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
48724816|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
48724817|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
48724818|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
48724819|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
48724820|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
48724821|NCT01986933|156842064|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
48724822|NCT01986933|156842065|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
48724823|NCT01986933|156842066|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
48724824|NCT01986933|156842067|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
48724825|NCT01986933|156842068|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
48724826|NCT00686998|156842069|FG000|Overall Study|Adverse Event|3|||
48724827|NCT00686998|156842070|FG001|Overall Study|Adverse Event|2|||
48724828|NCT00686998|156842071|FG002|Overall Study|Adverse Event|1|||
48724829|NCT00686998|156842069|FG000|Overall Study|Withdrawal by Subject|2|||
48724830|NCT00686998|156842070|FG001|Overall Study|Withdrawal by Subject|1|||
48724831|NCT00686998|156842071|FG002|Overall Study|Withdrawal by Subject|2|||
48724832|NCT00686998|156842069|FG000|Overall Study|Lack of Efficacy|7|||
48724833|NCT00686998|156842070|FG001|Overall Study|Lack of Efficacy|5|||
48724834|NCT00686998|156842071|FG002|Overall Study|Lack of Efficacy|0|||
48724835|NCT00686998|156842069|FG000|Overall Study|Other|0|||
48724836|NCT00686998|156842070|FG001|Overall Study|Other|0|||
48724837|NCT00686998|156842071|FG002|Overall Study|Other|1|||
48724838|NCT00686998|156842069|FG000|Overall Study|Safety Reasons|1|||
48724839|NCT00686998|156842070|FG001|Overall Study|Safety Reasons|0|||
48724840|NCT00686998|156842071|FG002|Overall Study|Safety Reasons|0|||
48724841|NCT01758289|156842072|FG000|Overall Study|Premature Study Termination|44|||
48724842|NCT01758289|156842072|FG000|Overall Study|Adverse Event|9|||
48505276|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
48505277|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
48505278|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
48505279|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
48505280|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
48505281|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
48505282|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
48505283|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
48505284|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
48505285|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
48505286|NCT00318461|156044537|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
48505287|NCT00318461|156044538|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
48505288|NCT00318461|156044539|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
48505289|NCT00318461|156044540|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
48505290|NCT00318461|156044541|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
48505291|NCT00318461|156044537|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
48505292|NCT00318461|156044538|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
48505293|NCT00318461|156044539|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
48505294|NCT00318461|156044540|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
48505295|NCT00318461|156044541|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
48505296|NCT00318461|156044537|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
48505297|NCT00318461|156044538|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
48505298|NCT00318461|156044539|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
48505299|NCT00318461|156044540|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
48505300|NCT00318461|156044541|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
48505301|NCT00318461|156044537|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
48505302|NCT00318461|156044538|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
48505303|NCT00318461|156044539|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
48505304|NCT00318461|156044540|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
48505305|NCT00318461|156044541|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
48724843|NCT02793128|156842077|FG000|Overall Study|Death|4|||
48724844|NCT02793128|156842077|FG000|Overall Study|Withdrawal by Subject|2|||
48724845|NCT02793128|156842077|FG000|Overall Study|Physician Decision|1|||
48724846|NCT02793128|156842077|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
48724847|NCT02793128|156842077|FG000|Overall Study|Patient elected nephroureterectomy|1|||
48724848|NCT04024020|156842083|FG000|Overall Study|Withdrawal by Subject|2|||
48724849|NCT04024020|156842084|FG001|Overall Study|Withdrawal by Subject|2|||
48724850|NCT00356122|156842087|FG000|TREATMENT|Lack of Efficacy|26|||
48724851|NCT00356122|156842087|FG000|TREATMENT|Adverse Event|10|||
48724852|NCT00356122|156842087|FG000|TREATMENT|Subject's request|4|||
48724853|NCT00356122|156842087|FG000|TREATMENT|Other|4|||
48724854|NCT00356122|156842087|FG000|TREATMENT|Did not receive study medication|1|||
48724855|NCT00356122|156842087|FG000|FOLLOW-UP|Death|37|||
48724856|NCT00356122|156842087|FG000|FOLLOW-UP|Lost to Follow-up|2|||
48724857|NCT00356122|156842087|FG000|FOLLOW-UP|Other|2|||
48724858|NCT00782795|156842088|FG000|Overall Study|Withdrawal by Subject|1|||
48505306|NCT00318461|156044537|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
48505307|NCT00318461|156044538|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
48505308|NCT00318461|156044539|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
48505309|NCT00318461|156044540|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
48505310|NCT00318461|156044541|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
48505311|NCT00318461|156044537|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
48505312|NCT00318461|156044538|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
48505313|NCT00318461|156044539|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
48505314|NCT00318461|156044540|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
48505315|NCT00318461|156044541|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
48505316|NCT01864174|156044542|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
48505317|NCT01864174|156044543|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
48505318|NCT01864174|156044542|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
48505319|NCT01864174|156044543|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
48505320|NCT01864174|156044542|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
48505321|NCT01864174|156044543|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
48505322|NCT01864174|156044542|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
48505323|NCT01864174|156044543|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
48505324|NCT01864174|156044542|FG000|Double Blind - Compliant Randomized|Death|1|||
48724859|NCT00782795|156842089|FG001|Overall Study|Withdrawal by Subject|2|||
48724860|NCT01015131|156842090|FG000|Overall Study|Physician Decision|1|||
48724861|NCT01015131|156842090|FG000|Overall Study|Protocol Violation|1|||
48724862|NCT01015131|156842090|FG000|Overall Study|Withdrawal by Subject|2|||
48724863|NCT01015131|156842090|FG000|Overall Study|Other Protocol Specified Criteria|4|||
48724864|NCT04480424|156842091|FG000|Overall Study|Withdrawal by Subject|0|||
48724865|NCT04480424|156842092|FG001|Overall Study|Withdrawal by Subject|2|||
48724866|NCT04480424|156842091|FG000|Overall Study|Lost to Follow-up|3|||
48724867|NCT04480424|156842092|FG001|Overall Study|Lost to Follow-up|3|||
48724868|NCT04480424|156842091|FG000|Overall Study|Death|14|||
48505325|NCT01864174|156044543|FG001|Double Blind - Compliant Randomized|Death|0|||
48505326|NCT01864174|156044542|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
48505327|NCT01864174|156044543|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
48505328|NCT01864174|156044542|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
48505329|NCT01864174|156044543|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
48505330|NCT01864174|156044542|FG000|Double Blind - Compliant Randomized|Other|6|||
48505331|NCT01864174|156044543|FG001|Double Blind - Compliant Randomized|Other|10|||
48505332|NCT01864174|156044542|FG000|Off Treatment Follow-Up|Other|2|||
48505333|NCT01864174|156044543|FG001|Off Treatment Follow-Up|Other|0|||
48505334|NCT01864174|156044542|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
48505335|NCT01864174|156044543|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
48505336|NCT02327130|156044544|FG000|Overall Study|Discharged in less than 5 days|5|||
48505337|NCT02327130|156044544|FG000|Overall Study|Physician Decision|2|||
48600221|NCT00807885|156391550|FG000|Overall Study|Lost to Follow-up|0|||
48724869|NCT04480424|156842092|FG001|Overall Study|Death|16|||
48724870|NCT04480424|156842091|FG000|Overall Study|Reason not Specified|5|||
48724871|NCT04480424|156842092|FG001|Overall Study|Reason not Specified|5|||
48724872|NCT01857583|156842093|FG000|Overall Study|Adverse Event|0|||
48724873|NCT01857583|156842094|FG001|Overall Study|Adverse Event|0|||
48724874|NCT01857583|156842095|FG002|Overall Study|Adverse Event|1|||
48724875|NCT01857583|156842096|FG003|Overall Study|Adverse Event|1|||
48724876|NCT01857583|156842093|FG000|Overall Study|Death|0|||
48724877|NCT01857583|156842094|FG001|Overall Study|Death|1|||
48724878|NCT01857583|156842095|FG002|Overall Study|Death|1|||
48724879|NCT01857583|156842096|FG003|Overall Study|Death|0|||
48724880|NCT01857583|156842093|FG000|Overall Study|Physician Decision|0|||
48724881|NCT01857583|156842094|FG001|Overall Study|Physician Decision|0|||
48724882|NCT01857583|156842095|FG002|Overall Study|Physician Decision|0|||
48724883|NCT01857583|156842096|FG003|Overall Study|Physician Decision|1|||
48724884|NCT01857583|156842093|FG000|Overall Study|Withdrawal by Subject|1|||
48724885|NCT01857583|156842094|FG001|Overall Study|Withdrawal by Subject|0|||
48724886|NCT01857583|156842095|FG002|Overall Study|Withdrawal by Subject|1|||
48724887|NCT01857583|156842096|FG003|Overall Study|Withdrawal by Subject|2|||
48724888|NCT02211638|156842097|FG000|Overall Study|Case Report Forms Uncollected|291|||
48724889|NCT02211638|156842097|FG000|Overall Study|Protocol Violation|692|||
48724890|NCT04382755|156842098|FG000|Overall Study|Withdrawal by Subject|1|||
48724891|NCT04382755|156842099|FG001|Overall Study|Withdrawal by Subject|0|||
48724892|NCT04382755|156842098|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
48724893|NCT04382755|156842099|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
48724894|NCT04382755|156842098|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
48724895|NCT04382755|156842099|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
48724896|NCT02867592|156842104|FG000|Overall Study|Adverse Event|3|||
48724897|NCT02867592|156842105|FG001|Overall Study|Adverse Event|0|||
48724898|NCT02867592|156842106|FG002|Overall Study|Adverse Event|2|||
48724899|NCT02867592|156842107|FG003|Overall Study|Adverse Event|1|||
48724900|NCT02867592|156842108|FG004|Overall Study|Adverse Event|1|||
48724901|NCT02867592|156842109|FG005|Overall Study|Adverse Event|5|||
48724902|NCT02867592|156842104|FG000|Overall Study|Death|0|||
48724903|NCT02867592|156842105|FG001|Overall Study|Death|0|||
48724904|NCT02867592|156842106|FG002|Overall Study|Death|0|||
48724905|NCT02867592|156842107|FG003|Overall Study|Death|1|||
48724906|NCT02867592|156842108|FG004|Overall Study|Death|0|||
48724907|NCT02867592|156842109|FG005|Overall Study|Death|1|||
48724908|NCT02867592|156842104|FG000|Overall Study|Lack of Efficacy|8|||
48724909|NCT02867592|156842105|FG001|Overall Study|Lack of Efficacy|10|||
48724910|NCT02867592|156842106|FG002|Overall Study|Lack of Efficacy|8|||
48724911|NCT02867592|156842107|FG003|Overall Study|Lack of Efficacy|8|||
48724912|NCT02867592|156842108|FG004|Overall Study|Lack of Efficacy|12|||
48724913|NCT02867592|156842109|FG005|Overall Study|Lack of Efficacy|17|||
48724914|NCT02867592|156842104|FG000|Overall Study|Physician Decision|1|||
48724915|NCT02867592|156842105|FG001|Overall Study|Physician Decision|2|||
48724916|NCT02867592|156842106|FG002|Overall Study|Physician Decision|2|||
48724917|NCT02867592|156842107|FG003|Overall Study|Physician Decision|0|||
48724918|NCT02867592|156842108|FG004|Overall Study|Physician Decision|5|||
48724919|NCT02867592|156842109|FG005|Overall Study|Physician Decision|1|||
48724920|NCT02867592|156842104|FG000|Overall Study|Protocol Violation|0|||
48724921|NCT02867592|156842105|FG001|Overall Study|Protocol Violation|0|||
48724922|NCT02867592|156842106|FG002|Overall Study|Protocol Violation|0|||
48724923|NCT02867592|156842107|FG003|Overall Study|Protocol Violation|0|||
48724924|NCT02867592|156842108|FG004|Overall Study|Protocol Violation|1|||
48724925|NCT02867592|156842109|FG005|Overall Study|Protocol Violation|1|||
48724926|NCT02867592|156842104|FG000|Overall Study|Withdrawal by Subject|0|||
48724927|NCT02867592|156842105|FG001|Overall Study|Withdrawal by Subject|1|||
48724928|NCT02867592|156842106|FG002|Overall Study|Withdrawal by Subject|0|||
48724929|NCT02867592|156842107|FG003|Overall Study|Withdrawal by Subject|1|||
48724930|NCT02867592|156842108|FG004|Overall Study|Withdrawal by Subject|3|||
48724931|NCT02867592|156842109|FG005|Overall Study|Withdrawal by Subject|3|||
48505338|NCT02327130|156044544|FG000|Overall Study|Unable to provide breath sample|1|||
48505339|NCT02327130|156044544|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
48505340|NCT02327130|156044544|FG000|Overall Study|Met exclusion criteria|3|||
48505341|NCT00420238|156044548|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
48505342|NCT00420238|156044549|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
48505343|NCT00420238|156044548|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
48505344|NCT00420238|156044549|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
48505345|NCT00420238|156044548|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
48505346|NCT00420238|156044549|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
48505347|NCT00420238|156044548|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
48505348|NCT00420238|156044549|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
48505349|NCT00420238|156044548|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
48505350|NCT00420238|156044549|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
48505351|NCT00420238|156044548|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
48505352|NCT00420238|156044549|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
48505353|NCT05214560|156044550|FG000|Overall Study|Screening Failure|1|||
48505354|NCT05214560|156044550|FG000|Overall Study|Physician Decision|4|||
48505355|NCT05214560|156044550|FG000|Overall Study|Withdrawal by Subject|1|||
48505356|NCT05214560|156044550|FG000|Overall Study|Lost to Follow-up|2|||
48505357|NCT05214560|156044550|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
48505358|NCT05214560|156044550|FG000|Overall Study|Study physician not available for the anesthesia|3|||
48505359|NCT05214560|156044550|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
48505360|NCT05214560|156044550|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
48505361|NCT05214560|156044550|FG000|Overall Study|Surgery not performed|3|||
48505362|NCT02296684|156044551|FG000|Overall Study|Withdrawal by Subject|0|||
48505363|NCT02296684|156044552|FG001|Overall Study|Withdrawal by Subject|1|||
48505364|NCT02296684|156044553|FG002|Overall Study|Withdrawal by Subject|1|||
48505365|NCT02296684|156044551|FG000|Overall Study|Death|2|||
48505366|NCT02296684|156044552|FG001|Overall Study|Death|0|||
48505367|NCT02296684|156044553|FG002|Overall Study|Death|0|||
48505368|NCT01474551|156044554|FG000|Overall Study|Death|1|||
48505369|NCT02392000|156044561|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
48505370|NCT02392000|156044561|FG000|Overall Study|Withdrawal by Subject|1|||
48505371|NCT02392000|156044561|FG000|Overall Study|Lost to Follow-up|8|||
48505372|NCT04384978|156044563|FG000|Overall Study|Withdrawal by Subject|4|||
48505373|NCT04384978|156044564|FG001|Overall Study|Withdrawal by Subject|0|||
48505374|NCT00385593|156044565|FG000|Overall Study|Adverse Event|3|||
48505375|NCT00385593|156044566|FG001|Overall Study|Adverse Event|2|||
48505376|NCT00385593|156044565|FG000|Overall Study|Withdrawal by Subject|17|||
48505377|NCT00385593|156044566|FG001|Overall Study|Withdrawal by Subject|7|||
48505378|NCT00385593|156044565|FG000|Overall Study|Lost to Follow-up|12|||
48505379|NCT00385593|156044566|FG001|Overall Study|Lost to Follow-up|8|||
48505380|NCT00385593|156044565|FG000|Overall Study|Protocol Violation|7|||
48505381|NCT00385593|156044566|FG001|Overall Study|Protocol Violation|4|||
48505382|NCT00385593|156044565|FG000|Overall Study|Several reasons|17|||
48505383|NCT00385593|156044566|FG001|Overall Study|Several reasons|15|||
48505384|NCT00385593|156044565|FG000|Overall Study|Incorrect inclusion|2|||
48505385|NCT00385593|156044566|FG001|Overall Study|Incorrect inclusion|0|||
48505386|NCT00385593|156044565|FG000|Overall Study|Incorrect randomization|0|||
48505387|NCT00385593|156044566|FG001|Overall Study|Incorrect randomization|1|||
48505388|NCT04419311|156044568|FG000|Overall Study|Lost to Follow-up|1|||
48505389|NCT04419311|156044569|FG001|Overall Study|Lost to Follow-up|0|||
48505390|NCT00304083|156044570|FG000|Overall Study|Withdrawal by Subject|4|||
48505391|NCT00304083|156044571|FG001|Overall Study|Withdrawal by Subject|2|||
48505392|NCT00304083|156044570|FG000|Overall Study|Physician Decision|8|||
48505393|NCT00304083|156044571|FG001|Overall Study|Physician Decision|3|||
48505394|NCT00304083|156044570|FG000|Overall Study|Disease Progression|5|||
48505395|NCT00304083|156044571|FG001|Overall Study|Disease Progression|1|||
48505396|NCT00304083|156044570|FG000|Overall Study|Other|5|||
48505397|NCT00304083|156044571|FG001|Overall Study|Other|2|||
48505398|NCT03725605|156044572|FG000|Overall Study|Unsuccessful TIL expansion|2|||
48505399|NCT03325985|156044573|FG000|Overall Study|Lost to Follow-up|122|||
48505400|NCT03325985|156044574|FG001|Overall Study|Lost to Follow-up|26|||
48505401|NCT03325985|156044575|FG002|Overall Study|Lost to Follow-up|141|||
48505402|NCT03325985|156044576|FG003|Overall Study|Lost to Follow-up|28|||
48505403|NCT03325985|156044573|FG000|Overall Study|Death|99|||
48505404|NCT03325985|156044574|FG001|Overall Study|Death|36|||
48505405|NCT03325985|156044575|FG002|Overall Study|Death|94|||
48505406|NCT03325985|156044576|FG003|Overall Study|Death|32|||
48505407|NCT03555305|156044577|FG000|Period 1|Physician Decision|0|||
48505408|NCT03555305|156044578|FG001|Period 1|Physician Decision|1|||
48505409|NCT03555305|156044577|FG000|Period 1|Adverse Event|0|||
48505410|NCT03555305|156044578|FG001|Period 1|Adverse Event|1|||
48505411|NCT02374853|156044585|FG000|Overall Study|Surgery Cancelled|5|||
48505412|NCT02374853|156044586|FG001|Overall Study|Surgery Cancelled|11|||
48505413|NCT03243630|156044587|FG000|Overall Study|Protocol Violation|1|||
48505414|NCT03243630|156044587|FG000|Overall Study|Physician Decision|1|||
48505415|NCT04611789|156044588|FG000|Overall Study|Lost to Follow-up|1|||
48505416|NCT04611789|156044589|FG001|Overall Study|Lost to Follow-up|0|||
48505417|NCT04611789|156044590|FG002|Overall Study|Lost to Follow-up|0|||
48505418|NCT03707912|156044591|FG000|Overall Study|Violation of inclusion criteria|1|||
48505419|NCT03707912|156044592|FG001|Overall Study|Violation of inclusion criteria|0|||
48505420|NCT02817841|156046297|FG000|Overall Study|Lost to Follow-up|287|||
48505421|NCT02817841|156046297|FG000|Overall Study|Withdrawal by Subject|183|||
48505422|NCT02817841|156046297|FG000|Overall Study|Adverse event not related to bleeding|131|||
48505423|NCT02817841|156046297|FG000|Overall Study|Adverse event related to bleeding|51|||
48505424|NCT02817841|156046297|FG000|Overall Study|Pregnancy|32|||
48505425|NCT02817841|156046297|FG000|Overall Study|Pregnancy wish|17|||
48505426|NCT02817841|156046297|FG000|Overall Study|Other reasons|53|||
48505427|NCT02817841|156046297|FG000|Overall Study|Protocol Violation|94|||
48505428|NCT04657770|156046298|FG000|Overall Study|Withdrawal by Subject|3|||
48505429|NCT04657770|156046298|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
48505430|NCT00864097|156046299|FG000|Overall Study|Death|0|||
48505431|NCT00864097|156046300|FG001|Overall Study|Death|1|||
48505432|NCT00864097|156046301|FG002|Overall Study|Death|0|||
48505433|NCT00864097|156046302|FG003|Overall Study|Death|0|||
48505434|NCT00864097|156046299|FG000|Overall Study|Adverse Event|6|||
48505435|NCT00864097|156046300|FG001|Overall Study|Adverse Event|8|||
48505436|NCT00864097|156046301|FG002|Overall Study|Adverse Event|11|||
48505437|NCT00864097|156046302|FG003|Overall Study|Adverse Event|9|||
48505438|NCT00864097|156046299|FG000|Overall Study|Lack of Efficacy|9|||
48505439|NCT00864097|156046300|FG001|Overall Study|Lack of Efficacy|3|||
48505440|NCT00864097|156046301|FG002|Overall Study|Lack of Efficacy|7|||
48505441|NCT00864097|156046302|FG003|Overall Study|Lack of Efficacy|2|||
48505442|NCT00864097|156046299|FG000|Overall Study|Lost to Follow-up|0|||
48505443|NCT00864097|156046300|FG001|Overall Study|Lost to Follow-up|1|||
48505444|NCT00864097|156046301|FG002|Overall Study|Lost to Follow-up|0|||
48505445|NCT00864097|156046302|FG003|Overall Study|Lost to Follow-up|1|||
48505446|NCT00864097|156046299|FG000|Overall Study|Withdrawal by Subject|15|||
48505447|NCT00864097|156046300|FG001|Overall Study|Withdrawal by Subject|11|||
48505448|NCT00864097|156046301|FG002|Overall Study|Withdrawal by Subject|11|||
48505449|NCT00864097|156046302|FG003|Overall Study|Withdrawal by Subject|12|||
48505450|NCT00864097|156046299|FG000|Overall Study|Protocol Violation|2|||
48505451|NCT00864097|156046300|FG001|Overall Study|Protocol Violation|1|||
48505452|NCT00864097|156046301|FG002|Overall Study|Protocol Violation|0|||
48505453|NCT00864097|156046302|FG003|Overall Study|Protocol Violation|1|||
48505454|NCT00864097|156046299|FG000|Overall Study|Terminated by sponsor|105|||
48505455|NCT00864097|156046300|FG001|Overall Study|Terminated by sponsor|112|||
48505456|NCT00864097|156046301|FG002|Overall Study|Terminated by sponsor|102|||
48505457|NCT00864097|156046302|FG003|Overall Study|Terminated by sponsor|99|||
48505458|NCT00864097|156046299|FG000|Overall Study|Randomized but not treated|2|||
48505459|NCT00864097|156046300|FG001|Overall Study|Randomized but not treated|0|||
48505460|NCT00864097|156046301|FG002|Overall Study|Randomized but not treated|1|||
48505461|NCT00864097|156046302|FG003|Overall Study|Randomized but not treated|0|||
48505462|NCT00864097|156046299|FG000|Overall Study|Other|0|||
48505463|NCT00864097|156046300|FG001|Overall Study|Other|0|||
48505464|NCT00864097|156046301|FG002|Overall Study|Other|0|||
48505465|NCT00864097|156046302|FG003|Overall Study|Other|1|||
48505466|NCT01918397|156046303|FG000|Overall Study|Never started treatment|2|||
48505467|NCT01918397|156046304|FG001|Overall Study|Never started treatment|1|||
48505468|NCT01918397|156046305|FG002|Overall Study|Never started treatment|0|||
48505469|NCT01918397|156046306|FG003|Overall Study|Never started treatment|0|||
48505470|NCT01918397|156046303|FG000|Overall Study|Adverse Event|1|||
48505471|NCT01918397|156046304|FG001|Overall Study|Adverse Event|1|||
48505472|NCT01918397|156046305|FG002|Overall Study|Adverse Event|1|||
48505473|NCT01918397|156046306|FG003|Overall Study|Adverse Event|0|||
48505474|NCT01918397|156046303|FG000|Overall Study|Lack of compliance|2|||
48505475|NCT01918397|156046304|FG001|Overall Study|Lack of compliance|2|||
48505476|NCT01918397|156046305|FG002|Overall Study|Lack of compliance|3|||
48505477|NCT01918397|156046306|FG003|Overall Study|Lack of compliance|0|||
48505478|NCT01918397|156046303|FG000|Overall Study|Pregnancy|0|||
48505479|NCT01918397|156046304|FG001|Overall Study|Pregnancy|1|||
48505480|NCT01918397|156046305|FG002|Overall Study|Pregnancy|0|||
48505481|NCT01918397|156046306|FG003|Overall Study|Pregnancy|0|||
48505482|NCT01918397|156046303|FG000|Overall Study|Rifampin susceptible|0|||
48505483|NCT01918397|156046304|FG001|Overall Study|Rifampin susceptible|0|||
48505484|NCT01918397|156046305|FG002|Overall Study|Rifampin susceptible|0|||
48505485|NCT01918397|156046306|FG003|Overall Study|Rifampin susceptible|2|||
48505486|NCT01918397|156046303|FG000|Overall Study|Treatment failure|0|||
48505487|NCT01918397|156046304|FG001|Overall Study|Treatment failure|0|||
48505488|NCT01918397|156046305|FG002|Overall Study|Treatment failure|0|||
48505489|NCT01918397|156046306|FG003|Overall Study|Treatment failure|1|||
48505490|NCT01918397|156046303|FG000|Overall Study|Withdrawal by Subject|3|||
48505491|NCT01918397|156046304|FG001|Overall Study|Withdrawal by Subject|2|||
48505492|NCT01918397|156046305|FG002|Overall Study|Withdrawal by Subject|1|||
48505493|NCT01918397|156046306|FG003|Overall Study|Withdrawal by Subject|1|||
48505494|NCT01918397|156046303|FG000|Overall Study|XDR at baseline|0|||
48505495|NCT01918397|156046304|FG001|Overall Study|XDR at baseline|0|||
48505496|NCT01918397|156046305|FG002|Overall Study|XDR at baseline|1|||
48505497|NCT01918397|156046306|FG003|Overall Study|XDR at baseline|0|||
48505498|NCT01918397|156046303|FG000|Overall Study|Lost to Follow-up|2|||
48505499|NCT01918397|156046304|FG001|Overall Study|Lost to Follow-up|1|||
48505500|NCT01918397|156046305|FG002|Overall Study|Lost to Follow-up|1|||
48505501|NCT01918397|156046306|FG003|Overall Study|Lost to Follow-up|1|||
48505502|NCT01918397|156046303|FG000|Overall Study|Increased QTc|1|||
48505503|NCT01918397|156046304|FG001|Overall Study|Increased QTc|0|||
48505504|NCT01918397|156046305|FG002|Overall Study|Increased QTc|0|||
48505505|NCT01918397|156046306|FG003|Overall Study|Increased QTc|1|||
48505506|NCT01918397|156046303|FG000|Overall Study|Death|0|||
48505507|NCT01918397|156046304|FG001|Overall Study|Death|0|||
48505508|NCT01918397|156046305|FG002|Overall Study|Death|1|||
48505509|NCT01918397|156046306|FG003|Overall Study|Death|0|||
48505510|NCT01918397|156046303|FG000|Overall Study|Involved in another investigative trial|0|||
48505511|NCT01918397|156046304|FG001|Overall Study|Involved in another investigative trial|0|||
48505512|NCT01918397|156046305|FG002|Overall Study|Involved in another investigative trial|0|||
48505513|NCT01918397|156046306|FG003|Overall Study|Involved in another investigative trial|1|||
48505514|NCT01591785|156046314|FG000|Overall Study|worsening condition|1|||
48505515|NCT01591785|156046315|FG001|Overall Study|worsening condition|2|||
48505516|NCT01591785|156046314|FG000|Overall Study|Protocol Violation|2|||
48505517|NCT01591785|156046315|FG001|Overall Study|Protocol Violation|0|||
48505518|NCT01591785|156046314|FG000|Overall Study|Lost to Follow-up|1|||
48505519|NCT01591785|156046315|FG001|Overall Study|Lost to Follow-up|0|||
48505520|NCT00667862|156046316|FG000|Overall Study|Adverse Event|9|||
48505521|NCT00667862|156046316|FG000|Overall Study|Death|1|||
48505522|NCT00667862|156046316|FG000|Overall Study|Disease Progression|22|||
48505523|NCT00667862|156046316|FG000|Overall Study|Withdrawal by Subject|3|||
48505524|NCT00262223|156046317|FG000|Treatment Phase|Withdrawal by Subject|3|||
48505525|NCT00262223|156046318|FG001|Treatment Phase|Withdrawal by Subject|6|||
48505526|NCT00262223|156046317|FG000|Treatment Phase|Adverse Event|1|||
48505527|NCT00262223|156046318|FG001|Treatment Phase|Adverse Event|2|||
48505528|NCT00262223|156046317|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
48505529|NCT00262223|156046318|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
48505530|NCT00262223|156046317|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
48505531|NCT00262223|156046318|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
48505532|NCT00262223|156046317|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
48505533|NCT00262223|156046318|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
48505534|NCT00358449|156046321|FG000|Overall Study|Adverse Event|1|||
48505535|NCT00358449|156046322|FG001|Overall Study|Adverse Event|0|||
48505536|NCT00358449|156046323|FG002|Overall Study|Adverse Event|1|||
48505537|NCT00358449|156046321|FG000|Overall Study|Lost to Follow-up|1|||
48505538|NCT00358449|156046322|FG001|Overall Study|Lost to Follow-up|0|||
48505539|NCT00358449|156046323|FG002|Overall Study|Lost to Follow-up|0|||
48505540|NCT00358449|156046321|FG000|Overall Study|Withdrawal by Subject|2|||
48505541|NCT00358449|156046322|FG001|Overall Study|Withdrawal by Subject|0|||
48505542|NCT00358449|156046323|FG002|Overall Study|Withdrawal by Subject|0|||
48505543|NCT00358449|156046321|FG000|Overall Study|Lack of Efficacy|0|||
48505544|NCT00358449|156046322|FG001|Overall Study|Lack of Efficacy|1|||
48505545|NCT00358449|156046323|FG002|Overall Study|Lack of Efficacy|0|||
48505546|NCT00358449|156046321|FG000|Overall Study|Steriod Inhaler was Increased|0|||
48505547|NCT00358449|156046322|FG001|Overall Study|Steriod Inhaler was Increased|0|||
48505548|NCT00358449|156046323|FG002|Overall Study|Steriod Inhaler was Increased|1|||
48505549|NCT01804270|156046324|FG000|Overall Study|Withdrawal by Subject|1|||
48505550|NCT01804270|156046325|FG001|Overall Study|Withdrawal by Subject|1|||
48505551|NCT02794974|156046330|FG000|Overall Study|Physician Decision|0|||
48505552|NCT02794974|156046331|FG001|Overall Study|Physician Decision|1|||
48505553|NCT00533273|156046332|FG000|Double-blind|Withdrew consent|0|||
48505554|NCT00533273|156046333|FG001|Double-blind|Withdrew consent|2|||
48505555|NCT00533273|156046332|FG000|Open-label|Withdrawal by Subject|6|||
48505556|NCT00533273|156046333|FG001|Open-label|Withdrawal by Subject|0|||
48505557|NCT02438722|156046336|FG000|Overall Study|Adverse Event|12|||
48600222|NCT00807885|156391551|FG001|Overall Study|Lost to Follow-up|0|||
48600223|NCT00807885|156391552|FG002|Overall Study|Lost to Follow-up|0|||
48505558|NCT02438722|156046337|FG001|Overall Study|Adverse Event|9|||
48600224|NCT00807885|156391553|FG003|Overall Study|Lost to Follow-up|0|||
48600225|NCT00807885|156391554|FG004|Overall Study|Lost to Follow-up|0|||
48505559|NCT02438722|156046336|FG000|Overall Study|Refusal unrelated to AE|2|||
48505560|NCT02438722|156046337|FG001|Overall Study|Refusal unrelated to AE|5|||
48505561|NCT02438722|156046336|FG000|Overall Study|Disease progression/relapse|46|||
48505562|NCT02438722|156046337|FG001|Overall Study|Disease progression/relapse|51|||
48505563|NCT02438722|156046336|FG000|Overall Study|Death|0|||
48505564|NCT02438722|156046337|FG001|Overall Study|Death|3|||
48505565|NCT02438722|156046336|FG000|Overall Study|Physician Decision|2|||
48600226|NCT00807885|156391555|FG005|Overall Study|Lost to Follow-up|1|||
48819408|NCT03366649|157181815|FG000|Overall Study|Failed preoperative screening|4|||
48819409|NCT03366649|157181816|FG001|Overall Study|Failed preoperative screening|0|||
48819410|NCT03366649|157181817|FG002|Overall Study|Failed preoperative screening|0|||
48819411|NCT03366649|157181815|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
48819412|NCT03366649|157181816|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
48819413|NCT03366649|157181817|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
48819414|NCT01676220|157181819|FG000|Overall Study|Randomized But Not Treated|4|||
48819415|NCT01676220|157181820|FG001|Overall Study|Randomized But Not Treated|1|||
48819416|NCT01676220|157181819|FG000|Overall Study|Adverse Event|10|||
48819417|NCT01676220|157181820|FG001|Overall Study|Adverse Event|8|||
48819418|NCT01676220|157181819|FG000|Overall Study|Lack of Efficacy|2|||
48819419|NCT01676220|157181820|FG001|Overall Study|Lack of Efficacy|5|||
48819420|NCT01676220|157181819|FG000|Overall Study|Protocol Violation|11|||
48819421|NCT01676220|157181820|FG001|Overall Study|Protocol Violation|12|||
48819422|NCT01676220|157181819|FG000|Overall Study|Received Rescue Therapy|14|||
48819423|NCT01676220|157181820|FG001|Overall Study|Received Rescue Therapy|22|||
48819424|NCT01676220|157181819|FG000|Overall Study|Personal Reason|34|||
48819425|NCT01676220|157181820|FG001|Overall Study|Personal Reason|45|||
48819426|NCT01676220|157181819|FG000|Overall Study|Lost to Follow-up|11|||
48819427|NCT01676220|157181820|FG001|Overall Study|Lost to Follow-up|18|||
48819428|NCT01676220|157181819|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
48819429|NCT01676220|157181820|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
48819430|NCT01676220|157181819|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
48819431|NCT01676220|157181820|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
48819432|NCT01676220|157181819|FG000|Overall Study|Perceived Lack of Efficacy|3|||
48819433|NCT01676220|157181820|FG001|Overall Study|Perceived Lack of Efficacy|1|||
48819434|NCT01676220|157181819|FG000|Overall Study|Non Serious Hypoglycemia|2|||
48819435|NCT01676220|157181820|FG001|Overall Study|Non Serious Hypoglycemia|0|||
48819436|NCT01676220|157181819|FG000|Overall Study|No More Need of Insulin|1|||
48819437|NCT01676220|157181820|FG001|Overall Study|No More Need of Insulin|0|||
48819438|NCT04347161|157181821|FG000|Overall Study|Death|0|||
48819439|NCT04347161|157181822|FG001|Overall Study|Death|2|||
48819440|NCT04347161|157181821|FG000|Overall Study|Withdrawal by Subject|1|||
48819441|NCT04347161|157181822|FG001|Overall Study|Withdrawal by Subject|0|||
48819442|NCT04347161|157181821|FG000|Overall Study|Lost to Follow-up|0|||
48819443|NCT04347161|157181822|FG001|Overall Study|Lost to Follow-up|1|||
48819444|NCT04347161|157181821|FG000|Overall Study|No longer on study medication|1|||
48819445|NCT04347161|157181822|FG001|Overall Study|No longer on study medication|1|||
48819446|NCT00896454|157181823|FG000|Overall Study|Death|10|||
48819447|NCT00896454|157181823|FG000|Overall Study|Adverse Event|8|||
48819448|NCT00896454|157181823|FG000|Overall Study|Disease Progression|5|||
48819449|NCT00896454|157181823|FG000|Overall Study|Other|4|||
48819450|NCT00896454|157181823|FG000|Overall Study|Requirement for alternative therapy|3|||
48819451|NCT00896454|157181823|FG000|Overall Study|Ongoing in study|2|||
48819452|NCT00896454|157181823|FG000|Overall Study|Withdrawal by Subject|1|||
48819453|NCT01712789|157181824|FG000|Overall Study|Lack of Efficacy|2|||
48819454|NCT01712789|157181824|FG000|Overall Study|Lost to Follow-up|1|||
48819455|NCT01712789|157181824|FG000|Overall Study|Progressive Disease|504|||
48819456|NCT01712789|157181824|FG000|Overall Study|Death|57|||
48819457|NCT01712789|157181824|FG000|Overall Study|Adverse Event|52|||
48819458|NCT01712789|157181824|FG000|Overall Study|Miscellaneous|31|||
48505566|NCT02438722|156046337|FG001|Overall Study|Physician Decision|2|||
48505567|NCT02438722|156046336|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
48505568|NCT02438722|156046337|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
48505569|NCT02438722|156046336|FG000|Overall Study|Withdrawal by Subject|0|||
48505570|NCT02438722|156046337|FG001|Overall Study|Withdrawal by Subject|1|||
48505571|NCT02438722|156046336|FG000|Overall Study|On protocol treatment|15|||
48505572|NCT02438722|156046337|FG001|Overall Study|On protocol treatment|14|||
48505573|NCT02438722|156046336|FG000|Overall Study|Did not receive protocol treatment|5|||
48505574|NCT02438722|156046337|FG001|Overall Study|Did not receive protocol treatment|0|||
48505575|NCT02202850|156046342|FG000|Overall Study|Other|2|||
48505576|NCT02202850|156046343|FG001|Overall Study|Other|2|||
48505577|NCT02202850|156046342|FG000|Overall Study|Enbrel treatment discontinued|15|||
48505578|NCT02202850|156046343|FG001|Overall Study|Enbrel treatment discontinued|3|||
48505579|NCT02202850|156046342|FG000|Overall Study|Lost to Follow-up|7|||
48819459|NCT01712789|157181824|FG000|Overall Study|Withdrawal by Subject|21|||
48819460|NCT01712789|157181824|FG000|Overall Study|Transition to Commercial Treatment|8|||
48819461|NCT01712789|157181824|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
48819462|NCT03018106|157181825|FG000|Overall Study|Lost to Follow-up|0|||
48819463|NCT03018106|157181826|FG001|Overall Study|Lost to Follow-up|1|||
48505580|NCT02202850|156046343|FG001|Overall Study|Lost to Follow-up|1|||
48505581|NCT02761057|156046344|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
48819464|NCT01994720|157181827|FG000|Overall Study|Withdrawal by Subject|46|||
48819465|NCT01994720|157181828|FG001|Overall Study|Withdrawal by Subject|56|||
48505582|NCT02761057|156046345|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
48505583|NCT02761057|156046346|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
48505584|NCT02761057|156046347|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
48505585|NCT02761057|156046344|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
48505586|NCT02761057|156046345|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
48505587|NCT02761057|156046346|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
48505588|NCT02761057|156046347|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
48505589|NCT02761057|156046344|FG000|Overall Study|Currently On Study Treatment|0|||
48505590|NCT02761057|156046345|FG001|Overall Study|Currently On Study Treatment|3|||
48505591|NCT02761057|156046346|FG002|Overall Study|Currently On Study Treatment|0|||
48505592|NCT02761057|156046347|FG003|Overall Study|Currently On Study Treatment|0|||
48505593|NCT02761057|156046344|FG000|Overall Study|Adverse Event|11|||
48505594|NCT02761057|156046345|FG001|Overall Study|Adverse Event|9|||
48505595|NCT02761057|156046346|FG002|Overall Study|Adverse Event|5|||
48724932|NCT02867592|156842104|FG000|Overall Study|Ineligible|1|||
48724933|NCT02867592|156842105|FG001|Overall Study|Ineligible|1|||
48724934|NCT02867592|156842106|FG002|Overall Study|Ineligible|0|||
48724935|NCT02867592|156842107|FG003|Overall Study|Ineligible|0|||
48724936|NCT02867592|156842108|FG004|Overall Study|Ineligible|2|||
48724937|NCT02867592|156842109|FG005|Overall Study|Ineligible|0|||
48724938|NCT02867592|156842104|FG000|Overall Study|No Treatment|1|||
48724939|NCT02867592|156842105|FG001|Overall Study|No Treatment|0|||
48724940|NCT02867592|156842106|FG002|Overall Study|No Treatment|0|||
48724941|NCT02867592|156842107|FG003|Overall Study|No Treatment|0|||
48724942|NCT02867592|156842108|FG004|Overall Study|No Treatment|0|||
48724943|NCT02867592|156842109|FG005|Overall Study|No Treatment|0|||
48724944|NCT02867592|156842104|FG000|Overall Study|Still on Therapy|0|||
48724945|NCT02867592|156842105|FG001|Overall Study|Still on Therapy|0|||
48724946|NCT02867592|156842106|FG002|Overall Study|Still on Therapy|0|||
48724947|NCT02867592|156842107|FG003|Overall Study|Still on Therapy|0|||
48724948|NCT02867592|156842108|FG004|Overall Study|Still on Therapy|1|||
48724949|NCT02867592|156842109|FG005|Overall Study|Still on Therapy|0|||
48724950|NCT02867592|156842104|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724951|NCT02867592|156842105|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724952|NCT02867592|156842106|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724953|NCT02867592|156842107|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724954|NCT02867592|156842108|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
48724955|NCT02867592|156842109|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
48724956|NCT02867592|156842104|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
48724957|NCT02867592|156842105|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
48724958|NCT02867592|156842106|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
48724959|NCT02867592|156842107|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
48724960|NCT02867592|156842108|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
48724961|NCT02867592|156842109|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
48724962|NCT02418156|156842110|FG000|Overall Study|Lost to Follow-up|12|||
48724963|NCT02418156|156842110|FG000|Overall Study|Death|2|||
48724964|NCT02418156|156842110|FG000|Overall Study|Physician Decision|1|||
48724965|NCT02418156|156842110|FG000|Overall Study|Withdrawal by Subject|1|||
48724966|NCT02418156|156842110|FG000|Overall Study|Subject refused to return|1|||
48724967|NCT00458536|156842111|FG000|Overall Study|Disease progression prior to treatment|7|||
48724968|NCT00458536|156842111|FG000|Overall Study|Unable to make vaccine|3|||
48724969|NCT00458536|156842111|FG000|Overall Study|No measurable disease after surgery|2|||
48724970|NCT00458536|156842111|FG000|Overall Study|Did not have renal cell carcinoma|2|||
48724971|NCT00458536|156842111|FG000|Overall Study|Patient did not have surgery|1|||
48724972|NCT00458536|156842111|FG000|Overall Study|Ineligible due to toxicity|1|||
48724973|NCT00458536|156842111|FG000|Overall Study|Withdrawal by Subject|1|||
48724974|NCT00458536|156842111|FG000|Overall Study|Progressive disease during treatment|2|||
48724975|NCT00285207|156842113|FG000|Overall Study|Lost to Follow-up|3|||
48724976|NCT00285207|156842114|FG001|Overall Study|Lost to Follow-up|2|||
48724977|NCT00285207|156842113|FG000|Overall Study|Withdrawal by Subject|5|||
48724978|NCT00285207|156842114|FG001|Overall Study|Withdrawal by Subject|2|||
48724979|NCT00285207|156842113|FG000|Overall Study|Pregnancy|1|||
48724980|NCT00285207|156842114|FG001|Overall Study|Pregnancy|1|||
48724981|NCT00285207|156842113|FG000|Overall Study|non-compliance|0|||
48724982|NCT00285207|156842114|FG001|Overall Study|non-compliance|1|||
48724983|NCT05140382|156842117|FG000|Overall Study|Death|3|||
48724984|NCT05140382|156842118|FG001|Overall Study|Death|0|||
48724985|NCT05140382|156842119|FG002|Overall Study|Death|0|||
48724986|NCT05140382|156842117|FG000|Overall Study|Investigator decision|1|||
48724987|NCT05140382|156842118|FG001|Overall Study|Investigator decision|0|||
48819466|NCT00146640|157181829|FG000|Overall Study|Adverse Event|12|||
48819467|NCT00146640|157181830|FG001|Overall Study|Adverse Event|10|||
48819468|NCT00146640|157181829|FG000|Overall Study|Medical Reasons|3|||
48819469|NCT00146640|157181830|FG001|Overall Study|Medical Reasons|0|||
48819470|NCT00146640|157181829|FG000|Overall Study|Non-Medical Reasons|8|||
48819471|NCT00146640|157181830|FG001|Overall Study|Non-Medical Reasons|4|||
48819472|NCT03867500|157181838|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
48819473|NCT05894577|157181839|FG000|Overall Study|No receipt of study drug|14|||
48819474|NCT05894577|157181840|FG001|Overall Study|No receipt of study drug|13|||
48505596|NCT02761057|156046347|FG003|Overall Study|Adverse Event|3|||
48505597|NCT02761057|156046344|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
48505598|NCT02761057|156046345|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
48505599|NCT02761057|156046346|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
48505600|NCT02761057|156046347|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
48505601|NCT02761057|156046344|FG000|Overall Study|Progression/Relapse|29|||
48505602|NCT02761057|156046345|FG001|Overall Study|Progression/Relapse|27|||
48505603|NCT02761057|156046346|FG002|Overall Study|Progression/Relapse|20|||
48505604|NCT02761057|156046347|FG003|Overall Study|Progression/Relapse|23|||
48505605|NCT02761057|156046344|FG000|Overall Study|Death|2|||
48505606|NCT02761057|156046345|FG001|Overall Study|Death|2|||
48505607|NCT02761057|156046346|FG002|Overall Study|Death|1|||
48505608|NCT02761057|156046347|FG003|Overall Study|Death|1|||
48505609|NCT02761057|156046344|FG000|Overall Study|Other - Not Protocol Specified|2|||
48505610|NCT02761057|156046345|FG001|Overall Study|Other - Not Protocol Specified|1|||
48505611|NCT02761057|156046346|FG002|Overall Study|Other - Not Protocol Specified|2|||
48505612|NCT02761057|156046347|FG003|Overall Study|Other - Not Protocol Specified|0|||
48505613|NCT02457520|156046348|FG000|Active Treatment Phase|Adverse Event|10|||
48505614|NCT02457520|156046348|FG000|Active Treatment Phase|Lost to Follow-up|8|||
48505615|NCT02457520|156046348|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
48505616|NCT02457520|156046348|FG000|Active Treatment Phase|other|4|||
48505617|NCT02457520|156046348|FG000|Active Treatment Phase|Physician Decision|1|||
48505618|NCT02457520|156046348|FG000|Active Treatment Phase|Protocol Violation|1|||
48505619|NCT02457520|156046348|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
48505620|NCT02457520|156046348|FG000|Post-treatment Period|Other: Retreatment Required|7|||
48505621|NCT02457520|156046348|FG000|Post-treatment Period|Lost to Follow-up|23|||
48505622|NCT02457520|156046348|FG000|Post-treatment Period|Other|3|||
48505623|NCT02457520|156046348|FG000|Post-treatment Period|Physician Decision|1|||
48505624|NCT02457520|156046348|FG000|Post-treatment Period|Withdrawal by Subject|14|||
48505625|NCT02587962|156046349|FG000|Overall Study|Adverse Event|0|||
48505626|NCT02587962|156046350|FG001|Overall Study|Adverse Event|0|||
48505627|NCT02587962|156046351|FG002|Overall Study|Adverse Event|1|||
48505628|NCT02587962|156046352|FG003|Overall Study|Adverse Event|0|||
48505629|NCT02587962|156046353|FG004|Overall Study|Adverse Event|0|||
48505630|NCT02587962|156046349|FG000|Overall Study|Withdrawal by Subject|0|||
48505631|NCT02587962|156046350|FG001|Overall Study|Withdrawal by Subject|0|||
48505632|NCT02587962|156046351|FG002|Overall Study|Withdrawal by Subject|1|||
48505633|NCT02587962|156046352|FG003|Overall Study|Withdrawal by Subject|1|||
48505634|NCT02587962|156046353|FG004|Overall Study|Withdrawal by Subject|4|||
48505635|NCT02587962|156046349|FG000|Overall Study|Radiological progression|2|||
48505636|NCT02587962|156046350|FG001|Overall Study|Radiological progression|2|||
48505637|NCT02587962|156046351|FG002|Overall Study|Radiological progression|2|||
48505638|NCT02587962|156046352|FG003|Overall Study|Radiological progression|5|||
48505639|NCT02587962|156046353|FG004|Overall Study|Radiological progression|10|||
48505640|NCT02587962|156046349|FG000|Overall Study|Clinical progression|0|||
48505641|NCT02587962|156046350|FG001|Overall Study|Clinical progression|1|||
48505642|NCT02587962|156046351|FG002|Overall Study|Clinical progression|2|||
48505643|NCT02587962|156046352|FG003|Overall Study|Clinical progression|0|||
48505644|NCT02587962|156046353|FG004|Overall Study|Clinical progression|1|||
48505645|NCT01981720|156046354|FG000|Overall Study|Adverse Event|1|||
48505646|NCT01981720|156046354|FG000|Overall Study|Withdrawal by Subject|3|||
48505647|NCT01981720|156046354|FG000|Overall Study|Pregnancy|1|||
48505648|NCT02458469|156046355|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
48505649|NCT02458469|156046356|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
48505650|NCT02458469|156046357|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
48505651|NCT02458469|156046358|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
48505652|NCT02458469|156046359|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
48819475|NCT05894577|157181839|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
48505653|NCT02458469|156046360|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
48505654|NCT02458469|156046355|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
48505655|NCT02458469|156046356|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
48505656|NCT02458469|156046357|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
48505657|NCT02458469|156046358|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
48505658|NCT02458469|156046359|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
48505659|NCT02458469|156046360|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
48600227|NCT00807885|156391556|FG006|Overall Study|Lost to Follow-up|0|||
48819476|NCT05894577|157181840|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
48819477|NCT05894577|157181839|FG000|Overall Study|Screen Fail|2|||
48819478|NCT05894577|157181840|FG001|Overall Study|Screen Fail|0|||
48819479|NCT05894577|157181839|FG000|Overall Study|Study drug recall|86|||
48819480|NCT05894577|157181840|FG001|Overall Study|Study drug recall|63|||
48819481|NCT01919554|157181841|FG000|Overall Study|Withdrawal by Subject|0|||
48819482|NCT01919554|157181842|FG001|Overall Study|Withdrawal by Subject|0|||
48819483|NCT01919554|157181843|FG002|Overall Study|Withdrawal by Subject|1|||
48819484|NCT01919554|157181844|FG003|Overall Study|Withdrawal by Subject|1|||
48819485|NCT06182033|157181845|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
48819486|NCT06182033|157181846|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
48819487|NCT06182033|157181845|FG000|Overall Study|Target child relocation|1|||
48819488|NCT06182033|157181846|FG001|Overall Study|Target child relocation|1|||
48819489|NCT06182033|157181845|FG000|Overall Study|Withdrawal by Subject|1|||
48819490|NCT06182033|157181846|FG001|Overall Study|Withdrawal by Subject|0|||
48819491|NCT00442286|157181858|FG000|Overall Study|Death|2|||
48819492|NCT00442286|157181859|FG001|Overall Study|Death|2|||
48819493|NCT00442286|157181858|FG000|Overall Study|Lost to Follow-up|1|||
48819494|NCT00442286|157181859|FG001|Overall Study|Lost to Follow-up|0|||
48819495|NCT00442286|157181858|FG000|Overall Study|Withdrawal by Subject|2|||
48819496|NCT00442286|157181859|FG001|Overall Study|Withdrawal by Subject|0|||
48819497|NCT00442286|157181858|FG000|Overall Study|System explanted|1|||
48819498|NCT00442286|157181859|FG001|Overall Study|System explanted|0|||
48819499|NCT00442286|157181858|FG000|Overall Study|Patient Injury|1|||
48819500|NCT00442286|157181859|FG001|Overall Study|Patient Injury|0|||
48819501|NCT05114590|157181860|FG000|Overall Study|Adverse Event|1|||
48819502|NCT05114590|157181860|FG000|Overall Study|Investigator decision|1|||
48819503|NCT05114590|157181860|FG000|Overall Study|Lost to Follow-up|5|||
48819504|NCT05114590|157181860|FG000|Overall Study|Withdrawal by Subject|5|||
48819505|NCT05114590|157181860|FG000|Overall Study|Other|2|||
48819506|NCT00429793|157181863|FG000|Overall Study|Improper pre-protocol treatment|3|||
48819507|NCT00429793|157181863|FG000|Overall Study|Required test not done|1|||
48819508|NCT00429793|157181863|FG000|Overall Study|Never treated|1|||
48819509|NCT00429793|157181863|FG000|Overall Study|Non-measurable|1|||
48819510|NCT01394991|157181864|FG000|Overall Study|Adverse Event|0|||
48819511|NCT01394991|157181865|FG001|Overall Study|Adverse Event|4|||
48819512|NCT01394991|157181864|FG000|Overall Study|Lack of Efficacy|5|||
48819513|NCT01394991|157181865|FG001|Overall Study|Lack of Efficacy|7|||
48819514|NCT01394991|157181864|FG000|Overall Study|Lost to Follow-up|6|||
48819515|NCT01394991|157181865|FG001|Overall Study|Lost to Follow-up|8|||
48819516|NCT01394991|157181864|FG000|Overall Study|Physician Decision|1|||
48819517|NCT01394991|157181865|FG001|Overall Study|Physician Decision|3|||
48819518|NCT01394991|157181864|FG000|Overall Study|Protocol Violation|1|||
48819519|NCT01394991|157181865|FG001|Overall Study|Protocol Violation|1|||
48819520|NCT01394991|157181864|FG000|Overall Study|Withdrawal by Subject|20|||
48819521|NCT01394991|157181865|FG001|Overall Study|Withdrawal by Subject|17|||
48819522|NCT01394991|157181864|FG000|Overall Study|Chemotherapy Termination|10|||
48819523|NCT01394991|157181865|FG001|Overall Study|Chemotherapy Termination|15|||
48819524|NCT01394991|157181864|FG000|Overall Study|Disease Progression|7|||
48819525|NCT01394991|157181865|FG001|Overall Study|Disease Progression|7|||
48819526|NCT01394991|157181864|FG000|Overall Study|Prematurely Termination of Trial|9|||
48819527|NCT01394991|157181865|FG001|Overall Study|Prematurely Termination of Trial|10|||
48819528|NCT02337361|157181866|FG000|3-month Follow-up|Lost to Follow-up|19|||
48819529|NCT02337361|157181867|FG001|3-month Follow-up|Lost to Follow-up|14|||
48819530|NCT02337361|157181866|FG000|6-month Follow-up|Lost to Follow-up|2|||
48819531|NCT02337361|157181867|FG001|6-month Follow-up|Lost to Follow-up|4|||
48819532|NCT03073005|157181868|FG000|Overall Study|Death|6|||
48819533|NCT03073005|157181869|FG001|Overall Study|Death|0|||
48819534|NCT03073005|157181870|FG002|Overall Study|Death|7|||
48819535|NCT03073005|157181871|FG003|Overall Study|Death|0|||
48505660|NCT02458469|156046355|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
48505661|NCT02458469|156046356|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
48505662|NCT02458469|156046357|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
48819536|NCT03073005|157181868|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
48819537|NCT03073005|157181869|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
48819538|NCT03073005|157181870|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
48819539|NCT03073005|157181871|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
48819540|NCT03073005|157181868|FG000|Overall Study|Lost to Follow-up|2|||
48819541|NCT03073005|157181869|FG001|Overall Study|Lost to Follow-up|2|||
48819542|NCT03073005|157181870|FG002|Overall Study|Lost to Follow-up|1|||
48819543|NCT03073005|157181871|FG003|Overall Study|Lost to Follow-up|2|||
48819544|NCT03073005|157181868|FG000|Overall Study|Withdrawal by Subject|0|||
48819545|NCT03073005|157181869|FG001|Overall Study|Withdrawal by Subject|4|||
48819546|NCT03073005|157181870|FG002|Overall Study|Withdrawal by Subject|4|||
48819547|NCT03073005|157181871|FG003|Overall Study|Withdrawal by Subject|4|||
48819548|NCT00725010|157181879|FG000|Overall Study|Toxicity|9|||
48819549|NCT00725010|157181879|FG000|Overall Study|Tumor Progression|7|||
48819550|NCT00725010|157181879|FG000|Overall Study|Withdrawal by Subject|2|||
48819551|NCT00725010|157181879|FG000|Overall Study|Death|1|||
48819552|NCT00725010|157181879|FG000|Overall Study|Lost to Follow-up|1|||
48819553|NCT00725010|157181879|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
48819554|NCT00725010|157181879|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
48819555|NCT00725010|157181879|FG000|Overall Study|No further documentation|1|||
48819556|NCT00725010|157181879|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
48819557|NCT02414828|157181880|FG000|Overall Study|Lost to Follow-up|0|||
48819558|NCT02414828|157181881|FG001|Overall Study|Lost to Follow-up|1|||
48819559|NCT02414828|157181882|FG002|Overall Study|Lost to Follow-up|1|||
48819560|NCT02414828|157181883|FG003|Overall Study|Lost to Follow-up|2|||
48819561|NCT00434837|157181884|FG000|Overall Study|Lost to Follow-up|20|||
48819562|NCT00434837|157181885|FG001|Overall Study|Lost to Follow-up|23|||
48819563|NCT00434837|157181886|FG002|Overall Study|Lost to Follow-up|30|||
48819564|NCT02499328|157181888|FG000|Overall Study|Withdrawal by Subject|1|||
48819565|NCT02499328|157181889|FG001|Overall Study|Withdrawal by Subject|1|||
48819566|NCT02499328|157181890|FG002|Overall Study|Withdrawal by Subject|5|||
48819567|NCT02499328|157181891|FG003|Overall Study|Withdrawal by Subject|3|||
48819568|NCT02499328|157181892|FG004|Overall Study|Withdrawal by Subject|5|||
48819569|NCT02499328|157181893|FG005|Overall Study|Withdrawal by Subject|0|||
48819570|NCT02499328|157181894|FG006|Overall Study|Withdrawal by Subject|0|||
48819571|NCT02499328|157181895|FG007|Overall Study|Withdrawal by Subject|0|||
48819572|NCT02499328|157181896|FG008|Overall Study|Withdrawal by Subject|2|||
48819573|NCT02499328|157181897|FG009|Overall Study|Withdrawal by Subject|2|||
48819574|NCT02499328|157181898|FG010|Overall Study|Withdrawal by Subject|0|||
48819575|NCT02499328|157181899|FG011|Overall Study|Withdrawal by Subject|3|||
48819576|NCT02499328|157181900|FG012|Overall Study|Withdrawal by Subject|7|||
48819577|NCT02499328|157181901|FG013|Overall Study|Withdrawal by Subject|3|||
48819578|NCT02499328|157181902|FG014|Overall Study|Withdrawal by Subject|1|||
48819579|NCT02499328|157181903|FG015|Overall Study|Withdrawal by Subject|0|||
48819580|NCT02499328|157181904|FG016|Overall Study|Withdrawal by Subject|0|||
48819581|NCT02499328|157181905|FG017|Overall Study|Withdrawal by Subject|3|||
48819582|NCT02499328|157181906|FG018|Overall Study|Withdrawal by Subject|0|||
48819583|NCT02499328|157181888|FG000|Overall Study|Lost to Follow-up|0|||
48819584|NCT02499328|157181889|FG001|Overall Study|Lost to Follow-up|1|||
48819585|NCT02499328|157181890|FG002|Overall Study|Lost to Follow-up|1|||
48819586|NCT02499328|157181891|FG003|Overall Study|Lost to Follow-up|2|||
48819587|NCT02499328|157181892|FG004|Overall Study|Lost to Follow-up|0|||
48819588|NCT02499328|157181893|FG005|Overall Study|Lost to Follow-up|0|||
48819589|NCT02499328|157181894|FG006|Overall Study|Lost to Follow-up|0|||
48819590|NCT02499328|157181895|FG007|Overall Study|Lost to Follow-up|2|||
48819591|NCT02499328|157181896|FG008|Overall Study|Lost to Follow-up|3|||
48819592|NCT02499328|157181897|FG009|Overall Study|Lost to Follow-up|0|||
48819593|NCT02499328|157181898|FG010|Overall Study|Lost to Follow-up|0|||
48819594|NCT02499328|157181899|FG011|Overall Study|Lost to Follow-up|0|||
48819595|NCT02499328|157181900|FG012|Overall Study|Lost to Follow-up|0|||
48819596|NCT02499328|157181901|FG013|Overall Study|Lost to Follow-up|0|||
48819597|NCT02499328|157181902|FG014|Overall Study|Lost to Follow-up|0|||
48819598|NCT02499328|157181903|FG015|Overall Study|Lost to Follow-up|0|||
48819599|NCT02499328|157181904|FG016|Overall Study|Lost to Follow-up|0|||
48505663|NCT02458469|156046358|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
48505664|NCT02458469|156046359|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
48505665|NCT02458469|156046360|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
48819600|NCT02499328|157181905|FG017|Overall Study|Lost to Follow-up|0|||
48819601|NCT02499328|157181906|FG018|Overall Study|Lost to Follow-up|1|||
48819602|NCT02499328|157181888|FG000|Overall Study|Death|0|||
48819603|NCT02499328|157181889|FG001|Overall Study|Death|3|||
48819604|NCT02499328|157181890|FG002|Overall Study|Death|3|||
48505666|NCT01422538|156046361|FG000|Overall Study|Lost to Follow-up|0|||
48505667|NCT01422538|156046362|FG001|Overall Study|Lost to Follow-up|1|||
48505668|NCT01422538|156046363|FG002|Overall Study|Lost to Follow-up|1|||
48505669|NCT01422538|156046361|FG000|Overall Study|Missed visit|0|||
48505670|NCT01422538|156046362|FG001|Overall Study|Missed visit|1|||
48600228|NCT00807885|156391557|FG007|Overall Study|Lost to Follow-up|0|||
48819605|NCT02499328|157181891|FG003|Overall Study|Death|2|||
48819606|NCT02499328|157181892|FG004|Overall Study|Death|4|||
48819607|NCT02499328|157181893|FG005|Overall Study|Death|7|||
48819608|NCT02499328|157181894|FG006|Overall Study|Death|3|||
48819609|NCT02499328|157181895|FG007|Overall Study|Death|0|||
48819610|NCT02499328|157181896|FG008|Overall Study|Death|2|||
48600229|NCT00807885|156391558|FG008|Overall Study|Lost to Follow-up|0|||
48819611|NCT02499328|157181897|FG009|Overall Study|Death|6|||
48819612|NCT02499328|157181898|FG010|Overall Study|Death|6|||
48819613|NCT02499328|157181899|FG011|Overall Study|Death|20|||
48819614|NCT02499328|157181900|FG012|Overall Study|Death|9|||
48819615|NCT02499328|157181901|FG013|Overall Study|Death|7|||
48819616|NCT02499328|157181902|FG014|Overall Study|Death|3|||
48819617|NCT02499328|157181903|FG015|Overall Study|Death|1|||
48819618|NCT02499328|157181904|FG016|Overall Study|Death|1|||
48819619|NCT02499328|157181905|FG017|Overall Study|Death|16|||
48505671|NCT01422538|156046363|FG002|Overall Study|Missed visit|1|||
48505672|NCT00004562|156046364|FG000|Overall Study|Lost to Follow-up|102|||
48505673|NCT00004562|156046365|FG001|Overall Study|Lost to Follow-up|91|||
48505674|NCT02076022|156046367|FG000|Overall Study|Withdrawal by Subject|2|||
48505675|NCT02076022|156046368|FG001|Overall Study|Withdrawal by Subject|0|||
48505676|NCT00312663|156046369|FG000|Immunization Phase|Adverse Event|0|||
48505677|NCT00312663|156046370|FG001|Immunization Phase|Adverse Event|1|||
48505678|NCT00312663|156046371|FG002|Immunization Phase|Adverse Event|0|||
48819620|NCT02499328|157181906|FG018|Overall Study|Death|5|||
48819621|NCT02499328|157181888|FG000|Overall Study|"Other"|2|||
48819622|NCT02499328|157181889|FG001|Overall Study|"Other"|2|||
48819623|NCT02499328|157181890|FG002|Overall Study|"Other"|1|||
48819624|NCT02499328|157181891|FG003|Overall Study|"Other"|3|||
48819625|NCT02499328|157181892|FG004|Overall Study|"Other"|6|||
48819626|NCT02499328|157181893|FG005|Overall Study|"Other"|2|||
48819627|NCT02499328|157181894|FG006|Overall Study|"Other"|3|||
48819628|NCT02499328|157181895|FG007|Overall Study|"Other"|4|||
48819629|NCT02499328|157181896|FG008|Overall Study|"Other"|6|||
48819630|NCT02499328|157181897|FG009|Overall Study|"Other"|16|||
48819631|NCT02499328|157181898|FG010|Overall Study|"Other"|13|||
48819632|NCT02499328|157181899|FG011|Overall Study|"Other"|31|||
48819633|NCT02499328|157181900|FG012|Overall Study|"Other"|8|||
48819634|NCT02499328|157181901|FG013|Overall Study|"Other"|7|||
48819635|NCT02499328|157181902|FG014|Overall Study|"Other"|6|||
48819636|NCT02499328|157181903|FG015|Overall Study|"Other"|0|||
48819637|NCT02499328|157181904|FG016|Overall Study|"Other"|0|||
48819638|NCT02499328|157181905|FG017|Overall Study|"Other"|34|||
48819639|NCT02499328|157181906|FG018|Overall Study|"Other"|43|||
48819640|NCT02499328|157181888|FG000|Overall Study|Disease Progression|0|||
48819641|NCT02499328|157181889|FG001|Overall Study|Disease Progression|0|||
48819642|NCT02499328|157181890|FG002|Overall Study|Disease Progression|0|||
48819643|NCT02499328|157181891|FG003|Overall Study|Disease Progression|0|||
48505679|NCT04274686|156046372|FG000|Overall Study|Physician Decision|1|||
48505680|NCT04274686|156046373|FG001|Overall Study|Physician Decision|0|||
48505681|NCT00819741|156046375|FG000|Overall Study|Adverse Event|5|||
48505682|NCT00819741|156046376|FG001|Overall Study|Adverse Event|2|||
48819644|NCT02499328|157181892|FG004|Overall Study|Disease Progression|0|||
48819645|NCT02499328|157181893|FG005|Overall Study|Disease Progression|0|||
48819646|NCT02499328|157181894|FG006|Overall Study|Disease Progression|1|||
48819647|NCT02499328|157181895|FG007|Overall Study|Disease Progression|0|||
48819648|NCT02499328|157181896|FG008|Overall Study|Disease Progression|1|||
48819649|NCT02499328|157181897|FG009|Overall Study|Disease Progression|0|||
48819650|NCT02499328|157181898|FG010|Overall Study|Disease Progression|1|||
48505683|NCT00819741|156046375|FG000|Overall Study|Lack of Efficacy|0|||
48505684|NCT00819741|156046376|FG001|Overall Study|Lack of Efficacy|2|||
48505685|NCT00819741|156046375|FG000|Overall Study|Lost to Follow-up|3|||
48505686|NCT00819741|156046376|FG001|Overall Study|Lost to Follow-up|1|||
48505687|NCT00819741|156046375|FG000|Overall Study|Protocol Violation|3|||
48505688|NCT00819741|156046376|FG001|Overall Study|Protocol Violation|4|||
48505689|NCT00819741|156046375|FG000|Overall Study|Withdrawal by Subject|2|||
48505690|NCT00819741|156046376|FG001|Overall Study|Withdrawal by Subject|2|||
48505691|NCT00819741|156046375|FG000|Overall Study|Unclassified|6|||
48505692|NCT00819741|156046376|FG001|Overall Study|Unclassified|0|||
48505693|NCT00819741|156046375|FG000|Overall Study|Reasons unknown|3|||
48505694|NCT00819741|156046376|FG001|Overall Study|Reasons unknown|3|||
48505695|NCT00376623|156046377|FG000|Overall Study|Progressive disease|35|||
48505696|NCT00376623|156046378|FG001|Overall Study|Progressive disease|22|||
48505697|NCT00376623|156046379|FG002|Overall Study|Progressive disease|17|||
48505698|NCT00376623|156046377|FG000|Overall Study|Lost to Follow-up|0|||
48505699|NCT00376623|156046378|FG001|Overall Study|Lost to Follow-up|1|||
48505700|NCT00376623|156046379|FG002|Overall Study|Lost to Follow-up|0|||
48505701|NCT00376623|156046377|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
48505702|NCT00376623|156046378|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
48505703|NCT00376623|156046379|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
48505704|NCT00376623|156046377|FG000|Overall Study|Not treated with BI 2536|1|||
48505705|NCT00376623|156046378|FG001|Overall Study|Not treated with BI 2536|0|||
48505706|NCT00376623|156046379|FG002|Overall Study|Not treated with BI 2536|0|||
48505707|NCT00376623|156046377|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
48819651|NCT02499328|157181899|FG011|Overall Study|Disease Progression|0|||
48819652|NCT02499328|157181900|FG012|Overall Study|Disease Progression|0|||
48819653|NCT02499328|157181901|FG013|Overall Study|Disease Progression|0|||
48819654|NCT02499328|157181902|FG014|Overall Study|Disease Progression|0|||
48584941|NCT00743288|156333718|FG004|Overall Study|Withdrawal by Subject|0|||
48819655|NCT02499328|157181903|FG015|Overall Study|Disease Progression|0|||
48819656|NCT02499328|157181904|FG016|Overall Study|Disease Progression|0|||
48819657|NCT02499328|157181905|FG017|Overall Study|Disease Progression|2|||
48819658|NCT02499328|157181906|FG018|Overall Study|Disease Progression|0|||
48819659|NCT02499328|157181888|FG000|Overall Study|Adverse Event|1|||
48819660|NCT02499328|157181889|FG001|Overall Study|Adverse Event|0|||
48819661|NCT02499328|157181890|FG002|Overall Study|Adverse Event|0|||
48505708|NCT00376623|156046378|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
48505709|NCT00376623|156046379|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
48505710|NCT00376623|156046377|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
48505711|NCT00376623|156046378|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
48505712|NCT00376623|156046379|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
48505713|NCT00376623|156046377|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
48505714|NCT00376623|156046378|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
48505715|NCT00376623|156046379|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
48505716|NCT00376623|156046377|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
48505717|NCT00376623|156046378|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
48505718|NCT00376623|156046379|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
48505719|NCT00376623|156046377|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
48505720|NCT00376623|156046378|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
48505721|NCT00376623|156046379|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
48505722|NCT00376623|156046377|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
48505723|NCT00376623|156046378|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
48505724|NCT00376623|156046379|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
48505725|NCT00376623|156046377|FG000|Overall Study|Increase of tumour markers|0|||
48505726|NCT00376623|156046378|FG001|Overall Study|Increase of tumour markers|1|||
48505727|NCT00376623|156046379|FG002|Overall Study|Increase of tumour markers|0|||
48505728|NCT00376623|156046377|FG000|Overall Study|Bone metastasis|1|||
48505729|NCT00376623|156046378|FG001|Overall Study|Bone metastasis|0|||
48505730|NCT00376623|156046379|FG002|Overall Study|Bone metastasis|0|||
48505731|NCT04652700|156046384|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
48505732|NCT04652700|156046385|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
48505733|NCT04652700|156046384|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
48505734|NCT04652700|156046385|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
48505735|NCT04652700|156046384|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
48505736|NCT04652700|156046385|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
48505737|NCT04652700|156046384|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
48505738|NCT04652700|156046385|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
48505739|NCT04652700|156046384|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
48505740|NCT04652700|156046385|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
48505741|NCT04652700|156046384|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
48505742|NCT04652700|156046385|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
48505743|NCT04652700|156046384|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
48505744|NCT04652700|156046385|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
48505745|NCT04652700|156046384|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
48505746|NCT04652700|156046385|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
48505747|NCT04652700|156046384|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
48505748|NCT04652700|156046385|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
48505749|NCT00286754|156046387|FG000|Overall Study|Adverse Event|2|||
48505750|NCT00286754|156046388|FG001|Overall Study|Adverse Event|2|||
48505751|NCT00286754|156046389|FG002|Overall Study|Adverse Event|3|||
48505752|NCT00286754|156046387|FG000|Overall Study|Withdrawal by Subject|6|||
48505753|NCT00286754|156046388|FG001|Overall Study|Withdrawal by Subject|2|||
48505754|NCT00286754|156046389|FG002|Overall Study|Withdrawal by Subject|0|||
48505755|NCT00286754|156046387|FG000|Overall Study|Lost to Follow-up|12|||
48505756|NCT00286754|156046388|FG001|Overall Study|Lost to Follow-up|14|||
48505757|NCT00286754|156046389|FG002|Overall Study|Lost to Follow-up|6|||
48505758|NCT00286754|156046387|FG000|Overall Study|Moved out of state|0|||
48505759|NCT00286754|156046388|FG001|Overall Study|Moved out of state|0|||
48505760|NCT00286754|156046389|FG002|Overall Study|Moved out of state|1|||
48505761|NCT01536405|156046390|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
48505762|NCT01536405|156046391|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
48505763|NCT01536405|156046390|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
48505764|NCT01536405|156046391|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
48505765|NCT01536405|156046390|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
48505766|NCT01536405|156046391|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
48505767|NCT01536405|156046390|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
48505768|NCT01536405|156046391|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
48505769|NCT01536405|156046390|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
48600230|NCT03489343|156391560|FG000|Overall Study|Documented progressive disease|1|||
48600231|NCT03489343|156391561|FG001|Overall Study|Documented progressive disease|0|||
48819662|NCT02499328|157181891|FG003|Overall Study|Adverse Event|1|||
48819663|NCT02499328|157181892|FG004|Overall Study|Adverse Event|0|||
48819664|NCT02499328|157181893|FG005|Overall Study|Adverse Event|0|||
48819665|NCT02499328|157181894|FG006|Overall Study|Adverse Event|0|||
48505770|NCT01536405|156046391|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
48505771|NCT01536405|156046390|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
48505772|NCT01536405|156046391|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
48505773|NCT01536405|156046390|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
48505774|NCT01536405|156046391|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
48505775|NCT01536405|156046390|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
48505776|NCT01536405|156046391|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
48505777|NCT01536405|156046390|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
48505778|NCT01536405|156046391|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
48505779|NCT01536405|156046390|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
48505780|NCT01536405|156046391|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
48505781|NCT01536405|156046390|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
48505782|NCT01536405|156046391|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
48505783|NCT01536405|156046390|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
48505784|NCT01536405|156046391|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
48505785|NCT01536405|156046390|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
48505786|NCT01536405|156046391|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
48505787|NCT02661295|156046392|FG000|Overall Study|Death|1|||
48505788|NCT02661295|156046392|FG000|Overall Study|Transferred Out|1|||
48505789|NCT02661295|156046392|FG000|Overall Study|Kidney Transplant|1|||
48505790|NCT02661295|156046392|FG000|Overall Study|Withdrawn due to side effects|8|||
48505791|NCT02661295|156046392|FG000|Overall Study|Withdrawn due to access type|1|||
48505792|NCT02661295|156046392|FG000|Overall Study|Withdrawn due to allergies|1|||
48505793|NCT02661295|156046392|FG000|Overall Study|Withdrawn due to non-compliance|1|||
48505794|NCT02661295|156046392|FG000|Overall Study|Withdrawal by Subject|3|||
48505795|NCT02661295|156046392|FG000|Overall Study|Failed screening|2|||
48505796|NCT00301366|156046393|FG000|Overall Study|Adverse Event|1|||
48505797|NCT04213326|156046394|FG000|Overall Study|Consent withdrawn|51|||
48505798|NCT04213326|156046395|FG001|Overall Study|Consent withdrawn|241|||
48505799|NCT04213326|156046394|FG000|Overall Study|Lost to Follow-up|50|||
48505800|NCT04213326|156046395|FG001|Overall Study|Lost to Follow-up|902|||
48505801|NCT04213326|156046394|FG000|Overall Study|Protocol Violation|3|||
48505802|NCT04213326|156046395|FG001|Overall Study|Protocol Violation|25|||
48505803|NCT04213326|156046394|FG000|Overall Study|Participant eligibility changed|106|||
48505804|NCT04213326|156046395|FG001|Overall Study|Participant eligibility changed|19|||
48505805|NCT04213326|156046394|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
48505806|NCT04213326|156046395|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
48505807|NCT04213326|156046394|FG000|Overall Study|Incomplete study visit|0|||
48505808|NCT04213326|156046395|FG001|Overall Study|Incomplete study visit|367|||
48505809|NCT01313273|156046400|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
48505810|NCT01313273|156046401|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
48505811|NCT01313273|156046400|FG000|Overall Study|Withdrawal by Subject|1|||
48505812|NCT01313273|156046401|FG001|Overall Study|Withdrawal by Subject|0|||
48505813|NCT01313273|156046400|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
48505814|NCT01313273|156046401|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
48505815|NCT02549092|156046402|FG000|Treatment Period|Adverse Event|2|||
48505816|NCT02549092|156046403|FG001|Treatment Period|Adverse Event|2|||
48505817|NCT02549092|156046402|FG000|Treatment Period|Withdrawal by Subject|1|||
48505818|NCT02549092|156046403|FG001|Treatment Period|Withdrawal by Subject|3|||
48505819|NCT02549092|156046402|FG000|Treatment Period|Lack of Efficacy|0|||
48505820|NCT02549092|156046403|FG001|Treatment Period|Lack of Efficacy|2|||
48505821|NCT02549092|156046402|FG000|Extension/Transition Period|Adverse Event|1|||
48505822|NCT02549092|156046403|FG001|Extension/Transition Period|Adverse Event|1|||
48505823|NCT02549092|156046402|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
48505824|NCT02549092|156046403|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
48505825|NCT02549092|156046402|FG000|Extension/Transition Period|Other, Not Specified|4|||
48505826|NCT02549092|156046403|FG001|Extension/Transition Period|Other, Not Specified|2|||
48505827|NCT03687736|156046408|FG000|Overall Study|Lost to Follow-up|7|||
48505828|NCT03687736|156046408|FG000|Overall Study|Withdrawal by Subject|3|||
48505829|NCT01496183|156046413|FG000|Overall Study|Physician Decision|3|||
48505830|NCT01496183|156046414|FG001|Overall Study|Physician Decision|1|||
48505831|NCT01496183|156046413|FG000|Overall Study|Withdrawal by Subject|0|||
48505832|NCT01496183|156046414|FG001|Overall Study|Withdrawal by Subject|1|||
48505833|NCT01546545|156046416|FG000|Overall Study|Withdrawal by Subject|1|||
48505834|NCT05093205|156046417|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
48505835|NCT05093205|156046418|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
48505836|NCT05093205|156046419|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
48505837|NCT05093205|156046420|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
48819666|NCT02499328|157181895|FG007|Overall Study|Adverse Event|0|||
48819667|NCT02499328|157181896|FG008|Overall Study|Adverse Event|0|||
48819668|NCT02499328|157181897|FG009|Overall Study|Adverse Event|0|||
48819669|NCT02499328|157181898|FG010|Overall Study|Adverse Event|0|||
48819670|NCT02499328|157181899|FG011|Overall Study|Adverse Event|0|||
48505838|NCT05093205|156046421|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
48505839|NCT05093205|156046422|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
48505840|NCT05093205|156046423|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
48505841|NCT05093205|156046424|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
48505842|NCT05093205|156046425|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
48505843|NCT05093205|156046426|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
48505844|NCT05093205|156046427|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
48505845|NCT05093205|156046428|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
48819671|NCT02499328|157181900|FG012|Overall Study|Adverse Event|1|||
48819672|NCT02499328|157181901|FG013|Overall Study|Adverse Event|0|||
48819673|NCT02499328|157181902|FG014|Overall Study|Adverse Event|0|||
48819674|NCT02499328|157181903|FG015|Overall Study|Adverse Event|0|||
48819675|NCT02499328|157181904|FG016|Overall Study|Adverse Event|0|||
48505846|NCT05093205|156046429|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
48505847|NCT05093205|156046417|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505848|NCT05093205|156046418|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505849|NCT05093205|156046419|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
48505850|NCT05093205|156046420|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505851|NCT05093205|156046421|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505852|NCT05093205|156046422|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505853|NCT05093205|156046423|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505854|NCT05093205|156046424|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505855|NCT05093205|156046425|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505856|NCT05093205|156046426|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505857|NCT05093205|156046427|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505858|NCT05093205|156046428|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505859|NCT05093205|156046429|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
48505860|NCT05093205|156046417|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
48505861|NCT05093205|156046418|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
48505862|NCT05093205|156046419|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
48505863|NCT05093205|156046420|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
48505864|NCT05093205|156046421|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
48505865|NCT05093205|156046422|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
48505866|NCT05093205|156046423|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
48505867|NCT05093205|156046424|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
48505868|NCT05093205|156046425|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
48505869|NCT05093205|156046426|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
48505870|NCT05093205|156046427|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
48505871|NCT05093205|156046428|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
48505872|NCT05093205|156046429|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
48505873|NCT05093205|156046417|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
48505874|NCT05093205|156046418|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
48505875|NCT05093205|156046419|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
48505876|NCT05093205|156046420|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
48505877|NCT05093205|156046421|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
48505878|NCT05093205|156046422|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
48505879|NCT05093205|156046423|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
48505880|NCT05093205|156046424|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
48505881|NCT05093205|156046425|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
48505882|NCT05093205|156046426|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
48505883|NCT05093205|156046427|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
48505884|NCT05093205|156046428|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
48505885|NCT05093205|156046429|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
48505886|NCT05093205|156046417|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
48505887|NCT05093205|156046418|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
48505888|NCT05093205|156046419|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
48505889|NCT05093205|156046420|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
48505890|NCT05093205|156046421|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
48505891|NCT05093205|156046422|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
48505892|NCT05093205|156046423|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
48505893|NCT05093205|156046424|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
48505894|NCT05093205|156046425|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
48505895|NCT05093205|156046426|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
48505896|NCT05093205|156046427|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
48505897|NCT05093205|156046428|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
48505898|NCT05093205|156046429|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
48505899|NCT05093205|156046417|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
48819676|NCT02499328|157181905|FG017|Overall Study|Adverse Event|0|||
48819677|NCT02499328|157181906|FG018|Overall Study|Adverse Event|0|||
48819678|NCT04214418|157181932|FG000|Overall Study|Withdrawal by Subject|1|||
48819679|NCT04214418|157181933|FG001|Overall Study|Withdrawal by Subject|0|||
48819680|NCT04214418|157181934|FG002|Overall Study|Withdrawal by Subject|0|||
48819681|NCT04214418|157181935|FG003|Overall Study|Withdrawal by Subject|0|||
48819682|NCT04214418|157181936|FG004|Overall Study|Withdrawal by Subject|0|||
48819683|NCT04214418|157181937|FG005|Overall Study|Withdrawal by Subject|0|||
48819684|NCT04214418|157181932|FG000|Overall Study|Adverse Event|0|||
48819685|NCT04214418|157181933|FG001|Overall Study|Adverse Event|2|||
48819686|NCT04214418|157181934|FG002|Overall Study|Adverse Event|0|||
48819687|NCT04214418|157181935|FG003|Overall Study|Adverse Event|0|||
48819688|NCT04214418|157181936|FG004|Overall Study|Adverse Event|0|||
48819689|NCT04214418|157181937|FG005|Overall Study|Adverse Event|0|||
48819690|NCT04214418|157181932|FG000|Overall Study|Death|1|||
48819691|NCT04214418|157181933|FG001|Overall Study|Death|0|||
48819692|NCT04214418|157181934|FG002|Overall Study|Death|0|||
48819693|NCT04214418|157181935|FG003|Overall Study|Death|0|||
48819694|NCT04214418|157181936|FG004|Overall Study|Death|0|||
48819695|NCT04214418|157181937|FG005|Overall Study|Death|0|||
48819696|NCT00802737|157183570|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
48819697|NCT00802737|157183571|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
48819698|NCT00802737|157183572|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
48505900|NCT05093205|156046418|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
48505901|NCT05093205|156046419|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
48505902|NCT05093205|156046420|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
48505903|NCT05093205|156046421|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
48505904|NCT05093205|156046422|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
48505905|NCT05093205|156046423|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
48505906|NCT05093205|156046424|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
48505907|NCT05093205|156046425|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
48505908|NCT05093205|156046426|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
48505909|NCT05093205|156046427|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
48505910|NCT05093205|156046428|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
48505911|NCT05093205|156046429|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
48505912|NCT05093205|156046417|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
48505913|NCT05093205|156046418|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
48505914|NCT05093205|156046419|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
48505915|NCT05093205|156046420|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
48505916|NCT05093205|156046421|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
48505917|NCT05093205|156046422|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
48505918|NCT05093205|156046423|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
48505919|NCT05093205|156046424|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
48505920|NCT05093205|156046425|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
48505921|NCT05093205|156046426|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
48505922|NCT05093205|156046427|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
48505923|NCT05093205|156046428|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
48505924|NCT05093205|156046429|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
48505925|NCT05093205|156046417|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
48505926|NCT05093205|156046418|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
48505927|NCT05093205|156046419|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
48505928|NCT05093205|156046420|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
48505929|NCT05093205|156046421|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
48505930|NCT05093205|156046422|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
48505931|NCT05093205|156046423|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
48505932|NCT05093205|156046424|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
48505933|NCT05093205|156046425|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
48505934|NCT05093205|156046426|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
48505935|NCT05093205|156046427|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
48505936|NCT05093205|156046428|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
48505937|NCT05093205|156046429|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
48505938|NCT05093205|156046417|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505939|NCT05093205|156046418|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505940|NCT05093205|156046419|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505941|NCT05093205|156046420|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505942|NCT05093205|156046421|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505943|NCT05093205|156046422|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48819699|NCT00802737|157183570|FG000|Overall Study|Death|6|||
48819700|NCT00802737|157183571|FG001|Overall Study|Death|5|||
48819701|NCT00802737|157183572|FG002|Overall Study|Death|1|||
48819702|NCT00802737|157183570|FG000|Overall Study|Adverse Event|1|||
48819703|NCT00802737|157183571|FG001|Overall Study|Adverse Event|0|||
48505944|NCT05093205|156046423|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505945|NCT05093205|156046424|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505946|NCT05093205|156046425|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48819704|NCT00802737|157183572|FG002|Overall Study|Adverse Event|0|||
48819705|NCT00802737|157183570|FG000|Overall Study|Received Prohibited Therapy|1|||
48505947|NCT05093205|156046426|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
48505948|NCT05093205|156046427|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505949|NCT05093205|156046428|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505950|NCT05093205|156046429|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
48505951|NCT05093205|156046417|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
48505952|NCT05093205|156046418|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
48505953|NCT05093205|156046419|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
48724988|NCT05140382|156842119|FG002|Overall Study|Investigator decision|0|||
48724989|NCT05140382|156842117|FG000|Overall Study|Other|4|||
48724990|NCT05140382|156842118|FG001|Overall Study|Other|0|||
48724991|NCT05140382|156842119|FG002|Overall Study|Other|1|||
48724992|NCT05140382|156842117|FG000|Overall Study|Progressive disease|20|||
48724993|NCT05140382|156842118|FG001|Overall Study|Progressive disease|1|||
48724994|NCT05140382|156842119|FG002|Overall Study|Progressive disease|12|||
48724995|NCT05140382|156842117|FG000|Overall Study|Subjective disease progression|2|||
48724996|NCT05140382|156842118|FG001|Overall Study|Subjective disease progression|1|||
48724997|NCT05140382|156842119|FG002|Overall Study|Subjective disease progression|0|||
48724998|NCT05140382|156842117|FG000|Overall Study|Unknown at data cut-off|0|||
48724999|NCT05140382|156842118|FG001|Overall Study|Unknown at data cut-off|0|||
48725000|NCT05140382|156842119|FG002|Overall Study|Unknown at data cut-off|1|||
48725001|NCT05140382|156842117|FG000|Overall Study|Withdrawal by Subject|1|||
48725002|NCT05140382|156842118|FG001|Overall Study|Withdrawal by Subject|0|||
48725003|NCT05140382|156842119|FG002|Overall Study|Withdrawal by Subject|4|||
48725004|NCT05140382|156842117|FG000|Overall Study|Withdrawal of consent|0|||
48725005|NCT05140382|156842118|FG001|Overall Study|Withdrawal of consent|0|||
48725006|NCT05140382|156842119|FG002|Overall Study|Withdrawal of consent|1|||
48725007|NCT02782949|156842120|FG000|Overall Study|Protocol Violation|1|||
48725008|NCT02782949|156842121|FG001|Overall Study|Protocol Violation|0|||
48725009|NCT02782949|156842120|FG000|Overall Study|Withdrawal by Subject|0|||
48725010|NCT02782949|156842121|FG001|Overall Study|Withdrawal by Subject|1|||
48725011|NCT03287635|156842123|FG000|Overall Study|Lost to Follow-up|5|||
48725012|NCT03287635|156842123|FG000|Overall Study|Withdrawal by Subject|1|||
48725013|NCT03287635|156842123|FG000|Overall Study|Physician Decision|1|||
48725014|NCT03641560|156842124|FG000|Overall Study|Withdrawal by Subject|6|||
48725015|NCT03641560|156842124|FG000|Overall Study|Progressive disease|40|||
48725016|NCT03641560|156842124|FG000|Overall Study|Death|6|||
48725017|NCT03269552|156843128|FG000|Overall Study|Adverse Event|2|||
48725018|NCT02616601|156843129|FG000|Overall Study|Withdrawal by Subject|4|||
48725019|NCT02616601|156843130|FG001|Overall Study|Withdrawal by Subject|4|||
48725020|NCT02616601|156843131|FG002|Overall Study|Withdrawal by Subject|3|||
48725021|NCT02616601|156843129|FG000|Overall Study|Adverse Event|2|||
48725022|NCT02616601|156843130|FG001|Overall Study|Adverse Event|0|||
48725023|NCT02616601|156843131|FG002|Overall Study|Adverse Event|2|||
48725024|NCT02616601|156843129|FG000|Overall Study|Death|1|||
48725025|NCT02616601|156843130|FG001|Overall Study|Death|0|||
48725026|NCT02616601|156843131|FG002|Overall Study|Death|0|||
48725027|NCT02616601|156843129|FG000|Overall Study|Lost to Follow-up|1|||
48725028|NCT02616601|156843130|FG001|Overall Study|Lost to Follow-up|0|||
48725029|NCT02616601|156843131|FG002|Overall Study|Lost to Follow-up|1|||
48725030|NCT02616601|156843129|FG000|Overall Study|Non-Compliance with Test Article|1|||
48725031|NCT02616601|156843130|FG001|Overall Study|Non-Compliance with Test Article|0|||
48725032|NCT02616601|156843131|FG002|Overall Study|Non-Compliance with Test Article|1|||
48725033|NCT02446743|156843132|FG000|Overall Study|Withdrawal by Subject|1|||
48725034|NCT02446743|156843133|FG001|Overall Study|Withdrawal by Subject|1|||
48725035|NCT02446743|156843132|FG000|Overall Study|Lost to Follow-up|1|||
48725036|NCT02446743|156843133|FG001|Overall Study|Lost to Follow-up|0|||
48725037|NCT02446743|156843132|FG000|Overall Study|Adverse Event|1|||
48725038|NCT02446743|156843133|FG001|Overall Study|Adverse Event|1|||
48725039|NCT02446743|156843132|FG000|Overall Study|Other|2|||
48725040|NCT02446743|156843133|FG001|Overall Study|Other|3|||
48725041|NCT00371761|156843134|FG000|Overall Study|Adverse Event|1|||
48725042|NCT00371761|156843135|FG001|Overall Study|Adverse Event|1|||
48725043|NCT00371761|156843134|FG000|Overall Study|Withdrawal by Subject|1|||
48725044|NCT00371761|156843135|FG001|Overall Study|Withdrawal by Subject|3|||
48505954|NCT05093205|156046420|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
48505955|NCT05093205|156046421|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
48505956|NCT05093205|156046422|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
48505957|NCT05093205|156046423|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
48505958|NCT05093205|156046424|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
48505959|NCT05093205|156046425|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
48505960|NCT05093205|156046426|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
48505961|NCT05093205|156046427|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
48505962|NCT05093205|156046428|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
48505963|NCT05093205|156046429|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
48505964|NCT05093205|156046417|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48725045|NCT00371761|156843134|FG000|Overall Study|Investigator Judgment|2|||
48725046|NCT00371761|156843135|FG001|Overall Study|Investigator Judgment|3|||
48725047|NCT00371761|156843134|FG000|Overall Study|Study termination|4|||
48725048|NCT00371761|156843135|FG001|Overall Study|Study termination|3|||
48725049|NCT02478398|156843136|FG000|Overall Study|Adverse Event|20|||
48725050|NCT02478398|156843137|FG001|Overall Study|Adverse Event|5|||
48725051|NCT02478398|156843136|FG000|Overall Study|Lost to Follow-up|5|||
48725052|NCT02478398|156843137|FG001|Overall Study|Lost to Follow-up|4|||
48725053|NCT02478398|156843136|FG000|Overall Study|Non-Compliance With Study Drug|5|||
48725054|NCT02478398|156843137|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48725055|NCT02478398|156843136|FG000|Overall Study|Protocol Violation|3|||
48725056|NCT02478398|156843137|FG001|Overall Study|Protocol Violation|1|||
48725057|NCT02478398|156843136|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
48725058|NCT02478398|156843137|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
48725059|NCT02478398|156843136|FG000|Overall Study|Withdrawal By Participant|10|||
48725060|NCT02478398|156843137|FG001|Overall Study|Withdrawal By Participant|4|||
48725061|NCT03828370|156843138|FG000|3 Month Follow-up|Lost to Follow-up|4|||
48725062|NCT03828370|156843139|FG001|3 Month Follow-up|Lost to Follow-up|12|||
48725063|NCT03828370|156843138|FG000|9 Month Follow up|Lost to Follow-up|12|||
48725064|NCT03828370|156843139|FG001|9 Month Follow up|Lost to Follow-up|20|||
48725065|NCT01155479|156843142|FG000|Part I|Adverse Event|13|||
48725066|NCT01155479|156843143|FG001|Part I|Adverse Event|8|||
48725067|NCT01155479|156843144|FG002|Part I|Adverse Event|18|||
48725068|NCT01155479|156843145|FG003|Part I|Adverse Event|7|||
48725069|NCT01155479|156843146|FG004|Part I|Adverse Event|6|||
48725070|NCT01155479|156843142|FG000|Part I|Administrative|2|||
48725071|NCT01155479|156843143|FG001|Part I|Administrative|2|||
48725072|NCT01155479|156843144|FG002|Part I|Administrative|2|||
48725073|NCT01155479|156843145|FG003|Part I|Administrative|0|||
48725074|NCT01155479|156843146|FG004|Part I|Administrative|0|||
48725075|NCT01155479|156843142|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
48725076|NCT01155479|156843143|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
48725077|NCT01155479|156843144|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
48725078|NCT01155479|156843145|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
48725079|NCT01155479|156843146|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
48725080|NCT01155479|156843142|FG000|Part I|Withdrawal by Subject|11|||
48725081|NCT01155479|156843143|FG001|Part I|Withdrawal by Subject|13|||
48725082|NCT01155479|156843144|FG002|Part I|Withdrawal by Subject|8|||
48725083|NCT01155479|156843145|FG003|Part I|Withdrawal by Subject|8|||
48725084|NCT01155479|156843146|FG004|Part I|Withdrawal by Subject|9|||
48725085|NCT01155479|156843142|FG000|Part I|Lost to Follow-up|0|||
48725086|NCT01155479|156843143|FG001|Part I|Lost to Follow-up|0|||
48725087|NCT01155479|156843144|FG002|Part I|Lost to Follow-up|1|||
48725088|NCT01155479|156843145|FG003|Part I|Lost to Follow-up|1|||
48725089|NCT01155479|156843146|FG004|Part I|Lost to Follow-up|0|||
48819706|NCT00802737|157183571|FG001|Overall Study|Received Prohibited Therapy|0|||
48819707|NCT00802737|157183572|FG002|Overall Study|Received Prohibited Therapy|0|||
48819708|NCT00802737|157183570|FG000|Overall Study|Ongoing CLL-Treatment|0|||
48819709|NCT00802737|157183571|FG001|Overall Study|Ongoing CLL-Treatment|1|||
48819710|NCT00802737|157183572|FG002|Overall Study|Ongoing CLL-Treatment|0|||
48819711|NCT00802737|157183570|FG000|Overall Study|Participant too Unwell|0|||
48600232|NCT03489343|156391562|FG002|Overall Study|Documented progressive disease|3|||
48600233|NCT03489343|156391563|FG003|Overall Study|Documented progressive disease|1|||
48600234|NCT03489343|156391564|FG004|Overall Study|Documented progressive disease|3|||
48600235|NCT03489343|156391565|FG005|Overall Study|Documented progressive disease|5|||
48600236|NCT03489343|156391566|FG006|Overall Study|Documented progressive disease|4|||
48600237|NCT03489343|156391560|FG000|Overall Study|Adverse Event|0|||
48600238|NCT03489343|156391561|FG001|Overall Study|Adverse Event|1|||
48600239|NCT03489343|156391562|FG002|Overall Study|Adverse Event|0|||
48600240|NCT03489343|156391563|FG003|Overall Study|Adverse Event|0|||
48600241|NCT03489343|156391564|FG004|Overall Study|Adverse Event|0|||
48725090|NCT01155479|156843142|FG000|Part I|Treatment Failure|3|||
48725091|NCT01155479|156843143|FG001|Part I|Treatment Failure|0|||
48725092|NCT01155479|156843144|FG002|Part I|Treatment Failure|3|||
48725093|NCT01155479|156843145|FG003|Part I|Treatment Failure|1|||
48725094|NCT01155479|156843146|FG004|Part I|Treatment Failure|2|||
48725095|NCT01155479|156843142|FG000|Part I|Did Not Receive Treatment|4|||
48725096|NCT01155479|156843143|FG001|Part I|Did Not Receive Treatment|2|||
48725097|NCT01155479|156843144|FG002|Part I|Did Not Receive Treatment|2|||
48725098|NCT01155479|156843145|FG003|Part I|Did Not Receive Treatment|6|||
48725099|NCT01155479|156843146|FG004|Part I|Did Not Receive Treatment|1|||
48725100|NCT01155479|156843142|FG000|Part I|Non-Compliance with Protocol|2|||
48725101|NCT01155479|156843143|FG001|Part I|Non-Compliance with Protocol|1|||
48725102|NCT01155479|156843144|FG002|Part I|Non-Compliance with Protocol|3|||
48725103|NCT01155479|156843145|FG003|Part I|Non-Compliance with Protocol|3|||
48600242|NCT03489343|156391565|FG005|Overall Study|Adverse Event|1|||
48725104|NCT01155479|156843146|FG004|Part I|Non-Compliance with Protocol|2|||
48725105|NCT01155479|156843142|FG000|Part II|Adverse Event|7|||
48725106|NCT01155479|156843143|FG001|Part II|Adverse Event|6|||
48819712|NCT00802737|157183571|FG001|Overall Study|Participant too Unwell|2|||
48819713|NCT00802737|157183572|FG002|Overall Study|Participant too Unwell|0|||
48819714|NCT04714216|157183573|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
48819715|NCT04714216|157183573|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
48819716|NCT01625910|157183575|FG000|Overall Study|Lost to Follow-up|3|||
48819717|NCT01625910|157183576|FG001|Overall Study|Lost to Follow-up|4|||
48819718|NCT02176928|157183577|FG000|Overall Study|Lost to Follow-up|2|||
48819719|NCT02176928|157183578|FG001|Overall Study|Lost to Follow-up|4|||
48819720|NCT02268396|157183583|FG000|Overall Study|Adverse Event|3|||
48819721|NCT02268396|157183583|FG000|Overall Study|Administrative|2|||
48819722|NCT02268396|157183583|FG000|Overall Study|Withdrawal by Subject|1|||
48819723|NCT02268396|157183583|FG000|Overall Study|Lost to Follow-up|2|||
48819724|NCT02268396|157183583|FG000|Overall Study|Protocol-Specified Criteria|2|||
48819725|NCT02268396|157183583|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
48819726|NCT03699124|157183585|FG000|Overall Study|Adverse Event|6|||
48819727|NCT03699124|157183586|FG001|Overall Study|Adverse Event|5|||
48819728|NCT03699124|157183587|FG002|Overall Study|Adverse Event|2|||
48819729|NCT03699124|157183585|FG000|Overall Study|Death|0|||
48819730|NCT03699124|157183586|FG001|Overall Study|Death|2|||
48819731|NCT03699124|157183587|FG002|Overall Study|Death|0|||
48819732|NCT03699124|157183585|FG000|Overall Study|Lost to Follow-up|20|||
48819733|NCT03699124|157183586|FG001|Overall Study|Lost to Follow-up|16|||
48819734|NCT03699124|157183587|FG002|Overall Study|Lost to Follow-up|15|||
48819735|NCT03699124|157183585|FG000|Overall Study|Protocol Violation|1|||
48819736|NCT03699124|157183586|FG001|Overall Study|Protocol Violation|0|||
48819737|NCT03699124|157183587|FG002|Overall Study|Protocol Violation|0|||
48819738|NCT03699124|157183585|FG000|Overall Study|Withdrawal by Subject|13|||
48819739|NCT03699124|157183586|FG001|Overall Study|Withdrawal by Subject|14|||
48819740|NCT03699124|157183587|FG002|Overall Study|Withdrawal by Subject|13|||
48819741|NCT03699124|157183585|FG000|Overall Study|Other reasons|5|||
48819742|NCT03699124|157183586|FG001|Overall Study|Other reasons|3|||
48819743|NCT03699124|157183587|FG002|Overall Study|Other reasons|10|||
48819744|NCT01333943|157183588|FG000|Overall Study|Known neuropathy|1|||
48819745|NCT01333943|157183589|FG001|Overall Study|Known neuropathy|0|||
48819746|NCT01244763|157183590|FG000|Overall Study|Adverse Event|1|||
48819747|NCT01244763|157183591|FG001|Overall Study|Adverse Event|0|||
48819748|NCT01244763|157183592|FG002|Overall Study|Adverse Event|0|||
48819749|NCT01244763|157183593|FG003|Overall Study|Adverse Event|0|||
48819750|NCT01244763|157183594|FG004|Overall Study|Adverse Event|0|||
48819751|NCT01244763|157183595|FG005|Overall Study|Adverse Event|1|||
48819752|NCT01244763|157183590|FG000|Overall Study|Death|1|||
48819753|NCT01244763|157183591|FG001|Overall Study|Death|0|||
48819754|NCT01244763|157183592|FG002|Overall Study|Death|1|||
48819755|NCT01244763|157183593|FG003|Overall Study|Death|0|||
48819756|NCT01244763|157183594|FG004|Overall Study|Death|2|||
48819757|NCT01244763|157183595|FG005|Overall Study|Death|0|||
48819758|NCT01244763|157183590|FG000|Overall Study|Physician Decision|0|||
48819759|NCT01244763|157183591|FG001|Overall Study|Physician Decision|0|||
48819760|NCT01244763|157183592|FG002|Overall Study|Physician Decision|1|||
48819761|NCT01244763|157183593|FG003|Overall Study|Physician Decision|0|||
48819762|NCT01244763|157183594|FG004|Overall Study|Physician Decision|0|||
48819763|NCT01244763|157183595|FG005|Overall Study|Physician Decision|0|||
48819764|NCT01244763|157183590|FG000|Overall Study|Withdrawal by Subject|1|||
48819765|NCT01244763|157183591|FG001|Overall Study|Withdrawal by Subject|2|||
48819766|NCT01244763|157183592|FG002|Overall Study|Withdrawal by Subject|0|||
48819767|NCT01244763|157183593|FG003|Overall Study|Withdrawal by Subject|1|||
48819768|NCT01244763|157183594|FG004|Overall Study|Withdrawal by Subject|1|||
48819769|NCT01244763|157183595|FG005|Overall Study|Withdrawal by Subject|2|||
48819770|NCT01244763|157183590|FG000|Overall Study|Lost to Follow-up|0|||
48819771|NCT01244763|157183591|FG001|Overall Study|Lost to Follow-up|1|||
48819772|NCT01244763|157183592|FG002|Overall Study|Lost to Follow-up|0|||
48819773|NCT01244763|157183593|FG003|Overall Study|Lost to Follow-up|0|||
48819774|NCT01244763|157183594|FG004|Overall Study|Lost to Follow-up|0|||
48819775|NCT01244763|157183595|FG005|Overall Study|Lost to Follow-up|0|||
48505965|NCT05093205|156046418|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48819776|NCT01244763|157183590|FG000|Overall Study|Enrolled into the Extension Study|0|||
48505966|NCT05093205|156046419|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48505967|NCT05093205|156046420|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48819777|NCT01244763|157183591|FG001|Overall Study|Enrolled into the Extension Study|0|||
48819778|NCT01244763|157183592|FG002|Overall Study|Enrolled into the Extension Study|0|||
48819779|NCT01244763|157183593|FG003|Overall Study|Enrolled into the Extension Study|0|||
48819780|NCT01244763|157183594|FG004|Overall Study|Enrolled into the Extension Study|0|||
48819781|NCT01244763|157183595|FG005|Overall Study|Enrolled into the Extension Study|1|||
48819782|NCT00997243|157183596|FG000|Overall Study|Early termination of study by sponsor|7|||
48819783|NCT03220737|157183600|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
48819784|NCT03220737|157183601|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
48819785|NCT03220737|157183602|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
48819786|NCT03220737|157183603|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
48819787|NCT03220737|157183604|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
48600243|NCT03489343|156391566|FG006|Overall Study|Adverse Event|0|||
48600244|NCT03489343|156391560|FG000|Overall Study|Withdrawal by Subject|0|||
48725107|NCT01155479|156843144|FG002|Part II|Adverse Event|8|||
48725108|NCT01155479|156843145|FG003|Part II|Adverse Event|3|||
48725109|NCT01155479|156843146|FG004|Part II|Adverse Event|4|||
48725110|NCT01155479|156843142|FG000|Part II|Administrative|43|||
48725111|NCT01155479|156843143|FG001|Part II|Administrative|49|||
48725112|NCT01155479|156843144|FG002|Part II|Administrative|36|||
48725113|NCT01155479|156843145|FG003|Part II|Administrative|38|||
48725114|NCT01155479|156843146|FG004|Part II|Administrative|46|||
48725115|NCT01155479|156843142|FG000|Part II|Withdrawal by Subject|8|||
48725116|NCT01155479|156843143|FG001|Part II|Withdrawal by Subject|4|||
48725117|NCT01155479|156843144|FG002|Part II|Withdrawal by Subject|12|||
48725118|NCT01155479|156843145|FG003|Part II|Withdrawal by Subject|7|||
48725119|NCT01155479|156843146|FG004|Part II|Withdrawal by Subject|3|||
48725120|NCT01155479|156843142|FG000|Part II|Lost to Follow-up|1|||
48725121|NCT01155479|156843143|FG001|Part II|Lost to Follow-up|0|||
48725122|NCT01155479|156843144|FG002|Part II|Lost to Follow-up|0|||
48725123|NCT01155479|156843145|FG003|Part II|Lost to Follow-up|0|||
48725124|NCT01155479|156843146|FG004|Part II|Lost to Follow-up|1|||
48725125|NCT01155479|156843142|FG000|Part II|Treatment Failure|0|||
48725126|NCT01155479|156843143|FG001|Part II|Treatment Failure|1|||
48725127|NCT01155479|156843144|FG002|Part II|Treatment Failure|2|||
48725128|NCT01155479|156843145|FG003|Part II|Treatment Failure|0|||
48725129|NCT01155479|156843146|FG004|Part II|Treatment Failure|1|||
48725130|NCT01155479|156843142|FG000|Part II|Non-Compliance with Protocol|0|||
48725131|NCT01155479|156843143|FG001|Part II|Non-Compliance with Protocol|1|||
48725132|NCT01155479|156843144|FG002|Part II|Non-Compliance with Protocol|0|||
48725133|NCT01155479|156843145|FG003|Part II|Non-Compliance with Protocol|2|||
48725134|NCT01155479|156843146|FG004|Part II|Non-Compliance with Protocol|0|||
48725135|NCT01634178|156843147|FG000|Treatment Period 1|Adverse Event|0|||
48725136|NCT01634178|156843148|FG001|Treatment Period 1|Adverse Event|1|||
48725137|NCT01634178|156843147|FG000|Treatment Period 2|Adverse Event|1|||
48725138|NCT01634178|156843148|FG001|Treatment Period 2|Adverse Event|0|||
48725139|NCT00609362|156843151|FG000|Overall Study|Withdrawal by Subject|2|||
48725140|NCT00609362|156843152|FG001|Overall Study|Withdrawal by Subject|1|||
48725141|NCT00609362|156843151|FG000|Overall Study|Adverse Event|1|||
48725142|NCT00609362|156843152|FG001|Overall Study|Adverse Event|0|||
48725143|NCT02283177|156843153|FG000|Overall Study|Withdrawal by Subject|1|||
48725144|NCT02283177|156843154|FG001|Overall Study|Withdrawal by Subject|1|||
48725145|NCT02045303|156843158|FG000|Overall Study|Protocol Violation|2|||
48725146|NCT02045303|156843159|FG001|Overall Study|Protocol Violation|1|||
48725147|NCT02045303|156843160|FG002|Overall Study|Protocol Violation|0|||
48725148|NCT02045303|156843158|FG000|Overall Study|Withdrawal by Subject|0|||
48725149|NCT02045303|156843159|FG001|Overall Study|Withdrawal by Subject|2|||
48725150|NCT02045303|156843160|FG002|Overall Study|Withdrawal by Subject|0|||
48725151|NCT00245583|156843163|FG000|Overall Study|Lost to Follow-up|1|||
48725152|NCT00245583|156843164|FG001|Overall Study|Lost to Follow-up|5|||
48725153|NCT00245583|156843163|FG000|Overall Study|Adverse Event|2|||
48725154|NCT00245583|156843164|FG001|Overall Study|Adverse Event|1|||
48725155|NCT00245583|156843163|FG000|Overall Study|Lack of Efficacy|1|||
48725156|NCT00245583|156843164|FG001|Overall Study|Lack of Efficacy|0|||
48725157|NCT00245583|156843163|FG000|Overall Study|Withdrawal by Subject|2|||
48725158|NCT00245583|156843164|FG001|Overall Study|Withdrawal by Subject|3|||
48725159|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
48725160|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
48725161|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Other|2|||
48725162|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Other|2|||
48725163|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Personal reasons|2|||
48725164|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Personal reasons|2|||
48725165|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
48725166|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
48725167|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
48725168|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
48725169|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
48725170|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
48725171|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
48725172|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
48725173|NCT00667446|156843165|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
48725174|NCT00667446|156843166|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
48725175|NCT00667446|156843165|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
48725176|NCT00667446|156843166|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
48725177|NCT01309893|156843167|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
48725178|NCT01309893|156843168|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
48725179|NCT01309893|156843167|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
48725180|NCT01309893|156843168|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
48725181|NCT02314143|156843174|FG000|Overall Study|Adverse Event|0|||
48819788|NCT03220737|157183605|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
48819789|NCT03220737|157183606|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
48819790|NCT03220737|157183600|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
48819791|NCT03220737|157183601|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
48819792|NCT03220737|157183602|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
48819793|NCT03220737|157183603|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
48819794|NCT03220737|157183604|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
48819795|NCT03220737|157183605|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
48819796|NCT03220737|157183606|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
48819797|NCT03220737|157183600|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
48819798|NCT03220737|157183601|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
48819799|NCT03220737|157183602|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
48819800|NCT03220737|157183603|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
48819801|NCT03220737|157183604|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
48819802|NCT03220737|157183605|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
48819803|NCT03220737|157183606|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
48819804|NCT03220737|157183600|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819805|NCT03220737|157183601|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819806|NCT03220737|157183602|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
48819807|NCT03220737|157183603|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819808|NCT03220737|157183604|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819809|NCT03220737|157183605|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819810|NCT03220737|157183606|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
48819811|NCT03220737|157183600|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819812|NCT03220737|157183601|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819813|NCT03220737|157183602|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819814|NCT03220737|157183603|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819815|NCT03220737|157183604|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
48819816|NCT03220737|157183605|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819817|NCT03220737|157183606|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
48819818|NCT03220737|157183600|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
48819819|NCT03220737|157183601|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819820|NCT03220737|157183602|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819821|NCT03220737|157183603|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819822|NCT03220737|157183604|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819823|NCT03220737|157183605|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819824|NCT03220737|157183606|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
48819825|NCT03220737|157183600|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
48819826|NCT03220737|157183601|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819827|NCT03220737|157183602|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819828|NCT03220737|157183603|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48725182|NCT02314143|156843175|FG001|Overall Study|Adverse Event|6|||
48725183|NCT02314143|156843176|FG002|Overall Study|Adverse Event|4|||
48725184|NCT02314143|156843174|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
48725185|NCT02314143|156843175|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
48725186|NCT02314143|156843176|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
48819829|NCT03220737|157183604|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819830|NCT03220737|157183605|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819831|NCT03220737|157183606|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
48819832|NCT03220737|157183600|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
48819833|NCT03220737|157183601|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819834|NCT03220737|157183602|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819835|NCT03220737|157183603|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819836|NCT03220737|157183604|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819837|NCT03220737|157183605|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819838|NCT03220737|157183606|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
48819839|NCT00983619|157183609|FG000|Overall Study|Lost to Follow-up|0|||
48819840|NCT00983619|157183610|FG001|Overall Study|Lost to Follow-up|1|||
48819841|NCT00983619|157183611|FG002|Overall Study|Lost to Follow-up|0|||
48819842|NCT00983619|157183612|FG003|Overall Study|Lost to Follow-up|0|||
48819843|NCT00983619|157183613|FG004|Overall Study|Lost to Follow-up|0|||
48505968|NCT05093205|156046421|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48725187|NCT02314143|156843174|FG000|Overall Study|Physician Decision|2|||
48725188|NCT02314143|156843175|FG001|Overall Study|Physician Decision|1|||
48725189|NCT02314143|156843176|FG002|Overall Study|Physician Decision|0|||
48725190|NCT02314143|156843174|FG000|Overall Study|Withdrawal by Subject|1|||
48725191|NCT02314143|156843175|FG001|Overall Study|Withdrawal by Subject|0|||
48725192|NCT02314143|156843176|FG002|Overall Study|Withdrawal by Subject|1|||
48819844|NCT00983619|157183614|FG005|Overall Study|Lost to Follow-up|2|||
48819845|NCT00983619|157183615|FG006|Overall Study|Lost to Follow-up|0|||
48819846|NCT00983619|157183616|FG007|Overall Study|Lost to Follow-up|0|||
48819847|NCT00983619|157183617|FG008|Overall Study|Lost to Follow-up|0|||
48819848|NCT00983619|157183618|FG009|Overall Study|Lost to Follow-up|0|||
48819849|NCT00983619|157183619|FG010|Overall Study|Lost to Follow-up|0|||
48819850|NCT00983619|157183620|FG011|Overall Study|Lost to Follow-up|2|||
48819851|NCT00983619|157183609|FG000|Overall Study|Withdrawal by Subject|2|||
48819852|NCT00983619|157183610|FG001|Overall Study|Withdrawal by Subject|1|||
48819853|NCT00983619|157183611|FG002|Overall Study|Withdrawal by Subject|1|||
48819854|NCT00983619|157183612|FG003|Overall Study|Withdrawal by Subject|3|||
48819855|NCT00983619|157183613|FG004|Overall Study|Withdrawal by Subject|1|||
48819856|NCT00983619|157183614|FG005|Overall Study|Withdrawal by Subject|23|||
48819857|NCT00983619|157183615|FG006|Overall Study|Withdrawal by Subject|0|||
48819858|NCT00983619|157183616|FG007|Overall Study|Withdrawal by Subject|0|||
48819859|NCT00983619|157183617|FG008|Overall Study|Withdrawal by Subject|0|||
48819860|NCT00983619|157183618|FG009|Overall Study|Withdrawal by Subject|0|||
48819861|NCT00983619|157183619|FG010|Overall Study|Withdrawal by Subject|1|||
48819862|NCT00983619|157183620|FG011|Overall Study|Withdrawal by Subject|1|||
48819863|NCT00983619|157183609|FG000|Overall Study|Death|0|||
48819864|NCT00983619|157183610|FG001|Overall Study|Death|2|||
48819865|NCT00983619|157183611|FG002|Overall Study|Death|2|||
48819866|NCT00983619|157183612|FG003|Overall Study|Death|1|||
48819867|NCT00983619|157183613|FG004|Overall Study|Death|2|||
48819868|NCT00983619|157183614|FG005|Overall Study|Death|30|||
48819869|NCT00983619|157183615|FG006|Overall Study|Death|1|||
48819870|NCT00983619|157183616|FG007|Overall Study|Death|0|||
48819871|NCT00983619|157183617|FG008|Overall Study|Death|1|||
48819872|NCT00983619|157183618|FG009|Overall Study|Death|2|||
48819873|NCT00983619|157183619|FG010|Overall Study|Death|9|||
48819874|NCT00983619|157183620|FG011|Overall Study|Death|8|||
48819875|NCT00983619|157183609|FG000|Overall Study|Other|1|||
48819876|NCT00983619|157183610|FG001|Overall Study|Other|0|||
48819877|NCT00983619|157183611|FG002|Overall Study|Other|0|||
48819878|NCT00983619|157183612|FG003|Overall Study|Other|1|||
48819879|NCT00983619|157183613|FG004|Overall Study|Other|0|||
48819880|NCT00983619|157183614|FG005|Overall Study|Other|12|||
48819881|NCT00983619|157183615|FG006|Overall Study|Other|2|||
48819882|NCT00983619|157183616|FG007|Overall Study|Other|2|||
48819883|NCT00983619|157183617|FG008|Overall Study|Other|0|||
48819884|NCT00983619|157183618|FG009|Overall Study|Other|1|||
48819885|NCT00983619|157183619|FG010|Overall Study|Other|1|||
48819886|NCT00983619|157183620|FG011|Overall Study|Other|0|||
48819887|NCT00691028|157183621|FG000|Open-label Period|Adverse Event|0|||
48819888|NCT00691028|157183622|FG001|Open-label Period|Adverse Event|0|||
48819889|NCT00691028|157183623|FG002|Open-label Period|Adverse Event|0|||
48819890|NCT00691028|157183624|FG003|Open-label Period|Adverse Event|16|||
48819891|NCT00691028|157183621|FG000|Open-label Period|Withdrawal by Subject|0|||
48819892|NCT00691028|157183622|FG001|Open-label Period|Withdrawal by Subject|0|||
48819893|NCT00691028|157183623|FG002|Open-label Period|Withdrawal by Subject|0|||
48819894|NCT00691028|157183624|FG003|Open-label Period|Withdrawal by Subject|3|||
48819895|NCT00691028|157183621|FG000|Open-label Period|not come to a hospital|0|||
48819896|NCT00691028|157183622|FG001|Open-label Period|not come to a hospital|0|||
48819897|NCT00691028|157183623|FG002|Open-label Period|not come to a hospital|0|||
48819898|NCT00691028|157183624|FG003|Open-label Period|not come to a hospital|1|||
48819899|NCT00691028|157183621|FG000|Double-blind Period|Adverse Event|8|||
48819900|NCT00691028|157183622|FG001|Double-blind Period|Adverse Event|9|||
48819901|NCT00691028|157183623|FG002|Double-blind Period|Adverse Event|6|||
48819902|NCT00691028|157183624|FG003|Double-blind Period|Adverse Event|0|||
48819903|NCT00691028|157183621|FG000|Double-blind Period|Lack of Efficacy|4|||
48819904|NCT00691028|157183622|FG001|Double-blind Period|Lack of Efficacy|3|||
48819905|NCT00691028|157183623|FG002|Double-blind Period|Lack of Efficacy|2|||
48819906|NCT00691028|157183624|FG003|Double-blind Period|Lack of Efficacy|0|||
48819907|NCT00691028|157183621|FG000|Double-blind Period|Withdrawal by Subject|1|||
48600245|NCT03489343|156391561|FG001|Overall Study|Withdrawal by Subject|0|||
48819908|NCT00691028|157183622|FG001|Double-blind Period|Withdrawal by Subject|0|||
48819909|NCT00691028|157183623|FG002|Double-blind Period|Withdrawal by Subject|1|||
48819910|NCT00691028|157183624|FG003|Double-blind Period|Withdrawal by Subject|0|||
48819911|NCT00691028|157183621|FG000|Double-blind Period|not come to a hospital.|0|||
48819912|NCT00691028|157183622|FG001|Double-blind Period|not come to a hospital.|1|||
48819913|NCT00691028|157183623|FG002|Double-blind Period|not come to a hospital.|0|||
48819914|NCT00691028|157183624|FG003|Double-blind Period|not come to a hospital.|0|||
48819915|NCT00972543|157183627|FG000|Overall Study|Adverse Event|1|||
48819916|NCT00972543|157183628|FG001|Overall Study|Adverse Event|0|||
48819917|NCT00972543|157183627|FG000|Overall Study|Early study termination by sponsor|4|||
48819918|NCT00972543|157183628|FG001|Overall Study|Early study termination by sponsor|1|||
48819919|NCT01066156|157183631|FG000|Overall Study|ineligible|2|||
48600246|NCT03489343|156391562|FG002|Overall Study|Withdrawal by Subject|0|||
48819920|NCT01066156|157183631|FG000|Overall Study|Lost to Follow-up|7|||
48819921|NCT01066156|157183631|FG000|Overall Study|Withdrawal by Subject|1|||
48819922|NCT03135548|157183634|FG000|Overall Study|Lost to Follow-up|3|||
48819923|NCT03135548|157183635|FG001|Overall Study|Lost to Follow-up|0|||
48819924|NCT03135548|157183636|FG002|Overall Study|Lost to Follow-up|0|||
48819925|NCT03135548|157183634|FG000|Overall Study|Withdrawal by Subject|2|||
48819926|NCT03135548|157183635|FG001|Overall Study|Withdrawal by Subject|2|||
48819927|NCT03135548|157183636|FG002|Overall Study|Withdrawal by Subject|1|||
48819928|NCT03135548|157183634|FG000|Overall Study|Other than listed|0|||
48819929|NCT03135548|157183635|FG001|Overall Study|Other than listed|2|||
48819930|NCT03135548|157183636|FG002|Overall Study|Other than listed|2|||
48819931|NCT00918749|157183637|FG000|Overall Study|Adverse Event|1|||
48819932|NCT00918749|157183638|FG001|Overall Study|Adverse Event|0|||
48819933|NCT00918749|157183639|FG002|Overall Study|Adverse Event|1|||
48819934|NCT00918749|157183637|FG000|Overall Study|Lost to Follow-up|0|||
48819935|NCT00918749|157183638|FG001|Overall Study|Lost to Follow-up|0|||
48819936|NCT00918749|157183639|FG002|Overall Study|Lost to Follow-up|1|||
48819937|NCT00918749|157183637|FG000|Overall Study|Withdrawal by Subject|5|||
48819938|NCT00918749|157183638|FG001|Overall Study|Withdrawal by Subject|3|||
48819939|NCT00918749|157183639|FG002|Overall Study|Withdrawal by Subject|5|||
48819940|NCT00918749|157183637|FG000|Overall Study|No Study Medication Taken|1|||
48819941|NCT00918749|157183638|FG001|Overall Study|No Study Medication Taken|0|||
48819942|NCT00918749|157183639|FG002|Overall Study|No Study Medication Taken|0|||
48819943|NCT01152554|157183640|FG000|Overall Study|Withdrawal by Subject|73|||
48819944|NCT01152554|157183641|FG001|Overall Study|Withdrawal by Subject|28|||
48819945|NCT01152554|157183640|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
48819946|NCT01152554|157183641|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
48819947|NCT01152554|157183640|FG000|Overall Study|Adverse Event|67|||
48819948|NCT01152554|157183641|FG001|Overall Study|Adverse Event|14|||
48819949|NCT01152554|157183640|FG000|Overall Study|Severe non-compliance to protocol|36|||
48819950|NCT01152554|157183641|FG001|Overall Study|Severe non-compliance to protocol|14|||
48819951|NCT01152554|157183640|FG000|Overall Study|Condition under investigation worsened|5|||
48819952|NCT01152554|157183641|FG001|Overall Study|Condition under investigation worsened|2|||
48819953|NCT01152554|157183640|FG000|Overall Study|Lack of Efficacy|20|||
48819954|NCT01152554|157183641|FG001|Overall Study|Lack of Efficacy|3|||
48819955|NCT01152554|157183640|FG000|Overall Study|Study-specific withdrawal criteria|17|||
48819956|NCT01152554|157183641|FG001|Overall Study|Study-specific withdrawal criteria|8|||
48819957|NCT01152554|157183640|FG000|Overall Study|Lost to Follow-up|87|||
48819958|NCT01152554|157183641|FG001|Overall Study|Lost to Follow-up|32|||
48819959|NCT01152554|157183640|FG000|Overall Study|Other|28|||
48819960|NCT01152554|157183641|FG001|Overall Study|Other|8|||
48819961|NCT01152554|157183640|FG000|Overall Study|Death|1|||
48819962|NCT01152554|157183641|FG001|Overall Study|Death|1|||
48819963|NCT02025205|157183643|FG000|Overall Study|Withdrawal by Subject|1|||
48819964|NCT02025205|157183644|FG001|Overall Study|Withdrawal by Subject|1|||
48819965|NCT02025205|157183643|FG000|Overall Study|Protocol Violation|2|||
48819966|NCT02025205|157183644|FG001|Overall Study|Protocol Violation|1|||
48819967|NCT02025205|157183643|FG000|Overall Study|Death|0|||
48819968|NCT02025205|157183644|FG001|Overall Study|Death|1|||
48819969|NCT03389893|157183645|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
48819970|NCT03389893|157183646|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
48819971|NCT03389893|157183647|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
48819972|NCT03389893|157183648|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
48819973|NCT03389893|157183645|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
48819974|NCT03389893|157183646|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
48819975|NCT03389893|157183647|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
48819976|NCT03389893|157183648|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
48819977|NCT03389893|157183645|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
48819978|NCT03389893|157183646|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
48819979|NCT03389893|157183647|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
48819980|NCT03389893|157183648|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
48819981|NCT03389893|157183645|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
48819982|NCT03389893|157183646|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
48819983|NCT03389893|157183647|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
48819984|NCT03389893|157183648|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
48819985|NCT01318811|157183650|FG000|Overall Study|Physician Decision|1|||
48819986|NCT01318811|157183651|FG001|Overall Study|Physician Decision|1|||
48819987|NCT01318811|157183650|FG000|Overall Study|CRRT stopped for head CT|0|||
48819988|NCT01318811|157183651|FG001|Overall Study|CRRT stopped for head CT|1|||
48819989|NCT01318811|157183650|FG000|Overall Study|Death|0|||
48819990|NCT01318811|157183651|FG001|Overall Study|Death|1|||
48819991|NCT01318811|157183650|FG000|Overall Study|CRRT stopped for head MRI|0|||
48819992|NCT01318811|157183651|FG001|Overall Study|CRRT stopped for head MRI|1|||
48819993|NCT02554513|157183652|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
48819994|NCT02554513|157183653|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
48819995|NCT03473743|157183654|FG000|Overall Study|Withdrawal by Subject|0|||
48819996|NCT03473743|157183655|FG001|Overall Study|Withdrawal by Subject|0|||
48819997|NCT03473743|157183656|FG002|Overall Study|Withdrawal by Subject|0|||
48819998|NCT03473743|157183657|FG003|Overall Study|Withdrawal by Subject|0|||
48819999|NCT03473743|157183658|FG004|Overall Study|Withdrawal by Subject|0|||
48820000|NCT03473743|157183659|FG005|Overall Study|Withdrawal by Subject|0|||
48820001|NCT03473743|157183660|FG006|Overall Study|Withdrawal by Subject|0|||
48820002|NCT03473743|157183661|FG007|Overall Study|Withdrawal by Subject|3|||
48820003|NCT03473743|157183654|FG000|Overall Study|Other|0|||
48820004|NCT03473743|157183655|FG001|Overall Study|Other|0|||
48820005|NCT03473743|157183656|FG002|Overall Study|Other|0|||
48820006|NCT03473743|157183657|FG003|Overall Study|Other|1|||
48820007|NCT03473743|157183658|FG004|Overall Study|Other|0|||
48820008|NCT03473743|157183659|FG005|Overall Study|Other|0|||
48820009|NCT03473743|157183660|FG006|Overall Study|Other|0|||
48820010|NCT03473743|157183661|FG007|Overall Study|Other|0|||
48820011|NCT03473743|157183654|FG000|Overall Study|Ongoing|0|||
48820012|NCT03473743|157183655|FG001|Overall Study|Ongoing|0|||
48820013|NCT03473743|157183656|FG002|Overall Study|Ongoing|6|||
48820014|NCT03473743|157183657|FG003|Overall Study|Ongoing|8|||
48820015|NCT03473743|157183658|FG004|Overall Study|Ongoing|1|||
48820016|NCT03473743|157183659|FG005|Overall Study|Ongoing|1|||
48820017|NCT03473743|157183660|FG006|Overall Study|Ongoing|22|||
48820018|NCT03473743|157183661|FG007|Overall Study|Ongoing|24|||
48820019|NCT03473743|157183654|FG000|Overall Study|Randomized but not treated|0|||
48820020|NCT03473743|157183655|FG001|Overall Study|Randomized but not treated|0|||
48820021|NCT03473743|157183656|FG002|Overall Study|Randomized but not treated|0|||
48820022|NCT03473743|157183657|FG003|Overall Study|Randomized but not treated|0|||
48820023|NCT03473743|157183658|FG004|Overall Study|Randomized but not treated|0|||
48820024|NCT03473743|157183659|FG005|Overall Study|Randomized but not treated|0|||
48820025|NCT03473743|157183660|FG006|Overall Study|Randomized but not treated|1|||
48820026|NCT03473743|157183661|FG007|Overall Study|Randomized but not treated|1|||
48820027|NCT04529538|157183662|FG000|Overall Study|Lost to Follow-up|3|||
48820028|NCT04529538|157183663|FG001|Overall Study|Lost to Follow-up|2|||
48820029|NCT04529538|157183664|FG002|Overall Study|Lost to Follow-up|1|||
48820030|NCT04529538|157183665|FG003|Overall Study|Lost to Follow-up|0|||
48820031|NCT04529538|157183666|FG004|Overall Study|Lost to Follow-up|1|||
48820032|NCT04529538|157183667|FG005|Overall Study|Lost to Follow-up|1|||
48820033|NCT04529538|157183668|FG006|Overall Study|Lost to Follow-up|2|||
48820034|NCT04529538|157183669|FG007|Overall Study|Lost to Follow-up|0|||
48820035|NCT04529538|157183662|FG000|Overall Study|Not eligible at enrollment|0|||
48820036|NCT04529538|157183663|FG001|Overall Study|Not eligible at enrollment|1|||
48820037|NCT04529538|157183664|FG002|Overall Study|Not eligible at enrollment|2|||
48820038|NCT04529538|157183665|FG003|Overall Study|Not eligible at enrollment|1|||
48820039|NCT04529538|157183666|FG004|Overall Study|Not eligible at enrollment|0|||
48820040|NCT04529538|157183667|FG005|Overall Study|Not eligible at enrollment|0|||
48820041|NCT04529538|157183668|FG006|Overall Study|Not eligible at enrollment|0|||
48820042|NCT04529538|157183669|FG007|Overall Study|Not eligible at enrollment|1|||
48820043|NCT04529538|157183662|FG000|Overall Study|Withdrawal by Subject|0|||
48820044|NCT04529538|157183663|FG001|Overall Study|Withdrawal by Subject|1|||
48820045|NCT04529538|157183664|FG002|Overall Study|Withdrawal by Subject|1|||
48820046|NCT04529538|157183665|FG003|Overall Study|Withdrawal by Subject|2|||
48820047|NCT04529538|157183666|FG004|Overall Study|Withdrawal by Subject|0|||
48820048|NCT04529538|157183667|FG005|Overall Study|Withdrawal by Subject|2|||
48820049|NCT04529538|157183668|FG006|Overall Study|Withdrawal by Subject|3|||
48820050|NCT04529538|157183669|FG007|Overall Study|Withdrawal by Subject|0|||
48820051|NCT04529538|157183662|FG000|Overall Study|Other|0|||
48820052|NCT04529538|157183663|FG001|Overall Study|Other|1|||
48820053|NCT04529538|157183664|FG002|Overall Study|Other|0|||
48820054|NCT04529538|157183665|FG003|Overall Study|Other|0|||
48820055|NCT04529538|157183666|FG004|Overall Study|Other|0|||
48820056|NCT04529538|157183667|FG005|Overall Study|Other|0|||
48820057|NCT04529538|157183668|FG006|Overall Study|Other|0|||
48820058|NCT04529538|157183669|FG007|Overall Study|Other|0|||
48820059|NCT04529538|157183662|FG000|Overall Study|Adverse Event|0|||
48820060|NCT04529538|157183663|FG001|Overall Study|Adverse Event|0|||
48820061|NCT04529538|157183664|FG002|Overall Study|Adverse Event|0|||
48820062|NCT04529538|157183665|FG003|Overall Study|Adverse Event|1|||
48820063|NCT04529538|157183666|FG004|Overall Study|Adverse Event|0|||
48820064|NCT04529538|157183667|FG005|Overall Study|Adverse Event|0|||
48600247|NCT03489343|156391563|FG003|Overall Study|Withdrawal by Subject|1|||
48820065|NCT04529538|157183668|FG006|Overall Study|Adverse Event|0|||
48820066|NCT04529538|157183669|FG007|Overall Study|Adverse Event|0|||
48820067|NCT04529538|157183662|FG000|Overall Study|Protocol Deviation|0|||
48820068|NCT04529538|157183663|FG001|Overall Study|Protocol Deviation|0|||
48820069|NCT04529538|157183664|FG002|Overall Study|Protocol Deviation|0|||
48820070|NCT04529538|157183665|FG003|Overall Study|Protocol Deviation|1|||
48820071|NCT04529538|157183666|FG004|Overall Study|Protocol Deviation|0|||
48600248|NCT03489343|156391564|FG004|Overall Study|Withdrawal by Subject|0|||
48820072|NCT04529538|157183667|FG005|Overall Study|Protocol Deviation|0|||
48820073|NCT04529538|157183668|FG006|Overall Study|Protocol Deviation|0|||
48820074|NCT04529538|157183669|FG007|Overall Study|Protocol Deviation|0|||
48820075|NCT04529538|157183662|FG000|Overall Study|Physician Decision|0|||
48820076|NCT04529538|157183663|FG001|Overall Study|Physician Decision|0|||
48820077|NCT04529538|157183664|FG002|Overall Study|Physician Decision|0|||
48820078|NCT04529538|157183665|FG003|Overall Study|Physician Decision|0|||
48820079|NCT04529538|157183666|FG004|Overall Study|Physician Decision|0|||
48820080|NCT04529538|157183667|FG005|Overall Study|Physician Decision|1|||
48820081|NCT04529538|157183668|FG006|Overall Study|Physician Decision|0|||
48820082|NCT04529538|157183669|FG007|Overall Study|Physician Decision|1|||
48820083|NCT04963062|157183670|FG000|Overall Study|withdrew by the study team|4|||
48820084|NCT04963062|157183671|FG001|Overall Study|withdrew by the study team|2|||
48820085|NCT02431533|157183672|FG000|Overall Study|Withdrawal by Subject|1|||
48820086|NCT02431533|157183673|FG001|Overall Study|Withdrawal by Subject|3|||
48820087|NCT02431533|157183672|FG000|Overall Study|Developed Exclusionary criteria|1|||
48820088|NCT02431533|157183673|FG001|Overall Study|Developed Exclusionary criteria|0|||
48820089|NCT00885495|157183678|FG000|Overall Study|Adverse Event|1|||
48820090|NCT00885495|157183679|FG001|Overall Study|Adverse Event|2|||
48820091|NCT00885495|157183678|FG000|Overall Study|Protocol Violation|0|||
48820092|NCT00885495|157183679|FG001|Overall Study|Protocol Violation|1|||
48820093|NCT00885495|157183678|FG000|Overall Study|Withdrawal by Subject|1|||
48820094|NCT00885495|157183679|FG001|Overall Study|Withdrawal by Subject|0|||
48820095|NCT01400893|157183680|FG000|Overall Study|Death|27|||
48820096|NCT01400893|157183681|FG001|Overall Study|Death|21|||
48820097|NCT01400893|157183680|FG000|Overall Study|Lost to Follow-up|0|||
48820098|NCT01400893|157183681|FG001|Overall Study|Lost to Follow-up|6|||
48820099|NCT02453282|157183684|FG000|Overall Study|Death|275|||
48820100|NCT02453282|157183685|FG001|Overall Study|Death|277|||
48820101|NCT02453282|157183686|FG002|Overall Study|Death|296|||
48820102|NCT02453282|157183684|FG000|Overall Study|Lost to Follow-up|1|||
48820103|NCT02453282|157183685|FG001|Overall Study|Lost to Follow-up|0|||
48820104|NCT02453282|157183686|FG002|Overall Study|Lost to Follow-up|2|||
48820105|NCT02453282|157183684|FG000|Overall Study|Withdrawal by Subject|12|||
48820106|NCT02453282|157183685|FG001|Overall Study|Withdrawal by Subject|10|||
48820107|NCT02453282|157183686|FG002|Overall Study|Withdrawal by Subject|11|||
48820108|NCT02453282|157183684|FG000|Overall Study|Participants ongoing at data cut-off|85|||
48820109|NCT02453282|157183685|FG001|Overall Study|Participants ongoing at data cut-off|84|||
48820110|NCT02453282|157183686|FG002|Overall Study|Participants ongoing at data cut-off|62|||
48820111|NCT02453282|157183684|FG000|Overall Study|Other|1|||
48820112|NCT02453282|157183685|FG001|Overall Study|Other|1|||
48820113|NCT02453282|157183686|FG002|Overall Study|Other|1|||
48820114|NCT04562779|157183690|FG000|Overall Study|Lost to Follow-up|7|||
48820115|NCT04562779|157183691|FG001|Overall Study|Lost to Follow-up|5|||
48820116|NCT04562779|157183692|FG002|Overall Study|Lost to Follow-up|10|||
48820117|NCT04562779|157183690|FG000|Overall Study|Protocol Violation|2|||
48820118|NCT04562779|157183691|FG001|Overall Study|Protocol Violation|2|||
48820119|NCT04562779|157183692|FG002|Overall Study|Protocol Violation|0|||
48820120|NCT00333138|157183693|FG000|Core Study (6 Months)|Adverse Event|4|||
48820121|NCT00333138|157183694|FG001|Core Study (6 Months)|Adverse Event|5|||
48820122|NCT00333138|157183695|FG002|Core Study (6 Months)|Adverse Event|8|||
48820123|NCT00333138|157183693|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
48820124|NCT00333138|157183694|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
48820125|NCT00333138|157183695|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
48820126|NCT00333138|157183693|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
48820127|NCT00333138|157183694|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
48820128|NCT00333138|157183695|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
48820129|NCT00333138|157183693|FG000|Core Study (6 Months)|Protocol Violation|1|||
48820130|NCT00333138|157183694|FG001|Core Study (6 Months)|Protocol Violation|0|||
48820131|NCT00333138|157183695|FG002|Core Study (6 Months)|Protocol Violation|1|||
48820132|NCT00333138|157183693|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
48820133|NCT00333138|157183694|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
48820134|NCT00333138|157183695|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
48820135|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
48820136|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
48820137|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
48820138|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
48820139|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
48820140|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
48820141|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
48820142|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
48820143|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
48820144|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
48820145|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
48820146|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
48820147|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
48820148|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
48820149|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
48820150|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
48820151|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
48820152|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
48820153|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
48820154|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
48820155|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
48820156|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
48820157|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
48820158|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
48820159|NCT00333138|157183693|FG000|Extension Study (Month6 to End of Study)|Death|0|||
48820160|NCT00333138|157183694|FG001|Extension Study (Month6 to End of Study)|Death|1|||
48820161|NCT00333138|157183695|FG002|Extension Study (Month6 to End of Study)|Death|0|||
48820162|NCT03499600|157183702|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
48505969|NCT05093205|156046422|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48505970|NCT05093205|156046423|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48505971|NCT05093205|156046424|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48505972|NCT05093205|156046425|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48505973|NCT05093205|156046426|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48505974|NCT05093205|156046427|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
48505975|NCT05093205|156046428|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48505976|NCT05093205|156046429|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
48505977|NCT05093205|156046417|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505978|NCT05093205|156046418|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505979|NCT05093205|156046419|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505980|NCT05093205|156046420|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505981|NCT05093205|156046421|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505982|NCT05093205|156046422|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505983|NCT05093205|156046423|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505984|NCT05093205|156046424|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505985|NCT05093205|156046425|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505986|NCT05093205|156046426|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505987|NCT05093205|156046427|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505988|NCT05093205|156046428|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
48505989|NCT05093205|156046429|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
48505990|NCT05093205|156046417|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
48505991|NCT05093205|156046418|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
48505992|NCT05093205|156046419|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
48505993|NCT05093205|156046420|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
48505994|NCT05093205|156046421|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
48505995|NCT05093205|156046422|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
48505996|NCT05093205|156046423|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
48505997|NCT05093205|156046424|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
48505998|NCT05093205|156046425|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
48505999|NCT05093205|156046426|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
48506000|NCT05093205|156046427|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
48506001|NCT05093205|156046428|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
48506002|NCT05093205|156046429|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
48506003|NCT05093205|156046417|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506004|NCT05093205|156046418|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506005|NCT05093205|156046419|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506006|NCT05093205|156046420|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506007|NCT05093205|156046421|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506008|NCT05093205|156046422|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506009|NCT05093205|156046423|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506010|NCT05093205|156046424|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506011|NCT05093205|156046425|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506012|NCT05093205|156046426|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506013|NCT05093205|156046427|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506014|NCT05093205|156046428|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
48600249|NCT03489343|156391565|FG005|Overall Study|Withdrawal by Subject|1|||
48600250|NCT03489343|156391566|FG006|Overall Study|Withdrawal by Subject|1|||
48600251|NCT03489343|156391560|FG000|Overall Study|Clinical progression|0|||
48600252|NCT03489343|156391561|FG001|Overall Study|Clinical progression|0|||
48820163|NCT03499600|157183703|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
48820164|NCT01290094|157183704|FG000|Overall Study|Withdrawal by Subject|1|||
48506015|NCT05093205|156046429|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
48506016|NCT00846495|156046433|FG000|Overall Study|Lost to Follow-up|1|||
48506017|NCT00846495|156046434|FG001|Overall Study|Lost to Follow-up|0|||
48506018|NCT00846495|156046433|FG000|Overall Study|Adverse Event|5|||
48725193|NCT00089674|156843177|FG000|Overall Study|Physician Decision|4|||
48725194|NCT00089674|156843178|FG001|Overall Study|Physician Decision|2|||
48725195|NCT00089674|156843177|FG000|Overall Study|Adverse Event|23|||
48725196|NCT00089674|156843178|FG001|Overall Study|Adverse Event|29|||
48725197|NCT00089674|156843177|FG000|Overall Study|Withdrawal by Subject|143|||
48725198|NCT00089674|156843178|FG001|Overall Study|Withdrawal by Subject|127|||
48725199|NCT00089674|156843177|FG000|Overall Study|Death|43|||
48725200|NCT00089674|156843178|FG001|Overall Study|Death|43|||
48725201|NCT00089674|156843177|FG000|Overall Study|Disease progression|21|||
48725202|NCT00089674|156843178|FG001|Overall Study|Disease progression|23|||
48725203|NCT00089674|156843177|FG000|Overall Study|Ineligibility determined|8|||
48725204|NCT00089674|156843178|FG001|Overall Study|Ineligibility determined|10|||
48725205|NCT00089674|156843177|FG000|Overall Study|Lost to Follow-up|21|||
48725206|NCT00089674|156843178|FG001|Overall Study|Lost to Follow-up|17|||
48725207|NCT00089674|156843177|FG000|Overall Study|Noncompliance|7|||
48725208|NCT00089674|156843178|FG001|Overall Study|Noncompliance|3|||
48725209|NCT00089674|156843177|FG000|Overall Study|Other|5|||
48725210|NCT00089674|156843178|FG001|Overall Study|Other|9|||
48725211|NCT00089674|156843177|FG000|Overall Study|Requirement for alternative therapy|14|||
48725212|NCT00089674|156843178|FG001|Overall Study|Requirement for alternative therapy|4|||
48725213|NCT03324581|156843179|FG000|Overall Study|Adverse Event|18|||
48725214|NCT03324581|156843180|FG001|Overall Study|Adverse Event|11|||
48725215|NCT03324581|156843181|FG002|Overall Study|Adverse Event|7|||
48725216|NCT03324581|156843179|FG000|Overall Study|Lack of Efficacy|0|||
48725217|NCT03324581|156843180|FG001|Overall Study|Lack of Efficacy|1|||
48725218|NCT03324581|156843181|FG002|Overall Study|Lack of Efficacy|0|||
48725219|NCT03324581|156843179|FG000|Overall Study|Lost to Follow-up|5|||
48725220|NCT03324581|156843180|FG001|Overall Study|Lost to Follow-up|3|||
48725221|NCT03324581|156843181|FG002|Overall Study|Lost to Follow-up|6|||
48725222|NCT03324581|156843179|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
48725223|NCT03324581|156843180|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
48725224|NCT03324581|156843181|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
48506019|NCT00846495|156046434|FG001|Overall Study|Adverse Event|1|||
48506020|NCT00846495|156046433|FG000|Overall Study|Lack of Efficacy|1|||
48506021|NCT00846495|156046434|FG001|Overall Study|Lack of Efficacy|2|||
48725225|NCT03324581|156843179|FG000|Overall Study|Physician Decision|0|||
48725226|NCT03324581|156843180|FG001|Overall Study|Physician Decision|1|||
48725227|NCT03324581|156843181|FG002|Overall Study|Physician Decision|2|||
48725228|NCT03324581|156843179|FG000|Overall Study|Protocol Deviation|8|||
48725229|NCT03324581|156843180|FG001|Overall Study|Protocol Deviation|9|||
48725230|NCT03324581|156843181|FG002|Overall Study|Protocol Deviation|4|||
48725231|NCT03324581|156843179|FG000|Overall Study|Withdrawal by Subject|6|||
48725232|NCT03324581|156843180|FG001|Overall Study|Withdrawal by Subject|8|||
48725233|NCT03324581|156843181|FG002|Overall Study|Withdrawal by Subject|6|||
48725234|NCT03324581|156843179|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
48506022|NCT00846495|156046433|FG000|Overall Study|Physician Decision|1|||
48506023|NCT00846495|156046434|FG001|Overall Study|Physician Decision|0|||
48506024|NCT00550537|156046438|FG000|Overall Study|Death|18|||
48506025|NCT00550537|156046438|FG000|Overall Study|Adverse Event|20|||
48506026|NCT00550537|156046438|FG000|Overall Study|Disease progression before|46|||
48506027|NCT00550537|156046438|FG000|Overall Study|Withdrawal by Subject|7|||
48506028|NCT00550537|156046438|FG000|Overall Study|Change in treatment plan|4|||
48506029|NCT00550537|156046438|FG000|Overall Study|Other complicating ilness|3|||
48506030|NCT00550537|156046438|FG000|Overall Study|Declining performance status|2|||
48506031|NCT00550537|156046438|FG000|Overall Study|Treated closer to home|4|||
48506032|NCT01029340|156046439|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
48506033|NCT01029340|156046440|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
48506034|NCT01029340|156046441|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
48506035|NCT01029340|156046442|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
48506036|NCT01029340|156046443|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
48506037|NCT01029340|156046444|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
48725235|NCT03324581|156843180|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
48725236|NCT03324581|156843181|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
48725237|NCT04271280|156843183|FG000|Overall Study|Lost to Follow-up|300|||
48725238|NCT04271280|156843183|FG000|Overall Study|Death|153|||
48725239|NCT04271280|156843183|FG000|Overall Study|Withdrawal of consent by patient|59|||
48506038|NCT01029340|156046439|FG000|Part B Treatment Period|Protocol Violation|0|||
48506039|NCT01029340|156046440|FG001|Part B Treatment Period|Protocol Violation|0|||
48725240|NCT04271280|156843183|FG000|Overall Study|Other|51|||
48725241|NCT04271280|156843183|FG000|Overall Study|No end of study information|42|||
48725242|NCT00510952|156843187|FG000|Overall Study|Adverse Event|1|||
48725243|NCT00510952|156843188|FG001|Overall Study|Adverse Event|0|||
48725244|NCT00510952|156843187|FG000|Overall Study|Entry Criteria Not Met|3|||
48725245|NCT00510952|156843188|FG001|Overall Study|Entry Criteria Not Met|1|||
48725246|NCT00510952|156843187|FG000|Overall Study|Lost to Follow-up|5|||
48600253|NCT03489343|156391562|FG002|Overall Study|Clinical progression|0|||
48600254|NCT03489343|156391563|FG003|Overall Study|Clinical progression|1|||
48600255|NCT03489343|156391564|FG004|Overall Study|Clinical progression|0|||
48600256|NCT03489343|156391565|FG005|Overall Study|Clinical progression|0|||
48600257|NCT03489343|156391566|FG006|Overall Study|Clinical progression|1|||
48600258|NCT02364388|156391569|FG000|Overall Study|Protocol Violation|1|||
48600259|NCT02364388|156391569|FG000|Overall Study|Technical Failure|3|||
48820165|NCT01290094|157183704|FG000|Overall Study|Lost to Follow-up|5|||
48600260|NCT02364388|156391569|FG000|Overall Study|No OA/US data|2|||
48820166|NCT02367040|157183705|FG000|Overall Study|Lost to Follow-up|1|||
48820167|NCT02367040|157183706|FG001|Overall Study|Lost to Follow-up|1|||
48820168|NCT02367040|157183705|FG000|Overall Study|Lack of Efficacy|1|||
48820169|NCT02367040|157183706|FG001|Overall Study|Lack of Efficacy|0|||
48820170|NCT02367040|157183705|FG000|Overall Study|Additional primary malignancy|0|||
48820171|NCT02367040|157183706|FG001|Overall Study|Additional primary malignancy|1|||
48820172|NCT02367040|157183705|FG000|Overall Study|AE not associated with clinical disease progression|114|||
48820173|NCT02367040|157183706|FG001|Overall Study|AE not associated with clinical disease progression|11|||
48820174|NCT02367040|157183705|FG000|Overall Study|AE associated with clinical disease progression|1|||
48820175|NCT02367040|157183706|FG001|Overall Study|AE associated with clinical disease progression|3|||
48820176|NCT02367040|157183705|FG000|Overall Study|Physician Decision|2|||
48820177|NCT02367040|157183706|FG001|Overall Study|Physician Decision|8|||
48820178|NCT02367040|157183705|FG000|Overall Study|Non-compliance with study drug|1|||
48820179|NCT02367040|157183706|FG001|Overall Study|Non-compliance with study drug|0|||
48820180|NCT02367040|157183705|FG000|Overall Study|Failure to meet continuation criteria|1|||
48820181|NCT02367040|157183706|FG001|Overall Study|Failure to meet continuation criteria|0|||
48820182|NCT02367040|157183705|FG000|Overall Study|Switching to other therapy|2|||
48820183|NCT02367040|157183706|FG001|Overall Study|Switching to other therapy|0|||
48820184|NCT02367040|157183705|FG000|Overall Study|Withdrawal by Subject|46|||
48820185|NCT02367040|157183706|FG001|Overall Study|Withdrawal by Subject|16|||
48820186|NCT02367040|157183705|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
48820187|NCT02367040|157183706|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48820188|NCT02367040|157183705|FG000|Overall Study|Patient decision|39|||
48820189|NCT02367040|157183706|FG001|Overall Study|Patient decision|14|||
48820190|NCT02367040|157183705|FG000|Overall Study|Required procedure failed|1|||
48820191|NCT02367040|157183706|FG001|Overall Study|Required procedure failed|0|||
48820192|NCT02367040|157183705|FG000|Overall Study|Randomized by mistake with study treatment|1|||
48820193|NCT02367040|157183706|FG001|Overall Study|Randomized by mistake with study treatment|0|||
48820194|NCT02367040|157183705|FG000|Overall Study|Protocol Violation|1|||
48820195|NCT02367040|157183706|FG001|Overall Study|Protocol Violation|0|||
48820196|NCT02367040|157183705|FG000|Overall Study|Progressive disease - radiological progression|51|||
48820197|NCT02367040|157183706|FG001|Overall Study|Progressive disease - radiological progression|78|||
48820198|NCT02367040|157183705|FG000|Overall Study|Progressive disease - clinical progression|6|||
48438414|NCT00438399|155792020|FG004|Overall Study|Protocol Violation|0|||
48600261|NCT02364388|156391569|FG000|Overall Study|No Biopsy|2|||
48600262|NCT00327717|156391570|FG000|Overall Study|Adverse Event|6|||
48600263|NCT00327717|156391571|FG001|Overall Study|Adverse Event|6|||
48438415|NCT00438399|155792021|FG005|Overall Study|Protocol Violation|1|||
48438416|NCT00438399|155792016|FG000|Overall Study|Subje stopped study|0|||
48438417|NCT00438399|155792017|FG001|Overall Study|Subje stopped study|0|||
48438418|NCT00438399|155792018|FG002|Overall Study|Subje stopped study|1|||
48600264|NCT00327717|156391570|FG000|Overall Study|Lack of Efficacy|0|||
48600265|NCT00327717|156391571|FG001|Overall Study|Lack of Efficacy|1|||
48600266|NCT00327717|156391570|FG000|Overall Study|Withdrawal by Subject|3|||
48600267|NCT00327717|156391571|FG001|Overall Study|Withdrawal by Subject|7|||
48600268|NCT01158261|156391572|FG000|Overall Study|Lost to Follow-up|9|||
48600269|NCT01158261|156391572|FG000|Overall Study|Death|7|||
48600270|NCT01158261|156391572|FG000|Overall Study|Withdrawal by Subject|1|||
48600271|NCT02899065|156391576|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
48600272|NCT02899065|156391577|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
48600273|NCT02899065|156391576|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
48820199|NCT02367040|157183706|FG001|Overall Study|Progressive disease - clinical progression|6|||
48820200|NCT02367040|157183705|FG000|Overall Study|Drug not administered|3|||
48438419|NCT00438399|155792019|FG003|Overall Study|Subje stopped study|0|||
48438420|NCT00438399|155792020|FG004|Overall Study|Subje stopped study|0|||
48438421|NCT00438399|155792021|FG005|Overall Study|Subje stopped study|0|||
48438422|NCT00438399|155792016|FG000|Overall Study|Pregnancy|0|||
48438423|NCT00438399|155792017|FG001|Overall Study|Pregnancy|0|||
48438424|NCT00438399|155792018|FG002|Overall Study|Pregnancy|0|||
48438425|NCT00438399|155792019|FG003|Overall Study|Pregnancy|0|||
48438426|NCT00438399|155792020|FG004|Overall Study|Pregnancy|0|||
48438427|NCT00438399|155792021|FG005|Overall Study|Pregnancy|1|||
48438428|NCT00438399|155792016|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
48438429|NCT00438399|155792017|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
48438430|NCT00438399|155792018|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
48725247|NCT00510952|156843188|FG001|Overall Study|Lost to Follow-up|3|||
48725248|NCT00510952|156843187|FG000|Overall Study|Physician Decision|1|||
48725249|NCT00510952|156843188|FG001|Overall Study|Physician Decision|1|||
48725250|NCT00510952|156843187|FG000|Overall Study|Protocol Violation|7|||
48725251|NCT00510952|156843188|FG001|Overall Study|Protocol Violation|4|||
48725252|NCT00510952|156843187|FG000|Overall Study|Sponsor Decision|1|||
48725253|NCT00510952|156843188|FG001|Overall Study|Sponsor Decision|0|||
48725254|NCT00510952|156843187|FG000|Overall Study|Withdrawal by Subject|6|||
48725255|NCT00510952|156843188|FG001|Overall Study|Withdrawal by Subject|7|||
48725256|NCT00510952|156843187|FG000|Overall Study|Did Not Receive Study Drug|2|||
48725257|NCT00510952|156843188|FG001|Overall Study|Did Not Receive Study Drug|0|||
48725258|NCT03119701|156843189|FG000|6-day Dosing|Death|4|||
48725259|NCT03119701|156843190|FG001|6-day Dosing|Death|1|||
48725260|NCT03119701|156843189|FG000|6-day Dosing|Adverse Event|3|||
48725261|NCT03119701|156843190|FG001|6-day Dosing|Adverse Event|0|||
48725262|NCT03119701|156843189|FG000|6-day Dosing|Physician Decision|0|||
48725263|NCT03119701|156843190|FG001|6-day Dosing|Physician Decision|1|||
48725264|NCT03119701|156843189|FG000|6-day Dosing|Withdrawal by Subject|0|||
48438509|NCT03655717|155792055|FG002|Overall Study|Physician Decision|0|||
48600274|NCT02899065|156391577|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
48600275|NCT02899065|156391576|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
48600276|NCT02899065|156391577|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
48600277|NCT00971867|156391578|FG000|Overall Study|Adverse Event|4|||
48600278|NCT00971867|156391578|FG000|Overall Study|Participant Withdrew Consent|1|||
48600279|NCT00971867|156391578|FG000|Overall Study|Disease Progression|6|||
48600280|NCT03586050|156391581|FG000|Overall Study|Death|3|||
48600281|NCT03586050|156391581|FG000|Overall Study|Withdrawal by Subject|2|||
48600282|NCT02689804|156391582|FG000|Overall Study|Withdrawal by Subject|2|||
48600283|NCT02689804|156391583|FG001|Overall Study|Withdrawal by Subject|0|||
48600284|NCT00901342|156391590|FG000|Overall Study|Adverse Event|1|||
48600285|NCT00901342|156391590|FG000|Overall Study|Death|4|||
48600286|NCT00901342|156391590|FG000|Overall Study|Disease progression|1|||
48600287|NCT00901342|156391590|FG000|Overall Study|Withdrawal by Subject|9|||
48600288|NCT01261390|156391593|FG000|Overall Study|Significant Concurrent Illness|1|||
48600289|NCT01261390|156391594|FG001|Overall Study|Significant Concurrent Illness|0|||
48600290|NCT01261390|156391595|FG002|Overall Study|Significant Concurrent Illness|1|||
48600291|NCT01261390|156391596|FG003|Overall Study|Significant Concurrent Illness|0|||
48600292|NCT01261390|156391593|FG000|Overall Study|Dissatisfaction with Treatment|2|||
48600293|NCT01261390|156391594|FG001|Overall Study|Dissatisfaction with Treatment|1|||
48600294|NCT01261390|156391595|FG002|Overall Study|Dissatisfaction with Treatment|1|||
48600295|NCT01261390|156391596|FG003|Overall Study|Dissatisfaction with Treatment|2|||
48600296|NCT01261390|156391593|FG000|Overall Study|Relocation|0|||
48600297|NCT01261390|156391594|FG001|Overall Study|Relocation|1|||
48600298|NCT01261390|156391595|FG002|Overall Study|Relocation|0|||
48600299|NCT01261390|156391596|FG003|Overall Study|Relocation|0|||
48600300|NCT01261390|156391593|FG000|Overall Study|Loss of Interest in the Study|3|||
48600301|NCT01261390|156391594|FG001|Overall Study|Loss of Interest in the Study|1|||
48600302|NCT01261390|156391595|FG002|Overall Study|Loss of Interest in the Study|0|||
48600303|NCT01261390|156391596|FG003|Overall Study|Loss of Interest in the Study|0|||
48600304|NCT01261390|156391593|FG000|Overall Study|Lost to Follow-up|1|||
48600305|NCT01261390|156391594|FG001|Overall Study|Lost to Follow-up|6|||
48600306|NCT01261390|156391595|FG002|Overall Study|Lost to Follow-up|5|||
48600307|NCT01261390|156391596|FG003|Overall Study|Lost to Follow-up|6|||
48600308|NCT00828113|156391597|FG000|Overall Study|Withdrawal by Subject|27|||
48600309|NCT00828113|156391598|FG001|Overall Study|Withdrawal by Subject|26|||
48600310|NCT00828113|156391597|FG000|Overall Study|Lost to Follow-up|3|||
48600311|NCT00828113|156391598|FG001|Overall Study|Lost to Follow-up|5|||
48600312|NCT02329327|156391599|FG000|Overall Study|Death|78|||
48600313|NCT02329327|156391600|FG001|Overall Study|Death|0|||
48600314|NCT02329327|156391599|FG000|Overall Study|Withdrawal by Subject|3|||
48600315|NCT02329327|156391600|FG001|Overall Study|Withdrawal by Subject|0|||
48725265|NCT03119701|156843190|FG001|6-day Dosing|Withdrawal by Subject|1|||
48725266|NCT03119701|156843189|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
48725267|NCT03119701|156843190|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
48725268|NCT02603887|156843197|FG000|Stage 1|Adverse Event|4|||
48725269|NCT02603887|156843197|FG000|Stage 1|Disease progression|1|||
48725270|NCT02603887|156843197|FG000|Stage 2|FDA guidance|1|||
48725271|NCT01074047|156843198|FG000|Treatment Phase|Adverse Event|89|||
48725272|NCT01074047|156843199|FG001|Treatment Phase|Adverse Event|66|||
48725273|NCT01074047|156843198|FG000|Treatment Phase|Disease Progression|16|||
48600316|NCT02329327|156391599|FG000|Overall Study|Lost to Follow-up|4|||
48600317|NCT02329327|156391600|FG001|Overall Study|Lost to Follow-up|0|||
48600318|NCT02493517|156391601|FG000|Overall Study|Protocol Violation|1|||
48600319|NCT02493517|156391602|FG001|Overall Study|Protocol Violation|2|||
48725274|NCT01074047|156843199|FG001|Treatment Phase|Disease Progression|21|||
48600320|NCT02493517|156391601|FG000|Overall Study|Withdrawal by Subject|1|||
48725275|NCT01074047|156843198|FG000|Treatment Phase|Withdrawal by Subject|27|||
48506040|NCT01029340|156046441|FG002|Part B Treatment Period|Protocol Violation|1|||
48506041|NCT01029340|156046442|FG003|Part B Treatment Period|Protocol Violation|0|||
48506042|NCT01029340|156046443|FG004|Part B Treatment Period|Protocol Violation|0|||
48506043|NCT01029340|156046444|FG005|Part B Treatment Period|Protocol Violation|0|||
48506044|NCT01029340|156046439|FG000|Extension Period|Adverse Event|0|||
48506045|NCT01029340|156046440|FG001|Extension Period|Adverse Event|0|||
48725276|NCT01074047|156843199|FG001|Treatment Phase|Withdrawal by Subject|48|||
48725277|NCT01074047|156843198|FG000|Treatment Phase|Death|53|||
48725278|NCT01074047|156843199|FG001|Treatment Phase|Death|58|||
48725279|NCT01074047|156843198|FG000|Treatment Phase|Lost to Follow-up|0|||
48725280|NCT01074047|156843199|FG001|Treatment Phase|Lost to Follow-up|1|||
48725281|NCT01074047|156843198|FG000|Treatment Phase|Protocol Violation|0|||
48725282|NCT01074047|156843199|FG001|Treatment Phase|Protocol Violation|1|||
48725283|NCT01074047|156843198|FG000|Treatment Phase|Miscellaneous|32|||
48725284|NCT01074047|156843199|FG001|Treatment Phase|Miscellaneous|39|||
48725285|NCT01074047|156843198|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
48725286|NCT01074047|156843199|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
48725287|NCT01074047|156843198|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
48725288|NCT01074047|156843199|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
48725289|NCT01074047|156843198|FG000|Survival Follow-Up Phase|Death|116|||
48725290|NCT01074047|156843199|FG001|Survival Follow-Up Phase|Death|124|||
48725291|NCT01074047|156843198|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
48725292|NCT01074047|156843199|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
48725293|NCT01074047|156843198|FG000|Extension Phase|Physician Decision|1|||
48725294|NCT01074047|156843199|FG001|Extension Phase|Physician Decision|0|||
48725295|NCT01074047|156843198|FG000|Extension Phase|Adverse Event|5|||
48725296|NCT01074047|156843199|FG001|Extension Phase|Adverse Event|0|||
48725297|NCT01074047|156843198|FG000|Extension Phase|Disease Progression|9|||
48725298|NCT01074047|156843199|FG001|Extension Phase|Disease Progression|0|||
48725299|NCT01074047|156843198|FG000|Extension Phase|Withdrawal by Subject|2|||
48725300|NCT01074047|156843199|FG001|Extension Phase|Withdrawal by Subject|0|||
48725301|NCT01074047|156843198|FG000|Extension Phase|Death|5|||
48725302|NCT01074047|156843199|FG001|Extension Phase|Death|0|||
48725303|NCT00395538|156843202|FG000|Overall Study|Did not re-consent to revised protocol|1|||
48725304|NCT00395538|156843203|FG001|Overall Study|Did not re-consent to revised protocol|10|||
48725305|NCT00395538|156843204|FG002|Overall Study|Did not re-consent to revised protocol|0|||
48725306|NCT00395538|156843202|FG000|Overall Study|FDA partial hold on PTH|0|||
48725307|NCT00395538|156843203|FG001|Overall Study|FDA partial hold on PTH|0|||
48725308|NCT00395538|156843204|FG002|Overall Study|FDA partial hold on PTH|11|||
48725309|NCT00395538|156843202|FG000|Overall Study|Failed screening|0|||
48725310|NCT00395538|156843203|FG001|Overall Study|Failed screening|0|||
48725311|NCT00395538|156843204|FG002|Overall Study|Failed screening|4|||
48725312|NCT00395538|156843202|FG000|Overall Study|Switch to Natpara|0|||
48725313|NCT00395538|156843203|FG001|Overall Study|Switch to Natpara|0|||
48725314|NCT00395538|156843204|FG002|Overall Study|Switch to Natpara|3|||
48725315|NCT00395538|156843202|FG000|Overall Study|Adverse Event|1|||
48725316|NCT00395538|156843203|FG001|Overall Study|Adverse Event|0|||
48725317|NCT00395538|156843204|FG002|Overall Study|Adverse Event|2|||
48725318|NCT00395538|156843202|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
48725319|NCT00395538|156843203|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
48725320|NCT00395538|156843204|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
48725321|NCT00395538|156843202|FG000|Overall Study|Non-compliance with study protocol|0|||
48725322|NCT00395538|156843203|FG001|Overall Study|Non-compliance with study protocol|1|||
48725323|NCT00395538|156843204|FG002|Overall Study|Non-compliance with study protocol|0|||
48725324|NCT00395538|156843202|FG000|Overall Study|PTH resistance|0|||
48725325|NCT00395538|156843203|FG001|Overall Study|PTH resistance|0|||
48725326|NCT00395538|156843204|FG002|Overall Study|PTH resistance|1|||
48725327|NCT00395538|156843202|FG000|Overall Study|Pregnancy|1|||
48725328|NCT00395538|156843203|FG001|Overall Study|Pregnancy|0|||
48725329|NCT00395538|156843204|FG002|Overall Study|Pregnancy|0|||
48725330|NCT00395538|156843202|FG000|Overall Study|Partial recovery of parathyroid function|0|||
48725331|NCT00395538|156843203|FG001|Overall Study|Partial recovery of parathyroid function|0|||
48725332|NCT00395538|156843204|FG002|Overall Study|Partial recovery of parathyroid function|1|||
48725333|NCT00395538|156843202|FG000|Overall Study|Participant elected to discontinue|0|||
48725334|NCT00395538|156843203|FG001|Overall Study|Participant elected to discontinue|0|||
48725335|NCT00395538|156843204|FG002|Overall Study|Participant elected to discontinue|1|||
48725336|NCT02782923|156843206|FG000|Overall Study|Lost to Follow-up|15|||
48725337|NCT01163318|156843207|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
48725338|NCT01163318|156843207|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
48725339|NCT01163318|156843207|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
48506046|NCT01029340|156046441|FG002|Extension Period|Adverse Event|0|||
48725340|NCT01163318|156843207|FG000|Overall Study|Participants Without Case Report Form|7|||
48725341|NCT01163318|156843207|FG000|Overall Study|Multiple Reasons Per Participant|224|||
48725342|NCT03484819|156843208|FG000|Overall Study|Death|2|||
48506047|NCT01029340|156046442|FG003|Extension Period|Adverse Event|0|||
48820201|NCT02367040|157183706|FG001|Overall Study|Drug not administered|2|||
48820202|NCT02367040|157183705|FG000|Overall Study|Progressive disease|0|||
48820203|NCT02367040|157183706|FG001|Overall Study|Progressive disease|1|||
48820204|NCT02367040|157183705|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
48820205|NCT02367040|157183706|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
48820206|NCT02367040|157183705|FG000|Overall Study|Death|2|||
48820207|NCT02367040|157183706|FG001|Overall Study|Death|0|||
48820208|NCT00742885|157185419|FG000|Overall Study|Lost to Follow-up|1|||
48820209|NCT00742885|157185420|FG001|Overall Study|Lost to Follow-up|0|||
48820210|NCT00802841|157185428|FG000|Overall Study|Administrative problems|1|||
48820211|NCT00802841|157185429|FG001|Overall Study|Administrative problems|0|||
48820212|NCT00802841|157185428|FG000|Overall Study|Lost to Follow-up|2|||
48820213|NCT00802841|157185429|FG001|Overall Study|Lost to Follow-up|1|||
48820214|NCT00802841|157185428|FG000|Overall Study|Death|1|||
48820215|NCT00802841|157185429|FG001|Overall Study|Death|2|||
48820216|NCT00802841|157185428|FG000|Overall Study|Adverse Event|8|||
48820217|NCT00802841|157185429|FG001|Overall Study|Adverse Event|2|||
48820218|NCT00802841|157185428|FG000|Overall Study|Disease progression|7|||
48820219|NCT00802841|157185429|FG001|Overall Study|Disease progression|3|||
48820220|NCT00802841|157185428|FG000|Overall Study|Withdrawal by Subject|9|||
48820221|NCT00802841|157185429|FG001|Overall Study|Withdrawal by Subject|5|||
48820222|NCT00802841|157185428|FG000|Overall Study|Protocol deviation|2|||
48820223|NCT00802841|157185429|FG001|Overall Study|Protocol deviation|6|||
48820224|NCT00802841|157185428|FG000|Overall Study|Treatment duration completed|66|||
48820225|NCT00802841|157185429|FG001|Overall Study|Treatment duration completed|76|||
48820226|NCT02955277|157185432|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
48820227|NCT02955277|157185433|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
48820228|NCT02955277|157185432|FG000|Post to Follow-up|Lost to Follow-up|8|||
48820229|NCT02955277|157185433|FG001|Post to Follow-up|Lost to Follow-up|11|||
48820230|NCT01668147|157185434|FG000|Overall Study|Withdrawal by Subject|6|||
48820231|NCT02459587|157185444|FG000|3-Month Follow-up Assessment|Death|0|||
48820232|NCT02459587|157185445|FG001|3-Month Follow-up Assessment|Death|2|||
48820233|NCT02459587|157185444|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
48820234|NCT02459587|157185445|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
48820235|NCT02459587|157185444|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
48820236|NCT02459587|157185445|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
48820237|NCT02459587|157185444|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
48820238|NCT02459587|157185445|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
48820239|NCT02459587|157185444|FG000|6-month Follow-up Assessment|Death|2|||
48820240|NCT02459587|157185445|FG001|6-month Follow-up Assessment|Death|1|||
48820241|NCT02459587|157185444|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
48820242|NCT02459587|157185445|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
48820243|NCT02459587|157185444|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
48820244|NCT02459587|157185445|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
48820245|NCT02459587|157185444|FG000|12-month Follow-up Assessment|Death|2|||
48820246|NCT02459587|157185445|FG001|12-month Follow-up Assessment|Death|0|||
48820247|NCT02459587|157185444|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
48820248|NCT02459587|157185445|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
48820249|NCT02459587|157185444|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
48820250|NCT02459587|157185445|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
48820251|NCT02459587|157185444|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
48820252|NCT02459587|157185445|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
48820253|NCT01744496|157185454|FG000|Titration Period|Adverse Event|2|||
48820254|NCT01744496|157185455|FG001|Titration Period|Adverse Event|1|||
48820255|NCT01744496|157185454|FG000|Titration Period|Personal reasons|0|||
48820256|NCT01744496|157185455|FG001|Titration Period|Personal reasons|1|||
48820257|NCT01744496|157185454|FG000|Maintenance Period|Adverse Event|1|||
48820258|NCT01744496|157185455|FG001|Maintenance Period|Adverse Event|3|||
48820259|NCT01744496|157185454|FG000|Maintenance Period|Protocol Violation|1|||
48820260|NCT01744496|157185455|FG001|Maintenance Period|Protocol Violation|0|||
48820261|NCT01744496|157185454|FG000|Maintenance Period|Withdrawal by Subject|1|||
48820262|NCT01744496|157185455|FG001|Maintenance Period|Withdrawal by Subject|1|||
48820263|NCT01744496|157185454|FG000|Maintenance Period|Subject left town|1|||
48820264|NCT01744496|157185455|FG001|Maintenance Period|Subject left town|0|||
48820265|NCT00372567|157185464|FG000|Phase 3 Study|Adverse Event|5|||
48820266|NCT00372567|157185465|FG001|Phase 3 Study|Adverse Event|1|||
48820267|NCT00372567|157185466|FG002|Phase 3 Study|Adverse Event|1|||
48820268|NCT00372567|157185464|FG000|Phase 3 Study|Death|1|||
48820269|NCT00372567|157185465|FG001|Phase 3 Study|Death|1|||
48820270|NCT00372567|157185466|FG002|Phase 3 Study|Death|0|||
48820271|NCT00372567|157185464|FG000|Phase 3 Study|Protocol Violation|0|||
48820272|NCT00372567|157185465|FG001|Phase 3 Study|Protocol Violation|0|||
48820273|NCT00372567|157185466|FG002|Phase 3 Study|Protocol Violation|1|||
48820274|NCT00372567|157185464|FG000|Phase 3 Study|Objective progression or relapse|10|||
48820275|NCT00372567|157185465|FG001|Phase 3 Study|Objective progression or relapse|13|||
48820276|NCT00372567|157185466|FG002|Phase 3 Study|Objective progression or relapse|4|||
48820277|NCT00372567|157185464|FG000|Phase 3 Study|Global deterioration of health status|0|||
48820278|NCT00372567|157185465|FG001|Phase 3 Study|Global deterioration of health status|1|||
48820279|NCT00372567|157185466|FG002|Phase 3 Study|Global deterioration of health status|0|||
48820280|NCT00372567|157185464|FG000|Phase 3 Study|Other|2|||
48820281|NCT00372567|157185465|FG001|Phase 3 Study|Other|2|||
48820282|NCT00372567|157185466|FG002|Phase 3 Study|Other|1|||
48820283|NCT00372567|157185464|FG000|Phase 3 Study|study terminated by sponsor|13|||
48820284|NCT00372567|157185465|FG001|Phase 3 Study|study terminated by sponsor|8|||
48820285|NCT00372567|157185466|FG002|Phase 3 Study|study terminated by sponsor|5|||
48725343|NCT03484819|156843208|FG000|Overall Study|Adverse Event|2|||
48725344|NCT03484819|156843208|FG000|Overall Study|Physician Decision|1|||
48725345|NCT03484819|156843208|FG000|Overall Study|Withdrawal by Subject|2|||
48725346|NCT03484819|156843208|FG000|Overall Study|Disease Progression|4|||
48725347|NCT03484819|156843208|FG000|Overall Study|Complicating Condition|1|||
48725348|NCT01121588|156843212|FG000|Overall Study|Death|5|||
48725349|NCT01121588|156843213|FG001|Overall Study|Death|3|||
48725350|NCT01121588|156843214|FG002|Overall Study|Death|13|||
48725351|NCT01121588|156843212|FG000|Overall Study|Study Terminated by Sponsor|1|||
48725352|NCT01121588|156843213|FG001|Overall Study|Study Terminated by Sponsor|1|||
48725353|NCT01121588|156843214|FG002|Overall Study|Study Terminated by Sponsor|0|||
48725354|NCT01121588|156843212|FG000|Overall Study|Participant Refused Further Followup|2|||
48725355|NCT01121588|156843213|FG001|Overall Study|Participant Refused Further Followup|0|||
48725356|NCT01121588|156843214|FG002|Overall Study|Participant Refused Further Followup|2|||
48725357|NCT01121588|156843212|FG000|Overall Study|Lost to Follow-up|0|||
48725358|NCT01121588|156843213|FG001|Overall Study|Lost to Follow-up|1|||
48725359|NCT01121588|156843214|FG002|Overall Study|Lost to Follow-up|1|||
48725360|NCT01121588|156843212|FG000|Overall Study|Non-Specified Reasons|9|||
48725361|NCT01121588|156843213|FG001|Overall Study|Non-Specified Reasons|4|||
48725362|NCT01121588|156843214|FG002|Overall Study|Non-Specified Reasons|2|||
48725363|NCT00130442|156845021|FG000|Overall Study|Withdrawal by Subject|0|||
48725364|NCT00130442|156845022|FG001|Overall Study|Withdrawal by Subject|1|||
48725365|NCT00130442|156845021|FG000|Overall Study|did not meet criteria|1|||
48725366|NCT00130442|156845022|FG001|Overall Study|did not meet criteria|1|||
48725367|NCT01142089|156845024|FG000|Overall Study|Physician Decision|1|||
48725368|NCT01142089|156845025|FG001|Overall Study|Physician Decision|0|||
48725369|NCT01142089|156845024|FG000|Overall Study|Withdrawal by Subject|1|||
48725370|NCT01142089|156845025|FG001|Overall Study|Withdrawal by Subject|2|||
48820286|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
48820287|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
48820288|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
48820289|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
48820290|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
48820291|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
48820292|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
48820293|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
48600321|NCT02493517|156391602|FG001|Overall Study|Withdrawal by Subject|2|||
48600322|NCT02493517|156391601|FG000|Overall Study|Adverse Event|0|||
48600323|NCT02493517|156391602|FG001|Overall Study|Adverse Event|2|||
48600324|NCT02493517|156391601|FG000|Overall Study|Missed study visit|0|||
48600325|NCT02493517|156391602|FG001|Overall Study|Missed study visit|1|||
48600326|NCT01367249|156391603|FG000|Overall Study|Withdrawal by Subject|6|||
48600327|NCT01367249|156391604|FG001|Overall Study|Withdrawal by Subject|6|||
48600328|NCT01367249|156391603|FG000|Overall Study|Other|3|||
48600329|NCT01367249|156391604|FG001|Overall Study|Other|10|||
48600330|NCT02007720|156391605|FG000|Overall Study|Withdrawal by Subject|9|||
48600331|NCT02007720|156391606|FG001|Overall Study|Withdrawal by Subject|11|||
48600332|NCT02007720|156391605|FG000|Overall Study|study terminated by sponsor|58|||
48600333|NCT02007720|156391606|FG001|Overall Study|study terminated by sponsor|54|||
48600334|NCT02007720|156391605|FG000|Overall Study|technical problem|4|||
48600335|NCT02007720|156391606|FG001|Overall Study|technical problem|2|||
48600336|NCT02007720|156391605|FG000|Overall Study|patient followd less than 165 days|11|||
48600337|NCT02007720|156391606|FG001|Overall Study|patient followd less than 165 days|5|||
48600338|NCT01296412|156391608|FG000|Overall Study|Adverse Event|8|||
48725371|NCT01142089|156845024|FG000|Overall Study|Use of prohibited medications|0|||
48725372|NCT01142089|156845025|FG001|Overall Study|Use of prohibited medications|1|||
48725373|NCT01142089|156845024|FG000|Overall Study|Noncompliance with study procedures|2|||
48725374|NCT01142089|156845025|FG001|Overall Study|Noncompliance with study procedures|1|||
48725375|NCT01142089|156845024|FG000|Overall Study|Patient required rescue medication|8|||
48600339|NCT01296412|156391609|FG001|Overall Study|Adverse Event|29|||
48600340|NCT01296412|156391608|FG000|Overall Study|Lack of Efficacy|1|||
48600341|NCT01296412|156391609|FG001|Overall Study|Lack of Efficacy|0|||
48600342|NCT01296412|156391608|FG000|Overall Study|Lost to Follow-up|10|||
48725376|NCT01142089|156845025|FG001|Overall Study|Patient required rescue medication|17|||
48506048|NCT01029340|156046443|FG004|Extension Period|Adverse Event|0|||
48506049|NCT01029340|156046444|FG005|Extension Period|Adverse Event|1|||
48506050|NCT01029340|156046439|FG000|Extension Period|starting another study|0|||
48506051|NCT01029340|156046440|FG001|Extension Period|starting another study|0|||
48506052|NCT01029340|156046441|FG002|Extension Period|starting another study|0|||
48506053|NCT01029340|156046442|FG003|Extension Period|starting another study|0|||
48506054|NCT01029340|156046443|FG004|Extension Period|starting another study|0|||
48506055|NCT01029340|156046444|FG005|Extension Period|starting another study|8|||
48506056|NCT01029340|156046439|FG000|Extension Period|non-compliance|0|||
48506057|NCT01029340|156046440|FG001|Extension Period|non-compliance|0|||
48506058|NCT01029340|156046441|FG002|Extension Period|non-compliance|0|||
48506059|NCT01029340|156046442|FG003|Extension Period|non-compliance|0|||
48506060|NCT01029340|156046443|FG004|Extension Period|non-compliance|0|||
48506061|NCT01029340|156046444|FG005|Extension Period|non-compliance|1|||
48506062|NCT01029340|156046439|FG000|Extension Period|Withdrawal by Subject|0|||
48506063|NCT01029340|156046440|FG001|Extension Period|Withdrawal by Subject|0|||
48506064|NCT01029340|156046441|FG002|Extension Period|Withdrawal by Subject|0|||
48506065|NCT01029340|156046442|FG003|Extension Period|Withdrawal by Subject|0|||
48506066|NCT01029340|156046443|FG004|Extension Period|Withdrawal by Subject|0|||
48506067|NCT01029340|156046444|FG005|Extension Period|Withdrawal by Subject|1|||
48506068|NCT01029340|156046439|FG000|Extension Period|Physician Decision|0|||
48506069|NCT01029340|156046440|FG001|Extension Period|Physician Decision|0|||
48506070|NCT01029340|156046441|FG002|Extension Period|Physician Decision|0|||
48506071|NCT01029340|156046442|FG003|Extension Period|Physician Decision|0|||
48506072|NCT01029340|156046443|FG004|Extension Period|Physician Decision|0|||
48506073|NCT01029340|156046444|FG005|Extension Period|Physician Decision|1|||
48506074|NCT00268905|156046445|FG000|Overall Study|Adverse Event|3|||
48506075|NCT00268905|156046446|FG001|Overall Study|Adverse Event|0|||
48506076|NCT00268905|156046447|FG002|Overall Study|Adverse Event|4|||
48506077|NCT00268905|156046445|FG000|Overall Study|Lost to Follow-up|0|||
48506078|NCT00268905|156046446|FG001|Overall Study|Lost to Follow-up|1|||
48506079|NCT00268905|156046447|FG002|Overall Study|Lost to Follow-up|0|||
48506080|NCT00268905|156046445|FG000|Overall Study|Withdrawal by Subject|0|||
48506081|NCT00268905|156046446|FG001|Overall Study|Withdrawal by Subject|0|||
48506082|NCT00268905|156046447|FG002|Overall Study|Withdrawal by Subject|3|||
48506083|NCT00268905|156046445|FG000|Overall Study|Progressive Disease|28|||
48506084|NCT00268905|156046446|FG001|Overall Study|Progressive Disease|4|||
48506085|NCT00268905|156046447|FG002|Overall Study|Progressive Disease|3|||
48506086|NCT00268905|156046445|FG000|Overall Study|Physician Decision|3|||
48506087|NCT00268905|156046446|FG001|Overall Study|Physician Decision|0|||
48506088|NCT00268905|156046447|FG002|Overall Study|Physician Decision|1|||
48506089|NCT00268905|156046445|FG000|Overall Study|Clinical Progression|9|||
48725377|NCT02582255|156845026|FG000|Overall Study|Protocol Violation|0|||
48725378|NCT02582255|156845027|FG001|Overall Study|Protocol Violation|3|||
48725379|NCT01879579|156845028|FG000|Overall Study|Phone incompatible with texting platform|3|||
48725380|NCT01879579|156845029|FG001|Overall Study|Phone incompatible with texting platform|0|||
48725381|NCT01879579|156845028|FG000|Overall Study|Did not enroll in texting platform|1|||
48725382|NCT01879579|156845029|FG001|Overall Study|Did not enroll in texting platform|0|||
48725383|NCT01879579|156845028|FG000|Overall Study|Did not initiate insulin treatment|1|||
48725384|NCT01879579|156845029|FG001|Overall Study|Did not initiate insulin treatment|0|||
48725385|NCT01879579|156845028|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
48725386|NCT01879579|156845029|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
48725387|NCT01879579|156845028|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
48725388|NCT01879579|156845029|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
48725389|NCT02093351|156845031|FG000|Part A|Adverse Event|0|||
48725390|NCT02093351|156845032|FG001|Part A|Adverse Event|1|||
48725391|NCT02093351|156845033|FG002|Part A|Adverse Event|1|||
48725392|NCT02093351|156845034|FG003|Part A|Adverse Event|0|||
48725393|NCT02093351|156845031|FG000|Part A|Condition under investigation worsened|2|||
48725394|NCT02093351|156845032|FG001|Part A|Condition under investigation worsened|0|||
48725395|NCT02093351|156845033|FG002|Part A|Condition under investigation worsened|2|||
48725396|NCT02093351|156845034|FG003|Part A|Condition under investigation worsened|0|||
48725397|NCT02093351|156845031|FG000|Part A|Death|0|||
48725398|NCT02093351|156845032|FG001|Part A|Death|1|||
48506090|NCT00268905|156046446|FG001|Overall Study|Clinical Progression|4|||
48506091|NCT00268905|156046447|FG002|Overall Study|Clinical Progression|1|||
48506092|NCT02648347|156046448|FG000|Overall Study|Death|174|||
48506093|NCT02648347|156046449|FG001|Overall Study|Death|167|||
48506094|NCT02648347|156046448|FG000|Overall Study|Withdrawal by Subject|16|||
48506095|NCT02648347|156046449|FG001|Overall Study|Withdrawal by Subject|9|||
48506096|NCT02648347|156046448|FG000|Overall Study|Lost to Follow-up|18|||
48506097|NCT02648347|156046449|FG001|Overall Study|Lost to Follow-up|21|||
48506098|NCT02648347|156046448|FG000|Overall Study|Missing|1|||
48506099|NCT02648347|156046449|FG001|Overall Study|Missing|0|||
48725399|NCT02093351|156845033|FG002|Part A|Death|0|||
48725400|NCT02093351|156845034|FG003|Part A|Death|0|||
48725401|NCT02093351|156845031|FG000|Part B|Patient decision|0|||
48725402|NCT02093351|156845032|FG001|Part B|Patient decision|0|||
48820294|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
48820295|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
48820296|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
48820297|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
48820298|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
48820299|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
48820300|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
48820301|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
48820302|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
48820303|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
48820304|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
48820305|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
48820306|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
48820307|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
48820308|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
48820309|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
48820310|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
48820311|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
48820312|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
48820313|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
48820314|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
48820315|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
48820316|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
48820317|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
48820318|NCT03890120|157185467|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
48820319|NCT03890120|157185468|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
48820320|NCT03890120|157185469|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
48820321|NCT03890120|157185470|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
48820322|NCT03890120|157185467|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
48820323|NCT03890120|157185468|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
48820324|NCT03890120|157185469|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
48820325|NCT03890120|157185470|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
48820326|NCT03890120|157185467|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
48820327|NCT03890120|157185468|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
48820328|NCT03890120|157185469|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
48820329|NCT03890120|157185470|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
48820330|NCT03890120|157185467|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
48820331|NCT03890120|157185468|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
48820332|NCT03890120|157185469|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
48820333|NCT03890120|157185470|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
48820334|NCT03890120|157185467|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
48820335|NCT03890120|157185468|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
48820336|NCT03890120|157185469|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
48820337|NCT03890120|157185470|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
48820338|NCT02400307|157185477|FG000|Overall Study|Enrolled and Never Dosed|1|||
48820339|NCT02400307|157185478|FG001|Overall Study|Enrolled and Never Dosed|0|||
48820340|NCT03101592|157185485|FG000|Overall Study|participant files could not be located|111|||
48820341|NCT03101592|157185486|FG001|Overall Study|participant files could not be located|170|||
48820342|NCT03101592|157185487|FG002|Overall Study|participant files could not be located|118|||
48820343|NCT03255941|157185488|FG000|Overall Study|Not eligible or refused injection|37|||
48820344|NCT03255941|157185489|FG001|Overall Study|Not eligible or refused injection|44|||
48820345|NCT03255941|157185490|FG002|Overall Study|Not eligible or refused injection|5|||
48820346|NCT03255941|157185491|FG003|Overall Study|Not eligible or refused injection|6|||
48820347|NCT03255941|157185488|FG000|Overall Study|Did not complete exit interview|1|||
48820348|NCT03255941|157185489|FG001|Overall Study|Did not complete exit interview|2|||
48820349|NCT03255941|157185490|FG002|Overall Study|Did not complete exit interview|0|||
48820350|NCT03255941|157185491|FG003|Overall Study|Did not complete exit interview|0|||
48820351|NCT01052662|157185492|FG000|Overall Study|Lost to Follow-up|15|||
48820352|NCT01052662|157185493|FG001|Overall Study|Lost to Follow-up|13|||
48506100|NCT03546842|156046454|FG000|Overall Study|Protocol Violation|1|||
48506101|NCT03546842|156046454|FG000|Overall Study|Withdrawal by Subject|2|||
48506102|NCT02739997|156046457|FG000|Overall Study|Death|1|||
48506103|NCT02739997|156046457|FG000|Overall Study|Withdrawal by Subject|1|||
48506104|NCT00617305|156046458|FG000|Overall Study|Adverse Event|4|||
48506105|NCT00617305|156046459|FG001|Overall Study|Adverse Event|0|||
48506106|NCT00617305|156046460|FG002|Overall Study|Adverse Event|0|||
48506107|NCT00617305|156046458|FG000|Overall Study|Death|1|||
48506108|NCT00617305|156046459|FG001|Overall Study|Death|0|||
48506109|NCT00617305|156046460|FG002|Overall Study|Death|0|||
48506110|NCT00617305|156046458|FG000|Overall Study|Physician Decision|1|||
48506111|NCT00617305|156046459|FG001|Overall Study|Physician Decision|0|||
48725403|NCT02093351|156845033|FG002|Part B|Patient decision|0|||
48725404|NCT02093351|156845034|FG003|Part B|Patient decision|3|||
48725405|NCT02093351|156845031|FG000|Part B|Disease progression|0|||
48725406|NCT02093351|156845032|FG001|Part B|Disease progression|0|||
48725407|NCT02093351|156845033|FG002|Part B|Disease progression|0|||
48506112|NCT00617305|156046460|FG002|Overall Study|Physician Decision|0|||
48506113|NCT00617305|156046458|FG000|Overall Study|Protocol Violation|1|||
48506114|NCT00617305|156046459|FG001|Overall Study|Protocol Violation|0|||
48506115|NCT00617305|156046460|FG002|Overall Study|Protocol Violation|1|||
48506116|NCT00617305|156046458|FG000|Overall Study|Withdrawal by Subject|1|||
48506117|NCT00617305|156046459|FG001|Overall Study|Withdrawal by Subject|0|||
48506118|NCT00617305|156046460|FG002|Overall Study|Withdrawal by Subject|0|||
48506119|NCT00468286|156046461|FG000|Overall Study|Adverse Event|1|||
48506120|NCT00468286|156046462|FG001|Overall Study|Adverse Event|6|||
48506121|NCT00468286|156046461|FG000|Overall Study|Protocol Violation|2|||
48506122|NCT00468286|156046462|FG001|Overall Study|Protocol Violation|2|||
48506123|NCT00468286|156046461|FG000|Overall Study|Withdrawal by Subject|4|||
48506124|NCT00468286|156046462|FG001|Overall Study|Withdrawal by Subject|3|||
48506125|NCT00468286|156046461|FG000|Overall Study|Physician Decision|0|||
48506126|NCT00468286|156046462|FG001|Overall Study|Physician Decision|1|||
48506127|NCT02751528|156046473|FG000|Overall Study|Withdrawal by Subject|1|||
48506128|NCT02751528|156046473|FG000|Overall Study|Adverse Event|1|||
48506129|NCT04720664|156047808|FG000|Overall Study|Adverse Event|2|||
48506130|NCT04720664|156047808|FG000|Overall Study|Lack of Efficacy|9|||
48506131|NCT04188106|156047815|FG000|Overall Study|Lost to Follow-up|5|||
48506132|NCT04188106|156047815|FG000|Overall Study|Non-Compliance|1|||
48506133|NCT00485472|156047816|FG000|Overall Study|Adverse Event|8|||
48506134|NCT00485472|156047817|FG001|Overall Study|Adverse Event|5|||
48506135|NCT00485472|156047816|FG000|Overall Study|Lack of Efficacy|5|||
48506136|NCT00485472|156047817|FG001|Overall Study|Lack of Efficacy|4|||
48506137|NCT00485472|156047816|FG000|Overall Study|Withdrawal by Subject|1|||
48506138|NCT00485472|156047817|FG001|Overall Study|Withdrawal by Subject|0|||
48506139|NCT00485472|156047816|FG000|Overall Study|Protocol Violation|0|||
48506140|NCT00485472|156047817|FG001|Overall Study|Protocol Violation|1|||
48506141|NCT00485472|156047816|FG000|Overall Study|Other|2|||
48506142|NCT00485472|156047817|FG001|Overall Study|Other|1|||
48506143|NCT00485472|156047816|FG000|Overall Study|Lost to Follow-up|0|||
48506144|NCT00485472|156047817|FG001|Overall Study|Lost to Follow-up|1|||
48506145|NCT00746798|156047818|FG000|Overall Study|Protocol Violation|0|||
48506146|NCT00746798|156047819|FG001|Overall Study|Protocol Violation|1|||
48506147|NCT00746798|156047820|FG002|Overall Study|Protocol Violation|0|||
48506148|NCT00746798|156047821|FG003|Overall Study|Protocol Violation|0|||
48506149|NCT00746798|156047818|FG000|Overall Study|Withdrawal by Subject|0|||
48506150|NCT00746798|156047819|FG001|Overall Study|Withdrawal by Subject|1|||
48506151|NCT00746798|156047820|FG002|Overall Study|Withdrawal by Subject|1|||
48506152|NCT00746798|156047821|FG003|Overall Study|Withdrawal by Subject|0|||
48506153|NCT00746798|156047818|FG000|Overall Study|Death|0|||
48506154|NCT00746798|156047819|FG001|Overall Study|Death|0|||
48506155|NCT00746798|156047820|FG002|Overall Study|Death|2|||
48506156|NCT00746798|156047821|FG003|Overall Study|Death|0|||
48506157|NCT00746798|156047818|FG000|Overall Study|Participant unable to return for visit|1|||
48506158|NCT00746798|156047819|FG001|Overall Study|Participant unable to return for visit|0|||
48506159|NCT00746798|156047820|FG002|Overall Study|Participant unable to return for visit|0|||
48506160|NCT00746798|156047821|FG003|Overall Study|Participant unable to return for visit|0|||
48506161|NCT02262377|156047824|FG000|Overall Study|Lost to Follow-up|5|||
48506162|NCT02262377|156047825|FG001|Overall Study|Lost to Follow-up|6|||
48506163|NCT02262377|156047824|FG000|Overall Study|Found ineligible after enrollment|3|||
48506164|NCT02262377|156047825|FG001|Overall Study|Found ineligible after enrollment|0|||
48600343|NCT01296412|156391609|FG001|Overall Study|Lost to Follow-up|7|||
48600344|NCT01296412|156391608|FG000|Overall Study|Non-compliance with study drug|1|||
48725408|NCT02093351|156845034|FG003|Part B|Disease progression|4|||
48725409|NCT02093351|156845031|FG000|Part B|Complete response|0|||
48725410|NCT02093351|156845032|FG001|Part B|Complete response|0|||
48725411|NCT02093351|156845033|FG002|Part B|Complete response|0|||
48725412|NCT02093351|156845034|FG003|Part B|Complete response|1|||
48725413|NCT02093351|156845031|FG000|Part B|Adverse event + disease progression|0|||
48506165|NCT02262377|156047824|FG000|Overall Study|Withdrawal by Subject|4|||
48506166|NCT02262377|156047825|FG001|Overall Study|Withdrawal by Subject|0|||
48725414|NCT02093351|156845032|FG001|Part B|Adverse event + disease progression|0|||
48725415|NCT02093351|156845033|FG002|Part B|Adverse event + disease progression|0|||
48506167|NCT00437658|156047826|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
48506168|NCT00437658|156047827|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
48506169|NCT00437658|156047828|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
48725416|NCT02093351|156845034|FG003|Part B|Adverse event + disease progression|1|||
48820353|NCT01052662|157185494|FG002|Overall Study|Lost to Follow-up|18|||
48506170|NCT00437658|156047826|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
48506171|NCT00437658|156047827|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
48506172|NCT00437658|156047828|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
48506173|NCT00437658|156047826|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
48506174|NCT00437658|156047827|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
48506175|NCT00437658|156047828|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
48506176|NCT00437658|156047826|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
48506177|NCT00437658|156047827|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
48506178|NCT00437658|156047828|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
48506179|NCT00437658|156047826|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
48506180|NCT00437658|156047827|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
48506181|NCT00437658|156047828|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
48506182|NCT00437658|156047826|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
48506183|NCT00437658|156047827|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
48506184|NCT00437658|156047828|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
48725417|NCT02093351|156845031|FG000|Part B|Lack of therapeutic response|0|||
48725418|NCT02093351|156845032|FG001|Part B|Lack of therapeutic response|0|||
48725419|NCT02093351|156845033|FG002|Part B|Lack of therapeutic response|0|||
48725420|NCT02093351|156845034|FG003|Part B|Lack of therapeutic response|12|||
48725421|NCT02093351|156845031|FG000|Part B|Condition under investigation worsened|0|||
48725422|NCT02093351|156845032|FG001|Part B|Condition under investigation worsened|0|||
48725423|NCT02093351|156845033|FG002|Part B|Condition under investigation worsened|0|||
48725424|NCT02093351|156845034|FG003|Part B|Condition under investigation worsened|39|||
48725425|NCT02093351|156845031|FG000|Part B|Adverse Event|0|||
48725426|NCT02093351|156845032|FG001|Part B|Adverse Event|0|||
48725427|NCT02093351|156845033|FG002|Part B|Adverse Event|0|||
48725428|NCT02093351|156845034|FG003|Part B|Adverse Event|2|||
48725429|NCT02093351|156845031|FG000|Part B|Death|0|||
48725430|NCT02093351|156845032|FG001|Part B|Death|0|||
48725431|NCT02093351|156845033|FG002|Part B|Death|0|||
48725432|NCT02093351|156845034|FG003|Part B|Death|1|||
48725433|NCT00706849|156845041|FG000|Treatment Period|Adverse Event|0|||
48725434|NCT00706849|156845042|FG001|Treatment Period|Adverse Event|9|||
48725435|NCT00706849|156845041|FG000|Treatment Period|Other|0|||
48725436|NCT00706849|156845042|FG001|Treatment Period|Other|1|||
48725437|NCT00706849|156845041|FG000|Follow-up Period|Withdrawal by Subject|0|||
48725438|NCT00706849|156845042|FG001|Follow-up Period|Withdrawal by Subject|2|||
48725439|NCT00706849|156845041|FG000|Follow-up Period|Protocol non-compliance|0|||
48725440|NCT00706849|156845042|FG001|Follow-up Period|Protocol non-compliance|1|||
48725441|NCT00588952|156845043|FG000|Overall Study|Adverse Event|0|||
48725442|NCT00588952|156845044|FG001|Overall Study|Adverse Event|2|||
48725443|NCT00588952|156845043|FG000|Overall Study|Withdrawal by Subject|3|||
48725444|NCT00588952|156845044|FG001|Overall Study|Withdrawal by Subject|5|||
48725445|NCT01461057|156845045|FG000|Overall Study|Death|10|||
48725446|NCT01461057|156845046|FG001|Overall Study|Death|9|||
48725447|NCT01461057|156845045|FG000|Overall Study|Withdrawal by Subject|2|||
48725448|NCT01461057|156845046|FG001|Overall Study|Withdrawal by Subject|3|||
48725449|NCT01461057|156845045|FG000|Overall Study|Physician Decision|0|||
48725450|NCT01461057|156845046|FG001|Overall Study|Physician Decision|2|||
48725451|NCT01461057|156845045|FG000|Overall Study|Adverse Event|0|||
48725452|NCT01461057|156845046|FG001|Overall Study|Adverse Event|1|||
48725453|NCT01461057|156845045|FG000|Overall Study|Progression of Disease|1|||
48725454|NCT01461057|156845046|FG001|Overall Study|Progression of Disease|0|||
48725455|NCT01461057|156845045|FG000|Overall Study|Study Terminated by Sponsor|2|||
48725456|NCT01461057|156845046|FG001|Overall Study|Study Terminated by Sponsor|0|||
48725457|NCT00039871|156845047|FG000|Overall Study|Adverse Event|165|||
48725458|NCT00039871|156845047|FG000|Overall Study|Lost to Follow-up|18|||
48725459|NCT00039871|156845047|FG000|Overall Study|Protocol Violation|24|||
48725460|NCT00039871|156845047|FG000|Overall Study|Withdrawal by Subject|97|||
48725461|NCT00039871|156845047|FG000|Overall Study|Did not meet eligibility criteria|11|||
48725462|NCT00039871|156845047|FG000|Overall Study|Administrative|1|||
48725463|NCT00039871|156845047|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
48725464|NCT00039871|156845047|FG000|Overall Study|Never entered follow-up|7|||
48725465|NCT03361176|156845052|FG000|Overall Study|Lost to Follow-up|1|||
48725466|NCT03361176|156845053|FG001|Overall Study|Lost to Follow-up|2|||
48725467|NCT03361176|156845052|FG000|Overall Study|Adverse Event|0|||
48725468|NCT03361176|156845053|FG001|Overall Study|Adverse Event|2|||
48725469|NCT03361176|156845052|FG000|Overall Study|Withdrawal by Subject|0|||
48725470|NCT03361176|156845053|FG001|Overall Study|Withdrawal by Subject|1|||
48725471|NCT03718299|156845054|FG000|Overall Study|Adverse Event|1|||
48725472|NCT03718299|156845054|FG000|Overall Study|Withdrawal by Subject|6|||
48725473|NCT03718299|156845054|FG000|Overall Study|Physician Decision|2|||
48725474|NCT03718299|156845054|FG000|Overall Study|Lost to Follow-up|1|||
48725475|NCT03123185|156845055|FG000|Overall Study|Withdrawal by Subject|0|||
48725476|NCT03123185|156845056|FG001|Overall Study|Withdrawal by Subject|0|||
48725477|NCT03123185|156845057|FG002|Overall Study|Withdrawal by Subject|0|||
48725478|NCT03123185|156845058|FG003|Overall Study|Withdrawal by Subject|0|||
48506185|NCT00437658|156047826|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
48506186|NCT00437658|156047827|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
48506187|NCT00437658|156047828|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
48506188|NCT00437658|156047826|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
48506189|NCT00437658|156047827|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
48506190|NCT00437658|156047828|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
48506191|NCT00437658|156047826|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
48506192|NCT00437658|156047827|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
48600345|NCT01296412|156391609|FG001|Overall Study|Non-compliance with study drug|2|||
48600346|NCT01296412|156391608|FG000|Overall Study|Other reason not specified|20|||
48600347|NCT01296412|156391609|FG001|Overall Study|Other reason not specified|15|||
48600348|NCT01296412|156391608|FG000|Overall Study|Physician Decision|1|||
48600349|NCT01296412|156391609|FG001|Overall Study|Physician Decision|3|||
48600350|NCT01296412|156391608|FG000|Overall Study|Pregnancy|0|||
48600351|NCT01296412|156391609|FG001|Overall Study|Pregnancy|1|||
48725479|NCT03123185|156845059|FG004|Overall Study|Withdrawal by Subject|0|||
48725480|NCT03123185|156845060|FG005|Overall Study|Withdrawal by Subject|0|||
48725481|NCT03123185|156845061|FG006|Overall Study|Withdrawal by Subject|0|||
48725482|NCT03123185|156845062|FG007|Overall Study|Withdrawal by Subject|0|||
48725483|NCT03123185|156845063|FG008|Overall Study|Withdrawal by Subject|0|||
48725484|NCT03123185|156845064|FG009|Overall Study|Withdrawal by Subject|0|||
48725485|NCT03123185|156845065|FG010|Overall Study|Withdrawal by Subject|0|||
48725486|NCT03123185|156845066|FG011|Overall Study|Withdrawal by Subject|0|||
48725487|NCT03123185|156845067|FG012|Overall Study|Withdrawal by Subject|1|||
48725488|NCT03123185|156845068|FG013|Overall Study|Withdrawal by Subject|0|||
48725489|NCT04352127|156845075|FG000|Overall Study|Unable to obtain readings|4|||
48725490|NCT04352127|156845076|FG001|Overall Study|Unable to obtain readings|1|||
48725491|NCT04535167|156845079|FG000|Treatment|Adverse Event|0|||
48725492|NCT04535167|156845080|FG001|Treatment|Adverse Event|0|||
48725493|NCT04535167|156845081|FG002|Treatment|Adverse Event|0|||
48725494|NCT04535167|156845082|FG003|Treatment|Adverse Event|0|||
48725495|NCT04535167|156845083|FG004|Treatment|Adverse Event|0|||
48725496|NCT04535167|156845084|FG005|Treatment|Adverse Event|0|||
48725497|NCT04535167|156845085|FG006|Treatment|Adverse Event|1|||
48725498|NCT04535167|156845079|FG000|Follow-Up|Death|0|||
48725499|NCT04535167|156845080|FG001|Follow-Up|Death|0|||
48725500|NCT04535167|156845081|FG002|Follow-Up|Death|0|||
48725501|NCT04535167|156845082|FG003|Follow-Up|Death|0|||
48725502|NCT04535167|156845083|FG004|Follow-Up|Death|0|||
48725503|NCT04535167|156845084|FG005|Follow-Up|Death|0|||
48725504|NCT04535167|156845085|FG006|Follow-Up|Death|1|||
48725505|NCT04535167|156845079|FG000|Follow-Up|Lost to Follow-up|0|||
48725506|NCT04535167|156845080|FG001|Follow-Up|Lost to Follow-up|0|||
48725507|NCT04535167|156845081|FG002|Follow-Up|Lost to Follow-up|0|||
48725508|NCT04535167|156845082|FG003|Follow-Up|Lost to Follow-up|1|||
48725509|NCT04535167|156845083|FG004|Follow-Up|Lost to Follow-up|0|||
48725510|NCT04535167|156845084|FG005|Follow-Up|Lost to Follow-up|0|||
48725511|NCT04535167|156845085|FG006|Follow-Up|Lost to Follow-up|0|||
48725512|NCT03584373|156845088|FG000|Overall Study|Lost to Follow-up|7|||
48725513|NCT03584373|156845089|FG001|Overall Study|Lost to Follow-up|8|||
48725514|NCT01487577|156845090|FG000|Overall Study|Became ineligible after signing consent|1|||
48725515|NCT04369924|156845091|FG000|Overall Study|Lost to Follow-up|302|||
48725516|NCT04369924|156845092|FG001|Overall Study|Lost to Follow-up|339|||
48725517|NCT01850602|156845094|FG000|Overall Study|Adverse Event|7|||
48725518|NCT01850602|156845095|FG001|Overall Study|Adverse Event|10|||
48725519|NCT01850602|156845094|FG000|Overall Study|Physician Decision|2|||
48725520|NCT01850602|156845095|FG001|Overall Study|Physician Decision|1|||
48725521|NCT01850602|156845094|FG000|Overall Study|Withdrawal by Subject|2|||
48725522|NCT01850602|156845095|FG001|Overall Study|Withdrawal by Subject|4|||
48725523|NCT01850602|156845094|FG000|Overall Study|Decrease in serum calcium|2|||
48725524|NCT01850602|156845095|FG001|Overall Study|Decrease in serum calcium|3|||
48725525|NCT01850602|156845094|FG000|Overall Study|Increase in serum ferritin|1|||
48725526|NCT01850602|156845095|FG001|Overall Study|Increase in serum ferritin|0|||
48725527|NCT01209832|156845096|FG000|Period 1|Sponsor Decision and was not dosed|1|||
48725528|NCT01209832|156845096|FG000|Period 2|Sponsor Decision|1|||
48725529|NCT02360605|156845098|FG000|Overall Study|Withdrawal by Subject|4|||
48725530|NCT02360605|156845099|FG001|Overall Study|Withdrawal by Subject|9|||
48725531|NCT02360605|156845098|FG000|Overall Study|Lost to Follow-up|7|||
48725532|NCT02360605|156845099|FG001|Overall Study|Lost to Follow-up|8|||
48725533|NCT02360605|156845098|FG000|Overall Study|Death|0|||
48725534|NCT02360605|156845099|FG001|Overall Study|Death|1|||
48725535|NCT01933789|156845100|FG000|Overall Study|Death|0|||
48600352|NCT01296412|156391608|FG000|Overall Study|Withdrawal by Subject|10|||
48725536|NCT01933789|156845101|FG001|Overall Study|Death|0|||
48600353|NCT01296412|156391609|FG001|Overall Study|Withdrawal by Subject|13|||
48725537|NCT01933789|156845102|FG002|Overall Study|Death|0|||
48725538|NCT01933789|156845103|FG003|Overall Study|Death|0|||
48725539|NCT01933789|156845104|FG004|Overall Study|Death|21|||
48725540|NCT01933789|156845105|FG005|Overall Study|Death|32|||
48725541|NCT01933789|156845106|FG006|Overall Study|Death|0|||
48725542|NCT01933789|156845107|FG007|Overall Study|Death|0|||
48725543|NCT01933789|156845108|FG008|Overall Study|Death|0|||
48725544|NCT01933789|156845100|FG000|Overall Study|Lost to Follow-up|0|||
48725545|NCT01933789|156845101|FG001|Overall Study|Lost to Follow-up|0|||
48725546|NCT01933789|156845102|FG002|Overall Study|Lost to Follow-up|0|||
48725547|NCT01933789|156845103|FG003|Overall Study|Lost to Follow-up|1|||
48725548|NCT01933789|156845104|FG004|Overall Study|Lost to Follow-up|8|||
48725549|NCT01933789|156845105|FG005|Overall Study|Lost to Follow-up|9|||
48725550|NCT01933789|156845106|FG006|Overall Study|Lost to Follow-up|1|||
48725551|NCT01933789|156845107|FG007|Overall Study|Lost to Follow-up|4|||
48725552|NCT01933789|156845108|FG008|Overall Study|Lost to Follow-up|0|||
48725553|NCT01933789|156845100|FG000|Overall Study|Withdrawal by Subject|2|||
48725554|NCT01933789|156845101|FG001|Overall Study|Withdrawal by Subject|1|||
48725555|NCT01933789|156845102|FG002|Overall Study|Withdrawal by Subject|0|||
48725556|NCT01933789|156845103|FG003|Overall Study|Withdrawal by Subject|0|||
48725557|NCT01933789|156845104|FG004|Overall Study|Withdrawal by Subject|17|||
48725558|NCT01933789|156845105|FG005|Overall Study|Withdrawal by Subject|16|||
48725559|NCT01933789|156845106|FG006|Overall Study|Withdrawal by Subject|1|||
48725560|NCT01933789|156845107|FG007|Overall Study|Withdrawal by Subject|4|||
48725561|NCT01933789|156845108|FG008|Overall Study|Withdrawal by Subject|0|||
48725562|NCT01933789|156845100|FG000|Overall Study|Became Ineligible|4|||
48725563|NCT01933789|156845101|FG001|Overall Study|Became Ineligible|0|||
48725564|NCT01933789|156845102|FG002|Overall Study|Became Ineligible|0|||
48725565|NCT01933789|156845103|FG003|Overall Study|Became Ineligible|0|||
48725566|NCT01933789|156845104|FG004|Overall Study|Became Ineligible|13|||
48725567|NCT01933789|156845105|FG005|Overall Study|Became Ineligible|10|||
48725568|NCT01933789|156845106|FG006|Overall Study|Became Ineligible|13|||
48725569|NCT01933789|156845107|FG007|Overall Study|Became Ineligible|6|||
48725570|NCT01933789|156845108|FG008|Overall Study|Became Ineligible|0|||
48725571|NCT01525901|156845114|FG000|Period 2: 12 Weeks|Adverse Event|0|||
48725572|NCT01525901|156845115|FG001|Period 2: 12 Weeks|Adverse Event|1|||
48725573|NCT01525901|156845116|FG002|Period 2: 12 Weeks|Adverse Event|0|||
48725574|NCT01525901|156845117|FG003|Period 2: 12 Weeks|Adverse Event|0|||
48725575|NCT04449029|156845118|FG000|Overall Study|Adverse Event|0|||
48725576|NCT04449029|156845119|FG001|Overall Study|Adverse Event|1|||
48725577|NCT04449029|156845120|FG002|Overall Study|Adverse Event|1|||
48725578|NCT04449029|156845121|FG003|Overall Study|Adverse Event|0|||
48725579|NCT04449029|156845122|FG004|Overall Study|Adverse Event|1|||
48725580|NCT04449029|156845123|FG005|Overall Study|Adverse Event|0|||
48725581|NCT04449029|156845124|FG006|Overall Study|Adverse Event|1|||
48725582|NCT04449029|156845125|FG007|Overall Study|Adverse Event|0|||
48725583|NCT04449029|156845118|FG000|Overall Study|Lost to Follow-up|0|||
48725584|NCT04449029|156845119|FG001|Overall Study|Lost to Follow-up|1|||
48725585|NCT04449029|156845120|FG002|Overall Study|Lost to Follow-up|0|||
48725586|NCT04449029|156845121|FG003|Overall Study|Lost to Follow-up|0|||
48725587|NCT04449029|156845122|FG004|Overall Study|Lost to Follow-up|0|||
48725588|NCT04449029|156845123|FG005|Overall Study|Lost to Follow-up|0|||
48725589|NCT04449029|156845124|FG006|Overall Study|Lost to Follow-up|0|||
48725590|NCT04449029|156845125|FG007|Overall Study|Lost to Follow-up|0|||
48725591|NCT04449029|156845118|FG000|Overall Study|Protocol Violation|0|||
48725592|NCT04449029|156845119|FG001|Overall Study|Protocol Violation|1|||
48725593|NCT04449029|156845120|FG002|Overall Study|Protocol Violation|0|||
48725594|NCT04449029|156845121|FG003|Overall Study|Protocol Violation|0|||
48725595|NCT04449029|156845122|FG004|Overall Study|Protocol Violation|0|||
48725596|NCT04449029|156845123|FG005|Overall Study|Protocol Violation|0|||
48725597|NCT04449029|156845124|FG006|Overall Study|Protocol Violation|0|||
48725598|NCT04449029|156845125|FG007|Overall Study|Protocol Violation|0|||
48725599|NCT04449029|156845118|FG000|Overall Study|Physician Decision|0|||
48725600|NCT04449029|156845119|FG001|Overall Study|Physician Decision|0|||
48725601|NCT04449029|156845120|FG002|Overall Study|Physician Decision|0|||
48725602|NCT04449029|156845121|FG003|Overall Study|Physician Decision|0|||
48725603|NCT04449029|156845122|FG004|Overall Study|Physician Decision|0|||
48725604|NCT04449029|156845123|FG005|Overall Study|Physician Decision|1|||
48725605|NCT04449029|156845124|FG006|Overall Study|Physician Decision|0|||
48725606|NCT04449029|156845125|FG007|Overall Study|Physician Decision|0|||
48725607|NCT04449029|156845118|FG000|Overall Study|Withdrawal by Subject|3|||
48725608|NCT04449029|156845119|FG001|Overall Study|Withdrawal by Subject|0|||
48725609|NCT04449029|156845120|FG002|Overall Study|Withdrawal by Subject|1|||
48725610|NCT04449029|156845121|FG003|Overall Study|Withdrawal by Subject|1|||
48725611|NCT04449029|156845122|FG004|Overall Study|Withdrawal by Subject|5|||
48725612|NCT04449029|156845123|FG005|Overall Study|Withdrawal by Subject|1|||
48725613|NCT04449029|156845124|FG006|Overall Study|Withdrawal by Subject|4|||
48725614|NCT04449029|156845125|FG007|Overall Study|Withdrawal by Subject|0|||
48725615|NCT03901456|156845126|FG000|Overall Study|Withdrawal by Subject|0|||
48725616|NCT03901456|156845127|FG001|Overall Study|Withdrawal by Subject|0|||
48725617|NCT03901456|156845128|FG002|Overall Study|Withdrawal by Subject|1|||
48725618|NCT03901456|156845126|FG000|Overall Study|Lost to Follow-up|0|||
48725619|NCT03901456|156845127|FG001|Overall Study|Lost to Follow-up|1|||
48725620|NCT03901456|156845128|FG002|Overall Study|Lost to Follow-up|0|||
48725621|NCT00814801|156845137|FG000|Overall Study|Adverse Event|15|||
48506193|NCT00437658|156047828|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
48506194|NCT00437658|156047826|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
48820354|NCT01052662|157185492|FG000|Overall Study|Withdrawal by Subject|3|||
48820355|NCT01052662|157185493|FG001|Overall Study|Withdrawal by Subject|2|||
48820356|NCT01052662|157185494|FG002|Overall Study|Withdrawal by Subject|1|||
48820357|NCT01052662|157185492|FG000|Overall Study|Pharmacy issue|1|||
48820358|NCT01052662|157185493|FG001|Overall Study|Pharmacy issue|3|||
48820359|NCT01052662|157185494|FG002|Overall Study|Pharmacy issue|3|||
48820360|NCT01052662|157185492|FG000|Overall Study|Adverse Event|1|||
48820361|NCT01052662|157185493|FG001|Overall Study|Adverse Event|1|||
48820362|NCT01052662|157185494|FG002|Overall Study|Adverse Event|0|||
48820363|NCT01052662|157185492|FG000|Overall Study|Legal Problem|2|||
48820364|NCT01052662|157185493|FG001|Overall Study|Legal Problem|0|||
48820365|NCT01052662|157185494|FG002|Overall Study|Legal Problem|0|||
48820366|NCT01052662|157185492|FG000|Overall Study|Administrative|0|||
48820367|NCT01052662|157185493|FG001|Overall Study|Administrative|3|||
48820368|NCT01052662|157185494|FG002|Overall Study|Administrative|0|||
48820369|NCT03523871|157185495|FG000|Overall Study|Death|1|||
48820370|NCT00372060|157185496|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
48820371|NCT00372060|157185497|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
48820372|NCT00372060|157185496|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
48820373|NCT00372060|157185497|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
48820374|NCT00372060|157185496|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
48820375|NCT00372060|157185497|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
48820376|NCT00372060|157185496|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
48820377|NCT00372060|157185497|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
48820378|NCT00372060|157185496|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
48820379|NCT00372060|157185497|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
48820380|NCT00372060|157185496|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
48506195|NCT00437658|156047827|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
48506196|NCT00437658|156047828|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
48820381|NCT00372060|157185497|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
48820382|NCT01579578|157185500|FG000|Overall Study|Death|4|||
48820383|NCT01579578|157185501|FG001|Overall Study|Death|1|||
48820384|NCT01579578|157185500|FG000|Overall Study|Lost to Follow-up|1|||
48820385|NCT01579578|157185501|FG001|Overall Study|Lost to Follow-up|1|||
48820386|NCT01579578|157185500|FG000|Overall Study|Withdrawal by Subject|2|||
48820387|NCT01579578|157185501|FG001|Overall Study|Withdrawal by Subject|1|||
48820388|NCT01579578|157185500|FG000|Overall Study|Eligibility criteria|3|||
48820389|NCT01579578|157185501|FG001|Overall Study|Eligibility criteria|9|||
48506197|NCT00437658|156047826|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
48506198|NCT00437658|156047827|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
48506199|NCT00437658|156047828|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
48506200|NCT00437658|156047826|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
48506201|NCT00437658|156047827|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
48506202|NCT00437658|156047828|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
48506203|NCT01049334|156047829|FG000|Overall Study|Withdrawal by Subject|5|||
48506204|NCT01049334|156047830|FG001|Overall Study|Withdrawal by Subject|3|||
48506205|NCT01049334|156047829|FG000|Overall Study|Adverse Event|2|||
48506206|NCT01049334|156047830|FG001|Overall Study|Adverse Event|3|||
48506207|NCT01049334|156047829|FG000|Overall Study|Physician Decision|2|||
48506208|NCT01049334|156047830|FG001|Overall Study|Physician Decision|0|||
48506209|NCT01049334|156047829|FG000|Overall Study|Protocol Violation|0|||
48506210|NCT01049334|156047830|FG001|Overall Study|Protocol Violation|1|||
48820390|NCT01579578|157185500|FG000|Overall Study|Ongoing|3|||
48820391|NCT01579578|157185501|FG001|Overall Study|Ongoing|0|||
48820392|NCT02015663|157185503|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
48820393|NCT02015663|157185504|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
48820394|NCT02015663|157185503|FG000|Overall Study|Withdrawal by Subject|1|||
48506211|NCT02152566|156047839|FG000|Overall Study|Lost to Follow-up|1|||
48506212|NCT02152566|156047839|FG000|Overall Study|Withdrawal by Subject|2|||
48506213|NCT02495857|156047843|FG000|Overall Study|Adverse Event|5|||
48506214|NCT02495857|156047844|FG001|Overall Study|Adverse Event|0|||
48820395|NCT02015663|157185504|FG001|Overall Study|Withdrawal by Subject|0|||
48820396|NCT02015663|157185503|FG000|Overall Study|Protocol Violation|0|||
48820397|NCT02015663|157185504|FG001|Overall Study|Protocol Violation|1|||
48820398|NCT02015663|157185503|FG000|Overall Study|Adverse Event|3|||
48820399|NCT02015663|157185504|FG001|Overall Study|Adverse Event|0|||
48820400|NCT02015663|157185503|FG000|Overall Study|Administrative problems|10|||
48820401|NCT02015663|157185504|FG001|Overall Study|Administrative problems|11|||
48506215|NCT02495857|156047845|FG002|Overall Study|Adverse Event|1|||
48506216|NCT02495857|156047843|FG000|Overall Study|Withdrawal by Subject|9|||
48820402|NCT01113463|157185507|FG000|Overall Study|Physician Decision|5|||
48820403|NCT00136916|157185508|FG000|Overall Study|Never received study treatment|3|||
48820404|NCT00136916|157185509|FG001|Overall Study|Never received study treatment|5|||
48820405|NCT00136916|157185508|FG000|Overall Study|Death|1|||
48820406|NCT00136916|157185509|FG001|Overall Study|Death|3|||
48820407|NCT00136916|157185508|FG000|Overall Study|Adverse Event|27|||
48820408|NCT00136916|157185509|FG001|Overall Study|Adverse Event|8|||
48820409|NCT00136916|157185508|FG000|Overall Study|Laboratory abnormality|0|||
48820410|NCT00136916|157185509|FG001|Overall Study|Laboratory abnormality|1|||
48820411|NCT00136916|157185508|FG000|Overall Study|Lack of Efficacy|13|||
48506217|NCT02495857|156047844|FG001|Overall Study|Withdrawal by Subject|6|||
48506218|NCT02495857|156047845|FG002|Overall Study|Withdrawal by Subject|10|||
48506219|NCT02495857|156047843|FG000|Overall Study|Physician Decision|0|||
48506220|NCT02495857|156047844|FG001|Overall Study|Physician Decision|1|||
48506221|NCT02495857|156047845|FG002|Overall Study|Physician Decision|0|||
48506222|NCT02495857|156047843|FG000|Overall Study|Protocol Violation|1|||
48506223|NCT02495857|156047844|FG001|Overall Study|Protocol Violation|1|||
48506224|NCT02495857|156047845|FG002|Overall Study|Protocol Violation|2|||
48506225|NCT02495857|156047843|FG000|Overall Study|Lost to Follow-up|4|||
48506226|NCT02495857|156047844|FG001|Overall Study|Lost to Follow-up|5|||
48506227|NCT02495857|156047845|FG002|Overall Study|Lost to Follow-up|3|||
48506228|NCT02495857|156047843|FG000|Overall Study|Other|3|||
48506229|NCT02495857|156047844|FG001|Overall Study|Other|3|||
48506230|NCT02495857|156047845|FG002|Overall Study|Other|2|||
48506231|NCT00396279|156047846|FG000|Overall Study|Ongoing in study|26|||
48506232|NCT00396279|156047846|FG000|Overall Study|Disease progression|2|||
48506233|NCT00396279|156047846|FG000|Overall Study|Withdrawal by Subject|1|||
48506234|NCT00396279|156047846|FG000|Overall Study|Physician Decision|1|||
48506235|NCT02883452|156047848|FG000|Overall Study|Withdrawal by Subject|1|||
48506236|NCT02883452|156047849|FG001|Overall Study|Withdrawal by Subject|1|||
48506237|NCT02883452|156047850|FG002|Overall Study|Withdrawal by Subject|3|||
48506238|NCT02883452|156047851|FG003|Overall Study|Withdrawal by Subject|0|||
48506239|NCT02883452|156047852|FG004|Overall Study|Withdrawal by Subject|2|||
48506240|NCT02883452|156047853|FG005|Overall Study|Withdrawal by Subject|5|||
48506241|NCT02883452|156047848|FG000|Overall Study|Disease progression|1|||
48506242|NCT02883452|156047849|FG001|Overall Study|Disease progression|0|||
48506243|NCT02883452|156047850|FG002|Overall Study|Disease progression|0|||
48506244|NCT02883452|156047851|FG003|Overall Study|Disease progression|1|||
48506245|NCT02883452|156047852|FG004|Overall Study|Disease progression|4|||
48506246|NCT02883452|156047853|FG005|Overall Study|Disease progression|5|||
48506247|NCT02883452|156047848|FG000|Overall Study|Adverse Event|2|||
48506248|NCT02883452|156047849|FG001|Overall Study|Adverse Event|1|||
48506249|NCT02883452|156047850|FG002|Overall Study|Adverse Event|1|||
48506250|NCT02883452|156047851|FG003|Overall Study|Adverse Event|1|||
48506251|NCT02883452|156047852|FG004|Overall Study|Adverse Event|1|||
48506252|NCT02883452|156047853|FG005|Overall Study|Adverse Event|3|||
48506253|NCT02883452|156047848|FG000|Overall Study|Physician Decision|0|||
48506254|NCT02883452|156047849|FG001|Overall Study|Physician Decision|0|||
48506255|NCT02883452|156047850|FG002|Overall Study|Physician Decision|0|||
48506256|NCT02883452|156047851|FG003|Overall Study|Physician Decision|0|||
48506257|NCT02883452|156047852|FG004|Overall Study|Physician Decision|4|||
48506258|NCT02883452|156047853|FG005|Overall Study|Physician Decision|1|||
48506259|NCT02883452|156047848|FG000|Overall Study|Death|1|||
48506260|NCT02883452|156047849|FG001|Overall Study|Death|0|||
48506261|NCT02883452|156047850|FG002|Overall Study|Death|1|||
48506262|NCT02883452|156047851|FG003|Overall Study|Death|0|||
48506263|NCT02883452|156047852|FG004|Overall Study|Death|0|||
48506264|NCT02883452|156047853|FG005|Overall Study|Death|0|||
48725622|NCT00814801|156845138|FG001|Overall Study|Adverse Event|16|||
48506265|NCT02883452|156047848|FG000|Overall Study|Other|0|||
48506266|NCT02883452|156047849|FG001|Overall Study|Other|0|||
48506267|NCT02883452|156047850|FG002|Overall Study|Other|0|||
48506268|NCT02883452|156047851|FG003|Overall Study|Other|0|||
48506269|NCT02883452|156047852|FG004|Overall Study|Other|0|||
48506270|NCT02883452|156047853|FG005|Overall Study|Other|1|||
48506271|NCT00553280|156047857|FG000|Overall Study|Adverse Event|19|||
48506272|NCT00553280|156047857|FG000|Overall Study|Lack of Efficacy|3|||
48725623|NCT00814801|156845139|FG002|Overall Study|Adverse Event|19|||
48725624|NCT00814801|156845137|FG000|Overall Study|Withdrawal by Subject|9|||
48725625|NCT00814801|156845138|FG001|Overall Study|Withdrawal by Subject|11|||
48725626|NCT00814801|156845139|FG002|Overall Study|Withdrawal by Subject|14|||
48725627|NCT00814801|156845137|FG000|Overall Study|Inappropriate as a subject|1|||
48725628|NCT00814801|156845138|FG001|Overall Study|Inappropriate as a subject|1|||
48725629|NCT00814801|156845139|FG002|Overall Study|Inappropriate as a subject|1|||
48725630|NCT00814801|156845137|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
48725631|NCT00814801|156845138|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
48725632|NCT00814801|156845139|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
48820412|NCT00136916|157185509|FG001|Overall Study|Lack of Efficacy|3|||
48506273|NCT00553280|156047857|FG000|Overall Study|Withdrawal by Subject|3|||
48506274|NCT00553280|156047857|FG000|Overall Study|Physician Decision|1|||
48506275|NCT00624065|156047862|FG000|Overall Study|Adverse Event|5|||
48506276|NCT00624065|156047863|FG001|Overall Study|Adverse Event|6|||
48820413|NCT00136916|157185508|FG000|Overall Study|Lost to Follow-up|12|||
48820414|NCT00136916|157185509|FG001|Overall Study|Lost to Follow-up|14|||
48506277|NCT00624065|156047862|FG000|Overall Study|Lost to Follow-up|4|||
48506278|NCT00624065|156047863|FG001|Overall Study|Lost to Follow-up|1|||
48506279|NCT00624065|156047862|FG000|Overall Study|Consent withdrawn|6|||
48506280|NCT00624065|156047863|FG001|Overall Study|Consent withdrawn|5|||
48506281|NCT00624065|156047862|FG000|Overall Study|Lack of Efficacy|0|||
48506282|NCT00624065|156047863|FG001|Overall Study|Lack of Efficacy|3|||
48506283|NCT00624065|156047862|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
48506284|NCT00624065|156047863|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
48820415|NCT00136916|157185508|FG000|Overall Study|Withdrawal by Subject|44|||
48820416|NCT00136916|157185509|FG001|Overall Study|Withdrawal by Subject|46|||
48820417|NCT00136916|157185508|FG000|Overall Study|Other|22|||
48820418|NCT00136916|157185509|FG001|Overall Study|Other|24|||
48820419|NCT00136916|157185508|FG000|Overall Study|Discontinued in follow up period|3|||
48820420|NCT00136916|157185509|FG001|Overall Study|Discontinued in follow up period|0|||
48820421|NCT04285229|157185516|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48820422|NCT04285229|157185517|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820423|NCT04285229|157185518|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820424|NCT04285229|157185519|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820425|NCT04285229|157185520|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820426|NCT04285229|157185521|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48820427|NCT04285229|157185516|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
48820428|NCT04285229|157185517|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
48820429|NCT04285229|157185518|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
48820430|NCT04285229|157185519|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
48820431|NCT04285229|157185520|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
48506285|NCT02770820|156047864|FG000|Overall Study|Death|1|||
48506286|NCT02770820|156047864|FG000|Overall Study|Physician Decision|2|||
48506287|NCT00696020|156047865|FG000|Overall Study|Adverse Event|3|||
48506288|NCT00696020|156047866|FG001|Overall Study|Adverse Event|1|||
48506289|NCT00696020|156047867|FG002|Overall Study|Adverse Event|2|||
48506290|NCT00696020|156047868|FG003|Overall Study|Adverse Event|1|||
48506291|NCT00696020|156047865|FG000|Overall Study|Lack of Efficacy|1|||
48506292|NCT00696020|156047866|FG001|Overall Study|Lack of Efficacy|0|||
48506293|NCT00696020|156047867|FG002|Overall Study|Lack of Efficacy|0|||
48506294|NCT00696020|156047868|FG003|Overall Study|Lack of Efficacy|0|||
48506295|NCT00696020|156047865|FG000|Overall Study|Protocol Violation|0|||
48506296|NCT00696020|156047866|FG001|Overall Study|Protocol Violation|0|||
48506297|NCT00696020|156047867|FG002|Overall Study|Protocol Violation|0|||
48506298|NCT00696020|156047868|FG003|Overall Study|Protocol Violation|1|||
48506299|NCT00696020|156047865|FG000|Overall Study|Withdrawal by Subject|0|||
48506300|NCT00696020|156047866|FG001|Overall Study|Withdrawal by Subject|1|||
48506301|NCT00696020|156047867|FG002|Overall Study|Withdrawal by Subject|0|||
48506302|NCT00696020|156047868|FG003|Overall Study|Withdrawal by Subject|1|||
48506303|NCT00696020|156047865|FG000|Overall Study|Other not stated above|0|||
48506304|NCT00696020|156047866|FG001|Overall Study|Other not stated above|0|||
48506305|NCT00696020|156047867|FG002|Overall Study|Other not stated above|1|||
48506306|NCT00696020|156047868|FG003|Overall Study|Other not stated above|1|||
48506307|NCT01387022|156047869|FG000|Overall Study|Death|1|||
48506308|NCT01387022|156047870|FG001|Overall Study|Death|1|||
48506309|NCT01387022|156047869|FG000|Overall Study|Lost to Follow-up|0|||
48506310|NCT01387022|156047870|FG001|Overall Study|Lost to Follow-up|3|||
48506311|NCT02331394|156047875|FG000|Overall Study|Disease progression|1|||
48506312|NCT02336165|156047876|FG000|Overall Study|Death|3|||
48506313|NCT02336165|156047877|FG001|Overall Study|Death|0|||
48506314|NCT02336165|156047878|FG002|Overall Study|Death|0|||
48506315|NCT02336165|156047879|FG003|Overall Study|Death|0|||
48506316|NCT02336165|156047880|FG004|Overall Study|Death|1|||
48506317|NCT02336165|156047876|FG000|Overall Study|Physician Decision|2|||
48506318|NCT02336165|156047877|FG001|Overall Study|Physician Decision|2|||
48506319|NCT02336165|156047878|FG002|Overall Study|Physician Decision|1|||
48506320|NCT02336165|156047879|FG003|Overall Study|Physician Decision|1|||
48506321|NCT02336165|156047880|FG004|Overall Study|Physician Decision|0|||
48506322|NCT02336165|156047876|FG000|Overall Study|Withdrawal by Subject|0|||
48506323|NCT02336165|156047877|FG001|Overall Study|Withdrawal by Subject|0|||
48506324|NCT02336165|156047878|FG002|Overall Study|Withdrawal by Subject|1|||
48506325|NCT02336165|156047879|FG003|Overall Study|Withdrawal by Subject|0|||
48506326|NCT02336165|156047880|FG004|Overall Study|Withdrawal by Subject|1|||
48506327|NCT02336165|156047876|FG000|Overall Study|Adverse Event|4|||
48506328|NCT02336165|156047877|FG001|Overall Study|Adverse Event|1|||
48506329|NCT02336165|156047878|FG002|Overall Study|Adverse Event|2|||
48506330|NCT02336165|156047879|FG003|Overall Study|Adverse Event|4|||
48506331|NCT02336165|156047880|FG004|Overall Study|Adverse Event|1|||
48506332|NCT02336165|156047876|FG000|Overall Study|Progressive disease|23|||
48506333|NCT02336165|156047877|FG001|Overall Study|Progressive disease|22|||
48506334|NCT02336165|156047878|FG002|Overall Study|Progressive disease|27|||
48820432|NCT04285229|157185521|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
48820433|NCT04285229|157185516|FG000|Extended Treatment Period|Adverse Event|0|||
48820434|NCT04285229|157185517|FG001|Extended Treatment Period|Adverse Event|0|||
48820435|NCT04285229|157185518|FG002|Extended Treatment Period|Adverse Event|0|||
48820436|NCT04285229|157185519|FG003|Extended Treatment Period|Adverse Event|1|||
48820437|NCT04285229|157185520|FG004|Extended Treatment Period|Adverse Event|0|||
48820438|NCT04285229|157185521|FG005|Extended Treatment Period|Adverse Event|0|||
48820439|NCT04285229|157185516|FG000|Extended Treatment Period|Physician Decision|0|||
48820440|NCT04285229|157185517|FG001|Extended Treatment Period|Physician Decision|0|||
48820441|NCT04285229|157185518|FG002|Extended Treatment Period|Physician Decision|1|||
48820442|NCT04285229|157185519|FG003|Extended Treatment Period|Physician Decision|0|||
48820443|NCT04285229|157185520|FG004|Extended Treatment Period|Physician Decision|0|||
48820444|NCT04285229|157185521|FG005|Extended Treatment Period|Physician Decision|0|||
48820445|NCT04285229|157185516|FG000|Follow-up Period|Adverse Event|0|||
48820446|NCT04285229|157185517|FG001|Follow-up Period|Adverse Event|0|||
48820447|NCT04285229|157185518|FG002|Follow-up Period|Adverse Event|0|||
48820448|NCT04285229|157185519|FG003|Follow-up Period|Adverse Event|0|||
48820449|NCT04285229|157185520|FG004|Follow-up Period|Adverse Event|1|||
48820450|NCT04285229|157185521|FG005|Follow-up Period|Adverse Event|4|||
48820451|NCT04285229|157185516|FG000|Follow-up Period|Withdrawal by Subject|0|||
48820452|NCT04285229|157185517|FG001|Follow-up Period|Withdrawal by Subject|0|||
48820453|NCT04285229|157185518|FG002|Follow-up Period|Withdrawal by Subject|0|||
48820454|NCT04285229|157185519|FG003|Follow-up Period|Withdrawal by Subject|0|||
48820455|NCT04285229|157185520|FG004|Follow-up Period|Withdrawal by Subject|0|||
48820456|NCT04285229|157185521|FG005|Follow-up Period|Withdrawal by Subject|5|||
48820457|NCT04285229|157185516|FG000|Follow-up Period|Covid-19|0|||
48820458|NCT04285229|157185517|FG001|Follow-up Period|Covid-19|0|||
48820459|NCT04285229|157185518|FG002|Follow-up Period|Covid-19|0|||
48820460|NCT04285229|157185519|FG003|Follow-up Period|Covid-19|0|||
48820461|NCT04285229|157185520|FG004|Follow-up Period|Covid-19|0|||
48820462|NCT04285229|157185521|FG005|Follow-up Period|Covid-19|2|||
48820463|NCT04285229|157185516|FG000|Follow-up Period|Physician Decision|0|||
48820464|NCT04285229|157185517|FG001|Follow-up Period|Physician Decision|0|||
48820465|NCT04285229|157185518|FG002|Follow-up Period|Physician Decision|0|||
48820466|NCT04285229|157185519|FG003|Follow-up Period|Physician Decision|0|||
48820467|NCT04285229|157185520|FG004|Follow-up Period|Physician Decision|0|||
48820468|NCT04285229|157185521|FG005|Follow-up Period|Physician Decision|1|||
48820469|NCT01723826|157185522|FG000|Overall Study|Adverse Event|4|||
48820470|NCT01723826|157185523|FG001|Overall Study|Adverse Event|1|||
48820471|NCT01723826|157185524|FG002|Overall Study|Adverse Event|4|||
48820472|NCT01723826|157185525|FG003|Overall Study|Adverse Event|5|||
48820473|NCT01723826|157185522|FG000|Overall Study|Death according to AE eCRF|2|||
48820474|NCT01723826|157185523|FG001|Overall Study|Death according to AE eCRF|3|||
48820475|NCT01723826|157185524|FG002|Overall Study|Death according to AE eCRF|3|||
48820476|NCT01723826|157185525|FG003|Overall Study|Death according to AE eCRF|7|||
48820477|NCT01723826|157185522|FG000|Overall Study|Lost to Follow-up|1|||
48820478|NCT01723826|157185523|FG001|Overall Study|Lost to Follow-up|3|||
48820479|NCT01723826|157185524|FG002|Overall Study|Lost to Follow-up|1|||
48820480|NCT01723826|157185525|FG003|Overall Study|Lost to Follow-up|1|||
48820481|NCT01723826|157185522|FG000|Overall Study|Non-compliance|0|||
48820482|NCT01723826|157185523|FG001|Overall Study|Non-compliance|1|||
48820483|NCT01723826|157185524|FG002|Overall Study|Non-compliance|3|||
48820484|NCT01723826|157185525|FG003|Overall Study|Non-compliance|3|||
48506335|NCT02336165|156047879|FG003|Overall Study|Progressive disease|24|||
48506336|NCT02336165|156047880|FG004|Overall Study|Progressive disease|19|||
48506337|NCT02336165|156047876|FG000|Overall Study|Non-compliance|1|||
48506338|NCT02336165|156047877|FG001|Overall Study|Non-compliance|0|||
48506339|NCT02336165|156047878|FG002|Overall Study|Non-compliance|0|||
48506340|NCT02336165|156047879|FG003|Overall Study|Non-compliance|1|||
48506341|NCT02336165|156047880|FG004|Overall Study|Non-compliance|0|||
48506342|NCT02336165|156047876|FG000|Overall Study|Other|1|||
48506343|NCT02336165|156047877|FG001|Overall Study|Other|0|||
48820485|NCT01723826|157185522|FG000|Overall Study|Non-compliance With Study Drug|0|||
48820486|NCT01723826|157185523|FG001|Overall Study|Non-compliance With Study Drug|1|||
48820487|NCT01723826|157185524|FG002|Overall Study|Non-compliance With Study Drug|0|||
48820488|NCT01723826|157185525|FG003|Overall Study|Non-compliance With Study Drug|0|||
48820489|NCT01723826|157185522|FG000|Overall Study|Other Reason|8|||
48820490|NCT01723826|157185523|FG001|Overall Study|Other Reason|6|||
48820491|NCT01723826|157185524|FG002|Overall Study|Other Reason|12|||
48820492|NCT01723826|157185525|FG003|Overall Study|Other Reason|14|||
48820493|NCT01723826|157185522|FG000|Overall Study|Physician Decision|1|||
48506344|NCT02336165|156047878|FG002|Overall Study|Other|0|||
48506345|NCT02336165|156047879|FG003|Overall Study|Other|1|||
48506346|NCT02336165|156047880|FG004|Overall Study|Other|0|||
48820494|NCT01723826|157185523|FG001|Overall Study|Physician Decision|3|||
48820495|NCT01723826|157185524|FG002|Overall Study|Physician Decision|4|||
48506347|NCT00910663|156047881|FG000|Period 1|Withdrawal by Subject|0|||
48820496|NCT01723826|157185525|FG003|Overall Study|Physician Decision|11|||
48820497|NCT01723826|157185522|FG000|Overall Study|Protocol Violation|1|||
48506348|NCT00910663|156047882|FG001|Period 1|Withdrawal by Subject|1|||
48506349|NCT02726581|156047883|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
48506350|NCT02726581|156047884|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
48506351|NCT02726581|156047885|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
48506352|NCT02726581|156047883|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
48506353|NCT02726581|156047884|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
48506354|NCT02726581|156047885|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
48506355|NCT02726581|156047883|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
48506356|NCT02726581|156047884|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48506357|NCT02726581|156047885|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48506358|NCT02726581|156047883|FG000|Treatment Period|Disease progression|47|||
48506359|NCT02726581|156047884|FG001|Treatment Period|Disease progression|50|||
48506360|NCT02726581|156047885|FG002|Treatment Period|Disease progression|16|||
48506361|NCT02726581|156047883|FG000|Treatment Period|Other reasons|9|||
48506362|NCT02726581|156047884|FG001|Treatment Period|Other reasons|8|||
48506363|NCT02726581|156047885|FG002|Treatment Period|Other reasons|2|||
48506364|NCT02726581|156047883|FG000|Treatment Period|Study drug toxicity|6|||
48506365|NCT02726581|156047884|FG001|Treatment Period|Study drug toxicity|3|||
48506366|NCT02726581|156047885|FG002|Treatment Period|Study drug toxicity|2|||
48506367|NCT02726581|156047883|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
48506368|NCT02726581|156047884|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
48506369|NCT02726581|156047885|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
48506370|NCT02726581|156047883|FG000|Treatment Period|Participant withdrew consent|3|||
48506371|NCT02726581|156047884|FG001|Treatment Period|Participant withdrew consent|1|||
48506372|NCT02726581|156047885|FG002|Treatment Period|Participant withdrew consent|1|||
48506373|NCT02726581|156047883|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
48506374|NCT02726581|156047884|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
48506375|NCT02726581|156047885|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
48506376|NCT02726581|156047883|FG000|Treatment Period|Maximum clinical benefit|0|||
48506377|NCT02726581|156047884|FG001|Treatment Period|Maximum clinical benefit|2|||
48506378|NCT02726581|156047885|FG002|Treatment Period|Maximum clinical benefit|0|||
48506379|NCT02726581|156047883|FG000|Treatment Period|Death|1|||
48506380|NCT02726581|156047884|FG001|Treatment Period|Death|0|||
48506381|NCT02726581|156047885|FG002|Treatment Period|Death|0|||
48506382|NCT02726581|156047883|FG000|Treatment Period|Poor/non-compliance|1|||
48506383|NCT02726581|156047884|FG001|Treatment Period|Poor/non-compliance|0|||
48506384|NCT02726581|156047885|FG002|Treatment Period|Poor/non-compliance|0|||
48506385|NCT02726581|156047883|FG000|Treatment Period|Participant no longer meets study criteria|0|||
48506386|NCT02726581|156047884|FG001|Treatment Period|Participant no longer meets study criteria|1|||
48506387|NCT02726581|156047885|FG002|Treatment Period|Participant no longer meets study criteria|0|||
48506388|NCT02865850|156047886|FG000|Overall Study|Death|15|||
48506389|NCT02865850|156047887|FG001|Overall Study|Death|19|||
48506390|NCT02865850|156047886|FG000|Overall Study|Withdrawal by Subject|3|||
48506391|NCT02865850|156047887|FG001|Overall Study|Withdrawal by Subject|2|||
48506392|NCT02865850|156047886|FG000|Overall Study|Lost to Follow-up|3|||
48506393|NCT02865850|156047887|FG001|Overall Study|Lost to Follow-up|2|||
48506394|NCT00552669|156047888|FG000|Overall Study|Death|3|||
48506395|NCT00552669|156047889|FG001|Overall Study|Death|7|||
48506396|NCT01844375|156047893|FG000|Overall Study|Protocol Violation|1|||
48506397|NCT01844375|156047894|FG001|Overall Study|Protocol Violation|1|||
48506398|NCT01313780|156047895|FG000|Overall Study|Lack of Efficacy|4|||
48506399|NCT01313780|156047896|FG001|Overall Study|Lack of Efficacy|2|||
48506400|NCT01313780|156047895|FG000|Overall Study|Adverse Event|6|||
48506401|NCT01313780|156047896|FG001|Overall Study|Adverse Event|11|||
48506402|NCT01313780|156047895|FG000|Overall Study|Withdrawal by Subject|2|||
48506403|NCT01313780|156047896|FG001|Overall Study|Withdrawal by Subject|8|||
48506404|NCT01313780|156047895|FG000|Overall Study|Protocol Violation|10|||
48506405|NCT01313780|156047896|FG001|Overall Study|Protocol Violation|4|||
48506406|NCT01313780|156047895|FG000|Overall Study|missing data|3|||
48506407|NCT01313780|156047896|FG001|Overall Study|missing data|3|||
48506408|NCT01263704|156047897|FG000|Overall Study|Progressive disease|18|||
48506409|NCT01263704|156047897|FG000|Overall Study|Adverse Event|3|||
48506410|NCT01263704|156047897|FG000|Overall Study|Death|2|||
48506411|NCT01263704|156047897|FG000|Overall Study|Patient withdrew consent|2|||
48506412|NCT01263704|156047897|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
48506413|NCT01263704|156047897|FG000|Overall Study|Lost to Follow-up|1|||
48506414|NCT01263704|156047897|FG000|Overall Study|Colon metastases|1|||
48820498|NCT01723826|157185523|FG001|Overall Study|Protocol Violation|1|||
48506415|NCT01263704|156047897|FG000|Overall Study|Principal Investigator (PI) decision|1|||
48506416|NCT00905840|156047898|FG000|Overall Study|Lost to Follow-up|11|||
48506417|NCT00905840|156047898|FG000|Overall Study|Death|3|||
48506418|NCT00905840|156047898|FG000|Overall Study|Withdrawal by Subject|1|||
48506419|NCT00905840|156047898|FG000|Overall Study|Adverse Event|1|||
48506420|NCT00448019|156047899|FG000|Overall Study|Withdrawal by Subject|3|||
48820499|NCT01723826|157185524|FG002|Overall Study|Protocol Violation|3|||
48820500|NCT01723826|157185525|FG003|Overall Study|Protocol Violation|1|||
48820501|NCT01723826|157185522|FG000|Overall Study|Withdrawal by Subject|10|||
48820502|NCT01723826|157185523|FG001|Overall Study|Withdrawal by Subject|17|||
48820503|NCT01723826|157185524|FG002|Overall Study|Withdrawal by Subject|27|||
48600354|NCT05259163|156393880|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
48600355|NCT05259163|156393881|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
48600356|NCT01381926|156393882|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
48600357|NCT01381926|156393883|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
48600358|NCT01381926|156393882|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
48600359|NCT01381926|156393883|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
48600360|NCT01212094|156393884|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
48725633|NCT00814801|156845137|FG000|Overall Study|Missing or change of caregiver|6|||
48725634|NCT00814801|156845138|FG001|Overall Study|Missing or change of caregiver|2|||
48725635|NCT00814801|156845139|FG002|Overall Study|Missing or change of caregiver|4|||
48725636|NCT00814801|156845137|FG000|Overall Study|Non-compliance|0|||
48725637|NCT00814801|156845138|FG001|Overall Study|Non-compliance|1|||
48725638|NCT00814801|156845139|FG002|Overall Study|Non-compliance|1|||
48725639|NCT00814801|156845137|FG000|Overall Study|Other|2|||
48725640|NCT00814801|156845138|FG001|Overall Study|Other|6|||
48725641|NCT00814801|156845139|FG002|Overall Study|Other|4|||
48725642|NCT02117427|156845140|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
48725643|NCT02117427|156845141|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
48725644|NCT02117427|156845142|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
48725645|NCT02117427|156845140|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
48725646|NCT02117427|156845141|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
48725647|NCT02117427|156845142|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
48725648|NCT02117427|156845140|FG000|Overall Study|Physician Decision|0|||
48725649|NCT02117427|156845141|FG001|Overall Study|Physician Decision|2|||
48725650|NCT02117427|156845142|FG002|Overall Study|Physician Decision|0|||
48725651|NCT02117427|156845140|FG000|Overall Study|No longer meets inclusion criteria|0|||
48725652|NCT02117427|156845141|FG001|Overall Study|No longer meets inclusion criteria|1|||
48725653|NCT02117427|156845142|FG002|Overall Study|No longer meets inclusion criteria|0|||
48725654|NCT02117427|156845140|FG000|Overall Study|Death|0|||
48725655|NCT02117427|156845141|FG001|Overall Study|Death|1|||
48725656|NCT02117427|156845142|FG002|Overall Study|Death|0|||
48725657|NCT03036800|156845143|FG000|Overall Study|Protocol Violation|1|||
48725658|NCT03036800|156845144|FG001|Overall Study|Protocol Violation|0|||
48725659|NCT03036800|156845143|FG000|Overall Study|Non-compliance|1|||
48725660|NCT03036800|156845144|FG001|Overall Study|Non-compliance|0|||
48725661|NCT03036800|156845143|FG000|Overall Study|Lost to Follow-up|1|||
48820504|NCT01723826|157185525|FG003|Overall Study|Withdrawal by Subject|48|||
48820505|NCT03023332|157185526|FG000|Overall Study|Withdrawal by Subject|10|||
48820506|NCT03023332|157185527|FG001|Overall Study|Withdrawal by Subject|5|||
48820507|NCT03023332|157185528|FG002|Overall Study|Withdrawal by Subject|4|||
48820508|NCT03023332|157185529|FG003|Overall Study|Withdrawal by Subject|7|||
48820509|NCT03023332|157185526|FG000|Overall Study|Lost to Follow-up|13|||
48820510|NCT03023332|157185527|FG001|Overall Study|Lost to Follow-up|16|||
48820511|NCT03023332|157185528|FG002|Overall Study|Lost to Follow-up|8|||
48820512|NCT03023332|157185529|FG003|Overall Study|Lost to Follow-up|13|||
48820513|NCT03023332|157185526|FG000|Overall Study|Death|1|||
48820514|NCT03023332|157185527|FG001|Overall Study|Death|0|||
48820515|NCT03023332|157185528|FG002|Overall Study|Death|0|||
48506421|NCT00448019|156047899|FG000|Overall Study|Disease progression|1|||
48820516|NCT03023332|157185529|FG003|Overall Study|Death|0|||
48820517|NCT04179461|157185532|FG000|Overall Study|Lost to Follow-up|4|||
48820518|NCT03100838|157185533|FG000|Overall Study|Adverse Event|1|||
48506422|NCT00448019|156047899|FG000|Overall Study|Death|2|||
48506423|NCT00448019|156047899|FG000|Overall Study|Insurance Issues|1|||
48506424|NCT03496623|156047900|FG000|Run-In Period (2 Weeks)|Death|1|||
48506425|NCT03496623|156047901|FG001|Run-In Period (2 Weeks)|Death|0|||
48506426|NCT03496623|156047902|FG002|Run-In Period (2 Weeks)|Death|0|||
48506427|NCT03496623|156047903|FG003|Run-In Period (2 Weeks)|Death|0|||
48506428|NCT03496623|156047904|FG004|Run-In Period (2 Weeks)|Death|0|||
48506429|NCT03496623|156047900|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
48506430|NCT03496623|156047901|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
48506431|NCT03496623|156047902|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
48506432|NCT03496623|156047903|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
48506433|NCT03496623|156047904|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
48506434|NCT03496623|156047900|FG000|Period 1 (12 Weeks)|Death|0|||
48506435|NCT03496623|156047901|FG001|Period 1 (12 Weeks)|Death|3|||
48506436|NCT03496623|156047902|FG002|Period 1 (12 Weeks)|Death|0|||
48820519|NCT03100838|157185534|FG001|Overall Study|Adverse Event|0|||
48820520|NCT03100838|157185535|FG002|Overall Study|Adverse Event|0|||
48506437|NCT03496623|156047903|FG003|Period 1 (12 Weeks)|Death|0|||
48820521|NCT03100838|157185536|FG003|Overall Study|Adverse Event|0|||
48820522|NCT03100838|157185533|FG000|Overall Study|Physician Decision|1|||
48820523|NCT03100838|157185534|FG001|Overall Study|Physician Decision|1|||
48820524|NCT03100838|157185535|FG002|Overall Study|Physician Decision|1|||
48820525|NCT03100838|157185536|FG003|Overall Study|Physician Decision|1|||
48820526|NCT03100838|157185533|FG000|Overall Study|Pregnancy|0|||
48725662|NCT03036800|156845144|FG001|Overall Study|Lost to Follow-up|0|||
48725663|NCT03036800|156845143|FG000|Overall Study|Death|1|||
48725664|NCT03036800|156845144|FG001|Overall Study|Death|0|||
48725665|NCT03036800|156845143|FG000|Overall Study|Tolerance|5|||
48725666|NCT03036800|156845144|FG001|Overall Study|Tolerance|0|||
48725667|NCT03036800|156845143|FG000|Overall Study|Unknown/no reason given|50|||
48725668|NCT03036800|156845144|FG001|Overall Study|Unknown/no reason given|39|||
48725669|NCT01505647|156845145|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
48725670|NCT01505647|156845146|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
48725671|NCT01505647|156845145|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
48725672|NCT01505647|156845146|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
48725673|NCT01505647|156845145|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
48725674|NCT01505647|156845146|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
48725675|NCT01505647|156845145|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
48725676|NCT01505647|156845146|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
48725677|NCT01505647|156845145|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
48820527|NCT03100838|157185534|FG001|Overall Study|Pregnancy|1|||
48820528|NCT03100838|157185535|FG002|Overall Study|Pregnancy|0|||
48725678|NCT01505647|156845146|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
48725679|NCT00596362|156845148|FG000|Overall Study|Progressive Disease|1|||
48725680|NCT03112590|156845149|FG000|Overall Study|Adverse Event|0|||
48725681|NCT03112590|156845150|FG001|Overall Study|Adverse Event|1|||
48725682|NCT03112590|156845151|FG002|Overall Study|Adverse Event|0|||
48725683|NCT01574079|156845152|FG000|Overall Study|Physician Decision|0|||
48725684|NCT01574079|156845153|FG001|Overall Study|Physician Decision|2|||
48820529|NCT03100838|157185536|FG003|Overall Study|Pregnancy|0|||
48820530|NCT03100838|157185533|FG000|Overall Study|Lost to Follow-up|0|||
48820531|NCT03100838|157185534|FG001|Overall Study|Lost to Follow-up|0|||
48820532|NCT03100838|157185535|FG002|Overall Study|Lost to Follow-up|1|||
48820533|NCT03100838|157185536|FG003|Overall Study|Lost to Follow-up|0|||
48820534|NCT00619151|157185540|FG000|Overall Study|Study terminated prior to followup|1|||
48506438|NCT03496623|156047904|FG004|Period 1 (12 Weeks)|Death|0|||
48506439|NCT03496623|156047900|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
48820535|NCT00619151|157185541|FG001|Overall Study|Study terminated prior to followup|0|||
48820536|NCT02015195|157185543|FG000|Overall Study|Adverse Event|0|||
48820537|NCT02015195|157185544|FG001|Overall Study|Adverse Event|0|||
48820538|NCT02015195|157185545|FG002|Overall Study|Adverse Event|0|||
48820539|NCT02015195|157185546|FG003|Overall Study|Adverse Event|1|||
48820540|NCT02015195|157185547|FG004|Overall Study|Adverse Event|0|||
48820541|NCT02015195|157185548|FG005|Overall Study|Adverse Event|0|||
48820542|NCT02015195|157185549|FG006|Overall Study|Adverse Event|0|||
48820543|NCT02303574|157185556|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820544|NCT02303574|157185557|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820545|NCT02303574|157185558|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
48506440|NCT03496623|156047901|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
48506441|NCT03496623|156047902|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
48506442|NCT03496623|156047903|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
48506443|NCT03496623|156047904|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
48506444|NCT03496623|156047900|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48506445|NCT03496623|156047901|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
48506446|NCT03496623|156047902|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
48506447|NCT03496623|156047903|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48506448|NCT03496623|156047904|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48725685|NCT01574079|156845152|FG000|Overall Study|Lost to Follow-up|1|||
48820546|NCT02303574|157185559|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820547|NCT02303574|157185560|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820548|NCT02303574|157185561|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820549|NCT02303574|157185562|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820550|NCT02303574|157185563|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48506449|NCT03496623|156047900|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
48506450|NCT03496623|156047901|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
48725686|NCT01574079|156845153|FG001|Overall Study|Lost to Follow-up|0|||
48725687|NCT02059005|156845156|FG000|Overall Study|Death|1|||
48725688|NCT02059005|156845157|FG001|Overall Study|Death|3|||
48725689|NCT02059005|156845156|FG000|Overall Study|Lost to Follow-up|19|||
48725690|NCT02059005|156845157|FG001|Overall Study|Lost to Follow-up|19|||
48725691|NCT02059005|156845156|FG000|Overall Study|Incarceration|0|||
48506451|NCT03496623|156047902|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
48506452|NCT03496623|156047903|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
48725692|NCT02059005|156845157|FG001|Overall Study|Incarceration|1|||
48820551|NCT02303574|157185564|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820552|NCT02303574|157185565|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
48820553|NCT02303574|157185556|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820554|NCT02303574|157185557|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820555|NCT02303574|157185558|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820556|NCT02303574|157185559|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820557|NCT02303574|157185560|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820558|NCT02303574|157185561|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820559|NCT02303574|157185562|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820560|NCT02303574|157185563|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
48820561|NCT02303574|157185564|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48725693|NCT02059005|156845156|FG000|Overall Study|Inpatient|0|||
48725694|NCT02059005|156845157|FG001|Overall Study|Inpatient|1|||
48725695|NCT00760084|156845162|FG000|Overall Study|Physician Decision|5|||
48725696|NCT00760084|156845162|FG000|Overall Study|Withdrawal by Subject|2|||
48725697|NCT00760084|156845162|FG000|Overall Study|Progressive Disease|3|||
48725698|NCT00973349|156845163|FG000|Overall Study|Adverse Event|0|||
48820562|NCT02303574|157185565|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
48820563|NCT01347645|157185566|FG000|Overall Study|Death|1|||
48820564|NCT01347645|157185567|FG001|Overall Study|Death|5|||
48820565|NCT01347645|157185568|FG002|Overall Study|Death|2|||
48820566|NCT01347645|157185569|FG003|Overall Study|Death|7|||
48820567|NCT01347645|157185570|FG004|Overall Study|Death|7|||
48820568|NCT01347645|157185566|FG000|Overall Study|Lost to Follow-up|1|||
48820569|NCT01347645|157185567|FG001|Overall Study|Lost to Follow-up|1|||
48820570|NCT01347645|157185568|FG002|Overall Study|Lost to Follow-up|0|||
48820571|NCT01347645|157185569|FG003|Overall Study|Lost to Follow-up|1|||
48820572|NCT01347645|157185570|FG004|Overall Study|Lost to Follow-up|1|||
48820573|NCT01347645|157185566|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
48820574|NCT01347645|157185567|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
48820575|NCT01347645|157185568|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
48820576|NCT01347645|157185569|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
48820577|NCT01347645|157185570|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
48820578|NCT01347645|157185566|FG000|Overall Study|Other|1|||
48820579|NCT01347645|157185567|FG001|Overall Study|Other|0|||
48820580|NCT01347645|157185568|FG002|Overall Study|Other|0|||
48820581|NCT01347645|157185569|FG003|Overall Study|Other|0|||
48820582|NCT01347645|157185570|FG004|Overall Study|Other|1|||
48820583|NCT01347645|157185566|FG000|Overall Study|Withdrawal by Subject|0|||
48820584|NCT01347645|157185567|FG001|Overall Study|Withdrawal by Subject|0|||
48820585|NCT01347645|157185568|FG002|Overall Study|Withdrawal by Subject|0|||
48820586|NCT01347645|157185569|FG003|Overall Study|Withdrawal by Subject|3|||
48820587|NCT01347645|157185570|FG004|Overall Study|Withdrawal by Subject|3|||
48820588|NCT01347645|157185566|FG000|Overall Study|Physician Decision|0|||
48725699|NCT00973349|156845164|FG001|Overall Study|Adverse Event|0|||
48820589|NCT01347645|157185567|FG001|Overall Study|Physician Decision|0|||
48820590|NCT01347645|157185568|FG002|Overall Study|Physician Decision|0|||
48820591|NCT01347645|157185569|FG003|Overall Study|Physician Decision|0|||
48820592|NCT01347645|157185570|FG004|Overall Study|Physician Decision|1|||
48820593|NCT01347645|157185566|FG000|Overall Study|Adverse Event|0|||
48820594|NCT01347645|157185567|FG001|Overall Study|Adverse Event|0|||
48820595|NCT01347645|157185568|FG002|Overall Study|Adverse Event|0|||
48820596|NCT01347645|157185569|FG003|Overall Study|Adverse Event|1|||
48820597|NCT01347645|157185570|FG004|Overall Study|Adverse Event|1|||
48820598|NCT00783718|157185571|FG000|Induction Phase|Adverse Event|4|||
48820599|NCT00783718|157185572|FG001|Induction Phase|Adverse Event|0|||
48820600|NCT00783718|157185573|FG002|Induction Phase|Adverse Event|7|||
48820601|NCT00783718|157185574|FG003|Induction Phase|Adverse Event|0|||
48820602|NCT00783718|157185575|FG004|Induction Phase|Adverse Event|0|||
48820603|NCT00783718|157185576|FG005|Induction Phase|Adverse Event|0|||
48820604|NCT00783718|157185577|FG006|Induction Phase|Adverse Event|0|||
48820605|NCT00783718|157185571|FG000|Induction Phase|Protocol Violation|1|||
48725700|NCT00973349|156845165|FG002|Overall Study|Adverse Event|0|||
48725701|NCT00973349|156845166|FG003|Overall Study|Adverse Event|0|||
48725702|NCT00973349|156845167|FG004|Overall Study|Adverse Event|1|||
48820606|NCT00783718|157185572|FG001|Induction Phase|Protocol Violation|1|||
48820607|NCT00783718|157185573|FG002|Induction Phase|Protocol Violation|6|||
48820608|NCT00783718|157185574|FG003|Induction Phase|Protocol Violation|0|||
48820609|NCT00783718|157185575|FG004|Induction Phase|Protocol Violation|0|||
48600361|NCT01212094|156393885|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
48725703|NCT00973349|156845168|FG005|Overall Study|Adverse Event|0|||
48725704|NCT00973349|156845169|FG006|Overall Study|Adverse Event|0|||
48725705|NCT00973349|156845170|FG007|Overall Study|Adverse Event|0|||
48820610|NCT00783718|157185576|FG005|Induction Phase|Protocol Violation|0|||
48600362|NCT01212094|156393886|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
48600363|NCT01212094|156393884|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
48600364|NCT01212094|156393885|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
48600365|NCT01212094|156393886|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
48600366|NCT01212094|156393884|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
48600367|NCT01212094|156393885|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
48600368|NCT01212094|156393886|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
48600369|NCT01212094|156393884|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
48600370|NCT01212094|156393885|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
48600371|NCT01212094|156393886|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
48600372|NCT01212094|156393884|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
48600373|NCT01212094|156393885|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
48600374|NCT01212094|156393886|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
48600375|NCT01212094|156393884|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
48600376|NCT01212094|156393885|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
48600377|NCT01212094|156393886|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
48600378|NCT02486692|156393887|FG000|Overall Study|did not login for randomization|4|||
48600379|NCT02486692|156393888|FG001|Overall Study|did not login for randomization|7|||
48600380|NCT05137717|156393892|FG000|Overall Study|Death|2|||
48725706|NCT00973349|156845171|FG008|Overall Study|Adverse Event|1|||
48725707|NCT00973349|156845172|FG009|Overall Study|Adverse Event|0|||
48725708|NCT00973349|156845173|FG010|Overall Study|Adverse Event|0|||
48725709|NCT00973349|156845174|FG011|Overall Study|Adverse Event|0|||
48725710|NCT00973349|156845175|FG012|Overall Study|Adverse Event|0|||
48725711|NCT00973349|156845176|FG013|Overall Study|Adverse Event|0|||
48725712|NCT00973349|156845177|FG014|Overall Study|Adverse Event|1|||
48725713|NCT00973349|156845178|FG015|Overall Study|Adverse Event|0|||
48725714|NCT00973349|156845163|FG000|Overall Study|Withdrawal by Subject|1|||
48725715|NCT00973349|156845164|FG001|Overall Study|Withdrawal by Subject|2|||
48725716|NCT00973349|156845165|FG002|Overall Study|Withdrawal by Subject|2|||
48725717|NCT00973349|156845166|FG003|Overall Study|Withdrawal by Subject|3|||
48725718|NCT00973349|156845167|FG004|Overall Study|Withdrawal by Subject|2|||
48725719|NCT00973349|156845168|FG005|Overall Study|Withdrawal by Subject|0|||
48725720|NCT00973349|156845169|FG006|Overall Study|Withdrawal by Subject|2|||
48725721|NCT00973349|156845170|FG007|Overall Study|Withdrawal by Subject|2|||
48725722|NCT00973349|156845171|FG008|Overall Study|Withdrawal by Subject|0|||
48725723|NCT00973349|156845172|FG009|Overall Study|Withdrawal by Subject|2|||
48725724|NCT00973349|156845173|FG010|Overall Study|Withdrawal by Subject|0|||
48725725|NCT00973349|156845174|FG011|Overall Study|Withdrawal by Subject|1|||
48725726|NCT00973349|156845175|FG012|Overall Study|Withdrawal by Subject|0|||
48725727|NCT00973349|156845176|FG013|Overall Study|Withdrawal by Subject|0|||
48725728|NCT00973349|156845177|FG014|Overall Study|Withdrawal by Subject|0|||
48725729|NCT00973349|156845178|FG015|Overall Study|Withdrawal by Subject|0|||
48725730|NCT00973349|156845163|FG000|Overall Study|Lost to Follow-up|3|||
48725731|NCT00973349|156845164|FG001|Overall Study|Lost to Follow-up|1|||
48725732|NCT00973349|156845165|FG002|Overall Study|Lost to Follow-up|2|||
48725733|NCT00973349|156845166|FG003|Overall Study|Lost to Follow-up|2|||
48725734|NCT00973349|156845167|FG004|Overall Study|Lost to Follow-up|1|||
48725735|NCT00973349|156845168|FG005|Overall Study|Lost to Follow-up|3|||
48725736|NCT00973349|156845169|FG006|Overall Study|Lost to Follow-up|0|||
48725737|NCT00973349|156845170|FG007|Overall Study|Lost to Follow-up|1|||
48725738|NCT00973349|156845171|FG008|Overall Study|Lost to Follow-up|2|||
48725739|NCT00973349|156845172|FG009|Overall Study|Lost to Follow-up|1|||
48725740|NCT00973349|156845173|FG010|Overall Study|Lost to Follow-up|0|||
48725741|NCT00973349|156845174|FG011|Overall Study|Lost to Follow-up|1|||
48725742|NCT00973349|156845175|FG012|Overall Study|Lost to Follow-up|0|||
48725743|NCT00973349|156845176|FG013|Overall Study|Lost to Follow-up|0|||
48725744|NCT00973349|156845177|FG014|Overall Study|Lost to Follow-up|0|||
48725745|NCT00973349|156845178|FG015|Overall Study|Lost to Follow-up|1|||
48725746|NCT00973349|156845163|FG000|Overall Study|Inappropriate enrolment|0|||
48725747|NCT00973349|156845164|FG001|Overall Study|Inappropriate enrolment|0|||
48725748|NCT00973349|156845165|FG002|Overall Study|Inappropriate enrolment|1|||
48725749|NCT00973349|156845166|FG003|Overall Study|Inappropriate enrolment|0|||
48725750|NCT00973349|156845167|FG004|Overall Study|Inappropriate enrolment|0|||
48725751|NCT00973349|156845168|FG005|Overall Study|Inappropriate enrolment|0|||
48725752|NCT00973349|156845169|FG006|Overall Study|Inappropriate enrolment|0|||
48725753|NCT00973349|156845170|FG007|Overall Study|Inappropriate enrolment|0|||
48725754|NCT00973349|156845171|FG008|Overall Study|Inappropriate enrolment|0|||
48725755|NCT00973349|156845172|FG009|Overall Study|Inappropriate enrolment|2|||
48725756|NCT00973349|156845173|FG010|Overall Study|Inappropriate enrolment|0|||
48725757|NCT00973349|156845174|FG011|Overall Study|Inappropriate enrolment|0|||
48725758|NCT00973349|156845175|FG012|Overall Study|Inappropriate enrolment|1|||
48725759|NCT00973349|156845176|FG013|Overall Study|Inappropriate enrolment|0|||
48725760|NCT00973349|156845177|FG014|Overall Study|Inappropriate enrolment|1|||
48725761|NCT00973349|156845178|FG015|Overall Study|Inappropriate enrolment|1|||
48725762|NCT00973349|156845163|FG000|Overall Study|Protocol Violation|0|||
48725763|NCT00973349|156845164|FG001|Overall Study|Protocol Violation|0|||
48725764|NCT00973349|156845165|FG002|Overall Study|Protocol Violation|0|||
48725765|NCT00973349|156845166|FG003|Overall Study|Protocol Violation|0|||
48725766|NCT00973349|156845167|FG004|Overall Study|Protocol Violation|0|||
48725767|NCT00973349|156845168|FG005|Overall Study|Protocol Violation|0|||
48506453|NCT03496623|156047904|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
48506454|NCT03496623|156047900|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48506455|NCT03496623|156047901|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48506456|NCT03496623|156047902|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
48506457|NCT03496623|156047903|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48506458|NCT03496623|156047904|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48506459|NCT03496623|156047900|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
48506460|NCT03496623|156047901|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
48506461|NCT03496623|156047902|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
48506462|NCT03496623|156047903|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
48506463|NCT03496623|156047904|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
48506464|NCT03496623|156047900|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48506465|NCT03496623|156047901|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
48506466|NCT03496623|156047902|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48725768|NCT00973349|156845169|FG006|Overall Study|Protocol Violation|0|||
48725769|NCT00973349|156845170|FG007|Overall Study|Protocol Violation|0|||
48725770|NCT00973349|156845171|FG008|Overall Study|Protocol Violation|1|||
48725771|NCT00973349|156845172|FG009|Overall Study|Protocol Violation|0|||
48725772|NCT00973349|156845173|FG010|Overall Study|Protocol Violation|0|||
48725773|NCT00973349|156845174|FG011|Overall Study|Protocol Violation|0|||
48725774|NCT00973349|156845175|FG012|Overall Study|Protocol Violation|0|||
48725775|NCT00973349|156845176|FG013|Overall Study|Protocol Violation|0|||
48725776|NCT00973349|156845177|FG014|Overall Study|Protocol Violation|0|||
48725777|NCT00973349|156845178|FG015|Overall Study|Protocol Violation|0|||
48725778|NCT00973349|156845163|FG000|Overall Study|Unable to classify|0|||
48725779|NCT00973349|156845164|FG001|Overall Study|Unable to classify|0|||
48725780|NCT00973349|156845165|FG002|Overall Study|Unable to classify|0|||
48725781|NCT00973349|156845166|FG003|Overall Study|Unable to classify|0|||
48725782|NCT00973349|156845167|FG004|Overall Study|Unable to classify|1|||
48725783|NCT00973349|156845168|FG005|Overall Study|Unable to classify|1|||
48725784|NCT00973349|156845169|FG006|Overall Study|Unable to classify|0|||
48725785|NCT00973349|156845170|FG007|Overall Study|Unable to classify|0|||
48725786|NCT00973349|156845171|FG008|Overall Study|Unable to classify|0|||
48725787|NCT00973349|156845172|FG009|Overall Study|Unable to classify|1|||
48725788|NCT00973349|156845173|FG010|Overall Study|Unable to classify|0|||
48725789|NCT00973349|156845174|FG011|Overall Study|Unable to classify|0|||
48725790|NCT00973349|156845175|FG012|Overall Study|Unable to classify|0|||
48725791|NCT00973349|156845176|FG013|Overall Study|Unable to classify|0|||
48725792|NCT00973349|156845177|FG014|Overall Study|Unable to classify|0|||
48725793|NCT00973349|156845178|FG015|Overall Study|Unable to classify|0|||
48725794|NCT02101112|156845181|FG000|Overall Study|Adverse Event|0|||
48725795|NCT02101112|156845182|FG001|Overall Study|Adverse Event|0|||
48725796|NCT02101112|156845183|FG002|Overall Study|Adverse Event|1|||
48725797|NCT02101112|156845184|FG003|Overall Study|Adverse Event|0|||
48725798|NCT02101112|156845185|FG004|Overall Study|Adverse Event|0|||
48725799|NCT02101112|156845186|FG005|Overall Study|Adverse Event|0|||
48725800|NCT02101112|156845181|FG000|Overall Study|Withdrawal by Subject|0|||
48725801|NCT02101112|156845182|FG001|Overall Study|Withdrawal by Subject|0|||
48725802|NCT02101112|156845183|FG002|Overall Study|Withdrawal by Subject|0|||
48725803|NCT02101112|156845184|FG003|Overall Study|Withdrawal by Subject|0|||
48725804|NCT02101112|156845185|FG004|Overall Study|Withdrawal by Subject|1|||
48725805|NCT02101112|156845186|FG005|Overall Study|Withdrawal by Subject|0|||
48725806|NCT02628769|156845187|FG000|First Intervention|Adverse Event|1|||
48438510|NCT03655717|155792056|FG003|Overall Study|Physician Decision|0|||
48438511|NCT03655717|155792057|FG004|Overall Study|Physician Decision|0|||
48438512|NCT03655717|155792058|FG005|Overall Study|Physician Decision|0|||
48438513|NCT03655717|155792059|FG006|Overall Study|Physician Decision|0|||
48438514|NCT03655717|155792060|FG007|Overall Study|Physician Decision|0|||
48438515|NCT03655717|155792061|FG008|Overall Study|Physician Decision|0|||
48438516|NCT03655717|155792062|FG009|Overall Study|Physician Decision|1|||
48438517|NCT03655717|155792063|FG010|Overall Study|Physician Decision|0|||
48438518|NCT03655717|155792064|FG011|Overall Study|Physician Decision|0|||
48438519|NCT03655717|155792065|FG012|Overall Study|Physician Decision|0|||
48438520|NCT03655717|155792066|FG013|Overall Study|Physician Decision|0|||
48438521|NCT03655717|155792067|FG014|Overall Study|Physician Decision|0|||
48438522|NCT03655717|155792068|FG015|Overall Study|Physician Decision|0|||
48438523|NCT03655717|155792069|FG016|Overall Study|Physician Decision|0|||
48438524|NCT03655717|155792070|FG017|Overall Study|Physician Decision|0|||
48438525|NCT03655717|155792071|FG018|Overall Study|Physician Decision|0|||
48438526|NCT03655717|155792072|FG019|Overall Study|Physician Decision|1|||
48438527|NCT03655717|155792073|FG020|Overall Study|Physician Decision|0|||
48438528|NCT03655717|155792074|FG021|Overall Study|Physician Decision|0|||
48506467|NCT03496623|156047903|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48506468|NCT03496623|156047904|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48506469|NCT02158663|156047906|FG000|Overall Study|Withdrawal by Subject|5|||
48506470|NCT02158663|156047907|FG001|Overall Study|Withdrawal by Subject|4|||
48506471|NCT01265056|156047908|FG000|Initial Study Period|Withdrawal by Subject|1|||
48506472|NCT01265056|156047909|FG001|Initial Study Period|Withdrawal by Subject|1|||
48506473|NCT01265056|156047908|FG000|Initial Study Period|Withdrawal by Subject|1|||
48506474|NCT01265056|156047909|FG001|Initial Study Period|Withdrawal by Subject|1|||
48506475|NCT01265056|156047908|FG000|Follow up|Lost to Follow-up|7|||
48506476|NCT01265056|156047909|FG001|Follow up|Lost to Follow-up|3|||
48506477|NCT00465270|156047922|FG000|Overall Study|Death|7|||
48506478|NCT00465270|156047923|FG001|Overall Study|Death|11|||
48506479|NCT00465270|156047922|FG000|Overall Study|Withdrawal by Subject|34|||
48506480|NCT00465270|156047923|FG001|Overall Study|Withdrawal by Subject|78|||
48506481|NCT00465270|156047922|FG000|Overall Study|Lost to Follow-up|60|||
48506482|NCT00465270|156047923|FG001|Overall Study|Lost to Follow-up|67|||
48506483|NCT00465270|156047922|FG000|Overall Study|Investigator request|3|||
48506484|NCT00465270|156047923|FG001|Overall Study|Investigator request|4|||
48506485|NCT01576042|156047924|FG000|Overall Study|Physician Decision|2|||
48506486|NCT01576042|156047925|FG001|Overall Study|Physician Decision|0|||
48506487|NCT03123471|156047928|FG000|Placebo-controlled Phase|Adverse Event|3|||
48506488|NCT03123471|156047929|FG001|Placebo-controlled Phase|Adverse Event|8|||
48506489|NCT03123471|156047928|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
48600381|NCT05137717|156393892|FG000|Overall Study|Withdrawal by Subject|6|||
48600382|NCT05556148|156393893|FG000|Overall Study|Early Termination|29|||
48725807|NCT02628769|156845188|FG001|First Intervention|Adverse Event|0|||
48725808|NCT02628769|156845187|FG000|First Intervention|Withdrawal by Subject|0|||
48725809|NCT02628769|156845188|FG001|First Intervention|Withdrawal by Subject|1|||
48725810|NCT02628769|156845187|FG000|Second Intervention|Adverse Event|2|||
48725811|NCT02628769|156845188|FG001|Second Intervention|Adverse Event|0|||
48725812|NCT02628769|156845187|FG000|Second Intervention|Physician Decision|0|||
48725813|NCT02628769|156845188|FG001|Second Intervention|Physician Decision|1|||
48725814|NCT00543855|156846505|FG000|Overall Study|Adverse Event|3|||
48725815|NCT00543855|156846506|FG001|Overall Study|Adverse Event|1|||
48725816|NCT00543855|156846507|FG002|Overall Study|Adverse Event|3|||
48725817|NCT00543855|156846508|FG003|Overall Study|Adverse Event|4|||
48725818|NCT00543855|156846505|FG000|Overall Study|Lost to Follow-up|0|||
48725819|NCT00543855|156846506|FG001|Overall Study|Lost to Follow-up|0|||
48725820|NCT00543855|156846507|FG002|Overall Study|Lost to Follow-up|1|||
48725821|NCT00543855|156846508|FG003|Overall Study|Lost to Follow-up|0|||
48725822|NCT00543855|156846505|FG000|Overall Study|Withdrawal by Subject|0|||
48725823|NCT00543855|156846506|FG001|Overall Study|Withdrawal by Subject|1|||
48725824|NCT00543855|156846507|FG002|Overall Study|Withdrawal by Subject|2|||
48725825|NCT00543855|156846508|FG003|Overall Study|Withdrawal by Subject|0|||
48725826|NCT00543855|156846505|FG000|Overall Study|Protocol Violation|1|||
48725827|NCT00543855|156846506|FG001|Overall Study|Protocol Violation|0|||
48725828|NCT00543855|156846507|FG002|Overall Study|Protocol Violation|0|||
48725829|NCT00543855|156846508|FG003|Overall Study|Protocol Violation|0|||
48725830|NCT03603509|156846509|FG000|Overall Study|Lost to Follow-up|3|||
48725831|NCT03603509|156846510|FG001|Overall Study|Lost to Follow-up|4|||
48725832|NCT00910247|156846515|FG000|Overall Study|Adverse Event|15|||
48725833|NCT00910247|156846515|FG000|Overall Study|Death|2|||
48725834|NCT00910247|156846515|FG000|Overall Study|Lost to Follow-up|10|||
48725835|NCT00910247|156846515|FG000|Overall Study|Physician Decision|3|||
48725836|NCT00910247|156846515|FG000|Overall Study|Protocol Violation|10|||
48725837|NCT00910247|156846515|FG000|Overall Study|Withdrawal by Subject|25|||
48725838|NCT00910247|156846515|FG000|Overall Study|Not collected|4|||
48725839|NCT04285580|156846516|FG000|Overall Study|Protocol Violation|0|||
48725840|NCT04285580|156846517|FG001|Overall Study|Protocol Violation|1|||
48725841|NCT02927067|156846518|FG000|Overall Study|Withdrawn Consent|20|||
48725842|NCT02927067|156846519|FG001|Overall Study|Withdrawn Consent|12|||
48725843|NCT02927067|156846518|FG000|Overall Study|Death|18|||
48725844|NCT02927067|156846519|FG001|Overall Study|Death|31|||
48506490|NCT03123471|156047929|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
48506491|NCT03123471|156047928|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
48725845|NCT02927067|156846518|FG000|Overall Study|Adverse Event|13|||
48725846|NCT02927067|156846519|FG001|Overall Study|Adverse Event|10|||
48506492|NCT03123471|156047929|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
48600383|NCT05556148|156393893|FG000|Overall Study|Baseline Tasks Expired|4|||
48725847|NCT02927067|156846518|FG000|Overall Study|Noncompliance|5|||
48725848|NCT02927067|156846519|FG001|Overall Study|Noncompliance|2|||
48725849|NCT02927067|156846518|FG000|Overall Study|Reason not Specified|4|||
48725850|NCT02927067|156846519|FG001|Overall Study|Reason not Specified|6|||
48506493|NCT03123471|156047928|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
48506494|NCT03123471|156047929|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
48506495|NCT03123471|156047928|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
48506496|NCT03123471|156047929|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
48506497|NCT03123471|156047928|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
48506498|NCT03123471|156047929|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
48506499|NCT03123471|156047928|FG000|Placebo-controlled Phase|Miscellaneous|0|||
48506500|NCT03123471|156047929|FG001|Placebo-controlled Phase|Miscellaneous|1|||
48506501|NCT03123471|156047928|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
48506502|NCT03123471|156047929|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
48506503|NCT03123471|156047928|FG000|Apremilast Extension Phase|Adverse Event|1|||
48506504|NCT03123471|156047929|FG001|Apremilast Extension Phase|Adverse Event|5|||
48506505|NCT03123471|156047928|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
48506506|NCT03123471|156047929|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
48506507|NCT03123471|156047928|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
48506508|NCT03123471|156047929|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
48506509|NCT00424047|156047930|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
48506510|NCT00424047|156047931|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
48506511|NCT00424047|156047930|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
48506512|NCT00424047|156047931|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
48506513|NCT00424047|156047930|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
48506514|NCT00424047|156047931|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
48506515|NCT00424047|156047930|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
48506516|NCT00424047|156047931|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
48506517|NCT00424047|156047930|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
48506518|NCT00424047|156047931|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
48506519|NCT00424047|156047930|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
48506520|NCT00424047|156047931|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
48506521|NCT00424047|156047930|FG000|On Study at Time of Unblinding|Adverse Event|22|||
48506522|NCT00424047|156047931|FG001|On Study at Time of Unblinding|Adverse Event|12|||
48506523|NCT00424047|156047930|FG000|On Study at Time of Unblinding|Progression of disease|92|||
48506524|NCT00424047|156047931|FG001|On Study at Time of Unblinding|Progression of disease|128|||
48506525|NCT00424047|156047930|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
48506526|NCT00424047|156047931|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
48506527|NCT00424047|156047930|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
48506528|NCT00424047|156047931|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
48506529|NCT00424047|156047930|FG000|On Study at Time of Unblinding|Death|11|||
48506530|NCT00424047|156047931|FG001|On Study at Time of Unblinding|Death|11|||
48506531|NCT00424047|156047930|FG000|On Study at Time of Unblinding|Other|5|||
48506532|NCT00424047|156047931|FG001|On Study at Time of Unblinding|Other|4|||
48506533|NCT00424047|156047930|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
48506534|NCT00424047|156047931|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
48506535|NCT00424047|156047930|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
48506536|NCT00424047|156047931|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
48506537|NCT00424047|156047930|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
48506538|NCT00424047|156047931|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
48506539|NCT00424047|156047930|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
48506540|NCT00424047|156047931|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
48506541|NCT00424047|156047930|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
48725851|NCT00622739|156846522|FG000|Overall Study|Physician Decision|1|||
48725852|NCT00622739|156846523|FG001|Overall Study|Physician Decision|0|||
48725853|NCT00622739|156846522|FG000|Overall Study|Adverse Event|1|||
48725854|NCT00622739|156846523|FG001|Overall Study|Adverse Event|2|||
48725855|NCT00622739|156846522|FG000|Overall Study|Lack of Efficacy|0|||
48725856|NCT00622739|156846523|FG001|Overall Study|Lack of Efficacy|2|||
48725857|NCT00622739|156846522|FG000|Overall Study|Withdrawal by Subject|0|||
48725858|NCT00622739|156846523|FG001|Overall Study|Withdrawal by Subject|1|||
48725859|NCT00622739|156846522|FG000|Overall Study|Lost to Follow-up|0|||
48725860|NCT00622739|156846523|FG001|Overall Study|Lost to Follow-up|1|||
48725861|NCT01314911|156846528|FG000|Overall Study|Lost to Follow-up|3|||
48725862|NCT01314911|156846529|FG001|Overall Study|Lost to Follow-up|2|||
48725863|NCT01314911|156846528|FG000|Overall Study|Withdrawal by Subject|1|||
48725864|NCT01314911|156846529|FG001|Overall Study|Withdrawal by Subject|3|||
48725865|NCT01314911|156846528|FG000|Overall Study|Received Non-randomized Study Drug|0|||
48725866|NCT01314911|156846529|FG001|Overall Study|Received Non-randomized Study Drug|1|||
48725867|NCT01314911|156846528|FG000|Overall Study|Never Started Treatment|1|||
48725868|NCT01314911|156846529|FG001|Overall Study|Never Started Treatment|0|||
48725869|NCT00773383|156846533|FG000|Overall Study|Adverse Event|4|||
48725870|NCT00773383|156846533|FG000|Overall Study|Death|1|||
48725871|NCT00773383|156846533|FG000|Overall Study|Progression of Disease|23|||
48506542|NCT00424047|156047931|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
48506543|NCT00095212|156047932|FG000|Overall Study|Withdrawal by Subject|1|||
48506544|NCT00095212|156047933|FG001|Overall Study|Withdrawal by Subject|3|||
48506545|NCT02335658|156047935|FG000|Overall Study|Adverse Event|18|||
48506546|NCT02335658|156047936|FG001|Overall Study|Adverse Event|12|||
48506547|NCT02335658|156047935|FG000|Overall Study|Lack of Efficacy|4|||
48506548|NCT02335658|156047936|FG001|Overall Study|Lack of Efficacy|5|||
48506549|NCT02335658|156047935|FG000|Overall Study|Pregnancy|1|||
48506550|NCT02335658|156047936|FG001|Overall Study|Pregnancy|0|||
48506551|NCT02335658|156047935|FG000|Overall Study|Withdrawal by Subject|13|||
48506552|NCT02335658|156047936|FG001|Overall Study|Withdrawal by Subject|21|||
48506553|NCT02335658|156047935|FG000|Overall Study|non-compliance|2|||
48506554|NCT02335658|156047936|FG001|Overall Study|non-compliance|3|||
48506555|NCT02335658|156047935|FG000|Overall Study|other reason|2|||
48506556|NCT02335658|156047936|FG001|Overall Study|other reason|3|||
48506557|NCT02140060|156047950|FG000|Overall Study|Adverse Event|0|||
48506558|NCT02140060|156047951|FG001|Overall Study|Adverse Event|0|||
48506559|NCT02140060|156047952|FG002|Overall Study|Adverse Event|0|||
48506560|NCT02140060|156047953|FG003|Overall Study|Adverse Event|1|||
48506561|NCT02140060|156047954|FG004|Overall Study|Adverse Event|1|||
48506562|NCT02140060|156047955|FG005|Overall Study|Adverse Event|1|||
48506563|NCT02140060|156047950|FG000|Overall Study|Lack of Efficacy|0|||
48506564|NCT02140060|156047951|FG001|Overall Study|Lack of Efficacy|0|||
48506565|NCT02140060|156047952|FG002|Overall Study|Lack of Efficacy|0|||
48725872|NCT00773383|156846533|FG000|Overall Study|Other|2|||
48725873|NCT00773383|156846533|FG000|Overall Study|No study dose received|1|||
48725874|NCT01611454|156846534|FG000|Overall Study|Lack of Efficacy|18|||
48725875|NCT01611454|156846535|FG001|Overall Study|Lack of Efficacy|10|||
48725876|NCT02987660|156846537|FG000|Overall Study|Study terminated by sponsor|10|||
48725877|NCT02987660|156846538|FG001|Overall Study|Study terminated by sponsor|10|||
48725878|NCT02361580|156846540|FG000|Overall Study|Lost to Follow-up|6|||
48725879|NCT02361580|156846541|FG001|Overall Study|Lost to Follow-up|3|||
48725880|NCT01653782|156846542|FG000|Overall Study|Withdrawal by Subject|9|||
48725881|NCT01653782|156846543|FG001|Overall Study|Withdrawal by Subject|15|||
48725882|NCT01653782|156846544|FG002|Overall Study|Withdrawal by Subject|4|||
48725883|NCT01653782|156846542|FG000|Overall Study|Lost to Follow-up|7|||
48725884|NCT01653782|156846543|FG001|Overall Study|Lost to Follow-up|3|||
48725885|NCT01653782|156846544|FG002|Overall Study|Lost to Follow-up|2|||
48725886|NCT03312751|156846546|FG000|Overall Study|Death|7|||
48725887|NCT03312751|156846547|FG001|Overall Study|Death|9|||
48725888|NCT03312751|156846546|FG000|Overall Study|Study discontinuation due to other reason|0|||
48725889|NCT03312751|156846547|FG001|Overall Study|Study discontinuation due to other reason|1|||
48725890|NCT01857310|156846548|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
48725891|NCT01857310|156846549|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
48725892|NCT01117792|156846550|FG000|Overall Study|Death|1|||
48725893|NCT01117792|156846550|FG000|Overall Study|Adverse Event|3|||
48725894|NCT01966432|156846551|FG000|Overall Study|Lost to Follow-up|3|||
48725895|NCT01966432|156846552|FG001|Overall Study|Lost to Follow-up|2|||
48725896|NCT01966432|156846553|FG002|Overall Study|Lost to Follow-up|5|||
48725897|NCT01966432|156846551|FG000|Overall Study|Withdrawal by Subject|1|||
48725898|NCT01966432|156846552|FG001|Overall Study|Withdrawal by Subject|3|||
48725899|NCT01966432|156846553|FG002|Overall Study|Withdrawal by Subject|0|||
48725900|NCT01966432|156846551|FG000|Overall Study|Subject Incarcerated|0|||
48725901|NCT01966432|156846552|FG001|Overall Study|Subject Incarcerated|0|||
48725902|NCT01966432|156846553|FG002|Overall Study|Subject Incarcerated|1|||
48725903|NCT01966432|156846551|FG000|Overall Study|SBIRT program ended|1|||
48725904|NCT01966432|156846552|FG001|Overall Study|SBIRT program ended|8|||
48725905|NCT01966432|156846553|FG002|Overall Study|SBIRT program ended|20|||
48725906|NCT03170232|156846554|FG000|Overall Study|Adverse Event|0|||
48725907|NCT03170232|156846555|FG001|Overall Study|Adverse Event|1|||
48725908|NCT03170232|156846554|FG000|Overall Study|Protocol Violation|0|||
48725909|NCT03170232|156846555|FG001|Overall Study|Protocol Violation|1|||
48725910|NCT03170232|156846554|FG000|Overall Study|Lack of Efficacy|0|||
48725911|NCT03170232|156846555|FG001|Overall Study|Lack of Efficacy|1|||
48725912|NCT03170232|156846554|FG000|Overall Study|Study closed/terminated|26|||
48725913|NCT03170232|156846555|FG001|Overall Study|Study closed/terminated|23|||
48725914|NCT03170232|156846554|FG000|Overall Study|Lost to Follow-up|1|||
48725915|NCT03170232|156846555|FG001|Overall Study|Lost to Follow-up|0|||
48725916|NCT03170232|156846554|FG000|Overall Study|Withdrawal by Subject|0|||
48725917|NCT03170232|156846555|FG001|Overall Study|Withdrawal by Subject|1|||
48725918|NCT01439347|156846556|FG000|Overall Study|Death|10|||
48725919|NCT01439347|156846557|FG001|Overall Study|Death|9|||
48725920|NCT01439347|156846556|FG000|Overall Study|Withdrawal by Subject|0|||
48725921|NCT01439347|156846557|FG001|Overall Study|Withdrawal by Subject|1|||
48725922|NCT01439347|156846556|FG000|Overall Study|Physician Decision|1|||
48506566|NCT02140060|156047953|FG003|Overall Study|Lack of Efficacy|1|||
48506567|NCT02140060|156047954|FG004|Overall Study|Lack of Efficacy|0|||
48506568|NCT02140060|156047955|FG005|Overall Study|Lack of Efficacy|0|||
48506569|NCT02039908|156047957|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
48506570|NCT02039908|156047958|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
48506571|NCT02039908|156047959|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
48506572|NCT02039908|156047960|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
48506573|NCT02039908|156047957|FG000|Phase 1-Summer|Protocol Violation|6|||
48506574|NCT02039908|156047958|FG001|Phase 1-Summer|Protocol Violation|0|||
48506575|NCT02039908|156047959|FG002|Phase 1-Summer|Protocol Violation|0|||
48506576|NCT02039908|156047960|FG003|Phase 1-Summer|Protocol Violation|0|||
48506577|NCT02039908|156047957|FG000|Phase 2-School Year|Lost to Follow-up|0|||
48506578|NCT02039908|156047958|FG001|Phase 2-School Year|Lost to Follow-up|0|||
48506579|NCT02039908|156047959|FG002|Phase 2-School Year|Lost to Follow-up|1|||
48506580|NCT02039908|156047960|FG003|Phase 2-School Year|Lost to Follow-up|3|||
48506581|NCT02039908|156047957|FG000|Phase 2-School Year|Protocol Violation|0|||
48506582|NCT02039908|156047958|FG001|Phase 2-School Year|Protocol Violation|0|||
48506583|NCT02039908|156047959|FG002|Phase 2-School Year|Protocol Violation|3|||
48506584|NCT02039908|156047960|FG003|Phase 2-School Year|Protocol Violation|0|||
48506585|NCT02039908|156047957|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
48506586|NCT02039908|156047958|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
48506587|NCT02039908|156047959|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
48506588|NCT02039908|156047960|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
48506589|NCT01108094|156048944|FG000|Overall Study|Adverse Event|2|||
48506590|NCT01108094|156048945|FG001|Overall Study|Adverse Event|0|||
48506591|NCT01108094|156048946|FG002|Overall Study|Adverse Event|0|||
48506592|NCT01108094|156048947|FG003|Overall Study|Adverse Event|0|||
48506593|NCT01108094|156048944|FG000|Overall Study|Withdrawal by Subject|1|||
48506594|NCT01108094|156048945|FG001|Overall Study|Withdrawal by Subject|0|||
48506595|NCT01108094|156048946|FG002|Overall Study|Withdrawal by Subject|0|||
48506596|NCT01108094|156048947|FG003|Overall Study|Withdrawal by Subject|0|||
48506597|NCT04349917|156048954|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
48506598|NCT04349917|156048955|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
48506599|NCT04349917|156048954|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
48506600|NCT04349917|156048955|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
48506601|NCT00441467|156048961|FG000|Overall Study|Adverse Event|6|||
48506602|NCT00441467|156048961|FG000|Overall Study|Withdrawal by Subject|3|||
48506603|NCT00441467|156048961|FG000|Overall Study|Progressive disease|9|||
48506604|NCT01518972|156048962|FG000|Overall Study|Lost to Follow-up|2|||
48506605|NCT01518972|156048963|FG001|Overall Study|Lost to Follow-up|1|||
48506606|NCT01518972|156048962|FG000|Overall Study|Withdrawal by Subject|1|||
48506607|NCT01518972|156048963|FG001|Overall Study|Withdrawal by Subject|0|||
48506608|NCT01518972|156048962|FG000|Overall Study|Moved from area|1|||
48506609|NCT01518972|156048963|FG001|Overall Study|Moved from area|0|||
48506610|NCT01518972|156048962|FG000|Overall Study|Transportation problems|1|||
48506611|NCT01518972|156048963|FG001|Overall Study|Transportation problems|0|||
48506612|NCT01518972|156048962|FG000|Overall Study|Exclusionary medical condition|1|||
48506613|NCT01518972|156048963|FG001|Overall Study|Exclusionary medical condition|0|||
48506614|NCT01518972|156048962|FG000|Overall Study|Missed safety visits|0|||
48506615|NCT01518972|156048963|FG001|Overall Study|Missed safety visits|1|||
48506616|NCT01518972|156048962|FG000|Overall Study|Exclusionary medication|0|||
48506617|NCT01518972|156048963|FG001|Overall Study|Exclusionary medication|1|||
48506618|NCT01518972|156048962|FG000|Overall Study|Declined medication starting on day 12|0|||
48506619|NCT01518972|156048963|FG001|Overall Study|Declined medication starting on day 12|1|||
48506620|NCT00667095|156048969|FG000|Overall Study|Withdrawal by Subject|0|||
48506621|NCT00667095|156048970|FG001|Overall Study|Withdrawal by Subject|1|||
48506622|NCT04407806|156048971|FG000|Overall Study|Withdrawal by Subject|1|||
48506623|NCT04407806|156048972|FG001|Overall Study|Withdrawal by Subject|2|||
48506624|NCT01520909|156048973|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
48725923|NCT01439347|156846557|FG001|Overall Study|Physician Decision|0|||
48725924|NCT01439347|156846556|FG000|Overall Study|Sponsor Terminated Study|2|||
48725925|NCT01439347|156846557|FG001|Overall Study|Sponsor Terminated Study|3|||
48725926|NCT03101267|156846558|FG000|Primary Study Period|Withdrawal by Subject|1|||
48725927|NCT03101267|156846559|FG001|Primary Study Period|Withdrawal by Subject|2|||
48725928|NCT03101267|156846560|FG002|Primary Study Period|Withdrawal by Subject|3|||
48725929|NCT03101267|156846558|FG000|Primary Study Period|Miscellaneous|2|||
48725930|NCT03101267|156846559|FG001|Primary Study Period|Miscellaneous|0|||
48725931|NCT03101267|156846560|FG002|Primary Study Period|Miscellaneous|0|||
48725932|NCT04322539|156846561|FG000|Overall Study|Withdrawal of consent|14|||
48725933|NCT04322539|156846562|FG001|Overall Study|Withdrawal of consent|8|||
48725934|NCT04322539|156846561|FG000|Overall Study|Death|317|||
48725935|NCT04322539|156846562|FG001|Overall Study|Death|173|||
48725936|NCT04322539|156846561|FG000|Overall Study|Adverse Event|1|||
48725937|NCT04322539|156846562|FG001|Overall Study|Adverse Event|0|||
48725938|NCT04322539|156846561|FG000|Overall Study|Lost to Follow-up|3|||
48725939|NCT04322539|156846562|FG001|Overall Study|Lost to Follow-up|0|||
48725940|NCT04322539|156846561|FG000|Overall Study|Other|2|||
48725941|NCT04322539|156846562|FG001|Overall Study|Other|3|||
48725942|NCT04322539|156846561|FG000|Overall Study|Ongoing|124|||
48725943|NCT04322539|156846562|FG001|Overall Study|Ongoing|46|||
48506625|NCT01520909|156048974|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
48506626|NCT01520909|156048975|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
48506627|NCT01520909|156048973|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
48506628|NCT01520909|156048974|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
48506629|NCT01520909|156048975|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
48506630|NCT01520909|156048973|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
48506631|NCT01520909|156048974|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
48506632|NCT01520909|156048975|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
48506633|NCT01520909|156048973|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
48506634|NCT01520909|156048974|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
48506635|NCT01520909|156048975|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
48506636|NCT03447262|156048976|FG000|Overall Study|Adverse Event|7|||
48506637|NCT03447262|156048976|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
48506638|NCT03447262|156048976|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
48506639|NCT03447262|156048976|FG000|Overall Study|Death|2|||
48506640|NCT03447262|156048976|FG000|Overall Study|Study Termination by Sponsor|455|||
48506641|NCT03447262|156048976|FG000|Overall Study|Other|4|||
48506642|NCT01882257|156048978|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
48506643|NCT01882257|156048979|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
48506644|NCT01882257|156048980|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
48506645|NCT01882257|156048978|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
48506646|NCT01882257|156048979|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
48506647|NCT01882257|156048980|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
48506648|NCT00830206|156048982|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
48506649|NCT00830206|156048983|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
48506650|NCT01866319|156048989|FG000|Overall Study|Adverse Event|12|||
48506651|NCT01866319|156048990|FG001|Overall Study|Adverse Event|5|||
48506652|NCT01866319|156048991|FG002|Overall Study|Adverse Event|9|||
48506653|NCT01866319|156048989|FG000|Overall Study|Clinical progression|3|||
48506654|NCT01866319|156048990|FG001|Overall Study|Clinical progression|2|||
48506655|NCT01866319|156048991|FG002|Overall Study|Clinical progression|2|||
48506656|NCT01866319|156048989|FG000|Overall Study|Death|153|||
48506657|NCT01866319|156048990|FG001|Overall Study|Death|154|||
48506658|NCT01866319|156048991|FG002|Overall Study|Death|147|||
48506659|NCT01866319|156048989|FG000|Overall Study|Lost to Follow-up|6|||
48506660|NCT01866319|156048990|FG001|Overall Study|Lost to Follow-up|3|||
48506661|NCT01866319|156048991|FG002|Overall Study|Lost to Follow-up|8|||
48725944|NCT01401959|156846563|FG000|Enrolled|Withdrawal by Subject|1|||
48725945|NCT01401959|156846564|FG001|Enrolled|Withdrawal by Subject|0|||
48725946|NCT01401959|156846565|FG002|Enrolled|Withdrawal by Subject|0|||
48725947|NCT01401959|156846563|FG000|Treated|Disease Progression|2|||
48725948|NCT01401959|156846564|FG001|Treated|Disease Progression|2|||
48725949|NCT01401959|156846565|FG002|Treated|Disease Progression|1|||
48725950|NCT01401959|156846563|FG000|Treated|Adverse Event|4|||
48725951|NCT01401959|156846564|FG001|Treated|Adverse Event|3|||
48725952|NCT01401959|156846565|FG002|Treated|Adverse Event|2|||
48725953|NCT01401959|156846563|FG000|Treated|Withdrawal by Subject|1|||
48725954|NCT01401959|156846564|FG001|Treated|Withdrawal by Subject|2|||
48725955|NCT01401959|156846565|FG002|Treated|Withdrawal by Subject|2|||
48725956|NCT01401959|156846563|FG000|Treated|Protocol Violation|0|||
48725957|NCT01401959|156846564|FG001|Treated|Protocol Violation|1|||
48725958|NCT01401959|156846565|FG002|Treated|Protocol Violation|0|||
48725959|NCT02925793|156846566|FG000|Overall Study|Adverse Event|3|||
48725960|NCT02925793|156846567|FG001|Overall Study|Adverse Event|3|||
48725961|NCT02925793|156846568|FG002|Overall Study|Adverse Event|6|||
48725962|NCT02925793|156846566|FG000|Overall Study|Withdrawal by Subject|16|||
48725963|NCT02925793|156846567|FG001|Overall Study|Withdrawal by Subject|15|||
48725964|NCT02925793|156846568|FG002|Overall Study|Withdrawal by Subject|13|||
48725965|NCT02925793|156846566|FG000|Overall Study|Investigator Discretion|0|||
48725966|NCT02925793|156846567|FG001|Overall Study|Investigator Discretion|1|||
48725967|NCT02925793|156846568|FG002|Overall Study|Investigator Discretion|1|||
48725968|NCT02925793|156846566|FG000|Overall Study|Lost to Follow-up|2|||
48725969|NCT02925793|156846567|FG001|Overall Study|Lost to Follow-up|3|||
48725970|NCT02925793|156846568|FG002|Overall Study|Lost to Follow-up|1|||
48725971|NCT02925793|156846566|FG000|Overall Study|Lack of Efficacy|2|||
48725972|NCT02925793|156846567|FG001|Overall Study|Lack of Efficacy|6|||
48725973|NCT02925793|156846568|FG002|Overall Study|Lack of Efficacy|4|||
48725974|NCT02925793|156846566|FG000|Overall Study|Other:|2|||
48725975|NCT02925793|156846567|FG001|Overall Study|Other:|1|||
48725976|NCT02925793|156846568|FG002|Overall Study|Other:|3|||
48725977|NCT01390220|156846570|FG000|Test Dose Phase|Adverse Event|17|||
48725978|NCT01390220|156846571|FG001|Test Dose Phase|Adverse Event|0|||
48506662|NCT01866319|156048989|FG000|Overall Study|Physician Decision|1|||
48725979|NCT01390220|156846572|FG002|Test Dose Phase|Adverse Event|0|||
48725980|NCT01390220|156846570|FG000|Test Dose Phase|Withdrawal by Subject|8|||
48725981|NCT01390220|156846571|FG001|Test Dose Phase|Withdrawal by Subject|0|||
48506663|NCT01866319|156048990|FG001|Overall Study|Physician Decision|0|||
48506664|NCT01866319|156048991|FG002|Overall Study|Physician Decision|1|||
48506665|NCT01866319|156048989|FG000|Overall Study|Protocol Violation|0|||
48506666|NCT01866319|156048990|FG001|Overall Study|Protocol Violation|0|||
48506667|NCT01866319|156048991|FG002|Overall Study|Protocol Violation|1|||
48506668|NCT01866319|156048989|FG000|Overall Study|Withdrawal by Subject|32|||
48506669|NCT01866319|156048990|FG001|Overall Study|Withdrawal by Subject|14|||
48506670|NCT01866319|156048991|FG002|Overall Study|Withdrawal by Subject|12|||
48506671|NCT04187833|156048993|FG000|Overall Study|Withdrawal by Subject|1|||
48506672|NCT01772537|156048995|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
48506673|NCT01772537|156048996|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
48506674|NCT01772537|156048997|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
48506675|NCT02511782|156048999|FG000|Overall Study|Withdrawal by Subject|1|||
48506676|NCT02511782|156049000|FG001|Overall Study|Withdrawal by Subject|0|||
48506677|NCT02511782|156049001|FG002|Overall Study|Withdrawal by Subject|0|||
48506678|NCT02098876|156049002|FG000|Overall Study|Withdrawal by Subject|5|||
48506679|NCT02098876|156049003|FG001|Overall Study|Withdrawal by Subject|5|||
48506680|NCT01061866|156049006|FG000|Overall Study|Adverse Event|2|||
48506681|NCT00450190|156049007|FG000|Overall Study|Withdrawal by Subject|2|||
48506682|NCT01270503|156049008|FG000|Overall Study|Lost to Follow-up|1|||
48506683|NCT02543203|156049009|FG000|Overall Study|Unpalatable Fragrance|2|||
48506684|NCT02543203|156049010|FG001|Overall Study|Unpalatable Fragrance|2|||
48506685|NCT02543203|156049009|FG000|Overall Study|Lost to Follow-up|1|||
48506686|NCT02543203|156049010|FG001|Overall Study|Lost to Follow-up|0|||
48506687|NCT02543203|156049009|FG000|Overall Study|Increased Irritability|1|||
48506688|NCT02543203|156049010|FG001|Overall Study|Increased Irritability|0|||
48506689|NCT02543203|156049009|FG000|Overall Study|Family|1|||
48506690|NCT02543203|156049010|FG001|Overall Study|Family|2|||
48506691|NCT02543203|156049009|FG000|Overall Study|Negative Behavior|1|||
48506692|NCT02543203|156049010|FG001|Overall Study|Negative Behavior|0|||
48506693|NCT02543203|156049009|FG000|Overall Study|Withdrawal by Subject|0|||
48506694|NCT02543203|156049010|FG001|Overall Study|Withdrawal by Subject|1|||
48506695|NCT03020615|156049011|FG000|Overall Study|Physician Decision|3|||
48506696|NCT03020615|156049012|FG001|Overall Study|Physician Decision|1|||
48506697|NCT03020615|156049013|FG002|Overall Study|Physician Decision|2|||
48725982|NCT01390220|156846572|FG002|Test Dose Phase|Withdrawal by Subject|0|||
48725983|NCT01390220|156846570|FG000|Test Dose Phase|Lost to Follow-up|2|||
48725984|NCT01390220|156846571|FG001|Test Dose Phase|Lost to Follow-up|0|||
48725985|NCT01390220|156846572|FG002|Test Dose Phase|Lost to Follow-up|0|||
48725986|NCT01390220|156846570|FG000|Test Dose Phase|Protocol Violation|8|||
48725987|NCT01390220|156846571|FG001|Test Dose Phase|Protocol Violation|0|||
48725988|NCT01390220|156846572|FG002|Test Dose Phase|Protocol Violation|0|||
48725989|NCT01390220|156846570|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
48725990|NCT01390220|156846571|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
48725991|NCT01390220|156846572|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
48725992|NCT01390220|156846570|FG000|Test Dose Phase|Study/Site closure|6|||
48725993|NCT01390220|156846571|FG001|Test Dose Phase|Study/Site closure|0|||
48725994|NCT01390220|156846572|FG002|Test Dose Phase|Study/Site closure|0|||
48725995|NCT01390220|156846570|FG000|Test Dose Phase|Caregiver no longer available|5|||
48725996|NCT01390220|156846571|FG001|Test Dose Phase|Caregiver no longer available|0|||
48725997|NCT01390220|156846572|FG002|Test Dose Phase|Caregiver no longer available|0|||
48725998|NCT01390220|156846570|FG000|Test Dose Phase|Noncompliance|2|||
48725999|NCT01390220|156846571|FG001|Test Dose Phase|Noncompliance|0|||
48726000|NCT01390220|156846572|FG002|Test Dose Phase|Noncompliance|0|||
48726001|NCT01390220|156846570|FG000|Test Dose Phase|Logistical|6|||
48726002|NCT01390220|156846571|FG001|Test Dose Phase|Logistical|0|||
48726003|NCT01390220|156846572|FG002|Test Dose Phase|Logistical|0|||
48726004|NCT01390220|156846570|FG000|Comparative Phase|Withdrawal by Subject|0|||
48726005|NCT01390220|156846571|FG001|Comparative Phase|Withdrawal by Subject|1|||
48726006|NCT01390220|156846572|FG002|Comparative Phase|Withdrawal by Subject|0|||
48726007|NCT00249288|156846573|FG000|Overall Study|Lost to Follow-up|3|||
48726008|NCT00249288|156846574|FG001|Overall Study|Lost to Follow-up|3|||
48726009|NCT00249288|156846573|FG000|Overall Study|Withdrawal by Subject|2|||
48726010|NCT00249288|156846574|FG001|Overall Study|Withdrawal by Subject|2|||
48726011|NCT00829283|156846575|FG000|Overall Study|Lost to Follow-up|7|||
48726012|NCT00829283|156846576|FG001|Overall Study|Lost to Follow-up|25|||
48726013|NCT02414139|156846577|FG000|Treatment Period|Adverse Event|11|||
48726014|NCT02414139|156846578|FG001|Treatment Period|Adverse Event|6|||
48726015|NCT02414139|156846579|FG002|Treatment Period|Adverse Event|8|||
48726016|NCT02414139|156846580|FG003|Treatment Period|Adverse Event|5|||
48726017|NCT02414139|156846581|FG004|Treatment Period|Adverse Event|14|||
48726018|NCT02414139|156846582|FG005|Treatment Period|Adverse Event|3|||
48726019|NCT02414139|156846583|FG006|Treatment Period|Adverse Event|6|||
48506698|NCT03020615|156049011|FG000|Overall Study|Parent/guardian/patient choice|3|||
48506699|NCT03020615|156049012|FG001|Overall Study|Parent/guardian/patient choice|0|||
48506700|NCT03020615|156049013|FG002|Overall Study|Parent/guardian/patient choice|4|||
48506701|NCT03020615|156049011|FG000|Overall Study|Screen failure|0|||
48506702|NCT03020615|156049012|FG001|Overall Study|Screen failure|0|||
48506703|NCT03020615|156049013|FG002|Overall Study|Screen failure|1|||
48506704|NCT03020615|156049011|FG000|Overall Study|Death|1|||
48506705|NCT03020615|156049012|FG001|Overall Study|Death|0|||
48506706|NCT03020615|156049013|FG002|Overall Study|Death|0|||
48506707|NCT03020615|156049011|FG000|Overall Study|Lost to Follow-up|0|||
48506708|NCT03020615|156049012|FG001|Overall Study|Lost to Follow-up|1|||
48506709|NCT03020615|156049013|FG002|Overall Study|Lost to Follow-up|0|||
48506710|NCT02459951|156049014|FG000|Overall Study|Unable to meet holding requirement|1|||
48506711|NCT02077465|156049020|FG000|Overall Study|Withdrew Consent|0|||
48506712|NCT02077465|156049021|FG001|Overall Study|Withdrew Consent|1|||
48506713|NCT02077465|156049020|FG000|Overall Study|Lost to Follow-up|1|||
48506714|NCT02077465|156049021|FG001|Overall Study|Lost to Follow-up|0|||
48506715|NCT00834756|156049022|FG000|First Intervention|Adverse Event|1|||
48506716|NCT00834756|156049023|FG001|First Intervention|Adverse Event|0|||
48506717|NCT00834756|156049022|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
48506718|NCT00834756|156049023|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
48506719|NCT02711852|156049032|FG000|Overall Study|Death|5|||
48600384|NCT05556148|156393893|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
48600385|NCT05556148|156393893|FG000|Overall Study|No Longer Wished to Participate|1|||
48600386|NCT05556148|156393893|FG000|Overall Study|Bacterial Conjunctivitis|1|||
48600387|NCT03131167|156393898|FG000|Overall Study|Other (Unspecified)|0|||
48600388|NCT03131167|156393899|FG001|Overall Study|Other (Unspecified)|0|||
48600389|NCT03131167|156393900|FG002|Overall Study|Other (Unspecified)|0|||
48600390|NCT03131167|156393901|FG003|Overall Study|Other (Unspecified)|0|||
48600391|NCT03131167|156393902|FG004|Overall Study|Other (Unspecified)|0|||
48600392|NCT03131167|156393903|FG005|Overall Study|Other (Unspecified)|1|||
48600393|NCT03131167|156393904|FG006|Overall Study|Other (Unspecified)|0|||
48726020|NCT02414139|156846584|FG007|Treatment Period|Adverse Event|1|||
48726021|NCT02414139|156846585|FG008|Treatment Period|Adverse Event|6|||
48726022|NCT02414139|156846586|FG009|Treatment Period|Adverse Event|8|||
48726023|NCT02414139|156846577|FG000|Treatment Period|Death|0|||
48726024|NCT02414139|156846578|FG001|Treatment Period|Death|0|||
48726025|NCT02414139|156846579|FG002|Treatment Period|Death|1|||
48726026|NCT02414139|156846580|FG003|Treatment Period|Death|1|||
48726027|NCT02414139|156846581|FG004|Treatment Period|Death|0|||
48726028|NCT02414139|156846582|FG005|Treatment Period|Death|0|||
48726029|NCT02414139|156846583|FG006|Treatment Period|Death|0|||
48726030|NCT02414139|156846584|FG007|Treatment Period|Death|0|||
48726031|NCT02414139|156846585|FG008|Treatment Period|Death|0|||
48726032|NCT02414139|156846586|FG009|Treatment Period|Death|1|||
48726033|NCT02414139|156846577|FG000|Treatment Period|Physician Decision|5|||
48726034|NCT02414139|156846578|FG001|Treatment Period|Physician Decision|4|||
48726035|NCT02414139|156846579|FG002|Treatment Period|Physician Decision|6|||
48726036|NCT02414139|156846580|FG003|Treatment Period|Physician Decision|1|||
48726037|NCT02414139|156846581|FG004|Treatment Period|Physician Decision|4|||
48726038|NCT02414139|156846582|FG005|Treatment Period|Physician Decision|0|||
48726039|NCT02414139|156846583|FG006|Treatment Period|Physician Decision|2|||
48726040|NCT02414139|156846584|FG007|Treatment Period|Physician Decision|0|||
48726041|NCT02414139|156846585|FG008|Treatment Period|Physician Decision|1|||
48726042|NCT02414139|156846586|FG009|Treatment Period|Physician Decision|4|||
48726043|NCT02414139|156846577|FG000|Treatment Period|Progressive disease|48|||
48726044|NCT02414139|156846578|FG001|Treatment Period|Progressive disease|31|||
48726045|NCT02414139|156846579|FG002|Treatment Period|Progressive disease|37|||
48726046|NCT02414139|156846580|FG003|Treatment Period|Progressive disease|21|||
48726047|NCT02414139|156846581|FG004|Treatment Period|Progressive disease|43|||
48726048|NCT02414139|156846582|FG005|Treatment Period|Progressive disease|12|||
48726049|NCT02414139|156846583|FG006|Treatment Period|Progressive disease|16|||
48726050|NCT02414139|156846584|FG007|Treatment Period|Progressive disease|2|||
48726051|NCT02414139|156846585|FG008|Treatment Period|Progressive disease|20|||
48726052|NCT02414139|156846586|FG009|Treatment Period|Progressive disease|14|||
48726053|NCT02414139|156846577|FG000|Treatment Period|Protocol deviation|0|||
48726054|NCT02414139|156846578|FG001|Treatment Period|Protocol deviation|0|||
48726055|NCT02414139|156846579|FG002|Treatment Period|Protocol deviation|1|||
48726056|NCT02414139|156846580|FG003|Treatment Period|Protocol deviation|0|||
48726057|NCT02414139|156846581|FG004|Treatment Period|Protocol deviation|0|||
48726058|NCT02414139|156846582|FG005|Treatment Period|Protocol deviation|0|||
48726059|NCT02414139|156846583|FG006|Treatment Period|Protocol deviation|0|||
48726060|NCT02414139|156846584|FG007|Treatment Period|Protocol deviation|0|||
48506720|NCT02711852|156049032|FG000|Overall Study|Lost to Follow-up|1|||
48506721|NCT02711852|156049032|FG000|Overall Study|Completed follow-up|3|||
48600394|NCT03131167|156393905|FG007|Overall Study|Other (Unspecified)|0|||
48726061|NCT02414139|156846585|FG008|Treatment Period|Protocol deviation|0|||
48726062|NCT02414139|156846586|FG009|Treatment Period|Protocol deviation|0|||
48726063|NCT02414139|156846577|FG000|Treatment Period|Subject/Guardian decision|5|||
48726064|NCT02414139|156846578|FG001|Treatment Period|Subject/Guardian decision|1|||
48726065|NCT02414139|156846579|FG002|Treatment Period|Subject/Guardian decision|1|||
48726066|NCT02414139|156846580|FG003|Treatment Period|Subject/Guardian decision|2|||
48600395|NCT03131167|156393906|FG008|Overall Study|Other (Unspecified)|0|||
48600396|NCT03131167|156393907|FG009|Overall Study|Other (Unspecified)|0|||
48600397|NCT03131167|156393908|FG010|Overall Study|Other (Unspecified)|0|||
48600398|NCT03131167|156393909|FG011|Overall Study|Other (Unspecified)|0|||
48600399|NCT03131167|156393910|FG012|Overall Study|Other (Unspecified)|0|||
48600400|NCT03286218|156393911|FG000|Qualification Phase Period 1|Adverse Event|1|||
48600401|NCT03286218|156393912|FG001|Qualification Phase Period 1|Adverse Event|0|||
48600402|NCT03286218|156393913|FG002|Qualification Phase Period 1|Adverse Event|0|||
48600403|NCT03286218|156393914|FG003|Qualification Phase Period 1|Adverse Event|0|||
48600404|NCT03286218|156393915|FG004|Qualification Phase Period 1|Adverse Event|0|||
48600405|NCT03286218|156393916|FG005|Qualification Phase Period 1|Adverse Event|0|||
48600406|NCT03286218|156393917|FG006|Qualification Phase Period 1|Adverse Event|0|||
48600407|NCT03286218|156393918|FG007|Qualification Phase Period 1|Adverse Event|0|||
48600408|NCT03286218|156393919|FG008|Qualification Phase Period 1|Adverse Event|0|||
48600409|NCT03286218|156393920|FG009|Qualification Phase Period 1|Adverse Event|0|||
48600410|NCT03286218|156393921|FG010|Qualification Phase Period 1|Adverse Event|0|||
48600411|NCT03286218|156393922|FG011|Qualification Phase Period 1|Adverse Event|0|||
48600412|NCT03286218|156393911|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600413|NCT03286218|156393912|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
48600414|NCT03286218|156393913|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600415|NCT03286218|156393914|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600416|NCT03286218|156393915|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600417|NCT03286218|156393916|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600418|NCT03286218|156393917|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600419|NCT03286218|156393918|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600420|NCT03286218|156393919|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600421|NCT03286218|156393920|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600422|NCT03286218|156393921|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600423|NCT03286218|156393922|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
48600424|NCT03286218|156393911|FG000|Qualification Phase Period 2|Adverse Event|0|||
48600425|NCT03286218|156393912|FG001|Qualification Phase Period 2|Adverse Event|1|||
48600426|NCT03286218|156393913|FG002|Qualification Phase Period 2|Adverse Event|0|||
48600427|NCT03286218|156393914|FG003|Qualification Phase Period 2|Adverse Event|0|||
48600428|NCT03286218|156393915|FG004|Qualification Phase Period 2|Adverse Event|0|||
48600429|NCT03286218|156393916|FG005|Qualification Phase Period 2|Adverse Event|0|||
48600430|NCT03286218|156393917|FG006|Qualification Phase Period 2|Adverse Event|0|||
48600431|NCT03286218|156393918|FG007|Qualification Phase Period 2|Adverse Event|0|||
48600432|NCT03286218|156393919|FG008|Qualification Phase Period 2|Adverse Event|0|||
48600433|NCT03286218|156393920|FG009|Qualification Phase Period 2|Adverse Event|0|||
48600434|NCT03286218|156393921|FG010|Qualification Phase Period 2|Adverse Event|0|||
48600435|NCT03286218|156393922|FG011|Qualification Phase Period 2|Adverse Event|0|||
48600436|NCT03286218|156393911|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
48600437|NCT03286218|156393912|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
48600438|NCT03286218|156393913|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600439|NCT03286218|156393914|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600440|NCT03286218|156393915|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600441|NCT03286218|156393916|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600442|NCT03286218|156393917|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600443|NCT03286218|156393918|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600444|NCT03286218|156393919|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600445|NCT03286218|156393920|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600446|NCT03286218|156393921|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600447|NCT03286218|156393922|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
48600448|NCT03286218|156393911|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
48600449|NCT03286218|156393912|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
48600450|NCT03286218|156393913|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
48600451|NCT03286218|156393914|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
48600452|NCT03286218|156393915|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
48820611|NCT00783718|157185577|FG006|Induction Phase|Protocol Violation|0|||
48820612|NCT00783718|157185571|FG000|Induction Phase|Lack of Efficacy|5|||
48600453|NCT03286218|156393916|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
48600454|NCT03286218|156393917|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
48600455|NCT03286218|156393918|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
48600456|NCT03286218|156393919|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
48600457|NCT03286218|156393920|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
48600458|NCT03286218|156393921|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
48600459|NCT03286218|156393922|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
48820613|NCT00783718|157185572|FG001|Induction Phase|Lack of Efficacy|2|||
48820614|NCT00783718|157185573|FG002|Induction Phase|Lack of Efficacy|14|||
48820615|NCT00783718|157185574|FG003|Induction Phase|Lack of Efficacy|0|||
48820616|NCT00783718|157185575|FG004|Induction Phase|Lack of Efficacy|0|||
48820617|NCT00783718|157185576|FG005|Induction Phase|Lack of Efficacy|0|||
48820618|NCT00783718|157185577|FG006|Induction Phase|Lack of Efficacy|0|||
48820619|NCT00783718|157185571|FG000|Induction Phase|Withdrawal by Subject|3|||
48820620|NCT00783718|157185572|FG001|Induction Phase|Withdrawal by Subject|4|||
48506722|NCT02711852|156049032|FG000|Overall Study|Withdrawal by Subject|1|||
48506723|NCT00537979|156049033|FG000|Overall Study|Adverse Event|2|||
48506724|NCT00537979|156049034|FG001|Overall Study|Adverse Event|2|||
48506725|NCT00537979|156049033|FG000|Overall Study|Withdrawal by Subject|1|||
48506726|NCT00537979|156049034|FG001|Overall Study|Withdrawal by Subject|4|||
48506727|NCT00537979|156049033|FG000|Overall Study|Lost to Follow-up|1|||
48506728|NCT00537979|156049034|FG001|Overall Study|Lost to Follow-up|4|||
48506729|NCT00537979|156049033|FG000|Overall Study|Lack of Efficacy|0|||
48506730|NCT00537979|156049034|FG001|Overall Study|Lack of Efficacy|1|||
48506731|NCT00537979|156049033|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
48506732|NCT00537979|156049034|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
48506733|NCT00537979|156049033|FG000|Overall Study|Death|0|||
48506734|NCT00537979|156049034|FG001|Overall Study|Death|3|||
48506735|NCT00537979|156049033|FG000|Overall Study|Kidney transplant|0|||
48506736|NCT00537979|156049034|FG001|Overall Study|Kidney transplant|3|||
48506737|NCT00537979|156049033|FG000|Overall Study|Heart failure|0|||
48506738|NCT00537979|156049034|FG001|Overall Study|Heart failure|1|||
48506739|NCT02412852|156049035|FG000|Overall Study|Withdrawal by Subject|0|||
48600460|NCT03286218|156393911|FG000|Qualification Phase Period 2|Protocol Violation|2|||
48600461|NCT03286218|156393912|FG001|Qualification Phase Period 2|Protocol Violation|0|||
48600462|NCT03286218|156393913|FG002|Qualification Phase Period 2|Protocol Violation|0|||
48600463|NCT03286218|156393914|FG003|Qualification Phase Period 2|Protocol Violation|0|||
48600464|NCT03286218|156393915|FG004|Qualification Phase Period 2|Protocol Violation|0|||
48820621|NCT00783718|157185573|FG002|Induction Phase|Withdrawal by Subject|8|||
48506740|NCT02412852|156049036|FG001|Overall Study|Withdrawal by Subject|1|||
48506741|NCT02412852|156049037|FG002|Overall Study|Withdrawal by Subject|0|||
48506742|NCT02412852|156049038|FG003|Overall Study|Withdrawal by Subject|0|||
48506743|NCT02412852|156049035|FG000|Overall Study|Physician Decision|0|||
48506744|NCT02412852|156049036|FG001|Overall Study|Physician Decision|0|||
48506745|NCT02412852|156049037|FG002|Overall Study|Physician Decision|0|||
48506746|NCT02412852|156049038|FG003|Overall Study|Physician Decision|1|||
48506747|NCT03459807|156049041|FG000|Overall Study|Withdrawal due to transplant|0|||
48506748|NCT03459807|156049042|FG001|Overall Study|Withdrawal due to transplant|1|||
48506749|NCT02414152|156049043|FG000|Overall Study|Withdrawal by Subject|1|||
48506750|NCT02414152|156049043|FG000|Overall Study|Lack of Efficacy|1|||
48506751|NCT00214422|156049053|FG000|Overall Study|Physician Decision|2|||
48506752|NCT00214422|156049054|FG001|Overall Study|Physician Decision|0|||
48506753|NCT00214422|156049055|FG002|Overall Study|Physician Decision|0|||
48506754|NCT00214422|156049053|FG000|Overall Study|Developed esophageal ca|1|||
48506755|NCT00214422|156049054|FG001|Overall Study|Developed esophageal ca|0|||
48506756|NCT00214422|156049055|FG002|Overall Study|Developed esophageal ca|0|||
48506757|NCT00214422|156049053|FG000|Overall Study|Pt taken off study|1|||
48506758|NCT00214422|156049054|FG001|Overall Study|Pt taken off study|1|||
48506759|NCT00214422|156049055|FG002|Overall Study|Pt taken off study|0|||
48506760|NCT00214422|156049053|FG000|Overall Study|Disease progression on study|1|||
48506761|NCT00214422|156049054|FG001|Overall Study|Disease progression on study|0|||
48506762|NCT00214422|156049055|FG002|Overall Study|Disease progression on study|0|||
48506763|NCT00214422|156049053|FG000|Overall Study|Unable to make a radiation treatment|0|||
48506764|NCT00214422|156049054|FG001|Overall Study|Unable to make a radiation treatment|0|||
48506765|NCT00214422|156049055|FG002|Overall Study|Unable to make a radiation treatment|1|||
48506766|NCT03134222|156049056|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
48506767|NCT03134222|156049057|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
48506768|NCT03134222|156049058|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
48506769|NCT03134222|156049059|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
48506770|NCT03134222|156049060|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
48506771|NCT03134222|156049056|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
48506772|NCT03134222|156049057|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
48506773|NCT03134222|156049058|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
48506774|NCT03134222|156049059|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
48506775|NCT03134222|156049060|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
48506776|NCT03134222|156049056|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
48506777|NCT03134222|156049057|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
48506778|NCT03134222|156049058|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
48506779|NCT03134222|156049059|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
48820622|NCT00783718|157185574|FG003|Induction Phase|Withdrawal by Subject|0|||
48506780|NCT03134222|156049060|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
48506781|NCT03134222|156049056|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
48820623|NCT00783718|157185575|FG004|Induction Phase|Withdrawal by Subject|0|||
48820624|NCT00783718|157185576|FG005|Induction Phase|Withdrawal by Subject|0|||
48820625|NCT00783718|157185577|FG006|Induction Phase|Withdrawal by Subject|0|||
48820626|NCT00783718|157185571|FG000|Induction Phase|Lost to Follow-up|1|||
48820627|NCT00783718|157185572|FG001|Induction Phase|Lost to Follow-up|0|||
48820628|NCT00783718|157185573|FG002|Induction Phase|Lost to Follow-up|1|||
48820629|NCT00783718|157185574|FG003|Induction Phase|Lost to Follow-up|0|||
48820630|NCT00783718|157185575|FG004|Induction Phase|Lost to Follow-up|0|||
48506782|NCT03134222|156049057|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
48506783|NCT03134222|156049058|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
48506784|NCT03134222|156049059|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
48506785|NCT03134222|156049060|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
48506786|NCT03134222|156049056|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
48506787|NCT03134222|156049057|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
48506788|NCT03134222|156049058|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
48506789|NCT03134222|156049059|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
48506790|NCT03134222|156049060|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
48506791|NCT03134222|156049056|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
48506792|NCT03134222|156049057|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
48506793|NCT03134222|156049058|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
48506794|NCT03134222|156049059|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
48506795|NCT03134222|156049060|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
48506796|NCT03134222|156049056|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
48506797|NCT03134222|156049057|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
48506798|NCT03134222|156049058|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
48506799|NCT03134222|156049059|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
48506800|NCT03134222|156049060|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
48506801|NCT03134222|156049056|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
48506802|NCT03134222|156049057|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
48506803|NCT03134222|156049058|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
48506804|NCT03134222|156049059|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
48506805|NCT03134222|156049060|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
48820631|NCT00783718|157185576|FG005|Induction Phase|Lost to Follow-up|0|||
48820632|NCT00783718|157185577|FG006|Induction Phase|Lost to Follow-up|0|||
48820633|NCT00783718|157185571|FG000|Maintenance Phase|Adverse Event|12|||
48506806|NCT02089997|156049061|FG000|Overall Study|Case report forms uncollected|99|||
48506807|NCT02089997|156049061|FG000|Overall Study|Protocol Violation|147|||
48506808|NCT03600376|156049062|FG000|Overall Study|Adverse Event|1|||
48506809|NCT03600376|156049063|FG001|Overall Study|Adverse Event|1|||
48506810|NCT03600376|156049062|FG000|Overall Study|Transferred to other facility|1|||
48506811|NCT03600376|156049063|FG001|Overall Study|Transferred to other facility|0|||
48506812|NCT03600376|156049062|FG000|Overall Study|Investigator Decision|0|||
48506813|NCT03600376|156049063|FG001|Overall Study|Investigator Decision|4|||
48506814|NCT03600376|156049062|FG000|Overall Study|Determined to be ineligible for study|0|||
48506815|NCT03600376|156049063|FG001|Overall Study|Determined to be ineligible for study|1|||
48506816|NCT00415363|156049064|FG000|Overall Study|Withdrawal by Subject|4|||
48506817|NCT00415363|156049065|FG001|Overall Study|Withdrawal by Subject|4|||
48506818|NCT00415363|156049064|FG000|Overall Study|Adverse Event|4|||
48506819|NCT00415363|156049065|FG001|Overall Study|Adverse Event|4|||
48506820|NCT00415363|156049064|FG000|Overall Study|Lost to Follow-up|2|||
48506821|NCT00415363|156049065|FG001|Overall Study|Lost to Follow-up|1|||
48506822|NCT00415363|156049064|FG000|Overall Study|Physician Decision|3|||
48506823|NCT00415363|156049065|FG001|Overall Study|Physician Decision|1|||
48506824|NCT00415363|156049064|FG000|Overall Study|Death|16|||
48506825|NCT00415363|156049065|FG001|Overall Study|Death|12|||
48506826|NCT00415363|156049064|FG000|Overall Study|Progressive disease|26|||
48506827|NCT00415363|156049065|FG001|Overall Study|Progressive disease|32|||
48506828|NCT01880593|156049069|FG000|Overall Study|Adverse Event|1|||
48506829|NCT01880593|156049070|FG001|Overall Study|Adverse Event|0|||
48506830|NCT01880593|156049069|FG000|Overall Study|Lack of Efficacy|1|||
48820634|NCT00783718|157185572|FG001|Maintenance Phase|Adverse Event|0|||
48506831|NCT01880593|156049070|FG001|Overall Study|Lack of Efficacy|5|||
48506832|NCT01880593|156049069|FG000|Overall Study|Withdrawal by Subject|6|||
48506833|NCT01880593|156049070|FG001|Overall Study|Withdrawal by Subject|1|||
48506834|NCT03206177|156049071|FG000|Overall Study|Withdrawal by Subject|1|||
48506835|NCT00705536|156050414|FG000|Start Period 1|Withdrawal by Subject|0|||
48506836|NCT00705536|156050415|FG001|Start Period 1|Withdrawal by Subject|0|||
48506837|NCT00705536|156050416|FG002|Start Period 1|Withdrawal by Subject|0|||
48506838|NCT00705536|156050417|FG003|Start Period 1|Withdrawal by Subject|1|||
48506839|NCT02918877|156050418|FG000|Overall Study|Withdrawal by Subject|2|||
48820635|NCT00783718|157185573|FG002|Maintenance Phase|Adverse Event|0|||
48506840|NCT02918877|156050419|FG001|Overall Study|Withdrawal by Subject|2|||
48506841|NCT02918877|156050418|FG000|Overall Study|Surgery cancelled|1|||
48506842|NCT02918877|156050419|FG001|Overall Study|Surgery cancelled|0|||
48600465|NCT03286218|156393916|FG005|Qualification Phase Period 2|Protocol Violation|0|||
48600466|NCT03286218|156393917|FG006|Qualification Phase Period 2|Protocol Violation|0|||
48600467|NCT03286218|156393918|FG007|Qualification Phase Period 2|Protocol Violation|0|||
48600468|NCT03286218|156393919|FG008|Qualification Phase Period 2|Protocol Violation|0|||
48506843|NCT02918877|156050418|FG000|Overall Study|Physician Decision|1|||
48506844|NCT02918877|156050419|FG001|Overall Study|Physician Decision|0|||
48506845|NCT02918877|156050418|FG000|Overall Study|Received intraoperative steroids|1|||
48506846|NCT02918877|156050419|FG001|Overall Study|Received intraoperative steroids|0|||
48506847|NCT02918877|156050418|FG000|Overall Study|Unable to obtain lab samples|1|||
48506848|NCT02918877|156050419|FG001|Overall Study|Unable to obtain lab samples|0|||
48506849|NCT02918877|156050418|FG000|Overall Study|Unsafe to perform BAL|0|||
48506850|NCT02918877|156050419|FG001|Overall Study|Unsafe to perform BAL|1|||
48506851|NCT00496964|156050434|FG000|Overall Study|Withdrawal by Subject|0|||
48506852|NCT00496964|156050435|FG001|Overall Study|Withdrawal by Subject|1|||
48506853|NCT02058498|156050439|FG000|Overall Study|Withdrawal by Subject|4|||
48506854|NCT03478397|156050440|FG000|Overall Study|Refused to participate|31|||
48506855|NCT03478397|156050441|FG001|Overall Study|Refused to participate|7|||
48506856|NCT01328093|156050442|FG000|Double-Blind Phase|Adverse Event|78|||
48506857|NCT01328093|156050443|FG001|Double-Blind Phase|Adverse Event|15|||
48506858|NCT01328093|156050442|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
48506859|NCT01328093|156050443|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
48506860|NCT01328093|156050442|FG000|Double-Blind Phase|Lost to Follow-up|39|||
48506861|NCT01328093|156050443|FG001|Double-Blind Phase|Lost to Follow-up|14|||
48506862|NCT01328093|156050442|FG000|Double-Blind Phase|Protocol Violation|30|||
48506863|NCT01328093|156050443|FG001|Double-Blind Phase|Protocol Violation|10|||
48506864|NCT01328093|156050442|FG000|Double-Blind Phase|Lack of Efficacy|55|||
48506865|NCT01328093|156050443|FG001|Double-Blind Phase|Lack of Efficacy|13|||
48506866|NCT01328093|156050442|FG000|Double-Blind Phase|Sponsor Decision|17|||
48506867|NCT01328093|156050443|FG001|Double-Blind Phase|Sponsor Decision|3|||
48506868|NCT01328093|156050442|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
48506869|NCT01328093|156050443|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
48506870|NCT01328093|156050442|FG000|Double-Blind Phase|Scheduling conflict|8|||
48506871|NCT01328093|156050443|FG001|Double-Blind Phase|Scheduling conflict|3|||
48506872|NCT01328093|156050442|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
48506873|NCT01328093|156050443|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
48506874|NCT01328093|156050442|FG000|Double-Blind Phase|Death|1|||
48506875|NCT01328093|156050443|FG001|Double-Blind Phase|Death|0|||
48506876|NCT01328093|156050442|FG000|Open-Label Phase|Sponsor Decision|98|||
48506877|NCT01328093|156050443|FG001|Open-Label Phase|Sponsor Decision|34|||
48506878|NCT01328093|156050442|FG000|Open-Label Phase|Protocol Violation|8|||
48506879|NCT01328093|156050443|FG001|Open-Label Phase|Protocol Violation|3|||
48506880|NCT01328093|156050442|FG000|Open-Label Phase|Lost to Follow-up|10|||
48506881|NCT01328093|156050443|FG001|Open-Label Phase|Lost to Follow-up|1|||
48506882|NCT01328093|156050442|FG000|Open-Label Phase|Adverse Event|10|||
48506883|NCT01328093|156050443|FG001|Open-Label Phase|Adverse Event|4|||
48506884|NCT01328093|156050442|FG000|Open-Label Phase|Lack of Efficacy|5|||
48506885|NCT01328093|156050443|FG001|Open-Label Phase|Lack of Efficacy|6|||
48506886|NCT01328093|156050442|FG000|Open-Label Phase|Withdrawal by Subject|4|||
48506887|NCT01328093|156050443|FG001|Open-Label Phase|Withdrawal by Subject|1|||
48506888|NCT01328093|156050442|FG000|Open-Label Phase|Scheduling conflict|2|||
48506889|NCT01328093|156050443|FG001|Open-Label Phase|Scheduling conflict|1|||
48506890|NCT01328093|156050442|FG000|Open-Label Phase|Subject is moving or has moved|2|||
48506891|NCT01328093|156050443|FG001|Open-Label Phase|Subject is moving or has moved|0|||
48506892|NCT01328093|156050442|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
48600469|NCT03286218|156393920|FG009|Qualification Phase Period 2|Protocol Violation|0|||
48506893|NCT01328093|156050443|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
48506894|NCT03195491|156050444|FG000|Overall Study|Study drug toxicity|25|||
48506895|NCT03195491|156050445|FG001|Overall Study|Study drug toxicity|3|||
48506896|NCT03195491|156050444|FG000|Overall Study|Maximum clinical benefit|5|||
48506897|NCT03195491|156050445|FG001|Overall Study|Maximum clinical benefit|0|||
48506898|NCT03195491|156050444|FG000|Overall Study|Lost to Follow-up|1|||
48506899|NCT03195491|156050445|FG001|Overall Study|Lost to Follow-up|0|||
48506900|NCT03195491|156050444|FG000|Overall Study|Death|3|||
48506901|NCT03195491|156050445|FG001|Overall Study|Death|0|||
48506902|NCT03195491|156050444|FG000|Overall Study|Adverse event unrelated to study drug|19|||
48600470|NCT03286218|156393921|FG010|Qualification Phase Period 2|Protocol Violation|0|||
48820636|NCT00783718|157185574|FG003|Maintenance Phase|Adverse Event|15|||
48506903|NCT03195491|156050445|FG001|Overall Study|Adverse event unrelated to study drug|2|||
48506904|NCT03195491|156050444|FG000|Overall Study|Disease progression|266|||
48506905|NCT03195491|156050445|FG001|Overall Study|Disease progression|8|||
48506906|NCT03195491|156050444|FG000|Overall Study|Other reasons|10|||
48506907|NCT03195491|156050445|FG001|Overall Study|Other reasons|0|||
48506908|NCT03195491|156050444|FG000|Overall Study|Participant withdrew consent|8|||
48506909|NCT03195491|156050445|FG001|Overall Study|Participant withdrew consent|1|||
48506910|NCT03195491|156050444|FG000|Overall Study|Participant no longer meets study criteria|0|||
48506911|NCT03195491|156050445|FG001|Overall Study|Participant no longer meets study criteria|1|||
48506912|NCT03195491|156050444|FG000|Overall Study|Participant request to discontinue study treatment|10|||
48506913|NCT03195491|156050445|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48506914|NCT03627091|156050446|FG000|Overall Study|Adverse Event|0|||
48506915|NCT03627091|156050447|FG001|Overall Study|Adverse Event|0|||
48506916|NCT03627091|156050448|FG002|Overall Study|Adverse Event|2|||
48506917|NCT03627091|156050446|FG000|Overall Study|Withdrawal by Subject|2|||
48506918|NCT03627091|156050447|FG001|Overall Study|Withdrawal by Subject|0|||
48506919|NCT03627091|156050448|FG002|Overall Study|Withdrawal by Subject|2|||
48506920|NCT03627091|156050446|FG000|Overall Study|Physician Decision|2|||
48506921|NCT03627091|156050447|FG001|Overall Study|Physician Decision|0|||
48726067|NCT02414139|156846581|FG004|Treatment Period|Subject/Guardian decision|5|||
48726068|NCT02414139|156846582|FG005|Treatment Period|Subject/Guardian decision|0|||
48726069|NCT02414139|156846583|FG006|Treatment Period|Subject/Guardian decision|2|||
48726070|NCT02414139|156846584|FG007|Treatment Period|Subject/Guardian decision|0|||
48726071|NCT02414139|156846585|FG008|Treatment Period|Subject/Guardian decision|1|||
48726072|NCT02414139|156846586|FG009|Treatment Period|Subject/Guardian decision|1|||
48726073|NCT02414139|156846577|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726074|NCT02414139|156846578|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726075|NCT02414139|156846579|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726076|NCT02414139|156846580|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726077|NCT02414139|156846581|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
48726078|NCT02414139|156846582|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726079|NCT02414139|156846583|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
48726080|NCT02414139|156846584|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
48726081|NCT02414139|156846585|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
48726082|NCT02414139|156846586|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
48726083|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
48726084|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726085|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726086|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726087|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
48726088|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726089|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726090|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726091|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726092|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48726093|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Death|0|||
48726094|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Death|1|||
48726095|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Death|0|||
48726096|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Death|0|||
48726097|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Death|1|||
48726098|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Death|0|||
48726099|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Death|0|||
48726100|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Death|0|||
48726101|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Death|0|||
48726102|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Death|1|||
48726103|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
48726104|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726105|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726106|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726107|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726108|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726109|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726110|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726111|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726112|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
48726113|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
48726114|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
48726115|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
48726116|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
48726117|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
48726118|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48726119|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48726120|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48726121|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48726122|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48726123|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
48820637|NCT00783718|157185575|FG004|Maintenance Phase|Adverse Event|7|||
48820638|NCT00783718|157185576|FG005|Maintenance Phase|Adverse Event|6|||
48820639|NCT00783718|157185577|FG006|Maintenance Phase|Adverse Event|16|||
48820640|NCT00783718|157185571|FG000|Maintenance Phase|Protocol Violation|1|||
48820641|NCT00783718|157185572|FG001|Maintenance Phase|Protocol Violation|0|||
48820642|NCT00783718|157185573|FG002|Maintenance Phase|Protocol Violation|0|||
48820643|NCT00783718|157185574|FG003|Maintenance Phase|Protocol Violation|0|||
48820644|NCT00783718|157185575|FG004|Maintenance Phase|Protocol Violation|0|||
48820645|NCT00783718|157185576|FG005|Maintenance Phase|Protocol Violation|0|||
48820646|NCT00783718|157185577|FG006|Maintenance Phase|Protocol Violation|2|||
48820647|NCT00783718|157185571|FG000|Maintenance Phase|Lack of Efficacy|83|||
48820648|NCT00783718|157185572|FG001|Maintenance Phase|Lack of Efficacy|0|||
48820649|NCT00783718|157185573|FG002|Maintenance Phase|Lack of Efficacy|0|||
48820650|NCT00783718|157185574|FG003|Maintenance Phase|Lack of Efficacy|61|||
48820651|NCT00783718|157185575|FG004|Maintenance Phase|Lack of Efficacy|31|||
48820652|NCT00783718|157185576|FG005|Maintenance Phase|Lack of Efficacy|33|||
48820653|NCT00783718|157185577|FG006|Maintenance Phase|Lack of Efficacy|155|||
48820654|NCT00783718|157185571|FG000|Maintenance Phase|Withdrawal by Subject|6|||
48820655|NCT00783718|157185572|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48820656|NCT00783718|157185573|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48820657|NCT00783718|157185574|FG003|Maintenance Phase|Withdrawal by Subject|2|||
48820658|NCT00783718|157185575|FG004|Maintenance Phase|Withdrawal by Subject|5|||
48820659|NCT00783718|157185576|FG005|Maintenance Phase|Withdrawal by Subject|2|||
48820660|NCT00783718|157185577|FG006|Maintenance Phase|Withdrawal by Subject|20|||
48820661|NCT00783718|157185571|FG000|Maintenance Phase|Lost to Follow-up|3|||
48820662|NCT00783718|157185572|FG001|Maintenance Phase|Lost to Follow-up|0|||
48820663|NCT00783718|157185573|FG002|Maintenance Phase|Lost to Follow-up|0|||
48820664|NCT00783718|157185574|FG003|Maintenance Phase|Lost to Follow-up|0|||
48820665|NCT00783718|157185575|FG004|Maintenance Phase|Lost to Follow-up|2|||
48820666|NCT00783718|157185576|FG005|Maintenance Phase|Lost to Follow-up|0|||
48820667|NCT00783718|157185577|FG006|Maintenance Phase|Lost to Follow-up|2|||
48820668|NCT04668144|157185587|FG000|Overall Study|Protocol Violation|0|||
48506922|NCT03627091|156050448|FG002|Overall Study|Physician Decision|0|||
48506923|NCT03627091|156050446|FG000|Overall Study|Site terminated by sponsor|0|||
48506924|NCT03627091|156050447|FG001|Overall Study|Site terminated by sponsor|1|||
48600471|NCT03286218|156393922|FG011|Qualification Phase Period 2|Protocol Violation|0|||
48600472|NCT03286218|156393911|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
48600473|NCT03286218|156393912|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
48600474|NCT03286218|156393913|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
48600475|NCT03286218|156393914|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
48600476|NCT03286218|156393915|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
48506925|NCT03627091|156050448|FG002|Overall Study|Site terminated by sponsor|0|||
48506926|NCT03627091|156050446|FG000|Overall Study|Disease relapse|7|||
48506927|NCT03627091|156050447|FG001|Overall Study|Disease relapse|5|||
48506928|NCT03627091|156050448|FG002|Overall Study|Disease relapse|1|||
48506929|NCT03627091|156050446|FG000|Overall Study|Other|1|||
48506930|NCT03627091|156050447|FG001|Overall Study|Other|0|||
48506931|NCT03627091|156050448|FG002|Overall Study|Other|0|||
48506932|NCT00089661|156050449|FG000|Overall Study|Adverse Event|0|||
48506933|NCT00089661|156050450|FG001|Overall Study|Adverse Event|2|||
48506934|NCT00089661|156050449|FG000|Overall Study|Death|1|||
48506935|NCT00089661|156050450|FG001|Overall Study|Death|0|||
48506936|NCT00089661|156050449|FG000|Overall Study|Lost to Follow-up|0|||
48506937|NCT00089661|156050450|FG001|Overall Study|Lost to Follow-up|3|||
48506938|NCT00089661|156050449|FG000|Overall Study|Withdrawal by Subject|11|||
48506939|NCT00089661|156050450|FG001|Overall Study|Withdrawal by Subject|9|||
48506940|NCT00089661|156050449|FG000|Overall Study|Disease progression|1|||
48506941|NCT00089661|156050450|FG001|Overall Study|Disease progression|3|||
48506942|NCT00089661|156050449|FG000|Overall Study|Ineligibility determined|4|||
48506943|NCT00089661|156050450|FG001|Overall Study|Ineligibility determined|4|||
48506944|NCT00089661|156050449|FG000|Overall Study|Noncompliance|2|||
48506945|NCT00089661|156050450|FG001|Overall Study|Noncompliance|4|||
48600477|NCT03286218|156393916|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
48600478|NCT03286218|156393917|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
48506946|NCT00089661|156050449|FG000|Overall Study|Other|2|||
48506947|NCT00089661|156050450|FG001|Overall Study|Other|1|||
48820669|NCT04668144|157185588|FG001|Overall Study|Protocol Violation|1|||
48820670|NCT04668144|157185589|FG002|Overall Study|Protocol Violation|2|||
48820671|NCT03909165|157185590|FG000|Overall Study|Physician Decision|0|||
48820672|NCT03909165|157185591|FG001|Overall Study|Physician Decision|1|||
48820673|NCT03909165|157185592|FG002|Overall Study|Physician Decision|0|||
48506948|NCT03002077|156050453|FG000|Overall Study|Non-compliance with Study Drug|4|||
48820674|NCT03909165|157185593|FG003|Overall Study|Physician Decision|0|||
48820675|NCT03909165|157185594|FG004|Overall Study|Physician Decision|0|||
48506949|NCT03002077|156050453|FG000|Overall Study|Non-compliance w/Background ADT|1|||
48506950|NCT03002077|156050453|FG000|Overall Study|Study Terminated by Sponsor|257|||
48726124|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
48726125|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
48726126|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
48726127|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
48726128|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
48506951|NCT03002077|156050453|FG000|Overall Study|Site Terminated by Sponsor|5|||
48506952|NCT03002077|156050453|FG000|Overall Study|Miscellaneous Reasons|10|||
48506953|NCT03002077|156050453|FG000|Overall Study|Adverse Event|23|||
48506954|NCT03002077|156050453|FG000|Overall Study|Lack of Efficacy|20|||
48506955|NCT03002077|156050453|FG000|Overall Study|Withdrawal by Subject|72|||
48506956|NCT03002077|156050453|FG000|Overall Study|Lost to Follow-up|21|||
48506957|NCT03002077|156050453|FG000|Overall Study|Pregnancy|4|||
48506958|NCT03002077|156050453|FG000|Overall Study|Protocol Violation|21|||
48726129|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
48506959|NCT00296647|156050460|FG000|Overall Study|Death|4|||
48506960|NCT00296647|156050461|FG001|Overall Study|Death|1|||
48506961|NCT00296647|156050462|FG002|Overall Study|Death|2|||
48506962|NCT00296647|156050463|FG003|Overall Study|Death|1|||
48506963|NCT00296647|156050464|FG004|Overall Study|Death|1|||
48506964|NCT00296647|156050460|FG000|Overall Study|Withdrawal by Subject|28|||
48506965|NCT00296647|156050461|FG001|Overall Study|Withdrawal by Subject|27|||
48506966|NCT00296647|156050462|FG002|Overall Study|Withdrawal by Subject|32|||
48506967|NCT00296647|156050463|FG003|Overall Study|Withdrawal by Subject|16|||
48506968|NCT00296647|156050464|FG004|Overall Study|Withdrawal by Subject|19|||
48506969|NCT04060147|156050465|FG000|Overall Study|Withdrew consent|1|||
48506970|NCT00102440|156050472|FG000|Overall Study|Lost to Follow-up|25|||
48506971|NCT00102440|156050473|FG001|Overall Study|Lost to Follow-up|18|||
48506972|NCT00102440|156050474|FG002|Overall Study|Lost to Follow-up|21|||
48506973|NCT00102440|156050472|FG000|Overall Study|Adverse Event|16|||
48506974|NCT00102440|156050473|FG001|Overall Study|Adverse Event|23|||
48506975|NCT00102440|156050474|FG002|Overall Study|Adverse Event|8|||
48506976|NCT00102440|156050472|FG000|Overall Study|Gout Flare|10|||
48506977|NCT00102440|156050473|FG001|Overall Study|Gout Flare|28|||
48506978|NCT00102440|156050474|FG002|Overall Study|Gout Flare|9|||
48506979|NCT00102440|156050472|FG000|Overall Study|Personal Reason(s)|19|||
48506980|NCT00102440|156050473|FG001|Overall Study|Personal Reason(s)|13|||
48506981|NCT00102440|156050474|FG002|Overall Study|Personal Reason(s)|13|||
48506982|NCT00102440|156050472|FG000|Overall Study|Other|11|||
48506983|NCT00102440|156050473|FG001|Overall Study|Other|14|||
48506984|NCT00102440|156050474|FG002|Overall Study|Other|14|||
48506985|NCT00102440|156050472|FG000|Overall Study|Protocol Violation|7|||
48506986|NCT00102440|156050473|FG001|Overall Study|Protocol Violation|2|||
48506987|NCT00102440|156050474|FG002|Overall Study|Protocol Violation|1|||
48506988|NCT01376167|156050475|FG000|Overall Study|Lost to Follow-up|2|||
48506989|NCT01376167|156050476|FG001|Overall Study|Lost to Follow-up|4|||
48506990|NCT01376167|156050477|FG002|Overall Study|Lost to Follow-up|2|||
48506991|NCT01376167|156050475|FG000|Overall Study|Physician Decision|1|||
48506992|NCT01376167|156050476|FG001|Overall Study|Physician Decision|1|||
48506993|NCT01376167|156050477|FG002|Overall Study|Physician Decision|0|||
48506994|NCT01376167|156050475|FG000|Overall Study|Withdrawal by Subject|1|||
48506995|NCT01376167|156050476|FG001|Overall Study|Withdrawal by Subject|5|||
48506996|NCT01376167|156050477|FG002|Overall Study|Withdrawal by Subject|4|||
48506997|NCT04627038|156050479|FG000|Overall Study|Adverse Event|36|||
48506998|NCT04627038|156050480|FG001|Overall Study|Adverse Event|8|||
48506999|NCT04627038|156050479|FG000|Overall Study|Lost to Follow-up|1|||
48726130|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
48726131|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
48726132|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
48726133|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726134|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
48726135|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726136|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726137|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726138|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726139|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726140|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48726141|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
48507000|NCT04627038|156050480|FG001|Overall Study|Lost to Follow-up|0|||
48507001|NCT04627038|156050479|FG000|Overall Study|Physician Decision|0|||
48507002|NCT04627038|156050480|FG001|Overall Study|Physician Decision|1|||
48507003|NCT04627038|156050479|FG000|Overall Study|Protocol Violation|3|||
48507004|NCT04627038|156050480|FG001|Overall Study|Protocol Violation|1|||
48507005|NCT04627038|156050479|FG000|Overall Study|Withdrawal by Subject|13|||
48507006|NCT04627038|156050480|FG001|Overall Study|Withdrawal by Subject|3|||
48507007|NCT04627038|156050479|FG000|Overall Study|Non-compliance with study drug|0|||
48507008|NCT04627038|156050480|FG001|Overall Study|Non-compliance with study drug|1|||
48507009|NCT04627038|156050479|FG000|Overall Study|Prohibited Concomitant Medication|1|||
48507010|NCT04627038|156050480|FG001|Overall Study|Prohibited Concomitant Medication|0|||
48820676|NCT03909165|157185590|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48820677|NCT03909165|157185591|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48820678|NCT03909165|157185592|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48820679|NCT03909165|157185593|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48820680|NCT03909165|157185594|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48820681|NCT03909165|157185590|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48820682|NCT03909165|157185591|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
48820683|NCT03909165|157185592|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
48820684|NCT03909165|157185593|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
48820685|NCT03909165|157185594|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
48820686|NCT03909165|157185590|FG000|Overall Study|Previous Drug Exposure|0|||
48820687|NCT03909165|157185591|FG001|Overall Study|Previous Drug Exposure|0|||
48820688|NCT03909165|157185592|FG002|Overall Study|Previous Drug Exposure|1|||
48820689|NCT03909165|157185593|FG003|Overall Study|Previous Drug Exposure|0|||
48820690|NCT03909165|157185594|FG004|Overall Study|Previous Drug Exposure|0|||
48820691|NCT03909165|157185590|FG000|Overall Study|Early Discharge|1|||
48820692|NCT03909165|157185591|FG001|Overall Study|Early Discharge|0|||
48820693|NCT03909165|157185592|FG002|Overall Study|Early Discharge|0|||
48820694|NCT03909165|157185593|FG003|Overall Study|Early Discharge|0|||
48820695|NCT03909165|157185594|FG004|Overall Study|Early Discharge|0|||
48820696|NCT04159896|157185595|FG000|Overall Study|Lack of Efficacy|7|||
48820697|NCT04159896|157185595|FG000|Overall Study|Withdrawal by Subject|1|||
48820698|NCT04159896|157185595|FG000|Overall Study|Adverse Event|1|||
48820699|NCT04159896|157185595|FG000|Overall Study|A transient ischaemic attack|1|||
48820700|NCT04515849|157185606|FG000|Overall Study|Adverse Event|0|||
48820701|NCT04515849|157185607|FG001|Overall Study|Adverse Event|0|||
48820702|NCT04515849|157185608|FG002|Overall Study|Adverse Event|0|||
48820703|NCT04515849|157185609|FG003|Overall Study|Adverse Event|1|||
48820704|NCT04515849|157185610|FG004|Overall Study|Adverse Event|2|||
48820705|NCT04515849|157185606|FG000|Overall Study|Death|2|||
48820706|NCT04515849|157185607|FG001|Overall Study|Death|0|||
48820707|NCT04515849|157185608|FG002|Overall Study|Death|0|||
48820708|NCT04515849|157185609|FG003|Overall Study|Death|0|||
48820709|NCT04515849|157185610|FG004|Overall Study|Death|0|||
48820710|NCT04515849|157185606|FG000|Overall Study|Other:family emergency|0|||
48820711|NCT04515849|157185607|FG001|Overall Study|Other:family emergency|0|||
48820712|NCT04515849|157185608|FG002|Overall Study|Other:family emergency|0|||
48820713|NCT04515849|157185609|FG003|Overall Study|Other:family emergency|1|||
48820714|NCT04515849|157185610|FG004|Overall Study|Other:family emergency|0|||
48820715|NCT04515849|157185606|FG000|Overall Study|Other:randomised by error|0|||
48820716|NCT04515849|157185607|FG001|Overall Study|Other:randomised by error|1|||
48820717|NCT04515849|157185608|FG002|Overall Study|Other:randomised by error|0|||
48820718|NCT04515849|157185609|FG003|Overall Study|Other:randomised by error|0|||
48820719|NCT04515849|157185610|FG004|Overall Study|Other:randomised by error|0|||
48820720|NCT04515849|157185606|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
48820721|NCT04515849|157185607|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
48820722|NCT04515849|157185608|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
48820723|NCT04515849|157185609|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
48820724|NCT04515849|157185610|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
48820725|NCT04515849|157185606|FG000|Overall Study|Physician Decision|0|||
48820726|NCT04515849|157185607|FG001|Overall Study|Physician Decision|1|||
48820727|NCT04515849|157185608|FG002|Overall Study|Physician Decision|0|||
48820728|NCT04515849|157185609|FG003|Overall Study|Physician Decision|0|||
48820729|NCT04515849|157185610|FG004|Overall Study|Physician Decision|0|||
48820730|NCT04515849|157185606|FG000|Overall Study|Withdrawal by Subject|1|||
48820731|NCT04515849|157185607|FG001|Overall Study|Withdrawal by Subject|2|||
48507011|NCT01204294|156050481|FG000|Overall Study|Adverse Event|2|||
48507012|NCT01204294|156050482|FG001|Overall Study|Adverse Event|6|||
48507013|NCT01204294|156050483|FG002|Overall Study|Adverse Event|0|||
48507014|NCT01204294|156050484|FG003|Overall Study|Adverse Event|7|||
48600479|NCT03286218|156393918|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
48820732|NCT04515849|157185608|FG002|Overall Study|Withdrawal by Subject|1|||
48820733|NCT04515849|157185609|FG003|Overall Study|Withdrawal by Subject|0|||
48820734|NCT04515849|157185610|FG004|Overall Study|Withdrawal by Subject|0|||
48820735|NCT03658811|157185613|FG000|Overall Study|Lost to Follow-up|3|||
48820736|NCT00235495|157185614|FG000|Overall Study|Death|52|||
48820737|NCT00235495|157185615|FG001|Overall Study|Death|42|||
48820738|NCT00235495|157185614|FG000|Overall Study|Withdrawal by Subject|5|||
48507015|NCT01204294|156050485|FG004|Overall Study|Adverse Event|1|||
48600480|NCT03286218|156393919|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
48600481|NCT03286218|156393920|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
48507016|NCT01204294|156050486|FG005|Overall Study|Adverse Event|4|||
48507017|NCT01204294|156050487|FG006|Overall Study|Adverse Event|0|||
48507018|NCT01204294|156050481|FG000|Overall Study|Protocol Violation|1|||
48507019|NCT01204294|156050482|FG001|Overall Study|Protocol Violation|0|||
48507020|NCT01204294|156050483|FG002|Overall Study|Protocol Violation|2|||
48507021|NCT01204294|156050484|FG003|Overall Study|Protocol Violation|1|||
48507022|NCT01204294|156050485|FG004|Overall Study|Protocol Violation|0|||
48507023|NCT01204294|156050486|FG005|Overall Study|Protocol Violation|0|||
48507024|NCT01204294|156050487|FG006|Overall Study|Protocol Violation|0|||
48507025|NCT01204294|156050481|FG000|Overall Study|Withdrawal by Subject|0|||
48507026|NCT01204294|156050482|FG001|Overall Study|Withdrawal by Subject|2|||
48507027|NCT01204294|156050483|FG002|Overall Study|Withdrawal by Subject|2|||
48507028|NCT01204294|156050484|FG003|Overall Study|Withdrawal by Subject|1|||
48507029|NCT01204294|156050485|FG004|Overall Study|Withdrawal by Subject|1|||
48507030|NCT01204294|156050486|FG005|Overall Study|Withdrawal by Subject|1|||
48507031|NCT01204294|156050487|FG006|Overall Study|Withdrawal by Subject|2|||
48507032|NCT01204294|156050481|FG000|Overall Study|Lack of Efficacy|0|||
48507033|NCT01204294|156050482|FG001|Overall Study|Lack of Efficacy|0|||
48507034|NCT01204294|156050483|FG002|Overall Study|Lack of Efficacy|0|||
48507035|NCT01204294|156050484|FG003|Overall Study|Lack of Efficacy|2|||
48507036|NCT01204294|156050485|FG004|Overall Study|Lack of Efficacy|0|||
48507037|NCT01204294|156050486|FG005|Overall Study|Lack of Efficacy|0|||
48507038|NCT01204294|156050487|FG006|Overall Study|Lack of Efficacy|0|||
48507039|NCT01204294|156050481|FG000|Overall Study|Other (house moving)|0|||
48507040|NCT01204294|156050482|FG001|Overall Study|Other (house moving)|0|||
48507041|NCT01204294|156050483|FG002|Overall Study|Other (house moving)|1|||
48507042|NCT01204294|156050484|FG003|Overall Study|Other (house moving)|0|||
48507043|NCT01204294|156050485|FG004|Overall Study|Other (house moving)|0|||
48507044|NCT01204294|156050486|FG005|Overall Study|Other (house moving)|0|||
48507045|NCT01204294|156050487|FG006|Overall Study|Other (house moving)|0|||
48507046|NCT01037114|156050495|FG000|Year 20|Others|1|||
48507047|NCT01602419|156050496|FG000|Overall Study|Not treated with Wilate|9|||
48507048|NCT01602419|156050496|FG000|Overall Study|Adverse Drug Reaction|4|||
48507049|NCT01602419|156050496|FG000|Overall Study|Insurance issues|3|||
48507050|NCT01602419|156050496|FG000|Overall Study|Changed treatment centre|1|||
48507051|NCT01602419|156050496|FG000|Overall Study|Treatment centre closed|1|||
48507052|NCT01602419|156050496|FG000|Overall Study|Withdrawal by Subject|5|||
48507053|NCT01602419|156050496|FG000|Overall Study|Lost to Follow-up|6|||
48507054|NCT01792635|156050497|FG000|Part B|Adverse Event|0|||
48507055|NCT01792635|156050498|FG001|Part B|Adverse Event|0|||
48507056|NCT01792635|156050499|FG002|Part B|Adverse Event|1|||
48507057|NCT01792635|156050497|FG000|Part B|Study terminated|0|||
48507058|NCT01792635|156050498|FG001|Part B|Study terminated|4|||
48507059|NCT01792635|156050499|FG002|Part B|Study terminated|3|||
48507060|NCT03620747|156050500|FG000|Overall Study|Participant decision|7|||
48507061|NCT03620747|156050500|FG000|Overall Study|Adverse Event|6|||
48507062|NCT03620747|156050500|FG000|Overall Study|Lack of Efficacy|1|||
48600482|NCT03286218|156393921|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
48600483|NCT03286218|156393922|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
48600484|NCT03286218|156393911|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
48600485|NCT03286218|156393912|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
48600486|NCT03286218|156393913|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
48600487|NCT03286218|156393914|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
48600488|NCT03286218|156393915|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
48600489|NCT03286218|156393916|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
48600490|NCT03286218|156393917|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
48600491|NCT03286218|156393918|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
48600492|NCT03286218|156393919|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
48600493|NCT03286218|156393920|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
48600494|NCT03286218|156393921|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
48600495|NCT03286218|156393922|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
48600496|NCT03286218|156393911|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
48600497|NCT03286218|156393912|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
48507063|NCT03620747|156050500|FG000|Overall Study|Poor compliance to protocol|2|||
48507064|NCT03620747|156050500|FG000|Overall Study|Other-unspecified|3|||
48507065|NCT02196675|156050501|FG000|Overall Study|Withdrawal by Subject|1|||
48507066|NCT02196675|156050502|FG001|Overall Study|Withdrawal by Subject|0|||
48507067|NCT02196675|156050503|FG002|Overall Study|Withdrawal by Subject|0|||
48507068|NCT02196675|156050501|FG000|Overall Study|Intra-operative surgical exclusion|1|||
48507069|NCT02196675|156050502|FG001|Overall Study|Intra-operative surgical exclusion|1|||
48507070|NCT02196675|156050503|FG002|Overall Study|Intra-operative surgical exclusion|0|||
48507071|NCT02196675|156050501|FG000|Overall Study|Protocol Violation|0|||
48507072|NCT02196675|156050502|FG001|Overall Study|Protocol Violation|1|||
48507073|NCT02196675|156050503|FG002|Overall Study|Protocol Violation|0|||
48507074|NCT02196675|156050501|FG000|Overall Study|Death|0|||
48507075|NCT02196675|156050502|FG001|Overall Study|Death|0|||
48507076|NCT02196675|156050503|FG002|Overall Study|Death|1|||
48507077|NCT03552393|156050504|FG000|Core Period|Kidney Transplant|1|||
48507078|NCT03552393|156050504|FG000|Core Period|Prohibited Medication|1|||
48507079|NCT03552393|156050504|FG000|Safety Extension Period|Kidney Transplant|4|||
48507080|NCT02009163|156050505|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
48507081|NCT02009163|156050506|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
48507082|NCT02009163|156050507|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
48507083|NCT02009163|156050505|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
48507084|NCT02009163|156050506|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
48507085|NCT02009163|156050507|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
48507086|NCT02009163|156050505|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
48507087|NCT02009163|156050506|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
48507088|NCT02009163|156050507|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
48507089|NCT02009163|156050505|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
48507090|NCT02009163|156050506|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
48507091|NCT02009163|156050507|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
48507092|NCT02009163|156050505|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
48507093|NCT02009163|156050506|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
48507094|NCT02009163|156050507|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
48507095|NCT02009163|156050505|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
48507096|NCT02009163|156050506|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
48507097|NCT02009163|156050507|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
48507098|NCT02009163|156050505|FG000|Open-label Period (Non-randomized)|Other|13|||
48507099|NCT02009163|156050506|FG001|Open-label Period (Non-randomized)|Other|0|||
48507100|NCT02009163|156050507|FG002|Open-label Period (Non-randomized)|Other|0|||
48507101|NCT02009163|156050505|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
48507102|NCT02009163|156050506|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
48507103|NCT02009163|156050507|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
48507104|NCT02009163|156050505|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
48507105|NCT02009163|156050506|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
48507106|NCT02009163|156050507|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
48507107|NCT02009163|156050505|FG000|Randomized-withdrawal Period|Adverse Event|0|||
48507108|NCT02009163|156050506|FG001|Randomized-withdrawal Period|Adverse Event|0|||
48507109|NCT02009163|156050507|FG002|Randomized-withdrawal Period|Adverse Event|6|||
48507110|NCT02009163|156050505|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
48507111|NCT02009163|156050506|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
48507112|NCT02009163|156050507|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
48507113|NCT02009163|156050505|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
48507114|NCT02009163|156050506|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
48507115|NCT02009163|156050507|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
48507116|NCT02009163|156050505|FG000|Randomized-withdrawal Period|Pregnancy|0|||
48820739|NCT00235495|157185615|FG001|Overall Study|Withdrawal by Subject|3|||
48820740|NCT00235495|157185614|FG000|Overall Study|Lost to Follow-up|11|||
48820741|NCT00235495|157185615|FG001|Overall Study|Lost to Follow-up|13|||
48820742|NCT00235495|157185614|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
48820743|NCT00235495|157185615|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
48820744|NCT05259033|157185616|FG000|Overall Study|Withdrawal by Subject|10|||
48820745|NCT05259033|157185617|FG001|Overall Study|Withdrawal by Subject|5|||
48507117|NCT02009163|156050506|FG001|Randomized-withdrawal Period|Pregnancy|0|||
48507118|NCT02009163|156050507|FG002|Randomized-withdrawal Period|Pregnancy|2|||
48507119|NCT02009163|156050505|FG000|Randomized-withdrawal Period|Other|0|||
48507120|NCT02009163|156050506|FG001|Randomized-withdrawal Period|Other|9|||
48507121|NCT02009163|156050507|FG002|Randomized-withdrawal Period|Other|5|||
48507122|NCT00359281|156050508|FG000|Overall Study|Adverse Event|1|||
48507123|NCT00359281|156050509|FG001|Overall Study|Adverse Event|0|||
48507124|NCT00359281|156050510|FG002|Overall Study|Adverse Event|0|||
48507125|NCT00359281|156050511|FG003|Overall Study|Adverse Event|0|||
48507126|NCT00359281|156050512|FG004|Overall Study|Adverse Event|0|||
48507127|NCT00359281|156050513|FG005|Overall Study|Adverse Event|0|||
48507128|NCT00359281|156050514|FG006|Overall Study|Adverse Event|1|||
48507129|NCT00359281|156050515|FG007|Overall Study|Adverse Event|0|||
48507130|NCT00359281|156050516|FG008|Overall Study|Adverse Event|0|||
48507131|NCT00359281|156050508|FG000|Overall Study|Withdrawal by Subject|0|||
48507132|NCT00359281|156050509|FG001|Overall Study|Withdrawal by Subject|0|||
48507133|NCT00359281|156050510|FG002|Overall Study|Withdrawal by Subject|0|||
48507134|NCT00359281|156050511|FG003|Overall Study|Withdrawal by Subject|0|||
48507135|NCT00359281|156050512|FG004|Overall Study|Withdrawal by Subject|0|||
48507136|NCT00359281|156050513|FG005|Overall Study|Withdrawal by Subject|0|||
48820746|NCT05259033|157185616|FG000|Overall Study|Lost to Follow-up|1|||
48820747|NCT05259033|157185617|FG001|Overall Study|Lost to Follow-up|0|||
48820748|NCT05259033|157185616|FG000|Overall Study|Death|2|||
48820749|NCT05259033|157185617|FG001|Overall Study|Death|0|||
48820750|NCT01513967|157185618|FG000|Overall Study|Pregnancy|0|||
48820751|NCT01513967|157185619|FG001|Overall Study|Pregnancy|0|||
48820752|NCT01513967|157185620|FG002|Overall Study|Pregnancy|0|||
48820753|NCT01513967|157185621|FG003|Overall Study|Pregnancy|0|||
48820754|NCT01513967|157185622|FG004|Overall Study|Pregnancy|0|||
48820755|NCT01513967|157185623|FG005|Overall Study|Pregnancy|0|||
48820756|NCT01513967|157185624|FG006|Overall Study|Pregnancy|1|||
48820757|NCT01513967|157185625|FG007|Overall Study|Pregnancy|0|||
48820758|NCT01513967|157185618|FG000|Overall Study|missed a study visit|0|||
48820759|NCT01513967|157185619|FG001|Overall Study|missed a study visit|0|||
48820760|NCT01513967|157185620|FG002|Overall Study|missed a study visit|0|||
48507137|NCT00359281|156050514|FG006|Overall Study|Withdrawal by Subject|1|||
48507138|NCT00359281|156050515|FG007|Overall Study|Withdrawal by Subject|0|||
48726142|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
48726143|NCT02414139|156846577|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
48726144|NCT02414139|156846578|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
48726145|NCT02414139|156846579|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
48507139|NCT00359281|156050516|FG008|Overall Study|Withdrawal by Subject|0|||
48507140|NCT01289262|156050519|FG000|Overall Study|Lost to Follow-up|29|||
48507141|NCT01289262|156050520|FG001|Overall Study|Lost to Follow-up|16|||
48507142|NCT01289262|156050519|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
48507143|NCT01289262|156050520|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
48507144|NCT03586726|156050525|FG000|Overall Study|Withdrawal by Subject|1|||
48507145|NCT03233724|156050526|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
48507146|NCT03233724|156050527|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
48507147|NCT03233724|156050528|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
48507148|NCT03233724|156050529|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
48507149|NCT03233724|156050530|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
48507150|NCT03233724|156050526|FG000|Phase I Dose Escalation|Best interest of participant|1|||
48507151|NCT03233724|156050527|FG001|Phase I Dose Escalation|Best interest of participant|1|||
48507152|NCT03233724|156050528|FG002|Phase I Dose Escalation|Best interest of participant|1|||
48507153|NCT03233724|156050529|FG003|Phase I Dose Escalation|Best interest of participant|0|||
48507154|NCT03233724|156050530|FG004|Phase I Dose Escalation|Best interest of participant|0|||
48507155|NCT03233724|156050526|FG000|Phase I Dose Escalation|Physician Decision|0|||
48507156|NCT03233724|156050527|FG001|Phase I Dose Escalation|Physician Decision|0|||
48507157|NCT03233724|156050528|FG002|Phase I Dose Escalation|Physician Decision|1|||
48507158|NCT03233724|156050529|FG003|Phase I Dose Escalation|Physician Decision|0|||
48726146|NCT02414139|156846580|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
48726147|NCT02414139|156846581|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
48726148|NCT02414139|156846582|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
48726149|NCT02414139|156846583|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
48726150|NCT02414139|156846584|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
48726151|NCT02414139|156846585|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
48726152|NCT02414139|156846586|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
48726153|NCT03631355|156846587|FG000|Overall Study|Lost to Follow-up|1|||
48726154|NCT03631355|156846588|FG001|Overall Study|Lost to Follow-up|2|||
48726155|NCT00378079|156846589|FG000|Overall Study|Lost to Follow-up|6|||
48726156|NCT00378079|156846590|FG001|Overall Study|Lost to Follow-up|1|||
48726157|NCT00378079|156846591|FG002|Overall Study|Lost to Follow-up|0|||
48726158|NCT04473482|156846593|FG000|Overall Study|Death|0|||
48726159|NCT04473482|156846594|FG001|Overall Study|Death|3|||
48726160|NCT04473482|156846593|FG000|Overall Study|Lost to Follow-up|9|||
48726161|NCT04473482|156846594|FG001|Overall Study|Lost to Follow-up|7|||
48726162|NCT04473482|156846593|FG000|Overall Study|Withdrawal by Subject|2|||
48726163|NCT04473482|156846594|FG001|Overall Study|Withdrawal by Subject|1|||
48726164|NCT02021656|156846601|FG000|Overall Study|Adverse Event|1|||
48726165|NCT02021656|156846601|FG000|Overall Study|Lack of Efficacy|2|||
48726166|NCT02021656|156846601|FG000|Overall Study|Lost to Follow-up|1|||
48726167|NCT02021656|156846601|FG000|Overall Study|Withdrew Consent|2|||
48726168|NCT02286089|156846604|FG000|Overall Study|Ongoing in Study|1|||
48726169|NCT02286089|156846605|FG001|Overall Study|Ongoing in Study|1|||
48726170|NCT02286089|156846606|FG002|Overall Study|Ongoing in Study|4|||
48820761|NCT01513967|157185621|FG003|Overall Study|missed a study visit|0|||
48820762|NCT01513967|157185622|FG004|Overall Study|missed a study visit|0|||
48820763|NCT01513967|157185623|FG005|Overall Study|missed a study visit|0|||
48820764|NCT01513967|157185624|FG006|Overall Study|missed a study visit|1|||
48820765|NCT01513967|157185625|FG007|Overall Study|missed a study visit|0|||
48820766|NCT01513967|157185618|FG000|Overall Study|excluded due to positive drug screen|0|||
48820767|NCT01513967|157185619|FG001|Overall Study|excluded due to positive drug screen|0|||
48507159|NCT03233724|156050530|FG004|Phase I Dose Escalation|Physician Decision|0|||
48507160|NCT03233724|156050526|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
48507161|NCT03233724|156050527|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
48507162|NCT03233724|156050528|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
48507163|NCT03233724|156050529|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
48507164|NCT03233724|156050530|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
48507165|NCT03122457|156050532|FG000|Overall Study|Withdrawal by Subject|6|||
48507166|NCT00651820|156050537|FG000|Overall Study|Lost to Follow-up|2|||
48507167|NCT01110005|156050546|FG000|Overall Study|ineligible|1|||
48507168|NCT01110005|156050547|FG001|Overall Study|ineligible|2|||
48507169|NCT01110005|156050546|FG000|Overall Study|missing consent|3|||
48507170|NCT01110005|156050547|FG001|Overall Study|missing consent|2|||
48507171|NCT01110005|156050546|FG000|Overall Study|Withdrawal by Subject|0|||
48507172|NCT01110005|156050547|FG001|Overall Study|Withdrawal by Subject|1|||
48507173|NCT04646213|156050548|FG000|Overall Study|Physician Decision|3|||
48507174|NCT04646213|156050548|FG000|Overall Study|Withdrawal by Subject|2|||
48507175|NCT00950989|156050549|FG000|Overall Study|Death|0|||
48507176|NCT00950989|156050550|FG001|Overall Study|Death|0|||
48507177|NCT00950989|156050551|FG002|Overall Study|Death|1|||
48507178|NCT00950989|156050552|FG003|Overall Study|Death|0|||
48507179|NCT00950989|156050549|FG000|Overall Study|Administrative Decision|0|||
48507180|NCT00950989|156050550|FG001|Overall Study|Administrative Decision|1|||
48507181|NCT00950989|156050551|FG002|Overall Study|Administrative Decision|0|||
48507182|NCT00950989|156050552|FG003|Overall Study|Administrative Decision|0|||
48507183|NCT00950989|156050549|FG000|Overall Study|Disease Progression|0|||
48507184|NCT00950989|156050550|FG001|Overall Study|Disease Progression|0|||
48507185|NCT00950989|156050551|FG002|Overall Study|Disease Progression|1|||
48507186|NCT00950989|156050552|FG003|Overall Study|Disease Progression|0|||
48507187|NCT00950989|156050549|FG000|Overall Study|Withdrawal by Subject|2|||
48507188|NCT00950989|156050550|FG001|Overall Study|Withdrawal by Subject|1|||
48507189|NCT00950989|156050551|FG002|Overall Study|Withdrawal by Subject|0|||
48507190|NCT00950989|156050552|FG003|Overall Study|Withdrawal by Subject|0|||
48507191|NCT00950989|156050549|FG000|Overall Study|Adverse Event|2|||
48507192|NCT00950989|156050550|FG001|Overall Study|Adverse Event|1|||
48507193|NCT00950989|156050551|FG002|Overall Study|Adverse Event|1|||
48507194|NCT00950989|156050552|FG003|Overall Study|Adverse Event|0|||
48507195|NCT02445339|156050553|FG000|Overall Study|Physician Decision|1|||
48507196|NCT02445339|156050554|FG001|Overall Study|Physician Decision|0|||
48507197|NCT02445339|156050553|FG000|Overall Study|Lost to Follow-up|11|||
48507198|NCT02445339|156050554|FG001|Overall Study|Lost to Follow-up|15|||
48820768|NCT01513967|157185620|FG002|Overall Study|excluded due to positive drug screen|0|||
48507199|NCT02289963|156052249|FG000|Overall Study|Adverse Event|1|||
48507200|NCT02289963|156052250|FG001|Overall Study|Adverse Event|2|||
48820769|NCT01513967|157185621|FG003|Overall Study|excluded due to positive drug screen|0|||
48820770|NCT01513967|157185622|FG004|Overall Study|excluded due to positive drug screen|0|||
48820771|NCT01513967|157185623|FG005|Overall Study|excluded due to positive drug screen|0|||
48820772|NCT01513967|157185624|FG006|Overall Study|excluded due to positive drug screen|0|||
48820773|NCT01513967|157185625|FG007|Overall Study|excluded due to positive drug screen|2|||
48507201|NCT02289963|156052249|FG000|Overall Study|Poor compliance to protocol|1|||
48507202|NCT02289963|156052250|FG001|Overall Study|Poor compliance to protocol|0|||
48507203|NCT02289963|156052249|FG000|Overall Study|Withdrawal by Subject|1|||
48507204|NCT02289963|156052250|FG001|Overall Study|Withdrawal by Subject|0|||
48507205|NCT02289963|156052249|FG000|Overall Study|Last injection missed|2|||
48507206|NCT02289963|156052250|FG001|Overall Study|Last injection missed|2|||
48507207|NCT02289963|156052249|FG000|Overall Study|End treatment visit outside visit window|0|||
48507208|NCT02289963|156052250|FG001|Overall Study|End treatment visit outside visit window|4|||
48507209|NCT02289963|156052249|FG000|Overall Study|Other than specified above|0|||
48507210|NCT02289963|156052250|FG001|Overall Study|Other than specified above|2|||
48507211|NCT01042522|156052253|FG000|Overall Study|Adverse Event|1|||
48507212|NCT01042522|156052254|FG001|Overall Study|Adverse Event|2|||
48820774|NCT01513967|157185618|FG000|Overall Study|Physician Decision|0|||
48820775|NCT01513967|157185619|FG001|Overall Study|Physician Decision|0|||
48820776|NCT01513967|157185620|FG002|Overall Study|Physician Decision|0|||
48507213|NCT01042522|156052253|FG000|Overall Study|Disease Progression|5|||
48507214|NCT01042522|156052254|FG001|Overall Study|Disease Progression|0|||
48507215|NCT01042522|156052253|FG000|Overall Study|Death|1|||
48820777|NCT01513967|157185621|FG003|Overall Study|Physician Decision|0|||
48820778|NCT01513967|157185622|FG004|Overall Study|Physician Decision|0|||
48507216|NCT01042522|156052254|FG001|Overall Study|Death|0|||
48507217|NCT01042522|156052253|FG000|Overall Study|Patient Refused|0|||
48507218|NCT01042522|156052254|FG001|Overall Study|Patient Refused|3|||
48507219|NCT01042522|156052253|FG000|Overall Study|Withdrawal by Subject|1|||
48507220|NCT01042522|156052254|FG001|Overall Study|Withdrawal by Subject|1|||
48507221|NCT01746017|156052255|FG000|Period 1|Withdrawal by Subject|0|||
48507222|NCT01746017|156052256|FG001|Period 1|Withdrawal by Subject|0|||
48507223|NCT01746017|156052257|FG002|Period 1|Withdrawal by Subject|0|||
48507224|NCT01746017|156052258|FG003|Period 1|Withdrawal by Subject|0|||
48507225|NCT01746017|156052259|FG004|Period 1|Withdrawal by Subject|0|||
48726171|NCT02286089|156846607|FG003|Overall Study|Ongoing in Study|10|||
48726172|NCT02286089|156846604|FG000|Overall Study|Withdrawal by Subject|0|||
48726173|NCT02286089|156846605|FG001|Overall Study|Withdrawal by Subject|0|||
48726174|NCT02286089|156846606|FG002|Overall Study|Withdrawal by Subject|2|||
48726175|NCT02286089|156846607|FG003|Overall Study|Withdrawal by Subject|2|||
48726176|NCT00336583|156847856|FG000|Overall Study|Lost to Follow-up|1|||
48726177|NCT00336583|156847856|FG000|Overall Study|Death|1|||
48726178|NCT01527357|156847857|FG000|Overall Study|Death|8|||
48507226|NCT01746017|156052260|FG005|Period 1|Withdrawal by Subject|0|||
48507227|NCT01746017|156052261|FG006|Period 1|Withdrawal by Subject|1|||
48726179|NCT01527357|156847858|FG001|Overall Study|Death|2|||
48507228|NCT01746017|156052262|FG007|Period 1|Withdrawal by Subject|0|||
48726180|NCT01527357|156847857|FG000|Overall Study|Lost to Follow-up|6|||
48507229|NCT01746017|156052263|FG008|Period 1|Withdrawal by Subject|0|||
48507230|NCT01746017|156052264|FG009|Period 1|Withdrawal by Subject|0|||
48507231|NCT01746017|156052265|FG010|Period 1|Withdrawal by Subject|0|||
48507232|NCT01746017|156052255|FG000|Period 3|Withdrawal by Subject|0|||
48507233|NCT01746017|156052256|FG001|Period 3|Withdrawal by Subject|0|||
48507234|NCT01746017|156052257|FG002|Period 3|Withdrawal by Subject|0|||
48507235|NCT01746017|156052258|FG003|Period 3|Withdrawal by Subject|0|||
48507236|NCT01746017|156052259|FG004|Period 3|Withdrawal by Subject|0|||
48507237|NCT01746017|156052260|FG005|Period 3|Withdrawal by Subject|1|||
48507238|NCT01746017|156052261|FG006|Period 3|Withdrawal by Subject|0|||
48507239|NCT01746017|156052262|FG007|Period 3|Withdrawal by Subject|0|||
48507240|NCT01746017|156052263|FG008|Period 3|Withdrawal by Subject|0|||
48507241|NCT01746017|156052264|FG009|Period 3|Withdrawal by Subject|0|||
48507242|NCT01746017|156052265|FG010|Period 3|Withdrawal by Subject|0|||
48507243|NCT02424097|156052270|FG000|Overall Study|Lost to Follow-up|1|||
48507244|NCT02424097|156052271|FG001|Overall Study|Lost to Follow-up|2|||
48507245|NCT01507051|156052275|FG000|Overall Study|Withdrawal by Subject|1|||
48507246|NCT01507051|156052276|FG001|Overall Study|Withdrawal by Subject|3|||
48507247|NCT01507051|156052277|FG002|Overall Study|Withdrawal by Subject|1|||
48507248|NCT01507051|156052278|FG003|Overall Study|Withdrawal by Subject|6|||
48507249|NCT01507051|156052275|FG000|Overall Study|Physician Decision|0|||
48507250|NCT01507051|156052276|FG001|Overall Study|Physician Decision|0|||
48507251|NCT01507051|156052277|FG002|Overall Study|Physician Decision|0|||
48507252|NCT01507051|156052278|FG003|Overall Study|Physician Decision|1|||
48507253|NCT01507051|156052275|FG000|Overall Study|Adverse Event|1|||
48507254|NCT01507051|156052276|FG001|Overall Study|Adverse Event|0|||
48507255|NCT01507051|156052277|FG002|Overall Study|Adverse Event|0|||
48507256|NCT01507051|156052278|FG003|Overall Study|Adverse Event|0|||
48507257|NCT03351335|156052281|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
48507258|NCT03351335|156052282|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
48507259|NCT03351335|156052283|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
48507260|NCT04605094|156052284|FG000|Overall Study|Adverse Event|2|||
48507261|NCT04605094|156052285|FG001|Overall Study|Adverse Event|2|||
48507262|NCT04605094|156052284|FG000|Overall Study|Lost to Follow-up|1|||
48507263|NCT04605094|156052285|FG001|Overall Study|Lost to Follow-up|4|||
48507264|NCT04605094|156052284|FG000|Overall Study|Physician Decision|2|||
48507265|NCT04605094|156052285|FG001|Overall Study|Physician Decision|2|||
48507266|NCT04605094|156052284|FG000|Overall Study|Study terminated by Sponsor|31|||
48507267|NCT04605094|156052285|FG001|Overall Study|Study terminated by Sponsor|33|||
48507268|NCT04605094|156052284|FG000|Overall Study|Withdrawal by Subject|22|||
48726181|NCT01527357|156847858|FG001|Overall Study|Lost to Follow-up|4|||
48726182|NCT01527357|156847857|FG000|Overall Study|Withdrew Consent|1|||
48507269|NCT04605094|156052285|FG001|Overall Study|Withdrawal by Subject|19|||
48507270|NCT04605094|156052284|FG000|Overall Study|Other|1|||
48507271|NCT04605094|156052285|FG001|Overall Study|Other|1|||
48507272|NCT01900691|156052286|FG000|Overall Study|Death|7|||
48507273|NCT01900691|156052286|FG000|Overall Study|Lost to Follow-up|4|||
48507274|NCT01900691|156052286|FG000|Overall Study|Study Device Not Placed|3|||
48507275|NCT01900691|156052286|FG000|Overall Study|Non study stent placed|2|||
48507276|NCT01900691|156052286|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
48507277|NCT01900691|156052286|FG000|Overall Study|Complete stent migration through digestive tract|1|||
48507278|NCT02724462|156052287|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
48726183|NCT01527357|156847858|FG001|Overall Study|Withdrew Consent|1|||
48726184|NCT01527357|156847857|FG000|Overall Study|Non-compliance|0|||
48726185|NCT01527357|156847858|FG001|Overall Study|Non-compliance|1|||
48726186|NCT01527357|156847857|FG000|Overall Study|No Day 29 Visit|0|||
48726187|NCT01527357|156847858|FG001|Overall Study|No Day 29 Visit|1|||
48726188|NCT01527357|156847857|FG000|Overall Study|Did Not Receive Treatment|2|||
48726189|NCT01527357|156847858|FG001|Overall Study|Did Not Receive Treatment|0|||
48726190|NCT02716896|156847864|FG000|Overall Study|Physician Decision|0|||
48726191|NCT02716896|156847865|FG001|Overall Study|Physician Decision|1|||
48726192|NCT01727700|156847866|FG000|Overall Study|Adverse Event|0|||
48726193|NCT01727700|156847867|FG001|Overall Study|Adverse Event|7|||
48726194|NCT01727700|156847868|FG002|Overall Study|Adverse Event|1|||
48507279|NCT02724462|156052288|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
48507280|NCT02724462|156052287|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
48507281|NCT02724462|156052288|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
48507282|NCT02724462|156052287|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
48507283|NCT02724462|156052288|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
48507284|NCT02724462|156052287|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
48507285|NCT02724462|156052288|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
48507286|NCT02724462|156052287|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
48507287|NCT02724462|156052288|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
48507288|NCT02724462|156052287|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
48507289|NCT02724462|156052288|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
48507290|NCT01149473|156052289|FG000|First Intervention|Adverse Event|1|||
48507291|NCT01149473|156052290|FG001|First Intervention|Adverse Event|1|||
48507292|NCT01149473|156052289|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48507293|NCT01149473|156052290|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
48507294|NCT00469417|156052291|FG000|Overall Study|Treatment failure all lesions|18|||
48507295|NCT00469417|156052292|FG001|Overall Study|Treatment failure all lesions|11|||
48507296|NCT00469417|156052291|FG000|Overall Study|Consent withdrawn|1|||
48507297|NCT00469417|156052292|FG001|Overall Study|Consent withdrawn|1|||
48507298|NCT00469417|156052291|FG000|Overall Study|Adverse Event|8|||
48507299|NCT00469417|156052292|FG001|Overall Study|Adverse Event|2|||
48507300|NCT00469417|156052291|FG000|Overall Study|Lost to Follow-up|1|||
48507301|NCT00469417|156052292|FG001|Overall Study|Lost to Follow-up|2|||
48507302|NCT00469417|156052291|FG000|Overall Study|Intercurrent disease|0|||
48507303|NCT00469417|156052292|FG001|Overall Study|Intercurrent disease|1|||
48507304|NCT00469417|156052291|FG000|Overall Study|Randomized but not treated|2|||
48507305|NCT00469417|156052292|FG001|Overall Study|Randomized but not treated|0|||
48507306|NCT02942264|156052295|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
48507307|NCT02942264|156052296|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
48507308|NCT02942264|156052297|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
48507309|NCT02942264|156052298|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
48507310|NCT02942264|156052299|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
48507311|NCT02942264|156052300|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
48507312|NCT02942264|156052301|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
48507313|NCT02942264|156052302|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
48507314|NCT02942264|156052303|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
48507315|NCT02942264|156052295|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
48507316|NCT02942264|156052296|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
48507317|NCT02942264|156052297|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
48507318|NCT02942264|156052298|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
48507319|NCT02942264|156052299|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
48507320|NCT02942264|156052300|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
48507321|NCT02942264|156052301|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
48507322|NCT02942264|156052302|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
48507323|NCT02942264|156052303|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
48507324|NCT01954394|156052306|FG000|Overall Study|Enrolled but not treated|1|||
48507325|NCT01954394|156052307|FG001|Overall Study|Enrolled but not treated|0|||
48726195|NCT01727700|156847866|FG000|Overall Study|Particpant withdrew consent|0|||
48726196|NCT01727700|156847867|FG001|Overall Study|Particpant withdrew consent|3|||
48507326|NCT01954394|156052306|FG000|Overall Study|Adverse Event|10|||
48507327|NCT01954394|156052307|FG001|Overall Study|Adverse Event|23|||
48507328|NCT01954394|156052306|FG000|Overall Study|Poor compliance to protocol|7|||
48507329|NCT01954394|156052307|FG001|Overall Study|Poor compliance to protocol|7|||
48507330|NCT01954394|156052306|FG000|Overall Study|Participant Moved|0|||
48507331|NCT01954394|156052307|FG001|Overall Study|Participant Moved|4|||
48507332|NCT01954394|156052306|FG000|Overall Study|Related to Study Drug administration|2|||
48507333|NCT01954394|156052307|FG001|Overall Study|Related to Study Drug administration|2|||
48507334|NCT01954394|156052306|FG000|Overall Study|Other than specified above|10|||
48507335|NCT01954394|156052307|FG001|Overall Study|Other than specified above|21|||
48507336|NCT00909610|156052308|FG000|Period: First Intervention|Adverse Event|0|||
48726197|NCT01727700|156847868|FG002|Overall Study|Particpant withdrew consent|1|||
48507337|NCT00909610|156052309|FG001|Period: First Intervention|Adverse Event|1|||
48507338|NCT00909610|156052308|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
48507339|NCT00909610|156052309|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
48507340|NCT00909610|156052308|FG000|Period: Second Intervention|Adverse Event|1|||
48507341|NCT00909610|156052309|FG001|Period: Second Intervention|Adverse Event|0|||
48507342|NCT05327491|156052320|FG000|Periods 1 & 2|Miscellaneous|0|||
48507343|NCT05327491|156052321|FG001|Periods 1 & 2|Miscellaneous|1|||
48507344|NCT05327491|156052322|FG002|Periods 1 & 2|Miscellaneous|0|||
48507345|NCT05327491|156052323|FG003|Periods 1 & 2|Miscellaneous|0|||
48507346|NCT05327491|156052320|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
48726198|NCT01727700|156847866|FG000|Overall Study|Protocol Violation|2|||
48507347|NCT05327491|156052321|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
48507348|NCT05327491|156052322|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
48507349|NCT05327491|156052323|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
48507350|NCT02188303|156052324|FG000|Overall Study|Adverse Event|0|||
48507351|NCT02188303|156052325|FG001|Overall Study|Adverse Event|0|||
48507352|NCT02188303|156052326|FG002|Overall Study|Adverse Event|0|||
48507353|NCT02188303|156052327|FG003|Overall Study|Adverse Event|0|||
48507354|NCT02188303|156052328|FG004|Overall Study|Adverse Event|0|||
48507355|NCT02188303|156052329|FG005|Overall Study|Adverse Event|2|||
48507356|NCT02188303|156052330|FG006|Overall Study|Adverse Event|0|||
48507357|NCT02188303|156052331|FG007|Overall Study|Adverse Event|2|||
48507358|NCT02188303|156052324|FG000|Overall Study|Dose Termination Criteria Met|0|||
48507359|NCT02188303|156052325|FG001|Overall Study|Dose Termination Criteria Met|0|||
48507360|NCT02188303|156052326|FG002|Overall Study|Dose Termination Criteria Met|0|||
48507361|NCT02188303|156052327|FG003|Overall Study|Dose Termination Criteria Met|0|||
48507362|NCT02188303|156052328|FG004|Overall Study|Dose Termination Criteria Met|0|||
48507363|NCT02188303|156052329|FG005|Overall Study|Dose Termination Criteria Met|0|||
48507364|NCT02188303|156052330|FG006|Overall Study|Dose Termination Criteria Met|2|||
48507365|NCT02188303|156052331|FG007|Overall Study|Dose Termination Criteria Met|4|||
48507366|NCT04206332|156052332|FG000|Part A|Lost to Follow-up|0|||
48507367|NCT04206332|156052333|FG001|Part A|Lost to Follow-up|1|||
48507368|NCT04206332|156052334|FG002|Part A|Lost to Follow-up|0|||
48507369|NCT04206332|156052335|FG003|Part A|Lost to Follow-up|0|||
48507370|NCT04206332|156052336|FG004|Part A|Lost to Follow-up|0|||
48507371|NCT04206332|156052337|FG005|Part A|Lost to Follow-up|0|||
48507372|NCT04206332|156052338|FG006|Part A|Lost to Follow-up|0|||
48507373|NCT04206332|156052339|FG007|Part A|Lost to Follow-up|0|||
48507374|NCT04206332|156052340|FG008|Part A|Lost to Follow-up|0|||
48507375|NCT04206332|156052341|FG009|Part A|Lost to Follow-up|0|||
48507376|NCT04206332|156052342|FG010|Part A|Lost to Follow-up|0|||
48507377|NCT04206332|156052343|FG011|Part A|Lost to Follow-up|0|||
48507378|NCT04206332|156052344|FG012|Part A|Lost to Follow-up|0|||
48507379|NCT04206332|156052345|FG013|Part A|Lost to Follow-up|0|||
48507380|NCT04206332|156052346|FG014|Part A|Lost to Follow-up|0|||
48507381|NCT04206332|156052347|FG015|Part A|Lost to Follow-up|0|||
48507382|NCT04206332|156052348|FG016|Part A|Lost to Follow-up|0|||
48507383|NCT04206332|156052332|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507384|NCT04206332|156052333|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507385|NCT04206332|156052334|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507386|NCT04206332|156052335|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507387|NCT04206332|156052336|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507388|NCT04206332|156052337|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
48507389|NCT04206332|156052338|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507390|NCT04206332|156052339|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507391|NCT04206332|156052340|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507392|NCT04206332|156052341|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507393|NCT04206332|156052342|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507394|NCT04206332|156052343|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507395|NCT04206332|156052344|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507396|NCT04206332|156052345|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507397|NCT04206332|156052346|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507398|NCT04206332|156052347|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507399|NCT04206332|156052348|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
48507400|NCT04206332|156052332|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507401|NCT04206332|156052333|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507402|NCT04206332|156052334|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507403|NCT04206332|156052335|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507404|NCT04206332|156052336|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507405|NCT04206332|156052337|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507406|NCT04206332|156052338|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507407|NCT04206332|156052339|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
48507408|NCT04206332|156052340|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507409|NCT04206332|156052341|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48726199|NCT01727700|156847867|FG001|Overall Study|Protocol Violation|0|||
48507410|NCT04206332|156052342|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
48507411|NCT04206332|156052343|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507412|NCT04206332|156052344|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507413|NCT04206332|156052345|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507414|NCT04206332|156052346|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507415|NCT04206332|156052347|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507416|NCT04206332|156052348|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507417|NCT04206332|156052332|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507418|NCT04206332|156052333|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507419|NCT04206332|156052334|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507420|NCT04206332|156052335|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507421|NCT04206332|156052336|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507422|NCT04206332|156052337|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507423|NCT04206332|156052338|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507424|NCT04206332|156052339|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507425|NCT04206332|156052340|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507426|NCT04206332|156052341|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507427|NCT04206332|156052342|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507428|NCT04206332|156052343|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507429|NCT04206332|156052344|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507430|NCT04206332|156052345|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507431|NCT04206332|156052346|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507432|NCT04206332|156052347|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
48507433|NCT04206332|156052348|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
48507434|NCT04206332|156052332|FG000|Part C|Withdrawal by Subject|0|||
48507435|NCT04206332|156052333|FG001|Part C|Withdrawal by Subject|0|||
48507436|NCT04206332|156052334|FG002|Part C|Withdrawal by Subject|0|||
48507437|NCT04206332|156052335|FG003|Part C|Withdrawal by Subject|0|||
48507438|NCT04206332|156052336|FG004|Part C|Withdrawal by Subject|0|||
48507439|NCT04206332|156052337|FG005|Part C|Withdrawal by Subject|0|||
48507440|NCT04206332|156052338|FG006|Part C|Withdrawal by Subject|0|||
48507441|NCT04206332|156052339|FG007|Part C|Withdrawal by Subject|0|||
48507442|NCT04206332|156052340|FG008|Part C|Withdrawal by Subject|0|||
48507443|NCT04206332|156052341|FG009|Part C|Withdrawal by Subject|0|||
48507444|NCT04206332|156052342|FG010|Part C|Withdrawal by Subject|0|||
48507445|NCT04206332|156052343|FG011|Part C|Withdrawal by Subject|0|||
48507446|NCT04206332|156052344|FG012|Part C|Withdrawal by Subject|0|||
48507447|NCT04206332|156052345|FG013|Part C|Withdrawal by Subject|0|||
48507448|NCT04206332|156052346|FG014|Part C|Withdrawal by Subject|2|||
48507449|NCT04206332|156052347|FG015|Part C|Withdrawal by Subject|0|||
48507450|NCT04206332|156052348|FG016|Part C|Withdrawal by Subject|0|||
48507451|NCT01273805|156052349|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
48507452|NCT01273805|156052350|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
48507453|NCT02481830|156052351|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
48507454|NCT02481830|156052352|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
48507455|NCT02481830|156052351|FG000|Pre-treatment|Withdrawal by Subject|0|||
48507456|NCT02481830|156052352|FG001|Pre-treatment|Withdrawal by Subject|10|||
48507457|NCT02481830|156052351|FG000|Pre-treatment|Disease Progression|1|||
48507458|NCT02481830|156052352|FG001|Pre-treatment|Disease Progression|1|||
48507459|NCT02481830|156052351|FG000|Pre-treatment|Other reasons|0|||
48600498|NCT03286218|156393913|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
48600499|NCT03286218|156393914|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
48600500|NCT03286218|156393915|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
48600501|NCT03286218|156393916|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
48820779|NCT01513967|157185623|FG005|Overall Study|Physician Decision|1|||
48507460|NCT02481830|156052352|FG001|Pre-treatment|Other reasons|1|||
48507461|NCT02481830|156052351|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
48507462|NCT02481830|156052352|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
48507463|NCT02481830|156052351|FG000|Treatment|Disease Progression|233|||
48507464|NCT02481830|156052352|FG001|Treatment|Disease Progression|171|||
48600502|NCT03286218|156393917|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
48600503|NCT03286218|156393918|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
48600504|NCT03286218|156393919|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
48507465|NCT02481830|156052351|FG000|Treatment|Study drug toxicity|18|||
48507466|NCT02481830|156052352|FG001|Treatment|Study drug toxicity|38|||
48507467|NCT02481830|156052351|FG000|Treatment|Death|1|||
48507468|NCT02481830|156052352|FG001|Treatment|Death|1|||
48507469|NCT02481830|156052351|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
48507470|NCT02481830|156052352|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
48507471|NCT02481830|156052351|FG000|Treatment|Participants request to discontinue Study treatment|6|||
48507472|NCT02481830|156052352|FG001|Treatment|Participants request to discontinue Study treatment|34|||
48507473|NCT02481830|156052351|FG000|Treatment|Withdrawal by Subject|2|||
48507474|NCT02481830|156052352|FG001|Treatment|Withdrawal by Subject|3|||
48507475|NCT02481830|156052351|FG000|Treatment|Lost to Follow-up|1|||
48507476|NCT02481830|156052352|FG001|Treatment|Lost to Follow-up|0|||
48507477|NCT02481830|156052351|FG000|Treatment|Maximum Clinical Benefit|0|||
48507478|NCT02481830|156052352|FG001|Treatment|Maximum Clinical Benefit|5|||
48507479|NCT02481830|156052351|FG000|Treatment|Administrative reason by sponsor|1|||
48507480|NCT02481830|156052352|FG001|Treatment|Administrative reason by sponsor|1|||
48507481|NCT02481830|156052351|FG000|Treatment|Other reasons|6|||
48507482|NCT02481830|156052352|FG001|Treatment|Other reasons|1|||
48507483|NCT01190930|156052353|FG000|Induction|Adverse Event|17|||
48507484|NCT01190930|156052354|FG001|Induction|Adverse Event|0|||
48507485|NCT01190930|156052355|FG002|Induction|Adverse Event|0|||
48507486|NCT01190930|156052356|FG003|Induction|Adverse Event|0|||
48507487|NCT01190930|156052357|FG004|Induction|Adverse Event|0|||
48507488|NCT01190930|156052358|FG005|Induction|Adverse Event|0|||
48507489|NCT01190930|156052359|FG006|Induction|Adverse Event|0|||
48507490|NCT01190930|156052360|FG007|Induction|Adverse Event|0|||
48507491|NCT01190930|156052361|FG008|Induction|Adverse Event|0|||
48507492|NCT01190930|156052362|FG009|Induction|Adverse Event|0|||
48507493|NCT01190930|156052353|FG000|Induction|Death|34|||
48507494|NCT01190930|156052354|FG001|Induction|Death|0|||
48507495|NCT01190930|156052355|FG002|Induction|Death|0|||
48507496|NCT01190930|156052356|FG003|Induction|Death|0|||
48507497|NCT01190930|156052357|FG004|Induction|Death|0|||
48507498|NCT01190930|156052358|FG005|Induction|Death|0|||
48507499|NCT01190930|156052359|FG006|Induction|Death|0|||
48507500|NCT01190930|156052360|FG007|Induction|Death|0|||
48507501|NCT01190930|156052361|FG008|Induction|Death|0|||
48507502|NCT01190930|156052362|FG009|Induction|Death|0|||
48507503|NCT01190930|156052353|FG000|Induction|Lost to Follow-up|1|||
48507504|NCT01190930|156052354|FG001|Induction|Lost to Follow-up|0|||
48507505|NCT01190930|156052355|FG002|Induction|Lost to Follow-up|0|||
48507506|NCT01190930|156052356|FG003|Induction|Lost to Follow-up|0|||
48507507|NCT01190930|156052357|FG004|Induction|Lost to Follow-up|0|||
48507508|NCT01190930|156052358|FG005|Induction|Lost to Follow-up|0|||
48507509|NCT01190930|156052359|FG006|Induction|Lost to Follow-up|0|||
48507510|NCT01190930|156052360|FG007|Induction|Lost to Follow-up|0|||
48507511|NCT01190930|156052361|FG008|Induction|Lost to Follow-up|0|||
48507512|NCT01190930|156052362|FG009|Induction|Lost to Follow-up|0|||
48507513|NCT01190930|156052353|FG000|Induction|Physician Decision|125|||
48507514|NCT01190930|156052354|FG001|Induction|Physician Decision|3|||
48507515|NCT01190930|156052355|FG002|Induction|Physician Decision|0|||
48507516|NCT01190930|156052356|FG003|Induction|Physician Decision|0|||
48507517|NCT01190930|156052357|FG004|Induction|Physician Decision|0|||
48507518|NCT01190930|156052358|FG005|Induction|Physician Decision|0|||
48507519|NCT01190930|156052359|FG006|Induction|Physician Decision|0|||
48507520|NCT01190930|156052360|FG007|Induction|Physician Decision|0|||
48726200|NCT01727700|156847868|FG002|Overall Study|Protocol Violation|0|||
48726201|NCT00084838|156847869|FG000|Overall Study|Death|1|||
48507521|NCT01190930|156052361|FG008|Induction|Physician Decision|0|||
48507522|NCT01190930|156052362|FG009|Induction|Physician Decision|0|||
48507523|NCT01190930|156052353|FG000|Induction|Withdrawal by Subject|9|||
48507524|NCT01190930|156052354|FG001|Induction|Withdrawal by Subject|0|||
48507525|NCT01190930|156052355|FG002|Induction|Withdrawal by Subject|0|||
48507526|NCT01190930|156052356|FG003|Induction|Withdrawal by Subject|0|||
48507527|NCT01190930|156052357|FG004|Induction|Withdrawal by Subject|0|||
48507528|NCT01190930|156052358|FG005|Induction|Withdrawal by Subject|0|||
48507529|NCT01190930|156052359|FG006|Induction|Withdrawal by Subject|0|||
48507530|NCT01190930|156052360|FG007|Induction|Withdrawal by Subject|0|||
48507531|NCT01190930|156052361|FG008|Induction|Withdrawal by Subject|0|||
48507532|NCT01190930|156052362|FG009|Induction|Withdrawal by Subject|0|||
48507533|NCT01190930|156052353|FG000|Induction|Refusal|235|||
48507534|NCT01190930|156052354|FG001|Induction|Refusal|0|||
48507535|NCT01190930|156052355|FG002|Induction|Refusal|0|||
48507536|NCT01190930|156052356|FG003|Induction|Refusal|0|||
48507537|NCT01190930|156052357|FG004|Induction|Refusal|0|||
48507538|NCT01190930|156052358|FG005|Induction|Refusal|0|||
48507539|NCT01190930|156052359|FG006|Induction|Refusal|0|||
48507540|NCT01190930|156052360|FG007|Induction|Refusal|0|||
48507541|NCT01190930|156052361|FG008|Induction|Refusal|0|||
48507542|NCT01190930|156052362|FG009|Induction|Refusal|0|||
48507543|NCT01190930|156052353|FG000|Induction|Inevaluable|23|||
48507544|NCT01190930|156052354|FG001|Induction|Inevaluable|1|||
48507545|NCT01190930|156052355|FG002|Induction|Inevaluable|0|||
48507546|NCT01190930|156052356|FG003|Induction|Inevaluable|0|||
48507547|NCT01190930|156052357|FG004|Induction|Inevaluable|0|||
48600505|NCT03286218|156393920|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
48600506|NCT03286218|156393921|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
48600507|NCT03286218|156393922|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
48600508|NCT02532374|156393923|FG000|Overall Study|Withdrawal by Subject|1|||
48600509|NCT02532374|156393923|FG000|Overall Study|Physician Decision|1|||
48600510|NCT01781962|156393924|FG000|Overall Study|Other Miscellaneous Reasons|5|||
48600511|NCT01089127|156393929|FG000|Overall Study|Adverse Event|5|||
48600512|NCT01089127|156393930|FG001|Overall Study|Adverse Event|1|||
48600513|NCT01089127|156393931|FG002|Overall Study|Adverse Event|1|||
48600514|NCT01089127|156393932|FG003|Overall Study|Adverse Event|0|||
48600515|NCT01089127|156393933|FG004|Overall Study|Adverse Event|0|||
48600516|NCT01089127|156393934|FG005|Overall Study|Adverse Event|1|||
48600517|NCT01089127|156393929|FG000|Overall Study|Subject withdrew consent|0|||
48600518|NCT01089127|156393930|FG001|Overall Study|Subject withdrew consent|1|||
48600519|NCT01089127|156393931|FG002|Overall Study|Subject withdrew consent|1|||
48600520|NCT01089127|156393932|FG003|Overall Study|Subject withdrew consent|1|||
48600521|NCT01089127|156393933|FG004|Overall Study|Subject withdrew consent|0|||
48600522|NCT01089127|156393934|FG005|Overall Study|Subject withdrew consent|2|||
48600523|NCT01089127|156393929|FG000|Overall Study|Abnormal test procedure result(s)|2|||
48600524|NCT01089127|156393930|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48600525|NCT01089127|156393931|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48600526|NCT01089127|156393932|FG003|Overall Study|Abnormal test procedure result(s)|0|||
48600527|NCT01089127|156393933|FG004|Overall Study|Abnormal test procedure result(s)|0|||
48600528|NCT01089127|156393934|FG005|Overall Study|Abnormal test procedure result(s)|0|||
48600529|NCT01089127|156393929|FG000|Overall Study|Lost to Follow-up|1|||
48600530|NCT01089127|156393930|FG001|Overall Study|Lost to Follow-up|1|||
48600531|NCT01089127|156393931|FG002|Overall Study|Lost to Follow-up|0|||
48600532|NCT01089127|156393932|FG003|Overall Study|Lost to Follow-up|0|||
48600533|NCT01089127|156393933|FG004|Overall Study|Lost to Follow-up|1|||
48507548|NCT01190930|156052358|FG005|Induction|Inevaluable|0|||
48507549|NCT01190930|156052359|FG006|Induction|Inevaluable|0|||
48507550|NCT01190930|156052360|FG007|Induction|Inevaluable|0|||
48600534|NCT01089127|156393934|FG005|Overall Study|Lost to Follow-up|0|||
48600535|NCT01089127|156393929|FG000|Overall Study|Protocol deviation|0|||
48600536|NCT01089127|156393930|FG001|Overall Study|Protocol deviation|1|||
48600537|NCT01089127|156393931|FG002|Overall Study|Protocol deviation|0|||
48507551|NCT01190930|156052361|FG008|Induction|Inevaluable|0|||
48507552|NCT01190930|156052362|FG009|Induction|Inevaluable|0|||
48507553|NCT01190930|156052353|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
48600538|NCT01089127|156393932|FG003|Overall Study|Protocol deviation|0|||
48600539|NCT01089127|156393933|FG004|Overall Study|Protocol deviation|1|||
48600540|NCT01089127|156393934|FG005|Overall Study|Protocol deviation|0|||
48600541|NCT01278342|156393937|FG000|Overall Study|Physician Decision|0|||
48600542|NCT01278342|156393938|FG001|Overall Study|Physician Decision|1|||
48600543|NCT01278342|156393939|FG002|Overall Study|Physician Decision|0|||
48600544|NCT01278342|156393937|FG000|Overall Study|Lost to Follow-up|1|||
48600545|NCT01278342|156393938|FG001|Overall Study|Lost to Follow-up|0|||
48600546|NCT01278342|156393939|FG002|Overall Study|Lost to Follow-up|0|||
48600547|NCT01278342|156393937|FG000|Overall Study|Administrative problems|2|||
48600548|NCT01278342|156393938|FG001|Overall Study|Administrative problems|0|||
48600549|NCT01278342|156393939|FG002|Overall Study|Administrative problems|0|||
48600550|NCT01278342|156393937|FG000|Overall Study|Other|1|||
48507554|NCT01190930|156052354|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48507555|NCT01190930|156052355|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48600551|NCT01278342|156393938|FG001|Overall Study|Other|0|||
48600552|NCT01278342|156393939|FG002|Overall Study|Other|0|||
48600553|NCT02982863|156393942|FG000|Overall Study|Not eligible patients|809|||
48600554|NCT02982863|156393943|FG001|Overall Study|Not eligible patients|4261|||
48600555|NCT02982863|156393944|FG002|Overall Study|Not eligible patients|1852|||
48600556|NCT02982863|156393945|FG003|Overall Study|Not eligible patients|1400|||
48600557|NCT02982863|156393946|FG004|Overall Study|Not eligible patients|492|||
48600558|NCT03257436|156393953|FG000|Overall Study|Withdrawal by Subject|76|||
48507556|NCT01190930|156052356|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48600559|NCT03257436|156393953|FG000|Overall Study|Death|19|||
48600560|NCT00698815|156393954|FG000|Overall Study|Death|1|||
48600561|NCT00698815|156393955|FG001|Overall Study|Death|2|||
48600562|NCT00698815|156393956|FG002|Overall Study|Death|4|||
48600563|NCT00698815|156393954|FG000|Overall Study|Withdrawal by Subject|6|||
48820780|NCT01513967|157185624|FG006|Overall Study|Physician Decision|0|||
48600564|NCT00698815|156393955|FG001|Overall Study|Withdrawal by Subject|3|||
48600565|NCT00698815|156393956|FG002|Overall Study|Withdrawal by Subject|2|||
48600566|NCT00698815|156393954|FG000|Overall Study|MD discretion|2|||
48507557|NCT01190930|156052357|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48507558|NCT01190930|156052358|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48600567|NCT00698815|156393955|FG001|Overall Study|MD discretion|7|||
48600568|NCT00698815|156393956|FG002|Overall Study|MD discretion|2|||
48600569|NCT00698815|156393954|FG000|Overall Study|Did not receive protocol treatment|1|||
48820781|NCT01513967|157185625|FG007|Overall Study|Physician Decision|0|||
48600570|NCT00698815|156393955|FG001|Overall Study|Did not receive protocol treatment|2|||
48600571|NCT00698815|156393956|FG002|Overall Study|Did not receive protocol treatment|2|||
48600572|NCT02048722|156393957|FG000|2 Cycles of Treatment|Adverse Event|2|||
48600573|NCT02048722|156393957|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
48600574|NCT02048722|156393957|FG000|2 Cycles of Treatment|Progressive Disease|2|||
48600575|NCT02048722|156393957|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
48600576|NCT02048722|156393957|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
48600577|NCT02048722|156393957|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
48600578|NCT01619865|156393960|FG000|Overall Study|Adverse Event|1|||
48600579|NCT01619865|156393960|FG000|Overall Study|Death|2|||
48600580|NCT01619865|156393960|FG000|Overall Study|subject not able to comply|1|||
48600581|NCT02111174|156393963|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
48600582|NCT02111174|156393964|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
48600583|NCT02111174|156393963|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
48600584|NCT02111174|156393964|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
48600585|NCT02111174|156393963|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
48600586|NCT02111174|156393964|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
48600587|NCT02111174|156393963|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
48600588|NCT02111174|156393964|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
48600589|NCT01077323|156393965|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
48600590|NCT01077323|156393966|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
48600591|NCT01077323|156393967|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
48600592|NCT01077323|156393965|FG000|Overall Study|Dispensing of drug in baseline period|0|||
48600593|NCT01077323|156393966|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
48600594|NCT01077323|156393967|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
48600595|NCT01077323|156393965|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
48600596|NCT01077323|156393966|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
48600597|NCT01077323|156393967|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
48600598|NCT00838097|156393970|FG000|Overall Study|Ineligibility determined|6|||
48600599|NCT00838097|156393970|FG000|Overall Study|Adverse Event|2|||
48600600|NCT00838097|156393970|FG000|Overall Study|Withdrawal by Subject|3|||
48600601|NCT00838097|156393970|FG000|Overall Study|Requirement for alternative therapy|2|||
48600602|NCT00838097|156393970|FG000|Overall Study|Physician Decision|4|||
48600603|NCT00838097|156393970|FG000|Overall Study|Lost to Follow-up|11|||
48600604|NCT00838097|156393970|FG000|Overall Study|Death|6|||
48600605|NCT00838097|156393970|FG000|Overall Study|Protocol-specified criteria|142|||
48600606|NCT00871234|156393971|FG000|Overall Study|Adverse Event|2|||
48600607|NCT00871234|156393971|FG000|Overall Study|Lost to Follow-up|3|||
48600608|NCT00325819|156393993|FG000|Overall Study|Study product lost in mail|2|||
48600609|NCT00325819|156393994|FG001|Overall Study|Study product lost in mail|1|||
48600610|NCT00325819|156393993|FG000|Overall Study|Did not take a dose of study product|4|||
48600611|NCT00325819|156393994|FG001|Overall Study|Did not take a dose of study product|9|||
48600612|NCT00325819|156393993|FG000|Overall Study|Lost to Follow-up|3|||
48600613|NCT00325819|156393994|FG001|Overall Study|Lost to Follow-up|3|||
48600614|NCT01026948|156394001|FG000|Overall Study|Physician Decision|8|||
48507559|NCT01190930|156052359|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48507560|NCT01190930|156052360|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48507561|NCT01190930|156052361|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48507562|NCT01190930|156052362|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
48507563|NCT01190930|156052353|FG000|Induction|High Risk Downs|80|||
48507564|NCT01190930|156052354|FG001|Induction|High Risk Downs|0|||
48507565|NCT01190930|156052355|FG002|Induction|High Risk Downs|0|||
48507566|NCT01190930|156052356|FG003|Induction|High Risk Downs|0|||
48507567|NCT01190930|156052357|FG004|Induction|High Risk Downs|0|||
48507568|NCT01190930|156052358|FG005|Induction|High Risk Downs|0|||
48507569|NCT01190930|156052359|FG006|Induction|High Risk Downs|0|||
48507570|NCT01190930|156052360|FG007|Induction|High Risk Downs|0|||
48507571|NCT01190930|156052361|FG008|Induction|High Risk Downs|0|||
48507572|NCT01190930|156052362|FG009|Induction|High Risk Downs|0|||
48507573|NCT01190930|156052353|FG000|Induction|Enrollment onto another COG Protocol|1|||
48507574|NCT01190930|156052354|FG001|Induction|Enrollment onto another COG Protocol|0|||
48507575|NCT01190930|156052355|FG002|Induction|Enrollment onto another COG Protocol|0|||
48507576|NCT01190930|156052356|FG003|Induction|Enrollment onto another COG Protocol|0|||
48507577|NCT01190930|156052357|FG004|Induction|Enrollment onto another COG Protocol|0|||
48507578|NCT01190930|156052358|FG005|Induction|Enrollment onto another COG Protocol|0|||
48507579|NCT01190930|156052359|FG006|Induction|Enrollment onto another COG Protocol|0|||
48507580|NCT01190930|156052360|FG007|Induction|Enrollment onto another COG Protocol|0|||
48600615|NCT03191552|156394002|FG000|Overall Study|Lost to Follow-up|1|||
48600616|NCT03191552|156394003|FG001|Overall Study|Lost to Follow-up|0|||
48600617|NCT03191552|156394004|FG002|Overall Study|Lost to Follow-up|0|||
48600618|NCT03191552|156394002|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
48507581|NCT01190930|156052361|FG008|Induction|Enrollment onto another COG Protocol|0|||
48507582|NCT01190930|156052362|FG009|Induction|Enrollment onto another COG Protocol|0|||
48600619|NCT03191552|156394003|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
48600620|NCT03191552|156394004|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
48600621|NCT00485069|156394005|FG000|Overall Study|Adverse Event|10|||
48600622|NCT00485069|156394006|FG001|Overall Study|Adverse Event|4|||
48600623|NCT00485069|156394005|FG000|Overall Study|Lack of Efficacy|2|||
48600624|NCT00485069|156394006|FG001|Overall Study|Lack of Efficacy|1|||
48600625|NCT00485069|156394005|FG000|Overall Study|Protocol Violation|0|||
48600626|NCT00485069|156394006|FG001|Overall Study|Protocol Violation|1|||
48600627|NCT00485069|156394005|FG000|Overall Study|Withdrawal by Subject|6|||
48600628|NCT00485069|156394006|FG001|Overall Study|Withdrawal by Subject|6|||
48507583|NCT01190930|156052353|FG000|Induction|Average Risk|1847|||
48600629|NCT00102596|156394007|FG000|Part A|Screen failures|6|||
48600630|NCT00102596|156394008|FG001|Part A|Screen failures|0|||
48600631|NCT00102596|156394007|FG000|Part A|Adverse Event|1|||
48600632|NCT00102596|156394008|FG001|Part A|Adverse Event|0|||
48507584|NCT01190930|156052354|FG001|Induction|Average Risk|0|||
48507585|NCT01190930|156052355|FG002|Induction|Average Risk|0|||
48507586|NCT01190930|156052356|FG003|Induction|Average Risk|0|||
48507587|NCT01190930|156052357|FG004|Induction|Average Risk|0|||
48507588|NCT01190930|156052358|FG005|Induction|Average Risk|0|||
48507589|NCT01190930|156052359|FG006|Induction|Average Risk|0|||
48507590|NCT01190930|156052360|FG007|Induction|Average Risk|0|||
48507591|NCT01190930|156052361|FG008|Induction|Average Risk|0|||
48507592|NCT01190930|156052362|FG009|Induction|Average Risk|0|||
48507593|NCT01190930|156052353|FG000|Induction|High Risk|1227|||
48507594|NCT01190930|156052354|FG001|Induction|High Risk|0|||
48507595|NCT01190930|156052355|FG002|Induction|High Risk|0|||
48507596|NCT01190930|156052356|FG003|Induction|High Risk|0|||
48507597|NCT01190930|156052357|FG004|Induction|High Risk|0|||
48507598|NCT01190930|156052358|FG005|Induction|High Risk|0|||
48507599|NCT01190930|156052359|FG006|Induction|High Risk|0|||
48507600|NCT01190930|156052360|FG007|Induction|High Risk|0|||
48507601|NCT01190930|156052361|FG008|Induction|High Risk|0|||
48507602|NCT01190930|156052362|FG009|Induction|High Risk|0|||
48507603|NCT01190930|156052353|FG000|Induction|Low Risk|443|||
48507604|NCT01190930|156052354|FG001|Induction|Low Risk|0|||
48507605|NCT01190930|156052355|FG002|Induction|Low Risk|0|||
48507606|NCT01190930|156052356|FG003|Induction|Low Risk|0|||
48507607|NCT01190930|156052357|FG004|Induction|Low Risk|0|||
48507608|NCT01190930|156052358|FG005|Induction|Low Risk|0|||
48507609|NCT01190930|156052359|FG006|Induction|Low Risk|0|||
48507610|NCT01190930|156052360|FG007|Induction|Low Risk|0|||
48507611|NCT01190930|156052361|FG008|Induction|Low Risk|0|||
48507612|NCT01190930|156052362|FG009|Induction|Low Risk|0|||
48507613|NCT01190930|156052353|FG000|Induction|Very High Risk|1012|||
48507614|NCT01190930|156052354|FG001|Induction|Very High Risk|0|||
48507615|NCT01190930|156052355|FG002|Induction|Very High Risk|0|||
48507616|NCT01190930|156052356|FG003|Induction|Very High Risk|0|||
48507617|NCT01190930|156052357|FG004|Induction|Very High Risk|0|||
48507618|NCT01190930|156052358|FG005|Induction|Very High Risk|0|||
48507619|NCT01190930|156052359|FG006|Induction|Very High Risk|0|||
48507620|NCT01190930|156052360|FG007|Induction|Very High Risk|0|||
48507621|NCT01190930|156052361|FG008|Induction|Very High Risk|0|||
48507622|NCT01190930|156052362|FG009|Induction|Very High Risk|0|||
48507623|NCT01190930|156052353|FG000|Induction|Philadelphia chromosome-positive|99|||
48507624|NCT01190930|156052354|FG001|Induction|Philadelphia chromosome-positive|0|||
48507625|NCT01190930|156052355|FG002|Induction|Philadelphia chromosome-positive|0|||
48507626|NCT01190930|156052356|FG003|Induction|Philadelphia chromosome-positive|0|||
48507627|NCT01190930|156052357|FG004|Induction|Philadelphia chromosome-positive|0|||
48507628|NCT01190930|156052358|FG005|Induction|Philadelphia chromosome-positive|0|||
48507629|NCT01190930|156052359|FG006|Induction|Philadelphia chromosome-positive|0|||
48507630|NCT01190930|156052360|FG007|Induction|Philadelphia chromosome-positive|0|||
48507631|NCT01190930|156052361|FG008|Induction|Philadelphia chromosome-positive|0|||
48507632|NCT01190930|156052362|FG009|Induction|Philadelphia chromosome-positive|0|||
48507633|NCT01190930|156052353|FG000|Induction|Incomplete Induction data|63|||
48507634|NCT01190930|156052354|FG001|Induction|Incomplete Induction data|0|||
48507635|NCT01190930|156052355|FG002|Induction|Incomplete Induction data|0|||
48507636|NCT01190930|156052356|FG003|Induction|Incomplete Induction data|0|||
48507637|NCT01190930|156052357|FG004|Induction|Incomplete Induction data|0|||
48600633|NCT02314728|156394009|FG000|Overall Study|Protocol Violation|1|||
48507638|NCT01190930|156052358|FG005|Induction|Incomplete Induction data|0|||
48507639|NCT01190930|156052359|FG006|Induction|Incomplete Induction data|0|||
48507640|NCT01190930|156052360|FG007|Induction|Incomplete Induction data|0|||
48507641|NCT01190930|156052361|FG008|Induction|Incomplete Induction data|0|||
48507642|NCT01190930|156052362|FG009|Induction|Incomplete Induction data|0|||
48507643|NCT01190930|156052353|FG000|Induction|Progressive disease|0|||
48507644|NCT01190930|156052354|FG001|Induction|Progressive disease|1|||
48507645|NCT01190930|156052355|FG002|Induction|Progressive disease|0|||
48507646|NCT01190930|156052356|FG003|Induction|Progressive disease|0|||
48507647|NCT01190930|156052357|FG004|Induction|Progressive disease|0|||
48600634|NCT02314728|156394010|FG001|Overall Study|Protocol Violation|0|||
48820782|NCT01458275|157185628|FG000|Overall Study|Adverse Event|3|||
48820783|NCT01458275|157185629|FG001|Overall Study|Adverse Event|4|||
48820784|NCT01458275|157185630|FG002|Overall Study|Adverse Event|1|||
48820785|NCT01458275|157185628|FG000|Overall Study|Lost to Follow-up|3|||
48820786|NCT01458275|157185629|FG001|Overall Study|Lost to Follow-up|2|||
48820787|NCT01458275|157185630|FG002|Overall Study|Lost to Follow-up|5|||
48507648|NCT01190930|156052358|FG005|Induction|Progressive disease|0|||
48507649|NCT01190930|156052359|FG006|Induction|Progressive disease|0|||
48507650|NCT01190930|156052360|FG007|Induction|Progressive disease|0|||
48507651|NCT01190930|156052361|FG008|Induction|Progressive disease|0|||
48507652|NCT01190930|156052362|FG009|Induction|Progressive disease|0|||
48507653|NCT01190930|156052353|FG000|Induction|No treatment|3|||
48507654|NCT01190930|156052354|FG001|Induction|No treatment|0|||
48507655|NCT01190930|156052355|FG002|Induction|No treatment|0|||
48507656|NCT01190930|156052356|FG003|Induction|No treatment|0|||
48820788|NCT01458275|157185628|FG000|Overall Study|Protocol Violation|5|||
48820789|NCT01458275|157185629|FG001|Overall Study|Protocol Violation|5|||
48820790|NCT01458275|157185630|FG002|Overall Study|Protocol Violation|2|||
48507657|NCT01190930|156052357|FG004|Induction|No treatment|0|||
48507658|NCT01190930|156052358|FG005|Induction|No treatment|0|||
48507659|NCT01190930|156052359|FG006|Induction|No treatment|0|||
48507660|NCT01190930|156052360|FG007|Induction|No treatment|0|||
48507661|NCT01190930|156052361|FG008|Induction|No treatment|0|||
48507662|NCT01190930|156052362|FG009|Induction|No treatment|0|||
48507663|NCT01190930|156052353|FG000|Induction|Ineligible|69|||
48507664|NCT01190930|156052354|FG001|Induction|Ineligible|4|||
48507665|NCT01190930|156052355|FG002|Induction|Ineligible|0|||
48507666|NCT01190930|156052356|FG003|Induction|Ineligible|0|||
48507667|NCT01190930|156052357|FG004|Induction|Ineligible|0|||
48507668|NCT01190930|156052358|FG005|Induction|Ineligible|0|||
48507669|NCT01190930|156052359|FG006|Induction|Ineligible|0|||
48507670|NCT01190930|156052360|FG007|Induction|Ineligible|0|||
48507671|NCT01190930|156052361|FG008|Induction|Ineligible|0|||
48507672|NCT01190930|156052362|FG009|Induction|Ineligible|0|||
48507673|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
48507674|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
48507675|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
48507676|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
48507677|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
48507678|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
48507679|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
48507680|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
48507681|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
48507682|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
48507683|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|Death|0|||
48507684|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|Death|0|||
48507685|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|Death|8|||
48507686|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|Death|4|||
48507687|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|Death|0|||
48507688|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|Death|0|||
48507689|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|Death|0|||
48507690|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|Death|0|||
48507691|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|Death|0|||
48507692|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|Death|0|||
48507693|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
48507694|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
48507695|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
48507696|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
48507697|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
48507698|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
48507699|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
48507700|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
48507701|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
48507702|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
48507703|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
48507704|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
48507705|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
48507706|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
48507707|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
48507708|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
48507709|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
48820791|NCT01458275|157185628|FG000|Overall Study|Withdrawal by Subject|3|||
48507710|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
48507711|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
48507712|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
48507713|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|Refusal|0|||
48820792|NCT01458275|157185629|FG001|Overall Study|Withdrawal by Subject|2|||
48507714|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|Refusal|2|||
48507715|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|Refusal|694|||
48507716|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|Refusal|4|||
48507717|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|Refusal|0|||
48507718|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|Refusal|3|||
48507719|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|Refusal|0|||
48507720|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|Refusal|0|||
48507721|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|Refusal|0|||
48507722|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|Refusal|0|||
48507723|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
48600635|NCT02314728|156394009|FG000|Overall Study|Lost to Follow-up|0|||
48600636|NCT02314728|156394010|FG001|Overall Study|Lost to Follow-up|1|||
48600637|NCT02688933|156394011|FG000|Overall Study|Adverse Event|3|||
48600638|NCT02688933|156394012|FG001|Overall Study|Adverse Event|1|||
48600639|NCT02688933|156394011|FG000|Overall Study|Lack of Efficacy|2|||
48600640|NCT02688933|156394012|FG001|Overall Study|Lack of Efficacy|2|||
48600641|NCT02688933|156394011|FG000|Overall Study|Poor compliance to protocol|7|||
48600642|NCT02688933|156394012|FG001|Overall Study|Poor compliance to protocol|4|||
48600643|NCT02688933|156394011|FG000|Overall Study|Hypoglycemia|2|||
48600644|NCT02688933|156394012|FG001|Overall Study|Hypoglycemia|0|||
48600645|NCT02688933|156394011|FG000|Overall Study|Other than Specified|14|||
48600646|NCT02688933|156394012|FG001|Overall Study|Other than Specified|25|||
48600647|NCT02688933|156394011|FG000|Overall Study|Lost to Follow-up|1|||
48600648|NCT02688933|156394012|FG001|Overall Study|Lost to Follow-up|5|||
48600649|NCT01275144|156394013|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
48600650|NCT01275144|156394014|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
48600651|NCT02039778|156394015|FG000|Overall Study|Death|2|||
48600652|NCT02039778|156394015|FG000|Overall Study|Withdrawal by Subject|1|||
48600653|NCT02039778|156394015|FG000|Overall Study|Never started the protocol treatment|1|||
48600654|NCT00810199|156394017|FG000|Overall Study|Adverse Event|24|||
48600655|NCT00810199|156394018|FG001|Overall Study|Adverse Event|26|||
48600656|NCT00810199|156394017|FG000|Overall Study|Death|4|||
48600657|NCT00810199|156394018|FG001|Overall Study|Death|6|||
48820793|NCT01458275|157185630|FG002|Overall Study|Withdrawal by Subject|1|||
48507724|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
48507725|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
48507726|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
48507727|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
48507728|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
48507729|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
48507730|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
48507731|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
48507732|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
48507733|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507734|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
48507735|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507736|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507737|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507738|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507739|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507740|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507741|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507742|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
48507743|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
48507744|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
48507745|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
48507746|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
48507747|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
48507748|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
48507749|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
48507750|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
48507751|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
48507752|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
48820794|NCT02419755|157185632|FG000|Overall Study|Death|1|||
48600658|NCT00810199|156394017|FG000|Overall Study|Withdrew consent|9|||
48600659|NCT00810199|156394018|FG001|Overall Study|Withdrew consent|12|||
48600660|NCT00810199|156394017|FG000|Overall Study|Insufficient therapeutic response|5|||
48600661|NCT00810199|156394018|FG001|Overall Study|Insufficient therapeutic response|14|||
48600662|NCT00810199|156394017|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
48600663|NCT00810199|156394018|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
48507753|NCT01190930|156052353|FG000|Post Induction Pre-Maintenance|Relapse|0|||
48507754|NCT01190930|156052354|FG001|Post Induction Pre-Maintenance|Relapse|0|||
48507755|NCT01190930|156052355|FG002|Post Induction Pre-Maintenance|Relapse|1|||
48507756|NCT01190930|156052356|FG003|Post Induction Pre-Maintenance|Relapse|0|||
48507757|NCT01190930|156052357|FG004|Post Induction Pre-Maintenance|Relapse|0|||
48507758|NCT01190930|156052358|FG005|Post Induction Pre-Maintenance|Relapse|0|||
48507759|NCT01190930|156052359|FG006|Post Induction Pre-Maintenance|Relapse|0|||
48507760|NCT01190930|156052360|FG007|Post Induction Pre-Maintenance|Relapse|0|||
48507761|NCT01190930|156052361|FG008|Post Induction Pre-Maintenance|Relapse|0|||
48507762|NCT01190930|156052362|FG009|Post Induction Pre-Maintenance|Relapse|0|||
48507763|NCT01190930|156052353|FG000|Maintenance|Adverse Event|0|||
48507764|NCT01190930|156052354|FG001|Maintenance|Adverse Event|0|||
48507765|NCT01190930|156052355|FG002|Maintenance|Adverse Event|0|||
48507766|NCT01190930|156052356|FG003|Maintenance|Adverse Event|0|||
48507767|NCT01190930|156052357|FG004|Maintenance|Adverse Event|0|||
48507768|NCT01190930|156052358|FG005|Maintenance|Adverse Event|1|||
48507769|NCT01190930|156052359|FG006|Maintenance|Adverse Event|1|||
48507770|NCT01190930|156052360|FG007|Maintenance|Adverse Event|3|||
48507771|NCT01190930|156052361|FG008|Maintenance|Adverse Event|3|||
48507772|NCT01190930|156052362|FG009|Maintenance|Adverse Event|0|||
48507773|NCT01190930|156052353|FG000|Maintenance|Death|0|||
48507774|NCT01190930|156052354|FG001|Maintenance|Death|0|||
48507775|NCT01190930|156052355|FG002|Maintenance|Death|0|||
48507776|NCT01190930|156052356|FG003|Maintenance|Death|1|||
48507777|NCT01190930|156052357|FG004|Maintenance|Death|0|||
48507778|NCT01190930|156052358|FG005|Maintenance|Death|0|||
48507779|NCT01190930|156052359|FG006|Maintenance|Death|2|||
48507780|NCT01190930|156052360|FG007|Maintenance|Death|2|||
48507781|NCT01190930|156052361|FG008|Maintenance|Death|2|||
48507782|NCT01190930|156052362|FG009|Maintenance|Death|2|||
48507783|NCT01190930|156052353|FG000|Maintenance|Lost to Follow-up|0|||
48507784|NCT01190930|156052354|FG001|Maintenance|Lost to Follow-up|0|||
48507785|NCT01190930|156052355|FG002|Maintenance|Lost to Follow-up|0|||
48507786|NCT01190930|156052356|FG003|Maintenance|Lost to Follow-up|0|||
48507787|NCT01190930|156052357|FG004|Maintenance|Lost to Follow-up|0|||
48507788|NCT01190930|156052358|FG005|Maintenance|Lost to Follow-up|0|||
48507789|NCT01190930|156052359|FG006|Maintenance|Lost to Follow-up|1|||
48507790|NCT01190930|156052360|FG007|Maintenance|Lost to Follow-up|1|||
48507791|NCT01190930|156052361|FG008|Maintenance|Lost to Follow-up|1|||
48507792|NCT01190930|156052362|FG009|Maintenance|Lost to Follow-up|0|||
48507793|NCT01190930|156052353|FG000|Maintenance|Physician Decision|0|||
48507794|NCT01190930|156052354|FG001|Maintenance|Physician Decision|1|||
48507795|NCT01190930|156052355|FG002|Maintenance|Physician Decision|0|||
48507796|NCT01190930|156052356|FG003|Maintenance|Physician Decision|5|||
48507797|NCT01190930|156052357|FG004|Maintenance|Physician Decision|9|||
48507798|NCT01190930|156052358|FG005|Maintenance|Physician Decision|4|||
48507799|NCT01190930|156052359|FG006|Maintenance|Physician Decision|8|||
48507800|NCT01190930|156052360|FG007|Maintenance|Physician Decision|8|||
48507801|NCT01190930|156052361|FG008|Maintenance|Physician Decision|10|||
48507802|NCT01190930|156052362|FG009|Maintenance|Physician Decision|17|||
48507803|NCT01190930|156052353|FG000|Maintenance|Withdrawal by Subject|0|||
48507804|NCT01190930|156052354|FG001|Maintenance|Withdrawal by Subject|0|||
48507805|NCT01190930|156052355|FG002|Maintenance|Withdrawal by Subject|0|||
48507806|NCT01190930|156052356|FG003|Maintenance|Withdrawal by Subject|0|||
48507807|NCT01190930|156052357|FG004|Maintenance|Withdrawal by Subject|0|||
48507808|NCT01190930|156052358|FG005|Maintenance|Withdrawal by Subject|0|||
48507809|NCT01190930|156052359|FG006|Maintenance|Withdrawal by Subject|2|||
48507810|NCT01190930|156052360|FG007|Maintenance|Withdrawal by Subject|1|||
48507811|NCT01190930|156052361|FG008|Maintenance|Withdrawal by Subject|4|||
48507812|NCT01190930|156052362|FG009|Maintenance|Withdrawal by Subject|1|||
48507813|NCT01190930|156052353|FG000|Maintenance|Refusal|0|||
48507814|NCT01190930|156052354|FG001|Maintenance|Refusal|1|||
48507815|NCT01190930|156052355|FG002|Maintenance|Refusal|0|||
48507816|NCT01190930|156052356|FG003|Maintenance|Refusal|2|||
48507817|NCT01190930|156052357|FG004|Maintenance|Refusal|0|||
48507818|NCT01190930|156052358|FG005|Maintenance|Refusal|4|||
48507819|NCT01190930|156052359|FG006|Maintenance|Refusal|5|||
48507820|NCT01190930|156052360|FG007|Maintenance|Refusal|17|||
48507821|NCT01190930|156052361|FG008|Maintenance|Refusal|13|||
48507822|NCT01190930|156052362|FG009|Maintenance|Refusal|6|||
48507823|NCT01190930|156052353|FG000|Maintenance|second malignant neoplasm|0|||
48507824|NCT01190930|156052354|FG001|Maintenance|second malignant neoplasm|0|||
48507825|NCT01190930|156052355|FG002|Maintenance|second malignant neoplasm|0|||
48507826|NCT01190930|156052356|FG003|Maintenance|second malignant neoplasm|1|||
48507827|NCT01190930|156052357|FG004|Maintenance|second malignant neoplasm|0|||
48507828|NCT01190930|156052358|FG005|Maintenance|second malignant neoplasm|1|||
48507829|NCT01190930|156052359|FG006|Maintenance|second malignant neoplasm|0|||
48507830|NCT01190930|156052360|FG007|Maintenance|second malignant neoplasm|0|||
48507831|NCT01190930|156052361|FG008|Maintenance|second malignant neoplasm|1|||
48507832|NCT01190930|156052362|FG009|Maintenance|second malignant neoplasm|0|||
48507833|NCT01190930|156052353|FG000|Maintenance|Inevaluable|0|||
48507834|NCT01190930|156052354|FG001|Maintenance|Inevaluable|0|||
48507835|NCT01190930|156052355|FG002|Maintenance|Inevaluable|0|||
48600664|NCT00810199|156394017|FG000|Overall Study|Administrative/Other|5|||
48600665|NCT00810199|156394018|FG001|Overall Study|Administrative/Other|6|||
48600666|NCT00810199|156394017|FG000|Overall Study|Protocol Violation|2|||
48600667|NCT00810199|156394018|FG001|Overall Study|Protocol Violation|6|||
48600668|NCT00810199|156394017|FG000|Overall Study|Failure to return|1|||
48600669|NCT00810199|156394018|FG001|Overall Study|Failure to return|4|||
48600670|NCT00810199|156394017|FG000|Overall Study|Did not receive study drug|2|||
48726202|NCT00084838|156847869|FG000|Overall Study|Adverse Event|2|||
48726203|NCT00084838|156847869|FG000|Overall Study|Withdrawal by Subject|1|||
48820795|NCT02419755|157185633|FG001|Overall Study|Death|3|||
48820796|NCT02419755|157185632|FG000|Overall Study|Relapse|0|||
48820797|NCT02419755|157185633|FG001|Overall Study|Relapse|1|||
48820798|NCT02419755|157185632|FG000|Overall Study|Ineligible|1|||
48820799|NCT02419755|157185633|FG001|Overall Study|Ineligible|0|||
48820800|NCT02419755|157185632|FG000|Overall Study|Withdrawal by Subject|1|||
48820801|NCT02419755|157185633|FG001|Overall Study|Withdrawal by Subject|0|||
48820802|NCT01959880|157185635|FG000|Overall Study|Withdrawal by Subject|11|||
48820803|NCT01959880|157185636|FG001|Overall Study|Withdrawal by Subject|13|||
48820804|NCT01959880|157185637|FG002|Overall Study|Withdrawal by Subject|8|||
48820805|NCT01959880|157185638|FG003|Overall Study|Withdrawal by Subject|7|||
48820806|NCT01959880|157185635|FG000|Overall Study|Death|1|||
48820807|NCT01959880|157185636|FG001|Overall Study|Death|10|||
48820808|NCT01959880|157185637|FG002|Overall Study|Death|1|||
48820809|NCT01959880|157185638|FG003|Overall Study|Death|2|||
48820810|NCT01959880|157185635|FG000|Overall Study|Lost to Follow-up|95|||
48820811|NCT01959880|157185636|FG001|Overall Study|Lost to Follow-up|18|||
48820812|NCT01959880|157185637|FG002|Overall Study|Lost to Follow-up|15|||
48820813|NCT01959880|157185638|FG003|Overall Study|Lost to Follow-up|8|||
48820814|NCT01959880|157185635|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
48820815|NCT01959880|157185636|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
48820816|NCT01959880|157185637|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
48820817|NCT01959880|157185638|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
48820818|NCT01959880|157185635|FG000|Overall Study|Study completed early-FDA approved|1003|||
48600671|NCT00810199|156394018|FG001|Overall Study|Did not receive study drug|1|||
48726204|NCT00084838|156847869|FG000|Overall Study|Progressive Disease|4|||
48726205|NCT00084838|156847869|FG000|Overall Study|Pt Non-Compliance|1|||
48726206|NCT00084838|156847869|FG000|Overall Study|Ineligible|4|||
48726207|NCT01757691|156847870|FG000|Overall Study|Administrative problems|2|||
48726208|NCT01757691|156847871|FG001|Overall Study|Administrative problems|0|||
48726209|NCT00400946|156847878|FG000|Overall Study|Ineligible|0|||
48726210|NCT00400946|156847879|FG001|Overall Study|Ineligible|0|||
48726211|NCT00400946|156847880|FG002|Overall Study|Ineligible|0|||
48726212|NCT00400946|156847881|FG003|Overall Study|Ineligible|5|||
48820819|NCT01959880|157185636|FG001|Overall Study|Study completed early-FDA approved|311|||
48600672|NCT01091246|156394020|FG000|Overall Study|Lost to Follow-up|23|||
48600673|NCT01091246|156394021|FG001|Overall Study|Lost to Follow-up|11|||
48600674|NCT01091246|156394022|FG002|Overall Study|Lost to Follow-up|7|||
48600675|NCT01091246|156394020|FG000|Overall Study|Adverse Event|1|||
48600676|NCT01091246|156394021|FG001|Overall Study|Adverse Event|0|||
48600677|NCT01091246|156394022|FG002|Overall Study|Adverse Event|1|||
48600678|NCT01091246|156394020|FG000|Overall Study|Withdrawal by Subject|9|||
48600679|NCT01091246|156394021|FG001|Overall Study|Withdrawal by Subject|5|||
48600680|NCT01091246|156394022|FG002|Overall Study|Withdrawal by Subject|4|||
48600681|NCT01091246|156394020|FG000|Overall Study|Subject not dosed|2|||
48600682|NCT01091246|156394021|FG001|Overall Study|Subject not dosed|0|||
48600683|NCT01091246|156394022|FG002|Overall Study|Subject not dosed|1|||
48600684|NCT01673178|156394023|FG000|Overall Study|Lost to Follow-up|0|||
48820820|NCT01959880|157185637|FG002|Overall Study|Study completed early-FDA approved|179|||
48820821|NCT01959880|157185638|FG003|Overall Study|Study completed early-FDA approved|152|||
48820822|NCT03418740|157185639|FG000|Overall Study|Lost to Follow-up|13|||
48820823|NCT03418740|157185639|FG000|Overall Study|Scheduling Issues|7|||
48600685|NCT01673178|156394024|FG001|Overall Study|Lost to Follow-up|1|||
48600686|NCT01673178|156394025|FG002|Overall Study|Lost to Follow-up|0|||
48726213|NCT00400946|156847882|FG004|Overall Study|Ineligible|1|||
48820824|NCT03418740|157185639|FG000|Overall Study|Withdrawal by Subject|2|||
48820825|NCT03418740|157185639|FG000|Overall Study|Unable to Continue Consent|1|||
48820826|NCT04535414|157185640|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
48438529|NCT03655717|155792075|FG022|Overall Study|Physician Decision|0|||
48438530|NCT03655717|155792076|FG023|Overall Study|Physician Decision|1|||
48438531|NCT03655717|155792077|FG024|Overall Study|Physician Decision|0|||
48438532|NCT03655717|155792078|FG025|Overall Study|Physician Decision|0|||
48438533|NCT03655717|155792053|FG000|Overall Study|Lost to Follow-up|3|||
48438534|NCT03655717|155792054|FG001|Overall Study|Lost to Follow-up|1|||
48438535|NCT03655717|155792055|FG002|Overall Study|Lost to Follow-up|0|||
48438536|NCT03655717|155792056|FG003|Overall Study|Lost to Follow-up|1|||
48438537|NCT03655717|155792057|FG004|Overall Study|Lost to Follow-up|0|||
48438538|NCT03655717|155792058|FG005|Overall Study|Lost to Follow-up|1|||
48438539|NCT03655717|155792059|FG006|Overall Study|Lost to Follow-up|0|||
48507836|NCT01190930|156052356|FG003|Maintenance|Inevaluable|0|||
48507837|NCT01190930|156052357|FG004|Maintenance|Inevaluable|0|||
48507838|NCT01190930|156052358|FG005|Maintenance|Inevaluable|1|||
48507839|NCT01190930|156052359|FG006|Maintenance|Inevaluable|1|||
48507840|NCT01190930|156052360|FG007|Maintenance|Inevaluable|1|||
48507841|NCT01190930|156052361|FG008|Maintenance|Inevaluable|0|||
48507842|NCT01190930|156052362|FG009|Maintenance|Inevaluable|0|||
48507843|NCT01190930|156052353|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
48507844|NCT01190930|156052354|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
48507845|NCT01190930|156052355|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
48507846|NCT01190930|156052356|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
48507847|NCT01190930|156052357|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
48507848|NCT01190930|156052358|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
48507849|NCT01190930|156052359|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
48507850|NCT01190930|156052360|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
48507851|NCT01190930|156052361|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
48507852|NCT01190930|156052362|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
48507853|NCT01190930|156052353|FG000|Maintenance|Relapse|0|||
48507854|NCT01190930|156052354|FG001|Maintenance|Relapse|0|||
48507855|NCT01190930|156052355|FG002|Maintenance|Relapse|0|||
48507856|NCT01190930|156052356|FG003|Maintenance|Relapse|2|||
48507857|NCT01190930|156052357|FG004|Maintenance|Relapse|0|||
48507858|NCT01190930|156052358|FG005|Maintenance|Relapse|1|||
48507859|NCT01190930|156052359|FG006|Maintenance|Relapse|6|||
48507860|NCT01190930|156052360|FG007|Maintenance|Relapse|13|||
48507861|NCT01190930|156052361|FG008|Maintenance|Relapse|11|||
48507862|NCT01190930|156052362|FG009|Maintenance|Relapse|11|||
48507863|NCT01190930|156052353|FG000|Maintenance|Still on therapy|0|||
48507864|NCT01190930|156052354|FG001|Maintenance|Still on therapy|8|||
48507865|NCT01190930|156052355|FG002|Maintenance|Still on therapy|0|||
48507866|NCT01190930|156052356|FG003|Maintenance|Still on therapy|29|||
48507867|NCT01190930|156052357|FG004|Maintenance|Still on therapy|0|||
48507868|NCT01190930|156052358|FG005|Maintenance|Still on therapy|0|||
48507869|NCT01190930|156052359|FG006|Maintenance|Still on therapy|0|||
48507870|NCT01190930|156052360|FG007|Maintenance|Still on therapy|0|||
48507871|NCT01190930|156052361|FG008|Maintenance|Still on therapy|0|||
48507872|NCT01190930|156052362|FG009|Maintenance|Still on therapy|0|||
48507873|NCT00772941|156052363|FG000|Overall Study|CRFs not available|195|||
48507874|NCT00772941|156052363|FG000|Overall Study|Study not completed|16|||
48507875|NCT00772941|156052363|FG000|Overall Study|Missed Visits|374|||
48507876|NCT00772941|156052363|FG000|Overall Study|Poor Compliance|7|||
48507877|NCT00772941|156052363|FG000|Overall Study|GPSP Violation|90|||
48507878|NCT04786184|156052364|FG000|Overall Study|Adverse Event|4|||
48507879|NCT04786184|156052365|FG001|Overall Study|Adverse Event|0|||
48507880|NCT04786184|156052364|FG000|Overall Study|Withdrawal by Subject|3|||
48507881|NCT04786184|156052365|FG001|Overall Study|Withdrawal by Subject|1|||
48820827|NCT04535414|157185641|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
48820828|NCT04535414|157185640|FG000|Overall Study|Cancelled appointment|1|||
48820829|NCT04535414|157185641|FG001|Overall Study|Cancelled appointment|0|||
48820830|NCT04535414|157185640|FG000|Overall Study|cancelled - food in stomach|2|||
48820831|NCT04535414|157185641|FG001|Overall Study|cancelled - food in stomach|0|||
48820832|NCT04535414|157185640|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
48820833|NCT04535414|157185641|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
48820834|NCT04535414|157185640|FG000|Overall Study|Withdrawal by Subject|0|||
48820835|NCT04535414|157185641|FG001|Overall Study|Withdrawal by Subject|1|||
48820836|NCT00619476|157187304|FG000|Overall Study|Adverse Event|12|||
48820837|NCT00619476|157187305|FG001|Overall Study|Adverse Event|6|||
48820838|NCT00619476|157187306|FG002|Overall Study|Adverse Event|12|||
48820839|NCT00619476|157187307|FG003|Overall Study|Adverse Event|16|||
48507882|NCT04786184|156052364|FG000|Overall Study|Lost to Follow-up|4|||
48507883|NCT04786184|156052365|FG001|Overall Study|Lost to Follow-up|2|||
48507884|NCT00986245|156052366|FG000|First Intervention|Poor compliance|8|||
48820840|NCT00619476|157187304|FG000|Overall Study|Lack of Efficacy|6|||
48507885|NCT00986245|156052367|FG001|First Intervention|Poor compliance|4|||
48507886|NCT00986245|156052366|FG000|First Intervention|Lack of Efficacy|1|||
48507887|NCT00986245|156052367|FG001|First Intervention|Lack of Efficacy|2|||
48507888|NCT00986245|156052366|FG000|First Intervention|Withdrawal by Subject|0|||
48507889|NCT00986245|156052367|FG001|First Intervention|Withdrawal by Subject|1|||
48507890|NCT00986245|156052366|FG000|First Intervention|Protocol Violation|0|||
48507891|NCT00986245|156052367|FG001|First Intervention|Protocol Violation|1|||
48507892|NCT00986245|156052366|FG000|First Intervention|Out of indication|1|||
48820841|NCT00619476|157187305|FG001|Overall Study|Lack of Efficacy|1|||
48820842|NCT00619476|157187306|FG002|Overall Study|Lack of Efficacy|1|||
48507893|NCT00986245|156052367|FG001|First Intervention|Out of indication|0|||
48507894|NCT00986245|156052366|FG000|Second Intervention|Poor compliance|1|||
48507895|NCT00986245|156052367|FG001|Second Intervention|Poor compliance|0|||
48507896|NCT00986245|156052366|FG000|Second Intervention|Lost to Follow-up|1|||
48507897|NCT00986245|156052367|FG001|Second Intervention|Lost to Follow-up|0|||
48820843|NCT00619476|157187307|FG003|Overall Study|Lack of Efficacy|4|||
48820844|NCT00619476|157187304|FG000|Overall Study|Protocol Violation|5|||
48820845|NCT00619476|157187305|FG001|Overall Study|Protocol Violation|4|||
48820846|NCT00619476|157187306|FG002|Overall Study|Protocol Violation|4|||
48820847|NCT00619476|157187307|FG003|Overall Study|Protocol Violation|9|||
48820848|NCT00619476|157187304|FG000|Overall Study|Lost to Follow-up|1|||
48820849|NCT00619476|157187305|FG001|Overall Study|Lost to Follow-up|2|||
48820850|NCT00619476|157187306|FG002|Overall Study|Lost to Follow-up|0|||
48820851|NCT00619476|157187307|FG003|Overall Study|Lost to Follow-up|1|||
48820852|NCT00619476|157187304|FG000|Overall Study|Investigator Discretion|2|||
48820853|NCT00619476|157187305|FG001|Overall Study|Investigator Discretion|2|||
48820854|NCT00619476|157187306|FG002|Overall Study|Investigator Discretion|2|||
48820855|NCT00619476|157187307|FG003|Overall Study|Investigator Discretion|0|||
48820856|NCT00619476|157187304|FG000|Overall Study|Withdrawal by Subject|5|||
48820857|NCT00619476|157187305|FG001|Overall Study|Withdrawal by Subject|7|||
48820858|NCT00619476|157187306|FG002|Overall Study|Withdrawal by Subject|5|||
48820859|NCT00619476|157187307|FG003|Overall Study|Withdrawal by Subject|4|||
48820860|NCT00795132|157187310|FG000|Overall Study|Death|1|||
48820861|NCT00795132|157187310|FG000|Overall Study|Relapse|2|||
48820862|NCT02403674|157187311|FG000|Base Study|Death|1|||
48820863|NCT02403674|157187312|FG001|Base Study|Death|4|||
48820864|NCT02403674|157187311|FG000|Base Study|Adverse Event|11|||
48820865|NCT02403674|157187312|FG001|Base Study|Adverse Event|26|||
48820866|NCT02403674|157187311|FG000|Base Study|Lack of Efficacy|31|||
48820867|NCT02403674|157187312|FG001|Base Study|Lack of Efficacy|23|||
48820868|NCT02403674|157187311|FG000|Base Study|Lost to Follow-up|6|||
48820869|NCT02403674|157187312|FG001|Base Study|Lost to Follow-up|8|||
48820870|NCT02403674|157187311|FG000|Base Study|Withdrawal by Subject|10|||
48820871|NCT02403674|157187312|FG001|Base Study|Withdrawal by Subject|17|||
48820872|NCT02403674|157187311|FG000|Base Study|Physician Decision|2|||
48507898|NCT00986245|156052366|FG000|Second Intervention|Protocol Violation|0|||
48507899|NCT00986245|156052367|FG001|Second Intervention|Protocol Violation|1|||
48507900|NCT02255097|156052368|FG000|Overall Study|Death|151|||
48507901|NCT02255097|156052368|FG000|Overall Study|Lost to Follow-up|5|||
48507902|NCT02255097|156052368|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
48507903|NCT02255097|156052368|FG000|Overall Study|Withdrawal by Subject|7|||
48507904|NCT02255097|156052368|FG000|Overall Study|Allocated but not treated|1|||
48507905|NCT00488774|156052369|FG000|Overall Study|Withdrawal of consent|2|||
48507906|NCT00488774|156052370|FG001|Overall Study|Withdrawal of consent|2|||
48507907|NCT00488774|156052371|FG002|Overall Study|Withdrawal of consent|2|||
48507908|NCT00488774|156052372|FG003|Overall Study|Withdrawal of consent|0|||
48507909|NCT00488774|156052369|FG000|Overall Study|Other|6|||
48507910|NCT00488774|156052370|FG001|Overall Study|Other|3|||
48507911|NCT00488774|156052371|FG002|Overall Study|Other|2|||
48507912|NCT00488774|156052372|FG003|Overall Study|Other|2|||
48507913|NCT00488774|156052369|FG000|Overall Study|Lost to Follow-up|0|||
48507914|NCT00488774|156052370|FG001|Overall Study|Lost to Follow-up|0|||
48507915|NCT00488774|156052371|FG002|Overall Study|Lost to Follow-up|1|||
48507916|NCT00488774|156052372|FG003|Overall Study|Lost to Follow-up|1|||
48507917|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
48507918|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
48507919|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
48600687|NCT01673178|156394026|FG003|Overall Study|Lost to Follow-up|0|||
48820873|NCT02403674|157187312|FG001|Base Study|Physician Decision|2|||
48820874|NCT02403674|157187311|FG000|Base Study|Pregnancy|2|||
48820875|NCT02403674|157187312|FG001|Base Study|Pregnancy|2|||
48820876|NCT02403674|157187311|FG000|Base Study|Protocol Violation|8|||
48820877|NCT02403674|157187312|FG001|Base Study|Protocol Violation|4|||
48820878|NCT02403674|157187311|FG000|Base Study|Non-Compliance with study drug|1|||
48820879|NCT02403674|157187312|FG001|Base Study|Non-Compliance with study drug|4|||
48820880|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
48507920|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
48507921|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
48600688|NCT01673178|156394027|FG004|Overall Study|Lost to Follow-up|0|||
48600689|NCT01673178|156394023|FG000|Overall Study|Withdrawal by Subject|0|||
48820881|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
48820882|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
48507922|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
48507923|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
48507924|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
48507925|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
48820883|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
48820884|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
48820885|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
48820886|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
48820887|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
48820888|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
48820889|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
48726214|NCT00400946|156847878|FG000|Overall Study|Induction Failure|0|||
48726215|NCT00400946|156847879|FG001|Overall Study|Induction Failure|0|||
48726216|NCT00400946|156847880|FG002|Overall Study|Induction Failure|0|||
48726217|NCT00400946|156847881|FG003|Overall Study|Induction Failure|11|||
48726218|NCT00400946|156847882|FG004|Overall Study|Induction Failure|8|||
48726219|NCT00400946|156847878|FG000|Overall Study|Induction Death|0|||
48726220|NCT00400946|156847879|FG001|Overall Study|Induction Death|0|||
48726221|NCT00400946|156847880|FG002|Overall Study|Induction Death|0|||
48726222|NCT00400946|156847881|FG003|Overall Study|Induction Death|13|||
48726223|NCT00400946|156847882|FG004|Overall Study|Induction Death|3|||
48507926|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
48507927|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
48726224|NCT00400946|156847878|FG000|Overall Study|Lost to Follow-up|1|||
48726225|NCT00400946|156847879|FG001|Overall Study|Lost to Follow-up|1|||
48726226|NCT00400946|156847880|FG002|Overall Study|Lost to Follow-up|0|||
48726227|NCT00400946|156847881|FG003|Overall Study|Lost to Follow-up|0|||
48820890|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
48820891|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
48820892|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Death|1|||
48820893|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Death|0|||
48820894|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
48820895|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
48820896|NCT02403674|157187311|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
48820897|NCT02403674|157187312|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
48726228|NCT00400946|156847882|FG004|Overall Study|Lost to Follow-up|1|||
48726229|NCT00400946|156847878|FG000|Overall Study|Remission Death|1|||
48726230|NCT00400946|156847879|FG001|Overall Study|Remission Death|1|||
48726231|NCT00400946|156847880|FG002|Overall Study|Remission Death|0|||
48726232|NCT00400946|156847881|FG003|Overall Study|Remission Death|0|||
48726233|NCT00400946|156847882|FG004|Overall Study|Remission Death|1|||
48726234|NCT00400946|156847878|FG000|Overall Study|Relapse|9|||
48726235|NCT00400946|156847879|FG001|Overall Study|Relapse|2|||
48726236|NCT00400946|156847880|FG002|Overall Study|Relapse|1|||
48726237|NCT00400946|156847881|FG003|Overall Study|Relapse|1|||
48726238|NCT00400946|156847882|FG004|Overall Study|Relapse|5|||
48726239|NCT00400946|156847878|FG000|Overall Study|Transplant in CR1|0|||
48726240|NCT00400946|156847879|FG001|Overall Study|Transplant in CR1|0|||
48726241|NCT00400946|156847880|FG002|Overall Study|Transplant in CR1|0|||
48726242|NCT00400946|156847881|FG003|Overall Study|Transplant in CR1|10|||
48726243|NCT00400946|156847882|FG004|Overall Study|Transplant in CR1|1|||
48726244|NCT00400946|156847878|FG000|Overall Study|Withdrawal by Subject|2|||
48726245|NCT00400946|156847879|FG001|Overall Study|Withdrawal by Subject|5|||
48726246|NCT00400946|156847880|FG002|Overall Study|Withdrawal by Subject|1|||
48726247|NCT00400946|156847881|FG003|Overall Study|Withdrawal by Subject|5|||
48726248|NCT00400946|156847882|FG004|Overall Study|Withdrawal by Subject|8|||
48726249|NCT00400946|156847878|FG000|Overall Study|Clinical|1|||
48726250|NCT00400946|156847879|FG001|Overall Study|Clinical|2|||
48726251|NCT00400946|156847880|FG002|Overall Study|Clinical|0|||
48726252|NCT00400946|156847881|FG003|Overall Study|Clinical|2|||
48726253|NCT00400946|156847882|FG004|Overall Study|Clinical|9|||
48726254|NCT00400946|156847878|FG000|Overall Study|Other|0|||
48726255|NCT00400946|156847879|FG001|Overall Study|Other|0|||
48726256|NCT00400946|156847880|FG002|Overall Study|Other|0|||
48726257|NCT00400946|156847881|FG003|Overall Study|Other|0|||
48726258|NCT00400946|156847882|FG004|Overall Study|Other|1|||
48820898|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
48820899|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
48820900|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
48726259|NCT00814879|156847884|FG000|By Week 24|Cancer Diagnosis|1|||
48726260|NCT00814879|156847885|FG001|By Week 24|Cancer Diagnosis|0|||
48726261|NCT00814879|156847884|FG000|By Week 24|Incarceration|0|||
48726262|NCT00814879|156847885|FG001|By Week 24|Incarceration|1|||
48726263|NCT00814879|156847884|FG000|By Week 48|Lost to Follow-up|2|||
48820901|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
48820902|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
48726264|NCT00814879|156847885|FG001|By Week 48|Lost to Follow-up|2|||
48726265|NCT00814879|156847884|FG000|By Week 48|Death|0|||
48726266|NCT00814879|156847885|FG001|By Week 48|Death|1|||
48726267|NCT00920907|156847886|FG000|Induction Period|Adverse Event|0|||
48726268|NCT00920907|156847887|FG001|Induction Period|Adverse Event|2|||
48726269|NCT00920907|156847886|FG000|Induction Period|Death|1|||
48726270|NCT00920907|156847887|FG001|Induction Period|Death|1|||
48726271|NCT00920907|156847886|FG000|Induction Period|Disease Progression|12|||
48726272|NCT00920907|156847887|FG001|Induction Period|Disease Progression|11|||
48726273|NCT00920907|156847886|FG000|Induction Period|Study Drug Toxicity|8|||
48820903|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
48726274|NCT00920907|156847887|FG001|Induction Period|Study Drug Toxicity|6|||
48726275|NCT00920907|156847886|FG000|Induction Period|No longer meets study criteria|0|||
48726276|NCT00920907|156847887|FG001|Induction Period|No longer meets study criteria|1|||
48726277|NCT00920907|156847886|FG000|Induction Period|Withdrawal by Subject|1|||
48726278|NCT00920907|156847887|FG001|Induction Period|Withdrawal by Subject|1|||
48726279|NCT00920907|156847886|FG000|Maintenance Period|Disease Progression|3|||
48726280|NCT00920907|156847887|FG001|Maintenance Period|Disease Progression|7|||
48726281|NCT00920907|156847886|FG000|Maintenance Period|Administrative (study closure)|7|||
48726282|NCT00920907|156847887|FG001|Maintenance Period|Administrative (study closure)|2|||
48726283|NCT00920907|156847886|FG000|Maintenance Period|Study Drug Toxicity|0|||
48726284|NCT00920907|156847887|FG001|Maintenance Period|Study Drug Toxicity|2|||
48726285|NCT00920907|156847886|FG000|Maintenance Period|Death|1|||
48726286|NCT00920907|156847887|FG001|Maintenance Period|Death|1|||
48726287|NCT00920907|156847886|FG000|Maintenance Period|Withdrawal by Subject|1|||
48726288|NCT00920907|156847887|FG001|Maintenance Period|Withdrawal by Subject|0|||
48726289|NCT00920907|156847886|FG000|Maintenance Period|Adverse Event|0|||
48726290|NCT00920907|156847887|FG001|Maintenance Period|Adverse Event|1|||
48726291|NCT01275339|156847890|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
48726292|NCT01275339|156847891|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
48726293|NCT01275339|156847892|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
48726294|NCT01275339|156847893|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
48726295|NCT01275339|156847890|FG000|Overall Study|Withdrawal by Subject|0|||
48726296|NCT01275339|156847891|FG001|Overall Study|Withdrawal by Subject|0|||
48726297|NCT01275339|156847892|FG002|Overall Study|Withdrawal by Subject|1|||
48726298|NCT01275339|156847893|FG003|Overall Study|Withdrawal by Subject|0|||
48726299|NCT01362595|156847894|FG000|Overall Study|Screen failure|10|||
48726300|NCT01362595|156847894|FG000|Overall Study|Withdrawal by Subject|2|||
48726301|NCT01475071|156847895|FG000|Overall Study|Physician Decision|1|||
48726302|NCT01475071|156847895|FG000|Overall Study|Withdrawal by Subject|6|||
48726303|NCT01475071|156847895|FG000|Overall Study|Lost to Follow-up|1|||
48726304|NCT01736657|156847898|FG000|Overall Study|insufficient vascular access|1|||
48726305|NCT01205581|156847899|FG000|Overall Study|Withdrawal by Subject|1|||
48726306|NCT01205581|156847900|FG001|Overall Study|Withdrawal by Subject|0|||
48726307|NCT01205581|156847901|FG002|Overall Study|Withdrawal by Subject|0|||
48726308|NCT01205581|156847902|FG003|Overall Study|Withdrawal by Subject|0|||
48726309|NCT01205581|156847903|FG004|Overall Study|Withdrawal by Subject|0|||
48726310|NCT01205581|156847904|FG005|Overall Study|Withdrawal by Subject|0|||
48726311|NCT03468543|156847905|FG000|Overall Study|Protocol stopping rules met|3|||
48726312|NCT01236118|156847907|FG000|Overall Study|Adverse Event|2|||
48726313|NCT01236118|156847908|FG001|Overall Study|Adverse Event|0|||
48726314|NCT01236118|156847909|FG002|Overall Study|Adverse Event|2|||
48726315|NCT01236118|156847907|FG000|Overall Study|Physician Decision|0|||
48726316|NCT01236118|156847908|FG001|Overall Study|Physician Decision|1|||
48726317|NCT01236118|156847909|FG002|Overall Study|Physician Decision|0|||
48726318|NCT01236118|156847907|FG000|Overall Study|Withdrawal by Subject|0|||
48726319|NCT01236118|156847908|FG001|Overall Study|Withdrawal by Subject|0|||
48726320|NCT01236118|156847909|FG002|Overall Study|Withdrawal by Subject|1|||
48726321|NCT04972630|156847914|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
48726322|NCT04972630|156847915|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
48726323|NCT04972630|156847916|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
48726324|NCT00397943|156847917|FG000|Overall Study|Unspecified reasons|12|||
48726325|NCT00397943|156847918|FG001|Overall Study|Unspecified reasons|9|||
48726326|NCT00397943|156847919|FG002|Overall Study|Unspecified reasons|0|||
48726327|NCT00397943|156847920|FG003|Overall Study|Unspecified reasons|0|||
48726328|NCT00397943|156847921|FG004|Overall Study|Unspecified reasons|0|||
48507928|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
48726329|NCT04251156|156847923|FG000|Overall Study|Lost to Follow-up|1|||
48726330|NCT04251156|156847924|FG001|Overall Study|Lost to Follow-up|1|||
48726331|NCT04251156|156847923|FG000|Overall Study|Withdrawal by Subject|4|||
48726332|NCT04251156|156847924|FG001|Overall Study|Withdrawal by Subject|4|||
48726333|NCT04626310|156847925|FG000|Overall Study|4-miss from treatment|6|||
48726334|NCT04626310|156847926|FG001|Overall Study|4-miss from treatment|5|||
48726335|NCT04626310|156847927|FG002|Overall Study|4-miss from treatment|5|||
48726336|NCT04626310|156847925|FG000|Overall Study|Withdrawal by Subject|1|||
48726337|NCT04626310|156847926|FG001|Overall Study|Withdrawal by Subject|0|||
48726338|NCT04626310|156847927|FG002|Overall Study|Withdrawal by Subject|3|||
48726339|NCT02604017|156847929|FG000|Overall Study|Withdrew Consent|0|||
48726340|NCT02604017|156847930|FG001|Overall Study|Withdrew Consent|2|||
48726341|NCT02604017|156847929|FG000|Overall Study|Lost to Follow-up|5|||
48726342|NCT02604017|156847930|FG001|Overall Study|Lost to Follow-up|6|||
48726343|NCT02604017|156847929|FG000|Overall Study|Other|1|||
48726344|NCT02604017|156847930|FG001|Overall Study|Other|0|||
48726345|NCT02195687|156847933|FG000|Overall Study|Personal Reasons|1|||
48507929|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
48507930|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
48820904|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
48820905|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
48820906|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
48820907|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
48820908|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Death|2|||
48820909|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Death|2|||
48820910|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
48820911|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
48820912|NCT02403674|157187311|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
48820913|NCT02403674|157187312|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
48820914|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
48820915|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
48820916|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
48820917|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
48507931|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
48507932|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
48507933|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
48507934|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
48820918|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
48820919|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
48507935|NCT01667679|156052378|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
48507936|NCT01667679|156052379|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
48507937|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
48507938|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
48507939|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
48507940|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
48507941|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
48726346|NCT02195687|156847934|FG001|Overall Study|Personal Reasons|1|||
48726347|NCT02195687|156847933|FG000|Overall Study|Lost to Follow-up|4|||
48726348|NCT02195687|156847934|FG001|Overall Study|Lost to Follow-up|1|||
48726349|NCT01142128|156847937|FG000|Overall Study|Physician Decision|1|||
48726350|NCT01142128|156847937|FG000|Overall Study|Lost to Follow-up|1|||
48726351|NCT01142128|156847937|FG000|Overall Study|Withdrawal by Subject|2|||
48726352|NCT00761748|156847938|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
48726353|NCT00761748|156847939|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
48726354|NCT00761748|156847938|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
48726355|NCT00761748|156847939|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
48726356|NCT01214174|156847940|FG000|Overall Study|Withdrawal by Subject|0|||
48820920|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
48820921|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
48820922|NCT02403674|157187311|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
48820923|NCT02403674|157187312|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
48820924|NCT03930186|157187314|FG000|Weeks 0 to 16|Adverse Event|6|||
48820925|NCT03930186|157187314|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
48820926|NCT03930186|157187314|FG000|Weeks 16 to 32|Adverse Event|1|||
48820927|NCT03930186|157187314|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
48726357|NCT01214174|156847941|FG001|Overall Study|Withdrawal by Subject|0|||
48726358|NCT01214174|156847942|FG002|Overall Study|Withdrawal by Subject|1|||
48726359|NCT00046891|156847946|FG000|Overall Study|Cancels|5|||
48726360|NCT00046891|156847947|FG001|Overall Study|Cancels|9|||
48726361|NCT00046891|156847946|FG000|Overall Study|Ineligible|1|||
48726362|NCT00046891|156847947|FG001|Overall Study|Ineligible|1|||
48726363|NCT00046891|156847946|FG000|Overall Study|Withdrawal by Subject|18|||
48726364|NCT00046891|156847947|FG001|Overall Study|Withdrawal by Subject|15|||
48820928|NCT04254679|157187315|FG000|Overall Study|Protocol Violation|1|||
48507942|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
48507943|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
48507944|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
48507945|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
48726365|NCT00046891|156847946|FG000|Overall Study|Adverse Event|5|||
48726366|NCT00046891|156847947|FG001|Overall Study|Adverse Event|5|||
48726367|NCT01055496|156847952|FG000|Overall Study|Withdrawal by Subject|2|||
48726368|NCT01055496|156847953|FG001|Overall Study|Withdrawal by Subject|4|||
48726369|NCT01055496|156847952|FG000|Overall Study|Death|13|||
48726370|NCT01055496|156847953|FG001|Overall Study|Death|23|||
48820929|NCT04254679|157187316|FG001|Overall Study|Protocol Violation|1|||
48726371|NCT01055496|156847952|FG000|Overall Study|Lost to Follow-up|0|||
48726372|NCT01055496|156847953|FG001|Overall Study|Lost to Follow-up|2|||
48726373|NCT01055496|156847952|FG000|Overall Study|Other - Unspecified|0|||
48820930|NCT04254679|157187315|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
48820931|NCT04254679|157187316|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
48820932|NCT04004208|157187323|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48507946|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
48507947|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
48507948|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
48507949|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
48507950|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
48507951|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
48507952|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
48507953|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
48507954|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
48507955|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
48507956|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
48507957|NCT01667679|156052378|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
48507958|NCT01667679|156052379|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
48507959|NCT02159183|156052383|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
48507960|NCT02159183|156052384|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
48507961|NCT02159183|156052383|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
48507962|NCT02159183|156052384|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
48507963|NCT02159183|156052383|FG000|Analysis After the 36 Months Follow-up|Death|0|||
48507964|NCT02159183|156052384|FG001|Analysis After the 36 Months Follow-up|Death|1|||
48507965|NCT02159183|156052383|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
48507966|NCT02159183|156052384|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
48507967|NCT02159183|156052383|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
48507968|NCT02159183|156052384|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
48507969|NCT01615198|156052387|FG000|Overall Study|Withdrawal by Subject|5|||
48507970|NCT01615198|156052388|FG001|Overall Study|Withdrawal by Subject|5|||
48507971|NCT01615198|156052387|FG000|Overall Study|Protocol deviation|1|||
48507972|NCT01615198|156052388|FG001|Overall Study|Protocol deviation|1|||
48507973|NCT01615198|156052387|FG000|Overall Study|Physician Decision|5|||
48507974|NCT01615198|156052388|FG001|Overall Study|Physician Decision|1|||
48507975|NCT01615198|156052387|FG000|Overall Study|Lost to Follow-up|1|||
48507976|NCT01615198|156052388|FG001|Overall Study|Lost to Follow-up|1|||
48507977|NCT01615198|156052387|FG000|Overall Study|Lack of Efficacy|1|||
48507978|NCT01615198|156052388|FG001|Overall Study|Lack of Efficacy|6|||
48507979|NCT01615198|156052387|FG000|Overall Study|Adverse Event|11|||
48507980|NCT01615198|156052388|FG001|Overall Study|Adverse Event|5|||
48507981|NCT02453386|156052392|FG000|Overall Study|Adverse Event|22|||
48507982|NCT02453386|156052393|FG001|Overall Study|Adverse Event|30|||
48507983|NCT02453386|156052394|FG002|Overall Study|Adverse Event|15|||
48507984|NCT02453386|156052392|FG000|Overall Study|Protocol Violation|1|||
48507985|NCT02453386|156052393|FG001|Overall Study|Protocol Violation|0|||
48507986|NCT02453386|156052394|FG002|Overall Study|Protocol Violation|1|||
48507987|NCT02453386|156052392|FG000|Overall Study|Withdrawal by Subject|10|||
48507988|NCT02453386|156052393|FG001|Overall Study|Withdrawal by Subject|9|||
48507989|NCT02453386|156052394|FG002|Overall Study|Withdrawal by Subject|9|||
48507990|NCT02453386|156052392|FG000|Overall Study|Sponsor Terminated Study|14|||
48507991|NCT02453386|156052393|FG001|Overall Study|Sponsor Terminated Study|8|||
48507992|NCT02453386|156052394|FG002|Overall Study|Sponsor Terminated Study|11|||
48507993|NCT02453386|156052392|FG000|Overall Study|Subject Terminated by Sponsor|1|||
48507994|NCT02453386|156052393|FG001|Overall Study|Subject Terminated by Sponsor|1|||
48507995|NCT02453386|156052394|FG002|Overall Study|Subject Terminated by Sponsor|1|||
48507996|NCT02453386|156052392|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
48507997|NCT02453386|156052393|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
48507998|NCT02453386|156052394|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
48507999|NCT02453386|156052392|FG000|Overall Study|Lost to Follow-up|0|||
48508000|NCT02453386|156052393|FG001|Overall Study|Lost to Follow-up|0|||
48508001|NCT02453386|156052394|FG002|Overall Study|Lost to Follow-up|1|||
48508002|NCT02453386|156052392|FG000|Overall Study|Other|1|||
48508003|NCT02453386|156052393|FG001|Overall Study|Other|0|||
48508004|NCT02453386|156052394|FG002|Overall Study|Other|1|||
48508005|NCT01757392|156052395|FG000|Overall Study|Withdrawal by Subject|1|||
48508006|NCT01757392|156052395|FG000|Overall Study|Screen Fail|3|||
48508007|NCT02530905|156052396|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
48508008|NCT02530905|156052397|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
48726374|NCT01055496|156847953|FG001|Overall Study|Other - Unspecified|1|||
48508009|NCT02530905|156052398|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
48726375|NCT01289782|156847954|FG000|Overall Study|Lost to Follow-up|14|||
48726376|NCT01289782|156847955|FG001|Overall Study|Lost to Follow-up|7|||
48726377|NCT01289782|156847954|FG000|Overall Study|Protocol Violation|1|||
48726378|NCT01289782|156847955|FG001|Overall Study|Protocol Violation|1|||
48508010|NCT00965185|156052399|FG000|Overall Study|Lost to Follow-up|2|||
48600690|NCT01673178|156394024|FG001|Overall Study|Withdrawal by Subject|0|||
48726379|NCT01289782|156847954|FG000|Overall Study|Withdrawal by Subject|8|||
48600691|NCT01673178|156394025|FG002|Overall Study|Withdrawal by Subject|1|||
48600692|NCT01673178|156394026|FG003|Overall Study|Withdrawal by Subject|4|||
48600693|NCT01673178|156394027|FG004|Overall Study|Withdrawal by Subject|2|||
48600694|NCT01673178|156394023|FG000|Overall Study|Protocol Violation|1|||
48600695|NCT01673178|156394024|FG001|Overall Study|Protocol Violation|1|||
48600696|NCT01673178|156394025|FG002|Overall Study|Protocol Violation|0|||
48600697|NCT01673178|156394026|FG003|Overall Study|Protocol Violation|1|||
48600698|NCT01673178|156394027|FG004|Overall Study|Protocol Violation|0|||
48600699|NCT01673178|156394023|FG000|Overall Study|Adverse Event|1|||
48600700|NCT01673178|156394024|FG001|Overall Study|Adverse Event|0|||
48600701|NCT01673178|156394025|FG002|Overall Study|Adverse Event|0|||
48600702|NCT01673178|156394026|FG003|Overall Study|Adverse Event|2|||
48600703|NCT01673178|156394027|FG004|Overall Study|Adverse Event|0|||
48600704|NCT01673178|156394023|FG000|Overall Study|Other|1|||
48600705|NCT01673178|156394024|FG001|Overall Study|Other|0|||
48600706|NCT01673178|156394025|FG002|Overall Study|Other|2|||
48600707|NCT01673178|156394026|FG003|Overall Study|Other|1|||
48600708|NCT01673178|156394027|FG004|Overall Study|Other|0|||
48600709|NCT02667301|156394036|FG000|Overall Study|Adverse Event|1|||
48600710|NCT02667301|156394036|FG000|Overall Study|Lack of Efficacy|1|||
48600711|NCT00003471|156394037|FG000|Overall Study|Not evaluable|4|||
48600712|NCT00689338|156394038|FG000|Overall Study|Death|65|||
48600713|NCT00689338|156394038|FG000|Overall Study|Adverse Event|13|||
48600714|NCT00689338|156394038|FG000|Overall Study|Insufficient Clinical Response|1|||
48600715|NCT00689338|156394038|FG000|Overall Study|Lack of Efficacy|6|||
48600716|NCT00689338|156394038|FG000|Overall Study|Other|8|||
48726380|NCT01289782|156847955|FG001|Overall Study|Withdrawal by Subject|2|||
48726381|NCT01289782|156847954|FG000|Overall Study|Sponsor's Decision|1|||
48726382|NCT01289782|156847955|FG001|Overall Study|Sponsor's Decision|0|||
48438540|NCT03655717|155792060|FG007|Overall Study|Lost to Follow-up|0|||
48438541|NCT03655717|155792061|FG008|Overall Study|Lost to Follow-up|0|||
48438542|NCT03655717|155792062|FG009|Overall Study|Lost to Follow-up|0|||
48438543|NCT03655717|155792063|FG010|Overall Study|Lost to Follow-up|0|||
48438544|NCT03655717|155792064|FG011|Overall Study|Lost to Follow-up|1|||
48438545|NCT03655717|155792065|FG012|Overall Study|Lost to Follow-up|0|||
48438546|NCT03655717|155792066|FG013|Overall Study|Lost to Follow-up|0|||
48438547|NCT03655717|155792067|FG014|Overall Study|Lost to Follow-up|0|||
48438548|NCT03655717|155792068|FG015|Overall Study|Lost to Follow-up|0|||
48438549|NCT03655717|155792069|FG016|Overall Study|Lost to Follow-up|0|||
48438550|NCT03655717|155792070|FG017|Overall Study|Lost to Follow-up|0|||
48438551|NCT03655717|155792071|FG018|Overall Study|Lost to Follow-up|0|||
48438552|NCT03655717|155792072|FG019|Overall Study|Lost to Follow-up|0|||
48438553|NCT03655717|155792073|FG020|Overall Study|Lost to Follow-up|0|||
48438554|NCT03655717|155792074|FG021|Overall Study|Lost to Follow-up|0|||
48438555|NCT03655717|155792075|FG022|Overall Study|Lost to Follow-up|0|||
48438556|NCT03655717|155792076|FG023|Overall Study|Lost to Follow-up|0|||
48438557|NCT03655717|155792077|FG024|Overall Study|Lost to Follow-up|0|||
48438558|NCT03655717|155792078|FG025|Overall Study|Lost to Follow-up|0|||
48438559|NCT00302718|155792082|FG000|Overall Study|Participant left the hospital|1|||
48438560|NCT00302718|155792083|FG001|Overall Study|Participant left the hospital|0|||
48438561|NCT00302718|155792084|FG002|Overall Study|Participant left the hospital|0|||
48438562|NCT00302718|155792085|FG003|Overall Study|Participant left the hospital|1|||
48438563|NCT00302718|155792082|FG000|Overall Study|Withdrawal by Subject|0|||
48438564|NCT00302718|155792083|FG001|Overall Study|Withdrawal by Subject|1|||
48438565|NCT00302718|155792084|FG002|Overall Study|Withdrawal by Subject|0|||
48438566|NCT00302718|155792085|FG003|Overall Study|Withdrawal by Subject|0|||
48438567|NCT00302718|155792082|FG000|Overall Study|Participant left primary care setting|0|||
48438568|NCT00302718|155792083|FG001|Overall Study|Participant left primary care setting|0|||
48438569|NCT00302718|155792084|FG002|Overall Study|Participant left primary care setting|2|||
48438570|NCT00302718|155792085|FG003|Overall Study|Participant left primary care setting|1|||
48438571|NCT02365584|155792086|FG000|Overall Study|Adverse Event|2|||
48438572|NCT02365584|155792087|FG001|Overall Study|Adverse Event|2|||
48438573|NCT02365584|155792086|FG000|Overall Study|Withdrawal by Subject|1|||
48438574|NCT02365584|155792087|FG001|Overall Study|Withdrawal by Subject|0|||
48438575|NCT02365584|155792086|FG000|Overall Study|Disease Progression|9|||
48438576|NCT02365584|155792087|FG001|Overall Study|Disease Progression|12|||
48438577|NCT01185249|155792088|FG000|Overall Study|Patients discharged or change in status|42|||
48438578|NCT00349752|155792093|FG000|Overall Study|Adverse Event|8|||
48438579|NCT00349752|155792094|FG001|Overall Study|Adverse Event|12|||
48438580|NCT00349752|155792093|FG000|Overall Study|Lack of Efficacy|37|||
48438581|NCT00349752|155792094|FG001|Overall Study|Lack of Efficacy|42|||
48438582|NCT00349752|155792093|FG000|Overall Study|Lost to Follow-up|4|||
48438583|NCT00349752|155792094|FG001|Overall Study|Lost to Follow-up|2|||
48438584|NCT00349752|155792093|FG000|Overall Study|Personal reasons|6|||
48438585|NCT00349752|155792094|FG001|Overall Study|Personal reasons|5|||
48438586|NCT00349752|155792093|FG000|Overall Study|Other: Required exclusionary medication|0|||
48438587|NCT00349752|155792094|FG001|Overall Study|Other: Required exclusionary medication|1|||
48508011|NCT00965185|156052400|FG001|Overall Study|Lost to Follow-up|0|||
48508012|NCT00965185|156052399|FG000|Overall Study|Withdrawal by Subject|0|||
48508013|NCT00965185|156052400|FG001|Overall Study|Withdrawal by Subject|1|||
48508014|NCT00312897|156052408|FG000|Overall Study|Adverse Event|1|||
48508015|NCT00312897|156052409|FG001|Overall Study|Adverse Event|0|||
48508016|NCT00312897|156052408|FG000|Overall Study|Lost to Follow-up|2|||
48508017|NCT00312897|156052409|FG001|Overall Study|Lost to Follow-up|0|||
48508018|NCT00312897|156052408|FG000|Overall Study|Physician Decision|1|||
48508019|NCT00312897|156052409|FG001|Overall Study|Physician Decision|0|||
48508020|NCT00312897|156052408|FG000|Overall Study|Withdrawal by Subject|1|||
48508021|NCT00312897|156052409|FG001|Overall Study|Withdrawal by Subject|3|||
48508022|NCT00312897|156052408|FG000|Overall Study|Pregnancy|1|||
48508023|NCT00312897|156052409|FG001|Overall Study|Pregnancy|0|||
48508024|NCT00312897|156052408|FG000|Overall Study|discontinued prior to getting treatment|0|||
48508025|NCT00312897|156052409|FG001|Overall Study|discontinued prior to getting treatment|3|||
48508026|NCT03041025|156052410|FG000|Overall Study|Adverse Event|0|||
48508027|NCT03041025|156052411|FG001|Overall Study|Adverse Event|0|||
48508028|NCT03041025|156052412|FG002|Overall Study|Adverse Event|1|||
48508029|NCT03041025|156052410|FG000|Overall Study|Lost to Follow-up|1|||
48508030|NCT03041025|156052411|FG001|Overall Study|Lost to Follow-up|0|||
48508031|NCT03041025|156052412|FG002|Overall Study|Lost to Follow-up|0|||
48508032|NCT03041025|156052410|FG000|Overall Study|Withdrawal by Subject|0|||
48508033|NCT03041025|156052411|FG001|Overall Study|Withdrawal by Subject|0|||
48508034|NCT03041025|156052412|FG002|Overall Study|Withdrawal by Subject|1|||
48508035|NCT00837486|156052416|FG000|Blinded-treatment Phase|Physician Decision|1|||
48508036|NCT00837486|156052417|FG001|Blinded-treatment Phase|Physician Decision|0|||
48508037|NCT00837486|156052416|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
48508038|NCT00837486|156052417|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
48508039|NCT00837486|156052416|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
48508040|NCT00837486|156052417|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
48508041|NCT00837486|156052416|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
48508042|NCT00837486|156052417|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
48508043|NCT00813592|156052418|FG000|Overall Study|Disease assessment was not completed per|2|||
48508044|NCT02820350|156052419|FG000|Overall Study|Withdrawal by Subject|3|||
48508045|NCT02820350|156052419|FG000|Overall Study|Death|4|||
48508046|NCT04118894|156052420|FG000|Overall Study|Lost to Follow-up|21|||
48508047|NCT04118894|156052420|FG000|Overall Study|Withdrawal by Subject|10|||
48508048|NCT04118894|156052420|FG000|Overall Study|Adverse Event|4|||
48508049|NCT00549718|156054296|FG000|Overall Study|Insufficient clinical response|20|||
48508050|NCT00549718|156054297|FG001|Overall Study|Insufficient clinical response|7|||
48508051|NCT00549718|156054298|FG002|Overall Study|Insufficient clinical response|18|||
48508052|NCT00549718|156054299|FG003|Overall Study|Insufficient clinical response|32|||
48508053|NCT00549718|156054296|FG000|Overall Study|Adverse Event|6|||
48508054|NCT00549718|156054297|FG001|Overall Study|Adverse Event|8|||
48508055|NCT00549718|156054298|FG002|Overall Study|Adverse Event|7|||
48508056|NCT00549718|156054299|FG003|Overall Study|Adverse Event|3|||
48508057|NCT00549718|156054296|FG000|Overall Study|Lost to Follow-up|4|||
48508058|NCT00549718|156054297|FG001|Overall Study|Lost to Follow-up|2|||
48508059|NCT00549718|156054298|FG002|Overall Study|Lost to Follow-up|0|||
48508060|NCT00549718|156054299|FG003|Overall Study|Lost to Follow-up|6|||
48508061|NCT00549718|156054296|FG000|Overall Study|Withdrawal by Subject|9|||
48508062|NCT00549718|156054297|FG001|Overall Study|Withdrawal by Subject|18|||
48508063|NCT00549718|156054298|FG002|Overall Study|Withdrawal by Subject|12|||
48508064|NCT00549718|156054299|FG003|Overall Study|Withdrawal by Subject|13|||
48508065|NCT00549718|156054296|FG000|Overall Study|Administrative|2|||
48508066|NCT00549718|156054297|FG001|Overall Study|Administrative|2|||
48508067|NCT00549718|156054298|FG002|Overall Study|Administrative|2|||
48508068|NCT00549718|156054299|FG003|Overall Study|Administrative|1|||
48508069|NCT01215981|156054300|FG000|Overall Study|Physician Decision|0|||
48508070|NCT01215981|156054301|FG001|Overall Study|Physician Decision|1|||
48508071|NCT01215981|156054300|FG000|Overall Study|Protocol Violation|1|||
48508072|NCT01215981|156054301|FG001|Overall Study|Protocol Violation|0|||
48508073|NCT01215981|156054300|FG000|Overall Study|Withdrawal by Subject|1|||
48508074|NCT01215981|156054301|FG001|Overall Study|Withdrawal by Subject|0|||
48726383|NCT01289782|156847954|FG000|Overall Study|Reason not specified|1|||
48508075|NCT01675622|156054302|FG000|Overall Study|Withdrawal by Subject|2|||
48726384|NCT01289782|156847955|FG001|Overall Study|Reason not specified|2|||
48726385|NCT01009281|156847961|FG000|Overall Study|Administrative problems|7|||
48726386|NCT02398227|156847963|FG000|Overall Study|Lost to Follow-up|21|||
48508076|NCT01675622|156054303|FG001|Overall Study|Withdrawal by Subject|2|||
48508077|NCT01675622|156054302|FG000|Overall Study|Adverse Event|12|||
48508078|NCT01675622|156054303|FG001|Overall Study|Adverse Event|10|||
48508079|NCT01675622|156054302|FG000|Overall Study|Protocol Violation|4|||
48508080|NCT01675622|156054303|FG001|Overall Study|Protocol Violation|1|||
48508081|NCT01675622|156054302|FG000|Overall Study|Lack of Efficacy|2|||
48508082|NCT01675622|156054303|FG001|Overall Study|Lack of Efficacy|4|||
48508083|NCT01675622|156054302|FG000|Overall Study|Lost to Follow-up|1|||
48508084|NCT01675622|156054303|FG001|Overall Study|Lost to Follow-up|3|||
48508085|NCT01675622|156054302|FG000|Overall Study|Other|5|||
48508086|NCT01675622|156054303|FG001|Overall Study|Other|4|||
48508087|NCT04032977|156054304|FG000|Overall Study|Withdrawal by Subject|6|||
48508088|NCT04032977|156054305|FG001|Overall Study|Withdrawal by Subject|1|||
48508089|NCT04032977|156054304|FG000|Overall Study|Lost to Follow-up|2|||
48508090|NCT04032977|156054305|FG001|Overall Study|Lost to Follow-up|7|||
48508091|NCT04032977|156054304|FG000|Overall Study|Pregnancy|1|||
48508092|NCT04032977|156054305|FG001|Overall Study|Pregnancy|0|||
48508093|NCT01101022|156054306|FG000|Overall Study|Adverse Event|6|||
48508094|NCT01101022|156054307|FG001|Overall Study|Adverse Event|2|||
48508095|NCT01101022|156054306|FG000|Overall Study|Protocol Violation|4|||
48508096|NCT01101022|156054307|FG001|Overall Study|Protocol Violation|3|||
48508097|NCT01101022|156054306|FG000|Overall Study|Withdrawal by Subject|3|||
48508098|NCT01101022|156054307|FG001|Overall Study|Withdrawal by Subject|8|||
48508099|NCT01101022|156054306|FG000|Overall Study|Lost to Follow-up|1|||
48508100|NCT01101022|156054307|FG001|Overall Study|Lost to Follow-up|4|||
48508101|NCT01101022|156054306|FG000|Overall Study|Lack of Efficacy|0|||
48508102|NCT01101022|156054307|FG001|Overall Study|Lack of Efficacy|7|||
48726387|NCT02398227|156847964|FG001|Overall Study|Lost to Follow-up|12|||
48726388|NCT02398227|156847963|FG000|Overall Study|Withdrawal by Subject|5|||
48726389|NCT02398227|156847964|FG001|Overall Study|Withdrawal by Subject|6|||
48726390|NCT02398227|156847963|FG000|Overall Study|Removed from treatment and dropped out|1|||
48726391|NCT02398227|156847964|FG001|Overall Study|Removed from treatment and dropped out|0|||
48726392|NCT00879879|156847965|FG000|Overall Study|Death|1|||
48726393|NCT00879879|156847965|FG000|Overall Study|Withdrawal by Subject|1|||
48726394|NCT00879879|156847965|FG000|Overall Study|Physician Decision|1|||
48726395|NCT00064298|156847966|FG000|Overall Study|Withdrawal by Subject|2|||
48820933|NCT04004208|157187324|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48820934|NCT04004208|157187323|FG000|Overall Study|Death|3|||
48820935|NCT04004208|157187324|FG001|Overall Study|Death|0|||
48820936|NCT04004208|157187323|FG000|Overall Study|COVID-19 pandemic|1|||
48820937|NCT04004208|157187324|FG001|Overall Study|COVID-19 pandemic|0|||
48820938|NCT04004208|157187323|FG000|Overall Study|Physician Decision|1|||
48820939|NCT04004208|157187324|FG001|Overall Study|Physician Decision|0|||
48508103|NCT01101022|156054306|FG000|Overall Study|Sponsor decision|1|||
48508104|NCT01101022|156054307|FG001|Overall Study|Sponsor decision|1|||
48508105|NCT01101022|156054306|FG000|Overall Study|Non-compliance|1|||
48508106|NCT01101022|156054307|FG001|Overall Study|Non-compliance|0|||
48508107|NCT01101022|156054306|FG000|Overall Study|Work schedule|1|||
48508108|NCT01101022|156054307|FG001|Overall Study|Work schedule|1|||
48600717|NCT00689338|156394038|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
48600718|NCT00689338|156394038|FG000|Overall Study|Lost to Follow-up|5|||
48600719|NCT00689338|156394038|FG000|Overall Study|Withdrawal by Subject|3|||
48600720|NCT00689338|156394038|FG000|Overall Study|Protocol Violation|15|||
48600721|NCT02949947|156394044|FG000|Overall Study|Non Compliance|0|||
48600722|NCT02949947|156394045|FG001|Overall Study|Non Compliance|1|||
48600723|NCT02949947|156394044|FG000|Overall Study|Insurance change|1|||
48600724|NCT02949947|156394045|FG001|Overall Study|Insurance change|0|||
48600725|NCT01190813|156394051|FG000|Overall Study|Lost to Follow-up|1|||
48600726|NCT01190813|156394052|FG001|Overall Study|Lost to Follow-up|2|||
48600727|NCT01190813|156394051|FG000|Overall Study|Withdrawal by Subject|2|||
48600728|NCT01190813|156394052|FG001|Overall Study|Withdrawal by Subject|1|||
48600729|NCT01190813|156394051|FG000|Overall Study|Refused study treatment after randomized|1|||
48600730|NCT01190813|156394052|FG001|Overall Study|Refused study treatment after randomized|0|||
48600731|NCT01190813|156394051|FG000|Overall Study|Adverse Event|0|||
48600732|NCT01190813|156394052|FG001|Overall Study|Adverse Event|1|||
48600733|NCT01817075|156394053|FG000|Overall Study|Adverse Event|7|||
48600734|NCT01817075|156394054|FG001|Overall Study|Adverse Event|5|||
48726396|NCT00064298|156847967|FG001|Overall Study|Withdrawal by Subject|1|||
48508109|NCT01101022|156054306|FG000|Overall Study|Vacation|0|||
48508110|NCT01101022|156054307|FG001|Overall Study|Vacation|1|||
48600735|NCT01817075|156394053|FG000|Overall Study|Physician Decision|9|||
48600736|NCT01817075|156394054|FG001|Overall Study|Physician Decision|12|||
48600737|NCT01817075|156394053|FG000|Overall Study|Withdrawal by Subject|31|||
48600738|NCT01817075|156394054|FG001|Overall Study|Withdrawal by Subject|15|||
48600739|NCT01817075|156394053|FG000|Overall Study|Received Sorafenib after enrollment|0|||
48726397|NCT00064298|156847966|FG000|Overall Study|Lost to Follow-up|2|||
48820940|NCT04004208|157187323|FG000|Overall Study|Adverse Event|1|||
48600740|NCT01817075|156394054|FG001|Overall Study|Received Sorafenib after enrollment|1|||
48726398|NCT00064298|156847967|FG001|Overall Study|Lost to Follow-up|2|||
48726399|NCT00064298|156847966|FG000|Overall Study|Death|0|||
48726400|NCT00064298|156847967|FG001|Overall Study|Death|1|||
48508111|NCT01519661|156054309|FG000|Overall Study|Protocol deviation|6|||
48508112|NCT01519661|156054309|FG000|Overall Study|Lost to Follow-up|3|||
48508113|NCT01519661|156054309|FG000|Overall Study|Withdrawal by Subject|17|||
48508114|NCT01519661|156054309|FG000|Overall Study|Lack of Efficacy|6|||
48508115|NCT01519661|156054309|FG000|Overall Study|Adverse Event|29|||
48508116|NCT03075761|156054310|FG000|Overall Study|Lost to Follow-up|1|||
48508117|NCT03075761|156054311|FG001|Overall Study|Lost to Follow-up|6|||
48508118|NCT02880761|156054312|FG000|Overall Study|Death|6|||
48508119|NCT02880761|156054313|FG001|Overall Study|Death|8|||
48508120|NCT02880761|156054312|FG000|Overall Study|Withdrawal by Subject|3|||
48508121|NCT02880761|156054313|FG001|Overall Study|Withdrawal by Subject|6|||
48508122|NCT02880761|156054312|FG000|Overall Study|Protocol Violation|4|||
48508123|NCT02880761|156054313|FG001|Overall Study|Protocol Violation|3|||
48508124|NCT02880761|156054312|FG000|Overall Study|Lost to Follow-up|3|||
48508125|NCT02880761|156054313|FG001|Overall Study|Lost to Follow-up|4|||
48508126|NCT01139047|156054314|FG000|Overall Study|Withdrawal by Subject|1|||
48508127|NCT00834522|156054317|FG000|Washout|Adverse Event|1|||
48508128|NCT00834522|156054318|FG001|Washout|Adverse Event|0|||
48508129|NCT00834522|156054317|FG000|Washout|Withdrawal by Subject|2|||
48508130|NCT00834522|156054318|FG001|Washout|Withdrawal by Subject|1|||
48508131|NCT00905346|156054319|FG000|Period 1|Withdrawal by Subject|1|||
48508132|NCT00905346|156054320|FG001|Period 1|Withdrawal by Subject|0|||
48600741|NCT01817075|156394053|FG000|Overall Study|Ineligible|0|||
48508133|NCT01435265|156054321|FG000|Overall Study|Lost to Follow-up|0|||
48508134|NCT01435265|156054322|FG001|Overall Study|Lost to Follow-up|1|||
48508135|NCT04089735|156054323|FG000|Overall Study|Adverse Event|1|||
48508136|NCT04089735|156054324|FG001|Overall Study|Adverse Event|0|||
48508137|NCT04089735|156054325|FG002|Overall Study|Adverse Event|1|||
48508138|NCT04089735|156054326|FG003|Overall Study|Adverse Event|1|||
48508139|NCT04089735|156054327|FG004|Overall Study|Adverse Event|0|||
48508140|NCT04089735|156054328|FG005|Overall Study|Adverse Event|0|||
48508141|NCT04089735|156054323|FG000|Overall Study|Physician Decision|0|||
48508142|NCT04089735|156054324|FG001|Overall Study|Physician Decision|3|||
48508143|NCT04089735|156054325|FG002|Overall Study|Physician Decision|0|||
48508144|NCT04089735|156054326|FG003|Overall Study|Physician Decision|0|||
48508145|NCT04089735|156054327|FG004|Overall Study|Physician Decision|0|||
48508146|NCT04089735|156054328|FG005|Overall Study|Physician Decision|0|||
48508147|NCT04089735|156054323|FG000|Overall Study|Withdrawal by Subject|0|||
48508148|NCT04089735|156054324|FG001|Overall Study|Withdrawal by Subject|0|||
48508149|NCT04089735|156054325|FG002|Overall Study|Withdrawal by Subject|1|||
48508150|NCT04089735|156054326|FG003|Overall Study|Withdrawal by Subject|0|||
48508151|NCT04089735|156054327|FG004|Overall Study|Withdrawal by Subject|0|||
48508152|NCT04089735|156054328|FG005|Overall Study|Withdrawal by Subject|0|||
48508153|NCT04089735|156054323|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
48508154|NCT04089735|156054324|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
48508155|NCT04089735|156054325|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
48508156|NCT04089735|156054326|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
48508157|NCT04089735|156054327|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
48508158|NCT04089735|156054328|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
48508159|NCT02334722|156054329|FG000|Overall Study|Lost to Follow-up|4|||
48508160|NCT02334722|156054330|FG001|Overall Study|Lost to Follow-up|0|||
48508161|NCT02334722|156054329|FG000|Overall Study|6 week questionnaire not completed|2|||
48508162|NCT02334722|156054330|FG001|Overall Study|6 week questionnaire not completed|0|||
48508163|NCT02334722|156054329|FG000|Overall Study|Unable to obtain medication|1|||
48508164|NCT02334722|156054330|FG001|Overall Study|Unable to obtain medication|1|||
48508165|NCT02334722|156054329|FG000|Overall Study|Withdrawal by Subject|0|||
48508166|NCT02334722|156054330|FG001|Overall Study|Withdrawal by Subject|3|||
48508167|NCT02334722|156054329|FG000|Overall Study|Adverse Event|0|||
48508168|NCT02334722|156054330|FG001|Overall Study|Adverse Event|2|||
48508169|NCT02334722|156054329|FG000|Overall Study|Physician Decision|0|||
48508170|NCT02334722|156054330|FG001|Overall Study|Physician Decision|1|||
48508171|NCT02159950|156054335|FG000|Overall Study|Adverse Event|0|||
48508172|NCT02159950|156054336|FG001|Overall Study|Adverse Event|1|||
48508173|NCT02159950|156054335|FG000|Overall Study|Progression|0|||
48508174|NCT02159950|156054336|FG001|Overall Study|Progression|1|||
48600742|NCT01817075|156394054|FG001|Overall Study|Ineligible|2|||
48600743|NCT00490971|156394056|FG000|Acute/Continuation|Adverse Event|62|||
48600744|NCT00490971|156394057|FG001|Acute/Continuation|Adverse Event|13|||
48600745|NCT00490971|156394058|FG002|Acute/Continuation|Adverse Event|0|||
48600746|NCT00490971|156394059|FG003|Acute/Continuation|Adverse Event|0|||
48508175|NCT01294917|156054337|FG000|Overall Study|Relocation|5|||
48508176|NCT01294917|156054337|FG000|Overall Study|Inconvenience|1|||
48508177|NCT00252720|156054338|FG000|Overall Study|Withdrawal by Subject|95|||
48508178|NCT00252720|156054339|FG001|Overall Study|Withdrawal by Subject|97|||
48508179|NCT00252720|156054338|FG000|Overall Study|Death|7|||
48508180|NCT00252720|156054339|FG001|Overall Study|Death|8|||
48508181|NCT00252720|156054338|FG000|Overall Study|Moving|23|||
48508182|NCT00252720|156054339|FG001|Overall Study|Moving|42|||
48508183|NCT00252720|156054338|FG000|Overall Study|Mainly patients lost to follow-up|7|||
48600747|NCT00490971|156394060|FG004|Acute/Continuation|Adverse Event|0|||
48508184|NCT00252720|156054339|FG001|Overall Study|Mainly patients lost to follow-up|18|||
48600748|NCT00490971|156394056|FG000|Acute/Continuation|Death|2|||
48600749|NCT00490971|156394057|FG001|Acute/Continuation|Death|0|||
48600750|NCT00490971|156394058|FG002|Acute/Continuation|Death|0|||
48600751|NCT00490971|156394059|FG003|Acute/Continuation|Death|0|||
48600752|NCT00490971|156394060|FG004|Acute/Continuation|Death|0|||
48600753|NCT00490971|156394056|FG000|Acute/Continuation|Lack of Efficacy|106|||
48600754|NCT00490971|156394057|FG001|Acute/Continuation|Lack of Efficacy|12|||
48600755|NCT00490971|156394058|FG002|Acute/Continuation|Lack of Efficacy|0|||
48600756|NCT00490971|156394059|FG003|Acute/Continuation|Lack of Efficacy|0|||
48600757|NCT00490971|156394060|FG004|Acute/Continuation|Lack of Efficacy|0|||
48600758|NCT00490971|156394056|FG000|Acute/Continuation|Lost to Follow-up|23|||
48600759|NCT00490971|156394057|FG001|Acute/Continuation|Lost to Follow-up|7|||
48600760|NCT00490971|156394058|FG002|Acute/Continuation|Lost to Follow-up|0|||
48600761|NCT00490971|156394059|FG003|Acute/Continuation|Lost to Follow-up|0|||
48600762|NCT00490971|156394060|FG004|Acute/Continuation|Lost to Follow-up|0|||
48600763|NCT00490971|156394056|FG000|Acute/Continuation|Protocol Violation|10|||
48600764|NCT00490971|156394057|FG001|Acute/Continuation|Protocol Violation|2|||
48600765|NCT00490971|156394058|FG002|Acute/Continuation|Protocol Violation|0|||
48600766|NCT00490971|156394059|FG003|Acute/Continuation|Protocol Violation|0|||
48600767|NCT00490971|156394060|FG004|Acute/Continuation|Protocol Violation|0|||
48600768|NCT00490971|156394056|FG000|Acute/Continuation|Withdrawal by Subject|92|||
48600769|NCT00490971|156394057|FG001|Acute/Continuation|Withdrawal by Subject|24|||
48600770|NCT00490971|156394058|FG002|Acute/Continuation|Withdrawal by Subject|0|||
48600771|NCT00490971|156394059|FG003|Acute/Continuation|Withdrawal by Subject|0|||
48600772|NCT00490971|156394060|FG004|Acute/Continuation|Withdrawal by Subject|0|||
48600773|NCT00490971|156394056|FG000|Acute/Continuation|Other|11|||
48600774|NCT00490971|156394057|FG001|Acute/Continuation|Other|4|||
48600775|NCT00490971|156394058|FG002|Acute/Continuation|Other|0|||
48600776|NCT00490971|156394059|FG003|Acute/Continuation|Other|0|||
48600777|NCT00490971|156394060|FG004|Acute/Continuation|Other|0|||
48600778|NCT00490971|156394056|FG000|Maintenance|Adverse Event|0|||
48600779|NCT00490971|156394057|FG001|Maintenance|Adverse Event|0|||
48600780|NCT00490971|156394058|FG002|Maintenance|Adverse Event|4|||
48600781|NCT00490971|156394059|FG003|Maintenance|Adverse Event|5|||
48600782|NCT00490971|156394060|FG004|Maintenance|Adverse Event|7|||
48600783|NCT00490971|156394056|FG000|Maintenance|Death|0|||
48600784|NCT00490971|156394057|FG001|Maintenance|Death|0|||
48600785|NCT00490971|156394058|FG002|Maintenance|Death|0|||
48600786|NCT00490971|156394059|FG003|Maintenance|Death|2|||
48600787|NCT00490971|156394060|FG004|Maintenance|Death|0|||
48600788|NCT00490971|156394056|FG000|Maintenance|Lost to Follow-up|0|||
48600789|NCT00490971|156394057|FG001|Maintenance|Lost to Follow-up|0|||
48600790|NCT00490971|156394058|FG002|Maintenance|Lost to Follow-up|5|||
48600791|NCT00490971|156394059|FG003|Maintenance|Lost to Follow-up|8|||
48600792|NCT00490971|156394060|FG004|Maintenance|Lost to Follow-up|10|||
48600793|NCT00490971|156394056|FG000|Maintenance|Pregnancy|0|||
48600794|NCT00490971|156394057|FG001|Maintenance|Pregnancy|0|||
48600795|NCT00490971|156394058|FG002|Maintenance|Pregnancy|1|||
48600796|NCT00490971|156394059|FG003|Maintenance|Pregnancy|0|||
48600797|NCT00490971|156394060|FG004|Maintenance|Pregnancy|0|||
48600798|NCT00490971|156394056|FG000|Maintenance|Protocol Violation|0|||
48600799|NCT00490971|156394057|FG001|Maintenance|Protocol Violation|0|||
48600800|NCT00490971|156394058|FG002|Maintenance|Protocol Violation|4|||
48600801|NCT00490971|156394059|FG003|Maintenance|Protocol Violation|1|||
48600802|NCT00490971|156394060|FG004|Maintenance|Protocol Violation|1|||
48600803|NCT00490971|156394056|FG000|Maintenance|Withdrawal by Subject|0|||
48600804|NCT00490971|156394057|FG001|Maintenance|Withdrawal by Subject|0|||
48600805|NCT00490971|156394058|FG002|Maintenance|Withdrawal by Subject|26|||
48600806|NCT00490971|156394059|FG003|Maintenance|Withdrawal by Subject|28|||
48600807|NCT00490971|156394060|FG004|Maintenance|Withdrawal by Subject|18|||
48600808|NCT00490971|156394056|FG000|Maintenance|Other|0|||
48600809|NCT00490971|156394057|FG001|Maintenance|Other|0|||
48600810|NCT00490971|156394058|FG002|Maintenance|Other|11|||
48600811|NCT00490971|156394059|FG003|Maintenance|Other|9|||
48600812|NCT00490971|156394060|FG004|Maintenance|Other|3|||
48600813|NCT01683604|156394065|FG000|Overall Study|Adverse Event|2|||
48600814|NCT01683604|156394065|FG000|Overall Study|Lack of Efficacy|1|||
48600815|NCT01683604|156394065|FG000|Overall Study|Other|2|||
48600816|NCT00919633|156394066|FG000|Overall Study|Adverse Event|1|||
48600817|NCT00919633|156394067|FG001|Overall Study|Adverse Event|9|||
48600818|NCT00919633|156394068|FG002|Overall Study|Adverse Event|12|||
48820941|NCT04004208|157187324|FG001|Overall Study|Adverse Event|1|||
48600819|NCT00919633|156394069|FG003|Overall Study|Adverse Event|10|||
48600820|NCT00919633|156394066|FG000|Overall Study|Death|0|||
48600821|NCT00919633|156394067|FG001|Overall Study|Death|0|||
48600822|NCT00919633|156394068|FG002|Overall Study|Death|2|||
48600823|NCT00919633|156394069|FG003|Overall Study|Death|0|||
48600824|NCT00919633|156394066|FG000|Overall Study|Lack of Efficacy|17|||
48600825|NCT00919633|156394067|FG001|Overall Study|Lack of Efficacy|3|||
48600826|NCT00919633|156394068|FG002|Overall Study|Lack of Efficacy|2|||
48600827|NCT00919633|156394069|FG003|Overall Study|Lack of Efficacy|3|||
48600828|NCT00919633|156394066|FG000|Overall Study|Withdrawal by Subject|1|||
48600829|NCT00919633|156394067|FG001|Overall Study|Withdrawal by Subject|2|||
48600830|NCT00919633|156394068|FG002|Overall Study|Withdrawal by Subject|4|||
48508185|NCT02647944|156054340|FG000|Overall Study|Withdrawal by Subject|0|||
48508186|NCT02647944|156054341|FG001|Overall Study|Withdrawal by Subject|3|||
48508187|NCT02647944|156054340|FG000|Overall Study|Adverse Event|2|||
48508188|NCT02647944|156054341|FG001|Overall Study|Adverse Event|0|||
48508189|NCT01536574|156054343|FG000|Overall Study|Adverse Event|4|||
48508190|NCT01536574|156054344|FG001|Overall Study|Adverse Event|5|||
48508191|NCT01536574|156054343|FG000|Overall Study|Withdrawal by Subject|1|||
48508192|NCT01536574|156054344|FG001|Overall Study|Withdrawal by Subject|2|||
48508193|NCT01536574|156054343|FG000|Overall Study|Lack of Efficacy|1|||
48508194|NCT01536574|156054344|FG001|Overall Study|Lack of Efficacy|0|||
48508195|NCT02514122|156054345|FG000|Overall Study|Withdrawal by Subject|2|||
48508196|NCT02514122|156054346|FG001|Overall Study|Withdrawal by Subject|0|||
48508197|NCT00794963|156054349|FG000|Overall Study|Withdrawal by Subject|1|||
48508198|NCT00794963|156054350|FG001|Overall Study|Withdrawal by Subject|4|||
48600831|NCT00919633|156394069|FG003|Overall Study|Withdrawal by Subject|3|||
48600832|NCT00919633|156394066|FG000|Overall Study|Lost to Follow-up|3|||
48600833|NCT00919633|156394067|FG001|Overall Study|Lost to Follow-up|1|||
48600834|NCT00919633|156394068|FG002|Overall Study|Lost to Follow-up|0|||
48600835|NCT00919633|156394069|FG003|Overall Study|Lost to Follow-up|2|||
48600836|NCT00919633|156394066|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
48600837|NCT00919633|156394067|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
48600838|NCT00919633|156394068|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
48600839|NCT00919633|156394069|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
48600840|NCT00919633|156394066|FG000|Overall Study|Protocol Violation|0|||
48820942|NCT01316692|157187325|FG000|Overall Study|Adverse Event|5|||
48820943|NCT01316692|157187325|FG000|Overall Study|Disease Progression|7|||
48820944|NCT03772314|157187329|FG000|Overall Study|Adverse Event|7|||
48508199|NCT03375463|156054351|FG000|Period 1|Lost to Follow-up|0|||
48508200|NCT03375463|156054352|FG001|Period 1|Lost to Follow-up|0|||
48508201|NCT03375463|156054353|FG002|Period 1|Lost to Follow-up|1|||
48508202|NCT03375463|156054354|FG003|Period 1|Lost to Follow-up|0|||
48508203|NCT03375463|156054355|FG004|Period 1|Lost to Follow-up|0|||
48508204|NCT03375463|156054356|FG005|Period 1|Lost to Follow-up|0|||
48508205|NCT03375463|156054351|FG000|Period 1|Adverse Event|0|||
48508206|NCT03375463|156054352|FG001|Period 1|Adverse Event|0|||
48508207|NCT03375463|156054353|FG002|Period 1|Adverse Event|0|||
48820945|NCT03772314|157187330|FG001|Overall Study|Adverse Event|2|||
48820946|NCT03138512|157187331|FG000|Randomization|Participants withdrew consent|0|||
48820947|NCT03138512|157187332|FG001|Randomization|Participants withdrew consent|1|||
48820948|NCT03138512|157187333|FG002|Randomization|Participants withdrew consent|1|||
48820949|NCT03138512|157187334|FG003|Randomization|Participants withdrew consent|0|||
48820950|NCT03138512|157187335|FG004|Randomization|Participants withdrew consent|0|||
48820951|NCT03138512|157187331|FG000|Randomization|Participant no longer meets study criteria|0|||
48820952|NCT03138512|157187332|FG001|Randomization|Participant no longer meets study criteria|3|||
48820953|NCT03138512|157187333|FG002|Randomization|Participant no longer meets study criteria|1|||
48820954|NCT03138512|157187334|FG003|Randomization|Participant no longer meets study criteria|1|||
48820955|NCT03138512|157187335|FG004|Randomization|Participant no longer meets study criteria|3|||
48820956|NCT03138512|157187331|FG000|Randomization|Other reasons|1|||
48820957|NCT03138512|157187332|FG001|Randomization|Other reasons|0|||
48820958|NCT03138512|157187333|FG002|Randomization|Other reasons|0|||
48820959|NCT03138512|157187334|FG003|Randomization|Other reasons|0|||
48820960|NCT03138512|157187335|FG004|Randomization|Other reasons|0|||
48820961|NCT03138512|157187331|FG000|Treatment Part A|Disease recurrence|10|||
48820962|NCT03138512|157187332|FG001|Treatment Part A|Disease recurrence|20|||
48820963|NCT03138512|157187333|FG002|Treatment Part A|Disease recurrence|0|||
48820964|NCT03138512|157187334|FG003|Treatment Part A|Disease recurrence|0|||
48820965|NCT03138512|157187335|FG004|Treatment Part A|Disease recurrence|0|||
48820966|NCT03138512|157187331|FG000|Treatment Part A|Study Drug Toxicity|132|||
48820967|NCT03138512|157187332|FG001|Treatment Part A|Study Drug Toxicity|5|||
48508208|NCT03375463|156054354|FG003|Period 1|Adverse Event|0|||
48600841|NCT00919633|156394067|FG001|Overall Study|Protocol Violation|0|||
48600842|NCT00919633|156394068|FG002|Overall Study|Protocol Violation|0|||
48600843|NCT00919633|156394069|FG003|Overall Study|Protocol Violation|1|||
48820968|NCT03138512|157187333|FG002|Treatment Part A|Study Drug Toxicity|0|||
48820969|NCT03138512|157187334|FG003|Treatment Part A|Study Drug Toxicity|0|||
48820970|NCT03138512|157187335|FG004|Treatment Part A|Study Drug Toxicity|0|||
48508209|NCT03375463|156054355|FG004|Period 1|Adverse Event|1|||
48508210|NCT03375463|156054356|FG005|Period 1|Adverse Event|0|||
48508211|NCT03375463|156054351|FG000|Period 2|Lost to Follow-up|1|||
48508212|NCT03375463|156054352|FG001|Period 2|Lost to Follow-up|1|||
48508213|NCT03375463|156054353|FG002|Period 2|Lost to Follow-up|0|||
48508214|NCT03375463|156054354|FG003|Period 2|Lost to Follow-up|0|||
48508215|NCT03375463|156054355|FG004|Period 2|Lost to Follow-up|0|||
48820971|NCT03138512|157187331|FG000|Treatment Part A|Death|1|||
48820972|NCT03138512|157187332|FG001|Treatment Part A|Death|0|||
48508216|NCT03375463|156054356|FG005|Period 2|Lost to Follow-up|0|||
48508217|NCT01827163|156054357|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
48508218|NCT01827163|156054357|FG000|Overall Study|Adverse Event|9|||
48508219|NCT01010542|156054370|FG000|Overall Study|Adverse Event|0|||
48508220|NCT01010542|156054371|FG001|Overall Study|Adverse Event|1|||
48508221|NCT01010542|156054372|FG002|Overall Study|Adverse Event|0|||
48820973|NCT03138512|157187333|FG002|Treatment Part A|Death|0|||
48820974|NCT03138512|157187334|FG003|Treatment Part A|Death|0|||
48820975|NCT03138512|157187335|FG004|Treatment Part A|Death|0|||
48820976|NCT03138512|157187331|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
48820977|NCT03138512|157187332|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
48820978|NCT03138512|157187333|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
48508222|NCT01010542|156054370|FG000|Overall Study|Lost to Follow-up|0|||
48508223|NCT01010542|156054371|FG001|Overall Study|Lost to Follow-up|1|||
48600844|NCT00919633|156394066|FG000|Overall Study|Physician Decision|0|||
48600845|NCT00919633|156394067|FG001|Overall Study|Physician Decision|0|||
48820979|NCT03138512|157187334|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
48820980|NCT03138512|157187335|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
48820981|NCT03138512|157187331|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
48820982|NCT03138512|157187332|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
48820983|NCT03138512|157187333|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
48820984|NCT03138512|157187334|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
48820985|NCT03138512|157187335|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
48820986|NCT03138512|157187331|FG000|Treatment Part A|Participant withdrew consent|2|||
48820987|NCT03138512|157187332|FG001|Treatment Part A|Participant withdrew consent|4|||
48820988|NCT03138512|157187333|FG002|Treatment Part A|Participant withdrew consent|0|||
48820989|NCT03138512|157187334|FG003|Treatment Part A|Participant withdrew consent|0|||
48820990|NCT03138512|157187335|FG004|Treatment Part A|Participant withdrew consent|0|||
48820991|NCT03138512|157187331|FG000|Treatment Part A|Lost to Follow-up|0|||
48820992|NCT03138512|157187332|FG001|Treatment Part A|Lost to Follow-up|1|||
48820993|NCT03138512|157187333|FG002|Treatment Part A|Lost to Follow-up|0|||
48508224|NCT01010542|156054372|FG002|Overall Study|Lost to Follow-up|0|||
48508225|NCT01010542|156054370|FG000|Overall Study|Withdrawal by Subject|0|||
48508226|NCT01010542|156054371|FG001|Overall Study|Withdrawal by Subject|3|||
48508227|NCT01010542|156054372|FG002|Overall Study|Withdrawal by Subject|2|||
48508228|NCT01745120|156054373|FG000|Overall Study|Investigator decision|1|||
48508229|NCT01745120|156054374|FG001|Overall Study|Investigator decision|0|||
48508230|NCT03956862|156054375|FG000|Overall Study|Lost to Follow-up|1|||
48508231|NCT03956862|156054376|FG001|Overall Study|Lost to Follow-up|1|||
48508232|NCT03956862|156054375|FG000|Overall Study|Withdrawal by Subject|1|||
48508233|NCT03956862|156054376|FG001|Overall Study|Withdrawal by Subject|1|||
48508234|NCT02714062|156054377|FG000|Overall Study|Adverse Event|0|||
48508235|NCT02714062|156054378|FG001|Overall Study|Adverse Event|0|||
48508236|NCT02714062|156054379|FG002|Overall Study|Adverse Event|2|||
48508237|NCT02714062|156054377|FG000|Overall Study|Withdrawal by Subject|1|||
48508238|NCT02714062|156054378|FG001|Overall Study|Withdrawal by Subject|0|||
48508239|NCT02714062|156054379|FG002|Overall Study|Withdrawal by Subject|1|||
48508240|NCT02714062|156054377|FG000|Overall Study|Protocol Violation|0|||
48508241|NCT02714062|156054378|FG001|Overall Study|Protocol Violation|1|||
48508242|NCT02714062|156054379|FG002|Overall Study|Protocol Violation|0|||
48508243|NCT01498120|156054382|FG000|Overall Study|Lost to Follow-up|1|||
48508244|NCT01498120|156054382|FG000|Overall Study|Withdrawal by Subject|5|||
48508245|NCT01498120|156054382|FG000|Overall Study|AE, non-serious non-fatal|3|||
48508246|NCT01498120|156054382|FG000|Overall Study|Other|4|||
48508247|NCT02682238|156054385|FG000|Overall Study|Lost to Follow-up|0|||
48508248|NCT02682238|156054386|FG001|Overall Study|Lost to Follow-up|2|||
48508249|NCT02682238|156054385|FG000|Overall Study|Withdrawal by Subject|1|||
48508250|NCT02682238|156054386|FG001|Overall Study|Withdrawal by Subject|0|||
48508251|NCT02682238|156054385|FG000|Overall Study|Adverse Event|1|||
48508252|NCT02682238|156054386|FG001|Overall Study|Adverse Event|0|||
48508253|NCT02682238|156054385|FG000|Overall Study|Non-compliance with Study Drug|1|||
48600846|NCT00919633|156394068|FG002|Overall Study|Physician Decision|0|||
48600847|NCT00919633|156394069|FG003|Overall Study|Physician Decision|1|||
48820994|NCT03138512|157187334|FG003|Treatment Part A|Lost to Follow-up|0|||
48508254|NCT02682238|156054386|FG001|Overall Study|Non-compliance with Study Drug|0|||
48508255|NCT02682238|156054385|FG000|Overall Study|Non-compliance with Protocol|0|||
48508256|NCT02682238|156054386|FG001|Overall Study|Non-compliance with Protocol|2|||
48508257|NCT01370317|156054389|FG000|Overall Study|Participant withdrew consent|1|||
48508258|NCT01370317|156054390|FG001|Overall Study|Participant withdrew consent|0|||
48508259|NCT01370317|156054389|FG000|Overall Study|Protocol deviation|0|||
48508260|NCT01370317|156054390|FG001|Overall Study|Protocol deviation|1|||
48508261|NCT03128723|156054392|FG000|Overall Study|Withdrawal by Subject|2|||
48600848|NCT00919633|156394066|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
48600849|NCT00919633|156394067|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
48508262|NCT00579670|156054395|FG000|Overall Study|Death|1|||
48508263|NCT00579670|156054396|FG001|Overall Study|Death|0|||
48508264|NCT00579670|156054397|FG002|Overall Study|Death|0|||
48381896|NCT00375219|155592861|FG002|Overall Study|Withdrawal by Subject|0|||
48381897|NCT04029961|155592864|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
48438742|NCT00819585|155792097|FG000|Extension Study|Death|0|||
48438743|NCT00819585|155792098|FG001|Extension Study|Death|0|||
48438744|NCT00819585|155792099|FG002|Extension Study|Death|0|||
48438745|NCT00819585|155792100|FG003|Extension Study|Death|0|||
48438746|NCT00819585|155792101|FG004|Extension Study|Death|0|||
48438747|NCT00819585|155792102|FG005|Extension Study|Death|0|||
48438748|NCT00819585|155792103|FG006|Extension Study|Death|0|||
48438749|NCT00819585|155792104|FG007|Extension Study|Death|0|||
48438750|NCT00819585|155792105|FG008|Extension Study|Death|2|||
48438751|NCT00819585|155792106|FG009|Extension Study|Death|0|||
48438752|NCT00819585|155792107|FG010|Extension Study|Death|0|||
48438753|NCT03521193|155792109|FG000|Overall Study|Withdrawal by Subject|8|||
48438754|NCT03521193|155792110|FG001|Overall Study|Withdrawal by Subject|0|||
48508265|NCT00579670|156054398|FG003|Overall Study|Death|0|||
48508266|NCT00579670|156054399|FG004|Overall Study|Death|0|||
48438755|NCT03521193|155792109|FG000|Overall Study|non compliant to ASA treatment|8|||
48508267|NCT00579670|156054395|FG000|Overall Study|Adverse Event|1|||
48508268|NCT00579670|156054396|FG001|Overall Study|Adverse Event|0|||
48508269|NCT00579670|156054397|FG002|Overall Study|Adverse Event|1|||
48508270|NCT00579670|156054398|FG003|Overall Study|Adverse Event|2|||
48508271|NCT00579670|156054399|FG004|Overall Study|Adverse Event|0|||
48508272|NCT00579670|156054395|FG000|Overall Study|Lack of Efficacy|0|||
48508273|NCT00579670|156054396|FG001|Overall Study|Lack of Efficacy|0|||
48508274|NCT00579670|156054397|FG002|Overall Study|Lack of Efficacy|1|||
48438756|NCT03521193|155792110|FG001|Overall Study|non compliant to ASA treatment|0|||
48508275|NCT00579670|156054398|FG003|Overall Study|Lack of Efficacy|14|||
48508276|NCT00579670|156054399|FG004|Overall Study|Lack of Efficacy|0|||
48508277|NCT00579670|156054395|FG000|Overall Study|Lost to Follow-up|0|||
48508278|NCT00579670|156054396|FG001|Overall Study|Lost to Follow-up|1|||
48508279|NCT00579670|156054397|FG002|Overall Study|Lost to Follow-up|0|||
48508280|NCT00579670|156054398|FG003|Overall Study|Lost to Follow-up|4|||
48508281|NCT00579670|156054399|FG004|Overall Study|Lost to Follow-up|0|||
48508282|NCT00579670|156054395|FG000|Overall Study|Other|0|||
48508283|NCT00579670|156054396|FG001|Overall Study|Other|0|||
48508284|NCT00579670|156054397|FG002|Overall Study|Other|1|||
48508285|NCT00579670|156054398|FG003|Overall Study|Other|2|||
48508286|NCT00579670|156054399|FG004|Overall Study|Other|0|||
48508287|NCT00579670|156054395|FG000|Overall Study|Withdrawal by Subject|0|||
48508288|NCT00579670|156054396|FG001|Overall Study|Withdrawal by Subject|0|||
48508289|NCT00579670|156054397|FG002|Overall Study|Withdrawal by Subject|1|||
48508290|NCT00579670|156054398|FG003|Overall Study|Withdrawal by Subject|0|||
48508291|NCT00579670|156054399|FG004|Overall Study|Withdrawal by Subject|0|||
48508292|NCT02909907|156054402|FG000|Overall Study|Withdrawal by Subject|0|||
48508293|NCT02909907|156054403|FG001|Overall Study|Withdrawal by Subject|1|||
48508294|NCT02902211|156054404|FG000|First Three Months|Withdrawal by Subject|7|||
48508295|NCT02902211|156054405|FG001|First Three Months|Withdrawal by Subject|3|||
48508296|NCT00075478|156054409|FG000|Overall Study|not eligible|1|||
48508297|NCT00075478|156054410|FG001|Overall Study|not eligible|0|||
48508298|NCT00075478|156054409|FG000|Overall Study|Physician Decision|0|||
48508299|NCT00075478|156054410|FG001|Overall Study|Physician Decision|1|||
48508300|NCT00850174|156054416|FG000|Washout: One Week|Withdrawal by Subject|0|||
48508301|NCT00850174|156054417|FG001|Washout: One Week|Withdrawal by Subject|2|||
48508302|NCT00850174|156054416|FG000|Second Intervention|Withdrawal by Subject|1|||
48508303|NCT00850174|156054417|FG001|Second Intervention|Withdrawal by Subject|0|||
48508304|NCT01513174|156054418|FG000|Overall Study|Inclusion Error|1|||
48508305|NCT01513174|156054419|FG001|Overall Study|Inclusion Error|7|||
48508306|NCT01513174|156054418|FG000|Overall Study|Not receive study treatment|3|||
48508307|NCT01513174|156054419|FG001|Overall Study|Not receive study treatment|1|||
48508308|NCT01900626|156054420|FG000|Overall Study|study was closed due to low enrollment|1|||
48508309|NCT01900626|156054421|FG001|Overall Study|study was closed due to low enrollment|1|||
48438757|NCT02349789|155793870|FG000|Overall Study|Withdrawal by Subject|2|||
48438758|NCT01575197|155793883|FG000|Overall Study|Migration out of study area|1|||
48438759|NCT01575197|155793884|FG001|Overall Study|Migration out of study area|5|||
48438760|NCT01575197|155793885|FG002|Overall Study|Migration out of study area|4|||
48438761|NCT01575197|155793883|FG000|Overall Study|SAE|0|||
48438762|NCT01575197|155793884|FG001|Overall Study|SAE|1|||
48438763|NCT01575197|155793885|FG002|Overall Study|SAE|0|||
48438764|NCT01575197|155793883|FG000|Overall Study|Lost to Follow-up|0|||
48438765|NCT01575197|155793884|FG001|Overall Study|Lost to Follow-up|1|||
48438766|NCT01575197|155793885|FG002|Overall Study|Lost to Follow-up|0|||
48438767|NCT01575197|155793883|FG000|Overall Study|Withdrawal by Subject|0|||
48438768|NCT01575197|155793884|FG001|Overall Study|Withdrawal by Subject|1|||
48438769|NCT01575197|155793885|FG002|Overall Study|Withdrawal by Subject|1|||
48438770|NCT01575197|155793883|FG000|Overall Study|Protocol Violation|2|||
48438771|NCT01575197|155793884|FG001|Overall Study|Protocol Violation|1|||
48438772|NCT01575197|155793885|FG002|Overall Study|Protocol Violation|1|||
48381898|NCT04029961|155592865|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
48381899|NCT04029961|155592864|FG000|Overall Study|Change in Treatment Course|0|||
48381900|NCT04029961|155592865|FG001|Overall Study|Change in Treatment Course|1|||
48381901|NCT01557348|155592866|FG000|Overall Study|Adverse Event|6|||
48381902|NCT01557348|155592867|FG001|Overall Study|Adverse Event|16|||
48381903|NCT01557348|155592866|FG000|Overall Study|Infusion reaction event|5|||
48381904|NCT01557348|155592867|FG001|Overall Study|Infusion reaction event|5|||
48381905|NCT01557348|155592866|FG000|Overall Study|Death|7|||
48381906|NCT01557348|155592867|FG001|Overall Study|Death|4|||
48381907|NCT01557348|155592866|FG000|Overall Study|Insufficient Therapeutic Response|13|||
48381908|NCT01557348|155592867|FG001|Overall Study|Insufficient Therapeutic Response|28|||
48381909|NCT01557348|155592866|FG000|Overall Study|Withdrawal by Subject|5|||
48381910|NCT01557348|155592867|FG001|Overall Study|Withdrawal by Subject|4|||
48381911|NCT01557348|155592866|FG000|Overall Study|Lost to Follow-up|26|||
48381912|NCT01557348|155592867|FG001|Overall Study|Lost to Follow-up|22|||
48381913|NCT01557348|155592866|FG000|Overall Study|Administrative|18|||
48381914|NCT01557348|155592867|FG001|Overall Study|Administrative|11|||
48381915|NCT02684279|155592868|FG000|Overall Study|Adverse Event|87|||
48381916|NCT02684279|155592868|FG000|Overall Study|Lack of Efficacy|4|||
48381917|NCT02684279|155592868|FG000|Overall Study|Lost to Follow-up|61|||
48381918|NCT02684279|155592868|FG000|Overall Study|Protocol Violation|6|||
48381919|NCT02684279|155592868|FG000|Overall Study|Pregnancy|8|||
48381920|NCT02684279|155592868|FG000|Overall Study|Withdrawal by Subject|92|||
48381921|NCT02684279|155592868|FG000|Overall Study|non-compliance with study drug|9|||
48508310|NCT02057458|156054431|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
48600850|NCT00919633|156394068|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
48600851|NCT00919633|156394069|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
48600852|NCT00919633|156394066|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
48600853|NCT00919633|156394067|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
48600854|NCT00919633|156394068|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
48600855|NCT00919633|156394069|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
48600856|NCT00960804|156394072|FG000|Overall Study|Adverse Event|1|||
48820995|NCT03138512|157187335|FG004|Treatment Part A|Lost to Follow-up|0|||
48508311|NCT02057458|156054432|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
48508312|NCT02057458|156054433|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
48508313|NCT02057458|156054431|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
48508314|NCT02057458|156054432|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
48508315|NCT02057458|156054433|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
48508316|NCT02057458|156054431|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
48508317|NCT02057458|156054432|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
48508318|NCT02057458|156054433|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
48508319|NCT04263649|156054434|FG000|Overall Study|Adverse Event|53|||
48508320|NCT04263649|156054434|FG000|Overall Study|Lost to Follow-up|3|||
48508321|NCT04263649|156054434|FG000|Overall Study|Death|29|||
48508322|NCT04263649|156054434|FG000|Overall Study|Device deficiency|19|||
48508323|NCT04263649|156054434|FG000|Overall Study|other reasons|11|||
48508324|NCT01171963|156054435|FG000|Overall Study|Adverse Event|10|||
48508325|NCT01171963|156054436|FG001|Overall Study|Adverse Event|15|||
48508326|NCT01171963|156054435|FG000|Overall Study|Lost to Follow-up|23|||
48508327|NCT01171963|156054436|FG001|Overall Study|Lost to Follow-up|24|||
48508328|NCT01171963|156054435|FG000|Overall Study|Other - diarrhoea|1|||
48508329|NCT01171963|156054436|FG001|Overall Study|Other - diarrhoea|0|||
48508330|NCT01171963|156054435|FG000|Overall Study|Withdrawal by Subject|114|||
48508331|NCT01171963|156054436|FG001|Overall Study|Withdrawal by Subject|129|||
48508332|NCT03236311|156054439|FG000|Overall Study|Study terminated by sponsor|0|||
48508333|NCT03236311|156054440|FG001|Overall Study|Study terminated by sponsor|2|||
48508334|NCT03236311|156054439|FG000|Overall Study|Adverse Event|0|||
48508335|NCT03236311|156054440|FG001|Overall Study|Adverse Event|1|||
48508336|NCT02388191|156054447|FG000|Overall Study|Patient did not receive IUD|1|||
48508337|NCT02388191|156054448|FG001|Overall Study|Patient did not receive IUD|0|||
48508338|NCT03135834|156054449|FG000|Stage 1|Adverse Event|1|||
48508339|NCT03135834|156054450|FG001|Stage 1|Adverse Event|2|||
48508340|NCT03135834|156054451|FG002|Stage 1|Adverse Event|2|||
48600857|NCT00960804|156394073|FG001|Overall Study|Adverse Event|0|||
48600858|NCT00960804|156394074|FG002|Overall Study|Adverse Event|0|||
48508341|NCT03135834|156054452|FG003|Stage 1|Adverse Event|1|||
48508342|NCT03135834|156054449|FG000|Stage 1|Death|1|||
48600859|NCT00960804|156394072|FG000|Overall Study|Withdrawal by Subject|1|||
48820996|NCT03138512|157187331|FG000|Treatment Part A|Poor/non-compliance|1|||
48381922|NCT02684279|155592868|FG000|Overall Study|non compliance with study visits|2|||
48508343|NCT03135834|156054450|FG001|Stage 1|Death|0|||
48508344|NCT03135834|156054451|FG002|Stage 1|Death|0|||
48508345|NCT03135834|156054452|FG003|Stage 1|Death|0|||
48508346|NCT03135834|156054449|FG000|Stage 1|Lost to Follow-up|17|||
48508347|NCT03135834|156054450|FG001|Stage 1|Lost to Follow-up|24|||
48508348|NCT03135834|156054451|FG002|Stage 1|Lost to Follow-up|21|||
48508349|NCT03135834|156054452|FG003|Stage 1|Lost to Follow-up|38|||
48508350|NCT03135834|156054449|FG000|Stage 1|No longer met eligibility criteria|1|||
48508351|NCT03135834|156054450|FG001|Stage 1|No longer met eligibility criteria|6|||
48508352|NCT03135834|156054451|FG002|Stage 1|No longer met eligibility criteria|2|||
48508353|NCT03135834|156054452|FG003|Stage 1|No longer met eligibility criteria|5|||
48508354|NCT03135834|156054449|FG000|Stage 1|Other|0|||
48600860|NCT00960804|156394073|FG001|Overall Study|Withdrawal by Subject|0|||
48600861|NCT00960804|156394074|FG002|Overall Study|Withdrawal by Subject|0|||
48508355|NCT03135834|156054450|FG001|Stage 1|Other|2|||
48508356|NCT03135834|156054451|FG002|Stage 1|Other|1|||
48508357|NCT03135834|156054452|FG003|Stage 1|Other|0|||
48508358|NCT03135834|156054449|FG000|Stage 1|Physician Decision|0|||
48508359|NCT03135834|156054450|FG001|Stage 1|Physician Decision|1|||
48508360|NCT03135834|156054451|FG002|Stage 1|Physician Decision|0|||
48508361|NCT03135834|156054452|FG003|Stage 1|Physician Decision|0|||
48508362|NCT03135834|156054449|FG000|Stage 1|Pregnancy|0|||
48508363|NCT03135834|156054450|FG001|Stage 1|Pregnancy|4|||
48508364|NCT03135834|156054451|FG002|Stage 1|Pregnancy|2|||
48508365|NCT03135834|156054452|FG003|Stage 1|Pregnancy|4|||
48508366|NCT03135834|156054449|FG000|Stage 1|Protocol Violation|1|||
48508367|NCT03135834|156054450|FG001|Stage 1|Protocol Violation|1|||
48508368|NCT03135834|156054451|FG002|Stage 1|Protocol Violation|2|||
48508369|NCT03135834|156054452|FG003|Stage 1|Protocol Violation|1|||
48508370|NCT03135834|156054449|FG000|Stage 1|Withdrawal by parent/guardian|2|||
48508371|NCT03135834|156054450|FG001|Stage 1|Withdrawal by parent/guardian|10|||
48508372|NCT03135834|156054451|FG002|Stage 1|Withdrawal by parent/guardian|2|||
48508373|NCT03135834|156054452|FG003|Stage 1|Withdrawal by parent/guardian|1|||
48508374|NCT03135834|156054449|FG000|Stage 1|Withdrawal by Subject|16|||
48600862|NCT00960804|156394072|FG000|Overall Study|Study terminated by the sponsor|5|||
48600863|NCT00960804|156394073|FG001|Overall Study|Study terminated by the sponsor|4|||
48600864|NCT00960804|156394074|FG002|Overall Study|Study terminated by the sponsor|10|||
48600865|NCT00669318|156395964|FG000|Overall Study|Withdrawal by Subject|2|||
48600866|NCT01223404|156395965|FG000|First Intervention (1 Day)|Adverse Event|0|||
48600867|NCT01223404|156395966|FG001|First Intervention (1 Day)|Adverse Event|0|||
48600868|NCT01223404|156395967|FG002|First Intervention (1 Day)|Adverse Event|0|||
48600869|NCT01223404|156395968|FG003|First Intervention (1 Day)|Adverse Event|1|||
48600870|NCT01223404|156395969|FG004|First Intervention (1 Day)|Adverse Event|0|||
48600871|NCT01223404|156395970|FG005|First Intervention (1 Day)|Adverse Event|0|||
48600872|NCT01223404|156395965|FG000|Second Intervention (1 Day)|Adverse Event|1|||
48820997|NCT03138512|157187332|FG001|Treatment Part A|Poor/non-compliance|0|||
48600873|NCT01223404|156395966|FG001|Second Intervention (1 Day)|Adverse Event|0|||
48600874|NCT01223404|156395967|FG002|Second Intervention (1 Day)|Adverse Event|0|||
48600875|NCT01223404|156395968|FG003|Second Intervention (1 Day)|Adverse Event|0|||
48600876|NCT01223404|156395969|FG004|Second Intervention (1 Day)|Adverse Event|0|||
48600877|NCT01223404|156395970|FG005|Second Intervention (1 Day)|Adverse Event|0|||
48600878|NCT01223404|156395965|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
48600879|NCT01223404|156395966|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
48600880|NCT01223404|156395967|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
48600881|NCT01223404|156395968|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
48600882|NCT01223404|156395969|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
48600883|NCT01223404|156395970|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
48600884|NCT00954122|156395971|FG000|Overall Study|Withdrawal by Subject|5|||
48600885|NCT00954122|156395971|FG000|Overall Study|Adverse Event|1|||
48600886|NCT00954122|156395971|FG000|Overall Study|Safety Reason|1|||
48600887|NCT01921517|156395972|FG000|Overall Study|Lost to Follow-up|5|||
48600888|NCT01921517|156395973|FG001|Overall Study|Lost to Follow-up|0|||
48600889|NCT01921517|156395972|FG000|Overall Study|Newly diagnosed health concern|2|||
48600890|NCT01921517|156395973|FG001|Overall Study|Newly diagnosed health concern|0|||
48600891|NCT01921517|156395972|FG000|Overall Study|Physician Decision|0|||
48600892|NCT01921517|156395973|FG001|Overall Study|Physician Decision|2|||
48600893|NCT01921517|156395972|FG000|Overall Study|Withdrawal by Subject|7|||
48600894|NCT01921517|156395973|FG001|Overall Study|Withdrawal by Subject|3|||
48600895|NCT01921517|156395972|FG000|Overall Study|Subject missed final imaging|1|||
48600896|NCT01921517|156395973|FG001|Overall Study|Subject missed final imaging|4|||
48600897|NCT03205150|156395974|FG000|Overall Study|Protocol deviation|1|||
48508375|NCT03135834|156054450|FG001|Stage 1|Withdrawal by Subject|22|||
48508376|NCT03135834|156054451|FG002|Stage 1|Withdrawal by Subject|7|||
48508377|NCT03135834|156054452|FG003|Stage 1|Withdrawal by Subject|10|||
48508378|NCT03135834|156054449|FG000|Stage 1|Randomized but not Vaccinated|0|||
48508379|NCT03135834|156054450|FG001|Stage 1|Randomized but not Vaccinated|3|||
48508380|NCT03135834|156054451|FG002|Stage 1|Randomized but not Vaccinated|1|||
48508381|NCT03135834|156054452|FG003|Stage 1|Randomized but not Vaccinated|6|||
48508382|NCT03135834|156054449|FG000|Stage 2|Lost to Follow-up|0|||
48508383|NCT03135834|156054450|FG001|Stage 2|Lost to Follow-up|1|||
48508384|NCT03135834|156054451|FG002|Stage 2|Lost to Follow-up|0|||
48508385|NCT03135834|156054452|FG003|Stage 2|Lost to Follow-up|0|||
48508386|NCT03135834|156054449|FG000|Stage 2|Withdrawal by Subject|0|||
48508387|NCT03135834|156054450|FG001|Stage 2|Withdrawal by Subject|1|||
48508388|NCT03135834|156054451|FG002|Stage 2|Withdrawal by Subject|0|||
48508389|NCT03135834|156054452|FG003|Stage 2|Withdrawal by Subject|0|||
48508390|NCT03135834|156054449|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
48508391|NCT03135834|156054450|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
48508392|NCT03135834|156054451|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
48508393|NCT03135834|156054452|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
48508394|NCT03135834|156054449|FG000|Stage 2|Did not receive Booster Vaccination|1|||
48508395|NCT03135834|156054450|FG001|Stage 2|Did not receive Booster Vaccination|1|||
48508396|NCT03135834|156054451|FG002|Stage 2|Did not receive Booster Vaccination|0|||
48508397|NCT03135834|156054452|FG003|Stage 2|Did not receive Booster Vaccination|0|||
48508398|NCT00576056|156054453|FG000|Overall Study|Adverse Event|1|||
48508399|NCT00576056|156054453|FG000|Overall Study|Death|1|||
48508400|NCT00576056|156054453|FG000|Overall Study|Lack of Efficacy|1|||
48508401|NCT00576056|156054453|FG000|Overall Study|Withdrawal by Subject|2|||
48508402|NCT00576056|156054453|FG000|Overall Study|did not meet eligibility criteria|8|||
48508403|NCT00576056|156054453|FG000|Overall Study|Physician Decision|1|||
48508404|NCT03197883|156054454|FG000|Overall Study|Adverse Event|1|||
48508405|NCT03197883|156054455|FG001|Overall Study|Adverse Event|1|||
48508406|NCT03197883|156054454|FG000|Overall Study|Lost to Follow-up|1|||
48508407|NCT03197883|156054455|FG001|Overall Study|Lost to Follow-up|0|||
48508408|NCT03197883|156054454|FG000|Overall Study|Protocol Violation|1|||
48508409|NCT03197883|156054455|FG001|Overall Study|Protocol Violation|0|||
48508410|NCT03197883|156054454|FG000|Overall Study|Other (Not Specified)|0|||
48508411|NCT03197883|156054455|FG001|Overall Study|Other (Not Specified)|5|||
48508412|NCT01854047|156054456|FG000|Overall Study|Lack of Efficacy|1|||
48508413|NCT01854047|156054457|FG001|Overall Study|Lack of Efficacy|0|||
48508414|NCT01854047|156054458|FG002|Overall Study|Lack of Efficacy|0|||
48508415|NCT01854047|156054459|FG003|Overall Study|Lack of Efficacy|0|||
48508416|NCT01854047|156054460|FG004|Overall Study|Lack of Efficacy|0|||
48508417|NCT01854047|156054456|FG000|Overall Study|Poor compliance to protocol|3|||
48508418|NCT01854047|156054457|FG001|Overall Study|Poor compliance to protocol|0|||
48508419|NCT01854047|156054458|FG002|Overall Study|Poor compliance to protocol|2|||
48508420|NCT01854047|156054459|FG003|Overall Study|Poor compliance to protocol|0|||
48508421|NCT01854047|156054460|FG004|Overall Study|Poor compliance to protocol|0|||
48508422|NCT01854047|156054456|FG000|Overall Study|Adverse Event|5|||
48508423|NCT01854047|156054457|FG001|Overall Study|Adverse Event|4|||
48508424|NCT01854047|156054458|FG002|Overall Study|Adverse Event|6|||
48508425|NCT01854047|156054459|FG003|Overall Study|Adverse Event|10|||
48508426|NCT01854047|156054460|FG004|Overall Study|Adverse Event|7|||
48508427|NCT01854047|156054456|FG000|Overall Study|Randomized but not treated|0|||
48508428|NCT01854047|156054457|FG001|Overall Study|Randomized but not treated|1|||
48508429|NCT01854047|156054458|FG002|Overall Study|Randomized but not treated|2|||
48508430|NCT01854047|156054459|FG003|Overall Study|Randomized but not treated|0|||
48508431|NCT01854047|156054460|FG004|Overall Study|Randomized but not treated|4|||
48508432|NCT01854047|156054456|FG000|Overall Study|Other than specified above|3|||
48508433|NCT01854047|156054457|FG001|Overall Study|Other than specified above|3|||
48508434|NCT01854047|156054458|FG002|Overall Study|Other than specified above|3|||
48508435|NCT01854047|156054459|FG003|Overall Study|Other than specified above|5|||
48508436|NCT01854047|156054460|FG004|Overall Study|Other than specified above|8|||
48508437|NCT03966365|156054461|FG000|Overall Study|Protocol Violation|1|||
48508438|NCT03966365|156054462|FG001|Overall Study|Protocol Violation|0|||
48508439|NCT01841554|156054467|FG000|Overall Study|Death|7|||
48508440|NCT01841554|156054467|FG000|Overall Study|No Implantation|1|||
48508441|NCT01841554|156054467|FG000|Overall Study|Discontinued Follow Up|5|||
48508442|NCT01841554|156054467|FG000|Overall Study|Study exit due to secondary intervention|6|||
48508443|NCT01473953|156054468|FG000|Overall Study|Other|1|||
48508444|NCT01473953|156054469|FG001|Overall Study|Other|0|||
48508445|NCT01473953|156054470|FG002|Overall Study|Other|0|||
48508446|NCT01473953|156054471|FG003|Overall Study|Other|0|||
48508447|NCT01473953|156054472|FG004|Overall Study|Other|0|||
48508448|NCT01249651|156054474|FG000|Overall Study|Withdrawal by Subject|4|||
48508449|NCT01249651|156054474|FG000|Overall Study|Adverse Event|1|||
48508450|NCT01249651|156054474|FG000|Overall Study|Protocol Violation|1|||
48508451|NCT01249651|156054474|FG000|Overall Study|Sponsor Decision|1|||
48508452|NCT01421277|156054475|FG000|Overall Study|Lack of qualifying event|0|||
48508453|NCT01421277|156054476|FG001|Overall Study|Lack of qualifying event|61|||
48508454|NCT01421277|156054475|FG000|Overall Study|Incomplete baseline data|0|||
48508455|NCT01421277|156054476|FG001|Overall Study|Incomplete baseline data|31|||
48508456|NCT00397488|156056366|FG000|Overall Study|Withdrawal by Subject|3|||
48508457|NCT00397488|156056366|FG000|Overall Study|Adverse Event|3|||
48508458|NCT00397488|156056366|FG000|Overall Study|Death|1|||
48508459|NCT03597256|156056367|FG000|Overall Study|Lost to Follow-up|3|||
48508460|NCT03597256|156056368|FG001|Overall Study|Lost to Follow-up|1|||
48508461|NCT03597256|156056367|FG000|Overall Study|Withdrawal by Subject|0|||
48508462|NCT03597256|156056368|FG001|Overall Study|Withdrawal by Subject|1|||
48508463|NCT03597256|156056367|FG000|Overall Study|Could not return for treatment|0|||
48508464|NCT03597256|156056368|FG001|Overall Study|Could not return for treatment|1|||
48508465|NCT03597256|156056367|FG000|Overall Study|Moved from location|0|||
48508466|NCT03597256|156056368|FG001|Overall Study|Moved from location|1|||
48508467|NCT03597256|156056367|FG000|Overall Study|Not accepted the treatment|0|||
48508468|NCT03597256|156056368|FG001|Overall Study|Not accepted the treatment|1|||
48508469|NCT02106156|156056369|FG000|Overall Study|Patient Died|19|||
48508470|NCT02106156|156056370|FG001|Overall Study|Patient Died|0|||
48508471|NCT02106156|156056371|FG002|Overall Study|Patient Died|0|||
48508472|NCT02106156|156056369|FG000|Overall Study|Lack of Tolerability|305|||
48508473|NCT02106156|156056370|FG001|Overall Study|Lack of Tolerability|3|||
48508474|NCT02106156|156056371|FG002|Overall Study|Lack of Tolerability|0|||
48508475|NCT02106156|156056369|FG000|Overall Study|Lack of Virological Response|1044|||
48508476|NCT02106156|156056370|FG001|Overall Study|Lack of Virological Response|8|||
48508477|NCT02106156|156056371|FG002|Overall Study|Lack of Virological Response|0|||
48508478|NCT02106156|156056369|FG000|Overall Study|Concomitant Disease|74|||
48508479|NCT02106156|156056370|FG001|Overall Study|Concomitant Disease|2|||
48508480|NCT02106156|156056371|FG002|Overall Study|Concomitant Disease|0|||
48508481|NCT02106156|156056369|FG000|Overall Study|Lack of Compliance|211|||
48508482|NCT02106156|156056370|FG001|Overall Study|Lack of Compliance|7|||
48508483|NCT02106156|156056371|FG002|Overall Study|Lack of Compliance|0|||
48508484|NCT02106156|156056369|FG000|Overall Study|Patients Request|307|||
48508485|NCT02106156|156056370|FG001|Overall Study|Patients Request|9|||
48508486|NCT02106156|156056371|FG002|Overall Study|Patients Request|0|||
48508487|NCT02106156|156056369|FG000|Overall Study|Lost to Follow-up|451|||
48508488|NCT02106156|156056370|FG001|Overall Study|Lost to Follow-up|8|||
48508489|NCT02106156|156056371|FG002|Overall Study|Lost to Follow-up|0|||
48508490|NCT02106156|156056369|FG000|Overall Study|Unplanned Event|82|||
48508491|NCT02106156|156056370|FG001|Overall Study|Unplanned Event|2|||
48508492|NCT02106156|156056371|FG002|Overall Study|Unplanned Event|0|||
48508493|NCT02106156|156056369|FG000|Overall Study|Change of Laboratory Parameter|10|||
48508494|NCT02106156|156056370|FG001|Overall Study|Change of Laboratory Parameter|0|||
48508495|NCT02106156|156056371|FG002|Overall Study|Change of Laboratory Parameter|0|||
48508496|NCT02106156|156056369|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
48508497|NCT02106156|156056370|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
48508498|NCT02106156|156056371|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
48508499|NCT02106156|156056369|FG000|Overall Study|Relocation/Change of Physician|40|||
48508500|NCT02106156|156056370|FG001|Overall Study|Relocation/Change of Physician|1|||
48508501|NCT02106156|156056371|FG002|Overall Study|Relocation/Change of Physician|0|||
48508502|NCT02943447|156056372|FG000|Blinded Study Phase|Withdrew Consent|1|||
48508503|NCT02943447|156056373|FG001|Blinded Study Phase|Withdrew Consent|2|||
48508504|NCT02943447|156056374|FG002|Blinded Study Phase|Withdrew Consent|1|||
48508505|NCT02943447|156056372|FG000|Blinded Study Phase|Adverse Event|3|||
48508506|NCT02943447|156056373|FG001|Blinded Study Phase|Adverse Event|0|||
48508507|NCT02943447|156056374|FG002|Blinded Study Phase|Adverse Event|0|||
48508508|NCT02943447|156056372|FG000|Blinded Study Phase|Investigator's discretion|1|||
48508509|NCT02943447|156056373|FG001|Blinded Study Phase|Investigator's discretion|0|||
48508510|NCT02943447|156056374|FG002|Blinded Study Phase|Investigator's discretion|0|||
48508511|NCT02943447|156056372|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
48508512|NCT02943447|156056373|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
48508513|NCT02943447|156056374|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
48508514|NCT02943447|156056372|FG000|Open-Label Extension Phase|Adverse Event|4|||
48508515|NCT02943447|156056373|FG001|Open-Label Extension Phase|Adverse Event|7|||
48508516|NCT02943447|156056374|FG002|Open-Label Extension Phase|Adverse Event|3|||
48508517|NCT02943447|156056372|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
48508518|NCT02943447|156056373|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
48508519|NCT02943447|156056374|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
48508520|NCT02943447|156056372|FG000|Open-Label Extension Phase|Withdrew consent|1|||
48508521|NCT02943447|156056373|FG001|Open-Label Extension Phase|Withdrew consent|1|||
48508522|NCT02943447|156056374|FG002|Open-Label Extension Phase|Withdrew consent|1|||
48508523|NCT02943447|156056372|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
48508524|NCT02943447|156056373|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
48508525|NCT02943447|156056374|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
48508526|NCT01629381|156056375|FG000|Overall Study|Withdrawal by Subject|2|||
48508527|NCT01629381|156056376|FG001|Overall Study|Withdrawal by Subject|5|||
48508528|NCT03290781|156056377|FG000|Overall Study|Adverse Event|5|||
48508529|NCT03290781|156056378|FG001|Overall Study|Adverse Event|7|||
48508530|NCT03290781|156056379|FG002|Overall Study|Adverse Event|4|||
48508531|NCT03290781|156056380|FG003|Overall Study|Adverse Event|1|||
48508532|NCT03290781|156056381|FG004|Overall Study|Adverse Event|0|||
48508533|NCT03290781|156056382|FG005|Overall Study|Adverse Event|0|||
48508534|NCT03290781|156056383|FG006|Overall Study|Adverse Event|0|||
48508535|NCT03290781|156056377|FG000|Overall Study|Death|0|||
48508536|NCT03290781|156056378|FG001|Overall Study|Death|0|||
48508537|NCT03290781|156056379|FG002|Overall Study|Death|1|||
48508538|NCT03290781|156056380|FG003|Overall Study|Death|0|||
48508539|NCT03290781|156056381|FG004|Overall Study|Death|1|||
48508540|NCT03290781|156056382|FG005|Overall Study|Death|0|||
48600898|NCT03205150|156395975|FG001|Overall Study|Protocol deviation|3|||
48508541|NCT03290781|156056383|FG006|Overall Study|Death|0|||
48508542|NCT03290781|156056377|FG000|Overall Study|Withdrawal by Subject|6|||
48508543|NCT03290781|156056378|FG001|Overall Study|Withdrawal by Subject|5|||
48508544|NCT03290781|156056379|FG002|Overall Study|Withdrawal by Subject|9|||
48600899|NCT03205150|156395976|FG002|Overall Study|Protocol deviation|0|||
48600900|NCT03205150|156395974|FG000|Overall Study|Patient/guardian decision|0|||
48600901|NCT03205150|156395975|FG001|Overall Study|Patient/guardian decision|3|||
48508545|NCT03290781|156056380|FG003|Overall Study|Withdrawal by Subject|10|||
48600902|NCT03205150|156395976|FG002|Overall Study|Patient/guardian decision|0|||
48600903|NCT03205150|156395974|FG000|Overall Study|Adverse Event|1|||
48508546|NCT03290781|156056381|FG004|Overall Study|Withdrawal by Subject|1|||
48508547|NCT03290781|156056382|FG005|Overall Study|Withdrawal by Subject|2|||
48508548|NCT03290781|156056383|FG006|Overall Study|Withdrawal by Subject|0|||
48508549|NCT03290781|156056377|FG000|Overall Study|Physician Decision|0|||
48508550|NCT03290781|156056378|FG001|Overall Study|Physician Decision|1|||
48508551|NCT03290781|156056379|FG002|Overall Study|Physician Decision|0|||
48508552|NCT03290781|156056380|FG003|Overall Study|Physician Decision|0|||
48508553|NCT03290781|156056381|FG004|Overall Study|Physician Decision|0|||
48508554|NCT03290781|156056382|FG005|Overall Study|Physician Decision|0|||
48508555|NCT03290781|156056383|FG006|Overall Study|Physician Decision|0|||
48508556|NCT03290781|156056377|FG000|Overall Study|Site Terminated by Sponsor|1|||
48508557|NCT03290781|156056378|FG001|Overall Study|Site Terminated by Sponsor|0|||
48508558|NCT03290781|156056379|FG002|Overall Study|Site Terminated by Sponsor|2|||
48508559|NCT03290781|156056380|FG003|Overall Study|Site Terminated by Sponsor|1|||
48508560|NCT03290781|156056381|FG004|Overall Study|Site Terminated by Sponsor|0|||
48508561|NCT03290781|156056382|FG005|Overall Study|Site Terminated by Sponsor|0|||
48508562|NCT03290781|156056383|FG006|Overall Study|Site Terminated by Sponsor|0|||
48508563|NCT03290781|156056377|FG000|Overall Study|Lost to Follow-up|0|||
48508564|NCT03290781|156056378|FG001|Overall Study|Lost to Follow-up|0|||
48508565|NCT03290781|156056379|FG002|Overall Study|Lost to Follow-up|0|||
48508566|NCT03290781|156056380|FG003|Overall Study|Lost to Follow-up|1|||
48508567|NCT03290781|156056381|FG004|Overall Study|Lost to Follow-up|0|||
48508568|NCT03290781|156056382|FG005|Overall Study|Lost to Follow-up|0|||
48508569|NCT03290781|156056383|FG006|Overall Study|Lost to Follow-up|0|||
48508570|NCT03290781|156056377|FG000|Overall Study|Protocol Deviation|2|||
48508571|NCT03290781|156056378|FG001|Overall Study|Protocol Deviation|0|||
48508572|NCT03290781|156056379|FG002|Overall Study|Protocol Deviation|0|||
48508573|NCT03290781|156056380|FG003|Overall Study|Protocol Deviation|1|||
48508574|NCT03290781|156056381|FG004|Overall Study|Protocol Deviation|0|||
48508575|NCT03290781|156056382|FG005|Overall Study|Protocol Deviation|0|||
48508576|NCT03290781|156056383|FG006|Overall Study|Protocol Deviation|0|||
48508577|NCT03290781|156056377|FG000|Overall Study|Disease Relapse|32|||
48508578|NCT03290781|156056378|FG001|Overall Study|Disease Relapse|5|||
48508579|NCT03290781|156056379|FG002|Overall Study|Disease Relapse|38|||
48508580|NCT03290781|156056380|FG003|Overall Study|Disease Relapse|7|||
48508581|NCT03290781|156056381|FG004|Overall Study|Disease Relapse|3|||
48508582|NCT03290781|156056382|FG005|Overall Study|Disease Relapse|1|||
48508583|NCT03290781|156056383|FG006|Overall Study|Disease Relapse|4|||
48508584|NCT03290781|156056377|FG000|Overall Study|Other|3|||
48508585|NCT03290781|156056378|FG001|Overall Study|Other|0|||
48508586|NCT03290781|156056379|FG002|Overall Study|Other|2|||
48508587|NCT03290781|156056380|FG003|Overall Study|Other|2|||
48508588|NCT03290781|156056381|FG004|Overall Study|Other|0|||
48508589|NCT03290781|156056382|FG005|Overall Study|Other|0|||
48508590|NCT03290781|156056383|FG006|Overall Study|Other|0|||
48508591|NCT02128997|156056384|FG000|Overall Study|Lost to Follow-up|6|||
48508592|NCT02128997|156056385|FG001|Overall Study|Lost to Follow-up|11|||
48508593|NCT01214850|156056386|FG000|Overall Study|Withdrawal by Subject|38|||
48508594|NCT01214850|156056387|FG001|Overall Study|Withdrawal by Subject|31|||
48508595|NCT01214850|156056388|FG002|Overall Study|Withdrawal by Subject|28|||
48508596|NCT01214850|156056386|FG000|Overall Study|Lost to Follow-up|124|||
48600904|NCT03205150|156395975|FG001|Overall Study|Adverse Event|1|||
48600905|NCT03205150|156395976|FG002|Overall Study|Adverse Event|1|||
48600906|NCT03205150|156395974|FG000|Overall Study|Lost to Follow-up|0|||
48508597|NCT01214850|156056387|FG001|Overall Study|Lost to Follow-up|98|||
48508598|NCT01214850|156056388|FG002|Overall Study|Lost to Follow-up|123|||
48508599|NCT01214850|156056386|FG000|Overall Study|Protocol Violation|5|||
48508600|NCT01214850|156056387|FG001|Overall Study|Protocol Violation|5|||
48508601|NCT01214850|156056388|FG002|Overall Study|Protocol Violation|6|||
48508602|NCT01214850|156056386|FG000|Overall Study|Adverse event or death|11|||
48508603|NCT01214850|156056387|FG001|Overall Study|Adverse event or death|8|||
48508604|NCT01214850|156056388|FG002|Overall Study|Adverse event or death|3|||
48508605|NCT01214850|156056386|FG000|Overall Study|Inappropriate enrollment|2|||
48508606|NCT01214850|156056387|FG001|Overall Study|Inappropriate enrollment|1|||
48508607|NCT01214850|156056388|FG002|Overall Study|Inappropriate enrollment|0|||
48508608|NCT01214850|156056386|FG000|Overall Study|Administrative reason|1|||
48508609|NCT01214850|156056387|FG001|Overall Study|Administrative reason|0|||
48508610|NCT01214850|156056388|FG002|Overall Study|Administrative reason|0|||
48508611|NCT01214850|156056386|FG000|Overall Study|Unable to classify|2|||
48508612|NCT01214850|156056387|FG001|Overall Study|Unable to classify|1|||
48508613|NCT01214850|156056388|FG002|Overall Study|Unable to classify|1|||
48508614|NCT04000815|156056395|FG000|Overall Study|Lost to Follow-up|9|||
48508615|NCT04000815|156056396|FG001|Overall Study|Lost to Follow-up|2|||
48508616|NCT04000815|156056397|FG002|Overall Study|Lost to Follow-up|3|||
48508617|NCT04000815|156056395|FG000|Overall Study|Withdrawal by Subject|4|||
48508618|NCT04000815|156056396|FG001|Overall Study|Withdrawal by Subject|3|||
48508619|NCT04000815|156056397|FG002|Overall Study|Withdrawal by Subject|2|||
48508620|NCT04000815|156056395|FG000|Overall Study|Right ovarian cyst occured|1|||
48508621|NCT04000815|156056396|FG001|Overall Study|Right ovarian cyst occured|0|||
48508622|NCT04000815|156056397|FG002|Overall Study|Right ovarian cyst occured|0|||
48508623|NCT04000815|156056395|FG000|Overall Study|Hypertension occured on follow up|0|||
48508624|NCT04000815|156056396|FG001|Overall Study|Hypertension occured on follow up|0|||
48508625|NCT04000815|156056397|FG002|Overall Study|Hypertension occured on follow up|2|||
48508626|NCT00519194|156056400|FG000|Overall Study|Withdrawal by Subject|9|||
48508627|NCT00519194|156056400|FG000|Overall Study|Death|9|||
48508628|NCT00519194|156056400|FG000|Overall Study|Lost to Follow-up|3|||
48508629|NCT02193165|156056409|FG000|4 Week Product Use|Lost to Follow-up|1|||
48508630|NCT02193165|156056410|FG001|4 Week Product Use|Lost to Follow-up|1|||
48508631|NCT02193165|156056411|FG002|4 Week Product Use|Lost to Follow-up|1|||
48508632|NCT02193165|156056409|FG000|6 Week Product Use|Lost to Follow-up|0|||
48508633|NCT02193165|156056410|FG001|6 Week Product Use|Lost to Follow-up|1|||
48508634|NCT02193165|156056411|FG002|6 Week Product Use|Lost to Follow-up|0|||
48508635|NCT02760368|156056412|FG000|Overall Study|Withdrawal by Subject|8|||
48508636|NCT02760368|156056413|FG001|Overall Study|Withdrawal by Subject|12|||
48508637|NCT02760368|156056414|FG002|Overall Study|Withdrawal by Subject|9|||
48508638|NCT02760368|156056412|FG000|Overall Study|Screen Failure|0|||
48508639|NCT02760368|156056413|FG001|Overall Study|Screen Failure|0|||
48508640|NCT02760368|156056414|FG002|Overall Study|Screen Failure|1|||
48508641|NCT02760368|156056412|FG000|Overall Study|Death|0|||
48508642|NCT02760368|156056413|FG001|Overall Study|Death|1|||
48508643|NCT02760368|156056414|FG002|Overall Study|Death|0|||
48508644|NCT02760368|156056412|FG000|Overall Study|Withdrawal by Sponsor|0|||
48508645|NCT02760368|156056413|FG001|Overall Study|Withdrawal by Sponsor|0|||
48508646|NCT02760368|156056414|FG002|Overall Study|Withdrawal by Sponsor|1|||
48508647|NCT04239872|156056415|FG000|Overall Study|Lost to Follow-up|0|||
48508648|NCT04239872|156056416|FG001|Overall Study|Lost to Follow-up|1|||
48508649|NCT01173692|156056422|FG000|Overall Study|Adverse Event|1|||
48508650|NCT01173692|156056423|FG001|Overall Study|Adverse Event|2|||
48508651|NCT01173692|156056422|FG000|Overall Study|Withdrawal by Subject|1|||
48508652|NCT01173692|156056423|FG001|Overall Study|Withdrawal by Subject|3|||
48508653|NCT02294604|156056424|FG000|Overall Study|Did not provide samples for culture|0|||
48508654|NCT02294604|156056425|FG001|Overall Study|Did not provide samples for culture|1|||
48508655|NCT02294604|156056426|FG002|Overall Study|Did not provide samples for culture|0|||
48508656|NCT02294604|156056424|FG000|Overall Study|Culture contamination|1|||
48508657|NCT02294604|156056425|FG001|Overall Study|Culture contamination|2|||
48508658|NCT02294604|156056426|FG002|Overall Study|Culture contamination|0|||
48508659|NCT01472341|156056427|FG000|Overall Study|Started insulin therapy|55|||
48508660|NCT01472341|156056427|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
48508661|NCT01472341|156056427|FG000|Overall Study|Withdrawal by Subject|39|||
48508662|NCT01472341|156056427|FG000|Overall Study|Lost to Follow-up|52|||
48508663|NCT01472341|156056427|FG000|Overall Study|Laboratory parameters unavailable|25|||
48508664|NCT01472341|156056427|FG000|Overall Study|Death|9|||
48508665|NCT01363765|156056431|FG000|Overall Study|non-diagnostic|2621|||
48508666|NCT01363765|156056432|FG001|Overall Study|non-diagnostic|1124|||
48508667|NCT01363765|156056431|FG000|Overall Study|duplicate records|736|||
48508668|NCT01363765|156056432|FG001|Overall Study|duplicate records|3177|||
48508669|NCT01363765|156056431|FG000|Overall Study|non-resident|156|||
48508670|NCT01363765|156056432|FG001|Overall Study|non-resident|76|||
48508671|NCT01363765|156056431|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
48508672|NCT01363765|156056432|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
48508673|NCT01363765|156056431|FG000|Overall Study|smear during intervention|2170|||
48508674|NCT01363765|156056432|FG001|Overall Study|smear during intervention|0|||
48508675|NCT00635492|156056433|FG000|Overall Study|Death|12|||
48508676|NCT00635492|156056434|FG001|Overall Study|Death|40|||
48508677|NCT00635492|156056433|FG000|Overall Study|Lost to Follow-up|151|||
48508678|NCT00635492|156056434|FG001|Overall Study|Lost to Follow-up|172|||
48508679|NCT00635492|156056433|FG000|Overall Study|Physician Decision|32|||
48508680|NCT00635492|156056434|FG001|Overall Study|Physician Decision|22|||
48508681|NCT00635492|156056433|FG000|Overall Study|Sponsor decision|2|||
48508682|NCT00635492|156056434|FG001|Overall Study|Sponsor decision|3|||
48508683|NCT00635492|156056433|FG000|Overall Study|Withdrawal by Subject|82|||
48508684|NCT00635492|156056434|FG001|Overall Study|Withdrawal by Subject|45|||
48508685|NCT02075463|156056436|FG000|Overall Study|Adverse Event|3|||
48508686|NCT02075463|156056436|FG000|Overall Study|Par. reached stopping criteria|4|||
48508687|NCT02075463|156056436|FG000|Overall Study|Withdrawal by Subject|1|||
48726401|NCT00064298|156847966|FG000|Overall Study|Disease Progression|2|||
48726402|NCT00064298|156847967|FG001|Overall Study|Disease Progression|1|||
48726403|NCT01569464|156847968|FG000|Overall Study|Adverse Event|4|||
48726404|NCT01569464|156847969|FG001|Overall Study|Adverse Event|0|||
48726405|NCT01569464|156847968|FG000|Overall Study|Lack of Efficacy|1|||
48726406|NCT01569464|156847969|FG001|Overall Study|Lack of Efficacy|0|||
48820998|NCT03138512|157187333|FG002|Treatment Part A|Poor/non-compliance|0|||
48820999|NCT03138512|157187334|FG003|Treatment Part A|Poor/non-compliance|0|||
48821000|NCT03138512|157187335|FG004|Treatment Part A|Poor/non-compliance|0|||
48821001|NCT03138512|157187331|FG000|Treatment Part A|Pregnancy|0|||
48821002|NCT03138512|157187332|FG001|Treatment Part A|Pregnancy|1|||
48508688|NCT01702987|156056440|FG000|Overall Study|Withdrawal by Subject|1|||
48508689|NCT01702987|156056441|FG001|Overall Study|Withdrawal by Subject|0|||
48508690|NCT04405570|156056442|FG000|Overall Study|Adverse Event|0|||
48508691|NCT04405570|156056443|FG001|Overall Study|Adverse Event|1|||
48726407|NCT01569464|156847968|FG000|Overall Study|Protocol Violation|1|||
48726408|NCT01569464|156847969|FG001|Overall Study|Protocol Violation|0|||
48726409|NCT01569464|156847968|FG000|Overall Study|Lost to Follow-up|2|||
48726410|NCT01569464|156847969|FG001|Overall Study|Lost to Follow-up|3|||
48508692|NCT04405570|156056444|FG002|Overall Study|Adverse Event|1|||
48508693|NCT04405570|156056445|FG003|Overall Study|Adverse Event|1|||
48508694|NCT04405570|156056442|FG000|Overall Study|Lost to Follow-up|0|||
48508695|NCT04405570|156056443|FG001|Overall Study|Lost to Follow-up|1|||
48508696|NCT04405570|156056444|FG002|Overall Study|Lost to Follow-up|0|||
48508697|NCT04405570|156056445|FG003|Overall Study|Lost to Follow-up|0|||
48508698|NCT04405570|156056442|FG000|Overall Study|Physician Decision|0|||
48508699|NCT04405570|156056443|FG001|Overall Study|Physician Decision|0|||
48508700|NCT04405570|156056444|FG002|Overall Study|Physician Decision|1|||
48508701|NCT04405570|156056445|FG003|Overall Study|Physician Decision|0|||
48508702|NCT04405570|156056442|FG000|Overall Study|Withdrawal by Subject|0|||
48508703|NCT04405570|156056443|FG001|Overall Study|Withdrawal by Subject|1|||
48508704|NCT04405570|156056444|FG002|Overall Study|Withdrawal by Subject|1|||
48508705|NCT04405570|156056445|FG003|Overall Study|Withdrawal by Subject|0|||
48508706|NCT04405570|156056442|FG000|Overall Study|Randomized not dosed|0|||
48508707|NCT04405570|156056443|FG001|Overall Study|Randomized not dosed|2|||
48508708|NCT04405570|156056444|FG002|Overall Study|Randomized not dosed|0|||
48508709|NCT04405570|156056445|FG003|Overall Study|Randomized not dosed|0|||
48508710|NCT01097577|156056451|FG000|Overall Study|Adverse Event|0|||
48508711|NCT01097577|156056452|FG001|Overall Study|Adverse Event|1|||
48508712|NCT00467363|156056453|FG000|Overall Study|Lost to Follow-up|80|||
48508713|NCT00467363|156056454|FG001|Overall Study|Lost to Follow-up|70|||
48508714|NCT01534520|156056459|FG000|Overall Study|Adverse Event|0|||
48508715|NCT01534520|156056460|FG001|Overall Study|Adverse Event|1|||
48508716|NCT00112463|156056461|FG000|Overall Study|Physician Decision|1|||
48508717|NCT00112463|156056461|FG000|Overall Study|Progression|30|||
48508718|NCT00112463|156056461|FG000|Overall Study|Second Primary|1|||
48508719|NCT00112463|156056461|FG000|Overall Study|Toxicity|3|||
48508720|NCT00112463|156056461|FG000|Overall Study|Withdrawal by Subject|2|||
48508721|NCT00112463|156056461|FG000|Overall Study|Never started treatment|2|||
48508722|NCT01118312|156056468|FG000|Overall Study|Lost to Follow-up|33|||
48508723|NCT01118312|156056469|FG001|Overall Study|Lost to Follow-up|32|||
48508724|NCT01118312|156056468|FG000|Overall Study|Withdrawal by Subject|1|||
48508725|NCT01118312|156056469|FG001|Overall Study|Withdrawal by Subject|3|||
48508726|NCT02017223|156056470|FG000|Overall Study|Algorithm problems|2|||
48508727|NCT01401647|156056471|FG000|Overall Study|Withdrawal by Subject|1|||
48508728|NCT01401647|156056472|FG001|Overall Study|Withdrawal by Subject|5|||
48508729|NCT01401647|156056473|FG002|Overall Study|Withdrawal by Subject|2|||
48508730|NCT01401647|156056471|FG000|Overall Study|Lost to Follow-up|3|||
48508731|NCT01401647|156056472|FG001|Overall Study|Lost to Follow-up|3|||
48508732|NCT01401647|156056473|FG002|Overall Study|Lost to Follow-up|1|||
48508733|NCT02089685|156056474|FG000|Overall Study|Adverse Event|1|||
48508734|NCT02089685|156056475|FG001|Overall Study|Adverse Event|0|||
48508735|NCT02089685|156056476|FG002|Overall Study|Adverse Event|0|||
48508736|NCT02089685|156056477|FG003|Overall Study|Adverse Event|0|||
48508737|NCT02089685|156056478|FG004|Overall Study|Adverse Event|1|||
48508738|NCT02089685|156056479|FG005|Overall Study|Adverse Event|0|||
48508739|NCT02089685|156056474|FG000|Overall Study|Clinical Progression|4|||
48508740|NCT02089685|156056475|FG001|Overall Study|Clinical Progression|0|||
48508741|NCT02089685|156056476|FG002|Overall Study|Clinical Progression|0|||
48508742|NCT02089685|156056477|FG003|Overall Study|Clinical Progression|5|||
48508743|NCT02089685|156056478|FG004|Overall Study|Clinical Progression|1|||
48508744|NCT02089685|156056479|FG005|Overall Study|Clinical Progression|2|||
48508745|NCT02089685|156056474|FG000|Overall Study|Excluded Medication|1|||
48821003|NCT03138512|157187333|FG002|Treatment Part A|Pregnancy|0|||
48508746|NCT02089685|156056475|FG001|Overall Study|Excluded Medication|0|||
48508747|NCT02089685|156056476|FG002|Overall Study|Excluded Medication|0|||
48726411|NCT01569464|156847968|FG000|Overall Study|Withdrawal by Subject|1|||
48726412|NCT01569464|156847969|FG001|Overall Study|Withdrawal by Subject|1|||
48508748|NCT02089685|156056477|FG003|Overall Study|Excluded Medication|11|||
48508749|NCT02089685|156056478|FG004|Overall Study|Excluded Medication|2|||
48508750|NCT02089685|156056479|FG005|Overall Study|Excluded Medication|1|||
48508751|NCT02089685|156056474|FG000|Overall Study|Progressive disease|13|||
48508752|NCT02089685|156056475|FG001|Overall Study|Progressive disease|10|||
48508753|NCT02089685|156056476|FG002|Overall Study|Progressive disease|3|||
48508754|NCT02089685|156056477|FG003|Overall Study|Progressive disease|51|||
48508755|NCT02089685|156056478|FG004|Overall Study|Progressive disease|17|||
48508756|NCT02089685|156056479|FG005|Overall Study|Progressive disease|12|||
48508757|NCT02089685|156056474|FG000|Overall Study|Follow up ended by sponsor|2|||
48508758|NCT02089685|156056475|FG001|Overall Study|Follow up ended by sponsor|2|||
48508759|NCT02089685|156056476|FG002|Overall Study|Follow up ended by sponsor|0|||
48508760|NCT02089685|156056477|FG003|Overall Study|Follow up ended by sponsor|70|||
48508761|NCT02089685|156056478|FG004|Overall Study|Follow up ended by sponsor|26|||
48508762|NCT02089685|156056479|FG005|Overall Study|Follow up ended by sponsor|26|||
48508763|NCT02089685|156056474|FG000|Overall Study|Withdrawal by Subject|0|||
48508764|NCT02089685|156056475|FG001|Overall Study|Withdrawal by Subject|2|||
48508765|NCT02089685|156056476|FG002|Overall Study|Withdrawal by Subject|0|||
48508766|NCT02089685|156056477|FG003|Overall Study|Withdrawal by Subject|8|||
48508767|NCT02089685|156056478|FG004|Overall Study|Withdrawal by Subject|1|||
48508768|NCT02089685|156056479|FG005|Overall Study|Withdrawal by Subject|1|||
48508769|NCT02089685|156056474|FG000|Overall Study|Status not recorded|1|||
48508770|NCT02089685|156056475|FG001|Overall Study|Status not recorded|0|||
48508771|NCT02089685|156056476|FG002|Overall Study|Status not recorded|0|||
48508772|NCT02089685|156056477|FG003|Overall Study|Status not recorded|0|||
48508773|NCT02089685|156056478|FG004|Overall Study|Status not recorded|1|||
48508774|NCT02089685|156056479|FG005|Overall Study|Status not recorded|0|||
48508775|NCT02089685|156056474|FG000|Overall Study|Death|0|||
48508776|NCT02089685|156056475|FG001|Overall Study|Death|0|||
48508777|NCT02089685|156056476|FG002|Overall Study|Death|0|||
48508778|NCT02089685|156056477|FG003|Overall Study|Death|7|||
48508779|NCT02089685|156056478|FG004|Overall Study|Death|2|||
48508780|NCT02089685|156056479|FG005|Overall Study|Death|5|||
48508781|NCT02089685|156056474|FG000|Overall Study|Lost to Follow-up|0|||
48508782|NCT02089685|156056475|FG001|Overall Study|Lost to Follow-up|0|||
48508783|NCT02089685|156056476|FG002|Overall Study|Lost to Follow-up|0|||
48508784|NCT02089685|156056477|FG003|Overall Study|Lost to Follow-up|1|||
48508785|NCT02089685|156056478|FG004|Overall Study|Lost to Follow-up|0|||
48508786|NCT02089685|156056479|FG005|Overall Study|Lost to Follow-up|0|||
48508787|NCT02089685|156056474|FG000|Overall Study|Physician Decision|0|||
48508788|NCT02089685|156056475|FG001|Overall Study|Physician Decision|0|||
48508789|NCT02089685|156056476|FG002|Overall Study|Physician Decision|0|||
48508790|NCT02089685|156056477|FG003|Overall Study|Physician Decision|0|||
48508791|NCT02089685|156056478|FG004|Overall Study|Physician Decision|0|||
48508792|NCT02089685|156056479|FG005|Overall Study|Physician Decision|4|||
48508793|NCT02089685|156056474|FG000|Overall Study|Screen failure|1|||
48508794|NCT02089685|156056475|FG001|Overall Study|Screen failure|0|||
48508795|NCT02089685|156056476|FG002|Overall Study|Screen failure|0|||
48508796|NCT02089685|156056477|FG003|Overall Study|Screen failure|0|||
48508797|NCT02089685|156056478|FG004|Overall Study|Screen failure|0|||
48508798|NCT02089685|156056479|FG005|Overall Study|Screen failure|0|||
48508799|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
48508800|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
48508801|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
48508802|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
48508803|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
48508804|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
48508805|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
48726413|NCT01569464|156847968|FG000|Overall Study|Other|1|||
48508806|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
48508807|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
48508808|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
48726414|NCT01569464|156847969|FG001|Overall Study|Other|1|||
48726415|NCT04010539|156847970|FG000|Overall Study|Withdrawal by Subject|4|||
48726416|NCT04010539|156847971|FG001|Overall Study|Withdrawal by Subject|1|||
48726417|NCT04010539|156847970|FG000|Overall Study|Physician Decision|0|||
48508809|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
48508810|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
48508811|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
48508812|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
48508813|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
48508814|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
48726418|NCT04010539|156847971|FG001|Overall Study|Physician Decision|2|||
48508815|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
48508816|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
48508817|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
48600907|NCT03205150|156395975|FG001|Overall Study|Lost to Follow-up|0|||
48508818|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
48508819|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Death|0|||
48508820|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Death|1|||
48508821|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Death|0|||
48508822|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Death|0|||
48508823|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
48508824|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
48508825|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
48508826|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
48508827|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
48726419|NCT04010539|156847970|FG000|Overall Study|Lost to Follow-up|10|||
48726420|NCT04010539|156847971|FG001|Overall Study|Lost to Follow-up|14|||
48508828|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
48508829|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
48726421|NCT04010539|156847970|FG000|Overall Study|Adverse Event|3|||
48726422|NCT04010539|156847971|FG001|Overall Study|Adverse Event|0|||
48726423|NCT04010539|156847970|FG000|Overall Study|Participant Did Not Receive IP|0|||
48726424|NCT04010539|156847971|FG001|Overall Study|Participant Did Not Receive IP|1|||
48726425|NCT04010539|156847970|FG000|Overall Study|Protocol Deviation|0|||
48821004|NCT03138512|157187334|FG003|Treatment Part A|Pregnancy|0|||
48821005|NCT03138512|157187335|FG004|Treatment Part A|Pregnancy|0|||
48821006|NCT03138512|157187331|FG000|Treatment Part A|Other reasons|11|||
48821007|NCT03138512|157187332|FG001|Treatment Part A|Other reasons|8|||
48821008|NCT03138512|157187333|FG002|Treatment Part A|Other reasons|0|||
48821009|NCT03138512|157187334|FG003|Treatment Part A|Other reasons|0|||
48821010|NCT03138512|157187335|FG004|Treatment Part A|Other reasons|0|||
48821011|NCT03138512|157187331|FG000|Treatment Part B|Disease recurrence|0|||
48821012|NCT03138512|157187332|FG001|Treatment Part B|Disease recurrence|0|||
48821013|NCT03138512|157187333|FG002|Treatment Part B|Disease recurrence|6|||
48821014|NCT03138512|157187334|FG003|Treatment Part B|Disease recurrence|12|||
48726426|NCT04010539|156847971|FG001|Overall Study|Protocol Deviation|1|||
48508830|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
48508831|NCT01940341|156056483|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
48508832|NCT01940341|156056484|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
48726427|NCT04010539|156847970|FG000|Overall Study|Randomized in Error/ Mistake|2|||
48726428|NCT04010539|156847971|FG001|Overall Study|Randomized in Error/ Mistake|0|||
48726429|NCT04010539|156847970|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
48726430|NCT04010539|156847971|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
48726431|NCT00322153|156847972|FG000|Overall Study|Adverse Event|21|||
48726432|NCT00322153|156847973|FG001|Overall Study|Adverse Event|34|||
48821015|NCT03138512|157187335|FG004|Treatment Part B|Disease recurrence|10|||
48508833|NCT01940341|156056485|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
48508834|NCT01940341|156056486|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
48508835|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
48508836|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
48508837|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
48508838|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
48508839|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
48508840|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
48508841|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
48508842|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
48508843|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
48508844|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
48508845|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
48508846|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
48508847|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
48508848|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
48508849|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
48508850|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
48508851|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
48508852|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
48508853|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
48508854|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
48508855|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
48508856|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
48508857|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
48726433|NCT00322153|156847972|FG000|Overall Study|Protocol Violation|6|||
48821016|NCT03138512|157187331|FG000|Treatment Part B|Study drug toxicity|0|||
48508858|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
48600908|NCT03205150|156395976|FG002|Overall Study|Lost to Follow-up|1|||
48600909|NCT01411319|156395977|FG000|Overall Study|Lost to Follow-up|1|||
48600910|NCT00419757|156395978|FG000|Overall Study|Adverse Event|1|||
48600911|NCT00419757|156395979|FG001|Overall Study|Adverse Event|4|||
48726434|NCT00322153|156847973|FG001|Overall Study|Protocol Violation|14|||
48726435|NCT00322153|156847972|FG000|Overall Study|Withdrawal by Subject|18|||
48508859|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48508860|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48508861|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
48508862|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48508863|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
48508864|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
48508865|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
48508866|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
48508867|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48508868|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48508869|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48508870|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
48508871|NCT01940341|156056483|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
48508872|NCT01940341|156056484|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
48508873|NCT01940341|156056485|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
48508874|NCT01940341|156056486|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
48508875|NCT04078022|156056492|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
48508876|NCT04078022|156056493|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
48508877|NCT00251979|156056494|FG000|Overall Study|Protocol Violation|3|||
48508878|NCT00251979|156056495|FG001|Overall Study|Protocol Violation|5|||
48508879|NCT00251979|156056494|FG000|Overall Study|Adverse Event|11|||
48508880|NCT00251979|156056495|FG001|Overall Study|Adverse Event|17|||
48508881|NCT00251979|156056494|FG000|Overall Study|Withdrawal by Subject|13|||
48508882|NCT00251979|156056495|FG001|Overall Study|Withdrawal by Subject|7|||
48508883|NCT00251979|156056494|FG000|Overall Study|Lost to Follow-up|8|||
48508884|NCT00251979|156056495|FG001|Overall Study|Lost to Follow-up|6|||
48508885|NCT00251979|156056494|FG000|Overall Study|Death|3|||
48508886|NCT00251979|156056495|FG001|Overall Study|Death|5|||
48508887|NCT00840411|156056497|FG000|First Intervention|Adverse Event|1|||
48508888|NCT00840411|156056498|FG001|First Intervention|Adverse Event|0|||
48508889|NCT00840411|156056497|FG000|Washout|Withdrawal by Subject|1|||
48508890|NCT00840411|156056498|FG001|Washout|Withdrawal by Subject|0|||
48508891|NCT01921062|156056499|FG000|Overall Study|Withdrawal by Subject|0|||
48508892|NCT01921062|156056500|FG001|Overall Study|Withdrawal by Subject|7|||
48508893|NCT01921062|156056499|FG000|Overall Study|Adverse Event|5|||
48508894|NCT01921062|156056500|FG001|Overall Study|Adverse Event|6|||
48508895|NCT01921062|156056499|FG000|Overall Study|Protocol Violation|0|||
48508896|NCT01921062|156056500|FG001|Overall Study|Protocol Violation|1|||
48508897|NCT01921062|156056499|FG000|Overall Study|VMIQ score > 72|4|||
48508898|NCT01921062|156056500|FG001|Overall Study|VMIQ score > 72|1|||
48508899|NCT01921062|156056499|FG000|Overall Study|Logistic error|0|||
48508900|NCT01921062|156056500|FG001|Overall Study|Logistic error|1|||
48508901|NCT03686033|156056505|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
48508902|NCT03686033|156056506|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
48508903|NCT03686033|156056507|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
48508904|NCT03686033|156056508|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
48508905|NCT03686033|156056509|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
48508906|NCT03686033|156056510|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
48508907|NCT01045161|156056511|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
48508908|NCT01045161|156056512|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
48508909|NCT01045161|156056513|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
48508910|NCT01045161|156056511|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
48508911|NCT01045161|156056512|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
48508912|NCT01045161|156056513|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
48726436|NCT00322153|156847973|FG001|Overall Study|Withdrawal by Subject|10|||
48726437|NCT00322153|156847972|FG000|Overall Study|Lack of Efficacy|8|||
48508913|NCT01045161|156056511|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
48508914|NCT01045161|156056512|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
48508915|NCT01045161|156056513|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
48508916|NCT01045161|156056511|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
48508917|NCT01045161|156056512|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
48508918|NCT01045161|156056513|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
48600912|NCT00419757|156395978|FG000|Overall Study|Lost to Follow-up|1|||
48726438|NCT00322153|156847973|FG001|Overall Study|Lack of Efficacy|3|||
48508919|NCT01045161|156056511|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
48508920|NCT01045161|156056512|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
48508921|NCT01045161|156056513|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
48508922|NCT01045161|156056511|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
48508923|NCT01045161|156056512|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
48508924|NCT01045161|156056513|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
48508925|NCT01045161|156056511|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
48508926|NCT01045161|156056512|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
48508927|NCT01045161|156056513|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
48508928|NCT01045161|156056511|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
48508929|NCT01045161|156056512|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
48508930|NCT01045161|156056513|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
48508931|NCT01045161|156056511|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
48508932|NCT01045161|156056512|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
48508933|NCT01045161|156056513|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
48600913|NCT00419757|156395979|FG001|Overall Study|Lost to Follow-up|4|||
48600914|NCT00419757|156395978|FG000|Overall Study|Withdrawal by Subject|7|||
48600915|NCT00419757|156395979|FG001|Overall Study|Withdrawal by Subject|1|||
48600916|NCT00419757|156395978|FG000|Overall Study|Protocol Violation|2|||
48600917|NCT00419757|156395979|FG001|Overall Study|Protocol Violation|3|||
48600918|NCT00419757|156395978|FG000|Overall Study|Study specific discontinuation criteria|4|||
48600919|NCT00419757|156395979|FG001|Overall Study|Study specific discontinuation criteria|8|||
48600920|NCT00419757|156395978|FG000|Overall Study|Multiple reasons|3|||
48600921|NCT00419757|156395979|FG001|Overall Study|Multiple reasons|1|||
48600922|NCT00823264|156395982|FG000|Overall Study|Protocol Violation|2|||
48600923|NCT00823264|156395983|FG001|Overall Study|Protocol Violation|0|||
48600924|NCT01396083|156395984|FG000|Overall Study|Adverse Event|2|||
48600925|NCT01396083|156395985|FG001|Overall Study|Adverse Event|28|||
48821017|NCT03138512|157187332|FG001|Treatment Part B|Study drug toxicity|0|||
48821018|NCT03138512|157187333|FG002|Treatment Part B|Study drug toxicity|63|||
48381923|NCT02684279|155592868|FG000|Overall Study|subject to have surgery|1|||
48381924|NCT02684279|155592868|FG000|Overall Study|family emergency|1|||
48381925|NCT02684279|155592868|FG000|Overall Study|Site closures|7|||
48381926|NCT02684279|155592868|FG000|Overall Study|Physician Decision|1|||
48821019|NCT03138512|157187334|FG003|Treatment Part B|Study drug toxicity|3|||
48821020|NCT03138512|157187335|FG004|Treatment Part B|Study drug toxicity|45|||
48821021|NCT03138512|157187331|FG000|Treatment Part B|Death|0|||
48508934|NCT01045161|156056511|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
48508935|NCT01045161|156056512|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
48508936|NCT01045161|156056513|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
48508937|NCT01045161|156056511|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
48508938|NCT01045161|156056512|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
48508939|NCT01045161|156056513|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
48508940|NCT01045161|156056511|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
48508941|NCT01045161|156056512|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
48508942|NCT01045161|156056513|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
48508943|NCT01045161|156056511|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
48508944|NCT01045161|156056512|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
48508945|NCT01045161|156056513|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
48508946|NCT01045161|156056511|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
48508947|NCT01045161|156056512|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
48508948|NCT01045161|156056513|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
48508949|NCT01911676|156056516|FG000|Period 1 of Study|Withdrawal by Subject|4|||
48508950|NCT01911676|156056517|FG001|Period 1 of Study|Withdrawal by Subject|2|||
48508951|NCT01911676|156056518|FG002|Period 1 of Study|Withdrawal by Subject|1|||
48821022|NCT03138512|157187332|FG001|Treatment Part B|Death|0|||
48821023|NCT03138512|157187333|FG002|Treatment Part B|Death|1|||
48821024|NCT03138512|157187334|FG003|Treatment Part B|Death|0|||
48821025|NCT03138512|157187335|FG004|Treatment Part B|Death|0|||
48821026|NCT03138512|157187331|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
48821027|NCT03138512|157187332|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
48381927|NCT00458341|155592869|FG000|Cycle 1|Adverse Event|1|||
48508952|NCT01911676|156056519|FG003|Period 1 of Study|Withdrawal by Subject|2|||
48508953|NCT01911676|156056516|FG000|Period 1 of Study|Physician Decision|2|||
48508954|NCT01911676|156056517|FG001|Period 1 of Study|Physician Decision|0|||
48600926|NCT01396083|156395984|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48381928|NCT00458341|155592870|FG001|Cycle 1|Adverse Event|0|||
48381929|NCT01890148|155595008|FG000|Overall Study|Adverse Event|1|||
48381930|NCT02020863|155595009|FG000|Overall Study|Discovery of Metastatic disease|4|||
48600927|NCT01396083|156395985|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
48381931|NCT02020863|155595009|FG000|Overall Study|Team chose not to place an a line|1|||
48726439|NCT00322153|156847972|FG000|Overall Study|Lost to Follow-up|5|||
48726440|NCT00322153|156847973|FG001|Overall Study|Lost to Follow-up|4|||
48726441|NCT00322153|156847972|FG000|Overall Study|Withdrawn for other reasons|5|||
48726442|NCT00322153|156847973|FG001|Overall Study|Withdrawn for other reasons|4|||
48726443|NCT03091777|156847975|FG000|Overall Study|Pregnancy|2|||
48508955|NCT01911676|156056518|FG002|Period 1 of Study|Physician Decision|0|||
48508956|NCT01911676|156056519|FG003|Period 1 of Study|Physician Decision|1|||
48508957|NCT01911676|156056516|FG000|Period 2 of Study|Physician Decision|2|||
48508958|NCT01911676|156056517|FG001|Period 2 of Study|Physician Decision|0|||
48508959|NCT01911676|156056518|FG002|Period 2 of Study|Physician Decision|0|||
48508960|NCT01911676|156056519|FG003|Period 2 of Study|Physician Decision|1|||
48508961|NCT01911676|156056516|FG000|Period 2 of Study|Lost to Follow-up|0|||
48508962|NCT01911676|156056517|FG001|Period 2 of Study|Lost to Follow-up|0|||
48508963|NCT01911676|156056518|FG002|Period 2 of Study|Lost to Follow-up|0|||
48508964|NCT01911676|156056519|FG003|Period 2 of Study|Lost to Follow-up|1|||
48508965|NCT00773253|156056526|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
48508966|NCT00773253|156056527|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
48508967|NCT01348789|156056528|FG000|Overall Study|Protocol Violation|2|||
48508968|NCT01348789|156056528|FG000|Overall Study|Withdrawal by Subject|2|||
48726444|NCT03091777|156847976|FG001|Overall Study|Pregnancy|1|||
48726445|NCT03091777|156847977|FG002|Overall Study|Pregnancy|0|||
48726446|NCT03091777|156847975|FG000|Overall Study|Adverse Event|2|||
48726447|NCT03091777|156847976|FG001|Overall Study|Adverse Event|1|||
48726448|NCT03091777|156847977|FG002|Overall Study|Adverse Event|4|||
48508969|NCT01878292|156056529|FG000|Randomized|Protocol Violation|1|||
48508970|NCT01878292|156056530|FG001|Randomized|Protocol Violation|0|||
48508971|NCT01878292|156056531|FG002|Randomized|Protocol Violation|0|||
48508972|NCT01878292|156056529|FG000|Randomized|Lost to Follow-up|1|||
48508973|NCT01878292|156056530|FG001|Randomized|Lost to Follow-up|0|||
48508974|NCT01878292|156056531|FG002|Randomized|Lost to Follow-up|0|||
48508975|NCT01878292|156056529|FG000|Randomized|Adverse Event|1|||
48508976|NCT01878292|156056530|FG001|Randomized|Adverse Event|0|||
48508977|NCT01878292|156056531|FG002|Randomized|Adverse Event|0|||
48508978|NCT01878292|156056529|FG000|Double-blind Treatment Period|Other Reasons|2|||
48508979|NCT01878292|156056530|FG001|Double-blind Treatment Period|Other Reasons|0|||
48508980|NCT01878292|156056531|FG002|Double-blind Treatment Period|Other Reasons|0|||
48508981|NCT01878292|156056529|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
48508982|NCT01878292|156056530|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
48508983|NCT01878292|156056531|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
48508984|NCT01878292|156056529|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
48508985|NCT01878292|156056530|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
48508986|NCT01878292|156056531|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
48508987|NCT01878292|156056529|FG000|Double-blind Treatment Period|Protocol Violation|3|||
48508988|NCT01878292|156056530|FG001|Double-blind Treatment Period|Protocol Violation|4|||
48508989|NCT01878292|156056531|FG002|Double-blind Treatment Period|Protocol Violation|2|||
48508990|NCT01878292|156056529|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
48508991|NCT01878292|156056530|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
48508992|NCT01878292|156056531|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
48508993|NCT01878292|156056529|FG000|Double-blind Treatment Period|Adverse Event|4|||
48508994|NCT01878292|156056530|FG001|Double-blind Treatment Period|Adverse Event|9|||
48508995|NCT01878292|156056531|FG002|Double-blind Treatment Period|Adverse Event|8|||
48508996|NCT01878292|156056529|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
48508997|NCT01878292|156056530|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
48508998|NCT01878292|156056531|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
48508999|NCT03880266|156056532|FG000|Overall Study|Withdrawal by Subject|0|||
48509000|NCT03880266|156056533|FG001|Overall Study|Withdrawal by Subject|1|||
48509001|NCT03880266|156056534|FG002|Overall Study|Withdrawal by Subject|1|||
48509002|NCT03880266|156056535|FG003|Overall Study|Withdrawal by Subject|0|||
48509003|NCT03880266|156056536|FG004|Overall Study|Withdrawal by Subject|0|||
48509004|NCT03880266|156056537|FG005|Overall Study|Withdrawal by Subject|0|||
48509005|NCT03880266|156056538|FG006|Overall Study|Withdrawal by Subject|0|||
48509006|NCT03880266|156056539|FG007|Overall Study|Withdrawal by Subject|0|||
48509007|NCT01279486|156056540|FG000|Overall Study|Lost to Follow-up|1|||
48509008|NCT02178787|156056545|FG000|Overall Study|Lost to Follow-up|1|||
48509009|NCT02178787|156056546|FG001|Overall Study|Lost to Follow-up|0|||
48509010|NCT02178787|156056545|FG000|Overall Study|Withdrawal by Subject|0|||
48509011|NCT02178787|156056546|FG001|Overall Study|Withdrawal by Subject|2|||
48509012|NCT02178787|156056545|FG000|Overall Study|No TCD window|3|||
48509013|NCT02178787|156056546|FG001|Overall Study|No TCD window|7|||
48509014|NCT02178787|156056545|FG000|Overall Study|Physician Decision|1|||
48509015|NCT02178787|156056546|FG001|Overall Study|Physician Decision|0|||
48726449|NCT03091777|156847975|FG000|Overall Study|Withdrawal by Subject|4|||
48726450|NCT03091777|156847976|FG001|Overall Study|Withdrawal by Subject|2|||
48726451|NCT03091777|156847977|FG002|Overall Study|Withdrawal by Subject|6|||
48509016|NCT01577381|156056547|FG000|Overall Study|Discontinued|2|||
48509017|NCT01577381|156056548|FG001|Overall Study|Discontinued|1|||
48509018|NCT01577381|156056549|FG002|Overall Study|Discontinued|2|||
48509019|NCT01577381|156056550|FG003|Overall Study|Discontinued|2|||
48509020|NCT01577381|156056547|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
48509021|NCT01577381|156056548|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
48509022|NCT01577381|156056549|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
48509023|NCT01577381|156056550|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
48509024|NCT03235739|156058836|FG000|Overall Study|Withdrawal by Subject|2|||
48509025|NCT03235739|156058837|FG001|Overall Study|Withdrawal by Subject|2|||
48509026|NCT03235739|156058836|FG000|Overall Study|Physician Decision|0|||
48509027|NCT03235739|156058837|FG001|Overall Study|Physician Decision|1|||
48509028|NCT01066143|156058839|FG000|Overall Study|ineligible for the study|8|||
48509029|NCT00840632|156058840|FG000|First Intervention|Withdrawal by Subject|0|||
48509030|NCT00840632|156058841|FG001|First Intervention|Withdrawal by Subject|1|||
48509031|NCT00840632|156058840|FG000|Washout|Withdrawal by Subject|1|||
48509032|NCT00840632|156058841|FG001|Washout|Withdrawal by Subject|1|||
48509033|NCT00088829|156058842|FG000|Overall Study|PI left institution and study was close|22|||
48509034|NCT01370733|156058843|FG000|Overall Study|Withdrawal by Subject|8|||
48509035|NCT01370733|156058844|FG001|Overall Study|Withdrawal by Subject|8|||
48509036|NCT01370733|156058843|FG000|Overall Study|Lost to Follow-up|3|||
48509037|NCT01370733|156058844|FG001|Overall Study|Lost to Follow-up|0|||
48509038|NCT01370733|156058843|FG000|Overall Study|Adverse Event|2|||
48509039|NCT01370733|156058844|FG001|Overall Study|Adverse Event|4|||
48509040|NCT01370733|156058843|FG000|Overall Study|Lack of Efficacy|3|||
48509041|NCT01370733|156058844|FG001|Overall Study|Lack of Efficacy|5|||
48509042|NCT01370733|156058843|FG000|Overall Study|Physician Decision|0|||
48509043|NCT01370733|156058844|FG001|Overall Study|Physician Decision|2|||
48509044|NCT01370733|156058843|FG000|Overall Study|Protocol Violation|1|||
48509045|NCT01370733|156058844|FG001|Overall Study|Protocol Violation|3|||
48726452|NCT03091777|156847975|FG000|Overall Study|Protocol Violation|2|||
48726453|NCT03091777|156847976|FG001|Overall Study|Protocol Violation|1|||
48726454|NCT03091777|156847977|FG002|Overall Study|Protocol Violation|1|||
48726455|NCT03091777|156847975|FG000|Overall Study|Lost to Follow-up|12|||
48726456|NCT03091777|156847976|FG001|Overall Study|Lost to Follow-up|14|||
48726457|NCT03091777|156847977|FG002|Overall Study|Lost to Follow-up|7|||
48726458|NCT03091777|156847975|FG000|Overall Study|Lack of Efficacy|0|||
48726459|NCT03091777|156847976|FG001|Overall Study|Lack of Efficacy|0|||
48726460|NCT03091777|156847977|FG002|Overall Study|Lack of Efficacy|5|||
48726461|NCT03091777|156847975|FG000|Overall Study|Noncompliance with study drug|2|||
48726462|NCT03091777|156847976|FG001|Overall Study|Noncompliance with study drug|3|||
48509046|NCT00239577|156058846|FG000|Primary Phase|Adverse Event|0|||
48509047|NCT00239577|156058847|FG001|Primary Phase|Adverse Event|0|||
48509048|NCT00239577|156058848|FG002|Primary Phase|Adverse Event|1|||
48509049|NCT00239577|156058849|FG003|Primary Phase|Adverse Event|0|||
48509050|NCT00239577|156058846|FG000|Primary Phase|Other|5|||
48509051|NCT00239577|156058847|FG001|Primary Phase|Other|3|||
48509052|NCT00239577|156058848|FG002|Primary Phase|Other|2|||
48509053|NCT00239577|156058849|FG003|Primary Phase|Other|0|||
48509054|NCT03165994|156058856|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
48509055|NCT03165994|156058856|FG000|Overall Study|Death|2|||
48509056|NCT03165994|156058856|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
48509057|NCT03165994|156058856|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
48509058|NCT03165994|156058856|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
48509059|NCT03165994|156058856|FG000|Overall Study|Miscellaneous|1|||
48509060|NCT03988803|156058857|FG000|Period 2|Prematurely discontinued from medication|2|||
48509061|NCT03988803|156058857|FG000|Period 2|Adverse Event|1|||
48509062|NCT02736721|156058858|FG000|Overall Study|Adverse Event|8|||
48509063|NCT02736721|156058858|FG000|Overall Study|Lost to Follow-up|3|||
48509064|NCT02736721|156058858|FG000|Overall Study|Other|5|||
48509065|NCT02422264|156058859|FG000|Overall Study|Serious Adverse Event|1|||
48509066|NCT02422264|156058860|FG001|Overall Study|Serious Adverse Event|0|||
48509067|NCT02422264|156058859|FG000|Overall Study|Withdrawal by Subject|1|||
48509068|NCT02422264|156058860|FG001|Overall Study|Withdrawal by Subject|2|||
48509069|NCT02422264|156058859|FG000|Overall Study|Migrated/moved from study area|3|||
48509070|NCT02422264|156058860|FG001|Overall Study|Migrated/moved from study area|1|||
48509071|NCT02422264|156058859|FG000|Overall Study|Subject vaccinated outside of the study|0|||
48509072|NCT02422264|156058860|FG001|Overall Study|Subject vaccinated outside of the study|1|||
48509073|NCT03021018|156058862|FG000|Overall Study|Adverse Event|1|||
48509074|NCT03021018|156058863|FG001|Overall Study|Adverse Event|0|||
48726463|NCT03091777|156847977|FG002|Overall Study|Noncompliance with study drug|1|||
48600928|NCT01396083|156395984|FG000|Overall Study|Consent withdrawn|4|||
48600929|NCT01396083|156395985|FG001|Overall Study|Consent withdrawn|5|||
48600930|NCT01396083|156395984|FG000|Overall Study|Protocol deviation(s)|0|||
48600931|NCT01396083|156395985|FG001|Overall Study|Protocol deviation(s)|1|||
48600932|NCT01396083|156395984|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48600933|NCT01396083|156395985|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48726464|NCT03091777|156847975|FG000|Overall Study|Physician Decision|1|||
48726465|NCT03091777|156847976|FG001|Overall Study|Physician Decision|0|||
48821028|NCT03138512|157187333|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
48821029|NCT03138512|157187334|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
48821030|NCT03138512|157187335|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
48821031|NCT03138512|157187331|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
48821032|NCT03138512|157187332|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
48821033|NCT03138512|157187333|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
48821034|NCT03138512|157187334|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
48821035|NCT03138512|157187335|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
48726466|NCT03091777|156847977|FG002|Overall Study|Physician Decision|1|||
48726467|NCT03091777|156847975|FG000|Overall Study|Abnormal Laboratory Value|7|||
48726468|NCT03091777|156847976|FG001|Overall Study|Abnormal Laboratory Value|11|||
48726469|NCT03091777|156847977|FG002|Overall Study|Abnormal Laboratory Value|12|||
48726470|NCT03021564|156847978|FG000|Overall Study|Death|84|||
48726471|NCT03021564|156847979|FG001|Overall Study|Death|466|||
48726472|NCT03021564|156847978|FG000|Overall Study|Lost to Follow-up|0|||
48726473|NCT03021564|156847979|FG001|Overall Study|Lost to Follow-up|2|||
48726474|NCT02469038|156849775|FG000|Overall Study|Physician Decision|4|||
48726475|NCT02469038|156849776|FG001|Overall Study|Physician Decision|5|||
48726476|NCT01251146|156849779|FG000|Overall Study|Lost to Follow-up|3|||
48726477|NCT01251146|156849780|FG001|Overall Study|Lost to Follow-up|10|||
48726478|NCT00815516|156849781|FG000|Overall Study|Death|3|||
48726479|NCT00815516|156849782|FG001|Overall Study|Death|1|||
48726480|NCT00815516|156849781|FG000|Overall Study|Physician Decision|1|||
48726481|NCT00815516|156849782|FG001|Overall Study|Physician Decision|0|||
48726482|NCT03350984|156849783|FG000|Overall Study|Death|1|||
48726483|NCT03350984|156849784|FG001|Overall Study|Death|0|||
48726484|NCT03350984|156849783|FG000|Overall Study|Lost to Follow-up|5|||
48726485|NCT03350984|156849784|FG001|Overall Study|Lost to Follow-up|6|||
48726486|NCT03350984|156849783|FG000|Overall Study|Protocol Violation|1|||
48726487|NCT03350984|156849784|FG001|Overall Study|Protocol Violation|2|||
48726488|NCT03350984|156849783|FG000|Overall Study|Physician Decision|1|||
48726489|NCT03350984|156849784|FG001|Overall Study|Physician Decision|0|||
48726490|NCT02278471|156849793|FG000|Overall Study|Lost to Follow-up|6|||
48726491|NCT02278471|156849794|FG001|Overall Study|Lost to Follow-up|15|||
48726492|NCT02278471|156849793|FG000|Overall Study|Death|2|||
48726493|NCT02278471|156849794|FG001|Overall Study|Death|2|||
48726494|NCT02278471|156849793|FG000|Overall Study|Withdrawal by Subject|0|||
48726495|NCT02278471|156849794|FG001|Overall Study|Withdrawal by Subject|3|||
48726496|NCT00640835|156849795|FG000|Overall Study|Adverse Event|5|||
48726497|NCT00640835|156849796|FG001|Overall Study|Adverse Event|3|||
48726498|NCT00640835|156849795|FG000|Overall Study|Withdrawal by Subject|12|||
48726499|NCT00640835|156849796|FG001|Overall Study|Withdrawal by Subject|14|||
48726500|NCT00640835|156849795|FG000|Overall Study|Physician Decision|10|||
48726501|NCT00640835|156849796|FG001|Overall Study|Physician Decision|14|||
48726502|NCT00640835|156849795|FG000|Overall Study|Sponsor's Decision|11|||
48726503|NCT00640835|156849796|FG001|Overall Study|Sponsor's Decision|7|||
48726504|NCT00640835|156849795|FG000|Overall Study|Protocol Violation|2|||
48726505|NCT00640835|156849796|FG001|Overall Study|Protocol Violation|2|||
48726506|NCT00640835|156849795|FG000|Overall Study|Lost to Follow-up|17|||
48726507|NCT00640835|156849796|FG001|Overall Study|Lost to Follow-up|13|||
48726508|NCT00640835|156849795|FG000|Overall Study|Other Reason|19|||
48726509|NCT00640835|156849796|FG001|Overall Study|Other Reason|4|||
48726510|NCT01249118|156849797|FG000|First Washout Period|Physician Decision|0|||
48726511|NCT01249118|156849798|FG001|First Washout Period|Physician Decision|1|||
48726512|NCT01249118|156849799|FG002|First Washout Period|Physician Decision|0|||
48726513|NCT00997438|156849800|FG000|Overall Study|Blood draw difficulty|2|||
48726514|NCT00997438|156849801|FG001|Overall Study|Blood draw difficulty|0|||
48726515|NCT00997438|156849802|FG002|Overall Study|Blood draw difficulty|1|||
48726516|NCT00997438|156849800|FG000|Overall Study|Withdrawal by Subject|1|||
48726517|NCT00997438|156849801|FG001|Overall Study|Withdrawal by Subject|1|||
48726518|NCT00997438|156849802|FG002|Overall Study|Withdrawal by Subject|0|||
48726519|NCT00997438|156849800|FG000|Overall Study|Exclusion criteria at visit 1|2|||
48726520|NCT00997438|156849801|FG001|Overall Study|Exclusion criteria at visit 1|2|||
48726521|NCT00997438|156849802|FG002|Overall Study|Exclusion criteria at visit 1|3|||
48726522|NCT04618770|156849808|FG000|Overall Study|Censored from Analysis|12|||
48726523|NCT04618770|156849808|FG000|Overall Study|Early Termination|25|||
48726524|NCT02579928|156849809|FG000|Overall Study|Withdrawal by Subject|1|||
48726525|NCT02579928|156849810|FG001|Overall Study|Withdrawal by Subject|0|||
48726526|NCT00737464|156849811|FG000|Overall Study|Adverse Event|1|||
48726527|NCT00737464|156849811|FG000|Overall Study|Death|6|||
48726528|NCT00737464|156849811|FG000|Overall Study|Other - Failure to Return|1|||
48726529|NCT00737464|156849811|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
48726530|NCT00737464|156849811|FG000|Overall Study|Other reasons|4|||
48726531|NCT03410823|156849812|FG000|Overall Study|Death|1|||
48726532|NCT03410823|156849812|FG000|Overall Study|Withdrawal by Subject|2|||
48726533|NCT03410823|156849812|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
48726534|NCT00206076|156849818|FG000|Overall Study|Physician Decision|2|||
48726535|NCT00206076|156849819|FG001|Overall Study|Physician Decision|0|||
48726536|NCT00206076|156849818|FG000|Overall Study|Withdrawal by Subject|1|||
48726537|NCT00206076|156849819|FG001|Overall Study|Withdrawal by Subject|1|||
48726538|NCT00366340|156849820|FG000|Infant Series|Protocol Violation|3|||
48726539|NCT00366340|156849821|FG001|Infant Series|Protocol Violation|4|||
48726540|NCT00366340|156849820|FG000|Infant Series|Withdrawal by Subject|3|||
48726541|NCT00366340|156849821|FG001|Infant Series|Withdrawal by Subject|3|||
48726542|NCT00366340|156849820|FG000|Infant Series|Adverse Event|0|||
48726543|NCT00366340|156849821|FG001|Infant Series|Adverse Event|2|||
48726544|NCT00366340|156849820|FG000|Infant Series|Lost to Follow-up|1|||
48726545|NCT00366340|156849821|FG001|Infant Series|Lost to Follow-up|1|||
48726546|NCT00366340|156849820|FG000|Infant Series|Failure to return|1|||
48726547|NCT00366340|156849821|FG001|Infant Series|Failure to return|0|||
48726548|NCT00366340|156849820|FG000|After the Infant Series|Parent/legal guardian request|1|||
48726549|NCT00366340|156849821|FG001|After the Infant Series|Parent/legal guardian request|1|||
48726550|NCT00366340|156849820|FG000|After the Infant Series|Failed to return|0|||
48726551|NCT00366340|156849821|FG001|After the Infant Series|Failed to return|1|||
48726552|NCT00366340|156849820|FG000|After the Infant Series|Protocol Violation|2|||
48726553|NCT00366340|156849821|FG001|After the Infant Series|Protocol Violation|2|||
48726554|NCT00366340|156849820|FG000|After the Infant Series|Adverse Event|0|||
48726555|NCT00366340|156849821|FG001|After the Infant Series|Adverse Event|1|||
48726556|NCT00366340|156849820|FG000|After the Infant Series|Lost to Follow-up|0|||
48726557|NCT00366340|156849821|FG001|After the Infant Series|Lost to Follow-up|1|||
48726558|NCT00366340|156849820|FG000|Toddler Dose|Failed to return|1|||
48726559|NCT00366340|156849821|FG001|Toddler Dose|Failed to return|0|||
48726560|NCT00366340|156849820|FG000|Toddler Dose|Parent/legal guardian request|0|||
48726561|NCT00366340|156849821|FG001|Toddler Dose|Parent/legal guardian request|1|||
48726562|NCT00761150|156849822|FG000|Open-label Period|Adverse Event|36|||
48726563|NCT00761150|156849823|FG001|Open-label Period|Adverse Event|0|||
48726564|NCT00761150|156849824|FG002|Open-label Period|Adverse Event|0|||
48726565|NCT00761150|156849822|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
48726566|NCT00761150|156849823|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
48726567|NCT00761150|156849824|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
48726568|NCT00761150|156849822|FG000|Open-label Period|Lost to Follow-up|7|||
48726569|NCT00761150|156849823|FG001|Open-label Period|Lost to Follow-up|0|||
48726570|NCT00761150|156849824|FG002|Open-label Period|Lost to Follow-up|0|||
48726571|NCT00761150|156849822|FG000|Open-label Period|Lack of Efficacy|4|||
48726572|NCT00761150|156849823|FG001|Open-label Period|Lack of Efficacy|0|||
48726573|NCT00761150|156849824|FG002|Open-label Period|Lack of Efficacy|0|||
48726574|NCT00761150|156849822|FG000|Open-label Period|Withdrawal by Subject|5|||
48726575|NCT00761150|156849823|FG001|Open-label Period|Withdrawal by Subject|0|||
48726576|NCT00761150|156849824|FG002|Open-label Period|Withdrawal by Subject|0|||
48726577|NCT00761150|156849822|FG000|Open-label Period|Noncompliance|2|||
48726578|NCT00761150|156849823|FG001|Open-label Period|Noncompliance|0|||
48726579|NCT00761150|156849824|FG002|Open-label Period|Noncompliance|0|||
48726580|NCT00761150|156849822|FG000|Open-label Period|Other|5|||
48726581|NCT00761150|156849823|FG001|Open-label Period|Other|0|||
48821036|NCT03138512|157187331|FG000|Treatment Part B|Participant withdrew consent|0|||
48821037|NCT03138512|157187332|FG001|Treatment Part B|Participant withdrew consent|0|||
48726582|NCT00761150|156849824|FG002|Open-label Period|Other|0|||
48726583|NCT00761150|156849822|FG000|Double-blind Period|Lack of Efficacy|0|||
48726584|NCT00761150|156849823|FG001|Double-blind Period|Lack of Efficacy|2|||
48726585|NCT00761150|156849824|FG002|Double-blind Period|Lack of Efficacy|19|||
48726586|NCT00761150|156849822|FG000|Double-blind Period|Adverse Event|0|||
48726587|NCT00761150|156849823|FG001|Double-blind Period|Adverse Event|3|||
48821038|NCT03138512|157187333|FG002|Treatment Part B|Participant withdrew consent|1|||
48726588|NCT00761150|156849824|FG002|Double-blind Period|Adverse Event|3|||
48726589|NCT00761150|156849822|FG000|Double-blind Period|Withdrawal by Subject|0|||
48726590|NCT00761150|156849823|FG001|Double-blind Period|Withdrawal by Subject|3|||
48726591|NCT00761150|156849824|FG002|Double-blind Period|Withdrawal by Subject|2|||
48821039|NCT03138512|157187334|FG003|Treatment Part B|Participant withdrew consent|1|||
48726592|NCT00761150|156849822|FG000|Double-blind Period|Lost to Follow-up|0|||
48726593|NCT00761150|156849823|FG001|Double-blind Period|Lost to Follow-up|2|||
48726594|NCT00761150|156849824|FG002|Double-blind Period|Lost to Follow-up|1|||
48726595|NCT00761150|156849822|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
48726596|NCT00761150|156849823|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
48726597|NCT00761150|156849824|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
48726598|NCT00761150|156849822|FG000|Double-blind Period|Noncompliance|0|||
48726599|NCT00761150|156849823|FG001|Double-blind Period|Noncompliance|1|||
48726600|NCT00761150|156849824|FG002|Double-blind Period|Noncompliance|0|||
48726601|NCT00761150|156849822|FG000|Double-blind Period|Other|0|||
48726602|NCT00761150|156849823|FG001|Double-blind Period|Other|3|||
48726603|NCT00761150|156849824|FG002|Double-blind Period|Other|3|||
48726604|NCT03823378|156849825|FG000|Overall Study|Adverse Event|2|||
48821040|NCT03138512|157187335|FG004|Treatment Part B|Participant withdrew consent|2|||
48821041|NCT03138512|157187331|FG000|Treatment Part B|Lost to Follow-up|0|||
48509075|NCT03021018|156058864|FG002|Overall Study|Adverse Event|0|||
48509076|NCT03021018|156058862|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
48509077|NCT03021018|156058863|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
48509078|NCT03021018|156058864|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
48509079|NCT01404988|156058865|FG000|Overall Study|Death|2|||
48509080|NCT01404988|156058866|FG001|Overall Study|Death|0|||
48509081|NCT01404988|156058867|FG002|Overall Study|Death|2|||
48509082|NCT01404988|156058865|FG000|Overall Study|Adverse Event|1|||
48509083|NCT01404988|156058866|FG001|Overall Study|Adverse Event|0|||
48509084|NCT01404988|156058867|FG002|Overall Study|Adverse Event|0|||
48509085|NCT01404988|156058865|FG000|Overall Study|Withdrawal by Subject|2|||
48509086|NCT01404988|156058866|FG001|Overall Study|Withdrawal by Subject|2|||
48509087|NCT01404988|156058867|FG002|Overall Study|Withdrawal by Subject|0|||
48509088|NCT01404988|156058865|FG000|Overall Study|Lost to Follow-up|1|||
48509089|NCT01404988|156058866|FG001|Overall Study|Lost to Follow-up|2|||
48509090|NCT01404988|156058867|FG002|Overall Study|Lost to Follow-up|1|||
48509091|NCT03925532|156058868|FG000|Overall Study|Lost to Follow-up|1|||
48509092|NCT03194217|156058871|FG000|Overall Study|Adverse Event|0|||
48509093|NCT03194217|156058872|FG001|Overall Study|Adverse Event|2|||
48509094|NCT03194217|156058873|FG002|Overall Study|Adverse Event|3|||
48509095|NCT03194217|156058874|FG003|Overall Study|Adverse Event|3|||
48509096|NCT03194217|156058871|FG000|Overall Study|Failure to meet randomisation criteria|0|||
48509097|NCT03194217|156058872|FG001|Overall Study|Failure to meet randomisation criteria|0|||
48509098|NCT03194217|156058873|FG002|Overall Study|Failure to meet randomisation criteria|0|||
48509099|NCT03194217|156058874|FG003|Overall Study|Failure to meet randomisation criteria|1|||
48821042|NCT03138512|157187332|FG001|Treatment Part B|Lost to Follow-up|0|||
48821043|NCT03138512|157187333|FG002|Treatment Part B|Lost to Follow-up|0|||
48821044|NCT03138512|157187334|FG003|Treatment Part B|Lost to Follow-up|1|||
48821045|NCT03138512|157187335|FG004|Treatment Part B|Lost to Follow-up|0|||
48821046|NCT03138512|157187331|FG000|Treatment Part B|Poor/non-compliance|0|||
48821047|NCT03138512|157187332|FG001|Treatment Part B|Poor/non-compliance|0|||
48821048|NCT03138512|157187333|FG002|Treatment Part B|Poor/non-compliance|1|||
48821049|NCT03138512|157187334|FG003|Treatment Part B|Poor/non-compliance|1|||
48821050|NCT03138512|157187335|FG004|Treatment Part B|Poor/non-compliance|1|||
48821051|NCT03138512|157187331|FG000|Treatment Part B|Other reasons|0|||
48821052|NCT03138512|157187332|FG001|Treatment Part B|Other reasons|0|||
48821053|NCT03138512|157187333|FG002|Treatment Part B|Other reasons|3|||
48821054|NCT03138512|157187334|FG003|Treatment Part B|Other reasons|1|||
48821055|NCT03138512|157187335|FG004|Treatment Part B|Other reasons|5|||
48509100|NCT03194217|156058871|FG000|Overall Study|Other|0|||
48509101|NCT03194217|156058872|FG001|Overall Study|Other|1|||
48509102|NCT03194217|156058873|FG002|Overall Study|Other|1|||
48509103|NCT03194217|156058874|FG003|Overall Study|Other|0|||
48509104|NCT03874715|156058875|FG000|Overall Study|Adverse Event|2|||
48509105|NCT03874715|156058876|FG001|Overall Study|Adverse Event|0|||
48509106|NCT03874715|156058875|FG000|Overall Study|Poor compliance to protocol|5|||
48509107|NCT03874715|156058876|FG001|Overall Study|Poor compliance to protocol|1|||
48509108|NCT03874715|156058875|FG000|Overall Study|Withdrawal by Subject|1|||
48509109|NCT03874715|156058876|FG001|Overall Study|Withdrawal by Subject|0|||
48509110|NCT03874715|156058875|FG000|Overall Study|Other-unspecified|1|||
48509111|NCT03874715|156058876|FG001|Overall Study|Other-unspecified|0|||
48509112|NCT00934050|156058877|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
48726605|NCT03823378|156849826|FG001|Overall Study|Adverse Event|2|||
48821056|NCT02118714|157187336|FG000|Overall Study|Lost to Follow-up|2|||
48509113|NCT00934050|156058878|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
48509114|NCT00934050|156058879|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
48509115|NCT00934050|156058880|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
48509116|NCT00934050|156058881|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
48509117|NCT00934050|156058882|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
48509118|NCT00934050|156058877|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
48509119|NCT00934050|156058878|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
48509120|NCT00934050|156058879|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
48509121|NCT00934050|156058880|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
48821057|NCT02118714|157187336|FG000|Overall Study|Protocol Violation|1|||
48821058|NCT01004263|157187338|FG000|Overall Study|Adverse Event|15|||
48726606|NCT03823378|156849827|FG002|Overall Study|Adverse Event|0|||
48509122|NCT00934050|156058881|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
48509123|NCT00934050|156058882|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
48509124|NCT00934050|156058877|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
48509125|NCT00934050|156058878|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
48509126|NCT00934050|156058879|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
48509127|NCT00934050|156058880|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
48509128|NCT00934050|156058881|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
48509129|NCT00934050|156058882|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
48509130|NCT00934050|156058877|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
48509131|NCT00934050|156058878|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
48509132|NCT00934050|156058879|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
48509133|NCT00934050|156058880|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
48509134|NCT00934050|156058881|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
48509135|NCT00934050|156058882|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
48509136|NCT00934050|156058877|FG000|Enrolled After 15 Dec 2009|Death|0|||
48509137|NCT00934050|156058878|FG001|Enrolled After 15 Dec 2009|Death|0|||
48509138|NCT00934050|156058879|FG002|Enrolled After 15 Dec 2009|Death|0|||
48509139|NCT00934050|156058880|FG003|Enrolled After 15 Dec 2009|Death|0|||
48509140|NCT00934050|156058881|FG004|Enrolled After 15 Dec 2009|Death|0|||
48509141|NCT00934050|156058882|FG005|Enrolled After 15 Dec 2009|Death|1|||
48509142|NCT00934050|156058877|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
48509143|NCT00934050|156058878|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
48509144|NCT00934050|156058879|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
48509145|NCT00934050|156058880|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
48509146|NCT00934050|156058881|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
48509147|NCT00934050|156058882|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
48509148|NCT00934050|156058877|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
48509149|NCT00934050|156058878|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
48509150|NCT00934050|156058879|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
48509151|NCT00934050|156058880|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
48509152|NCT00934050|156058881|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
48509153|NCT00934050|156058882|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
48509154|NCT00723710|156058891|FG000|Overall Study|Disease progression|48|||
48509155|NCT00723710|156058891|FG000|Overall Study|Adverse Event|88|||
48509156|NCT00723710|156058891|FG000|Overall Study|Withdrawal by Subject|36|||
48509157|NCT00723710|156058891|FG000|Overall Study|Physician Decision|2|||
48509158|NCT01175018|156058892|FG000|Overall Study|Adverse Event|3|||
48509159|NCT01175018|156058893|FG001|Overall Study|Adverse Event|1|||
48509160|NCT02682784|156058894|FG000|Overall Study|Withdrawal by Subject|0|||
48509161|NCT02682784|156058895|FG001|Overall Study|Withdrawal by Subject|2|||
48509162|NCT02682784|156058896|FG002|Overall Study|Withdrawal by Subject|1|||
48509163|NCT02682784|156058897|FG003|Overall Study|Withdrawal by Subject|2|||
48726607|NCT03823378|156849828|FG003|Overall Study|Adverse Event|0|||
48509164|NCT02682784|156058894|FG000|Overall Study|Physician Decision|1|||
48509165|NCT02682784|156058895|FG001|Overall Study|Physician Decision|0|||
48509166|NCT02682784|156058896|FG002|Overall Study|Physician Decision|1|||
48509167|NCT02682784|156058897|FG003|Overall Study|Physician Decision|1|||
48509168|NCT00731783|156058898|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
48509169|NCT00731783|156058899|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
48509170|NCT00731783|156058898|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
48509171|NCT00731783|156058899|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
48509172|NCT00731783|156058898|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
48509173|NCT00731783|156058899|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
48509174|NCT00731783|156058898|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
48509175|NCT00731783|156058899|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
48509176|NCT00904215|156058903|FG000|Overall Study|Adverse Event|25|||
48509177|NCT00904215|156058903|FG000|Overall Study|Protocol Violation|10|||
48509178|NCT00904215|156058903|FG000|Overall Study|Lost to Follow-up|63|||
48600934|NCT01396083|156395984|FG000|Overall Study|Administrative problems|1|||
48600935|NCT01396083|156395985|FG001|Overall Study|Administrative problems|0|||
48600936|NCT01396083|156395984|FG000|Overall Study|Lost to Follow-up|1|||
48600937|NCT01396083|156395985|FG001|Overall Study|Lost to Follow-up|0|||
48600938|NCT00577772|156395986|FG000|Overall Study|Lost to Follow-up|0|||
48600939|NCT00577772|156395987|FG001|Overall Study|Lost to Follow-up|1|||
48600940|NCT01249417|156395989|FG000|Randomised Population|Study treatment not received|0|||
48600941|NCT01249417|156395990|FG001|Randomised Population|Study treatment not received|0|||
48600942|NCT01249417|156395991|FG002|Randomised Population|Study treatment not received|2|||
48600943|NCT01249417|156395989|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
48509179|NCT00904215|156058903|FG000|Overall Study|Withdrawal by Subject|9|||
48600944|NCT01249417|156395990|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
48509180|NCT00904215|156058903|FG000|Overall Study|Other|28|||
48509181|NCT03663179|156058910|FG000|Overall Study|Withdrawal by Subject|2|||
48509182|NCT03663179|156058911|FG001|Overall Study|Withdrawal by Subject|0|||
48726608|NCT03823378|156849829|FG004|Overall Study|Adverse Event|0|||
48509183|NCT03663179|156058910|FG000|Overall Study|Lost to Follow-up|1|||
48509184|NCT03663179|156058911|FG001|Overall Study|Lost to Follow-up|1|||
48509185|NCT03663179|156058910|FG000|Overall Study|Revealed exclusionary condition|1|||
48509186|NCT03663179|156058911|FG001|Overall Study|Revealed exclusionary condition|0|||
48726609|NCT03823378|156849830|FG005|Overall Study|Adverse Event|0|||
48726610|NCT03823378|156849825|FG000|Overall Study|Lost to Follow-up|0|||
48726611|NCT03823378|156849826|FG001|Overall Study|Lost to Follow-up|1|||
48726612|NCT03823378|156849827|FG002|Overall Study|Lost to Follow-up|0|||
48726613|NCT03823378|156849828|FG003|Overall Study|Lost to Follow-up|0|||
48726614|NCT03823378|156849829|FG004|Overall Study|Lost to Follow-up|1|||
48726615|NCT03823378|156849830|FG005|Overall Study|Lost to Follow-up|0|||
48726616|NCT03823378|156849825|FG000|Overall Study|Withdrawal by Subject|0|||
48726617|NCT03823378|156849826|FG001|Overall Study|Withdrawal by Subject|1|||
48726618|NCT03823378|156849827|FG002|Overall Study|Withdrawal by Subject|4|||
48726619|NCT03823378|156849828|FG003|Overall Study|Withdrawal by Subject|2|||
48726620|NCT03823378|156849829|FG004|Overall Study|Withdrawal by Subject|0|||
48726621|NCT03823378|156849830|FG005|Overall Study|Withdrawal by Subject|1|||
48726622|NCT03823378|156849825|FG000|Overall Study|Other, not specified|19|||
48726623|NCT03823378|156849826|FG001|Overall Study|Other, not specified|12|||
48726624|NCT03823378|156849827|FG002|Overall Study|Other, not specified|6|||
48726625|NCT03823378|156849828|FG003|Overall Study|Other, not specified|8|||
48726626|NCT03823378|156849829|FG004|Overall Study|Other, not specified|17|||
48726627|NCT03823378|156849830|FG005|Overall Study|Other, not specified|7|||
48726628|NCT02497976|156849831|FG000|Overall Study|Withdrawal by Subject|2|||
48726629|NCT02497976|156849832|FG001|Overall Study|Withdrawal by Subject|0|||
48726630|NCT02497976|156849831|FG000|Overall Study|Moved out of area|0|||
48726631|NCT02497976|156849832|FG001|Overall Study|Moved out of area|1|||
48726632|NCT05442775|156849833|FG000|Overall Study|Trial terminated|61|||
48726633|NCT05442775|156849833|FG000|Overall Study|Lack of Efficacy|4|||
48726634|NCT05442775|156849833|FG000|Overall Study|Withdrawal by Subject|4|||
48726635|NCT05442775|156849833|FG000|Overall Study|Death|1|||
48726636|NCT05442775|156849833|FG000|Overall Study|Participant removed at Sponsor request|1|||
48726637|NCT00058539|156849834|FG000|Overall Study|Disease progression|24|||
48726638|NCT00058539|156849834|FG000|Overall Study|Adverse Event|3|||
48726639|NCT00058539|156849834|FG000|Overall Study|Withdrawal by Subject|5|||
48726640|NCT00058539|156849834|FG000|Overall Study|Physician Decision|9|||
48726641|NCT00058539|156849834|FG000|Overall Study|Death|1|||
48726642|NCT00930982|156849840|FG000|Overall Study|Adverse Event|19|||
48726643|NCT00930982|156849841|FG001|Overall Study|Adverse Event|23|||
48726644|NCT00930982|156849840|FG000|Overall Study|Protocol Violation|1|||
48726645|NCT00930982|156849841|FG001|Overall Study|Protocol Violation|5|||
48726646|NCT00930982|156849840|FG000|Overall Study|Withdrawal by Subject|1|||
48726647|NCT00930982|156849841|FG001|Overall Study|Withdrawal by Subject|1|||
48726648|NCT02093026|156849842|FG000|Overall Study|Adverse Event|26|||
48726649|NCT02093026|156849842|FG000|Overall Study|Death|10|||
48726650|NCT02093026|156849842|FG000|Overall Study|Other|157|||
48726651|NCT02483533|156849843|FG000|Overall Study|Lack of Efficacy|50|||
48726652|NCT02483533|156849844|FG001|Overall Study|Lack of Efficacy|50|||
48726653|NCT01565499|156849847|FG000|Overall Study|Physician Decision|1|||
48726654|NCT01565499|156849847|FG000|Overall Study|Adverse Event|5|||
48726655|NCT01565499|156849847|FG000|Overall Study|Withdrawal by Subject|2|||
48726656|NCT01923168|156849851|FG000|Overall Study|Protocol Violation|1|||
48726657|NCT01923168|156849852|FG001|Overall Study|Protocol Violation|1|||
48726658|NCT01923168|156849853|FG002|Overall Study|Protocol Violation|0|||
48726659|NCT01923168|156849851|FG000|Overall Study|Subject/guardian decision|14|||
48509187|NCT00796653|156058917|FG000|Overall Study|Adverse Event|19|||
48509188|NCT00796653|156058918|FG001|Overall Study|Adverse Event|16|||
48509189|NCT00796653|156058919|FG002|Overall Study|Adverse Event|16|||
48600945|NCT01249417|156395991|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
48726660|NCT01923168|156849852|FG001|Overall Study|Subject/guardian decision|14|||
48509190|NCT00796653|156058920|FG003|Overall Study|Adverse Event|16|||
48726661|NCT01923168|156849853|FG002|Overall Study|Subject/guardian decision|4|||
48726662|NCT01923168|156849851|FG000|Overall Study|Adverse Event|12|||
48726663|NCT01923168|156849852|FG001|Overall Study|Adverse Event|12|||
48726664|NCT01923168|156849853|FG002|Overall Study|Adverse Event|0|||
48726665|NCT01923168|156849851|FG000|Overall Study|Physician Decision|6|||
48726666|NCT01923168|156849852|FG001|Overall Study|Physician Decision|9|||
48726667|NCT01923168|156849853|FG002|Overall Study|Physician Decision|5|||
48726668|NCT01923168|156849851|FG000|Overall Study|Progressive disease|4|||
48726669|NCT01923168|156849852|FG001|Overall Study|Progressive disease|3|||
48726670|NCT01923168|156849853|FG002|Overall Study|Progressive disease|7|||
48726671|NCT01923168|156849851|FG000|Overall Study|Death|0|||
48726672|NCT01923168|156849852|FG001|Overall Study|Death|0|||
48726673|NCT01923168|156849853|FG002|Overall Study|Death|1|||
48726674|NCT01466595|156849854|FG000|Overall Study|Withdrawal by Subject|0|||
48726675|NCT01466595|156849855|FG001|Overall Study|Withdrawal by Subject|1|||
48726676|NCT00450112|156849858|FG000|Overall Study|Other Treatment Required|5|||
48726677|NCT00450112|156849859|FG001|Overall Study|Other Treatment Required|1|||
48726678|NCT00450112|156849858|FG000|Overall Study|Withdrawal by Subject|4|||
48726679|NCT00450112|156849859|FG001|Overall Study|Withdrawal by Subject|1|||
48726680|NCT00450112|156849858|FG000|Overall Study|Lost to Follow-up|2|||
48726681|NCT00450112|156849859|FG001|Overall Study|Lost to Follow-up|1|||
48726682|NCT00450112|156849858|FG000|Overall Study|Others|2|||
48726683|NCT00450112|156849859|FG001|Overall Study|Others|3|||
48726684|NCT03418571|156849860|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
48726685|NCT03418571|156849861|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
48726686|NCT01255787|156849865|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
48726687|NCT01255787|156849866|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
48726688|NCT01255787|156849867|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
48726689|NCT01255787|156849868|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
48726690|NCT01255787|156849865|FG000|Overall Study|Major Protocol Deviation|1|||
48726691|NCT01255787|156849866|FG001|Overall Study|Major Protocol Deviation|1|||
48726692|NCT01255787|156849867|FG002|Overall Study|Major Protocol Deviation|0|||
48726693|NCT01255787|156849868|FG003|Overall Study|Major Protocol Deviation|4|||
48726694|NCT01255787|156849865|FG000|Overall Study|Lost to Follow-up|1|||
48726695|NCT01255787|156849866|FG001|Overall Study|Lost to Follow-up|2|||
48726696|NCT01255787|156849867|FG002|Overall Study|Lost to Follow-up|4|||
48726697|NCT01255787|156849868|FG003|Overall Study|Lost to Follow-up|2|||
48726698|NCT01255787|156849865|FG000|Overall Study|Withdrawal of Consent|3|||
48726699|NCT01255787|156849866|FG001|Overall Study|Withdrawal of Consent|9|||
48726700|NCT01255787|156849867|FG002|Overall Study|Withdrawal of Consent|3|||
48726701|NCT01255787|156849868|FG003|Overall Study|Withdrawal of Consent|4|||
48726702|NCT01255787|156849865|FG000|Overall Study|Pregnancy|0|||
48726703|NCT01255787|156849866|FG001|Overall Study|Pregnancy|0|||
48726704|NCT01255787|156849867|FG002|Overall Study|Pregnancy|0|||
48726705|NCT01255787|156849868|FG003|Overall Study|Pregnancy|1|||
48726706|NCT01255787|156849865|FG000|Overall Study|Lack of Efficacy|2|||
48726707|NCT01255787|156849866|FG001|Overall Study|Lack of Efficacy|2|||
48726708|NCT01255787|156849867|FG002|Overall Study|Lack of Efficacy|2|||
48726709|NCT01255787|156849868|FG003|Overall Study|Lack of Efficacy|2|||
48726710|NCT01255787|156849865|FG000|Overall Study|Noncompliance with Study Drug|3|||
48726711|NCT01255787|156849866|FG001|Overall Study|Noncompliance with Study Drug|1|||
48726712|NCT01255787|156849867|FG002|Overall Study|Noncompliance with Study Drug|0|||
48726713|NCT01255787|156849868|FG003|Overall Study|Noncompliance with Study Drug|0|||
48726714|NCT00214500|156849869|FG000|Treatment Period|Adverse Event|1|||
48726715|NCT00214500|156849869|FG000|Extension Period|Withdrawal by Subject|2|||
48726716|NCT00476047|156849870|FG000|Overall Study|Lost to Follow-up|1|||
48726717|NCT01056380|156849871|FG000|Overall Study|Lost to Follow-up|2|||
48726718|NCT01056380|156849872|FG001|Overall Study|Lost to Follow-up|3|||
48726719|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
48726720|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
48726721|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
48726722|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
48726723|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
48726724|NCT00586326|156849873|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
48726725|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
48726726|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
48726727|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
48726728|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
48726729|NCT00586326|156849873|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
48726730|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
48509191|NCT00796653|156058917|FG000|Overall Study|Lost to Follow-up|2|||
48509192|NCT00796653|156058918|FG001|Overall Study|Lost to Follow-up|1|||
48726731|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
48726732|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
48726733|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
48726734|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
48726735|NCT00586326|156849873|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
48726736|NCT00542451|156849874|FG000|Overall Study|Adverse Event|31|||
48726737|NCT00542451|156849874|FG000|Overall Study|Withdrawal by Subject|30|||
48726738|NCT00542451|156849874|FG000|Overall Study|Physician Decision|4|||
48726739|NCT00542451|156849874|FG000|Overall Study|Recurrent disease|1|||
48381932|NCT01215175|155595010|FG000|Overall Study|Lost to Follow-up|0|||
48509193|NCT00796653|156058919|FG002|Overall Study|Lost to Follow-up|2|||
48726740|NCT00542451|156849874|FG000|Overall Study|unknown reason|1|||
48726741|NCT00542451|156849874|FG000|Overall Study|Death|2|||
48726742|NCT00542451|156849874|FG000|Overall Study|Lost to Follow-up|10|||
48726743|NCT05342532|156849876|FG000|Overall Study|Adverse Event|5|||
48726744|NCT05342532|156849877|FG001|Overall Study|Adverse Event|20|||
48726745|NCT05342532|156849876|FG000|Overall Study|Lost to Follow-up|10|||
48726746|NCT05342532|156849877|FG001|Overall Study|Lost to Follow-up|15|||
48726747|NCT02652767|156849879|FG000|Overall Study|Death|2|||
48726748|NCT02652767|156849879|FG000|Overall Study|Lost to Follow-up|1|||
48726749|NCT02652767|156849879|FG000|Overall Study|Withdrawal by Subject|1|||
48726750|NCT02220998|156849880|FG000|Overall Study|Randomized but Never Treated|1|||
48726751|NCT02220998|156849881|FG001|Overall Study|Randomized but Never Treated|2|||
48726752|NCT02220998|156849880|FG000|Overall Study|Death|2|||
48726753|NCT02220998|156849881|FG001|Overall Study|Death|0|||
48726754|NCT02220998|156849880|FG000|Overall Study|Lack of Efficacy|0|||
48726755|NCT02220998|156849881|FG001|Overall Study|Lack of Efficacy|5|||
48726756|NCT02220998|156849880|FG000|Overall Study|Lost to Follow-up|4|||
48726757|NCT02220998|156849881|FG001|Overall Study|Lost to Follow-up|4|||
48726758|NCT02764190|156849882|FG000|Overall Study|Lost to Follow-up|17|||
48509194|NCT00796653|156058920|FG003|Overall Study|Lost to Follow-up|3|||
48509195|NCT00796653|156058917|FG000|Overall Study|Withdrawal by Subject|16|||
48509196|NCT00796653|156058918|FG001|Overall Study|Withdrawal by Subject|8|||
48509197|NCT00796653|156058919|FG002|Overall Study|Withdrawal by Subject|8|||
48509198|NCT00796653|156058920|FG003|Overall Study|Withdrawal by Subject|13|||
48509199|NCT00796653|156058917|FG000|Overall Study|Lack of Efficacy|8|||
48726759|NCT02764190|156849883|FG001|Overall Study|Lost to Follow-up|13|||
48726760|NCT01233687|156849884|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
48726761|NCT01233687|156849884|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
48726762|NCT01233687|156849884|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
48726763|NCT00938964|156849889|FG000|Overall Study|Death|3|||
48821059|NCT01004263|157187338|FG000|Overall Study|Withdrawal by Subject|58|||
48821060|NCT01004263|157187338|FG000|Overall Study|Protocol Violation|10|||
48821061|NCT01004263|157187338|FG000|Overall Study|Lost to Follow-up|64|||
48821062|NCT01004263|157187338|FG000|Overall Study|Lack of Efficacy|13|||
48821063|NCT01004263|157187338|FG000|Overall Study|Pregnancy|2|||
48821064|NCT01004263|157187338|FG000|Overall Study|Physician Decision|15|||
48821065|NCT01004263|157187338|FG000|Overall Study|Lack of Qualifying Event|2|||
48821066|NCT04545619|157187341|FG000|Overall Study|due to equipment challenges|1|||
48821067|NCT02013687|157187342|FG000|Overall Study|Lost to Follow-up|0|||
48821068|NCT02013687|157187343|FG001|Overall Study|Lost to Follow-up|0|||
48821069|NCT02013687|157187344|FG002|Overall Study|Lost to Follow-up|1|||
48821070|NCT02013687|157187345|FG003|Overall Study|Lost to Follow-up|0|||
48821071|NCT02013687|157187342|FG000|Overall Study|Protocol Violation|0|||
48821072|NCT02013687|157187343|FG001|Overall Study|Protocol Violation|0|||
48821073|NCT02013687|157187344|FG002|Overall Study|Protocol Violation|0|||
48381933|NCT01215175|155595011|FG001|Overall Study|Lost to Follow-up|1|||
48509200|NCT00796653|156058918|FG001|Overall Study|Lack of Efficacy|1|||
48509201|NCT00796653|156058919|FG002|Overall Study|Lack of Efficacy|3|||
48509202|NCT00796653|156058920|FG003|Overall Study|Lack of Efficacy|2|||
48509203|NCT00796653|156058917|FG000|Overall Study|Non compliance with protocol|2|||
48509204|NCT00796653|156058918|FG001|Overall Study|Non compliance with protocol|2|||
48509205|NCT00796653|156058919|FG002|Overall Study|Non compliance with protocol|0|||
48509206|NCT00796653|156058920|FG003|Overall Study|Non compliance with protocol|2|||
48509207|NCT00796653|156058917|FG000|Overall Study|Other reason not described above|4|||
48509208|NCT00796653|156058918|FG001|Overall Study|Other reason not described above|9|||
48509209|NCT00796653|156058919|FG002|Overall Study|Other reason not described above|7|||
48509210|NCT00796653|156058920|FG003|Overall Study|Other reason not described above|4|||
48509211|NCT01848938|156058923|FG000|Overall Study|Lost to Follow-up|1|||
48509212|NCT01848938|156058924|FG001|Overall Study|Lost to Follow-up|1|||
48509213|NCT02601560|156058925|FG000|Overall Study|Other|0|||
48509214|NCT02601560|156058926|FG001|Overall Study|Other|0|||
48509215|NCT02601560|156058927|FG002|Overall Study|Other|0|||
48509216|NCT02601560|156058928|FG003|Overall Study|Other|0|||
48509217|NCT02601560|156058929|FG004|Overall Study|Other|0|||
48509218|NCT02601560|156058930|FG005|Overall Study|Other|0|||
48509219|NCT02601560|156058931|FG006|Overall Study|Other|1|||
48509220|NCT02601560|156058932|FG007|Overall Study|Other|0|||
48509221|NCT01250912|156058935|FG000|Overall Study|Lost to Follow-up|1|||
48509222|NCT01218867|156058940|FG000|Overall Study|Death during treatment|0|||
48509223|NCT01218867|156058941|FG001|Overall Study|Death during treatment|0|||
48509224|NCT01218867|156058942|FG002|Overall Study|Death during treatment|0|||
48509225|NCT01218867|156058943|FG003|Overall Study|Death during treatment|0|||
48509226|NCT01218867|156058944|FG004|Overall Study|Death during treatment|0|||
48509227|NCT01218867|156058945|FG005|Overall Study|Death during treatment|0|||
48509228|NCT01218867|156058946|FG006|Overall Study|Death during treatment|1|||
48726764|NCT00938964|156849890|FG001|Overall Study|Death|3|||
48726765|NCT00938964|156849889|FG000|Overall Study|Lost to Follow-up|2|||
48726766|NCT00938964|156849890|FG001|Overall Study|Lost to Follow-up|3|||
48726767|NCT00938964|156849889|FG000|Overall Study|Withdrawal by Subject|22|||
48726768|NCT00938964|156849890|FG001|Overall Study|Withdrawal by Subject|18|||
48726769|NCT00938964|156849889|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
48821074|NCT02013687|157187345|FG003|Overall Study|Protocol Violation|1|||
48821075|NCT02013687|157187342|FG000|Overall Study|Withdrawal by Subject|0|||
48821076|NCT02013687|157187343|FG001|Overall Study|Withdrawal by Subject|0|||
48509229|NCT01218867|156058947|FG007|Overall Study|Death during treatment|0|||
48509230|NCT01218867|156058948|FG008|Overall Study|Death during treatment|0|||
48509231|NCT01218867|156058949|FG009|Overall Study|Death during treatment|0|||
48509232|NCT01218867|156058950|FG010|Overall Study|Death during treatment|0|||
48509233|NCT03792477|156058952|FG000|Overall Study|Adverse Event|0|||
48509234|NCT03792477|156058953|FG001|Overall Study|Adverse Event|0|||
48509235|NCT03792477|156058954|FG002|Overall Study|Adverse Event|0|||
48509236|NCT03792477|156058955|FG003|Overall Study|Adverse Event|1|||
48509237|NCT03792477|156058956|FG004|Overall Study|Adverse Event|0|||
48509238|NCT03792477|156058952|FG000|Overall Study|Lost to Follow-up|0|||
48509239|NCT03792477|156058953|FG001|Overall Study|Lost to Follow-up|0|||
48509240|NCT03792477|156058954|FG002|Overall Study|Lost to Follow-up|2|||
48509241|NCT03792477|156058955|FG003|Overall Study|Lost to Follow-up|0|||
48509242|NCT03792477|156058956|FG004|Overall Study|Lost to Follow-up|0|||
48509243|NCT03792477|156058952|FG000|Overall Study|Other|0|||
48509244|NCT03792477|156058953|FG001|Overall Study|Other|0|||
48509245|NCT03792477|156058954|FG002|Overall Study|Other|0|||
48509246|NCT03792477|156058955|FG003|Overall Study|Other|0|||
48509247|NCT03792477|156058956|FG004|Overall Study|Other|1|||
48509248|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
48509249|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
48509250|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
48509251|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
48509252|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
48509253|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
48509254|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
48509255|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
48509256|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
48509257|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
48509258|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
48509259|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
48509260|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
48509261|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
48509262|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
48509263|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
48509264|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
48509265|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
48509266|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
48509267|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
48509268|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
48509269|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
48509270|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
48509271|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
48509272|NCT00073307|156058958|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
48509273|NCT00073307|156058959|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
48509274|NCT00073307|156058960|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
48509275|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
48509276|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
48509277|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
48509278|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
48509279|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
48509280|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
48509281|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
48509282|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
48509283|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
48509284|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
48381934|NCT01215175|155595012|FG002|Overall Study|Lost to Follow-up|0|||
48381935|NCT01215175|155595013|FG003|Overall Study|Lost to Follow-up|1|||
48381936|NCT01215175|155595014|FG004|Overall Study|Lost to Follow-up|0|||
48381937|NCT01016964|155595015|FG000|Overall Study|Lost to Follow-up|3|||
48381938|NCT01016964|155595016|FG001|Overall Study|Lost to Follow-up|3|||
48381939|NCT03872453|155595017|FG000|Overall Study|Adverse Event|1|||
48381940|NCT03872453|155595018|FG001|Overall Study|Adverse Event|1|||
48381941|NCT03872453|155595019|FG002|Overall Study|Adverse Event|0|||
48381942|NCT03872453|155595020|FG003|Overall Study|Adverse Event|0|||
48381943|NCT03872453|155595017|FG000|Overall Study|Lost to Follow-up|8|||
48381944|NCT03872453|155595018|FG001|Overall Study|Lost to Follow-up|7|||
48381945|NCT03872453|155595019|FG002|Overall Study|Lost to Follow-up|4|||
48381946|NCT03872453|155595020|FG003|Overall Study|Lost to Follow-up|4|||
48726770|NCT00938964|156849890|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
48726771|NCT02862600|156849894|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
48726772|NCT02862600|156849894|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
48726773|NCT02862600|156849894|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
48726774|NCT02862600|156849894|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
48726775|NCT00570232|156849908|FG000|Overall Study|Adverse Event|10|||
48726776|NCT00570232|156849908|FG000|Overall Study|discontinued due to medical condition|3|||
48726777|NCT00570232|156849908|FG000|Overall Study|discontinued due to recurrence|8|||
48726778|NCT00570232|156849908|FG000|Overall Study|discontinued due to noncompliance|2|||
48726779|NCT01076075|156849909|FG000|Overall Study|Adverse Event|3|||
48726780|NCT01076075|156849910|FG001|Overall Study|Adverse Event|9|||
48726781|NCT01076075|156849909|FG000|Overall Study|Lack of Efficacy|5|||
48726782|NCT01076075|156849910|FG001|Overall Study|Lack of Efficacy|4|||
48726783|NCT01076075|156849909|FG000|Overall Study|Lost to Follow-up|6|||
48726784|NCT01076075|156849910|FG001|Overall Study|Lost to Follow-up|5|||
48381947|NCT03872453|155595017|FG000|Overall Study|Never Treated Migraine|19|||
48726785|NCT01076075|156849909|FG000|Overall Study|other|19|||
48509285|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
48509286|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
48509287|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
48509288|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
48509289|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
48509290|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
48509291|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
48509292|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
48509293|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
48509294|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
48509295|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
48509296|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
48509297|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
48509298|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
48509299|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
48509300|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
48509301|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
48509302|NCT00073307|156058958|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
48509303|NCT00073307|156058959|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
48509304|NCT00073307|156058960|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
48509305|NCT03606408|156058964|FG000|Overall Study|Adverse Event|13|||
48509306|NCT03606408|156058964|FG000|Overall Study|Withdrawal by Subject|7|||
48509307|NCT03606408|156058964|FG000|Overall Study|Physician Decision|4|||
48509308|NCT03606408|156058964|FG000|Overall Study|Lack of Efficacy|2|||
48509309|NCT03606408|156058964|FG000|Overall Study|Death|1|||
48509310|NCT03606408|156058964|FG000|Overall Study|new therapy for study indication|1|||
48509311|NCT01494532|156058966|FG000|Overall Study|Adverse Event|4|||
48509312|NCT01494532|156058967|FG001|Overall Study|Adverse Event|1|||
48509313|NCT01494532|156058968|FG002|Overall Study|Adverse Event|8|||
48509314|NCT01494532|156058969|FG003|Overall Study|Adverse Event|6|||
48509315|NCT01494532|156058970|FG004|Overall Study|Adverse Event|5|||
48509316|NCT01494532|156058971|FG005|Overall Study|Adverse Event|0|||
48509317|NCT01494532|156058966|FG000|Overall Study|Lack of Efficacy|0|||
48509318|NCT01494532|156058967|FG001|Overall Study|Lack of Efficacy|0|||
48509319|NCT01494532|156058968|FG002|Overall Study|Lack of Efficacy|0|||
48509320|NCT01494532|156058969|FG003|Overall Study|Lack of Efficacy|0|||
48509321|NCT01494532|156058970|FG004|Overall Study|Lack of Efficacy|2|||
48509322|NCT01494532|156058971|FG005|Overall Study|Lack of Efficacy|0|||
48509323|NCT01494532|156058966|FG000|Overall Study|Protocol deviation|2|||
48509324|NCT01494532|156058967|FG001|Overall Study|Protocol deviation|1|||
48509325|NCT01494532|156058968|FG002|Overall Study|Protocol deviation|3|||
48726786|NCT01076075|156849910|FG001|Overall Study|other|9|||
48726787|NCT01076075|156849909|FG000|Overall Study|Protocol Violation|0|||
48726788|NCT01076075|156849910|FG001|Overall Study|Protocol Violation|1|||
48509326|NCT01494532|156058969|FG003|Overall Study|Protocol deviation|2|||
48509327|NCT01494532|156058970|FG004|Overall Study|Protocol deviation|3|||
48509328|NCT01494532|156058971|FG005|Overall Study|Protocol deviation|0|||
48509329|NCT01494532|156058966|FG000|Overall Study|Protocol-defined stopping criteria|0|||
48509330|NCT01494532|156058967|FG001|Overall Study|Protocol-defined stopping criteria|0|||
48509331|NCT01494532|156058968|FG002|Overall Study|Protocol-defined stopping criteria|1|||
48726789|NCT01076075|156849909|FG000|Overall Study|Withdrawal by Subject|8|||
48726790|NCT01076075|156849910|FG001|Overall Study|Withdrawal by Subject|19|||
48726791|NCT01285960|156849911|FG000|Overall Study|Withdrawal by Subject|2|||
48726792|NCT01285960|156849911|FG000|Overall Study|Lost to Follow-up|2|||
48726793|NCT01285960|156849911|FG000|Overall Study|2 subjects received less 10 sonications|2|||
48726794|NCT00667420|156849913|FG000|Overall Study|Adverse Event|2|||
48726795|NCT00667420|156849913|FG000|Overall Study|Lack of Efficacy|5|||
48726796|NCT00667420|156849913|FG000|Overall Study|Physician Decision|1|||
48726797|NCT00667420|156849913|FG000|Overall Study|Withdrawal by Subject|2|||
48726798|NCT03194490|156849920|FG000|Overall Study|Lost to Follow-up|1|||
48726799|NCT03194490|156849921|FG001|Overall Study|Lost to Follow-up|3|||
48509332|NCT01494532|156058969|FG003|Overall Study|Protocol-defined stopping criteria|0|||
48726800|NCT03194490|156849920|FG000|Overall Study|participant developed specific neck pain|1|||
48726801|NCT03194490|156849921|FG001|Overall Study|participant developed specific neck pain|0|||
48726802|NCT01931202|156849922|FG000|Overall Study|Withdrawal by Subject|0|||
48821077|NCT02013687|157187344|FG002|Overall Study|Withdrawal by Subject|0|||
48821078|NCT02013687|157187345|FG003|Overall Study|Withdrawal by Subject|1|||
48821079|NCT02013687|157187342|FG000|Overall Study|Missed visits due to patient travel|0|||
48821080|NCT02013687|157187343|FG001|Overall Study|Missed visits due to patient travel|0|||
48821081|NCT02013687|157187344|FG002|Overall Study|Missed visits due to patient travel|1|||
48821082|NCT02013687|157187345|FG003|Overall Study|Missed visits due to patient travel|0|||
48821083|NCT01782326|157187346|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
48821084|NCT01782326|157187347|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
48821085|NCT01782326|157187346|FG000|Planned Treatment Epoch|Death|29|||
48821086|NCT01782326|157187347|FG001|Planned Treatment Epoch|Death|30|||
48821087|NCT01782326|157187346|FG000|Planned Treatment Epoch|Physician Decision|18|||
48821088|NCT01782326|157187347|FG001|Planned Treatment Epoch|Physician Decision|16|||
48821089|NCT01782326|157187346|FG000|Planned Treatment Epoch|Protocol deviation|2|||
48821090|NCT01782326|157187347|FG001|Planned Treatment Epoch|Protocol deviation|3|||
48821091|NCT01782326|157187346|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
48821092|NCT01782326|157187347|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
48821093|NCT01782326|157187346|FG000|Planned Treatment Epoch|Technical problems|0|||
48821094|NCT01782326|157187347|FG001|Planned Treatment Epoch|Technical problems|4|||
48821095|NCT01782326|157187346|FG000|Double-blind Treatment|Adverse Event|129|||
48821096|NCT01782326|157187347|FG001|Double-blind Treatment|Adverse Event|145|||
48821097|NCT01782326|157187346|FG000|Double-blind Treatment|Subject/guardian decision|111|||
48509333|NCT01494532|156058970|FG004|Overall Study|Protocol-defined stopping criteria|0|||
48509334|NCT01494532|156058971|FG005|Overall Study|Protocol-defined stopping criteria|0|||
48509335|NCT01494532|156058966|FG000|Overall Study|Lost to Follow-up|1|||
48509336|NCT01494532|156058967|FG001|Overall Study|Lost to Follow-up|0|||
48509337|NCT01494532|156058968|FG002|Overall Study|Lost to Follow-up|0|||
48509338|NCT01494532|156058969|FG003|Overall Study|Lost to Follow-up|2|||
48509339|NCT01494532|156058970|FG004|Overall Study|Lost to Follow-up|0|||
48509340|NCT01494532|156058971|FG005|Overall Study|Lost to Follow-up|0|||
48509341|NCT01494532|156058966|FG000|Overall Study|Physician Decision|0|||
48509342|NCT01494532|156058967|FG001|Overall Study|Physician Decision|1|||
48509343|NCT01494532|156058968|FG002|Overall Study|Physician Decision|1|||
48509344|NCT01494532|156058969|FG003|Overall Study|Physician Decision|2|||
48509345|NCT01494532|156058970|FG004|Overall Study|Physician Decision|0|||
48509346|NCT01494532|156058971|FG005|Overall Study|Physician Decision|0|||
48509347|NCT01494532|156058966|FG000|Overall Study|Withdrawal by Subject|3|||
48509348|NCT01494532|156058967|FG001|Overall Study|Withdrawal by Subject|1|||
48509349|NCT01494532|156058968|FG002|Overall Study|Withdrawal by Subject|4|||
48509350|NCT01494532|156058969|FG003|Overall Study|Withdrawal by Subject|3|||
48509351|NCT01494532|156058970|FG004|Overall Study|Withdrawal by Subject|2|||
48509352|NCT01494532|156058971|FG005|Overall Study|Withdrawal by Subject|0|||
48509353|NCT00323882|156058972|FG000|Overall Study|Adverse Event|2|||
48509354|NCT00323882|156058973|FG001|Overall Study|Adverse Event|1|||
48509355|NCT00323882|156058974|FG002|Overall Study|Adverse Event|1|||
48509356|NCT00323882|156058975|FG003|Overall Study|Adverse Event|1|||
48509357|NCT00323882|156058976|FG004|Overall Study|Adverse Event|3|||
48509358|NCT00323882|156058972|FG000|Overall Study|Disease Progression|6|||
48509359|NCT00323882|156058973|FG001|Overall Study|Disease Progression|4|||
48509360|NCT00323882|156058974|FG002|Overall Study|Disease Progression|10|||
48509361|NCT00323882|156058975|FG003|Overall Study|Disease Progression|5|||
48509362|NCT00323882|156058976|FG004|Overall Study|Disease Progression|22|||
48509363|NCT00323882|156058972|FG000|Overall Study|Death|0|||
48509364|NCT00323882|156058973|FG001|Overall Study|Death|1|||
48509365|NCT00323882|156058974|FG002|Overall Study|Death|1|||
48509366|NCT00323882|156058975|FG003|Overall Study|Death|0|||
48509367|NCT00323882|156058976|FG004|Overall Study|Death|5|||
48509368|NCT00323882|156058972|FG000|Overall Study|Lost to Follow-up|0|||
48509369|NCT00323882|156058973|FG001|Overall Study|Lost to Follow-up|0|||
48509370|NCT00323882|156058974|FG002|Overall Study|Lost to Follow-up|1|||
48509371|NCT00323882|156058975|FG003|Overall Study|Lost to Follow-up|0|||
48509372|NCT00323882|156058976|FG004|Overall Study|Lost to Follow-up|1|||
48509373|NCT00323882|156058972|FG000|Overall Study|Other|0|||
48509374|NCT00323882|156058973|FG001|Overall Study|Other|0|||
48509375|NCT00323882|156058974|FG002|Overall Study|Other|0|||
48509376|NCT00323882|156058975|FG003|Overall Study|Other|1|||
48509377|NCT00323882|156058976|FG004|Overall Study|Other|1|||
48509378|NCT01597245|156058977|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
48509379|NCT01597245|156058978|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
48509380|NCT01597245|156058979|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
48509381|NCT01597245|156058980|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
48509382|NCT01597245|156058981|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509383|NCT01597245|156058982|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509384|NCT01597245|156058983|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509385|NCT01597245|156058984|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509386|NCT01597245|156058985|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509387|NCT01597245|156058986|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48600946|NCT01249417|156395989|FG000|Treatment Phase - ITT Population|Other|0|||
48509388|NCT01597245|156058987|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509389|NCT01597245|156058988|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509390|NCT01597245|156058989|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509391|NCT01597245|156058990|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509392|NCT01597245|156058991|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509393|NCT01597245|156058992|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509394|NCT01597245|156058993|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509395|NCT01597245|156058994|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509396|NCT01597245|156058995|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509397|NCT01597245|156058996|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509398|NCT01597245|156058997|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
48509399|NCT01597245|156058977|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
48509400|NCT01597245|156058978|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
48509401|NCT01597245|156058979|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
48509402|NCT01597245|156058980|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
48509403|NCT01597245|156058981|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509404|NCT01597245|156058982|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509405|NCT01597245|156058983|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509406|NCT01597245|156058984|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509407|NCT01597245|156058985|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509408|NCT01597245|156058986|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509409|NCT01597245|156058987|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509410|NCT01597245|156058988|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509411|NCT01597245|156058989|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509412|NCT01597245|156058990|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509413|NCT01597245|156058991|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509414|NCT01597245|156058992|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509415|NCT01597245|156058993|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509416|NCT01597245|156058994|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509417|NCT01597245|156058995|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509418|NCT01597245|156058996|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509419|NCT01597245|156058997|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
48509420|NCT01597245|156058977|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
48509421|NCT01597245|156058978|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
48509422|NCT01597245|156058979|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
48509423|NCT01597245|156058980|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
48509424|NCT01597245|156058981|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509425|NCT01597245|156058982|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509426|NCT01597245|156058983|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509427|NCT01597245|156058984|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509428|NCT01597245|156058985|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509429|NCT01597245|156058986|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509430|NCT01597245|156058987|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509431|NCT01597245|156058988|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509432|NCT01597245|156058989|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509433|NCT01597245|156058990|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509434|NCT01597245|156058991|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509435|NCT01597245|156058992|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509436|NCT01597245|156058993|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509437|NCT01597245|156058994|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509438|NCT01597245|156058995|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509439|NCT01597245|156058996|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509440|NCT01597245|156058997|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
48509441|NCT01597245|156058977|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
48509442|NCT01597245|156058978|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
48509443|NCT01597245|156058979|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
48509444|NCT01597245|156058980|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509445|NCT01597245|156058981|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509446|NCT01597245|156058982|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509447|NCT01597245|156058983|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509448|NCT01597245|156058984|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509449|NCT01597245|156058985|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509450|NCT01597245|156058986|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509451|NCT01597245|156058987|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509452|NCT01597245|156058988|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509453|NCT01597245|156058989|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48726803|NCT01931202|156849923|FG001|Overall Study|Withdrawal by Subject|0|||
48509454|NCT01597245|156058990|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509455|NCT01597245|156058991|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509456|NCT01597245|156058992|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509457|NCT01597245|156058993|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509458|NCT01597245|156058994|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509459|NCT01597245|156058995|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509460|NCT01597245|156058996|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509461|NCT01597245|156058997|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
48509462|NCT01597245|156058977|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
48509463|NCT01597245|156058978|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509464|NCT01597245|156058979|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509465|NCT01597245|156058980|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
48509466|NCT01597245|156058981|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509467|NCT01597245|156058982|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509468|NCT01597245|156058983|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509469|NCT01597245|156058984|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509470|NCT01597245|156058985|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509471|NCT01597245|156058986|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509472|NCT01597245|156058987|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509473|NCT01597245|156058988|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509474|NCT01597245|156058989|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509475|NCT01597245|156058990|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509476|NCT01597245|156058991|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509477|NCT01597245|156058992|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509478|NCT01597245|156058993|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509479|NCT01597245|156058994|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509480|NCT01597245|156058995|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509481|NCT01597245|156058996|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509482|NCT01597245|156058997|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
48509483|NCT01597245|156058977|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
48509484|NCT01597245|156058978|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
48509485|NCT01597245|156058979|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
48509486|NCT01597245|156058980|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509487|NCT01597245|156058981|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509488|NCT01597245|156058982|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509489|NCT01597245|156058983|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509490|NCT01597245|156058984|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509491|NCT01597245|156058985|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509492|NCT01597245|156058986|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509493|NCT01597245|156058987|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509494|NCT01597245|156058988|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509495|NCT01597245|156058989|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509496|NCT01597245|156058990|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509497|NCT01597245|156058991|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509498|NCT01597245|156058992|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509499|NCT01597245|156058993|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509500|NCT01597245|156058994|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509501|NCT01597245|156058995|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509502|NCT01597245|156058996|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509503|NCT01597245|156058997|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
48509504|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509505|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509506|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509507|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509508|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509509|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
48509510|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
48509511|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509512|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509513|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509514|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509515|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509516|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509517|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509518|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509519|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509520|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509521|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509522|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509523|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509524|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
48509525|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509526|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509527|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509528|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509529|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
48509530|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
48509531|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
48509532|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
48509533|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509534|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
48509535|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509536|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509537|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509538|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509539|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509540|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509541|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48726804|NCT01931202|156849924|FG002|Overall Study|Withdrawal by Subject|2|||
48726805|NCT01931202|156849922|FG000|Overall Study|Lost to Follow-up|0|||
48509542|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509543|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509544|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509545|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
48509546|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509547|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48726806|NCT01931202|156849923|FG001|Overall Study|Lost to Follow-up|5|||
48726807|NCT01931202|156849924|FG002|Overall Study|Lost to Follow-up|2|||
48726808|NCT04597918|156849925|FG000|Overall Study|Withdrawal by Subject|6|||
48726809|NCT04597918|156849925|FG000|Overall Study|Lost to Follow-up|3|||
48726810|NCT04597918|156849925|FG000|Overall Study|Death|1|||
48726811|NCT00171054|156849926|FG000|Overall Study|Protocol Violation|1|||
48726812|NCT00171054|156849927|FG001|Overall Study|Protocol Violation|2|||
48726813|NCT00171054|156849926|FG000|Overall Study|Patient withdrew consent|1|||
48726814|NCT00171054|156849927|FG001|Overall Study|Patient withdrew consent|0|||
48726815|NCT00171054|156849926|FG000|Overall Study|Lost to Follow-up|0|||
48726816|NCT00171054|156849927|FG001|Overall Study|Lost to Follow-up|1|||
48726817|NCT00171054|156849926|FG000|Overall Study|Adverse Event|8|||
48726818|NCT00171054|156849927|FG001|Overall Study|Adverse Event|8|||
48726819|NCT00171054|156849926|FG000|Overall Study|Condition no longer required study drug|0|||
48726820|NCT00171054|156849927|FG001|Overall Study|Condition no longer required study drug|1|||
48726821|NCT02775903|156849928|FG000|Overall Study|Death|7|||
48726822|NCT02775903|156849929|FG001|Overall Study|Death|11|||
48726823|NCT02775903|156849930|FG002|Overall Study|Death|12|||
48726824|NCT02775903|156849931|FG003|Overall Study|Death|11|||
48726825|NCT02775903|156849928|FG000|Overall Study|Adverse Event|0|||
48726826|NCT02775903|156849929|FG001|Overall Study|Adverse Event|1|||
48726827|NCT02775903|156849930|FG002|Overall Study|Adverse Event|12|||
48726828|NCT02775903|156849931|FG003|Overall Study|Adverse Event|3|||
48726829|NCT02775903|156849928|FG000|Overall Study|Progressive disease|15|||
48726830|NCT02775903|156849929|FG001|Overall Study|Progressive disease|14|||
48726831|NCT02775903|156849930|FG002|Overall Study|Progressive disease|30|||
48726832|NCT02775903|156849931|FG003|Overall Study|Progressive disease|20|||
48726833|NCT02775903|156849928|FG000|Overall Study|Lack of Efficacy|2|||
48726834|NCT02775903|156849929|FG001|Overall Study|Lack of Efficacy|2|||
48726835|NCT02775903|156849930|FG002|Overall Study|Lack of Efficacy|2|||
48726836|NCT02775903|156849931|FG003|Overall Study|Lack of Efficacy|6|||
48726837|NCT02775903|156849928|FG000|Overall Study|Withdrawal by Subject|7|||
48726838|NCT02775903|156849929|FG001|Overall Study|Withdrawal by Subject|5|||
48726839|NCT02775903|156849930|FG002|Overall Study|Withdrawal by Subject|5|||
48726840|NCT02775903|156849931|FG003|Overall Study|Withdrawal by Subject|8|||
48726841|NCT02775903|156849928|FG000|Overall Study|Other reasons|7|||
48726842|NCT02775903|156849929|FG001|Overall Study|Other reasons|8|||
48726843|NCT02775903|156849930|FG002|Overall Study|Other reasons|2|||
48726844|NCT02775903|156849931|FG003|Overall Study|Other reasons|12|||
48726845|NCT02718300|156849934|FG000|Overall Study|Death|4|||
48726846|NCT02718300|156849935|FG001|Overall Study|Death|5|||
48726847|NCT02718300|156849936|FG002|Overall Study|Death|17|||
48726848|NCT02718300|156849934|FG000|Overall Study|Lost to Follow-up|1|||
48726849|NCT02718300|156849935|FG001|Overall Study|Lost to Follow-up|0|||
48726850|NCT02718300|156849936|FG002|Overall Study|Lost to Follow-up|2|||
48509548|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509549|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509550|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509551|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
48509552|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509553|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48726851|NCT02718300|156849934|FG000|Overall Study|Physician Decision|1|||
48381948|NCT03872453|155595018|FG001|Overall Study|Never Treated Migraine|17|||
48381949|NCT03872453|155595019|FG002|Overall Study|Never Treated Migraine|13|||
48381950|NCT03872453|155595020|FG003|Overall Study|Never Treated Migraine|12|||
48381951|NCT03872453|155595017|FG000|Overall Study|Pregnancy|1|||
48381952|NCT03872453|155595018|FG001|Overall Study|Pregnancy|0|||
48381953|NCT03872453|155595019|FG002|Overall Study|Pregnancy|0|||
48381954|NCT03872453|155595020|FG003|Overall Study|Pregnancy|0|||
48381955|NCT03872453|155595017|FG000|Overall Study|Protocol Deviation|2|||
48381956|NCT03872453|155595018|FG001|Overall Study|Protocol Deviation|0|||
48381957|NCT03872453|155595019|FG002|Overall Study|Protocol Deviation|0|||
48381958|NCT03872453|155595020|FG003|Overall Study|Protocol Deviation|2|||
48381959|NCT03872453|155595017|FG000|Overall Study|Withdrawal by Subject|0|||
48726852|NCT02718300|156849935|FG001|Overall Study|Physician Decision|0|||
48726853|NCT02718300|156849936|FG002|Overall Study|Physician Decision|2|||
48381960|NCT03872453|155595018|FG001|Overall Study|Withdrawal by Subject|1|||
48381961|NCT03872453|155595019|FG002|Overall Study|Withdrawal by Subject|2|||
48381962|NCT03872453|155595020|FG003|Overall Study|Withdrawal by Subject|0|||
48726854|NCT02718300|156849934|FG000|Overall Study|Study Terminated by Sponsor|6|||
48381963|NCT03872453|155595017|FG000|Overall Study|Other Than Specified|1|||
48381964|NCT03872453|155595018|FG001|Overall Study|Other Than Specified|0|||
48381965|NCT03872453|155595019|FG002|Overall Study|Other Than Specified|0|||
48726855|NCT02718300|156849935|FG001|Overall Study|Study Terminated by Sponsor|3|||
48726856|NCT02718300|156849936|FG002|Overall Study|Study Terminated by Sponsor|4|||
48726857|NCT02718300|156849934|FG000|Overall Study|Withdrawal by Subject|0|||
48726858|NCT02718300|156849935|FG001|Overall Study|Withdrawal by Subject|4|||
48726859|NCT02718300|156849936|FG002|Overall Study|Withdrawal by Subject|3|||
48726860|NCT02718300|156849934|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
48743059|NCT00968201|156910495|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
48726861|NCT02718300|156849935|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
48726862|NCT02718300|156849936|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
48509554|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
48509555|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509556|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
48509557|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
48509558|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
48509559|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509560|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509561|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509562|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509563|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509564|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509565|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509566|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
48509567|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509568|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509569|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509570|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509571|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
48509572|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
48509573|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
48509574|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
48509575|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
48509576|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
48509577|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
48509578|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
48509579|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
48509580|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509581|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509582|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509583|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509584|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509585|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509586|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509587|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
48509588|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509589|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509590|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509591|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509592|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
48509593|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
48509594|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
48509595|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509596|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
48509597|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
48509598|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
48509599|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
48509600|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
48509601|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509602|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509603|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509604|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509605|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509606|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48726863|NCT03729362|156851480|FG000|Overall Study|Withdrawal by Subject|2|||
48509607|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509608|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
48509609|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509610|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509611|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48726864|NCT03729362|156851481|FG001|Overall Study|Withdrawal by Subject|0|||
48726865|NCT03729362|156851480|FG000|Overall Study|Physician Decision|1|||
48726866|NCT03729362|156851481|FG001|Overall Study|Physician Decision|0|||
48821098|NCT01782326|157187347|FG001|Double-blind Treatment|Subject/guardian decision|125|||
48821099|NCT01782326|157187346|FG000|Double-blind Treatment|Lack of Efficacy|17|||
48821100|NCT01782326|157187347|FG001|Double-blind Treatment|Lack of Efficacy|22|||
48821101|NCT01782326|157187346|FG000|Double-blind Treatment|Physician Decision|13|||
48821102|NCT01782326|157187347|FG001|Double-blind Treatment|Physician Decision|16|||
48821103|NCT01782326|157187346|FG000|Double-blind Treatment|Protocol deviation|8|||
48509612|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509613|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
48509614|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509615|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509616|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509617|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
48509618|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
48509619|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
48509620|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509621|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
48509622|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48821104|NCT01782326|157187347|FG001|Double-blind Treatment|Protocol deviation|7|||
48821105|NCT01782326|157187346|FG000|Double-blind Treatment|Technical problems|0|||
48381966|NCT03872453|155595020|FG003|Overall Study|Other Than Specified|0|||
48381967|NCT01920594|155595021|FG000|Overall Study|Adverse Event|4|||
48381968|NCT01920594|155595022|FG001|Overall Study|Adverse Event|2|||
48381969|NCT01920594|155595021|FG000|Overall Study|Lost to Follow-up|1|||
48381970|NCT01920594|155595022|FG001|Overall Study|Lost to Follow-up|0|||
48381971|NCT01920594|155595021|FG000|Overall Study|Recovery|2|||
48381972|NCT01920594|155595022|FG001|Overall Study|Recovery|0|||
48381973|NCT01920594|155595021|FG000|Overall Study|Investigator discretion|0|||
48381974|NCT01920594|155595022|FG001|Overall Study|Investigator discretion|1|||
48381975|NCT01176968|155595032|FG000|Overall Study|Adverse Event|10|||
48381976|NCT01176968|155595033|FG001|Overall Study|Adverse Event|11|||
48381977|NCT01176968|155595032|FG000|Overall Study|Death|2|||
48381978|NCT01176968|155595033|FG001|Overall Study|Death|3|||
48381979|NCT01176968|155595032|FG000|Overall Study|Lack of Efficacy|0|||
48381980|NCT01176968|155595033|FG001|Overall Study|Lack of Efficacy|1|||
48381981|NCT01176968|155595032|FG000|Overall Study|Lost to Follow-up|16|||
48381982|NCT01176968|155595033|FG001|Overall Study|Lost to Follow-up|14|||
48381983|NCT01176968|155595032|FG000|Overall Study|Withdrawal by Subject|48|||
48381984|NCT01176968|155595033|FG001|Overall Study|Withdrawal by Subject|48|||
48381985|NCT01176968|155595032|FG000|Overall Study|Protocol Violation|2|||
48381986|NCT01176968|155595033|FG001|Overall Study|Protocol Violation|1|||
48381987|NCT01176968|155595032|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
48381988|NCT01176968|155595033|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
48381989|NCT01176968|155595032|FG000|Overall Study|Study terminated by sponsor|0|||
48381990|NCT01176968|155595033|FG001|Overall Study|Study terminated by sponsor|1|||
48381991|NCT01176968|155595032|FG000|Overall Study|Reason not defined|5|||
48381992|NCT01176968|155595033|FG001|Overall Study|Reason not defined|3|||
48381993|NCT00818389|155595040|FG000|Overall Study|Death|1|||
48381994|NCT00818389|155595041|FG001|Overall Study|Death|3|||
48381995|NCT00818389|155595040|FG000|Overall Study|ALS Disease Progression|1|||
48381996|NCT00818389|155595041|FG001|Overall Study|ALS Disease Progression|0|||
48381997|NCT00818389|155595040|FG000|Overall Study|Withdrawal by Subject|2|||
48381998|NCT00818389|155595041|FG001|Overall Study|Withdrawal by Subject|2|||
48381999|NCT00818389|155595040|FG000|Overall Study|Adverse Event|0|||
48382000|NCT00818389|155595041|FG001|Overall Study|Adverse Event|1|||
48382001|NCT01137955|155595042|FG000|Overall Study|Withdrawal by Subject|5|||
48382002|NCT01137955|155595043|FG001|Overall Study|Withdrawal by Subject|4|||
48382003|NCT03953508|155595044|FG000|Baseline|Lost to Follow-up|3|||
48382004|NCT03953508|155595045|FG001|Baseline|Lost to Follow-up|2|||
48382005|NCT03953508|155595044|FG000|6-month Follow-up|Lost to Follow-up|62|||
48382006|NCT03953508|155595045|FG001|6-month Follow-up|Lost to Follow-up|70|||
48382007|NCT03678103|155595048|FG000|Overall Study|Withdrawn prior to completion|4|||
48382008|NCT00975715|155595049|FG000|Titration Period|Adverse Event|6|||
48382009|NCT00975715|155595050|FG001|Titration Period|Adverse Event|0|||
48382010|NCT00975715|155595049|FG000|Titration Period|Protocol Violation|1|||
48382011|NCT00975715|155595050|FG001|Titration Period|Protocol Violation|0|||
48382012|NCT00975715|155595049|FG000|Maintenance Period|Adverse Event|2|||
48382013|NCT00975715|155595050|FG001|Maintenance Period|Adverse Event|1|||
48382014|NCT01241552|155595051|FG000|Overall Study|Lack of Efficacy|1|||
48382015|NCT01241552|155595052|FG001|Overall Study|Lack of Efficacy|0|||
48382016|NCT01241552|155595053|FG002|Overall Study|Lack of Efficacy|0|||
48382017|NCT01241552|155595054|FG003|Overall Study|Lack of Efficacy|0|||
48382018|NCT01241552|155595051|FG000|Overall Study|Death|26|||
48382019|NCT01241552|155595052|FG001|Overall Study|Death|30|||
48382020|NCT01241552|155595053|FG002|Overall Study|Death|20|||
48382021|NCT01241552|155595054|FG003|Overall Study|Death|25|||
48382022|NCT01241552|155595051|FG000|Overall Study|Adverse Event|1|||
48821106|NCT01782326|157187347|FG001|Double-blind Treatment|Technical problems|5|||
48821107|NCT00647348|157187348|FG000|Overall Study|Lost to Follow-up|3|||
48821108|NCT00647348|157187349|FG001|Overall Study|Lost to Follow-up|6|||
48821109|NCT01719861|157187350|FG000|Cycle 1|Death|4|||
48821110|NCT01719861|157187350|FG000|Cycle 2|Death|1|||
48821111|NCT02448719|157187351|FG000|Overall Study|Withdrawal by Subject|0|||
48821112|NCT02448719|157187352|FG001|Overall Study|Withdrawal by Subject|0|||
48821113|NCT02448719|157187353|FG002|Overall Study|Withdrawal by Subject|0|||
48821114|NCT02448719|157187354|FG003|Overall Study|Withdrawal by Subject|0|||
48821115|NCT02448719|157187355|FG004|Overall Study|Withdrawal by Subject|1|||
48821116|NCT02448719|157187356|FG005|Overall Study|Withdrawal by Subject|0|||
48821117|NCT02448719|157187357|FG006|Overall Study|Withdrawal by Subject|0|||
48821118|NCT02448719|157187358|FG007|Overall Study|Withdrawal by Subject|0|||
48821119|NCT02448719|157187359|FG008|Overall Study|Withdrawal by Subject|0|||
48821120|NCT02448719|157187360|FG009|Overall Study|Withdrawal by Subject|0|||
48821121|NCT02448719|157187361|FG010|Overall Study|Withdrawal by Subject|0|||
48821122|NCT01232556|157187362|FG000|Overall Study|Withdrawal by Subject|21|||
48821123|NCT01232556|157187363|FG001|Overall Study|Withdrawal by Subject|17|||
48821124|NCT01232556|157187362|FG000|Overall Study|Death|97|||
48821125|NCT01232556|157187363|FG001|Overall Study|Death|97|||
48821126|NCT01232556|157187362|FG000|Overall Study|Lost to Follow-up|0|||
48821127|NCT01232556|157187363|FG001|Overall Study|Lost to Follow-up|2|||
48821128|NCT01232556|157187362|FG000|Overall Study|Terminated by Sponsor|35|||
48821129|NCT01232556|157187363|FG001|Overall Study|Terminated by Sponsor|51|||
48821130|NCT01232556|157187362|FG000|Overall Study|Other|6|||
48821131|NCT01232556|157187363|FG001|Overall Study|Other|4|||
48821132|NCT01925170|157187377|FG000|Overall Study|Unverified cancer status|53|||
48821133|NCT00848211|157187378|FG000|Overall Study|Protocol Violation|0|||
48821134|NCT00848211|157187379|FG001|Overall Study|Protocol Violation|1|||
48821135|NCT00848211|157187380|FG002|Overall Study|Protocol Violation|1|||
48821136|NCT00848211|157187381|FG003|Overall Study|Protocol Violation|0|||
48821137|NCT00848211|157187378|FG000|Overall Study|Adverse Event|0|||
48821138|NCT00848211|157187379|FG001|Overall Study|Adverse Event|0|||
48821139|NCT00848211|157187380|FG002|Overall Study|Adverse Event|0|||
48821140|NCT00848211|157187381|FG003|Overall Study|Adverse Event|0|||
48821141|NCT00801242|157187384|FG000|Overall Study|Adverse Event|10|||
48821142|NCT00801242|157187384|FG000|Overall Study|Withdrawal by Subject|13|||
48726867|NCT03729362|156851480|FG000|Overall Study|COVID-19 Pandemic|1|||
48726868|NCT03729362|156851481|FG001|Overall Study|COVID-19 Pandemic|0|||
48726869|NCT03729362|156851480|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
48726870|NCT03729362|156851481|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
48726871|NCT03729362|156851480|FG000|Overall Study|Adverse Event|0|||
48726872|NCT03729362|156851481|FG001|Overall Study|Adverse Event|1|||
48726873|NCT03729362|156851480|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
48726874|NCT03729362|156851481|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
48726875|NCT00504582|156851482|FG000|Overall Study|Lost to Follow-up|1|||
48726876|NCT00504582|156851483|FG001|Overall Study|Lost to Follow-up|0|||
48509623|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509624|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509625|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509626|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509627|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48509628|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48726877|NCT00504582|156851484|FG002|Overall Study|Lost to Follow-up|0|||
48821143|NCT00801242|157187384|FG000|Overall Study|Protocol Violation|5|||
48821144|NCT00801242|157187384|FG000|Overall Study|Physician Decision|3|||
48382023|NCT01241552|155595052|FG001|Overall Study|Adverse Event|1|||
48382024|NCT01241552|155595053|FG002|Overall Study|Adverse Event|0|||
48382025|NCT01241552|155595054|FG003|Overall Study|Adverse Event|0|||
48821145|NCT00801242|157187384|FG000|Overall Study|Lost to Follow-up|1|||
48821146|NCT00801242|157187384|FG000|Overall Study|Miscellaneous reasons|20|||
48821147|NCT04319094|157187387|FG000|Baseline|Lost to Follow-up|4|||
48821148|NCT04319094|157187388|FG001|Baseline|Lost to Follow-up|5|||
48821149|NCT04319094|157187387|FG000|Baseline|Protocol Violation|0|||
48821150|NCT04319094|157187388|FG001|Baseline|Protocol Violation|3|||
48821151|NCT04319094|157187387|FG000|Baseline|Withdrawal by Subject|2|||
48821152|NCT04319094|157187388|FG001|Baseline|Withdrawal by Subject|1|||
48821153|NCT04319094|157187387|FG000|Post-Intervention|Death|0|||
48821154|NCT04319094|157187388|FG001|Post-Intervention|Death|1|||
48821155|NCT04319094|157187387|FG000|Post-Intervention|Lost to Follow-up|4|||
48821156|NCT04319094|157187388|FG001|Post-Intervention|Lost to Follow-up|4|||
48821157|NCT04319094|157187387|FG000|Post-Intervention|Withdrawal by Subject|8|||
48821158|NCT04319094|157187388|FG001|Post-Intervention|Withdrawal by Subject|5|||
48821159|NCT04319094|157187387|FG000|Post-Intervention|Incomplete Data Collection|1|||
48382026|NCT01241552|155595051|FG000|Overall Study|Technical Problems|2|||
48509629|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
48382027|NCT01241552|155595052|FG001|Overall Study|Technical Problems|0|||
48726878|NCT00076024|156851486|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
48726879|NCT00076024|156851487|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
48726880|NCT00076024|156851488|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
48726881|NCT00076024|156851489|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
48726882|NCT00076024|156851486|FG000|Phase 1, Lead-in|Adverse Event|1|||
48821160|NCT04319094|157187388|FG001|Post-Intervention|Incomplete Data Collection|3|||
48821161|NCT04319094|157187387|FG000|3-month|Death|1|||
48821162|NCT04319094|157187388|FG001|3-month|Death|0|||
48821163|NCT04319094|157187387|FG000|3-month|Lost to Follow-up|2|||
48382028|NCT01241552|155595053|FG002|Overall Study|Technical Problems|2|||
48382029|NCT01241552|155595054|FG003|Overall Study|Technical Problems|2|||
48726883|NCT00076024|156851487|FG001|Phase 1, Lead-in|Adverse Event|0|||
48726884|NCT00076024|156851488|FG002|Phase 1, Lead-in|Adverse Event|0|||
48726885|NCT00076024|156851489|FG003|Phase 1, Lead-in|Adverse Event|0|||
48726886|NCT00076024|156851486|FG000|Phase 1, Lead-in|Clinical progression|1|||
48726887|NCT00076024|156851487|FG001|Phase 1, Lead-in|Clinical progression|0|||
48726888|NCT00076024|156851488|FG002|Phase 1, Lead-in|Clinical progression|0|||
48726889|NCT00076024|156851489|FG003|Phase 1, Lead-in|Clinical progression|0|||
48726890|NCT00076024|156851486|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
48726891|NCT00076024|156851487|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
48726892|NCT00076024|156851488|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
48726893|NCT00076024|156851489|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
48726894|NCT00076024|156851486|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
48726895|NCT00076024|156851487|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
48726896|NCT00076024|156851488|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
48726897|NCT00076024|156851489|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
48726898|NCT00076024|156851486|FG000|Phase 2, Double-blind|Adverse Event|0|||
48726899|NCT00076024|156851487|FG001|Phase 2, Double-blind|Adverse Event|25|||
48726900|NCT00076024|156851488|FG002|Phase 2, Double-blind|Adverse Event|6|||
48726901|NCT00076024|156851489|FG003|Phase 2, Double-blind|Adverse Event|0|||
48726902|NCT00076024|156851486|FG000|Phase 2, Double-blind|Un-specified|0|||
48821164|NCT04319094|157187388|FG001|3-month|Lost to Follow-up|2|||
48821165|NCT04319094|157187387|FG000|3-month|Withdrawal by Subject|0|||
48821166|NCT04319094|157187388|FG001|3-month|Withdrawal by Subject|3|||
48821167|NCT04319094|157187387|FG000|3-month|Incomplete data collection|9|||
48821168|NCT04319094|157187388|FG001|3-month|Incomplete data collection|7|||
48821169|NCT04319094|157187387|FG000|6-month|Lost to Follow-up|1|||
48821170|NCT04319094|157187388|FG001|6-month|Lost to Follow-up|1|||
48726903|NCT00076024|156851487|FG001|Phase 2, Double-blind|Un-specified|14|||
48726904|NCT00076024|156851488|FG002|Phase 2, Double-blind|Un-specified|6|||
48726905|NCT00076024|156851489|FG003|Phase 2, Double-blind|Un-specified|0|||
48726906|NCT00076024|156851486|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
48726907|NCT00076024|156851487|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
48726908|NCT00076024|156851488|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
48726909|NCT00076024|156851489|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
48726910|NCT00076024|156851486|FG000|Phase 2, Open-label|Adverse Event|0|||
48726911|NCT00076024|156851487|FG001|Phase 2, Open-label|Adverse Event|0|||
48726912|NCT00076024|156851488|FG002|Phase 2, Open-label|Adverse Event|0|||
48726913|NCT00076024|156851489|FG003|Phase 2, Open-label|Adverse Event|2|||
48726914|NCT00076024|156851486|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
48726915|NCT00076024|156851487|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
48726916|NCT00076024|156851488|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
48726917|NCT00076024|156851489|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
48726918|NCT00076024|156851486|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
48726919|NCT00076024|156851487|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
48726920|NCT00076024|156851488|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
48726921|NCT00076024|156851489|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
48726922|NCT00076024|156851486|FG000|Phase 2, Open-label|Other|0|||
48726923|NCT00076024|156851487|FG001|Phase 2, Open-label|Other|0|||
48726924|NCT00076024|156851488|FG002|Phase 2, Open-label|Other|0|||
48821171|NCT04319094|157187387|FG000|6-month|Withdrawal by Subject|0|||
48821172|NCT04319094|157187388|FG001|6-month|Withdrawal by Subject|3|||
48821173|NCT04319094|157187387|FG000|6-month|Incomplete data collection|14|||
48382030|NCT01241552|155595051|FG000|Overall Study|Progressive Disease|0|||
48382031|NCT01241552|155595052|FG001|Overall Study|Progressive Disease|0|||
48726925|NCT00076024|156851489|FG003|Phase 2, Open-label|Other|2|||
48726926|NCT00301821|156851490|FG000|Overall Study|Ineligible|25|||
48821174|NCT04319094|157187388|FG001|6-month|Incomplete data collection|9|||
48821175|NCT04319094|157187387|FG000|9-month|Lost to Follow-up|8|||
48382032|NCT01241552|155595053|FG002|Overall Study|Progressive Disease|1|||
48382033|NCT01241552|155595054|FG003|Overall Study|Progressive Disease|2|||
48726927|NCT00301821|156851490|FG000|Overall Study|Cancel|1|||
48726928|NCT03206073|156851491|FG000|Overall Study|Participant Noncompliance|0|||
48726929|NCT03206073|156851492|FG001|Overall Study|Participant Noncompliance|1|||
48726930|NCT03206073|156851493|FG002|Overall Study|Participant Noncompliance|0|||
48726931|NCT03206073|156851494|FG003|Overall Study|Participant Noncompliance|0|||
48726932|NCT03206073|156851491|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
48509630|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509631|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509632|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48600947|NCT01249417|156395990|FG001|Treatment Phase - ITT Population|Other|0|||
48600948|NCT01249417|156395991|FG002|Treatment Phase - ITT Population|Other|1|||
48600949|NCT01249417|156395989|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
48726933|NCT03206073|156851492|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
48726934|NCT03206073|156851493|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
48726935|NCT03206073|156851494|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
48726936|NCT03206073|156851491|FG000|Overall Study|Death|0|||
48726937|NCT03206073|156851492|FG001|Overall Study|Death|0|||
48726938|NCT03206073|156851493|FG002|Overall Study|Death|1|||
48726939|NCT03206073|156851494|FG003|Overall Study|Death|0|||
48726940|NCT03206073|156851491|FG000|Overall Study|Taken off active treatment|0|||
48726941|NCT03206073|156851492|FG001|Overall Study|Taken off active treatment|0|||
48726942|NCT03206073|156851493|FG002|Overall Study|Taken off active treatment|3|||
48821176|NCT04319094|157187388|FG001|9-month|Lost to Follow-up|4|||
48821177|NCT04319094|157187387|FG000|9-month|Withdrawal by Subject|0|||
48821178|NCT04319094|157187388|FG001|9-month|Withdrawal by Subject|1|||
48726943|NCT03206073|156851494|FG003|Overall Study|Taken off active treatment|0|||
48821179|NCT04319094|157187387|FG000|9-month|Incomplete data collection|8|||
48821180|NCT04319094|157187388|FG001|9-month|Incomplete data collection|5|||
48821181|NCT04319094|157187387|FG000|12-month|Lost to Follow-up|11|||
48821182|NCT04319094|157187388|FG001|12-month|Lost to Follow-up|8|||
48821183|NCT02956967|157187391|FG000|Overall Study|Adverse Event|3|||
48821184|NCT02956967|157187391|FG000|Overall Study|Reason non-related to neutropenia|10|||
48821185|NCT02956967|157187391|FG000|Overall Study|Lost to Follow-up|5|||
48821186|NCT02956967|157187391|FG000|Overall Study|Missing|1|||
48821187|NCT02956967|157187391|FG000|Overall Study|Termination of Nivestim administration|29|||
48821188|NCT00057811|157187392|FG000|Overall Study|Lack of Efficacy|1|||
48821189|NCT00057811|157187393|FG001|Overall Study|Lack of Efficacy|4|||
48821190|NCT00057811|157187392|FG000|Overall Study|Physician Decision|1|||
48821191|NCT00057811|157187393|FG001|Overall Study|Physician Decision|0|||
48821192|NCT00057811|157187392|FG000|Overall Study|Withdrawal by Subject|3|||
48821193|NCT00057811|157187393|FG001|Overall Study|Withdrawal by Subject|4|||
48821194|NCT00057811|157187392|FG000|Overall Study|Ineligible|4|||
48821195|NCT00057811|157187393|FG001|Overall Study|Ineligible|2|||
48821196|NCT00057811|157187392|FG000|Overall Study|Inevaluable|1|||
48821197|NCT00057811|157187393|FG001|Overall Study|Inevaluable|2|||
48821198|NCT04482855|157187394|FG000|Overall Study|Lost to Follow-up|1|||
48821199|NCT04482855|157187395|FG001|Overall Study|Lost to Follow-up|0|||
48821200|NCT04482855|157187394|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
48821201|NCT04482855|157187395|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
48821202|NCT04482855|157187394|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
48821203|NCT04482855|157187395|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
48821204|NCT00701311|157187398|FG000|Overall Study|Lack of Efficacy|3|||
48821205|NCT00701311|157187398|FG000|Overall Study|Adverse Event|3|||
48726944|NCT03442764|156851495|FG000|Overall Study|Adverse Event|1|||
48726945|NCT03442764|156851496|FG001|Overall Study|Adverse Event|0|||
48726946|NCT03442764|156851497|FG002|Overall Study|Adverse Event|0|||
48726947|NCT00719264|156851498|FG000|Overall Study|Adverse Event|41|||
48726948|NCT00719264|156851499|FG001|Overall Study|Adverse Event|49|||
48726949|NCT00719264|156851498|FG000|Overall Study|Death|13|||
48726950|NCT00719264|156851499|FG001|Overall Study|Death|10|||
48726951|NCT00719264|156851498|FG000|Overall Study|Administrative Problems|6|||
48726952|NCT00719264|156851499|FG001|Overall Study|Administrative Problems|4|||
48726953|NCT00719264|156851498|FG000|Overall Study|Lost to Follow-up|1|||
48726954|NCT00719264|156851499|FG001|Overall Study|Lost to Follow-up|1|||
48726955|NCT00719264|156851498|FG000|Overall Study|Withdrawal by Subject|12|||
48726956|NCT00719264|156851499|FG001|Overall Study|Withdrawal by Subject|7|||
48726957|NCT00719264|156851498|FG000|Overall Study|Protocol Deviation|1|||
48726958|NCT00719264|156851499|FG001|Overall Study|Protocol Deviation|3|||
48726959|NCT00719264|156851498|FG000|Overall Study|New Cancer Therapy|4|||
48726960|NCT00719264|156851499|FG001|Overall Study|New Cancer Therapy|2|||
48821206|NCT00701311|157187398|FG000|Overall Study|Withdrawal by Subject|2|||
48821207|NCT02501811|157187399|FG000|Overall Study|Death|1|||
48821208|NCT02501811|157187400|FG001|Overall Study|Death|3|||
48821209|NCT02501811|157187401|FG002|Overall Study|Death|2|||
48509633|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509634|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
48509635|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
48509636|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
48509637|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509638|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
48509639|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
48509640|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
48509641|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
48509642|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
48509643|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509644|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509645|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509646|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509647|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48726961|NCT00719264|156851498|FG000|Overall Study|Disease Progression|104|||
48726962|NCT00719264|156851499|FG001|Overall Study|Disease Progression|107|||
48821210|NCT02501811|157187402|FG003|Overall Study|Death|3|||
48821211|NCT02501811|157187399|FG000|Overall Study|Withdrawal by Subject|3|||
48821212|NCT02501811|157187400|FG001|Overall Study|Withdrawal by Subject|3|||
48821213|NCT02501811|157187401|FG002|Overall Study|Withdrawal by Subject|2|||
48821214|NCT02501811|157187402|FG003|Overall Study|Withdrawal by Subject|3|||
48821215|NCT02501811|157187399|FG000|Overall Study|Lost to Follow-up|0|||
48821216|NCT02501811|157187400|FG001|Overall Study|Lost to Follow-up|0|||
48726963|NCT01277042|156851500|FG000|Overall Study|Adverse Event|4|||
48726964|NCT01277042|156851501|FG001|Overall Study|Adverse Event|3|||
48726965|NCT01277042|156851500|FG000|Overall Study|Lost to Follow-up|2|||
48726966|NCT01277042|156851501|FG001|Overall Study|Lost to Follow-up|2|||
48726967|NCT01277042|156851500|FG000|Overall Study|Withdrawal by Subject|2|||
48726968|NCT01277042|156851501|FG001|Overall Study|Withdrawal by Subject|0|||
48726969|NCT04389970|156851502|FG000|Overall Study|Lost to Follow-up|1|||
48726970|NCT01739400|156851503|FG000|Overall Study|Physician Decision|3|||
48726971|NCT01739400|156851504|FG001|Overall Study|Physician Decision|0|||
48726972|NCT01739400|156851503|FG000|Overall Study|Lost to Follow-up|2|||
48726973|NCT01739400|156851504|FG001|Overall Study|Lost to Follow-up|0|||
48726974|NCT01739400|156851503|FG000|Overall Study|Death|5|||
48726975|NCT01739400|156851504|FG001|Overall Study|Death|2|||
48726976|NCT01739400|156851503|FG000|Overall Study|Withdrawal by Subject|7|||
48726977|NCT01739400|156851504|FG001|Overall Study|Withdrawal by Subject|7|||
48726978|NCT00470158|156851507|FG000|Overall Study|Death|0|||
48726979|NCT00470158|156851508|FG001|Overall Study|Death|0|||
48726980|NCT00470158|156851509|FG002|Overall Study|Death|0|||
48726981|NCT00470158|156851510|FG003|Overall Study|Death|0|||
48726982|NCT00470158|156851511|FG004|Overall Study|Death|2|||
48726983|NCT00470158|156851507|FG000|Overall Study|Lost to Follow-up|7|||
48726984|NCT00470158|156851508|FG001|Overall Study|Lost to Follow-up|8|||
48726985|NCT00470158|156851509|FG002|Overall Study|Lost to Follow-up|8|||
48726986|NCT00470158|156851510|FG003|Overall Study|Lost to Follow-up|5|||
48726987|NCT00470158|156851511|FG004|Overall Study|Lost to Follow-up|4|||
48726988|NCT00470158|156851507|FG000|Overall Study|Protocol Violation|1|||
48726989|NCT00470158|156851508|FG001|Overall Study|Protocol Violation|0|||
48726990|NCT00470158|156851509|FG002|Overall Study|Protocol Violation|0|||
48726991|NCT00470158|156851510|FG003|Overall Study|Protocol Violation|0|||
48726992|NCT00470158|156851511|FG004|Overall Study|Protocol Violation|0|||
48726993|NCT02038829|156851512|FG000|Washout Period 1|Death|0|||
48726994|NCT02038829|156851513|FG001|Washout Period 1|Death|0|||
48726995|NCT02038829|156851514|FG002|Washout Period 1|Death|0|||
48726996|NCT02038829|156851515|FG003|Washout Period 1|Death|0|||
48726997|NCT02038829|156851516|FG004|Washout Period 1|Death|1|||
48726998|NCT02038829|156851517|FG005|Washout Period 1|Death|0|||
48726999|NCT02038829|156851518|FG006|Washout Period 1|Death|0|||
48727000|NCT02038829|156851519|FG007|Washout Period 1|Death|0|||
48727001|NCT02038829|156851520|FG008|Washout Period 1|Death|0|||
48727002|NCT02038829|156851521|FG009|Washout Period 1|Death|0|||
48727003|NCT02038829|156851522|FG010|Washout Period 1|Death|0|||
48727004|NCT02038829|156851523|FG011|Washout Period 1|Death|0|||
48727005|NCT02038829|156851512|FG000|Treatment Period 2|Adverse Event|0|||
48727006|NCT02038829|156851513|FG001|Treatment Period 2|Adverse Event|0|||
48727007|NCT02038829|156851514|FG002|Treatment Period 2|Adverse Event|0|||
48727008|NCT02038829|156851515|FG003|Treatment Period 2|Adverse Event|0|||
48727009|NCT02038829|156851516|FG004|Treatment Period 2|Adverse Event|0|||
48727010|NCT02038829|156851517|FG005|Treatment Period 2|Adverse Event|0|||
48727011|NCT02038829|156851518|FG006|Treatment Period 2|Adverse Event|0|||
48727012|NCT02038829|156851519|FG007|Treatment Period 2|Adverse Event|0|||
48821217|NCT02501811|157187401|FG002|Overall Study|Lost to Follow-up|2|||
48727013|NCT02038829|156851520|FG008|Treatment Period 2|Adverse Event|0|||
48727014|NCT02038829|156851521|FG009|Treatment Period 2|Adverse Event|0|||
48727015|NCT02038829|156851522|FG010|Treatment Period 2|Adverse Event|1|||
48727016|NCT02038829|156851523|FG011|Treatment Period 2|Adverse Event|0|||
48727017|NCT02038829|156851512|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48727018|NCT02038829|156851513|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48727019|NCT02038829|156851514|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48727020|NCT02038829|156851515|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48727021|NCT02038829|156851516|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48727022|NCT02038829|156851517|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48821218|NCT02501811|157187402|FG003|Overall Study|Lost to Follow-up|1|||
48821219|NCT02997202|157187403|FG000|Overall Study|Miscellaneous|2|||
48821220|NCT02997202|157187404|FG001|Overall Study|Miscellaneous|2|||
48821221|NCT02997202|157187403|FG000|Overall Study|Withdrawal by Subject|8|||
48821222|NCT02997202|157187404|FG001|Overall Study|Withdrawal by Subject|12|||
48821223|NCT02997202|157187403|FG000|Overall Study|Lost to Follow-up|5|||
48821224|NCT02997202|157187404|FG001|Overall Study|Lost to Follow-up|3|||
48821225|NCT02997202|157187403|FG000|Overall Study|Death|41|||
48821226|NCT02997202|157187404|FG001|Overall Study|Death|45|||
48821227|NCT03248479|157187405|FG000|Overall Study|Death|12|||
48821228|NCT03248479|157187406|FG001|Overall Study|Death|44|||
48821229|NCT03248479|157187407|FG002|Overall Study|Death|1|||
48821230|NCT03248479|157187408|FG003|Overall Study|Death|72|||
48821231|NCT03248479|157187409|FG004|Overall Study|Death|17|||
48821232|NCT03248479|157187410|FG005|Overall Study|Death|6|||
48821233|NCT03248479|157187411|FG006|Overall Study|Death|1|||
48821234|NCT03248479|157187412|FG007|Overall Study|Death|14|||
48821235|NCT03248479|157187413|FG008|Overall Study|Death|3|||
48821236|NCT03248479|157187414|FG009|Overall Study|Death|7|||
48821237|NCT03248479|157187415|FG010|Overall Study|Death|3|||
48821238|NCT03248479|157187416|FG011|Overall Study|Death|1|||
48727023|NCT02038829|156851518|FG006|Treatment Period 2|Withdrawal by Subject|0|||
48821239|NCT03248479|157187417|FG012|Overall Study|Death|1|||
48382034|NCT01241552|155595051|FG000|Overall Study|Protocol Violation|0|||
48382035|NCT01241552|155595052|FG001|Overall Study|Protocol Violation|2|||
48382036|NCT01241552|155595053|FG002|Overall Study|Protocol Violation|6|||
48382037|NCT01241552|155595054|FG003|Overall Study|Protocol Violation|1|||
48382038|NCT01241552|155595051|FG000|Overall Study|Withdrawal by Subject|7|||
48382039|NCT01241552|155595052|FG001|Overall Study|Withdrawal by Subject|15|||
48727024|NCT02038829|156851519|FG007|Treatment Period 2|Withdrawal by Subject|0|||
48727025|NCT02038829|156851520|FG008|Treatment Period 2|Withdrawal by Subject|0|||
48727026|NCT02038829|156851521|FG009|Treatment Period 2|Withdrawal by Subject|0|||
48727027|NCT02038829|156851522|FG010|Treatment Period 2|Withdrawal by Subject|0|||
48727028|NCT02038829|156851523|FG011|Treatment Period 2|Withdrawal by Subject|0|||
48727029|NCT02038829|156851512|FG000|Washout Period 2|Adverse Event|0|||
48727030|NCT02038829|156851513|FG001|Washout Period 2|Adverse Event|0|||
48727031|NCT02038829|156851514|FG002|Washout Period 2|Adverse Event|0|||
48727032|NCT02038829|156851515|FG003|Washout Period 2|Adverse Event|0|||
48727033|NCT02038829|156851516|FG004|Washout Period 2|Adverse Event|0|||
48727034|NCT02038829|156851517|FG005|Washout Period 2|Adverse Event|0|||
48727035|NCT02038829|156851518|FG006|Washout Period 2|Adverse Event|0|||
48727036|NCT02038829|156851519|FG007|Washout Period 2|Adverse Event|0|||
48727037|NCT02038829|156851520|FG008|Washout Period 2|Adverse Event|1|||
48727038|NCT02038829|156851521|FG009|Washout Period 2|Adverse Event|0|||
48727039|NCT02038829|156851522|FG010|Washout Period 2|Adverse Event|0|||
48727040|NCT02038829|156851523|FG011|Washout Period 2|Adverse Event|0|||
48727041|NCT02038829|156851512|FG000|Washout Period 2|Withdrawal by Subject|0|||
48727042|NCT02038829|156851513|FG001|Washout Period 2|Withdrawal by Subject|0|||
48727043|NCT02038829|156851514|FG002|Washout Period 2|Withdrawal by Subject|0|||
48727044|NCT02038829|156851515|FG003|Washout Period 2|Withdrawal by Subject|0|||
48727045|NCT02038829|156851516|FG004|Washout Period 2|Withdrawal by Subject|0|||
48727046|NCT02038829|156851517|FG005|Washout Period 2|Withdrawal by Subject|1|||
48727047|NCT02038829|156851518|FG006|Washout Period 2|Withdrawal by Subject|0|||
48727048|NCT02038829|156851519|FG007|Washout Period 2|Withdrawal by Subject|0|||
48727049|NCT02038829|156851520|FG008|Washout Period 2|Withdrawal by Subject|0|||
48727050|NCT02038829|156851521|FG009|Washout Period 2|Withdrawal by Subject|0|||
48727051|NCT02038829|156851522|FG010|Washout Period 2|Withdrawal by Subject|0|||
48727052|NCT02038829|156851523|FG011|Washout Period 2|Withdrawal by Subject|0|||
48727053|NCT02038829|156851512|FG000|Treatment Period 4|Adverse Event|0|||
48727054|NCT02038829|156851513|FG001|Treatment Period 4|Adverse Event|1|||
48727055|NCT02038829|156851514|FG002|Treatment Period 4|Adverse Event|0|||
48727056|NCT02038829|156851515|FG003|Treatment Period 4|Adverse Event|0|||
48727057|NCT02038829|156851516|FG004|Treatment Period 4|Adverse Event|0|||
48727058|NCT02038829|156851517|FG005|Treatment Period 4|Adverse Event|0|||
48727059|NCT02038829|156851518|FG006|Treatment Period 4|Adverse Event|0|||
48727060|NCT02038829|156851519|FG007|Treatment Period 4|Adverse Event|0|||
48727061|NCT02038829|156851520|FG008|Treatment Period 4|Adverse Event|0|||
48727062|NCT02038829|156851521|FG009|Treatment Period 4|Adverse Event|0|||
48821240|NCT03248479|157187405|FG000|Overall Study|Study terminated by sponsor|12|||
48821241|NCT03248479|157187406|FG001|Overall Study|Study terminated by sponsor|15|||
48821242|NCT03248479|157187407|FG002|Overall Study|Study terminated by sponsor|0|||
48821243|NCT03248479|157187408|FG003|Overall Study|Study terminated by sponsor|5|||
48382040|NCT01241552|155595053|FG002|Overall Study|Withdrawal by Subject|14|||
48727063|NCT02038829|156851522|FG010|Treatment Period 4|Adverse Event|0|||
48727064|NCT02038829|156851523|FG011|Treatment Period 4|Adverse Event|0|||
48727065|NCT02038829|156851512|FG000|Washout Period 4|Adverse Event|0|||
48727066|NCT02038829|156851513|FG001|Washout Period 4|Adverse Event|0|||
48727067|NCT02038829|156851514|FG002|Washout Period 4|Adverse Event|0|||
48821244|NCT03248479|157187409|FG004|Overall Study|Study terminated by sponsor|0|||
48727068|NCT02038829|156851515|FG003|Washout Period 4|Adverse Event|0|||
48821245|NCT03248479|157187410|FG005|Overall Study|Study terminated by sponsor|0|||
48727069|NCT02038829|156851516|FG004|Washout Period 4|Adverse Event|0|||
48727070|NCT02038829|156851517|FG005|Washout Period 4|Adverse Event|0|||
48727071|NCT02038829|156851518|FG006|Washout Period 4|Adverse Event|1|||
48727072|NCT02038829|156851519|FG007|Washout Period 4|Adverse Event|0|||
48727073|NCT02038829|156851520|FG008|Washout Period 4|Adverse Event|0|||
48727074|NCT02038829|156851521|FG009|Washout Period 4|Adverse Event|0|||
48821246|NCT03248479|157187411|FG006|Overall Study|Study terminated by sponsor|0|||
48727075|NCT02038829|156851522|FG010|Washout Period 4|Adverse Event|0|||
48727076|NCT02038829|156851523|FG011|Washout Period 4|Adverse Event|0|||
48821247|NCT03248479|157187412|FG007|Overall Study|Study terminated by sponsor|1|||
48821248|NCT03248479|157187413|FG008|Overall Study|Study terminated by sponsor|1|||
48821249|NCT03248479|157187414|FG009|Overall Study|Study terminated by sponsor|0|||
48821250|NCT03248479|157187415|FG010|Overall Study|Study terminated by sponsor|5|||
48821251|NCT03248479|157187416|FG011|Overall Study|Study terminated by sponsor|4|||
48821252|NCT03248479|157187417|FG012|Overall Study|Study terminated by sponsor|0|||
48821253|NCT03248479|157187405|FG000|Overall Study|Consent withdrawn|6|||
48821254|NCT03248479|157187406|FG001|Overall Study|Consent withdrawn|3|||
48821255|NCT03248479|157187407|FG002|Overall Study|Consent withdrawn|0|||
48821256|NCT03248479|157187408|FG003|Overall Study|Consent withdrawn|9|||
48821257|NCT03248479|157187409|FG004|Overall Study|Consent withdrawn|1|||
48821258|NCT03248479|157187410|FG005|Overall Study|Consent withdrawn|0|||
48821259|NCT03248479|157187411|FG006|Overall Study|Consent withdrawn|0|||
48821260|NCT03248479|157187412|FG007|Overall Study|Consent withdrawn|1|||
48821261|NCT03248479|157187413|FG008|Overall Study|Consent withdrawn|0|||
48821262|NCT03248479|157187414|FG009|Overall Study|Consent withdrawn|3|||
48821263|NCT03248479|157187415|FG010|Overall Study|Consent withdrawn|1|||
48821264|NCT03248479|157187416|FG011|Overall Study|Consent withdrawn|0|||
48821265|NCT03248479|157187417|FG012|Overall Study|Consent withdrawn|1|||
48821266|NCT03248479|157187405|FG000|Overall Study|Lost to Follow-up|2|||
48821267|NCT03248479|157187406|FG001|Overall Study|Lost to Follow-up|1|||
48821268|NCT03248479|157187407|FG002|Overall Study|Lost to Follow-up|0|||
48821269|NCT03248479|157187408|FG003|Overall Study|Lost to Follow-up|0|||
48821270|NCT03248479|157187409|FG004|Overall Study|Lost to Follow-up|0|||
48821271|NCT03248479|157187410|FG005|Overall Study|Lost to Follow-up|0|||
48821272|NCT03248479|157187411|FG006|Overall Study|Lost to Follow-up|0|||
48821273|NCT03248479|157187412|FG007|Overall Study|Lost to Follow-up|0|||
48821274|NCT03248479|157187413|FG008|Overall Study|Lost to Follow-up|0|||
48821275|NCT03248479|157187414|FG009|Overall Study|Lost to Follow-up|0|||
48821276|NCT03248479|157187415|FG010|Overall Study|Lost to Follow-up|0|||
48821277|NCT03248479|157187416|FG011|Overall Study|Lost to Follow-up|0|||
48821278|NCT03248479|157187417|FG012|Overall Study|Lost to Follow-up|1|||
48821279|NCT03248479|157187405|FG000|Overall Study|Not reported|0|||
48821280|NCT03248479|157187406|FG001|Overall Study|Not reported|0|||
48821281|NCT03248479|157187407|FG002|Overall Study|Not reported|0|||
48821282|NCT03248479|157187408|FG003|Overall Study|Not reported|1|||
48821283|NCT03248479|157187409|FG004|Overall Study|Not reported|1|||
48821284|NCT03248479|157187410|FG005|Overall Study|Not reported|0|||
48821285|NCT03248479|157187411|FG006|Overall Study|Not reported|0|||
48821286|NCT03248479|157187412|FG007|Overall Study|Not reported|1|||
48821287|NCT03248479|157187413|FG008|Overall Study|Not reported|1|||
48821288|NCT03248479|157187414|FG009|Overall Study|Not reported|0|||
48821289|NCT03248479|157187415|FG010|Overall Study|Not reported|0|||
48821290|NCT03248479|157187416|FG011|Overall Study|Not reported|0|||
48821291|NCT03248479|157187417|FG012|Overall Study|Not reported|0|||
48821292|NCT04626427|157187418|FG000|Overall Study|Death|1|||
48821293|NCT04626427|157187418|FG000|Overall Study|Withdrawal by Subject|1|||
48821294|NCT04626427|157187418|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
48821295|NCT04626427|157187418|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
48821296|NCT01349829|157188638|FG000|Overall Study|Lost to Follow-up|4|||
48821297|NCT01349829|157188639|FG001|Overall Study|Lost to Follow-up|8|||
48821298|NCT01349829|157188638|FG000|Overall Study|Consent withdrawal|3|||
48509648|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509649|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509650|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
48509651|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509652|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509653|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48727077|NCT02038829|156851512|FG000|Treatment Period 6|Adverse Event|0|||
48727078|NCT02038829|156851513|FG001|Treatment Period 6|Adverse Event|0|||
48821299|NCT01349829|157188639|FG001|Overall Study|Consent withdrawal|8|||
48821300|NCT01349829|157188638|FG000|Overall Study|Migrated/moved|2|||
48821301|NCT01349829|157188639|FG001|Overall Study|Migrated/moved|7|||
48821302|NCT00231179|157188642|FG000|Overall Study|Lost to Follow-up|21|||
48821303|NCT00231179|157188643|FG001|Overall Study|Lost to Follow-up|21|||
48821304|NCT00231179|157188642|FG000|Overall Study|Withdrawal by Subject|3|||
48821305|NCT00231179|157188643|FG001|Overall Study|Withdrawal by Subject|3|||
48821306|NCT00262743|157188644|FG000|Overall Study|Adverse Event|0|||
48382041|NCT01241552|155595054|FG003|Overall Study|Withdrawal by Subject|15|||
48382042|NCT01241552|155595051|FG000|Overall Study|Physician Decision|2|||
48382043|NCT01241552|155595052|FG001|Overall Study|Physician Decision|4|||
48382044|NCT01241552|155595053|FG002|Overall Study|Physician Decision|2|||
48382045|NCT01241552|155595054|FG003|Overall Study|Physician Decision|3|||
48382046|NCT01241552|155595051|FG000|Overall Study|Lost to Follow-up|2|||
48382047|NCT01241552|155595052|FG001|Overall Study|Lost to Follow-up|11|||
48382048|NCT01241552|155595053|FG002|Overall Study|Lost to Follow-up|15|||
48382049|NCT01241552|155595054|FG003|Overall Study|Lost to Follow-up|16|||
48382050|NCT00528866|155595055|FG000|Overall Study|Protocol Violation|6|||
48509654|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509655|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48600950|NCT01249417|156395990|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
48727079|NCT02038829|156851514|FG002|Treatment Period 6|Adverse Event|1|||
48727080|NCT02038829|156851515|FG003|Treatment Period 6|Adverse Event|0|||
48727081|NCT02038829|156851516|FG004|Treatment Period 6|Adverse Event|0|||
48727082|NCT02038829|156851517|FG005|Treatment Period 6|Adverse Event|0|||
48727083|NCT02038829|156851518|FG006|Treatment Period 6|Adverse Event|0|||
48727084|NCT02038829|156851519|FG007|Treatment Period 6|Adverse Event|0|||
48727085|NCT02038829|156851520|FG008|Treatment Period 6|Adverse Event|0|||
48727086|NCT02038829|156851521|FG009|Treatment Period 6|Adverse Event|0|||
48727087|NCT02038829|156851522|FG010|Treatment Period 6|Adverse Event|0|||
48727088|NCT02038829|156851523|FG011|Treatment Period 6|Adverse Event|0|||
48727089|NCT01117051|156851528|FG000|Overall Study|Withdrawal by Subject|5|||
48727090|NCT01117051|156851529|FG001|Overall Study|Withdrawal by Subject|3|||
48727091|NCT01117051|156851528|FG000|Overall Study|Adverse Event|4|||
48727092|NCT01117051|156851529|FG001|Overall Study|Adverse Event|3|||
48727093|NCT01117051|156851528|FG000|Overall Study|Lost to Follow-up|0|||
48727094|NCT01117051|156851529|FG001|Overall Study|Lost to Follow-up|1|||
48727095|NCT01117051|156851528|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
48727096|NCT01117051|156851529|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
48727097|NCT01117051|156851528|FG000|Overall Study|Sponsor's decision|3|||
48727098|NCT01117051|156851529|FG001|Overall Study|Sponsor's decision|1|||
48727099|NCT01117051|156851528|FG000|Overall Study|Surgical procedure|0|||
48727100|NCT01117051|156851529|FG001|Overall Study|Surgical procedure|1|||
48727101|NCT01117051|156851528|FG000|Overall Study|Randomized by mistake|0|||
48727102|NCT01117051|156851529|FG001|Overall Study|Randomized by mistake|1|||
48727103|NCT01117051|156851528|FG000|Overall Study|Convenience issue|1|||
48727104|NCT01117051|156851529|FG001|Overall Study|Convenience issue|0|||
48727105|NCT01479985|156851530|FG000|Overall Study|Tablet malfunction, no data saved|1|||
48727106|NCT01479985|156851531|FG001|Overall Study|Tablet malfunction, no data saved|1|||
48727107|NCT01479985|156851530|FG000|Overall Study|No decisional conflict scale responses|0|||
48727108|NCT01479985|156851531|FG001|Overall Study|No decisional conflict scale responses|2|||
48727109|NCT01479985|156851530|FG000|Overall Study|No post-visit survey|5|||
48727110|NCT01479985|156851531|FG001|Overall Study|No post-visit survey|3|||
48727111|NCT00367770|156851532|FG000|Overall Study|Adverse Event|1|||
48727112|NCT00367770|156851532|FG000|Overall Study|Withdrawal by Subject|1|||
48727113|NCT02480712|156851533|FG000|Overall Study|Enrolled but Never Treated|1|||
48727114|NCT02480712|156851533|FG000|Overall Study|Lost to Follow-up|5|||
48727115|NCT02480712|156851533|FG000|Overall Study|Withdrew Consent|3|||
48727116|NCT02480712|156851533|FG000|Overall Study|Death|1|||
48727117|NCT02480712|156851533|FG000|Overall Study|Lack of Efficacy|1|||
48727118|NCT01751802|156851534|FG000|Overall Study|Adverse Event|4|||
48727119|NCT01751802|156851535|FG001|Overall Study|Adverse Event|2|||
48727120|NCT00442468|156851536|FG000|Overall Study|Adverse Event|4|||
48727121|NCT00442468|156851536|FG000|Overall Study|Withdrawal by Subject|91|||
48509656|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
48509657|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509658|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509659|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
48509660|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
48509661|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
48509662|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
48509663|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509664|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509665|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509666|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509667|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48727122|NCT00442468|156851536|FG000|Overall Study|Did not complete all study procedures|88|||
48727123|NCT01721577|156851543|FG000|Overall Study|Lack of Efficacy|1|||
48727124|NCT01721577|156851544|FG001|Overall Study|Lack of Efficacy|0|||
48727125|NCT01721577|156851543|FG000|Overall Study|Death|1|||
48727126|NCT01721577|156851544|FG001|Overall Study|Death|0|||
48727127|NCT01721577|156851543|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
48509668|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509669|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509670|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48727128|NCT01721577|156851544|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
48727129|NCT01721577|156851543|FG000|Overall Study|Adverse Event|0|||
48727130|NCT01721577|156851544|FG001|Overall Study|Adverse Event|2|||
48727131|NCT01151098|156851545|FG000|Overall Study|Adverse Event|82|||
48727132|NCT01151098|156851545|FG000|Overall Study|Lost to Follow-up|6|||
48727133|NCT01151098|156851545|FG000|Overall Study|Lack of Efficacy|15|||
48727134|NCT01151098|156851545|FG000|Overall Study|Protocol Violation|1|||
48727135|NCT01151098|156851545|FG000|Overall Study|Miscellaneous|13|||
48727136|NCT02325791|156851553|FG000|Overall Study|Adverse Event|0|||
48727137|NCT02325791|156851554|FG001|Overall Study|Adverse Event|1|||
48727138|NCT02325791|156851555|FG002|Overall Study|Adverse Event|1|||
48727139|NCT02325791|156851556|FG003|Overall Study|Adverse Event|0|||
48727140|NCT02325791|156851553|FG000|Overall Study|Death|0|||
48727141|NCT02325791|156851554|FG001|Overall Study|Death|3|||
48727142|NCT02325791|156851555|FG002|Overall Study|Death|0|||
48727143|NCT02325791|156851556|FG003|Overall Study|Death|1|||
48727144|NCT02325791|156851553|FG000|Overall Study|Lost to Follow-up|0|||
48727145|NCT02325791|156851554|FG001|Overall Study|Lost to Follow-up|15|||
48727146|NCT02325791|156851555|FG002|Overall Study|Lost to Follow-up|14|||
48727147|NCT02325791|156851556|FG003|Overall Study|Lost to Follow-up|9|||
48727148|NCT02325791|156851553|FG000|Overall Study|Physician Decision|0|||
48727149|NCT02325791|156851554|FG001|Overall Study|Physician Decision|1|||
48727150|NCT02325791|156851555|FG002|Overall Study|Physician Decision|1|||
48727151|NCT02325791|156851556|FG003|Overall Study|Physician Decision|0|||
48727152|NCT02325791|156851553|FG000|Overall Study|Protocol Violation|0|||
48727153|NCT02325791|156851554|FG001|Overall Study|Protocol Violation|0|||
48727154|NCT02325791|156851555|FG002|Overall Study|Protocol Violation|1|||
48727155|NCT02325791|156851556|FG003|Overall Study|Protocol Violation|0|||
48727156|NCT02325791|156851553|FG000|Overall Study|Withdrawal by Subject|0|||
48727157|NCT02325791|156851554|FG001|Overall Study|Withdrawal by Subject|5|||
48727158|NCT02325791|156851555|FG002|Overall Study|Withdrawal by Subject|8|||
48727159|NCT02325791|156851556|FG003|Overall Study|Withdrawal by Subject|16|||
48727160|NCT02456103|156851558|FG000|Overall Study|Study Closure|207|||
48727161|NCT02456103|156851558|FG000|Overall Study|Physician Decision|1|||
48727162|NCT02456103|156851558|FG000|Overall Study|Required prohibited medications|5|||
48727163|NCT02456103|156851558|FG000|Overall Study|Protocol Violation|1|||
48727164|NCT02456103|156851558|FG000|Overall Study|Adverse Event|5|||
48727165|NCT02456103|156851558|FG000|Overall Study|Abnormal Laboratory Value|2|||
48727166|NCT02456103|156851558|FG000|Overall Study|Lost to Follow-up|1|||
48727167|NCT02456103|156851558|FG000|Overall Study|Withdrawal by Subject|24|||
48727168|NCT01975831|156851559|FG000|Overall Study|Adverse Event|1|||
48727169|NCT01975831|156851560|FG001|Overall Study|Adverse Event|2|||
48727170|NCT01975831|156851561|FG002|Overall Study|Adverse Event|2|||
48727171|NCT01975831|156851562|FG003|Overall Study|Adverse Event|0|||
48727172|NCT01975831|156851563|FG004|Overall Study|Adverse Event|1|||
48727173|NCT01975831|156851564|FG005|Overall Study|Adverse Event|1|||
48727174|NCT01975831|156851565|FG006|Overall Study|Adverse Event|3|||
48727175|NCT01975831|156851566|FG007|Overall Study|Adverse Event|4|||
48727176|NCT01975831|156851567|FG008|Overall Study|Adverse Event|1|||
48727177|NCT01975831|156851559|FG000|Overall Study|Death|1|||
48727178|NCT01975831|156851560|FG001|Overall Study|Death|1|||
48727179|NCT01975831|156851561|FG002|Overall Study|Death|0|||
48727180|NCT01975831|156851562|FG003|Overall Study|Death|0|||
48727181|NCT01975831|156851563|FG004|Overall Study|Death|1|||
48727182|NCT01975831|156851564|FG005|Overall Study|Death|0|||
48727183|NCT01975831|156851565|FG006|Overall Study|Death|1|||
48727184|NCT01975831|156851566|FG007|Overall Study|Death|0|||
48727185|NCT01975831|156851567|FG008|Overall Study|Death|0|||
48727186|NCT01975831|156851559|FG000|Overall Study|Progressive Disease|1|||
48727187|NCT01975831|156851560|FG001|Overall Study|Progressive Disease|3|||
48727188|NCT01975831|156851561|FG002|Overall Study|Progressive Disease|2|||
48727189|NCT01975831|156851562|FG003|Overall Study|Progressive Disease|4|||
48727190|NCT01975831|156851563|FG004|Overall Study|Progressive Disease|13|||
48727191|NCT01975831|156851564|FG005|Overall Study|Progressive Disease|9|||
48727192|NCT01975831|156851565|FG006|Overall Study|Progressive Disease|10|||
48727193|NCT01975831|156851566|FG007|Overall Study|Progressive Disease|8|||
48727194|NCT01975831|156851567|FG008|Overall Study|Progressive Disease|10|||
48727195|NCT01975831|156851559|FG000|Overall Study|Withdrawal by Subject|0|||
48727196|NCT01975831|156851560|FG001|Overall Study|Withdrawal by Subject|3|||
48727197|NCT01975831|156851561|FG002|Overall Study|Withdrawal by Subject|0|||
48727198|NCT01975831|156851562|FG003|Overall Study|Withdrawal by Subject|0|||
48727199|NCT01975831|156851563|FG004|Overall Study|Withdrawal by Subject|3|||
48727200|NCT01975831|156851564|FG005|Overall Study|Withdrawal by Subject|1|||
48727201|NCT01975831|156851565|FG006|Overall Study|Withdrawal by Subject|1|||
48727202|NCT01975831|156851566|FG007|Overall Study|Withdrawal by Subject|0|||
48727203|NCT01975831|156851567|FG008|Overall Study|Withdrawal by Subject|0|||
48727204|NCT01975831|156851559|FG000|Overall Study|Physician Decision|0|||
48509671|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
48509672|NCT01597245|156058977|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509673|NCT01597245|156058978|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509674|NCT01597245|156058979|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509675|NCT01597245|156058980|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509676|NCT01597245|156058981|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509677|NCT01597245|156058982|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509678|NCT01597245|156058983|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509679|NCT01597245|156058984|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48600951|NCT01249417|156395991|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
48600952|NCT01249417|156395989|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
48600953|NCT01249417|156395990|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
48600954|NCT01249417|156395991|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
48727205|NCT01975831|156851560|FG001|Overall Study|Physician Decision|0|||
48727206|NCT01975831|156851561|FG002|Overall Study|Physician Decision|0|||
48727207|NCT01975831|156851562|FG003|Overall Study|Physician Decision|0|||
48727208|NCT01975831|156851563|FG004|Overall Study|Physician Decision|0|||
48727209|NCT01975831|156851564|FG005|Overall Study|Physician Decision|1|||
48727210|NCT01975831|156851565|FG006|Overall Study|Physician Decision|0|||
48727211|NCT01975831|156851566|FG007|Overall Study|Physician Decision|1|||
48727212|NCT01975831|156851567|FG008|Overall Study|Physician Decision|0|||
48727213|NCT01975831|156851559|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
48727214|NCT01975831|156851560|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
48727215|NCT01975831|156851561|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
48727216|NCT01975831|156851562|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
48727217|NCT01975831|156851563|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
48727218|NCT01975831|156851564|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
48727219|NCT01975831|156851565|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
48727220|NCT01975831|156851566|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
48727221|NCT01975831|156851567|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
48727222|NCT01975831|156851559|FG000|Overall Study|Entered Hospice|0|||
48727223|NCT01975831|156851560|FG001|Overall Study|Entered Hospice|0|||
48727224|NCT01975831|156851561|FG002|Overall Study|Entered Hospice|0|||
48727225|NCT01975831|156851562|FG003|Overall Study|Entered Hospice|0|||
48727226|NCT01975831|156851563|FG004|Overall Study|Entered Hospice|0|||
48727227|NCT01975831|156851564|FG005|Overall Study|Entered Hospice|1|||
48727228|NCT01975831|156851565|FG006|Overall Study|Entered Hospice|0|||
48727229|NCT01975831|156851566|FG007|Overall Study|Entered Hospice|0|||
48727230|NCT01975831|156851567|FG008|Overall Study|Entered Hospice|0|||
48727231|NCT01975831|156851559|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727232|NCT01975831|156851560|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727233|NCT01975831|156851561|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727234|NCT01975831|156851562|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727235|NCT01975831|156851563|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727236|NCT01975831|156851564|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727237|NCT01975831|156851565|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
48727238|NCT01975831|156851566|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
48727239|NCT01975831|156851567|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
48727240|NCT03614975|156851568|FG000|Overall Study|Physician Decision|7|||
48727241|NCT03614975|156851569|FG001|Overall Study|Physician Decision|5|||
48727242|NCT03614975|156851568|FG000|Overall Study|Withdrawal by Subject|2|||
48727243|NCT03614975|156851569|FG001|Overall Study|Withdrawal by Subject|2|||
48727244|NCT03614975|156851568|FG000|Overall Study|Specimens not in lab batch shipment|1|||
48727245|NCT03614975|156851569|FG001|Overall Study|Specimens not in lab batch shipment|1|||
48727246|NCT02581943|156851570|FG000|Overall Study|Death|5|||
48727247|NCT02581943|156851571|FG001|Overall Study|Death|2|||
48727248|NCT02581943|156851570|FG000|Overall Study|Disease Progression|12|||
48727249|NCT02581943|156851571|FG001|Overall Study|Disease Progression|15|||
48727250|NCT02581943|156851570|FG000|Overall Study|Withdrawal by Subject|1|||
48727251|NCT02581943|156851571|FG001|Overall Study|Withdrawal by Subject|2|||
48727252|NCT02536833|156851574|FG000|Overall Study|Discontinued Before Treatment|0|||
48727253|NCT02536833|156851575|FG001|Overall Study|Discontinued Before Treatment|0|||
48727254|NCT02536833|156851576|FG002|Overall Study|Discontinued Before Treatment|1|||
48727255|NCT02536833|156851577|FG003|Overall Study|Discontinued Before Treatment|2|||
48727256|NCT02536833|156851574|FG000|Overall Study|Adverse Event|1|||
48727257|NCT02536833|156851575|FG001|Overall Study|Adverse Event|3|||
48727258|NCT02536833|156851576|FG002|Overall Study|Adverse Event|4|||
48727259|NCT02536833|156851577|FG003|Overall Study|Adverse Event|1|||
48727260|NCT02536833|156851574|FG000|Overall Study|Lost to Follow-up|2|||
48727261|NCT02536833|156851575|FG001|Overall Study|Lost to Follow-up|1|||
48727262|NCT02536833|156851576|FG002|Overall Study|Lost to Follow-up|2|||
48727263|NCT02536833|156851577|FG003|Overall Study|Lost to Follow-up|2|||
48509680|NCT01597245|156058985|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509681|NCT01597245|156058986|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509682|NCT01597245|156058987|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
48509683|NCT01597245|156058988|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509684|NCT01597245|156058989|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509685|NCT01597245|156058990|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509686|NCT01597245|156058991|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509687|NCT01597245|156058992|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509688|NCT01597245|156058993|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509689|NCT01597245|156058994|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509690|NCT01597245|156058995|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509691|NCT01597245|156058996|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509692|NCT01597245|156058997|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
48509693|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509694|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509695|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509696|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509697|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509698|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509699|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509700|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509701|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509702|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509703|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509704|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509705|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509706|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
48509707|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
48509708|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
48509709|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509710|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509711|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509712|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509713|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
48509714|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509715|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509716|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509717|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509718|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509719|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509720|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509721|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509722|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509723|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509724|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509725|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509726|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509727|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
48509728|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
48509729|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
48509730|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48727264|NCT02536833|156851574|FG000|Overall Study|Physician Decision|0|||
48727265|NCT02536833|156851575|FG001|Overall Study|Physician Decision|0|||
48727266|NCT02536833|156851576|FG002|Overall Study|Physician Decision|0|||
48727267|NCT02536833|156851577|FG003|Overall Study|Physician Decision|1|||
48727268|NCT02536833|156851574|FG000|Overall Study|Site Terminated by Sponsor|2|||
48727269|NCT02536833|156851575|FG001|Overall Study|Site Terminated by Sponsor|2|||
48727270|NCT02536833|156851576|FG002|Overall Study|Site Terminated by Sponsor|2|||
48727271|NCT02536833|156851577|FG003|Overall Study|Site Terminated by Sponsor|2|||
48727272|NCT02536833|156851574|FG000|Overall Study|Subject Non-Compliance|0|||
48727273|NCT02536833|156851575|FG001|Overall Study|Subject Non-Compliance|1|||
48727274|NCT02536833|156851576|FG002|Overall Study|Subject Non-Compliance|1|||
48727275|NCT02536833|156851577|FG003|Overall Study|Subject Non-Compliance|0|||
48727276|NCT02536833|156851574|FG000|Overall Study|Withdrawal by Subject|4|||
48727277|NCT02536833|156851575|FG001|Overall Study|Withdrawal by Subject|3|||
48727278|NCT02536833|156851576|FG002|Overall Study|Withdrawal by Subject|5|||
48600955|NCT01249417|156395989|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
48600956|NCT01249417|156395990|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
48600957|NCT01249417|156395991|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
48600958|NCT00613821|156395992|FG000|Overall Study|Withdrawal by Subject|1|||
48600959|NCT00613821|156395993|FG001|Overall Study|Withdrawal by Subject|0|||
48821307|NCT00262743|157188645|FG001|Overall Study|Adverse Event|9|||
48821308|NCT00262743|157188644|FG000|Overall Study|Disease progression|0|||
48821309|NCT00262743|157188645|FG001|Overall Study|Disease progression|3|||
48821310|NCT02297503|157188650|FG000|Overall Study|Withdrawal by Subject|1|||
48821311|NCT02297503|157188651|FG001|Overall Study|Withdrawal by Subject|1|||
48821312|NCT02297503|157188650|FG000|Overall Study|Protocol Violation|1|||
48821313|NCT02297503|157188651|FG001|Overall Study|Protocol Violation|0|||
48821314|NCT02297503|157188650|FG000|Overall Study|Pregnancy|0|||
48821315|NCT02297503|157188651|FG001|Overall Study|Pregnancy|1|||
48821316|NCT02297503|157188650|FG000|Overall Study|Lost to Follow-up|0|||
48821317|NCT02297503|157188651|FG001|Overall Study|Lost to Follow-up|1|||
48821318|NCT02297503|157188650|FG000|Overall Study|Medical reason|0|||
48727279|NCT02536833|156851577|FG003|Overall Study|Withdrawal by Subject|11|||
48727280|NCT02889562|156851578|FG000|Overall Study|Physician Decision|0|||
48509731|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509732|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509733|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509734|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
48509735|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509736|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509737|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509738|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509739|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509740|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509741|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509742|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509743|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509744|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509745|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509746|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509747|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509748|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509749|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
48509750|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
48509751|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509752|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509753|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509754|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509755|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
48509756|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509757|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509758|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509759|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48600960|NCT00613821|156395992|FG000|Overall Study|Physician Decision|1|||
48600961|NCT00613821|156395993|FG001|Overall Study|Physician Decision|1|||
48727281|NCT02889562|156851579|FG001|Overall Study|Physician Decision|1|||
48727282|NCT02889562|156851578|FG000|Overall Study|Withdrawal by Subject|0|||
48821319|NCT02297503|157188651|FG001|Overall Study|Medical reason|1|||
48600962|NCT04110314|156395994|FG000|Overall Study|Did not meet inclusion criteria|35255|||
48600963|NCT04110314|156395995|FG001|Overall Study|Did not meet inclusion criteria|35104|||
48727283|NCT02889562|156851579|FG001|Overall Study|Withdrawal by Subject|1|||
48727284|NCT00873860|156851580|FG000|Overall Study|Lost to Follow-up|1|||
48727285|NCT00873860|156851581|FG001|Overall Study|Lost to Follow-up|0|||
48727286|NCT00873860|156851582|FG002|Overall Study|Lost to Follow-up|0|||
48727287|NCT00873860|156851583|FG003|Overall Study|Lost to Follow-up|1|||
48600964|NCT04110314|156395996|FG002|Overall Study|Did not meet inclusion criteria|35636|||
48727288|NCT00873860|156851580|FG000|Overall Study|Withdrawal by Subject|1|||
48727289|NCT00873860|156851581|FG001|Overall Study|Withdrawal by Subject|0|||
48727290|NCT00873860|156851582|FG002|Overall Study|Withdrawal by Subject|2|||
48727291|NCT00873860|156851583|FG003|Overall Study|Withdrawal by Subject|0|||
48727292|NCT00873860|156851580|FG000|Overall Study|Death|1|||
48821320|NCT01154036|157188652|FG000|Phase I|Physician Decision|0|||
48821321|NCT01154036|157188653|FG001|Phase I|Physician Decision|1|||
48821322|NCT01154036|157188654|FG002|Phase I|Physician Decision|0|||
48821323|NCT01154036|157188655|FG003|Phase I|Physician Decision|0|||
48727293|NCT00873860|156851581|FG001|Overall Study|Death|0|||
48509760|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509761|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509762|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509763|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509764|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509765|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509766|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509767|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509768|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509769|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509770|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
48509771|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
48509772|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509773|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509774|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509775|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509776|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
48509777|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509778|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509779|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509780|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509781|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509782|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509783|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509784|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509785|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509786|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509787|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509788|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509789|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509790|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
48509791|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
48509792|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
48509793|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509794|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509795|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509796|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509797|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
48509798|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509799|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509800|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509801|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509802|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509803|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509804|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509805|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509806|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509807|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509808|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509809|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
48727294|NCT00873860|156851582|FG002|Overall Study|Death|0|||
48727295|NCT00873860|156851583|FG003|Overall Study|Death|0|||
48727296|NCT00873860|156851580|FG000|Overall Study|Other|1|||
48727297|NCT00873860|156851581|FG001|Overall Study|Other|0|||
48727298|NCT00873860|156851582|FG002|Overall Study|Other|1|||
48727299|NCT00873860|156851583|FG003|Overall Study|Other|0|||
48727300|NCT00321893|156851586|FG000|Overall Study|Non-Compliance/Refusal|16|||
48727301|NCT00321893|156851587|FG001|Overall Study|Non-Compliance/Refusal|10|||
48727302|NCT00321893|156851586|FG000|Overall Study|Lost to Follow-up|2|||
48727303|NCT00321893|156851587|FG001|Overall Study|Lost to Follow-up|1|||
48727304|NCT00321893|156851586|FG000|Overall Study|Adverse Event|6|||
48727305|NCT00321893|156851587|FG001|Overall Study|Adverse Event|3|||
48727306|NCT00769483|156851588|FG000|Overall Study|Withdrawal by Subject|0|||
48727307|NCT00769483|156851589|FG001|Overall Study|Withdrawal by Subject|1|||
48727308|NCT00769483|156851590|FG002|Overall Study|Withdrawal by Subject|0|||
48727309|NCT00769483|156851591|FG003|Overall Study|Withdrawal by Subject|0|||
48821324|NCT01154036|157188656|FG004|Phase I|Physician Decision|0|||
48821325|NCT01154036|157188657|FG005|Phase I|Physician Decision|0|||
48727310|NCT00769483|156851592|FG004|Overall Study|Withdrawal by Subject|1|||
48727311|NCT00769483|156851593|FG005|Overall Study|Withdrawal by Subject|0|||
48727312|NCT03455764|156851594|FG000|Overall Study|Adverse Event|1|||
48727313|NCT03455764|156851595|FG001|Overall Study|Adverse Event|0|||
48727314|NCT03455764|156851596|FG002|Overall Study|Adverse Event|0|||
48727315|NCT03455764|156851597|FG003|Overall Study|Adverse Event|0|||
48727316|NCT03455764|156851598|FG004|Overall Study|Adverse Event|0|||
48727317|NCT03455764|156851594|FG000|Overall Study|Disease Progression|4|||
48727318|NCT03455764|156851595|FG001|Overall Study|Disease Progression|0|||
48727319|NCT03455764|156851596|FG002|Overall Study|Disease Progression|0|||
48727320|NCT03455764|156851597|FG003|Overall Study|Disease Progression|0|||
48727321|NCT03455764|156851598|FG004|Overall Study|Disease Progression|0|||
48727322|NCT03455764|156851594|FG000|Overall Study|On Treatment|1|||
48727323|NCT03455764|156851595|FG001|Overall Study|On Treatment|0|||
48727324|NCT03455764|156851596|FG002|Overall Study|On Treatment|0|||
48727325|NCT03455764|156851597|FG003|Overall Study|On Treatment|0|||
48727326|NCT03455764|156851598|FG004|Overall Study|On Treatment|0|||
48727327|NCT01172275|156851599|FG000|Overall Study|Lost to Follow-up|1|||
48727328|NCT01172275|156851600|FG001|Overall Study|Lost to Follow-up|0|||
48727329|NCT01172275|156851599|FG000|Overall Study|Protocol Violation|1|||
48727330|NCT01172275|156851600|FG001|Overall Study|Protocol Violation|0|||
48727331|NCT00194675|156851611|FG000|Overall Study|Lost to Follow-up|1|||
48727332|NCT00194675|156851612|FG001|Overall Study|Lost to Follow-up|1|||
48509810|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509811|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
48727333|NCT00194675|156851611|FG000|Overall Study|lack of interest|1|||
48727334|NCT00194675|156851612|FG001|Overall Study|lack of interest|1|||
48727335|NCT00194675|156851611|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
48727336|NCT00194675|156851612|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
48821326|NCT01154036|157188658|FG006|Phase I|Physician Decision|0|||
48821327|NCT01154036|157188659|FG007|Phase I|Physician Decision|0|||
48509812|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
48509813|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
48509814|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509815|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509816|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509817|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509818|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
48509819|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48821328|NCT01154036|157188652|FG000|Phase I|Lost to Follow-up|0|||
48821329|NCT01154036|157188653|FG001|Phase I|Lost to Follow-up|3|||
48821330|NCT01154036|157188654|FG002|Phase I|Lost to Follow-up|6|||
48821331|NCT01154036|157188655|FG003|Phase I|Lost to Follow-up|0|||
48821332|NCT01154036|157188656|FG004|Phase I|Lost to Follow-up|0|||
48821333|NCT01154036|157188657|FG005|Phase I|Lost to Follow-up|0|||
48821334|NCT01154036|157188658|FG006|Phase I|Lost to Follow-up|0|||
48821335|NCT01154036|157188659|FG007|Phase I|Lost to Follow-up|0|||
48509820|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509821|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509822|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509823|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509824|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509825|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509826|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48821336|NCT01154036|157188652|FG000|Phase I|Protocol Violation|0|||
48509827|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509828|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509829|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509830|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509831|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509832|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509833|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
48727337|NCT00194675|156851611|FG000|Overall Study|Protocol Violation|1|||
48821337|NCT01154036|157188653|FG001|Phase I|Protocol Violation|3|||
48509834|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
48509835|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48727338|NCT00194675|156851612|FG001|Overall Study|Protocol Violation|0|||
48821338|NCT01154036|157188654|FG002|Phase I|Protocol Violation|9|||
48727339|NCT00194675|156851611|FG000|Overall Study|Death|1|||
48727340|NCT00194675|156851612|FG001|Overall Study|Death|0|||
48727341|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Adverse Event|1|||
48727342|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Adverse Event|0|||
48821339|NCT01154036|157188655|FG003|Phase I|Protocol Violation|0|||
48821340|NCT01154036|157188656|FG004|Phase I|Protocol Violation|0|||
48821341|NCT01154036|157188657|FG005|Phase I|Protocol Violation|0|||
48727343|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Adverse Event|0|||
48727344|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Adverse Event|0|||
48727345|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Adverse Event|0|||
48727346|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
48727347|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
48727348|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
48727349|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
48727350|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
48821342|NCT01154036|157188658|FG006|Phase I|Protocol Violation|0|||
48821343|NCT01154036|157188659|FG007|Phase I|Protocol Violation|0|||
48821344|NCT01154036|157188652|FG000|Phase I|Withdrawal by Subject|2|||
48509836|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509837|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509838|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509839|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
48509840|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509841|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509842|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509843|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509844|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509845|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509846|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509847|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509848|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509849|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509850|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509851|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509852|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509853|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509854|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
48509855|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
48509856|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509857|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509858|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48600965|NCT04110314|156395997|FG003|Overall Study|Did not meet inclusion criteria|35135|||
48600966|NCT04110314|156395998|FG004|Overall Study|Did not meet inclusion criteria|35247|||
48600967|NCT04110314|156395999|FG005|Overall Study|Did not meet inclusion criteria|35727|||
48600968|NCT02735980|156396004|FG000|Overall Study|Adverse Event|0|||
48600969|NCT02735980|156396005|FG001|Overall Study|Adverse Event|4|||
48600970|NCT02735980|156396006|FG002|Overall Study|Adverse Event|1|||
48600971|NCT02735980|156396004|FG000|Overall Study|Death|5|||
48600972|NCT02735980|156396005|FG001|Overall Study|Death|4|||
48600973|NCT02735980|156396006|FG002|Overall Study|Death|0|||
48600974|NCT02735980|156396004|FG000|Overall Study|Physician Decision|3|||
48600975|NCT02735980|156396005|FG001|Overall Study|Physician Decision|1|||
48600976|NCT02735980|156396006|FG002|Overall Study|Physician Decision|0|||
48600977|NCT02735980|156396004|FG000|Overall Study|Screen failure|1|||
48600978|NCT02735980|156396005|FG001|Overall Study|Screen failure|0|||
48600979|NCT02735980|156396006|FG002|Overall Study|Screen failure|0|||
48600980|NCT02735980|156396004|FG000|Overall Study|Withdrawal by Subject|1|||
48600981|NCT02735980|156396005|FG001|Overall Study|Withdrawal by Subject|2|||
48600982|NCT02735980|156396006|FG002|Overall Study|Withdrawal by Subject|0|||
48727351|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
48821345|NCT01154036|157188653|FG001|Phase I|Withdrawal by Subject|10|||
48821346|NCT01154036|157188654|FG002|Phase I|Withdrawal by Subject|29|||
48821347|NCT01154036|157188655|FG003|Phase I|Withdrawal by Subject|0|||
48821348|NCT01154036|157188656|FG004|Phase I|Withdrawal by Subject|0|||
48821349|NCT01154036|157188657|FG005|Phase I|Withdrawal by Subject|0|||
48821350|NCT01154036|157188658|FG006|Phase I|Withdrawal by Subject|0|||
48821351|NCT01154036|157188659|FG007|Phase I|Withdrawal by Subject|0|||
48821352|NCT01154036|157188652|FG000|Phase I|Adverse Event|1|||
48821353|NCT01154036|157188653|FG001|Phase I|Adverse Event|11|||
48821354|NCT01154036|157188654|FG002|Phase I|Adverse Event|12|||
48821355|NCT01154036|157188655|FG003|Phase I|Adverse Event|0|||
48821356|NCT01154036|157188656|FG004|Phase I|Adverse Event|0|||
48821357|NCT01154036|157188657|FG005|Phase I|Adverse Event|0|||
48821358|NCT01154036|157188658|FG006|Phase I|Adverse Event|0|||
48821359|NCT01154036|157188659|FG007|Phase I|Adverse Event|0|||
48821360|NCT01154036|157188652|FG000|Phase II|Adverse Event|0|||
48821361|NCT01154036|157188653|FG001|Phase II|Adverse Event|0|||
48821362|NCT01154036|157188654|FG002|Phase II|Adverse Event|0|||
48821363|NCT01154036|157188655|FG003|Phase II|Adverse Event|0|||
48821364|NCT01154036|157188656|FG004|Phase II|Adverse Event|1|||
48821365|NCT01154036|157188657|FG005|Phase II|Adverse Event|1|||
48821366|NCT01154036|157188658|FG006|Phase II|Adverse Event|1|||
48821367|NCT01154036|157188659|FG007|Phase II|Adverse Event|1|||
48727352|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
48727353|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
48727354|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
48727355|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
48727356|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
48727357|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
48727358|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
48727359|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
48727360|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
48727361|NCT00473746|156851613|FG000|Period 1 (Phase 1)|Reason not specified|0|||
48727362|NCT00473746|156851614|FG001|Period 1 (Phase 1)|Reason not specified|1|||
48727363|NCT00473746|156851615|FG002|Period 1 (Phase 1)|Reason not specified|0|||
48727364|NCT00473746|156851616|FG003|Period 1 (Phase 1)|Reason not specified|0|||
48727365|NCT00473746|156851617|FG004|Period 1 (Phase 1)|Reason not specified|0|||
48727366|NCT00473746|156851613|FG000|Period 2 (Phase 2)|Adverse Event|0|||
48727367|NCT00473746|156851614|FG001|Period 2 (Phase 2)|Adverse Event|0|||
48727368|NCT00473746|156851615|FG002|Period 2 (Phase 2)|Adverse Event|0|||
48727369|NCT00473746|156851616|FG003|Period 2 (Phase 2)|Adverse Event|0|||
48727370|NCT00473746|156851617|FG004|Period 2 (Phase 2)|Adverse Event|3|||
48727371|NCT00473746|156851613|FG000|Period 2 (Phase 2)|Death|0|||
48727372|NCT00473746|156851614|FG001|Period 2 (Phase 2)|Death|0|||
48727373|NCT00473746|156851615|FG002|Period 2 (Phase 2)|Death|0|||
48727374|NCT00473746|156851616|FG003|Period 2 (Phase 2)|Death|0|||
48727375|NCT00473746|156851617|FG004|Period 2 (Phase 2)|Death|1|||
48727376|NCT00473746|156851613|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
48727377|NCT00473746|156851614|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
48727378|NCT00473746|156851615|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
48727379|NCT00473746|156851616|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
48727380|NCT00473746|156851617|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
48727381|NCT00473746|156851613|FG000|Period 2 (Phase 2)|Reason not specified|0|||
48727382|NCT00473746|156851614|FG001|Period 2 (Phase 2)|Reason not specified|0|||
48727383|NCT00473746|156851615|FG002|Period 2 (Phase 2)|Reason not specified|0|||
48727384|NCT00473746|156851616|FG003|Period 2 (Phase 2)|Reason not specified|0|||
48727385|NCT00473746|156851617|FG004|Period 2 (Phase 2)|Reason not specified|3|||
48727386|NCT01445886|156851618|FG000|Overall Study|Lost to Follow-up|2|||
48727387|NCT01445886|156851618|FG000|Overall Study|Protocol Violation|3|||
48727388|NCT03224546|156851619|FG000|Overall Study|Lost to Follow-up|9|||
48727389|NCT03224546|156851620|FG001|Overall Study|Lost to Follow-up|8|||
48727390|NCT03224546|156851621|FG002|Overall Study|Lost to Follow-up|3|||
48727391|NCT03224546|156851619|FG000|Overall Study|Withdrawal by Subject|7|||
48727392|NCT03224546|156851620|FG001|Overall Study|Withdrawal by Subject|14|||
48727393|NCT03224546|156851621|FG002|Overall Study|Withdrawal by Subject|12|||
48727394|NCT00976573|156851624|FG000|Overall Study|Ineligible|0|||
48727395|NCT00976573|156851625|FG001|Overall Study|Ineligible|1|||
48727396|NCT00976573|156851624|FG000|Overall Study|Cancel prior to receiving treatment|4|||
48727397|NCT00976573|156851625|FG001|Overall Study|Cancel prior to receiving treatment|2|||
48727398|NCT00937391|156851626|FG000|Stage 2|Withdrawal by Subject|1|||
48727399|NCT00880165|156851635|FG000|Overall Study|Withdrawal by Subject|27|||
48727400|NCT00880165|156851636|FG001|Overall Study|Withdrawal by Subject|23|||
48727401|NCT00880165|156851635|FG000|Overall Study|Not diagnosed with OSA|14|||
48727402|NCT00880165|156851636|FG001|Overall Study|Not diagnosed with OSA|8|||
48727403|NCT00880165|156851635|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
48727404|NCT00880165|156851636|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
48727405|NCT00880165|156851635|FG000|Overall Study|Lost to follow|9|||
48727406|NCT00880165|156851636|FG001|Overall Study|Lost to follow|15|||
48727407|NCT02359851|156851639|FG000|Overall Study|Death|1|||
48727408|NCT02359851|156851639|FG000|Overall Study|Disease progression|1|||
48727409|NCT01854944|156851640|FG000|Overall Study|Withdrawal by Subject|0|||
48727410|NCT01854944|156851641|FG001|Overall Study|Withdrawal by Subject|0|||
48727411|NCT01854944|156851642|FG002|Overall Study|Withdrawal by Subject|1|||
48727412|NCT00323869|156851643|FG000|Overall Study|Death|1|||
48727413|NCT06106022|156851649|FG000|Overall Study|Lost to Follow-up|1|||
48727414|NCT06106022|156851650|FG001|Overall Study|Lost to Follow-up|0|||
48727415|NCT06106022|156851649|FG000|Overall Study|Voluntary Withdrawal|0|||
48727416|NCT06106022|156851650|FG001|Overall Study|Voluntary Withdrawal|2|||
48727417|NCT04085367|156853289|FG000|Overall Study|Adverse Event|1|||
48727418|NCT04085367|156853290|FG001|Overall Study|Adverse Event|1|||
48727419|NCT04085367|156853289|FG000|Overall Study|Withdrawal by Subject|13|||
48727420|NCT04085367|156853290|FG001|Overall Study|Withdrawal by Subject|4|||
48727421|NCT04085367|156853289|FG000|Overall Study|Lost to Follow-up|3|||
48727422|NCT04085367|156853290|FG001|Overall Study|Lost to Follow-up|1|||
48727423|NCT04085367|156853289|FG000|Overall Study|Other unspecified|2|||
48821368|NCT01154036|157188652|FG000|Phase II|Physician Decision|0|||
48821369|NCT01154036|157188653|FG001|Phase II|Physician Decision|0|||
48821370|NCT01154036|157188654|FG002|Phase II|Physician Decision|0|||
48821371|NCT01154036|157188655|FG003|Phase II|Physician Decision|0|||
48821372|NCT01154036|157188656|FG004|Phase II|Physician Decision|0|||
48821373|NCT01154036|157188657|FG005|Phase II|Physician Decision|0|||
48727424|NCT04085367|156853290|FG001|Overall Study|Other unspecified|1|||
48727425|NCT04085367|156853289|FG000|Overall Study|Status Unknown|1|||
48727426|NCT04085367|156853290|FG001|Overall Study|Status Unknown|1|||
48727427|NCT00510874|156853291|FG000|Overall Study|Withdrawal by Subject|1|||
48727428|NCT00510874|156853292|FG001|Overall Study|Withdrawal by Subject|1|||
48727429|NCT00510874|156853293|FG002|Overall Study|Withdrawal by Subject|0|||
48727430|NCT00510874|156853294|FG003|Overall Study|Withdrawal by Subject|0|||
48727431|NCT00510874|156853295|FG004|Overall Study|Withdrawal by Subject|3|||
48727432|NCT00510874|156853296|FG005|Overall Study|Withdrawal by Subject|0|||
48727433|NCT00510874|156853297|FG006|Overall Study|Withdrawal by Subject|0|||
48727434|NCT00510874|156853291|FG000|Overall Study|Lost to Follow-up|2|||
48727435|NCT00510874|156853292|FG001|Overall Study|Lost to Follow-up|3|||
48727436|NCT00510874|156853293|FG002|Overall Study|Lost to Follow-up|1|||
48727437|NCT00510874|156853294|FG003|Overall Study|Lost to Follow-up|3|||
48727438|NCT00510874|156853295|FG004|Overall Study|Lost to Follow-up|4|||
48727439|NCT00510874|156853296|FG005|Overall Study|Lost to Follow-up|0|||
48727440|NCT00510874|156853297|FG006|Overall Study|Lost to Follow-up|1|||
48727441|NCT03023046|156853300|FG000|Overall Study|Withdrawal by Subject|1|||
48727442|NCT05691309|156853303|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
48727443|NCT05691309|156853303|FG000|Overall Study|vancomycin levels not evaluable|2|||
48821374|NCT01154036|157188658|FG006|Phase II|Physician Decision|1|||
48821375|NCT01154036|157188659|FG007|Phase II|Physician Decision|0|||
48727444|NCT00708201|156853304|FG000|Overall Study|Adverse Event|4|||
48727445|NCT00708201|156853305|FG001|Overall Study|Adverse Event|4|||
48727446|NCT00708201|156853304|FG000|Overall Study|Withdrawal by Subject|1|||
48727447|NCT00708201|156853305|FG001|Overall Study|Withdrawal by Subject|1|||
48727448|NCT00708201|156853304|FG000|Overall Study|Lost to Follow-up|2|||
48727449|NCT00708201|156853305|FG001|Overall Study|Lost to Follow-up|0|||
48727450|NCT00708201|156853304|FG000|Overall Study|Protocol Violation|0|||
48727451|NCT00708201|156853305|FG001|Overall Study|Protocol Violation|1|||
48727452|NCT01860846|156853311|FG000|Overall Study|Lost to Follow-up|33|||
48727453|NCT00998764|156853315|FG000|Overall Study|Lack of Efficacy|3|||
48727454|NCT00998764|156853316|FG001|Overall Study|Lack of Efficacy|6|||
48727455|NCT00998764|156853315|FG000|Overall Study|Adverse Event|17|||
48821376|NCT01154036|157188652|FG000|Phase II|Lost to Follow-up|0|||
48821377|NCT01154036|157188653|FG001|Phase II|Lost to Follow-up|0|||
48821378|NCT01154036|157188654|FG002|Phase II|Lost to Follow-up|0|||
48509859|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509860|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
48509861|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509862|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509863|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509864|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509865|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48821379|NCT01154036|157188655|FG003|Phase II|Lost to Follow-up|1|||
48821380|NCT01154036|157188656|FG004|Phase II|Lost to Follow-up|2|||
48509866|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509867|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509868|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509869|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48821381|NCT01154036|157188657|FG005|Phase II|Lost to Follow-up|0|||
48821382|NCT01154036|157188658|FG006|Phase II|Lost to Follow-up|2|||
48821383|NCT01154036|157188659|FG007|Phase II|Lost to Follow-up|1|||
48821384|NCT01154036|157188652|FG000|Phase II|Protocol Violation|0|||
48821385|NCT01154036|157188653|FG001|Phase II|Protocol Violation|0|||
48509870|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48727456|NCT00998764|156853316|FG001|Overall Study|Adverse Event|12|||
48727457|NCT00998764|156853315|FG000|Overall Study|Withdrawal by Subject|19|||
48727458|NCT00998764|156853316|FG001|Overall Study|Withdrawal by Subject|25|||
48727459|NCT00998764|156853315|FG000|Overall Study|Physician Decision|3|||
48727460|NCT00998764|156853316|FG001|Overall Study|Physician Decision|3|||
48727461|NCT00998764|156853315|FG000|Overall Study|Death|3|||
48727462|NCT00998764|156853316|FG001|Overall Study|Death|1|||
48727463|NCT00998764|156853315|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
48821386|NCT01154036|157188654|FG002|Phase II|Protocol Violation|0|||
48821387|NCT01154036|157188655|FG003|Phase II|Protocol Violation|0|||
48821388|NCT01154036|157188656|FG004|Phase II|Protocol Violation|1|||
48821389|NCT01154036|157188657|FG005|Phase II|Protocol Violation|2|||
48727464|NCT00998764|156853316|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
48821390|NCT01154036|157188658|FG006|Phase II|Protocol Violation|0|||
48727465|NCT00998764|156853315|FG000|Overall Study|Protocol Violation|0|||
48727466|NCT00998764|156853316|FG001|Overall Study|Protocol Violation|1|||
48727467|NCT00998764|156853315|FG000|Overall Study|Failed to Return|1|||
48727468|NCT00998764|156853316|FG001|Overall Study|Failed to Return|1|||
48727469|NCT00998764|156853315|FG000|Overall Study|Lost to Follow-up|1|||
48727470|NCT00998764|156853316|FG001|Overall Study|Lost to Follow-up|1|||
48727471|NCT00998764|156853315|FG000|Overall Study|Loss of Caregiver|0|||
48727472|NCT00998764|156853316|FG001|Overall Study|Loss of Caregiver|3|||
48727473|NCT00998764|156853315|FG000|Overall Study|Other|4|||
48727474|NCT00998764|156853316|FG001|Overall Study|Other|4|||
48727475|NCT00998764|156853315|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
48727476|NCT00998764|156853316|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
48727477|NCT01315236|156853317|FG000|Double-blind Phase|Death|1|||
48727478|NCT01315236|156853318|FG001|Double-blind Phase|Death|0|||
48727479|NCT01315236|156853317|FG000|Double-blind Phase|Adverse Event|1|||
48727480|NCT01315236|156853318|FG001|Double-blind Phase|Adverse Event|0|||
48727481|NCT01315236|156853317|FG000|Double-blind Phase|Withdrawal of Consent|1|||
48509871|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509872|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509873|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509874|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509875|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
48509876|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
48509877|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509878|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509879|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509880|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48727482|NCT01315236|156853318|FG001|Double-blind Phase|Withdrawal of Consent|0|||
48727483|NCT01315236|156853317|FG000|Double-blind Phase|Lost to Follow-up|1|||
48727484|NCT01315236|156853318|FG001|Double-blind Phase|Lost to Follow-up|0|||
48727485|NCT01315236|156853317|FG000|Open-label Phase|Death|1|||
48727486|NCT01315236|156853318|FG001|Open-label Phase|Death|0|||
48727487|NCT01315236|156853317|FG000|Open-label Phase|Adverse Event|0|||
48727488|NCT01315236|156853318|FG001|Open-label Phase|Adverse Event|1|||
48727489|NCT01315236|156853317|FG000|Open-label Phase|Other|0|||
48727490|NCT01315236|156853318|FG001|Open-label Phase|Other|1|||
48727491|NCT01315236|156853317|FG000|12-Month Follow-up Period|Death|0|||
48727492|NCT01315236|156853318|FG001|12-Month Follow-up Period|Death|1|||
48727493|NCT01315236|156853317|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
48727494|NCT01315236|156853318|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
48727495|NCT00521001|156853327|FG000|Overall Study|Ineligible|1|||
48727496|NCT00470184|156853330|FG000|Overall Study|Not Treated(became ineligible)|4|||
48727497|NCT00470184|156853330|FG000|Overall Study|Not treated (other)|1|||
48727498|NCT00470184|156853330|FG000|Overall Study|disease Progression|4|||
48727499|NCT00470184|156853330|FG000|Overall Study|Adverse Event|3|||
48727500|NCT00470184|156853330|FG000|Overall Study|Withdrawal by Subject|4|||
48727501|NCT00470184|156853330|FG000|Overall Study|other|5|||
48727502|NCT00470184|156853330|FG000|Overall Study|recurrence|1|||
48727503|NCT01082640|156853331|FG000|Overall Study|Adverse Event|9|||
48727504|NCT01082640|156853332|FG001|Overall Study|Adverse Event|5|||
48509881|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
48509882|NCT01597245|156058977|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509883|NCT01597245|156058978|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509884|NCT01597245|156058979|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509885|NCT01597245|156058980|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509886|NCT01597245|156058981|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509887|NCT01597245|156058982|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509888|NCT01597245|156058983|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509889|NCT01597245|156058984|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509890|NCT01597245|156058985|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509891|NCT01597245|156058986|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509892|NCT01597245|156058987|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509893|NCT01597245|156058988|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509894|NCT01597245|156058989|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509895|NCT01597245|156058990|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
48509896|NCT01597245|156058991|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509897|NCT01597245|156058992|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509898|NCT01597245|156058993|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48727505|NCT01082640|156853333|FG002|Overall Study|Adverse Event|3|||
48727506|NCT01082640|156853331|FG000|Overall Study|Withdrawal by Subject|3|||
48727507|NCT01082640|156853332|FG001|Overall Study|Withdrawal by Subject|3|||
48727508|NCT01082640|156853333|FG002|Overall Study|Withdrawal by Subject|2|||
48821391|NCT01154036|157188659|FG007|Phase II|Protocol Violation|0|||
48821392|NCT01154036|157188652|FG000|Phase II|Withdrawal by Subject|0|||
48821393|NCT01154036|157188653|FG001|Phase II|Withdrawal by Subject|0|||
48821394|NCT01154036|157188654|FG002|Phase II|Withdrawal by Subject|0|||
48821395|NCT01154036|157188655|FG003|Phase II|Withdrawal by Subject|0|||
48821396|NCT01154036|157188656|FG004|Phase II|Withdrawal by Subject|4|||
48821397|NCT01154036|157188657|FG005|Phase II|Withdrawal by Subject|2|||
48821398|NCT01154036|157188658|FG006|Phase II|Withdrawal by Subject|5|||
48821399|NCT01154036|157188659|FG007|Phase II|Withdrawal by Subject|4|||
48727509|NCT01082640|156853331|FG000|Overall Study|Major protocol deviation|3|||
48727510|NCT01082640|156853332|FG001|Overall Study|Major protocol deviation|3|||
48727511|NCT01082640|156853333|FG002|Overall Study|Major protocol deviation|0|||
48821400|NCT03330119|157188664|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
48821401|NCT03330119|157188665|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
48821402|NCT03929302|157188666|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
48821403|NCT03929302|157188667|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
48821404|NCT03929302|157188668|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
48821405|NCT03929302|157188666|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
48821406|NCT03929302|157188667|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
48821407|NCT03929302|157188668|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
48821408|NCT03929302|157188666|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
48821409|NCT03929302|157188667|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
48821410|NCT03929302|157188668|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
48821411|NCT02800928|157188670|FG000|Overall Study|Withdrawal by Subject|1|||
48821412|NCT02800928|157188671|FG001|Overall Study|Withdrawal by Subject|1|||
48821413|NCT02800928|157188670|FG000|Overall Study|Protocol Violation|1|||
48821414|NCT02800928|157188671|FG001|Overall Study|Protocol Violation|1|||
48821415|NCT00278564|157188672|FG000|Overall Study|Lack of Efficacy|4|||
48821416|NCT01458249|157188675|FG000|Overall Study|Not treated|1|||
48821417|NCT01458249|157188675|FG000|Overall Study|Adverse Event|4|||
48821418|NCT01458249|157188675|FG000|Overall Study|Other|2|||
48821419|NCT01458249|157188675|FG000|Overall Study|Ongoing|1|||
48821420|NCT03606460|157188676|FG000|Overall Study|Lost to Follow-up|1|||
48821421|NCT03606460|157188677|FG001|Overall Study|Lost to Follow-up|8|||
48821422|NCT04990440|157188678|FG000|Overall Study|Sponsor's Decision|0|||
48821423|NCT04990440|157188679|FG001|Overall Study|Sponsor's Decision|0|||
48821424|NCT04990440|157188680|FG002|Overall Study|Sponsor's Decision|1|||
48821425|NCT02408549|157188684|FG000|Overall Study|Adverse Event|15|||
48821426|NCT02408549|157188684|FG000|Overall Study|Death|4|||
48821427|NCT02408549|157188684|FG000|Overall Study|Lack of Efficacy|17|||
48821428|NCT02408549|157188684|FG000|Overall Study|Protocol Violation|4|||
48821429|NCT02408549|157188684|FG000|Overall Study|Lost to Follow-up|6|||
48821430|NCT02408549|157188684|FG000|Overall Study|Consent withdrawn|30|||
48821431|NCT02408549|157188684|FG000|Overall Study|Neurology research program closing at site|1|||
48821432|NCT02408549|157188684|FG000|Overall Study|Site closure|1|||
48821433|NCT02408549|157188684|FG000|Overall Study|Pregnancy|1|||
48727512|NCT01082640|156853331|FG000|Overall Study|Lost to Follow-up|0|||
48727513|NCT01082640|156853332|FG001|Overall Study|Lost to Follow-up|3|||
48727514|NCT01082640|156853333|FG002|Overall Study|Lost to Follow-up|0|||
48727515|NCT01082640|156853331|FG000|Overall Study|Other|2|||
48727516|NCT01082640|156853332|FG001|Overall Study|Other|1|||
48727517|NCT01082640|156853333|FG002|Overall Study|Other|3|||
48727518|NCT02011893|156853339|FG000|Enrollment to Randomization|Adverse Event|2|||
48727519|NCT02011893|156853340|FG001|Enrollment to Randomization|Adverse Event|0|||
48727520|NCT02011893|156853341|FG002|Enrollment to Randomization|Adverse Event|0|||
48727521|NCT02011893|156853339|FG000|Enrollment to Randomization|Physician Decision|10|||
48727522|NCT02011893|156853340|FG001|Enrollment to Randomization|Physician Decision|0|||
48727523|NCT02011893|156853341|FG002|Enrollment to Randomization|Physician Decision|0|||
48821434|NCT02408549|157188684|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
48821435|NCT02408549|157188684|FG000|Overall Study|Subject moved to another place, far from site|1|||
48821436|NCT02408549|157188684|FG000|Overall Study|Study terminated at site|1|||
48727524|NCT02011893|156853339|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
48821437|NCT01657032|157188685|FG000|Overall Study|Lost to Follow-up|0|||
48821438|NCT01657032|157188686|FG001|Overall Study|Lost to Follow-up|7|||
48821439|NCT02696785|157188687|FG000|Blinded Treatment Period|Adverse Event|0|||
48821440|NCT02696785|157188688|FG001|Blinded Treatment Period|Adverse Event|1|||
48821441|NCT02696785|157188689|FG002|Blinded Treatment Period|Adverse Event|3|||
48821442|NCT02696785|157188690|FG003|Blinded Treatment Period|Adverse Event|0|||
48821443|NCT02696785|157188687|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
48727525|NCT02011893|156853340|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
48727526|NCT02011893|156853341|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
48727527|NCT02011893|156853339|FG000|Enrollment to Randomization|Screening Failure|29|||
48509899|NCT01597245|156058994|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509900|NCT01597245|156058995|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509901|NCT01597245|156058996|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509902|NCT01597245|156058997|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
48509903|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509904|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509905|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509906|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509907|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509908|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509909|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509910|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509911|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509912|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509913|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509914|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509915|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48727528|NCT02011893|156853340|FG001|Enrollment to Randomization|Screening Failure|0|||
48727529|NCT02011893|156853341|FG002|Enrollment to Randomization|Screening Failure|0|||
48727530|NCT02011893|156853339|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
48727531|NCT02011893|156853340|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
48727532|NCT02011893|156853341|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
48727533|NCT02011893|156853339|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
48727534|NCT02011893|156853340|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
48727535|NCT02011893|156853341|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
48727536|NCT02011893|156853339|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
48727537|NCT02011893|156853340|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
48727538|NCT02011893|156853341|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
48727539|NCT02011893|156853339|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
48727540|NCT02011893|156853340|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
48727541|NCT02011893|156853341|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
48727542|NCT02011893|156853339|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
48727543|NCT02011893|156853340|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
48727544|NCT02011893|156853341|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
48727545|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
48727546|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
48727547|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
48727548|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
48727549|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48727550|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
48727551|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48509916|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509917|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509918|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
48509919|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
48509920|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
48509921|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
48509922|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
48509923|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
48509924|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509925|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509926|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509927|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48727552|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
48727553|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
48727554|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
48727555|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
48727556|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
48727557|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
48727558|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
48727559|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
48727560|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
48509928|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48727561|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Program Termination|3|||
48727562|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Program Termination|0|||
48509929|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509930|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509931|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509932|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509933|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509934|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509935|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48821444|NCT02696785|157188688|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
48821445|NCT02696785|157188689|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
48821446|NCT02696785|157188690|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
48821447|NCT02696785|157188687|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
48509936|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509937|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509938|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509939|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509940|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
48509941|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
48509942|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
48509943|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
48509944|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
48509945|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509946|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509947|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509948|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509949|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509950|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48821448|NCT02696785|157188688|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
48821449|NCT02696785|157188689|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
48821450|NCT02696785|157188690|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
48821451|NCT02696785|157188687|FG000|Blinded Treatment Period|Screen Failure|1|||
48821452|NCT02696785|157188688|FG001|Blinded Treatment Period|Screen Failure|0|||
48821453|NCT02696785|157188689|FG002|Blinded Treatment Period|Screen Failure|0|||
48821454|NCT02696785|157188690|FG003|Blinded Treatment Period|Screen Failure|0|||
48821455|NCT02696785|157188687|FG000|Washout Period|Withdrawal by Subject|0|||
48727563|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Program Termination|1|||
48727564|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Program Termination|1|||
48727565|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
48727566|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
48727567|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
48727568|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
48727569|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
48509951|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48821456|NCT02696785|157188688|FG001|Washout Period|Withdrawal by Subject|1|||
48821457|NCT02696785|157188689|FG002|Washout Period|Withdrawal by Subject|0|||
48821458|NCT02696785|157188690|FG003|Washout Period|Withdrawal by Subject|0|||
48821459|NCT02696785|157188687|FG000|Washout Period|Lack of Efficacy|0|||
48821460|NCT02696785|157188688|FG001|Washout Period|Lack of Efficacy|1|||
48821461|NCT02696785|157188689|FG002|Washout Period|Lack of Efficacy|0|||
48821462|NCT02696785|157188690|FG003|Washout Period|Lack of Efficacy|0|||
48821463|NCT02696785|157188687|FG000|Extended Treatment Period|Adverse Event|2|||
48821464|NCT02696785|157188688|FG001|Extended Treatment Period|Adverse Event|3|||
48821465|NCT02696785|157188689|FG002|Extended Treatment Period|Adverse Event|2|||
48821466|NCT02696785|157188690|FG003|Extended Treatment Period|Adverse Event|1|||
48509952|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509953|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509954|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509955|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509956|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509957|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509958|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509959|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509960|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48727570|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
48821467|NCT02696785|157188687|FG000|Extended Treatment Period|Lack of Efficacy|0|||
48821468|NCT02696785|157188688|FG001|Extended Treatment Period|Lack of Efficacy|1|||
48821469|NCT02696785|157188689|FG002|Extended Treatment Period|Lack of Efficacy|0|||
48821470|NCT02696785|157188690|FG003|Extended Treatment Period|Lack of Efficacy|0|||
48727571|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
48727572|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
48727573|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
48727574|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
48727575|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
48727576|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
48727577|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
48727578|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
48727579|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
48727580|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
48727581|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
48727582|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
48727583|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
48727584|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
48727585|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
48727586|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
48727587|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
48727588|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
48727589|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
48727590|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
48727591|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
48727592|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
48727593|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
48727594|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
48727595|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
48727596|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
48727597|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
48727598|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
48727599|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
48727600|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
48727601|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
48727602|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
48727603|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
48727604|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
48727605|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
48727606|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
48727607|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
48727608|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
48727609|NCT03739840|156853342|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
48727610|NCT03739840|156853343|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
48727611|NCT03739840|156853344|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
48727612|NCT03739840|156853345|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
48727613|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
48727614|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
48727615|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
48727616|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
48727617|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
48727618|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
48727619|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
48727620|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
48727621|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
48727622|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
48727623|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
48727624|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
48727625|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
48727626|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
48727627|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
48727628|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
48727629|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
48727630|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
48727631|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
48727632|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
48727633|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
48727634|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
48727635|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
48821471|NCT02696785|157188687|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
48821472|NCT02696785|157188688|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
48821473|NCT02696785|157188689|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
48821474|NCT02696785|157188690|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
48821475|NCT02696785|157188687|FG000|Follow-up Period|Adverse Event|0|||
48821476|NCT02696785|157188688|FG001|Follow-up Period|Adverse Event|0|||
48821477|NCT02696785|157188689|FG002|Follow-up Period|Adverse Event|8|||
48821478|NCT02696785|157188690|FG003|Follow-up Period|Adverse Event|2|||
48821479|NCT02696785|157188687|FG000|Follow-up Period|Lost to Follow-up|0|||
48821480|NCT02696785|157188688|FG001|Follow-up Period|Lost to Follow-up|0|||
48821481|NCT02696785|157188689|FG002|Follow-up Period|Lost to Follow-up|0|||
48821482|NCT02696785|157188690|FG003|Follow-up Period|Lost to Follow-up|1|||
48821483|NCT02696785|157188687|FG000|Follow-up Period|Lack of Efficacy|0|||
48821484|NCT02696785|157188688|FG001|Follow-up Period|Lack of Efficacy|0|||
48821485|NCT02696785|157188689|FG002|Follow-up Period|Lack of Efficacy|0|||
48821486|NCT02696785|157188690|FG003|Follow-up Period|Lack of Efficacy|1|||
48821487|NCT02696785|157188687|FG000|Follow-up Period|Withdrawal by Subject|1|||
48821488|NCT02696785|157188688|FG001|Follow-up Period|Withdrawal by Subject|0|||
48821489|NCT02696785|157188689|FG002|Follow-up Period|Withdrawal by Subject|5|||
48821490|NCT02696785|157188690|FG003|Follow-up Period|Withdrawal by Subject|4|||
48821491|NCT01880515|157188693|FG000|Overall Study|Lost to Follow-up|3|||
48821492|NCT01880515|157188694|FG001|Overall Study|Lost to Follow-up|2|||
48821493|NCT01880515|157188693|FG000|Overall Study|Disease Progression|5|||
48821494|NCT01880515|157188694|FG001|Overall Study|Disease Progression|7|||
48821495|NCT02061761|157188695|FG000|Overall Study|Disease progression|2|||
48821496|NCT02061761|157188696|FG001|Overall Study|Disease progression|8|||
48821497|NCT02061761|157188697|FG002|Overall Study|Disease progression|4|||
48821498|NCT02061761|157188698|FG003|Overall Study|Disease progression|5|||
48821499|NCT02061761|157188699|FG004|Overall Study|Disease progression|9|||
48821500|NCT02061761|157188700|FG005|Overall Study|Disease progression|3|||
48821501|NCT02061761|157188701|FG006|Overall Study|Disease progression|1|||
48821502|NCT02061761|157188702|FG007|Overall Study|Disease progression|2|||
48821503|NCT02061761|157188703|FG008|Overall Study|Disease progression|28|||
48821504|NCT02061761|157188695|FG000|Overall Study|Study Drug toxicity|0|||
48821505|NCT02061761|157188696|FG001|Overall Study|Study Drug toxicity|0|||
48821506|NCT02061761|157188697|FG002|Overall Study|Study Drug toxicity|0|||
48821507|NCT02061761|157188698|FG003|Overall Study|Study Drug toxicity|0|||
48821508|NCT02061761|157188699|FG004|Overall Study|Study Drug toxicity|0|||
48821509|NCT02061761|157188700|FG005|Overall Study|Study Drug toxicity|1|||
48821510|NCT02061761|157188701|FG006|Overall Study|Study Drug toxicity|0|||
48821511|NCT02061761|157188702|FG007|Overall Study|Study Drug toxicity|2|||
48821512|NCT02061761|157188703|FG008|Overall Study|Study Drug toxicity|6|||
48821513|NCT02061761|157188695|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
48509961|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
48821514|NCT02061761|157188696|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
48821515|NCT02061761|157188697|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
48821516|NCT02061761|157188698|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
48821517|NCT02061761|157188699|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
48821518|NCT02061761|157188700|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
48821519|NCT02061761|157188701|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
48509962|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509963|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
48509964|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
48509965|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
48509966|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509967|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509968|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509969|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509970|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509971|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509972|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509973|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509974|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509975|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509976|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509977|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509978|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509979|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509980|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509981|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48821520|NCT02061761|157188702|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
48727636|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
48727637|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
48727638|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
48727639|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
48727640|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
48727641|NCT03739840|156853342|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
48727642|NCT03739840|156853343|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
48727643|NCT03739840|156853344|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
48727644|NCT03739840|156853345|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
48727645|NCT01028378|156853346|FG000|Overall Study|Lost to Follow-up|12|||
48727646|NCT01028378|156853346|FG000|Overall Study|Withdrawal by Subject|1|||
48727647|NCT01028378|156853346|FG000|Overall Study|Adminstrative Reasons|4|||
48727648|NCT01298193|156853347|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
48727649|NCT01298193|156853347|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
48727650|NCT01298193|156853347|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
48727651|NCT01298193|156853347|FG000|Efficacy Phase (Second Cycle)|Death|1|||
48727652|NCT01115803|156853348|FG000|Overall Study|Withdrawal by Subject|0|||
48727653|NCT01115803|156853349|FG001|Overall Study|Withdrawal by Subject|0|||
48727654|NCT01115803|156853350|FG002|Overall Study|Withdrawal by Subject|0|||
48727655|NCT01115803|156853351|FG003|Overall Study|Withdrawal by Subject|0|||
48727656|NCT01115803|156853352|FG004|Overall Study|Withdrawal by Subject|0|||
48727657|NCT01115803|156853353|FG005|Overall Study|Withdrawal by Subject|0|||
48727658|NCT01115803|156853354|FG006|Overall Study|Withdrawal by Subject|1|||
48727659|NCT01115803|156853348|FG000|Overall Study|Lost to Follow-up|0|||
48727660|NCT01115803|156853349|FG001|Overall Study|Lost to Follow-up|0|||
48727661|NCT01115803|156853350|FG002|Overall Study|Lost to Follow-up|1|||
48727662|NCT01115803|156853351|FG003|Overall Study|Lost to Follow-up|0|||
48727663|NCT01115803|156853352|FG004|Overall Study|Lost to Follow-up|0|||
48727664|NCT01115803|156853353|FG005|Overall Study|Lost to Follow-up|0|||
48727665|NCT01115803|156853354|FG006|Overall Study|Lost to Follow-up|0|||
48727666|NCT01115803|156853348|FG000|Overall Study|Progressive Disease during Cycle1|0|||
48727667|NCT01115803|156853349|FG001|Overall Study|Progressive Disease during Cycle1|0|||
48727668|NCT01115803|156853350|FG002|Overall Study|Progressive Disease during Cycle1|0|||
48727669|NCT01115803|156853351|FG003|Overall Study|Progressive Disease during Cycle1|0|||
48727670|NCT01115803|156853352|FG004|Overall Study|Progressive Disease during Cycle1|0|||
48727671|NCT01115803|156853353|FG005|Overall Study|Progressive Disease during Cycle1|0|||
48727672|NCT01115803|156853354|FG006|Overall Study|Progressive Disease during Cycle1|1|||
48727673|NCT03475875|156853356|FG000|Period 1|Lost to Follow-up|1|||
48727674|NCT03475875|156853357|FG001|Period 1|Lost to Follow-up|0|||
48727675|NCT03475875|156853356|FG000|Period 1|Adverse Event|2|||
48727676|NCT03475875|156853357|FG001|Period 1|Adverse Event|1|||
48727677|NCT03475875|156853356|FG000|Period 2|Adverse Event|3|||
48727678|NCT03475875|156853357|FG001|Period 2|Adverse Event|0|||
48727679|NCT03475875|156853356|FG000|Period 2|Protocol Violation|0|||
48727680|NCT03475875|156853357|FG001|Period 2|Protocol Violation|1|||
48727681|NCT03059446|156853358|FG000|Overall Study|Adverse Event|11|||
48727682|NCT03059446|156853358|FG000|Overall Study|Withdrawal of Consent|16|||
48727683|NCT03059446|156853358|FG000|Overall Study|Lost to Follow-up|3|||
48727684|NCT03059446|156853358|FG000|Overall Study|Protocol Violation|1|||
48727685|NCT03059446|156853358|FG000|Overall Study|Study Terminated by Sponsor|131|||
48727686|NCT03059446|156853358|FG000|Overall Study|Reason not Specified|5|||
48821521|NCT02061761|157188703|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
48821522|NCT02061761|157188695|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48821523|NCT02061761|157188696|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48821524|NCT02061761|157188697|FG002|Overall Study|Participant request to discontinue study treatment|2|||
48821525|NCT02061761|157188698|FG003|Overall Study|Participant request to discontinue study treatment|2|||
48821526|NCT02061761|157188699|FG004|Overall Study|Participant request to discontinue study treatment|0|||
48821527|NCT02061761|157188700|FG005|Overall Study|Participant request to discontinue study treatment|1|||
48821528|NCT02061761|157188701|FG006|Overall Study|Participant request to discontinue study treatment|0|||
48727687|NCT02992132|156853359|FG000|Overall Study|Adverse Event|4|||
48727688|NCT02992132|156853360|FG001|Overall Study|Adverse Event|1|||
48727689|NCT02992132|156853361|FG002|Overall Study|Adverse Event|3|||
48727690|NCT02992132|156853359|FG000|Overall Study|Lack of Efficacy|2|||
48727691|NCT02992132|156853360|FG001|Overall Study|Lack of Efficacy|0|||
48727692|NCT02992132|156853361|FG002|Overall Study|Lack of Efficacy|0|||
48727693|NCT02992132|156853359|FG000|Overall Study|Non-compliance with study drug|2|||
48727694|NCT02992132|156853360|FG001|Overall Study|Non-compliance with study drug|0|||
48727695|NCT02992132|156853361|FG002|Overall Study|Non-compliance with study drug|0|||
48727696|NCT02992132|156853359|FG000|Overall Study|Progressive disease|1|||
48727697|NCT02992132|156853360|FG001|Overall Study|Progressive disease|0|||
48727698|NCT02992132|156853361|FG002|Overall Study|Progressive disease|0|||
48727699|NCT02992132|156853359|FG000|Overall Study|Protocol Violation|2|||
48727700|NCT02992132|156853360|FG001|Overall Study|Protocol Violation|2|||
48509982|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509983|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
48509984|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
48509985|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
48509986|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
48509987|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509988|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509989|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509990|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509991|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509992|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509993|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509994|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509995|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509996|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509997|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509998|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48509999|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48510000|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48510001|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48510002|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48510003|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
48510004|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48510005|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
48510006|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
48510007|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
48510008|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510009|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510010|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48727701|NCT02992132|156853361|FG002|Overall Study|Protocol Violation|0|||
48727702|NCT02992132|156853359|FG000|Overall Study|Caregiver withdrew consent|2|||
48727703|NCT02992132|156853360|FG001|Overall Study|Caregiver withdrew consent|3|||
48727704|NCT02992132|156853361|FG002|Overall Study|Caregiver withdrew consent|2|||
48727705|NCT02992132|156853359|FG000|Overall Study|Withdrawal by Subject|0|||
48727706|NCT02992132|156853360|FG001|Overall Study|Withdrawal by Subject|2|||
48727707|NCT02992132|156853361|FG002|Overall Study|Withdrawal by Subject|1|||
48821529|NCT02061761|157188702|FG007|Overall Study|Participant request to discontinue study treatment|0|||
48821530|NCT02061761|157188703|FG008|Overall Study|Participant request to discontinue study treatment|2|||
48821531|NCT02061761|157188695|FG000|Overall Study|Withdrawal by Subject|0|||
48821532|NCT02061761|157188696|FG001|Overall Study|Withdrawal by Subject|0|||
48821533|NCT02061761|157188697|FG002|Overall Study|Withdrawal by Subject|0|||
48821534|NCT02061761|157188698|FG003|Overall Study|Withdrawal by Subject|0|||
48821535|NCT02061761|157188699|FG004|Overall Study|Withdrawal by Subject|0|||
48821536|NCT02061761|157188700|FG005|Overall Study|Withdrawal by Subject|0|||
48727708|NCT02992132|156853359|FG000|Overall Study|Physician Decision|0|||
48510011|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510012|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510013|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48727709|NCT02992132|156853360|FG001|Overall Study|Physician Decision|0|||
48727710|NCT02992132|156853361|FG002|Overall Study|Physician Decision|1|||
48510014|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510015|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510016|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510017|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510018|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510019|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48727711|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
48727712|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
48727713|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
48727714|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
48727715|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
48727716|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
48821537|NCT02061761|157188701|FG006|Overall Study|Withdrawal by Subject|0|||
48821538|NCT02061761|157188702|FG007|Overall Study|Withdrawal by Subject|0|||
48821539|NCT02061761|157188703|FG008|Overall Study|Withdrawal by Subject|2|||
48821540|NCT02061761|157188695|FG000|Overall Study|Maximum clinical benefit|0|||
48727717|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
48727718|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
48727719|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
48727720|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
48727721|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
48727722|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
48727723|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
48727724|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
48821541|NCT02061761|157188696|FG001|Overall Study|Maximum clinical benefit|0|||
48821542|NCT02061761|157188697|FG002|Overall Study|Maximum clinical benefit|0|||
48821543|NCT02061761|157188698|FG003|Overall Study|Maximum clinical benefit|1|||
48821544|NCT02061761|157188699|FG004|Overall Study|Maximum clinical benefit|0|||
48727725|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
48727726|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
48727727|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
48510020|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48821545|NCT02061761|157188700|FG005|Overall Study|Maximum clinical benefit|0|||
48821546|NCT02061761|157188701|FG006|Overall Study|Maximum clinical benefit|0|||
48821547|NCT02061761|157188702|FG007|Overall Study|Maximum clinical benefit|0|||
48821548|NCT02061761|157188703|FG008|Overall Study|Maximum clinical benefit|6|||
48727728|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
48510021|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510022|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48727729|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
48821549|NCT02061761|157188695|FG000|Overall Study|Participant no longer meets study criteria|0|||
48821550|NCT02061761|157188696|FG001|Overall Study|Participant no longer meets study criteria|0|||
48821551|NCT02061761|157188697|FG002|Overall Study|Participant no longer meets study criteria|0|||
48821552|NCT02061761|157188698|FG003|Overall Study|Participant no longer meets study criteria|0|||
48821553|NCT02061761|157188699|FG004|Overall Study|Participant no longer meets study criteria|0|||
48821554|NCT02061761|157188700|FG005|Overall Study|Participant no longer meets study criteria|0|||
48821555|NCT02061761|157188701|FG006|Overall Study|Participant no longer meets study criteria|0|||
48510023|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510024|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
48510025|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510026|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
48510027|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
48510028|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
48510029|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510030|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510031|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510032|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510033|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510034|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510035|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510036|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510037|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510038|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510039|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510040|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510041|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510042|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510043|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510044|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510045|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
48510046|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510047|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510048|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
48510049|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
48510050|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510051|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510052|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510053|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510054|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510055|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510056|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510057|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510058|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510059|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510060|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510061|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510062|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510063|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510064|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510065|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510066|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
48510067|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510068|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510069|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
48510070|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
48510071|NCT01597245|156058977|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510072|NCT01597245|156058978|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510073|NCT01597245|156058979|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510074|NCT01597245|156058980|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510075|NCT01597245|156058981|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510076|NCT01597245|156058982|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510077|NCT01597245|156058983|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510078|NCT01597245|156058984|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510079|NCT01597245|156058985|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510080|NCT01597245|156058986|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48600983|NCT00369915|156396007|FG000|Overall Study|expected side effects|2|||
48600984|NCT00369915|156396008|FG001|Overall Study|expected side effects|1|||
48600985|NCT00369915|156396007|FG000|Overall Study|Withdrawal by Subject|4|||
48600986|NCT00369915|156396008|FG001|Overall Study|Withdrawal by Subject|1|||
48600987|NCT00369915|156396007|FG000|Overall Study|W/drawl by investigators|0|||
48600988|NCT00369915|156396008|FG001|Overall Study|W/drawl by investigators|1|||
48600989|NCT00411450|156396009|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
48510081|NCT01597245|156058987|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510082|NCT01597245|156058988|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510083|NCT01597245|156058989|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510084|NCT01597245|156058990|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510085|NCT01597245|156058991|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510086|NCT01597245|156058992|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510087|NCT01597245|156058993|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510088|NCT01597245|156058994|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510089|NCT01597245|156058995|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510090|NCT01597245|156058996|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
48510091|NCT01597245|156058997|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
48510092|NCT03649477|156059000|FG000|Overall Study|Adverse Event|2|||
48510093|NCT03649477|156059001|FG001|Overall Study|Adverse Event|0|||
48510094|NCT03649477|156059002|FG002|Overall Study|Adverse Event|0|||
48510095|NCT01456221|156059003|FG000|Overall Study|Withdrawal by Subject|56|||
48510096|NCT01456221|156059004|FG001|Overall Study|Withdrawal by Subject|49|||
48510097|NCT01456221|156059003|FG000|Overall Study|Lost to Follow-up|1|||
48510098|NCT01456221|156059004|FG001|Overall Study|Lost to Follow-up|4|||
48821556|NCT02061761|157188702|FG007|Overall Study|Participant no longer meets study criteria|0|||
48821557|NCT02061761|157188703|FG008|Overall Study|Participant no longer meets study criteria|1|||
48821558|NCT02061761|157188695|FG000|Overall Study|Other reasons|0|||
48821559|NCT02061761|157188696|FG001|Overall Study|Other reasons|0|||
48821560|NCT02061761|157188697|FG002|Overall Study|Other reasons|0|||
48510099|NCT01456221|156059003|FG000|Overall Study|Received medication|3|||
48510100|NCT01456221|156059004|FG001|Overall Study|Received medication|2|||
48510101|NCT01456221|156059003|FG000|Overall Study|Incomplete data|4|||
48600990|NCT00141518|156396018|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
48600991|NCT00141518|156396019|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
48600992|NCT00141518|156396020|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
48600993|NCT00141518|156396018|FG000|Overall Study|Adverse Event|7|||
48600994|NCT00141518|156396019|FG001|Overall Study|Adverse Event|5|||
48600995|NCT00141518|156396020|FG002|Overall Study|Adverse Event|2|||
48600996|NCT00141518|156396018|FG000|Overall Study|Withdrawal by Subject|2|||
48600997|NCT00141518|156396019|FG001|Overall Study|Withdrawal by Subject|0|||
48600998|NCT00141518|156396020|FG002|Overall Study|Withdrawal by Subject|2|||
48600999|NCT00141518|156396018|FG000|Overall Study|Protocol Violation|1|||
48601000|NCT00141518|156396019|FG001|Overall Study|Protocol Violation|1|||
48601001|NCT00141518|156396020|FG002|Overall Study|Protocol Violation|2|||
48821561|NCT02061761|157188698|FG003|Overall Study|Other reasons|0|||
48510102|NCT01456221|156059004|FG001|Overall Study|Incomplete data|2|||
48510103|NCT02409355|156059005|FG000|Overall Study|Withdrawal by Subject|1|||
48510104|NCT02409355|156059006|FG001|Overall Study|Withdrawal by Subject|0|||
48510105|NCT02409355|156059005|FG000|Overall Study|Death|1|||
48510106|NCT02409355|156059006|FG001|Overall Study|Death|1|||
48510107|NCT02409355|156059005|FG000|Overall Study|Study terminated by Sponsor|2|||
48510108|NCT02409355|156059006|FG001|Overall Study|Study terminated by Sponsor|3|||
48510109|NCT00436163|156059009|FG000|Overall Study|Lost to Follow-up|2|||
48510110|NCT00436163|156059009|FG000|Overall Study|Adverse Event|1|||
48510111|NCT03161405|156059012|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
48510112|NCT02655679|156059013|FG000|Overall Study|Adverse Event|0|||
48510113|NCT02655679|156059014|FG001|Overall Study|Adverse Event|1|||
48510114|NCT02655679|156059015|FG002|Overall Study|Adverse Event|0|||
48510115|NCT02655679|156059016|FG003|Overall Study|Adverse Event|0|||
48510116|NCT02655679|156059017|FG004|Overall Study|Adverse Event|0|||
48510117|NCT02655679|156059013|FG000|Overall Study|Withdrawal by Subject|1|||
48510118|NCT02655679|156059014|FG001|Overall Study|Withdrawal by Subject|1|||
48510119|NCT02655679|156059015|FG002|Overall Study|Withdrawal by Subject|0|||
48510120|NCT02655679|156059016|FG003|Overall Study|Withdrawal by Subject|3|||
48510121|NCT02655679|156059017|FG004|Overall Study|Withdrawal by Subject|1|||
48510122|NCT02655679|156059013|FG000|Overall Study|Inability to Comply with the Protocol|1|||
48510123|NCT02655679|156059014|FG001|Overall Study|Inability to Comply with the Protocol|0|||
48510124|NCT02655679|156059015|FG002|Overall Study|Inability to Comply with the Protocol|0|||
48510125|NCT02655679|156059016|FG003|Overall Study|Inability to Comply with the Protocol|0|||
48510126|NCT02655679|156059017|FG004|Overall Study|Inability to Comply with the Protocol|0|||
48510127|NCT02655679|156059013|FG000|Overall Study|Lost to Follow-up|0|||
48510128|NCT02655679|156059014|FG001|Overall Study|Lost to Follow-up|1|||
48510129|NCT02655679|156059015|FG002|Overall Study|Lost to Follow-up|1|||
48510130|NCT02655679|156059016|FG003|Overall Study|Lost to Follow-up|1|||
48510131|NCT02655679|156059017|FG004|Overall Study|Lost to Follow-up|0|||
48510132|NCT02655679|156059013|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48510133|NCT02655679|156059014|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48510134|NCT02655679|156059015|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48510135|NCT02655679|156059016|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48510136|NCT02655679|156059017|FG004|Overall Study|Other Miscellaneous Reasons|0|||
48510137|NCT00811655|156059022|FG000|Overall Study|Physician Decision|1|||
48510138|NCT04175808|156060786|FG000|Part A|Miscellaneous|2|||
48510139|NCT04175808|156060787|FG001|Part A|Miscellaneous|0|||
48510140|NCT04175808|156060788|FG002|Part A|Miscellaneous|0|||
48510141|NCT04175808|156060789|FG003|Part A|Miscellaneous|0|||
48510142|NCT04175808|156060790|FG004|Part A|Miscellaneous|0|||
48510143|NCT04175808|156060791|FG005|Part A|Miscellaneous|0|||
48510144|NCT04175808|156060792|FG006|Part A|Miscellaneous|0|||
48510145|NCT00420303|156060793|FG000|Overall Study|Serious Adverse Event|1|||
48510146|NCT00420303|156060794|FG001|Overall Study|Serious Adverse Event|0|||
48510147|NCT00420303|156060793|FG000|Overall Study|Lack of Efficacy|0|||
48510148|NCT00420303|156060794|FG001|Overall Study|Lack of Efficacy|3|||
48510149|NCT00420303|156060793|FG000|Overall Study|Physician Decision|0|||
48510150|NCT00420303|156060794|FG001|Overall Study|Physician Decision|1|||
48510151|NCT01294787|156060795|FG000|Period 1|Adverse Event|0|||
48510152|NCT01294787|156060796|FG001|Period 1|Adverse Event|0|||
48510153|NCT01294787|156060797|FG002|Period 1|Adverse Event|0|||
48510154|NCT01294787|156060798|FG003|Period 1|Adverse Event|0|||
48510155|NCT01294787|156060799|FG004|Period 1|Adverse Event|1|||
48510156|NCT01294787|156060800|FG005|Period 1|Adverse Event|0|||
48510157|NCT01294787|156060795|FG000|Period 1|Withdrawal by Subject|0|||
48510158|NCT01294787|156060796|FG001|Period 1|Withdrawal by Subject|0|||
48510159|NCT01294787|156060797|FG002|Period 1|Withdrawal by Subject|0|||
48510160|NCT01294787|156060798|FG003|Period 1|Withdrawal by Subject|1|||
48510161|NCT01294787|156060799|FG004|Period 1|Withdrawal by Subject|1|||
48510162|NCT01294787|156060800|FG005|Period 1|Withdrawal by Subject|1|||
48510163|NCT01294787|156060795|FG000|Period 1|Administrative problem|0|||
48510164|NCT01294787|156060796|FG001|Period 1|Administrative problem|0|||
48510165|NCT01294787|156060797|FG002|Period 1|Administrative problem|1|||
48510166|NCT01294787|156060798|FG003|Period 1|Administrative problem|0|||
48510167|NCT01294787|156060799|FG004|Period 1|Administrative problem|0|||
48510168|NCT01294787|156060800|FG005|Period 1|Administrative problem|1|||
48601002|NCT00141518|156396018|FG000|Overall Study|Lack of Efficacy|5|||
48510169|NCT01294787|156060795|FG000|Period 2|Adverse Event|0|||
48510170|NCT01294787|156060796|FG001|Period 2|Adverse Event|3|||
48510171|NCT01294787|156060797|FG002|Period 2|Adverse Event|0|||
48510172|NCT01294787|156060798|FG003|Period 2|Adverse Event|1|||
48727730|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
48510173|NCT01294787|156060799|FG004|Period 2|Adverse Event|0|||
48510174|NCT01294787|156060800|FG005|Period 2|Adverse Event|0|||
48510175|NCT01294787|156060795|FG000|Period 2|No longer needs study drug|0|||
48510176|NCT01294787|156060796|FG001|Period 2|No longer needs study drug|0|||
48510177|NCT01294787|156060797|FG002|Period 2|No longer needs study drug|0|||
48510178|NCT01294787|156060798|FG003|Period 2|No longer needs study drug|1|||
48510179|NCT01294787|156060799|FG004|Period 2|No longer needs study drug|0|||
48510180|NCT01294787|156060800|FG005|Period 2|No longer needs study drug|0|||
48510181|NCT01294787|156060795|FG000|Period 3|Adverse Event|0|||
48510182|NCT01294787|156060796|FG001|Period 3|Adverse Event|0|||
48510183|NCT01294787|156060797|FG002|Period 3|Adverse Event|0|||
48510184|NCT01294787|156060798|FG003|Period 3|Adverse Event|0|||
48510185|NCT01294787|156060799|FG004|Period 3|Adverse Event|1|||
48510186|NCT01294787|156060800|FG005|Period 3|Adverse Event|0|||
48510187|NCT05017480|156060801|FG000|Stage 1 Study|Withdrawal by Subject|8|||
48510188|NCT05017480|156060802|FG001|Stage 1 Study|Withdrawal by Subject|6|||
48510189|NCT05017480|156060803|FG002|Stage 1 Study|Withdrawal by Subject|0|||
48510190|NCT05017480|156060804|FG003|Stage 1 Study|Withdrawal by Subject|0|||
48727731|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
48727732|NCT02431247|156853362|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
48727733|NCT02431247|156853363|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
48510191|NCT05017480|156060805|FG004|Stage 1 Study|Withdrawal by Subject|0|||
48510192|NCT05017480|156060801|FG000|Stage 1 Study|Adverse Event|1|||
48510193|NCT05017480|156060802|FG001|Stage 1 Study|Adverse Event|1|||
48510194|NCT05017480|156060803|FG002|Stage 1 Study|Adverse Event|0|||
48727734|NCT02431247|156853364|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
48727735|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
48821562|NCT02061761|157188699|FG004|Overall Study|Other reasons|2|||
48821563|NCT02061761|157188700|FG005|Overall Study|Other reasons|0|||
48821564|NCT02061761|157188701|FG006|Overall Study|Other reasons|0|||
48821565|NCT02061761|157188702|FG007|Overall Study|Other reasons|0|||
48510195|NCT05017480|156060804|FG003|Stage 1 Study|Adverse Event|0|||
48510196|NCT05017480|156060805|FG004|Stage 1 Study|Adverse Event|0|||
48727736|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
48727737|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
48727738|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
48727739|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
48727740|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
48727741|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
48727742|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
48727743|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
48727744|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
48727745|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
48727746|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
48727747|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
48727748|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
48727749|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
48727750|NCT02431247|156853362|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
48727751|NCT02431247|156853363|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
48727752|NCT02431247|156853364|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
48727753|NCT01562873|156853365|FG000|Overall Study|Disease Progression per RECIST|10|||
48727754|NCT01562873|156853366|FG001|Overall Study|Disease Progression per RECIST|0|||
48727755|NCT01562873|156853365|FG000|Overall Study|Adverse Event|1|||
48727756|NCT01562873|156853366|FG001|Overall Study|Adverse Event|0|||
48727757|NCT01562873|156853365|FG000|Overall Study|Clinical Disease Progression|9|||
48727758|NCT01562873|156853366|FG001|Overall Study|Clinical Disease Progression|0|||
48727759|NCT01562873|156853365|FG000|Overall Study|Clinical PD and adverse event|1|||
48727760|NCT01562873|156853366|FG001|Overall Study|Clinical PD and adverse event|0|||
48727761|NCT01369485|156853367|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
48727762|NCT01369485|156853368|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
48727763|NCT01369485|156853367|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
48727764|NCT01369485|156853368|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
48727765|NCT01369485|156853367|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
48727766|NCT01369485|156853368|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
48727767|NCT01369485|156853367|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
48727768|NCT01369485|156853368|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
48727769|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
48727770|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
48727771|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
48727772|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
48727773|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
48727774|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
48727775|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
48821566|NCT02061761|157188703|FG008|Overall Study|Other reasons|6|||
48821567|NCT01473420|157188704|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
48510197|NCT05017480|156060801|FG000|Stage 1 Study|Poor Compliance|1|||
48510198|NCT05017480|156060802|FG001|Stage 1 Study|Poor Compliance|1|||
48510199|NCT05017480|156060803|FG002|Stage 1 Study|Poor Compliance|0|||
48510200|NCT05017480|156060804|FG003|Stage 1 Study|Poor Compliance|0|||
48510201|NCT05017480|156060805|FG004|Stage 1 Study|Poor Compliance|0|||
48510202|NCT05017480|156060801|FG000|Stage 1 Study|Physician Decision|0|||
48510203|NCT05017480|156060802|FG001|Stage 1 Study|Physician Decision|1|||
48510204|NCT05017480|156060803|FG002|Stage 1 Study|Physician Decision|0|||
48510205|NCT05017480|156060804|FG003|Stage 1 Study|Physician Decision|0|||
48510206|NCT05017480|156060805|FG004|Stage 1 Study|Physician Decision|0|||
48510207|NCT05017480|156060801|FG000|Stage 2 Study|Withdrawal by Subject|0|||
48510208|NCT05017480|156060802|FG001|Stage 2 Study|Withdrawal by Subject|0|||
48510209|NCT05017480|156060803|FG002|Stage 2 Study|Withdrawal by Subject|6|||
48510210|NCT05017480|156060804|FG003|Stage 2 Study|Withdrawal by Subject|9|||
48510211|NCT05017480|156060805|FG004|Stage 2 Study|Withdrawal by Subject|11|||
48510212|NCT05017480|156060801|FG000|Stage 2 Study|Lost to Follow-up|0|||
48510213|NCT05017480|156060802|FG001|Stage 2 Study|Lost to Follow-up|0|||
48510214|NCT05017480|156060803|FG002|Stage 2 Study|Lost to Follow-up|0|||
48510215|NCT05017480|156060804|FG003|Stage 2 Study|Lost to Follow-up|2|||
48510216|NCT05017480|156060805|FG004|Stage 2 Study|Lost to Follow-up|1|||
48510217|NCT05017480|156060801|FG000|Stage 2 Study|Adverse Event|0|||
48510218|NCT05017480|156060802|FG001|Stage 2 Study|Adverse Event|0|||
48510219|NCT05017480|156060803|FG002|Stage 2 Study|Adverse Event|0|||
48510220|NCT05017480|156060804|FG003|Stage 2 Study|Adverse Event|1|||
48510221|NCT05017480|156060805|FG004|Stage 2 Study|Adverse Event|0|||
48727776|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
48727777|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
48727778|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
48727779|NCT01369485|156853367|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
48727780|NCT01369485|156853368|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
48727781|NCT02140775|156853369|FG000|Overall Study|Withdrawal by Subject|30|||
48727782|NCT02140775|156853370|FG001|Overall Study|Withdrawal by Subject|7|||
48727783|NCT03783702|156853371|FG000|Overall Study|Lost to Follow-up|6|||
48727784|NCT03783702|156853372|FG001|Overall Study|Lost to Follow-up|8|||
48727785|NCT03783702|156853371|FG000|Overall Study|Protocol Violation|1|||
48727786|NCT03783702|156853372|FG001|Overall Study|Protocol Violation|3|||
48727787|NCT01306877|156853373|FG000|Overall Study|Lost to Follow-up|3|||
48727788|NCT01306877|156853374|FG001|Overall Study|Lost to Follow-up|3|||
48727789|NCT01306877|156853373|FG000|Overall Study|Physician Decision|0|||
48727790|NCT01306877|156853374|FG001|Overall Study|Physician Decision|1|||
48727791|NCT00459979|156853375|FG000|Overall Study|Withdrawal by Subject|1|||
48727792|NCT00459979|156853375|FG000|Overall Study|Protocol Violation|1|||
48727793|NCT00381381|156853376|FG000|Overall Study|Adverse Event|3|||
48727794|NCT00381381|156853376|FG000|Overall Study|Lost to Follow-up|52|||
48727795|NCT00381381|156853376|FG000|Overall Study|Withdrawal by Subject|9|||
48727796|NCT01227564|156853378|FG000|Overall Study|No Longer Willing to Participate|4|||
48727797|NCT01227564|156853379|FG001|Overall Study|No Longer Willing to Participate|2|||
48727798|NCT01227564|156853380|FG002|Overall Study|No Longer Willing to Participate|5|||
48727799|NCT01227564|156853378|FG000|Overall Study|Participant moved to another town|0|||
48727800|NCT01227564|156853379|FG001|Overall Study|Participant moved to another town|0|||
48821568|NCT01473420|157188705|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
48821569|NCT01473420|157188704|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
48510222|NCT05017480|156060801|FG000|Stage 2 Study|COVID-19|0|||
48510223|NCT05017480|156060802|FG001|Stage 2 Study|COVID-19|0|||
48510224|NCT05017480|156060803|FG002|Stage 2 Study|COVID-19|0|||
48510225|NCT05017480|156060804|FG003|Stage 2 Study|COVID-19|1|||
48510226|NCT05017480|156060805|FG004|Stage 2 Study|COVID-19|0|||
48510227|NCT05017480|156060801|FG000|Stage 2 Study|Pregnancy|0|||
48510228|NCT05017480|156060802|FG001|Stage 2 Study|Pregnancy|0|||
48510229|NCT05017480|156060803|FG002|Stage 2 Study|Pregnancy|0|||
48821570|NCT01473420|157188705|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
48510230|NCT05017480|156060804|FG003|Stage 2 Study|Pregnancy|0|||
48510231|NCT05017480|156060805|FG004|Stage 2 Study|Pregnancy|1|||
48510232|NCT02632344|156060806|FG000|Overall Study|Adverse Event|3|||
48510233|NCT02632344|156060806|FG000|Overall Study|Lack of Efficacy|3|||
48510234|NCT02632344|156060806|FG000|Overall Study|Withdrawal by Subject|2|||
48510235|NCT01136382|156060807|FG000|Overall Study|Other|8|||
48510236|NCT01136382|156060808|FG001|Overall Study|Other|3|||
48510237|NCT01136382|156060807|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
48727801|NCT01227564|156853380|FG002|Overall Study|Participant moved to another town|1|||
48727802|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
48727803|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
48821571|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
48510238|NCT01136382|156060808|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
48510239|NCT01136382|156060807|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
48510240|NCT01136382|156060808|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
48727804|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
48510241|NCT01136382|156060807|FG000|Overall Study|Withdrawal by Subject|4|||
48510242|NCT01136382|156060808|FG001|Overall Study|Withdrawal by Subject|1|||
48510243|NCT00467896|156060813|FG000|Overall Study|Consent Withdrawal|18|||
48510244|NCT00467896|156060813|FG000|Overall Study|Adverse Event|7|||
48510245|NCT00467896|156060813|FG000|Overall Study|Serious Adverse Event|13|||
48510246|NCT00467896|156060813|FG000|Overall Study|Non-compliance|3|||
48510247|NCT00467896|156060813|FG000|Overall Study|Changed therapy|2|||
48510248|NCT00467896|156060813|FG000|Overall Study|Patient received transplant|2|||
48510249|NCT00467896|156060813|FG000|Overall Study|Patient had atrial septostomy|1|||
48510250|NCT00467896|156060813|FG000|Overall Study|Patient weaned off iloprost|1|||
48510251|NCT00467896|156060813|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
48510252|NCT00467896|156060813|FG000|Overall Study|Started intravenous prostacyclin|1|||
48510253|NCT00467896|156060813|FG000|Overall Study|Started inhaled Remodulin|1|||
48510254|NCT00467896|156060813|FG000|Overall Study|Patient had no improvement|1|||
48510255|NCT02847650|156060814|FG000|Overall Study|Adverse Event|2|||
48510256|NCT02847650|156060815|FG001|Overall Study|Adverse Event|4|||
48510257|NCT02847650|156060814|FG000|Overall Study|Lost to Follow-up|1|||
48510258|NCT02847650|156060815|FG001|Overall Study|Lost to Follow-up|0|||
48510259|NCT02847650|156060814|FG000|Overall Study|Protocol Violation|0|||
48510260|NCT02847650|156060815|FG001|Overall Study|Protocol Violation|1|||
48510261|NCT02847650|156060814|FG000|Overall Study|Withdrawal by Subject|1|||
48510262|NCT02847650|156060815|FG001|Overall Study|Withdrawal by Subject|1|||
48510263|NCT02911792|156060819|FG000|Overall Study|Lost to Follow-up|3|||
48510264|NCT02911792|156060820|FG001|Overall Study|Lost to Follow-up|3|||
48510265|NCT02911792|156060821|FG002|Overall Study|Lost to Follow-up|3|||
48727805|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
48727806|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
48727807|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
48510266|NCT02911792|156060822|FG003|Overall Study|Lost to Follow-up|3|||
48510267|NCT00633594|156060823|FG000|Overall Study|Adverse Event|0|||
48510268|NCT00633594|156060824|FG001|Overall Study|Adverse Event|4|||
48510269|NCT00633594|156060825|FG002|Overall Study|Adverse Event|7|||
48510270|NCT00633594|156060823|FG000|Overall Study|Death|0|||
48510271|NCT00633594|156060824|FG001|Overall Study|Death|1|||
48510272|NCT00633594|156060825|FG002|Overall Study|Death|2|||
48510273|NCT00633594|156060823|FG000|Overall Study|Disease Progression|0|||
48510274|NCT00633594|156060824|FG001|Overall Study|Disease Progression|0|||
48510275|NCT00633594|156060825|FG002|Overall Study|Disease Progression|1|||
48510276|NCT00927069|156060826|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
48727808|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727809|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
48510277|NCT00927069|156060827|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
48510278|NCT00927069|156060828|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
48510279|NCT00927069|156060829|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
48510280|NCT00927069|156060826|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
48510281|NCT00927069|156060827|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
48601003|NCT00141518|156396019|FG001|Overall Study|Lack of Efficacy|0|||
48601004|NCT00141518|156396020|FG002|Overall Study|Lack of Efficacy|0|||
48601005|NCT01064414|156396021|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
48601006|NCT01064414|156396022|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
48601007|NCT01064414|156396023|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
48727810|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727811|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727812|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727813|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
48727814|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
48727815|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
48727816|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
48727817|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
48727818|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
48727819|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
48727820|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48727821|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
48727822|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48510282|NCT00927069|156060828|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
48601008|NCT01064414|156396021|FG000|Core Period: Baseline to Week 26|Death|0|||
48601009|NCT01064414|156396022|FG001|Core Period: Baseline to Week 26|Death|1|||
48601010|NCT01064414|156396023|FG002|Core Period: Baseline to Week 26|Death|0|||
48601011|NCT01064414|156396021|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
48601012|NCT01064414|156396022|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
48601013|NCT01064414|156396023|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
48601014|NCT01064414|156396021|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
48601015|NCT01064414|156396022|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
48727823|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48727824|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48727825|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
48727826|NCT00745615|156853387|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727827|NCT00745615|156853388|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
48727828|NCT00745615|156853389|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727829|NCT00745615|156853390|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727830|NCT00745615|156853391|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727831|NCT00745615|156853392|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
48727832|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
48727833|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
48727834|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
48510283|NCT00927069|156060829|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
48510284|NCT00927069|156060826|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
48510285|NCT00927069|156060827|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
48510286|NCT00927069|156060828|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
48510287|NCT00927069|156060829|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
48510288|NCT00927069|156060826|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
48510289|NCT00927069|156060827|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
48510290|NCT00927069|156060828|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
48510291|NCT00927069|156060829|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
48510292|NCT00927069|156060826|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
48510293|NCT00927069|156060827|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
48727835|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
48727836|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
48727837|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
48727838|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
48727839|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
48727840|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
48727841|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
48727842|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
48727843|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
48727844|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
48727845|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
48727846|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
48727847|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
48727848|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
48727849|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
48727850|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
48727851|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
48727852|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
48727853|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
48727854|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
48727855|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
48727856|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
48727857|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
48727858|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
48727859|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
48727860|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
48727861|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
48510294|NCT00927069|156060828|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
48510295|NCT00927069|156060829|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
48510296|NCT05612724|156060831|FG000|Overall Study|Lost to Follow-up|4|||
48510297|NCT00316186|156060832|FG000|Overall Study|Adverse Event|6|||
48727862|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
48727863|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
48727864|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
48727865|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
48727866|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
48727867|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
48510298|NCT00316186|156060832|FG000|Overall Study|Disease Progression|4|||
48510299|NCT00316186|156060832|FG000|Overall Study|Lost to Follow-up|1|||
48510300|NCT00316186|156060832|FG000|Overall Study|Other|1|||
48727868|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48510301|NCT01439880|156060833|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
48510302|NCT01439880|156060834|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
48510303|NCT01439880|156060833|FG000|SOC-controlled Period (Year 1)|Death|2|||
48510304|NCT01439880|156060834|FG001|SOC-controlled Period (Year 1)|Death|1|||
48510305|NCT01439880|156060833|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
48510306|NCT01439880|156060834|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
48510307|NCT01439880|156060833|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
48510308|NCT01439880|156060834|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
48510309|NCT01439880|156060833|FG000|SOC-controlled Period (Year 1)|Other|8|||
48510310|NCT01439880|156060834|FG001|SOC-controlled Period (Year 1)|Other|13|||
48510311|NCT01439880|156060833|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
48510312|NCT01439880|156060834|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
48510313|NCT01439880|156060833|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
48510314|NCT01439880|156060834|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
48727869|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48727870|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48727871|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48727872|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
48727873|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
48727874|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727875|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727876|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727877|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727878|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
48727879|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
48727880|NCT00745615|156853387|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
48727881|NCT00745615|156853388|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
48727882|NCT00745615|156853389|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
48727883|NCT00745615|156853390|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
48727884|NCT00745615|156853391|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
48727885|NCT00745615|156853392|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
48727886|NCT00772070|156853395|FG000|Overall Study|Lost to Follow-up|0|||
48727887|NCT00772070|156853396|FG001|Overall Study|Lost to Follow-up|8|||
48727888|NCT00772070|156853395|FG000|Overall Study|Withdrawal by Subject|0|||
48727889|NCT00772070|156853396|FG001|Overall Study|Withdrawal by Subject|2|||
48727890|NCT00772070|156853395|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
48727891|NCT00772070|156853396|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
48727892|NCT01982331|156853397|FG000|Received Vaccination 2|Adverse Event|1|||
48727893|NCT01982331|156853398|FG001|Received Vaccination 2|Adverse Event|2|||
48727894|NCT01982331|156853397|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
48727895|NCT01982331|156853398|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
48727896|NCT01982331|156853397|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
48727897|NCT01982331|156853398|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
48727898|NCT01962922|156853405|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
48727899|NCT01962922|156853406|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
48727900|NCT01962922|156853405|FG000|PK Portion Day 7|non-compliance|1|||
48727901|NCT01962922|156853406|FG001|PK Portion Day 7|non-compliance|0|||
48727902|NCT01962922|156853405|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
48727903|NCT01962922|156853406|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
48727904|NCT01962922|156853405|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
48727905|NCT01962922|156853406|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
48727906|NCT00568685|156853407|FG000|Overall Study|Adverse Event|2|||
48510315|NCT01439880|156060833|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
48510316|NCT01439880|156060834|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
48510317|NCT01439880|156060833|FG000|All-IP Period (Years 2 to 5)|Death|3|||
48510318|NCT01439880|156060834|FG001|All-IP Period (Years 2 to 5)|Death|13|||
48510319|NCT01439880|156060833|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
48727907|NCT00568685|156853408|FG001|Overall Study|Adverse Event|3|||
48727908|NCT00568685|156853409|FG002|Overall Study|Adverse Event|3|||
48727909|NCT00568685|156853407|FG000|Overall Study|Withdrawal by Subject|7|||
48727910|NCT00568685|156853408|FG001|Overall Study|Withdrawal by Subject|2|||
48727911|NCT00568685|156853409|FG002|Overall Study|Withdrawal by Subject|2|||
48727912|NCT00568685|156853407|FG000|Overall Study|Protocol Violation|1|||
48727913|NCT00568685|156853408|FG001|Overall Study|Protocol Violation|0|||
48727914|NCT00568685|156853409|FG002|Overall Study|Protocol Violation|0|||
48510320|NCT01439880|156060834|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
48510321|NCT01439880|156060833|FG000|All-IP Period (Years 2 to 5)|Other|14|||
48510322|NCT01439880|156060834|FG001|All-IP Period (Years 2 to 5)|Other|31|||
48510323|NCT01439880|156060833|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
48510324|NCT01439880|156060834|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
48510325|NCT00461786|156060837|FG000|Overall Study|Entry Criteria Not Met|2|||
48510326|NCT00461786|156060837|FG000|Overall Study|Inevaluable (Never Treated)|1|||
48727915|NCT01163032|156853410|FG000|Randomization Phase|Withdrawal by Subject|2|||
48727916|NCT01163032|156853411|FG001|Randomization Phase|Withdrawal by Subject|3|||
48727917|NCT01163032|156853412|FG002|Randomization Phase|Withdrawal by Subject|0|||
48510327|NCT02301975|156060838|FG000|Overall Study|Adverse Event|8|||
48510328|NCT02301975|156060839|FG001|Overall Study|Adverse Event|3|||
48510329|NCT02301975|156060840|FG002|Overall Study|Adverse Event|2|||
48510330|NCT02301975|156060838|FG000|Overall Study|Lack of Efficacy|1|||
48510331|NCT02301975|156060839|FG001|Overall Study|Lack of Efficacy|1|||
48727918|NCT01163032|156853410|FG000|Randomization Phase|Adverse Event|3|||
48727919|NCT01163032|156853411|FG001|Randomization Phase|Adverse Event|3|||
48727920|NCT01163032|156853412|FG002|Randomization Phase|Adverse Event|0|||
48727921|NCT01163032|156853410|FG000|Randomization Phase|Protocol Violation|0|||
48510332|NCT02301975|156060840|FG002|Overall Study|Lack of Efficacy|1|||
48510333|NCT02301975|156060838|FG000|Overall Study|Protocol Violation|3|||
48510334|NCT02301975|156060839|FG001|Overall Study|Protocol Violation|5|||
48510335|NCT02301975|156060840|FG002|Overall Study|Protocol Violation|3|||
48510336|NCT02301975|156060838|FG000|Overall Study|Lost to Follow-up|0|||
48510337|NCT02301975|156060839|FG001|Overall Study|Lost to Follow-up|2|||
48510338|NCT02301975|156060840|FG002|Overall Study|Lost to Follow-up|2|||
48510339|NCT02301975|156060838|FG000|Overall Study|Physician Decision|4|||
48510340|NCT02301975|156060839|FG001|Overall Study|Physician Decision|2|||
48510341|NCT02301975|156060840|FG002|Overall Study|Physician Decision|3|||
48510342|NCT02301975|156060838|FG000|Overall Study|Withdrawal by Subject|15|||
48510343|NCT02301975|156060839|FG001|Overall Study|Withdrawal by Subject|12|||
48510344|NCT02301975|156060840|FG002|Overall Study|Withdrawal by Subject|11|||
48510345|NCT04533594|156060841|FG000|Overall Study|Death|26|||
48510346|NCT03181594|156060842|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
48510347|NCT03181594|156060842|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
48510348|NCT03181594|156060842|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
48510349|NCT03181594|156060842|FG000|Initial Study Protocol (12-month FU)|Death|1|||
48510350|NCT03181594|156060842|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
48510351|NCT03181594|156060842|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
48510352|NCT01244620|156060852|FG000|Overall Study|Study terminated|4|||
48510353|NCT01244620|156060853|FG001|Overall Study|Study terminated|4|||
48510354|NCT01244620|156060854|FG002|Overall Study|Study terminated|4|||
48510355|NCT01244620|156060855|FG003|Overall Study|Study terminated|4|||
48510356|NCT00473330|156060859|FG000|Core Study|Adverse Event|4|||
48510357|NCT00473330|156060860|FG001|Core Study|Adverse Event|4|||
48510358|NCT00473330|156060861|FG002|Core Study|Adverse Event|1|||
48510359|NCT00473330|156060859|FG000|Core Study|Death|6|||
48510360|NCT00473330|156060860|FG001|Core Study|Death|4|||
48510361|NCT00473330|156060861|FG002|Core Study|Death|4|||
48510362|NCT00473330|156060859|FG000|Core Study|Lost to Follow-up|5|||
48510363|NCT00473330|156060860|FG001|Core Study|Lost to Follow-up|5|||
48510364|NCT00473330|156060861|FG002|Core Study|Lost to Follow-up|10|||
48510365|NCT00473330|156060859|FG000|Core Study|Physician Decision|2|||
48510366|NCT00473330|156060860|FG001|Core Study|Physician Decision|1|||
48510367|NCT00473330|156060861|FG002|Core Study|Physician Decision|3|||
48510368|NCT00473330|156060859|FG000|Core Study|Subject Non-compliance|1|||
48510369|NCT00473330|156060860|FG001|Core Study|Subject Non-compliance|2|||
48510370|NCT00473330|156060861|FG002|Core Study|Subject Non-compliance|1|||
48510371|NCT00473330|156060859|FG000|Core Study|Subject Required Other Therapy|0|||
48510372|NCT00473330|156060860|FG001|Core Study|Subject Required Other Therapy|1|||
48510373|NCT00473330|156060861|FG002|Core Study|Subject Required Other Therapy|3|||
48510374|NCT00473330|156060859|FG000|Core Study|Subject's Decision|9|||
48510375|NCT00473330|156060860|FG001|Core Study|Subject's Decision|8|||
48510376|NCT00473330|156060861|FG002|Core Study|Subject's Decision|19|||
48510377|NCT00473330|156060859|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
48510378|NCT00473330|156060860|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
48510379|NCT00473330|156060861|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
48510380|NCT00473330|156060859|FG000|Open-label Extension Through Month 48|Death|2|||
48510381|NCT00473330|156060860|FG001|Open-label Extension Through Month 48|Death|0|||
48510382|NCT00473330|156060861|FG002|Open-label Extension Through Month 48|Death|0|||
48510383|NCT00473330|156060859|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
48510384|NCT00473330|156060860|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
48510385|NCT00473330|156060861|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
48510386|NCT00473330|156060859|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
48510387|NCT00473330|156060860|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
48510388|NCT00473330|156060861|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
48510389|NCT00473330|156060859|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
48510390|NCT00473330|156060860|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
48510391|NCT00473330|156060861|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
48510392|NCT00473330|156060859|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
48510393|NCT00473330|156060860|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
48510394|NCT00473330|156060861|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
48510395|NCT00473330|156060859|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
48727922|NCT01163032|156853411|FG001|Randomization Phase|Protocol Violation|1|||
48727923|NCT01163032|156853412|FG002|Randomization Phase|Protocol Violation|0|||
48727924|NCT01163032|156853410|FG000|Randomization Phase|Various*|5|||
48727925|NCT01163032|156853411|FG001|Randomization Phase|Various*|4|||
48510396|NCT00473330|156060860|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
48510397|NCT00473330|156060861|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
48510398|NCT00473330|156060859|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
48510399|NCT00473330|156060860|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
48601016|NCT01064414|156396023|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
48601017|NCT01064414|156396021|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48601018|NCT01064414|156396022|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
48601019|NCT01064414|156396023|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48601020|NCT01064414|156396021|FG000|Core Period: Baseline to Week 26|Other|4|||
48601021|NCT01064414|156396022|FG001|Core Period: Baseline to Week 26|Other|7|||
48601022|NCT01064414|156396023|FG002|Core Period: Baseline to Week 26|Other|2|||
48601023|NCT01064414|156396021|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
48601024|NCT01064414|156396022|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
48601025|NCT01064414|156396023|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
48601026|NCT01064414|156396021|FG000|Extension Period: Week 26 to Week 52|Death|0|||
48601027|NCT01064414|156396022|FG001|Extension Period: Week 26 to Week 52|Death|1|||
48601028|NCT01064414|156396023|FG002|Extension Period: Week 26 to Week 52|Death|0|||
48601029|NCT01064414|156396021|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
48601030|NCT01064414|156396022|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48601031|NCT01064414|156396023|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48601032|NCT01064414|156396021|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
48601033|NCT01064414|156396022|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48601034|NCT01064414|156396023|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48601035|NCT01064414|156396021|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48601036|NCT01064414|156396022|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
48601037|NCT01064414|156396023|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48601038|NCT01064414|156396021|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
48727926|NCT01163032|156853412|FG002|Randomization Phase|Various*|0|||
48727927|NCT01163032|156853410|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
48510400|NCT00473330|156060861|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
48510401|NCT00473330|156060859|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
48510402|NCT00473330|156060860|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
48510403|NCT00473330|156060861|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
48510404|NCT00473330|156060859|FG000|Open-label Extension Through Month 60|Death|2|||
48510405|NCT00473330|156060860|FG001|Open-label Extension Through Month 60|Death|2|||
48510406|NCT00473330|156060861|FG002|Open-label Extension Through Month 60|Death|1|||
48510407|NCT00473330|156060859|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
48510408|NCT00473330|156060860|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
48510409|NCT00473330|156060861|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
48510410|NCT00473330|156060859|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
48727928|NCT01163032|156853411|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
48727929|NCT01163032|156853412|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
48727930|NCT01163032|156853410|FG000|Open Label Extension Phase|Adverse Event|0|||
48727931|NCT01163032|156853411|FG001|Open Label Extension Phase|Adverse Event|0|||
48727932|NCT01163032|156853412|FG002|Open Label Extension Phase|Adverse Event|3|||
48727933|NCT01163032|156853410|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
48727934|NCT01163032|156853411|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
48727935|NCT01163032|156853412|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
48727936|NCT01163032|156853410|FG000|Open Label Extension Phase|Protocol Violation|0|||
48727937|NCT01163032|156853411|FG001|Open Label Extension Phase|Protocol Violation|0|||
48727938|NCT01163032|156853412|FG002|Open Label Extension Phase|Protocol Violation|1|||
48727939|NCT01163032|156853410|FG000|Open Label Extension Phase|Study Termination|0|||
48727940|NCT01163032|156853411|FG001|Open Label Extension Phase|Study Termination|0|||
48727941|NCT01163032|156853412|FG002|Open Label Extension Phase|Study Termination|7|||
48727942|NCT01163032|156853410|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
48727943|NCT01163032|156853411|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
48727944|NCT01163032|156853412|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
48727945|NCT03687970|156853413|FG000|Overall Study|visit scheduling conflicts|2|||
48727946|NCT03687970|156853414|FG001|Overall Study|visit scheduling conflicts|0|||
48821572|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
48821573|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
48821574|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
48821575|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
48821576|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
48821577|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
48821578|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
48510411|NCT00473330|156060860|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
48510412|NCT00473330|156060861|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
48510413|NCT00473330|156060859|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
48510414|NCT00473330|156060860|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
48510415|NCT00473330|156060861|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
48510416|NCT00473330|156060859|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
48510417|NCT00473330|156060860|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
48510418|NCT00473330|156060861|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
48510419|NCT00473330|156060859|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
48510420|NCT00473330|156060860|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
48510421|NCT00473330|156060861|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
48510422|NCT00473330|156060859|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
48510423|NCT00473330|156060860|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
48510424|NCT00473330|156060861|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
48510425|NCT01975948|156060862|FG000|Overall Study|Withdrawal by Subject|17|||
48510426|NCT01975948|156060863|FG001|Overall Study|Withdrawal by Subject|21|||
48510427|NCT01975948|156060864|FG002|Overall Study|Withdrawal by Subject|7|||
48510428|NCT01975948|156060865|FG003|Overall Study|Withdrawal by Subject|6|||
48510429|NCT01675765|156060866|FG000|Overall Study|Progressive disease|4|||
48510430|NCT01675765|156060867|FG001|Overall Study|Progressive disease|4|||
48510431|NCT01675765|156060866|FG000|Overall Study|Adverse Event|1|||
48510432|NCT01675765|156060867|FG001|Overall Study|Adverse Event|2|||
48510433|NCT01675765|156060866|FG000|Overall Study|Withdrawal by Subject|2|||
48510434|NCT01675765|156060867|FG001|Overall Study|Withdrawal by Subject|0|||
48510435|NCT01675765|156060866|FG000|Overall Study|Death|1|||
48510436|NCT01675765|156060867|FG001|Overall Study|Death|0|||
48510437|NCT01675765|156060866|FG000|Overall Study|Clinical progression|3|||
48510438|NCT01675765|156060867|FG001|Overall Study|Clinical progression|2|||
48510439|NCT00365846|156060872|FG000|Overall Study|Lost to Follow-up|1|||
48510440|NCT01200810|156060873|FG000|Overall Study|Physician Decision|1|||
48510441|NCT01200810|156060874|FG001|Overall Study|Physician Decision|0|||
48510442|NCT01200810|156060873|FG000|Overall Study|Withdrawal by Subject|1|||
48510443|NCT01200810|156060874|FG001|Overall Study|Withdrawal by Subject|2|||
48821579|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
48727947|NCT02711345|156853415|FG000|Overall Study|Adverse Event|0|||
48727948|NCT02711345|156853416|FG001|Overall Study|Adverse Event|0|||
48727949|NCT02711345|156853417|FG002|Overall Study|Adverse Event|0|||
48727950|NCT02711345|156853418|FG003|Overall Study|Adverse Event|1|||
48727951|NCT02711345|156853419|FG004|Overall Study|Adverse Event|1|||
48727952|NCT02711345|156853420|FG005|Overall Study|Adverse Event|2|||
48727953|NCT02711345|156853421|FG006|Overall Study|Adverse Event|1|||
48727954|NCT02711345|156853422|FG007|Overall Study|Adverse Event|0|||
48727955|NCT02711345|156853423|FG008|Overall Study|Adverse Event|0|||
48727956|NCT02711345|156853424|FG009|Overall Study|Adverse Event|2|||
48727957|NCT02711345|156853415|FG000|Overall Study|Physician Decision|0|||
48727958|NCT02711345|156853416|FG001|Overall Study|Physician Decision|0|||
48727959|NCT02711345|156853417|FG002|Overall Study|Physician Decision|1|||
48727960|NCT02711345|156853418|FG003|Overall Study|Physician Decision|0|||
48727961|NCT02711345|156853419|FG004|Overall Study|Physician Decision|0|||
48727962|NCT02711345|156853420|FG005|Overall Study|Physician Decision|0|||
48727963|NCT02711345|156853421|FG006|Overall Study|Physician Decision|0|||
48727964|NCT02711345|156853422|FG007|Overall Study|Physician Decision|0|||
48727965|NCT02711345|156853423|FG008|Overall Study|Physician Decision|1|||
48727966|NCT02711345|156853424|FG009|Overall Study|Physician Decision|0|||
48727967|NCT02711345|156853415|FG000|Overall Study|Progressive disease|1|||
48727968|NCT02711345|156853416|FG001|Overall Study|Progressive disease|3|||
48727969|NCT02711345|156853417|FG002|Overall Study|Progressive disease|5|||
48727970|NCT02711345|156853418|FG003|Overall Study|Progressive disease|3|||
48727971|NCT02711345|156853419|FG004|Overall Study|Progressive disease|7|||
48727972|NCT02711345|156853420|FG005|Overall Study|Progressive disease|2|||
48727973|NCT02711345|156853421|FG006|Overall Study|Progressive disease|8|||
48727974|NCT02711345|156853422|FG007|Overall Study|Progressive disease|4|||
48727975|NCT02711345|156853423|FG008|Overall Study|Progressive disease|5|||
48727976|NCT02711345|156853424|FG009|Overall Study|Progressive disease|6|||
48727977|NCT02711345|156853415|FG000|Overall Study|Subject/guardian decision|0|||
48727978|NCT02711345|156853416|FG001|Overall Study|Subject/guardian decision|0|||
48727979|NCT02711345|156853417|FG002|Overall Study|Subject/guardian decision|0|||
48727980|NCT02711345|156853418|FG003|Overall Study|Subject/guardian decision|0|||
48727981|NCT02711345|156853419|FG004|Overall Study|Subject/guardian decision|0|||
48727982|NCT02711345|156853420|FG005|Overall Study|Subject/guardian decision|2|||
48727983|NCT02711345|156853421|FG006|Overall Study|Subject/guardian decision|3|||
48727984|NCT02711345|156853422|FG007|Overall Study|Subject/guardian decision|1|||
48727985|NCT02711345|156853423|FG008|Overall Study|Subject/guardian decision|0|||
48727986|NCT02711345|156853424|FG009|Overall Study|Subject/guardian decision|4|||
48727987|NCT02711345|156853415|FG000|Overall Study|Death|1|||
48727988|NCT02711345|156853416|FG001|Overall Study|Death|0|||
48727989|NCT02711345|156853417|FG002|Overall Study|Death|0|||
48727990|NCT02711345|156853418|FG003|Overall Study|Death|0|||
48727991|NCT02711345|156853419|FG004|Overall Study|Death|0|||
48727992|NCT02711345|156853420|FG005|Overall Study|Death|0|||
48727993|NCT02711345|156853421|FG006|Overall Study|Death|0|||
48727994|NCT02711345|156853422|FG007|Overall Study|Death|1|||
48727995|NCT02711345|156853423|FG008|Overall Study|Death|0|||
48727996|NCT02711345|156853424|FG009|Overall Study|Death|0|||
48727997|NCT00739596|156853425|FG000|Overall Study|Adverse Event|12|||
48727998|NCT00739596|156853426|FG001|Overall Study|Adverse Event|6|||
48727999|NCT00739596|156853425|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
48728000|NCT00739596|156853426|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48728001|NCT00739596|156853425|FG000|Overall Study|Patient Withdrew Consent|8|||
48728002|NCT00739596|156853426|FG001|Overall Study|Patient Withdrew Consent|8|||
48728003|NCT00739596|156853425|FG000|Overall Study|Lost to Follow-up|0|||
48728004|NCT00739596|156853426|FG001|Overall Study|Lost to Follow-up|2|||
48728005|NCT00739596|156853425|FG000|Overall Study|Protocol Deviation|1|||
48728006|NCT00739596|156853426|FG001|Overall Study|Protocol Deviation|1|||
48728007|NCT01888003|156853429|FG000|Overall Study|Study Terminated|5|||
48728008|NCT01888003|156853430|FG001|Overall Study|Study Terminated|6|||
48728009|NCT01888003|156853431|FG002|Overall Study|Study Terminated|40|||
48821580|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
48821581|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
48821582|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
48821583|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
48728010|NCT02734433|156853436|FG000|Overall Study|Disease progression|1|||
48728011|NCT02734433|156853437|FG001|Overall Study|Disease progression|5|||
48821584|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
48821585|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
48821586|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
48728012|NCT02734433|156853436|FG000|Overall Study|Clinical progression|0|||
48728013|NCT02734433|156853437|FG001|Overall Study|Clinical progression|1|||
48728014|NCT02734433|156853436|FG000|Overall Study|Withdrawal by Subject|1|||
48728015|NCT02734433|156853437|FG001|Overall Study|Withdrawal by Subject|2|||
48728016|NCT03505671|156854308|FG000|Overall Study|Withdrawal by Subject|2|||
48728017|NCT03505671|156854309|FG001|Overall Study|Withdrawal by Subject|1|||
48728018|NCT03505671|156854308|FG000|Overall Study|Lost to Follow-up|1|||
48728019|NCT03505671|156854309|FG001|Overall Study|Lost to Follow-up|0|||
48728020|NCT04423939|156854312|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
48728021|NCT04423939|156854313|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
48728022|NCT04423939|156854312|FG000|Overall Study|Death|3|||
48728023|NCT04423939|156854313|FG001|Overall Study|Death|0|||
48728024|NCT04423939|156854312|FG000|Overall Study|Withdrawal by Subject|3|||
48728025|NCT04423939|156854313|FG001|Overall Study|Withdrawal by Subject|0|||
48728026|NCT04423939|156854312|FG000|Overall Study|Caregiver to patient who died|0|||
48728027|NCT04423939|156854313|FG001|Overall Study|Caregiver to patient who died|3|||
48728028|NCT04423939|156854312|FG000|Overall Study|Caregiver to patient who withdrew|0|||
48510444|NCT01200810|156060873|FG000|Overall Study|Sponsor stopped making study drug|3|||
48510445|NCT01200810|156060874|FG001|Overall Study|Sponsor stopped making study drug|3|||
48510446|NCT03017885|156060877|FG000|Overall Study|Adverse Event|2|||
48510447|NCT03017885|156060878|FG001|Overall Study|Adverse Event|0|||
48510448|NCT03017885|156060879|FG002|Overall Study|Adverse Event|0|||
48510449|NCT03017885|156060880|FG003|Overall Study|Adverse Event|0|||
48510450|NCT03017885|156060881|FG004|Overall Study|Adverse Event|0|||
48510451|NCT03017885|156060882|FG005|Overall Study|Adverse Event|0|||
48510452|NCT03017885|156060877|FG000|Overall Study|Progression of disease|4|||
48510453|NCT03017885|156060878|FG001|Overall Study|Progression of disease|3|||
48510454|NCT03017885|156060879|FG002|Overall Study|Progression of disease|4|||
48510455|NCT03017885|156060880|FG003|Overall Study|Progression of disease|0|||
48510456|NCT03017885|156060881|FG004|Overall Study|Progression of disease|0|||
48510457|NCT03017885|156060882|FG005|Overall Study|Progression of disease|0|||
48510458|NCT03017885|156060877|FG000|Overall Study|Other than listed|1|||
48510459|NCT03017885|156060878|FG001|Overall Study|Other than listed|2|||
48510460|NCT03017885|156060879|FG002|Overall Study|Other than listed|1|||
48510461|NCT03017885|156060880|FG003|Overall Study|Other than listed|0|||
48510462|NCT03017885|156060881|FG004|Overall Study|Other than listed|0|||
48510463|NCT03017885|156060882|FG005|Overall Study|Other than listed|0|||
48510464|NCT03017885|156060877|FG000|Overall Study|Lost to Follow-up|2|||
48510465|NCT03017885|156060878|FG001|Overall Study|Lost to Follow-up|0|||
48510466|NCT03017885|156060879|FG002|Overall Study|Lost to Follow-up|3|||
48510467|NCT03017885|156060880|FG003|Overall Study|Lost to Follow-up|0|||
48510468|NCT03017885|156060881|FG004|Overall Study|Lost to Follow-up|0|||
48510469|NCT03017885|156060882|FG005|Overall Study|Lost to Follow-up|0|||
48510470|NCT03017885|156060877|FG000|Overall Study|Change to other anti-cancer therapy|0|||
48510471|NCT03017885|156060878|FG001|Overall Study|Change to other anti-cancer therapy|0|||
48510472|NCT03017885|156060879|FG002|Overall Study|Change to other anti-cancer therapy|1|||
48510473|NCT03017885|156060880|FG003|Overall Study|Change to other anti-cancer therapy|0|||
48510474|NCT03017885|156060881|FG004|Overall Study|Change to other anti-cancer therapy|0|||
48510475|NCT03017885|156060882|FG005|Overall Study|Change to other anti-cancer therapy|0|||
48510476|NCT02645409|156060885|FG000|Overall Study|Withdrawal by Subject|3|||
48510477|NCT02645409|156060886|FG001|Overall Study|Withdrawal by Subject|0|||
48510478|NCT02645409|156060885|FG000|Overall Study|Physician Decision|1|||
48510479|NCT02645409|156060886|FG001|Overall Study|Physician Decision|0|||
48510480|NCT01723397|156060889|FG000|Study Period 1|Protocol Violation|0|||
48510481|NCT01723397|156060890|FG001|Study Period 1|Protocol Violation|1|||
48510482|NCT01723397|156060889|FG000|Study Period 2|Protocol Violation|0|||
48728029|NCT04423939|156854313|FG001|Overall Study|Caregiver to patient who withdrew|3|||
48728030|NCT04711135|156854314|FG000|Overall Study|Physician Decision|0|||
48728031|NCT04711135|156854315|FG001|Overall Study|Physician Decision|1|||
48728032|NCT04711135|156854314|FG000|Overall Study|Ongoing treatment|0|||
48728033|NCT04711135|156854315|FG001|Overall Study|Ongoing treatment|1|||
48728034|NCT01903525|156854322|FG000|Overall Study|Lost to Follow-up|5|||
48728035|NCT01903525|156854323|FG001|Overall Study|Lost to Follow-up|9|||
48728036|NCT01903525|156854322|FG000|Overall Study|Adverse Event|0|||
48728037|NCT01903525|156854323|FG001|Overall Study|Adverse Event|1|||
48728038|NCT02537574|156854324|FG000|Overall Study|Adverse Event|1|||
48728039|NCT02537574|156854325|FG001|Overall Study|Adverse Event|3|||
48728040|NCT02537574|156854326|FG002|Overall Study|Adverse Event|2|||
48728041|NCT02537574|156854324|FG000|Overall Study|Lost to Follow-up|40|||
48510483|NCT01723397|156060890|FG001|Study Period 2|Protocol Violation|1|||
48510484|NCT03084471|156060894|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
48510485|NCT03084471|156060894|FG000|Overall Study|Condition under investigation worsened|84|||
48510486|NCT03084471|156060894|FG000|Overall Study|Lack of therapeutic response|2|||
48510487|NCT03084471|156060894|FG000|Overall Study|Protocol Violation|1|||
48510488|NCT03084471|156060894|FG000|Overall Study|Adverse Event|73|||
48510489|NCT03084471|156060894|FG000|Overall Study|Withdrawal by Subject|12|||
48728042|NCT02537574|156854325|FG001|Overall Study|Lost to Follow-up|51|||
48510490|NCT03084471|156060894|FG000|Overall Study|Disease relapse|181|||
48510491|NCT03084471|156060894|FG000|Overall Study|Subjective disease progression|359|||
48510492|NCT03084471|156060894|FG000|Overall Study|Other (as recorded)|33|||
48510493|NCT03084471|156060894|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
48510494|NCT04608188|156060899|FG000|Overall Study|Withdrawal by Subject|4|||
48510495|NCT04608188|156060900|FG001|Overall Study|Withdrawal by Subject|8|||
48510496|NCT00657553|156060905|FG000|Overall Study|low accrual, no analysis run|5|||
48728043|NCT02537574|156854326|FG002|Overall Study|Lost to Follow-up|55|||
48728044|NCT02537574|156854324|FG000|Overall Study|Noncompliance with study drug|0|||
48728045|NCT02537574|156854325|FG001|Overall Study|Noncompliance with study drug|1|||
48728046|NCT02537574|156854326|FG002|Overall Study|Noncompliance with study drug|1|||
48728047|NCT02537574|156854324|FG000|Overall Study|Physician Decision|2|||
48728048|NCT02537574|156854325|FG001|Overall Study|Physician Decision|0|||
48728049|NCT02537574|156854326|FG002|Overall Study|Physician Decision|0|||
48728050|NCT02537574|156854324|FG000|Overall Study|Protocol Violation|4|||
48728051|NCT02537574|156854325|FG001|Overall Study|Protocol Violation|2|||
48728052|NCT02537574|156854326|FG002|Overall Study|Protocol Violation|3|||
48728053|NCT02537574|156854324|FG000|Overall Study|Withdrawal by Subject|37|||
48728054|NCT02537574|156854325|FG001|Overall Study|Withdrawal by Subject|27|||
48728055|NCT02537574|156854326|FG002|Overall Study|Withdrawal by Subject|29|||
48728056|NCT02537574|156854324|FG000|Overall Study|Lack of Efficacy|14|||
48728057|NCT02537574|156854325|FG001|Overall Study|Lack of Efficacy|16|||
48728058|NCT02537574|156854326|FG002|Overall Study|Lack of Efficacy|15|||
48728059|NCT02537574|156854324|FG000|Overall Study|Duplicate Patient|1|||
48728060|NCT02537574|156854325|FG001|Overall Study|Duplicate Patient|0|||
48728061|NCT02537574|156854326|FG002|Overall Study|Duplicate Patient|0|||
48728062|NCT02537574|156854324|FG000|Overall Study|Patient not Stable|0|||
48728063|NCT02537574|156854325|FG001|Overall Study|Patient not Stable|1|||
48728064|NCT02537574|156854326|FG002|Overall Study|Patient not Stable|0|||
48728065|NCT02537574|156854324|FG000|Overall Study|Incarceration|0|||
48728066|NCT02537574|156854325|FG001|Overall Study|Incarceration|1|||
48728067|NCT02537574|156854326|FG002|Overall Study|Incarceration|0|||
48728068|NCT02537574|156854324|FG000|Overall Study|Failed Naloxone Challenge|0|||
48728069|NCT02537574|156854325|FG001|Overall Study|Failed Naloxone Challenge|1|||
48728070|NCT02537574|156854326|FG002|Overall Study|Failed Naloxone Challenge|0|||
48728071|NCT02537574|156854324|FG000|Overall Study|Transportation Issues|0|||
48728072|NCT02537574|156854325|FG001|Overall Study|Transportation Issues|0|||
48728073|NCT02537574|156854326|FG002|Overall Study|Transportation Issues|1|||
48728074|NCT02537574|156854324|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
48728075|NCT02537574|156854325|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
48728076|NCT02537574|156854326|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
48728077|NCT02537574|156854324|FG000|Overall Study|Noncompliance with Protocol|0|||
48728078|NCT02537574|156854325|FG001|Overall Study|Noncompliance with Protocol|0|||
48728079|NCT02537574|156854326|FG002|Overall Study|Noncompliance with Protocol|1|||
48728080|NCT00433654|156854327|FG000|Overall Study|Death|4|||
48728081|NCT00433654|156854328|FG001|Overall Study|Death|0|||
48728082|NCT00433654|156854327|FG000|Overall Study|Missed visit|6|||
48728083|NCT00433654|156854328|FG001|Overall Study|Missed visit|3|||
48728084|NCT00433654|156854327|FG000|Overall Study|Subject not yet due for visit|4|||
48728085|NCT00433654|156854328|FG001|Overall Study|Subject not yet due for visit|0|||
48728086|NCT00433654|156854327|FG000|Overall Study|Withdrawal by Subject|1|||
48728087|NCT00433654|156854328|FG001|Overall Study|Withdrawal by Subject|2|||
48728088|NCT02663687|156854329|FG000|Overall Study|Adverse Event|1|||
48728089|NCT02663687|156854330|FG001|Overall Study|Adverse Event|0|||
48728090|NCT02663687|156854331|FG002|Overall Study|Adverse Event|0|||
48728091|NCT02663687|156854332|FG003|Overall Study|Adverse Event|0|||
48728092|NCT02663687|156854333|FG004|Overall Study|Adverse Event|0|||
48728093|NCT02663687|156854329|FG000|Overall Study|Other|1|||
48728094|NCT02663687|156854330|FG001|Overall Study|Other|0|||
48728095|NCT02663687|156854331|FG002|Overall Study|Other|1|||
48728096|NCT02663687|156854332|FG003|Overall Study|Other|0|||
48728097|NCT02663687|156854333|FG004|Overall Study|Other|0|||
48728098|NCT00679055|156854337|FG000|Overall Study|Adverse Event|0|||
48728099|NCT00679055|156854338|FG001|Overall Study|Adverse Event|1|||
48728100|NCT00679055|156854337|FG000|Overall Study|Other|0|||
48728101|NCT00679055|156854338|FG001|Overall Study|Other|3|||
48728102|NCT00679055|156854337|FG000|Overall Study|Study Terminated|2|||
48728103|NCT00679055|156854338|FG001|Overall Study|Study Terminated|1|||
48728104|NCT05291689|156854339|FG000|Overall Study|Adverse Event|3|||
48728105|NCT05291689|156854339|FG000|Overall Study|Lack of Efficacy|10|||
48821587|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
48821588|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
48821589|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
48821590|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
48821591|NCT01473420|157188704|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
48821592|NCT01473420|157188705|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
48821593|NCT00761774|157188706|FG000|Overall Study|Adverse Event|17|||
48821594|NCT00761774|157188706|FG000|Overall Study|Lack of Efficacy|37|||
48821595|NCT00761774|157188706|FG000|Overall Study|Lost to Follow-up|2|||
48821596|NCT00761774|157188706|FG000|Overall Study|Withdrawal by Subject|9|||
48821597|NCT00761774|157188706|FG000|Overall Study|Non-compliance|4|||
48821598|NCT00761774|157188706|FG000|Overall Study|End of study|2|||
48821599|NCT00761774|157188706|FG000|Overall Study|Reclassification of seizures|1|||
48821600|NCT00761774|157188706|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
48821601|NCT00761774|157188706|FG000|Overall Study|Sponsor decision|1|||
48821602|NCT00761774|157188706|FG000|Overall Study|Investigator clinical judgement|1|||
48821603|NCT00761774|157188706|FG000|Overall Study|Patient moved out of study area|1|||
48728106|NCT05291689|156854339|FG000|Overall Study|Withdrawal by Subject|4|||
48728107|NCT01222403|156854340|FG000|Overall Study|Inappropriate enrollment|0|||
48728108|NCT01222403|156854341|FG001|Overall Study|Inappropriate enrollment|2|||
48728109|NCT02017171|156854346|FG000|Overall Study|Death|10|||
48728110|NCT02017171|156854347|FG001|Overall Study|Death|4|||
48821604|NCT00761774|157188706|FG000|Overall Study|Coordinator leaving site|1|||
48821605|NCT00761774|157188706|FG000|Overall Study|Subject IP non-compliance|1|||
48821606|NCT00761774|157188706|FG000|Overall Study|IP stopped by hospital physician|1|||
48821607|NCT01077024|157188707|FG000|Overall Study|Lost to Follow-up|20|||
48821608|NCT01077024|157188708|FG001|Overall Study|Lost to Follow-up|14|||
48821609|NCT01077024|157188707|FG000|Overall Study|Withdrawal by Subject|0|||
48821610|NCT01077024|157188708|FG001|Overall Study|Withdrawal by Subject|2|||
48821611|NCT01077024|157188707|FG000|Overall Study|Incarcerated|7|||
48821612|NCT01077024|157188708|FG001|Overall Study|Incarcerated|8|||
48821613|NCT01077024|157188707|FG000|Overall Study|Other|4|||
48821614|NCT01077024|157188708|FG001|Overall Study|Other|4|||
48821615|NCT03379233|157188709|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
48821616|NCT03379233|157188710|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
48821617|NCT00965484|157188711|FG000|Overall Study|Protocol Violation|1|||
48821618|NCT00965484|157188711|FG000|Overall Study|Withdrawal by Subject|1|||
48821619|NCT01603121|157188712|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
48821620|NCT01603121|157188713|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
48821621|NCT02839681|157188719|FG000|Overall Study|Death|2|||
48821622|NCT00738530|157188720|FG000|Overall Study|Death|220|||
48821623|NCT00738530|157188721|FG001|Overall Study|Death|224|||
48728111|NCT02017171|156854346|FG000|Overall Study|Withdrawal by Subject|23|||
48821624|NCT00738530|157188720|FG000|Overall Study|Lost to Follow-up|8|||
48821625|NCT00738530|157188721|FG001|Overall Study|Lost to Follow-up|6|||
48821626|NCT00738530|157188720|FG000|Overall Study|Withdrawal by Subject|6|||
48821627|NCT00738530|157188721|FG001|Overall Study|Withdrawal by Subject|8|||
48821628|NCT01656759|157188722|FG000|Overall Study|Protocol Violation|2|||
48821629|NCT01656759|157188723|FG001|Overall Study|Protocol Violation|3|||
48821630|NCT00772928|157188724|FG000|Overall Study|Lost to Follow-up|9|||
48821631|NCT00772928|157188725|FG001|Overall Study|Lost to Follow-up|6|||
48821632|NCT00772928|157188724|FG000|Overall Study|Protocol Violation|10|||
48821633|NCT00772928|157188725|FG001|Overall Study|Protocol Violation|12|||
48821634|NCT00772928|157188724|FG000|Overall Study|Withdrawal by Subject|25|||
48821635|NCT00772928|157188725|FG001|Overall Study|Withdrawal by Subject|22|||
48821636|NCT00772928|157188724|FG000|Overall Study|Did not receive vaccine|0|||
48821637|NCT00772928|157188725|FG001|Overall Study|Did not receive vaccine|1|||
48821638|NCT01582243|157188727|FG000|Overall Study|Withdrawal by Subject|1|||
48821639|NCT01582243|157188727|FG000|Overall Study|Adverse Event|1|||
48821640|NCT01582243|157188727|FG000|Overall Study|Lost to Follow-up|1|||
48821641|NCT00994279|157188728|FG000|Overall Study|Withdrawal by Subject|2|||
48821642|NCT00994279|157188729|FG001|Overall Study|Withdrawal by Subject|2|||
48821643|NCT00994279|157188728|FG000|Overall Study|Toxicity|1|||
48821644|NCT00994279|157188729|FG001|Overall Study|Toxicity|0|||
48821645|NCT00994279|157188728|FG000|Overall Study|Multiple reasons|1|||
48821646|NCT00994279|157188729|FG001|Overall Study|Multiple reasons|3|||
48728112|NCT02017171|156854347|FG001|Overall Study|Withdrawal by Subject|17|||
48728113|NCT02017171|156854346|FG000|Overall Study|Lost to Follow-up|21|||
48728114|NCT02017171|156854347|FG001|Overall Study|Lost to Follow-up|20|||
48728115|NCT02017171|156854346|FG000|Overall Study|ESKD|6|||
48728116|NCT02017171|156854347|FG001|Overall Study|ESKD|2|||
48728117|NCT02017171|156854346|FG000|Overall Study|Miscellaneous|2|||
48728118|NCT02017171|156854347|FG001|Overall Study|Miscellaneous|3|||
48728119|NCT03370289|156854348|FG000|Overall Study|Screen Failure|1|||
48728120|NCT03370289|156854348|FG000|Overall Study|Sample Size Sufficient|4|||
48728121|NCT03309046|156854349|FG000|Overall Study|Withdrawal by Subject|4|||
48728122|NCT03309046|156854350|FG001|Overall Study|Withdrawal by Subject|17|||
48728123|NCT01484938|156854352|FG000|Overall Study|Adverse Event|2|||
48728124|NCT01484938|156854352|FG000|Overall Study|Lost to Follow-up|1|||
48728125|NCT01484938|156854352|FG000|Overall Study|Noncompliance|1|||
48728126|NCT01858636|156854357|FG000|Overall Study|No Device Deployment Attempted|24|||
48728127|NCT01858636|156854357|FG000|Overall Study|Physician Decision|1|||
48728128|NCT01858636|156854357|FG000|Overall Study|Death|1|||
48728129|NCT01858636|156854357|FG000|Overall Study|Lost to Follow-up|1|||
48728130|NCT01858636|156854357|FG000|Overall Study|Withdrawal by Subject|1|||
48728131|NCT03523000|156854360|FG000|Overall Study|Withdrawal by Subject|3|||
48728132|NCT03523000|156854361|FG001|Overall Study|Withdrawal by Subject|0|||
48821647|NCT01253200|157188732|FG000|Overall Study|Death|1|||
48821648|NCT01253200|157188733|FG001|Overall Study|Death|0|||
48821649|NCT01253200|157188734|FG002|Overall Study|Death|0|||
48821650|NCT01253200|157188735|FG003|Overall Study|Death|0|||
48821651|NCT01253200|157188736|FG004|Overall Study|Death|0|||
48821652|NCT01253200|157188732|FG000|Overall Study|Lost to Follow-up|1|||
48821653|NCT01253200|157188733|FG001|Overall Study|Lost to Follow-up|1|||
48821654|NCT01253200|157188734|FG002|Overall Study|Lost to Follow-up|0|||
48510497|NCT00657553|156060906|FG001|Overall Study|low accrual, no analysis run|5|||
48510498|NCT03031847|156060907|FG000|Overall Study|Death|1|||
48510499|NCT03031847|156060908|FG001|Overall Study|Death|1|||
48510500|NCT03031847|156060909|FG002|Overall Study|Death|2|||
48510501|NCT03031847|156060910|FG003|Overall Study|Death|3|||
48510502|NCT03031847|156060907|FG000|Overall Study|Lost to Follow-up|1|||
48510503|NCT03031847|156060908|FG001|Overall Study|Lost to Follow-up|1|||
48510504|NCT03031847|156060909|FG002|Overall Study|Lost to Follow-up|2|||
48510505|NCT03031847|156060910|FG003|Overall Study|Lost to Follow-up|3|||
48510506|NCT03173547|156060911|FG000|Overall Study|Adverse Event|2|||
48510507|NCT03173547|156060912|FG001|Overall Study|Adverse Event|0|||
48510508|NCT03173547|156060911|FG000|Overall Study|Withdrawal by Subject|2|||
48510509|NCT03173547|156060912|FG001|Overall Study|Withdrawal by Subject|2|||
48510510|NCT00858845|156060914|FG000|Overall Study|Patient underwent heart transplant.|0|||
48510511|NCT00858845|156060915|FG001|Overall Study|Patient underwent heart transplant.|1|||
48510512|NCT01237054|156060916|FG000|Overall Study|imaging 10C0096|1|||
48510513|NCT00147498|156060921|FG000|Overall Study|Adverse Event|1|||
48510514|NCT00147498|156060922|FG001|Overall Study|Adverse Event|6|||
48510515|NCT00147498|156060923|FG002|Overall Study|Adverse Event|7|||
48510516|NCT00147498|156060924|FG003|Overall Study|Adverse Event|3|||
48510517|NCT00147498|156060921|FG000|Overall Study|Lack of Efficacy|1|||
48510518|NCT00147498|156060922|FG001|Overall Study|Lack of Efficacy|1|||
48728133|NCT03523000|156854360|FG000|Overall Study|Unsuccessful trial|2|||
48728134|NCT03523000|156854361|FG001|Overall Study|Unsuccessful trial|0|||
48728135|NCT00999921|156854364|FG000|Overall Study|Lost to Follow-up|10|||
48728136|NCT00999921|156854365|FG001|Overall Study|Lost to Follow-up|19|||
48728137|NCT01912963|156854373|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
48728138|NCT01912963|156854374|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
48728139|NCT01912963|156854375|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
48728140|NCT01912963|156854373|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
48728141|NCT01912963|156854374|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
48728142|NCT01912963|156854375|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
48728143|NCT01912963|156854373|FG000|Overall Study|Adverse Event|0|||
48728144|NCT01912963|156854374|FG001|Overall Study|Adverse Event|1|||
48728145|NCT01912963|156854375|FG002|Overall Study|Adverse Event|1|||
48728146|NCT01912963|156854373|FG000|Overall Study|Withdrawal by Subject|0|||
48728147|NCT01912963|156854374|FG001|Overall Study|Withdrawal by Subject|1|||
48728148|NCT01912963|156854375|FG002|Overall Study|Withdrawal by Subject|0|||
48728149|NCT01912963|156854373|FG000|Overall Study|Sought treatment locally|0|||
48728150|NCT01912963|156854374|FG001|Overall Study|Sought treatment locally|1|||
48728151|NCT01912963|156854375|FG002|Overall Study|Sought treatment locally|0|||
48728152|NCT00144027|156854381|FG000|Overall Study|Lost to Follow-up|1|||
48728153|NCT00144027|156854382|FG001|Overall Study|Lost to Follow-up|3|||
48728154|NCT00144027|156854381|FG000|Overall Study|Withdrawal by Subject|2|||
48728155|NCT00144027|156854382|FG001|Overall Study|Withdrawal by Subject|2|||
48728156|NCT00144027|156854381|FG000|Overall Study|did not complete baseline assessment|0|||
48728157|NCT00144027|156854382|FG001|Overall Study|did not complete baseline assessment|6|||
48728158|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
48728159|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
48728160|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
48728161|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
48728162|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
48728163|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
48728164|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
48728165|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
48728166|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
48728167|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
48728168|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
48728169|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
48728170|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
48510519|NCT00147498|156060923|FG002|Overall Study|Lack of Efficacy|1|||
48510520|NCT00147498|156060924|FG003|Overall Study|Lack of Efficacy|8|||
48510521|NCT00147498|156060921|FG000|Overall Study|Laboratory abnormality|0|||
48510522|NCT00147498|156060922|FG001|Overall Study|Laboratory abnormality|0|||
48510523|NCT00147498|156060923|FG002|Overall Study|Laboratory abnormality|2|||
48510524|NCT00147498|156060924|FG003|Overall Study|Laboratory abnormality|0|||
48510525|NCT00147498|156060921|FG000|Overall Study|Participant defaulted|0|||
48510526|NCT00147498|156060922|FG001|Overall Study|Participant defaulted|1|||
48510527|NCT00147498|156060923|FG002|Overall Study|Participant defaulted|4|||
48510528|NCT00147498|156060924|FG003|Overall Study|Participant defaulted|3|||
48728171|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
48728172|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
48728173|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
48728174|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
48728175|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
48728176|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
48728177|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
48728178|NCT01226043|156854383|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
48728179|NCT01226043|156854384|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
48728180|NCT01226043|156854385|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
48728181|NCT01226043|156854386|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
48728182|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Adverse Event|0|||
48728183|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Adverse Event|0|||
48728184|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Adverse Event|1|||
48728185|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Adverse Event|1|||
48728186|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
48728187|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
48728188|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
48728189|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
48728190|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
48728191|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
48728192|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
48728193|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
48728194|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
48728195|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
48728196|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
48728197|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
48728198|NCT01226043|156854383|FG000|6-week Re-randomization Phase|Physician Decision|0|||
48728199|NCT01226043|156854384|FG001|6-week Re-randomization Phase|Physician Decision|0|||
48728200|NCT01226043|156854385|FG002|6-week Re-randomization Phase|Physician Decision|3|||
48728201|NCT01226043|156854386|FG003|6-week Re-randomization Phase|Physician Decision|2|||
48728202|NCT01226043|156854383|FG000|6-week Re-randomization Phase|completed in error|0|||
48728203|NCT01226043|156854384|FG001|6-week Re-randomization Phase|completed in error|0|||
48728204|NCT01226043|156854385|FG002|6-week Re-randomization Phase|completed in error|0|||
48728205|NCT01226043|156854386|FG003|6-week Re-randomization Phase|completed in error|1|||
48510529|NCT00147498|156060921|FG000|Overall Study|Other|1|||
48510530|NCT00147498|156060922|FG001|Overall Study|Other|1|||
48510531|NCT00147498|156060923|FG002|Overall Study|Other|3|||
48510532|NCT00147498|156060924|FG003|Overall Study|Other|3|||
48510533|NCT03804983|156060928|FG000|Overall Study|Adverse Event|0|||
48510534|NCT03804983|156060929|FG001|Overall Study|Adverse Event|1|||
48510535|NCT03804983|156060928|FG000|Overall Study|Family Obligation|1|||
48510536|NCT03804983|156060929|FG001|Overall Study|Family Obligation|0|||
48510537|NCT02152163|156060930|FG000|Overall Study|Physician Decision|12|||
48728206|NCT01226043|156854383|FG000|30-week Observational Phase|Adverse Event|0|||
48510538|NCT02152163|156060931|FG001|Overall Study|Physician Decision|13|||
48510539|NCT01963728|156060936|FG000|Overall Study|Study terminated early|0|||
48510540|NCT01963728|156060937|FG001|Overall Study|Study terminated early|1|||
48510541|NCT01686477|156060942|FG000|Feeding Intervention|Death|1|||
48728207|NCT01226043|156854384|FG001|30-week Observational Phase|Adverse Event|0|||
48728208|NCT01226043|156854385|FG002|30-week Observational Phase|Adverse Event|1|||
48728209|NCT01226043|156854386|FG003|30-week Observational Phase|Adverse Event|1|||
48510542|NCT01686477|156060943|FG001|Feeding Intervention|Death|0|||
48510543|NCT01686477|156060944|FG002|Feeding Intervention|Death|1|||
48510544|NCT01686477|156060942|FG000|Feeding Intervention|Withdrawal by Subject|0|||
48510545|NCT01686477|156060943|FG001|Feeding Intervention|Withdrawal by Subject|6|||
48510546|NCT01686477|156060944|FG002|Feeding Intervention|Withdrawal by Subject|0|||
48510547|NCT01686477|156060942|FG000|Feeding Intervention|Physician Decision|1|||
48510548|NCT01686477|156060943|FG001|Feeding Intervention|Physician Decision|2|||
48510549|NCT01686477|156060944|FG002|Feeding Intervention|Physician Decision|0|||
48728210|NCT01226043|156854383|FG000|30-week Observational Phase|Protocol Violation|0|||
48728211|NCT01226043|156854384|FG001|30-week Observational Phase|Protocol Violation|0|||
48728212|NCT01226043|156854385|FG002|30-week Observational Phase|Protocol Violation|0|||
48728213|NCT01226043|156854386|FG003|30-week Observational Phase|Protocol Violation|1|||
48728214|NCT01226043|156854383|FG000|30-week Observational Phase|Lost to Follow-up|0|||
48728215|NCT01226043|156854384|FG001|30-week Observational Phase|Lost to Follow-up|0|||
48728216|NCT01226043|156854385|FG002|30-week Observational Phase|Lost to Follow-up|2|||
48728217|NCT01226043|156854386|FG003|30-week Observational Phase|Lost to Follow-up|2|||
48728218|NCT01226043|156854383|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
48728219|NCT01226043|156854384|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
48510550|NCT01686477|156060942|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
48510551|NCT01686477|156060943|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
48510552|NCT01686477|156060944|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
48510553|NCT01686477|156060942|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
48510554|NCT01686477|156060943|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
48510555|NCT01686477|156060944|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
48510556|NCT01686477|156060942|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
48510557|NCT01686477|156060943|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
48510558|NCT01686477|156060944|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
48510559|NCT01686477|156060942|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
48510560|NCT01686477|156060943|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
48510561|NCT01686477|156060944|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
48510562|NCT01686477|156060942|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
48510563|NCT01686477|156060943|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
48510564|NCT01686477|156060944|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
48510565|NCT01686477|156060942|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
48510566|NCT01686477|156060943|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
48510567|NCT01686477|156060944|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
48510568|NCT01686477|156060942|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
48510569|NCT01686477|156060943|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
48510570|NCT01686477|156060944|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
48510571|NCT02963259|156060945|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
48510572|NCT02963259|156060945|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
48510573|NCT02963259|156060945|FG000|Overall Study|Death|1|||
48510574|NCT02963259|156060945|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
48510575|NCT01136174|156060946|FG000|Overall Study|Adverse Event|0|||
48510576|NCT01136174|156060947|FG001|Overall Study|Adverse Event|0|||
48510577|NCT01136174|156060948|FG002|Overall Study|Adverse Event|0|||
48510578|NCT01136174|156060949|FG003|Overall Study|Adverse Event|4|||
48510579|NCT02554890|156060950|FG000|Double-blind|Adverse Event|45|||
48510580|NCT02554890|156060951|FG001|Double-blind|Adverse Event|51|||
48510581|NCT02554890|156060950|FG000|Double-blind|Death|6|||
48510582|NCT02554890|156060951|FG001|Double-blind|Death|4|||
48510583|NCT02554890|156060950|FG000|Double-blind|Protocol Violation|1|||
48510584|NCT02554890|156060951|FG001|Double-blind|Protocol Violation|1|||
48510585|NCT02554890|156060950|FG000|Double-blind|Physician Decision|4|||
48510586|NCT02554890|156060951|FG001|Double-blind|Physician Decision|3|||
48510587|NCT02554890|156060950|FG000|Double-blind|Subject/Guardian decision|21|||
48510588|NCT02554890|156060951|FG001|Double-blind|Subject/Guardian decision|16|||
48510589|NCT02554890|156060950|FG000|Double-blind|Lost to Follow-up|7|||
48510590|NCT02554890|156060951|FG001|Double-blind|Lost to Follow-up|5|||
48728220|NCT01226043|156854385|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
48510591|NCT02554890|156060950|FG000|Double-blind|Technical problems|1|||
48510592|NCT02554890|156060951|FG001|Double-blind|Technical problems|0|||
48510593|NCT02554890|156060950|FG000|Double-blind|Withdrawal by Subject|5|||
48510594|NCT02554890|156060951|FG001|Double-blind|Withdrawal by Subject|6|||
48510595|NCT02554890|156060950|FG000|Double-blind|Noncompliance with study treatment|6|||
48728221|NCT01226043|156854386|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
48728222|NCT01226043|156854383|FG000|30-week Observational Phase|Physician Decision|0|||
48821655|NCT01253200|157188735|FG003|Overall Study|Lost to Follow-up|0|||
48510596|NCT02554890|156060951|FG001|Double-blind|Noncompliance with study treatment|5|||
48510597|NCT02554890|156060950|FG000|Open-label|Adverse Event|0|||
48510598|NCT02554890|156060951|FG001|Open-label|Adverse Event|30|||
48510599|NCT02554890|156060950|FG000|Open-label|Death|0|||
48510600|NCT02554890|156060951|FG001|Open-label|Death|1|||
48728223|NCT01226043|156854384|FG001|30-week Observational Phase|Physician Decision|0|||
48728224|NCT01226043|156854385|FG002|30-week Observational Phase|Physician Decision|2|||
48728225|NCT01226043|156854386|FG003|30-week Observational Phase|Physician Decision|2|||
48510601|NCT02554890|156060950|FG000|Open-label|Physician Decision|0|||
48728226|NCT01278160|156854389|FG000|Overall Study|Adverse Event|1|||
48728227|NCT01278160|156854390|FG001|Overall Study|Adverse Event|1|||
48728228|NCT01278160|156854389|FG000|Overall Study|Lost to Follow-up|0|||
48510602|NCT02554890|156060951|FG001|Open-label|Physician Decision|1|||
48728229|NCT01278160|156854390|FG001|Overall Study|Lost to Follow-up|1|||
48728230|NCT01278160|156854389|FG000|Overall Study|Withdrawal by Subject|3|||
48510603|NCT02554890|156060950|FG000|Open-label|Subject/Guardian decision|0|||
48510604|NCT02554890|156060951|FG001|Open-label|Subject/Guardian decision|11|||
48510605|NCT02554890|156060950|FG000|Open-label|Lost to Follow-up|0|||
48510606|NCT02554890|156060951|FG001|Open-label|Lost to Follow-up|7|||
48821656|NCT01253200|157188736|FG004|Overall Study|Lost to Follow-up|0|||
48821657|NCT01253200|157188732|FG000|Overall Study|Withdrawal by Subject|2|||
48821658|NCT01253200|157188733|FG001|Overall Study|Withdrawal by Subject|0|||
48821659|NCT01253200|157188734|FG002|Overall Study|Withdrawal by Subject|0|||
48821660|NCT01253200|157188735|FG003|Overall Study|Withdrawal by Subject|0|||
48821661|NCT01253200|157188736|FG004|Overall Study|Withdrawal by Subject|0|||
48821662|NCT01253200|157188732|FG000|Overall Study|Protocol Violation|1|||
48510607|NCT02554890|156060950|FG000|Open-label|Technical problems|0|||
48510608|NCT02554890|156060951|FG001|Open-label|Technical problems|1|||
48728231|NCT01278160|156854390|FG001|Overall Study|Withdrawal by Subject|2|||
48728232|NCT01278160|156854389|FG000|Overall Study|Unclassified|1|||
48510609|NCT02554890|156060950|FG000|Open-label|Withdrawal by Subject|0|||
48510610|NCT02554890|156060951|FG001|Open-label|Withdrawal by Subject|1|||
48510611|NCT02186821|156060952|FG000|Overall Study|Adverse Event|9|||
48510612|NCT02186821|156060952|FG000|Overall Study|Death|2|||
48510613|NCT02186821|156060952|FG000|Overall Study|Disease progression|32|||
48510614|NCT02186821|156060952|FG000|Overall Study|Protocol Violation|1|||
48510615|NCT02186821|156060952|FG000|Overall Study|Physician Decision|1|||
48510616|NCT02186821|156060952|FG000|Overall Study|Study terminated by sponsor|2|||
48510617|NCT04852978|156060955|FG000|Overall Study|Physician Decision|0|||
48510618|NCT04852978|156060956|FG001|Overall Study|Physician Decision|1|||
48510619|NCT04852978|156060957|FG002|Overall Study|Physician Decision|0|||
48510620|NCT04852978|156060958|FG003|Overall Study|Physician Decision|0|||
48510621|NCT04852978|156060959|FG004|Overall Study|Physician Decision|0|||
48510622|NCT04852978|156060960|FG005|Overall Study|Physician Decision|0|||
48510623|NCT04852978|156060961|FG006|Overall Study|Physician Decision|0|||
48510624|NCT04852978|156060962|FG007|Overall Study|Physician Decision|2|||
48510625|NCT04852978|156060963|FG008|Overall Study|Physician Decision|0|||
48510626|NCT04852978|156060955|FG000|Overall Study|Sponsor request|0|||
48510627|NCT04852978|156060956|FG001|Overall Study|Sponsor request|0|||
48510628|NCT04852978|156060957|FG002|Overall Study|Sponsor request|1|||
48510629|NCT04852978|156060958|FG003|Overall Study|Sponsor request|0|||
48510630|NCT04852978|156060959|FG004|Overall Study|Sponsor request|0|||
48510631|NCT04852978|156060960|FG005|Overall Study|Sponsor request|0|||
48510632|NCT04852978|156060961|FG006|Overall Study|Sponsor request|0|||
48728233|NCT01278160|156854390|FG001|Overall Study|Unclassified|2|||
48728234|NCT03187756|156854391|FG000|Overall Study|Termination of study|4|||
48728235|NCT04041700|156854395|FG000|Overall Study|Pregnancy|1|||
48510633|NCT04852978|156060962|FG007|Overall Study|Sponsor request|0|||
48510634|NCT04852978|156060963|FG008|Overall Study|Sponsor request|0|||
48510635|NCT04852978|156060955|FG000|Overall Study|Death|0|||
48510636|NCT04852978|156060956|FG001|Overall Study|Death|0|||
48510637|NCT04852978|156060957|FG002|Overall Study|Death|0|||
48510638|NCT04852978|156060958|FG003|Overall Study|Death|0|||
48510639|NCT04852978|156060959|FG004|Overall Study|Death|0|||
48510640|NCT04852978|156060960|FG005|Overall Study|Death|0|||
48510641|NCT04852978|156060961|FG006|Overall Study|Death|1|||
48510642|NCT04852978|156060962|FG007|Overall Study|Death|0|||
48510643|NCT04852978|156060963|FG008|Overall Study|Death|0|||
48510644|NCT04852978|156060955|FG000|Overall Study|Lost to Follow-up|3|||
48510645|NCT04852978|156060956|FG001|Overall Study|Lost to Follow-up|2|||
48510646|NCT04852978|156060957|FG002|Overall Study|Lost to Follow-up|2|||
48510647|NCT04852978|156060958|FG003|Overall Study|Lost to Follow-up|0|||
48510648|NCT04852978|156060959|FG004|Overall Study|Lost to Follow-up|2|||
48510649|NCT04852978|156060960|FG005|Overall Study|Lost to Follow-up|4|||
48510650|NCT04852978|156060961|FG006|Overall Study|Lost to Follow-up|1|||
48510651|NCT04852978|156060962|FG007|Overall Study|Lost to Follow-up|2|||
48728236|NCT04041700|156854395|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
48728237|NCT00560885|156854397|FG000|Overall Study|Death|7|||
48728238|NCT00560885|156854397|FG000|Overall Study|Withdrawal by Subject|1|||
48821663|NCT01253200|157188733|FG001|Overall Study|Protocol Violation|4|||
48821664|NCT01253200|157188734|FG002|Overall Study|Protocol Violation|0|||
48510652|NCT04852978|156060963|FG008|Overall Study|Lost to Follow-up|2|||
48510653|NCT04852978|156060955|FG000|Overall Study|Withdrawal by Subject|4|||
48510654|NCT04852978|156060956|FG001|Overall Study|Withdrawal by Subject|2|||
48510655|NCT04852978|156060957|FG002|Overall Study|Withdrawal by Subject|2|||
48510656|NCT04852978|156060958|FG003|Overall Study|Withdrawal by Subject|1|||
48510657|NCT04852978|156060959|FG004|Overall Study|Withdrawal by Subject|5|||
48510658|NCT04852978|156060960|FG005|Overall Study|Withdrawal by Subject|3|||
48510659|NCT04852978|156060961|FG006|Overall Study|Withdrawal by Subject|2|||
48510660|NCT04852978|156060962|FG007|Overall Study|Withdrawal by Subject|2|||
48510661|NCT04852978|156060963|FG008|Overall Study|Withdrawal by Subject|1|||
48510662|NCT00859430|156060964|FG000|First Intervention|Withdrawal by Subject|0|||
48510663|NCT00859430|156060965|FG001|First Intervention|Withdrawal by Subject|1|||
48510664|NCT02311361|156062173|FG000|Overall Study|Did not receive treatment|0|||
48510665|NCT02311361|156062174|FG001|Overall Study|Did not receive treatment|1|||
48510666|NCT02311361|156062175|FG002|Overall Study|Did not receive treatment|0|||
48510667|NCT02311361|156062176|FG003|Overall Study|Did not receive treatment|1|||
48510668|NCT01725529|156062177|FG000|Overall Study|Adverse Event|1|||
48510669|NCT01725529|156062178|FG001|Overall Study|Adverse Event|0|||
48510670|NCT01725529|156062179|FG002|Overall Study|Adverse Event|0|||
48510671|NCT01725529|156062177|FG000|Overall Study|Lost to Follow-up|2|||
48510672|NCT01725529|156062178|FG001|Overall Study|Lost to Follow-up|1|||
48510673|NCT01725529|156062179|FG002|Overall Study|Lost to Follow-up|1|||
48510674|NCT01725529|156062177|FG000|Overall Study|Protocol Violation|0|||
48510675|NCT01725529|156062178|FG001|Overall Study|Protocol Violation|1|||
48510676|NCT01725529|156062179|FG002|Overall Study|Protocol Violation|1|||
48510677|NCT01725529|156062177|FG000|Overall Study|Withdrawal by Subject|12|||
48510678|NCT01725529|156062178|FG001|Overall Study|Withdrawal by Subject|14|||
48510679|NCT01725529|156062179|FG002|Overall Study|Withdrawal by Subject|8|||
48510680|NCT03772522|156062180|FG000|Pre-intervention|Withdrawal by Subject|3|||
48510681|NCT03772522|156062181|FG001|Pre-intervention|Withdrawal by Subject|4|||
48510682|NCT03772522|156062180|FG000|Intervention|Withdrawal by Subject|1|||
48510683|NCT03772522|156062181|FG001|Intervention|Withdrawal by Subject|0|||
48510684|NCT03772522|156062180|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
48510685|NCT03772522|156062181|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
48510686|NCT05376319|156062183|FG000|Overall Study|Funding termination|2|||
48510687|NCT05376319|156062184|FG001|Overall Study|Funding termination|4|||
48510688|NCT00001703|156062185|FG000|Overall Study|progressed disease|2|||
48510689|NCT00001703|156062185|FG000|Overall Study|No evidence of disease|1|||
48510690|NCT00001703|156062185|FG000|Overall Study|recurrent disease|2|||
48510691|NCT01124175|156062186|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
48510692|NCT01124175|156062187|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
48510693|NCT03872128|156062193|FG000|Overall Study|Dropped out before treatment|1|||
48510694|NCT03872128|156062194|FG001|Overall Study|Dropped out before treatment|0|||
48510695|NCT03872128|156062195|FG002|Overall Study|Dropped out before treatment|4|||
48510696|NCT03872128|156062193|FG000|Overall Study|Lost to Follow-up|2|||
48510697|NCT03872128|156062194|FG001|Overall Study|Lost to Follow-up|5|||
48510698|NCT03872128|156062195|FG002|Overall Study|Lost to Follow-up|8|||
48510699|NCT01802320|156062201|FG000|Overall Study|Death|1|||
48510700|NCT01802320|156062201|FG000|Overall Study|Withdrawal by Subject|1|||
48510701|NCT00328926|156062202|FG000|Overall Study|Pregnancy|2|||
48510702|NCT00328926|156062203|FG001|Overall Study|Pregnancy|1|||
48510703|NCT00328926|156062204|FG002|Overall Study|Pregnancy|0|||
48510704|NCT00328926|156062202|FG000|Overall Study|Lost to Follow-up|0|||
48510705|NCT00328926|156062203|FG001|Overall Study|Lost to Follow-up|1|||
48510706|NCT00328926|156062204|FG002|Overall Study|Lost to Follow-up|0|||
48510707|NCT00328926|156062202|FG000|Overall Study|Death|0|||
48510708|NCT00328926|156062203|FG001|Overall Study|Death|0|||
48510709|NCT00328926|156062204|FG002|Overall Study|Death|1|||
48510710|NCT00328926|156062202|FG000|Overall Study|In vitro fertilization treatment|0|||
48510711|NCT00328926|156062203|FG001|Overall Study|In vitro fertilization treatment|0|||
48510712|NCT00328926|156062204|FG002|Overall Study|In vitro fertilization treatment|1|||
48510713|NCT00328926|156062202|FG000|Overall Study|Lack of ovarian response|0|||
48510714|NCT00328926|156062203|FG001|Overall Study|Lack of ovarian response|1|||
48510715|NCT00328926|156062204|FG002|Overall Study|Lack of ovarian response|0|||
48510716|NCT04123548|156062205|FG000|Overall Study|Withdrawal by Subject|1|||
48510717|NCT04123548|156062205|FG000|Overall Study|Lost to Follow-up|8|||
48510718|NCT04123548|156062205|FG000|Overall Study|Death|4|||
48510719|NCT04123548|156062205|FG000|Overall Study|Reason Not Specified|1|||
48510720|NCT05038293|156062210|FG000|Overall Study|device was not operating properly for one subject.|1|||
48510721|NCT05038293|156062211|FG001|Overall Study|device was not operating properly for one subject.|0|||
48510722|NCT05038293|156062210|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
48510723|NCT05038293|156062211|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
48510724|NCT00834249|156062216|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
48510725|NCT00834249|156062217|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
48510726|NCT00834249|156062216|FG000|Second Intervention|Adverse Event|1|||
48510727|NCT00834249|156062217|FG001|Second Intervention|Adverse Event|0|||
48510728|NCT02440711|156062219|FG000|Second Intervention|Lost to Follow-up|1|||
48510729|NCT02440711|156062220|FG001|Second Intervention|Lost to Follow-up|0|||
48510730|NCT01838941|156062221|FG000|Overall Study|Adverse Event|1|||
48510731|NCT01838941|156062221|FG000|Overall Study|Withdrawal by Subject|1|||
48510732|NCT00678639|156062222|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
48510733|NCT00678639|156062223|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
48510734|NCT01527006|156062224|FG000|Core Study|Adverse Event|0|||
48510735|NCT01527006|156062225|FG001|Core Study|Adverse Event|2|||
48510736|NCT01527006|156062224|FG000|Core Study|Lost to Follow-up|0|||
48510737|NCT01527006|156062225|FG001|Core Study|Lost to Follow-up|1|||
48510738|NCT01527006|156062224|FG000|Core Study|Subject Choice|1|||
48510739|NCT01527006|156062225|FG001|Core Study|Subject Choice|0|||
48510740|NCT01527006|156062224|FG000|Core Study|Inadequate Therapeutic Effect|1|||
48510741|NCT01527006|156062225|FG001|Core Study|Inadequate Therapeutic Effect|0|||
48510742|NCT01527006|156062224|FG000|Core Study|Withdrawal by Subject|0|||
48510743|NCT01527006|156062225|FG001|Core Study|Withdrawal by Subject|1|||
48510744|NCT01527006|156062224|FG000|Core Study|Other|0|||
48510745|NCT01527006|156062225|FG001|Core Study|Other|2|||
48510746|NCT01527006|156062224|FG000|Extension Phase|Adverse Event|4|||
48510747|NCT01527006|156062225|FG001|Extension Phase|Adverse Event|2|||
48510748|NCT01527006|156062224|FG000|Extension Phase|Lost to Follow-up|0|||
48510749|NCT01527006|156062225|FG001|Extension Phase|Lost to Follow-up|1|||
48510750|NCT01527006|156062224|FG000|Extension Phase|Subject Choice|1|||
48510751|NCT01527006|156062225|FG001|Extension Phase|Subject Choice|1|||
48510752|NCT01527006|156062224|FG000|Extension Phase|Inadequate therapeutic effect|1|||
48510753|NCT01527006|156062225|FG001|Extension Phase|Inadequate therapeutic effect|1|||
48510754|NCT01527006|156062224|FG000|Extension Phase|Other|0|||
48510755|NCT01527006|156062225|FG001|Extension Phase|Other|3|||
48510756|NCT00960297|156062228|FG000|Overall Study|Physician Decision|1|||
48510757|NCT00960297|156062228|FG000|Overall Study|Venous port infection|1|||
48510758|NCT00960297|156062228|FG000|Overall Study|Disease progression|1|||
48510759|NCT00824291|156062229|FG000|Overall Study|Adverse Event|15|||
48510760|NCT00824291|156062230|FG001|Overall Study|Adverse Event|6|||
48510761|NCT00824291|156062229|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
48510762|NCT00824291|156062230|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
48510763|NCT00824291|156062229|FG000|Overall Study|Lost to Follow-up|11|||
48510764|NCT00824291|156062230|FG001|Overall Study|Lost to Follow-up|9|||
48728239|NCT04551066|156854398|FG000|Overall Study|Death|5|||
48510765|NCT00824291|156062229|FG000|Overall Study|Non-compliance|1|||
48510766|NCT00824291|156062230|FG001|Overall Study|Non-compliance|1|||
48510767|NCT00824291|156062229|FG000|Overall Study|Protocol Violation|4|||
48510768|NCT00824291|156062230|FG001|Overall Study|Protocol Violation|1|||
48510769|NCT00824291|156062229|FG000|Overall Study|Withdrawal by Subject|14|||
48510770|NCT00824291|156062230|FG001|Overall Study|Withdrawal by Subject|8|||
48728240|NCT04551066|156854399|FG001|Overall Study|Death|3|||
48821665|NCT01253200|157188735|FG003|Overall Study|Protocol Violation|0|||
48821666|NCT01253200|157188736|FG004|Overall Study|Protocol Violation|5|||
48821667|NCT01253200|157188732|FG000|Overall Study|intents|10|||
48821668|NCT01253200|157188733|FG001|Overall Study|intents|10|||
48510771|NCT00824291|156062229|FG000|Overall Study|Lack of Efficacy|7|||
48821669|NCT01253200|157188734|FG002|Overall Study|intents|1|||
48821670|NCT01253200|157188735|FG003|Overall Study|intents|3|||
48821671|NCT01253200|157188736|FG004|Overall Study|intents|0|||
48821672|NCT01253200|157188732|FG000|Overall Study|Attempts|6|||
48821673|NCT01253200|157188733|FG001|Overall Study|Attempts|4|||
48728241|NCT04551066|156854398|FG000|Overall Study|Lost to Follow-up|1|||
48728242|NCT04551066|156854399|FG001|Overall Study|Lost to Follow-up|0|||
48728243|NCT04551066|156854398|FG000|Overall Study|Sponsor Decision|103|||
48728244|NCT04551066|156854399|FG001|Overall Study|Sponsor Decision|117|||
48728245|NCT04551066|156854398|FG000|Overall Study|Withdrawal by Subject|8|||
48728246|NCT04551066|156854399|FG001|Overall Study|Withdrawal by Subject|2|||
48728247|NCT04551066|156854398|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
48728248|NCT04551066|156854399|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
48728249|NCT04551066|156854398|FG000|Overall Study|Adverse Event|2|||
48728250|NCT04551066|156854399|FG001|Overall Study|Adverse Event|0|||
48728251|NCT04551066|156854398|FG000|Overall Study|Physician Decision|2|||
48728252|NCT04551066|156854399|FG001|Overall Study|Physician Decision|0|||
48728253|NCT04551066|156854398|FG000|Overall Study|Protocol Violation|1|||
48728254|NCT04551066|156854399|FG001|Overall Study|Protocol Violation|0|||
48728255|NCT04551066|156854398|FG000|Overall Study|Lack of Efficacy|0|||
48728256|NCT04551066|156854399|FG001|Overall Study|Lack of Efficacy|1|||
48728257|NCT04551066|156854398|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
48728258|NCT04551066|156854399|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
48728259|NCT03387150|156855479|FG000|Overall Study|Withdrawal by Subject|3|||
48728260|NCT03387150|156855480|FG001|Overall Study|Withdrawal by Subject|0|||
48728261|NCT03387150|156855481|FG002|Overall Study|Withdrawal by Subject|3|||
48728262|NCT03387150|156855482|FG003|Overall Study|Withdrawal by Subject|4|||
48728263|NCT03387150|156855483|FG004|Overall Study|Withdrawal by Subject|1|||
48728264|NCT03387150|156855484|FG005|Overall Study|Withdrawal by Subject|2|||
48728265|NCT03387150|156855485|FG006|Overall Study|Withdrawal by Subject|0|||
48728266|NCT03387150|156855479|FG000|Overall Study|Lost to Follow-up|3|||
48728267|NCT03387150|156855480|FG001|Overall Study|Lost to Follow-up|2|||
48728268|NCT03387150|156855481|FG002|Overall Study|Lost to Follow-up|2|||
48728269|NCT03387150|156855482|FG003|Overall Study|Lost to Follow-up|3|||
48728270|NCT03387150|156855483|FG004|Overall Study|Lost to Follow-up|3|||
48728271|NCT03387150|156855484|FG005|Overall Study|Lost to Follow-up|3|||
48728272|NCT03387150|156855485|FG006|Overall Study|Lost to Follow-up|0|||
48728273|NCT03387150|156855479|FG000|Overall Study|Participant unable to adhere to visit|0|||
48728274|NCT03387150|156855480|FG001|Overall Study|Participant unable to adhere to visit|1|||
48728275|NCT03387150|156855481|FG002|Overall Study|Participant unable to adhere to visit|0|||
48728276|NCT03387150|156855482|FG003|Overall Study|Participant unable to adhere to visit|0|||
48728277|NCT03387150|156855483|FG004|Overall Study|Participant unable to adhere to visit|2|||
48728278|NCT03387150|156855484|FG005|Overall Study|Participant unable to adhere to visit|2|||
48728279|NCT03387150|156855485|FG006|Overall Study|Participant unable to adhere to visit|0|||
48728280|NCT02425644|156855491|FG000|Overall Study|Lost to Follow-up|2|||
48728281|NCT02425644|156855492|FG001|Overall Study|Lost to Follow-up|3|||
48728282|NCT02425644|156855491|FG000|Overall Study|Withdrawal by Subject|41|||
48728283|NCT02425644|156855492|FG001|Overall Study|Withdrawal by Subject|36|||
48728284|NCT02425644|156855491|FG000|Overall Study|Lack of Efficacy|3|||
48728285|NCT02425644|156855492|FG001|Overall Study|Lack of Efficacy|10|||
48728286|NCT02425644|156855491|FG000|Overall Study|Adverse Event|13|||
48728287|NCT02425644|156855492|FG001|Overall Study|Adverse Event|3|||
48728288|NCT02425644|156855491|FG000|Overall Study|Death|0|||
48728289|NCT02425644|156855492|FG001|Overall Study|Death|2|||
48728290|NCT02425644|156855491|FG000|Overall Study|Other|18|||
48728291|NCT02425644|156855492|FG001|Overall Study|Other|17|||
48728292|NCT02448680|156855495|FG000|Overall Study|Physician Decision|1|||
48728293|NCT02448680|156855496|FG001|Overall Study|Physician Decision|1|||
48728294|NCT02448680|156855495|FG000|Overall Study|Withdrawal by Subject|0|||
48728295|NCT02448680|156855496|FG001|Overall Study|Withdrawal by Subject|2|||
48728296|NCT03435640|156855497|FG000|Overall Study|Withdrawal by Subject|0|||
48728297|NCT03435640|156855498|FG001|Overall Study|Withdrawal by Subject|1|||
48728298|NCT03435640|156855499|FG002|Overall Study|Withdrawal by Subject|0|||
48728299|NCT03435640|156855500|FG003|Overall Study|Withdrawal by Subject|2|||
48728300|NCT03435640|156855501|FG004|Overall Study|Withdrawal by Subject|0|||
48728301|NCT03435640|156855502|FG005|Overall Study|Withdrawal by Subject|0|||
48728302|NCT03435640|156855503|FG006|Overall Study|Withdrawal by Subject|3|||
48728303|NCT03435640|156855504|FG007|Overall Study|Withdrawal by Subject|0|||
48821674|NCT01253200|157188734|FG002|Overall Study|Attempts|1|||
48821675|NCT01253200|157188735|FG003|Overall Study|Attempts|2|||
48821676|NCT01253200|157188736|FG004|Overall Study|Attempts|0|||
48821677|NCT03285711|157188741|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
48510772|NCT00824291|156062230|FG001|Overall Study|Lack of Efficacy|8|||
48510773|NCT00824291|156062229|FG000|Overall Study|Participant on prohibited medication|1|||
48510774|NCT00824291|156062230|FG001|Overall Study|Participant on prohibited medication|0|||
48510775|NCT03965091|156062233|FG000|Overall Study|Adverse Event|0|||
48510776|NCT03965091|156062234|FG001|Overall Study|Adverse Event|2|||
48510777|NCT03965091|156062235|FG002|Overall Study|Adverse Event|3|||
48510778|NCT03965091|156062233|FG000|Overall Study|Withdrawal by Subject|11|||
48510779|NCT03965091|156062234|FG001|Overall Study|Withdrawal by Subject|3|||
48510780|NCT03965091|156062235|FG002|Overall Study|Withdrawal by Subject|5|||
48510781|NCT03965091|156062233|FG000|Overall Study|Non-compliance with study drug|0|||
48510782|NCT03965091|156062234|FG001|Overall Study|Non-compliance with study drug|0|||
48510783|NCT03965091|156062235|FG002|Overall Study|Non-compliance with study drug|1|||
48510784|NCT03965091|156062233|FG000|Overall Study|Lost to Follow-up|1|||
48510785|NCT03965091|156062234|FG001|Overall Study|Lost to Follow-up|1|||
48510786|NCT03965091|156062235|FG002|Overall Study|Lost to Follow-up|1|||
48510787|NCT03965091|156062233|FG000|Overall Study|Lack of Efficacy|2|||
48510788|NCT03965091|156062234|FG001|Overall Study|Lack of Efficacy|0|||
48510789|NCT03965091|156062235|FG002|Overall Study|Lack of Efficacy|0|||
48728304|NCT03435640|156855505|FG008|Overall Study|Withdrawal by Subject|0|||
48728305|NCT03435640|156855506|FG009|Overall Study|Withdrawal by Subject|2|||
48728306|NCT03435640|156855507|FG010|Overall Study|Withdrawal by Subject|3|||
48728307|NCT03435640|156855497|FG000|Overall Study|Lost to Follow-up|0|||
48728308|NCT03435640|156855498|FG001|Overall Study|Lost to Follow-up|0|||
48728309|NCT03435640|156855499|FG002|Overall Study|Lost to Follow-up|1|||
48728310|NCT03435640|156855500|FG003|Overall Study|Lost to Follow-up|0|||
48728311|NCT03435640|156855501|FG004|Overall Study|Lost to Follow-up|0|||
48728312|NCT03435640|156855502|FG005|Overall Study|Lost to Follow-up|0|||
48728313|NCT03435640|156855503|FG006|Overall Study|Lost to Follow-up|0|||
48728314|NCT03435640|156855504|FG007|Overall Study|Lost to Follow-up|0|||
48728315|NCT03435640|156855505|FG008|Overall Study|Lost to Follow-up|0|||
48728316|NCT03435640|156855506|FG009|Overall Study|Lost to Follow-up|0|||
48728317|NCT03435640|156855507|FG010|Overall Study|Lost to Follow-up|0|||
48728318|NCT01920555|156855508|FG000|Overall Study|Physician Decision|1|||
48510790|NCT03965091|156062233|FG000|Overall Study|Other than specified|9|||
48510791|NCT03965091|156062234|FG001|Overall Study|Other than specified|11|||
48728319|NCT01920555|156855509|FG001|Overall Study|Physician Decision|2|||
48728320|NCT01920555|156855510|FG002|Overall Study|Physician Decision|1|||
48728321|NCT01920555|156855511|FG003|Overall Study|Physician Decision|2|||
48728322|NCT01920555|156855512|FG004|Overall Study|Physician Decision|0|||
48728323|NCT01920555|156855508|FG000|Overall Study|Lack of Efficacy|2|||
48728324|NCT01920555|156855509|FG001|Overall Study|Lack of Efficacy|0|||
48728325|NCT01920555|156855510|FG002|Overall Study|Lack of Efficacy|0|||
48728326|NCT01920555|156855511|FG003|Overall Study|Lack of Efficacy|0|||
48728327|NCT01920555|156855512|FG004|Overall Study|Lack of Efficacy|0|||
48728328|NCT01920555|156855508|FG000|Overall Study|Travel Difficulties|1|||
48728329|NCT01920555|156855509|FG001|Overall Study|Travel Difficulties|1|||
48728330|NCT01920555|156855510|FG002|Overall Study|Travel Difficulties|0|||
48728331|NCT01920555|156855511|FG003|Overall Study|Travel Difficulties|0|||
48728332|NCT01920555|156855512|FG004|Overall Study|Travel Difficulties|1|||
48728333|NCT01920555|156855508|FG000|Overall Study|Lost to Follow-up|0|||
48728334|NCT01920555|156855509|FG001|Overall Study|Lost to Follow-up|1|||
48728335|NCT01920555|156855510|FG002|Overall Study|Lost to Follow-up|0|||
48728336|NCT01920555|156855511|FG003|Overall Study|Lost to Follow-up|1|||
48728337|NCT01920555|156855512|FG004|Overall Study|Lost to Follow-up|0|||
48728338|NCT01741012|156855515|FG000|Overall Study|Lost to Follow-up|1|||
48728339|NCT01741012|156855515|FG000|Overall Study|Withdrawal by Subject|2|||
48728340|NCT00880685|156855518|FG000|Memantine 10mg|Lost to Follow-up|2|||
48728341|NCT00880685|156855518|FG000|Memantine 20mg|Withdrawal by Subject|1|||
48728342|NCT01711879|156855519|FG000|Overall Study|Death|1|||
48728343|NCT01711879|156855520|FG001|Overall Study|Death|0|||
48728344|NCT03845296|156855524|FG000|Overall Study|On Treatment|2|||
48728345|NCT03845296|156855525|FG001|Overall Study|On Treatment|1|||
48728346|NCT03845296|156855524|FG000|Overall Study|Adverse Event|4|||
48728347|NCT03845296|156855525|FG001|Overall Study|Adverse Event|11|||
48728348|NCT03845296|156855524|FG000|Overall Study|Refusal unrelated to adverse event|0|||
48728349|NCT03845296|156855525|FG001|Overall Study|Refusal unrelated to adverse event|1|||
48728350|NCT03845296|156855524|FG000|Overall Study|Progression/relapse|14|||
48728351|NCT03845296|156855525|FG001|Overall Study|Progression/relapse|18|||
48728352|NCT03845296|156855524|FG000|Overall Study|Death|4|||
48728353|NCT03845296|156855525|FG001|Overall Study|Death|0|||
48728354|NCT03845296|156855524|FG000|Overall Study|Other - not protocol specified|1|||
48728355|NCT03845296|156855525|FG001|Overall Study|Other - not protocol specified|3|||
48510792|NCT03965091|156062235|FG002|Overall Study|Other than specified|8|||
48510793|NCT03351244|156062237|FG000|Overall Study|Adverse Event|7|||
48510794|NCT03351244|156062238|FG001|Overall Study|Adverse Event|11|||
48728356|NCT00589784|156855531|FG000|Overall Study|Withdrawal by Subject|0|||
48510795|NCT03351244|156062239|FG002|Overall Study|Adverse Event|12|||
48510796|NCT03351244|156062237|FG000|Overall Study|Investigator's decision|0|||
48510797|NCT03351244|156062238|FG001|Overall Study|Investigator's decision|0|||
48510798|NCT03351244|156062239|FG002|Overall Study|Investigator's decision|2|||
48510799|NCT03351244|156062237|FG000|Overall Study|System error|0|||
48510800|NCT03351244|156062238|FG001|Overall Study|System error|0|||
48510801|NCT03351244|156062239|FG002|Overall Study|System error|2|||
48510802|NCT03351244|156062237|FG000|Overall Study|COVID-19 restrictions|3|||
48510803|NCT03351244|156062238|FG001|Overall Study|COVID-19 restrictions|0|||
48510804|NCT03351244|156062239|FG002|Overall Study|COVID-19 restrictions|1|||
48510805|NCT03351244|156062237|FG000|Overall Study|Non-compliance|2|||
48510806|NCT03351244|156062238|FG001|Overall Study|Non-compliance|5|||
48510807|NCT03351244|156062239|FG002|Overall Study|Non-compliance|0|||
48510808|NCT03351244|156062237|FG000|Overall Study|Withdrawal by Subject|11|||
48510809|NCT03351244|156062238|FG001|Overall Study|Withdrawal by Subject|16|||
48510810|NCT03351244|156062239|FG002|Overall Study|Withdrawal by Subject|13|||
48510811|NCT03351244|156062237|FG000|Overall Study|Lost to Follow-up|2|||
48510812|NCT03351244|156062238|FG001|Overall Study|Lost to Follow-up|6|||
48510813|NCT03351244|156062239|FG002|Overall Study|Lost to Follow-up|4|||
48510814|NCT03351244|156062237|FG000|Overall Study|Protocol Violation|2|||
48510815|NCT03351244|156062238|FG001|Overall Study|Protocol Violation|2|||
48510816|NCT03351244|156062239|FG002|Overall Study|Protocol Violation|0|||
48510817|NCT03247972|156062240|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
48510818|NCT03247972|156062240|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
48510819|NCT00968812|156062243|FG000|Overall Study|Adverse Event|30|||
48510820|NCT00968812|156062244|FG001|Overall Study|Adverse Event|46|||
48510821|NCT00968812|156062245|FG002|Overall Study|Adverse Event|33|||
48510822|NCT00968812|156062243|FG000|Overall Study|Death|2|||
48510823|NCT00968812|156062244|FG001|Overall Study|Death|2|||
48510824|NCT00968812|156062245|FG002|Overall Study|Death|1|||
48510825|NCT00968812|156062243|FG000|Overall Study|Lack of Efficacy|9|||
48510826|NCT00968812|156062244|FG001|Overall Study|Lack of Efficacy|7|||
48510827|NCT00968812|156062245|FG002|Overall Study|Lack of Efficacy|16|||
48510828|NCT00968812|156062243|FG000|Overall Study|Lost to Follow-up|17|||
48510829|NCT00968812|156062244|FG001|Overall Study|Lost to Follow-up|12|||
48510830|NCT00968812|156062245|FG002|Overall Study|Lost to Follow-up|11|||
48510831|NCT00968812|156062243|FG000|Overall Study|Physician Decision|8|||
48510832|NCT00968812|156062244|FG001|Overall Study|Physician Decision|5|||
48510833|NCT00968812|156062245|FG002|Overall Study|Physician Decision|9|||
48510834|NCT00968812|156062243|FG000|Overall Study|Protocol Violation|7|||
48510835|NCT00968812|156062244|FG001|Overall Study|Protocol Violation|4|||
48510836|NCT00968812|156062245|FG002|Overall Study|Protocol Violation|3|||
48510837|NCT00968812|156062243|FG000|Overall Study|Withdrawal by Subject|17|||
48510838|NCT00968812|156062244|FG001|Overall Study|Withdrawal by Subject|23|||
48510839|NCT00968812|156062245|FG002|Overall Study|Withdrawal by Subject|25|||
48510840|NCT00968812|156062243|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
48510841|NCT00968812|156062244|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
48510842|NCT00968812|156062245|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
48510843|NCT00968812|156062243|FG000|Overall Study|Noncompliance with study drug|4|||
48510844|NCT00968812|156062244|FG001|Overall Study|Noncompliance with study drug|1|||
48510845|NCT00968812|156062245|FG002|Overall Study|Noncompliance with study drug|6|||
48510846|NCT00968812|156062243|FG000|Overall Study|Unable to take rescue therapy|12|||
48510847|NCT00968812|156062244|FG001|Overall Study|Unable to take rescue therapy|12|||
48510848|NCT00968812|156062245|FG002|Overall Study|Unable to take rescue therapy|17|||
48510849|NCT00968812|156062243|FG000|Overall Study|Other|25|||
48728357|NCT00589784|156855532|FG001|Overall Study|Withdrawal by Subject|6|||
48510850|NCT00968812|156062244|FG001|Overall Study|Other|37|||
48510851|NCT00968812|156062245|FG002|Overall Study|Other|40|||
48510852|NCT02576938|156062246|FG000|Overall Study|Adverse Event|5|||
48510853|NCT02576938|156062247|FG001|Overall Study|Adverse Event|3|||
48728358|NCT00589784|156855531|FG000|Overall Study|Patient inevaluable|1|||
48510854|NCT02576938|156062248|FG002|Overall Study|Adverse Event|6|||
48510855|NCT02576938|156062246|FG000|Overall Study|Protocol Violation|1|||
48728359|NCT00589784|156855532|FG001|Overall Study|Patient inevaluable|0|||
48510856|NCT02576938|156062247|FG001|Overall Study|Protocol Violation|1|||
48510857|NCT02576938|156062248|FG002|Overall Study|Protocol Violation|1|||
48510858|NCT02576938|156062246|FG000|Overall Study|Withdrawal by Subject|3|||
48510859|NCT02576938|156062247|FG001|Overall Study|Withdrawal by Subject|2|||
48510860|NCT02576938|156062248|FG002|Overall Study|Withdrawal by Subject|4|||
48510861|NCT02576938|156062246|FG000|Overall Study|Lack of Efficacy|9|||
48510862|NCT02576938|156062247|FG001|Overall Study|Lack of Efficacy|4|||
48510863|NCT02576938|156062248|FG002|Overall Study|Lack of Efficacy|0|||
48510864|NCT02576938|156062246|FG000|Overall Study|Lost to Follow-up|2|||
48510865|NCT02576938|156062247|FG001|Overall Study|Lost to Follow-up|0|||
48510866|NCT02576938|156062248|FG002|Overall Study|Lost to Follow-up|1|||
48510867|NCT02576938|156062246|FG000|Overall Study|Physician Decision|0|||
48510868|NCT02576938|156062247|FG001|Overall Study|Physician Decision|1|||
48510869|NCT02576938|156062248|FG002|Overall Study|Physician Decision|0|||
48510870|NCT02576938|156062246|FG000|Overall Study|Met Exclusion Criteria|0|||
48510871|NCT02576938|156062247|FG001|Overall Study|Met Exclusion Criteria|1|||
48510872|NCT02576938|156062248|FG002|Overall Study|Met Exclusion Criteria|0|||
48510873|NCT00840073|156062253|FG000|Second Intervention|Missed 72 hour blood draw|1|||
48510874|NCT00840073|156062254|FG001|Second Intervention|Missed 72 hour blood draw|1|||
48510875|NCT01663233|156062255|FG000|Overall Study|Withdrawal by Subject|3|||
48510876|NCT01663233|156062256|FG001|Overall Study|Withdrawal by Subject|2|||
48510877|NCT01663233|156062255|FG000|Overall Study|Protocol Deviation|1|||
48510878|NCT01663233|156062256|FG001|Overall Study|Protocol Deviation|4|||
48510879|NCT01663233|156062255|FG000|Overall Study|Lost to Follow-up|0|||
48510880|NCT01663233|156062256|FG001|Overall Study|Lost to Follow-up|1|||
48510881|NCT00787254|156062259|FG000|Overall Study|Adverse Event|24|||
48510882|NCT00787254|156062260|FG001|Overall Study|Adverse Event|23|||
48510883|NCT00787254|156062259|FG000|Overall Study|Protocol Violation|26|||
48510884|NCT00787254|156062260|FG001|Overall Study|Protocol Violation|23|||
48510885|NCT00787254|156062259|FG000|Overall Study|Withdrawal by Subject|16|||
48510886|NCT00787254|156062260|FG001|Overall Study|Withdrawal by Subject|11|||
48510887|NCT00787254|156062259|FG000|Overall Study|Lack of Efficacy|4|||
48510888|NCT00787254|156062260|FG001|Overall Study|Lack of Efficacy|15|||
48510889|NCT00787254|156062259|FG000|Overall Study|NSAIDs discontinuation|1|||
48510890|NCT00787254|156062260|FG001|Overall Study|NSAIDs discontinuation|2|||
48510891|NCT00787254|156062259|FG000|Overall Study|Institution closed|1|||
48510892|NCT00787254|156062260|FG001|Overall Study|Institution closed|0|||
48510893|NCT00787254|156062259|FG000|Overall Study|Physician Decision|4|||
48510894|NCT00787254|156062260|FG001|Overall Study|Physician Decision|8|||
48510895|NCT00836056|156062264|FG000|First Intervention|Adverse Event|1|||
48510896|NCT00836056|156062265|FG001|First Intervention|Adverse Event|0|||
48510897|NCT01353664|156062274|FG000|Overall Study|Other|3|||
48510898|NCT01353664|156062274|FG000|Overall Study|Disease Progression|16|||
48510899|NCT03100344|156062277|FG000|Overall Study|Adverse Event|0|||
48510900|NCT03100344|156062278|FG001|Overall Study|Adverse Event|3|||
48510901|NCT03100344|156062279|FG002|Overall Study|Adverse Event|2|||
48510902|NCT03100344|156062280|FG003|Overall Study|Adverse Event|3|||
48510903|NCT03100344|156062277|FG000|Overall Study|Lack of Efficacy|2|||
48510904|NCT03100344|156062278|FG001|Overall Study|Lack of Efficacy|0|||
48510905|NCT03100344|156062279|FG002|Overall Study|Lack of Efficacy|0|||
48510906|NCT03100344|156062280|FG003|Overall Study|Lack of Efficacy|0|||
48728360|NCT00589784|156855531|FG000|Overall Study|Adverse Event|0|||
48510907|NCT03100344|156062277|FG000|Overall Study|Protocol Violation|1|||
48728361|NCT00589784|156855532|FG001|Overall Study|Adverse Event|4|||
48728362|NCT01058265|156855541|FG000|Overall Study|Lost to Follow-up|11|||
48728363|NCT01058265|156855542|FG001|Overall Study|Lost to Follow-up|12|||
48728364|NCT00566501|156855543|FG000|Overall Study|Adverse Event|68|||
48728365|NCT00566501|156855544|FG001|Overall Study|Adverse Event|59|||
48728366|NCT00566501|156855543|FG000|Overall Study|Medication Non-compliance|5|||
48728367|NCT00566501|156855544|FG001|Overall Study|Medication Non-compliance|0|||
48728368|NCT00566501|156855543|FG000|Overall Study|Protocol Violation|2|||
48728369|NCT00566501|156855544|FG001|Overall Study|Protocol Violation|2|||
48728370|NCT00566501|156855543|FG000|Overall Study|Request of Investigator or Sponsor|6|||
48728371|NCT00566501|156855544|FG001|Overall Study|Request of Investigator or Sponsor|7|||
48728372|NCT00566501|156855543|FG000|Overall Study|Withdrawal by Subject|33|||
48728373|NCT00566501|156855544|FG001|Overall Study|Withdrawal by Subject|30|||
48728374|NCT00566501|156855543|FG000|Overall Study|Lack of Efficacy|8|||
48728375|NCT00566501|156855544|FG001|Overall Study|Lack of Efficacy|3|||
48728376|NCT00566501|156855543|FG000|Overall Study|Other|25|||
48728377|NCT00566501|156855544|FG001|Overall Study|Other|21|||
48728378|NCT01367119|156855545|FG000|Overall Study|Adverse Event|1|||
48728379|NCT01367119|156855546|FG001|Overall Study|Adverse Event|0|||
48728380|NCT01367119|156855545|FG000|Overall Study|Withdrawal by Subject|1|||
48728381|NCT01367119|156855546|FG001|Overall Study|Withdrawal by Subject|1|||
48728382|NCT02310321|156855547|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
48728383|NCT02310321|156855548|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
48728384|NCT02310321|156855549|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
48728385|NCT02310321|156855547|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
48728386|NCT02310321|156855548|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
48728387|NCT02310321|156855549|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
48728388|NCT02310321|156855547|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
48821678|NCT03285711|157188742|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
48821679|NCT03285711|157188743|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
48821680|NCT03285711|157188744|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
48821681|NCT03285711|157188741|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
48821682|NCT03285711|157188742|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
48821683|NCT03285711|157188743|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
48510908|NCT03100344|156062278|FG001|Overall Study|Protocol Violation|0|||
48510909|NCT03100344|156062279|FG002|Overall Study|Protocol Violation|0|||
48510910|NCT03100344|156062280|FG003|Overall Study|Protocol Violation|0|||
48510911|NCT03100344|156062277|FG000|Overall Study|Withdrawal by Subject|10|||
48510912|NCT03100344|156062278|FG001|Overall Study|Withdrawal by Subject|7|||
48510913|NCT03100344|156062279|FG002|Overall Study|Withdrawal by Subject|4|||
48510914|NCT03100344|156062280|FG003|Overall Study|Withdrawal by Subject|8|||
48510915|NCT03100344|156062277|FG000|Overall Study|Lost to Follow-up|1|||
48510916|NCT03100344|156062278|FG001|Overall Study|Lost to Follow-up|1|||
48510917|NCT03100344|156062279|FG002|Overall Study|Lost to Follow-up|1|||
48510918|NCT03100344|156062280|FG003|Overall Study|Lost to Follow-up|1|||
48510919|NCT04198363|156062281|FG000|Overall Study|Adverse Event|1|||
48510920|NCT04198363|156062282|FG001|Overall Study|Adverse Event|1|||
48510921|NCT04198363|156062281|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
48510922|NCT04198363|156062282|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
48510923|NCT04198363|156062281|FG000|Overall Study|Reason not Specified|1|||
48510924|NCT04198363|156062282|FG001|Overall Study|Reason not Specified|0|||
48510925|NCT02286739|156063846|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
48510926|NCT02286739|156063847|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
48510927|NCT02286739|156063846|FG000|Overall Study|No Verasense type documented|0|||
48728389|NCT02310321|156855548|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
48728390|NCT02310321|156855549|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
48728391|NCT02310321|156855547|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
48728392|NCT02310321|156855548|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
48728393|NCT02310321|156855549|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
48728394|NCT02310321|156855547|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
48728395|NCT02310321|156855548|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
48728396|NCT02310321|156855549|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
48728397|NCT02310321|156855547|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
48728398|NCT02310321|156855548|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
48728399|NCT02310321|156855549|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
48728400|NCT02310321|156855547|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
48728401|NCT02310321|156855548|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
48821684|NCT03285711|157188744|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
48821685|NCT03285711|157188741|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
48821686|NCT03285711|157188742|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
48821687|NCT03285711|157188743|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
48821688|NCT03285711|157188744|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
48821689|NCT03285711|157188741|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
48510928|NCT02286739|156063847|FG001|Overall Study|No Verasense type documented|23|||
48510929|NCT02286739|156063846|FG000|Overall Study|Adverse Event|1|||
48510930|NCT02286739|156063847|FG001|Overall Study|Adverse Event|2|||
48510931|NCT02286739|156063846|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
48510932|NCT02286739|156063847|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
48510933|NCT00835991|156063857|FG000|First Intervention|Adverse Event|0|||
48510934|NCT00835991|156063858|FG001|First Intervention|Adverse Event|1|||
48510935|NCT00835991|156063857|FG000|Washout|Protocol Violation|0|||
48510936|NCT00835991|156063858|FG001|Washout|Protocol Violation|2|||
48510937|NCT00835991|156063857|FG000|Washout|Withdrawal by Subject|3|||
48510938|NCT00835991|156063858|FG001|Washout|Withdrawal by Subject|1|||
48510939|NCT02149420|156063859|FG000|Core Study|Administrative problems|0|||
48510940|NCT02149420|156063860|FG001|Core Study|Administrative problems|1|||
48601039|NCT01064414|156396022|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
48601040|NCT01064414|156396023|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
48510941|NCT02149420|156063861|FG002|Core Study|Administrative problems|2|||
48510942|NCT02149420|156063859|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
48510943|NCT02149420|156063860|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
48510944|NCT02149420|156063861|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
48510945|NCT02269657|156063862|FG000|Overall Study|Protocol Violation|3|||
48510946|NCT00856388|156063864|FG000|Overall Study|Other|1|||
48510947|NCT02956460|156063867|FG000|Lens 1|Lost to Follow-up|1|||
48510948|NCT02956460|156063868|FG001|Lens 1|Lost to Follow-up|0|||
48510949|NCT01111461|156063869|FG000|Overall Study|Adverse Event|32|||
48510950|NCT01111461|156063869|FG000|Overall Study|Participant choice|11|||
48510951|NCT01111461|156063869|FG000|Overall Study|Lost to Follow-up|1|||
48728402|NCT02310321|156855549|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
48728403|NCT02310321|156855547|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
48728404|NCT02310321|156855548|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
48728405|NCT02310321|156855549|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
48728406|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
48510952|NCT01111461|156063869|FG000|Overall Study|Withdrawal by Subject|1|||
48510953|NCT01111461|156063869|FG000|Overall Study|Other|6|||
48510954|NCT00851877|156063870|FG000|Phase I-1|Death|1|||
48510955|NCT00851877|156063871|FG001|Phase I-1|Death|0|||
48510956|NCT00851877|156063872|FG002|Phase I-1|Death|0|||
48510957|NCT00851877|156063870|FG000|Phase II|Withdrawal by Subject|0|||
48510958|NCT00851877|156063871|FG001|Phase II|Withdrawal by Subject|0|||
48510959|NCT00851877|156063872|FG002|Phase II|Withdrawal by Subject|3|||
48510960|NCT00620074|156063873|FG000|Overall Study|Adverse Event|1|||
48510961|NCT04278560|156063874|FG000|Overall Study|Adverse Event|1|||
48510962|NCT04278560|156063875|FG001|Overall Study|Adverse Event|2|||
48510963|NCT04278560|156063874|FG000|Overall Study|Withdrawal by Subject|0|||
48510964|NCT04278560|156063875|FG001|Overall Study|Withdrawal by Subject|1|||
48728407|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
48728408|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
48728409|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
48821690|NCT03285711|157188742|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
48821691|NCT03285711|157188743|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
48821692|NCT03285711|157188744|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
48821693|NCT00877851|157188745|FG000|Overall Study|Lost to Follow-up|5|||
48821694|NCT00877851|157188746|FG001|Overall Study|Lost to Follow-up|5|||
48728410|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
48728411|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
48728412|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
48728413|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
48728414|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
48728415|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
48728416|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
48728417|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
48821695|NCT00877851|157188745|FG000|Overall Study|computer problem|3|||
48821696|NCT00877851|157188746|FG001|Overall Study|computer problem|0|||
48821697|NCT00877851|157188745|FG000|Overall Study|no longer interested in participating|1|||
48821698|NCT00877851|157188746|FG001|Overall Study|no longer interested in participating|0|||
48821699|NCT01871285|157188747|FG000|First Intervention (1 Day)|Adverse Event|1|||
48821700|NCT01871285|157188748|FG001|First Intervention (1 Day)|Adverse Event|0|||
48821701|NCT01871285|157188749|FG002|First Intervention (1 Day)|Adverse Event|0|||
48821702|NCT01871285|157188750|FG003|First Intervention (1 Day)|Adverse Event|0|||
48821703|NCT01871285|157188747|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
48821704|NCT01871285|157188748|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
48821705|NCT01871285|157188749|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
48821706|NCT01871285|157188750|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
48821707|NCT00114959|157188751|FG000|Overall Study|Lack of Efficacy|6|||
48821708|NCT00114959|157188751|FG000|Overall Study|Physician Decision|1|||
48821709|NCT00114959|157188751|FG000|Overall Study|Death|1|||
48821710|NCT01866917|157188759|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
48821711|NCT01866917|157188760|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
48821712|NCT01515319|157188761|FG000|Overall Study|Withdrawal by Subject|0|||
48821713|NCT01515319|157188762|FG001|Overall Study|Withdrawal by Subject|0|||
48728418|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
48728419|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
48728420|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
48728421|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
48728422|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
48728423|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
48510965|NCT00829673|156063878|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48510966|NCT00829673|156063879|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48510967|NCT00834067|156063881|FG000|Washout of 21 Days|Protocol Violation|0|||
48510968|NCT00834067|156063882|FG001|Washout of 21 Days|Protocol Violation|1|||
48510969|NCT01247701|156063883|FG000|Overall Study|Death|2|||
48510970|NCT01247701|156063883|FG000|Overall Study|Relapsed|8|||
48510971|NCT02979522|156063884|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
48510972|NCT02979522|156063885|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
48510973|NCT02979522|156063884|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
48510974|NCT02979522|156063885|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
48510975|NCT04166630|156063886|FG000|Overall Study|Withdrawal by Subject|0|||
48510976|NCT04166630|156063887|FG001|Overall Study|Withdrawal by Subject|1|||
48510977|NCT02832063|156063888|FG000|Overall Study|Adverse Event|2|||
48510978|NCT02832063|156063889|FG001|Overall Study|Adverse Event|1|||
48510979|NCT02832063|156063888|FG000|Overall Study|Physician Decision|5|||
48510980|NCT02832063|156063889|FG001|Overall Study|Physician Decision|7|||
48510981|NCT02832063|156063888|FG000|Overall Study|Lost to Follow-up|15|||
48510982|NCT02832063|156063889|FG001|Overall Study|Lost to Follow-up|8|||
48510983|NCT02832063|156063888|FG000|Overall Study|Withdrawal by Subject|10|||
48510984|NCT02832063|156063889|FG001|Overall Study|Withdrawal by Subject|21|||
48510985|NCT02832063|156063888|FG000|Overall Study|Other|2|||
48510986|NCT02832063|156063889|FG001|Overall Study|Other|1|||
48510987|NCT02378935|156063890|FG000|Overall Study|Lack of Efficacy|10|||
48510988|NCT02378935|156063891|FG001|Overall Study|Lack of Efficacy|0|||
48510989|NCT02378935|156063892|FG002|Overall Study|Lack of Efficacy|2|||
48510990|NCT02378935|156063893|FG003|Overall Study|Lack of Efficacy|6|||
48510991|NCT02378935|156063894|FG004|Overall Study|Lack of Efficacy|0|||
48510992|NCT02378935|156063895|FG005|Overall Study|Lack of Efficacy|0|||
48510993|NCT02378935|156063896|FG006|Overall Study|Lack of Efficacy|0|||
48510994|NCT02378935|156063890|FG000|Overall Study|Death|0|||
48510995|NCT02378935|156063891|FG001|Overall Study|Death|0|||
48510996|NCT02378935|156063892|FG002|Overall Study|Death|1|||
48510997|NCT02378935|156063893|FG003|Overall Study|Death|0|||
48510998|NCT02378935|156063894|FG004|Overall Study|Death|0|||
48510999|NCT02378935|156063895|FG005|Overall Study|Death|0|||
48511000|NCT02378935|156063896|FG006|Overall Study|Death|0|||
48511001|NCT00440518|156063897|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
48511002|NCT00440518|156063898|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
48511003|NCT00440518|156063899|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
48511004|NCT00440518|156063897|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
48511005|NCT00440518|156063898|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
48511006|NCT00440518|156063899|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
48511007|NCT00440518|156063897|FG000|Randomized /Titration Period|Protocol Deviation|1|||
48511008|NCT00440518|156063898|FG001|Randomized /Titration Period|Protocol Deviation|0|||
48511009|NCT00440518|156063899|FG002|Randomized /Titration Period|Protocol Deviation|0|||
48511010|NCT00440518|156063897|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
48511011|NCT00440518|156063898|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
48511012|NCT00440518|156063899|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
48511013|NCT00440518|156063897|FG000|Randomized /Titration Period|Other|1|||
48511014|NCT00440518|156063898|FG001|Randomized /Titration Period|Other|0|||
48511015|NCT00440518|156063899|FG002|Randomized /Titration Period|Other|0|||
48511016|NCT00440518|156063897|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
48511017|NCT00440518|156063898|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
48511018|NCT00440518|156063899|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
48511019|NCT00440518|156063897|FG000|Randomized /Titration Period|Adverse Event|2|||
48511020|NCT00440518|156063898|FG001|Randomized /Titration Period|Adverse Event|3|||
48728424|NCT02310321|156855547|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
48728425|NCT02310321|156855548|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
48511021|NCT00440518|156063899|FG002|Randomized /Titration Period|Adverse Event|0|||
48511022|NCT00440518|156063897|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
48511023|NCT00440518|156063898|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
48511024|NCT00440518|156063899|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
48511025|NCT00440518|156063897|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
48511026|NCT00440518|156063898|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
48511027|NCT00440518|156063899|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
48511028|NCT00440518|156063897|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
48511029|NCT00440518|156063898|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
48511030|NCT00440518|156063899|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
48511031|NCT00440518|156063897|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
48511032|NCT00440518|156063898|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
48511033|NCT00440518|156063899|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
48728426|NCT02310321|156855549|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
48728427|NCT02310321|156855547|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
48511034|NCT00440518|156063897|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
48511035|NCT00440518|156063898|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
48511036|NCT00440518|156063899|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
48511037|NCT00440518|156063897|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
48511038|NCT00440518|156063898|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
48511039|NCT00440518|156063899|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
48511040|NCT00272779|156063901|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
48511041|NCT00272779|156063902|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
48511042|NCT00272779|156063901|FG000|Baseline Through Week 48|Death before Week 48|4|||
48511043|NCT00272779|156063902|FG001|Baseline Through Week 48|Death before Week 48|4|||
48511044|NCT00272779|156063901|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
48511045|NCT00272779|156063902|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
48511046|NCT00272779|156063901|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
48511047|NCT00272779|156063902|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
48511048|NCT00272779|156063901|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
48511049|NCT00272779|156063902|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
48511050|NCT00272779|156063901|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
48511051|NCT00272779|156063902|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
48511052|NCT00272779|156063901|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
48511053|NCT00272779|156063902|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
48511054|NCT00272779|156063901|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
48511055|NCT00272779|156063902|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
48511056|NCT00272779|156063901|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
48511057|NCT00272779|156063902|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
48511058|NCT00272779|156063901|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
48728428|NCT02310321|156855548|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
48728429|NCT02310321|156855549|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
48728430|NCT02310321|156855547|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
48728431|NCT02310321|156855548|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
48728432|NCT02310321|156855549|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
48382051|NCT01674712|155595056|FG000|Overall Study|Adverse Event|5|||
48728433|NCT02310321|156855547|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
48728434|NCT02310321|156855548|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
48728435|NCT02310321|156855549|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
48728436|NCT02310321|156855547|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
48728437|NCT02310321|156855548|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
48728438|NCT02310321|156855549|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
48728439|NCT02310321|156855547|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
48728440|NCT02310321|156855548|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
48728441|NCT02310321|156855549|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
48728442|NCT02310321|156855547|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
48728443|NCT02310321|156855548|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
48728444|NCT02310321|156855549|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
48728445|NCT02310321|156855547|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
48728446|NCT02310321|156855548|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
48728447|NCT02310321|156855549|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
48728448|NCT02495233|156855550|FG000|Overall Study|Miscellaneous|0|||
48728449|NCT02495233|156855551|FG001|Overall Study|Miscellaneous|1|||
48728450|NCT03953183|156855554|FG000|Overall Study|Physician Decision|0|||
48728451|NCT03953183|156855555|FG001|Overall Study|Physician Decision|1|||
48728452|NCT03953183|156855554|FG000|Overall Study|Withdrawal by Subject|0|||
48728453|NCT03953183|156855555|FG001|Overall Study|Withdrawal by Subject|1|||
48728454|NCT00107952|156855559|FG000|Overall Study|Death|75|||
48728455|NCT00107952|156855560|FG001|Overall Study|Death|61|||
48728456|NCT00107952|156855559|FG000|Overall Study|Lost to Follow-up|0|||
48728457|NCT00107952|156855560|FG001|Overall Study|Lost to Follow-up|3|||
48728458|NCT00107952|156855559|FG000|Overall Study|Withdrawal by Subject|9|||
48728459|NCT00107952|156855560|FG001|Overall Study|Withdrawal by Subject|6|||
48728460|NCT00107952|156855559|FG000|Overall Study|Other|2|||
48728461|NCT00107952|156855560|FG001|Overall Study|Other|5|||
48728462|NCT00107952|156855559|FG000|Overall Study|Never received study treatment|9|||
48728463|NCT00107952|156855560|FG001|Overall Study|Never received study treatment|6|||
48821714|NCT01515319|157188763|FG002|Overall Study|Withdrawal by Subject|0|||
48821715|NCT01515319|157188764|FG003|Overall Study|Withdrawal by Subject|0|||
48821716|NCT01515319|157188765|FG004|Overall Study|Withdrawal by Subject|0|||
48821717|NCT01515319|157188766|FG005|Overall Study|Withdrawal by Subject|0|||
48821718|NCT01515319|157188767|FG006|Overall Study|Withdrawal by Subject|1|||
48821719|NCT01515319|157188768|FG007|Overall Study|Withdrawal by Subject|0|||
48821720|NCT01515319|157188769|FG008|Overall Study|Withdrawal by Subject|0|||
48821721|NCT01515319|157188770|FG009|Overall Study|Withdrawal by Subject|0|||
48821722|NCT01515319|157188761|FG000|Overall Study|Adverse Event|0|||
48821723|NCT01515319|157188762|FG001|Overall Study|Adverse Event|0|||
48821724|NCT01515319|157188763|FG002|Overall Study|Adverse Event|0|||
48821725|NCT01515319|157188764|FG003|Overall Study|Adverse Event|0|||
48821726|NCT01515319|157188765|FG004|Overall Study|Adverse Event|0|||
48821727|NCT01515319|157188766|FG005|Overall Study|Adverse Event|0|||
48821728|NCT01515319|157188767|FG006|Overall Study|Adverse Event|0|||
48821729|NCT01515319|157188768|FG007|Overall Study|Adverse Event|0|||
48821730|NCT01515319|157188769|FG008|Overall Study|Adverse Event|3|||
48821731|NCT01515319|157188770|FG009|Overall Study|Adverse Event|0|||
48821732|NCT01515319|157188761|FG000|Overall Study|Protocol Violation|0|||
48821733|NCT01515319|157188762|FG001|Overall Study|Protocol Violation|0|||
48821734|NCT01515319|157188763|FG002|Overall Study|Protocol Violation|0|||
48821735|NCT01515319|157188764|FG003|Overall Study|Protocol Violation|0|||
48821736|NCT01515319|157188765|FG004|Overall Study|Protocol Violation|0|||
48728464|NCT02280473|156855566|FG000|Overall Study|Adverse Event|1|||
48728465|NCT02280473|156855567|FG001|Overall Study|Adverse Event|1|||
48728466|NCT02280473|156855566|FG000|Overall Study|Lack of Efficacy|0|||
48728467|NCT02280473|156855567|FG001|Overall Study|Lack of Efficacy|1|||
48728468|NCT02280473|156855566|FG000|Overall Study|Lost to Follow-up|0|||
48728469|NCT02280473|156855567|FG001|Overall Study|Lost to Follow-up|1|||
48728470|NCT04706416|156855570|FG000|Overall Study|Lost to Follow-up|2|||
48728471|NCT04706416|156855571|FG001|Overall Study|Lost to Follow-up|0|||
48728472|NCT00995865|156855575|FG000|Overall Study|Protocol Violation|2|||
48728473|NCT00995865|156855576|FG001|Overall Study|Protocol Violation|0|||
48728474|NCT00995865|156855577|FG002|Overall Study|Protocol Violation|0|||
48728475|NCT00995865|156855575|FG000|Overall Study|Lost to Follow-up|0|||
48728476|NCT00995865|156855576|FG001|Overall Study|Lost to Follow-up|0|||
48728477|NCT00995865|156855577|FG002|Overall Study|Lost to Follow-up|1|||
48728478|NCT03131453|156855591|FG000|Overall Study|Study terminated by Sponsor|424|||
48728479|NCT03131453|156855592|FG001|Overall Study|Study terminated by Sponsor|222|||
48728480|NCT03131453|156855593|FG002|Overall Study|Study terminated by Sponsor|438|||
48728481|NCT03131453|156855591|FG000|Overall Study|Withdrawal by Subject|18|||
48728482|NCT03131453|156855592|FG001|Overall Study|Withdrawal by Subject|7|||
48728483|NCT03131453|156855593|FG002|Overall Study|Withdrawal by Subject|13|||
48728484|NCT03131453|156855591|FG000|Overall Study|Adverse Event|10|||
48728485|NCT03131453|156855592|FG001|Overall Study|Adverse Event|3|||
48728486|NCT03131453|156855593|FG002|Overall Study|Adverse Event|3|||
48728487|NCT03131453|156855591|FG000|Overall Study|Lost to Follow-up|1|||
48728488|NCT03131453|156855592|FG001|Overall Study|Lost to Follow-up|0|||
48728489|NCT03131453|156855593|FG002|Overall Study|Lost to Follow-up|1|||
48728490|NCT03131453|156855591|FG000|Overall Study|Physician Decision|1|||
48728491|NCT03131453|156855592|FG001|Overall Study|Physician Decision|0|||
48728492|NCT03131453|156855593|FG002|Overall Study|Physician Decision|1|||
48728493|NCT03131453|156855591|FG000|Overall Study|Non-compliance with study treatment|1|||
48728494|NCT03131453|156855592|FG001|Overall Study|Non-compliance with study treatment|0|||
48821737|NCT01515319|157188766|FG005|Overall Study|Protocol Violation|0|||
48821738|NCT01515319|157188767|FG006|Overall Study|Protocol Violation|0|||
48821739|NCT01515319|157188768|FG007|Overall Study|Protocol Violation|0|||
48821740|NCT01515319|157188769|FG008|Overall Study|Protocol Violation|2|||
48821741|NCT01515319|157188770|FG009|Overall Study|Protocol Violation|0|||
48821742|NCT04174560|157188772|FG000|Overall Study|Lost to Follow-up|1|||
48821743|NCT04174560|157188773|FG001|Overall Study|Lost to Follow-up|0|||
48821744|NCT04174560|157188774|FG002|Overall Study|Lost to Follow-up|0|||
48821745|NCT04174560|157188775|FG003|Overall Study|Lost to Follow-up|0|||
48821746|NCT04174560|157188772|FG000|Overall Study|Withdrawal by Subject|0|||
48821747|NCT04174560|157188773|FG001|Overall Study|Withdrawal by Subject|0|||
48821748|NCT04174560|157188774|FG002|Overall Study|Withdrawal by Subject|2|||
48821749|NCT04174560|157188775|FG003|Overall Study|Withdrawal by Subject|0|||
48821750|NCT04834362|157190438|FG000|Overall Study|Death|1|||
48821751|NCT04834362|157190439|FG001|Overall Study|Death|2|||
48821752|NCT04922021|157190442|FG000|Overall Study|Withdrawal by Subject|4|||
48821753|NCT04922021|157190443|FG001|Overall Study|Withdrawal by Subject|10|||
48728495|NCT03131453|156855593|FG002|Overall Study|Non-compliance with study treatment|0|||
48728496|NCT03131453|156855591|FG000|Overall Study|Technical problems|1|||
48728497|NCT03131453|156855592|FG001|Overall Study|Technical problems|0|||
48728498|NCT03131453|156855593|FG002|Overall Study|Technical problems|0|||
48821754|NCT04922021|157190442|FG000|Overall Study|Adverse Event|2|||
48821755|NCT04922021|157190443|FG001|Overall Study|Adverse Event|2|||
48821756|NCT04922021|157190442|FG000|Overall Study|Lack of Efficacy|0|||
48821757|NCT04922021|157190443|FG001|Overall Study|Lack of Efficacy|1|||
48511059|NCT00272779|156063902|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
48511060|NCT00272779|156063901|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
48511061|NCT00272779|156063902|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
48511062|NCT00272779|156063901|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
48511063|NCT00272779|156063902|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
48511064|NCT00272779|156063901|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
48511065|NCT00272779|156063902|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
48511066|NCT00272779|156063901|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
48511067|NCT00272779|156063902|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
48511068|NCT00272779|156063901|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
48511069|NCT00272779|156063902|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
48511070|NCT00272779|156063901|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
48511071|NCT00272779|156063902|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
48511072|NCT00272779|156063901|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
48511073|NCT00272779|156063902|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
48511074|NCT00272779|156063901|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
48511075|NCT00272779|156063902|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
48511076|NCT00272779|156063901|FG000|Baseline Through Week 48|Continuing treatment|385|||
48511077|NCT00272779|156063902|FG001|Baseline Through Week 48|Continuing treatment|368|||
48511078|NCT00272779|156063901|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
48511079|NCT00272779|156063902|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
48511080|NCT00272779|156063901|FG000|Baseline Through Week 48|Never treated|2|||
48511081|NCT00272779|156063902|FG001|Baseline Through Week 48|Never treated|3|||
48511082|NCT00272779|156063901|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
48511083|NCT00272779|156063902|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
48511084|NCT00272779|156063901|FG000|Baseline Through Week 96|Death before Week 96|6|||
48511085|NCT00272779|156063902|FG001|Baseline Through Week 96|Death before Week 96|5|||
48511086|NCT00272779|156063901|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
48511087|NCT00272779|156063902|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
48511088|NCT00272779|156063901|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
48511089|NCT00272779|156063902|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
48511090|NCT00272779|156063901|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
48511091|NCT00272779|156063902|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
48511092|NCT00272779|156063901|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
48511093|NCT00272779|156063902|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
48511094|NCT00272779|156063901|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
48511095|NCT00272779|156063902|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
48511096|NCT00272779|156063901|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
48511097|NCT00272779|156063902|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
48511098|NCT00272779|156063901|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
48511099|NCT00272779|156063902|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
48511100|NCT00272779|156063901|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
48511101|NCT00272779|156063902|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
48511102|NCT00272779|156063901|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
48511103|NCT00272779|156063902|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
48511104|NCT00272779|156063901|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
48511105|NCT00272779|156063902|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
48511106|NCT00272779|156063901|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
48511107|NCT00272779|156063902|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
48511108|NCT00272779|156063901|FG000|Baseline Through Week 96|Never treated|2|||
48511109|NCT00272779|156063902|FG001|Baseline Through Week 96|Never treated|3|||
48511110|NCT00272779|156063901|FG000|Baseline Through Week 96|Continuing on treatment|61|||
48511111|NCT00272779|156063902|FG001|Baseline Through Week 96|Continuing on treatment|38|||
48511112|NCT00561015|156063903|FG000|Overall Study|Adverse Event|0|||
48511113|NCT00561015|156063904|FG001|Overall Study|Adverse Event|0|||
48511114|NCT00561015|156063905|FG002|Overall Study|Adverse Event|0|||
48511115|NCT00561015|156063906|FG003|Overall Study|Adverse Event|0|||
48511116|NCT00561015|156063907|FG004|Overall Study|Adverse Event|1|||
48511117|NCT00561015|156063908|FG005|Overall Study|Adverse Event|0|||
48511118|NCT00561015|156063903|FG000|Overall Study|Lost to Follow-up|2|||
48511119|NCT00561015|156063904|FG001|Overall Study|Lost to Follow-up|0|||
48511120|NCT00561015|156063905|FG002|Overall Study|Lost to Follow-up|0|||
48511121|NCT00561015|156063906|FG003|Overall Study|Lost to Follow-up|1|||
48511122|NCT00561015|156063907|FG004|Overall Study|Lost to Follow-up|0|||
48511123|NCT00561015|156063908|FG005|Overall Study|Lost to Follow-up|3|||
48511124|NCT00561015|156063903|FG000|Overall Study|Participant non-compliance|2|||
48511125|NCT00561015|156063904|FG001|Overall Study|Participant non-compliance|0|||
48511126|NCT00561015|156063905|FG002|Overall Study|Participant non-compliance|0|||
48511127|NCT00561015|156063906|FG003|Overall Study|Participant non-compliance|0|||
48511128|NCT00561015|156063907|FG004|Overall Study|Participant non-compliance|0|||
48511129|NCT00561015|156063908|FG005|Overall Study|Participant non-compliance|0|||
48511130|NCT00096447|156063911|FG000|Overall Study|Never treated|1|||
48511131|NCT03733730|156063914|FG000|Overall Study|Lost to Follow-up|1|||
48511132|NCT03733730|156063915|FG001|Overall Study|Lost to Follow-up|32|||
48511133|NCT03733730|156063914|FG000|Overall Study|Other|1|||
48821758|NCT04922021|157190442|FG000|Overall Study|Multiple reasons|1|||
48821759|NCT04922021|157190443|FG001|Overall Study|Multiple reasons|0|||
48821760|NCT01327547|157190444|FG000|Overall Study|Adverse Event|4|||
48821761|NCT01327547|157190445|FG001|Overall Study|Adverse Event|1|||
48821762|NCT01327547|157190444|FG000|Overall Study|Death|1|||
48821763|NCT01327547|157190445|FG001|Overall Study|Death|2|||
48821764|NCT01327547|157190444|FG000|Overall Study|Lost to Follow-up|6|||
48821765|NCT01327547|157190445|FG001|Overall Study|Lost to Follow-up|6|||
48821766|NCT01327547|157190444|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
48821767|NCT01327547|157190445|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
48821768|NCT01327547|157190444|FG000|Overall Study|Withdrawal by Subject|3|||
48821769|NCT01327547|157190445|FG001|Overall Study|Withdrawal by Subject|7|||
48821770|NCT01327547|157190444|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
48821771|NCT01327547|157190445|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
48821772|NCT01327547|157190444|FG000|Overall Study|Protocol Violation|1|||
48821773|NCT01327547|157190445|FG001|Overall Study|Protocol Violation|0|||
48511134|NCT03733730|156063915|FG001|Overall Study|Other|0|||
48511135|NCT03733730|156063914|FG000|Overall Study|Adverse Event|0|||
48511136|NCT03733730|156063915|FG001|Overall Study|Adverse Event|4|||
48511137|NCT03733730|156063914|FG000|Overall Study|Death|0|||
48511138|NCT03733730|156063915|FG001|Overall Study|Death|5|||
48511139|NCT03733730|156063914|FG000|Overall Study|Withdrawal by Subject|0|||
48511140|NCT03733730|156063915|FG001|Overall Study|Withdrawal by Subject|8|||
48511141|NCT00163657|156063916|FG000|Overall Study|Death|12|||
48511142|NCT00163657|156063917|FG001|Overall Study|Death|14|||
48511143|NCT00163657|156063918|FG002|Overall Study|Death|19|||
48511144|NCT00163657|156063916|FG000|Overall Study|graft loss|4|||
48511145|NCT00163657|156063917|FG001|Overall Study|graft loss|1|||
48511146|NCT00163657|156063918|FG002|Overall Study|graft loss|2|||
48511147|NCT00163657|156063916|FG000|Overall Study|Withdrawal by Subject|2|||
48511148|NCT00163657|156063917|FG001|Overall Study|Withdrawal by Subject|3|||
48511149|NCT00163657|156063918|FG002|Overall Study|Withdrawal by Subject|2|||
48511150|NCT00163657|156063916|FG000|Overall Study|Physician Decision|0|||
48511151|NCT00163657|156063917|FG001|Overall Study|Physician Decision|1|||
48511152|NCT00163657|156063918|FG002|Overall Study|Physician Decision|1|||
48511153|NCT00163657|156063916|FG000|Overall Study|Non Compliance|1|||
48511154|NCT00163657|156063917|FG001|Overall Study|Non Compliance|0|||
48511155|NCT00163657|156063918|FG002|Overall Study|Non Compliance|0|||
48511156|NCT00163657|156063916|FG000|Overall Study|Lost to Follow-up|1|||
48511157|NCT00163657|156063917|FG001|Overall Study|Lost to Follow-up|3|||
48511158|NCT00163657|156063918|FG002|Overall Study|Lost to Follow-up|10|||
48821774|NCT01327547|157190444|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
48821775|NCT01327547|157190445|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
48821776|NCT01327547|157190444|FG000|Overall Study|Required prohibited medication|2|||
48821777|NCT01327547|157190445|FG001|Overall Study|Required prohibited medication|0|||
48821778|NCT01327547|157190444|FG000|Overall Study|Non-compliance with study procedures|1|||
48821779|NCT01327547|157190445|FG001|Overall Study|Non-compliance with study procedures|0|||
48511159|NCT00163657|156063916|FG000|Overall Study|Other reason|0|||
48511160|NCT00163657|156063917|FG001|Overall Study|Other reason|1|||
48511161|NCT00163657|156063918|FG002|Overall Study|Other reason|3|||
48511162|NCT03450057|156063919|FG000|Overall Study|Death|17|||
48511163|NCT03450057|156063919|FG000|Overall Study|ICF withdrawal|4|||
48511164|NCT03450057|156063919|FG000|Overall Study|Lost to Follow-up|2|||
48821780|NCT01327547|157190444|FG000|Overall Study|By investigator in subject's interest|0|||
48821781|NCT01327547|157190445|FG001|Overall Study|By investigator in subject's interest|1|||
48511165|NCT02146105|156063920|FG000|Overall Study|Adverse Event|1|||
48511166|NCT02146105|156063920|FG000|Overall Study|Withdrawal by Subject|5|||
48821782|NCT02462083|157190446|FG000|Overall Study|Sponsor request|39|||
48821783|NCT02462083|157190446|FG000|Overall Study|Withdrawal by Subject|87|||
48821784|NCT02462083|157190446|FG000|Overall Study|Lost to Follow-up|41|||
48821785|NCT02462083|157190446|FG000|Overall Study|Lack of Efficacy|151|||
48511167|NCT05755282|156063921|FG000|Overall Study|Protocol Violation|0|||
48511168|NCT05755282|156063922|FG001|Overall Study|Protocol Violation|1|||
48511169|NCT00573066|156063923|FG000|Overall Study|Exclusion criteria|18|||
48511170|NCT00573066|156063923|FG000|Overall Study|IV malfunction|1|||
48511171|NCT00573066|156063923|FG000|Overall Study|Postoperative bleeding|1|||
48511172|NCT01034358|156063925|FG000|Overall Study|Withdrawal by Subject|1|||
48511173|NCT01034358|156063925|FG000|Overall Study|Protocol Violation|1|||
48511174|NCT00933686|156063926|FG000|Overall Study|Protocol Violation|0|||
48511175|NCT00933686|156063927|FG001|Overall Study|Protocol Violation|1|||
48821786|NCT02462083|157190446|FG000|Overall Study|Pregnancy|1|||
48821787|NCT02462083|157190446|FG000|Overall Study|Protocol Violation|6|||
48511176|NCT00933686|156063926|FG000|Overall Study|Lost to Follow-up|2|||
48511177|NCT00933686|156063927|FG001|Overall Study|Lost to Follow-up|2|||
48511178|NCT00933686|156063926|FG000|Overall Study|Withdrawal by Subject|6|||
48511179|NCT00933686|156063927|FG001|Overall Study|Withdrawal by Subject|5|||
48511180|NCT00933686|156063926|FG000|Overall Study|Adverse Event|1|||
48511181|NCT00933686|156063927|FG001|Overall Study|Adverse Event|1|||
48511182|NCT00933686|156063926|FG000|Overall Study|Physician Decision|1|||
48511183|NCT00933686|156063927|FG001|Overall Study|Physician Decision|0|||
48511184|NCT00933686|156063926|FG000|Overall Study|Failure to show up at endpoint visits|0|||
48511185|NCT00933686|156063927|FG001|Overall Study|Failure to show up at endpoint visits|2|||
48511186|NCT01383486|156063928|FG000|Overall Study|Lost to Follow-up|10|||
48511187|NCT01383486|156063928|FG000|Overall Study|Incomplete information for analysis|2|||
48511188|NCT01383486|156063928|FG000|Overall Study|Did not take any product|6|||
48511189|NCT00245063|156063929|FG000|Overall Study|Adverse Event|6|||
48511190|NCT00245063|156063930|FG001|Overall Study|Adverse Event|5|||
48728499|NCT03131453|156855591|FG000|Overall Study|Protocol deviation|0|||
48511191|NCT00245063|156063929|FG000|Overall Study|Death|1|||
48511192|NCT00245063|156063930|FG001|Overall Study|Death|0|||
48511193|NCT00123734|156063938|FG000|Overall Study|Death|3|||
48511194|NCT00123734|156063938|FG000|Overall Study|Lost to Follow-up|3|||
48511195|NCT00123734|156063938|FG000|Overall Study|Dropout|1|||
48511196|NCT00123734|156063938|FG000|Overall Study|Withdrawal by Subject|1|||
48511197|NCT00113386|156063939|FG000|Overall Study|Withdrawal by Subject|1|||
48511198|NCT00113386|156063940|FG001|Overall Study|Withdrawal by Subject|0|||
48511199|NCT00113386|156063939|FG000|Overall Study|Physician Decision|0|||
48511200|NCT00113386|156063940|FG001|Overall Study|Physician Decision|1|||
48511201|NCT00113386|156063939|FG000|Overall Study|Toxicity|3|||
48511202|NCT00113386|156063940|FG001|Overall Study|Toxicity|0|||
48511203|NCT00113386|156063939|FG000|Overall Study|Ineligible|1|||
48511204|NCT00113386|156063940|FG001|Overall Study|Ineligible|2|||
48511205|NCT00113386|156063939|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
48511206|NCT00113386|156063940|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
48511207|NCT01839279|156063941|FG000|Overall Study|Adverse Event|4|||
48511208|NCT01839279|156063942|FG001|Overall Study|Adverse Event|1|||
48511209|NCT01839279|156063943|FG002|Overall Study|Adverse Event|1|||
48511210|NCT01839279|156063941|FG000|Overall Study|Withdrawal by Subject|4|||
48511211|NCT01839279|156063942|FG001|Overall Study|Withdrawal by Subject|1|||
48511212|NCT01839279|156063943|FG002|Overall Study|Withdrawal by Subject|1|||
48511213|NCT01839279|156063941|FG000|Overall Study|Classified as 'Other'|5|||
48511214|NCT01839279|156063942|FG001|Overall Study|Classified as 'Other'|0|||
48511215|NCT01839279|156063943|FG002|Overall Study|Classified as 'Other'|0|||
48511216|NCT02321098|156063944|FG000|12 Weeks Treament|Lost to Follow-up|1|||
48511217|NCT02321098|156063945|FG001|12 Weeks Treament|Lost to Follow-up|1|||
48511218|NCT02321098|156063946|FG002|12 Weeks Treament|Lost to Follow-up|0|||
48511219|NCT02321098|156063944|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
48511220|NCT02321098|156063945|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
48511221|NCT02321098|156063946|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
48511222|NCT02321098|156063944|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
48511223|NCT02321098|156063945|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
48511224|NCT02321098|156063946|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
48511225|NCT02321098|156063944|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
48511226|NCT02321098|156063945|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
48511227|NCT02321098|156063946|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
48511228|NCT00448591|156063949|FG000|Overall Study|Withdrawal by Subject|178|||
48728500|NCT03131453|156855592|FG001|Overall Study|Protocol deviation|1|||
48728501|NCT03131453|156855593|FG002|Overall Study|Protocol deviation|0|||
48511229|NCT00448591|156063949|FG000|Overall Study|Progressive Disease|1382|||
48511230|NCT00448591|156063949|FG000|Overall Study|Adverse Event|382|||
48511231|NCT00448591|156063949|FG000|Overall Study|Protocol Violation|41|||
48511232|NCT00448591|156063949|FG000|Overall Study|Lost to Follow-up|19|||
48728502|NCT00908011|156855594|FG000|Overall Study|Withdrawal by Subject|2|||
48728503|NCT00908011|156855595|FG001|Overall Study|Withdrawal by Subject|2|||
48728504|NCT02567552|156855598|FG000|Overall Study|Adverse Event|0|||
48728505|NCT02567552|156855599|FG001|Overall Study|Adverse Event|1|||
48728506|NCT00055471|156855600|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
48728507|NCT00055471|156855601|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
48728508|NCT00055471|156855602|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
48728509|NCT00055471|156855600|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
48728510|NCT00055471|156855601|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
48728511|NCT00055471|156855602|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
48728512|NCT00055471|156855600|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
48728513|NCT00055471|156855601|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
48728514|NCT00055471|156855602|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
48728515|NCT02301988|156855603|FG000|Overall Study|Withdrawal by Subject|2|||
48511233|NCT00448591|156063949|FG000|Overall Study|Treatment Regimen Completed|70|||
48511234|NCT00448591|156063949|FG000|Overall Study|Other|154|||
48511235|NCT00448591|156063949|FG000|Overall Study|Termination of Study|70|||
48511236|NCT00640562|156063950|FG000|Overall Study|Adverse Event|8|||
48511237|NCT00640562|156063951|FG001|Overall Study|Adverse Event|5|||
48511238|NCT00640562|156063950|FG000|Overall Study|Lack of Efficacy|1|||
48511239|NCT00640562|156063951|FG001|Overall Study|Lack of Efficacy|4|||
48511240|NCT00640562|156063950|FG000|Overall Study|Protocol Violation|2|||
48511241|NCT00640562|156063951|FG001|Overall Study|Protocol Violation|4|||
48511242|NCT00640562|156063950|FG000|Overall Study|Withdrawal by Subject|6|||
48511243|NCT00640562|156063951|FG001|Overall Study|Withdrawal by Subject|10|||
48511244|NCT00640562|156063950|FG000|Overall Study|Known risperidone intolerance|0|||
48511245|NCT00640562|156063951|FG001|Overall Study|Known risperidone intolerance|1|||
48511246|NCT00640562|156063950|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
48511247|NCT00640562|156063951|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
48511248|NCT00640562|156063950|FG000|Overall Study|Low study drug dose|0|||
48511249|NCT00640562|156063951|FG001|Overall Study|Low study drug dose|1|||
48511250|NCT00640562|156063950|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
48511251|NCT00640562|156063951|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
48511252|NCT03276754|156063955|FG000|Overall Study|Withdrawal of informed consent|4|||
48511253|NCT03276754|156063955|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
48511254|NCT03276754|156063955|FG000|Overall Study|Lost to Follow-up|27|||
48511255|NCT03276754|156063955|FG000|Overall Study|No data reported at Month 24|31|||
48511256|NCT03276754|156063955|FG000|Overall Study|Death|39|||
48511257|NCT03098394|156063956|FG000|Overall Study|Pregnancy|0|||
48511258|NCT03098394|156063957|FG001|Overall Study|Pregnancy|1|||
48511259|NCT01188681|156063962|FG000|Overall Study|bladder cancer|0|||
48511260|NCT01188681|156063963|FG001|Overall Study|bladder cancer|0|||
48511261|NCT01188681|156063964|FG002|Overall Study|bladder cancer|1|||
48511262|NCT01188681|156063965|FG003|Overall Study|bladder cancer|0|||
48511263|NCT01188681|156063962|FG000|Overall Study|Withdrawal by Subject|0|||
48511264|NCT01188681|156063963|FG001|Overall Study|Withdrawal by Subject|0|||
48511265|NCT01188681|156063964|FG002|Overall Study|Withdrawal by Subject|0|||
48511266|NCT01188681|156063965|FG003|Overall Study|Withdrawal by Subject|1|||
48511267|NCT02890992|156063966|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
48511268|NCT02890992|156063967|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
48511269|NCT02890992|156063968|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
48511270|NCT02890992|156063969|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
48511271|NCT02890992|156063970|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
48511272|NCT02890992|156063971|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
48511273|NCT02890992|156063972|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
48511274|NCT02890992|156063973|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
48511275|NCT02890992|156063966|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
48511276|NCT02890992|156063967|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
48511277|NCT02890992|156063968|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
48511278|NCT02890992|156063969|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
48511279|NCT02890992|156063970|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
48511280|NCT02890992|156063971|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
48728516|NCT02301988|156855604|FG001|Overall Study|Withdrawal by Subject|1|||
48728517|NCT02301988|156855603|FG000|Overall Study|Physician Decision|2|||
48728518|NCT02301988|156855604|FG001|Overall Study|Physician Decision|2|||
48728519|NCT02301988|156855603|FG000|Overall Study|Unknown Reason|1|||
48728520|NCT02301988|156855604|FG001|Overall Study|Unknown Reason|3|||
48728521|NCT02301988|156855603|FG000|Overall Study|Lack of Efficacy|3|||
48728522|NCT02301988|156855604|FG001|Overall Study|Lack of Efficacy|2|||
48728523|NCT02301988|156855603|FG000|Overall Study|Death|1|||
48728524|NCT02301988|156855604|FG001|Overall Study|Death|0|||
48728525|NCT02301988|156855603|FG000|Overall Study|Adverse Event|1|||
48728526|NCT02301988|156855604|FG001|Overall Study|Adverse Event|1|||
48728527|NCT06010836|156855605|FG000|Overall Study|Lost to Follow-up|2|||
48728528|NCT06010836|156855606|FG001|Overall Study|Lost to Follow-up|2|||
48728529|NCT06010836|156855605|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
48728530|NCT06010836|156855606|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
48728531|NCT06010836|156855605|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
48728532|NCT06010836|156855606|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
48728533|NCT06010836|156855605|FG000|Overall Study|Did not receive intervention discussion|0|||
48728534|NCT06010836|156855606|FG001|Overall Study|Did not receive intervention discussion|4|||
48728535|NCT01898494|156857102|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
48728536|NCT01898494|156857103|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
48728537|NCT01898494|156857104|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
48728538|NCT01898494|156857105|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
48728539|NCT01898494|156857106|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
48728540|NCT01898494|156857102|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
48511281|NCT02890992|156063972|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
48511282|NCT02890992|156063973|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
48511283|NCT02890992|156063966|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
48511284|NCT02890992|156063967|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
48511285|NCT02890992|156063968|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
48511286|NCT02890992|156063969|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
48511287|NCT02890992|156063970|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
48511288|NCT02890992|156063971|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
48511289|NCT02890992|156063972|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
48511290|NCT02890992|156063973|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
48511291|NCT02622386|156063974|FG000|First Assignment|Withdrawal by Subject|3|||
48511292|NCT02622386|156063975|FG001|First Assignment|Withdrawal by Subject|2|||
48511293|NCT02622386|156063974|FG000|Washout|Withdrawal by Subject|4|||
48511294|NCT02622386|156063975|FG001|Washout|Withdrawal by Subject|4|||
48821788|NCT02462083|157190446|FG000|Overall Study|Adverse Event|33|||
48821789|NCT02462083|157190446|FG000|Overall Study|Worsening condition|16|||
48821790|NCT02462083|157190446|FG000|Overall Study|Other than specified|45|||
48821791|NCT02711995|157190447|FG000|Washout (90 Days)|Conflicting medication|1|||
48821792|NCT00322868|157190448|FG000|Overall Study|disease progression|1|||
48821793|NCT01852162|157190449|FG000|Overall Study|Adverse Event|1|||
48821794|NCT01852162|157190450|FG001|Overall Study|Adverse Event|0|||
48728541|NCT01898494|156857103|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
48821795|NCT01852162|157190449|FG000|Overall Study|Withdrawal by Subject|3|||
48511295|NCT02622386|156063974|FG000|Second Assignment|Withdrawal by Subject|0|||
48511296|NCT02622386|156063975|FG001|Second Assignment|Withdrawal by Subject|2|||
48511297|NCT03503318|156063987|FG000|Overall Study|Death|1|||
48511298|NCT03503318|156063988|FG001|Overall Study|Death|0|||
48511299|NCT03503318|156063989|FG002|Overall Study|Death|4|||
48511300|NCT03503318|156063987|FG000|Overall Study|Adverse Event|3|||
48511301|NCT03503318|156063988|FG001|Overall Study|Adverse Event|4|||
48511302|NCT03503318|156063989|FG002|Overall Study|Adverse Event|2|||
48511303|NCT03503318|156063987|FG000|Overall Study|Withdrawal by Subject|12|||
48511304|NCT03503318|156063988|FG001|Overall Study|Withdrawal by Subject|17|||
48511305|NCT03503318|156063989|FG002|Overall Study|Withdrawal by Subject|16|||
48511306|NCT03503318|156063987|FG000|Overall Study|Protocol Violation|5|||
48511307|NCT03503318|156063988|FG001|Overall Study|Protocol Violation|0|||
48511308|NCT03503318|156063989|FG002|Overall Study|Protocol Violation|3|||
48511309|NCT03503318|156063987|FG000|Overall Study|Lost to Follow-up|17|||
48511310|NCT03503318|156063988|FG001|Overall Study|Lost to Follow-up|15|||
48511311|NCT03503318|156063989|FG002|Overall Study|Lost to Follow-up|12|||
48511312|NCT03503318|156063987|FG000|Overall Study|Other than specified|1|||
48511313|NCT03503318|156063988|FG001|Overall Study|Other than specified|3|||
48511314|NCT03503318|156063989|FG002|Overall Study|Other than specified|3|||
48511315|NCT01794845|156063990|FG000|Overall Study|Withdrawal by Subject|1|||
48511316|NCT00942968|156065675|FG000|Overall Study|Adverse Event|60|||
48511317|NCT00942968|156065675|FG000|Overall Study|Death|76|||
48511318|NCT00942968|156065675|FG000|Overall Study|Protocol Violation|9|||
48728542|NCT01898494|156857104|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
48728543|NCT01898494|156857105|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
48728544|NCT01898494|156857106|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
48728545|NCT01898494|156857102|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
48728546|NCT01898494|156857103|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
48728547|NCT01898494|156857104|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
48728548|NCT01898494|156857105|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
48728549|NCT01898494|156857106|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
48728550|NCT01898494|156857102|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
48728551|NCT01898494|156857103|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
48728552|NCT01898494|156857104|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
48728553|NCT01898494|156857105|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
48728554|NCT01898494|156857106|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
48728555|NCT01898494|156857102|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
48728556|NCT01898494|156857103|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
48728557|NCT01898494|156857104|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
48728558|NCT01898494|156857105|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
48821796|NCT01852162|157190450|FG001|Overall Study|Withdrawal by Subject|1|||
48821797|NCT04212169|157190451|FG000|Overall Study|Adverse Event|0|||
48821798|NCT04212169|157190452|FG001|Overall Study|Adverse Event|0|||
48821799|NCT04212169|157190453|FG002|Overall Study|Adverse Event|0|||
48511319|NCT00942968|156065675|FG000|Overall Study|Lost to Follow-up|4|||
48511320|NCT00942968|156065675|FG000|Overall Study|Withdrawal by Subject|44|||
48511321|NCT00942968|156065675|FG000|Overall Study|Sponsor request|5|||
48511322|NCT00942968|156065675|FG000|Overall Study|Physician Decision|11|||
48511323|NCT00942968|156065675|FG000|Overall Study|Progression of disease|12|||
48821800|NCT04212169|157190454|FG003|Overall Study|Adverse Event|2|||
48821801|NCT04212169|157190451|FG000|Overall Study|Lost to Follow-up|1|||
48728559|NCT01898494|156857106|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
48728560|NCT01898494|156857102|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
48728561|NCT01898494|156857103|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
48728562|NCT01898494|156857104|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
48728563|NCT01898494|156857105|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
48728564|NCT01898494|156857106|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
48728565|NCT01898494|156857102|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
48728566|NCT01898494|156857103|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
48728567|NCT01898494|156857104|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
48728568|NCT01898494|156857105|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
48728569|NCT01898494|156857106|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
48728570|NCT01898494|156857102|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
48821802|NCT04212169|157190452|FG001|Overall Study|Lost to Follow-up|0|||
48821803|NCT04212169|157190453|FG002|Overall Study|Lost to Follow-up|0|||
48511324|NCT00942968|156065675|FG000|Overall Study|Inferior vena cava filter placement|4|||
48511325|NCT00942968|156065675|FG000|Overall Study|Pulmonary embolism (PE)|1|||
48511326|NCT00942968|156065675|FG000|Overall Study|Participant required pancreatic biopsy|1|||
48821804|NCT04212169|157190454|FG003|Overall Study|Lost to Follow-up|2|||
48511327|NCT00942968|156065675|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
48511328|NCT01948258|156065678|FG000|Overall Study|Pregnancy|41|||
48511329|NCT01948258|156065678|FG000|Overall Study|Did not complete by cut-off date|35|||
48511330|NCT01948258|156065678|FG000|Overall Study|Lost to Follow-up|27|||
48511331|NCT01948258|156065678|FG000|Overall Study|Withdrawal by SPD|8|||
48511332|NCT01948258|156065678|FG000|Overall Study|Withdrawal by Subject|6|||
48511333|NCT01948258|156065678|FG000|Overall Study|Health Care Professional|43|||
48511334|NCT01948258|156065678|FG000|Overall Study|Removed from statistical analysis|2|||
48511335|NCT00834795|156065680|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
48511336|NCT00834795|156065681|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
48511337|NCT00834795|156065680|FG000|Second Intervention|Adverse Event|1|||
48511338|NCT00834795|156065681|FG001|Second Intervention|Adverse Event|0|||
48511339|NCT03818581|156065682|FG000|Overall Study|Adverse Event|1|||
48511340|NCT03818581|156065683|FG001|Overall Study|Adverse Event|0|||
48511341|NCT03818581|156065684|FG002|Overall Study|Adverse Event|0|||
48511342|NCT03818581|156065685|FG003|Overall Study|Adverse Event|0|||
48511343|NCT03818581|156065686|FG004|Overall Study|Adverse Event|0|||
48511344|NCT03818581|156065682|FG000|Overall Study|Covid-19|2|||
48511345|NCT03818581|156065683|FG001|Overall Study|Covid-19|0|||
48511346|NCT03818581|156065684|FG002|Overall Study|Covid-19|0|||
48511347|NCT03818581|156065685|FG003|Overall Study|Covid-19|0|||
48511348|NCT03818581|156065686|FG004|Overall Study|Covid-19|1|||
48511349|NCT03818581|156065682|FG000|Overall Study|Withdrawal by Subject|0|||
48511350|NCT03818581|156065683|FG001|Overall Study|Withdrawal by Subject|0|||
48511351|NCT03818581|156065684|FG002|Overall Study|Withdrawal by Subject|0|||
48511352|NCT03818581|156065685|FG003|Overall Study|Withdrawal by Subject|0|||
48511353|NCT03818581|156065686|FG004|Overall Study|Withdrawal by Subject|1|||
48511354|NCT03818581|156065682|FG000|Overall Study|No longer met study criteria|0|||
48511355|NCT03818581|156065683|FG001|Overall Study|No longer met study criteria|0|||
48511356|NCT03818581|156065684|FG002|Overall Study|No longer met study criteria|0|||
48511357|NCT03818581|156065685|FG003|Overall Study|No longer met study criteria|0|||
48511358|NCT03818581|156065686|FG004|Overall Study|No longer met study criteria|1|||
48511359|NCT00218257|156065690|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
48511360|NCT00218257|156065691|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
48511361|NCT00579345|156065694|FG000|Overall Study|Withdrawal by Subject|2|||
48511362|NCT00579345|156065695|FG001|Overall Study|Withdrawal by Subject|0|||
48511363|NCT00579345|156065696|FG002|Overall Study|Withdrawal by Subject|0|||
48511364|NCT00579345|156065697|FG003|Overall Study|Withdrawal by Subject|0|||
48511365|NCT00579345|156065698|FG004|Overall Study|Withdrawal by Subject|0|||
48511366|NCT00579345|156065699|FG005|Overall Study|Withdrawal by Subject|0|||
48511367|NCT00579345|156065700|FG006|Overall Study|Withdrawal by Subject|0|||
48511368|NCT00579345|156065701|FG007|Overall Study|Withdrawal by Subject|1|||
48511369|NCT00579345|156065694|FG000|Overall Study|Lost to Follow-up|1|||
48511370|NCT00579345|156065695|FG001|Overall Study|Lost to Follow-up|0|||
48511371|NCT00579345|156065696|FG002|Overall Study|Lost to Follow-up|0|||
48511372|NCT00579345|156065697|FG003|Overall Study|Lost to Follow-up|0|||
48511373|NCT00579345|156065698|FG004|Overall Study|Lost to Follow-up|0|||
48511374|NCT00579345|156065699|FG005|Overall Study|Lost to Follow-up|0|||
48511375|NCT00579345|156065700|FG006|Overall Study|Lost to Follow-up|0|||
48511376|NCT00579345|156065701|FG007|Overall Study|Lost to Follow-up|0|||
48511377|NCT00579345|156065694|FG000|Overall Study|Adverse Event|0|||
48511378|NCT00579345|156065695|FG001|Overall Study|Adverse Event|0|||
48821805|NCT04212169|157190451|FG000|Overall Study|Withdrawal by Subject|10|||
48821806|NCT04212169|157190452|FG001|Overall Study|Withdrawal by Subject|2|||
48511379|NCT00579345|156065696|FG002|Overall Study|Adverse Event|1|||
48511380|NCT00579345|156065697|FG003|Overall Study|Adverse Event|0|||
48382052|NCT01674712|155595057|FG001|Overall Study|Adverse Event|6|||
48382053|NCT01674712|155595058|FG002|Overall Study|Adverse Event|3|||
48382054|NCT01674712|155595059|FG003|Overall Study|Adverse Event|4|||
48382055|NCT01674712|155595060|FG004|Overall Study|Adverse Event|6|||
48382056|NCT01674712|155595056|FG000|Overall Study|Lost to Follow-up|1|||
48511381|NCT00579345|156065698|FG004|Overall Study|Adverse Event|0|||
48511382|NCT00579345|156065699|FG005|Overall Study|Adverse Event|0|||
48728571|NCT01898494|156857103|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
48728572|NCT01898494|156857104|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
48728573|NCT01898494|156857105|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
48728574|NCT01898494|156857106|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
48728575|NCT01898494|156857102|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
48511383|NCT00579345|156065700|FG006|Overall Study|Adverse Event|0|||
48511384|NCT00579345|156065701|FG007|Overall Study|Adverse Event|0|||
48511385|NCT00579345|156065694|FG000|Overall Study|Protocol Violation|1|||
48511386|NCT00579345|156065695|FG001|Overall Study|Protocol Violation|0|||
48511387|NCT00579345|156065696|FG002|Overall Study|Protocol Violation|0|||
48511388|NCT00579345|156065697|FG003|Overall Study|Protocol Violation|0|||
48511389|NCT00579345|156065698|FG004|Overall Study|Protocol Violation|0|||
48511390|NCT00579345|156065699|FG005|Overall Study|Protocol Violation|0|||
48511391|NCT00579345|156065700|FG006|Overall Study|Protocol Violation|0|||
48728576|NCT01898494|156857103|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
48728577|NCT01898494|156857104|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
48728578|NCT01898494|156857105|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
48511392|NCT00579345|156065701|FG007|Overall Study|Protocol Violation|1|||
48511393|NCT00579345|156065694|FG000|Overall Study|Death|1|||
48511394|NCT00579345|156065695|FG001|Overall Study|Death|1|||
48511395|NCT00579345|156065696|FG002|Overall Study|Death|1|||
48511396|NCT00579345|156065697|FG003|Overall Study|Death|1|||
48511397|NCT00579345|156065698|FG004|Overall Study|Death|0|||
48511398|NCT00579345|156065699|FG005|Overall Study|Death|0|||
48511399|NCT00579345|156065700|FG006|Overall Study|Death|0|||
48511400|NCT00579345|156065701|FG007|Overall Study|Death|0|||
48511401|NCT01171989|156065705|FG000|Overall Study|Lost to Follow-up|0|||
48511402|NCT01171989|156065706|FG001|Overall Study|Lost to Follow-up|0|||
48511403|NCT01171989|156065707|FG002|Overall Study|Lost to Follow-up|1|||
48511404|NCT01319383|156065710|FG000|Overall Study|No ex vivo or in vivo response|4|||
48511405|NCT01319383|156065711|FG001|Overall Study|No ex vivo or in vivo response|0|||
48511406|NCT01319383|156065710|FG000|Overall Study|Physician Decision|3|||
48511407|NCT01319383|156065711|FG001|Overall Study|Physician Decision|0|||
48511408|NCT01319383|156065710|FG000|Overall Study|Lack of Efficacy|5|||
48728579|NCT01898494|156857106|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
48728580|NCT01898494|156857102|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
48728581|NCT01898494|156857103|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
48728582|NCT01898494|156857104|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
48728583|NCT01898494|156857105|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
48728584|NCT01898494|156857106|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
48728585|NCT01898494|156857102|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
48728586|NCT01898494|156857103|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
48728587|NCT01898494|156857104|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
48728588|NCT01898494|156857105|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
48728589|NCT01898494|156857106|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
48728590|NCT01898494|156857102|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
48728591|NCT01898494|156857103|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
48728592|NCT01898494|156857104|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
48728593|NCT01898494|156857105|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
48728594|NCT01898494|156857106|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
48821807|NCT04212169|157190453|FG002|Overall Study|Withdrawal by Subject|5|||
48821808|NCT04212169|157190454|FG003|Overall Study|Withdrawal by Subject|7|||
48821809|NCT04212169|157190451|FG000|Overall Study|Other reason, unspecified|3|||
48821810|NCT04212169|157190452|FG001|Overall Study|Other reason, unspecified|1|||
48821811|NCT04212169|157190453|FG002|Overall Study|Other reason, unspecified|0|||
48821812|NCT04212169|157190454|FG003|Overall Study|Other reason, unspecified|2|||
48511409|NCT01319383|156065711|FG001|Overall Study|Lack of Efficacy|9|||
48511410|NCT01319383|156065710|FG000|Overall Study|No in vivo response to interval doses|0|||
48511411|NCT01319383|156065711|FG001|Overall Study|No in vivo response to interval doses|1|||
48728595|NCT01898494|156857102|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
48728596|NCT01898494|156857103|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
48821813|NCT01809210|157190463|FG000|Overall Study|Withdrawal by Subject|0|||
48382057|NCT01674712|155595057|FG001|Overall Study|Lost to Follow-up|0|||
48511412|NCT04129346|156065714|FG000|Overall Study|Death|1|||
48511413|NCT04129346|156065715|FG001|Overall Study|Death|0|||
48511414|NCT02822235|156065718|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
48511415|NCT02822235|156065719|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
48511416|NCT02822235|156065718|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
48511417|NCT02822235|156065719|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
48511418|NCT02822235|156065718|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
48511419|NCT02822235|156065719|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
48511420|NCT02822235|156065718|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
48511421|NCT02822235|156065719|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
48511422|NCT02822235|156065718|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
48511423|NCT02822235|156065719|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
48511424|NCT02822235|156065718|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
48511425|NCT02822235|156065719|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
48511426|NCT00829790|156065723|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
48511427|NCT00829790|156065724|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
48511428|NCT03214952|156065725|FG000|Overall Study|Protocol Deviation|45|||
48511429|NCT03214952|156065725|FG000|Overall Study|Case Report Forms Uncollected|13|||
48511430|NCT01987765|156065728|FG000|Overall Study|Protocol Violation|65|||
48511431|NCT01987765|156065728|FG000|Overall Study|Lost to Follow-up|37|||
48511432|NCT02246166|156065731|FG000|Overall Study|Protocol Violation|1|||
48511433|NCT02246166|156065732|FG001|Overall Study|Protocol Violation|0|||
48511434|NCT02563561|156065733|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
48511435|NCT02563561|156065734|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
48511436|NCT02563561|156065735|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
48821814|NCT01809210|157190464|FG001|Overall Study|Withdrawal by Subject|0|||
48821815|NCT01809210|157190465|FG002|Overall Study|Withdrawal by Subject|1|||
48821816|NCT01809210|157190466|FG003|Overall Study|Withdrawal by Subject|1|||
48821817|NCT01809210|157190467|FG004|Overall Study|Withdrawal by Subject|1|||
48821818|NCT01809210|157190468|FG005|Overall Study|Withdrawal by Subject|0|||
48821819|NCT01809210|157190469|FG006|Overall Study|Withdrawal by Subject|4|||
48821820|NCT01809210|157190463|FG000|Overall Study|Death|1|||
48821821|NCT01809210|157190464|FG001|Overall Study|Death|1|||
48821822|NCT01809210|157190465|FG002|Overall Study|Death|2|||
48821823|NCT01809210|157190466|FG003|Overall Study|Death|0|||
48821824|NCT01809210|157190467|FG004|Overall Study|Death|1|||
48821825|NCT01809210|157190468|FG005|Overall Study|Death|3|||
48821826|NCT01809210|157190469|FG006|Overall Study|Death|1|||
48821827|NCT01115998|157190471|FG000|Overall Study|Lost to Follow-up|6|||
48821828|NCT01115998|157190472|FG001|Overall Study|Lost to Follow-up|6|||
48821829|NCT00590980|157190473|FG000|Overall Study|Did not meet all inclusion criteria|10|||
48511437|NCT02563561|156065733|FG000|Overall Study|Withdrew of Consent|1|||
48511438|NCT02563561|156065734|FG001|Overall Study|Withdrew of Consent|1|||
48728597|NCT01898494|156857104|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
48728598|NCT01898494|156857105|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
48728599|NCT01898494|156857106|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
48728600|NCT01898494|156857102|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
48728601|NCT01898494|156857103|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
48728602|NCT01898494|156857104|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
48728603|NCT01898494|156857105|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
48728604|NCT01898494|156857106|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
48728605|NCT00920829|156857113|FG000|Allocation|No post randomization data|3|||
48728606|NCT00920829|156857114|FG001|Allocation|No post randomization data|1|||
48728607|NCT00920829|156857115|FG002|Allocation|No post randomization data|0|||
48728608|NCT00920829|156857116|FG003|Allocation|No post randomization data|2|||
48728609|NCT00920829|156857113|FG000|Available for Analysis|Withdrawal by Subject|6|||
48728610|NCT00920829|156857114|FG001|Available for Analysis|Withdrawal by Subject|6|||
48728611|NCT00920829|156857115|FG002|Available for Analysis|Withdrawal by Subject|6|||
48728612|NCT00920829|156857116|FG003|Available for Analysis|Withdrawal by Subject|10|||
48728613|NCT00920829|156857113|FG000|Available for Analysis|Required Medical Treatment|0|||
48728614|NCT00920829|156857114|FG001|Available for Analysis|Required Medical Treatment|1|||
48728615|NCT00920829|156857115|FG002|Available for Analysis|Required Medical Treatment|2|||
48728616|NCT00920829|156857116|FG003|Available for Analysis|Required Medical Treatment|0|||
48728617|NCT00920829|156857113|FG000|Available for Analysis|Adverse Event|1|||
48728618|NCT00920829|156857114|FG001|Available for Analysis|Adverse Event|2|||
48728619|NCT00920829|156857115|FG002|Available for Analysis|Adverse Event|1|||
48728620|NCT00920829|156857116|FG003|Available for Analysis|Adverse Event|0|||
48728621|NCT00920829|156857113|FG000|Available for Analysis|Death|1|||
48728622|NCT00920829|156857114|FG001|Available for Analysis|Death|0|||
48728623|NCT00920829|156857115|FG002|Available for Analysis|Death|0|||
48728624|NCT00920829|156857116|FG003|Available for Analysis|Death|0|||
48728625|NCT00920829|156857113|FG000|Available for Analysis|Protocol Violation|0|||
48821830|NCT02819479|157190474|FG000|Overall Study|Adverse Event|2|||
48821831|NCT03850444|157190475|FG000|Overall Study|Adverse Event|16|||
48821832|NCT03850444|157190476|FG001|Overall Study|Adverse Event|10|||
48821833|NCT03850444|157190475|FG000|Overall Study|Death|87|||
48821834|NCT03850444|157190476|FG001|Overall Study|Death|107|||
48821835|NCT03850444|157190475|FG000|Overall Study|Lost to Follow-up|1|||
48511439|NCT02563561|156065735|FG002|Overall Study|Withdrew of Consent|2|||
48511440|NCT02563561|156065733|FG000|Overall Study|Lost to Follow-up|1|||
48511441|NCT02563561|156065734|FG001|Overall Study|Lost to Follow-up|1|||
48511442|NCT02563561|156065735|FG002|Overall Study|Lost to Follow-up|0|||
48511443|NCT02563561|156065733|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
48728626|NCT00920829|156857114|FG001|Available for Analysis|Protocol Violation|0|||
48728627|NCT00920829|156857115|FG002|Available for Analysis|Protocol Violation|1|||
48728628|NCT00920829|156857116|FG003|Available for Analysis|Protocol Violation|0|||
48728629|NCT00920829|156857113|FG000|Available for Analysis|Required more treatment|0|||
48728630|NCT00920829|156857114|FG001|Available for Analysis|Required more treatment|2|||
48728631|NCT00920829|156857115|FG002|Available for Analysis|Required more treatment|0|||
48728632|NCT00920829|156857116|FG003|Available for Analysis|Required more treatment|1|||
48728633|NCT02284178|156857120|FG000|Overall Study|Met exclusion criteria|49|||
48728634|NCT02284178|156857121|FG001|Overall Study|Met exclusion criteria|54|||
48728635|NCT00978432|156857122|FG000|Overall Study|Withdrawal by Subject|0|||
48728636|NCT00978432|156857123|FG001|Overall Study|Withdrawal by Subject|0|||
48728637|NCT00978432|156857124|FG002|Overall Study|Withdrawal by Subject|1|||
48728638|NCT00978432|156857122|FG000|Overall Study|Lack of Efficacy|1|||
48728639|NCT00978432|156857123|FG001|Overall Study|Lack of Efficacy|1|||
48728640|NCT00978432|156857124|FG002|Overall Study|Lack of Efficacy|3|||
48728641|NCT00978432|156857122|FG000|Overall Study|Adverse Event|2|||
48728642|NCT00978432|156857123|FG001|Overall Study|Adverse Event|0|||
48728643|NCT00978432|156857124|FG002|Overall Study|Adverse Event|1|||
48821836|NCT03850444|157190476|FG001|Overall Study|Lost to Follow-up|1|||
48728644|NCT02910583|156857125|FG000|Overall Study|Death|7|||
48728645|NCT02910583|156857126|FG001|Overall Study|Death|3|||
48728646|NCT02910583|156857125|FG000|Overall Study|Lost to Follow-up|1|||
48728647|NCT02910583|156857126|FG001|Overall Study|Lost to Follow-up|0|||
48821837|NCT03850444|157190475|FG000|Overall Study|Withdrawal by Subject|1|||
48728648|NCT02910583|156857125|FG000|Overall Study|Withdrawal by Subject|12|||
48728649|NCT02910583|156857126|FG001|Overall Study|Withdrawal by Subject|8|||
48728650|NCT02910583|156857125|FG000|Overall Study|Other, Not Specified|6|||
48728651|NCT02910583|156857126|FG001|Overall Study|Other, Not Specified|3|||
48728652|NCT01385176|156857127|FG000|Randomization Phase|Death|1|||
48728653|NCT01385176|156857128|FG001|Randomization Phase|Death|2|||
48728654|NCT01385176|156857127|FG000|6-18 Month All VNS Active|Death|1|||
48728655|NCT01385176|156857128|FG001|6-18 Month All VNS Active|Death|2|||
48728656|NCT01385176|156857127|FG000|6-18 Month All VNS Active|Physician Decision|0|||
48728657|NCT01385176|156857128|FG001|6-18 Month All VNS Active|Physician Decision|1|||
48728658|NCT01385176|156857127|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
48728659|NCT01385176|156857128|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
48728660|NCT01385176|156857127|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
48728661|NCT01385176|156857128|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
48728662|NCT04656275|156857129|FG000|Overall Study|Study terminated by sponsor|2|||
48728663|NCT04656275|156857130|FG001|Overall Study|Study terminated by sponsor|4|||
48728664|NCT04902326|156857131|FG000|Overall Study|Withdrawal by Subject|1|||
48728665|NCT04902326|156857132|FG001|Overall Study|Withdrawal by Subject|3|||
48728666|NCT04902326|156857133|FG002|Overall Study|Withdrawal by Subject|0|||
48728667|NCT04902326|156857134|FG003|Overall Study|Withdrawal by Subject|1|||
48728668|NCT04902326|156857131|FG000|Overall Study|Lost to Follow-up|14|||
48728669|NCT04902326|156857132|FG001|Overall Study|Lost to Follow-up|14|||
48728670|NCT04902326|156857133|FG002|Overall Study|Lost to Follow-up|14|||
48728671|NCT04902326|156857134|FG003|Overall Study|Lost to Follow-up|6|||
48728672|NCT02821910|156857137|FG000|Overall Study|Withdrawal by Subject|0|||
48728673|NCT02821910|156857138|FG001|Overall Study|Withdrawal by Subject|0|||
48728674|NCT02821910|156857139|FG002|Overall Study|Withdrawal by Subject|1|||
48728675|NCT02821910|156857140|FG003|Overall Study|Withdrawal by Subject|0|||
48728676|NCT02821910|156857141|FG004|Overall Study|Withdrawal by Subject|0|||
48728677|NCT02821910|156857142|FG005|Overall Study|Withdrawal by Subject|1|||
48728678|NCT02821910|156857137|FG000|Overall Study|Other than specified|1|||
48821838|NCT03850444|157190476|FG001|Overall Study|Withdrawal by Subject|5|||
48728679|NCT02821910|156857138|FG001|Overall Study|Other than specified|0|||
48728680|NCT02821910|156857139|FG002|Overall Study|Other than specified|1|||
48728681|NCT02821910|156857140|FG003|Overall Study|Other than specified|0|||
48728682|NCT02821910|156857141|FG004|Overall Study|Other than specified|0|||
48821839|NCT03850444|157190475|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
48821840|NCT03850444|157190476|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
48728683|NCT02821910|156857142|FG005|Overall Study|Other than specified|0|||
48728684|NCT05867342|156857143|FG000|Overall Study|Investigator Decision|3|||
48728685|NCT05867342|156857144|FG001|Overall Study|Investigator Decision|3|||
48728686|NCT00287079|156857145|FG000|Overall Study|Qualifying relapse|12|||
48728687|NCT00287079|156857146|FG001|Overall Study|Qualifying relapse|1|||
48728688|NCT00287079|156857145|FG000|Overall Study|Non-qualifying relapse|1|||
48728689|NCT00287079|156857146|FG001|Overall Study|Non-qualifying relapse|0|||
48728690|NCT00287079|156857145|FG000|Overall Study|Adverse Event|5|||
48728691|NCT00287079|156857146|FG001|Overall Study|Adverse Event|0|||
48728692|NCT00287079|156857145|FG000|Overall Study|Protocol Violation|1|||
48511444|NCT02563561|156065734|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
48511445|NCT02563561|156065735|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
48511446|NCT02563561|156065733|FG000|Overall Study|Investigator Decision|3|||
48511447|NCT02563561|156065734|FG001|Overall Study|Investigator Decision|4|||
48511448|NCT02563561|156065735|FG002|Overall Study|Investigator Decision|2|||
48511449|NCT02563561|156065733|FG000|Overall Study|Sponsor Decision|5|||
48511450|NCT02563561|156065734|FG001|Overall Study|Sponsor Decision|2|||
48728693|NCT00287079|156857146|FG001|Overall Study|Protocol Violation|0|||
48728694|NCT00287079|156857145|FG000|Overall Study|Other|3|||
48728695|NCT00287079|156857146|FG001|Overall Study|Other|0|||
48511451|NCT02563561|156065735|FG002|Overall Study|Sponsor Decision|4|||
48511452|NCT02563561|156065733|FG000|Overall Study|Other|1|||
48511453|NCT02563561|156065734|FG001|Overall Study|Other|5|||
48511454|NCT02563561|156065735|FG002|Overall Study|Other|2|||
48511455|NCT02646124|156065744|FG000|Overall Study|Lost to Follow-up|0|||
48511456|NCT02646124|156065745|FG001|Overall Study|Lost to Follow-up|2|||
48511457|NCT03600805|156065748|FG000|Overall Study|Adverse Event|2|||
48511458|NCT03600805|156065749|FG001|Overall Study|Adverse Event|1|||
48511459|NCT03600805|156065750|FG002|Overall Study|Adverse Event|1|||
48511460|NCT03600805|156065751|FG003|Overall Study|Adverse Event|7|||
48511461|NCT03600805|156065748|FG000|Overall Study|Lack of Efficacy|2|||
48511462|NCT03600805|156065749|FG001|Overall Study|Lack of Efficacy|1|||
48511463|NCT03600805|156065750|FG002|Overall Study|Lack of Efficacy|0|||
48511464|NCT03600805|156065751|FG003|Overall Study|Lack of Efficacy|0|||
48511465|NCT03600805|156065748|FG000|Overall Study|Withdrawal by Subject|1|||
48511466|NCT03600805|156065749|FG001|Overall Study|Withdrawal by Subject|0|||
48511467|NCT03600805|156065750|FG002|Overall Study|Withdrawal by Subject|0|||
48511468|NCT03600805|156065751|FG003|Overall Study|Withdrawal by Subject|1|||
48511469|NCT03600805|156065748|FG000|Overall Study|Other unspecified|14|||
48511470|NCT03600805|156065749|FG001|Overall Study|Other unspecified|6|||
48511471|NCT03600805|156065750|FG002|Overall Study|Other unspecified|7|||
48511472|NCT03600805|156065751|FG003|Overall Study|Other unspecified|11|||
48511473|NCT03500341|156065754|FG000|Overall Study|Withdrawn prior to Completion|2|||
48511474|NCT03904147|156065757|FG000|Overall Study|Death|15|||
48511475|NCT03904147|156065758|FG001|Overall Study|Death|13|||
48511476|NCT03904147|156065759|FG002|Overall Study|Death|15|||
48511477|NCT03904147|156065757|FG000|Overall Study|Withdrawal by Subject|7|||
48511478|NCT03904147|156065758|FG001|Overall Study|Withdrawal by Subject|12|||
48511479|NCT03904147|156065759|FG002|Overall Study|Withdrawal by Subject|1|||
48511480|NCT03904147|156065757|FG000|Overall Study|1Y visit completed after 365 days|1|||
48511481|NCT03904147|156065758|FG001|Overall Study|1Y visit completed after 365 days|1|||
48511482|NCT03904147|156065759|FG002|Overall Study|1Y visit completed after 365 days|0|||
48511483|NCT05099380|156065760|FG000|Overall Study|Subject enrolled in error|1|||
48511484|NCT05099380|156065761|FG001|Overall Study|Subject enrolled in error|0|||
48511485|NCT05099380|156065760|FG000|Overall Study|Study Procedure|1|||
48511486|NCT05099380|156065761|FG001|Overall Study|Study Procedure|0|||
48511487|NCT05099380|156065760|FG000|Overall Study|Protocol Violation|1|||
48511488|NCT05099380|156065761|FG001|Overall Study|Protocol Violation|0|||
48511489|NCT05099380|156065760|FG000|Overall Study|Adverse Event|1|||
48511490|NCT05099380|156065761|FG001|Overall Study|Adverse Event|1|||
48511491|NCT05099380|156065760|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
48511492|NCT05099380|156065761|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
48511493|NCT00838630|156065762|FG000|First Intervention|Adverse Event|1|||
48511494|NCT00838630|156065763|FG001|First Intervention|Adverse Event|0|||
48511495|NCT00838630|156065762|FG000|Washout: 7 Days|Protocol Violation|1|||
48511496|NCT00838630|156065763|FG001|Washout: 7 Days|Protocol Violation|0|||
48511497|NCT00395694|156065766|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
48511498|NCT00395694|156065767|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
48511499|NCT00395694|156065766|FG000|Continuation Phase|Adverse Event|1|||
48511500|NCT00395694|156065767|FG001|Continuation Phase|Adverse Event|0|||
48511501|NCT00395694|156065766|FG000|Continuation Phase|Lack of Efficacy|12|||
48511502|NCT00395694|156065767|FG001|Continuation Phase|Lack of Efficacy|11|||
48728696|NCT00723203|156857147|FG000|Overall Study|Withdrawal by Subject|3|||
48728697|NCT03416374|156857150|FG000|Between Treatment Period I and II|Other|0|||
48728698|NCT03416374|156857151|FG001|Between Treatment Period I and II|Other|9|||
48728699|NCT03416374|156857150|FG000|Treatment Period II|Lack of Efficacy|3|||
48728700|NCT03416374|156857151|FG001|Treatment Period II|Lack of Efficacy|11|||
48728701|NCT03416374|156857150|FG000|Treatment Period II|Adverse Event|1|||
48728702|NCT03416374|156857151|FG001|Treatment Period II|Adverse Event|4|||
48728703|NCT03416374|156857150|FG000|Treatment Period II|Death|0|||
48728704|NCT03416374|156857151|FG001|Treatment Period II|Death|1|||
48728705|NCT03416374|156857150|FG000|Treatment Period II|Other|0|||
48728706|NCT03416374|156857151|FG001|Treatment Period II|Other|2|||
48728707|NCT03463031|156857154|FG000|Overall Study|Withdrawal by Subject|4|||
48728708|NCT03463031|156857155|FG001|Overall Study|Withdrawal by Subject|2|||
48728709|NCT03463031|156857154|FG000|Overall Study|Investigator/Sponsor Decision|0|||
48728710|NCT03463031|156857155|FG001|Overall Study|Investigator/Sponsor Decision|1|||
48728711|NCT03463031|156857154|FG000|Overall Study|Lost to Follow-up|1|||
48821841|NCT00224133|157190477|FG000|Overall Study|Adverse Event|93|||
48821842|NCT00224133|157190477|FG000|Overall Study|Protocol Violation|6|||
48821843|NCT00224133|157190477|FG000|Overall Study|Withdrawal by Subject|33|||
48821844|NCT00224133|157190477|FG000|Overall Study|Lack of Efficacy|58|||
48821845|NCT00224133|157190477|FG000|Overall Study|Lost to Follow-up|21|||
48821846|NCT00224133|157190477|FG000|Overall Study|Physician Decision|1|||
48821847|NCT00224133|157190477|FG000|Overall Study|Other|14|||
48821848|NCT04096365|157190480|FG000|Overall Study|Adverse Event|1|||
48821849|NCT02401529|157190481|FG000|Overall Study|Lost to Follow-up|2|||
48821850|NCT02401529|157190482|FG001|Overall Study|Lost to Follow-up|1|||
48511503|NCT00395694|156065766|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
48511504|NCT00395694|156065767|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
48511505|NCT00395694|156065766|FG000|Continuation Phase|Poor Compliance|1|||
48511506|NCT00395694|156065767|FG001|Continuation Phase|Poor Compliance|0|||
48511507|NCT00395694|156065766|FG000|Continuation Phase|Withdrawal by Subject|0|||
48511508|NCT00395694|156065767|FG001|Continuation Phase|Withdrawal by Subject|2|||
48382058|NCT01674712|155595058|FG002|Overall Study|Lost to Follow-up|0|||
48382059|NCT01674712|155595059|FG003|Overall Study|Lost to Follow-up|0|||
48382060|NCT01674712|155595060|FG004|Overall Study|Lost to Follow-up|0|||
48382061|NCT01674712|155595056|FG000|Overall Study|Protocol Violation|2|||
48382062|NCT01674712|155595057|FG001|Overall Study|Protocol Violation|0|||
48382063|NCT01674712|155595058|FG002|Overall Study|Protocol Violation|0|||
48382064|NCT01674712|155595059|FG003|Overall Study|Protocol Violation|0|||
48728712|NCT03463031|156857155|FG001|Overall Study|Lost to Follow-up|1|||
48728713|NCT03463031|156857154|FG000|Overall Study|Adverse Event|4|||
48728714|NCT03463031|156857155|FG001|Overall Study|Adverse Event|1|||
48728715|NCT03463031|156857154|FG000|Overall Study|Use of prohibited medication by subject|1|||
48728716|NCT03463031|156857155|FG001|Overall Study|Use of prohibited medication by subject|0|||
48728717|NCT03116347|156857156|FG000|Overall Study|Withdrawal by Subject|1|||
48511509|NCT01648582|156065768|FG000|Overall Study|Adverse Event|6|||
48511510|NCT01648582|156065769|FG001|Overall Study|Adverse Event|11|||
48511511|NCT01648582|156065770|FG002|Overall Study|Adverse Event|2|||
48511512|NCT01648582|156065768|FG000|Overall Study|Lost to Follow-up|9|||
48511513|NCT01648582|156065769|FG001|Overall Study|Lost to Follow-up|6|||
48511514|NCT01648582|156065770|FG002|Overall Study|Lost to Follow-up|8|||
48511515|NCT01648582|156065768|FG000|Overall Study|Protocol Violation|1|||
48511516|NCT01648582|156065769|FG001|Overall Study|Protocol Violation|2|||
48511517|NCT01648582|156065770|FG002|Overall Study|Protocol Violation|1|||
48511518|NCT01648582|156065768|FG000|Overall Study|Withdrawal by Subject|15|||
48511519|NCT01648582|156065769|FG001|Overall Study|Withdrawal by Subject|17|||
48511520|NCT01648582|156065770|FG002|Overall Study|Withdrawal by Subject|17|||
48511521|NCT01648582|156065768|FG000|Overall Study|Physician Decision|0|||
48511522|NCT01648582|156065769|FG001|Overall Study|Physician Decision|1|||
48511523|NCT01648582|156065770|FG002|Overall Study|Physician Decision|3|||
48511524|NCT01648582|156065768|FG000|Overall Study|Death|1|||
48511525|NCT01648582|156065769|FG001|Overall Study|Death|0|||
48511526|NCT01648582|156065770|FG002|Overall Study|Death|0|||
48511527|NCT01648582|156065768|FG000|Overall Study|Sponsor Decision|0|||
48511528|NCT01648582|156065769|FG001|Overall Study|Sponsor Decision|1|||
48511529|NCT01648582|156065770|FG002|Overall Study|Sponsor Decision|1|||
48511530|NCT02849457|156065771|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
48511531|NCT02849457|156065772|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
48511532|NCT02849457|156065773|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
48511533|NCT02849457|156065774|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
48511534|NCT01959672|156065778|FG000|Overall Study|Death|1|||
48511535|NCT02392195|156065780|FG000|Overall Study|Lost to Follow-up|4|||
48511536|NCT02392195|156065780|FG000|Overall Study|Withdrawal by Subject|4|||
48511537|NCT00840216|156065783|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
48511538|NCT00840216|156065784|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
48511539|NCT03673670|156065786|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
48511540|NCT03673670|156065787|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
48511541|NCT03673670|156065788|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
48511542|NCT03673670|156065789|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
48511543|NCT03673670|156065790|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
48382065|NCT01674712|155595060|FG004|Overall Study|Protocol Violation|0|||
48382066|NCT01674712|155595056|FG000|Overall Study|Withdrawal by Subject|2|||
48382067|NCT01674712|155595057|FG001|Overall Study|Withdrawal by Subject|2|||
48728718|NCT03116347|156857157|FG001|Overall Study|Withdrawal by Subject|2|||
48511544|NCT03673670|156065791|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
48511545|NCT03673670|156065786|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
48821851|NCT02401529|157190481|FG000|Overall Study|Physician Decision|2|||
48821852|NCT02401529|157190482|FG001|Overall Study|Physician Decision|6|||
48728719|NCT01629706|156857158|FG000|Phase 1 PureVision|Screen Failure|4|||
48821853|NCT02401529|157190481|FG000|Overall Study|Protocol Violation|5|||
48821854|NCT02401529|157190482|FG001|Overall Study|Protocol Violation|0|||
48821855|NCT01474512|157190483|FG000|Induction Period|Adverse Event|6|||
48821856|NCT01474512|157190484|FG001|Induction Period|Adverse Event|10|||
48821857|NCT01474512|157190485|FG002|Induction Period|Adverse Event|10|||
48821858|NCT01474512|157190486|FG003|Induction Period|Adverse Event|0|||
48821859|NCT01474512|157190487|FG004|Induction Period|Adverse Event|0|||
48821860|NCT01474512|157190488|FG005|Induction Period|Adverse Event|0|||
48821861|NCT01474512|157190489|FG006|Induction Period|Adverse Event|0|||
48821862|NCT01474512|157190490|FG007|Induction Period|Adverse Event|0|||
48821863|NCT01474512|157190491|FG008|Induction Period|Adverse Event|0|||
48821864|NCT01474512|157190492|FG009|Induction Period|Adverse Event|0|||
48821865|NCT01474512|157190493|FG010|Induction Period|Adverse Event|0|||
48821866|NCT01474512|157190494|FG011|Induction Period|Adverse Event|0|||
48511546|NCT03673670|156065787|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
48511547|NCT03673670|156065788|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
48511548|NCT03673670|156065789|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
48511549|NCT03673670|156065790|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
48511550|NCT03673670|156065791|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
48511551|NCT03673670|156065786|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
48511552|NCT03673670|156065787|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
48511553|NCT03673670|156065788|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
48511554|NCT03673670|156065789|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
48511555|NCT03673670|156065790|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
48511556|NCT03673670|156065791|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
48511557|NCT03673670|156065786|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
48511558|NCT03673670|156065787|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
48511559|NCT03673670|156065788|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
48728720|NCT01629706|156857158|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
48728721|NCT01629706|156857158|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
48728722|NCT01629706|156857158|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
48728723|NCT01629706|156857158|FG000|Phase 2 Habitual|Screen Failure|6|||
48728724|NCT01629706|156857158|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
48728725|NCT01629706|156857158|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
48728726|NCT01629706|156857158|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
48728727|NCT01629706|156857158|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
48511560|NCT03673670|156065789|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
48511561|NCT03673670|156065790|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
48511562|NCT03673670|156065791|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
48511563|NCT03673670|156065786|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
48511564|NCT03673670|156065787|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
48511565|NCT03673670|156065788|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
48511566|NCT03673670|156065789|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
48511567|NCT03673670|156065790|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
48511568|NCT03673670|156065791|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
48511569|NCT03673670|156065786|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
48511570|NCT03673670|156065787|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
48511571|NCT03673670|156065788|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
48511572|NCT03673670|156065789|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
48511573|NCT03673670|156065790|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
48511574|NCT03673670|156065791|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
48511575|NCT03673670|156065786|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
48511576|NCT03673670|156065787|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
48511577|NCT03673670|156065788|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
48511578|NCT03673670|156065789|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
48511579|NCT03673670|156065790|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
48728728|NCT02117414|156857159|FG000|Overall Study|Death|5|||
48728729|NCT02117414|156857160|FG001|Overall Study|Death|2|||
48728730|NCT02117414|156857159|FG000|Overall Study|Withdrawal by Subject|10|||
48728731|NCT02117414|156857160|FG001|Overall Study|Withdrawal by Subject|4|||
48728732|NCT00417482|156857165|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
48728733|NCT00417482|156857166|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
48728734|NCT00417482|156857167|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
48511580|NCT03673670|156065791|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
48511581|NCT02937870|156065792|FG000|Overall Study|Adverse Event|1|||
48511582|NCT02937870|156065792|FG000|Overall Study|Protocol Deviation|2|||
48511583|NCT00609674|156065796|FG000|Overall Study|Adverse Event|1|||
48728735|NCT00417482|156857165|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
48728736|NCT00417482|156857166|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
48821867|NCT01474512|157190495|FG012|Induction Period|Adverse Event|0|||
48821868|NCT01474512|157190496|FG013|Induction Period|Adverse Event|0|||
48821869|NCT01474512|157190497|FG014|Induction Period|Adverse Event|0|||
48821870|NCT01474512|157190498|FG015|Induction Period|Adverse Event|0|||
48821871|NCT01474512|157190499|FG016|Induction Period|Adverse Event|0|||
48511584|NCT00609674|156065797|FG001|Overall Study|Adverse Event|1|||
48511585|NCT00609674|156065796|FG000|Overall Study|Protocol Violation|3|||
48511586|NCT00609674|156065797|FG001|Overall Study|Protocol Violation|5|||
48511587|NCT00609674|156065796|FG000|Overall Study|Lost to Follow-up|1|||
48511588|NCT00609674|156065797|FG001|Overall Study|Lost to Follow-up|0|||
48511589|NCT00609674|156065796|FG000|Overall Study|Withdrew consent|2|||
48511590|NCT00609674|156065797|FG001|Overall Study|Withdrew consent|1|||
48511591|NCT02815566|156065799|FG000|Overall Study|Adverse Event|1|||
48511592|NCT02815566|156065800|FG001|Overall Study|Adverse Event|1|||
48511593|NCT02815566|156065799|FG000|Overall Study|Withdrawal by Subject|1|||
48511594|NCT02815566|156065800|FG001|Overall Study|Withdrawal by Subject|0|||
48382068|NCT01674712|155595058|FG002|Overall Study|Withdrawal by Subject|5|||
48382069|NCT01674712|155595059|FG003|Overall Study|Withdrawal by Subject|4|||
48821872|NCT01474512|157190500|FG017|Induction Period|Adverse Event|0|||
48821873|NCT01474512|157190483|FG000|Induction Period|Lack of Efficacy|7|||
48821874|NCT01474512|157190484|FG001|Induction Period|Lack of Efficacy|1|||
48821875|NCT01474512|157190485|FG002|Induction Period|Lack of Efficacy|0|||
48821876|NCT01474512|157190486|FG003|Induction Period|Lack of Efficacy|0|||
48821877|NCT01474512|157190487|FG004|Induction Period|Lack of Efficacy|0|||
48821878|NCT01474512|157190488|FG005|Induction Period|Lack of Efficacy|0|||
48821879|NCT01474512|157190489|FG006|Induction Period|Lack of Efficacy|0|||
48821880|NCT01474512|157190490|FG007|Induction Period|Lack of Efficacy|0|||
48821881|NCT01474512|157190491|FG008|Induction Period|Lack of Efficacy|0|||
48821882|NCT01474512|157190492|FG009|Induction Period|Lack of Efficacy|0|||
48821883|NCT01474512|157190493|FG010|Induction Period|Lack of Efficacy|0|||
48821884|NCT01474512|157190494|FG011|Induction Period|Lack of Efficacy|0|||
48821885|NCT01474512|157190495|FG012|Induction Period|Lack of Efficacy|0|||
48821886|NCT01474512|157190496|FG013|Induction Period|Lack of Efficacy|0|||
48821887|NCT01474512|157190497|FG014|Induction Period|Lack of Efficacy|0|||
48821888|NCT01474512|157190498|FG015|Induction Period|Lack of Efficacy|0|||
48821889|NCT01474512|157190499|FG016|Induction Period|Lack of Efficacy|0|||
48821890|NCT01474512|157190500|FG017|Induction Period|Lack of Efficacy|0|||
48821891|NCT01474512|157190483|FG000|Induction Period|Withdrawal by Subject|6|||
48821892|NCT01474512|157190484|FG001|Induction Period|Withdrawal by Subject|6|||
48821893|NCT01474512|157190485|FG002|Induction Period|Withdrawal by Subject|5|||
48821894|NCT01474512|157190486|FG003|Induction Period|Withdrawal by Subject|0|||
48821895|NCT01474512|157190487|FG004|Induction Period|Withdrawal by Subject|0|||
48821896|NCT01474512|157190488|FG005|Induction Period|Withdrawal by Subject|0|||
48821897|NCT01474512|157190489|FG006|Induction Period|Withdrawal by Subject|0|||
48821898|NCT01474512|157190490|FG007|Induction Period|Withdrawal by Subject|0|||
48821899|NCT01474512|157190491|FG008|Induction Period|Withdrawal by Subject|0|||
48821900|NCT01474512|157190492|FG009|Induction Period|Withdrawal by Subject|0|||
48821901|NCT01474512|157190493|FG010|Induction Period|Withdrawal by Subject|0|||
48821902|NCT01474512|157190494|FG011|Induction Period|Withdrawal by Subject|0|||
48821903|NCT01474512|157190495|FG012|Induction Period|Withdrawal by Subject|0|||
48821904|NCT01474512|157190496|FG013|Induction Period|Withdrawal by Subject|0|||
48821905|NCT01474512|157190497|FG014|Induction Period|Withdrawal by Subject|0|||
48821906|NCT01474512|157190498|FG015|Induction Period|Withdrawal by Subject|0|||
48821907|NCT01474512|157190499|FG016|Induction Period|Withdrawal by Subject|0|||
48821908|NCT01474512|157190500|FG017|Induction Period|Withdrawal by Subject|0|||
48821909|NCT01474512|157190483|FG000|Induction Period|Protocol Violation|3|||
48821910|NCT01474512|157190484|FG001|Induction Period|Protocol Violation|6|||
48821911|NCT01474512|157190485|FG002|Induction Period|Protocol Violation|0|||
48821912|NCT01474512|157190486|FG003|Induction Period|Protocol Violation|0|||
48821913|NCT01474512|157190487|FG004|Induction Period|Protocol Violation|0|||
48821914|NCT01474512|157190488|FG005|Induction Period|Protocol Violation|0|||
48821915|NCT01474512|157190489|FG006|Induction Period|Protocol Violation|0|||
48821916|NCT01474512|157190490|FG007|Induction Period|Protocol Violation|0|||
48821917|NCT01474512|157190491|FG008|Induction Period|Protocol Violation|0|||
48821918|NCT01474512|157190492|FG009|Induction Period|Protocol Violation|0|||
48821919|NCT01474512|157190493|FG010|Induction Period|Protocol Violation|0|||
48821920|NCT01474512|157190494|FG011|Induction Period|Protocol Violation|0|||
48821921|NCT01474512|157190495|FG012|Induction Period|Protocol Violation|0|||
48511595|NCT02815566|156065799|FG000|Overall Study|Lost to Follow-up|0|||
48511596|NCT02815566|156065800|FG001|Overall Study|Lost to Follow-up|1|||
48511597|NCT00316277|156065801|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
48511598|NCT00316277|156065802|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
48821922|NCT01474512|157190496|FG013|Induction Period|Protocol Violation|0|||
48821923|NCT01474512|157190497|FG014|Induction Period|Protocol Violation|0|||
48821924|NCT01474512|157190498|FG015|Induction Period|Protocol Violation|0|||
48821925|NCT01474512|157190499|FG016|Induction Period|Protocol Violation|0|||
48821926|NCT01474512|157190500|FG017|Induction Period|Protocol Violation|0|||
48821927|NCT01474512|157190483|FG000|Induction Period|Sponsor Decision|1|||
48821928|NCT01474512|157190484|FG001|Induction Period|Sponsor Decision|1|||
48821929|NCT01474512|157190485|FG002|Induction Period|Sponsor Decision|1|||
48821930|NCT01474512|157190486|FG003|Induction Period|Sponsor Decision|0|||
48821931|NCT01474512|157190487|FG004|Induction Period|Sponsor Decision|0|||
48821932|NCT01474512|157190488|FG005|Induction Period|Sponsor Decision|0|||
48511599|NCT00316277|156065801|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
48511600|NCT00316277|156065802|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
48511601|NCT00316277|156065801|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
48511602|NCT00316277|156065802|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
48511603|NCT00316277|156065801|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
48511604|NCT00316277|156065802|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
48511605|NCT00316277|156065801|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
48511606|NCT00316277|156065802|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
48511607|NCT03679598|156065803|FG000|Overall Study|Adverse Event|2|||
48511608|NCT03679598|156065804|FG001|Overall Study|Adverse Event|0|||
48511609|NCT00207090|156065811|FG000|Overall Study|Study drug toxicity|3|||
48511610|NCT00207090|156065811|FG000|Overall Study|Chest wall mass larger|1|||
48511611|NCT00207090|156065811|FG000|Overall Study|Disease progression/relapse|2|||
48511612|NCT00207090|156065811|FG000|Overall Study|Physician Decision|1|||
48511613|NCT00838279|156065814|FG000|Washout|Protocol Violation|1|||
48511614|NCT00838279|156065815|FG001|Washout|Protocol Violation|0|||
48511615|NCT00838279|156065814|FG000|Washout|Withdrawal by Subject|0|||
48511616|NCT00838279|156065815|FG001|Washout|Withdrawal by Subject|1|||
48511617|NCT00185458|156065818|FG000|Contraception Phase|Adverse Event|37|||
48511618|NCT00185458|156065818|FG000|Contraception Phase|Lost to Follow-up|10|||
48511619|NCT00185458|156065818|FG000|Contraception Phase|Protocol Violation|2|||
48511620|NCT00185458|156065818|FG000|Contraception Phase|Physician Decision|2|||
48511621|NCT00185458|156065818|FG000|Contraception Phase|Withdrawal by Subject|7|||
48511622|NCT00185458|156065818|FG000|HRT Phase|Adverse Event|18|||
48511623|NCT00185458|156065818|FG000|HRT Phase|Lost to Follow-up|4|||
48511624|NCT00185458|156065818|FG000|HRT Phase|Protocol Violation|2|||
48511625|NCT00185458|156065818|FG000|HRT Phase|Withdrawal by Subject|3|||
48511626|NCT04499963|156065826|FG000|Overall Study|Adverse Event|3|||
48511627|NCT04499963|156065827|FG001|Overall Study|Adverse Event|0|||
48511628|NCT04499963|156065826|FG000|Overall Study|Death|3|||
48511629|NCT04499963|156065827|FG001|Overall Study|Death|0|||
48511630|NCT04499963|156065826|FG000|Overall Study|Lack of Efficacy|7|||
48511631|NCT04499963|156065827|FG001|Overall Study|Lack of Efficacy|0|||
48511632|NCT04499963|156065826|FG000|Overall Study|Lost to Follow-up|2|||
48511633|NCT04499963|156065827|FG001|Overall Study|Lost to Follow-up|0|||
48821933|NCT01474512|157190489|FG006|Induction Period|Sponsor Decision|0|||
48821934|NCT01474512|157190490|FG007|Induction Period|Sponsor Decision|0|||
48821935|NCT01474512|157190491|FG008|Induction Period|Sponsor Decision|0|||
48821936|NCT01474512|157190492|FG009|Induction Period|Sponsor Decision|0|||
48821937|NCT01474512|157190493|FG010|Induction Period|Sponsor Decision|0|||
48511634|NCT01566721|156065828|FG000|Treatment Period|Withdrawal by Subject|35|||
48511635|NCT01566721|156065829|FG001|Treatment Period|Withdrawal by Subject|9|||
48511636|NCT01566721|156065828|FG000|Treatment Period|Disease Progression/Recurrence|37|||
48511637|NCT01566721|156065829|FG001|Treatment Period|Disease Progression/Recurrence|13|||
48821938|NCT01474512|157190494|FG011|Induction Period|Sponsor Decision|0|||
48821939|NCT01474512|157190495|FG012|Induction Period|Sponsor Decision|0|||
48821940|NCT01474512|157190496|FG013|Induction Period|Sponsor Decision|0|||
48821941|NCT01474512|157190497|FG014|Induction Period|Sponsor Decision|0|||
48821942|NCT01474512|157190498|FG015|Induction Period|Sponsor Decision|0|||
48821943|NCT01474512|157190499|FG016|Induction Period|Sponsor Decision|0|||
48821944|NCT01474512|157190500|FG017|Induction Period|Sponsor Decision|0|||
48821945|NCT01474512|157190483|FG000|Induction Period|Lost to Follow-up|1|||
48821946|NCT01474512|157190484|FG001|Induction Period|Lost to Follow-up|0|||
48821947|NCT01474512|157190485|FG002|Induction Period|Lost to Follow-up|2|||
48821948|NCT01474512|157190486|FG003|Induction Period|Lost to Follow-up|0|||
48821949|NCT01474512|157190487|FG004|Induction Period|Lost to Follow-up|0|||
48821950|NCT01474512|157190488|FG005|Induction Period|Lost to Follow-up|0|||
48821951|NCT01474512|157190489|FG006|Induction Period|Lost to Follow-up|0|||
48821952|NCT01474512|157190490|FG007|Induction Period|Lost to Follow-up|0|||
48821953|NCT01474512|157190491|FG008|Induction Period|Lost to Follow-up|0|||
48821954|NCT01474512|157190492|FG009|Induction Period|Lost to Follow-up|0|||
48821955|NCT01474512|157190493|FG010|Induction Period|Lost to Follow-up|0|||
48821956|NCT01474512|157190494|FG011|Induction Period|Lost to Follow-up|0|||
48511638|NCT01566721|156065828|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
48511639|NCT01566721|156065829|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
48511640|NCT01566721|156065828|FG000|Treatment Period|Other|13|||
48511641|NCT01566721|156065829|FG001|Treatment Period|Other|2|||
48511642|NCT01566721|156065828|FG000|Treatment Period|Lack of Compliance|5|||
48821957|NCT01474512|157190495|FG012|Induction Period|Lost to Follow-up|0|||
48821958|NCT01474512|157190496|FG013|Induction Period|Lost to Follow-up|0|||
48821959|NCT01474512|157190497|FG014|Induction Period|Lost to Follow-up|0|||
48821960|NCT01474512|157190498|FG015|Induction Period|Lost to Follow-up|0|||
48511643|NCT01566721|156065829|FG001|Treatment Period|Lack of Compliance|1|||
48821961|NCT01474512|157190499|FG016|Induction Period|Lost to Follow-up|0|||
48511644|NCT01566721|156065828|FG000|Treatment Period|Adverse Event|100|||
48511645|NCT01566721|156065829|FG001|Treatment Period|Adverse Event|30|||
48511646|NCT01566721|156065828|FG000|Treatment Period|Pregnancy|1|||
48728737|NCT00417482|156857167|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
48728738|NCT00417482|156857165|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
48821962|NCT01474512|157190500|FG017|Induction Period|Lost to Follow-up|0|||
48821963|NCT01474512|157190483|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821964|NCT01474512|157190484|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821965|NCT01474512|157190485|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821966|NCT01474512|157190486|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
48821967|NCT01474512|157190487|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
48821968|NCT01474512|157190488|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
48821969|NCT01474512|157190489|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
48821970|NCT01474512|157190490|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821971|NCT01474512|157190491|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821972|NCT01474512|157190492|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821973|NCT01474512|157190493|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821974|NCT01474512|157190494|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821975|NCT01474512|157190495|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48728739|NCT00417482|156857166|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
48728740|NCT00417482|156857167|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
48382070|NCT01674712|155595060|FG004|Overall Study|Withdrawal by Subject|3|||
48382071|NCT01674712|155595056|FG000|Overall Study|Administrative|0|||
48382072|NCT01674712|155595057|FG001|Overall Study|Administrative|1|||
48821976|NCT01474512|157190496|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48728741|NCT00417482|156857165|FG000|Phase B 1st 16 Weeks|Death|1|||
48728742|NCT00417482|156857166|FG001|Phase B 1st 16 Weeks|Death|0|||
48728743|NCT00417482|156857167|FG002|Phase B 1st 16 Weeks|Death|0|||
48728744|NCT00417482|156857165|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
48728745|NCT00417482|156857166|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
48728746|NCT00417482|156857167|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
48728747|NCT00417482|156857165|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
48728748|NCT00417482|156857166|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
48728749|NCT00417482|156857167|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
48728750|NCT00417482|156857165|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
48728751|NCT00417482|156857166|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
48821977|NCT01474512|157190497|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48728752|NCT00417482|156857167|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
48728753|NCT00417482|156857165|FG000|Phase B 2nd 16 Weeks|Death|1|||
48728754|NCT00417482|156857166|FG001|Phase B 2nd 16 Weeks|Death|1|||
48728755|NCT00417482|156857167|FG002|Phase B 2nd 16 Weeks|Death|0|||
48728756|NCT01465191|156857168|FG000|Overall Study|Protocol Violation|6|||
48728757|NCT01465191|156857169|FG001|Overall Study|Protocol Violation|3|||
48728758|NCT01465191|156857170|FG002|Overall Study|Protocol Violation|3|||
48728759|NCT01465191|156857168|FG000|Overall Study|Lost to Follow-up|3|||
48728760|NCT01465191|156857169|FG001|Overall Study|Lost to Follow-up|6|||
48728761|NCT01465191|156857170|FG002|Overall Study|Lost to Follow-up|4|||
48728762|NCT01152450|156857173|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
48511647|NCT01566721|156065829|FG001|Treatment Period|Pregnancy|0|||
48511648|NCT01566721|156065828|FG000|Safety Follow-up|Physician Decision|6|||
48511649|NCT01566721|156065829|FG001|Safety Follow-up|Physician Decision|4|||
48511650|NCT01566721|156065828|FG000|Safety Follow-up|Lost to Follow-up|101|||
48511651|NCT01566721|156065829|FG001|Safety Follow-up|Lost to Follow-up|48|||
48511652|NCT01566721|156065828|FG000|Safety Follow-up|Withdrawal by Subject|155|||
48511653|NCT01566721|156065829|FG001|Safety Follow-up|Withdrawal by Subject|49|||
48511654|NCT01566721|156065828|FG000|Safety Follow-up|Death|28|||
48511655|NCT01566721|156065829|FG001|Safety Follow-up|Death|4|||
48511656|NCT01566721|156065828|FG000|Safety Follow-up|Non-compliance|7|||
48821978|NCT01474512|157190498|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48728763|NCT01152450|156857174|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
48728764|NCT01152450|156857175|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
48728765|NCT01152450|156857176|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
48728766|NCT01152450|156857177|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
48728767|NCT01152450|156857178|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
48728768|NCT01152450|156857173|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
48728769|NCT01152450|156857174|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
48511657|NCT01566721|156065829|FG001|Safety Follow-up|Non-compliance|3|||
48511658|NCT01566721|156065828|FG000|Safety Follow-up|Protocol Violation|7|||
48821979|NCT01474512|157190499|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48821980|NCT01474512|157190500|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
48382073|NCT01674712|155595058|FG002|Overall Study|Administrative|0|||
48728770|NCT01152450|156857175|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
48728771|NCT01152450|156857176|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
48728772|NCT01152450|156857177|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
48382074|NCT01674712|155595059|FG003|Overall Study|Administrative|0|||
48511659|NCT01566721|156065829|FG001|Safety Follow-up|Protocol Violation|0|||
48511660|NCT01566721|156065828|FG000|Safety Follow-up|Site closure|2|||
48511661|NCT01566721|156065829|FG001|Safety Follow-up|Site closure|3|||
48728773|NCT01152450|156857178|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
48728774|NCT01152450|156857173|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48511662|NCT01566721|156065828|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
48511663|NCT01566721|156065829|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
48511664|NCT01566721|156065828|FG000|Safety Follow-up|Missing|7|||
48511665|NCT01566721|156065829|FG001|Safety Follow-up|Missing|2|||
48511666|NCT01566721|156065828|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
48511667|NCT01566721|156065829|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
48511668|NCT01566721|156065828|FG000|Safety Follow-up|Sponsor decision|1|||
48511669|NCT01566721|156065829|FG001|Safety Follow-up|Sponsor decision|0|||
48511670|NCT01566721|156065828|FG000|Safety Follow-up|Adverse Event|8|||
48511671|NCT01566721|156065829|FG001|Safety Follow-up|Adverse Event|4|||
48511672|NCT00446563|156065832|FG000|Overall Study|Adverse Event|4|||
48511673|NCT00446563|156065833|FG001|Overall Study|Adverse Event|3|||
48511674|NCT00446563|156065832|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48511675|NCT00446563|156065833|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48511676|NCT00446563|156065832|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48511677|NCT00446563|156065833|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48511678|NCT00446563|156065832|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48511679|NCT00446563|156065833|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48511680|NCT00446563|156065832|FG000|Overall Study|Withdrawal by Subject|2|||
48511681|NCT00446563|156065833|FG001|Overall Study|Withdrawal by Subject|1|||
48511682|NCT00446563|156065832|FG000|Overall Study|Administrative problems|0|||
48511683|NCT00446563|156065833|FG001|Overall Study|Administrative problems|1|||
48511684|NCT01863745|156065839|FG000|Overall Study|Disease Progression|9|||
48511685|NCT01863745|156065839|FG000|Overall Study|Adverse Event|2|||
48511686|NCT01863745|156065839|FG000|Overall Study|Death|1|||
48821981|NCT01474512|157190483|FG000|Maintenance Period|Adverse Event|0|||
48821982|NCT01474512|157190484|FG001|Maintenance Period|Adverse Event|0|||
48821983|NCT01474512|157190485|FG002|Maintenance Period|Adverse Event|0|||
48821984|NCT01474512|157190486|FG003|Maintenance Period|Adverse Event|4|||
48821985|NCT01474512|157190487|FG004|Maintenance Period|Adverse Event|2|||
48821986|NCT01474512|157190488|FG005|Maintenance Period|Adverse Event|7|||
48821987|NCT01474512|157190489|FG006|Maintenance Period|Adverse Event|0|||
48821988|NCT01474512|157190490|FG007|Maintenance Period|Adverse Event|19|||
48821989|NCT01474512|157190491|FG008|Maintenance Period|Adverse Event|1|||
48821990|NCT01474512|157190492|FG009|Maintenance Period|Adverse Event|3|||
48821991|NCT01474512|157190493|FG010|Maintenance Period|Adverse Event|0|||
48821992|NCT01474512|157190494|FG011|Maintenance Period|Adverse Event|0|||
48821993|NCT01474512|157190495|FG012|Maintenance Period|Adverse Event|0|||
48821994|NCT01474512|157190496|FG013|Maintenance Period|Adverse Event|0|||
48821995|NCT01474512|157190497|FG014|Maintenance Period|Adverse Event|0|||
48821996|NCT01474512|157190498|FG015|Maintenance Period|Adverse Event|0|||
48821997|NCT01474512|157190499|FG016|Maintenance Period|Adverse Event|0|||
48821998|NCT01474512|157190500|FG017|Maintenance Period|Adverse Event|0|||
48821999|NCT01474512|157190483|FG000|Maintenance Period|Withdrawal by Subject|0|||
48822000|NCT01474512|157190484|FG001|Maintenance Period|Withdrawal by Subject|0|||
48822001|NCT01474512|157190485|FG002|Maintenance Period|Withdrawal by Subject|0|||
48822002|NCT01474512|157190486|FG003|Maintenance Period|Withdrawal by Subject|6|||
48822003|NCT01474512|157190487|FG004|Maintenance Period|Withdrawal by Subject|2|||
48822004|NCT01474512|157190488|FG005|Maintenance Period|Withdrawal by Subject|3|||
48822005|NCT01474512|157190489|FG006|Maintenance Period|Withdrawal by Subject|1|||
48822006|NCT01474512|157190490|FG007|Maintenance Period|Withdrawal by Subject|6|||
48822007|NCT01474512|157190491|FG008|Maintenance Period|Withdrawal by Subject|3|||
48822008|NCT01474512|157190492|FG009|Maintenance Period|Withdrawal by Subject|1|||
48822009|NCT01474512|157190493|FG010|Maintenance Period|Withdrawal by Subject|0|||
48822010|NCT01474512|157190494|FG011|Maintenance Period|Withdrawal by Subject|0|||
48822011|NCT01474512|157190495|FG012|Maintenance Period|Withdrawal by Subject|0|||
48822012|NCT01474512|157190496|FG013|Maintenance Period|Withdrawal by Subject|0|||
48822013|NCT01474512|157190497|FG014|Maintenance Period|Withdrawal by Subject|0|||
48822014|NCT01474512|157190498|FG015|Maintenance Period|Withdrawal by Subject|0|||
48822015|NCT01474512|157190499|FG016|Maintenance Period|Withdrawal by Subject|0|||
48822016|NCT01474512|157190500|FG017|Maintenance Period|Withdrawal by Subject|0|||
48822017|NCT01474512|157190483|FG000|Maintenance Period|Lost to Follow-up|0|||
48822018|NCT01474512|157190484|FG001|Maintenance Period|Lost to Follow-up|0|||
48822019|NCT01474512|157190485|FG002|Maintenance Period|Lost to Follow-up|0|||
48822020|NCT01474512|157190486|FG003|Maintenance Period|Lost to Follow-up|3|||
48822021|NCT01474512|157190487|FG004|Maintenance Period|Lost to Follow-up|3|||
48822022|NCT01474512|157190488|FG005|Maintenance Period|Lost to Follow-up|0|||
48822023|NCT01474512|157190489|FG006|Maintenance Period|Lost to Follow-up|0|||
48822024|NCT01474512|157190490|FG007|Maintenance Period|Lost to Follow-up|2|||
48822025|NCT01474512|157190491|FG008|Maintenance Period|Lost to Follow-up|1|||
48822026|NCT01474512|157190492|FG009|Maintenance Period|Lost to Follow-up|1|||
48822027|NCT01474512|157190493|FG010|Maintenance Period|Lost to Follow-up|0|||
48511687|NCT01863745|156065839|FG000|Overall Study|Withdrawal by Subject|1|||
48584942|NCT00743288|156333719|FG005|Overall Study|Withdrawal by Subject|1|||
48584943|NCT00743288|156333720|FG006|Overall Study|Withdrawal by Subject|1|||
48584944|NCT00743288|156333714|FG000|Overall Study|Progressive disease (PD)|2|||
48728775|NCT01152450|156857174|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
48728776|NCT01152450|156857175|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
48728777|NCT01152450|156857176|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48728778|NCT01152450|156857177|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48728779|NCT01152450|156857178|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48728780|NCT04764162|156857182|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
48728781|NCT04764162|156857183|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
48728782|NCT00704808|156857184|FG000|Overall Study|Discontinued prior to starting treatment|14|||
48728783|NCT00704808|156857184|FG000|Overall Study|Death|7|||
48728784|NCT00704808|156857184|FG000|Overall Study|Tumor progression|80|||
48728785|NCT00704808|156857184|FG000|Overall Study|Patient's decision|11|||
48728786|NCT00704808|156857184|FG000|Overall Study|Early therapy discontinuation|16|||
48728787|NCT00704808|156857184|FG000|Overall Study|Adverse Event|1|||
48728788|NCT00704808|156857184|FG000|Overall Study|Lost to Follow-up|1|||
48511688|NCT02476994|156067318|FG000|Overall Study|Based on feedback from FDA|1|||
48511689|NCT02476994|156067319|FG001|Overall Study|Based on feedback from FDA|0|||
48511690|NCT03086460|156067320|FG000|Study Participants|Lost to Follow-up|2|||
48511691|NCT03086460|156067320|FG000|Study Participants|Protocol Violation|1|||
48511692|NCT03086460|156067320|FG000|Study Participants|Withdrawal by Subject|6|||
48728789|NCT00704808|156857184|FG000|Overall Study|Treatment change|1|||
48728790|NCT01476644|156857185|FG000|Overall Study|Death|5|||
48728791|NCT01476644|156857185|FG000|Overall Study|moved to another state|2|||
48728792|NCT01476644|156857185|FG000|Overall Study|Lost to Follow-up|19|||
48728793|NCT01476644|156857185|FG000|Overall Study|Withdrawal by Subject|13|||
48728794|NCT00095628|156857186|FG000|Overall Study|Disease progression prior to treatment|1|||
48728795|NCT00495131|156857188|FG000|Overall Study|Adverse Event|6|||
48728796|NCT00495131|156857189|FG001|Overall Study|Adverse Event|2|||
48728797|NCT00495131|156857188|FG000|Overall Study|Lack of Efficacy|0|||
48728798|NCT00495131|156857189|FG001|Overall Study|Lack of Efficacy|2|||
48728799|NCT00495131|156857188|FG000|Overall Study|Lost to Follow-up|0|||
48728800|NCT00495131|156857189|FG001|Overall Study|Lost to Follow-up|2|||
48728801|NCT00495131|156857188|FG000|Overall Study|Withdrawal by Subject|1|||
48728802|NCT00495131|156857189|FG001|Overall Study|Withdrawal by Subject|0|||
48511693|NCT03086460|156067320|FG000|Treatment A|Lost to Follow-up|1|||
48511694|NCT03086460|156067320|FG000|Treatment A|Protocol Violation|1|||
48511695|NCT03086460|156067320|FG000|Treatment A|Withdrawal by Subject|2|||
48511696|NCT03086460|156067320|FG000|Treatment C|Withdrawal by Subject|2|||
48511697|NCT03086460|156067320|FG000|Treatment E|Lost to Follow-up|1|||
48511698|NCT03086460|156067320|FG000|Treatment E|Withdrawal by Subject|3|||
48511699|NCT05292365|156067321|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
48511700|NCT05292365|156067322|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
48511701|NCT05292365|156067323|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
48511702|NCT05292365|156067324|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
48511703|NCT00834743|156067325|FG000|Second Intervention|Withdrawal by Subject|1|||
48511704|NCT00834743|156067326|FG001|Second Intervention|Withdrawal by Subject|0|||
48511705|NCT00772603|156067327|FG000|Overall Study|Withdrawal by Subject|11|||
48511706|NCT00772603|156067328|FG001|Overall Study|Withdrawal by Subject|10|||
48511707|NCT00772603|156067329|FG002|Overall Study|Withdrawal by Subject|6|||
48511708|NCT00772603|156067327|FG000|Overall Study|Adverse Event|37|||
48511709|NCT00772603|156067328|FG001|Overall Study|Adverse Event|18|||
48511710|NCT00772603|156067329|FG002|Overall Study|Adverse Event|10|||
48511711|NCT00772603|156067327|FG000|Overall Study|Subject Non-compliance|1|||
48511712|NCT00772603|156067328|FG001|Overall Study|Subject Non-compliance|6|||
48511713|NCT00772603|156067329|FG002|Overall Study|Subject Non-compliance|4|||
48511714|NCT00772603|156067327|FG000|Overall Study|Protocol Violation|0|||
48511715|NCT00772603|156067328|FG001|Overall Study|Protocol Violation|1|||
48511716|NCT00772603|156067329|FG002|Overall Study|Protocol Violation|1|||
48511717|NCT00772603|156067327|FG000|Overall Study|Lost to Follow-up|1|||
48511718|NCT00772603|156067328|FG001|Overall Study|Lost to Follow-up|5|||
48511719|NCT00772603|156067329|FG002|Overall Study|Lost to Follow-up|2|||
48511720|NCT00772603|156067327|FG000|Overall Study|Physician Decision|0|||
48511721|NCT00772603|156067328|FG001|Overall Study|Physician Decision|0|||
48511722|NCT00772603|156067329|FG002|Overall Study|Physician Decision|1|||
48511723|NCT00772603|156067327|FG000|Overall Study|Other|2|||
48511724|NCT00772603|156067328|FG001|Overall Study|Other|0|||
48511725|NCT00772603|156067329|FG002|Overall Study|Other|2|||
48511726|NCT03769896|156067332|FG000|Open-label Phase|Lack of Efficacy|5|||
48511727|NCT03769896|156067333|FG001|Open-label Phase|Lack of Efficacy|0|||
48511728|NCT03769896|156067332|FG000|Open-label Phase|Adverse Event|3|||
48511729|NCT03769896|156067333|FG001|Open-label Phase|Adverse Event|0|||
48728803|NCT00744471|156857190|FG000|Overall Study|Randomized but not treated|1|||
48728804|NCT00744471|156857191|FG001|Overall Study|Randomized but not treated|1|||
48728805|NCT00744471|156857192|FG002|Overall Study|Randomized but not treated|4|||
48728806|NCT00744471|156857193|FG003|Overall Study|Randomized but not treated|0|||
48728807|NCT00744471|156857190|FG000|Overall Study|Death|0|||
48511730|NCT03769896|156067332|FG000|Open-label Phase|Withdrawal by Subject|1|||
48511731|NCT03769896|156067333|FG001|Open-label Phase|Withdrawal by Subject|0|||
48511732|NCT01015703|156067338|FG000|Overall Study|Withdrawal by Subject|0|||
48511733|NCT01015703|156067339|FG001|Overall Study|Withdrawal by Subject|1|||
48511734|NCT01015703|156067340|FG002|Overall Study|Withdrawal by Subject|0|||
48511735|NCT01015703|156067341|FG003|Overall Study|Withdrawal by Subject|0|||
48511736|NCT01015703|156067342|FG004|Overall Study|Withdrawal by Subject|0|||
48511737|NCT01015703|156067338|FG000|Overall Study|Adverse Event|1|||
48511738|NCT01015703|156067339|FG001|Overall Study|Adverse Event|0|||
48511739|NCT01015703|156067340|FG002|Overall Study|Adverse Event|0|||
48511740|NCT01015703|156067341|FG003|Overall Study|Adverse Event|0|||
48511741|NCT01015703|156067342|FG004|Overall Study|Adverse Event|0|||
48511742|NCT01015703|156067338|FG000|Overall Study|Protocol Violation|1|||
48511743|NCT01015703|156067339|FG001|Overall Study|Protocol Violation|0|||
48511744|NCT01015703|156067340|FG002|Overall Study|Protocol Violation|0|||
48511745|NCT01015703|156067341|FG003|Overall Study|Protocol Violation|0|||
48511746|NCT01015703|156067342|FG004|Overall Study|Protocol Violation|0|||
48511747|NCT01534663|156067343|FG000|Overall Study|Lost to Follow-up|0|||
48511748|NCT01534663|156067344|FG001|Overall Study|Lost to Follow-up|2|||
48511749|NCT01534663|156067343|FG000|Overall Study|Adverse Event|2|||
48511750|NCT01534663|156067344|FG001|Overall Study|Adverse Event|1|||
48511751|NCT01528696|156067348|FG000|Overall Study|See detailed description|18|||
48511752|NCT01528696|156067349|FG001|Overall Study|See detailed description|19|||
48511753|NCT03154047|156067353|FG000|Overall Study|Death|1|||
48511754|NCT03154047|156067353|FG000|Overall Study|Study terminated by sponsor|76|||
48511755|NCT03154047|156067353|FG000|Overall Study|Withdrawal by Subject|3|||
48511756|NCT00857454|156067354|FG000|Overall Study|Withdrawal by Subject|2|||
48511757|NCT00857454|156067354|FG000|Overall Study|Lost to Follow-up|1|||
48511758|NCT00857454|156067354|FG000|Overall Study|Adverse Event|2|||
48511759|NCT00857454|156067354|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
48511760|NCT00857454|156067354|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
48511761|NCT00857454|156067354|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
48511762|NCT00834340|156067357|FG000|Washout|Adverse Event|1|||
48511763|NCT00834340|156067358|FG001|Washout|Adverse Event|0|||
48511764|NCT00834340|156067357|FG000|Washout|Withdrawal by Subject|1|||
48511765|NCT00834340|156067358|FG001|Washout|Withdrawal by Subject|0|||
48511766|NCT00834431|156067359|FG000|First Intervention|Adverse Event|0|||
48511767|NCT00834431|156067360|FG001|First Intervention|Adverse Event|1|||
48511768|NCT00834431|156067359|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
48511769|NCT00834431|156067360|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
48511770|NCT00392665|156067361|FG000|Overall Study|Death|16|||
48511771|NCT00392665|156067362|FG001|Overall Study|Death|14|||
48511772|NCT00392665|156067361|FG000|Overall Study|Lost to Follow-up|1|||
48511773|NCT00392665|156067362|FG001|Overall Study|Lost to Follow-up|1|||
48511774|NCT01058668|156067363|FG000|Double-blind Treatment Phase|Adverse Event|8|||
48511775|NCT01058668|156067364|FG001|Double-blind Treatment Phase|Adverse Event|15|||
48511776|NCT01058668|156067365|FG002|Double-blind Treatment Phase|Adverse Event|25|||
48511777|NCT01058668|156067363|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
48511778|NCT01058668|156067364|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
48382075|NCT01674712|155595060|FG004|Overall Study|Administrative|1|||
48822028|NCT01474512|157190494|FG011|Maintenance Period|Lost to Follow-up|0|||
48822029|NCT01474512|157190495|FG012|Maintenance Period|Lost to Follow-up|0|||
48822030|NCT01474512|157190496|FG013|Maintenance Period|Lost to Follow-up|0|||
48822031|NCT01474512|157190497|FG014|Maintenance Period|Lost to Follow-up|0|||
48822032|NCT01474512|157190498|FG015|Maintenance Period|Lost to Follow-up|0|||
48822033|NCT01474512|157190499|FG016|Maintenance Period|Lost to Follow-up|0|||
48822034|NCT01474512|157190500|FG017|Maintenance Period|Lost to Follow-up|0|||
48822035|NCT01474512|157190483|FG000|Maintenance Period|Death|0|||
48822036|NCT01474512|157190484|FG001|Maintenance Period|Death|0|||
48822037|NCT01474512|157190485|FG002|Maintenance Period|Death|0|||
48822038|NCT01474512|157190486|FG003|Maintenance Period|Death|0|||
48822039|NCT01474512|157190487|FG004|Maintenance Period|Death|0|||
48822040|NCT01474512|157190488|FG005|Maintenance Period|Death|2|||
48822041|NCT01474512|157190489|FG006|Maintenance Period|Death|0|||
48822042|NCT01474512|157190490|FG007|Maintenance Period|Death|0|||
48822043|NCT01474512|157190491|FG008|Maintenance Period|Death|0|||
48511779|NCT01058668|156067365|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
48511780|NCT01058668|156067363|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
48511781|NCT01058668|156067364|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
48511782|NCT01058668|156067365|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
48511783|NCT01058668|156067363|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
48511784|NCT01058668|156067364|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
48511785|NCT01058668|156067365|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
48511786|NCT01058668|156067363|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48822044|NCT01474512|157190492|FG009|Maintenance Period|Death|0|||
48822045|NCT01474512|157190493|FG010|Maintenance Period|Death|0|||
48382076|NCT01674712|155595056|FG000|Overall Study|Lack of Efficacy|0|||
48511787|NCT01058668|156067364|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
48511788|NCT01058668|156067365|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
48511789|NCT01058668|156067363|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
48511790|NCT01058668|156067364|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
48511791|NCT01058668|156067365|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
48511792|NCT00545792|156067368|FG000|Overall Study|Withdrawal by Subject|1|||
48511793|NCT03437265|156067369|FG000|Overall Study|Protocol Violation|6|||
48511794|NCT02294786|156067372|FG000|Overall Study|Withdrawal by Subject|0|||
48511795|NCT02294786|156067373|FG001|Overall Study|Withdrawal by Subject|1|||
48511796|NCT02294786|156067372|FG000|Overall Study|Physician Decision|6|||
48511797|NCT02294786|156067373|FG001|Overall Study|Physician Decision|7|||
48728808|NCT00744471|156857191|FG001|Overall Study|Death|0|||
48728809|NCT00744471|156857192|FG002|Overall Study|Death|0|||
48728810|NCT00744471|156857193|FG003|Overall Study|Death|1|||
48728811|NCT00744471|156857190|FG000|Overall Study|Adverse Event|6|||
48728812|NCT00744471|156857191|FG001|Overall Study|Adverse Event|7|||
48728813|NCT00744471|156857192|FG002|Overall Study|Adverse Event|5|||
48728814|NCT00744471|156857193|FG003|Overall Study|Adverse Event|9|||
48728815|NCT00744471|156857190|FG000|Overall Study|Withdrawal by Subject|9|||
48728816|NCT00744471|156857191|FG001|Overall Study|Withdrawal by Subject|9|||
48728817|NCT00744471|156857192|FG002|Overall Study|Withdrawal by Subject|15|||
48728818|NCT00744471|156857193|FG003|Overall Study|Withdrawal by Subject|12|||
48728819|NCT00744471|156857190|FG000|Overall Study|Protocol Violation|1|||
48728820|NCT00744471|156857191|FG001|Overall Study|Protocol Violation|4|||
48728821|NCT00744471|156857192|FG002|Overall Study|Protocol Violation|1|||
48728822|NCT00744471|156857193|FG003|Overall Study|Protocol Violation|2|||
48728823|NCT00744471|156857190|FG000|Overall Study|Entered extension study|41|||
48728824|NCT00744471|156857191|FG001|Overall Study|Entered extension study|84|||
48728825|NCT00744471|156857192|FG002|Overall Study|Entered extension study|100|||
48728826|NCT00744471|156857193|FG003|Overall Study|Entered extension study|91|||
48728827|NCT00744471|156857190|FG000|Overall Study|Other|2|||
48728828|NCT00744471|156857191|FG001|Overall Study|Other|3|||
48728829|NCT00744471|156857192|FG002|Overall Study|Other|6|||
48728830|NCT00744471|156857193|FG003|Overall Study|Other|2|||
48728831|NCT00744471|156857190|FG000|Overall Study|Lack of Efficacy|83|||
48728832|NCT00744471|156857191|FG001|Overall Study|Lack of Efficacy|37|||
48728833|NCT00744471|156857192|FG002|Overall Study|Lack of Efficacy|19|||
48728834|NCT00744471|156857193|FG003|Overall Study|Lack of Efficacy|31|||
48728835|NCT00744471|156857190|FG000|Overall Study|Lost to Follow-up|0|||
48728836|NCT00744471|156857191|FG001|Overall Study|Lost to Follow-up|0|||
48728837|NCT00744471|156857192|FG002|Overall Study|Lost to Follow-up|2|||
48728838|NCT00744471|156857193|FG003|Overall Study|Lost to Follow-up|0|||
48728839|NCT01280955|156857196|FG000|Overall Study|Death|2|||
48728840|NCT01280955|156857196|FG000|Overall Study|Withdrawal by Subject|1|||
48728841|NCT01539317|156857197|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
48728842|NCT01539317|156857198|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
48728843|NCT02730208|156857199|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48728844|NCT02730208|156857200|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
48728845|NCT00364130|156857201|FG000|Intervention Period|Lost to Follow-up|4|||
48728846|NCT00364130|156857202|FG001|Intervention Period|Lost to Follow-up|3|||
48728847|NCT00364130|156857201|FG000|Intervention Period|Pregnancy|1|||
48728848|NCT00364130|156857202|FG001|Intervention Period|Pregnancy|0|||
48728849|NCT00364130|156857201|FG000|Intervention Period|Withdrawal by Subject|4|||
48728850|NCT00364130|156857202|FG001|Intervention Period|Withdrawal by Subject|5|||
48728851|NCT00364130|156857201|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
48728852|NCT00364130|156857202|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
48728853|NCT01638819|156857211|FG000|Overall Study|Lost to Follow-up|1|||
48728854|NCT01638819|156857212|FG001|Overall Study|Lost to Follow-up|0|||
48728855|NCT01336569|156857213|FG000|Overall Study|Lost to Follow-up|4|||
48728856|NCT04263454|156857214|FG000|Overall Study|Adverse Event|0|||
48728857|NCT04263454|156857215|FG001|Overall Study|Adverse Event|2|||
48728858|NCT04263454|156857214|FG000|Overall Study|Physician Decision|3|||
48728859|NCT04263454|156857215|FG001|Overall Study|Physician Decision|5|||
48728860|NCT04263454|156857214|FG000|Overall Study|Poor Data Quality|0|||
48728861|NCT04263454|156857215|FG001|Overall Study|Poor Data Quality|1|||
48822046|NCT01474512|157190494|FG011|Maintenance Period|Death|0|||
48822047|NCT01474512|157190495|FG012|Maintenance Period|Death|0|||
48728862|NCT02898116|156857217|FG000|Overall Study|Adverse Event|1|||
48728863|NCT02898116|156857217|FG000|Overall Study|Progressive disease|1|||
48728864|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
48728865|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
48728866|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
48728867|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
48728868|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
48728869|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
48511798|NCT02294786|156067372|FG000|Overall Study|Lost to Follow-up|1|||
48822048|NCT01474512|157190496|FG013|Maintenance Period|Death|0|||
48728870|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
48728871|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
48728872|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
48728873|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
48728874|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
48728875|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
48728876|NCT04059185|156857219|FG000|Longitudinal Assessment-Adults Only|Death|4|||
48728877|NCT04059185|156857220|FG001|Longitudinal Assessment-Adults Only|Death|4|||
48728878|NCT04059185|156857221|FG002|Longitudinal Assessment-Adults Only|Death|3|||
48728879|NCT03805646|156857222|FG000|Overall Study|Death|40|||
48728880|NCT03805646|156857223|FG001|Overall Study|Death|49|||
48728881|NCT03805646|156857222|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
48728882|NCT03805646|156857223|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
48511799|NCT02294786|156067373|FG001|Overall Study|Lost to Follow-up|2|||
48511800|NCT02294786|156067372|FG000|Overall Study|Protocol Violation|1|||
48511801|NCT02294786|156067373|FG001|Overall Study|Protocol Violation|0|||
48511802|NCT02294786|156067372|FG000|Overall Study|Adverse Event|1|||
48511803|NCT02294786|156067373|FG001|Overall Study|Adverse Event|1|||
48511804|NCT02294786|156067372|FG000|Overall Study|Death|2|||
48511805|NCT02294786|156067373|FG001|Overall Study|Death|3|||
48511806|NCT00571064|156067376|FG000|Overall Study|Adverse Event|13|||
48728883|NCT04544956|156857224|FG000|Overall Study|Withdrawal by Subject|1|||
48728884|NCT01554397|156857226|FG000|Overall Study|Withdrawal by Subject|1|||
48728885|NCT01554397|156857227|FG001|Overall Study|Withdrawal by Subject|0|||
48728886|NCT01554397|156857226|FG000|Overall Study|Ineligible|7|||
48728887|NCT01554397|156857227|FG001|Overall Study|Ineligible|0|||
48728888|NCT02233946|156858243|FG000|Baseline|Withdrawal by Subject|2|||
48728889|NCT02233946|156858244|FG001|Baseline|Withdrawal by Subject|0|||
48728890|NCT02233946|156858243|FG000|3-months Follow-up|Lost to Follow-up|53|||
48728891|NCT02233946|156858244|FG001|3-months Follow-up|Lost to Follow-up|29|||
48728892|NCT02233946|156858243|FG000|6-months Follow-up|Lost to Follow-up|21|||
48728893|NCT02233946|156858244|FG001|6-months Follow-up|Lost to Follow-up|2|||
48728894|NCT02233946|156858243|FG000|9-month Follow-up|Lost to Follow-up|20|||
48728895|NCT02233946|156858244|FG001|9-month Follow-up|Lost to Follow-up|11|||
48511807|NCT00571064|156067376|FG000|Overall Study|Protocol Violation|4|||
48511808|NCT00571064|156067376|FG000|Overall Study|Withdrawal by Subject|2|||
48511809|NCT00571064|156067376|FG000|Overall Study|Other|2|||
48511810|NCT00244764|156067377|FG000|Overall Study|Adverse Event|37|||
48511811|NCT00244764|156067377|FG000|Overall Study|Lost to Follow-up|23|||
48511812|NCT00244764|156067377|FG000|Overall Study|Withdrawal by Subject|12|||
48511813|NCT00244764|156067377|FG000|Overall Study|Disease Progression|13|||
48511814|NCT00244764|156067377|FG000|Overall Study|Protocol Violation|2|||
48728896|NCT02233946|156858243|FG000|12-month Follow-up|Lost to Follow-up|28|||
48822049|NCT01474512|157190497|FG014|Maintenance Period|Death|0|||
48822050|NCT01474512|157190498|FG015|Maintenance Period|Death|0|||
48822051|NCT01474512|157190499|FG016|Maintenance Period|Death|0|||
48822052|NCT01474512|157190500|FG017|Maintenance Period|Death|0|||
48822053|NCT01474512|157190483|FG000|Maintenance Period|Physician Decision|0|||
48822054|NCT01474512|157190484|FG001|Maintenance Period|Physician Decision|0|||
48822055|NCT01474512|157190485|FG002|Maintenance Period|Physician Decision|0|||
48822056|NCT01474512|157190486|FG003|Maintenance Period|Physician Decision|0|||
48822057|NCT01474512|157190487|FG004|Maintenance Period|Physician Decision|0|||
48822058|NCT01474512|157190488|FG005|Maintenance Period|Physician Decision|1|||
48822059|NCT01474512|157190489|FG006|Maintenance Period|Physician Decision|0|||
48822060|NCT01474512|157190490|FG007|Maintenance Period|Physician Decision|2|||
48822061|NCT01474512|157190491|FG008|Maintenance Period|Physician Decision|0|||
48822062|NCT01474512|157190492|FG009|Maintenance Period|Physician Decision|0|||
48822063|NCT01474512|157190493|FG010|Maintenance Period|Physician Decision|0|||
48822064|NCT01474512|157190494|FG011|Maintenance Period|Physician Decision|0|||
48822065|NCT01474512|157190495|FG012|Maintenance Period|Physician Decision|0|||
48822066|NCT01474512|157190496|FG013|Maintenance Period|Physician Decision|0|||
48822067|NCT01474512|157190497|FG014|Maintenance Period|Physician Decision|0|||
48822068|NCT01474512|157190498|FG015|Maintenance Period|Physician Decision|0|||
48511815|NCT00244764|156067377|FG000|Overall Study|Death|1|||
48511816|NCT00244764|156067377|FG000|Overall Study|Off Study Medication for >21 Days|1|||
48511817|NCT00244764|156067377|FG000|Overall Study|Declining Performance Status|1|||
48511818|NCT00244764|156067377|FG000|Overall Study|Participant was Hospitalized until Death|1|||
48511819|NCT00244764|156067377|FG000|Overall Study|Primary Investigator Discretion|2|||
48728897|NCT02233946|156858244|FG001|12-month Follow-up|Lost to Follow-up|11|||
48728898|NCT00625742|156858246|FG000|Overall Study|Disease Progression|2|||
48822069|NCT01474512|157190499|FG016|Maintenance Period|Physician Decision|0|||
48511820|NCT00244764|156067377|FG000|Overall Study|Sponsor Terminated Study|2|||
48511821|NCT00244764|156067377|FG000|Overall Study|Developed Secondary Malignancy|1|||
48511822|NCT01642277|156067380|FG000|Overall Study|Adverse Event|10|||
48822070|NCT01474512|157190500|FG017|Maintenance Period|Physician Decision|0|||
48822071|NCT01474512|157190483|FG000|Maintenance Period|Clinical Relapse|0|||
48728899|NCT00625742|156858246|FG000|Overall Study|Withdrawal by Subject|1|||
48728900|NCT00625742|156858246|FG000|Overall Study|Adverse Event|4|||
48728901|NCT00625742|156858246|FG000|Overall Study|Lost to Follow-up|4|||
48728902|NCT00625742|156858246|FG000|Overall Study|Ineligible|1|||
48728903|NCT04099251|156858247|FG000|Pre-Treatment|Other reasons|1|||
48728904|NCT04099251|156858248|FG001|Pre-Treatment|Other reasons|0|||
48728905|NCT04099251|156858247|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
48728906|NCT04099251|156858248|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
48728907|NCT04099251|156858247|FG000|Blinded Treatment Phase|Other reasons|16|||
48728908|NCT04099251|156858248|FG001|Blinded Treatment Phase|Other reasons|7|||
48728909|NCT04099251|156858247|FG000|Blinded Treatment Phase|Disease recurrence|26|||
48728910|NCT04099251|156858248|FG001|Blinded Treatment Phase|Disease recurrence|41|||
48728911|NCT04099251|156858247|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
48728912|NCT04099251|156858248|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
48728913|NCT04099251|156858247|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
48728914|NCT04099251|156858248|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
48728915|NCT04099251|156858247|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
48728916|NCT04099251|156858248|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
48728917|NCT04099251|156858247|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
48728918|NCT04099251|156858248|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
48728919|NCT04099251|156858247|FG000|Blinded Treatment Phase|Death|6|||
48728920|NCT04099251|156858248|FG001|Blinded Treatment Phase|Death|2|||
48728921|NCT04099251|156858247|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
48728922|NCT04099251|156858248|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
48728923|NCT04099251|156858247|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
48728924|NCT04099251|156858248|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
48728925|NCT04099251|156858247|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
48728926|NCT04099251|156858248|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
48728927|NCT04099251|156858247|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
48728928|NCT04099251|156858248|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
48728929|NCT04099251|156858247|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
48728930|NCT04099251|156858248|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
48728931|NCT04099251|156858247|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
48728932|NCT04099251|156858248|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
48728933|NCT04099251|156858247|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
48728934|NCT04099251|156858248|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
48728935|NCT04099251|156858247|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
48728936|NCT04099251|156858248|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
48728937|NCT04099251|156858247|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
48728938|NCT04099251|156858248|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
48728939|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Adverse Event|2|||
48728940|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Adverse Event|0|||
48728941|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
48728942|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
48728943|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
48728944|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
48728945|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
48728946|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48728947|NCT03052764|156858252|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
48728948|NCT03052764|156858253|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
48728949|NCT04850313|156858255|FG000|Overall Study|Withdrawal by Subject|0|||
48728950|NCT04850313|156858256|FG001|Overall Study|Withdrawal by Subject|1|||
48728951|NCT02316548|156858257|FG000|Overall Study|Protocol Violation|0|||
48728952|NCT02316548|156858258|FG001|Overall Study|Protocol Violation|1|||
48728953|NCT04123665|156858259|FG000|Overall Study|Withdrawal by Subject|7|||
48728954|NCT04123665|156858260|FG001|Overall Study|Withdrawal by Subject|0|||
48728955|NCT04123665|156858259|FG000|Overall Study|Lost to Follow-up|1|||
48728956|NCT04123665|156858260|FG001|Overall Study|Lost to Follow-up|0|||
48728957|NCT01483690|156858261|FG000|Overall Study|Adverse Event|1|||
48728958|NCT01483690|156858262|FG001|Overall Study|Adverse Event|2|||
48728959|NCT01483690|156858261|FG000|Overall Study|clinical deterioration|1|||
48822072|NCT01474512|157190484|FG001|Maintenance Period|Clinical Relapse|0|||
48382077|NCT01674712|155595057|FG001|Overall Study|Lack of Efficacy|0|||
48728960|NCT01483690|156858262|FG001|Overall Study|clinical deterioration|0|||
48728961|NCT01483690|156858261|FG000|Overall Study|Physician Decision|0|||
48728962|NCT01483690|156858262|FG001|Overall Study|Physician Decision|2|||
48728963|NCT01483690|156858261|FG000|Overall Study|exclusionary procedure|0|||
48728964|NCT01483690|156858262|FG001|Overall Study|exclusionary procedure|1|||
48728965|NCT03422627|156858268|FG000|Overall Study|Protocol-specified Criteria|1|||
48728966|NCT03422627|156858269|FG001|Overall Study|Protocol-specified Criteria|1|||
48728967|NCT03422627|156858270|FG002|Overall Study|Protocol-specified Criteria|0|||
48728968|NCT03422627|156858271|FG003|Overall Study|Protocol-specified Criteria|0|||
48728969|NCT03422627|156858272|FG004|Overall Study|Protocol-specified Criteria|2|||
48728970|NCT03422627|156858268|FG000|Overall Study|Requirement for Alternative Therapy|1|||
48728971|NCT03422627|156858269|FG001|Overall Study|Requirement for Alternative Therapy|1|||
48728972|NCT03422627|156858270|FG002|Overall Study|Requirement for Alternative Therapy|2|||
48728973|NCT03422627|156858271|FG003|Overall Study|Requirement for Alternative Therapy|0|||
48728974|NCT03422627|156858272|FG004|Overall Study|Requirement for Alternative Therapy|0|||
48728975|NCT03422627|156858268|FG000|Overall Study|Disease Progression|1|||
48728976|NCT03422627|156858269|FG001|Overall Study|Disease Progression|0|||
48728977|NCT03422627|156858270|FG002|Overall Study|Disease Progression|1|||
48728978|NCT03422627|156858271|FG003|Overall Study|Disease Progression|2|||
48728979|NCT03422627|156858272|FG004|Overall Study|Disease Progression|0|||
48728980|NCT03422627|156858268|FG000|Overall Study|Adverse Event|2|||
48728981|NCT03422627|156858269|FG001|Overall Study|Adverse Event|1|||
48728982|NCT03422627|156858270|FG002|Overall Study|Adverse Event|0|||
48728983|NCT03422627|156858271|FG003|Overall Study|Adverse Event|0|||
48728984|NCT03422627|156858272|FG004|Overall Study|Adverse Event|2|||
48728985|NCT03422627|156858268|FG000|Overall Study|Ineligibility Determined|0|||
48728986|NCT03422627|156858269|FG001|Overall Study|Ineligibility Determined|1|||
48728987|NCT03422627|156858270|FG002|Overall Study|Ineligibility Determined|0|||
48728988|NCT03422627|156858271|FG003|Overall Study|Ineligibility Determined|0|||
48728989|NCT03422627|156858272|FG004|Overall Study|Ineligibility Determined|0|||
48728990|NCT03422627|156858268|FG000|Overall Study|Death|0|||
48728991|NCT03422627|156858269|FG001|Overall Study|Death|1|||
48728992|NCT03422627|156858270|FG002|Overall Study|Death|1|||
48728993|NCT03422627|156858271|FG003|Overall Study|Death|0|||
48728994|NCT03422627|156858272|FG004|Overall Study|Death|0|||
48728995|NCT03422627|156858268|FG000|Overall Study|Withdrawal by Subject|0|||
48728996|NCT03422627|156858269|FG001|Overall Study|Withdrawal by Subject|0|||
48728997|NCT03422627|156858270|FG002|Overall Study|Withdrawal by Subject|0|||
48728998|NCT03422627|156858271|FG003|Overall Study|Withdrawal by Subject|1|||
48728999|NCT03422627|156858272|FG004|Overall Study|Withdrawal by Subject|0|||
48729000|NCT03707184|156858273|FG000|Overall Study|Withdrawal by Subject|2|||
48729001|NCT04982588|156858274|FG000|Overall Study|Withdrawal by Subject|2|||
48729002|NCT02923427|156858275|FG000|Overall Study|convert to laparatomy|2|||
48729003|NCT02923427|156858276|FG001|Overall Study|convert to laparatomy|2|||
48729004|NCT02923427|156858275|FG000|Overall Study|destaturation|1|||
48729005|NCT02923427|156858276|FG001|Overall Study|destaturation|0|||
48729006|NCT02923427|156858275|FG000|Overall Study|can not replace LMA|1|||
48729007|NCT02923427|156858276|FG001|Overall Study|can not replace LMA|0|||
48729008|NCT01229397|156858277|FG000|Overall Study|Withdrawal by Subject|3|||
48729009|NCT01229397|156858278|FG001|Overall Study|Withdrawal by Subject|3|||
48729010|NCT01229397|156858277|FG000|Overall Study|Lost to Follow-up|7|||
48729011|NCT01229397|156858278|FG001|Overall Study|Lost to Follow-up|6|||
48729012|NCT01229397|156858277|FG000|Overall Study|Migrated/moved from study area|1|||
48729013|NCT01229397|156858278|FG001|Overall Study|Migrated/moved from study area|0|||
48729014|NCT03026088|156858279|FG000|Overall Study|Study termination|20|||
48729015|NCT04163718|156858283|FG000|Overall Study|Study terminated|12|||
48729016|NCT01606254|156858284|FG000|Overall Study|Withdrawal by Subject|1|||
48729017|NCT01606254|156858285|FG001|Overall Study|Withdrawal by Subject|3|||
48729018|NCT01606254|156858286|FG002|Overall Study|Withdrawal by Subject|0|||
48729019|NCT01606254|156858287|FG003|Overall Study|Withdrawal by Subject|2|||
48729020|NCT01606254|156858284|FG000|Overall Study|Adverse Event|1|||
48729021|NCT01606254|156858285|FG001|Overall Study|Adverse Event|1|||
48729022|NCT01606254|156858286|FG002|Overall Study|Adverse Event|0|||
48729023|NCT01606254|156858287|FG003|Overall Study|Adverse Event|1|||
48729024|NCT02131532|156858288|FG000|Overall Study|Withdrawal by Subject|1|||
48729025|NCT02131532|156858288|FG000|Overall Study|Physician Decision|1|||
48729026|NCT02131532|156858288|FG000|Overall Study|Other health conditions|2|||
48729027|NCT02376829|156858291|FG000|Overall Study|Withdrawal by Subject|27|||
48729028|NCT02376829|156858292|FG001|Overall Study|Withdrawal by Subject|44|||
48511823|NCT01642277|156067381|FG001|Overall Study|Adverse Event|0|||
48511824|NCT01642277|156067380|FG000|Overall Study|Physician Decision|2|||
48511825|NCT01642277|156067381|FG001|Overall Study|Physician Decision|0|||
48511826|NCT01642277|156067380|FG000|Overall Study|Protocol Violation|1|||
48511827|NCT01642277|156067381|FG001|Overall Study|Protocol Violation|0|||
48729029|NCT05153473|156858293|FG000|Overall Study|Death|46|||
48511828|NCT01642277|156067380|FG000|Overall Study|Withdrawal by Subject|11|||
48511829|NCT01642277|156067381|FG001|Overall Study|Withdrawal by Subject|0|||
48729030|NCT05153473|156858293|FG000|Overall Study|Lost to Follow-up|3|||
48729031|NCT02788474|156858294|FG000|Double Blind Treatment Period|Not treated|1|||
48729032|NCT02788474|156858295|FG001|Double Blind Treatment Period|Not treated|0|||
48729033|NCT02788474|156858294|FG000|Double Blind Treatment Period|Patient's refusal|3|||
48729034|NCT02788474|156858295|FG001|Double Blind Treatment Period|Patient's refusal|0|||
48729035|NCT02788474|156858294|FG000|Double Blind Treatment Period|Adverse Event|6|||
48729036|NCT02788474|156858295|FG001|Double Blind Treatment Period|Adverse Event|4|||
48382078|NCT01674712|155595058|FG002|Overall Study|Lack of Efficacy|1|||
48382079|NCT01674712|155595059|FG003|Overall Study|Lack of Efficacy|0|||
48382080|NCT01674712|155595060|FG004|Overall Study|Lack of Efficacy|1|||
48382081|NCT00233363|155595061|FG000|Overall Study|Adverse Event|1|||
48382082|NCT00233363|155595062|FG001|Overall Study|Adverse Event|2|||
48382083|NCT00233363|155595061|FG000|Overall Study|Lack of Efficacy|0|||
48382084|NCT00233363|155595062|FG001|Overall Study|Lack of Efficacy|2|||
48382085|NCT00233363|155595061|FG000|Overall Study|Withdrawal by Subject|1|||
48382086|NCT00233363|155595062|FG001|Overall Study|Withdrawal by Subject|1|||
48382087|NCT00233363|155595061|FG000|Overall Study|Aggravation of complication|1|||
48382088|NCT00233363|155595062|FG001|Overall Study|Aggravation of complication|0|||
48382089|NCT00993915|155595063|FG000|Overall Study|Insufficient clinical response|3|||
48382090|NCT00993915|155595063|FG000|Overall Study|Withdrawal by Subject|2|||
48382091|NCT00993915|155595063|FG000|Overall Study|Other|1|||
48382092|NCT00993915|155595063|FG000|Overall Study|Ongoing|3|||
48382093|NCT01526551|155595064|FG000|Overall Study|Lack of returned parental consent form|424|||
48382094|NCT02234323|155595065|FG000|All Enrolled|Not Treated: Completed study in database|2|||
48382095|NCT02234323|155595065|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
48382096|NCT02234323|155595065|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
48382097|NCT02234323|155595065|FG000|All Treated|Death|1|||
48382098|NCT02234323|155595065|FG000|All Treated|Physician Decision|5|||
48382099|NCT02234323|155595065|FG000|All Treated|Lack of Efficacy|3|||
48382100|NCT02234323|155595065|FG000|All Treated|Exceeded lab value limit|2|||
48382101|NCT02234323|155595065|FG000|All Treated|Other|7|||
48382102|NCT00867113|155595066|FG000|Treatment Period|Adverse Event|15|||
48382103|NCT00867113|155595066|FG000|Treatment Period|Death|2|||
48382104|NCT00867113|155595066|FG000|Treatment Period|Withdrawal by Subject|19|||
48382105|NCT00867113|155595066|FG000|Treatment Period|Lost to Follow-up|3|||
48382106|NCT00867113|155595066|FG000|Treatment Period|Administrative problems|1|||
48382107|NCT00867113|155595066|FG000|Treatment Period|Disease progression/relapse|1|||
48382108|NCT00867113|155595066|FG000|Treatment Period|Protocol Violation|4|||
48382109|NCT00867113|155595066|FG000|Post Treatment After Survival Follow-up|Death|1|||
48382110|NCT00867113|155595066|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
48382111|NCT00867113|155595066|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
48382112|NCT00867113|155595066|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
48382113|NCT01970488|155595067|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
48382114|NCT01970488|155595068|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
48382115|NCT01970488|155595069|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
48382116|NCT01970488|155595070|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
48382117|NCT01970488|155595071|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
48382118|NCT01970488|155595067|FG000|Part 1: Through Week 16|Protocol Violation|1|||
48382119|NCT01970488|155595068|FG001|Part 1: Through Week 16|Protocol Violation|2|||
48382120|NCT01970488|155595069|FG002|Part 1: Through Week 16|Protocol Violation|0|||
48382121|NCT01970488|155595070|FG003|Part 1: Through Week 16|Protocol Violation|0|||
48382122|NCT01970488|155595071|FG004|Part 1: Through Week 16|Protocol Violation|0|||
48382123|NCT01970488|155595067|FG000|Part 1: Through Week 16|Adverse Event|6|||
48382124|NCT01970488|155595068|FG001|Part 1: Through Week 16|Adverse Event|5|||
48382125|NCT01970488|155595069|FG002|Part 1: Through Week 16|Adverse Event|0|||
48382126|NCT01970488|155595070|FG003|Part 1: Through Week 16|Adverse Event|0|||
48729037|NCT02788474|156858294|FG000|Open Label Treatment Period|Adverse Event|29|||
48729038|NCT02788474|156858295|FG001|Open Label Treatment Period|Adverse Event|9|||
48382127|NCT01970488|155595071|FG004|Part 1: Through Week 16|Adverse Event|0|||
48382128|NCT01970488|155595067|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
48382129|NCT01970488|155595068|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
48382130|NCT01970488|155595069|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
48382131|NCT01970488|155595070|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
48382132|NCT01970488|155595071|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
48382133|NCT01970488|155595067|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
48382134|NCT01970488|155595068|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
48511830|NCT04238754|156067382|FG000|Washout - 1 Week|Lost to Follow-up|1|||
48511831|NCT04238754|156067383|FG001|Washout - 1 Week|Lost to Follow-up|0|||
48511832|NCT01208337|156067384|FG000|Overall Study|Death|3|||
48511833|NCT00505622|156067385|FG000|Overall Study|Adverse Event|5|||
48511834|NCT00505622|156067386|FG001|Overall Study|Adverse Event|6|||
48511835|NCT00505622|156067387|FG002|Overall Study|Adverse Event|4|||
48511836|NCT00505622|156067385|FG000|Overall Study|Protocol Violation|1|||
48511837|NCT00505622|156067386|FG001|Overall Study|Protocol Violation|1|||
48511838|NCT00505622|156067387|FG002|Overall Study|Protocol Violation|0|||
48511839|NCT00505622|156067385|FG000|Overall Study|Withdrawal by Subject|0|||
48511840|NCT00505622|156067386|FG001|Overall Study|Withdrawal by Subject|3|||
48511841|NCT00505622|156067387|FG002|Overall Study|Withdrawal by Subject|2|||
48511842|NCT00505622|156067385|FG000|Overall Study|Study termination by sponsor|115|||
48511843|NCT00505622|156067386|FG001|Overall Study|Study termination by sponsor|98|||
48511844|NCT00505622|156067387|FG002|Overall Study|Study termination by sponsor|90|||
48511845|NCT02601625|156067388|FG000|Overall Study|Lost to Follow-up|0|||
48511846|NCT02601625|156067389|FG001|Overall Study|Lost to Follow-up|0|||
48511847|NCT02601625|156067390|FG002|Overall Study|Lost to Follow-up|1|||
48511848|NCT02601625|156067391|FG003|Overall Study|Lost to Follow-up|1|||
48511849|NCT04887415|156067394|FG000|Overall Study|Lost to Follow-up|2|||
48511850|NCT00841698|156067395|FG000|First Intervention|Withdrawal by Subject|1|||
48511851|NCT00841698|156067396|FG001|First Intervention|Withdrawal by Subject|0|||
48511852|NCT00418145|156067399|FG000|Overall Study|study terminated|6|||
48511853|NCT01929863|156067404|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
48511854|NCT01929863|156067405|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
48511855|NCT01929863|156067404|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
48511856|NCT01929863|156067405|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
48511857|NCT01929863|156067404|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
48511858|NCT01929863|156067405|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
48511859|NCT01316055|156067406|FG000|Overall Study|Lost to Follow-up|1|||
48511860|NCT01316055|156067407|FG001|Overall Study|Lost to Follow-up|0|||
48511861|NCT01316055|156067408|FG002|Overall Study|Lost to Follow-up|0|||
48511862|NCT00906399|156067409|FG000|Year 1|Randomized But Not Treated|0|||
48511863|NCT00906399|156067410|FG001|Year 1|Randomized But Not Treated|1|||
48511864|NCT00906399|156067411|FG002|Year 1|Randomized But Not Treated|3|||
48511865|NCT00906399|156067412|FG003|Year 1|Randomized But Not Treated|0|||
48511866|NCT00906399|156067413|FG004|Year 1|Randomized But Not Treated|0|||
48511867|NCT00906399|156067414|FG005|Year 1|Randomized But Not Treated|0|||
48511868|NCT00906399|156067415|FG006|Year 1|Randomized But Not Treated|0|||
48511869|NCT00906399|156067409|FG000|Year 1|Adverse Event|4|||
48511870|NCT00906399|156067410|FG001|Year 1|Adverse Event|22|||
48511871|NCT00906399|156067411|FG002|Year 1|Adverse Event|24|||
48511872|NCT00906399|156067412|FG003|Year 1|Adverse Event|0|||
48511873|NCT00906399|156067413|FG004|Year 1|Adverse Event|0|||
48511874|NCT00906399|156067414|FG005|Year 1|Adverse Event|0|||
48511875|NCT00906399|156067415|FG006|Year 1|Adverse Event|0|||
48511876|NCT00906399|156067409|FG000|Year 1|Lost to Follow-up|4|||
48511877|NCT00906399|156067410|FG001|Year 1|Lost to Follow-up|4|||
48511878|NCT00906399|156067411|FG002|Year 1|Lost to Follow-up|2|||
48511879|NCT00906399|156067412|FG003|Year 1|Lost to Follow-up|0|||
48511880|NCT00906399|156067413|FG004|Year 1|Lost to Follow-up|0|||
48511881|NCT00906399|156067414|FG005|Year 1|Lost to Follow-up|0|||
48511882|NCT00906399|156067415|FG006|Year 1|Lost to Follow-up|0|||
48511883|NCT00906399|156067409|FG000|Year 1|Withdrawal by Subject|30|||
48511884|NCT00906399|156067410|FG001|Year 1|Withdrawal by Subject|32|||
48511885|NCT00906399|156067411|FG002|Year 1|Withdrawal by Subject|36|||
48511886|NCT00906399|156067412|FG003|Year 1|Withdrawal by Subject|0|||
48511887|NCT00906399|156067413|FG004|Year 1|Withdrawal by Subject|0|||
48511888|NCT00906399|156067414|FG005|Year 1|Withdrawal by Subject|0|||
48511889|NCT00906399|156067415|FG006|Year 1|Withdrawal by Subject|0|||
48511890|NCT00906399|156067409|FG000|Year 1|Physician Decision|0|||
48511891|NCT00906399|156067410|FG001|Year 1|Physician Decision|1|||
48511892|NCT00906399|156067411|FG002|Year 1|Physician Decision|3|||
48511893|NCT00906399|156067412|FG003|Year 1|Physician Decision|0|||
48511894|NCT00906399|156067413|FG004|Year 1|Physician Decision|0|||
48511895|NCT00906399|156067414|FG005|Year 1|Physician Decision|0|||
48511896|NCT00906399|156067415|FG006|Year 1|Physician Decision|0|||
48511897|NCT00906399|156067409|FG000|Year 1|Death|2|||
48511898|NCT00906399|156067410|FG001|Year 1|Death|1|||
48511899|NCT00906399|156067411|FG002|Year 1|Death|1|||
48511900|NCT00906399|156067412|FG003|Year 1|Death|0|||
48511901|NCT00906399|156067413|FG004|Year 1|Death|0|||
48511902|NCT00906399|156067414|FG005|Year 1|Death|0|||
48511903|NCT00906399|156067415|FG006|Year 1|Death|0|||
48511904|NCT00906399|156067409|FG000|Year 1|Other|4|||
48511905|NCT00906399|156067410|FG001|Year 1|Other|2|||
48511906|NCT00906399|156067411|FG002|Year 1|Other|7|||
48511907|NCT00906399|156067412|FG003|Year 1|Other|0|||
48511908|NCT00906399|156067413|FG004|Year 1|Other|0|||
48511909|NCT00906399|156067414|FG005|Year 1|Other|0|||
48511910|NCT00906399|156067415|FG006|Year 1|Other|0|||
48511911|NCT00906399|156067409|FG000|Year 2|Adverse Event|0|||
48511912|NCT00906399|156067410|FG001|Year 2|Adverse Event|0|||
48822073|NCT01474512|157190485|FG002|Maintenance Period|Clinical Relapse|0|||
48822074|NCT01474512|157190486|FG003|Maintenance Period|Clinical Relapse|1|||
48822075|NCT01474512|157190487|FG004|Maintenance Period|Clinical Relapse|0|||
48511913|NCT00906399|156067411|FG002|Year 2|Adverse Event|0|||
48511914|NCT00906399|156067412|FG003|Year 2|Adverse Event|9|||
48511915|NCT00906399|156067413|FG004|Year 2|Adverse Event|8|||
48511916|NCT00906399|156067414|FG005|Year 2|Adverse Event|11|||
48511917|NCT00906399|156067415|FG006|Year 2|Adverse Event|6|||
48511918|NCT00906399|156067409|FG000|Year 2|Lost to Follow-up|0|||
48511919|NCT00906399|156067410|FG001|Year 2|Lost to Follow-up|0|||
48382135|NCT01970488|155595069|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
48382136|NCT01970488|155595070|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
48382137|NCT01970488|155595071|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
48382138|NCT01970488|155595067|FG000|Part 2: Post Week 16|Physician Decision|0|||
48382139|NCT01970488|155595068|FG001|Part 2: Post Week 16|Physician Decision|0|||
48382140|NCT01970488|155595069|FG002|Part 2: Post Week 16|Physician Decision|0|||
48382141|NCT01970488|155595070|FG003|Part 2: Post Week 16|Physician Decision|0|||
48382142|NCT01970488|155595071|FG004|Part 2: Post Week 16|Physician Decision|1|||
48511920|NCT00906399|156067411|FG002|Year 2|Lost to Follow-up|0|||
48511921|NCT00906399|156067412|FG003|Year 2|Lost to Follow-up|1|||
48382143|NCT01970488|155595067|FG000|Part 2: Post Week 16|Non-compliance|0|||
48382144|NCT01970488|155595068|FG001|Part 2: Post Week 16|Non-compliance|0|||
48382145|NCT01970488|155595069|FG002|Part 2: Post Week 16|Non-compliance|1|||
48382146|NCT01970488|155595070|FG003|Part 2: Post Week 16|Non-compliance|0|||
48382147|NCT01970488|155595071|FG004|Part 2: Post Week 16|Non-compliance|0|||
48382148|NCT01970488|155595067|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
48382149|NCT01970488|155595068|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
48382150|NCT01970488|155595069|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
48511922|NCT00906399|156067413|FG004|Year 2|Lost to Follow-up|4|||
48382151|NCT01970488|155595070|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
48382152|NCT01970488|155595071|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
48382153|NCT01970488|155595067|FG000|Part 2: Post Week 16|Adverse Event|0|||
48382154|NCT01970488|155595068|FG001|Part 2: Post Week 16|Adverse Event|0|||
48822076|NCT01474512|157190488|FG005|Maintenance Period|Clinical Relapse|0|||
48822077|NCT01474512|157190489|FG006|Maintenance Period|Clinical Relapse|0|||
48822078|NCT01474512|157190490|FG007|Maintenance Period|Clinical Relapse|0|||
48822079|NCT01474512|157190491|FG008|Maintenance Period|Clinical Relapse|0|||
48511923|NCT00906399|156067414|FG005|Year 2|Lost to Follow-up|2|||
48382155|NCT01970488|155595069|FG002|Part 2: Post Week 16|Adverse Event|5|||
48382156|NCT01970488|155595070|FG003|Part 2: Post Week 16|Adverse Event|1|||
48382157|NCT01970488|155595071|FG004|Part 2: Post Week 16|Adverse Event|1|||
48382158|NCT01970488|155595067|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
48382159|NCT01970488|155595068|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
48382160|NCT01970488|155595069|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
48382161|NCT01970488|155595070|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
48382162|NCT01970488|155595071|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
48382163|NCT01970488|155595067|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
48382164|NCT01970488|155595068|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
48382165|NCT01970488|155595069|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
48382166|NCT01970488|155595070|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
48382167|NCT01970488|155595071|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
48382168|NCT01287364|155595074|FG000|Overall Study|Adverse Event|0|||
48382169|NCT01287364|155595075|FG001|Overall Study|Adverse Event|3|||
48382170|NCT01287364|155595074|FG000|Overall Study|Protocol Violation|5|||
48382171|NCT01287364|155595075|FG001|Overall Study|Protocol Violation|5|||
48822080|NCT01474512|157190492|FG009|Maintenance Period|Clinical Relapse|0|||
48822081|NCT01474512|157190493|FG010|Maintenance Period|Clinical Relapse|0|||
48511924|NCT00906399|156067415|FG006|Year 2|Lost to Follow-up|4|||
48822082|NCT01474512|157190494|FG011|Maintenance Period|Clinical Relapse|0|||
48822083|NCT01474512|157190495|FG012|Maintenance Period|Clinical Relapse|0|||
48382172|NCT01287364|155595074|FG000|Overall Study|Other Reason|4|||
48511925|NCT00906399|156067409|FG000|Year 2|Withdrawal by Subject|0|||
48511926|NCT00906399|156067410|FG001|Year 2|Withdrawal by Subject|0|||
48511927|NCT00906399|156067411|FG002|Year 2|Withdrawal by Subject|0|||
48511928|NCT00906399|156067412|FG003|Year 2|Withdrawal by Subject|17|||
48511929|NCT00906399|156067413|FG004|Year 2|Withdrawal by Subject|18|||
48382173|NCT01287364|155595075|FG001|Overall Study|Other Reason|2|||
48382174|NCT00769860|155595076|FG000|Overall Study|Withdrawal by Subject|2|||
48382175|NCT00769860|155595077|FG001|Overall Study|Withdrawal by Subject|0|||
48382176|NCT01026142|155595078|FG000|Overall Study|Death|136|||
48382177|NCT01026142|155595079|FG001|Overall Study|Death|134|||
48511930|NCT00906399|156067414|FG005|Year 2|Withdrawal by Subject|27|||
48511931|NCT00906399|156067415|FG006|Year 2|Withdrawal by Subject|13|||
48382178|NCT01026142|155595078|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
48382179|NCT01026142|155595079|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
48511932|NCT00906399|156067409|FG000|Year 2|Physician Decision|0|||
48511933|NCT00906399|156067410|FG001|Year 2|Physician Decision|0|||
48822084|NCT01474512|157190496|FG013|Maintenance Period|Clinical Relapse|0|||
48382180|NCT03037619|155595080|FG000|Overall Study|Lost to Follow-up|0|||
48382181|NCT03037619|155595081|FG001|Overall Study|Lost to Follow-up|1|||
48382182|NCT01106027|155595082|FG000|Overall Study|Lost graft early, discontinued|1|||
48382183|NCT02545322|155595083|FG000|Overall Study|Withdrawal by Subject|3|||
48382184|NCT01641809|155595084|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
48382185|NCT01641809|155595085|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
48382186|NCT01641809|155595086|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
48382187|NCT01641809|155595087|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
48382188|NCT01641809|155595084|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
48382189|NCT01641809|155595085|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
48382190|NCT01641809|155595086|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
48382191|NCT01641809|155595087|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
48382192|NCT01641809|155595084|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
48382193|NCT01641809|155595085|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
48382194|NCT01641809|155595086|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
48382195|NCT01641809|155595087|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
48382196|NCT01641809|155595084|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
48382197|NCT01641809|155595085|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
48382198|NCT01641809|155595086|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
48382199|NCT01641809|155595087|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
48382200|NCT01641809|155595084|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
48382201|NCT01641809|155595085|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
48382202|NCT01641809|155595086|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
48382203|NCT01641809|155595087|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
48382204|NCT01641809|155595084|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
48382205|NCT01641809|155595085|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
48382206|NCT01641809|155595086|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
48382207|NCT01641809|155595087|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
48382208|NCT01641809|155595084|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
48382209|NCT01641809|155595085|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
48382210|NCT01641809|155595086|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
48382211|NCT01641809|155595087|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
48382212|NCT01641809|155595084|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
48382213|NCT01641809|155595085|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
48382214|NCT01641809|155595086|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
48382215|NCT01641809|155595087|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
48382216|NCT01641809|155595084|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
48382217|NCT01641809|155595085|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
48382218|NCT01641809|155595086|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
48382219|NCT01641809|155595087|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
48382220|NCT01641809|155595084|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
48382221|NCT01641809|155595085|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
48382222|NCT01641809|155595086|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
48382223|NCT01641809|155595087|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
48382224|NCT01641809|155595084|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
48382225|NCT01641809|155595085|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
48382226|NCT01641809|155595086|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
48382227|NCT01641809|155595087|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
48382228|NCT01641809|155595084|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
48382229|NCT01641809|155595085|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
48382230|NCT01641809|155595086|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
48382231|NCT01641809|155595087|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
48382232|NCT01641809|155595084|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
48382233|NCT01641809|155595085|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
48729039|NCT02788474|156858294|FG000|Open Label Treatment Period|Other than reason specified|1|||
48382234|NCT01641809|155595086|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
48382235|NCT01641809|155595087|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
48382236|NCT01641809|155595084|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
48438773|NCT03303092|155793889|FG000|Overall Study|Adverse Event|1|||
48438774|NCT03303092|155793890|FG001|Overall Study|Adverse Event|0|||
48438775|NCT03303092|155793891|FG002|Overall Study|Adverse Event|1|||
48438776|NCT03303092|155793889|FG000|Overall Study|Protocol Violation|1|||
48438777|NCT03303092|155793890|FG001|Overall Study|Protocol Violation|5|||
48438778|NCT03303092|155793891|FG002|Overall Study|Protocol Violation|1|||
48438779|NCT03303092|155793889|FG000|Overall Study|Withdrawal by Subject|1|||
48438780|NCT03303092|155793890|FG001|Overall Study|Withdrawal by Subject|1|||
48438781|NCT03303092|155793891|FG002|Overall Study|Withdrawal by Subject|3|||
48382237|NCT01641809|155595085|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
48382238|NCT01641809|155595086|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
48382239|NCT01641809|155595087|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
48382240|NCT01641809|155595084|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
48382241|NCT01641809|155595085|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
48382242|NCT01641809|155595086|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
48382243|NCT01641809|155595087|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
48382244|NCT01641809|155595084|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
48382245|NCT01641809|155595085|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
48382246|NCT01641809|155595086|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
48382247|NCT01641809|155595087|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
48382248|NCT01641809|155595084|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
48382249|NCT01641809|155595085|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
48382250|NCT01641809|155595086|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
48382251|NCT01641809|155595087|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
48382252|NCT01641809|155595084|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
48382253|NCT01641809|155595085|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
48382254|NCT01641809|155595086|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
48382255|NCT01641809|155595087|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
48382256|NCT01294683|155595088|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
48382257|NCT01294683|155595089|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
48382258|NCT01294683|155595088|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
48382259|NCT01294683|155595089|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
48382260|NCT01294683|155595088|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
48382261|NCT01294683|155595089|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
48382262|NCT01294683|155595088|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
48382263|NCT01294683|155595089|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
48382264|NCT01294683|155595088|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
48382265|NCT01294683|155595089|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
48382266|NCT01294683|155595088|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
48382267|NCT01294683|155595089|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
48382268|NCT01294683|155595088|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
48382269|NCT01294683|155595089|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
48382270|NCT01294683|155595088|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
48382271|NCT01294683|155595089|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
48382272|NCT01294683|155595088|FG000|Post Crossover (Period III)|Adverse Event|6|||
48382273|NCT01294683|155595089|FG001|Post Crossover (Period III)|Adverse Event|6|||
48382274|NCT01294683|155595088|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
48382275|NCT01294683|155595089|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
48382276|NCT01294683|155595088|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
48382277|NCT01294683|155595089|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
48382278|NCT01294683|155595088|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
48382279|NCT01294683|155595089|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
48382280|NCT01423253|155595090|FG000|Overall Study|Adverse Event|2|||
48382281|NCT01423253|155595090|FG000|Overall Study|Lack of Efficacy|2|||
48601041|NCT01064414|156396021|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
48601042|NCT01064414|156396022|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
48601043|NCT01064414|156396023|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
48601044|NCT01064414|156396021|FG000|Extension Period: Week 26 to Week 52|Other|5|||
48601045|NCT01064414|156396022|FG001|Extension Period: Week 26 to Week 52|Other|2|||
48601046|NCT01064414|156396023|FG002|Extension Period: Week 26 to Week 52|Other|1|||
48382282|NCT01423253|155595090|FG000|Overall Study|Lost to Follow-up|1|||
48382283|NCT01423253|155595090|FG000|Overall Study|Protocol Violation|2|||
48382284|NCT01423253|155595090|FG000|Overall Study|Withdrawal by Subject|2|||
48382285|NCT00147823|155595094|FG000|Overall Study|Lost to Follow-up|6|||
48382286|NCT00147823|155595095|FG001|Overall Study|Lost to Follow-up|12|||
48382287|NCT00147823|155595094|FG000|Overall Study|Physician Decision|1|||
48382288|NCT00147823|155595095|FG001|Overall Study|Physician Decision|0|||
48382289|NCT00147823|155595094|FG000|Overall Study|Withdrawal by Subject|0|||
48382290|NCT00147823|155595095|FG001|Overall Study|Withdrawal by Subject|1|||
48382291|NCT00147823|155595094|FG000|Overall Study|Did not receive vitoss due to infection|6|||
48601047|NCT02185417|156396025|FG000|Overall Study|Death|448|||
48601048|NCT02185417|156396026|FG001|Overall Study|Death|446|||
48601049|NCT02185417|156396027|FG002|Overall Study|Death|0|||
48601050|NCT02185417|156396025|FG000|Overall Study|Withdrawal by Subject|7|||
48601051|NCT02185417|156396026|FG001|Overall Study|Withdrawal by Subject|12|||
48601052|NCT02185417|156396027|FG002|Overall Study|Withdrawal by Subject|0|||
48601053|NCT01806168|156396028|FG000|Overall Study|Adverse Event|1|||
48601054|NCT01806168|156396029|FG001|Overall Study|Adverse Event|0|||
48601055|NCT01806168|156396030|FG002|Overall Study|Adverse Event|0|||
48601056|NCT01806168|156396028|FG000|Overall Study|Withdrawal by Subject|0|||
48601057|NCT01806168|156396029|FG001|Overall Study|Withdrawal by Subject|1|||
48511934|NCT00906399|156067411|FG002|Year 2|Physician Decision|0|||
48511935|NCT00906399|156067412|FG003|Year 2|Physician Decision|0|||
48511936|NCT00906399|156067413|FG004|Year 2|Physician Decision|2|||
48511937|NCT00906399|156067414|FG005|Year 2|Physician Decision|6|||
48511938|NCT00906399|156067415|FG006|Year 2|Physician Decision|3|||
48511939|NCT00906399|156067409|FG000|Year 2|Death|0|||
48511940|NCT00906399|156067410|FG001|Year 2|Death|0|||
48511941|NCT00906399|156067411|FG002|Year 2|Death|0|||
48511942|NCT00906399|156067412|FG003|Year 2|Death|1|||
48511943|NCT00906399|156067413|FG004|Year 2|Death|0|||
48511944|NCT00906399|156067414|FG005|Year 2|Death|0|||
48511945|NCT00906399|156067415|FG006|Year 2|Death|3|||
48511946|NCT00906399|156067409|FG000|Year 2|Other|0|||
48511947|NCT00906399|156067410|FG001|Year 2|Other|0|||
48511948|NCT00906399|156067411|FG002|Year 2|Other|0|||
48511949|NCT00906399|156067412|FG003|Year 2|Other|2|||
48511950|NCT00906399|156067413|FG004|Year 2|Other|3|||
48511951|NCT00906399|156067414|FG005|Year 2|Other|1|||
48511952|NCT00906399|156067415|FG006|Year 2|Other|0|||
48511953|NCT01168856|156067416|FG000|Overall Study|Lost to Follow-up|4|||
48511954|NCT01168856|156067417|FG001|Overall Study|Lost to Follow-up|34|||
48511955|NCT01168856|156067416|FG000|Overall Study|Withdrawal by Subject|6|||
48511956|NCT01168856|156067417|FG001|Overall Study|Withdrawal by Subject|8|||
48511957|NCT01168856|156067416|FG000|Overall Study|Physician Decision|2|||
48511958|NCT01168856|156067417|FG001|Overall Study|Physician Decision|1|||
48511959|NCT01168856|156067416|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
48511960|NCT01168856|156067417|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
48511961|NCT01168856|156067416|FG000|Overall Study|Participant received anti-HCV treatment|1|||
48511962|NCT01168856|156067417|FG001|Overall Study|Participant received anti-HCV treatment|0|||
48511963|NCT01168856|156067416|FG000|Overall Study|Death|0|||
48511964|NCT01168856|156067417|FG001|Overall Study|Death|2|||
48511965|NCT01168856|156067416|FG000|Overall Study|Other|1|||
48511966|NCT01168856|156067417|FG001|Overall Study|Other|291|||
48382292|NCT00147823|155595095|FG001|Overall Study|Did not receive vitoss due to infection|2|||
48511967|NCT01168856|156067416|FG000|Overall Study|Protocol Violation|4|||
48511968|NCT01168856|156067417|FG001|Overall Study|Protocol Violation|6|||
48511969|NCT00833937|156067420|FG000|Washout|Withdrawal by Subject|1|||
48511970|NCT00833937|156067421|FG001|Washout|Withdrawal by Subject|0|||
48511971|NCT04631562|156067422|FG000|Overall Study|Withdrawal by Subject|0|||
48511972|NCT04631562|156067423|FG001|Overall Study|Withdrawal by Subject|0|||
48511973|NCT04631562|156067424|FG002|Overall Study|Withdrawal by Subject|0|||
48511974|NCT04631562|156067425|FG003|Overall Study|Withdrawal by Subject|0|||
48511975|NCT04631562|156067426|FG004|Overall Study|Withdrawal by Subject|0|||
48511976|NCT04631562|156067427|FG005|Overall Study|Withdrawal by Subject|0|||
48511977|NCT04631562|156067428|FG006|Overall Study|Withdrawal by Subject|0|||
48511978|NCT04631562|156067429|FG007|Overall Study|Withdrawal by Subject|1|||
48511979|NCT04631562|156067430|FG008|Overall Study|Withdrawal by Subject|0|||
48511980|NCT04631562|156067422|FG000|Overall Study|Other|0|||
48511981|NCT04631562|156067423|FG001|Overall Study|Other|0|||
48511982|NCT04631562|156067424|FG002|Overall Study|Other|0|||
48822085|NCT01474512|157190497|FG014|Maintenance Period|Clinical Relapse|0|||
48822086|NCT01474512|157190498|FG015|Maintenance Period|Clinical Relapse|0|||
48822087|NCT01474512|157190499|FG016|Maintenance Period|Clinical Relapse|0|||
48822088|NCT01474512|157190500|FG017|Maintenance Period|Clinical Relapse|0|||
48511983|NCT04631562|156067425|FG003|Overall Study|Other|0|||
48511984|NCT04631562|156067426|FG004|Overall Study|Other|0|||
48511985|NCT04631562|156067427|FG005|Overall Study|Other|0|||
48511986|NCT04631562|156067428|FG006|Overall Study|Other|0|||
48822089|NCT01474512|157190483|FG000|Maintenance Period|Lack of Efficacy|0|||
48822090|NCT01474512|157190484|FG001|Maintenance Period|Lack of Efficacy|0|||
48822091|NCT01474512|157190485|FG002|Maintenance Period|Lack of Efficacy|0|||
48822092|NCT01474512|157190486|FG003|Maintenance Period|Lack of Efficacy|1|||
48822093|NCT01474512|157190487|FG004|Maintenance Period|Lack of Efficacy|0|||
48822094|NCT01474512|157190488|FG005|Maintenance Period|Lack of Efficacy|0|||
48822095|NCT01474512|157190489|FG006|Maintenance Period|Lack of Efficacy|0|||
48822096|NCT01474512|157190490|FG007|Maintenance Period|Lack of Efficacy|11|||
48822097|NCT01474512|157190491|FG008|Maintenance Period|Lack of Efficacy|11|||
48822098|NCT01474512|157190492|FG009|Maintenance Period|Lack of Efficacy|12|||
48822099|NCT01474512|157190493|FG010|Maintenance Period|Lack of Efficacy|0|||
48822100|NCT01474512|157190494|FG011|Maintenance Period|Lack of Efficacy|0|||
48822101|NCT01474512|157190495|FG012|Maintenance Period|Lack of Efficacy|0|||
48822102|NCT01474512|157190496|FG013|Maintenance Period|Lack of Efficacy|0|||
48822103|NCT01474512|157190497|FG014|Maintenance Period|Lack of Efficacy|0|||
48822104|NCT01474512|157190498|FG015|Maintenance Period|Lack of Efficacy|0|||
48822105|NCT01474512|157190499|FG016|Maintenance Period|Lack of Efficacy|0|||
48822106|NCT01474512|157190500|FG017|Maintenance Period|Lack of Efficacy|0|||
48822107|NCT01474512|157190483|FG000|Maintenance Period|Protocol Violation|0|||
48822108|NCT01474512|157190484|FG001|Maintenance Period|Protocol Violation|0|||
48511987|NCT04631562|156067429|FG007|Overall Study|Other|0|||
48511988|NCT04631562|156067430|FG008|Overall Study|Other|1|||
48511989|NCT04631562|156067422|FG000|Overall Study|Lost to Follow-up|0|||
48382293|NCT01749540|155595097|FG000|Overall Study|Protocol Violation|0|||
48382294|NCT01749540|155595098|FG001|Overall Study|Protocol Violation|0|||
48382295|NCT01749540|155595099|FG002|Overall Study|Protocol Violation|0|||
48382296|NCT01749540|155595100|FG003|Overall Study|Protocol Violation|0|||
48382297|NCT01749540|155595101|FG004|Overall Study|Protocol Violation|0|||
48382298|NCT01749540|155595102|FG005|Overall Study|Protocol Violation|1|||
48382299|NCT01749540|155595103|FG006|Overall Study|Protocol Violation|1|||
48382300|NCT01749540|155595097|FG000|Overall Study|Withdrawal by Subject|0|||
48382301|NCT01749540|155595098|FG001|Overall Study|Withdrawal by Subject|0|||
48382302|NCT01749540|155595099|FG002|Overall Study|Withdrawal by Subject|0|||
48601058|NCT01806168|156396030|FG002|Overall Study|Withdrawal by Subject|2|||
48601059|NCT01806168|156396028|FG000|Overall Study|Protocol Violation|0|||
48601060|NCT01806168|156396029|FG001|Overall Study|Protocol Violation|0|||
48601061|NCT01806168|156396030|FG002|Overall Study|Protocol Violation|1|||
48601062|NCT02219685|156396031|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
48601063|NCT02219685|156396032|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
48601064|NCT02219685|156396031|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
48601065|NCT02219685|156396032|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
48601066|NCT00661089|156396033|FG000|Overall Study|1 subject withdrawal|0|||
48601067|NCT00661089|156396034|FG001|Overall Study|1 subject withdrawal|1|||
48601068|NCT00661089|156396033|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
48601069|NCT00661089|156396034|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
48601070|NCT01545388|156396035|FG000|Overall Study|Adverse Event|2|||
48601071|NCT01545388|156396036|FG001|Overall Study|Adverse Event|4|||
48601072|NCT01545388|156396037|FG002|Overall Study|Adverse Event|1|||
48601073|NCT01545388|156396035|FG000|Overall Study|Lack of Efficacy|3|||
48601074|NCT01545388|156396036|FG001|Overall Study|Lack of Efficacy|2|||
48601075|NCT01545388|156396037|FG002|Overall Study|Lack of Efficacy|5|||
48601076|NCT01545388|156396035|FG000|Overall Study|Participant moved or relocated|1|||
48601077|NCT01545388|156396036|FG001|Overall Study|Participant moved or relocated|0|||
48601078|NCT01545388|156396037|FG002|Overall Study|Participant moved or relocated|0|||
48601079|NCT01545388|156396035|FG000|Overall Study|Withdrawal by Subject|1|||
48601080|NCT01545388|156396036|FG001|Overall Study|Withdrawal by Subject|4|||
48601081|NCT01545388|156396037|FG002|Overall Study|Withdrawal by Subject|2|||
48601082|NCT01545388|156396035|FG000|Overall Study|Other|1|||
48601083|NCT01545388|156396036|FG001|Overall Study|Other|1|||
48729040|NCT02788474|156858295|FG001|Open Label Treatment Period|Other than reason specified|0|||
48511990|NCT04631562|156067423|FG001|Overall Study|Lost to Follow-up|0|||
48511991|NCT04631562|156067424|FG002|Overall Study|Lost to Follow-up|0|||
48511992|NCT04631562|156067425|FG003|Overall Study|Lost to Follow-up|1|||
48511993|NCT04631562|156067426|FG004|Overall Study|Lost to Follow-up|0|||
48511994|NCT04631562|156067427|FG005|Overall Study|Lost to Follow-up|0|||
48511995|NCT04631562|156067428|FG006|Overall Study|Lost to Follow-up|0|||
48511996|NCT04631562|156067429|FG007|Overall Study|Lost to Follow-up|0|||
48511997|NCT04631562|156067430|FG008|Overall Study|Lost to Follow-up|0|||
48511998|NCT04631562|156067422|FG000|Overall Study|Adverse Event|0|||
48511999|NCT04631562|156067423|FG001|Overall Study|Adverse Event|0|||
48512000|NCT04631562|156067424|FG002|Overall Study|Adverse Event|0|||
48512001|NCT04631562|156067425|FG003|Overall Study|Adverse Event|0|||
48512002|NCT04631562|156067426|FG004|Overall Study|Adverse Event|0|||
48512003|NCT04631562|156067427|FG005|Overall Study|Adverse Event|0|||
48512004|NCT04631562|156067428|FG006|Overall Study|Adverse Event|1|||
48512005|NCT04631562|156067429|FG007|Overall Study|Adverse Event|0|||
48512006|NCT04631562|156067430|FG008|Overall Study|Adverse Event|0|||
48512007|NCT00835536|156067431|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
48512008|NCT00835536|156067432|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
48512009|NCT02028715|156067437|FG000|Overall Study|Adverse Event|2|||
48512010|NCT02028715|156067438|FG001|Overall Study|Adverse Event|2|||
48512011|NCT02028715|156067437|FG000|Overall Study|Physician Decision|1|||
48512012|NCT02028715|156067438|FG001|Overall Study|Physician Decision|0|||
48512013|NCT02028715|156067437|FG000|Overall Study|Did not complete satisfaction surveys|2|||
48512014|NCT02028715|156067438|FG001|Overall Study|Did not complete satisfaction surveys|2|||
48512015|NCT02139826|156067439|FG000|Overall Study|Adverse Event|1|||
48512016|NCT03769025|156067444|FG000|Overall Study|Withdrawal by Subject|1|||
48512017|NCT03769025|156067445|FG001|Overall Study|Withdrawal by Subject|1|||
48512018|NCT03769025|156067444|FG000|Overall Study|Lost to Follow-up|4|||
48512019|NCT03769025|156067445|FG001|Overall Study|Lost to Follow-up|3|||
48512020|NCT00520130|156067446|FG000|Overall Study|Disease progression on study|4|||
48601084|NCT01545388|156396037|FG002|Overall Study|Other|0|||
48601085|NCT02567188|156396038|FG000|Overall Study|Death|10|||
48601086|NCT02567188|156396038|FG000|Overall Study|Terminated Mircera Treatment|9|||
48512021|NCT00520130|156067447|FG001|Overall Study|Disease progression on study|0|||
48512022|NCT00520130|156067446|FG000|Overall Study|Physician Decision|1|||
48512023|NCT00520130|156067447|FG001|Overall Study|Physician Decision|1|||
48512024|NCT01302548|156067448|FG000|Overall Study|Lost to Follow-up|2|||
48601087|NCT02567188|156396038|FG000|Overall Study|Lost to Follow-up|5|||
48601088|NCT02567188|156396038|FG000|Overall Study|Adverse Event|1|||
48601089|NCT02567188|156396038|FG000|Overall Study|Withdrawal by Subject|1|||
48822109|NCT01474512|157190485|FG002|Maintenance Period|Protocol Violation|0|||
48822110|NCT01474512|157190486|FG003|Maintenance Period|Protocol Violation|1|||
48822111|NCT01474512|157190487|FG004|Maintenance Period|Protocol Violation|0|||
48822112|NCT01474512|157190488|FG005|Maintenance Period|Protocol Violation|0|||
48512025|NCT01302548|156067449|FG001|Overall Study|Lost to Follow-up|1|||
48512026|NCT00489307|156067452|FG000|Overall Study|Death|1|||
48512027|NCT00489307|156067453|FG001|Overall Study|Death|1|||
48512028|NCT00489307|156067452|FG000|Overall Study|Lost to Follow-up|2|||
48512029|NCT00489307|156067453|FG001|Overall Study|Lost to Follow-up|2|||
48512030|NCT00489307|156067452|FG000|Overall Study|Physician Decision|1|||
48512031|NCT00489307|156067453|FG001|Overall Study|Physician Decision|0|||
48512032|NCT00489307|156067452|FG000|Overall Study|Withdrawal by Subject|2|||
48512033|NCT00489307|156067453|FG001|Overall Study|Withdrawal by Subject|4|||
48512034|NCT00489307|156067452|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
48512035|NCT00489307|156067453|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
48512036|NCT00489307|156067452|FG000|Overall Study|Surgery after assignment|1|||
48512037|NCT00489307|156067453|FG001|Overall Study|Surgery after assignment|0|||
48512038|NCT00489307|156067452|FG000|Overall Study|Did not fill up the forms|2|||
48512039|NCT00489307|156067453|FG001|Overall Study|Did not fill up the forms|1|||
48512040|NCT00489307|156067452|FG000|Overall Study|Patient or family refusal|5|||
48512041|NCT00489307|156067453|FG001|Overall Study|Patient or family refusal|9|||
48512042|NCT03114891|156067456|FG000|First Treatment Round|Lost to Follow-up|0|||
48512043|NCT03114891|156067457|FG001|First Treatment Round|Lost to Follow-up|1|||
48512044|NCT03114891|156067458|FG002|First Treatment Round|Lost to Follow-up|1|||
48512045|NCT03114891|156067459|FG003|First Treatment Round|Lost to Follow-up|0|||
48512046|NCT03114891|156067456|FG000|First Treatment Round|Withdrawal by Subject|0|||
48512047|NCT03114891|156067457|FG001|First Treatment Round|Withdrawal by Subject|2|||
48512048|NCT03114891|156067458|FG002|First Treatment Round|Withdrawal by Subject|0|||
48512049|NCT03114891|156067459|FG003|First Treatment Round|Withdrawal by Subject|1|||
48512050|NCT03114891|156067456|FG000|3 Week Break|Lost to Follow-up|1|||
48512051|NCT03114891|156067457|FG001|3 Week Break|Lost to Follow-up|0|||
48512052|NCT03114891|156067458|FG002|3 Week Break|Lost to Follow-up|0|||
48512053|NCT03114891|156067459|FG003|3 Week Break|Lost to Follow-up|1|||
48512054|NCT03114891|156067456|FG000|3 Week Break|Withdrawal by Subject|0|||
48512055|NCT03114891|156067457|FG001|3 Week Break|Withdrawal by Subject|1|||
48512056|NCT03114891|156067458|FG002|3 Week Break|Withdrawal by Subject|0|||
48512057|NCT03114891|156067459|FG003|3 Week Break|Withdrawal by Subject|0|||
48512058|NCT03114891|156067456|FG000|Second Treatment Round|Lost to Follow-up|1|||
48512059|NCT03114891|156067457|FG001|Second Treatment Round|Lost to Follow-up|0|||
48512060|NCT03114891|156067458|FG002|Second Treatment Round|Lost to Follow-up|0|||
48512061|NCT03114891|156067459|FG003|Second Treatment Round|Lost to Follow-up|0|||
48512062|NCT03114891|156067456|FG000|Second Treatment Round|Physician Decision|1|||
48512063|NCT03114891|156067457|FG001|Second Treatment Round|Physician Decision|0|||
48512064|NCT03114891|156067458|FG002|Second Treatment Round|Physician Decision|0|||
48512065|NCT03114891|156067459|FG003|Second Treatment Round|Physician Decision|0|||
48512066|NCT00745420|156068881|FG000|Overall Study|Ineligible|1|||
48512067|NCT01466166|156068882|FG000|Overall Study|Death|1|||
48512068|NCT01466166|156068882|FG000|Overall Study|Lost to Follow-up|7|||
48512069|NCT01466166|156068882|FG000|Overall Study|Infusion Reaction (IR)|27|||
48512070|NCT01466166|156068882|FG000|Overall Study|Adverse Event (Other than IR)|11|||
48512071|NCT01466166|156068882|FG000|Overall Study|Elevated Serum Uric Acid|78|||
48512072|NCT01466166|156068882|FG000|Overall Study|Withdrawal by Subject|13|||
48512073|NCT01466166|156068882|FG000|Overall Study|Sponsor Decision|4|||
48512074|NCT01466166|156068882|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
48512075|NCT01466166|156068882|FG000|Overall Study|Other|20|||
48512076|NCT02566850|156068888|FG000|Overall Study|Protocol Violation|1|||
48512077|NCT03447353|156068889|FG000|Overall Study|Failure at Screening Visit|2|||
48512078|NCT03447353|156068889|FG000|Overall Study|Lost to Follow-up|4|||
48512079|NCT03447353|156068889|FG000|Overall Study|Scheduling Conflicts|3|||
48512080|NCT03447353|156068889|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
48512081|NCT02175095|156068890|FG000|Overall Study|Withdrawal by Subject|3|||
48512082|NCT02635750|156068891|FG000|Part 1, Period 2|Adverse Event|1|||
48512083|NCT02635750|156068892|FG001|Part 1, Period 2|Adverse Event|0|||
48512084|NCT02635750|156068893|FG002|Part 1, Period 2|Adverse Event|0|||
48512085|NCT01857934|156068894|FG000|Overall Study|Relapse or progression|2|||
48512086|NCT01857934|156068894|FG000|Overall Study|Unacceptable toxicity|3|||
48512087|NCT01857934|156068894|FG000|Overall Study|Unwillingness or inability to comply|2|||
48512088|NCT01857934|156068894|FG000|Overall Study|Physician Decision|3|||
48512089|NCT00371839|156068895|FG000|Overall Study|Death|4|||
48512090|NCT00371839|156068896|FG001|Overall Study|Death|0|||
48512091|NCT00371839|156068897|FG002|Overall Study|Death|0|||
48512092|NCT00371839|156068895|FG000|Overall Study|Withdrawal by Subject|7|||
48512093|NCT00371839|156068896|FG001|Overall Study|Withdrawal by Subject|4|||
48512094|NCT00371839|156068897|FG002|Overall Study|Withdrawal by Subject|0|||
48512095|NCT00371839|156068895|FG000|Overall Study|Lost to Follow-up|6|||
48512096|NCT00371839|156068896|FG001|Overall Study|Lost to Follow-up|3|||
48822113|NCT01474512|157190489|FG006|Maintenance Period|Protocol Violation|0|||
48512097|NCT00371839|156068897|FG002|Overall Study|Lost to Follow-up|2|||
48512098|NCT03935880|156068898|FG000|Overall Study|Lost to Follow-up|0|||
48601090|NCT02567188|156396038|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
48601091|NCT02567188|156396038|FG000|Overall Study|Moved and Changed Clinic|1|||
48512099|NCT03935880|156068899|FG001|Overall Study|Lost to Follow-up|1|||
48512100|NCT01531894|156068900|FG000|Overall Study|Physician Decision|8|||
48512101|NCT01531894|156068900|FG000|Overall Study|Death|1|||
48512102|NCT02718326|156068901|FG000|Overall Study|Adverse Event|4|||
48512103|NCT02718326|156068902|FG001|Overall Study|Adverse Event|9|||
48512104|NCT02718326|156068903|FG002|Overall Study|Adverse Event|0|||
48512105|NCT02718326|156068901|FG000|Overall Study|Death|8|||
48512106|NCT02718326|156068902|FG001|Overall Study|Death|1|||
48512107|NCT02718326|156068903|FG002|Overall Study|Death|2|||
48512108|NCT02718326|156068901|FG000|Overall Study|Withdrawal by Subject|4|||
48512109|NCT02718326|156068902|FG001|Overall Study|Withdrawal by Subject|9|||
48512110|NCT02718326|156068903|FG002|Overall Study|Withdrawal by Subject|6|||
48512111|NCT02718326|156068901|FG000|Overall Study|Lost to Follow-up|18|||
48512112|NCT02718326|156068902|FG001|Overall Study|Lost to Follow-up|5|||
48512113|NCT02718326|156068903|FG002|Overall Study|Lost to Follow-up|14|||
48382303|NCT01749540|155595100|FG003|Overall Study|Withdrawal by Subject|1|||
48382304|NCT01749540|155595101|FG004|Overall Study|Withdrawal by Subject|0|||
48382305|NCT01749540|155595102|FG005|Overall Study|Withdrawal by Subject|0|||
48601092|NCT02567188|156396038|FG000|Overall Study|Started Hemodialysis|2|||
48601093|NCT02567188|156396038|FG000|Overall Study|Protocol Violation|5|||
48601094|NCT00072384|156396039|FG000|Overall Study|Physician Decision|1|||
48729041|NCT02788474|156858294|FG000|Open Label Treatment Period|Patient's refusal|1|||
48729042|NCT02788474|156858295|FG001|Open Label Treatment Period|Patient's refusal|3|||
48512114|NCT02718326|156068901|FG000|Overall Study|Protocol Deviation|1|||
48512115|NCT02718326|156068902|FG001|Overall Study|Protocol Deviation|0|||
48512116|NCT02718326|156068903|FG002|Overall Study|Protocol Deviation|0|||
48512117|NCT02718326|156068901|FG000|Overall Study|Pregnancy|1|||
48512118|NCT02718326|156068902|FG001|Overall Study|Pregnancy|0|||
48512119|NCT02718326|156068903|FG002|Overall Study|Pregnancy|0|||
48512120|NCT00627016|156068904|FG000|Overall Study|Adverse Event|1|||
48512121|NCT00627016|156068905|FG001|Overall Study|Adverse Event|1|||
48512122|NCT00627016|156068904|FG000|Overall Study|Protocol Violation|0|||
48512123|NCT00627016|156068905|FG001|Overall Study|Protocol Violation|2|||
48512124|NCT00627016|156068904|FG000|Overall Study|Lost to Follow-up|0|||
48512125|NCT00627016|156068905|FG001|Overall Study|Lost to Follow-up|1|||
48512126|NCT00627016|156068904|FG000|Overall Study|Withdrawal by Subject|2|||
48512127|NCT00627016|156068905|FG001|Overall Study|Withdrawal by Subject|1|||
48512128|NCT00627016|156068904|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
48512129|NCT00627016|156068905|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
48512130|NCT00627016|156068904|FG000|Overall Study|Lack of Efficacy|1|||
48729043|NCT02788474|156858294|FG000|Open Label Treatment Period|Non-compliance|1|||
48729044|NCT02788474|156858295|FG001|Open Label Treatment Period|Non-compliance|0|||
48729045|NCT03053271|156858297|FG000|Overall Study|Did not meet randomization criteria|3|||
48729046|NCT03053271|156858297|FG000|Overall Study|Withdrawal by Subject|1|||
48729047|NCT02694523|156858298|FG000|Part A|Adverse Event|7|||
48729048|NCT02694523|156858299|FG001|Part A|Adverse Event|3|||
48729049|NCT02694523|156858300|FG002|Part A|Adverse Event|0|||
48729050|NCT02694523|156858301|FG003|Part A|Adverse Event|0|||
48729051|NCT02694523|156858302|FG004|Part A|Adverse Event|0|||
48729052|NCT02694523|156858303|FG005|Part A|Adverse Event|0|||
48729053|NCT02694523|156858304|FG006|Part A|Adverse Event|0|||
48729054|NCT02694523|156858298|FG000|Part A|Protocol Violation|1|||
48729055|NCT02694523|156858299|FG001|Part A|Protocol Violation|0|||
48729056|NCT02694523|156858300|FG002|Part A|Protocol Violation|0|||
48729057|NCT02694523|156858301|FG003|Part A|Protocol Violation|0|||
48729058|NCT02694523|156858302|FG004|Part A|Protocol Violation|0|||
48729059|NCT02694523|156858303|FG005|Part A|Protocol Violation|0|||
48729060|NCT02694523|156858304|FG006|Part A|Protocol Violation|0|||
48729061|NCT02694523|156858298|FG000|Part A|Lost to Follow-up|1|||
48729062|NCT02694523|156858299|FG001|Part A|Lost to Follow-up|2|||
48729063|NCT02694523|156858300|FG002|Part A|Lost to Follow-up|0|||
48729064|NCT02694523|156858301|FG003|Part A|Lost to Follow-up|0|||
48729065|NCT02694523|156858302|FG004|Part A|Lost to Follow-up|0|||
48382306|NCT01749540|155595103|FG006|Overall Study|Withdrawal by Subject|0|||
48512131|NCT00627016|156068905|FG001|Overall Study|Lack of Efficacy|0|||
48512132|NCT00627016|156068904|FG000|Overall Study|Placed on Excluded Drugs|1|||
48512133|NCT00627016|156068905|FG001|Overall Study|Placed on Excluded Drugs|0|||
48512134|NCT00627016|156068904|FG000|Overall Study|Pregnancy|1|||
48729066|NCT02694523|156858303|FG005|Part A|Lost to Follow-up|0|||
48601095|NCT00072384|156396039|FG000|Overall Study|Ineligible|8|||
48382307|NCT01749540|155595097|FG000|Overall Study|Initiated into extension study A536-06|0|||
48512135|NCT00627016|156068905|FG001|Overall Study|Pregnancy|0|||
48512136|NCT03122535|156068906|FG000|Overall Study|Lost to Follow-up|68|||
48512137|NCT03122535|156068907|FG001|Overall Study|Lost to Follow-up|68|||
48512138|NCT03122535|156068906|FG000|Overall Study|Physician Decision|3|||
48729067|NCT02694523|156858304|FG006|Part A|Lost to Follow-up|0|||
48729068|NCT02694523|156858298|FG000|Part A|Withdrawal by Subject|3|||
48512139|NCT03122535|156068907|FG001|Overall Study|Physician Decision|3|||
48512140|NCT03122535|156068906|FG000|Overall Study|Withdrawal by Subject|2|||
48512141|NCT03122535|156068907|FG001|Overall Study|Withdrawal by Subject|2|||
48512142|NCT00377260|156068908|FG000|Overall Study|Lost to Follow-up|0|||
48512143|NCT00377260|156068909|FG001|Overall Study|Lost to Follow-up|1|||
48512144|NCT00377260|156068908|FG000|Overall Study|Withdrawal by Subject|2|||
48512145|NCT00377260|156068909|FG001|Overall Study|Withdrawal by Subject|4|||
48512146|NCT00829530|156068912|FG000|First Intervention|Adverse Event|0|||
48512147|NCT00829530|156068913|FG001|First Intervention|Adverse Event|1|||
48512148|NCT00829530|156068912|FG000|First Intervention|Intolerance to Venopuncture|0|||
48512149|NCT00829530|156068913|FG001|First Intervention|Intolerance to Venopuncture|1|||
48512150|NCT00829530|156068912|FG000|Second Intervention|Intolerance to Venopuncture|1|||
48512151|NCT00829530|156068913|FG001|Second Intervention|Intolerance to Venopuncture|0|||
48512152|NCT01056484|156068914|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
48512153|NCT01056484|156068915|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
48512154|NCT01056484|156068914|FG000|Randomized Controlled Trial|Physician Decision|1|||
48512155|NCT01056484|156068915|FG001|Randomized Controlled Trial|Physician Decision|0|||
48512156|NCT01056484|156068914|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
48512157|NCT01056484|156068915|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
48512158|NCT06195579|156068916|FG000|Overall Study|Withdrawal by Subject|1|||
48512159|NCT02545283|156068917|FG000|Overall Study|Lost to Follow-up|2|||
48512160|NCT02545283|156068918|FG001|Overall Study|Lost to Follow-up|4|||
48512161|NCT02545283|156068917|FG000|Overall Study|Withdrawal by Subject|5|||
48512162|NCT02545283|156068918|FG001|Overall Study|Withdrawal by Subject|9|||
48512163|NCT02545283|156068917|FG000|Overall Study|Death|109|||
48512164|NCT02545283|156068918|FG001|Overall Study|Death|211|||
48512165|NCT02545283|156068917|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
48512166|NCT02545283|156068918|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
48512167|NCT02545283|156068917|FG000|Overall Study|Study Terminated By Sponsor|33|||
48512168|NCT02545283|156068918|FG001|Overall Study|Study Terminated By Sponsor|71|||
48512169|NCT02436005|156068921|FG000|Second Intervention|Adverse Event|0|||
48512170|NCT02436005|156068922|FG001|Second Intervention|Adverse Event|1|||
48512171|NCT00583453|156068923|FG000|Overall Study|discontinued intervention|0|||
48512172|NCT00583453|156068924|FG001|Overall Study|discontinued intervention|2|||
48512173|NCT03106415|156068925|FG000|Phase 1|Withdrawal by Subject|1|||
48512174|NCT03106415|156068926|FG001|Phase 1|Withdrawal by Subject|0|||
48512175|NCT03106415|156068927|FG002|Phase 1|Withdrawal by Subject|0|||
48512176|NCT03106415|156068925|FG000|Phase 1|Adverse Event|1|||
48512177|NCT03106415|156068926|FG001|Phase 1|Adverse Event|1|||
48512178|NCT03106415|156068927|FG002|Phase 1|Adverse Event|0|||
48512179|NCT03106415|156068925|FG000|Phase 1|Protocol Violation|0|||
48512180|NCT03106415|156068926|FG001|Phase 1|Protocol Violation|1|||
48512181|NCT03106415|156068927|FG002|Phase 1|Protocol Violation|0|||
48512182|NCT00984022|156068930|FG000|Overall Study|Lost to Follow-up|10|||
48512183|NCT00984022|156068931|FG001|Overall Study|Lost to Follow-up|14|||
48512184|NCT04112823|156068934|FG000|Overall Study|Lost to Follow-up|2|||
48512185|NCT04112823|156068935|FG001|Overall Study|Lost to Follow-up|3|||
48512186|NCT04408794|156068936|FG000|Overall Study|Adverse Event|43|||
48512187|NCT04408794|156068936|FG000|Overall Study|Infrequent study drug usage|43|||
48512188|NCT04408794|156068936|FG000|Overall Study|Lack of Efficacy|61|||
48512189|NCT04408794|156068936|FG000|Overall Study|Lost to Follow-up|33|||
48512190|NCT04408794|156068936|FG000|Overall Study|Non-compliance|6|||
48512191|NCT04408794|156068936|FG000|Overall Study|Physician Decision|1|||
48512192|NCT04408794|156068936|FG000|Overall Study|Pregnancy|6|||
48512193|NCT04408794|156068936|FG000|Overall Study|Protocol Deviation|9|||
48512194|NCT04408794|156068936|FG000|Overall Study|Sheehan-STS Result|1|||
48512195|NCT04408794|156068936|FG000|Overall Study|Withdrawal by Subject|57|||
48512196|NCT04408794|156068936|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
48512197|NCT04408794|156068936|FG000|Overall Study|Never Treated Migraine|5|||
48512198|NCT01778010|156068938|FG000|Overall Study|Withdrawal by Subject|2|||
48512199|NCT01778010|156068938|FG000|Overall Study|abnormal ECG before meds|1|||
48512200|NCT01778010|156068938|FG000|Overall Study|Arrested|1|||
48512201|NCT01778010|156068938|FG000|Overall Study|rash while on placebo|1|||
48512202|NCT05041361|156068946|FG000|Overall Study|Lost to Follow-up|1|||
48512203|NCT05041361|156068947|FG001|Overall Study|Lost to Follow-up|3|||
48512204|NCT00556322|156068954|FG000|Overall Study|Insufficient therapeutic response|158|||
48512205|NCT00556322|156068955|FG001|Overall Study|Insufficient therapeutic response|168|||
48512206|NCT00556322|156068954|FG000|Overall Study|Adverse Event|7|||
48512207|NCT00556322|156068955|FG001|Overall Study|Adverse Event|4|||
48512208|NCT00556322|156068954|FG000|Overall Study|Other|4|||
48512209|NCT00556322|156068955|FG001|Overall Study|Other|1|||
48601096|NCT02718911|156396040|FG000|Overall Study|Adverse Event|0|||
48601097|NCT02718911|156396041|FG001|Overall Study|Adverse Event|0|||
48512210|NCT00556322|156068954|FG000|Overall Study|Lost to Follow-up|5|||
48512211|NCT00556322|156068955|FG001|Overall Study|Lost to Follow-up|3|||
48512212|NCT00556322|156068954|FG000|Overall Study|Withdrawal by Subject|19|||
48512213|NCT00556322|156068955|FG001|Overall Study|Withdrawal by Subject|7|||
48512214|NCT00556322|156068954|FG000|Overall Study|Protocol Violation|5|||
48512215|NCT00556322|156068955|FG001|Overall Study|Protocol Violation|1|||
48512216|NCT00556322|156068954|FG000|Overall Study|Ongoing at data cutoff|3|||
48512217|NCT00556322|156068955|FG001|Overall Study|Ongoing at data cutoff|5|||
48512218|NCT00556322|156068954|FG000|Overall Study|Death|20|||
48512219|NCT00556322|156068955|FG001|Overall Study|Death|14|||
48729069|NCT02694523|156858299|FG001|Part A|Withdrawal by Subject|1|||
48512220|NCT02488408|156068963|FG000|Part A|Adverse Event|2|||
48512221|NCT02488408|156068964|FG001|Part A|Adverse Event|0|||
48512222|NCT02488408|156068965|FG002|Part A|Adverse Event|0|||
48512223|NCT02488408|156068966|FG003|Part A|Adverse Event|0|||
48512224|NCT02488408|156068967|FG004|Part A|Adverse Event|0|||
48512225|NCT02488408|156068968|FG005|Part A|Adverse Event|0|||
48512226|NCT02488408|156068969|FG006|Part A|Adverse Event|0|||
48512227|NCT02488408|156068970|FG007|Part A|Adverse Event|0|||
48512228|NCT02488408|156068971|FG008|Part A|Adverse Event|0|||
48512229|NCT02488408|156068972|FG009|Part A|Adverse Event|0|||
48512230|NCT02488408|156068963|FG000|Part A|Death|1|||
48512231|NCT02488408|156068964|FG001|Part A|Death|5|||
48512232|NCT02488408|156068965|FG002|Part A|Death|0|||
48512233|NCT02488408|156068966|FG003|Part A|Death|0|||
48512234|NCT02488408|156068967|FG004|Part A|Death|3|||
48512235|NCT02488408|156068968|FG005|Part A|Death|0|||
48512236|NCT02488408|156068969|FG006|Part A|Death|0|||
48512237|NCT02488408|156068970|FG007|Part A|Death|0|||
48512238|NCT02488408|156068971|FG008|Part A|Death|0|||
48512239|NCT02488408|156068972|FG009|Part A|Death|0|||
48512240|NCT02488408|156068963|FG000|Part A|Disease Progression|2|||
48512241|NCT02488408|156068964|FG001|Part A|Disease Progression|8|||
48512242|NCT02488408|156068965|FG002|Part A|Disease Progression|2|||
48512243|NCT02488408|156068966|FG003|Part A|Disease Progression|3|||
48512244|NCT02488408|156068967|FG004|Part A|Disease Progression|4|||
48512245|NCT02488408|156068968|FG005|Part A|Disease Progression|0|||
48512246|NCT02488408|156068969|FG006|Part A|Disease Progression|0|||
48512247|NCT02488408|156068970|FG007|Part A|Disease Progression|0|||
48512248|NCT02488408|156068971|FG008|Part A|Disease Progression|0|||
48512249|NCT02488408|156068972|FG009|Part A|Disease Progression|0|||
48512250|NCT02488408|156068963|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
48512251|NCT02488408|156068964|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
48512252|NCT02488408|156068965|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
48512253|NCT02488408|156068966|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
48512254|NCT02488408|156068967|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
48512255|NCT02488408|156068968|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
48512256|NCT02488408|156068969|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
48512257|NCT02488408|156068970|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
48512258|NCT02488408|156068971|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
48512259|NCT02488408|156068972|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
48512260|NCT02488408|156068963|FG000|Part A|Investigator Decision|0|||
48512261|NCT02488408|156068964|FG001|Part A|Investigator Decision|1|||
48512262|NCT02488408|156068965|FG002|Part A|Investigator Decision|1|||
48512263|NCT02488408|156068966|FG003|Part A|Investigator Decision|0|||
48512264|NCT02488408|156068967|FG004|Part A|Investigator Decision|0|||
48512265|NCT02488408|156068968|FG005|Part A|Investigator Decision|0|||
48512266|NCT02488408|156068969|FG006|Part A|Investigator Decision|0|||
48512267|NCT02488408|156068970|FG007|Part A|Investigator Decision|0|||
48512268|NCT02488408|156068971|FG008|Part A|Investigator Decision|0|||
48512269|NCT02488408|156068972|FG009|Part A|Investigator Decision|0|||
48512270|NCT02488408|156068963|FG000|Part A|Withdrawal by Subject|0|||
48512271|NCT02488408|156068964|FG001|Part A|Withdrawal by Subject|0|||
48512272|NCT02488408|156068965|FG002|Part A|Withdrawal by Subject|2|||
48512273|NCT02488408|156068966|FG003|Part A|Withdrawal by Subject|0|||
48512274|NCT02488408|156068967|FG004|Part A|Withdrawal by Subject|0|||
48512275|NCT02488408|156068968|FG005|Part A|Withdrawal by Subject|0|||
48512276|NCT02488408|156068969|FG006|Part A|Withdrawal by Subject|0|||
48512277|NCT02488408|156068970|FG007|Part A|Withdrawal by Subject|0|||
48512278|NCT02488408|156068971|FG008|Part A|Withdrawal by Subject|0|||
48729070|NCT02694523|156858300|FG002|Part A|Withdrawal by Subject|0|||
48729071|NCT02694523|156858301|FG003|Part A|Withdrawal by Subject|0|||
48729072|NCT02694523|156858302|FG004|Part A|Withdrawal by Subject|0|||
48729073|NCT02694523|156858303|FG005|Part A|Withdrawal by Subject|0|||
48729074|NCT02694523|156858304|FG006|Part A|Withdrawal by Subject|0|||
48729075|NCT02694523|156858298|FG000|Part A|Other|1|||
48512279|NCT02488408|156068972|FG009|Part A|Withdrawal by Subject|0|||
48512280|NCT02488408|156068963|FG000|Part A|Other|1|||
48512281|NCT02488408|156068964|FG001|Part A|Other|0|||
48512282|NCT02488408|156068965|FG002|Part A|Other|0|||
48512283|NCT02488408|156068966|FG003|Part A|Other|0|||
48512284|NCT02488408|156068967|FG004|Part A|Other|0|||
48512285|NCT02488408|156068968|FG005|Part A|Other|0|||
48512286|NCT02488408|156068969|FG006|Part A|Other|0|||
48512287|NCT02488408|156068970|FG007|Part A|Other|0|||
48729076|NCT02694523|156858299|FG001|Part A|Other|1|||
48729077|NCT02694523|156858300|FG002|Part A|Other|0|||
48822114|NCT01474512|157190490|FG007|Maintenance Period|Protocol Violation|1|||
48822115|NCT01474512|157190491|FG008|Maintenance Period|Protocol Violation|0|||
48822116|NCT01474512|157190492|FG009|Maintenance Period|Protocol Violation|1|||
48822117|NCT01474512|157190493|FG010|Maintenance Period|Protocol Violation|0|||
48822118|NCT01474512|157190494|FG011|Maintenance Period|Protocol Violation|0|||
48822119|NCT01474512|157190495|FG012|Maintenance Period|Protocol Violation|0|||
48822120|NCT01474512|157190496|FG013|Maintenance Period|Protocol Violation|0|||
48822121|NCT01474512|157190497|FG014|Maintenance Period|Protocol Violation|0|||
48822122|NCT01474512|157190498|FG015|Maintenance Period|Protocol Violation|0|||
48822123|NCT01474512|157190499|FG016|Maintenance Period|Protocol Violation|0|||
48822124|NCT01474512|157190500|FG017|Maintenance Period|Protocol Violation|0|||
48512288|NCT02488408|156068971|FG008|Part A|Other|0|||
48512289|NCT02488408|156068972|FG009|Part A|Other|0|||
48729078|NCT02694523|156858301|FG003|Part A|Other|0|||
48729079|NCT02694523|156858302|FG004|Part A|Other|0|||
48729080|NCT02694523|156858303|FG005|Part A|Other|0|||
48512290|NCT02488408|156068963|FG000|Part B|Adverse Event|0|||
48512291|NCT02488408|156068964|FG001|Part B|Adverse Event|0|||
48822125|NCT01474512|157190483|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
48822126|NCT01474512|157190484|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
48822127|NCT01474512|157190485|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
48822128|NCT01474512|157190486|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
48822129|NCT01474512|157190487|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
48822130|NCT01474512|157190488|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
48822131|NCT01474512|157190489|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
48822132|NCT01474512|157190490|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
48729081|NCT02694523|156858304|FG006|Part A|Other|0|||
48729082|NCT02694523|156858298|FG000|Part B|Adverse Event|0|||
48822133|NCT01474512|157190491|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
48729083|NCT02694523|156858299|FG001|Part B|Adverse Event|0|||
48512292|NCT02488408|156068965|FG002|Part B|Adverse Event|0|||
48512293|NCT02488408|156068966|FG003|Part B|Adverse Event|0|||
48512294|NCT02488408|156068967|FG004|Part B|Adverse Event|0|||
48512295|NCT02488408|156068968|FG005|Part B|Adverse Event|2|||
48512296|NCT02488408|156068969|FG006|Part B|Adverse Event|2|||
48512297|NCT02488408|156068970|FG007|Part B|Adverse Event|7|||
48729084|NCT02694523|156858300|FG002|Part B|Adverse Event|7|||
48729085|NCT02694523|156858301|FG003|Part B|Adverse Event|1|||
48729086|NCT02694523|156858302|FG004|Part B|Adverse Event|1|||
48729087|NCT02694523|156858303|FG005|Part B|Adverse Event|2|||
48729088|NCT02694523|156858304|FG006|Part B|Adverse Event|0|||
48729089|NCT02694523|156858298|FG000|Part B|Protocol Violation|0|||
48729090|NCT02694523|156858299|FG001|Part B|Protocol Violation|0|||
48729091|NCT02694523|156858300|FG002|Part B|Protocol Violation|1|||
48729092|NCT02694523|156858301|FG003|Part B|Protocol Violation|0|||
48512298|NCT02488408|156068971|FG008|Part B|Adverse Event|2|||
48512299|NCT02488408|156068972|FG009|Part B|Adverse Event|2|||
48512300|NCT02488408|156068963|FG000|Part B|Death|0|||
48729093|NCT02694523|156858302|FG004|Part B|Protocol Violation|0|||
48822134|NCT01474512|157190492|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
48822135|NCT01474512|157190493|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
48822136|NCT01474512|157190494|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
48822137|NCT01474512|157190495|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
48729094|NCT02694523|156858303|FG005|Part B|Protocol Violation|0|||
48729095|NCT02694523|156858304|FG006|Part B|Protocol Violation|0|||
48729096|NCT02694523|156858298|FG000|Part B|Lost to Follow-up|0|||
48729097|NCT02694523|156858299|FG001|Part B|Lost to Follow-up|0|||
48729098|NCT02694523|156858300|FG002|Part B|Lost to Follow-up|2|||
48822138|NCT01474512|157190496|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
48822139|NCT01474512|157190497|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
48512301|NCT02488408|156068964|FG001|Part B|Death|0|||
48512302|NCT02488408|156068965|FG002|Part B|Death|0|||
48512303|NCT02488408|156068966|FG003|Part B|Death|0|||
48512304|NCT02488408|156068967|FG004|Part B|Death|0|||
48512305|NCT02488408|156068968|FG005|Part B|Death|3|||
48822140|NCT01474512|157190498|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
48512306|NCT02488408|156068969|FG006|Part B|Death|1|||
48512307|NCT02488408|156068970|FG007|Part B|Death|2|||
48822141|NCT01474512|157190499|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
48512308|NCT02488408|156068971|FG008|Part B|Death|2|||
48729099|NCT02694523|156858301|FG003|Part B|Lost to Follow-up|3|||
48512309|NCT02488408|156068972|FG009|Part B|Death|2|||
48512310|NCT02488408|156068963|FG000|Part B|Death due to Disease Progression|0|||
48512311|NCT02488408|156068964|FG001|Part B|Death due to Disease Progression|0|||
48512312|NCT02488408|156068965|FG002|Part B|Death due to Disease Progression|0|||
48512313|NCT02488408|156068966|FG003|Part B|Death due to Disease Progression|0|||
48512314|NCT02488408|156068967|FG004|Part B|Death due to Disease Progression|0|||
48729100|NCT02694523|156858302|FG004|Part B|Lost to Follow-up|2|||
48729101|NCT02694523|156858303|FG005|Part B|Lost to Follow-up|0|||
48729102|NCT02694523|156858304|FG006|Part B|Lost to Follow-up|1|||
48729103|NCT02694523|156858298|FG000|Part B|Withdrawal by Subject|0|||
48729104|NCT02694523|156858299|FG001|Part B|Withdrawal by Subject|0|||
48729105|NCT02694523|156858300|FG002|Part B|Withdrawal by Subject|9|||
48729106|NCT02694523|156858301|FG003|Part B|Withdrawal by Subject|0|||
48729107|NCT02694523|156858302|FG004|Part B|Withdrawal by Subject|1|||
48729108|NCT02694523|156858303|FG005|Part B|Withdrawal by Subject|3|||
48729109|NCT02694523|156858304|FG006|Part B|Withdrawal by Subject|0|||
48729110|NCT02694523|156858298|FG000|Part B|Other|0|||
48729111|NCT02694523|156858299|FG001|Part B|Other|0|||
48729112|NCT02694523|156858300|FG002|Part B|Other|1|||
48729113|NCT02694523|156858301|FG003|Part B|Other|0|||
48729114|NCT02694523|156858302|FG004|Part B|Other|0|||
48729115|NCT02694523|156858303|FG005|Part B|Other|0|||
48729116|NCT02694523|156858304|FG006|Part B|Other|1|||
48729117|NCT01272661|156858305|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
48729118|NCT01272661|156858306|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
48729119|NCT01272661|156858307|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
48729120|NCT02962765|156858308|FG000|Overall Study|Protocol Violation|9|||
48729121|NCT02962765|156858308|FG000|Overall Study|Withdrawal by Subject|3|||
48729122|NCT02962765|156858308|FG000|Overall Study|Lost to Follow-up|1|||
48729123|NCT02962765|156858308|FG000|Overall Study|Death|1|||
48729124|NCT02962765|156858308|FG000|Overall Study|Limited access to study medication|3|||
48729125|NCT05409183|156858314|FG000|Complete Study|Adverse Event|1|||
48729126|NCT05409183|156858315|FG001|Complete Study|Adverse Event|2|||
48729127|NCT05409183|156858314|FG000|Complete Study|Withdrawal by Subject|3|||
48729128|NCT05409183|156858315|FG001|Complete Study|Withdrawal by Subject|0|||
48729129|NCT04654468|156858317|FG000|Overall Study|Death|1|||
48729130|NCT04654468|156858317|FG000|Overall Study|Ongoing in the Study|50|||
48729131|NCT00764504|156858319|FG000|Overall Study|Death|12|||
48729132|NCT00764504|156858320|FG001|Overall Study|Death|6|||
48729133|NCT00764504|156858321|FG002|Overall Study|Death|13|||
48729134|NCT00764504|156858319|FG000|Overall Study|Revision of Device|12|||
48729135|NCT00764504|156858320|FG001|Overall Study|Revision of Device|23|||
48729136|NCT00764504|156858321|FG002|Overall Study|Revision of Device|14|||
48729137|NCT00764504|156858319|FG000|Overall Study|Physician Decision|1|||
48729138|NCT00764504|156858320|FG001|Overall Study|Physician Decision|0|||
48729139|NCT00764504|156858321|FG002|Overall Study|Physician Decision|0|||
48729140|NCT00764504|156858319|FG000|Overall Study|Withdrawal by Subject|1|||
48729141|NCT00764504|156858320|FG001|Overall Study|Withdrawal by Subject|7|||
48729142|NCT00764504|156858321|FG002|Overall Study|Withdrawal by Subject|4|||
48822142|NCT01474512|157190500|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
48822143|NCT01474512|157190483|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
48822144|NCT01474512|157190484|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
48822145|NCT01474512|157190485|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
48822146|NCT01474512|157190486|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
48822147|NCT01474512|157190487|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
48822148|NCT01474512|157190488|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
48822149|NCT01474512|157190489|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
48822150|NCT01474512|157190490|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
48822151|NCT01474512|157190491|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
48822152|NCT01474512|157190492|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
48822153|NCT01474512|157190493|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
48822154|NCT01474512|157190494|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
48822155|NCT01474512|157190495|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
48822156|NCT01474512|157190496|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
48822157|NCT01474512|157190497|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
48822158|NCT01474512|157190498|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
48822159|NCT01474512|157190499|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
48822160|NCT01474512|157190500|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
48822161|NCT01474512|157190483|FG000|Long-Term Extension Period|Adverse Event|0|||
48729143|NCT00764504|156858319|FG000|Overall Study|Lost to Follow-up|40|||
48822162|NCT01474512|157190484|FG001|Long-Term Extension Period|Adverse Event|0|||
48822163|NCT01474512|157190485|FG002|Long-Term Extension Period|Adverse Event|0|||
48822164|NCT01474512|157190486|FG003|Long-Term Extension Period|Adverse Event|0|||
48438861|NCT01797965|155793953|FG001|Overall Study|Adverse Event|129|||
48438862|NCT01797965|155793954|FG002|Overall Study|Adverse Event|4|||
48438863|NCT01797965|155793955|FG003|Overall Study|Adverse Event|21|||
48438864|NCT01797965|155793952|FG000|Overall Study|Lost to Follow-up|9|||
48438865|NCT01797965|155793953|FG001|Overall Study|Lost to Follow-up|8|||
48438866|NCT01797965|155793954|FG002|Overall Study|Lost to Follow-up|1|||
48438867|NCT01797965|155793955|FG003|Overall Study|Lost to Follow-up|2|||
48438868|NCT01797965|155793952|FG000|Overall Study|Consent withdrawn|130|||
48438869|NCT01797965|155793953|FG001|Overall Study|Consent withdrawn|117|||
48438870|NCT01797965|155793954|FG002|Overall Study|Consent withdrawn|3|||
48438871|NCT01797965|155793955|FG003|Overall Study|Consent withdrawn|35|||
48438872|NCT01797965|155793952|FG000|Overall Study|Investigator decision|21|||
48438873|NCT01797965|155793953|FG001|Overall Study|Investigator decision|15|||
48438874|NCT01797965|155793954|FG002|Overall Study|Investigator decision|0|||
48512315|NCT02488408|156068968|FG005|Part B|Death due to Disease Progression|2|||
48512316|NCT02488408|156068969|FG006|Part B|Death due to Disease Progression|2|||
48512317|NCT02488408|156068970|FG007|Part B|Death due to Disease Progression|1|||
48512318|NCT02488408|156068971|FG008|Part B|Death due to Disease Progression|1|||
48512319|NCT02488408|156068972|FG009|Part B|Death due to Disease Progression|1|||
48729144|NCT00764504|156858320|FG001|Overall Study|Lost to Follow-up|34|||
48729145|NCT00764504|156858321|FG002|Overall Study|Lost to Follow-up|72|||
48729146|NCT02028871|156858322|FG000|Overall Study|Positive urine drug screen|1|||
48729147|NCT02028871|156858323|FG001|Overall Study|Positive urine drug screen|1|||
48729148|NCT02028871|156858322|FG000|Overall Study|Withdrawal by Subject|1|||
48729149|NCT02028871|156858323|FG001|Overall Study|Withdrawal by Subject|2|||
48729150|NCT02028871|156858322|FG000|Overall Study|IV placement difficulty|1|||
48729151|NCT02028871|156858323|FG001|Overall Study|IV placement difficulty|0|||
48729152|NCT02028871|156858322|FG000|Overall Study|Current Illness|1|||
48729153|NCT02028871|156858323|FG001|Overall Study|Current Illness|0|||
48729154|NCT00006389|156858329|FG000|Overall Study|Adverse Event|1|||
48729155|NCT00989573|156858340|FG000|Overall Study|Adverse Event|8|||
48729156|NCT00989573|156858341|FG001|Overall Study|Adverse Event|12|||
48729157|NCT00989573|156858342|FG002|Overall Study|Adverse Event|4|||
48729158|NCT00989573|156858340|FG000|Overall Study|Physician Decision|0|||
48729159|NCT00989573|156858341|FG001|Overall Study|Physician Decision|2|||
48729160|NCT00989573|156858342|FG002|Overall Study|Physician Decision|0|||
48729161|NCT00989573|156858340|FG000|Overall Study|Protocol Violation|1|||
48729162|NCT00989573|156858341|FG001|Overall Study|Protocol Violation|1|||
48729163|NCT00989573|156858342|FG002|Overall Study|Protocol Violation|1|||
48729164|NCT00989573|156858340|FG000|Overall Study|Withdrawal by Subject|4|||
48729165|NCT00989573|156858341|FG001|Overall Study|Withdrawal by Subject|7|||
48729166|NCT00989573|156858342|FG002|Overall Study|Withdrawal by Subject|3|||
48729167|NCT01674634|156858354|FG000|Overall Study|Withdrawal by Subject|3|||
48729168|NCT01674634|156858354|FG000|Overall Study|Lost to Follow-up|3|||
48729169|NCT04690582|156858359|FG000|Overall Study|Withdrawal by Subject|6|||
48729170|NCT04690582|156858360|FG001|Overall Study|Withdrawal by Subject|4|||
48729171|NCT05736224|156858361|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
48729172|NCT02452697|156858362|FG000|Overall Study|Physician Decision|4|||
48729173|NCT02452697|156858363|FG001|Overall Study|Physician Decision|4|||
48729174|NCT02452697|156858364|FG002|Overall Study|Physician Decision|3|||
48729175|NCT02452697|156858365|FG003|Overall Study|Physician Decision|2|||
48729176|NCT02452697|156858362|FG000|Overall Study|Withdrawal by Subject|1|||
48729177|NCT02452697|156858363|FG001|Overall Study|Withdrawal by Subject|0|||
48729178|NCT02452697|156858364|FG002|Overall Study|Withdrawal by Subject|0|||
48729179|NCT02452697|156858365|FG003|Overall Study|Withdrawal by Subject|0|||
48729180|NCT02452697|156858362|FG000|Overall Study|still in follow-up|2|||
48729181|NCT02452697|156858363|FG001|Overall Study|still in follow-up|2|||
48729182|NCT02452697|156858364|FG002|Overall Study|still in follow-up|1|||
48729183|NCT02452697|156858365|FG003|Overall Study|still in follow-up|3|||
48729184|NCT03803683|156858368|FG000|Overall Study|Lost to Follow-up|41|||
48729185|NCT03803683|156858369|FG001|Overall Study|Lost to Follow-up|18|||
48729186|NCT03803683|156858370|FG002|Overall Study|Lost to Follow-up|12|||
48729187|NCT03803683|156858368|FG000|Overall Study|Withdrawal by Subject|9|||
48729188|NCT03803683|156858369|FG001|Overall Study|Withdrawal by Subject|1|||
48729189|NCT03803683|156858370|FG002|Overall Study|Withdrawal by Subject|4|||
48729190|NCT01709578|156859686|FG000|Overall Study|Rescued and entered in long term safety|63|||
48729191|NCT01709578|156859687|FG001|Overall Study|Rescued and entered in long term safety|25|||
48729192|NCT01709578|156859688|FG002|Overall Study|Rescued and entered in long term safety|26|||
48729193|NCT01709578|156859686|FG000|Overall Study|Adverse Event|9|||
48729194|NCT01709578|156859687|FG001|Overall Study|Adverse Event|18|||
48729195|NCT01709578|156859688|FG002|Overall Study|Adverse Event|17|||
48729196|NCT01709578|156859686|FG000|Overall Study|Lack of Efficacy|5|||
48729197|NCT01709578|156859687|FG001|Overall Study|Lack of Efficacy|4|||
48729198|NCT01709578|156859688|FG002|Overall Study|Lack of Efficacy|2|||
48729199|NCT01709578|156859686|FG000|Overall Study|Poor compliance to protocol|1|||
48729200|NCT01709578|156859687|FG001|Overall Study|Poor compliance to protocol|2|||
48729201|NCT01709578|156859688|FG002|Overall Study|Poor compliance to protocol|1|||
48729202|NCT01709578|156859686|FG000|Overall Study|Other, not related to safety or efficacy|2|||
48729203|NCT01709578|156859687|FG001|Overall Study|Other, not related to safety or efficacy|7|||
48729204|NCT01709578|156859688|FG002|Overall Study|Other, not related to safety or efficacy|5|||
48729205|NCT04050371|156859689|FG000|Overall Study|Withdrawal by Subject|1|||
48729206|NCT04050371|156859690|FG001|Overall Study|Withdrawal by Subject|0|||
48729207|NCT02294773|156859691|FG000|Overall Study|Withdrawal by Subject|0|||
48729208|NCT02294773|156859692|FG001|Overall Study|Withdrawal by Subject|2|||
48729209|NCT05108922|156859693|FG000|Overall Study|Adverse Event|2|||
48729210|NCT05108922|156859694|FG001|Overall Study|Adverse Event|3|||
48729211|NCT05108922|156859693|FG000|Overall Study|Lost to Follow-up|2|||
48729212|NCT05108922|156859694|FG001|Overall Study|Lost to Follow-up|1|||
48512320|NCT02488408|156068963|FG000|Part B|Disease Progression|0|||
48729213|NCT05108922|156859693|FG000|Overall Study|Inadvertent enrollment|0|||
48512321|NCT02488408|156068964|FG001|Part B|Disease Progression|0|||
48512322|NCT02488408|156068965|FG002|Part B|Disease Progression|0|||
48512323|NCT02488408|156068966|FG003|Part B|Disease Progression|0|||
48512324|NCT02488408|156068967|FG004|Part B|Disease Progression|0|||
48512325|NCT02488408|156068968|FG005|Part B|Disease Progression|6|||
48512326|NCT02488408|156068969|FG006|Part B|Disease Progression|9|||
48512327|NCT02488408|156068970|FG007|Part B|Disease Progression|7|||
48512328|NCT02488408|156068971|FG008|Part B|Disease Progression|9|||
48512329|NCT02488408|156068972|FG009|Part B|Disease Progression|11|||
48512330|NCT02488408|156068963|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
48512331|NCT02488408|156068964|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
48512332|NCT02488408|156068965|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
48512333|NCT02488408|156068966|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
48512334|NCT02488408|156068967|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
48512335|NCT02488408|156068968|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
48601098|NCT02718911|156396042|FG002|Overall Study|Adverse Event|0|||
48601099|NCT02718911|156396043|FG003|Overall Study|Adverse Event|0|||
48729214|NCT05108922|156859694|FG001|Overall Study|Inadvertent enrollment|1|||
48729215|NCT05108922|156859693|FG000|Overall Study|Physician Decision|2|||
48729216|NCT05108922|156859694|FG001|Overall Study|Physician Decision|3|||
48729217|NCT05108922|156859693|FG000|Overall Study|Protocol deviation|1|||
48729218|NCT05108922|156859694|FG001|Overall Study|Protocol deviation|0|||
48729219|NCT05108922|156859693|FG000|Overall Study|Screen failure|1|||
48729220|NCT05108922|156859694|FG001|Overall Study|Screen failure|0|||
48729221|NCT05108922|156859693|FG000|Overall Study|Withdrawal by Subject|11|||
48729222|NCT05108922|156859694|FG001|Overall Study|Withdrawal by Subject|8|||
48729223|NCT03183778|156859698|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
48729224|NCT00749580|156859699|FG000|Overall Study|Lost to Follow-up|4|||
48729225|NCT00749580|156859700|FG001|Overall Study|Lost to Follow-up|8|||
48382308|NCT01749540|155595098|FG001|Overall Study|Initiated into extension study A536-06|0|||
48382309|NCT01749540|155595099|FG002|Overall Study|Initiated into extension study A536-06|0|||
48382310|NCT01749540|155595100|FG003|Overall Study|Initiated into extension study A536-06|0|||
48729226|NCT00749580|156859699|FG000|Overall Study|Adverse Event|0|||
48729227|NCT00749580|156859700|FG001|Overall Study|Adverse Event|1|||
48729228|NCT01083173|156859701|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
48729229|NCT01083173|156859702|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
48729230|NCT01083173|156859701|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
48729231|NCT01083173|156859702|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
48729232|NCT01083173|156859701|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
48729233|NCT01083173|156859702|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
48729234|NCT01083173|156859701|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
48729235|NCT01083173|156859702|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
48729236|NCT01083173|156859701|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
48729237|NCT01083173|156859702|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
48729238|NCT01083173|156859701|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
48729239|NCT01083173|156859702|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
48729240|NCT01083173|156859701|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
48729241|NCT01083173|156859702|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
48729242|NCT01083173|156859701|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
48729243|NCT01083173|156859702|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
48729244|NCT01083173|156859701|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
48729245|NCT01083173|156859702|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
48729246|NCT01083173|156859701|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
48729247|NCT01083173|156859702|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
48729248|NCT01083173|156859701|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
48729249|NCT01083173|156859702|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
48439394|NCT00082758|155795988|FG001|Overall Study|Adverse Event|2|||
48439395|NCT00082758|155795989|FG002|Overall Study|Adverse Event|0|||
48439396|NCT00082758|155795987|FG000|Overall Study|Lack of Efficacy|12|||
48439397|NCT00082758|155795988|FG001|Overall Study|Lack of Efficacy|13|||
48439398|NCT00082758|155795989|FG002|Overall Study|Lack of Efficacy|0|||
48439399|NCT00082758|155795987|FG000|Overall Study|Physician Decision|0|||
48439400|NCT00082758|155795988|FG001|Overall Study|Physician Decision|1|||
48439401|NCT00082758|155795989|FG002|Overall Study|Physician Decision|0|||
48439402|NCT00082758|155795987|FG000|Overall Study|Withdrawal by Subject|3|||
48439403|NCT00082758|155795988|FG001|Overall Study|Withdrawal by Subject|0|||
48439404|NCT00082758|155795989|FG002|Overall Study|Withdrawal by Subject|0|||
48439405|NCT00082758|155795987|FG000|Overall Study|Protocol Violation|0|||
48439406|NCT00082758|155795988|FG001|Overall Study|Protocol Violation|1|||
48822165|NCT01474512|157190487|FG004|Long-Term Extension Period|Adverse Event|0|||
48822166|NCT01474512|157190488|FG005|Long-Term Extension Period|Adverse Event|0|||
48822167|NCT01474512|157190489|FG006|Long-Term Extension Period|Adverse Event|0|||
48822168|NCT01474512|157190490|FG007|Long-Term Extension Period|Adverse Event|0|||
48822169|NCT01474512|157190491|FG008|Long-Term Extension Period|Adverse Event|0|||
48512336|NCT02488408|156068969|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
48512337|NCT02488408|156068970|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
48512338|NCT02488408|156068971|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
48512339|NCT02488408|156068972|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
48512340|NCT02488408|156068963|FG000|Part B|Investigator Decision|0|||
48512341|NCT02488408|156068964|FG001|Part B|Investigator Decision|0|||
48512342|NCT02488408|156068965|FG002|Part B|Investigator Decision|0|||
48512343|NCT02488408|156068966|FG003|Part B|Investigator Decision|0|||
48512344|NCT02488408|156068967|FG004|Part B|Investigator Decision|0|||
48512345|NCT02488408|156068968|FG005|Part B|Investigator Decision|0|||
48512346|NCT02488408|156068969|FG006|Part B|Investigator Decision|1|||
48512347|NCT02488408|156068970|FG007|Part B|Investigator Decision|0|||
48512348|NCT02488408|156068971|FG008|Part B|Investigator Decision|2|||
48382311|NCT01749540|155595101|FG004|Overall Study|Initiated into extension study A536-06|0|||
48382312|NCT01749540|155595102|FG005|Overall Study|Initiated into extension study A536-06|2|||
48382313|NCT01749540|155595103|FG006|Overall Study|Initiated into extension study A536-06|24|||
48382314|NCT02243865|155595104|FG000|Overall Study|Protocol Violation|1|||
48382315|NCT02243865|155595105|FG001|Overall Study|Protocol Violation|3|||
48382316|NCT02243865|155595104|FG000|Overall Study|Lost to Follow-up|1|||
48382317|NCT02243865|155595105|FG001|Overall Study|Lost to Follow-up|1|||
48382318|NCT02243865|155595104|FG000|Overall Study|Withdrawal by Subject|1|||
48382319|NCT02243865|155595105|FG001|Overall Study|Withdrawal by Subject|0|||
48382320|NCT02243865|155595104|FG000|Overall Study|Adverse Event|1|||
48382321|NCT02243865|155595105|FG001|Overall Study|Adverse Event|1|||
48382322|NCT02054325|155595106|FG000|Overall Study|Lost to Follow-up|8|||
48382323|NCT02054325|155595107|FG001|Overall Study|Lost to Follow-up|5|||
48382324|NCT00387764|155595108|FG000|Overall Study|Adverse Event|12|||
48382325|NCT00387764|155595108|FG000|Overall Study|Withdrawal by Subject|8|||
48382326|NCT00387764|155595108|FG000|Overall Study|Sponsor Terminated Study|1|||
48382327|NCT00387764|155595108|FG000|Overall Study|Physician Decision|1|||
48382328|NCT00387764|155595108|FG000|Overall Study|Other|2|||
48382329|NCT00387764|155595108|FG000|Overall Study|Death|7|||
48382330|NCT01326728|155595109|FG000|Overall Study|Death|13|||
48382331|NCT01326728|155595110|FG001|Overall Study|Death|0|||
48382332|NCT01326728|155595109|FG000|Overall Study|Early closure of study|34|||
48382333|NCT01326728|155595110|FG001|Overall Study|Early closure of study|9|||
48382334|NCT01323621|155595112|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
48382335|NCT01323621|155595113|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
48382336|NCT01323621|155595114|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
48382337|NCT01323621|155595112|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
48382338|NCT01323621|155595113|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
48382339|NCT01323621|155595114|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
48382340|NCT01323621|155595112|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
48382341|NCT01323621|155595113|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
48382342|NCT01323621|155595114|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
48382343|NCT01323621|155595112|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
48512349|NCT02488408|156068972|FG009|Part B|Investigator Decision|1|||
48512350|NCT02087423|156068973|FG000|Overall Study|Withdrawal by Subject|20|||
48512351|NCT02087423|156068974|FG001|Overall Study|Withdrawal by Subject|20|||
48512352|NCT02087423|156068975|FG002|Overall Study|Withdrawal by Subject|3|||
48512353|NCT02087423|156068973|FG000|Overall Study|Death|68|||
48512354|NCT02087423|156068974|FG001|Overall Study|Death|207|||
48512355|NCT02087423|156068975|FG002|Overall Study|Death|40|||
48512356|NCT02087423|156068973|FG000|Overall Study|Lost to Follow-up|0|||
48512357|NCT02087423|156068974|FG001|Overall Study|Lost to Follow-up|2|||
48512358|NCT02087423|156068975|FG002|Overall Study|Lost to Follow-up|0|||
48512359|NCT02087423|156068973|FG000|Overall Study|Terminated from study at final DCO|23|||
48512360|NCT02087423|156068974|FG001|Overall Study|Terminated from study at final DCO|36|||
48512361|NCT02087423|156068975|FG002|Overall Study|Terminated from study at final DCO|25|||
48382344|NCT01323621|155595113|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
48382345|NCT01323621|155595114|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
48382346|NCT01323621|155595112|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
48382347|NCT01323621|155595113|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
48512362|NCT03138967|156068976|FG000|Overall Study|Death|0|||
48512363|NCT03138967|156068977|FG001|Overall Study|Death|1|||
48512364|NCT03138967|156068976|FG000|Overall Study|Physician Decision|1|||
48382348|NCT01323621|155595114|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
48512365|NCT03138967|156068977|FG001|Overall Study|Physician Decision|3|||
48512366|NCT02588339|156068978|FG000|Overall Study|Withdrawal by Subject|1|||
48822170|NCT01474512|157190492|FG009|Long-Term Extension Period|Adverse Event|0|||
48729250|NCT03954041|156859703|FG000|Overall Study|Lost to Follow-up|3|||
48729251|NCT03954041|156859704|FG001|Overall Study|Lost to Follow-up|3|||
48729252|NCT03954041|156859705|FG002|Overall Study|Lost to Follow-up|6|||
48729253|NCT03954041|156859703|FG000|Overall Study|Death|4|||
48729254|NCT03954041|156859704|FG001|Overall Study|Death|0|||
48729255|NCT03954041|156859705|FG002|Overall Study|Death|1|||
48729256|NCT03954041|156859703|FG000|Overall Study|Death by neurologic criteria|0|||
48729257|NCT03954041|156859704|FG001|Overall Study|Death by neurologic criteria|0|||
48729258|NCT03954041|156859705|FG002|Overall Study|Death by neurologic criteria|1|||
48729259|NCT03954041|156859703|FG000|Overall Study|Reason not specified|7|||
48729260|NCT03954041|156859704|FG001|Overall Study|Reason not specified|4|||
48729261|NCT03954041|156859705|FG002|Overall Study|Reason not specified|2|||
48729262|NCT03954041|156859703|FG000|Overall Study|Withdrew prior to dosing|4|||
48729263|NCT03954041|156859704|FG001|Overall Study|Withdrew prior to dosing|2|||
48729264|NCT03954041|156859705|FG002|Overall Study|Withdrew prior to dosing|0|||
48729265|NCT03868124|156859706|FG000|Overall Study|Withdrawal by Subject|4|||
48729266|NCT03868124|156859707|FG001|Overall Study|Withdrawal by Subject|0|||
48382349|NCT01323621|155595112|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
48439407|NCT00082758|155795989|FG002|Overall Study|Protocol Violation|0|||
48439408|NCT01114373|155795990|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
48439409|NCT01114373|155795991|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
48439410|NCT01114373|155795990|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
48439411|NCT01114373|155795991|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
48439412|NCT01114373|155795990|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
48439413|NCT01114373|155795991|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
48439414|NCT01114373|155795990|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
48439415|NCT01114373|155795991|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
48439416|NCT00848250|155795992|FG000|Overall Study|surgery was completed without cardiopulm|0|||
48439417|NCT00848250|155795993|FG001|Overall Study|surgery was completed without cardiopulm|1|||
48439418|NCT05631548|155795994|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
48439419|NCT05631548|155795995|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
48439420|NCT00390416|155795996|FG000|Overall Study|Withdrawal by Subject|1|||
48439421|NCT00390416|155795996|FG000|Overall Study|Not treated|3|||
48439422|NCT02207556|155796008|FG000|Overall Study|Physician Decision|1|||
48439423|NCT02207556|155796009|FG001|Overall Study|Physician Decision|0|||
48439424|NCT02207556|155796008|FG000|Overall Study|Withdrawal by Subject|1|||
48439425|NCT02207556|155796009|FG001|Overall Study|Withdrawal by Subject|0|||
48439426|NCT02207556|155796008|FG000|Overall Study|Death|0|||
48439427|NCT02207556|155796009|FG001|Overall Study|Death|5|||
48439428|NCT00502320|155796010|FG000|Overall Study|Lost to Follow-up|1|||
48439429|NCT00502320|155796011|FG001|Overall Study|Lost to Follow-up|1|||
48439430|NCT00502320|155796010|FG000|Overall Study|Withdrew Consent|1|||
48439431|NCT00502320|155796011|FG001|Overall Study|Withdrew Consent|0|||
48439432|NCT00502320|155796010|FG000|Overall Study|No longer met criteria|1|||
48439433|NCT00502320|155796011|FG001|Overall Study|No longer met criteria|0|||
48439434|NCT00502320|155796010|FG000|Overall Study|Screen Failure|0|||
48439435|NCT00502320|155796011|FG001|Overall Study|Screen Failure|1|||
48439436|NCT00502320|155796010|FG000|Overall Study|Adverse Event|3|||
48439437|NCT00502320|155796011|FG001|Overall Study|Adverse Event|5|||
48439438|NCT00194025|155796012|FG000|Overall Study|Adverse Event|1|||
48439439|NCT00194025|155796012|FG000|Overall Study|non-adherence with study medication|4|||
48439440|NCT03943953|155796014|FG000|Trial of ITG 1|Lost to Follow-up|19|||
48439441|NCT03943953|155796015|FG001|Trial of ITG 1|Lost to Follow-up|1|||
48439442|NCT03943953|155796014|FG000|Trial of ITG 2|Lost to Follow-up|8|||
48439443|NCT03943953|155796015|FG001|Trial of ITG 2|Lost to Follow-up|0|||
48439444|NCT03943953|155796014|FG000|Trial of ITG 3|Lost to Follow-up|2|||
48439445|NCT03943953|155796015|FG001|Trial of ITG 3|Lost to Follow-up|0|||
48439446|NCT03943953|155796014|FG000|Trial of ITG 4|Lost to Follow-up|2|||
48439447|NCT03943953|155796015|FG001|Trial of ITG 4|Lost to Follow-up|0|||
48439448|NCT03341923|155796018|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
48439449|NCT03341923|155796019|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
48439450|NCT02432040|155796022|FG000|Overall Study|Lack of Efficacy|3|||
48439451|NCT02432040|155796023|FG001|Overall Study|Lack of Efficacy|0|||
48439452|NCT02432040|155796022|FG000|Overall Study|Lost to Follow-up|4|||
48439453|NCT02432040|155796023|FG001|Overall Study|Lost to Follow-up|5|||
48439454|NCT02432040|155796022|FG000|Overall Study|Physician Decision|1|||
48439455|NCT02432040|155796023|FG001|Overall Study|Physician Decision|1|||
48439456|NCT03247413|155796025|FG000|Overall Study|Lost to Follow-up|28|||
48439457|NCT00664209|155796026|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
48439458|NCT00664209|155796026|FG000|Study Treatment Period|Physician Decision|4|||
48439459|NCT00664209|155796026|FG000|Study Treatment Period|Withdrawal by Subject|2|||
48439460|NCT02767856|155796037|FG000|Overall Study|Lost to Follow-up|9|||
48439461|NCT02767856|155796038|FG001|Overall Study|Lost to Follow-up|1|||
48439462|NCT02767856|155796037|FG000|Overall Study|Withdrawal by Subject|2|||
48512367|NCT02588339|156068978|FG000|Overall Study|GVHD Progression prior to treatment|2|||
48512368|NCT01686438|156068981|FG000|Overall Study|Lost to Follow-up|8|||
48512369|NCT01686438|156068982|FG001|Overall Study|Lost to Follow-up|9|||
48382350|NCT01323621|155595113|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
48382351|NCT01323621|155595114|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
48382352|NCT01323621|155595112|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
48382353|NCT01323621|155595113|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
48382354|NCT01323621|155595114|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
48382355|NCT01323621|155595112|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
48382356|NCT01323621|155595113|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
48382357|NCT01323621|155595114|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
48382358|NCT01323621|155595112|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
48382359|NCT01323621|155595113|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
48382360|NCT01323621|155595114|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
48382361|NCT01323621|155595112|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48382362|NCT01323621|155595113|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48382363|NCT01323621|155595114|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48382364|NCT01323621|155595112|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
48382365|NCT01323621|155595113|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
48822171|NCT01474512|157190493|FG010|Long-Term Extension Period|Adverse Event|0|||
48822172|NCT01474512|157190494|FG011|Long-Term Extension Period|Adverse Event|1|||
48822173|NCT01474512|157190495|FG012|Long-Term Extension Period|Adverse Event|57|||
48822174|NCT01474512|157190496|FG013|Long-Term Extension Period|Adverse Event|58|||
48822175|NCT01474512|157190497|FG014|Long-Term Extension Period|Adverse Event|0|||
48822176|NCT01474512|157190498|FG015|Long-Term Extension Period|Adverse Event|0|||
48822177|NCT01474512|157190499|FG016|Long-Term Extension Period|Adverse Event|0|||
48512370|NCT01686438|156068983|FG002|Overall Study|Lost to Follow-up|10|||
48512371|NCT01686438|156068981|FG000|Overall Study|Adverse Event|0|||
48512372|NCT01686438|156068982|FG001|Overall Study|Adverse Event|0|||
48512373|NCT01686438|156068983|FG002|Overall Study|Adverse Event|1|||
48512374|NCT01686438|156068981|FG000|Overall Study|Protocol Violation|0|||
48512375|NCT01686438|156068982|FG001|Overall Study|Protocol Violation|0|||
48512376|NCT01686438|156068983|FG002|Overall Study|Protocol Violation|1|||
48512377|NCT01686438|156068981|FG000|Overall Study|Withdrawal by Subject|0|||
48512378|NCT01686438|156068982|FG001|Overall Study|Withdrawal by Subject|0|||
48512379|NCT01686438|156068983|FG002|Overall Study|Withdrawal by Subject|1|||
48512380|NCT00463684|156068984|FG000|Overall Study|Withdrawal by Subject|1|||
48512381|NCT00463684|156068984|FG000|Overall Study|Lost to Follow-up|3|||
48512382|NCT02911701|156068987|FG000|Overall Study|Withdrawal by Subject|2|||
48512383|NCT02911701|156068988|FG001|Overall Study|Withdrawal by Subject|4|||
48512384|NCT02911701|156068987|FG000|Overall Study|Adverse Event|1|||
48512385|NCT02911701|156068988|FG001|Overall Study|Adverse Event|0|||
48512386|NCT01190865|156068989|FG000|Overall Study|Withdrawal by Subject|1|||
48512387|NCT01190865|156068989|FG000|Overall Study|Non-compliance|2|||
48512388|NCT03292484|156068990|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
48512389|NCT03292484|156068990|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
48512390|NCT03292484|156068990|FG000|Overall Study|Protocol Violation|2|||
48512391|NCT03292484|156068990|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
48512392|NCT03292484|156068990|FG000|Overall Study|Sponsor decision|349|||
48512393|NCT03292484|156068990|FG000|Overall Study|Lost to Follow-up|7|||
48512394|NCT03292484|156068990|FG000|Overall Study|Coronavirus Disease 2019|1|||
48512395|NCT03292484|156068990|FG000|Overall Study|Other|20|||
48512396|NCT01983969|156068991|FG000|Overall Study|Disease Progression|0|||
48512397|NCT01983969|156068992|FG001|Overall Study|Disease Progression|1|||
48512398|NCT01983969|156068993|FG002|Overall Study|Disease Progression|0|||
48512399|NCT01010503|156068994|FG000|Overall Study|Adverse Event|1|||
48512400|NCT01010503|156068994|FG000|Overall Study|Death|1|||
48512401|NCT04633564|156068995|FG000|Period 1|Adverse Event|28|||
48512402|NCT04633564|156068996|FG001|Period 1|Adverse Event|19|||
48512403|NCT04633564|156068995|FG000|Period 1|Death|8|||
48512404|NCT04633564|156068996|FG001|Period 1|Death|7|||
48512405|NCT04633564|156068995|FG000|Period 1|Lost to Follow-up|3|||
48822178|NCT01474512|157190500|FG017|Long-Term Extension Period|Adverse Event|0|||
48822179|NCT01474512|157190483|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
48382366|NCT01323621|155595114|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
48512406|NCT04633564|156068996|FG001|Period 1|Lost to Follow-up|5|||
48512407|NCT04633564|156068995|FG000|Period 1|Physician Decision|4|||
48512408|NCT04633564|156068996|FG001|Period 1|Physician Decision|12|||
48512409|NCT04633564|156068995|FG000|Period 1|Protocol Violation|0|||
48512410|NCT04633564|156068996|FG001|Period 1|Protocol Violation|1|||
48512411|NCT04633564|156068995|FG000|Period 1|Withdrawal by Subject|10|||
48512412|NCT04633564|156068996|FG001|Period 1|Withdrawal by Subject|8|||
48512413|NCT04633564|156068995|FG000|Period 1|Progressive disease|47|||
48512414|NCT04633564|156068996|FG001|Period 1|Progressive disease|51|||
48512415|NCT04633564|156068995|FG000|Period 1|Terminated by Sponsor|8|||
48729267|NCT03868124|156859708|FG002|Overall Study|Withdrawal by Subject|1|||
48512416|NCT04633564|156068996|FG001|Period 1|Terminated by Sponsor|6|||
48512417|NCT04633564|156068995|FG000|Period 2|Adverse Event|3|||
48512418|NCT04633564|156068996|FG001|Period 2|Adverse Event|4|||
48512419|NCT04633564|156068995|FG000|Period 2|Death|0|||
48512420|NCT04633564|156068996|FG001|Period 2|Death|2|||
48512421|NCT04633564|156068995|FG000|Period 2|Lost to Follow-up|0|||
48512422|NCT04633564|156068996|FG001|Period 2|Lost to Follow-up|1|||
48512423|NCT04633564|156068995|FG000|Period 2|Physician Decision|2|||
48512424|NCT04633564|156068996|FG001|Period 2|Physician Decision|4|||
48512425|NCT04633564|156068995|FG000|Period 2|Withdrawal by Subject|5|||
48512426|NCT04633564|156068996|FG001|Period 2|Withdrawal by Subject|1|||
48512427|NCT04633564|156068995|FG000|Period 2|Progressive Disease|74|||
48512428|NCT04633564|156068996|FG001|Period 2|Progressive Disease|82|||
48512429|NCT04633564|156068995|FG000|Period 2|Terminated by Sponsor|9|||
48512430|NCT04633564|156068996|FG001|Period 2|Terminated by Sponsor|3|||
48512431|NCT02281084|156068997|FG000|Overall Study|Death|21|||
48512432|NCT02281084|156068998|FG001|Overall Study|Death|18|||
48512433|NCT02281084|156068999|FG002|Overall Study|Death|3|||
48512434|NCT02281084|156069000|FG003|Overall Study|Death|5|||
48512435|NCT02281084|156068997|FG000|Overall Study|Adverse Event|1|||
48512436|NCT02281084|156068998|FG001|Overall Study|Adverse Event|0|||
48512437|NCT02281084|156068999|FG002|Overall Study|Adverse Event|0|||
48512438|NCT02281084|156069000|FG003|Overall Study|Adverse Event|0|||
48512439|NCT02281084|156068997|FG000|Overall Study|Withdrawal by Subject|2|||
48512440|NCT02281084|156068998|FG001|Overall Study|Withdrawal by Subject|2|||
48512441|NCT02281084|156068999|FG002|Overall Study|Withdrawal by Subject|0|||
48512442|NCT02281084|156069000|FG003|Overall Study|Withdrawal by Subject|0|||
48512443|NCT02281084|156068997|FG000|Overall Study|Site Closure by Sponsor|5|||
48512444|NCT02281084|156068998|FG001|Overall Study|Site Closure by Sponsor|1|||
48512445|NCT02281084|156068999|FG002|Overall Study|Site Closure by Sponsor|2|||
48512446|NCT02281084|156069000|FG003|Overall Study|Site Closure by Sponsor|0|||
48512447|NCT04173247|156069003|FG000|Overall Study|Withdrawal by Subject|0|||
48512448|NCT04173247|156069004|FG001|Overall Study|Withdrawal by Subject|2|||
48512449|NCT04173247|156069003|FG000|Overall Study|Death|1|||
48512450|NCT04173247|156069004|FG001|Overall Study|Death|0|||
48512451|NCT04173247|156069003|FG000|Overall Study|Physician Decision|1|||
48512452|NCT04173247|156069004|FG001|Overall Study|Physician Decision|0|||
48512453|NCT03238781|156069005|FG000|Overall Study|Adverse Event|1|||
48512454|NCT03238781|156069006|FG001|Overall Study|Adverse Event|1|||
48512455|NCT03238781|156069007|FG002|Overall Study|Adverse Event|2|||
48512456|NCT03238781|156069005|FG000|Overall Study|Lost to Follow-up|2|||
48512457|NCT03238781|156069006|FG001|Overall Study|Lost to Follow-up|1|||
48512458|NCT03238781|156069007|FG002|Overall Study|Lost to Follow-up|2|||
48512459|NCT03238781|156069005|FG000|Overall Study|Withdrawal by Subject|23|||
48512460|NCT03238781|156069006|FG001|Overall Study|Withdrawal by Subject|14|||
48512461|NCT03238781|156069007|FG002|Overall Study|Withdrawal by Subject|16|||
48512462|NCT03238781|156069005|FG000|Overall Study|Decision by sponsor|0|||
48512463|NCT03238781|156069006|FG001|Overall Study|Decision by sponsor|1|||
48512464|NCT03238781|156069007|FG002|Overall Study|Decision by sponsor|0|||
48512465|NCT03873272|156070793|FG000|Overall Study|Withdrawal by Subject|2|||
48512466|NCT03873272|156070794|FG001|Overall Study|Withdrawal by Subject|0|||
48512467|NCT03873272|156070795|FG002|Overall Study|Withdrawal by Subject|1|||
48512468|NCT03873272|156070793|FG000|Overall Study|Death|0|||
48512469|NCT03873272|156070794|FG001|Overall Study|Death|2|||
48512470|NCT03873272|156070795|FG002|Overall Study|Death|1|||
48512471|NCT02653664|156070798|FG000|Post-Treatment|Withdrawal by Subject|6|||
48512472|NCT02653664|156070799|FG001|Post-Treatment|Withdrawal by Subject|5|||
48729268|NCT03868124|156859706|FG000|Overall Study|Physician Decision|1|||
48729269|NCT03868124|156859707|FG001|Overall Study|Physician Decision|0|||
48729270|NCT03868124|156859708|FG002|Overall Study|Physician Decision|1|||
48729271|NCT03868124|156859706|FG000|Overall Study|Lost to Follow-up|1|||
48729272|NCT03868124|156859707|FG001|Overall Study|Lost to Follow-up|1|||
48729273|NCT03868124|156859708|FG002|Overall Study|Lost to Follow-up|2|||
48729274|NCT03868124|156859706|FG000|Overall Study|Death|1|||
48512473|NCT02653664|156070800|FG002|Post-Treatment|Withdrawal by Subject|7|||
48512474|NCT02653664|156070798|FG000|Post-Treatment|Lost to Follow-up|8|||
48512475|NCT02653664|156070799|FG001|Post-Treatment|Lost to Follow-up|1|||
48512476|NCT02653664|156070800|FG002|Post-Treatment|Lost to Follow-up|7|||
48512477|NCT02653664|156070798|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
48512478|NCT02653664|156070799|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
48512479|NCT02653664|156070800|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
48512480|NCT02653664|156070798|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
48512481|NCT02653664|156070799|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
48512482|NCT02653664|156070800|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
48512483|NCT02653664|156070798|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
48512484|NCT02653664|156070799|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
48512485|NCT02653664|156070800|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
48729275|NCT03868124|156859707|FG001|Overall Study|Death|1|||
48729276|NCT03868124|156859708|FG002|Overall Study|Death|2|||
48729277|NCT03868124|156859706|FG000|Overall Study|Adverse Event|0|||
48729278|NCT03868124|156859707|FG001|Overall Study|Adverse Event|0|||
48729279|NCT03868124|156859708|FG002|Overall Study|Adverse Event|3|||
48729280|NCT03868124|156859706|FG000|Overall Study|Explanted|2|||
48729281|NCT03868124|156859707|FG001|Overall Study|Explanted|1|||
48729282|NCT03868124|156859708|FG002|Overall Study|Explanted|0|||
48729283|NCT03868124|156859706|FG000|Overall Study|Ongoing in study|176|||
48729284|NCT03868124|156859707|FG001|Overall Study|Ongoing in study|180|||
48729285|NCT03868124|156859708|FG002|Overall Study|Ongoing in study|183|||
48729286|NCT04024462|156859711|FG000|Overall Study|Withdrawal by Subject|6|||
48729287|NCT04024462|156859712|FG001|Overall Study|Withdrawal by Subject|7|||
48729288|NCT04024462|156859711|FG000|Overall Study|Progressive Disease|0|||
48729289|NCT04024462|156859712|FG001|Overall Study|Progressive Disease|1|||
48729290|NCT04024462|156859711|FG000|Overall Study|Adverse Event|0|||
48729291|NCT04024462|156859712|FG001|Overall Study|Adverse Event|1|||
48729292|NCT04024462|156859711|FG000|Overall Study|Death|0|||
48729293|NCT04024462|156859712|FG001|Overall Study|Death|1|||
48729294|NCT04024462|156859711|FG000|Overall Study|Lost to Follow-up|1|||
48729295|NCT04024462|156859712|FG001|Overall Study|Lost to Follow-up|0|||
48729296|NCT04024462|156859711|FG000|Overall Study|Ongoing in the Study|94|||
48729297|NCT04024462|156859712|FG001|Overall Study|Ongoing in the Study|89|||
48822180|NCT01474512|157190484|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
48822181|NCT01474512|157190485|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
48822182|NCT01474512|157190486|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
48512486|NCT02653664|156070798|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
48512487|NCT02653664|156070799|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
48512488|NCT02653664|156070800|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
48512489|NCT02653664|156070798|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
48512490|NCT02653664|156070799|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
48512491|NCT02653664|156070800|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
48512492|NCT02653664|156070798|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
48512493|NCT02653664|156070799|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
48512494|NCT02653664|156070800|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
48512495|NCT02653664|156070798|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
48512496|NCT02653664|156070799|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
48512497|NCT02653664|156070800|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
48512498|NCT02653664|156070798|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
48512499|NCT02653664|156070799|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
48512500|NCT02653664|156070800|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
48512501|NCT00462345|156070803|FG000|Overall Study|Withdrawal by Subject|2|||
48512502|NCT00462345|156070803|FG000|Overall Study|Did not complete second course|1|||
48512503|NCT02642653|156070805|FG000|Overall Study|Adverse Event|2|||
48512504|NCT02642653|156070806|FG001|Overall Study|Adverse Event|0|||
48512505|NCT00365365|156070807|FG000|Overall Study|Randomized but not treated|0|||
48512506|NCT00365365|156070808|FG001|Overall Study|Randomized but not treated|2|||
48512507|NCT00365365|156070809|FG002|Overall Study|Randomized but not treated|0|||
48512508|NCT00365365|156070807|FG000|Overall Study|Poor compliance to protocol|0|||
48512509|NCT00365365|156070808|FG001|Overall Study|Poor compliance to protocol|1|||
48512510|NCT00365365|156070809|FG002|Overall Study|Poor compliance to protocol|0|||
48512511|NCT00365365|156070807|FG000|Overall Study|Lost to Follow-up|3|||
48512512|NCT00365365|156070808|FG001|Overall Study|Lost to Follow-up|3|||
48512513|NCT00365365|156070809|FG002|Overall Study|Lost to Follow-up|3|||
48512514|NCT00365365|156070807|FG000|Overall Study|Death|1|||
48512515|NCT00365365|156070808|FG001|Overall Study|Death|3|||
48512516|NCT00365365|156070809|FG002|Overall Study|Death|0|||
48512517|NCT00365365|156070807|FG000|Overall Study|Subject's request|11|||
48512518|NCT00365365|156070808|FG001|Overall Study|Subject's request|13|||
48512519|NCT00365365|156070809|FG002|Overall Study|Subject's request|1|||
48512520|NCT00365365|156070807|FG000|Overall Study|Disease progression/relapse|9|||
48601100|NCT02718911|156396044|FG004|Overall Study|Adverse Event|0|||
48729298|NCT05128929|156859715|FG000|Overall Study|Adverse Event|0|||
48729299|NCT05128929|156859716|FG001|Overall Study|Adverse Event|1|||
48729300|NCT04622735|156859717|FG000|Overall Study|Lost to Follow-up|1|||
48729301|NCT04622735|156859718|FG001|Overall Study|Lost to Follow-up|2|||
48729302|NCT04622735|156859719|FG002|Overall Study|Lost to Follow-up|1|||
48729303|NCT04622735|156859717|FG000|Overall Study|Adverse Event|0|||
48729304|NCT04622735|156859718|FG001|Overall Study|Adverse Event|0|||
48822183|NCT01474512|157190487|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
48822184|NCT01474512|157190488|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
48512521|NCT00365365|156070808|FG001|Overall Study|Disease progression/relapse|6|||
48512522|NCT00365365|156070809|FG002|Overall Study|Disease progression/relapse|7|||
48512523|NCT00365365|156070807|FG000|Overall Study|Adverse Event|6|||
48512524|NCT00365365|156070808|FG001|Overall Study|Adverse Event|6|||
48512525|NCT00365365|156070809|FG002|Overall Study|Adverse Event|3|||
48729305|NCT04622735|156859719|FG002|Overall Study|Adverse Event|1|||
48822185|NCT01474512|157190489|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
48729306|NCT04622735|156859717|FG000|Overall Study|Protocol Violation|1|||
48729307|NCT04622735|156859718|FG001|Overall Study|Protocol Violation|0|||
48729308|NCT04622735|156859719|FG002|Overall Study|Protocol Violation|0|||
48729309|NCT01809691|156859720|FG000|Overall Study|Currently on Treatment|192|||
48729310|NCT01809691|156859721|FG001|Overall Study|Currently on Treatment|100|||
48729311|NCT01809691|156859720|FG000|Overall Study|No Protocol Treatment|10|||
48729312|NCT01809691|156859721|FG001|Overall Study|No Protocol Treatment|11|||
48729313|NCT01809691|156859720|FG000|Overall Study|Adverse Event|80|||
48729314|NCT01809691|156859721|FG001|Overall Study|Adverse Event|21|||
48729315|NCT01809691|156859720|FG000|Overall Study|Disease Progression|226|||
48822186|NCT01474512|157190490|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
48822187|NCT01474512|157190491|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
48729316|NCT01809691|156859721|FG001|Overall Study|Disease Progression|372|||
48729317|NCT01809691|156859720|FG000|Overall Study|Death|26|||
48729318|NCT01809691|156859721|FG001|Overall Study|Death|13|||
48822188|NCT01474512|157190492|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
48822189|NCT01474512|157190493|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
48822190|NCT01474512|157190494|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
48822191|NCT01474512|157190495|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
48822192|NCT01474512|157190496|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
48822193|NCT01474512|157190497|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
48822194|NCT01474512|157190498|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
48822195|NCT01474512|157190499|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
48822196|NCT01474512|157190500|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
48822197|NCT01474512|157190483|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
48822198|NCT01474512|157190484|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
48822199|NCT01474512|157190485|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
48822200|NCT01474512|157190486|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
48822201|NCT01474512|157190487|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
48822202|NCT01474512|157190488|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
48822203|NCT01474512|157190489|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
48822204|NCT01474512|157190490|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
48822205|NCT01474512|157190491|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
48822206|NCT01474512|157190492|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
48822207|NCT01474512|157190493|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
48822208|NCT01474512|157190494|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
48822209|NCT01474512|157190495|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
48822210|NCT01474512|157190496|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
48822211|NCT01474512|157190497|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
48822212|NCT01474512|157190498|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
48822213|NCT01474512|157190499|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
48822214|NCT01474512|157190500|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
48822215|NCT01474512|157190483|FG000|Long-Term Extension Period|Physician Decision|0|||
48822216|NCT01474512|157190484|FG001|Long-Term Extension Period|Physician Decision|0|||
48822217|NCT01474512|157190485|FG002|Long-Term Extension Period|Physician Decision|0|||
48822218|NCT01474512|157190486|FG003|Long-Term Extension Period|Physician Decision|0|||
48822219|NCT01474512|157190487|FG004|Long-Term Extension Period|Physician Decision|0|||
48822220|NCT01474512|157190488|FG005|Long-Term Extension Period|Physician Decision|0|||
48822221|NCT01474512|157190489|FG006|Long-Term Extension Period|Physician Decision|0|||
48822222|NCT01474512|157190490|FG007|Long-Term Extension Period|Physician Decision|0|||
48822223|NCT01474512|157190491|FG008|Long-Term Extension Period|Physician Decision|0|||
48822224|NCT01474512|157190492|FG009|Long-Term Extension Period|Physician Decision|0|||
48822225|NCT01474512|157190493|FG010|Long-Term Extension Period|Physician Decision|0|||
48822226|NCT01474512|157190494|FG011|Long-Term Extension Period|Physician Decision|0|||
48439536|NCT01486784|155796062|FG002|Overall Study|Death|0|||
48439537|NCT01486784|155796063|FG003|Overall Study|Death|0|||
48439538|NCT01486784|155796064|FG004|Overall Study|Death|0|||
48439539|NCT01486784|155796065|FG005|Overall Study|Death|1|||
48439540|NCT02670330|155796069|FG000|Overall Study|Protocol Deviation|1|||
48439541|NCT02670330|155796070|FG001|Overall Study|Protocol Deviation|0|||
48439542|NCT02670330|155796069|FG000|Overall Study|Study Terminated By Sponsor|36|||
48439543|NCT02670330|155796070|FG001|Overall Study|Study Terminated By Sponsor|43|||
48439544|NCT02670330|155796069|FG000|Overall Study|Adverse Event|1|||
48439545|NCT02670330|155796070|FG001|Overall Study|Adverse Event|3|||
48439546|NCT02670330|155796069|FG000|Overall Study|Withdrawal by Subject|34|||
48439547|NCT02670330|155796070|FG001|Overall Study|Withdrawal by Subject|29|||
48439548|NCT02670330|155796069|FG000|Overall Study|Lost to Follow-up|3|||
48439549|NCT02670330|155796070|FG001|Overall Study|Lost to Follow-up|2|||
48439550|NCT01561560|155796071|FG000|First Two Weeks of Wear|Time/job conflict|0|||
48439551|NCT01561560|155796072|FG001|First Two Weeks of Wear|Time/job conflict|1|||
48439552|NCT01561560|155796071|FG000|First Two Weeks of Wear|Adverse Event|0|||
48439553|NCT01561560|155796072|FG001|First Two Weeks of Wear|Adverse Event|1|||
48382367|NCT01323621|155595112|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48382368|NCT01323621|155595113|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
48512526|NCT00365365|156070807|FG000|Overall Study|Moved|2|||
48512527|NCT00365365|156070808|FG001|Overall Study|Moved|0|||
48512528|NCT00365365|156070809|FG002|Overall Study|Moved|0|||
48512529|NCT00365365|156070807|FG000|Overall Study|New cancer|1|||
48512530|NCT00365365|156070808|FG001|Overall Study|New cancer|0|||
48512531|NCT00365365|156070809|FG002|Overall Study|New cancer|0|||
48512532|NCT00365365|156070807|FG000|Overall Study|Withdrew consent|1|||
48512533|NCT00365365|156070808|FG001|Overall Study|Withdrew consent|1|||
48512534|NCT00365365|156070809|FG002|Overall Study|Withdrew consent|0|||
48512535|NCT00365365|156070807|FG000|Overall Study|Second malignancy|0|||
48512536|NCT00365365|156070808|FG001|Overall Study|Second malignancy|1|||
48512537|NCT00365365|156070809|FG002|Overall Study|Second malignancy|0|||
48512538|NCT00365365|156070807|FG000|Overall Study|Patient/physician decision|0|||
48512539|NCT00365365|156070808|FG001|Overall Study|Patient/physician decision|0|||
48512540|NCT00365365|156070809|FG002|Overall Study|Patient/physician decision|1|||
48512541|NCT02300103|156070810|FG000|Overall Study|Lack of Efficacy|3|||
48512542|NCT02300103|156070810|FG000|Overall Study|Protocol Violation|1|||
48512543|NCT02300103|156070810|FG000|Overall Study|Withdrew Consent|2|||
48512544|NCT00573443|156070811|FG000|Double-Blind Phase|Lost to Follow-up|1|||
48512545|NCT00573443|156070812|FG001|Double-Blind Phase|Lost to Follow-up|3|||
48512546|NCT00573443|156070813|FG002|Double-Blind Phase|Lost to Follow-up|2|||
48512547|NCT00573443|156070811|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
48512548|NCT00573443|156070812|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
48512549|NCT00573443|156070813|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
48512550|NCT00573443|156070811|FG000|Double-Blind Phase|Adverse Event|1|||
48512551|NCT00573443|156070812|FG001|Double-Blind Phase|Adverse Event|5|||
48512552|NCT00573443|156070813|FG002|Double-Blind Phase|Adverse Event|0|||
48512553|NCT00573443|156070811|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
48512554|NCT00573443|156070812|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
48512555|NCT00573443|156070813|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
48512556|NCT00573443|156070811|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
48512557|NCT00573443|156070812|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
48512558|NCT00573443|156070813|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
48512559|NCT00573443|156070811|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
48512560|NCT00573443|156070812|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
48512561|NCT00573443|156070813|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
48512562|NCT00573443|156070811|FG000|Double-Blind Phase|Protocol Violation|0|||
48512563|NCT00573443|156070812|FG001|Double-Blind Phase|Protocol Violation|2|||
48512564|NCT00573443|156070813|FG002|Double-Blind Phase|Protocol Violation|1|||
48512565|NCT00573443|156070811|FG000|Double-Blind Phase|Other|0|||
48512566|NCT00573443|156070812|FG001|Double-Blind Phase|Other|2|||
48512567|NCT00573443|156070813|FG002|Double-Blind Phase|Other|3|||
48512568|NCT00573443|156070811|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
48729319|NCT01809691|156859720|FG000|Overall Study|Participant Refusal|70|||
48729320|NCT01809691|156859721|FG001|Overall Study|Participant Refusal|72|||
48729321|NCT01809691|156859720|FG000|Overall Study|Other, Not Specified|34|||
48729322|NCT01809691|156859721|FG001|Overall Study|Other, Not Specified|52|||
48729323|NCT03834493|156859722|FG000|Overall Study|Participants Ongoing|311|||
48729324|NCT03834493|156859723|FG001|Overall Study|Participants Ongoing|324|||
48729325|NCT03834493|156859722|FG000|Overall Study|Withdrawal by Subject|20|||
48729326|NCT03834493|156859723|FG001|Overall Study|Withdrawal by Subject|17|||
48729327|NCT03834493|156859722|FG000|Overall Study|Physician Decision|1|||
48729328|NCT03834493|156859723|FG001|Overall Study|Physician Decision|0|||
48729329|NCT03834493|156859722|FG000|Overall Study|Death|289|||
48729330|NCT03834493|156859723|FG001|Overall Study|Death|282|||
48729331|NCT02278341|156859725|FG000|Overall Study|Randomized but never received study drug|1|||
48729332|NCT02278341|156859726|FG001|Overall Study|Randomized but never received study drug|1|||
48729333|NCT02278341|156859725|FG000|Overall Study|Adverse Event|3|||
48729334|NCT02278341|156859726|FG001|Overall Study|Adverse Event|0|||
48729335|NCT02278341|156859725|FG000|Overall Study|Death|68|||
48729336|NCT02278341|156859726|FG001|Overall Study|Death|56|||
48729337|NCT02278341|156859725|FG000|Overall Study|Withdrawal by Subject|30|||
48729338|NCT02278341|156859726|FG001|Overall Study|Withdrawal by Subject|19|||
48729339|NCT02278341|156859725|FG000|Overall Study|Lost to Follow-up|0|||
48729340|NCT02278341|156859726|FG001|Overall Study|Lost to Follow-up|1|||
48729341|NCT02278341|156859725|FG000|Overall Study|Physician Decision|1|||
48729342|NCT02278341|156859726|FG001|Overall Study|Physician Decision|1|||
48729343|NCT02278341|156859725|FG000|Overall Study|Miscellaneous|15|||
48729344|NCT02278341|156859726|FG001|Overall Study|Miscellaneous|14|||
48729345|NCT05710107|156859727|FG000|Overall Study|Withdrawal by Subject|1|||
48729346|NCT05710107|156859728|FG001|Overall Study|Withdrawal by Subject|1|||
48729347|NCT05710107|156859727|FG000|Overall Study|Lost to Follow-up|8|||
48729348|NCT05710107|156859728|FG001|Overall Study|Lost to Follow-up|9|||
48729349|NCT05710107|156859727|FG000|Overall Study|Unable to place assigned block|2|||
48729350|NCT05710107|156859728|FG001|Overall Study|Unable to place assigned block|0|||
48822227|NCT01474512|157190495|FG012|Long-Term Extension Period|Physician Decision|21|||
48822228|NCT01474512|157190496|FG013|Long-Term Extension Period|Physician Decision|21|||
48822229|NCT01474512|157190497|FG014|Long-Term Extension Period|Physician Decision|0|||
48822230|NCT01474512|157190498|FG015|Long-Term Extension Period|Physician Decision|0|||
48822231|NCT01474512|157190499|FG016|Long-Term Extension Period|Physician Decision|0|||
48822232|NCT01474512|157190500|FG017|Long-Term Extension Period|Physician Decision|0|||
48822233|NCT01474512|157190483|FG000|Long-Term Extension Period|Clinical Relapse|0|||
48822234|NCT01474512|157190484|FG001|Long-Term Extension Period|Clinical Relapse|0|||
48822235|NCT01474512|157190485|FG002|Long-Term Extension Period|Clinical Relapse|0|||
48822236|NCT01474512|157190486|FG003|Long-Term Extension Period|Clinical Relapse|0|||
48822237|NCT01474512|157190487|FG004|Long-Term Extension Period|Clinical Relapse|0|||
48822238|NCT01474512|157190488|FG005|Long-Term Extension Period|Clinical Relapse|0|||
48822239|NCT01474512|157190489|FG006|Long-Term Extension Period|Clinical Relapse|0|||
48512569|NCT00573443|156070812|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
48512570|NCT00573443|156070813|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
48512571|NCT00573443|156070811|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
48512572|NCT00573443|156070812|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
48512573|NCT00573443|156070813|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
48512574|NCT00573443|156070811|FG000|Open-Label Extension Phase|Adverse Event|3|||
48512575|NCT00573443|156070812|FG001|Open-Label Extension Phase|Adverse Event|0|||
48512576|NCT00573443|156070813|FG002|Open-Label Extension Phase|Adverse Event|0|||
48512577|NCT00573443|156070811|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
48512578|NCT00573443|156070812|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
48512579|NCT00573443|156070813|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
48512580|NCT00573443|156070811|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
48512581|NCT00573443|156070812|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
48512582|NCT00573443|156070813|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
48512583|NCT00573443|156070811|FG000|Open-Label Extension Phase|Protocol Violation|2|||
48512584|NCT00573443|156070812|FG001|Open-Label Extension Phase|Protocol Violation|0|||
48512585|NCT00573443|156070813|FG002|Open-Label Extension Phase|Protocol Violation|0|||
48512586|NCT00573443|156070811|FG000|Open-Label Extension Phase|Other|2|||
48512587|NCT00573443|156070812|FG001|Open-Label Extension Phase|Other|0|||
48512588|NCT00573443|156070813|FG002|Open-Label Extension Phase|Other|0|||
48512589|NCT00905606|156070817|FG000|Period 1|Adverse Event|0|||
48729351|NCT05710107|156859727|FG000|Overall Study|Withdrawn by study team|0|||
48729352|NCT05710107|156859728|FG001|Overall Study|Withdrawn by study team|1|||
48729353|NCT00145600|156859729|FG000|Overall Study|Death|1|||
48729354|NCT00145600|156859730|FG001|Overall Study|Death|2|||
48729355|NCT00145600|156859731|FG002|Overall Study|Death|2|||
48729356|NCT00145600|156859732|FG003|Overall Study|Death|6|||
48729357|NCT00145600|156859729|FG000|Overall Study|Ineligible|3|||
48729358|NCT00145600|156859730|FG001|Overall Study|Ineligible|0|||
48729359|NCT00145600|156859731|FG002|Overall Study|Ineligible|1|||
48729360|NCT00145600|156859732|FG003|Overall Study|Ineligible|5|||
48729361|NCT00145600|156859729|FG000|Overall Study|Lost to Follow-up|2|||
48729362|NCT00145600|156859730|FG001|Overall Study|Lost to Follow-up|6|||
48729363|NCT00145600|156859731|FG002|Overall Study|Lost to Follow-up|2|||
48729364|NCT00145600|156859732|FG003|Overall Study|Lost to Follow-up|4|||
48729365|NCT00145600|156859729|FG000|Overall Study|Noncompliance|1|||
48729366|NCT00145600|156859730|FG001|Overall Study|Noncompliance|0|||
48729367|NCT00145600|156859731|FG002|Overall Study|Noncompliance|0|||
48729368|NCT00145600|156859732|FG003|Overall Study|Noncompliance|0|||
48729369|NCT00145600|156859729|FG000|Overall Study|Withdrawal by Subject|1|||
48729370|NCT00145600|156859730|FG001|Overall Study|Withdrawal by Subject|2|||
48729371|NCT00145600|156859731|FG002|Overall Study|Withdrawal by Subject|0|||
48729372|NCT00145600|156859732|FG003|Overall Study|Withdrawal by Subject|1|||
48729373|NCT05128773|156859737|FG000|Overall Study|Sponsor decision to terminate study|3|||
48729374|NCT04543409|156859738|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48729375|NCT04543409|156859739|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48729376|NCT04543409|156859738|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
48729377|NCT04543409|156859739|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
48729378|NCT04543409|156859738|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
48729379|NCT04543409|156859739|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
48729380|NCT04543409|156859738|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
48729381|NCT04543409|156859739|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
48822240|NCT01474512|157190490|FG007|Long-Term Extension Period|Clinical Relapse|0|||
48822241|NCT01474512|157190491|FG008|Long-Term Extension Period|Clinical Relapse|0|||
48822242|NCT01474512|157190492|FG009|Long-Term Extension Period|Clinical Relapse|0|||
48382369|NCT01323621|155595114|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
48512590|NCT00905606|156070818|FG001|Period 1|Adverse Event|1|||
48512591|NCT00905606|156070817|FG000|Washout|Withdrawal by Subject|1|||
48512592|NCT00905606|156070818|FG001|Washout|Withdrawal by Subject|0|||
48601101|NCT02718911|156396045|FG005|Overall Study|Adverse Event|0|||
48512593|NCT03635320|156070819|FG000|Overall Study|not implanted the device|1|||
48512594|NCT03635320|156070820|FG001|Overall Study|not implanted the device|2|||
48512595|NCT03635320|156070819|FG000|Overall Study|Withdrawal by Subject|11|||
48512596|NCT03635320|156070820|FG001|Overall Study|Withdrawal by Subject|6|||
48512597|NCT01015625|156070822|FG000|Overall Study|Lost to Follow-up|3|||
48512598|NCT01015625|156070823|FG001|Overall Study|Lost to Follow-up|1|||
48512599|NCT01015625|156070822|FG000|Overall Study|Withdrawal by Subject|2|||
48512600|NCT01015625|156070823|FG001|Overall Study|Withdrawal by Subject|3|||
48822243|NCT01474512|157190493|FG010|Long-Term Extension Period|Clinical Relapse|0|||
48382370|NCT04540133|155595121|FG000|Overall Study|Lost to Follow-up|1|||
48382371|NCT04540133|155595122|FG001|Overall Study|Lost to Follow-up|0|||
48512601|NCT01015625|156070822|FG000|Overall Study|Physician Decision|2|||
48822244|NCT01474512|157190494|FG011|Long-Term Extension Period|Clinical Relapse|0|||
48512602|NCT01015625|156070823|FG001|Overall Study|Physician Decision|0|||
48512603|NCT01015625|156070822|FG000|Overall Study|Death|30|||
48512604|NCT01015625|156070823|FG001|Overall Study|Death|22|||
48512605|NCT01796171|156070828|FG000|Enrolled|Death|0|||
48512606|NCT01796171|156070829|FG001|Enrolled|Death|0|||
48512607|NCT01796171|156070830|FG002|Enrolled|Death|0|||
48512608|NCT01796171|156070831|FG003|Enrolled|Death|0|||
48512609|NCT01796171|156070832|FG004|Enrolled|Death|0|||
48512610|NCT01796171|156070833|FG005|Enrolled|Death|0|||
48512611|NCT01796171|156070834|FG006|Enrolled|Death|0|||
48512612|NCT01796171|156070835|FG007|Enrolled|Death|0|||
48512613|NCT01796171|156070836|FG008|Enrolled|Death|0|||
48512614|NCT01796171|156070837|FG009|Enrolled|Death|0|||
48512615|NCT01796171|156070838|FG010|Enrolled|Death|0|||
48822245|NCT01474512|157190495|FG012|Long-Term Extension Period|Clinical Relapse|9|||
48822246|NCT01474512|157190496|FG013|Long-Term Extension Period|Clinical Relapse|9|||
48822247|NCT01474512|157190497|FG014|Long-Term Extension Period|Clinical Relapse|0|||
48822248|NCT01474512|157190498|FG015|Long-Term Extension Period|Clinical Relapse|0|||
48822249|NCT01474512|157190499|FG016|Long-Term Extension Period|Clinical Relapse|0|||
48822250|NCT01474512|157190500|FG017|Long-Term Extension Period|Clinical Relapse|0|||
48512616|NCT01796171|156070839|FG011|Enrolled|Death|0|||
48729382|NCT04543409|156859738|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
48729383|NCT04543409|156859739|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
48512617|NCT01796171|156070840|FG012|Enrolled|Death|0|||
48512618|NCT01796171|156070841|FG013|Enrolled|Death|0|||
48512619|NCT01796171|156070842|FG014|Enrolled|Death|1|||
48512620|NCT01796171|156070828|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
48512621|NCT01796171|156070829|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
48512622|NCT01796171|156070830|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
48512623|NCT01796171|156070831|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
48512624|NCT01796171|156070832|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
48512625|NCT01796171|156070833|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
48512626|NCT01796171|156070834|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
48512627|NCT01796171|156070835|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
48512628|NCT01796171|156070836|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
48512629|NCT01796171|156070837|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
48512630|NCT01796171|156070838|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
48601102|NCT02718911|156396046|FG006|Overall Study|Adverse Event|0|||
48729384|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
48729385|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
48729386|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
48729387|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
48729388|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
48729389|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
48729390|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
48822251|NCT01474512|157190483|FG000|Long-Term Extension Period|Death|0|||
48822252|NCT01474512|157190484|FG001|Long-Term Extension Period|Death|0|||
48822253|NCT01474512|157190485|FG002|Long-Term Extension Period|Death|0|||
48822254|NCT01474512|157190486|FG003|Long-Term Extension Period|Death|0|||
48439713|NCT01969799|155796098|FG000|Overall Study|Lost to Follow-up|0|||
48439714|NCT01969799|155796099|FG001|Overall Study|Lost to Follow-up|2|||
48439715|NCT01969799|155796098|FG000|Overall Study|Physician Decision|1|||
48439716|NCT01969799|155796099|FG001|Overall Study|Physician Decision|0|||
48439717|NCT01617187|155796100|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
48439718|NCT01617187|155796101|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
48439719|NCT01617187|155796102|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
48439720|NCT01617187|155796103|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
48439721|NCT01617187|155796100|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
48439722|NCT01617187|155796101|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
48439723|NCT01617187|155796102|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
48439724|NCT01617187|155796103|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
48439725|NCT01617187|155796100|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
48822255|NCT01474512|157190487|FG004|Long-Term Extension Period|Death|0|||
48822256|NCT01474512|157190488|FG005|Long-Term Extension Period|Death|0|||
48822257|NCT01474512|157190489|FG006|Long-Term Extension Period|Death|0|||
48729391|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
48729392|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
48729393|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
48729394|NCT04543409|156859738|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
48729395|NCT04543409|156859739|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
48729396|NCT03977454|156859740|FG000|Overall Study|immediate postoperative revision|2|||
48729397|NCT03977454|156859741|FG001|Overall Study|immediate postoperative revision|2|||
48822258|NCT01474512|157190490|FG007|Long-Term Extension Period|Death|0|||
48822259|NCT01474512|157190491|FG008|Long-Term Extension Period|Death|0|||
48822260|NCT01474512|157190492|FG009|Long-Term Extension Period|Death|0|||
48822261|NCT01474512|157190493|FG010|Long-Term Extension Period|Death|0|||
48822262|NCT01474512|157190494|FG011|Long-Term Extension Period|Death|0|||
48822263|NCT01474512|157190495|FG012|Long-Term Extension Period|Death|9|||
48822264|NCT01474512|157190496|FG013|Long-Term Extension Period|Death|9|||
48822265|NCT01474512|157190497|FG014|Long-Term Extension Period|Death|0|||
48822266|NCT01474512|157190498|FG015|Long-Term Extension Period|Death|0|||
48822267|NCT01474512|157190499|FG016|Long-Term Extension Period|Death|0|||
48822268|NCT01474512|157190500|FG017|Long-Term Extension Period|Death|0|||
48439870|NCT01107405|155798243|FG001|Overall Study|Adverse Event|1|||
48439871|NCT01107405|155798244|FG002|Overall Study|Adverse Event|0|||
48439872|NCT01107405|155798245|FG003|Overall Study|Adverse Event|0|||
48439873|NCT01107405|155798246|FG004|Overall Study|Adverse Event|2|||
48439874|NCT01107405|155798242|FG000|Overall Study|Withdrawal by Subject|1|||
48439875|NCT01107405|155798243|FG001|Overall Study|Withdrawal by Subject|0|||
48439876|NCT01107405|155798244|FG002|Overall Study|Withdrawal by Subject|1|||
48439877|NCT01107405|155798245|FG003|Overall Study|Withdrawal by Subject|2|||
48439878|NCT01107405|155798246|FG004|Overall Study|Withdrawal by Subject|1|||
48439879|NCT01107405|155798242|FG000|Overall Study|Protocol Violation|0|||
48439880|NCT01107405|155798243|FG001|Overall Study|Protocol Violation|0|||
48439881|NCT01107405|155798244|FG002|Overall Study|Protocol Violation|1|||
48439882|NCT01107405|155798245|FG003|Overall Study|Protocol Violation|1|||
48439883|NCT01107405|155798246|FG004|Overall Study|Protocol Violation|0|||
48439884|NCT00238303|155798247|FG000|Overall Study|Withdrawal by Subject|11|||
48439885|NCT00238303|155798248|FG001|Overall Study|Withdrawal by Subject|1|||
48439886|NCT00238303|155798249|FG002|Overall Study|Withdrawal by Subject|2|||
48439887|NCT00238303|155798247|FG000|Overall Study|Death|1|||
48439888|NCT00238303|155798248|FG001|Overall Study|Death|0|||
48439889|NCT00238303|155798249|FG002|Overall Study|Death|1|||
48439890|NCT00238303|155798247|FG000|Overall Study|Other Medical Problems|2|||
48439891|NCT00238303|155798248|FG001|Overall Study|Other Medical Problems|0|||
48439892|NCT00238303|155798249|FG002|Overall Study|Other Medical Problems|2|||
48439893|NCT00238303|155798247|FG000|Overall Study|Poor tolerance of study treatment|1|||
48439894|NCT00238303|155798248|FG001|Overall Study|Poor tolerance of study treatment|0|||
48439895|NCT00238303|155798249|FG002|Overall Study|Poor tolerance of study treatment|1|||
48439896|NCT00238303|155798247|FG000|Overall Study|Adverse Event|0|||
48439897|NCT00238303|155798248|FG001|Overall Study|Adverse Event|1|||
48439898|NCT00238303|155798249|FG002|Overall Study|Adverse Event|3|||
48439899|NCT01895452|155798256|FG000|Overall Study|Adverse Event|1|||
48439900|NCT01895452|155798257|FG001|Overall Study|Adverse Event|4|||
48439901|NCT01895452|155798256|FG000|Overall Study|Lost to Follow-up|1|||
48439902|NCT01895452|155798257|FG001|Overall Study|Lost to Follow-up|5|||
48439903|NCT01895452|155798256|FG000|Overall Study|Pregnancy|0|||
48439904|NCT01895452|155798257|FG001|Overall Study|Pregnancy|1|||
48439905|NCT01895452|155798256|FG000|Overall Study|Withdrawal by Subject|2|||
48439906|NCT01895452|155798257|FG001|Overall Study|Withdrawal by Subject|14|||
48439907|NCT01895452|155798256|FG000|Overall Study|Underlying disease|0|||
48439908|NCT01895452|155798257|FG001|Overall Study|Underlying disease|3|||
48439909|NCT01895452|155798256|FG000|Overall Study|Noncompliance with study drug|0|||
48439910|NCT01895452|155798257|FG001|Overall Study|Noncompliance with study drug|1|||
48439911|NCT01653158|155798258|FG000|Overall Study|Death|0|||
48439912|NCT01653158|155798259|FG001|Overall Study|Death|0|||
48439913|NCT01653158|155798260|FG002|Overall Study|Death|0|||
48439914|NCT01653158|155798261|FG003|Overall Study|Death|1|||
48439915|NCT01653158|155798262|FG004|Overall Study|Death|0|||
48439916|NCT01653158|155798263|FG005|Overall Study|Death|0|||
48439917|NCT01653158|155798264|FG006|Overall Study|Death|0|||
48439918|NCT01653158|155798265|FG007|Overall Study|Death|2|||
48439919|NCT01653158|155798258|FG000|Overall Study|Adverse Event|0|||
48439920|NCT01653158|155798259|FG001|Overall Study|Adverse Event|0|||
48439921|NCT01653158|155798260|FG002|Overall Study|Adverse Event|0|||
48439922|NCT01653158|155798261|FG003|Overall Study|Adverse Event|1|||
48439923|NCT01653158|155798262|FG004|Overall Study|Adverse Event|0|||
48439924|NCT01653158|155798263|FG005|Overall Study|Adverse Event|0|||
48512631|NCT01796171|156070839|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
48512632|NCT01796171|156070840|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
48512633|NCT01796171|156070841|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
48512634|NCT01796171|156070842|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
48512635|NCT01796171|156070828|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512636|NCT01796171|156070829|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512637|NCT01796171|156070830|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512638|NCT01796171|156070831|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512639|NCT01796171|156070832|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512640|NCT01796171|156070833|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512641|NCT01796171|156070834|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512642|NCT01796171|156070835|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512643|NCT01796171|156070836|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512644|NCT01796171|156070837|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512645|NCT01796171|156070838|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512646|NCT01796171|156070839|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512647|NCT01796171|156070840|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512648|NCT01796171|156070841|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
48512649|NCT01796171|156070842|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
48512650|NCT01796171|156070828|FG000|Treatment Period With Betalutin|Progressive disease|0|||
48512651|NCT01796171|156070829|FG001|Treatment Period With Betalutin|Progressive disease|1|||
48512652|NCT01796171|156070830|FG002|Treatment Period With Betalutin|Progressive disease|0|||
48512653|NCT01796171|156070831|FG003|Treatment Period With Betalutin|Progressive disease|0|||
48512654|NCT01796171|156070832|FG004|Treatment Period With Betalutin|Progressive disease|0|||
48512655|NCT01796171|156070833|FG005|Treatment Period With Betalutin|Progressive disease|0|||
48512656|NCT01796171|156070834|FG006|Treatment Period With Betalutin|Progressive disease|0|||
48512657|NCT01796171|156070835|FG007|Treatment Period With Betalutin|Progressive disease|0|||
48512658|NCT01796171|156070836|FG008|Treatment Period With Betalutin|Progressive disease|0|||
48512659|NCT01796171|156070837|FG009|Treatment Period With Betalutin|Progressive disease|0|||
48512660|NCT01796171|156070838|FG010|Treatment Period With Betalutin|Progressive disease|0|||
48512661|NCT01796171|156070839|FG011|Treatment Period With Betalutin|Progressive disease|0|||
48512662|NCT01796171|156070840|FG012|Treatment Period With Betalutin|Progressive disease|0|||
48512663|NCT01796171|156070841|FG013|Treatment Period With Betalutin|Progressive disease|0|||
48512664|NCT01796171|156070842|FG014|Treatment Period With Betalutin|Progressive disease|0|||
48512665|NCT01796171|156070828|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512666|NCT01796171|156070829|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512667|NCT01796171|156070830|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512668|NCT01796171|156070831|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512669|NCT01796171|156070832|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512670|NCT01796171|156070833|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512671|NCT01796171|156070834|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512672|NCT01796171|156070835|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512673|NCT01796171|156070836|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
48729398|NCT01052844|156859742|FG000|Overall Study|Adverse Event|0|||
48729399|NCT01052844|156859743|FG001|Overall Study|Adverse Event|1|||
48729400|NCT04250714|156859744|FG000|Overall Study|Treatment - withdrawal by subject|14|||
48729401|NCT04250714|156859744|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
48729402|NCT04250714|156859744|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
48729403|NCT04250714|156859744|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
48729404|NCT04250714|156859744|FG000|Overall Study|Treatment - Death|1|||
48729405|NCT04250714|156859744|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
48729406|NCT04250714|156859744|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
48729407|NCT04250714|156859744|FG000|Overall Study|Attempt|2|||
48729408|NCT04250714|156859744|FG000|Overall Study|Intent|7|||
48729409|NCT03960554|156859745|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
48729410|NCT03960554|156859746|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
48729411|NCT03882008|156859764|FG000|Overall Study|Withdrawal by Subject|1|||
48729412|NCT03882008|156859764|FG000|Overall Study|Lost to Follow-up|1|||
48729413|NCT00048061|156859765|FG000|Overall Study|Adverse Event|41|||
48729414|NCT00048061|156859766|FG001|Overall Study|Adverse Event|32|||
48729415|NCT00048061|156859767|FG002|Overall Study|Adverse Event|44|||
48729416|NCT00048061|156859768|FG003|Overall Study|Adverse Event|37|||
48729417|NCT00048061|156859765|FG000|Overall Study|Lost to Follow-up|3|||
48729418|NCT00048061|156859766|FG001|Overall Study|Lost to Follow-up|2|||
48729419|NCT00048061|156859767|FG002|Overall Study|Lost to Follow-up|4|||
48729420|NCT00048061|156859768|FG003|Overall Study|Lost to Follow-up|5|||
48729421|NCT00048061|156859765|FG000|Overall Study|Withdrawal by Subject|20|||
48729422|NCT00048061|156859766|FG001|Overall Study|Withdrawal by Subject|29|||
48729423|NCT00048061|156859767|FG002|Overall Study|Withdrawal by Subject|29|||
48512674|NCT01796171|156070837|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512675|NCT01796171|156070838|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
48512676|NCT01796171|156070839|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
48512677|NCT01796171|156070840|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512678|NCT01796171|156070841|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512679|NCT01796171|156070842|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
48512680|NCT01796171|156070828|FG000|Treatment Period With Betalutin|Physician Decision|0|||
48512681|NCT01796171|156070829|FG001|Treatment Period With Betalutin|Physician Decision|0|||
48512682|NCT01796171|156070830|FG002|Treatment Period With Betalutin|Physician Decision|0|||
48512683|NCT01796171|156070831|FG003|Treatment Period With Betalutin|Physician Decision|0|||
48512684|NCT01796171|156070832|FG004|Treatment Period With Betalutin|Physician Decision|0|||
48512685|NCT01796171|156070833|FG005|Treatment Period With Betalutin|Physician Decision|0|||
48512686|NCT01796171|156070834|FG006|Treatment Period With Betalutin|Physician Decision|0|||
48512687|NCT01796171|156070835|FG007|Treatment Period With Betalutin|Physician Decision|0|||
48512688|NCT01796171|156070836|FG008|Treatment Period With Betalutin|Physician Decision|0|||
48512689|NCT01796171|156070837|FG009|Treatment Period With Betalutin|Physician Decision|0|||
48512690|NCT01796171|156070838|FG010|Treatment Period With Betalutin|Physician Decision|5|||
48512691|NCT01796171|156070839|FG011|Treatment Period With Betalutin|Physician Decision|1|||
48512692|NCT01796171|156070840|FG012|Treatment Period With Betalutin|Physician Decision|1|||
48512693|NCT01796171|156070841|FG013|Treatment Period With Betalutin|Physician Decision|0|||
48512694|NCT01796171|156070842|FG014|Treatment Period With Betalutin|Physician Decision|0|||
48512695|NCT01796171|156070828|FG000|Treatment Period With Betalutin|Death|0|||
48512696|NCT01796171|156070829|FG001|Treatment Period With Betalutin|Death|0|||
48512697|NCT01796171|156070830|FG002|Treatment Period With Betalutin|Death|0|||
48512698|NCT01796171|156070831|FG003|Treatment Period With Betalutin|Death|0|||
48512699|NCT01796171|156070832|FG004|Treatment Period With Betalutin|Death|0|||
48512700|NCT01796171|156070833|FG005|Treatment Period With Betalutin|Death|0|||
48512701|NCT01796171|156070834|FG006|Treatment Period With Betalutin|Death|0|||
48512702|NCT01796171|156070835|FG007|Treatment Period With Betalutin|Death|0|||
48512703|NCT01796171|156070836|FG008|Treatment Period With Betalutin|Death|0|||
48512704|NCT01796171|156070837|FG009|Treatment Period With Betalutin|Death|0|||
48512705|NCT01796171|156070838|FG010|Treatment Period With Betalutin|Death|2|||
48512706|NCT01796171|156070839|FG011|Treatment Period With Betalutin|Death|0|||
48512707|NCT01796171|156070840|FG012|Treatment Period With Betalutin|Death|0|||
48512708|NCT01796171|156070841|FG013|Treatment Period With Betalutin|Death|0|||
48512709|NCT01796171|156070842|FG014|Treatment Period With Betalutin|Death|0|||
48512710|NCT01796171|156070828|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
48512711|NCT01796171|156070829|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
48512712|NCT01796171|156070830|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
48512713|NCT01796171|156070831|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
48512714|NCT01796171|156070832|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
48512715|NCT01796171|156070833|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
48729424|NCT00048061|156859768|FG003|Overall Study|Withdrawal by Subject|32|||
48729425|NCT00048061|156859765|FG000|Overall Study|Did not follow-up|5|||
48729426|NCT00048061|156859766|FG001|Overall Study|Did not follow-up|5|||
48512716|NCT01796171|156070834|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
48512717|NCT01796171|156070835|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
48512718|NCT01796171|156070836|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
48512719|NCT01796171|156070837|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
48512720|NCT01796171|156070838|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
48512721|NCT01796171|156070839|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
48512722|NCT01796171|156070840|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
48512723|NCT01796171|156070841|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
48512724|NCT01796171|156070842|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
48512725|NCT01796171|156070828|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512726|NCT01796171|156070829|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512727|NCT01796171|156070830|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512728|NCT01796171|156070831|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512729|NCT01796171|156070832|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512730|NCT01796171|156070833|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512731|NCT01796171|156070834|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512732|NCT01796171|156070835|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512733|NCT01796171|156070836|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512734|NCT01796171|156070837|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512735|NCT01796171|156070838|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
48512736|NCT01796171|156070839|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
48512737|NCT01796171|156070840|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512738|NCT01796171|156070841|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512739|NCT01796171|156070842|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
48512740|NCT01796171|156070828|FG000|Follow-up Period|Start of further anticancer therapy|4|||
48512741|NCT01796171|156070829|FG001|Follow-up Period|Start of further anticancer therapy|25|||
48512742|NCT01796171|156070830|FG002|Follow-up Period|Start of further anticancer therapy|2|||
48512743|NCT01796171|156070831|FG003|Follow-up Period|Start of further anticancer therapy|1|||
48512744|NCT01796171|156070832|FG004|Follow-up Period|Start of further anticancer therapy|2|||
48512745|NCT01796171|156070833|FG005|Follow-up Period|Start of further anticancer therapy|2|||
48512746|NCT01796171|156070834|FG006|Follow-up Period|Start of further anticancer therapy|1|||
48512747|NCT01796171|156070835|FG007|Follow-up Period|Start of further anticancer therapy|15|||
48512748|NCT01796171|156070836|FG008|Follow-up Period|Start of further anticancer therapy|2|||
48512749|NCT01796171|156070837|FG009|Follow-up Period|Start of further anticancer therapy|0|||
48512750|NCT01796171|156070838|FG010|Follow-up Period|Start of further anticancer therapy|0|||
48512751|NCT01796171|156070839|FG011|Follow-up Period|Start of further anticancer therapy|0|||
48512752|NCT01796171|156070840|FG012|Follow-up Period|Start of further anticancer therapy|0|||
48512753|NCT01796171|156070841|FG013|Follow-up Period|Start of further anticancer therapy|0|||
48512754|NCT01796171|156070842|FG014|Follow-up Period|Start of further anticancer therapy|0|||
48512755|NCT01796171|156070828|FG000|Follow-up Period|Progressive disease|0|||
48512756|NCT01796171|156070829|FG001|Follow-up Period|Progressive disease|1|||
48512757|NCT01796171|156070830|FG002|Follow-up Period|Progressive disease|0|||
48822269|NCT01474512|157190483|FG000|Long-Term Extension Period|Sponsor Decision|0|||
48822270|NCT01474512|157190484|FG001|Long-Term Extension Period|Sponsor Decision|0|||
48822271|NCT01474512|157190485|FG002|Long-Term Extension Period|Sponsor Decision|0|||
48822272|NCT01474512|157190486|FG003|Long-Term Extension Period|Sponsor Decision|0|||
48822273|NCT01474512|157190487|FG004|Long-Term Extension Period|Sponsor Decision|0|||
48822274|NCT01474512|157190488|FG005|Long-Term Extension Period|Sponsor Decision|0|||
48822275|NCT01474512|157190489|FG006|Long-Term Extension Period|Sponsor Decision|0|||
48512758|NCT01796171|156070831|FG003|Follow-up Period|Progressive disease|0|||
48512759|NCT01796171|156070832|FG004|Follow-up Period|Progressive disease|0|||
48512760|NCT01796171|156070833|FG005|Follow-up Period|Progressive disease|0|||
48512761|NCT01796171|156070834|FG006|Follow-up Period|Progressive disease|0|||
48512762|NCT01796171|156070835|FG007|Follow-up Period|Progressive disease|3|||
48512763|NCT01796171|156070836|FG008|Follow-up Period|Progressive disease|0|||
48512764|NCT01796171|156070837|FG009|Follow-up Period|Progressive disease|0|||
48512765|NCT01796171|156070838|FG010|Follow-up Period|Progressive disease|0|||
48512766|NCT01796171|156070839|FG011|Follow-up Period|Progressive disease|0|||
48512767|NCT01796171|156070840|FG012|Follow-up Period|Progressive disease|0|||
48512768|NCT01796171|156070841|FG013|Follow-up Period|Progressive disease|0|||
48512769|NCT01796171|156070842|FG014|Follow-up Period|Progressive disease|0|||
48512770|NCT01796171|156070828|FG000|Follow-up Period|Physician Decision|0|||
48512771|NCT01796171|156070829|FG001|Follow-up Period|Physician Decision|2|||
48512772|NCT01796171|156070830|FG002|Follow-up Period|Physician Decision|0|||
48512773|NCT01796171|156070831|FG003|Follow-up Period|Physician Decision|0|||
48512774|NCT01796171|156070832|FG004|Follow-up Period|Physician Decision|0|||
48512775|NCT01796171|156070833|FG005|Follow-up Period|Physician Decision|0|||
48512776|NCT01796171|156070834|FG006|Follow-up Period|Physician Decision|0|||
48512777|NCT01796171|156070835|FG007|Follow-up Period|Physician Decision|0|||
48512778|NCT01796171|156070836|FG008|Follow-up Period|Physician Decision|0|||
48512779|NCT01796171|156070837|FG009|Follow-up Period|Physician Decision|0|||
48512780|NCT01796171|156070838|FG010|Follow-up Period|Physician Decision|5|||
48512781|NCT01796171|156070839|FG011|Follow-up Period|Physician Decision|0|||
48512782|NCT01796171|156070840|FG012|Follow-up Period|Physician Decision|0|||
48512783|NCT01796171|156070841|FG013|Follow-up Period|Physician Decision|0|||
48512784|NCT01796171|156070842|FG014|Follow-up Period|Physician Decision|0|||
48512785|NCT01796171|156070828|FG000|Follow-up Period|Withdrawal by Subject|0|||
48512786|NCT01796171|156070829|FG001|Follow-up Period|Withdrawal by Subject|1|||
48512787|NCT01796171|156070830|FG002|Follow-up Period|Withdrawal by Subject|0|||
48512788|NCT01796171|156070831|FG003|Follow-up Period|Withdrawal by Subject|0|||
48512789|NCT01796171|156070832|FG004|Follow-up Period|Withdrawal by Subject|0|||
48512790|NCT01796171|156070833|FG005|Follow-up Period|Withdrawal by Subject|1|||
48512791|NCT01796171|156070834|FG006|Follow-up Period|Withdrawal by Subject|0|||
48512792|NCT01796171|156070835|FG007|Follow-up Period|Withdrawal by Subject|0|||
48512793|NCT01796171|156070836|FG008|Follow-up Period|Withdrawal by Subject|0|||
48512794|NCT01796171|156070837|FG009|Follow-up Period|Withdrawal by Subject|0|||
48512795|NCT01796171|156070838|FG010|Follow-up Period|Withdrawal by Subject|3|||
48512796|NCT01796171|156070839|FG011|Follow-up Period|Withdrawal by Subject|1|||
48822276|NCT01474512|157190490|FG007|Long-Term Extension Period|Sponsor Decision|0|||
48512797|NCT01796171|156070840|FG012|Follow-up Period|Withdrawal by Subject|0|||
48512798|NCT01796171|156070841|FG013|Follow-up Period|Withdrawal by Subject|0|||
48512799|NCT01796171|156070842|FG014|Follow-up Period|Withdrawal by Subject|0|||
48512800|NCT01796171|156070828|FG000|Follow-up Period|Death|0|||
48512801|NCT01796171|156070829|FG001|Follow-up Period|Death|0|||
48512802|NCT01796171|156070830|FG002|Follow-up Period|Death|0|||
48822277|NCT01474512|157190491|FG008|Long-Term Extension Period|Sponsor Decision|0|||
48512803|NCT01796171|156070831|FG003|Follow-up Period|Death|0|||
48512804|NCT01796171|156070832|FG004|Follow-up Period|Death|0|||
48512805|NCT01796171|156070833|FG005|Follow-up Period|Death|0|||
48512806|NCT01796171|156070834|FG006|Follow-up Period|Death|1|||
48512807|NCT01796171|156070835|FG007|Follow-up Period|Death|0|||
48512808|NCT01796171|156070836|FG008|Follow-up Period|Death|0|||
48512809|NCT01796171|156070837|FG009|Follow-up Period|Death|0|||
48512810|NCT01796171|156070838|FG010|Follow-up Period|Death|17|||
48512811|NCT01796171|156070839|FG011|Follow-up Period|Death|9|||
48512812|NCT01796171|156070840|FG012|Follow-up Period|Death|1|||
48512813|NCT01796171|156070841|FG013|Follow-up Period|Death|0|||
48512814|NCT01796171|156070842|FG014|Follow-up Period|Death|0|||
48512815|NCT01796171|156070828|FG000|Follow-up Period|Patient transferred to other hospital|0|||
48512816|NCT01796171|156070829|FG001|Follow-up Period|Patient transferred to other hospital|1|||
48512817|NCT01796171|156070830|FG002|Follow-up Period|Patient transferred to other hospital|0|||
48512818|NCT01796171|156070831|FG003|Follow-up Period|Patient transferred to other hospital|0|||
48512819|NCT01796171|156070832|FG004|Follow-up Period|Patient transferred to other hospital|0|||
48512820|NCT01796171|156070833|FG005|Follow-up Period|Patient transferred to other hospital|0|||
48512821|NCT01796171|156070834|FG006|Follow-up Period|Patient transferred to other hospital|0|||
48512822|NCT01796171|156070835|FG007|Follow-up Period|Patient transferred to other hospital|0|||
48512823|NCT01796171|156070836|FG008|Follow-up Period|Patient transferred to other hospital|0|||
48512824|NCT01796171|156070837|FG009|Follow-up Period|Patient transferred to other hospital|0|||
48512825|NCT01796171|156070838|FG010|Follow-up Period|Patient transferred to other hospital|0|||
48512826|NCT01796171|156070839|FG011|Follow-up Period|Patient transferred to other hospital|0|||
48512827|NCT01796171|156070840|FG012|Follow-up Period|Patient transferred to other hospital|0|||
48512828|NCT01796171|156070841|FG013|Follow-up Period|Patient transferred to other hospital|0|||
48382447|NCT02141074|155595138|FG000|Pre-prophylaxis|Adverse Event|3|||
48382448|NCT02141074|155595139|FG001|Pre-prophylaxis|Adverse Event|0|||
48382449|NCT02141074|155595138|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
48382450|NCT02141074|155595139|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
48382451|NCT02141074|155595138|FG000|Prophylaxis|Adverse Event|0|||
48382452|NCT02141074|155595139|FG001|Prophylaxis|Adverse Event|4|||
48382453|NCT02141074|155595138|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
48382454|NCT02141074|155595139|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
48382455|NCT02141074|155595138|FG000|Prophylaxis|Withdrawal by Subject|0|||
48382456|NCT02141074|155595139|FG001|Prophylaxis|Withdrawal by Subject|1|||
48382457|NCT02593786|155595140|FG000|Overall Study|Disease progression|12|||
48382458|NCT02593786|155595141|FG001|Overall Study|Disease progression|16|||
48382459|NCT02593786|155595142|FG002|Overall Study|Disease progression|10|||
48382460|NCT02593786|155595143|FG003|Overall Study|Disease progression|7|||
48512829|NCT01796171|156070842|FG014|Follow-up Period|Patient transferred to other hospital|0|||
48512830|NCT01796171|156070828|FG000|Follow-up Period|Sponsor Decision|0|||
48512831|NCT01796171|156070829|FG001|Follow-up Period|Sponsor Decision|0|||
48512832|NCT01796171|156070830|FG002|Follow-up Period|Sponsor Decision|0|||
48512833|NCT01796171|156070831|FG003|Follow-up Period|Sponsor Decision|0|||
48512834|NCT01796171|156070832|FG004|Follow-up Period|Sponsor Decision|0|||
48512835|NCT01796171|156070833|FG005|Follow-up Period|Sponsor Decision|0|||
48512836|NCT01796171|156070834|FG006|Follow-up Period|Sponsor Decision|0|||
48512837|NCT01796171|156070835|FG007|Follow-up Period|Sponsor Decision|0|||
48512838|NCT01796171|156070836|FG008|Follow-up Period|Sponsor Decision|0|||
48512839|NCT01796171|156070837|FG009|Follow-up Period|Sponsor Decision|0|||
48512840|NCT01796171|156070838|FG010|Follow-up Period|Sponsor Decision|40|||
48512841|NCT01796171|156070839|FG011|Follow-up Period|Sponsor Decision|15|||
48512842|NCT01796171|156070840|FG012|Follow-up Period|Sponsor Decision|7|||
48512843|NCT01796171|156070841|FG013|Follow-up Period|Sponsor Decision|0|||
48512844|NCT01796171|156070842|FG014|Follow-up Period|Sponsor Decision|0|||
48512845|NCT00418561|156070843|FG000|Overall Study|Participant's (guardian's) decision|0|||
48512846|NCT00418561|156070844|FG001|Overall Study|Participant's (guardian's) decision|1|||
48512847|NCT00418561|156070845|FG002|Overall Study|Participant's (guardian's) decision|0|||
48512848|NCT01000961|156070846|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
48382461|NCT02593786|155595140|FG000|Overall Study|Study drug toxicity|1|||
48382462|NCT02593786|155595141|FG001|Overall Study|Study drug toxicity|0|||
48382463|NCT02593786|155595142|FG002|Overall Study|Study drug toxicity|0|||
48382464|NCT02593786|155595143|FG003|Overall Study|Study drug toxicity|0|||
48382465|NCT02593786|155595140|FG000|Overall Study|Adverse event unrelated to study drug|1|||
48512849|NCT01000961|156070847|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48512850|NCT01000961|156070846|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
48512851|NCT01000961|156070847|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
48382466|NCT02593786|155595141|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48382467|NCT02593786|155595142|FG002|Overall Study|Adverse event unrelated to study drug|1|||
48382468|NCT02593786|155595143|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48512852|NCT00829309|156070850|FG000|Washout: 7 Days|Protocol Violation|1|||
48382469|NCT02593786|155595140|FG000|Overall Study|Participant request to discontinue study therapy|0|||
48512853|NCT00829309|156070851|FG001|Washout: 7 Days|Protocol Violation|0|||
48512854|NCT01083693|156070854|FG000|Overall Study|Adverse Event|1|||
48512855|NCT01083693|156070855|FG001|Overall Study|Adverse Event|1|||
48512856|NCT01083693|156070856|FG002|Overall Study|Adverse Event|0|||
48512857|NCT01083693|156070854|FG000|Overall Study|Lost to Follow-up|2|||
48512858|NCT01083693|156070855|FG001|Overall Study|Lost to Follow-up|0|||
48512859|NCT01083693|156070856|FG002|Overall Study|Lost to Follow-up|2|||
48512860|NCT01083693|156070854|FG000|Overall Study|Lack of effectiveness|13|||
48512861|NCT01083693|156070855|FG001|Overall Study|Lack of effectiveness|2|||
48512862|NCT01083693|156070856|FG002|Overall Study|Lack of effectiveness|2|||
48512863|NCT01083693|156070854|FG000|Overall Study|Patient Moved|0|||
48512864|NCT01083693|156070855|FG001|Overall Study|Patient Moved|1|||
48512865|NCT01083693|156070856|FG002|Overall Study|Patient Moved|0|||
48512866|NCT01083693|156070854|FG000|Overall Study|Complete remission|0|||
48512867|NCT01083693|156070855|FG001|Overall Study|Complete remission|1|||
48512868|NCT01083693|156070856|FG002|Overall Study|Complete remission|0|||
48512869|NCT01083693|156070854|FG000|Overall Study|Other medical condition/surgery|1|||
48512870|NCT01083693|156070855|FG001|Overall Study|Other medical condition/surgery|1|||
48512871|NCT01083693|156070856|FG002|Overall Study|Other medical condition/surgery|0|||
48512872|NCT01083693|156070854|FG000|Overall Study|Withdrawal by Subject|3|||
48512873|NCT01083693|156070855|FG001|Overall Study|Withdrawal by Subject|0|||
48512874|NCT01083693|156070856|FG002|Overall Study|Withdrawal by Subject|2|||
48382470|NCT02593786|155595141|FG001|Overall Study|Participant request to discontinue study therapy|2|||
48382471|NCT02593786|155595142|FG002|Overall Study|Participant request to discontinue study therapy|0|||
48382472|NCT02593786|155595143|FG003|Overall Study|Participant request to discontinue study therapy|0|||
48382473|NCT02593786|155595140|FG000|Overall Study|Other reasons|1|||
48512875|NCT01083693|156070854|FG000|Overall Study|Reason unknown|0|||
48512876|NCT01083693|156070855|FG001|Overall Study|Reason unknown|0|||
48512877|NCT01083693|156070856|FG002|Overall Study|Reason unknown|1|||
48512878|NCT03107091|156070857|FG000|Overall Study|Physician Decision|1|||
48512879|NCT01444378|156070861|FG000|Overall Study|Lost to Follow-up|1|||
48512880|NCT01444378|156070861|FG000|Overall Study|Withdrawal by Subject|1|||
48382474|NCT02593786|155595141|FG001|Overall Study|Other reasons|1|||
48382475|NCT02593786|155595142|FG002|Overall Study|Other reasons|0|||
48382476|NCT02593786|155595143|FG003|Overall Study|Other reasons|5|||
48382477|NCT03049735|155595144|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
48382478|NCT03049735|155595145|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
48382479|NCT03049735|155595146|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
48382480|NCT03049735|155595144|FG000|Overall Study|Other|5|||
48382481|NCT03049735|155595145|FG001|Overall Study|Other|3|||
48382482|NCT03049735|155595146|FG002|Overall Study|Other|1|||
48382483|NCT03049735|155595144|FG000|Overall Study|Lack of Efficacy|4|||
48382484|NCT03049735|155595145|FG001|Overall Study|Lack of Efficacy|0|||
48382485|NCT03049735|155595146|FG002|Overall Study|Lack of Efficacy|3|||
48382486|NCT03049735|155595144|FG000|Overall Study|Protocol deviation|1|||
48729427|NCT00048061|156859767|FG002|Overall Study|Did not follow-up|4|||
48729428|NCT00048061|156859768|FG003|Overall Study|Did not follow-up|5|||
48512881|NCT01444378|156070861|FG000|Overall Study|Death|3|||
48382487|NCT03049735|155595145|FG001|Overall Study|Protocol deviation|0|||
48382488|NCT03049735|155595146|FG002|Overall Study|Protocol deviation|0|||
48382489|NCT03049735|155595144|FG000|Overall Study|Pregnancy|0|||
48382490|NCT03049735|155595145|FG001|Overall Study|Pregnancy|0|||
48382491|NCT03049735|155595146|FG002|Overall Study|Pregnancy|1|||
48382492|NCT03049735|155595144|FG000|Overall Study|Adverse Event|7|||
48382493|NCT03049735|155595145|FG001|Overall Study|Adverse Event|18|||
48382494|NCT03049735|155595146|FG002|Overall Study|Adverse Event|5|||
48512882|NCT01444378|156070861|FG000|Overall Study|Administrative Closure Of The Study|2|||
48512883|NCT01444378|156070861|FG000|Overall Study|Missed Visits|10|||
48512884|NCT04022954|156070862|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
48512885|NCT04022954|156070862|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
48512886|NCT04022954|156070862|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
48512887|NCT03285594|156070866|FG000|Overall Study|At the Participant's Own Request|10|||
48512888|NCT03285594|156070867|FG001|Overall Study|At the Participant's Own Request|5|||
48512889|NCT03285594|156070868|FG002|Overall Study|At the Participant's Own Request|21|||
48512890|NCT03285594|156070866|FG000|Overall Study|Adverse Event|2|||
48512891|NCT03285594|156070867|FG001|Overall Study|Adverse Event|2|||
48729429|NCT00048061|156859765|FG000|Overall Study|Early improvement|6|||
48382495|NCT03049735|155595144|FG000|Overall Study|Withdrawal by Subject|10|||
48382496|NCT03049735|155595145|FG001|Overall Study|Withdrawal by Subject|3|||
48382497|NCT03049735|155595146|FG002|Overall Study|Withdrawal by Subject|7|||
48382498|NCT03049735|155595144|FG000|Overall Study|Lost to Follow-up|1|||
48382499|NCT03049735|155595145|FG001|Overall Study|Lost to Follow-up|5|||
48382500|NCT03049735|155595146|FG002|Overall Study|Lost to Follow-up|5|||
48512892|NCT03285594|156070868|FG002|Overall Study|Adverse Event|6|||
48512893|NCT03285594|156070866|FG000|Overall Study|Poor Compliance to Protocol|0|||
48512894|NCT03285594|156070867|FG001|Overall Study|Poor Compliance to Protocol|0|||
48512895|NCT03285594|156070868|FG002|Overall Study|Poor Compliance to Protocol|1|||
48512896|NCT03285594|156070866|FG000|Overall Study|Lost to Follow-up|0|||
48512897|NCT03285594|156070867|FG001|Overall Study|Lost to Follow-up|0|||
48729430|NCT00048061|156859766|FG001|Overall Study|Early improvement|5|||
48512898|NCT03285594|156070868|FG002|Overall Study|Lost to Follow-up|1|||
48512899|NCT03285594|156070866|FG000|Overall Study|Reason Not Specified|3|||
48512900|NCT03285594|156070867|FG001|Overall Study|Reason Not Specified|4|||
48512901|NCT03285594|156070868|FG002|Overall Study|Reason Not Specified|8|||
48512902|NCT02558491|156070869|FG000|First Invention|Withdrawal by Subject|3|||
48512903|NCT02558491|156070870|FG001|First Invention|Withdrawal by Subject|1|||
48512904|NCT02558491|156070869|FG000|First Invention|Data collection issues|1|||
48512905|NCT02558491|156070870|FG001|First Invention|Data collection issues|0|||
48512906|NCT02558491|156070869|FG000|First Invention|Stopping criteria|0|||
48512907|NCT02558491|156070870|FG001|First Invention|Stopping criteria|1|||
48512908|NCT02558491|156070869|FG000|First Invention|Changed parameters during trial|1|||
48512909|NCT02558491|156070870|FG001|First Invention|Changed parameters during trial|0|||
48512910|NCT02558491|156070869|FG000|Second Intervention|Withdrawal by Subject|1|||
48512911|NCT02558491|156070870|FG001|Second Intervention|Withdrawal by Subject|0|||
48512912|NCT02558491|156070869|FG000|Second Intervention|Stopping Criteria|1|||
48512913|NCT02558491|156070870|FG001|Second Intervention|Stopping Criteria|0|||
48512914|NCT03733444|156070875|FG000|Overall Study|Adverse Event|8|||
48512915|NCT03733444|156070876|FG001|Overall Study|Adverse Event|10|||
48512916|NCT03733444|156070877|FG002|Overall Study|Adverse Event|5|||
48512917|NCT03733444|156070875|FG000|Overall Study|Death|20|||
48512918|NCT03733444|156070876|FG001|Overall Study|Death|19|||
48512919|NCT03733444|156070877|FG002|Overall Study|Death|11|||
48512920|NCT03733444|156070875|FG000|Overall Study|Lost to Follow-up|3|||
48512921|NCT03733444|156070876|FG001|Overall Study|Lost to Follow-up|0|||
48512922|NCT03733444|156070877|FG002|Overall Study|Lost to Follow-up|1|||
48512923|NCT03733444|156070875|FG000|Overall Study|Lack of Efficacy|0|||
48512924|NCT03733444|156070876|FG001|Overall Study|Lack of Efficacy|1|||
48512925|NCT03733444|156070877|FG002|Overall Study|Lack of Efficacy|1|||
48512926|NCT03733444|156070875|FG000|Overall Study|Physician Decision|2|||
48512927|NCT03733444|156070876|FG001|Overall Study|Physician Decision|1|||
48382501|NCT04448756|155595148|FG000|Overall Study|Adverse Event|0|||
48382502|NCT04448756|155595149|FG001|Overall Study|Adverse Event|1|||
48382503|NCT04448756|155595150|FG002|Overall Study|Adverse Event|0|||
48382504|NCT04448756|155595148|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
48382505|NCT04448756|155595149|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
48382506|NCT04448756|155595150|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
48382507|NCT04448756|155595148|FG000|Overall Study|Withdrawal by Subject|0|||
48382508|NCT04448756|155595149|FG001|Overall Study|Withdrawal by Subject|3|||
48382509|NCT04448756|155595150|FG002|Overall Study|Withdrawal by Subject|1|||
48382510|NCT04448756|155595148|FG000|Overall Study|Death|2|||
48382511|NCT04448756|155595149|FG001|Overall Study|Death|1|||
48382512|NCT04448756|155595150|FG002|Overall Study|Death|0|||
48382513|NCT00174265|155595151|FG000|Overall Study|Adverse Event|7|||
48382514|NCT00174265|155595152|FG001|Overall Study|Adverse Event|4|||
48382515|NCT00174265|155595151|FG000|Overall Study|Lack of Efficacy|2|||
48382516|NCT00174265|155595152|FG001|Overall Study|Lack of Efficacy|2|||
48382517|NCT00174265|155595151|FG000|Overall Study|Withdrawal by Subject|3|||
48382518|NCT00174265|155595152|FG001|Overall Study|Withdrawal by Subject|5|||
48382519|NCT00174265|155595151|FG000|Overall Study|Lost to Follow-up|1|||
48382520|NCT00174265|155595152|FG001|Overall Study|Lost to Follow-up|0|||
48382521|NCT00174265|155595151|FG000|Overall Study|Other (Not specified)|16|||
48382522|NCT00174265|155595152|FG001|Overall Study|Other (Not specified)|10|||
48382523|NCT00447382|155595153|FG000|Overall Study|Adverse Event|1|||
48382524|NCT00447382|155595154|FG001|Overall Study|Adverse Event|1|||
48822278|NCT01474512|157190492|FG009|Long-Term Extension Period|Sponsor Decision|0|||
48512928|NCT03733444|156070877|FG002|Overall Study|Physician Decision|0|||
48512929|NCT03733444|156070875|FG000|Overall Study|Protocol Violation|2|||
48512930|NCT03733444|156070876|FG001|Overall Study|Protocol Violation|1|||
48512931|NCT03733444|156070877|FG002|Overall Study|Protocol Violation|0|||
48512932|NCT03733444|156070875|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
48512933|NCT03733444|156070876|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
48512934|NCT03733444|156070877|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
48512935|NCT03733444|156070875|FG000|Overall Study|Study Terminated by Sponsor|203|||
48512936|NCT03733444|156070876|FG001|Overall Study|Study Terminated by Sponsor|209|||
48512937|NCT03733444|156070877|FG002|Overall Study|Study Terminated by Sponsor|221|||
48512938|NCT03733444|156070875|FG000|Overall Study|Withdrawal by Subject|19|||
48512939|NCT03733444|156070876|FG001|Overall Study|Withdrawal by Subject|18|||
48512940|NCT03733444|156070877|FG002|Overall Study|Withdrawal by Subject|16|||
48822279|NCT01474512|157190493|FG010|Long-Term Extension Period|Sponsor Decision|0|||
48382525|NCT00447382|155595153|FG000|Overall Study|Lack of Efficacy|1|||
48512941|NCT03733444|156070875|FG000|Overall Study|Miscellaneous|1|||
48512942|NCT03733444|156070876|FG001|Overall Study|Miscellaneous|0|||
48512943|NCT03733444|156070877|FG002|Overall Study|Miscellaneous|1|||
48512944|NCT03733444|156070875|FG000|Overall Study|Not Treated|1|||
48512945|NCT03733444|156070876|FG001|Overall Study|Not Treated|2|||
48382526|NCT00447382|155595154|FG001|Overall Study|Lack of Efficacy|0|||
48382527|NCT00447382|155595153|FG000|Overall Study|Protocol Violation|2|||
48382528|NCT00447382|155595154|FG001|Overall Study|Protocol Violation|0|||
48729431|NCT00048061|156859767|FG002|Overall Study|Early improvement|3|||
48729432|NCT00048061|156859768|FG003|Overall Study|Early improvement|0|||
48729433|NCT00901927|156859772|FG000|Overall Study|Lack of Efficacy|1|||
48512946|NCT03733444|156070877|FG002|Overall Study|Not Treated|1|||
48512947|NCT00835263|156070878|FG000|Second Intervention|Adverse Event|1|||
48512948|NCT00835263|156070879|FG001|Second Intervention|Adverse Event|0|||
48512949|NCT04230681|156070880|FG000|Overall Study|Physician Decision|2|||
48512950|NCT04230681|156070881|FG001|Overall Study|Physician Decision|3|||
48512951|NCT04230681|156070880|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
48512952|NCT04230681|156070881|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
48512953|NCT04230681|156070880|FG000|Overall Study|IV inadvertently removed|0|||
48512954|NCT04230681|156070881|FG001|Overall Study|IV inadvertently removed|1|||
48512955|NCT01788423|156070882|FG000|Overall Study|See Comments in Completed (above)|0|||
48512956|NCT01788423|156070883|FG001|Overall Study|See Comments in Completed (above)|4|||
48512957|NCT01788423|156070884|FG002|Overall Study|See Comments in Completed (above)|5|||
48512958|NCT01501955|156070885|FG000|Overall Study|Withdrawal by Subject|1|||
48512959|NCT01501955|156070886|FG001|Overall Study|Withdrawal by Subject|0|||
48512960|NCT01501955|156070885|FG000|Overall Study|Adverse Event|1|||
48512961|NCT01501955|156070886|FG001|Overall Study|Adverse Event|3|||
48512962|NCT03637764|156070887|FG000|Overall Study|Adverse Event|2|||
48512963|NCT03637764|156070888|FG001|Overall Study|Adverse Event|0|||
48512964|NCT03637764|156070889|FG002|Overall Study|Adverse Event|0|||
48512965|NCT03637764|156070890|FG003|Overall Study|Adverse Event|1|||
48512966|NCT03637764|156070887|FG000|Overall Study|Progressive Disease|23|||
48512967|NCT03637764|156070888|FG001|Overall Study|Progressive Disease|23|||
48512968|NCT03637764|156070889|FG002|Overall Study|Progressive Disease|18|||
48512969|NCT03637764|156070890|FG003|Overall Study|Progressive Disease|31|||
48512970|NCT03637764|156070887|FG000|Overall Study|Withdrawal by Subject|1|||
48512971|NCT03637764|156070888|FG001|Overall Study|Withdrawal by Subject|3|||
48512972|NCT03637764|156070889|FG002|Overall Study|Withdrawal by Subject|0|||
48512973|NCT03637764|156070890|FG003|Overall Study|Withdrawal by Subject|1|||
48512974|NCT02648438|156070891|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48512975|NCT02648438|156070892|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
48512976|NCT02648438|156070893|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
48512977|NCT02648438|156070891|FG000|Overall Study|Protocol Violation|2|||
48512978|NCT02648438|156070892|FG001|Overall Study|Protocol Violation|0|||
48512979|NCT02648438|156070893|FG002|Overall Study|Protocol Violation|0|||
48512980|NCT02648438|156070891|FG000|Overall Study|Withdrawal by Subject|1|||
48512981|NCT02648438|156070892|FG001|Overall Study|Withdrawal by Subject|1|||
48512982|NCT02648438|156070893|FG002|Overall Study|Withdrawal by Subject|0|||
48512983|NCT03249454|156070894|FG000|Overall Study|Withdrawal by Subject|0|||
48512984|NCT03249454|156070895|FG001|Overall Study|Withdrawal by Subject|0|||
48512985|NCT03249454|156070896|FG002|Overall Study|Withdrawal by Subject|0|||
48512986|NCT03249454|156070897|FG003|Overall Study|Withdrawal by Subject|0|||
48512987|NCT03249454|156070898|FG004|Overall Study|Withdrawal by Subject|0|||
48512988|NCT03249454|156070899|FG005|Overall Study|Withdrawal by Subject|0|||
48512989|NCT03249454|156070900|FG006|Overall Study|Withdrawal by Subject|0|||
48512990|NCT03249454|156070901|FG007|Overall Study|Withdrawal by Subject|0|||
48512991|NCT03249454|156070902|FG008|Overall Study|Withdrawal by Subject|0|||
48512992|NCT03249454|156070903|FG009|Overall Study|Withdrawal by Subject|1|||
48512993|NCT03249454|156070904|FG010|Overall Study|Withdrawal by Subject|1|||
48512994|NCT01175135|156070905|FG000|Overall Study|Adverse Event|2|||
48512995|NCT01175135|156070906|FG001|Overall Study|Adverse Event|5|||
48512996|NCT01175135|156070907|FG002|Overall Study|Adverse Event|3|||
48512997|NCT01175135|156070908|FG003|Overall Study|Adverse Event|4|||
48512998|NCT01175135|156070905|FG000|Overall Study|Death|1|||
48512999|NCT01175135|156070906|FG001|Overall Study|Death|0|||
48513000|NCT01175135|156070907|FG002|Overall Study|Death|0|||
48513001|NCT01175135|156070908|FG003|Overall Study|Death|0|||
48513002|NCT01175135|156070905|FG000|Overall Study|Lack of Efficacy|4|||
48513003|NCT01175135|156070906|FG001|Overall Study|Lack of Efficacy|5|||
48513004|NCT01175135|156070907|FG002|Overall Study|Lack of Efficacy|0|||
48513005|NCT01175135|156070908|FG003|Overall Study|Lack of Efficacy|5|||
48513006|NCT01175135|156070905|FG000|Overall Study|Lost to Follow-up|1|||
48729434|NCT00901927|156859772|FG000|Overall Study|Protocol Violation|3|||
48729435|NCT00901927|156859772|FG000|Overall Study|Withdrawal by Subject|2|||
48729436|NCT00072176|156859783|FG000|Overall Study|Withdrawal by Subject|1|||
48513007|NCT01175135|156070906|FG001|Overall Study|Lost to Follow-up|2|||
48513008|NCT01175135|156070907|FG002|Overall Study|Lost to Follow-up|0|||
48513009|NCT01175135|156070908|FG003|Overall Study|Lost to Follow-up|0|||
48513010|NCT01175135|156070905|FG000|Overall Study|Protocol Violation|1|||
48513011|NCT01175135|156070906|FG001|Overall Study|Protocol Violation|1|||
48513012|NCT01175135|156070907|FG002|Overall Study|Protocol Violation|0|||
48513013|NCT01175135|156070908|FG003|Overall Study|Protocol Violation|0|||
48513014|NCT01175135|156070905|FG000|Overall Study|Withdrawal by Subject|4|||
48513015|NCT01175135|156070906|FG001|Overall Study|Withdrawal by Subject|8|||
48513016|NCT01175135|156070907|FG002|Overall Study|Withdrawal by Subject|5|||
48822280|NCT01474512|157190494|FG011|Long-Term Extension Period|Sponsor Decision|0|||
48822281|NCT01474512|157190495|FG012|Long-Term Extension Period|Sponsor Decision|6|||
48822282|NCT01474512|157190496|FG013|Long-Term Extension Period|Sponsor Decision|6|||
48822283|NCT01474512|157190497|FG014|Long-Term Extension Period|Sponsor Decision|0|||
48822284|NCT01474512|157190498|FG015|Long-Term Extension Period|Sponsor Decision|0|||
48513017|NCT01175135|156070908|FG003|Overall Study|Withdrawal by Subject|5|||
48513018|NCT01175135|156070905|FG000|Overall Study|Other|3|||
48513019|NCT01175135|156070906|FG001|Overall Study|Other|1|||
48513020|NCT01175135|156070907|FG002|Overall Study|Other|3|||
48513021|NCT01175135|156070908|FG003|Overall Study|Other|0|||
48513022|NCT01175135|156070905|FG000|Overall Study|Randomized But Not Treated|0|||
48513023|NCT01175135|156070906|FG001|Overall Study|Randomized But Not Treated|0|||
48513024|NCT01175135|156070907|FG002|Overall Study|Randomized But Not Treated|1|||
48513025|NCT01175135|156070908|FG003|Overall Study|Randomized But Not Treated|0|||
48513026|NCT05169710|156070909|FG000|Overall Study|Adverse Event|1|||
48513027|NCT05169710|156070910|FG001|Overall Study|Adverse Event|2|||
48513028|NCT05169710|156070911|FG002|Overall Study|Adverse Event|2|||
48513029|NCT05169710|156070909|FG000|Overall Study|Lost to Follow-up|0|||
48513030|NCT05169710|156070910|FG001|Overall Study|Lost to Follow-up|0|||
48513031|NCT05169710|156070911|FG002|Overall Study|Lost to Follow-up|1|||
48513032|NCT05169710|156070909|FG000|Overall Study|Withdrawal by Subject|2|||
48513033|NCT05169710|156070910|FG001|Overall Study|Withdrawal by Subject|1|||
48513034|NCT05169710|156070911|FG002|Overall Study|Withdrawal by Subject|0|||
48513035|NCT05169710|156070909|FG000|Overall Study|Other Study Discontinuation Reason|0|||
48513036|NCT05169710|156070910|FG001|Overall Study|Other Study Discontinuation Reason|2|||
48513037|NCT05169710|156070911|FG002|Overall Study|Other Study Discontinuation Reason|0|||
48513038|NCT04400890|156070912|FG000|Overall Study|Withdrawal by Subject|3|||
48513039|NCT04400890|156070913|FG001|Overall Study|Withdrawal by Subject|2|||
48513040|NCT03199963|156070918|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
48513041|NCT03199963|156070919|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
48513042|NCT03199963|156070918|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
48513043|NCT03199963|156070919|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
48513044|NCT03199963|156070918|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
48513045|NCT03199963|156070919|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
48513046|NCT03199963|156070918|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
48513047|NCT03199963|156070919|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
48513048|NCT03199963|156070918|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
48513049|NCT03199963|156070919|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
48513050|NCT03199963|156070918|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
48513051|NCT03199963|156070919|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
48513052|NCT00466167|156070920|FG000|Overall Study|Adverse Event|8|||
48513053|NCT00466167|156070921|FG001|Overall Study|Adverse Event|8|||
48513054|NCT00466167|156070922|FG002|Overall Study|Adverse Event|7|||
48513055|NCT00466167|156070920|FG000|Overall Study|Lack of Efficacy|2|||
48513056|NCT00466167|156070921|FG001|Overall Study|Lack of Efficacy|0|||
48513057|NCT00466167|156070922|FG002|Overall Study|Lack of Efficacy|3|||
48513058|NCT00466167|156070920|FG000|Overall Study|Protocol Violation|1|||
48513059|NCT00466167|156070921|FG001|Overall Study|Protocol Violation|1|||
48513060|NCT00466167|156070922|FG002|Overall Study|Protocol Violation|2|||
48513061|NCT00466167|156070920|FG000|Overall Study|Lost to Follow-up|3|||
48513062|NCT00466167|156070921|FG001|Overall Study|Lost to Follow-up|2|||
48513063|NCT00466167|156070922|FG002|Overall Study|Lost to Follow-up|2|||
48513064|NCT00466167|156070920|FG000|Overall Study|Withdrawal by Subject|4|||
48513065|NCT00466167|156070921|FG001|Overall Study|Withdrawal by Subject|1|||
48513066|NCT00466167|156070922|FG002|Overall Study|Withdrawal by Subject|6|||
48513067|NCT00466167|156070920|FG000|Overall Study|patient did not meet inclusion criteria|1|||
48513068|NCT00466167|156070921|FG001|Overall Study|patient did not meet inclusion criteria|0|||
48513069|NCT00466167|156070922|FG002|Overall Study|patient did not meet inclusion criteria|1|||
48513070|NCT00466167|156070920|FG000|Overall Study|Not treated|1|||
48513071|NCT00466167|156070921|FG001|Overall Study|Not treated|0|||
48513072|NCT00466167|156070922|FG002|Overall Study|Not treated|0|||
48513073|NCT02213263|156070923|FG000|Overall Study|Insufficient clinical response|4|||
48513074|NCT02213263|156070924|FG001|Overall Study|Insufficient clinical response|3|||
48513075|NCT02213263|156070923|FG000|Overall Study|Lost to Follow-up|0|||
48513076|NCT02213263|156070924|FG001|Overall Study|Lost to Follow-up|1|||
48513077|NCT02213263|156070923|FG000|Overall Study|No longer willing to participate|3|||
48513078|NCT02213263|156070924|FG001|Overall Study|No longer willing to participate|4|||
48513079|NCT02213263|156070923|FG000|Overall Study|Progressive disease|20|||
48513080|NCT02213263|156070924|FG001|Overall Study|Progressive disease|14|||
48513081|NCT02213263|156070923|FG000|Overall Study|Protocol Violation|0|||
48513082|NCT02213263|156070924|FG001|Overall Study|Protocol Violation|1|||
48513083|NCT02213263|156070923|FG000|Overall Study|Adverse Event|1|||
48513084|NCT02213263|156070924|FG001|Overall Study|Adverse Event|3|||
48382529|NCT00447382|155595153|FG000|Overall Study|Unclassified|2|||
48382530|NCT00447382|155595154|FG001|Overall Study|Unclassified|5|||
48382531|NCT03144804|155595155|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
48382532|NCT01399190|155596674|FG000|Overall Study|Not Eligible for Final Analysis|5|||
48382533|NCT01399190|155596674|FG000|Overall Study|Adverse Event|8|||
48382534|NCT01399190|155596674|FG000|Overall Study|Participant's Request|5|||
48382535|NCT01399190|155596674|FG000|Overall Study|Physician Decision|2|||
48382536|NCT03781323|155596677|FG000|Overall Study|Withdrawal by Subject|1|||
48382537|NCT02308007|155596678|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
48382538|NCT02308007|155596679|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
48382539|NCT02308007|155596680|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
48382540|NCT02308007|155596678|FG000|Overall Study|Positive for STD at Baseline|7|||
48382541|NCT02308007|155596679|FG001|Overall Study|Positive for STD at Baseline|11|||
48382542|NCT02308007|155596680|FG002|Overall Study|Positive for STD at Baseline|7|||
48382543|NCT02308007|155596678|FG000|Overall Study|Lost to Follow-up|3|||
48382544|NCT02308007|155596679|FG001|Overall Study|Lost to Follow-up|0|||
48382545|NCT02308007|155596680|FG002|Overall Study|Lost to Follow-up|1|||
48382546|NCT01296035|155596685|FG000|Overall Study|Withdrawal by Subject|1|||
48382547|NCT04004429|155596686|FG000|Overall Study|Protocol Violation|1|||
48382548|NCT04004429|155596687|FG001|Overall Study|Protocol Violation|0|||
48382549|NCT04004429|155596688|FG002|Overall Study|Protocol Violation|0|||
48382550|NCT04004429|155596686|FG000|Overall Study|Physician Decision|0|||
48382551|NCT04004429|155596687|FG001|Overall Study|Physician Decision|1|||
48382552|NCT04004429|155596688|FG002|Overall Study|Physician Decision|1|||
48382553|NCT04004429|155596686|FG000|Overall Study|Withdrawal by Subject|1|||
48382554|NCT04004429|155596687|FG001|Overall Study|Withdrawal by Subject|1|||
48382555|NCT04004429|155596688|FG002|Overall Study|Withdrawal by Subject|1|||
48382556|NCT03085758|155596689|FG000|Overall Study|Death|26|||
48513085|NCT00263588|156070925|FG000|Overall Study|Death|54|||
48513086|NCT00263588|156070926|FG001|Overall Study|Death|90|||
48513087|NCT00263588|156070925|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
48513088|NCT00263588|156070926|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
48513089|NCT00263588|156070925|FG000|Overall Study|Lost to Follow-up|7|||
48513090|NCT00263588|156070926|FG001|Overall Study|Lost to Follow-up|10|||
48513091|NCT00263588|156070925|FG000|Overall Study|Withdrawal by Subject|3|||
48513092|NCT00263588|156070926|FG001|Overall Study|Withdrawal by Subject|4|||
48513093|NCT00263588|156070925|FG000|Overall Study|Protocol Violation|0|||
48513094|NCT00263588|156070926|FG001|Overall Study|Protocol Violation|1|||
48513095|NCT00263588|156070925|FG000|Overall Study|Investigator decision|7|||
48513096|NCT00263588|156070926|FG001|Overall Study|Investigator decision|15|||
48513097|NCT00263588|156070925|FG000|Overall Study|Sponsor terminated study|0|||
48513098|NCT00263588|156070926|FG001|Overall Study|Sponsor terminated study|1|||
48382557|NCT03085758|155596690|FG001|Overall Study|Death|24|||
48382558|NCT03085758|155596691|FG002|Overall Study|Death|53|||
48382559|NCT03085758|155596689|FG000|Overall Study|Lost to Follow-up|1|||
48382560|NCT03085758|155596690|FG001|Overall Study|Lost to Follow-up|1|||
48382561|NCT03085758|155596691|FG002|Overall Study|Lost to Follow-up|1|||
48382562|NCT03085758|155596689|FG000|Overall Study|Withdrawal by Subject|2|||
48382563|NCT03085758|155596690|FG001|Overall Study|Withdrawal by Subject|2|||
48382564|NCT03085758|155596691|FG002|Overall Study|Withdrawal by Subject|1|||
48382565|NCT03085758|155596689|FG000|Overall Study|Refusal to recall it up to day 90|0|||
48382566|NCT03085758|155596690|FG001|Overall Study|Refusal to recall it up to day 90|0|||
48382567|NCT03085758|155596691|FG002|Overall Study|Refusal to recall it up to day 90|1|||
48382568|NCT03085758|155596689|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
48382569|NCT03085758|155596690|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
48382570|NCT03085758|155596691|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
48382571|NCT00056862|155596697|FG000|Overall Study|Protocol Violation|1|||
48382572|NCT00056862|155596698|FG001|Overall Study|Protocol Violation|0|||
48382573|NCT04880447|155596700|FG000|Overall Study|No vaccination information|1|||
48382574|NCT04880447|155596700|FG000|Overall Study|No adverse event information (missing information)|1|||
48382575|NCT04880447|155596700|FG000|Overall Study|Disease not covered in this study|35|||
48382576|NCT00146757|155596701|FG000|Overall Study|Death|1|||
48382577|NCT00146757|155596702|FG001|Overall Study|Death|0|||
48382578|NCT00146757|155596701|FG000|Overall Study|Adverse Event|1|||
48382579|NCT00146757|155596702|FG001|Overall Study|Adverse Event|0|||
48382580|NCT04585646|155596703|FG000|First Intervention|Physician Decision|1|||
48382581|NCT04585646|155596704|FG001|First Intervention|Physician Decision|0|||
48382582|NCT04585646|155596703|FG000|First Intervention|Lost to Follow-up|0|||
48382583|NCT04585646|155596704|FG001|First Intervention|Lost to Follow-up|3|||
48382584|NCT04585646|155596703|FG000|First Intervention|Withdrawal by Subject|0|||
48382585|NCT04585646|155596704|FG001|First Intervention|Withdrawal by Subject|1|||
48382586|NCT02092350|155596705|FG000|Overall Study|Adverse Event|0|||
48513099|NCT00835692|156070927|FG000|First Intervention|Withdrawal by Subject|1|||
48382587|NCT02092350|155596706|FG001|Overall Study|Adverse Event|3|||
48382588|NCT02092350|155596705|FG000|Overall Study|Death|2|||
48513100|NCT00835692|156070928|FG001|First Intervention|Withdrawal by Subject|0|||
48382589|NCT02092350|155596706|FG001|Overall Study|Death|5|||
48382590|NCT02092350|155596705|FG000|Overall Study|Lost to Follow-up|3|||
48382591|NCT02092350|155596706|FG001|Overall Study|Lost to Follow-up|1|||
48382592|NCT02092350|155596705|FG000|Overall Study|Protocol Violation|1|||
48382593|NCT02092350|155596706|FG001|Overall Study|Protocol Violation|0|||
48382594|NCT02092350|155596705|FG000|Overall Study|Physician Decision|1|||
48382595|NCT02092350|155596706|FG001|Overall Study|Physician Decision|1|||
48382596|NCT02092350|155596705|FG000|Overall Study|Screen Failure|1|||
48382597|NCT02092350|155596706|FG001|Overall Study|Screen Failure|0|||
48382598|NCT02092350|155596705|FG000|Overall Study|Withdrawal by Subject|2|||
48382599|NCT02092350|155596706|FG001|Overall Study|Withdrawal by Subject|2|||
48382600|NCT01603082|155596711|FG000|Overall Study|Adverse Event|0|||
48382601|NCT01603082|155596712|FG001|Overall Study|Adverse Event|1|||
48382602|NCT01603082|155596711|FG000|Overall Study|Withdrawal by Subject|1|||
48382603|NCT01603082|155596712|FG001|Overall Study|Withdrawal by Subject|0|||
48382604|NCT01603082|155596711|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
48382605|NCT01603082|155596712|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
48382606|NCT03690141|155596720|FG000|Overall Study|Adverse Event|5|||
48382607|NCT03690141|155596720|FG000|Overall Study|Withdrawal by Subject|3|||
48382608|NCT03690141|155596720|FG000|Overall Study|Physician Decision|4|||
48382609|NCT03690141|155596720|FG000|Overall Study|Disease progression|4|||
48382610|NCT00041067|155596721|FG000|Overall Study|Adverse Event|20|||
48382611|NCT00041067|155596721|FG000|Overall Study|Progression|19|||
48382612|NCT00041067|155596721|FG000|Overall Study|Patient refusal|12|||
48382613|NCT00041067|155596721|FG000|Overall Study|Other reasons|23|||
48382614|NCT00041067|155596721|FG000|Overall Study|Ineligible|2|||
48382615|NCT01807923|155596726|FG000|Overall Study|Adverse Event|2|||
48382616|NCT01807923|155596727|FG001|Overall Study|Adverse Event|1|||
48382617|NCT01807923|155596728|FG002|Overall Study|Adverse Event|2|||
48382618|NCT01807923|155596726|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
48382619|NCT01807923|155596727|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
48513101|NCT00003470|156070929|FG000|Overall Study|Not evaluable|6|||
48513102|NCT01169558|156070931|FG000|Overall Study|Disease progression|98|||
48513103|NCT01169558|156070931|FG000|Overall Study|Adverse Event|25|||
48729437|NCT00072176|156859784|FG001|Overall Study|Withdrawal by Subject|0|||
48729438|NCT00072176|156859783|FG000|Overall Study|Protocol Violation|0|||
48729439|NCT00072176|156859784|FG001|Overall Study|Protocol Violation|1|||
48729440|NCT04567615|156859796|FG000|Randomization|Participant withdrew consent|1|||
48729441|NCT04567615|156859797|FG001|Randomization|Participant withdrew consent|0|||
48729442|NCT04567615|156859798|FG002|Randomization|Participant withdrew consent|0|||
48729443|NCT04567615|156859796|FG000|Randomization|Adverse event unrelated to study drug|0|||
48729444|NCT04567615|156859797|FG001|Randomization|Adverse event unrelated to study drug|1|||
48729445|NCT04567615|156859798|FG002|Randomization|Adverse event unrelated to study drug|0|||
48729446|NCT04567615|156859796|FG000|Treatment Period|Participant Withdrew Consent|2|||
48513104|NCT01169558|156070931|FG000|Overall Study|Withdrawal of Consent|8|||
48729447|NCT04567615|156859797|FG001|Treatment Period|Participant Withdrew Consent|5|||
48513105|NCT01169558|156070931|FG000|Overall Study|Medical Decision|7|||
48513106|NCT01169558|156070931|FG000|Overall Study|Stable Disease|4|||
48513107|NCT01169558|156070931|FG000|Overall Study|Lost to Follow-up|4|||
48513108|NCT01169558|156070931|FG000|Overall Study|Need for Surgery|4|||
48513109|NCT01169558|156070931|FG000|Overall Study|Non-compliance|2|||
48513110|NCT01169558|156070931|FG000|Overall Study|Protocol Violation|2|||
48513111|NCT01169558|156070931|FG000|Overall Study|Partial response|2|||
48513112|NCT00838539|156070934|FG000|Overall Study|Disease Progression|2|||
48513113|NCT00838539|156070935|FG001|Overall Study|Disease Progression|4|||
48513114|NCT00838539|156070936|FG002|Overall Study|Disease Progression|3|||
48513115|NCT00838539|156070937|FG003|Overall Study|Disease Progression|2|||
48513116|NCT00838539|156070938|FG004|Overall Study|Disease Progression|4|||
48513117|NCT00838539|156070939|FG005|Overall Study|Disease Progression|2|||
48513118|NCT00838539|156070940|FG006|Overall Study|Disease Progression|3|||
48513119|NCT00838539|156070941|FG007|Overall Study|Disease Progression|4|||
48513120|NCT00838539|156070942|FG008|Overall Study|Disease Progression|4|||
48513121|NCT00838539|156070943|FG009|Overall Study|Disease Progression|5|||
48513122|NCT00838539|156070944|FG010|Overall Study|Disease Progression|1|||
48513123|NCT00838539|156070945|FG011|Overall Study|Disease Progression|4|||
48513124|NCT00838539|156070934|FG000|Overall Study|Adverse Event|1|||
48513125|NCT00838539|156070935|FG001|Overall Study|Adverse Event|1|||
48513126|NCT00838539|156070936|FG002|Overall Study|Adverse Event|1|||
48513127|NCT00838539|156070937|FG003|Overall Study|Adverse Event|1|||
48513128|NCT00838539|156070938|FG004|Overall Study|Adverse Event|2|||
48513129|NCT00838539|156070939|FG005|Overall Study|Adverse Event|1|||
48513130|NCT00838539|156070940|FG006|Overall Study|Adverse Event|0|||
48513131|NCT00838539|156070941|FG007|Overall Study|Adverse Event|2|||
48513132|NCT00838539|156070942|FG008|Overall Study|Adverse Event|0|||
48513133|NCT00838539|156070943|FG009|Overall Study|Adverse Event|1|||
48513134|NCT00838539|156070944|FG010|Overall Study|Adverse Event|2|||
48513135|NCT00838539|156070945|FG011|Overall Study|Adverse Event|0|||
48513136|NCT00838539|156070934|FG000|Overall Study|Withdrawal by Subject|0|||
48513137|NCT00838539|156070935|FG001|Overall Study|Withdrawal by Subject|1|||
48513138|NCT00838539|156070936|FG002|Overall Study|Withdrawal by Subject|0|||
48513139|NCT00838539|156070937|FG003|Overall Study|Withdrawal by Subject|0|||
48513140|NCT00838539|156070938|FG004|Overall Study|Withdrawal by Subject|0|||
48382620|NCT01807923|155596728|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
48382621|NCT01807923|155596726|FG000|Overall Study|Physician Decision|0|||
48513141|NCT00838539|156070939|FG005|Overall Study|Withdrawal by Subject|0|||
48513142|NCT00838539|156070940|FG006|Overall Study|Withdrawal by Subject|0|||
48513143|NCT00838539|156070941|FG007|Overall Study|Withdrawal by Subject|0|||
48382622|NCT01807923|155596727|FG001|Overall Study|Physician Decision|0|||
48382623|NCT01807923|155596728|FG002|Overall Study|Physician Decision|1|||
48382624|NCT01807923|155596726|FG000|Overall Study|Not Eligible (Genotype)|0|||
48382625|NCT01807923|155596727|FG001|Overall Study|Not Eligible (Genotype)|0|||
48382626|NCT01807923|155596728|FG002|Overall Study|Not Eligible (Genotype)|1|||
48382627|NCT01807923|155596726|FG000|Overall Study|Randomized But Not Treated|3|||
48382628|NCT01807923|155596727|FG001|Overall Study|Randomized But Not Treated|2|||
48729448|NCT04567615|156859798|FG002|Treatment Period|Participant Withdrew Consent|1|||
48729449|NCT04567615|156859796|FG000|Treatment Period|Death|1|||
48729450|NCT04567615|156859797|FG001|Treatment Period|Death|2|||
48822285|NCT01474512|157190499|FG016|Long-Term Extension Period|Sponsor Decision|0|||
48822286|NCT01474512|157190500|FG017|Long-Term Extension Period|Sponsor Decision|0|||
48822287|NCT01474512|157190483|FG000|Long-Term Extension Period|Protocol Violation|0|||
48822288|NCT01474512|157190484|FG001|Long-Term Extension Period|Protocol Violation|0|||
48822289|NCT01474512|157190485|FG002|Long-Term Extension Period|Protocol Violation|0|||
48822290|NCT01474512|157190486|FG003|Long-Term Extension Period|Protocol Violation|0|||
48822291|NCT01474512|157190487|FG004|Long-Term Extension Period|Protocol Violation|0|||
48513144|NCT00838539|156070942|FG008|Overall Study|Withdrawal by Subject|0|||
48513145|NCT00838539|156070943|FG009|Overall Study|Withdrawal by Subject|1|||
48513146|NCT00838539|156070944|FG010|Overall Study|Withdrawal by Subject|2|||
48513147|NCT00838539|156070945|FG011|Overall Study|Withdrawal by Subject|0|||
48513148|NCT00838539|156070934|FG000|Overall Study|Death|0|||
48513149|NCT00838539|156070935|FG001|Overall Study|Death|0|||
48513150|NCT00838539|156070936|FG002|Overall Study|Death|0|||
48513151|NCT00838539|156070937|FG003|Overall Study|Death|0|||
48513152|NCT00838539|156070938|FG004|Overall Study|Death|0|||
48513153|NCT00838539|156070939|FG005|Overall Study|Death|0|||
48513154|NCT00838539|156070940|FG006|Overall Study|Death|1|||
48513155|NCT00838539|156070941|FG007|Overall Study|Death|0|||
48513156|NCT00838539|156070942|FG008|Overall Study|Death|0|||
48513157|NCT00838539|156070943|FG009|Overall Study|Death|0|||
48513158|NCT00838539|156070944|FG010|Overall Study|Death|0|||
48513159|NCT00838539|156070945|FG011|Overall Study|Death|0|||
48729451|NCT04567615|156859798|FG002|Treatment Period|Death|0|||
48729452|NCT04567615|156859796|FG000|Treatment Period|Lost to Follow-up|0|||
48729453|NCT04567615|156859797|FG001|Treatment Period|Lost to Follow-up|1|||
48729454|NCT04567615|156859798|FG002|Treatment Period|Lost to Follow-up|0|||
48729455|NCT04567615|156859796|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
48729456|NCT04567615|156859797|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
48729457|NCT04567615|156859798|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
48729458|NCT04567615|156859796|FG000|Treatment Period|Disease Progression|85|||
48729459|NCT04567615|156859797|FG001|Treatment Period|Disease Progression|63|||
48729460|NCT04567615|156859798|FG002|Treatment Period|Disease Progression|16|||
48729461|NCT04567615|156859796|FG000|Treatment Period|Study Drug Toxicity|3|||
48729462|NCT04567615|156859797|FG001|Treatment Period|Study Drug Toxicity|10|||
48729463|NCT04567615|156859798|FG002|Treatment Period|Study Drug Toxicity|4|||
48729464|NCT04567615|156859796|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
48729465|NCT04567615|156859797|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
48729466|NCT04567615|156859798|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
48729467|NCT04567615|156859796|FG000|Treatment Period|Other Reasons|1|||
48729468|NCT04567615|156859797|FG001|Treatment Period|Other Reasons|2|||
48513160|NCT00838539|156070934|FG000|Overall Study|Physician Decision|0|||
48729469|NCT04567615|156859798|FG002|Treatment Period|Other Reasons|0|||
48729470|NCT04567615|156859796|FG000|Treatment Period|Still On-going Treatment|21|||
48729471|NCT04567615|156859797|FG001|Treatment Period|Still On-going Treatment|22|||
48822292|NCT01474512|157190488|FG005|Long-Term Extension Period|Protocol Violation|0|||
48822293|NCT01474512|157190489|FG006|Long-Term Extension Period|Protocol Violation|0|||
48822294|NCT01474512|157190490|FG007|Long-Term Extension Period|Protocol Violation|0|||
48382629|NCT01807923|155596728|FG002|Overall Study|Randomized But Not Treated|5|||
48513161|NCT00838539|156070935|FG001|Overall Study|Physician Decision|0|||
48513162|NCT00838539|156070936|FG002|Overall Study|Physician Decision|0|||
48513163|NCT00838539|156070937|FG003|Overall Study|Physician Decision|0|||
48513164|NCT00838539|156070938|FG004|Overall Study|Physician Decision|0|||
48513165|NCT00838539|156070939|FG005|Overall Study|Physician Decision|0|||
48513166|NCT00838539|156070940|FG006|Overall Study|Physician Decision|0|||
48513167|NCT00838539|156070941|FG007|Overall Study|Physician Decision|0|||
48513168|NCT00838539|156070942|FG008|Overall Study|Physician Decision|1|||
48513169|NCT00838539|156070943|FG009|Overall Study|Physician Decision|0|||
48513170|NCT00838539|156070944|FG010|Overall Study|Physician Decision|0|||
48513171|NCT00838539|156070945|FG011|Overall Study|Physician Decision|0|||
48513172|NCT00838539|156070934|FG000|Overall Study|Clinical Progression|0|||
48513173|NCT00838539|156070935|FG001|Overall Study|Clinical Progression|0|||
48513174|NCT00838539|156070936|FG002|Overall Study|Clinical Progression|0|||
48513175|NCT00838539|156070937|FG003|Overall Study|Clinical Progression|0|||
48513176|NCT00838539|156070938|FG004|Overall Study|Clinical Progression|0|||
48513177|NCT00838539|156070939|FG005|Overall Study|Clinical Progression|0|||
48513178|NCT00838539|156070940|FG006|Overall Study|Clinical Progression|1|||
48513179|NCT00838539|156070941|FG007|Overall Study|Clinical Progression|0|||
48513180|NCT00838539|156070942|FG008|Overall Study|Clinical Progression|0|||
48513181|NCT00838539|156070943|FG009|Overall Study|Clinical Progression|0|||
48513182|NCT00838539|156070944|FG010|Overall Study|Clinical Progression|0|||
48513183|NCT00838539|156070945|FG011|Overall Study|Clinical Progression|0|||
48513184|NCT00838539|156070934|FG000|Overall Study|Symptomatic Deterioration|0|||
48513185|NCT00838539|156070935|FG001|Overall Study|Symptomatic Deterioration|0|||
48513186|NCT00838539|156070936|FG002|Overall Study|Symptomatic Deterioration|1|||
48729472|NCT04567615|156859798|FG002|Treatment Period|Still On-going Treatment|2|||
48822295|NCT01474512|157190491|FG008|Long-Term Extension Period|Protocol Violation|0|||
48822296|NCT01474512|157190492|FG009|Long-Term Extension Period|Protocol Violation|0|||
48822297|NCT01474512|157190493|FG010|Long-Term Extension Period|Protocol Violation|0|||
48822298|NCT01474512|157190494|FG011|Long-Term Extension Period|Protocol Violation|0|||
48729473|NCT04854642|156861228|FG000|Overall Study|Adverse Event|1|||
48729474|NCT04854642|156861229|FG001|Overall Study|Adverse Event|2|||
48729475|NCT04854642|156861228|FG000|Overall Study|Withdrawal by Subject|0|||
48729476|NCT04854642|156861229|FG001|Overall Study|Withdrawal by Subject|1|||
48729477|NCT00597701|156861230|FG000|Overall Study|Withdrawal by Subject|5|||
48729478|NCT00597701|156861231|FG001|Overall Study|Withdrawal by Subject|5|||
48729479|NCT00597701|156861230|FG000|Overall Study|Death|0|||
48729480|NCT00597701|156861231|FG001|Overall Study|Death|1|||
48729481|NCT00597701|156861230|FG000|Overall Study|Physician Decision|2|||
48729482|NCT00597701|156861231|FG001|Overall Study|Physician Decision|0|||
48729483|NCT00597701|156861230|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
48513187|NCT00838539|156070937|FG003|Overall Study|Symptomatic Deterioration|1|||
48822299|NCT01474512|157190495|FG012|Long-Term Extension Period|Protocol Violation|5|||
48822300|NCT01474512|157190496|FG013|Long-Term Extension Period|Protocol Violation|5|||
48822301|NCT01474512|157190497|FG014|Long-Term Extension Period|Protocol Violation|0|||
48822302|NCT01474512|157190498|FG015|Long-Term Extension Period|Protocol Violation|0|||
48822303|NCT01474512|157190499|FG016|Long-Term Extension Period|Protocol Violation|0|||
48822304|NCT01474512|157190500|FG017|Long-Term Extension Period|Protocol Violation|0|||
48822305|NCT01474512|157190483|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822306|NCT01474512|157190484|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822307|NCT01474512|157190485|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822308|NCT01474512|157190486|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822309|NCT01474512|157190487|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822310|NCT01474512|157190488|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822311|NCT01474512|157190489|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822312|NCT01474512|157190490|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822313|NCT01474512|157190491|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822314|NCT01474512|157190492|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822315|NCT01474512|157190493|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822316|NCT01474512|157190494|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822317|NCT01474512|157190495|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
48822318|NCT01474512|157190496|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
48822319|NCT01474512|157190497|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822320|NCT01474512|157190498|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822321|NCT01474512|157190499|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822322|NCT01474512|157190500|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
48822323|NCT01474512|157190483|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48729484|NCT00597701|156861231|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
48729485|NCT01107418|156861232|FG000|Overall Study|Disease Progression|45|||
48513188|NCT00838539|156070938|FG004|Overall Study|Symptomatic Deterioration|0|||
48822324|NCT01474512|157190484|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48513189|NCT00838539|156070939|FG005|Overall Study|Symptomatic Deterioration|1|||
48513190|NCT00838539|156070940|FG006|Overall Study|Symptomatic Deterioration|0|||
48513191|NCT00838539|156070941|FG007|Overall Study|Symptomatic Deterioration|0|||
48729486|NCT01107418|156861232|FG000|Overall Study|Adverse Event|3|||
48729487|NCT01107418|156861232|FG000|Overall Study|Withdrawal by Subject|1|||
48729488|NCT01107418|156861232|FG000|Overall Study|Study Closing|1|||
48729489|NCT01107418|156861232|FG000|Overall Study|Started Other Therapy|1|||
48729490|NCT01107418|156861232|FG000|Overall Study|Entered Extension Study|1|||
48513192|NCT00838539|156070942|FG008|Overall Study|Symptomatic Deterioration|0|||
48513193|NCT00838539|156070943|FG009|Overall Study|Symptomatic Deterioration|1|||
48513194|NCT00838539|156070944|FG010|Overall Study|Symptomatic Deterioration|0|||
48513195|NCT00838539|156070945|FG011|Overall Study|Symptomatic Deterioration|0|||
48513196|NCT03719040|156070946|FG000|Overall Study|Withdrawal by Subject|177|||
48513197|NCT03719040|156070946|FG000|Overall Study|Lost to Follow-up|26|||
48513198|NCT02358538|156070950|FG000|Through Week 26|Adverse Event|0|||
48513199|NCT02358538|156070951|FG001|Through Week 26|Adverse Event|1|||
48513200|NCT02358538|156070952|FG002|Through Week 26|Adverse Event|1|||
48513201|NCT02358538|156070953|FG003|Through Week 26|Adverse Event|2|||
48513202|NCT02358538|156070950|FG000|Through Week 26|Lack of Efficacy|1|||
48513203|NCT02358538|156070951|FG001|Through Week 26|Lack of Efficacy|1|||
48513204|NCT02358538|156070952|FG002|Through Week 26|Lack of Efficacy|3|||
48822325|NCT01474512|157190485|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822326|NCT01474512|157190486|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822327|NCT01474512|157190487|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822328|NCT01474512|157190488|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822329|NCT01474512|157190489|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822330|NCT01474512|157190490|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822331|NCT01474512|157190491|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822332|NCT01474512|157190492|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822333|NCT01474512|157190493|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822334|NCT01474512|157190494|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
48822335|NCT01474512|157190495|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822336|NCT01474512|157190496|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822337|NCT01474512|157190497|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822338|NCT01474512|157190498|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822339|NCT01474512|157190499|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48822340|NCT01474512|157190500|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
48513205|NCT02358538|156070953|FG003|Through Week 26|Lack of Efficacy|3|||
48513206|NCT02358538|156070950|FG000|Through Week 26|Withdrawal by Subject|1|||
48513207|NCT02358538|156070951|FG001|Through Week 26|Withdrawal by Subject|0|||
48513208|NCT02358538|156070952|FG002|Through Week 26|Withdrawal by Subject|0|||
48513209|NCT02358538|156070953|FG003|Through Week 26|Withdrawal by Subject|0|||
48513210|NCT02358538|156070950|FG000|Through Week 26|Non-Compliance|0|||
48513211|NCT02358538|156070951|FG001|Through Week 26|Non-Compliance|0|||
48822341|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
48822342|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
48822343|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
48822344|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
48822345|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
48822346|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
48822347|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
48822348|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
48822349|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
48822350|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
48822351|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
48822352|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
48822353|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
48822354|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
48822355|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
48822356|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
48822357|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
48822358|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
48822359|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822360|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822361|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822362|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822363|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822364|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822365|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822366|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822367|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48513212|NCT02358538|156070952|FG002|Through Week 26|Non-Compliance|1|||
48822368|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48513213|NCT02358538|156070953|FG003|Through Week 26|Non-Compliance|0|||
48513214|NCT02358538|156070950|FG000|Through Week 26|Family did not see benefit from IP|1|||
48513215|NCT02358538|156070951|FG001|Through Week 26|Family did not see benefit from IP|0|||
48513216|NCT02358538|156070952|FG002|Through Week 26|Family did not see benefit from IP|0|||
48513217|NCT02358538|156070953|FG003|Through Week 26|Family did not see benefit from IP|0|||
48513218|NCT02358538|156070950|FG000|52 Week Extension Period|Lack of Efficacy|0|||
48822369|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48513219|NCT02358538|156070951|FG001|52 Week Extension Period|Lack of Efficacy|0|||
48513220|NCT02358538|156070952|FG002|52 Week Extension Period|Lack of Efficacy|2|||
48513221|NCT02358538|156070953|FG003|52 Week Extension Period|Lack of Efficacy|4|||
48513222|NCT00829764|156070961|FG000|First Intervention|Adverse Event|1|||
48513223|NCT00829764|156070962|FG001|First Intervention|Adverse Event|0|||
48513224|NCT00829764|156070961|FG000|First Intervention|Withdrawal by Subject|1|||
48513225|NCT00829764|156070962|FG001|First Intervention|Withdrawal by Subject|1|||
48513226|NCT04594252|156070963|FG000|Overall Study|Adverse Event|0|||
48513227|NCT04594252|156070964|FG001|Overall Study|Adverse Event|2|||
48513228|NCT00830258|156072192|FG000|First Intervention|Adverse Event|1|||
48513229|NCT00830258|156072193|FG001|First Intervention|Adverse Event|0|||
48513230|NCT00830258|156072192|FG000|Washout: 7 Days|Protocol Violation|1|||
48513231|NCT00830258|156072193|FG001|Washout: 7 Days|Protocol Violation|0|||
48513232|NCT02057835|156072194|FG000|Overall Study|Withdrawal by Subject|0|||
48513233|NCT02057835|156072195|FG001|Overall Study|Withdrawal by Subject|2|||
48513234|NCT02057835|156072196|FG002|Overall Study|Withdrawal by Subject|0|||
48513235|NCT02057835|156072197|FG003|Overall Study|Withdrawal by Subject|0|||
48513236|NCT02057835|156072198|FG004|Overall Study|Withdrawal by Subject|0|||
48513237|NCT02057835|156072199|FG005|Overall Study|Withdrawal by Subject|0|||
48513238|NCT02057835|156072200|FG006|Overall Study|Withdrawal by Subject|0|||
48513239|NCT02057835|156072201|FG007|Overall Study|Withdrawal by Subject|0|||
48513240|NCT02057835|156072202|FG008|Overall Study|Withdrawal by Subject|0|||
48513241|NCT02057835|156072203|FG009|Overall Study|Withdrawal by Subject|0|||
48513242|NCT00124618|156072204|FG000|Overall Study|Ineligible|1|||
48513243|NCT00804856|156072212|FG000|Overall Study|Progressive Disease|3|||
48513244|NCT00804856|156072213|FG001|Overall Study|Progressive Disease|2|||
48513245|NCT00804856|156072214|FG002|Overall Study|Progressive Disease|4|||
48513246|NCT00804856|156072215|FG003|Overall Study|Progressive Disease|6|||
48513247|NCT00804856|156072216|FG004|Overall Study|Progressive Disease|4|||
48513248|NCT00804856|156072217|FG005|Overall Study|Progressive Disease|1|||
48513249|NCT00804856|156072218|FG006|Overall Study|Progressive Disease|8|||
48513250|NCT00804856|156072219|FG007|Overall Study|Progressive Disease|2|||
48513251|NCT00804856|156072220|FG008|Overall Study|Progressive Disease|4|||
48513252|NCT00804856|156072221|FG009|Overall Study|Progressive Disease|5|||
48513253|NCT00804856|156072222|FG010|Overall Study|Progressive Disease|12|||
48513254|NCT00804856|156072223|FG011|Overall Study|Progressive Disease|2|||
48513255|NCT00804856|156072224|FG012|Overall Study|Progressive Disease|2|||
48513256|NCT00804856|156072225|FG013|Overall Study|Progressive Disease|26|||
48513257|NCT00804856|156072226|FG014|Overall Study|Progressive Disease|20|||
48513258|NCT00804856|156072212|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513259|NCT00804856|156072213|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513260|NCT00804856|156072214|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513261|NCT00804856|156072215|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513262|NCT00804856|156072216|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48513263|NCT00804856|156072217|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513264|NCT00804856|156072218|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513265|NCT00804856|156072219|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513266|NCT00804856|156072220|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513267|NCT00804856|156072221|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513268|NCT00804856|156072222|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513269|NCT00804856|156072223|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513270|NCT00804856|156072224|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513271|NCT00804856|156072225|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48513272|NCT00804856|156072226|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48513273|NCT00804856|156072212|FG000|Overall Study|Other Adverse Event|1|||
48513274|NCT00804856|156072213|FG001|Overall Study|Other Adverse Event|1|||
48513275|NCT00804856|156072214|FG002|Overall Study|Other Adverse Event|1|||
48513276|NCT00804856|156072215|FG003|Overall Study|Other Adverse Event|2|||
48513277|NCT00804856|156072216|FG004|Overall Study|Other Adverse Event|2|||
48513278|NCT00804856|156072217|FG005|Overall Study|Other Adverse Event|1|||
48513279|NCT00804856|156072218|FG006|Overall Study|Other Adverse Event|3|||
48513280|NCT00804856|156072219|FG007|Overall Study|Other Adverse Event|0|||
48513281|NCT00804856|156072220|FG008|Overall Study|Other Adverse Event|0|||
48513282|NCT00804856|156072221|FG009|Overall Study|Other Adverse Event|1|||
48729491|NCT01002482|156861233|FG000|Overall Study|Withdrawal by Subject|14|||
48513283|NCT00804856|156072222|FG010|Overall Study|Other Adverse Event|5|||
48729492|NCT01002482|156861234|FG001|Overall Study|Withdrawal by Subject|21|||
48729493|NCT01002482|156861233|FG000|Overall Study|Included twice|1|||
48729494|NCT01002482|156861234|FG001|Overall Study|Included twice|0|||
48729495|NCT03150485|156861235|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
48729496|NCT03150485|156861236|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
48729497|NCT03150485|156861237|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
48729498|NCT03150485|156861238|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
48729499|NCT03150485|156861239|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
48729500|NCT03150485|156861240|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
48513284|NCT00804856|156072223|FG011|Overall Study|Other Adverse Event|2|||
48513285|NCT00804856|156072224|FG012|Overall Study|Other Adverse Event|0|||
48729501|NCT00697073|156861246|FG000|Overall Study|Withdrawal by Subject|2|||
48729502|NCT00697073|156861246|FG000|Overall Study|Pregnancy|1|||
48729503|NCT00697073|156861246|FG000|Overall Study|non compliance and other|6|||
48513286|NCT00804856|156072225|FG013|Overall Study|Other Adverse Event|6|||
48513287|NCT00804856|156072226|FG014|Overall Study|Other Adverse Event|13|||
48382630|NCT00890929|155596729|FG000|Overall Study|Death before treatment|2|||
48822370|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822371|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822372|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
48822373|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
48822374|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
48822375|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
48822376|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
48822377|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822378|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822379|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822380|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822381|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822382|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822383|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822384|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822385|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822386|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822387|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822388|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822389|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822390|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
48822391|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
48822392|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
48822393|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
48822394|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
48822395|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822396|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822397|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822398|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822399|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822400|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822401|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822402|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822403|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822404|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822405|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822406|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48729504|NCT03981822|156861247|FG000|Overall Study|Lost to Follow-up|0|||
48729505|NCT03981822|156861248|FG001|Overall Study|Lost to Follow-up|1|||
48513288|NCT00804856|156072212|FG000|Overall Study|Non compliance with protocol|0|||
48513289|NCT00804856|156072213|FG001|Overall Study|Non compliance with protocol|0|||
48513290|NCT00804856|156072214|FG002|Overall Study|Non compliance with protocol|0|||
48513291|NCT00804856|156072215|FG003|Overall Study|Non compliance with protocol|0|||
48513292|NCT00804856|156072216|FG004|Overall Study|Non compliance with protocol|0|||
48513293|NCT00804856|156072217|FG005|Overall Study|Non compliance with protocol|0|||
48513294|NCT00804856|156072218|FG006|Overall Study|Non compliance with protocol|0|||
48513295|NCT00804856|156072219|FG007|Overall Study|Non compliance with protocol|0|||
48513296|NCT00804856|156072220|FG008|Overall Study|Non compliance with protocol|0|||
48513297|NCT00804856|156072221|FG009|Overall Study|Non compliance with protocol|0|||
48513298|NCT00804856|156072222|FG010|Overall Study|Non compliance with protocol|0|||
48513299|NCT00804856|156072223|FG011|Overall Study|Non compliance with protocol|0|||
48513300|NCT00804856|156072224|FG012|Overall Study|Non compliance with protocol|0|||
48513301|NCT00804856|156072225|FG013|Overall Study|Non compliance with protocol|2|||
48513302|NCT00804856|156072226|FG014|Overall Study|Non compliance with protocol|0|||
48513303|NCT00804856|156072212|FG000|Overall Study|Refused to continue medication|0|||
48513304|NCT00804856|156072213|FG001|Overall Study|Refused to continue medication|0|||
48822407|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48513305|NCT00804856|156072214|FG002|Overall Study|Refused to continue medication|0|||
48513306|NCT00804856|156072215|FG003|Overall Study|Refused to continue medication|1|||
48513307|NCT00804856|156072216|FG004|Overall Study|Refused to continue medication|1|||
48729506|NCT03981822|156861249|FG002|Overall Study|Lost to Follow-up|1|||
48822408|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822409|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48729507|NCT03981822|156861250|FG003|Overall Study|Lost to Follow-up|0|||
48729508|NCT03981822|156861251|FG004|Overall Study|Lost to Follow-up|6|||
48382631|NCT00890929|155596729|FG000|Overall Study|Withdrawal by Subject|3|||
48382632|NCT00890929|155596729|FG000|Overall Study|Physician Decision|1|||
48513308|NCT00804856|156072217|FG005|Overall Study|Refused to continue medication|0|||
48513309|NCT00804856|156072218|FG006|Overall Study|Refused to continue medication|0|||
48513310|NCT00804856|156072219|FG007|Overall Study|Refused to continue medication|0|||
48513311|NCT00804856|156072220|FG008|Overall Study|Refused to continue medication|0|||
48513312|NCT00804856|156072221|FG009|Overall Study|Refused to continue medication|0|||
48513313|NCT00804856|156072222|FG010|Overall Study|Refused to continue medication|3|||
48513314|NCT00804856|156072223|FG011|Overall Study|Refused to continue medication|0|||
48513315|NCT00804856|156072224|FG012|Overall Study|Refused to continue medication|1|||
48513316|NCT00804856|156072225|FG013|Overall Study|Refused to continue medication|1|||
48513317|NCT00804856|156072226|FG014|Overall Study|Refused to continue medication|5|||
48513318|NCT00804856|156072212|FG000|Overall Study|Other reason than listed above|0|||
48513319|NCT00804856|156072213|FG001|Overall Study|Other reason than listed above|0|||
48513320|NCT00804856|156072214|FG002|Overall Study|Other reason than listed above|0|||
48513321|NCT00804856|156072215|FG003|Overall Study|Other reason than listed above|0|||
48513322|NCT00804856|156072216|FG004|Overall Study|Other reason than listed above|0|||
48513323|NCT00804856|156072217|FG005|Overall Study|Other reason than listed above|1|||
48513324|NCT00804856|156072218|FG006|Overall Study|Other reason than listed above|0|||
48513325|NCT00804856|156072219|FG007|Overall Study|Other reason than listed above|0|||
48513326|NCT00804856|156072220|FG008|Overall Study|Other reason than listed above|1|||
48513327|NCT00804856|156072221|FG009|Overall Study|Other reason than listed above|0|||
48513328|NCT00804856|156072222|FG010|Overall Study|Other reason than listed above|3|||
48513329|NCT00804856|156072223|FG011|Overall Study|Other reason than listed above|1|||
48513330|NCT00804856|156072224|FG012|Overall Study|Other reason than listed above|1|||
48513331|NCT00804856|156072225|FG013|Overall Study|Other reason than listed above|10|||
48513332|NCT00804856|156072226|FG014|Overall Study|Other reason than listed above|3|||
48729509|NCT03981822|156861252|FG005|Overall Study|Lost to Follow-up|4|||
48729510|NCT03981822|156861253|FG006|Overall Study|Lost to Follow-up|4|||
48513333|NCT00446966|156072227|FG000|Overall Study|Lost to Follow-up|10|||
48513334|NCT00446966|156072228|FG001|Overall Study|Lost to Follow-up|7|||
48513335|NCT01558635|156072231|FG000|Overall Study|Death|1|||
48513336|NCT01558635|156072231|FG000|Overall Study|Withdrawal by Subject|2|||
48513337|NCT01558635|156072231|FG000|Overall Study|Physician Decision|1|||
48513338|NCT01558635|156072231|FG000|Overall Study|Subject received other treatment|1|||
48513339|NCT01558635|156072231|FG000|Overall Study|Reveal XT was explanted|1|||
48513340|NCT01440803|156072234|FG000|Overall Study|Met study stopping rule|2|||
48513341|NCT01440803|156072235|FG001|Overall Study|Met study stopping rule|1|||
48513342|NCT01440803|156072234|FG000|Overall Study|Lost to Follow-up|0|||
48513343|NCT01440803|156072235|FG001|Overall Study|Lost to Follow-up|2|||
48513344|NCT01440803|156072234|FG000|Overall Study|Withdrawal by Subject|0|||
48513345|NCT01440803|156072235|FG001|Overall Study|Withdrawal by Subject|1|||
48513346|NCT05746455|156072236|FG000|Overall Study|Discharged from Clinical Service|1|||
48513347|NCT05746455|156072236|FG000|Overall Study|Lost to Follow-up|1|||
48513348|NCT03605342|156072237|FG000|Overall Study|Withdrawal by Subject|9|||
48513349|NCT03605342|156072238|FG001|Overall Study|Withdrawal by Subject|7|||
48513350|NCT03605342|156072237|FG000|Overall Study|Lost to Follow-up|1|||
48513351|NCT03605342|156072238|FG001|Overall Study|Lost to Follow-up|1|||
48729511|NCT03981822|156861254|FG007|Overall Study|Lost to Follow-up|2|||
48729512|NCT03981822|156861247|FG000|Overall Study|Withdrawal by Subject|0|||
48729513|NCT03981822|156861248|FG001|Overall Study|Withdrawal by Subject|1|||
48729514|NCT03981822|156861249|FG002|Overall Study|Withdrawal by Subject|0|||
48729515|NCT03981822|156861250|FG003|Overall Study|Withdrawal by Subject|0|||
48729516|NCT03981822|156861251|FG004|Overall Study|Withdrawal by Subject|0|||
48729517|NCT03981822|156861252|FG005|Overall Study|Withdrawal by Subject|1|||
48729518|NCT03981822|156861253|FG006|Overall Study|Withdrawal by Subject|0|||
48729519|NCT03981822|156861254|FG007|Overall Study|Withdrawal by Subject|2|||
48729520|NCT03981822|156861247|FG000|Overall Study|COVID-19 Related|0|||
48729521|NCT03981822|156861248|FG001|Overall Study|COVID-19 Related|0|||
48729522|NCT03981822|156861249|FG002|Overall Study|COVID-19 Related|0|||
48729523|NCT03981822|156861250|FG003|Overall Study|COVID-19 Related|0|||
48729524|NCT03981822|156861251|FG004|Overall Study|COVID-19 Related|2|||
48729525|NCT03981822|156861252|FG005|Overall Study|COVID-19 Related|1|||
48729526|NCT03981822|156861253|FG006|Overall Study|COVID-19 Related|2|||
48729527|NCT03981822|156861254|FG007|Overall Study|COVID-19 Related|1|||
48729528|NCT03646643|156861255|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
48729529|NCT03646643|156861256|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
48513352|NCT00003659|156072239|FG000|Overall Study|Withdrawal by Subject|3|||
48513353|NCT02861300|156072244|FG000|Overall Study|Death|0|||
48513354|NCT02861300|156072245|FG001|Overall Study|Death|0|||
48513355|NCT02861300|156072246|FG002|Overall Study|Death|0|||
48513356|NCT02861300|156072247|FG003|Overall Study|Death|0|||
48513357|NCT02861300|156072248|FG004|Overall Study|Death|0|||
48513358|NCT02861300|156072249|FG005|Overall Study|Death|0|||
48513359|NCT02861300|156072250|FG006|Overall Study|Death|24|||
48513360|NCT02861300|156072244|FG000|Overall Study|Delay in treatment|0|||
48729530|NCT03646643|156861255|FG000|Overall Study|Lost to Follow-up|0|||
48822410|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
48822411|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
48822412|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
48822413|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
48822414|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
48822415|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
48513361|NCT02861300|156072245|FG001|Overall Study|Delay in treatment|0|||
48513362|NCT02861300|156072246|FG002|Overall Study|Delay in treatment|0|||
48513363|NCT02861300|156072247|FG003|Overall Study|Delay in treatment|0|||
48513364|NCT02861300|156072248|FG004|Overall Study|Delay in treatment|0|||
48513365|NCT02861300|156072249|FG005|Overall Study|Delay in treatment|1|||
48513366|NCT02861300|156072250|FG006|Overall Study|Delay in treatment|0|||
48513367|NCT02861300|156072244|FG000|Overall Study|Disease Progression|0|||
48513368|NCT02861300|156072245|FG001|Overall Study|Disease Progression|1|||
48513369|NCT02861300|156072246|FG002|Overall Study|Disease Progression|0|||
48513370|NCT02861300|156072247|FG003|Overall Study|Disease Progression|0|||
48513371|NCT02861300|156072248|FG004|Overall Study|Disease Progression|0|||
48513372|NCT02861300|156072249|FG005|Overall Study|Disease Progression|0|||
48513373|NCT02861300|156072250|FG006|Overall Study|Disease Progression|2|||
48513374|NCT02861300|156072244|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
48513375|NCT02861300|156072245|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
48513376|NCT02861300|156072246|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
48513377|NCT02861300|156072247|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
48513378|NCT02861300|156072248|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
48513379|NCT02861300|156072249|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
48513380|NCT02861300|156072250|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
48513381|NCT02861300|156072244|FG000|Overall Study|Clinical Complications|0|||
48513382|NCT02861300|156072245|FG001|Overall Study|Clinical Complications|0|||
48513383|NCT02861300|156072246|FG002|Overall Study|Clinical Complications|0|||
48513384|NCT02861300|156072247|FG003|Overall Study|Clinical Complications|0|||
48513385|NCT02861300|156072248|FG004|Overall Study|Clinical Complications|0|||
48513386|NCT02861300|156072249|FG005|Overall Study|Clinical Complications|0|||
48513387|NCT02861300|156072250|FG006|Overall Study|Clinical Complications|1|||
48513388|NCT00848536|156072251|FG000|Overall Study|Adverse Event|2|||
48513389|NCT00848536|156072252|FG001|Overall Study|Adverse Event|2|||
48513390|NCT00848536|156072251|FG000|Overall Study|Withdrawal by Subject|0|||
48513391|NCT00848536|156072252|FG001|Overall Study|Withdrawal by Subject|1|||
48513392|NCT00848536|156072251|FG000|Overall Study|Protocol Violation|0|||
48513393|NCT00848536|156072252|FG001|Overall Study|Protocol Violation|1|||
48513394|NCT00848536|156072251|FG000|Overall Study|Noncompliance|1|||
48513395|NCT00848536|156072252|FG001|Overall Study|Noncompliance|0|||
48513396|NCT00848536|156072251|FG000|Overall Study|Inadequate Control of IOP|1|||
48513397|NCT00848536|156072252|FG001|Overall Study|Inadequate Control of IOP|1|||
48513398|NCT00848536|156072251|FG000|Overall Study|Patient Moved|0|||
48513399|NCT00848536|156072252|FG001|Overall Study|Patient Moved|2|||
48822416|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
48822417|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
48822418|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
48822419|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
48822420|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
48822421|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
48822422|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
48382633|NCT03027557|155596732|FG000|Overall Study|Adverse Event|1|||
48382634|NCT03027557|155596733|FG001|Overall Study|Adverse Event|0|||
48822423|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
48513400|NCT02993159|156072253|FG000|Overall Study|Withdrawal by Subject|1|||
48513401|NCT02993159|156072254|FG001|Overall Study|Withdrawal by Subject|3|||
48513402|NCT02993159|156072253|FG000|Overall Study|Protocol Violation|1|||
48382635|NCT03027557|155596734|FG002|Overall Study|Adverse Event|0|||
48822424|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
48822425|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
48822426|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
48382636|NCT03836807|155596735|FG000|Overall Study|Physician Decision|1|||
48382637|NCT03836807|155596736|FG001|Overall Study|Physician Decision|0|||
48382638|NCT01289821|155596740|FG000|Treatment Period|Withdrawal by Subject|1|||
48513403|NCT02993159|156072254|FG001|Overall Study|Protocol Violation|0|||
48513404|NCT02993159|156072253|FG000|Overall Study|Opted out of surgery|2|||
48513405|NCT02993159|156072254|FG001|Overall Study|Opted out of surgery|0|||
48513406|NCT02993159|156072253|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
48513407|NCT02993159|156072254|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
48513408|NCT02993159|156072253|FG000|Overall Study|Physician Decision|0|||
48513409|NCT02993159|156072254|FG001|Overall Study|Physician Decision|1|||
48513410|NCT00796328|156072257|FG000|Overall Study|experienced hypotension requiring tx|6|||
48513411|NCT01380782|156072260|FG000|Overall Study|Adverse Event|0|||
48513412|NCT01380782|156072261|FG001|Overall Study|Adverse Event|1|||
48513413|NCT01380782|156072262|FG002|Overall Study|Adverse Event|0|||
48513414|NCT01380782|156072263|FG003|Overall Study|Adverse Event|0|||
48513415|NCT01380782|156072260|FG000|Overall Study|Death|1|||
48513416|NCT01380782|156072261|FG001|Overall Study|Death|0|||
48513417|NCT01380782|156072262|FG002|Overall Study|Death|0|||
48513418|NCT01380782|156072263|FG003|Overall Study|Death|0|||
48513419|NCT01380782|156072260|FG000|Overall Study|Lack of Efficacy|10|||
48513420|NCT01380782|156072261|FG001|Overall Study|Lack of Efficacy|9|||
48513421|NCT01380782|156072262|FG002|Overall Study|Lack of Efficacy|10|||
48513422|NCT01380782|156072263|FG003|Overall Study|Lack of Efficacy|3|||
48513423|NCT01380782|156072260|FG000|Overall Study|Physician Decision|1|||
48513424|NCT01380782|156072261|FG001|Overall Study|Physician Decision|0|||
48513425|NCT01380782|156072262|FG002|Overall Study|Physician Decision|0|||
48513426|NCT01380782|156072263|FG003|Overall Study|Physician Decision|0|||
48513427|NCT01380782|156072260|FG000|Overall Study|Withdrawal by Subject|0|||
48513428|NCT01380782|156072261|FG001|Overall Study|Withdrawal by Subject|0|||
48513429|NCT01380782|156072262|FG002|Overall Study|Withdrawal by Subject|1|||
48513430|NCT01380782|156072263|FG003|Overall Study|Withdrawal by Subject|1|||
48513431|NCT04827394|156072267|FG000|Overall Study|Physician Decision|0|||
48513432|NCT04827394|156072268|FG001|Overall Study|Physician Decision|2|||
48513433|NCT00477594|156072269|FG000|Year 1 and Year 2|Adverse Event|4|||
48513434|NCT00477594|156072270|FG001|Year 1 and Year 2|Adverse Event|2|||
48513435|NCT00477594|156072269|FG000|Year 1 and Year 2|Physician Decision|2|||
48729531|NCT03646643|156861256|FG001|Overall Study|Lost to Follow-up|1|||
48729532|NCT03489551|156861257|FG000|Overall Study|Withdrawal by Subject|2|||
48729533|NCT04541706|156861258|FG000|Overall Study|Withdrawal by Subject|3|||
48729534|NCT04541706|156861258|FG000|Overall Study|Progressive disease|33|||
48729535|NCT04541706|156861258|FG000|Overall Study|Physician Decision|1|||
48729536|NCT04541706|156861258|FG000|Overall Study|Lost to Follow-up|2|||
48729537|NCT04541706|156861258|FG000|Overall Study|Death|5|||
48729538|NCT04541706|156861258|FG000|Overall Study|Adverse Event|1|||
48729539|NCT03150810|156861259|FG000|Overall Study|Death|4|||
48729540|NCT03150810|156861260|FG001|Overall Study|Death|8|||
48729541|NCT03150810|156861261|FG002|Overall Study|Death|7|||
48729542|NCT03150810|156861262|FG003|Overall Study|Death|2|||
48729543|NCT03150810|156861263|FG004|Overall Study|Death|2|||
48729544|NCT03150810|156861264|FG005|Overall Study|Death|10|||
48729545|NCT03150810|156861265|FG006|Overall Study|Death|8|||
48729546|NCT03150810|156861266|FG007|Overall Study|Death|6|||
48729547|NCT03150810|156861267|FG008|Overall Study|Death|18|||
48729548|NCT03150810|156861268|FG009|Overall Study|Death|3|||
48729549|NCT03150810|156861269|FG010|Overall Study|Death|19|||
48729550|NCT03150810|156861270|FG011|Overall Study|Death|1|||
48729551|NCT03150810|156861271|FG012|Overall Study|Death|19|||
48729552|NCT03150810|156861259|FG000|Overall Study|Withdrawal by Subject|0|||
48729553|NCT03150810|156861260|FG001|Overall Study|Withdrawal by Subject|1|||
48729554|NCT03150810|156861261|FG002|Overall Study|Withdrawal by Subject|1|||
48729555|NCT03150810|156861262|FG003|Overall Study|Withdrawal by Subject|1|||
48729556|NCT03150810|156861263|FG004|Overall Study|Withdrawal by Subject|0|||
48729557|NCT03150810|156861264|FG005|Overall Study|Withdrawal by Subject|0|||
48729558|NCT03150810|156861265|FG006|Overall Study|Withdrawal by Subject|2|||
48729559|NCT03150810|156861266|FG007|Overall Study|Withdrawal by Subject|0|||
48729560|NCT03150810|156861267|FG008|Overall Study|Withdrawal by Subject|2|||
48729561|NCT03150810|156861268|FG009|Overall Study|Withdrawal by Subject|0|||
48729562|NCT03150810|156861269|FG010|Overall Study|Withdrawal by Subject|1|||
48513436|NCT00477594|156072270|FG001|Year 1 and Year 2|Physician Decision|1|||
48513437|NCT00477594|156072269|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
48513438|NCT00477594|156072270|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
48513439|NCT00477594|156072269|FG000|Year 1 and Year 2|Other|1|||
48513440|NCT00477594|156072270|FG001|Year 1 and Year 2|Other|0|||
48513441|NCT00477594|156072269|FG000|Year 3|Adverse Event|1|||
48513442|NCT00477594|156072270|FG001|Year 3|Adverse Event|0|||
48513443|NCT00477594|156072269|FG000|Year 3|Withdrawal by Subject|1|||
48729563|NCT03150810|156861270|FG011|Overall Study|Withdrawal by Subject|0|||
48513444|NCT00477594|156072270|FG001|Year 3|Withdrawal by Subject|0|||
48513445|NCT00477594|156072269|FG000|Follow-up Period|Withdrawal by Subject|2|||
48513446|NCT00477594|156072270|FG001|Follow-up Period|Withdrawal by Subject|1|||
48513447|NCT00477594|156072269|FG000|Follow-up Period|Other|1|||
48513448|NCT00477594|156072270|FG001|Follow-up Period|Other|0|||
48513449|NCT01403194|156072271|FG000|Overall Study|Screen Failure|2|||
48513450|NCT01403194|156072271|FG000|Overall Study|Lost to Follow-up|8|||
48513451|NCT03987191|156072272|FG000|Overall Study|COVID-19 related research disruption|0|||
48729564|NCT03150810|156861271|FG012|Overall Study|Withdrawal by Subject|1|||
48729565|NCT03150810|156861259|FG000|Overall Study|Sponsor Decision|0|||
48729566|NCT03150810|156861260|FG001|Overall Study|Sponsor Decision|2|||
48729567|NCT03150810|156861261|FG002|Overall Study|Sponsor Decision|0|||
48729568|NCT03150810|156861262|FG003|Overall Study|Sponsor Decision|0|||
48729569|NCT03150810|156861263|FG004|Overall Study|Sponsor Decision|1|||
48729570|NCT03150810|156861264|FG005|Overall Study|Sponsor Decision|1|||
48729571|NCT03150810|156861265|FG006|Overall Study|Sponsor Decision|0|||
48729572|NCT03150810|156861266|FG007|Overall Study|Sponsor Decision|0|||
48729573|NCT03150810|156861267|FG008|Overall Study|Sponsor Decision|1|||
48822427|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
48822428|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
48822429|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
48822430|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
48822431|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822432|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822433|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822434|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822435|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
48729574|NCT03150810|156861268|FG009|Overall Study|Sponsor Decision|0|||
48729575|NCT03150810|156861269|FG010|Overall Study|Sponsor Decision|0|||
48729576|NCT03150810|156861270|FG011|Overall Study|Sponsor Decision|0|||
48729577|NCT03150810|156861271|FG012|Overall Study|Sponsor Decision|5|||
48729578|NCT03150810|156861259|FG000|Overall Study|Lost to Follow-up|0|||
48729579|NCT03150810|156861260|FG001|Overall Study|Lost to Follow-up|1|||
48729580|NCT03150810|156861261|FG002|Overall Study|Lost to Follow-up|1|||
48729581|NCT03150810|156861262|FG003|Overall Study|Lost to Follow-up|0|||
48729582|NCT03150810|156861263|FG004|Overall Study|Lost to Follow-up|0|||
48729583|NCT03150810|156861264|FG005|Overall Study|Lost to Follow-up|0|||
48729584|NCT03150810|156861265|FG006|Overall Study|Lost to Follow-up|1|||
48729585|NCT03150810|156861266|FG007|Overall Study|Lost to Follow-up|0|||
48729586|NCT03150810|156861267|FG008|Overall Study|Lost to Follow-up|0|||
48729587|NCT03150810|156861268|FG009|Overall Study|Lost to Follow-up|0|||
48729588|NCT03150810|156861269|FG010|Overall Study|Lost to Follow-up|1|||
48729589|NCT03150810|156861270|FG011|Overall Study|Lost to Follow-up|0|||
48729590|NCT03150810|156861271|FG012|Overall Study|Lost to Follow-up|0|||
48729591|NCT03150810|156861259|FG000|Overall Study|Physician Decision|0|||
48729592|NCT03150810|156861260|FG001|Overall Study|Physician Decision|0|||
48729593|NCT03150810|156861261|FG002|Overall Study|Physician Decision|0|||
48729594|NCT03150810|156861262|FG003|Overall Study|Physician Decision|0|||
48729595|NCT03150810|156861263|FG004|Overall Study|Physician Decision|0|||
48729596|NCT03150810|156861264|FG005|Overall Study|Physician Decision|1|||
48729597|NCT03150810|156861265|FG006|Overall Study|Physician Decision|1|||
48729598|NCT03150810|156861266|FG007|Overall Study|Physician Decision|0|||
48729599|NCT03150810|156861267|FG008|Overall Study|Physician Decision|0|||
48729600|NCT03150810|156861268|FG009|Overall Study|Physician Decision|0|||
48729601|NCT03150810|156861269|FG010|Overall Study|Physician Decision|0|||
48729602|NCT03150810|156861270|FG011|Overall Study|Physician Decision|0|||
48729603|NCT03150810|156861271|FG012|Overall Study|Physician Decision|0|||
48729604|NCT03150810|156861259|FG000|Overall Study|Site withdrawal from study|0|||
48729605|NCT03150810|156861260|FG001|Overall Study|Site withdrawal from study|1|||
48822436|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
48439925|NCT01653158|155798264|FG006|Overall Study|Adverse Event|0|||
48439926|NCT01653158|155798265|FG007|Overall Study|Adverse Event|3|||
48439927|NCT01653158|155798258|FG000|Overall Study|Other|0|||
48439928|NCT01653158|155798259|FG001|Overall Study|Other|0|||
48439929|NCT01653158|155798260|FG002|Overall Study|Other|0|||
48439930|NCT01653158|155798261|FG003|Overall Study|Other|0|||
48439931|NCT01653158|155798262|FG004|Overall Study|Other|0|||
48439932|NCT01653158|155798263|FG005|Overall Study|Other|0|||
48439933|NCT01653158|155798264|FG006|Overall Study|Other|0|||
48439934|NCT01653158|155798265|FG007|Overall Study|Other|1|||
48439935|NCT01653158|155798258|FG000|Overall Study|Progressive disease|0|||
48439936|NCT01653158|155798259|FG001|Overall Study|Progressive disease|0|||
48439937|NCT01653158|155798260|FG002|Overall Study|Progressive disease|0|||
48439938|NCT01653158|155798261|FG003|Overall Study|Progressive disease|0|||
48439939|NCT01653158|155798262|FG004|Overall Study|Progressive disease|1|||
48439940|NCT01653158|155798263|FG005|Overall Study|Progressive disease|1|||
48439941|NCT01653158|155798264|FG006|Overall Study|Progressive disease|2|||
48439942|NCT01653158|155798265|FG007|Overall Study|Progressive disease|9|||
48439943|NCT01653158|155798258|FG000|Overall Study|Withdrawal by Subject|1|||
48439944|NCT01653158|155798259|FG001|Overall Study|Withdrawal by Subject|0|||
48439945|NCT01653158|155798260|FG002|Overall Study|Withdrawal by Subject|0|||
48439946|NCT01653158|155798261|FG003|Overall Study|Withdrawal by Subject|0|||
48439947|NCT01653158|155798262|FG004|Overall Study|Withdrawal by Subject|0|||
48439948|NCT01653158|155798263|FG005|Overall Study|Withdrawal by Subject|0|||
48439949|NCT01653158|155798264|FG006|Overall Study|Withdrawal by Subject|0|||
48439950|NCT01653158|155798265|FG007|Overall Study|Withdrawal by Subject|0|||
48439951|NCT01205451|155798268|FG000|Overall Study|Lost to Follow-up|1|||
48439952|NCT01205451|155798269|FG001|Overall Study|Lost to Follow-up|1|||
48439953|NCT01205451|155798268|FG000|Overall Study|Withdrawal by Subject|5|||
48439954|NCT01205451|155798269|FG001|Overall Study|Withdrawal by Subject|9|||
48439955|NCT00190983|155798271|FG000|Overall Study|Inevaluable (never treated)|2|||
48439956|NCT02287402|155798272|FG000|Treatment Period|Adverse Event|17|||
48439957|NCT02287402|155798272|FG000|Treatment Period|Voluntary Withdrawal|10|||
48439958|NCT02287402|155798272|FG000|Follow-up|Lost to Follow-up|1|||
48439959|NCT02287402|155798272|FG000|Follow-up|Voluntary Withdrawal|2|||
48439960|NCT01844830|155798273|FG000|Overall Study|Withdrawal by Subject|1|||
48729606|NCT03150810|156861261|FG002|Overall Study|Site withdrawal from study|0|||
48729607|NCT03150810|156861262|FG003|Overall Study|Site withdrawal from study|0|||
48729608|NCT03150810|156861263|FG004|Overall Study|Site withdrawal from study|0|||
48729609|NCT03150810|156861264|FG005|Overall Study|Site withdrawal from study|0|||
48729610|NCT03150810|156861265|FG006|Overall Study|Site withdrawal from study|0|||
48729611|NCT03150810|156861266|FG007|Overall Study|Site withdrawal from study|0|||
48729612|NCT03150810|156861267|FG008|Overall Study|Site withdrawal from study|0|||
48382639|NCT01289821|155596740|FG000|Treatment Period|Physician Decision|3|||
48382640|NCT01289821|155596740|FG000|Treatment Period|Adverse Event|4|||
48382641|NCT01289821|155596740|FG000|Treatment Period|Radiological Progression|43|||
48440609|NCT01199055|155799786|FG000|Overall Study|Progressive disease|2|||
48440610|NCT01199055|155799787|FG001|Overall Study|Progressive disease|1|||
48440611|NCT01199055|155799788|FG002|Overall Study|Progressive disease|2|||
48440612|NCT01199055|155799786|FG000|Overall Study|Withdrawal by Subject|0|||
48440613|NCT01199055|155799787|FG001|Overall Study|Withdrawal by Subject|0|||
48440614|NCT01199055|155799788|FG002|Overall Study|Withdrawal by Subject|1|||
48440615|NCT01875367|155799789|FG000|Overall Study|Not complete at least 2 questionaries|4|||
48440616|NCT01875367|155799790|FG001|Overall Study|Not complete at least 2 questionaries|2|||
48440617|NCT01875367|155799789|FG000|Overall Study|Not receive study treatment|1|||
48440618|NCT01875367|155799790|FG001|Overall Study|Not receive study treatment|0|||
48440619|NCT02260648|155799793|FG000|Overall Study|Adverse Event|3|||
48440620|NCT02260648|155799794|FG001|Overall Study|Adverse Event|0|||
48440621|NCT02260648|155799795|FG002|Overall Study|Adverse Event|1|||
48440622|NCT02260648|155799793|FG000|Overall Study|Withdrawal by Subject|1|||
48440623|NCT02260648|155799794|FG001|Overall Study|Withdrawal by Subject|1|||
48440624|NCT02260648|155799795|FG002|Overall Study|Withdrawal by Subject|0|||
48440625|NCT02260648|155799793|FG000|Overall Study|Protocol Violation|1|||
48440626|NCT02260648|155799794|FG001|Overall Study|Protocol Violation|0|||
48440627|NCT02260648|155799795|FG002|Overall Study|Protocol Violation|0|||
48440628|NCT02260648|155799793|FG000|Overall Study|Discontinue Due to Study Termination|13|||
48440629|NCT02260648|155799794|FG001|Overall Study|Discontinue Due to Study Termination|12|||
48440630|NCT02260648|155799795|FG002|Overall Study|Discontinue Due to Study Termination|7|||
48440631|NCT03956225|155799796|FG000|Overall Study|Lack of Efficacy|1|||
48440632|NCT03956225|155799797|FG001|Overall Study|Lack of Efficacy|1|||
48440633|NCT03956225|155799796|FG000|Overall Study|Lost to Follow-up|0|||
48440634|NCT03956225|155799797|FG001|Overall Study|Lost to Follow-up|1|||
48440635|NCT03956225|155799796|FG000|Overall Study|Withdrawal by Subject|2|||
48440636|NCT03956225|155799797|FG001|Overall Study|Withdrawal by Subject|1|||
48440637|NCT03956225|155799796|FG000|Overall Study|Other Reasons|2|||
48440638|NCT03956225|155799797|FG001|Overall Study|Other Reasons|1|||
48440639|NCT04093258|155799798|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
48440640|NCT04093258|155799799|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
48440641|NCT00594204|155799800|FG000|Overall Study|Adverse Event|15|||
48440642|NCT00594204|155799801|FG001|Overall Study|Adverse Event|3|||
48440643|NCT00594204|155799800|FG000|Overall Study|Lost to Follow-up|9|||
48440644|NCT00594204|155799801|FG001|Overall Study|Lost to Follow-up|5|||
48440645|NCT00594204|155799800|FG000|Overall Study|Withdrawal by Subject|23|||
48440646|NCT00594204|155799801|FG001|Overall Study|Withdrawal by Subject|29|||
48440647|NCT00594204|155799800|FG000|Overall Study|Other|4|||
48440648|NCT00594204|155799801|FG001|Overall Study|Other|3|||
48440649|NCT00594204|155799800|FG000|Overall Study|Lack of Efficacy|3|||
48440650|NCT00594204|155799801|FG001|Overall Study|Lack of Efficacy|4|||
48440651|NCT00594204|155799800|FG000|Overall Study|Randomized but not treated|4|||
48440652|NCT00594204|155799801|FG001|Overall Study|Randomized but not treated|1|||
48440653|NCT00567541|155799809|FG000|Overall Study|Adverse Event|0|||
48440654|NCT00567541|155799810|FG001|Overall Study|Adverse Event|1|||
48440655|NCT00039741|155799811|FG000|Overall Study|Death|0|||
48440656|NCT00039741|155799812|FG001|Overall Study|Death|1|||
48440657|NCT00039741|155799813|FG002|Overall Study|Death|0|||
48440658|NCT00039741|155799814|FG003|Overall Study|Death|0|||
48440659|NCT00039741|155799811|FG000|Overall Study|Lost to Follow-up|3|||
48440660|NCT00039741|155799812|FG001|Overall Study|Lost to Follow-up|1|||
48440661|NCT00039741|155799813|FG002|Overall Study|Lost to Follow-up|5|||
48440662|NCT00039741|155799814|FG003|Overall Study|Lost to Follow-up|2|||
48440663|NCT00039741|155799811|FG000|Overall Study|Confounding medical condition|1|||
48440664|NCT00039741|155799812|FG001|Overall Study|Confounding medical condition|0|||
48440665|NCT00039741|155799813|FG002|Overall Study|Confounding medical condition|0|||
48440666|NCT00039741|155799814|FG003|Overall Study|Confounding medical condition|0|||
48440667|NCT00039741|155799811|FG000|Overall Study|Not able to get to clinic|5|||
48440668|NCT00039741|155799812|FG001|Overall Study|Not able to get to clinic|2|||
48440669|NCT00039741|155799813|FG002|Overall Study|Not able to get to clinic|0|||
48440670|NCT00039741|155799814|FG003|Overall Study|Not able to get to clinic|3|||
48440671|NCT00039741|155799811|FG000|Overall Study|Moved|3|||
48440672|NCT00039741|155799812|FG001|Overall Study|Moved|2|||
48440673|NCT00039741|155799813|FG002|Overall Study|Moved|3|||
48513452|NCT03987191|156072273|FG001|Overall Study|COVID-19 related research disruption|2|||
48513453|NCT01020474|156072274|FG000|Overall Study|Adverse Event|4|||
48513454|NCT01020474|156072275|FG001|Overall Study|Adverse Event|4|||
48513455|NCT01020474|156072274|FG000|Overall Study|Protocol Violation|0|||
48513456|NCT01020474|156072275|FG001|Overall Study|Protocol Violation|2|||
48513457|NCT01020474|156072274|FG000|Overall Study|Withdrawal by Subject|5|||
48513458|NCT01020474|156072275|FG001|Overall Study|Withdrawal by Subject|7|||
48513459|NCT01020474|156072274|FG000|Overall Study|Other Reasons|1|||
48513460|NCT01020474|156072275|FG001|Overall Study|Other Reasons|1|||
48513461|NCT01020474|156072274|FG000|Overall Study|Insufficient Clinical Response|0|||
48513462|NCT01020474|156072275|FG001|Overall Study|Insufficient Clinical Response|3|||
48513463|NCT03261167|156072276|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
48513464|NCT03261167|156072277|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
48513465|NCT03261167|156072276|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
48513466|NCT03261167|156072277|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
48513467|NCT03261167|156072276|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
48513468|NCT03261167|156072277|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
48513469|NCT03261167|156072276|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
48513470|NCT03261167|156072277|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
48513471|NCT03261167|156072276|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
48513472|NCT03261167|156072277|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
48513473|NCT01701063|156072280|FG000|Overall Study|Lost to Follow-up|0|||
48513474|NCT01701063|156072281|FG001|Overall Study|Lost to Follow-up|1|||
48513475|NCT01701063|156072282|FG002|Overall Study|Lost to Follow-up|0|||
48513476|NCT01701063|156072280|FG000|Overall Study|Withdrawal by Subject|0|||
48513477|NCT01701063|156072281|FG001|Overall Study|Withdrawal by Subject|0|||
48513478|NCT01701063|156072282|FG002|Overall Study|Withdrawal by Subject|1|||
48513479|NCT01701063|156072280|FG000|Overall Study|Other|0|||
48513480|NCT01701063|156072281|FG001|Overall Study|Other|0|||
48513481|NCT01701063|156072282|FG002|Overall Study|Other|1|||
48513482|NCT05387408|156072283|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
48729613|NCT03150810|156861268|FG009|Overall Study|Site withdrawal from study|1|||
48729614|NCT03150810|156861269|FG010|Overall Study|Site withdrawal from study|1|||
48729615|NCT03150810|156861270|FG011|Overall Study|Site withdrawal from study|0|||
48513483|NCT01919112|156072284|FG000|Secondary Analysis-day 30|Death|1|||
48382642|NCT01289821|155596740|FG000|Treatment Period|Clinical Progression|2|||
48382643|NCT01289821|155596740|FG000|Treatment Period|Therapeutic procedure required|1|||
48382644|NCT01289821|155596740|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
48382645|NCT01289821|155596740|FG000|Safety Follow-up Period|Protocol Violation|3|||
48382646|NCT01289821|155596740|FG000|Safety Follow-up Period|Unspecified reason|1|||
48382647|NCT01289821|155596740|FG000|Survival Follow-up Period|Protocol Violation|1|||
48382648|NCT01289821|155596740|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
48382649|NCT01289821|155596740|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
48513484|NCT01919112|156072285|FG001|Secondary Analysis-day 30|Death|1|||
48513485|NCT01919112|156072286|FG002|Secondary Analysis-day 30|Death|1|||
48513486|NCT01919112|156072284|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
48513487|NCT01919112|156072285|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
48513488|NCT01919112|156072286|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
48513489|NCT04692155|156072289|FG000|Overall Study|Death|1|||
48513490|NCT02043132|156072290|FG000|Overall Study|Lost to Follow-up|1|||
48513491|NCT02043132|156072291|FG001|Overall Study|Lost to Follow-up|1|||
48513492|NCT02043132|156072290|FG000|Overall Study|screen failures|4|||
48513493|NCT02043132|156072291|FG001|Overall Study|screen failures|8|||
48513494|NCT02280863|156072294|FG000|Integrated Platform|Met stopping criteria|0|||
48513495|NCT02280863|156072295|FG001|Integrated Platform|Met stopping criteria|1|||
48382650|NCT02019420|155596741|FG000|Overall Study|Did not receive study drug|2|||
48382651|NCT02019420|155596742|FG001|Overall Study|Did not receive study drug|2|||
48382652|NCT02019420|155596741|FG000|Overall Study|Withdrawal by Subject|1|||
48382653|NCT02019420|155596742|FG001|Overall Study|Withdrawal by Subject|3|||
48382654|NCT02019420|155596741|FG000|Overall Study|At request of sponsor or investigator|0|||
48513496|NCT03419403|156072296|FG000|Overall Study|Withdrawal by Subject|5|||
48513497|NCT03419403|156072297|FG001|Overall Study|Withdrawal by Subject|2|||
48513498|NCT03419403|156072298|FG002|Overall Study|Withdrawal by Subject|5|||
48513499|NCT03419403|156072299|FG003|Overall Study|Withdrawal by Subject|1|||
48513500|NCT03419403|156072296|FG000|Overall Study|Progressive disease (per protocol)|0|||
48513501|NCT03419403|156072297|FG001|Overall Study|Progressive disease (per protocol)|2|||
48382655|NCT02019420|155596742|FG001|Overall Study|At request of sponsor or investigator|1|||
48513502|NCT03419403|156072298|FG002|Overall Study|Progressive disease (per protocol)|2|||
48729616|NCT03150810|156861271|FG012|Overall Study|Site withdrawal from study|0|||
48513503|NCT03419403|156072299|FG003|Overall Study|Progressive disease (per protocol)|0|||
48513504|NCT03419403|156072296|FG000|Overall Study|Other, not specified|6|||
48513505|NCT03419403|156072297|FG001|Overall Study|Other, not specified|4|||
48822437|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822438|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822439|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
48513506|NCT03419403|156072298|FG002|Overall Study|Other, not specified|5|||
48513507|NCT03419403|156072299|FG003|Overall Study|Other, not specified|1|||
48513508|NCT03419403|156072296|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
48513509|NCT03419403|156072297|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
48513510|NCT03419403|156072298|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
48513511|NCT03419403|156072299|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
48513512|NCT01415986|156072300|FG000|Overall Study|Lost to Follow-up|1|||
48513513|NCT00830024|156072303|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
48382656|NCT02019420|155596741|FG000|Overall Study|Death|104|||
48382657|NCT02019420|155596742|FG001|Overall Study|Death|99|||
48382658|NCT02019420|155596741|FG000|Overall Study|Transferred to other care facility|1|||
48382659|NCT02019420|155596742|FG001|Overall Study|Transferred to other care facility|1|||
48382660|NCT01668719|155596745|FG000|Phase I|On treatment|1|||
48382661|NCT01668719|155596746|FG001|Phase I|On treatment|0|||
48382662|NCT01668719|155596747|FG002|Phase I|On treatment|0|||
48382663|NCT01668719|155596745|FG000|Phase I|Adverse Event|2|||
48382664|NCT01668719|155596746|FG001|Phase I|Adverse Event|0|||
48382665|NCT01668719|155596747|FG002|Phase I|Adverse Event|0|||
48382666|NCT01668719|155596745|FG000|Phase I|Progression/relapse|1|||
48382667|NCT01668719|155596746|FG001|Phase I|Progression/relapse|0|||
48382668|NCT01668719|155596747|FG002|Phase I|Progression/relapse|0|||
48382669|NCT01668719|155596745|FG000|Phase I|not protocol specified|2|||
48382670|NCT01668719|155596746|FG001|Phase I|not protocol specified|0|||
48382671|NCT01668719|155596747|FG002|Phase I|not protocol specified|0|||
48382672|NCT01668719|155596745|FG000|Phase II|On treatment|0|||
48382673|NCT01668719|155596746|FG001|Phase II|On treatment|4|||
48382674|NCT01668719|155596747|FG002|Phase II|On treatment|3|||
48382675|NCT01668719|155596745|FG000|Phase II|Adverse Event|0|||
48382676|NCT01668719|155596746|FG001|Phase II|Adverse Event|18|||
48382677|NCT01668719|155596747|FG002|Phase II|Adverse Event|18|||
48382678|NCT01668719|155596745|FG000|Phase II|Refusal unrelated to adverse event|0|||
48382679|NCT01668719|155596746|FG001|Phase II|Refusal unrelated to adverse event|4|||
48382680|NCT01668719|155596747|FG002|Phase II|Refusal unrelated to adverse event|1|||
48382681|NCT01668719|155596745|FG000|Phase II|Progression/relapse|0|||
48382682|NCT01668719|155596746|FG001|Phase II|Progression/relapse|13|||
48382683|NCT01668719|155596747|FG002|Phase II|Progression/relapse|17|||
48382684|NCT01668719|155596745|FG000|Phase II|Death|0|||
48382685|NCT01668719|155596746|FG001|Phase II|Death|0|||
48382686|NCT01668719|155596747|FG002|Phase II|Death|2|||
48382687|NCT01668719|155596745|FG000|Phase II|not protocol specified|0|||
48382688|NCT01668719|155596746|FG001|Phase II|not protocol specified|13|||
48382689|NCT01668719|155596747|FG002|Phase II|not protocol specified|7|||
48382690|NCT01351623|155596748|FG000|Overall Study|Protocol Violation|2|||
48382691|NCT01351623|155596748|FG000|Overall Study|Adverse Event|4|||
48382692|NCT01351623|155596748|FG000|Overall Study|Withdrawal by Subject|1|||
48382693|NCT01351623|155596748|FG000|Overall Study|Death|2|||
48382694|NCT00651157|155596749|FG000|Overall Study|Death|1|||
48382695|NCT00651157|155596749|FG000|Overall Study|Protocol Violation|1|||
48382696|NCT00617604|155596759|FG000|Overall Study|Death|2|||
48382697|NCT00617604|155596760|FG001|Overall Study|Death|1|||
48382698|NCT00617604|155596759|FG000|Overall Study|Lost to Follow-up|1|||
48382699|NCT00617604|155596760|FG001|Overall Study|Lost to Follow-up|0|||
48382700|NCT00617604|155596759|FG000|Overall Study|Miscellaneous Reasons|8|||
48382701|NCT00617604|155596760|FG001|Overall Study|Miscellaneous Reasons|10|||
48382702|NCT00617604|155596759|FG000|Overall Study|Withdrawal by Subject|4|||
48382703|NCT00617604|155596760|FG001|Overall Study|Withdrawal by Subject|6|||
48382704|NCT00617604|155596759|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
48382705|NCT00617604|155596760|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
48382706|NCT02511678|155596761|FG000|Overall Study|Withdrawal by Subject|2|||
48382707|NCT02511678|155596761|FG000|Overall Study|Lost to Follow-up|4|||
48382708|NCT02511678|155596761|FG000|Overall Study|Death|19|||
48382709|NCT02511678|155596761|FG000|Overall Study|Adverse Event|1|||
48382710|NCT02511678|155596761|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
48382711|NCT02511678|155596761|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
48382712|NCT02511678|155596761|FG000|Overall Study|Required Radiofrequency Ablation|1|||
48382713|NCT02511678|155596761|FG000|Overall Study|Biopsy was Negative|1|||
48382714|NCT02511678|155596761|FG000|Overall Study|Protocol Violation|1|||
48382715|NCT02511678|155596761|FG000|Overall Study|Received Radiation Treatment|1|||
48382716|NCT03065023|155596762|FG000|Overall Study|Progressive Disease|0|||
48382717|NCT03065023|155596763|FG001|Overall Study|Progressive Disease|1|||
48382718|NCT03065023|155596764|FG002|Overall Study|Progressive Disease|0|||
48382719|NCT03065023|155596765|FG003|Overall Study|Progressive Disease|0|||
48382720|NCT03065023|155596766|FG004|Overall Study|Progressive Disease|0|||
48382721|NCT03065023|155596762|FG000|Overall Study|Death|2|||
48382722|NCT03065023|155596763|FG001|Overall Study|Death|0|||
48382723|NCT03065023|155596764|FG002|Overall Study|Death|1|||
48729617|NCT03150810|156861259|FG000|Overall Study|Hospice|0|||
48729618|NCT03150810|156861260|FG001|Overall Study|Hospice|0|||
48729619|NCT03150810|156861261|FG002|Overall Study|Hospice|0|||
48513514|NCT00830024|156072304|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
48513515|NCT00429416|156072305|FG000|Overall Study|Death|1|||
48513516|NCT00875524|156072306|FG000|Overall Study|Serious adverse event|0|||
48513517|NCT00875524|156072307|FG001|Overall Study|Serious adverse event|1|||
48513518|NCT00875524|156072306|FG000|Overall Study|Protocol Violation|4|||
48513519|NCT00875524|156072307|FG001|Overall Study|Protocol Violation|0|||
48513520|NCT00875524|156072306|FG000|Overall Study|Lost to Follow-up|1|||
48513521|NCT00875524|156072307|FG001|Overall Study|Lost to Follow-up|0|||
48513522|NCT00875524|156072306|FG000|Overall Study|Withdrawal by Subject|3|||
48513523|NCT00875524|156072307|FG001|Overall Study|Withdrawal by Subject|5|||
48513524|NCT02615249|156072308|FG000|Overall Study|Withdrawal by Subject|1|||
48513525|NCT00829452|156072309|FG000|First Intervention|Withdrawal by Subject|0|||
48513526|NCT00829452|156072310|FG001|First Intervention|Withdrawal by Subject|1|||
48513527|NCT00829452|156072309|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
48513528|NCT00829452|156072310|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
48513529|NCT00829452|156072309|FG000|Second Intervention|Physician Decision|0|||
48513530|NCT00829452|156072310|FG001|Second Intervention|Physician Decision|1|||
48513531|NCT01180634|156073327|FG000|Overall Study|Adverse Event|4|||
48513532|NCT01180634|156073328|FG001|Overall Study|Adverse Event|1|||
48513533|NCT01180634|156073327|FG000|Overall Study|Miscellaneous|2|||
48513534|NCT01180634|156073328|FG001|Overall Study|Miscellaneous|0|||
48513535|NCT01180634|156073327|FG000|Overall Study|Withdrawal by Subject|4|||
48513536|NCT01180634|156073328|FG001|Overall Study|Withdrawal by Subject|0|||
48513537|NCT02267187|156073330|FG000|Overall Study|Physician Decision|2|||
48513538|NCT02267187|156073330|FG000|Overall Study|Screen fail|3|||
48513539|NCT03713086|156073331|FG000|Overall Study|Withdrawal by Subject|0|||
48513540|NCT03713086|156073332|FG001|Overall Study|Withdrawal by Subject|2|||
48513541|NCT03713086|156073333|FG002|Overall Study|Withdrawal by Subject|1|||
48513542|NCT03713086|156073334|FG003|Overall Study|Withdrawal by Subject|0|||
48513543|NCT03713086|156073331|FG000|Overall Study|Lost to Follow-up|0|||
48513544|NCT03713086|156073332|FG001|Overall Study|Lost to Follow-up|1|||
48513545|NCT03713086|156073333|FG002|Overall Study|Lost to Follow-up|0|||
48513546|NCT03713086|156073334|FG003|Overall Study|Lost to Follow-up|1|||
48513547|NCT01340495|156073340|FG000|Overall Study|Withdrawal by Subject|1|||
48513548|NCT02957942|156073343|FG000|Overall Study|Withdrawal by Subject|0|||
48513549|NCT02957942|156073344|FG001|Overall Study|Withdrawal by Subject|1|||
48513550|NCT02957942|156073343|FG000|Overall Study|Practicing experiment protocol|0|||
48513551|NCT02957942|156073344|FG001|Overall Study|Practicing experiment protocol|6|||
48513552|NCT00835575|156073347|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
48513553|NCT00835575|156073348|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
48513554|NCT01693523|156073351|FG000|Overall Study|Adverse Event|2|||
48513555|NCT01693523|156073352|FG001|Overall Study|Adverse Event|1|||
48513556|NCT01693523|156073353|FG002|Overall Study|Adverse Event|0|||
48513557|NCT01693523|156073351|FG000|Overall Study|Death|0|||
48513558|NCT01693523|156073352|FG001|Overall Study|Death|1|||
48513559|NCT01693523|156073353|FG002|Overall Study|Death|1|||
48513560|NCT01693523|156073351|FG000|Overall Study|Lost to Follow-up|0|||
48513561|NCT01693523|156073352|FG001|Overall Study|Lost to Follow-up|0|||
48513562|NCT01693523|156073353|FG002|Overall Study|Lost to Follow-up|4|||
48513563|NCT01693523|156073351|FG000|Overall Study|Physician Decision|0|||
48513564|NCT01693523|156073352|FG001|Overall Study|Physician Decision|0|||
48513565|NCT01693523|156073353|FG002|Overall Study|Physician Decision|1|||
48513566|NCT01693523|156073351|FG000|Overall Study|Withdrawal by Subject|1|||
48513567|NCT01693523|156073352|FG001|Overall Study|Withdrawal by Subject|2|||
48513568|NCT01693523|156073353|FG002|Overall Study|Withdrawal by Subject|2|||
48513569|NCT01693523|156073351|FG000|Overall Study|Lack of compliance study medication|1|||
48513570|NCT01693523|156073352|FG001|Overall Study|Lack of compliance study medication|2|||
48513571|NCT01693523|156073353|FG002|Overall Study|Lack of compliance study medication|0|||
48729620|NCT03150810|156861262|FG003|Overall Study|Hospice|0|||
48729621|NCT03150810|156861263|FG004|Overall Study|Hospice|0|||
48513572|NCT01693523|156073351|FG000|Overall Study|Chemotherapy was held|1|||
48513573|NCT01693523|156073352|FG001|Overall Study|Chemotherapy was held|2|||
48513574|NCT01693523|156073353|FG002|Overall Study|Chemotherapy was held|0|||
48513575|NCT03343535|156073354|FG000|Overall Study|Lost to Follow-up|1|||
48513576|NCT03343535|156073354|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
48513577|NCT03343535|156073354|FG000|Overall Study|Death|12|||
48513578|NCT00834418|156073357|FG000|Overall Study|Adverse Event|0|||
48513579|NCT00834418|156073358|FG001|Overall Study|Adverse Event|2|||
48513580|NCT00443651|156073359|FG000|Overall Study|Death|1|||
48513581|NCT00443651|156073360|FG001|Overall Study|Death|5|||
48513582|NCT00443651|156073359|FG000|Overall Study|Adverse Event|5|||
48513583|NCT00443651|156073360|FG001|Overall Study|Adverse Event|6|||
48513584|NCT00443651|156073359|FG000|Overall Study|Lost to Follow-up|18|||
48729622|NCT03150810|156861264|FG005|Overall Study|Hospice|1|||
48513585|NCT00443651|156073360|FG001|Overall Study|Lost to Follow-up|12|||
48513586|NCT00443651|156073359|FG000|Overall Study|Patient's/Guardian's Decision|58|||
48513587|NCT00443651|156073360|FG001|Overall Study|Patient's/Guardian's Decision|30|||
48513588|NCT00443651|156073359|FG000|Overall Study|Physician Decision|13|||
48513589|NCT00443651|156073360|FG001|Overall Study|Physician Decision|4|||
48513590|NCT00443651|156073359|FG000|Overall Study|Pregnancy|0|||
48513591|NCT00443651|156073360|FG001|Overall Study|Pregnancy|1|||
48513592|NCT02125461|156073365|FG000|Overall Study|Withdrawal by Subject|30|||
48513593|NCT02125461|156073366|FG001|Overall Study|Withdrawal by Subject|16|||
48513594|NCT02125461|156073365|FG000|Overall Study|Lost to Follow-up|8|||
48513595|NCT02125461|156073366|FG001|Overall Study|Lost to Follow-up|3|||
48513596|NCT02125461|156073365|FG000|Overall Study|Death|260|||
48513597|NCT02125461|156073366|FG001|Overall Study|Death|149|||
48513598|NCT02125461|156073365|FG000|Overall Study|Missing Termination Reason|0|||
48513599|NCT02125461|156073366|FG001|Overall Study|Missing Termination Reason|1|||
48513600|NCT02888756|156073368|FG000|Analytical Treatment Interruption|Physician Decision|10|||
48513601|NCT02888756|156073369|FG001|Analytical Treatment Interruption|Physician Decision|6|||
48513602|NCT02888756|156073370|FG002|Analytical Treatment Interruption|Physician Decision|5|||
48513603|NCT02842853|156073371|FG000|Overall Study|Non-compliance with the protocol|3|||
48382724|NCT03065023|155596765|FG003|Overall Study|Death|1|||
48382725|NCT03065023|155596766|FG004|Overall Study|Death|0|||
48729623|NCT03150810|156861265|FG006|Overall Study|Hospice|0|||
48729624|NCT03150810|156861266|FG007|Overall Study|Hospice|0|||
48729625|NCT03150810|156861267|FG008|Overall Study|Hospice|0|||
48513604|NCT02842853|156073372|FG001|Overall Study|Non-compliance with the protocol|7|||
48513605|NCT02842853|156073373|FG002|Overall Study|Non-compliance with the protocol|2|||
48513606|NCT02842853|156073374|FG003|Overall Study|Non-compliance with the protocol|5|||
48513607|NCT02842853|156073371|FG000|Overall Study|Subject met exclusion criteria|0|||
48513608|NCT02842853|156073372|FG001|Overall Study|Subject met exclusion criteria|1|||
48513609|NCT02842853|156073373|FG002|Overall Study|Subject met exclusion criteria|0|||
48513610|NCT02842853|156073374|FG003|Overall Study|Subject met exclusion criteria|0|||
48513611|NCT02842853|156073371|FG000|Overall Study|Withdrawal by Subject|11|||
48729626|NCT03150810|156861268|FG009|Overall Study|Hospice|0|||
48729627|NCT03150810|156861269|FG010|Overall Study|Hospice|0|||
48729628|NCT03150810|156861270|FG011|Overall Study|Hospice|0|||
48729629|NCT03150810|156861271|FG012|Overall Study|Hospice|0|||
48729630|NCT03150810|156861259|FG000|Overall Study|Participant relocated abroad.|0|||
48729631|NCT03150810|156861260|FG001|Overall Study|Participant relocated abroad.|0|||
48729632|NCT03150810|156861261|FG002|Overall Study|Participant relocated abroad.|0|||
48729633|NCT03150810|156861262|FG003|Overall Study|Participant relocated abroad.|0|||
48729634|NCT03150810|156861263|FG004|Overall Study|Participant relocated abroad.|0|||
48729635|NCT03150810|156861264|FG005|Overall Study|Participant relocated abroad.|1|||
48729636|NCT03150810|156861265|FG006|Overall Study|Participant relocated abroad.|0|||
48513612|NCT02842853|156073372|FG001|Overall Study|Withdrawal by Subject|13|||
48513613|NCT02842853|156073373|FG002|Overall Study|Withdrawal by Subject|9|||
48513614|NCT02842853|156073374|FG003|Overall Study|Withdrawal by Subject|8|||
48513615|NCT02842853|156073371|FG000|Overall Study|Lost to Follow-up|9|||
48513616|NCT02842853|156073372|FG001|Overall Study|Lost to Follow-up|13|||
48513617|NCT02842853|156073373|FG002|Overall Study|Lost to Follow-up|10|||
48513618|NCT02842853|156073374|FG003|Overall Study|Lost to Follow-up|11|||
48513619|NCT03364192|156073380|FG000|Overall Study|Ineligible|10|||
48382726|NCT03065023|155596762|FG000|Overall Study|Lost to Follow-up|0|||
48382727|NCT03065023|155596763|FG001|Overall Study|Lost to Follow-up|1|||
48382728|NCT03065023|155596764|FG002|Overall Study|Lost to Follow-up|0|||
48382729|NCT03065023|155596765|FG003|Overall Study|Lost to Follow-up|0|||
48382730|NCT03065023|155596766|FG004|Overall Study|Lost to Follow-up|0|||
48382731|NCT03065023|155596762|FG000|Overall Study|Participant Decision|0|||
48382732|NCT03065023|155596763|FG001|Overall Study|Participant Decision|0|||
48382733|NCT03065023|155596764|FG002|Overall Study|Participant Decision|0|||
48382734|NCT03065023|155596765|FG003|Overall Study|Participant Decision|1|||
48382735|NCT03065023|155596766|FG004|Overall Study|Participant Decision|0|||
48382736|NCT03065023|155596762|FG000|Overall Study|Withdrawal by Subject|0|||
48382737|NCT03065023|155596763|FG001|Overall Study|Withdrawal by Subject|0|||
48382738|NCT03065023|155596764|FG002|Overall Study|Withdrawal by Subject|0|||
48382739|NCT03065023|155596765|FG003|Overall Study|Withdrawal by Subject|1|||
48513620|NCT03364192|156073380|FG000|Overall Study|Withdrawal by Subject|5|||
48513621|NCT03364192|156073380|FG000|Overall Study|Lost to Follow-up|1|||
48729637|NCT03150810|156861266|FG007|Overall Study|Participant relocated abroad.|0|||
48382740|NCT03065023|155596766|FG004|Overall Study|Withdrawal by Subject|0|||
48382741|NCT01102803|155596767|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
48382742|NCT01102803|155596768|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
48513622|NCT02554877|156073390|FG000|Overall Study|Adverse Event|2|||
48822440|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
48513623|NCT02554877|156073391|FG001|Overall Study|Adverse Event|0|||
48729638|NCT03150810|156861267|FG008|Overall Study|Participant relocated abroad.|0|||
48729639|NCT03150810|156861268|FG009|Overall Study|Participant relocated abroad.|0|||
48729640|NCT03150810|156861269|FG010|Overall Study|Participant relocated abroad.|0|||
48729641|NCT03150810|156861270|FG011|Overall Study|Participant relocated abroad.|0|||
48729642|NCT03150810|156861271|FG012|Overall Study|Participant relocated abroad.|0|||
48729643|NCT03150810|156861259|FG000|Overall Study|Transferred care to oncologist|0|||
48729644|NCT03150810|156861260|FG001|Overall Study|Transferred care to oncologist|0|||
48729645|NCT03150810|156861261|FG002|Overall Study|Transferred care to oncologist|0|||
48729646|NCT03150810|156861262|FG003|Overall Study|Transferred care to oncologist|0|||
48729647|NCT03150810|156861263|FG004|Overall Study|Transferred care to oncologist|0|||
48729648|NCT03150810|156861264|FG005|Overall Study|Transferred care to oncologist|0|||
48729649|NCT03150810|156861265|FG006|Overall Study|Transferred care to oncologist|2|||
48729650|NCT03150810|156861266|FG007|Overall Study|Transferred care to oncologist|0|||
48729651|NCT03150810|156861267|FG008|Overall Study|Transferred care to oncologist|0|||
48729652|NCT03150810|156861268|FG009|Overall Study|Transferred care to oncologist|0|||
48729653|NCT03150810|156861269|FG010|Overall Study|Transferred care to oncologist|0|||
48729654|NCT03150810|156861270|FG011|Overall Study|Transferred care to oncologist|0|||
48729655|NCT03150810|156861271|FG012|Overall Study|Transferred care to oncologist|0|||
48729656|NCT01323946|156861272|FG000|Overall Study|Lost to Follow-up|0|||
48729657|NCT01323946|156861273|FG001|Overall Study|Lost to Follow-up|1|||
48729658|NCT01323946|156861274|FG002|Overall Study|Lost to Follow-up|0|||
48729659|NCT01323946|156861272|FG000|Overall Study|Parents refused the last blood draw|1|||
48729660|NCT01323946|156861273|FG001|Overall Study|Parents refused the last blood draw|0|||
48729661|NCT01323946|156861274|FG002|Overall Study|Parents refused the last blood draw|0|||
48729662|NCT01323946|156861272|FG000|Overall Study|Withdrawal by Subject|2|||
48729663|NCT01323946|156861273|FG001|Overall Study|Withdrawal by Subject|2|||
48729664|NCT01323946|156861274|FG002|Overall Study|Withdrawal by Subject|0|||
48822441|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822442|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822443|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
48513624|NCT02554877|156073392|FG002|Overall Study|Adverse Event|0|||
48513625|NCT02554877|156073393|FG003|Overall Study|Adverse Event|1|||
48822444|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822445|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
48822446|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
48513626|NCT02554877|156073390|FG000|Overall Study|Lost to Follow-up|1|||
48513627|NCT02554877|156073391|FG001|Overall Study|Lost to Follow-up|1|||
48513628|NCT02554877|156073392|FG002|Overall Study|Lost to Follow-up|1|||
48513629|NCT02554877|156073393|FG003|Overall Study|Lost to Follow-up|2|||
48513630|NCT02554877|156073390|FG000|Overall Study|Did not meet entrance criteria|0|||
48513631|NCT02554877|156073391|FG001|Overall Study|Did not meet entrance criteria|0|||
48513632|NCT02554877|156073392|FG002|Overall Study|Did not meet entrance criteria|1|||
48513633|NCT02554877|156073393|FG003|Overall Study|Did not meet entrance criteria|0|||
48513634|NCT02554877|156073390|FG000|Overall Study|No longer met eligibility criteria|1|||
48513635|NCT02554877|156073391|FG001|Overall Study|No longer met eligibility criteria|0|||
48729665|NCT03711266|156861275|FG000|Overall Study|Lost to Follow-up|10|||
48822447|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
48822448|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
48822449|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
48822450|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
48822451|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
48822452|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
48822453|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
48822454|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
48822455|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
48822456|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
48513636|NCT02554877|156073392|FG002|Overall Study|No longer met eligibility criteria|1|||
48513637|NCT02554877|156073393|FG003|Overall Study|No longer met eligibility criteria|1|||
48513638|NCT02554877|156073390|FG000|Overall Study|Protocol Violation|3|||
48513639|NCT02554877|156073391|FG001|Overall Study|Protocol Violation|1|||
48513640|NCT02554877|156073392|FG002|Overall Study|Protocol Violation|1|||
48513641|NCT02554877|156073393|FG003|Overall Study|Protocol Violation|0|||
48513642|NCT02554877|156073390|FG000|Overall Study|Other|1|||
48513643|NCT02554877|156073391|FG001|Overall Study|Other|3|||
48513644|NCT02554877|156073392|FG002|Overall Study|Other|0|||
48513645|NCT02554877|156073393|FG003|Overall Study|Other|3|||
48513646|NCT02554877|156073390|FG000|Overall Study|Insufficient clinical response|4|||
48513647|NCT02554877|156073391|FG001|Overall Study|Insufficient clinical response|0|||
48513648|NCT02554877|156073392|FG002|Overall Study|Insufficient clinical response|0|||
48513649|NCT02554877|156073393|FG003|Overall Study|Insufficient clinical response|0|||
48513650|NCT02554877|156073390|FG000|Overall Study|No longer willing to participate|0|||
48513651|NCT02554877|156073391|FG001|Overall Study|No longer willing to participate|2|||
48513652|NCT02554877|156073392|FG002|Overall Study|No longer willing to participate|2|||
48513653|NCT02554877|156073393|FG003|Overall Study|No longer willing to participate|0|||
48513654|NCT00274651|156073394|FG000|Overall Study|Adverse Event|6|||
48513655|NCT00274651|156073395|FG001|Overall Study|Adverse Event|3|||
48513656|NCT00274651|156073394|FG000|Overall Study|Lack of Efficacy|13|||
48513657|NCT00274651|156073395|FG001|Overall Study|Lack of Efficacy|6|||
48513658|NCT00274651|156073394|FG000|Overall Study|Death|1|||
48513659|NCT00274651|156073395|FG001|Overall Study|Death|3|||
48513660|NCT00274651|156073394|FG000|Overall Study|Withdrawal by Subject|0|||
48513661|NCT00274651|156073395|FG001|Overall Study|Withdrawal by Subject|1|||
48513662|NCT00274651|156073394|FG000|Overall Study|Physician Decision|8|||
48513663|NCT00274651|156073395|FG001|Overall Study|Physician Decision|7|||
48513664|NCT04474405|156073396|FG000|Overall Study|Withdrawal by Subject|0|||
48513665|NCT04474405|156073397|FG001|Overall Study|Withdrawal by Subject|0|||
48513666|NCT04474405|156073398|FG002|Overall Study|Withdrawal by Subject|1|||
48513667|NCT04474405|156073399|FG003|Overall Study|Withdrawal by Subject|0|||
48513668|NCT04474405|156073400|FG004|Overall Study|Withdrawal by Subject|1|||
48513669|NCT04474405|156073401|FG005|Overall Study|Withdrawal by Subject|0|||
48513670|NCT04474405|156073396|FG000|Overall Study|Other|0|||
48513671|NCT04474405|156073397|FG001|Overall Study|Other|0|||
48513672|NCT04474405|156073398|FG002|Overall Study|Other|0|||
48513673|NCT04474405|156073399|FG003|Overall Study|Other|0|||
48513674|NCT04474405|156073400|FG004|Overall Study|Other|3|||
48513675|NCT04474405|156073401|FG005|Overall Study|Other|0|||
48513676|NCT05133180|156073404|FG000|Overall Study|Withdrawal of consent|1|||
48513677|NCT05133180|156073405|FG001|Overall Study|Withdrawal of consent|1|||
48513678|NCT05133180|156073404|FG000|Overall Study|Lost to Follow-up|1|||
48513679|NCT05133180|156073405|FG001|Overall Study|Lost to Follow-up|1|||
48513680|NCT05133180|156073404|FG000|Overall Study|Documented disease progression|0|||
48513681|NCT05133180|156073405|FG001|Overall Study|Documented disease progression|1|||
48513682|NCT04345653|156073406|FG000|Overall Study|Withdrawal by Subject|2|||
48513683|NCT01895335|156073407|FG000|Overall Study|Adverse Event|106|||
48513684|NCT01895335|156073407|FG000|Overall Study|Lack of Efficacy|53|||
48513685|NCT01895335|156073407|FG000|Overall Study|Poor Compliance to Protocol|11|||
48513686|NCT01895335|156073407|FG000|Overall Study|Included But Not treated|1|||
48513687|NCT01895335|156073407|FG000|Overall Study|Other than Specified Above|44|||
48513688|NCT00191815|156073408|FG000|Overall Study|Adverse Event|2|||
48513689|NCT00191815|156073408|FG000|Overall Study|Disease progression or relapse|24|||
48513690|NCT00191815|156073408|FG000|Overall Study|Death|2|||
48513691|NCT00191815|156073408|FG000|Overall Study|Protocol Violation|3|||
48513692|NCT00191815|156073408|FG000|Overall Study|Physician Decision|2|||
48513693|NCT00191815|156073408|FG000|Overall Study|Withdrawal by Subject|7|||
48513694|NCT00700739|156073409|FG000|Overall Study|Lost to Follow-up|4|||
48513695|NCT00700739|156073410|FG001|Overall Study|Lost to Follow-up|4|||
48513696|NCT00574847|156073413|FG000|Overall Study|Adverse Event|2|||
48513697|NCT00574847|156073414|FG001|Overall Study|Adverse Event|0|||
48513698|NCT00574847|156073413|FG000|Overall Study|Death|1|||
48513699|NCT00574847|156073414|FG001|Overall Study|Death|0|||
48513700|NCT00574847|156073413|FG000|Overall Study|Withdrawal by Subject|2|||
48513701|NCT00574847|156073414|FG001|Overall Study|Withdrawal by Subject|2|||
48513702|NCT00574847|156073413|FG000|Overall Study|Physician Decision|1|||
48513703|NCT00574847|156073414|FG001|Overall Study|Physician Decision|0|||
48513704|NCT00574847|156073413|FG000|Overall Study|Did not receive medication (declined)|2|||
48513705|NCT00574847|156073414|FG001|Overall Study|Did not receive medication (declined)|5|||
48513706|NCT03681470|156073415|FG000|Overall Study|Lack of Efficacy|3|||
48513707|NCT03681470|156073415|FG000|Overall Study|Lost to Follow-up|1|||
48513708|NCT03681470|156073415|FG000|Overall Study|Protocol Violation|3|||
48513709|NCT03681470|156073415|FG000|Overall Study|Withdrawal by Subject|1|||
48513710|NCT00835081|156073419|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48513711|NCT00835081|156073420|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48513712|NCT02535923|156073423|FG000|Overall Study|Lost to Follow-up|5|||
48513713|NCT02535923|156073424|FG001|Overall Study|Lost to Follow-up|5|||
48513714|NCT02535923|156073423|FG000|Overall Study|Withdrawal by Subject|4|||
48822457|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
48513715|NCT02535923|156073424|FG001|Overall Study|Withdrawal by Subject|3|||
48513716|NCT01018862|156073427|FG000|Overall Study|Adverse Event|2|||
48513717|NCT01018862|156073428|FG001|Overall Study|Adverse Event|0|||
48513718|NCT01018862|156073429|FG002|Overall Study|Adverse Event|6|||
48513719|NCT01018862|156073427|FG000|Overall Study|Lack of Efficacy|1|||
48513720|NCT01018862|156073428|FG001|Overall Study|Lack of Efficacy|0|||
48513721|NCT01018862|156073429|FG002|Overall Study|Lack of Efficacy|2|||
48513722|NCT01018862|156073427|FG000|Overall Study|Lost to Follow-up|3|||
48513723|NCT01018862|156073428|FG001|Overall Study|Lost to Follow-up|1|||
48513724|NCT01018862|156073429|FG002|Overall Study|Lost to Follow-up|0|||
48513725|NCT01018862|156073427|FG000|Overall Study|Protocol Violation|1|||
48513726|NCT01018862|156073428|FG001|Overall Study|Protocol Violation|3|||
48513727|NCT01018862|156073429|FG002|Overall Study|Protocol Violation|3|||
48513728|NCT01018862|156073427|FG000|Overall Study|Withdrawal by Subject|1|||
48513729|NCT01018862|156073428|FG001|Overall Study|Withdrawal by Subject|2|||
48513730|NCT01018862|156073429|FG002|Overall Study|Withdrawal by Subject|1|||
48513731|NCT01018862|156073427|FG000|Overall Study|administrative problems|5|||
48513732|NCT01018862|156073428|FG001|Overall Study|administrative problems|4|||
48513733|NCT01018862|156073429|FG002|Overall Study|administrative problems|4|||
48513734|NCT03279978|156073430|FG000|Overall Study|Withdrawal by Subject|0|||
48513735|NCT03279978|156073431|FG001|Overall Study|Withdrawal by Subject|1|||
48513736|NCT03279978|156073432|FG002|Overall Study|Withdrawal by Subject|0|||
48513737|NCT03279978|156073433|FG003|Overall Study|Withdrawal by Subject|0|||
48513738|NCT03279978|156073434|FG004|Overall Study|Withdrawal by Subject|0|||
48513739|NCT03279978|156073435|FG005|Overall Study|Withdrawal by Subject|0|||
48513740|NCT03279978|156073436|FG006|Overall Study|Withdrawal by Subject|0|||
48513741|NCT03279978|156073437|FG007|Overall Study|Withdrawal by Subject|0|||
48513742|NCT03279978|156073438|FG008|Overall Study|Withdrawal by Subject|0|||
48513743|NCT03279978|156073439|FG009|Overall Study|Withdrawal by Subject|1|||
48513744|NCT03279978|156073430|FG000|Overall Study|Lost to Follow-up|1|||
48513745|NCT03279978|156073431|FG001|Overall Study|Lost to Follow-up|0|||
48513746|NCT03279978|156073432|FG002|Overall Study|Lost to Follow-up|1|||
48729666|NCT01954342|156861276|FG000|Overall Study|Missing data from 13-16week study visit|0|||
48729667|NCT01954342|156861277|FG001|Overall Study|Missing data from 13-16week study visit|0|||
48729668|NCT01954342|156861278|FG002|Overall Study|Missing data from 13-16week study visit|0|||
48729669|NCT01954342|156861279|FG003|Overall Study|Missing data from 13-16week study visit|1|||
48729670|NCT01954342|156861276|FG000|Overall Study|Miscarriage|0|||
48729671|NCT01954342|156861277|FG001|Overall Study|Miscarriage|0|||
48729672|NCT01954342|156861278|FG002|Overall Study|Miscarriage|0|||
48729673|NCT01954342|156861279|FG003|Overall Study|Miscarriage|3|||
48729674|NCT01954342|156861276|FG000|Overall Study|Lost to Follow-up|0|||
48729675|NCT01954342|156861277|FG001|Overall Study|Lost to Follow-up|0|||
48729676|NCT01954342|156861278|FG002|Overall Study|Lost to Follow-up|0|||
48729677|NCT01954342|156861279|FG003|Overall Study|Lost to Follow-up|5|||
48513747|NCT03279978|156073433|FG003|Overall Study|Lost to Follow-up|0|||
48513748|NCT03279978|156073434|FG004|Overall Study|Lost to Follow-up|0|||
48513749|NCT03279978|156073435|FG005|Overall Study|Lost to Follow-up|0|||
48513750|NCT03279978|156073436|FG006|Overall Study|Lost to Follow-up|0|||
48729678|NCT01954342|156861276|FG000|Overall Study|Preterm delivery|0|||
48729679|NCT01954342|156861277|FG001|Overall Study|Preterm delivery|0|||
48729680|NCT01954342|156861278|FG002|Overall Study|Preterm delivery|0|||
48729681|NCT01954342|156861279|FG003|Overall Study|Preterm delivery|3|||
48729682|NCT01954342|156861276|FG000|Overall Study|Pre-eclampsia|0|||
48729683|NCT01954342|156861277|FG001|Overall Study|Pre-eclampsia|0|||
48729684|NCT01954342|156861278|FG002|Overall Study|Pre-eclampsia|0|||
48513751|NCT03279978|156073437|FG007|Overall Study|Lost to Follow-up|0|||
48513752|NCT03279978|156073438|FG008|Overall Study|Lost to Follow-up|0|||
48513753|NCT03279978|156073439|FG009|Overall Study|Lost to Follow-up|0|||
48513754|NCT03279978|156073430|FG000|Overall Study|Other than stated above|0|||
48513755|NCT03279978|156073431|FG001|Overall Study|Other than stated above|0|||
48513756|NCT03279978|156073432|FG002|Overall Study|Other than stated above|0|||
48513757|NCT03279978|156073433|FG003|Overall Study|Other than stated above|0|||
48513758|NCT03279978|156073434|FG004|Overall Study|Other than stated above|0|||
48513759|NCT03279978|156073435|FG005|Overall Study|Other than stated above|0|||
48513760|NCT03279978|156073436|FG006|Overall Study|Other than stated above|1|||
48513761|NCT03279978|156073437|FG007|Overall Study|Other than stated above|0|||
48513762|NCT03279978|156073438|FG008|Overall Study|Other than stated above|0|||
48729685|NCT01954342|156861279|FG003|Overall Study|Pre-eclampsia|4|||
48729686|NCT01954342|156861276|FG000|Overall Study|Unreliable Data|0|||
48729687|NCT01954342|156861277|FG001|Overall Study|Unreliable Data|0|||
48729688|NCT01954342|156861278|FG002|Overall Study|Unreliable Data|0|||
48729689|NCT01954342|156861279|FG003|Overall Study|Unreliable Data|2|||
48729690|NCT00057876|156861280|FG000|Overall Study|Adverse Event|8|||
48729691|NCT00057876|156861281|FG001|Overall Study|Adverse Event|8|||
48729692|NCT00057876|156861280|FG000|Overall Study|Death|2|||
48729693|NCT00057876|156861281|FG001|Overall Study|Death|1|||
48729694|NCT00057876|156861280|FG000|Overall Study|Withdrawal by Subject|5|||
48729695|NCT00057876|156861281|FG001|Overall Study|Withdrawal by Subject|6|||
48729696|NCT00057876|156861280|FG000|Overall Study|Lack of Efficacy|10|||
48729697|NCT00057876|156861281|FG001|Overall Study|Lack of Efficacy|8|||
48729698|NCT00057876|156861280|FG000|Overall Study|Ineligible|1|||
48729699|NCT00057876|156861281|FG001|Overall Study|Ineligible|2|||
48729700|NCT00057876|156861280|FG000|Overall Study|other reason|2|||
48729701|NCT00057876|156861281|FG001|Overall Study|other reason|2|||
48729702|NCT00057876|156861280|FG000|Overall Study|other complicating disease|1|||
48729703|NCT00057876|156861281|FG001|Overall Study|other complicating disease|0|||
48729704|NCT00750880|156861282|FG000|Overall Study|Adverse Event|76|||
48729705|NCT00750880|156861282|FG000|Overall Study|Death|4|||
48729706|NCT00750880|156861282|FG000|Overall Study|Lack of Efficacy|46|||
48513763|NCT03279978|156073439|FG009|Overall Study|Other than stated above|0|||
48513764|NCT00840879|156073440|FG000|Second Intervention|Withdrawal by Subject|1|||
48513765|NCT00840879|156073441|FG001|Second Intervention|Withdrawal by Subject|0|||
48729707|NCT00750880|156861282|FG000|Overall Study|Lost to Follow-up|10|||
48729708|NCT00750880|156861282|FG000|Overall Study|Protocol Violation|15|||
48729709|NCT00750880|156861282|FG000|Overall Study|Withdrawal by Subject|33|||
48729710|NCT00750880|156861282|FG000|Overall Study|Physician Decision|20|||
48729711|NCT00750880|156861282|FG000|Overall Study|Administrative|11|||
48382743|NCT01102803|155596767|FG000|Post to Follow-Up|Lost to Follow-up|1|||
48382744|NCT01102803|155596768|FG001|Post to Follow-Up|Lost to Follow-up|3|||
48729712|NCT02105766|156861283|FG000|Overall Study|Physician Decision|1|||
48729713|NCT02105766|156861284|FG001|Overall Study|Physician Decision|1|||
48729714|NCT02105766|156861285|FG002|Overall Study|Physician Decision|0|||
48729715|NCT02105766|156861283|FG000|Overall Study|Lost to Follow-up|2|||
48729716|NCT02105766|156861284|FG001|Overall Study|Lost to Follow-up|0|||
48729717|NCT02105766|156861285|FG002|Overall Study|Lost to Follow-up|0|||
48729718|NCT02105766|156861283|FG000|Overall Study|Death|1|||
48729719|NCT02105766|156861284|FG001|Overall Study|Death|1|||
48729720|NCT02105766|156861285|FG002|Overall Study|Death|0|||
48729721|NCT00925990|156861286|FG000|Overall Study|Adverse Event|1|||
48729722|NCT00925990|156861287|FG001|Overall Study|Adverse Event|3|||
48729723|NCT00925990|156861286|FG000|Overall Study|Withdrawal by Subject|2|||
48729724|NCT00925990|156861287|FG001|Overall Study|Withdrawal by Subject|2|||
48729725|NCT00925990|156861286|FG000|Overall Study|Lost to Follow-up|1|||
48729726|NCT00925990|156861287|FG001|Overall Study|Lost to Follow-up|3|||
48729727|NCT00925990|156861286|FG000|Overall Study|Physician Decision|1|||
48729728|NCT00925990|156861287|FG001|Overall Study|Physician Decision|1|||
48729729|NCT00925990|156861286|FG000|Overall Study|moved out of state, missed medication|0|||
48729730|NCT00925990|156861287|FG001|Overall Study|moved out of state, missed medication|2|||
48729731|NCT00853073|156861288|FG000|Overall Study|Withdrawal by Subject|3|||
48513766|NCT00682461|156074848|FG000|Overall Study|Adverse Event|5|||
48513767|NCT00682461|156074849|FG001|Overall Study|Adverse Event|7|||
48513768|NCT00682461|156074848|FG000|Overall Study|Lost to Follow-up|8|||
48513769|NCT00682461|156074849|FG001|Overall Study|Lost to Follow-up|5|||
48513770|NCT00682461|156074848|FG000|Overall Study|Withdrawal by Subject|12|||
48513771|NCT00682461|156074849|FG001|Overall Study|Withdrawal by Subject|19|||
48513772|NCT02875392|156074850|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
48513773|NCT02875392|156074851|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
48513774|NCT03599193|156074854|FG000|Overall Study|Adverse Event|0|||
48513775|NCT03599193|156074855|FG001|Overall Study|Adverse Event|2|||
48513776|NCT03599193|156074854|FG000|Overall Study|Withdrawal by Subject|1|||
48513777|NCT03599193|156074855|FG001|Overall Study|Withdrawal by Subject|0|||
48513778|NCT03599193|156074854|FG000|Overall Study|Protocol Violation|1|||
48513779|NCT03599193|156074855|FG001|Overall Study|Protocol Violation|0|||
48513780|NCT03599193|156074854|FG000|Overall Study|Lost to Follow-up|0|||
48513781|NCT03599193|156074855|FG001|Overall Study|Lost to Follow-up|1|||
48513782|NCT00834717|156074856|FG000|First Intervention|Adverse Event|1|||
48513783|NCT00834717|156074857|FG001|First Intervention|Adverse Event|0|||
48513784|NCT00834717|156074856|FG000|First Intervention|Withdrawal by Subject|0|||
48513785|NCT00834717|156074857|FG001|First Intervention|Withdrawal by Subject|1|||
48513786|NCT02222818|156074858|FG000|Period 1|Eligibility criteria not met|0|||
48513787|NCT02222818|156074859|FG001|Period 1|Eligibility criteria not met|3|||
48513788|NCT01811953|156074860|FG000|Overall Study|Adverse Event|0|||
48513789|NCT01811953|156074861|FG001|Overall Study|Adverse Event|0|||
48513790|NCT01811953|156074862|FG002|Overall Study|Adverse Event|0|||
48513791|NCT01811953|156074863|FG003|Overall Study|Adverse Event|1|||
48513792|NCT01811953|156074864|FG004|Overall Study|Adverse Event|0|||
48513793|NCT01811953|156074865|FG005|Overall Study|Adverse Event|1|||
48513794|NCT01811953|156074860|FG000|Overall Study|Protocol Violation|0|||
48513795|NCT01811953|156074861|FG001|Overall Study|Protocol Violation|0|||
48513796|NCT01811953|156074862|FG002|Overall Study|Protocol Violation|0|||
48513797|NCT01811953|156074863|FG003|Overall Study|Protocol Violation|0|||
48513798|NCT01811953|156074864|FG004|Overall Study|Protocol Violation|1|||
48513799|NCT01811953|156074865|FG005|Overall Study|Protocol Violation|0|||
48382745|NCT00705432|155596769|FG000|Treatment Period|Adverse Event|45|||
48729732|NCT00853073|156861289|FG001|Overall Study|Withdrawal by Subject|2|||
48729733|NCT03381274|156861290|FG000|Overall Study|Death|2|||
48729734|NCT03381274|156861291|FG001|Overall Study|Death|9|||
48729735|NCT03381274|156861292|FG002|Overall Study|Death|3|||
48729736|NCT03381274|156861293|FG003|Overall Study|Death|2|||
48729737|NCT03381274|156861294|FG004|Overall Study|Death|3|||
48729738|NCT03381274|156861290|FG000|Overall Study|Lost to Follow-up|0|||
48513800|NCT02611687|156074866|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
48513801|NCT02611687|156074867|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
48513802|NCT01913405|156074868|FG000|Overall Study|Withdrawal by Subject|1|||
48513803|NCT01913405|156074868|FG000|Overall Study|Adverse Event|1|||
48513804|NCT04089553|156074872|FG000|Overall Study|Death|1|||
48513805|NCT04089553|156074873|FG001|Overall Study|Death|1|||
48513806|NCT04089553|156074872|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
48729739|NCT03381274|156861291|FG001|Overall Study|Lost to Follow-up|0|||
48729740|NCT03381274|156861292|FG002|Overall Study|Lost to Follow-up|0|||
48729741|NCT03381274|156861293|FG003|Overall Study|Lost to Follow-up|1|||
48729742|NCT03381274|156861294|FG004|Overall Study|Lost to Follow-up|0|||
48729743|NCT03381274|156861290|FG000|Overall Study|Withdrawal by Subject|2|||
48729744|NCT03381274|156861291|FG001|Overall Study|Withdrawal by Subject|1|||
48382746|NCT00705432|155596770|FG001|Treatment Period|Adverse Event|37|||
48729745|NCT03381274|156861292|FG002|Overall Study|Withdrawal by Subject|3|||
48729746|NCT03381274|156861293|FG003|Overall Study|Withdrawal by Subject|1|||
48729747|NCT03381274|156861294|FG004|Overall Study|Withdrawal by Subject|0|||
48729748|NCT03381274|156861290|FG000|Overall Study|Other|1|||
48729749|NCT03381274|156861291|FG001|Overall Study|Other|11|||
48729750|NCT03381274|156861292|FG002|Overall Study|Other|0|||
48729751|NCT03381274|156861293|FG003|Overall Study|Other|2|||
48729752|NCT03381274|156861294|FG004|Overall Study|Other|2|||
48729753|NCT04966741|156861295|FG000|Overall Study|Lost to Follow-up|1|||
48729754|NCT04966741|156861296|FG001|Overall Study|Lost to Follow-up|0|||
48729755|NCT02675231|156861297|FG000|Overall Study|Withdrawal by Subject|2|||
48729756|NCT02675231|156861298|FG001|Overall Study|Withdrawal by Subject|4|||
48729757|NCT02675231|156861299|FG002|Overall Study|Withdrawal by Subject|2|||
48729758|NCT02675231|156861297|FG000|Overall Study|Lost to Follow-up|3|||
48729759|NCT02675231|156861298|FG001|Overall Study|Lost to Follow-up|4|||
48729760|NCT02675231|156861299|FG002|Overall Study|Lost to Follow-up|3|||
48729761|NCT02810340|156861300|FG000|Overall Study|Withdrawal by Subject|1|||
48729762|NCT02810340|156861301|FG001|Overall Study|Withdrawal by Subject|0|||
48729763|NCT02810340|156861302|FG002|Overall Study|Withdrawal by Subject|0|||
48729764|NCT02810340|156861300|FG000|Overall Study|Incarceration|0|||
48729765|NCT02810340|156861301|FG001|Overall Study|Incarceration|1|||
48729766|NCT02810340|156861302|FG002|Overall Study|Incarceration|0|||
48729767|NCT02810340|156861300|FG000|Overall Study|Lost to Follow-up|0|||
48729768|NCT02810340|156861301|FG001|Overall Study|Lost to Follow-up|0|||
48729769|NCT02810340|156861302|FG002|Overall Study|Lost to Follow-up|1|||
48729770|NCT01484054|156861310|FG000|Period 1|Withdrawal by Subject|0|||
48729771|NCT01484054|156861311|FG001|Period 1|Withdrawal by Subject|1|||
48729772|NCT01610271|156861312|FG000|Overall Study|Surgery not complete|0|||
48729773|NCT01610271|156861313|FG001|Overall Study|Surgery not complete|1|||
48729774|NCT01610271|156861312|FG000|Overall Study|Prosthesis not implanted|2|||
48729775|NCT01610271|156861313|FG001|Overall Study|Prosthesis not implanted|3|||
48729776|NCT02961218|156861314|FG000|Overall Study|Lost to Follow-up|0|||
48729777|NCT02961218|156861315|FG001|Overall Study|Lost to Follow-up|2|||
48729778|NCT02961218|156861314|FG000|Overall Study|Physician Decision|0|||
48729779|NCT02961218|156861315|FG001|Overall Study|Physician Decision|2|||
48729780|NCT02961218|156861314|FG000|Overall Study|Subject/Guardian Decision|3|||
48729781|NCT02961218|156861315|FG001|Overall Study|Subject/Guardian Decision|1|||
48729782|NCT02393690|156861316|FG000|Overall Study|Ineligible|0|||
48729783|NCT02393690|156861317|FG001|Overall Study|Ineligible|1|||
48729784|NCT00586846|156861318|FG000|Overall Study|Physician Decision|1|||
48729785|NCT00586846|156861318|FG000|Overall Study|Death|1|||
48729786|NCT00586846|156861318|FG000|Overall Study|Evaluable for Toxicity Only|4|||
48729787|NCT05080660|156861319|FG000|Overall Study|Adverse Event|4|||
48729788|NCT05080660|156861320|FG001|Overall Study|Adverse Event|0|||
48729789|NCT05080660|156861319|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
48729790|NCT05080660|156861320|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
48729791|NCT05080660|156861319|FG000|Overall Study|Physician Decision|1|||
48729792|NCT05080660|156861320|FG001|Overall Study|Physician Decision|0|||
48729793|NCT05080660|156861319|FG000|Overall Study|Protocol Deviation|2|||
48729794|NCT05080660|156861320|FG001|Overall Study|Protocol Deviation|0|||
48729795|NCT05080660|156861319|FG000|Overall Study|Withdrawal by Subject|5|||
48729796|NCT05080660|156861320|FG001|Overall Study|Withdrawal by Subject|2|||
48729797|NCT01721070|156861321|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
48729798|NCT02204007|156861331|FG000|Overall Study|Surgery Canceled|1|||
48729799|NCT02204007|156861332|FG001|Overall Study|Surgery Canceled|1|||
48729800|NCT05070728|156861335|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
48729801|NCT05070728|156861336|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
48729802|NCT00292318|156861341|FG000|Overall Study|Study terminated by officials|2|||
48729803|NCT00292318|156861342|FG001|Overall Study|Study terminated by officials|1|||
48729804|NCT03438383|156861345|FG000|Overall Study|Protocol Violation|9|||
48729805|NCT03438383|156861346|FG001|Overall Study|Protocol Violation|3|||
48729806|NCT02819518|156861347|FG000|Overall Study|Death|9|||
48513807|NCT04089553|156074873|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
48729807|NCT02819518|156861348|FG001|Overall Study|Death|12|||
48729808|NCT02819518|156861349|FG002|Overall Study|Death|9|||
48729809|NCT02819518|156861350|FG003|Overall Study|Death|475|||
48729810|NCT02819518|156861351|FG004|Overall Study|Death|244|||
48729811|NCT02819518|156861347|FG000|Overall Study|Withdrawal by Subject|0|||
48513808|NCT04089553|156074872|FG000|Overall Study|Withdrawal by Subject|3|||
48729812|NCT02819518|156861348|FG001|Overall Study|Withdrawal by Subject|0|||
48729813|NCT02819518|156861349|FG002|Overall Study|Withdrawal by Subject|0|||
48729814|NCT02819518|156861350|FG003|Overall Study|Withdrawal by Subject|25|||
48729815|NCT02819518|156861351|FG004|Overall Study|Withdrawal by Subject|8|||
48729816|NCT02819518|156861347|FG000|Overall Study|Lost to Follow-up|0|||
48729817|NCT02819518|156861348|FG001|Overall Study|Lost to Follow-up|0|||
48729818|NCT02819518|156861349|FG002|Overall Study|Lost to Follow-up|0|||
48601103|NCT02718911|156396047|FG007|Overall Study|Adverse Event|0|||
48729819|NCT02819518|156861350|FG003|Overall Study|Lost to Follow-up|0|||
48729820|NCT02819518|156861351|FG004|Overall Study|Lost to Follow-up|1|||
48729821|NCT02819518|156861347|FG000|Overall Study|Sponsor Decision|1|||
48729822|NCT02819518|156861348|FG001|Overall Study|Sponsor Decision|1|||
48729823|NCT02819518|156861349|FG002|Overall Study|Sponsor Decision|0|||
48513809|NCT04089553|156074873|FG001|Overall Study|Withdrawal by Subject|3|||
48513810|NCT04089553|156074872|FG000|Overall Study|Physician Decision|1|||
48513811|NCT04089553|156074873|FG001|Overall Study|Physician Decision|0|||
48513812|NCT04089553|156074872|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
48513813|NCT04089553|156074873|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
48513814|NCT04089553|156074872|FG000|Overall Study|Other|1|||
48513815|NCT04089553|156074873|FG001|Overall Study|Other|0|||
48513816|NCT04089553|156074872|FG000|Overall Study|Adverse Event|1|||
48513817|NCT04089553|156074873|FG001|Overall Study|Adverse Event|1|||
48513818|NCT01030133|156074874|FG000|Overall Study|failed to experience pain at level 7/10|2|||
48729824|NCT02819518|156861350|FG003|Overall Study|Sponsor Decision|34|||
48729825|NCT02819518|156861351|FG004|Overall Study|Sponsor Decision|17|||
48729826|NCT02819518|156861347|FG000|Overall Study|Transferred to extension study|1|||
48729827|NCT02819518|156861348|FG001|Overall Study|Transferred to extension study|1|||
48729828|NCT02819518|156861349|FG002|Overall Study|Transferred to extension study|1|||
48729829|NCT02819518|156861350|FG003|Overall Study|Transferred to extension study|32|||
48729830|NCT02819518|156861351|FG004|Overall Study|Transferred to extension study|11|||
48729831|NCT02435069|156861352|FG000|Dose Response - First Intervention|Adverse Event|0|||
48729832|NCT02435069|156861353|FG001|Dose Response - First Intervention|Adverse Event|1|||
48729833|NCT02435069|156861354|FG002|Dose Response - First Intervention|Adverse Event|1|||
48729834|NCT02435069|156861355|FG003|Dose Response - First Intervention|Adverse Event|0|||
48729835|NCT02435069|156861356|FG004|Dose Response - First Intervention|Adverse Event|0|||
48729836|NCT02435069|156861352|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
48729837|NCT02435069|156861353|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
48729838|NCT02435069|156861354|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
48729839|NCT02435069|156861355|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
48729840|NCT02435069|156861356|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
48729841|NCT00843726|156861358|FG000|Overall Study|Death|1|||
48729842|NCT00843726|156861359|FG001|Overall Study|Death|0|||
48729843|NCT00843726|156861358|FG000|Overall Study|Withdrawal by Subject|0|||
48729844|NCT00843726|156861359|FG001|Overall Study|Withdrawal by Subject|1|||
48729845|NCT00667602|156861360|FG000|Overall Study|Withdrawal by Subject|4|||
48729846|NCT00667602|156861361|FG001|Overall Study|Withdrawal by Subject|9|||
48729847|NCT00667602|156861362|FG002|Overall Study|Withdrawal by Subject|10|||
48729848|NCT00667602|156861360|FG000|Overall Study|Lost to Follow-up|4|||
48729849|NCT00667602|156861361|FG001|Overall Study|Lost to Follow-up|5|||
48729850|NCT00667602|156861362|FG002|Overall Study|Lost to Follow-up|6|||
48729851|NCT00667602|156861360|FG000|Overall Study|Administrative reason|0|||
48729852|NCT00667602|156861361|FG001|Overall Study|Administrative reason|0|||
48729853|NCT00667602|156861362|FG002|Overall Study|Administrative reason|2|||
48729854|NCT00667602|156861360|FG000|Overall Study|Protocol Violation|0|||
48729855|NCT00667602|156861361|FG001|Overall Study|Protocol Violation|1|||
48729856|NCT00667602|156861362|FG002|Overall Study|Protocol Violation|0|||
48729857|NCT03035409|156861363|FG000|Overall Study|Adverse Event|5|||
48729858|NCT03035409|156861363|FG000|Overall Study|Death|2|||
48729859|NCT03035409|156861363|FG000|Overall Study|Withdrawal by Subject|2|||
48729860|NCT03035409|156861363|FG000|Overall Study|Non compliance|4|||
48729861|NCT03035409|156861363|FG000|Overall Study|Patient was jittery|1|||
48729862|NCT03035409|156861363|FG000|Overall Study|Did not like Questionnaire|1|||
48729863|NCT03035409|156861363|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
48729864|NCT03035409|156861363|FG000|Overall Study|Did not like taking drugs|1|||
48729865|NCT02750943|156861364|FG000|Overall Study|Lost to Follow-up|1|||
48729866|NCT02750943|156861365|FG001|Overall Study|Lost to Follow-up|2|||
48729867|NCT02750943|156861364|FG000|Overall Study|Withdrawal by Subject|5|||
48729868|NCT02750943|156861365|FG001|Overall Study|Withdrawal by Subject|7|||
48513819|NCT01030133|156074875|FG001|Overall Study|failed to experience pain at level 7/10|2|||
48513820|NCT00455312|156074876|FG000|Overall Study|Death|0|||
48729869|NCT01467583|156861366|FG000|Overall Study|Death|1|||
48729870|NCT01467583|156861367|FG001|Overall Study|Death|1|||
48729871|NCT01467583|156861368|FG002|Overall Study|Death|0|||
48729872|NCT01467583|156861366|FG000|Overall Study|Withdrawal by Subject|1|||
48729873|NCT01467583|156861367|FG001|Overall Study|Withdrawal by Subject|0|||
48729874|NCT01467583|156861368|FG002|Overall Study|Withdrawal by Subject|0|||
48729875|NCT01467583|156861366|FG000|Overall Study|Protocol Violation|0|||
48729876|NCT01467583|156861367|FG001|Overall Study|Protocol Violation|0|||
48729877|NCT01467583|156861368|FG002|Overall Study|Protocol Violation|2|||
48513821|NCT00455312|156074877|FG001|Overall Study|Death|1|||
48513822|NCT03868891|156074878|FG000|Overall Study|Adverse Event|1|||
48729878|NCT05868382|156861369|FG000|Overall Study|Lost to Follow-up|5|||
48729879|NCT05868382|156861370|FG001|Overall Study|Lost to Follow-up|0|||
48729880|NCT05868382|156861371|FG002|Overall Study|Lost to Follow-up|6|||
48729881|NCT05868382|156861372|FG003|Overall Study|Lost to Follow-up|4|||
48729882|NCT05868382|156861373|FG004|Overall Study|Lost to Follow-up|2|||
48729883|NCT05868382|156861374|FG005|Overall Study|Lost to Follow-up|6|||
48729884|NCT05868382|156861369|FG000|Overall Study|Withdrawal by Subject|1|||
48729885|NCT05868382|156861370|FG001|Overall Study|Withdrawal by Subject|0|||
48382747|NCT00705432|155596771|FG002|Treatment Period|Adverse Event|51|||
48382748|NCT00705432|155596772|FG003|Treatment Period|Adverse Event|12|||
48382749|NCT00705432|155596773|FG004|Treatment Period|Adverse Event|8|||
48382750|NCT00705432|155596774|FG005|Treatment Period|Adverse Event|9|||
48382751|NCT00705432|155596769|FG000|Treatment Period|Treatment failure|92|||
48382752|NCT00705432|155596770|FG001|Treatment Period|Treatment failure|42|||
48382753|NCT00705432|155596771|FG002|Treatment Period|Treatment failure|33|||
48382754|NCT00705432|155596772|FG003|Treatment Period|Treatment failure|25|||
48729886|NCT05868382|156861371|FG002|Overall Study|Withdrawal by Subject|0|||
48729887|NCT05868382|156861372|FG003|Overall Study|Withdrawal by Subject|0|||
48729888|NCT05868382|156861373|FG004|Overall Study|Withdrawal by Subject|1|||
48513823|NCT03868891|156074879|FG001|Overall Study|Adverse Event|0|||
48513824|NCT03868891|156074878|FG000|Overall Study|Lost to Follow-up|2|||
48513825|NCT03868891|156074879|FG001|Overall Study|Lost to Follow-up|1|||
48513826|NCT03868891|156074878|FG000|Overall Study|COVID-19 Restrictions|1|||
48513827|NCT03868891|156074879|FG001|Overall Study|COVID-19 Restrictions|2|||
48513828|NCT01705574|156074880|FG000|Double-Blind Phase|Lost to Follow-up|12|||
48513829|NCT01705574|156074881|FG001|Double-Blind Phase|Lost to Follow-up|16|||
48513830|NCT01705574|156074882|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48513831|NCT01705574|156074883|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48513832|NCT01705574|156074880|FG000|Double-Blind Phase|Adverse Event|3|||
48513833|NCT01705574|156074881|FG001|Double-Blind Phase|Adverse Event|10|||
48513834|NCT01705574|156074882|FG002|Double-Blind Phase|Adverse Event|0|||
48513835|NCT01705574|156074883|FG003|Double-Blind Phase|Adverse Event|0|||
48513836|NCT01705574|156074880|FG000|Double-Blind Phase|Withdrew Consent|8|||
48513837|NCT01705574|156074881|FG001|Double-Blind Phase|Withdrew Consent|5|||
48513838|NCT01705574|156074882|FG002|Double-Blind Phase|Withdrew Consent|0|||
48513839|NCT01705574|156074883|FG003|Double-Blind Phase|Withdrew Consent|0|||
48513840|NCT01705574|156074880|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
48513841|NCT01705574|156074881|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
48513842|NCT01705574|156074882|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
48513843|NCT01705574|156074883|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
48513844|NCT01705574|156074880|FG000|Double-Blind Phase|Pregnancy|1|||
48513845|NCT01705574|156074881|FG001|Double-Blind Phase|Pregnancy|1|||
48729889|NCT05868382|156861374|FG005|Overall Study|Withdrawal by Subject|0|||
48729890|NCT02445391|156861377|FG000|Overall Study|No active protocol treatment|3|||
48382755|NCT00705432|155596773|FG004|Treatment Period|Treatment failure|13|||
48382756|NCT00705432|155596774|FG005|Treatment Period|Treatment failure|14|||
48729891|NCT02445391|156861378|FG001|Overall Study|No active protocol treatment|0|||
48729892|NCT02445391|156861379|FG002|Overall Study|No active protocol treatment|0|||
48729893|NCT02445391|156861377|FG000|Overall Study|Adverse Event|0|||
48729894|NCT02445391|156861378|FG001|Overall Study|Adverse Event|21|||
48729895|NCT02445391|156861379|FG002|Overall Study|Adverse Event|12|||
48729896|NCT02445391|156861377|FG000|Overall Study|Alternative therapy|0|||
48729897|NCT02445391|156861378|FG001|Overall Study|Alternative therapy|0|||
48729898|NCT02445391|156861379|FG002|Overall Study|Alternative therapy|1|||
48729899|NCT02445391|156861377|FG000|Overall Study|Disease progression|0|||
48729900|NCT02445391|156861378|FG001|Overall Study|Disease progression|7|||
48729901|NCT02445391|156861379|FG002|Overall Study|Disease progression|22|||
48729902|NCT02445391|156861377|FG000|Overall Study|Complicating disease|0|||
48729903|NCT02445391|156861378|FG001|Overall Study|Complicating disease|2|||
48729904|NCT02445391|156861379|FG002|Overall Study|Complicating disease|1|||
48729905|NCT02445391|156861377|FG000|Overall Study|Withdrawal by Subject|0|||
48729906|NCT02445391|156861378|FG001|Overall Study|Withdrawal by Subject|4|||
48729907|NCT02445391|156861379|FG002|Overall Study|Withdrawal by Subject|9|||
48729908|NCT02445391|156861377|FG000|Overall Study|Financial issue|0|||
48729909|NCT02445391|156861378|FG001|Overall Study|Financial issue|0|||
48729910|NCT02445391|156861379|FG002|Overall Study|Financial issue|2|||
48729911|NCT02445391|156861377|FG000|Overall Study|Still on treatment|0|||
48729912|NCT02445391|156861378|FG001|Overall Study|Still on treatment|7|||
48729913|NCT02445391|156861379|FG002|Overall Study|Still on treatment|16|||
48729914|NCT02445391|156861377|FG000|Overall Study|Not start protocol therapy|0|||
48729915|NCT02445391|156861378|FG001|Overall Study|Not start protocol therapy|12|||
48729916|NCT02445391|156861379|FG002|Overall Study|Not start protocol therapy|9|||
48729917|NCT01155219|156862914|FG000|Overall Study|Adverse Event|3|||
48729918|NCT01155219|156862915|FG001|Overall Study|Adverse Event|1|||
48513846|NCT01705574|156074882|FG002|Double-Blind Phase|Pregnancy|0|||
48513847|NCT01705574|156074883|FG003|Double-Blind Phase|Pregnancy|0|||
48513848|NCT01705574|156074880|FG000|Double-Blind Phase|Protocol Violation|1|||
48729919|NCT01155219|156862914|FG000|Overall Study|non-medical reason|1|||
48729920|NCT01155219|156862915|FG001|Overall Study|non-medical reason|2|||
48729921|NCT01865084|156862916|FG000|Double Blind Period (DB)|Adverse Event|2|||
48729922|NCT01865084|156862917|FG001|Double Blind Period (DB)|Adverse Event|2|||
48729923|NCT01865084|156862918|FG002|Double Blind Period (DB)|Adverse Event|1|||
48513849|NCT01705574|156074881|FG001|Double-Blind Phase|Protocol Violation|0|||
48513850|NCT01705574|156074882|FG002|Double-Blind Phase|Protocol Violation|0|||
48513851|NCT01705574|156074883|FG003|Double-Blind Phase|Protocol Violation|0|||
48513852|NCT01705574|156074880|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
48729924|NCT01865084|156862916|FG000|Double Blind Period (DB)|Protocol Violation|0|||
48729925|NCT01865084|156862917|FG001|Double Blind Period (DB)|Protocol Violation|0|||
48729926|NCT01865084|156862918|FG002|Double Blind Period (DB)|Protocol Violation|1|||
48729927|NCT01865084|156862916|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
48513853|NCT01705574|156074881|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
48513854|NCT01705574|156074882|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
48513855|NCT01705574|156074883|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
48513856|NCT01705574|156074880|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
48729928|NCT01865084|156862917|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
48729929|NCT01865084|156862918|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
48729930|NCT01865084|156862916|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
48729931|NCT01865084|156862917|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
48729932|NCT01865084|156862918|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
48729933|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
48729934|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
48729935|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
48729936|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
48729937|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
48729938|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
48729939|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
48729940|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
48729941|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
48729942|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
48729943|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
48729944|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
48729945|NCT01865084|156862916|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
48729946|NCT01865084|156862917|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
48729947|NCT01865084|156862918|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
48729948|NCT00096954|156862919|FG000|Overall Study|Adverse Event|3|||
48729949|NCT00096954|156862920|FG001|Overall Study|Adverse Event|1|||
48729950|NCT00096954|156862919|FG000|Overall Study|Withdrawal by Subject|9|||
48729951|NCT00096954|156862920|FG001|Overall Study|Withdrawal by Subject|8|||
48729952|NCT00096954|156862919|FG000|Overall Study|Physician Decision|1|||
48729953|NCT00096954|156862920|FG001|Overall Study|Physician Decision|1|||
48729954|NCT00096954|156862919|FG000|Overall Study|Sponsors Decision|1|||
48729955|NCT00096954|156862920|FG001|Overall Study|Sponsors Decision|1|||
48729956|NCT00096954|156862919|FG000|Overall Study|Pregnancy|1|||
48729957|NCT00096954|156862920|FG001|Overall Study|Pregnancy|1|||
48729958|NCT00096954|156862919|FG000|Overall Study|Initiation of immunotherapy|1|||
48729959|NCT00096954|156862920|FG001|Overall Study|Initiation of immunotherapy|0|||
48729960|NCT00096954|156862919|FG000|Overall Study|Non-compliance|0|||
48729961|NCT00096954|156862920|FG001|Overall Study|Non-compliance|3|||
48729962|NCT00096954|156862919|FG000|Overall Study|Lost to Follow-up|8|||
48729963|NCT00096954|156862920|FG001|Overall Study|Lost to Follow-up|5|||
48729964|NCT04478123|156862921|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
48729965|NCT04478123|156862921|FG000|Overall Study|NE|1|||
48729966|NCT03034200|156862922|FG000|Overall Study|Disease progression|8|||
48729967|NCT03034200|156862923|FG001|Overall Study|Disease progression|10|||
48729968|NCT03034200|156862924|FG002|Overall Study|Disease progression|4|||
48729969|NCT03034200|156862922|FG000|Overall Study|Physician Decision|2|||
48729970|NCT03034200|156862923|FG001|Overall Study|Physician Decision|0|||
48729971|NCT03034200|156862924|FG002|Overall Study|Physician Decision|3|||
48729972|NCT03034200|156862922|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
48729973|NCT03034200|156862923|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
48729974|NCT03034200|156862924|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
48729975|NCT03034200|156862922|FG000|Overall Study|Adjuvant Therapy|0|||
48729976|NCT03034200|156862923|FG001|Overall Study|Adjuvant Therapy|0|||
48729977|NCT03034200|156862924|FG002|Overall Study|Adjuvant Therapy|1|||
48729978|NCT00642473|156862925|FG000|Overall Study|Withdrawal by Subject|0|||
48729979|NCT00642473|156862926|FG001|Overall Study|Withdrawal by Subject|5|||
48729980|NCT00642473|156862925|FG000|Overall Study|Progression or death|2|||
48729981|NCT00642473|156862926|FG001|Overall Study|Progression or death|4|||
48729982|NCT00642473|156862925|FG000|Overall Study|Other|2|||
48729983|NCT00642473|156862926|FG001|Overall Study|Other|2|||
48729984|NCT03213457|156862929|FG000|Screening Period|Withdrawal by Subject|0|||
48729985|NCT03213457|156862930|FG001|Screening Period|Withdrawal by Subject|1|||
48729986|NCT03213457|156862931|FG002|Screening Period|Withdrawal by Subject|0|||
48729987|NCT03213457|156862929|FG000|Screening Period|Other|1|||
48513857|NCT01705574|156074881|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
48513858|NCT01705574|156074882|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
48513859|NCT01705574|156074883|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
48513860|NCT01705574|156074880|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
48513861|NCT01705574|156074881|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
48513862|NCT01705574|156074882|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
48513863|NCT01705574|156074883|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
48513864|NCT01705574|156074880|FG000|Open-Label Extension Phase|Adverse Event|3|||
48513865|NCT01705574|156074881|FG001|Open-Label Extension Phase|Adverse Event|0|||
48513866|NCT01705574|156074882|FG002|Open-Label Extension Phase|Adverse Event|0|||
48513867|NCT01705574|156074883|FG003|Open-Label Extension Phase|Adverse Event|1|||
48513868|NCT01705574|156074880|FG000|Open-Label Extension Phase|Death|2|||
48513869|NCT01705574|156074881|FG001|Open-Label Extension Phase|Death|0|||
48513870|NCT01705574|156074882|FG002|Open-Label Extension Phase|Death|1|||
48513871|NCT01705574|156074883|FG003|Open-Label Extension Phase|Death|0|||
48513872|NCT01705574|156074880|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
48513873|NCT01705574|156074881|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
48513874|NCT01705574|156074882|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
48513875|NCT01705574|156074883|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
48513876|NCT01705574|156074880|FG000|Open-Label Extension Phase|Physician Decision|0|||
48513877|NCT01705574|156074881|FG001|Open-Label Extension Phase|Physician Decision|0|||
48513878|NCT01705574|156074882|FG002|Open-Label Extension Phase|Physician Decision|2|||
48513879|NCT01705574|156074883|FG003|Open-Label Extension Phase|Physician Decision|0|||
48513880|NCT01705574|156074880|FG000|Open-Label Extension Phase|Pregnancy|0|||
48513881|NCT01705574|156074881|FG001|Open-Label Extension Phase|Pregnancy|0|||
48513882|NCT01705574|156074882|FG002|Open-Label Extension Phase|Pregnancy|1|||
48513883|NCT01705574|156074883|FG003|Open-Label Extension Phase|Pregnancy|1|||
48513884|NCT01564394|156074888|FG000|Overall Study|Withdrawal by Subject|6|||
48513885|NCT01564394|156074889|FG001|Overall Study|Withdrawal by Subject|10|||
48513886|NCT04639219|156074890|FG000|Overall Study|Withdrawal by Subject|8|||
48513887|NCT04639219|156074890|FG000|Overall Study|Lost to Follow-up|6|||
48513888|NCT04639219|156074890|FG000|Overall Study|Death|55|||
48513889|NCT00777023|156074891|FG000|Overall Study|Adverse Event|15|||
48513890|NCT00777023|156074892|FG001|Overall Study|Adverse Event|21|||
48513891|NCT00777023|156074893|FG002|Overall Study|Adverse Event|8|||
48513892|NCT00777023|156074891|FG000|Overall Study|Lack of Efficacy|1|||
48513893|NCT00777023|156074892|FG001|Overall Study|Lack of Efficacy|0|||
48513894|NCT00777023|156074893|FG002|Overall Study|Lack of Efficacy|14|||
48513895|NCT00777023|156074891|FG000|Overall Study|Protocol Violation|2|||
48513896|NCT00777023|156074892|FG001|Overall Study|Protocol Violation|1|||
48513897|NCT00777023|156074893|FG002|Overall Study|Protocol Violation|1|||
48513898|NCT00777023|156074891|FG000|Overall Study|Lost to Follow-up|2|||
48513899|NCT00777023|156074892|FG001|Overall Study|Lost to Follow-up|3|||
48513900|NCT00777023|156074893|FG002|Overall Study|Lost to Follow-up|3|||
48513901|NCT00777023|156074891|FG000|Overall Study|Death|0|||
48513902|NCT00777023|156074892|FG001|Overall Study|Death|1|||
48513903|NCT00777023|156074893|FG002|Overall Study|Death|0|||
48513904|NCT00777023|156074891|FG000|Overall Study|Withdrawal by Subject|7|||
48513905|NCT00777023|156074892|FG001|Overall Study|Withdrawal by Subject|7|||
48513906|NCT00777023|156074893|FG002|Overall Study|Withdrawal by Subject|8|||
48513907|NCT00777023|156074891|FG000|Overall Study|Missing data|1|||
48513908|NCT00777023|156074892|FG001|Overall Study|Missing data|1|||
48513909|NCT00777023|156074893|FG002|Overall Study|Missing data|0|||
48513910|NCT00777023|156074891|FG000|Overall Study|Reasons not specified|4|||
48513911|NCT00777023|156074892|FG001|Overall Study|Reasons not specified|4|||
48513912|NCT00777023|156074893|FG002|Overall Study|Reasons not specified|2|||
48513913|NCT00777023|156074891|FG000|Overall Study|Last dose date unknown|3|||
48513914|NCT00777023|156074892|FG001|Overall Study|Last dose date unknown|3|||
48513915|NCT00777023|156074893|FG002|Overall Study|Last dose date unknown|1|||
48513916|NCT04466111|156074896|FG000|Prior to Trial Phase|Physician Decision|1|||
48513917|NCT00849797|156074897|FG000|First Intervention|bad veins|1|||
48513918|NCT00849797|156074898|FG001|First Intervention|bad veins|0|||
48513919|NCT00849797|156074897|FG000|First Intervention|Adverse Event|0|||
48513920|NCT00849797|156074898|FG001|First Intervention|Adverse Event|1|||
48729988|NCT03213457|156862930|FG001|Screening Period|Other|0|||
48729989|NCT03213457|156862931|FG002|Screening Period|Other|0|||
48729990|NCT03213457|156862929|FG000|Double-Blind Period|Adverse Event|3|||
48513921|NCT00849797|156074897|FG000|Washout: One Week|Withdrawal by Subject|0|||
48513922|NCT00849797|156074898|FG001|Washout: One Week|Withdrawal by Subject|2|||
48513923|NCT01471353|156074901|FG000|Overall Study|remain on study|3|||
48513924|NCT00918645|156074902|FG000|Overall Study|Withdrawal by Subject|1|||
48513925|NCT00835666|156074903|FG000|Washout|Protocol Violation|1|||
48513926|NCT00835666|156074904|FG001|Washout|Protocol Violation|0|||
48513927|NCT00835666|156074903|FG000|Washout|Withdrawal by Subject|1|||
48513928|NCT00835666|156074904|FG001|Washout|Withdrawal by Subject|0|||
48513929|NCT03599362|156074905|FG000|Overall Study|Screen Failure|3|||
48513930|NCT03446768|156074906|FG000|Overall Study|Withdrawal by Subject|0|||
48729991|NCT03213457|156862930|FG001|Double-Blind Period|Adverse Event|2|||
48513931|NCT03446768|156074907|FG001|Overall Study|Withdrawal by Subject|1|||
48513932|NCT00107991|156074908|FG000|Eligibility Assessment|Disease not severe enough|7|||
48513933|NCT00107991|156074908|FG000|Eligibility Assessment|Unwilling to participate|7|||
48513934|NCT00107991|156074908|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
48513935|NCT00107991|156074908|FG000|Eligibility Assessment|Abnormal labs|2|||
48513936|NCT00107991|156074908|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
48513937|NCT00107991|156074908|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
48513938|NCT00107991|156074908|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
48513939|NCT00107991|156074908|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
48513940|NCT00107991|156074908|FG000|12 Week Treatment Period|Adverse Event|1|||
48513941|NCT00107991|156074908|FG000|12 Week Treatment Period|Protocol Violation|1|||
48513942|NCT00107991|156074908|FG000|12 Week Treatment Period|Incarcerated|1|||
48513943|NCT00107991|156074908|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
48513944|NCT00935012|156074914|FG000|Overall Study|Death|19|||
48513945|NCT00935012|156074914|FG000|Overall Study|Withdrawal by Subject|3|||
48513946|NCT00935012|156074914|FG000|Overall Study|Other|5|||
48513947|NCT00935012|156074914|FG000|Overall Study|Adverse Event|2|||
48513948|NCT03827395|156074915|FG000|Overall Study|Lost to Follow-up|1|||
48513949|NCT03827395|156074916|FG001|Overall Study|Lost to Follow-up|0|||
48513950|NCT03827395|156074915|FG000|Overall Study|Protocol Violation|1|||
48513951|NCT03827395|156074916|FG001|Overall Study|Protocol Violation|0|||
48513952|NCT03827395|156074915|FG000|Overall Study|Became ineligible after enrollment|1|||
48513953|NCT03827395|156074916|FG001|Overall Study|Became ineligible after enrollment|2|||
48513954|NCT01537887|156074917|FG000|Period 1|Physician Decision|0|||
48513955|NCT01537887|156074918|FG001|Period 1|Physician Decision|0|||
48513956|NCT01537887|156074919|FG002|Period 1|Physician Decision|0|||
48513957|NCT01537887|156074920|FG003|Period 1|Physician Decision|0|||
48513958|NCT01537887|156074921|FG004|Period 1|Physician Decision|1|||
48513959|NCT01537887|156074922|FG005|Period 1|Physician Decision|1|||
48513960|NCT01537887|156074917|FG000|Period 1|Did not receive treatment|0|||
48513961|NCT01537887|156074918|FG001|Period 1|Did not receive treatment|0|||
48513962|NCT01537887|156074919|FG002|Period 1|Did not receive treatment|1|||
48513963|NCT01537887|156074920|FG003|Period 1|Did not receive treatment|0|||
48513964|NCT01537887|156074921|FG004|Period 1|Did not receive treatment|0|||
48513965|NCT01537887|156074922|FG005|Period 1|Did not receive treatment|0|||
48513966|NCT01537887|156074917|FG000|Period 2|Withdrawal by Subject|0|||
48513967|NCT01537887|156074918|FG001|Period 2|Withdrawal by Subject|1|||
48513968|NCT01537887|156074919|FG002|Period 2|Withdrawal by Subject|0|||
48513969|NCT01537887|156074920|FG003|Period 2|Withdrawal by Subject|0|||
48513970|NCT01537887|156074921|FG004|Period 2|Withdrawal by Subject|0|||
48513971|NCT01537887|156074922|FG005|Period 2|Withdrawal by Subject|0|||
48513972|NCT01537887|156074917|FG000|Period 3|Adverse Event|0|||
48513973|NCT01537887|156074918|FG001|Period 3|Adverse Event|0|||
48513974|NCT01537887|156074919|FG002|Period 3|Adverse Event|1|||
48513975|NCT01537887|156074920|FG003|Period 3|Adverse Event|0|||
48513976|NCT01537887|156074921|FG004|Period 3|Adverse Event|0|||
48513977|NCT01537887|156074922|FG005|Period 3|Adverse Event|0|||
48513978|NCT01537887|156074917|FG000|Period 3|Withdrawal by Subject|0|||
48513979|NCT01537887|156074918|FG001|Period 3|Withdrawal by Subject|1|||
48513980|NCT01537887|156074919|FG002|Period 3|Withdrawal by Subject|0|||
48513981|NCT01537887|156074920|FG003|Period 3|Withdrawal by Subject|0|||
48513982|NCT01537887|156074921|FG004|Period 3|Withdrawal by Subject|0|||
48513983|NCT01537887|156074922|FG005|Period 3|Withdrawal by Subject|0|||
48513984|NCT04723693|156074923|FG000|Overall Study|Withdrawal by Subject|2|||
48513985|NCT03669861|156074924|FG000|Overall Study|Disease Flare|5|||
48513986|NCT03669861|156074924|FG000|Overall Study|Lack of Efficacy|2|||
48513987|NCT01370083|156074930|FG000|Overall Study|Lost to Follow-up|2|||
48513988|NCT01370083|156074931|FG001|Overall Study|Lost to Follow-up|0|||
48513989|NCT01370083|156074930|FG000|Overall Study|Adverse Event|0|||
48513990|NCT01370083|156074931|FG001|Overall Study|Adverse Event|1|||
48513991|NCT00294047|156074932|FG000|Month 48|Adverse Event|28|||
48513992|NCT00294047|156074933|FG001|Month 48|Adverse Event|13|||
48513993|NCT00294047|156074932|FG000|Month 48|Protocol Violation|4|||
48513994|NCT00294047|156074933|FG001|Month 48|Protocol Violation|4|||
48513995|NCT00294047|156074932|FG000|Month 48|Withdrawal by Subject|111|||
48513996|NCT00294047|156074933|FG001|Month 48|Withdrawal by Subject|115|||
48513997|NCT00294047|156074932|FG000|Month 48|Lost to Follow-up|272|||
48729992|NCT03213457|156862931|FG002|Double-Blind Period|Adverse Event|7|||
48729993|NCT03213457|156862929|FG000|Double-Blind Period|Withdrawal by Subject|14|||
48513998|NCT00294047|156074933|FG001|Month 48|Lost to Follow-up|287|||
48513999|NCT00294047|156074932|FG000|Month 48|Other|10|||
48514000|NCT00294047|156074933|FG001|Month 48|Other|14|||
48514001|NCT00294047|156074932|FG000|Month 84|Adverse Event|4|||
48514002|NCT00294047|156074933|FG001|Month 84|Adverse Event|2|||
48514003|NCT00294047|156074932|FG000|Month 84|Protocol Violation|1|||
48514004|NCT00294047|156074933|FG001|Month 84|Protocol Violation|1|||
48514005|NCT00294047|156074932|FG000|Month 84|Withdrawal by Subject|33|||
48514006|NCT00294047|156074933|FG001|Month 84|Withdrawal by Subject|31|||
48514007|NCT00294047|156074932|FG000|Month 84|Lost to Follow-up|187|||
48514008|NCT00294047|156074933|FG001|Month 84|Lost to Follow-up|190|||
48514009|NCT00294047|156074932|FG000|Month 84|Absent Cervix|2|||
48514010|NCT00294047|156074933|FG001|Month 84|Absent Cervix|0|||
48514011|NCT00294047|156074932|FG000|Month 84|Work related reasons|4|||
48514012|NCT00294047|156074933|FG001|Month 84|Work related reasons|2|||
48514013|NCT00294047|156074932|FG000|Month 84|Center closed, subject did not transfer|1|||
48514014|NCT00294047|156074933|FG001|Month 84|Center closed, subject did not transfer|0|||
48514015|NCT00294047|156074932|FG000|Month 84|Family problems|2|||
48514016|NCT00294047|156074933|FG001|Month 84|Family problems|2|||
48514017|NCT00294047|156074932|FG000|Month 84|Lack of time|3|||
48514018|NCT00294047|156074933|FG001|Month 84|Lack of time|1|||
48514019|NCT00294047|156074932|FG000|Month 84|Personal reason|2|||
48514020|NCT00294047|156074933|FG001|Month 84|Personal reason|4|||
48514021|NCT00294047|156074932|FG000|Month 84|Subject does not want male physician|1|||
48514022|NCT00294047|156074933|FG001|Month 84|Subject does not want male physician|0|||
48514023|NCT00294047|156074932|FG000|Month 84|Transport reimbursement delayed|0|||
48514024|NCT00294047|156074933|FG001|Month 84|Transport reimbursement delayed|1|||
48514025|NCT00294047|156074932|FG000|Month 84|Unable to reach study site|1|||
48382757|NCT00705432|155596769|FG000|Treatment Period|Non medical reason|26|||
48382758|NCT00705432|155596770|FG001|Treatment Period|Non medical reason|32|||
48382759|NCT00705432|155596771|FG002|Treatment Period|Non medical reason|37|||
48382760|NCT00705432|155596772|FG003|Treatment Period|Non medical reason|4|||
48382761|NCT00705432|155596773|FG004|Treatment Period|Non medical reason|7|||
48382762|NCT00705432|155596774|FG005|Treatment Period|Non medical reason|7|||
48514026|NCT00294047|156074933|FG001|Month 84|Unable to reach study site|0|||
48514027|NCT00294047|156074932|FG000|Month 84|Under investigation locally|1|||
48514028|NCT00294047|156074933|FG001|Month 84|Under investigation locally|0|||
48514029|NCT00294047|156074932|FG000|Month 84|Visit missed|0|||
48382763|NCT00705432|155596769|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
48382764|NCT00705432|155596770|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
48382765|NCT00705432|155596771|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
48382766|NCT00705432|155596772|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
48382767|NCT00705432|155596773|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
48382768|NCT00705432|155596774|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
48382769|NCT00705432|155596769|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
48729994|NCT03213457|156862930|FG001|Double-Blind Period|Withdrawal by Subject|2|||
48729995|NCT03213457|156862931|FG002|Double-Blind Period|Withdrawal by Subject|14|||
48729996|NCT03213457|156862929|FG000|Double-Blind Period|Lost to Follow-up|2|||
48514030|NCT00294047|156074933|FG001|Month 84|Visit missed|1|||
48514031|NCT00294047|156074932|FG000|Month 84|No consent for Month 84 Follow-up|731|||
48514032|NCT00294047|156074933|FG001|Month 84|No consent for Month 84 Follow-up|754|||
48514033|NCT02157974|156074934|FG000|Overall Study|Withdrawal by Subject|0|||
48514034|NCT02157974|156074935|FG001|Overall Study|Withdrawal by Subject|1|||
48514035|NCT02157974|156074936|FG002|Overall Study|Withdrawal by Subject|0|||
48514036|NCT02157974|156074937|FG003|Overall Study|Withdrawal by Subject|0|||
48514037|NCT02157974|156074938|FG004|Overall Study|Withdrawal by Subject|0|||
48514038|NCT02157974|156074934|FG000|Overall Study|Screen Failure|0|||
48514039|NCT02157974|156074935|FG001|Overall Study|Screen Failure|1|||
48514040|NCT02157974|156074936|FG002|Overall Study|Screen Failure|0|||
48514041|NCT02157974|156074937|FG003|Overall Study|Screen Failure|0|||
48514042|NCT02157974|156074938|FG004|Overall Study|Screen Failure|0|||
48514043|NCT02157974|156074934|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
48514044|NCT02157974|156074935|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
48514045|NCT02157974|156074936|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
48514046|NCT02157974|156074937|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
48514047|NCT02157974|156074938|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
48514048|NCT01590563|156074941|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
48514049|NCT01604941|156074944|FG000|Overall Study|Adverse Event|1|||
48514050|NCT01604941|156074945|FG001|Overall Study|Adverse Event|2|||
48514051|NCT01604941|156074946|FG002|Overall Study|Adverse Event|0|||
48514052|NCT01604941|156074947|FG003|Overall Study|Adverse Event|0|||
48382770|NCT00705432|155596770|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
48382771|NCT00705432|155596771|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
48382772|NCT00705432|155596772|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
48729997|NCT03213457|156862930|FG001|Double-Blind Period|Lost to Follow-up|3|||
48729998|NCT03213457|156862931|FG002|Double-Blind Period|Lost to Follow-up|9|||
48382773|NCT00705432|155596773|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
48514053|NCT01604941|156074948|FG004|Overall Study|Adverse Event|1|||
48514054|NCT01604941|156074949|FG005|Overall Study|Adverse Event|5|||
48729999|NCT03213457|156862929|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
48730000|NCT03213457|156862930|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
48514055|NCT01604941|156074944|FG000|Overall Study|Non-compliance|1|||
48514056|NCT01604941|156074945|FG001|Overall Study|Non-compliance|0|||
48514057|NCT01604941|156074946|FG002|Overall Study|Non-compliance|0|||
48382774|NCT00705432|155596774|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
48382775|NCT01667107|155596776|FG000|Overall Study|Adverse Event|4|||
48382776|NCT01667107|155596777|FG001|Overall Study|Adverse Event|3|||
48382777|NCT01667107|155596776|FG000|Overall Study|Tolerability issues|0|||
48382778|NCT01667107|155596777|FG001|Overall Study|Tolerability issues|2|||
48730001|NCT03213457|156862931|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
48730002|NCT03213457|156862929|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
48730003|NCT03213457|156862930|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
48730004|NCT03213457|156862931|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
48730005|NCT03213457|156862929|FG000|Double-Blind Period|Pregnancy|5|||
48730006|NCT03213457|156862930|FG001|Double-Blind Period|Pregnancy|0|||
48730007|NCT03213457|156862931|FG002|Double-Blind Period|Pregnancy|0|||
48730008|NCT03213457|156862929|FG000|Double-Blind Period|Other|10|||
48730009|NCT03213457|156862930|FG001|Double-Blind Period|Other|3|||
48730010|NCT03213457|156862931|FG002|Double-Blind Period|Other|17|||
48730011|NCT03213457|156862929|FG000|Open-Label Period|Adverse Event|1|||
48730012|NCT03213457|156862930|FG001|Open-Label Period|Adverse Event|2|||
48730013|NCT03213457|156862931|FG002|Open-Label Period|Adverse Event|2|||
48822458|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
48822459|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
48822460|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
48822461|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
48822462|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
48822463|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
48822464|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
48822465|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
48822466|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
48822467|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822468|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822469|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822470|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
48382779|NCT01667107|155596776|FG000|Overall Study|Protocol Violation|0|||
48382780|NCT01667107|155596777|FG001|Overall Study|Protocol Violation|1|||
48382781|NCT01667107|155596776|FG000|Overall Study|Lack of Efficacy|0|||
48382782|NCT01667107|155596777|FG001|Overall Study|Lack of Efficacy|1|||
48382783|NCT01252810|155596778|FG000|Overall Study|Withdrawal by Subject|4|||
48382784|NCT01252810|155596779|FG001|Overall Study|Withdrawal by Subject|1|||
48382785|NCT01252810|155596778|FG000|Overall Study|Lost to Follow-up|0|||
48382786|NCT01252810|155596779|FG001|Overall Study|Lost to Follow-up|1|||
48382787|NCT01252810|155596778|FG000|Overall Study|Physician Decision|2|||
48382788|NCT01252810|155596779|FG001|Overall Study|Physician Decision|1|||
48382789|NCT01252810|155596778|FG000|Overall Study|Various reasons|8|||
48382790|NCT01252810|155596779|FG001|Overall Study|Various reasons|0|||
48440674|NCT00039741|155799814|FG003|Overall Study|Moved|6|||
48440675|NCT00039741|155799811|FG000|Overall Study|Non-compliance with protocol|1|||
48440676|NCT00039741|155799812|FG001|Overall Study|Non-compliance with protocol|0|||
48440677|NCT00039741|155799813|FG002|Overall Study|Non-compliance with protocol|1|||
48440678|NCT00039741|155799814|FG003|Overall Study|Non-compliance with protocol|0|||
48440679|NCT00039741|155799811|FG000|Overall Study|Withdrew consent|0|||
48440680|NCT00039741|155799812|FG001|Overall Study|Withdrew consent|5|||
48440681|NCT00039741|155799813|FG002|Overall Study|Withdrew consent|0|||
48440682|NCT00039741|155799814|FG003|Overall Study|Withdrew consent|1|||
48440683|NCT00039741|155799811|FG000|Overall Study|Missed final visit|2|||
48440684|NCT00039741|155799812|FG001|Overall Study|Missed final visit|1|||
48440685|NCT00039741|155799813|FG002|Overall Study|Missed final visit|2|||
48440686|NCT00039741|155799814|FG003|Overall Study|Missed final visit|2|||
48440687|NCT02293902|155799815|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
48440688|NCT02293902|155799816|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
48440689|NCT02293902|155799817|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
48440690|NCT02293902|155799818|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
48440691|NCT02293902|155799819|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
48440692|NCT02293902|155799815|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
48440693|NCT02293902|155799816|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
48440694|NCT02293902|155799817|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
48440695|NCT02293902|155799818|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
48440696|NCT02293902|155799819|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
48440697|NCT02293902|155799815|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
48440698|NCT02293902|155799816|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
48440699|NCT02293902|155799817|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
48440700|NCT02293902|155799818|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
48440701|NCT02293902|155799819|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
48440702|NCT02293902|155799815|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
48514058|NCT01604941|156074947|FG003|Overall Study|Non-compliance|0|||
48514059|NCT01604941|156074948|FG004|Overall Study|Non-compliance|0|||
48514060|NCT01604941|156074949|FG005|Overall Study|Non-compliance|0|||
48514061|NCT01604941|156074944|FG000|Overall Study|Participant Decision|0|||
48514062|NCT01604941|156074945|FG001|Overall Study|Participant Decision|0|||
48514063|NCT01604941|156074946|FG002|Overall Study|Participant Decision|0|||
48514064|NCT01604941|156074947|FG003|Overall Study|Participant Decision|0|||
48514065|NCT01604941|156074948|FG004|Overall Study|Participant Decision|0|||
48514066|NCT01604941|156074949|FG005|Overall Study|Participant Decision|2|||
48514067|NCT01604941|156074944|FG000|Overall Study|Early Study Termination|9|||
48730014|NCT03213457|156862929|FG000|Open-Label Period|Withdrawal by Subject|12|||
48730015|NCT03213457|156862930|FG001|Open-Label Period|Withdrawal by Subject|5|||
48730016|NCT03213457|156862931|FG002|Open-Label Period|Withdrawal by Subject|24|||
48730017|NCT03213457|156862929|FG000|Open-Label Period|Lost to Follow-up|1|||
48730018|NCT03213457|156862930|FG001|Open-Label Period|Lost to Follow-up|2|||
48730019|NCT03213457|156862931|FG002|Open-Label Period|Lost to Follow-up|8|||
48730020|NCT03213457|156862929|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
48730021|NCT03213457|156862930|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
48730022|NCT03213457|156862931|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
48730023|NCT03213457|156862929|FG000|Open-Label Period|Non-compliance with study procedures|1|||
48730024|NCT03213457|156862930|FG001|Open-Label Period|Non-compliance with study procedures|1|||
48730025|NCT03213457|156862931|FG002|Open-Label Period|Non-compliance with study procedures|2|||
48730026|NCT03213457|156862929|FG000|Open-Label Period|Exclusionary medications|0|||
48730027|NCT03213457|156862930|FG001|Open-Label Period|Exclusionary medications|0|||
48730028|NCT03213457|156862931|FG002|Open-Label Period|Exclusionary medications|1|||
48730029|NCT03213457|156862929|FG000|Open-Label Period|Other|1|||
48730030|NCT03213457|156862930|FG001|Open-Label Period|Other|1|||
48730031|NCT03213457|156862931|FG002|Open-Label Period|Other|6|||
48730032|NCT03213457|156862929|FG000|Follow-Up Period|Adverse Event|16|||
48730033|NCT03213457|156862930|FG001|Follow-Up Period|Adverse Event|8|||
48730034|NCT03213457|156862931|FG002|Follow-Up Period|Adverse Event|37|||
48730035|NCT03213457|156862929|FG000|Follow-Up Period|Withdrawal by Subject|18|||
48730036|NCT03213457|156862930|FG001|Follow-Up Period|Withdrawal by Subject|11|||
48730037|NCT03213457|156862931|FG002|Follow-Up Period|Withdrawal by Subject|55|||
48730038|NCT03213457|156862929|FG000|Follow-Up Period|Lost to Follow-up|28|||
48730039|NCT03213457|156862930|FG001|Follow-Up Period|Lost to Follow-up|15|||
48730040|NCT03213457|156862931|FG002|Follow-Up Period|Lost to Follow-up|50|||
48730041|NCT03213457|156862929|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
48730042|NCT03213457|156862930|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
48730043|NCT03213457|156862931|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
48730044|NCT03213457|156862929|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
48730045|NCT03213457|156862930|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
48730046|NCT03213457|156862931|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
48514068|NCT01604941|156074945|FG001|Overall Study|Early Study Termination|2|||
48514069|NCT01604941|156074946|FG002|Overall Study|Early Study Termination|3|||
48514070|NCT01604941|156074947|FG003|Overall Study|Early Study Termination|3|||
48514071|NCT01604941|156074948|FG004|Overall Study|Early Study Termination|0|||
48514072|NCT01604941|156074949|FG005|Overall Study|Early Study Termination|0|||
48514073|NCT03256695|156074950|FG000|Overall Study|Adverse Event|8|||
48514074|NCT03256695|156074950|FG000|Overall Study|Death|2|||
48514075|NCT03256695|156074950|FG000|Overall Study|Withdrawal by Subject|14|||
48514076|NCT03256695|156074950|FG000|Overall Study|Non-compliance with study drug|1|||
48514077|NCT03256695|156074950|FG000|Overall Study|Lost to Follow-up|3|||
48514078|NCT03256695|156074950|FG000|Overall Study|Lack of Efficacy|3|||
48514079|NCT03256695|156074950|FG000|Overall Study|Protocol Violation|5|||
48514080|NCT03256695|156074950|FG000|Overall Study|Other than specified|3|||
48514081|NCT03322267|156074951|FG000|Overall Study|Lack of Efficacy|11|||
48514082|NCT03322267|156074951|FG000|Overall Study|Adverse Event|1|||
48514083|NCT03322267|156074951|FG000|Overall Study|Withdrawal by Subject|2|||
48514084|NCT00909753|156074954|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
48514085|NCT00909753|156074955|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
48514086|NCT00909753|156074954|FG000|Period: Second Intervention|Protocol Violation|1|||
48514087|NCT00909753|156074955|FG001|Period: Second Intervention|Protocol Violation|0|||
48514088|NCT00472212|156074956|FG000|Overall Study|Lost to Follow-up|6|||
48514089|NCT00472212|156074957|FG001|Overall Study|Lost to Follow-up|4|||
48514090|NCT03480763|156074958|FG000|Overall Study|Withdrawal by Subject|18|||
48730047|NCT03213457|156862929|FG000|Follow-Up Period|Pregnancy|7|||
48730048|NCT03213457|156862930|FG001|Follow-Up Period|Pregnancy|0|||
48730049|NCT03213457|156862931|FG002|Follow-Up Period|Pregnancy|18|||
48730050|NCT03213457|156862929|FG000|Follow-Up Period|Exclusionary medications|1|||
48730051|NCT03213457|156862930|FG001|Follow-Up Period|Exclusionary medications|1|||
48514091|NCT03480763|156074959|FG001|Overall Study|Withdrawal by Subject|10|||
48730052|NCT03213457|156862931|FG002|Follow-Up Period|Exclusionary medications|5|||
48514092|NCT03480763|156074958|FG000|Overall Study|Lost to Follow-up|4|||
48514093|NCT03480763|156074959|FG001|Overall Study|Lost to Follow-up|7|||
48514094|NCT03480763|156074958|FG000|Overall Study|non-study pneumococcal vaccine|1|||
48514095|NCT03480763|156074959|FG001|Overall Study|non-study pneumococcal vaccine|0|||
48514096|NCT03480763|156074958|FG000|Overall Study|oncological treatment|0|||
48514097|NCT03480763|156074959|FG001|Overall Study|oncological treatment|2|||
48514098|NCT03480763|156074958|FG000|Overall Study|pain with vaccination|1|||
48514099|NCT03480763|156074959|FG001|Overall Study|pain with vaccination|0|||
48514100|NCT00418938|156074964|FG000|Overall Study|Reimbursement|1|||
48514101|NCT00418938|156074965|FG001|Overall Study|Reimbursement|0|||
48514102|NCT00418938|156074964|FG000|Overall Study|Administrative decision|3|||
48514103|NCT00418938|156074965|FG001|Overall Study|Administrative decision|3|||
48514104|NCT00418938|156074964|FG000|Overall Study|Withdrawal by Subject|16|||
48514105|NCT00418938|156074965|FG001|Overall Study|Withdrawal by Subject|15|||
48514106|NCT00418938|156074964|FG000|Overall Study|Lost to Follow-up|1|||
48514107|NCT00418938|156074965|FG001|Overall Study|Lost to Follow-up|3|||
48514108|NCT00418938|156074964|FG000|Overall Study|Adverse Event|1|||
48514109|NCT00418938|156074965|FG001|Overall Study|Adverse Event|1|||
48514110|NCT00418938|156074964|FG000|Overall Study|On-going|1|||
48514111|NCT00418938|156074965|FG001|Overall Study|On-going|1|||
48514112|NCT00418938|156074964|FG000|Overall Study|Ineligibility Determined|1|||
48514113|NCT00418938|156074965|FG001|Overall Study|Ineligibility Determined|0|||
48514114|NCT00115063|156074966|FG000|Overall Study|Lost to Follow-up|98|||
48514115|NCT00115063|156074967|FG001|Overall Study|Lost to Follow-up|104|||
48730053|NCT03213457|156862929|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
48730054|NCT03213457|156862930|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
48730055|NCT03213457|156862931|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
48730056|NCT03213457|156862929|FG000|Follow-Up Period|Other|14|||
48730057|NCT03213457|156862930|FG001|Follow-Up Period|Other|10|||
48730058|NCT03213457|156862931|FG002|Follow-Up Period|Other|31|||
48730059|NCT00054717|156862937|FG000|Overall Study|Randomized but not treated|2|||
48730060|NCT00054717|156862938|FG001|Overall Study|Randomized but not treated|8|||
48730061|NCT00054717|156862937|FG000|Overall Study|Adverse Event|70|||
48730062|NCT00054717|156862938|FG001|Overall Study|Adverse Event|22|||
48730063|NCT00054717|156862937|FG000|Overall Study|Protocol Violation|18|||
48730064|NCT00054717|156862938|FG001|Overall Study|Protocol Violation|19|||
48730065|NCT00054717|156862937|FG000|Overall Study|Lost to Follow-up|23|||
48730066|NCT00054717|156862938|FG001|Overall Study|Lost to Follow-up|13|||
48730067|NCT00054717|156862937|FG000|Overall Study|Withdrawal by Subject|32|||
48730068|NCT00054717|156862938|FG001|Overall Study|Withdrawal by Subject|20|||
48730069|NCT00054717|156862937|FG000|Overall Study|Other reason not defined above|117|||
48730070|NCT00054717|156862938|FG001|Overall Study|Other reason not defined above|217|||
48730071|NCT05007717|156862941|FG000|Overall Study|Death|3|||
48730072|NCT05007717|156862942|FG001|Overall Study|Death|2|||
48730073|NCT03553836|156862943|FG000|Overall Study|Ongoing in Study|460|||
48730074|NCT03553836|156862944|FG001|Overall Study|Ongoing in Study|459|||
48730075|NCT03553836|156862943|FG000|Overall Study|Withdrawal by Subject|9|||
48730076|NCT03553836|156862944|FG001|Overall Study|Withdrawal by Subject|10|||
48730077|NCT03553836|156862943|FG000|Overall Study|Lost to Follow-up|1|||
48730078|NCT03553836|156862944|FG001|Overall Study|Lost to Follow-up|3|||
48730079|NCT03553836|156862943|FG000|Overall Study|Death|17|||
48730080|NCT03553836|156862944|FG001|Overall Study|Death|17|||
48730081|NCT01041495|156862948|FG000|Overall Study|Withdrawal by Subject|2|||
48730082|NCT01041495|156862949|FG001|Overall Study|Withdrawal by Subject|5|||
48730083|NCT01041495|156862948|FG000|Overall Study|Adverse Event|2|||
48730084|NCT01041495|156862949|FG001|Overall Study|Adverse Event|1|||
48730085|NCT01041495|156862948|FG000|Overall Study|Lost to Follow-up|0|||
48730086|NCT01041495|156862949|FG001|Overall Study|Lost to Follow-up|1|||
48730087|NCT00846742|156862950|FG000|Overall Study|Withdrawal by Subject|1|||
48730088|NCT00427960|156862951|FG000|Overall Study|Adverse Event|2|||
48730089|NCT00427960|156862952|FG001|Overall Study|Adverse Event|0|||
48514116|NCT00115063|156074966|FG000|Overall Study|Death|1|||
48514117|NCT00115063|156074967|FG001|Overall Study|Death|0|||
48514118|NCT00881751|156074968|FG000|Overall Study|Physician Decision|0|||
48730090|NCT00427960|156862951|FG000|Overall Study|Withdrawal by Subject|0|||
48730091|NCT00427960|156862952|FG001|Overall Study|Withdrawal by Subject|3|||
48730092|NCT00427960|156862951|FG000|Overall Study|Other|0|||
48730093|NCT00427960|156862952|FG001|Overall Study|Other|1|||
48730094|NCT01325623|156862955|FG000|Overall Study|Withdrawal by Subject|3|||
48514119|NCT00881751|156074969|FG001|Overall Study|Physician Decision|1|||
48514120|NCT00881751|156074968|FG000|Overall Study|Adverse Event|0|||
48514121|NCT00881751|156074969|FG001|Overall Study|Adverse Event|2|||
48514122|NCT00881751|156074968|FG000|Overall Study|Withdrawal by Subject|0|||
48514123|NCT00881751|156074969|FG001|Overall Study|Withdrawal by Subject|2|||
48730095|NCT01539642|156862956|FG000|Overall Study|Lack of Efficacy|20|||
48730096|NCT01539642|156862957|FG001|Overall Study|Lack of Efficacy|18|||
48730097|NCT01539642|156862956|FG000|Overall Study|Patient ready for early discharge|8|||
48730098|NCT01539642|156862957|FG001|Overall Study|Patient ready for early discharge|7|||
48730099|NCT01539642|156862956|FG000|Overall Study|Adverse Event|6|||
48514124|NCT03273153|156074970|FG000|Overall Study|Adverse Event|1|||
48514125|NCT03273153|156074971|FG001|Overall Study|Adverse Event|2|||
48514126|NCT03273153|156074970|FG000|Overall Study|Missing|0|||
48514127|NCT03273153|156074971|FG001|Overall Study|Missing|2|||
48514128|NCT03273153|156074970|FG000|Overall Study|Other|3|||
48514129|NCT03273153|156074971|FG001|Overall Study|Other|2|||
48514130|NCT03273153|156074970|FG000|Overall Study|Symptomatic Deterioration|0|||
48514131|NCT03273153|156074971|FG001|Overall Study|Symptomatic Deterioration|1|||
48514132|NCT03273153|156074970|FG000|Overall Study|Progressive Disease|6|||
48514133|NCT03273153|156074971|FG001|Overall Study|Progressive Disease|5|||
48514134|NCT03273153|156074970|FG000|Overall Study|Physician Decision|1|||
48514135|NCT03273153|156074971|FG001|Overall Study|Physician Decision|3|||
48514136|NCT03273153|156074970|FG000|Overall Study|Study Terminated by Sponsor|112|||
48514137|NCT03273153|156074971|FG001|Overall Study|Study Terminated by Sponsor|102|||
48514138|NCT03273153|156074970|FG000|Overall Study|Withdrawal by Subject|26|||
48514139|NCT03273153|156074971|FG001|Overall Study|Withdrawal by Subject|25|||
48514140|NCT03273153|156074970|FG000|Overall Study|Protocol Deviation|3|||
48514141|NCT03273153|156074971|FG001|Overall Study|Protocol Deviation|0|||
48514142|NCT03273153|156074970|FG000|Overall Study|Lost to Follow-up|6|||
48514143|NCT03273153|156074971|FG001|Overall Study|Lost to Follow-up|11|||
48514144|NCT03273153|156074970|FG000|Overall Study|Death|66|||
48514145|NCT03273153|156074971|FG001|Overall Study|Death|69|||
48514146|NCT02436200|156074972|FG000|Overall Study|Significant outlier|1|||
48514147|NCT01559363|156074987|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
48514148|NCT01559363|156074988|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
48514149|NCT01559363|156074989|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
48514150|NCT01559363|156074990|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
48514151|NCT01559363|156074991|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
48514152|NCT01559363|156074992|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
48514153|NCT01559363|156074987|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
48514154|NCT01559363|156074988|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
48514155|NCT01559363|156074989|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
48514156|NCT01559363|156074990|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
48514157|NCT01559363|156074991|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
48514158|NCT01559363|156074992|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
48514159|NCT01559363|156074987|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
48514160|NCT01559363|156074988|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
48514161|NCT01559363|156074989|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
48822471|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822472|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
48514162|NCT01559363|156074990|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
48514163|NCT01559363|156074991|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
48514164|NCT01559363|156074992|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
48514165|NCT01559363|156074987|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
48514166|NCT01559363|156074988|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
48514167|NCT01559363|156074989|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
48514168|NCT01559363|156074990|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
48514169|NCT01559363|156074991|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
48514170|NCT01559363|156074992|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
48514171|NCT01559363|156074987|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
48514172|NCT01559363|156074988|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
48514173|NCT01559363|156074989|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
48514174|NCT01559363|156074990|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
48514175|NCT01559363|156074991|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
48514176|NCT01559363|156074992|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
48514177|NCT01559363|156074987|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
48514178|NCT01559363|156074988|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
48514179|NCT01559363|156074989|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
48514180|NCT01559363|156074990|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
48514181|NCT01559363|156074991|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
48514182|NCT01559363|156074992|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
48514183|NCT01559363|156074987|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
48514184|NCT01559363|156074988|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
48514185|NCT01559363|156074989|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
48514186|NCT01559363|156074990|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
48822473|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
48514187|NCT01559363|156074991|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
48514188|NCT01559363|156074992|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
48514189|NCT00268203|156074993|FG000|Overall Study|Lost to Follow-up|92|||
48514190|NCT00268203|156074993|FG000|Overall Study|Withdrawal by Subject|9|||
48514191|NCT00268203|156074993|FG000|Overall Study|Received Other NHL Therapy|7|||
48514192|NCT00268203|156074993|FG000|Overall Study|Progressive Disease|359|||
48514193|NCT00268203|156074993|FG000|Overall Study|Death|84|||
48514194|NCT00268203|156074993|FG000|Overall Study|Reason Not Specified|34|||
48514195|NCT00268203|156074993|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
48514196|NCT00243347|156074994|FG000|Overall Study|Lack of Efficacy|4|||
48514197|NCT00243347|156074994|FG000|Overall Study|Adverse Event|2|||
48514198|NCT00243347|156074994|FG000|Overall Study|Death|1|||
48514199|NCT00243347|156074994|FG000|Overall Study|Withdrawal by Subject|5|||
48514200|NCT00243347|156074994|FG000|Overall Study|Condition worsened|7|||
48514201|NCT01838681|156074995|FG000|Period A|Adverse Event|39|||
48514202|NCT01838681|156074996|FG001|Period A|Adverse Event|0|||
48514203|NCT01838681|156074997|FG002|Period A|Adverse Event|0|||
48514204|NCT01838681|156074998|FG003|Period A|Adverse Event|0|||
48514205|NCT01838681|156074995|FG000|Period A|Lack of Efficacy|21|||
48514206|NCT01838681|156074996|FG001|Period A|Lack of Efficacy|0|||
48514207|NCT01838681|156074997|FG002|Period A|Lack of Efficacy|0|||
48514208|NCT01838681|156074998|FG003|Period A|Lack of Efficacy|0|||
48514209|NCT01838681|156074995|FG000|Period A|Early response|148|||
48514210|NCT01838681|156074996|FG001|Period A|Early response|0|||
48514211|NCT01838681|156074997|FG002|Period A|Early response|0|||
48514212|NCT01838681|156074998|FG003|Period A|Early response|0|||
48514213|NCT01838681|156074995|FG000|Period A|Withdrawal by Subject|70|||
48514214|NCT01838681|156074996|FG001|Period A|Withdrawal by Subject|0|||
48514215|NCT01838681|156074997|FG002|Period A|Withdrawal by Subject|0|||
48514216|NCT01838681|156074998|FG003|Period A|Withdrawal by Subject|0|||
48514217|NCT01838681|156074995|FG000|Period A|Protocol Violation|16|||
48514218|NCT01838681|156074996|FG001|Period A|Protocol Violation|0|||
48514219|NCT01838681|156074997|FG002|Period A|Protocol Violation|0|||
48514220|NCT01838681|156074998|FG003|Period A|Protocol Violation|0|||
48514221|NCT01838681|156074995|FG000|Period A|Non-compliance with IMP|6|||
48514222|NCT01838681|156074996|FG001|Period A|Non-compliance with IMP|0|||
48514223|NCT01838681|156074997|FG002|Period A|Non-compliance with IMP|0|||
48514224|NCT01838681|156074998|FG003|Period A|Non-compliance with IMP|0|||
48514225|NCT01838681|156074995|FG000|Period A|Lost to Follow-up|4|||
48514226|NCT01838681|156074996|FG001|Period A|Lost to Follow-up|0|||
48514227|NCT01838681|156074997|FG002|Period A|Lost to Follow-up|0|||
48514228|NCT01838681|156074998|FG003|Period A|Lost to Follow-up|0|||
48514229|NCT01838681|156074995|FG000|Period A|Withdrawal before treatment|4|||
48730100|NCT01539642|156862957|FG001|Overall Study|Adverse Event|4|||
48730101|NCT01539642|156862956|FG000|Overall Study|Withdrawal by Subject|2|||
48730102|NCT01539642|156862957|FG001|Overall Study|Withdrawal by Subject|2|||
48730103|NCT00608543|156862958|FG000|Overall Study|Adverse Event|4|||
48730104|NCT04365257|156862959|FG000|Overall Study|Physician Decision|1|||
48730105|NCT04365257|156862960|FG001|Overall Study|Physician Decision|0|||
48730106|NCT04365257|156862959|FG000|Overall Study|Patient Noncompliance|1|||
48730107|NCT04365257|156862960|FG001|Overall Study|Patient Noncompliance|0|||
48730108|NCT04365257|156862959|FG000|Overall Study|Withdrawal by Subject|0|||
48730109|NCT04365257|156862960|FG001|Overall Study|Withdrawal by Subject|1|||
48730110|NCT00174291|156862961|FG000|Overall Study|Lost to Follow-up|1|||
48730111|NCT00174291|156862962|FG001|Overall Study|Lost to Follow-up|1|||
48730112|NCT00174291|156862961|FG000|Overall Study|Protocol Violation|0|||
48822474|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822475|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822476|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822477|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822478|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822479|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822480|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822481|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
48822482|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822483|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
48822484|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
48822485|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822486|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822487|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822488|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822489|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822490|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822491|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48730113|NCT00174291|156862962|FG001|Overall Study|Protocol Violation|2|||
48514230|NCT01838681|156074996|FG001|Period A|Withdrawal before treatment|0|||
48514231|NCT01838681|156074997|FG002|Period A|Withdrawal before treatment|0|||
48514232|NCT01838681|156074998|FG003|Period A|Withdrawal before treatment|0|||
48514233|NCT01838681|156074995|FG000|Period A|Administrative or other reasons|17|||
48514234|NCT01838681|156074996|FG001|Period A|Administrative or other reasons|0|||
48514235|NCT01838681|156074997|FG002|Period A|Administrative or other reasons|0|||
48514236|NCT01838681|156074998|FG003|Period A|Administrative or other reasons|0|||
48514237|NCT01838681|156074995|FG000|Period B/A+|Adverse Event|0|||
48514238|NCT01838681|156074996|FG001|Period B/A+|Adverse Event|13|||
48730114|NCT00174291|156862961|FG000|Overall Study|Study terminated by sponsor|1|||
48730115|NCT00174291|156862962|FG001|Overall Study|Study terminated by sponsor|0|||
48822492|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48514239|NCT01838681|156074997|FG002|Period B/A+|Adverse Event|27|||
48514240|NCT01838681|156074998|FG003|Period B/A+|Adverse Event|16|||
48514241|NCT01838681|156074995|FG000|Period B/A+|Lack of Efficacy|0|||
48514242|NCT01838681|156074996|FG001|Period B/A+|Lack of Efficacy|9|||
48514243|NCT01838681|156074997|FG002|Period B/A+|Lack of Efficacy|11|||
48514244|NCT01838681|156074998|FG003|Period B/A+|Lack of Efficacy|6|||
48514245|NCT01838681|156074995|FG000|Period B/A+|Withdrawal by Subject|0|||
48514246|NCT01838681|156074996|FG001|Period B/A+|Withdrawal by Subject|28|||
48514247|NCT01838681|156074997|FG002|Period B/A+|Withdrawal by Subject|35|||
48514248|NCT01838681|156074998|FG003|Period B/A+|Withdrawal by Subject|47|||
48514249|NCT01838681|156074995|FG000|Period B/A+|Protocol Violation|0|||
48514250|NCT01838681|156074996|FG001|Period B/A+|Protocol Violation|1|||
48514251|NCT01838681|156074997|FG002|Period B/A+|Protocol Violation|4|||
48514252|NCT01838681|156074998|FG003|Period B/A+|Protocol Violation|6|||
48514253|NCT01838681|156074995|FG000|Period B/A+|Non-compliance with IMP|0|||
48514254|NCT01838681|156074996|FG001|Period B/A+|Non-compliance with IMP|2|||
48514255|NCT01838681|156074997|FG002|Period B/A+|Non-compliance with IMP|3|||
48514256|NCT01838681|156074998|FG003|Period B/A+|Non-compliance with IMP|3|||
48822493|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822494|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822495|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822496|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48514257|NCT01838681|156074995|FG000|Period B/A+|Lost to Follow-up|0|||
48514258|NCT01838681|156074996|FG001|Period B/A+|Lost to Follow-up|2|||
48514259|NCT01838681|156074997|FG002|Period B/A+|Lost to Follow-up|5|||
48514260|NCT01838681|156074998|FG003|Period B/A+|Lost to Follow-up|11|||
48514261|NCT01838681|156074995|FG000|Period B/A+|Withdrawal before treatment|0|||
48730116|NCT00174291|156862961|FG000|Overall Study|Withdrawal by Subject|3|||
48730117|NCT00174291|156862962|FG001|Overall Study|Withdrawal by Subject|3|||
48730118|NCT01439568|156862963|FG000|Overall Study|Lost to Follow-up|1|||
48730119|NCT01439568|156862964|FG001|Overall Study|Lost to Follow-up|0|||
48730120|NCT01439568|156862963|FG000|Overall Study|Withdrawal by Subject|2|||
48730121|NCT01439568|156862964|FG001|Overall Study|Withdrawal by Subject|2|||
48514262|NCT01838681|156074996|FG001|Period B/A+|Withdrawal before treatment|1|||
48514263|NCT01838681|156074997|FG002|Period B/A+|Withdrawal before treatment|0|||
48514264|NCT01838681|156074998|FG003|Period B/A+|Withdrawal before treatment|0|||
48514265|NCT01838681|156074995|FG000|Period B/A+|Administrative or other reasons|0|||
48514266|NCT01838681|156074996|FG001|Period B/A+|Administrative or other reasons|6|||
48514267|NCT01838681|156074997|FG002|Period B/A+|Administrative or other reasons|10|||
48514268|NCT01838681|156074998|FG003|Period B/A+|Administrative or other reasons|28|||
48514269|NCT02452463|156074999|FG000|Overall Study|Death|1|||
48514270|NCT02452463|156075000|FG001|Overall Study|Death|0|||
48514271|NCT02452463|156075001|FG002|Overall Study|Death|0|||
48822497|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822498|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822499|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
48822500|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822501|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
48822502|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
48822503|NCT01474512|157190483|FG000|Post-Treatment Follow-Up|Death|0|||
48822504|NCT01474512|157190484|FG001|Post-Treatment Follow-Up|Death|0|||
48822505|NCT01474512|157190485|FG002|Post-Treatment Follow-Up|Death|0|||
48822506|NCT01474512|157190486|FG003|Post-Treatment Follow-Up|Death|0|||
48730122|NCT00117286|156862965|FG000|Overall Study|Adverse Event|12|||
48514272|NCT02452463|156074999|FG000|Overall Study|Study Suspended|1|||
48514273|NCT02452463|156075000|FG001|Overall Study|Study Suspended|0|||
48514274|NCT02452463|156075001|FG002|Overall Study|Study Suspended|0|||
48514275|NCT02452463|156074999|FG000|Overall Study|Recommended by DSMB|0|||
48514276|NCT02452463|156075000|FG001|Overall Study|Recommended by DSMB|1|||
48514277|NCT02452463|156075001|FG002|Overall Study|Recommended by DSMB|0|||
48514278|NCT02452463|156074999|FG000|Overall Study|Withdrawal by Subject|0|||
48514279|NCT02452463|156075000|FG001|Overall Study|Withdrawal by Subject|1|||
48730123|NCT00117286|156862966|FG001|Overall Study|Adverse Event|6|||
48730124|NCT00117286|156862965|FG000|Overall Study|Lost to Follow-up|2|||
48514280|NCT02452463|156075001|FG002|Overall Study|Withdrawal by Subject|0|||
48514281|NCT05740098|156075002|FG000|Overall Study|Lost to Follow-up|26|||
48514282|NCT05740098|156075003|FG001|Overall Study|Lost to Follow-up|17|||
48822507|NCT01474512|157190487|FG004|Post-Treatment Follow-Up|Death|0|||
48822508|NCT01474512|157190488|FG005|Post-Treatment Follow-Up|Death|0|||
48514283|NCT05740098|156075004|FG002|Overall Study|Lost to Follow-up|21|||
48514284|NCT00730691|156075007|FG000|Overall Study|Adverse Event|4|||
48514285|NCT00730691|156075008|FG001|Overall Study|Adverse Event|8|||
48514286|NCT00730691|156075009|FG002|Overall Study|Adverse Event|11|||
48514287|NCT00730691|156075010|FG003|Overall Study|Adverse Event|11|||
48822509|NCT01474512|157190489|FG006|Post-Treatment Follow-Up|Death|0|||
48514288|NCT00730691|156075011|FG004|Overall Study|Adverse Event|23|||
48514289|NCT00730691|156075007|FG000|Overall Study|Lack of Efficacy|4|||
48514290|NCT00730691|156075008|FG001|Overall Study|Lack of Efficacy|4|||
48514291|NCT00730691|156075009|FG002|Overall Study|Lack of Efficacy|2|||
48514292|NCT00730691|156075010|FG003|Overall Study|Lack of Efficacy|1|||
48514293|NCT00730691|156075011|FG004|Overall Study|Lack of Efficacy|1|||
48514294|NCT00730691|156075007|FG000|Overall Study|Non-compliance with Study Drug|6|||
48514295|NCT00730691|156075008|FG001|Overall Study|Non-compliance with Study Drug|1|||
48514296|NCT00730691|156075009|FG002|Overall Study|Non-compliance with Study Drug|6|||
48514297|NCT00730691|156075010|FG003|Overall Study|Non-compliance with Study Drug|3|||
48514298|NCT00730691|156075011|FG004|Overall Study|Non-compliance with Study Drug|3|||
48514299|NCT00730691|156075007|FG000|Overall Study|Protocol Deviations|3|||
48514300|NCT00730691|156075008|FG001|Overall Study|Protocol Deviations|5|||
48514301|NCT00730691|156075009|FG002|Overall Study|Protocol Deviations|3|||
48514302|NCT00730691|156075010|FG003|Overall Study|Protocol Deviations|7|||
48514303|NCT00730691|156075011|FG004|Overall Study|Protocol Deviations|5|||
48514304|NCT00730691|156075007|FG000|Overall Study|Withdrawal of Consent|7|||
48514305|NCT00730691|156075008|FG001|Overall Study|Withdrawal of Consent|9|||
48514306|NCT00730691|156075009|FG002|Overall Study|Withdrawal of Consent|3|||
48514307|NCT00730691|156075010|FG003|Overall Study|Withdrawal of Consent|6|||
48514308|NCT00730691|156075011|FG004|Overall Study|Withdrawal of Consent|3|||
48514309|NCT00730691|156075007|FG000|Overall Study|Lost to Follow-up|11|||
48514310|NCT00730691|156075008|FG001|Overall Study|Lost to Follow-up|8|||
48514311|NCT00730691|156075009|FG002|Overall Study|Lost to Follow-up|13|||
48514312|NCT00730691|156075010|FG003|Overall Study|Lost to Follow-up|15|||
48514313|NCT00730691|156075011|FG004|Overall Study|Lost to Follow-up|13|||
48514314|NCT00730691|156075007|FG000|Overall Study|Other|1|||
48514315|NCT00730691|156075008|FG001|Overall Study|Other|1|||
48514316|NCT00730691|156075009|FG002|Overall Study|Other|1|||
48514317|NCT00730691|156075010|FG003|Overall Study|Other|2|||
48822510|NCT01474512|157190490|FG007|Post-Treatment Follow-Up|Death|0|||
48822511|NCT01474512|157190491|FG008|Post-Treatment Follow-Up|Death|0|||
48822512|NCT01474512|157190492|FG009|Post-Treatment Follow-Up|Death|0|||
48822513|NCT01474512|157190493|FG010|Post-Treatment Follow-Up|Death|0|||
48822514|NCT01474512|157190494|FG011|Post-Treatment Follow-Up|Death|0|||
48822515|NCT01474512|157190495|FG012|Post-Treatment Follow-Up|Death|0|||
48822516|NCT01474512|157190496|FG013|Post-Treatment Follow-Up|Death|0|||
48822517|NCT01474512|157190497|FG014|Post-Treatment Follow-Up|Death|0|||
48822518|NCT01474512|157190498|FG015|Post-Treatment Follow-Up|Death|0|||
48514318|NCT00730691|156075011|FG004|Overall Study|Other|2|||
48514319|NCT04236596|156075012|FG000|Overall Study|Withdrawal by Subject|1|||
48514320|NCT04236596|156075012|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
48514321|NCT04236596|156075012|FG000|Overall Study|Participants did not receive implant at all|4|||
48514322|NCT04183335|156076389|FG000|Overall Study|Adverse Event|1|||
48822519|NCT01474512|157190499|FG016|Post-Treatment Follow-Up|Death|1|||
48822520|NCT01474512|157190500|FG017|Post-Treatment Follow-Up|Death|0|||
48822521|NCT01118962|157190501|FG000|Overall Study|Adverse Event|2|||
48822522|NCT01118962|157190501|FG000|Overall Study|Lack of Efficacy|1|||
48822523|NCT01118962|157190501|FG000|Overall Study|Protocol Violation|1|||
48822524|NCT01118962|157190501|FG000|Overall Study|Withdrawal by Subject|4|||
48822525|NCT01118962|157190501|FG000|Overall Study|Pregnancy|1|||
48822526|NCT01118962|157190501|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
48822527|NCT01536262|157190509|FG000|Overall Study|Adverse Event|6|||
48822528|NCT01536262|157190510|FG001|Overall Study|Adverse Event|1|||
48822529|NCT01536262|157190511|FG002|Overall Study|Adverse Event|2|||
48514323|NCT04183335|156076390|FG001|Overall Study|Adverse Event|0|||
48514324|NCT04183335|156076389|FG000|Overall Study|Withdrawal by Subject|12|||
48514325|NCT04183335|156076390|FG001|Overall Study|Withdrawal by Subject|3|||
48514326|NCT01660243|156076391|FG000|Overall Study|Adverse Event|1|||
48514327|NCT01660243|156076392|FG001|Overall Study|Adverse Event|0|||
48514328|NCT01660243|156076393|FG002|Overall Study|Adverse Event|1|||
48514329|NCT01660243|156076394|FG003|Overall Study|Adverse Event|0|||
48514330|NCT01660243|156076391|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
48514331|NCT01660243|156076392|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
48514332|NCT01660243|156076393|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
48514333|NCT01660243|156076394|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
48822530|NCT01536262|157190509|FG000|Overall Study|Withdrawal by Subject|1|||
48822531|NCT01536262|157190510|FG001|Overall Study|Withdrawal by Subject|1|||
48822532|NCT01536262|157190511|FG002|Overall Study|Withdrawal by Subject|0|||
48822533|NCT01536262|157190509|FG000|Overall Study|Other than stated above|1|||
48822534|NCT01536262|157190510|FG001|Overall Study|Other than stated above|0|||
48822535|NCT01536262|157190511|FG002|Overall Study|Other than stated above|0|||
48822536|NCT01440049|157190515|FG000|Overall Study|Adverse Event|5|||
48822537|NCT03738241|157190518|FG000|Overall Study|Withdrawal by Subject|0|||
48822538|NCT03738241|157190519|FG001|Overall Study|Withdrawal by Subject|0|||
48822539|NCT03738241|157190520|FG002|Overall Study|Withdrawal by Subject|0|||
48514334|NCT01660243|156076391|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
48514335|NCT01660243|156076392|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
48514336|NCT01660243|156076393|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
48601104|NCT02718911|156396048|FG008|Overall Study|Adverse Event|0|||
48382791|NCT03427125|155596780|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
48440929|NCT00280150|155801437|FG000|Overall Study|Physician Decision|0|||
48440930|NCT00280150|155801438|FG001|Overall Study|Physician Decision|0|||
48440931|NCT00280150|155801439|FG002|Overall Study|Physician Decision|0|||
48440932|NCT00280150|155801440|FG003|Overall Study|Physician Decision|1|||
48440933|NCT00280150|155801437|FG000|Overall Study|Protocol Violation|0|||
48440934|NCT00280150|155801438|FG001|Overall Study|Protocol Violation|0|||
48440935|NCT00280150|155801439|FG002|Overall Study|Protocol Violation|0|||
48440936|NCT00280150|155801440|FG003|Overall Study|Protocol Violation|1|||
48440937|NCT00280150|155801437|FG000|Overall Study|Withdrawal by Subject|0|||
48440938|NCT00280150|155801438|FG001|Overall Study|Withdrawal by Subject|0|||
48440939|NCT00280150|155801439|FG002|Overall Study|Withdrawal by Subject|0|||
48440940|NCT00280150|155801440|FG003|Overall Study|Withdrawal by Subject|1|||
48440941|NCT00280150|155801437|FG000|Overall Study|Did not get consolidation therapy|3|||
48440942|NCT00280150|155801438|FG001|Overall Study|Did not get consolidation therapy|0|||
48440943|NCT00280150|155801439|FG002|Overall Study|Did not get consolidation therapy|3|||
48440944|NCT00280150|155801440|FG003|Overall Study|Did not get consolidation therapy|0|||
48440945|NCT00280150|155801437|FG000|Overall Study|Declining Performance Status|0|||
48440946|NCT00280150|155801438|FG001|Overall Study|Declining Performance Status|0|||
48440947|NCT00280150|155801439|FG002|Overall Study|Declining Performance Status|0|||
48440948|NCT00280150|155801440|FG003|Overall Study|Declining Performance Status|1|||
48440949|NCT02690207|155801445|FG000|Overall Study|Lost to Follow-up|48|||
48440950|NCT02690207|155801445|FG000|Overall Study|Withdrawal by Subject|46|||
48440951|NCT02690207|155801445|FG000|Overall Study|Protocol Violation|2|||
48440952|NCT02690207|155801445|FG000|Overall Study|Serious adverse event|110|||
48440953|NCT02690207|155801445|FG000|Overall Study|Non-serious Adverse Event|18|||
48440954|NCT02690207|155801445|FG000|Overall Study|Migrated/moved from study area|5|||
48440955|NCT02690207|155801445|FG000|Overall Study|Suspected HZ Episode|1|||
48440956|NCT02690207|155801445|FG000|Overall Study|Other reasons for withdrawal|23|||
48440957|NCT04410198|155801448|FG000|Overall Study|Death|10|||
48440958|NCT04410198|155801448|FG000|Overall Study|Withdrawal by Subject|7|||
48440959|NCT04410198|155801448|FG000|Overall Study|Transferred/Relocation|4|||
48440960|NCT04410198|155801448|FG000|Overall Study|Kidney Transplant|9|||
48440961|NCT04410198|155801448|FG000|Overall Study|Adverse Event|4|||
48440962|NCT04410198|155801448|FG000|Overall Study|Physician Decision|2|||
48440963|NCT04410198|155801448|FG000|Overall Study|Other than specified|1|||
48440964|NCT02156492|155801456|FG000|Period 1|No Reason Given|0|||
48440965|NCT02156492|155801457|FG001|Period 1|No Reason Given|1|||
48440966|NCT02156492|155801458|FG002|Period 1|No Reason Given|0|||
48440967|NCT02156492|155801456|FG000|Period 3|Adverse Event|0|||
48440968|NCT02156492|155801457|FG001|Period 3|Adverse Event|1|||
48440969|NCT02156492|155801458|FG002|Period 3|Adverse Event|0|||
48440970|NCT00600028|155801466|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
48440971|NCT00600028|155801467|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
48440972|NCT00600028|155801466|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
48440973|NCT00600028|155801467|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
48440974|NCT00600028|155801466|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
48440975|NCT00600028|155801467|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
48440976|NCT00174785|155801470|FG000|Overall Study|Adverse Event|293|||
48440977|NCT00174785|155801471|FG001|Overall Study|Adverse Event|191|||
48440978|NCT00174785|155801470|FG000|Overall Study|Protocol Violation|14|||
48440979|NCT00174785|155801471|FG001|Overall Study|Protocol Violation|14|||
48440980|NCT00174785|155801470|FG000|Overall Study|Withdrawal by Subject|173|||
48440981|NCT00174785|155801471|FG001|Overall Study|Withdrawal by Subject|175|||
48440982|NCT00174785|155801470|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
48440983|NCT00174785|155801471|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
48440984|NCT00174785|155801470|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
48440985|NCT00174785|155801471|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
48440986|NCT00174785|155801470|FG000|Overall Study|Other prohibited medication|5|||
48440987|NCT00174785|155801471|FG001|Overall Study|Other prohibited medication|3|||
48440988|NCT00174785|155801470|FG000|Overall Study|Family request|6|||
48440989|NCT00174785|155801471|FG001|Overall Study|Family request|8|||
48440990|NCT00174785|155801470|FG000|Overall Study|Not pre-specified/Not coded|56|||
48440991|NCT00174785|155801471|FG001|Overall Study|Not pre-specified/Not coded|70|||
48440992|NCT01093755|155801474|FG000|Overall Study|Withdrawal by Subject|3|||
48440993|NCT01093755|155801475|FG001|Overall Study|Withdrawal by Subject|4|||
48440994|NCT03115112|155801476|FG000|Overall Study|Adverse Event|5|||
48514337|NCT01660243|156076394|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
48514338|NCT01660243|156076391|FG000|Overall Study|Randomization error|0|||
48514339|NCT01660243|156076392|FG001|Overall Study|Randomization error|0|||
48514340|NCT01660243|156076393|FG002|Overall Study|Randomization error|0|||
48514341|NCT01660243|156076394|FG003|Overall Study|Randomization error|1|||
48514342|NCT03255733|156076396|FG000|Overall Study|Lost to Follow-up|4|||
48514343|NCT03606174|156076397|FG000|Overall Study|Death|37|||
48514344|NCT03606174|156076398|FG001|Overall Study|Death|15|||
48514345|NCT03606174|156076399|FG002|Overall Study|Death|15|||
48514346|NCT03606174|156076400|FG003|Overall Study|Death|7|||
48514347|NCT03606174|156076401|FG004|Overall Study|Death|35|||
48514348|NCT03606174|156076402|FG005|Overall Study|Death|12|||
48514349|NCT03606174|156076403|FG006|Overall Study|Death|35|||
48514350|NCT03606174|156076404|FG007|Overall Study|Death|8|||
48514351|NCT03606174|156076405|FG008|Overall Study|Death|5|||
48514352|NCT03606174|156076406|FG009|Overall Study|Death|3|||
48514353|NCT03606174|156076407|FG010|Overall Study|Death|0|||
48514354|NCT03606174|156076397|FG000|Overall Study|Lost to Follow-up|0|||
48514355|NCT03606174|156076398|FG001|Overall Study|Lost to Follow-up|0|||
48514356|NCT03606174|156076399|FG002|Overall Study|Lost to Follow-up|0|||
48514357|NCT03606174|156076400|FG003|Overall Study|Lost to Follow-up|0|||
48514358|NCT03606174|156076401|FG004|Overall Study|Lost to Follow-up|1|||
48514359|NCT03606174|156076402|FG005|Overall Study|Lost to Follow-up|1|||
48730125|NCT00117286|156862966|FG001|Overall Study|Lost to Follow-up|0|||
48730126|NCT00117286|156862965|FG000|Overall Study|Protocol Violation|3|||
48730127|NCT00117286|156862966|FG001|Overall Study|Protocol Violation|3|||
48730128|NCT00117286|156862965|FG000|Overall Study|Withdrawal by Subject|6|||
48730129|NCT00117286|156862966|FG001|Overall Study|Withdrawal by Subject|2|||
48730130|NCT00117286|156862965|FG000|Overall Study|Physician Decision|3|||
48730131|NCT00117286|156862966|FG001|Overall Study|Physician Decision|7|||
48730132|NCT00117286|156862965|FG000|Overall Study|Lack of Efficacy|2|||
48730133|NCT00117286|156862966|FG001|Overall Study|Lack of Efficacy|1|||
48730134|NCT00117286|156862965|FG000|Overall Study|Research site closing|0|||
48730135|NCT00117286|156862966|FG001|Overall Study|Research site closing|2|||
48730136|NCT02057393|156862969|FG000|Overall Study|Withdrawal by Subject|1|||
48730137|NCT02057393|156862969|FG000|Overall Study|Patient did not meet criteria|1|||
48730138|NCT05896748|156862972|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
48730139|NCT05896748|156862972|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
48730140|NCT05896748|156862972|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
48730141|NCT05896748|156862972|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
48822540|NCT03738241|157190521|FG003|Overall Study|Withdrawal by Subject|0|||
48730142|NCT05896748|156862972|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
48730143|NCT04508140|156862973|FG000|Overall Study|Adverse Event|2|||
48730144|NCT04508140|156862974|FG001|Overall Study|Adverse Event|2|||
48730145|NCT04508140|156862973|FG000|Overall Study|Withdrawal by Subject|0|||
48730146|NCT04508140|156862974|FG001|Overall Study|Withdrawal by Subject|2|||
48730147|NCT04508140|156862973|FG000|Overall Study|progressive disease|9|||
48730148|NCT04508140|156862974|FG001|Overall Study|progressive disease|3|||
48730149|NCT05298306|156862975|FG000|Overall Study|Physician Decision|0|||
48730150|NCT05298306|156862976|FG001|Overall Study|Physician Decision|0|||
48730151|NCT05298306|156862977|FG002|Overall Study|Physician Decision|0|||
48730152|NCT05298306|156862978|FG003|Overall Study|Physician Decision|1|||
48730153|NCT05298306|156862979|FG004|Overall Study|Physician Decision|0|||
48730154|NCT05298306|156862980|FG005|Overall Study|Physician Decision|0|||
48730155|NCT00467610|156862981|FG000|Overall Study|Withdrawal by Subject|1|||
48730156|NCT01917929|156862984|FG000|Overall Study|Death|5|||
48730157|NCT01917929|156862984|FG000|Overall Study|Lost to Follow-up|19|||
48730158|NCT01917929|156862984|FG000|Overall Study|Withdrawal by Subject|31|||
48730159|NCT01917929|156862984|FG000|Overall Study|Adverse Event|6|||
48730160|NCT01917929|156862984|FG000|Overall Study|Investigative Site Terminated|11|||
48730161|NCT01917929|156862984|FG000|Overall Study|Censored because study device not implanted|6|||
48730162|NCT01917929|156862984|FG000|Overall Study|Censored because surgery not performed|3|||
48730163|NCT01917929|156862984|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
48730164|NCT01917929|156862984|FG000|Overall Study|No 5 year data|70|||
48730165|NCT01917929|156862984|FG000|Overall Study|Sponsor terminated study|26|||
48730166|NCT03971071|156862987|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
48730167|NCT03971071|156862988|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
48822541|NCT03738241|157190522|FG004|Overall Study|Withdrawal by Subject|0|||
48730168|NCT03971071|156862989|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
48730169|NCT03971071|156862990|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
48514360|NCT03606174|156076403|FG006|Overall Study|Lost to Follow-up|0|||
48514361|NCT03606174|156076404|FG007|Overall Study|Lost to Follow-up|0|||
48514362|NCT03606174|156076405|FG008|Overall Study|Lost to Follow-up|0|||
48514363|NCT03606174|156076406|FG009|Overall Study|Lost to Follow-up|0|||
48514364|NCT03606174|156076407|FG010|Overall Study|Lost to Follow-up|0|||
48730170|NCT03971071|156862991|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
48822542|NCT03738241|157190523|FG005|Overall Study|Withdrawal by Subject|0|||
48822543|NCT03738241|157190524|FG006|Overall Study|Withdrawal by Subject|0|||
48822544|NCT03738241|157190525|FG007|Overall Study|Withdrawal by Subject|0|||
48822545|NCT03738241|157190526|FG008|Overall Study|Withdrawal by Subject|0|||
48822546|NCT03738241|157190527|FG009|Overall Study|Withdrawal by Subject|1|||
48822547|NCT03738241|157190518|FG000|Overall Study|Physician Decision|0|||
48822548|NCT03738241|157190519|FG001|Overall Study|Physician Decision|0|||
48822549|NCT03738241|157190520|FG002|Overall Study|Physician Decision|0|||
48822550|NCT03738241|157190521|FG003|Overall Study|Physician Decision|0|||
48822551|NCT03738241|157190522|FG004|Overall Study|Physician Decision|0|||
48822552|NCT03738241|157190523|FG005|Overall Study|Physician Decision|0|||
48822553|NCT03738241|157190524|FG006|Overall Study|Physician Decision|0|||
48822554|NCT03738241|157190525|FG007|Overall Study|Physician Decision|0|||
48822555|NCT03738241|157190526|FG008|Overall Study|Physician Decision|1|||
48822556|NCT03738241|157190527|FG009|Overall Study|Physician Decision|0|||
48822557|NCT03738241|157190518|FG000|Overall Study|Adverse Event|1|||
48822558|NCT03738241|157190519|FG001|Overall Study|Adverse Event|0|||
48822559|NCT03738241|157190520|FG002|Overall Study|Adverse Event|0|||
48822560|NCT03738241|157190521|FG003|Overall Study|Adverse Event|0|||
48822561|NCT03738241|157190522|FG004|Overall Study|Adverse Event|0|||
48822562|NCT03738241|157190523|FG005|Overall Study|Adverse Event|0|||
48822563|NCT03738241|157190524|FG006|Overall Study|Adverse Event|0|||
48822564|NCT03738241|157190525|FG007|Overall Study|Adverse Event|0|||
48822565|NCT03738241|157190526|FG008|Overall Study|Adverse Event|0|||
48822566|NCT03738241|157190527|FG009|Overall Study|Adverse Event|0|||
48822567|NCT01106976|157190528|FG000|Overall Study|Lost to Follow-up|8|||
48822568|NCT02559817|157190529|FG000|Treatment Period|Adverse Event|1|||
48822569|NCT02559817|157190530|FG001|Treatment Period|Adverse Event|0|||
48822570|NCT02559817|157190531|FG002|Treatment Period|Adverse Event|1|||
48822571|NCT02559817|157190532|FG003|Treatment Period|Adverse Event|0|||
48822572|NCT02559817|157190533|FG004|Treatment Period|Adverse Event|0|||
48822573|NCT02559817|157190529|FG000|Treatment Period|Lack of Efficacy|0|||
48822574|NCT02559817|157190530|FG001|Treatment Period|Lack of Efficacy|1|||
48822575|NCT02559817|157190531|FG002|Treatment Period|Lack of Efficacy|0|||
48822576|NCT02559817|157190532|FG003|Treatment Period|Lack of Efficacy|0|||
48822577|NCT02559817|157190533|FG004|Treatment Period|Lack of Efficacy|0|||
48822578|NCT02559817|157190529|FG000|Treatment Period|Lost to Follow-up|0|||
48822579|NCT02559817|157190530|FG001|Treatment Period|Lost to Follow-up|1|||
48822580|NCT02559817|157190531|FG002|Treatment Period|Lost to Follow-up|0|||
48822581|NCT02559817|157190532|FG003|Treatment Period|Lost to Follow-up|1|||
48822582|NCT02559817|157190533|FG004|Treatment Period|Lost to Follow-up|0|||
48822583|NCT02559817|157190529|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
48822584|NCT02559817|157190530|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
48822585|NCT02559817|157190531|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
48822586|NCT02559817|157190532|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
48822587|NCT02559817|157190533|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
48822588|NCT02559817|157190529|FG000|Treatment Period|Protocol Violation|0|||
48822589|NCT02559817|157190530|FG001|Treatment Period|Protocol Violation|0|||
48822590|NCT02559817|157190531|FG002|Treatment Period|Protocol Violation|0|||
48822591|NCT02559817|157190532|FG003|Treatment Period|Protocol Violation|1|||
48822592|NCT02559817|157190533|FG004|Treatment Period|Protocol Violation|0|||
48514365|NCT03606174|156076397|FG000|Overall Study|Withdrawal by Subject|6|||
48514366|NCT03606174|156076398|FG001|Overall Study|Withdrawal by Subject|0|||
48514367|NCT03606174|156076399|FG002|Overall Study|Withdrawal by Subject|0|||
48822593|NCT04172987|157190534|FG000|Lead In Period|Adverse Event|1|||
48822594|NCT04172987|157190534|FG000|Lead In Period|Protocol Violation|1|||
48822595|NCT04172987|157190534|FG000|Period 1|Physician Decision|1|||
48822596|NCT04172987|157190534|FG000|Period 2|Adverse Event|5|||
48822597|NCT04172987|157190534|FG000|Period 2|Dosing Termination by Sponsor|4|||
48822598|NCT02687919|157190535|FG000|Overall Study|Withdrawal by Subject|6|||
48822599|NCT02687919|157190536|FG001|Overall Study|Withdrawal by Subject|6|||
48822600|NCT02687919|157190535|FG000|Overall Study|Protocol Violation|2|||
48822601|NCT02687919|157190536|FG001|Overall Study|Protocol Violation|0|||
48822602|NCT00419003|157190537|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
48822603|NCT00419003|157190538|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
48822604|NCT00419003|157190537|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
48822605|NCT00419003|157190538|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
48822606|NCT01813422|157190539|FG000|Overall Study|Withdrawal by Subject|14|||
48822607|NCT01813422|157190540|FG001|Overall Study|Withdrawal by Subject|8|||
48822608|NCT01813422|157190539|FG000|Overall Study|Death|2|||
48822609|NCT01813422|157190540|FG001|Overall Study|Death|3|||
48822610|NCT01813422|157190539|FG000|Overall Study|Sponsor Decision|2|||
48822611|NCT01813422|157190540|FG001|Overall Study|Sponsor Decision|1|||
48822612|NCT01813422|157190539|FG000|Overall Study|Lost to Follow-up|2|||
48822613|NCT01813422|157190540|FG001|Overall Study|Lost to Follow-up|4|||
48822614|NCT01167023|157190544|FG000|Overall Study|Lost to Follow-up|0|||
48822615|NCT01167023|157190545|FG001|Overall Study|Lost to Follow-up|1|||
48822616|NCT01167023|157190546|FG002|Overall Study|Lost to Follow-up|1|||
48514368|NCT03606174|156076400|FG003|Overall Study|Withdrawal by Subject|1|||
48514369|NCT03606174|156076401|FG004|Overall Study|Withdrawal by Subject|2|||
48514370|NCT03606174|156076402|FG005|Overall Study|Withdrawal by Subject|1|||
48514371|NCT03606174|156076403|FG006|Overall Study|Withdrawal by Subject|4|||
48514372|NCT03606174|156076404|FG007|Overall Study|Withdrawal by Subject|0|||
48514373|NCT03606174|156076405|FG008|Overall Study|Withdrawal by Subject|0|||
48514374|NCT03606174|156076406|FG009|Overall Study|Withdrawal by Subject|0|||
48514375|NCT03606174|156076407|FG010|Overall Study|Withdrawal by Subject|1|||
48514376|NCT03606174|156076397|FG000|Overall Study|Study Terminated by Sponsor|5|||
48514377|NCT03606174|156076398|FG001|Overall Study|Study Terminated by Sponsor|7|||
48514378|NCT03606174|156076399|FG002|Overall Study|Study Terminated by Sponsor|3|||
48514379|NCT03606174|156076400|FG003|Overall Study|Study Terminated by Sponsor|0|||
48514380|NCT03606174|156076401|FG004|Overall Study|Study Terminated by Sponsor|11|||
48514381|NCT03606174|156076402|FG005|Overall Study|Study Terminated by Sponsor|6|||
48514382|NCT03606174|156076403|FG006|Overall Study|Study Terminated by Sponsor|12|||
48514383|NCT03606174|156076404|FG007|Overall Study|Study Terminated by Sponsor|1|||
48514384|NCT03606174|156076405|FG008|Overall Study|Study Terminated by Sponsor|3|||
48514385|NCT03606174|156076406|FG009|Overall Study|Study Terminated by Sponsor|1|||
48514386|NCT03606174|156076407|FG010|Overall Study|Study Terminated by Sponsor|2|||
48514387|NCT03606174|156076397|FG000|Overall Study|Miscellaneous|1|||
48382792|NCT03427125|155596781|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
48382793|NCT03427125|155596782|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
48514388|NCT03606174|156076398|FG001|Overall Study|Miscellaneous|1|||
48514389|NCT03606174|156076399|FG002|Overall Study|Miscellaneous|0|||
48514390|NCT03606174|156076400|FG003|Overall Study|Miscellaneous|1|||
48514391|NCT03606174|156076401|FG004|Overall Study|Miscellaneous|4|||
48514392|NCT03606174|156076402|FG005|Overall Study|Miscellaneous|7|||
48514393|NCT03606174|156076403|FG006|Overall Study|Miscellaneous|5|||
48514394|NCT03606174|156076404|FG007|Overall Study|Miscellaneous|0|||
48514395|NCT03606174|156076405|FG008|Overall Study|Miscellaneous|0|||
48514396|NCT03606174|156076406|FG009|Overall Study|Miscellaneous|0|||
48514397|NCT03606174|156076407|FG010|Overall Study|Miscellaneous|1|||
48514398|NCT00859521|156076408|FG000|Washout|Withdrawal by Subject|0|||
48514399|NCT00859521|156076409|FG001|Washout|Withdrawal by Subject|1|||
48514400|NCT01609257|156076413|FG000|Overall Study|Lost to Follow-up|2|||
48514401|NCT01609257|156076414|FG001|Overall Study|Lost to Follow-up|1|||
48514402|NCT01609257|156076413|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
48514403|NCT01609257|156076414|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
48514404|NCT01609257|156076413|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
48514405|NCT01609257|156076414|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
48514406|NCT01547286|156076425|FG000|Overall Study|Did not meet all eligibility criteria|1|||
48514407|NCT01547286|156076425|FG000|Overall Study|Physician Decision|1|||
48514408|NCT03049748|156076426|FG000|Overall Study|Lost to Follow-up|1|||
48514409|NCT03049748|156076427|FG001|Overall Study|Lost to Follow-up|0|||
48514410|NCT03049748|156076426|FG000|Overall Study|Death|3|||
48514411|NCT03049748|156076427|FG001|Overall Study|Death|0|||
48514412|NCT03049748|156076426|FG000|Overall Study|Withdrawal by Subject|0|||
48514413|NCT03049748|156076427|FG001|Overall Study|Withdrawal by Subject|3|||
48514414|NCT03049748|156076426|FG000|Overall Study|Protocol Violation|0|||
48514415|NCT03049748|156076427|FG001|Overall Study|Protocol Violation|2|||
48514416|NCT03049748|156076426|FG000|Overall Study|Moved out of state (relocation)|0|||
48514417|NCT03049748|156076427|FG001|Overall Study|Moved out of state (relocation)|1|||
48514418|NCT02659150|156076430|FG000|Subject Enrollment|Physician Decision|3|||
48514419|NCT02659150|156076430|FG000|Subject Enrollment|Withdrawal by Subject|2|||
48514420|NCT02659150|156076430|FG000|Baseline Imaging|Withdrawal by Subject|1|||
48514421|NCT02659150|156076430|FG000|Baseline Imaging|Physician Decision|1|||
48514422|NCT02659150|156076430|FG000|Study Drug Dosing|Adverse Event|1|||
48514423|NCT03307343|156076432|FG000|Overall Study|Withdrawal by Subject|1|||
48514424|NCT03307343|156076433|FG001|Overall Study|Withdrawal by Subject|2|||
48514425|NCT03307343|156076432|FG000|Overall Study|Pregnancy|0|||
48514426|NCT03307343|156076433|FG001|Overall Study|Pregnancy|2|||
48514427|NCT03307343|156076432|FG000|Overall Study|Physician Decision|1|||
48514428|NCT03307343|156076433|FG001|Overall Study|Physician Decision|0|||
48514429|NCT03307343|156076432|FG000|Overall Study|Lost to Follow-up|0|||
48514430|NCT03307343|156076433|FG001|Overall Study|Lost to Follow-up|2|||
48514431|NCT03415308|156076434|FG000|Overall Study|Lost to Follow-up|0|||
48514432|NCT03415308|156076435|FG001|Overall Study|Lost to Follow-up|0|||
48514433|NCT03415308|156076436|FG002|Overall Study|Lost to Follow-up|1|||
48514434|NCT03415308|156076434|FG000|Overall Study|Scheduling Conflicts|0|||
48514435|NCT03415308|156076435|FG001|Overall Study|Scheduling Conflicts|0|||
48514436|NCT03415308|156076436|FG002|Overall Study|Scheduling Conflicts|7|||
48514437|NCT00679081|156076437|FG000|Overall Study|Lost to Follow-up|1|||
48514438|NCT00836472|156076443|FG000|Washout|Adverse Event|1|||
48822617|NCT01167023|157190544|FG000|Overall Study|Screen Failure|0|||
48822618|NCT01167023|157190545|FG001|Overall Study|Screen Failure|1|||
48514439|NCT00836472|156076444|FG001|Washout|Adverse Event|2|||
48514440|NCT00836472|156076443|FG000|Washout|Withdrawal by Subject|1|||
48730171|NCT03971071|156862987|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
48822619|NCT01167023|157190546|FG002|Overall Study|Screen Failure|0|||
48514441|NCT00836472|156076444|FG001|Washout|Withdrawal by Subject|1|||
48514442|NCT03913377|156076445|FG000|Period 1|Test Article no longer available|0|||
48514443|NCT03913377|156076446|FG001|Period 1|Test Article no longer available|1|||
48514444|NCT03913377|156076447|FG002|Period 1|Test Article no longer available|0|||
48514445|NCT03913377|156076445|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
48514446|NCT03913377|156076446|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
48514447|NCT03913377|156076447|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
48514448|NCT04547192|156076448|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
48514449|NCT04547192|156076449|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
48514450|NCT04547192|156076450|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
48514451|NCT04547192|156076451|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
48514452|NCT04547192|156076448|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
48730172|NCT03971071|156862988|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
48730173|NCT03971071|156862989|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
48730174|NCT03971071|156862990|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48822620|NCT01167023|157190544|FG000|Overall Study|Sponsor Decision|0|||
48822621|NCT01167023|157190545|FG001|Overall Study|Sponsor Decision|1|||
48822622|NCT01167023|157190546|FG002|Overall Study|Sponsor Decision|0|||
48822623|NCT01167023|157190544|FG000|Overall Study|Withdrawal by Subject|0|||
48822624|NCT01167023|157190545|FG001|Overall Study|Withdrawal by Subject|0|||
48822625|NCT01167023|157190546|FG002|Overall Study|Withdrawal by Subject|1|||
48822626|NCT01700530|157190547|FG000|Overall Study|Withdrawal by Subject|0|||
48822627|NCT01700530|157190548|FG001|Overall Study|Withdrawal by Subject|3|||
48822628|NCT01700530|157190549|FG002|Overall Study|Withdrawal by Subject|1|||
48822629|NCT03251378|157190554|FG000|Overall Study|Death|3|||
48822630|NCT03251378|157190555|FG001|Overall Study|Death|2|||
48822631|NCT03251378|157190556|FG002|Overall Study|Death|3|||
48822632|NCT03251378|157190557|FG003|Overall Study|Death|30|||
48822633|NCT03251378|157190558|FG004|Overall Study|Death|24|||
48822634|NCT03251378|157190559|FG005|Overall Study|Death|12|||
48822635|NCT03251378|157190560|FG006|Overall Study|Death|12|||
48822636|NCT03251378|157190554|FG000|Overall Study|Lost to Follow-up|0|||
48822637|NCT03251378|157190555|FG001|Overall Study|Lost to Follow-up|0|||
48822638|NCT03251378|157190556|FG002|Overall Study|Lost to Follow-up|1|||
48822639|NCT03251378|157190557|FG003|Overall Study|Lost to Follow-up|3|||
48822640|NCT03251378|157190558|FG004|Overall Study|Lost to Follow-up|0|||
48822641|NCT03251378|157190559|FG005|Overall Study|Lost to Follow-up|0|||
48822642|NCT03251378|157190560|FG006|Overall Study|Lost to Follow-up|0|||
48822643|NCT03251378|157190554|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
48822644|NCT03251378|157190555|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
48822645|NCT03251378|157190556|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
48822646|NCT03251378|157190557|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
48822647|NCT03251378|157190558|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
48514453|NCT04547192|156076449|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
48514454|NCT04547192|156076450|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
48514455|NCT04547192|156076451|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
48514456|NCT04547192|156076448|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
48514457|NCT04547192|156076449|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
48514458|NCT04547192|156076450|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
48514459|NCT04547192|156076451|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
48514460|NCT04547192|156076448|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
48514461|NCT04547192|156076449|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
48514462|NCT04547192|156076450|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
48514463|NCT04547192|156076451|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
48514464|NCT04547192|156076448|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
48514465|NCT04547192|156076449|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
48382794|NCT02708095|155596783|FG000|Overall Study|Adverse Event|4|||
48382795|NCT02708095|155596784|FG001|Overall Study|Adverse Event|10|||
48382796|NCT02708095|155596785|FG002|Overall Study|Adverse Event|11|||
48514466|NCT04547192|156076450|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
48514467|NCT04547192|156076451|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
48730175|NCT03971071|156862991|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48382797|NCT02708095|155596783|FG000|Overall Study|Lack of Efficacy|9|||
48382798|NCT02708095|155596784|FG001|Overall Study|Lack of Efficacy|3|||
48382799|NCT02708095|155596785|FG002|Overall Study|Lack of Efficacy|0|||
48730176|NCT03971071|156862987|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
48822648|NCT03251378|157190559|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
48822649|NCT03251378|157190560|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
48514468|NCT00635648|156076452|FG000|Overall Study|Adverse Event|12|||
48514469|NCT00635648|156076452|FG000|Overall Study|Withdrawal by Subject|9|||
48822650|NCT03251378|157190554|FG000|Overall Study|Progressive disease|2|||
48822651|NCT03251378|157190555|FG001|Overall Study|Progressive disease|0|||
48822652|NCT03251378|157190556|FG002|Overall Study|Progressive disease|0|||
48822653|NCT03251378|157190557|FG003|Overall Study|Progressive disease|1|||
48822654|NCT03251378|157190558|FG004|Overall Study|Progressive disease|0|||
48822655|NCT03251378|157190559|FG005|Overall Study|Progressive disease|0|||
48822656|NCT03251378|157190560|FG006|Overall Study|Progressive disease|0|||
48822657|NCT03251378|157190554|FG000|Overall Study|Physician Decision|0|||
48822658|NCT03251378|157190555|FG001|Overall Study|Physician Decision|2|||
48822659|NCT03251378|157190556|FG002|Overall Study|Physician Decision|0|||
48822660|NCT03251378|157190557|FG003|Overall Study|Physician Decision|0|||
48822661|NCT03251378|157190558|FG004|Overall Study|Physician Decision|0|||
48822662|NCT03251378|157190559|FG005|Overall Study|Physician Decision|0|||
48822663|NCT03251378|157190560|FG006|Overall Study|Physician Decision|0|||
48822664|NCT03251378|157190554|FG000|Overall Study|Other|2|||
48822665|NCT03251378|157190555|FG001|Overall Study|Other|3|||
48822666|NCT03251378|157190556|FG002|Overall Study|Other|2|||
48822667|NCT03251378|157190557|FG003|Overall Study|Other|0|||
48822668|NCT03251378|157190558|FG004|Overall Study|Other|1|||
48822669|NCT03251378|157190559|FG005|Overall Study|Other|1|||
48822670|NCT03251378|157190560|FG006|Overall Study|Other|1|||
48822671|NCT03251378|157190554|FG000|Overall Study|Other|0|||
48822672|NCT03251378|157190555|FG001|Overall Study|Other|0|||
48822673|NCT03251378|157190556|FG002|Overall Study|Other|0|||
48822674|NCT03251378|157190557|FG003|Overall Study|Other|4|||
48822675|NCT03251378|157190558|FG004|Overall Study|Other|13|||
48822676|NCT03251378|157190559|FG005|Overall Study|Other|0|||
48822677|NCT03251378|157190560|FG006|Overall Study|Other|0|||
48514470|NCT00635648|156076452|FG000|Overall Study|Physician Decision|4|||
48514471|NCT00635648|156076452|FG000|Overall Study|Rapid progression of baseline disease|4|||
48730177|NCT03971071|156862988|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
48822678|NCT04060680|157190563|FG000|Overall Study|Unsuccessful implant|17|||
48822679|NCT04060680|157190564|FG001|Overall Study|Unsuccessful implant|2|||
48822680|NCT04060680|157190563|FG000|Overall Study|Adverse Event|3|||
48822681|NCT04060680|157190564|FG001|Overall Study|Adverse Event|0|||
48822682|NCT04060680|157190563|FG000|Overall Study|Death|2|||
48822683|NCT04060680|157190564|FG001|Overall Study|Death|0|||
48382800|NCT02708095|155596783|FG000|Overall Study|Lost to Follow-up|2|||
48730178|NCT03971071|156862989|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
48730179|NCT03971071|156862990|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
48730180|NCT03971071|156862991|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
48730181|NCT03971071|156862987|FG000|Open-label Treatment Period|Sponsor decision|0|||
48730182|NCT03971071|156862988|FG001|Open-label Treatment Period|Sponsor decision|0|||
48730183|NCT03971071|156862989|FG002|Open-label Treatment Period|Sponsor decision|0|||
48730184|NCT03971071|156862990|FG003|Open-label Treatment Period|Sponsor decision|0|||
48730185|NCT03971071|156862991|FG004|Open-label Treatment Period|Sponsor decision|1|||
48730186|NCT03971071|156862987|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
48730187|NCT03971071|156862988|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48730188|NCT03971071|156862989|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
48730189|NCT03971071|156862990|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
48730190|NCT03971071|156862991|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
48730191|NCT03971071|156862987|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
48730192|NCT03971071|156862988|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
48730193|NCT03971071|156862989|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
48730194|NCT03971071|156862990|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
48730195|NCT03971071|156862991|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
48730196|NCT00602667|156862995|FG000|Overall Study|Still on Therapy|0|||
48730197|NCT00602667|156862996|FG001|Overall Study|Still on Therapy|2|||
48730198|NCT00602667|156862997|FG002|Overall Study|Still on Therapy|2|||
48730199|NCT00602667|156862995|FG000|Overall Study|Death|0|||
48730200|NCT00602667|156862996|FG001|Overall Study|Death|1|||
48822684|NCT04060680|157190563|FG000|Overall Study|Study product no longer in use|1|||
48822685|NCT04060680|157190564|FG001|Overall Study|Study product no longer in use|0|||
48822686|NCT04060680|157190563|FG000|Overall Study|Withdrawal by Subject|1|||
48822687|NCT04060680|157190564|FG001|Overall Study|Withdrawal by Subject|0|||
48822688|NCT01661881|157190565|FG000|Overall Study|Disease Progression|1|||
48822689|NCT02886936|157190566|FG000|Overall Study|Lost to Follow-up|4|||
48822690|NCT02886936|157190567|FG001|Overall Study|Lost to Follow-up|3|||
48822691|NCT02886936|157190568|FG002|Overall Study|Lost to Follow-up|0|||
48822692|NCT02081391|157190573|FG000|12-hour Treatment|Withdrawal by Subject|3|||
48822693|NCT02081391|157190574|FG001|12-hour Treatment|Withdrawal by Subject|2|||
48822694|NCT02081391|157190575|FG002|12-hour Treatment|Withdrawal by Subject|0|||
48822695|NCT02081391|157190576|FG003|12-hour Treatment|Withdrawal by Subject|0|||
48822696|NCT02081391|157190573|FG000|12-hour Treatment|Physician Decision|4|||
48601105|NCT02718911|156396049|FG009|Overall Study|Adverse Event|2|||
48822697|NCT02081391|157190574|FG001|12-hour Treatment|Physician Decision|1|||
48822698|NCT02081391|157190575|FG002|12-hour Treatment|Physician Decision|0|||
48822699|NCT02081391|157190576|FG003|12-hour Treatment|Physician Decision|0|||
48822700|NCT02081391|157190573|FG000|12-hour Treatment|Lack of Efficacy|3|||
48514472|NCT00635648|156076452|FG000|Overall Study|Use of other antifungal agent needed|1|||
48514473|NCT00635648|156076452|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
48514474|NCT00635648|156076452|FG000|Overall Study|Noncompliance with protocol|1|||
48514475|NCT00635648|156076452|FG000|Overall Study|Other reason|2|||
48514476|NCT03889639|156076453|FG000|Overall Study|Withdrawal by Subject|0|||
48514477|NCT03889639|156076454|FG001|Overall Study|Withdrawal by Subject|0|||
48514478|NCT03889639|156076455|FG002|Overall Study|Withdrawal by Subject|0|||
48514479|NCT03889639|156076456|FG003|Overall Study|Withdrawal by Subject|0|||
48514480|NCT03889639|156076457|FG004|Overall Study|Withdrawal by Subject|0|||
48514481|NCT03889639|156076458|FG005|Overall Study|Withdrawal by Subject|0|||
48514482|NCT03889639|156076459|FG006|Overall Study|Withdrawal by Subject|0|||
48514483|NCT03889639|156076460|FG007|Overall Study|Withdrawal by Subject|1|||
48514484|NCT01535222|156076461|FG000|Overall Study|Inclusion/exclusion|0|||
48514485|NCT01535222|156076462|FG001|Overall Study|Inclusion/exclusion|0|||
48514486|NCT01535222|156076463|FG002|Overall Study|Inclusion/exclusion|1|||
48514487|NCT01535222|156076464|FG003|Overall Study|Inclusion/exclusion|0|||
48514488|NCT01535222|156076465|FG004|Overall Study|Inclusion/exclusion|0|||
48514489|NCT01535222|156076466|FG005|Overall Study|Inclusion/exclusion|0|||
48514490|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
48514491|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
48514492|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
48514493|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
48514494|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
48514495|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
48514496|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
48382801|NCT02708095|155596784|FG001|Overall Study|Lost to Follow-up|0|||
48822701|NCT02081391|157190574|FG001|12-hour Treatment|Lack of Efficacy|0|||
48514497|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
48382802|NCT02708095|155596785|FG002|Overall Study|Lost to Follow-up|0|||
48514498|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
48514499|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
48514500|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
48514501|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
48514502|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
48514503|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
48514504|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
48514505|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
48514506|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
48514507|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
48514508|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
48730201|NCT00602667|156862997|FG002|Overall Study|Death|1|||
48730202|NCT00602667|156862995|FG000|Overall Study|Family request|3|||
48730203|NCT00602667|156862996|FG001|Overall Study|Family request|25|||
48730204|NCT00602667|156862997|FG002|Overall Study|Family request|6|||
48730205|NCT00602667|156862995|FG000|Overall Study|Excessive toxicity|1|||
48730206|NCT00602667|156862996|FG001|Overall Study|Excessive toxicity|1|||
48730207|NCT00602667|156862997|FG002|Overall Study|Excessive toxicity|0|||
48730208|NCT00602667|156862995|FG000|Overall Study|Second malignancy|0|||
48730209|NCT00602667|156862996|FG001|Overall Study|Second malignancy|1|||
48730210|NCT00602667|156862997|FG002|Overall Study|Second malignancy|0|||
48822702|NCT02081391|157190575|FG002|12-hour Treatment|Lack of Efficacy|0|||
48822703|NCT02081391|157190576|FG003|12-hour Treatment|Lack of Efficacy|0|||
48822704|NCT02081391|157190573|FG000|12-hour Treatment|Adverse Event|4|||
48822705|NCT02081391|157190574|FG001|12-hour Treatment|Adverse Event|2|||
48822706|NCT02081391|157190575|FG002|12-hour Treatment|Adverse Event|0|||
48822707|NCT02081391|157190576|FG003|12-hour Treatment|Adverse Event|0|||
48514509|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
48514510|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
48514511|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
48382803|NCT02708095|155596783|FG000|Overall Study|Physician Decision|2|||
48382804|NCT02708095|155596784|FG001|Overall Study|Physician Decision|3|||
48382805|NCT02708095|155596785|FG002|Overall Study|Physician Decision|2|||
48382806|NCT02708095|155596783|FG000|Overall Study|Protocol Violation|0|||
48382807|NCT02708095|155596784|FG001|Overall Study|Protocol Violation|0|||
48382808|NCT02708095|155596785|FG002|Overall Study|Protocol Violation|1|||
48822708|NCT02081391|157190573|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
48822709|NCT02081391|157190574|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
48514512|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
48382809|NCT02708095|155596783|FG000|Overall Study|Withdrawal by Subject|5|||
48730211|NCT00602667|156862995|FG000|Overall Study|Physician Decision|2|||
48730212|NCT00602667|156862996|FG001|Overall Study|Physician Decision|3|||
48822710|NCT02081391|157190575|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
48382810|NCT02708095|155596784|FG001|Overall Study|Withdrawal by Subject|3|||
48382811|NCT02708095|155596785|FG002|Overall Study|Withdrawal by Subject|4|||
48382812|NCT03701763|155596786|FG000|Placebo-controlled Phase|Adverse Event|1|||
48382813|NCT03701763|155596787|FG001|Placebo-controlled Phase|Adverse Event|5|||
48382814|NCT03701763|155596788|FG002|Placebo-controlled Phase|Adverse Event|0|||
48730213|NCT00602667|156862997|FG002|Overall Study|Physician Decision|8|||
48730214|NCT00602667|156862995|FG000|Overall Study|Progressive disease|13|||
48730215|NCT00602667|156862996|FG001|Overall Study|Progressive disease|48|||
48730216|NCT00602667|156862997|FG002|Overall Study|Progressive disease|45|||
48730217|NCT00602667|156862995|FG000|Overall Study|Progressive disease prior to therapy|0|||
48730218|NCT00602667|156862996|FG001|Overall Study|Progressive disease prior to therapy|0|||
48730219|NCT00602667|156862997|FG002|Overall Study|Progressive disease prior to therapy|1|||
48730220|NCT00445978|156862998|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
48730221|NCT00445978|156862998|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
48730222|NCT00445978|156862998|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
48730223|NCT00445978|156862998|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
48730224|NCT00445978|156862998|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
48730225|NCT00445978|156862998|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
48730226|NCT00445978|156862998|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
48730227|NCT00445978|156862998|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
48730228|NCT00445978|156862998|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
48730229|NCT01822496|156862999|FG000|Overall Study|Protocol Violation|2|||
48730230|NCT01822496|156863000|FG001|Overall Study|Protocol Violation|2|||
48730231|NCT01822496|156863001|FG002|Overall Study|Protocol Violation|0|||
48730232|NCT01822496|156863002|FG003|Overall Study|Protocol Violation|1|||
48730233|NCT01822496|156862999|FG000|Overall Study|Withdrawal by Subject|0|||
48730234|NCT01822496|156863000|FG001|Overall Study|Withdrawal by Subject|0|||
48730235|NCT01822496|156863001|FG002|Overall Study|Withdrawal by Subject|0|||
48730236|NCT01822496|156863002|FG003|Overall Study|Withdrawal by Subject|3|||
48730237|NCT01011738|156863003|FG000|Overall Study|Death|12|||
48730238|NCT01011738|156863004|FG001|Overall Study|Death|3|||
48730239|NCT01011738|156863005|FG002|Overall Study|Death|0|||
48730240|NCT01011738|156863003|FG000|Overall Study|Unknown reasons|312|||
48730241|NCT01011738|156863004|FG001|Overall Study|Unknown reasons|291|||
48730242|NCT01011738|156863005|FG002|Overall Study|Unknown reasons|17|||
48730243|NCT01163266|156863008|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
48730244|NCT01163266|156863009|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
48730245|NCT01163266|156863010|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
48730246|NCT01163266|156863008|FG000|Overall Study|Lack of Efficacy|1|||
48730247|NCT01163266|156863009|FG001|Overall Study|Lack of Efficacy|3|||
48730248|NCT01163266|156863010|FG002|Overall Study|Lack of Efficacy|1|||
48730249|NCT01163266|156863008|FG000|Overall Study|Noncompliance with Study Drug|0|||
48730250|NCT01163266|156863009|FG001|Overall Study|Noncompliance with Study Drug|2|||
48730251|NCT01163266|156863010|FG002|Overall Study|Noncompliance with Study Drug|0|||
48730252|NCT01163266|156863008|FG000|Overall Study|Protocol Deviations|2|||
48730253|NCT01163266|156863009|FG001|Overall Study|Protocol Deviations|2|||
48730254|NCT01163266|156863010|FG002|Overall Study|Protocol Deviations|5|||
48730255|NCT01163266|156863008|FG000|Overall Study|Withdrawal of Consent|5|||
48730256|NCT01163266|156863009|FG001|Overall Study|Withdrawal of Consent|7|||
48730257|NCT01163266|156863010|FG002|Overall Study|Withdrawal of Consent|3|||
48730258|NCT01163266|156863008|FG000|Overall Study|Lost to Follow-up|7|||
48730259|NCT01163266|156863009|FG001|Overall Study|Lost to Follow-up|7|||
48730260|NCT01163266|156863010|FG002|Overall Study|Lost to Follow-up|10|||
48730261|NCT01163266|156863008|FG000|Overall Study|Other|1|||
48730262|NCT01163266|156863009|FG001|Overall Study|Other|1|||
48730263|NCT01163266|156863010|FG002|Overall Study|Other|2|||
48730264|NCT02719327|156863015|FG000|Overall Study|Withdrawal by Subject|11|||
48730265|NCT02719327|156863016|FG001|Overall Study|Withdrawal by Subject|8|||
48730266|NCT05008055|156863021|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
48730267|NCT05008055|156863022|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
48730268|NCT05008055|156863023|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
48730269|NCT06238362|156863024|FG000|Overall Study|Insufficient total sleep time|1|||
48730270|NCT06238362|156863025|FG001|Overall Study|Insufficient total sleep time|0|||
48730271|NCT06238362|156863024|FG000|Overall Study|Inadequate signal quality|1|||
48730272|NCT06238362|156863025|FG001|Overall Study|Inadequate signal quality|0|||
48730273|NCT05419908|156863026|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
48730274|NCT05419908|156863027|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
48730275|NCT05419908|156863026|FG000|Overall Study|Serious Adverse Event|0|||
48730276|NCT05419908|156863027|FG001|Overall Study|Serious Adverse Event|2|||
48730277|NCT05419908|156863026|FG000|Overall Study|Withdrawal by Subject|2|||
48730278|NCT05419908|156863027|FG001|Overall Study|Withdrawal by Subject|0|||
48730279|NCT05419908|156863026|FG000|Overall Study|Miscellaneous|1|||
48730280|NCT05419908|156863027|FG001|Overall Study|Miscellaneous|1|||
48730281|NCT04493333|156864258|FG000|Overall Study|Withdrawal by Subject|1|||
48382815|NCT03701763|155596789|FG003|Placebo-controlled Phase|Adverse Event|0|||
48514513|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
48514514|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
48514515|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
48514516|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
48514517|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
48514518|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
48514519|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
48514520|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
48514521|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
48514522|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
48514523|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
48514524|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
48514525|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
48514526|NCT04194801|156076467|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
48514527|NCT04194801|156076468|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
48514528|NCT04194801|156076469|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
48514529|NCT04194801|156076467|FG000|Part Ib/II End of Study|Death|2|||
48514530|NCT04194801|156076468|FG001|Part Ib/II End of Study|Death|3|||
48514531|NCT04194801|156076469|FG002|Part Ib/II End of Study|Death|3|||
48514532|NCT04194801|156076467|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
48514533|NCT04194801|156076468|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
48514534|NCT04194801|156076469|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
48514535|NCT04194801|156076467|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
48514536|NCT04194801|156076468|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
48514537|NCT04194801|156076469|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
48514538|NCT04194801|156076467|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
48514539|NCT04194801|156076468|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
48514540|NCT04194801|156076469|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
48514541|NCT04194801|156076467|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
48514542|NCT04194801|156076468|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
48514543|NCT04194801|156076469|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
48514544|NCT01442155|156076473|FG000|Overall Study|Complete remission|35|||
48514545|NCT01442155|156076473|FG000|Overall Study|Recurrence|26|||
48514546|NCT01442155|156076473|FG000|Overall Study|Adverse Event|2|||
48514547|NCT01442155|156076473|FG000|Overall Study|Lost to Follow-up|2|||
48514548|NCT03707587|156076474|FG000|Overall Study|Death|0|||
48514549|NCT03707587|156076475|FG001|Overall Study|Death|1|||
48514550|NCT02760927|156076476|FG000|Overall Study|Tube Slippage from Device|1|||
48514551|NCT00705666|156076477|FG000|Overall Study|No post-treatment questionnaire|279|||
48514552|NCT00705666|156076477|FG000|Overall Study|Withdrawal by Subject|21|||
48514553|NCT00705666|156076477|FG000|Overall Study|Physician Decision|7|||
48514554|NCT00705666|156076477|FG000|Overall Study|Lost to Follow-up|5|||
48514555|NCT00705666|156076477|FG000|Overall Study|Death|1|||
48514556|NCT00705666|156076477|FG000|Overall Study|Adverse Event|4|||
48514557|NCT00705666|156076477|FG000|Overall Study|Other|12|||
48514558|NCT00705666|156076477|FG000|Overall Study|Other|2|||
48514559|NCT00705666|156076477|FG000|Overall Study|Lack of data|3|||
48514560|NCT00705666|156076477|FG000|Overall Study|Untreated|5|||
48382816|NCT03701763|155596786|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
48382817|NCT03701763|155596787|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
48382818|NCT03701763|155596788|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
48382819|NCT03701763|155596789|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
48382820|NCT03701763|155596786|FG000|Placebo-controlled Phase|Miscellaneous|2|||
48382821|NCT03701763|155596787|FG001|Placebo-controlled Phase|Miscellaneous|0|||
48382822|NCT03701763|155596788|FG002|Placebo-controlled Phase|Miscellaneous|0|||
48382823|NCT03701763|155596789|FG003|Placebo-controlled Phase|Miscellaneous|0|||
48382824|NCT03701763|155596786|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
48382825|NCT03701763|155596787|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
48382826|NCT03701763|155596788|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
48382827|NCT03701763|155596789|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
48382828|NCT03701763|155596786|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
48382829|NCT03701763|155596787|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
48382830|NCT03701763|155596788|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
48382831|NCT03701763|155596789|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
48382832|NCT03701763|155596786|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
48382833|NCT03701763|155596787|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
48382834|NCT03701763|155596788|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
48382835|NCT03701763|155596789|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
48382836|NCT03701763|155596786|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
48382837|NCT03701763|155596787|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
48514561|NCT00506831|156076480|FG000|Overall Study|Death|1|||
48514562|NCT00506831|156076480|FG000|Overall Study|Withdrawal by Subject|1|||
48514563|NCT02105272|156076482|FG000|Overall Study|Adverse Event|1|||
48514564|NCT02105272|156076483|FG001|Overall Study|Adverse Event|2|||
48514565|NCT02105272|156076482|FG000|Overall Study|Physician Decision|0|||
48514566|NCT02105272|156076483|FG001|Overall Study|Physician Decision|1|||
48514567|NCT02105272|156076482|FG000|Overall Study|Protocol Violation|2|||
48514568|NCT02105272|156076483|FG001|Overall Study|Protocol Violation|0|||
48514569|NCT02105272|156076482|FG000|Overall Study|Withdrawal by Subject|2|||
48514570|NCT02105272|156076483|FG001|Overall Study|Withdrawal by Subject|0|||
48514571|NCT03930732|156076487|FG000|Overall Study|Adverse Event|9|||
48514572|NCT03930732|156076488|FG001|Overall Study|Adverse Event|7|||
48514573|NCT03930732|156076487|FG000|Overall Study|Poor compliance to protocol|0|||
48514574|NCT03930732|156076488|FG001|Overall Study|Poor compliance to protocol|1|||
48514575|NCT03930732|156076487|FG000|Overall Study|Withdrawal by Subject|23|||
48514576|NCT03930732|156076488|FG001|Overall Study|Withdrawal by Subject|11|||
48514577|NCT03930732|156076487|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
48514578|NCT03930732|156076488|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
48514579|NCT03930732|156076487|FG000|Overall Study|Other reason not related to COVID-19|5|||
48514580|NCT03930732|156076488|FG001|Overall Study|Other reason not related to COVID-19|8|||
48514581|NCT01075282|156076489|FG000|Overall Study|Withdrawal by Subject|11|||
48514582|NCT01075282|156076490|FG001|Overall Study|Withdrawal by Subject|7|||
48514583|NCT01075282|156076491|FG002|Overall Study|Withdrawal by Subject|11|||
48514584|NCT01075282|156076489|FG000|Overall Study|Adverse Event|9|||
48514585|NCT01075282|156076490|FG001|Overall Study|Adverse Event|8|||
48514586|NCT01075282|156076491|FG002|Overall Study|Adverse Event|5|||
48514587|NCT01075282|156076489|FG000|Overall Study|Entry Criteria Not Met|3|||
48514588|NCT01075282|156076490|FG001|Overall Study|Entry Criteria Not Met|2|||
48514589|NCT01075282|156076491|FG002|Overall Study|Entry Criteria Not Met|0|||
48514590|NCT01075282|156076489|FG000|Overall Study|Lost to Follow-up|3|||
48514591|NCT01075282|156076490|FG001|Overall Study|Lost to Follow-up|3|||
48514592|NCT01075282|156076491|FG002|Overall Study|Lost to Follow-up|3|||
48514593|NCT01075282|156076489|FG000|Overall Study|Physician Decision|3|||
48514594|NCT01075282|156076490|FG001|Overall Study|Physician Decision|3|||
48514595|NCT01075282|156076491|FG002|Overall Study|Physician Decision|3|||
48514596|NCT01075282|156076489|FG000|Overall Study|Lack of Efficacy|1|||
48514597|NCT01075282|156076490|FG001|Overall Study|Lack of Efficacy|1|||
48514598|NCT01075282|156076491|FG002|Overall Study|Lack of Efficacy|0|||
48514599|NCT01075282|156076489|FG000|Overall Study|Treatment Non-compliance|1|||
48514600|NCT01075282|156076490|FG001|Overall Study|Treatment Non-compliance|2|||
48514601|NCT01075282|156076491|FG002|Overall Study|Treatment Non-compliance|2|||
48514602|NCT01075282|156076489|FG000|Overall Study|Protocol Violation|0|||
48514603|NCT01075282|156076490|FG001|Overall Study|Protocol Violation|2|||
48514604|NCT01075282|156076491|FG002|Overall Study|Protocol Violation|1|||
48514605|NCT01075282|156076489|FG000|Overall Study|Death|0|||
48514606|NCT01075282|156076490|FG001|Overall Study|Death|1|||
48514607|NCT01075282|156076491|FG002|Overall Study|Death|2|||
48514608|NCT01252953|156076497|FG000|Overall Study|Withdrawal by Subject|16|||
48514609|NCT01252953|156076498|FG001|Overall Study|Withdrawal by Subject|17|||
48514610|NCT01252953|156076497|FG000|Overall Study|Lost to Follow-up|22|||
48514611|NCT01252953|156076498|FG001|Overall Study|Lost to Follow-up|21|||
48514612|NCT05616728|156076499|FG000|Overall Study|Lost to Follow-up|0|||
48514613|NCT05616728|156076500|FG001|Overall Study|Lost to Follow-up|0|||
48514614|NCT05616728|156076501|FG002|Overall Study|Lost to Follow-up|1|||
48514615|NCT05616728|156076499|FG000|Overall Study|Withdrawal by Subject|1|||
48514616|NCT05616728|156076500|FG001|Overall Study|Withdrawal by Subject|1|||
48514617|NCT05616728|156076501|FG002|Overall Study|Withdrawal by Subject|0|||
48514618|NCT05616728|156076499|FG000|Overall Study|Physician Decision|1|||
48514619|NCT05616728|156076500|FG001|Overall Study|Physician Decision|1|||
48514620|NCT05616728|156076501|FG002|Overall Study|Physician Decision|1|||
48514621|NCT05616728|156076499|FG000|Overall Study|Other|0|||
48514622|NCT05616728|156076500|FG001|Overall Study|Other|2|||
48514623|NCT05616728|156076501|FG002|Overall Study|Other|0|||
48514624|NCT01926119|156076504|FG000|Overall Study|Withdrawal by Subject|1|||
48514625|NCT00957021|156076505|FG000|Overall Study|Death|5|||
48514626|NCT00957021|156076505|FG000|Overall Study|Lost to Follow-up|8|||
48514627|NCT00957021|156076505|FG000|Overall Study|Withdrawal by Subject|34|||
48514628|NCT00957021|156076505|FG000|Overall Study|No 2 yr ROM data|35|||
48514629|NCT00957021|156076505|FG000|Overall Study|Revised study component by 2 yr visit|8|||
48514630|NCT00957021|156076505|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
48514631|NCT00957021|156076505|FG000|Overall Study|Surgery Cancelled|9|||
48514632|NCT00957021|156076505|FG000|Overall Study|Termination due to language issue|2|||
48514633|NCT00672984|156076511|FG000|First Intervention|Adverse Event|5|||
48514634|NCT00672984|156076512|FG001|First Intervention|Adverse Event|0|||
48514635|NCT00672984|156076513|FG002|First Intervention|Adverse Event|0|||
48514636|NCT00672984|156076511|FG000|First Intervention|Withdrawal by Subject|1|||
48514637|NCT00672984|156076512|FG001|First Intervention|Withdrawal by Subject|2|||
48514638|NCT00672984|156076513|FG002|First Intervention|Withdrawal by Subject|2|||
48514639|NCT00672984|156076511|FG000|First Intervention|Sponsor decision|3|||
48514640|NCT00672984|156076512|FG001|First Intervention|Sponsor decision|0|||
48514641|NCT00672984|156076513|FG002|First Intervention|Sponsor decision|0|||
48514642|NCT00672984|156076511|FG000|Second Intervention|Non-compliance with facility policies|0|||
48514643|NCT00672984|156076512|FG001|Second Intervention|Non-compliance with facility policies|2|||
48514644|NCT00672984|156076513|FG002|Second Intervention|Non-compliance with facility policies|0|||
48514645|NCT00672984|156076511|FG000|Second Intervention|Withdrawal by Subject|0|||
48514646|NCT00672984|156076512|FG001|Second Intervention|Withdrawal by Subject|3|||
48514647|NCT00672984|156076513|FG002|Second Intervention|Withdrawal by Subject|0|||
48514648|NCT00672984|156076511|FG000|Second Intervention|Protocol Violation|0|||
48514649|NCT00672984|156076512|FG001|Second Intervention|Protocol Violation|1|||
48514650|NCT00672984|156076513|FG002|Second Intervention|Protocol Violation|1|||
48514651|NCT00672984|156076511|FG000|Third Intervention|Adverse Event|1|||
48514652|NCT00672984|156076512|FG001|Third Intervention|Adverse Event|0|||
48514653|NCT00672984|156076513|FG002|Third Intervention|Adverse Event|1|||
48514654|NCT03218787|156076522|FG000|Overall Study|Lost to Follow-up|12|||
48514655|NCT03218787|156076522|FG000|Overall Study|Withdrawal by Subject|72|||
48514656|NCT03218787|156076522|FG000|Overall Study|Physician Decision|11|||
48514657|NCT03218787|156076522|FG000|Overall Study|Death|111|||
48514658|NCT01576705|156076523|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
48514659|NCT01576705|156076524|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
48514660|NCT01576705|156076525|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
48382838|NCT03701763|155596788|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
48382839|NCT03701763|155596789|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
48382840|NCT03701763|155596786|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
48382841|NCT03701763|155596787|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
48382842|NCT03701763|155596788|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
48382843|NCT03701763|155596789|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
48382844|NCT03701763|155596786|FG000|Apremilast Extension Phase|Adverse Event|0|||
48382845|NCT03701763|155596787|FG001|Apremilast Extension Phase|Adverse Event|0|||
48382846|NCT03701763|155596788|FG002|Apremilast Extension Phase|Adverse Event|3|||
48382847|NCT03701763|155596789|FG003|Apremilast Extension Phase|Adverse Event|1|||
48382848|NCT03701763|155596786|FG000|Apremilast Extension Phase|Miscellaneous|0|||
48382849|NCT03701763|155596787|FG001|Apremilast Extension Phase|Miscellaneous|0|||
48382850|NCT03701763|155596788|FG002|Apremilast Extension Phase|Miscellaneous|2|||
48382851|NCT03701763|155596789|FG003|Apremilast Extension Phase|Miscellaneous|1|||
48382852|NCT03701763|155596786|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
48382853|NCT03701763|155596787|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
48382854|NCT03701763|155596788|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
48382855|NCT03701763|155596789|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
48382856|NCT03701763|155596786|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
48382857|NCT03701763|155596787|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
48514661|NCT01576705|156076526|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
48514662|NCT01576705|156076523|FG000|Overall Study|invalid ICF|0|||
48514663|NCT01576705|156076524|FG001|Overall Study|invalid ICF|1|||
48382858|NCT03701763|155596788|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
48382859|NCT03701763|155596789|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
48382860|NCT03701763|155596786|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
48382861|NCT03701763|155596787|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
48382862|NCT03701763|155596788|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
48382863|NCT03701763|155596789|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
48382864|NCT03701763|155596786|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
48382865|NCT03701763|155596787|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
48514664|NCT01576705|156076525|FG002|Overall Study|invalid ICF|0|||
48514665|NCT01576705|156076526|FG003|Overall Study|invalid ICF|0|||
48514666|NCT02272803|156076527|FG000|Overall Study|Disease progression|16|||
48514667|NCT02272803|156076528|FG001|Overall Study|Disease progression|8|||
48514668|NCT02272803|156076527|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
48514669|NCT02272803|156076528|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
48514670|NCT02272803|156076527|FG000|Overall Study|Study drug toxicity|4|||
48514671|NCT02272803|156076528|FG001|Overall Study|Study drug toxicity|9|||
48514672|NCT02272803|156076527|FG000|Overall Study|Participant request to discontinue study treatment|3|||
48514673|NCT02272803|156076528|FG001|Overall Study|Participant request to discontinue study treatment|7|||
48382866|NCT03701763|155596788|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
48382867|NCT03701763|155596789|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
48382868|NCT03701763|155596786|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
48382869|NCT03701763|155596787|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
48382870|NCT03701763|155596788|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
48382871|NCT03701763|155596789|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
48382872|NCT03701763|155596786|FG000|14-Week Observational Follow-up Phase|Other|0|||
48514674|NCT02272803|156076527|FG000|Overall Study|Maximum clinical benefit|4|||
48514675|NCT02272803|156076528|FG001|Overall Study|Maximum clinical benefit|2|||
48514676|NCT02272803|156076527|FG000|Overall Study|Poor/non-compliance|2|||
48514677|NCT02272803|156076528|FG001|Overall Study|Poor/non-compliance|2|||
48514678|NCT02272803|156076527|FG000|Overall Study|Withdrawal by Subject|2|||
48514679|NCT02272803|156076528|FG001|Overall Study|Withdrawal by Subject|1|||
48514680|NCT02272803|156076527|FG000|Overall Study|Death|0|||
48514681|NCT02272803|156076528|FG001|Overall Study|Death|1|||
48514682|NCT02272803|156076527|FG000|Overall Study|Other reasons|1|||
48514683|NCT02272803|156076528|FG001|Overall Study|Other reasons|3|||
48514684|NCT02272803|156076527|FG000|Overall Study|Administrative reason by sponsor|5|||
48514685|NCT02272803|156076528|FG001|Overall Study|Administrative reason by sponsor|4|||
48514686|NCT02264977|156076529|FG000|Overall Study|Death|3|||
48514687|NCT02264977|156076529|FG000|Overall Study|Physician Decision|1|||
48514688|NCT02264977|156076529|FG000|Overall Study|Refuse to return|1|||
48514689|NCT00796562|156076536|FG000|Overall Study|Death|49|||
48514690|NCT04223791|156076537|FG000|Overall Study|Lost to Follow-up|0|||
48514691|NCT04223791|156076538|FG001|Overall Study|Lost to Follow-up|4|||
48514692|NCT04223791|156076537|FG000|Overall Study|Physician Decision|5|||
48514693|NCT04223791|156076538|FG001|Overall Study|Physician Decision|1|||
48514694|NCT04223791|156076537|FG000|Overall Study|Protocol Violation|1|||
48514695|NCT04223791|156076538|FG001|Overall Study|Protocol Violation|1|||
48514696|NCT04223791|156076537|FG000|Overall Study|Withdrawal by Subject|10|||
48514697|NCT04223791|156076538|FG001|Overall Study|Withdrawal by Subject|12|||
48514698|NCT04223791|156076537|FG000|Overall Study|Pregnancy|1|||
48514699|NCT04223791|156076538|FG001|Overall Study|Pregnancy|1|||
48514700|NCT04223791|156076537|FG000|Overall Study|Ongoing in Study|305|||
48514701|NCT04223791|156076538|FG001|Overall Study|Ongoing in Study|302|||
48514702|NCT02475681|156078407|FG000|Overall Study|Death|16|||
48514703|NCT02475681|156078408|FG001|Overall Study|Death|6|||
48514704|NCT02475681|156078409|FG002|Overall Study|Death|9|||
48514705|NCT02475681|156078407|FG000|Overall Study|Physician Decision|0|||
48514706|NCT02475681|156078408|FG001|Overall Study|Physician Decision|3|||
48514707|NCT02475681|156078409|FG002|Overall Study|Physician Decision|1|||
48514708|NCT02475681|156078407|FG000|Overall Study|Withdrawal by Subject|12|||
48514709|NCT02475681|156078408|FG001|Overall Study|Withdrawal by Subject|6|||
48514710|NCT02475681|156078409|FG002|Overall Study|Withdrawal by Subject|9|||
48514711|NCT02475681|156078407|FG000|Overall Study|Lost to Follow-up|2|||
48514712|NCT02475681|156078408|FG001|Overall Study|Lost to Follow-up|1|||
48514713|NCT02475681|156078409|FG002|Overall Study|Lost to Follow-up|3|||
48514714|NCT02475681|156078407|FG000|Overall Study|Ongoing in Study|0|||
48514715|NCT02475681|156078408|FG001|Overall Study|Ongoing in Study|163|||
48514716|NCT02475681|156078409|FG002|Overall Study|Ongoing in Study|157|||
48514717|NCT02475681|156078407|FG000|Overall Study|Reasons other than above listed|2|||
48514718|NCT02475681|156078408|FG001|Overall Study|Reasons other than above listed|0|||
48514719|NCT02475681|156078409|FG002|Overall Study|Reasons other than above listed|0|||
48514720|NCT00798603|156078410|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
48514721|NCT00798603|156078410|FG000|Overall Study|Withdrawal by Subject|10|||
48514722|NCT00798603|156078410|FG000|Overall Study|Adverse Event|22|||
48514723|NCT00798603|156078410|FG000|Overall Study|Physician Decision|1|||
48514724|NCT00798603|156078410|FG000|Overall Study|Lack of insurance coverage|1|||
48514725|NCT00835705|156078411|FG000|First Intervention|Difficulty with vein|1|||
48514726|NCT00835705|156078412|FG001|First Intervention|Difficulty with vein|0|||
48514727|NCT00835705|156078411|FG000|Second Intervention|Difficulty with vein|1|||
48514728|NCT00835705|156078412|FG001|Second Intervention|Difficulty with vein|0|||
48514729|NCT00594035|156078413|FG000|Overall Study|Lost to Follow-up|1|||
48514730|NCT00594035|156078414|FG001|Overall Study|Lost to Follow-up|1|||
48514731|NCT00594035|156078413|FG000|Overall Study|Withdrawal by Subject|1|||
48514732|NCT00594035|156078414|FG001|Overall Study|Withdrawal by Subject|0|||
48382873|NCT03701763|155596787|FG001|14-Week Observational Follow-up Phase|Other|0|||
48382874|NCT03701763|155596788|FG002|14-Week Observational Follow-up Phase|Other|1|||
48382875|NCT03701763|155596789|FG003|14-Week Observational Follow-up Phase|Other|0|||
48382876|NCT03701763|155596786|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
48382877|NCT03701763|155596787|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
48382878|NCT03701763|155596788|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
48382879|NCT03701763|155596789|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
48514733|NCT00594035|156078413|FG000|Overall Study|Subject transferred to nursing home|0|||
48514734|NCT00594035|156078414|FG001|Overall Study|Subject transferred to nursing home|1|||
48514735|NCT00594035|156078413|FG000|Overall Study|Subject couldn't return due to job|0|||
48514736|NCT00594035|156078414|FG001|Overall Study|Subject couldn't return due to job|1|||
48514737|NCT04035187|156078415|FG000|Overall Study|Withdrawal by Subject|2|||
48514738|NCT04035187|156078416|FG001|Overall Study|Withdrawal by Subject|1|||
48514739|NCT04035187|156078417|FG002|Overall Study|Withdrawal by Subject|0|||
48382880|NCT03701763|155596786|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
48514740|NCT04035187|156078418|FG003|Overall Study|Withdrawal by Subject|0|||
48514741|NCT04035187|156078415|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
48514742|NCT04035187|156078416|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
48514743|NCT04035187|156078417|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
48584945|NCT00743288|156333715|FG001|Overall Study|Progressive disease (PD)|0|||
48382881|NCT03701763|155596787|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
48382882|NCT03701763|155596788|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
48382883|NCT03701763|155596789|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
48382884|NCT02273726|155596796|FG000|Overall Study|Death|70|||
48382885|NCT02273726|155596797|FG001|Overall Study|Death|62|||
48382886|NCT02273726|155596796|FG000|Overall Study|Withdrawal by Subject|41|||
48382887|NCT02273726|155596797|FG001|Overall Study|Withdrawal by Subject|29|||
48382888|NCT02273726|155596796|FG000|Overall Study|Kidney transplant|31|||
48382889|NCT02273726|155596797|FG001|Overall Study|Kidney transplant|39|||
48382890|NCT02273726|155596796|FG000|Overall Study|Physician Decision|30|||
48382891|NCT02273726|155596797|FG001|Overall Study|Physician Decision|15|||
48382892|NCT02273726|155596796|FG000|Overall Study|Adverse Event|27|||
48382893|NCT02273726|155596797|FG001|Overall Study|Adverse Event|9|||
48382894|NCT02273726|155596796|FG000|Overall Study|Lost to Follow-up|6|||
48382895|NCT02273726|155596797|FG001|Overall Study|Lost to Follow-up|3|||
48382896|NCT02273726|155596796|FG000|Overall Study|Lack of Efficacy|6|||
48382897|NCT02273726|155596797|FG001|Overall Study|Lack of Efficacy|1|||
48382898|NCT02273726|155596796|FG000|Overall Study|Protocol Violation|4|||
48382899|NCT02273726|155596797|FG001|Overall Study|Protocol Violation|0|||
48382900|NCT02273726|155596796|FG000|Overall Study|Other than specified|28|||
48382901|NCT02273726|155596797|FG001|Overall Study|Other than specified|30|||
48382902|NCT01019980|155596798|FG000|Overall Study|Drug not available.|2|||
48382903|NCT01019980|155596799|FG001|Overall Study|Drug not available.|0|||
48382904|NCT01979835|155596803|FG000|Primary Outcome SA Measurment|failed insertion|18|||
48382905|NCT01979835|155596803|FG000|Follow-up|Lost to Follow-up|32|||
48382906|NCT00601250|155596806|FG000|Overall Study|Adverse Event|3|||
48382907|NCT00601250|155596807|FG001|Overall Study|Adverse Event|9|||
48382908|NCT00601250|155596806|FG000|Overall Study|Protocol Violation|3|||
48382909|NCT00601250|155596807|FG001|Overall Study|Protocol Violation|2|||
48382910|NCT00601250|155596806|FG000|Overall Study|Lost to Follow-up|2|||
48382911|NCT00601250|155596807|FG001|Overall Study|Lost to Follow-up|6|||
48382912|NCT00601250|155596806|FG000|Overall Study|Withdrawal by Subject|4|||
48382913|NCT00601250|155596807|FG001|Overall Study|Withdrawal by Subject|13|||
48514744|NCT04035187|156078418|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
48514745|NCT00470704|156078425|FG000|Overall Study|Withdrawal by Subject|4|||
48514746|NCT00470704|156078426|FG001|Overall Study|Withdrawal by Subject|3|||
48514747|NCT00470704|156078425|FG000|Overall Study|Relapse/Progression|37|||
48514748|NCT00470704|156078426|FG001|Overall Study|Relapse/Progression|42|||
48514749|NCT00470704|156078425|FG000|Overall Study|toxicity|0|||
48514750|NCT00470704|156078426|FG001|Overall Study|toxicity|1|||
48514751|NCT01695239|156078428|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
48514752|NCT01695239|156078429|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
48514753|NCT01695239|156078430|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
48514754|NCT01695239|156078431|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
48514755|NCT01695239|156078432|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514756|NCT01695239|156078433|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514757|NCT01695239|156078434|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514758|NCT01695239|156078435|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514759|NCT01695239|156078436|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514760|NCT01695239|156078437|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514761|NCT01695239|156078438|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514762|NCT01695239|156078439|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514763|NCT01695239|156078440|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514764|NCT01695239|156078441|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
48514765|NCT01695239|156078428|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
48514766|NCT01695239|156078429|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
48514767|NCT01695239|156078430|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
48514768|NCT01695239|156078431|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
48514769|NCT01695239|156078432|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48514770|NCT01695239|156078433|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48601106|NCT02718911|156396040|FG000|Overall Study|Death|2|||
48382914|NCT00601250|155596806|FG000|Overall Study|Other incl. lack of efficacy|2|||
48382915|NCT00601250|155596807|FG001|Overall Study|Other incl. lack of efficacy|9|||
48382916|NCT00047320|155596809|FG000|Overall Study|Lack of Efficacy|8|||
48382917|NCT00047320|155596809|FG000|Overall Study|Lost to Follow-up|1|||
48382918|NCT00047320|155596809|FG000|Overall Study|Physician Decision|8|||
48382919|NCT00047320|155596809|FG000|Overall Study|Withdrawal by Subject|9|||
48382920|NCT00047320|155596809|FG000|Overall Study|Ineligible|2|||
48382921|NCT02818920|155596811|FG000|Overall Study|Unresectable|4|||
48382922|NCT02818920|155596811|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
48382923|NCT02818920|155596811|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
48382924|NCT02818920|155596811|FG000|Overall Study|Adverse Event|3|||
48382925|NCT02818920|155596811|FG000|Overall Study|Developed Other Disease|1|||
48382926|NCT02818920|155596811|FG000|Overall Study|Refused Further Treatment|1|||
48514771|NCT01695239|156078434|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48514772|NCT01695239|156078435|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48514773|NCT01695239|156078436|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48730282|NCT04493333|156864259|FG001|Overall Study|Withdrawal by Subject|1|||
48730283|NCT04493333|156864258|FG000|Overall Study|Ineligible|0|||
48730284|NCT04493333|156864259|FG001|Overall Study|Ineligible|1|||
48730285|NCT04493333|156864258|FG000|Overall Study|Noncompliance|2|||
48730286|NCT04493333|156864259|FG001|Overall Study|Noncompliance|1|||
48730287|NCT00674973|156864260|FG000|Overall Study|Insufficient Therapeutic Response|77|||
48514774|NCT01695239|156078437|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48514775|NCT01695239|156078438|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48514776|NCT01695239|156078439|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48514777|NCT01695239|156078440|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48514778|NCT01695239|156078441|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48514779|NCT01695239|156078428|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
48514780|NCT01695239|156078429|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514781|NCT01695239|156078430|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
48514782|NCT01695239|156078431|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514783|NCT01695239|156078432|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514784|NCT01695239|156078433|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514785|NCT01695239|156078434|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514786|NCT01695239|156078435|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514787|NCT01695239|156078436|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514788|NCT01695239|156078437|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514789|NCT01695239|156078438|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514790|NCT01695239|156078439|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514791|NCT01695239|156078440|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48730288|NCT00674973|156864261|FG001|Overall Study|Insufficient Therapeutic Response|72|||
48730289|NCT00674973|156864260|FG000|Overall Study|Refused Treatment|1|||
48730290|NCT00674973|156864261|FG001|Overall Study|Refused Treatment|5|||
48730291|NCT00674973|156864260|FG000|Overall Study|Failure to Return|1|||
48514792|NCT01695239|156078441|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48514793|NCT01695239|156078428|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
48514794|NCT01695239|156078429|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
48514795|NCT01695239|156078430|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
48514796|NCT01695239|156078431|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514797|NCT01695239|156078432|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514798|NCT01695239|156078433|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514799|NCT01695239|156078434|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514800|NCT01695239|156078435|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514801|NCT01695239|156078436|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514802|NCT01695239|156078437|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514803|NCT01695239|156078438|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48730292|NCT00674973|156864261|FG001|Overall Study|Failure to Return|0|||
48730293|NCT00674973|156864260|FG000|Overall Study|Adverse Event|2|||
48730294|NCT00674973|156864261|FG001|Overall Study|Adverse Event|9|||
48730295|NCT00674973|156864260|FG000|Overall Study|Death|19|||
48730296|NCT00674973|156864261|FG001|Overall Study|Death|15|||
48730297|NCT00674973|156864260|FG000|Overall Study|Protocol Violation|0|||
48730298|NCT00674973|156864261|FG001|Overall Study|Protocol Violation|1|||
48730299|NCT01801072|156864262|FG000|Overall Study|Lost to Follow-up|17|||
48730300|NCT01801072|156864263|FG001|Overall Study|Lost to Follow-up|14|||
48730301|NCT01801072|156864262|FG000|Overall Study|Physician Decision|2|||
48730302|NCT01801072|156864263|FG001|Overall Study|Physician Decision|3|||
48730303|NCT01801072|156864262|FG000|Overall Study|Withdrawal by Subject|1|||
48730304|NCT01801072|156864263|FG001|Overall Study|Withdrawal by Subject|0|||
48730305|NCT01801072|156864262|FG000|Overall Study|Protocol Violation|2|||
48730306|NCT01801072|156864263|FG001|Overall Study|Protocol Violation|0|||
48730307|NCT01801072|156864262|FG000|Overall Study|Death|7|||
48730308|NCT01801072|156864263|FG001|Overall Study|Death|8|||
48730309|NCT03190369|156864265|FG000|Overall Study|Poor compliance to protocol|0|||
48730310|NCT03190369|156864266|FG001|Overall Study|Poor compliance to protocol|1|||
48730311|NCT03190369|156864265|FG000|Overall Study|Withdraw before treatment|1|||
48730312|NCT03190369|156864266|FG001|Overall Study|Withdraw before treatment|5|||
48730313|NCT03190369|156864265|FG000|Overall Study|Randomized but not treated|0|||
48730314|NCT03190369|156864266|FG001|Overall Study|Randomized but not treated|2|||
48730315|NCT01143207|156864267|FG000|Overall Study|Lost to Follow-up|2|||
48730316|NCT00116168|156864268|FG000|Overall Study|Lost to Follow-up|6|||
48730317|NCT00116168|156864269|FG001|Overall Study|Lost to Follow-up|5|||
48730318|NCT00116168|156864270|FG002|Overall Study|Lost to Follow-up|0|||
48730319|NCT00116168|156864271|FG003|Overall Study|Lost to Follow-up|0|||
48730320|NCT03555435|156864272|FG000|Overall Study|Lost to Follow-up|17|||
48730321|NCT03555435|156864273|FG001|Overall Study|Lost to Follow-up|19|||
48514804|NCT01695239|156078439|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514805|NCT01695239|156078440|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514806|NCT01695239|156078441|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48514807|NCT01695239|156078428|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
48514808|NCT01695239|156078429|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514809|NCT01695239|156078430|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
48514810|NCT01695239|156078431|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514811|NCT01695239|156078432|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514812|NCT01695239|156078433|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514813|NCT01695239|156078434|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514814|NCT01695239|156078435|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514815|NCT01695239|156078436|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514816|NCT01695239|156078437|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514817|NCT01695239|156078438|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514818|NCT01695239|156078439|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514819|NCT01695239|156078440|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514820|NCT01695239|156078441|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
48514821|NCT01695239|156078428|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
48514822|NCT01695239|156078429|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514823|NCT01695239|156078430|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
48514824|NCT01695239|156078431|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514825|NCT01695239|156078432|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514826|NCT01695239|156078433|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514827|NCT01695239|156078434|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514828|NCT01695239|156078435|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514829|NCT01695239|156078436|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514830|NCT01695239|156078437|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514831|NCT01695239|156078438|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514832|NCT01695239|156078439|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514833|NCT01695239|156078440|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514834|NCT01695239|156078441|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48514835|NCT01695239|156078428|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
48514836|NCT01695239|156078429|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514837|NCT01695239|156078430|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514838|NCT01695239|156078431|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514839|NCT01695239|156078432|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514840|NCT01695239|156078433|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514841|NCT01695239|156078434|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514842|NCT01695239|156078435|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514843|NCT01695239|156078436|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514844|NCT01695239|156078437|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514845|NCT01695239|156078438|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514846|NCT01695239|156078439|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514847|NCT01695239|156078440|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514848|NCT01695239|156078441|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48514849|NCT01695239|156078428|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514850|NCT01695239|156078429|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514851|NCT01695239|156078430|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514852|NCT01695239|156078431|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514853|NCT01695239|156078432|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514854|NCT01695239|156078433|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514855|NCT01695239|156078434|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514856|NCT01695239|156078435|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
48514857|NCT01695239|156078436|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514858|NCT01695239|156078437|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514859|NCT01695239|156078438|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514860|NCT01695239|156078439|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514861|NCT01695239|156078440|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514862|NCT01695239|156078441|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
48514863|NCT01695239|156078428|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514864|NCT01695239|156078429|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514865|NCT01695239|156078430|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514866|NCT01695239|156078431|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514867|NCT01695239|156078432|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514868|NCT01695239|156078433|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48601107|NCT02718911|156396041|FG001|Overall Study|Death|3|||
48514869|NCT01695239|156078434|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514870|NCT01695239|156078435|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
48514871|NCT01695239|156078436|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514872|NCT01695239|156078437|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514873|NCT01695239|156078438|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514874|NCT01695239|156078439|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514875|NCT01695239|156078440|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514876|NCT01695239|156078441|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
48514877|NCT01695239|156078428|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514878|NCT01695239|156078429|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514879|NCT01695239|156078430|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514880|NCT01695239|156078431|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514881|NCT01695239|156078432|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514882|NCT01695239|156078433|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514883|NCT01695239|156078434|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514884|NCT01695239|156078435|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
48514885|NCT01695239|156078436|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514886|NCT01695239|156078437|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514887|NCT01695239|156078438|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514888|NCT01695239|156078439|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514889|NCT01695239|156078440|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514890|NCT01695239|156078441|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
48514891|NCT01695239|156078428|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514892|NCT01695239|156078429|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514893|NCT01695239|156078430|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514894|NCT01695239|156078431|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514895|NCT01695239|156078432|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514896|NCT01695239|156078433|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514897|NCT01695239|156078434|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514898|NCT01695239|156078435|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514899|NCT01695239|156078436|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
48514900|NCT01695239|156078437|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
48514901|NCT01695239|156078438|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514902|NCT01695239|156078439|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514903|NCT01695239|156078440|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514904|NCT01695239|156078441|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
48514905|NCT01695239|156078428|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
48514906|NCT01695239|156078429|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
48514907|NCT01695239|156078430|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
48514908|NCT01695239|156078431|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
48514909|NCT01695239|156078432|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
48514910|NCT01695239|156078433|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
48514911|NCT01695239|156078434|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
48514912|NCT01695239|156078435|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
48514913|NCT01695239|156078436|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
48514914|NCT01695239|156078437|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
48514915|NCT01695239|156078438|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
48514916|NCT01695239|156078439|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
48514917|NCT01695239|156078440|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
48514918|NCT01695239|156078441|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
48514919|NCT01695239|156078428|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514920|NCT01695239|156078429|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514921|NCT01695239|156078430|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514922|NCT01695239|156078431|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514923|NCT01695239|156078432|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514924|NCT01695239|156078433|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514925|NCT01695239|156078434|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514926|NCT01695239|156078435|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514927|NCT01695239|156078436|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
48514928|NCT01695239|156078437|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
48514929|NCT01695239|156078438|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514930|NCT01695239|156078439|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514931|NCT01695239|156078440|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48514932|NCT01695239|156078441|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
48382927|NCT00445068|155596812|FG000|Overall Study|Disease progression|26|||
48382928|NCT00445068|155596812|FG000|Overall Study|Adverse Event|5|||
48382929|NCT00445068|155596812|FG000|Overall Study|Abnormal laboratory value|2|||
48382930|NCT00445068|155596812|FG000|Overall Study|Withdrawal by Subject|2|||
48382931|NCT00445068|155596812|FG000|Overall Study|Death|1|||
48382932|NCT00583024|155596813|FG000|Overall Study|Lost to Follow-up|4|||
48382933|NCT01563185|155596814|FG000|Overall Study|Withdrawal by Subject|1|||
48382934|NCT01563185|155596814|FG000|Overall Study|Non-Compliance with study drug|1|||
48382935|NCT01103245|155598722|FG000|Overall Study|Withdrawal by Subject|1|||
48382936|NCT01103245|155598723|FG001|Overall Study|Withdrawal by Subject|0|||
48730322|NCT03555435|156864274|FG002|Overall Study|Lost to Follow-up|8|||
48730323|NCT01646073|156864275|FG000|Period A (12 Weeks)|Adverse Event|0|||
48730324|NCT01646073|156864276|FG001|Period A (12 Weeks)|Adverse Event|2|||
48730325|NCT01646073|156864275|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
48730326|NCT01646073|156864276|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
48730327|NCT01646073|156864275|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
48514933|NCT01695239|156078428|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
48382937|NCT01103245|155598724|FG002|Overall Study|Withdrawal by Subject|3|||
48382938|NCT01103245|155598725|FG003|Overall Study|Withdrawal by Subject|0|||
48382939|NCT01103245|155598722|FG000|Overall Study|Inadequate IV access|1|||
48382940|NCT01103245|155598723|FG001|Overall Study|Inadequate IV access|0|||
48382941|NCT01103245|155598724|FG002|Overall Study|Inadequate IV access|0|||
48382942|NCT01103245|155598725|FG003|Overall Study|Inadequate IV access|0|||
48382943|NCT01103245|155598722|FG000|Overall Study|Adverse Event|0|||
48382944|NCT01103245|155598723|FG001|Overall Study|Adverse Event|2|||
48382945|NCT01103245|155598724|FG002|Overall Study|Adverse Event|1|||
48382946|NCT01103245|155598725|FG003|Overall Study|Adverse Event|0|||
48382947|NCT01103245|155598722|FG000|Overall Study|Physician Decision|1|||
48382948|NCT01103245|155598723|FG001|Overall Study|Physician Decision|0|||
48382949|NCT01103245|155598724|FG002|Overall Study|Physician Decision|0|||
48382950|NCT01103245|155598725|FG003|Overall Study|Physician Decision|0|||
48382951|NCT01436071|155598732|FG000|Overall Study|Adverse Event|1|||
48382952|NCT01436071|155598733|FG001|Overall Study|Adverse Event|0|||
48382953|NCT01436071|155598732|FG000|Overall Study|Lack of Efficacy|16|||
48382954|NCT01436071|155598733|FG001|Overall Study|Lack of Efficacy|7|||
48382955|NCT01436071|155598732|FG000|Overall Study|Protocol Violation|0|||
48382956|NCT01436071|155598733|FG001|Overall Study|Protocol Violation|1|||
48382957|NCT01436071|155598732|FG000|Overall Study|Lost to Follow-up|3|||
48382958|NCT01436071|155598733|FG001|Overall Study|Lost to Follow-up|1|||
48382959|NCT01436071|155598732|FG000|Overall Study|Physician Decision|1|||
48382960|NCT01436071|155598733|FG001|Overall Study|Physician Decision|0|||
48382961|NCT01436071|155598732|FG000|Overall Study|Withdrawal by Subject|2|||
48730328|NCT01646073|156864276|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
48514934|NCT01695239|156078429|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
48514935|NCT01695239|156078430|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
48514936|NCT01695239|156078431|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
48514937|NCT01695239|156078432|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
48514938|NCT01695239|156078433|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
48514939|NCT01695239|156078434|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
48514940|NCT01695239|156078435|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
48514941|NCT01695239|156078436|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
48514942|NCT01695239|156078437|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
48514943|NCT01695239|156078438|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
48514944|NCT01695239|156078439|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
48514945|NCT01695239|156078440|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
48514946|NCT01695239|156078441|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
48514947|NCT01695239|156078428|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514948|NCT01695239|156078429|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514949|NCT01695239|156078430|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514950|NCT01695239|156078431|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48730329|NCT01646073|156864275|FG000|Period A (12 Weeks)|Protocol Violation|0|||
48730330|NCT01646073|156864276|FG001|Period A (12 Weeks)|Protocol Violation|1|||
48730331|NCT01646073|156864275|FG000|Period A (12 Weeks)|Other|0|||
48382962|NCT01436071|155598733|FG001|Overall Study|Withdrawal by Subject|2|||
48382963|NCT01436071|155598732|FG000|Overall Study|Did Not Receive Trial Medication|3|||
48730332|NCT01646073|156864276|FG001|Period A (12 Weeks)|Other|1|||
48382964|NCT01436071|155598733|FG001|Overall Study|Did Not Receive Trial Medication|3|||
48382965|NCT01955122|155598734|FG000|Overall Study|Physician Decision|5|||
48382966|NCT01955122|155598735|FG001|Overall Study|Physician Decision|5|||
48382967|NCT01195545|155598736|FG000|Overall Study|Protocol Violation|4|||
48382968|NCT01028222|155598739|FG000|Overall Study|Protocol deviation|1|||
48382969|NCT01028222|155598740|FG001|Overall Study|Protocol deviation|0|||
48382970|NCT01028222|155598739|FG000|Overall Study|Disease progression|33|||
48382971|NCT01028222|155598740|FG001|Overall Study|Disease progression|9|||
48382972|NCT01028222|155598739|FG000|Overall Study|Administrative problems|1|||
48382973|NCT01028222|155598740|FG001|Overall Study|Administrative problems|1|||
48382974|NCT01028222|155598739|FG000|Overall Study|Lost to Follow-up|0|||
48382975|NCT01028222|155598740|FG001|Overall Study|Lost to Follow-up|1|||
48382976|NCT01028222|155598739|FG000|Overall Study|Withdrawal by Subject|1|||
48382977|NCT01028222|155598740|FG001|Overall Study|Withdrawal by Subject|0|||
48382978|NCT01028222|155598739|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
48382979|NCT01028222|155598740|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
48382980|NCT01028222|155598739|FG000|Overall Study|Adverse Event|2|||
48382981|NCT01028222|155598740|FG001|Overall Study|Adverse Event|0|||
48382982|NCT02525861|155598744|FG000|Overall Study|Adverse Event|1|||
48382983|NCT02525861|155598745|FG001|Overall Study|Adverse Event|0|||
48382984|NCT02525861|155598744|FG000|Overall Study|Withdrawal by Subject|0|||
48382985|NCT02525861|155598745|FG001|Overall Study|Withdrawal by Subject|1|||
48382986|NCT02525861|155598744|FG000|Overall Study|Physician Decision|0|||
48382987|NCT02525861|155598745|FG001|Overall Study|Physician Decision|1|||
48382988|NCT04439071|155598753|FG000|Overall Study|Lost to Follow-up|0|||
48382989|NCT04439071|155598754|FG001|Overall Study|Lost to Follow-up|3|||
48382990|NCT04439071|155598753|FG000|Overall Study|Withdrawal by Subject|3|||
48382991|NCT04439071|155598754|FG001|Overall Study|Withdrawal by Subject|8|||
48382992|NCT04439071|155598753|FG000|Overall Study|Death|6|||
48382993|NCT04439071|155598754|FG001|Overall Study|Death|4|||
48382994|NCT04439071|155598753|FG000|Overall Study|Other than specified|3|||
48382995|NCT04439071|155598754|FG001|Overall Study|Other than specified|3|||
48382996|NCT04439071|155598753|FG000|Overall Study|Randomized but not treated|2|||
48382997|NCT04439071|155598754|FG001|Overall Study|Randomized but not treated|0|||
48382998|NCT01118325|155598762|FG000|Overall Study|Adverse Event|1|||
48382999|NCT01118325|155598763|FG001|Overall Study|Adverse Event|0|||
48383000|NCT01118325|155598764|FG002|Overall Study|Adverse Event|1|||
48383001|NCT01309230|155598765|FG000|Overall Study|Withdrawal by Subject|0|||
48383002|NCT01309230|155598766|FG001|Overall Study|Withdrawal by Subject|2|||
48383003|NCT01309230|155598765|FG000|Overall Study|Observation arm closed|0|||
48383004|NCT01309230|155598766|FG001|Overall Study|Observation arm closed|2|||
48383005|NCT00536809|155598767|FG000|Phase II|Adverse Event|1|||
48383006|NCT00536809|155598767|FG000|Phase II|Referred for surgical resection|1|||
48383007|NCT01386658|155598774|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
48383008|NCT01386658|155598775|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
48383009|NCT01386658|155598774|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
48383010|NCT01386658|155598775|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
48383011|NCT00631189|155598776|FG000|Initial Phase|Protocol Violation|347|||
48383012|NCT00631189|155598777|FG001|Initial Phase|Protocol Violation|0|||
48383013|NCT00631189|155598778|FG002|Initial Phase|Protocol Violation|0|||
48383014|NCT00631189|155598779|FG003|Initial Phase|Protocol Violation|0|||
48383015|NCT00631189|155598776|FG000|Initial Phase|Withdrawal by Subject|4|||
48383016|NCT00631189|155598777|FG001|Initial Phase|Withdrawal by Subject|0|||
48383017|NCT00631189|155598778|FG002|Initial Phase|Withdrawal by Subject|0|||
48383018|NCT00631189|155598779|FG003|Initial Phase|Withdrawal by Subject|0|||
48383019|NCT00631189|155598776|FG000|Treatment Phase|Withdrawal by Subject|0|||
48383020|NCT00631189|155598777|FG001|Treatment Phase|Withdrawal by Subject|2|||
48383021|NCT00631189|155598778|FG002|Treatment Phase|Withdrawal by Subject|1|||
48383022|NCT00631189|155598779|FG003|Treatment Phase|Withdrawal by Subject|1|||
48383023|NCT00631189|155598776|FG000|Treatment Phase|Protocol Violation|0|||
48383024|NCT00631189|155598777|FG001|Treatment Phase|Protocol Violation|1|||
48383025|NCT00631189|155598778|FG002|Treatment Phase|Protocol Violation|6|||
48383026|NCT00631189|155598779|FG003|Treatment Phase|Protocol Violation|2|||
48383027|NCT00631189|155598776|FG000|Treatment Phase|Adverse Event|0|||
48383028|NCT00631189|155598777|FG001|Treatment Phase|Adverse Event|3|||
48383029|NCT00631189|155598778|FG002|Treatment Phase|Adverse Event|2|||
48383030|NCT00631189|155598779|FG003|Treatment Phase|Adverse Event|4|||
48383031|NCT00631189|155598776|FG000|Treatment Phase|Lost to Follow-up|0|||
48383032|NCT00631189|155598777|FG001|Treatment Phase|Lost to Follow-up|1|||
48383033|NCT00631189|155598778|FG002|Treatment Phase|Lost to Follow-up|0|||
48383034|NCT00631189|155598779|FG003|Treatment Phase|Lost to Follow-up|0|||
48730333|NCT01646073|156864275|FG000|Period B (12 Weeks)|Adverse Event|0|||
48730334|NCT01646073|156864276|FG001|Period B (12 Weeks)|Adverse Event|7|||
48383035|NCT00631189|155598776|FG000|Treatment Phase|Pregnancy|0|||
48383036|NCT00631189|155598777|FG001|Treatment Phase|Pregnancy|0|||
48383037|NCT00631189|155598778|FG002|Treatment Phase|Pregnancy|1|||
48383038|NCT00631189|155598779|FG003|Treatment Phase|Pregnancy|0|||
48383039|NCT00631189|155598776|FG000|Treatment Phase|patient did not take pravastatin|0|||
48730335|NCT01646073|156864275|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
48730336|NCT01646073|156864276|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
48383040|NCT00631189|155598777|FG001|Treatment Phase|patient did not take pravastatin|0|||
48383041|NCT00631189|155598778|FG002|Treatment Phase|patient did not take pravastatin|1|||
48383042|NCT00631189|155598779|FG003|Treatment Phase|patient did not take pravastatin|0|||
48383043|NCT00874770|155598780|FG000|Overall Study|Lack of Efficacy|2|||
48383044|NCT00874770|155598781|FG001|Overall Study|Lack of Efficacy|0|||
48383045|NCT00874770|155598782|FG002|Overall Study|Lack of Efficacy|0|||
48383046|NCT00874770|155598783|FG003|Overall Study|Lack of Efficacy|2|||
48383047|NCT00874770|155598780|FG000|Overall Study|Adverse Event|1|||
48383048|NCT00874770|155598781|FG001|Overall Study|Adverse Event|1|||
48383049|NCT00874770|155598782|FG002|Overall Study|Adverse Event|4|||
48383050|NCT00874770|155598783|FG003|Overall Study|Adverse Event|2|||
48383051|NCT00874770|155598780|FG000|Overall Study|Lost to Follow-up|1|||
48383052|NCT00874770|155598781|FG001|Overall Study|Lost to Follow-up|0|||
48383053|NCT00874770|155598782|FG002|Overall Study|Lost to Follow-up|0|||
48383054|NCT00874770|155598783|FG003|Overall Study|Lost to Follow-up|1|||
48383055|NCT00874770|155598780|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
48383056|NCT00874770|155598781|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
48383057|NCT00874770|155598782|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
48383058|NCT00874770|155598783|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
48514951|NCT01695239|156078432|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514952|NCT01695239|156078433|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514953|NCT01695239|156078434|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514954|NCT01695239|156078435|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514955|NCT01695239|156078436|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
48514956|NCT01695239|156078437|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
48514957|NCT01695239|156078438|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514958|NCT01695239|156078439|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514959|NCT01695239|156078440|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514960|NCT01695239|156078441|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
48514961|NCT01695239|156078428|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514962|NCT01695239|156078429|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514963|NCT01695239|156078430|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514964|NCT01695239|156078431|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514965|NCT01695239|156078432|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514966|NCT01695239|156078433|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514967|NCT01695239|156078434|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514968|NCT01695239|156078435|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514969|NCT01695239|156078436|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
48514970|NCT01695239|156078437|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
48514971|NCT01695239|156078438|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514972|NCT01695239|156078439|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514973|NCT01695239|156078440|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514974|NCT01695239|156078441|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
48514975|NCT01695239|156078428|FG000|Extension Long-Term Extension Periods|Death|0|||
48514976|NCT01695239|156078429|FG001|Extension Long-Term Extension Periods|Death|0|||
48514977|NCT01695239|156078430|FG002|Extension Long-Term Extension Periods|Death|0|||
48514978|NCT01695239|156078431|FG003|Extension Long-Term Extension Periods|Death|0|||
48514979|NCT01695239|156078432|FG004|Extension Long-Term Extension Periods|Death|0|||
48514980|NCT01695239|156078433|FG005|Extension Long-Term Extension Periods|Death|0|||
48514981|NCT01695239|156078434|FG006|Extension Long-Term Extension Periods|Death|0|||
48514982|NCT01695239|156078435|FG007|Extension Long-Term Extension Periods|Death|0|||
48514983|NCT01695239|156078436|FG008|Extension Long-Term Extension Periods|Death|1|||
48514984|NCT01695239|156078437|FG009|Extension Long-Term Extension Periods|Death|0|||
48514985|NCT01695239|156078438|FG010|Extension Long-Term Extension Periods|Death|0|||
48514986|NCT01695239|156078439|FG011|Extension Long-Term Extension Periods|Death|0|||
48514987|NCT01695239|156078440|FG012|Extension Long-Term Extension Periods|Death|0|||
48514988|NCT01695239|156078441|FG013|Extension Long-Term Extension Periods|Death|0|||
48514989|NCT01695239|156078428|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514990|NCT01695239|156078429|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514991|NCT01695239|156078430|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514992|NCT01695239|156078431|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514993|NCT01695239|156078432|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514994|NCT01695239|156078433|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514995|NCT01695239|156078434|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514996|NCT01695239|156078435|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514997|NCT01695239|156078436|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514998|NCT01695239|156078437|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48514999|NCT01695239|156078438|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48515000|NCT01695239|156078439|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
48515001|NCT01695239|156078440|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
48515002|NCT01695239|156078441|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
48515003|NCT01695239|156078428|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515004|NCT01695239|156078429|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515005|NCT01695239|156078430|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48730337|NCT01646073|156864275|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
48730338|NCT01646073|156864276|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
48730339|NCT04950166|156864285|FG000|Overall Study|Withdrawal by Subject|1|||
48730340|NCT02969707|156864286|FG000|Overall Study|Withdrawal by Subject|6|||
48730341|NCT02969707|156864287|FG001|Overall Study|Withdrawal by Subject|5|||
48730342|NCT02969707|156864286|FG000|Overall Study|Severe anxiety|0|||
48730343|NCT02969707|156864287|FG001|Overall Study|Severe anxiety|1|||
48730344|NCT02969707|156864286|FG000|Overall Study|Positive toxicology screen|0|||
48730345|NCT02969707|156864287|FG001|Overall Study|Positive toxicology screen|2|||
48730346|NCT02969707|156864286|FG000|Overall Study|Claustrophobia|2|||
48730347|NCT02969707|156864287|FG001|Overall Study|Claustrophobia|2|||
48730348|NCT02969707|156864286|FG000|Overall Study|Non-compliance|1|||
48730349|NCT02969707|156864287|FG001|Overall Study|Non-compliance|2|||
48730350|NCT04718103|156864288|FG000|Overall Study|Adverse Event|1|||
48730351|NCT04718103|156864289|FG001|Overall Study|Adverse Event|1|||
48730352|NCT04718103|156864288|FG000|Overall Study|Lack of Efficacy|4|||
48730353|NCT04718103|156864289|FG001|Overall Study|Lack of Efficacy|1|||
48730354|NCT04718103|156864288|FG000|Overall Study|Lost to Follow-up|2|||
48730355|NCT04718103|156864289|FG001|Overall Study|Lost to Follow-up|2|||
48730356|NCT04718103|156864288|FG000|Overall Study|Physician Decision|2|||
48730357|NCT04718103|156864289|FG001|Overall Study|Physician Decision|0|||
48730358|NCT04718103|156864288|FG000|Overall Study|Pregnancy|0|||
48730359|NCT04718103|156864289|FG001|Overall Study|Pregnancy|1|||
48730360|NCT04718103|156864288|FG000|Overall Study|Withdrawal by Subject|10|||
48730361|NCT04718103|156864289|FG001|Overall Study|Withdrawal by Subject|6|||
48730362|NCT04718103|156864288|FG000|Overall Study|Randomized, not treated|4|||
48730363|NCT04718103|156864289|FG001|Overall Study|Randomized, not treated|1|||
48730364|NCT04718103|156864288|FG000|Overall Study|GCP violations|7|||
48730365|NCT04718103|156864289|FG001|Overall Study|GCP violations|5|||
48730366|NCT04795622|156864290|FG000|Overall Study|Adverse Event|1|||
48730367|NCT04795622|156864291|FG001|Overall Study|Adverse Event|0|||
48730368|NCT04795622|156864290|FG000|Overall Study|Withdrawal by Subject|3|||
48730369|NCT04795622|156864291|FG001|Overall Study|Withdrawal by Subject|3|||
48730370|NCT04795622|156864290|FG000|Overall Study|Protocol Violation|0|||
48730371|NCT04795622|156864291|FG001|Overall Study|Protocol Violation|2|||
48730372|NCT04795622|156864290|FG000|Overall Study|Lost to Follow-up|2|||
48730373|NCT04795622|156864291|FG001|Overall Study|Lost to Follow-up|3|||
48730374|NCT04795622|156864290|FG000|Overall Study|Other|7|||
48730375|NCT04795622|156864291|FG001|Overall Study|Other|8|||
48730376|NCT01437878|156864299|FG000|Overall Study|Withdrawal by Subject|1|||
48730377|NCT01437878|156864300|FG001|Overall Study|Withdrawal by Subject|0|||
48730378|NCT01070043|156864301|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
48515006|NCT01695239|156078431|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515007|NCT01695239|156078432|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515008|NCT01695239|156078433|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515009|NCT01695239|156078434|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515010|NCT01695239|156078435|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515011|NCT01695239|156078436|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515012|NCT01695239|156078437|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515013|NCT01695239|156078438|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515014|NCT01695239|156078439|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48515015|NCT01695239|156078440|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
48515016|NCT01695239|156078441|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
48515017|NCT01695239|156078428|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515018|NCT01695239|156078429|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515019|NCT01695239|156078430|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515020|NCT01695239|156078431|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515021|NCT01695239|156078432|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515022|NCT01695239|156078433|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515023|NCT01695239|156078434|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515024|NCT01695239|156078435|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515025|NCT01695239|156078436|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515026|NCT01695239|156078437|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515027|NCT01695239|156078438|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515028|NCT01695239|156078439|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
48515029|NCT01695239|156078440|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
48515030|NCT01695239|156078441|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
48730379|NCT01070043|156864302|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
48383059|NCT00974090|155598784|FG000|Period 1: Double Blind Period|Adverse Event|2|||
48730380|NCT01070043|156864303|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
48730381|NCT01070043|156864301|FG000|Double-Blind Treatment|Adverse Event|0|||
48730382|NCT01070043|156864302|FG001|Double-Blind Treatment|Adverse Event|0|||
48730383|NCT01070043|156864303|FG002|Double-Blind Treatment|Adverse Event|2|||
48730384|NCT01309308|156864306|FG000|Overall Study|Lost to Follow-up|6|||
48383060|NCT00974090|155598785|FG001|Period 1: Double Blind Period|Adverse Event|1|||
48383061|NCT00974090|155598784|FG000|Period 1: Double Blind Period|Physician Decision|1|||
48383062|NCT00974090|155598785|FG001|Period 1: Double Blind Period|Physician Decision|0|||
48383063|NCT00974090|155598784|FG000|Period 2: Open-label Period|Adverse Event|4|||
48383064|NCT00974090|155598785|FG001|Period 2: Open-label Period|Adverse Event|6|||
48383065|NCT00974090|155598784|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
48383066|NCT00974090|155598785|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
48730385|NCT01309308|156864307|FG001|Overall Study|Lost to Follow-up|4|||
48730386|NCT04223232|156864310|FG000|Overall Study|Withdrawal by Subject|1|||
48730387|NCT03488927|156864311|FG000|Overall Study|Withdrawal by Subject|44|||
48730388|NCT03488927|156864312|FG001|Overall Study|Withdrawal by Subject|118|||
48730389|NCT03488927|156864313|FG002|Overall Study|Withdrawal by Subject|217|||
48730390|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
48730391|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
48730392|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Death|1|||
48730393|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Death|0|||
48730394|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
48730395|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
48730396|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
48730397|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
48730398|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
48730399|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
48730400|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
48730401|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
48730402|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
48730403|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
48730404|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
48730405|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
48730406|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
48730407|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
48730408|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
48730409|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
48730410|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
48730411|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
48730412|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
48730413|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
48730414|NCT02927262|156864314|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
48730415|NCT02927262|156864315|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
48730416|NCT02927262|156864314|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
48730417|NCT02927262|156864315|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
48730418|NCT02927262|156864314|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
48730419|NCT02927262|156864315|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
48730420|NCT02927262|156864314|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
48730421|NCT02927262|156864315|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
48730422|NCT00620464|156864316|FG000|Overall Study|Adverse Event|15|||
48730423|NCT00620464|156864317|FG001|Overall Study|Adverse Event|17|||
48730424|NCT00620464|156864316|FG000|Overall Study|Lost to Follow-up|1|||
48730425|NCT00620464|156864317|FG001|Overall Study|Lost to Follow-up|1|||
48730426|NCT00620464|156864316|FG000|Overall Study|Planning Pregnancy|1|||
48730427|NCT00620464|156864317|FG001|Overall Study|Planning Pregnancy|4|||
48730428|NCT00620464|156864316|FG000|Overall Study|Personal|2|||
48730429|NCT00620464|156864317|FG001|Overall Study|Personal|2|||
48730430|NCT00620464|156864316|FG000|Overall Study|Used prohibited medication|1|||
48730431|NCT00620464|156864317|FG001|Overall Study|Used prohibited medication|0|||
48730432|NCT02038452|156864318|FG000|Overall Study|Withdrawal by Subject|7|||
48730433|NCT02038452|156864319|FG001|Overall Study|Withdrawal by Subject|9|||
48730434|NCT02038452|156864318|FG000|Overall Study|Lost to Follow-up|31|||
48730435|NCT02038452|156864319|FG001|Overall Study|Lost to Follow-up|28|||
48730436|NCT00410202|156864322|FG000|On-Treatment|Continuing treatment|69|||
48730437|NCT00410202|156864323|FG001|On-Treatment|Continuing treatment|71|||
48730438|NCT00410202|156864324|FG002|On-Treatment|Continuing treatment|66|||
48730439|NCT00410202|156864322|FG000|On-Treatment|Adverse Event|1|||
48730440|NCT00410202|156864323|FG001|On-Treatment|Adverse Event|3|||
48730441|NCT00410202|156864324|FG002|On-Treatment|Adverse Event|2|||
48383067|NCT00974090|155598784|FG000|Period 2: Open-label Period|Physician Decision|0|||
48383068|NCT00974090|155598785|FG001|Period 2: Open-label Period|Physician Decision|3|||
48383069|NCT00974090|155598784|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
48730442|NCT00410202|156864322|FG000|On-Treatment|Death|1|||
48383070|NCT00974090|155598785|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
48515031|NCT01695239|156078428|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515032|NCT01695239|156078429|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515033|NCT01695239|156078430|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515034|NCT01695239|156078431|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515035|NCT01695239|156078432|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515036|NCT01695239|156078433|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515037|NCT01695239|156078434|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515038|NCT01695239|156078435|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515039|NCT01695239|156078436|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515040|NCT01695239|156078437|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515041|NCT01695239|156078438|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515042|NCT01695239|156078439|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515043|NCT01695239|156078440|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48515044|NCT01695239|156078441|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
48515045|NCT03502811|156078445|FG000|Overall Study|Death|157|||
48515046|NCT03502811|156078445|FG000|Overall Study|Withdrawal by Subject|105|||
48515047|NCT03502811|156078445|FG000|Overall Study|Lost to Follow-up|26|||
48515048|NCT03502811|156078445|FG000|Overall Study|No Visits (Missed)|31|||
48515049|NCT03684928|156078446|FG000|First Intervention|Lost to Follow-up|0|||
48515050|NCT03684928|156078447|FG001|First Intervention|Lost to Follow-up|1|||
48515051|NCT03684928|156078446|FG000|First Intervention|Withdrawal by Subject|0|||
48515052|NCT03684928|156078447|FG001|First Intervention|Withdrawal by Subject|2|||
48515053|NCT03684928|156078446|FG000|Second Intervention|Soft Tissue Injury|1|||
48515054|NCT03684928|156078447|FG001|Second Intervention|Soft Tissue Injury|0|||
48515055|NCT03123094|156078448|FG000|Overall Study|Withdrawal by Subject|0|||
48515056|NCT03123094|156078449|FG001|Overall Study|Withdrawal by Subject|2|||
48515057|NCT03123094|156078450|FG002|Overall Study|Withdrawal by Subject|1|||
48515058|NCT03123094|156078451|FG003|Overall Study|Withdrawal by Subject|0|||
48515059|NCT03123094|156078452|FG004|Overall Study|Withdrawal by Subject|1|||
48515060|NCT03406156|156078461|FG000|Overall Study|Death|9|||
48515061|NCT03406156|156078462|FG001|Overall Study|Death|3|||
48515062|NCT03406156|156078461|FG000|Overall Study|Withdrawal by Subject|1|||
48515063|NCT03406156|156078462|FG001|Overall Study|Withdrawal by Subject|2|||
48515064|NCT03406156|156078461|FG000|Overall Study|COVID-19 infection|1|||
48515065|NCT03406156|156078462|FG001|Overall Study|COVID-19 infection|0|||
48515066|NCT03406156|156078461|FG000|Overall Study|Non-compliance with study procedures|1|||
48515067|NCT03406156|156078462|FG001|Overall Study|Non-compliance with study procedures|1|||
48515068|NCT03406156|156078461|FG000|Overall Study|Lost to Follow-up|0|||
48515069|NCT03406156|156078462|FG001|Overall Study|Lost to Follow-up|2|||
48515070|NCT03406156|156078461|FG000|Overall Study|Other, not specified|72|||
48515071|NCT03406156|156078462|FG001|Overall Study|Other, not specified|28|||
48515072|NCT03325881|156078468|FG000|Overall Study|Protocol Violation|0|||
48515073|NCT03325881|156078469|FG001|Overall Study|Protocol Violation|1|||
48515074|NCT03325881|156078468|FG000|Overall Study|Withdrawal by Subject|0|||
48515075|NCT03325881|156078469|FG001|Overall Study|Withdrawal by Subject|2|||
48515076|NCT03325881|156078468|FG000|Overall Study|Lack of Efficacy|2|||
48515077|NCT03325881|156078469|FG001|Overall Study|Lack of Efficacy|0|||
48515078|NCT03325881|156078468|FG000|Overall Study|Not treated|1|||
48515079|NCT03325881|156078469|FG001|Overall Study|Not treated|0|||
48515080|NCT01410227|156078470|FG000|Overall Study|Adverse Event|1|||
48515081|NCT01410227|156078471|FG001|Overall Study|Adverse Event|0|||
48515082|NCT01410227|156078472|FG002|Overall Study|Adverse Event|0|||
48515083|NCT01410227|156078473|FG003|Overall Study|Adverse Event|0|||
48515084|NCT01410227|156078470|FG000|Overall Study|Withdrawal by Subject|3|||
48515085|NCT01410227|156078471|FG001|Overall Study|Withdrawal by Subject|0|||
48515086|NCT01410227|156078472|FG002|Overall Study|Withdrawal by Subject|1|||
48515087|NCT01410227|156078473|FG003|Overall Study|Withdrawal by Subject|0|||
48515088|NCT01410227|156078470|FG000|Overall Study|Pregnancy|0|||
48515089|NCT01410227|156078471|FG001|Overall Study|Pregnancy|0|||
48515090|NCT01410227|156078472|FG002|Overall Study|Pregnancy|0|||
48515091|NCT01410227|156078473|FG003|Overall Study|Pregnancy|1|||
48515092|NCT01410227|156078470|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
48515093|NCT01410227|156078471|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
48515094|NCT01410227|156078472|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
48515095|NCT01410227|156078473|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
48515096|NCT03366792|156078474|FG000|Overall Study|Withdrawal by Subject|7|||
48515097|NCT03366792|156078474|FG000|Overall Study|Lost to Follow-up|2|||
48515098|NCT03366792|156078474|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
48515099|NCT03366792|156078474|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
48515100|NCT02699463|156078475|FG000|Overall Study|Lost to Follow-up|11|||
48515101|NCT02699463|156078476|FG001|Overall Study|Lost to Follow-up|8|||
48515102|NCT02699463|156078475|FG000|Overall Study|Withdrawal by Subject|4|||
48383071|NCT01145495|155598787|FG000|Overall Study|Adverse Event|6|||
48515103|NCT02699463|156078476|FG001|Overall Study|Withdrawal by Subject|1|||
48515104|NCT04583423|156078477|FG000|Overall Study|Lost to Follow-up|0|||
48515105|NCT04583423|156078478|FG001|Overall Study|Lost to Follow-up|1|||
48515106|NCT04583423|156078479|FG002|Overall Study|Lost to Follow-up|0|||
48515107|NCT04583423|156078480|FG003|Overall Study|Lost to Follow-up|2|||
48515108|NCT04583423|156078477|FG000|Overall Study|Study Terminated by Sponsor|32|||
48515109|NCT04583423|156078478|FG001|Overall Study|Study Terminated by Sponsor|35|||
48515110|NCT04583423|156078479|FG002|Overall Study|Study Terminated by Sponsor|36|||
48515111|NCT04583423|156078480|FG003|Overall Study|Study Terminated by Sponsor|33|||
48515112|NCT04583423|156078477|FG000|Overall Study|Withdrawal by Subject|3|||
48515113|NCT04583423|156078478|FG001|Overall Study|Withdrawal by Subject|1|||
48515114|NCT04583423|156078479|FG002|Overall Study|Withdrawal by Subject|2|||
48515115|NCT04583423|156078480|FG003|Overall Study|Withdrawal by Subject|1|||
48730443|NCT00410202|156864323|FG001|On-Treatment|Death|0|||
48730444|NCT00410202|156864324|FG002|On-Treatment|Death|0|||
48730445|NCT00410202|156864322|FG000|On-Treatment|Lost to Follow-up|1|||
48730446|NCT00410202|156864323|FG001|On-Treatment|Lost to Follow-up|0|||
48730447|NCT00410202|156864324|FG002|On-Treatment|Lost to Follow-up|1|||
48515116|NCT01808651|156078481|FG000|Study Period 1|Lost to Follow-up|1|||
48515117|NCT01808651|156078482|FG001|Study Period 1|Lost to Follow-up|3|||
48515118|NCT01808651|156078483|FG002|Study Period 1|Lost to Follow-up|0|||
48515119|NCT01808651|156078481|FG000|Study Period 1|Protocol Violation|1|||
48515120|NCT01808651|156078482|FG001|Study Period 1|Protocol Violation|0|||
48515121|NCT01808651|156078483|FG002|Study Period 1|Protocol Violation|1|||
48515122|NCT01808651|156078481|FG000|Study Period 1|Physician Decision|3|||
48515123|NCT01808651|156078482|FG001|Study Period 1|Physician Decision|2|||
48515124|NCT01808651|156078483|FG002|Study Period 1|Physician Decision|0|||
48515125|NCT01808651|156078481|FG000|Study Period 1|Lack of Efficacy|2|||
48515126|NCT01808651|156078482|FG001|Study Period 1|Lack of Efficacy|1|||
48515127|NCT01808651|156078483|FG002|Study Period 1|Lack of Efficacy|0|||
48730448|NCT00410202|156864322|FG000|On-Treatment|Lack of Efficacy|1|||
48730449|NCT00410202|156864323|FG001|On-Treatment|Lack of Efficacy|4|||
48515128|NCT01808651|156078481|FG000|Study Period 1|Adverse Event|10|||
48515129|NCT01808651|156078482|FG001|Study Period 1|Adverse Event|4|||
48515130|NCT01808651|156078483|FG002|Study Period 1|Adverse Event|1|||
48515131|NCT01808651|156078481|FG000|Study Period 1|Participant Decision|9|||
48515132|NCT01808651|156078482|FG001|Study Period 1|Participant Decision|7|||
48515133|NCT01808651|156078483|FG002|Study Period 1|Participant Decision|3|||
48515134|NCT00585286|156078487|FG000|Overall Study|Lost to Follow-up|1|||
48515135|NCT02488239|156078488|FG000|Overall Study|Death|3|||
48515136|NCT02488239|156078488|FG000|Overall Study|Withdrawal by Subject|3|||
48515137|NCT02488239|156078488|FG000|Overall Study|Physician Decision|2|||
48515138|NCT02488239|156078488|FG000|Overall Study|Consent ineligible|1|||
48515139|NCT02488239|156078488|FG000|Overall Study|Did not undergo implant procedure|1|||
48515140|NCT01103713|156078492|FG000|Overall Study|Lost to Follow-up|2|||
48515141|NCT01103713|156078492|FG000|Overall Study|Withdrawal by Subject|8|||
48515142|NCT01103713|156078492|FG000|Overall Study|Study terminated by sponsor|2|||
48515143|NCT01103713|156078492|FG000|Overall Study|Other|1|||
48515144|NCT05752721|156078493|FG000|Overall Study|Lost to Follow-up|22|||
48515145|NCT05752721|156078494|FG001|Overall Study|Lost to Follow-up|20|||
48515146|NCT05752721|156078493|FG000|Overall Study|Withdrawal by Subject|15|||
48730450|NCT00410202|156864324|FG002|On-Treatment|Lack of Efficacy|0|||
48730451|NCT00410202|156864322|FG000|On-Treatment|Withdrawal by Subject|2|||
48730452|NCT00410202|156864323|FG001|On-Treatment|Withdrawal by Subject|1|||
48730453|NCT00410202|156864324|FG002|On-Treatment|Withdrawal by Subject|1|||
48730454|NCT00410202|156864322|FG000|On-Treatment|Other Reason|0|||
48730455|NCT00410202|156864323|FG001|On-Treatment|Other Reason|0|||
48730456|NCT00410202|156864324|FG002|On-Treatment|Other Reason|1|||
48515147|NCT05752721|156078494|FG001|Overall Study|Withdrawal by Subject|12|||
48515148|NCT02072096|156078497|FG000|Overall Study|Lack of Efficacy|18|||
48515149|NCT02072096|156078498|FG001|Overall Study|Lack of Efficacy|29|||
48515150|NCT02072096|156078497|FG000|Overall Study|Protocol Violation|7|||
48515151|NCT02072096|156078498|FG001|Overall Study|Protocol Violation|7|||
48515152|NCT02072096|156078497|FG000|Overall Study|Withdrawal by Subject|5|||
48515153|NCT02072096|156078498|FG001|Overall Study|Withdrawal by Subject|7|||
48515154|NCT02072096|156078497|FG000|Overall Study|Adverse Event|5|||
48730457|NCT00410202|156864322|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
48730458|NCT00410202|156864323|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
48730459|NCT00410202|156864324|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
48515155|NCT02072096|156078498|FG001|Overall Study|Adverse Event|2|||
48515156|NCT02072096|156078497|FG000|Overall Study|No Reason Provided|4|||
48515157|NCT02072096|156078498|FG001|Overall Study|No Reason Provided|2|||
48515158|NCT02072096|156078497|FG000|Overall Study|Death|2|||
48730460|NCT00410202|156864322|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
48730461|NCT00410202|156864323|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
48515159|NCT02072096|156078498|FG001|Overall Study|Death|0|||
48515160|NCT02072096|156078497|FG000|Overall Study|Physician Decision|0|||
48515161|NCT02072096|156078498|FG001|Overall Study|Physician Decision|1|||
48730462|NCT00410202|156864324|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
48730463|NCT00410202|156864322|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
48730464|NCT00410202|156864323|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
48730465|NCT00410202|156864324|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
48730466|NCT02676466|156864325|FG000|Overall Study|Death|0|||
48730467|NCT02676466|156864326|FG001|Overall Study|Death|2|||
48730468|NCT02676466|156864327|FG002|Overall Study|Death|1|||
48730469|NCT02676466|156864328|FG003|Overall Study|Death|0|||
48730470|NCT02676466|156864329|FG004|Overall Study|Death|0|||
48730471|NCT02676466|156864330|FG005|Overall Study|Death|0|||
48730472|NCT02676466|156864331|FG006|Overall Study|Death|0|||
48730473|NCT02676466|156864332|FG007|Overall Study|Death|0|||
48730474|NCT02676466|156864325|FG000|Overall Study|Withdrawal by Subject|4|||
48730475|NCT02676466|156864326|FG001|Overall Study|Withdrawal by Subject|3|||
48730476|NCT02676466|156864327|FG002|Overall Study|Withdrawal by Subject|1|||
48730477|NCT02676466|156864328|FG003|Overall Study|Withdrawal by Subject|0|||
48730478|NCT02676466|156864329|FG004|Overall Study|Withdrawal by Subject|3|||
48730479|NCT02676466|156864330|FG005|Overall Study|Withdrawal by Subject|1|||
48730480|NCT02676466|156864331|FG006|Overall Study|Withdrawal by Subject|1|||
48730481|NCT02676466|156864332|FG007|Overall Study|Withdrawal by Subject|1|||
48730482|NCT01178073|156864333|FG000|Overall Study|Adverse Event|34|||
48515162|NCT02072096|156078497|FG000|Overall Study|Study Terminated by Sponsor|43|||
48515163|NCT02072096|156078498|FG001|Overall Study|Study Terminated by Sponsor|30|||
48515164|NCT02072096|156078497|FG000|Overall Study|Lost to Follow-up|1|||
48515165|NCT02072096|156078498|FG001|Overall Study|Lost to Follow-up|0|||
48515166|NCT00216736|156078499|FG000|Overall Study|Lost to Follow-up|1|||
48515167|NCT00216736|156078500|FG001|Overall Study|Lost to Follow-up|1|||
48515168|NCT00152451|156078501|FG000|Overall Study|Adverse Event|4|||
48515169|NCT03644550|156078502|FG000|Overall Study|Withdrawal by Subject|3|||
48515170|NCT03644550|156078502|FG000|Overall Study|Progressive disease|15|||
48515171|NCT00367133|156078506|FG000|2 Years|Death|20|||
48515172|NCT00367133|156078507|FG001|2 Years|Death|12|||
48515173|NCT00367133|156078508|FG002|2 Years|Death|12|||
48515174|NCT00367133|156078506|FG000|2 Years|Dropped|34|||
48515175|NCT00367133|156078507|FG001|2 Years|Dropped|19|||
48515176|NCT00367133|156078508|FG002|2 Years|Dropped|33|||
48515177|NCT00367133|156078506|FG000|2 Years|Missed visit|4|||
48730483|NCT01178073|156864334|FG001|Overall Study|Adverse Event|27|||
48730484|NCT01178073|156864335|FG002|Overall Study|Adverse Event|24|||
48730485|NCT01178073|156864333|FG000|Overall Study|Protocol Violation|1|||
48730486|NCT01178073|156864334|FG001|Overall Study|Protocol Violation|1|||
48730487|NCT01178073|156864335|FG002|Overall Study|Protocol Violation|1|||
48730488|NCT01178073|156864333|FG000|Overall Study|Lost to Follow-up|2|||
48730489|NCT01178073|156864334|FG001|Overall Study|Lost to Follow-up|0|||
48730490|NCT01178073|156864335|FG002|Overall Study|Lost to Follow-up|3|||
48730491|NCT01178073|156864333|FG000|Overall Study|Physician Decision|14|||
48730492|NCT01178073|156864334|FG001|Overall Study|Physician Decision|10|||
48730493|NCT01178073|156864335|FG002|Overall Study|Physician Decision|10|||
48730494|NCT01178073|156864333|FG000|Overall Study|Withdrawal by Subject|10|||
48730495|NCT01178073|156864334|FG001|Overall Study|Withdrawal by Subject|6|||
48730496|NCT01178073|156864335|FG002|Overall Study|Withdrawal by Subject|8|||
48730497|NCT01178073|156864333|FG000|Overall Study|Missing Completion Status|1|||
48822711|NCT02081391|157190576|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
48822712|NCT02081391|157190573|FG000|12-hour Treatment|Further reasons|2|||
48822713|NCT02081391|157190574|FG001|12-hour Treatment|Further reasons|1|||
48822714|NCT02081391|157190575|FG002|12-hour Treatment|Further reasons|0|||
48822715|NCT02081391|157190576|FG003|12-hour Treatment|Further reasons|0|||
48822716|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
48822717|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
48822718|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
48822719|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
48440995|NCT03115112|155801477|FG001|Overall Study|Adverse Event|1|||
48730498|NCT01178073|156864334|FG001|Overall Study|Missing Completion Status|0|||
48440996|NCT03115112|155801476|FG000|Overall Study|Withdrawal by Subject|4|||
48440997|NCT03115112|155801477|FG001|Overall Study|Withdrawal by Subject|2|||
48822720|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
48440998|NCT03115112|155801476|FG000|Overall Study|Lost to Follow-up|0|||
48440999|NCT03115112|155801477|FG001|Overall Study|Lost to Follow-up|1|||
48441000|NCT03115112|155801476|FG000|Overall Study|Death|1|||
48441001|NCT03115112|155801477|FG001|Overall Study|Death|0|||
48441002|NCT03115112|155801476|FG000|Overall Study|Pregnancy|1|||
48441003|NCT03115112|155801477|FG001|Overall Study|Pregnancy|0|||
48441004|NCT03115112|155801476|FG000|Overall Study|Site closure|1|||
48441005|NCT03115112|155801477|FG001|Overall Study|Site closure|1|||
48441006|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
48441007|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
48441008|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
48441009|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
48515178|NCT00367133|156078507|FG001|2 Years|Missed visit|5|||
48515179|NCT00367133|156078508|FG002|2 Years|Missed visit|4|||
48515180|NCT00847535|156078514|FG000|Overall Study|Withdrawal by Subject|2|||
48515181|NCT00847535|156078515|FG001|Overall Study|Withdrawal by Subject|1|||
48515182|NCT00847535|156078516|FG002|Overall Study|Withdrawal by Subject|1|||
48515183|NCT00847535|156078514|FG000|Overall Study|Lost to Follow-up|0|||
48515184|NCT00847535|156078515|FG001|Overall Study|Lost to Follow-up|1|||
48515185|NCT00847535|156078516|FG002|Overall Study|Lost to Follow-up|0|||
48515186|NCT02336074|156078517|FG000|Overall Study|Adverse Event|0|||
48515187|NCT02336074|156078518|FG001|Overall Study|Adverse Event|2|||
48515188|NCT00834873|156078523|FG000|First Intervention|Adverse Event|0|||
48515189|NCT00834873|156078524|FG001|First Intervention|Adverse Event|1|||
48515190|NCT00354835|156078525|FG000|Overall Study|Death|1|||
48515191|NCT00354835|156078526|FG001|Overall Study|Death|1|||
48515192|NCT00354835|156078525|FG000|Overall Study|Physician Decision|8|||
48515193|NCT00354835|156078526|FG001|Overall Study|Physician Decision|13|||
48515194|NCT00354835|156078525|FG000|Overall Study|Withdrawal by Subject|2|||
48515195|NCT00354835|156078526|FG001|Overall Study|Withdrawal by Subject|1|||
48515196|NCT00354835|156078525|FG000|Overall Study|Ineligible|17|||
48515197|NCT00354835|156078526|FG001|Overall Study|Ineligible|16|||
48515198|NCT00354835|156078525|FG000|Overall Study|Disease progression or relapse|15|||
48515199|NCT00354835|156078526|FG001|Overall Study|Disease progression or relapse|22|||
48515200|NCT00354835|156078525|FG000|Overall Study|Adverse Event|6|||
48515201|NCT00354835|156078526|FG001|Overall Study|Adverse Event|0|||
48515202|NCT00354835|156078525|FG000|Overall Study|Refusal of further therapy|3|||
48515203|NCT00354835|156078526|FG001|Overall Study|Refusal of further therapy|8|||
48515204|NCT01968551|156078531|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
48515205|NCT01968551|156078532|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
48515206|NCT01968551|156078533|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
48515207|NCT01968551|156078531|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
48515208|NCT01968551|156078532|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
48515209|NCT01968551|156078533|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
48515210|NCT01968551|156078531|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
48515211|NCT01968551|156078532|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
48515212|NCT01968551|156078533|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
48515213|NCT01968551|156078531|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
48515214|NCT01968551|156078532|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
48515215|NCT01968551|156078533|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
48515216|NCT01968551|156078531|FG000|Extension Phase|Adverse Event|0|||
48515217|NCT01968551|156078532|FG001|Extension Phase|Adverse Event|0|||
48515218|NCT01968551|156078533|FG002|Extension Phase|Adverse Event|2|||
48515219|NCT01968551|156078531|FG000|Extension Phase|Death|0|||
48515220|NCT01968551|156078532|FG001|Extension Phase|Death|1|||
48515221|NCT01968551|156078533|FG002|Extension Phase|Death|0|||
48515222|NCT01968551|156078531|FG000|Extension Phase|Withdrew Consent|0|||
48515223|NCT01968551|156078532|FG001|Extension Phase|Withdrew Consent|0|||
48515224|NCT01968551|156078533|FG002|Extension Phase|Withdrew Consent|1|||
48515225|NCT01968551|156078531|FG000|Extension Phase|Lost to Follow-up|1|||
48515226|NCT01968551|156078532|FG001|Extension Phase|Lost to Follow-up|0|||
48515227|NCT01968551|156078533|FG002|Extension Phase|Lost to Follow-up|1|||
48515228|NCT02625974|156078539|FG000|Part 1|Lost to Follow-up|9|||
48515229|NCT02625974|156078540|FG001|Part 1|Lost to Follow-up|3|||
48515230|NCT02625974|156078539|FG000|Part 2|Lost to Follow-up|4|||
48515231|NCT02625974|156078540|FG001|Part 2|Lost to Follow-up|6|||
48515232|NCT02625974|156078539|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
48515233|NCT02625974|156078540|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
48515234|NCT00725322|156078541|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
48515235|NCT00725322|156078542|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
48515236|NCT00725322|156078541|FG000|Washout (28 Days)|Protocol Violation|0|||
48515237|NCT00725322|156078542|FG001|Washout (28 Days)|Protocol Violation|1|||
48515238|NCT02061280|156078543|FG000|Overall Study|Protocol Violation|12|||
48515239|NCT02061280|156078544|FG001|Overall Study|Protocol Violation|8|||
48515240|NCT02061280|156078543|FG000|Overall Study|moved out of state|0|||
48515241|NCT02061280|156078544|FG001|Overall Study|moved out of state|1|||
48515242|NCT02061280|156078543|FG000|Overall Study|Withdrawal by Subject|1|||
48515243|NCT02061280|156078544|FG001|Overall Study|Withdrawal by Subject|2|||
48730499|NCT01178073|156864335|FG002|Overall Study|Missing Completion Status|0|||
48730500|NCT00986479|156864336|FG000|Period 1|Improved mood|1|||
48730501|NCT00986479|156864337|FG001|Period 1|Improved mood|0|||
48730502|NCT00986479|156864336|FG000|Period 1|Administrative reasons|1|||
48515244|NCT02061280|156078543|FG000|Overall Study|Lost to Follow-up|5|||
48515245|NCT02061280|156078544|FG001|Overall Study|Lost to Follow-up|1|||
48515246|NCT00645853|156078545|FG000|Overall Study|Adverse Event|18|||
48515247|NCT00645853|156078546|FG001|Overall Study|Adverse Event|7|||
48515248|NCT00645853|156078545|FG000|Overall Study|AZ study closure in Hungary|60|||
48515249|NCT00645853|156078546|FG001|Overall Study|AZ study closure in Hungary|40|||
48515250|NCT00645853|156078545|FG000|Overall Study|Withdrawal by Subject|5|||
48515251|NCT00645853|156078546|FG001|Overall Study|Withdrawal by Subject|2|||
48515252|NCT00645853|156078545|FG000|Overall Study|Protocol Violation|0|||
48515253|NCT00645853|156078546|FG001|Overall Study|Protocol Violation|2|||
48515254|NCT00645853|156078545|FG000|Overall Study|Discontinuation criteria|2|||
48515255|NCT00645853|156078546|FG001|Overall Study|Discontinuation criteria|2|||
48515256|NCT00645853|156078545|FG000|Overall Study|recall of ICF, planned operation, death|7|||
48515257|NCT00645853|156078546|FG001|Overall Study|recall of ICF, planned operation, death|4|||
48515258|NCT02055547|156078547|FG000|Overall Study|Protocol Violation|0|||
48515259|NCT02055547|156078548|FG001|Overall Study|Protocol Violation|0|||
48515260|NCT02055547|156078549|FG002|Overall Study|Protocol Violation|1|||
48515261|NCT02055547|156078550|FG003|Overall Study|Protocol Violation|0|||
48515262|NCT02055547|156078551|FG004|Overall Study|Protocol Violation|0|||
48515263|NCT02055547|156078552|FG005|Overall Study|Protocol Violation|0|||
48515264|NCT02055547|156078553|FG006|Overall Study|Protocol Violation|1|||
48515265|NCT02055547|156078554|FG007|Overall Study|Protocol Violation|0|||
48515266|NCT02055547|156078555|FG008|Overall Study|Protocol Violation|0|||
48515267|NCT02055547|156078556|FG009|Overall Study|Protocol Violation|0|||
48515268|NCT02055547|156078557|FG010|Overall Study|Protocol Violation|0|||
48515269|NCT02055547|156078558|FG011|Overall Study|Protocol Violation|0|||
48515270|NCT02055547|156078559|FG012|Overall Study|Protocol Violation|0|||
48515271|NCT02055547|156078560|FG013|Overall Study|Protocol Violation|0|||
48515272|NCT02055547|156078561|FG014|Overall Study|Protocol Violation|0|||
48515273|NCT02055547|156078562|FG015|Overall Study|Protocol Violation|0|||
48515274|NCT02055547|156078563|FG016|Overall Study|Protocol Violation|0|||
48515275|NCT02055547|156078564|FG017|Overall Study|Protocol Violation|0|||
48515276|NCT02055547|156078565|FG018|Overall Study|Protocol Violation|0|||
48515277|NCT02055547|156078547|FG000|Overall Study|Physician Decision|0|||
48515278|NCT02055547|156078548|FG001|Overall Study|Physician Decision|1|||
48515279|NCT02055547|156078549|FG002|Overall Study|Physician Decision|1|||
48515280|NCT02055547|156078550|FG003|Overall Study|Physician Decision|0|||
48515281|NCT02055547|156078551|FG004|Overall Study|Physician Decision|1|||
48515282|NCT02055547|156078552|FG005|Overall Study|Physician Decision|0|||
48515283|NCT02055547|156078553|FG006|Overall Study|Physician Decision|0|||
48515284|NCT02055547|156078554|FG007|Overall Study|Physician Decision|0|||
48515285|NCT02055547|156078555|FG008|Overall Study|Physician Decision|0|||
48515286|NCT02055547|156078556|FG009|Overall Study|Physician Decision|1|||
48515287|NCT02055547|156078557|FG010|Overall Study|Physician Decision|1|||
48515288|NCT02055547|156078558|FG011|Overall Study|Physician Decision|0|||
48515289|NCT02055547|156078559|FG012|Overall Study|Physician Decision|0|||
48822721|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
48822722|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
48822723|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
48515290|NCT02055547|156078560|FG013|Overall Study|Physician Decision|0|||
48515291|NCT02055547|156078561|FG014|Overall Study|Physician Decision|0|||
48515292|NCT02055547|156078562|FG015|Overall Study|Physician Decision|0|||
48515293|NCT02055547|156078563|FG016|Overall Study|Physician Decision|0|||
48822724|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
48822725|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
48822726|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
48822727|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
48822728|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
48822729|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
48822730|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
48822731|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
48822732|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
48822733|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
48822734|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
48822735|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
48822736|NCT02081391|157190573|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
48822737|NCT02081391|157190574|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
48822738|NCT02081391|157190575|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
48822739|NCT02081391|157190576|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
48822740|NCT01712685|157190580|FG000|Overall Study|pt declined to participate before trmt|1|||
48822741|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Adverse Event|5|||
48822742|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Adverse Event|13|||
48515294|NCT02055547|156078564|FG017|Overall Study|Physician Decision|0|||
48515295|NCT02055547|156078565|FG018|Overall Study|Physician Decision|0|||
48515296|NCT02055547|156078547|FG000|Overall Study|Adverse Event|0|||
48515297|NCT02055547|156078548|FG001|Overall Study|Adverse Event|0|||
48515298|NCT02055547|156078549|FG002|Overall Study|Adverse Event|0|||
48515299|NCT02055547|156078550|FG003|Overall Study|Adverse Event|0|||
48515300|NCT02055547|156078551|FG004|Overall Study|Adverse Event|0|||
48515301|NCT02055547|156078552|FG005|Overall Study|Adverse Event|0|||
48515302|NCT02055547|156078553|FG006|Overall Study|Adverse Event|1|||
48515303|NCT02055547|156078554|FG007|Overall Study|Adverse Event|0|||
48515304|NCT02055547|156078555|FG008|Overall Study|Adverse Event|1|||
48515305|NCT02055547|156078556|FG009|Overall Study|Adverse Event|0|||
48515306|NCT02055547|156078557|FG010|Overall Study|Adverse Event|0|||
48515307|NCT02055547|156078558|FG011|Overall Study|Adverse Event|0|||
48515308|NCT02055547|156078559|FG012|Overall Study|Adverse Event|0|||
48515309|NCT02055547|156078560|FG013|Overall Study|Adverse Event|0|||
48730503|NCT00986479|156864337|FG001|Period 1|Administrative reasons|0|||
48730504|NCT00771316|156864345|FG000|Overall Study|Adverse Event|0|||
48515310|NCT02055547|156078561|FG014|Overall Study|Adverse Event|0|||
48515311|NCT02055547|156078562|FG015|Overall Study|Adverse Event|0|||
48515312|NCT02055547|156078563|FG016|Overall Study|Adverse Event|0|||
48515313|NCT02055547|156078564|FG017|Overall Study|Adverse Event|0|||
48515314|NCT02055547|156078565|FG018|Overall Study|Adverse Event|0|||
48515315|NCT02055547|156078547|FG000|Overall Study|Withdrawal by Subject|0|||
48515316|NCT02055547|156078548|FG001|Overall Study|Withdrawal by Subject|0|||
48515317|NCT02055547|156078549|FG002|Overall Study|Withdrawal by Subject|0|||
48515318|NCT02055547|156078550|FG003|Overall Study|Withdrawal by Subject|0|||
48515319|NCT02055547|156078551|FG004|Overall Study|Withdrawal by Subject|0|||
48515320|NCT02055547|156078552|FG005|Overall Study|Withdrawal by Subject|1|||
48515321|NCT02055547|156078553|FG006|Overall Study|Withdrawal by Subject|0|||
48515322|NCT02055547|156078554|FG007|Overall Study|Withdrawal by Subject|0|||
48515323|NCT02055547|156078555|FG008|Overall Study|Withdrawal by Subject|1|||
48515324|NCT02055547|156078556|FG009|Overall Study|Withdrawal by Subject|0|||
48515325|NCT02055547|156078557|FG010|Overall Study|Withdrawal by Subject|0|||
48515326|NCT02055547|156078558|FG011|Overall Study|Withdrawal by Subject|0|||
48515327|NCT02055547|156078559|FG012|Overall Study|Withdrawal by Subject|0|||
48515328|NCT02055547|156078560|FG013|Overall Study|Withdrawal by Subject|1|||
48515329|NCT02055547|156078561|FG014|Overall Study|Withdrawal by Subject|0|||
48515330|NCT02055547|156078562|FG015|Overall Study|Withdrawal by Subject|1|||
48515331|NCT02055547|156078563|FG016|Overall Study|Withdrawal by Subject|0|||
48515332|NCT02055547|156078564|FG017|Overall Study|Withdrawal by Subject|0|||
48515333|NCT02055547|156078565|FG018|Overall Study|Withdrawal by Subject|0|||
48515334|NCT02055547|156078547|FG000|Overall Study|Lost to Follow-up|0|||
48515335|NCT02055547|156078548|FG001|Overall Study|Lost to Follow-up|0|||
48515336|NCT02055547|156078549|FG002|Overall Study|Lost to Follow-up|1|||
48515337|NCT02055547|156078550|FG003|Overall Study|Lost to Follow-up|0|||
48515338|NCT02055547|156078551|FG004|Overall Study|Lost to Follow-up|0|||
48515339|NCT02055547|156078552|FG005|Overall Study|Lost to Follow-up|0|||
48515340|NCT02055547|156078553|FG006|Overall Study|Lost to Follow-up|0|||
48515341|NCT02055547|156078554|FG007|Overall Study|Lost to Follow-up|0|||
48515342|NCT02055547|156078555|FG008|Overall Study|Lost to Follow-up|0|||
48515343|NCT02055547|156078556|FG009|Overall Study|Lost to Follow-up|0|||
48515344|NCT02055547|156078557|FG010|Overall Study|Lost to Follow-up|0|||
48515345|NCT02055547|156078558|FG011|Overall Study|Lost to Follow-up|0|||
48515346|NCT02055547|156078559|FG012|Overall Study|Lost to Follow-up|0|||
48515347|NCT02055547|156078560|FG013|Overall Study|Lost to Follow-up|0|||
48515348|NCT02055547|156078561|FG014|Overall Study|Lost to Follow-up|0|||
48515349|NCT02055547|156078562|FG015|Overall Study|Lost to Follow-up|0|||
48515350|NCT02055547|156078563|FG016|Overall Study|Lost to Follow-up|0|||
48515351|NCT02055547|156078564|FG017|Overall Study|Lost to Follow-up|0|||
48515352|NCT02055547|156078565|FG018|Overall Study|Lost to Follow-up|0|||
48515353|NCT02905435|156078566|FG000|Overall Study|Death|2|||
48515354|NCT02905435|156078566|FG000|Overall Study|Physician Decision|1|||
48515355|NCT02905435|156078566|FG000|Overall Study|Lost to Follow-up|4|||
48515356|NCT01004510|156078567|FG000|Overall Study|Adverse Event|1|||
48515357|NCT00537095|156078568|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
48515358|NCT00537095|156078569|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
48515359|NCT00537095|156078568|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
48515360|NCT00537095|156078569|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
48515361|NCT00537095|156078568|FG000|Randomized Treatment Period (433 Days)|Death|3|||
48515362|NCT00537095|156078569|FG001|Randomized Treatment Period (433 Days)|Death|1|||
48515363|NCT00537095|156078568|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
48515364|NCT00537095|156078569|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
48515365|NCT00537095|156078568|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
48515366|NCT00537095|156078569|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
48515367|NCT00537095|156078568|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
48515368|NCT00537095|156078569|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
48383072|NCT01145495|155598787|FG000|Overall Study|Withdrawal by Subject|6|||
48515369|NCT00537095|156078568|FG000|Open-label Period (590 Days)|Adverse Event|2|||
48515370|NCT00537095|156078569|FG001|Open-label Period (590 Days)|Adverse Event|11|||
48515371|NCT00537095|156078568|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
48515372|NCT00537095|156078569|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
48515373|NCT00537095|156078568|FG000|Open-label Period (590 Days)|Death|2|||
48515374|NCT00537095|156078569|FG001|Open-label Period (590 Days)|Death|2|||
48515375|NCT00537095|156078568|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
48515376|NCT00537095|156078569|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
48515377|NCT00537095|156078568|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
48515378|NCT00537095|156078569|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
48515379|NCT02911025|156078570|FG000|Overall Study|Lost to Follow-up|3|||
48515380|NCT01960296|156078571|FG000|Overall Study|Postponed surgery|1|||
48515381|NCT01960296|156078572|FG001|Overall Study|Postponed surgery|0|||
48515382|NCT01960296|156078571|FG000|Overall Study|Received different procedure|1|||
48515383|NCT01960296|156078572|FG001|Overall Study|Received different procedure|3|||
48515384|NCT00045162|156078573|FG000|Overall Study|Ineligible|12|||
48515385|NCT00045162|156078574|FG001|Overall Study|Ineligible|8|||
48515386|NCT00045162|156078573|FG000|Overall Study|Not treated|7|||
48515387|NCT00045162|156078574|FG001|Overall Study|Not treated|2|||
48515388|NCT00045162|156078573|FG000|Overall Study|Adverse Event|55|||
48515389|NCT00045162|156078574|FG001|Overall Study|Adverse Event|50|||
48515390|NCT00045162|156078573|FG000|Overall Study|Lack of Efficacy|32|||
48515391|NCT00045162|156078574|FG001|Overall Study|Lack of Efficacy|29|||
48515392|NCT00045162|156078573|FG000|Overall Study|Death|10|||
48515393|NCT00045162|156078574|FG001|Overall Study|Death|10|||
48515394|NCT00045162|156078573|FG000|Overall Study|Withdrawal by Subject|5|||
48515395|NCT00045162|156078574|FG001|Overall Study|Withdrawal by Subject|3|||
48515396|NCT00045162|156078573|FG000|Overall Study|Other|21|||
48515397|NCT00045162|156078574|FG001|Overall Study|Other|16|||
48515398|NCT00421304|156078581|FG000|Overall Study|Lost to Follow-up|5|||
48515399|NCT00421304|156078582|FG001|Overall Study|Lost to Follow-up|2|||
48515400|NCT00421304|156078583|FG002|Overall Study|Lost to Follow-up|5|||
48515401|NCT00421304|156078581|FG000|Overall Study|Withdrawal by Subject|2|||
48515402|NCT00421304|156078582|FG001|Overall Study|Withdrawal by Subject|2|||
48515403|NCT00421304|156078583|FG002|Overall Study|Withdrawal by Subject|2|||
48515404|NCT00421304|156078581|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
48822743|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Adverse Event|0|||
48822744|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
48515405|NCT00421304|156078582|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
48515406|NCT00421304|156078583|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
48515407|NCT00421304|156078581|FG000|Overall Study|Did not attend Day 360 visit|0|||
48515408|NCT00421304|156078582|FG001|Overall Study|Did not attend Day 360 visit|0|||
48515409|NCT00421304|156078583|FG002|Overall Study|Did not attend Day 360 visit|1|||
48515410|NCT01539239|156078588|FG000|Overall Study|Death|5|||
48515411|NCT01539239|156078589|FG001|Overall Study|Death|5|||
48515412|NCT01539239|156078588|FG000|Overall Study|Lost to Follow-up|7|||
48515413|NCT01539239|156078589|FG001|Overall Study|Lost to Follow-up|12|||
48515414|NCT00070291|156080421|FG000|Step 1|Withdrawal by Subject|1|||
48515415|NCT00070291|156080421|FG000|Step 1|Adverse Event|1|||
48515416|NCT00070291|156080421|FG000|Step 2|Adverse Event|1|||
48515417|NCT04299087|156080422|FG000|Overall Study|Lost to Follow-up|2|||
48822745|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
48822746|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
48822747|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
48822748|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
48822749|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
48822750|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
48822751|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
48822752|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
48822753|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
48822754|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
48822755|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
48822756|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
48822757|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
48822758|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
48383073|NCT01145495|155598787|FG000|Overall Study|Disease progression after respone|2|||
48515418|NCT04299087|156080423|FG001|Overall Study|Lost to Follow-up|1|||
48515419|NCT03025087|156080424|FG000|Overall Study|Physician Decision|3|||
48515420|NCT03025087|156080425|FG001|Overall Study|Physician Decision|3|||
48515421|NCT03025087|156080426|FG002|Overall Study|Physician Decision|0|||
48515422|NCT03025087|156080427|FG003|Overall Study|Physician Decision|0|||
48515423|NCT03025087|156080428|FG004|Overall Study|Physician Decision|0|||
48515424|NCT03025087|156080424|FG000|Overall Study|Withdrawal by Subject|1|||
48515425|NCT03025087|156080425|FG001|Overall Study|Withdrawal by Subject|1|||
48515426|NCT03025087|156080426|FG002|Overall Study|Withdrawal by Subject|0|||
48515427|NCT03025087|156080427|FG003|Overall Study|Withdrawal by Subject|0|||
48515428|NCT03025087|156080428|FG004|Overall Study|Withdrawal by Subject|0|||
48822759|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Physician Decision|2|||
48822760|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Physician Decision|3|||
48822761|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Physician Decision|0|||
48822762|NCT01449929|157190587|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
48822763|NCT01449929|157190588|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
48822764|NCT01449929|157190589|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
48822765|NCT01449929|157190587|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
48822766|NCT01449929|157190588|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
48822767|NCT01449929|157190589|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
48822768|NCT01449929|157190587|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
48822769|NCT01449929|157190588|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
48822770|NCT01449929|157190589|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
48822771|NCT01449929|157190587|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
48822772|NCT01449929|157190588|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
48822773|NCT01449929|157190589|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
48822774|NCT00901485|157190590|FG000|Overall Study|Lack of Efficacy|0|||
48822775|NCT00901485|157190591|FG001|Overall Study|Lack of Efficacy|2|||
48822776|NCT00901485|157190590|FG000|Overall Study|Withdrawal by Subject|1|||
48822777|NCT00901485|157190591|FG001|Overall Study|Withdrawal by Subject|2|||
48822778|NCT02449044|157190592|FG000|Overall Study|Lost to Follow-up|2|||
48822779|NCT02449044|157190592|FG000|Overall Study|Withdrawal by Subject|13|||
48822780|NCT02449044|157190592|FG000|Overall Study|Adverse Event|30|||
48822781|NCT02449044|157190592|FG000|Overall Study|Met Withdrawal Criteria|7|||
48822782|NCT02449044|157190592|FG000|Overall Study|Physician Decision|9|||
48822783|NCT02449044|157190592|FG000|Overall Study|Sponsor Discontinued Trial|3|||
48822784|NCT01040780|157192214|FG000|Overall Study|Protocol Violation|1|||
48822785|NCT01040780|157192215|FG001|Overall Study|Protocol Violation|3|||
48441291|NCT03084718|155801526|FG004|Overall Study|Physician Decision|0|||
48441292|NCT03084718|155801522|FG000|Overall Study|Adverse Event|3|||
48441293|NCT03084718|155801523|FG001|Overall Study|Adverse Event|5|||
48441294|NCT03084718|155801524|FG002|Overall Study|Adverse Event|5|||
48441295|NCT03084718|155801525|FG003|Overall Study|Adverse Event|8|||
48441296|NCT03084718|155801526|FG004|Overall Study|Adverse Event|2|||
48441297|NCT03084718|155801522|FG000|Overall Study|Lack of Efficacy|2|||
48441298|NCT03084718|155801523|FG001|Overall Study|Lack of Efficacy|0|||
48441299|NCT03084718|155801524|FG002|Overall Study|Lack of Efficacy|1|||
48441300|NCT03084718|155801525|FG003|Overall Study|Lack of Efficacy|4|||
48441301|NCT03084718|155801526|FG004|Overall Study|Lack of Efficacy|0|||
48441302|NCT03084718|155801522|FG000|Overall Study|Lost to Follow-up|0|||
48441303|NCT03084718|155801523|FG001|Overall Study|Lost to Follow-up|1|||
48441304|NCT03084718|155801524|FG002|Overall Study|Lost to Follow-up|0|||
48441305|NCT03084718|155801525|FG003|Overall Study|Lost to Follow-up|0|||
48441306|NCT03084718|155801526|FG004|Overall Study|Lost to Follow-up|2|||
48441307|NCT03084718|155801522|FG000|Overall Study|Protocol Violation|0|||
48441308|NCT03084718|155801523|FG001|Overall Study|Protocol Violation|0|||
48441309|NCT03084718|155801524|FG002|Overall Study|Protocol Violation|1|||
48441310|NCT03084718|155801525|FG003|Overall Study|Protocol Violation|0|||
48441311|NCT03084718|155801526|FG004|Overall Study|Protocol Violation|0|||
48441312|NCT03084718|155801522|FG000|Overall Study|Death|0|||
48441313|NCT03084718|155801523|FG001|Overall Study|Death|1|||
48441314|NCT03084718|155801524|FG002|Overall Study|Death|0|||
48441315|NCT03084718|155801525|FG003|Overall Study|Death|0|||
48441316|NCT03084718|155801526|FG004|Overall Study|Death|0|||
48441317|NCT03084718|155801522|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
48441318|NCT03084718|155801523|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
48441319|NCT03084718|155801524|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
48441320|NCT03084718|155801525|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
48441321|NCT03084718|155801526|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
48441322|NCT03986190|155801527|FG000|Overall Study|Withdrawal by Subject|12|||
48441323|NCT03986190|155801528|FG001|Overall Study|Withdrawal by Subject|0|||
48441324|NCT04511819|155801529|FG000|Overall Study|Non-compliance with study drug|5|||
48441325|NCT04511819|155801530|FG001|Overall Study|Non-compliance with study drug|1|||
48441326|NCT04511819|155801529|FG000|Overall Study|Withdrawal by Subject|0|||
48441327|NCT04511819|155801530|FG001|Overall Study|Withdrawal by Subject|3|||
48441328|NCT04511819|155801529|FG000|Overall Study|Adverse Event|0|||
48441329|NCT04511819|155801530|FG001|Overall Study|Adverse Event|1|||
48441330|NCT04511819|155801529|FG000|Overall Study|Protocol deviation|1|||
48441331|NCT04511819|155801530|FG001|Overall Study|Protocol deviation|0|||
48441332|NCT01742078|155801534|FG000|Overall Study|Withdrawal by Subject|0|||
48441333|NCT01742078|155801535|FG001|Overall Study|Withdrawal by Subject|0|||
48441334|NCT01742078|155801536|FG002|Overall Study|Withdrawal by Subject|0|||
48441335|NCT01742078|155801537|FG003|Overall Study|Withdrawal by Subject|1|||
48441336|NCT01742078|155801538|FG004|Overall Study|Withdrawal by Subject|0|||
48441337|NCT01742078|155801539|FG005|Overall Study|Withdrawal by Subject|0|||
48441338|NCT01742078|155801540|FG006|Overall Study|Withdrawal by Subject|0|||
48441339|NCT01742078|155801541|FG007|Overall Study|Withdrawal by Subject|0|||
48515429|NCT03025087|156080424|FG000|Overall Study|Unable to complete MRI|2|||
48515430|NCT03025087|156080425|FG001|Overall Study|Unable to complete MRI|2|||
48822786|NCT00654940|157192216|FG000|Period 1|Adverse Event|0|||
48822787|NCT00654940|157192217|FG001|Period 1|Adverse Event|1|||
48822788|NCT00654940|157192216|FG000|Period 1|Intolerable Pain Level|1|||
48822789|NCT00654940|157192217|FG001|Period 1|Intolerable Pain Level|0|||
48822790|NCT02906683|157192218|FG000|Overall Study|Adverse Event|0|||
48822791|NCT02906683|157192219|FG001|Overall Study|Adverse Event|1|||
48822792|NCT02906683|157192220|FG002|Overall Study|Adverse Event|0|||
48822793|NCT02906683|157192218|FG000|Overall Study|Physician Decision|0|||
48822794|NCT02906683|157192219|FG001|Overall Study|Physician Decision|1|||
48822795|NCT02906683|157192220|FG002|Overall Study|Physician Decision|1|||
48822796|NCT02906683|157192218|FG000|Overall Study|Withdrawal by Subject|0|||
48822797|NCT02906683|157192219|FG001|Overall Study|Withdrawal by Subject|2|||
48515431|NCT03025087|156080426|FG002|Overall Study|Unable to complete MRI|0|||
48515432|NCT03025087|156080427|FG003|Overall Study|Unable to complete MRI|0|||
48822798|NCT02906683|157192220|FG002|Overall Study|Withdrawal by Subject|1|||
48822799|NCT02906683|157192218|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
48822800|NCT02906683|157192219|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
48822801|NCT02906683|157192220|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
48822802|NCT02906683|157192218|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
48441413|NCT01309841|155801572|FG002|Overall Study|Lost to Follow-up|4|||
48441414|NCT01309841|155801570|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
48515433|NCT03025087|156080428|FG004|Overall Study|Unable to complete MRI|0|||
48515434|NCT01750294|156080429|FG000|Overall Study|Withdrawal by Subject|1|||
48515435|NCT01750294|156080429|FG000|Overall Study|Safety Endpoint|1|||
48515436|NCT00665925|156080430|FG000|Overall Study|Lack of Efficacy|10|||
48515437|NCT00665925|156080431|FG001|Overall Study|Lack of Efficacy|8|||
48515438|NCT00665925|156080432|FG002|Overall Study|Lack of Efficacy|9|||
48515439|NCT00665925|156080433|FG003|Overall Study|Lack of Efficacy|8|||
48515440|NCT00665925|156080430|FG000|Overall Study|Lost to Follow-up|1|||
48515441|NCT00665925|156080431|FG001|Overall Study|Lost to Follow-up|2|||
48515442|NCT00665925|156080432|FG002|Overall Study|Lost to Follow-up|2|||
48515443|NCT00665925|156080433|FG003|Overall Study|Lost to Follow-up|2|||
48515444|NCT00665925|156080430|FG000|Overall Study|Withdrawal by Subject|2|||
48515445|NCT00665925|156080431|FG001|Overall Study|Withdrawal by Subject|2|||
48515446|NCT00665925|156080432|FG002|Overall Study|Withdrawal by Subject|3|||
48515447|NCT00665925|156080433|FG003|Overall Study|Withdrawal by Subject|2|||
48515448|NCT00665925|156080430|FG000|Overall Study|Physician Decision|0|||
48515449|NCT00665925|156080431|FG001|Overall Study|Physician Decision|0|||
48515450|NCT00665925|156080432|FG002|Overall Study|Physician Decision|1|||
48515451|NCT00665925|156080433|FG003|Overall Study|Physician Decision|2|||
48515452|NCT00665925|156080430|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
48515453|NCT00665925|156080431|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
48601108|NCT02718911|156396042|FG002|Overall Study|Death|1|||
48441415|NCT01309841|155801571|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
48730505|NCT00771316|156864346|FG001|Overall Study|Adverse Event|1|||
48730506|NCT00771316|156864345|FG000|Overall Study|Patient withdrew consent|1|||
48730507|NCT00771316|156864346|FG001|Overall Study|Patient withdrew consent|0|||
48730508|NCT00771316|156864345|FG000|Overall Study|Discontinued due to early termination|1|||
48730509|NCT00771316|156864346|FG001|Overall Study|Discontinued due to early termination|0|||
48730510|NCT00945555|156864349|FG000|Overall Study|Referred to another hospital|5|||
48730511|NCT00945555|156864349|FG000|Overall Study|Worsening condition, intensive care unit|1|||
48730512|NCT00945555|156864349|FG000|Overall Study|Withdrawal by Subject|2|||
48730513|NCT00945555|156864349|FG000|Overall Study|Participant continued treatment at home|1|||
48730514|NCT00945555|156864349|FG000|Overall Study|Death|18|||
48730515|NCT00945555|156864349|FG000|Overall Study|Other|1|||
48730516|NCT01067976|156864350|FG000|Overall Study|Study drug never administered|20|||
48730517|NCT01067976|156864350|FG000|Overall Study|Study prematurely discontinued|2|||
48730518|NCT00589290|156864351|FG000|Overall Study|Withdrawal by Subject|1|||
48730519|NCT04815031|156864352|FG000|Overall Study|No adverse event information (missing information)|33|||
48730520|NCT00932737|156864353|FG000|Overall Study|Not treated in second episode|1|||
48730521|NCT00932737|156864354|FG001|Overall Study|Not treated in second episode|0|||
48822803|NCT02906683|157192219|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
48441416|NCT01309841|155801572|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
48441417|NCT01309841|155801570|FG000|Overall Study|Lack of Efficacy|0|||
48441418|NCT01309841|155801571|FG001|Overall Study|Lack of Efficacy|0|||
48441419|NCT01309841|155801572|FG002|Overall Study|Lack of Efficacy|2|||
48441420|NCT01309841|155801570|FG000|Overall Study|Adverse Event|9|||
48441421|NCT01309841|155801571|FG001|Overall Study|Adverse Event|22|||
48441422|NCT01309841|155801572|FG002|Overall Study|Adverse Event|11|||
48441423|NCT01309841|155801570|FG000|Overall Study|Death|1|||
48441424|NCT01309841|155801571|FG001|Overall Study|Death|0|||
48441425|NCT01309841|155801572|FG002|Overall Study|Death|0|||
48441426|NCT01309841|155801570|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48515454|NCT00665925|156080432|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
48515455|NCT00665925|156080433|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
48515456|NCT00665925|156080430|FG000|Overall Study|Adverse Event|1|||
48515457|NCT00665925|156080431|FG001|Overall Study|Adverse Event|5|||
48515458|NCT00665925|156080432|FG002|Overall Study|Adverse Event|10|||
48515459|NCT00665925|156080433|FG003|Overall Study|Adverse Event|5|||
48515460|NCT00665925|156080430|FG000|Overall Study|Enrolled by mistake|0|||
48515461|NCT00665925|156080431|FG001|Overall Study|Enrolled by mistake|0|||
48515462|NCT00665925|156080432|FG002|Overall Study|Enrolled by mistake|0|||
48515463|NCT00665925|156080433|FG003|Overall Study|Enrolled by mistake|1|||
48515464|NCT00665925|156080430|FG000|Overall Study|Due to exclusion criteria|1|||
48515465|NCT00665925|156080431|FG001|Overall Study|Due to exclusion criteria|0|||
48515466|NCT00665925|156080432|FG002|Overall Study|Due to exclusion criteria|0|||
48515467|NCT00665925|156080433|FG003|Overall Study|Due to exclusion criteria|0|||
48515468|NCT01116739|156080440|FG000|Overall Study|Child had 2 years of HS|110|||
48515469|NCT01116739|156080441|FG001|Overall Study|Child had 2 years of HS|128|||
48515470|NCT01116739|156080440|FG000|Overall Study|Withdrawal by Subject|6|||
48515471|NCT01116739|156080441|FG001|Overall Study|Withdrawal by Subject|0|||
48515472|NCT01116739|156080440|FG000|Overall Study|child too young|2|||
48515473|NCT01116739|156080441|FG001|Overall Study|child too young|6|||
48515474|NCT01116739|156080440|FG000|Overall Study|child not enrolled in head start|10|||
48515475|NCT01116739|156080441|FG001|Overall Study|child not enrolled in head start|2|||
48515476|NCT01116739|156080440|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
48515477|NCT01116739|156080441|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
48515478|NCT01735994|156080442|FG000|Overall Study|Withdrawal by Subject|6|||
48515479|NCT01735994|156080443|FG001|Overall Study|Withdrawal by Subject|4|||
48515480|NCT01735994|156080442|FG000|Overall Study|Injury|2|||
48515481|NCT01735994|156080443|FG001|Overall Study|Injury|0|||
48515482|NCT01735994|156080442|FG000|Overall Study|Kicked off team|5|||
48515483|NCT01735994|156080443|FG001|Overall Study|Kicked off team|0|||
48515484|NCT01735994|156080442|FG000|Overall Study|Lost to Follow-up|50|||
48515485|NCT01735994|156080443|FG001|Overall Study|Lost to Follow-up|62|||
48515486|NCT05239195|156080446|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
48515487|NCT05239195|156080447|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
48515488|NCT04994535|156080448|FG000|Overall Study|Lost to Follow-up|7|||
48515489|NCT04994535|156080449|FG001|Overall Study|Lost to Follow-up|7|||
48515490|NCT04994535|156080448|FG000|Overall Study|Withdrawal by Subject|10|||
48515491|NCT04994535|156080449|FG001|Overall Study|Withdrawal by Subject|7|||
48515492|NCT04994535|156080448|FG000|Overall Study|Other|1|||
48515493|NCT04994535|156080449|FG001|Overall Study|Other|1|||
48822804|NCT02906683|157192220|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
48822805|NCT02328014|157192221|FG000|Overall Study|Adverse Event|1|||
48822806|NCT02328014|157192222|FG001|Overall Study|Adverse Event|0|||
48822807|NCT02328014|157192223|FG002|Overall Study|Adverse Event|0|||
48822808|NCT02328014|157192224|FG003|Overall Study|Adverse Event|1|||
48822809|NCT02328014|157192221|FG000|Overall Study|Death|0|||
48822810|NCT02328014|157192222|FG001|Overall Study|Death|0|||
48822811|NCT02328014|157192223|FG002|Overall Study|Death|0|||
48822812|NCT02328014|157192224|FG003|Overall Study|Death|4|||
48822813|NCT02328014|157192221|FG000|Overall Study|Physician Decision|0|||
48822814|NCT02328014|157192222|FG001|Overall Study|Physician Decision|0|||
48822815|NCT02328014|157192223|FG002|Overall Study|Physician Decision|0|||
48822816|NCT02328014|157192224|FG003|Overall Study|Physician Decision|1|||
48822817|NCT02328014|157192221|FG000|Overall Study|Disease Progression|1|||
48822818|NCT02328014|157192222|FG001|Overall Study|Disease Progression|0|||
48515494|NCT01158118|156080450|FG000|Overall Study|Screen failure|1|||
48515495|NCT01158118|156080451|FG001|Overall Study|Screen failure|0|||
48515496|NCT01158118|156080450|FG000|Overall Study|Donor match was a screen failure|0|||
48515497|NCT01158118|156080451|FG001|Overall Study|Donor match was a screen failure|1|||
48822819|NCT02328014|157192223|FG002|Overall Study|Disease Progression|1|||
48515498|NCT01158118|156080450|FG000|Overall Study|Suffered stroke prior to transplant|0|||
48515499|NCT01158118|156080451|FG001|Overall Study|Suffered stroke prior to transplant|1|||
48515500|NCT01158118|156080450|FG000|Overall Study|Death|0|||
48383074|NCT02448225|155598788|FG000|Overall Study|Withdrawal by Subject|1|||
48515501|NCT01158118|156080451|FG001|Overall Study|Death|1|||
48515502|NCT03552484|156080454|FG000|Overall Study|Death|6|||
48515503|NCT03552484|156080455|FG001|Overall Study|Death|4|||
48515504|NCT03552484|156080454|FG000|Overall Study|Lost to Follow-up|0|||
48515505|NCT03552484|156080455|FG001|Overall Study|Lost to Follow-up|16|||
48515506|NCT00604162|156080456|FG000|Overall Study|Physician Decision|3|||
48515507|NCT00604162|156080456|FG000|Overall Study|Withdrawal by Subject|1|||
48515508|NCT03499353|156080457|FG000|Treatment|Adverse Event|3|||
48515509|NCT03499353|156080457|FG000|Treatment|Progressive Disease|10|||
48515510|NCT03499353|156080457|FG000|Treatment|Other|1|||
48822820|NCT02328014|157192224|FG003|Overall Study|Disease Progression|3|||
48822821|NCT02328014|157192221|FG000|Overall Study|Study Terminated by Sponsor|4|||
48822822|NCT02328014|157192222|FG001|Overall Study|Study Terminated by Sponsor|1|||
48822823|NCT02328014|157192223|FG002|Overall Study|Study Terminated by Sponsor|1|||
48515511|NCT03499353|156080457|FG000|Treatment|Withdrawal by Subject|2|||
48515512|NCT03499353|156080457|FG000|Long-Term Follow-up|Death|2|||
48515513|NCT03499353|156080457|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
48515514|NCT03499353|156080457|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
48515515|NCT00081653|156080458|FG000|Overall Study|Adverse Event|23|||
48515516|NCT00081653|156080459|FG001|Overall Study|Adverse Event|17|||
48515517|NCT00081653|156080458|FG000|Overall Study|Lost to Follow-up|2|||
48515518|NCT00081653|156080459|FG001|Overall Study|Lost to Follow-up|4|||
48515519|NCT00081653|156080458|FG000|Overall Study|Refused Treatment|18|||
48515520|NCT00081653|156080459|FG001|Overall Study|Refused Treatment|14|||
48515521|NCT00081653|156080458|FG000|Overall Study|Low bone mineral density|1|||
48515522|NCT00081653|156080459|FG001|Overall Study|Low bone mineral density|0|||
48515523|NCT00081653|156080458|FG000|Overall Study|Bone loss|2|||
48515524|NCT00081653|156080459|FG001|Overall Study|Bone loss|0|||
48515525|NCT00081653|156080458|FG000|Overall Study|Participant leaving country|1|||
48515526|NCT00081653|156080459|FG001|Overall Study|Participant leaving country|0|||
48515527|NCT00081653|156080458|FG000|Overall Study|Loss of bone mass|0|||
48515528|NCT00081653|156080459|FG001|Overall Study|Loss of bone mass|2|||
48515529|NCT02241551|156080460|FG000|Overall Study|Adverse Event|1|||
48515530|NCT02241551|156080461|FG001|Overall Study|Adverse Event|0|||
48515531|NCT01592240|156080462|FG000|Overall Study|Adverse Event|1|||
48515532|NCT01592240|156080463|FG001|Overall Study|Adverse Event|0|||
48515533|NCT01592240|156080464|FG002|Overall Study|Adverse Event|0|||
48515534|NCT01592240|156080465|FG003|Overall Study|Adverse Event|1|||
48515535|NCT01592240|156080466|FG004|Overall Study|Adverse Event|1|||
48515536|NCT01592240|156080467|FG005|Overall Study|Adverse Event|0|||
48515537|NCT01592240|156080468|FG006|Overall Study|Adverse Event|0|||
48515538|NCT01592240|156080462|FG000|Overall Study|Death|0|||
48515539|NCT01592240|156080463|FG001|Overall Study|Death|1|||
48515540|NCT01592240|156080464|FG002|Overall Study|Death|0|||
48515541|NCT01592240|156080465|FG003|Overall Study|Death|0|||
48515542|NCT01592240|156080466|FG004|Overall Study|Death|0|||
48515543|NCT01592240|156080467|FG005|Overall Study|Death|0|||
48515544|NCT01592240|156080468|FG006|Overall Study|Death|0|||
48383075|NCT02448225|155598788|FG000|Overall Study|Did not get FSPG scan|18|||
48515545|NCT01592240|156080462|FG000|Overall Study|Lost to Follow-up|1|||
48515546|NCT01592240|156080463|FG001|Overall Study|Lost to Follow-up|3|||
48515547|NCT01592240|156080464|FG002|Overall Study|Lost to Follow-up|1|||
48515548|NCT01592240|156080465|FG003|Overall Study|Lost to Follow-up|0|||
48515549|NCT01592240|156080466|FG004|Overall Study|Lost to Follow-up|3|||
48515550|NCT01592240|156080467|FG005|Overall Study|Lost to Follow-up|2|||
48515551|NCT01592240|156080468|FG006|Overall Study|Lost to Follow-up|0|||
48515552|NCT01592240|156080462|FG000|Overall Study|Protocol Violation|0|||
48515553|NCT01592240|156080463|FG001|Overall Study|Protocol Violation|0|||
48515554|NCT01592240|156080464|FG002|Overall Study|Protocol Violation|0|||
48515555|NCT01592240|156080465|FG003|Overall Study|Protocol Violation|0|||
48515556|NCT01592240|156080466|FG004|Overall Study|Protocol Violation|0|||
48515557|NCT01592240|156080467|FG005|Overall Study|Protocol Violation|1|||
48515558|NCT01592240|156080468|FG006|Overall Study|Protocol Violation|0|||
48515559|NCT01592240|156080462|FG000|Overall Study|Withdrawal by Subject|0|||
48515560|NCT01592240|156080463|FG001|Overall Study|Withdrawal by Subject|4|||
48730522|NCT00932737|156864353|FG000|Overall Study|Adverse Event|0|||
48730523|NCT00932737|156864354|FG001|Overall Study|Adverse Event|1|||
48730524|NCT05156073|156864356|FG000|Overall Study|Patient canceled appointment with PCP|1|||
48730525|NCT02891161|156864357|FG000|Study Treatment|Disease Progression|2|||
48730526|NCT02891161|156864358|FG001|Study Treatment|Disease Progression|4|||
48730527|NCT02891161|156864357|FG000|Study Treatment|AE/Side Effects/Complications|1|||
48730528|NCT02891161|156864358|FG001|Study Treatment|AE/Side Effects/Complications|5|||
48730529|NCT02891161|156864357|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
48730530|NCT02891161|156864358|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
48730531|NCT02891161|156864357|FG000|Follow up|Death|4|||
48730532|NCT02891161|156864358|FG001|Follow up|Death|8|||
48730533|NCT02891161|156864357|FG000|Follow up|Refused to Follow up|0|||
48730534|NCT02891161|156864358|FG001|Follow up|Refused to Follow up|2|||
48730535|NCT02891161|156864357|FG000|Follow up|Symptomatic deterioration|0|||
48730536|NCT02891161|156864358|FG001|Follow up|Symptomatic deterioration|1|||
48730537|NCT02891161|156864357|FG000|Follow up|Study terminated|0|||
48730538|NCT02891161|156864358|FG001|Follow up|Study terminated|6|||
48730539|NCT03350620|156864360|FG000|Stage 2|Adverse Event|0|||
48730540|NCT03350620|156864361|FG001|Stage 2|Adverse Event|1|||
48730541|NCT03350620|156864362|FG002|Stage 2|Adverse Event|1|||
48730542|NCT03350620|156864360|FG000|Stage 2|Lack of Efficacy|0|||
48730543|NCT03350620|156864361|FG001|Stage 2|Lack of Efficacy|2|||
48730544|NCT03350620|156864362|FG002|Stage 2|Lack of Efficacy|0|||
48730545|NCT03350620|156864360|FG000|Stage 2|Lost to Follow-up|1|||
48730546|NCT03350620|156864361|FG001|Stage 2|Lost to Follow-up|2|||
48730547|NCT03350620|156864362|FG002|Stage 2|Lost to Follow-up|2|||
48730548|NCT03350620|156864360|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
48730549|NCT03350620|156864361|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
48730550|NCT03350620|156864362|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
48730551|NCT02544074|156865805|FG000|Overall Study|Withdrawal by Subject|0|||
48730552|NCT02544074|156865806|FG001|Overall Study|Withdrawal by Subject|1|||
48730553|NCT02544074|156865807|FG002|Overall Study|Withdrawal by Subject|0|||
48730554|NCT02544074|156865808|FG003|Overall Study|Withdrawal by Subject|0|||
48515561|NCT01592240|156080464|FG002|Overall Study|Withdrawal by Subject|4|||
48515562|NCT01592240|156080465|FG003|Overall Study|Withdrawal by Subject|1|||
48515563|NCT01592240|156080466|FG004|Overall Study|Withdrawal by Subject|3|||
48515564|NCT01592240|156080467|FG005|Overall Study|Withdrawal by Subject|0|||
48515565|NCT01592240|156080468|FG006|Overall Study|Withdrawal by Subject|2|||
48515566|NCT01592240|156080462|FG000|Overall Study|Other|0|||
48515567|NCT01592240|156080463|FG001|Overall Study|Other|3|||
48515568|NCT01592240|156080464|FG002|Overall Study|Other|1|||
48515569|NCT01592240|156080465|FG003|Overall Study|Other|1|||
48515570|NCT01592240|156080466|FG004|Overall Study|Other|0|||
48515571|NCT01592240|156080467|FG005|Overall Study|Other|0|||
48515572|NCT01592240|156080468|FG006|Overall Study|Other|1|||
48515573|NCT01592240|156080462|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
48515574|NCT01592240|156080463|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
48515575|NCT01592240|156080464|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
48515576|NCT01592240|156080465|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
48515577|NCT01592240|156080466|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
48515578|NCT01592240|156080467|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
48515579|NCT01592240|156080468|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
48515580|NCT02450539|156080471|FG000|Overall Study|Withdrawal by Subject|12|||
48515581|NCT02450539|156080472|FG001|Overall Study|Withdrawal by Subject|6|||
48515582|NCT02450539|156080471|FG000|Overall Study|Lost to Follow-up|4|||
48515583|NCT02450539|156080472|FG001|Overall Study|Lost to Follow-up|1|||
48515584|NCT02964039|156080477|FG000|Overall Study|Medical reason unrelated to study participation|1|||
48515585|NCT02964039|156080478|FG001|Overall Study|Medical reason unrelated to study participation|0|||
48515586|NCT02964039|156080479|FG002|Overall Study|Medical reason unrelated to study participation|3|||
48515587|NCT02964039|156080477|FG000|Overall Study|Research shutdown due to pandemic|2|||
48515588|NCT02964039|156080478|FG001|Overall Study|Research shutdown due to pandemic|0|||
48515589|NCT02964039|156080479|FG002|Overall Study|Research shutdown due to pandemic|1|||
48515590|NCT02964039|156080477|FG000|Overall Study|Withdrawal by Subject|0|||
48515591|NCT02964039|156080478|FG001|Overall Study|Withdrawal by Subject|1|||
48515592|NCT02964039|156080479|FG002|Overall Study|Withdrawal by Subject|0|||
48730555|NCT02544074|156865809|FG004|Overall Study|Withdrawal by Subject|0|||
48730556|NCT02544074|156865810|FG005|Overall Study|Withdrawal by Subject|0|||
48730557|NCT02544074|156865811|FG006|Overall Study|Withdrawal by Subject|0|||
48730558|NCT02544074|156865812|FG007|Overall Study|Withdrawal by Subject|0|||
48383076|NCT02448225|155598788|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
48383077|NCT00578786|155598791|FG000|Overall Study|Adverse Event|27|||
48383078|NCT00578786|155598792|FG001|Overall Study|Adverse Event|37|||
48383079|NCT00578786|155598793|FG002|Overall Study|Adverse Event|17|||
48383080|NCT00578786|155598791|FG000|Overall Study|Lack of Efficacy|2|||
48383081|NCT00578786|155598792|FG001|Overall Study|Lack of Efficacy|5|||
48383082|NCT00578786|155598793|FG002|Overall Study|Lack of Efficacy|2|||
48730559|NCT02544074|156865813|FG008|Overall Study|Withdrawal by Subject|0|||
48730560|NCT02544074|156865814|FG009|Overall Study|Withdrawal by Subject|0|||
48730561|NCT02544074|156865815|FG010|Overall Study|Withdrawal by Subject|0|||
48730562|NCT02544074|156865816|FG011|Overall Study|Withdrawal by Subject|0|||
48730563|NCT02544074|156865817|FG012|Overall Study|Withdrawal by Subject|0|||
48730564|NCT02544074|156865818|FG013|Overall Study|Withdrawal by Subject|0|||
48730565|NCT02544074|156865819|FG014|Overall Study|Withdrawal by Subject|0|||
48515593|NCT02964039|156080477|FG000|Overall Study|Lost to Follow-up|1|||
48515594|NCT02964039|156080478|FG001|Overall Study|Lost to Follow-up|0|||
48515595|NCT02964039|156080479|FG002|Overall Study|Lost to Follow-up|1|||
48515596|NCT00669162|156080490|FG000|Overall Study|Withdrawal by Subject|1|||
48515597|NCT00841542|156080493|FG000|Period 1|Adverse Event|1|||
48515598|NCT00841542|156080494|FG001|Period 1|Adverse Event|0|||
48515599|NCT03801707|156080495|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
48515600|NCT00425308|156080496|FG000|Overall Study|Adverse Event|2|||
48515601|NCT00425308|156080497|FG001|Overall Study|Adverse Event|1|||
48515602|NCT00425308|156080496|FG000|Overall Study|Withdrawal by Subject|1|||
48515603|NCT00425308|156080497|FG001|Overall Study|Withdrawal by Subject|0|||
48515604|NCT00425308|156080496|FG000|Overall Study|Death|1|||
48515605|NCT00425308|156080497|FG001|Overall Study|Death|0|||
48515606|NCT01647828|156080498|FG000|Overall Study|Death|3|||
48515607|NCT01647828|156080499|FG001|Overall Study|Death|4|||
48515608|NCT01647828|156080500|FG002|Overall Study|Death|4|||
48383083|NCT00578786|155598791|FG000|Overall Study|Early Escape from Prior Study|2|||
48515609|NCT01647828|156080501|FG003|Overall Study|Death|5|||
48515610|NCT01647828|156080502|FG004|Overall Study|Death|6|||
48515611|NCT01647828|156080503|FG005|Overall Study|Death|3|||
48515612|NCT01647828|156080504|FG006|Overall Study|Death|10|||
48383084|NCT00578786|155598792|FG001|Overall Study|Early Escape from Prior Study|1|||
48383085|NCT00578786|155598793|FG002|Overall Study|Early Escape from Prior Study|2|||
48383086|NCT00578786|155598791|FG000|Overall Study|Withdrawal by Subject|7|||
48383087|NCT00578786|155598792|FG001|Overall Study|Withdrawal by Subject|8|||
48383088|NCT00578786|155598793|FG002|Overall Study|Withdrawal by Subject|5|||
48383089|NCT00578786|155598791|FG000|Overall Study|Protocol Violation|0|||
48383090|NCT00578786|155598792|FG001|Overall Study|Protocol Violation|3|||
48383091|NCT00578786|155598793|FG002|Overall Study|Protocol Violation|1|||
48383092|NCT00578786|155598791|FG000|Overall Study|Physician Decision|1|||
48383093|NCT00578786|155598792|FG001|Overall Study|Physician Decision|0|||
48383094|NCT00578786|155598793|FG002|Overall Study|Physician Decision|1|||
48383095|NCT00578786|155598791|FG000|Overall Study|Sponsor Decision|0|||
48383096|NCT00578786|155598792|FG001|Overall Study|Sponsor Decision|0|||
48383097|NCT00578786|155598793|FG002|Overall Study|Sponsor Decision|1|||
48383098|NCT00578786|155598791|FG000|Overall Study|Lost to Follow-up|0|||
48383099|NCT00578786|155598792|FG001|Overall Study|Lost to Follow-up|4|||
48383100|NCT00578786|155598793|FG002|Overall Study|Lost to Follow-up|0|||
48383101|NCT00578786|155598791|FG000|Overall Study|Pregnancy|0|||
48383102|NCT00578786|155598792|FG001|Overall Study|Pregnancy|1|||
48383103|NCT00578786|155598793|FG002|Overall Study|Pregnancy|0|||
48383104|NCT00578786|155598791|FG000|Overall Study|Not Otherwise Specified|0|||
48383105|NCT00578786|155598792|FG001|Overall Study|Not Otherwise Specified|4|||
48822824|NCT02328014|157192224|FG003|Overall Study|Study Terminated by Sponsor|0|||
48822825|NCT02328014|157192221|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
48822826|NCT02328014|157192222|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
48822827|NCT02328014|157192223|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
48822828|NCT02328014|157192224|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
48822829|NCT02328014|157192221|FG000|Overall Study|Withdrawal by Subject|0|||
48822830|NCT02328014|157192222|FG001|Overall Study|Withdrawal by Subject|0|||
48822831|NCT02328014|157192223|FG002|Overall Study|Withdrawal by Subject|0|||
48822832|NCT02328014|157192224|FG003|Overall Study|Withdrawal by Subject|1|||
48822833|NCT02692235|157192227|FG000|Overall Study|Withdrawal by Subject|2|||
48822834|NCT02692235|157192228|FG001|Overall Study|Withdrawal by Subject|1|||
48822835|NCT02692235|157192227|FG000|Overall Study|Adverse Event|1|||
48822836|NCT02692235|157192228|FG001|Overall Study|Adverse Event|2|||
48822837|NCT00121199|157192230|FG000|Overall Study|Adverse Event|11|||
48822838|NCT00121199|157192230|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
48822839|NCT00121199|157192230|FG000|Overall Study|Progression/Relapse|1|||
48822840|NCT00121199|157192230|FG000|Overall Study|Death|3|||
48822841|NCT00121199|157192230|FG000|Overall Study|Other - Not Protocol Specified|3|||
48822842|NCT00121199|157192230|FG000|Overall Study|Ineligible|9|||
48822843|NCT01256476|157192231|FG000|Overall Study|Adverse Event|2|||
48822844|NCT01256476|157192232|FG001|Overall Study|Adverse Event|1|||
48822845|NCT01256476|157192231|FG000|Overall Study|Withdrawal by Subject|2|||
48822846|NCT01256476|157192232|FG001|Overall Study|Withdrawal by Subject|1|||
48822847|NCT01256476|157192231|FG000|Overall Study|Lost to Follow-up|1|||
48822848|NCT01256476|157192232|FG001|Overall Study|Lost to Follow-up|2|||
48822849|NCT01256476|157192231|FG000|Overall Study|Persistent ALT or AST elevation|1|||
48822850|NCT01256476|157192232|FG001|Overall Study|Persistent ALT or AST elevation|0|||
48822851|NCT01256476|157192231|FG000|Overall Study|Physician Decision|0|||
48822852|NCT01256476|157192232|FG001|Overall Study|Physician Decision|1|||
48822853|NCT01256476|157192231|FG000|Overall Study|Subject non-compliance|0|||
48822854|NCT01256476|157192232|FG001|Overall Study|Subject non-compliance|1|||
48822855|NCT01256476|157192231|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
48822856|NCT01256476|157192232|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
48822857|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822858|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
48822859|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
48822860|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
48822861|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
48822862|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
48383106|NCT00578786|155598793|FG002|Overall Study|Not Otherwise Specified|1|||
48383107|NCT00578786|155598791|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
48383108|NCT00578786|155598792|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
48383109|NCT00578786|155598793|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
48383110|NCT05085665|155598798|FG000|Overall Study|Physician Decision|2|||
48383111|NCT01478360|155598800|FG000|Overall Study|Lost to Follow-up|1|||
48822863|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822864|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822865|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822866|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
48822867|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822868|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48383112|NCT01478360|155598801|FG001|Overall Study|Lost to Follow-up|0|||
48515613|NCT01647828|156080505|FG007|Overall Study|Death|60|||
48515614|NCT01647828|156080506|FG008|Overall Study|Death|71|||
48515615|NCT01647828|156080498|FG000|Overall Study|Withdrawal by Subject|2|||
48515616|NCT01647828|156080499|FG001|Overall Study|Withdrawal by Subject|0|||
48515617|NCT01647828|156080500|FG002|Overall Study|Withdrawal by Subject|0|||
48515618|NCT01647828|156080501|FG003|Overall Study|Withdrawal by Subject|1|||
48515619|NCT01647828|156080502|FG004|Overall Study|Withdrawal by Subject|0|||
48515620|NCT01647828|156080503|FG005|Overall Study|Withdrawal by Subject|0|||
48515621|NCT01647828|156080504|FG006|Overall Study|Withdrawal by Subject|1|||
48515622|NCT01647828|156080505|FG007|Overall Study|Withdrawal by Subject|0|||
48515623|NCT01647828|156080506|FG008|Overall Study|Withdrawal by Subject|2|||
48515624|NCT01647828|156080498|FG000|Overall Study|Study terminated by Sponsor|0|||
48515625|NCT01647828|156080499|FG001|Overall Study|Study terminated by Sponsor|0|||
48515626|NCT01647828|156080500|FG002|Overall Study|Study terminated by Sponsor|0|||
48515627|NCT01647828|156080501|FG003|Overall Study|Study terminated by Sponsor|0|||
48515628|NCT01647828|156080502|FG004|Overall Study|Study terminated by Sponsor|0|||
48515629|NCT01647828|156080503|FG005|Overall Study|Study terminated by Sponsor|0|||
48515630|NCT01647828|156080504|FG006|Overall Study|Study terminated by Sponsor|1|||
48515631|NCT01647828|156080505|FG007|Overall Study|Study terminated by Sponsor|26|||
48515632|NCT01647828|156080506|FG008|Overall Study|Study terminated by Sponsor|16|||
48515633|NCT01647828|156080498|FG000|Overall Study|Lost to Follow-up|0|||
48515634|NCT01647828|156080499|FG001|Overall Study|Lost to Follow-up|0|||
48515635|NCT01647828|156080500|FG002|Overall Study|Lost to Follow-up|0|||
48515636|NCT01647828|156080501|FG003|Overall Study|Lost to Follow-up|0|||
48515637|NCT01647828|156080502|FG004|Overall Study|Lost to Follow-up|0|||
48515638|NCT01647828|156080503|FG005|Overall Study|Lost to Follow-up|0|||
48515639|NCT01647828|156080504|FG006|Overall Study|Lost to Follow-up|0|||
48515640|NCT01647828|156080505|FG007|Overall Study|Lost to Follow-up|2|||
48515641|NCT01647828|156080506|FG008|Overall Study|Lost to Follow-up|0|||
48515642|NCT01906372|156080507|FG000|Overall Study|Withdrawal by Subject|2|||
48515643|NCT03629054|156080511|FG000|Period 2 (4 Days)|Not treated|0|||
48515644|NCT03629054|156080512|FG001|Period 2 (4 Days)|Not treated|1|||
48515645|NCT03808376|156080513|FG000|Overall Study|Withdrawal by Subject|10|||
48515646|NCT00573313|156080516|FG000|Overall Study|Protocol Violation|5|||
48515647|NCT00573313|156080517|FG001|Overall Study|Protocol Violation|0|||
48515648|NCT00573313|156080518|FG002|Overall Study|Protocol Violation|6|||
48515649|NCT00573313|156080519|FG003|Overall Study|Protocol Violation|0|||
48515650|NCT03677141|156080520|FG000|Overall Study|Death|2|||
48515651|NCT03677141|156080521|FG001|Overall Study|Death|1|||
48515652|NCT03677141|156080522|FG002|Overall Study|Death|6|||
48515653|NCT03677141|156080523|FG003|Overall Study|Death|9|||
48515654|NCT03677141|156080524|FG004|Overall Study|Death|5|||
48515655|NCT03677141|156080525|FG005|Overall Study|Death|3|||
48515656|NCT03677141|156080520|FG000|Overall Study|Lost to Follow-up|0|||
48515657|NCT03677141|156080521|FG001|Overall Study|Lost to Follow-up|0|||
48515658|NCT03677141|156080522|FG002|Overall Study|Lost to Follow-up|0|||
48515659|NCT03677141|156080523|FG003|Overall Study|Lost to Follow-up|2|||
48515660|NCT03677141|156080524|FG004|Overall Study|Lost to Follow-up|0|||
48515661|NCT03677141|156080525|FG005|Overall Study|Lost to Follow-up|0|||
48515662|NCT03677141|156080520|FG000|Overall Study|Screen failure or enrolled in error|0|||
48515663|NCT03677141|156080521|FG001|Overall Study|Screen failure or enrolled in error|0|||
48515664|NCT03677141|156080522|FG002|Overall Study|Screen failure or enrolled in error|0|||
48515665|NCT03677141|156080523|FG003|Overall Study|Screen failure or enrolled in error|0|||
48515666|NCT03677141|156080524|FG004|Overall Study|Screen failure or enrolled in error|2|||
48515667|NCT03677141|156080525|FG005|Overall Study|Screen failure or enrolled in error|0|||
48515668|NCT03677141|156080520|FG000|Overall Study|Physician Decision|0|||
48515669|NCT03677141|156080521|FG001|Overall Study|Physician Decision|0|||
48515670|NCT03677141|156080522|FG002|Overall Study|Physician Decision|0|||
48515671|NCT03677141|156080523|FG003|Overall Study|Physician Decision|0|||
48515672|NCT03677141|156080524|FG004|Overall Study|Physician Decision|1|||
48515673|NCT03677141|156080525|FG005|Overall Study|Physician Decision|0|||
48515674|NCT03677141|156080520|FG000|Overall Study|Withdrawal by Subject|0|||
48515675|NCT03677141|156080521|FG001|Overall Study|Withdrawal by Subject|0|||
48515676|NCT03677141|156080522|FG002|Overall Study|Withdrawal by Subject|1|||
48515677|NCT03677141|156080523|FG003|Overall Study|Withdrawal by Subject|1|||
48515678|NCT03677141|156080524|FG004|Overall Study|Withdrawal by Subject|1|||
48515679|NCT03677141|156080525|FG005|Overall Study|Withdrawal by Subject|0|||
48515680|NCT01229150|156080533|FG000|Overall Study|Toxicity|2|||
48515681|NCT01229150|156080534|FG001|Overall Study|Toxicity|2|||
48515682|NCT01229150|156080535|FG002|Overall Study|Toxicity|0|||
48515683|NCT01229150|156080536|FG003|Overall Study|Toxicity|0|||
48515684|NCT03196284|156080540|FG000|Main Part|Withdrawal by Subject|0|||
48515685|NCT03196284|156080541|FG001|Main Part|Withdrawal by Subject|1|||
48515686|NCT03196284|156080542|FG002|Main Part|Withdrawal by Subject|0|||
48515687|NCT03196284|156080540|FG000|Extension Part|Lack of Efficacy|0|||
48515688|NCT03196284|156080541|FG001|Extension Part|Lack of Efficacy|0|||
48515689|NCT03196284|156080542|FG002|Extension Part|Lack of Efficacy|1|||
48515690|NCT03196284|156080540|FG000|Extension Part|Withdrawal by Subject|0|||
48515691|NCT03196284|156080541|FG001|Extension Part|Withdrawal by Subject|0|||
48383113|NCT01478360|155598800|FG000|Overall Study|Adverse Event|0|||
48383114|NCT01478360|155598801|FG001|Overall Study|Adverse Event|1|||
48383115|NCT01478360|155598800|FG000|Overall Study|Administrative problems|1|||
48383116|NCT01478360|155598801|FG001|Overall Study|Administrative problems|2|||
48383117|NCT00529451|155598827|FG000|Overall Study|Subject withdrew consent|16|||
48383118|NCT00529451|155598828|FG001|Overall Study|Subject withdrew consent|21|||
48383119|NCT00529451|155598829|FG002|Overall Study|Subject withdrew consent|13|||
48383120|NCT00529451|155598830|FG003|Overall Study|Subject withdrew consent|12|||
48383121|NCT00529451|155598827|FG000|Overall Study|Adverse Event|9|||
48383122|NCT00529451|155598828|FG001|Overall Study|Adverse Event|16|||
48383123|NCT00529451|155598829|FG002|Overall Study|Adverse Event|14|||
48383124|NCT00529451|155598830|FG003|Overall Study|Adverse Event|8|||
48383125|NCT00529451|155598827|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
48383126|NCT00529451|155598828|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
48383127|NCT00529451|155598829|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
48383128|NCT00529451|155598830|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
48383129|NCT00529451|155598827|FG000|Overall Study|Lost to Follow-up|4|||
48383130|NCT00529451|155598828|FG001|Overall Study|Lost to Follow-up|7|||
48383131|NCT00529451|155598829|FG002|Overall Study|Lost to Follow-up|4|||
48383132|NCT00529451|155598830|FG003|Overall Study|Lost to Follow-up|4|||
48383133|NCT00529451|155598827|FG000|Overall Study|Protocol deviation|1|||
48383134|NCT00529451|155598828|FG001|Overall Study|Protocol deviation|1|||
48383135|NCT00529451|155598829|FG002|Overall Study|Protocol deviation|4|||
48383136|NCT00529451|155598830|FG003|Overall Study|Protocol deviation|1|||
48383137|NCT00529451|155598827|FG000|Overall Study|Administrative problems|1|||
48383138|NCT00529451|155598828|FG001|Overall Study|Administrative problems|1|||
48383139|NCT00529451|155598829|FG002|Overall Study|Administrative problems|0|||
48383140|NCT00529451|155598830|FG003|Overall Study|Administrative problems|2|||
48383141|NCT00894686|155598831|FG000|Overall Study|Withdrawal by Subject|50|||
48383142|NCT00894686|155598831|FG000|Overall Study|Physician Decision|1|||
48383143|NCT00894686|155598831|FG000|Overall Study|Other|5|||
48383144|NCT02941926|155598832|FG000|Core Phase|Progressive disease|1109|||
48383145|NCT02941926|155598832|FG000|Core Phase|Adverse Event|504|||
48383146|NCT02941926|155598832|FG000|Core Phase|Subject/guardian decision|127|||
48383147|NCT02941926|155598832|FG000|Core Phase|Physician Decision|112|||
48383148|NCT02941926|155598832|FG000|Core Phase|Death|46|||
48383149|NCT02941926|155598832|FG000|Core Phase|Protocol deviation|34|||
48383150|NCT02941926|155598832|FG000|Core Phase|Lost to Follow-up|8|||
48383151|NCT02941926|155598832|FG000|Core Phase|Technical problems|5|||
48383152|NCT02941926|155598832|FG000|Extension Phase|Physician Decision|155|||
48383153|NCT02941926|155598832|FG000|Extension Phase|Progressive disease|115|||
48383154|NCT02941926|155598832|FG000|Extension Phase|Adverse Event|13|||
48383155|NCT02941926|155598832|FG000|Extension Phase|Subject/Guardian decision|12|||
48383156|NCT02941926|155598832|FG000|Extension Phase|Death|6|||
48383157|NCT03675776|155598833|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
48383158|NCT03675776|155598834|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
48383159|NCT03675776|155598835|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
48383160|NCT03675776|155598833|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
48383161|NCT03675776|155598834|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
48383162|NCT03675776|155598835|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
48383163|NCT01009034|155598836|FG000|Overall Study|Lost to Follow-up|2|||
48383164|NCT01009034|155598836|FG000|Overall Study|Withdrawal by Subject|2|||
48383165|NCT02536755|155598843|FG000|Overall Study|Adverse Event|4|||
48383166|NCT02322229|155598845|FG000|Overall Study|Physician Decision|2|||
48383167|NCT04136184|155598854|FG000|Overall Study|Lost to Follow-up|0|||
48383168|NCT04136184|155598855|FG001|Overall Study|Lost to Follow-up|3|||
48383169|NCT04136184|155598854|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
48383170|NCT04136184|155598855|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
48383171|NCT03952338|155598856|FG000|Overall Study|Lost to Follow-up|11|||
48383172|NCT03952338|155598857|FG001|Overall Study|Lost to Follow-up|17|||
48383173|NCT03952338|155598856|FG000|Overall Study|Withdrawal by Subject|1|||
48383174|NCT03952338|155598857|FG001|Overall Study|Withdrawal by Subject|1|||
48383175|NCT03952338|155598856|FG000|Overall Study|Protocol Violation|1|||
48383176|NCT03952338|155598857|FG001|Overall Study|Protocol Violation|0|||
48383177|NCT02129205|155598862|FG000|Overall Study|Withdrawal by Subject|0|||
48383178|NCT02129205|155598863|FG001|Overall Study|Withdrawal by Subject|0|||
48383179|NCT02129205|155598864|FG002|Overall Study|Withdrawal by Subject|0|||
48383180|NCT02129205|155598865|FG003|Overall Study|Withdrawal by Subject|0|||
48383181|NCT02129205|155598866|FG004|Overall Study|Withdrawal by Subject|1|||
48383182|NCT02129205|155598867|FG005|Overall Study|Withdrawal by Subject|1|||
48383183|NCT02129205|155598868|FG006|Overall Study|Withdrawal by Subject|1|||
48383184|NCT02129205|155598869|FG007|Overall Study|Withdrawal by Subject|0|||
48383185|NCT02129205|155598870|FG008|Overall Study|Withdrawal by Subject|1|||
48383186|NCT02129205|155598871|FG009|Overall Study|Withdrawal by Subject|0|||
48383187|NCT02129205|155598862|FG000|Overall Study|Other|1|||
48383188|NCT02129205|155598863|FG001|Overall Study|Other|0|||
48383189|NCT02129205|155598864|FG002|Overall Study|Other|0|||
48515692|NCT03196284|156080542|FG002|Extension Part|Withdrawal by Subject|1|||
48515693|NCT03196284|156080540|FG000|Extension Part|Physician Decision|0|||
48515694|NCT03196284|156080541|FG001|Extension Part|Physician Decision|0|||
48515695|NCT03196284|156080542|FG002|Extension Part|Physician Decision|1|||
48515696|NCT01562613|156080548|FG000|Overall Study|Lost to Follow-up|2|||
48515697|NCT01562613|156080548|FG000|Overall Study|Withdrawal by Subject|2|||
48515698|NCT03500094|156080551|FG000|Overall Study|Withdrawal by Subject|1|||
48515699|NCT03500094|156080551|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
48515700|NCT03500094|156080551|FG000|Overall Study|Lost to Follow-up|1|||
48515701|NCT03201003|156080552|FG000|Overall Study|Adverse Event|14|||
48515702|NCT03201003|156080553|FG001|Overall Study|Adverse Event|1|||
48515703|NCT03201003|156080552|FG000|Overall Study|Other reasons|5|||
48515704|NCT03201003|156080553|FG001|Overall Study|Other reasons|1|||
48515705|NCT03201003|156080552|FG000|Overall Study|Withdrawal by Subject|4|||
48515706|NCT03201003|156080553|FG001|Overall Study|Withdrawal by Subject|1|||
48515707|NCT03201003|156080552|FG000|Overall Study|Lost to Follow-up|2|||
48515708|NCT03201003|156080553|FG001|Overall Study|Lost to Follow-up|0|||
48515709|NCT03201003|156080552|FG000|Overall Study|Protocol Violation|1|||
48515710|NCT03201003|156080553|FG001|Overall Study|Protocol Violation|0|||
48515711|NCT05068284|156080554|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
48515712|NCT05068284|156080555|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
48515713|NCT05068284|156080556|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
48515714|NCT05068284|156080557|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
48515715|NCT05068284|156080558|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
48515716|NCT05068284|156080559|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
48515717|NCT05068284|156080560|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
48515718|NCT05068284|156080561|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
48515719|NCT05068284|156080554|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48515720|NCT05068284|156080555|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48515721|NCT05068284|156080556|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
48515722|NCT05068284|156080557|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48515723|NCT05068284|156080558|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48515724|NCT05068284|156080559|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48515725|NCT05068284|156080560|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48515726|NCT05068284|156080561|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
48515727|NCT05068284|156080554|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
48515728|NCT05068284|156080555|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
48515729|NCT05068284|156080556|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
48515730|NCT05068284|156080557|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
48515731|NCT05068284|156080558|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
48515732|NCT05068284|156080559|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
48515733|NCT05068284|156080560|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
48515734|NCT05068284|156080561|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
48515735|NCT05068284|156080554|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
48515736|NCT05068284|156080555|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
48515737|NCT05068284|156080556|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
48515738|NCT05068284|156080557|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
48515739|NCT05068284|156080558|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
48515740|NCT05068284|156080559|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
48515741|NCT05068284|156080560|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
48515742|NCT05068284|156080561|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
48515743|NCT05068284|156080554|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
48515744|NCT05068284|156080555|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
48515745|NCT05068284|156080556|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
48515746|NCT05068284|156080557|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
48515747|NCT05068284|156080558|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
48515748|NCT05068284|156080559|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
48515749|NCT05068284|156080560|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
48515750|NCT05068284|156080561|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
48515751|NCT05068284|156080554|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
48515752|NCT05068284|156080555|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
48515753|NCT05068284|156080556|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
48515754|NCT05068284|156080557|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
48515755|NCT05068284|156080558|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
48515756|NCT05068284|156080559|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
48515757|NCT05068284|156080560|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
48515758|NCT05068284|156080561|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
48515759|NCT05068284|156080554|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
48383190|NCT02129205|155598865|FG003|Overall Study|Other|0|||
48383191|NCT02129205|155598866|FG004|Overall Study|Other|2|||
48383192|NCT02129205|155598867|FG005|Overall Study|Other|3|||
48383193|NCT02129205|155598868|FG006|Overall Study|Other|3|||
48383194|NCT02129205|155598869|FG007|Overall Study|Other|2|||
48383195|NCT02129205|155598870|FG008|Overall Study|Other|1|||
48383196|NCT02129205|155598871|FG009|Overall Study|Other|0|||
48383197|NCT01479829|155598872|FG000|Overall Study|Withdrawal by Subject|8|||
48383198|NCT01479829|155598873|FG001|Overall Study|Withdrawal by Subject|10|||
48383199|NCT02877927|155598874|FG000|Overall Study|Adverse Event|1|||
48383200|NCT02877927|155598875|FG001|Overall Study|Adverse Event|0|||
48383201|NCT02877927|155598874|FG000|Overall Study|Lost to Follow-up|37|||
48383202|NCT02877927|155598875|FG001|Overall Study|Lost to Follow-up|38|||
48383203|NCT02877927|155598874|FG000|Overall Study|Withdrawal by Subject|11|||
48383204|NCT02877927|155598875|FG001|Overall Study|Withdrawal by Subject|12|||
48383205|NCT02877927|155598874|FG000|Overall Study|Physician Decision|0|||
48383206|NCT02877927|155598875|FG001|Overall Study|Physician Decision|1|||
48383207|NCT02877927|155598874|FG000|Overall Study|Missed EOT/PTE Visit|5|||
48383208|NCT02877927|155598875|FG001|Overall Study|Missed EOT/PTE Visit|6|||
48383209|NCT01810016|155598876|FG000|Overall Study|Progressive disease|1|||
48383210|NCT01810016|155598877|FG001|Overall Study|Progressive disease|1|||
48383211|NCT01810016|155598878|FG002|Overall Study|Progressive disease|0|||
48383212|NCT01810016|155598876|FG000|Overall Study|Death|0|||
48383213|NCT01810016|155598877|FG001|Overall Study|Death|0|||
48383214|NCT01810016|155598878|FG002|Overall Study|Death|1|||
48383215|NCT00866697|155598879|FG000|Overall Study|Study closed/terminated|156|||
48383216|NCT00866697|155598880|FG001|Overall Study|Study closed/terminated|138|||
48383217|NCT00866697|155598879|FG000|Overall Study|Lost to Follow-up|22|||
48383218|NCT00866697|155598880|FG001|Overall Study|Lost to Follow-up|28|||
48383219|NCT00866697|155598879|FG000|Overall Study|Physician Decision|3|||
48383220|NCT00866697|155598880|FG001|Overall Study|Physician Decision|5|||
48383221|NCT00866697|155598879|FG000|Overall Study|Withdrawal by Subject|33|||
48383222|NCT00866697|155598880|FG001|Overall Study|Withdrawal by Subject|57|||
48383223|NCT01572922|155598881|FG000|Overall Study|Adverse Event|1|||
48383224|NCT01572922|155598881|FG000|Overall Study|Protocol Violation|1|||
48383225|NCT01572922|155598881|FG000|Overall Study|Death|1|||
48383226|NCT01428661|155598882|FG000|Double-Masked Phase|Protocol Violation|9|||
48383227|NCT01428661|155598883|FG001|Double-Masked Phase|Protocol Violation|4|||
48383228|NCT01428661|155598884|FG002|Double-Masked Phase|Protocol Violation|0|||
48383229|NCT01428661|155598882|FG000|Double-Masked Phase|Adverse Event|13|||
48383230|NCT01428661|155598883|FG001|Double-Masked Phase|Adverse Event|4|||
48383231|NCT01428661|155598884|FG002|Double-Masked Phase|Adverse Event|0|||
48383232|NCT01428661|155598882|FG000|Double-Masked Phase|Lost to Follow-up|14|||
48383233|NCT01428661|155598883|FG001|Double-Masked Phase|Lost to Follow-up|14|||
48383234|NCT01428661|155598884|FG002|Double-Masked Phase|Lost to Follow-up|0|||
48383235|NCT01428661|155598882|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
48383236|NCT01428661|155598883|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
48383237|NCT01428661|155598884|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
48383238|NCT01428661|155598882|FG000|Double-Masked Phase|Lack of Efficacy|2|||
48383239|NCT01428661|155598883|FG001|Double-Masked Phase|Lack of Efficacy|1|||
48383240|NCT01428661|155598884|FG002|Double-Masked Phase|Lack of Efficacy|0|||
48383241|NCT01428661|155598882|FG000|Double-Masked Phase|*Various|1|||
48383242|NCT01428661|155598883|FG001|Double-Masked Phase|*Various|6|||
48383243|NCT01428661|155598884|FG002|Double-Masked Phase|*Various|0|||
48383244|NCT01428661|155598882|FG000|Open Label Extension|Protocol Violation|0|||
48383245|NCT01428661|155598883|FG001|Open Label Extension|Protocol Violation|0|||
48383246|NCT01428661|155598884|FG002|Open Label Extension|Protocol Violation|9|||
48383247|NCT01428661|155598882|FG000|Open Label Extension|Adverse Event|0|||
48383248|NCT01428661|155598883|FG001|Open Label Extension|Adverse Event|0|||
48383249|NCT01428661|155598884|FG002|Open Label Extension|Adverse Event|15|||
48383250|NCT01428661|155598882|FG000|Open Label Extension|Lost to Follow-up|0|||
48383251|NCT01428661|155598883|FG001|Open Label Extension|Lost to Follow-up|0|||
48383252|NCT01428661|155598884|FG002|Open Label Extension|Lost to Follow-up|38|||
48383253|NCT01428661|155598882|FG000|Open Label Extension|Withdrawal by Subject|0|||
48383254|NCT01428661|155598883|FG001|Open Label Extension|Withdrawal by Subject|0|||
48383255|NCT01428661|155598884|FG002|Open Label Extension|Withdrawal by Subject|49|||
48383256|NCT01428661|155598882|FG000|Open Label Extension|Lack of Efficacy|0|||
48383257|NCT01428661|155598883|FG001|Open Label Extension|Lack of Efficacy|0|||
48383258|NCT01428661|155598884|FG002|Open Label Extension|Lack of Efficacy|24|||
48383259|NCT01428661|155598882|FG000|Open Label Extension|**Various|0|||
48383260|NCT01428661|155598883|FG001|Open Label Extension|**Various|0|||
48383261|NCT01428661|155598884|FG002|Open Label Extension|**Various|185|||
48383262|NCT06065735|155598886|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
48383263|NCT06065735|155598887|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
48383264|NCT06065735|155598888|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
48383265|NCT06065735|155598886|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
48383266|NCT06065735|155598887|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
48383267|NCT06065735|155598888|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
48822869|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822870|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
48730566|NCT02544074|156865820|FG015|Overall Study|Withdrawal by Subject|0|||
48822871|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
48730567|NCT02544074|156865821|FG016|Overall Study|Withdrawal by Subject|0|||
48730568|NCT02544074|156865822|FG017|Overall Study|Withdrawal by Subject|0|||
48822872|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822873|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822874|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822875|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822876|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
48822877|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48441655|NCT01714817|155803410|FG000|Year 2 Period|Pregnancy|1|||
48730569|NCT02544074|156865823|FG018|Overall Study|Withdrawal by Subject|0|||
48730570|NCT02544074|156865824|FG019|Overall Study|Withdrawal by Subject|0|||
48730571|NCT02544074|156865825|FG020|Overall Study|Withdrawal by Subject|0|||
48730572|NCT02544074|156865805|FG000|Overall Study|Tablet error|0|||
48730573|NCT02544074|156865806|FG001|Overall Study|Tablet error|0|||
48730574|NCT02544074|156865807|FG002|Overall Study|Tablet error|0|||
48730575|NCT02544074|156865808|FG003|Overall Study|Tablet error|0|||
48730576|NCT02544074|156865809|FG004|Overall Study|Tablet error|0|||
48730577|NCT02544074|156865810|FG005|Overall Study|Tablet error|1|||
48730578|NCT02544074|156865811|FG006|Overall Study|Tablet error|0|||
48730579|NCT02544074|156865812|FG007|Overall Study|Tablet error|0|||
48730580|NCT02544074|156865813|FG008|Overall Study|Tablet error|0|||
48730581|NCT02544074|156865814|FG009|Overall Study|Tablet error|1|||
48730582|NCT02544074|156865815|FG010|Overall Study|Tablet error|0|||
48730583|NCT02544074|156865816|FG011|Overall Study|Tablet error|0|||
48730584|NCT02544074|156865817|FG012|Overall Study|Tablet error|0|||
48730585|NCT02544074|156865818|FG013|Overall Study|Tablet error|0|||
48730586|NCT02544074|156865819|FG014|Overall Study|Tablet error|0|||
48730587|NCT02544074|156865820|FG015|Overall Study|Tablet error|0|||
48730588|NCT02544074|156865821|FG016|Overall Study|Tablet error|0|||
48730589|NCT02544074|156865822|FG017|Overall Study|Tablet error|0|||
48730590|NCT02544074|156865823|FG018|Overall Study|Tablet error|0|||
48730591|NCT02544074|156865824|FG019|Overall Study|Tablet error|0|||
48730592|NCT02544074|156865825|FG020|Overall Study|Tablet error|0|||
48730593|NCT03384693|156865832|FG000|Overall Study|Adverse Event|3|||
48730594|NCT01394718|156865833|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
48730595|NCT01394718|156865834|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
48730596|NCT03693170|156865835|FG000|Overall Study|Disease Progression|48|||
48730597|NCT03693170|156865835|FG000|Overall Study|Adverse Event|16|||
48730598|NCT03693170|156865835|FG000|Overall Study|Physician Decision|6|||
48730599|NCT03693170|156865835|FG000|Overall Study|Protocol Violation|2|||
48730600|NCT03693170|156865835|FG000|Overall Study|Death|1|||
48730601|NCT03693170|156865835|FG000|Overall Study|Non compliance with study drug|1|||
48730602|NCT03693170|156865835|FG000|Overall Study|Withdrawal by Subject|1|||
48822878|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
48441656|NCT01714817|155803411|FG001|Year 2 Period|Pregnancy|1|||
48441657|NCT01714817|155803410|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
48441658|NCT01714817|155803411|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
48441659|NCT01714817|155803410|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
48441660|NCT01714817|155803411|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
48441661|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
48441662|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
48441663|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
48441664|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
48441665|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
48441666|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
48441667|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
48441668|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
48441669|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
48441670|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
48441671|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
48441672|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
48441673|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48441674|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
48441675|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
48441676|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
48441677|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
48822879|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
48822880|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
48822881|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
48822882|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
48822883|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48822884|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48822885|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48822886|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
48822887|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
48822888|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822889|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48515760|NCT05068284|156080555|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
48515761|NCT05068284|156080556|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
48515762|NCT05068284|156080557|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
48515763|NCT05068284|156080558|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
48515764|NCT05068284|156080559|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
48515765|NCT05068284|156080560|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
48822890|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
48822891|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
48822892|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822893|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822894|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822895|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822896|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
48822897|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822898|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822899|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
48822900|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
48822901|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822902|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822903|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48515766|NCT05068284|156080561|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
48515767|NCT05068284|156080554|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
48515768|NCT05068284|156080555|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
48515769|NCT05068284|156080556|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
48515770|NCT05068284|156080557|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
48515771|NCT05068284|156080558|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
48515772|NCT05068284|156080559|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
48515773|NCT05068284|156080560|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
48515774|NCT05068284|156080561|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
48515775|NCT05068284|156080554|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
48515776|NCT05068284|156080555|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
48515777|NCT05068284|156080556|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
48515778|NCT05068284|156080557|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
48515779|NCT05068284|156080558|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
48515780|NCT05068284|156080559|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
48515781|NCT05068284|156080560|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
48515782|NCT05068284|156080561|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
48515783|NCT05068284|156080554|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
48515784|NCT05068284|156080555|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
48515785|NCT05068284|156080556|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
48515786|NCT05068284|156080557|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
48515787|NCT05068284|156080558|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
48515788|NCT05068284|156080559|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
48515789|NCT05068284|156080560|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
48515790|NCT05068284|156080561|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
48515791|NCT05068284|156080554|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
48822904|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822905|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822906|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
48822907|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822908|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822909|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822910|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822911|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
48822912|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822913|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822914|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822915|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822916|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
48822917|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822918|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822919|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822920|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
48822921|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
48822922|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
48822923|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822924|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822925|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822926|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
48822927|NCT02018861|157192233|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822928|NCT02018861|157192234|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822929|NCT02018861|157192235|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822930|NCT02018861|157192236|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
48822931|NCT02018861|157192237|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
48822932|NCT02018861|157192238|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822933|NCT02018861|157192239|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822934|NCT02018861|157192240|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822935|NCT02018861|157192241|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822936|NCT02018861|157192242|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
48822937|NCT02018861|157192233|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822938|NCT02018861|157192234|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822939|NCT02018861|157192235|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822940|NCT02018861|157192236|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822941|NCT02018861|157192237|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822942|NCT02018861|157192238|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822943|NCT02018861|157192239|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
48822944|NCT02018861|157192240|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
48822945|NCT02018861|157192241|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822946|NCT02018861|157192242|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
48822947|NCT02018861|157192233|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822948|NCT02018861|157192234|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822949|NCT02018861|157192235|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822950|NCT02018861|157192236|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822951|NCT02018861|157192237|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822952|NCT02018861|157192238|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822953|NCT02018861|157192239|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
48822954|NCT02018861|157192240|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
48822955|NCT02018861|157192241|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822956|NCT02018861|157192242|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
48822957|NCT02018861|157192233|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822958|NCT02018861|157192234|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822959|NCT02018861|157192235|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822960|NCT02018861|157192236|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822961|NCT02018861|157192237|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822962|NCT02018861|157192238|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822963|NCT02018861|157192239|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822964|NCT02018861|157192240|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48822965|NCT02018861|157192241|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
48822966|NCT02018861|157192242|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
48441753|NCT02007954|155803437|FG000|Overall Study|Death|1|||
48822967|NCT02018861|157192233|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822968|NCT02018861|157192234|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822969|NCT02018861|157192235|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822970|NCT02018861|157192236|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822971|NCT02018861|157192237|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822972|NCT02018861|157192238|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822973|NCT02018861|157192239|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822974|NCT02018861|157192240|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822975|NCT02018861|157192241|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
48822976|NCT02018861|157192242|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
48822977|NCT02018861|157192233|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822978|NCT02018861|157192234|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822979|NCT02018861|157192235|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822980|NCT02018861|157192236|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822981|NCT02018861|157192237|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822982|NCT02018861|157192238|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822983|NCT02018861|157192239|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822984|NCT02018861|157192240|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822985|NCT02018861|157192241|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
48822986|NCT02018861|157192242|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
48822987|NCT03673098|157192243|FG000|Overall Study|Lost to Follow-up|2|||
48822988|NCT03673098|157192244|FG001|Overall Study|Lost to Follow-up|3|||
48822989|NCT03673098|157192243|FG000|Overall Study|Withdrawal by Subject|6|||
48822990|NCT03673098|157192244|FG001|Overall Study|Withdrawal by Subject|1|||
48383268|NCT06065735|155598886|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
48383269|NCT06065735|155598887|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
48383270|NCT06065735|155598888|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
48383271|NCT06065735|155598886|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
48383272|NCT06065735|155598887|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
48515792|NCT05068284|156080555|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
48383273|NCT06065735|155598888|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
48383274|NCT06065735|155598886|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
48383275|NCT06065735|155598887|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
48383276|NCT06065735|155598888|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
48383277|NCT01310803|155600109|FG000|Overall Study|Subject terminated by Sponsor|1|||
48383278|NCT01310803|155600110|FG001|Overall Study|Subject terminated by Sponsor|0|||
48383279|NCT01306890|155600113|FG000|Overall Study|Adverse Event|2|||
48383280|NCT01306890|155600113|FG000|Overall Study|Death|1223|||
48383281|NCT01306890|155600113|FG000|Overall Study|Lost to Follow-up|58|||
48383282|NCT01306890|155600113|FG000|Overall Study|Withdrawal by Subject|88|||
48383283|NCT01306890|155600113|FG000|Overall Study|Unspecified reasons|104|||
48383284|NCT01306890|155600113|FG000|Overall Study|Study Termination|3|||
48383285|NCT01306890|155600113|FG000|Overall Study|No discontinuation documentation|41|||
48383286|NCT01444651|155600115|FG000|Overall Study|Adverse Event|3|||
48515793|NCT05068284|156080556|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
48515794|NCT05068284|156080557|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
48515795|NCT05068284|156080558|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
48822991|NCT03673098|157192243|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
48822992|NCT03673098|157192244|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
48822993|NCT01642186|157192248|FG000|Overall Study|Death|0|||
48822994|NCT01642186|157192249|FG001|Overall Study|Death|2|||
48822995|NCT01642186|157192250|FG002|Overall Study|Death|2|||
48383287|NCT01444651|155600116|FG001|Overall Study|Adverse Event|2|||
48515796|NCT05068284|156080559|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
48515797|NCT05068284|156080560|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
48515798|NCT05068284|156080561|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
48515799|NCT05068284|156080554|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
48515800|NCT05068284|156080555|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
48515801|NCT05068284|156080556|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
48515802|NCT05068284|156080557|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
48515803|NCT05068284|156080558|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
48515804|NCT05068284|156080559|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
48515805|NCT05068284|156080560|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
48515806|NCT05068284|156080561|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
48822996|NCT01642186|157192248|FG000|Overall Study|Lost to Follow-up|0|||
48383288|NCT01444651|155600115|FG000|Overall Study|Lost to Follow-up|5|||
48515807|NCT05068284|156080554|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
48515808|NCT05068284|156080555|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
48515809|NCT05068284|156080556|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
48515810|NCT05068284|156080557|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
48515811|NCT05068284|156080558|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
48515812|NCT05068284|156080559|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
48515813|NCT05068284|156080560|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
48515814|NCT05068284|156080561|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
48515815|NCT05068284|156080554|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
48515816|NCT05068284|156080555|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
48383289|NCT01444651|155600116|FG001|Overall Study|Lost to Follow-up|5|||
48383290|NCT01444651|155600115|FG000|Overall Study|Non-fasting|2|||
48383291|NCT01444651|155600116|FG001|Overall Study|Non-fasting|1|||
48383292|NCT01444651|155600115|FG000|Overall Study|Missing data|1|||
48383293|NCT01444651|155600116|FG001|Overall Study|Missing data|1|||
48383294|NCT03047551|155600120|FG000|Overall Study|Did not receive TAS|1|||
48383295|NCT03047551|155600121|FG001|Overall Study|Did not receive TAS|0|||
48383296|NCT03047551|155600120|FG000|Overall Study|Physician Decision|1|||
48383297|NCT03047551|155600121|FG001|Overall Study|Physician Decision|0|||
48383298|NCT03047551|155600120|FG000|Overall Study|Withdrawal by Subject|0|||
48383299|NCT03047551|155600121|FG001|Overall Study|Withdrawal by Subject|1|||
48383300|NCT03047551|155600120|FG000|Overall Study|Probe malfunction|0|||
48383301|NCT03047551|155600121|FG001|Overall Study|Probe malfunction|1|||
48383302|NCT03047551|155600120|FG000|Overall Study|Ineligible|0|||
48383303|NCT03047551|155600121|FG001|Overall Study|Ineligible|1|||
48383304|NCT00726622|155600122|FG000|Overall Study|Withdrawal by Subject|16|||
48383305|NCT00726622|155600123|FG001|Overall Study|Withdrawal by Subject|2|||
48383306|NCT00726622|155600122|FG000|Overall Study|Physician Decision|0|||
48383307|NCT00726622|155600123|FG001|Overall Study|Physician Decision|1|||
48515817|NCT05068284|156080556|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
48515818|NCT05068284|156080557|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
48515819|NCT05068284|156080558|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
48515820|NCT05068284|156080559|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
48515821|NCT05068284|156080560|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
48515822|NCT05068284|156080561|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
48515823|NCT01958294|156082192|FG000|Overall Study|Clinical Circumstances|2|||
48515824|NCT00795821|156082195|FG000|Acute Treatment Phase|Adverse Event|23|||
48515825|NCT00795821|156082196|FG001|Acute Treatment Phase|Adverse Event|4|||
48515826|NCT00795821|156082195|FG000|Acute Treatment Phase|Death|1|||
48515827|NCT00795821|156082196|FG001|Acute Treatment Phase|Death|0|||
48515828|NCT00795821|156082195|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
48515829|NCT00795821|156082196|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
48515830|NCT00795821|156082195|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
48515831|NCT00795821|156082196|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
48515832|NCT00795821|156082195|FG000|Acute Treatment Phase|Physician Decision|1|||
48515833|NCT00795821|156082196|FG001|Acute Treatment Phase|Physician Decision|1|||
48515834|NCT00795821|156082195|FG000|Acute Treatment Phase|Protocol Violation|1|||
48515835|NCT00795821|156082196|FG001|Acute Treatment Phase|Protocol Violation|2|||
48515836|NCT00795821|156082195|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
48515837|NCT00795821|156082196|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
48515838|NCT00795821|156082195|FG000|Long-term Extension Phase|Adverse Event|25|||
48515839|NCT00795821|156082196|FG001|Long-term Extension Phase|Adverse Event|32|||
48515840|NCT00795821|156082195|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
48515841|NCT00795821|156082196|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
48515842|NCT00795821|156082195|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
48515843|NCT00795821|156082196|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
48515844|NCT00795821|156082195|FG000|Long-term Extension Phase|Physician Decision|1|||
48515845|NCT00795821|156082196|FG001|Long-term Extension Phase|Physician Decision|2|||
48601109|NCT02718911|156396043|FG003|Overall Study|Death|0|||
48730603|NCT01347307|156865836|FG000|Overall Study|Death|0|||
48730604|NCT01347307|156865837|FG001|Overall Study|Death|4|||
48730605|NCT01347307|156865836|FG000|Overall Study|Physician Decision|0|||
48730606|NCT01347307|156865837|FG001|Overall Study|Physician Decision|1|||
48730607|NCT04533880|156865838|FG000|Overall Study|Lost to Follow-up|0|||
48730608|NCT04533880|156865839|FG001|Overall Study|Lost to Follow-up|1|||
48730609|NCT04533880|156865840|FG002|Overall Study|Lost to Follow-up|1|||
48730610|NCT02237911|156865842|FG000|Overall Study|Withdrawal by Subject|4|||
48730611|NCT02237911|156865843|FG001|Overall Study|Withdrawal by Subject|7|||
48730612|NCT02237911|156865844|FG002|Overall Study|Withdrawal by Subject|2|||
48730613|NCT02237911|156865842|FG000|Overall Study|Lost to Follow-up|3|||
48730614|NCT02237911|156865843|FG001|Overall Study|Lost to Follow-up|1|||
48730615|NCT02237911|156865844|FG002|Overall Study|Lost to Follow-up|1|||
48383308|NCT00726622|155600122|FG000|Overall Study|Metastasis|2|||
48515846|NCT00795821|156082195|FG000|Long-term Extension Phase|Protocol Violation|3|||
48515847|NCT00795821|156082196|FG001|Long-term Extension Phase|Protocol Violation|5|||
48515848|NCT00795821|156082195|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
48383309|NCT00726622|155600123|FG001|Overall Study|Metastasis|0|||
48383310|NCT02805725|155600124|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
48383311|NCT02805725|155600125|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
48383312|NCT02805725|155600126|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
48383313|NCT02805725|155600127|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
48383314|NCT02805725|155600128|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
48383315|NCT02805725|155600124|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
48383316|NCT02805725|155600125|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
48383317|NCT02805725|155600126|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
48383318|NCT02805725|155600127|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
48383319|NCT02805725|155600128|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
48383320|NCT02805725|155600124|FG000|Phase II|Protocol Violation|0|||
48383321|NCT02805725|155600125|FG001|Phase II|Protocol Violation|0|||
48383322|NCT02805725|155600126|FG002|Phase II|Protocol Violation|0|||
48383323|NCT02805725|155600127|FG003|Phase II|Protocol Violation|0|||
48383324|NCT02805725|155600128|FG004|Phase II|Protocol Violation|6|||
48383325|NCT02462928|155600131|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
48383326|NCT02462928|155600132|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
48383327|NCT02462928|155600133|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
48515849|NCT00795821|156082196|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
48515850|NCT00795821|156082195|FG000|Taper Phase|Adverse Event|2|||
48515851|NCT00795821|156082196|FG001|Taper Phase|Adverse Event|0|||
48515852|NCT00795821|156082195|FG000|Taper Phase|Lost to Follow-up|1|||
48515853|NCT00795821|156082196|FG001|Taper Phase|Lost to Follow-up|0|||
48515854|NCT00795821|156082195|FG000|Taper Phase|Physician Decision|2|||
48515855|NCT00795821|156082196|FG001|Taper Phase|Physician Decision|0|||
48515856|NCT00795821|156082195|FG000|Taper Phase|Withdrawal by Subject|4|||
48515857|NCT00795821|156082196|FG001|Taper Phase|Withdrawal by Subject|0|||
48515858|NCT00712959|156082199|FG000|Overall Study|Protocol Violation|3|||
48515859|NCT00712959|156082200|FG001|Overall Study|Protocol Violation|1|||
48515860|NCT00712959|156082199|FG000|Overall Study|Lost to Follow-up|13|||
48515861|NCT00712959|156082200|FG001|Overall Study|Lost to Follow-up|2|||
48515862|NCT00712959|156082199|FG000|Overall Study|Withdrawal by Subject|3|||
48515863|NCT00712959|156082200|FG001|Overall Study|Withdrawal by Subject|0|||
48515864|NCT00508651|156082203|FG000|Overall Study|Lost to Follow-up|3|||
48515865|NCT00508651|156082204|FG001|Overall Study|Lost to Follow-up|1|||
48515866|NCT00508651|156082203|FG000|Overall Study|Withdrawal by Subject|1|||
48383328|NCT02462928|155600131|FG000|Overall Study|Adverse Event|47|||
48383329|NCT02462928|155600132|FG001|Overall Study|Adverse Event|51|||
48515867|NCT00508651|156082204|FG001|Overall Study|Withdrawal by Subject|1|||
48515868|NCT01015287|156082214|FG000|Overall Study|Death|21|||
48515869|NCT01015287|156082215|FG001|Overall Study|Death|16|||
48383330|NCT02462928|155600133|FG002|Overall Study|Adverse Event|25|||
48383331|NCT02462928|155600131|FG000|Overall Study|Lack of Efficacy|3|||
48383332|NCT02462928|155600132|FG001|Overall Study|Lack of Efficacy|8|||
48383333|NCT02462928|155600133|FG002|Overall Study|Lack of Efficacy|3|||
48515870|NCT01015287|156082214|FG000|Overall Study|Adverse Event|1|||
48515871|NCT01015287|156082215|FG001|Overall Study|Adverse Event|0|||
48515872|NCT01015287|156082214|FG000|Overall Study|Sponsor Decision|3|||
48515873|NCT01015287|156082215|FG001|Overall Study|Sponsor Decision|7|||
48515874|NCT01015287|156082214|FG000|Overall Study|Physician Decision|19|||
48515875|NCT01015287|156082215|FG001|Overall Study|Physician Decision|21|||
48383334|NCT02462928|155600131|FG000|Overall Study|Lost to Follow-up|4|||
48383335|NCT02462928|155600132|FG001|Overall Study|Lost to Follow-up|4|||
48383336|NCT02462928|155600133|FG002|Overall Study|Lost to Follow-up|1|||
48383337|NCT02462928|155600131|FG000|Overall Study|Withdrawal by Patient|31|||
48515876|NCT01015287|156082214|FG000|Overall Study|Withdrawal by Subject|14|||
48515877|NCT01015287|156082215|FG001|Overall Study|Withdrawal by Subject|19|||
48515878|NCT01015287|156082214|FG000|Overall Study|Entry Criteria not Met|11|||
48515879|NCT01015287|156082215|FG001|Overall Study|Entry Criteria not Met|14|||
48515880|NCT01015287|156082214|FG000|Overall Study|Lost to Follow-up|2|||
48383338|NCT02462928|155600132|FG001|Overall Study|Withdrawal by Patient|21|||
48383339|NCT02462928|155600133|FG002|Overall Study|Withdrawal by Patient|21|||
48383340|NCT02462928|155600131|FG000|Overall Study|Protocol Violation|0|||
48383341|NCT02462928|155600132|FG001|Overall Study|Protocol Violation|1|||
48383342|NCT02462928|155600133|FG002|Overall Study|Protocol Violation|0|||
48515881|NCT01015287|156082215|FG001|Overall Study|Lost to Follow-up|1|||
48515882|NCT01015287|156082214|FG000|Overall Study|Protocol Violation|1|||
48515883|NCT01015287|156082215|FG001|Overall Study|Protocol Violation|1|||
48515884|NCT02658487|156082216|FG000|Overall Study|Death|2|||
48515885|NCT02658487|156082216|FG000|Overall Study|Disease progression|10|||
48515886|NCT02658487|156082216|FG000|Overall Study|Alternative therapy|1|||
48515887|NCT02658487|156082216|FG000|Overall Study|Adverse Event|1|||
48515888|NCT02658487|156082216|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
48730616|NCT02239224|156865846|FG000|Overall Study|Administrative|0|||
48730617|NCT02239224|156865847|FG001|Overall Study|Administrative|0|||
48730618|NCT02239224|156865848|FG002|Overall Study|Administrative|3|||
48515889|NCT02658487|156082216|FG000|Overall Study|Refractory AML|1|||
48515890|NCT00608322|156082218|FG000|Overall Study|Death|2|||
48515891|NCT00608322|156082219|FG001|Overall Study|Death|1|||
48515892|NCT02258074|156082220|FG000|Overall Study|Withdrawal by Subject|1|||
48515893|NCT02258074|156082221|FG001|Overall Study|Withdrawal by Subject|0|||
48515894|NCT02258074|156082222|FG002|Overall Study|Withdrawal by Subject|0|||
48515895|NCT02258074|156082223|FG003|Overall Study|Withdrawal by Subject|0|||
48515896|NCT05479058|156082224|FG000|Overall Study|Withdrawal by Subject|1|||
48515897|NCT05479058|156082225|FG001|Overall Study|Withdrawal by Subject|1|||
48515898|NCT05479058|156082224|FG000|Overall Study|Study terminated by sponsor|10|||
48515899|NCT05479058|156082225|FG001|Overall Study|Study terminated by sponsor|10|||
48515900|NCT02593773|156082226|FG000|Overall Study|Voluntary Withdrawal|3|||
48515901|NCT02593773|156082226|FG000|Overall Study|Study Terminated by Sponsor|31|||
48515902|NCT02593773|156082226|FG000|Overall Study|Death|1|||
48515903|NCT00834444|156082227|FG000|First Intervention|Adverse Event|1|||
48515904|NCT00834444|156082228|FG001|First Intervention|Adverse Event|0|||
48515905|NCT00834444|156082227|FG000|First Intervention|Intolerance to Venopuncture|0|||
48515906|NCT00834444|156082228|FG001|First Intervention|Intolerance to Venopuncture|1|||
48822997|NCT01642186|157192249|FG001|Overall Study|Lost to Follow-up|0|||
48822998|NCT01642186|157192250|FG002|Overall Study|Lost to Follow-up|1|||
48515907|NCT00834444|156082227|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
48515908|NCT00834444|156082228|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
48515909|NCT00834444|156082227|FG000|Second Intervention|Adverse Event|1|||
48515910|NCT00834444|156082228|FG001|Second Intervention|Adverse Event|0|||
48515911|NCT00829712|156082235|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
48515912|NCT00829712|156082236|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
48515913|NCT00606281|156082237|FG000|Overall Study|Adverse Event|11|||
48515914|NCT00606281|156082238|FG001|Overall Study|Adverse Event|12|||
48515915|NCT00606281|156082237|FG000|Overall Study|Death|1|||
48515916|NCT00606281|156082238|FG001|Overall Study|Death|0|||
48515917|NCT00606281|156082237|FG000|Overall Study|Lack of Efficacy|28|||
48515918|NCT00606281|156082238|FG001|Overall Study|Lack of Efficacy|35|||
48515919|NCT00606281|156082237|FG000|Overall Study|Physician Decision|0|||
48515920|NCT00606281|156082238|FG001|Overall Study|Physician Decision|1|||
48515921|NCT00606281|156082237|FG000|Overall Study|Protocol Violation|3|||
48515922|NCT00606281|156082238|FG001|Overall Study|Protocol Violation|3|||
48515923|NCT00606281|156082237|FG000|Overall Study|Withdrawal by Subject|11|||
48515924|NCT00606281|156082238|FG001|Overall Study|Withdrawal by Subject|13|||
48515925|NCT00606281|156082237|FG000|Overall Study|Progression to depressive phase|1|||
48515926|NCT00606281|156082238|FG001|Overall Study|Progression to depressive phase|1|||
48515927|NCT00606281|156082237|FG000|Overall Study|Change of residence or other commitments|1|||
48515928|NCT00606281|156082238|FG001|Overall Study|Change of residence or other commitments|1|||
48515929|NCT01484912|156082239|FG000|Overall Study|Withdrawal by Subject|1|||
48515930|NCT01484912|156082240|FG001|Overall Study|Withdrawal by Subject|0|||
48515931|NCT01484912|156082239|FG000|Overall Study|Physician Decision|0|||
48515932|NCT01484912|156082240|FG001|Overall Study|Physician Decision|1|||
48515933|NCT02294981|156082241|FG000|Overall Study|Lost to Follow-up|1|||
48515934|NCT03131895|156082243|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
48515935|NCT03131895|156082244|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
48515936|NCT03131895|156082245|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
48601110|NCT02718911|156396044|FG004|Overall Study|Death|1|||
48730619|NCT02239224|156865849|FG003|Overall Study|Administrative|1|||
48730620|NCT01466179|156865850|FG000|Overall Study|Ongoing in core study|2|||
48730621|NCT01466179|156865850|FG000|Overall Study|Physician Decision|46|||
48730622|NCT01466179|156865850|FG000|Overall Study|Progressive disease|43|||
48730623|NCT01466179|156865850|FG000|Overall Study|Adverse Event|32|||
48730624|NCT01466179|156865850|FG000|Overall Study|Disease relapse|23|||
48730625|NCT01466179|156865850|FG000|Overall Study|Lack of Efficacy|14|||
48730626|NCT01466179|156865850|FG000|Overall Study|Death|7|||
48730627|NCT01466179|156865850|FG000|Overall Study|Withdrawal by Subject|7|||
48730628|NCT01466179|156865850|FG000|Overall Study|Protocol Violation|2|||
48730629|NCT01466179|156865850|FG000|Overall Study|Other|3|||
48730630|NCT01886716|156865852|FG000|Week 1|Lost to Follow-up|0|||
48730631|NCT01886716|156865853|FG001|Week 1|Lost to Follow-up|0|||
48730632|NCT01886716|156865854|FG002|Week 1|Lost to Follow-up|2|||
48730633|NCT01886716|156865855|FG003|Week 1|Lost to Follow-up|2|||
48730634|NCT01886716|156865852|FG000|Week 2|Lost to Follow-up|3|||
48730635|NCT01886716|156865853|FG001|Week 2|Lost to Follow-up|2|||
48730636|NCT01886716|156865854|FG002|Week 2|Lost to Follow-up|1|||
48730637|NCT01886716|156865855|FG003|Week 2|Lost to Follow-up|3|||
48730638|NCT01886716|156865852|FG000|Week 3|Lost to Follow-up|1|||
48730639|NCT01886716|156865853|FG001|Week 3|Lost to Follow-up|1|||
48730640|NCT01886716|156865854|FG002|Week 3|Lost to Follow-up|0|||
48730641|NCT01886716|156865855|FG003|Week 3|Lost to Follow-up|1|||
48730642|NCT03589469|156865857|FG000|Overall Study|Withdrawal by Subject|8|||
48730643|NCT03589469|156865857|FG000|Overall Study|Physician Decision|20|||
48730644|NCT03589469|156865857|FG000|Overall Study|Death|97|||
48515937|NCT03131895|156082246|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
48515938|NCT03131895|156082243|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
48515939|NCT03131895|156082244|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
48515940|NCT03131895|156082245|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
48515941|NCT03131895|156082246|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
48515942|NCT03131895|156082243|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48515943|NCT03131895|156082244|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
48515944|NCT03131895|156082245|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48515945|NCT03131895|156082246|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
48515946|NCT03131895|156082243|FG000|Washout Period (at Least 5 Days)|Other|0|||
48515947|NCT03131895|156082244|FG001|Washout Period (at Least 5 Days)|Other|0|||
48515948|NCT03131895|156082245|FG002|Washout Period (at Least 5 Days)|Other|2|||
48515949|NCT03131895|156082246|FG003|Washout Period (at Least 5 Days)|Other|0|||
48822999|NCT01268059|157192256|FG000|Overall Study|Lost to Follow-up|0|||
48823000|NCT01268059|157192257|FG001|Overall Study|Lost to Follow-up|1|||
48823001|NCT01268059|157192258|FG002|Overall Study|Lost to Follow-up|0|||
48383343|NCT02462928|155600131|FG000|Overall Study|Reason not Specified|4|||
48383344|NCT02462928|155600132|FG001|Overall Study|Reason not Specified|6|||
48383345|NCT02462928|155600133|FG002|Overall Study|Reason not Specified|5|||
48383346|NCT01493557|155600134|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
48823002|NCT01268059|157192259|FG003|Overall Study|Lost to Follow-up|0|||
48823003|NCT01268059|157192256|FG000|Overall Study|Withdrawal by Subject|7|||
48823004|NCT01268059|157192257|FG001|Overall Study|Withdrawal by Subject|4|||
48823005|NCT01268059|157192258|FG002|Overall Study|Withdrawal by Subject|0|||
48823006|NCT01268059|157192259|FG003|Overall Study|Withdrawal by Subject|0|||
48823007|NCT01268059|157192256|FG000|Overall Study|Death|20|||
48823008|NCT01268059|157192257|FG001|Overall Study|Death|30|||
48823009|NCT01268059|157192258|FG002|Overall Study|Death|3|||
48823010|NCT01268059|157192259|FG003|Overall Study|Death|5|||
48823011|NCT01268059|157192256|FG000|Overall Study|Progression of disease|1|||
48823012|NCT01268059|157192257|FG001|Overall Study|Progression of disease|0|||
48823013|NCT01268059|157192258|FG002|Overall Study|Progression of disease|0|||
48823014|NCT01268059|157192259|FG003|Overall Study|Progression of disease|0|||
48823015|NCT03660943|157192260|FG000|Overall Study|Adverse Event|5|||
48823016|NCT03660943|157192261|FG001|Overall Study|Adverse Event|3|||
48823017|NCT03660943|157192260|FG000|Overall Study|Death|0|||
48823018|NCT03660943|157192261|FG001|Overall Study|Death|2|||
48823019|NCT03660943|157192260|FG000|Overall Study|Lost to Follow-up|7|||
48823020|NCT03660943|157192261|FG001|Overall Study|Lost to Follow-up|3|||
48823021|NCT03660943|157192260|FG000|Overall Study|Protocol Violation|3|||
48823022|NCT03660943|157192261|FG001|Overall Study|Protocol Violation|5|||
48823023|NCT03660943|157192260|FG000|Overall Study|Withdrawal by Subject|8|||
48823024|NCT03660943|157192261|FG001|Overall Study|Withdrawal by Subject|15|||
48823025|NCT03660943|157192260|FG000|Overall Study|Lack of Efficacy|9|||
48823026|NCT03660943|157192261|FG001|Overall Study|Lack of Efficacy|12|||
48823027|NCT03660943|157192260|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
48823028|NCT03660943|157192261|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
48823029|NCT02491411|157192262|FG000|Overall Study|Physician Decision|4|||
48823030|NCT01036087|157192267|FG000|Overall Study|Adverse Event|2|||
48823031|NCT01036087|157192267|FG000|Overall Study|Lack of Efficacy|1|||
48823032|NCT02123966|157192268|FG000|Overall Study|Intercurrent Illness|1|||
48823033|NCT00465361|157192269|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
48823034|NCT02451930|157192270|FG000|Overall Study|Death|0|||
48823035|NCT02451930|157192271|FG001|Overall Study|Death|15|||
48823036|NCT02451930|157192270|FG000|Overall Study|Lost to Follow-up|0|||
48823037|NCT02451930|157192271|FG001|Overall Study|Lost to Follow-up|3|||
48823038|NCT02451930|157192270|FG000|Overall Study|Sponsor Decision|2|||
48823039|NCT02451930|157192271|FG001|Overall Study|Sponsor Decision|10|||
48823040|NCT02451930|157192270|FG000|Overall Study|Withdrawal by Subject|0|||
48383347|NCT01493557|155600135|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
48383348|NCT01493557|155600136|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
48515950|NCT03131895|156082243|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
48823041|NCT02451930|157192271|FG001|Overall Study|Withdrawal by Subject|1|||
48823042|NCT02451930|157192270|FG000|Overall Study|Other|0|||
48823043|NCT02451930|157192271|FG001|Overall Study|Other|1|||
48823044|NCT03639675|157192272|FG000|Overall Study|Withdrawal by Subject|1|||
48823045|NCT02748512|157192273|FG000|Overall Study|Lost to Follow-up|1|||
48823046|NCT02748512|157192274|FG001|Overall Study|Lost to Follow-up|1|||
48823047|NCT01403987|157192275|FG000|Overall Study|Residents forgot their secret PIN|18|||
48823048|NCT01403987|157192276|FG001|Overall Study|Residents forgot their secret PIN|17|||
48515951|NCT03131895|156082244|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
48515952|NCT03131895|156082245|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
48823049|NCT01403987|157192277|FG002|Overall Study|Residents forgot their secret PIN|18|||
48823050|NCT00180674|157192280|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
48383349|NCT01493557|155600134|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
48383350|NCT01493557|155600135|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
48383351|NCT01493557|155600136|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
48383352|NCT01493557|155600134|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
48383353|NCT01493557|155600135|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
48383354|NCT01493557|155600136|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
48383355|NCT01493557|155600134|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
48383356|NCT01493557|155600135|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
48383357|NCT01493557|155600136|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
48383358|NCT01493557|155600134|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
48383359|NCT01493557|155600135|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
48383360|NCT01493557|155600136|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
48515953|NCT03131895|156082246|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
48515954|NCT03131895|156082243|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
48515955|NCT03131895|156082244|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
48515956|NCT03131895|156082245|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
48383361|NCT01493557|155600134|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
48383362|NCT01493557|155600135|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
48515957|NCT03131895|156082246|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
48515958|NCT00540423|156082247|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48515959|NCT00540423|156082248|FG001|Double-Blind Treatment Period|Adverse Event|1|||
48515960|NCT00540423|156082249|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48515961|NCT00540423|156082247|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
48515962|NCT00540423|156082248|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
48515963|NCT00540423|156082249|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
48515964|NCT02854800|156082250|FG000|Overall Study|Protocol Violation|16|||
48515965|NCT02854800|156082251|FG001|Overall Study|Protocol Violation|11|||
48515966|NCT02854800|156082252|FG002|Overall Study|Protocol Violation|3|||
48515967|NCT02854800|156082250|FG000|Overall Study|Withdrawal by Subject|4|||
48515968|NCT02854800|156082251|FG001|Overall Study|Withdrawal by Subject|2|||
48515969|NCT02854800|156082252|FG002|Overall Study|Withdrawal by Subject|3|||
48515970|NCT00985439|156082258|FG000|Overall Study|Adverse Event|0|||
48515971|NCT00985439|156082259|FG001|Overall Study|Adverse Event|0|||
48515972|NCT00985439|156082260|FG002|Overall Study|Adverse Event|1|||
48515973|NCT00985439|156082261|FG003|Overall Study|Adverse Event|0|||
48515974|NCT03676634|156082262|FG000|Overall Study|Red blood cell loss|1|||
48515975|NCT03676634|156082262|FG000|Overall Study|Out-of-limit pulse|2|||
48515976|NCT02441686|156082263|FG000|Induction|Adverse Event|4|||
48515977|NCT02441686|156082263|FG000|Induction|Complicating disease|1|||
48515978|NCT02441686|156082263|FG000|Induction|Physician Decision|1|||
48515979|NCT02441686|156082263|FG000|Induction|Withdrawal by Subject|1|||
48515980|NCT02441686|156082263|FG000|Induction|Did not receive treatment|1|||
48515981|NCT02441686|156082263|FG000|Maintenance|Remaining on Treatment|23|||
48515982|NCT02441686|156082263|FG000|Maintenance|Physician Decision|1|||
48515983|NCT02441686|156082263|FG000|Maintenance|Adverse Event|3|||
48515984|NCT02441686|156082263|FG000|Maintenance|Progressive Disease|10|||
48515985|NCT02441686|156082263|FG000|Maintenance|Withdrawal by Subject|1|||
48515986|NCT01174186|156082264|FG000|Overall Study|Lost to Follow-up|0|||
48515987|NCT01174186|156082265|FG001|Overall Study|Lost to Follow-up|1|||
48515988|NCT01174186|156082264|FG000|Overall Study|Withdrawal by Subject|0|||
48515989|NCT01174186|156082265|FG001|Overall Study|Withdrawal by Subject|2|||
48515990|NCT01634139|156082266|FG000|Overall Study|Non compliant with protocol|1|||
48515991|NCT01634139|156082267|FG001|Overall Study|Non compliant with protocol|0|||
48515992|NCT01634139|156082268|FG002|Overall Study|Non compliant with protocol|0|||
48515993|NCT01634139|156082266|FG000|Overall Study|Consent withdrawn not due to AE|4|||
48515994|NCT01634139|156082267|FG001|Overall Study|Consent withdrawn not due to AE|3|||
48515995|NCT01634139|156082268|FG002|Overall Study|Consent withdrawn not due to AE|2|||
48515996|NCT01634139|156082266|FG000|Overall Study|Other|4|||
48515997|NCT01634139|156082267|FG001|Overall Study|Other|0|||
48515998|NCT01634139|156082268|FG002|Overall Study|Other|3|||
48515999|NCT01634139|156082266|FG000|Overall Study|Lost to Follow-up|0|||
48516000|NCT01634139|156082267|FG001|Overall Study|Lost to Follow-up|2|||
48516001|NCT01634139|156082268|FG002|Overall Study|Lost to Follow-up|0|||
48516002|NCT01634139|156082266|FG000|Overall Study|Not treated|1|||
48516003|NCT01634139|156082267|FG001|Overall Study|Not treated|1|||
48516004|NCT01634139|156082268|FG002|Overall Study|Not treated|0|||
48516005|NCT05274763|156082269|FG000|Overall Study|Lost to Follow-up|1|||
48516006|NCT00909038|156082270|FG000|Overall Study|Protocol Violation|187|||
48516007|NCT00909038|156082270|FG000|Overall Study|Non-evaluable Subjects|230|||
48516008|NCT05315713|156082271|FG000|Overall Study|Death|5|||
48516009|NCT05315713|156082271|FG000|Overall Study|Progressive disease|1|||
48516010|NCT05315713|156082271|FG000|Overall Study|Withdrawal by Subject|1|||
48516011|NCT05315713|156082271|FG000|Overall Study|Study terminated by sponsor|1|||
48516012|NCT00402103|156082272|FG000|Overall Study|Adverse Event|60|||
48516013|NCT00402103|156082273|FG001|Overall Study|Adverse Event|7|||
48516014|NCT00402103|156082272|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48516015|NCT00402103|156082273|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48516016|NCT00402103|156082272|FG000|Overall Study|Condition no longer requires study drug|2|||
48516017|NCT00402103|156082273|FG001|Overall Study|Condition no longer requires study drug|0|||
48516018|NCT00402103|156082272|FG000|Overall Study|Protocol Deviation|8|||
48516019|NCT00402103|156082273|FG001|Overall Study|Protocol Deviation|0|||
48516020|NCT00402103|156082272|FG000|Overall Study|Patient withdrew consent|12|||
48516021|NCT00402103|156082273|FG001|Overall Study|Patient withdrew consent|1|||
48516022|NCT00402103|156082272|FG000|Overall Study|Lost to Follow-up|6|||
48516023|NCT00402103|156082273|FG001|Overall Study|Lost to Follow-up|3|||
48516024|NCT00402103|156082272|FG000|Overall Study|Administrative problems|2|||
48516025|NCT00402103|156082273|FG001|Overall Study|Administrative problems|0|||
48516026|NCT00484679|156082274|FG000|Overall Study|Withdrawal by Subject|3|||
48516027|NCT03214588|156082284|FG000|Overall Study|Adverse Event|1|||
48516028|NCT03214588|156082285|FG001|Overall Study|Adverse Event|0|||
48516029|NCT03214588|156082286|FG002|Overall Study|Adverse Event|2|||
48516030|NCT03214588|156082284|FG000|Overall Study|Reason Not Specified|0|||
48516031|NCT03214588|156082285|FG001|Overall Study|Reason Not Specified|1|||
48516032|NCT03214588|156082286|FG002|Overall Study|Reason Not Specified|0|||
48516033|NCT00205777|156082291|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
48516034|NCT00205777|156082292|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
48516035|NCT00205777|156082293|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
48516036|NCT00205777|156082294|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
48516037|NCT00205777|156082295|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
48516038|NCT00205777|156082296|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
48516039|NCT00205777|156082291|FG000|Core Study (Up to 3 Years)|Death|9|||
48516040|NCT00205777|156082292|FG001|Core Study (Up to 3 Years)|Death|7|||
48516041|NCT00205777|156082293|FG002|Core Study (Up to 3 Years)|Death|14|||
48516042|NCT00205777|156082294|FG003|Core Study (Up to 3 Years)|Death|7|||
48516043|NCT00205777|156082295|FG004|Core Study (Up to 3 Years)|Death|0|||
48516044|NCT00205777|156082296|FG005|Core Study (Up to 3 Years)|Death|0|||
48516045|NCT00205777|156082291|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
48516046|NCT00205777|156082292|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
48516047|NCT00205777|156082293|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
48516048|NCT00205777|156082294|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
48516049|NCT00205777|156082295|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
48516050|NCT00205777|156082296|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
48516051|NCT00205777|156082291|FG000|Core Study (Up to 3 Years)|Other Event|49|||
48516052|NCT00205777|156082292|FG001|Core Study (Up to 3 Years)|Other Event|52|||
48516053|NCT00205777|156082293|FG002|Core Study (Up to 3 Years)|Other Event|41|||
48516054|NCT00205777|156082294|FG003|Core Study (Up to 3 Years)|Other Event|58|||
48516055|NCT00205777|156082295|FG004|Core Study (Up to 3 Years)|Other Event|0|||
48516056|NCT00205777|156082296|FG005|Core Study (Up to 3 Years)|Other Event|0|||
48516057|NCT00205777|156082291|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
48516058|NCT00205777|156082292|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
48516059|NCT00205777|156082293|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
48516060|NCT00205777|156082294|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
48516061|NCT00205777|156082295|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
48516062|NCT00205777|156082296|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
48516063|NCT00205777|156082291|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
48516064|NCT00205777|156082292|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
48516065|NCT00205777|156082293|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
48516066|NCT00205777|156082294|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
48516067|NCT00205777|156082295|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
48516068|NCT00205777|156082296|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
48516069|NCT00205777|156082291|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
48516070|NCT00205777|156082292|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
48516071|NCT00205777|156082293|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
48516072|NCT00205777|156082294|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
48516073|NCT00205777|156082295|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
48516074|NCT00205777|156082296|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
48516075|NCT00205777|156082291|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
48516076|NCT00205777|156082292|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
48516077|NCT00205777|156082293|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
48516078|NCT00205777|156082294|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
48516079|NCT00205777|156082295|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
48516080|NCT00205777|156082296|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
48516081|NCT00205777|156082291|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
48516082|NCT00205777|156082292|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
48516083|NCT00205777|156082293|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
48516084|NCT00205777|156082294|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
48601111|NCT02718911|156396045|FG005|Overall Study|Death|3|||
48516085|NCT00205777|156082295|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
48516086|NCT00205777|156082296|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
48516087|NCT00205777|156082291|FG000|Completed Core Study, Entered SE I|Other Event|52|||
48516088|NCT00205777|156082292|FG001|Completed Core Study, Entered SE I|Other Event|46|||
48516089|NCT00205777|156082293|FG002|Completed Core Study, Entered SE I|Other Event|47|||
48516090|NCT00205777|156082294|FG003|Completed Core Study, Entered SE I|Other Event|50|||
48516091|NCT00205777|156082295|FG004|Completed Core Study, Entered SE I|Other Event|0|||
48516092|NCT00205777|156082296|FG005|Completed Core Study, Entered SE I|Other Event|0|||
48516093|NCT00205777|156082291|FG000|Study Extension I|Adverse Event|57|||
48516094|NCT00205777|156082292|FG001|Study Extension I|Adverse Event|0|||
48516095|NCT00205777|156082293|FG002|Study Extension I|Adverse Event|0|||
48516096|NCT00205777|156082294|FG003|Study Extension I|Adverse Event|61|||
48516097|NCT00205777|156082295|FG004|Study Extension I|Adverse Event|58|||
48516098|NCT00205777|156082296|FG005|Study Extension I|Adverse Event|0|||
48516099|NCT00205777|156082291|FG000|Study Extension I|Death|5|||
48516100|NCT00205777|156082292|FG001|Study Extension I|Death|0|||
48516101|NCT00205777|156082293|FG002|Study Extension I|Death|0|||
48516102|NCT00205777|156082294|FG003|Study Extension I|Death|1|||
48516103|NCT00205777|156082295|FG004|Study Extension I|Death|2|||
48516104|NCT00205777|156082296|FG005|Study Extension I|Death|0|||
48516105|NCT00205777|156082291|FG000|Study Extension I|Withdrawal by Subject|99|||
48516106|NCT00205777|156082292|FG001|Study Extension I|Withdrawal by Subject|0|||
48516107|NCT00205777|156082293|FG002|Study Extension I|Withdrawal by Subject|0|||
48516108|NCT00205777|156082294|FG003|Study Extension I|Withdrawal by Subject|106|||
48516109|NCT00205777|156082295|FG004|Study Extension I|Withdrawal by Subject|89|||
48516110|NCT00205777|156082296|FG005|Study Extension I|Withdrawal by Subject|0|||
48516111|NCT00205777|156082291|FG000|Study Extension I|Protocol Violation|4|||
48516112|NCT00205777|156082292|FG001|Study Extension I|Protocol Violation|0|||
48516113|NCT00205777|156082293|FG002|Study Extension I|Protocol Violation|0|||
48516114|NCT00205777|156082294|FG003|Study Extension I|Protocol Violation|8|||
48516115|NCT00205777|156082295|FG004|Study Extension I|Protocol Violation|8|||
48516116|NCT00205777|156082296|FG005|Study Extension I|Protocol Violation|0|||
48516117|NCT00205777|156082291|FG000|Study Extension I|Lack of Efficacy|0|||
48516118|NCT00205777|156082292|FG001|Study Extension I|Lack of Efficacy|0|||
48516119|NCT00205777|156082293|FG002|Study Extension I|Lack of Efficacy|0|||
48516120|NCT00205777|156082294|FG003|Study Extension I|Lack of Efficacy|1|||
48516121|NCT00205777|156082295|FG004|Study Extension I|Lack of Efficacy|2|||
48516122|NCT00205777|156082296|FG005|Study Extension I|Lack of Efficacy|0|||
48516123|NCT00205777|156082291|FG000|Study Extension I|Failed to return|15|||
48516124|NCT00205777|156082292|FG001|Study Extension I|Failed to return|0|||
48516125|NCT00205777|156082293|FG002|Study Extension I|Failed to return|0|||
48516126|NCT00205777|156082294|FG003|Study Extension I|Failed to return|17|||
48823051|NCT00180674|157192280|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
48823052|NCT02851511|157192290|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
48823053|NCT02851511|157192291|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
48823054|NCT02851511|157192292|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
48823055|NCT02851511|157192293|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
48823056|NCT02851511|157192290|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
48823057|NCT02851511|157192291|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
48823058|NCT02851511|157192292|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
48516127|NCT00205777|156082295|FG004|Study Extension I|Failed to return|13|||
48516128|NCT00205777|156082296|FG005|Study Extension I|Failed to return|0|||
48516129|NCT00205777|156082291|FG000|Study Extension I|Other Event|34|||
48516130|NCT00205777|156082292|FG001|Study Extension I|Other Event|0|||
48516131|NCT00205777|156082293|FG002|Study Extension I|Other Event|0|||
48516132|NCT00205777|156082294|FG003|Study Extension I|Other Event|34|||
48516133|NCT00205777|156082295|FG004|Study Extension I|Other Event|29|||
48516134|NCT00205777|156082296|FG005|Study Extension I|Other Event|0|||
48516135|NCT00205777|156082291|FG000|Study Extension I|Withdrawn as per protocol|0|||
48516136|NCT00205777|156082292|FG001|Study Extension I|Withdrawn as per protocol|0|||
48516137|NCT00205777|156082293|FG002|Study Extension I|Withdrawn as per protocol|1070|||
48516138|NCT00205777|156082294|FG003|Study Extension I|Withdrawn as per protocol|0|||
48516139|NCT00205777|156082295|FG004|Study Extension I|Withdrawn as per protocol|0|||
48516140|NCT00205777|156082296|FG005|Study Extension I|Withdrawn as per protocol|0|||
48516141|NCT00205777|156082291|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
48516142|NCT00205777|156082292|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
48516143|NCT00205777|156082293|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
48516144|NCT00205777|156082294|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
48823059|NCT02851511|157192293|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
48516145|NCT00205777|156082295|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
48516146|NCT00205777|156082296|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
48516147|NCT00205777|156082291|FG000|Study Extension II|Adverse Event|0|||
48516148|NCT00205777|156082292|FG001|Study Extension II|Adverse Event|0|||
48516149|NCT00205777|156082293|FG002|Study Extension II|Adverse Event|0|||
48516150|NCT00205777|156082294|FG003|Study Extension II|Adverse Event|14|||
48516151|NCT00205777|156082295|FG004|Study Extension II|Adverse Event|0|||
48516152|NCT00205777|156082296|FG005|Study Extension II|Adverse Event|30|||
48516153|NCT00205777|156082291|FG000|Study Extension II|Death|0|||
48516154|NCT00205777|156082292|FG001|Study Extension II|Death|0|||
48516155|NCT00205777|156082293|FG002|Study Extension II|Death|0|||
48516156|NCT00205777|156082294|FG003|Study Extension II|Death|2|||
48516157|NCT00205777|156082295|FG004|Study Extension II|Death|0|||
48516158|NCT00205777|156082296|FG005|Study Extension II|Death|5|||
48516159|NCT00205777|156082291|FG000|Study Extension II|Withdrawal by Subject|0|||
48516160|NCT00205777|156082292|FG001|Study Extension II|Withdrawal by Subject|0|||
48516161|NCT00205777|156082293|FG002|Study Extension II|Withdrawal by Subject|0|||
48516162|NCT00205777|156082294|FG003|Study Extension II|Withdrawal by Subject|35|||
48516163|NCT00205777|156082295|FG004|Study Extension II|Withdrawal by Subject|0|||
48516164|NCT00205777|156082296|FG005|Study Extension II|Withdrawal by Subject|59|||
48516165|NCT00205777|156082291|FG000|Study Extension II|Protocol Violation|0|||
48516166|NCT00205777|156082292|FG001|Study Extension II|Protocol Violation|0|||
48516167|NCT00205777|156082293|FG002|Study Extension II|Protocol Violation|0|||
48516168|NCT00205777|156082294|FG003|Study Extension II|Protocol Violation|1|||
48516169|NCT00205777|156082295|FG004|Study Extension II|Protocol Violation|0|||
48516170|NCT00205777|156082296|FG005|Study Extension II|Protocol Violation|10|||
48516171|NCT00205777|156082291|FG000|Study Extension II|Lack of Efficacy|0|||
48516172|NCT00205777|156082292|FG001|Study Extension II|Lack of Efficacy|0|||
48516173|NCT00205777|156082293|FG002|Study Extension II|Lack of Efficacy|0|||
48516174|NCT00205777|156082294|FG003|Study Extension II|Lack of Efficacy|0|||
48516175|NCT00205777|156082295|FG004|Study Extension II|Lack of Efficacy|0|||
48516176|NCT00205777|156082296|FG005|Study Extension II|Lack of Efficacy|1|||
48516177|NCT00205777|156082291|FG000|Study Extension II|Failed to return|0|||
48516178|NCT00205777|156082292|FG001|Study Extension II|Failed to return|0|||
48516179|NCT00205777|156082293|FG002|Study Extension II|Failed to return|0|||
48516180|NCT00205777|156082294|FG003|Study Extension II|Failed to return|14|||
48516181|NCT00205777|156082295|FG004|Study Extension II|Failed to return|0|||
48516182|NCT00205777|156082296|FG005|Study Extension II|Failed to return|26|||
48516183|NCT00205777|156082291|FG000|Study Extension II|Other Event|0|||
48516184|NCT00205777|156082292|FG001|Study Extension II|Other Event|0|||
48516185|NCT00205777|156082293|FG002|Study Extension II|Other Event|0|||
48516186|NCT00205777|156082294|FG003|Study Extension II|Other Event|12|||
48516187|NCT00205777|156082295|FG004|Study Extension II|Other Event|0|||
48516188|NCT00205777|156082296|FG005|Study Extension II|Other Event|20|||
48516189|NCT00205777|156082291|FG000|Study Extension II|Enrolled but not treated|0|||
48516190|NCT00205777|156082292|FG001|Study Extension II|Enrolled but not treated|0|||
48516191|NCT00205777|156082293|FG002|Study Extension II|Enrolled but not treated|0|||
48516192|NCT00205777|156082294|FG003|Study Extension II|Enrolled but not treated|71|||
48516193|NCT00205777|156082295|FG004|Study Extension II|Enrolled but not treated|0|||
48516194|NCT00205777|156082296|FG005|Study Extension II|Enrolled but not treated|131|||
48516195|NCT02462837|156082297|FG000|Overall Study|pt developed hives|1|||
48516196|NCT02462837|156082298|FG001|Overall Study|pt developed hives|0|||
48516197|NCT02462837|156082297|FG000|Overall Study|Withdrawal by Subject|1|||
48516198|NCT02462837|156082298|FG001|Overall Study|Withdrawal by Subject|0|||
48516199|NCT00840203|156082302|FG000|First Intervention|Protocol Violation|1|||
48516200|NCT00840203|156082303|FG001|First Intervention|Protocol Violation|1|||
48516201|NCT00840203|156082302|FG000|Washout|Protocol Violation|1|||
48516202|NCT00840203|156082303|FG001|Washout|Protocol Violation|0|||
48516203|NCT02121184|156082304|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
48516204|NCT02121184|156082305|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
48516205|NCT02121184|156082304|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
48516206|NCT02121184|156082305|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
48516207|NCT02121184|156082304|FG000|Overall Study|Emergency cesarean section required|0|||
48516208|NCT02121184|156082305|FG001|Overall Study|Emergency cesarean section required|2|||
48516209|NCT02121184|156082304|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
48516210|NCT02121184|156082305|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
48516211|NCT03694197|156082315|FG000|Overall Study|Adverse Event|9|||
48516212|NCT03694197|156082315|FG000|Overall Study|Protocol became inconvenient to participate|1|||
48516213|NCT03694197|156082315|FG000|Overall Study|Physician Decision|4|||
48516214|NCT03694197|156082315|FG000|Overall Study|Study terminated by sponsor|1350|||
48516215|NCT03694197|156082315|FG000|Overall Study|Participant moved|5|||
48516216|NCT03694197|156082315|FG000|Overall Study|Participant withdrew consent|10|||
48516217|NCT03694197|156082315|FG000|Overall Study|Related to IMP administration|1|||
48516218|NCT03694197|156082315|FG000|Overall Study|Not disclosed|5|||
48516219|NCT00387153|156082316|FG000|Overall Study|Adverse Event|1|||
48516220|NCT00387153|156082316|FG000|Overall Study|Disease Progression|3|||
48516221|NCT00387153|156082316|FG000|Overall Study|Lack of Response|4|||
48516222|NCT03073798|156082317|FG000|Overall Study|Adverse Event|1|||
48516223|NCT03073798|156082317|FG000|Overall Study|Withdrawal by Subject|1|||
48516224|NCT00819169|156082320|FG000|Overall Study|Withdrawal by Subject|2|||
48730645|NCT03589469|156865857|FG000|Overall Study|Lost to Follow-up|8|||
48383363|NCT01493557|155600136|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
48383364|NCT01493557|155600134|FG000|Not Randomized to Management Strategies|Early termination|0|||
48383365|NCT01493557|155600135|FG001|Not Randomized to Management Strategies|Early termination|0|||
48383366|NCT01493557|155600136|FG002|Not Randomized to Management Strategies|Early termination|34|||
48383367|NCT01493557|155600134|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
48383368|NCT01493557|155600135|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
48383369|NCT01493557|155600136|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
48383370|NCT01493557|155600134|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
48383371|NCT01493557|155600135|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
48383372|NCT01493557|155600136|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
48383373|NCT01493557|155600134|FG000|Randomized to Management Strategies|Other adverse event|8|||
48383374|NCT01493557|155600135|FG001|Randomized to Management Strategies|Other adverse event|5|||
48383375|NCT01493557|155600136|FG002|Randomized to Management Strategies|Other adverse event|0|||
48383376|NCT01493557|155600134|FG000|Randomized to Management Strategies|Protocol Violation|3|||
48383377|NCT01493557|155600135|FG001|Randomized to Management Strategies|Protocol Violation|0|||
48383378|NCT01493557|155600136|FG002|Randomized to Management Strategies|Protocol Violation|0|||
48383379|NCT01493557|155600134|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
48823060|NCT02851511|157192290|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
48823061|NCT02851511|157192291|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
48383380|NCT01493557|155600135|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
48383381|NCT01493557|155600136|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
48383382|NCT01493557|155600134|FG000|Randomized to Management Strategies|Other than stated above|1|||
48383383|NCT01493557|155600135|FG001|Randomized to Management Strategies|Other than stated above|3|||
48383384|NCT01493557|155600136|FG002|Randomized to Management Strategies|Other than stated above|0|||
48383385|NCT01493557|155600134|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
48441979|NCT02062463|155805376|FG003|Stage 2|Adverse Event|20|||
48441980|NCT02062463|155805373|FG000|Stage 2|Lack of Efficacy|0|||
48730646|NCT03589469|156865857|FG000|Overall Study|Miscellaneous|1|||
48730647|NCT04439279|156865858|FG000|Overall Study|Adverse Event|7|||
48730648|NCT04439279|156865858|FG000|Overall Study|Death|4|||
48730649|NCT04439279|156865858|FG000|Overall Study|Disease progression|17|||
48730650|NCT04439279|156865858|FG000|Overall Study|Complicating disease|3|||
48730651|NCT04439279|156865858|FG000|Overall Study|Withdrawal by Subject|2|||
48730652|NCT04439279|156865858|FG000|Overall Study|Ineligible|1|||
48730653|NCT04439279|156865858|FG000|Overall Study|Treatment still ongoing|1|||
48516225|NCT00819169|156082321|FG001|Overall Study|Withdrawal by Subject|0|||
48516226|NCT00819169|156082322|FG002|Overall Study|Withdrawal by Subject|0|||
48516227|NCT00819169|156082323|FG003|Overall Study|Withdrawal by Subject|1|||
48516228|NCT00819169|156082324|FG004|Overall Study|Withdrawal by Subject|1|||
48516229|NCT00819169|156082325|FG005|Overall Study|Withdrawal by Subject|1|||
48516230|NCT00819169|156082326|FG006|Overall Study|Withdrawal by Subject|5|||
48516231|NCT00819169|156082327|FG007|Overall Study|Withdrawal by Subject|1|||
48516232|NCT00819169|156082328|FG008|Overall Study|Withdrawal by Subject|4|||
48516233|NCT00819169|156082320|FG000|Overall Study|Lost to Follow-up|0|||
48730654|NCT04963231|156865863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
48823062|NCT02851511|157192292|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
48823063|NCT02851511|157192293|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
48823064|NCT02851511|157192290|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
48441981|NCT02062463|155805374|FG001|Stage 2|Lack of Efficacy|0|||
48441982|NCT02062463|155805375|FG002|Stage 2|Lack of Efficacy|3|||
48441983|NCT02062463|155805376|FG003|Stage 2|Lack of Efficacy|4|||
48441984|NCT02062463|155805373|FG000|Stage 2|Lost to Follow-up|0|||
48441985|NCT02062463|155805374|FG001|Stage 2|Lost to Follow-up|0|||
48441986|NCT02062463|155805375|FG002|Stage 2|Lost to Follow-up|20|||
48441987|NCT02062463|155805376|FG003|Stage 2|Lost to Follow-up|20|||
48441988|NCT02062463|155805373|FG000|Stage 2|Non-Compliance|0|||
48441989|NCT02062463|155805374|FG001|Stage 2|Non-Compliance|0|||
48441990|NCT02062463|155805375|FG002|Stage 2|Non-Compliance|0|||
48441991|NCT02062463|155805376|FG003|Stage 2|Non-Compliance|1|||
48441992|NCT02062463|155805373|FG000|Stage 2|Other than specified|0|||
48441993|NCT02062463|155805374|FG001|Stage 2|Other than specified|0|||
48441994|NCT02062463|155805375|FG002|Stage 2|Other than specified|3|||
48441995|NCT02062463|155805376|FG003|Stage 2|Other than specified|1|||
48441996|NCT02062463|155805373|FG000|Stage 2|Withdrawal by Subject|0|||
48441997|NCT02062463|155805374|FG001|Stage 2|Withdrawal by Subject|0|||
48441998|NCT02062463|155805375|FG002|Stage 2|Withdrawal by Subject|15|||
48441999|NCT02062463|155805376|FG003|Stage 2|Withdrawal by Subject|10|||
48442000|NCT02716194|155805377|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
48383386|NCT01493557|155600135|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
48516234|NCT00819169|156082321|FG001|Overall Study|Lost to Follow-up|2|||
48516235|NCT00819169|156082322|FG002|Overall Study|Lost to Follow-up|0|||
48516236|NCT00819169|156082323|FG003|Overall Study|Lost to Follow-up|1|||
48516237|NCT00819169|156082324|FG004|Overall Study|Lost to Follow-up|0|||
48383387|NCT01493557|155600136|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
48383388|NCT01493557|155600134|FG000|Adding the Second Strategy|Other adverse event|1|||
48383389|NCT01493557|155600135|FG001|Adding the Second Strategy|Other adverse event|2|||
48383390|NCT01493557|155600136|FG002|Adding the Second Strategy|Other adverse event|0|||
48383391|NCT01493557|155600134|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
48383392|NCT01493557|155600135|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
48383393|NCT01493557|155600136|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
48383394|NCT02973425|155600143|FG000|Overall Study|Lost to Follow-up|49|||
48383395|NCT02973425|155600144|FG001|Overall Study|Lost to Follow-up|53|||
48383396|NCT03876171|155600145|FG000|Overall Study|Withdrawal by Subject|3|||
48383397|NCT03876171|155600146|FG001|Overall Study|Withdrawal by Subject|3|||
48383398|NCT03876171|155600145|FG000|Overall Study|Re-arrest|0|||
48383399|NCT03876171|155600146|FG001|Overall Study|Re-arrest|4|||
48383400|NCT01448213|155600147|FG000|Overall Study|Lost to Follow-up|12|||
48383401|NCT01448213|155600148|FG001|Overall Study|Lost to Follow-up|10|||
48383402|NCT01448213|155600147|FG000|Overall Study|Adverse Event|4|||
48383403|NCT01448213|155600148|FG001|Overall Study|Adverse Event|10|||
48383404|NCT01448213|155600147|FG000|Overall Study|Protocol Violation|1|||
48383405|NCT01448213|155600148|FG001|Overall Study|Protocol Violation|2|||
48383406|NCT03434353|155600149|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
48383407|NCT03434353|155600150|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
48383408|NCT03434353|155600151|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
48383409|NCT03434353|155600152|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
48383410|NCT03434353|155600153|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
48383411|NCT03434353|155600149|FG000|Overall Study|Withdrew consent|1|||
48383412|NCT03434353|155600150|FG001|Overall Study|Withdrew consent|0|||
48383413|NCT03434353|155600151|FG002|Overall Study|Withdrew consent|3|||
48383414|NCT03434353|155600152|FG003|Overall Study|Withdrew consent|0|||
48383415|NCT03434353|155600153|FG004|Overall Study|Withdrew consent|0|||
48383416|NCT03434353|155600149|FG000|Overall Study|Adverse Event|1|||
48516238|NCT00819169|156082325|FG005|Overall Study|Lost to Follow-up|6|||
48516239|NCT00819169|156082326|FG006|Overall Study|Lost to Follow-up|2|||
48516240|NCT00819169|156082327|FG007|Overall Study|Lost to Follow-up|2|||
48516241|NCT00819169|156082328|FG008|Overall Study|Lost to Follow-up|1|||
48516242|NCT00819169|156082320|FG000|Overall Study|Death|1|||
48516243|NCT00819169|156082321|FG001|Overall Study|Death|1|||
48516244|NCT00819169|156082322|FG002|Overall Study|Death|3|||
48516245|NCT00819169|156082323|FG003|Overall Study|Death|8|||
48823065|NCT02851511|157192291|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
48823066|NCT02851511|157192292|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
48823067|NCT02851511|157192293|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
48823068|NCT02851511|157192290|FG000|Phase I|Physician Decision|0|||
48823069|NCT02851511|157192291|FG001|Phase I|Physician Decision|0|||
48823070|NCT02851511|157192292|FG002|Phase I|Physician Decision|0|||
48823071|NCT02851511|157192293|FG003|Phase I|Physician Decision|1|||
48823072|NCT02851511|157192290|FG000|Phase I|Withdrawal by Subject|2|||
48516246|NCT00819169|156082324|FG004|Overall Study|Death|5|||
48516247|NCT00819169|156082325|FG005|Overall Study|Death|7|||
48516248|NCT00819169|156082326|FG006|Overall Study|Death|9|||
48516249|NCT00819169|156082327|FG007|Overall Study|Death|4|||
48516250|NCT00819169|156082328|FG008|Overall Study|Death|7|||
48516251|NCT00819169|156082320|FG000|Overall Study|Ineligibility determined|0|||
48516252|NCT00819169|156082321|FG001|Overall Study|Ineligibility determined|0|||
48516253|NCT00819169|156082322|FG002|Overall Study|Ineligibility determined|0|||
48516254|NCT00819169|156082323|FG003|Overall Study|Ineligibility determined|2|||
48516255|NCT00819169|156082324|FG004|Overall Study|Ineligibility determined|0|||
48516256|NCT00819169|156082325|FG005|Overall Study|Ineligibility determined|0|||
48516257|NCT00819169|156082326|FG006|Overall Study|Ineligibility determined|0|||
48516258|NCT00819169|156082327|FG007|Overall Study|Ineligibility determined|0|||
48516259|NCT00819169|156082328|FG008|Overall Study|Ineligibility determined|1|||
48383417|NCT03434353|155600150|FG001|Overall Study|Adverse Event|0|||
48823073|NCT02851511|157192291|FG001|Phase I|Withdrawal by Subject|1|||
48516260|NCT00819169|156082320|FG000|Overall Study|Adverse Event|0|||
48823074|NCT02851511|157192292|FG002|Phase I|Withdrawal by Subject|0|||
48383418|NCT03434353|155600151|FG002|Overall Study|Adverse Event|0|||
48383419|NCT03434353|155600152|FG003|Overall Study|Adverse Event|0|||
48383420|NCT03434353|155600153|FG004|Overall Study|Adverse Event|1|||
48383421|NCT03434353|155600149|FG000|Overall Study|Lost to Follow-up|2|||
48516261|NCT00819169|156082321|FG001|Overall Study|Adverse Event|0|||
48516262|NCT00819169|156082322|FG002|Overall Study|Adverse Event|0|||
48516263|NCT00819169|156082323|FG003|Overall Study|Adverse Event|0|||
48516264|NCT00819169|156082324|FG004|Overall Study|Adverse Event|1|||
48823075|NCT02851511|157192293|FG003|Phase I|Withdrawal by Subject|3|||
48383422|NCT03434353|155600150|FG001|Overall Study|Lost to Follow-up|0|||
48383423|NCT03434353|155600151|FG002|Overall Study|Lost to Follow-up|0|||
48383424|NCT03434353|155600152|FG003|Overall Study|Lost to Follow-up|0|||
48383425|NCT03434353|155600153|FG004|Overall Study|Lost to Follow-up|0|||
48383426|NCT03503513|155600154|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
48383427|NCT03503513|155600154|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
48516265|NCT00819169|156082325|FG005|Overall Study|Adverse Event|0|||
48516266|NCT00819169|156082326|FG006|Overall Study|Adverse Event|0|||
48516267|NCT00819169|156082327|FG007|Overall Study|Adverse Event|0|||
48516268|NCT00819169|156082328|FG008|Overall Study|Adverse Event|0|||
48516269|NCT00819169|156082320|FG000|Overall Study|Administrative Decision|0|||
48516270|NCT00819169|156082321|FG001|Overall Study|Administrative Decision|0|||
48383428|NCT03503513|155600154|FG000|Overall Study|Physician Decision|3|||
48383429|NCT03503513|155600154|FG000|Overall Study|Withdrawal by Subject|2|||
48383430|NCT03503513|155600154|FG000|Overall Study|Lost to Follow-up|1|||
48383431|NCT04906616|155600159|FG000|Overall Study|Divorce|3|||
48383432|NCT04906616|155600160|FG001|Overall Study|Divorce|2|||
48383433|NCT03739762|155600161|FG000|Overall Study|Lost to Follow-up|1|||
48383434|NCT03739762|155600162|FG001|Overall Study|Lost to Follow-up|1|||
48383435|NCT03739762|155600161|FG000|Overall Study|Withdrawal by Subject|2|||
48383436|NCT03739762|155600162|FG001|Overall Study|Withdrawal by Subject|6|||
48383437|NCT02598557|155600163|FG000|Overall Study|Withdrawal by Subject|1|||
48383438|NCT02598557|155600164|FG001|Overall Study|Withdrawal by Subject|0|||
48516271|NCT00819169|156082322|FG002|Overall Study|Administrative Decision|0|||
48383439|NCT02598557|155600165|FG002|Overall Study|Withdrawal by Subject|1|||
48383440|NCT02598557|155600163|FG000|Overall Study|Participant did not start treatment|2|||
48383441|NCT02598557|155600164|FG001|Overall Study|Participant did not start treatment|1|||
48383442|NCT02598557|155600165|FG002|Overall Study|Participant did not start treatment|1|||
48383443|NCT02598557|155600163|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
48383444|NCT02598557|155600164|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
48383445|NCT02598557|155600165|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
48383446|NCT02598557|155600163|FG000|Overall Study|Adverse Event|1|||
48516272|NCT00819169|156082323|FG003|Overall Study|Administrative Decision|0|||
48516273|NCT00819169|156082324|FG004|Overall Study|Administrative Decision|1|||
48516274|NCT00819169|156082325|FG005|Overall Study|Administrative Decision|2|||
48383447|NCT02598557|155600164|FG001|Overall Study|Adverse Event|1|||
48383448|NCT02598557|155600165|FG002|Overall Study|Adverse Event|0|||
48383449|NCT00908583|155600166|FG000|Phase 1|Withdrawal by Subject|1|||
48383450|NCT00908583|155600166|FG000|Phase 1|Adverse Event|4|||
48383451|NCT00908583|155600166|FG000|Phase 2|Physician Decision|1|||
48383452|NCT00908583|155600166|FG000|Phase 2|Adverse Event|1|||
48383453|NCT00908583|155600166|FG000|Phase 3|Adverse Event|2|||
48383454|NCT00908583|155600166|FG000|Phase 4|Adverse Event|1|||
48383455|NCT00908583|155600166|FG000|Phase 4|Physician Decision|1|||
48383456|NCT00908583|155600166|FG000|Phase 5|Adverse Event|3|||
48383457|NCT02072434|155600167|FG000|Overall Study|Protocol Violation|10|||
48383458|NCT02072434|155600168|FG001|Overall Study|Protocol Violation|9|||
48383459|NCT02072434|155600167|FG000|Overall Study|Physician Decision|5|||
48383460|NCT02072434|155600168|FG001|Overall Study|Physician Decision|10|||
48383461|NCT02072434|155600167|FG000|Overall Study|Adverse event, serious fatal|1|||
48383462|NCT02072434|155600168|FG001|Overall Study|Adverse event, serious fatal|6|||
48383463|NCT02072434|155600167|FG000|Overall Study|Adverse Event|7|||
48383464|NCT02072434|155600168|FG001|Overall Study|Adverse Event|6|||
48383465|NCT02072434|155600167|FG000|Overall Study|Withdrawal by Subject|17|||
48383466|NCT02072434|155600168|FG001|Overall Study|Withdrawal by Subject|29|||
48383467|NCT02072434|155600167|FG000|Overall Study|Other|14|||
48383468|NCT02072434|155600168|FG001|Overall Study|Other|29|||
48383469|NCT02072434|155600167|FG000|Overall Study|Lost to Follow-up|0|||
48383470|NCT02072434|155600168|FG001|Overall Study|Lost to Follow-up|1|||
48383471|NCT00993954|155600169|FG000|Overall Study|Protocol Violation|21|||
48383472|NCT00993954|155600170|FG001|Overall Study|Protocol Violation|2|||
48383473|NCT01990534|155600173|FG000|Overall Study|Death|22|||
48383474|NCT01990534|155600173|FG000|Overall Study|Progressive disease|3|||
48383475|NCT01990534|155600173|FG000|Overall Study|Protocol Violation|1|||
48383476|NCT01990534|155600173|FG000|Overall Study|Withdrawal of Informed Consent|2|||
48516275|NCT00819169|156082326|FG006|Overall Study|Administrative Decision|0|||
48383477|NCT01990534|155600173|FG000|Overall Study|Symptomatic Deterioration|1|||
48516276|NCT00819169|156082327|FG007|Overall Study|Administrative Decision|2|||
48516277|NCT00819169|156082328|FG008|Overall Study|Administrative Decision|0|||
48516278|NCT02637141|156082331|FG000|Overall Study|Adverse Event|1|||
48730655|NCT04963231|156865864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
48730656|NCT04963231|156865865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
48730657|NCT04963231|156865863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
48383478|NCT01990534|155600173|FG000|Overall Study|Withdrawal by Subject|3|||
48383479|NCT01990534|155600173|FG000|Overall Study|Reason not Specified|2|||
48383480|NCT01990534|155600173|FG000|Overall Study|Lost to Follow-up|1|||
48383481|NCT00727649|155600176|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
48383482|NCT00727649|155600177|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
48383483|NCT00727649|155600176|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
48516279|NCT02637141|156082332|FG001|Overall Study|Adverse Event|1|||
48516280|NCT02637141|156082333|FG002|Overall Study|Adverse Event|0|||
48516281|NCT02637141|156082331|FG000|Overall Study|Withdrawal by Subject|1|||
48516282|NCT02637141|156082332|FG001|Overall Study|Withdrawal by Subject|1|||
48516283|NCT02637141|156082333|FG002|Overall Study|Withdrawal by Subject|1|||
48516284|NCT03541252|156082345|FG000|Overall Study|Withdrawal by Subject|1|||
48383484|NCT00727649|155600177|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
48383485|NCT00727649|155600176|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
48516285|NCT00533507|156082346|FG000|Overall Study|Withdrawal by Subject|1|||
48516286|NCT01912807|156082347|FG000|Overall Study|Did not meet elegibility criteria|6|||
48516287|NCT01912807|156082348|FG001|Overall Study|Did not meet elegibility criteria|4|||
48516288|NCT01912807|156082347|FG000|Overall Study|Lost to Follow-up|36|||
48516289|NCT01912807|156082348|FG001|Overall Study|Lost to Follow-up|37|||
48516290|NCT02316223|156084121|FG000|Overall Study|Lack of Efficacy|0|||
48516291|NCT02316223|156084122|FG001|Overall Study|Lack of Efficacy|1|||
48516292|NCT02316223|156084123|FG002|Overall Study|Lack of Efficacy|1|||
48516293|NCT02316223|156084121|FG000|Overall Study|Lost to Follow-up|27|||
48516294|NCT02316223|156084122|FG001|Overall Study|Lost to Follow-up|34|||
48516295|NCT02316223|156084123|FG002|Overall Study|Lost to Follow-up|36|||
48516296|NCT02316223|156084121|FG000|Overall Study|COPD Diagnosis|3|||
48823076|NCT02851511|157192290|FG000|Phase II|Physician Decision|18|||
48823077|NCT02851511|157192291|FG001|Phase II|Physician Decision|16|||
48823078|NCT02851511|157192292|FG002|Phase II|Physician Decision|0|||
48823079|NCT02851511|157192293|FG003|Phase II|Physician Decision|0|||
48823080|NCT02851511|157192290|FG000|Phase II|Withdrawal by Subject|18|||
48823081|NCT02851511|157192291|FG001|Phase II|Withdrawal by Subject|16|||
48823082|NCT02851511|157192292|FG002|Phase II|Withdrawal by Subject|0|||
48823083|NCT02851511|157192293|FG003|Phase II|Withdrawal by Subject|0|||
48823084|NCT02851511|157192290|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
48823085|NCT02851511|157192291|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
48516297|NCT02316223|156084122|FG001|Overall Study|COPD Diagnosis|2|||
48516298|NCT02316223|156084123|FG002|Overall Study|COPD Diagnosis|3|||
48516299|NCT02316223|156084121|FG000|Overall Study|Reside outside study area|1|||
48516300|NCT02316223|156084122|FG001|Overall Study|Reside outside study area|1|||
48516301|NCT02316223|156084123|FG002|Overall Study|Reside outside study area|1|||
48516302|NCT02316223|156084121|FG000|Overall Study|No asthma|2|||
48823086|NCT02851511|157192292|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
48823087|NCT02851511|157192293|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
48823088|NCT02851511|157192290|FG000|Phase II|Lost to Follow-up|0|||
48823089|NCT02851511|157192291|FG001|Phase II|Lost to Follow-up|1|||
48823090|NCT02851511|157192292|FG002|Phase II|Lost to Follow-up|0|||
48823091|NCT02851511|157192293|FG003|Phase II|Lost to Follow-up|0|||
48516303|NCT02316223|156084122|FG001|Overall Study|No asthma|0|||
48516304|NCT02316223|156084123|FG002|Overall Study|No asthma|0|||
48516305|NCT02316223|156084121|FG000|Overall Study|Discontinued by PI|11|||
48516306|NCT02316223|156084122|FG001|Overall Study|Discontinued by PI|19|||
48516307|NCT02316223|156084123|FG002|Overall Study|Discontinued by PI|3|||
48516308|NCT00452348|156084128|FG000|Overall Study|Adverse Event|6|||
48516309|NCT00452348|156084129|FG001|Overall Study|Adverse Event|9|||
48516310|NCT00452348|156084128|FG000|Overall Study|Lack of Efficacy|10|||
48516311|NCT00452348|156084129|FG001|Overall Study|Lack of Efficacy|9|||
48516312|NCT00452348|156084128|FG000|Overall Study|Lost to Follow-up|14|||
48516313|NCT00452348|156084129|FG001|Overall Study|Lost to Follow-up|8|||
48516314|NCT00452348|156084128|FG000|Overall Study|Protocol Violation|22|||
48516315|NCT00452348|156084129|FG001|Overall Study|Protocol Violation|28|||
48516316|NCT00452348|156084128|FG000|Overall Study|Withdrawal by Subject|18|||
48516317|NCT00452348|156084129|FG001|Overall Study|Withdrawal by Subject|21|||
48516318|NCT00452348|156084128|FG000|Overall Study|Other|9|||
48516319|NCT00452348|156084129|FG001|Overall Study|Other|9|||
48516320|NCT00828321|156084133|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
48516321|NCT00828321|156084134|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
48383486|NCT00727649|155600177|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
48383487|NCT00727649|155600176|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
48516322|NCT00828321|156084133|FG000|Second Intervention|Protocol Violation|0|||
48823092|NCT02056119|157192302|FG000|Overall Study|Death|1|||
48383488|NCT00727649|155600177|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
48516323|NCT00828321|156084134|FG001|Second Intervention|Protocol Violation|1|||
48516324|NCT00396162|156084136|FG000|Overall Study|Withdrawal by Subject|2|||
48516325|NCT00396162|156084137|FG001|Overall Study|Withdrawal by Subject|3|||
48516326|NCT01117623|156084140|FG000|Overall Study|Adverse Event|0|||
48516327|NCT01117623|156084141|FG001|Overall Study|Adverse Event|2|||
48516328|NCT01117623|156084142|FG002|Overall Study|Adverse Event|4|||
48516329|NCT01117623|156084143|FG003|Overall Study|Adverse Event|0|||
48823093|NCT02056119|157192303|FG001|Overall Study|Death|2|||
48823094|NCT02056119|157192302|FG000|Overall Study|Intubated for less than 24 hrs|2|||
48516330|NCT01117623|156084144|FG004|Overall Study|Adverse Event|2|||
48516331|NCT01117623|156084145|FG005|Overall Study|Adverse Event|0|||
48516332|NCT01117623|156084146|FG006|Overall Study|Adverse Event|0|||
48516333|NCT01117623|156084147|FG007|Overall Study|Adverse Event|2|||
48516334|NCT01117623|156084140|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
48516335|NCT01117623|156084141|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
48516336|NCT01117623|156084142|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
48516337|NCT01117623|156084143|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
48516338|NCT01117623|156084144|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
48516339|NCT01117623|156084145|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
48516340|NCT01117623|156084146|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
48516341|NCT01117623|156084147|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
48516342|NCT01117623|156084140|FG000|Overall Study|Withdrawal by Subject|0|||
48516343|NCT01117623|156084141|FG001|Overall Study|Withdrawal by Subject|0|||
48516344|NCT01117623|156084142|FG002|Overall Study|Withdrawal by Subject|2|||
48516345|NCT01117623|156084143|FG003|Overall Study|Withdrawal by Subject|0|||
48516346|NCT01117623|156084144|FG004|Overall Study|Withdrawal by Subject|0|||
48516347|NCT01117623|156084145|FG005|Overall Study|Withdrawal by Subject|1|||
48516348|NCT01117623|156084146|FG006|Overall Study|Withdrawal by Subject|1|||
48516349|NCT01117623|156084147|FG007|Overall Study|Withdrawal by Subject|1|||
48516350|NCT01117623|156084140|FG000|Overall Study|Non-compliance with study medication|0|||
48516351|NCT01117623|156084141|FG001|Overall Study|Non-compliance with study medication|0|||
48516352|NCT01117623|156084142|FG002|Overall Study|Non-compliance with study medication|0|||
48516353|NCT01117623|156084143|FG003|Overall Study|Non-compliance with study medication|0|||
48516354|NCT01117623|156084144|FG004|Overall Study|Non-compliance with study medication|0|||
48516355|NCT01117623|156084145|FG005|Overall Study|Non-compliance with study medication|0|||
48516356|NCT01117623|156084146|FG006|Overall Study|Non-compliance with study medication|0|||
48516357|NCT01117623|156084147|FG007|Overall Study|Non-compliance with study medication|1|||
48823095|NCT02056119|157192303|FG001|Overall Study|Intubated for less than 24 hrs|7|||
48823096|NCT02056119|157192302|FG000|Overall Study|No aerosol treatments were given.|3|||
48823097|NCT02056119|157192303|FG001|Overall Study|No aerosol treatments were given.|2|||
48823098|NCT02056119|157192302|FG000|Overall Study|Received Metaneb treatment|0|||
48823099|NCT02056119|157192303|FG001|Overall Study|Received Metaneb treatment|2|||
48823100|NCT02056119|157192302|FG000|Overall Study|Protocol Violation|4|||
48823101|NCT02056119|157192303|FG001|Overall Study|Protocol Violation|7|||
48823102|NCT01348854|157192304|FG000|Overall Study|Lost to Follow-up|2|||
48823103|NCT01348854|157192305|FG001|Overall Study|Lost to Follow-up|1|||
48823104|NCT01348854|157192304|FG000|Overall Study|Withdrawal by Subject|1|||
48823105|NCT01348854|157192305|FG001|Overall Study|Withdrawal by Subject|0|||
48823106|NCT04170023|157192306|FG000|LTE Period|Withdrawal by Subject|1|||
48823107|NCT04170023|157192307|FG001|LTE Period|Withdrawal by Subject|0|||
48823108|NCT04170023|157192308|FG002|LTE Period|Withdrawal by Subject|0|||
48823109|NCT04170023|157192306|FG000|LTE Period|Study Termination|11|||
48823110|NCT04170023|157192307|FG001|LTE Period|Study Termination|11|||
48823111|NCT04170023|157192308|FG002|LTE Period|Study Termination|5|||
48823112|NCT00003377|157192309|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
48823113|NCT00003377|157192310|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
48823114|NCT00003377|157192311|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
48823115|NCT00003377|157192312|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
48823116|NCT00003377|157192313|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
48823117|NCT00003377|157192309|FG000|Period II|Ureteral stent complications|0|||
48823118|NCT00003377|157192310|FG001|Period II|Ureteral stent complications|0|||
48823119|NCT00003377|157192311|FG002|Period II|Ureteral stent complications|0|||
48823120|NCT00003377|157192312|FG003|Period II|Ureteral stent complications|0|||
48823121|NCT00003377|157192313|FG004|Period II|Ureteral stent complications|1|||
48823122|NCT04541186|157192316|FG000|Main Study|Adverse Event|0|||
48823123|NCT04541186|157192317|FG001|Main Study|Adverse Event|0|||
48823124|NCT04541186|157192318|FG002|Main Study|Adverse Event|4|||
48823125|NCT04541186|157192319|FG003|Main Study|Adverse Event|0|||
48823126|NCT04541186|157192320|FG004|Main Study|Adverse Event|0|||
48823127|NCT04541186|157192316|FG000|Main Study|Investigator Decision|0|||
48823128|NCT04541186|157192317|FG001|Main Study|Investigator Decision|0|||
48823129|NCT04541186|157192318|FG002|Main Study|Investigator Decision|1|||
48823130|NCT04541186|157192319|FG003|Main Study|Investigator Decision|1|||
48823131|NCT04541186|157192320|FG004|Main Study|Investigator Decision|0|||
48516358|NCT01117623|156084140|FG000|Overall Study|Invest. text: completed all planned txs|0|||
48516359|NCT01117623|156084141|FG001|Overall Study|Invest. text: completed all planned txs|0|||
48516360|NCT01117623|156084142|FG002|Overall Study|Invest. text: completed all planned txs|0|||
48601112|NCT02718911|156396046|FG006|Overall Study|Death|1|||
48823132|NCT04541186|157192316|FG000|Main Study|Withdrawal by Subject|1|||
48823133|NCT04541186|157192317|FG001|Main Study|Withdrawal by Subject|1|||
48823134|NCT04541186|157192318|FG002|Main Study|Withdrawal by Subject|0|||
48823135|NCT04541186|157192319|FG003|Main Study|Withdrawal by Subject|0|||
48823136|NCT04541186|157192320|FG004|Main Study|Withdrawal by Subject|0|||
48823137|NCT04541186|157192316|FG000|Main Study|COVID-19-related Dose Interruption|0|||
48383489|NCT00727649|155600176|FG000|Second Intervention (4-weeks)|Death|1|||
48516361|NCT01117623|156084143|FG003|Overall Study|Invest. text: completed all planned txs|0|||
48516362|NCT01117623|156084144|FG004|Overall Study|Invest. text: completed all planned txs|0|||
48516363|NCT01117623|156084145|FG005|Overall Study|Invest. text: completed all planned txs|1|||
48516364|NCT01117623|156084146|FG006|Overall Study|Invest. text: completed all planned txs|0|||
48516365|NCT01117623|156084147|FG007|Overall Study|Invest. text: completed all planned txs|0|||
48516366|NCT03158727|156084151|FG000|Overall Study|Withdrawal by Subject|2|||
48516367|NCT03158727|156084152|FG001|Overall Study|Withdrawal by Subject|6|||
48516368|NCT03158727|156084151|FG000|Overall Study|Death|11|||
48516369|NCT03158727|156084152|FG001|Overall Study|Death|12|||
48516370|NCT03158727|156084151|FG000|Overall Study|Lost to Follow-up|1|||
48516371|NCT03158727|156084152|FG001|Overall Study|Lost to Follow-up|0|||
48516372|NCT03158727|156084151|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
48516373|NCT03158727|156084152|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
48516374|NCT03158727|156084151|FG000|Overall Study|Visit 11 not done by mistake|0|||
48516375|NCT03158727|156084152|FG001|Overall Study|Visit 11 not done by mistake|1|||
48516376|NCT03158727|156084151|FG000|Overall Study|Enrolled, not treated|1|||
48516377|NCT03158727|156084152|FG001|Overall Study|Enrolled, not treated|0|||
48516378|NCT00807495|156084153|FG000|Overall Study|Adverse Event|6|||
48516379|NCT00807495|156084154|FG001|Overall Study|Adverse Event|3|||
48516380|NCT00807495|156084155|FG002|Overall Study|Adverse Event|1|||
48516381|NCT00807495|156084156|FG003|Overall Study|Adverse Event|1|||
48516382|NCT00807495|156084157|FG004|Overall Study|Adverse Event|2|||
48516383|NCT00807495|156084153|FG000|Overall Study|Withdrawal by Patient|2|||
48516384|NCT00807495|156084154|FG001|Overall Study|Withdrawal by Patient|0|||
48516385|NCT00807495|156084155|FG002|Overall Study|Withdrawal by Patient|1|||
48516386|NCT00807495|156084156|FG003|Overall Study|Withdrawal by Patient|0|||
48516387|NCT00807495|156084157|FG004|Overall Study|Withdrawal by Patient|0|||
48516388|NCT00807495|156084153|FG000|Overall Study|Reason Not Specified|0|||
48516389|NCT00807495|156084154|FG001|Overall Study|Reason Not Specified|3|||
48516390|NCT00807495|156084155|FG002|Overall Study|Reason Not Specified|2|||
48516391|NCT00807495|156084156|FG003|Overall Study|Reason Not Specified|0|||
48516392|NCT00807495|156084157|FG004|Overall Study|Reason Not Specified|3|||
48516393|NCT02704091|156084158|FG000|Overall Study|Adverse Event|4|||
48516394|NCT02704091|156084159|FG001|Overall Study|Adverse Event|3|||
48516395|NCT02704091|156084158|FG000|Overall Study|Protocol Violation|5|||
48516396|NCT02704091|156084159|FG001|Overall Study|Protocol Violation|3|||
48516397|NCT02704091|156084158|FG000|Overall Study|Consent withdrawn|4|||
48516398|NCT02704091|156084159|FG001|Overall Study|Consent withdrawn|4|||
48516399|NCT02704091|156084158|FG000|Overall Study|Lost to Follow-up|13|||
48516400|NCT02704091|156084159|FG001|Overall Study|Lost to Follow-up|5|||
48516401|NCT02704091|156084158|FG000|Overall Study|Other|2|||
48516402|NCT02704091|156084159|FG001|Overall Study|Other|8|||
48516403|NCT00918684|156084161|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
48516404|NCT00918684|156084161|FG000|Treatment Phase|Lack of Efficacy|6|||
48516405|NCT00918684|156084161|FG000|Treatment Phase|Lost to Follow-up|2|||
48516406|NCT00918684|156084161|FG000|Treatment Phase|Physician Decision|8|||
48516407|NCT00918684|156084161|FG000|Treatment Phase|Protocol Violation|1|||
48516408|NCT00918684|156084161|FG000|Treatment Phase|Withdrawal by Subject|8|||
48516409|NCT01051349|156084163|FG000|Overall Study|Adverse Event|88|||
48516410|NCT01051349|156084163|FG000|Overall Study|Consent Withdrawn|54|||
48516411|NCT01051349|156084163|FG000|Overall Study|Investigator Decision|6|||
48516412|NCT01051349|156084163|FG000|Overall Study|Lost to Follow-up|6|||
48516413|NCT01051349|156084163|FG000|Overall Study|Subject non-compliance|7|||
48516414|NCT01051349|156084163|FG000|Overall Study|Reason not Specified|12|||
48516415|NCT02679729|156084165|FG000|Overall Study|Lost to Follow-up|0|||
48516416|NCT02679729|156084166|FG001|Overall Study|Lost to Follow-up|1|||
48516417|NCT02679729|156084167|FG002|Overall Study|Lost to Follow-up|0|||
48516418|NCT02679729|156084168|FG003|Overall Study|Lost to Follow-up|0|||
48516419|NCT02679729|156084169|FG004|Overall Study|Lost to Follow-up|1|||
48516420|NCT02679729|156084170|FG005|Overall Study|Lost to Follow-up|0|||
48516421|NCT02679729|156084171|FG006|Overall Study|Lost to Follow-up|0|||
48516422|NCT02679729|156084172|FG007|Overall Study|Lost to Follow-up|0|||
48516423|NCT02679729|156084173|FG008|Overall Study|Lost to Follow-up|0|||
48516424|NCT02679729|156084165|FG000|Overall Study|Participant decision|0|||
48516425|NCT02679729|156084166|FG001|Overall Study|Participant decision|1|||
48516426|NCT02679729|156084167|FG002|Overall Study|Participant decision|0|||
48516427|NCT02679729|156084168|FG003|Overall Study|Participant decision|0|||
48601113|NCT02718911|156396047|FG007|Overall Study|Death|1|||
48516428|NCT02679729|156084169|FG004|Overall Study|Participant decision|0|||
48516429|NCT02679729|156084170|FG005|Overall Study|Participant decision|0|||
48516430|NCT02679729|156084171|FG006|Overall Study|Participant decision|1|||
48516431|NCT02679729|156084172|FG007|Overall Study|Participant decision|0|||
48516432|NCT02679729|156084173|FG008|Overall Study|Participant decision|0|||
48516433|NCT00958724|156084175|FG000|Overall Study|Disease Progression|6|||
48516434|NCT05604014|156084176|FG000|Overall Study|Lost to Follow-up|13|||
48601114|NCT02718911|156396048|FG008|Overall Study|Death|4|||
48516435|NCT04567329|156084194|FG000|Overall Study|Withdrawal by Subject|5|||
48516436|NCT04567329|156084195|FG001|Overall Study|Withdrawal by Subject|6|||
48516437|NCT04567329|156084194|FG000|Overall Study|Protocol Violation|2|||
48516438|NCT04567329|156084195|FG001|Overall Study|Protocol Violation|3|||
48516439|NCT04567329|156084194|FG000|Overall Study|Discontinued|2|||
48516440|NCT04567329|156084195|FG001|Overall Study|Discontinued|2|||
48516441|NCT04567329|156084194|FG000|Overall Study|Lost to Follow-up|0|||
48516442|NCT04567329|156084195|FG001|Overall Study|Lost to Follow-up|1|||
48516443|NCT04567329|156084194|FG000|Overall Study|Lack of Efficacy|0|||
48516444|NCT04567329|156084195|FG001|Overall Study|Lack of Efficacy|1|||
48516445|NCT04281472|156084198|FG000|Stage A|Lack of Efficacy|8|||
48516446|NCT04281472|156084199|FG001|Stage A|Lack of Efficacy|0|||
48516447|NCT04281472|156084200|FG002|Stage A|Lack of Efficacy|0|||
48516448|NCT04281472|156084198|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
48516449|NCT04281472|156084199|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
48516450|NCT04281472|156084200|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
48516451|NCT04281472|156084198|FG000|Stage A|Adverse Event|20|||
48516452|NCT04281472|156084199|FG001|Stage A|Adverse Event|0|||
48516453|NCT04281472|156084200|FG002|Stage A|Adverse Event|0|||
48516454|NCT04281472|156084198|FG000|Stage A|Death|1|||
48383490|NCT00727649|155600177|FG001|Second Intervention (4-weeks)|Death|0|||
48383491|NCT00727649|155600176|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
48383492|NCT00727649|155600177|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
48383493|NCT00727649|155600176|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
48383494|NCT00727649|155600177|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
48516455|NCT04281472|156084199|FG001|Stage A|Death|0|||
48516456|NCT04281472|156084200|FG002|Stage A|Death|0|||
48516457|NCT04281472|156084198|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
48516458|NCT04281472|156084199|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
48516459|NCT04281472|156084200|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
48516460|NCT04281472|156084198|FG000|Stage A|Lost to Follow-up|2|||
48516461|NCT04281472|156084199|FG001|Stage A|Lost to Follow-up|0|||
48516462|NCT04281472|156084200|FG002|Stage A|Lost to Follow-up|0|||
48516463|NCT04281472|156084198|FG000|Stage A|Non-compliance with study drug|1|||
48516464|NCT04281472|156084199|FG001|Stage A|Non-compliance with study drug|0|||
48516465|NCT04281472|156084200|FG002|Stage A|Non-compliance with study drug|0|||
48516466|NCT04281472|156084198|FG000|Stage A|Physician Decision|1|||
48516467|NCT04281472|156084199|FG001|Stage A|Physician Decision|0|||
48516468|NCT04281472|156084200|FG002|Stage A|Physician Decision|0|||
48516469|NCT04281472|156084198|FG000|Stage A|Prohibited medications|2|||
48516470|NCT04281472|156084199|FG001|Stage A|Prohibited medications|0|||
48516471|NCT04281472|156084200|FG002|Stage A|Prohibited medications|0|||
48516472|NCT04281472|156084198|FG000|Stage A|Withdrawal by Subject|11|||
48516473|NCT04281472|156084199|FG001|Stage A|Withdrawal by Subject|0|||
48516474|NCT04281472|156084200|FG002|Stage A|Withdrawal by Subject|0|||
48516475|NCT04281472|156084198|FG000|Stage A|Other|5|||
48516476|NCT04281472|156084199|FG001|Stage A|Other|0|||
48516477|NCT04281472|156084200|FG002|Stage A|Other|0|||
48516478|NCT04281472|156084198|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
48516479|NCT04281472|156084199|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
48516480|NCT04281472|156084200|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
48516481|NCT04281472|156084198|FG000|Stage B|Adverse Event|0|||
48516482|NCT04281472|156084199|FG001|Stage B|Adverse Event|3|||
48516483|NCT04281472|156084200|FG002|Stage B|Adverse Event|0|||
48516484|NCT04281472|156084198|FG000|Stage B|Death|0|||
48516485|NCT04281472|156084199|FG001|Stage B|Death|0|||
48516486|NCT04281472|156084200|FG002|Stage B|Death|1|||
48516487|NCT04281472|156084198|FG000|Stage B|Lack of Efficacy|0|||
48516488|NCT04281472|156084199|FG001|Stage B|Lack of Efficacy|0|||
48516489|NCT04281472|156084200|FG002|Stage B|Lack of Efficacy|1|||
48516490|NCT04281472|156084198|FG000|Stage B|Lost to Follow-up|0|||
48516491|NCT04281472|156084199|FG001|Stage B|Lost to Follow-up|0|||
48516492|NCT04281472|156084200|FG002|Stage B|Lost to Follow-up|2|||
48516493|NCT04281472|156084198|FG000|Stage B|Prohibited medications|0|||
48823138|NCT04541186|157192317|FG001|Main Study|COVID-19-related Dose Interruption|0|||
48516494|NCT04281472|156084199|FG001|Stage B|Prohibited medications|2|||
48383495|NCT01681628|155600178|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
48383496|NCT01681628|155600179|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
48383497|NCT01681628|155600178|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
48383498|NCT01681628|155600179|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
48516495|NCT04281472|156084200|FG002|Stage B|Prohibited medications|1|||
48516496|NCT04281472|156084198|FG000|Stage B|Protocol Violation|0|||
48516497|NCT04281472|156084199|FG001|Stage B|Protocol Violation|1|||
48516498|NCT04281472|156084200|FG002|Stage B|Protocol Violation|1|||
48516499|NCT04281472|156084198|FG000|Stage B|Sponsor decision|0|||
48516500|NCT04281472|156084199|FG001|Stage B|Sponsor decision|0|||
48516501|NCT04281472|156084200|FG002|Stage B|Sponsor decision|1|||
48516502|NCT04281472|156084198|FG000|Stage B|Withdrawal by Subject|0|||
48516503|NCT04281472|156084199|FG001|Stage B|Withdrawal by Subject|3|||
48516504|NCT04281472|156084200|FG002|Stage B|Withdrawal by Subject|3|||
48516505|NCT04281472|156084198|FG000|Stage B|Other|0|||
48516506|NCT04281472|156084199|FG001|Stage B|Other|3|||
48516507|NCT04281472|156084200|FG002|Stage B|Other|0|||
48516508|NCT02957331|156084201|FG000|Overall Study|Protocol Violation|1|||
48516509|NCT02957331|156084202|FG001|Overall Study|Protocol Violation|0|||
48516510|NCT02426918|156084203|FG000|Overall Study|Adverse Event|2|||
48516511|NCT02426918|156084204|FG001|Overall Study|Adverse Event|2|||
48516512|NCT02426918|156084205|FG002|Overall Study|Adverse Event|0|||
48516513|NCT02426918|156084203|FG000|Overall Study|Physician Decision|1|||
48516514|NCT02426918|156084204|FG001|Overall Study|Physician Decision|1|||
48516515|NCT02426918|156084205|FG002|Overall Study|Physician Decision|1|||
48516516|NCT02426918|156084203|FG000|Overall Study|Withdrawal by Subject|5|||
48516517|NCT02426918|156084204|FG001|Overall Study|Withdrawal by Subject|5|||
48516518|NCT02426918|156084205|FG002|Overall Study|Withdrawal by Subject|4|||
48516519|NCT02426918|156084203|FG000|Overall Study|Other|9|||
48516520|NCT02426918|156084204|FG001|Overall Study|Other|11|||
48516521|NCT02426918|156084205|FG002|Overall Study|Other|9|||
48516522|NCT01496118|156084206|FG000|Overall Study|Disease progression|3|||
48516523|NCT01496118|156084207|FG001|Overall Study|Disease progression|2|||
48516524|NCT01496118|156084208|FG002|Overall Study|Disease progression|3|||
48516525|NCT01496118|156084209|FG003|Overall Study|Disease progression|1|||
48516526|NCT01496118|156084210|FG004|Overall Study|Disease progression|2|||
48516527|NCT01496118|156084211|FG005|Overall Study|Disease progression|2|||
48516528|NCT01496118|156084212|FG006|Overall Study|Disease progression|14|||
48516529|NCT01496118|156084213|FG007|Overall Study|Disease progression|10|||
48516530|NCT01496118|156084206|FG000|Overall Study|Physician Decision|0|||
48516531|NCT01496118|156084207|FG001|Overall Study|Physician Decision|0|||
48516532|NCT01496118|156084208|FG002|Overall Study|Physician Decision|0|||
48516533|NCT01496118|156084209|FG003|Overall Study|Physician Decision|0|||
48516534|NCT01496118|156084210|FG004|Overall Study|Physician Decision|1|||
48516535|NCT01496118|156084211|FG005|Overall Study|Physician Decision|0|||
48516536|NCT01496118|156084212|FG006|Overall Study|Physician Decision|3|||
48516537|NCT01496118|156084213|FG007|Overall Study|Physician Decision|6|||
48516538|NCT01496118|156084206|FG000|Overall Study|Adverse Event|1|||
48516539|NCT01496118|156084207|FG001|Overall Study|Adverse Event|1|||
48516540|NCT01496118|156084208|FG002|Overall Study|Adverse Event|0|||
48516541|NCT01496118|156084209|FG003|Overall Study|Adverse Event|0|||
48516542|NCT01496118|156084210|FG004|Overall Study|Adverse Event|0|||
48516543|NCT01496118|156084211|FG005|Overall Study|Adverse Event|0|||
48516544|NCT01496118|156084212|FG006|Overall Study|Adverse Event|6|||
48516545|NCT01496118|156084213|FG007|Overall Study|Adverse Event|10|||
48516546|NCT01496118|156084206|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
48516547|NCT01496118|156084207|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
48516548|NCT01496118|156084208|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
48516549|NCT01496118|156084209|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
48516550|NCT01496118|156084210|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
48516551|NCT01496118|156084211|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
48516552|NCT01496118|156084212|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
48516553|NCT01496118|156084213|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
48516554|NCT01496118|156084206|FG000|Overall Study|Death|0|||
48516555|NCT01496118|156084207|FG001|Overall Study|Death|0|||
48516556|NCT01496118|156084208|FG002|Overall Study|Death|0|||
48516557|NCT01496118|156084209|FG003|Overall Study|Death|0|||
48516558|NCT01496118|156084210|FG004|Overall Study|Death|0|||
48823139|NCT04541186|157192318|FG002|Main Study|COVID-19-related Dose Interruption|0|||
48516559|NCT01496118|156084211|FG005|Overall Study|Death|0|||
48516560|NCT01496118|156084212|FG006|Overall Study|Death|1|||
48516561|NCT01496118|156084213|FG007|Overall Study|Death|1|||
48516562|NCT01496118|156084206|FG000|Overall Study|Withdrawal by Subject|0|||
48516563|NCT01496118|156084207|FG001|Overall Study|Withdrawal by Subject|0|||
48516564|NCT01496118|156084208|FG002|Overall Study|Withdrawal by Subject|0|||
48823140|NCT04541186|157192319|FG003|Main Study|COVID-19-related Dose Interruption|0|||
48516565|NCT01496118|156084209|FG003|Overall Study|Withdrawal by Subject|2|||
48516566|NCT01496118|156084210|FG004|Overall Study|Withdrawal by Subject|0|||
48516567|NCT01496118|156084211|FG005|Overall Study|Withdrawal by Subject|1|||
48516568|NCT01496118|156084212|FG006|Overall Study|Withdrawal by Subject|6|||
48516569|NCT01496118|156084213|FG007|Overall Study|Withdrawal by Subject|3|||
48516570|NCT02845336|156084214|FG000|Overall Study|Lost to Follow-up|3|||
48516571|NCT02845336|156084215|FG001|Overall Study|Lost to Follow-up|1|||
48516572|NCT02845336|156084214|FG000|Overall Study|Inability to get medication|2|||
48516573|NCT02845336|156084215|FG001|Overall Study|Inability to get medication|0|||
48516574|NCT03488108|156084216|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
48516575|NCT03488108|156084217|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
48516576|NCT03488108|156084216|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
48516577|NCT03488108|156084217|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
48516578|NCT02420353|156084225|FG000|Overall Study|Withdrawal by Subject|0|||
48516579|NCT02420353|156084226|FG001|Overall Study|Withdrawal by Subject|1|||
48516580|NCT00874276|156084227|FG000|Overall Study|Withdrawal by Subject|1|||
48516581|NCT00874276|156084228|FG001|Overall Study|Withdrawal by Subject|1|||
48516582|NCT01943435|156084231|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
48516583|NCT01943435|156084232|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
48516584|NCT01943435|156084233|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
48516585|NCT01943435|156084231|FG000|Intervention Period|Withdrawal by Subject|3|||
48516586|NCT01943435|156084232|FG001|Intervention Period|Withdrawal by Subject|3|||
48516587|NCT01943435|156084233|FG002|Intervention Period|Withdrawal by Subject|4|||
48516588|NCT01943435|156084231|FG000|2 Month Follow up|Lost to Follow-up|2|||
48516589|NCT01943435|156084232|FG001|2 Month Follow up|Lost to Follow-up|3|||
48516590|NCT01943435|156084233|FG002|2 Month Follow up|Lost to Follow-up|0|||
48516591|NCT01943435|156084231|FG000|6 Month Follow up|Lost to Follow-up|12|||
48516592|NCT01943435|156084232|FG001|6 Month Follow up|Lost to Follow-up|7|||
48516593|NCT01943435|156084233|FG002|6 Month Follow up|Lost to Follow-up|15|||
48516594|NCT00295490|156084234|FG000|Overall Study|Protocol Violation|0|||
48516595|NCT00295490|156084235|FG001|Overall Study|Protocol Violation|0|||
48516596|NCT00295490|156084236|FG002|Overall Study|Protocol Violation|3|||
48516597|NCT00295490|156084237|FG003|Overall Study|Protocol Violation|3|||
48516598|NCT00295490|156084234|FG000|Overall Study|Withdrawal by Subject|0|||
48516599|NCT00295490|156084235|FG001|Overall Study|Withdrawal by Subject|2|||
48516600|NCT00295490|156084236|FG002|Overall Study|Withdrawal by Subject|0|||
48516601|NCT00295490|156084237|FG003|Overall Study|Withdrawal by Subject|1|||
48516602|NCT00295490|156084234|FG000|Overall Study|Lost to Follow-up|0|||
48516603|NCT00295490|156084235|FG001|Overall Study|Lost to Follow-up|0|||
48516604|NCT00295490|156084236|FG002|Overall Study|Lost to Follow-up|1|||
48516605|NCT00295490|156084237|FG003|Overall Study|Lost to Follow-up|0|||
48516606|NCT00295490|156084234|FG000|Overall Study|Adverse Event|1|||
48516607|NCT00295490|156084235|FG001|Overall Study|Adverse Event|0|||
48516608|NCT00295490|156084236|FG002|Overall Study|Adverse Event|0|||
48516609|NCT00295490|156084237|FG003|Overall Study|Adverse Event|0|||
48516610|NCT00295490|156084234|FG000|Overall Study|Other|0|||
48516611|NCT00295490|156084235|FG001|Overall Study|Other|2|||
48516612|NCT00295490|156084236|FG002|Overall Study|Other|0|||
48516613|NCT00295490|156084237|FG003|Overall Study|Other|1|||
48516614|NCT01049581|156084242|FG000|Overall Study|Lost to Follow-up|2|||
48516615|NCT01049581|156084243|FG001|Overall Study|Lost to Follow-up|1|||
48516616|NCT05098743|156084246|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
48516617|NCT05098743|156084247|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
48516618|NCT05098743|156084246|FG000|Overall Study|Lost to Follow-up|1|||
48516619|NCT05098743|156084247|FG001|Overall Study|Lost to Follow-up|2|||
48516620|NCT01874535|156084252|FG000|Overall Study|Lost to Follow-up|10|||
48516621|NCT01874535|156084253|FG001|Overall Study|Lost to Follow-up|9|||
48516622|NCT01874535|156084252|FG000|Overall Study|incomplete symptom resolution|45|||
48516623|NCT01874535|156084253|FG001|Overall Study|incomplete symptom resolution|35|||
48516624|NCT03573544|156084255|FG000|Overall Study|Adverse Event|0|||
48516625|NCT03573544|156084256|FG001|Overall Study|Adverse Event|0|||
48516626|NCT03573544|156084257|FG002|Overall Study|Adverse Event|0|||
48516627|NCT03573544|156084258|FG003|Overall Study|Adverse Event|3|||
48516628|NCT03573544|156084259|FG004|Overall Study|Adverse Event|1|||
48516629|NCT03573544|156084260|FG005|Overall Study|Adverse Event|0|||
48516630|NCT03573544|156084261|FG006|Overall Study|Adverse Event|2|||
48516631|NCT03573544|156084262|FG007|Overall Study|Adverse Event|0|||
48516632|NCT03573544|156084255|FG000|Overall Study|Physician Decision|0|||
48516633|NCT03573544|156084256|FG001|Overall Study|Physician Decision|0|||
48516634|NCT03573544|156084257|FG002|Overall Study|Physician Decision|0|||
48516635|NCT03573544|156084258|FG003|Overall Study|Physician Decision|0|||
48516636|NCT03573544|156084259|FG004|Overall Study|Physician Decision|0|||
48516637|NCT03573544|156084260|FG005|Overall Study|Physician Decision|0|||
48516638|NCT03573544|156084261|FG006|Overall Study|Physician Decision|1|||
48516639|NCT03573544|156084262|FG007|Overall Study|Physician Decision|0|||
48516640|NCT03573544|156084255|FG000|Overall Study|Withdrawal by Subject|2|||
48516641|NCT03573544|156084256|FG001|Overall Study|Withdrawal by Subject|0|||
48516642|NCT03573544|156084257|FG002|Overall Study|Withdrawal by Subject|0|||
48516643|NCT03573544|156084258|FG003|Overall Study|Withdrawal by Subject|1|||
48516644|NCT03573544|156084259|FG004|Overall Study|Withdrawal by Subject|1|||
48516645|NCT03573544|156084260|FG005|Overall Study|Withdrawal by Subject|1|||
48516646|NCT03573544|156084261|FG006|Overall Study|Withdrawal by Subject|0|||
48516647|NCT03573544|156084262|FG007|Overall Study|Withdrawal by Subject|1|||
48516648|NCT03573544|156084255|FG000|Overall Study|Disease progression|3|||
48516649|NCT03573544|156084256|FG001|Overall Study|Disease progression|3|||
48516650|NCT03573544|156084257|FG002|Overall Study|Disease progression|6|||
48516651|NCT03573544|156084258|FG003|Overall Study|Disease progression|4|||
48516652|NCT03573544|156084259|FG004|Overall Study|Disease progression|5|||
48516653|NCT03573544|156084260|FG005|Overall Study|Disease progression|7|||
48516654|NCT03573544|156084261|FG006|Overall Study|Disease progression|6|||
48516655|NCT03573544|156084262|FG007|Overall Study|Disease progression|7|||
48516656|NCT03828539|156084263|FG000|Overall Study|Adverse Event|3|||
48516657|NCT03828539|156084264|FG001|Overall Study|Adverse Event|12|||
48516658|NCT03828539|156084263|FG000|Overall Study|Patient's/guardian's decision|3|||
48516659|NCT03828539|156084264|FG001|Overall Study|Patient's/guardian's decision|5|||
48516660|NCT03828539|156084263|FG000|Overall Study|Lost to Follow-up|4|||
48516661|NCT03828539|156084264|FG001|Overall Study|Lost to Follow-up|2|||
48516662|NCT03828539|156084263|FG000|Overall Study|Protocol Violation|3|||
48516663|NCT03828539|156084264|FG001|Overall Study|Protocol Violation|2|||
48516664|NCT03828539|156084263|FG000|Overall Study|Withdrawal of informed consent|2|||
48516665|NCT03828539|156084264|FG001|Overall Study|Withdrawal of informed consent|1|||
48516666|NCT03828539|156084263|FG000|Overall Study|New therapy for study indication|1|||
48516667|NCT03828539|156084264|FG001|Overall Study|New therapy for study indication|0|||
48516668|NCT00227370|156084266|FG000|Overall Study|Withdrawal by Subject|1|||
48516669|NCT00227370|156084267|FG001|Overall Study|Withdrawal by Subject|2|||
48516670|NCT00227370|156084266|FG000|Overall Study|Death|3|||
48516671|NCT00227370|156084267|FG001|Overall Study|Death|4|||
48516672|NCT00227370|156084266|FG000|Overall Study|Adverse Event|6|||
48516673|NCT00227370|156084267|FG001|Overall Study|Adverse Event|11|||
48516674|NCT00227370|156084266|FG000|Overall Study|Physician Decision|9|||
48516675|NCT00227370|156084267|FG001|Overall Study|Physician Decision|6|||
48516676|NCT00227370|156084266|FG000|Overall Study|Other reasons|2|||
48516677|NCT00227370|156084267|FG001|Overall Study|Other reasons|1|||
48516678|NCT03867760|156084268|FG000|Overall Study|Lost to Follow-up|2|||
48516679|NCT03867760|156084269|FG001|Overall Study|Lost to Follow-up|3|||
48516680|NCT03867760|156084268|FG000|Overall Study|Withdrawal by Subject|1|||
48516681|NCT03867760|156084269|FG001|Overall Study|Withdrawal by Subject|2|||
48516682|NCT03867760|156084268|FG000|Overall Study|subject could not meet study logistics|3|||
48516683|NCT03867760|156084269|FG001|Overall Study|subject could not meet study logistics|3|||
48516684|NCT01401062|156084272|FG000|Overall Study|Death|9|||
48516685|NCT01401062|156084273|FG001|Overall Study|Death|7|||
48516686|NCT01401062|156084272|FG000|Overall Study|Physician Decision|1|||
48516687|NCT01401062|156084273|FG001|Overall Study|Physician Decision|0|||
48516688|NCT01401062|156084272|FG000|Overall Study|Withdrawal by Subject|1|||
48516689|NCT01401062|156084273|FG001|Overall Study|Withdrawal by Subject|1|||
48516690|NCT01131260|156084274|FG000|Overall Study|Randomization error|5|||
48516691|NCT01131260|156084275|FG001|Overall Study|Randomization error|1|||
48516692|NCT01131260|156084274|FG000|Overall Study|Declined to continue participation|8|||
48516693|NCT01131260|156084275|FG001|Overall Study|Declined to continue participation|13|||
48516694|NCT01131260|156084274|FG000|Overall Study|Physician Decision|22|||
48383499|NCT01681628|155600178|FG000|19 Months Follow-up|Death|1|||
48383500|NCT01681628|155600179|FG001|19 Months Follow-up|Death|0|||
48383501|NCT01681628|155600178|FG000|19 Months Follow-up|Lost to Follow-up|61|||
48383502|NCT01681628|155600179|FG001|19 Months Follow-up|Lost to Follow-up|43|||
48383503|NCT00659529|155600180|FG000|Overall Study|Withdrawal by Subject|4|||
48383504|NCT00659529|155600180|FG000|Overall Study|Protocol Violation|3|||
48383505|NCT00659529|155600180|FG000|Overall Study|Screen failure|9|||
48383506|NCT00907257|155600182|FG000|Overall Study|Adverse Event|0|||
48383507|NCT00907257|155600183|FG001|Overall Study|Adverse Event|4|||
48383508|NCT00907257|155600182|FG000|Overall Study|Protocol Violation|1|||
48383509|NCT00907257|155600183|FG001|Overall Study|Protocol Violation|2|||
48383510|NCT00907257|155600182|FG000|Overall Study|Lost to Follow-up|3|||
48383511|NCT00907257|155600183|FG001|Overall Study|Lost to Follow-up|3|||
48383512|NCT00907257|155600182|FG000|Overall Study|Withdrawal by Subject|1|||
48383513|NCT00907257|155600183|FG001|Overall Study|Withdrawal by Subject|2|||
48383514|NCT00907257|155600182|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
48383515|NCT00907257|155600183|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
48383516|NCT00907257|155600182|FG000|Overall Study|Moved|1|||
48383517|NCT00907257|155600183|FG001|Overall Study|Moved|0|||
48383518|NCT00907257|155600182|FG000|Overall Study|Personal Reasons|6|||
48383519|NCT00907257|155600183|FG001|Overall Study|Personal Reasons|1|||
48383520|NCT04163900|155600184|FG000|Overall Study|Radiological disease progression|112|||
48383521|NCT04163900|155600185|FG001|Overall Study|Radiological disease progression|127|||
48383522|NCT04163900|155600184|FG000|Overall Study|Study closure|98|||
48730658|NCT04963231|156865864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
48516695|NCT01131260|156084275|FG001|Overall Study|Physician Decision|24|||
48516696|NCT01131260|156084274|FG000|Overall Study|Technical problems|7|||
48516697|NCT01131260|156084275|FG001|Overall Study|Technical problems|6|||
48516698|NCT01131260|156084274|FG000|Overall Study|Staff error|2|||
48516699|NCT01131260|156084275|FG001|Overall Study|Staff error|1|||
48730659|NCT04963231|156865865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
48730660|NCT04963231|156865863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
48383523|NCT04163900|155600185|FG001|Overall Study|Study closure|133|||
48383524|NCT04163900|155600184|FG000|Overall Study|Adverse Event|78|||
48516700|NCT01131260|156084274|FG000|Overall Study|Ineligible|0|||
48516701|NCT01131260|156084275|FG001|Overall Study|Ineligible|2|||
48516702|NCT03555695|156084276|FG000|Overall Study|Withdrawal by Subject|1|||
48516703|NCT03555695|156084276|FG000|Overall Study|Lost to Follow-up|1|||
48516704|NCT03555695|156084276|FG000|Overall Study|appendicitis (unrelated)|1|||
48516705|NCT03555695|156084276|FG000|Overall Study|pre-existing sciatica|1|||
48516706|NCT01426854|156084277|FG000|Overall Study|Adverse Event|1|||
48516707|NCT01426854|156084278|FG001|Overall Study|Adverse Event|5|||
48516708|NCT01426854|156084277|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
48516709|NCT01426854|156084278|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
48516710|NCT01426854|156084277|FG000|Overall Study|Lost to Follow-up|3|||
48516711|NCT01426854|156084278|FG001|Overall Study|Lost to Follow-up|0|||
48516712|NCT01426854|156084277|FG000|Overall Study|Noncompliance|0|||
48516713|NCT01426854|156084278|FG001|Overall Study|Noncompliance|1|||
48516714|NCT01426854|156084277|FG000|Overall Study|Treatment Failure|0|||
48516715|NCT01426854|156084278|FG001|Overall Study|Treatment Failure|16|||
48516716|NCT01426854|156084277|FG000|Overall Study|Protocol Deviation|0|||
48516717|NCT01426854|156084278|FG001|Overall Study|Protocol Deviation|1|||
48516718|NCT01426854|156084277|FG000|Overall Study|Other|3|||
48516719|NCT01426854|156084278|FG001|Overall Study|Other|2|||
48516720|NCT02286466|156084282|FG000|Overall Study|Death|1|||
48516721|NCT02286466|156084283|FG001|Overall Study|Death|3|||
48516722|NCT02286466|156084282|FG000|Overall Study|Withdrawal by Subject|5|||
48516723|NCT02286466|156084283|FG001|Overall Study|Withdrawal by Subject|2|||
48516724|NCT02286466|156084282|FG000|Overall Study|Lost to Follow-up|1|||
48516725|NCT02286466|156084283|FG001|Overall Study|Lost to Follow-up|4|||
48516726|NCT02286466|156084282|FG000|Overall Study|Declined Clinician Assessment|0|||
48516727|NCT02286466|156084283|FG001|Overall Study|Declined Clinician Assessment|1|||
48516728|NCT01139762|156084284|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
48516729|NCT01139762|156084285|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
48516730|NCT01139762|156084286|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
48516731|NCT01139762|156084284|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
48516732|NCT01139762|156084285|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
48516733|NCT01139762|156084286|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
48516734|NCT01139762|156084284|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
48516735|NCT01139762|156084285|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
48516736|NCT01139762|156084286|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
48516737|NCT01139762|156084284|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
48516738|NCT01139762|156084285|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
48516739|NCT01139762|156084286|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
48516740|NCT01139762|156084284|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
48516741|NCT01139762|156084285|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
48516742|NCT01139762|156084286|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
48516743|NCT01139762|156084284|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
48516744|NCT01139762|156084285|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
48516745|NCT01139762|156084286|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
48516746|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
48516747|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
48516748|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
48516749|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Death|0|||
48516750|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Death|1|||
48516751|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Death|1|||
48516752|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
48823141|NCT04541186|157192320|FG004|Main Study|COVID-19-related Dose Interruption|1|||
48516753|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
48516754|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
48516755|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
48383525|NCT04163900|155600185|FG001|Overall Study|Adverse Event|32|||
48823142|NCT04541186|157192316|FG000|Main Study|Randomized in Error Not Treated|0|||
48823143|NCT04541186|157192317|FG001|Main Study|Randomized in Error Not Treated|0|||
48823144|NCT04541186|157192318|FG002|Main Study|Randomized in Error Not Treated|1|||
48823145|NCT04541186|157192319|FG003|Main Study|Randomized in Error Not Treated|0|||
48823146|NCT04541186|157192320|FG004|Main Study|Randomized in Error Not Treated|0|||
48823147|NCT04541186|157192316|FG000|Fibrate Expansion Study|Other than Specified|0|||
48823148|NCT04541186|157192317|FG001|Fibrate Expansion Study|Other than Specified|0|||
48823149|NCT04541186|157192318|FG002|Fibrate Expansion Study|Other than Specified|0|||
48516756|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
48516757|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
48516758|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
48516759|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
48516760|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
48823150|NCT04541186|157192319|FG003|Fibrate Expansion Study|Other than Specified|0|||
48516761|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
48516762|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
48516763|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
48516764|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
48516765|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
48516766|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
48516767|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
48516768|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
48516769|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
48516770|NCT01139762|156084284|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
48516771|NCT01139762|156084285|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
48516772|NCT01139762|156084286|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
48516773|NCT01675596|156084287|FG000|Overall Study|Death|6|||
48516774|NCT01675596|156084287|FG000|Overall Study|Exit with other reason|1|||
48516775|NCT01675596|156084287|FG000|Overall Study|Missed Visit|1|||
48516776|NCT04750239|156084288|FG000|Overall Study|Withdrawal by Subject|2|||
48516777|NCT04750239|156084288|FG000|Overall Study|Trial terminated by sponsor|1|||
48516778|NCT00903877|156084289|FG000|Overall Study|Did not meet study criteria|33|||
48516779|NCT00903877|156084289|FG000|Overall Study|Withdrawal by Subject|3|||
48516780|NCT00903877|156084289|FG000|Overall Study|Adverse Event|2|||
48516781|NCT00903877|156084289|FG000|Overall Study|Lost to Follow-up|1|||
48516782|NCT00903877|156084289|FG000|Overall Study|Participation put on hold|4|||
48516783|NCT00087529|156084291|FG000|Overall Study|Death|1|||
48516784|NCT00087529|156084292|FG001|Overall Study|Death|0|||
48516785|NCT00087529|156084291|FG000|Overall Study|Adverse Event|0|||
48516786|NCT00087529|156084292|FG001|Overall Study|Adverse Event|8|||
48516787|NCT00087529|156084291|FG000|Overall Study|Pregnancy|0|||
48516788|NCT00087529|156084292|FG001|Overall Study|Pregnancy|1|||
48516789|NCT00087529|156084291|FG000|Overall Study|Lost to Follow-up|2|||
48516790|NCT00087529|156084292|FG001|Overall Study|Lost to Follow-up|3|||
48516791|NCT00087529|156084291|FG000|Overall Study|Participant Decision|14|||
48516792|NCT00087529|156084292|FG001|Overall Study|Participant Decision|37|||
48516793|NCT00087529|156084291|FG000|Overall Study|Physician Decision|4|||
48516794|NCT00087529|156084292|FG001|Overall Study|Physician Decision|8|||
48730661|NCT04963231|156865864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
48730662|NCT04963231|156865865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
48730663|NCT04963231|156865863|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
48730664|NCT04963231|156865864|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
48730665|NCT04963231|156865865|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
48730666|NCT04963231|156865863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
48730667|NCT04963231|156865864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
48730668|NCT04963231|156865865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
48730669|NCT04963231|156865863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
48730670|NCT04963231|156865864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
48730671|NCT04963231|156865865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
48730672|NCT04963231|156865863|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
48442076|NCT05590767|155805415|FG000|Overall Study|surgery canceled|1|||
48442077|NCT05590767|155805415|FG000|Overall Study|interscalene brachial block not performed|1|||
48442078|NCT00424294|155805416|FG000|Overall Study|Adverse Event|4|||
48442079|NCT00424294|155805417|FG001|Overall Study|Adverse Event|10|||
48442080|NCT00424294|155805416|FG000|Overall Study|Lack of Efficacy|2|||
48442081|NCT00424294|155805417|FG001|Overall Study|Lack of Efficacy|1|||
48442082|NCT00424294|155805416|FG000|Overall Study|Withdrawal by Subject|1|||
48442083|NCT00424294|155805417|FG001|Overall Study|Withdrawal by Subject|2|||
48442084|NCT00424294|155805416|FG000|Overall Study|Other|0|||
48442085|NCT00424294|155805417|FG001|Overall Study|Other|2|||
48442086|NCT00424294|155805416|FG000|Overall Study|Randomized but not Treated|1|||
48442087|NCT00424294|155805417|FG001|Overall Study|Randomized but not Treated|0|||
48442088|NCT01700985|155805421|FG000|Overall Study|Incarcerated|0|||
48442089|NCT01700985|155805422|FG001|Overall Study|Incarcerated|1|||
48442090|NCT01409993|155805423|FG000|Overall Study|Adverse Event|4|||
48442091|NCT01409993|155805424|FG001|Overall Study|Adverse Event|4|||
48442092|NCT01409993|155805425|FG002|Overall Study|Adverse Event|3|||
48442093|NCT01409993|155805426|FG003|Overall Study|Adverse Event|1|||
48442094|NCT01409993|155805423|FG000|Overall Study|Withdrawal by Subject|0|||
48442095|NCT01409993|155805424|FG001|Overall Study|Withdrawal by Subject|0|||
48442096|NCT01409993|155805425|FG002|Overall Study|Withdrawal by Subject|0|||
48442097|NCT01409993|155805426|FG003|Overall Study|Withdrawal by Subject|4|||
48442098|NCT01409993|155805423|FG000|Overall Study|Lost to Follow-up|0|||
48442099|NCT01409993|155805424|FG001|Overall Study|Lost to Follow-up|1|||
48442100|NCT01409993|155805425|FG002|Overall Study|Lost to Follow-up|0|||
48442101|NCT01409993|155805426|FG003|Overall Study|Lost to Follow-up|0|||
48442102|NCT04533815|155805427|FG000|Overall Study|Adverse Event|2|||
48442103|NCT04533815|155805427|FG000|Overall Study|Site withdrew|5|||
48442104|NCT02677220|155805428|FG000|Overall Study|Adverse Event|1|||
48442105|NCT00965146|155805430|FG000|Overall Study|Death|7|||
48442106|NCT00965146|155805430|FG000|Overall Study|Lost to Follow-up|22|||
48442107|NCT00965146|155805430|FG000|Overall Study|Withdrawal by Subject|17|||
48442108|NCT00965146|155805430|FG000|Overall Study|Unable to return|1|||
48442109|NCT00965146|155805430|FG000|Overall Study|Unwilling to return|11|||
48442110|NCT00965146|155805430|FG000|Overall Study|Intercurrent illness|1|||
48442111|NCT00965146|155805430|FG000|Overall Study|Revision / Removal of Study Implant|6|||
48442112|NCT00965146|155805430|FG000|Overall Study|Overall Study Termination|145|||
48442113|NCT00067470|155805433|FG000|Overall Study|Withdrawal by Subject|0|||
48442114|NCT00067470|155805434|FG001|Overall Study|Withdrawal by Subject|1|||
48442115|NCT01074658|155805435|FG000|Overall Study|No implant attempted|19|||
48442116|NCT01181102|155805436|FG000|Overall Study|Adverse Event|28|||
48442117|NCT01181102|155805437|FG001|Overall Study|Adverse Event|26|||
48442118|NCT01181102|155805436|FG000|Overall Study|Lack of Efficacy|3|||
48442119|NCT01181102|155805437|FG001|Overall Study|Lack of Efficacy|1|||
48442120|NCT01181102|155805436|FG000|Overall Study|Lost to Follow-up|2|||
48442121|NCT01181102|155805437|FG001|Overall Study|Lost to Follow-up|0|||
48442122|NCT01181102|155805436|FG000|Overall Study|Physician Decision|3|||
48442123|NCT01181102|155805437|FG001|Overall Study|Physician Decision|1|||
48442124|NCT01181102|155805436|FG000|Overall Study|Protocol Violation|5|||
48442125|NCT01181102|155805437|FG001|Overall Study|Protocol Violation|6|||
48442126|NCT01181102|155805436|FG000|Overall Study|Withdrawal by Subject|10|||
48442127|NCT01181102|155805437|FG001|Overall Study|Withdrawal by Subject|12|||
48442128|NCT00764478|155805438|FG000|Overall Study|Adverse Event|1|||
48442129|NCT00764478|155805439|FG001|Overall Study|Adverse Event|1|||
48442130|NCT00764478|155805440|FG002|Overall Study|Adverse Event|1|||
48442131|NCT00764478|155805438|FG000|Overall Study|Withdrawal by Subject|7|||
48442132|NCT00764478|155805439|FG001|Overall Study|Withdrawal by Subject|12|||
48442133|NCT00764478|155805440|FG002|Overall Study|Withdrawal by Subject|1|||
48442134|NCT00764478|155805438|FG000|Overall Study|Lost to Follow-up|7|||
48442135|NCT00764478|155805439|FG001|Overall Study|Lost to Follow-up|8|||
48442136|NCT00764478|155805440|FG002|Overall Study|Lost to Follow-up|5|||
48442137|NCT00764478|155805438|FG000|Overall Study|Protocol Violation|0|||
48442138|NCT00764478|155805439|FG001|Overall Study|Protocol Violation|1|||
48442139|NCT00764478|155805440|FG002|Overall Study|Protocol Violation|1|||
48442140|NCT03571256|155805441|FG000|Overall Study|Adverse Event|3|||
48442141|NCT03571256|155805442|FG001|Overall Study|Adverse Event|0|||
48442142|NCT03571256|155805443|FG002|Overall Study|Adverse Event|1|||
48442143|NCT03571256|155805441|FG000|Overall Study|Withdrawal by Subject|3|||
48442144|NCT03571256|155805442|FG001|Overall Study|Withdrawal by Subject|1|||
48442145|NCT03571256|155805443|FG002|Overall Study|Withdrawal by Subject|1|||
48442146|NCT03571256|155805441|FG000|Overall Study|Other than specified|0|||
48442147|NCT03571256|155805442|FG001|Overall Study|Other than specified|1|||
48442148|NCT03571256|155805443|FG002|Overall Study|Other than specified|1|||
48442149|NCT03571256|155805441|FG000|Overall Study|Protocol Violation|0|||
48442150|NCT03571256|155805442|FG001|Overall Study|Protocol Violation|1|||
48442151|NCT03571256|155805443|FG002|Overall Study|Protocol Violation|1|||
48516795|NCT00087529|156084291|FG000|Overall Study|Initiation of Excluded Therapy|0|||
48516796|NCT00087529|156084292|FG001|Overall Study|Initiation of Excluded Therapy|1|||
48516797|NCT00087529|156084291|FG000|Overall Study|Participant Noncompliance|0|||
48516798|NCT00087529|156084292|FG001|Overall Study|Participant Noncompliance|1|||
48516799|NCT00087529|156084291|FG000|Overall Study|Disease Progression|5|||
48516800|NCT00087529|156084292|FG001|Overall Study|Disease Progression|4|||
48516801|NCT00087529|156084291|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
48516802|NCT00087529|156084292|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
48516803|NCT04773600|156084295|FG000|Overall Study|Withdrawal by Subject|15|||
48516804|NCT04773600|156084296|FG001|Overall Study|Withdrawal by Subject|9|||
48516805|NCT04773600|156084295|FG000|Overall Study|Lost to Follow-up|10|||
48516806|NCT04773600|156084296|FG001|Overall Study|Lost to Follow-up|6|||
48516807|NCT04773600|156084295|FG000|Overall Study|Adverse Event|8|||
48730673|NCT04963231|156865864|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
48730674|NCT04963231|156865865|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
48516808|NCT04773600|156084296|FG001|Overall Study|Adverse Event|2|||
48516809|NCT04773600|156084295|FG000|Overall Study|Lack of Efficacy|2|||
48383526|NCT04163900|155600184|FG000|Overall Study|Withdrawal by Subject|37|||
48383527|NCT04163900|155600185|FG001|Overall Study|Withdrawal by Subject|34|||
48383528|NCT04163900|155600184|FG000|Overall Study|Death|29|||
48383529|NCT04163900|155600185|FG001|Overall Study|Death|16|||
48383530|NCT04163900|155600184|FG000|Overall Study|Physician Decision|17|||
48383531|NCT04163900|155600185|FG001|Overall Study|Physician Decision|25|||
48383532|NCT04163900|155600184|FG000|Overall Study|Clinical disease progression|14|||
48730675|NCT03315754|156865866|FG000|Overall Study|COVID-19 complications leading to death|1|||
48730676|NCT03315754|156865866|FG000|Overall Study|insurance coverage issue|1|||
48730677|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Death|1|||
48730678|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Death|1|||
48730679|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Death|0|||
48516810|NCT04773600|156084296|FG001|Overall Study|Lack of Efficacy|3|||
48383533|NCT04163900|155600185|FG001|Overall Study|Clinical disease progression|13|||
48383534|NCT04163900|155600184|FG000|Overall Study|Protocol Violation|3|||
48383535|NCT04163900|155600185|FG001|Overall Study|Protocol Violation|4|||
48383536|NCT04163900|155600184|FG000|Overall Study|Lost to Follow-up|0|||
48383537|NCT04163900|155600185|FG001|Overall Study|Lost to Follow-up|1|||
48383538|NCT04196803|155600186|FG000|Overall Study|Withdrawal by Subject|1|||
48383539|NCT04196803|155600187|FG001|Overall Study|Withdrawal by Subject|3|||
48383540|NCT04196803|155600186|FG000|Overall Study|Adverse Event|4|||
48383541|NCT04196803|155600187|FG001|Overall Study|Adverse Event|2|||
48383542|NCT04196803|155600186|FG000|Overall Study|Lost to Follow-up|0|||
48383543|NCT04196803|155600187|FG001|Overall Study|Lost to Follow-up|1|||
48383544|NCT03422172|155600191|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
48516811|NCT04773600|156084295|FG000|Overall Study|Noncompliance|2|||
48516812|NCT04773600|156084296|FG001|Overall Study|Noncompliance|0|||
48516813|NCT04773600|156084295|FG000|Overall Study|Protocol Violation|2|||
48516814|NCT04773600|156084296|FG001|Overall Study|Protocol Violation|0|||
48516815|NCT04773600|156084295|FG000|Overall Study|Physician Decision|0|||
48516816|NCT04773600|156084296|FG001|Overall Study|Physician Decision|1|||
48383545|NCT03422172|155600191|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
48383546|NCT03422172|155600191|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
48516817|NCT04773600|156084295|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
48516818|NCT04773600|156084296|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
48516819|NCT04773600|156084295|FG000|Overall Study|Emergency Travel Out of Country|1|||
48516820|NCT04773600|156084296|FG001|Overall Study|Emergency Travel Out of Country|0|||
48730680|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Death|0|||
48730681|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
48730682|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
48730683|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
48730684|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
48730685|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
48730686|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
48730687|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
48730688|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
48730689|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
48730690|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
48730691|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
48730692|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
48730693|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
48730694|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
48730695|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
48730696|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
48730697|NCT04612790|156865867|FG000|DB Period (Up to 36 Weeks)|Other|1|||
48730698|NCT04612790|156865868|FG001|DB Period (Up to 36 Weeks)|Other|0|||
48730699|NCT04612790|156865869|FG002|DB Period (Up to 36 Weeks)|Other|0|||
48730700|NCT04612790|156865870|FG003|DB Period (Up to 36 Weeks)|Other|0|||
48383547|NCT04047797|155600192|FG000|Overall Study|Progressive Disease|1|||
48383548|NCT01480284|155600199|FG000|Overall Study|Withdrawal by Subject|2|||
48383549|NCT01480284|155600200|FG001|Overall Study|Withdrawal by Subject|0|||
48516821|NCT02255149|156085994|FG000|Overall Study|Lost to Follow-up|2|||
48516822|NCT02255149|156085994|FG000|Overall Study|Withdrawal by Subject|1|||
48516823|NCT02255149|156085994|FG000|Overall Study|Withdrawal by PI|1|||
48516824|NCT02255149|156085994|FG000|Overall Study|Implant Failure|1|||
48516825|NCT00521586|156085995|FG000|Initial Vaccination (Year 0)|Subject request|8|||
48516826|NCT00521586|156085996|FG001|Initial Vaccination (Year 0)|Subject request|11|||
48516827|NCT00521586|156085995|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
48516828|NCT00521586|156085996|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
48516829|NCT00521586|156085995|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
48516830|NCT00521586|156085996|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
48516831|NCT00521586|156085995|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
48516832|NCT00521586|156085996|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
48516833|NCT00521586|156085995|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
48516834|NCT00521586|156085996|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
48516835|NCT00521586|156085995|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
48516836|NCT00521586|156085996|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
48516837|NCT00521586|156085995|FG000|Initial Vaccination (Year 0)|Death|1|||
48516838|NCT00521586|156085996|FG001|Initial Vaccination (Year 0)|Death|0|||
48516839|NCT00521586|156085995|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
48516840|NCT00521586|156085996|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
48516841|NCT00521586|156085995|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
48516842|NCT00521586|156085996|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
48516843|NCT00521586|156085995|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
48516844|NCT00521586|156085996|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
48516845|NCT00521586|156085995|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
48516846|NCT00521586|156085996|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
48516847|NCT00521586|156085995|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
48516848|NCT00521586|156085996|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
48516849|NCT00521586|156085995|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
48516850|NCT00521586|156085996|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
48516851|NCT00521586|156085995|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
48516852|NCT00521586|156085996|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
48516853|NCT00521586|156085995|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
48516854|NCT00521586|156085996|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
48516855|NCT00521586|156085995|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
48516856|NCT00521586|156085996|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
48516857|NCT00521586|156085995|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
48516858|NCT00521586|156085996|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
48516859|NCT00521586|156085995|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
48516860|NCT00521586|156085996|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
48516861|NCT00521586|156085995|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
48516862|NCT00521586|156085996|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
48516863|NCT00660660|156085997|FG000|Overall Study|Adverse Event|1|||
48516864|NCT00660660|156085998|FG001|Overall Study|Adverse Event|0|||
48516865|NCT00660660|156085997|FG000|Overall Study|Lost to Follow-up|0|||
48516866|NCT00660660|156085998|FG001|Overall Study|Lost to Follow-up|6|||
48516867|NCT00660660|156085997|FG000|Overall Study|Lack of Efficacy|0|||
48516868|NCT00660660|156085998|FG001|Overall Study|Lack of Efficacy|2|||
48516869|NCT00660660|156085997|FG000|Overall Study|Withdrawal by Subject|3|||
48516870|NCT00660660|156085998|FG001|Overall Study|Withdrawal by Subject|0|||
48516871|NCT00660660|156085997|FG000|Overall Study|Incorrect enrollment and other|0|||
48516872|NCT00660660|156085998|FG001|Overall Study|Incorrect enrollment and other|1|||
48516873|NCT00660660|156085997|FG000|Overall Study|New medication after randomization|1|||
48516874|NCT00660660|156085998|FG001|Overall Study|New medication after randomization|0|||
48516875|NCT01253564|156086005|FG000|Overall Study|Disease Progression|22|||
48516876|NCT01253564|156086005|FG000|Overall Study|Withdrawal by Subject|1|||
48516877|NCT01253564|156086005|FG000|Overall Study|Serious Adverse Event|1|||
48516878|NCT02694536|156086006|FG000|Overall Study|Progressive Disease|40|||
48516879|NCT02694536|156086006|FG000|Overall Study|Lost to Follow-up|1|||
48516880|NCT02694536|156086006|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
48516881|NCT02694536|156086006|FG000|Overall Study|Withdrawal by Subject|8|||
48516882|NCT02694536|156086006|FG000|Overall Study|Death|8|||
48516883|NCT02694536|156086006|FG000|Overall Study|Other|22|||
48516884|NCT00059332|156086007|FG000|Overall Study|Withdrawal by Subject|2|||
48516885|NCT00059332|156086008|FG001|Overall Study|Withdrawal by Subject|1|||
48516886|NCT00059332|156086007|FG000|Overall Study|Lost to Follow-up|1|||
48516887|NCT00059332|156086008|FG001|Overall Study|Lost to Follow-up|1|||
48383550|NCT01480284|155600199|FG000|Overall Study|Adverse Event|1|||
48516888|NCT02627963|156086018|FG000|Overall Study|Randomized but not treated|2|||
48516889|NCT02627963|156086019|FG001|Overall Study|Randomized but not treated|6|||
48516890|NCT00663234|156086020|FG000|Overall Study|Not willing to adhere to requirements|1|||
48516891|NCT01266902|156086021|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
48516892|NCT01266902|156086022|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
48516893|NCT01266902|156086023|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
48516894|NCT01266902|156086021|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
48516895|NCT01266902|156086022|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
48516896|NCT01266902|156086023|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
48516897|NCT01266902|156086021|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
48516898|NCT01266902|156086022|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
48516899|NCT01266902|156086023|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
48516900|NCT01266902|156086021|FG000|Period 1 (Main Study)|Adverse Event|3|||
48516901|NCT01266902|156086022|FG001|Period 1 (Main Study)|Adverse Event|11|||
48516902|NCT01266902|156086023|FG002|Period 1 (Main Study)|Adverse Event|0|||
48516903|NCT01266902|156086021|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
48516904|NCT01266902|156086022|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
48823151|NCT04541186|157192320|FG004|Fibrate Expansion Study|Other than Specified|1|||
48823152|NCT03836664|157192335|FG000|Overall Study|Didn't complete forms and lost drug|3|||
48823153|NCT03836664|157192336|FG001|Overall Study|Didn't complete forms and lost drug|3|||
48823154|NCT01427907|157192338|FG000|Overall Study|Withdrawal by Subject|3|||
48823155|NCT01427907|157192339|FG001|Overall Study|Withdrawal by Subject|4|||
48823156|NCT04011384|157192344|FG000|Overall Study|Withdrawal by Subject|2|||
48823157|NCT04011384|157192345|FG001|Overall Study|Withdrawal by Subject|0|||
48823158|NCT01686932|157192346|FG000|Period 1|Adverse Event|1|||
48823159|NCT01686932|157192347|FG001|Period 1|Adverse Event|1|||
48823160|NCT00463151|157192348|FG000|Overall Study|Adverse Event|0|||
48516905|NCT01266902|156086023|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
48516906|NCT01266902|156086021|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
48516907|NCT01266902|156086022|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
48823161|NCT00463151|157192349|FG001|Overall Study|Adverse Event|0|||
48823162|NCT00463151|157192350|FG002|Overall Study|Adverse Event|1|||
48516908|NCT01266902|156086023|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
48516909|NCT01266902|156086021|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
48516910|NCT01266902|156086022|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
48516911|NCT01266902|156086023|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
48516912|NCT01266902|156086021|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
48516913|NCT01266902|156086022|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
48516914|NCT01266902|156086023|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
48516915|NCT01266902|156086021|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
48516916|NCT01266902|156086022|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
48516917|NCT01266902|156086023|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
48516918|NCT01266902|156086021|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
48516919|NCT01266902|156086022|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
48516920|NCT01266902|156086023|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
48516921|NCT05562011|156086028|FG000|Overall Study|Withdrawal by Subject|3|||
48516922|NCT05562011|156086028|FG000|Overall Study|Lost to Follow-up|1|||
48516923|NCT05562011|156086028|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
48516924|NCT05562011|156086028|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
48516925|NCT05562011|156086028|FG000|Overall Study|Device malfunction|13|||
48516926|NCT01186458|156086034|FG000|Overall Study|Adverse Event|1|||
48516927|NCT01945580|156086037|FG000|Overall Study|Withdrawal by Subject|13|||
48516928|NCT01945580|156086038|FG001|Overall Study|Withdrawal by Subject|35|||
48516929|NCT01945580|156086037|FG000|Overall Study|Physician Decision|3|||
48516930|NCT01945580|156086038|FG001|Overall Study|Physician Decision|2|||
48516931|NCT01945580|156086037|FG000|Overall Study|Lost to Follow-up|26|||
48516932|NCT01945580|156086038|FG001|Overall Study|Lost to Follow-up|39|||
48516933|NCT01945580|156086037|FG000|Overall Study|Death|7|||
48516934|NCT01945580|156086038|FG001|Overall Study|Death|2|||
48516935|NCT01945580|156086037|FG000|Overall Study|Patient moved out of state|0|||
48516936|NCT01945580|156086038|FG001|Overall Study|Patient moved out of state|1|||
48823163|NCT00463151|157192351|FG003|Overall Study|Adverse Event|0|||
48516937|NCT01945580|156086037|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
48516938|NCT01945580|156086038|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
48516939|NCT01945580|156086037|FG000|Overall Study|Family illness - unable to return|0|||
48516940|NCT01945580|156086038|FG001|Overall Study|Family illness - unable to return|1|||
48601115|NCT02718911|156396049|FG009|Overall Study|Death|3|||
48823164|NCT00463151|157192348|FG000|Overall Study|Lack of Efficacy|2|||
48823165|NCT00463151|157192349|FG001|Overall Study|Lack of Efficacy|5|||
48823166|NCT00463151|157192350|FG002|Overall Study|Lack of Efficacy|2|||
48516941|NCT01945580|156086037|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
48516942|NCT01945580|156086038|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
48516943|NCT01945580|156086037|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
48516944|NCT01945580|156086038|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
48516945|NCT01945580|156086037|FG000|Overall Study|Noncompliance with 36 month visit|1|||
48516946|NCT01945580|156086038|FG001|Overall Study|Noncompliance with 36 month visit|0|||
48516947|NCT01945580|156086037|FG000|Overall Study|The patient moved.|1|||
48516948|NCT01945580|156086038|FG001|Overall Study|The patient moved.|0|||
48516949|NCT01945580|156086037|FG000|Overall Study|No data available|0|||
48516950|NCT01945580|156086038|FG001|Overall Study|No data available|2|||
48516951|NCT02933060|156086039|FG000|Overall Study|Withdrawal by Subject|0|||
48516952|NCT02933060|156086040|FG001|Overall Study|Withdrawal by Subject|1|||
48516953|NCT00748566|156086043|FG000|Overall Study|Adverse Event|49|||
48516954|NCT00748566|156086043|FG000|Overall Study|Death|1|||
48516955|NCT00748566|156086043|FG000|Overall Study|Lack of Efficacy|12|||
48516956|NCT00748566|156086043|FG000|Overall Study|Lost to Follow-up|1|||
48516957|NCT00748566|156086043|FG000|Overall Study|Protocol Violation|13|||
48516958|NCT00748566|156086043|FG000|Overall Study|Withdrawal by Subject|22|||
48516959|NCT00748566|156086043|FG000|Overall Study|Study terminated by sponsor|5|||
48516960|NCT00748566|156086043|FG000|Overall Study|Other|9|||
48516961|NCT05034874|156086044|FG000|Overall Study|Withdrawal by Subject|6|||
48516962|NCT05034874|156086045|FG001|Overall Study|Withdrawal by Subject|6|||
48516963|NCT05034874|156086044|FG000|Overall Study|Lost to Follow-up|18|||
48516964|NCT05034874|156086045|FG001|Overall Study|Lost to Follow-up|8|||
48516965|NCT05034874|156086044|FG000|Overall Study|Physician Decision|0|||
48516966|NCT05034874|156086045|FG001|Overall Study|Physician Decision|1|||
48516967|NCT05034874|156086044|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
48516968|NCT05034874|156086045|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
48516969|NCT00989950|156086050|FG000|Randomized Phase|Protocol Violation|1|||
48516970|NCT00989950|156086051|FG001|Randomized Phase|Protocol Violation|0|||
48516971|NCT00989950|156086052|FG002|Randomized Phase|Protocol Violation|0|||
48516972|NCT00989950|156086053|FG003|Randomized Phase|Protocol Violation|0|||
48516973|NCT00989950|156086050|FG000|Randomized Phase|Adverse Event|0|||
48516974|NCT00989950|156086051|FG001|Randomized Phase|Adverse Event|1|||
48516975|NCT00989950|156086052|FG002|Randomized Phase|Adverse Event|0|||
48516976|NCT00989950|156086053|FG003|Randomized Phase|Adverse Event|0|||
48516977|NCT00101439|156086054|FG000|Period 2|Withdrawal by Subject|0|||
48516978|NCT00101439|156086055|FG001|Period 2|Withdrawal by Subject|2|||
48516979|NCT00840658|156086064|FG000|Overall Study|Death|2|||
48516980|NCT00840658|156086065|FG001|Overall Study|Death|2|||
48516981|NCT00840658|156086066|FG002|Overall Study|Death|3|||
48516982|NCT00840658|156086067|FG003|Overall Study|Death|3|||
48516983|NCT00840658|156086064|FG000|Overall Study|Lost to Follow-up|3|||
48516984|NCT00840658|156086065|FG001|Overall Study|Lost to Follow-up|1|||
48516985|NCT00840658|156086066|FG002|Overall Study|Lost to Follow-up|2|||
48516986|NCT00840658|156086067|FG003|Overall Study|Lost to Follow-up|1|||
48516987|NCT01867658|156086068|FG000|Overall Study|Withdrawal by Subject|6|||
48516988|NCT01867658|156086068|FG000|Overall Study|Death|2|||
48516989|NCT01867658|156086068|FG000|Overall Study|Subject could not be contacted|1|||
48516990|NCT05278858|156086069|FG000|Overall Study|Withdrawal by Subject|1|||
48516991|NCT03101358|156086070|FG000|Overall Study|Non-compliance with study schedule|1|||
48516992|NCT03101358|156086071|FG001|Overall Study|Non-compliance with study schedule|0|||
48516993|NCT03101358|156086072|FG002|Overall Study|Non-compliance with study schedule|0|||
48516994|NCT03101358|156086073|FG003|Overall Study|Non-compliance with study schedule|1|||
48516995|NCT03101358|156086070|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
48516996|NCT03101358|156086071|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
48516997|NCT03101358|156086072|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
48516998|NCT03101358|156086073|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
48516999|NCT03101358|156086070|FG000|Overall Study|Physician Decision|1|||
48517000|NCT03101358|156086071|FG001|Overall Study|Physician Decision|0|||
48517001|NCT03101358|156086072|FG002|Overall Study|Physician Decision|0|||
48517002|NCT03101358|156086073|FG003|Overall Study|Physician Decision|3|||
48517003|NCT03101358|156086070|FG000|Overall Study|Adverse Event|0|||
48517004|NCT03101358|156086071|FG001|Overall Study|Adverse Event|0|||
48517005|NCT03101358|156086072|FG002|Overall Study|Adverse Event|1|||
48517006|NCT03101358|156086073|FG003|Overall Study|Adverse Event|0|||
48517007|NCT03101358|156086070|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
48517008|NCT03101358|156086071|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
48517009|NCT03101358|156086072|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
48517010|NCT03101358|156086073|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
48517011|NCT03101358|156086070|FG000|Overall Study|Lost to Follow-up|1|||
48517012|NCT03101358|156086071|FG001|Overall Study|Lost to Follow-up|0|||
48517013|NCT03101358|156086072|FG002|Overall Study|Lost to Follow-up|0|||
48517014|NCT03101358|156086073|FG003|Overall Study|Lost to Follow-up|1|||
48517015|NCT00474058|156086074|FG000|Overall Study|Adverse Event|11|||
48517016|NCT00474058|156086075|FG001|Overall Study|Adverse Event|6|||
48517017|NCT00474058|156086074|FG000|Overall Study|Lack of Efficacy|0|||
48517018|NCT00474058|156086075|FG001|Overall Study|Lack of Efficacy|4|||
48517019|NCT00474058|156086074|FG000|Overall Study|Withdrawal by Subject|11|||
48517020|NCT00474058|156086075|FG001|Overall Study|Withdrawal by Subject|7|||
48517021|NCT00474058|156086074|FG000|Overall Study|Other|2|||
48517022|NCT00474058|156086075|FG001|Overall Study|Other|0|||
48517023|NCT02640235|156086078|FG000|Overall Study|Withdrawal by Subject|7|||
48517024|NCT02640235|156086079|FG001|Overall Study|Withdrawal by Subject|6|||
48517025|NCT02640235|156086078|FG000|Overall Study|Lost to Follow-up|4|||
48517026|NCT02640235|156086079|FG001|Overall Study|Lost to Follow-up|3|||
48517027|NCT02640235|156086078|FG000|Overall Study|Death|2|||
48517028|NCT02640235|156086079|FG001|Overall Study|Death|3|||
48517029|NCT02640235|156086078|FG000|Overall Study|Other|1|||
48517030|NCT02640235|156086079|FG001|Overall Study|Other|2|||
48517031|NCT00624286|156086084|FG000|Overall Study|Protocol Deviation|7|||
48517032|NCT00624286|156086085|FG001|Overall Study|Protocol Deviation|9|||
48517033|NCT00624286|156086084|FG000|Overall Study|Adverse Event|6|||
48517034|NCT00624286|156086085|FG001|Overall Study|Adverse Event|3|||
48517035|NCT00624286|156086084|FG000|Overall Study|Withdrawal by Subject|5|||
48517036|NCT00624286|156086085|FG001|Overall Study|Withdrawal by Subject|4|||
48517037|NCT00624286|156086084|FG000|Overall Study|Lost to Follow-up|3|||
48517038|NCT00624286|156086085|FG001|Overall Study|Lost to Follow-up|2|||
48517039|NCT00624286|156086084|FG000|Overall Study|Administrative problems|3|||
48517040|NCT00624286|156086085|FG001|Overall Study|Administrative problems|0|||
48517041|NCT00624286|156086084|FG000|Overall Study|Lack of Efficacy|1|||
48517042|NCT00624286|156086085|FG001|Overall Study|Lack of Efficacy|6|||
48383551|NCT01480284|155600200|FG001|Overall Study|Adverse Event|0|||
48383552|NCT01480284|155600199|FG000|Overall Study|Study closed/terminated|3|||
48383553|NCT01480284|155600200|FG001|Overall Study|Study closed/terminated|0|||
48383554|NCT01480284|155600199|FG000|Overall Study|Lost to Follow-up|1|||
48383555|NCT01480284|155600200|FG001|Overall Study|Lost to Follow-up|0|||
48383556|NCT01480284|155600199|FG000|Overall Study|Physician Decision|1|||
48383557|NCT01480284|155600200|FG001|Overall Study|Physician Decision|0|||
48383558|NCT00066742|155600201|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
48383559|NCT00066742|155600201|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
48383560|NCT00066742|155600201|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
48383561|NCT00066742|155600201|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
48383562|NCT00066742|155600201|FG000|Induction Chemoradiotherapy|Ineligible|3|||
48383563|NCT00066742|155600201|FG000|Consolidation Chemotherapy|not protocol specified|1|||
48517043|NCT00624286|156086084|FG000|Overall Study|Not stated|0|||
48517044|NCT00624286|156086085|FG001|Overall Study|Not stated|1|||
48517045|NCT00624286|156086084|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48517046|NCT00624286|156086085|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48517047|NCT00624286|156086084|FG000|Overall Study|Death|0|||
48517048|NCT00624286|156086085|FG001|Overall Study|Death|1|||
48517049|NCT01993186|156086086|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
48517050|NCT01993186|156086087|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
48517051|NCT01993186|156086086|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
48517052|NCT01993186|156086087|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
48517053|NCT01993186|156086086|FG000|Open-Label Extension Period|Other, Not Specified|0|||
48517054|NCT01993186|156086087|FG001|Open-Label Extension Period|Other, Not Specified|1|||
48517055|NCT01993186|156086086|FG000|Open-Label Extension Period|Adverse Event|1|||
48517056|NCT01993186|156086087|FG001|Open-Label Extension Period|Adverse Event|0|||
48517057|NCT01993186|156086086|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
48517058|NCT01993186|156086087|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
48517059|NCT01993186|156086086|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
48517060|NCT01993186|156086087|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
48517061|NCT01993186|156086086|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
48517062|NCT01993186|156086087|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
48517063|NCT00841659|156086095|FG000|Washout: 2 Weeks|Protocol Violation|1|||
48517064|NCT00841659|156086096|FG001|Washout: 2 Weeks|Protocol Violation|0|||
48517065|NCT04277507|156086101|FG000|Overall Study|Lost to Follow-up|17|||
48517066|NCT04277507|156086101|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
48517067|NCT04277507|156086101|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
48517068|NCT04277507|156086101|FG000|Overall Study|Withdrawal by Subject|3|||
48517069|NCT04277507|156086101|FG000|Overall Study|Death due to COVID-19|1|||
48383564|NCT00066742|155600201|FG000|Consolidation Chemotherapy|Ineligible|2|||
48383565|NCT00832117|155600203|FG000|Overall Study|Death|1|||
48383566|NCT00832117|155600203|FG000|Overall Study|Disease Progression|11|||
48517070|NCT04277507|156086101|FG000|Overall Study|Data missing for full evaluation|5|||
48383567|NCT03374995|155600204|FG000|Overall Study|Withdrawal by Subject|0|||
48517071|NCT02054715|156086102|FG000|Baseline/Follow-up 1|Refused|1|||
48517072|NCT02054715|156086103|FG001|Baseline/Follow-up 1|Refused|3|||
48517073|NCT02054715|156086102|FG000|Baseline/Follow-up 1|Medical|0|||
48517074|NCT02054715|156086103|FG001|Baseline/Follow-up 1|Medical|1|||
48517075|NCT02054715|156086102|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
48517076|NCT02054715|156086103|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
48517077|NCT02054715|156086102|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
48517078|NCT02054715|156086103|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
48517079|NCT02054715|156086102|FG000|Baseline/Follow-up 1|No Reason|0|||
48517080|NCT02054715|156086103|FG001|Baseline/Follow-up 1|No Reason|1|||
48517081|NCT02054715|156086102|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
48517082|NCT02054715|156086103|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
48517083|NCT02054715|156086102|FG000|Baseline/Follow-up 1|Ineligible|3|||
48517084|NCT02054715|156086103|FG001|Baseline/Follow-up 1|Ineligible|0|||
48517085|NCT02054715|156086102|FG000|Baseline/Follow-up 1|Hospitalization|1|||
48517086|NCT02054715|156086103|FG001|Baseline/Follow-up 1|Hospitalization|0|||
48517087|NCT02054715|156086102|FG000|Baseline/Follow-up 1|Changed Mind|1|||
48517088|NCT02054715|156086103|FG001|Baseline/Follow-up 1|Changed Mind|0|||
48517089|NCT02054715|156086102|FG000|Follow-up 2|Lost to Followup|3|||
48517090|NCT02054715|156086103|FG001|Follow-up 2|Lost to Followup|1|||
48517091|NCT02054715|156086102|FG000|Follow-up 2|Refused|3|||
48517092|NCT02054715|156086103|FG001|Follow-up 2|Refused|2|||
48517093|NCT02054715|156086102|FG000|Follow-up 2|Followup Not Completed|3|||
48517094|NCT02054715|156086103|FG001|Follow-up 2|Followup Not Completed|4|||
48517095|NCT02054715|156086102|FG000|Follow-up 2|Ineligible|4|||
48517096|NCT02054715|156086103|FG001|Follow-up 2|Ineligible|5|||
48517097|NCT02054715|156086102|FG000|Follow-up 2|Death|3|||
48517098|NCT02054715|156086103|FG001|Follow-up 2|Death|3|||
48517099|NCT02054715|156086102|FG000|Follow-up 2|Hospitalization|0|||
48517100|NCT02054715|156086103|FG001|Follow-up 2|Hospitalization|2|||
48517101|NCT02054715|156086102|FG000|Follow-up 2|Changed MD/Facility|0|||
48517102|NCT02054715|156086103|FG001|Follow-up 2|Changed MD/Facility|1|||
48823167|NCT00463151|157192351|FG003|Overall Study|Lack of Efficacy|5|||
48823168|NCT00463151|157192348|FG000|Overall Study|Protocol Violation|0|||
48823169|NCT00463151|157192349|FG001|Overall Study|Protocol Violation|0|||
48823170|NCT00463151|157192350|FG002|Overall Study|Protocol Violation|0|||
48823171|NCT00463151|157192351|FG003|Overall Study|Protocol Violation|1|||
48823172|NCT00463151|157192348|FG000|Overall Study|Withdrawal by Subject|0|||
48823173|NCT00463151|157192349|FG001|Overall Study|Withdrawal by Subject|0|||
48823174|NCT00463151|157192350|FG002|Overall Study|Withdrawal by Subject|0|||
48517103|NCT02054715|156086102|FG000|Follow-up 2|Changed Mind|0|||
48517104|NCT02054715|156086103|FG001|Follow-up 2|Changed Mind|1|||
48517105|NCT02054715|156086102|FG000|Follow-up 2|No Reason|2|||
48517106|NCT02054715|156086103|FG001|Follow-up 2|No Reason|0|||
48517107|NCT02054715|156086102|FG000|Follow-up 2|Treatment Change or Delay|1|||
48517108|NCT02054715|156086103|FG001|Follow-up 2|Treatment Change or Delay|0|||
48517109|NCT04608448|156086106|FG000|Overall Study|Withdrawal by Subject|1|||
48517110|NCT04608448|156086106|FG000|Overall Study|Adverse Event|1|||
48517111|NCT00863330|156086107|FG000|Overall Study|study terminated early due to administra|6|||
48517112|NCT01297504|156086108|FG000|Overall Study|Invalid Consent|1|||
48517113|NCT01297504|156086108|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
48517114|NCT01297504|156086108|FG000|Overall Study|No Study Visits|4|||
48517115|NCT01297504|156086108|FG000|Overall Study|Death|3|||
48517116|NCT01297504|156086108|FG000|Overall Study|Lost to Follow-up|43|||
48517117|NCT01297504|156086108|FG000|Overall Study|Withdrawal by Subject|9|||
48517118|NCT01297504|156086108|FG000|Overall Study|Site Closure|3|||
48517119|NCT01297504|156086108|FG000|Overall Study|Protocol Violation|3|||
48517120|NCT00323258|156086111|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
48517121|NCT00323258|156086112|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
48517122|NCT00323258|156086111|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
48517123|NCT00323258|156086112|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
48517124|NCT00323258|156086111|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
48517125|NCT00323258|156086112|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
48517126|NCT00323258|156086111|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
48517127|NCT00323258|156086112|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
48517128|NCT00323258|156086111|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
48517129|NCT00323258|156086112|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
48517130|NCT00323258|156086111|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
48517131|NCT00323258|156086112|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
48517132|NCT00323258|156086111|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
48517133|NCT00323258|156086112|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
48517134|NCT01075516|156086113|FG000|Overall Study|Death|5|||
48517135|NCT01075516|156086114|FG001|Overall Study|Death|9|||
48517136|NCT01075516|156086113|FG000|Overall Study|Lost to Follow-up|10|||
48823175|NCT00463151|157192351|FG003|Overall Study|Withdrawal by Subject|1|||
48823176|NCT01628874|157192352|FG000|Overall Study|Physician Decision|1|||
48517137|NCT01075516|156086114|FG001|Overall Study|Lost to Follow-up|2|||
48517138|NCT01075516|156086113|FG000|Overall Study|Withdrawal by Subject|3|||
48517139|NCT01075516|156086114|FG001|Overall Study|Withdrawal by Subject|5|||
48517140|NCT00654186|156086122|FG000|Overall Study|Withdrawal by Subject|5|||
48517141|NCT02252016|156086123|FG000|Overall Study|Lost to Follow-up|2|||
48517142|NCT02252016|156086124|FG001|Overall Study|Lost to Follow-up|1|||
48517143|NCT02252016|156086123|FG000|Overall Study|Physician Decision|1|||
48517144|NCT02252016|156086124|FG001|Overall Study|Physician Decision|0|||
48517145|NCT02252016|156086123|FG000|Overall Study|Withdrawal by Subject|0|||
48517146|NCT02252016|156086124|FG001|Overall Study|Withdrawal by Subject|2|||
48517147|NCT03885934|156086125|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
48517148|NCT03885934|156086126|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
48517149|NCT03885934|156086127|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
48517150|NCT03885934|156086128|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
48517151|NCT03885934|156086129|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
48517152|NCT03885934|156086130|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
48517153|NCT00406393|156086131|FG000|Overall Study|Did not undergo transplantation|2|||
48517154|NCT00406393|156086132|FG001|Overall Study|Did not undergo transplantation|1|||
48517155|NCT04060251|156086133|FG000|Overall Study|Study terminated due to low enrollment.|7|||
48517156|NCT04060251|156086134|FG001|Overall Study|Study terminated due to low enrollment.|5|||
48517157|NCT04060251|156086135|FG002|Overall Study|Study terminated due to low enrollment.|7|||
48517158|NCT04060251|156086133|FG000|Overall Study|Adverse Event|1|||
48517159|NCT04060251|156086134|FG001|Overall Study|Adverse Event|1|||
48517160|NCT04060251|156086135|FG002|Overall Study|Adverse Event|0|||
48517161|NCT00487435|156086136|FG000|Overall Study|Adverse Event|146|||
48517162|NCT00487435|156086136|FG000|Overall Study|Death|2|||
48517163|NCT00487435|156086136|FG000|Overall Study|Lack of Efficacy|33|||
48517164|NCT00487435|156086136|FG000|Overall Study|Lost to Follow-up|54|||
48442152|NCT02247401|155805446|FG000|Overall Study|Adverse Event|1|||
48442153|NCT02247401|155805447|FG001|Overall Study|Adverse Event|0|||
48442154|NCT02247401|155805448|FG002|Overall Study|Adverse Event|0|||
48442155|NCT02247401|155805446|FG000|Overall Study|Withdrawal by Subject|4|||
48442156|NCT02247401|155805447|FG001|Overall Study|Withdrawal by Subject|1|||
48442157|NCT02247401|155805448|FG002|Overall Study|Withdrawal by Subject|1|||
48442158|NCT02247401|155805446|FG000|Overall Study|Lost to Follow-up|1|||
48442159|NCT02247401|155805447|FG001|Overall Study|Lost to Follow-up|1|||
48442160|NCT02247401|155805448|FG002|Overall Study|Lost to Follow-up|1|||
48442161|NCT03498287|155805449|FG000|Overall Study|Withdrawal by Subject|3|||
48442162|NCT03498287|155805450|FG001|Overall Study|Withdrawal by Subject|0|||
48442163|NCT03498287|155805449|FG000|Overall Study|Protocol Violation|0|||
48442164|NCT03498287|155805450|FG001|Overall Study|Protocol Violation|4|||
48442165|NCT03498287|155805449|FG000|Overall Study|Adverse Event|0|||
48442166|NCT03498287|155805450|FG001|Overall Study|Adverse Event|1|||
48442167|NCT01244191|155805453|FG000|Overall Study|Progressive disease|295|||
48442168|NCT01244191|155805454|FG001|Overall Study|Progressive disease|350|||
48442169|NCT01244191|155805453|FG000|Overall Study|Clinical disease progression|54|||
48442170|NCT01244191|155805454|FG001|Overall Study|Clinical disease progression|36|||
48442171|NCT01244191|155805453|FG000|Overall Study|Adverse Event|65|||
48442172|NCT01244191|155805454|FG001|Overall Study|Adverse Event|48|||
48442173|NCT01244191|155805453|FG000|Overall Study|Death|22|||
48442174|NCT01244191|155805454|FG001|Overall Study|Death|29|||
48442175|NCT01244191|155805453|FG000|Overall Study|Lost to Follow-up|0|||
48442176|NCT01244191|155805454|FG001|Overall Study|Lost to Follow-up|2|||
48442177|NCT01244191|155805453|FG000|Overall Study|Protocol Violation|1|||
48442178|NCT01244191|155805454|FG001|Overall Study|Protocol Violation|2|||
48442179|NCT01244191|155805453|FG000|Overall Study|Withdrawal by Subject|31|||
48442180|NCT01244191|155805454|FG001|Overall Study|Withdrawal by Subject|23|||
48442181|NCT01244191|155805453|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
48442182|NCT01244191|155805454|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
48442183|NCT04142216|155805456|FG000|Overall Study|Hospitalization|0|||
48442184|NCT04142216|155805457|FG001|Overall Study|Hospitalization|2|||
48442185|NCT04142216|155805456|FG000|Overall Study|Death|3|||
48442186|NCT04142216|155805457|FG001|Overall Study|Death|1|||
48442187|NCT04142216|155805456|FG000|Overall Study|Referral to another hemodialysis unit|3|||
48442188|NCT04142216|155805457|FG001|Overall Study|Referral to another hemodialysis unit|2|||
48442189|NCT04142216|155805456|FG000|Overall Study|Use of clove|0|||
48442190|NCT04142216|155805457|FG001|Overall Study|Use of clove|1|||
48442191|NCT01117012|155805458|FG000|Overall Study|Adverse Event|0|||
48442192|NCT01117012|155805459|FG001|Overall Study|Adverse Event|1|||
48442193|NCT01117012|155805458|FG000|Overall Study|Death|1|||
48442194|NCT01117012|155805459|FG001|Overall Study|Death|1|||
48442195|NCT01117012|155805458|FG000|Overall Study|Withdrawal by Subject|3|||
48442196|NCT01117012|155805459|FG001|Overall Study|Withdrawal by Subject|0|||
48442197|NCT01117012|155805458|FG000|Overall Study|Undefined|4|||
48442198|NCT01117012|155805459|FG001|Overall Study|Undefined|3|||
48442199|NCT02726113|155805467|FG000|Total Enrollment|Physician Decision|0|||
48383568|NCT03374995|155600205|FG001|Overall Study|Withdrawal by Subject|1|||
48383569|NCT01383096|155600206|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
48383570|NCT01383096|155600207|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
48383571|NCT01383096|155600208|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
48383572|NCT01383096|155600206|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
48383573|NCT01383096|155600207|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
48383574|NCT01383096|155600208|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
48383575|NCT01383096|155600206|FG000|Third Intervention (8 Days)|Elevated AST|0|||
48383576|NCT01383096|155600207|FG001|Third Intervention (8 Days)|Elevated AST|1|||
48383577|NCT01383096|155600208|FG002|Third Intervention (8 Days)|Elevated AST|0|||
48383578|NCT01383096|155600206|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
48383579|NCT01383096|155600207|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
48383580|NCT01383096|155600208|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
48383581|NCT01383096|155600206|FG000|Third Intervention (8 Days)|Adverse Event|1|||
48383582|NCT01383096|155600207|FG001|Third Intervention (8 Days)|Adverse Event|0|||
48383583|NCT01383096|155600208|FG002|Third Intervention (8 Days)|Adverse Event|0|||
48383584|NCT01383096|155600206|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
48383585|NCT01383096|155600207|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
48383586|NCT01383096|155600208|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
48383587|NCT01383096|155600206|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
48383588|NCT01383096|155600207|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
48383589|NCT01383096|155600208|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
48383590|NCT01383096|155600206|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
48383591|NCT01383096|155600207|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
48383592|NCT01383096|155600208|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
48383593|NCT01383096|155600206|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
48383594|NCT01383096|155600207|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
48383595|NCT01383096|155600208|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
48383596|NCT01383096|155600206|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
48383597|NCT01383096|155600207|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
48383598|NCT01383096|155600208|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
48383599|NCT01383096|155600206|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
48383600|NCT01383096|155600207|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
48383601|NCT01383096|155600208|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
48383602|NCT01186939|155600214|FG000|Overall Study|Death|7|||
48383603|NCT01186939|155600214|FG000|Overall Study|Withdrawal by Subject|2|||
48383604|NCT01186939|155600214|FG000|Overall Study|No longer receiving clinical benefit|17|||
48383605|NCT01186939|155600214|FG000|Overall Study|Program closed|5|||
48383606|NCT01186939|155600214|FG000|Overall Study|Sponsor decision|4|||
48383607|NCT01186939|155600214|FG000|Overall Study|Started additional treatment|1|||
48383608|NCT01186939|155600214|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
48383609|NCT01186939|155600214|FG000|Overall Study|Myocardial infarction|1|||
48383610|NCT01186939|155600214|FG000|Overall Study|Bone marrow transplant|1|||
48383611|NCT01186939|155600214|FG000|Overall Study|Transformation to AML|1|||
48383612|NCT00597753|155600215|FG000|Overall Study|Adverse Event|6|||
48383613|NCT00597753|155600216|FG001|Overall Study|Adverse Event|2|||
48383614|NCT00597753|155600215|FG000|Overall Study|Death|55|||
48383615|NCT00597753|155600216|FG001|Overall Study|Death|29|||
48383616|NCT00597753|155600215|FG000|Overall Study|Lack of Efficacy|2|||
48383617|NCT00597753|155600216|FG001|Overall Study|Lack of Efficacy|0|||
48383618|NCT00597753|155600215|FG000|Overall Study|Lost to Follow-up|10|||
48383619|NCT00597753|155600216|FG001|Overall Study|Lost to Follow-up|3|||
48383620|NCT00597753|155600215|FG000|Overall Study|Physician Decision|5|||
48383621|NCT00597753|155600216|FG001|Overall Study|Physician Decision|1|||
48383622|NCT00597753|155600215|FG000|Overall Study|Pregnancy|1|||
48383623|NCT00597753|155600216|FG001|Overall Study|Pregnancy|0|||
48383624|NCT00597753|155600215|FG000|Overall Study|Withdrawal by Subject|35|||
48383625|NCT00597753|155600216|FG001|Overall Study|Withdrawal by Subject|12|||
48383626|NCT00597753|155600215|FG000|Overall Study|Discontinued Dialysis|0|||
48383627|NCT00597753|155600216|FG001|Overall Study|Discontinued Dialysis|1|||
48383628|NCT00597753|155600215|FG000|Overall Study|Never dosed|2|||
48383629|NCT00597753|155600216|FG001|Overall Study|Never dosed|0|||
48383630|NCT00597753|155600215|FG000|Overall Study|Noncompliance|2|||
48383631|NCT00597753|155600216|FG001|Overall Study|Noncompliance|1|||
48383632|NCT00597753|155600215|FG000|Overall Study|Relocation|17|||
48383633|NCT00597753|155600216|FG001|Overall Study|Relocation|6|||
48517165|NCT00487435|156086136|FG000|Overall Study|Pregnancy|2|||
48517166|NCT00487435|156086136|FG000|Overall Study|Withdrawal by Subject|132|||
48517167|NCT00487435|156086136|FG000|Overall Study|Resolution Of Pain|1|||
48517168|NCT00487435|156086136|FG000|Overall Study|Study Medication Non-Compliant|32|||
48517169|NCT00487435|156086136|FG000|Overall Study|Other|83|||
48517170|NCT01566435|156086142|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
48383634|NCT00597753|155600215|FG000|Overall Study|Renal transplant|10|||
48383635|NCT00597753|155600216|FG001|Overall Study|Renal transplant|3|||
48383636|NCT00597753|155600215|FG000|Overall Study|Site closed by sponsor|19|||
48383637|NCT00597753|155600216|FG001|Overall Study|Site closed by sponsor|7|||
48383638|NCT00597753|155600215|FG000|Overall Study|Site elected to close|2|||
48383639|NCT00597753|155600216|FG001|Overall Study|Site elected to close|4|||
48383640|NCT00528567|155600220|FG000|Overall Study|Death|4|||
48383641|NCT00528567|155600221|FG001|Overall Study|Death|5|||
48383642|NCT00528567|155600220|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
48383643|NCT00528567|155600221|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
48383644|NCT00528567|155600220|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
48383645|NCT00528567|155600221|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
48383646|NCT00528567|155600220|FG000|Overall Study|Violation Criteria at Entry|3|||
48383647|NCT00528567|155600221|FG001|Overall Study|Violation Criteria at Entry|17|||
48383648|NCT00528567|155600220|FG000|Overall Study|Withdrew Consent|59|||
48383649|NCT00528567|155600221|FG001|Overall Study|Withdrew Consent|55|||
48383650|NCT00528567|155600220|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
48383651|NCT00528567|155600221|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
48383652|NCT00528567|155600220|FG000|Overall Study|Failure to Return|1|||
48730701|NCT04612790|156865867|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
48730702|NCT04612790|156865868|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
48730703|NCT04612790|156865869|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
48517171|NCT01942135|156086143|FG000|Overall Study|Adverse Event|21|||
48517172|NCT01942135|156086144|FG001|Overall Study|Adverse Event|7|||
48517173|NCT01942135|156086143|FG000|Overall Study|Global Deterioration of Health Status|9|||
48517174|NCT01942135|156086144|FG001|Overall Study|Global Deterioration of Health Status|6|||
48517175|NCT01942135|156086143|FG000|Overall Study|Randomized Not Treated|2|||
48517176|NCT01942135|156086144|FG001|Overall Study|Randomized Not Treated|2|||
48517177|NCT01942135|156086143|FG000|Overall Study|Death|2|||
48517178|NCT01942135|156086144|FG001|Overall Study|Death|1|||
48517179|NCT01942135|156086143|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
48517180|NCT01942135|156086144|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
48517181|NCT01942135|156086143|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
48517182|NCT01942135|156086144|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
48517183|NCT01942135|156086143|FG000|Overall Study|Withdrawal by Subject|4|||
48517184|NCT01942135|156086144|FG001|Overall Study|Withdrawal by Subject|3|||
48517185|NCT01942135|156086143|FG000|Overall Study|Protocol Violation|1|||
48517186|NCT01942135|156086144|FG001|Overall Study|Protocol Violation|0|||
48517187|NCT01942135|156086143|FG000|Overall Study|Other|19|||
48517188|NCT01942135|156086144|FG001|Overall Study|Other|4|||
48517189|NCT03193021|156086145|FG000|Overall Study|Lost to Follow-up|1|||
48517190|NCT03193021|156086146|FG001|Overall Study|Lost to Follow-up|1|||
48517191|NCT00529763|156087287|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
48517192|NCT00529763|156087288|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
48517193|NCT00529763|156087289|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
48517194|NCT00529763|156087287|FG000|Overall Study|Death|1|||
48517195|NCT00529763|156087288|FG001|Overall Study|Death|1|||
48517196|NCT00529763|156087289|FG002|Overall Study|Death|1|||
48517197|NCT00529763|156087287|FG000|Overall Study|Disease Progression|10|||
48517198|NCT00529763|156087288|FG001|Overall Study|Disease Progression|16|||
48517199|NCT00529763|156087289|FG002|Overall Study|Disease Progression|11|||
48517200|NCT00529763|156087287|FG000|Overall Study|Lost to Follow-up|1|||
48517201|NCT00529763|156087288|FG001|Overall Study|Lost to Follow-up|2|||
48517202|NCT00529763|156087289|FG002|Overall Study|Lost to Follow-up|3|||
48517203|NCT00529763|156087287|FG000|Overall Study|Stem Cell Transplant|0|||
48517204|NCT00529763|156087288|FG001|Overall Study|Stem Cell Transplant|3|||
48517205|NCT00529763|156087289|FG002|Overall Study|Stem Cell Transplant|1|||
48517206|NCT00529763|156087287|FG000|Overall Study|Study Drug Toxicity|3|||
48517207|NCT00529763|156087288|FG001|Overall Study|Study Drug Toxicity|6|||
48517208|NCT00529763|156087289|FG002|Overall Study|Study Drug Toxicity|4|||
48517209|NCT00529763|156087287|FG000|Overall Study|Participant Withdrew Consent|2|||
48517210|NCT00529763|156087288|FG001|Overall Study|Participant Withdrew Consent|3|||
48517211|NCT00529763|156087289|FG002|Overall Study|Participant Withdrew Consent|4|||
48517212|NCT00529763|156087287|FG000|Overall Study|Other reasons|2|||
48517213|NCT00529763|156087288|FG001|Overall Study|Other reasons|0|||
48383653|NCT00528567|155600221|FG001|Overall Study|Failure to Return|4|||
48383654|NCT00528567|155600220|FG000|Overall Study|Other Protocol Violation|5|||
48383655|NCT00528567|155600221|FG001|Overall Study|Other Protocol Violation|21|||
48383656|NCT00528567|155600220|FG000|Overall Study|Administrative/Other|22|||
48383657|NCT00528567|155600221|FG001|Overall Study|Administrative/Other|75|||
48383658|NCT02119325|155600222|FG000|Washout Period 1|Adverse Event|0|||
48383659|NCT02119325|155600223|FG001|Washout Period 1|Adverse Event|1|||
48383660|NCT04464265|155600224|FG000|Overall Study|Physician Decision|2|||
48383661|NCT01438151|155600229|FG000|Overall Study|study terminated|8|||
48517214|NCT00529763|156087289|FG002|Overall Study|Other reasons|2|||
48383662|NCT01303965|155600230|FG000|Overall Study|Adverse Event|1|||
48383663|NCT01303965|155600231|FG001|Overall Study|Adverse Event|1|||
48383664|NCT01303965|155600230|FG000|Overall Study|Death|0|||
48383665|NCT01303965|155600231|FG001|Overall Study|Death|3|||
48383666|NCT01303965|155600230|FG000|Overall Study|Withdrawal by Subject|1|||
48383667|NCT01303965|155600231|FG001|Overall Study|Withdrawal by Subject|0|||
48383668|NCT01303965|155600230|FG000|Overall Study|Disease Progression|1|||
48383669|NCT01303965|155600231|FG001|Overall Study|Disease Progression|6|||
48517215|NCT00529763|156087287|FG000|Overall Study|Participant request to discontinue treatment|1|||
48517216|NCT00529763|156087288|FG001|Overall Study|Participant request to discontinue treatment|1|||
48517217|NCT00529763|156087289|FG002|Overall Study|Participant request to discontinue treatment|3|||
48517218|NCT03669250|156087290|FG000|Overall Study|Adverse Event|0|||
48517219|NCT03669250|156087291|FG001|Overall Study|Adverse Event|0|||
48517220|NCT03669250|156087292|FG002|Overall Study|Adverse Event|0|||
48517221|NCT03669250|156087293|FG003|Overall Study|Adverse Event|0|||
48517222|NCT03669250|156087294|FG004|Overall Study|Adverse Event|1|||
48517223|NCT03669250|156087295|FG005|Overall Study|Adverse Event|0|||
48517224|NCT03669250|156087290|FG000|Overall Study|Withdrawal by Subject|0|||
48517225|NCT03669250|156087291|FG001|Overall Study|Withdrawal by Subject|1|||
48517226|NCT03669250|156087292|FG002|Overall Study|Withdrawal by Subject|0|||
48517227|NCT03669250|156087293|FG003|Overall Study|Withdrawal by Subject|1|||
48517228|NCT03669250|156087294|FG004|Overall Study|Withdrawal by Subject|0|||
48517229|NCT03669250|156087295|FG005|Overall Study|Withdrawal by Subject|0|||
48517230|NCT01513239|156087296|FG000|Period 1: Main Phase|Adverse Event|1|||
48517231|NCT01513239|156087297|FG001|Period 1: Main Phase|Adverse Event|1|||
48517232|NCT01513239|156087298|FG002|Period 1: Main Phase|Adverse Event|2|||
48517233|NCT01513239|156087299|FG003|Period 1: Main Phase|Adverse Event|0|||
48517234|NCT01513239|156087300|FG004|Period 1: Main Phase|Adverse Event|0|||
48517235|NCT01513239|156087301|FG005|Period 1: Main Phase|Adverse Event|0|||
48517236|NCT01513239|156087296|FG000|Period 1: Main Phase|Death|29|||
48517237|NCT01513239|156087297|FG001|Period 1: Main Phase|Death|22|||
48517238|NCT01513239|156087298|FG002|Period 1: Main Phase|Death|32|||
48517239|NCT01513239|156087299|FG003|Period 1: Main Phase|Death|0|||
48517240|NCT01513239|156087300|FG004|Period 1: Main Phase|Death|0|||
48517241|NCT01513239|156087301|FG005|Period 1: Main Phase|Death|0|||
48517242|NCT01513239|156087296|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
48517243|NCT01513239|156087297|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
48517244|NCT01513239|156087298|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
48517245|NCT01513239|156087299|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
48517246|NCT01513239|156087300|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
48517247|NCT01513239|156087301|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
48517248|NCT01513239|156087296|FG000|Period 1: Main Phase|Physician Decision|4|||
48517249|NCT01513239|156087297|FG001|Period 1: Main Phase|Physician Decision|4|||
48517250|NCT01513239|156087298|FG002|Period 1: Main Phase|Physician Decision|4|||
48517251|NCT01513239|156087299|FG003|Period 1: Main Phase|Physician Decision|0|||
48517252|NCT01513239|156087300|FG004|Period 1: Main Phase|Physician Decision|0|||
48517253|NCT01513239|156087301|FG005|Period 1: Main Phase|Physician Decision|0|||
48517254|NCT01513239|156087296|FG000|Period 1: Main Phase|Protocol Violation|2|||
48517255|NCT01513239|156087297|FG001|Period 1: Main Phase|Protocol Violation|2|||
48517256|NCT01513239|156087298|FG002|Period 1: Main Phase|Protocol Violation|2|||
48517257|NCT01513239|156087299|FG003|Period 1: Main Phase|Protocol Violation|0|||
48517258|NCT01513239|156087300|FG004|Period 1: Main Phase|Protocol Violation|0|||
48517259|NCT01513239|156087301|FG005|Period 1: Main Phase|Protocol Violation|0|||
48517260|NCT01513239|156087296|FG000|Period 1: Main Phase|Technical Problems|1|||
48517261|NCT01513239|156087297|FG001|Period 1: Main Phase|Technical Problems|2|||
48517262|NCT01513239|156087298|FG002|Period 1: Main Phase|Technical Problems|0|||
48517263|NCT01513239|156087299|FG003|Period 1: Main Phase|Technical Problems|0|||
48517264|NCT01513239|156087300|FG004|Period 1: Main Phase|Technical Problems|0|||
48517265|NCT01513239|156087301|FG005|Period 1: Main Phase|Technical Problems|0|||
48517266|NCT01513239|156087296|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
48517267|NCT01513239|156087297|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
48517268|NCT01513239|156087298|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
48517269|NCT01513239|156087299|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
48517270|NCT01513239|156087300|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
48517271|NCT01513239|156087301|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
48517272|NCT01513239|156087296|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
48517273|NCT01513239|156087297|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
48383670|NCT00962390|155600232|FG000|Overall Study|Adverse Event|0|||
48383671|NCT00962390|155600233|FG001|Overall Study|Adverse Event|0|||
48383672|NCT00962390|155600234|FG002|Overall Study|Adverse Event|3|||
48383673|NCT00962390|155600235|FG003|Overall Study|Adverse Event|1|||
48383674|NCT00962390|155600232|FG000|Overall Study|Lost to Follow-up|2|||
48517274|NCT01513239|156087298|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
48517275|NCT01513239|156087299|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
48517276|NCT01513239|156087300|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
48383675|NCT00962390|155600233|FG001|Overall Study|Lost to Follow-up|2|||
48383676|NCT00962390|155600234|FG002|Overall Study|Lost to Follow-up|0|||
48383677|NCT00962390|155600235|FG003|Overall Study|Lost to Follow-up|0|||
48383678|NCT00962390|155600232|FG000|Overall Study|Protocol Violation|1|||
48383679|NCT00962390|155600233|FG001|Overall Study|Protocol Violation|0|||
48383680|NCT00962390|155600234|FG002|Overall Study|Protocol Violation|0|||
48383681|NCT00962390|155600235|FG003|Overall Study|Protocol Violation|0|||
48383682|NCT00962390|155600232|FG000|Overall Study|Withdrawal by Subject|1|||
48383683|NCT00962390|155600233|FG001|Overall Study|Withdrawal by Subject|1|||
48383684|NCT00962390|155600234|FG002|Overall Study|Withdrawal by Subject|1|||
48383685|NCT00962390|155600235|FG003|Overall Study|Withdrawal by Subject|0|||
48383686|NCT02178553|155600236|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
48517277|NCT01513239|156087301|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
48517278|NCT01513239|156087296|FG000|Period 2: 9 Month Extension Phase|Death|0|||
48517279|NCT01513239|156087297|FG001|Period 2: 9 Month Extension Phase|Death|0|||
48517280|NCT01513239|156087298|FG002|Period 2: 9 Month Extension Phase|Death|0|||
48383687|NCT02178553|155600237|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
48383688|NCT02178553|155600236|FG000|Overall Study|Physician Decision|0|||
48383689|NCT02178553|155600237|FG001|Overall Study|Physician Decision|4|||
48383690|NCT02178553|155600236|FG000|Overall Study|Technical problem with injection|1|||
48383691|NCT02178553|155600237|FG001|Overall Study|Technical problem with injection|3|||
48383692|NCT00448435|155600239|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
48383693|NCT00448435|155600240|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
48383694|NCT00108069|155600241|FG000|Overall Study|Never rec'd study drug|0|||
48823177|NCT01628874|157192353|FG001|Overall Study|Physician Decision|1|||
48823178|NCT01628874|157192352|FG000|Overall Study|Age >4 months|4|||
48517281|NCT01513239|156087299|FG003|Period 2: 9 Month Extension Phase|Death|2|||
48517282|NCT01513239|156087300|FG004|Period 2: 9 Month Extension Phase|Death|5|||
48517283|NCT01513239|156087301|FG005|Period 2: 9 Month Extension Phase|Death|2|||
48517284|NCT01513239|156087296|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
48517285|NCT01513239|156087297|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
48517286|NCT01513239|156087298|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
48517287|NCT01513239|156087299|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
48517288|NCT01513239|156087300|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
48517289|NCT01513239|156087301|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
48517290|NCT01513239|156087296|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
48517291|NCT01513239|156087297|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
48517292|NCT01513239|156087298|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
48517293|NCT01513239|156087299|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
48517294|NCT01513239|156087300|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
48517295|NCT01513239|156087301|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
48517296|NCT01513239|156087296|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
48517297|NCT01513239|156087297|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
48517298|NCT01513239|156087298|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
48517299|NCT01513239|156087299|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
48517300|NCT01513239|156087300|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
48517301|NCT01513239|156087301|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
48517302|NCT03167606|156087302|FG000|Overall Study|Lost to Follow-up|73|||
48517303|NCT03167606|156087303|FG001|Overall Study|Lost to Follow-up|64|||
48517304|NCT03167606|156087302|FG000|Overall Study|Withdrawal by Subject|6|||
48517305|NCT03167606|156087303|FG001|Overall Study|Withdrawal by Subject|5|||
48517306|NCT03167606|156087302|FG000|Overall Study|Withdrawal by Investigator|0|||
48517307|NCT03167606|156087303|FG001|Overall Study|Withdrawal by Investigator|2|||
48517308|NCT00385736|156087307|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
48383695|NCT00108069|155600242|FG001|Overall Study|Never rec'd study drug|1|||
48517309|NCT00385736|156087308|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
48517310|NCT00385736|156087309|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
48517311|NCT00385736|156087307|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
48517312|NCT00385736|156087308|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
48517313|NCT00385736|156087309|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
48383696|NCT00108069|155600241|FG000|Overall Study|Adverse Event|1|||
48383697|NCT00108069|155600242|FG001|Overall Study|Adverse Event|1|||
48383698|NCT00108069|155600241|FG000|Overall Study|Withdrawal by Subject|1|||
48383699|NCT00108069|155600242|FG001|Overall Study|Withdrawal by Subject|0|||
48517314|NCT00385736|156087307|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
48517315|NCT00385736|156087308|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
48517316|NCT00385736|156087309|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
48517317|NCT00385736|156087307|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
48517318|NCT00385736|156087308|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
48823179|NCT01628874|157192353|FG001|Overall Study|Age >4 months|2|||
48383700|NCT00108069|155600241|FG000|Overall Study|Death|1|||
48383701|NCT00108069|155600242|FG001|Overall Study|Death|0|||
48823180|NCT03398356|157192367|FG000|Before Treatment|Lost to Follow-up|1|||
48823181|NCT03398356|157192368|FG001|Before Treatment|Lost to Follow-up|2|||
48823182|NCT03398356|157192369|FG002|Before Treatment|Lost to Follow-up|0|||
48517319|NCT00385736|156087309|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
48517320|NCT00385736|156087307|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
48517321|NCT00385736|156087308|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
48517322|NCT00385736|156087309|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
48517323|NCT00385736|156087307|FG000|Efficacy Analysis Set - Induction|Other|0|||
48517324|NCT00385736|156087308|FG001|Efficacy Analysis Set - Induction|Other|0|||
48517325|NCT00385736|156087309|FG002|Efficacy Analysis Set - Induction|Other|1|||
48517326|NCT00385736|156087307|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
48823183|NCT03398356|157192367|FG000|Before Treatment|drug intolerance|2|||
48823184|NCT03398356|157192368|FG001|Before Treatment|drug intolerance|1|||
48823185|NCT03398356|157192369|FG002|Before Treatment|drug intolerance|0|||
48823186|NCT03398356|157192367|FG000|Before Treatment|Withdrawal by Subject|0|||
48823187|NCT03398356|157192368|FG001|Before Treatment|Withdrawal by Subject|5|||
48823188|NCT03398356|157192369|FG002|Before Treatment|Withdrawal by Subject|0|||
48823189|NCT03398356|157192367|FG000|Before Treatment|Physician Decision|0|||
48823190|NCT03398356|157192368|FG001|Before Treatment|Physician Decision|0|||
48517327|NCT00385736|156087308|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
48517328|NCT00385736|156087309|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
48517329|NCT00385736|156087307|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
48517330|NCT00385736|156087308|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
48517331|NCT00385736|156087309|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
48517332|NCT00385736|156087307|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
48517333|NCT00385736|156087308|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
48823191|NCT03398356|157192369|FG002|Before Treatment|Physician Decision|11|||
48823192|NCT03398356|157192367|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
48823193|NCT03398356|157192368|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
48823194|NCT03398356|157192369|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
48823195|NCT01627340|157192370|FG000|Overall Study|Adverse Event|1|||
48823196|NCT01627340|157192371|FG001|Overall Study|Adverse Event|0|||
48823197|NCT01627340|157192370|FG000|Overall Study|Lost to Follow-up|8|||
48823198|NCT01627340|157192371|FG001|Overall Study|Lost to Follow-up|4|||
48823199|NCT01627340|157192370|FG000|Overall Study|Pregnancy|1|||
48823200|NCT01627340|157192371|FG001|Overall Study|Pregnancy|0|||
48517334|NCT00385736|156087309|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
48517335|NCT00385736|156087307|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
48517336|NCT00385736|156087308|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
48517337|NCT00385736|156087309|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
48730704|NCT04612790|156865870|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
48730705|NCT04612790|156865867|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
48730706|NCT04612790|156865868|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
48730707|NCT04612790|156865869|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
48730708|NCT04612790|156865870|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
48730709|NCT04612790|156865867|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
48730710|NCT04612790|156865868|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
48823201|NCT01627340|157192370|FG000|Overall Study|Withdrawal by Subject|2|||
48823202|NCT01627340|157192371|FG001|Overall Study|Withdrawal by Subject|0|||
48823203|NCT01272011|157192372|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
48823204|NCT01272011|157192373|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
48823205|NCT01272011|157192374|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
48823206|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
48823207|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
48823208|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
48823209|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
48823210|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
48823211|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
48823212|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
48823213|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
48823214|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
48517338|NCT00385736|156087307|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
48517339|NCT00385736|156087308|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
48517340|NCT00385736|156087309|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
48517341|NCT00385736|156087307|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
48517342|NCT00385736|156087308|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
48517343|NCT00385736|156087309|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
48517344|NCT00385736|156087307|FG000|Safety Analysis Set|Adverse Event|23|||
48517345|NCT00385736|156087308|FG001|Safety Analysis Set|Adverse Event|15|||
48517346|NCT00385736|156087309|FG002|Safety Analysis Set|Adverse Event|23|||
48517347|NCT00385736|156087307|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
48517348|NCT00385736|156087308|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
48517349|NCT00385736|156087309|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
48517350|NCT00385736|156087307|FG000|Safety Analysis Set|Lost to Follow-up|0|||
48517351|NCT00385736|156087308|FG001|Safety Analysis Set|Lost to Follow-up|2|||
48517352|NCT00385736|156087309|FG002|Safety Analysis Set|Lost to Follow-up|2|||
48517353|NCT00385736|156087307|FG000|Safety Analysis Set|Lack of Efficacy|38|||
48517354|NCT00385736|156087308|FG001|Safety Analysis Set|Lack of Efficacy|16|||
48517355|NCT00385736|156087309|FG002|Safety Analysis Set|Lack of Efficacy|31|||
48517356|NCT00385736|156087307|FG000|Safety Analysis Set|Protocol Violation|2|||
48517357|NCT00385736|156087308|FG001|Safety Analysis Set|Protocol Violation|1|||
48517358|NCT00385736|156087309|FG002|Safety Analysis Set|Protocol Violation|6|||
48517359|NCT00385736|156087307|FG000|Safety Analysis Set|Other|1|||
48517360|NCT00385736|156087308|FG001|Safety Analysis Set|Other|4|||
48517361|NCT00385736|156087309|FG002|Safety Analysis Set|Other|4|||
48517362|NCT00469898|156087313|FG000|Overall Study|Adverse Event|7|||
48517363|NCT00469898|156087313|FG000|Overall Study|Withdrawal by Subject|4|||
48517364|NCT00469898|156087313|FG000|Overall Study|Death|4|||
48517365|NCT00469898|156087313|FG000|Overall Study|Disease progression|9|||
48517366|NCT00469898|156087313|FG000|Overall Study|Decreased performance status|1|||
48517367|NCT01741545|156087314|FG000|Treatment Period|Lack of Efficacy|0|||
48517368|NCT01741545|156087315|FG001|Treatment Period|Lack of Efficacy|1|||
48517369|NCT01741545|156087314|FG000|Treatment Period|Adverse event, non-fatal|1|||
48517370|NCT01741545|156087315|FG001|Treatment Period|Adverse event, non-fatal|3|||
48517371|NCT01741545|156087314|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
48517372|NCT01741545|156087315|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
48517373|NCT01741545|156087314|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
48517374|NCT01741545|156087315|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
48517375|NCT02483416|156087316|FG000|Overall Study|Other reason|0|||
48517376|NCT02483416|156087317|FG001|Overall Study|Other reason|1|||
48517377|NCT02483416|156087316|FG000|Overall Study|Treatment stop|3|||
48517378|NCT02483416|156087317|FG001|Overall Study|Treatment stop|0|||
48517379|NCT00924638|156087318|FG000|Overall Study|Death|3|||
48517380|NCT00924638|156087319|FG001|Overall Study|Death|2|||
48517381|NCT00924638|156087318|FG000|Overall Study|Lost to Follow-up|1|||
48517382|NCT00924638|156087319|FG001|Overall Study|Lost to Follow-up|1|||
48517383|NCT00924638|156087318|FG000|Overall Study|Withdrawal by Subject|5|||
48517384|NCT00924638|156087319|FG001|Overall Study|Withdrawal by Subject|7|||
48517385|NCT00924638|156087318|FG000|Overall Study|Physician Decision|3|||
48517386|NCT00924638|156087319|FG001|Overall Study|Physician Decision|3|||
48517387|NCT03961204|156087327|FG000|Overall Study|Withdrawal by Subject|2|||
48517388|NCT03961204|156087327|FG000|Overall Study|Lost to Follow-up|3|||
48517389|NCT03961204|156087327|FG000|Overall Study|Other|1|||
48517390|NCT03961204|156087327|FG000|Overall Study|Missing|1|||
48517391|NCT04442503|156087328|FG000|Overall Study|Adverse Event|1|||
48517392|NCT04442503|156087329|FG001|Overall Study|Adverse Event|1|||
48517393|NCT04442503|156087328|FG000|Overall Study|Lost to Follow-up|8|||
48517394|NCT04442503|156087329|FG001|Overall Study|Lost to Follow-up|6|||
48517395|NCT04442503|156087328|FG000|Overall Study|Physician Decision|0|||
48517396|NCT04442503|156087329|FG001|Overall Study|Physician Decision|2|||
48517397|NCT04442503|156087328|FG000|Overall Study|Withdrawal by Subject|3|||
48517398|NCT04442503|156087329|FG001|Overall Study|Withdrawal by Subject|4|||
48517399|NCT04442503|156087328|FG000|Overall Study|Reason not Specified|0|||
48517400|NCT04442503|156087329|FG001|Overall Study|Reason not Specified|1|||
48517401|NCT04442503|156087328|FG000|Overall Study|Randomized but not Treated|3|||
48517402|NCT04442503|156087329|FG001|Overall Study|Randomized but not Treated|1|||
48517403|NCT00177164|156087330|FG000|Overall Study|Protocol Violation|0|||
48517404|NCT00177164|156087331|FG001|Overall Study|Protocol Violation|7|||
48517405|NCT00177164|156087330|FG000|Overall Study|Lost to Follow-up|4|||
48517406|NCT00177164|156087331|FG001|Overall Study|Lost to Follow-up|5|||
48517407|NCT00177164|156087330|FG000|Overall Study|increase in alcohol and drug use|1|||
48517408|NCT00177164|156087331|FG001|Overall Study|increase in alcohol and drug use|2|||
48517409|NCT00177164|156087330|FG000|Overall Study|Adverse Event|1|||
48823215|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
48517410|NCT00177164|156087331|FG001|Overall Study|Adverse Event|0|||
48517411|NCT00177164|156087330|FG000|Overall Study|discharge from hospital|1|||
48517412|NCT00177164|156087331|FG001|Overall Study|discharge from hospital|0|||
48517413|NCT00177164|156087330|FG000|Overall Study|Lack of Efficacy|2|||
48517414|NCT00177164|156087331|FG001|Overall Study|Lack of Efficacy|1|||
48823216|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
48823217|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
48517415|NCT00177164|156087330|FG000|Overall Study|Pregnancy|0|||
48517416|NCT00177164|156087331|FG001|Overall Study|Pregnancy|1|||
48517417|NCT01751087|156087332|FG000|Overall Study|Withdrawal by Subject|1|||
48517418|NCT01751087|156087333|FG001|Overall Study|Withdrawal by Subject|0|||
48517419|NCT01751087|156087334|FG002|Overall Study|Withdrawal by Subject|0|||
48517420|NCT01751087|156087332|FG000|Overall Study|Physician Decision|0|||
48517421|NCT01751087|156087333|FG001|Overall Study|Physician Decision|0|||
48517422|NCT01751087|156087334|FG002|Overall Study|Physician Decision|1|||
48517423|NCT04411680|156087337|FG000|Treatment Period|Adverse Event|3|||
48517424|NCT04411680|156087338|FG001|Treatment Period|Adverse Event|0|||
48823218|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
48823219|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
48823220|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
48823221|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
48823222|NCT02240680|157192375|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
48823223|NCT02240680|157192376|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
48823224|NCT02240680|157192377|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
48823225|NCT02240680|157192378|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
48823226|NCT02240680|157192375|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
48823227|NCT02240680|157192376|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
48823228|NCT02240680|157192377|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
48823229|NCT02240680|157192378|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
48823230|NCT02240680|157192375|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
48823231|NCT02240680|157192376|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
48823232|NCT02240680|157192377|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
48823233|NCT02240680|157192378|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
48823234|NCT02240680|157192375|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
48823235|NCT02240680|157192376|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
48823236|NCT02240680|157192377|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
48823237|NCT02240680|157192378|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
48517425|NCT04411680|156087337|FG000|Treatment Period|Discharged from hospital|18|||
48517426|NCT04411680|156087338|FG001|Treatment Period|Discharged from hospital|7|||
48517427|NCT04411680|156087337|FG000|Treatment Period|Missed 1 or more doses|8|||
48517428|NCT04411680|156087338|FG001|Treatment Period|Missed 1 or more doses|0|||
48517429|NCT04411680|156087337|FG000|Treatment Period|Transferred to another hospital|0|||
48517430|NCT04411680|156087338|FG001|Treatment Period|Transferred to another hospital|1|||
48517431|NCT04411680|156087337|FG000|Follow up Period|Withdrawal by Subject|2|||
48517432|NCT04411680|156087338|FG001|Follow up Period|Withdrawal by Subject|0|||
48517433|NCT04411680|156087337|FG000|Follow up Period|Lost to Follow-up|5|||
48517434|NCT04411680|156087338|FG001|Follow up Period|Lost to Follow-up|6|||
48517435|NCT04411680|156087337|FG000|Follow up Period|Death|11|||
48517436|NCT04411680|156087338|FG001|Follow up Period|Death|8|||
48517437|NCT04697173|156087344|FG000|Overall Study|Withdrawal by Subject|34|||
48517438|NCT04697173|156087345|FG001|Overall Study|Withdrawal by Subject|38|||
48517439|NCT03499873|156087346|FG000|Overall Study|Withdrawal by Subject|4|||
48517440|NCT03499873|156087347|FG001|Overall Study|Withdrawal by Subject|6|||
48517441|NCT03499873|156087348|FG002|Overall Study|Withdrawal by Subject|1|||
48517442|NCT03499873|156087346|FG000|Overall Study|Subjects condition worsened|0|||
48517443|NCT03499873|156087347|FG001|Overall Study|Subjects condition worsened|3|||
48517444|NCT03499873|156087348|FG002|Overall Study|Subjects condition worsened|11|||
48517445|NCT03499873|156087346|FG000|Overall Study|Adverse Event|8|||
48517446|NCT03499873|156087347|FG001|Overall Study|Adverse Event|3|||
48517447|NCT03499873|156087348|FG002|Overall Study|Adverse Event|6|||
48517448|NCT03499873|156087346|FG000|Overall Study|Physician Decision|1|||
48517449|NCT03499873|156087347|FG001|Overall Study|Physician Decision|0|||
48517450|NCT03499873|156087348|FG002|Overall Study|Physician Decision|0|||
48517451|NCT03499873|156087346|FG000|Overall Study|Administrative reasons|0|||
48517452|NCT03499873|156087347|FG001|Overall Study|Administrative reasons|1|||
48517453|NCT03499873|156087348|FG002|Overall Study|Administrative reasons|0|||
48517454|NCT03499873|156087346|FG000|Overall Study|Concomitant therapy|5|||
48517455|NCT03499873|156087347|FG001|Overall Study|Concomitant therapy|4|||
48517456|NCT03499873|156087348|FG002|Overall Study|Concomitant therapy|7|||
48517457|NCT03499873|156087346|FG000|Overall Study|Miscellaneous|1|||
48823238|NCT03704298|157192379|FG000|Overall Study|Death|3|||
48823239|NCT03704298|157192380|FG001|Overall Study|Death|1|||
48823240|NCT03704298|157192381|FG002|Overall Study|Death|1|||
48823241|NCT03704298|157192382|FG003|Overall Study|Death|0|||
48823242|NCT03704298|157192379|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
48823243|NCT03704298|157192380|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
48517458|NCT03499873|156087347|FG001|Overall Study|Miscellaneous|2|||
48823244|NCT03704298|157192381|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
48823245|NCT03704298|157192382|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
48517459|NCT03499873|156087348|FG002|Overall Study|Miscellaneous|2|||
48823246|NCT03704298|157192379|FG000|Overall Study|Withdrawal by Subject|1|||
48517460|NCT03499873|156087346|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
48517461|NCT03499873|156087347|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
48517462|NCT03499873|156087348|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
48517463|NCT01149057|156087349|FG000|Overall Study|Lack of Efficacy|16|||
48517464|NCT01149057|156087349|FG000|Overall Study|Adverse Event|13|||
48517465|NCT01149057|156087349|FG000|Overall Study|Withdrawal by Subject|9|||
48601116|NCT02718911|156396040|FG000|Overall Study|Lost to Follow-up|0|||
48517466|NCT01149057|156087349|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
48823247|NCT03704298|157192380|FG001|Overall Study|Withdrawal by Subject|0|||
48823248|NCT03704298|157192381|FG002|Overall Study|Withdrawal by Subject|0|||
48823249|NCT03704298|157192382|FG003|Overall Study|Withdrawal by Subject|0|||
48823250|NCT03704298|157192379|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
48823251|NCT03704298|157192380|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
48823252|NCT03704298|157192381|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
48823253|NCT03704298|157192382|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
48517467|NCT01149057|156087349|FG000|Overall Study|B Cell Depletion|4|||
48517468|NCT01149057|156087349|FG000|Overall Study|Participant Non-Compliance|2|||
48517469|NCT01149057|156087349|FG000|Overall Study|Lost to Follow-up|1|||
48517470|NCT01149057|156087349|FG000|Overall Study|High Parathyroid Hormone Value|1|||
48517471|NCT01149057|156087349|FG000|Overall Study|Other|6|||
48517472|NCT01964950|156087350|FG000|Overall Study|Protocol Violation|25|||
48823254|NCT00184028|157192385|FG000|Overall Study|Death|1|||
48823255|NCT00184028|157192385|FG000|Overall Study|Lack of Efficacy|4|||
48823256|NCT00184028|157192385|FG000|Overall Study|Adverse Event|2|||
48823257|NCT00184028|157192385|FG000|Overall Study|Withdrawal by Subject|1|||
48823258|NCT00184028|157192385|FG000|Overall Study|Non-compliance|2|||
48823259|NCT01606189|157192386|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
48517473|NCT03428750|156087351|FG000|Overall Study|Withdrawal by Subject|11|||
48517474|NCT03428750|156087352|FG001|Overall Study|Withdrawal by Subject|10|||
48517475|NCT03428750|156087351|FG000|Overall Study|Lost to Follow-up|3|||
48517476|NCT03428750|156087352|FG001|Overall Study|Lost to Follow-up|9|||
48517477|NCT03428750|156087351|FG000|Overall Study|Adverse Event|9|||
48517478|NCT03428750|156087352|FG001|Overall Study|Adverse Event|1|||
48517479|NCT03428750|156087351|FG000|Overall Study|Protocol Violation|1|||
48517480|NCT03428750|156087352|FG001|Overall Study|Protocol Violation|0|||
48517481|NCT03428750|156087351|FG000|Overall Study|Administrative|0|||
48517482|NCT03428750|156087352|FG001|Overall Study|Administrative|1|||
48517483|NCT04404725|156087353|FG000|First Intervention|Withdrawal by Subject|0|||
48517484|NCT04404725|156087354|FG001|First Intervention|Withdrawal by Subject|2|||
48517485|NCT04404725|156087353|FG000|Second Intervention|Adverse Event|1|||
48517486|NCT04404725|156087354|FG001|Second Intervention|Adverse Event|1|||
48517487|NCT04404725|156087353|FG000|Second Intervention|Withdrawal by Subject|0|||
48517488|NCT04404725|156087354|FG001|Second Intervention|Withdrawal by Subject|1|||
48517489|NCT03602339|156087355|FG000|Overall Study|Withdrawal by Subject|9|||
48517490|NCT03602339|156087355|FG000|Overall Study|Physician Decision|2|||
48517491|NCT03602339|156087355|FG000|Overall Study|Other reason|4|||
48517492|NCT01024855|156087356|FG000|Overall Study|Inclusion/exclusion criteria|1|||
48517493|NCT00577655|156087357|FG000|Overall Study|Patient Request|0|||
48517494|NCT00577655|156087358|FG001|Overall Study|Patient Request|2|||
48517495|NCT00577655|156087357|FG000|Overall Study|Protocol Violation|0|||
48517496|NCT00577655|156087358|FG001|Overall Study|Protocol Violation|1|||
48517497|NCT00577655|156087357|FG000|Overall Study|Lost to Follow-up|1|||
48823260|NCT01606189|157192387|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
48823261|NCT01606189|157192388|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
48823262|NCT01606189|157192389|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
48517498|NCT00577655|156087358|FG001|Overall Study|Lost to Follow-up|1|||
48517499|NCT02372006|156087361|FG000|Overall Study|Progressive disease|8|||
48517500|NCT02372006|156087362|FG001|Overall Study|Progressive disease|7|||
48517501|NCT02372006|156087363|FG002|Overall Study|Progressive disease|34|||
48517502|NCT02372006|156087361|FG000|Overall Study|Dose limiting toxicity|0|||
48517503|NCT02372006|156087362|FG001|Overall Study|Dose limiting toxicity|1|||
48517504|NCT02372006|156087363|FG002|Overall Study|Dose limiting toxicity|0|||
48517505|NCT02372006|156087361|FG000|Overall Study|Adverse Event|0|||
48517506|NCT02372006|156087362|FG001|Overall Study|Adverse Event|0|||
48517507|NCT02372006|156087363|FG002|Overall Study|Adverse Event|3|||
48517508|NCT02372006|156087361|FG000|Overall Study|Withdrawal by Subject|0|||
48517509|NCT02372006|156087362|FG001|Overall Study|Withdrawal by Subject|1|||
48517510|NCT02372006|156087363|FG002|Overall Study|Withdrawal by Subject|1|||
48517511|NCT02372006|156087361|FG000|Overall Study|Other reason for not completing|0|||
48517512|NCT02372006|156087362|FG001|Overall Study|Other reason for not completing|0|||
48517513|NCT02372006|156087363|FG002|Overall Study|Other reason for not completing|1|||
48517514|NCT00674128|156087366|FG000|Overall Study|Withdrawal by Subject|25|||
48517515|NCT00674128|156087367|FG001|Overall Study|Withdrawal by Subject|23|||
48517516|NCT01370863|156087378|FG000|Overall Study|Adverse Event|1|||
48517517|NCT01370863|156087379|FG001|Overall Study|Adverse Event|1|||
48517518|NCT01370863|156087378|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
48517519|NCT01370863|156087379|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
48517520|NCT01370863|156087378|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48517521|NCT01370863|156087379|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
48823263|NCT01606189|157192390|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
48823264|NCT01606189|157192391|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
48517522|NCT01698554|156087381|FG000|Overall Study|Adverse Event|2|||
48517523|NCT01698554|156087382|FG001|Overall Study|Adverse Event|5|||
48517524|NCT01698554|156087383|FG002|Overall Study|Adverse Event|0|||
48517525|NCT01698554|156087384|FG003|Overall Study|Adverse Event|1|||
48517526|NCT01698554|156087381|FG000|Overall Study|Lost to Follow-up|1|||
48517527|NCT01698554|156087382|FG001|Overall Study|Lost to Follow-up|0|||
48517528|NCT01698554|156087383|FG002|Overall Study|Lost to Follow-up|0|||
48517529|NCT01698554|156087384|FG003|Overall Study|Lost to Follow-up|0|||
48517530|NCT01698554|156087381|FG000|Overall Study|Personal Reasons|0|||
48517531|NCT01698554|156087382|FG001|Overall Study|Personal Reasons|5|||
48517532|NCT01698554|156087383|FG002|Overall Study|Personal Reasons|1|||
48517533|NCT01698554|156087384|FG003|Overall Study|Personal Reasons|1|||
48517534|NCT01698554|156087381|FG000|Overall Study|Protocol Violation|2|||
48517535|NCT01698554|156087382|FG001|Overall Study|Protocol Violation|0|||
48517536|NCT01698554|156087383|FG002|Overall Study|Protocol Violation|1|||
48517537|NCT01698554|156087384|FG003|Overall Study|Protocol Violation|0|||
48517538|NCT01698554|156087381|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48517539|NCT01698554|156087382|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48517540|NCT01698554|156087383|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48517541|NCT01698554|156087384|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48517542|NCT01859598|156087385|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
48517543|NCT01617096|156087390|FG000|Overall Study|Withdrawal by Subject|96|||
48517544|NCT01617096|156087391|FG001|Overall Study|Withdrawal by Subject|81|||
48517545|NCT01617096|156087390|FG000|Overall Study|Lost to Follow-up|37|||
48517546|NCT01617096|156087391|FG001|Overall Study|Lost to Follow-up|32|||
48517547|NCT01617096|156087390|FG000|Overall Study|Physician Decision|10|||
48517548|NCT01617096|156087391|FG001|Overall Study|Physician Decision|18|||
48517549|NCT01617096|156087390|FG000|Overall Study|Death|4|||
48517550|NCT01617096|156087391|FG001|Overall Study|Death|3|||
48517551|NCT01617096|156087390|FG000|Overall Study|Other|1|||
48517552|NCT01617096|156087391|FG001|Overall Study|Other|3|||
48517553|NCT02616380|156087392|FG000|Overall Study|Lost to Follow-up|1|||
48517554|NCT02616380|156087392|FG000|Overall Study|Other|2|||
48517555|NCT00919711|156087393|FG000|Overall Study|Withdrawal by Subject|15|||
48517556|NCT00919711|156087394|FG001|Overall Study|Withdrawal by Subject|7|||
48517557|NCT00919711|156087393|FG000|Overall Study|Adverse Event|13|||
48517558|NCT00919711|156087394|FG001|Overall Study|Adverse Event|3|||
48517559|NCT00919711|156087393|FG000|Overall Study|Other|1|||
48517560|NCT00919711|156087394|FG001|Overall Study|Other|2|||
48517561|NCT00919711|156087393|FG000|Overall Study|Administrative Decision|0|||
48517562|NCT00919711|156087394|FG001|Overall Study|Administrative Decision|1|||
48517563|NCT00919711|156087393|FG000|Overall Study|Lost to Follow-up|2|||
48517564|NCT00919711|156087394|FG001|Overall Study|Lost to Follow-up|0|||
48517565|NCT00919711|156087393|FG000|Overall Study|Death|1|||
48517566|NCT00919711|156087394|FG001|Overall Study|Death|0|||
48517567|NCT00919711|156087393|FG000|Overall Study|Noncompliance|1|||
48517568|NCT00919711|156087394|FG001|Overall Study|Noncompliance|0|||
48517569|NCT00642811|156087395|FG000|Overall Study|Adverse Event|2|||
48517570|NCT00642811|156087396|FG001|Overall Study|Adverse Event|3|||
48517571|NCT00642811|156087397|FG002|Overall Study|Adverse Event|0|||
48517572|NCT00642811|156087398|FG003|Overall Study|Adverse Event|0|||
48517573|NCT00642811|156087399|FG004|Overall Study|Adverse Event|0|||
48517574|NCT00642811|156087400|FG005|Overall Study|Adverse Event|1|||
48517575|NCT00642811|156087395|FG000|Overall Study|Developement of discontinuation criteria|0|||
48517576|NCT00642811|156087396|FG001|Overall Study|Developement of discontinuation criteria|0|||
48517577|NCT00642811|156087397|FG002|Overall Study|Developement of discontinuation criteria|0|||
48517578|NCT00642811|156087398|FG003|Overall Study|Developement of discontinuation criteria|0|||
48517579|NCT00642811|156087399|FG004|Overall Study|Developement of discontinuation criteria|1|||
48517580|NCT00642811|156087400|FG005|Overall Study|Developement of discontinuation criteria|0|||
48517581|NCT00642811|156087395|FG000|Overall Study|Severe Non-compliance to protocol|1|||
48517582|NCT00642811|156087396|FG001|Overall Study|Severe Non-compliance to protocol|0|||
48517583|NCT00642811|156087397|FG002|Overall Study|Severe Non-compliance to protocol|0|||
48517584|NCT00642811|156087398|FG003|Overall Study|Severe Non-compliance to protocol|0|||
48517585|NCT00642811|156087399|FG004|Overall Study|Severe Non-compliance to protocol|0|||
48517586|NCT00642811|156087400|FG005|Overall Study|Severe Non-compliance to protocol|0|||
48517587|NCT00642811|156087395|FG000|Overall Study|Other|0|||
48517588|NCT00642811|156087396|FG001|Overall Study|Other|1|||
48517589|NCT00642811|156087397|FG002|Overall Study|Other|0|||
48517590|NCT00642811|156087398|FG003|Overall Study|Other|1|||
48517591|NCT00642811|156087399|FG004|Overall Study|Other|0|||
48517592|NCT00642811|156087400|FG005|Overall Study|Other|0|||
48517593|NCT00633022|156087401|FG000|Overall Study|Adverse Event|1|||
48517594|NCT00633022|156087402|FG001|Overall Study|Adverse Event|0|||
48517595|NCT00633022|156087403|FG002|Overall Study|Adverse Event|5|||
48517596|NCT00633022|156087401|FG000|Overall Study|Physician Decision|0|||
48517597|NCT00633022|156087402|FG001|Overall Study|Physician Decision|1|||
48517598|NCT00633022|156087403|FG002|Overall Study|Physician Decision|0|||
48517599|NCT03067987|156087404|FG000|Overall Study|Lost to Follow-up|7|||
48517600|NCT03067987|156087405|FG001|Overall Study|Lost to Follow-up|10|||
48517601|NCT03067987|156087404|FG000|Overall Study|Protocol Violation|1|||
48517602|NCT03067987|156087405|FG001|Overall Study|Protocol Violation|2|||
48517603|NCT03067987|156087404|FG000|Overall Study|Withdrawal by Subject|2|||
48517604|NCT03067987|156087405|FG001|Overall Study|Withdrawal by Subject|1|||
48517605|NCT02614898|156087406|FG000|Overall Study|Participated until study termination|10|||
48517606|NCT02614898|156087407|FG001|Overall Study|Participated until study termination|26|||
48517607|NCT02614898|156087406|FG000|Overall Study|Lost to Follow-up|0|||
48517608|NCT02614898|156087407|FG001|Overall Study|Lost to Follow-up|2|||
48517609|NCT02614898|156087406|FG000|Overall Study|Physician Decision|1|||
48517610|NCT02614898|156087407|FG001|Overall Study|Physician Decision|8|||
48517611|NCT02614898|156087406|FG000|Overall Study|Study Terminated by Sponsor|3|||
48517612|NCT02614898|156087407|FG001|Overall Study|Study Terminated by Sponsor|0|||
48517613|NCT02614898|156087406|FG000|Overall Study|Withdrawal by Subject|0|||
48517614|NCT02614898|156087407|FG001|Overall Study|Withdrawal by Subject|2|||
48517615|NCT02614898|156087406|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48517616|NCT02614898|156087407|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48517617|NCT02614898|156087406|FG000|Overall Study|Other-Additional Information Unavailable|0|||
48517618|NCT02614898|156087407|FG001|Overall Study|Other-Additional Information Unavailable|11|||
48517619|NCT02614898|156087406|FG000|Overall Study|Missing|0|||
48730711|NCT04612790|156865869|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
48517620|NCT02614898|156087407|FG001|Overall Study|Missing|1|||
48517621|NCT04428645|156087408|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
48517622|NCT02997176|156089547|FG000|Overall Study|Adverse Event|0|||
48517623|NCT02997176|156089548|FG001|Overall Study|Adverse Event|0|||
48517624|NCT02997176|156089549|FG002|Overall Study|Adverse Event|0|||
48517625|NCT02997176|156089550|FG003|Overall Study|Adverse Event|8|||
48517626|NCT02997176|156089547|FG000|Overall Study|Progressive Disease|1|||
48517627|NCT02997176|156089548|FG001|Overall Study|Progressive Disease|0|||
48517628|NCT02997176|156089549|FG002|Overall Study|Progressive Disease|1|||
48517629|NCT02997176|156089550|FG003|Overall Study|Progressive Disease|1|||
48517630|NCT02997176|156089547|FG000|Overall Study|Death|0|||
48517631|NCT02997176|156089548|FG001|Overall Study|Death|0|||
48517632|NCT02997176|156089549|FG002|Overall Study|Death|1|||
48517633|NCT02997176|156089550|FG003|Overall Study|Death|1|||
48517634|NCT02997176|156089547|FG000|Overall Study|Withdrawal by Subject|0|||
48517635|NCT02997176|156089548|FG001|Overall Study|Withdrawal by Subject|2|||
48517636|NCT02997176|156089549|FG002|Overall Study|Withdrawal by Subject|0|||
48517637|NCT02997176|156089550|FG003|Overall Study|Withdrawal by Subject|1|||
48517638|NCT05511935|156089553|FG000|Overall Study|Lost to Follow-up|9|||
48517639|NCT05511935|156089554|FG001|Overall Study|Lost to Follow-up|27|||
48517640|NCT01911429|156089559|FG000|Overall Study|Adverse Event|5|||
48517641|NCT01911429|156089560|FG001|Overall Study|Adverse Event|3|||
48517642|NCT01911429|156089561|FG002|Overall Study|Adverse Event|9|||
48517643|NCT01911429|156089559|FG000|Overall Study|Lack of Efficacy|1|||
48517644|NCT01911429|156089560|FG001|Overall Study|Lack of Efficacy|2|||
48517645|NCT01911429|156089561|FG002|Overall Study|Lack of Efficacy|4|||
48517646|NCT01911429|156089559|FG000|Overall Study|Lost to Follow-up|0|||
48517647|NCT01911429|156089560|FG001|Overall Study|Lost to Follow-up|0|||
48517648|NCT01911429|156089561|FG002|Overall Study|Lost to Follow-up|1|||
48517649|NCT01911429|156089559|FG000|Overall Study|Protocol Violation|0|||
48517650|NCT01911429|156089560|FG001|Overall Study|Protocol Violation|0|||
48517651|NCT01911429|156089561|FG002|Overall Study|Protocol Violation|1|||
48517652|NCT01911429|156089559|FG000|Overall Study|Withdrawal by Subject|5|||
48517653|NCT01911429|156089560|FG001|Overall Study|Withdrawal by Subject|5|||
48517654|NCT01911429|156089561|FG002|Overall Study|Withdrawal by Subject|4|||
48517655|NCT01911429|156089559|FG000|Overall Study|Accidental randomization|0|||
48517656|NCT01911429|156089560|FG001|Overall Study|Accidental randomization|0|||
48517657|NCT01911429|156089561|FG002|Overall Study|Accidental randomization|1|||
48517658|NCT01911429|156089559|FG000|Overall Study|subject left study|1|||
48517659|NCT01911429|156089560|FG001|Overall Study|subject left study|0|||
48517660|NCT01911429|156089561|FG002|Overall Study|subject left study|0|||
48517661|NCT01205035|156089562|FG000|Overall Study|Withdrawal by Subject|1|||
48517662|NCT01205035|156089563|FG001|Overall Study|Withdrawal by Subject|0|||
48517663|NCT01205035|156089562|FG000|Overall Study|Physician Decision|1|||
48517664|NCT01205035|156089563|FG001|Overall Study|Physician Decision|0|||
48730712|NCT04612790|156865870|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
48730713|NCT04612790|156865867|FG000|OLE Period (Up to 1 Year)|Other|0|||
48730714|NCT04612790|156865868|FG001|OLE Period (Up to 1 Year)|Other|0|||
48730715|NCT04612790|156865869|FG002|OLE Period (Up to 1 Year)|Other|0|||
48730716|NCT04612790|156865870|FG003|OLE Period (Up to 1 Year)|Other|1|||
48730717|NCT02806973|156865872|FG000|Period 1|Withdrawal by Subject|0|||
48730718|NCT02806973|156865873|FG001|Period 1|Withdrawal by Subject|2|||
48730719|NCT02806973|156865874|FG002|Period 1|Withdrawal by Subject|1|||
48730720|NCT02806973|156865875|FG003|Period 1|Withdrawal by Subject|1|||
48730721|NCT02806973|156865872|FG000|Period 1|Adverse Event|0|||
48730722|NCT02806973|156865873|FG001|Period 1|Adverse Event|0|||
48730723|NCT02806973|156865874|FG002|Period 1|Adverse Event|0|||
48730724|NCT02806973|156865875|FG003|Period 1|Adverse Event|1|||
48730725|NCT02806973|156865872|FG000|Period 3|Withdrawal by Subject|0|||
48730726|NCT02806973|156865873|FG001|Period 3|Withdrawal by Subject|0|||
48730727|NCT02806973|156865874|FG002|Period 3|Withdrawal by Subject|0|||
48517665|NCT02663349|156089564|FG000|Overall Study|Withdrawal by Subject|6|||
48517666|NCT01499043|156089569|FG000|Overall Study|Progressive disease (radiographic)|2|||
48517667|NCT01499043|156089569|FG000|Overall Study|Progressive disease (clinical)|1|||
48517668|NCT01499043|156089569|FG000|Overall Study|Withdrawal by Subject|2|||
48517669|NCT01499043|156089569|FG000|Overall Study|Adverse Event|1|||
48517670|NCT04590027|156089575|FG000|Overall Study|Lost to Follow-up|17|||
48517671|NCT04590027|156089576|FG001|Overall Study|Lost to Follow-up|14|||
48517672|NCT04590027|156089575|FG000|Overall Study|Protocol Violation|0|||
48517673|NCT04590027|156089576|FG001|Overall Study|Protocol Violation|3|||
48517674|NCT01572662|156089577|FG000|Overall Study|Withdrawal by Subject|1|||
48517675|NCT01572662|156089578|FG001|Overall Study|Withdrawal by Subject|0|||
48517676|NCT01572662|156089577|FG000|Overall Study|Physician Decision|0|||
48517677|NCT01572662|156089578|FG001|Overall Study|Physician Decision|1|||
48517678|NCT00673660|156089579|FG000|Overall Study|Lost to Follow-up|107|||
48517679|NCT02699866|156089580|FG000|Overall Study|Withdrawal by Subject|3|||
48517680|NCT02699866|156089580|FG000|Overall Study|Physician Decision|2|||
48517681|NCT02699866|156089580|FG000|Overall Study|Adverse Event|3|||
48517682|NCT01923740|156089581|FG000|Overall Study|Lost to Follow-up|4|||
48517683|NCT01923740|156089582|FG001|Overall Study|Lost to Follow-up|9|||
48517684|NCT01923740|156089581|FG000|Overall Study|Withdrawal by Subject|2|||
48517685|NCT01923740|156089582|FG001|Overall Study|Withdrawal by Subject|0|||
48517686|NCT04002648|156089583|FG000|Overall Study|Lost to Follow-up|2|||
48517687|NCT04002648|156089584|FG001|Overall Study|Lost to Follow-up|0|||
48517688|NCT00874822|156089586|FG000|Overall Study|excluded by criteria|8|||
48517689|NCT01438060|156089587|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
48517690|NCT01438060|156089588|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
48517691|NCT01438060|156089587|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
48730728|NCT02806973|156865875|FG003|Period 3|Withdrawal by Subject|3|||
48517692|NCT01438060|156089588|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
48517693|NCT01438060|156089587|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
48517694|NCT01438060|156089588|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
48517695|NCT01438060|156089587|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
48517696|NCT01438060|156089588|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
48517697|NCT01438060|156089587|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
48517698|NCT01438060|156089588|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
48517699|NCT01438060|156089587|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
48517700|NCT01438060|156089588|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
48517701|NCT01438060|156089587|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
48517702|NCT01438060|156089588|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
48517703|NCT01438060|156089587|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
48517704|NCT01438060|156089588|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
48517705|NCT01438060|156089587|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
48517706|NCT01438060|156089588|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
48517707|NCT01438060|156089587|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
48517708|NCT01438060|156089588|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
48517709|NCT01438060|156089587|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
48517710|NCT01438060|156089588|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
48517711|NCT01438060|156089587|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
48517712|NCT01438060|156089588|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
48517713|NCT01438060|156089587|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
48517714|NCT01438060|156089588|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
48517715|NCT01438060|156089587|FG000|On Study Beyond Week 140|Adverse Event|0|||
48517716|NCT01438060|156089588|FG001|On Study Beyond Week 140|Adverse Event|2|||
48517717|NCT01438060|156089587|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
48517718|NCT01438060|156089588|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
48517719|NCT01438060|156089587|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
48517720|NCT01438060|156089588|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
48517721|NCT01438060|156089587|FG000|On Study Beyond Week 140|Death|0|||
48517722|NCT01438060|156089588|FG001|On Study Beyond Week 140|Death|1|||
48517723|NCT01438060|156089587|FG000|On Study Beyond Week 140|Other Reason|0|||
48517724|NCT01438060|156089588|FG001|On Study Beyond Week 140|Other Reason|3|||
48517725|NCT00503867|156089592|FG000|Overall Study|Lost to Follow-up|1|||
48517726|NCT00503867|156089592|FG000|Overall Study|Adverse Event|1|||
48517727|NCT01442376|156089595|FG000|Overall Study|Adverse Event|0|||
48517728|NCT01442376|156089596|FG001|Overall Study|Adverse Event|3|||
48517729|NCT01442376|156089597|FG002|Overall Study|Adverse Event|2|||
48517730|NCT01442376|156089595|FG000|Overall Study|Death|0|||
48517731|NCT01442376|156089596|FG001|Overall Study|Death|1|||
48730729|NCT02806973|156865872|FG000|Period 3|Adverse Event|0|||
48730730|NCT02806973|156865873|FG001|Period 3|Adverse Event|0|||
48730731|NCT02806973|156865874|FG002|Period 3|Adverse Event|1|||
48730732|NCT02806973|156865875|FG003|Period 3|Adverse Event|0|||
48730733|NCT04029688|156865876|FG000|Overall Study|Death|8|||
48730734|NCT04029688|156865877|FG001|Overall Study|Death|3|||
48730735|NCT04029688|156865878|FG002|Overall Study|Death|6|||
48517732|NCT01442376|156089597|FG002|Overall Study|Death|1|||
48517733|NCT01442376|156089595|FG000|Overall Study|Withdrawal of consent|0|||
48517734|NCT01442376|156089596|FG001|Overall Study|Withdrawal of consent|0|||
48517735|NCT01442376|156089597|FG002|Overall Study|Withdrawal of consent|1|||
48517736|NCT01442376|156089595|FG000|Overall Study|Patients not treated|2|||
48517737|NCT01442376|156089596|FG001|Overall Study|Patients not treated|3|||
48517738|NCT01442376|156089597|FG002|Overall Study|Patients not treated|1|||
48517739|NCT01442376|156089595|FG000|Overall Study|Not eligible for subsequent cycles|1|||
48517740|NCT01442376|156089596|FG001|Overall Study|Not eligible for subsequent cycles|2|||
48517741|NCT01442376|156089597|FG002|Overall Study|Not eligible for subsequent cycles|0|||
48517742|NCT00858780|156089598|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
48517743|NCT00858780|156089599|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
48517744|NCT00858780|156089600|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
48517745|NCT00858780|156089601|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
48823265|NCT01606189|157192386|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823266|NCT01606189|157192387|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823267|NCT01606189|157192388|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823268|NCT01606189|157192389|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823269|NCT01606189|157192390|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
48823270|NCT01606189|157192391|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
48823271|NCT04796935|157192392|FG000|Overall Study|Withdrawal by Subject|0|||
48823272|NCT04796935|157192393|FG001|Overall Study|Withdrawal by Subject|1|||
48823273|NCT04796935|157192392|FG000|Overall Study|Physician Decision|0|||
48823274|NCT04796935|157192393|FG001|Overall Study|Physician Decision|1|||
48823275|NCT04796935|157192392|FG000|Overall Study|Device not available|1|||
48823276|NCT04796935|157192393|FG001|Overall Study|Device not available|0|||
48823277|NCT04796935|157192392|FG000|Overall Study|Trained provider not available|1|||
48823278|NCT04796935|157192393|FG001|Overall Study|Trained provider not available|0|||
48517746|NCT00858780|156089602|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
48517747|NCT00858780|156089598|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
48517748|NCT00858780|156089599|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
48517749|NCT00858780|156089600|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
48517750|NCT00858780|156089601|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
48517751|NCT00858780|156089602|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
48517752|NCT00858780|156089598|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
48517753|NCT00858780|156089599|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
48517754|NCT00858780|156089600|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
48517755|NCT00858780|156089601|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
48517756|NCT00858780|156089602|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
48517757|NCT00858780|156089598|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
48517758|NCT00858780|156089599|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
48517759|NCT00858780|156089600|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
48517760|NCT00858780|156089601|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
48517761|NCT00858780|156089602|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
48517762|NCT00858780|156089598|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
48517763|NCT00858780|156089599|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
48517764|NCT00858780|156089600|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
48517765|NCT00858780|156089601|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
48517766|NCT00858780|156089602|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
48517767|NCT00858780|156089598|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
48517768|NCT00858780|156089599|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
48517769|NCT00858780|156089600|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
48517770|NCT00858780|156089601|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
48517771|NCT00858780|156089602|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
48517772|NCT03807440|156089603|FG000|Overall Study|No documentation of index date 2|320|||
48517773|NCT03807440|156089603|FG000|Overall Study|No informed consent for index date 2|117|||
48517774|NCT03306277|156089606|FG000|Overall Study|Death|1|||
48517775|NCT03306277|156089606|FG000|Overall Study|Adverse Event|1|||
48517776|NCT03306277|156089606|FG000|Overall Study|Withdrawal by Subject|1|||
48517777|NCT05004649|156089611|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
48517778|NCT05004649|156089611|FG000|Overall Study|Lost to Follow-up|1|||
48517779|NCT05004649|156089611|FG000|Overall Study|Withdrawal by Subject|2|||
48517780|NCT05004649|156089611|FG000|Overall Study|COVID-19|1|||
48823279|NCT02162732|157192394|FG000|Overall Study|Biopsy not performed.|18|||
48823280|NCT02362035|157192395|FG000|Overall Study|Death|67|||
48823281|NCT02362035|157192395|FG000|Overall Study|Lost to Follow-up|3|||
48823282|NCT02362035|157192395|FG000|Overall Study|Adverse Event|1|||
48823283|NCT02362035|157192395|FG000|Overall Study|Physician Decision|1|||
48823284|NCT02362035|157192395|FG000|Overall Study|Subject started another cancer therapy|10|||
48823285|NCT02362035|157192395|FG000|Overall Study|Study terminated by sponsor|45|||
48823286|NCT02362035|157192395|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
48517781|NCT00301964|156089612|FG000|Overall Study|Second primary|2|||
48517782|NCT00301964|156089612|FG000|Overall Study|Wrong primary|1|||
48517783|NCT00301964|156089612|FG000|Overall Study|Inadequate pathology|1|||
48517784|NCT02385708|156089614|FG000|Overall Study|Withdrawal by Subject|0|||
48517785|NCT02385708|156089615|FG001|Overall Study|Withdrawal by Subject|2|||
48517786|NCT02385708|156089614|FG000|Overall Study|Withdrawn - surgery canceled|2|||
48517787|NCT02385708|156089615|FG001|Overall Study|Withdrawn - surgery canceled|5|||
48517788|NCT02385708|156089614|FG000|Overall Study|Investigator decision|5|||
48517789|NCT02385708|156089615|FG001|Overall Study|Investigator decision|7|||
48517790|NCT02385708|156089614|FG000|Overall Study|Protocol Violation|1|||
48517791|NCT02385708|156089615|FG001|Overall Study|Protocol Violation|1|||
48517792|NCT03504085|156089616|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
48517793|NCT03504085|156089617|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
48517794|NCT03504085|156089616|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
48517795|NCT03504085|156089617|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
48517796|NCT02761915|156089618|FG000|Overall Study|Death|3|||
48517797|NCT02761915|156089619|FG001|Overall Study|Death|1|||
48517798|NCT02761915|156089620|FG002|Overall Study|Death|1|||
48517799|NCT02761915|156089621|FG003|Overall Study|Death|1|||
48517800|NCT02761915|156089622|FG004|Overall Study|Death|0|||
48517801|NCT02761915|156089623|FG005|Overall Study|Death|1|||
48517802|NCT02761915|156089618|FG000|Overall Study|Withdrawal by Subject|1|||
48517803|NCT02761915|156089619|FG001|Overall Study|Withdrawal by Subject|0|||
48517804|NCT02761915|156089620|FG002|Overall Study|Withdrawal by Subject|0|||
48517805|NCT02761915|156089621|FG003|Overall Study|Withdrawal by Subject|0|||
48517806|NCT02761915|156089622|FG004|Overall Study|Withdrawal by Subject|1|||
48517807|NCT02761915|156089623|FG005|Overall Study|Withdrawal by Subject|2|||
48517808|NCT02761915|156089618|FG000|Overall Study|Disease Progression|0|||
48517809|NCT02761915|156089619|FG001|Overall Study|Disease Progression|0|||
48517810|NCT02761915|156089620|FG002|Overall Study|Disease Progression|0|||
48517811|NCT02761915|156089621|FG003|Overall Study|Disease Progression|2|||
48517812|NCT02761915|156089622|FG004|Overall Study|Disease Progression|2|||
48517813|NCT02761915|156089623|FG005|Overall Study|Disease Progression|2|||
48517814|NCT04133311|156089624|FG000|Period 1 Double Masked Treatment Period|Death|1|||
48517815|NCT04133311|156089625|FG001|Period 1 Double Masked Treatment Period|Death|0|||
48823287|NCT02362035|157192395|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
48823288|NCT02362035|157192395|FG000|Overall Study|Disease progression|11|||
48823289|NCT02362035|157192395|FG000|Overall Study|Withdrawal by Subject|20|||
48823290|NCT01222247|157192398|FG000|Overall Study|Lost to Follow-up|2|||
48823291|NCT01222247|157192399|FG001|Overall Study|Lost to Follow-up|2|||
48823292|NCT02338609|157192402|FG000|Overall Study|Physician Decision|1|||
48823293|NCT02338609|157192402|FG000|Overall Study|Death|1|||
48823294|NCT03884231|157193911|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
48823295|NCT03884231|157193911|FG000|Overall Study|Subject Withdrew Consent|1|||
48823296|NCT03884231|157193911|FG000|Overall Study|MRI Scan Not Performed|1|||
48823297|NCT01929993|157193912|FG000|Overall Study|Protocol Violation|4|||
48823298|NCT01929993|157193913|FG001|Overall Study|Protocol Violation|6|||
48517816|NCT04133311|156089626|FG002|Period 1 Double Masked Treatment Period|Death|0|||
48517817|NCT04133311|156089627|FG003|Period 1 Double Masked Treatment Period|Death|0|||
48517818|NCT04133311|156089624|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
48517819|NCT04133311|156089625|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
48517820|NCT04133311|156089626|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
48517821|NCT04133311|156089627|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
48517822|NCT04133311|156089624|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
48517823|NCT04133311|156089625|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
48517824|NCT04133311|156089626|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
48383702|NCT00108069|155600241|FG000|Overall Study|Progessive disease|27|||
48383703|NCT00108069|155600242|FG001|Overall Study|Progessive disease|11|||
48517825|NCT04133311|156089627|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
48517826|NCT04133311|156089624|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
48517827|NCT04133311|156089625|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
48517828|NCT04133311|156089626|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
48823299|NCT01929993|157193912|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
48823300|NCT01929993|157193913|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
48823301|NCT02065245|157193922|FG000|Infusion 1|Lost to Follow-up|0|||
48383704|NCT03606980|155600243|FG000|Overall Study|Lost to Follow-up|3|||
48517829|NCT04133311|156089627|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
48517830|NCT04133311|156089624|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
48823302|NCT02065245|157193923|FG001|Infusion 1|Lost to Follow-up|0|||
48823303|NCT02065245|157193924|FG002|Infusion 1|Lost to Follow-up|0|||
48823304|NCT02065245|157193925|FG003|Infusion 1|Lost to Follow-up|0|||
48517831|NCT04133311|156089625|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
48517832|NCT04133311|156089626|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
48730736|NCT04029688|156865879|FG003|Overall Study|Death|2|||
48730737|NCT04029688|156865880|FG004|Overall Study|Death|5|||
48730738|NCT04029688|156865881|FG005|Overall Study|Death|0|||
48730739|NCT04029688|156865882|FG006|Overall Study|Death|2|||
48730740|NCT04029688|156865883|FG007|Overall Study|Death|3|||
48730741|NCT04029688|156865876|FG000|Overall Study|Study Terminated by Sponsor|0|||
48517833|NCT04133311|156089627|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
48517834|NCT04133311|156089624|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
48517835|NCT04133311|156089625|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
48517836|NCT04133311|156089626|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
48517837|NCT04133311|156089627|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
48517838|NCT04133311|156089624|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
48517839|NCT04133311|156089625|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
48517840|NCT04133311|156089626|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
48517841|NCT04133311|156089627|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
48517842|NCT04133311|156089624|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
48517843|NCT04133311|156089625|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
48517844|NCT04133311|156089626|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
48517845|NCT04133311|156089627|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
48517846|NCT01143337|156089633|FG000|Overall Study|Adverse Event|3|||
48517847|NCT01143337|156089634|FG001|Overall Study|Adverse Event|9|||
48517848|NCT01143337|156089635|FG002|Overall Study|Adverse Event|5|||
48517849|NCT01143337|156089633|FG000|Overall Study|Lack of Efficacy|6|||
48517850|NCT01143337|156089634|FG001|Overall Study|Lack of Efficacy|2|||
48517851|NCT01143337|156089635|FG002|Overall Study|Lack of Efficacy|1|||
48517852|NCT01143337|156089633|FG000|Overall Study|Protocol Violation|1|||
48517853|NCT01143337|156089634|FG001|Overall Study|Protocol Violation|0|||
48517854|NCT01143337|156089635|FG002|Overall Study|Protocol Violation|0|||
48517855|NCT01143337|156089633|FG000|Overall Study|Withdrawal by Subject|0|||
48517856|NCT01143337|156089634|FG001|Overall Study|Withdrawal by Subject|0|||
48517857|NCT01143337|156089635|FG002|Overall Study|Withdrawal by Subject|1|||
48517858|NCT01143337|156089633|FG000|Overall Study|Other reason|0|||
48517859|NCT01143337|156089634|FG001|Overall Study|Other reason|0|||
48517860|NCT01143337|156089635|FG002|Overall Study|Other reason|5|||
48517861|NCT02471807|156089636|FG000|Overall Study|Death|14|||
48517862|NCT02471807|156089636|FG000|Overall Study|Withdrawal by Subject|2|||
48517863|NCT02471807|156089636|FG000|Overall Study|Explant|5|||
48517864|NCT02471807|156089636|FG000|Overall Study|Lost to Follow-up|1|||
48517865|NCT01120028|156089641|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
48517866|NCT01120028|156089642|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
48517867|NCT01120028|156089643|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
48517868|NCT01120028|156089644|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
48517869|NCT01120028|156089641|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
48517870|NCT01120028|156089642|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
48517871|NCT01120028|156089643|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
48517872|NCT01120028|156089644|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
48517873|NCT00728754|156089645|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
48517874|NCT00728754|156089646|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
48517875|NCT00728754|156089645|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
48517876|NCT00728754|156089646|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
48517877|NCT00728754|156089645|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
48517878|NCT00728754|156089646|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
48517879|NCT00009945|156089649|FG000|Overall Study|no follow up data|7|||
48517880|NCT00009945|156089650|FG001|Overall Study|no follow up data|5|||
48517881|NCT02654145|156089651|FG000|Overall Study|Lack of Efficacy|1|||
48517882|NCT02654145|156089651|FG000|Overall Study|Protocol Violation|1|||
48730742|NCT04029688|156865877|FG001|Overall Study|Study Terminated by Sponsor|0|||
48730743|NCT04029688|156865878|FG002|Overall Study|Study Terminated by Sponsor|0|||
48730744|NCT04029688|156865879|FG003|Overall Study|Study Terminated by Sponsor|0|||
48730745|NCT04029688|156865880|FG004|Overall Study|Study Terminated by Sponsor|1|||
48730746|NCT04029688|156865881|FG005|Overall Study|Study Terminated by Sponsor|3|||
48730747|NCT04029688|156865882|FG006|Overall Study|Study Terminated by Sponsor|1|||
48730748|NCT04029688|156865883|FG007|Overall Study|Study Terminated by Sponsor|3|||
48730749|NCT04029688|156865876|FG000|Overall Study|Withdrawal by Subject|0|||
48730750|NCT04029688|156865877|FG001|Overall Study|Withdrawal by Subject|0|||
48730751|NCT04029688|156865878|FG002|Overall Study|Withdrawal by Subject|0|||
48730752|NCT04029688|156865879|FG003|Overall Study|Withdrawal by Subject|1|||
48730753|NCT04029688|156865880|FG004|Overall Study|Withdrawal by Subject|0|||
48730754|NCT04029688|156865881|FG005|Overall Study|Withdrawal by Subject|0|||
48730755|NCT04029688|156865882|FG006|Overall Study|Withdrawal by Subject|0|||
48730756|NCT04029688|156865883|FG007|Overall Study|Withdrawal by Subject|0|||
48517883|NCT02654145|156089651|FG000|Overall Study|Withdrawal by Subject|5|||
48517884|NCT02611362|156089663|FG000|Overall Study|Withdrawal by Subject|7|||
48517885|NCT02611362|156089664|FG001|Overall Study|Withdrawal by Subject|2|||
48517886|NCT02611362|156089663|FG000|Overall Study|Lost to Follow-up|2|||
48517887|NCT02611362|156089664|FG001|Overall Study|Lost to Follow-up|4|||
48517888|NCT00354159|156089667|FG000|Randomized Study Period|Withdrawal by Subject|5|||
48517889|NCT00354159|156089668|FG001|Randomized Study Period|Withdrawal by Subject|3|||
48823305|NCT02065245|157193926|FG004|Infusion 1|Lost to Follow-up|0|||
48823306|NCT02065245|157193927|FG005|Infusion 1|Lost to Follow-up|0|||
48517890|NCT00354159|156089667|FG000|Randomized Study Period|Physician Decision|6|||
48517891|NCT00354159|156089668|FG001|Randomized Study Period|Physician Decision|10|||
48383705|NCT03606980|155600244|FG001|Overall Study|Lost to Follow-up|2|||
48383706|NCT03606980|155600245|FG002|Overall Study|Lost to Follow-up|3|||
48383707|NCT03606980|155600243|FG000|Overall Study|Withdrawal by Subject|1|||
48383708|NCT03606980|155600244|FG001|Overall Study|Withdrawal by Subject|0|||
48383709|NCT03606980|155600245|FG002|Overall Study|Withdrawal by Subject|4|||
48383710|NCT01849497|155600246|FG000|Overall Study|Withdrawal by Subject|1|||
48383711|NCT01849497|155600247|FG001|Overall Study|Withdrawal by Subject|2|||
48383712|NCT01849497|155600246|FG000|Overall Study|Sponsor Decision|0|||
48383713|NCT01849497|155600247|FG001|Overall Study|Sponsor Decision|1|||
48383714|NCT01849497|155600246|FG000|Overall Study|Lost to Follow-up|0|||
48383715|NCT01849497|155600247|FG001|Overall Study|Lost to Follow-up|1|||
48383716|NCT00911625|155600248|FG000|Overall Study|Lost to Follow-up|7|||
48383717|NCT00911625|155600249|FG001|Overall Study|Lost to Follow-up|0|||
48517892|NCT00354159|156089667|FG000|Randomized Study Period|Lost to Follow-up|4|||
48823307|NCT02065245|157193928|FG006|Infusion 1|Lost to Follow-up|1|||
48517893|NCT00354159|156089668|FG001|Randomized Study Period|Lost to Follow-up|0|||
48517894|NCT00354159|156089667|FG000|Randomized Study Period|Death|7|||
48517895|NCT00354159|156089668|FG001|Randomized Study Period|Death|9|||
48517896|NCT00354159|156089667|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
48517897|NCT00354159|156089668|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
48517898|NCT00354159|156089667|FG000|Long-term Follow-up|Physician Decision|127|||
48517899|NCT00354159|156089668|FG001|Long-term Follow-up|Physician Decision|122|||
48517900|NCT00354159|156089667|FG000|Long-term Follow-up|Lost to Follow-up|1|||
48517901|NCT00354159|156089668|FG001|Long-term Follow-up|Lost to Follow-up|0|||
48517902|NCT00354159|156089667|FG000|Long-term Follow-up|Death|14|||
48517903|NCT00354159|156089668|FG001|Long-term Follow-up|Death|11|||
48517904|NCT00354159|156089667|FG000|Long-term Follow-up|Study Closed|29|||
48517905|NCT00354159|156089668|FG001|Long-term Follow-up|Study Closed|34|||
48517906|NCT02046122|156089669|FG000|Overall Study|Physician Decision|8|||
48517907|NCT02046122|156089669|FG000|Overall Study|Withdrawal by Subject|1|||
48517908|NCT01559116|156089674|FG000|Overall Study|Adverse Event|10|||
48517909|NCT01559116|156089674|FG000|Overall Study|Lack of Efficacy|1|||
48517910|NCT01559116|156089674|FG000|Overall Study|Lost to Follow-up|1|||
48517911|NCT01559116|156089674|FG000|Overall Study|Protocol Violation|1|||
48517912|NCT01559116|156089674|FG000|Overall Study|Withdrawal by Subject|4|||
48517913|NCT01559116|156089674|FG000|Overall Study|other than stated above|9|||
48517914|NCT02227238|156089675|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
48517915|NCT02227238|156089676|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
48517916|NCT02227238|156089677|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
48517917|NCT02227238|156089675|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
48517918|NCT02227238|156089676|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
48517919|NCT02227238|156089677|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
48517920|NCT02227238|156089675|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
48517921|NCT02227238|156089676|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
48517922|NCT02227238|156089677|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
48517923|NCT02227238|156089675|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
48517924|NCT02227238|156089676|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
48517925|NCT02227238|156089677|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
48517926|NCT02227238|156089675|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
48517927|NCT02227238|156089676|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
48517928|NCT02227238|156089677|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
48517929|NCT02227238|156089675|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
48517930|NCT02227238|156089676|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
48517931|NCT02227238|156089677|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
48517932|NCT02227238|156089675|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
48517933|NCT02227238|156089676|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
48517934|NCT02227238|156089677|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
48517935|NCT02227238|156089675|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
48517936|NCT02227238|156089676|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
48517937|NCT02227238|156089677|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
48517938|NCT02227238|156089675|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
48601117|NCT02718911|156396041|FG001|Overall Study|Lost to Follow-up|0|||
48383718|NCT03785678|155600250|FG000|Overall Study|Death|44|||
48517939|NCT02227238|156089676|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
48517940|NCT02227238|156089677|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
48517941|NCT02227238|156089675|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
48517942|NCT02227238|156089676|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
48517943|NCT02227238|156089677|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
48517944|NCT02227238|156089675|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
48517945|NCT02227238|156089676|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
48517946|NCT02227238|156089677|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
48517947|NCT02227238|156089675|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
48517948|NCT02227238|156089676|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
48517949|NCT02227238|156089677|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
48517950|NCT02227238|156089675|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
48517951|NCT02227238|156089676|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
48517952|NCT02227238|156089677|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
48517953|NCT02227238|156089675|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
48517954|NCT02227238|156089676|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
48517955|NCT02227238|156089677|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
48517956|NCT03277248|156089678|FG000|Overall Study|Adverse Event|3|||
48517957|NCT03277248|156089679|FG001|Overall Study|Adverse Event|1|||
48517958|NCT03277248|156089678|FG000|Overall Study|Subject Withdrawal of Consent|6|||
48517959|NCT03277248|156089679|FG001|Overall Study|Subject Withdrawal of Consent|23|||
48517960|NCT03277248|156089678|FG000|Overall Study|Investigator/Sponsor Decision|2|||
48517961|NCT03277248|156089679|FG001|Overall Study|Investigator/Sponsor Decision|2|||
48517962|NCT03277248|156089678|FG000|Overall Study|Pregnancy|4|||
48517963|NCT03277248|156089679|FG001|Overall Study|Pregnancy|1|||
48517964|NCT03277248|156089678|FG000|Overall Study|Lost to Follow-up|0|||
48517965|NCT03277248|156089679|FG001|Overall Study|Lost to Follow-up|2|||
48517966|NCT03277248|156089678|FG000|Overall Study|Lack of Efficacy|0|||
48517967|NCT03277248|156089679|FG001|Overall Study|Lack of Efficacy|2|||
48517968|NCT03277248|156089678|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
48517969|NCT03277248|156089679|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
48517970|NCT02011945|156089680|FG000|Overall Study|Participant requested to Discontinue|0|||
48517971|NCT02011945|156089681|FG001|Overall Study|Participant requested to Discontinue|1|||
48517972|NCT02011945|156089682|FG002|Overall Study|Participant requested to Discontinue|1|||
48517973|NCT02011945|156089680|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
48517974|NCT02011945|156089681|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
48517975|NCT02011945|156089682|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
48517976|NCT02011945|156089680|FG000|Overall Study|Study Drug Toxicity|0|||
48517977|NCT02011945|156089681|FG001|Overall Study|Study Drug Toxicity|0|||
48517978|NCT02011945|156089682|FG002|Overall Study|Study Drug Toxicity|1|||
48517979|NCT02011945|156089680|FG000|Overall Study|Treatment Failure|0|||
48517980|NCT02011945|156089681|FG001|Overall Study|Treatment Failure|7|||
48517981|NCT02011945|156089682|FG002|Overall Study|Treatment Failure|6|||
48517982|NCT02011945|156089680|FG000|Overall Study|No Longer Meets Study Criteria|1|||
48517983|NCT02011945|156089681|FG001|Overall Study|No Longer Meets Study Criteria|0|||
48517984|NCT02011945|156089682|FG002|Overall Study|No Longer Meets Study Criteria|0|||
48517985|NCT02011945|156089680|FG000|Overall Study|Proceeded to stem cell transplant|0|||
48517986|NCT02011945|156089681|FG001|Overall Study|Proceeded to stem cell transplant|0|||
48517987|NCT02011945|156089682|FG002|Overall Study|Proceeded to stem cell transplant|1|||
48517988|NCT02011945|156089680|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
48517989|NCT02011945|156089681|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
48517990|NCT02011945|156089682|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
48517991|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
48517992|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
48517993|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
48517994|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
48517995|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
48517996|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
48517997|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
48517998|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
48517999|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
48518000|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
48518001|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
48518002|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
48518003|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
48383719|NCT03785678|155600251|FG001|Overall Study|Death|42|||
48518004|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
48518005|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
48518006|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
48518007|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
48518008|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
48518009|NCT00950300|156089683|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
48518010|NCT00950300|156089684|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
48518011|NCT00950300|156089683|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
48518012|NCT00950300|156089684|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
48518013|NCT00950300|156089683|FG000|TFFU Period|Death|4|||
48518014|NCT00950300|156089684|FG001|TFFU Period|Death|1|||
48518015|NCT00950300|156089683|FG000|TFFU Period|Refused Treatment|10|||
48518016|NCT00950300|156089684|FG001|TFFU Period|Refused Treatment|11|||
48518017|NCT00950300|156089683|FG000|TFFU Period|Failure to Return|16|||
48518018|NCT00950300|156089684|FG001|TFFU Period|Failure to Return|16|||
48518019|NCT00950300|156089683|FG000|TFFU Period|Recurrence of Disease|63|||
48518020|NCT00950300|156089684|FG001|TFFU Period|Recurrence of Disease|72|||
48518021|NCT00950300|156089683|FG000|TFFU Period|Other|4|||
48518022|NCT00950300|156089684|FG001|TFFU Period|Other|3|||
48518023|NCT00950300|156089683|FG000|SFU Period|Death|44|||
48823308|NCT02065245|157193922|FG000|Infusion 1|Death|0|||
48823309|NCT02065245|157193923|FG001|Infusion 1|Death|0|||
48823310|NCT02065245|157193924|FG002|Infusion 1|Death|1|||
48518024|NCT00950300|156089684|FG001|SFU Period|Death|42|||
48518025|NCT00950300|156089683|FG000|SFU Period|Lost to Follow-up|30|||
48823311|NCT02065245|157193925|FG003|Infusion 1|Death|0|||
48823312|NCT02065245|157193926|FG004|Infusion 1|Death|1|||
48823313|NCT02065245|157193927|FG005|Infusion 1|Death|0|||
48823314|NCT02065245|157193928|FG006|Infusion 1|Death|0|||
48823315|NCT02065245|157193922|FG000|Infusion 2|Death|0|||
48823316|NCT02065245|157193923|FG001|Infusion 2|Death|0|||
48823317|NCT02065245|157193924|FG002|Infusion 2|Death|0|||
48823318|NCT02065245|157193925|FG003|Infusion 2|Death|0|||
48518026|NCT00950300|156089684|FG001|SFU Period|Lost to Follow-up|28|||
48518027|NCT00950300|156089683|FG000|SFU Period|Withdrawal by Subject|4|||
48518028|NCT00950300|156089684|FG001|SFU Period|Withdrawal by Subject|8|||
48518029|NCT00902538|156089685|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
48518030|NCT00902538|156089686|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
48518031|NCT00902538|156089687|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
48518032|NCT00902538|156089688|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
48518033|NCT00902538|156089689|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
48518034|NCT00902538|156089690|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
48518035|NCT00902538|156089685|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
48518036|NCT00902538|156089686|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
48518037|NCT00902538|156089687|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
48518038|NCT00902538|156089688|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
48518039|NCT00902538|156089689|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
48518040|NCT00902538|156089690|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
48518041|NCT00902538|156089685|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
48518042|NCT00902538|156089686|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
48518043|NCT00902538|156089687|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
48518044|NCT00902538|156089688|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
48518045|NCT00902538|156089689|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
48518046|NCT00902538|156089690|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
48518047|NCT00902538|156089685|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
48518048|NCT00902538|156089686|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
48518049|NCT00902538|156089687|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
48518050|NCT00902538|156089688|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
48518051|NCT00902538|156089689|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
48518052|NCT00902538|156089690|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
48518053|NCT00902538|156089685|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
48518054|NCT00902538|156089686|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
48518055|NCT00902538|156089687|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
48518056|NCT00902538|156089688|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
48518057|NCT00902538|156089689|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
48518058|NCT00902538|156089690|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
48518059|NCT00902538|156089685|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
48518060|NCT00902538|156089686|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
48823319|NCT02065245|157193926|FG004|Infusion 2|Death|0|||
48823320|NCT02065245|157193927|FG005|Infusion 2|Death|0|||
48823321|NCT02065245|157193928|FG006|Infusion 2|Death|1|||
48823322|NCT02065245|157193922|FG000|Infusion 3|Lost to Follow-up|1|||
48823323|NCT02065245|157193923|FG001|Infusion 3|Lost to Follow-up|1|||
48518061|NCT00902538|156089687|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
48518062|NCT00902538|156089688|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
48518063|NCT00902538|156089689|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
48518064|NCT00902538|156089690|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
48518065|NCT00902538|156089685|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
48518066|NCT00902538|156089686|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
48518067|NCT00902538|156089687|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
48518068|NCT00902538|156089688|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
48518069|NCT00902538|156089689|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
48518070|NCT00902538|156089690|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
48518071|NCT00902538|156089685|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
48518072|NCT00902538|156089686|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
48518073|NCT00902538|156089687|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
48518074|NCT00902538|156089688|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
48518075|NCT00902538|156089689|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
48518076|NCT00902538|156089690|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
48518077|NCT00902538|156089685|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
48518078|NCT00902538|156089686|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
48518079|NCT00902538|156089687|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
48518080|NCT00902538|156089688|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
48518081|NCT00902538|156089689|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
48518082|NCT00902538|156089690|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
48518083|NCT00902538|156089685|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
48518084|NCT00902538|156089686|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
48518085|NCT00902538|156089687|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
48518086|NCT00902538|156089688|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
48518087|NCT00902538|156089689|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
48518088|NCT00902538|156089690|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
48518089|NCT00902538|156089685|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
48518090|NCT00902538|156089686|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
48518091|NCT00902538|156089687|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
48518092|NCT00902538|156089688|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
48518093|NCT00902538|156089689|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
48518094|NCT00902538|156089690|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
48518095|NCT00902538|156089685|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
48518096|NCT00902538|156089686|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
48518097|NCT00902538|156089687|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
48518098|NCT00902538|156089688|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
48518099|NCT00902538|156089689|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
48518100|NCT00902538|156089690|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
48518101|NCT00902538|156089685|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
48518102|NCT00902538|156089686|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
48518103|NCT00902538|156089687|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
48518104|NCT00902538|156089688|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
48518105|NCT00902538|156089689|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
48518106|NCT00902538|156089690|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
48518107|NCT00902538|156089685|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
48518108|NCT00902538|156089686|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
48518109|NCT00902538|156089687|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
48518110|NCT00902538|156089688|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
48518111|NCT00902538|156089689|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
48518112|NCT00902538|156089690|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
48518113|NCT00902538|156089685|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
48518114|NCT00902538|156089686|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
48518115|NCT00902538|156089687|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
48518116|NCT00902538|156089688|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
48518117|NCT00902538|156089689|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
48518118|NCT00902538|156089690|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
48518119|NCT00902538|156089685|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
48518120|NCT00902538|156089686|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
48518121|NCT00902538|156089687|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
48518122|NCT00902538|156089688|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
48518123|NCT00902538|156089689|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
48518124|NCT00902538|156089690|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
48823324|NCT02065245|157193924|FG002|Infusion 3|Lost to Follow-up|0|||
48823325|NCT02065245|157193925|FG003|Infusion 3|Lost to Follow-up|0|||
48823326|NCT02065245|157193926|FG004|Infusion 3|Lost to Follow-up|0|||
48518125|NCT00902538|156089685|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
48518126|NCT00902538|156089686|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
48518127|NCT00902538|156089687|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
48518128|NCT00902538|156089688|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
48518129|NCT00902538|156089689|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
48518130|NCT00902538|156089690|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
48518131|NCT02030535|156089691|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
48518132|NCT01374451|156089694|FG000|Overall Study|Administrative problems|1|||
48518133|NCT01374451|156089695|FG001|Overall Study|Administrative problems|0|||
48518134|NCT01490190|156090778|FG000|Overall Study|Withdrawal by Subject|9|||
48823327|NCT02065245|157193927|FG005|Infusion 3|Lost to Follow-up|0|||
48823328|NCT02065245|157193928|FG006|Infusion 3|Lost to Follow-up|0|||
48823329|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
48823330|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
48823331|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
48823332|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
48823333|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
48823334|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
48823335|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
48823336|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
48823337|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
48823338|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
48823339|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
48823340|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
48823341|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
48823342|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
48823343|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
48823344|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
48823345|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
48823346|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
48823347|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823348|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
48823349|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823350|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823351|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823352|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
48823353|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
48823354|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823355|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823356|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823357|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823358|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
48823359|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
48823360|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
48823361|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
48823362|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
48823363|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
48823364|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
48823365|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
48823366|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
48823367|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
48823368|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
48823369|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
48518135|NCT01490190|156090778|FG000|Overall Study|Adverse Event|17|||
48518136|NCT01490190|156090778|FG000|Overall Study|Protocol Violation|5|||
48518137|NCT01490190|156090778|FG000|Overall Study|Lost to Follow-up|13|||
48823370|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
48518138|NCT01490190|156090778|FG000|Overall Study|Relocation|1|||
48518139|NCT01490190|156090778|FG000|Overall Study|Inconvenience|1|||
48518140|NCT01490190|156090778|FG000|Overall Study|Ring expulsion|2|||
48518141|NCT01376037|156090785|FG000|Overall Study|Lost to Follow-up|0|||
48518142|NCT01376037|156090786|FG001|Overall Study|Lost to Follow-up|2|||
48518143|NCT03234907|156090787|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
48518144|NCT03234907|156090788|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
48823371|NCT01089556|157193929|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
48823372|NCT01089556|157193930|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
48823373|NCT01089556|157193931|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
48518145|NCT03234907|156090789|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
48518146|NCT03234907|156090790|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
48518147|NCT03234907|156090791|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
48518148|NCT03234907|156090792|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
48518149|NCT03234907|156090787|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
48518150|NCT03234907|156090788|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
48518151|NCT03234907|156090789|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
48518152|NCT03234907|156090790|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
48518153|NCT03234907|156090791|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
48518154|NCT03234907|156090792|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
48518155|NCT03234907|156090787|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
48518156|NCT03234907|156090788|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
48518157|NCT03234907|156090789|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
48518158|NCT03234907|156090790|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
48518159|NCT03234907|156090791|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
48518160|NCT03234907|156090792|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
48518161|NCT03234907|156090787|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
48823374|NCT01089556|157193932|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
48823375|NCT01089556|157193933|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
48823376|NCT01089556|157193934|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
48823377|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
48823378|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
48823379|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
48823380|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
48823381|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
48823382|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
48823383|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
48823384|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
48823385|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
48823386|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
48823387|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
48823388|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
48518162|NCT03234907|156090788|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
48518163|NCT03234907|156090789|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
48518164|NCT03234907|156090790|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
48518165|NCT03234907|156090791|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
48518166|NCT03234907|156090792|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
48518167|NCT03234907|156090787|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
48518168|NCT03234907|156090788|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
48518169|NCT03234907|156090789|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
48518170|NCT03234907|156090790|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
48518171|NCT03234907|156090791|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
48518172|NCT03234907|156090792|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
48518173|NCT03234907|156090787|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
48518174|NCT03234907|156090788|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
48518175|NCT03234907|156090789|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
48518176|NCT03234907|156090790|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
48518177|NCT03234907|156090791|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
48518178|NCT03234907|156090792|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
48518179|NCT03234907|156090787|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
48518180|NCT03234907|156090788|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
48518181|NCT03234907|156090789|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
48518182|NCT03234907|156090790|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
48518183|NCT03234907|156090791|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
48518184|NCT03234907|156090792|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
48518185|NCT02664415|156090793|FG000|Overall Study|Adverse Event|1|||
48518186|NCT02664415|156090794|FG001|Overall Study|Adverse Event|0|||
48518187|NCT00642993|156090795|FG000|Overall Study|Adverse Event|85|||
48518188|NCT00642993|156090796|FG001|Overall Study|Adverse Event|4|||
48518189|NCT00642993|156090795|FG000|Overall Study|Lost to Follow-up|8|||
48518190|NCT00642993|156090796|FG001|Overall Study|Lost to Follow-up|4|||
48518191|NCT00642993|156090795|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
48518192|NCT00642993|156090796|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
48518193|NCT00642993|156090795|FG000|Overall Study|Protocol Violation|1|||
48518194|NCT00642993|156090796|FG001|Overall Study|Protocol Violation|4|||
48518195|NCT00642993|156090795|FG000|Overall Study|Did not meet protocol eligibility|0|||
48518196|NCT00642993|156090796|FG001|Overall Study|Did not meet protocol eligibility|1|||
48518197|NCT00642993|156090795|FG000|Overall Study|Administrative|1|||
48518198|NCT00642993|156090796|FG001|Overall Study|Administrative|0|||
48383720|NCT03785678|155600250|FG000|Overall Study|Lost to Follow-up|4|||
48518199|NCT00373256|156090802|FG000|Overall Study|Adverse Event (AE)|1|||
48518200|NCT00373256|156090803|FG001|Overall Study|Adverse Event (AE)|5|||
48383721|NCT03785678|155600251|FG001|Overall Study|Lost to Follow-up|2|||
48383722|NCT03785678|155600250|FG000|Overall Study|Physician Decision|0|||
48383723|NCT03785678|155600251|FG001|Overall Study|Physician Decision|2|||
48383724|NCT03785678|155600250|FG000|Overall Study|Withdrawal by Subject|5|||
48383725|NCT03785678|155600251|FG001|Overall Study|Withdrawal by Subject|3|||
48383726|NCT03308942|155601430|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
48383727|NCT03308942|155601431|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
48383728|NCT03308942|155601432|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
48518201|NCT00373256|156090802|FG000|Overall Study|Lost to Follow-up|2|||
48518202|NCT00373256|156090803|FG001|Overall Study|Lost to Follow-up|1|||
48518203|NCT00373256|156090802|FG000|Overall Study|Death|9|||
48518204|NCT00373256|156090803|FG001|Overall Study|Death|8|||
48518205|NCT00373256|156090802|FG000|Overall Study|Objective Progression or Relapse|111|||
48518206|NCT00373256|156090803|FG001|Overall Study|Objective Progression or Relapse|104|||
48518207|NCT00373256|156090802|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
48518208|NCT00373256|156090803|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
48518209|NCT00373256|156090802|FG000|Overall Study|Other|73|||
48518210|NCT00373256|156090803|FG001|Overall Study|Other|107|||
48518211|NCT00373256|156090802|FG000|Overall Study|Protocol Violation|0|||
48518212|NCT00373256|156090803|FG001|Overall Study|Protocol Violation|2|||
48518213|NCT00373256|156090802|FG000|Overall Study|Study Terminated by Sponsor|41|||
48518214|NCT00373256|156090803|FG001|Overall Study|Study Terminated by Sponsor|13|||
48518215|NCT02986139|156090805|FG000|Overall Study|Sponsor Decision|1|||
48518216|NCT02986139|156090806|FG001|Overall Study|Sponsor Decision|2|||
48518217|NCT02986139|156090805|FG000|Overall Study|Withdrawal by Subject|0|||
48518218|NCT02986139|156090806|FG001|Overall Study|Withdrawal by Subject|1|||
48518219|NCT02986139|156090805|FG000|Overall Study|Lost to Follow-up|0|||
48518220|NCT02986139|156090806|FG001|Overall Study|Lost to Follow-up|1|||
48823389|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
48823390|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
48823391|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
48518221|NCT00516295|156090808|FG000|Overall Study|Lack of Efficacy|2|||
48518222|NCT00516295|156090809|FG001|Overall Study|Lack of Efficacy|0|||
48518223|NCT00516295|156090810|FG002|Overall Study|Lack of Efficacy|0|||
48518224|NCT00516295|156090808|FG000|Overall Study|Ineligible|1|||
48518225|NCT00516295|156090809|FG001|Overall Study|Ineligible|0|||
48518226|NCT00516295|156090810|FG002|Overall Study|Ineligible|0|||
48518227|NCT01456962|156090811|FG000|Overall Study|Lost to Follow-up|2|||
48518228|NCT01456962|156090812|FG001|Overall Study|Lost to Follow-up|1|||
48518229|NCT04968925|156090819|FG000|Phase I- Period 1|COVID-19 related|0|||
48518230|NCT04968925|156090820|FG001|Phase I- Period 1|COVID-19 related|1|||
48518231|NCT04968925|156090821|FG002|Phase I- Period 1|COVID-19 related|0|||
48518232|NCT04968925|156090822|FG003|Phase I- Period 1|COVID-19 related|0|||
48518233|NCT04968925|156090819|FG000|Phase I- Period 1|Subject enrolled in error|1|||
48518234|NCT04968925|156090820|FG001|Phase I- Period 1|Subject enrolled in error|1|||
48518235|NCT04968925|156090821|FG002|Phase I- Period 1|Subject enrolled in error|0|||
48518236|NCT04968925|156090822|FG003|Phase I- Period 1|Subject enrolled in error|0|||
48518237|NCT04968925|156090819|FG000|Phase II- Period 1|COVID-19 Related|0|||
48383729|NCT03308942|155601433|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
48383730|NCT03308942|155601434|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
48518238|NCT04968925|156090820|FG001|Phase II- Period 1|COVID-19 Related|0|||
48518239|NCT04968925|156090821|FG002|Phase II- Period 1|COVID-19 Related|6|||
48518240|NCT04968925|156090822|FG003|Phase II- Period 1|COVID-19 Related|6|||
48518241|NCT04968925|156090819|FG000|Phase II- Period 1|Subject enrolled in error|0|||
48518242|NCT04968925|156090820|FG001|Phase II- Period 1|Subject enrolled in error|0|||
48518243|NCT04968925|156090821|FG002|Phase II- Period 1|Subject enrolled in error|1|||
48518244|NCT04968925|156090822|FG003|Phase II- Period 1|Subject enrolled in error|0|||
48518245|NCT04968925|156090819|FG000|Phase II -Period 2|COVID-19 related|0|||
48518246|NCT04968925|156090820|FG001|Phase II -Period 2|COVID-19 related|0|||
48518247|NCT04968925|156090821|FG002|Phase II -Period 2|COVID-19 related|4|||
48518248|NCT04968925|156090822|FG003|Phase II -Period 2|COVID-19 related|3|||
48518249|NCT04968925|156090819|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
48518250|NCT04968925|156090820|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
48518251|NCT04968925|156090821|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
48518252|NCT04968925|156090822|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
48518253|NCT02727192|156090824|FG000|Overall Study|Lost to Follow-up|1|||
48518254|NCT02727192|156090825|FG001|Overall Study|Lost to Follow-up|0|||
48518255|NCT02727192|156090826|FG002|Overall Study|Lost to Follow-up|0|||
48518256|NCT03497130|156090827|FG000|Overall Study|Lost to Follow-up|1|||
48518257|NCT03497130|156090828|FG001|Overall Study|Lost to Follow-up|1|||
48518258|NCT00731939|156090829|FG000|Overall Study|Adverse Event|6|||
48518259|NCT00731939|156090829|FG000|Overall Study|Lost to Follow-up|15|||
48823392|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
48823393|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
48823394|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
48823395|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823396|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823397|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
48823398|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823399|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823400|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
48823401|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
48823402|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
48823403|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
48823404|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
48823405|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
48518260|NCT00731939|156090829|FG000|Overall Study|Not implanted with study device|9|||
48518261|NCT00731939|156090829|FG000|Overall Study|Withdrawal by Subject|2|||
48518262|NCT00731939|156090829|FG000|Overall Study|Did not meet enrollment criteria|2|||
48518263|NCT00965757|156090831|FG000|Double-blind Phase|Progression of concomitant disease|1|||
48518264|NCT00965757|156090832|FG001|Double-blind Phase|Progression of concomitant disease|2|||
48518265|NCT00965757|156090833|FG002|Double-blind Phase|Progression of concomitant disease|0|||
48518266|NCT00965757|156090834|FG003|Double-blind Phase|Progression of concomitant disease|0|||
48518267|NCT00965757|156090831|FG000|Double-blind Phase|Adverse drug reaction|2|||
48518268|NCT00965757|156090832|FG001|Double-blind Phase|Adverse drug reaction|1|||
48518269|NCT00965757|156090833|FG002|Double-blind Phase|Adverse drug reaction|0|||
48518270|NCT00965757|156090834|FG003|Double-blind Phase|Adverse drug reaction|0|||
48518271|NCT00965757|156090831|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
48518272|NCT00965757|156090832|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
48518273|NCT00965757|156090833|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
48518274|NCT00965757|156090834|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
48518275|NCT00965757|156090831|FG000|Double-blind Phase|Lack of Efficacy|7|||
48518276|NCT00965757|156090832|FG001|Double-blind Phase|Lack of Efficacy|11|||
48518277|NCT00965757|156090833|FG002|Double-blind Phase|Lack of Efficacy|0|||
48518278|NCT00965757|156090834|FG003|Double-blind Phase|Lack of Efficacy|0|||
48518279|NCT00965757|156090831|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
48518280|NCT00965757|156090832|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
48518281|NCT00965757|156090833|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
48518282|NCT00965757|156090834|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
48518283|NCT00965757|156090831|FG000|Double-blind Phase|Lost to Follow-up|0|||
48518284|NCT00965757|156090832|FG001|Double-blind Phase|Lost to Follow-up|1|||
48518285|NCT00965757|156090833|FG002|Double-blind Phase|Lost to Follow-up|0|||
48518286|NCT00965757|156090834|FG003|Double-blind Phase|Lost to Follow-up|0|||
48518287|NCT00965757|156090831|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
48518288|NCT00965757|156090832|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
48518289|NCT00965757|156090833|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
48823406|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
48442278|NCT01763866|155805486|FG017|Overall Study|Lost to Follow-up|0|||
48442279|NCT01763866|155805487|FG018|Overall Study|Lost to Follow-up|1|||
48442280|NCT01763866|155805488|FG019|Overall Study|Lost to Follow-up|1|||
48442281|NCT01763866|155805489|FG020|Overall Study|Lost to Follow-up|0|||
48442282|NCT01763866|155805490|FG021|Overall Study|Lost to Follow-up|0|||
48442283|NCT01763866|155805491|FG022|Overall Study|Lost to Follow-up|0|||
48442284|NCT01763866|155805492|FG023|Overall Study|Lost to Follow-up|1|||
48442285|NCT01763866|155805469|FG000|Overall Study|Death|0|||
48442286|NCT01763866|155805470|FG001|Overall Study|Death|0|||
48442287|NCT01763866|155805471|FG002|Overall Study|Death|0|||
48442288|NCT01763866|155805472|FG003|Overall Study|Death|0|||
48442289|NCT01763866|155805473|FG004|Overall Study|Death|0|||
48442290|NCT01763866|155805474|FG005|Overall Study|Death|0|||
48442291|NCT01763866|155805475|FG006|Overall Study|Death|0|||
48442292|NCT01763866|155805476|FG007|Overall Study|Death|0|||
48442293|NCT01763866|155805477|FG008|Overall Study|Death|0|||
48442294|NCT01763866|155805478|FG009|Overall Study|Death|0|||
48442295|NCT01763866|155805479|FG010|Overall Study|Death|0|||
48442296|NCT01763866|155805480|FG011|Overall Study|Death|0|||
48442297|NCT01763866|155805481|FG012|Overall Study|Death|0|||
48442298|NCT01763866|155805482|FG013|Overall Study|Death|0|||
48442299|NCT01763866|155805483|FG014|Overall Study|Death|0|||
48442300|NCT01763866|155805484|FG015|Overall Study|Death|0|||
48442301|NCT01763866|155805485|FG016|Overall Study|Death|1|||
48442302|NCT01763866|155805486|FG017|Overall Study|Death|0|||
48442303|NCT01763866|155805487|FG018|Overall Study|Death|0|||
48442304|NCT01763866|155805488|FG019|Overall Study|Death|0|||
48442305|NCT01763866|155805489|FG020|Overall Study|Death|0|||
48442306|NCT01763866|155805490|FG021|Overall Study|Death|0|||
48442307|NCT01763866|155805491|FG022|Overall Study|Death|0|||
48442308|NCT01763866|155805492|FG023|Overall Study|Death|0|||
48442309|NCT01164865|155805497|FG000|Overall Study|Lost to Follow-up|2|||
48518290|NCT00965757|156090834|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
48518291|NCT00965757|156090831|FG000|Double-blind Phase|Other|1|||
48518292|NCT00965757|156090832|FG001|Double-blind Phase|Other|0|||
48518293|NCT00965757|156090833|FG002|Double-blind Phase|Other|0|||
48518294|NCT00965757|156090834|FG003|Double-blind Phase|Other|0|||
48518295|NCT00965757|156090831|FG000|Extension Phase|Progression of concomitant disease|0|||
48518296|NCT00965757|156090832|FG001|Extension Phase|Progression of concomitant disease|0|||
48518297|NCT00965757|156090833|FG002|Extension Phase|Progression of concomitant disease|4|||
48518298|NCT00965757|156090834|FG003|Extension Phase|Progression of concomitant disease|2|||
48518299|NCT00965757|156090831|FG000|Extension Phase|Adverse drug reaction|0|||
48518300|NCT00965757|156090832|FG001|Extension Phase|Adverse drug reaction|0|||
48518301|NCT00965757|156090833|FG002|Extension Phase|Adverse drug reaction|6|||
48518302|NCT00965757|156090834|FG003|Extension Phase|Adverse drug reaction|3|||
48518303|NCT00965757|156090831|FG000|Extension Phase|Abnormal Laboratory Value|0|||
48518304|NCT00965757|156090832|FG001|Extension Phase|Abnormal Laboratory Value|0|||
48518305|NCT00965757|156090833|FG002|Extension Phase|Abnormal Laboratory Value|6|||
48518306|NCT00965757|156090834|FG003|Extension Phase|Abnormal Laboratory Value|1|||
48518307|NCT00965757|156090831|FG000|Extension Phase|Lack of Efficacy|0|||
48518308|NCT00965757|156090832|FG001|Extension Phase|Lack of Efficacy|0|||
48518309|NCT00965757|156090833|FG002|Extension Phase|Lack of Efficacy|8|||
48518310|NCT00965757|156090834|FG003|Extension Phase|Lack of Efficacy|12|||
48518311|NCT00965757|156090831|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
48518312|NCT00965757|156090832|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
48518313|NCT00965757|156090833|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
48518314|NCT00965757|156090834|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
48518315|NCT00965757|156090831|FG000|Extension Phase|Lost to Follow-up|0|||
48518316|NCT00965757|156090832|FG001|Extension Phase|Lost to Follow-up|0|||
48518317|NCT00965757|156090833|FG002|Extension Phase|Lost to Follow-up|0|||
48518318|NCT00965757|156090834|FG003|Extension Phase|Lost to Follow-up|1|||
48518319|NCT00965757|156090831|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
48518320|NCT00965757|156090832|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
48518321|NCT00965757|156090833|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
48518322|NCT00965757|156090834|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
48518323|NCT00965757|156090831|FG000|Extension Phase|Protocol Violation|0|||
48518324|NCT00965757|156090832|FG001|Extension Phase|Protocol Violation|0|||
48518325|NCT00965757|156090833|FG002|Extension Phase|Protocol Violation|0|||
48518326|NCT00965757|156090834|FG003|Extension Phase|Protocol Violation|1|||
48518327|NCT00965757|156090831|FG000|Extension Phase|Other|0|||
48518328|NCT00965757|156090832|FG001|Extension Phase|Other|0|||
48518329|NCT00965757|156090833|FG002|Extension Phase|Other|2|||
48518330|NCT00965757|156090834|FG003|Extension Phase|Other|1|||
48518331|NCT02451358|156090835|FG000|Overall Study|Withdrawal by Subject|1|||
48518332|NCT02451358|156090836|FG001|Overall Study|Withdrawal by Subject|1|||
48518333|NCT02451358|156090837|FG002|Overall Study|Withdrawal by Subject|0|||
48518334|NCT02451358|156090838|FG003|Overall Study|Withdrawal by Subject|0|||
48518335|NCT02451358|156090835|FG000|Overall Study|Protocol Violation|0|||
48518336|NCT02451358|156090836|FG001|Overall Study|Protocol Violation|1|||
48518337|NCT02451358|156090837|FG002|Overall Study|Protocol Violation|1|||
48518338|NCT02451358|156090838|FG003|Overall Study|Protocol Violation|0|||
48518339|NCT00685334|156090839|FG000|Overall Study|Withdrawal by Subject|5|||
48518340|NCT00685334|156090840|FG001|Overall Study|Withdrawal by Subject|6|||
48518341|NCT00685334|156090839|FG000|Overall Study|Lost to Follow-up|4|||
48518342|NCT00685334|156090840|FG001|Overall Study|Lost to Follow-up|0|||
48518343|NCT00685334|156090839|FG000|Overall Study|Chose to enter hospital|1|||
48518344|NCT00685334|156090840|FG001|Overall Study|Chose to enter hospital|1|||
48518345|NCT01055834|156090847|FG000|Treatment Period I|Adverse Event|1|||
48518346|NCT01055834|156090848|FG001|Treatment Period I|Adverse Event|0|||
48518347|NCT01717313|156090849|FG000|Phase A (Weeks 0 to 24)|Death|0|||
48518348|NCT01717313|156090850|FG001|Phase A (Weeks 0 to 24)|Death|1|||
48518349|NCT01717313|156090849|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
48518350|NCT01717313|156090850|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
48518351|NCT01717313|156090849|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
48518352|NCT01717313|156090850|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
48518353|NCT01717313|156090849|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
48518354|NCT01717313|156090850|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
48518355|NCT01717313|156090849|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
48518356|NCT01717313|156090850|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
48518357|NCT01717313|156090849|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
48518358|NCT01717313|156090850|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
48518359|NCT01717313|156090849|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
48518360|NCT01717313|156090850|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
48518361|NCT01717313|156090849|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
48518362|NCT01717313|156090850|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
48518363|NCT01717313|156090849|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
48518364|NCT01717313|156090850|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
48518365|NCT03255980|156090851|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
48518366|NCT03255980|156090852|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
48518367|NCT03255980|156090853|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
48518368|NCT03255980|156090854|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
48518369|NCT03255980|156090851|FG000|Overall Study|Adverse Event|1|||
48518370|NCT03255980|156090852|FG001|Overall Study|Adverse Event|1|||
48518371|NCT03255980|156090853|FG002|Overall Study|Adverse Event|0|||
48518372|NCT03255980|156090854|FG003|Overall Study|Adverse Event|1|||
48518373|NCT03255980|156090851|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
48518374|NCT03255980|156090852|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
48518375|NCT03255980|156090853|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
48518376|NCT03255980|156090854|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
48518377|NCT03255980|156090851|FG000|Overall Study|Lost to Follow-up|1|||
48518378|NCT03255980|156090852|FG001|Overall Study|Lost to Follow-up|1|||
48518379|NCT03255980|156090853|FG002|Overall Study|Lost to Follow-up|0|||
48518380|NCT03255980|156090854|FG003|Overall Study|Lost to Follow-up|3|||
48518381|NCT03255980|156090851|FG000|Overall Study|Withdrawal by Subject|0|||
48518382|NCT03255980|156090852|FG001|Overall Study|Withdrawal by Subject|1|||
48518383|NCT03255980|156090853|FG002|Overall Study|Withdrawal by Subject|0|||
48518384|NCT03255980|156090854|FG003|Overall Study|Withdrawal by Subject|3|||
48518385|NCT04473326|156090863|FG000|Overall Study|Death|0|||
48518386|NCT04473326|156090864|FG001|Overall Study|Death|1|||
48823407|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
48823408|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
48518387|NCT04473326|156090863|FG000|Overall Study|Withdrawal by Subject|1|||
48518388|NCT04473326|156090864|FG001|Overall Study|Withdrawal by Subject|2|||
48823409|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
48823410|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
48823411|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
48823412|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
48823413|NCT01089556|157193929|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
48823414|NCT01089556|157193930|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
48823415|NCT01089556|157193931|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
48823416|NCT01089556|157193932|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
48823417|NCT01089556|157193933|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
48823418|NCT01089556|157193934|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
48823419|NCT01890967|157193935|FG000|Overall Study|Adverse Event|3|||
48823420|NCT01890967|157193936|FG001|Overall Study|Adverse Event|3|||
48823421|NCT01890967|157193937|FG002|Overall Study|Adverse Event|3|||
48823422|NCT01890967|157193938|FG003|Overall Study|Adverse Event|2|||
48823423|NCT01890967|157193939|FG004|Overall Study|Adverse Event|1|||
48823424|NCT01890967|157193940|FG005|Overall Study|Adverse Event|7|||
48823425|NCT01890967|157193935|FG000|Overall Study|Death|1|||
48823426|NCT01890967|157193936|FG001|Overall Study|Death|0|||
48823427|NCT01890967|157193937|FG002|Overall Study|Death|0|||
48823428|NCT01890967|157193938|FG003|Overall Study|Death|0|||
48823429|NCT01890967|157193939|FG004|Overall Study|Death|0|||
48518389|NCT01597791|156090865|FG000|Overall Study|Physician Decision|2|||
48518390|NCT01597791|156090866|FG001|Overall Study|Physician Decision|1|||
48518391|NCT01597791|156090865|FG000|Overall Study|Cesarean Section|6|||
48518392|NCT01597791|156090866|FG001|Overall Study|Cesarean Section|7|||
48518393|NCT01597791|156090865|FG000|Overall Study|Subject withdrawal|0|||
48518394|NCT01597791|156090866|FG001|Overall Study|Subject withdrawal|1|||
48518395|NCT01597791|156090865|FG000|Overall Study|Protocol Violation|0|||
48518396|NCT01597791|156090866|FG001|Overall Study|Protocol Violation|1|||
48518397|NCT01155531|156090867|FG000|Overall Study|Adverse Event|0|||
48518398|NCT01155531|156090868|FG001|Overall Study|Adverse Event|0|||
48518399|NCT01155531|156090869|FG002|Overall Study|Adverse Event|1|||
48518400|NCT01155531|156090870|FG003|Overall Study|Adverse Event|0|||
48518401|NCT01155531|156090867|FG000|Overall Study|Lost to Follow-up|0|||
48518402|NCT01155531|156090868|FG001|Overall Study|Lost to Follow-up|0|||
48518403|NCT01155531|156090869|FG002|Overall Study|Lost to Follow-up|0|||
48518404|NCT01155531|156090870|FG003|Overall Study|Lost to Follow-up|1|||
48518405|NCT01155531|156090867|FG000|Overall Study|Withdrawal by Subject|1|||
48518406|NCT01155531|156090868|FG001|Overall Study|Withdrawal by Subject|0|||
48518407|NCT01155531|156090869|FG002|Overall Study|Withdrawal by Subject|1|||
48518408|NCT01155531|156090870|FG003|Overall Study|Withdrawal by Subject|0|||
48518409|NCT04203823|156090871|FG000|Overall Study|Withdrawal by Subject|2|||
48518410|NCT04203823|156090872|FG001|Overall Study|Withdrawal by Subject|2|||
48518411|NCT04203823|156090871|FG000|Overall Study|Adverse Event|1|||
48518412|NCT04203823|156090872|FG001|Overall Study|Adverse Event|1|||
48518413|NCT04203823|156090871|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48518414|NCT04203823|156090872|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
48518415|NCT00438633|156090873|FG000|Overall Study|Withdrawal by Subject|1|||
48518416|NCT00438633|156090874|FG001|Overall Study|Withdrawal by Subject|0|||
48518417|NCT00438633|156090873|FG000|Overall Study|Lost to Follow-up|15|||
48518418|NCT00438633|156090874|FG001|Overall Study|Lost to Follow-up|17|||
48518419|NCT01087502|156090878|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
48518420|NCT01087502|156090879|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
48518421|NCT01087502|156090878|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
48518422|NCT01087502|156090879|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
48518423|NCT01087502|156090878|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
48518424|NCT01087502|156090879|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
48518425|NCT01087502|156090878|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
48518426|NCT01087502|156090879|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
48518427|NCT01087502|156090878|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
48518428|NCT01087502|156090879|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
48518429|NCT01087502|156090878|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
48518430|NCT01087502|156090879|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
48518431|NCT01087502|156090878|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
48518432|NCT01087502|156090879|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
48518433|NCT01087502|156090878|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
48518434|NCT01087502|156090879|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
48518435|NCT01087502|156090878|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
48518436|NCT01087502|156090879|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
48518437|NCT01087502|156090878|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
48518438|NCT01087502|156090879|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
48518439|NCT01087502|156090878|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
48518440|NCT01087502|156090879|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
48518441|NCT01087502|156090878|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
48518442|NCT01087502|156090879|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
48518443|NCT02229084|156090880|FG000|Overall Study|Adverse Event|1|||
48518444|NCT02229084|156090881|FG001|Overall Study|Adverse Event|0|||
48518445|NCT02229084|156090882|FG002|Overall Study|Adverse Event|0|||
48518446|NCT02229084|156090883|FG003|Overall Study|Adverse Event|0|||
48518447|NCT02229084|156090884|FG004|Overall Study|Adverse Event|0|||
48518448|NCT02229084|156090885|FG005|Overall Study|Adverse Event|0|||
48518449|NCT02229084|156090886|FG006|Overall Study|Adverse Event|0|||
48518450|NCT02229084|156090880|FG000|Overall Study|Lost to Follow-up|0|||
48518451|NCT02229084|156090881|FG001|Overall Study|Lost to Follow-up|0|||
48518452|NCT02229084|156090882|FG002|Overall Study|Lost to Follow-up|1|||
48518453|NCT02229084|156090883|FG003|Overall Study|Lost to Follow-up|1|||
48518454|NCT02229084|156090884|FG004|Overall Study|Lost to Follow-up|0|||
48518455|NCT02229084|156090885|FG005|Overall Study|Lost to Follow-up|0|||
48518456|NCT02229084|156090886|FG006|Overall Study|Lost to Follow-up|1|||
48518457|NCT02229084|156090880|FG000|Overall Study|Physician Decision|0|||
48518458|NCT02229084|156090881|FG001|Overall Study|Physician Decision|0|||
48518459|NCT02229084|156090882|FG002|Overall Study|Physician Decision|0|||
48518460|NCT02229084|156090883|FG003|Overall Study|Physician Decision|1|||
48518461|NCT02229084|156090884|FG004|Overall Study|Physician Decision|3|||
48518462|NCT02229084|156090885|FG005|Overall Study|Physician Decision|0|||
48518463|NCT02229084|156090886|FG006|Overall Study|Physician Decision|1|||
48518464|NCT02229084|156090880|FG000|Overall Study|Withdrawal by Subject|0|||
48518465|NCT02229084|156090881|FG001|Overall Study|Withdrawal by Subject|0|||
48518466|NCT02229084|156090882|FG002|Overall Study|Withdrawal by Subject|1|||
48518467|NCT02229084|156090883|FG003|Overall Study|Withdrawal by Subject|0|||
48518468|NCT02229084|156090884|FG004|Overall Study|Withdrawal by Subject|1|||
48518469|NCT02229084|156090885|FG005|Overall Study|Withdrawal by Subject|1|||
48518470|NCT02229084|156090886|FG006|Overall Study|Withdrawal by Subject|1|||
48518471|NCT02229084|156090880|FG000|Overall Study|Death|0|||
48518472|NCT02229084|156090881|FG001|Overall Study|Death|0|||
48518473|NCT02229084|156090882|FG002|Overall Study|Death|0|||
48518474|NCT02229084|156090883|FG003|Overall Study|Death|0|||
48518475|NCT02229084|156090884|FG004|Overall Study|Death|0|||
48518476|NCT02229084|156090885|FG005|Overall Study|Death|0|||
48518477|NCT02229084|156090886|FG006|Overall Study|Death|1|||
48518478|NCT01653704|156090887|FG000|Overall Study|Technical failure during recording|1|||
48518479|NCT01653704|156090888|FG001|Overall Study|Technical failure during recording|1|||
48518480|NCT01653704|156090887|FG000|Overall Study|Performance not reflective of training|1|||
48518481|NCT01653704|156090888|FG001|Overall Study|Performance not reflective of training|0|||
48518482|NCT01598896|156090891|FG000|Overall Study|Withdrawal by Subject|0|||
48518483|NCT01598896|156090892|FG001|Overall Study|Withdrawal by Subject|1|||
48601118|NCT02718911|156396042|FG002|Overall Study|Lost to Follow-up|0|||
48601119|NCT02718911|156396043|FG003|Overall Study|Lost to Follow-up|0|||
48518484|NCT01598896|156090891|FG000|Overall Study|Lack of Efficacy|0|||
48518485|NCT01598896|156090892|FG001|Overall Study|Lack of Efficacy|1|||
48518486|NCT01532908|156090895|FG000|Overall Study|Not Transplanted|1|||
48518487|NCT01532908|156090896|FG001|Overall Study|Not Transplanted|0|||
48518488|NCT00562718|156090897|FG000|Overall Study|Death|1|||
48518489|NCT00562718|156090897|FG000|Overall Study|Withdrawal by Subject|3|||
48518490|NCT00562718|156090897|FG000|Overall Study|Adverse Event|4|||
48518491|NCT00562718|156090897|FG000|Overall Study|Lack of Efficacy|2|||
48518492|NCT00562718|156090897|FG000|Overall Study|not stated|1|||
48518493|NCT01868243|156090898|FG000|Overall Study|Death|0|||
48518494|NCT01868243|156090899|FG001|Overall Study|Death|1|||
48518495|NCT00252564|156090900|FG000|Overall Study|Adverse Event|17|||
48518496|NCT00252564|156090901|FG001|Overall Study|Adverse Event|13|||
48518497|NCT00252564|156090900|FG000|Overall Study|Unrelated Complication|2|||
48518498|NCT00252564|156090901|FG001|Overall Study|Unrelated Complication|1|||
48518499|NCT00252564|156090900|FG000|Overall Study|Disease Progression|14|||
48518500|NCT00252564|156090901|FG001|Overall Study|Disease Progression|20|||
48518501|NCT00252564|156090900|FG000|Overall Study|Death|0|||
48518502|NCT00252564|156090901|FG001|Overall Study|Death|3|||
48518503|NCT00252564|156090900|FG000|Overall Study|Physician Decision|1|||
48518504|NCT00252564|156090901|FG001|Overall Study|Physician Decision|0|||
48518505|NCT00252564|156090900|FG000|Overall Study|Lost to Follow-up|1|||
48518506|NCT00252564|156090901|FG001|Overall Study|Lost to Follow-up|0|||
48518507|NCT00252564|156090900|FG000|Overall Study|Patient Request|4|||
48518508|NCT00252564|156090901|FG001|Overall Study|Patient Request|5|||
48518509|NCT00252564|156090900|FG000|Overall Study|Withdrawal by Subject|0|||
48518510|NCT00252564|156090901|FG001|Overall Study|Withdrawal by Subject|2|||
48518511|NCT04025021|156090902|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
48518512|NCT04025021|156090903|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
48518513|NCT02096705|156090905|FG000|Treatment|Adverse Event|6|||
48518514|NCT02096705|156090906|FG001|Treatment|Adverse Event|3|||
48383731|NCT03308942|155601430|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
48383732|NCT03308942|155601431|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
48383733|NCT03308942|155601432|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
48518515|NCT02096705|156090905|FG000|Treatment|Subject request to discontinue treatment|1|||
48518516|NCT02096705|156090906|FG001|Treatment|Subject request to discontinue treatment|1|||
48518517|NCT02096705|156090905|FG000|Treatment|Withdrawal by Subject|1|||
48518518|NCT02096705|156090906|FG001|Treatment|Withdrawal by Subject|0|||
48383734|NCT03308942|155601433|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
48518519|NCT02096705|156090905|FG000|Treatment|Other|1|||
48518520|NCT02096705|156090906|FG001|Treatment|Other|1|||
48518521|NCT02096705|156090905|FG000|Follow-up|Withdrawal by Subject|1|||
48518522|NCT02096705|156090906|FG001|Follow-up|Withdrawal by Subject|0|||
48518523|NCT02096705|156090905|FG000|Follow-up|Adverse Event|2|||
48518524|NCT02096705|156090906|FG001|Follow-up|Adverse Event|2|||
48518525|NCT02096705|156090905|FG000|Follow-up|Subjects not reporting status|1|||
48518526|NCT02096705|156090906|FG001|Follow-up|Subjects not reporting status|2|||
48518527|NCT01507662|156090907|FG000|Overall Study|Death|26|||
48518528|NCT01507662|156090908|FG001|Overall Study|Death|18|||
48518529|NCT01507662|156090907|FG000|Overall Study|Withdrawal by Subject|290|||
48518530|NCT01507662|156090908|FG001|Overall Study|Withdrawal by Subject|287|||
48518531|NCT01507662|156090907|FG000|Overall Study|Lost to Follow-up|498|||
48518532|NCT01507662|156090908|FG001|Overall Study|Lost to Follow-up|523|||
48518533|NCT01507662|156090907|FG000|Overall Study|Proxy interview done|2|||
48518534|NCT01507662|156090908|FG001|Overall Study|Proxy interview done|3|||
48518535|NCT01993940|156090911|FG000|Overall Study|Adverse Event|16|||
48518536|NCT01993940|156090912|FG001|Overall Study|Adverse Event|11|||
48518537|NCT01993940|156090911|FG000|Overall Study|Withdrawal by Subject|15|||
48518538|NCT01993940|156090912|FG001|Overall Study|Withdrawal by Subject|19|||
48518539|NCT01993940|156090911|FG000|Overall Study|Lost to Follow-up|2|||
48518540|NCT01993940|156090912|FG001|Overall Study|Lost to Follow-up|5|||
48518541|NCT01993940|156090911|FG000|Overall Study|Protocol Violation|5|||
48518542|NCT01993940|156090912|FG001|Overall Study|Protocol Violation|8|||
48518543|NCT01993940|156090911|FG000|Overall Study|Death|1|||
48518544|NCT01993940|156090912|FG001|Overall Study|Death|0|||
48518545|NCT01993940|156090911|FG000|Overall Study|Other - Miscellaneous|1|||
48518546|NCT01993940|156090912|FG001|Overall Study|Other - Miscellaneous|1|||
48518547|NCT03203642|156090913|FG000|Overall Study|Adverse Event|3|||
48518548|NCT03203642|156090914|FG001|Overall Study|Adverse Event|1|||
48518549|NCT03203642|156090913|FG000|Overall Study|Withdrawal by Subject|6|||
48518550|NCT03203642|156090914|FG001|Overall Study|Withdrawal by Subject|6|||
48518551|NCT03203642|156090913|FG000|Overall Study|Lost to Follow-up|2|||
48518552|NCT03203642|156090914|FG001|Overall Study|Lost to Follow-up|1|||
48518553|NCT03203642|156090913|FG000|Overall Study|Termination of the study by sponsor|1|||
48518554|NCT03203642|156090914|FG001|Overall Study|Termination of the study by sponsor|1|||
48518555|NCT03203642|156090913|FG000|Overall Study|Participant moved|0|||
48518556|NCT03203642|156090914|FG001|Overall Study|Participant moved|1|||
48518557|NCT03203642|156090913|FG000|Overall Study|Investigator's decision|3|||
48383735|NCT03308942|155601434|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
48518558|NCT03203642|156090914|FG001|Overall Study|Investigator's decision|0|||
48518559|NCT03203642|156090913|FG000|Overall Study|Other than above specified|0|||
48518560|NCT03203642|156090914|FG001|Overall Study|Other than above specified|1|||
48518561|NCT02760433|156090915|FG000|Overall Study|Lost to Follow-up|1|||
48518562|NCT02760433|156090916|FG001|Overall Study|Lost to Follow-up|0|||
48518563|NCT02760433|156090917|FG002|Overall Study|Lost to Follow-up|1|||
48518564|NCT02760433|156090918|FG003|Overall Study|Lost to Follow-up|0|||
48518565|NCT02760433|156090919|FG004|Overall Study|Lost to Follow-up|0|||
48518566|NCT02760433|156090915|FG000|Overall Study|Withdrawal by Subject|23|||
48518567|NCT02760433|156090916|FG001|Overall Study|Withdrawal by Subject|9|||
48518568|NCT02760433|156090917|FG002|Overall Study|Withdrawal by Subject|0|||
48518569|NCT02760433|156090918|FG003|Overall Study|Withdrawal by Subject|2|||
48518570|NCT02760433|156090919|FG004|Overall Study|Withdrawal by Subject|9|||
48518571|NCT02760433|156090915|FG000|Overall Study|Lack of Response At Week 14|0|||
48518572|NCT02760433|156090916|FG001|Overall Study|Lack of Response At Week 14|0|||
48518573|NCT02760433|156090917|FG002|Overall Study|Lack of Response At Week 14|0|||
48518574|NCT02760433|156090918|FG003|Overall Study|Lack of Response At Week 14|0|||
48518575|NCT02760433|156090919|FG004|Overall Study|Lack of Response At Week 14|1|||
48518576|NCT02760433|156090915|FG000|Overall Study|Subject refused to continue the study|1|||
48518577|NCT02760433|156090916|FG001|Overall Study|Subject refused to continue the study|0|||
48518578|NCT02760433|156090917|FG002|Overall Study|Subject refused to continue the study|0|||
48518579|NCT02760433|156090918|FG003|Overall Study|Subject refused to continue the study|0|||
48518580|NCT02760433|156090919|FG004|Overall Study|Subject refused to continue the study|0|||
48518581|NCT02760433|156090915|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
48518582|NCT02760433|156090916|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
48518583|NCT02760433|156090917|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
48518584|NCT02760433|156090918|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
48518585|NCT02760433|156090919|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
48518586|NCT02760433|156090915|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
48518587|NCT02760433|156090916|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
48518588|NCT02760433|156090917|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
48518589|NCT02760433|156090918|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
48442310|NCT01164865|155805498|FG001|Overall Study|Lost to Follow-up|1|||
48442311|NCT00599027|155805506|FG000|Overall Study|Withdrawal by Subject|1|||
48442312|NCT00599027|155805507|FG001|Overall Study|Withdrawal by Subject|1|||
48442313|NCT00599027|155805506|FG000|Overall Study|Adverse Event|0|||
48442314|NCT00599027|155805507|FG001|Overall Study|Adverse Event|1|||
48442315|NCT00599027|155805506|FG000|Overall Study|Treatment Failure|0|||
48442316|NCT00599027|155805507|FG001|Overall Study|Treatment Failure|1|||
48442317|NCT02581982|155805508|FG000|Overall Study|Lack of Efficacy|12|||
48442318|NCT02581982|155805508|FG000|Overall Study|Adverse Event|3|||
48442319|NCT02581982|155805508|FG000|Overall Study|Physician Decision|1|||
48442320|NCT05425719|155805509|FG000|Overall Study|Lost to Follow-up|4|||
48442321|NCT05425719|155805510|FG001|Overall Study|Lost to Follow-up|0|||
48442322|NCT05425719|155805509|FG000|Overall Study|Withdrew consent|1|||
48442323|NCT05425719|155805510|FG001|Overall Study|Withdrew consent|1|||
48442324|NCT00131664|155805512|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
48442325|NCT00131664|155805513|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
48442326|NCT00131664|155805514|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
48442327|NCT00131664|155805515|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
48442328|NCT00131664|155805516|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
48442329|NCT00131664|155805517|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
48442330|NCT00131664|155805512|FG000|First Period (First 6 Months)|Death|0|||
48442331|NCT00131664|155805513|FG001|First Period (First 6 Months)|Death|1|||
48442332|NCT00131664|155805514|FG002|First Period (First 6 Months)|Death|0|||
48442333|NCT00131664|155805515|FG003|First Period (First 6 Months)|Death|0|||
48442334|NCT00131664|155805516|FG004|First Period (First 6 Months)|Death|0|||
48442335|NCT00131664|155805517|FG005|First Period (First 6 Months)|Death|0|||
48442336|NCT00131664|155805512|FG000|First Period (First 6 Months)|Protocol Violation|2|||
48442337|NCT00131664|155805513|FG001|First Period (First 6 Months)|Protocol Violation|2|||
48442338|NCT00131664|155805514|FG002|First Period (First 6 Months)|Protocol Violation|1|||
48442339|NCT00131664|155805515|FG003|First Period (First 6 Months)|Protocol Violation|0|||
48442340|NCT00131664|155805516|FG004|First Period (First 6 Months)|Protocol Violation|0|||
48442341|NCT00131664|155805517|FG005|First Period (First 6 Months)|Protocol Violation|0|||
48442342|NCT00131664|155805512|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
48442343|NCT00131664|155805513|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
48442344|NCT00131664|155805514|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
48442345|NCT00131664|155805515|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
48442346|NCT00131664|155805516|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
48442347|NCT00131664|155805517|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
48442348|NCT00131664|155805512|FG000|First Period (First 6 Months)|Adverse Event|9|||
48442349|NCT00131664|155805513|FG001|First Period (First 6 Months)|Adverse Event|4|||
48442350|NCT00131664|155805514|FG002|First Period (First 6 Months)|Adverse Event|5|||
48518590|NCT02760433|156090919|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
48518591|NCT01624233|156092922|FG000|Period 2 - Induction|Adverse Event|1|||
48518592|NCT01624233|156092922|FG000|Period 3 - Maintenance|Adverse Event|2|||
48518593|NCT01624233|156092922|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
48518594|NCT01624233|156092922|FG000|Period 3 - Maintenance|Physician Decision|2|||
48518595|NCT01624233|156092922|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
48518596|NCT01624233|156092922|FG000|Period 4 - Drug Free Period|Relapsed|61|||
48518597|NCT01624233|156092922|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
48823430|NCT01890967|157193940|FG005|Overall Study|Death|0|||
48518598|NCT01624233|156092922|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
48518599|NCT01624233|156092922|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
48518600|NCT01624233|156092922|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
48518601|NCT01624233|156092922|FG000|Period 6: Follow-up|Adverse Event|3|||
48518602|NCT01624233|156092922|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
48518603|NCT01624233|156092922|FG000|Period 6: Follow-up|Physician Decision|1|||
48518604|NCT01624233|156092922|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
48518605|NCT02583048|156092928|FG000|Overall Study|Withdrawal by Subject|0|||
48518606|NCT02583048|156092929|FG001|Overall Study|Withdrawal by Subject|1|||
48518607|NCT02583048|156092930|FG002|Overall Study|Withdrawal by Subject|0|||
48518608|NCT02583048|156092928|FG000|Overall Study|Failed to meet eligibility criterion|0|||
48518609|NCT02583048|156092929|FG001|Overall Study|Failed to meet eligibility criterion|0|||
48518610|NCT02583048|156092930|FG002|Overall Study|Failed to meet eligibility criterion|1|||
48518611|NCT00414726|156092935|FG000|Overall Study|Withdrawal by Subject|0|||
48518612|NCT00414726|156092936|FG001|Overall Study|Withdrawal by Subject|1|||
48518613|NCT02328040|156092937|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
48518614|NCT02328040|156092938|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
48518615|NCT01709903|156092939|FG000|Overall Study|administrative problems|2|||
48518616|NCT01709903|156092940|FG001|Overall Study|administrative problems|6|||
48518617|NCT01709903|156092939|FG000|Overall Study|Abnormal test procedure results|1|||
48518618|NCT01709903|156092940|FG001|Overall Study|Abnormal test procedure results|0|||
48518619|NCT01709903|156092939|FG000|Overall Study|In ability to use device|1|||
48518620|NCT01709903|156092940|FG001|Overall Study|In ability to use device|1|||
48518621|NCT01709903|156092939|FG000|Overall Study|no longer needed study drug|0|||
48518622|NCT01709903|156092940|FG001|Overall Study|no longer needed study drug|1|||
48518623|NCT01709903|156092939|FG000|Overall Study|Lost to Follow-up|0|||
48518624|NCT01709903|156092940|FG001|Overall Study|Lost to Follow-up|2|||
48518625|NCT01709903|156092939|FG000|Overall Study|Death|2|||
48518626|NCT01709903|156092940|FG001|Overall Study|Death|0|||
48518627|NCT01709903|156092939|FG000|Overall Study|Protocol Violation|3|||
48518628|NCT01709903|156092940|FG001|Overall Study|Protocol Violation|2|||
48518629|NCT01709903|156092939|FG000|Overall Study|Lack of Efficacy|3|||
48518630|NCT01709903|156092940|FG001|Overall Study|Lack of Efficacy|3|||
48518631|NCT01709903|156092939|FG000|Overall Study|Withdrawal by Subject|6|||
48518632|NCT01709903|156092940|FG001|Overall Study|Withdrawal by Subject|6|||
48518633|NCT01709903|156092939|FG000|Overall Study|Adverse Event|11|||
48518634|NCT01709903|156092940|FG001|Overall Study|Adverse Event|18|||
48518635|NCT00928057|156092946|FG000|Overall Study|Adverse Event|1|||
48518636|NCT00928057|156092947|FG001|Overall Study|Adverse Event|2|||
48518637|NCT00928057|156092946|FG000|Overall Study|Withdrawal by Subject|1|||
48518638|NCT00928057|156092947|FG001|Overall Study|Withdrawal by Subject|0|||
48518639|NCT00928057|156092946|FG000|Overall Study|Lost to Follow-up|0|||
48518640|NCT00928057|156092947|FG001|Overall Study|Lost to Follow-up|1|||
48518641|NCT00928057|156092946|FG000|Overall Study|Protocol Violation|0|||
48518642|NCT00928057|156092947|FG001|Overall Study|Protocol Violation|1|||
48518643|NCT03387462|156092948|FG000|Overall Study|Lost to Follow-up|1|||
48518644|NCT05497557|156092949|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
48518645|NCT05497557|156092950|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
48518646|NCT05497557|156092951|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
48518647|NCT01896934|156092954|FG000|Overall Study|Adverse Event|1|||
48518648|NCT01896934|156092954|FG000|Overall Study|Withdrawal by Subject|1|||
48518649|NCT02751424|156092955|FG000|Part 2|Adverse Event|0|||
48518650|NCT02751424|156092956|FG001|Part 2|Adverse Event|0|||
48823431|NCT01890967|157193935|FG000|Overall Study|Lost to Follow-up|1|||
48518651|NCT02751424|156092957|FG002|Part 2|Adverse Event|0|||
48518652|NCT02751424|156092958|FG003|Part 2|Adverse Event|0|||
48518653|NCT02751424|156092959|FG004|Part 2|Adverse Event|0|||
48518654|NCT02751424|156092960|FG005|Part 2|Adverse Event|0|||
48518655|NCT02751424|156092961|FG006|Part 2|Adverse Event|0|||
48518656|NCT02751424|156092962|FG007|Part 2|Adverse Event|5|||
48518657|NCT02751424|156092963|FG008|Part 2|Adverse Event|0|||
48518658|NCT02197416|156092964|FG000|Overall Study|Other reasons|0|||
48518659|NCT02197416|156092965|FG001|Overall Study|Other reasons|2|||
48823432|NCT01890967|157193936|FG001|Overall Study|Lost to Follow-up|1|||
48823433|NCT01890967|157193937|FG002|Overall Study|Lost to Follow-up|1|||
48518660|NCT02197416|156092966|FG002|Overall Study|Other reasons|5|||
48518661|NCT02197416|156092964|FG000|Overall Study|Withdrawal by Subject|0|||
48823434|NCT01890967|157193938|FG003|Overall Study|Lost to Follow-up|1|||
48518662|NCT02197416|156092965|FG001|Overall Study|Withdrawal by Subject|2|||
48518663|NCT02197416|156092966|FG002|Overall Study|Withdrawal by Subject|1|||
48518664|NCT02197416|156092964|FG000|Overall Study|Protocol Violation|1|||
48518665|NCT02197416|156092965|FG001|Overall Study|Protocol Violation|0|||
48518666|NCT02197416|156092966|FG002|Overall Study|Protocol Violation|1|||
48518667|NCT02197416|156092964|FG000|Overall Study|Adverse Event|0|||
48518668|NCT02197416|156092965|FG001|Overall Study|Adverse Event|0|||
48518669|NCT02197416|156092966|FG002|Overall Study|Adverse Event|1|||
48518670|NCT02415127|156092969|FG000|Overall Study|Adverse Event|1|||
48518671|NCT02415127|156092970|FG001|Overall Study|Adverse Event|0|||
48518672|NCT01728116|156092973|FG000|Overall Study|Sponsor Terminated Study|106|||
48518673|NCT01728116|156092974|FG001|Overall Study|Sponsor Terminated Study|35|||
48518674|NCT01728116|156092973|FG000|Overall Study|Withdrawal by Subject|16|||
48518675|NCT01728116|156092974|FG001|Overall Study|Withdrawal by Subject|9|||
48518676|NCT01728116|156092973|FG000|Overall Study|Adverse Event|13|||
48518677|NCT01728116|156092974|FG001|Overall Study|Adverse Event|0|||
48518678|NCT01728116|156092973|FG000|Overall Study|Procedure/device failure|7|||
48518679|NCT01728116|156092974|FG001|Overall Study|Procedure/device failure|0|||
48518680|NCT01728116|156092973|FG000|Overall Study|Lost to Follow-up|9|||
48518681|NCT01728116|156092974|FG001|Overall Study|Lost to Follow-up|2|||
48518682|NCT01728116|156092973|FG000|Overall Study|Physician Decision|2|||
48518683|NCT01728116|156092974|FG001|Overall Study|Physician Decision|0|||
48518684|NCT01728116|156092973|FG000|Overall Study|Subject Non-Compliance|2|||
48518685|NCT01728116|156092974|FG001|Overall Study|Subject Non-Compliance|0|||
48518686|NCT01728116|156092973|FG000|Overall Study|Inter-current finding at procedure|1|||
48518687|NCT01728116|156092974|FG001|Overall Study|Inter-current finding at procedure|0|||
48518688|NCT01728116|156092973|FG000|Overall Study|Incorrectly enrolled in Study|0|||
48518689|NCT01728116|156092974|FG001|Overall Study|Incorrectly enrolled in Study|1|||
48518690|NCT01728116|156092973|FG000|Overall Study|various not noted previously|5|||
48518691|NCT01728116|156092974|FG001|Overall Study|various not noted previously|0|||
48518692|NCT02705716|156092975|FG000|Overall Study|Adverse Event|0|||
48518693|NCT02705716|156092976|FG001|Overall Study|Adverse Event|1|||
48518694|NCT02705716|156092975|FG000|Overall Study|Protocol Violation|3|||
48518695|NCT02705716|156092976|FG001|Overall Study|Protocol Violation|0|||
48518696|NCT02705716|156092975|FG000|Overall Study|Withdrawal of Consent|1|||
48518697|NCT02705716|156092976|FG001|Overall Study|Withdrawal of Consent|1|||
48518698|NCT01344018|156092977|FG000|Overall Study|Death|22|||
48518699|NCT01344018|156092978|FG001|Overall Study|Death|25|||
48518700|NCT01344018|156092977|FG000|Overall Study|Lost to Follow-up|4|||
48518701|NCT01344018|156092978|FG001|Overall Study|Lost to Follow-up|7|||
48518702|NCT05070754|156092981|FG000|Overall Study|Withdrawal by Subject|0|||
48518703|NCT05070754|156092982|FG001|Overall Study|Withdrawal by Subject|0|||
48518704|NCT05070754|156092983|FG002|Overall Study|Withdrawal by Subject|0|||
48518705|NCT05070754|156092984|FG003|Overall Study|Withdrawal by Subject|1|||
48518706|NCT05070754|156092981|FG000|Overall Study|Protocol Violation|0|||
48518707|NCT05070754|156092982|FG001|Overall Study|Protocol Violation|0|||
48518708|NCT05070754|156092983|FG002|Overall Study|Protocol Violation|0|||
48518709|NCT05070754|156092984|FG003|Overall Study|Protocol Violation|1|||
48518710|NCT01196390|156092988|FG000|Overall Study|Protocol Violation|4|||
48518711|NCT01196390|156092989|FG001|Overall Study|Protocol Violation|5|||
48518712|NCT01151618|156092990|FG000|Overall Study|Adverse Event|2|||
48518713|NCT01151618|156092990|FG000|Overall Study|Withdrawal by Subject|7|||
48518714|NCT01632306|156092991|FG000|Overall Study|Protocol Violation|1|||
48518715|NCT01632306|156092992|FG001|Overall Study|Protocol Violation|0|||
48518716|NCT01632306|156092993|FG002|Overall Study|Protocol Violation|0|||
48518717|NCT03248128|156092994|FG000|Overall Study|Lost to Follow-up|1|||
48518718|NCT03248128|156092995|FG001|Overall Study|Lost to Follow-up|0|||
48518719|NCT03248128|156092994|FG000|Overall Study|Withdrawal by Subject|16|||
48518720|NCT03248128|156092995|FG001|Overall Study|Withdrawal by Subject|14|||
48518721|NCT03248128|156092994|FG000|Overall Study|Site Closed|4|||
48518722|NCT03248128|156092995|FG001|Overall Study|Site Closed|3|||
48518723|NCT03248128|156092994|FG000|Overall Study|Randomized, but did not receive treatment|1|||
48518724|NCT03248128|156092995|FG001|Overall Study|Randomized, but did not receive treatment|3|||
48518725|NCT03141151|156093002|FG000|Overall Study|Lost to Follow-up|3|||
48518726|NCT03141151|156093003|FG001|Overall Study|Lost to Follow-up|2|||
48518727|NCT03141151|156093002|FG000|Overall Study|Withdrawal by Subject|3|||
48518728|NCT03141151|156093003|FG001|Overall Study|Withdrawal by Subject|2|||
48518729|NCT01986647|156093004|FG000|Overall Study|Lost to Follow-up|4|||
48518730|NCT01986647|156093005|FG001|Overall Study|Lost to Follow-up|1|||
48518731|NCT01986647|156093006|FG002|Overall Study|Lost to Follow-up|4|||
48518732|NCT01986647|156093007|FG003|Overall Study|Lost to Follow-up|4|||
48518733|NCT01986647|156093004|FG000|Overall Study|Withdrawal by Subject|1|||
48518734|NCT01986647|156093005|FG001|Overall Study|Withdrawal by Subject|3|||
48518735|NCT01986647|156093006|FG002|Overall Study|Withdrawal by Subject|2|||
48518736|NCT01986647|156093007|FG003|Overall Study|Withdrawal by Subject|3|||
48518737|NCT01986647|156093004|FG000|Overall Study|Health|5|||
48518738|NCT01986647|156093005|FG001|Overall Study|Health|3|||
48518739|NCT01986647|156093006|FG002|Overall Study|Health|6|||
48518740|NCT01986647|156093007|FG003|Overall Study|Health|4|||
48518741|NCT01483820|156093008|FG000|Overall Study|Lack of Efficacy|6|||
48518742|NCT01483820|156093008|FG000|Overall Study|Adverse Event|1|||
48518743|NCT01483820|156093008|FG000|Overall Study|Death|1|||
48518744|NCT03498560|156093011|FG000|Overall Study|Found Ineligible|2|||
48518745|NCT03498560|156093011|FG000|Overall Study|Withdrawal by Subject|14|||
48518746|NCT03498560|156093011|FG000|Overall Study|Lost to Follow-up|4|||
48518747|NCT03498560|156093011|FG000|Overall Study|Death|1|||
48518748|NCT00867360|156093016|FG000|Overall Study|Withdrawal by Subject|1|||
48518749|NCT00867360|156093017|FG001|Overall Study|Withdrawal by Subject|0|||
48518750|NCT00867360|156093016|FG000|Overall Study|Physician Decision|0|||
48518751|NCT00867360|156093017|FG001|Overall Study|Physician Decision|1|||
48518752|NCT00640926|156093020|FG000|Overall Study|Adverse Event|2|||
48518753|NCT00640926|156093021|FG001|Overall Study|Adverse Event|3|||
48518754|NCT00640926|156093022|FG002|Overall Study|Adverse Event|2|||
48518755|NCT00640926|156093020|FG000|Overall Study|Lack of Efficacy|0|||
48518756|NCT00640926|156093021|FG001|Overall Study|Lack of Efficacy|2|||
48518757|NCT00640926|156093022|FG002|Overall Study|Lack of Efficacy|1|||
48518758|NCT00640926|156093020|FG000|Overall Study|Protocol Violation|2|||
48518759|NCT00640926|156093021|FG001|Overall Study|Protocol Violation|0|||
48518760|NCT00640926|156093022|FG002|Overall Study|Protocol Violation|2|||
48518761|NCT00640926|156093020|FG000|Overall Study|Lost to Follow-up|3|||
48518762|NCT00640926|156093021|FG001|Overall Study|Lost to Follow-up|1|||
48518763|NCT00640926|156093022|FG002|Overall Study|Lost to Follow-up|2|||
48518764|NCT00640926|156093020|FG000|Overall Study|Withdrawal by Subject|1|||
48518765|NCT00640926|156093021|FG001|Overall Study|Withdrawal by Subject|0|||
48518766|NCT00640926|156093022|FG002|Overall Study|Withdrawal by Subject|1|||
48518767|NCT03922750|156093029|FG000|Overall Study|Unclassified|0|||
48518768|NCT03922750|156093030|FG001|Overall Study|Unclassified|0|||
48518769|NCT03922750|156093031|FG002|Overall Study|Unclassified|1|||
48518770|NCT03922750|156093029|FG000|Overall Study|Adverse Event|0|||
48518771|NCT03922750|156093030|FG001|Overall Study|Adverse Event|1|||
48518772|NCT03922750|156093031|FG002|Overall Study|Adverse Event|0|||
48518773|NCT01663896|156093032|FG000|Overall Study|Various reasons|43|||
48518774|NCT02313558|156093033|FG000|Overall Study|Withdrawal by Subject|2|||
48518775|NCT02313558|156093034|FG001|Overall Study|Withdrawal by Subject|0|||
48518776|NCT02313558|156093033|FG000|Overall Study|Lost to Follow-up|4|||
48518777|NCT02313558|156093034|FG001|Overall Study|Lost to Follow-up|4|||
48518778|NCT01395017|156093035|FG000|Overall Study|Lost to Follow-up|1|||
48518779|NCT01395017|156093036|FG001|Overall Study|Lost to Follow-up|0|||
48518780|NCT01395017|156093035|FG000|Overall Study|Adverse Event|26|||
48518781|NCT01395017|156093036|FG001|Overall Study|Adverse Event|12|||
48518782|NCT01395017|156093035|FG000|Overall Study|Physician Decision|11|||
48518783|NCT01395017|156093036|FG001|Overall Study|Physician Decision|15|||
48518784|NCT01395017|156093035|FG000|Overall Study|Withdrawal by Subject|14|||
48518785|NCT01395017|156093036|FG001|Overall Study|Withdrawal by Subject|8|||
48518786|NCT01395017|156093035|FG000|Overall Study|Protocol deviation|1|||
48518787|NCT01395017|156093036|FG001|Overall Study|Protocol deviation|2|||
48518788|NCT01395017|156093035|FG000|Overall Study|Death|4|||
48518789|NCT01395017|156093036|FG001|Overall Study|Death|3|||
48518790|NCT01395017|156093035|FG000|Overall Study|Disease progression|42|||
48518791|NCT01395017|156093036|FG001|Overall Study|Disease progression|58|||
48518792|NCT01395017|156093035|FG000|Overall Study|Sponsor discontinued study|1|||
48518793|NCT01395017|156093036|FG001|Overall Study|Sponsor discontinued study|4|||
48518794|NCT00668395|156093039|FG000|Overall Study|Withdrawal by Subject|4|||
48518795|NCT00668395|156093040|FG001|Overall Study|Withdrawal by Subject|4|||
48518796|NCT00668395|156093041|FG002|Overall Study|Withdrawal by Subject|1|||
48518797|NCT00668395|156093039|FG000|Overall Study|Adverse Event|1|||
48518798|NCT00668395|156093040|FG001|Overall Study|Adverse Event|1|||
48518799|NCT00668395|156093041|FG002|Overall Study|Adverse Event|0|||
48518800|NCT00668395|156093039|FG000|Overall Study|Physician Decision|1|||
48518801|NCT00668395|156093040|FG001|Overall Study|Physician Decision|1|||
48518802|NCT00668395|156093041|FG002|Overall Study|Physician Decision|0|||
48518803|NCT03250117|156093042|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
48518804|NCT03250117|156093043|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
48518805|NCT03250117|156093044|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
48518806|NCT03250117|156093045|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
48518807|NCT03366428|156093055|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
48518808|NCT03366428|156093055|FG000|Overall Study|Adverse Event|12|||
48518809|NCT03366428|156093055|FG000|Overall Study|Clinical progression|2|||
48518810|NCT03366428|156093055|FG000|Overall Study|Withdrawal by Subject|4|||
48518811|NCT01670097|156093058|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
48518812|NCT01670097|156093059|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
48518813|NCT01670097|156093058|FG000|Overall Study|Study burden|1|||
48518814|NCT01670097|156093059|FG001|Overall Study|Study burden|0|||
48518815|NCT01670097|156093058|FG000|Overall Study|COPD exacerbation|0|||
48518816|NCT01670097|156093059|FG001|Overall Study|COPD exacerbation|1|||
48518817|NCT01670097|156093058|FG000|Overall Study|Neutropenia|0|||
48518818|NCT01670097|156093059|FG001|Overall Study|Neutropenia|1|||
48518819|NCT01670097|156093058|FG000|Overall Study|Clinical deterioration|0|||
48518820|NCT01670097|156093059|FG001|Overall Study|Clinical deterioration|1|||
48518821|NCT01670097|156093058|FG000|Overall Study|Disease progression|0|||
48518822|NCT01670097|156093059|FG001|Overall Study|Disease progression|1|||
48518823|NCT03259165|156093063|FG000|Overall Study|COVID 19 pandemic|1|||
48518824|NCT03259165|156093064|FG001|Overall Study|COVID 19 pandemic|1|||
48518825|NCT00210639|156093065|FG000|Overall Study|Lost to Follow-up|37|||
48518826|NCT00210639|156093066|FG001|Overall Study|Lost to Follow-up|29|||
48518827|NCT00210639|156093065|FG000|Overall Study|Withdrawal by Subject|8|||
48518828|NCT00210639|156093066|FG001|Overall Study|Withdrawal by Subject|1|||
48518829|NCT00210639|156093065|FG000|Overall Study|Other|18|||
48383736|NCT03308942|155601430|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
48383737|NCT03308942|155601431|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
48383738|NCT03308942|155601432|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
48383739|NCT03308942|155601433|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
48383740|NCT03308942|155601434|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
48383741|NCT03308942|155601430|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
48383742|NCT03308942|155601431|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
48518830|NCT00210639|156093066|FG001|Overall Study|Other|12|||
48518831|NCT00474188|156093076|FG000|Overall Study|Withdrawal by Subject|1|||
48518832|NCT00474188|156093076|FG000|Overall Study|Study discontinued by sponsor|5|||
48518833|NCT00112437|156093077|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
48518834|NCT00112437|156093078|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
48518835|NCT00112437|156093079|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
48518836|NCT00112437|156093080|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
48518837|NCT00112437|156093081|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
48518838|NCT00112437|156093082|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518839|NCT00112437|156093083|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518840|NCT00112437|156093084|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518841|NCT00112437|156093085|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518842|NCT00112437|156093086|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518843|NCT00112437|156093087|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518844|NCT00112437|156093088|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
48823435|NCT01890967|157193939|FG004|Overall Study|Lost to Follow-up|0|||
48518845|NCT00112437|156093089|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518846|NCT00112437|156093090|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518847|NCT00112437|156093091|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518848|NCT00112437|156093092|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518849|NCT00112437|156093093|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518850|NCT00112437|156093094|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518851|NCT00112437|156093095|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518852|NCT00112437|156093096|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518853|NCT00112437|156093097|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518854|NCT00112437|156093098|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518855|NCT00112437|156093099|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518856|NCT00112437|156093100|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518857|NCT00112437|156093101|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518858|NCT00112437|156093102|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
48518859|NCT00112437|156093077|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518860|NCT00112437|156093078|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
48518861|NCT00112437|156093079|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518862|NCT00112437|156093080|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518863|NCT00112437|156093081|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518864|NCT00112437|156093082|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518865|NCT00112437|156093083|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518866|NCT00112437|156093084|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518867|NCT00112437|156093085|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518868|NCT00112437|156093086|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518869|NCT00112437|156093087|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518870|NCT00112437|156093088|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518871|NCT00112437|156093089|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518872|NCT00112437|156093090|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518873|NCT00112437|156093091|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518874|NCT00112437|156093092|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518875|NCT00112437|156093093|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518876|NCT00112437|156093094|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518877|NCT00112437|156093095|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518878|NCT00112437|156093096|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518879|NCT00112437|156093097|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48601120|NCT02718911|156396044|FG004|Overall Study|Lost to Follow-up|0|||
48601121|NCT02718911|156396045|FG005|Overall Study|Lost to Follow-up|0|||
48518880|NCT00112437|156093098|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518881|NCT00112437|156093099|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518882|NCT00112437|156093100|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518883|NCT00112437|156093101|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518884|NCT00112437|156093102|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
48518885|NCT00112437|156093077|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518886|NCT00112437|156093078|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
48518887|NCT00112437|156093079|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518888|NCT00112437|156093080|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518889|NCT00112437|156093081|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518890|NCT00112437|156093082|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518891|NCT00112437|156093083|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518892|NCT00112437|156093084|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518893|NCT00112437|156093085|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518894|NCT00112437|156093086|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518895|NCT00112437|156093087|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518896|NCT00112437|156093088|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518897|NCT00112437|156093089|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518898|NCT00112437|156093090|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518899|NCT00112437|156093091|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518900|NCT00112437|156093092|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518901|NCT00112437|156093093|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518902|NCT00112437|156093094|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518903|NCT00112437|156093095|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518904|NCT00112437|156093096|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518905|NCT00112437|156093097|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518906|NCT00112437|156093098|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518907|NCT00112437|156093099|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518908|NCT00112437|156093100|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518909|NCT00112437|156093101|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518910|NCT00112437|156093102|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
48518911|NCT00112437|156093077|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
48518912|NCT00112437|156093078|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518913|NCT00112437|156093079|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
48518914|NCT00112437|156093080|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
48518915|NCT00112437|156093081|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
48518916|NCT00112437|156093082|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518917|NCT00112437|156093083|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518918|NCT00112437|156093084|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518919|NCT00112437|156093085|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518920|NCT00112437|156093086|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518921|NCT00112437|156093087|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518922|NCT00112437|156093088|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518923|NCT00112437|156093089|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518924|NCT00112437|156093090|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518925|NCT00112437|156093091|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518926|NCT00112437|156093092|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518927|NCT00112437|156093093|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518928|NCT00112437|156093094|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518929|NCT00112437|156093095|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518930|NCT00112437|156093096|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518931|NCT00112437|156093097|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518932|NCT00112437|156093098|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518933|NCT00112437|156093099|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518934|NCT00112437|156093100|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518935|NCT00112437|156093101|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518936|NCT00112437|156093102|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
48518937|NCT00112437|156093077|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
48518938|NCT00112437|156093078|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
48518939|NCT00112437|156093079|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
48518940|NCT00112437|156093080|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
48518941|NCT00112437|156093081|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
48518942|NCT00112437|156093082|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518943|NCT00112437|156093083|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518944|NCT00112437|156093084|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518945|NCT00112437|156093085|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518946|NCT00112437|156093086|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518947|NCT00112437|156093087|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518948|NCT00112437|156093088|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518949|NCT00112437|156093089|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518950|NCT00112437|156093090|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518951|NCT00112437|156093091|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518952|NCT00112437|156093092|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518953|NCT00112437|156093093|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518954|NCT00112437|156093094|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518955|NCT00112437|156093095|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518956|NCT00112437|156093096|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518957|NCT00112437|156093097|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518958|NCT00112437|156093098|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518959|NCT00112437|156093099|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518960|NCT00112437|156093100|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518961|NCT00112437|156093101|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518962|NCT00112437|156093102|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
48518963|NCT00112437|156093077|FG000|Year 1 (12-Month Base Study)|moved|0|||
48518964|NCT00112437|156093078|FG001|Year 1 (12-Month Base Study)|moved|1|||
48518965|NCT00112437|156093079|FG002|Year 1 (12-Month Base Study)|moved|1|||
48518966|NCT00112437|156093080|FG003|Year 1 (12-Month Base Study)|moved|0|||
48518967|NCT00112437|156093081|FG004|Year 1 (12-Month Base Study)|moved|0|||
48518968|NCT00112437|156093082|FG005|Year 1 (12-Month Base Study)|moved|0|||
48518969|NCT00112437|156093083|FG006|Year 1 (12-Month Base Study)|moved|0|||
48518970|NCT00112437|156093084|FG007|Year 1 (12-Month Base Study)|moved|0|||
48518971|NCT00112437|156093085|FG008|Year 1 (12-Month Base Study)|moved|0|||
48518972|NCT00112437|156093086|FG009|Year 1 (12-Month Base Study)|moved|0|||
48518973|NCT00112437|156093087|FG010|Year 1 (12-Month Base Study)|moved|0|||
48518974|NCT00112437|156093088|FG011|Year 1 (12-Month Base Study)|moved|0|||
48518975|NCT00112437|156093089|FG012|Year 1 (12-Month Base Study)|moved|0|||
48518976|NCT00112437|156093090|FG013|Year 1 (12-Month Base Study)|moved|0|||
48518977|NCT00112437|156093091|FG014|Year 1 (12-Month Base Study)|moved|0|||
48518978|NCT00112437|156093092|FG015|Year 1 (12-Month Base Study)|moved|0|||
48518979|NCT00112437|156093093|FG016|Year 1 (12-Month Base Study)|moved|0|||
48383743|NCT03308942|155601432|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
48383744|NCT03308942|155601433|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
48383745|NCT03308942|155601434|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
48383746|NCT03308942|155601430|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
48518980|NCT00112437|156093094|FG017|Year 1 (12-Month Base Study)|moved|0|||
48518981|NCT00112437|156093095|FG018|Year 1 (12-Month Base Study)|moved|0|||
48518982|NCT00112437|156093096|FG019|Year 1 (12-Month Base Study)|moved|0|||
48518983|NCT00112437|156093097|FG020|Year 1 (12-Month Base Study)|moved|0|||
48518984|NCT00112437|156093098|FG021|Year 1 (12-Month Base Study)|moved|0|||
48518985|NCT00112437|156093099|FG022|Year 1 (12-Month Base Study)|moved|0|||
48518986|NCT00112437|156093100|FG023|Year 1 (12-Month Base Study)|moved|0|||
48518987|NCT00112437|156093101|FG024|Year 1 (12-Month Base Study)|moved|0|||
48518988|NCT00112437|156093102|FG025|Year 1 (12-Month Base Study)|moved|0|||
48518989|NCT00112437|156093077|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518990|NCT00112437|156093078|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518991|NCT00112437|156093079|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518992|NCT00112437|156093080|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
48518993|NCT00112437|156093081|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518994|NCT00112437|156093082|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518995|NCT00112437|156093083|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518996|NCT00112437|156093084|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518997|NCT00112437|156093085|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518998|NCT00112437|156093086|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48518999|NCT00112437|156093087|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519000|NCT00112437|156093088|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519001|NCT00112437|156093089|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519002|NCT00112437|156093090|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519003|NCT00112437|156093091|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519004|NCT00112437|156093092|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519005|NCT00112437|156093093|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519006|NCT00112437|156093094|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519007|NCT00112437|156093095|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48383747|NCT03308942|155601431|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
48519008|NCT00112437|156093096|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519009|NCT00112437|156093097|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519010|NCT00112437|156093098|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519011|NCT00112437|156093099|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519012|NCT00112437|156093100|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519013|NCT00112437|156093101|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519014|NCT00112437|156093102|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
48519015|NCT00112437|156093077|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519016|NCT00112437|156093078|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519017|NCT00112437|156093079|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519018|NCT00112437|156093080|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519019|NCT00112437|156093081|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
48519020|NCT00112437|156093082|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519021|NCT00112437|156093083|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519022|NCT00112437|156093084|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519023|NCT00112437|156093085|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519024|NCT00112437|156093086|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519025|NCT00112437|156093087|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519026|NCT00112437|156093088|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519027|NCT00112437|156093089|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519028|NCT00112437|156093090|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519029|NCT00112437|156093091|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519030|NCT00112437|156093092|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519031|NCT00112437|156093093|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519032|NCT00112437|156093094|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519033|NCT00112437|156093095|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519034|NCT00112437|156093096|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519035|NCT00112437|156093097|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519036|NCT00112437|156093098|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519037|NCT00112437|156093099|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519038|NCT00112437|156093100|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519039|NCT00112437|156093101|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519040|NCT00112437|156093102|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
48519041|NCT00112437|156093077|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
48519042|NCT00112437|156093078|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
48519043|NCT00112437|156093079|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
48519044|NCT00112437|156093080|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
48519045|NCT00112437|156093081|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
48519046|NCT00112437|156093082|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
48519047|NCT00112437|156093083|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
48519048|NCT00112437|156093084|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
48519049|NCT00112437|156093085|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
48519050|NCT00112437|156093086|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
48519051|NCT00112437|156093087|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
48519052|NCT00112437|156093088|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
48519053|NCT00112437|156093089|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
48519054|NCT00112437|156093090|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
48519055|NCT00112437|156093091|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
48519056|NCT00112437|156093092|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
48519057|NCT00112437|156093093|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
48519058|NCT00112437|156093094|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
48519059|NCT00112437|156093095|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
48519060|NCT00112437|156093096|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
48519061|NCT00112437|156093097|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
48519062|NCT00112437|156093098|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
48519063|NCT00112437|156093099|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
48519064|NCT00112437|156093100|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
48519065|NCT00112437|156093101|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
48519066|NCT00112437|156093102|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
48519067|NCT00112437|156093077|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519068|NCT00112437|156093078|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519069|NCT00112437|156093079|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519070|NCT00112437|156093080|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519071|NCT00112437|156093081|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519072|NCT00112437|156093082|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
48519073|NCT00112437|156093083|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
48823436|NCT01890967|157193940|FG005|Overall Study|Lost to Follow-up|1|||
48601122|NCT02718911|156396046|FG006|Overall Study|Lost to Follow-up|0|||
48823437|NCT01890967|157193935|FG000|Overall Study|Protocol Violation|0|||
48823438|NCT01890967|157193936|FG001|Overall Study|Protocol Violation|3|||
48823439|NCT01890967|157193937|FG002|Overall Study|Protocol Violation|3|||
48823440|NCT01890967|157193938|FG003|Overall Study|Protocol Violation|2|||
48823441|NCT01890967|157193939|FG004|Overall Study|Protocol Violation|4|||
48823442|NCT01890967|157193940|FG005|Overall Study|Protocol Violation|1|||
48823443|NCT01890967|157193935|FG000|Overall Study|Sponsor Decision|2|||
48823444|NCT01890967|157193936|FG001|Overall Study|Sponsor Decision|0|||
48823445|NCT01890967|157193937|FG002|Overall Study|Sponsor Decision|1|||
48383748|NCT03308942|155601432|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
48823446|NCT01890967|157193938|FG003|Overall Study|Sponsor Decision|3|||
48823447|NCT01890967|157193939|FG004|Overall Study|Sponsor Decision|2|||
48823448|NCT01890967|157193940|FG005|Overall Study|Sponsor Decision|3|||
48823449|NCT01890967|157193935|FG000|Overall Study|Withdrawal by Subject|3|||
48823450|NCT01890967|157193936|FG001|Overall Study|Withdrawal by Subject|4|||
48823451|NCT01890967|157193937|FG002|Overall Study|Withdrawal by Subject|2|||
48823452|NCT01890967|157193938|FG003|Overall Study|Withdrawal by Subject|3|||
48823453|NCT01890967|157193939|FG004|Overall Study|Withdrawal by Subject|3|||
48823454|NCT01890967|157193940|FG005|Overall Study|Withdrawal by Subject|1|||
48823455|NCT02424344|157193943|FG000|Overall Study|Lack of Efficacy|0|||
48823456|NCT02424344|157193944|FG001|Overall Study|Lack of Efficacy|1|||
48823457|NCT02424344|157193943|FG000|Overall Study|Withdrawal by Subject|2|||
48823458|NCT02424344|157193944|FG001|Overall Study|Withdrawal by Subject|1|||
48823459|NCT02424344|157193943|FG000|Overall Study|Lost to Follow-up|1|||
48823460|NCT02424344|157193944|FG001|Overall Study|Lost to Follow-up|0|||
48823461|NCT02424344|157193943|FG000|Overall Study|Adverse Event|4|||
48442416|NCT03162055|155806961|FG000|Overall Study|Adverse Event|6|||
48823462|NCT02424344|157193944|FG001|Overall Study|Adverse Event|8|||
48823463|NCT00852475|157193945|FG000|Overall Study|Lost to Follow-up|3|||
48823464|NCT00852475|157193946|FG001|Overall Study|Lost to Follow-up|4|||
48823465|NCT00354029|157193947|FG000|Overall Study|Protocol Violation|4|||
48823466|NCT00354029|157193948|FG001|Overall Study|Protocol Violation|2|||
48823467|NCT01764386|157193953|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
48823468|NCT01764386|157193954|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
48823469|NCT01764386|157193953|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
48823470|NCT01764386|157193954|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
48823471|NCT01764386|157193953|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
48823472|NCT01764386|157193954|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
48823473|NCT01764386|157193953|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
48823474|NCT01764386|157193954|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
48823475|NCT01764386|157193953|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
48823476|NCT01764386|157193954|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
48823477|NCT01764386|157193953|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
48823478|NCT01764386|157193954|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
48823479|NCT01764386|157193953|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
48823480|NCT01764386|157193954|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
48823481|NCT01764386|157193953|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
48823482|NCT01764386|157193954|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
48823483|NCT00557505|157193956|FG000|Overall Study|Death|0|||
48823484|NCT00557505|157193957|FG001|Overall Study|Death|0|||
48823485|NCT00557505|157193958|FG002|Overall Study|Death|0|||
48823486|NCT00557505|157193959|FG003|Overall Study|Death|0|||
48823487|NCT00557505|157193960|FG004|Overall Study|Death|0|||
48823488|NCT00557505|157193961|FG005|Overall Study|Death|0|||
48823489|NCT00557505|157193962|FG006|Overall Study|Death|0|||
48823490|NCT00557505|157193963|FG007|Overall Study|Death|0|||
48823491|NCT00557505|157193964|FG008|Overall Study|Death|1|||
48823492|NCT00557505|157193956|FG000|Overall Study|Adverse Event|0|||
48823493|NCT00557505|157193957|FG001|Overall Study|Adverse Event|0|||
48823494|NCT00557505|157193958|FG002|Overall Study|Adverse Event|1|||
48823495|NCT00557505|157193959|FG003|Overall Study|Adverse Event|0|||
48823496|NCT00557505|157193960|FG004|Overall Study|Adverse Event|0|||
48823497|NCT00557505|157193961|FG005|Overall Study|Adverse Event|0|||
48442417|NCT03162055|155806962|FG001|Overall Study|Adverse Event|5|||
48442418|NCT03162055|155806961|FG000|Overall Study|Death|3|||
48442419|NCT03162055|155806962|FG001|Overall Study|Death|3|||
48442420|NCT03162055|155806961|FG000|Overall Study|Lost to Follow-up|0|||
48442421|NCT03162055|155806962|FG001|Overall Study|Lost to Follow-up|1|||
48442422|NCT03162055|155806961|FG000|Overall Study|Study-specific withdrawal criteria|22|||
48442423|NCT03162055|155806962|FG001|Overall Study|Study-specific withdrawal criteria|14|||
48442424|NCT03162055|155806961|FG000|Overall Study|Withdrawal by Subject|17|||
48442425|NCT03162055|155806962|FG001|Overall Study|Withdrawal by Subject|2|||
48442426|NCT03162055|155806961|FG000|Overall Study|Did not receive treatment|2|||
48442427|NCT03162055|155806962|FG001|Overall Study|Did not receive treatment|0|||
48519074|NCT00112437|156093084|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519075|NCT00112437|156093085|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519076|NCT00112437|156093086|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
48519077|NCT00112437|156093087|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519078|NCT00112437|156093088|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519079|NCT00112437|156093089|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519080|NCT00112437|156093090|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519081|NCT00112437|156093091|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519082|NCT00112437|156093092|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519083|NCT00112437|156093093|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519084|NCT00112437|156093094|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519085|NCT00112437|156093095|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519086|NCT00112437|156093096|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519087|NCT00112437|156093097|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519088|NCT00112437|156093098|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519089|NCT00112437|156093099|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519090|NCT00112437|156093100|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519091|NCT00112437|156093101|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519092|NCT00112437|156093102|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
48519093|NCT00112437|156093077|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519094|NCT00112437|156093078|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519095|NCT00112437|156093079|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519096|NCT00112437|156093080|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519097|NCT00112437|156093081|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519098|NCT00112437|156093082|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519099|NCT00112437|156093083|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519100|NCT00112437|156093084|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519101|NCT00112437|156093085|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
48519102|NCT00112437|156093086|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519103|NCT00112437|156093087|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519104|NCT00112437|156093088|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519105|NCT00112437|156093089|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519106|NCT00112437|156093090|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519107|NCT00112437|156093091|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519108|NCT00112437|156093092|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519109|NCT00112437|156093093|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519110|NCT00112437|156093094|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519111|NCT00112437|156093095|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519112|NCT00112437|156093096|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519113|NCT00112437|156093097|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519114|NCT00112437|156093098|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519115|NCT00112437|156093099|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519116|NCT00112437|156093100|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519117|NCT00112437|156093101|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519118|NCT00112437|156093102|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
48519119|NCT00112437|156093077|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519120|NCT00112437|156093078|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519121|NCT00112437|156093079|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519122|NCT00112437|156093080|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519123|NCT00112437|156093081|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519124|NCT00112437|156093082|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519125|NCT00112437|156093083|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519126|NCT00112437|156093084|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519127|NCT00112437|156093085|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
48519128|NCT00112437|156093086|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519129|NCT00112437|156093087|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519130|NCT00112437|156093088|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519131|NCT00112437|156093089|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
48383749|NCT03308942|155601433|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
48383750|NCT03308942|155601434|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
48519132|NCT00112437|156093090|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519133|NCT00112437|156093091|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519134|NCT00112437|156093092|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519135|NCT00112437|156093093|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519136|NCT00112437|156093094|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519137|NCT00112437|156093095|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519138|NCT00112437|156093096|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519139|NCT00112437|156093097|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519140|NCT00112437|156093098|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519141|NCT00112437|156093099|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519142|NCT00112437|156093100|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519143|NCT00112437|156093101|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519144|NCT00112437|156093102|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
48519145|NCT00112437|156093077|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519146|NCT00112437|156093078|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519147|NCT00112437|156093079|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519148|NCT00112437|156093080|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519149|NCT00112437|156093081|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519150|NCT00112437|156093082|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
48519151|NCT00112437|156093083|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
48519152|NCT00112437|156093084|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
48519153|NCT00112437|156093085|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
48519154|NCT00112437|156093086|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
48519155|NCT00112437|156093087|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519156|NCT00112437|156093088|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519157|NCT00112437|156093089|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519158|NCT00112437|156093090|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519159|NCT00112437|156093091|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519160|NCT00112437|156093092|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519161|NCT00112437|156093093|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519162|NCT00112437|156093094|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519163|NCT00112437|156093095|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519164|NCT00112437|156093096|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519165|NCT00112437|156093097|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519166|NCT00112437|156093098|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519167|NCT00112437|156093099|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519168|NCT00112437|156093100|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519169|NCT00112437|156093101|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519170|NCT00112437|156093102|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
48519171|NCT00112437|156093077|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519172|NCT00112437|156093078|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519173|NCT00112437|156093079|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519174|NCT00112437|156093080|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519175|NCT00112437|156093081|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519176|NCT00112437|156093082|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519177|NCT00112437|156093083|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519178|NCT00112437|156093084|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519179|NCT00112437|156093085|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519180|NCT00112437|156093086|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
48519181|NCT00112437|156093087|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519182|NCT00112437|156093088|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519183|NCT00112437|156093089|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519184|NCT00112437|156093090|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519185|NCT00112437|156093091|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519186|NCT00112437|156093092|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519187|NCT00112437|156093093|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519188|NCT00112437|156093094|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519189|NCT00112437|156093095|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519190|NCT00112437|156093096|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519191|NCT00112437|156093097|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519192|NCT00112437|156093098|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519193|NCT00112437|156093099|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519194|NCT00112437|156093100|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519195|NCT00112437|156093101|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519196|NCT00112437|156093102|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
48519197|NCT00112437|156093077|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519198|NCT00112437|156093078|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519199|NCT00112437|156093079|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519200|NCT00112437|156093080|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519201|NCT00112437|156093081|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519202|NCT00112437|156093082|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519203|NCT00112437|156093083|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519204|NCT00112437|156093084|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519205|NCT00112437|156093085|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
48823498|NCT00557505|157193962|FG006|Overall Study|Adverse Event|1|||
48519206|NCT00112437|156093086|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
48519207|NCT00112437|156093087|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519208|NCT00112437|156093088|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519209|NCT00112437|156093089|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519210|NCT00112437|156093090|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519211|NCT00112437|156093091|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519212|NCT00112437|156093092|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519213|NCT00112437|156093093|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519214|NCT00112437|156093094|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519215|NCT00112437|156093095|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519216|NCT00112437|156093096|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519217|NCT00112437|156093097|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519218|NCT00112437|156093098|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519219|NCT00112437|156093099|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519220|NCT00112437|156093100|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519221|NCT00112437|156093101|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519222|NCT00112437|156093102|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
48519223|NCT00112437|156093077|FG000|Year 2 (12-Month Extension)|Moved|0|||
48519224|NCT00112437|156093078|FG001|Year 2 (12-Month Extension)|Moved|0|||
48519225|NCT00112437|156093079|FG002|Year 2 (12-Month Extension)|Moved|0|||
48519226|NCT00112437|156093080|FG003|Year 2 (12-Month Extension)|Moved|0|||
48519227|NCT00112437|156093081|FG004|Year 2 (12-Month Extension)|Moved|0|||
48519228|NCT00112437|156093082|FG005|Year 2 (12-Month Extension)|Moved|0|||
48519229|NCT00112437|156093083|FG006|Year 2 (12-Month Extension)|Moved|0|||
48519230|NCT00112437|156093084|FG007|Year 2 (12-Month Extension)|Moved|0|||
48519231|NCT00112437|156093085|FG008|Year 2 (12-Month Extension)|Moved|0|||
48519232|NCT00112437|156093086|FG009|Year 2 (12-Month Extension)|Moved|1|||
48519233|NCT00112437|156093087|FG010|Year 2 (12-Month Extension)|Moved|0|||
48519234|NCT00112437|156093088|FG011|Year 2 (12-Month Extension)|Moved|0|||
48519235|NCT00112437|156093089|FG012|Year 2 (12-Month Extension)|Moved|0|||
48519236|NCT00112437|156093090|FG013|Year 2 (12-Month Extension)|Moved|0|||
48519237|NCT00112437|156093091|FG014|Year 2 (12-Month Extension)|Moved|0|||
48519238|NCT00112437|156093092|FG015|Year 2 (12-Month Extension)|Moved|0|||
48519239|NCT00112437|156093093|FG016|Year 2 (12-Month Extension)|Moved|0|||
48519240|NCT00112437|156093094|FG017|Year 2 (12-Month Extension)|Moved|0|||
48519241|NCT00112437|156093095|FG018|Year 2 (12-Month Extension)|Moved|0|||
48519242|NCT00112437|156093096|FG019|Year 2 (12-Month Extension)|Moved|0|||
48519243|NCT00112437|156093097|FG020|Year 2 (12-Month Extension)|Moved|0|||
48519244|NCT00112437|156093098|FG021|Year 2 (12-Month Extension)|Moved|0|||
48519245|NCT00112437|156093099|FG022|Year 2 (12-Month Extension)|Moved|0|||
48519246|NCT00112437|156093100|FG023|Year 2 (12-Month Extension)|Moved|0|||
48519247|NCT00112437|156093101|FG024|Year 2 (12-Month Extension)|Moved|0|||
48519248|NCT00112437|156093102|FG025|Year 2 (12-Month Extension)|Moved|0|||
48519249|NCT00112437|156093077|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
48519250|NCT00112437|156093078|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
48519251|NCT00112437|156093079|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
48519252|NCT00112437|156093080|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
48519253|NCT00112437|156093081|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
48519254|NCT00112437|156093082|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
48519255|NCT00112437|156093083|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
48519256|NCT00112437|156093084|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
48519257|NCT00112437|156093085|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
48519258|NCT00112437|156093086|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
48519259|NCT00112437|156093087|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
48519260|NCT00112437|156093088|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
48519261|NCT00112437|156093089|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
48519262|NCT00112437|156093090|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
48519263|NCT00112437|156093091|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
48519264|NCT00112437|156093092|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
48519265|NCT00112437|156093093|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
48519266|NCT00112437|156093094|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
48519267|NCT00112437|156093095|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
48519268|NCT00112437|156093096|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
48519269|NCT00112437|156093097|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
48519270|NCT00112437|156093098|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
48519271|NCT00112437|156093099|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
48519272|NCT00112437|156093100|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
48519273|NCT00112437|156093101|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
48519274|NCT00112437|156093102|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
48519275|NCT00112437|156093077|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519276|NCT00112437|156093078|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519277|NCT00112437|156093079|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519278|NCT00112437|156093080|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519279|NCT00112437|156093081|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519280|NCT00112437|156093082|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519281|NCT00112437|156093083|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519282|NCT00112437|156093084|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519283|NCT00112437|156093085|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519284|NCT00112437|156093086|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48823499|NCT00557505|157193963|FG007|Overall Study|Adverse Event|0|||
48823500|NCT00557505|157193964|FG008|Overall Study|Adverse Event|0|||
48823501|NCT00557505|157193956|FG000|Overall Study|Global deterioration of health|1|||
48823502|NCT00557505|157193957|FG001|Overall Study|Global deterioration of health|0|||
48823503|NCT00557505|157193958|FG002|Overall Study|Global deterioration of health|0|||
48823504|NCT00557505|157193959|FG003|Overall Study|Global deterioration of health|0|||
48823505|NCT00557505|157193960|FG004|Overall Study|Global deterioration of health|0|||
48823506|NCT00557505|157193961|FG005|Overall Study|Global deterioration of health|0|||
48823507|NCT00557505|157193962|FG006|Overall Study|Global deterioration of health|0|||
48823508|NCT00557505|157193963|FG007|Overall Study|Global deterioration of health|0|||
48823509|NCT00557505|157193964|FG008|Overall Study|Global deterioration of health|0|||
48823510|NCT00557505|157193956|FG000|Overall Study|Objective progression or relapse|2|||
48823511|NCT00557505|157193957|FG001|Overall Study|Objective progression or relapse|3|||
48823512|NCT00557505|157193958|FG002|Overall Study|Objective progression or relapse|3|||
48823513|NCT00557505|157193959|FG003|Overall Study|Objective progression or relapse|2|||
48823514|NCT00557505|157193960|FG004|Overall Study|Objective progression or relapse|2|||
48823515|NCT00557505|157193961|FG005|Overall Study|Objective progression or relapse|3|||
48823516|NCT00557505|157193962|FG006|Overall Study|Objective progression or relapse|2|||
48823517|NCT00557505|157193963|FG007|Overall Study|Objective progression or relapse|5|||
48823518|NCT00557505|157193964|FG008|Overall Study|Objective progression or relapse|15|||
48823519|NCT00557505|157193956|FG000|Overall Study|Withdrawal by Subject|0|||
48823520|NCT00557505|157193957|FG001|Overall Study|Withdrawal by Subject|0|||
48823521|NCT00557505|157193958|FG002|Overall Study|Withdrawal by Subject|0|||
48823522|NCT00557505|157193959|FG003|Overall Study|Withdrawal by Subject|1|||
48823523|NCT00557505|157193960|FG004|Overall Study|Withdrawal by Subject|0|||
48823524|NCT00557505|157193961|FG005|Overall Study|Withdrawal by Subject|0|||
48823525|NCT00557505|157193962|FG006|Overall Study|Withdrawal by Subject|0|||
48823526|NCT00557505|157193963|FG007|Overall Study|Withdrawal by Subject|0|||
48823527|NCT00557505|157193964|FG008|Overall Study|Withdrawal by Subject|1|||
48823528|NCT03169361|157193967|FG000|Overall Study|Protocol Violation|32|||
48823529|NCT02788656|157193968|FG000|Overall Study|Withdrawal by Subject|1|||
48823530|NCT02788656|157193969|FG001|Overall Study|Withdrawal by Subject|0|||
48823531|NCT02271594|157193970|FG000|Overall Study|Study closed; recruiting failure|19|||
48823532|NCT02271594|157193971|FG001|Overall Study|Study closed; recruiting failure|12|||
48823533|NCT01561079|157193972|FG000|Overall Study|Physician Decision|17|||
48823534|NCT01561079|157193972|FG000|Overall Study|Withdrawal by Subject|59|||
48823535|NCT01561079|157193972|FG000|Overall Study|Protocol Violation|2|||
48823536|NCT00664521|157193979|FG000|Overall Study|Adverse Event|4|||
48823537|NCT00664521|157193980|FG001|Overall Study|Adverse Event|1|||
48823538|NCT00664521|157193979|FG000|Overall Study|Lost to Follow-up|1|||
48823539|NCT00664521|157193980|FG001|Overall Study|Lost to Follow-up|0|||
48823540|NCT00664521|157193979|FG000|Overall Study|Other|1|||
48823541|NCT00664521|157193980|FG001|Overall Study|Other|0|||
48823542|NCT00367237|157193981|FG000|Overall Study|Adverse Event|7|||
48823543|NCT00367237|157193982|FG001|Overall Study|Adverse Event|2|||
48823544|NCT00367237|157193981|FG000|Overall Study|Lost to Follow-up|1|||
48823545|NCT00367237|157193982|FG001|Overall Study|Lost to Follow-up|0|||
48823546|NCT00367237|157193981|FG000|Overall Study|Withdrawal by Subject|0|||
48519285|NCT00112437|156093087|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519286|NCT00112437|156093088|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
48519287|NCT00112437|156093089|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519288|NCT00112437|156093090|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
48519289|NCT00112437|156093091|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519290|NCT00112437|156093092|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
48519291|NCT00112437|156093093|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519292|NCT00112437|156093094|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519293|NCT00112437|156093095|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
48519294|NCT00112437|156093096|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519295|NCT00112437|156093097|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519296|NCT00112437|156093098|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519297|NCT00112437|156093099|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519298|NCT00112437|156093100|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519299|NCT00112437|156093101|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519300|NCT00112437|156093102|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
48519301|NCT00112437|156093077|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519302|NCT00112437|156093078|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519303|NCT00112437|156093079|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519304|NCT00112437|156093080|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48601123|NCT02718911|156396047|FG007|Overall Study|Lost to Follow-up|0|||
48383751|NCT03308942|155601430|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
48383752|NCT03308942|155601431|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
48519305|NCT00112437|156093081|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519306|NCT00112437|156093082|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519307|NCT00112437|156093083|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519308|NCT00112437|156093084|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519309|NCT00112437|156093085|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519310|NCT00112437|156093086|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519311|NCT00112437|156093087|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519312|NCT00112437|156093088|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519313|NCT00112437|156093089|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519314|NCT00112437|156093090|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519315|NCT00112437|156093091|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519316|NCT00112437|156093092|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
48519317|NCT00112437|156093093|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519318|NCT00112437|156093094|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519319|NCT00112437|156093095|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519320|NCT00112437|156093096|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519321|NCT00112437|156093097|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519322|NCT00112437|156093098|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519323|NCT00112437|156093099|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519324|NCT00112437|156093100|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519325|NCT00112437|156093101|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519326|NCT00112437|156093102|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
48519327|NCT00112437|156093077|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519328|NCT00112437|156093078|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519329|NCT00112437|156093079|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519330|NCT00112437|156093080|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519331|NCT00112437|156093081|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519332|NCT00112437|156093082|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519333|NCT00112437|156093083|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519334|NCT00112437|156093084|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519335|NCT00112437|156093085|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519336|NCT00112437|156093086|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519337|NCT00112437|156093087|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519338|NCT00112437|156093088|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519339|NCT00112437|156093089|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519340|NCT00112437|156093090|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519341|NCT00112437|156093091|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519342|NCT00112437|156093092|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
48383753|NCT03308942|155601432|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
48383754|NCT03308942|155601433|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
48383755|NCT03308942|155601434|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
48519343|NCT00112437|156093093|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519344|NCT00112437|156093094|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519345|NCT00112437|156093095|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519346|NCT00112437|156093096|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519347|NCT00112437|156093097|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519348|NCT00112437|156093098|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519349|NCT00112437|156093099|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519350|NCT00112437|156093100|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519351|NCT00112437|156093101|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519352|NCT00112437|156093102|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
48519353|NCT00112437|156093077|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519354|NCT00112437|156093078|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519355|NCT00112437|156093079|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519356|NCT00112437|156093080|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519357|NCT00112437|156093081|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519358|NCT00112437|156093082|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519359|NCT00112437|156093083|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519360|NCT00112437|156093084|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519361|NCT00112437|156093085|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519362|NCT00112437|156093086|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519363|NCT00112437|156093087|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519364|NCT00112437|156093088|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
48519365|NCT00112437|156093089|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519366|NCT00112437|156093090|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519367|NCT00112437|156093091|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
48519368|NCT00112437|156093092|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48730757|NCT03611010|156865885|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
48823547|NCT00367237|157193982|FG001|Overall Study|Withdrawal by Subject|4|||
48823548|NCT00367237|157193981|FG000|Overall Study|Protocol Violation|2|||
48823549|NCT00367237|157193982|FG001|Overall Study|Protocol Violation|5|||
48823550|NCT02368886|157193983|FG000|Overall Study|Cancel|1|||
48823551|NCT02368886|157193984|FG001|Overall Study|Cancel|1|||
48823552|NCT02368886|157193985|FG002|Overall Study|Cancel|1|||
48823553|NCT02368886|157193986|FG003|Overall Study|Cancel|3|||
48823554|NCT02368886|157193983|FG000|Overall Study|Ineligible|0|||
48823555|NCT02368886|157193984|FG001|Overall Study|Ineligible|0|||
48823556|NCT02368886|157193985|FG002|Overall Study|Ineligible|0|||
48823557|NCT02368886|157193986|FG003|Overall Study|Ineligible|1|||
48823558|NCT00550732|157193987|FG000|Overall Study|Death|4|||
48823559|NCT00550732|157193987|FG000|Overall Study|Withdrawal by Subject|2|||
48823560|NCT00550732|157193987|FG000|Overall Study|Physician Decision|2|||
48823561|NCT00550732|157193987|FG000|Overall Study|Lost to Follow-up|1|||
48823562|NCT00550732|157193987|FG000|Overall Study|Palliative care|1|||
48519369|NCT00112437|156093093|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519370|NCT00112437|156093094|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519371|NCT00112437|156093095|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519372|NCT00112437|156093096|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519373|NCT00112437|156093097|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519374|NCT00112437|156093098|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519375|NCT00112437|156093099|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519376|NCT00112437|156093100|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519377|NCT00112437|156093101|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519378|NCT00112437|156093102|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
48519379|NCT00112437|156093077|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519380|NCT00112437|156093078|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519381|NCT00112437|156093079|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519382|NCT00112437|156093080|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519383|NCT00112437|156093081|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519384|NCT00112437|156093082|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519385|NCT00112437|156093083|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519386|NCT00112437|156093084|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519387|NCT00112437|156093085|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519388|NCT00112437|156093086|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519389|NCT00112437|156093087|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
48519390|NCT00112437|156093088|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
48519391|NCT00112437|156093089|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519392|NCT00112437|156093090|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519393|NCT00112437|156093091|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519394|NCT00112437|156093092|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519395|NCT00112437|156093093|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519396|NCT00112437|156093094|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519397|NCT00112437|156093095|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48823563|NCT00550732|157193987|FG000|Overall Study|Adverse Event|1|||
48823564|NCT02688621|157193990|FG000|Overall Study|Pregnancy|1|||
48823565|NCT02688621|157193991|FG001|Overall Study|Pregnancy|3|||
48823566|NCT02688621|157193990|FG000|Overall Study|Lost to Follow-up|38|||
48823567|NCT02688621|157193991|FG001|Overall Study|Lost to Follow-up|15|||
48823568|NCT02688621|157193990|FG000|Overall Study|Withdrawal by Subject|1|||
48823569|NCT02688621|157193991|FG001|Overall Study|Withdrawal by Subject|0|||
48823570|NCT03415022|157193992|FG000|Overall Study|Withdrawal by Subject|1|||
48823571|NCT03415022|157193993|FG001|Overall Study|Withdrawal by Subject|2|||
48823572|NCT03415022|157193992|FG000|Overall Study|COVID-19 Suspension|2|||
48823573|NCT03415022|157193993|FG001|Overall Study|COVID-19 Suspension|3|||
48823574|NCT03415022|157193992|FG000|Overall Study|Lost to Follow-up|2|||
48823575|NCT03415022|157193993|FG001|Overall Study|Lost to Follow-up|0|||
48823576|NCT01094743|157193994|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
48519398|NCT00112437|156093096|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519399|NCT00112437|156093097|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519400|NCT00112437|156093098|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48823577|NCT00742274|157193997|FG000|Overall Study|Death|1|||
48823578|NCT00742274|157193998|FG001|Overall Study|Death|0|||
48823579|NCT00742274|157193997|FG000|Overall Study|Withdrawal by Subject|1|||
48823580|NCT00742274|157193998|FG001|Overall Study|Withdrawal by Subject|2|||
48823581|NCT00742274|157193997|FG000|Overall Study|Removed for medical reasons|1|||
48823582|NCT00742274|157193998|FG001|Overall Study|Removed for medical reasons|1|||
48823583|NCT02034435|157194008|FG000|Overall Study|Withdrawal by Subject|1|||
48823584|NCT02034435|157194009|FG001|Overall Study|Withdrawal by Subject|0|||
48823585|NCT02034435|157194010|FG002|Overall Study|Withdrawal by Subject|0|||
48823586|NCT02034435|157194011|FG003|Overall Study|Withdrawal by Subject|0|||
48823587|NCT02034435|157194008|FG000|Overall Study|Illness|0|||
48823588|NCT02034435|157194009|FG001|Overall Study|Illness|2|||
48823589|NCT02034435|157194010|FG002|Overall Study|Illness|0|||
48823590|NCT02034435|157194011|FG003|Overall Study|Illness|0|||
48823591|NCT02034435|157194008|FG000|Overall Study|Inadequate IV access|1|||
48823592|NCT02034435|157194009|FG001|Overall Study|Inadequate IV access|0|||
48823593|NCT02034435|157194010|FG002|Overall Study|Inadequate IV access|0|||
48823594|NCT02034435|157194011|FG003|Overall Study|Inadequate IV access|1|||
48823595|NCT02300311|157194012|FG000|Overall Study|Other than the reason specified|1|||
48823596|NCT02300311|157194013|FG001|Overall Study|Other than the reason specified|0|||
48823597|NCT02300311|157194012|FG000|Overall Study|Refused to continue taking medication|18|||
48519401|NCT00112437|156093099|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519402|NCT00112437|156093100|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519403|NCT00112437|156093101|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519404|NCT00112437|156093102|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
48519405|NCT00112437|156093077|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519406|NCT00112437|156093078|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519407|NCT00112437|156093079|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519408|NCT00112437|156093080|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519409|NCT00112437|156093081|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519410|NCT00112437|156093082|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519411|NCT00112437|156093083|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519412|NCT00112437|156093084|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519413|NCT00112437|156093085|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519414|NCT00112437|156093086|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519415|NCT00112437|156093087|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519416|NCT00112437|156093088|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519417|NCT00112437|156093089|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519418|NCT00112437|156093090|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519419|NCT00112437|156093091|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519420|NCT00112437|156093092|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519421|NCT00112437|156093093|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519422|NCT00112437|156093094|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519423|NCT00112437|156093095|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519424|NCT00112437|156093096|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519425|NCT00112437|156093097|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
48519426|NCT00112437|156093098|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
48519427|NCT00112437|156093099|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519428|NCT00112437|156093100|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519429|NCT00112437|156093101|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48823598|NCT02300311|157194013|FG001|Overall Study|Refused to continue taking medication|0|||
48519430|NCT00112437|156093102|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
48519431|NCT00112437|156093077|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519432|NCT00112437|156093078|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519433|NCT00112437|156093079|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519434|NCT00112437|156093080|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519435|NCT00112437|156093081|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519436|NCT00112437|156093082|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519437|NCT00112437|156093083|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519438|NCT00112437|156093084|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519439|NCT00112437|156093085|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519440|NCT00112437|156093086|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519441|NCT00112437|156093087|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519442|NCT00112437|156093088|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519443|NCT00112437|156093089|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519444|NCT00112437|156093090|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519445|NCT00112437|156093091|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519446|NCT00112437|156093092|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519447|NCT00112437|156093093|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48823599|NCT02531438|157194014|FG000|Overall Study|Adverse Event|7|||
48519448|NCT00112437|156093094|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519449|NCT00112437|156093095|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519450|NCT00112437|156093096|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519451|NCT00112437|156093097|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
48519452|NCT00112437|156093098|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519453|NCT00112437|156093099|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48823600|NCT02531438|157194015|FG001|Overall Study|Adverse Event|9|||
48823601|NCT02531438|157194014|FG000|Overall Study|Lost to Follow-up|0|||
48519454|NCT00112437|156093100|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48823602|NCT02531438|157194015|FG001|Overall Study|Lost to Follow-up|3|||
48823603|NCT02531438|157194014|FG000|Overall Study|Withdrawal by Subject|7|||
48823604|NCT02531438|157194015|FG001|Overall Study|Withdrawal by Subject|8|||
48823605|NCT02531438|157194014|FG000|Overall Study|Physician Decision|0|||
48823606|NCT02531438|157194015|FG001|Overall Study|Physician Decision|1|||
48823607|NCT02531438|157194014|FG000|Overall Study|Death|6|||
48823608|NCT02531438|157194015|FG001|Overall Study|Death|3|||
48823609|NCT02531438|157194014|FG000|Overall Study|Randomized, but Not Treated|4|||
48823610|NCT02531438|157194015|FG001|Overall Study|Randomized, but Not Treated|0|||
48823611|NCT02531438|157194014|FG000|Overall Study|Missed EOT/PTE Visit|5|||
48823612|NCT02531438|157194015|FG001|Overall Study|Missed EOT/PTE Visit|2|||
48823613|NCT02531438|157194014|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
48823614|NCT02531438|157194015|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
48823615|NCT01124617|157194016|FG000|Overall Study|Adverse Event|5|||
48519455|NCT00112437|156093101|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519456|NCT00112437|156093102|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
48519457|NCT00112437|156093077|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519458|NCT00112437|156093078|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519459|NCT00112437|156093079|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519460|NCT00112437|156093080|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519461|NCT00112437|156093081|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519462|NCT00112437|156093082|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519463|NCT00112437|156093083|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519464|NCT00112437|156093084|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519465|NCT00112437|156093085|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519466|NCT00112437|156093086|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519467|NCT00112437|156093087|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519468|NCT00112437|156093088|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519469|NCT00112437|156093089|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519470|NCT00112437|156093090|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519471|NCT00112437|156093091|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519472|NCT00112437|156093092|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519473|NCT00112437|156093093|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519474|NCT00112437|156093094|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519475|NCT00112437|156093095|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519476|NCT00112437|156093096|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519477|NCT00112437|156093097|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48823616|NCT01124617|157194017|FG001|Overall Study|Adverse Event|2|||
48823617|NCT01124617|157194016|FG000|Overall Study|Lack of Efficacy|2|||
48823618|NCT01124617|157194017|FG001|Overall Study|Lack of Efficacy|1|||
48383756|NCT03308942|155601430|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
48383757|NCT03308942|155601431|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
48383758|NCT03308942|155601432|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
48383759|NCT03308942|155601433|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
48383760|NCT03308942|155601434|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
48383761|NCT02294682|155601435|FG000|Overall Study|Could not swallow pills|1|||
48383762|NCT02294682|155601436|FG001|Overall Study|Could not swallow pills|0|||
48383763|NCT00763971|155601437|FG000|Overall Study|Adverse Event|5|||
48383764|NCT00763971|155601438|FG001|Overall Study|Adverse Event|2|||
48383765|NCT00763971|155601439|FG002|Overall Study|Adverse Event|4|||
48383766|NCT00763971|155601437|FG000|Overall Study|Protocol Violation|3|||
48383767|NCT00763971|155601438|FG001|Overall Study|Protocol Violation|3|||
48383768|NCT00763971|155601439|FG002|Overall Study|Protocol Violation|2|||
48383769|NCT00763971|155601437|FG000|Overall Study|Withdrawal by Subject|4|||
48383770|NCT00763971|155601438|FG001|Overall Study|Withdrawal by Subject|5|||
48383771|NCT00763971|155601439|FG002|Overall Study|Withdrawal by Subject|5|||
48383772|NCT00763971|155601437|FG000|Overall Study|Lost to Follow-up|0|||
48383773|NCT00763971|155601438|FG001|Overall Study|Lost to Follow-up|1|||
48383774|NCT00763971|155601439|FG002|Overall Study|Lost to Follow-up|0|||
48383775|NCT00763971|155601437|FG000|Overall Study|Lack of Efficacy|11|||
48383776|NCT00763971|155601438|FG001|Overall Study|Lack of Efficacy|22|||
48383777|NCT00763971|155601439|FG002|Overall Study|Lack of Efficacy|54|||
48383778|NCT00763971|155601437|FG000|Overall Study|Unable to swallow capsule|2|||
48383779|NCT00763971|155601438|FG001|Overall Study|Unable to swallow capsule|1|||
48383780|NCT00763971|155601439|FG002|Overall Study|Unable to swallow capsule|1|||
48383781|NCT00763971|155601437|FG000|Overall Study|Personal reason|3|||
48383782|NCT00763971|155601438|FG001|Overall Study|Personal reason|0|||
48383783|NCT00763971|155601439|FG002|Overall Study|Personal reason|0|||
48383784|NCT00763971|155601437|FG000|Overall Study|Exclusion criteria met|1|||
48383785|NCT00763971|155601438|FG001|Overall Study|Exclusion criteria met|0|||
48383786|NCT00763971|155601439|FG002|Overall Study|Exclusion criteria met|0|||
48383787|NCT00763971|155601437|FG000|Overall Study|Sponsor decision|1|||
48383788|NCT00763971|155601438|FG001|Overall Study|Sponsor decision|0|||
48823619|NCT01124617|157194016|FG000|Overall Study|Protocol Violation|1|||
48823620|NCT01124617|157194017|FG001|Overall Study|Protocol Violation|1|||
48823621|NCT01124617|157194016|FG000|Overall Study|Withdrawal by Subject|9|||
48823622|NCT01124617|157194017|FG001|Overall Study|Withdrawal by Subject|1|||
48519478|NCT00112437|156093098|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
48519479|NCT00112437|156093099|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519480|NCT00112437|156093100|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519481|NCT00112437|156093101|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519482|NCT00112437|156093102|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
48519483|NCT00112437|156093077|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519484|NCT00112437|156093078|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519485|NCT00112437|156093079|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519486|NCT00112437|156093080|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519487|NCT00112437|156093081|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519488|NCT00112437|156093082|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
48823623|NCT01124617|157194016|FG000|Overall Study|Other|2|||
48823624|NCT01124617|157194017|FG001|Overall Study|Other|1|||
48823625|NCT01653743|157194018|FG000|Overall Study|Withdrawal by Subject|1|||
48823626|NCT01653743|157194019|FG001|Overall Study|Withdrawal by Subject|0|||
48823627|NCT01653743|157194018|FG000|Overall Study|Investigator discretion|3|||
48823628|NCT01653743|157194019|FG001|Overall Study|Investigator discretion|0|||
48823629|NCT03246672|157194020|FG000|Overall Study|Lost to Follow-up|2|||
48519489|NCT00112437|156093083|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519490|NCT00112437|156093084|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
48823630|NCT00811187|157194021|FG000|Overall Study|Unable to place device / procedure abort|3|||
48823631|NCT00811187|157194022|FG001|Overall Study|Unable to place device / procedure abort|3|||
48823632|NCT00329303|157194023|FG000|Overall Study|Lack of Efficacy|1|||
48519491|NCT00112437|156093085|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
48823633|NCT00329303|157194024|FG001|Overall Study|Lack of Efficacy|0|||
48823634|NCT00329303|157194023|FG000|Overall Study|Decision of the sponsor|0|||
48823635|NCT00329303|157194024|FG001|Overall Study|Decision of the sponsor|1|||
48823636|NCT00329303|157194023|FG000|Overall Study|Patient no longer available|1|||
48823637|NCT00329303|157194024|FG001|Overall Study|Patient no longer available|0|||
48823638|NCT00329303|157194023|FG000|Overall Study|Patient relocated|0|||
48823639|NCT00329303|157194024|FG001|Overall Study|Patient relocated|1|||
48823640|NCT03697460|157194026|FG000|Overall Study|Withdrawal by Subject|3|||
48823641|NCT01559090|157194027|FG000|Stage I|Withdrawal by Subject|2|||
48823642|NCT01559090|157194028|FG001|Stage I|Withdrawal by Subject|2|||
48823643|NCT01559090|157194029|FG002|Stage I|Withdrawal by Subject|3|||
48823644|NCT01559090|157194027|FG000|Stage II|Withdrawal by Subject|1|||
48823645|NCT01559090|157194028|FG001|Stage II|Withdrawal by Subject|0|||
48823646|NCT01559090|157194029|FG002|Stage II|Withdrawal by Subject|0|||
48823647|NCT00062868|157194030|FG000|Dose Level 1|Death|2|||
48823648|NCT00062868|157194031|FG001|Dose Level 1|Death|0|||
48823649|NCT00062868|157194032|FG002|Dose Level 1|Death|0|||
48823650|NCT00062868|157194033|FG003|Dose Level 1|Death|2|||
48823651|NCT00062868|157194034|FG004|Dose Level 1|Death|0|||
48823652|NCT00062868|157194035|FG005|Dose Level 1|Death|0|||
48823653|NCT00062868|157194036|FG006|Dose Level 1|Death|3|||
48823654|NCT00062868|157194037|FG007|Dose Level 1|Death|0|||
48823655|NCT00062868|157194038|FG008|Dose Level 1|Death|0|||
48823656|NCT00062868|157194039|FG009|Dose Level 1|Death|0|||
48823657|NCT00062868|157194040|FG010|Dose Level 1|Death|0|||
48823658|NCT00062868|157194041|FG011|Dose Level 1|Death|0|||
48519492|NCT00112437|156093086|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519493|NCT00112437|156093087|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519494|NCT00112437|156093088|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519495|NCT00112437|156093089|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519496|NCT00112437|156093090|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519497|NCT00112437|156093091|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519498|NCT00112437|156093092|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519499|NCT00112437|156093093|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519500|NCT00112437|156093094|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519501|NCT00112437|156093095|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519502|NCT00112437|156093096|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
48823659|NCT00062868|157194042|FG012|Dose Level 1|Death|0|||
48823660|NCT00062868|157194043|FG013|Dose Level 1|Death|0|||
48823661|NCT00062868|157194044|FG014|Dose Level 1|Death|0|||
48823662|NCT00062868|157194045|FG015|Dose Level 1|Death|0|||
48823663|NCT00062868|157194046|FG016|Dose Level 1|Death|0|||
48823664|NCT00062868|157194047|FG017|Dose Level 1|Death|0|||
48823665|NCT00062868|157194048|FG018|Dose Level 1|Death|7|||
48823666|NCT00062868|157194049|FG019|Dose Level 1|Death|0|||
48519503|NCT00112437|156093097|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519504|NCT00112437|156093098|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
48823667|NCT00062868|157194050|FG020|Dose Level 1|Death|1|||
48823668|NCT00062868|157194030|FG000|Dose Level 1|Lost to Follow-up|0|||
48823669|NCT00062868|157194031|FG001|Dose Level 1|Lost to Follow-up|0|||
48823670|NCT00062868|157194032|FG002|Dose Level 1|Lost to Follow-up|0|||
48823671|NCT00062868|157194033|FG003|Dose Level 1|Lost to Follow-up|0|||
48823672|NCT00062868|157194034|FG004|Dose Level 1|Lost to Follow-up|0|||
48823673|NCT00062868|157194035|FG005|Dose Level 1|Lost to Follow-up|0|||
48823674|NCT00062868|157194036|FG006|Dose Level 1|Lost to Follow-up|0|||
48823675|NCT00062868|157194037|FG007|Dose Level 1|Lost to Follow-up|0|||
48823676|NCT00062868|157194038|FG008|Dose Level 1|Lost to Follow-up|0|||
48823677|NCT00062868|157194039|FG009|Dose Level 1|Lost to Follow-up|0|||
48823678|NCT00062868|157194040|FG010|Dose Level 1|Lost to Follow-up|0|||
48519505|NCT00112437|156093099|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519506|NCT00112437|156093100|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519507|NCT00112437|156093101|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519508|NCT00112437|156093102|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
48519509|NCT00112437|156093077|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519510|NCT00112437|156093078|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519511|NCT00112437|156093079|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519512|NCT00112437|156093080|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519513|NCT00112437|156093081|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519514|NCT00112437|156093082|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519515|NCT00112437|156093083|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519516|NCT00112437|156093084|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519517|NCT00112437|156093085|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519518|NCT00112437|156093086|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519519|NCT00112437|156093087|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48823679|NCT00062868|157194041|FG011|Dose Level 1|Lost to Follow-up|0|||
48823680|NCT00062868|157194042|FG012|Dose Level 1|Lost to Follow-up|1|||
48823681|NCT00062868|157194043|FG013|Dose Level 1|Lost to Follow-up|0|||
48823682|NCT00062868|157194044|FG014|Dose Level 1|Lost to Follow-up|0|||
48823683|NCT00062868|157194045|FG015|Dose Level 1|Lost to Follow-up|0|||
48823684|NCT00062868|157194046|FG016|Dose Level 1|Lost to Follow-up|0|||
48823685|NCT00062868|157194047|FG017|Dose Level 1|Lost to Follow-up|0|||
48823686|NCT00062868|157194048|FG018|Dose Level 1|Lost to Follow-up|2|||
48823687|NCT00062868|157194049|FG019|Dose Level 1|Lost to Follow-up|0|||
48823688|NCT00062868|157194050|FG020|Dose Level 1|Lost to Follow-up|1|||
48823689|NCT00062868|157194030|FG000|Dose Level 2|Death|0|||
48823690|NCT00062868|157194031|FG001|Dose Level 2|Death|3|||
48823691|NCT00062868|157194032|FG002|Dose Level 2|Death|0|||
48823692|NCT00062868|157194033|FG003|Dose Level 2|Death|0|||
48823693|NCT00062868|157194034|FG004|Dose Level 2|Death|2|||
48823694|NCT00062868|157194035|FG005|Dose Level 2|Death|0|||
48823695|NCT00062868|157194036|FG006|Dose Level 2|Death|0|||
48823696|NCT00062868|157194037|FG007|Dose Level 2|Death|0|||
48823697|NCT00062868|157194038|FG008|Dose Level 2|Death|0|||
48823698|NCT00062868|157194039|FG009|Dose Level 2|Death|0|||
48823699|NCT00062868|157194040|FG010|Dose Level 2|Death|1|||
48823700|NCT00062868|157194041|FG011|Dose Level 2|Death|0|||
48823701|NCT00062868|157194042|FG012|Dose Level 2|Death|0|||
48823702|NCT00062868|157194043|FG013|Dose Level 2|Death|0|||
48823703|NCT00062868|157194044|FG014|Dose Level 2|Death|0|||
48519520|NCT00112437|156093088|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519521|NCT00112437|156093089|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519522|NCT00112437|156093090|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519523|NCT00112437|156093091|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519524|NCT00112437|156093092|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519525|NCT00112437|156093093|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48823704|NCT00062868|157194045|FG015|Dose Level 2|Death|0|||
48823705|NCT00062868|157194046|FG016|Dose Level 2|Death|2|||
48823706|NCT00062868|157194047|FG017|Dose Level 2|Death|0|||
48823707|NCT00062868|157194048|FG018|Dose Level 2|Death|0|||
48823708|NCT00062868|157194049|FG019|Dose Level 2|Death|0|||
48823709|NCT00062868|157194050|FG020|Dose Level 2|Death|0|||
48823710|NCT00062868|157194030|FG000|Dose Level 2|Lost to Follow-up|0|||
48519526|NCT00112437|156093094|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519527|NCT00112437|156093095|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48823711|NCT00062868|157194031|FG001|Dose Level 2|Lost to Follow-up|0|||
48823712|NCT00062868|157194032|FG002|Dose Level 2|Lost to Follow-up|0|||
48823713|NCT00062868|157194033|FG003|Dose Level 2|Lost to Follow-up|0|||
48823714|NCT00062868|157194034|FG004|Dose Level 2|Lost to Follow-up|0|||
48823715|NCT00062868|157194035|FG005|Dose Level 2|Lost to Follow-up|0|||
48823716|NCT00062868|157194036|FG006|Dose Level 2|Lost to Follow-up|0|||
48823717|NCT00062868|157194037|FG007|Dose Level 2|Lost to Follow-up|0|||
48823718|NCT00062868|157194038|FG008|Dose Level 2|Lost to Follow-up|0|||
48823719|NCT00062868|157194039|FG009|Dose Level 2|Lost to Follow-up|0|||
48823720|NCT00062868|157194040|FG010|Dose Level 2|Lost to Follow-up|0|||
48823721|NCT00062868|157194041|FG011|Dose Level 2|Lost to Follow-up|0|||
48823722|NCT00062868|157194042|FG012|Dose Level 2|Lost to Follow-up|0|||
48823723|NCT00062868|157194043|FG013|Dose Level 2|Lost to Follow-up|1|||
48823724|NCT00062868|157194044|FG014|Dose Level 2|Lost to Follow-up|0|||
48823725|NCT00062868|157194045|FG015|Dose Level 2|Lost to Follow-up|0|||
48823726|NCT00062868|157194046|FG016|Dose Level 2|Lost to Follow-up|1|||
48823727|NCT00062868|157194047|FG017|Dose Level 2|Lost to Follow-up|0|||
48823728|NCT00062868|157194048|FG018|Dose Level 2|Lost to Follow-up|0|||
48823729|NCT00062868|157194049|FG019|Dose Level 2|Lost to Follow-up|0|||
48823730|NCT00062868|157194050|FG020|Dose Level 2|Lost to Follow-up|0|||
48823731|NCT00062868|157194030|FG000|Dose Level 3|Death|0|||
48823732|NCT00062868|157194031|FG001|Dose Level 3|Death|0|||
48823733|NCT00062868|157194032|FG002|Dose Level 3|Death|0|||
48823734|NCT00062868|157194033|FG003|Dose Level 3|Death|0|||
48823735|NCT00062868|157194034|FG004|Dose Level 3|Death|0|||
48823736|NCT00062868|157194035|FG005|Dose Level 3|Death|0|||
48823737|NCT00062868|157194036|FG006|Dose Level 3|Death|0|||
48823738|NCT00062868|157194037|FG007|Dose Level 3|Death|0|||
48823739|NCT00062868|157194038|FG008|Dose Level 3|Death|0|||
48823740|NCT00062868|157194039|FG009|Dose Level 3|Death|0|||
48823741|NCT00062868|157194040|FG010|Dose Level 3|Death|0|||
48823742|NCT00062868|157194041|FG011|Dose Level 3|Death|1|||
48823743|NCT00062868|157194042|FG012|Dose Level 3|Death|0|||
48823744|NCT00062868|157194043|FG013|Dose Level 3|Death|0|||
48823745|NCT00062868|157194044|FG014|Dose Level 3|Death|0|||
48823746|NCT00062868|157194045|FG015|Dose Level 3|Death|0|||
48823747|NCT00062868|157194046|FG016|Dose Level 3|Death|0|||
48823748|NCT00062868|157194047|FG017|Dose Level 3|Death|1|||
48823749|NCT00062868|157194048|FG018|Dose Level 3|Death|0|||
48519528|NCT00112437|156093096|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519529|NCT00112437|156093097|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
48519530|NCT00112437|156093098|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
48519531|NCT00112437|156093099|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519532|NCT00112437|156093100|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519533|NCT00112437|156093101|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519534|NCT00112437|156093102|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
48519535|NCT00112437|156093077|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519536|NCT00112437|156093078|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519537|NCT00112437|156093079|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519538|NCT00112437|156093080|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519539|NCT00112437|156093081|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519540|NCT00112437|156093082|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519541|NCT00112437|156093083|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519542|NCT00112437|156093084|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519543|NCT00112437|156093085|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519544|NCT00112437|156093086|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519545|NCT00112437|156093087|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519546|NCT00112437|156093088|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519547|NCT00112437|156093089|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519548|NCT00112437|156093090|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519549|NCT00112437|156093091|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519550|NCT00112437|156093092|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519551|NCT00112437|156093093|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519552|NCT00112437|156093094|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519553|NCT00112437|156093095|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519554|NCT00112437|156093096|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519555|NCT00112437|156093097|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48519556|NCT00112437|156093098|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48823750|NCT00062868|157194049|FG019|Dose Level 3|Death|0|||
48823751|NCT00062868|157194050|FG020|Dose Level 3|Death|0|||
48823752|NCT00062868|157194030|FG000|Dose Level 3|Lost to Follow-up|0|||
48823753|NCT00062868|157194031|FG001|Dose Level 3|Lost to Follow-up|0|||
48823754|NCT00062868|157194032|FG002|Dose Level 3|Lost to Follow-up|0|||
48519557|NCT00112437|156093099|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
48823755|NCT00062868|157194033|FG003|Dose Level 3|Lost to Follow-up|0|||
48823756|NCT00062868|157194034|FG004|Dose Level 3|Lost to Follow-up|0|||
48823757|NCT00062868|157194035|FG005|Dose Level 3|Lost to Follow-up|0|||
48519558|NCT00112437|156093100|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
48823758|NCT00062868|157194036|FG006|Dose Level 3|Lost to Follow-up|0|||
48823759|NCT00062868|157194037|FG007|Dose Level 3|Lost to Follow-up|0|||
48519559|NCT00112437|156093101|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
48601124|NCT02718911|156396048|FG008|Overall Study|Lost to Follow-up|1|||
48823760|NCT00062868|157194038|FG008|Dose Level 3|Lost to Follow-up|0|||
48823761|NCT00062868|157194039|FG009|Dose Level 3|Lost to Follow-up|0|||
48823762|NCT00062868|157194040|FG010|Dose Level 3|Lost to Follow-up|0|||
48823763|NCT00062868|157194041|FG011|Dose Level 3|Lost to Follow-up|0|||
48823764|NCT00062868|157194042|FG012|Dose Level 3|Lost to Follow-up|0|||
48823765|NCT00062868|157194043|FG013|Dose Level 3|Lost to Follow-up|0|||
48823766|NCT00062868|157194044|FG014|Dose Level 3|Lost to Follow-up|1|||
48823767|NCT00062868|157194045|FG015|Dose Level 3|Lost to Follow-up|0|||
48519560|NCT00112437|156093102|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
48519561|NCT00112437|156093077|FG000|Years 6-10 (60-Month Extension)|Death|0|||
48519562|NCT00112437|156093078|FG001|Years 6-10 (60-Month Extension)|Death|0|||
48519563|NCT00112437|156093079|FG002|Years 6-10 (60-Month Extension)|Death|0|||
48519564|NCT00112437|156093080|FG003|Years 6-10 (60-Month Extension)|Death|0|||
48519565|NCT00112437|156093081|FG004|Years 6-10 (60-Month Extension)|Death|0|||
48519566|NCT00112437|156093082|FG005|Years 6-10 (60-Month Extension)|Death|0|||
48519567|NCT00112437|156093083|FG006|Years 6-10 (60-Month Extension)|Death|0|||
48519568|NCT00112437|156093084|FG007|Years 6-10 (60-Month Extension)|Death|0|||
48519569|NCT00112437|156093085|FG008|Years 6-10 (60-Month Extension)|Death|0|||
48519570|NCT00112437|156093086|FG009|Years 6-10 (60-Month Extension)|Death|0|||
48519571|NCT00112437|156093087|FG010|Years 6-10 (60-Month Extension)|Death|0|||
48823768|NCT00062868|157194046|FG016|Dose Level 3|Lost to Follow-up|0|||
48519572|NCT00112437|156093088|FG011|Years 6-10 (60-Month Extension)|Death|0|||
48519573|NCT00112437|156093089|FG012|Years 6-10 (60-Month Extension)|Death|0|||
48519574|NCT00112437|156093090|FG013|Years 6-10 (60-Month Extension)|Death|0|||
48519575|NCT00112437|156093091|FG014|Years 6-10 (60-Month Extension)|Death|0|||
48519576|NCT00112437|156093092|FG015|Years 6-10 (60-Month Extension)|Death|0|||
48519577|NCT00112437|156093093|FG016|Years 6-10 (60-Month Extension)|Death|0|||
48519578|NCT00112437|156093094|FG017|Years 6-10 (60-Month Extension)|Death|0|||
48519579|NCT00112437|156093095|FG018|Years 6-10 (60-Month Extension)|Death|0|||
48519580|NCT00112437|156093096|FG019|Years 6-10 (60-Month Extension)|Death|0|||
48519581|NCT00112437|156093097|FG020|Years 6-10 (60-Month Extension)|Death|0|||
48519582|NCT00112437|156093098|FG021|Years 6-10 (60-Month Extension)|Death|0|||
48519583|NCT00112437|156093099|FG022|Years 6-10 (60-Month Extension)|Death|0|||
48823769|NCT00062868|157194047|FG017|Dose Level 3|Lost to Follow-up|0|||
48823770|NCT00062868|157194048|FG018|Dose Level 3|Lost to Follow-up|0|||
48823771|NCT00062868|157194049|FG019|Dose Level 3|Lost to Follow-up|0|||
48823772|NCT00062868|157194050|FG020|Dose Level 3|Lost to Follow-up|0|||
48823773|NCT00062868|157194030|FG000|Dose Level 3|Withdrew|0|||
48823774|NCT00062868|157194031|FG001|Dose Level 3|Withdrew|0|||
48823775|NCT00062868|157194032|FG002|Dose Level 3|Withdrew|2|||
48823776|NCT00062868|157194033|FG003|Dose Level 3|Withdrew|0|||
48823777|NCT00062868|157194034|FG004|Dose Level 3|Withdrew|0|||
48823778|NCT00062868|157194035|FG005|Dose Level 3|Withdrew|0|||
48823779|NCT00062868|157194036|FG006|Dose Level 3|Withdrew|0|||
48823780|NCT00062868|157194037|FG007|Dose Level 3|Withdrew|0|||
48823781|NCT00062868|157194038|FG008|Dose Level 3|Withdrew|0|||
48823782|NCT00062868|157194039|FG009|Dose Level 3|Withdrew|0|||
48823783|NCT00062868|157194040|FG010|Dose Level 3|Withdrew|0|||
48823784|NCT00062868|157194041|FG011|Dose Level 3|Withdrew|0|||
48823785|NCT00062868|157194042|FG012|Dose Level 3|Withdrew|0|||
48823786|NCT00062868|157194043|FG013|Dose Level 3|Withdrew|0|||
48823787|NCT00062868|157194044|FG014|Dose Level 3|Withdrew|0|||
48823788|NCT00062868|157194045|FG015|Dose Level 3|Withdrew|0|||
48823789|NCT00062868|157194046|FG016|Dose Level 3|Withdrew|0|||
48823790|NCT00062868|157194047|FG017|Dose Level 3|Withdrew|0|||
48823791|NCT00062868|157194048|FG018|Dose Level 3|Withdrew|0|||
48823792|NCT00062868|157194049|FG019|Dose Level 3|Withdrew|0|||
48383789|NCT00763971|155601439|FG002|Overall Study|Sponsor decision|0|||
48519584|NCT00112437|156093100|FG023|Years 6-10 (60-Month Extension)|Death|2|||
48519585|NCT00112437|156093101|FG024|Years 6-10 (60-Month Extension)|Death|0|||
48519586|NCT00112437|156093102|FG025|Years 6-10 (60-Month Extension)|Death|0|||
48519587|NCT00112437|156093077|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519588|NCT00112437|156093078|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519589|NCT00112437|156093079|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519590|NCT00112437|156093080|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519591|NCT00112437|156093081|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519592|NCT00112437|156093082|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519593|NCT00112437|156093083|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519594|NCT00112437|156093084|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519595|NCT00112437|156093085|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519596|NCT00112437|156093086|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519597|NCT00112437|156093087|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519598|NCT00112437|156093088|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48823793|NCT00062868|157194050|FG020|Dose Level 3|Withdrew|0|||
48823794|NCT01101542|157194054|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
48823795|NCT01101542|157194054|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
48823796|NCT01101542|157194054|FG000|Year 4 Surveillance Period|Other|287|||
48519599|NCT00112437|156093089|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519600|NCT00112437|156093090|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519601|NCT00112437|156093091|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519602|NCT00112437|156093092|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519603|NCT00112437|156093093|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519604|NCT00112437|156093094|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48823797|NCT01101542|157194054|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
48823798|NCT01101542|157194054|FG000|Year 5 Surveillance Period|Pregnancy|1|||
48519605|NCT00112437|156093095|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519606|NCT00112437|156093096|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519607|NCT00112437|156093097|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519608|NCT00112437|156093098|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519609|NCT00112437|156093099|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519610|NCT00112437|156093100|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519611|NCT00112437|156093101|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
48519612|NCT00112437|156093102|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
48519613|NCT00112437|156093077|FG000|Years 6-10 (60-Month Extension)|Other|0|||
48519614|NCT00112437|156093078|FG001|Years 6-10 (60-Month Extension)|Other|0|||
48519615|NCT00112437|156093079|FG002|Years 6-10 (60-Month Extension)|Other|0|||
48519616|NCT00112437|156093080|FG003|Years 6-10 (60-Month Extension)|Other|0|||
48519617|NCT00112437|156093081|FG004|Years 6-10 (60-Month Extension)|Other|0|||
48519618|NCT00112437|156093082|FG005|Years 6-10 (60-Month Extension)|Other|0|||
48519619|NCT00112437|156093083|FG006|Years 6-10 (60-Month Extension)|Other|0|||
48519620|NCT00112437|156093084|FG007|Years 6-10 (60-Month Extension)|Other|0|||
48519621|NCT00112437|156093085|FG008|Years 6-10 (60-Month Extension)|Other|0|||
48519622|NCT00112437|156093086|FG009|Years 6-10 (60-Month Extension)|Other|0|||
48519623|NCT00112437|156093087|FG010|Years 6-10 (60-Month Extension)|Other|0|||
48519624|NCT00112437|156093088|FG011|Years 6-10 (60-Month Extension)|Other|0|||
48519625|NCT00112437|156093089|FG012|Years 6-10 (60-Month Extension)|Other|0|||
48519626|NCT00112437|156093090|FG013|Years 6-10 (60-Month Extension)|Other|0|||
48519627|NCT00112437|156093091|FG014|Years 6-10 (60-Month Extension)|Other|0|||
48519628|NCT00112437|156093092|FG015|Years 6-10 (60-Month Extension)|Other|0|||
48519629|NCT00112437|156093093|FG016|Years 6-10 (60-Month Extension)|Other|0|||
48519630|NCT00112437|156093094|FG017|Years 6-10 (60-Month Extension)|Other|0|||
48519631|NCT00112437|156093095|FG018|Years 6-10 (60-Month Extension)|Other|0|||
48519632|NCT00112437|156093096|FG019|Years 6-10 (60-Month Extension)|Other|0|||
48519633|NCT00112437|156093097|FG020|Years 6-10 (60-Month Extension)|Other|0|||
48519634|NCT00112437|156093098|FG021|Years 6-10 (60-Month Extension)|Other|0|||
48519635|NCT00112437|156093099|FG022|Years 6-10 (60-Month Extension)|Other|0|||
48519636|NCT00112437|156093100|FG023|Years 6-10 (60-Month Extension)|Other|0|||
48519637|NCT00112437|156093101|FG024|Years 6-10 (60-Month Extension)|Other|1|||
48519638|NCT00112437|156093102|FG025|Years 6-10 (60-Month Extension)|Other|0|||
48519639|NCT00112437|156093077|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519640|NCT00112437|156093078|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519641|NCT00112437|156093079|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519642|NCT00112437|156093080|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519643|NCT00112437|156093081|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519644|NCT00112437|156093082|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519645|NCT00112437|156093083|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519646|NCT00112437|156093084|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519647|NCT00112437|156093085|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519648|NCT00112437|156093086|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519649|NCT00112437|156093087|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519650|NCT00112437|156093088|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519651|NCT00112437|156093089|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48730758|NCT03611010|156865886|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
48730759|NCT03611010|156865887|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
48730760|NCT03611010|156865888|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
48730761|NCT02063880|156865891|FG000|Overall Study|Death|21|||
48383790|NCT00763971|155601437|FG000|Overall Study|Due to holiday season|2|||
48383791|NCT00763971|155601438|FG001|Overall Study|Due to holiday season|0|||
48383792|NCT00763971|155601439|FG002|Overall Study|Due to holiday season|1|||
48383793|NCT00763971|155601437|FG000|Overall Study|Randomization error|0|||
48383794|NCT00763971|155601438|FG001|Overall Study|Randomization error|0|||
48383795|NCT00763971|155601439|FG002|Overall Study|Randomization error|1|||
48730762|NCT02063880|156865892|FG001|Overall Study|Death|18|||
48730763|NCT02063880|156865891|FG000|Overall Study|Lost to Follow-up|7|||
48730764|NCT02063880|156865892|FG001|Overall Study|Lost to Follow-up|7|||
48730765|NCT02063880|156865891|FG000|Overall Study|Ineligible|0|||
48383796|NCT00763971|155601437|FG000|Overall Study|Medical monitor decision|0|||
48383797|NCT00763971|155601438|FG001|Overall Study|Medical monitor decision|0|||
48383798|NCT00763971|155601439|FG002|Overall Study|Medical monitor decision|1|||
48383799|NCT00763971|155601437|FG000|Overall Study|Moved to another country|0|||
48730766|NCT02063880|156865892|FG001|Overall Study|Ineligible|2|||
48730767|NCT00567593|156865893|FG000|Overall Study|Adverse Event|1|||
48383800|NCT00763971|155601438|FG001|Overall Study|Moved to another country|1|||
48383801|NCT00763971|155601439|FG002|Overall Study|Moved to another country|0|||
48383802|NCT00763971|155601437|FG000|Overall Study|Subject wanted dose reduction|0|||
48519652|NCT00112437|156093090|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519653|NCT00112437|156093091|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519654|NCT00112437|156093092|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48730768|NCT00567593|156865893|FG000|Overall Study|Physician Decision|1|||
48730769|NCT02476422|156865895|FG000|Overall Study|Subject/guardian decision|0|||
48730770|NCT02476422|156865896|FG001|Overall Study|Subject/guardian decision|1|||
48730771|NCT01859143|156865897|FG000|Overall Study|Lost to Follow-up|2|||
48730772|NCT01859143|156865898|FG001|Overall Study|Lost to Follow-up|0|||
48730773|NCT01241240|156865899|FG000|Overall Study|Adverse Event|5|||
48730774|NCT01241240|156865900|FG001|Overall Study|Adverse Event|4|||
48730775|NCT01241240|156865899|FG000|Overall Study|Lost to Follow-up|2|||
48730776|NCT01241240|156865900|FG001|Overall Study|Lost to Follow-up|4|||
48730777|NCT01241240|156865899|FG000|Overall Study|Personal Reasons|1|||
48730778|NCT01241240|156865900|FG001|Overall Study|Personal Reasons|1|||
48730779|NCT00760214|156865901|FG000|Overall Study|Adverse Event|8|||
48730780|NCT00760214|156865902|FG001|Overall Study|Adverse Event|9|||
48730781|NCT00760214|156865903|FG002|Overall Study|Adverse Event|12|||
48730782|NCT00760214|156865901|FG000|Overall Study|Protocol Violation|3|||
48730783|NCT00760214|156865902|FG001|Overall Study|Protocol Violation|0|||
48519655|NCT00112437|156093093|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519656|NCT00112437|156093094|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519657|NCT00112437|156093095|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519658|NCT00112437|156093096|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519659|NCT00112437|156093097|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48383803|NCT00763971|155601438|FG001|Overall Study|Subject wanted dose reduction|1|||
48383804|NCT00763971|155601439|FG002|Overall Study|Subject wanted dose reduction|0|||
48519660|NCT00112437|156093098|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519661|NCT00112437|156093099|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519662|NCT00112437|156093100|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
48519663|NCT00112437|156093101|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519664|NCT00112437|156093102|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
48519665|NCT00112437|156093077|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519666|NCT00112437|156093078|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48730784|NCT00760214|156865903|FG002|Overall Study|Protocol Violation|3|||
48730785|NCT00760214|156865901|FG000|Overall Study|Lost to Follow-up|0|||
48730786|NCT00760214|156865902|FG001|Overall Study|Lost to Follow-up|0|||
48730787|NCT00760214|156865903|FG002|Overall Study|Lost to Follow-up|1|||
48730788|NCT00760214|156865901|FG000|Overall Study|Withdrawal by Subject|12|||
48730789|NCT00760214|156865902|FG001|Overall Study|Withdrawal by Subject|14|||
48730790|NCT00760214|156865903|FG002|Overall Study|Withdrawal by Subject|13|||
48730791|NCT00760214|156865901|FG000|Overall Study|Lack of Efficacy|3|||
48519667|NCT00112437|156093079|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519668|NCT00112437|156093080|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48730792|NCT00760214|156865902|FG001|Overall Study|Lack of Efficacy|2|||
48730793|NCT00760214|156865903|FG002|Overall Study|Lack of Efficacy|4|||
48730794|NCT00760214|156865901|FG000|Overall Study|Pregnancy|0|||
48730795|NCT00760214|156865902|FG001|Overall Study|Pregnancy|0|||
48519669|NCT00112437|156093081|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519670|NCT00112437|156093082|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519671|NCT00112437|156093083|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519672|NCT00112437|156093084|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519673|NCT00112437|156093085|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519674|NCT00112437|156093086|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519675|NCT00112437|156093087|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519676|NCT00112437|156093088|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519677|NCT00112437|156093089|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519678|NCT00112437|156093090|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519679|NCT00112437|156093091|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519680|NCT00112437|156093092|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519681|NCT00112437|156093093|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519682|NCT00112437|156093094|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519683|NCT00112437|156093095|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519684|NCT00112437|156093096|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519685|NCT00112437|156093097|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519686|NCT00112437|156093098|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519687|NCT00112437|156093099|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
48519688|NCT00112437|156093100|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
48519689|NCT00112437|156093101|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
48519690|NCT00112437|156093102|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
48519691|NCT00379353|156093105|FG000|Overall Study|Hospitalization|3|||
48519692|NCT00379353|156093106|FG001|Overall Study|Hospitalization|3|||
48519693|NCT00379353|156093105|FG000|Overall Study|Withdrawal by Subject|5|||
48730796|NCT00760214|156865903|FG002|Overall Study|Pregnancy|1|||
48730797|NCT00760214|156865901|FG000|Overall Study|Physician Decision|1|||
48383805|NCT00763971|155601437|FG000|Overall Study|Lack of availability|0|||
48730798|NCT00760214|156865902|FG001|Overall Study|Physician Decision|1|||
48730799|NCT00760214|156865903|FG002|Overall Study|Physician Decision|1|||
48730800|NCT00760214|156865901|FG000|Overall Study|Other|3|||
48730801|NCT00760214|156865902|FG001|Overall Study|Other|4|||
48730802|NCT00760214|156865903|FG002|Overall Study|Other|6|||
48730803|NCT00518973|156865905|FG000|Overall Study|Withdrawal by Subject|3|||
48730804|NCT00518973|156865906|FG001|Overall Study|Withdrawal by Subject|2|||
48730805|NCT02545075|156865907|FG000|Randomization|Lost to Follow-up|0|||
48730806|NCT02545075|156865908|FG001|Randomization|Lost to Follow-up|1|||
48730807|NCT02545075|156865907|FG000|Randomization|Withdrawal by Subject|0|||
48730808|NCT02545075|156865908|FG001|Randomization|Withdrawal by Subject|6|||
48730809|NCT02545075|156865907|FG000|Treatment|Disease progression|71|||
48730810|NCT02545075|156865908|FG001|Treatment|Disease progression|32|||
48730811|NCT02545075|156865907|FG000|Treatment|Participant dicontinued study treatment|7|||
48730812|NCT02545075|156865908|FG001|Treatment|Participant dicontinued study treatment|9|||
48730813|NCT02545075|156865907|FG000|Treatment|Withdrawal by Subject|1|||
48730814|NCT02545075|156865908|FG001|Treatment|Withdrawal by Subject|0|||
48730815|NCT02545075|156865907|FG000|Treatment|Adverse event not related to study drug|1|||
48730816|NCT02545075|156865908|FG001|Treatment|Adverse event not related to study drug|0|||
48730817|NCT02545075|156865907|FG000|Treatment|Death|1|||
48730818|NCT02545075|156865908|FG001|Treatment|Death|0|||
48730819|NCT02545075|156865907|FG000|Treatment|Participant drug toxicity|1|||
48730820|NCT02545075|156865908|FG001|Treatment|Participant drug toxicity|0|||
48730821|NCT02545075|156865907|FG000|Treatment|Completed treatment|40|||
48730822|NCT02545075|156865908|FG001|Treatment|Completed treatment|12|||
48519694|NCT00379353|156093106|FG001|Overall Study|Withdrawal by Subject|2|||
48519695|NCT00379353|156093105|FG000|Overall Study|Death|1|||
48519696|NCT00379353|156093106|FG001|Overall Study|Death|0|||
48519697|NCT00379353|156093105|FG000|Overall Study|Cardiac Tamponade|1|||
48519698|NCT00379353|156093106|FG001|Overall Study|Cardiac Tamponade|0|||
48519699|NCT00379353|156093105|FG000|Overall Study|Non-compliance|1|||
48519700|NCT00379353|156093106|FG001|Overall Study|Non-compliance|0|||
48519701|NCT00379353|156093105|FG000|Overall Study|Conflicting drug treatment|0|||
48519702|NCT00379353|156093106|FG001|Overall Study|Conflicting drug treatment|1|||
48519703|NCT04892147|156093107|FG000|Overall Study|Withdrawal by Subject|2|||
48519704|NCT04892147|156093108|FG001|Overall Study|Withdrawal by Subject|0|||
48519705|NCT01215721|156093109|FG000|Overall Study|Adverse Event|2|||
48519706|NCT00826241|156093110|FG000|Overall Study|Withdrawal from Follow-up|1|||
48519707|NCT00826241|156093110|FG000|Overall Study|Withdrew consent|2|||
48519708|NCT00826241|156093110|FG000|Overall Study|Death|4|||
48519709|NCT00826241|156093110|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
48519710|NCT00826241|156093110|FG000|Overall Study|Non-compliance|1|||
48519711|NCT00826241|156093110|FG000|Overall Study|Progression of disease|1|||
48519712|NCT00826241|156093110|FG000|Overall Study|Patient refused follow-up|3|||
48519713|NCT00826241|156093110|FG000|Overall Study|Lost to Follow-up|9|||
48519714|NCT00826241|156093110|FG000|Overall Study|Could not obtain records|1|||
48519715|NCT00826241|156093110|FG000|Overall Study|Screen failure|2|||
48519716|NCT00826241|156093110|FG000|Overall Study|Pt unable to proceed to registration|1|||
48519717|NCT00826241|156093110|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
48519718|NCT02416934|156093111|FG000|Overall Study|given steroids|1|||
48519719|NCT02416934|156093112|FG001|Overall Study|given steroids|2|||
48519720|NCT02416934|156093111|FG000|Overall Study|Lost to Follow-up|0|||
48519721|NCT02416934|156093112|FG001|Overall Study|Lost to Follow-up|2|||
48519722|NCT02416934|156093111|FG000|Overall Study|Withdrawal by Subject|1|||
48519723|NCT02416934|156093112|FG001|Overall Study|Withdrawal by Subject|0|||
48519724|NCT02416934|156093111|FG000|Overall Study|recruited during continuing renewal proc|0|||
48519725|NCT02416934|156093112|FG001|Overall Study|recruited during continuing renewal proc|1|||
48519726|NCT02416934|156093111|FG000|Overall Study|Protocol Violation|0|||
48519727|NCT02416934|156093112|FG001|Overall Study|Protocol Violation|1|||
48519728|NCT02416934|156093111|FG000|Overall Study|surgery started late|0|||
48519729|NCT02416934|156093112|FG001|Overall Study|surgery started late|1|||
48519730|NCT02416934|156093111|FG000|Overall Study|re-operation|1|||
48519731|NCT02416934|156093112|FG001|Overall Study|re-operation|0|||
48519732|NCT03531827|156093115|FG000|Overall Study|Adverse Event|2|||
48519733|NCT03531827|156093116|FG001|Overall Study|Adverse Event|0|||
48519734|NCT03531827|156093115|FG000|Overall Study|Progressive disease|1|||
48519735|NCT03531827|156093116|FG001|Overall Study|Progressive disease|0|||
48519736|NCT02387762|156093117|FG000|Overall Study|Withdrawal by Subject|1|||
48519737|NCT02387762|156093118|FG001|Overall Study|Withdrawal by Subject|0|||
48519738|NCT04553406|156093120|FG000|Overall Study|Study Discontinuation|0|||
48519739|NCT04553406|156093121|FG001|Overall Study|Study Discontinuation|1|||
48519740|NCT03370510|156093122|FG000|Overall Study|COVID-19|2|||
48730823|NCT00736879|156865911|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
48730824|NCT00736879|156865912|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
48730825|NCT00736879|156865913|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
48730826|NCT00736879|156865914|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
48519741|NCT03370510|156093123|FG001|Overall Study|COVID-19|0|||
48519742|NCT03185741|156093124|FG000|Baseline|Withdrawal by Subject|1|||
48519743|NCT03185741|156093125|FG001|Baseline|Withdrawal by Subject|3|||
48519744|NCT03185741|156093126|FG002|Baseline|Withdrawal by Subject|2|||
48519745|NCT03185741|156093124|FG000|Baseline|Lost to Follow-up|1|||
48519746|NCT03185741|156093125|FG001|Baseline|Lost to Follow-up|2|||
48730827|NCT00736879|156865911|FG000|Double Blind Treatment Period|Adverse Event|0|||
48730828|NCT00736879|156865912|FG001|Double Blind Treatment Period|Adverse Event|1|||
48730829|NCT00736879|156865913|FG002|Double Blind Treatment Period|Adverse Event|1|||
48519747|NCT03185741|156093126|FG002|Baseline|Lost to Follow-up|3|||
48519748|NCT03185741|156093124|FG000|3Month|Death|1|||
48519749|NCT03185741|156093125|FG001|3Month|Death|1|||
48519750|NCT03185741|156093126|FG002|3Month|Death|2|||
48519751|NCT03185741|156093124|FG000|3Month|Withdrawal by Subject|1|||
48519752|NCT03185741|156093125|FG001|3Month|Withdrawal by Subject|5|||
48519753|NCT03185741|156093126|FG002|3Month|Withdrawal by Subject|1|||
48519754|NCT03185741|156093124|FG000|3Month|Lost to Follow-up|7|||
48519755|NCT03185741|156093125|FG001|3Month|Lost to Follow-up|9|||
48519756|NCT03185741|156093126|FG002|3Month|Lost to Follow-up|8|||
48519757|NCT03185741|156093124|FG000|3Month|Unavailable for 3Month|11|||
48519758|NCT03185741|156093125|FG001|3Month|Unavailable for 3Month|10|||
48519759|NCT03185741|156093126|FG002|3Month|Unavailable for 3Month|11|||
48519760|NCT03185741|156093124|FG000|3Month|Protocol Violation|0|||
48519761|NCT03185741|156093125|FG001|3Month|Protocol Violation|0|||
48519762|NCT03185741|156093126|FG002|3Month|Protocol Violation|3|||
48519763|NCT03185741|156093124|FG000|6Month|Death|1|||
48519764|NCT03185741|156093125|FG001|6Month|Death|1|||
48519765|NCT03185741|156093126|FG002|6Month|Death|2|||
48519766|NCT03185741|156093124|FG000|6Month|Withdrawal by Subject|2|||
48519767|NCT03185741|156093125|FG001|6Month|Withdrawal by Subject|3|||
48519768|NCT03185741|156093126|FG002|6Month|Withdrawal by Subject|1|||
48519769|NCT03185741|156093124|FG000|6Month|Lost to Follow-up|16|||
48519770|NCT03185741|156093125|FG001|6Month|Lost to Follow-up|15|||
48519771|NCT03185741|156093126|FG002|6Month|Lost to Follow-up|16|||
48519772|NCT00772148|156093127|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
48519773|NCT00772148|156093128|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
48519774|NCT00772148|156093127|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
48519775|NCT00772148|156093128|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
48519776|NCT00772148|156093127|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
48519777|NCT00772148|156093128|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
48519778|NCT00772148|156093127|FG000|Maintenance Phase (Week 52)|Death|2|||
48519779|NCT00772148|156093128|FG001|Maintenance Phase (Week 52)|Death|2|||
48519780|NCT00772148|156093127|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
48519781|NCT00772148|156093128|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
48519782|NCT00772148|156093127|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
48519783|NCT00772148|156093128|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
48519784|NCT00772148|156093127|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
48519785|NCT00772148|156093128|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
48519786|NCT04148287|156093129|FG000|Overall Study|Death|2|||
48519787|NCT01525628|156093130|FG000|Overall Study|Adverse Event|1|||
48519788|NCT01525628|156093131|FG001|Overall Study|Adverse Event|1|||
48519789|NCT01525628|156093132|FG002|Overall Study|Adverse Event|2|||
48519790|NCT01525628|156093133|FG003|Overall Study|Adverse Event|0|||
48519791|NCT01525628|156093134|FG004|Overall Study|Adverse Event|1|||
48519792|NCT01525628|156093130|FG000|Overall Study|Lack of Efficacy|0|||
48519793|NCT01525628|156093131|FG001|Overall Study|Lack of Efficacy|2|||
48519794|NCT01525628|156093132|FG002|Overall Study|Lack of Efficacy|2|||
48519795|NCT01525628|156093133|FG003|Overall Study|Lack of Efficacy|1|||
48519796|NCT01525628|156093134|FG004|Overall Study|Lack of Efficacy|2|||
48519797|NCT01525628|156093130|FG000|Overall Study|Protocol Violation|0|||
48519798|NCT01525628|156093131|FG001|Overall Study|Protocol Violation|0|||
48519799|NCT01525628|156093132|FG002|Overall Study|Protocol Violation|1|||
48519800|NCT01525628|156093133|FG003|Overall Study|Protocol Violation|0|||
48601125|NCT02718911|156396049|FG009|Overall Study|Lost to Follow-up|0|||
48730830|NCT00736879|156865914|FG003|Double Blind Treatment Period|Adverse Event|0|||
48730831|NCT00736879|156865911|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
48730832|NCT00736879|156865912|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
48730833|NCT00736879|156865913|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
48730834|NCT00736879|156865914|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
48730835|NCT00736879|156865911|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
48730836|NCT00736879|156865912|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48730837|NCT00736879|156865913|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
48730838|NCT00736879|156865914|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
48730839|NCT00736879|156865911|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
48730840|NCT00736879|156865912|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
48730841|NCT00736879|156865913|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
48730842|NCT00736879|156865914|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
48730843|NCT00736879|156865911|FG000|Double Blind Treatment Period|No longer met criteria|0|||
48730844|NCT00736879|156865912|FG001|Double Blind Treatment Period|No longer met criteria|1|||
48519801|NCT01525628|156093134|FG004|Overall Study|Protocol Violation|0|||
48519802|NCT01525628|156093130|FG000|Overall Study|Lost to Follow-up|1|||
48519803|NCT01525628|156093131|FG001|Overall Study|Lost to Follow-up|1|||
48519804|NCT01525628|156093132|FG002|Overall Study|Lost to Follow-up|0|||
48519805|NCT01525628|156093133|FG003|Overall Study|Lost to Follow-up|0|||
48519806|NCT01525628|156093134|FG004|Overall Study|Lost to Follow-up|0|||
48519807|NCT01525628|156093130|FG000|Overall Study|Withdrawal by Subject|0|||
48519808|NCT01525628|156093131|FG001|Overall Study|Withdrawal by Subject|1|||
48519809|NCT01525628|156093132|FG002|Overall Study|Withdrawal by Subject|0|||
48519810|NCT01525628|156093133|FG003|Overall Study|Withdrawal by Subject|0|||
48519811|NCT01525628|156093134|FG004|Overall Study|Withdrawal by Subject|0|||
48519812|NCT01525628|156093130|FG000|Overall Study|Other reason not defined above|0|||
48519813|NCT01525628|156093131|FG001|Overall Study|Other reason not defined above|0|||
48519814|NCT01525628|156093132|FG002|Overall Study|Other reason not defined above|0|||
48519815|NCT01525628|156093133|FG003|Overall Study|Other reason not defined above|3|||
48519816|NCT01525628|156093134|FG004|Overall Study|Other reason not defined above|0|||
48519817|NCT04388787|156093135|FG000|Blinded Period|Patient could not follow instructions|1|||
48519818|NCT04388787|156093135|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
48519819|NCT03382041|156093136|FG000|Overall Study|Consent Form Lost|2|||
48519820|NCT03382041|156093137|FG001|Overall Study|Consent Form Lost|1|||
48519821|NCT03382041|156093136|FG000|Overall Study|Withdrawal by Subject|1|||
48519822|NCT03382041|156093137|FG001|Overall Study|Withdrawal by Subject|4|||
48519823|NCT03382041|156093136|FG000|Overall Study|Lost to Follow-up|1|||
48519824|NCT03382041|156093137|FG001|Overall Study|Lost to Follow-up|4|||
48519825|NCT01891357|156093138|FG000|Overall Study|Protocol Violation|3|||
48519826|NCT02107196|156094902|FG000|12-week Treatment Period|Adverse Event|6|||
48519827|NCT02107196|156094903|FG001|12-week Treatment Period|Adverse Event|3|||
48519828|NCT02107196|156094902|FG000|12-week Treatment Period|Lack of Efficacy|2|||
48519829|NCT02107196|156094903|FG001|12-week Treatment Period|Lack of Efficacy|1|||
48519830|NCT02107196|156094902|FG000|12-week Treatment Period|Lost to Follow-up|3|||
48519831|NCT02107196|156094903|FG001|12-week Treatment Period|Lost to Follow-up|6|||
48519832|NCT02107196|156094902|FG000|12-week Treatment Period|Physician Decision|0|||
48519833|NCT02107196|156094903|FG001|12-week Treatment Period|Physician Decision|1|||
48519834|NCT02107196|156094902|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
48519835|NCT02107196|156094903|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
48519836|NCT02107196|156094902|FG000|12-week Treatment Period|Protocol Violation|7|||
48519837|NCT02107196|156094903|FG001|12-week Treatment Period|Protocol Violation|8|||
48730845|NCT00736879|156865913|FG002|Double Blind Treatment Period|No longer met criteria|0|||
48730846|NCT00736879|156865914|FG003|Double Blind Treatment Period|No longer met criteria|0|||
48730847|NCT00736879|156865911|FG000|Double Blind Treatment Period|non-specified|0|||
48730848|NCT00736879|156865912|FG001|Double Blind Treatment Period|non-specified|1|||
48730849|NCT00736879|156865913|FG002|Double Blind Treatment Period|non-specified|0|||
48730850|NCT00736879|156865914|FG003|Double Blind Treatment Period|non-specified|0|||
48730851|NCT00736879|156865911|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
48519838|NCT02107196|156094902|FG000|12-week Treatment Period|Reason Missing|11|||
48519839|NCT02107196|156094903|FG001|12-week Treatment Period|Reason Missing|8|||
48519840|NCT02107196|156094902|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
48519841|NCT02107196|156094903|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
48519842|NCT02107196|156094902|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
48519843|NCT02107196|156094903|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48519844|NCT02107196|156094902|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
48730852|NCT00736879|156865912|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
48730853|NCT00736879|156865913|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
48730854|NCT00736879|156865914|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
48730855|NCT00736879|156865911|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
48730856|NCT00736879|156865912|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
48730857|NCT00736879|156865913|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
48730858|NCT00736879|156865914|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
48730859|NCT02360111|156865915|FG000|Overall Study|Death|2|||
48730860|NCT01933217|156865920|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
48730861|NCT01933217|156865921|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
48730862|NCT01933217|156865920|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
48730863|NCT01933217|156865921|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
48730864|NCT03923738|156865923|FG000|Period 1|Adverse Event|1|||
48730865|NCT03923738|156865923|FG000|Period 1|Withdrawal by Subject|1|||
48730866|NCT03583164|156865924|FG000|Overall Study|Death in Main Phase|35|||
48730867|NCT03583164|156865924|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
48730868|NCT03583164|156865924|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
48730869|NCT03583164|156865924|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
48730870|NCT03583164|156865924|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
48519845|NCT02107196|156094903|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
48519846|NCT02107196|156094902|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
48519847|NCT02107196|156094903|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
48519848|NCT02034513|156094906|FG000|Overall Study|Adverse Event|11|||
48519849|NCT02034513|156094907|FG001|Overall Study|Adverse Event|10|||
48519850|NCT02034513|156094906|FG000|Overall Study|Lack of Efficacy|0|||
48519851|NCT02034513|156094907|FG001|Overall Study|Lack of Efficacy|1|||
48519852|NCT02034513|156094906|FG000|Overall Study|Lost to Follow-up|6|||
48519853|NCT02034513|156094907|FG001|Overall Study|Lost to Follow-up|7|||
48519854|NCT02034513|156094906|FG000|Overall Study|Pregnancy|0|||
48519855|NCT02034513|156094907|FG001|Overall Study|Pregnancy|3|||
48519856|NCT02034513|156094906|FG000|Overall Study|Protocol Violation|7|||
48519857|NCT02034513|156094907|FG001|Overall Study|Protocol Violation|10|||
48519858|NCT02034513|156094906|FG000|Overall Study|Withdrawal by Subject|25|||
48519859|NCT02034513|156094907|FG001|Overall Study|Withdrawal by Subject|25|||
48519860|NCT02034513|156094906|FG000|Overall Study|Unclassified|0|||
48519861|NCT02034513|156094907|FG001|Overall Study|Unclassified|1|||
48519862|NCT01243151|156094910|FG000|Overall Study|Adverse Event|0|||
48519863|NCT01243151|156094911|FG001|Overall Study|Adverse Event|1|||
48519864|NCT01243151|156094912|FG002|Overall Study|Adverse Event|0|||
48519865|NCT01243151|156094913|FG003|Overall Study|Adverse Event|0|||
48519866|NCT01243151|156094914|FG004|Overall Study|Adverse Event|0|||
48519867|NCT01243151|156094910|FG000|Overall Study|Protocol Violation|0|||
48519868|NCT01243151|156094911|FG001|Overall Study|Protocol Violation|0|||
48519869|NCT01243151|156094912|FG002|Overall Study|Protocol Violation|1|||
48519870|NCT01243151|156094913|FG003|Overall Study|Protocol Violation|0|||
48519871|NCT01243151|156094914|FG004|Overall Study|Protocol Violation|0|||
48519872|NCT01243151|156094910|FG000|Overall Study|Other|0|||
48730871|NCT03583164|156865924|FG000|Overall Study|Physician decision in Main Phase|1|||
48519873|NCT01243151|156094911|FG001|Overall Study|Other|0|||
48519874|NCT01243151|156094912|FG002|Overall Study|Other|0|||
48519875|NCT01243151|156094913|FG003|Overall Study|Other|1|||
48519876|NCT01243151|156094914|FG004|Overall Study|Other|0|||
48519877|NCT01243151|156094910|FG000|Overall Study|Randomized but not treated|0|||
48519878|NCT01243151|156094911|FG001|Overall Study|Randomized but not treated|0|||
48519879|NCT01243151|156094912|FG002|Overall Study|Randomized but not treated|0|||
48519880|NCT01243151|156094913|FG003|Overall Study|Randomized but not treated|1|||
48519881|NCT01243151|156094914|FG004|Overall Study|Randomized but not treated|0|||
48519882|NCT03119662|156094915|FG000|Overall Study|Withdrawal by Subject|0|||
48519883|NCT03119662|156094916|FG001|Overall Study|Withdrawal by Subject|1|||
48519884|NCT00874549|156094917|FG000|Overall Study|Adverse Event|0|||
48519885|NCT00874549|156094918|FG001|Overall Study|Adverse Event|0|||
48519886|NCT00874549|156094919|FG002|Overall Study|Adverse Event|1|||
48519887|NCT00874549|156094920|FG003|Overall Study|Adverse Event|0|||
48730872|NCT03583164|156865924|FG000|Overall Study|Physician decision in Extended Phase|2|||
48730873|NCT03583164|156865924|FG000|Overall Study|Death in Extended Phase|13|||
48730874|NCT03583164|156865924|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
48730875|NCT03583164|156865924|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
48730876|NCT03583164|156865924|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
48730877|NCT03583164|156865924|FG000|Overall Study|Treatment failure in Main Phase|2|||
48730878|NCT03583164|156865924|FG000|Overall Study|Treatment failure in Extended Phase|4|||
48730879|NCT03583164|156865924|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
48823799|NCT01101542|157194054|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
48823800|NCT01101542|157194054|FG000|Year 6 Surveillance Period|Pregnancy|1|||
48823801|NCT01101542|157194054|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
48823802|NCT03681639|157195481|FG000|Overall Study|Death|4|||
48823803|NCT03681639|157195481|FG000|Overall Study|Lost to Follow-up|2|||
48823804|NCT03681639|157195481|FG000|Overall Study|Withdrawal by Subject|1|||
48823805|NCT03681639|157195481|FG000|Overall Study|Adverse Event|2|||
48823806|NCT04129580|157195484|FG000|Overall Study|Lost to Follow-up|14|||
48823807|NCT04129580|157195485|FG001|Overall Study|Lost to Follow-up|25|||
48823808|NCT00432159|157195488|FG000|Overall Study|Death|0|||
48823809|NCT00432159|157195489|FG001|Overall Study|Death|1|||
48823810|NCT00432159|157195490|FG002|Overall Study|Death|0|||
48823811|NCT00432159|157195491|FG003|Overall Study|Death|0|||
48823812|NCT00432159|157195492|FG004|Overall Study|Death|0|||
48823813|NCT00432159|157195488|FG000|Overall Study|Failure|9|||
48519888|NCT00874549|156094917|FG000|Overall Study|Protocol Violation|1|||
48519889|NCT00874549|156094918|FG001|Overall Study|Protocol Violation|0|||
48730880|NCT03583164|156865924|FG000|Overall Study|Other not specified reason in Main Phase|2|||
48823814|NCT00432159|157195489|FG001|Overall Study|Failure|5|||
48519890|NCT00874549|156094919|FG002|Overall Study|Protocol Violation|2|||
48519891|NCT00874549|156094920|FG003|Overall Study|Protocol Violation|1|||
48519892|NCT00874549|156094917|FG000|Overall Study|Lost to Follow-up|0|||
48519893|NCT00874549|156094918|FG001|Overall Study|Lost to Follow-up|0|||
48519894|NCT00874549|156094919|FG002|Overall Study|Lost to Follow-up|1|||
48519895|NCT00874549|156094920|FG003|Overall Study|Lost to Follow-up|0|||
48601126|NCT02718911|156396040|FG000|Overall Study|Physician Decision|2|||
48823815|NCT00432159|157195490|FG002|Overall Study|Failure|3|||
48823816|NCT00432159|157195491|FG003|Overall Study|Failure|2|||
48823817|NCT00432159|157195492|FG004|Overall Study|Failure|3|||
48823818|NCT00432159|157195488|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
48823819|NCT00432159|157195489|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
48823820|NCT00432159|157195490|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
48823821|NCT00432159|157195491|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
48823822|NCT00432159|157195492|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
48823823|NCT04822298|157195494|FG000|Overall Study|Death|3|||
48823824|NCT01575860|157195495|FG000|Overall Study|Withdrawal by Subject|1|||
48823825|NCT01575860|157195495|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
48823826|NCT00594932|157195502|FG000|First 3 Months|Withdrawal by Subject|1|||
48823827|NCT00594932|157195503|FG001|First 3 Months|Withdrawal by Subject|3|||
48823828|NCT00594932|157195502|FG000|Final 3 Months|Withdrawal by Subject|4|||
48823829|NCT00594932|157195503|FG001|Final 3 Months|Withdrawal by Subject|3|||
48823830|NCT00582790|157195504|FG000|Overall Study|Rapid progression of disease|1|||
48823831|NCT00480441|157195505|FG000|Screening|Not Eligible|37|||
48823832|NCT00480441|157195506|FG001|Screening|Not Eligible|0|||
48823833|NCT00480441|157195507|FG002|Screening|Not Eligible|0|||
48823834|NCT00480441|157195505|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
48823835|NCT00480441|157195506|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
48823836|NCT00480441|157195507|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
48823837|NCT00480441|157195505|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
48823838|NCT00480441|157195506|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
48823839|NCT00480441|157195507|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
48823840|NCT00480441|157195505|FG000|Baseline Functional MRI|physical contraindication|4|||
48823841|NCT00480441|157195506|FG001|Baseline Functional MRI|physical contraindication|0|||
48823842|NCT00480441|157195507|FG002|Baseline Functional MRI|physical contraindication|0|||
48823843|NCT00480441|157195505|FG000|Randomization|Lost to Follow-up|0|||
48823844|NCT00480441|157195506|FG001|Randomization|Lost to Follow-up|7|||
48823845|NCT00480441|157195507|FG002|Randomization|Lost to Follow-up|2|||
48823846|NCT01687270|157195508|FG000|Overall Study|Lack of Efficacy|11|||
48823847|NCT01687270|157195508|FG000|Overall Study|Lost to Follow-up|1|||
48823848|NCT02179918|157195509|FG000|Overall Study|Death|0|||
48823849|NCT02179918|157195510|FG001|Overall Study|Death|0|||
48823850|NCT02179918|157195511|FG002|Overall Study|Death|0|||
48823851|NCT02179918|157195512|FG003|Overall Study|Death|1|||
48823852|NCT02179918|157195513|FG004|Overall Study|Death|0|||
48823853|NCT02179918|157195509|FG000|Overall Study|Lost to Follow-up|0|||
48823854|NCT02179918|157195510|FG001|Overall Study|Lost to Follow-up|0|||
48823855|NCT02179918|157195511|FG002|Overall Study|Lost to Follow-up|1|||
48823856|NCT02179918|157195512|FG003|Overall Study|Lost to Follow-up|0|||
48823857|NCT02179918|157195513|FG004|Overall Study|Lost to Follow-up|0|||
48823858|NCT02179918|157195509|FG000|Overall Study|Progressive Disease|4|||
48823859|NCT02179918|157195510|FG001|Overall Study|Progressive Disease|1|||
48823860|NCT02179918|157195511|FG002|Overall Study|Progressive Disease|1|||
48823861|NCT02179918|157195512|FG003|Overall Study|Progressive Disease|2|||
48823862|NCT02179918|157195513|FG004|Overall Study|Progressive Disease|6|||
48823863|NCT02179918|157195509|FG000|Overall Study|Other|0|||
48823864|NCT02179918|157195510|FG001|Overall Study|Other|1|||
48823865|NCT02179918|157195511|FG002|Overall Study|Other|0|||
48823866|NCT02179918|157195512|FG003|Overall Study|Other|0|||
48823867|NCT02179918|157195513|FG004|Overall Study|Other|1|||
48823868|NCT02179918|157195509|FG000|Overall Study|Subject refused further follow-up|0|||
48823869|NCT02179918|157195510|FG001|Overall Study|Subject refused further follow-up|1|||
48823870|NCT02179918|157195511|FG002|Overall Study|Subject refused further follow-up|0|||
48823871|NCT02179918|157195512|FG003|Overall Study|Subject refused further follow-up|0|||
48823872|NCT02179918|157195513|FG004|Overall Study|Subject refused further follow-up|1|||
48823873|NCT00293462|157195514|FG000|Overall Study|Withdrawal by Subject|4|||
48823874|NCT00293462|157195515|FG001|Overall Study|Withdrawal by Subject|3|||
48823875|NCT00293462|157195516|FG002|Overall Study|Withdrawal by Subject|8|||
48823876|NCT00293462|157195514|FG000|Overall Study|Death|1|||
48823877|NCT00293462|157195515|FG001|Overall Study|Death|0|||
48823878|NCT00293462|157195516|FG002|Overall Study|Death|0|||
48823879|NCT00293462|157195514|FG000|Overall Study|Lost to Follow-up|0|||
48823880|NCT00293462|157195515|FG001|Overall Study|Lost to Follow-up|1|||
48823881|NCT00293462|157195516|FG002|Overall Study|Lost to Follow-up|0|||
48823882|NCT00293462|157195514|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
48823883|NCT00293462|157195515|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
48823884|NCT00293462|157195516|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
48823885|NCT00293462|157195514|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
48823886|NCT00293462|157195515|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
48823887|NCT00293462|157195516|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
48823888|NCT00293462|157195514|FG000|Overall Study|Refuse Radiation Treatment|1|||
48823889|NCT00293462|157195515|FG001|Overall Study|Refuse Radiation Treatment|0|||
48823890|NCT00293462|157195516|FG002|Overall Study|Refuse Radiation Treatment|0|||
48823891|NCT00293462|157195514|FG000|Overall Study|No Show|0|||
48519896|NCT00874549|156094917|FG000|Overall Study|Withdrawal by Subject|0|||
48519897|NCT00874549|156094918|FG001|Overall Study|Withdrawal by Subject|1|||
48519898|NCT00874549|156094919|FG002|Overall Study|Withdrawal by Subject|0|||
48519899|NCT00874549|156094920|FG003|Overall Study|Withdrawal by Subject|1|||
48519900|NCT00397254|156094921|FG000|Overall Study|Lost to Follow-up|2|||
48519901|NCT00397254|156094922|FG001|Overall Study|Lost to Follow-up|2|||
48519902|NCT03246503|156094924|FG000|Overall Study|Lost to Follow-up|23|||
48519903|NCT03246503|156094924|FG000|Overall Study|Withdrawal by Subject|20|||
48519904|NCT03246503|156094924|FG000|Overall Study|Physician Decision|5|||
48519905|NCT03246503|156094924|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
48519906|NCT03206749|156094926|FG000|Overall Study|Withdrawal of consent|5|||
48519907|NCT03206749|156094927|FG001|Overall Study|Withdrawal of consent|3|||
48730881|NCT02943460|156865928|FG000|Blinded Study Phase|Adverse Event|3|||
48730882|NCT02943460|156865929|FG001|Blinded Study Phase|Adverse Event|0|||
48730883|NCT02943460|156865930|FG002|Blinded Study Phase|Adverse Event|0|||
48730884|NCT02943460|156865928|FG000|Blinded Study Phase|Withdrew Consent|0|||
48730885|NCT02943460|156865929|FG001|Blinded Study Phase|Withdrew Consent|1|||
48730886|NCT02943460|156865930|FG002|Blinded Study Phase|Withdrew Consent|0|||
48730887|NCT02943460|156865928|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
48730888|NCT02943460|156865929|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
48730889|NCT02943460|156865930|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
48730890|NCT02943460|156865928|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
48730891|NCT02943460|156865929|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
48730892|NCT02943460|156865930|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
48730893|NCT02943460|156865928|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
48730894|NCT02943460|156865929|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
48730895|NCT02943460|156865930|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
48730896|NCT01264016|156865931|FG000|Overall Study|Withdrawal by Subject|1|||
48519908|NCT03206749|156094928|FG002|Overall Study|Withdrawal of consent|6|||
48519909|NCT03206749|156094926|FG000|Overall Study|Lost to Follow-up|0|||
48519910|NCT03206749|156094927|FG001|Overall Study|Lost to Follow-up|0|||
48519911|NCT03206749|156094928|FG002|Overall Study|Lost to Follow-up|1|||
48519912|NCT00835796|156094929|FG000|First Intervention|Withdrawal by Subject|0|||
48519913|NCT00835796|156094930|FG001|First Intervention|Withdrawal by Subject|1|||
48519914|NCT00467597|156094936|FG000|Overall Study|Withdrawal by Subject|2|||
48519915|NCT00467597|156094937|FG001|Overall Study|Withdrawal by Subject|0|||
48519916|NCT00985751|156094938|FG000|Overall Study|Adverse Event|0|||
48730897|NCT01264016|156865931|FG000|Overall Study|Felt faint at sight of blood|1|||
48730898|NCT00267189|156865932|FG000|Overall Study|Patient withdrew consent|1|||
48730899|NCT00267189|156865933|FG001|Overall Study|Patient withdrew consent|1|||
48730900|NCT00267189|156865932|FG000|Overall Study|Death|1|||
48730901|NCT00267189|156865933|FG001|Overall Study|Death|0|||
48730902|NCT00267189|156865932|FG000|Overall Study|Missing|3|||
48730903|NCT00267189|156865933|FG001|Overall Study|Missing|0|||
48730904|NCT00777205|156865934|FG000|Overall Study|Lost to Follow-up|25|||
48730905|NCT00777205|156865935|FG001|Overall Study|Lost to Follow-up|9|||
48730906|NCT00777205|156865934|FG000|Overall Study|Withdrawal by Subject|6|||
48730907|NCT00777205|156865935|FG001|Overall Study|Withdrawal by Subject|4|||
48730908|NCT00777205|156865934|FG000|Overall Study|Death|0|||
48730909|NCT00777205|156865935|FG001|Overall Study|Death|2|||
48730910|NCT00777205|156865934|FG000|Overall Study|Protocol Violation|0|||
48730911|NCT00777205|156865935|FG001|Overall Study|Protocol Violation|56|||
48730912|NCT00751621|156865936|FG000|Overall Study|Adverse Event|1|||
48730913|NCT00751621|156865936|FG000|Overall Study|Withdrawal by Subject|1|||
48730914|NCT00751621|156865936|FG000|Overall Study|Subject moved to another country|1|||
48730915|NCT00751621|156865936|FG000|Overall Study|Poor adherence to asthma treatment|1|||
48730916|NCT03114488|156865938|FG000|Time Period 2|Withdrawal by Subject|1|||
48730917|NCT03114488|156865939|FG001|Time Period 2|Withdrawal by Subject|3|||
48730918|NCT01243671|156865940|FG000|Overall Study|Adverse Event|3|||
48730919|NCT01243671|156865940|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
48730920|NCT01243671|156865940|FG000|Overall Study|Other|1|||
48730921|NCT00629772|156865945|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
48730922|NCT00629772|156865946|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
48730923|NCT00629772|156865945|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
48730924|NCT00629772|156865946|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
48730925|NCT03519386|156865948|FG000|Overall Study|Withdrawal by Subject|4|||
48730926|NCT03519386|156865949|FG001|Overall Study|Withdrawal by Subject|1|||
48730927|NCT03519386|156865950|FG002|Overall Study|Withdrawal by Subject|2|||
48730928|NCT03519386|156865948|FG000|Overall Study|Physician Decision|1|||
48730929|NCT03519386|156865949|FG001|Overall Study|Physician Decision|1|||
48730930|NCT03519386|156865950|FG002|Overall Study|Physician Decision|1|||
48730931|NCT03519386|156865948|FG000|Overall Study|Lost to Follow-up|0|||
48519917|NCT00985751|156094939|FG001|Overall Study|Adverse Event|0|||
48730932|NCT03519386|156865949|FG001|Overall Study|Lost to Follow-up|1|||
48730933|NCT03519386|156865950|FG002|Overall Study|Lost to Follow-up|1|||
48730934|NCT03519386|156865948|FG000|Overall Study|Death|1|||
48730935|NCT03519386|156865949|FG001|Overall Study|Death|0|||
48730936|NCT03519386|156865950|FG002|Overall Study|Death|4|||
48730937|NCT03519386|156865948|FG000|Overall Study|Adverse Event|2|||
48730938|NCT03519386|156865949|FG001|Overall Study|Adverse Event|1|||
48730939|NCT03519386|156865950|FG002|Overall Study|Adverse Event|2|||
48730940|NCT03519386|156865948|FG000|Overall Study|Explanted|2|||
48730941|NCT03519386|156865949|FG001|Overall Study|Explanted|1|||
48730942|NCT03519386|156865950|FG002|Overall Study|Explanted|0|||
48823892|NCT00293462|157195515|FG001|Overall Study|No Show|0|||
48823893|NCT00293462|157195516|FG002|Overall Study|No Show|1|||
48823894|NCT00293462|157195514|FG000|Overall Study|Went back to his home country|0|||
48823895|NCT00293462|157195515|FG001|Overall Study|Went back to his home country|0|||
48823896|NCT00293462|157195516|FG002|Overall Study|Went back to his home country|1|||
48823897|NCT00293462|157195514|FG000|Overall Study|Blood clot after chemotherapy|0|||
48730943|NCT03519386|156865948|FG000|Overall Study|Ongoing in study|190|||
48730944|NCT03519386|156865949|FG001|Overall Study|Ongoing in study|192|||
48730945|NCT03519386|156865950|FG002|Overall Study|Ongoing in study|183|||
48730946|NCT00573248|156865951|FG000|Overall Study|scheduling conflicts|15|||
48730947|NCT00573248|156865952|FG001|Overall Study|scheduling conflicts|11|||
48730948|NCT03583073|156865953|FG000|Overall Study|Lost to Follow-up|8|||
48730949|NCT03583073|156865954|FG001|Overall Study|Lost to Follow-up|12|||
48730950|NCT03063203|156865955|FG000|Overall Study|Chose alternative therapy|3|||
48730951|NCT03063203|156865955|FG000|Overall Study|Death|2|||
48730952|NCT03063203|156865955|FG000|Overall Study|Disease progression|4|||
48730953|NCT03063203|156865955|FG000|Overall Study|Physician Decision|5|||
48730954|NCT01916967|156865956|FG000|Overall Study|Adverse Event|0|||
48730955|NCT01916967|156865957|FG001|Overall Study|Adverse Event|0|||
48730956|NCT01916967|156865958|FG002|Overall Study|Adverse Event|2|||
48730957|NCT01916967|156865956|FG000|Overall Study|Lack of Efficacy|0|||
48730958|NCT01916967|156865957|FG001|Overall Study|Lack of Efficacy|0|||
48730959|NCT01916967|156865958|FG002|Overall Study|Lack of Efficacy|6|||
48730960|NCT01916967|156865956|FG000|Overall Study|Physician Decision|0|||
48730961|NCT01916967|156865957|FG001|Overall Study|Physician Decision|0|||
48730962|NCT01916967|156865958|FG002|Overall Study|Physician Decision|1|||
48730963|NCT01916967|156865956|FG000|Overall Study|Protocol Violation|0|||
48730964|NCT01916967|156865957|FG001|Overall Study|Protocol Violation|1|||
48730965|NCT01916967|156865958|FG002|Overall Study|Protocol Violation|0|||
48730966|NCT01986140|156865959|FG000|Overall Study|Withdrawal by Subject|31|||
48730967|NCT01986140|156865960|FG001|Overall Study|Withdrawal by Subject|25|||
48730968|NCT01986140|156865959|FG000|Overall Study|alternative treatment|1|||
48730969|NCT01986140|156865960|FG001|Overall Study|alternative treatment|1|||
48730970|NCT01986140|156865959|FG000|Overall Study|found not eligible|3|||
48730971|NCT01986140|156865960|FG001|Overall Study|found not eligible|0|||
48730972|NCT01986140|156865959|FG000|Overall Study|Adverse Event|0|||
48730973|NCT01986140|156865960|FG001|Overall Study|Adverse Event|1|||
48730974|NCT01986140|156865959|FG000|Overall Study|progression disease|0|||
48730975|NCT01986140|156865960|FG001|Overall Study|progression disease|1|||
48730976|NCT00764491|156865962|FG000|Overall Study|Lost to Follow-up|35|||
48730977|NCT00764491|156865963|FG001|Overall Study|Lost to Follow-up|17|||
48730978|NCT01462227|156865964|FG000|Second Assignment|Lost to Follow-up|1|||
48730979|NCT01462227|156865965|FG001|Second Assignment|Lost to Follow-up|0|||
48519918|NCT00985751|156094940|FG002|Overall Study|Adverse Event|0|||
48519919|NCT00985751|156094941|FG003|Overall Study|Adverse Event|0|||
48519920|NCT00985751|156094942|FG004|Overall Study|Adverse Event|1|||
48519921|NCT00868998|156094943|FG000|Overall Study|Screen Failure|1|||
48519922|NCT00868998|156094943|FG000|Overall Study|Withdrawal by Subject|1|||
48519923|NCT00868998|156094943|FG000|Overall Study|Progression of disease|2|||
48519924|NCT00868998|156094943|FG000|Overall Study|Death|1|||
48519925|NCT04010227|156094944|FG000|Overall Study|Death|1|||
48519926|NCT04010227|156094945|FG001|Overall Study|Death|2|||
48823898|NCT00293462|157195515|FG001|Overall Study|Blood clot after chemotherapy|0|||
48519927|NCT04010227|156094944|FG000|Overall Study|Medical Reasons|4|||
48519928|NCT04010227|156094945|FG001|Overall Study|Medical Reasons|3|||
48519929|NCT04010227|156094944|FG000|Overall Study|Withdrawal by Subject|2|||
48519930|NCT04010227|156094945|FG001|Overall Study|Withdrawal by Subject|0|||
48730980|NCT01462227|156865966|FG002|Second Assignment|Lost to Follow-up|0|||
48730981|NCT01462227|156865967|FG003|Second Assignment|Lost to Follow-up|0|||
48730982|NCT01462227|156865964|FG000|Second Assignment|Protocol Violation|0|||
48730983|NCT01462227|156865965|FG001|Second Assignment|Protocol Violation|1|||
48730984|NCT01462227|156865966|FG002|Second Assignment|Protocol Violation|1|||
48730985|NCT01462227|156865967|FG003|Second Assignment|Protocol Violation|0|||
48730986|NCT02035475|156865973|FG000|Overall Study|Withdrawal by Subject|4|||
48730987|NCT02035475|156865973|FG000|Overall Study|Physician Decision|1|||
48730988|NCT02035475|156865973|FG000|Overall Study|Equipment Error|1|||
48730989|NCT00191646|156865974|FG000|Overall Study|Toxicity|26|||
48519931|NCT04010227|156094944|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
48519932|NCT04010227|156094945|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
48519933|NCT00881569|156094946|FG000|Overall Study|Disease progression|1|||
48730990|NCT00191646|156865975|FG001|Overall Study|Toxicity|37|||
48519934|NCT00881569|156094947|FG001|Overall Study|Disease progression|1|||
48519935|NCT01451541|156094948|FG000|Overall Study|Adverse Event|4|||
48519936|NCT01451541|156094949|FG001|Overall Study|Adverse Event|3|||
48519937|NCT01451541|156094950|FG002|Overall Study|Adverse Event|6|||
48519938|NCT01451541|156094948|FG000|Overall Study|Lack of Efficacy|2|||
48519939|NCT01451541|156094949|FG001|Overall Study|Lack of Efficacy|0|||
48519940|NCT01451541|156094950|FG002|Overall Study|Lack of Efficacy|0|||
48519941|NCT01451541|156094948|FG000|Overall Study|Lost to Follow-up|4|||
48519942|NCT01451541|156094949|FG001|Overall Study|Lost to Follow-up|4|||
48519943|NCT01451541|156094950|FG002|Overall Study|Lost to Follow-up|7|||
48519944|NCT01451541|156094948|FG000|Overall Study|Withdrawal by Subject|15|||
48519945|NCT01451541|156094949|FG001|Overall Study|Withdrawal by Subject|8|||
48519946|NCT01451541|156094950|FG002|Overall Study|Withdrawal by Subject|6|||
48519947|NCT01451541|156094948|FG000|Overall Study|randomization error, noncompliance|11|||
48519948|NCT01451541|156094949|FG001|Overall Study|randomization error, noncompliance|10|||
48519949|NCT01451541|156094950|FG002|Overall Study|randomization error, noncompliance|8|||
48519950|NCT02858037|156094952|FG000|Overall Study|Death|1|||
48519951|NCT02858037|156094952|FG000|Overall Study|Withdrawal by Subject|18|||
48519952|NCT02858037|156094952|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
48519953|NCT02858037|156094952|FG000|Overall Study|Lost to Follow-up|3|||
48519954|NCT02858037|156094952|FG000|Overall Study|Other|4|||
48519955|NCT00697827|156094953|FG000|Overall Study|enrolled but not treated|2|||
48519956|NCT00697827|156094954|FG001|Overall Study|enrolled but not treated|1|||
48519957|NCT00724958|156094957|FG000|Overall Study|Adverse Event|28|||
48519958|NCT00724958|156094957|FG000|Overall Study|Loss of Response|40|||
48519959|NCT00724958|156094957|FG000|Overall Study|No Response|18|||
48519960|NCT00724958|156094957|FG000|Overall Study|Remission|7|||
48519961|NCT00724958|156094957|FG000|Overall Study|Other Reason|76|||
48519962|NCT00724958|156094957|FG000|Overall Study|No documentation for end of therapy|13|||
48519963|NCT01046084|156094965|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
48519964|NCT01046084|156094966|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
48519965|NCT02166606|156094967|FG000|Overall Study|Adverse Event|3|||
48823899|NCT00293462|157195516|FG002|Overall Study|Blood clot after chemotherapy|1|||
48519966|NCT02166606|156094967|FG000|Overall Study|Death|31|||
48519967|NCT02166606|156094967|FG000|Overall Study|Protocol Violation|7|||
48519968|NCT02166606|156094967|FG000|Overall Study|Lost to Follow-up|30|||
48519969|NCT02166606|156094967|FG000|Overall Study|Withdrawal by Subject|1|||
48601127|NCT02718911|156396041|FG001|Overall Study|Physician Decision|0|||
48601128|NCT02718911|156396042|FG002|Overall Study|Physician Decision|1|||
48519970|NCT02166606|156094967|FG000|Overall Study|Physician Decision|1|||
48519971|NCT02166606|156094967|FG000|Overall Study|Device upgrade|1|||
48519972|NCT02166606|156094967|FG000|Overall Study|Enrolled after End of Enrollment|4|||
48519973|NCT00999687|156094968|FG000|First Intervention|Withdrawal by Subject|1|||
48519974|NCT00999687|156094968|FG000|Second Intervention|Withdrawal by Subject|2|||
48519975|NCT00999687|156094968|FG000|Second Intervention|Lack of Efficacy|1|||
48519976|NCT01949532|156094971|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
48519977|NCT01949532|156094972|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
48519978|NCT05665387|156094977|FG000|Overall Study|Withdrawal by Subject|1|||
48519979|NCT05665387|156094978|FG001|Overall Study|Withdrawal by Subject|0|||
48519980|NCT05665387|156094979|FG002|Overall Study|Withdrawal by Subject|1|||
48823900|NCT00293462|157195514|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
48823901|NCT00293462|157195515|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
48823902|NCT00293462|157195516|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
48823903|NCT00293462|157195514|FG000|Overall Study|Possible Tracheostomy leakage|0|||
48823904|NCT00293462|157195515|FG001|Overall Study|Possible Tracheostomy leakage|1|||
48823905|NCT00293462|157195516|FG002|Overall Study|Possible Tracheostomy leakage|0|||
48823906|NCT00293462|157195514|FG000|Overall Study|Low radiation dose in oral cavity|0|||
48823907|NCT00293462|157195515|FG001|Overall Study|Low radiation dose in oral cavity|1|||
48823908|NCT00293462|157195516|FG002|Overall Study|Low radiation dose in oral cavity|0|||
48823909|NCT00293462|157195514|FG000|Overall Study|Physician Decision|0|||
48823910|NCT00293462|157195515|FG001|Overall Study|Physician Decision|1|||
48519981|NCT03614728|156094983|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
48519982|NCT03614728|156094984|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
48519983|NCT03614728|156094985|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
48519984|NCT03614728|156094986|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
48519985|NCT03614728|156094983|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
48823911|NCT00293462|157195516|FG002|Overall Study|Physician Decision|0|||
48519986|NCT03614728|156094984|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
48519987|NCT03614728|156094985|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
48519988|NCT03614728|156094986|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
48519989|NCT03732833|156094987|FG000|Overall Study|Adverse Event|0|||
48519990|NCT03732833|156094988|FG001|Overall Study|Adverse Event|3|||
48519991|NCT03732833|156094989|FG002|Overall Study|Adverse Event|1|||
48519992|NCT03732833|156094987|FG000|Overall Study|Withdrawal by Subject|11|||
48519993|NCT03732833|156094988|FG001|Overall Study|Withdrawal by Subject|13|||
48519994|NCT03732833|156094989|FG002|Overall Study|Withdrawal by Subject|8|||
48519995|NCT03732833|156094987|FG000|Overall Study|Lost to Follow-up|3|||
48519996|NCT03732833|156094988|FG001|Overall Study|Lost to Follow-up|5|||
48519997|NCT03732833|156094989|FG002|Overall Study|Lost to Follow-up|4|||
48519998|NCT03732833|156094987|FG000|Overall Study|Pregnancy|0|||
48519999|NCT03732833|156094988|FG001|Overall Study|Pregnancy|2|||
48520000|NCT03732833|156094989|FG002|Overall Study|Pregnancy|0|||
48520001|NCT03732833|156094987|FG000|Overall Study|Physician Decision|2|||
48520002|NCT03732833|156094988|FG001|Overall Study|Physician Decision|3|||
48520003|NCT03732833|156094989|FG002|Overall Study|Physician Decision|1|||
48520004|NCT03732833|156094987|FG000|Overall Study|Covid-19 related and other reasons|2|||
48520005|NCT03732833|156094988|FG001|Overall Study|Covid-19 related and other reasons|7|||
48520006|NCT03732833|156094989|FG002|Overall Study|Covid-19 related and other reasons|3|||
48520007|NCT00550147|156094990|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
48520008|NCT00550147|156094990|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
48520009|NCT00550147|156094990|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
48520010|NCT00550147|156094990|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
48520011|NCT00550147|156094990|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
48520012|NCT01519947|156094991|FG000|Overall Study|Death|0|||
48520013|NCT01519947|156094992|FG001|Overall Study|Death|0|||
48520014|NCT01519947|156094993|FG002|Overall Study|Death|0|||
48520015|NCT01519947|156094994|FG003|Overall Study|Death|1|||
48520016|NCT01519947|156094991|FG000|Overall Study|Protocol Violation|0|||
48520017|NCT01519947|156094992|FG001|Overall Study|Protocol Violation|0|||
48520018|NCT01519947|156094993|FG002|Overall Study|Protocol Violation|2|||
48520019|NCT01519947|156094994|FG003|Overall Study|Protocol Violation|1|||
48520020|NCT01519947|156094991|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
48520021|NCT01519947|156094992|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
48520022|NCT01519947|156094993|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
48520023|NCT01519947|156094994|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
48520024|NCT01519947|156094991|FG000|Overall Study|Development of Anemia|0|||
48520025|NCT01519947|156094992|FG001|Overall Study|Development of Anemia|1|||
48520026|NCT01519947|156094993|FG002|Overall Study|Development of Anemia|0|||
48520027|NCT01519947|156094994|FG003|Overall Study|Development of Anemia|1|||
48520028|NCT01519947|156094991|FG000|Overall Study|Blood Transfusion|0|||
48520029|NCT01519947|156094992|FG001|Overall Study|Blood Transfusion|1|||
48520030|NCT01519947|156094993|FG002|Overall Study|Blood Transfusion|1|||
48520031|NCT01519947|156094994|FG003|Overall Study|Blood Transfusion|0|||
48730991|NCT00191646|156865974|FG000|Overall Study|Disease Progression|5|||
48730992|NCT00191646|156865975|FG001|Overall Study|Disease Progression|6|||
48730993|NCT00191646|156865974|FG000|Overall Study|Physician Decision|20|||
48730994|NCT00191646|156865975|FG001|Overall Study|Physician Decision|11|||
48730995|NCT00191646|156865974|FG000|Overall Study|Withdrawal by Subject|58|||
48730996|NCT00191646|156865975|FG001|Overall Study|Withdrawal by Subject|39|||
48730997|NCT00191646|156865974|FG000|Overall Study|Protocol Violation|5|||
48730998|NCT00191646|156865975|FG001|Overall Study|Protocol Violation|7|||
48730999|NCT00191646|156865974|FG000|Overall Study|Death|6|||
48731000|NCT00191646|156865975|FG001|Overall Study|Death|8|||
48731001|NCT00191646|156865974|FG000|Overall Study|Other|33|||
48731002|NCT00191646|156865975|FG001|Overall Study|Other|34|||
48731003|NCT00191646|156865974|FG000|Overall Study|Missing Data|18|||
48520032|NCT01519947|156094991|FG000|Overall Study|Withdrawal by Subject|0|||
48520033|NCT01519947|156094992|FG001|Overall Study|Withdrawal by Subject|1|||
48731004|NCT00191646|156865975|FG001|Overall Study|Missing Data|11|||
48731005|NCT01927341|156867721|FG000|Phase 1b|Lost to Follow-up|1|||
48731006|NCT01927341|156867722|FG001|Phase 1b|Lost to Follow-up|0|||
48731007|NCT01927341|156867723|FG002|Phase 1b|Lost to Follow-up|0|||
48731008|NCT01927341|156867724|FG003|Phase 1b|Lost to Follow-up|0|||
48731009|NCT01927341|156867725|FG004|Phase 1b|Lost to Follow-up|0|||
48731010|NCT01927341|156867721|FG000|Phase 1b|Death|2|||
48731011|NCT01927341|156867722|FG001|Phase 1b|Death|0|||
48731012|NCT01927341|156867723|FG002|Phase 1b|Death|0|||
48731013|NCT01927341|156867724|FG003|Phase 1b|Death|0|||
48731014|NCT01927341|156867725|FG004|Phase 1b|Death|0|||
48731015|NCT01927341|156867721|FG000|Phase 1b|Follow-up completed|7|||
48731016|NCT01927341|156867722|FG001|Phase 1b|Follow-up completed|0|||
48731017|NCT01927341|156867723|FG002|Phase 1b|Follow-up completed|0|||
48731018|NCT01927341|156867724|FG003|Phase 1b|Follow-up completed|0|||
48731019|NCT01927341|156867725|FG004|Phase 1b|Follow-up completed|0|||
48731020|NCT01927341|156867721|FG000|Phase 2|Lost to Follow-up|0|||
48731021|NCT01927341|156867722|FG001|Phase 2|Lost to Follow-up|1|||
48731022|NCT01927341|156867723|FG002|Phase 2|Lost to Follow-up|0|||
48731023|NCT01927341|156867724|FG003|Phase 2|Lost to Follow-up|0|||
48731024|NCT01927341|156867725|FG004|Phase 2|Lost to Follow-up|0|||
48731025|NCT01927341|156867721|FG000|Phase 2|Participant withdrew consent|0|||
48520034|NCT01519947|156094993|FG002|Overall Study|Withdrawal by Subject|0|||
48520035|NCT01519947|156094994|FG003|Overall Study|Withdrawal by Subject|1|||
48520036|NCT01519947|156094991|FG000|Overall Study|Lost to Follow-up|0|||
48520037|NCT01519947|156094992|FG001|Overall Study|Lost to Follow-up|0|||
48520038|NCT01519947|156094993|FG002|Overall Study|Lost to Follow-up|3|||
48520039|NCT01519947|156094994|FG003|Overall Study|Lost to Follow-up|2|||
48520040|NCT01519947|156094991|FG000|Overall Study|Poor Response|1|||
48520041|NCT01519947|156094992|FG001|Overall Study|Poor Response|0|||
48520042|NCT01519947|156094993|FG002|Overall Study|Poor Response|0|||
48520043|NCT01519947|156094994|FG003|Overall Study|Poor Response|1|||
48520044|NCT01519947|156094991|FG000|Overall Study|Adverse Event|1|||
48731026|NCT01927341|156867722|FG001|Phase 2|Participant withdrew consent|2|||
48731027|NCT01927341|156867723|FG002|Phase 2|Participant withdrew consent|1|||
48731028|NCT01927341|156867724|FG003|Phase 2|Participant withdrew consent|2|||
48731029|NCT01927341|156867725|FG004|Phase 2|Participant withdrew consent|3|||
48731030|NCT01927341|156867721|FG000|Phase 2|Death|0|||
48731031|NCT01927341|156867722|FG001|Phase 2|Death|4|||
48731032|NCT01927341|156867723|FG002|Phase 2|Death|0|||
48731033|NCT01927341|156867724|FG003|Phase 2|Death|3|||
48731034|NCT01927341|156867725|FG004|Phase 2|Death|2|||
48731035|NCT01927341|156867721|FG000|Phase 2|New cancer therapy|0|||
48731036|NCT01927341|156867722|FG001|Phase 2|New cancer therapy|1|||
48731037|NCT01927341|156867723|FG002|Phase 2|New cancer therapy|0|||
48520045|NCT01519947|156094992|FG001|Overall Study|Adverse Event|0|||
48520046|NCT01519947|156094993|FG002|Overall Study|Adverse Event|1|||
48520047|NCT01519947|156094994|FG003|Overall Study|Adverse Event|1|||
48520048|NCT01958476|156094995|FG000|Overall Study|Parent requested exclusion from analysis|1|||
48520049|NCT01958476|156094996|FG001|Overall Study|Parent requested exclusion from analysis|0|||
48520050|NCT00046839|156094998|FG000|Overall Study|Ineligible / No protocol treatment|0|||
48731038|NCT01927341|156867724|FG003|Phase 2|New cancer therapy|4|||
48731039|NCT01927341|156867725|FG004|Phase 2|New cancer therapy|1|||
48731040|NCT01927341|156867721|FG000|Phase 2|Disease progression|0|||
48731041|NCT01927341|156867722|FG001|Phase 2|Disease progression|1|||
48731042|NCT01927341|156867723|FG002|Phase 2|Disease progression|1|||
48731043|NCT01927341|156867724|FG003|Phase 2|Disease progression|1|||
48731044|NCT01927341|156867725|FG004|Phase 2|Disease progression|0|||
48731045|NCT01927341|156867721|FG000|Phase 2|Follow-up completed|0|||
48731046|NCT01927341|156867722|FG001|Phase 2|Follow-up completed|6|||
48731047|NCT01927341|156867723|FG002|Phase 2|Follow-up completed|3|||
48731048|NCT01927341|156867724|FG003|Phase 2|Follow-up completed|5|||
48520051|NCT00046839|156094999|FG001|Overall Study|Ineligible / No protocol treatment|2|||
48520052|NCT00046839|156094998|FG000|Overall Study|Withdrawal of consent|1|||
48520053|NCT00046839|156094999|FG001|Overall Study|Withdrawal of consent|0|||
48731049|NCT01927341|156867725|FG004|Phase 2|Follow-up completed|2|||
48731050|NCT00884377|156867726|FG000|Overall Study|Withdrawal by Subject|1|||
48731051|NCT00884377|156867727|FG001|Overall Study|Withdrawal by Subject|0|||
48731052|NCT00884377|156867726|FG000|Overall Study|Could not confirm diagnosis|1|||
48731053|NCT00884377|156867727|FG001|Overall Study|Could not confirm diagnosis|0|||
48731054|NCT00884377|156867726|FG000|Overall Study|Physician Decision|0|||
48731055|NCT00884377|156867727|FG001|Overall Study|Physician Decision|1|||
48731056|NCT01397201|156867728|FG000|Overall Study|Not treated|0|||
48731057|NCT01397201|156867729|FG001|Overall Study|Not treated|0|||
48731058|NCT01397201|156867730|FG002|Overall Study|Not treated|1|||
48731059|NCT01397201|156867731|FG003|Overall Study|Not treated|0|||
48731060|NCT01397201|156867732|FG004|Overall Study|Not treated|0|||
48731061|NCT01397201|156867728|FG000|Overall Study|Not yet defined|3|||
48731062|NCT01397201|156867729|FG001|Overall Study|Not yet defined|6|||
48731063|NCT01397201|156867730|FG002|Overall Study|Not yet defined|5|||
48731064|NCT01397201|156867731|FG003|Overall Study|Not yet defined|5|||
48731065|NCT01397201|156867732|FG004|Overall Study|Not yet defined|4|||
48731066|NCT01397201|156867728|FG000|Overall Study|Adverse Event|2|||
48731067|NCT01397201|156867729|FG001|Overall Study|Adverse Event|0|||
48731068|NCT01397201|156867730|FG002|Overall Study|Adverse Event|0|||
48731069|NCT01397201|156867731|FG003|Overall Study|Adverse Event|0|||
48731070|NCT01397201|156867732|FG004|Overall Study|Adverse Event|0|||
48731071|NCT00562627|156867739|FG000|Overall Study|Protocol Violation|1|||
48731072|NCT00562627|156867740|FG001|Overall Study|Protocol Violation|1|||
48731073|NCT00562627|156867741|FG002|Overall Study|Protocol Violation|1|||
48731074|NCT00122278|156867742|FG000|Overall Study|Lost to Follow-up|2|||
48731075|NCT00122278|156867743|FG001|Overall Study|Lost to Follow-up|0|||
48731076|NCT01994590|156867749|FG000|Overall Study|Adverse Event|1|||
48731077|NCT01994590|156867749|FG000|Overall Study|Trial Terminated|1|||
48520054|NCT03493919|156095000|FG000|Overall Study|Other|2|||
48731085|NCT04761822|156867757|FG000|Overall Study|Adverse Event|3|||
48520055|NCT03493919|156095001|FG001|Overall Study|Other|0|||
48520056|NCT03493919|156095002|FG002|Overall Study|Other|1|||
48520057|NCT03493919|156095003|FG003|Overall Study|Other|0|||
48520058|NCT03493919|156095000|FG000|Overall Study|Withdrawal by Subject|9|||
48520059|NCT03493919|156095001|FG001|Overall Study|Withdrawal by Subject|3|||
48520060|NCT03493919|156095002|FG002|Overall Study|Withdrawal by Subject|1|||
48520061|NCT03493919|156095003|FG003|Overall Study|Withdrawal by Subject|1|||
48520062|NCT03493919|156095000|FG000|Overall Study|Lost to Follow-up|5|||
48520063|NCT03493919|156095001|FG001|Overall Study|Lost to Follow-up|0|||
48520064|NCT03493919|156095002|FG002|Overall Study|Lost to Follow-up|0|||
48520065|NCT03493919|156095003|FG003|Overall Study|Lost to Follow-up|3|||
48520066|NCT03493919|156095000|FG000|Overall Study|Adverse Event|0|||
48520067|NCT03493919|156095001|FG001|Overall Study|Adverse Event|1|||
48520068|NCT03493919|156095002|FG002|Overall Study|Adverse Event|0|||
48520069|NCT03493919|156095003|FG003|Overall Study|Adverse Event|0|||
48520070|NCT00884390|156095004|FG000|Overall Study|Adverse Event|0|||
48520071|NCT00884390|156095005|FG001|Overall Study|Adverse Event|1|||
48520072|NCT00884390|156095004|FG000|Overall Study|Lost to Follow-up|0|||
48520073|NCT00884390|156095005|FG001|Overall Study|Lost to Follow-up|1|||
48520074|NCT00884390|156095004|FG000|Overall Study|Physician Decision|2|||
48520075|NCT00884390|156095005|FG001|Overall Study|Physician Decision|1|||
48520076|NCT00884390|156095004|FG000|Overall Study|Protocol Violation|4|||
48520077|NCT00884390|156095005|FG001|Overall Study|Protocol Violation|1|||
48520078|NCT00884390|156095004|FG000|Overall Study|Withdrawal by Subject|4|||
48520079|NCT00884390|156095005|FG001|Overall Study|Withdrawal by Subject|1|||
48520080|NCT00884390|156095004|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
48520081|NCT00884390|156095005|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
48520082|NCT00884390|156095004|FG000|Overall Study|Other|11|||
48520083|NCT00884390|156095005|FG001|Overall Study|Other|1|||
48520084|NCT00751023|156095008|FG000|Overall Study|Lost to Follow-up|11|||
48520085|NCT00751023|156095009|FG001|Overall Study|Lost to Follow-up|7|||
48520086|NCT03358147|156095010|FG000|Overall Study|Withdrawal by Subject|13|||
48520087|NCT03358147|156095011|FG001|Overall Study|Withdrawal by Subject|19|||
48731086|NCT04761822|156867758|FG001|Overall Study|Adverse Event|1|||
48731087|NCT04761822|156867759|FG002|Overall Study|Adverse Event|1|||
48731088|NCT04761822|156867760|FG003|Overall Study|Adverse Event|3|||
48731089|NCT04761822|156867757|FG000|Overall Study|Lost to Follow-up|1|||
48731090|NCT04761822|156867758|FG001|Overall Study|Lost to Follow-up|0|||
48731091|NCT04761822|156867759|FG002|Overall Study|Lost to Follow-up|2|||
48731092|NCT04761822|156867760|FG003|Overall Study|Lost to Follow-up|3|||
48731093|NCT04761822|156867757|FG000|Overall Study|Physician Decision|0|||
48731094|NCT04761822|156867758|FG001|Overall Study|Physician Decision|1|||
48731095|NCT04761822|156867759|FG002|Overall Study|Physician Decision|0|||
48731096|NCT04761822|156867760|FG003|Overall Study|Physician Decision|0|||
48731097|NCT04761822|156867757|FG000|Overall Study|Withdrawal by Subject|3|||
48731098|NCT04761822|156867758|FG001|Overall Study|Withdrawal by Subject|8|||
48731099|NCT04761822|156867759|FG002|Overall Study|Withdrawal by Subject|1|||
48731100|NCT04761822|156867760|FG003|Overall Study|Withdrawal by Subject|11|||
48731101|NCT04761822|156867757|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
48731102|NCT04761822|156867758|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
48731103|NCT04761822|156867759|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
48731104|NCT04761822|156867760|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
48731105|NCT04761822|156867757|FG000|Overall Study|Participant requested unblinding|0|||
48731106|NCT04761822|156867758|FG001|Overall Study|Participant requested unblinding|0|||
48731107|NCT04761822|156867759|FG002|Overall Study|Participant requested unblinding|0|||
48731108|NCT04761822|156867760|FG003|Overall Study|Participant requested unblinding|1|||
48731109|NCT02395016|156867761|FG000|Overall Study|Adverse Event|4|||
48731110|NCT02395016|156867762|FG001|Overall Study|Adverse Event|3|||
48731111|NCT02395016|156867761|FG000|Overall Study|Withdrawal by Subject|9|||
48731112|NCT02395016|156867762|FG001|Overall Study|Withdrawal by Subject|6|||
48731113|NCT02395016|156867761|FG000|Overall Study|Protocol Violation|2|||
48731114|NCT02395016|156867762|FG001|Overall Study|Protocol Violation|3|||
48731115|NCT01442038|156867764|FG000|Overall Study|Death|35|||
48731116|NCT01442038|156867765|FG001|Overall Study|Death|29|||
48731117|NCT01442038|156867764|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
48731118|NCT01442038|156867765|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
48731119|NCT01442038|156867764|FG000|Overall Study|Participant Withdrew Consent|137|||
48520088|NCT03358147|156095012|FG002|Overall Study|Withdrawal by Subject|16|||
48520089|NCT03358147|156095013|FG003|Overall Study|Withdrawal by Subject|10|||
48520090|NCT03358147|156095014|FG004|Overall Study|Withdrawal by Subject|5|||
48520091|NCT03358147|156095010|FG000|Overall Study|Adverse Event|3|||
48520092|NCT03358147|156095011|FG001|Overall Study|Adverse Event|9|||
48520093|NCT03358147|156095012|FG002|Overall Study|Adverse Event|7|||
48520094|NCT03358147|156095013|FG003|Overall Study|Adverse Event|5|||
48520095|NCT03358147|156095014|FG004|Overall Study|Adverse Event|2|||
48520096|NCT03358147|156095010|FG000|Overall Study|Lost to Follow-up|4|||
48520097|NCT03358147|156095011|FG001|Overall Study|Lost to Follow-up|3|||
48520098|NCT03358147|156095012|FG002|Overall Study|Lost to Follow-up|7|||
48823912|NCT00688688|157195517|FG000|Overall Study|Eligibility criterion not met|7|||
48823913|NCT00688688|157195518|FG001|Overall Study|Eligibility criterion not met|7|||
48823914|NCT00688688|157195519|FG002|Overall Study|Eligibility criterion not met|10|||
48823915|NCT00688688|157195517|FG000|Overall Study|Adverse Event|52|||
48823916|NCT00688688|157195518|FG001|Overall Study|Adverse Event|51|||
48823917|NCT00688688|157195519|FG002|Overall Study|Adverse Event|50|||
48823918|NCT00688688|157195517|FG000|Overall Study|Lack of Efficacy|34|||
48823919|NCT00688688|157195518|FG001|Overall Study|Lack of Efficacy|25|||
48601129|NCT02718911|156396043|FG003|Overall Study|Physician Decision|1|||
48601130|NCT02718911|156396044|FG004|Overall Study|Physician Decision|0|||
48601131|NCT02718911|156396045|FG005|Overall Study|Physician Decision|0|||
48601132|NCT02718911|156396046|FG006|Overall Study|Physician Decision|0|||
48601133|NCT02718911|156396047|FG007|Overall Study|Physician Decision|1|||
48823920|NCT00688688|157195519|FG002|Overall Study|Lack of Efficacy|45|||
48823921|NCT00688688|157195517|FG000|Overall Study|Withdrawal by Subject|66|||
48823922|NCT00688688|157195518|FG001|Overall Study|Withdrawal by Subject|75|||
48823923|NCT00688688|157195519|FG002|Overall Study|Withdrawal by Subject|65|||
48823924|NCT00688688|157195517|FG000|Overall Study|Lost to Follow-up|14|||
48823925|NCT00688688|157195518|FG001|Overall Study|Lost to Follow-up|7|||
48823926|NCT00688688|157195519|FG002|Overall Study|Lost to Follow-up|7|||
48823927|NCT00688688|157195517|FG000|Overall Study|Protocol Violation|6|||
48823928|NCT00688688|157195518|FG001|Overall Study|Protocol Violation|9|||
48823929|NCT00688688|157195519|FG002|Overall Study|Protocol Violation|11|||
48823930|NCT00688688|157195517|FG000|Overall Study|Randomized but never received study drug|1|||
48823931|NCT00688688|157195518|FG001|Overall Study|Randomized but never received study drug|0|||
48823932|NCT00688688|157195519|FG002|Overall Study|Randomized but never received study drug|0|||
48823933|NCT00688688|157195517|FG000|Overall Study|Non-compliance with study procedures|5|||
48823934|NCT00688688|157195518|FG001|Overall Study|Non-compliance with study procedures|3|||
48823935|NCT00688688|157195519|FG002|Overall Study|Non-compliance with study procedures|4|||
48823936|NCT00688688|157195517|FG000|Overall Study|Taking exclusionary medications|1|||
48823937|NCT00688688|157195518|FG001|Overall Study|Taking exclusionary medications|0|||
48823938|NCT00688688|157195519|FG002|Overall Study|Taking exclusionary medications|0|||
48601134|NCT02718911|156396048|FG008|Overall Study|Physician Decision|2|||
48601135|NCT02718911|156396049|FG009|Overall Study|Physician Decision|1|||
48823939|NCT00688688|157195517|FG000|Overall Study|Site closure|0|||
48823940|NCT00688688|157195518|FG001|Overall Study|Site closure|1|||
48823941|NCT00688688|157195519|FG002|Overall Study|Site closure|0|||
48520099|NCT03358147|156095013|FG003|Overall Study|Lost to Follow-up|6|||
48520100|NCT03358147|156095014|FG004|Overall Study|Lost to Follow-up|4|||
48520101|NCT03358147|156095010|FG000|Overall Study|Major Protocol Deviation|11|||
48520102|NCT03358147|156095011|FG001|Overall Study|Major Protocol Deviation|3|||
48520103|NCT03358147|156095012|FG002|Overall Study|Major Protocol Deviation|2|||
48520104|NCT03358147|156095013|FG003|Overall Study|Major Protocol Deviation|3|||
48520105|NCT03358147|156095014|FG004|Overall Study|Major Protocol Deviation|1|||
48520106|NCT03358147|156095010|FG000|Overall Study|Protocol specified criteria|2|||
48520107|NCT03358147|156095011|FG001|Overall Study|Protocol specified criteria|3|||
48520108|NCT03358147|156095012|FG002|Overall Study|Protocol specified criteria|0|||
48520109|NCT03358147|156095013|FG003|Overall Study|Protocol specified criteria|3|||
48520110|NCT03358147|156095014|FG004|Overall Study|Protocol specified criteria|1|||
48823942|NCT00688688|157195517|FG000|Overall Study|Violation of exclusion criterion|0|||
48823943|NCT00688688|157195518|FG001|Overall Study|Violation of exclusion criterion|1|||
48823944|NCT00688688|157195519|FG002|Overall Study|Violation of exclusion criterion|0|||
48823945|NCT02950545|157195520|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48823946|NCT02950545|157195521|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48823947|NCT02950545|157195522|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48823948|NCT02950545|157195523|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48520111|NCT03358147|156095010|FG000|Overall Study|Physician Decision|1|||
48520112|NCT03358147|156095011|FG001|Overall Study|Physician Decision|0|||
48520113|NCT03358147|156095012|FG002|Overall Study|Physician Decision|1|||
48520114|NCT03358147|156095013|FG003|Overall Study|Physician Decision|6|||
48520115|NCT03358147|156095014|FG004|Overall Study|Physician Decision|1|||
48520116|NCT03358147|156095010|FG000|Overall Study|Administrative reasons|0|||
48520117|NCT03358147|156095011|FG001|Overall Study|Administrative reasons|1|||
48601136|NCT02718911|156396040|FG000|Overall Study|Withdrawal by Subject|0|||
48601137|NCT02718911|156396041|FG001|Overall Study|Withdrawal by Subject|0|||
48823949|NCT02950545|157195524|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
48823950|NCT02950545|157195525|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
48823951|NCT02950545|157195520|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
48823952|NCT02950545|157195521|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
48823953|NCT02950545|157195522|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
48823954|NCT02950545|157195523|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
48520118|NCT03358147|156095012|FG002|Overall Study|Administrative reasons|0|||
48520119|NCT03358147|156095013|FG003|Overall Study|Administrative reasons|3|||
48520120|NCT03358147|156095014|FG004|Overall Study|Administrative reasons|0|||
48601138|NCT02718911|156396042|FG002|Overall Study|Withdrawal by Subject|0|||
48823955|NCT02950545|157195524|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
48520121|NCT03358147|156095010|FG000|Overall Study|Lack of Efficacy|0|||
48520122|NCT03358147|156095011|FG001|Overall Study|Lack of Efficacy|1|||
48520123|NCT03358147|156095012|FG002|Overall Study|Lack of Efficacy|1|||
48520124|NCT03358147|156095013|FG003|Overall Study|Lack of Efficacy|0|||
48520125|NCT03358147|156095014|FG004|Overall Study|Lack of Efficacy|0|||
48520126|NCT02786953|156095015|FG000|Overall Study|Withdrawal by Subject|3|||
48520127|NCT02786953|156095016|FG001|Overall Study|Withdrawal by Subject|0|||
48520128|NCT02786953|156095015|FG000|Overall Study|Physician Decision|0|||
48520129|NCT02786953|156095016|FG001|Overall Study|Physician Decision|1|||
48520130|NCT02308696|156095019|FG000|Overall Study|Lost to Follow-up|28|||
48520131|NCT02308696|156095020|FG001|Overall Study|Lost to Follow-up|21|||
48520132|NCT02308696|156095019|FG000|Overall Study|Death|8|||
48520133|NCT02308696|156095020|FG001|Overall Study|Death|4|||
48520134|NCT02308696|156095019|FG000|Overall Study|Moved to a Higher Level of Care|17|||
48520135|NCT02308696|156095020|FG001|Overall Study|Moved to a Higher Level of Care|6|||
48520136|NCT01073631|156095023|FG000|Overall Study|Death|82|||
48520137|NCT01073631|156095023|FG000|Overall Study|Adverse Event|24|||
48520138|NCT01073631|156095023|FG000|Overall Study|Other|63|||
48520139|NCT00556673|156095024|FG000|Overall Study|Protocol deviation|3|||
48520140|NCT00556673|156095025|FG001|Overall Study|Protocol deviation|2|||
48520141|NCT01528735|156095026|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
48520142|NCT01528735|156095027|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
48520143|NCT01528735|156095026|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
48520144|NCT01528735|156095027|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
48520145|NCT01971554|156095028|FG000|Overall Study|Lost to Follow-up|1|||
48520146|NCT01971554|156095029|FG001|Overall Study|Lost to Follow-up|0|||
48520147|NCT01971554|156095030|FG002|Overall Study|Lost to Follow-up|0|||
48520148|NCT01971554|156095031|FG003|Overall Study|Lost to Follow-up|0|||
48520149|NCT00757172|156095032|FG000|Overall Study|Withdrawal by Subject|4|||
48520150|NCT00757172|156095032|FG000|Overall Study|Physician Decision|3|||
48520151|NCT00757172|156095032|FG000|Overall Study|Progression|4|||
48520152|NCT01717040|156095039|FG000|Overall Study|Lost to Follow-up|2|||
48520153|NCT01717040|156095040|FG001|Overall Study|Lost to Follow-up|3|||
48520154|NCT01717040|156095039|FG000|Overall Study|Lack of Efficacy|1|||
48520155|NCT01717040|156095040|FG001|Overall Study|Lack of Efficacy|1|||
48520156|NCT01717040|156095039|FG000|Overall Study|Adverse Event|1|||
48520157|NCT01717040|156095040|FG001|Overall Study|Adverse Event|0|||
48520158|NCT01717040|156095039|FG000|Overall Study|Required Medication Change|0|||
48520159|NCT01717040|156095040|FG001|Overall Study|Required Medication Change|1|||
48520160|NCT01717040|156095039|FG000|Overall Study|New Substance Use Disorder|1|||
48520161|NCT01717040|156095040|FG001|Overall Study|New Substance Use Disorder|0|||
48520162|NCT00494013|156095041|FG000|Overall Study|Adverse Event|0|||
48520163|NCT00494013|156095042|FG001|Overall Study|Adverse Event|1|||
48520164|NCT00494013|156095041|FG000|Overall Study|Entry Criteria Not Met|1|||
48520165|NCT00494013|156095042|FG001|Overall Study|Entry Criteria Not Met|4|||
48520166|NCT00494013|156095041|FG000|Overall Study|Lost to Follow-up|5|||
48520167|NCT00494013|156095042|FG001|Overall Study|Lost to Follow-up|6|||
48520168|NCT00494013|156095041|FG000|Overall Study|Physician Decision|3|||
48520169|NCT00494013|156095042|FG001|Overall Study|Physician Decision|5|||
48520170|NCT00494013|156095041|FG000|Overall Study|Protocol Violation|8|||
48520171|NCT00494013|156095042|FG001|Overall Study|Protocol Violation|5|||
48520172|NCT00494013|156095041|FG000|Overall Study|Withdrawal by Subject|13|||
48520173|NCT00494013|156095042|FG001|Overall Study|Withdrawal by Subject|14|||
48520174|NCT00494013|156095041|FG000|Overall Study|Sponsor Decision|0|||
48520175|NCT00494013|156095042|FG001|Overall Study|Sponsor Decision|1|||
48520176|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Adverse Event|8|||
48520177|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Adverse Event|5|||
48520178|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Adverse Event|9|||
48520179|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Adverse Event|0|||
48520180|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Adverse Event|0|||
48520181|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Adverse Event|0|||
48520182|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
48520183|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
48520184|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
48520185|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
48731120|NCT01442038|156867765|FG001|Overall Study|Participant Withdrew Consent|102|||
48731121|NCT01442038|156867764|FG000|Overall Study|Lost to Follow-up|37|||
48731122|NCT01442038|156867765|FG001|Overall Study|Lost to Follow-up|51|||
48731123|NCT01442038|156867764|FG000|Overall Study|Adverse Event|26|||
48731124|NCT01442038|156867765|FG001|Overall Study|Adverse Event|15|||
48731125|NCT01442038|156867764|FG000|Overall Study|Protocol Deviation|9|||
48731126|NCT01442038|156867765|FG001|Overall Study|Protocol Deviation|20|||
48731127|NCT01442038|156867764|FG000|Overall Study|Investigator's Discretion|13|||
48520186|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
48520187|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
48520188|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
48601139|NCT02718911|156396043|FG003|Overall Study|Withdrawal by Subject|0|||
48601140|NCT02718911|156396044|FG004|Overall Study|Withdrawal by Subject|1|||
48601141|NCT02718911|156396045|FG005|Overall Study|Withdrawal by Subject|0|||
48601142|NCT02718911|156396046|FG006|Overall Study|Withdrawal by Subject|0|||
48601143|NCT02718911|156396047|FG007|Overall Study|Withdrawal by Subject|0|||
48731128|NCT01442038|156867765|FG001|Overall Study|Investigator's Discretion|16|||
48520189|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
48520190|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
48520191|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
48520192|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
48520193|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
48520194|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Physician Decision|4|||
48520195|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Physician Decision|0|||
48520196|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Physician Decision|2|||
48520197|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Physician Decision|0|||
48520198|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Physician Decision|0|||
48520199|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Physician Decision|0|||
48520200|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Pregnancy|1|||
48520201|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Pregnancy|2|||
48520202|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Pregnancy|0|||
48520203|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Pregnancy|0|||
48520204|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Pregnancy|0|||
48520205|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Pregnancy|0|||
48520206|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
48731129|NCT01442038|156867764|FG000|Overall Study|Study Terminated By Sponsor|2|||
48520207|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
48520208|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
48520209|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
48520210|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
48520211|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
48520212|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
48520213|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
48520214|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
48731130|NCT01442038|156867765|FG001|Overall Study|Study Terminated By Sponsor|3|||
48731131|NCT00089284|156867766|FG000|Overall Study|Adverse event before starting treatment|0|||
48731132|NCT00089284|156867767|FG001|Overall Study|Adverse event before starting treatment|0|||
48731133|NCT00089284|156867768|FG002|Overall Study|Adverse event before starting treatment|0|||
48731134|NCT00089284|156867769|FG003|Overall Study|Adverse event before starting treatment|0|||
48731135|NCT00089284|156867770|FG004|Overall Study|Adverse event before starting treatment|0|||
48731136|NCT00089284|156867771|FG005|Overall Study|Adverse event before starting treatment|0|||
48731137|NCT00089284|156867772|FG006|Overall Study|Adverse event before starting treatment|1|||
48731138|NCT00053365|156867773|FG000|Overall Study|Incorrect cell type|1|||
48731139|NCT00053365|156867773|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
48731140|NCT00053365|156867773|FG000|Overall Study|Never treated|4|||
48731141|NCT00478881|156867779|FG000|Overall Study|Adverse Event|31|||
48731142|NCT00478881|156867780|FG001|Overall Study|Adverse Event|12|||
48731143|NCT00478881|156867779|FG000|Overall Study|Lack of Efficacy|0|||
48731144|NCT00478881|156867780|FG001|Overall Study|Lack of Efficacy|3|||
48731145|NCT00478881|156867779|FG000|Overall Study|Lost to Follow-up|0|||
48731146|NCT00478881|156867780|FG001|Overall Study|Lost to Follow-up|1|||
48731147|NCT00478881|156867779|FG000|Overall Study|Protocol Violation|2|||
48520215|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
48520216|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
48520217|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
48520218|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
48520219|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
48520220|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
48520221|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
48520222|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
48731148|NCT00478881|156867780|FG001|Overall Study|Protocol Violation|2|||
48731149|NCT00478881|156867779|FG000|Overall Study|Withdrawal by Subject|6|||
48731150|NCT00478881|156867780|FG001|Overall Study|Withdrawal by Subject|2|||
48731151|NCT00478881|156867779|FG000|Overall Study|Non-Compliance with Study Medication|0|||
48731152|NCT00478881|156867780|FG001|Overall Study|Non-Compliance with Study Medication|2|||
48731153|NCT03956056|156867781|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
48731154|NCT03956056|156867781|FG000|Overall Study|Lack of Efficacy|1|||
48731155|NCT01193660|156867785|FG000|Overall Study|Withdrawal by Subject|2|||
48731156|NCT01193660|156867786|FG001|Overall Study|Withdrawal by Subject|3|||
48731157|NCT01193660|156867787|FG002|Overall Study|Withdrawal by Subject|1|||
48731158|NCT01193660|156867785|FG000|Overall Study|Death|1|||
48520223|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
48823956|NCT02950545|157195525|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
48823957|NCT02950545|157195520|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823958|NCT02950545|157195521|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823959|NCT02950545|157195522|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823960|NCT02950545|157195523|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823961|NCT02950545|157195524|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
48823962|NCT02950545|157195525|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
48823963|NCT02950545|157195520|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
48823964|NCT02950545|157195521|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823965|NCT02950545|157195522|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823966|NCT02950545|157195523|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823967|NCT02950545|157195524|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823968|NCT02950545|157195525|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
48823969|NCT02950545|157195520|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823970|NCT02950545|157195521|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823971|NCT02950545|157195522|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823972|NCT02950545|157195523|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823973|NCT02950545|157195524|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
48823974|NCT02950545|157195525|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
48823975|NCT04003974|157195526|FG000|Overall Study|Missing|1|||
48823976|NCT04003974|157195527|FG001|Overall Study|Missing|0|||
48823977|NCT04003974|157195526|FG000|Overall Study|Withdrawal by Subject|0|||
48823978|NCT04003974|157195527|FG001|Overall Study|Withdrawal by Subject|2|||
48823979|NCT02478359|157195528|FG000|Overall Study|Disenrolled from health plan|106|||
48823980|NCT02478359|157195529|FG001|Overall Study|Disenrolled from health plan|65|||
48823981|NCT01770860|157195530|FG000|Overall Study|Withdrawal by Subject|4|||
48823982|NCT01770860|157195530|FG000|Overall Study|Lost to Follow-up|1|||
48823983|NCT01770860|157195530|FG000|Overall Study|Administrative decision made by the PI|1|||
48823984|NCT02100722|157195531|FG000|Overall Study|Withdrawal pre-procedure|4|||
48823985|NCT02100722|157195532|FG001|Overall Study|Withdrawal pre-procedure|9|||
48823986|NCT02100722|157195531|FG000|Overall Study|Withdrawal post-procedure|0|||
48823987|NCT02100722|157195532|FG001|Overall Study|Withdrawal post-procedure|3|||
48823988|NCT02100722|157195531|FG000|Overall Study|Lost to Follow-up|2|||
48823989|NCT02100722|157195532|FG001|Overall Study|Lost to Follow-up|2|||
48823990|NCT02100722|157195531|FG000|Overall Study|Continuing on study|751|||
48520224|NCT02614196|156095043|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
48520225|NCT02614196|156095044|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
48520226|NCT02614196|156095045|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
48520227|NCT02614196|156095046|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
48520228|NCT02614196|156095047|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
48520229|NCT02614196|156095048|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
48520230|NCT02614196|156095043|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
48520231|NCT02614196|156095044|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
48520232|NCT02614196|156095045|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
48520233|NCT02614196|156095046|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
48520234|NCT02614196|156095047|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
48520235|NCT02614196|156095048|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
48520236|NCT02614196|156095043|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
48520237|NCT02614196|156095044|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
48520238|NCT02614196|156095045|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
48520239|NCT02614196|156095046|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
48520240|NCT02614196|156095047|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
48520241|NCT02614196|156095048|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
48520242|NCT02614196|156095043|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
48520243|NCT02614196|156095044|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
48520244|NCT02614196|156095045|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
48520245|NCT02614196|156095046|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
48520246|NCT02614196|156095047|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
48520247|NCT02614196|156095048|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
48520248|NCT02614196|156095043|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
48520249|NCT02614196|156095044|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
48520250|NCT02614196|156095045|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
48520251|NCT02614196|156095046|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
48823991|NCT02100722|157195532|FG001|Overall Study|Continuing on study|729|||
48823992|NCT01528709|157195533|FG000|Overall Study|Death|2|||
48520252|NCT02614196|156095047|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
48520253|NCT02614196|156095048|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
48823993|NCT01528709|157195534|FG001|Overall Study|Death|0|||
48823994|NCT01528709|157195533|FG000|Overall Study|Withdrawal by Subject|10|||
48823995|NCT01528709|157195534|FG001|Overall Study|Withdrawal by Subject|15|||
48731159|NCT01193660|156867786|FG001|Overall Study|Death|0|||
48731160|NCT01193660|156867787|FG002|Overall Study|Death|0|||
48731161|NCT01193660|156867785|FG000|Overall Study|Physician Decision|1|||
48520254|NCT03573336|156095049|FG000|Overall Study|Study terminated|2|||
48520255|NCT03573336|156095050|FG001|Overall Study|Study terminated|4|||
48520256|NCT03573336|156095051|FG002|Overall Study|Study terminated|2|||
48520257|NCT01151280|156096278|FG000|Overall Study|Adverse Event|1|||
48520258|NCT01151280|156096278|FG000|Overall Study|Lack of Efficacy|3|||
48520259|NCT02435433|156096279|FG000|Overall Study|Withdrawal by Subject|2|||
48520260|NCT02435433|156096280|FG001|Overall Study|Withdrawal by Subject|3|||
48520261|NCT02435433|156096281|FG002|Overall Study|Withdrawal by Subject|1|||
48520262|NCT02435433|156096282|FG003|Overall Study|Withdrawal by Subject|0|||
48520263|NCT02435433|156096283|FG004|Overall Study|Withdrawal by Subject|0|||
48520264|NCT02435433|156096279|FG000|Overall Study|Lost to Follow-up|2|||
48520265|NCT02435433|156096280|FG001|Overall Study|Lost to Follow-up|2|||
48520266|NCT02435433|156096281|FG002|Overall Study|Lost to Follow-up|4|||
48520267|NCT02435433|156096282|FG003|Overall Study|Lost to Follow-up|1|||
48520268|NCT02435433|156096283|FG004|Overall Study|Lost to Follow-up|0|||
48520269|NCT00960154|156096284|FG000|Overall Study|Study termination|25|||
48520270|NCT00960154|156096285|FG001|Overall Study|Study termination|25|||
48520271|NCT00757705|156096286|FG000|Overall Study|Adverse Event|19|||
48520272|NCT00757705|156096286|FG000|Overall Study|Lost to Follow-up|16|||
48520273|NCT00757705|156096286|FG000|Overall Study|Withdrawal by Subject|25|||
48520274|NCT00757705|156096286|FG000|Overall Study|Insufficient Response|26|||
48520275|NCT00757705|156096286|FG000|Overall Study|Ineligible to continue|8|||
48520276|NCT00757705|156096286|FG000|Overall Study|Non-compliant|9|||
48520277|NCT00757705|156096286|FG000|Overall Study|Other|18|||
48520278|NCT02817828|156096287|FG000|Overall Study|Lost to Follow-up|41|||
48520279|NCT02817828|156096287|FG000|Overall Study|Adverse event not related to bleeding|104|||
48520280|NCT02817828|156096287|FG000|Overall Study|Adverse event related to bleeding|53|||
48520281|NCT02817828|156096287|FG000|Overall Study|Protocol Violation|11|||
48520282|NCT02817828|156096287|FG000|Overall Study|Pregnancy|7|||
48520283|NCT02817828|156096287|FG000|Overall Study|Pregnancy wish|15|||
48520284|NCT02817828|156096287|FG000|Overall Study|Withdrawal by Subject|78|||
48520285|NCT02817828|156096287|FG000|Overall Study|Other|26|||
48520286|NCT02308241|156096289|FG000|Overall Study|Withdrawal by Subject|3|||
48520287|NCT02651987|156096290|FG000|Overall Study|Adverse Event|2|||
48520288|NCT02651987|156096291|FG001|Overall Study|Adverse Event|2|||
48520289|NCT02651987|156096290|FG000|Overall Study|Consent Withdrawn|2|||
48520290|NCT02651987|156096291|FG001|Overall Study|Consent Withdrawn|0|||
48520291|NCT02651987|156096290|FG000|Overall Study|Local PD|0|||
48520292|NCT02651987|156096291|FG001|Overall Study|Local PD|2|||
48520293|NCT02651987|156096290|FG000|Overall Study|Investigator Decision|1|||
48520294|NCT02651987|156096291|FG001|Overall Study|Investigator Decision|1|||
48731162|NCT01193660|156867786|FG001|Overall Study|Physician Decision|0|||
48731163|NCT01193660|156867787|FG002|Overall Study|Physician Decision|1|||
48731164|NCT02595970|156867788|FG000|Overall Study|Withdrawal by Subject|2|||
48731165|NCT02595970|156867788|FG000|Overall Study|Physician Decision|2|||
48731166|NCT02595970|156867788|FG000|Overall Study|Protocol Violation|4|||
48731167|NCT02595970|156867788|FG000|Overall Study|Adverse Event|5|||
48731168|NCT02595970|156867788|FG000|Overall Study|Lack of Efficacy|7|||
48731169|NCT02367131|156867789|FG000|Overall Study|Adverse Event|64|||
48731170|NCT02367131|156867789|FG000|Overall Study|No visit since the first visit|3|||
48731171|NCT02367131|156867789|FG000|Overall Study|Request by patient|53|||
48823996|NCT01528709|157195533|FG000|Overall Study|allergy|1|||
48520295|NCT01630616|156096292|FG000|Overall Study|Adverse Event|0|||
48520296|NCT01630616|156096293|FG001|Overall Study|Adverse Event|0|||
48520297|NCT01630616|156096294|FG002|Overall Study|Adverse Event|0|||
48520298|NCT01630616|156096295|FG003|Overall Study|Adverse Event|1|||
48520299|NCT01630616|156096296|FG004|Overall Study|Adverse Event|0|||
48520300|NCT01630616|156096297|FG005|Overall Study|Adverse Event|0|||
48520301|NCT01630616|156096292|FG000|Overall Study|Withdrawal by Subject|0|||
48731172|NCT02367131|156867789|FG000|Overall Study|Improvement/remission|2|||
48731173|NCT02367131|156867789|FG000|Overall Study|No change/progressive disease|78|||
48520302|NCT01630616|156096293|FG001|Overall Study|Withdrawal by Subject|0|||
48520303|NCT01630616|156096294|FG002|Overall Study|Withdrawal by Subject|0|||
48823997|NCT01528709|157195534|FG001|Overall Study|allergy|0|||
48520304|NCT01630616|156096295|FG003|Overall Study|Withdrawal by Subject|2|||
48823998|NCT01237678|157195535|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
48823999|NCT01237678|157195536|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
48520305|NCT01630616|156096296|FG004|Overall Study|Withdrawal by Subject|0|||
48520306|NCT01630616|156096297|FG005|Overall Study|Withdrawal by Subject|0|||
48520307|NCT04408924|156096298|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
48520308|NCT04408924|156096298|FG000|Overall Study|Lost to Follow-up|3|||
48520309|NCT04408924|156096298|FG000|Overall Study|Withdrawal by Subject|5|||
48520310|NCT04408924|156096298|FG000|Overall Study|Sponsor Decision|2|||
48520311|NCT00736190|156096299|FG000|Overall Study|Pregnancy|1|||
48520312|NCT00736190|156096299|FG000|Overall Study|Withdrawal by Subject|1|||
48520313|NCT00736190|156096299|FG000|Overall Study|Adverse Event|1|||
48520314|NCT02587143|156096306|FG000|Overall Study|Adverse Event|1|||
48520315|NCT02587143|156096307|FG001|Overall Study|Adverse Event|0|||
48520316|NCT03224624|156096311|FG000|Overall Study|Lost to Follow-up|9|||
48520317|NCT03224624|156096312|FG001|Overall Study|Lost to Follow-up|4|||
48520318|NCT03224624|156096311|FG000|Overall Study|Death|1|||
48520319|NCT03224624|156096312|FG001|Overall Study|Death|0|||
48520320|NCT00716625|156096313|FG000|Overall Study|Safety was not Assessable|1|||
48520321|NCT01492439|156096314|FG000|Overall Study|Withdrew from RTE|4|||
48520322|NCT01492439|156096315|FG001|Overall Study|Withdrew from RTE|9|||
48520323|NCT01664039|156096316|FG000|Overall Study|Adverse Event|3|||
48520324|NCT01664039|156096317|FG001|Overall Study|Adverse Event|4|||
48520325|NCT01664039|156096316|FG000|Overall Study|Lost to Follow-up|1|||
48520326|NCT01664039|156096317|FG001|Overall Study|Lost to Follow-up|1|||
48520327|NCT01664039|156096316|FG000|Overall Study|Withdrawal by Subject|1|||
48520328|NCT01664039|156096317|FG001|Overall Study|Withdrawal by Subject|3|||
48520329|NCT01664039|156096316|FG000|Overall Study|Noncompliance|1|||
48520330|NCT01664039|156096317|FG001|Overall Study|Noncompliance|1|||
48520331|NCT02451696|156096318|FG000|Overall Study|Surgery postponed|1|||
48520332|NCT02451696|156096319|FG001|Overall Study|Surgery postponed|0|||
48520333|NCT01944722|156096322|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
48520334|NCT01944722|156096322|FG000|Overall Study|Specimen Shipping Issues|34|||
48520335|NCT01944722|156096322|FG000|Overall Study|Improper Storage/Transport|5|||
48520336|NCT01944722|156096322|FG000|Overall Study|Insufficient Volume for Test|1|||
48520337|NCT01944722|156096322|FG000|Overall Study|Missing Specimens|3|||
48520338|NCT01944722|156096322|FG000|Overall Study|Specimens Mislabeled|2|||
48520339|NCT01944722|156096322|FG000|Overall Study|Withdrawal by Subject|8|||
48520340|NCT01944722|156096322|FG000|Overall Study|NILM Subjects <30 years old|8106|||
48520341|NCT01944722|156096322|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
48520342|NCT01944722|156096322|FG000|Overall Study|>ASCUS Cytology|1122|||
48520343|NCT04535986|156096323|FG000|Overall Study|Death|4|||
48520344|NCT04535986|156096324|FG001|Overall Study|Death|5|||
48520345|NCT04535986|156096323|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
48520346|NCT04535986|156096324|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
48520347|NCT04535986|156096323|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
48520348|NCT04535986|156096324|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
48520349|NCT04535986|156096323|FG000|Overall Study|Adverse Event|10|||
48520350|NCT04535986|156096324|FG001|Overall Study|Adverse Event|1|||
48520351|NCT04535986|156096323|FG000|Overall Study|Lack of Efficacy|3|||
48520352|NCT04535986|156096324|FG001|Overall Study|Lack of Efficacy|2|||
48520353|NCT04535986|156096323|FG000|Overall Study|Investigator discretion|3|||
48601144|NCT02718911|156396048|FG008|Overall Study|Withdrawal by Subject|1|||
48601145|NCT02718911|156396049|FG009|Overall Study|Withdrawal by Subject|4|||
48442505|NCT02924688|155806983|FG002|Overall Study|Lost to Follow-up|2|||
48442506|NCT02924688|155806984|FG003|Overall Study|Lost to Follow-up|4|||
48442507|NCT02924688|155806985|FG004|Overall Study|Lost to Follow-up|2|||
48442508|NCT02924688|155806986|FG005|Overall Study|Lost to Follow-up|4|||
48442509|NCT02924688|155806981|FG000|Overall Study|Physician Decision|2|||
48442510|NCT02924688|155806982|FG001|Overall Study|Physician Decision|1|||
48442511|NCT02924688|155806983|FG002|Overall Study|Physician Decision|0|||
48442512|NCT02924688|155806984|FG003|Overall Study|Physician Decision|1|||
48442513|NCT02924688|155806985|FG004|Overall Study|Physician Decision|1|||
48442514|NCT02924688|155806986|FG005|Overall Study|Physician Decision|1|||
48442515|NCT02924688|155806981|FG000|Overall Study|Withdrawal by Subject|14|||
48442516|NCT02924688|155806982|FG001|Overall Study|Withdrawal by Subject|13|||
48442517|NCT02924688|155806983|FG002|Overall Study|Withdrawal by Subject|9|||
48442518|NCT02924688|155806984|FG003|Overall Study|Withdrawal by Subject|12|||
48442519|NCT02924688|155806985|FG004|Overall Study|Withdrawal by Subject|13|||
48442520|NCT02924688|155806986|FG005|Overall Study|Withdrawal by Subject|14|||
48442521|NCT02293993|155806987|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
48442522|NCT02293993|155806988|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
48442523|NCT02293993|155806989|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
48442524|NCT02293993|155806990|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
48442525|NCT02293993|155806987|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
48442526|NCT02293993|155806988|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
48442527|NCT02293993|155806989|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
48442528|NCT02293993|155806990|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
48442529|NCT02293993|155806987|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
48442530|NCT02293993|155806988|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
48442531|NCT02293993|155806989|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
48442532|NCT02293993|155806990|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
48442533|NCT02293993|155806987|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
48520354|NCT04535986|156096324|FG001|Overall Study|Investigator discretion|0|||
48520355|NCT04535986|156096323|FG000|Overall Study|Withdrawal by Subject|32|||
48520356|NCT04535986|156096324|FG001|Overall Study|Withdrawal by Subject|14|||
48520357|NCT04535986|156096323|FG000|Overall Study|Lost to Follow-up|5|||
48520358|NCT04535986|156096324|FG001|Overall Study|Lost to Follow-up|3|||
48520359|NCT04535986|156096323|FG000|Overall Study|Other|7|||
48520360|NCT04535986|156096324|FG001|Overall Study|Other|3|||
48731174|NCT02367131|156867789|FG000|Overall Study|Other than stated above|20|||
48731175|NCT02367131|156867789|FG000|Overall Study|Not treated|2|||
48520361|NCT03966911|156096329|FG000|Overall Study|Adverse Event|1|||
48520362|NCT03966911|156096330|FG001|Overall Study|Adverse Event|1|||
48520363|NCT03966911|156096329|FG000|Overall Study|Withdrawal by Subject|8|||
48731176|NCT02428608|156867793|FG000|Overall Study|Pregnancy|2|||
48731177|NCT02428608|156867793|FG000|Overall Study|Lost to Follow-up|37|||
48731178|NCT02428608|156867793|FG000|Overall Study|Withdrawal by Subject|2|||
48731179|NCT02428608|156867793|FG000|Overall Study|scheduling conflicts|15|||
48731180|NCT02428608|156867793|FG000|Overall Study|moved away|10|||
48731181|NCT02428608|156867793|FG000|Overall Study|Death|1|||
48731182|NCT02428608|156867793|FG000|Overall Study|various|16|||
48731183|NCT04073368|156867797|FG000|Overall Study|Adverse Event|2|||
48731184|NCT04073368|156867798|FG001|Overall Study|Adverse Event|0|||
48731185|NCT04073368|156867799|FG002|Overall Study|Adverse Event|1|||
48731186|NCT04073368|156867800|FG003|Overall Study|Adverse Event|1|||
48731187|NCT04073368|156867797|FG000|Overall Study|Withdrawal by Subject|2|||
48731188|NCT04073368|156867798|FG001|Overall Study|Withdrawal by Subject|2|||
48731189|NCT04073368|156867799|FG002|Overall Study|Withdrawal by Subject|1|||
48731190|NCT04073368|156867800|FG003|Overall Study|Withdrawal by Subject|1|||
48731191|NCT04073368|156867797|FG000|Overall Study|Lost to Follow-up|1|||
48731192|NCT04073368|156867798|FG001|Overall Study|Lost to Follow-up|1|||
48731193|NCT04073368|156867799|FG002|Overall Study|Lost to Follow-up|1|||
48824000|NCT01237678|157195537|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
48824001|NCT01237678|157195535|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
48824002|NCT01237678|157195536|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
48824003|NCT01237678|157195537|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
48824004|NCT01237678|157195535|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
48824005|NCT01237678|157195536|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
48824006|NCT01237678|157195537|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
48824007|NCT01237678|157195535|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
48824008|NCT01237678|157195536|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
48824009|NCT01237678|157195537|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
48824010|NCT01237678|157195535|FG000|Phase II|Adverse Event|0|||
48824011|NCT01237678|157195536|FG001|Phase II|Adverse Event|39|||
48824012|NCT01237678|157195537|FG002|Phase II|Adverse Event|9|||
48824013|NCT01237678|157195535|FG000|Phase II|Death|0|||
48824014|NCT01237678|157195536|FG001|Phase II|Death|0|||
48824015|NCT01237678|157195537|FG002|Phase II|Death|2|||
48824016|NCT01237678|157195535|FG000|Phase II|Lack of Efficacy|0|||
48824017|NCT01237678|157195536|FG001|Phase II|Lack of Efficacy|25|||
48824018|NCT01237678|157195537|FG002|Phase II|Lack of Efficacy|3|||
48824019|NCT01237678|157195535|FG000|Phase II|Withdrawal by Subject|0|||
48824020|NCT01237678|157195536|FG001|Phase II|Withdrawal by Subject|1|||
48824021|NCT01237678|157195537|FG002|Phase II|Withdrawal by Subject|5|||
48824022|NCT01237678|157195535|FG000|Phase II|Completed Cycles 4-6|0|||
48824023|NCT01237678|157195536|FG001|Phase II|Completed Cycles 4-6|11|||
48824024|NCT01237678|157195537|FG002|Phase II|Completed Cycles 4-6|21|||
48824025|NCT01237678|157195535|FG000|Phase II|Sponsor Decision/Study Closed|0|||
48824026|NCT01237678|157195536|FG001|Phase II|Sponsor Decision/Study Closed|18|||
48824027|NCT01237678|157195537|FG002|Phase II|Sponsor Decision/Study Closed|7|||
48824028|NCT01237678|157195535|FG000|Phase II|Randomized but were not treated|0|||
48824029|NCT01237678|157195536|FG001|Phase II|Randomized but were not treated|4|||
48520364|NCT03966911|156096330|FG001|Overall Study|Withdrawal by Subject|2|||
48520365|NCT03966911|156096329|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
48520366|NCT03966911|156096330|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
48520367|NCT01583530|156096333|FG000|Overall Study|Adverse Event|0|||
48520368|NCT01583530|156096334|FG001|Overall Study|Adverse Event|0|||
48520369|NCT01583530|156096335|FG002|Overall Study|Adverse Event|0|||
48520370|NCT01583530|156096336|FG003|Overall Study|Adverse Event|0|||
48520371|NCT01583530|156096337|FG004|Overall Study|Adverse Event|0|||
48520372|NCT01583530|156096338|FG005|Overall Study|Adverse Event|1|||
48520373|NCT01583530|156096333|FG000|Overall Study|Withdrawal by Subject|0|||
48520374|NCT01583530|156096334|FG001|Overall Study|Withdrawal by Subject|3|||
48520375|NCT01583530|156096335|FG002|Overall Study|Withdrawal by Subject|0|||
48520376|NCT01583530|156096336|FG003|Overall Study|Withdrawal by Subject|1|||
48520377|NCT01583530|156096337|FG004|Overall Study|Withdrawal by Subject|1|||
48731194|NCT04073368|156867800|FG003|Overall Study|Lost to Follow-up|0|||
48731195|NCT04073368|156867797|FG000|Overall Study|Protocol Violation|0|||
48731196|NCT04073368|156867798|FG001|Overall Study|Protocol Violation|1|||
48731197|NCT04073368|156867799|FG002|Overall Study|Protocol Violation|0|||
48731198|NCT04073368|156867800|FG003|Overall Study|Protocol Violation|0|||
48731199|NCT04073368|156867797|FG000|Overall Study|Subject noncompliance|7|||
48731200|NCT04073368|156867798|FG001|Overall Study|Subject noncompliance|4|||
48731201|NCT04073368|156867799|FG002|Overall Study|Subject noncompliance|0|||
48731202|NCT04073368|156867800|FG003|Overall Study|Subject noncompliance|0|||
48731203|NCT00900601|156867801|FG000|Overall Study|Physician Decision|1|||
48731204|NCT02106910|156867809|FG000|Overall Study|Lost to Follow-up|1|||
48520378|NCT01583530|156096338|FG005|Overall Study|Withdrawal by Subject|2|||
48520379|NCT01583530|156096333|FG000|Overall Study|Lost to Follow-up|0|||
48520380|NCT01583530|156096334|FG001|Overall Study|Lost to Follow-up|0|||
48520381|NCT01583530|156096335|FG002|Overall Study|Lost to Follow-up|0|||
48520382|NCT01583530|156096336|FG003|Overall Study|Lost to Follow-up|0|||
48520383|NCT01583530|156096337|FG004|Overall Study|Lost to Follow-up|3|||
48520384|NCT01583530|156096338|FG005|Overall Study|Lost to Follow-up|0|||
48520385|NCT01583530|156096333|FG000|Overall Study|Lack of compliance|0|||
48520386|NCT01583530|156096334|FG001|Overall Study|Lack of compliance|0|||
48520387|NCT01583530|156096335|FG002|Overall Study|Lack of compliance|0|||
48520388|NCT01583530|156096336|FG003|Overall Study|Lack of compliance|0|||
48520389|NCT01583530|156096337|FG004|Overall Study|Lack of compliance|1|||
48520390|NCT01583530|156096338|FG005|Overall Study|Lack of compliance|0|||
48520391|NCT00283842|156096339|FG000|Overall Study|Adverse Event|8|||
48520392|NCT00283842|156096340|FG001|Overall Study|Adverse Event|7|||
48520393|NCT00283842|156096341|FG002|Overall Study|Adverse Event|21|||
48520394|NCT00283842|156096342|FG003|Overall Study|Adverse Event|21|||
48520395|NCT00283842|156096343|FG004|Overall Study|Adverse Event|5|||
48520396|NCT00283842|156096339|FG000|Overall Study|Protocol Violation|1|||
48731205|NCT02106910|156867810|FG001|Overall Study|Lost to Follow-up|1|||
48731206|NCT01134315|156867819|FG000|Overall Study|Adverse Event|1|||
48731207|NCT01134315|156867820|FG001|Overall Study|Adverse Event|2|||
48731208|NCT01134315|156867819|FG000|Overall Study|Other Reason|8|||
48731209|NCT01134315|156867820|FG001|Overall Study|Other Reason|17|||
48731210|NCT01251744|156867823|FG000|Overall Study|Lost to Follow-up|1|||
48731211|NCT01251744|156867824|FG001|Overall Study|Lost to Follow-up|0|||
48731212|NCT05939388|156867828|FG000|Overall Study|Lost to Follow-up|1|||
48731213|NCT01822678|156867833|FG000|Overall Study|Withdrawal by Subject|5|||
48731214|NCT01822678|156867834|FG001|Overall Study|Withdrawal by Subject|4|||
48731215|NCT01822678|156867835|FG002|Overall Study|Withdrawal by Subject|4|||
48731216|NCT01822678|156867833|FG000|Overall Study|Adverse Event|4|||
48520397|NCT00283842|156096340|FG001|Overall Study|Protocol Violation|5|||
48520398|NCT00283842|156096341|FG002|Overall Study|Protocol Violation|4|||
48520399|NCT00283842|156096342|FG003|Overall Study|Protocol Violation|0|||
48520400|NCT00283842|156096343|FG004|Overall Study|Protocol Violation|0|||
48520401|NCT00283842|156096339|FG000|Overall Study|Protocol deviation|0|||
48731217|NCT01822678|156867834|FG001|Overall Study|Adverse Event|3|||
48731218|NCT01822678|156867835|FG002|Overall Study|Adverse Event|1|||
48731219|NCT01822678|156867833|FG000|Overall Study|Lack of Efficacy|3|||
48731220|NCT01822678|156867834|FG001|Overall Study|Lack of Efficacy|6|||
48731221|NCT01822678|156867835|FG002|Overall Study|Lack of Efficacy|5|||
48520402|NCT00283842|156096340|FG001|Overall Study|Protocol deviation|0|||
48601146|NCT02718911|156396040|FG000|Overall Study|Reason Not Collected|0|||
48731222|NCT01822678|156867833|FG000|Overall Study|Lost to Follow-up|0|||
48731223|NCT01822678|156867834|FG001|Overall Study|Lost to Follow-up|2|||
48731224|NCT01822678|156867835|FG002|Overall Study|Lost to Follow-up|1|||
48731225|NCT04041375|156867836|FG000|Intervention Phase|Withdrawal by Subject|2|||
48731226|NCT04041375|156867837|FG001|Intervention Phase|Withdrawal by Subject|2|||
48731227|NCT04041375|156867836|FG000|Follow-up Phase|Death|2|||
48731228|NCT04041375|156867837|FG001|Follow-up Phase|Death|0|||
48731229|NCT04041375|156867836|FG000|Follow-up Phase|Lost to Follow-up|2|||
48731230|NCT04041375|156867837|FG001|Follow-up Phase|Lost to Follow-up|1|||
48731231|NCT04041375|156867836|FG000|Follow-up Phase|Too ill|3|||
48731232|NCT04041375|156867837|FG001|Follow-up Phase|Too ill|0|||
48731233|NCT01230710|156867838|FG000|Overall Study|Disease Progression|41|||
48731234|NCT01230710|156867838|FG000|Overall Study|Lost to Follow-up|3|||
48731235|NCT01230710|156867838|FG000|Overall Study|Death|4|||
48731236|NCT01230710|156867838|FG000|Overall Study|Withdrawal of Consent|1|||
48731237|NCT00943124|156867839|FG000|Period 1|Withdrawal by Subject|1|||
48731238|NCT00943124|156867840|FG001|Period 1|Withdrawal by Subject|1|||
48731239|NCT00943124|156867839|FG000|Period 1|Did Not Follow Study Procedures|1|||
48731240|NCT00943124|156867840|FG001|Period 1|Did Not Follow Study Procedures|0|||
48731241|NCT00943124|156867839|FG000|Period 1|Personal Reasons|0|||
48731242|NCT00943124|156867840|FG001|Period 1|Personal Reasons|1|||
48731243|NCT02305888|156867841|FG000|Overall Study|Lost to Follow-up|0|||
48731244|NCT02305888|156867842|FG001|Overall Study|Lost to Follow-up|0|||
48731245|NCT02305888|156867843|FG002|Overall Study|Lost to Follow-up|1|||
48731246|NCT02305888|156867841|FG000|Overall Study|Adverse Event|0|||
48731247|NCT02305888|156867842|FG001|Overall Study|Adverse Event|1|||
48731248|NCT02305888|156867843|FG002|Overall Study|Adverse Event|0|||
48520403|NCT00283842|156096341|FG002|Overall Study|Protocol deviation|0|||
48731249|NCT01369615|156867844|FG000|Overall Study|Withdrawal by Subject|0|||
48520404|NCT00283842|156096342|FG003|Overall Study|Protocol deviation|0|||
48520405|NCT00283842|156096343|FG004|Overall Study|Protocol deviation|2|||
48520406|NCT00283842|156096339|FG000|Overall Study|Withdrawal by Subject|2|||
48520407|NCT00283842|156096340|FG001|Overall Study|Withdrawal by Subject|1|||
48520408|NCT00283842|156096341|FG002|Overall Study|Withdrawal by Subject|1|||
48520409|NCT00283842|156096342|FG003|Overall Study|Withdrawal by Subject|5|||
48520410|NCT00283842|156096343|FG004|Overall Study|Withdrawal by Subject|4|||
48520411|NCT00283842|156096339|FG000|Overall Study|Lack of Efficacy|1|||
48520412|NCT00283842|156096340|FG001|Overall Study|Lack of Efficacy|3|||
48520413|NCT00283842|156096341|FG002|Overall Study|Lack of Efficacy|1|||
48520414|NCT00283842|156096342|FG003|Overall Study|Lack of Efficacy|0|||
48520415|NCT00283842|156096343|FG004|Overall Study|Lack of Efficacy|3|||
48520416|NCT00283842|156096339|FG000|Overall Study|Lost to Follow-up|0|||
48520417|NCT00283842|156096340|FG001|Overall Study|Lost to Follow-up|2|||
48601147|NCT02718911|156396041|FG001|Overall Study|Reason Not Collected|0|||
48601148|NCT02718911|156396042|FG002|Overall Study|Reason Not Collected|1|||
48601149|NCT02718911|156396043|FG003|Overall Study|Reason Not Collected|0|||
48601150|NCT02718911|156396044|FG004|Overall Study|Reason Not Collected|0|||
48601151|NCT02718911|156396045|FG005|Overall Study|Reason Not Collected|0|||
48601152|NCT02718911|156396046|FG006|Overall Study|Reason Not Collected|2|||
48601153|NCT02718911|156396047|FG007|Overall Study|Reason Not Collected|1|||
48601154|NCT02718911|156396048|FG008|Overall Study|Reason Not Collected|4|||
48601155|NCT02718911|156396049|FG009|Overall Study|Reason Not Collected|9|||
48601156|NCT02053493|156396050|FG000|Overall Study|Withdrawal by Subject|1|||
48601157|NCT02053493|156396051|FG001|Overall Study|Withdrawal by Subject|1|||
48601158|NCT03589807|156396055|FG000|Overall Study|Lost to Follow-up|0|||
48601159|NCT03589807|156396056|FG001|Overall Study|Lost to Follow-up|2|||
48601160|NCT03589807|156396057|FG002|Overall Study|Lost to Follow-up|2|||
48601161|NCT03589807|156396058|FG003|Overall Study|Lost to Follow-up|3|||
48601162|NCT03589807|156396059|FG004|Overall Study|Lost to Follow-up|1|||
48601163|NCT03589807|156396060|FG005|Overall Study|Lost to Follow-up|1|||
48601164|NCT03589807|156396055|FG000|Overall Study|Withdrawal by Subject|0|||
48601165|NCT03589807|156396056|FG001|Overall Study|Withdrawal by Subject|5|||
48731250|NCT01369615|156867845|FG001|Overall Study|Withdrawal by Subject|1|||
48731251|NCT01369615|156867844|FG000|Overall Study|Lost to Follow-up|0|||
48731252|NCT01369615|156867845|FG001|Overall Study|Lost to Follow-up|1|||
48731253|NCT01702571|156867846|FG000|Overall Study|Death|1067|||
48731254|NCT01702571|156867847|FG001|Overall Study|Death|76|||
48731255|NCT01702571|156867846|FG000|Overall Study|Lost to Follow-up|144|||
48731256|NCT01702571|156867847|FG001|Overall Study|Lost to Follow-up|10|||
48731257|NCT01702571|156867846|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
48731258|NCT01702571|156867847|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
48520418|NCT00283842|156096341|FG002|Overall Study|Lost to Follow-up|4|||
48520419|NCT00283842|156096342|FG003|Overall Study|Lost to Follow-up|1|||
48520420|NCT00283842|156096343|FG004|Overall Study|Lost to Follow-up|1|||
48601166|NCT03589807|156396057|FG002|Overall Study|Withdrawal by Subject|0|||
48601167|NCT03589807|156396058|FG003|Overall Study|Withdrawal by Subject|0|||
48731259|NCT01702571|156867846|FG000|Overall Study|Investigator Decision|5|||
48731260|NCT01702571|156867847|FG001|Overall Study|Investigator Decision|0|||
48731261|NCT01702571|156867846|FG000|Overall Study|Not Classifiable|1|||
48731262|NCT01702571|156867847|FG001|Overall Study|Not Classifiable|0|||
48731263|NCT01702571|156867846|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
48731264|NCT01702571|156867847|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
48731265|NCT01702571|156867846|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
48731266|NCT01702571|156867847|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
48731267|NCT01702571|156867846|FG000|Overall Study|Progressive Disease|3|||
48731268|NCT01702571|156867847|FG001|Overall Study|Progressive Disease|0|||
48731269|NCT01702571|156867846|FG000|Overall Study|Protocol Violation|2|||
48731270|NCT01702571|156867847|FG001|Overall Study|Protocol Violation|0|||
48731271|NCT01702571|156867846|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
48731272|NCT01702571|156867847|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
48731273|NCT01702571|156867846|FG000|Overall Study|Termination By Sponsor|4|||
48731274|NCT01702571|156867847|FG001|Overall Study|Termination By Sponsor|0|||
48731275|NCT01702571|156867846|FG000|Overall Study|Withdrawal by Subject|177|||
48731276|NCT01702571|156867847|FG001|Overall Study|Withdrawal by Subject|29|||
48731277|NCT02027376|156867848|FG000|Overall Study|Death|1|||
48731278|NCT02027376|156867849|FG001|Overall Study|Death|0|||
48731279|NCT02027376|156867850|FG002|Overall Study|Death|0|||
48731280|NCT04176705|156867851|FG000|Overall Study|Withdrawal by Subject|4|||
48731281|NCT04176705|156867852|FG001|Overall Study|Withdrawal by Subject|4|||
48731282|NCT04176705|156867851|FG000|Overall Study|Death|1|||
48731283|NCT04176705|156867852|FG001|Overall Study|Death|1|||
48731284|NCT04176705|156867851|FG000|Overall Study|Lost to Follow-up|3|||
48731285|NCT04176705|156867852|FG001|Overall Study|Lost to Follow-up|3|||
48731286|NCT03104374|156867861|FG000|Overall Study|Adverse Event|7|||
48731287|NCT03104374|156867862|FG001|Overall Study|Adverse Event|6|||
48731288|NCT03104374|156867863|FG002|Overall Study|Adverse Event|12|||
48824030|NCT01237678|157195537|FG002|Phase II|Randomized but were not treated|3|||
48601168|NCT03589807|156396059|FG004|Overall Study|Withdrawal by Subject|0|||
48601169|NCT03589807|156396060|FG005|Overall Study|Withdrawal by Subject|0|||
48601170|NCT03589807|156396055|FG000|Overall Study|Protocol Violation|0|||
48601171|NCT03589807|156396056|FG001|Overall Study|Protocol Violation|0|||
48601172|NCT03589807|156396057|FG002|Overall Study|Protocol Violation|0|||
48383806|NCT00763971|155601438|FG001|Overall Study|Lack of availability|1|||
48383807|NCT00763971|155601439|FG002|Overall Study|Lack of availability|0|||
48601173|NCT03589807|156396058|FG003|Overall Study|Protocol Violation|1|||
48601174|NCT03589807|156396059|FG004|Overall Study|Protocol Violation|0|||
48601175|NCT03589807|156396060|FG005|Overall Study|Protocol Violation|0|||
48520421|NCT04320745|156096344|FG000|Overall Study|Adverse Event|26|||
48520422|NCT04320745|156096344|FG000|Overall Study|Withdrawal by Subject|4|||
48520423|NCT04320745|156096344|FG000|Overall Study|Lost to Follow-up|12|||
48520424|NCT04320745|156096344|FG000|Overall Study|Protocol Deviation|2|||
48520425|NCT04320745|156096344|FG000|Overall Study|Non-compliance With Study Drug|2|||
48520426|NCT04320745|156096344|FG000|Overall Study|Reason Not Specified|1|||
48520427|NCT01824498|156096345|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
48520428|NCT01824498|156096346|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
48601176|NCT03589807|156396055|FG000|Overall Study|Enrolled but treatment not administered|0|||
48824031|NCT02412761|157195538|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48601177|NCT03589807|156396056|FG001|Overall Study|Enrolled but treatment not administered|0|||
48601178|NCT03589807|156396057|FG002|Overall Study|Enrolled but treatment not administered|0|||
48601179|NCT03589807|156396058|FG003|Overall Study|Enrolled but treatment not administered|0|||
48601180|NCT03589807|156396059|FG004|Overall Study|Enrolled but treatment not administered|1|||
48601181|NCT03589807|156396060|FG005|Overall Study|Enrolled but treatment not administered|0|||
48601182|NCT01076543|156396062|FG000|Overall Study|Withdrawal by Subject|2|||
48601183|NCT01076543|156396063|FG001|Overall Study|Withdrawal by Subject|0|||
48601184|NCT01076543|156396064|FG002|Overall Study|Withdrawal by Subject|0|||
48601185|NCT01076543|156396065|FG003|Overall Study|Withdrawal by Subject|0|||
48383808|NCT00763971|155601437|FG000|Overall Study|Performed final visit on phone|0|||
48383809|NCT00763971|155601438|FG001|Overall Study|Performed final visit on phone|1|||
48383810|NCT00763971|155601439|FG002|Overall Study|Performed final visit on phone|0|||
48383811|NCT00763971|155601437|FG000|Overall Study|Participation in 489-326 required|1|||
48383812|NCT00763971|155601438|FG001|Overall Study|Participation in 489-326 required|0|||
48601186|NCT01076543|156396066|FG004|Overall Study|Withdrawal by Subject|0|||
48601187|NCT01076543|156396067|FG005|Overall Study|Withdrawal by Subject|0|||
48383813|NCT00763971|155601439|FG002|Overall Study|Participation in 489-326 required|0|||
48383814|NCT01383161|155601442|FG000|Overall Study|Adverse Event|5|||
48383815|NCT01383161|155601443|FG001|Overall Study|Adverse Event|1|||
48383816|NCT01383161|155601442|FG000|Overall Study|Withdrawal by Subject|0|||
48520429|NCT01824498|156096347|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
48520430|NCT01824498|156096348|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
48520431|NCT01824498|156096349|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
48601188|NCT01630135|156396068|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
48601189|NCT01630135|156396069|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
48824032|NCT02412761|157195539|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48824033|NCT02412761|157195540|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48824034|NCT02412761|157195541|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48824035|NCT02412761|157195542|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48824036|NCT02412761|157195543|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48824037|NCT00562965|157195551|FG000|Overall Study|Withdrawal by Subject|0|||
48824038|NCT00562965|157195552|FG001|Overall Study|Withdrawal by Subject|1|||
48824039|NCT00562965|157195551|FG000|Overall Study|Death|2|||
48824040|NCT00562965|157195552|FG001|Overall Study|Death|4|||
48824041|NCT00562965|157195551|FG000|Overall Study|Lost to Follow-up|1|||
48824042|NCT00562965|157195552|FG001|Overall Study|Lost to Follow-up|0|||
48824043|NCT00562965|157195551|FG000|Overall Study|Other|0|||
48601190|NCT04396626|156396077|FG000|Overall Study|Premature termination of study|975|||
48601191|NCT02782741|156396080|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
48601192|NCT02782741|156396081|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
48601193|NCT02782741|156396082|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
48601194|NCT02782741|156396080|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
48601195|NCT02782741|156396081|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
48601196|NCT02782741|156396082|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
48601197|NCT02782741|156396080|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
48601198|NCT02782741|156396081|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
48824044|NCT00562965|157195552|FG001|Overall Study|Other|1|||
48824045|NCT01657682|157195553|FG000|Overall Study|Lost to Follow-up|1|||
48824046|NCT01657682|157195554|FG001|Overall Study|Lost to Follow-up|0|||
48824047|NCT01657682|157195555|FG002|Overall Study|Lost to Follow-up|0|||
48824048|NCT01657682|157195553|FG000|Overall Study|Withdrawal by Subject|0|||
48824049|NCT01657682|157195554|FG001|Overall Study|Withdrawal by Subject|1|||
48383817|NCT01383161|155601443|FG001|Overall Study|Withdrawal by Subject|2|||
48824050|NCT01657682|157195555|FG002|Overall Study|Withdrawal by Subject|1|||
48824051|NCT01657682|157195553|FG000|Overall Study|Adverse Event|0|||
48824052|NCT01657682|157195554|FG001|Overall Study|Adverse Event|1|||
48824053|NCT01657682|157195555|FG002|Overall Study|Adverse Event|0|||
48824054|NCT00958009|157195558|FG000|Overall Study|Adverse Event|1|||
48824055|NCT00958009|157195558|FG000|Overall Study|Subject found device difficult to use|1|||
48824056|NCT00821236|157195565|FG000|Overall Study|Lost to Follow-up|3|||
48824057|NCT00859014|157195568|FG000|Overall Study|Death|4|||
48824058|NCT00859014|157195568|FG000|Overall Study|Lost to Follow-up|1|||
48601199|NCT02782741|156396082|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
48601200|NCT02782741|156396080|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
48601201|NCT02782741|156396081|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
48601202|NCT02782741|156396082|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
48601203|NCT02782741|156396080|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
48601204|NCT02782741|156396081|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
48601205|NCT02782741|156396082|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
48731289|NCT03104374|156867864|FG003|Overall Study|Adverse Event|15|||
48731290|NCT03104374|156867861|FG000|Overall Study|Withdrawal by Subject|18|||
48731291|NCT03104374|156867862|FG001|Overall Study|Withdrawal by Subject|10|||
48731292|NCT03104374|156867863|FG002|Overall Study|Withdrawal by Subject|10|||
48731293|NCT03104374|156867864|FG003|Overall Study|Withdrawal by Subject|17|||
48731294|NCT03104374|156867861|FG000|Overall Study|Lost to Follow-up|4|||
48731295|NCT03104374|156867862|FG001|Overall Study|Lost to Follow-up|4|||
48731296|NCT03104374|156867863|FG002|Overall Study|Lost to Follow-up|6|||
48731297|NCT03104374|156867864|FG003|Overall Study|Lost to Follow-up|8|||
48731298|NCT03104374|156867861|FG000|Overall Study|Lack of Efficacy|6|||
48731299|NCT03104374|156867862|FG001|Overall Study|Lack of Efficacy|7|||
48731300|NCT03104374|156867863|FG002|Overall Study|Lack of Efficacy|12|||
48731301|NCT03104374|156867864|FG003|Overall Study|Lack of Efficacy|6|||
48731302|NCT03104374|156867861|FG000|Overall Study|Other|2|||
48731303|NCT03104374|156867862|FG001|Overall Study|Other|2|||
48731304|NCT03104374|156867863|FG002|Overall Study|Other|4|||
48731305|NCT03104374|156867864|FG003|Overall Study|Other|7|||
48731306|NCT01602380|156867865|FG000|Overall Study|Death|147|||
48731307|NCT01602380|156867866|FG001|Overall Study|Death|145|||
48731308|NCT01602380|156867865|FG000|Overall Study|Withdrawal by Subject|39|||
48731309|NCT01602380|156867866|FG001|Overall Study|Withdrawal by Subject|41|||
48731310|NCT01602380|156867865|FG000|Overall Study|Lost to Follow-up|15|||
48731311|NCT01602380|156867866|FG001|Overall Study|Lost to Follow-up|12|||
48731312|NCT01602380|156867865|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48731313|NCT01602380|156867866|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
48731314|NCT01602380|156867865|FG000|Overall Study|Other|2|||
48731315|NCT01602380|156867866|FG001|Overall Study|Other|0|||
48731316|NCT02612129|156867867|FG000|Single Dose Treatment Period|Screening Failure|1|||
48731317|NCT02612129|156867868|FG001|Single Dose Treatment Period|Screening Failure|0|||
48731318|NCT02612129|156867869|FG002|Single Dose Treatment Period|Screening Failure|0|||
48731319|NCT02612129|156867867|FG000|Continuous Treatment Period|Early Escape|0|||
48731320|NCT02612129|156867868|FG001|Continuous Treatment Period|Early Escape|2|||
48731321|NCT02612129|156867869|FG002|Continuous Treatment Period|Early Escape|0|||
48731322|NCT02612129|156867867|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
48731323|NCT02612129|156867868|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
48731324|NCT02612129|156867869|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
48731325|NCT02612129|156867867|FG000|Continuous Treatment Period|Safety Reasons|0|||
48731326|NCT02612129|156867868|FG001|Continuous Treatment Period|Safety Reasons|3|||
48731327|NCT02612129|156867869|FG002|Continuous Treatment Period|Safety Reasons|0|||
48601206|NCT01705977|156396083|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
48731328|NCT02612129|156867867|FG000|Continuous Treatment Period|Death|0|||
48731329|NCT02612129|156867868|FG001|Continuous Treatment Period|Death|1|||
48731330|NCT02612129|156867869|FG002|Continuous Treatment Period|Death|0|||
48731331|NCT02612129|156867867|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
48731332|NCT02612129|156867868|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
48731333|NCT02612129|156867869|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
48731334|NCT02557295|156867870|FG000|Overall Study|Withdrawal by Subject|9|||
48731335|NCT02557295|156867871|FG001|Overall Study|Withdrawal by Subject|2|||
48731336|NCT02557295|156867872|FG002|Overall Study|Withdrawal by Subject|4|||
48731337|NCT02557295|156867873|FG003|Overall Study|Withdrawal by Subject|0|||
48731338|NCT02557295|156867874|FG004|Overall Study|Withdrawal by Subject|0|||
48824059|NCT00410384|157195569|FG000|Overall Study|Withdrawal by Subject|28|||
48824060|NCT00410384|157195570|FG001|Overall Study|Withdrawal by Subject|17|||
48731339|NCT02557295|156867875|FG005|Overall Study|Withdrawal by Subject|0|||
48731340|NCT02557295|156867876|FG006|Overall Study|Withdrawal by Subject|15|||
48731341|NCT02557295|156867877|FG007|Overall Study|Withdrawal by Subject|1|||
48731342|NCT02557295|156867878|FG008|Overall Study|Withdrawal by Subject|3|||
48731343|NCT02557295|156867870|FG000|Overall Study|Disease Progression|0|||
48731344|NCT02557295|156867871|FG001|Overall Study|Disease Progression|0|||
48731345|NCT02557295|156867872|FG002|Overall Study|Disease Progression|0|||
48731346|NCT02557295|156867873|FG003|Overall Study|Disease Progression|0|||
48731347|NCT02557295|156867874|FG004|Overall Study|Disease Progression|0|||
48731348|NCT02557295|156867875|FG005|Overall Study|Disease Progression|0|||
48731349|NCT02557295|156867876|FG006|Overall Study|Disease Progression|1|||
48731350|NCT02557295|156867877|FG007|Overall Study|Disease Progression|0|||
48731351|NCT02557295|156867878|FG008|Overall Study|Disease Progression|0|||
48731352|NCT02557295|156867870|FG000|Overall Study|Lack of Efficacy|24|||
48731353|NCT02557295|156867871|FG001|Overall Study|Lack of Efficacy|1|||
48731354|NCT02557295|156867872|FG002|Overall Study|Lack of Efficacy|3|||
48731355|NCT02557295|156867873|FG003|Overall Study|Lack of Efficacy|0|||
48731356|NCT02557295|156867874|FG004|Overall Study|Lack of Efficacy|0|||
48731357|NCT02557295|156867875|FG005|Overall Study|Lack of Efficacy|0|||
48731358|NCT02557295|156867876|FG006|Overall Study|Lack of Efficacy|12|||
48731359|NCT02557295|156867877|FG007|Overall Study|Lack of Efficacy|1|||
48731360|NCT02557295|156867878|FG008|Overall Study|Lack of Efficacy|0|||
48731361|NCT02557295|156867870|FG000|Overall Study|Adverse Event|16|||
48731362|NCT02557295|156867871|FG001|Overall Study|Adverse Event|2|||
48731363|NCT02557295|156867872|FG002|Overall Study|Adverse Event|3|||
48731364|NCT02557295|156867873|FG003|Overall Study|Adverse Event|0|||
48731365|NCT02557295|156867874|FG004|Overall Study|Adverse Event|0|||
48731366|NCT02557295|156867875|FG005|Overall Study|Adverse Event|0|||
48731367|NCT02557295|156867876|FG006|Overall Study|Adverse Event|2|||
48731368|NCT02557295|156867877|FG007|Overall Study|Adverse Event|1|||
48731369|NCT02557295|156867878|FG008|Overall Study|Adverse Event|1|||
48731370|NCT02557295|156867870|FG000|Overall Study|Lost to Follow-up|4|||
48731371|NCT02557295|156867871|FG001|Overall Study|Lost to Follow-up|0|||
48731372|NCT02557295|156867872|FG002|Overall Study|Lost to Follow-up|0|||
48731373|NCT02557295|156867873|FG003|Overall Study|Lost to Follow-up|0|||
48731374|NCT02557295|156867874|FG004|Overall Study|Lost to Follow-up|0|||
48731375|NCT02557295|156867875|FG005|Overall Study|Lost to Follow-up|0|||
48731376|NCT02557295|156867876|FG006|Overall Study|Lost to Follow-up|9|||
48731377|NCT02557295|156867877|FG007|Overall Study|Lost to Follow-up|0|||
48731378|NCT02557295|156867878|FG008|Overall Study|Lost to Follow-up|0|||
48731379|NCT02557295|156867870|FG000|Overall Study|Study Close|54|||
48731380|NCT02557295|156867871|FG001|Overall Study|Study Close|3|||
48731381|NCT02557295|156867872|FG002|Overall Study|Study Close|5|||
48731382|NCT02557295|156867873|FG003|Overall Study|Study Close|3|||
48731383|NCT02557295|156867874|FG004|Overall Study|Study Close|0|||
48731384|NCT02557295|156867875|FG005|Overall Study|Study Close|0|||
48731385|NCT02557295|156867876|FG006|Overall Study|Study Close|37|||
48731386|NCT02557295|156867877|FG007|Overall Study|Study Close|3|||
48731387|NCT02557295|156867878|FG008|Overall Study|Study Close|19|||
48731388|NCT02557295|156867870|FG000|Overall Study|except for study close|4|||
48824061|NCT00410384|157195571|FG002|Overall Study|Withdrawal by Subject|20|||
48520432|NCT01824498|156096350|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
48520433|NCT01567527|156096351|FG000|Conversion Phase.|Protocol deviation|3|||
48520434|NCT01567527|156096352|FG001|Conversion Phase.|Protocol deviation|0|||
48520435|NCT01567527|156096353|FG002|Conversion Phase.|Protocol deviation|0|||
48520436|NCT01567527|156096354|FG003|Conversion Phase.|Protocol deviation|0|||
48520437|NCT01567527|156096355|FG004|Conversion Phase.|Protocol deviation|0|||
48520438|NCT01567527|156096351|FG000|Conversion Phase.|Met withdrawal criteria|10|||
48520439|NCT01567527|156096352|FG001|Conversion Phase.|Met withdrawal criteria|0|||
48520440|NCT01567527|156096353|FG002|Conversion Phase.|Met withdrawal criteria|0|||
48520441|NCT01567527|156096354|FG003|Conversion Phase.|Met withdrawal criteria|0|||
48520442|NCT01567527|156096355|FG004|Conversion Phase.|Met withdrawal criteria|0|||
48520443|NCT01567527|156096351|FG000|Conversion Phase.|Withdrawal by Subject|32|||
48520444|NCT01567527|156096352|FG001|Conversion Phase.|Withdrawal by Subject|0|||
48520445|NCT01567527|156096353|FG002|Conversion Phase.|Withdrawal by Subject|0|||
48520446|NCT01567527|156096354|FG003|Conversion Phase.|Withdrawal by Subject|0|||
48601207|NCT01705977|156396084|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
48601208|NCT01705977|156396083|FG000|Treatment Period (Year 1)|Adverse Event|57|||
48601209|NCT01705977|156396084|FG001|Treatment Period (Year 1)|Adverse Event|49|||
48601210|NCT01705977|156396083|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
48601211|NCT01705977|156396084|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
48601212|NCT01705977|156396083|FG000|Treatment Period (Year 1)|Site closure|3|||
48601213|NCT01705977|156396084|FG001|Treatment Period (Year 1)|Site closure|2|||
48731389|NCT02557295|156867871|FG001|Overall Study|except for study close|0|||
48731390|NCT02557295|156867872|FG002|Overall Study|except for study close|0|||
48731391|NCT02557295|156867873|FG003|Overall Study|except for study close|0|||
48731392|NCT02557295|156867874|FG004|Overall Study|except for study close|0|||
48731393|NCT02557295|156867875|FG005|Overall Study|except for study close|0|||
48824062|NCT00410384|157195569|FG000|Overall Study|Adverse Event|23|||
48731394|NCT02557295|156867876|FG006|Overall Study|except for study close|5|||
48731395|NCT02557295|156867877|FG007|Overall Study|except for study close|1|||
48731396|NCT02557295|156867878|FG008|Overall Study|except for study close|0|||
48601214|NCT01705977|156396083|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
48601215|NCT01705977|156396084|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
48601216|NCT01705977|156396083|FG000|Treatment Period (Year 1)|Physician Decision|48|||
48731397|NCT04340193|156867879|FG000|Overall Study|Other reason|0|||
48731398|NCT04340193|156867880|FG001|Overall Study|Other reason|0|||
48731399|NCT04340193|156867881|FG002|Overall Study|Other reason|1|||
48731400|NCT04340193|156867879|FG000|Overall Study|Disease recurrence|0|||
48731401|NCT04340193|156867880|FG001|Overall Study|Disease recurrence|1|||
48731402|NCT04340193|156867881|FG002|Overall Study|Disease recurrence|0|||
48731403|NCT04340193|156867879|FG000|Overall Study|Study drug toxicity|1|||
48731404|NCT04340193|156867880|FG001|Overall Study|Study drug toxicity|0|||
48731405|NCT04340193|156867881|FG002|Overall Study|Study drug toxicity|0|||
48731406|NCT04340193|156867879|FG000|Overall Study|Disease progression|1|||
48731407|NCT04340193|156867880|FG001|Overall Study|Disease progression|2|||
48731408|NCT04340193|156867881|FG002|Overall Study|Disease progression|3|||
48731409|NCT04340193|156867879|FG000|Overall Study|Administrative reasons by sponsor|0|||
48731410|NCT04340193|156867880|FG001|Overall Study|Administrative reasons by sponsor|1|||
48731411|NCT04340193|156867881|FG002|Overall Study|Administrative reasons by sponsor|0|||
48731412|NCT04340193|156867879|FG000|Overall Study|Adverse Event|1|||
48731413|NCT04340193|156867880|FG001|Overall Study|Adverse Event|1|||
48731414|NCT04340193|156867881|FG002|Overall Study|Adverse Event|0|||
48601217|NCT01705977|156396084|FG001|Treatment Period (Year 1)|Physician Decision|38|||
48601218|NCT01705977|156396083|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
48601219|NCT01705977|156396084|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
48601220|NCT01705977|156396083|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
48601221|NCT01705977|156396084|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
48601222|NCT01705977|156396083|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
48601223|NCT01705977|156396084|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
48601224|NCT01705977|156396083|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
48601225|NCT01705977|156396084|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
48601226|NCT01705977|156396083|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
48601227|NCT01705977|156396084|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
48601228|NCT01705977|156396083|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
48601229|NCT01705977|156396084|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
48601230|NCT02989402|156396085|FG000|Overall Study|Adverse event, or serious adverse event|4|||
48601231|NCT02989402|156396085|FG000|Overall Study|Death|2|||
48601232|NCT02989402|156396085|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
48601233|NCT02989402|156396085|FG000|Overall Study|Lost to Follow-up|8|||
48601234|NCT02989402|156396085|FG000|Overall Study|Patient no longer on monotherapy|1|||
48601235|NCT02989402|156396085|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
48601236|NCT02989402|156396085|FG000|Overall Study|Withdrawal by Subject|7|||
48601237|NCT02989402|156396085|FG000|Overall Study|Other|2|||
48601238|NCT01419314|156396088|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
48601239|NCT01419314|156396089|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
48601240|NCT01419314|156396088|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
48601241|NCT01419314|156396089|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
48601242|NCT01419314|156396088|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
48601243|NCT01419314|156396089|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
48601244|NCT03372798|156396101|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
48601245|NCT03372798|156396102|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
48601246|NCT03372798|156396101|FG000|Overall Study|Failure of imaging probe|0|||
48601247|NCT03372798|156396102|FG001|Overall Study|Failure of imaging probe|1|||
48601248|NCT03188055|156396103|FG000|Overall Study|Unavailable for training|0|||
48601249|NCT03188055|156396104|FG001|Overall Study|Unavailable for training|0|||
48601250|NCT03188055|156396105|FG002|Overall Study|Unavailable for training|19|||
48601251|NCT03188055|156396106|FG003|Overall Study|Unavailable for training|0|||
48601252|NCT03188055|156396107|FG004|Overall Study|Unavailable for training|0|||
48601253|NCT03188055|156396108|FG005|Overall Study|Unavailable for training|0|||
48601254|NCT03188055|156396103|FG000|Overall Study|Lost to Follow-up|0|||
48601255|NCT03188055|156396104|FG001|Overall Study|Lost to Follow-up|18|||
48601256|NCT03188055|156396105|FG002|Overall Study|Lost to Follow-up|0|||
48601257|NCT03188055|156396106|FG003|Overall Study|Lost to Follow-up|11|||
48601258|NCT03188055|156396107|FG004|Overall Study|Lost to Follow-up|0|||
48601259|NCT03188055|156396108|FG005|Overall Study|Lost to Follow-up|0|||
48601260|NCT03188055|156396103|FG000|Overall Study|Withdrawal by Subject|0|||
48601261|NCT03188055|156396104|FG001|Overall Study|Withdrawal by Subject|1|||
48601262|NCT03188055|156396105|FG002|Overall Study|Withdrawal by Subject|0|||
48731415|NCT00976677|156867884|FG000|Overall Study|Adverse Event|1|||
48731416|NCT00976677|156867885|FG001|Overall Study|Adverse Event|0|||
48731417|NCT00976677|156867884|FG000|Overall Study|Withdrawal by Subject|0|||
48731418|NCT00976677|156867885|FG001|Overall Study|Withdrawal by Subject|2|||
48731419|NCT00976677|156867884|FG000|Overall Study|Disease progression|1|||
48731420|NCT00976677|156867885|FG001|Overall Study|Disease progression|1|||
48731421|NCT00976677|156867884|FG000|Overall Study|Trial unblinded|2|||
48824063|NCT00410384|157195570|FG001|Overall Study|Adverse Event|18|||
48824064|NCT00410384|157195571|FG002|Overall Study|Adverse Event|23|||
48824065|NCT00410384|157195569|FG000|Overall Study|Lack of Efficacy|20|||
48824066|NCT00410384|157195570|FG001|Overall Study|Lack of Efficacy|12|||
48824067|NCT00410384|157195571|FG002|Overall Study|Lack of Efficacy|17|||
48520447|NCT01567527|156096355|FG004|Conversion Phase.|Withdrawal by Subject|0|||
48520448|NCT01567527|156096351|FG000|Conversion Phase.|Lost to Follow-up|16|||
48824068|NCT00410384|157195569|FG000|Overall Study|Lack of Compliance|2|||
48824069|NCT00410384|157195570|FG001|Overall Study|Lack of Compliance|2|||
48824070|NCT00410384|157195571|FG002|Overall Study|Lack of Compliance|2|||
48824071|NCT00410384|157195569|FG000|Overall Study|Lost to Follow-up|4|||
48824072|NCT00410384|157195570|FG001|Overall Study|Lost to Follow-up|6|||
48824073|NCT00410384|157195571|FG002|Overall Study|Lost to Follow-up|6|||
48824074|NCT00410384|157195569|FG000|Overall Study|Protocol Violation|6|||
48824075|NCT00410384|157195570|FG001|Overall Study|Protocol Violation|6|||
48824076|NCT00410384|157195571|FG002|Overall Study|Protocol Violation|6|||
48824077|NCT00410384|157195569|FG000|Overall Study|Physician Decision|3|||
48824078|NCT00410384|157195570|FG001|Overall Study|Physician Decision|3|||
48824079|NCT00410384|157195571|FG002|Overall Study|Physician Decision|4|||
48824080|NCT00410384|157195569|FG000|Overall Study|Other|3|||
48824081|NCT00410384|157195570|FG001|Overall Study|Other|8|||
48824082|NCT00410384|157195571|FG002|Overall Study|Other|4|||
48824083|NCT01027871|157195577|FG000|Overall Study|Physician Decision|1|||
48824084|NCT01027871|157195578|FG001|Overall Study|Physician Decision|5|||
48824085|NCT01027871|157195579|FG002|Overall Study|Physician Decision|0|||
48824086|NCT01027871|157195577|FG000|Overall Study|Protocol Violation|0|||
48824087|NCT01027871|157195578|FG001|Overall Study|Protocol Violation|2|||
48824088|NCT01027871|157195579|FG002|Overall Study|Protocol Violation|2|||
48824089|NCT01027871|157195577|FG000|Overall Study|Withdrawal by Subject|1|||
48824090|NCT01027871|157195578|FG001|Overall Study|Withdrawal by Subject|2|||
48824091|NCT01027871|157195579|FG002|Overall Study|Withdrawal by Subject|2|||
48824092|NCT01027871|157195577|FG000|Overall Study|Adverse Event|0|||
48824093|NCT01027871|157195578|FG001|Overall Study|Adverse Event|2|||
48824094|NCT01027871|157195579|FG002|Overall Study|Adverse Event|2|||
48824095|NCT01027871|157195577|FG000|Overall Study|Sponsor Decision|0|||
48824096|NCT01027871|157195578|FG001|Overall Study|Sponsor Decision|2|||
48824097|NCT01027871|157195579|FG002|Overall Study|Sponsor Decision|0|||
48824098|NCT01027871|157195577|FG000|Overall Study|Discontinued Prior to Treatment|0|||
48824099|NCT01027871|157195578|FG001|Overall Study|Discontinued Prior to Treatment|0|||
48824100|NCT01027871|157195579|FG002|Overall Study|Discontinued Prior to Treatment|1|||
48824101|NCT02084082|157195582|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
48824102|NCT02084082|157195583|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
48824103|NCT02084082|157195584|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
48824104|NCT02084082|157195585|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
48824105|NCT02084082|157195582|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48824106|NCT02084082|157195583|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48824107|NCT02084082|157195584|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48824108|NCT02084082|157195585|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
48824109|NCT01767909|157195588|FG000|Overall Study|Withdrawal by Subject|4|||
48520449|NCT01567527|156096352|FG001|Conversion Phase.|Lost to Follow-up|0|||
48520450|NCT01567527|156096353|FG002|Conversion Phase.|Lost to Follow-up|0|||
48520451|NCT01567527|156096354|FG003|Conversion Phase.|Lost to Follow-up|0|||
48520452|NCT01567527|156096355|FG004|Conversion Phase.|Lost to Follow-up|0|||
48520453|NCT01567527|156096351|FG000|Conversion Phase.|Lack of Efficacy|2|||
48520454|NCT01567527|156096352|FG001|Conversion Phase.|Lack of Efficacy|0|||
48520455|NCT01567527|156096353|FG002|Conversion Phase.|Lack of Efficacy|0|||
48520456|NCT01567527|156096354|FG003|Conversion Phase.|Lack of Efficacy|0|||
48520457|NCT01567527|156096355|FG004|Conversion Phase.|Lack of Efficacy|0|||
48520458|NCT01567527|156096351|FG000|Conversion Phase.|Adverse Event|33|||
48520459|NCT01567527|156096352|FG001|Conversion Phase.|Adverse Event|0|||
48520460|NCT01567527|156096353|FG002|Conversion Phase.|Adverse Event|0|||
48520461|NCT01567527|156096354|FG003|Conversion Phase.|Adverse Event|0|||
48520462|NCT01567527|156096355|FG004|Conversion Phase.|Adverse Event|0|||
48520463|NCT01567527|156096351|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
48824110|NCT01767909|157195589|FG001|Overall Study|Withdrawal by Subject|7|||
48824111|NCT01767909|157195588|FG000|Overall Study|Adverse Event|3|||
48520464|NCT01567527|156096352|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
48520465|NCT01567527|156096353|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
48520466|NCT01567527|156096354|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
48824112|NCT01767909|157195589|FG001|Overall Study|Adverse Event|1|||
48824113|NCT01767909|157195588|FG000|Overall Study|Withdrawal by Study Partner|3|||
48824114|NCT01767909|157195589|FG001|Overall Study|Withdrawal by Study Partner|1|||
48824115|NCT01767909|157195588|FG000|Overall Study|Non-Compliance|2|||
48824116|NCT01767909|157195589|FG001|Overall Study|Non-Compliance|0|||
48824117|NCT01767909|157195588|FG000|Overall Study|Perceived Lack of Efficacy|1|||
48520467|NCT01567527|156096355|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
48824118|NCT01767909|157195589|FG001|Overall Study|Perceived Lack of Efficacy|0|||
48824119|NCT01767909|157195588|FG000|Overall Study|Investigator Recommendation|0|||
48601263|NCT03188055|156396106|FG003|Overall Study|Withdrawal by Subject|1|||
48601264|NCT03188055|156396107|FG004|Overall Study|Withdrawal by Subject|0|||
48601265|NCT03188055|156396108|FG005|Overall Study|Withdrawal by Subject|0|||
48601266|NCT04030598|156396109|FG000|Overall Study|Voluntary Withdrawal|0|||
48601267|NCT04030598|156396110|FG001|Overall Study|Voluntary Withdrawal|1|||
48824120|NCT01767909|157195589|FG001|Overall Study|Investigator Recommendation|1|||
48824121|NCT01767909|157195588|FG000|Overall Study|Lost to Follow-up|0|||
48824122|NCT01767909|157195589|FG001|Overall Study|Lost to Follow-up|1|||
48824123|NCT01767909|157195588|FG000|Overall Study|LP uncessessful|0|||
48824124|NCT01767909|157195589|FG001|Overall Study|LP uncessessful|1|||
48824125|NCT00654238|157195595|FG000|Overall Study|Screen Failures|4|||
48824126|NCT02320253|157195599|FG000|Overall Study|Withdrawal by Subject|3|||
48824127|NCT02320253|157195600|FG001|Overall Study|Withdrawal by Subject|0|||
48824128|NCT02320253|157195601|FG002|Overall Study|Withdrawal by Subject|0|||
48824129|NCT02320253|157195599|FG000|Overall Study|Lost to Follow-up|2|||
48601268|NCT04030598|156396111|FG002|Overall Study|Voluntary Withdrawal|0|||
48601269|NCT02823470|156397540|FG000|Overall Study|Adverse Event|1|||
48601270|NCT02823470|156397541|FG001|Overall Study|Adverse Event|0|||
48601271|NCT02823470|156397540|FG000|Overall Study|Study terminated by sponsor|8|||
48601272|NCT02823470|156397541|FG001|Overall Study|Study terminated by sponsor|15|||
48601273|NCT02492165|156397544|FG000|Overall Study|Withdrawal by Subject|0|||
48601274|NCT02492165|156397545|FG001|Overall Study|Withdrawal by Subject|1|||
48601275|NCT02492165|156397546|FG002|Overall Study|Withdrawal by Subject|0|||
48601276|NCT02492165|156397547|FG003|Overall Study|Withdrawal by Subject|0|||
48601277|NCT01705080|156397548|FG000|Overall Study|Missed visit|10|||
48601278|NCT01705080|156397549|FG001|Overall Study|Missed visit|4|||
48731422|NCT00976677|156867885|FG001|Overall Study|Trial unblinded|2|||
48731423|NCT00976677|156867884|FG000|Overall Study|Unknown/Missing|1|||
48731424|NCT00976677|156867885|FG001|Overall Study|Unknown/Missing|0|||
48731425|NCT05268055|156867886|FG000|Overall Study|Lost to Follow-up|68|||
48731426|NCT05268055|156867887|FG001|Overall Study|Lost to Follow-up|68|||
48731427|NCT05268055|156867886|FG000|Overall Study|Withdrawal by Subject|12|||
48731428|NCT05268055|156867887|FG001|Overall Study|Withdrawal by Subject|8|||
48731429|NCT01555983|156867888|FG000|Overall Study|Withdrawal by Subject|1|||
48731430|NCT01555983|156867889|FG001|Overall Study|Withdrawal by Subject|0|||
48731431|NCT01555983|156867890|FG002|Overall Study|Withdrawal by Subject|0|||
48731432|NCT01555983|156867891|FG003|Overall Study|Withdrawal by Subject|0|||
48731433|NCT01555983|156867892|FG004|Overall Study|Withdrawal by Subject|1|||
48731434|NCT01555983|156867893|FG005|Overall Study|Withdrawal by Subject|1|||
48731435|NCT03148275|156867894|FG000|Overall Study|Death|6|||
48731436|NCT03148275|156867894|FG000|Overall Study|Adverse Event|3|||
48731437|NCT03148275|156867894|FG000|Overall Study|Liver transplant|2|||
48731438|NCT03148275|156867894|FG000|Overall Study|Patient decision|5|||
48731439|NCT03148275|156867894|FG000|Overall Study|transition to commercial drug|1|||
48731440|NCT03148275|156867894|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
48731441|NCT03332771|156869407|FG000|Overall Study|Adverse Event|6|||
48731442|NCT03332771|156869408|FG001|Overall Study|Adverse Event|4|||
48731443|NCT03332771|156869409|FG002|Overall Study|Adverse Event|1|||
48731444|NCT03332771|156869410|FG003|Overall Study|Adverse Event|3|||
48731445|NCT03332771|156869407|FG000|Overall Study|Poor Compliance to Protocol|0|||
48731446|NCT03332771|156869408|FG001|Overall Study|Poor Compliance to Protocol|1|||
48731447|NCT03332771|156869409|FG002|Overall Study|Poor Compliance to Protocol|0|||
48731448|NCT03332771|156869410|FG003|Overall Study|Poor Compliance to Protocol|1|||
48731449|NCT03332771|156869407|FG000|Overall Study|Lost to Follow-up|2|||
48731450|NCT03332771|156869408|FG001|Overall Study|Lost to Follow-up|2|||
48731451|NCT03332771|156869409|FG002|Overall Study|Lost to Follow-up|1|||
48731452|NCT03332771|156869410|FG003|Overall Study|Lost to Follow-up|2|||
48731453|NCT03332771|156869407|FG000|Overall Study|At the Participant's own request|20|||
48731454|NCT03332771|156869408|FG001|Overall Study|At the Participant's own request|26|||
48731455|NCT03332771|156869409|FG002|Overall Study|At the Participant's own request|14|||
48731456|NCT03332771|156869410|FG003|Overall Study|At the Participant's own request|23|||
48731457|NCT03332771|156869407|FG000|Overall Study|Reason Not Specified|6|||
48731458|NCT03332771|156869408|FG001|Overall Study|Reason Not Specified|18|||
48731459|NCT03332771|156869409|FG002|Overall Study|Reason Not Specified|16|||
48731460|NCT03332771|156869410|FG003|Overall Study|Reason Not Specified|19|||
48731461|NCT03875118|156869415|FG000|Overall Study|Withdrawal by Subject|4|||
48731462|NCT03875118|156869416|FG001|Overall Study|Withdrawal by Subject|4|||
48731463|NCT02213926|156869419|FG000|Overall Study|Death|59|||
48731464|NCT02213926|156869419|FG000|Overall Study|Withdrawal by Subject|10|||
48731465|NCT02213926|156869419|FG000|Overall Study|study terminated by sponsor|51|||
48731466|NCT02213926|156869419|FG000|Overall Study|Lost to Follow-up|3|||
48731467|NCT02213926|156869419|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
48731468|NCT00423670|156869421|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
48601279|NCT01705080|156397550|FG002|Overall Study|Missed visit|1|||
48824130|NCT02320253|157195600|FG001|Overall Study|Lost to Follow-up|2|||
48824131|NCT02320253|157195601|FG002|Overall Study|Lost to Follow-up|1|||
48824132|NCT02320253|157195599|FG000|Overall Study|Death|1|||
48824133|NCT02320253|157195600|FG001|Overall Study|Death|0|||
48824134|NCT02320253|157195601|FG002|Overall Study|Death|1|||
48824135|NCT05750745|157195602|FG000|Overall Study|Adverse Event|1|||
48824136|NCT05750745|157195603|FG001|Overall Study|Adverse Event|0|||
48824137|NCT05750745|157195604|FG002|Overall Study|Adverse Event|0|||
48824138|NCT05750745|157195602|FG000|Overall Study|Protocol Violation|1|||
48824139|NCT05750745|157195603|FG001|Overall Study|Protocol Violation|0|||
48824140|NCT05750745|157195604|FG002|Overall Study|Protocol Violation|0|||
48824141|NCT05750745|157195602|FG000|Overall Study|Withdrawal by Subject|0|||
48824142|NCT05750745|157195603|FG001|Overall Study|Withdrawal by Subject|1|||
48824143|NCT05750745|157195604|FG002|Overall Study|Withdrawal by Subject|0|||
48824144|NCT05196737|157195605|FG000|Non-intervention Week|Lost to Follow-up|2|||
48824145|NCT05196737|157195605|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
48824146|NCT02926937|157195606|FG000|Overall Study|Adverse Event|0|||
48824147|NCT02926937|157195607|FG001|Overall Study|Adverse Event|1|||
48824148|NCT02926937|157195608|FG002|Overall Study|Adverse Event|1|||
48824149|NCT02926937|157195606|FG000|Overall Study|Poor Compliance to Protocol|1|||
48824150|NCT02926937|157195607|FG001|Overall Study|Poor Compliance to Protocol|0|||
48824151|NCT02926937|157195608|FG002|Overall Study|Poor Compliance to Protocol|0|||
48824152|NCT02926937|157195606|FG000|Overall Study|Lost to Follow-up|4|||
48824153|NCT02926937|157195607|FG001|Overall Study|Lost to Follow-up|5|||
48824154|NCT02926937|157195608|FG002|Overall Study|Lost to Follow-up|0|||
48824155|NCT02926937|157195606|FG000|Overall Study|At the Participant's own Request|11|||
48824156|NCT02926937|157195607|FG001|Overall Study|At the Participant's own Request|5|||
48824157|NCT02926937|157195608|FG002|Overall Study|At the Participant's own Request|8|||
48824158|NCT02926937|157195606|FG000|Overall Study|Reason not Specified|3|||
48824159|NCT02926937|157195607|FG001|Overall Study|Reason not Specified|4|||
48824160|NCT02926937|157195608|FG002|Overall Study|Reason not Specified|2|||
48824161|NCT03824236|157195611|FG000|Overall Study|Lost to Follow-up|0|||
48824162|NCT03824236|157195612|FG001|Overall Study|Lost to Follow-up|0|||
48824163|NCT03824236|157195613|FG002|Overall Study|Lost to Follow-up|1|||
48824164|NCT00924664|157197168|FG000|Overall Study|Adverse Event|23|||
48824165|NCT00924664|157197169|FG001|Overall Study|Adverse Event|39|||
48824166|NCT00924664|157197168|FG000|Overall Study|Lack of Efficacy|10|||
48824167|NCT00924664|157197169|FG001|Overall Study|Lack of Efficacy|15|||
48824168|NCT00924664|157197168|FG000|Overall Study|Lost to Follow-up|10|||
48824169|NCT00924664|157197169|FG001|Overall Study|Lost to Follow-up|12|||
48824170|NCT00924664|157197168|FG000|Overall Study|Withdrawal by Subject|47|||
48824171|NCT00924664|157197169|FG001|Overall Study|Withdrawal by Subject|71|||
48824172|NCT00924664|157197168|FG000|Overall Study|Protocol Violation|2|||
48824173|NCT00924664|157197169|FG001|Overall Study|Protocol Violation|5|||
48520468|NCT01567527|156096351|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
48520469|NCT01567527|156096352|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
48824174|NCT00924664|157197168|FG000|Overall Study|Pregnancy|1|||
48824175|NCT00924664|157197169|FG001|Overall Study|Pregnancy|1|||
48824176|NCT00924664|157197168|FG000|Overall Study|Death|0|||
48824177|NCT00924664|157197169|FG001|Overall Study|Death|2|||
48824178|NCT00924664|157197168|FG000|Overall Study|Study terminated by sponsor|199|||
48520470|NCT01567527|156096353|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
48520471|NCT01567527|156096354|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
48520472|NCT01567527|156096355|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
48520473|NCT01567527|156096351|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
48520474|NCT01567527|156096352|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
48520475|NCT01567527|156096353|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
48520476|NCT01567527|156096354|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
48520477|NCT01567527|156096355|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
48520478|NCT01567527|156096351|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
48520479|NCT01567527|156096352|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
48520480|NCT01567527|156096353|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
48520481|NCT01567527|156096354|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
48520482|NCT01567527|156096355|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
48520483|NCT01567527|156096351|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
48520484|NCT01567527|156096352|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
48520485|NCT01567527|156096353|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
48520486|NCT01567527|156096354|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
48520487|NCT01567527|156096355|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
48520488|NCT01567527|156096351|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
48520489|NCT01567527|156096352|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
48520490|NCT01567527|156096353|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
48601280|NCT01705080|156397548|FG000|Overall Study|Death|4|||
48824179|NCT00924664|157197169|FG001|Overall Study|Study terminated by sponsor|330|||
48824180|NCT00924664|157197168|FG000|Overall Study|Other|29|||
48824181|NCT00924664|157197169|FG001|Overall Study|Other|52|||
48824182|NCT00924664|157197168|FG000|Overall Study|Randomized but not Treated|1|||
48824183|NCT00924664|157197169|FG001|Overall Study|Randomized but not Treated|0|||
48824184|NCT02107274|157197170|FG000|Treatment vs. Placebo|Adverse Event|3|||
48824185|NCT02107274|157197171|FG001|Treatment vs. Placebo|Adverse Event|0|||
48824186|NCT02107274|157197170|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
48824187|NCT02107274|157197171|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
48824188|NCT02107274|157197170|FG000|Control Phase|Lost to Follow-up|1|||
48824189|NCT02107274|157197171|FG001|Control Phase|Lost to Follow-up|1|||
48824190|NCT02107274|157197170|FG000|Control Phase|Death|2|||
48824191|NCT02107274|157197171|FG001|Control Phase|Death|0|||
48824192|NCT02107274|157197170|FG000|Control Phase|Adverse Event|0|||
48824193|NCT02107274|157197171|FG001|Control Phase|Adverse Event|1|||
48824194|NCT01616563|157197173|FG000|Overall Study|Lost to Follow-up|40|||
48824195|NCT01033643|157197174|FG000|Overall Study|Withdrew Consent|0|||
48824196|NCT01033643|157197175|FG001|Overall Study|Withdrew Consent|3|||
48824197|NCT01033643|157197176|FG002|Overall Study|Withdrew Consent|0|||
48824198|NCT01033643|157197177|FG003|Overall Study|Withdrew Consent|0|||
48824199|NCT01033643|157197178|FG004|Overall Study|Withdrew Consent|0|||
48824200|NCT01033643|157197179|FG005|Overall Study|Withdrew Consent|1|||
48824201|NCT00031447|157197183|FG000|Overall Study|Lost to Follow-up|0|||
48824202|NCT00031447|157197184|FG001|Overall Study|Lost to Follow-up|1|||
48824203|NCT00031447|157197183|FG000|Overall Study|Non-compliant|1|||
48824204|NCT00031447|157197184|FG001|Overall Study|Non-compliant|1|||
48824205|NCT00031447|157197183|FG000|Overall Study|Re-activation of Disease|2|||
48824206|NCT00031447|157197184|FG001|Overall Study|Re-activation of Disease|1|||
48824207|NCT00031447|157197183|FG000|Overall Study|Disruption of blinded study drug supply|7|||
48824208|NCT00031447|157197184|FG001|Overall Study|Disruption of blinded study drug supply|4|||
48824209|NCT00519779|157197185|FG000|Overall Study|Withdrawal by Subject|0|||
48824210|NCT00519779|157197186|FG001|Overall Study|Withdrawal by Subject|1|||
48824211|NCT00724061|157197190|FG000|Dose Escalation Phase|Adverse Event|2|||
48824212|NCT00724061|157197190|FG000|Dose Escalation Phase|Disease Progression|3|||
48601281|NCT01705080|156397549|FG001|Overall Study|Death|4|||
48601282|NCT01705080|156397550|FG002|Overall Study|Death|6|||
48601283|NCT01705080|156397548|FG000|Overall Study|Withdrawal by Subject|61|||
48601284|NCT01705080|156397549|FG001|Overall Study|Withdrawal by Subject|44|||
48601285|NCT01705080|156397550|FG002|Overall Study|Withdrawal by Subject|9|||
48601286|NCT03492437|156397556|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48601287|NCT03492437|156397557|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48601288|NCT01298700|156397558|FG000|Overall Study|Adverse Event|50|||
48601289|NCT01298700|156397559|FG001|Overall Study|Adverse Event|51|||
48601290|NCT01298700|156397558|FG000|Overall Study|Lack of Efficacy|9|||
48601291|NCT01298700|156397559|FG001|Overall Study|Lack of Efficacy|14|||
48601292|NCT01298700|156397558|FG000|Overall Study|Lost to Follow-up|5|||
48601293|NCT01298700|156397559|FG001|Overall Study|Lost to Follow-up|2|||
48601294|NCT01298700|156397558|FG000|Overall Study|Withdrawal by Subject|12|||
48601295|NCT01298700|156397559|FG001|Overall Study|Withdrawal by Subject|9|||
48601296|NCT01298700|156397558|FG000|Overall Study|Protocol Violation|6|||
48601297|NCT01298700|156397559|FG001|Overall Study|Protocol Violation|4|||
48601298|NCT01298700|156397558|FG000|Overall Study|Other Miscellaneous Reasons|16|||
48601299|NCT01298700|156397559|FG001|Overall Study|Other Miscellaneous Reasons|15|||
48601300|NCT01298700|156397558|FG000|Overall Study|Did not Receive Study Drug|3|||
48601301|NCT01298700|156397559|FG001|Overall Study|Did not Receive Study Drug|5|||
48601302|NCT04534517|156397560|FG000|Overall Study|Adverse Event|1|||
48601303|NCT04534517|156397560|FG000|Overall Study|Withdrawal by Subject|1|||
48601304|NCT04534517|156397560|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
48601305|NCT04534517|156397560|FG000|Overall Study|COVID-19 Related|1|||
48601306|NCT01716806|156397561|FG000|Overall Study|Patient withdrawal of consent|4|||
48601307|NCT01716806|156397562|FG001|Overall Study|Patient withdrawal of consent|2|||
48824213|NCT00953160|157197191|FG000|Overall Study|Lost to Follow-up|23|||
48824214|NCT00953160|157197191|FG000|Overall Study|Withdrawal by Subject|4|||
48824215|NCT02724020|157197196|FG000|Overall Study|Death|16|||
48824216|NCT02724020|157197197|FG001|Overall Study|Death|18|||
48824217|NCT02724020|157197198|FG002|Overall Study|Death|19|||
48383818|NCT01383161|155601442|FG000|Overall Study|Lack of Efficacy|0|||
48601308|NCT01716806|156397563|FG002|Overall Study|Patient withdrawal of consent|4|||
48601309|NCT01716806|156397564|FG003|Overall Study|Patient withdrawal of consent|3|||
48601310|NCT01716806|156397565|FG004|Overall Study|Patient withdrawal of consent|2|||
48601311|NCT01716806|156397566|FG005|Overall Study|Patient withdrawal of consent|0|||
48601312|NCT01716806|156397561|FG000|Overall Study|Lost to Follow-up|3|||
48601313|NCT01716806|156397562|FG001|Overall Study|Lost to Follow-up|3|||
48824218|NCT02724020|157197196|FG000|Overall Study|Lost to Follow-up|0|||
48824219|NCT02724020|157197197|FG001|Overall Study|Lost to Follow-up|3|||
48824220|NCT02724020|157197198|FG002|Overall Study|Lost to Follow-up|0|||
48824221|NCT02724020|157197196|FG000|Overall Study|Site Terminated by Sponsor|15|||
48824222|NCT02724020|157197197|FG001|Overall Study|Site Terminated by Sponsor|8|||
48824223|NCT02724020|157197198|FG002|Overall Study|Site Terminated by Sponsor|8|||
48824224|NCT02724020|157197196|FG000|Overall Study|Withdrawal by Subject|1|||
48824225|NCT02724020|157197197|FG001|Overall Study|Withdrawal by Subject|3|||
48824226|NCT02724020|157197198|FG002|Overall Study|Withdrawal by Subject|5|||
48520491|NCT01567527|156096354|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
48520492|NCT01567527|156096355|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
48520493|NCT01567527|156096351|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
48520494|NCT01567527|156096352|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
48520495|NCT01567527|156096353|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
48731469|NCT00423670|156869422|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731470|NCT00423670|156869423|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731471|NCT00423670|156869424|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731472|NCT00423670|156869425|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
48520496|NCT01567527|156096354|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
48520497|NCT01567527|156096355|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
48520498|NCT01567527|156096351|FG000|IM Depot Stabilization.|Protocol deviation|0|||
48520499|NCT01567527|156096352|FG001|IM Depot Stabilization.|Protocol deviation|0|||
48520500|NCT01567527|156096353|FG002|IM Depot Stabilization.|Protocol deviation|5|||
48520501|NCT01567527|156096354|FG003|IM Depot Stabilization.|Protocol deviation|0|||
48520502|NCT01567527|156096355|FG004|IM Depot Stabilization.|Protocol deviation|0|||
48520503|NCT01567527|156096351|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
48520504|NCT01567527|156096352|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
48520505|NCT01567527|156096353|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
48520506|NCT01567527|156096354|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
48520507|NCT01567527|156096355|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
48520508|NCT01567527|156096351|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
48520509|NCT01567527|156096352|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
48520510|NCT01567527|156096353|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
48520511|NCT01567527|156096354|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
48520512|NCT01567527|156096355|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
48520513|NCT01567527|156096351|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
48520514|NCT01567527|156096352|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
48520515|NCT01567527|156096353|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
48520516|NCT01567527|156096354|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
48520517|NCT01567527|156096355|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
48520518|NCT01567527|156096351|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
48520519|NCT01567527|156096352|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
48520520|NCT01567527|156096353|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
48520521|NCT01567527|156096354|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
48520522|NCT01567527|156096355|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
48520523|NCT01567527|156096351|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
48520524|NCT01567527|156096352|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
48520525|NCT01567527|156096353|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
48520526|NCT01567527|156096354|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
48520527|NCT01567527|156096355|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
48520528|NCT01567527|156096351|FG000|IM Depot Stabilization.|Adverse Event|0|||
48731473|NCT00423670|156869426|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731474|NCT00423670|156869427|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731475|NCT00423670|156869428|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
48731476|NCT00423670|156869421|FG000|Treatment Period|Adverse Event|8|||
48731477|NCT00423670|156869422|FG001|Treatment Period|Adverse Event|12|||
48731478|NCT00423670|156869423|FG002|Treatment Period|Adverse Event|15|||
48731479|NCT00423670|156869424|FG003|Treatment Period|Adverse Event|20|||
48731480|NCT00423670|156869425|FG004|Treatment Period|Adverse Event|9|||
48731481|NCT00423670|156869426|FG005|Treatment Period|Adverse Event|4|||
48731482|NCT00423670|156869427|FG006|Treatment Period|Adverse Event|7|||
48731483|NCT00423670|156869428|FG007|Treatment Period|Adverse Event|2|||
48731484|NCT00423670|156869421|FG000|Treatment Period|Protocol-defined clinical event|0|||
48731485|NCT00423670|156869422|FG001|Treatment Period|Protocol-defined clinical event|7|||
48731486|NCT00423670|156869423|FG002|Treatment Period|Protocol-defined clinical event|4|||
48731487|NCT00423670|156869424|FG003|Treatment Period|Protocol-defined clinical event|12|||
48731488|NCT00423670|156869425|FG004|Treatment Period|Protocol-defined clinical event|5|||
48731489|NCT00423670|156869426|FG005|Treatment Period|Protocol-defined clinical event|4|||
48731490|NCT00423670|156869427|FG006|Treatment Period|Protocol-defined clinical event|16|||
48731491|NCT00423670|156869428|FG007|Treatment Period|Protocol-defined clinical event|15|||
48731492|NCT00423670|156869421|FG000|Treatment Period|Lost to Follow-up|2|||
48731493|NCT00423670|156869422|FG001|Treatment Period|Lost to Follow-up|1|||
48731494|NCT00423670|156869423|FG002|Treatment Period|Lost to Follow-up|3|||
48731495|NCT00423670|156869424|FG003|Treatment Period|Lost to Follow-up|1|||
48731496|NCT00423670|156869425|FG004|Treatment Period|Lost to Follow-up|6|||
48731497|NCT00423670|156869426|FG005|Treatment Period|Lost to Follow-up|0|||
48731498|NCT00423670|156869427|FG006|Treatment Period|Lost to Follow-up|3|||
48731499|NCT00423670|156869428|FG007|Treatment Period|Lost to Follow-up|1|||
48520529|NCT01567527|156096352|FG001|IM Depot Stabilization.|Adverse Event|0|||
48520530|NCT01567527|156096353|FG002|IM Depot Stabilization.|Adverse Event|37|||
48601314|NCT01716806|156397563|FG002|Overall Study|Lost to Follow-up|0|||
48601315|NCT01716806|156397564|FG003|Overall Study|Lost to Follow-up|2|||
48601316|NCT01716806|156397565|FG004|Overall Study|Lost to Follow-up|1|||
48601317|NCT01716806|156397566|FG005|Overall Study|Lost to Follow-up|0|||
48601318|NCT01716806|156397561|FG000|Overall Study|Death|13|||
48601319|NCT01716806|156397562|FG001|Overall Study|Death|9|||
48601320|NCT01716806|156397563|FG002|Overall Study|Death|12|||
48601321|NCT01716806|156397564|FG003|Overall Study|Death|4|||
48601322|NCT01716806|156397565|FG004|Overall Study|Death|10|||
48601323|NCT01716806|156397566|FG005|Overall Study|Death|5|||
48601324|NCT01716806|156397561|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
48731500|NCT00423670|156869421|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
48731501|NCT00423670|156869422|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
48731502|NCT00423670|156869423|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
48731503|NCT00423670|156869424|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
48731504|NCT00423670|156869425|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
48731505|NCT00423670|156869426|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
48520531|NCT01567527|156096354|FG003|IM Depot Stabilization.|Adverse Event|0|||
48520532|NCT01567527|156096355|FG004|IM Depot Stabilization.|Adverse Event|0|||
48601325|NCT01716806|156397562|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
48601326|NCT01716806|156397563|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
48601327|NCT01716806|156397564|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
48601328|NCT01716806|156397565|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
48601329|NCT01716806|156397566|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
48601330|NCT01716806|156397561|FG000|Overall Study|PI decision|0|||
48601331|NCT01716806|156397562|FG001|Overall Study|PI decision|0|||
48601332|NCT01716806|156397563|FG002|Overall Study|PI decision|0|||
48601333|NCT01716806|156397564|FG003|Overall Study|PI decision|0|||
48601334|NCT01716806|156397565|FG004|Overall Study|PI decision|1|||
48601335|NCT01716806|156397566|FG005|Overall Study|PI decision|0|||
48601336|NCT01716806|156397561|FG000|Overall Study|Change in performance status|1|||
48601337|NCT01716806|156397562|FG001|Overall Study|Change in performance status|0|||
48731506|NCT00423670|156869427|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
48731507|NCT00423670|156869428|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
48731508|NCT00423670|156869421|FG000|Treatment Period|Investigator decision|0|||
48731509|NCT00423670|156869422|FG001|Treatment Period|Investigator decision|0|||
48731510|NCT00423670|156869423|FG002|Treatment Period|Investigator decision|0|||
48520533|NCT01567527|156096351|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
48520534|NCT01567527|156096352|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
48520535|NCT01567527|156096353|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
48520536|NCT01567527|156096354|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
48520537|NCT01567527|156096355|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
48520538|NCT01567527|156096351|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
48520539|NCT01567527|156096352|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
48520540|NCT01567527|156096353|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
48520541|NCT01567527|156096354|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
48520542|NCT01567527|156096355|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
48520543|NCT01567527|156096351|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
48520544|NCT01567527|156096352|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
48520545|NCT01567527|156096353|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
48520546|NCT01567527|156096354|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
48520547|NCT01567527|156096355|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
48520548|NCT01567527|156096351|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
48520549|NCT01567527|156096352|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
48520550|NCT01567527|156096353|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
48520551|NCT01567527|156096354|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
48601338|NCT01716806|156397563|FG002|Overall Study|Change in performance status|0|||
48601339|NCT01716806|156397564|FG003|Overall Study|Change in performance status|0|||
48731511|NCT00423670|156869424|FG003|Treatment Period|Investigator decision|0|||
48731512|NCT00423670|156869425|FG004|Treatment Period|Investigator decision|0|||
48731513|NCT00423670|156869426|FG005|Treatment Period|Investigator decision|0|||
48731514|NCT00423670|156869427|FG006|Treatment Period|Investigator decision|0|||
48731515|NCT00423670|156869428|FG007|Treatment Period|Investigator decision|1|||
48731516|NCT00423670|156869421|FG000|Treatment Period|Non-compliance with protocol|3|||
48731517|NCT00423670|156869422|FG001|Treatment Period|Non-compliance with protocol|1|||
48601340|NCT01716806|156397565|FG004|Overall Study|Change in performance status|0|||
48601341|NCT01716806|156397566|FG005|Overall Study|Change in performance status|0|||
48601342|NCT01716806|156397561|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
48601343|NCT01716806|156397562|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
48601344|NCT01716806|156397563|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
48601345|NCT01716806|156397564|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
48601346|NCT01716806|156397565|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
48601347|NCT01716806|156397566|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
48601348|NCT01716806|156397561|FG000|Overall Study|Sponsor direction|7|||
48601349|NCT01716806|156397562|FG001|Overall Study|Sponsor direction|8|||
48601350|NCT01716806|156397563|FG002|Overall Study|Sponsor direction|5|||
48601351|NCT01716806|156397564|FG003|Overall Study|Sponsor direction|12|||
48601352|NCT01716806|156397565|FG004|Overall Study|Sponsor direction|16|||
48601353|NCT01716806|156397566|FG005|Overall Study|Sponsor direction|1|||
48601354|NCT02692586|156397567|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
48601355|NCT02692586|156397567|FG000|Overall Study|Received adjunctive thrombolytics|2|||
48601356|NCT01128296|156397568|FG000|Overall Study|Physician Decision|0|||
48601357|NCT01128296|156397569|FG001|Overall Study|Physician Decision|0|||
48601358|NCT01128296|156397570|FG002|Overall Study|Physician Decision|0|||
48601359|NCT01128296|156397571|FG003|Overall Study|Physician Decision|0|||
48601360|NCT01128296|156397572|FG004|Overall Study|Physician Decision|0|||
48601361|NCT01128296|156397573|FG005|Overall Study|Physician Decision|3|||
48601362|NCT01128296|156397568|FG000|Overall Study|Withdrawal by Subject|0|||
48601363|NCT01128296|156397569|FG001|Overall Study|Withdrawal by Subject|0|||
48601364|NCT01128296|156397570|FG002|Overall Study|Withdrawal by Subject|0|||
48601365|NCT01128296|156397571|FG003|Overall Study|Withdrawal by Subject|0|||
48601366|NCT01128296|156397572|FG004|Overall Study|Withdrawal by Subject|0|||
48601367|NCT01128296|156397573|FG005|Overall Study|Withdrawal by Subject|2|||
48601368|NCT03934216|156397574|FG000|Overall Study|Other Reasons|5|||
48601369|NCT03934216|156397575|FG001|Overall Study|Other Reasons|5|||
48824227|NCT01094171|157197199|FG000|Overall Study|Lost to Follow-up|2|||
48824228|NCT01094171|157197199|FG000|Overall Study|Informed consent withdrawal|4|||
48824229|NCT01094171|157197199|FG000|Overall Study|Migration from the study area|3|||
48824230|NCT01094171|157197199|FG000|Overall Study|Other|1|||
48824231|NCT03283553|157197200|FG000|Patient Participant Flow|Death|5|||
48824232|NCT03283553|157197201|FG001|Patient Participant Flow|Death|10|||
48824233|NCT03283553|157197200|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
48824234|NCT03283553|157197201|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
48824235|NCT03283553|157197200|FG000|Patient Participant Flow|Lost to Follow-up|1|||
48824236|NCT03283553|157197201|FG001|Patient Participant Flow|Lost to Follow-up|1|||
48824237|NCT03283553|157197200|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
48824238|NCT03283553|157197201|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
48824239|NCT03283553|157197200|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
48824240|NCT03283553|157197201|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
48824241|NCT03283553|157197200|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
48824242|NCT03283553|157197201|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
48824243|NCT01982760|157197205|FG000|Overall Study|Physician Decision|1|||
48824244|NCT01982760|157197206|FG001|Overall Study|Physician Decision|0|||
48824245|NCT00162942|157197207|FG000|Overall Study|Adverse Event|10|||
48824246|NCT00162942|157197208|FG001|Overall Study|Adverse Event|6|||
48824247|NCT00162942|157197207|FG000|Overall Study|Death|1|||
48824248|NCT00162942|157197208|FG001|Overall Study|Death|0|||
48601370|NCT03934216|156397574|FG000|Overall Study|Adverse Event|22|||
48520552|NCT01567527|156096355|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
48520553|NCT01567527|156096351|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
48520554|NCT01567527|156096352|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
48520555|NCT01567527|156096353|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
48520556|NCT01567527|156096354|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
48520557|NCT01567527|156096355|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
48520558|NCT01567527|156096351|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48520559|NCT01567527|156096352|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48520560|NCT01567527|156096353|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48520561|NCT01567527|156096354|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
48520562|NCT01567527|156096355|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
48520563|NCT01567527|156096351|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
48601371|NCT03934216|156397575|FG001|Overall Study|Adverse Event|11|||
48601372|NCT03934216|156397574|FG000|Overall Study|Lack of Efficacy|8|||
48601373|NCT03934216|156397575|FG001|Overall Study|Lack of Efficacy|7|||
48824249|NCT00162942|157197207|FG000|Overall Study|Withdrawal by Subject|3|||
48824250|NCT00162942|157197208|FG001|Overall Study|Withdrawal by Subject|6|||
48824251|NCT00162942|157197207|FG000|Overall Study|Physician Decision|1|||
48601374|NCT03934216|156397574|FG000|Overall Study|Lost to Follow-up|2|||
48601375|NCT03934216|156397575|FG001|Overall Study|Lost to Follow-up|0|||
48601376|NCT03934216|156397574|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48601377|NCT03934216|156397575|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48601378|NCT03934216|156397574|FG000|Overall Study|Pregnancy|1|||
48601379|NCT03934216|156397575|FG001|Overall Study|Pregnancy|0|||
48601380|NCT03934216|156397574|FG000|Overall Study|Withdrawal by Subject|18|||
48601381|NCT03934216|156397575|FG001|Overall Study|Withdrawal by Subject|6|||
48601382|NCT03934216|156397574|FG000|Overall Study|Randomized but not treated|1|||
48601383|NCT03934216|156397575|FG001|Overall Study|Randomized but not treated|1|||
48601384|NCT01714544|156397576|FG000|Overall Study|Lost to Follow-up|1|||
48601385|NCT01714544|156397576|FG000|Overall Study|Physician Decision|1|||
48601386|NCT01714544|156397576|FG000|Overall Study|Withdrawal by Subject|1|||
48601387|NCT00994110|156397577|FG000|Overall Study|Withdrawal by Subject|9|||
48601388|NCT00994110|156397578|FG001|Overall Study|Withdrawal by Subject|9|||
48731518|NCT00423670|156869423|FG002|Treatment Period|Non-compliance with protocol|1|||
48731519|NCT00423670|156869424|FG003|Treatment Period|Non-compliance with protocol|3|||
48731520|NCT00423670|156869425|FG004|Treatment Period|Non-compliance with protocol|2|||
48731521|NCT00423670|156869426|FG005|Treatment Period|Non-compliance with protocol|0|||
48731522|NCT00423670|156869427|FG006|Treatment Period|Non-compliance with protocol|2|||
48731523|NCT00423670|156869428|FG007|Treatment Period|Non-compliance with protocol|2|||
48731524|NCT00423670|156869421|FG000|Follow-up Period|Lost to Follow-up|0|||
48731525|NCT00423670|156869422|FG001|Follow-up Period|Lost to Follow-up|12|||
48731526|NCT00423670|156869423|FG002|Follow-up Period|Lost to Follow-up|8|||
48731527|NCT00423670|156869424|FG003|Follow-up Period|Lost to Follow-up|3|||
48731528|NCT00423670|156869425|FG004|Follow-up Period|Lost to Follow-up|1|||
48731529|NCT00423670|156869426|FG005|Follow-up Period|Lost to Follow-up|0|||
48731530|NCT00423670|156869427|FG006|Follow-up Period|Lost to Follow-up|5|||
48731531|NCT00423670|156869428|FG007|Follow-up Period|Lost to Follow-up|0|||
48731532|NCT00423670|156869421|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731533|NCT00423670|156869422|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
48731534|NCT00423670|156869423|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
48731535|NCT00423670|156869424|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731536|NCT00423670|156869425|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731537|NCT00423670|156869426|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
48731538|NCT00423670|156869427|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731539|NCT00423670|156869428|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
48731540|NCT00423670|156869421|FG000|Follow-up Period|Non-compliance with protocol|2|||
48731541|NCT00423670|156869422|FG001|Follow-up Period|Non-compliance with protocol|0|||
48731542|NCT00423670|156869423|FG002|Follow-up Period|Non-compliance with protocol|1|||
48731543|NCT00423670|156869424|FG003|Follow-up Period|Non-compliance with protocol|1|||
48731544|NCT00423670|156869425|FG004|Follow-up Period|Non-compliance with protocol|0|||
48731545|NCT00423670|156869426|FG005|Follow-up Period|Non-compliance with protocol|0|||
48731546|NCT00423670|156869427|FG006|Follow-up Period|Non-compliance with protocol|3|||
48731547|NCT00423670|156869428|FG007|Follow-up Period|Non-compliance with protocol|2|||
48731548|NCT01282203|156869429|FG000|Overall Study|Adverse Event|1|||
48731549|NCT01869725|156869430|FG000|Overall Study|ineligible after registration|1|||
48731550|NCT01869725|156869430|FG000|Overall Study|Death|1|||
48731551|NCT01869725|156869430|FG000|Overall Study|Lost to Follow-up|2|||
48731552|NCT00735254|156869433|FG000|Overall Study|Protocol Violation|1|||
48731553|NCT00735254|156869434|FG001|Overall Study|Protocol Violation|1|||
48731554|NCT00735254|156869435|FG002|Overall Study|Protocol Violation|1|||
48731555|NCT00735254|156869436|FG003|Overall Study|Protocol Violation|0|||
48731556|NCT01068652|156869437|FG000|Overall Study|Adverse Event|4|||
48731557|NCT01068652|156869438|FG001|Overall Study|Adverse Event|0|||
48731558|NCT01068652|156869437|FG000|Overall Study|Lack of Efficacy|0|||
48731559|NCT01068652|156869438|FG001|Overall Study|Lack of Efficacy|2|||
48731560|NCT01068652|156869437|FG000|Overall Study|Lost to Follow-up|2|||
48731561|NCT01068652|156869438|FG001|Overall Study|Lost to Follow-up|1|||
48731562|NCT01068652|156869437|FG000|Overall Study|Protocol Violation|3|||
48731563|NCT01068652|156869438|FG001|Overall Study|Protocol Violation|6|||
48731564|NCT01068652|156869437|FG000|Overall Study|Withdrawal criteria|1|||
48731565|NCT01068652|156869438|FG001|Overall Study|Withdrawal criteria|2|||
48731566|NCT01068652|156869437|FG000|Overall Study|Patient was not eligible|1|||
48731567|NCT01068652|156869438|FG001|Overall Study|Patient was not eligible|0|||
48731568|NCT01068652|156869437|FG000|Overall Study|Unclassified|7|||
48731569|NCT01068652|156869438|FG001|Overall Study|Unclassified|4|||
48731570|NCT00147251|156869439|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
48731571|NCT00147251|156869440|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
48731572|NCT01669928|156869441|FG000|First Intervention|Withdrawal by Subject|3|||
48731573|NCT01669928|156869442|FG001|First Intervention|Withdrawal by Subject|5|||
48731574|NCT03387683|156869445|FG000|Overall Study|In receipt of disallowed medication|1|||
48731575|NCT03387683|156869446|FG001|Overall Study|In receipt of disallowed medication|0|||
48601389|NCT00994110|156397577|FG000|Overall Study|Not Treated|4|||
48601390|NCT00994110|156397578|FG001|Overall Study|Not Treated|8|||
48601391|NCT00994110|156397577|FG000|Overall Study|Adverse Event|1|||
48601392|NCT00994110|156397578|FG001|Overall Study|Adverse Event|0|||
48601393|NCT00994110|156397577|FG000|Overall Study|Patient not resected|41|||
48601394|NCT00994110|156397578|FG001|Overall Study|Patient not resected|52|||
48824252|NCT00162942|157197208|FG001|Overall Study|Physician Decision|0|||
48824253|NCT00162942|157197207|FG000|Overall Study|Enter Open-Label Study|76|||
48601395|NCT00994110|156397577|FG000|Overall Study|Pt not eligible|10|||
48601396|NCT00994110|156397578|FG001|Overall Study|Pt not eligible|5|||
48601397|NCT01063855|156397579|FG000|Overall Study|Adverse Event|4|||
48824254|NCT00162942|157197208|FG001|Overall Study|Enter Open-Label Study|35|||
48824255|NCT00162942|157197207|FG000|Overall Study|Alternate Therapy|6|||
48824256|NCT00162942|157197208|FG001|Overall Study|Alternate Therapy|2|||
48824257|NCT00162942|157197207|FG000|Overall Study|Lack of Efficacy|1|||
48824258|NCT00162942|157197208|FG001|Overall Study|Lack of Efficacy|0|||
48824259|NCT00162942|157197207|FG000|Overall Study|Flare During Active Treatment|7|||
48824260|NCT00162942|157197208|FG001|Overall Study|Flare During Active Treatment|3|||
48824261|NCT00162942|157197207|FG000|Overall Study|2 or more consecutive treatments missed|1|||
48824262|NCT00162942|157197208|FG001|Overall Study|2 or more consecutive treatments missed|0|||
48824263|NCT01354938|157197209|FG000|Overall Study|Lost to Follow-up|1|||
48824264|NCT02335268|157197210|FG000|Overall Study|Physician Decision|5|||
48824265|NCT02335268|157197211|FG001|Overall Study|Physician Decision|1|||
48824266|NCT02335268|157197210|FG000|Overall Study|Lack of Efficacy|2|||
48824267|NCT02335268|157197211|FG001|Overall Study|Lack of Efficacy|1|||
48824268|NCT02335268|157197210|FG000|Overall Study|Adverse Event|5|||
48824269|NCT02335268|157197211|FG001|Overall Study|Adverse Event|2|||
48824270|NCT02335268|157197210|FG000|Overall Study|increase blasts|2|||
48824271|NCT02335268|157197211|FG001|Overall Study|increase blasts|0|||
48824272|NCT02335268|157197210|FG000|Overall Study|Withdrawal by Subject|3|||
48824273|NCT02335268|157197211|FG001|Overall Study|Withdrawal by Subject|2|||
48824274|NCT01192295|157197212|FG000|Overall Study|Adverse Event|3|||
48824275|NCT01192295|157197213|FG001|Overall Study|Adverse Event|7|||
48824276|NCT01192295|157197212|FG000|Overall Study|Withdrawal by Subject|3|||
48824277|NCT01192295|157197213|FG001|Overall Study|Withdrawal by Subject|4|||
48824278|NCT01192295|157197212|FG000|Overall Study|Lost to Follow-up|0|||
48601398|NCT01063855|156397580|FG001|Overall Study|Adverse Event|4|||
48601399|NCT01063855|156397579|FG000|Overall Study|Death|0|||
48601400|NCT01063855|156397580|FG001|Overall Study|Death|1|||
48601401|NCT01063855|156397579|FG000|Overall Study|Lost to Follow-up|8|||
48601402|NCT01063855|156397580|FG001|Overall Study|Lost to Follow-up|4|||
48601403|NCT01063855|156397579|FG000|Overall Study|Pregnancy|1|||
48601404|NCT01063855|156397580|FG001|Overall Study|Pregnancy|0|||
48601405|NCT01063855|156397579|FG000|Overall Study|Lack of Efficacy|0|||
48601406|NCT01063855|156397580|FG001|Overall Study|Lack of Efficacy|1|||
48601407|NCT01063855|156397579|FG000|Overall Study|Withdrawal by Subject|11|||
48601408|NCT01063855|156397580|FG001|Overall Study|Withdrawal by Subject|8|||
48601409|NCT01063855|156397579|FG000|Overall Study|Reason not specified|13|||
48601410|NCT01063855|156397580|FG001|Overall Study|Reason not specified|11|||
48601411|NCT02806713|156397581|FG000|Overall Study|Urethral injury during procedure|1|||
48601412|NCT02806713|156397582|FG001|Overall Study|Urethral injury during procedure|0|||
48601413|NCT02806713|156397581|FG000|Overall Study|cancelled surgery|1|||
48601414|NCT02806713|156397582|FG001|Overall Study|cancelled surgery|2|||
48601415|NCT00115778|156397583|FG000|Overall Study|Withdrawal by Subject|0|||
48601416|NCT00115778|156397584|FG001|Overall Study|Withdrawal by Subject|1|||
48601417|NCT02762084|156397585|FG000|Overall Study|Withdrawal by Subject|1|||
48601418|NCT02762084|156397586|FG001|Overall Study|Withdrawal by Subject|0|||
48601419|NCT02762084|156397587|FG002|Overall Study|Withdrawal by Subject|0|||
48601420|NCT02762084|156397585|FG000|Overall Study|Adverse Event|0|||
48601421|NCT02762084|156397586|FG001|Overall Study|Adverse Event|0|||
48601422|NCT02762084|156397587|FG002|Overall Study|Adverse Event|1|||
48601423|NCT00165503|156397590|FG000|Overall Study|Death|1|||
48601424|NCT00165503|156397590|FG000|Overall Study|Lost to Follow-up|12|||
48601425|NCT00165503|156397590|FG000|Overall Study|Unresectable|3|||
48601426|NCT02346708|156397591|FG000|Overall Study|Adverse Event|2|||
48601427|NCT02346708|156397592|FG001|Overall Study|Adverse Event|0|||
48601428|NCT02346708|156397591|FG000|Overall Study|Protocol Violation|0|||
48601429|NCT02346708|156397592|FG001|Overall Study|Protocol Violation|1|||
48601430|NCT00614874|156397593|FG000|Overall Study|Protocol Violation|1|||
48601431|NCT00614874|156397593|FG000|Overall Study|Withdrawal by Subject|1|||
48601432|NCT03904420|156397594|FG000|Overall Study|Study terminated|2|||
48601433|NCT03904420|156397595|FG001|Overall Study|Study terminated|2|||
48824279|NCT01192295|157197213|FG001|Overall Study|Lost to Follow-up|1|||
48824280|NCT01192295|157197212|FG000|Overall Study|Lack of Efficacy|0|||
48824281|NCT01192295|157197213|FG001|Overall Study|Lack of Efficacy|5|||
48824282|NCT01192295|157197212|FG000|Overall Study|Administrative|4|||
48824283|NCT01192295|157197213|FG001|Overall Study|Administrative|6|||
48601434|NCT01001910|156397596|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
48824284|NCT00630539|157197214|FG000|Overall Study|Adverse Event|1|||
48601435|NCT01765296|156397599|FG000|Overall Study|Protocol Violation|0|||
48601436|NCT01765296|156397600|FG001|Overall Study|Protocol Violation|5|||
48601437|NCT01765296|156397601|FG002|Overall Study|Protocol Violation|4|||
48601438|NCT01765296|156397599|FG000|Overall Study|Withdrawal by Subject|4|||
48601439|NCT01765296|156397600|FG001|Overall Study|Withdrawal by Subject|2|||
48601440|NCT01765296|156397601|FG002|Overall Study|Withdrawal by Subject|2|||
48601441|NCT01765296|156397599|FG000|Overall Study|Adverse Event|1|||
48601442|NCT01765296|156397600|FG001|Overall Study|Adverse Event|13|||
48601443|NCT01765296|156397601|FG002|Overall Study|Adverse Event|5|||
48601444|NCT01765296|156397599|FG000|Overall Study|Lack of Efficacy|0|||
48601445|NCT01765296|156397600|FG001|Overall Study|Lack of Efficacy|0|||
48601446|NCT01765296|156397601|FG002|Overall Study|Lack of Efficacy|2|||
48601447|NCT01619852|156397602|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
48601448|NCT01619852|156397603|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
48731576|NCT03387683|156869445|FG000|Overall Study|Did not receive treatment|1|||
48731577|NCT03387683|156869446|FG001|Overall Study|Did not receive treatment|0|||
48601449|NCT01619852|156397602|FG000|3 Month Follow up|Lost to Follow-up|31|||
48601450|NCT01619852|156397603|FG001|3 Month Follow up|Lost to Follow-up|34|||
48601451|NCT03933449|156397604|FG000|Overall Study|Adverse Event|6|||
48601452|NCT03933449|156397605|FG001|Overall Study|Adverse Event|4|||
48601453|NCT03933449|156397604|FG000|Overall Study|Death|55|||
48601454|NCT03933449|156397605|FG001|Overall Study|Death|57|||
48601455|NCT03933449|156397604|FG000|Overall Study|Sponsor Decision|1|||
48601456|NCT03933449|156397605|FG001|Overall Study|Sponsor Decision|0|||
48601457|NCT01576575|156397606|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
48601458|NCT01576575|156397606|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
48601459|NCT01576575|156397606|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
48601460|NCT02592447|156397609|FG000|Overall Study|Lost to Follow-up|1|||
48601461|NCT02592447|156397610|FG001|Overall Study|Lost to Follow-up|0|||
48601462|NCT02592447|156397609|FG000|Overall Study|Ineligible after randomization|1|||
48601463|NCT02592447|156397610|FG001|Overall Study|Ineligible after randomization|0|||
48601464|NCT02592447|156397609|FG000|Overall Study|Withdrawal by Subject|0|||
48601465|NCT02592447|156397610|FG001|Overall Study|Withdrawal by Subject|1|||
48601466|NCT02021292|156397612|FG000|Overall Study|Physician Decision|0|||
48601467|NCT02021292|156397613|FG001|Overall Study|Physician Decision|1|||
48601468|NCT02021292|156397612|FG000|Overall Study|Lost to Follow-up|0|||
48731578|NCT01368432|156869448|FG000|Overall Study|Lost to Follow-up|0|||
48731579|NCT01368432|156869449|FG001|Overall Study|Lost to Follow-up|1|||
48731580|NCT02169284|156869452|FG000|Overall Study|Physician Decision|0|||
48731581|NCT02169284|156869453|FG001|Overall Study|Physician Decision|1|||
48731582|NCT01008150|156869454|FG000|Overall Study|did not receive study drug|1|||
48731583|NCT01008150|156869455|FG001|Overall Study|did not receive study drug|1|||
48731584|NCT01008150|156869456|FG002|Overall Study|did not receive study drug|1|||
48731585|NCT01008150|156869457|FG003|Overall Study|did not receive study drug|0|||
48731586|NCT01938573|156869459|FG000|Overall Study|Lack of Efficacy|1|||
48731587|NCT01938573|156869460|FG001|Overall Study|Lack of Efficacy|0|||
48731588|NCT01938573|156869459|FG000|Overall Study|Operation at other hospital|1|||
48731589|NCT01938573|156869460|FG001|Overall Study|Operation at other hospital|0|||
48520564|NCT01567527|156096352|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
48520565|NCT01567527|156096353|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
48520566|NCT01567527|156096354|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
48520567|NCT01567527|156096355|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
48520568|NCT01567527|156096351|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
48520569|NCT01567527|156096352|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
48520570|NCT01567527|156096353|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
48520571|NCT01567527|156096354|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
48520572|NCT01567527|156096355|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
48520573|NCT01567527|156096351|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48520574|NCT01567527|156096352|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48601469|NCT02021292|156397613|FG001|Overall Study|Lost to Follow-up|1|||
48601470|NCT02021292|156397612|FG000|Overall Study|Death|0|||
48601471|NCT02021292|156397613|FG001|Overall Study|Death|1|||
48601472|NCT03669549|156397617|FG000|Overall Study|Adverse Event|4|||
48601473|NCT03669549|156397617|FG000|Overall Study|Withdrawal by Subject|1|||
48601474|NCT03669549|156397617|FG000|Overall Study|Study terminated by the Sponsor|1|||
48601475|NCT00676403|156397621|FG000|Overall Study|Adverse Event|1|||
48601476|NCT00676403|156397622|FG001|Overall Study|Adverse Event|2|||
48601477|NCT00676403|156397623|FG002|Overall Study|Adverse Event|0|||
48601478|NCT00676403|156397624|FG003|Overall Study|Adverse Event|5|||
48601479|NCT00676403|156397625|FG004|Overall Study|Adverse Event|1|||
48731590|NCT03766685|156869466|FG000|Overall Study|Lost to Follow-up|1|||
48731591|NCT03766685|156869467|FG001|Overall Study|Lost to Follow-up|1|||
48601480|NCT00676403|156397626|FG005|Overall Study|Adverse Event|2|||
48731592|NCT03766685|156869468|FG002|Overall Study|Lost to Follow-up|0|||
48731593|NCT03766685|156869469|FG003|Overall Study|Lost to Follow-up|0|||
48520575|NCT01567527|156096353|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48520576|NCT01567527|156096354|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
48520577|NCT01567527|156096355|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
48520578|NCT01824576|156096363|FG000|Overall Study|Device deficiency|2|||
48520579|NCT02004691|156096365|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
48520580|NCT02004691|156096366|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
48520581|NCT02004691|156096365|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
48520582|NCT02004691|156096366|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
48520583|NCT02004691|156096365|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
48520584|NCT02004691|156096366|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
48520585|NCT02004691|156096365|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
48520586|NCT02004691|156096366|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
48520587|NCT02004691|156096365|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
48520588|NCT02004691|156096366|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
48520589|NCT02004691|156096365|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
48520590|NCT02004691|156096366|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
48520591|NCT02311894|156096367|FG000|Overall Study|Discontinued in error|1|||
48520592|NCT02311894|156096367|FG000|Overall Study|Lost to Follow-up|1|||
48520593|NCT02311894|156096367|FG000|Overall Study|Adverse Event|1|||
48520594|NCT02311894|156096367|FG000|Overall Study|Withdrawal by Subject|1|||
48520595|NCT02676973|156096368|FG000|Overall Study|Withdrawal by Subject|9|||
48520596|NCT02676973|156096369|FG001|Overall Study|Withdrawal by Subject|8|||
48520597|NCT02676973|156096370|FG002|Overall Study|Withdrawal by Subject|11|||
48520598|NCT02676973|156096368|FG000|Overall Study|Lost to Follow-up|8|||
48520599|NCT02676973|156096369|FG001|Overall Study|Lost to Follow-up|12|||
48520600|NCT02676973|156096370|FG002|Overall Study|Lost to Follow-up|8|||
48520601|NCT02676973|156096368|FG000|Overall Study|Death|2|||
48520602|NCT02676973|156096369|FG001|Overall Study|Death|1|||
48520603|NCT02676973|156096370|FG002|Overall Study|Death|5|||
48520604|NCT02472639|156096371|FG000|Overall Study|Physician Decision|4|||
48520605|NCT02472639|156096372|FG001|Overall Study|Physician Decision|3|||
48520606|NCT00420095|156096373|FG000|Overall Study|Adverse Event|1|||
48520607|NCT00420095|156096374|FG001|Overall Study|Adverse Event|0|||
48520608|NCT00420095|156096373|FG000|Overall Study|Protocol Violation|1|||
48520609|NCT00420095|156096374|FG001|Overall Study|Protocol Violation|1|||
48520610|NCT00420095|156096373|FG000|Overall Study|Lost to Follow-up|1|||
48520611|NCT00420095|156096374|FG001|Overall Study|Lost to Follow-up|0|||
48520612|NCT02448563|156096377|FG000|Overall Study|Lost to Follow-up|16|||
48520613|NCT02448563|156096378|FG001|Overall Study|Lost to Follow-up|10|||
48520614|NCT02448563|156096377|FG000|Overall Study|Withdrawal by Subject|0|||
48520615|NCT02448563|156096378|FG001|Overall Study|Withdrawal by Subject|1|||
48520616|NCT01726803|156096381|FG000|Overall Study|Lost to Follow-up|6|||
48520617|NCT01726803|156096382|FG001|Overall Study|Lost to Follow-up|1|||
48520618|NCT01726803|156096381|FG000|Overall Study|Withdrawal by Subject|1|||
48520619|NCT01726803|156096382|FG001|Overall Study|Withdrawal by Subject|0|||
48520620|NCT00702507|156096383|FG000|Initial Treatment Phase|Adverse Event|2|||
48520621|NCT00702507|156096383|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
48520622|NCT00702507|156096383|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
48520623|NCT00702507|156096383|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
48520624|NCT00702507|156096383|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
48520625|NCT00702507|156096383|FG000|Follow-up Phase|Protocol Violation|2|||
48520626|NCT00702507|156096383|FG000|Follow-up Phase|Lost to Follow-up|23|||
48520627|NCT00702507|156096383|FG000|Follow-up Phase|Late Enrollment|1|||
48520628|NCT00393705|156096384|FG000|Overall Study|Adverse Event|0|||
48520629|NCT00393705|156096385|FG001|Overall Study|Adverse Event|2|||
48520630|NCT00393705|156096384|FG000|Overall Study|Death|0|||
48520631|NCT00393705|156096385|FG001|Overall Study|Death|1|||
48520632|NCT00393705|156096384|FG000|Overall Study|Lost to Follow-up|2|||
48520633|NCT00393705|156096385|FG001|Overall Study|Lost to Follow-up|2|||
48520634|NCT00393705|156096384|FG000|Overall Study|Entry Criteria Not Met|10|||
48520635|NCT00393705|156096385|FG001|Overall Study|Entry Criteria Not Met|10|||
48520636|NCT00393705|156096384|FG000|Overall Study|Protocol Violation|4|||
48520637|NCT00393705|156096385|FG001|Overall Study|Protocol Violation|3|||
48520638|NCT00393705|156096384|FG000|Overall Study|Withdrawal by Subject|5|||
48520639|NCT00393705|156096385|FG001|Overall Study|Withdrawal by Subject|3|||
48520640|NCT00393705|156096384|FG000|Overall Study|Physician Decision|2|||
48520641|NCT00393705|156096385|FG001|Overall Study|Physician Decision|2|||
48520642|NCT04974580|156096387|FG000|Overall Study|Lost to Follow-up|33|||
48520643|NCT04974580|156096388|FG001|Overall Study|Lost to Follow-up|39|||
48520644|NCT04974580|156096389|FG002|Overall Study|Lost to Follow-up|30|||
48520645|NCT04974580|156096390|FG003|Overall Study|Lost to Follow-up|29|||
48520646|NCT01971645|156096391|FG000|Overall Study|Adverse Event|1|||
48520647|NCT01971645|156096392|FG001|Overall Study|Adverse Event|0|||
48520648|NCT01971645|156096393|FG002|Overall Study|Adverse Event|0|||
48520649|NCT01971645|156096391|FG000|Overall Study|Lost to Follow-up|1|||
48520650|NCT01971645|156096392|FG001|Overall Study|Lost to Follow-up|0|||
48520651|NCT01971645|156096393|FG002|Overall Study|Lost to Follow-up|1|||
48520652|NCT01971645|156096391|FG000|Overall Study|Protocol Violation|0|||
48520653|NCT01971645|156096392|FG001|Overall Study|Protocol Violation|0|||
48520654|NCT01971645|156096393|FG002|Overall Study|Protocol Violation|1|||
48520655|NCT01962298|156096394|FG000|Overall Study|Protocol Violation|1|||
48520656|NCT01962298|156096395|FG001|Overall Study|Protocol Violation|0|||
48520657|NCT01962298|156096396|FG002|Overall Study|Protocol Violation|1|||
48520658|NCT01962298|156096397|FG003|Overall Study|Protocol Violation|1|||
48520659|NCT01962298|156096398|FG004|Overall Study|Protocol Violation|0|||
48520660|NCT01962298|156096394|FG000|Overall Study|Data quality insufficient|2|||
48520661|NCT01962298|156096395|FG001|Overall Study|Data quality insufficient|0|||
48520662|NCT01962298|156096396|FG002|Overall Study|Data quality insufficient|3|||
48520663|NCT01962298|156096397|FG003|Overall Study|Data quality insufficient|1|||
48520664|NCT01962298|156096398|FG004|Overall Study|Data quality insufficient|4|||
48520665|NCT01962298|156096394|FG000|Overall Study|Insufficient data|0|||
48520666|NCT01962298|156096395|FG001|Overall Study|Insufficient data|2|||
48520667|NCT01962298|156096396|FG002|Overall Study|Insufficient data|1|||
48520668|NCT01962298|156096397|FG003|Overall Study|Insufficient data|0|||
48520669|NCT01962298|156096398|FG004|Overall Study|Insufficient data|1|||
48520670|NCT01962298|156096394|FG000|Overall Study|Incorrect data recorded|0|||
48520671|NCT01962298|156096395|FG001|Overall Study|Incorrect data recorded|1|||
48520672|NCT01962298|156096396|FG002|Overall Study|Incorrect data recorded|0|||
48520673|NCT01962298|156096397|FG003|Overall Study|Incorrect data recorded|0|||
48520674|NCT01962298|156096398|FG004|Overall Study|Incorrect data recorded|0|||
48520675|NCT01962298|156096394|FG000|Overall Study|Physician Decision|0|||
48520676|NCT01962298|156096395|FG001|Overall Study|Physician Decision|1|||
48520677|NCT01962298|156096396|FG002|Overall Study|Physician Decision|0|||
48520678|NCT01962298|156096397|FG003|Overall Study|Physician Decision|0|||
48520679|NCT01962298|156096398|FG004|Overall Study|Physician Decision|1|||
48520680|NCT04203667|156096407|FG000|Overall Study|Withdrawal by Subject|1|||
48520681|NCT04203667|156096407|FG000|Overall Study|Lost to Follow-up|1|||
48520682|NCT04203667|156096407|FG000|Overall Study|Death|1|||
48520683|NCT04203667|156096407|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
48520684|NCT00613730|156096408|FG000|Overall Study|Disease progression|2|||
48520685|NCT00613730|156096408|FG000|Overall Study|Administrative decision|1|||
48520686|NCT02167594|156096409|FG000|Overall Study|Withdrawal by Subject|2|||
48520687|NCT02167594|156096410|FG001|Overall Study|Withdrawal by Subject|0|||
48520688|NCT02167594|156096411|FG002|Overall Study|Withdrawal by Subject|0|||
48520689|NCT02167594|156096409|FG000|Overall Study|Death|0|||
48520690|NCT02167594|156096410|FG001|Overall Study|Death|1|||
48520691|NCT02167594|156096411|FG002|Overall Study|Death|0|||
48520692|NCT01835548|156096417|FG000|Dose Optimization Period|Adverse Event|0|||
48520693|NCT01835548|156096418|FG001|Dose Optimization Period|Adverse Event|0|||
48520694|NCT01835548|156096419|FG002|Dose Optimization Period|Adverse Event|1|||
48520695|NCT01835548|156096417|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
48520696|NCT01835548|156096418|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
48520697|NCT01835548|156096419|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
48520698|NCT01835548|156096417|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48520699|NCT01835548|156096418|FG001|Double-Blind Treatment Period|Adverse Event|1|||
48520700|NCT01835548|156096419|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48520701|NCT01835548|156096417|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48520702|NCT01835548|156096418|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48520703|NCT01835548|156096419|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48520704|NCT00659815|156098120|FG000|Overall Study|Study related symptoms and complaints|2|||
48520705|NCT00659815|156098121|FG001|Overall Study|Study related symptoms and complaints|1|||
48520706|NCT00659815|156098120|FG000|Overall Study|Inability to maintain wearing schedule|1|||
48520707|NCT00659815|156098121|FG001|Overall Study|Inability to maintain wearing schedule|2|||
48520708|NCT00659815|156098120|FG000|Overall Study|Withdrawal by Subject|1|||
48520709|NCT00659815|156098121|FG001|Overall Study|Withdrawal by Subject|1|||
48520710|NCT00377156|156098124|FG000|Overall Study|Death|23|||
48520711|NCT00377156|156098125|FG001|Overall Study|Death|19|||
48520712|NCT00377156|156098124|FG000|Overall Study|Withdrawal by Subject|16|||
48520713|NCT00377156|156098125|FG001|Overall Study|Withdrawal by Subject|24|||
48520714|NCT00377156|156098124|FG000|Overall Study|Had follow-up <90 d|3|||
48520715|NCT00377156|156098125|FG001|Overall Study|Had follow-up <90 d|6|||
48520716|NCT00377156|156098124|FG000|Overall Study|Cancellation|1|||
48520717|NCT00377156|156098125|FG001|Overall Study|Cancellation|0|||
48520718|NCT00377156|156098124|FG000|Overall Study|Refused testing|0|||
48520719|NCT00377156|156098125|FG001|Overall Study|Refused testing|1|||
48520720|NCT00377156|156098124|FG000|Overall Study|Ineligible|0|||
48520721|NCT00377156|156098125|FG001|Overall Study|Ineligible|1|||
48520722|NCT00377156|156098124|FG000|Overall Study|Disability or language problem|0|||
48520723|NCT00377156|156098125|FG001|Overall Study|Disability or language problem|1|||
48520724|NCT00377156|156098124|FG000|Overall Study|Other|5|||
48520725|NCT00377156|156098125|FG001|Overall Study|Other|2|||
48520726|NCT00522041|156098126|FG000|Overall Study|Adverse Event|9|||
48520727|NCT00522041|156098127|FG001|Overall Study|Adverse Event|3|||
48520728|NCT00522041|156098126|FG000|Overall Study|Protocol Violation|2|||
48520729|NCT00522041|156098127|FG001|Overall Study|Protocol Violation|0|||
48520730|NCT00522041|156098126|FG000|Overall Study|Lost to Follow-up|1|||
48520731|NCT00522041|156098127|FG001|Overall Study|Lost to Follow-up|4|||
48520732|NCT00522041|156098126|FG000|Overall Study|Voluntary withdrawal|5|||
48520733|NCT00522041|156098127|FG001|Overall Study|Voluntary withdrawal|4|||
48520734|NCT00522041|156098126|FG000|Overall Study|Did not receive treatment|0|||
48520735|NCT00522041|156098127|FG001|Overall Study|Did not receive treatment|1|||
48520736|NCT00486434|156098128|FG000|Overall Study|Withdrawal by Subject|34|||
48520737|NCT00486434|156098129|FG001|Overall Study|Withdrawal by Subject|39|||
48520738|NCT00486434|156098128|FG000|Overall Study|Adverse Event|118|||
48520739|NCT00486434|156098129|FG001|Overall Study|Adverse Event|44|||
48520740|NCT00486434|156098128|FG000|Overall Study|Protocol Violation|22|||
48520741|NCT00486434|156098129|FG001|Overall Study|Protocol Violation|21|||
48520742|NCT00486434|156098128|FG000|Overall Study|Lack of Efficacy|12|||
48520743|NCT00486434|156098129|FG001|Overall Study|Lack of Efficacy|19|||
48601481|NCT00676403|156397621|FG000|Overall Study|Lost to Follow-up|0|||
48601482|NCT00676403|156397622|FG001|Overall Study|Lost to Follow-up|0|||
48601483|NCT00676403|156397623|FG002|Overall Study|Lost to Follow-up|0|||
48520744|NCT00486434|156098128|FG000|Overall Study|Lost to Follow-up|2|||
48520745|NCT00486434|156098129|FG001|Overall Study|Lost to Follow-up|3|||
48520746|NCT00486434|156098128|FG000|Overall Study|Death|1|||
48520747|NCT00486434|156098129|FG001|Overall Study|Death|2|||
48520748|NCT00486434|156098128|FG000|Overall Study|Personal reasons|5|||
48520749|NCT00486434|156098129|FG001|Overall Study|Personal reasons|6|||
48520750|NCT02218541|156098130|FG000|Overall Study|Lost to Follow-up|2|||
48601484|NCT00676403|156397624|FG003|Overall Study|Lost to Follow-up|0|||
48824285|NCT00630539|157197215|FG001|Overall Study|Adverse Event|3|||
48520751|NCT02218541|156098131|FG001|Overall Study|Lost to Follow-up|1|||
48520752|NCT02218541|156098130|FG000|Overall Study|Implant Failure|4|||
48520753|NCT02218541|156098131|FG001|Overall Study|Implant Failure|1|||
48520754|NCT04878211|156098132|FG000|Overall Study|Lost to Follow-up|0|||
48520755|NCT04878211|156098133|FG001|Overall Study|Lost to Follow-up|0|||
48520756|NCT04878211|156098134|FG002|Overall Study|Lost to Follow-up|0|||
48824286|NCT00630539|157197216|FG002|Overall Study|Adverse Event|1|||
48520757|NCT04878211|156098135|FG003|Overall Study|Lost to Follow-up|1|||
48520758|NCT04878211|156098136|FG004|Overall Study|Lost to Follow-up|0|||
48520759|NCT04878211|156098137|FG005|Overall Study|Lost to Follow-up|1|||
48520760|NCT04878211|156098132|FG000|Overall Study|Protocol deviation|1|||
48520761|NCT04878211|156098133|FG001|Overall Study|Protocol deviation|0|||
48520762|NCT04878211|156098134|FG002|Overall Study|Protocol deviation|0|||
48520763|NCT04878211|156098135|FG003|Overall Study|Protocol deviation|0|||
48520764|NCT04878211|156098136|FG004|Overall Study|Protocol deviation|0|||
48520765|NCT04878211|156098137|FG005|Overall Study|Protocol deviation|0|||
48520766|NCT04878211|156098132|FG000|Overall Study|Study terminated by sponsor|0|||
48824287|NCT00630539|157197217|FG003|Overall Study|Adverse Event|2|||
48824288|NCT00630539|157197214|FG000|Overall Study|Withdrawal by Subject|0|||
48824289|NCT00630539|157197215|FG001|Overall Study|Withdrawal by Subject|1|||
48824290|NCT00630539|157197216|FG002|Overall Study|Withdrawal by Subject|0|||
48824291|NCT00630539|157197217|FG003|Overall Study|Withdrawal by Subject|1|||
48824292|NCT00577629|157197218|FG000|Treatment Period|Death|1|||
48824293|NCT00577629|157197218|FG000|Long Term Follow-Up|Death|15|||
48824294|NCT00577629|157197218|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
48824295|NCT00577629|157197218|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
48824296|NCT00577629|157197218|FG000|Long Term Follow-Up|Physician Decision|1|||
48824297|NCT01072929|157197219|FG000|Overall Study|Adverse Event|8|||
48824298|NCT01072929|157197220|FG001|Overall Study|Adverse Event|11|||
48824299|NCT01072929|157197221|FG002|Overall Study|Adverse Event|2|||
48824300|NCT01072929|157197219|FG000|Overall Study|Lack of Efficacy|7|||
48824301|NCT01072929|157197220|FG001|Overall Study|Lack of Efficacy|4|||
48520767|NCT04878211|156098133|FG001|Overall Study|Study terminated by sponsor|0|||
48520768|NCT04878211|156098134|FG002|Overall Study|Study terminated by sponsor|0|||
48520769|NCT04878211|156098135|FG003|Overall Study|Study terminated by sponsor|0|||
48520770|NCT04878211|156098136|FG004|Overall Study|Study terminated by sponsor|9|||
48520771|NCT04878211|156098137|FG005|Overall Study|Study terminated by sponsor|4|||
48520772|NCT04878211|156098132|FG000|Overall Study|Subject decision|0|||
48520773|NCT04878211|156098133|FG001|Overall Study|Subject decision|0|||
48520774|NCT04878211|156098134|FG002|Overall Study|Subject decision|0|||
48520775|NCT04878211|156098135|FG003|Overall Study|Subject decision|0|||
48520776|NCT04878211|156098136|FG004|Overall Study|Subject decision|1|||
48601485|NCT00676403|156397625|FG004|Overall Study|Lost to Follow-up|0|||
48601486|NCT00676403|156397626|FG005|Overall Study|Lost to Follow-up|1|||
48601487|NCT00676403|156397621|FG000|Overall Study|Reason Unspecified|1|||
48824302|NCT01072929|157197221|FG002|Overall Study|Lack of Efficacy|0|||
48824303|NCT01072929|157197219|FG000|Overall Study|Withdrawal by Subject|7|||
48824304|NCT01072929|157197220|FG001|Overall Study|Withdrawal by Subject|15|||
48520777|NCT04878211|156098137|FG005|Overall Study|Subject decision|0|||
48601488|NCT00676403|156397622|FG001|Overall Study|Reason Unspecified|0|||
48824305|NCT01072929|157197221|FG002|Overall Study|Withdrawal by Subject|3|||
48824306|NCT01072929|157197219|FG000|Overall Study|Protocol Violation|13|||
48731594|NCT03766685|156869466|FG000|Overall Study|Adverse Event, not fatal|0|||
48731595|NCT03766685|156869467|FG001|Overall Study|Adverse Event, not fatal|1|||
48731596|NCT03766685|156869468|FG002|Overall Study|Adverse Event, not fatal|0|||
48731597|NCT03766685|156869469|FG003|Overall Study|Adverse Event, not fatal|1|||
48731598|NCT03766685|156869466|FG000|Overall Study|Withdrawal by Subject|0|||
48731599|NCT03766685|156869467|FG001|Overall Study|Withdrawal by Subject|2|||
48731600|NCT03766685|156869468|FG002|Overall Study|Withdrawal by Subject|0|||
48520778|NCT04661202|156098138|FG000|Overall Study|Withdrawal by Subject|1|||
48520779|NCT04661202|156098139|FG001|Overall Study|Withdrawal by Subject|1|||
48520780|NCT04661202|156098138|FG000|Overall Study|Lack of Efficacy|2|||
48520781|NCT04661202|156098139|FG001|Overall Study|Lack of Efficacy|0|||
48520782|NCT02578641|156098140|FG000|Overall Study|Adverse Event|5|||
48520783|NCT02578641|156098141|FG001|Overall Study|Adverse Event|15|||
48520784|NCT02578641|156098140|FG000|Overall Study|Death|16|||
48520785|NCT02578641|156098141|FG001|Overall Study|Death|8|||
48520786|NCT02578641|156098140|FG000|Overall Study|Lost to Follow-up|0|||
48520787|NCT02578641|156098141|FG001|Overall Study|Lost to Follow-up|1|||
48520788|NCT02578641|156098140|FG000|Overall Study|Withdrawal by Subject|14|||
48520789|NCT02578641|156098141|FG001|Overall Study|Withdrawal by Subject|7|||
48520790|NCT02578641|156098140|FG000|Overall Study|Progressive Disease|69|||
48520791|NCT02578641|156098141|FG001|Overall Study|Progressive Disease|21|||
48520792|NCT02578641|156098140|FG000|Overall Study|No Study Drug|2|||
48520793|NCT02578641|156098141|FG001|Overall Study|No Study Drug|0|||
48520794|NCT02578641|156098140|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
48520795|NCT02578641|156098141|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
48520796|NCT02578641|156098140|FG000|Overall Study|Non-compliance with Study Schedule|1|||
48520797|NCT02578641|156098141|FG001|Overall Study|Non-compliance with Study Schedule|0|||
48520798|NCT02578641|156098140|FG000|Overall Study|Other|1|||
48520799|NCT02578641|156098141|FG001|Overall Study|Other|10|||
48520800|NCT02578641|156098140|FG000|Overall Study|Not treated|1|||
48520801|NCT02578641|156098141|FG001|Overall Study|Not treated|4|||
48520802|NCT00413049|156098143|FG000|Overall Study|Adverse Event|10|||
48520803|NCT00413049|156098144|FG001|Overall Study|Adverse Event|8|||
48520804|NCT00413049|156098143|FG000|Overall Study|Withdrawal by Subject|7|||
48520805|NCT00413049|156098144|FG001|Overall Study|Withdrawal by Subject|5|||
48520806|NCT00413049|156098143|FG000|Overall Study|Lost to Follow-up|2|||
48520807|NCT00413049|156098144|FG001|Overall Study|Lost to Follow-up|3|||
48520808|NCT00413049|156098143|FG000|Overall Study|Protocol Violation|3|||
48520809|NCT00413049|156098144|FG001|Overall Study|Protocol Violation|1|||
48520810|NCT00413049|156098143|FG000|Overall Study|Subject no longer requires study drug|0|||
48731601|NCT03766685|156869469|FG003|Overall Study|Withdrawal by Subject|0|||
48824307|NCT01072929|157197220|FG001|Overall Study|Protocol Violation|11|||
48824308|NCT01072929|157197221|FG002|Overall Study|Protocol Violation|2|||
48824309|NCT01072929|157197219|FG000|Overall Study|Lost to Follow-up|8|||
48824310|NCT01072929|157197220|FG001|Overall Study|Lost to Follow-up|4|||
48824311|NCT01072929|157197221|FG002|Overall Study|Lost to Follow-up|1|||
48824312|NCT01072929|157197219|FG000|Overall Study|Noncompliance with study medication|0|||
48824313|NCT01072929|157197220|FG001|Overall Study|Noncompliance with study medication|3|||
48824314|NCT01072929|157197221|FG002|Overall Study|Noncompliance with study medication|0|||
48824315|NCT01072929|157197219|FG000|Overall Study|Noncompliance with study procedures|1|||
48824316|NCT01072929|157197220|FG001|Overall Study|Noncompliance with study procedures|0|||
48824317|NCT01072929|157197221|FG002|Overall Study|Noncompliance with study procedures|1|||
48824318|NCT01072929|157197219|FG000|Overall Study|Other|0|||
48824319|NCT01072929|157197220|FG001|Overall Study|Other|3|||
48824320|NCT01072929|157197221|FG002|Overall Study|Other|0|||
48824321|NCT03782727|157197223|FG000|Overall Study|Lost to Follow-up|32|||
48824322|NCT03682536|157197224|FG000|Randomization|Withdrawal by Subject|0|||
48824323|NCT03682536|157197225|FG001|Randomization|Withdrawal by Subject|2|||
48824324|NCT03682536|157197224|FG000|Treatment|Other Reasons|8|||
48824325|NCT03682536|157197225|FG001|Treatment|Other Reasons|7|||
48520811|NCT00413049|156098144|FG001|Overall Study|Subject no longer requires study drug|1|||
48520812|NCT00413049|156098143|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48520813|NCT00413049|156098144|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48520814|NCT00413049|156098143|FG000|Overall Study|Lack of Efficacy|1|||
48520815|NCT00413049|156098144|FG001|Overall Study|Lack of Efficacy|0|||
48520816|NCT01460628|156098145|FG000|Overall Study|Adverse Event|3|||
48520817|NCT01460628|156098145|FG000|Overall Study|Withdrawal by Subject|2|||
48520818|NCT03540160|156098146|FG000|Overall Study|Protocol Violation|1|||
48520819|NCT03540160|156098146|FG000|Overall Study|Physician Decision|8|||
48520820|NCT03540160|156098146|FG000|Overall Study|Lack of Efficacy|60|||
48520821|NCT03540160|156098146|FG000|Overall Study|Pregnancy|1|||
48520822|NCT03540160|156098146|FG000|Overall Study|Adverse Event|20|||
48520823|NCT03540160|156098146|FG000|Overall Study|Withdrawal by Subject|68|||
48824326|NCT03682536|157197224|FG000|Treatment|Physician Decision|5|||
48824327|NCT03682536|157197225|FG001|Treatment|Physician Decision|5|||
48520824|NCT03540160|156098146|FG000|Overall Study|COVID-19|2|||
48520825|NCT03540160|156098146|FG000|Overall Study|Study Closure|10|||
48520826|NCT03540160|156098146|FG000|Overall Study|Lost to Follow-up|18|||
48520827|NCT03540160|156098146|FG000|Overall Study|Sponsor decision|191|||
48520828|NCT01853176|156098147|FG000|Overall Study|Study terminated|4|||
48520829|NCT01853176|156098148|FG001|Overall Study|Study terminated|0|||
48731602|NCT03766685|156869466|FG000|Overall Study|Protocol Violation|0|||
48731603|NCT03766685|156869467|FG001|Overall Study|Protocol Violation|1|||
48731604|NCT03766685|156869468|FG002|Overall Study|Protocol Violation|0|||
48731605|NCT03766685|156869469|FG003|Overall Study|Protocol Violation|0|||
48731606|NCT03766685|156869466|FG000|Overall Study|Non-compliance|0|||
48731607|NCT03766685|156869467|FG001|Overall Study|Non-compliance|2|||
48731608|NCT03766685|156869468|FG002|Overall Study|Non-compliance|0|||
48731609|NCT03766685|156869469|FG003|Overall Study|Non-compliance|0|||
48824328|NCT03682536|157197224|FG000|Treatment|Protocol Violation|1|||
48824329|NCT03682536|157197225|FG001|Treatment|Protocol Violation|0|||
48824330|NCT03682536|157197224|FG000|Treatment|Study Terminated by Sponsor|1|||
48824331|NCT03682536|157197225|FG001|Treatment|Study Terminated by Sponsor|2|||
48824332|NCT03682536|157197224|FG000|Treatment|Lost to Follow-up|0|||
48824333|NCT03682536|157197225|FG001|Treatment|Lost to Follow-up|1|||
48824334|NCT03682536|157197224|FG000|Treatment|Withdrawal by Subject|16|||
48824335|NCT03682536|157197225|FG001|Treatment|Withdrawal by Subject|18|||
48824336|NCT03682536|157197224|FG000|Treatment|Lack of Efficacy|41|||
48824337|NCT03682536|157197225|FG001|Treatment|Lack of Efficacy|68|||
48824338|NCT03682536|157197224|FG000|Treatment|Disease Progression|9|||
48824339|NCT03682536|157197225|FG001|Treatment|Disease Progression|7|||
48824340|NCT03682536|157197224|FG000|Treatment|Adverse Event|9|||
48824341|NCT03682536|157197225|FG001|Treatment|Adverse Event|5|||
48824342|NCT03682536|157197224|FG000|Treatment|Death|14|||
48824343|NCT03682536|157197225|FG001|Treatment|Death|13|||
48824344|NCT03176134|157197226|FG000|Overall Study|Lost to Follow-up|0|||
48824345|NCT03176134|157197227|FG001|Overall Study|Lost to Follow-up|2|||
48824346|NCT03176134|157197228|FG002|Overall Study|Lost to Follow-up|0|||
48824347|NCT03176134|157197229|FG003|Overall Study|Lost to Follow-up|0|||
48824348|NCT03176134|157197230|FG004|Overall Study|Lost to Follow-up|0|||
48824349|NCT03176134|157197231|FG005|Overall Study|Lost to Follow-up|0|||
48824350|NCT03176134|157197232|FG006|Overall Study|Lost to Follow-up|0|||
48824351|NCT03176134|157197233|FG007|Overall Study|Lost to Follow-up|0|||
48824352|NCT03176134|157197226|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48824353|NCT03176134|157197227|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48824354|NCT03176134|157197228|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48824355|NCT03176134|157197229|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48824356|NCT03176134|157197230|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48824357|NCT03176134|157197231|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
48824358|NCT03176134|157197232|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
48824359|NCT03176134|157197233|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
48824360|NCT05008224|157197234|FG000|Overall Study|Death|3|||
48824361|NCT05008224|157197234|FG000|Overall Study|Lost to Follow-up|2|||
48824362|NCT05008224|157197234|FG000|Overall Study|Did Not Continue on Extension Study|39|||
48824363|NCT05008224|157197234|FG000|Overall Study|Transferred to Extension Study|100|||
48520830|NCT01721772|156098149|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
48520831|NCT01721772|156098150|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
48520832|NCT01721772|156098149|FG000|Pre-Treatment|Poor/non-compliance|0|||
48520833|NCT01721772|156098150|FG001|Pre-Treatment|Poor/non-compliance|1|||
48520834|NCT01721772|156098149|FG000|Pre-Treatment|Participant withdrew consent|0|||
48520835|NCT01721772|156098150|FG001|Pre-Treatment|Participant withdrew consent|1|||
48520836|NCT01721772|156098149|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
48520837|NCT01721772|156098150|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
48520838|NCT01721772|156098149|FG000|Treatment|Disease progression|119|||
48520839|NCT01721772|156098150|FG001|Treatment|Disease progression|168|||
48520840|NCT01721772|156098149|FG000|Treatment|Study drug toxicity|19|||
48520841|NCT01721772|156098150|FG001|Treatment|Study drug toxicity|10|||
48520842|NCT01721772|156098149|FG000|Treatment|Adverse event unrelated to study drug|7|||
48520843|NCT01721772|156098150|FG001|Treatment|Adverse event unrelated to study drug|7|||
48520844|NCT01721772|156098149|FG000|Treatment|Maximum clinical benefit|16|||
48520845|NCT01721772|156098150|FG001|Treatment|Maximum clinical benefit|4|||
48520846|NCT01721772|156098149|FG000|Treatment|Other|19|||
48520847|NCT01721772|156098150|FG001|Treatment|Other|2|||
48520848|NCT01721772|156098149|FG000|Treatment|Participant withdrew consent|2|||
48520849|NCT01721772|156098150|FG001|Treatment|Participant withdrew consent|5|||
48824364|NCT05008224|157197234|FG000|Overall Study|Withdrawal by Subject|2|||
48824365|NCT02223182|157197235|FG000|Double-Blind Period|Adverse Event|0|||
48520850|NCT01721772|156098149|FG000|Treatment|Participant request to discontinue study treatment|21|||
48520851|NCT01721772|156098150|FG001|Treatment|Participant request to discontinue study treatment|8|||
48520852|NCT01721772|156098149|FG000|Treatment|Death|1|||
48731610|NCT01484132|156869472|FG000|Overall Study|Lost to Follow-up|8|||
48824366|NCT02223182|157197236|FG001|Double-Blind Period|Adverse Event|2|||
48824367|NCT02223182|157197237|FG002|Double-Blind Period|Adverse Event|1|||
48824368|NCT02223182|157197238|FG003|Double-Blind Period|Adverse Event|0|||
48824369|NCT02223182|157197235|FG000|Double-Blind Period|Withdrawal by Subject|1|||
48824370|NCT02223182|157197236|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48520853|NCT01721772|156098150|FG001|Treatment|Death|0|||
48520854|NCT01721772|156098149|FG000|Treatment|Not reported|1|||
48520855|NCT01721772|156098150|FG001|Treatment|Not reported|0|||
48520856|NCT01721772|156098149|FG000|Treatment|Poor/non-compliance|1|||
48520857|NCT01721772|156098150|FG001|Treatment|Poor/non-compliance|0|||
48520858|NCT01721772|156098149|FG000|Treatment|Lost to Follow-up|0|||
48520859|NCT01721772|156098150|FG001|Treatment|Lost to Follow-up|1|||
48520860|NCT02327325|156098151|FG000|Overall Study|Withdrawal by Subject|1|||
48520861|NCT02327325|156098152|FG001|Overall Study|Withdrawal by Subject|4|||
48520862|NCT02327325|156098153|FG002|Overall Study|Withdrawal by Subject|4|||
48520863|NCT02327325|156098151|FG000|Overall Study|Excluded by Study Team|0|||
48520864|NCT02327325|156098152|FG001|Overall Study|Excluded by Study Team|0|||
48520865|NCT02327325|156098153|FG002|Overall Study|Excluded by Study Team|1|||
48520866|NCT01408888|156098154|FG000|First Intervention|Adverse Event|0|||
48520867|NCT01408888|156098155|FG001|First Intervention|Adverse Event|1|||
48520868|NCT01408888|156098154|FG000|First Intervention|Withdrawal by Subject|0|||
48520869|NCT01408888|156098155|FG001|First Intervention|Withdrawal by Subject|2|||
48520870|NCT01408888|156098154|FG000|Second Intervention|Withdrawal by Subject|1|||
48520871|NCT01408888|156098155|FG001|Second Intervention|Withdrawal by Subject|0|||
48520872|NCT01408888|156098154|FG000|Second Intervention|Adverse Event|1|||
48520873|NCT01408888|156098155|FG001|Second Intervention|Adverse Event|0|||
48520874|NCT01398787|156098156|FG000|Overall Study|Adverse Event|1|||
48520875|NCT02623218|156098158|FG000|Overall Study|Lost to Follow-up|0|||
48520876|NCT02623218|156098159|FG001|Overall Study|Lost to Follow-up|1|||
48520877|NCT02623218|156098160|FG002|Overall Study|Lost to Follow-up|0|||
48520878|NCT02623218|156098161|FG003|Overall Study|Lost to Follow-up|0|||
48520879|NCT02623218|156098162|FG004|Overall Study|Lost to Follow-up|0|||
48520880|NCT03008005|156098164|FG000|Overall Study|Physician Decision|1|||
48520881|NCT03008005|156098165|FG001|Overall Study|Physician Decision|0|||
48520882|NCT03008005|156098166|FG002|Overall Study|Physician Decision|0|||
48520883|NCT03008005|156098164|FG000|Overall Study|Withdrawal by Subject|1|||
48520884|NCT03008005|156098165|FG001|Overall Study|Withdrawal by Subject|0|||
48520885|NCT03008005|156098166|FG002|Overall Study|Withdrawal by Subject|0|||
48520886|NCT03008005|156098164|FG000|Overall Study|Ineligible|0|||
48520887|NCT03008005|156098165|FG001|Overall Study|Ineligible|1|||
48520888|NCT03008005|156098166|FG002|Overall Study|Ineligible|0|||
48520889|NCT01685008|156098168|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
48520890|NCT01685008|156098169|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
48520891|NCT01685008|156098170|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
48520892|NCT01685008|156098171|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
48520893|NCT01685008|156098168|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
48520894|NCT01685008|156098169|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
48520895|NCT01685008|156098170|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
48520896|NCT01685008|156098171|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
48520897|NCT01685008|156098168|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
48520898|NCT01685008|156098169|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
48520899|NCT01685008|156098170|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
48520900|NCT01685008|156098171|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
48520901|NCT01685008|156098168|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
48520902|NCT01685008|156098169|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
48520903|NCT01685008|156098170|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
48520904|NCT01685008|156098171|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
48520905|NCT01685008|156098168|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
48520906|NCT01685008|156098169|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
48731611|NCT01484132|156869472|FG000|Overall Study|Difficulty with time commitment|2|||
48731612|NCT01484132|156869472|FG000|Overall Study|Ineligible|1|||
48731613|NCT01484132|156869472|FG000|Overall Study|No pre-treatment urine sample collected|1|||
48731614|NCT01484132|156869472|FG000|Overall Study|No post-treatment urine sample collected|10|||
48731615|NCT01672736|156869473|FG000|Overall Study|Available drug expired on 31 May 16|3|||
48520907|NCT01685008|156098170|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
48824371|NCT02223182|157197237|FG002|Double-Blind Period|Withdrawal by Subject|1|||
48824372|NCT02223182|157197238|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48824373|NCT02223182|157197235|FG000|Double-Blind Period|Lost to Follow-up|0|||
48824374|NCT02223182|157197236|FG001|Double-Blind Period|Lost to Follow-up|1|||
48824375|NCT02223182|157197237|FG002|Double-Blind Period|Lost to Follow-up|0|||
48824376|NCT02223182|157197238|FG003|Double-Blind Period|Lost to Follow-up|0|||
48824377|NCT02223182|157197235|FG000|Double-Blind Period|Non Compliance|0|||
48824378|NCT02223182|157197236|FG001|Double-Blind Period|Non Compliance|0|||
48824379|NCT02223182|157197237|FG002|Double-Blind Period|Non Compliance|0|||
48824380|NCT02223182|157197238|FG003|Double-Blind Period|Non Compliance|1|||
48824381|NCT02223182|157197235|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
48824382|NCT02223182|157197236|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
48824383|NCT02223182|157197237|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
48824384|NCT02223182|157197238|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
48824385|NCT02223182|157197235|FG000|Open-Label 500 Period|Adverse Event|1|||
48824386|NCT02223182|157197236|FG001|Open-Label 500 Period|Adverse Event|0|||
48824387|NCT02223182|157197237|FG002|Open-Label 500 Period|Adverse Event|2|||
48824388|NCT02223182|157197238|FG003|Open-Label 500 Period|Adverse Event|1|||
48824389|NCT02223182|157197235|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
48824390|NCT02223182|157197236|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
48824391|NCT02223182|157197237|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
48824392|NCT02223182|157197238|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
48824393|NCT02223182|157197235|FG000|Open-Label 500 Period|Physician Decision|0|||
48824394|NCT02223182|157197236|FG001|Open-Label 500 Period|Physician Decision|0|||
48824395|NCT02223182|157197237|FG002|Open-Label 500 Period|Physician Decision|0|||
48824396|NCT02223182|157197238|FG003|Open-Label 500 Period|Physician Decision|1|||
48824397|NCT02223182|157197235|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
48824398|NCT02223182|157197236|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
48824399|NCT02223182|157197237|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
48824400|NCT02223182|157197238|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
48520908|NCT01685008|156098171|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
48824401|NCT02223182|157197235|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
48520909|NCT04439123|156098172|FG000|Overall Study|Adverse Event|11|||
48520910|NCT04439123|156098172|FG000|Overall Study|Death|1|||
48520911|NCT04439123|156098172|FG000|Overall Study|Disease progression|19|||
48520912|NCT04439123|156098172|FG000|Overall Study|Withdrawal by Subject|2|||
48520913|NCT04439123|156098172|FG000|Overall Study|Still on treatment|2|||
48520914|NCT00842309|156098181|FG000|Overall Study|Withdrawal by Subject|3|||
48520915|NCT00842309|156098182|FG001|Overall Study|Withdrawal by Subject|1|||
48520916|NCT04049097|156098184|FG000|Overall Study|Adverse Event|18|||
48520917|NCT04049097|156098184|FG000|Overall Study|Death|2|||
48520918|NCT04049097|156098184|FG000|Overall Study|Lost to Follow-up|1|||
48520919|NCT04049097|156098184|FG000|Overall Study|Physician Decision|2|||
48520920|NCT04049097|156098184|FG000|Overall Study|Withdrawal by Subject|9|||
48520921|NCT04049097|156098184|FG000|Overall Study|Protocol Violation|2|||
48520922|NCT04049097|156098184|FG000|Overall Study|Other|1|||
48520923|NCT04049097|156098184|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
48520924|NCT04476277|156098187|FG000|Overall Study|Withdrawal by Subject|0|||
48520925|NCT04476277|156098188|FG001|Overall Study|Withdrawal by Subject|0|||
48520926|NCT04476277|156098189|FG002|Overall Study|Withdrawal by Subject|1|||
48520927|NCT04476277|156098190|FG003|Overall Study|Withdrawal by Subject|0|||
48520928|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
48520929|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
48520930|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
48520931|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
48520932|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
48520933|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
48520934|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
48520935|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
48520936|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
48520937|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
48520938|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
48520939|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
48520940|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
48520941|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
48520942|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
48520943|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
48520944|NCT01067521|156098195|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
48520945|NCT01067521|156098196|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
48520946|NCT01067521|156098195|FG000|Open-Label Period|Death|3|||
48520947|NCT01067521|156098196|FG001|Open-Label Period|Death|1|||
48601489|NCT00676403|156397623|FG002|Overall Study|Reason Unspecified|1|||
48601490|NCT00676403|156397624|FG003|Overall Study|Reason Unspecified|0|||
48601491|NCT00676403|156397625|FG004|Overall Study|Reason Unspecified|0|||
48601492|NCT00676403|156397626|FG005|Overall Study|Reason Unspecified|1|||
48601493|NCT00676403|156397621|FG000|Overall Study|Withdrawal by Subject|0|||
48601494|NCT00676403|156397622|FG001|Overall Study|Withdrawal by Subject|0|||
48601495|NCT00676403|156397623|FG002|Overall Study|Withdrawal by Subject|0|||
48601496|NCT00676403|156397624|FG003|Overall Study|Withdrawal by Subject|0|||
48601497|NCT00676403|156397625|FG004|Overall Study|Withdrawal by Subject|0|||
48601498|NCT00676403|156397626|FG005|Overall Study|Withdrawal by Subject|1|||
48520948|NCT01067521|156098195|FG000|Open-Label Period|Adverse Event|30|||
48520949|NCT01067521|156098196|FG001|Open-Label Period|Adverse Event|28|||
48520950|NCT01067521|156098195|FG000|Open-Label Period|Withdrawal by Subject|160|||
48520951|NCT01067521|156098196|FG001|Open-Label Period|Withdrawal by Subject|88|||
48520952|NCT01067521|156098195|FG000|Open-Label Period|Physician Decision|13|||
48520953|NCT01067521|156098196|FG001|Open-Label Period|Physician Decision|11|||
48520954|NCT01067521|156098195|FG000|Open-Label Period|Non-compliance with study drug|5|||
48520955|NCT01067521|156098196|FG001|Open-Label Period|Non-compliance with study drug|0|||
48520956|NCT01067521|156098195|FG000|Open-Label Period|Protocol Violation|3|||
48520957|NCT01067521|156098196|FG001|Open-Label Period|Protocol Violation|0|||
48520958|NCT01067521|156098195|FG000|Open-Label Period|Pregnancy|14|||
48520959|NCT01067521|156098196|FG001|Open-Label Period|Pregnancy|8|||
48520960|NCT01067521|156098195|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
48601499|NCT01566604|156397627|FG000|Overall Study|Patient's inability to use the device|1|||
48601500|NCT01566604|156397628|FG001|Overall Study|Patient's inability to use the device|0|||
48601501|NCT01566604|156397627|FG000|Overall Study|Administrative problems|1|||
48601502|NCT01566604|156397628|FG001|Overall Study|Administrative problems|0|||
48601503|NCT01566604|156397627|FG000|Overall Study|Lack of Efficacy|1|||
48601504|NCT01566604|156397628|FG001|Overall Study|Lack of Efficacy|2|||
48601505|NCT01566604|156397627|FG000|Overall Study|Protocol deviation|2|||
48601506|NCT01566604|156397628|FG001|Overall Study|Protocol deviation|0|||
48601507|NCT01566604|156397627|FG000|Overall Study|Abnormal laboratory value|2|||
48601508|NCT01566604|156397628|FG001|Overall Study|Abnormal laboratory value|0|||
48601509|NCT01566604|156397627|FG000|Overall Study|Death|4|||
48601510|NCT01566604|156397628|FG001|Overall Study|Death|1|||
48601511|NCT01566604|156397627|FG000|Overall Study|Adverse Event|4|||
48601512|NCT01566604|156397628|FG001|Overall Study|Adverse Event|2|||
48601513|NCT01566604|156397627|FG000|Overall Study|Withdrawal by Subject|9|||
48601514|NCT01566604|156397628|FG001|Overall Study|Withdrawal by Subject|6|||
48601515|NCT03225170|156397630|FG000|Overall Study|Lost to Follow-up|4|||
48601516|NCT03225170|156397631|FG001|Overall Study|Lost to Follow-up|4|||
48601517|NCT03225170|156397632|FG002|Overall Study|Lost to Follow-up|0|||
48601518|NCT03225170|156397630|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
48601519|NCT03225170|156397631|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
48601520|NCT03225170|156397632|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
48601521|NCT00248651|156397638|FG000|Overall Study|Withdrawal by Subject|28|||
48601522|NCT00248651|156397639|FG001|Overall Study|Withdrawal by Subject|40|||
48601523|NCT00248651|156397640|FG002|Overall Study|Withdrawal by Subject|32|||
48601524|NCT01365130|156397643|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
48601525|NCT01691378|156397652|FG000|Overall Study|Withdrawal by Subject|2|||
48601526|NCT01691378|156397653|FG001|Overall Study|Withdrawal by Subject|0|||
48601527|NCT01691378|156397652|FG000|Overall Study|Lost to Follow-up|5|||
48601528|NCT01691378|156397653|FG001|Overall Study|Lost to Follow-up|2|||
48601529|NCT01687218|156397654|FG000|Overall Study|Withdrawal by Subject|2|||
48601530|NCT01687218|156397655|FG001|Overall Study|Withdrawal by Subject|3|||
48601531|NCT01687218|156397656|FG002|Overall Study|Withdrawal by Subject|0|||
48601532|NCT01687218|156397657|FG003|Overall Study|Withdrawal by Subject|1|||
48601533|NCT01687218|156397658|FG004|Overall Study|Withdrawal by Subject|1|||
48601534|NCT01687218|156397659|FG005|Overall Study|Withdrawal by Subject|0|||
48601535|NCT01687218|156397654|FG000|Overall Study|Relocated, no follow-up planned|1|||
48601536|NCT01687218|156397655|FG001|Overall Study|Relocated, no follow-up planned|0|||
48601537|NCT01687218|156397656|FG002|Overall Study|Relocated, no follow-up planned|1|||
48601538|NCT01687218|156397657|FG003|Overall Study|Relocated, no follow-up planned|1|||
48601539|NCT01687218|156397658|FG004|Overall Study|Relocated, no follow-up planned|0|||
48601540|NCT01687218|156397659|FG005|Overall Study|Relocated, no follow-up planned|0|||
48601541|NCT03139552|156397661|FG000|Overall Study|unable to attend tasting due to schedule|3|||
48601542|NCT03528551|156397662|FG000|Overall Study|Lost to Follow-up|0|||
48601543|NCT03528551|156397663|FG001|Overall Study|Lost to Follow-up|1|||
48601544|NCT03528551|156397664|FG002|Overall Study|Lost to Follow-up|0|||
48601545|NCT03528551|156397662|FG000|Overall Study|Transferred to other arm/group|2|||
48601546|NCT03528551|156397663|FG001|Overall Study|Transferred to other arm/group|3|||
48601547|NCT03528551|156397664|FG002|Overall Study|Transferred to other arm/group|0|||
48601548|NCT03528551|156397662|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48601549|NCT03528551|156397663|FG001|Overall Study|Withdrawal by parent/guardian|5|||
48601550|NCT03528551|156397664|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48601551|NCT03528551|156397662|FG000|Overall Study|Protocol Violation|0|||
48520961|NCT01067521|156098196|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
48520962|NCT01067521|156098195|FG000|Open-Label Period|Lost to Follow-up|21|||
48520963|NCT01067521|156098196|FG001|Open-Label Period|Lost to Follow-up|20|||
48520964|NCT02597049|156098197|FG000|Overall Study|Lost to Follow-up|0|||
48731664|NCT01570868|156869477|FG000|Overall Study|Adverse Event|8|||
48731665|NCT01570868|156869478|FG001|Overall Study|Adverse Event|1|||
48731666|NCT01570868|156869477|FG000|Overall Study|FDA Recommendation|23|||
48731667|NCT01570868|156869478|FG001|Overall Study|FDA Recommendation|3|||
48520965|NCT02597049|156098198|FG001|Overall Study|Lost to Follow-up|3|||
48520966|NCT02597049|156098199|FG002|Overall Study|Lost to Follow-up|2|||
48520967|NCT02597049|156098197|FG000|Overall Study|Withdrawal by Subject|2|||
48520968|NCT02597049|156098198|FG001|Overall Study|Withdrawal by Subject|2|||
48520969|NCT02597049|156098199|FG002|Overall Study|Withdrawal by Subject|1|||
48520970|NCT02597049|156098197|FG000|Overall Study|Adverse Event|2|||
48520971|NCT02597049|156098198|FG001|Overall Study|Adverse Event|0|||
48520972|NCT02597049|156098199|FG002|Overall Study|Adverse Event|0|||
48520973|NCT02597049|156098197|FG000|Overall Study|Death|2|||
48520974|NCT02597049|156098198|FG001|Overall Study|Death|0|||
48520975|NCT02597049|156098199|FG002|Overall Study|Death|0|||
48520976|NCT02597049|156098197|FG000|Overall Study|Noncompliant with Study Visits|1|||
48520977|NCT02597049|156098198|FG001|Overall Study|Noncompliant with Study Visits|0|||
48520978|NCT02597049|156098199|FG002|Overall Study|Noncompliant with Study Visits|0|||
48520979|NCT01044433|156098202|FG000|Overall Study|Lost to Follow-up|3|||
48520980|NCT01044433|156098202|FG000|Overall Study|Withdrawal by Subject|3|||
48520981|NCT01547728|156098208|FG000|Overall Study|Change in procedure and equipment|1|||
48520982|NCT01547728|156098208|FG000|Overall Study|Drug not ready for subject|1|||
48601552|NCT03528551|156397663|FG001|Overall Study|Protocol Violation|3|||
48520983|NCT01547728|156098208|FG000|Overall Study|Screen failure|39|||
48520984|NCT01341405|156098210|FG000|Overall Study|Adverse Event|0|||
48520985|NCT01341405|156098211|FG001|Overall Study|Adverse Event|1|||
48520986|NCT01341405|156098212|FG002|Overall Study|Adverse Event|1|||
48731668|NCT01570868|156869477|FG000|Overall Study|Physician Decision|10|||
48731669|NCT01570868|156869478|FG001|Overall Study|Physician Decision|4|||
48731670|NCT01570868|156869477|FG000|Overall Study|Lost to Follow-up|1|||
48731671|NCT01570868|156869478|FG001|Overall Study|Lost to Follow-up|0|||
48731672|NCT01570868|156869477|FG000|Overall Study|Withdrawal by Subject|1|||
48731673|NCT01570868|156869478|FG001|Overall Study|Withdrawal by Subject|0|||
48731674|NCT00923936|156869481|FG000|Overall Study|progressive disease on study|2|||
48731675|NCT00923936|156869482|FG001|Overall Study|progressive disease on study|1|||
48731676|NCT00923936|156869481|FG000|Overall Study|Adverse Event|2|||
48731677|NCT00923936|156869482|FG001|Overall Study|Adverse Event|1|||
48731678|NCT00923936|156869481|FG000|Overall Study|Lost to follow up|2|||
48731679|NCT00923936|156869482|FG001|Overall Study|Lost to follow up|0|||
48731680|NCT00923936|156869481|FG000|Overall Study|Continuing in follow up period|2|||
48731681|NCT00923936|156869482|FG001|Overall Study|Continuing in follow up period|1|||
48731682|NCT01697358|156869487|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
48520987|NCT01341405|156098210|FG000|Overall Study|Withdrawal by Subject|3|||
48520988|NCT01341405|156098211|FG001|Overall Study|Withdrawal by Subject|2|||
48520989|NCT01341405|156098212|FG002|Overall Study|Withdrawal by Subject|1|||
48520990|NCT03105297|156098213|FG000|Baseline Phase (Day 1)|Other|21|||
48520991|NCT03105297|156098213|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
48520992|NCT03105297|156098213|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
48520993|NCT05263505|156098214|FG000|Overall Study|Adverse Event|0|||
48520994|NCT05263505|156098215|FG001|Overall Study|Adverse Event|1|||
48520995|NCT05692154|156098216|FG000|Overall Study|Adverse Event|0|||
48520996|NCT05692154|156098217|FG001|Overall Study|Adverse Event|1|||
48520997|NCT02218216|156098218|FG000|Overall Study|Study terminated before completed|6|||
48520998|NCT02218216|156098219|FG001|Overall Study|Study terminated before completed|0|||
48520999|NCT02218216|156098220|FG002|Overall Study|Study terminated before completed|0|||
48521000|NCT02151149|156098221|FG000|Treatment Period|Death|2|||
48521001|NCT02151149|156098222|FG001|Treatment Period|Death|3|||
48521002|NCT02151149|156098221|FG000|Treatment Period|Adverse Event|17|||
48521003|NCT02151149|156098222|FG001|Treatment Period|Adverse Event|14|||
48521004|NCT02151149|156098221|FG000|Treatment Period|Progressive Disease|25|||
48521005|NCT02151149|156098222|FG001|Treatment Period|Progressive Disease|24|||
48521006|NCT02151149|156098221|FG000|Treatment Period|Symptomatic Deterioration|2|||
48521007|NCT02151149|156098222|FG001|Treatment Period|Symptomatic Deterioration|10|||
48521008|NCT02151149|156098221|FG000|Treatment Period|Withdrawal by Subject|13|||
48521009|NCT02151149|156098222|FG001|Treatment Period|Withdrawal by Subject|11|||
48521010|NCT02151149|156098221|FG000|Treatment Period|Miscellaneous|8|||
48521011|NCT02151149|156098222|FG001|Treatment Period|Miscellaneous|7|||
48521012|NCT02151149|156098221|FG000|Treatment Period|Participants randomized but not treated|3|||
48521013|NCT02151149|156098222|FG001|Treatment Period|Participants randomized but not treated|2|||
48521014|NCT02151149|156098221|FG000|Follow-Up Period|Lost to Follow-up|2|||
48521015|NCT02151149|156098222|FG001|Follow-Up Period|Lost to Follow-up|3|||
48521016|NCT02151149|156098221|FG000|Follow-Up Period|Death|37|||
48521017|NCT02151149|156098222|FG001|Follow-Up Period|Death|34|||
48824402|NCT02223182|157197236|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
48824403|NCT02223182|157197237|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
48824404|NCT02223182|157197238|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
48824405|NCT02223182|157197235|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
48824406|NCT02223182|157197236|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
48824407|NCT02223182|157197237|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
48824408|NCT02223182|157197238|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
48521018|NCT00766493|156098223|FG000|30 Days Post-Procedure|Discontinued|7|||
48824409|NCT02223182|157197235|FG000|Open-Label 300 Period|Non Compliance|0|||
48824410|NCT02223182|157197236|FG001|Open-Label 300 Period|Non Compliance|2|||
48521019|NCT00766493|156098223|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
48521020|NCT00766493|156098223|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
48824411|NCT02223182|157197237|FG002|Open-Label 300 Period|Non Compliance|1|||
48521021|NCT00714051|156098224|FG000|Overall Study|Withdrawal by Subject|1|||
48521022|NCT00714051|156098225|FG001|Overall Study|Withdrawal by Subject|0|||
48731683|NCT01697358|156869488|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
48731684|NCT01697358|156869487|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
48731685|NCT01697358|156869488|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
48521023|NCT00714051|156098224|FG000|Overall Study|Death|0|||
48521024|NCT00714051|156098225|FG001|Overall Study|Death|1|||
48521025|NCT00860262|156098228|FG000|Overall Study|Adverse Event|9|||
48521026|NCT00860262|156098229|FG001|Overall Study|Adverse Event|6|||
48521027|NCT00860262|156098230|FG002|Overall Study|Adverse Event|7|||
48521028|NCT00860262|156098228|FG000|Overall Study|Protocol Violation|0|||
48521029|NCT00860262|156098229|FG001|Overall Study|Protocol Violation|1|||
48601553|NCT03528551|156397664|FG002|Overall Study|Protocol Violation|0|||
48731686|NCT01697358|156869487|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
48824412|NCT02223182|157197238|FG003|Open-Label 300 Period|Non Compliance|0|||
48824413|NCT01321073|157197239|FG000|Overall Study|Did not attempt implant|4|||
48824414|NCT01321073|157197239|FG000|Overall Study|Death|3|||
48731687|NCT01697358|156869488|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
48731688|NCT01697358|156869487|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
48824415|NCT04956692|157197240|FG000|Overall Study|Death|115|||
48824416|NCT04956692|157197241|FG001|Overall Study|Death|47|||
48731689|NCT01697358|156869488|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
48731690|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
48731691|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
48731692|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
48731693|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
48731694|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
48731695|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
48731696|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
48731697|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
48731698|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
48731699|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
48731700|NCT01697358|156869487|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
48731701|NCT01697358|156869488|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
48731702|NCT03538431|156869490|FG000|Overall Study|Physician Decision|0|||
48824417|NCT04956692|157197240|FG000|Overall Study|Lost to Follow-up|0|||
48824418|NCT04956692|157197241|FG001|Overall Study|Lost to Follow-up|1|||
48824419|NCT04956692|157197240|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48824420|NCT04956692|157197241|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48824421|NCT04956692|157197240|FG000|Overall Study|Withdrawal by Subject|5|||
48824422|NCT04956692|157197241|FG001|Overall Study|Withdrawal by Subject|2|||
48824423|NCT04956692|157197240|FG000|Overall Study|Ongoing in Study|236|||
48824424|NCT04956692|157197241|FG001|Overall Study|Ongoing in Study|123|||
48824425|NCT03424239|157197245|FG000|Overall Study|Withdrawal by Subject|2|||
48824426|NCT03289455|157197247|FG000|Overall Study|Death|1|||
48824427|NCT03289455|157197248|FG001|Overall Study|Death|0|||
48824428|NCT03289455|157197249|FG002|Overall Study|Death|0|||
48824429|NCT03289455|157197247|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
48824430|NCT03289455|157197248|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
48824431|NCT03289455|157197249|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
48824432|NCT03289455|157197247|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
48824433|NCT03289455|157197248|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
48824434|NCT03289455|157197249|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
48824435|NCT03289455|157197247|FG000|Overall Study|Progressive disease|3|||
48824436|NCT03289455|157197248|FG001|Overall Study|Progressive disease|4|||
48824437|NCT03289455|157197249|FG002|Overall Study|Progressive disease|5|||
48824438|NCT01822821|157197250|FG000|Overall Study|Eligible surgery cancelled|1|||
48824439|NCT01822821|157197251|FG001|Overall Study|Eligible surgery cancelled|1|||
48824440|NCT01822821|157197250|FG000|Overall Study|Other reasons|1|||
48824441|NCT01822821|157197251|FG001|Overall Study|Other reasons|0|||
48824442|NCT04305912|157197252|FG000|First Intervention|COVID-19 Suspension|2|||
48824443|NCT04305912|157197253|FG001|First Intervention|COVID-19 Suspension|0|||
48824444|NCT04305912|157197252|FG000|First Intervention|Withdrawal by Subject|0|||
48824445|NCT04305912|157197253|FG001|First Intervention|Withdrawal by Subject|1|||
48824446|NCT04305912|157197252|FG000|Second Intervention|Adverse Event|0|||
48824447|NCT04305912|157197253|FG001|Second Intervention|Adverse Event|1|||
48824448|NCT01649427|157197260|FG000|Overall Study|Adverse Event|1|||
48824449|NCT01649427|157197261|FG001|Overall Study|Adverse Event|1|||
48824450|NCT01649427|157197260|FG000|Overall Study|Withdrawal by Subject|8|||
48824451|NCT01649427|157197261|FG001|Overall Study|Withdrawal by Subject|7|||
48824452|NCT01649427|157197260|FG000|Overall Study|Lost to Follow-up|0|||
48824453|NCT01649427|157197261|FG001|Overall Study|Lost to Follow-up|1|||
48824454|NCT01649427|157197260|FG000|Overall Study|Graft loss|0|||
48824455|NCT01649427|157197261|FG001|Overall Study|Graft loss|1|||
48824456|NCT01649427|157197260|FG000|Overall Study|Surgical problems during nephrectomy|2|||
48824457|NCT01649427|157197261|FG001|Overall Study|Surgical problems during nephrectomy|2|||
48824458|NCT04794179|157197264|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
48824459|NCT04794179|157197265|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
48824460|NCT05780047|157197266|FG000|Overall Study|Did not submit baseline urine test kit|226|||
48824461|NCT05780047|157197266|FG000|Overall Study|Lost to Follow-up|34|||
48824462|NCT05780047|157197266|FG000|Overall Study|Did not submit second urine test kit|124|||
48824463|NCT03212365|157197271|FG000|Overall Study|Discharged prior to Xa level|12|||
48521030|NCT00860262|156098230|FG002|Overall Study|Protocol Violation|0|||
48824464|NCT03212365|157197272|FG001|Overall Study|Discharged prior to Xa level|8|||
48824465|NCT03212365|157197271|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
48521031|NCT00860262|156098228|FG000|Overall Study|Lost to Follow-up|2|||
48521032|NCT00860262|156098229|FG001|Overall Study|Lost to Follow-up|0|||
48521033|NCT00860262|156098230|FG002|Overall Study|Lost to Follow-up|1|||
48521034|NCT00860262|156098228|FG000|Overall Study|Withdrawal by Subject|4|||
48731703|NCT03538431|156869491|FG001|Overall Study|Physician Decision|1|||
48731704|NCT03538431|156869490|FG000|Overall Study|Withdrawal by Subject|1|||
48731705|NCT03538431|156869491|FG001|Overall Study|Withdrawal by Subject|0|||
48731706|NCT00586066|156869492|FG000|Overall Study|Lost to Follow-up|6|||
48731707|NCT00586066|156869493|FG001|Overall Study|Lost to Follow-up|3|||
48731708|NCT00586066|156869492|FG000|Overall Study|Lack of Efficacy|5|||
48731709|NCT00586066|156869493|FG001|Overall Study|Lack of Efficacy|3|||
48731710|NCT00586066|156869492|FG000|Overall Study|Adverse Event|2|||
48731711|NCT00586066|156869493|FG001|Overall Study|Adverse Event|2|||
48731712|NCT00586066|156869492|FG000|Overall Study|Physician Decision|1|||
48731713|NCT00586066|156869493|FG001|Overall Study|Physician Decision|0|||
48731714|NCT00586066|156869492|FG000|Overall Study|Withdrawal of consent|4|||
48731715|NCT00586066|156869493|FG001|Overall Study|Withdrawal of consent|2|||
48731716|NCT01231347|156869496|FG000|Overall Study|Full Consent withdrawn|19|||
48731717|NCT01231347|156869497|FG001|Overall Study|Full Consent withdrawn|19|||
48731718|NCT01231347|156869498|FG002|Overall Study|Full Consent withdrawn|11|||
48731719|NCT01231347|156869496|FG000|Overall Study|Lost to Follow-up|4|||
48731720|NCT01231347|156869497|FG001|Overall Study|Lost to Follow-up|2|||
48731721|NCT01231347|156869498|FG002|Overall Study|Lost to Follow-up|2|||
48731722|NCT01231347|156869496|FG000|Overall Study|Death|202|||
48731723|NCT01231347|156869497|FG001|Overall Study|Death|210|||
48731724|NCT01231347|156869498|FG002|Overall Study|Death|101|||
48731725|NCT01231347|156869496|FG000|Overall Study|other event|7|||
48731726|NCT01231347|156869497|FG001|Overall Study|other event|9|||
48731727|NCT01231347|156869498|FG002|Overall Study|other event|3|||
48731728|NCT00910988|156869505|FG000|Overall Study|Lost to Follow-up|2|||
48731729|NCT00910988|156869506|FG001|Overall Study|Lost to Follow-up|4|||
48731730|NCT00910988|156869507|FG002|Overall Study|Lost to Follow-up|3|||
48731731|NCT00910988|156869508|FG003|Overall Study|Lost to Follow-up|0|||
48731732|NCT04545554|156869509|FG000|Overall Study|Withdrawal by Subject|0|||
48731733|NCT04545554|156869510|FG001|Overall Study|Withdrawal by Subject|0|||
48731734|NCT04545554|156869511|FG002|Overall Study|Withdrawal by Subject|0|||
48731735|NCT04545554|156869512|FG003|Overall Study|Withdrawal by Subject|1|||
48731736|NCT04545554|156869513|FG004|Overall Study|Withdrawal by Subject|0|||
48731737|NCT04545554|156869514|FG005|Overall Study|Withdrawal by Subject|0|||
48731738|NCT03004443|156869515|FG000|Overall Study|Pregnancy|0|||
48731739|NCT03004443|156869516|FG001|Overall Study|Pregnancy|1|||
48731740|NCT00915356|156869517|FG000|Overall Study|Withdrawal by Subject|1|||
48731741|NCT00915356|156869518|FG001|Overall Study|Withdrawal by Subject|0|||
48731742|NCT00915356|156869519|FG002|Overall Study|Withdrawal by Subject|0|||
48731743|NCT00915356|156869520|FG003|Overall Study|Withdrawal by Subject|0|||
48731744|NCT00915356|156869521|FG004|Overall Study|Withdrawal by Subject|0|||
48731745|NCT02713204|156869524|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
48731746|NCT02713204|156869525|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731747|NCT02713204|156869526|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
48731748|NCT02713204|156869527|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731749|NCT02713204|156869528|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731750|NCT02713204|156869529|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731751|NCT02713204|156869530|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731752|NCT02713204|156869531|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
48731753|NCT02713204|156869524|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731754|NCT02713204|156869525|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731755|NCT02713204|156869526|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
48731756|NCT02713204|156869527|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731757|NCT02713204|156869528|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731758|NCT02713204|156869529|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731759|NCT02713204|156869530|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731760|NCT02713204|156869531|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48731761|NCT02713204|156869524|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731762|NCT02713204|156869525|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
48731763|NCT02713204|156869526|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731764|NCT02713204|156869527|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731765|NCT02713204|156869528|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731766|NCT02713204|156869529|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731767|NCT02713204|156869530|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731768|NCT02713204|156869531|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48731769|NCT02713204|156869524|FG000|From Week 12 up to Week 36|Adverse Event|1|||
48731770|NCT02713204|156869525|FG001|From Week 12 up to Week 36|Adverse Event|0|||
48731771|NCT02713204|156869526|FG002|From Week 12 up to Week 36|Adverse Event|0|||
48731772|NCT02713204|156869527|FG003|From Week 12 up to Week 36|Adverse Event|1|||
48731773|NCT02713204|156869528|FG004|From Week 12 up to Week 36|Adverse Event|1|||
48731774|NCT02713204|156869529|FG005|From Week 12 up to Week 36|Adverse Event|0|||
48731775|NCT02713204|156869530|FG006|From Week 12 up to Week 36|Adverse Event|2|||
48731776|NCT02713204|156869531|FG007|From Week 12 up to Week 36|Adverse Event|1|||
48731777|NCT02713204|156869524|FG000|From Week 12 up to Week 36|Death|0|||
48824466|NCT03212365|157197272|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
48824467|NCT03212365|157197271|FG000|Overall Study|Refused study medication|3|||
48824468|NCT03212365|157197272|FG001|Overall Study|Refused study medication|0|||
48824469|NCT03212365|157197271|FG000|Overall Study|Initiated heparin infusion on floor|1|||
48824470|NCT03212365|157197272|FG001|Overall Study|Initiated heparin infusion on floor|1|||
48824471|NCT03212365|157197271|FG000|Overall Study|Unexpected return to OR|1|||
48824472|NCT03212365|157197272|FG001|Overall Study|Unexpected return to OR|1|||
48824473|NCT03212365|157197271|FG000|Overall Study|Medication distribution error|1|||
48824474|NCT03212365|157197272|FG001|Overall Study|Medication distribution error|0|||
48824475|NCT03212365|157197271|FG000|Overall Study|Required epidural placement|1|||
48824476|NCT03212365|157197272|FG001|Overall Study|Required epidural placement|0|||
48824477|NCT03212365|157197271|FG000|Overall Study|Withdrawal by Subject|0|||
48824478|NCT03212365|157197272|FG001|Overall Study|Withdrawal by Subject|1|||
48824479|NCT03212365|157197271|FG000|Overall Study|developed acute renal failure|0|||
48824480|NCT03212365|157197272|FG001|Overall Study|developed acute renal failure|1|||
48824481|NCT04394624|157197273|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|6|||
48824482|NCT04394624|157197273|FG000|Overall Study|Adverse Event|5|||
48824483|NCT04394624|157197273|FG000|Overall Study|Progressive disease|20|||
48824484|NCT03369951|157197274|FG000|Overall Study|Withdrawal by Subject|3|||
48824485|NCT03369951|157197274|FG000|Overall Study|Death|1|||
48824486|NCT03369951|157197274|FG000|Overall Study|Lost to Follow-up|1|||
48824487|NCT03369951|157197274|FG000|Overall Study|Protocol Violation|1|||
48824488|NCT01641861|157197280|FG000|Overall Study|Lost to Follow-up|21|||
48824489|NCT01641861|157197281|FG001|Overall Study|Lost to Follow-up|16|||
48824490|NCT01641861|157197280|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
48824491|NCT01641861|157197281|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
48824492|NCT01641861|157197280|FG000|Overall Study|Died due to drowning|0|||
48824493|NCT01641861|157197281|FG001|Overall Study|Died due to drowning|1|||
48824494|NCT01556243|157197282|FG000|Overall Study|Ineligible|34|||
48824495|NCT01556243|157197282|FG000|Overall Study|Converted to mastectomy|14|||
48824496|NCT01556243|157197282|FG000|Overall Study|Unable to achieve negative margins|2|||
48824497|NCT01556243|157197282|FG000|Overall Study|Withdrawal by Subject|16|||
48824498|NCT01388543|157197283|FG000|Day 14|Adverse Event|1|||
48824499|NCT01388543|157197284|FG001|Day 14|Adverse Event|4|||
48824500|NCT00430677|157197287|FG000|Short-term Period|Death|1|||
48824501|NCT00430677|157197288|FG001|Short-term Period|Death|1|||
48824502|NCT00430677|157197289|FG002|Short-term Period|Death|5|||
48824503|NCT00430677|157197287|FG000|Short-term Period|Adverse Event|15|||
48824504|NCT00430677|157197288|FG001|Short-term Period|Adverse Event|13|||
48824505|NCT00430677|157197289|FG002|Short-term Period|Adverse Event|9|||
48824506|NCT00430677|157197287|FG000|Short-term Period|Lack of Efficacy|5|||
48824507|NCT00430677|157197288|FG001|Short-term Period|Lack of Efficacy|6|||
48824508|NCT00430677|157197289|FG002|Short-term Period|Lack of Efficacy|4|||
48824509|NCT00430677|157197287|FG000|Short-term Period|Withdrawal by Subject|1|||
48824510|NCT00430677|157197288|FG001|Short-term Period|Withdrawal by Subject|1|||
48824511|NCT00430677|157197289|FG002|Short-term Period|Withdrawal by Subject|2|||
48824512|NCT00430677|157197287|FG000|Short-term Period|Participant no longer met study criteria|1|||
48824513|NCT00430677|157197288|FG001|Short-term Period|Participant no longer met study criteria|1|||
48824514|NCT00430677|157197289|FG002|Short-term Period|Participant no longer met study criteria|2|||
48824515|NCT00430677|157197287|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
48824516|NCT00430677|157197288|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
48824517|NCT00430677|157197289|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
48824518|NCT00430677|157197287|FG000|Short-term Period|Pregnancy|0|||
48824519|NCT00430677|157197288|FG001|Short-term Period|Pregnancy|2|||
48824520|NCT00430677|157197289|FG002|Short-term Period|Pregnancy|0|||
48824521|NCT00430677|157197287|FG000|Long-term Extension Period|Death|1|||
48824522|NCT00430677|157197288|FG001|Long-term Extension Period|Death|0|||
48824523|NCT00430677|157197289|FG002|Long-term Extension Period|Death|0|||
48824524|NCT00430677|157197287|FG000|Long-term Extension Period|Adverse Event|3|||
48601554|NCT03528551|156397662|FG000|Overall Study|Withdrawal by Subject|0|||
48824525|NCT00430677|157197288|FG001|Long-term Extension Period|Adverse Event|2|||
48824526|NCT00430677|157197289|FG002|Long-term Extension Period|Adverse Event|5|||
48824527|NCT00430677|157197287|FG000|Long-term Extension Period|Lack of Efficacy|5|||
48824528|NCT00430677|157197288|FG001|Long-term Extension Period|Lack of Efficacy|3|||
48824529|NCT00430677|157197289|FG002|Long-term Extension Period|Lack of Efficacy|8|||
48824530|NCT00430677|157197287|FG000|Long-term Extension Period|Lost to Follow-up|1|||
48824531|NCT00430677|157197288|FG001|Long-term Extension Period|Lost to Follow-up|1|||
48824532|NCT00430677|157197289|FG002|Long-term Extension Period|Lost to Follow-up|1|||
48824533|NCT00430677|157197287|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
48601555|NCT03528551|156397663|FG001|Overall Study|Withdrawal by Subject|7|||
48601556|NCT03528551|156397664|FG002|Overall Study|Withdrawal by Subject|0|||
48824534|NCT00430677|157197288|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
48824535|NCT00430677|157197289|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
48824536|NCT00430677|157197287|FG000|Long-term Extension Period|Pregnancy|1|||
48824537|NCT00430677|157197288|FG001|Long-term Extension Period|Pregnancy|1|||
48824538|NCT00430677|157197289|FG002|Long-term Extension Period|Pregnancy|0|||
48824539|NCT00430677|157197287|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
48824540|NCT00430677|157197288|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
48824541|NCT00430677|157197289|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
48824542|NCT00430677|157197287|FG000|Long-term Extension Period|Other|2|||
48824543|NCT00430677|157197288|FG001|Long-term Extension Period|Other|1|||
48824544|NCT00430677|157197289|FG002|Long-term Extension Period|Other|1|||
48824545|NCT00430677|157197287|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
48824546|NCT00430677|157197288|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
48824547|NCT00430677|157197289|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
48824548|NCT00670540|157197290|FG000|Overall Study|ineligible|17|||
48731778|NCT02713204|156869525|FG001|From Week 12 up to Week 36|Death|0|||
48824549|NCT00670540|157197290|FG000|Overall Study|not living in France|348|||
48731779|NCT02713204|156869526|FG002|From Week 12 up to Week 36|Death|0|||
48731780|NCT02713204|156869527|FG003|From Week 12 up to Week 36|Death|1|||
48731781|NCT02713204|156869528|FG004|From Week 12 up to Week 36|Death|0|||
48731782|NCT02713204|156869529|FG005|From Week 12 up to Week 36|Death|1|||
48731783|NCT02713204|156869530|FG006|From Week 12 up to Week 36|Death|0|||
48731784|NCT02713204|156869531|FG007|From Week 12 up to Week 36|Death|3|||
48731785|NCT02713204|156869524|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731786|NCT02713204|156869525|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731787|NCT02713204|156869526|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731788|NCT02713204|156869527|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
48731789|NCT02713204|156869528|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731790|NCT02713204|156869529|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731791|NCT02713204|156869530|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731792|NCT02713204|156869531|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
48731793|NCT02713204|156869524|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
48731794|NCT02713204|156869525|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
48731795|NCT02713204|156869526|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
48731796|NCT02713204|156869527|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
48731797|NCT02713204|156869528|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
48731798|NCT02713204|156869529|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
48731799|NCT02713204|156869530|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
48731800|NCT02713204|156869531|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
48731801|NCT04399837|156869539|FG000|Overall Study|Other than listed|0|||
48731802|NCT04399837|156869540|FG001|Overall Study|Other than listed|2|||
48731803|NCT04399837|156869541|FG002|Overall Study|Other than listed|2|||
48731804|NCT04399837|156869542|FG003|Overall Study|Other than listed|3|||
48731805|NCT04399837|156869539|FG000|Overall Study|Withdrawal by Subject|1|||
48731806|NCT04399837|156869540|FG001|Overall Study|Withdrawal by Subject|2|||
48731807|NCT04399837|156869541|FG002|Overall Study|Withdrawal by Subject|1|||
48731808|NCT04399837|156869542|FG003|Overall Study|Withdrawal by Subject|1|||
48731809|NCT03698331|156869546|FG000|Overall Study|Adverse Event|2|||
48731810|NCT03698331|156869547|FG001|Overall Study|Adverse Event|3|||
48731811|NCT03698331|156869546|FG000|Overall Study|Withdrawal by Subject|1|||
48731812|NCT03698331|156869547|FG001|Overall Study|Withdrawal by Subject|1|||
48731813|NCT03698331|156869546|FG000|Overall Study|Lost to Follow-up|0|||
48521035|NCT00860262|156098229|FG001|Overall Study|Withdrawal by Subject|8|||
48521036|NCT00860262|156098230|FG002|Overall Study|Withdrawal by Subject|6|||
48521037|NCT00860262|156098228|FG000|Overall Study|Lack of Efficacy|0|||
48521038|NCT00860262|156098229|FG001|Overall Study|Lack of Efficacy|4|||
48521039|NCT00860262|156098230|FG002|Overall Study|Lack of Efficacy|3|||
48521040|NCT00860262|156098228|FG000|Overall Study|Other|5|||
48731814|NCT03698331|156869547|FG001|Overall Study|Lost to Follow-up|2|||
48731815|NCT03698331|156869546|FG000|Overall Study|Non-compliance with study drug|1|||
48824550|NCT00670540|157197290|FG000|Overall Study|refused to participate|189|||
48824551|NCT00670540|157197290|FG000|Overall Study|controls randomised for no follow up|2770|||
48521041|NCT00860262|156098229|FG001|Overall Study|Other|3|||
48731816|NCT03698331|156869547|FG001|Overall Study|Non-compliance with study drug|0|||
48731817|NCT00678080|156869548|FG000|Overall Study|Physician Decision|2|||
48731818|NCT00678080|156869549|FG001|Overall Study|Physician Decision|0|||
48731819|NCT00678080|156869548|FG000|Overall Study|Lost to Follow-up|1|||
48731820|NCT00678080|156869549|FG001|Overall Study|Lost to Follow-up|0|||
48731821|NCT00678080|156869548|FG000|Overall Study|Withdrawal by Subject|0|||
48824552|NCT00670540|157197290|FG000|Overall Study|missing information inclusion criteria|1|||
48824553|NCT00681811|157197291|FG000|Overall Study|Adverse Event|1|||
48824554|NCT00681811|157197292|FG001|Overall Study|Adverse Event|1|||
48521042|NCT00860262|156098230|FG002|Overall Study|Other|1|||
48521043|NCT01596127|156098235|FG000|Overall Study|Patient Ineligible|1|||
48521044|NCT04194151|156098237|FG000|Overall Study|Physician Decision|1|||
48731822|NCT00678080|156869549|FG001|Overall Study|Withdrawal by Subject|1|||
48731823|NCT05274165|156869550|FG000|Overall Study|Withdrawal by Subject|3|||
48731824|NCT05274165|156869551|FG001|Overall Study|Withdrawal by Subject|3|||
48731825|NCT02484690|156869552|FG000|Overall Study|Adverse Event|1|||
48521045|NCT04194151|156098238|FG001|Overall Study|Physician Decision|1|||
48521046|NCT04194151|156098239|FG002|Overall Study|Physician Decision|1|||
48521047|NCT04194151|156098240|FG003|Overall Study|Physician Decision|1|||
48521048|NCT04194151|156098241|FG004|Overall Study|Physician Decision|0|||
48521049|NCT04194151|156098242|FG005|Overall Study|Physician Decision|1|||
48521050|NCT04194151|156098237|FG000|Overall Study|Monitorization problem|0|||
48521051|NCT04194151|156098238|FG001|Overall Study|Monitorization problem|1|||
48521052|NCT04194151|156098239|FG002|Overall Study|Monitorization problem|0|||
48521053|NCT04194151|156098240|FG003|Overall Study|Monitorization problem|0|||
48521054|NCT04194151|156098241|FG004|Overall Study|Monitorization problem|0|||
48521055|NCT04194151|156098242|FG005|Overall Study|Monitorization problem|0|||
48521056|NCT01378962|156098243|FG000|Overall Study|Death|14|||
48521057|NCT01378962|156098243|FG000|Overall Study|Lost to Follow-up|1|||
48521058|NCT01378962|156098243|FG000|Overall Study|Other|2|||
48521059|NCT02369458|156098244|FG000|Overall Study|Determined to be not eligible|1|||
48521060|NCT02369458|156098245|FG001|Overall Study|Determined to be not eligible|0|||
48731826|NCT02484690|156869553|FG001|Overall Study|Adverse Event|3|||
48521061|NCT00239005|156098246|FG000|Overall Study|Adverse Event|6|||
48521062|NCT00239005|156098247|FG001|Overall Study|Adverse Event|6|||
48521063|NCT00239005|156098246|FG000|Overall Study|Withdrawal by Subject|3|||
48521064|NCT00239005|156098247|FG001|Overall Study|Withdrawal by Subject|4|||
48521065|NCT00239005|156098246|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
48521066|NCT00239005|156098247|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
48521067|NCT00239005|156098246|FG000|Overall Study|Protocol Violation|1|||
48521068|NCT00239005|156098247|FG001|Overall Study|Protocol Violation|0|||
48521069|NCT00239005|156098246|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
48521070|NCT00239005|156098247|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
48521071|NCT00239005|156098246|FG000|Overall Study|Lost to Follow-up|0|||
48521072|NCT00239005|156098247|FG001|Overall Study|Lost to Follow-up|1|||
48521073|NCT00688844|156098248|FG000|Overall Study|Lost to Follow-up|10|||
48521074|NCT01968031|156098253|FG000|Overall Study|Adverse Event|13|||
48521075|NCT01968031|156098254|FG001|Overall Study|Adverse Event|10|||
48521076|NCT01968031|156098255|FG002|Overall Study|Adverse Event|22|||
48521077|NCT01968031|156098253|FG000|Overall Study|Withdrawal by Subject|3|||
48521078|NCT01968031|156098254|FG001|Overall Study|Withdrawal by Subject|7|||
48521079|NCT01968031|156098255|FG002|Overall Study|Withdrawal by Subject|3|||
48521080|NCT01968031|156098253|FG000|Overall Study|Did not meet entry criteria|1|||
48521081|NCT01968031|156098254|FG001|Overall Study|Did not meet entry criteria|1|||
48521082|NCT01968031|156098255|FG002|Overall Study|Did not meet entry criteria|1|||
48521083|NCT01968031|156098253|FG000|Overall Study|Noncompliance|0|||
48731827|NCT02484690|156869554|FG002|Overall Study|Adverse Event|0|||
48731828|NCT02484690|156869555|FG003|Overall Study|Adverse Event|0|||
48731829|NCT02484690|156869556|FG004|Overall Study|Adverse Event|5|||
48731830|NCT02484690|156869552|FG000|Overall Study|Death|0|||
48731831|NCT02484690|156869553|FG001|Overall Study|Death|0|||
48731832|NCT02484690|156869554|FG002|Overall Study|Death|0|||
48731833|NCT02484690|156869555|FG003|Overall Study|Death|0|||
48731834|NCT02484690|156869556|FG004|Overall Study|Death|1|||
48731835|NCT02484690|156869552|FG000|Overall Study|Withdrawal by Subject|1|||
48731836|NCT02484690|156869553|FG001|Overall Study|Withdrawal by Subject|3|||
48731837|NCT02484690|156869554|FG002|Overall Study|Withdrawal by Subject|1|||
48731838|NCT02484690|156869555|FG003|Overall Study|Withdrawal by Subject|2|||
48731839|NCT02484690|156869556|FG004|Overall Study|Withdrawal by Subject|0|||
48731840|NCT02484690|156869552|FG000|Overall Study|Physician Decision|2|||
48731841|NCT02484690|156869553|FG001|Overall Study|Physician Decision|0|||
48731842|NCT02484690|156869554|FG002|Overall Study|Physician Decision|1|||
48731843|NCT02484690|156869555|FG003|Overall Study|Physician Decision|0|||
48731844|NCT02484690|156869556|FG004|Overall Study|Physician Decision|0|||
48731845|NCT02484690|156869552|FG000|Overall Study|Lost to Follow-up|0|||
48731846|NCT02484690|156869553|FG001|Overall Study|Lost to Follow-up|0|||
48731847|NCT02484690|156869554|FG002|Overall Study|Lost to Follow-up|1|||
48731848|NCT02484690|156869555|FG003|Overall Study|Lost to Follow-up|0|||
48731849|NCT02484690|156869556|FG004|Overall Study|Lost to Follow-up|0|||
48731850|NCT03360747|156869557|FG000|Overall Study|Voluntary Withdrawal|1|||
48731851|NCT04916769|156869559|FG000|Period 1|Physician Decision|0|||
48731852|NCT04916769|156869560|FG001|Period 1|Physician Decision|0|||
48731853|NCT04916769|156869561|FG002|Period 1|Physician Decision|0|||
48731854|NCT04916769|156869562|FG003|Period 1|Physician Decision|0|||
48731855|NCT04916769|156869563|FG004|Period 1|Physician Decision|0|||
48731856|NCT04916769|156869564|FG005|Period 1|Physician Decision|1|||
48521084|NCT01968031|156098254|FG001|Overall Study|Noncompliance|0|||
48521085|NCT01968031|156098255|FG002|Overall Study|Noncompliance|2|||
48521086|NCT01968031|156098253|FG000|Overall Study|Failed inclusion criteria|0|||
48521087|NCT01968031|156098254|FG001|Overall Study|Failed inclusion criteria|2|||
48521088|NCT01968031|156098255|FG002|Overall Study|Failed inclusion criteria|0|||
48521089|NCT01968031|156098253|FG000|Overall Study|Death|0|||
48521090|NCT01968031|156098254|FG001|Overall Study|Death|0|||
48521091|NCT01968031|156098255|FG002|Overall Study|Death|1|||
48601557|NCT00846586|156397665|FG000|Overall Study|Adverse Event|20|||
48521092|NCT01968031|156098253|FG000|Overall Study|Prohibited concomitant medication|1|||
48521093|NCT01968031|156098254|FG001|Overall Study|Prohibited concomitant medication|0|||
48521094|NCT01968031|156098255|FG002|Overall Study|Prohibited concomitant medication|0|||
48521095|NCT01169038|156098257|FG000|Overall Study|Death|1|||
48521096|NCT01169038|156098257|FG000|Overall Study|Adverse Event|5|||
48521097|NCT01169038|156098257|FG000|Overall Study|Required antibiotic administration|1|||
48521098|NCT02490800|156098258|FG000|Overall Study|Adverse Event|0|||
48521099|NCT02490800|156098259|FG001|Overall Study|Adverse Event|0|||
48521100|NCT02490800|156098260|FG002|Overall Study|Adverse Event|0|||
48521101|NCT02490800|156098261|FG003|Overall Study|Adverse Event|2|||
48521102|NCT02490800|156098262|FG004|Overall Study|Adverse Event|3|||
48521103|NCT02490800|156098263|FG005|Overall Study|Adverse Event|2|||
48521104|NCT02490800|156098264|FG006|Overall Study|Adverse Event|0|||
48521105|NCT02490800|156098265|FG007|Overall Study|Adverse Event|0|||
48521106|NCT02490800|156098266|FG008|Overall Study|Adverse Event|0|||
48521107|NCT02490800|156098267|FG009|Overall Study|Adverse Event|0|||
48521108|NCT02490800|156098268|FG010|Overall Study|Adverse Event|0|||
48521109|NCT02490800|156098269|FG011|Overall Study|Adverse Event|2|||
48521110|NCT02490800|156098270|FG012|Overall Study|Adverse Event|2|||
48521111|NCT02490800|156098258|FG000|Overall Study|Withdrawal by Subject|0|||
48824555|NCT00681811|157197291|FG000|Overall Study|Withdrawal by Subject|2|||
48824556|NCT00681811|157197292|FG001|Overall Study|Withdrawal by Subject|2|||
48824557|NCT00681811|157197291|FG000|Overall Study|Non-compliance|0|||
48824558|NCT00681811|157197292|FG001|Overall Study|Non-compliance|1|||
48824559|NCT00814489|157197293|FG000|Overall Study|Other|2|||
48824560|NCT00814489|157197294|FG001|Overall Study|Other|0|||
48824561|NCT00814489|157197295|FG002|Overall Study|Other|1|||
48824562|NCT01244828|157197298|FG000|Overall Study|Adverse Event|37|||
48824563|NCT01244828|157197298|FG000|Overall Study|Withdrawal by Subject|31|||
48824564|NCT01244828|157197298|FG000|Overall Study|Lack of Efficacy|7|||
48824565|NCT01244828|157197298|FG000|Overall Study|Lost to Follow-up|2|||
48824566|NCT01244828|157197298|FG000|Overall Study|Other reason (not specified)|1|||
48824567|NCT04155424|157197299|FG000|Overall Study|Other than specified|3|||
48824568|NCT04155424|157197299|FG000|Overall Study|Withdrawal by Subject|1|||
48824569|NCT04155424|157197299|FG000|Overall Study|Adverse Event|1|||
48824570|NCT03015740|157197300|FG000|Overall Study|Adverse Event|1|||
48824571|NCT03015740|157197301|FG001|Overall Study|Adverse Event|0|||
48824572|NCT03015740|157197302|FG002|Overall Study|Adverse Event|0|||
48824573|NCT03015740|157197300|FG000|Overall Study|Death|3|||
48824574|NCT03015740|157197301|FG001|Overall Study|Death|5|||
48824575|NCT03015740|157197302|FG002|Overall Study|Death|0|||
48824576|NCT03015740|157197300|FG000|Overall Study|Withdrawal by Subject|2|||
48824577|NCT03015740|157197301|FG001|Overall Study|Withdrawal by Subject|0|||
48824578|NCT03015740|157197302|FG002|Overall Study|Withdrawal by Subject|0|||
48824579|NCT04610684|157198907|FG000|Study Treatment|Withdrawal by Subject|1|||
48824580|NCT04610684|157198907|FG000|Study Treatment|Disease Progression|2|||
48824581|NCT04610684|157198907|FG000|Follow up|Death|2|||
48824582|NCT04610684|157198907|FG000|Follow up|Withdrawal by Subject|1|||
48824583|NCT01598987|157198908|FG000|Baseline to Month 12|Administrative problems|2|||
48824584|NCT01598987|157198908|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
48824585|NCT01598987|157198908|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
48824586|NCT01598987|157198908|FG000|Baseline to 24 Month|Administrative problems|2|||
48824587|NCT01598987|157198908|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
48824588|NCT00551213|157198910|FG000|Overall Study|Adverse Event|6|||
48824589|NCT00551213|157198911|FG001|Overall Study|Adverse Event|3|||
48824590|NCT00551213|157198910|FG000|Overall Study|Progressive Disease|41|||
48824591|NCT00551213|157198911|FG001|Overall Study|Progressive Disease|12|||
48824592|NCT00551213|157198910|FG000|Overall Study|Withdrawal by Subject|2|||
48824593|NCT00551213|157198911|FG001|Overall Study|Withdrawal by Subject|0|||
48824594|NCT00551213|157198910|FG000|Overall Study|Not Treated|1|||
48824595|NCT00551213|157198911|FG001|Overall Study|Not Treated|2|||
48824596|NCT01021878|157198912|FG000|Overall Study|Lost to Follow-up|4|||
48824597|NCT01021878|157198913|FG001|Overall Study|Lost to Follow-up|3|||
48824598|NCT01021878|157198912|FG000|Overall Study|Death|0|||
48824599|NCT01021878|157198913|FG001|Overall Study|Death|1|||
48521112|NCT02490800|156098259|FG001|Overall Study|Withdrawal by Subject|0|||
48824600|NCT01021878|157198912|FG000|Overall Study|Adverse Event|6|||
48824601|NCT01021878|157198913|FG001|Overall Study|Adverse Event|5|||
48824602|NCT01021878|157198912|FG000|Overall Study|Transplantation|6|||
48824603|NCT01021878|157198913|FG001|Overall Study|Transplantation|1|||
48824604|NCT02892409|157198914|FG000|Overall Study|Adverse Event|1|||
48824605|NCT02892409|157198915|FG001|Overall Study|Adverse Event|0|||
48824606|NCT02892409|157198914|FG000|Overall Study|Withdrawal by Subject|2|||
48824607|NCT02892409|157198915|FG001|Overall Study|Withdrawal by Subject|1|||
48824608|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
48824609|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
48521113|NCT02490800|156098260|FG002|Overall Study|Withdrawal by Subject|0|||
48521114|NCT02490800|156098261|FG003|Overall Study|Withdrawal by Subject|1|||
48521115|NCT02490800|156098262|FG004|Overall Study|Withdrawal by Subject|0|||
48521116|NCT02490800|156098263|FG005|Overall Study|Withdrawal by Subject|0|||
48521117|NCT02490800|156098264|FG006|Overall Study|Withdrawal by Subject|0|||
48521118|NCT02490800|156098265|FG007|Overall Study|Withdrawal by Subject|0|||
48521119|NCT02490800|156098266|FG008|Overall Study|Withdrawal by Subject|1|||
48521120|NCT02490800|156098267|FG009|Overall Study|Withdrawal by Subject|0|||
48521121|NCT02490800|156098268|FG010|Overall Study|Withdrawal by Subject|0|||
48521122|NCT02490800|156098269|FG011|Overall Study|Withdrawal by Subject|0|||
48521123|NCT02490800|156098270|FG012|Overall Study|Withdrawal by Subject|0|||
48521124|NCT02490800|156098258|FG000|Overall Study|Progressive disease|3|||
48521125|NCT02490800|156098259|FG001|Overall Study|Progressive disease|3|||
48521126|NCT02490800|156098260|FG002|Overall Study|Progressive disease|3|||
48521127|NCT02490800|156098261|FG003|Overall Study|Progressive disease|4|||
48521128|NCT02490800|156098262|FG004|Overall Study|Progressive disease|4|||
48521129|NCT02490800|156098263|FG005|Overall Study|Progressive disease|1|||
48521130|NCT02490800|156098264|FG006|Overall Study|Progressive disease|4|||
48521131|NCT02490800|156098265|FG007|Overall Study|Progressive disease|3|||
48521132|NCT02490800|156098266|FG008|Overall Study|Progressive disease|6|||
48521133|NCT02490800|156098267|FG009|Overall Study|Progressive disease|2|||
48521134|NCT02490800|156098268|FG010|Overall Study|Progressive disease|7|||
48521135|NCT02490800|156098269|FG011|Overall Study|Progressive disease|1|||
48521136|NCT02490800|156098270|FG012|Overall Study|Progressive disease|10|||
48521137|NCT02490800|156098258|FG000|Overall Study|Patient enrolled in post-trial access|0|||
48521138|NCT02490800|156098259|FG001|Overall Study|Patient enrolled in post-trial access|0|||
48521139|NCT02490800|156098260|FG002|Overall Study|Patient enrolled in post-trial access|0|||
48521140|NCT02490800|156098261|FG003|Overall Study|Patient enrolled in post-trial access|0|||
48521141|NCT02490800|156098262|FG004|Overall Study|Patient enrolled in post-trial access|0|||
48521142|NCT02490800|156098263|FG005|Overall Study|Patient enrolled in post-trial access|0|||
48521143|NCT02490800|156098264|FG006|Overall Study|Patient enrolled in post-trial access|0|||
48521144|NCT02490800|156098265|FG007|Overall Study|Patient enrolled in post-trial access|0|||
48521145|NCT02490800|156098266|FG008|Overall Study|Patient enrolled in post-trial access|0|||
48521146|NCT02490800|156098267|FG009|Overall Study|Patient enrolled in post-trial access|1|||
48521147|NCT02490800|156098268|FG010|Overall Study|Patient enrolled in post-trial access|1|||
48521148|NCT02490800|156098269|FG011|Overall Study|Patient enrolled in post-trial access|0|||
48521149|NCT02490800|156098270|FG012|Overall Study|Patient enrolled in post-trial access|6|||
48521150|NCT01488448|156098271|FG000|Overall Study|Withdrawal by Subject|3|||
48521151|NCT01488448|156098272|FG001|Overall Study|Withdrawal by Subject|1|||
48521152|NCT01488448|156098271|FG000|Overall Study|Adverse Event|9|||
48521153|NCT01488448|156098272|FG001|Overall Study|Adverse Event|4|||
48521154|NCT01488448|156098271|FG000|Overall Study|Physician Decision|4|||
48521155|NCT01488448|156098272|FG001|Overall Study|Physician Decision|9|||
48521156|NCT01488448|156098271|FG000|Overall Study|Protocol Violation|4|||
48521157|NCT01488448|156098272|FG001|Overall Study|Protocol Violation|3|||
48521158|NCT01992094|156098273|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
48521159|NCT01992094|156098274|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
48521160|NCT01992094|156098275|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
48521161|NCT01992094|156098273|FG000|Overall Study|Adverse Event|1|||
48521162|NCT01992094|156098274|FG001|Overall Study|Adverse Event|0|||
48521163|NCT01992094|156098275|FG002|Overall Study|Adverse Event|0|||
48521164|NCT01992094|156098273|FG000|Overall Study|Death|5|||
48521165|NCT01992094|156098274|FG001|Overall Study|Death|5|||
48521166|NCT01992094|156098275|FG002|Overall Study|Death|2|||
48521167|NCT01992094|156098273|FG000|Overall Study|Lost to Follow-up|26|||
48521168|NCT01992094|156098274|FG001|Overall Study|Lost to Follow-up|9|||
48521169|NCT01992094|156098275|FG002|Overall Study|Lost to Follow-up|13|||
48521170|NCT01992094|156098273|FG000|Overall Study|OTHER|4|||
48521171|NCT01992094|156098274|FG001|Overall Study|OTHER|0|||
48521172|NCT01992094|156098275|FG002|Overall Study|OTHER|0|||
48521173|NCT01992094|156098273|FG000|Overall Study|Protocol Violation|1|||
48521174|NCT01992094|156098274|FG001|Overall Study|Protocol Violation|0|||
48521175|NCT01992094|156098275|FG002|Overall Study|Protocol Violation|1|||
48521176|NCT01992094|156098273|FG000|Overall Study|Withdrawal by Subject|7|||
48521177|NCT01992094|156098274|FG001|Overall Study|Withdrawal by Subject|3|||
48521178|NCT01992094|156098275|FG002|Overall Study|Withdrawal by Subject|4|||
48521179|NCT04640194|156098276|FG000|Overall Study|Adverse Event|3|||
48521180|NCT04640194|156098277|FG001|Overall Study|Adverse Event|7|||
48521181|NCT04640194|156098278|FG002|Overall Study|Adverse Event|0|||
48521182|NCT04640194|156098279|FG003|Overall Study|Adverse Event|5|||
48521183|NCT04640194|156098280|FG004|Overall Study|Adverse Event|0|||
48521184|NCT04640194|156098281|FG005|Overall Study|Adverse Event|4|||
48521185|NCT04640194|156098282|FG006|Overall Study|Adverse Event|0|||
48521186|NCT04640194|156098276|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
48521187|NCT04640194|156098277|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
48521188|NCT04640194|156098278|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
48521189|NCT04640194|156098279|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
48521190|NCT04640194|156098280|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
48521191|NCT04640194|156098281|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
48521192|NCT04640194|156098282|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
48521193|NCT04640194|156098276|FG000|Overall Study|fibrinogen level too low|0|||
48521194|NCT04640194|156098277|FG001|Overall Study|fibrinogen level too low|0|||
48521195|NCT04640194|156098278|FG002|Overall Study|fibrinogen level too low|0|||
48521196|NCT04640194|156098279|FG003|Overall Study|fibrinogen level too low|1|||
48521197|NCT04640194|156098280|FG004|Overall Study|fibrinogen level too low|0|||
48521198|NCT04640194|156098281|FG005|Overall Study|fibrinogen level too low|0|||
48521199|NCT04640194|156098282|FG006|Overall Study|fibrinogen level too low|0|||
48521200|NCT04640194|156098276|FG000|Overall Study|mild bleeding|0|||
48521201|NCT04640194|156098277|FG001|Overall Study|mild bleeding|0|||
48521202|NCT04640194|156098278|FG002|Overall Study|mild bleeding|0|||
48521203|NCT04640194|156098279|FG003|Overall Study|mild bleeding|1|||
48521204|NCT04640194|156098280|FG004|Overall Study|mild bleeding|0|||
48731857|NCT04916769|156869559|FG000|Period 2|Physician Decision|0|||
48731858|NCT04916769|156869560|FG001|Period 2|Physician Decision|1|||
48731859|NCT04916769|156869561|FG002|Period 2|Physician Decision|0|||
48731860|NCT04916769|156869562|FG003|Period 2|Physician Decision|0|||
48731861|NCT04916769|156869563|FG004|Period 2|Physician Decision|0|||
48731862|NCT04916769|156869564|FG005|Period 2|Physician Decision|0|||
48731863|NCT05430022|156869577|FG000|Overall Study|Withdrawal by Subject|4|||
48731864|NCT05430022|156869578|FG001|Overall Study|Withdrawal by Subject|4|||
48731865|NCT02254278|156869579|FG000|Overall Study|Protocol Violation|1|||
48731866|NCT02254278|156869580|FG001|Overall Study|Protocol Violation|1|||
48731867|NCT03487549|156869583|FG000|Overall Study|Protocol Violation|0|||
48731868|NCT03487549|156869584|FG001|Overall Study|Protocol Violation|1|||
48731869|NCT03487549|156869583|FG000|Overall Study|Lost to Follow-up|2|||
48731870|NCT03487549|156869584|FG001|Overall Study|Lost to Follow-up|1|||
48731871|NCT03487549|156869583|FG000|Overall Study|Withdrawal by Subject|2|||
48731872|NCT03487549|156869584|FG001|Overall Study|Withdrawal by Subject|0|||
48731873|NCT05136690|156869585|FG000|Period 1|Withdrawal by Subject|0|||
48731874|NCT05136690|156869586|FG001|Period 1|Withdrawal by Subject|1|||
48731875|NCT05136690|156869585|FG000|Period 2|Lost to Follow-up|0|||
48731876|NCT05136690|156869586|FG001|Period 2|Lost to Follow-up|3|||
48731877|NCT05136690|156869585|FG000|Period 2|Withdrawal by Subject|0|||
48731878|NCT05136690|156869586|FG001|Period 2|Withdrawal by Subject|1|||
48731879|NCT03730012|156869587|FG000|Overall Study|Adverse Event|0|||
48731880|NCT03730012|156869588|FG001|Overall Study|Adverse Event|1|||
48731881|NCT03730012|156869587|FG000|Overall Study|Lack of Efficacy|1|||
48731882|NCT03730012|156869588|FG001|Overall Study|Lack of Efficacy|5|||
48731883|NCT03730012|156869587|FG000|Overall Study|Withdrawal by Subject|0|||
48731884|NCT03730012|156869588|FG001|Overall Study|Withdrawal by Subject|1|||
48731885|NCT03730012|156869587|FG000|Overall Study|Miscellaneous|2|||
48731886|NCT03730012|156869588|FG001|Overall Study|Miscellaneous|1|||
48731887|NCT00215683|156871189|FG000|Overall Study|Adverse Event|15|||
48731888|NCT00215683|156871190|FG001|Overall Study|Adverse Event|16|||
48731889|NCT00215683|156871191|FG002|Overall Study|Adverse Event|15|||
48731890|NCT00215683|156871189|FG000|Overall Study|Lack of Efficacy|5|||
48731891|NCT00215683|156871190|FG001|Overall Study|Lack of Efficacy|1|||
48731892|NCT00215683|156871191|FG002|Overall Study|Lack of Efficacy|2|||
48731893|NCT00215683|156871189|FG000|Overall Study|Lost to Follow-up|0|||
48731894|NCT00215683|156871190|FG001|Overall Study|Lost to Follow-up|2|||
48731895|NCT00215683|156871191|FG002|Overall Study|Lost to Follow-up|1|||
48731896|NCT00215683|156871189|FG000|Overall Study|Withdrawal by Subject|9|||
48731897|NCT00215683|156871190|FG001|Overall Study|Withdrawal by Subject|4|||
48731898|NCT00215683|156871191|FG002|Overall Study|Withdrawal by Subject|13|||
48731899|NCT00215683|156871189|FG000|Overall Study|Physician Decision|0|||
48731900|NCT00215683|156871190|FG001|Overall Study|Physician Decision|0|||
48731901|NCT00215683|156871191|FG002|Overall Study|Physician Decision|1|||
48731902|NCT00215683|156871189|FG000|Overall Study|Difficult to attend visits|0|||
48731903|NCT00215683|156871190|FG001|Overall Study|Difficult to attend visits|1|||
48731904|NCT00215683|156871191|FG002|Overall Study|Difficult to attend visits|0|||
48731905|NCT00215683|156871189|FG000|Overall Study|No study drug available|0|||
48731906|NCT00215683|156871190|FG001|Overall Study|No study drug available|1|||
48731907|NCT00215683|156871191|FG002|Overall Study|No study drug available|0|||
48731908|NCT00215683|156871189|FG000|Overall Study|Intermittent therapy required|0|||
48731909|NCT00215683|156871190|FG001|Overall Study|Intermittent therapy required|1|||
48731910|NCT00215683|156871191|FG002|Overall Study|Intermittent therapy required|0|||
48731911|NCT03894046|156871198|FG000|Overall Study|Protocol Violation|1|||
48731912|NCT03894046|156871199|FG001|Overall Study|Protocol Violation|0|||
48731913|NCT03894046|156871200|FG002|Overall Study|Protocol Violation|0|||
48521205|NCT04640194|156098281|FG005|Overall Study|mild bleeding|0|||
48731914|NCT03894046|156871198|FG000|Overall Study|Adverse Event|0|||
48731915|NCT03894046|156871199|FG001|Overall Study|Adverse Event|1|||
48521206|NCT04640194|156098282|FG006|Overall Study|mild bleeding|0|||
48601558|NCT00846586|156397666|FG001|Overall Study|Adverse Event|10|||
48731916|NCT03894046|156871200|FG002|Overall Study|Adverse Event|0|||
48731917|NCT03894046|156871198|FG000|Overall Study|Withdrawal by Subject|2|||
48731918|NCT03894046|156871199|FG001|Overall Study|Withdrawal by Subject|3|||
48731919|NCT03894046|156871200|FG002|Overall Study|Withdrawal by Subject|1|||
48731920|NCT03894046|156871198|FG000|Overall Study|Death|15|||
48521207|NCT04640194|156098276|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
48521208|NCT04640194|156098277|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
48521209|NCT04640194|156098278|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
48521210|NCT04640194|156098279|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
48521211|NCT04640194|156098280|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
48521212|NCT04640194|156098281|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
48521213|NCT04640194|156098282|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
48521214|NCT01214239|156098288|FG000|Overall Study|Adverse Event|3|||
48521215|NCT01214239|156098289|FG001|Overall Study|Adverse Event|4|||
48521216|NCT01214239|156098288|FG000|Overall Study|Protocol Violation|2|||
48521217|NCT01214239|156098289|FG001|Overall Study|Protocol Violation|1|||
48521218|NCT01214239|156098288|FG000|Overall Study|Lost to Follow-up|1|||
48731921|NCT03894046|156871199|FG001|Overall Study|Death|21|||
48824610|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
48824611|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
48824612|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
48824613|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
48824614|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
48824615|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
48824616|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
48824617|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
48824618|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
48824619|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
48824620|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
48824621|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
48824622|NCT04672460|157198916|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
48824623|NCT04672460|157198917|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
48731922|NCT03894046|156871200|FG002|Overall Study|Death|4|||
48731923|NCT03894046|156871198|FG000|Overall Study|No growth of ABC|2|||
48731924|NCT03894046|156871199|FG001|Overall Study|No growth of ABC|1|||
48731925|NCT03894046|156871200|FG002|Overall Study|No growth of ABC|0|||
48731926|NCT03894046|156871198|FG000|Overall Study|Physician Decision|1|||
48731927|NCT03894046|156871199|FG001|Overall Study|Physician Decision|1|||
48731928|NCT03894046|156871200|FG002|Overall Study|Physician Decision|1|||
48731929|NCT03894046|156871198|FG000|Overall Study|Prohibited concomitant medication|1|||
48731930|NCT03894046|156871199|FG001|Overall Study|Prohibited concomitant medication|0|||
48731931|NCT03894046|156871200|FG002|Overall Study|Prohibited concomitant medication|0|||
48731932|NCT03894046|156871198|FG000|Overall Study|Transferred to other arm/group|1|||
48731933|NCT03894046|156871199|FG001|Overall Study|Transferred to other arm/group|1|||
48731934|NCT03894046|156871200|FG002|Overall Study|Transferred to other arm/group|0|||
48731935|NCT02611960|156871201|FG000|Overall Study|Adverse Event|7|||
48731936|NCT02611960|156871202|FG001|Overall Study|Adverse Event|8|||
48731937|NCT02611960|156871201|FG000|Overall Study|Death|98|||
48731938|NCT02611960|156871202|FG001|Overall Study|Death|92|||
48731939|NCT02611960|156871201|FG000|Overall Study|Withdrawal by Subject|1|||
48731940|NCT02611960|156871202|FG001|Overall Study|Withdrawal by Subject|5|||
48731941|NCT02611960|156871201|FG000|Overall Study|Sponsor Decision|11|||
48731942|NCT02611960|156871202|FG001|Overall Study|Sponsor Decision|11|||
48521219|NCT01214239|156098289|FG001|Overall Study|Lost to Follow-up|1|||
48521220|NCT01214239|156098288|FG000|Overall Study|Withdrawal by Subject|4|||
48521221|NCT01214239|156098289|FG001|Overall Study|Withdrawal by Subject|9|||
48521222|NCT01214239|156098288|FG000|Overall Study|Lack of Efficacy|1|||
48521223|NCT01214239|156098289|FG001|Overall Study|Lack of Efficacy|2|||
48521224|NCT01214239|156098288|FG000|Overall Study|patient's private reason|1|||
48521225|NCT01214239|156098289|FG001|Overall Study|patient's private reason|1|||
48521226|NCT00834613|156098290|FG000|First Intervention|Protocol Violation|1|||
48521227|NCT00834613|156098291|FG001|First Intervention|Protocol Violation|0|||
48521228|NCT03088813|156099708|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
48731943|NCT03793556|156871203|FG000|Overall Study|Withdrawal by Subject|12|||
48731944|NCT03793556|156871204|FG001|Overall Study|Withdrawal by Subject|1|||
48731945|NCT03793556|156871203|FG000|Overall Study|Lost to Follow-up|1|||
48824624|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
48731946|NCT03793556|156871204|FG001|Overall Study|Lost to Follow-up|1|||
48731947|NCT00378105|156871205|FG000|Overall Study|Adverse Event|3|||
48824625|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
48521229|NCT03088813|156099709|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
48521230|NCT03088813|156099710|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
48521231|NCT03088813|156099711|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
48521232|NCT03088813|156099708|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
48731948|NCT00378105|156871206|FG001|Overall Study|Adverse Event|1|||
48521233|NCT03088813|156099709|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
48521234|NCT03088813|156099710|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
48521235|NCT03088813|156099711|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
48521236|NCT03088813|156099708|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
48521237|NCT03088813|156099709|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
48521238|NCT03088813|156099710|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
48521239|NCT03088813|156099711|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
48521240|NCT03088813|156099708|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
48521241|NCT03088813|156099709|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
48521242|NCT03088813|156099710|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
48521243|NCT03088813|156099711|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
48521244|NCT03088813|156099708|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
48521245|NCT03088813|156099709|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
48521246|NCT03088813|156099710|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
48601559|NCT00846586|156397665|FG000|Overall Study|Subject withdrew consent|8|||
48601560|NCT00846586|156397666|FG001|Overall Study|Subject withdrew consent|10|||
48731949|NCT00378105|156871205|FG000|Overall Study|Withdrawal by Subject|3|||
48731950|NCT00378105|156871206|FG001|Overall Study|Withdrawal by Subject|3|||
48731951|NCT00378105|156871205|FG000|Overall Study|Death|1|||
48731952|NCT00378105|156871206|FG001|Overall Study|Death|0|||
48731953|NCT00378105|156871205|FG000|Overall Study|Going to transplant|7|||
48731954|NCT00378105|156871206|FG001|Overall Study|Going to transplant|8|||
48731955|NCT00378105|156871205|FG000|Overall Study|Progressive disease|3|||
48731956|NCT00378105|156871206|FG001|Overall Study|Progressive disease|3|||
48731957|NCT00378105|156871205|FG000|Overall Study|remain on study|3|||
48731958|NCT00378105|156871206|FG001|Overall Study|remain on study|11|||
48731959|NCT00378105|156871205|FG000|Overall Study|Physician Decision|0|||
48731960|NCT00378105|156871206|FG001|Overall Study|Physician Decision|2|||
48731961|NCT00378105|156871205|FG000|Overall Study|Going non-protocol therapy|0|||
48731962|NCT00378105|156871206|FG001|Overall Study|Going non-protocol therapy|1|||
48731963|NCT00378105|156871205|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
48731964|NCT00378105|156871206|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
48731965|NCT02963831|156871209|FG000|Overall Study|Progressive Disease|3|||
48731966|NCT02963831|156871210|FG001|Overall Study|Progressive Disease|3|||
48731967|NCT02963831|156871211|FG002|Overall Study|Progressive Disease|16|||
48731968|NCT02963831|156871212|FG003|Overall Study|Progressive Disease|27|||
48731969|NCT02963831|156871209|FG000|Overall Study|Withdrawal by Subject|1|||
48731970|NCT02963831|156871210|FG001|Overall Study|Withdrawal by Subject|0|||
48731971|NCT02963831|156871211|FG002|Overall Study|Withdrawal by Subject|2|||
48731972|NCT02963831|156871212|FG003|Overall Study|Withdrawal by Subject|4|||
48731973|NCT02963831|156871209|FG000|Overall Study|Adverse Event|0|||
48731974|NCT02963831|156871210|FG001|Overall Study|Adverse Event|1|||
48731975|NCT02963831|156871211|FG002|Overall Study|Adverse Event|1|||
48731976|NCT02963831|156871212|FG003|Overall Study|Adverse Event|2|||
48731977|NCT02963831|156871209|FG000|Overall Study|Death|0|||
48731978|NCT02963831|156871210|FG001|Overall Study|Death|0|||
48731979|NCT02963831|156871211|FG002|Overall Study|Death|0|||
48731980|NCT02963831|156871212|FG003|Overall Study|Death|2|||
48731981|NCT01675427|156871217|FG000|Overall Study|Withdrawal by Subject|7|||
48731982|NCT01675427|156871217|FG000|Overall Study|Participant Refused Sample Collection|18|||
48731983|NCT01675427|156871217|FG000|Overall Study|Sample not Collected by Mistake|2|||
48731984|NCT01675427|156871217|FG000|Overall Study|Lost to Follow-up|5|||
48731985|NCT01675427|156871217|FG000|Overall Study|Other|2|||
48731986|NCT00700570|156871218|FG000|Overall Study|Adverse Event|2|||
48731987|NCT00700570|156871219|FG001|Overall Study|Adverse Event|6|||
48731988|NCT00700570|156871218|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
48731989|NCT00700570|156871219|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
48731990|NCT00700570|156871218|FG000|Overall Study|Disease Progression|8|||
48731991|NCT00700570|156871219|FG001|Overall Study|Disease Progression|11|||
48731992|NCT00700570|156871218|FG000|Overall Study|Withdrawal by Subject|1|||
48731993|NCT00700570|156871219|FG001|Overall Study|Withdrawal by Subject|6|||
48731994|NCT02517866|156871222|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48731995|NCT02517866|156871223|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
48731996|NCT02517866|156871224|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48731997|NCT02517866|156871222|FG000|Overall Study|Significant Protocol Deviation|4|||
48731998|NCT02517866|156871223|FG001|Overall Study|Significant Protocol Deviation|1|||
48731999|NCT02517866|156871224|FG002|Overall Study|Significant Protocol Deviation|0|||
48732000|NCT02517866|156871222|FG000|Overall Study|Lost to Follow-up|1|||
48732001|NCT02517866|156871223|FG001|Overall Study|Lost to Follow-up|0|||
48732002|NCT02517866|156871224|FG002|Overall Study|Lost to Follow-up|0|||
48732003|NCT02517866|156871222|FG000|Overall Study|Voluntary Withdrawal|2|||
48732004|NCT02517866|156871223|FG001|Overall Study|Voluntary Withdrawal|2|||
48732005|NCT02517866|156871224|FG002|Overall Study|Voluntary Withdrawal|0|||
48732006|NCT02517866|156871222|FG000|Overall Study|Investigator Decision|2|||
48732007|NCT02517866|156871223|FG001|Overall Study|Investigator Decision|1|||
48732008|NCT02517866|156871224|FG002|Overall Study|Investigator Decision|0|||
48732009|NCT02517866|156871222|FG000|Overall Study|Reason not specified|2|||
48732010|NCT02517866|156871223|FG001|Overall Study|Reason not specified|0|||
48732011|NCT02517866|156871224|FG002|Overall Study|Reason not specified|0|||
48732012|NCT02791594|156871225|FG000|Overall Study|Physician Decision|2|||
48732013|NCT03845543|156871226|FG000|Overall Study|Death|25|||
48732014|NCT03845543|156871226|FG000|Overall Study|Withdrawal by Subject|2|||
48732015|NCT03845543|156871226|FG000|Overall Study|Lost to Follow-up|12|||
48732016|NCT03845543|156871226|FG000|Overall Study|Adverse Event|17|||
48732017|NCT02046733|156871227|FG000|Overall Study|never initiated 'treatment visits'|6|||
48732018|NCT02046733|156871228|FG001|Overall Study|never initiated 'treatment visits'|0|||
48732019|NCT01199731|156871229|FG000|Overall Study|Adverse Event|0|||
48732020|NCT01199731|156871230|FG001|Overall Study|Adverse Event|1|||
48732021|NCT01199731|156871231|FG002|Overall Study|Adverse Event|0|||
48732022|NCT01199731|156871229|FG000|Overall Study|Study closed/terminated|7|||
48732023|NCT01199731|156871230|FG001|Overall Study|Study closed/terminated|9|||
48732024|NCT01199731|156871231|FG002|Overall Study|Study closed/terminated|7|||
48732025|NCT01199731|156871229|FG000|Overall Study|Lost to Follow-up|0|||
48732026|NCT01199731|156871230|FG001|Overall Study|Lost to Follow-up|0|||
48732027|NCT01199731|156871231|FG002|Overall Study|Lost to Follow-up|2|||
48732028|NCT01199731|156871229|FG000|Overall Study|Physician Decision|0|||
48732029|NCT01199731|156871230|FG001|Overall Study|Physician Decision|1|||
48732030|NCT01199731|156871231|FG002|Overall Study|Physician Decision|1|||
48732031|NCT01199731|156871229|FG000|Overall Study|Withdrawal by Subject|2|||
48732032|NCT01199731|156871230|FG001|Overall Study|Withdrawal by Subject|0|||
48732033|NCT01199731|156871231|FG002|Overall Study|Withdrawal by Subject|0|||
48732034|NCT01756053|156871233|FG000|Period 1 (10 Days)|Protocol Violation|1|||
48732035|NCT01756053|156871234|FG001|Period 1 (10 Days)|Protocol Violation|1|||
48732036|NCT01756053|156871233|FG000|Period 2 (10 Days)|Protocol Violation|0|||
48732037|NCT01756053|156871234|FG001|Period 2 (10 Days)|Protocol Violation|2|||
48732038|NCT01642407|156871235|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
48732039|NCT01642407|156871235|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
48732040|NCT01642407|156871235|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
48732041|NCT02448810|156871236|FG000|Overall Study|Adverse Event|0|||
48732042|NCT02448810|156871237|FG001|Overall Study|Adverse Event|0|||
48732043|NCT02448810|156871238|FG002|Overall Study|Adverse Event|1|||
48732044|NCT02448810|156871239|FG003|Overall Study|Adverse Event|0|||
48732045|NCT02448810|156871240|FG004|Overall Study|Adverse Event|0|||
48732046|NCT02448810|156871241|FG005|Overall Study|Adverse Event|0|||
48732047|NCT02448810|156871242|FG006|Overall Study|Adverse Event|0|||
48732048|NCT02448810|156871243|FG007|Overall Study|Adverse Event|0|||
48732049|NCT02448810|156871236|FG000|Overall Study|Withdrawal by Subject|0|||
48732050|NCT02448810|156871237|FG001|Overall Study|Withdrawal by Subject|0|||
48732051|NCT02448810|156871238|FG002|Overall Study|Withdrawal by Subject|1|||
48732052|NCT02448810|156871239|FG003|Overall Study|Withdrawal by Subject|0|||
48732053|NCT02448810|156871240|FG004|Overall Study|Withdrawal by Subject|3|||
48732054|NCT02448810|156871241|FG005|Overall Study|Withdrawal by Subject|5|||
48732055|NCT02448810|156871242|FG006|Overall Study|Withdrawal by Subject|0|||
48732056|NCT02448810|156871243|FG007|Overall Study|Withdrawal by Subject|2|||
48732057|NCT02448810|156871236|FG000|Overall Study|Other (study terminated by sponsor)|0|||
48732058|NCT02448810|156871237|FG001|Overall Study|Other (study terminated by sponsor)|0|||
48732059|NCT02448810|156871238|FG002|Overall Study|Other (study terminated by sponsor)|0|||
48732060|NCT02448810|156871239|FG003|Overall Study|Other (study terminated by sponsor)|0|||
48732061|NCT02448810|156871240|FG004|Overall Study|Other (study terminated by sponsor)|4|||
48732062|NCT02448810|156871241|FG005|Overall Study|Other (study terminated by sponsor)|2|||
48732063|NCT02448810|156871242|FG006|Overall Study|Other (study terminated by sponsor)|2|||
48732064|NCT02448810|156871243|FG007|Overall Study|Other (study terminated by sponsor)|1|||
48732065|NCT02448810|156871236|FG000|Overall Study|Death|1|||
48732066|NCT02448810|156871237|FG001|Overall Study|Death|0|||
48732067|NCT02448810|156871238|FG002|Overall Study|Death|1|||
48732068|NCT02448810|156871239|FG003|Overall Study|Death|0|||
48732069|NCT02448810|156871240|FG004|Overall Study|Death|1|||
48732070|NCT02448810|156871241|FG005|Overall Study|Death|0|||
48732071|NCT02448810|156871242|FG006|Overall Study|Death|0|||
48732072|NCT02448810|156871243|FG007|Overall Study|Death|0|||
48732073|NCT02448810|156871236|FG000|Overall Study|Other (Progressive disease)|2|||
48732074|NCT02448810|156871237|FG001|Overall Study|Other (Progressive disease)|2|||
48732075|NCT02448810|156871238|FG002|Overall Study|Other (Progressive disease)|0|||
48732076|NCT02448810|156871239|FG003|Overall Study|Other (Progressive disease)|3|||
48732077|NCT02448810|156871240|FG004|Overall Study|Other (Progressive disease)|23|||
48732078|NCT02448810|156871241|FG005|Overall Study|Other (Progressive disease)|9|||
48732079|NCT02448810|156871242|FG006|Overall Study|Other (Progressive disease)|14|||
48732080|NCT02448810|156871243|FG007|Overall Study|Other (Progressive disease)|5|||
48732081|NCT02448810|156871236|FG000|Overall Study|Lost to Follow-up|0|||
48732082|NCT02448810|156871237|FG001|Overall Study|Lost to Follow-up|1|||
48732083|NCT02448810|156871238|FG002|Overall Study|Lost to Follow-up|0|||
48521247|NCT03088813|156099711|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
48824626|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
48824627|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
48521248|NCT03088813|156099708|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
48824628|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
48824629|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
48824630|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
48824631|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
48824632|NCT04672460|157198916|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
48824633|NCT04672460|157198917|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
48824634|NCT04672460|157198916|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
48824635|NCT04672460|157198917|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
48824636|NCT04672460|157198916|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
48824637|NCT04672460|157198917|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
48824638|NCT04672460|157198916|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
48824639|NCT04672460|157198917|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
48824640|NCT04672460|157198916|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
48824641|NCT04672460|157198917|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
48824642|NCT01876043|157198918|FG000|Overall Study|Death|1|||
48824643|NCT01876043|157198918|FG000|Overall Study|Withdrawal by Subject|1|||
48824644|NCT00079937|157198919|FG000|Overall Study|Adverse Event|2|||
48824645|NCT00079937|157198920|FG001|Overall Study|Adverse Event|1|||
48824646|NCT00079937|157198919|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48824647|NCT00079937|157198920|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48824648|NCT00079937|157198919|FG000|Overall Study|Subject no longer requires study drug|3|||
48824649|NCT00079937|157198920|FG001|Overall Study|Subject no longer requires study drug|0|||
48824650|NCT00079937|157198919|FG000|Overall Study|Protocol Violation|8|||
48824651|NCT00079937|157198920|FG001|Overall Study|Protocol Violation|6|||
48521249|NCT03088813|156099709|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
48521250|NCT03088813|156099710|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
48521251|NCT03088813|156099711|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
48521252|NCT03088813|156099708|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
48521253|NCT03088813|156099709|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
48521254|NCT03088813|156099710|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
48521255|NCT03088813|156099711|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
48521256|NCT00288704|156099713|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
48521257|NCT00288704|156099714|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
48521258|NCT00288704|156099715|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
48521259|NCT00288704|156099713|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
48521260|NCT00288704|156099714|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
48521261|NCT00288704|156099715|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
48521262|NCT00288704|156099713|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
48521263|NCT00288704|156099714|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
48521264|NCT00288704|156099715|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
48521265|NCT00288704|156099713|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
48521266|NCT00288704|156099714|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
48521267|NCT00288704|156099715|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
48521268|NCT00288704|156099713|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
48521269|NCT00288704|156099714|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
48521270|NCT00288704|156099715|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
48521271|NCT00288704|156099713|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
48521272|NCT00288704|156099714|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
48521273|NCT00288704|156099715|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
48732084|NCT02448810|156871239|FG003|Overall Study|Lost to Follow-up|0|||
48732085|NCT02448810|156871240|FG004|Overall Study|Lost to Follow-up|0|||
48732086|NCT02448810|156871241|FG005|Overall Study|Lost to Follow-up|0|||
48732087|NCT02448810|156871242|FG006|Overall Study|Lost to Follow-up|0|||
48732088|NCT02448810|156871243|FG007|Overall Study|Lost to Follow-up|0|||
48732089|NCT02448810|156871236|FG000|Overall Study|Other (unspecified)|0|||
48732090|NCT02448810|156871237|FG001|Overall Study|Other (unspecified)|0|||
48732091|NCT02448810|156871238|FG002|Overall Study|Other (unspecified)|0|||
48732092|NCT02448810|156871239|FG003|Overall Study|Other (unspecified)|0|||
48732093|NCT02448810|156871240|FG004|Overall Study|Other (unspecified)|0|||
48824652|NCT00079937|157198919|FG000|Overall Study|Withdrawal by Subject|21|||
48824653|NCT00079937|157198920|FG001|Overall Study|Withdrawal by Subject|7|||
48824654|NCT00079937|157198919|FG000|Overall Study|Lost to Follow-up|12|||
48824655|NCT00079937|157198920|FG001|Overall Study|Lost to Follow-up|5|||
48824656|NCT00079937|157198919|FG000|Overall Study|Administrative problems|22|||
48824657|NCT00079937|157198920|FG001|Overall Study|Administrative problems|11|||
48521274|NCT00288704|156099713|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
48521275|NCT00288704|156099714|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
48521276|NCT00288704|156099715|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
48521277|NCT00691704|156099716|FG000|Induction Therapy|Disease Progression|1|||
48521278|NCT00691704|156099716|FG000|Induction Therapy|Active Hepatitis|1|||
48521279|NCT00691704|156099716|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
48521280|NCT00691704|156099716|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
48521281|NCT00691704|156099716|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
48521282|NCT01579006|156099717|FG000|Overall Study|Lack of Efficacy|10|||
48521283|NCT01579006|156099717|FG000|Overall Study|Adverse Event|13|||
48521284|NCT01579006|156099717|FG000|Overall Study|Withdrawal by Subject|5|||
48521285|NCT01579006|156099717|FG000|Overall Study|Non-compliance|3|||
48521286|NCT01579006|156099717|FG000|Overall Study|Due to participant's health fund|1|||
48521287|NCT01579006|156099717|FG000|Overall Study|Scheduled surgery|1|||
48521288|NCT00544167|156099718|FG000|Overall Study|Adverse Event|21|||
48521289|NCT00544167|156099718|FG000|Overall Study|Physician Decision|8|||
48521290|NCT02161549|156099719|FG000|Overall Study|Physician Decision|6|||
48521291|NCT02161549|156099720|FG001|Overall Study|Physician Decision|2|||
48521292|NCT00198133|156099723|FG000|Overall Study|Disease progression|2|||
48521293|NCT00198133|156099724|FG001|Overall Study|Disease progression|5|||
48521294|NCT00198133|156099723|FG000|Overall Study|Adverse Event|1|||
48521295|NCT00198133|156099724|FG001|Overall Study|Adverse Event|3|||
48521296|NCT00198133|156099723|FG000|Overall Study|Withdrawal by Subject|1|||
48521297|NCT00198133|156099724|FG001|Overall Study|Withdrawal by Subject|0|||
48521298|NCT00198133|156099723|FG000|Overall Study|Physician Decision|1|||
48521299|NCT00198133|156099724|FG001|Overall Study|Physician Decision|0|||
48521300|NCT00396630|156099725|FG000|Overall Study|Lost to Follow-up|1|||
48521301|NCT00396630|156099726|FG001|Overall Study|Lost to Follow-up|1|||
48521302|NCT00396630|156099725|FG000|Overall Study|Withdrawal by Subject|1|||
48521303|NCT00396630|156099726|FG001|Overall Study|Withdrawal by Subject|1|||
48521304|NCT00396630|156099725|FG000|Overall Study|Not vaccinated at Visit 3|3|||
48521305|NCT00396630|156099726|FG001|Overall Study|Not vaccinated at Visit 3|3|||
48521306|NCT03314857|156099727|FG000|Overall Study|Death|4|||
48521307|NCT03314857|156099727|FG000|Overall Study|Physician Decision|1|||
48521308|NCT02906917|156099730|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
48521309|NCT02906917|156099731|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
48521310|NCT02906917|156099730|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
48521311|NCT02906917|156099731|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
48521312|NCT02906917|156099730|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
48521313|NCT02906917|156099731|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
48521314|NCT02906917|156099730|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
48521315|NCT02906917|156099731|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
48521316|NCT02906917|156099730|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
48521317|NCT02906917|156099731|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
48521318|NCT02906917|156099730|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
48521319|NCT02906917|156099731|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
48521320|NCT02906917|156099730|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
48521321|NCT02906917|156099731|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
48521322|NCT02906917|156099730|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
48521323|NCT02906917|156099731|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
48521324|NCT03888235|156099732|FG000|Overall Study|Lost to Follow-up|1|||
48521325|NCT03888235|156099733|FG001|Overall Study|Lost to Follow-up|1|||
48521326|NCT03888235|156099734|FG002|Overall Study|Lost to Follow-up|0|||
48521327|NCT01119625|156099735|FG000|Overall Study|Lost to Follow-up|1|||
48521328|NCT01119625|156099736|FG001|Overall Study|Lost to Follow-up|2|||
48521329|NCT01119625|156099735|FG000|Overall Study|Withdrawal by Subject|2|||
48521330|NCT01119625|156099736|FG001|Overall Study|Withdrawal by Subject|1|||
48521331|NCT01119625|156099735|FG000|Overall Study|Other|0|||
48521332|NCT01119625|156099736|FG001|Overall Study|Other|1|||
48521333|NCT01557751|156099750|FG000|Overall Study|Physician Decision|3|||
48521334|NCT00380588|156099751|FG000|Overall Study|Unequivocal Disease Progression|25|||
48521335|NCT00380588|156099752|FG001|Overall Study|Unequivocal Disease Progression|34|||
48521336|NCT00380588|156099751|FG000|Overall Study|Next Cycle Not Started|4|||
48521337|NCT00380588|156099752|FG001|Overall Study|Next Cycle Not Started|0|||
48521338|NCT00380588|156099751|FG000|Overall Study|Adverse Event|7|||
48521339|NCT00380588|156099752|FG001|Overall Study|Adverse Event|3|||
48521340|NCT00380588|156099751|FG000|Overall Study|Withdrawal by Subject|1|||
48521341|NCT00380588|156099752|FG001|Overall Study|Withdrawal by Subject|3|||
48521342|NCT00380588|156099751|FG000|Overall Study|Physician Decision|2|||
48521343|NCT00380588|156099752|FG001|Overall Study|Physician Decision|0|||
48732094|NCT02448810|156871241|FG005|Overall Study|Other (unspecified)|0|||
48732095|NCT02448810|156871242|FG006|Overall Study|Other (unspecified)|2|||
48732096|NCT02448810|156871243|FG007|Overall Study|Other (unspecified)|0|||
48732097|NCT00470847|156871246|FG000|Overall Study|Pt still receiving treatment|1|||
48732098|NCT01268150|156871247|FG000|Treatment Phase|Progression of disease|18|||
48732099|NCT01268150|156871247|FG000|Treatment Phase|Adverse Event|3|||
48732100|NCT01268150|156871247|FG000|Treatment Phase|Withdrawal by Subject|3|||
48824658|NCT05257837|157198923|FG000|Overall Study|Excluded (did not find the guns)|4|||
48824659|NCT05257837|157198924|FG001|Overall Study|Excluded (did not find the guns)|2|||
48824660|NCT05257837|157198925|FG002|Overall Study|Excluded (did not find the guns)|4|||
48824661|NCT05257837|157198926|FG003|Overall Study|Excluded (did not find the guns)|0|||
48824662|NCT02561455|157198927|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
48824663|NCT02561455|157198928|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
48824664|NCT02561455|157198929|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
48824665|NCT02561455|157198930|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
48824666|NCT02561455|157198927|FG000|Overall Study|Withdrawal by Subject|1|||
48824667|NCT02561455|157198928|FG001|Overall Study|Withdrawal by Subject|0|||
48824668|NCT02561455|157198929|FG002|Overall Study|Withdrawal by Subject|1|||
48521344|NCT04561115|156099753|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
48521345|NCT04561115|156099754|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
48521346|NCT04561115|156099753|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
48824669|NCT02561455|157198930|FG003|Overall Study|Withdrawal by Subject|0|||
48521347|NCT04561115|156099754|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
48521348|NCT04561115|156099753|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
48521349|NCT04561115|156099754|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
48521350|NCT00743145|156099755|FG000|Overall Study|Withdrawal by Subject|1|||
48521351|NCT00743145|156099755|FG000|Overall Study|Adverse Event|2|||
48521352|NCT00743145|156099755|FG000|Overall Study|Pregnancy|1|||
48521353|NCT01691612|156099756|FG000|Overall Study|deemed ineligible after 1st visit|6|||
48521354|NCT01691612|156099756|FG000|Overall Study|Adverse Event|1|||
48521355|NCT02050321|156099758|FG000|Overall Study|Withdrawal by Subject|1|||
48601561|NCT00846586|156397665|FG000|Overall Study|Administrative problems|5|||
48824670|NCT02561455|157198927|FG000|Overall Study|Disease Progression|0|||
48824671|NCT02561455|157198928|FG001|Overall Study|Disease Progression|1|||
48824672|NCT02561455|157198929|FG002|Overall Study|Disease Progression|0|||
48824673|NCT02561455|157198930|FG003|Overall Study|Disease Progression|0|||
48824674|NCT00409708|157198941|FG000|Treatment|Abnormal test procedure result(s)|1|||
48824675|NCT00409708|157198942|FG001|Treatment|Abnormal test procedure result(s)|0|||
48824676|NCT00409708|157198941|FG000|Treatment|Lack of Efficacy|0|||
48824677|NCT00409708|157198942|FG001|Treatment|Lack of Efficacy|1|||
48824678|NCT00409708|157198941|FG000|Treatment|Protocol Violation|6|||
48824679|NCT00409708|157198942|FG001|Treatment|Protocol Violation|2|||
48824680|NCT00409708|157198941|FG000|Treatment|Withdrawal by Subject|3|||
48824681|NCT00409708|157198942|FG001|Treatment|Withdrawal by Subject|8|||
48824682|NCT00409708|157198941|FG000|Treatment|Lost to Follow-up|0|||
48824683|NCT00409708|157198942|FG001|Treatment|Lost to Follow-up|6|||
48824684|NCT00409708|157198941|FG000|Treatment|Administrative problems|5|||
48824685|NCT00409708|157198942|FG001|Treatment|Administrative problems|0|||
48824686|NCT00409708|157198941|FG000|Washout|Lack of Efficacy|9|||
48824687|NCT00409708|157198942|FG001|Washout|Lack of Efficacy|1|||
48824688|NCT00409708|157198941|FG000|Washout|Protocol Violation|0|||
48824689|NCT00409708|157198942|FG001|Washout|Protocol Violation|1|||
48824690|NCT00409708|157198941|FG000|Washout|Withdrawal by Subject|11|||
48824691|NCT00409708|157198942|FG001|Washout|Withdrawal by Subject|5|||
48824692|NCT00409708|157198941|FG000|Washout|Lost to Follow-up|1|||
48824693|NCT00409708|157198942|FG001|Washout|Lost to Follow-up|3|||
48601562|NCT00846586|156397666|FG001|Overall Study|Administrative problems|4|||
48601563|NCT00846586|156397665|FG000|Overall Study|Death|2|||
48601564|NCT00846586|156397666|FG001|Overall Study|Death|0|||
48601565|NCT00846586|156397665|FG000|Overall Study|Protocol deviation|2|||
48601566|NCT00846586|156397666|FG001|Overall Study|Protocol deviation|6|||
48601567|NCT00846586|156397665|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48601568|NCT00846586|156397666|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48732101|NCT01268150|156871247|FG000|Treatment Phase|Other|4|||
48732102|NCT01268150|156871247|FG000|Extension Phase|Adverse Event|3|||
48732103|NCT01268150|156871247|FG000|Extension Phase|Disease progression|18|||
48732104|NCT01268150|156871247|FG000|Extension Phase|Other|6|||
48824694|NCT02485353|157198943|FG000|Overall Study|Death|1|||
48521356|NCT02050321|156099758|FG000|Overall Study|Adverse Event|1|||
48601569|NCT00846586|156397665|FG000|Overall Study|Lost to Follow-up|1|||
48732105|NCT01147172|156871248|FG000|Overall Study|Withdrawal by Subject|2|||
48732106|NCT01147172|156871248|FG000|Overall Study|Lost to Follow-up|2|||
48824695|NCT02485353|157198943|FG000|Overall Study|Disease Progression|1|||
48824696|NCT02373813|157198944|FG000|Run-In Period|Other, Not Specified|5|||
48732107|NCT02808650|156871249|FG000|Overall Study|Death|0|||
48732108|NCT02808650|156871250|FG001|Overall Study|Death|0|||
48824697|NCT02373813|157198945|FG001|Run-In Period|Other, Not Specified|0|||
48824698|NCT02373813|157198946|FG002|Run-In Period|Other, Not Specified|0|||
48824699|NCT02373813|157198947|FG003|Run-In Period|Other, Not Specified|0|||
48824700|NCT02373813|157198944|FG000|Run-In Period|Withdrawal by Subject|16|||
48824701|NCT02373813|157198945|FG001|Run-In Period|Withdrawal by Subject|0|||
48824702|NCT02373813|157198946|FG002|Run-In Period|Withdrawal by Subject|0|||
48824703|NCT02373813|157198947|FG003|Run-In Period|Withdrawal by Subject|0|||
48824704|NCT02373813|157198944|FG000|Run-In Period|Decision by Sponsor|11|||
48824705|NCT02373813|157198945|FG001|Run-In Period|Decision by Sponsor|0|||
48824706|NCT02373813|157198946|FG002|Run-In Period|Decision by Sponsor|0|||
48824707|NCT02373813|157198947|FG003|Run-In Period|Decision by Sponsor|0|||
48824708|NCT02373813|157198944|FG000|Run-In Period|Protocol Violation|75|||
48824709|NCT02373813|157198945|FG001|Run-In Period|Protocol Violation|0|||
48824710|NCT02373813|157198946|FG002|Run-In Period|Protocol Violation|0|||
48824711|NCT02373813|157198947|FG003|Run-In Period|Protocol Violation|0|||
48824712|NCT02373813|157198944|FG000|Run-In Period|Lost to Follow-up|2|||
48824713|NCT02373813|157198945|FG001|Run-In Period|Lost to Follow-up|0|||
48824714|NCT02373813|157198946|FG002|Run-In Period|Lost to Follow-up|0|||
48824715|NCT02373813|157198947|FG003|Run-In Period|Lost to Follow-up|0|||
48521357|NCT01211262|156099760|FG000|Overall Study|Progressive Disease|18|||
48521358|NCT01211262|156099761|FG001|Overall Study|Progressive Disease|9|||
48521359|NCT01211262|156099760|FG000|Overall Study|Adverse Event|4|||
48824716|NCT02373813|157198944|FG000|Run-In Period|Adverse Event|3|||
48824717|NCT02373813|157198945|FG001|Run-In Period|Adverse Event|0|||
48824718|NCT02373813|157198946|FG002|Run-In Period|Adverse Event|0|||
48824719|NCT02373813|157198947|FG003|Run-In Period|Adverse Event|0|||
48824720|NCT02373813|157198944|FG000|Run-In Period|Noncompliance|1|||
48824721|NCT02373813|157198945|FG001|Run-In Period|Noncompliance|0|||
48824722|NCT02373813|157198946|FG002|Run-In Period|Noncompliance|0|||
48824723|NCT02373813|157198947|FG003|Run-In Period|Noncompliance|0|||
48824724|NCT02373813|157198944|FG000|Run-In Period|Ineligibility Determined|3|||
48824725|NCT02373813|157198945|FG001|Run-In Period|Ineligibility Determined|0|||
48824726|NCT02373813|157198946|FG002|Run-In Period|Ineligibility Determined|0|||
48824727|NCT02373813|157198947|FG003|Run-In Period|Ineligibility Determined|0|||
48824728|NCT02373813|157198944|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
48824729|NCT02373813|157198945|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
48824730|NCT02373813|157198946|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
48824731|NCT02373813|157198947|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
48824732|NCT02373813|157198944|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48824733|NCT02373813|157198945|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
48824734|NCT02373813|157198946|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
48824735|NCT02373813|157198947|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
48824736|NCT02373813|157198944|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48824737|NCT02373813|157198945|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
48824738|NCT02373813|157198946|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
48824739|NCT02373813|157198947|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
48824740|NCT02373813|157198944|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48824741|NCT02373813|157198945|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
48824742|NCT02373813|157198946|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
48824743|NCT02373813|157198947|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
48824744|NCT00826280|157198948|FG000|Overall Study|Randomized but drug not received|1|||
48824745|NCT00826280|157198949|FG001|Overall Study|Randomized but drug not received|0|||
48824746|NCT00826280|157198950|FG002|Overall Study|Randomized but drug not received|1|||
48824747|NCT00826280|157198948|FG000|Overall Study|Adverse Event|1|||
48824748|NCT00826280|157198949|FG001|Overall Study|Adverse Event|3|||
48824749|NCT00826280|157198950|FG002|Overall Study|Adverse Event|0|||
48824750|NCT00826280|157198948|FG000|Overall Study|Lost to Follow-up|0|||
48824751|NCT00826280|157198949|FG001|Overall Study|Lost to Follow-up|1|||
48824752|NCT00826280|157198950|FG002|Overall Study|Lost to Follow-up|0|||
48824753|NCT00826280|157198948|FG000|Overall Study|Sponsor discontinued subject or study|1|||
48824754|NCT00826280|157198949|FG001|Overall Study|Sponsor discontinued subject or study|0|||
48824755|NCT00826280|157198950|FG002|Overall Study|Sponsor discontinued subject or study|0|||
48521360|NCT01211262|156099761|FG001|Overall Study|Adverse Event|0|||
48824756|NCT00826280|157198948|FG000|Overall Study|Reversible ischemic defect not present|43|||
48824757|NCT00826280|157198949|FG001|Overall Study|Reversible ischemic defect not present|40|||
48824758|NCT00826280|157198950|FG002|Overall Study|Reversible ischemic defect not present|44|||
48824759|NCT00826280|157198948|FG000|Overall Study|Interpretation Failure|1|||
48824760|NCT00826280|157198949|FG001|Overall Study|Interpretation Failure|0|||
48824761|NCT00826280|157198950|FG002|Overall Study|Interpretation Failure|0|||
48824762|NCT00826280|157198948|FG000|Overall Study|Machine Failure|1|||
48824763|NCT00826280|157198949|FG001|Overall Study|Machine Failure|1|||
48824764|NCT00826280|157198950|FG002|Overall Study|Machine Failure|0|||
48824765|NCT00826280|157198948|FG000|Overall Study|One or more non-interpretable scan|0|||
48824766|NCT00826280|157198949|FG001|Overall Study|One or more non-interpretable scan|1|||
48824767|NCT00826280|157198950|FG002|Overall Study|One or more non-interpretable scan|1|||
48824768|NCT01511536|157198953|FG000|Phase 1|Other|0|||
48521361|NCT01211262|156099760|FG000|Overall Study|Withdrawal of Consent|1|||
48824769|NCT01511536|157198954|FG001|Phase 1|Other|1|||
48824770|NCT01511536|157198955|FG002|Phase 1|Other|0|||
48824771|NCT01511536|157198953|FG000|Phase 2|Other|0|||
48824772|NCT01511536|157198954|FG001|Phase 2|Other|0|||
48824773|NCT01511536|157198955|FG002|Phase 2|Other|9|||
48824774|NCT02703532|157198956|FG000|Overall Study|Withdrawal by Subject|0|||
48824775|NCT02703532|157198957|FG001|Overall Study|Withdrawal by Subject|1|||
48824776|NCT02703532|157198958|FG002|Overall Study|Withdrawal by Subject|0|||
48824777|NCT02703532|157198959|FG003|Overall Study|Withdrawal by Subject|1|||
48824778|NCT02703532|157198956|FG000|Overall Study|Lost to Follow-up|2|||
48824779|NCT02703532|157198957|FG001|Overall Study|Lost to Follow-up|0|||
48824780|NCT02703532|157198958|FG002|Overall Study|Lost to Follow-up|2|||
48824781|NCT02703532|157198959|FG003|Overall Study|Lost to Follow-up|0|||
48824782|NCT03239210|157198972|FG000|Overall Study|Lost to Follow-up|2|||
48824783|NCT03239210|157198973|FG001|Overall Study|Lost to Follow-up|2|||
48824784|NCT03239210|157198972|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
48824785|NCT03239210|157198973|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
48824786|NCT03239210|157198972|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
48824787|NCT03239210|157198973|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
48824788|NCT02359435|157198978|FG000|Overall Study|Lost to Follow-up|4|||
48824789|NCT02359435|157198979|FG001|Overall Study|Lost to Follow-up|4|||
48824790|NCT02321540|157198984|FG000|Overall Study|Death|0|||
48824791|NCT02321540|157198985|FG001|Overall Study|Death|1|||
48521362|NCT01211262|156099761|FG001|Overall Study|Withdrawal of Consent|0|||
48824792|NCT02321540|157198984|FG000|Overall Study|Progression|3|||
48824793|NCT02321540|157198985|FG001|Overall Study|Progression|9|||
48824794|NCT00051311|157198986|FG000|Overall Study|Starting new study|0|||
48824795|NCT00051311|157198987|FG001|Overall Study|Starting new study|1|||
48824796|NCT00051311|157198986|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
48824797|NCT00051311|157198987|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
48824798|NCT00051311|157198986|FG000|Overall Study|Death of recipient|8|||
48521363|NCT01211262|156099760|FG000|Overall Study|Other|0|||
48824799|NCT00051311|157198987|FG001|Overall Study|Death of recipient|8|||
48824800|NCT00051311|157198986|FG000|Overall Study|Recipient taken off study|4|||
48824801|NCT00051311|157198987|FG001|Overall Study|Recipient taken off study|4|||
48824802|NCT03532178|157198994|FG000|First Period|Withdrawal by Subject|1|||
48824803|NCT03532178|157198995|FG001|First Period|Withdrawal by Subject|3|||
48824804|NCT03532178|157198994|FG000|First Period|technical issues in data collection Technical issues|0|||
48824805|NCT03532178|157198995|FG001|First Period|technical issues in data collection Technical issues|1|||
48824806|NCT03532178|157198994|FG000|Second Period|Withdrawal by Subject|1|||
48824807|NCT03532178|157198995|FG001|Second Period|Withdrawal by Subject|1|||
48824808|NCT03532178|157198994|FG000|Second Period|Technical issues|0|||
48824809|NCT03532178|157198995|FG001|Second Period|Technical issues|1|||
48824810|NCT05349084|157198996|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
48824811|NCT05124899|157198997|FG000|Overall Study|Lost to Follow-up|3|||
48824812|NCT03633903|157198998|FG000|Overall Study|Withdrawal by Subject|1|||
48824813|NCT03633903|157198999|FG001|Overall Study|Withdrawal by Subject|2|||
48521364|NCT01211262|156099761|FG001|Overall Study|Other|1|||
48521365|NCT04768114|156099764|FG000|Overall Study|Lost to Follow-up|5|||
48521366|NCT04768114|156099765|FG001|Overall Study|Lost to Follow-up|10|||
48521367|NCT04768114|156099764|FG000|Overall Study|Withdrawal by Subject|0|||
48521368|NCT04768114|156099765|FG001|Overall Study|Withdrawal by Subject|1|||
48521369|NCT01277510|156099766|FG000|Double-blind Phase|Non-compliance|0|||
48521370|NCT01277510|156099767|FG001|Double-blind Phase|Non-compliance|1|||
48521371|NCT01277510|156099766|FG000|Double-blind Phase|Adverse Event|1|||
48521372|NCT01277510|156099767|FG001|Double-blind Phase|Adverse Event|0|||
48521373|NCT01277510|156099766|FG000|Double-blind Phase|Withdrawal by Subject|2|||
48521374|NCT01277510|156099767|FG001|Double-blind Phase|Withdrawal by Subject|0|||
48521375|NCT01277510|156099766|FG000|Double-blind Phase|Administrative decision|7|||
48824814|NCT03633903|157198998|FG000|Overall Study|Lost to Follow-up|5|||
48824815|NCT03633903|157198999|FG001|Overall Study|Lost to Follow-up|5|||
48824816|NCT00087490|157199000|FG000|Overall Study|Death|6|||
48521376|NCT01277510|156099767|FG001|Double-blind Phase|Administrative decision|9|||
48521377|NCT01277510|156099766|FG000|Double-blind Phase|Death|0|||
48824817|NCT00087490|157199001|FG001|Overall Study|Death|4|||
48824818|NCT00087490|157199000|FG000|Overall Study|Adverse Event|3|||
48824819|NCT00087490|157199001|FG001|Overall Study|Adverse Event|8|||
48521378|NCT01277510|156099767|FG001|Double-blind Phase|Death|1|||
48824820|NCT00087490|157199000|FG000|Overall Study|Lack of Efficacy|0|||
48824821|NCT00087490|157199001|FG001|Overall Study|Lack of Efficacy|2|||
48824822|NCT00087490|157199000|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
48824823|NCT00087490|157199001|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
48824824|NCT00087490|157199000|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
48521379|NCT01277510|156099766|FG000|Double-blind Phase|Protocol-specified criteria|2|||
48521380|NCT01277510|156099767|FG001|Double-blind Phase|Protocol-specified criteria|6|||
48521381|NCT01277510|156099766|FG000|Double-blind Phase|Other|1|||
48732109|NCT02808650|156871251|FG002|Overall Study|Death|0|||
48824825|NCT00087490|157199001|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
48732110|NCT02808650|156871252|FG003|Overall Study|Death|0|||
48732111|NCT02808650|156871253|FG004|Overall Study|Death|1|||
48732112|NCT02808650|156871249|FG000|Overall Study|Lack of Efficacy|5|||
48732113|NCT02808650|156871250|FG001|Overall Study|Lack of Efficacy|5|||
48732114|NCT02808650|156871251|FG002|Overall Study|Lack of Efficacy|6|||
48732115|NCT02808650|156871252|FG003|Overall Study|Lack of Efficacy|5|||
48732116|NCT02808650|156871253|FG004|Overall Study|Lack of Efficacy|4|||
48732117|NCT02808650|156871249|FG000|Overall Study|Physician Decision|1|||
48732118|NCT02808650|156871250|FG001|Overall Study|Physician Decision|1|||
48732119|NCT02808650|156871251|FG002|Overall Study|Physician Decision|0|||
48732120|NCT02808650|156871252|FG003|Overall Study|Physician Decision|0|||
48732121|NCT02808650|156871253|FG004|Overall Study|Physician Decision|0|||
48732122|NCT02808650|156871249|FG000|Overall Study|Withdrawal by Subject|0|||
48732123|NCT02808650|156871250|FG001|Overall Study|Withdrawal by Subject|0|||
48824826|NCT00087490|157199000|FG000|Overall Study|Randomized but not treated|7|||
48824827|NCT00087490|157199001|FG001|Overall Study|Randomized but not treated|18|||
48824828|NCT03382821|157199009|FG000|Overall Study|Did not receive allocated intervention.|0|||
48824829|NCT03382821|157199010|FG001|Overall Study|Did not receive allocated intervention.|3|||
48824830|NCT01141660|157199013|FG000|Overall Study|Physician Decision|0|||
48824831|NCT01141660|157199014|FG001|Overall Study|Physician Decision|12|||
48824832|NCT02775435|157199017|FG000|Overall Study|Adverse Event|32|||
48824833|NCT02775435|157199018|FG001|Overall Study|Adverse Event|27|||
48824834|NCT02775435|157199017|FG000|Overall Study|Lost to Follow-up|2|||
48824835|NCT02775435|157199018|FG001|Overall Study|Lost to Follow-up|2|||
48824836|NCT02775435|157199017|FG000|Overall Study|Sponsor decision|44|||
48824837|NCT02775435|157199018|FG001|Overall Study|Sponsor decision|19|||
48824838|NCT02775435|157199017|FG000|Overall Study|Withdrawal by Subject|4|||
48824839|NCT02775435|157199018|FG001|Overall Study|Withdrawal by Subject|9|||
48824840|NCT02775435|157199017|FG000|Overall Study|Death|196|||
48824841|NCT02775435|157199018|FG001|Overall Study|Death|224|||
48824842|NCT00052962|157199019|FG000|Overall Study|Not evaluable|0|||
48824843|NCT00052962|157199020|FG001|Overall Study|Not evaluable|2|||
48824844|NCT00052962|157199019|FG000|Overall Study|Not randomized/not evaluable|1|||
48824845|NCT00052962|157199020|FG001|Overall Study|Not randomized/not evaluable|0|||
48824846|NCT02099539|157199023|FG000|Overall Study|Progressive Disease|3|||
48824847|NCT02099539|157199024|FG001|Overall Study|Progressive Disease|2|||
48824848|NCT02099539|157199025|FG002|Overall Study|Progressive Disease|2|||
48824849|NCT02099539|157199026|FG003|Overall Study|Progressive Disease|1|||
48824850|NCT02099539|157199027|FG004|Overall Study|Progressive Disease|4|||
48824851|NCT02099539|157199028|FG005|Overall Study|Progressive Disease|2|||
48824852|NCT02099539|157199029|FG006|Overall Study|Progressive Disease|0|||
48824853|NCT02099539|157199023|FG000|Overall Study|Adverse Event|0|||
48824854|NCT02099539|157199024|FG001|Overall Study|Adverse Event|0|||
48824855|NCT02099539|157199025|FG002|Overall Study|Adverse Event|1|||
48824856|NCT02099539|157199026|FG003|Overall Study|Adverse Event|1|||
48824857|NCT02099539|157199027|FG004|Overall Study|Adverse Event|0|||
48824858|NCT02099539|157199028|FG005|Overall Study|Adverse Event|0|||
48824859|NCT02099539|157199029|FG006|Overall Study|Adverse Event|0|||
48824860|NCT02099539|157199023|FG000|Overall Study|Physician Decision|0|||
48824861|NCT02099539|157199024|FG001|Overall Study|Physician Decision|0|||
48824862|NCT02099539|157199025|FG002|Overall Study|Physician Decision|0|||
48824863|NCT02099539|157199026|FG003|Overall Study|Physician Decision|0|||
48824864|NCT02099539|157199027|FG004|Overall Study|Physician Decision|0|||
48824865|NCT02099539|157199028|FG005|Overall Study|Physician Decision|1|||
48824866|NCT02099539|157199029|FG006|Overall Study|Physician Decision|0|||
48824867|NCT04863898|157199031|FG000|Overall Study|Away from study clinic during intervention training period|2|||
48824868|NCT04863898|157199031|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
48824869|NCT04863898|157199031|FG000|Overall Study|Lost to Follow-up|3|||
48521382|NCT01277510|156099767|FG001|Double-blind Phase|Other|1|||
48521383|NCT01277510|156099766|FG000|Open-label Phase|Administrative decision|4|||
48824870|NCT04863898|157199031|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
48824871|NCT04863898|157199031|FG000|Overall Study|No longer employed at clinic|3|||
48824872|NCT00614744|157199032|FG000|Overall Study|Lost to Follow-up|5|||
48824873|NCT00614744|157199033|FG001|Overall Study|Lost to Follow-up|4|||
48824874|NCT00614744|157199032|FG000|Overall Study|Incomplete for Behavior Issues|0|||
48824875|NCT00614744|157199033|FG001|Overall Study|Incomplete for Behavior Issues|2|||
48824876|NCT00770211|157199041|FG000|Overall Study|Lost to Follow-up|1|||
48824877|NCT00770211|157199042|FG001|Overall Study|Lost to Follow-up|0|||
48824878|NCT00770211|157199041|FG000|Overall Study|Withdrawal by Subject|0|||
48824879|NCT00770211|157199042|FG001|Overall Study|Withdrawal by Subject|2|||
48732124|NCT02808650|156871251|FG002|Overall Study|Withdrawal by Subject|0|||
48824880|NCT03005288|157199049|FG000|Overall Study|Withdrawal by Subject|7|||
48824881|NCT03005288|157199050|FG001|Overall Study|Withdrawal by Subject|5|||
48824882|NCT03005288|157199049|FG000|Overall Study|Lost to Follow-up|0|||
48601570|NCT00846586|156397666|FG001|Overall Study|Lost to Follow-up|4|||
48732125|NCT02808650|156871252|FG003|Overall Study|Withdrawal by Subject|1|||
48732126|NCT02808650|156871253|FG004|Overall Study|Withdrawal by Subject|1|||
48732127|NCT03799211|156871256|FG000|Overall Study|Lost to Follow-up|2|||
48732128|NCT03799211|156871257|FG001|Overall Study|Lost to Follow-up|13|||
48521384|NCT01277510|156099767|FG001|Open-label Phase|Administrative decision|3|||
48521385|NCT01277510|156099766|FG000|Open-label Phase|Protocol-specified criteria|1|||
48521386|NCT01277510|156099767|FG001|Open-label Phase|Protocol-specified criteria|0|||
48521387|NCT01277510|156099766|FG000|Open-label Phase|Never received investigational product|2|||
48732129|NCT03799211|156871256|FG000|Overall Study|Withdrawal by Subject|2|||
48732130|NCT03799211|156871257|FG001|Overall Study|Withdrawal by Subject|0|||
48732131|NCT01069627|156871259|FG000|Overall Study|Disease progression|7|||
48824883|NCT03005288|157199050|FG001|Overall Study|Lost to Follow-up|1|||
48732132|NCT01069627|156871259|FG000|Overall Study|Adverse Event|12|||
48732133|NCT01069627|156871259|FG000|Overall Study|Protocol Violation|1|||
48732134|NCT04209348|156871260|FG000|Overall Study|Lost to Follow-up|1|||
48732135|NCT04209348|156871261|FG001|Overall Study|Lost to Follow-up|0|||
48732136|NCT03139279|156871262|FG000|Overall Study|Physician Decision|2|||
48732137|NCT03139279|156871263|FG001|Overall Study|Physician Decision|0|||
48732138|NCT03139279|156871262|FG000|Overall Study|Protocol Violation|5|||
48732139|NCT03139279|156871263|FG001|Overall Study|Protocol Violation|4|||
48732140|NCT03139279|156871262|FG000|Overall Study|Withdrawal by Subject|0|||
48732141|NCT03139279|156871263|FG001|Overall Study|Withdrawal by Subject|2|||
48732142|NCT05394350|156871264|FG000|Overall Study|Death|2|||
48732143|NCT05394350|156871265|FG001|Overall Study|Death|2|||
48732144|NCT05394350|156871266|FG002|Overall Study|Death|4|||
48732145|NCT05394350|156871267|FG003|Overall Study|Death|0|||
48732146|NCT05394350|156871268|FG004|Overall Study|Death|1|||
48732147|NCT05394350|156871269|FG005|Overall Study|Death|0|||
48521388|NCT01277510|156099767|FG001|Open-label Phase|Never received investigational product|0|||
48732148|NCT05394350|156871264|FG000|Overall Study|Study terminated by sponsor|1|||
48732149|NCT05394350|156871265|FG001|Overall Study|Study terminated by sponsor|1|||
48732150|NCT05394350|156871266|FG002|Overall Study|Study terminated by sponsor|7|||
48732151|NCT05394350|156871267|FG003|Overall Study|Study terminated by sponsor|3|||
48824884|NCT03005288|157199049|FG000|Overall Study|Adverse Event|5|||
48824885|NCT03005288|157199050|FG001|Overall Study|Adverse Event|0|||
48824886|NCT03005288|157199049|FG000|Overall Study|Protocol deviation|0|||
48824887|NCT03005288|157199050|FG001|Overall Study|Protocol deviation|1|||
48824888|NCT03005288|157199049|FG000|Overall Study|Physician Decision|0|||
48824889|NCT03005288|157199050|FG001|Overall Study|Physician Decision|1|||
48824890|NCT03717194|157199053|FG000|Overall Study|Withdrawal by Subject|2|||
48824891|NCT03717194|157199054|FG001|Overall Study|Withdrawal by Subject|4|||
48824892|NCT03717194|157199053|FG000|Overall Study|Adverse Event|1|||
48824893|NCT03717194|157199054|FG001|Overall Study|Adverse Event|1|||
48824894|NCT00689104|157199055|FG000|Overall Study|Eligibility criterion not met|5|||
48824895|NCT00689104|157199056|FG001|Overall Study|Eligibility criterion not met|8|||
48824896|NCT00689104|157199057|FG002|Overall Study|Eligibility criterion not met|0|||
48824897|NCT00689104|157199058|FG003|Overall Study|Eligibility criterion not met|4|||
48824898|NCT00689104|157199055|FG000|Overall Study|Adverse Event|13|||
48824899|NCT00689104|157199056|FG001|Overall Study|Adverse Event|25|||
48824900|NCT00689104|157199057|FG002|Overall Study|Adverse Event|16|||
48732152|NCT05394350|156871268|FG004|Overall Study|Study terminated by sponsor|2|||
48732153|NCT05394350|156871269|FG005|Overall Study|Study terminated by sponsor|4|||
48732154|NCT02963935|156871270|FG000|Overall Study|Adverse Event|12|||
48732155|NCT02963935|156871271|FG001|Overall Study|Adverse Event|6|||
48824901|NCT00689104|157199058|FG003|Overall Study|Adverse Event|24|||
48824902|NCT00689104|157199055|FG000|Overall Study|Lack of Efficacy|5|||
48824903|NCT00689104|157199056|FG001|Overall Study|Lack of Efficacy|6|||
48824904|NCT00689104|157199057|FG002|Overall Study|Lack of Efficacy|2|||
48521389|NCT00113919|156099768|FG000|Overall Study|Physician Decision|8|||
48824905|NCT00689104|157199058|FG003|Overall Study|Lack of Efficacy|3|||
48383819|NCT01383161|155601443|FG001|Overall Study|Lack of Efficacy|1|||
48521390|NCT00113919|156099768|FG000|Overall Study|Death|6|||
48521391|NCT05412121|156099769|FG000|Overall Study|Withdrawal by Subject|4|||
48521392|NCT05412121|156099769|FG000|Overall Study|Physician Decision|1|||
48521393|NCT05412121|156099769|FG000|Overall Study|Lost to Follow-up|5|||
48521394|NCT02670551|156099770|FG000|Overall Study|Adverse Event|4|||
48521395|NCT02670551|156099771|FG001|Overall Study|Adverse Event|7|||
48521396|NCT02670551|156099772|FG002|Overall Study|Adverse Event|9|||
48521397|NCT02670551|156099770|FG000|Overall Study|Lack of Efficacy|2|||
48521398|NCT02670551|156099771|FG001|Overall Study|Lack of Efficacy|0|||
48521399|NCT02670551|156099772|FG002|Overall Study|Lack of Efficacy|3|||
48521400|NCT02670551|156099770|FG000|Overall Study|Withdrawal of Consent|6|||
48521401|NCT02670551|156099771|FG001|Overall Study|Withdrawal of Consent|3|||
48521402|NCT02670551|156099772|FG002|Overall Study|Withdrawal of Consent|8|||
48732156|NCT02963935|156871270|FG000|Overall Study|Protocol Violation|2|||
48732157|NCT02963935|156871271|FG001|Overall Study|Protocol Violation|1|||
48824906|NCT00689104|157199055|FG000|Overall Study|Withdrawal by Subject|12|||
48824907|NCT00689104|157199056|FG001|Overall Study|Withdrawal by Subject|11|||
48521403|NCT02670551|156099770|FG000|Overall Study|Lost to Follow-up|5|||
48521404|NCT02670551|156099771|FG001|Overall Study|Lost to Follow-up|7|||
48521405|NCT02670551|156099772|FG002|Overall Study|Lost to Follow-up|6|||
48521406|NCT02670551|156099770|FG000|Overall Study|Protocol Violation|1|||
48521407|NCT02670551|156099771|FG001|Overall Study|Protocol Violation|0|||
48521408|NCT02670551|156099772|FG002|Overall Study|Protocol Violation|0|||
48732158|NCT02963935|156871270|FG000|Overall Study|Lack of Efficacy|0|||
48732159|NCT02963935|156871271|FG001|Overall Study|Lack of Efficacy|2|||
48732160|NCT02963935|156871270|FG000|Overall Study|Lost to Follow-up|1|||
48732161|NCT02963935|156871271|FG001|Overall Study|Lost to Follow-up|6|||
48732162|NCT02963935|156871270|FG000|Overall Study|Unclassified|13|||
48732163|NCT02963935|156871271|FG001|Overall Study|Unclassified|22|||
48732164|NCT00237185|156871272|FG000|Core|Adverse Event|3|||
48732165|NCT00237185|156871273|FG001|Core|Adverse Event|4|||
48732166|NCT00237185|156871272|FG000|Core|Abnormal laboratory value|0|||
48732167|NCT00237185|156871273|FG001|Core|Abnormal laboratory value|4|||
48732168|NCT00237185|156871272|FG000|Core|Abnormal test procedure results|1|||
48732169|NCT00237185|156871273|FG001|Core|Abnormal test procedure results|0|||
48732170|NCT00237185|156871272|FG000|Core|Lack of Efficacy|30|||
48732171|NCT00237185|156871273|FG001|Core|Lack of Efficacy|23|||
48732172|NCT00237185|156871272|FG000|Core|Protocol Violation|1|||
48732173|NCT00237185|156871273|FG001|Core|Protocol Violation|1|||
48521409|NCT02670551|156099770|FG000|Overall Study|Noncompliance with study drug|3|||
48521410|NCT02670551|156099771|FG001|Overall Study|Noncompliance with study drug|3|||
48521411|NCT02670551|156099772|FG002|Overall Study|Noncompliance with study drug|2|||
48521412|NCT02670551|156099770|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48521413|NCT02670551|156099771|FG001|Overall Study|Other Miscellaneous Reasons|3|||
48521414|NCT02670551|156099772|FG002|Overall Study|Other Miscellaneous Reasons|3|||
48521415|NCT02670551|156099770|FG000|Overall Study|Did Not Receive Treatment|5|||
48521416|NCT02670551|156099771|FG001|Overall Study|Did Not Receive Treatment|3|||
48521417|NCT02670551|156099772|FG002|Overall Study|Did Not Receive Treatment|0|||
48521418|NCT00715676|156099773|FG000|Overall Study|Adverse Event|3|||
48521419|NCT00715676|156099774|FG001|Overall Study|Adverse Event|5|||
48521420|NCT00715676|156099775|FG002|Overall Study|Adverse Event|21|||
48521421|NCT00715676|156099773|FG000|Overall Study|Withdrawal by Subject|1|||
48521422|NCT00715676|156099774|FG001|Overall Study|Withdrawal by Subject|3|||
48521423|NCT00715676|156099775|FG002|Overall Study|Withdrawal by Subject|8|||
48521424|NCT00715676|156099773|FG000|Overall Study|Lost to Follow-up|1|||
48521425|NCT00715676|156099774|FG001|Overall Study|Lost to Follow-up|2|||
48521426|NCT00715676|156099775|FG002|Overall Study|Lost to Follow-up|1|||
48521427|NCT00715676|156099773|FG000|Overall Study|Terminated by Sponsor|1|||
48521428|NCT00715676|156099774|FG001|Overall Study|Terminated by Sponsor|0|||
48732174|NCT00237185|156871272|FG000|Core|Withdrawal by Subject|4|||
48732175|NCT00237185|156871273|FG001|Core|Withdrawal by Subject|4|||
48732176|NCT00237185|156871272|FG000|Core|Administrative problems|0|||
48732177|NCT00237185|156871273|FG001|Core|Administrative problems|1|||
48732178|NCT00237185|156871272|FG000|Core|Death|4|||
48732179|NCT00237185|156871273|FG001|Core|Death|0|||
48732180|NCT00237185|156871272|FG000|Core|Determined ineligible post randomization|1|||
48732181|NCT00237185|156871273|FG001|Core|Determined ineligible post randomization|0|||
48732182|NCT00237185|156871272|FG000|Extension|Adverse Event|1|||
48732183|NCT00237185|156871273|FG001|Extension|Adverse Event|0|||
48732184|NCT00237185|156871272|FG000|Extension|Abnormal laboratory value|0|||
48732185|NCT00237185|156871273|FG001|Extension|Abnormal laboratory value|1|||
48732186|NCT00237185|156871272|FG000|Extension|Lack of Efficacy|9|||
48732187|NCT00237185|156871273|FG001|Extension|Lack of Efficacy|14|||
48732188|NCT00237185|156871272|FG000|Extension|Condition no longer required study drug|0|||
48732189|NCT00237185|156871273|FG001|Extension|Condition no longer required study drug|1|||
48732190|NCT00237185|156871272|FG000|Extension|Withdrawal by Subject|3|||
48732191|NCT00237185|156871273|FG001|Extension|Withdrawal by Subject|2|||
48732192|NCT00237185|156871272|FG000|Extension|Lost to Follow-up|1|||
48732193|NCT00237185|156871273|FG001|Extension|Lost to Follow-up|0|||
48732194|NCT00237185|156871272|FG000|Extension|Administrative problems|1|||
48732195|NCT00237185|156871273|FG001|Extension|Administrative problems|0|||
48732196|NCT00237185|156871272|FG000|Extension|Death|1|||
48732197|NCT00237185|156871273|FG001|Extension|Death|1|||
48732198|NCT02322021|156871274|FG000|Core Phase|Adverse Event|1|||
48732199|NCT02322021|156871275|FG001|Core Phase|Adverse Event|3|||
48732200|NCT02322021|156871276|FG002|Core Phase|Adverse Event|4|||
48732201|NCT02322021|156871277|FG003|Core Phase|Adverse Event|2|||
48732202|NCT02322021|156871278|FG004|Core Phase|Adverse Event|0|||
48732203|NCT02322021|156871274|FG000|Core Phase|Participant Choice|4|||
48732204|NCT02322021|156871275|FG001|Core Phase|Participant Choice|5|||
48732205|NCT02322021|156871276|FG002|Core Phase|Participant Choice|4|||
48732206|NCT02322021|156871277|FG003|Core Phase|Participant Choice|2|||
48732207|NCT02322021|156871278|FG004|Core Phase|Participant Choice|0|||
48732208|NCT02322021|156871274|FG000|Core Phase|Lost to Follow-up|0|||
48732209|NCT02322021|156871275|FG001|Core Phase|Lost to Follow-up|0|||
48732210|NCT02322021|156871276|FG002|Core Phase|Lost to Follow-up|0|||
48732211|NCT02322021|156871277|FG003|Core Phase|Lost to Follow-up|1|||
48732212|NCT02322021|156871278|FG004|Core Phase|Lost to Follow-up|0|||
48732213|NCT02322021|156871274|FG000|Core Phase|Other|0|||
48732214|NCT02322021|156871275|FG001|Core Phase|Other|0|||
48732215|NCT02322021|156871276|FG002|Core Phase|Other|1|||
48732216|NCT02322021|156871277|FG003|Core Phase|Other|0|||
48732217|NCT02322021|156871278|FG004|Core Phase|Other|0|||
48732218|NCT02322021|156871274|FG000|Extension Phase|Adverse Event|0|||
48732219|NCT02322021|156871275|FG001|Extension Phase|Adverse Event|0|||
48732220|NCT02322021|156871276|FG002|Extension Phase|Adverse Event|0|||
48732221|NCT02322021|156871277|FG003|Extension Phase|Adverse Event|0|||
48732222|NCT02322021|156871278|FG004|Extension Phase|Adverse Event|3|||
48601571|NCT00846586|156397665|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48601572|NCT00846586|156397666|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48601573|NCT00808067|156397667|FG000|Overall Study|Major/minor bleed|30|||
48601574|NCT00808067|156397668|FG001|Overall Study|Major/minor bleed|44|||
48601575|NCT00808067|156397667|FG000|Overall Study|Outcome event - other|33|||
48601576|NCT00808067|156397668|FG001|Overall Study|Outcome event - other|25|||
48601577|NCT00808067|156397667|FG000|Overall Study|Adverse Event|111|||
48601578|NCT00808067|156397668|FG001|Overall Study|Adverse Event|121|||
48601579|NCT00808067|156397667|FG000|Overall Study|Hospitalization (not including surgery)|18|||
48601580|NCT00808067|156397668|FG001|Overall Study|Hospitalization (not including surgery)|17|||
48521429|NCT00715676|156099775|FG002|Overall Study|Terminated by Sponsor|0|||
48521430|NCT00715676|156099773|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
48732223|NCT02322021|156871274|FG000|Extension Phase|Participant Choice|0|||
48732224|NCT02322021|156871275|FG001|Extension Phase|Participant Choice|0|||
48732225|NCT02322021|156871276|FG002|Extension Phase|Participant Choice|0|||
48732226|NCT02322021|156871277|FG003|Extension Phase|Participant Choice|0|||
48521431|NCT00715676|156099774|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
48521432|NCT00715676|156099775|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
48521433|NCT00715676|156099773|FG000|Overall Study|Use of Exclusionary Medication|0|||
48521434|NCT00715676|156099774|FG001|Overall Study|Use of Exclusionary Medication|0|||
48521435|NCT00715676|156099775|FG002|Overall Study|Use of Exclusionary Medication|1|||
48521436|NCT00715676|156099773|FG000|Overall Study|Elevated Blood Glucose|0|||
48521437|NCT00715676|156099774|FG001|Overall Study|Elevated Blood Glucose|1|||
48521438|NCT00715676|156099775|FG002|Overall Study|Elevated Blood Glucose|0|||
48521439|NCT01963260|156099776|FG000|Overall Study|Withdrawal by Subject|2|||
48521440|NCT01963260|156099777|FG001|Overall Study|Withdrawal by Subject|0|||
48521441|NCT01963260|156099778|FG002|Overall Study|Withdrawal by Subject|0|||
48521442|NCT01963260|156099779|FG003|Overall Study|Withdrawal by Subject|1|||
48521443|NCT01963260|156099780|FG004|Overall Study|Withdrawal by Subject|2|||
48521444|NCT01963260|156099781|FG005|Overall Study|Withdrawal by Subject|0|||
48521445|NCT01963260|156099782|FG006|Overall Study|Withdrawal by Subject|0|||
48521446|NCT01963260|156099783|FG007|Overall Study|Withdrawal by Subject|0|||
48521447|NCT01963260|156099784|FG008|Overall Study|Withdrawal by Subject|0|||
48521448|NCT01963260|156099785|FG009|Overall Study|Withdrawal by Subject|0|||
48521449|NCT02340962|156099786|FG000|Overall Study|Lost to Follow-up|1|||
48521450|NCT02340962|156099787|FG001|Overall Study|Lost to Follow-up|0|||
48521451|NCT01970592|156099788|FG000|Overall Study|Withdrawal by Subject|4|||
48521452|NCT01970592|156099788|FG000|Overall Study|Physician Decision|1|||
48521453|NCT01970592|156099788|FG000|Overall Study|Adverse Event|1|||
48521454|NCT02003391|156099789|FG000|Overall Study|Withdrawal by Subject|2|||
48521455|NCT02003391|156099790|FG001|Overall Study|Withdrawal by Subject|1|||
48521456|NCT02003391|156099789|FG000|Overall Study|Protocol Violation|0|||
48521457|NCT02003391|156099790|FG001|Overall Study|Protocol Violation|1|||
48521458|NCT02003391|156099789|FG000|Overall Study|Adverse Event|1|||
48521459|NCT02003391|156099790|FG001|Overall Study|Adverse Event|0|||
48521460|NCT03727139|156099791|FG000|Overall Study|Protocol Violation|60|||
48521461|NCT00566722|156099792|FG000|Overall Study|Adverse Event|0|||
48521462|NCT00566722|156099793|FG001|Overall Study|Adverse Event|1|||
48521463|NCT00566722|156099794|FG002|Overall Study|Adverse Event|0|||
48521464|NCT00566722|156099792|FG000|Overall Study|Withdrawal by Subject|0|||
48521465|NCT00566722|156099793|FG001|Overall Study|Withdrawal by Subject|0|||
48521466|NCT00566722|156099794|FG002|Overall Study|Withdrawal by Subject|1|||
48521467|NCT00566722|156099792|FG000|Overall Study|Lost to Follow-up|1|||
48521468|NCT00566722|156099793|FG001|Overall Study|Lost to Follow-up|1|||
48521469|NCT00566722|156099794|FG002|Overall Study|Lost to Follow-up|1|||
48521470|NCT00566722|156099792|FG000|Overall Study|Lack of Efficacy|1|||
48521471|NCT00566722|156099793|FG001|Overall Study|Lack of Efficacy|2|||
48601581|NCT00808067|156397667|FG000|Overall Study|Hospitalization due to surgery|37|||
48601582|NCT00808067|156397668|FG001|Overall Study|Hospitalization due to surgery|40|||
48732227|NCT02322021|156871278|FG004|Extension Phase|Participant Choice|6|||
48732228|NCT02322021|156871274|FG000|Extension Phase|Other|0|||
48732229|NCT02322021|156871275|FG001|Extension Phase|Other|0|||
48732230|NCT02322021|156871276|FG002|Extension Phase|Other|0|||
48732231|NCT02322021|156871277|FG003|Extension Phase|Other|0|||
48732232|NCT02322021|156871278|FG004|Extension Phase|Other|3|||
48732233|NCT02322021|156871274|FG000|Extension Phase|Lost to Follow-up|0|||
48521472|NCT00566722|156099794|FG002|Overall Study|Lack of Efficacy|4|||
48521473|NCT00566722|156099792|FG000|Overall Study|Did not meet exclusion criteria|0|||
48521474|NCT00566722|156099793|FG001|Overall Study|Did not meet exclusion criteria|0|||
48521475|NCT00566722|156099794|FG002|Overall Study|Did not meet exclusion criteria|2|||
48521476|NCT00566722|156099792|FG000|Overall Study|Serious adverse event|0|||
48521477|NCT00566722|156099793|FG001|Overall Study|Serious adverse event|1|||
48521478|NCT00566722|156099794|FG002|Overall Study|Serious adverse event|0|||
48521479|NCT00566722|156099792|FG000|Overall Study|Noncompliant with drug administration|0|||
48521480|NCT00566722|156099793|FG001|Overall Study|Noncompliant with drug administration|0|||
48521481|NCT00566722|156099794|FG002|Overall Study|Noncompliant with drug administration|1|||
48521482|NCT01320722|156099795|FG000|Overall Study|Did not Receive Intervention|3|||
48521483|NCT01320722|156099796|FG001|Overall Study|Did not Receive Intervention|2|||
48521484|NCT01320722|156099797|FG002|Overall Study|Did not Receive Intervention|1|||
48521485|NCT01320722|156099798|FG003|Overall Study|Did not Receive Intervention|1|||
48521486|NCT01320722|156099799|FG004|Overall Study|Did not Receive Intervention|2|||
48521487|NCT01320722|156099795|FG000|Overall Study|Lost to Follow-up|0|||
48521488|NCT01320722|156099796|FG001|Overall Study|Lost to Follow-up|1|||
48521489|NCT01320722|156099797|FG002|Overall Study|Lost to Follow-up|0|||
48521490|NCT01320722|156099798|FG003|Overall Study|Lost to Follow-up|1|||
48521491|NCT01320722|156099799|FG004|Overall Study|Lost to Follow-up|3|||
48521492|NCT01320722|156099795|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
48521493|NCT01320722|156099796|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
48521494|NCT01320722|156099797|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
48521495|NCT01320722|156099798|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
48521496|NCT01320722|156099799|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
48521497|NCT01320722|156099795|FG000|Overall Study|Participant Developed a Rash|0|||
48521498|NCT01320722|156099796|FG001|Overall Study|Participant Developed a Rash|0|||
48521499|NCT01320722|156099797|FG002|Overall Study|Participant Developed a Rash|2|||
48521500|NCT01320722|156099798|FG003|Overall Study|Participant Developed a Rash|1|||
48521501|NCT01320722|156099799|FG004|Overall Study|Participant Developed a Rash|1|||
48521502|NCT01320722|156099795|FG000|Overall Study|Non-compliant with Medication|0|||
48521503|NCT01320722|156099796|FG001|Overall Study|Non-compliant with Medication|0|||
48521504|NCT01320722|156099797|FG002|Overall Study|Non-compliant with Medication|1|||
48521505|NCT01320722|156099798|FG003|Overall Study|Non-compliant with Medication|0|||
48521506|NCT01320722|156099799|FG004|Overall Study|Non-compliant with Medication|0|||
48521507|NCT01320722|156099795|FG000|Overall Study|Adverse Event|0|||
48521508|NCT01320722|156099796|FG001|Overall Study|Adverse Event|0|||
48521509|NCT01320722|156099797|FG002|Overall Study|Adverse Event|3|||
48521510|NCT01320722|156099798|FG003|Overall Study|Adverse Event|6|||
48521511|NCT01320722|156099799|FG004|Overall Study|Adverse Event|0|||
48521512|NCT01320722|156099795|FG000|Overall Study|Not Compliant with Study Procedures|0|||
48521513|NCT01320722|156099796|FG001|Overall Study|Not Compliant with Study Procedures|0|||
48521514|NCT01320722|156099797|FG002|Overall Study|Not Compliant with Study Procedures|0|||
48521515|NCT01320722|156099798|FG003|Overall Study|Not Compliant with Study Procedures|4|||
48521516|NCT01320722|156099799|FG004|Overall Study|Not Compliant with Study Procedures|0|||
48521517|NCT01320722|156099795|FG000|Overall Study|Pregnancy|0|||
48521518|NCT01320722|156099796|FG001|Overall Study|Pregnancy|0|||
48521519|NCT01320722|156099797|FG002|Overall Study|Pregnancy|0|||
48521520|NCT01320722|156099798|FG003|Overall Study|Pregnancy|1|||
48521521|NCT01320722|156099799|FG004|Overall Study|Pregnancy|0|||
48521522|NCT01320722|156099795|FG000|Overall Study|Started an Exclusionary Medication|0|||
48521523|NCT01320722|156099796|FG001|Overall Study|Started an Exclusionary Medication|0|||
48521524|NCT01320722|156099797|FG002|Overall Study|Started an Exclusionary Medication|0|||
48521525|NCT01320722|156099798|FG003|Overall Study|Started an Exclusionary Medication|0|||
48521526|NCT01320722|156099799|FG004|Overall Study|Started an Exclusionary Medication|1|||
48521527|NCT01320722|156099795|FG000|Overall Study|Withdrew due to Health Condition|0|||
48521528|NCT01320722|156099796|FG001|Overall Study|Withdrew due to Health Condition|0|||
48521529|NCT01320722|156099797|FG002|Overall Study|Withdrew due to Health Condition|0|||
48521530|NCT01320722|156099798|FG003|Overall Study|Withdrew due to Health Condition|0|||
48521531|NCT01320722|156099799|FG004|Overall Study|Withdrew due to Health Condition|1|||
48521532|NCT03980522|156099800|FG000|Treatment Period|Adverse Event|1|||
48521533|NCT03980522|156099801|FG001|Treatment Period|Adverse Event|0|||
48521534|NCT03980522|156099802|FG002|Treatment Period|Adverse Event|0|||
48521535|NCT03980522|156099803|FG003|Treatment Period|Adverse Event|0|||
48521536|NCT03980522|156099804|FG004|Treatment Period|Adverse Event|0|||
48521537|NCT04994431|156099805|FG000|Overall Study|Adverse Event|1|||
48521538|NCT04994431|156099806|FG001|Overall Study|Adverse Event|0|||
48521539|NCT02896296|156099807|FG000|Overall Study|Adverse Event|1|||
48521540|NCT02896296|156099807|FG000|Overall Study|Lost to Follow-up|19|||
48521541|NCT02896296|156099807|FG000|Overall Study|Pregnancy|1|||
48521542|NCT02896296|156099807|FG000|Overall Study|Physician Decision|2|||
48521543|NCT02896296|156099807|FG000|Overall Study|Withdrawal by Subject|10|||
48521544|NCT02896296|156099807|FG000|Overall Study|Site closing|7|||
48521545|NCT02896296|156099807|FG000|Overall Study|Incarceration|1|||
48521546|NCT02896296|156099807|FG000|Overall Study|Relocation|1|||
48521547|NCT04364763|156099808|FG000|Overall Study|Death|1|||
48521548|NCT04364763|156099809|FG001|Overall Study|Death|2|||
48824908|NCT00689104|157199057|FG002|Overall Study|Withdrawal by Subject|18|||
48824909|NCT00689104|157199058|FG003|Overall Study|Withdrawal by Subject|11|||
48824910|NCT00689104|157199055|FG000|Overall Study|Lost to Follow-up|4|||
48521549|NCT04364763|156099808|FG000|Overall Study|Lost to Follow-up|1|||
48521550|NCT04364763|156099809|FG001|Overall Study|Lost to Follow-up|0|||
48521551|NCT00697619|156099810|FG000|Overall Study|Lack of Efficacy|2|||
48521552|NCT00697619|156099811|FG001|Overall Study|Lack of Efficacy|2|||
48521553|NCT00697619|156099810|FG000|Overall Study|Adverse Event|4|||
48521554|NCT00697619|156099811|FG001|Overall Study|Adverse Event|6|||
48521555|NCT00160524|156099812|FG000|Overall Study|Adverse Event|119|||
48521556|NCT00160524|156099812|FG000|Overall Study|Adverse Event and Other|94|||
48521557|NCT00160524|156099812|FG000|Overall Study|Protocol Violation|16|||
48521558|NCT00160524|156099812|FG000|Overall Study|Protocol Violation and Other|2|||
48521559|NCT00160524|156099812|FG000|Overall Study|Withdrawal by Subject|141|||
48521560|NCT00160524|156099812|FG000|Overall Study|Withdrawal by Subject and Other|17|||
48521561|NCT00160524|156099812|FG000|Overall Study|Physician Decision|27|||
48521562|NCT00160524|156099812|FG000|Overall Study|Physician Decision and Other|6|||
48521563|NCT00160524|156099812|FG000|Overall Study|Lost to Follow-up|13|||
48521564|NCT00160524|156099812|FG000|Overall Study|Lost to Follow-up and Other|1|||
48521565|NCT00160524|156099812|FG000|Overall Study|Lack of Efficacy|21|||
48521566|NCT00160524|156099812|FG000|Overall Study|Lack of Efficacy and Other|1|||
48521567|NCT00160524|156099812|FG000|Overall Study|Other|20|||
48521568|NCT00021541|156099813|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
48521569|NCT00021541|156099814|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
48521570|NCT00021541|156099813|FG000|Period 1-First Treatment|Adverse Event|2|||
48521571|NCT00021541|156099814|FG001|Period 1-First Treatment|Adverse Event|1|||
48521572|NCT00021541|156099813|FG000|Period 1-First Treatment|non-adherence|3|||
48521573|NCT00021541|156099814|FG001|Period 1-First Treatment|non-adherence|0|||
48521574|NCT00021541|156099813|FG000|Period 1-First Treatment|Death|1|||
48521575|NCT00021541|156099814|FG001|Period 1-First Treatment|Death|0|||
48521576|NCT00021541|156099813|FG000|Period 1-First Treatment|Pts that did not progress|2|||
48521577|NCT00021541|156099814|FG001|Period 1-First Treatment|Pts that did not progress|2|||
48521578|NCT00021541|156099813|FG000|Period 1-First Treatment|Ineligible|0|||
48521579|NCT00021541|156099814|FG001|Period 1-First Treatment|Ineligible|2|||
48521580|NCT00021541|156099813|FG000|Period 2-crossover|refused phase B|2|||
48521581|NCT00021541|156099814|FG001|Period 2-crossover|refused phase B|2|||
48521582|NCT00021541|156099813|FG000|Period 2-crossover|Withdrawal by Subject|3|||
48521583|NCT00021541|156099814|FG001|Period 2-crossover|Withdrawal by Subject|4|||
48521584|NCT00021541|156099813|FG000|Period 2-crossover|Adverse Event|2|||
48521585|NCT00021541|156099814|FG001|Period 2-crossover|Adverse Event|2|||
48521586|NCT00021541|156099813|FG000|Period 2-crossover|non-adherence|1|||
48521587|NCT00021541|156099814|FG001|Period 2-crossover|non-adherence|0|||
48521588|NCT00021541|156099813|FG000|Period 2-crossover|Pts that did not progress|2|||
48521589|NCT00021541|156099814|FG001|Period 2-crossover|Pts that did not progress|3|||
48521590|NCT02611323|156099816|FG000|Overall Study|Death|3|||
48521591|NCT02611323|156099817|FG001|Overall Study|Death|1|||
48521592|NCT02611323|156099818|FG002|Overall Study|Death|0|||
48521593|NCT02611323|156099819|FG003|Overall Study|Death|0|||
48521594|NCT02611323|156099820|FG004|Overall Study|Death|1|||
48521595|NCT02611323|156099821|FG005|Overall Study|Death|1|||
48521596|NCT02611323|156099822|FG006|Overall Study|Death|8|||
48521597|NCT02611323|156099823|FG007|Overall Study|Death|0|||
48521598|NCT02611323|156099824|FG008|Overall Study|Death|4|||
48521599|NCT02611323|156099825|FG009|Overall Study|Death|6|||
48521600|NCT02611323|156099826|FG010|Overall Study|Death|26|||
48521601|NCT02611323|156099816|FG000|Overall Study|Lost to Follow-up|1|||
48521602|NCT02611323|156099817|FG001|Overall Study|Lost to Follow-up|0|||
48521603|NCT02611323|156099818|FG002|Overall Study|Lost to Follow-up|0|||
48521604|NCT02611323|156099819|FG003|Overall Study|Lost to Follow-up|0|||
48601583|NCT00808067|156397667|FG000|Overall Study|Reduced creatinine clearance|53|||
48601584|NCT00808067|156397668|FG001|Overall Study|Reduced creatinine clearance|55|||
48521605|NCT02611323|156099820|FG004|Overall Study|Lost to Follow-up|0|||
48521606|NCT02611323|156099821|FG005|Overall Study|Lost to Follow-up|0|||
48521607|NCT02611323|156099822|FG006|Overall Study|Lost to Follow-up|3|||
48521608|NCT02611323|156099823|FG007|Overall Study|Lost to Follow-up|0|||
48521609|NCT02611323|156099824|FG008|Overall Study|Lost to Follow-up|0|||
48521610|NCT02611323|156099825|FG009|Overall Study|Lost to Follow-up|0|||
48521611|NCT02611323|156099826|FG010|Overall Study|Lost to Follow-up|2|||
48521612|NCT02611323|156099816|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521613|NCT02611323|156099817|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521614|NCT02611323|156099818|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
48824911|NCT00689104|157199056|FG001|Overall Study|Lost to Follow-up|3|||
48824912|NCT00689104|157199057|FG002|Overall Study|Lost to Follow-up|2|||
48824913|NCT00689104|157199058|FG003|Overall Study|Lost to Follow-up|5|||
48521615|NCT02611323|156099819|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521616|NCT02611323|156099820|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521617|NCT02611323|156099821|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521618|NCT02611323|156099822|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521619|NCT02611323|156099823|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521620|NCT02611323|156099824|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521621|NCT02611323|156099825|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
48521622|NCT02611323|156099826|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
48521623|NCT02611323|156099816|FG000|Overall Study|Progressive Disease|0|||
48521624|NCT02611323|156099817|FG001|Overall Study|Progressive Disease|0|||
48521625|NCT02611323|156099818|FG002|Overall Study|Progressive Disease|0|||
48521626|NCT02611323|156099819|FG003|Overall Study|Progressive Disease|0|||
48521627|NCT02611323|156099820|FG004|Overall Study|Progressive Disease|0|||
48521628|NCT02611323|156099821|FG005|Overall Study|Progressive Disease|0|||
48521629|NCT02611323|156099822|FG006|Overall Study|Progressive Disease|0|||
48521630|NCT02611323|156099823|FG007|Overall Study|Progressive Disease|0|||
48521631|NCT02611323|156099824|FG008|Overall Study|Progressive Disease|0|||
48521632|NCT02611323|156099825|FG009|Overall Study|Progressive Disease|0|||
48521633|NCT02611323|156099826|FG010|Overall Study|Progressive Disease|1|||
48521634|NCT02611323|156099816|FG000|Overall Study|Withdrawal by Subject|1|||
48521635|NCT02611323|156099817|FG001|Overall Study|Withdrawal by Subject|0|||
48521636|NCT02611323|156099818|FG002|Overall Study|Withdrawal by Subject|0|||
48521637|NCT02611323|156099819|FG003|Overall Study|Withdrawal by Subject|0|||
48521638|NCT02611323|156099820|FG004|Overall Study|Withdrawal by Subject|0|||
48521639|NCT02611323|156099821|FG005|Overall Study|Withdrawal by Subject|0|||
48521640|NCT02611323|156099822|FG006|Overall Study|Withdrawal by Subject|0|||
48521641|NCT02611323|156099823|FG007|Overall Study|Withdrawal by Subject|1|||
48521642|NCT02611323|156099824|FG008|Overall Study|Withdrawal by Subject|0|||
48521643|NCT02611323|156099825|FG009|Overall Study|Withdrawal by Subject|1|||
48521644|NCT02611323|156099826|FG010|Overall Study|Withdrawal by Subject|0|||
48521645|NCT00858403|156099827|FG000|Overall Study|Withdrawal by Subject|1|||
48521646|NCT00858403|156099827|FG000|Overall Study|Death|3|||
48521647|NCT00858403|156099827|FG000|Overall Study|Disease Progression|1|||
48521648|NCT00024258|156099828|FG000|Overall Study|Withdrawal by Subject|1|||
48521649|NCT00024258|156099828|FG000|Overall Study|Disease Progression|8|||
48521650|NCT03439085|156099833|FG000|Overall Study|Death|2|||
48521651|NCT03439085|156099833|FG000|Overall Study|Screen Failure|20|||
48521652|NCT01863433|156099835|FG000|Overall Study|Protocol Violation|1|||
48521653|NCT01292837|156099836|FG000|Overall Study|Adverse Event|1|||
48521654|NCT01292837|156099836|FG000|Overall Study|Further treatment determined|1|||
48521655|NCT03942211|156099837|FG000|Overall Study|Death|1|||
48521656|NCT03942211|156099838|FG001|Overall Study|Death|0|||
48521657|NCT03942211|156099837|FG000|Overall Study|Study terminated by sponsor|5|||
48521658|NCT03942211|156099838|FG001|Overall Study|Study terminated by sponsor|3|||
48601585|NCT00808067|156397667|FG000|Overall Study|Elevated LFT results|7|||
48521659|NCT03942211|156099837|FG000|Overall Study|Adverse Event|0|||
48521660|NCT03942211|156099838|FG001|Overall Study|Adverse Event|1|||
48521661|NCT00593827|156099839|FG000|Overall Study|On Active Treatment/Pending|0|||
48521662|NCT00593827|156099840|FG001|Overall Study|On Active Treatment/Pending|2|||
48521663|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
48521664|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
48521665|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
48521666|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
48521667|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
48521668|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
48521669|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
48521670|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
48521671|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
48521672|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
48601586|NCT00808067|156397668|FG001|Overall Study|Elevated LFT results|3|||
48601587|NCT00808067|156397667|FG000|Overall Study|Patient refused to take study medication|65|||
48601588|NCT00808067|156397668|FG001|Overall Study|Patient refused to take study medication|76|||
48521673|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
48521674|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
48521675|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
48521676|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
48521677|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
48521678|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
48521679|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
48521680|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
48521681|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
48521682|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
48521683|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
48601589|NCT00808067|156397667|FG000|Overall Study|Missing|1|||
48732234|NCT02322021|156871275|FG001|Extension Phase|Lost to Follow-up|0|||
48732235|NCT02322021|156871276|FG002|Extension Phase|Lost to Follow-up|0|||
48732236|NCT02322021|156871277|FG003|Extension Phase|Lost to Follow-up|0|||
48732237|NCT02322021|156871278|FG004|Extension Phase|Lost to Follow-up|1|||
48732238|NCT02322021|156871274|FG000|Extension Phase|Study terminated by sponsor|0|||
48732239|NCT02322021|156871275|FG001|Extension Phase|Study terminated by sponsor|0|||
48732240|NCT02322021|156871276|FG002|Extension Phase|Study terminated by sponsor|0|||
48732241|NCT02322021|156871277|FG003|Extension Phase|Study terminated by sponsor|0|||
48732242|NCT02322021|156871278|FG004|Extension Phase|Study terminated by sponsor|28|||
48732243|NCT01385371|156871279|FG000|Overall Study|Adverse Event|54|||
48732244|NCT01385371|156871280|FG001|Overall Study|Adverse Event|19|||
48732245|NCT01385371|156871279|FG000|Overall Study|Lost to Follow-up|16|||
48732246|NCT01385371|156871280|FG001|Overall Study|Lost to Follow-up|16|||
48732247|NCT01385371|156871279|FG000|Overall Study|Withdrawal by Subject|52|||
48732248|NCT01385371|156871280|FG001|Overall Study|Withdrawal by Subject|39|||
48732249|NCT01385371|156871279|FG000|Overall Study|Protocol Violation|25|||
48732250|NCT01385371|156871280|FG001|Overall Study|Protocol Violation|21|||
48732251|NCT01385371|156871279|FG000|Overall Study|Administrative|2|||
48732252|NCT01385371|156871280|FG001|Overall Study|Administrative|2|||
48732253|NCT00828854|156871281|FG000|Overall Study|Disease Progression|17|||
48732254|NCT00828854|156871281|FG000|Overall Study|Adverse Event|9|||
48732255|NCT00828854|156871281|FG000|Overall Study|Reason not Specified|1|||
48732256|NCT00116428|156871282|FG000|Overall Study|Withdrawal by Subject|2|||
48732257|NCT00116428|156871283|FG001|Overall Study|Withdrawal by Subject|5|||
48732258|NCT00116428|156871282|FG000|Overall Study|Did not meet inclusion criteria|1|||
48732259|NCT00116428|156871283|FG001|Overall Study|Did not meet inclusion criteria|0|||
48732260|NCT00386607|156871284|FG000|Core|Adverse Event|40|||
48732261|NCT00386607|156871285|FG001|Core|Adverse Event|0|||
48732262|NCT00386607|156871284|FG000|Core|Abnormal laboratory value(s)|3|||
48732263|NCT00386607|156871285|FG001|Core|Abnormal laboratory value(s)|0|||
48732264|NCT00386607|156871284|FG000|Core|Unsatisfactory therapeutic effect|23|||
48732265|NCT00386607|156871285|FG001|Core|Unsatisfactory therapeutic effect|0|||
48732266|NCT00386607|156871284|FG000|Core|Condition no longer requires study drug|4|||
48732267|NCT00386607|156871285|FG001|Core|Condition no longer requires study drug|0|||
48732268|NCT00386607|156871284|FG000|Core|Patient withdrew consent|15|||
48732269|NCT00386607|156871285|FG001|Core|Patient withdrew consent|0|||
48732270|NCT00386607|156871284|FG000|Core|Lost to Follow-up|23|||
48732271|NCT00386607|156871285|FG001|Core|Lost to Follow-up|0|||
48732272|NCT00386607|156871284|FG000|Core|Administrative problems|1|||
48601590|NCT00808067|156397668|FG001|Overall Study|Missing|0|||
48601591|NCT00808067|156397667|FG000|Overall Study|Death|1|||
48601592|NCT00808067|156397668|FG001|Overall Study|Death|1|||
48601593|NCT00808067|156397667|FG000|Overall Study|Procedure|6|||
48601594|NCT00808067|156397668|FG001|Overall Study|Procedure|7|||
48601595|NCT00808067|156397667|FG000|Overall Study|Withdrawal by Subject|21|||
48601596|NCT00808067|156397668|FG001|Overall Study|Withdrawal by Subject|25|||
48601597|NCT00808067|156397667|FG000|Overall Study|Site closed|4|||
48601598|NCT00808067|156397668|FG001|Overall Study|Site closed|3|||
48601599|NCT00808067|156397667|FG000|Overall Study|Physician Decision|47|||
48601600|NCT00808067|156397668|FG001|Overall Study|Physician Decision|38|||
48601601|NCT00808067|156397667|FG000|Overall Study|Protocol Violation|3|||
48601602|NCT00808067|156397668|FG001|Overall Study|Protocol Violation|11|||
48601603|NCT00808067|156397667|FG000|Overall Study|Patient elected|7|||
48601604|NCT00808067|156397668|FG001|Overall Study|Patient elected|9|||
48601605|NCT00808067|156397667|FG000|Overall Study|Site closed for cause|19|||
48601606|NCT00808067|156397668|FG001|Overall Study|Site closed for cause|19|||
48601607|NCT00808067|156397667|FG000|Overall Study|Other reason not defined above|5|||
48601608|NCT00808067|156397668|FG001|Overall Study|Other reason not defined above|5|||
48601609|NCT00808067|156397667|FG000|Overall Study|Excluded from analysis|13|||
48601610|NCT00808067|156397668|FG001|Overall Study|Excluded from analysis|19|||
48601611|NCT00780975|156397672|FG000|Overall Study|Progressive disease|3|||
48601612|NCT00780975|156397672|FG000|Overall Study|Toxicity|5|||
48601613|NCT01305564|156397675|FG000|Overall Study|Death|21|||
48601614|NCT01305564|156397675|FG000|Overall Study|Lost to Follow-up|12|||
48732273|NCT00386607|156871285|FG001|Core|Administrative problems|0|||
48732274|NCT00386607|156871284|FG000|Core|Protocol Deviation|6|||
48732275|NCT00386607|156871285|FG001|Core|Protocol Deviation|0|||
48732276|NCT00386607|156871284|FG000|Extension|Adverse Event|0|||
48824914|NCT00689104|157199055|FG000|Overall Study|Protocol Violation|2|||
48732277|NCT00386607|156871285|FG001|Extension|Adverse Event|6|||
48601615|NCT01305564|156397675|FG000|Overall Study|Withdrawal by Subject|1|||
48601616|NCT01305564|156397675|FG000|Overall Study|Physician Decision|3|||
48732278|NCT00386607|156871284|FG000|Extension|Abnormal laboratory value(s)|0|||
48732279|NCT00386607|156871285|FG001|Extension|Abnormal laboratory value(s)|1|||
48732280|NCT00386607|156871284|FG000|Extension|Administrative problems|0|||
48732281|NCT00386607|156871285|FG001|Extension|Administrative problems|1|||
48732282|NCT00386607|156871284|FG000|Extension|Lost to Follow-up|0|||
48601617|NCT01973218|156397676|FG000|Overall Study|Adverse Event|1|||
48601618|NCT01973218|156397677|FG001|Overall Study|Adverse Event|0|||
48824915|NCT00689104|157199056|FG001|Overall Study|Protocol Violation|3|||
48521684|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
48521685|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
48824916|NCT00689104|157199057|FG002|Overall Study|Protocol Violation|5|||
48824917|NCT00689104|157199058|FG003|Overall Study|Protocol Violation|3|||
48824918|NCT00689104|157199055|FG000|Overall Study|Randomized but never received study drug|2|||
48824919|NCT00689104|157199056|FG001|Overall Study|Randomized but never received study drug|1|||
48824920|NCT00689104|157199057|FG002|Overall Study|Randomized but never received study drug|1|||
48824921|NCT00689104|157199058|FG003|Overall Study|Randomized but never received study drug|0|||
48824922|NCT00689104|157199055|FG000|Overall Study|Physician Decision|1|||
48824923|NCT00689104|157199056|FG001|Overall Study|Physician Decision|0|||
48824924|NCT00689104|157199057|FG002|Overall Study|Physician Decision|0|||
48824925|NCT00689104|157199058|FG003|Overall Study|Physician Decision|0|||
48824926|NCT00689104|157199055|FG000|Overall Study|Non-compliance with study procedures|0|||
48824927|NCT00689104|157199056|FG001|Overall Study|Non-compliance with study procedures|0|||
48824928|NCT00689104|157199057|FG002|Overall Study|Non-compliance with study procedures|1|||
48824929|NCT00689104|157199058|FG003|Overall Study|Non-compliance with study procedures|0|||
48824930|NCT01737268|157199059|FG000|Overall Study|Adverse Event|6|||
48824931|NCT01737268|157199059|FG000|Overall Study|Worsening of Target Disease|2|||
48824932|NCT01737268|157199059|FG000|Overall Study|In consideration of the patient's safety|1|||
48824933|NCT01543685|157199061|FG000|Overall Study|Lack of Efficacy|1|||
48824934|NCT01543685|157199062|FG001|Overall Study|Lack of Efficacy|2|||
48824935|NCT01543685|157199063|FG002|Overall Study|Lack of Efficacy|2|||
48521686|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
48521687|NCT01435928|156099841|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
48521688|NCT01435928|156099842|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
48521689|NCT01435928|156099843|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
48732283|NCT00386607|156871285|FG001|Extension|Lost to Follow-up|3|||
48732284|NCT00386607|156871284|FG000|Extension|Patient withdrew consent|0|||
48732285|NCT00386607|156871285|FG001|Extension|Patient withdrew consent|5|||
48732286|NCT00386607|156871284|FG000|Extension|Unsatisfactory therapeutic effect|0|||
48732287|NCT00386607|156871285|FG001|Extension|Unsatisfactory therapeutic effect|1|||
48732288|NCT02001181|156871286|FG000|Overall Study|Adverse Event|0|||
48732289|NCT02001181|156871287|FG001|Overall Study|Adverse Event|2|||
48732290|NCT02001181|156871286|FG000|Overall Study|Lost to Follow-up|1|||
48732291|NCT02001181|156871287|FG001|Overall Study|Lost to Follow-up|0|||
48732292|NCT02001181|156871286|FG000|Overall Study|Withdrawal by Subject|0|||
48732293|NCT02001181|156871287|FG001|Overall Study|Withdrawal by Subject|1|||
48732294|NCT01626495|156871288|FG000|Overall Study|Adverse Event|3|||
48732295|NCT01626495|156871288|FG000|Overall Study|Disease progression|27|||
48732296|NCT01626495|156871288|FG000|Overall Study|Withdrawal by Subject|1|||
48732297|NCT01626495|156871288|FG000|Overall Study|Administrative problem|1|||
48732298|NCT01626495|156871288|FG000|Overall Study|Death|2|||
48732299|NCT01626495|156871288|FG000|Overall Study|Physician Decision|1|||
48732300|NCT01626495|156871288|FG000|Overall Study|New cancer therapy|16|||
48732301|NCT01626495|156871288|FG000|Overall Study|Manufacturing failure|1|||
48732302|NCT01631812|156871291|FG000|Overall Study|Adverse Event|25|||
48732303|NCT01631812|156871291|FG000|Overall Study|Lack of Efficacy|5|||
48732304|NCT01631812|156871291|FG000|Overall Study|Withdrawal by Subject|4|||
48732305|NCT01631812|156871291|FG000|Overall Study|Physician Decision|3|||
48732306|NCT01907100|156871292|FG000|Overall Study|PD based on modified RECIST criteria|31|||
48732307|NCT01907100|156871293|FG001|Overall Study|PD based on modified RECIST criteria|32|||
48732308|NCT01907100|156871294|FG002|Overall Study|PD based on modified RECIST criteria|95|||
48732309|NCT01907100|156871295|FG003|Overall Study|PD based on modified RECIST criteria|92|||
48732310|NCT01907100|156871292|FG000|Overall Study|Withdrawal by Subject|2|||
48732311|NCT01907100|156871293|FG001|Overall Study|Withdrawal by Subject|5|||
48732312|NCT01907100|156871294|FG002|Overall Study|Withdrawal by Subject|10|||
48732313|NCT01907100|156871295|FG003|Overall Study|Withdrawal by Subject|13|||
48732314|NCT01907100|156871292|FG000|Overall Study|Protocol Violation|0|||
48732315|NCT01907100|156871293|FG001|Overall Study|Protocol Violation|0|||
48732316|NCT01907100|156871294|FG002|Overall Study|Protocol Violation|1|||
48732317|NCT01907100|156871295|FG003|Overall Study|Protocol Violation|1|||
48732318|NCT01907100|156871292|FG000|Overall Study|Lost to Follow-up|0|||
48732319|NCT01907100|156871293|FG001|Overall Study|Lost to Follow-up|0|||
48732320|NCT01907100|156871294|FG002|Overall Study|Lost to Follow-up|0|||
48732321|NCT01907100|156871295|FG003|Overall Study|Lost to Follow-up|1|||
48732322|NCT01907100|156871292|FG000|Overall Study|Not treated|2|||
48732323|NCT01907100|156871293|FG001|Overall Study|Not treated|0|||
48732324|NCT01907100|156871294|FG002|Overall Study|Not treated|1|||
48732325|NCT01907100|156871295|FG003|Overall Study|Not treated|2|||
48732326|NCT01907100|156871292|FG000|Overall Study|Other than reasons specified|1|||
48732327|NCT01907100|156871293|FG001|Overall Study|Other than reasons specified|0|||
48732328|NCT01907100|156871294|FG002|Overall Study|Other than reasons specified|10|||
48732329|NCT01907100|156871295|FG003|Overall Study|Other than reasons specified|6|||
48732330|NCT01907100|156871292|FG000|Overall Study|Adverse event (AE)|6|||
48521690|NCT01435928|156099841|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
48521691|NCT01435928|156099842|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
48521692|NCT01435928|156099843|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
48521693|NCT01435928|156099841|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
48521694|NCT01435928|156099842|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
48521695|NCT01435928|156099843|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
48521696|NCT01435928|156099841|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
48521697|NCT01435928|156099842|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
48521698|NCT01435928|156099843|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
48521699|NCT01435928|156099841|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
48521700|NCT01435928|156099842|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
48521701|NCT01435928|156099843|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
48521702|NCT01435928|156099841|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
48521703|NCT01435928|156099842|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
48521704|NCT01435928|156099843|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
48521705|NCT01435928|156099841|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
48521706|NCT01435928|156099842|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
48521707|NCT01435928|156099843|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
48521708|NCT01435928|156099841|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
48521709|NCT01435928|156099842|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
48521710|NCT01435928|156099843|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
48521711|NCT00292227|156099845|FG000|Patch Period|Adverse Event|1|||
48521712|NCT00292227|156099846|FG001|Patch Period|Adverse Event|0|||
48521713|NCT00292227|156099847|FG002|Patch Period|Adverse Event|2|||
48521714|NCT00292227|156099845|FG000|Patch Period|Withdrawal by Subject|0|||
48521715|NCT00292227|156099846|FG001|Patch Period|Withdrawal by Subject|0|||
48521716|NCT00292227|156099847|FG002|Patch Period|Withdrawal by Subject|1|||
48521717|NCT01223027|156099848|FG000|Overall Study|Adverse Event|20|||
48521718|NCT01223027|156099849|FG001|Overall Study|Adverse Event|10|||
48521719|NCT01223027|156099848|FG000|Overall Study|Death|42|||
48521720|NCT01223027|156099849|FG001|Overall Study|Death|42|||
48521721|NCT01223027|156099848|FG000|Overall Study|Lost to Follow-up|2|||
48521722|NCT01223027|156099849|FG001|Overall Study|Lost to Follow-up|1|||
48521723|NCT01223027|156099848|FG000|Overall Study|Physician Decision|4|||
48521724|NCT01223027|156099849|FG001|Overall Study|Physician Decision|8|||
48521725|NCT01223027|156099848|FG000|Overall Study|Progressive Disease|167|||
48521726|NCT01223027|156099849|FG001|Overall Study|Progressive Disease|183|||
48521727|NCT01223027|156099848|FG000|Overall Study|Protocol Violation|2|||
48521728|NCT01223027|156099849|FG001|Overall Study|Protocol Violation|1|||
48521729|NCT01223027|156099848|FG000|Overall Study|Subject/guardian decicion|18|||
48521730|NCT01223027|156099849|FG001|Overall Study|Subject/guardian decicion|16|||
48521731|NCT01223027|156099848|FG000|Overall Study|New therapy for study indication|17|||
48521732|NCT01223027|156099849|FG001|Overall Study|New therapy for study indication|8|||
48521733|NCT01223027|156099848|FG000|Overall Study|Study terminated by sponsor|2|||
48521734|NCT01223027|156099849|FG001|Overall Study|Study terminated by sponsor|8|||
48521735|NCT04232540|156099850|FG000|Overall Study|Lost to Follow-up|1|||
48521736|NCT04232540|156099851|FG001|Overall Study|Lost to Follow-up|0|||
48521737|NCT03257254|156099852|FG000|Overall Study|Withdrawal by Subject|7|||
48521738|NCT03257254|156099852|FG000|Overall Study|Lost to Follow-up|9|||
48521739|NCT03257254|156099852|FG000|Overall Study|Study discontinued by sponsor|5|||
48521740|NCT02279095|156101011|FG000|Overall Study|Non-Compliance|1|||
48521741|NCT02279095|156101011|FG000|Overall Study|Withdrawal by Subject|8|||
48521742|NCT02279095|156101011|FG000|Overall Study|Adverse Event|2|||
48521743|NCT02279095|156101011|FG000|Overall Study|Other|7|||
48521744|NCT02279095|156101011|FG000|Overall Study|Lost to Follow-up|1|||
48521745|NCT03945773|156101012|FG000|Overall Study|Consent Withdrawn|1|||
48521746|NCT03945773|156101013|FG001|Overall Study|Consent Withdrawn|1|||
48521747|NCT03945773|156101012|FG000|Overall Study|Lost to Follow-up|1|||
48521748|NCT03945773|156101013|FG001|Overall Study|Lost to Follow-up|0|||
48521749|NCT03945773|156101012|FG000|Overall Study|Death|46|||
48521750|NCT03945773|156101013|FG001|Overall Study|Death|22|||
48521751|NCT03945773|156101012|FG000|Overall Study|Physician Decision|1|||
48521752|NCT03945773|156101013|FG001|Overall Study|Physician Decision|0|||
48521753|NCT03945773|156101012|FG000|Overall Study|Other|1|||
48732331|NCT01907100|156871293|FG001|Overall Study|Adverse event (AE)|3|||
48732332|NCT01907100|156871294|FG002|Overall Study|Adverse event (AE)|22|||
48732333|NCT01907100|156871295|FG003|Overall Study|Adverse event (AE)|23|||
48521754|NCT03945773|156101013|FG001|Overall Study|Other|0|||
48521755|NCT03945773|156101012|FG000|Overall Study|Ongoing at the time of DCO|4|||
48521756|NCT03945773|156101013|FG001|Overall Study|Ongoing at the time of DCO|3|||
48521757|NCT02605837|156101014|FG000|Overall Study|Adverse Event|3|||
48521758|NCT02605837|156101015|FG001|Overall Study|Adverse Event|1|||
48521759|NCT02605837|156101014|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48521760|NCT02605837|156101015|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48521761|NCT02605837|156101014|FG000|Overall Study|Withdrawal by Subject|8|||
48521762|NCT02605837|156101015|FG001|Overall Study|Withdrawal by Subject|8|||
48732334|NCT01907100|156871292|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
48732335|NCT01907100|156871293|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
48732336|NCT01907100|156871294|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
48732337|NCT01907100|156871295|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
48732338|NCT04068610|156871296|FG000|Overall Study|Death|4|||
48732339|NCT04068610|156871297|FG001|Overall Study|Death|8|||
48732340|NCT04068610|156871298|FG002|Overall Study|Death|13|||
48732341|NCT04068610|156871296|FG000|Overall Study|Lost to Follow-up|0|||
48732342|NCT04068610|156871297|FG001|Overall Study|Lost to Follow-up|2|||
48732343|NCT04068610|156871298|FG002|Overall Study|Lost to Follow-up|0|||
48732344|NCT04068610|156871296|FG000|Overall Study|Withdrawal by Subject|0|||
48732345|NCT04068610|156871297|FG001|Overall Study|Withdrawal by Subject|4|||
48732346|NCT04068610|156871298|FG002|Overall Study|Withdrawal by Subject|2|||
48732347|NCT04068610|156871296|FG000|Overall Study|Other|3|||
48732348|NCT04068610|156871297|FG001|Overall Study|Other|12|||
48732349|NCT04068610|156871298|FG002|Overall Study|Other|11|||
48732350|NCT04502979|156871299|FG000|Overall Study|Lost to Follow-up|1|||
48732351|NCT04502979|156871300|FG001|Overall Study|Lost to Follow-up|3|||
48732352|NCT04502979|156871299|FG000|Overall Study|Withdrawal by Subject|2|||
48732353|NCT04502979|156871300|FG001|Overall Study|Withdrawal by Subject|1|||
48732354|NCT00423514|156871304|FG000|Overall Study|Ineligible|1|||
48732355|NCT00423514|156871305|FG001|Overall Study|Ineligible|0|||
48732356|NCT03113916|156871310|FG000|Overall Study|Withdrawal by Subject|9|||
48732357|NCT03113916|156871311|FG001|Overall Study|Withdrawal by Subject|7|||
48732358|NCT03113916|156871310|FG000|Overall Study|Pregnancy|1|||
48732359|NCT03113916|156871311|FG001|Overall Study|Pregnancy|3|||
48732360|NCT03113916|156871310|FG000|Overall Study|Lost to Follow-up|1|||
48732361|NCT03113916|156871311|FG001|Overall Study|Lost to Follow-up|2|||
48732362|NCT03439657|156871312|FG000|Overall Study|Adverse Event|2|||
48732363|NCT03439657|156871313|FG001|Overall Study|Adverse Event|3|||
48732364|NCT03439657|156871312|FG000|Overall Study|Lost to Follow-up|1|||
48732365|NCT03439657|156871313|FG001|Overall Study|Lost to Follow-up|0|||
48732366|NCT03439657|156871312|FG000|Overall Study|Protocol Violation|1|||
48732367|NCT03439657|156871313|FG001|Overall Study|Protocol Violation|1|||
48732368|NCT03439657|156871312|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
48732369|NCT03439657|156871313|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
48732370|NCT02764697|156871314|FG000|Overall Study|Lack of Efficacy|3|||
48732371|NCT04996797|156871315|FG000|Overall Study|Adverse Event|0|||
48732372|NCT04996797|156871316|FG001|Overall Study|Adverse Event|2|||
48732373|NCT04996797|156871317|FG002|Overall Study|Adverse Event|0|||
48732374|NCT04996797|156871318|FG003|Overall Study|Adverse Event|1|||
48732375|NCT04996797|156871315|FG000|Overall Study|Lack of Efficacy|0|||
48732376|NCT04996797|156871316|FG001|Overall Study|Lack of Efficacy|2|||
48732377|NCT04996797|156871317|FG002|Overall Study|Lack of Efficacy|0|||
48732378|NCT04996797|156871318|FG003|Overall Study|Lack of Efficacy|0|||
48732379|NCT04996797|156871315|FG000|Overall Study|Prohibited Medication|0|||
48732380|NCT04996797|156871316|FG001|Overall Study|Prohibited Medication|1|||
48732381|NCT04996797|156871317|FG002|Overall Study|Prohibited Medication|0|||
48732382|NCT04996797|156871318|FG003|Overall Study|Prohibited Medication|0|||
48732383|NCT04996797|156871315|FG000|Overall Study|Ongoing|68|||
48732384|NCT04996797|156871316|FG001|Overall Study|Ongoing|60|||
48732385|NCT04996797|156871317|FG002|Overall Study|Ongoing|22|||
48732386|NCT04996797|156871318|FG003|Overall Study|Ongoing|20|||
48732387|NCT04996797|156871315|FG000|Overall Study|Withdrawal by Subject|0|||
48732388|NCT04996797|156871316|FG001|Overall Study|Withdrawal by Subject|2|||
48732389|NCT04996797|156871317|FG002|Overall Study|Withdrawal by Subject|0|||
48732390|NCT04996797|156871318|FG003|Overall Study|Withdrawal by Subject|0|||
48732391|NCT02423772|156871319|FG000|Overall Study|Lost to Follow-up|3|||
48732392|NCT02423772|156871320|FG001|Overall Study|Lost to Follow-up|3|||
48732393|NCT02423772|156871319|FG000|Overall Study|Did not begin intervention|2|||
48732394|NCT02423772|156871320|FG001|Overall Study|Did not begin intervention|5|||
48732395|NCT02003365|156872306|FG000|Overall Study|Lost to Follow-up|0|||
48732396|NCT02003365|156872307|FG001|Overall Study|Lost to Follow-up|0|||
48732397|NCT02003365|156872308|FG002|Overall Study|Lost to Follow-up|1|||
48732398|NCT04078178|156872309|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
48732399|NCT04078178|156872310|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
48521763|NCT02605837|156101014|FG000|Overall Study|Physician Decision|0|||
48732400|NCT04078178|156872309|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
48732401|NCT04078178|156872310|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
48732402|NCT04078178|156872309|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
48732403|NCT04078178|156872310|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
48732404|NCT04078178|156872309|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
48732405|NCT04078178|156872310|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
48521764|NCT02605837|156101015|FG001|Overall Study|Physician Decision|1|||
48732406|NCT04078178|156872309|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
48732407|NCT04078178|156872310|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
48732408|NCT03078907|156872311|FG000|Overall Study|Adverse Event|2|||
48732409|NCT03078907|156872312|FG001|Overall Study|Adverse Event|0|||
48521765|NCT00609791|156101016|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
48521766|NCT02396199|156101020|FG000|Overall Study|Lost to Follow-up|1|||
48521767|NCT02396199|156101020|FG000|Overall Study|Death|4|||
48521768|NCT02597946|156101028|FG000|Overall Study|Withdrawal by Subject|1|||
48521769|NCT02597946|156101028|FG000|Overall Study|Progressive disease|16|||
48521770|NCT02597946|156101028|FG000|Overall Study|Other than above|1|||
48521771|NCT05062265|156101029|FG000|Overall Study|Withdrawal by Subject|1|||
48521772|NCT05062265|156101030|FG001|Overall Study|Withdrawal by Subject|0|||
48521773|NCT03113500|156101033|FG000|Overall Study|Withdrawal by Subject|1|||
48521774|NCT00856349|156101036|FG000|Overall Study|Death|418|||
48521775|NCT00856349|156101036|FG000|Overall Study|Withdrawal by Subject|116|||
48521776|NCT00856349|156101036|FG000|Overall Study|Lost to Follow-up|91|||
48521777|NCT00856349|156101036|FG000|Overall Study|Protocol Violation|38|||
48521778|NCT00856349|156101036|FG000|Overall Study|Physician Decision|13|||
48521779|NCT00856349|156101036|FG000|Overall Study|Subject relocation|104|||
48521780|NCT00856349|156101036|FG000|Overall Study|Device explant|33|||
48521781|NCT00856349|156101036|FG000|Overall Study|Site closure|78|||
48521782|NCT00856349|156101036|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
48521783|NCT02725515|156101037|FG000|Overall Study|Refused infusion (no study treatment)|1|||
48521784|NCT02725515|156101038|FG001|Overall Study|Refused infusion (no study treatment)|0|||
48521785|NCT02725515|156101037|FG000|Overall Study|Loss of Improvement per Protocol|14|||
48521786|NCT02725515|156101038|FG001|Overall Study|Loss of Improvement per Protocol|25|||
48521787|NCT02725515|156101037|FG000|Overall Study|Withdrawal by Subject|2|||
48521788|NCT02725515|156101038|FG001|Overall Study|Withdrawal by Subject|1|||
48521789|NCT02725515|156101037|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48521790|NCT02725515|156101038|FG001|Overall Study|Non-Compliance With Study Drug|3|||
48521791|NCT02725515|156101037|FG000|Overall Study|Lost to Follow-up|1|||
48521792|NCT02725515|156101038|FG001|Overall Study|Lost to Follow-up|1|||
48521793|NCT02725515|156101037|FG000|Overall Study|Adverse Event|7|||
48521794|NCT02725515|156101038|FG001|Overall Study|Adverse Event|2|||
48521795|NCT02725515|156101037|FG000|Overall Study|No Documented Disease Improvement|0|||
48521796|NCT02725515|156101038|FG001|Overall Study|No Documented Disease Improvement|1|||
48521797|NCT02725515|156101037|FG000|Overall Study|Completed Study Under Original Protocol|0|||
48521798|NCT02725515|156101038|FG001|Overall Study|Completed Study Under Original Protocol|1|||
48521799|NCT02725515|156101037|FG000|Overall Study|Lack of Response|0|||
48521800|NCT02725515|156101038|FG001|Overall Study|Lack of Response|1|||
48521801|NCT02736409|156101039|FG000|Overall Study|Withdrawal by Subject|4|||
48521802|NCT02736409|156101040|FG001|Overall Study|Withdrawal by Subject|2|||
48521803|NCT02736409|156101041|FG002|Overall Study|Withdrawal by Subject|17|||
48521804|NCT02736409|156101042|FG003|Overall Study|Withdrawal by Subject|3|||
48521805|NCT02736409|156101039|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48521806|NCT02736409|156101040|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48521807|NCT02736409|156101041|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48521808|NCT02736409|156101042|FG003|Overall Study|Non-Compliance with Study Drug|1|||
48521809|NCT02736409|156101039|FG000|Overall Study|Adverse Event|0|||
48521810|NCT02736409|156101040|FG001|Overall Study|Adverse Event|1|||
48521811|NCT02736409|156101041|FG002|Overall Study|Adverse Event|5|||
48521812|NCT02736409|156101042|FG003|Overall Study|Adverse Event|4|||
48521813|NCT02736409|156101039|FG000|Overall Study|Other|0|||
48521814|NCT02736409|156101040|FG001|Overall Study|Other|0|||
48521815|NCT02736409|156101041|FG002|Overall Study|Other|1|||
48521816|NCT02736409|156101042|FG003|Overall Study|Other|1|||
48521817|NCT02736409|156101039|FG000|Overall Study|Pregnancy|0|||
48732410|NCT03078907|156872311|FG000|Overall Study|Other|1|||
48732411|NCT03078907|156872312|FG001|Overall Study|Other|0|||
48732412|NCT03078907|156872311|FG000|Overall Study|Protocol Violation|0|||
48732413|NCT03078907|156872312|FG001|Overall Study|Protocol Violation|1|||
48732414|NCT04439175|156872313|FG000|Overall Study|Never started treatment|4|||
48732415|NCT04439175|156872313|FG000|Overall Study|Ineligible|5|||
48732416|NCT04439175|156872313|FG000|Overall Study|Adverse Event|6|||
48732417|NCT04439175|156872313|FG000|Overall Study|Death|4|||
48732418|NCT04439175|156872313|FG000|Overall Study|Disease progression|44|||
48732419|NCT04439175|156872313|FG000|Overall Study|Withdrawal by Subject|4|||
48732420|NCT04439175|156872313|FG000|Overall Study|Alternative Therapy|1|||
48732421|NCT04439175|156872313|FG000|Overall Study|Other|2|||
48732422|NCT00107783|156872314|FG000|Overall Study|Adverse Event|0|||
48732423|NCT00107783|156872315|FG001|Overall Study|Adverse Event|2|||
48732424|NCT00107783|156872314|FG000|Overall Study|Death|0|||
48824936|NCT01543685|157199064|FG003|Overall Study|Lack of Efficacy|0|||
48521818|NCT02736409|156101040|FG001|Overall Study|Pregnancy|0|||
48732425|NCT00107783|156872315|FG001|Overall Study|Death|1|||
48824937|NCT01543685|157199065|FG004|Overall Study|Lack of Efficacy|2|||
48521819|NCT02736409|156101041|FG002|Overall Study|Pregnancy|1|||
48521820|NCT02736409|156101042|FG003|Overall Study|Pregnancy|0|||
48521821|NCT02736409|156101039|FG000|Overall Study|Lost to Follow-up|0|||
48521822|NCT02736409|156101040|FG001|Overall Study|Lost to Follow-up|0|||
48732426|NCT00107783|156872314|FG000|Overall Study|Withdrawal by Subject|2|||
48521823|NCT02736409|156101041|FG002|Overall Study|Lost to Follow-up|2|||
48521824|NCT02736409|156101042|FG003|Overall Study|Lost to Follow-up|1|||
48521825|NCT02736409|156101039|FG000|Overall Study|Physician Decision|0|||
48521826|NCT02736409|156101040|FG001|Overall Study|Physician Decision|0|||
48521827|NCT02736409|156101041|FG002|Overall Study|Physician Decision|0|||
48521828|NCT02736409|156101042|FG003|Overall Study|Physician Decision|2|||
48521829|NCT04221490|156101050|FG000|At 30 Days Follow-up|Death|7|||
48521830|NCT04221490|156101050|FG000|At 30 Days Follow-up|Missed Visit|4|||
48521831|NCT04221490|156101050|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
48521832|NCT04221490|156101050|FG000|At 6 Months Follow-up|Death|9|||
48521833|NCT04221490|156101050|FG000|At 6 Months Follow-up|Physician Decision|1|||
48521834|NCT04221490|156101050|FG000|At 6 Months Follow-up|Missed Visit|8|||
48521835|NCT04221490|156101050|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
48521836|NCT03557697|156101055|FG000|Overall Study|Withdrawal by Subject|2|||
48521837|NCT03557697|156101056|FG001|Overall Study|Withdrawal by Subject|4|||
48521838|NCT05087992|156101057|FG000|Overall Study|Adverse Event|0|||
48521839|NCT05087992|156101058|FG001|Overall Study|Adverse Event|1|||
48521840|NCT05087992|156101059|FG002|Overall Study|Adverse Event|0|||
48521841|NCT05087992|156101057|FG000|Overall Study|Withdrawal by Subject|2|||
48521842|NCT05087992|156101058|FG001|Overall Study|Withdrawal by Subject|0|||
48732427|NCT00107783|156872315|FG001|Overall Study|Withdrawal by Subject|0|||
48521843|NCT05087992|156101059|FG002|Overall Study|Withdrawal by Subject|0|||
48521844|NCT05087992|156101057|FG000|Overall Study|clinical disease progression|3|||
48521845|NCT05087992|156101058|FG001|Overall Study|clinical disease progression|1|||
48521846|NCT05087992|156101059|FG002|Overall Study|clinical disease progression|0|||
48521847|NCT05087992|156101057|FG000|Overall Study|objective disease progression|4|||
48521848|NCT05087992|156101058|FG001|Overall Study|objective disease progression|1|||
48521849|NCT05087992|156101059|FG002|Overall Study|objective disease progression|0|||
48521850|NCT03097549|156101062|FG000|Overall Study|Withdrawal by Subject|1|||
48521851|NCT03097549|156101063|FG001|Overall Study|Withdrawal by Subject|0|||
48521852|NCT03097549|156101062|FG000|Overall Study|Lost to Follow-up|1|||
48521853|NCT03097549|156101063|FG001|Overall Study|Lost to Follow-up|0|||
48521854|NCT03596866|156101064|FG000|Overall Study|Ongoing at Data Cut-off|91|||
48521855|NCT03596866|156101065|FG001|Overall Study|Ongoing at Data Cut-off|101|||
48521856|NCT03596866|156101064|FG000|Overall Study|Randomized but Never Received Drug|0|||
48521857|NCT03596866|156101065|FG001|Overall Study|Randomized but Never Received Drug|1|||
48732428|NCT00107783|156872314|FG000|Overall Study|Second hip replacement|1|||
48732429|NCT00107783|156872315|FG001|Overall Study|Second hip replacement|1|||
48732430|NCT01092507|156872316|FG000|Overall Study|Withdrawal by Subject|2|||
48732431|NCT01092507|156872317|FG001|Overall Study|Withdrawal by Subject|0|||
48521858|NCT03596866|156101064|FG000|Overall Study|Death|27|||
48521859|NCT03596866|156101065|FG001|Overall Study|Death|14|||
48521860|NCT03596866|156101064|FG000|Overall Study|Withdrawal by Subject|6|||
48521861|NCT03596866|156101065|FG001|Overall Study|Withdrawal by Subject|5|||
48521862|NCT03596866|156101064|FG000|Overall Study|Lost to Follow-up|1|||
48521863|NCT03596866|156101065|FG001|Overall Study|Lost to Follow-up|1|||
48521864|NCT03596866|156101064|FG000|Overall Study|Reason Not Specified|0|||
48521865|NCT03596866|156101065|FG001|Overall Study|Reason Not Specified|1|||
48521866|NCT03092518|156101066|FG000|Overall Study|Ineligible|2|||
48521867|NCT03113487|156101067|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
48521868|NCT04537715|156101068|FG000|Overall Study|Death|3|||
48521869|NCT04537715|156101069|FG001|Overall Study|Death|1|||
48732432|NCT03468985|156872318|FG000|Overall Study|Adverse Event|0|||
48732433|NCT03468985|156872319|FG001|Overall Study|Adverse Event|2|||
48732434|NCT03468985|156872320|FG002|Overall Study|Adverse Event|0|||
48521870|NCT04537715|156101068|FG000|Overall Study|Withdrawal by Subject|3|||
48732435|NCT03468985|156872321|FG003|Overall Study|Adverse Event|0|||
48732436|NCT03468985|156872318|FG000|Overall Study|Withdrawal by Subject|0|||
48732437|NCT03468985|156872319|FG001|Overall Study|Withdrawal by Subject|0|||
48732438|NCT03468985|156872320|FG002|Overall Study|Withdrawal by Subject|0|||
48732439|NCT03468985|156872321|FG003|Overall Study|Withdrawal by Subject|1|||
48732440|NCT04060862|156872324|FG000|Overall Study|Symptomatic Deterioration|1|||
48732441|NCT04060862|156872324|FG000|Overall Study|Un-specified|6|||
48732442|NCT04060862|156872324|FG000|Overall Study|Progressive disease|12|||
48732443|NCT04060862|156872324|FG000|Overall Study|Physician Decision|1|||
48732444|NCT03282565|156872325|FG000|Overall Study|COVID-19 Research Shutdown|0|||
48521871|NCT04537715|156101069|FG001|Overall Study|Withdrawal by Subject|1|||
48521872|NCT04537715|156101068|FG000|Overall Study|Other|4|||
48521873|NCT04537715|156101069|FG001|Overall Study|Other|3|||
48521874|NCT04537715|156101068|FG000|Overall Study|Progressive disease|1|||
48521875|NCT04537715|156101069|FG001|Overall Study|Progressive disease|0|||
48521876|NCT02043678|156101070|FG000|Overall Study|Never treated|11|||
48732445|NCT03282565|156872326|FG001|Overall Study|COVID-19 Research Shutdown|2|||
48732446|NCT03282565|156872327|FG002|Overall Study|COVID-19 Research Shutdown|2|||
48732447|NCT00950911|156872328|FG000|Overall Study|Adverse Event|0|||
48732448|NCT00950911|156872329|FG001|Overall Study|Adverse Event|2|||
48732449|NCT00950911|156872328|FG000|Overall Study|Death|4|||
48732450|NCT00950911|156872329|FG001|Overall Study|Death|6|||
48732451|NCT00950911|156872328|FG000|Overall Study|Disease progression|2|||
48732452|NCT00950911|156872329|FG001|Overall Study|Disease progression|2|||
48521877|NCT02043678|156101071|FG001|Overall Study|Never treated|9|||
48521878|NCT02043678|156101070|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
48521879|NCT02043678|156101071|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
48521880|NCT02043678|156101070|FG000|Overall Study|AE without clinical PD|54|||
48521881|NCT02043678|156101071|FG001|Overall Study|AE without clinical PD|36|||
48521882|NCT02043678|156101070|FG000|Overall Study|Lost to Follow-up|1|||
48521883|NCT02043678|156101071|FG001|Overall Study|Lost to Follow-up|1|||
48521884|NCT02043678|156101070|FG000|Overall Study|Other|10|||
48521885|NCT02043678|156101071|FG001|Overall Study|Other|14|||
48521886|NCT02043678|156101070|FG000|Overall Study|Clinical PD|114|||
48521887|NCT02043678|156101071|FG001|Overall Study|Clinical PD|148|||
48521888|NCT02043678|156101070|FG000|Overall Study|Radiological PD|100|||
48521889|NCT02043678|156101071|FG001|Overall Study|Radiological PD|90|||
48521890|NCT02043678|156101070|FG000|Overall Study|Protocol-driven decision point|59|||
48521891|NCT02043678|156101071|FG001|Overall Study|Protocol-driven decision point|58|||
48521892|NCT02043678|156101070|FG000|Overall Study|Withdrawal by Subject|16|||
48521893|NCT02043678|156101071|FG001|Overall Study|Withdrawal by Subject|20|||
48521894|NCT02043678|156101070|FG000|Overall Study|Protocol Violation|1|||
48521895|NCT02043678|156101071|FG001|Overall Study|Protocol Violation|0|||
48521896|NCT02043678|156101070|FG000|Overall Study|Deterioration of general conditions|1|||
48521897|NCT02043678|156101071|FG001|Overall Study|Deterioration of general conditions|1|||
48521898|NCT02043678|156101070|FG000|Overall Study|Logistical difficulties|2|||
48521899|NCT02043678|156101071|FG001|Overall Study|Logistical difficulties|0|||
48521900|NCT02043678|156101070|FG000|Overall Study|Non-compliance with study drug|3|||
48521901|NCT02043678|156101071|FG001|Overall Study|Non-compliance with study drug|1|||
48521902|NCT02043678|156101070|FG000|Overall Study|Physician Decision|4|||
48521903|NCT02043678|156101071|FG001|Overall Study|Physician Decision|3|||
48521904|NCT02043678|156101070|FG000|Overall Study|Subject decision|0|||
48521905|NCT02043678|156101071|FG001|Overall Study|Subject decision|1|||
48521906|NCT02043678|156101070|FG000|Overall Study|Switching to other therapy|3|||
48521907|NCT02043678|156101071|FG001|Overall Study|Switching to other therapy|2|||
48521908|NCT02043678|156101070|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
48521909|NCT02043678|156101071|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
48521910|NCT02043678|156101070|FG000|Overall Study|Missing|1|||
48521911|NCT02043678|156101071|FG001|Overall Study|Missing|0|||
48521912|NCT02043678|156101070|FG000|Overall Study|Adverse Event|0|||
48521913|NCT02043678|156101071|FG001|Overall Study|Adverse Event|1|||
48521914|NCT03652389|156101072|FG000|Overall Study|Lost to Follow-up|1|||
48521915|NCT03652389|156101073|FG001|Overall Study|Lost to Follow-up|5|||
48521916|NCT03652389|156101072|FG000|Overall Study|Withdrawal by Subject|5|||
48521917|NCT03652389|156101073|FG001|Overall Study|Withdrawal by Subject|1|||
48521918|NCT03652389|156101072|FG000|Overall Study|New diagnosis|2|||
48521919|NCT03652389|156101073|FG001|Overall Study|New diagnosis|0|||
48521920|NCT03625167|156101076|FG000|Overall Study|Protocol Violation|5|||
48521921|NCT04314713|156101077|FG000|Overall Study|Lost to Follow-up|0|||
48521922|NCT04314713|156101078|FG001|Overall Study|Lost to Follow-up|0|||
48521923|NCT04314713|156101079|FG002|Overall Study|Lost to Follow-up|0|||
48521924|NCT04314713|156101080|FG003|Overall Study|Lost to Follow-up|1|||
48521925|NCT04314713|156101081|FG004|Overall Study|Lost to Follow-up|0|||
48521926|NCT04314713|156101082|FG005|Overall Study|Lost to Follow-up|0|||
48521927|NCT05029622|156101083|FG000|Overall Study|Lost to Follow-up|1|||
48521928|NCT04158141|156101084|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
48521929|NCT04158141|156101085|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
48521930|NCT04158141|156101086|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
48521931|NCT04158141|156101084|FG000|Step 1: Registration|Adverse Event|1|||
48732453|NCT00950911|156872328|FG000|Overall Study|Consent withdrawn|1|||
48732454|NCT00950911|156872329|FG001|Overall Study|Consent withdrawn|3|||
48732455|NCT00950911|156872328|FG000|Overall Study|Administrative decision|3|||
48732456|NCT00950911|156872329|FG001|Overall Study|Administrative decision|1|||
48732457|NCT00950911|156872328|FG000|Overall Study|Ineligibility determined|1|||
48732458|NCT00950911|156872329|FG001|Overall Study|Ineligibility determined|0|||
48732459|NCT00950911|156872328|FG000|Overall Study|Noncompliance|1|||
48732460|NCT00950911|156872329|FG001|Overall Study|Noncompliance|0|||
48732461|NCT00950911|156872328|FG000|Overall Study|Poor performance status|0|||
48732462|NCT00950911|156872329|FG001|Overall Study|Poor performance status|1|||
48732463|NCT02642029|156872332|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
48732464|NCT02642029|156872333|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
48732465|NCT02642029|156872334|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
48521932|NCT04158141|156101085|FG001|Step 1: Registration|Adverse Event|0|||
48521933|NCT04158141|156101086|FG002|Step 1: Registration|Adverse Event|0|||
48521934|NCT04158141|156101084|FG000|Step 1: Registration|Withdrawal by Subject|1|||
48521935|NCT04158141|156101085|FG001|Step 1: Registration|Withdrawal by Subject|0|||
48732466|NCT02642029|156872335|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
48521936|NCT04158141|156101086|FG002|Step 1: Registration|Withdrawal by Subject|0|||
48521937|NCT04158141|156101084|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
48521938|NCT04158141|156101085|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
48521939|NCT04158141|156101086|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
48521940|NCT00530348|156101087|FG000|Overall Study|Adverse Event|5|||
48521941|NCT00530348|156101088|FG001|Overall Study|Adverse Event|1|||
48521942|NCT00530348|156101087|FG000|Overall Study|Death|0|||
48521943|NCT00530348|156101088|FG001|Overall Study|Death|1|||
48521944|NCT00530348|156101087|FG000|Overall Study|Lack of Efficacy|2|||
48521945|NCT00530348|156101088|FG001|Overall Study|Lack of Efficacy|0|||
48521946|NCT00530348|156101087|FG000|Overall Study|Lost to Follow-up|0|||
48521947|NCT00530348|156101088|FG001|Overall Study|Lost to Follow-up|2|||
48521948|NCT00530348|156101087|FG000|Overall Study|Physician Decision|1|||
48521949|NCT00530348|156101088|FG001|Overall Study|Physician Decision|2|||
48521950|NCT00530348|156101087|FG000|Overall Study|Pregnancy|1|||
48521951|NCT00530348|156101088|FG001|Overall Study|Pregnancy|0|||
48521952|NCT00530348|156101087|FG000|Overall Study|Withdrawal by Subject|12|||
48521953|NCT00530348|156101088|FG001|Overall Study|Withdrawal by Subject|12|||
48521954|NCT00530348|156101087|FG000|Overall Study|Randomised in error|1|||
48521955|NCT00530348|156101088|FG001|Overall Study|Randomised in error|0|||
48521956|NCT00530348|156101087|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
48521957|NCT00530348|156101088|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
48521958|NCT01091363|156101089|FG000|Overall Study|Withdrawal by Subject|11|||
48521959|NCT01091363|156101090|FG001|Overall Study|Withdrawal by Subject|15|||
48521960|NCT01091363|156101089|FG000|Overall Study|Lost to Follow-up|2|||
48521961|NCT01091363|156101090|FG001|Overall Study|Lost to Follow-up|2|||
48521962|NCT04419168|156101825|FG000|Overall Study|Protocol Violation|1|||
48521963|NCT04419168|156101826|FG001|Overall Study|Protocol Violation|1|||
48521964|NCT04419168|156101825|FG000|Overall Study|Lost to Follow-up|7|||
48521965|NCT04419168|156101826|FG001|Overall Study|Lost to Follow-up|7|||
48521966|NCT04419168|156101825|FG000|Overall Study|Missed 6-month Visit|48|||
48521967|NCT04419168|156101826|FG001|Overall Study|Missed 6-month Visit|45|||
48521968|NCT04523480|156101831|FG000|Overall Study|Lost to Follow-up|30|||
48521969|NCT04523480|156101832|FG001|Overall Study|Lost to Follow-up|35|||
48521970|NCT04523480|156101833|FG002|Overall Study|Lost to Follow-up|0|||
48521971|NCT00735696|156101834|FG000|Overall Study|Withdrawal by Subject|1|||
48521972|NCT00735696|156101834|FG000|Overall Study|Enrolled but never Treated|1|||
48521973|NCT02473393|156101835|FG000|Overall Study|Adverse Event|0|||
48521974|NCT02473393|156101836|FG001|Overall Study|Adverse Event|0|||
48521975|NCT02473393|156101837|FG002|Overall Study|Adverse Event|1|||
48521976|NCT02473393|156101838|FG003|Overall Study|Adverse Event|0|||
48521977|NCT02473393|156101835|FG000|Overall Study|Withdrawal by Subject|0|||
48824938|NCT01543685|157199061|FG000|Overall Study|Adverse Event|2|||
48824939|NCT01543685|157199062|FG001|Overall Study|Adverse Event|1|||
48824940|NCT01543685|157199063|FG002|Overall Study|Adverse Event|0|||
48824941|NCT01543685|157199064|FG003|Overall Study|Adverse Event|0|||
48824942|NCT01543685|157199065|FG004|Overall Study|Adverse Event|2|||
48824943|NCT00665561|157199066|FG000|Overall Study|Death recorded on subject summary pages|75|||
48824944|NCT00665561|157199067|FG001|Overall Study|Death recorded on subject summary pages|75|||
48824945|NCT00665561|157199066|FG000|Overall Study|Does not meet entrance criteria|19|||
48824946|NCT00665561|157199067|FG001|Overall Study|Does not meet entrance criteria|21|||
48521978|NCT02473393|156101836|FG001|Overall Study|Withdrawal by Subject|0|||
48521979|NCT02473393|156101837|FG002|Overall Study|Withdrawal by Subject|1|||
48521980|NCT02473393|156101838|FG003|Overall Study|Withdrawal by Subject|1|||
48521981|NCT00640393|156101839|FG000|Part 1|Lost to Follow-up|2|||
48521982|NCT00640393|156101840|FG001|Part 1|Lost to Follow-up|0|||
48521983|NCT00640393|156101841|FG002|Part 1|Lost to Follow-up|0|||
48521984|NCT00640393|156101839|FG000|Part 1|Withdrawal by Subject|3|||
48824947|NCT00665561|157199066|FG000|Overall Study|Lost to Follow-up|203|||
48824948|NCT00665561|157199067|FG001|Overall Study|Lost to Follow-up|264|||
48824949|NCT00665561|157199066|FG000|Overall Study|Withdrawal by Subject|74|||
48824950|NCT00665561|157199067|FG001|Overall Study|Withdrawal by Subject|65|||
48521985|NCT00640393|156101840|FG001|Part 1|Withdrawal by Subject|0|||
48521986|NCT00640393|156101841|FG002|Part 1|Withdrawal by Subject|0|||
48521987|NCT00640393|156101839|FG000|Randomization|Withdrawn per protocol|17|||
48824951|NCT00665561|157199066|FG000|Overall Study|Other|123|||
48824952|NCT00665561|157199067|FG001|Overall Study|Other|108|||
48824953|NCT00665561|157199066|FG000|Overall Study|Site closed|8|||
48521988|NCT00640393|156101840|FG001|Randomization|Withdrawn per protocol|0|||
48521989|NCT00640393|156101841|FG002|Randomization|Withdrawn per protocol|0|||
48521990|NCT00640393|156101839|FG000|Randomization|Never randomized by site|2|||
48521991|NCT00640393|156101840|FG001|Randomization|Never randomized by site|0|||
48521992|NCT00640393|156101841|FG002|Randomization|Never randomized by site|0|||
48521993|NCT00640393|156101839|FG000|Part 2|Lost to Follow-up|0|||
48521994|NCT00640393|156101840|FG001|Part 2|Lost to Follow-up|2|||
48521995|NCT00640393|156101841|FG002|Part 2|Lost to Follow-up|2|||
48521996|NCT00640393|156101839|FG000|Part 2|Withdrawal by Subject|0|||
48521997|NCT00640393|156101840|FG001|Part 2|Withdrawal by Subject|6|||
48521998|NCT00640393|156101841|FG002|Part 2|Withdrawal by Subject|1|||
48824954|NCT00665561|157199067|FG001|Overall Study|Site closed|0|||
48824955|NCT00665561|157199066|FG000|Overall Study|Withdrawn due to pregnancy|0|||
48732467|NCT02642029|156872336|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
48732468|NCT02642029|156872337|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
48521999|NCT00640393|156101839|FG000|Part 2|Non-adherence|0|||
48522000|NCT00640393|156101840|FG001|Part 2|Non-adherence|1|||
48522001|NCT00640393|156101841|FG002|Part 2|Non-adherence|0|||
48522002|NCT00640393|156101839|FG000|Part 2|Adverse Event|0|||
48522003|NCT00640393|156101840|FG001|Part 2|Adverse Event|1|||
48522004|NCT00640393|156101841|FG002|Part 2|Adverse Event|0|||
48522005|NCT02907099|156101847|FG000|Overall Study|Adverse Event|1|||
48522006|NCT02907099|156101847|FG000|Overall Study|Withdrawal by Subject|2|||
48522007|NCT02907099|156101847|FG000|Overall Study|Screen Fail|2|||
48522008|NCT00876265|156101849|FG000|Overall Study|Miscellaneous reasons|4|||
48522009|NCT00876265|156101849|FG000|Overall Study|Lost to Follow-up|6|||
48522010|NCT00876265|156101849|FG000|Overall Study|Withdrawal by Subject|2|||
48522011|NCT02754492|156101850|FG000|Overall Study|Protocol Violation|2|||
48522012|NCT02754492|156101851|FG001|Overall Study|Protocol Violation|2|||
48522013|NCT02754492|156101852|FG002|Overall Study|Protocol Violation|0|||
48522014|NCT02754492|156101853|FG003|Overall Study|Protocol Violation|1|||
48522015|NCT02754492|156101850|FG000|Overall Study|Withdrawal by Subject|2|||
48732469|NCT02642029|156872332|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48732470|NCT02642029|156872333|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
48732471|NCT02642029|156872334|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48732472|NCT02642029|156872335|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48522016|NCT02754492|156101851|FG001|Overall Study|Withdrawal by Subject|0|||
48522017|NCT02754492|156101852|FG002|Overall Study|Withdrawal by Subject|0|||
48522018|NCT02754492|156101853|FG003|Overall Study|Withdrawal by Subject|0|||
48522019|NCT02754492|156101850|FG000|Overall Study|Equipment malfuntion|0|||
48522020|NCT02754492|156101851|FG001|Overall Study|Equipment malfuntion|0|||
48522021|NCT02754492|156101852|FG002|Overall Study|Equipment malfuntion|2|||
48732473|NCT02642029|156872336|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48732474|NCT02642029|156872337|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
48824956|NCT00665561|157199067|FG001|Overall Study|Withdrawn due to pregnancy|1|||
48824957|NCT00604721|157199069|FG000|Overall Study|Physician Decision|1|||
48824958|NCT00604721|157199069|FG000|Overall Study|Withdrawal by Subject|1|||
48824959|NCT04776213|157199070|FG000|Overall Study|Other|1|||
48732475|NCT02642029|156872332|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
48732476|NCT02642029|156872333|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
48732477|NCT02642029|156872334|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
48522022|NCT02754492|156101853|FG003|Overall Study|Equipment malfuntion|5|||
48522023|NCT02754492|156101850|FG000|Overall Study|Adverse Event|0|||
48522024|NCT02754492|156101851|FG001|Overall Study|Adverse Event|0|||
48522025|NCT02754492|156101852|FG002|Overall Study|Adverse Event|0|||
48522026|NCT02754492|156101853|FG003|Overall Study|Adverse Event|13|||
48522027|NCT02754492|156101850|FG000|Overall Study|Venous access issues not resulting in AE|0|||
48522028|NCT02754492|156101851|FG001|Overall Study|Venous access issues not resulting in AE|0|||
48522029|NCT02754492|156101852|FG002|Overall Study|Venous access issues not resulting in AE|0|||
48522030|NCT02754492|156101853|FG003|Overall Study|Venous access issues not resulting in AE|4|||
48522031|NCT04909801|156101854|FG000|Overall Study|Lack of Efficacy|2|||
48824960|NCT04776213|157199070|FG000|Overall Study|Withdrawal by Subject|7|||
48522032|NCT04909801|156101855|FG001|Overall Study|Lack of Efficacy|1|||
48522033|NCT04909801|156101854|FG000|Overall Study|Adverse Event|1|||
48732478|NCT02642029|156872335|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
48522034|NCT04909801|156101855|FG001|Overall Study|Adverse Event|2|||
48522035|NCT04909801|156101854|FG000|Overall Study|Participant request to discontinue study treatment|1|||
48601619|NCT01973218|156397676|FG000|Overall Study|Withdrawal by Subject|1|||
48601620|NCT01973218|156397677|FG001|Overall Study|Withdrawal by Subject|0|||
48601621|NCT02247466|156397678|FG000|Overall Study|Procedure changed to open surgery|0|||
48601622|NCT02247466|156397679|FG001|Overall Study|Procedure changed to open surgery|3|||
48601623|NCT00492726|156397680|FG000|Overall Study|Adverse Event|10|||
48601624|NCT00492726|156397681|FG001|Overall Study|Adverse Event|6|||
48732479|NCT02642029|156872336|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
48732480|NCT02642029|156872337|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
48732481|NCT02642029|156872332|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
48522036|NCT04909801|156101855|FG001|Overall Study|Participant request to discontinue study treatment|2|||
48732482|NCT02642029|156872333|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
48824961|NCT04776213|157199070|FG000|Overall Study|Protocol Violation|1|||
48522037|NCT04909801|156101854|FG000|Overall Study|Withdrawal by Subject|2|||
48522038|NCT04909801|156101855|FG001|Overall Study|Withdrawal by Subject|1|||
48522039|NCT04909801|156101854|FG000|Overall Study|other reasons|1|||
48601625|NCT00492726|156397680|FG000|Overall Study|Death|7|||
48522040|NCT04909801|156101855|FG001|Overall Study|other reasons|1|||
48522041|NCT04295759|156101856|FG000|Overall Study|Lack of Efficacy|9|||
48522042|NCT04295759|156101856|FG000|Overall Study|Death|1|||
48522043|NCT04295759|156101856|FG000|Overall Study|Withdrawal by Subject|2|||
48522044|NCT04295759|156101856|FG000|Overall Study|Deemed ineligible|1|||
48522045|NCT03386578|156101857|FG000|PK Component|Lost to Follow-up|0|||
48522046|NCT03386578|156101858|FG001|PK Component|Lost to Follow-up|1|||
48522047|NCT03386578|156101859|FG002|PK Component|Lost to Follow-up|0|||
48522048|NCT03386578|156101860|FG003|PK Component|Lost to Follow-up|0|||
48522049|NCT03386578|156101861|FG004|PK Component|Lost to Follow-up|0|||
48522050|NCT03386578|156101862|FG005|PK Component|Lost to Follow-up|0|||
48522051|NCT03386578|156101863|FG006|PK Component|Lost to Follow-up|1|||
48522052|NCT03386578|156101864|FG007|PK Component|Lost to Follow-up|0|||
48522053|NCT03386578|156101865|FG008|PK Component|Lost to Follow-up|0|||
48522054|NCT03386578|156101866|FG009|PK Component|Lost to Follow-up|0|||
48522055|NCT03386578|156101857|FG000|PK Component|Stillbirth/Abortion|0|||
48522056|NCT03386578|156101858|FG001|PK Component|Stillbirth/Abortion|0|||
48522057|NCT03386578|156101859|FG002|PK Component|Stillbirth/Abortion|0|||
48522058|NCT03386578|156101860|FG003|PK Component|Stillbirth/Abortion|0|||
48522059|NCT03386578|156101861|FG004|PK Component|Stillbirth/Abortion|0|||
48522060|NCT03386578|156101862|FG005|PK Component|Stillbirth/Abortion|2|||
48522061|NCT03386578|156101863|FG006|PK Component|Stillbirth/Abortion|0|||
48522062|NCT03386578|156101864|FG007|PK Component|Stillbirth/Abortion|0|||
48522063|NCT03386578|156101865|FG008|PK Component|Stillbirth/Abortion|0|||
48522064|NCT03386578|156101866|FG009|PK Component|Stillbirth/Abortion|0|||
48522065|NCT03386578|156101857|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
48732483|NCT02642029|156872334|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
48732484|NCT02642029|156872335|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
48522066|NCT03386578|156101858|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
48522067|NCT03386578|156101859|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
48522068|NCT03386578|156101860|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
48522069|NCT03386578|156101861|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
48522070|NCT03386578|156101862|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
48522071|NCT03386578|156101863|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
48522072|NCT03386578|156101864|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
48522073|NCT03386578|156101865|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
48522074|NCT03386578|156101866|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
48522075|NCT03386578|156101857|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
48522076|NCT03386578|156101858|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
48522077|NCT03386578|156101859|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
48522078|NCT03386578|156101860|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
48522079|NCT03386578|156101861|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
48522080|NCT03386578|156101862|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
48522081|NCT03386578|156101863|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
48522082|NCT03386578|156101864|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
48522083|NCT03386578|156101865|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
48522084|NCT03386578|156101866|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
48522085|NCT03386578|156101857|FG000|PrEP Comparison Component Step 1|Death|0|||
48522086|NCT03386578|156101858|FG001|PrEP Comparison Component Step 1|Death|0|||
48522087|NCT03386578|156101859|FG002|PrEP Comparison Component Step 1|Death|1|||
48522088|NCT03386578|156101860|FG003|PrEP Comparison Component Step 1|Death|0|||
48522089|NCT03386578|156101861|FG004|PrEP Comparison Component Step 1|Death|0|||
48522090|NCT03386578|156101862|FG005|PrEP Comparison Component Step 1|Death|0|||
48522091|NCT03386578|156101863|FG006|PrEP Comparison Component Step 1|Death|0|||
48601626|NCT00492726|156397681|FG001|Overall Study|Death|2|||
48601627|NCT00492726|156397680|FG000|Overall Study|Lack of Efficacy|0|||
48601628|NCT00492726|156397681|FG001|Overall Study|Lack of Efficacy|2|||
48601629|NCT00492726|156397680|FG000|Overall Study|Lost to Follow-up|27|||
48601630|NCT00492726|156397681|FG001|Overall Study|Lost to Follow-up|19|||
48601631|NCT00492726|156397680|FG000|Overall Study|Physician Decision|0|||
48601632|NCT00492726|156397681|FG001|Overall Study|Physician Decision|1|||
48522092|NCT03386578|156101864|FG007|PrEP Comparison Component Step 1|Death|9|||
48601633|NCT00492726|156397680|FG000|Overall Study|Withdrawal by Subject|6|||
48522093|NCT03386578|156101865|FG008|PrEP Comparison Component Step 1|Death|5|||
48601634|NCT00492726|156397681|FG001|Overall Study|Withdrawal by Subject|3|||
48732485|NCT02642029|156872336|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
48732486|NCT02642029|156872337|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
48732487|NCT02642029|156872332|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
48732488|NCT02642029|156872333|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48732489|NCT02642029|156872334|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48732490|NCT02642029|156872335|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48732491|NCT02642029|156872336|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48732492|NCT02642029|156872337|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
48824962|NCT04776213|157199070|FG000|Overall Study|Lost to Follow-up|2|||
48601635|NCT00492726|156397680|FG000|Overall Study|Non compliant with study medication|0|||
48732493|NCT02642029|156872332|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
48732494|NCT02642029|156872333|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732495|NCT02642029|156872334|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732496|NCT02642029|156872335|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732497|NCT02642029|156872336|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732498|NCT02642029|156872337|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
48732499|NCT01086423|156872344|FG000|Overall Study|Protocol Violation|0|||
48732500|NCT01086423|156872345|FG001|Overall Study|Protocol Violation|0|||
48732501|NCT01086423|156872346|FG002|Overall Study|Protocol Violation|1|||
48732502|NCT01086423|156872344|FG000|Overall Study|Migrated/moved from study area|2|||
48732503|NCT01086423|156872345|FG001|Overall Study|Migrated/moved from study area|0|||
48732504|NCT01086423|156872346|FG002|Overall Study|Migrated/moved from study area|4|||
48732505|NCT01086423|156872344|FG000|Overall Study|Adverse event, fatal|1|||
48732506|NCT01086423|156872345|FG001|Overall Study|Adverse event, fatal|1|||
48732507|NCT01086423|156872346|FG002|Overall Study|Adverse event, fatal|0|||
48732508|NCT01086423|156872344|FG000|Overall Study|Adverse event, non-fatal|2|||
48732509|NCT01086423|156872345|FG001|Overall Study|Adverse event, non-fatal|1|||
48732510|NCT01086423|156872346|FG002|Overall Study|Adverse event, non-fatal|0|||
48732511|NCT01086423|156872344|FG000|Overall Study|Withdrawal by Subject|5|||
48732512|NCT01086423|156872345|FG001|Overall Study|Withdrawal by Subject|1|||
48732513|NCT01086423|156872346|FG002|Overall Study|Withdrawal by Subject|3|||
48732514|NCT01086423|156872344|FG000|Overall Study|Lost to Follow-up|0|||
48732515|NCT01086423|156872345|FG001|Overall Study|Lost to Follow-up|0|||
48732516|NCT01086423|156872346|FG002|Overall Study|Lost to Follow-up|1|||
48732517|NCT01225887|156872347|FG000|Overall Study|Ineligible:required test not done|2|||
48732518|NCT01225887|156872347|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
48732519|NCT01225887|156872347|FG000|Overall Study|Ineligible:inadequate pathology|2|||
48732520|NCT02869438|156872348|FG000|Overall Study|Lost to Follow-up|1|||
48732521|NCT02869438|156872349|FG001|Overall Study|Lost to Follow-up|0|||
48732522|NCT02869438|156872348|FG000|Overall Study|Adverse Event|1|||
48522094|NCT03386578|156101866|FG009|PrEP Comparison Component Step 1|Death|0|||
48732523|NCT02869438|156872349|FG001|Overall Study|Adverse Event|0|||
48732524|NCT02869438|156872348|FG000|Overall Study|Withdrawal by Subject|1|||
48522095|NCT03386578|156101857|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
48522096|NCT03386578|156101858|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
48522097|NCT03386578|156101859|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
48522098|NCT03386578|156101860|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
48522099|NCT03386578|156101861|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
48522100|NCT03386578|156101862|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
48522101|NCT03386578|156101863|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
48522102|NCT03386578|156101864|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
48522103|NCT03386578|156101865|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
48522104|NCT03386578|156101866|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
48522105|NCT03386578|156101857|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
48522106|NCT03386578|156101858|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
48522107|NCT03386578|156101859|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
48522108|NCT03386578|156101860|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
48522109|NCT03386578|156101861|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
48522110|NCT03386578|156101862|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
48522111|NCT03386578|156101863|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
48522112|NCT03386578|156101864|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
48522113|NCT03386578|156101865|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
48522114|NCT03386578|156101866|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
48522115|NCT03386578|156101857|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48522116|NCT03386578|156101858|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48522117|NCT03386578|156101859|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48522118|NCT03386578|156101860|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48522119|NCT03386578|156101861|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48522120|NCT03386578|156101862|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48522121|NCT03386578|156101863|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48522122|NCT03386578|156101864|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
48522123|NCT03386578|156101865|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
48522124|NCT03386578|156101866|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
48522125|NCT01005745|156101867|FG000|Overall Study|No TIL growth|1|||
48522126|NCT01005745|156101867|FG000|Overall Study|Disease progressed during TIL growth|3|||
48522127|NCT01005745|156101867|FG000|Overall Study|Death prior to treatment|1|||
48732525|NCT02869438|156872349|FG001|Overall Study|Withdrawal by Subject|2|||
48732526|NCT00591344|156872350|FG000|Overall Study|Transportation issues|1|||
48732527|NCT00591344|156872351|FG001|Overall Study|Transportation issues|0|||
48732528|NCT00591344|156872350|FG000|Overall Study|Moved out of state|1|||
48732529|NCT00591344|156872351|FG001|Overall Study|Moved out of state|0|||
48732530|NCT00591344|156872350|FG000|Overall Study|Medical complications|1|||
48732531|NCT00591344|156872351|FG001|Overall Study|Medical complications|3|||
48732532|NCT00591344|156872350|FG000|Overall Study|Underwent DBS|2|||
48732533|NCT00591344|156872351|FG001|Overall Study|Underwent DBS|2|||
48732534|NCT00591344|156872350|FG000|Overall Study|Death|0|||
48732535|NCT00591344|156872351|FG001|Overall Study|Death|1|||
48732536|NCT00591344|156872350|FG000|Overall Study|Lost to Follow-up|0|||
48732537|NCT00591344|156872351|FG001|Overall Study|Lost to Follow-up|1|||
48732538|NCT00591344|156872350|FG000|Overall Study|Did not want to come off medication|0|||
48732539|NCT00591344|156872351|FG001|Overall Study|Did not want to come off medication|1|||
48732540|NCT00694707|156872352|FG000|Overall Study|Did Not Receive Treatment|0|||
48732541|NCT00694707|156872353|FG001|Overall Study|Did Not Receive Treatment|0|||
48732542|NCT00694707|156872354|FG002|Overall Study|Did Not Receive Treatment|1|||
48732543|NCT00694707|156872355|FG003|Overall Study|Did Not Receive Treatment|1|||
48732544|NCT00694707|156872356|FG004|Overall Study|Did Not Receive Treatment|1|||
48732545|NCT00694707|156872352|FG000|Overall Study|Adverse Event|22|||
48732546|NCT00694707|156872353|FG001|Overall Study|Adverse Event|14|||
48732547|NCT00694707|156872354|FG002|Overall Study|Adverse Event|8|||
48732548|NCT00694707|156872355|FG003|Overall Study|Adverse Event|12|||
48732549|NCT00694707|156872356|FG004|Overall Study|Adverse Event|13|||
48732550|NCT00694707|156872352|FG000|Overall Study|Insufficient Therapeutic Response|33|||
48732551|NCT00694707|156872353|FG001|Overall Study|Insufficient Therapeutic Response|18|||
48732552|NCT00694707|156872354|FG002|Overall Study|Insufficient Therapeutic Response|17|||
48732553|NCT00694707|156872355|FG003|Overall Study|Insufficient Therapeutic Response|15|||
48732554|NCT00694707|156872356|FG004|Overall Study|Insufficient Therapeutic Response|10|||
48732555|NCT00694707|156872352|FG000|Overall Study|Protocol Violation|1|||
48732556|NCT00694707|156872353|FG001|Overall Study|Protocol Violation|2|||
48732557|NCT00694707|156872354|FG002|Overall Study|Protocol Violation|1|||
48522128|NCT01005745|156101867|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
48522129|NCT03513302|156101868|FG000|First Intervention (14 Days)|Screen failure|15|||
48522130|NCT03513302|156101869|FG001|First Intervention (14 Days)|Screen failure|16|||
48522131|NCT02970318|156101870|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
48522132|NCT02970318|156101871|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
48522133|NCT02970318|156101872|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
48732558|NCT00694707|156872355|FG003|Overall Study|Protocol Violation|3|||
48732559|NCT00694707|156872356|FG004|Overall Study|Protocol Violation|1|||
48732560|NCT00694707|156872352|FG000|Overall Study|Withdrawal of Consent|14|||
48522134|NCT02970318|156101873|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
48522135|NCT02970318|156101870|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
48522136|NCT02970318|156101871|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
48522137|NCT02970318|156101872|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
48522138|NCT02970318|156101873|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
48522139|NCT02970318|156101870|FG000|Overall for Arm A & Main for Arm B|Death|41|||
48522140|NCT02970318|156101871|FG001|Overall for Arm A & Main for Arm B|Death|33|||
48522141|NCT02970318|156101872|FG002|Overall for Arm A & Main for Arm B|Death|0|||
48522142|NCT02970318|156101873|FG003|Overall for Arm A & Main for Arm B|Death|0|||
48522143|NCT02970318|156101870|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
48522144|NCT02970318|156101871|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
48522145|NCT02970318|156101872|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
48522146|NCT02970318|156101873|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
48522147|NCT02970318|156101870|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
48522148|NCT02970318|156101871|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
48522149|NCT02970318|156101872|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
48522150|NCT02970318|156101873|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
48522151|NCT02970318|156101870|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
48522152|NCT02970318|156101871|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
48522153|NCT02970318|156101872|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
48522154|NCT02970318|156101873|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
48732561|NCT00694707|156872353|FG001|Overall Study|Withdrawal of Consent|18|||
48732562|NCT00694707|156872354|FG002|Overall Study|Withdrawal of Consent|22|||
48732563|NCT00694707|156872355|FG003|Overall Study|Withdrawal of Consent|16|||
48732564|NCT00694707|156872356|FG004|Overall Study|Withdrawal of Consent|15|||
48732565|NCT00694707|156872352|FG000|Overall Study|Lost to Follow-up|0|||
48732566|NCT00694707|156872353|FG001|Overall Study|Lost to Follow-up|1|||
48732567|NCT00694707|156872354|FG002|Overall Study|Lost to Follow-up|2|||
48732568|NCT00694707|156872355|FG003|Overall Study|Lost to Follow-up|0|||
48732569|NCT00694707|156872356|FG004|Overall Study|Lost to Follow-up|0|||
48732570|NCT00694707|156872352|FG000|Overall Study|Jeopardizing Parole Status|1|||
48732571|NCT00694707|156872353|FG001|Overall Study|Jeopardizing Parole Status|0|||
48732572|NCT00694707|156872354|FG002|Overall Study|Jeopardizing Parole Status|0|||
48732573|NCT00694707|156872355|FG003|Overall Study|Jeopardizing Parole Status|0|||
48732574|NCT00694707|156872356|FG004|Overall Study|Jeopardizing Parole Status|0|||
48732575|NCT00694707|156872352|FG000|Overall Study|Death in the Family|1|||
48732576|NCT00694707|156872353|FG001|Overall Study|Death in the Family|0|||
48732577|NCT00694707|156872354|FG002|Overall Study|Death in the Family|0|||
48732578|NCT00694707|156872355|FG003|Overall Study|Death in the Family|0|||
48732579|NCT00694707|156872356|FG004|Overall Study|Death in the Family|0|||
48732580|NCT00694707|156872352|FG000|Overall Study|Arrest by Police|0|||
48732581|NCT00694707|156872353|FG001|Overall Study|Arrest by Police|1|||
48732582|NCT00694707|156872354|FG002|Overall Study|Arrest by Police|0|||
48732583|NCT00694707|156872355|FG003|Overall Study|Arrest by Police|0|||
48732584|NCT00694707|156872356|FG004|Overall Study|Arrest by Police|0|||
48732585|NCT00694707|156872352|FG000|Overall Study|Administrative Reasons|0|||
48732586|NCT00694707|156872353|FG001|Overall Study|Administrative Reasons|1|||
48732587|NCT00694707|156872354|FG002|Overall Study|Administrative Reasons|0|||
48732588|NCT00694707|156872355|FG003|Overall Study|Administrative Reasons|2|||
48732589|NCT00694707|156872356|FG004|Overall Study|Administrative Reasons|0|||
48732590|NCT00694707|156872352|FG000|Overall Study|Notification of Past Head Injury|0|||
48732591|NCT00694707|156872353|FG001|Overall Study|Notification of Past Head Injury|0|||
48732592|NCT00694707|156872354|FG002|Overall Study|Notification of Past Head Injury|0|||
48732593|NCT00694707|156872355|FG003|Overall Study|Notification of Past Head Injury|1|||
48732594|NCT00694707|156872356|FG004|Overall Study|Notification of Past Head Injury|0|||
48732595|NCT01400815|156872357|FG000|Overall Study|Adverse Event|3|||
48732596|NCT01400815|156872358|FG001|Overall Study|Adverse Event|0|||
48824963|NCT01143077|157199072|FG000|Overall Study|Lack of Efficacy|0|||
48824964|NCT01143077|157199073|FG001|Overall Study|Lack of Efficacy|2|||
48732597|NCT01400815|156872357|FG000|Overall Study|Death|0|||
48732598|NCT01400815|156872358|FG001|Overall Study|Death|1|||
48732599|NCT01400815|156872357|FG000|Overall Study|Lost to Follow-up|18|||
48732600|NCT01400815|156872358|FG001|Overall Study|Lost to Follow-up|11|||
48732601|NCT01400815|156872357|FG000|Overall Study|Protocol Violation|0|||
48732602|NCT01400815|156872358|FG001|Overall Study|Protocol Violation|1|||
48732603|NCT01400815|156872357|FG000|Overall Study|Physician Decision|1|||
48601636|NCT00492726|156397681|FG001|Overall Study|Non compliant with study medication|3|||
48601637|NCT02230891|156397682|FG000|Baseline|Did not meet inclusion|0|||
48601638|NCT02230891|156397683|FG001|Baseline|Did not meet inclusion|1|||
48601639|NCT02230891|156397684|FG002|Baseline|Did not meet inclusion|1|||
48824965|NCT01143077|157199074|FG002|Overall Study|Lack of Efficacy|1|||
48824966|NCT01143077|157199072|FG000|Overall Study|Adverse Event|5|||
48824967|NCT01143077|157199073|FG001|Overall Study|Adverse Event|6|||
48522155|NCT02970318|156101870|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
48601640|NCT02230891|156397682|FG000|2 Week|Withdrawal by Subject|2|||
48601641|NCT02230891|156397683|FG001|2 Week|Withdrawal by Subject|2|||
48601642|NCT02230891|156397684|FG002|2 Week|Withdrawal by Subject|0|||
48601643|NCT02230891|156397682|FG000|2 Week|Consent withdrawn|1|||
48601644|NCT02230891|156397683|FG001|2 Week|Consent withdrawn|0|||
48601645|NCT02230891|156397684|FG002|2 Week|Consent withdrawn|0|||
48522156|NCT02970318|156101871|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
48522157|NCT02970318|156101872|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
48601646|NCT02230891|156397682|FG000|6 Month|Withdrawal by Subject|1|||
48522158|NCT02970318|156101873|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
48522159|NCT02000115|156101875|FG000|Overall Study|Death|56|||
48522160|NCT02000115|156101876|FG001|Overall Study|Death|45|||
48522161|NCT02000115|156101877|FG002|Overall Study|Death|0|||
48522162|NCT02000115|156101878|FG003|Overall Study|Death|0|||
48522163|NCT02000115|156101875|FG000|Overall Study|Missed Visit|6|||
48522164|NCT02000115|156101876|FG001|Overall Study|Missed Visit|8|||
48522165|NCT02000115|156101877|FG002|Overall Study|Missed Visit|1|||
48522166|NCT02000115|156101878|FG003|Overall Study|Missed Visit|0|||
48522167|NCT02000115|156101875|FG000|Overall Study|Protocol Violation|2|||
48522168|NCT02000115|156101876|FG001|Overall Study|Protocol Violation|1|||
48522169|NCT02000115|156101877|FG002|Overall Study|Protocol Violation|0|||
48522170|NCT02000115|156101878|FG003|Overall Study|Protocol Violation|0|||
48601647|NCT02230891|156397683|FG001|6 Month|Withdrawal by Subject|1|||
48824968|NCT01143077|157199074|FG002|Overall Study|Adverse Event|5|||
48522171|NCT02000115|156101875|FG000|Overall Study|Physician Decision|2|||
48522172|NCT02000115|156101876|FG001|Overall Study|Physician Decision|0|||
48732604|NCT01400815|156872358|FG001|Overall Study|Physician Decision|0|||
48732605|NCT01400815|156872357|FG000|Overall Study|Withdrawal by Subject|15|||
48732606|NCT01400815|156872358|FG001|Overall Study|Withdrawal by Subject|8|||
48732607|NCT01400815|156872357|FG000|Overall Study|Subject in jail|1|||
48732608|NCT01400815|156872358|FG001|Overall Study|Subject in jail|0|||
48732609|NCT00857415|156872362|FG000|Overall Study|Image acquisition failure|2|||
48732610|NCT00857415|156872363|FG001|Overall Study|Image acquisition failure|0|||
48601648|NCT02230891|156397684|FG002|6 Month|Withdrawal by Subject|1|||
48601649|NCT02230891|156397682|FG000|6 Month|Physician Decision|0|||
48732611|NCT00857415|156872362|FG000|Overall Study|Invalid image or not imaged|3|||
48732612|NCT00857415|156872363|FG001|Overall Study|Invalid image or not imaged|0|||
48732613|NCT00857415|156872362|FG000|Overall Study|Subject still living at end of study|110|||
48732614|NCT00857415|156872363|FG001|Overall Study|Subject still living at end of study|0|||
48732615|NCT00857415|156872362|FG000|Overall Study|Deceased with no autopsy|2|||
48732616|NCT00857415|156872363|FG001|Overall Study|Deceased with no autopsy|0|||
48732617|NCT01130103|156872364|FG000|Randomized Treatment|Adverse Event|1|||
48732618|NCT01130103|156872365|FG001|Randomized Treatment|Adverse Event|1|||
48732619|NCT01130103|156872364|FG000|Randomized Treatment|Lost to Follow-up|1|||
48824969|NCT01143077|157199072|FG000|Overall Study|Lost to Follow-up|2|||
48522173|NCT02000115|156101877|FG002|Overall Study|Physician Decision|0|||
48522174|NCT02000115|156101878|FG003|Overall Study|Physician Decision|0|||
48522175|NCT02000115|156101875|FG000|Overall Study|Withdrawal by Subject|11|||
48522176|NCT02000115|156101876|FG001|Overall Study|Withdrawal by Subject|11|||
48522177|NCT02000115|156101877|FG002|Overall Study|Withdrawal by Subject|0|||
48522178|NCT02000115|156101878|FG003|Overall Study|Withdrawal by Subject|0|||
48522179|NCT02000115|156101875|FG000|Overall Study|Lost to Follow-up|0|||
48522180|NCT02000115|156101876|FG001|Overall Study|Lost to Follow-up|1|||
48522181|NCT02000115|156101877|FG002|Overall Study|Lost to Follow-up|0|||
48522182|NCT02000115|156101878|FG003|Overall Study|Lost to Follow-up|0|||
48522183|NCT02000115|156101875|FG000|Overall Study|Non-compliance|2|||
48522184|NCT02000115|156101876|FG001|Overall Study|Non-compliance|1|||
48522185|NCT02000115|156101877|FG002|Overall Study|Non-compliance|0|||
48522186|NCT02000115|156101878|FG003|Overall Study|Non-compliance|0|||
48522187|NCT02000115|156101875|FG000|Overall Study|Withdrawn on day of randomization|0|||
48522188|NCT02000115|156101876|FG001|Overall Study|Withdrawn on day of randomization|1|||
48522189|NCT02000115|156101877|FG002|Overall Study|Withdrawn on day of randomization|0|||
48522190|NCT02000115|156101878|FG003|Overall Study|Withdrawn on day of randomization|0|||
48522191|NCT02000115|156101875|FG000|Overall Study|Still on Study|0|||
48522192|NCT02000115|156101876|FG001|Overall Study|Still on Study|0|||
48824970|NCT01143077|157199073|FG001|Overall Study|Lost to Follow-up|3|||
48824971|NCT01143077|157199074|FG002|Overall Study|Lost to Follow-up|4|||
48522193|NCT02000115|156101877|FG002|Overall Study|Still on Study|0|||
48522194|NCT02000115|156101878|FG003|Overall Study|Still on Study|53|||
48824972|NCT01143077|157199072|FG000|Overall Study|Protocol Violation|2|||
48824973|NCT01143077|157199073|FG001|Overall Study|Protocol Violation|0|||
48824974|NCT01143077|157199074|FG002|Overall Study|Protocol Violation|0|||
48824975|NCT01143077|157199072|FG000|Overall Study|Withdrawal by Subject|4|||
48824976|NCT01143077|157199073|FG001|Overall Study|Withdrawal by Subject|3|||
48824977|NCT01143077|157199074|FG002|Overall Study|Withdrawal by Subject|3|||
48824978|NCT01143077|157199072|FG000|Overall Study|Non-compliance with study drug|0|||
48824979|NCT01143077|157199073|FG001|Overall Study|Non-compliance with study drug|1|||
48522195|NCT02163694|156101880|FG000|Overall Study|Adverse event- related to progression|4|||
48522196|NCT02163694|156101881|FG001|Overall Study|Adverse event- related to progression|10|||
48522197|NCT02163694|156101880|FG000|Overall Study|Adverse event- not related to progression|7|||
48522198|NCT02163694|156101881|FG001|Overall Study|Adverse event- not related to progression|22|||
48522199|NCT02163694|156101880|FG000|Overall Study|Withdrew consent|13|||
48601650|NCT02230891|156397683|FG001|6 Month|Physician Decision|2|||
48601651|NCT02230891|156397684|FG002|6 Month|Physician Decision|0|||
48601652|NCT02230891|156397682|FG000|12 Month|Death|1|||
48601653|NCT02230891|156397683|FG001|12 Month|Death|0|||
48601654|NCT02230891|156397684|FG002|12 Month|Death|0|||
48601655|NCT02230891|156397682|FG000|12 Month|Lost to Follow-up|0|||
48601656|NCT02230891|156397683|FG001|12 Month|Lost to Follow-up|1|||
48601657|NCT02230891|156397684|FG002|12 Month|Lost to Follow-up|0|||
48601658|NCT02230891|156397682|FG000|12 Month|Withdrawal by Subject|0|||
48601659|NCT02230891|156397683|FG001|12 Month|Withdrawal by Subject|2|||
48601660|NCT02230891|156397684|FG002|12 Month|Withdrawal by Subject|0|||
48522200|NCT02163694|156101881|FG001|Overall Study|Withdrew consent|28|||
48601661|NCT02230891|156397682|FG000|18 Month End of Study|Death|0|||
48383820|NCT03239483|155601445|FG000|Overall Study|Lost to Follow-up|1|||
48522201|NCT02163694|156101880|FG000|Overall Study|Lost to Follow-up|2|||
48522202|NCT02163694|156101881|FG001|Overall Study|Lost to Follow-up|2|||
48522203|NCT02163694|156101880|FG000|Overall Study|Sponsor discontinued study|3|||
48522204|NCT02163694|156101881|FG001|Overall Study|Sponsor discontinued study|29|||
48522205|NCT02163694|156101880|FG000|Overall Study|Progressive disease per protocol|125|||
48522206|NCT02163694|156101881|FG001|Overall Study|Progressive disease per protocol|224|||
48522207|NCT02163694|156101880|FG000|Overall Study|Other, not specified|17|||
48522208|NCT02163694|156101881|FG001|Overall Study|Other, not specified|22|||
48522209|NCT02163694|156101880|FG000|Overall Study|Randomized but Not Treated|1|||
48522210|NCT02163694|156101881|FG001|Overall Study|Randomized but Not Treated|0|||
48601662|NCT02230891|156397683|FG001|18 Month End of Study|Death|0|||
48601663|NCT02230891|156397684|FG002|18 Month End of Study|Death|1|||
48601664|NCT02230891|156397682|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
48601665|NCT02230891|156397683|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
48732620|NCT01130103|156872365|FG001|Randomized Treatment|Lost to Follow-up|0|||
48824980|NCT01143077|157199074|FG002|Overall Study|Non-compliance with study drug|1|||
48732621|NCT01130103|156872364|FG000|Randomized Treatment|Protocol Violation|3|||
48732622|NCT01130103|156872365|FG001|Randomized Treatment|Protocol Violation|2|||
48732623|NCT01130103|156872364|FG000|Randomized Treatment|Withdrawal by Subject|1|||
48732624|NCT01130103|156872365|FG001|Randomized Treatment|Withdrawal by Subject|2|||
48732625|NCT01130103|156872364|FG000|Maintenance Treatment|Lack of Efficacy|0|||
48732626|NCT01130103|156872365|FG001|Maintenance Treatment|Lack of Efficacy|1|||
48732627|NCT01130103|156872364|FG000|Maintenance Treatment|Lost to Follow-up|1|||
48732628|NCT01130103|156872365|FG001|Maintenance Treatment|Lost to Follow-up|1|||
48732629|NCT01130103|156872364|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
48732630|NCT01130103|156872365|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
48732631|NCT04025710|156872368|FG000|Overall Study|Death|3|||
48732632|NCT04025710|156872368|FG000|Overall Study|Lost to Follow-up|5|||
48732633|NCT04025710|156872368|FG000|Overall Study|Withdrawal by Subject|1|||
48732634|NCT04025710|156872368|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
48732635|NCT04025710|156872368|FG000|Overall Study|Drop-out according to protocol|34|||
48732636|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Adverse Event|10|||
48732637|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Adverse Event|0|||
48824981|NCT01143077|157199072|FG000|Overall Study|Administrative|1|||
48824982|NCT01143077|157199073|FG001|Overall Study|Administrative|0|||
48824983|NCT01143077|157199074|FG002|Overall Study|Administrative|0|||
48824984|NCT01143077|157199072|FG000|Overall Study|Principal Investigator Decision|2|||
48824985|NCT01143077|157199073|FG001|Overall Study|Principal Investigator Decision|0|||
48824986|NCT01143077|157199074|FG002|Overall Study|Principal Investigator Decision|1|||
48522211|NCT02163694|156101880|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
48522212|NCT02163694|156101881|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
48522213|NCT05652010|156101882|FG000|First Intervention|Withdrawal by Subject|0|||
48522214|NCT05652010|156101883|FG001|First Intervention|Withdrawal by Subject|1|||
48522215|NCT05652010|156101882|FG000|Second Intervention|Withdrawal by Subject|1|||
48732638|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
48732639|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
48522216|NCT05652010|156101883|FG001|Second Intervention|Withdrawal by Subject|0|||
48522217|NCT04287868|156101886|FG000|Overall Study|Screening fail|1|||
48522218|NCT04287868|156101887|FG001|Overall Study|Screening fail|0|||
48522219|NCT03222856|156101888|FG000|Overall Study|Adverse Event|6|||
48522220|NCT03222856|156101888|FG000|Overall Study|Death|1|||
48522221|NCT02208362|156101889|FG000|Overall Study|Participant did not complete treatment|0|||
48522222|NCT02208362|156101890|FG001|Overall Study|Participant did not complete treatment|1|||
48522223|NCT02208362|156101891|FG002|Overall Study|Participant did not complete treatment|0|||
48522224|NCT02208362|156101892|FG003|Overall Study|Participant did not complete treatment|0|||
48522225|NCT02208362|156101893|FG004|Overall Study|Participant did not complete treatment|0|||
48522226|NCT02208362|156101894|FG005|Overall Study|Participant did not complete treatment|0|||
48522227|NCT02208362|156101895|FG006|Overall Study|Participant did not complete treatment|1|||
48522228|NCT02208362|156101896|FG007|Overall Study|Participant did not complete treatment|1|||
48522229|NCT02208362|156101897|FG008|Overall Study|Participant did not complete treatment|2|||
48522230|NCT02208362|156101898|FG009|Overall Study|Participant did not complete treatment|0|||
48522231|NCT02208362|156101899|FG010|Overall Study|Participant did not complete treatment|1|||
48522232|NCT02208362|156101900|FG011|Overall Study|Participant did not complete treatment|0|||
48522233|NCT02208362|156101889|FG000|Overall Study|Participant received disallowed treatment|0|||
48601666|NCT02230891|156397684|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
48383821|NCT03239483|155601446|FG001|Overall Study|Lost to Follow-up|0|||
48522234|NCT02208362|156101890|FG001|Overall Study|Participant received disallowed treatment|0|||
48522235|NCT02208362|156101891|FG002|Overall Study|Participant received disallowed treatment|0|||
48522236|NCT02208362|156101892|FG003|Overall Study|Participant received disallowed treatment|0|||
48522237|NCT02208362|156101893|FG004|Overall Study|Participant received disallowed treatment|0|||
48522238|NCT02208362|156101894|FG005|Overall Study|Participant received disallowed treatment|0|||
48522239|NCT02208362|156101895|FG006|Overall Study|Participant received disallowed treatment|0|||
48522240|NCT02208362|156101896|FG007|Overall Study|Participant received disallowed treatment|0|||
48522241|NCT02208362|156101897|FG008|Overall Study|Participant received disallowed treatment|1|||
48522242|NCT02208362|156101898|FG009|Overall Study|Participant received disallowed treatment|0|||
48732640|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
48732641|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
48732642|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
48732643|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
48732644|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
48732645|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
48732646|NCT02787551|156872369|FG000|Core Period: 26 Weeks|Other than specified|3|||
48732647|NCT02787551|156872370|FG001|Core Period: 26 Weeks|Other than specified|1|||
48732648|NCT02787551|156872369|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
48732649|NCT02787551|156872370|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
48732650|NCT02787551|156872369|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
48732651|NCT02787551|156872370|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
48732652|NCT02787551|156872369|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
48732653|NCT02787551|156872370|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
48732654|NCT05490771|156872371|FG000|Overall Study|Disease progression|18|||
48732655|NCT05490771|156872371|FG000|Overall Study|Adverse Event|3|||
48732656|NCT05490771|156872371|FG000|Overall Study|Other complicating disease|1|||
48732657|NCT05490771|156872371|FG000|Overall Study|Withdrawal by Subject|3|||
48732658|NCT05490771|156872371|FG000|Overall Study|Physician Decision|1|||
48732659|NCT05490771|156872371|FG000|Overall Study|Still on treatment|2|||
48732660|NCT05490771|156872371|FG000|Overall Study|Never start protocol therapy|5|||
48732661|NCT05490771|156872371|FG000|Overall Study|Ineligible|2|||
48732662|NCT00591266|156872372|FG000|Overall Study|Adverse Event|2|||
48732663|NCT00591266|156872373|FG001|Overall Study|Adverse Event|2|||
48732664|NCT00591266|156872374|FG002|Overall Study|Adverse Event|3|||
48732665|NCT00591266|156872372|FG000|Overall Study|Lost to Follow-up|0|||
48732666|NCT00591266|156872373|FG001|Overall Study|Lost to Follow-up|1|||
48732667|NCT00591266|156872374|FG002|Overall Study|Lost to Follow-up|0|||
48732668|NCT00591266|156872372|FG000|Overall Study|Protocol Violation|0|||
48732669|NCT00591266|156872373|FG001|Overall Study|Protocol Violation|0|||
48732670|NCT00591266|156872374|FG002|Overall Study|Protocol Violation|1|||
48732671|NCT00591266|156872372|FG000|Overall Study|Withdrawal by Subject|6|||
48732672|NCT00591266|156872373|FG001|Overall Study|Withdrawal by Subject|2|||
48732673|NCT00591266|156872374|FG002|Overall Study|Withdrawal by Subject|5|||
48732674|NCT00591266|156872372|FG000|Overall Study|Lack of Efficacy|0|||
48732675|NCT00591266|156872373|FG001|Overall Study|Lack of Efficacy|2|||
48732676|NCT00591266|156872374|FG002|Overall Study|Lack of Efficacy|0|||
48732677|NCT00591266|156872372|FG000|Overall Study|Other|1|||
48732678|NCT00591266|156872373|FG001|Overall Study|Other|4|||
48732679|NCT00591266|156872374|FG002|Overall Study|Other|5|||
48732680|NCT02939079|156872375|FG000|Overall Study|Adverse Event|2|||
48732681|NCT02939079|156872376|FG001|Overall Study|Adverse Event|1|||
48732682|NCT02939079|156872375|FG000|Overall Study|Lost to Follow-up|0|||
48732683|NCT02939079|156872376|FG001|Overall Study|Lost to Follow-up|2|||
48732684|NCT02939079|156872375|FG000|Overall Study|Protocol Violation|1|||
48732685|NCT02939079|156872376|FG001|Overall Study|Protocol Violation|0|||
48824987|NCT00731042|157200684|FG000|Second Intervention|Did not meet inclusion criteria|0|||
48522243|NCT02208362|156101899|FG010|Overall Study|Participant received disallowed treatment|0|||
48522244|NCT02208362|156101900|FG011|Overall Study|Participant received disallowed treatment|0|||
48522245|NCT04153890|156101901|FG000|Overall Study|Lost to Follow-up|9|||
48522246|NCT04153890|156101902|FG001|Overall Study|Lost to Follow-up|0|||
48522247|NCT04153890|156101903|FG002|Overall Study|Lost to Follow-up|9|||
48522248|NCT04153890|156101904|FG003|Overall Study|Lost to Follow-up|0|||
48522249|NCT04153890|156101901|FG000|Overall Study|Death|0|||
48522250|NCT04153890|156101902|FG001|Overall Study|Death|2|||
48522251|NCT04153890|156101903|FG002|Overall Study|Death|0|||
48522252|NCT04153890|156101904|FG003|Overall Study|Death|0|||
48601667|NCT03718429|156397685|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
48601668|NCT03718429|156397686|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
48601669|NCT03718429|156397687|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
48601670|NCT03718429|156397688|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
48601671|NCT02370511|156397689|FG000|Overall Study|Death|10|||
48601672|NCT02370511|156397690|FG001|Overall Study|Death|7|||
48601673|NCT02370511|156397691|FG002|Overall Study|Death|1|||
48601674|NCT02370511|156397689|FG000|Overall Study|Withdrawal by Subject|2|||
48601675|NCT02370511|156397690|FG001|Overall Study|Withdrawal by Subject|0|||
48601676|NCT02370511|156397691|FG002|Overall Study|Withdrawal by Subject|0|||
48601677|NCT02370511|156397689|FG000|Overall Study|Lost to Follow-up|0|||
48522253|NCT04153890|156101901|FG000|Overall Study|Withdrawal by Subject|0|||
48522254|NCT04153890|156101902|FG001|Overall Study|Withdrawal by Subject|0|||
48601678|NCT02370511|156397690|FG001|Overall Study|Lost to Follow-up|4|||
48601679|NCT02370511|156397691|FG002|Overall Study|Lost to Follow-up|0|||
48732686|NCT02939079|156872375|FG000|Overall Study|Withdrawal by Subject|0|||
48732687|NCT02939079|156872376|FG001|Overall Study|Withdrawal by Subject|1|||
48732688|NCT02939079|156872375|FG000|Overall Study|relapse during the study|1|||
48732689|NCT02939079|156872376|FG001|Overall Study|relapse during the study|1|||
48732690|NCT04093414|156872377|FG000|3 Month Follow up|Physician Decision|0|||
48732691|NCT04093414|156872378|FG001|3 Month Follow up|Physician Decision|1|||
48732692|NCT04093414|156872377|FG000|6month Follow up|Physician Decision|1|||
48732693|NCT04093414|156872378|FG001|6month Follow up|Physician Decision|3|||
48732694|NCT02337738|156872379|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
48522255|NCT04153890|156101903|FG002|Overall Study|Withdrawal by Subject|0|||
48522256|NCT04153890|156101904|FG003|Overall Study|Withdrawal by Subject|2|||
48522257|NCT02969356|156101907|FG000|Overall Study|Adverse Event|7|||
48522258|NCT02969356|156101907|FG000|Overall Study|Consent withdrawn|2|||
48522259|NCT02969356|156101907|FG000|Overall Study|Lost to Follow-up|3|||
48522260|NCT02969356|156101907|FG000|Overall Study|Did not need to be reinjected|6|||
48522261|NCT02969356|156101907|FG000|Overall Study|Personal reasons|5|||
48522262|NCT00640341|156103101|FG000|Overall Study|Adverse Event|0|||
48522263|NCT00640341|156103102|FG001|Overall Study|Adverse Event|0|||
48522264|NCT00640341|156103103|FG002|Overall Study|Adverse Event|1|||
48522265|NCT00640341|156103101|FG000|Overall Study|Positive Slit Lamp Findings|0|||
48522266|NCT00640341|156103102|FG001|Overall Study|Positive Slit Lamp Findings|0|||
48522267|NCT00640341|156103103|FG002|Overall Study|Positive Slit Lamp Findings|1|||
48522268|NCT00640341|156103101|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
48522269|NCT00640341|156103102|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
48522270|NCT00640341|156103103|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
48824988|NCT00731042|157200685|FG001|Second Intervention|Did not meet inclusion criteria|2|||
48824989|NCT04213846|157200686|FG000|Overall Study|Withdrawal by Subject|7|||
48824990|NCT04213846|157200687|FG001|Overall Study|Withdrawal by Subject|6|||
48824991|NCT04213846|157200686|FG000|Overall Study|Lost to Follow-up|15|||
48824992|NCT04213846|157200687|FG001|Overall Study|Lost to Follow-up|21|||
48824993|NCT02264574|157200691|FG000|Overall Study|Death|21|||
48824994|NCT02264574|157200692|FG001|Overall Study|Death|21|||
48824995|NCT02264574|157200691|FG000|Overall Study|Withdrawal by Subject|8|||
48824996|NCT02264574|157200692|FG001|Overall Study|Withdrawal by Subject|6|||
48824997|NCT02264574|157200691|FG000|Overall Study|Other, Not Specified|0|||
48824998|NCT02264574|157200692|FG001|Overall Study|Other, Not Specified|3|||
48824999|NCT02263885|157200694|FG000|Overall Study|Withdrawal by Subject|7|||
48825000|NCT02263885|157200694|FG000|Overall Study|Alternative Treatment|3|||
48825001|NCT02256969|157200701|FG000|Overall Study|Screenfailed or withdrew|2|||
48522271|NCT00640341|156103101|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
48522272|NCT00640341|156103102|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
48522273|NCT00640341|156103103|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
48522274|NCT00640341|156103101|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
48522275|NCT00640341|156103102|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
48825002|NCT02256969|157200702|FG001|Overall Study|Screenfailed or withdrew|1|||
48825003|NCT02256969|157200703|FG002|Overall Study|Screenfailed or withdrew|1|||
48825004|NCT02347943|157200704|FG000|Overall Study|Study was cancelled|140|||
48825005|NCT02347943|157200705|FG001|Overall Study|Study was cancelled|67|||
48825006|NCT02347943|157200706|FG002|Overall Study|Study was cancelled|45|||
48825007|NCT02049437|157200711|FG000|Period 1|Adverse Event|1|||
48825008|NCT02049437|157200712|FG001|Period 1|Adverse Event|1|||
48825009|NCT02049437|157200711|FG000|Period 1|Adverse Event|1|||
48825010|NCT02049437|157200712|FG001|Period 1|Adverse Event|0|||
48825011|NCT00797225|157200720|FG000|Weeks 1 to 12|Adverse Event|0|||
48825012|NCT00797225|157200721|FG001|Weeks 1 to 12|Adverse Event|0|||
48825013|NCT00797225|157200722|FG002|Weeks 1 to 12|Adverse Event|1|||
48825014|NCT00797225|157200723|FG003|Weeks 1 to 12|Adverse Event|0|||
48825015|NCT00797225|157200724|FG004|Weeks 1 to 12|Adverse Event|0|||
48825016|NCT00797225|157200725|FG005|Weeks 1 to 12|Adverse Event|0|||
48825017|NCT00797225|157200726|FG006|Weeks 1 to 12|Adverse Event|0|||
48825018|NCT00797225|157200727|FG007|Weeks 1 to 12|Adverse Event|0|||
48825019|NCT00797225|157200720|FG000|Weeks 1 to 12|Non-compliance|0|||
48522276|NCT00640341|156103103|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
48825020|NCT00797225|157200721|FG001|Weeks 1 to 12|Non-compliance|1|||
48825021|NCT00797225|157200722|FG002|Weeks 1 to 12|Non-compliance|0|||
48825022|NCT00797225|157200723|FG003|Weeks 1 to 12|Non-compliance|0|||
48825023|NCT00797225|157200724|FG004|Weeks 1 to 12|Non-compliance|0|||
48522277|NCT00640341|156103101|FG000|Overall Study|Lost to Follow-up|2|||
48522278|NCT00640341|156103102|FG001|Overall Study|Lost to Follow-up|0|||
48522279|NCT00640341|156103103|FG002|Overall Study|Lost to Follow-up|0|||
48522280|NCT00640341|156103101|FG000|Overall Study|Withdrawal by Subject|4|||
48522281|NCT00640341|156103102|FG001|Overall Study|Withdrawal by Subject|0|||
48522282|NCT00640341|156103103|FG002|Overall Study|Withdrawal by Subject|1|||
48522283|NCT00640341|156103101|FG000|Overall Study|Unacceptable Lens Movement|1|||
48522284|NCT00640341|156103102|FG001|Overall Study|Unacceptable Lens Movement|0|||
48522285|NCT00640341|156103103|FG002|Overall Study|Unacceptable Lens Movement|0|||
48522286|NCT00640341|156103101|FG000|Overall Study|Poor fit/Uncomfortable|4|||
48522287|NCT00640341|156103102|FG001|Overall Study|Poor fit/Uncomfortable|0|||
48522288|NCT00640341|156103103|FG002|Overall Study|Poor fit/Uncomfortable|0|||
48522289|NCT00640341|156103101|FG000|Overall Study|Ineligable at Baseline|5|||
48522290|NCT00640341|156103102|FG001|Overall Study|Ineligable at Baseline|3|||
48522291|NCT00640341|156103103|FG002|Overall Study|Ineligable at Baseline|2|||
48522292|NCT00640341|156103101|FG000|Overall Study|Adverse event and positive slit lamp|1|||
48825024|NCT00797225|157200725|FG005|Weeks 1 to 12|Non-compliance|0|||
48825025|NCT00797225|157200726|FG006|Weeks 1 to 12|Non-compliance|0|||
48825026|NCT00797225|157200727|FG007|Weeks 1 to 12|Non-compliance|0|||
48522293|NCT00640341|156103102|FG001|Overall Study|Adverse event and positive slit lamp|0|||
48522294|NCT00640341|156103103|FG002|Overall Study|Adverse event and positive slit lamp|0|||
48522295|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
48522296|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
48522297|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
48522298|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
48522299|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
48522300|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
48522301|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
48522302|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
48522303|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
48522304|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
48522305|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
48522306|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
48522307|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
48522308|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
48522309|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
48522310|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
48522311|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
48522312|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
48522313|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
48522314|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
48522315|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
48522316|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
48522317|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
48522318|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
48522319|NCT01710358|156103109|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
48522320|NCT01710358|156103110|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
48522321|NCT01710358|156103111|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
48522322|NCT01710358|156103109|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
48522323|NCT01710358|156103110|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
48522324|NCT01710358|156103111|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
48522325|NCT01710358|156103109|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
48522326|NCT01710358|156103110|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
48522327|NCT01710358|156103111|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
48522328|NCT01710358|156103109|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
48522329|NCT01710358|156103110|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
48522330|NCT01710358|156103111|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
48522331|NCT01710358|156103109|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
48522332|NCT01710358|156103110|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
48522333|NCT01710358|156103111|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
48522334|NCT01710358|156103109|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
48522335|NCT01710358|156103110|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
48522336|NCT01710358|156103111|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
48522337|NCT01710358|156103109|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
48522338|NCT01710358|156103110|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
48522339|NCT01710358|156103111|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
48522340|NCT01710358|156103109|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
48522341|NCT01710358|156103110|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
48522342|NCT01710358|156103111|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
48522343|NCT01710358|156103109|FG000|Rescue Period|Adverse Event|0|||
48522344|NCT01710358|156103110|FG001|Rescue Period|Adverse Event|15|||
48825027|NCT00797225|157200720|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
48522345|NCT01710358|156103111|FG002|Rescue Period|Adverse Event|0|||
48522346|NCT01710358|156103109|FG000|Rescue Period|Death|0|||
48522347|NCT01710358|156103110|FG001|Rescue Period|Death|1|||
48522348|NCT01710358|156103111|FG002|Rescue Period|Death|0|||
48522349|NCT01710358|156103109|FG000|Rescue Period|Lack of Efficacy|0|||
48522350|NCT01710358|156103110|FG001|Rescue Period|Lack of Efficacy|7|||
48522351|NCT01710358|156103111|FG002|Rescue Period|Lack of Efficacy|0|||
48522352|NCT01710358|156103109|FG000|Rescue Period|Withdrawal by Subject|0|||
48522353|NCT01710358|156103110|FG001|Rescue Period|Withdrawal by Subject|8|||
48522354|NCT01710358|156103111|FG002|Rescue Period|Withdrawal by Subject|0|||
48522355|NCT05061992|156103113|FG000|Overall Study|Excess bowel movements|1|||
48522356|NCT05061992|156103114|FG001|Overall Study|Excess bowel movements|0|||
48522357|NCT05061992|156103113|FG000|Overall Study|Complications of Medical Care|1|||
48522358|NCT05061992|156103114|FG001|Overall Study|Complications of Medical Care|0|||
48825028|NCT00797225|157200721|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
48825029|NCT00797225|157200722|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
48825030|NCT00797225|157200723|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
48732695|NCT02337738|156872380|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
48522359|NCT05061992|156103113|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
48522360|NCT05061992|156103114|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
48522361|NCT05061992|156103113|FG000|Overall Study|Withdrawal by Subject|0|||
48825031|NCT00797225|157200724|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
48825032|NCT00797225|157200725|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
48825033|NCT00797225|157200726|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
48825034|NCT00797225|157200727|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
48825035|NCT00797225|157200720|FG000|Weeks 1 to 12|Sponsor Decision|1|||
48825036|NCT00797225|157200721|FG001|Weeks 1 to 12|Sponsor Decision|0|||
48825037|NCT00797225|157200722|FG002|Weeks 1 to 12|Sponsor Decision|0|||
48825038|NCT00797225|157200723|FG003|Weeks 1 to 12|Sponsor Decision|0|||
48825039|NCT00797225|157200724|FG004|Weeks 1 to 12|Sponsor Decision|0|||
48732696|NCT02337738|156872381|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
48732697|NCT02337738|156872379|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48732698|NCT02337738|156872380|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
48732699|NCT02337738|156872381|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
48732700|NCT02337738|156872379|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
48732701|NCT02337738|156872380|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
48732702|NCT02337738|156872381|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
48732703|NCT02337738|156872379|FG000|Overall Study|Voluntary Withdrawal|10|||
48732704|NCT02337738|156872380|FG001|Overall Study|Voluntary Withdrawal|5|||
48732705|NCT02337738|156872381|FG002|Overall Study|Voluntary Withdrawal|2|||
48732706|NCT02337738|156872379|FG000|Overall Study|Lack of Efficacy|2|||
48732707|NCT02337738|156872380|FG001|Overall Study|Lack of Efficacy|4|||
48732708|NCT02337738|156872381|FG002|Overall Study|Lack of Efficacy|0|||
48825040|NCT00797225|157200725|FG005|Weeks 1 to 12|Sponsor Decision|0|||
48825041|NCT00797225|157200726|FG006|Weeks 1 to 12|Sponsor Decision|0|||
48825042|NCT00797225|157200727|FG007|Weeks 1 to 12|Sponsor Decision|0|||
48825043|NCT00797225|157200720|FG000|Weeks 13 to 24|Non-compliance|0|||
48732709|NCT02337738|156872379|FG000|Overall Study|Investigator's Judgment|1|||
48732710|NCT02337738|156872380|FG001|Overall Study|Investigator's Judgment|1|||
48732711|NCT02337738|156872381|FG002|Overall Study|Investigator's Judgment|3|||
48732712|NCT02047227|156872385|FG000|Overall Study|Adverse Event|2|||
48732713|NCT02047227|156872386|FG001|Overall Study|Adverse Event|4|||
48732714|NCT02047227|156872385|FG000|Overall Study|Lost to Follow-up|0|||
48732715|NCT02047227|156872386|FG001|Overall Study|Lost to Follow-up|3|||
48732716|NCT02047227|156872385|FG000|Overall Study|Protocol Violation|1|||
48732717|NCT02047227|156872386|FG001|Overall Study|Protocol Violation|0|||
48732718|NCT02047227|156872385|FG000|Overall Study|Spontaneous pregnancy|1|||
48732719|NCT02047227|156872386|FG001|Overall Study|Spontaneous pregnancy|0|||
48732720|NCT02047227|156872385|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
48732721|NCT02047227|156872386|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
48732722|NCT02047227|156872385|FG000|Overall Study|No oocytes retrieved|21|||
48732723|NCT02047227|156872386|FG001|Overall Study|No oocytes retrieved|20|||
48732724|NCT02047227|156872385|FG000|Overall Study|No fertilization|61|||
48732725|NCT02047227|156872386|FG001|Overall Study|No fertilization|51|||
48825044|NCT00797225|157200721|FG001|Weeks 13 to 24|Non-compliance|2|||
48825045|NCT00797225|157200722|FG002|Weeks 13 to 24|Non-compliance|0|||
48522362|NCT05061992|156103114|FG001|Overall Study|Withdrawal by Subject|1|||
48522363|NCT02340780|156103117|FG000|Overall Study|Ineligible|1|||
48522364|NCT00084864|156103124|FG000|Overall Study|Adverse Event|1|||
48522365|NCT00084864|156103125|FG001|Overall Study|Adverse Event|0|||
48522366|NCT00084864|156103126|FG002|Overall Study|Adverse Event|0|||
48522367|NCT00084864|156103127|FG003|Overall Study|Adverse Event|0|||
48522368|NCT04406194|156103128|FG000|Period 1|Withdrawal by Subject|0|||
48522369|NCT04406194|156103129|FG001|Period 1|Withdrawal by Subject|1|||
48522370|NCT01841060|156103130|FG000|Overall Study|Protocol Violation|10|||
48522371|NCT00651183|156103133|FG000|Overall Study|Lack of Efficacy|1|||
48522372|NCT00651183|156103134|FG001|Overall Study|Lack of Efficacy|0|||
48522373|NCT00651183|156103133|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
48522374|NCT00651183|156103134|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
48522375|NCT00651183|156103133|FG000|Overall Study|Tolerability insufficient|5|||
48522376|NCT00651183|156103134|FG001|Overall Study|Tolerability insufficient|2|||
48522377|NCT00651183|156103133|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
48732726|NCT02047227|156872385|FG000|Overall Study|Intention to freeze all embryos|1|||
48732727|NCT02047227|156872386|FG001|Overall Study|Intention to freeze all embryos|0|||
48732728|NCT02047227|156872385|FG000|Overall Study|All embryos discarded|12|||
48732729|NCT02047227|156872386|FG001|Overall Study|All embryos discarded|11|||
48732730|NCT02047227|156872385|FG000|Overall Study|Other|10|||
48732731|NCT02047227|156872386|FG001|Overall Study|Other|9|||
48522378|NCT00651183|156103134|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
48825046|NCT00797225|157200723|FG003|Weeks 13 to 24|Non-compliance|0|||
48825047|NCT00797225|157200724|FG004|Weeks 13 to 24|Non-compliance|0|||
48825048|NCT00797225|157200725|FG005|Weeks 13 to 24|Non-compliance|0|||
48732732|NCT01898208|156872395|FG000|Overall Study|Positive blood culture|17|||
48732733|NCT01898208|156872396|FG001|Overall Study|Positive blood culture|23|||
48522379|NCT00651183|156103133|FG000|Overall Study|Withdrawal by Subject|6|||
48522380|NCT00651183|156103134|FG001|Overall Study|Withdrawal by Subject|3|||
48732734|NCT01898208|156872397|FG002|Overall Study|Positive blood culture|15|||
48732735|NCT01898208|156872395|FG000|Overall Study|Death/comfort care within 24 hours|10|||
48732736|NCT01898208|156872396|FG001|Overall Study|Death/comfort care within 24 hours|9|||
48732737|NCT01898208|156872397|FG002|Overall Study|Death/comfort care within 24 hours|8|||
48825049|NCT00797225|157200726|FG006|Weeks 13 to 24|Non-compliance|0|||
48825050|NCT00797225|157200727|FG007|Weeks 13 to 24|Non-compliance|0|||
48825051|NCT00797225|157200720|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
48825052|NCT00797225|157200721|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
48732738|NCT01898208|156872395|FG000|Overall Study|Negative Gram Stain|6|||
48732739|NCT01898208|156872396|FG001|Overall Study|Negative Gram Stain|9|||
48732740|NCT01898208|156872397|FG002|Overall Study|Negative Gram Stain|6|||
48732741|NCT01898208|156872395|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
48732742|NCT01898208|156872396|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
48732743|NCT01898208|156872397|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
48732744|NCT01898208|156872395|FG000|Overall Study|System/Technical Error|1|||
48732745|NCT01898208|156872396|FG001|Overall Study|System/Technical Error|2|||
48825053|NCT00797225|157200722|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
48825054|NCT00797225|157200723|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
48601680|NCT01149655|156397692|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
48601681|NCT01149655|156397693|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
48601682|NCT01149655|156397694|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
48601683|NCT01149655|156397695|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
48601684|NCT01149655|156397692|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
48601685|NCT01149655|156397693|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
48601686|NCT01149655|156397694|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
48601687|NCT01149655|156397695|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
48601688|NCT01149655|156397692|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
48601689|NCT01149655|156397693|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
48601690|NCT01149655|156397694|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
48601691|NCT01149655|156397695|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
48601692|NCT01149655|156397692|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
48601693|NCT01149655|156397693|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
48601694|NCT01149655|156397694|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
48601695|NCT01149655|156397695|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
48601696|NCT01149655|156397692|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
48601697|NCT01149655|156397693|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
48601698|NCT01149655|156397694|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
48601699|NCT01149655|156397695|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
48601700|NCT01149655|156397692|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
48601701|NCT01149655|156397693|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
48601702|NCT01149655|156397694|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
48601703|NCT01149655|156397695|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
48601704|NCT01149655|156397692|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
48601705|NCT01149655|156397693|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
48601706|NCT01149655|156397694|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
48732746|NCT01898208|156872397|FG002|Overall Study|System/Technical Error|3|||
48732747|NCT01898208|156872395|FG000|Overall Study|Lost to Follow-up|3|||
48522381|NCT00651183|156103133|FG000|Overall Study|Lost to Follow-up|3|||
48522382|NCT00651183|156103134|FG001|Overall Study|Lost to Follow-up|1|||
48522383|NCT00651183|156103133|FG000|Overall Study|Other reasons|4|||
48522384|NCT00651183|156103134|FG001|Overall Study|Other reasons|2|||
48522385|NCT00651183|156103133|FG000|Overall Study|missing|1|||
48522386|NCT00651183|156103134|FG001|Overall Study|missing|0|||
48522387|NCT00695110|156103135|FG000|Treatment Period 1|Adverse Event|1|||
48522388|NCT00695110|156103135|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48522389|NCT00695110|156103135|FG000|Treatment Period 3|Withdrawal by Subject|1|||
48522390|NCT00695110|156103135|FG000|Treatment Period 4|Adverse Event|1|||
48522391|NCT00487695|156103136|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
48522392|NCT00487695|156103137|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
48601707|NCT01149655|156397695|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
48601708|NCT01149655|156397692|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
48732748|NCT01898208|156872396|FG001|Overall Study|Lost to Follow-up|1|||
48601709|NCT01149655|156397693|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
48732749|NCT01898208|156872397|FG002|Overall Study|Lost to Follow-up|1|||
48732750|NCT03954132|156872398|FG000|Overall Study|Adverse Event|2|||
48732751|NCT03954132|156872399|FG001|Overall Study|Adverse Event|0|||
48732752|NCT03954132|156872398|FG000|Overall Study|Patient's wish|5|||
48732753|NCT03954132|156872399|FG001|Overall Study|Patient's wish|0|||
48732754|NCT03954132|156872398|FG000|Overall Study|Lost to Follow-up|10|||
48732755|NCT03954132|156872399|FG001|Overall Study|Lost to Follow-up|0|||
48732756|NCT03954132|156872398|FG000|Overall Study|Screening failure|0|||
48732757|NCT03954132|156872399|FG001|Overall Study|Screening failure|1|||
48732758|NCT03954132|156872398|FG000|Overall Study|No registration after Visit 1|5|||
48732759|NCT03954132|156872399|FG001|Overall Study|No registration after Visit 1|2|||
48732760|NCT03954132|156872398|FG000|Overall Study|Other reason than listed|2|||
48732761|NCT03954132|156872399|FG001|Overall Study|Other reason than listed|2|||
48732762|NCT03954132|156872398|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
48732763|NCT03954132|156872399|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
48732764|NCT03954132|156872398|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
48825055|NCT00797225|157200724|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
48825056|NCT00797225|157200725|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
48825057|NCT00797225|157200726|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
48825058|NCT00797225|157200727|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
48522393|NCT00487695|156103136|FG000|First Procedure|active wheezing (did not have procedure)|1|||
48522394|NCT00487695|156103137|FG001|First Procedure|active wheezing (did not have procedure)|0|||
48522395|NCT00487695|156103136|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
48522396|NCT00487695|156103137|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
48522397|NCT00487695|156103136|FG000|Second Procedure|active wheezing|0|||
48522398|NCT00487695|156103137|FG001|Second Procedure|active wheezing|1|||
48522399|NCT00487695|156103136|FG000|Second Procedure|Withdrawal by Subject|1|||
48522400|NCT00487695|156103137|FG001|Second Procedure|Withdrawal by Subject|2|||
48522401|NCT02416180|156103142|FG000|Overall Study|Withdrawal by Subject|1|||
48522402|NCT01745094|156103143|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
48522403|NCT01745094|156103144|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
48522404|NCT01745094|156103145|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
48522405|NCT01745094|156103146|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
48522406|NCT01745094|156103143|FG000|Overall Study|Adverse Event|0|||
48522407|NCT01745094|156103144|FG001|Overall Study|Adverse Event|0|||
48522408|NCT01745094|156103145|FG002|Overall Study|Adverse Event|3|||
48522409|NCT01745094|156103146|FG003|Overall Study|Adverse Event|0|||
48601710|NCT01149655|156397694|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
48601711|NCT01149655|156397695|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
48601712|NCT01149655|156397692|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
48601713|NCT01149655|156397693|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
48601714|NCT01149655|156397694|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
48601715|NCT01149655|156397695|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
48601716|NCT01149655|156397692|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
48601717|NCT01149655|156397693|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
48601718|NCT01149655|156397694|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
48601719|NCT01149655|156397695|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
48601720|NCT01149655|156397692|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
48601721|NCT01149655|156397693|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
48601722|NCT01149655|156397694|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
48601723|NCT01149655|156397695|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
48601724|NCT01149655|156397692|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
48601725|NCT01149655|156397693|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
48601726|NCT01149655|156397694|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
48601727|NCT01149655|156397695|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
48601728|NCT01149655|156397692|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
48601729|NCT01149655|156397693|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
48601730|NCT01149655|156397694|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
48601731|NCT01149655|156397695|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
48601732|NCT01149655|156397692|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
48601733|NCT01149655|156397693|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
48601734|NCT01149655|156397694|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
48601735|NCT01149655|156397695|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
48601736|NCT01149655|156397692|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
48601737|NCT01149655|156397693|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
48601738|NCT01149655|156397694|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
48601739|NCT01149655|156397695|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
48601740|NCT01149655|156397692|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
48601741|NCT01149655|156397693|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
48732765|NCT03954132|156872399|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
48732766|NCT03516812|156872402|FG000|Overall Study|Adverse Event|4|||
48825059|NCT00797225|157200720|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
48732767|NCT03516812|156872402|FG000|Overall Study|Lack of Efficacy|2|||
48732768|NCT03945266|156872403|FG000|Overall Study|Withdrawal by Subject|1|||
48732769|NCT03945266|156872404|FG001|Overall Study|Withdrawal by Subject|0|||
48732770|NCT03945266|156872403|FG000|Overall Study|Miscarriage|0|||
48732771|NCT03945266|156872404|FG001|Overall Study|Miscarriage|2|||
48825060|NCT00797225|157200721|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
48825061|NCT00797225|157200722|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
48522410|NCT01745094|156103143|FG000|Overall Study|Withdrawal by Subject|2|||
48522411|NCT01745094|156103144|FG001|Overall Study|Withdrawal by Subject|0|||
48522412|NCT01745094|156103145|FG002|Overall Study|Withdrawal by Subject|1|||
48522413|NCT01745094|156103146|FG003|Overall Study|Withdrawal by Subject|2|||
48522414|NCT01745094|156103143|FG000|Overall Study|Protocol Violation|1|||
48522415|NCT01745094|156103144|FG001|Overall Study|Protocol Violation|0|||
48522416|NCT01745094|156103145|FG002|Overall Study|Protocol Violation|3|||
48522417|NCT01745094|156103146|FG003|Overall Study|Protocol Violation|1|||
48522418|NCT01745094|156103143|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
48522419|NCT01745094|156103144|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
48522420|NCT01745094|156103145|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
48522421|NCT01745094|156103146|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
48732772|NCT03945266|156872403|FG000|Overall Study|Lost to Follow-up|1|||
48732773|NCT03945266|156872404|FG001|Overall Study|Lost to Follow-up|0|||
48732774|NCT05147428|156872409|FG000|Overall Study|Removed prior to mailing|289|||
48732775|NCT05147428|156872410|FG001|Overall Study|Removed prior to mailing|306|||
48732776|NCT05147428|156872411|FG002|Overall Study|Removed prior to mailing|270|||
48732777|NCT05147428|156872409|FG000|Overall Study|Died or disenrolled during blackout period|239|||
48732778|NCT05147428|156872410|FG001|Overall Study|Died or disenrolled during blackout period|278|||
48825062|NCT00797225|157200723|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
48825063|NCT00797225|157200724|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
48825064|NCT00797225|157200725|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
48825065|NCT00797225|157200726|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
48825066|NCT00797225|157200727|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
48825067|NCT00797225|157200720|FG000|Weeks 13 to 24|Adverse Event|0|||
48825068|NCT00797225|157200721|FG001|Weeks 13 to 24|Adverse Event|1|||
48825069|NCT00797225|157200722|FG002|Weeks 13 to 24|Adverse Event|0|||
48825070|NCT00797225|157200723|FG003|Weeks 13 to 24|Adverse Event|0|||
48825071|NCT00797225|157200724|FG004|Weeks 13 to 24|Adverse Event|0|||
48732779|NCT05147428|156872411|FG002|Overall Study|Died or disenrolled during blackout period|273|||
48732780|NCT00537238|156873740|FG000|Overall Study|Death|1|||
48732781|NCT00537238|156873741|FG001|Overall Study|Death|2|||
48732782|NCT00537238|156873740|FG000|Overall Study|Adverse Event|31|||
48732783|NCT00537238|156873741|FG001|Overall Study|Adverse Event|22|||
48732784|NCT00537238|156873740|FG000|Overall Study|Lack of Efficacy|20|||
48732785|NCT00537238|156873741|FG001|Overall Study|Lack of Efficacy|21|||
48732786|NCT00537238|156873740|FG000|Overall Study|Lost to Follow-up|12|||
48732787|NCT00537238|156873741|FG001|Overall Study|Lost to Follow-up|8|||
48732788|NCT00537238|156873740|FG000|Overall Study|Withdrawal by Subject|51|||
48732789|NCT00537238|156873741|FG001|Overall Study|Withdrawal by Subject|47|||
48732790|NCT00537238|156873740|FG000|Overall Study|Protocol Violation|15|||
48732791|NCT00537238|156873741|FG001|Overall Study|Protocol Violation|19|||
48732792|NCT00537238|156873740|FG000|Overall Study|Does not meet entrance criteria|0|||
48732793|NCT00537238|156873741|FG001|Overall Study|Does not meet entrance criteria|2|||
48732794|NCT00537238|156873740|FG000|Overall Study|Other|44|||
48732795|NCT00537238|156873741|FG001|Overall Study|Other|52|||
48732796|NCT01795638|156873744|FG000|Overall Study|Death|0|||
48732797|NCT01795638|156873745|FG001|Overall Study|Death|3|||
48732798|NCT01795638|156873744|FG000|Overall Study|transferred to quaternary hospital|2|||
48732799|NCT01795638|156873745|FG001|Overall Study|transferred to quaternary hospital|3|||
48732800|NCT01795638|156873744|FG000|Overall Study|Protocol Violation|3|||
48732801|NCT01795638|156873745|FG001|Overall Study|Protocol Violation|0|||
48825072|NCT00797225|157200725|FG005|Weeks 13 to 24|Adverse Event|0|||
48825073|NCT00797225|157200726|FG006|Weeks 13 to 24|Adverse Event|1|||
48825074|NCT00797225|157200727|FG007|Weeks 13 to 24|Adverse Event|0|||
48825075|NCT00797225|157200720|FG000|Weeks 13 to 24|Sponsor Decision|0|||
48825076|NCT00797225|157200721|FG001|Weeks 13 to 24|Sponsor Decision|0|||
48522422|NCT01745094|156103143|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
48732802|NCT01795638|156873744|FG000|Overall Study|discharged from hospital|7|||
48732803|NCT01795638|156873745|FG001|Overall Study|discharged from hospital|5|||
48732804|NCT01795638|156873744|FG000|Overall Study|Withdrawal by Subject|1|||
48732805|NCT01795638|156873745|FG001|Overall Study|Withdrawal by Subject|0|||
48732806|NCT03265665|156873746|FG000|24-week Data Collection|Withdrawal by Subject|2|||
48732807|NCT03265665|156873747|FG001|24-week Data Collection|Withdrawal by Subject|2|||
48825077|NCT00797225|157200722|FG002|Weeks 13 to 24|Sponsor Decision|0|||
48522423|NCT01745094|156103144|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
48732808|NCT03265665|156873746|FG000|24-week Data Collection|Lost to Follow-up|4|||
48732809|NCT03265665|156873747|FG001|24-week Data Collection|Lost to Follow-up|5|||
48732810|NCT03265665|156873746|FG000|36-week Data Collection|Lost to Follow-up|6|||
48825078|NCT00797225|157200723|FG003|Weeks 13 to 24|Sponsor Decision|0|||
48825079|NCT00797225|157200724|FG004|Weeks 13 to 24|Sponsor Decision|0|||
48825080|NCT00797225|157200725|FG005|Weeks 13 to 24|Sponsor Decision|0|||
48825081|NCT00797225|157200726|FG006|Weeks 13 to 24|Sponsor Decision|1|||
48825082|NCT00797225|157200727|FG007|Weeks 13 to 24|Sponsor Decision|0|||
48825083|NCT00578227|157200728|FG000|Overall Study|Lost to Follow-up|0|||
48825084|NCT00578227|157200729|FG001|Overall Study|Lost to Follow-up|1|||
48825085|NCT00578227|157200730|FG002|Overall Study|Lost to Follow-up|1|||
48825086|NCT00578227|157200728|FG000|Overall Study|Withdrawal by Subject|5|||
48825087|NCT00578227|157200729|FG001|Overall Study|Withdrawal by Subject|1|||
48825088|NCT00578227|157200730|FG002|Overall Study|Withdrawal by Subject|3|||
48825089|NCT02096003|157200731|FG000|Overall Study|Protocol Violation|0|||
48825090|NCT02096003|157200732|FG001|Overall Study|Protocol Violation|2|||
48825091|NCT02096003|157200731|FG000|Overall Study|additional surgery|2|||
48825092|NCT02096003|157200732|FG001|Overall Study|additional surgery|1|||
48825093|NCT01008748|157200733|FG000|Overall Study|Lost to Follow-up|80|||
48825094|NCT01008748|157200733|FG000|Overall Study|Other|1|||
48825095|NCT00506519|157200735|FG000|Overall Study|Death|4|||
48732811|NCT03265665|156873747|FG001|36-week Data Collection|Lost to Follow-up|8|||
48732812|NCT00721123|156873748|FG000|Overall Study|Adverse Event|96|||
48732813|NCT00721123|156873748|FG000|Overall Study|Death|10|||
48825096|NCT00506519|157200736|FG001|Overall Study|Death|6|||
48825097|NCT00506519|157200737|FG002|Overall Study|Death|0|||
48732814|NCT00721123|156873748|FG000|Overall Study|Insufficient Therapeutic Response|21|||
48732815|NCT00721123|156873748|FG000|Overall Study|Protocol Violation|1|||
48732816|NCT00721123|156873748|FG000|Overall Study|Refused Treatment|41|||
48732817|NCT00721123|156873748|FG000|Overall Study|Failure to Return|9|||
48825098|NCT00506519|157200735|FG000|Overall Study|Adverse Event|1|||
48825099|NCT00506519|157200736|FG001|Overall Study|Adverse Event|0|||
48522424|NCT01745094|156103145|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
48522425|NCT01745094|156103146|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
48522426|NCT01745094|156103143|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
48522427|NCT01745094|156103144|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
48522428|NCT01745094|156103145|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
48522429|NCT01745094|156103146|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
48522430|NCT04610580|156103147|FG000|Two-way Crossover Period|Adverse Event|1|||
48522431|NCT04610580|156103148|FG001|Two-way Crossover Period|Adverse Event|0|||
48522432|NCT04610580|156103149|FG002|Two-way Crossover Period|Adverse Event|0|||
48522433|NCT04610580|156103150|FG003|Two-way Crossover Period|Adverse Event|0|||
48601742|NCT01149655|156397694|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
48825100|NCT00506519|157200737|FG002|Overall Study|Adverse Event|0|||
48825101|NCT01446003|157200738|FG000|Period 1|Protocol Violation|2|||
48825102|NCT01446003|157200739|FG001|Period 1|Protocol Violation|0|||
48825103|NCT01446003|157200738|FG000|Period 2|Adverse Event|1|||
48825104|NCT01446003|157200739|FG001|Period 2|Adverse Event|0|||
48601743|NCT01149655|156397695|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
48601744|NCT04158219|156397700|FG000|Overall Study|Lost to Follow-up|1|||
48601745|NCT01093846|156397701|FG000|Overall Study|Adverse Event|0|||
48601746|NCT01093846|156397702|FG001|Overall Study|Adverse Event|0|||
48732818|NCT00721123|156873748|FG000|Overall Study|Withdrawal by Subject|5|||
48732819|NCT02437513|156873749|FG000|Overall Study|Withdrawal by Subject|2|||
48732820|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
48732821|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
48732822|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
48825105|NCT00318656|157200741|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
48601747|NCT01093846|156397703|FG002|Overall Study|Adverse Event|1|||
48601748|NCT01093846|156397701|FG000|Overall Study|Lack of Efficacy|0|||
48601749|NCT01093846|156397702|FG001|Overall Study|Lack of Efficacy|0|||
48601750|NCT01093846|156397703|FG002|Overall Study|Lack of Efficacy|4|||
48601751|NCT01093846|156397701|FG000|Overall Study|Condition no longer required study drug|1|||
48601752|NCT01093846|156397702|FG001|Overall Study|Condition no longer required study drug|1|||
48601753|NCT01093846|156397703|FG002|Overall Study|Condition no longer required study drug|1|||
48601754|NCT01093846|156397701|FG000|Overall Study|Administrative Problems|18|||
48601755|NCT01093846|156397702|FG001|Overall Study|Administrative Problems|17|||
48601756|NCT01093846|156397703|FG002|Overall Study|Administrative Problems|15|||
48601757|NCT02922153|156399415|FG000|Overall Study|Death|8|||
48601758|NCT02922153|156399416|FG001|Overall Study|Death|1|||
48825106|NCT00318656|157200742|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
48825107|NCT00318656|157200741|FG000|Overall Study|Did not receive any treatment|0|||
48522434|NCT04610580|156103151|FG004|Two-way Crossover Period|Adverse Event|0|||
48522435|NCT04610580|156103152|FG005|Two-way Crossover Period|Adverse Event|0|||
48601759|NCT02922153|156399415|FG000|Overall Study|Lost to Follow-up|1|||
48732823|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
48732824|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
48825108|NCT00318656|157200742|FG001|Overall Study|Did not receive any treatment|1|||
48601760|NCT02922153|156399416|FG001|Overall Study|Lost to Follow-up|0|||
48732825|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
48522436|NCT04610580|156103147|FG000|Two-way Crossover Period|Physician Decision|1|||
48522437|NCT04610580|156103148|FG001|Two-way Crossover Period|Physician Decision|0|||
48522438|NCT04610580|156103149|FG002|Two-way Crossover Period|Physician Decision|0|||
48522439|NCT04610580|156103150|FG003|Two-way Crossover Period|Physician Decision|0|||
48522440|NCT04610580|156103151|FG004|Two-way Crossover Period|Physician Decision|0|||
48522441|NCT04610580|156103152|FG005|Two-way Crossover Period|Physician Decision|0|||
48522442|NCT04610580|156103147|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
48522443|NCT04610580|156103148|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
48522444|NCT04610580|156103149|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
48522445|NCT04610580|156103150|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
48522446|NCT04610580|156103151|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
48522447|NCT04610580|156103152|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
48522448|NCT04610580|156103147|FG000|Two-way Crossover Period|Other than specified|0|||
48522449|NCT04610580|156103148|FG001|Two-way Crossover Period|Other than specified|1|||
48522450|NCT04610580|156103149|FG002|Two-way Crossover Period|Other than specified|0|||
48522451|NCT04610580|156103150|FG003|Two-way Crossover Period|Other than specified|0|||
48522452|NCT04610580|156103151|FG004|Two-way Crossover Period|Other than specified|0|||
48522453|NCT04610580|156103152|FG005|Two-way Crossover Period|Other than specified|0|||
48522454|NCT04610580|156103147|FG000|Washout Before Extension Period|Other than specified|0|||
48522455|NCT04610580|156103148|FG001|Washout Before Extension Period|Other than specified|1|||
48522456|NCT04610580|156103149|FG002|Washout Before Extension Period|Other than specified|0|||
48522457|NCT04610580|156103150|FG003|Washout Before Extension Period|Other than specified|0|||
48522458|NCT04610580|156103151|FG004|Washout Before Extension Period|Other than specified|0|||
48522459|NCT04610580|156103152|FG005|Washout Before Extension Period|Other than specified|0|||
48522460|NCT04610580|156103147|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
48522461|NCT04610580|156103148|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
48522462|NCT04610580|156103149|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
48522463|NCT04610580|156103150|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
48522464|NCT04610580|156103151|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
48522465|NCT04610580|156103152|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
48522466|NCT04610580|156103147|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
48522467|NCT04610580|156103148|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
48522468|NCT04610580|156103149|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
48522469|NCT04610580|156103150|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
48522470|NCT04610580|156103151|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
48522471|NCT04610580|156103152|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
48522472|NCT01097694|156103153|FG000|Overall Study|Adverse Event|5|||
48522473|NCT01097694|156103154|FG001|Overall Study|Adverse Event|0|||
48522474|NCT01097694|156103153|FG000|Overall Study|Lost to Follow-up|0|||
48522475|NCT01097694|156103154|FG001|Overall Study|Lost to Follow-up|3|||
48522476|NCT01097694|156103153|FG000|Overall Study|Withdrawal by Subject|3|||
48522477|NCT01097694|156103154|FG001|Overall Study|Withdrawal by Subject|1|||
48522478|NCT02179190|156103155|FG000|Enrollment|Exit Prior to Device Attempt|11|||
48522479|NCT02179190|156103155|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
48522480|NCT02179190|156103155|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
48522481|NCT02179190|156103155|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
48522482|NCT02179190|156103155|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
48825109|NCT04550039|157200743|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
48825110|NCT04550039|157200744|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
48825111|NCT04550039|157200743|FG000|Overall Study|patient self-withdrew from study|0|||
48825112|NCT04550039|157200744|FG001|Overall Study|patient self-withdrew from study|1|||
48825113|NCT02138916|157200745|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
48522483|NCT02179190|156103155|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
48522484|NCT02005276|156103156|FG000|Overall Study|No longer interested|5|||
48522485|NCT02005276|156103157|FG001|Overall Study|No longer interested|2|||
48522486|NCT02005276|156103158|FG002|Overall Study|No longer interested|3|||
48522487|NCT02005276|156103159|FG003|Overall Study|No longer interested|3|||
48522488|NCT00372996|156103162|FG000|Overall Study|Death|11|||
48522489|NCT00372996|156103163|FG001|Overall Study|Death|4|||
48522490|NCT00372996|156103164|FG002|Overall Study|Death|8|||
48522491|NCT00372996|156103165|FG003|Overall Study|Death|7|||
48522492|NCT00372996|156103162|FG000|Overall Study|Lost to Follow-up|0|||
48522493|NCT00372996|156103163|FG001|Overall Study|Lost to Follow-up|2|||
48522494|NCT00372996|156103164|FG002|Overall Study|Lost to Follow-up|0|||
48522495|NCT00372996|156103165|FG003|Overall Study|Lost to Follow-up|1|||
48522496|NCT00372996|156103162|FG000|Overall Study|Withdrawal by Subject|12|||
48522497|NCT00372996|156103163|FG001|Overall Study|Withdrawal by Subject|6|||
48522498|NCT00372996|156103164|FG002|Overall Study|Withdrawal by Subject|9|||
48522499|NCT00372996|156103165|FG003|Overall Study|Withdrawal by Subject|5|||
48522500|NCT00372996|156103162|FG000|Overall Study|Study Terminated by Sponsor|4|||
48522501|NCT00372996|156103163|FG001|Overall Study|Study Terminated by Sponsor|0|||
48522502|NCT00372996|156103164|FG002|Overall Study|Study Terminated by Sponsor|4|||
48522503|NCT00372996|156103165|FG003|Overall Study|Study Terminated by Sponsor|0|||
48522504|NCT00372996|156103162|FG000|Overall Study|Other|10|||
48522505|NCT00372996|156103163|FG001|Overall Study|Other|2|||
48732826|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
48732827|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
48732828|NCT03347188|156873757|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
48732829|NCT03347188|156873758|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
48732830|NCT03347188|156873757|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
48522506|NCT00372996|156103164|FG002|Overall Study|Other|7|||
48522507|NCT00372996|156103165|FG003|Overall Study|Other|7|||
48522508|NCT01186016|156103166|FG000|Overall Study|Withdrawal by Subject|46|||
48522509|NCT01186016|156103167|FG001|Overall Study|Withdrawal by Subject|29|||
48522510|NCT03750695|156103171|FG000|Overall Study|Lost to Follow-up|0|||
48522511|NCT03750695|156103172|FG001|Overall Study|Lost to Follow-up|1|||
48522512|NCT01899053|156103176|FG000|Overall Study|Progressive Disease|4|||
48522513|NCT01899053|156103177|FG001|Overall Study|Progressive Disease|0|||
48522514|NCT01899053|156103178|FG002|Overall Study|Progressive Disease|3|||
48522515|NCT01899053|156103179|FG003|Overall Study|Progressive Disease|0|||
48522516|NCT01899053|156103180|FG004|Overall Study|Progressive Disease|3|||
48522517|NCT01899053|156103181|FG005|Overall Study|Progressive Disease|1|||
48522518|NCT01899053|156103182|FG006|Overall Study|Progressive Disease|1|||
48601761|NCT02922153|156399415|FG000|Overall Study|Physician Decision|1|||
48601762|NCT02922153|156399416|FG001|Overall Study|Physician Decision|1|||
48601763|NCT00327340|156399417|FG000|Overall Study|Withdrawal by Subject|1|||
48601764|NCT00327340|156399418|FG001|Overall Study|Withdrawal by Subject|5|||
48732831|NCT03347188|156873758|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
48732832|NCT03347188|156873757|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
48732833|NCT03347188|156873758|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
48732834|NCT03347188|156873757|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
48732835|NCT03347188|156873758|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
48732836|NCT01845818|156873759|FG000|Overall Study|Withdrawal by Subject|0|||
48732837|NCT01845818|156873760|FG001|Overall Study|Withdrawal by Subject|1|||
48732838|NCT01845818|156873759|FG000|Overall Study|Lost to Follow-up|7|||
48732839|NCT01845818|156873760|FG001|Overall Study|Lost to Follow-up|5|||
48732840|NCT01845818|156873759|FG000|Overall Study|Administrative Reasons|3|||
48732841|NCT01845818|156873760|FG001|Overall Study|Administrative Reasons|1|||
48732842|NCT01845818|156873759|FG000|Overall Study|Serious Adverse Event|1|||
48732843|NCT01845818|156873760|FG001|Overall Study|Serious Adverse Event|1|||
48732844|NCT01845818|156873759|FG000|Overall Study|Other|25|||
48732845|NCT01845818|156873760|FG001|Overall Study|Other|8|||
48732846|NCT01845818|156873759|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
48732847|NCT01845818|156873760|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
48732848|NCT01845818|156873759|FG000|Overall Study|No Follow-Up Data Available|4|||
48732849|NCT01845818|156873760|FG001|Overall Study|No Follow-Up Data Available|1|||
48732850|NCT03403374|156873761|FG000|Overall Study|Lost to Follow-up|1|||
48732851|NCT03228420|156873762|FG000|Overall Study|Lost to Follow-up|5|||
48732852|NCT03228420|156873763|FG001|Overall Study|Lost to Follow-up|3|||
48732853|NCT03228420|156873762|FG000|Overall Study|Withdrawal by Subject|10|||
48732854|NCT03228420|156873763|FG001|Overall Study|Withdrawal by Subject|0|||
48732855|NCT03228420|156873762|FG000|Overall Study|Adverse Event|5|||
48732856|NCT03228420|156873763|FG001|Overall Study|Adverse Event|2|||
48732857|NCT01298531|156873764|FG000|Overall Study|Lack of Efficacy|0|||
48732858|NCT01298531|156873765|FG001|Overall Study|Lack of Efficacy|1|||
48732859|NCT01298531|156873764|FG000|Overall Study|Lost to Follow-up|2|||
48732860|NCT01298531|156873765|FG001|Overall Study|Lost to Follow-up|0|||
48732861|NCT01298531|156873764|FG000|Overall Study|Protocol Violation|1|||
48732862|NCT01298531|156873765|FG001|Overall Study|Protocol Violation|1|||
48732863|NCT01298531|156873764|FG000|Overall Study|Adverse Event|4|||
48732864|NCT01298531|156873765|FG001|Overall Study|Adverse Event|3|||
48732865|NCT01298531|156873764|FG000|Overall Study|Does not meet entrance criteria|0|||
48732866|NCT01298531|156873765|FG001|Overall Study|Does not meet entrance criteria|1|||
48522519|NCT01899053|156103183|FG007|Overall Study|Progressive Disease|1|||
48522520|NCT01899053|156103184|FG008|Overall Study|Progressive Disease|4|||
48522521|NCT01899053|156103185|FG009|Overall Study|Progressive Disease|3|||
48732867|NCT01298531|156873764|FG000|Overall Study|Other|2|||
48732868|NCT01298531|156873765|FG001|Overall Study|Other|1|||
48732869|NCT00736957|156873766|FG000|Overall Study|Adverse Event|43|||
48732870|NCT00736957|156873766|FG000|Overall Study|Withdrawal by Subject|49|||
48732871|NCT00736957|156873766|FG000|Overall Study|violation of eligibility criteria|2|||
48732872|NCT00736957|156873766|FG000|Overall Study|did not attend hospital appointments|1|||
48522522|NCT01899053|156103186|FG010|Overall Study|Progressive Disease|12|||
48522523|NCT01899053|156103187|FG011|Overall Study|Progressive Disease|5|||
48522524|NCT01899053|156103188|FG012|Overall Study|Progressive Disease|8|||
48522525|NCT01899053|156103189|FG013|Overall Study|Progressive Disease|17|||
48601765|NCT00327340|156399417|FG000|Overall Study|Physician Decision|1|||
48522526|NCT01899053|156103176|FG000|Overall Study|Adverse Event|1|||
48522527|NCT01899053|156103177|FG001|Overall Study|Adverse Event|1|||
48522528|NCT01899053|156103178|FG002|Overall Study|Adverse Event|1|||
48522529|NCT01899053|156103179|FG003|Overall Study|Adverse Event|3|||
48522530|NCT01899053|156103180|FG004|Overall Study|Adverse Event|1|||
48522531|NCT01899053|156103181|FG005|Overall Study|Adverse Event|1|||
48522532|NCT01899053|156103182|FG006|Overall Study|Adverse Event|1|||
48522533|NCT01899053|156103183|FG007|Overall Study|Adverse Event|0|||
48522534|NCT01899053|156103184|FG008|Overall Study|Adverse Event|2|||
48522535|NCT01899053|156103185|FG009|Overall Study|Adverse Event|0|||
48522536|NCT01899053|156103186|FG010|Overall Study|Adverse Event|3|||
48522537|NCT01899053|156103187|FG011|Overall Study|Adverse Event|1|||
48522538|NCT01899053|156103188|FG012|Overall Study|Adverse Event|2|||
48522539|NCT01899053|156103189|FG013|Overall Study|Adverse Event|2|||
48522540|NCT01899053|156103176|FG000|Overall Study|Reason Not Specified|0|||
48522541|NCT01899053|156103177|FG001|Overall Study|Reason Not Specified|0|||
48522542|NCT01899053|156103178|FG002|Overall Study|Reason Not Specified|0|||
48522543|NCT01899053|156103179|FG003|Overall Study|Reason Not Specified|0|||
48522544|NCT01899053|156103180|FG004|Overall Study|Reason Not Specified|0|||
48522545|NCT01899053|156103181|FG005|Overall Study|Reason Not Specified|0|||
48522546|NCT01899053|156103182|FG006|Overall Study|Reason Not Specified|1|||
48522547|NCT01899053|156103183|FG007|Overall Study|Reason Not Specified|0|||
48522548|NCT01899053|156103184|FG008|Overall Study|Reason Not Specified|0|||
48522549|NCT01899053|156103185|FG009|Overall Study|Reason Not Specified|0|||
48732873|NCT00736957|156873766|FG000|Overall Study|not eligible for Treatment Period I|22|||
48732874|NCT00736957|156873766|FG000|Overall Study|Physician Decision|5|||
48732875|NCT00422097|156873767|FG000|Dose Level 2|Still on treatment|0|||
48732876|NCT00422097|156873768|FG001|Dose Level 2|Still on treatment|1|||
48732877|NCT00422097|156873769|FG002|Dose Level 2|Still on treatment|0|||
48732878|NCT00422097|156873770|FG003|Dose Level 2|Still on treatment|0|||
48732879|NCT00422097|156873771|FG004|Dose Level 2|Still on treatment|0|||
48732880|NCT00422097|156873772|FG005|Dose Level 2|Still on treatment|0|||
48732881|NCT00422097|156873773|FG006|Dose Level 2|Still on treatment|0|||
48732882|NCT00422097|156873774|FG007|Dose Level 2|Still on treatment|0|||
48732883|NCT01051466|156873775|FG000|Overall Study|Adverse Event|1|||
48732884|NCT01051466|156873776|FG001|Overall Study|Adverse Event|0|||
48732885|NCT01051466|156873775|FG000|Overall Study|Lost to Follow-up|1|||
48732886|NCT01051466|156873776|FG001|Overall Study|Lost to Follow-up|1|||
48732887|NCT01051466|156873775|FG000|Overall Study|Withdrawal by Subject|5|||
48825114|NCT02138916|157200746|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
48825115|NCT02138916|157200747|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
48825116|NCT02138916|157200745|FG000|Overall Study|Death|14|||
48825117|NCT02138916|157200746|FG001|Overall Study|Death|11|||
48825118|NCT02138916|157200747|FG002|Overall Study|Death|12|||
48825119|NCT02138916|157200745|FG000|Overall Study|Withdrawal by Subject|27|||
48825120|NCT02138916|157200746|FG001|Overall Study|Withdrawal by Subject|31|||
48825121|NCT02138916|157200747|FG002|Overall Study|Withdrawal by Subject|32|||
48825122|NCT02138916|157200745|FG000|Overall Study|Study specific withdrawal criteria|0|||
48825123|NCT02138916|157200746|FG001|Overall Study|Study specific withdrawal criteria|0|||
48522550|NCT01899053|156103186|FG010|Overall Study|Reason Not Specified|0|||
48732888|NCT01051466|156873776|FG001|Overall Study|Withdrawal by Subject|1|||
48732889|NCT01051466|156873775|FG000|Overall Study|Entry Criteria Not Met|0|||
48732890|NCT01051466|156873776|FG001|Overall Study|Entry Criteria Not Met|3|||
48732891|NCT01051466|156873775|FG000|Overall Study|Physician Decision|1|||
48732892|NCT01051466|156873776|FG001|Overall Study|Physician Decision|0|||
48732893|NCT00331864|156873782|FG000|Overall Study|Adverse Event|30|||
48732894|NCT00331864|156873783|FG001|Overall Study|Adverse Event|1|||
48732895|NCT00331864|156873782|FG000|Overall Study|Lack of Efficacy|4|||
48732896|NCT00331864|156873783|FG001|Overall Study|Lack of Efficacy|0|||
48732897|NCT00331864|156873782|FG000|Overall Study|Protocol Violation|3|||
48732898|NCT00331864|156873783|FG001|Overall Study|Protocol Violation|0|||
48732899|NCT00331864|156873782|FG000|Overall Study|Withdrawal by Subject|10|||
48825124|NCT02138916|157200747|FG002|Overall Study|Study specific withdrawal criteria|1|||
48732900|NCT00331864|156873783|FG001|Overall Study|Withdrawal by Subject|0|||
48825125|NCT02138916|157200745|FG000|Overall Study|incorrect enrolment|1|||
48522551|NCT01899053|156103187|FG011|Overall Study|Reason Not Specified|0|||
48522552|NCT01899053|156103188|FG012|Overall Study|Reason Not Specified|1|||
48522553|NCT01899053|156103189|FG013|Overall Study|Reason Not Specified|0|||
48522554|NCT01899053|156103176|FG000|Overall Study|Withdrawal by Subject|1|||
48522555|NCT01899053|156103177|FG001|Overall Study|Withdrawal by Subject|1|||
48522556|NCT01899053|156103178|FG002|Overall Study|Withdrawal by Subject|2|||
48732901|NCT00331864|156873782|FG000|Overall Study|Lost to Follow-up|4|||
48732902|NCT00331864|156873783|FG001|Overall Study|Lost to Follow-up|3|||
48732903|NCT00331864|156873782|FG000|Overall Study|Administrative Problems|1|||
48732904|NCT00331864|156873783|FG001|Overall Study|Administrative Problems|0|||
48732905|NCT00331864|156873782|FG000|Overall Study|Death|6|||
48732906|NCT00331864|156873783|FG001|Overall Study|Death|0|||
48732907|NCT04521777|156873795|FG000|Overall Study|Death|2|||
48825126|NCT02138916|157200746|FG001|Overall Study|incorrect enrolment|1|||
48732908|NCT04521777|156873795|FG000|Overall Study|Withdrawal by Subject|2|||
48732909|NCT02213042|156873796|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
48825127|NCT02138916|157200747|FG002|Overall Study|incorrect enrolment|0|||
48825128|NCT02138916|157200745|FG000|Overall Study|Severe non-compliance|1|||
48825129|NCT02138916|157200746|FG001|Overall Study|Severe non-compliance|2|||
48825130|NCT02138916|157200747|FG002|Overall Study|Severe non-compliance|1|||
48732910|NCT02213042|156873797|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
48732911|NCT02213042|156873798|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
48732912|NCT02213042|156873796|FG000|Overall Study|Adverse Event|2|||
48732913|NCT02213042|156873797|FG001|Overall Study|Adverse Event|1|||
48732914|NCT02213042|156873798|FG002|Overall Study|Adverse Event|0|||
48732915|NCT02213042|156873796|FG000|Overall Study|Withdrawal by Subject|0|||
48732916|NCT02213042|156873797|FG001|Overall Study|Withdrawal by Subject|1|||
48732917|NCT02213042|156873798|FG002|Overall Study|Withdrawal by Subject|1|||
48732918|NCT02213042|156873796|FG000|Overall Study|Protocol Violation|1|||
48732919|NCT02213042|156873797|FG001|Overall Study|Protocol Violation|0|||
48732920|NCT02213042|156873798|FG002|Overall Study|Protocol Violation|0|||
48732921|NCT02213042|156873796|FG000|Overall Study|Investigator discretion|0|||
48732922|NCT02213042|156873797|FG001|Overall Study|Investigator discretion|0|||
48732923|NCT02213042|156873798|FG002|Overall Study|Investigator discretion|1|||
48732924|NCT04416633|156873799|FG000|Overall Study|Death|1|||
48825131|NCT02138916|157200745|FG000|Overall Study|Lost to Follow-up|4|||
48825132|NCT02138916|157200746|FG001|Overall Study|Lost to Follow-up|2|||
48825133|NCT02138916|157200747|FG002|Overall Study|Lost to Follow-up|3|||
48825134|NCT02138916|157200745|FG000|Overall Study|Adverse Event|4|||
48825135|NCT02138916|157200746|FG001|Overall Study|Adverse Event|4|||
48825136|NCT02138916|157200747|FG002|Overall Study|Adverse Event|3|||
48825137|NCT00783692|157200750|FG000|Induction Phase|Adverse Event|7|||
48825138|NCT00783692|157200751|FG001|Induction Phase|Adverse Event|9|||
48825139|NCT00783692|157200752|FG002|Induction Phase|Adverse Event|24|||
48825140|NCT00783692|157200753|FG003|Induction Phase|Adverse Event|0|||
48825141|NCT00783692|157200754|FG004|Induction Phase|Adverse Event|0|||
48825142|NCT00783692|157200755|FG005|Induction Phase|Adverse Event|0|||
48825143|NCT00783692|157200756|FG006|Induction Phase|Adverse Event|0|||
48825144|NCT00783692|157200750|FG000|Induction Phase|Protocol Violation|0|||
48825145|NCT00783692|157200751|FG001|Induction Phase|Protocol Violation|0|||
48825146|NCT00783692|157200752|FG002|Induction Phase|Protocol Violation|1|||
48825147|NCT00783692|157200753|FG003|Induction Phase|Protocol Violation|0|||
48825148|NCT00783692|157200754|FG004|Induction Phase|Protocol Violation|0|||
48825149|NCT00783692|157200755|FG005|Induction Phase|Protocol Violation|0|||
48825150|NCT00783692|157200756|FG006|Induction Phase|Protocol Violation|0|||
48825151|NCT00783692|157200750|FG000|Induction Phase|Lack of Efficacy|1|||
48825152|NCT00783692|157200751|FG001|Induction Phase|Lack of Efficacy|3|||
48825153|NCT00783692|157200752|FG002|Induction Phase|Lack of Efficacy|28|||
48825154|NCT00783692|157200753|FG003|Induction Phase|Lack of Efficacy|0|||
48825155|NCT00783692|157200754|FG004|Induction Phase|Lack of Efficacy|0|||
48825156|NCT00783692|157200755|FG005|Induction Phase|Lack of Efficacy|0|||
48825157|NCT00783692|157200756|FG006|Induction Phase|Lack of Efficacy|0|||
48825158|NCT00783692|157200750|FG000|Induction Phase|Withdrawal by Subject|3|||
48825159|NCT00783692|157200751|FG001|Induction Phase|Withdrawal by Subject|9|||
48825160|NCT00783692|157200752|FG002|Induction Phase|Withdrawal by Subject|16|||
48825161|NCT00783692|157200753|FG003|Induction Phase|Withdrawal by Subject|0|||
48825162|NCT00783692|157200754|FG004|Induction Phase|Withdrawal by Subject|0|||
48825163|NCT00783692|157200755|FG005|Induction Phase|Withdrawal by Subject|0|||
48825164|NCT00783692|157200756|FG006|Induction Phase|Withdrawal by Subject|0|||
48825165|NCT00783692|157200750|FG000|Induction Phase|Lost to Follow-up|0|||
48732925|NCT04416633|156873799|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
48732926|NCT04416633|156873799|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
48732927|NCT04416633|156873799|FG000|Overall Study|Adverse Event|6|||
48825166|NCT00783692|157200751|FG001|Induction Phase|Lost to Follow-up|0|||
48825167|NCT00783692|157200752|FG002|Induction Phase|Lost to Follow-up|3|||
48732928|NCT04416633|156873799|FG000|Overall Study|Withdrawal by Subject|6|||
48732929|NCT05314478|156873800|FG000|Overall Study|Physician Decision|1|||
48825168|NCT00783692|157200753|FG003|Induction Phase|Lost to Follow-up|0|||
48825169|NCT00783692|157200754|FG004|Induction Phase|Lost to Follow-up|0|||
48825170|NCT00783692|157200755|FG005|Induction Phase|Lost to Follow-up|0|||
48825171|NCT00783692|157200756|FG006|Induction Phase|Lost to Follow-up|0|||
48825172|NCT00783692|157200750|FG000|Induction Phase|Other|0|||
48732930|NCT01025154|156873804|FG000|Overall Study|Lost to Follow-up|1|||
48825173|NCT00783692|157200751|FG001|Induction Phase|Other|0|||
48825174|NCT00783692|157200752|FG002|Induction Phase|Other|2|||
48732931|NCT01025154|156873804|FG000|Overall Study|Withdrawal by Subject|1|||
48732932|NCT03875768|156873806|FG000|Overall Study|Lost to Follow-up|16|||
48825175|NCT00783692|157200753|FG003|Induction Phase|Other|0|||
48732933|NCT03875768|156873807|FG001|Overall Study|Lost to Follow-up|13|||
48825176|NCT00783692|157200754|FG004|Induction Phase|Other|0|||
48732934|NCT03875768|156873806|FG000|Overall Study|Withdrawal by Subject|10|||
48732935|NCT03875768|156873807|FG001|Overall Study|Withdrawal by Subject|21|||
48732936|NCT03875768|156873806|FG000|Overall Study|Did not complete assessment|21|||
48732937|NCT03875768|156873807|FG001|Overall Study|Did not complete assessment|12|||
48732938|NCT03875768|156873806|FG000|Overall Study|Became ineligible|1|||
48732939|NCT03875768|156873807|FG001|Overall Study|Became ineligible|0|||
48732940|NCT03343067|156873808|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
48522557|NCT01899053|156103179|FG003|Overall Study|Withdrawal by Subject|0|||
48522558|NCT01899053|156103180|FG004|Overall Study|Withdrawal by Subject|2|||
48522559|NCT01899053|156103181|FG005|Overall Study|Withdrawal by Subject|0|||
48522560|NCT01899053|156103182|FG006|Overall Study|Withdrawal by Subject|0|||
48732941|NCT03343067|156873809|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
48732942|NCT03343067|156873810|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
48522561|NCT01899053|156103183|FG007|Overall Study|Withdrawal by Subject|1|||
48732943|NCT00580970|156873813|FG000|Pre-treatment|Non-compliance|1|||
48522562|NCT01899053|156103184|FG008|Overall Study|Withdrawal by Subject|0|||
48522563|NCT01899053|156103185|FG009|Overall Study|Withdrawal by Subject|0|||
48601766|NCT00327340|156399418|FG001|Overall Study|Physician Decision|1|||
48732944|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Non-compliance|6|||
48732945|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
48732946|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Physician Decision|4|||
48732947|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
48732948|NCT00580970|156873813|FG000|Treatment (Lovastatin)|Death|1|||
48732949|NCT01104155|156873821|FG000|Overall Study|Adverse Event|15|||
48732950|NCT01104155|156873822|FG001|Overall Study|Adverse Event|8|||
48732951|NCT01104155|156873821|FG000|Overall Study|Participant choice|6|||
48732952|NCT01104155|156873822|FG001|Overall Study|Participant choice|5|||
48732953|NCT01104155|156873821|FG000|Overall Study|Withdrawal of consent|1|||
48732954|NCT01104155|156873822|FG001|Overall Study|Withdrawal of consent|1|||
48732955|NCT01104155|156873821|FG000|Overall Study|Other|3|||
48732956|NCT01104155|156873822|FG001|Overall Study|Other|4|||
48522564|NCT01899053|156103186|FG010|Overall Study|Withdrawal by Subject|0|||
48522565|NCT01899053|156103187|FG011|Overall Study|Withdrawal by Subject|0|||
48522566|NCT01899053|156103188|FG012|Overall Study|Withdrawal by Subject|1|||
48522567|NCT01899053|156103189|FG013|Overall Study|Withdrawal by Subject|1|||
48522568|NCT01899053|156103176|FG000|Overall Study|Protocol Violation|0|||
48522569|NCT01899053|156103177|FG001|Overall Study|Protocol Violation|0|||
48522570|NCT01899053|156103178|FG002|Overall Study|Protocol Violation|1|||
48522571|NCT01899053|156103179|FG003|Overall Study|Protocol Violation|0|||
48522572|NCT01899053|156103180|FG004|Overall Study|Protocol Violation|0|||
48522573|NCT01899053|156103181|FG005|Overall Study|Protocol Violation|0|||
48522574|NCT01899053|156103182|FG006|Overall Study|Protocol Violation|0|||
48522575|NCT01899053|156103183|FG007|Overall Study|Protocol Violation|0|||
48522576|NCT01899053|156103184|FG008|Overall Study|Protocol Violation|0|||
48522577|NCT01899053|156103185|FG009|Overall Study|Protocol Violation|0|||
48522578|NCT01899053|156103186|FG010|Overall Study|Protocol Violation|0|||
48522579|NCT01899053|156103187|FG011|Overall Study|Protocol Violation|0|||
48522580|NCT01899053|156103188|FG012|Overall Study|Protocol Violation|0|||
48522581|NCT01899053|156103189|FG013|Overall Study|Protocol Violation|0|||
48522582|NCT01899053|156103176|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
48522583|NCT01899053|156103177|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
48522584|NCT01899053|156103178|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522585|NCT01899053|156103179|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522586|NCT01899053|156103180|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522587|NCT01899053|156103181|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522588|NCT01899053|156103182|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522589|NCT01899053|156103183|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522590|NCT01899053|156103184|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522591|NCT01899053|156103185|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522592|NCT01899053|156103186|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
48825177|NCT00783692|157200755|FG005|Induction Phase|Other|0|||
48825178|NCT00783692|157200756|FG006|Induction Phase|Other|0|||
48522593|NCT01899053|156103187|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522594|NCT01899053|156103188|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
48601767|NCT00327340|156399417|FG000|Overall Study|Disease Progression|10|||
48601768|NCT00327340|156399418|FG001|Overall Study|Disease Progression|19|||
48601769|NCT00327340|156399417|FG000|Overall Study|Symptomatic Disease|0|||
48601770|NCT00327340|156399418|FG001|Overall Study|Symptomatic Disease|2|||
48825179|NCT00783692|157200750|FG000|Maintenance Phase|Adverse Event|7|||
48825180|NCT00783692|157200751|FG001|Maintenance Phase|Adverse Event|0|||
48522595|NCT01899053|156103189|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
48522596|NCT01899053|156103176|FG000|Overall Study|Symptomatic Deterioration|0|||
48522597|NCT01899053|156103177|FG001|Overall Study|Symptomatic Deterioration|0|||
48522598|NCT01899053|156103178|FG002|Overall Study|Symptomatic Deterioration|0|||
48522599|NCT01899053|156103179|FG003|Overall Study|Symptomatic Deterioration|0|||
48522600|NCT01899053|156103180|FG004|Overall Study|Symptomatic Deterioration|0|||
48522601|NCT01899053|156103181|FG005|Overall Study|Symptomatic Deterioration|1|||
48522602|NCT01899053|156103182|FG006|Overall Study|Symptomatic Deterioration|0|||
48522603|NCT01899053|156103183|FG007|Overall Study|Symptomatic Deterioration|1|||
48522604|NCT01899053|156103184|FG008|Overall Study|Symptomatic Deterioration|0|||
48522605|NCT01899053|156103185|FG009|Overall Study|Symptomatic Deterioration|0|||
48522606|NCT01899053|156103186|FG010|Overall Study|Symptomatic Deterioration|0|||
48522607|NCT01899053|156103187|FG011|Overall Study|Symptomatic Deterioration|1|||
48522608|NCT01899053|156103188|FG012|Overall Study|Symptomatic Deterioration|2|||
48522609|NCT01899053|156103189|FG013|Overall Study|Symptomatic Deterioration|0|||
48522610|NCT00057941|156103190|FG000|Overall Study|Death|1|||
48522611|NCT00057941|156103191|FG001|Overall Study|Death|2|||
48522612|NCT00057941|156103190|FG000|Overall Study|Adverse Event|7|||
48825181|NCT00783692|157200752|FG002|Maintenance Phase|Adverse Event|0|||
48825182|NCT00783692|157200753|FG003|Maintenance Phase|Adverse Event|15|||
48825183|NCT00783692|157200754|FG004|Maintenance Phase|Adverse Event|12|||
48825184|NCT00783692|157200755|FG005|Maintenance Phase|Adverse Event|9|||
48522613|NCT00057941|156103191|FG001|Overall Study|Adverse Event|9|||
48522614|NCT00057941|156103190|FG000|Overall Study|Lack of Efficacy|54|||
48522615|NCT00057941|156103191|FG001|Overall Study|Lack of Efficacy|53|||
48522616|NCT00057941|156103190|FG000|Overall Study|Withdrawal by Subject|6|||
48522617|NCT00057941|156103191|FG001|Overall Study|Withdrawal by Subject|1|||
48522618|NCT00057941|156103190|FG000|Overall Study|still on treatment|3|||
48522619|NCT00057941|156103191|FG001|Overall Study|still on treatment|1|||
48522620|NCT00057941|156103190|FG000|Overall Study|insurance, symptomatic deterioration|1|||
48522621|NCT00057941|156103191|FG001|Overall Study|insurance, symptomatic deterioration|3|||
48522622|NCT00057941|156103190|FG000|Overall Study|Ineligible|2|||
48522623|NCT00057941|156103191|FG001|Overall Study|Ineligible|5|||
48522624|NCT00965731|156103192|FG000|Overall Study|Death|0|||
48522625|NCT00965731|156103193|FG001|Overall Study|Death|4|||
48522626|NCT00965731|156103192|FG000|Overall Study|Withdrawal by Subject|0|||
48601771|NCT00327340|156399417|FG000|Overall Study|Adverse Event|3|||
48601772|NCT00327340|156399418|FG001|Overall Study|Adverse Event|3|||
48522627|NCT00965731|156103193|FG001|Overall Study|Withdrawal by Subject|1|||
48522628|NCT00965731|156103192|FG000|Overall Study|Other|7|||
48522629|NCT00965731|156103193|FG001|Overall Study|Other|15|||
48522630|NCT01098539|156103196|FG000|Overall Study|Adverse Event|26|||
48522631|NCT01098539|156103197|FG001|Overall Study|Adverse Event|26|||
48522632|NCT01098539|156103196|FG000|Overall Study|Protocol Violation|1|||
48522633|NCT01098539|156103197|FG001|Overall Study|Protocol Violation|4|||
48522634|NCT01098539|156103196|FG000|Overall Study|Noncompliance|3|||
48522635|NCT01098539|156103197|FG001|Overall Study|Noncompliance|5|||
48522636|NCT01098539|156103196|FG000|Overall Study|Lost to Follow-up|4|||
48522637|NCT01098539|156103197|FG001|Overall Study|Lost to Follow-up|4|||
48522638|NCT01098539|156103196|FG000|Overall Study|Withdrawal by Subject|12|||
48522639|NCT01098539|156103197|FG001|Overall Study|Withdrawal by Subject|26|||
48522640|NCT01098539|156103196|FG000|Overall Study|Physician Decision|5|||
48522641|NCT01098539|156103197|FG001|Overall Study|Physician Decision|3|||
48522642|NCT01849458|156103201|FG000|Overall Study|Lost to Follow-up|4|||
48522643|NCT04142658|156103202|FG000|Overall Study|Death|2|||
48522644|NCT04142658|156103203|FG001|Overall Study|Death|1|||
48522645|NCT04142658|156103202|FG000|Overall Study|Lost to Follow-up|4|||
48522646|NCT04142658|156103203|FG001|Overall Study|Lost to Follow-up|13|||
48522647|NCT04142658|156103202|FG000|Overall Study|Withdrawal by Subject|9|||
48522648|NCT04142658|156103203|FG001|Overall Study|Withdrawal by Subject|16|||
48522649|NCT02834390|156103204|FG000|Induction Phase|Progressive disease|0|||
48522650|NCT02834390|156103205|FG001|Induction Phase|Progressive disease|1|||
48522651|NCT02834390|156103204|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
48522652|NCT02834390|156103205|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
48522653|NCT02834390|156103204|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
48522654|NCT02834390|156103205|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
48522655|NCT02834390|156103204|FG000|Consolidation Phase|Physician Decision|1|||
48522656|NCT02834390|156103205|FG001|Consolidation Phase|Physician Decision|1|||
48522657|NCT00939523|156103208|FG000|Overall Study|Lack of Efficacy|1|||
48522658|NCT00939523|156103208|FG000|Overall Study|Physician Decision|2|||
48522659|NCT03950674|156103209|FG000|Overall Study|Death|16|||
48522660|NCT03950674|156103210|FG001|Overall Study|Death|15|||
48522661|NCT03950674|156103209|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
48522662|NCT03950674|156103210|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
48522663|NCT02119936|156103215|FG000|Overall Study|Lost to Follow-up|10|||
48522664|NCT00879684|156103217|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
48522665|NCT00879684|156103218|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
48522666|NCT00879684|156103219|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
48522667|NCT00879684|156103220|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
48522668|NCT00879684|156103221|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
48522669|NCT00879684|156103222|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
48522670|NCT00879684|156103223|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
48522671|NCT00879684|156103217|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
48522672|NCT00879684|156103218|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
48522673|NCT00879684|156103219|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
48522674|NCT00879684|156103220|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
48522675|NCT00879684|156103221|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
48522676|NCT00879684|156103222|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
48522677|NCT00879684|156103223|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
48522678|NCT00879684|156103217|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
48522679|NCT00879684|156103218|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
48522680|NCT00879684|156103219|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
48522681|NCT00879684|156103220|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
48522682|NCT00879684|156103221|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
48522683|NCT00879684|156103222|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
48522684|NCT00879684|156103223|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
48522685|NCT00879684|156103217|FG000|Stage 1: Dose Escalation|Death|0|||
48522686|NCT00879684|156103218|FG001|Stage 1: Dose Escalation|Death|0|||
48522687|NCT00879684|156103219|FG002|Stage 1: Dose Escalation|Death|1|||
48522688|NCT00879684|156103220|FG003|Stage 1: Dose Escalation|Death|0|||
48522689|NCT00879684|156103221|FG004|Stage 1: Dose Escalation|Death|0|||
48522690|NCT00879684|156103222|FG005|Stage 1: Dose Escalation|Death|0|||
48522691|NCT00879684|156103223|FG006|Stage 1: Dose Escalation|Death|0|||
48522692|NCT00879684|156103217|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
48522693|NCT00879684|156103218|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
48522694|NCT00879684|156103219|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
48522695|NCT00879684|156103220|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
48522696|NCT00879684|156103221|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
48522697|NCT00879684|156103222|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
48522698|NCT00879684|156103223|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
48522699|NCT00879684|156103217|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
48522700|NCT00879684|156103218|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
48825185|NCT00783692|157200756|FG006|Maintenance Phase|Adverse Event|38|||
48825186|NCT00783692|157200750|FG000|Maintenance Phase|Protocol Violation|0|||
48825187|NCT00783692|157200751|FG001|Maintenance Phase|Protocol Violation|0|||
48825188|NCT00783692|157200752|FG002|Maintenance Phase|Protocol Violation|0|||
48825189|NCT00783692|157200753|FG003|Maintenance Phase|Protocol Violation|1|||
48825190|NCT00783692|157200754|FG004|Maintenance Phase|Protocol Violation|2|||
48825191|NCT00783692|157200755|FG005|Maintenance Phase|Protocol Violation|3|||
48825192|NCT00783692|157200756|FG006|Maintenance Phase|Protocol Violation|4|||
48825193|NCT00783692|157200750|FG000|Maintenance Phase|Lack of Efficacy|79|||
48825194|NCT00783692|157200751|FG001|Maintenance Phase|Lack of Efficacy|0|||
48825195|NCT00783692|157200752|FG002|Maintenance Phase|Lack of Efficacy|0|||
48825196|NCT00783692|157200753|FG003|Maintenance Phase|Lack of Efficacy|64|||
48825197|NCT00783692|157200754|FG004|Maintenance Phase|Lack of Efficacy|58|||
48825198|NCT00783692|157200755|FG005|Maintenance Phase|Lack of Efficacy|48|||
48825199|NCT00783692|157200756|FG006|Maintenance Phase|Lack of Efficacy|177|||
48825200|NCT00783692|157200750|FG000|Maintenance Phase|Withdrawal by Subject|7|||
48825201|NCT00783692|157200751|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48825202|NCT00783692|157200752|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48825203|NCT00783692|157200753|FG003|Maintenance Phase|Withdrawal by Subject|7|||
48825204|NCT00783692|157200754|FG004|Maintenance Phase|Withdrawal by Subject|6|||
48825205|NCT00783692|157200755|FG005|Maintenance Phase|Withdrawal by Subject|9|||
48825206|NCT00783692|157200756|FG006|Maintenance Phase|Withdrawal by Subject|24|||
48825207|NCT00783692|157200750|FG000|Maintenance Phase|Lost to Follow-up|2|||
48825208|NCT00783692|157200751|FG001|Maintenance Phase|Lost to Follow-up|0|||
48825209|NCT00783692|157200752|FG002|Maintenance Phase|Lost to Follow-up|0|||
48825210|NCT00783692|157200753|FG003|Maintenance Phase|Lost to Follow-up|1|||
48825211|NCT00783692|157200754|FG004|Maintenance Phase|Lost to Follow-up|3|||
48825212|NCT00783692|157200755|FG005|Maintenance Phase|Lost to Follow-up|2|||
48825213|NCT00783692|157200756|FG006|Maintenance Phase|Lost to Follow-up|5|||
48825214|NCT00783692|157200750|FG000|Maintenance Phase|Other|0|||
48825215|NCT00783692|157200751|FG001|Maintenance Phase|Other|0|||
48825216|NCT00783692|157200752|FG002|Maintenance Phase|Other|0|||
48825217|NCT00783692|157200753|FG003|Maintenance Phase|Other|1|||
48825218|NCT00783692|157200754|FG004|Maintenance Phase|Other|0|||
48825219|NCT00783692|157200755|FG005|Maintenance Phase|Other|1|||
48825220|NCT00783692|157200756|FG006|Maintenance Phase|Other|1|||
48825221|NCT05550337|157200757|FG000|Overall Study|Lack of Efficacy|0|||
48825222|NCT05550337|157200758|FG001|Overall Study|Lack of Efficacy|0|||
48825223|NCT05550337|157200759|FG002|Overall Study|Lack of Efficacy|1|||
48825224|NCT05550337|157200757|FG000|Overall Study|Adverse Event|1|||
48825225|NCT05550337|157200758|FG001|Overall Study|Adverse Event|5|||
48825226|NCT05550337|157200759|FG002|Overall Study|Adverse Event|0|||
48825227|NCT05550337|157200757|FG000|Overall Study|Withdrawal by Subject|8|||
48825228|NCT05550337|157200758|FG001|Overall Study|Withdrawal by Subject|14|||
48825229|NCT05550337|157200759|FG002|Overall Study|Withdrawal by Subject|10|||
48825230|NCT05550337|157200757|FG000|Overall Study|Pregnancy|0|||
48825231|NCT05550337|157200758|FG001|Overall Study|Pregnancy|0|||
48825232|NCT05550337|157200759|FG002|Overall Study|Pregnancy|1|||
48825233|NCT05550337|157200757|FG000|Overall Study|Protocol Violation|1|||
48825234|NCT05550337|157200758|FG001|Overall Study|Protocol Violation|3|||
48825235|NCT05550337|157200759|FG002|Overall Study|Protocol Violation|4|||
48825236|NCT05550337|157200757|FG000|Overall Study|Physician Decision|2|||
48825237|NCT05550337|157200758|FG001|Overall Study|Physician Decision|1|||
48825238|NCT05550337|157200759|FG002|Overall Study|Physician Decision|1|||
48825239|NCT05550337|157200757|FG000|Overall Study|Lost to Follow-up|16|||
48442760|NCT02585999|155808467|FG000|Overall Study|Protocol Violation|1|||
48442761|NCT01925612|155808468|FG000|Overall Study|Progressive Disease|1|||
48442762|NCT01925612|155808469|FG001|Overall Study|Progressive Disease|1|||
48442763|NCT01925612|155808470|FG002|Overall Study|Progressive Disease|1|||
48442764|NCT01925612|155808471|FG003|Overall Study|Progressive Disease|0|||
48442765|NCT01925612|155808472|FG004|Overall Study|Progressive Disease|0|||
48442766|NCT01925612|155808468|FG000|Overall Study|Adverse Event|3|||
48442767|NCT01925612|155808469|FG001|Overall Study|Adverse Event|3|||
48442768|NCT01925612|155808470|FG002|Overall Study|Adverse Event|0|||
48442769|NCT01925612|155808471|FG003|Overall Study|Adverse Event|1|||
48442770|NCT01925612|155808472|FG004|Overall Study|Adverse Event|2|||
48442771|NCT00433446|155808475|FG000|Overall Study|Adverse Event|4|||
48442772|NCT00433446|155808475|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
48442773|NCT00433446|155808475|FG000|Overall Study|Progression|44|||
48442774|NCT00433446|155808475|FG000|Overall Study|Other - Not Protocol specified|3|||
48442775|NCT00433446|155808475|FG000|Overall Study|Ineligible|9|||
48442776|NCT03017846|155808476|FG000|Overall Study|Lost to Follow-up|3|||
48442777|NCT03017846|155808476|FG000|Overall Study|Adverse Event|2|||
48442778|NCT00089479|155808477|FG000|Overall Study|Death|108|||
48442779|NCT00089479|155808478|FG001|Overall Study|Death|75|||
48442780|NCT00089479|155808477|FG000|Overall Study|Withdrawal by Subject|86|||
48442781|NCT00089479|155808478|FG001|Overall Study|Withdrawal by Subject|107|||
48825240|NCT05550337|157200758|FG001|Overall Study|Lost to Follow-up|11|||
48825241|NCT05550337|157200759|FG002|Overall Study|Lost to Follow-up|11|||
48825242|NCT03861273|157200760|FG000|Screening Phase (3 Weeks)|Other|1|||
48825243|NCT03861273|157200760|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
48825244|NCT03861273|157200760|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
48825245|NCT03861273|157200760|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
48825246|NCT03861273|157200760|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
48825247|NCT04873817|157200762|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
48522701|NCT00879684|156103219|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
48522702|NCT00879684|156103220|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
48522703|NCT00879684|156103221|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
48522704|NCT00879684|156103222|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
48522705|NCT00879684|156103223|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
48522706|NCT00879684|156103217|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
48522707|NCT00879684|156103218|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
48522708|NCT00879684|156103219|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
48522709|NCT00879684|156103220|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
48522710|NCT00879684|156103221|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
48522711|NCT00879684|156103222|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
48522712|NCT00879684|156103223|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
48522713|NCT03245840|156103224|FG000|Overall Study|Adverse Event|6|||
48522714|NCT03245840|156103225|FG001|Overall Study|Adverse Event|0|||
48522715|NCT03245840|156103224|FG000|Overall Study|Death|2|||
48522716|NCT03245840|156103225|FG001|Overall Study|Death|0|||
48522717|NCT03245840|156103224|FG000|Overall Study|Withdrawal by Subject|31|||
48522718|NCT03245840|156103225|FG001|Overall Study|Withdrawal by Subject|1|||
48522719|NCT03245840|156103224|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48522720|NCT03245840|156103225|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48522721|NCT03245840|156103224|FG000|Overall Study|Physician Decision|4|||
48522722|NCT03245840|156103225|FG001|Overall Study|Physician Decision|1|||
48522723|NCT03245840|156103224|FG000|Overall Study|Study Terminated by Sponsor|56|||
48522724|NCT03245840|156103225|FG001|Overall Study|Study Terminated by Sponsor|6|||
48522725|NCT03245840|156103224|FG000|Overall Study|Site Terminated by Sponsor|4|||
48522726|NCT03245840|156103225|FG001|Overall Study|Site Terminated by Sponsor|0|||
48522727|NCT03245840|156103224|FG000|Overall Study|Lost to Follow-up|12|||
48522728|NCT03245840|156103225|FG001|Overall Study|Lost to Follow-up|2|||
48522729|NCT03245840|156103224|FG000|Overall Study|Pregnancy|2|||
48522730|NCT03245840|156103225|FG001|Overall Study|Pregnancy|0|||
48522731|NCT03245840|156103224|FG000|Overall Study|Non-Compliance with Study Drug|2|||
48522732|NCT03245840|156103225|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48522733|NCT03245840|156103224|FG000|Overall Study|Not treated|1|||
48522734|NCT03245840|156103225|FG001|Overall Study|Not treated|1|||
48522735|NCT04573309|156105216|FG000|Overall Study|Protocol Violation|1|||
48522736|NCT04573309|156105217|FG001|Overall Study|Protocol Violation|0|||
48522737|NCT03247686|156105218|FG000|Overall Study|Withdrawal by Subject|1|||
48522738|NCT03247686|156105219|FG001|Overall Study|Withdrawal by Subject|2|||
48522739|NCT01872715|156105224|FG000|Overall Study|Adverse Event|1|||
48522740|NCT01872715|156105224|FG000|Overall Study|Protocol Violation|1|||
48522741|NCT01872715|156105224|FG000|Overall Study|Withdrawal by Subject|2|||
48522742|NCT01929681|156105225|FG000|Overall Study|Withdrawal by Subject|1|||
48522743|NCT01929681|156105226|FG001|Overall Study|Withdrawal by Subject|0|||
48522744|NCT01929681|156105225|FG000|Overall Study|Physician Decision|1|||
48522745|NCT01929681|156105226|FG001|Overall Study|Physician Decision|1|||
48522746|NCT02377349|156105244|FG000|Overall Study|Serious Adverse Event|1|||
48522747|NCT02377349|156105245|FG001|Overall Study|Serious Adverse Event|0|||
48522748|NCT02377349|156105244|FG000|Overall Study|Protocol Violation|3|||
48522749|NCT02377349|156105245|FG001|Overall Study|Protocol Violation|2|||
48522750|NCT02377349|156105244|FG000|Overall Study|Withdrawal by Subject|5|||
48522751|NCT02377349|156105245|FG001|Overall Study|Withdrawal by Subject|3|||
48522752|NCT02377349|156105244|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
48522753|NCT02377349|156105245|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
48522754|NCT02377349|156105244|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
48522755|NCT02377349|156105245|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
48522756|NCT02377349|156105244|FG000|Overall Study|Other|0|||
48522757|NCT02377349|156105245|FG001|Overall Study|Other|1|||
48522758|NCT03407729|156105250|FG000|Overall Study|Lost to Follow-up|2|||
48522759|NCT03407729|156105251|FG001|Overall Study|Lost to Follow-up|0|||
48522760|NCT03407729|156105250|FG000|Overall Study|Unable to schedule|0|||
48522761|NCT03407729|156105251|FG001|Overall Study|Unable to schedule|3|||
48522762|NCT03419962|156105252|FG000|Overall Study|Change to other medication|1|||
48522763|NCT03419962|156105252|FG000|Overall Study|Refusal of continuing with trial drug|1|||
48522764|NCT03419962|156105252|FG000|Overall Study|Lost to Follow-up|3|||
48601773|NCT01325350|156399421|FG000|Overall Study|Adverse Event|3|||
48825248|NCT04873817|157200762|FG000|Overall Study|Lost to Follow-up|4|||
48825249|NCT04873817|157200762|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
48825250|NCT04873817|157200762|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
48825251|NCT04873817|157200762|FG000|Overall Study|Other Reasons|3|||
48825252|NCT00813488|157200763|FG000|Titration Period 1|Adverse Event|6|||
48825253|NCT00813488|157200764|FG001|Titration Period 1|Adverse Event|1|||
48825254|NCT00813488|157200763|FG000|Titration Period 1|Lack of Efficacy|9|||
48825255|NCT00813488|157200764|FG001|Titration Period 1|Lack of Efficacy|7|||
48825256|NCT00813488|157200763|FG000|Titration Period 1|Withdrawal by Subject|2|||
48825257|NCT00813488|157200764|FG001|Titration Period 1|Withdrawal by Subject|2|||
48825258|NCT00813488|157200763|FG000|Titration Period 1|Protocol Violation|4|||
48825259|NCT00813488|157200764|FG001|Titration Period 1|Protocol Violation|3|||
48825260|NCT00813488|157200763|FG000|Titration Period 1|Non-compliance to study medication|4|||
48825261|NCT00813488|157200764|FG001|Titration Period 1|Non-compliance to study medication|1|||
48825262|NCT00813488|157200763|FG000|Titration Period 1|Non-compliance to study procedures|2|||
48522765|NCT03419962|156105252|FG000|Overall Study|Difficulty in inhaling the doses|1|||
48522766|NCT03419962|156105252|FG000|Overall Study|Missing completion data|31|||
48522767|NCT02914457|156105255|FG000|Overall Study|Withdrawal by Subject|1|||
48732957|NCT04738734|156873823|FG000|Overall Study|Withdrawal by Subject|2|||
48732958|NCT04738734|156873824|FG001|Overall Study|Withdrawal by Subject|4|||
48732959|NCT04738734|156873823|FG000|Overall Study|Lost to Follow-up|5|||
48732960|NCT04738734|156873824|FG001|Overall Study|Lost to Follow-up|2|||
48732961|NCT04738734|156873823|FG000|Overall Study|Physician Decision|0|||
48732962|NCT04738734|156873824|FG001|Overall Study|Physician Decision|1|||
48732963|NCT04738734|156873823|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
48732964|NCT04738734|156873824|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
48732965|NCT01977937|156873828|FG000|Overall Study|Withdrawal by Subject|2|||
48732966|NCT01977937|156873829|FG001|Overall Study|Withdrawal by Subject|1|||
48522768|NCT02914457|156105255|FG000|Overall Study|Physician Decision|1|||
48522769|NCT02914457|156105255|FG000|Overall Study|No veins available for lead placement|1|||
48522770|NCT02914457|156105255|FG000|Overall Study|Electrical instability of patient|1|||
48522771|NCT02914457|156105255|FG000|Overall Study|ECG acquisition error due to sweating|1|||
48522772|NCT02914457|156105255|FG000|Overall Study|Protocol Violation|1|||
48732967|NCT01977937|156873828|FG000|Overall Study|Adverse Event|1|||
48732968|NCT01977937|156873829|FG001|Overall Study|Adverse Event|0|||
48732969|NCT01977937|156873828|FG000|Overall Study|Physician Decision|0|||
48732970|NCT01977937|156873829|FG001|Overall Study|Physician Decision|1|||
48732971|NCT00810693|156873830|FG000|Treatment Period|Adverse Event|8|||
48732972|NCT00810693|156873831|FG001|Treatment Period|Adverse Event|1|||
48732973|NCT00810693|156873832|FG002|Treatment Period|Adverse Event|7|||
48732974|NCT00810693|156873830|FG000|Treatment Period|Death|0|||
48732975|NCT00810693|156873831|FG001|Treatment Period|Death|1|||
48732976|NCT00810693|156873832|FG002|Treatment Period|Death|2|||
48732977|NCT00810693|156873830|FG000|Treatment Period|Lack of Efficacy|0|||
48732978|NCT00810693|156873831|FG001|Treatment Period|Lack of Efficacy|0|||
48732979|NCT00810693|156873832|FG002|Treatment Period|Lack of Efficacy|1|||
48732980|NCT00810693|156873830|FG000|Treatment Period|Lost to Follow-up|1|||
48732981|NCT00810693|156873831|FG001|Treatment Period|Lost to Follow-up|0|||
48732982|NCT00810693|156873832|FG002|Treatment Period|Lost to Follow-up|0|||
48732983|NCT00810693|156873830|FG000|Treatment Period|Non-compliance|1|||
48732984|NCT00810693|156873831|FG001|Treatment Period|Non-compliance|0|||
48732985|NCT00810693|156873832|FG002|Treatment Period|Non-compliance|0|||
48732986|NCT00810693|156873830|FG000|Treatment Period|Protocol Violation|1|||
48522773|NCT01386125|156105256|FG000|Overall Study|Lost to Follow-up|3|||
48522774|NCT01386125|156105257|FG001|Overall Study|Lost to Follow-up|9|||
48522775|NCT01386125|156105256|FG000|Overall Study|Physician Decision|0|||
48522776|NCT01386125|156105257|FG001|Overall Study|Physician Decision|1|||
48522777|NCT01386125|156105256|FG000|Overall Study|Protocol Violation|5|||
48522778|NCT01386125|156105257|FG001|Overall Study|Protocol Violation|7|||
48522779|NCT01386125|156105256|FG000|Overall Study|Disease Progress|1|||
48522780|NCT01386125|156105257|FG001|Overall Study|Disease Progress|2|||
48522781|NCT01386125|156105256|FG000|Overall Study|Withdrawal by Subject|13|||
48522782|NCT01386125|156105257|FG001|Overall Study|Withdrawal by Subject|12|||
48522783|NCT01386125|156105256|FG000|Overall Study|Adverse Event|2|||
48522784|NCT01386125|156105257|FG001|Overall Study|Adverse Event|5|||
48601774|NCT01325350|156399422|FG001|Overall Study|Adverse Event|3|||
48601775|NCT01325350|156399423|FG002|Overall Study|Adverse Event|3|||
48732987|NCT00810693|156873831|FG001|Treatment Period|Protocol Violation|2|||
48732988|NCT00810693|156873832|FG002|Treatment Period|Protocol Violation|2|||
48732989|NCT00810693|156873830|FG000|Treatment Period|Withdrawal by Subject|6|||
48732990|NCT00810693|156873831|FG001|Treatment Period|Withdrawal by Subject|2|||
48825263|NCT00813488|157200764|FG001|Titration Period 1|Non-compliance to study procedures|2|||
48825264|NCT00813488|157200763|FG000|Titration Period 1|Technical Difficulties|0|||
48825265|NCT00813488|157200764|FG001|Titration Period 1|Technical Difficulties|1|||
48825266|NCT00813488|157200763|FG000|Titration Period 2|Adverse Event|2|||
48825267|NCT00813488|157200764|FG001|Titration Period 2|Adverse Event|3|||
48732991|NCT00810693|156873832|FG002|Treatment Period|Withdrawal by Subject|3|||
48732992|NCT00810693|156873830|FG000|Treatment Period|Not treated|0|||
48732993|NCT00810693|156873831|FG001|Treatment Period|Not treated|1|||
48522785|NCT01386125|156105256|FG000|Overall Study|Lack of Efficacy|0|||
48522786|NCT01386125|156105257|FG001|Overall Study|Lack of Efficacy|1|||
48522787|NCT01386125|156105256|FG000|Overall Study|Participant Leaving Country|1|||
48522788|NCT01386125|156105257|FG001|Overall Study|Participant Leaving Country|0|||
48522789|NCT03843125|156105258|FG000|Overall Study|Adverse Event|17|||
48522790|NCT03843125|156105259|FG001|Overall Study|Adverse Event|13|||
48522791|NCT03843125|156105260|FG002|Overall Study|Adverse Event|5|||
48522792|NCT03843125|156105261|FG003|Overall Study|Adverse Event|9|||
48522793|NCT03843125|156105258|FG000|Overall Study|Death|0|||
48522794|NCT03843125|156105259|FG001|Overall Study|Death|6|||
48522795|NCT03843125|156105260|FG002|Overall Study|Death|2|||
48522796|NCT03843125|156105261|FG003|Overall Study|Death|0|||
48522797|NCT03843125|156105258|FG000|Overall Study|Lack of Efficacy|14|||
48522798|NCT03843125|156105259|FG001|Overall Study|Lack of Efficacy|11|||
48522799|NCT03843125|156105260|FG002|Overall Study|Lack of Efficacy|9|||
48522800|NCT03843125|156105261|FG003|Overall Study|Lack of Efficacy|4|||
48522801|NCT03843125|156105258|FG000|Overall Study|Lost to Follow-up|3|||
48522802|NCT03843125|156105259|FG001|Overall Study|Lost to Follow-up|4|||
48522803|NCT03843125|156105260|FG002|Overall Study|Lost to Follow-up|0|||
48522804|NCT03843125|156105261|FG003|Overall Study|Lost to Follow-up|2|||
48522805|NCT03843125|156105258|FG000|Overall Study|Other|12|||
48522806|NCT03843125|156105259|FG001|Overall Study|Other|14|||
48522807|NCT03843125|156105260|FG002|Overall Study|Other|3|||
48522808|NCT03843125|156105261|FG003|Overall Study|Other|4|||
48522809|NCT03843125|156105258|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
48522810|NCT03843125|156105259|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
48522811|NCT03843125|156105260|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
48522812|NCT03843125|156105261|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
48522813|NCT03843125|156105258|FG000|Overall Study|Study Terminated by Sponsor|318|||
48522814|NCT03843125|156105259|FG001|Overall Study|Study Terminated by Sponsor|318|||
48522815|NCT03843125|156105260|FG002|Overall Study|Study Terminated by Sponsor|163|||
48522816|NCT03843125|156105261|FG003|Overall Study|Study Terminated by Sponsor|163|||
48522817|NCT03843125|156105258|FG000|Overall Study|Withdrawal by Subject|23|||
48522818|NCT03843125|156105259|FG001|Overall Study|Withdrawal by Subject|12|||
48522819|NCT03843125|156105260|FG002|Overall Study|Withdrawal by Subject|6|||
48522820|NCT03843125|156105261|FG003|Overall Study|Withdrawal by Subject|9|||
48522821|NCT03843125|156105258|FG000|Overall Study|Missing data|0|||
48522822|NCT03843125|156105259|FG001|Overall Study|Missing data|1|||
48522823|NCT03843125|156105260|FG002|Overall Study|Missing data|1|||
48522824|NCT03843125|156105261|FG003|Overall Study|Missing data|0|||
48522825|NCT02943096|156105264|FG000|Overall Study|Lack of Efficacy|0|||
48522826|NCT02943096|156105265|FG001|Overall Study|Lack of Efficacy|1|||
48522827|NCT01781234|156105266|FG000|Overall Study|Adverse Event|2|||
48522828|NCT01781234|156105267|FG001|Overall Study|Adverse Event|0|||
48732994|NCT00810693|156873832|FG002|Treatment Period|Not treated|1|||
48522829|NCT01781234|156105266|FG000|Overall Study|Protocol Violation|3|||
48522830|NCT01781234|156105267|FG001|Overall Study|Protocol Violation|0|||
48522831|NCT01781234|156105266|FG000|Overall Study|Withdrawal by Subject|4|||
48522832|NCT01781234|156105267|FG001|Overall Study|Withdrawal by Subject|3|||
48522833|NCT05065619|156105268|FG000|Up to Day 42|Lost to Follow-up|1|||
48732995|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Adverse Event|3|||
48732996|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Adverse Event|1|||
48732997|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Adverse Event|1|||
48732998|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Death|2|||
48732999|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Death|0|||
48733000|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Death|1|||
48733001|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
48733002|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
48733003|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
48733004|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
48733005|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
48733006|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
48733007|NCT00810693|156873830|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
48733008|NCT00810693|156873831|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
48733009|NCT00810693|156873832|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
48733010|NCT02955797|156873833|FG000|Overall Study|Protocol Violation|1|||
48733011|NCT02955797|156873834|FG001|Overall Study|Protocol Violation|0|||
48733012|NCT02955797|156873835|FG002|Overall Study|Protocol Violation|0|||
48733013|NCT02955797|156873836|FG003|Overall Study|Protocol Violation|1|||
48522834|NCT05065619|156105269|FG001|Up to Day 42|Lost to Follow-up|0|||
48522835|NCT05065619|156105268|FG000|Up to Day 42|Withdrawal by Subject|1|||
48733014|NCT02955797|156873833|FG000|Overall Study|Withdrawal by Subject|2|||
48733015|NCT02955797|156873834|FG001|Overall Study|Withdrawal by Subject|2|||
48522836|NCT05065619|156105269|FG001|Up to Day 42|Withdrawal by Subject|0|||
48522837|NCT05065619|156105268|FG000|After Day 43|Lost to Follow-up|1|||
48522838|NCT05065619|156105269|FG001|After Day 43|Lost to Follow-up|0|||
48522839|NCT05065619|156105268|FG000|After Day 43|Physician Decision|3|||
48522840|NCT05065619|156105269|FG001|After Day 43|Physician Decision|0|||
48601776|NCT01325350|156399424|FG003|Overall Study|Adverse Event|1|||
48522841|NCT05065619|156105268|FG000|After Day 43|Withdrawal by Subject|1|||
48522842|NCT05065619|156105269|FG001|After Day 43|Withdrawal by Subject|2|||
48522843|NCT05065619|156105268|FG000|After Day 43|Public vaccination|6|||
48522844|NCT05065619|156105269|FG001|After Day 43|Public vaccination|8|||
48522845|NCT05065619|156105268|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
48522846|NCT05065619|156105269|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
48522847|NCT05065619|156105268|FG000|After Day 43|Study Terminated by Sponsor|88|||
48522848|NCT05065619|156105269|FG001|After Day 43|Study Terminated by Sponsor|16|||
48522849|NCT02174276|156105276|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
48825268|NCT00813488|157200763|FG000|Titration Period 2|Lack of Efficacy|8|||
48825269|NCT00813488|157200764|FG001|Titration Period 2|Lack of Efficacy|4|||
48522850|NCT02174276|156105277|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
48522851|NCT02174276|156105278|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
48522852|NCT02174276|156105279|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
48522853|NCT02174276|156105276|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
48522854|NCT02174276|156105277|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
48522855|NCT02174276|156105278|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
48522856|NCT02174276|156105279|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
48522857|NCT02174276|156105276|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
48522858|NCT02174276|156105277|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
48522859|NCT02174276|156105278|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
48522860|NCT02174276|156105279|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
48522861|NCT02174276|156105276|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
48522862|NCT02174276|156105277|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
48522863|NCT02174276|156105278|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
48522864|NCT02174276|156105279|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
48522865|NCT02174276|156105276|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
48522866|NCT02174276|156105277|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
48522867|NCT02174276|156105278|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
48522868|NCT02174276|156105279|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
48522869|NCT02174276|156105276|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
48522870|NCT02174276|156105277|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
48522871|NCT02174276|156105278|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
48522872|NCT02174276|156105279|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
48522873|NCT01206439|156105282|FG000|Overall Study|subject did not meet inclusion criteria|1|||
48522874|NCT02661022|156105283|FG000|Overall Study|Withdrawal by Subject|3|||
48522875|NCT02661022|156105284|FG001|Overall Study|Withdrawal by Subject|0|||
48522876|NCT02661022|156105283|FG000|Overall Study|Adverse Event|1|||
48522877|NCT02661022|156105284|FG001|Overall Study|Adverse Event|1|||
48522878|NCT02661022|156105283|FG000|Overall Study|Physician Decision|1|||
48522879|NCT02661022|156105284|FG001|Overall Study|Physician Decision|0|||
48522880|NCT02661022|156105283|FG000|Overall Study|Progressive Disease|2|||
48733016|NCT02955797|156873835|FG002|Overall Study|Withdrawal by Subject|0|||
48733017|NCT02955797|156873836|FG003|Overall Study|Withdrawal by Subject|1|||
48733018|NCT02955797|156873833|FG000|Overall Study|Lost to Follow-up|0|||
48733019|NCT02955797|156873834|FG001|Overall Study|Lost to Follow-up|1|||
48733020|NCT02955797|156873835|FG002|Overall Study|Lost to Follow-up|0|||
48733021|NCT02955797|156873836|FG003|Overall Study|Lost to Follow-up|0|||
48733022|NCT01033851|156873839|FG000|Overall Study|Withdrawal by Subject|3|||
48733023|NCT01033851|156873840|FG001|Overall Study|Withdrawal by Subject|7|||
48733024|NCT02520661|156873843|FG000|Overall Study|Lost to Follow-up|7|||
48733025|NCT02520661|156873844|FG001|Overall Study|Lost to Follow-up|3|||
48733026|NCT02520661|156873843|FG000|Overall Study|Admitted from ED|49|||
48733027|NCT02520661|156873844|FG001|Overall Study|Admitted from ED|48|||
48733028|NCT02520661|156873843|FG000|Overall Study|ED greater than 24 hours|29|||
48733029|NCT02520661|156873844|FG001|Overall Study|ED greater than 24 hours|38|||
48733030|NCT02520661|156873843|FG000|Overall Study|other ineligibility|14|||
48733031|NCT02520661|156873844|FG001|Overall Study|other ineligibility|22|||
48733032|NCT02520661|156873843|FG000|Overall Study|Withdrawal by Subject|7|||
48733033|NCT02520661|156873844|FG001|Overall Study|Withdrawal by Subject|16|||
48733034|NCT02586064|156873847|FG000|Overall Study|Other Obligations|6|||
48733035|NCT02586064|156873848|FG001|Overall Study|Other Obligations|6|||
48733036|NCT02586064|156873847|FG000|Overall Study|Other|3|||
48733037|NCT02586064|156873848|FG001|Overall Study|Other|7|||
48733038|NCT02586064|156873847|FG000|Overall Study|Never Started|3|||
48733039|NCT02586064|156873848|FG001|Overall Study|Never Started|3|||
48733040|NCT02586064|156873847|FG000|Overall Study|Lost Interest|1|||
48733041|NCT02586064|156873848|FG001|Overall Study|Lost Interest|4|||
48733042|NCT02586064|156873847|FG000|Overall Study|Miscellaneous Life Issues|0|||
48733043|NCT02586064|156873848|FG001|Overall Study|Miscellaneous Life Issues|5|||
48733044|NCT02586064|156873847|FG000|Overall Study|Infrequent Attendance|2|||
48733045|NCT02586064|156873848|FG001|Overall Study|Infrequent Attendance|1|||
48733046|NCT02586064|156873847|FG000|Overall Study|Timed Out|2|||
48733047|NCT02586064|156873848|FG001|Overall Study|Timed Out|0|||
48733048|NCT02586064|156873847|FG000|Overall Study|AUD relapse|0|||
48733049|NCT02586064|156873848|FG001|Overall Study|AUD relapse|2|||
48522881|NCT02661022|156105284|FG001|Overall Study|Progressive Disease|1|||
48522882|NCT05889039|156105289|FG000|Overall Study|error in completing survey|0|||
48522883|NCT05889039|156105290|FG001|Overall Study|error in completing survey|2|||
48522884|NCT05889039|156105291|FG002|Overall Study|error in completing survey|0|||
48522885|NCT05889039|156105292|FG003|Overall Study|error in completing survey|0|||
48522886|NCT05889039|156105289|FG000|Overall Study|Lost to Follow-up|4|||
48522887|NCT05889039|156105290|FG001|Overall Study|Lost to Follow-up|0|||
48522888|NCT05889039|156105291|FG002|Overall Study|Lost to Follow-up|0|||
48522889|NCT05889039|156105292|FG003|Overall Study|Lost to Follow-up|0|||
48522890|NCT00830167|156105303|FG000|Overall Study|Lack of Efficacy|26|||
48522891|NCT00830167|156105304|FG001|Overall Study|Lack of Efficacy|10|||
48522892|NCT00830167|156105303|FG000|Overall Study|Adverse Event|8|||
48522893|NCT00830167|156105304|FG001|Overall Study|Adverse Event|24|||
48522894|NCT00830167|156105303|FG000|Overall Study|Not meeting entrance criteria|2|||
48522895|NCT00830167|156105304|FG001|Overall Study|Not meeting entrance criteria|5|||
48522896|NCT00830167|156105303|FG000|Overall Study|Withdrawal by Subject|2|||
48522897|NCT00830167|156105304|FG001|Overall Study|Withdrawal by Subject|0|||
48522898|NCT00830167|156105303|FG000|Overall Study|Lost to Follow-up|0|||
48522899|NCT00830167|156105304|FG001|Overall Study|Lost to Follow-up|1|||
48522900|NCT00830167|156105303|FG000|Overall Study|Protocol Violation|0|||
48522901|NCT00830167|156105304|FG001|Overall Study|Protocol Violation|1|||
48522902|NCT00830167|156105303|FG000|Overall Study|Other|2|||
48522903|NCT00830167|156105304|FG001|Overall Study|Other|2|||
48522904|NCT01055886|156105305|FG000|Overall Study|Withdrawal by Subject|4|||
48522905|NCT01055886|156105306|FG001|Overall Study|Withdrawal by Subject|9|||
48733050|NCT02586064|156873847|FG000|Overall Study|Legal Issue|1|||
48733051|NCT02586064|156873848|FG001|Overall Study|Legal Issue|0|||
48733052|NCT04128371|156873849|FG000|Overall Study|Lack of Efficacy|1|||
48733053|NCT01346969|156873850|FG000|Overall Study|Withdrawal by Subject|0|||
48733054|NCT01346969|156873851|FG001|Overall Study|Withdrawal by Subject|0|||
48733055|NCT01346969|156873852|FG002|Overall Study|Withdrawal by Subject|1|||
48733056|NCT01346969|156873853|FG003|Overall Study|Withdrawal by Subject|0|||
48522906|NCT01055886|156105305|FG000|Overall Study|Lost to Follow-up|1|||
48522907|NCT01055886|156105306|FG001|Overall Study|Lost to Follow-up|1|||
48522908|NCT01055886|156105305|FG000|Overall Study|Withdrawal by PI|0|||
48522909|NCT01055886|156105306|FG001|Overall Study|Withdrawal by PI|1|||
48522910|NCT02359864|156105307|FG000|Overall Study|Withdrawal by Subject|1|||
48522911|NCT02359864|156105308|FG001|Overall Study|Withdrawal by Subject|0|||
48522912|NCT00725764|156105309|FG000|Overall Study|Withdrawal by Subject|2|||
48522913|NCT00725764|156105309|FG000|Overall Study|Physician Decision|1|||
48522914|NCT00725764|156105309|FG000|Overall Study|Progressive Disease|7|||
48522915|NCT00725764|156105309|FG000|Overall Study|Lost to Follow-up|1|||
48522916|NCT00725764|156105309|FG000|Overall Study|Death|1|||
48522917|NCT00725764|156105309|FG000|Overall Study|Participant non compliant with protocol|1|||
48522918|NCT00725764|156105309|FG000|Overall Study|Decline in performance status|1|||
48522919|NCT04254809|156105312|FG000|Overall Study|Lost to Follow-up|5|||
48522920|NCT04254809|156105313|FG001|Overall Study|Lost to Follow-up|10|||
48522921|NCT04480307|156105314|FG000|Overall Study|Withdrawal by Subject|0|||
48522922|NCT04480307|156105315|FG001|Overall Study|Withdrawal by Subject|1|||
48522923|NCT04480307|156105316|FG002|Overall Study|Withdrawal by Subject|0|||
48522924|NCT04480307|156105317|FG003|Overall Study|Withdrawal by Subject|0|||
48522925|NCT04480307|156105314|FG000|Overall Study|Adverse Event|0|||
48522926|NCT04480307|156105315|FG001|Overall Study|Adverse Event|0|||
48522927|NCT04480307|156105316|FG002|Overall Study|Adverse Event|0|||
48522928|NCT04480307|156105317|FG003|Overall Study|Adverse Event|1|||
48733057|NCT01346969|156873850|FG000|Overall Study|Lost to Follow-up|1|||
48733058|NCT01346969|156873851|FG001|Overall Study|Lost to Follow-up|0|||
48733059|NCT01346969|156873852|FG002|Overall Study|Lost to Follow-up|2|||
48733060|NCT01346969|156873853|FG003|Overall Study|Lost to Follow-up|0|||
48733061|NCT01346969|156873850|FG000|Overall Study|Physician Decision|0|||
48733062|NCT01346969|156873851|FG001|Overall Study|Physician Decision|0|||
48733063|NCT01346969|156873852|FG002|Overall Study|Physician Decision|0|||
48733064|NCT01346969|156873853|FG003|Overall Study|Physician Decision|1|||
48733065|NCT01346969|156873850|FG000|Overall Study|Randomized but not treated|1|||
48733066|NCT01346969|156873851|FG001|Overall Study|Randomized but not treated|0|||
48733067|NCT01346969|156873852|FG002|Overall Study|Randomized but not treated|0|||
48733068|NCT01346969|156873853|FG003|Overall Study|Randomized but not treated|0|||
48522929|NCT01928615|156105318|FG000|Overall Study|Study Terminated by Sponsor|2|||
48733069|NCT01187433|156873859|FG000|Overall Study|Protocol Violation|6|||
48733070|NCT01187433|156873860|FG001|Overall Study|Protocol Violation|2|||
48522930|NCT02972515|156105319|FG000|Overall Study|Lost to Follow-up|78|||
48733071|NCT01187433|156873859|FG000|Overall Study|Withdrawal by Subject|5|||
48522931|NCT02224053|156105322|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
48522932|NCT02224053|156105322|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
48522933|NCT02224053|156105322|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
48522934|NCT02224053|156105322|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
48522935|NCT02224053|156105322|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
48522936|NCT01898598|156105326|FG000|Overall Study|Adverse Event|1|||
48522937|NCT01898598|156105327|FG001|Overall Study|Adverse Event|0|||
48522938|NCT01898598|156105326|FG000|Overall Study|Withdrawal by Subject|3|||
48522939|NCT01898598|156105327|FG001|Overall Study|Withdrawal by Subject|0|||
48522940|NCT01898598|156105326|FG000|Overall Study|Lost to Follow-up|0|||
48522941|NCT01898598|156105327|FG001|Overall Study|Lost to Follow-up|1|||
48522942|NCT01898598|156105326|FG000|Overall Study|Other|0|||
48522943|NCT01898598|156105327|FG001|Overall Study|Other|1|||
48522944|NCT04531527|156105328|FG000|Overall Study|Found to be Ineligible|3|||
48522945|NCT03833427|156105329|FG000|Overall Study|Death|4|||
48733072|NCT01187433|156873860|FG001|Overall Study|Withdrawal by Subject|2|||
48733073|NCT03553927|156873861|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
48522946|NCT03833427|156105330|FG001|Overall Study|Death|2|||
48522947|NCT03833427|156105331|FG002|Overall Study|Death|9|||
48522948|NCT03833427|156105332|FG003|Overall Study|Death|11|||
48522949|NCT03833427|156105333|FG004|Overall Study|Death|0|||
48522950|NCT03833427|156105334|FG005|Overall Study|Death|0|||
48522951|NCT03833427|156105335|FG006|Overall Study|Death|0|||
48522952|NCT03833427|156105329|FG000|Overall Study|Withdrawal by Subject|0|||
48522953|NCT03833427|156105330|FG001|Overall Study|Withdrawal by Subject|1|||
48522954|NCT03833427|156105331|FG002|Overall Study|Withdrawal by Subject|1|||
48522955|NCT03833427|156105332|FG003|Overall Study|Withdrawal by Subject|0|||
48522956|NCT03833427|156105333|FG004|Overall Study|Withdrawal by Subject|0|||
48522957|NCT03833427|156105334|FG005|Overall Study|Withdrawal by Subject|0|||
48522958|NCT03833427|156105335|FG006|Overall Study|Withdrawal by Subject|0|||
48522959|NCT03833427|156105329|FG000|Overall Study|Sponsor Decision|0|||
48522960|NCT03833427|156105330|FG001|Overall Study|Sponsor Decision|0|||
48522961|NCT03833427|156105331|FG002|Overall Study|Sponsor Decision|1|||
48522962|NCT03833427|156105332|FG003|Overall Study|Sponsor Decision|3|||
48522963|NCT03833427|156105333|FG004|Overall Study|Sponsor Decision|0|||
48522964|NCT03833427|156105334|FG005|Overall Study|Sponsor Decision|0|||
48522965|NCT03833427|156105335|FG006|Overall Study|Sponsor Decision|0|||
48522966|NCT03310619|156105341|FG000|Pre-Treatment Period|Death|1|||
48522967|NCT03310619|156105342|FG001|Pre-Treatment Period|Death|0|||
48522968|NCT03310619|156105343|FG002|Pre-Treatment Period|Death|0|||
48522969|NCT03310619|156105344|FG003|Pre-Treatment Period|Death|0|||
48522970|NCT03310619|156105345|FG004|Pre-Treatment Period|Death|1|||
48522971|NCT03310619|156105346|FG005|Pre-Treatment Period|Death|0|||
48522972|NCT03310619|156105347|FG006|Pre-Treatment Period|Death|0|||
48522973|NCT03310619|156105348|FG007|Pre-Treatment Period|Death|0|||
48522974|NCT03310619|156105341|FG000|Pre-Treatment Period|Other reasons|2|||
48522975|NCT03310619|156105342|FG001|Pre-Treatment Period|Other reasons|1|||
48522976|NCT03310619|156105343|FG002|Pre-Treatment Period|Other reasons|2|||
48522977|NCT03310619|156105344|FG003|Pre-Treatment Period|Other reasons|0|||
48522978|NCT03310619|156105345|FG004|Pre-Treatment Period|Other reasons|0|||
48522979|NCT03310619|156105346|FG005|Pre-Treatment Period|Other reasons|0|||
48522980|NCT03310619|156105347|FG006|Pre-Treatment Period|Other reasons|2|||
48522981|NCT03310619|156105348|FG007|Pre-Treatment Period|Other reasons|0|||
48522982|NCT03310619|156105341|FG000|Treatment Period|Death|1|||
48601777|NCT01325350|156399425|FG004|Overall Study|Adverse Event|2|||
48601778|NCT01325350|156399421|FG000|Overall Study|Pregnancy|0|||
48601779|NCT01325350|156399422|FG001|Overall Study|Pregnancy|0|||
48601780|NCT01325350|156399423|FG002|Overall Study|Pregnancy|1|||
48601781|NCT01325350|156399424|FG003|Overall Study|Pregnancy|0|||
48601782|NCT01325350|156399425|FG004|Overall Study|Pregnancy|1|||
48601783|NCT01325350|156399421|FG000|Overall Study|Lost to Follow-up|1|||
48601784|NCT01325350|156399422|FG001|Overall Study|Lost to Follow-up|0|||
48601785|NCT01325350|156399423|FG002|Overall Study|Lost to Follow-up|5|||
48601786|NCT01325350|156399424|FG003|Overall Study|Lost to Follow-up|1|||
48601787|NCT01325350|156399425|FG004|Overall Study|Lost to Follow-up|5|||
48733074|NCT03553927|156873862|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
48733075|NCT03553927|156873861|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
48733076|NCT03553927|156873862|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
48733077|NCT01193842|156873863|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
48733078|NCT01193842|156873864|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
48733079|NCT01193842|156873865|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
48733080|NCT01193842|156873866|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
48733081|NCT01193842|156873867|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
48522983|NCT03310619|156105342|FG001|Treatment Period|Death|2|||
48601788|NCT01325350|156399421|FG000|Overall Study|Personal Reasons|2|||
48601789|NCT01325350|156399422|FG001|Overall Study|Personal Reasons|1|||
48601790|NCT01325350|156399423|FG002|Overall Study|Personal Reasons|6|||
48733082|NCT01193842|156873863|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
48825270|NCT00813488|157200763|FG000|Titration Period 2|Protocol Violation|3|||
48825271|NCT00813488|157200764|FG001|Titration Period 2|Protocol Violation|2|||
48825272|NCT00813488|157200763|FG000|Titration Period 2|Lost to Follow-up|1|||
48825273|NCT00813488|157200764|FG001|Titration Period 2|Lost to Follow-up|0|||
48825274|NCT00813488|157200763|FG000|Titration Period 2|Non-compliance with study procedures|2|||
48825275|NCT00813488|157200764|FG001|Titration Period 2|Non-compliance with study procedures|1|||
48825276|NCT00813488|157200763|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
48825277|NCT00813488|157200764|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
48733083|NCT01193842|156873864|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
48733084|NCT01193842|156873865|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
48733085|NCT01193842|156873866|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
48733086|NCT01193842|156873867|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
48733087|NCT01193842|156873863|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
48733088|NCT01193842|156873864|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
48733089|NCT01193842|156873865|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
48825278|NCT00813488|157200763|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
48825279|NCT00813488|157200764|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
48825280|NCT00813488|157200763|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
48825281|NCT00813488|157200764|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
48825282|NCT00813488|157200763|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
48522984|NCT03310619|156105343|FG002|Treatment Period|Death|0|||
48522985|NCT03310619|156105344|FG003|Treatment Period|Death|0|||
48522986|NCT03310619|156105345|FG004|Treatment Period|Death|1|||
48522987|NCT03310619|156105346|FG005|Treatment Period|Death|0|||
48522988|NCT03310619|156105347|FG006|Treatment Period|Death|2|||
48522989|NCT03310619|156105348|FG007|Treatment Period|Death|0|||
48522990|NCT03310619|156105341|FG000|Treatment Period|Adverse Event|0|||
48522991|NCT03310619|156105342|FG001|Treatment Period|Adverse Event|1|||
48522992|NCT03310619|156105343|FG002|Treatment Period|Adverse Event|4|||
48522993|NCT03310619|156105344|FG003|Treatment Period|Adverse Event|1|||
48825283|NCT00813488|157200764|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
48825284|NCT00813488|157200763|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
48825285|NCT00813488|157200764|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
48825286|NCT00813488|157200763|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
48825287|NCT00813488|157200764|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
48825288|NCT00813488|157200763|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
48825289|NCT00813488|157200764|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
48522994|NCT03310619|156105345|FG004|Treatment Period|Adverse Event|0|||
48522995|NCT03310619|156105346|FG005|Treatment Period|Adverse Event|0|||
48522996|NCT03310619|156105347|FG006|Treatment Period|Adverse Event|0|||
48825290|NCT00813488|157200763|FG000|Double-blind Treatment Period 2|Other|1|||
48825291|NCT00813488|157200764|FG001|Double-blind Treatment Period 2|Other|0|||
48825292|NCT00813488|157200763|FG000|Open-label Extension|Adverse Event|1|||
48825293|NCT00813488|157200764|FG001|Open-label Extension|Adverse Event|2|||
48825294|NCT00813488|157200763|FG000|Open-label Extension|Lack of Efficacy|3|||
48825295|NCT00813488|157200764|FG001|Open-label Extension|Lack of Efficacy|0|||
48825296|NCT00813488|157200763|FG000|Open-label Extension|Withdrawal by Subject|0|||
48825297|NCT00813488|157200764|FG001|Open-label Extension|Withdrawal by Subject|2|||
48825298|NCT00813488|157200763|FG000|Open-label Extension|Protocol Violation|1|||
48825299|NCT00813488|157200764|FG001|Open-label Extension|Protocol Violation|2|||
48825300|NCT00813488|157200763|FG000|Open-label Extension|Non-compliance study medication|4|||
48825301|NCT00813488|157200764|FG001|Open-label Extension|Non-compliance study medication|0|||
48825302|NCT00813488|157200763|FG000|Open-label Extension|Non-compliance study procedures|2|||
48522997|NCT03310619|156105348|FG007|Treatment Period|Adverse Event|0|||
48522998|NCT03310619|156105341|FG000|Treatment Period|Withdrawal by participant|0|||
48522999|NCT03310619|156105342|FG001|Treatment Period|Withdrawal by participant|0|||
48523000|NCT03310619|156105343|FG002|Treatment Period|Withdrawal by participant|1|||
48523001|NCT03310619|156105344|FG003|Treatment Period|Withdrawal by participant|0|||
48523002|NCT03310619|156105345|FG004|Treatment Period|Withdrawal by participant|0|||
48733090|NCT01193842|156873866|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
48733091|NCT01193842|156873867|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
48825303|NCT00813488|157200764|FG001|Open-label Extension|Non-compliance study procedures|1|||
48523003|NCT03310619|156105346|FG005|Treatment Period|Withdrawal by participant|0|||
48523004|NCT03310619|156105347|FG006|Treatment Period|Withdrawal by participant|0|||
48523005|NCT03310619|156105348|FG007|Treatment Period|Withdrawal by participant|0|||
48523006|NCT03310619|156105341|FG000|Treatment Period|Lost to Follow-up|0|||
48523007|NCT03310619|156105342|FG001|Treatment Period|Lost to Follow-up|0|||
48601791|NCT01325350|156399424|FG003|Overall Study|Personal Reasons|5|||
48825304|NCT00813488|157200763|FG000|Open-label Extension|Other|1|||
48825305|NCT00813488|157200764|FG001|Open-label Extension|Other|0|||
48825306|NCT03677375|157200766|FG000|Overall Study|Incomplete procedure|8|||
48523008|NCT03310619|156105343|FG002|Treatment Period|Lost to Follow-up|0|||
48523009|NCT03310619|156105344|FG003|Treatment Period|Lost to Follow-up|0|||
48523010|NCT03310619|156105345|FG004|Treatment Period|Lost to Follow-up|0|||
48523011|NCT03310619|156105346|FG005|Treatment Period|Lost to Follow-up|0|||
48523012|NCT03310619|156105347|FG006|Treatment Period|Lost to Follow-up|0|||
48523013|NCT03310619|156105348|FG007|Treatment Period|Lost to Follow-up|1|||
48523014|NCT03310619|156105341|FG000|Treatment Period|Study terminated by sponsor|0|||
48523015|NCT03310619|156105342|FG001|Treatment Period|Study terminated by sponsor|0|||
48523016|NCT03310619|156105343|FG002|Treatment Period|Study terminated by sponsor|0|||
48523017|NCT03310619|156105344|FG003|Treatment Period|Study terminated by sponsor|0|||
48523018|NCT03310619|156105345|FG004|Treatment Period|Study terminated by sponsor|0|||
48523019|NCT03310619|156105346|FG005|Treatment Period|Study terminated by sponsor|0|||
48523020|NCT03310619|156105347|FG006|Treatment Period|Study terminated by sponsor|0|||
48523021|NCT03310619|156105348|FG007|Treatment Period|Study terminated by sponsor|1|||
48523022|NCT03310619|156105341|FG000|Treatment Period|Physician Decision|0|||
48523023|NCT03310619|156105342|FG001|Treatment Period|Physician Decision|0|||
48523024|NCT03310619|156105343|FG002|Treatment Period|Physician Decision|0|||
48523025|NCT03310619|156105344|FG003|Treatment Period|Physician Decision|0|||
48523026|NCT03310619|156105345|FG004|Treatment Period|Physician Decision|3|||
48523027|NCT03310619|156105346|FG005|Treatment Period|Physician Decision|0|||
48523028|NCT03310619|156105347|FG006|Treatment Period|Physician Decision|0|||
48523029|NCT03310619|156105348|FG007|Treatment Period|Physician Decision|0|||
48523030|NCT03310619|156105341|FG000|Treatment Period|Other reasons|1|||
48523031|NCT03310619|156105342|FG001|Treatment Period|Other reasons|0|||
48523032|NCT03310619|156105343|FG002|Treatment Period|Other reasons|2|||
48523033|NCT03310619|156105344|FG003|Treatment Period|Other reasons|0|||
48523034|NCT03310619|156105345|FG004|Treatment Period|Other reasons|0|||
48523035|NCT03310619|156105346|FG005|Treatment Period|Other reasons|0|||
48523036|NCT03310619|156105347|FG006|Treatment Period|Other reasons|0|||
48523037|NCT03310619|156105348|FG007|Treatment Period|Other reasons|0|||
48523038|NCT00360490|156105349|FG000|Overall Study|Adverse Event|4|||
48523039|NCT00360490|156105350|FG001|Overall Study|Adverse Event|2|||
48523040|NCT00360490|156105349|FG000|Overall Study|Lost to Follow-up|2|||
48523041|NCT00360490|156105350|FG001|Overall Study|Lost to Follow-up|1|||
48523042|NCT00360490|156105349|FG000|Overall Study|Physician Decision|2|||
48733092|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Death|0|||
48523043|NCT00360490|156105350|FG001|Overall Study|Physician Decision|1|||
48523044|NCT00360490|156105349|FG000|Overall Study|Protocol Violation|0|||
48523045|NCT00360490|156105350|FG001|Overall Study|Protocol Violation|4|||
48523046|NCT00360490|156105349|FG000|Overall Study|Withdrawal by Subject|1|||
48523047|NCT00360490|156105350|FG001|Overall Study|Withdrawal by Subject|3|||
48523048|NCT02941523|156105351|FG000|Monotherapy|Withdrawal by Subject|0|||
48523049|NCT02941523|156105352|FG001|Monotherapy|Withdrawal by Subject|1|||
48523050|NCT02941523|156105351|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
48523051|NCT02941523|156105352|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
48523052|NCT02941523|156105351|FG000|Carboplatin Combination Therapy|Death|1|||
48523053|NCT02941523|156105352|FG001|Carboplatin Combination Therapy|Death|2|||
48523054|NCT02941523|156105351|FG000|Carboplatin Combination Therapy|Disease progression|2|||
48523055|NCT02941523|156105352|FG001|Carboplatin Combination Therapy|Disease progression|0|||
48523056|NCT02941523|156105351|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
48523057|NCT02941523|156105352|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
48523058|NCT04449341|156105353|FG000|Overall Study|Protocol Violation|1|||
48733093|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Death|0|||
48733094|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Death|0|||
48733095|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Death|1|||
48733096|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Death|1|||
48733097|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Adverse Event|0|||
48733098|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Adverse Event|0|||
48733099|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Adverse Event|0|||
48733100|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Adverse Event|5|||
48733101|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Adverse Event|3|||
48733102|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
48733103|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
48733104|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
48733105|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
48733106|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
48733107|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Ineligible|0|||
48733108|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Ineligible|0|||
48733109|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Ineligible|0|||
48523059|NCT04449341|156105354|FG001|Overall Study|Protocol Violation|0|||
48523060|NCT01183884|156105355|FG000|Overall Study|Progressive Disease|26|||
48733110|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Ineligible|0|||
48733111|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Ineligible|1|||
48733112|NCT01193842|156873863|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
48825307|NCT03677375|157200766|FG000|Overall Study|Adverse Event|3|||
48825308|NCT03677375|157200766|FG000|Overall Study|Physician Decision|1|||
48825309|NCT01734811|157200767|FG000|Overall Study|Lost to Follow-up|2|||
48825310|NCT01734811|157200768|FG001|Overall Study|Lost to Follow-up|3|||
48825311|NCT01734811|157200767|FG000|Overall Study|Withdrawal by Subject|2|||
48825312|NCT01734811|157200768|FG001|Overall Study|Withdrawal by Subject|0|||
48825313|NCT00708097|157200773|FG000|Period 1|Protocol Violation|0|||
48825314|NCT00708097|157200774|FG001|Period 1|Protocol Violation|1|||
48825315|NCT00708097|157200775|FG002|Period 1|Protocol Violation|0|||
48825316|NCT00708097|157200776|FG003|Period 1|Protocol Violation|2|||
48825317|NCT00708097|157200777|FG004|Period 1|Protocol Violation|0|||
48825318|NCT00708097|157200773|FG000|Period 1|Other Reason|0|||
48825319|NCT00708097|157200774|FG001|Period 1|Other Reason|0|||
48825320|NCT00708097|157200775|FG002|Period 1|Other Reason|0|||
48523061|NCT01183884|156105355|FG000|Overall Study|Adverse Event|3|||
48523062|NCT01183884|156105355|FG000|Overall Study|Withdrawal by Subject|1|||
48523063|NCT01183884|156105355|FG000|Overall Study|Other Complicating Disease|3|||
48523064|NCT01183884|156105355|FG000|Overall Study|Not Treated|1|||
48523065|NCT01183884|156105355|FG000|Overall Study|Other|4|||
48523066|NCT00127166|156105356|FG000|Period I|Protocol Violation|0|||
48523067|NCT00127166|156105357|FG001|Period I|Protocol Violation|2|||
48523068|NCT00127166|156105356|FG000|Period I|Withdrawal by Subject|2|||
48523069|NCT00127166|156105357|FG001|Period I|Withdrawal by Subject|0|||
48523070|NCT00127166|156105356|FG000|Period I|Patient did not meet inclusion criteria|1|||
48523071|NCT00127166|156105357|FG001|Period I|Patient did not meet inclusion criteria|0|||
48523072|NCT00127166|156105356|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
48523073|NCT00127166|156105357|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
48523074|NCT00127166|156105356|FG000|Period II|Withdrawal by Subject|2|||
48523075|NCT00127166|156105357|FG001|Period II|Withdrawal by Subject|0|||
48523076|NCT00127166|156105356|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
48523077|NCT00127166|156105357|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
48523078|NCT00105157|156105358|FG000|Double-Blind (DB)|Never Treated|1|||
48523079|NCT00105157|156105359|FG001|Double-Blind (DB)|Never Treated|0|||
48523080|NCT00105157|156105360|FG002|Double-Blind (DB)|Never Treated|0|||
48523081|NCT00105157|156105361|FG003|Double-Blind (DB)|Never Treated|0|||
48523082|NCT00105157|156105358|FG000|Double-Blind (DB)|Adverse Event|2|||
48523083|NCT00105157|156105359|FG001|Double-Blind (DB)|Adverse Event|0|||
48523084|NCT00105157|156105360|FG002|Double-Blind (DB)|Adverse Event|1|||
48523085|NCT00105157|156105361|FG003|Double-Blind (DB)|Adverse Event|1|||
48523086|NCT00105157|156105358|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
48523087|NCT00105157|156105359|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
48523088|NCT00105157|156105360|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
48523089|NCT00105157|156105361|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
48825321|NCT00708097|157200776|FG003|Period 1|Other Reason|0|||
48825322|NCT00708097|157200777|FG004|Period 1|Other Reason|1|||
48825323|NCT00708097|157200773|FG000|Period 2|Protocol Violation|0|||
48825324|NCT00708097|157200774|FG001|Period 2|Protocol Violation|1|||
48825325|NCT00708097|157200775|FG002|Period 2|Protocol Violation|1|||
48825326|NCT00708097|157200776|FG003|Period 2|Protocol Violation|1|||
48825327|NCT00708097|157200777|FG004|Period 2|Protocol Violation|0|||
48825328|NCT00561574|157200778|FG000|Overall Study|Adverse Event|21|||
48825329|NCT00561574|157200779|FG001|Overall Study|Adverse Event|24|||
48523090|NCT00105157|156105358|FG000|Open-Label Continuation of DB|Adverse Event|3|||
48825330|NCT00561574|157200778|FG000|Overall Study|Lack of Efficacy|11|||
48825331|NCT00561574|157200779|FG001|Overall Study|Lack of Efficacy|21|||
48825332|NCT00561574|157200778|FG000|Overall Study|Withdrawal by Subject|4|||
48825333|NCT00561574|157200779|FG001|Overall Study|Withdrawal by Subject|4|||
48825334|NCT00561574|157200778|FG000|Overall Study|Reason Unrelated to Trial|6|||
48523091|NCT00105157|156105359|FG001|Open-Label Continuation of DB|Adverse Event|1|||
48601792|NCT01325350|156399425|FG004|Overall Study|Personal Reasons|3|||
48523092|NCT00105157|156105360|FG002|Open-Label Continuation of DB|Adverse Event|0|||
48601793|NCT01325350|156399421|FG000|Overall Study|Protocol Violation|0|||
48825335|NCT00561574|157200779|FG001|Overall Study|Reason Unrelated to Trial|2|||
48825336|NCT00561574|157200778|FG000|Overall Study|Lost to Follow-up|1|||
48825337|NCT00561574|157200779|FG001|Overall Study|Lost to Follow-up|0|||
48523093|NCT00105157|156105361|FG003|Open-Label Continuation of DB|Adverse Event|0|||
48523094|NCT00105157|156105358|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
48442782|NCT00089479|155808477|FG000|Overall Study|Lost to Follow-up|137|||
48523095|NCT00105157|156105359|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
48523096|NCT00105157|156105360|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
48523097|NCT00105157|156105361|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
48523098|NCT00105157|156105358|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
48523099|NCT00105157|156105359|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
48523100|NCT00105157|156105360|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
48523101|NCT00105157|156105361|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
48523102|NCT00105157|156105358|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
48523103|NCT00105157|156105359|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
48523104|NCT00105157|156105360|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
48523105|NCT00105157|156105361|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
48523106|NCT00105157|156105358|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
48523107|NCT00105157|156105359|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
48523108|NCT00105157|156105360|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
48733113|NCT01193842|156873864|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
48733114|NCT01193842|156873865|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
48733115|NCT01193842|156873866|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
48733116|NCT01193842|156873867|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
48733117|NCT03672643|156873868|FG000|Overall Study|Adverse Event|3|||
48733118|NCT03672643|156873868|FG000|Overall Study|Death|2|||
48733119|NCT03672643|156873868|FG000|Overall Study|Withdrawal by Subject|1|||
48733120|NCT03672643|156873868|FG000|Overall Study|Progressive disease|11|||
48733121|NCT03672643|156873868|FG000|Overall Study|Global deterioration of health status|1|||
48733122|NCT03672643|156873868|FG000|Overall Study|Refused further treatment|7|||
48733123|NCT03672643|156873868|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
48733124|NCT02900976|156873873|FG000|Overall Study|Adverse Event|0|||
48733125|NCT02900976|156873874|FG001|Overall Study|Adverse Event|1|||
48733126|NCT02900976|156873873|FG000|Overall Study|Physician Decision|0|||
48733127|NCT02900976|156873874|FG001|Overall Study|Physician Decision|2|||
48733128|NCT02900976|156873873|FG000|Overall Study|Progressive disease|0|||
48733129|NCT02900976|156873874|FG001|Overall Study|Progressive disease|6|||
48733130|NCT02160782|156876104|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
48733131|NCT02160782|156876105|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
48733132|NCT02160782|156876106|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
48733133|NCT02160782|156876107|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
48733134|NCT02160782|156876108|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
48733135|NCT02160782|156876104|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
48733136|NCT02160782|156876105|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
48733137|NCT02160782|156876106|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
48442783|NCT00089479|155808478|FG001|Overall Study|Lost to Follow-up|107|||
48442784|NCT04724733|155808479|FG000|Overall Study|Lost to Follow-up|1|||
48442785|NCT04724733|155808480|FG001|Overall Study|Lost to Follow-up|1|||
48442786|NCT04724733|155808481|FG002|Overall Study|Lost to Follow-up|1|||
48442787|NCT04929613|155808482|FG000|Overall Study|Withdrawal by Subject|12|||
48442788|NCT00091026|155808483|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
48442789|NCT00091026|155808484|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
48442790|NCT00091026|155808483|FG000|Overall Study|Patient withdrew and never received trea|0|||
48442791|NCT00091026|155808484|FG001|Overall Study|Patient withdrew and never received trea|2|||
48442792|NCT00091026|155808483|FG000|Overall Study|Unknown-never received treatment|0|||
48442793|NCT00091026|155808484|FG001|Overall Study|Unknown-never received treatment|1|||
48442794|NCT00565058|155808485|FG000|Overall Study|Adverse Event|1|||
48442795|NCT00565058|155808486|FG001|Overall Study|Adverse Event|0|||
48442796|NCT00304915|155808487|FG000|Overall Study|Lost to Follow-up|11|||
48442797|NCT00304915|155808488|FG001|Overall Study|Lost to Follow-up|11|||
48442798|NCT00304915|155808487|FG000|Overall Study|Death|4|||
48442799|NCT00304915|155808488|FG001|Overall Study|Death|5|||
48442800|NCT00304915|155808487|FG000|Overall Study|Withdrawal by Subject|3|||
48442801|NCT00304915|155808488|FG001|Overall Study|Withdrawal by Subject|0|||
48442802|NCT01819506|155808489|FG000|Overall Study|Physician Decision|5|||
48442803|NCT01819506|155808490|FG001|Overall Study|Physician Decision|2|||
48442804|NCT01819506|155808489|FG000|Overall Study|Withdrawal by Subject|3|||
48442805|NCT01819506|155808490|FG001|Overall Study|Withdrawal by Subject|3|||
48442806|NCT00475540|155808491|FG000|36 Months|Lost to Follow-up|4|||
48442807|NCT00475540|155808492|FG001|36 Months|Lost to Follow-up|4|||
48442808|NCT00475540|155808491|FG000|36 Months|Death|1|||
48442809|NCT00475540|155808492|FG001|36 Months|Death|2|||
48442810|NCT00475540|155808491|FG000|36 Months|Censored due to reoperation|3|||
48442811|NCT00475540|155808492|FG001|36 Months|Censored due to reoperation|0|||
48523109|NCT00105157|156105361|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
48523110|NCT00105157|156105358|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
48523111|NCT00105157|156105359|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
48523112|NCT00105157|156105360|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
48523113|NCT00105157|156105361|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
48523114|NCT00105157|156105358|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
48523115|NCT00105157|156105359|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
48523116|NCT00105157|156105360|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
48601794|NCT01325350|156399422|FG001|Overall Study|Protocol Violation|0|||
48733138|NCT02160782|156876107|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
48733139|NCT02160782|156876108|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
48733140|NCT02160782|156876104|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
48733141|NCT02160782|156876105|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
48733142|NCT02160782|156876106|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
48733143|NCT02160782|156876107|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
48733144|NCT02160782|156876108|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
48733145|NCT02160782|156876104|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
48733146|NCT02160782|156876105|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
48733147|NCT02160782|156876106|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
48733148|NCT02160782|156876107|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
48733149|NCT02160782|156876108|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
48733150|NCT02160782|156876104|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
48733151|NCT02160782|156876105|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
48733152|NCT02160782|156876106|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
48733153|NCT02160782|156876107|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
48733154|NCT02160782|156876108|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
48733155|NCT02160782|156876104|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
48733156|NCT02160782|156876105|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
48733157|NCT02160782|156876106|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
48733158|NCT02160782|156876107|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
48733159|NCT02160782|156876108|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
48733160|NCT02160782|156876104|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
48733161|NCT02160782|156876105|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
48733162|NCT02160782|156876106|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
48733163|NCT02160782|156876107|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
48733164|NCT02160782|156876108|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
48733165|NCT00891462|156876112|FG000|Overall Study|Withdrawal by Subject|9|||
48733166|NCT00891462|156876113|FG001|Overall Study|Withdrawal by Subject|6|||
48733167|NCT00891462|156876114|FG002|Overall Study|Withdrawal by Subject|7|||
48733168|NCT00891462|156876112|FG000|Overall Study|Adverse Event|7|||
48733169|NCT00891462|156876113|FG001|Overall Study|Adverse Event|8|||
48733170|NCT00891462|156876114|FG002|Overall Study|Adverse Event|7|||
48733171|NCT00891462|156876112|FG000|Overall Study|Lack of Efficacy|10|||
48733172|NCT00891462|156876113|FG001|Overall Study|Lack of Efficacy|5|||
48733173|NCT00891462|156876114|FG002|Overall Study|Lack of Efficacy|1|||
48733174|NCT00891462|156876112|FG000|Overall Study|COPD exacerbation|7|||
48733175|NCT00891462|156876113|FG001|Overall Study|COPD exacerbation|4|||
48733176|NCT00891462|156876114|FG002|Overall Study|COPD exacerbation|1|||
48733177|NCT00891462|156876112|FG000|Overall Study|Other Reason|2|||
48733178|NCT00891462|156876113|FG001|Overall Study|Other Reason|5|||
48733179|NCT00891462|156876114|FG002|Overall Study|Other Reason|3|||
48733180|NCT00891462|156876112|FG000|Overall Study|Protocol Violation|2|||
48733181|NCT00891462|156876113|FG001|Overall Study|Protocol Violation|1|||
48733182|NCT00891462|156876114|FG002|Overall Study|Protocol Violation|3|||
48733183|NCT00891462|156876112|FG000|Overall Study|Inclusion/exclusion criteria|0|||
48733184|NCT00891462|156876113|FG001|Overall Study|Inclusion/exclusion criteria|2|||
48733185|NCT00891462|156876114|FG002|Overall Study|Inclusion/exclusion criteria|2|||
48733186|NCT00891462|156876112|FG000|Overall Study|Lost to Follow-up|0|||
48733187|NCT00891462|156876113|FG001|Overall Study|Lost to Follow-up|2|||
48733188|NCT00891462|156876114|FG002|Overall Study|Lost to Follow-up|0|||
48733189|NCT05036369|156876117|FG000|Overall Study|Run In non compliance|1|||
48733190|NCT05036369|156876118|FG001|Overall Study|Run In non compliance|2|||
48733191|NCT05036369|156876117|FG000|Overall Study|Change in eligibility criteria|0|||
48733192|NCT05036369|156876118|FG001|Overall Study|Change in eligibility criteria|1|||
48825338|NCT00561574|157200778|FG000|Overall Study|Other|5|||
48825339|NCT00561574|157200779|FG001|Overall Study|Other|7|||
48825340|NCT00445692|157200780|FG000|Overall Study|Adverse Event|11|||
48825341|NCT00445692|157200780|FG000|Overall Study|Lack of Efficacy|5|||
48825342|NCT01555762|157200781|FG000|Overall Study|No information on Bevacizumab intake|11|||
48825343|NCT01555762|157200781|FG000|Overall Study|Missing start date of infusion|8|||
48825344|NCT01555762|157200781|FG000|Overall Study|75 years old or more ticked No|1|||
48825345|NCT01555762|157200781|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
48825346|NCT01555762|157200781|FG000|Overall Study|Death linked to progression of disease|165|||
48825347|NCT01555762|157200781|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
48825348|NCT01555762|157200781|FG000|Overall Study|Investigator's decision|10|||
48825349|NCT01555762|157200781|FG000|Overall Study|Participant not wishing to continue|5|||
48825350|NCT01555762|157200781|FG000|Overall Study|Missing data|1|||
48825351|NCT01555762|157200781|FG000|Overall Study|Death linked to an adverse event|14|||
48825352|NCT05233085|157200782|FG000|Overall Study|Adverse Event|1|||
48825353|NCT05233085|157200783|FG001|Overall Study|Adverse Event|0|||
48825354|NCT05233085|157200784|FG002|Overall Study|Adverse Event|0|||
48825355|NCT05233085|157200785|FG003|Overall Study|Adverse Event|0|||
48825356|NCT00836810|157200786|FG000|Overall Study|New diagnosis|1|||
48825357|NCT00836810|157200787|FG001|Overall Study|New diagnosis|0|||
48825358|NCT04949399|157200788|FG000|Overall Study|Lost to Follow-up|11|||
48825359|NCT04949399|157200789|FG001|Overall Study|Lost to Follow-up|6|||
48825360|NCT04949399|157200788|FG000|Overall Study|Withdrawal by Subject|2|||
48825361|NCT04949399|157200789|FG001|Overall Study|Withdrawal by Subject|3|||
48523117|NCT00105157|156105361|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
48523118|NCT00105157|156105358|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
48523119|NCT00105157|156105359|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
48523120|NCT00105157|156105360|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
48523121|NCT00105157|156105361|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
48523122|NCT00105157|156105358|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
48523123|NCT00105157|156105359|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
48825362|NCT02068885|157200790|FG000|Overall Study|Withdrew|3|||
48825363|NCT02068885|157200791|FG001|Overall Study|Withdrew|5|||
48523124|NCT00105157|156105360|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
48523125|NCT00105157|156105361|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
48523126|NCT00105157|156105358|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
48523127|NCT00105157|156105359|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
48523128|NCT00105157|156105360|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
48523129|NCT00105157|156105361|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
48523130|NCT00105157|156105358|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
48523131|NCT00105157|156105359|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
48523132|NCT00105157|156105360|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
48523133|NCT00105157|156105361|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
48523134|NCT01160640|156105362|FG000|Overall Study|Physician Decision|3|||
48523135|NCT01160640|156105363|FG001|Overall Study|Physician Decision|3|||
48523136|NCT01160640|156105362|FG000|Overall Study|Incarceration|1|||
48523137|NCT01160640|156105363|FG001|Overall Study|Incarceration|0|||
48523138|NCT01160640|156105362|FG000|Overall Study|Withdrawal by Subject|0|||
48523139|NCT01160640|156105363|FG001|Overall Study|Withdrawal by Subject|3|||
48523140|NCT00708682|156105368|FG000|Infant Series|Adverse Event|1|||
48523141|NCT00708682|156105368|FG000|Infant Series|Lost to Follow-up|4|||
48523142|NCT00708682|156105368|FG000|Infant Series|Protocol Violation|1|||
48523143|NCT00708682|156105368|FG000|Infant Series|Parent/legal guardian request|6|||
48523144|NCT00708682|156105368|FG000|Infant Series|Failed to return|2|||
48523145|NCT00708682|156105368|FG000|Infant Series|Other|19|||
48523146|NCT00708682|156105368|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
48523147|NCT00708682|156105368|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
48523148|NCT00708682|156105368|FG000|Toddler Dose|Lost to Follow-up|3|||
48523149|NCT00708682|156105368|FG000|Toddler Dose|Failed to Return|4|||
48523150|NCT01833169|156105371|FG000|Overall Study|Disease Progression|99|||
48523151|NCT01833169|156105371|FG000|Overall Study|Adverse Event|33|||
48523152|NCT01833169|156105371|FG000|Overall Study|Withdrawal by Subject|9|||
48523153|NCT01833169|156105371|FG000|Overall Study|Death|3|||
48523154|NCT01833169|156105371|FG000|Overall Study|Physician Decision|2|||
48523155|NCT00258856|156107216|FG000|Overall Study|Lost to Follow-up|1|||
48825364|NCT02068885|157200792|FG002|Overall Study|Withdrew|8|||
48523156|NCT00258856|156107217|FG001|Overall Study|Lost to Follow-up|0|||
48825365|NCT01562743|157200793|FG000|Overall Study|Adverse Event|29|||
48825366|NCT01562743|157200793|FG000|Overall Study|Lack of Efficacy|3|||
48825367|NCT01562743|157200793|FG000|Overall Study|Withdrawal by Subject|13|||
48825368|NCT01562743|157200793|FG000|Overall Study|Protocol Violation|1|||
48825369|NCT01562743|157200793|FG000|Overall Study|Discontinuation criteria|2|||
48825370|NCT01562743|157200793|FG000|Overall Study|Lost to Follow-up|2|||
48523157|NCT00258856|156107218|FG002|Overall Study|Lost to Follow-up|2|||
48825371|NCT01562743|157200793|FG000|Overall Study|Physician Decision|2|||
48825372|NCT00662909|157200795|FG000|Overall Study|Adverse Event|17|||
48825373|NCT00662909|157200796|FG001|Overall Study|Adverse Event|18|||
48825374|NCT00662909|157200797|FG002|Overall Study|Adverse Event|19|||
48825375|NCT00662909|157200795|FG000|Overall Study|Lack of Efficacy|9|||
48825376|NCT00662909|157200796|FG001|Overall Study|Lack of Efficacy|1|||
48825377|NCT00662909|157200797|FG002|Overall Study|Lack of Efficacy|5|||
48825378|NCT00662909|157200795|FG000|Overall Study|Withdrawal by Subject|29|||
48825379|NCT00662909|157200796|FG001|Overall Study|Withdrawal by Subject|22|||
48825380|NCT00662909|157200797|FG002|Overall Study|Withdrawal by Subject|16|||
48825381|NCT00662909|157200795|FG000|Overall Study|Lost to Follow-up|2|||
48825382|NCT00662909|157200796|FG001|Overall Study|Lost to Follow-up|9|||
48825383|NCT00662909|157200797|FG002|Overall Study|Lost to Follow-up|3|||
48825384|NCT00662909|157200795|FG000|Overall Study|Protocol Violation|7|||
48825385|NCT00662909|157200796|FG001|Overall Study|Protocol Violation|4|||
48523158|NCT00258856|156107219|FG003|Overall Study|Lost to Follow-up|0|||
48523159|NCT00258856|156107216|FG000|Overall Study|Non-compliance|2|||
48523160|NCT00258856|156107217|FG001|Overall Study|Non-compliance|0|||
48523161|NCT00258856|156107218|FG002|Overall Study|Non-compliance|0|||
48523162|NCT00258856|156107219|FG003|Overall Study|Non-compliance|1|||
48523163|NCT03578809|156107220|FG000|Overall Study|Death|0|||
48523164|NCT03578809|156107221|FG001|Overall Study|Death|2|||
48523165|NCT03578809|156107222|FG002|Overall Study|Death|0|||
48523166|NCT03578809|156107223|FG003|Overall Study|Death|1|||
48523167|NCT03578809|156107220|FG000|Overall Study|Lost to Follow-up|0|||
48523168|NCT03578809|156107221|FG001|Overall Study|Lost to Follow-up|1|||
48523169|NCT03578809|156107222|FG002|Overall Study|Lost to Follow-up|0|||
48523170|NCT03578809|156107223|FG003|Overall Study|Lost to Follow-up|0|||
48523171|NCT03578809|156107220|FG000|Overall Study|Withdrawal by Subject|3|||
48523172|NCT03578809|156107221|FG001|Overall Study|Withdrawal by Subject|5|||
48523173|NCT03578809|156107222|FG002|Overall Study|Withdrawal by Subject|2|||
48523174|NCT03578809|156107223|FG003|Overall Study|Withdrawal by Subject|0|||
48523175|NCT03578809|156107220|FG000|Overall Study|Other|3|||
48523176|NCT03578809|156107221|FG001|Overall Study|Other|6|||
48523177|NCT03578809|156107222|FG002|Overall Study|Other|2|||
48523178|NCT03578809|156107223|FG003|Overall Study|Other|8|||
48523179|NCT01520987|156107225|FG000|Overall Study|Withdrawal by Subject|1|||
48523180|NCT01520987|156107226|FG001|Overall Study|Withdrawal by Subject|0|||
48523181|NCT01520987|156107227|FG002|Overall Study|Withdrawal by Subject|0|||
48523182|NCT01520987|156107228|FG003|Overall Study|Withdrawal by Subject|0|||
48523183|NCT01520987|156107229|FG004|Overall Study|Withdrawal by Subject|0|||
48523184|NCT01520987|156107230|FG005|Overall Study|Withdrawal by Subject|1|||
48523185|NCT01520987|156107231|FG006|Overall Study|Withdrawal by Subject|0|||
48523186|NCT01520987|156107232|FG007|Overall Study|Withdrawal by Subject|0|||
48523187|NCT00526162|156107233|FG000|Overall Study|Device not implanted|3|||
48523188|NCT02005562|156107234|FG000|Overall Study|Death|2|||
48523189|NCT02005562|156107235|FG001|Overall Study|Death|2|||
48523190|NCT02005562|156107234|FG000|Overall Study|Graft loss|7|||
48523191|NCT02005562|156107235|FG001|Overall Study|Graft loss|6|||
48825386|NCT00662909|157200797|FG002|Overall Study|Protocol Violation|5|||
48825387|NCT00662909|157200795|FG000|Overall Study|Randomized- never received study drug|1|||
48825388|NCT00662909|157200796|FG001|Overall Study|Randomized- never received study drug|0|||
48825389|NCT00662909|157200797|FG002|Overall Study|Randomized- never received study drug|0|||
48825390|NCT00662909|157200795|FG000|Overall Study|Non-compliance with study procedures|3|||
48523192|NCT02005562|156107234|FG000|Overall Study|Withdrawal by Subject|2|||
48523193|NCT02005562|156107235|FG001|Overall Study|Withdrawal by Subject|2|||
48523194|NCT02005562|156107234|FG000|Overall Study|No transplant|1|||
48523195|NCT02005562|156107235|FG001|Overall Study|No transplant|4|||
48523196|NCT02005562|156107234|FG000|Overall Study|Physician Decision|0|||
48523197|NCT02005562|156107235|FG001|Overall Study|Physician Decision|1|||
48825391|NCT00662909|157200796|FG001|Overall Study|Non-compliance with study procedures|3|||
48825392|NCT00662909|157200797|FG002|Overall Study|Non-compliance with study procedures|2|||
48523198|NCT00199901|156107236|FG000|Overall Study|Protocol Violation|2|||
48523199|NCT00199901|156107237|FG001|Overall Study|Protocol Violation|0|||
48523200|NCT00199901|156107236|FG000|Overall Study|Withdrawal by Subject|1|||
48523201|NCT00199901|156107237|FG001|Overall Study|Withdrawal by Subject|0|||
48523202|NCT00199901|156107236|FG000|Overall Study|Progressive Disease|24|||
48825393|NCT00662909|157200795|FG000|Overall Study|Physician Decision|1|||
48825394|NCT00662909|157200796|FG001|Overall Study|Physician Decision|1|||
48523203|NCT00199901|156107237|FG001|Overall Study|Progressive Disease|24|||
48523204|NCT01691430|156107238|FG000|Overall Study|Death|17|||
48523205|NCT01691430|156107239|FG001|Overall Study|Death|16|||
48825395|NCT00662909|157200797|FG002|Overall Study|Physician Decision|2|||
48523206|NCT01691430|156107238|FG000|Overall Study|Withdrawal by Subject|5|||
48523207|NCT01691430|156107239|FG001|Overall Study|Withdrawal by Subject|1|||
48523208|NCT01691430|156107238|FG000|Overall Study|Lost to Follow-up|0|||
48523209|NCT01691430|156107239|FG001|Overall Study|Lost to Follow-up|3|||
48523210|NCT01894230|156107240|FG000|Overall Study|Lost to Follow-up|2|||
48523211|NCT01894230|156107241|FG001|Overall Study|Lost to Follow-up|2|||
48523212|NCT01894230|156107240|FG000|Overall Study|Withdrawal by Subject|4|||
48523213|NCT01894230|156107241|FG001|Overall Study|Withdrawal by Subject|4|||
48523214|NCT01894230|156107240|FG000|Overall Study|Non-adherent|0|||
48523215|NCT01894230|156107241|FG001|Overall Study|Non-adherent|1|||
48523216|NCT01894230|156107240|FG000|Overall Study|Death|1|||
48523217|NCT01894230|156107241|FG001|Overall Study|Death|0|||
48523218|NCT01109849|156107246|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
48523219|NCT01109849|156107247|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
48523220|NCT01109849|156107248|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
48523221|NCT01109849|156107249|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
48523222|NCT01109849|156107250|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
48523223|NCT01109849|156107246|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
48523224|NCT01109849|156107247|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
48523225|NCT01109849|156107248|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
48523226|NCT01109849|156107249|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
48523227|NCT01109849|156107250|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
48523228|NCT01109849|156107246|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
48523229|NCT01109849|156107247|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
48523230|NCT01109849|156107248|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
48523231|NCT01109849|156107249|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
48523232|NCT01109849|156107250|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
48523233|NCT01109849|156107246|FG000|Initial Randomization: ADHD Treatment|move away|2|||
48523234|NCT01109849|156107247|FG001|Initial Randomization: ADHD Treatment|move away|7|||
48523235|NCT01109849|156107248|FG002|Initial Randomization: ADHD Treatment|move away|0|||
48523236|NCT01109849|156107249|FG003|Initial Randomization: ADHD Treatment|move away|0|||
48523237|NCT01109849|156107250|FG004|Initial Randomization: ADHD Treatment|move away|0|||
48523238|NCT01109849|156107246|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
48523239|NCT01109849|156107247|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
48523240|NCT01109849|156107248|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
48523241|NCT01109849|156107249|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
48523242|NCT01109849|156107250|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
48523243|NCT01109849|156107246|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
48523244|NCT01109849|156107247|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
48523245|NCT01109849|156107248|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
48523246|NCT01109849|156107249|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
48523247|NCT01109849|156107250|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
48523248|NCT02300987|156107251|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
48523249|NCT02300987|156107252|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
48523250|NCT02300987|156107251|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
48523251|NCT02300987|156107252|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
48523252|NCT02300987|156107251|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
48523253|NCT02300987|156107252|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
48523254|NCT02300987|156107251|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
48523255|NCT02300987|156107252|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
48523256|NCT02300987|156107251|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
48523257|NCT02300987|156107252|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
48523258|NCT02219009|156107256|FG000|Overall Study|Withdrawal by Subject|5|||
48523259|NCT02219009|156107257|FG001|Overall Study|Withdrawal by Subject|1|||
48523260|NCT02219009|156107256|FG000|Overall Study|Adverse Event|2|||
48523261|NCT02219009|156107257|FG001|Overall Study|Adverse Event|4|||
48523262|NCT02219009|156107256|FG000|Overall Study|Lost to Follow-up|2|||
48523263|NCT02219009|156107257|FG001|Overall Study|Lost to Follow-up|2|||
48523264|NCT02219009|156107256|FG000|Overall Study|Protocol deviation|1|||
48523265|NCT02219009|156107257|FG001|Overall Study|Protocol deviation|0|||
48523266|NCT02219009|156107256|FG000|Overall Study|Physician Decision|0|||
48601795|NCT01325350|156399423|FG002|Overall Study|Protocol Violation|0|||
48601796|NCT01325350|156399424|FG003|Overall Study|Protocol Violation|1|||
48601797|NCT01325350|156399425|FG004|Overall Study|Protocol Violation|0|||
48601798|NCT01325350|156399421|FG000|Overall Study|Withdrawal by Subject|0|||
48733193|NCT02247531|156876119|FG000|Overall Study|Adverse Event|3|||
48523267|NCT02219009|156107257|FG001|Overall Study|Physician Decision|1|||
48523268|NCT02488109|156107260|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
48523269|NCT02488109|156107261|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
48523270|NCT02488109|156107260|FG000|12-month Follow-Up|Lost to Follow-up|4|||
48601799|NCT01325350|156399422|FG001|Overall Study|Withdrawal by Subject|0|||
48523271|NCT02488109|156107261|FG001|12-month Follow-Up|Lost to Follow-up|7|||
48523272|NCT00660387|156107266|FG000|Overall Study|Adverse Event|1|||
48523273|NCT00660387|156107267|FG001|Overall Study|Adverse Event|2|||
48523274|NCT00660387|156107266|FG000|Overall Study|Lack of Efficacy|0|||
48523275|NCT00660387|156107267|FG001|Overall Study|Lack of Efficacy|1|||
48523276|NCT00660387|156107266|FG000|Overall Study|Protocol Violation|1|||
48523277|NCT00660387|156107267|FG001|Overall Study|Protocol Violation|0|||
48523278|NCT02129062|156107268|FG000|Overall Study|Death|1|||
48523279|NCT02129062|156107268|FG000|Overall Study|Disease Progression|2|||
48523280|NCT04729101|156107269|FG000|Overall Study|Adverse Event|1|||
48523281|NCT04729101|156107270|FG001|Overall Study|Adverse Event|0|||
48523282|NCT04729101|156107269|FG000|Overall Study|Physician Decision|1|||
48523283|NCT04729101|156107270|FG001|Overall Study|Physician Decision|0|||
48733194|NCT02247531|156876120|FG001|Overall Study|Adverse Event|4|||
48733195|NCT02247531|156876121|FG002|Overall Study|Adverse Event|9|||
48825396|NCT00662909|157200795|FG000|Overall Study|Eligibility criterion not met|0|||
48825397|NCT00662909|157200796|FG001|Overall Study|Eligibility criterion not met|1|||
48825398|NCT00662909|157200797|FG002|Overall Study|Eligibility criterion not met|1|||
48825399|NCT01174550|157202059|FG000|Overall Study|Death|75|||
48825400|NCT01174550|157202060|FG001|Overall Study|Death|74|||
48523284|NCT04729101|156107269|FG000|Overall Study|Withdrawal by Subject|1|||
48523285|NCT04729101|156107270|FG001|Overall Study|Withdrawal by Subject|0|||
48825401|NCT01174550|157202059|FG000|Overall Study|Lost to Follow-up|652|||
48825402|NCT01174550|157202060|FG001|Overall Study|Lost to Follow-up|510|||
48523286|NCT05776901|156107271|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
48523287|NCT00676650|156107275|FG000|Overall Study|Death|45|||
48523288|NCT00676650|156107276|FG001|Overall Study|Death|14|||
48523289|NCT00676650|156107275|FG000|Overall Study|Adverse Event|159|||
48523290|NCT00676650|156107276|FG001|Overall Study|Adverse Event|21|||
48523291|NCT00676650|156107275|FG000|Overall Study|Global deterioration of health status|66|||
48523292|NCT00676650|156107276|FG001|Overall Study|Global deterioration of health status|31|||
48523293|NCT00676650|156107275|FG000|Overall Study|Lost to Follow-up|0|||
48523294|NCT00676650|156107276|FG001|Overall Study|Lost to Follow-up|1|||
48523295|NCT00676650|156107275|FG000|Overall Study|Objective progression or relapse|189|||
48523296|NCT00676650|156107276|FG001|Overall Study|Objective progression or relapse|140|||
48523297|NCT00676650|156107275|FG000|Overall Study|Other|14|||
48523298|NCT00676650|156107276|FG001|Overall Study|Other|10|||
48523299|NCT00676650|156107275|FG000|Overall Study|Protocol Violation|3|||
48523300|NCT00676650|156107276|FG001|Overall Study|Protocol Violation|1|||
48523301|NCT00676650|156107275|FG000|Overall Study|Study terminated by sponsor|57|||
48523302|NCT00676650|156107276|FG001|Overall Study|Study terminated by sponsor|43|||
48523303|NCT00676650|156107275|FG000|Overall Study|Withdrawal by Subject|48|||
48523304|NCT00676650|156107276|FG001|Overall Study|Withdrawal by Subject|24|||
48523305|NCT00676650|156107275|FG000|Overall Study|Randomized but not treated|3|||
48523306|NCT00676650|156107276|FG001|Overall Study|Randomized but not treated|4|||
48523307|NCT03414034|156107281|FG000|Overall Study|Adverse Event|6|||
48523308|NCT03414034|156107282|FG001|Overall Study|Adverse Event|1|||
48523309|NCT03414034|156107283|FG002|Overall Study|Adverse Event|1|||
48523310|NCT03414034|156107281|FG000|Overall Study|Death|0|||
48523311|NCT03414034|156107282|FG001|Overall Study|Death|0|||
48523312|NCT03414034|156107283|FG002|Overall Study|Death|1|||
48523313|NCT03414034|156107281|FG000|Overall Study|Non-compliance With Study Drug|0|||
48523314|NCT03414034|156107282|FG001|Overall Study|Non-compliance With Study Drug|0|||
48523315|NCT03414034|156107283|FG002|Overall Study|Non-compliance With Study Drug|1|||
48733196|NCT02247531|156876119|FG000|Overall Study|Death|8|||
48825403|NCT01174550|157202059|FG000|Overall Study|Withdrawal by Subject|543|||
48733197|NCT02247531|156876120|FG001|Overall Study|Death|9|||
48825404|NCT01174550|157202060|FG001|Overall Study|Withdrawal by Subject|289|||
48825405|NCT01789203|157202061|FG000|Overall Study|Adverse Event|2|||
48733198|NCT02247531|156876121|FG002|Overall Study|Death|5|||
48733199|NCT02247531|156876119|FG000|Overall Study|Lost to Follow-up|1|||
48733200|NCT02247531|156876120|FG001|Overall Study|Lost to Follow-up|8|||
48733201|NCT02247531|156876121|FG002|Overall Study|Lost to Follow-up|3|||
48733202|NCT02247531|156876119|FG000|Overall Study|Non-compliance|2|||
48523316|NCT03414034|156107281|FG000|Overall Study|Physician Decision|1|||
48733203|NCT02247531|156876120|FG001|Overall Study|Non-compliance|2|||
48733204|NCT02247531|156876121|FG002|Overall Study|Non-compliance|0|||
48733205|NCT02247531|156876119|FG000|Overall Study|Withdrawal by Subject|26|||
48733206|NCT02247531|156876120|FG001|Overall Study|Withdrawal by Subject|31|||
48825406|NCT01789203|157202062|FG001|Overall Study|Adverse Event|2|||
48523317|NCT03414034|156107282|FG001|Overall Study|Physician Decision|3|||
48523318|NCT03414034|156107283|FG002|Overall Study|Physician Decision|2|||
48523319|NCT03414034|156107281|FG000|Overall Study|Withdrawal of Informed Consent|2|||
48523320|NCT03414034|156107282|FG001|Overall Study|Withdrawal of Informed Consent|1|||
48733207|NCT02247531|156876121|FG002|Overall Study|Withdrawal by Subject|25|||
48733208|NCT02247531|156876119|FG000|Overall Study|Study Terminated by Sponsor|64|||
48733209|NCT02247531|156876120|FG001|Overall Study|Study Terminated by Sponsor|66|||
48733210|NCT02247531|156876121|FG002|Overall Study|Study Terminated by Sponsor|62|||
48825407|NCT01789203|157202061|FG000|Overall Study|Withdrawal by Subject|1|||
48825408|NCT01789203|157202062|FG001|Overall Study|Withdrawal by Subject|0|||
48825409|NCT01789203|157202061|FG000|Overall Study|Death|1|||
48825410|NCT01789203|157202062|FG001|Overall Study|Death|0|||
48825411|NCT01789203|157202061|FG000|Overall Study|Protocol Violation|2|||
48825412|NCT01789203|157202062|FG001|Overall Study|Protocol Violation|1|||
48825413|NCT01789203|157202061|FG000|Overall Study|Other|1|||
48825414|NCT01789203|157202062|FG001|Overall Study|Other|1|||
48825415|NCT01789203|157202061|FG000|Overall Study|patient non-adherent|2|||
48825416|NCT01789203|157202062|FG001|Overall Study|patient non-adherent|0|||
48825417|NCT03070392|157202063|FG000|Overall Study|Not Treated|7|||
48825418|NCT03070392|157202064|FG001|Overall Study|Not Treated|0|||
48825419|NCT03070392|157202065|FG002|Overall Study|Not Treated|3|||
48825420|NCT03070392|157202066|FG003|Overall Study|Not Treated|12|||
48825421|NCT03070392|157202063|FG000|Overall Study|Death|3|||
48825422|NCT03070392|157202064|FG001|Overall Study|Death|0|||
48825423|NCT03070392|157202065|FG002|Overall Study|Death|0|||
48825424|NCT03070392|157202066|FG003|Overall Study|Death|1|||
48825425|NCT03070392|157202063|FG000|Overall Study|Withdrawal by Subject|7|||
48825426|NCT03070392|157202064|FG001|Overall Study|Withdrawal by Subject|0|||
48825427|NCT03070392|157202065|FG002|Overall Study|Withdrawal by Subject|0|||
48825428|NCT03070392|157202066|FG003|Overall Study|Withdrawal by Subject|3|||
48825429|NCT03070392|157202063|FG000|Overall Study|Physician Decision|1|||
48825430|NCT03070392|157202064|FG001|Overall Study|Physician Decision|0|||
48825431|NCT03070392|157202065|FG002|Overall Study|Physician Decision|0|||
48825432|NCT03070392|157202066|FG003|Overall Study|Physician Decision|2|||
48825433|NCT03070392|157202063|FG000|Overall Study|Progressive Disease|154|||
48825434|NCT03070392|157202064|FG001|Overall Study|Progressive Disease|6|||
48825435|NCT03070392|157202065|FG002|Overall Study|Progressive Disease|2|||
48825436|NCT03070392|157202066|FG003|Overall Study|Progressive Disease|70|||
48825437|NCT03070392|157202063|FG000|Overall Study|Adverse Event|6|||
48825438|NCT03070392|157202064|FG001|Overall Study|Adverse Event|1|||
48825439|NCT03070392|157202065|FG002|Overall Study|Adverse Event|1|||
48825440|NCT03070392|157202066|FG003|Overall Study|Adverse Event|3|||
48825441|NCT03070392|157202063|FG000|Overall Study|Alternate anticancer treatment|1|||
48825442|NCT03070392|157202064|FG001|Overall Study|Alternate anticancer treatment|0|||
48825443|NCT03070392|157202065|FG002|Overall Study|Alternate anticancer treatment|0|||
48443037|NCT02394795|155808566|FG001|Overall Study|Lack of Efficacy|211|||
48443038|NCT02394795|155808565|FG000|Overall Study|Death|4|||
48443039|NCT02394795|155808566|FG001|Overall Study|Death|5|||
48443040|NCT02394795|155808565|FG000|Overall Study|Physician Decision|109|||
48443041|NCT02394795|155808566|FG001|Overall Study|Physician Decision|93|||
48443042|NCT02483078|155808567|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
48443043|NCT02483078|155808568|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
48443044|NCT02483078|155808567|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
48443045|NCT02483078|155808568|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
48443046|NCT02483078|155808567|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
48443047|NCT02483078|155808568|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
48443048|NCT02483078|155808567|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
48443049|NCT02483078|155808568|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
48443050|NCT02483078|155808567|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
48443051|NCT02483078|155808568|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
48443052|NCT02483078|155808567|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
48443053|NCT02483078|155808568|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
48443054|NCT00617656|155808569|FG000|Overall Study|Inclusion error|4|||
48443055|NCT00617656|155808570|FG001|Overall Study|Inclusion error|4|||
48443056|NCT00617656|155808571|FG002|Overall Study|Inclusion error|0|||
48443057|NCT00617656|155808572|FG003|Overall Study|Inclusion error|0|||
48443058|NCT00617656|155808569|FG000|Overall Study|Missing data|44|||
48443059|NCT00617656|155808570|FG001|Overall Study|Missing data|30|||
48443060|NCT00617656|155808571|FG002|Overall Study|Missing data|13|||
48443061|NCT00617656|155808572|FG003|Overall Study|Missing data|6|||
48443062|NCT00617656|155808569|FG000|Overall Study|Withdrawal by Subject|0|||
48443063|NCT00617656|155808570|FG001|Overall Study|Withdrawal by Subject|2|||
48443064|NCT00617656|155808571|FG002|Overall Study|Withdrawal by Subject|0|||
48443065|NCT00617656|155808572|FG003|Overall Study|Withdrawal by Subject|0|||
48443066|NCT00795509|155808573|FG000|Overall Study|Protocol Violation|31|||
48443067|NCT02146833|155808574|FG000|Overall Study|Death|10|||
48443068|NCT02146833|155808574|FG000|Overall Study|No longer consented to study treatment|1|||
48443069|NCT02849626|155808579|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
48443070|NCT02849626|155808580|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
48443071|NCT02849626|155808581|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
48443072|NCT02849626|155808582|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
48443073|NCT02849626|155808579|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
48443074|NCT02849626|155808580|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
48443075|NCT02849626|155808581|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
48825444|NCT03070392|157202066|FG003|Overall Study|Alternate anticancer treatment|1|||
48825445|NCT03070392|157202063|FG000|Overall Study|Ongoing|73|||
48825446|NCT03070392|157202064|FG001|Overall Study|Ongoing|0|||
48825447|NCT03070392|157202065|FG002|Overall Study|Ongoing|0|||
48825448|NCT03070392|157202066|FG003|Overall Study|Ongoing|11|||
48825449|NCT00723294|157202067|FG000|Overall Study|Lobular histology|2|||
48825450|NCT00723294|157202067|FG000|Overall Study|>25% intraductal component|1|||
48825451|NCT00723294|157202067|FG000|Overall Study|No MRI tumor enhancement|1|||
48825452|NCT00723294|157202067|FG000|Overall Study|1.0-Tesla MRI|1|||
48825453|NCT00723294|157202067|FG000|Overall Study|No cryoabalation|2|||
48825454|NCT00723294|157202067|FG000|Overall Study|Did not undergo surgery|1|||
48825455|NCT00723294|157202067|FG000|Overall Study|Treated prior to registration|1|||
48825456|NCT00723294|157202067|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
48825457|NCT00723294|157202067|FG000|Overall Study|Benign lesion|1|||
48825458|NCT00723294|157202067|FG000|Overall Study|Withdrawal by Subject|1|||
48825459|NCT00723294|157202067|FG000|Overall Study|No treatment due to probe failure|1|||
48825460|NCT05343455|157202068|FG000|Overall Study|Withdrawal by Subject|4|||
48825461|NCT05343455|157202069|FG001|Overall Study|Withdrawal by Subject|9|||
48825462|NCT05343455|157202070|FG002|Overall Study|Withdrawal by Subject|7|||
48825463|NCT05343455|157202068|FG000|Overall Study|Adverse Event|2|||
48825464|NCT05343455|157202069|FG001|Overall Study|Adverse Event|1|||
48825465|NCT05343455|157202070|FG002|Overall Study|Adverse Event|2|||
48825466|NCT05343455|157202068|FG000|Overall Study|Lost to Follow-up|1|||
48825467|NCT05343455|157202069|FG001|Overall Study|Lost to Follow-up|1|||
48825468|NCT05343455|157202070|FG002|Overall Study|Lost to Follow-up|3|||
48825469|NCT05343455|157202068|FG000|Overall Study|Pregnancy|1|||
48825470|NCT05343455|157202069|FG001|Overall Study|Pregnancy|0|||
48825471|NCT05343455|157202070|FG002|Overall Study|Pregnancy|0|||
48825472|NCT05343455|157202068|FG000|Overall Study|Physician Decision|0|||
48825473|NCT05343455|157202069|FG001|Overall Study|Physician Decision|0|||
48825474|NCT05343455|157202070|FG002|Overall Study|Physician Decision|1|||
48825475|NCT05343455|157202068|FG000|Overall Study|Protocol Violation|0|||
48825476|NCT05343455|157202069|FG001|Overall Study|Protocol Violation|1|||
48825477|NCT05343455|157202070|FG002|Overall Study|Protocol Violation|1|||
48443520|NCT02853032|155810408|FG001|Overall Study|Adverse Event|0|||
48443521|NCT02853032|155810407|FG000|Overall Study|Withdrawal by Subject|3|||
48443522|NCT02853032|155810408|FG001|Overall Study|Withdrawal by Subject|1|||
48443523|NCT02853032|155810407|FG000|Overall Study|Requested to withdraw from all treatment|2|||
48443524|NCT02853032|155810408|FG001|Overall Study|Requested to withdraw from all treatment|2|||
48443525|NCT00405652|155810409|FG000|Overall Study|Adverse Event|4|||
48443526|NCT02565615|155810418|FG000|Overall Study|Death|0|||
48443527|NCT02565615|155810419|FG001|Overall Study|Death|1|||
48443528|NCT02565615|155810420|FG002|Overall Study|Death|0|||
48443529|NCT02565615|155810421|FG003|Overall Study|Death|0|||
48443530|NCT02565615|155810422|FG004|Overall Study|Death|4|||
48443531|NCT02565615|155810418|FG000|Overall Study|Not willing to participate in study|2|||
48443532|NCT02565615|155810419|FG001|Overall Study|Not willing to participate in study|21|||
48443533|NCT02565615|155810420|FG002|Overall Study|Not willing to participate in study|0|||
48443534|NCT02565615|155810421|FG003|Overall Study|Not willing to participate in study|1|||
48443535|NCT02565615|155810422|FG004|Overall Study|Not willing to participate in study|169|||
48443536|NCT02565615|155810418|FG000|Overall Study|Lost to Follow-up|0|||
48443537|NCT02565615|155810419|FG001|Overall Study|Lost to Follow-up|4|||
48443538|NCT02565615|155810420|FG002|Overall Study|Lost to Follow-up|0|||
48443539|NCT02565615|155810421|FG003|Overall Study|Lost to Follow-up|1|||
48443540|NCT02565615|155810422|FG004|Overall Study|Lost to Follow-up|765|||
48443541|NCT02565615|155810418|FG000|Overall Study|Not meeting eligibility criteria|0|||
48443542|NCT02565615|155810419|FG001|Overall Study|Not meeting eligibility criteria|7|||
48443543|NCT02565615|155810420|FG002|Overall Study|Not meeting eligibility criteria|0|||
48443544|NCT02565615|155810421|FG003|Overall Study|Not meeting eligibility criteria|0|||
48443545|NCT02565615|155810422|FG004|Overall Study|Not meeting eligibility criteria|25|||
48443546|NCT02565615|155810418|FG000|Overall Study|Reason not defined|0|||
48443547|NCT02565615|155810419|FG001|Overall Study|Reason not defined|2|||
48443548|NCT02565615|155810420|FG002|Overall Study|Reason not defined|0|||
48443549|NCT02565615|155810421|FG003|Overall Study|Reason not defined|1|||
48443550|NCT02565615|155810422|FG004|Overall Study|Reason not defined|62|||
48443551|NCT02565615|155810418|FG000|Overall Study|Adverse Event|1|||
48443552|NCT02565615|155810419|FG001|Overall Study|Adverse Event|1|||
48443553|NCT02565615|155810420|FG002|Overall Study|Adverse Event|0|||
48825478|NCT00448864|157202071|FG000|Overall Study|Death|1|||
48825479|NCT00448864|157202072|FG001|Overall Study|Death|0|||
48825480|NCT00448864|157202073|FG002|Overall Study|Death|0|||
48825481|NCT00448864|157202071|FG000|Overall Study|Lost to Follow-up|3|||
48825482|NCT00448864|157202072|FG001|Overall Study|Lost to Follow-up|1|||
48825483|NCT00448864|157202073|FG002|Overall Study|Lost to Follow-up|0|||
48825484|NCT00448864|157202071|FG000|Overall Study|Physician Decision|1|||
48523321|NCT03414034|156107283|FG002|Overall Study|Withdrawal of Informed Consent|4|||
48523322|NCT03414034|156107281|FG000|Overall Study|Progressive Disease|15|||
48523323|NCT03414034|156107282|FG001|Overall Study|Progressive Disease|15|||
48523324|NCT03414034|156107283|FG002|Overall Study|Progressive Disease|17|||
48523325|NCT03414034|156107281|FG000|Overall Study|Miscellaneous|0|||
48523326|NCT03414034|156107282|FG001|Overall Study|Miscellaneous|0|||
48523327|NCT03414034|156107283|FG002|Overall Study|Miscellaneous|2|||
48523328|NCT00721955|156107286|FG000|Overall Study|Adverse Event|0|||
48523329|NCT00721955|156107287|FG001|Overall Study|Adverse Event|0|||
48523330|NCT00721955|156107288|FG002|Overall Study|Adverse Event|2|||
48523331|NCT01050764|156107289|FG000|Overall Study|Death, before HSCT|1|||
48523332|NCT01050764|156107289|FG000|Overall Study|Donor mobilization failure, death|1|||
48523333|NCT01050764|156107289|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
48523334|NCT00570128|156107291|FG000|Overall Study|Adverse Event|1|||
48523335|NCT00570128|156107292|FG001|Overall Study|Adverse Event|0|||
48523336|NCT00570128|156107291|FG000|Overall Study|Lost to Follow-up|1|||
48523337|NCT00570128|156107292|FG001|Overall Study|Lost to Follow-up|0|||
48523338|NCT00570128|156107291|FG000|Overall Study|Withdrawal by Subject|2|||
48523339|NCT00570128|156107292|FG001|Overall Study|Withdrawal by Subject|0|||
48523340|NCT00609154|156107293|FG000|Overall Study|Protocol Violation|1|||
48523341|NCT00609154|156107294|FG001|Overall Study|Protocol Violation|2|||
48523342|NCT00609154|156107293|FG000|Overall Study|Unable to establish IV access|0|||
48523343|NCT00609154|156107294|FG001|Overall Study|Unable to establish IV access|4|||
48523344|NCT00609154|156107293|FG000|Overall Study|Adverse Event|0|||
48523345|NCT00609154|156107294|FG001|Overall Study|Adverse Event|2|||
48523346|NCT01499160|156107299|FG000|Overall Study|Adverse Event|1|||
48523347|NCT01499160|156107299|FG000|Overall Study|Withdrawal by Subject|1|||
48523348|NCT03868631|156107304|FG000|Baseline to Week 6|Adverse Event|0|||
48523349|NCT03868631|156107305|FG001|Baseline to Week 6|Adverse Event|3|||
48523350|NCT03868631|156107304|FG000|Baseline to Week 6|Protocol Violation|1|||
48523351|NCT03868631|156107305|FG001|Baseline to Week 6|Protocol Violation|1|||
48523352|NCT03868631|156107304|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
48523353|NCT03868631|156107305|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
48523354|NCT03868631|156107304|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
48523355|NCT03868631|156107305|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
48523356|NCT03868631|156107304|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
48523357|NCT03868631|156107305|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
48523358|NCT03868631|156107304|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
48523359|NCT03868631|156107305|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
48523360|NCT03448692|156107309|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
48523361|NCT03448692|156107310|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
48825485|NCT00448864|157202072|FG001|Overall Study|Physician Decision|0|||
48825486|NCT00448864|157202073|FG002|Overall Study|Physician Decision|1|||
48523362|NCT03448692|156107309|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
48523363|NCT03448692|156107310|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
48523364|NCT03448692|156107309|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
48523365|NCT03448692|156107310|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
48523366|NCT03448692|156107309|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
48523367|NCT03448692|156107310|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
48523368|NCT03448692|156107309|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
48523369|NCT03448692|156107310|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
48523370|NCT01077258|156107315|FG000|Overall Study|Lost to Follow-up|1390|||
48825487|NCT00448864|157202071|FG000|Overall Study|Withdrawal by Subject|0|||
48523371|NCT01077258|156107315|FG000|Overall Study|Adverse drug reaction|218|||
48523372|NCT01077258|156107315|FG000|Overall Study|Lack of Efficacy|663|||
48523373|NCT01077258|156107315|FG000|Overall Study|Clinical remission|37|||
48825488|NCT00448864|157202072|FG001|Overall Study|Withdrawal by Subject|2|||
48601800|NCT01325350|156399423|FG002|Overall Study|Withdrawal by Subject|1|||
48523374|NCT01077258|156107315|FG000|Overall Study|Other reasons|260|||
48601801|NCT01325350|156399424|FG003|Overall Study|Withdrawal by Subject|1|||
48601802|NCT01325350|156399425|FG004|Overall Study|Withdrawal by Subject|0|||
48601803|NCT01325350|156399421|FG000|Overall Study|Did Not Receive Treatment|0|||
48825489|NCT00448864|157202073|FG002|Overall Study|Withdrawal by Subject|0|||
48825490|NCT00448864|157202071|FG000|Overall Study|Protocol Violation|0|||
48825491|NCT00448864|157202072|FG001|Overall Study|Protocol Violation|2|||
48825492|NCT00448864|157202073|FG002|Overall Study|Protocol Violation|0|||
48523375|NCT02911935|156107316|FG000|Overall Study|Lost to Follow-up|5|||
48523376|NCT02911935|156107317|FG001|Overall Study|Lost to Follow-up|7|||
48523377|NCT01685216|156107318|FG000|Overall Study|Did not receive study drug|1|||
48523378|NCT00515216|156107319|FG000|Overall Study|Withdrawal by Subject|1|||
48523379|NCT00726895|156107324|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
48523380|NCT00726895|156107325|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48523381|NCT04194008|156107326|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
48523382|NCT04194008|156107326|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
48523383|NCT04194008|156107326|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
48523384|NCT04194008|156107326|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
48523385|NCT04194008|156107326|FG000|Treatment Phase With Nerivio|Missing data|4|||
48523386|NCT04194008|156107326|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
48523387|NCT04158687|156107327|FG000|Overall Study|Adverse Event|2|||
48523388|NCT04158687|156107328|FG001|Overall Study|Adverse Event|3|||
48523389|NCT04158687|156107329|FG002|Overall Study|Adverse Event|0|||
48523390|NCT04158687|156107330|FG003|Overall Study|Adverse Event|3|||
48523391|NCT04158687|156107327|FG000|Overall Study|Lost to Follow-up|5|||
48523392|NCT04158687|156107328|FG001|Overall Study|Lost to Follow-up|12|||
48523393|NCT04158687|156107329|FG002|Overall Study|Lost to Follow-up|4|||
48523394|NCT04158687|156107330|FG003|Overall Study|Lost to Follow-up|5|||
48523395|NCT04158687|156107327|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
48523396|NCT04158687|156107328|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
48523397|NCT04158687|156107329|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
48523398|NCT04158687|156107330|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
48523399|NCT04158687|156107327|FG000|Overall Study|Non-Compliance with Study Medication|2|||
48523400|NCT04158687|156107328|FG001|Overall Study|Non-Compliance with Study Medication|2|||
48523401|NCT04158687|156107329|FG002|Overall Study|Non-Compliance with Study Medication|3|||
48523402|NCT04158687|156107330|FG003|Overall Study|Non-Compliance with Study Medication|0|||
48523403|NCT04158687|156107327|FG000|Overall Study|Investigator Decision|0|||
48523404|NCT04158687|156107328|FG001|Overall Study|Investigator Decision|0|||
48523405|NCT04158687|156107329|FG002|Overall Study|Investigator Decision|2|||
48523406|NCT04158687|156107330|FG003|Overall Study|Investigator Decision|0|||
48523407|NCT04158687|156107327|FG000|Overall Study|Protocol Violation|0|||
48523408|NCT04158687|156107328|FG001|Overall Study|Protocol Violation|2|||
48523409|NCT04158687|156107329|FG002|Overall Study|Protocol Violation|1|||
48523410|NCT04158687|156107330|FG003|Overall Study|Protocol Violation|0|||
48523411|NCT04158687|156107327|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
48523412|NCT04158687|156107328|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
48523413|NCT04158687|156107329|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
48523414|NCT04158687|156107330|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
48523415|NCT04158687|156107327|FG000|Overall Study|Reason not Specified|3|||
48523416|NCT04158687|156107328|FG001|Overall Study|Reason not Specified|2|||
48523417|NCT04158687|156107329|FG002|Overall Study|Reason not Specified|4|||
48523418|NCT04158687|156107330|FG003|Overall Study|Reason not Specified|4|||
48523419|NCT01785615|156107335|FG000|Dietary Phase|Lost to Follow-up|0|||
48523420|NCT01785615|156107336|FG001|Dietary Phase|Lost to Follow-up|0|||
48523421|NCT01785615|156107337|FG002|Dietary Phase|Lost to Follow-up|0|||
48523422|NCT01785615|156107338|FG003|Dietary Phase|Lost to Follow-up|24|||
48523423|NCT01881737|156107341|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
48523424|NCT01881737|156107341|FG000|Overall Study|Withdrawal by Subject|1|||
48523425|NCT01881737|156107341|FG000|Overall Study|Worsening of baseline behavior|1|||
48523426|NCT01450800|156107342|FG000|Overall Study|Protocol Violation|1|||
48523427|NCT01450800|156107343|FG001|Overall Study|Protocol Violation|3|||
48523428|NCT03023137|156107346|FG000|Overall Study|Multiple pregnancy|2|||
48523429|NCT03023137|156107347|FG001|Overall Study|Multiple pregnancy|4|||
48523430|NCT03023137|156107346|FG000|Overall Study|Lost to Follow-up|1|||
48523431|NCT03023137|156107347|FG001|Overall Study|Lost to Follow-up|1|||
48733211|NCT02247531|156876119|FG000|Overall Study|Physician Decision|0|||
48523432|NCT03023137|156107346|FG000|Overall Study|Protocol Violation|0|||
48733212|NCT02247531|156876120|FG001|Overall Study|Physician Decision|2|||
48523433|NCT03023137|156107347|FG001|Overall Study|Protocol Violation|4|||
48523434|NCT03023137|156107346|FG000|Overall Study|Lost the baby in a car accident|1|||
48523435|NCT03023137|156107347|FG001|Overall Study|Lost the baby in a car accident|0|||
48523436|NCT00982228|156107356|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
48523437|NCT00982228|156107357|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
48523438|NCT00982228|156107356|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
48523439|NCT00982228|156107357|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
48523440|NCT00982228|156107356|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
48523441|NCT00982228|156107357|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
48523442|NCT00982228|156107356|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
48523443|NCT00982228|156107357|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
48523444|NCT00982228|156107356|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
48825493|NCT02374957|157202079|FG000|Overall Study|Patient did not complete forms correctly|1|||
48825494|NCT02374957|157202080|FG001|Overall Study|Patient did not complete forms correctly|0|||
48825495|NCT00748969|157202081|FG000|Overall Study|Withdrawal by Subject|1|||
48825496|NCT00748969|157202082|FG001|Overall Study|Withdrawal by Subject|0|||
48825497|NCT00748969|157202081|FG000|Overall Study|Withdrawal by Subject|0|||
48733213|NCT02247531|156876121|FG002|Overall Study|Physician Decision|2|||
48733214|NCT02247531|156876119|FG000|Overall Study|Unspecified Reason|2|||
48733215|NCT02247531|156876120|FG001|Overall Study|Unspecified Reason|3|||
48733216|NCT02247531|156876121|FG002|Overall Study|Unspecified Reason|4|||
48733217|NCT03906461|156876122|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
48733218|NCT03906461|156876122|FG000|Completed 12-month Follow-up|Missed Visit|6|||
48733219|NCT00426231|156876123|FG000|Overall Study|Withdrawal by Subject|9|||
48733220|NCT00426231|156876124|FG001|Overall Study|Withdrawal by Subject|12|||
48733221|NCT03061097|156876125|FG000|Overall Study|Withdrawal by Subject|0|||
48825498|NCT00748969|157202082|FG001|Overall Study|Withdrawal by Subject|1|||
48825499|NCT04296942|157202083|FG000|Overall Study|Study closure by sponsor|1|||
48825500|NCT04296942|157202084|FG001|Overall Study|Study closure by sponsor|0|||
48443554|NCT02565615|155810421|FG003|Overall Study|Adverse Event|0|||
48443555|NCT02565615|155810422|FG004|Overall Study|Adverse Event|9|||
48443556|NCT02565615|155810418|FG000|Overall Study|Untreated|0|||
48443557|NCT02565615|155810419|FG001|Overall Study|Untreated|0|||
48443558|NCT02565615|155810420|FG002|Overall Study|Untreated|0|||
48443559|NCT02565615|155810421|FG003|Overall Study|Untreated|0|||
48443560|NCT02565615|155810422|FG004|Overall Study|Untreated|567|||
48443561|NCT01283997|155812784|FG000|Overall Study|Physician Decision|8|||
48443562|NCT01283997|155812785|FG001|Overall Study|Physician Decision|10|||
48443563|NCT01283997|155812784|FG000|Overall Study|Withdrawal by Subject|3|||
48443564|NCT01283997|155812785|FG001|Overall Study|Withdrawal by Subject|2|||
48443565|NCT01283997|155812784|FG000|Overall Study|Physically unable to continue|0|||
48443566|NCT01283997|155812785|FG001|Overall Study|Physically unable to continue|1|||
48443567|NCT01283997|155812784|FG000|Overall Study|Progressive disease|1|||
48443568|NCT01283997|155812785|FG001|Overall Study|Progressive disease|0|||
48443569|NCT01283997|155812784|FG000|Overall Study|Other|4|||
48443570|NCT01283997|155812785|FG001|Overall Study|Other|4|||
48443571|NCT02862548|155812789|FG000|Randomized Phase (Up to Week 48)|Death|0|||
48443572|NCT02862548|155812790|FG001|Randomized Phase (Up to Week 48)|Death|1|||
48443573|NCT02862548|155812789|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
48443574|NCT02862548|155812790|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
48443575|NCT02862548|155812789|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
48443576|NCT02862548|155812790|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
48443577|NCT02862548|155812789|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
48443578|NCT02862548|155812790|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
48443579|NCT00880763|155812791|FG000|Extension Period (Part 2)|Adverse Event|0|||
48443580|NCT00880763|155812792|FG001|Extension Period (Part 2)|Adverse Event|0|||
48443581|NCT00880763|155812793|FG002|Extension Period (Part 2)|Adverse Event|1|||
48443582|NCT00880763|155812794|FG003|Extension Period (Part 2)|Adverse Event|1|||
48443583|NCT00880763|155812791|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
48443584|NCT00880763|155812792|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
48443585|NCT00880763|155812793|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
48443586|NCT00880763|155812794|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
48443587|NCT00880763|155812791|FG000|Extension Period (Part 2)|Physician Decision|0|||
48443588|NCT00880763|155812792|FG001|Extension Period (Part 2)|Physician Decision|1|||
48443589|NCT00880763|155812793|FG002|Extension Period (Part 2)|Physician Decision|1|||
48443590|NCT00880763|155812794|FG003|Extension Period (Part 2)|Physician Decision|0|||
48443591|NCT00880763|155812791|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
48443592|NCT00880763|155812792|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
48443593|NCT00880763|155812793|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
48443594|NCT00880763|155812794|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
48443595|NCT01993615|155812795|FG000|Overall Study|Death|1|||
48443596|NCT01993615|155812796|FG001|Overall Study|Death|0|||
48443597|NCT01617655|155812797|FG000|Overall Study|Adverse Event|2|||
48443598|NCT01617655|155812798|FG001|Overall Study|Adverse Event|3|||
48443599|NCT01617655|155812797|FG000|Overall Study|Poor compliance to protocol|1|||
48443600|NCT01617655|155812798|FG001|Overall Study|Poor compliance to protocol|4|||
48443601|NCT01617655|155812797|FG000|Overall Study|Participants moved|0|||
48443602|NCT01617655|155812798|FG001|Overall Study|Participants moved|4|||
48443603|NCT01617655|155812797|FG000|Overall Study|Consent withdrawn by participant|1|||
48443604|NCT01617655|155812798|FG001|Overall Study|Consent withdrawn by participant|1|||
48443605|NCT01617655|155812797|FG000|Overall Study|Last visit outside protocol visit window|1|||
48443606|NCT01617655|155812798|FG001|Overall Study|Last visit outside protocol visit window|10|||
48523445|NCT00982228|156107357|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
48523446|NCT00982228|156107356|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
48523447|NCT00982228|156107357|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
48523448|NCT00982228|156107356|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
48523449|NCT00982228|156107357|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
48523450|NCT00982228|156107356|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
48523451|NCT00982228|156107357|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
48523452|NCT00982228|156107356|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
48523453|NCT00982228|156107357|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
48523454|NCT00982228|156107356|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
48523455|NCT00982228|156107357|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
48523456|NCT02250651|156107358|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
48523457|NCT02250651|156107359|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
48523458|NCT02250651|156107360|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
48523459|NCT02250651|156107358|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
48523460|NCT02250651|156107359|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
48523461|NCT02250651|156107360|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
48523462|NCT02250651|156107358|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
48523463|NCT02250651|156107359|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
48523464|NCT02250651|156107360|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
48523465|NCT02250651|156107358|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
48523466|NCT02250651|156107359|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
48523467|NCT02250651|156107360|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
48523468|NCT02250651|156107358|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
48523469|NCT02250651|156107359|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
48523470|NCT02250651|156107360|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
48523471|NCT02250651|156107358|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
48523472|NCT02250651|156107359|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
48523473|NCT02250651|156107360|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
48523474|NCT02250651|156107358|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
48523475|NCT02250651|156107359|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
48523476|NCT02250651|156107360|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
48523477|NCT02250651|156107358|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
48523478|NCT02250651|156107359|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
48523479|NCT02250651|156107360|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
48523480|NCT02250651|156107358|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
48523481|NCT02250651|156107359|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
48733222|NCT03061097|156876126|FG001|Overall Study|Withdrawal by Subject|3|||
48733223|NCT02572388|156876129|FG000|Overall Study|Withdrawal by Subject|1|||
48733224|NCT02572388|156876130|FG001|Overall Study|Withdrawal by Subject|1|||
48733225|NCT02572388|156876131|FG002|Overall Study|Withdrawal by Subject|2|||
48733226|NCT02572388|156876132|FG003|Overall Study|Withdrawal by Subject|2|||
48733227|NCT02231918|156876133|FG000|Overall Study|Withdrawal by Subject|0|||
48733228|NCT02231918|156876134|FG001|Overall Study|Withdrawal by Subject|1|||
48733229|NCT02231918|156876135|FG002|Overall Study|Withdrawal by Subject|0|||
48733230|NCT02231918|156876133|FG000|Overall Study|Adverse Event|0|||
48733231|NCT02231918|156876134|FG001|Overall Study|Adverse Event|0|||
48733232|NCT02231918|156876135|FG002|Overall Study|Adverse Event|1|||
48733233|NCT02486302|156876138|FG000|Overall Study|Discontinued prematurely|410|||
48733234|NCT02486302|156876138|FG000|Overall Study|Documentation not completed|255|||
48733235|NCT02486302|156876138|FG000|Overall Study|Excluded due to legal reasons|8|||
48733236|NCT02486302|156876138|FG000|Overall Study|Not treated|3|||
48733237|NCT00598702|156876147|FG000|Overall Study|Other|0|||
48733238|NCT00598702|156876148|FG001|Overall Study|Other|2|||
48733239|NCT00598702|156876149|FG002|Overall Study|Other|0|||
48733240|NCT00598702|156876150|FG003|Overall Study|Other|0|||
48733241|NCT00598702|156876151|FG004|Overall Study|Other|0|||
48733242|NCT00598702|156876152|FG005|Overall Study|Other|1|||
48825501|NCT04296942|157202085|FG002|Overall Study|Study closure by sponsor|0|||
48733243|NCT00598702|156876153|FG006|Overall Study|Other|0|||
48825502|NCT03432533|157202086|FG000|Overall Study|Lost to Follow-up|1|||
48825503|NCT03432533|157202087|FG001|Overall Study|Lost to Follow-up|2|||
48523482|NCT02250651|156107360|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
48733244|NCT00598702|156876154|FG007|Overall Study|Other|0|||
48733245|NCT00598702|156876147|FG000|Overall Study|Early discharge from hospital|0|||
48825504|NCT03432533|157202086|FG000|Overall Study|Withdrawal by Subject|14|||
48825505|NCT03432533|157202087|FG001|Overall Study|Withdrawal by Subject|9|||
48825506|NCT03582137|157202088|FG000|Overall Study|Adverse Event|1|||
48523483|NCT02250651|156107358|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
48733246|NCT00598702|156876148|FG001|Overall Study|Early discharge from hospital|0|||
48733247|NCT00598702|156876149|FG002|Overall Study|Early discharge from hospital|2|||
48733248|NCT00598702|156876150|FG003|Overall Study|Early discharge from hospital|5|||
48733249|NCT00598702|156876151|FG004|Overall Study|Early discharge from hospital|0|||
48733250|NCT00598702|156876152|FG005|Overall Study|Early discharge from hospital|10|||
48733251|NCT00598702|156876153|FG006|Overall Study|Early discharge from hospital|1|||
48523484|NCT02250651|156107359|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
48523485|NCT02250651|156107360|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
48523486|NCT02250651|156107358|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
48523487|NCT02250651|156107359|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
48523488|NCT02250651|156107360|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
48523489|NCT02250651|156107358|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
48523490|NCT02250651|156107359|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
48523491|NCT02250651|156107360|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
48523492|NCT02250651|156107358|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
48523493|NCT02250651|156107359|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
48523494|NCT02250651|156107360|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
48523495|NCT02250651|156107358|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
48523496|NCT02250651|156107359|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
48523497|NCT02250651|156107360|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
48523498|NCT02250651|156107358|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
48523499|NCT02250651|156107359|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
48523500|NCT02250651|156107360|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
48523501|NCT01390948|156107361|FG000|Overall Study|End of Study|1|||
48523502|NCT01390948|156107362|FG001|Overall Study|End of Study|0|||
48523503|NCT01390948|156107363|FG002|Overall Study|End of Study|0|||
48523504|NCT01390948|156107361|FG000|Overall Study|Withdrew consent|2|||
48523505|NCT01390948|156107362|FG001|Overall Study|Withdrew consent|2|||
48523506|NCT01390948|156107363|FG002|Overall Study|Withdrew consent|0|||
48523507|NCT01390948|156107361|FG000|Overall Study|Progressive Disease|2|||
48523508|NCT01390948|156107362|FG001|Overall Study|Progressive Disease|5|||
48523509|NCT01390948|156107363|FG002|Overall Study|Progressive Disease|0|||
48523510|NCT01390948|156107361|FG000|Overall Study|Death during follow-up|10|||
48523511|NCT01390948|156107362|FG001|Overall Study|Death during follow-up|11|||
48523512|NCT01390948|156107363|FG002|Overall Study|Death during follow-up|1|||
48523513|NCT00676494|156107366|FG000|Overall Study|Missed Visit|8|||
48733252|NCT00598702|156876154|FG007|Overall Study|Early discharge from hospital|0|||
48733253|NCT00598702|156876147|FG000|Overall Study|Adverse Event|0|||
48733254|NCT00598702|156876148|FG001|Overall Study|Adverse Event|0|||
48733255|NCT00598702|156876149|FG002|Overall Study|Adverse Event|0|||
48733256|NCT00598702|156876150|FG003|Overall Study|Adverse Event|1|||
48733257|NCT00598702|156876151|FG004|Overall Study|Adverse Event|0|||
48733258|NCT00598702|156876152|FG005|Overall Study|Adverse Event|0|||
48733259|NCT00598702|156876153|FG006|Overall Study|Adverse Event|0|||
48733260|NCT00598702|156876154|FG007|Overall Study|Adverse Event|0|||
48733261|NCT00598702|156876147|FG000|Overall Study|Withdrawal by Subject|0|||
48733262|NCT00598702|156876148|FG001|Overall Study|Withdrawal by Subject|0|||
48733263|NCT00598702|156876149|FG002|Overall Study|Withdrawal by Subject|0|||
48733264|NCT00598702|156876150|FG003|Overall Study|Withdrawal by Subject|1|||
48733265|NCT00598702|156876151|FG004|Overall Study|Withdrawal by Subject|1|||
48733266|NCT00598702|156876152|FG005|Overall Study|Withdrawal by Subject|0|||
48733267|NCT00598702|156876153|FG006|Overall Study|Withdrawal by Subject|0|||
48733268|NCT00598702|156876154|FG007|Overall Study|Withdrawal by Subject|0|||
48733269|NCT00598702|156876147|FG000|Overall Study|Physician Decision|0|||
48733270|NCT00598702|156876148|FG001|Overall Study|Physician Decision|0|||
48733271|NCT00598702|156876149|FG002|Overall Study|Physician Decision|0|||
48733272|NCT00598702|156876150|FG003|Overall Study|Physician Decision|0|||
48733273|NCT00598702|156876151|FG004|Overall Study|Physician Decision|1|||
48733274|NCT00598702|156876152|FG005|Overall Study|Physician Decision|0|||
48733275|NCT00598702|156876153|FG006|Overall Study|Physician Decision|0|||
48733276|NCT00598702|156876154|FG007|Overall Study|Physician Decision|0|||
48733277|NCT00598702|156876147|FG000|Overall Study|Dose limiting toxicity|0|||
48733278|NCT00598702|156876148|FG001|Overall Study|Dose limiting toxicity|0|||
48733279|NCT00598702|156876149|FG002|Overall Study|Dose limiting toxicity|0|||
48733280|NCT00598702|156876150|FG003|Overall Study|Dose limiting toxicity|1|||
48733281|NCT00598702|156876151|FG004|Overall Study|Dose limiting toxicity|1|||
48733282|NCT00598702|156876152|FG005|Overall Study|Dose limiting toxicity|1|||
48733283|NCT00598702|156876153|FG006|Overall Study|Dose limiting toxicity|0|||
48733284|NCT00598702|156876154|FG007|Overall Study|Dose limiting toxicity|0|||
48733285|NCT02600351|156876155|FG000|Overall Study|Lack of Efficacy|3|||
48733286|NCT02600351|156876156|FG001|Overall Study|Lack of Efficacy|0|||
48523514|NCT00676494|156107366|FG000|Overall Study|Withdrawal by Subject|6|||
48523515|NCT01115933|156107369|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
48733287|NCT02600351|156876157|FG002|Overall Study|Lack of Efficacy|5|||
48733288|NCT02600351|156876158|FG003|Overall Study|Lack of Efficacy|2|||
48733289|NCT02600351|156876155|FG000|Overall Study|Lost to Follow-up|1|||
48733290|NCT02600351|156876156|FG001|Overall Study|Lost to Follow-up|0|||
48733291|NCT02600351|156876157|FG002|Overall Study|Lost to Follow-up|0|||
48733292|NCT02600351|156876158|FG003|Overall Study|Lost to Follow-up|0|||
48733293|NCT02600351|156876155|FG000|Overall Study|Randomized but Not Treated|1|||
48733294|NCT02600351|156876156|FG001|Overall Study|Randomized but Not Treated|0|||
48733295|NCT02600351|156876157|FG002|Overall Study|Randomized but Not Treated|1|||
48733296|NCT02600351|156876158|FG003|Overall Study|Randomized but Not Treated|3|||
48733297|NCT02413372|156876159|FG000|Treatment|Lost to Follow-up|0|||
48733298|NCT02413372|156876160|FG001|Treatment|Lost to Follow-up|2|||
48733299|NCT02413372|156876161|FG002|Treatment|Lost to Follow-up|1|||
48733300|NCT02413372|156876159|FG000|Treatment|Withdrawal by Subject|1|||
48733301|NCT02413372|156876160|FG001|Treatment|Withdrawal by Subject|0|||
48733302|NCT02413372|156876161|FG002|Treatment|Withdrawal by Subject|0|||
48733303|NCT02413372|156876159|FG000|Follow-up|Lost to Follow-up|1|||
48733304|NCT02413372|156876160|FG001|Follow-up|Lost to Follow-up|1|||
48825507|NCT03582137|157202089|FG001|Overall Study|Adverse Event|0|||
48825508|NCT01928940|157202092|FG000|Overall Study|Adverse Event|0|||
48825509|NCT01928940|157202093|FG001|Overall Study|Adverse Event|1|||
48825510|NCT02365298|157202094|FG000|Period 2|incorrect Rx dispensed|1|||
48825511|NCT02365298|157202095|FG001|Period 2|incorrect Rx dispensed|0|||
48825512|NCT02365298|157202094|FG000|Period 2|Discontinued at request of Sponsor|1|||
48825513|NCT02365298|157202095|FG001|Period 2|Discontinued at request of Sponsor|0|||
48825514|NCT02365298|157202094|FG000|Period 2|Test Article longer available|0|||
48523516|NCT02212457|156107370|FG000|Overall Study|Adverse Event|1|||
48523517|NCT02212457|156107371|FG001|Overall Study|Adverse Event|2|||
48523518|NCT02212457|156107372|FG002|Overall Study|Adverse Event|2|||
48523519|NCT02212457|156107373|FG003|Overall Study|Adverse Event|2|||
48523520|NCT02212457|156107374|FG004|Overall Study|Adverse Event|0|||
48523521|NCT02212457|156107375|FG005|Overall Study|Adverse Event|1|||
48523522|NCT02212457|156107370|FG000|Overall Study|Withdrawal by Subject|8|||
48733305|NCT02413372|156876161|FG002|Follow-up|Lost to Follow-up|0|||
48733306|NCT02413372|156876159|FG000|Follow-up|Subject Withdrew Consent|1|||
48733307|NCT02413372|156876160|FG001|Follow-up|Subject Withdrew Consent|0|||
48733308|NCT02413372|156876161|FG002|Follow-up|Subject Withdrew Consent|1|||
48733309|NCT02413372|156876159|FG000|Follow-up|Subject unable to return for visit|0|||
48733310|NCT02413372|156876160|FG001|Follow-up|Subject unable to return for visit|0|||
48733311|NCT02413372|156876161|FG002|Follow-up|Subject unable to return for visit|1|||
48733312|NCT02556203|156876165|FG000|Overall Study|Withdrawal by Subject|21|||
48733313|NCT02556203|156876166|FG001|Overall Study|Withdrawal by Subject|21|||
48733314|NCT02556203|156876165|FG000|Overall Study|Lost to Follow-up|5|||
48733315|NCT02556203|156876166|FG001|Overall Study|Lost to Follow-up|5|||
48733316|NCT02556203|156876165|FG000|Overall Study|Adverse Event|1|||
48733317|NCT02556203|156876166|FG001|Overall Study|Adverse Event|0|||
48733318|NCT01810432|156876168|FG000|Washout|Protocol Violation|0|||
48733319|NCT01810432|156876169|FG001|Washout|Protocol Violation|1|||
48733320|NCT01810432|156876168|FG000|Washout|Adverse Event|1|||
48733321|NCT01810432|156876169|FG001|Washout|Adverse Event|0|||
48733322|NCT01810432|156876168|FG000|Period 2|Withdrawal by Subject|2|||
48733323|NCT01810432|156876169|FG001|Period 2|Withdrawal by Subject|1|||
48733324|NCT01810432|156876168|FG000|Period 2|Physician Decision|1|||
48733325|NCT01810432|156876169|FG001|Period 2|Physician Decision|0|||
48733326|NCT01810432|156876168|FG000|Period 2|Lost to Follow-up|1|||
48733327|NCT01810432|156876169|FG001|Period 2|Lost to Follow-up|1|||
48733328|NCT02497612|156876174|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
48733329|NCT02497612|156876175|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
48733330|NCT02497612|156876176|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
48733331|NCT02497612|156876177|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
48733332|NCT02497612|156876174|FG000|Overall Study|Participant's request|2|||
48733333|NCT02497612|156876175|FG001|Overall Study|Participant's request|3|||
48733334|NCT02497612|156876176|FG002|Overall Study|Participant's request|4|||
48733335|NCT02497612|156876177|FG003|Overall Study|Participant's request|1|||
48733336|NCT02497612|156876174|FG000|Overall Study|Investigator's judgement|1|||
48733337|NCT02497612|156876175|FG001|Overall Study|Investigator's judgement|0|||
48733338|NCT02497612|156876176|FG002|Overall Study|Investigator's judgement|0|||
48733339|NCT02497612|156876177|FG003|Overall Study|Investigator's judgement|2|||
48733340|NCT02497612|156876174|FG000|Overall Study|Adverse Event|3|||
48733341|NCT02497612|156876175|FG001|Overall Study|Adverse Event|1|||
48733342|NCT02497612|156876176|FG002|Overall Study|Adverse Event|4|||
48733343|NCT02497612|156876177|FG003|Overall Study|Adverse Event|1|||
48733344|NCT02497612|156876174|FG000|Overall Study|Lost to Follow-up|1|||
48733345|NCT02497612|156876175|FG001|Overall Study|Lost to Follow-up|1|||
48825515|NCT02365298|157202095|FG001|Period 2|Test Article longer available|1|||
48523523|NCT02212457|156107371|FG001|Overall Study|Withdrawal by Subject|10|||
48733346|NCT02497612|156876176|FG002|Overall Study|Lost to Follow-up|0|||
48523524|NCT02212457|156107372|FG002|Overall Study|Withdrawal by Subject|8|||
48733347|NCT02497612|156876177|FG003|Overall Study|Lost to Follow-up|1|||
48733348|NCT02497612|156876174|FG000|Overall Study|Other unspecified|1|||
48825516|NCT02365298|157202094|FG000|Period 2|Protocol Violation|0|||
48825517|NCT02365298|157202095|FG001|Period 2|Protocol Violation|1|||
48825518|NCT02498613|157202098|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
48825519|NCT02498613|157202099|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
48825520|NCT02498613|157202100|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
48825521|NCT02498613|157202101|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
48825522|NCT02498613|157202098|FG000|Overall Study|Withdrawal by Subject|3|||
48825523|NCT02498613|157202099|FG001|Overall Study|Withdrawal by Subject|1|||
48825524|NCT02498613|157202100|FG002|Overall Study|Withdrawal by Subject|0|||
48825525|NCT02498613|157202101|FG003|Overall Study|Withdrawal by Subject|0|||
48825526|NCT01872611|157202114|FG000|Overall Study|Adverse Event|3|||
48825527|NCT01872611|157202115|FG001|Overall Study|Adverse Event|1|||
48825528|NCT01872611|157202114|FG000|Overall Study|Adverse Event, prior to treatment|0|||
48825529|NCT01872611|157202115|FG001|Overall Study|Adverse Event, prior to treatment|1|||
48825530|NCT01872611|157202114|FG000|Overall Study|Death|0|||
48825531|NCT01872611|157202115|FG001|Overall Study|Death|1|||
48825532|NCT01872611|157202114|FG000|Overall Study|Death, prior to treatment|0|||
48825533|NCT01872611|157202115|FG001|Overall Study|Death, prior to treatment|1|||
48825534|NCT01872611|157202114|FG000|Overall Study|Lost to Follow-up|8|||
48825535|NCT01872611|157202115|FG001|Overall Study|Lost to Follow-up|1|||
48825536|NCT01872611|157202114|FG000|Overall Study|Physician Decision|1|||
48825537|NCT01872611|157202115|FG001|Overall Study|Physician Decision|0|||
48825538|NCT01872611|157202114|FG000|Overall Study|Withdrawal by Subject|6|||
48825539|NCT01872611|157202115|FG001|Overall Study|Withdrawal by Subject|1|||
48825540|NCT01872611|157202114|FG000|Overall Study|Reason not provided|6|||
48825541|NCT01872611|157202115|FG001|Overall Study|Reason not provided|6|||
48825542|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
48825543|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
48825544|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
48825545|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Death|3|||
48825546|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Death|0|||
48825547|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Death|0|||
48825548|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
48825549|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
48825550|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
48825551|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
48825552|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
48825553|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
48825554|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
48825555|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
48825556|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
48825557|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
48825558|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
48825559|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
48825560|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
48825561|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
48825562|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
48825563|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Other|1|||
48825564|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Other|0|||
48825565|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Other|0|||
48825566|NCT02403323|157202122|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
48825567|NCT02403323|157202123|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
48825568|NCT02403323|157202124|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
48825569|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
48825570|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
48825571|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
48523525|NCT02212457|156107373|FG003|Overall Study|Withdrawal by Subject|6|||
48523526|NCT02212457|156107374|FG004|Overall Study|Withdrawal by Subject|5|||
48523527|NCT02212457|156107375|FG005|Overall Study|Withdrawal by Subject|4|||
48523528|NCT02212457|156107370|FG000|Overall Study|Lost to Follow-up|6|||
48523529|NCT02212457|156107371|FG001|Overall Study|Lost to Follow-up|7|||
48523530|NCT02212457|156107372|FG002|Overall Study|Lost to Follow-up|4|||
48825572|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
48825573|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
48523531|NCT02212457|156107373|FG003|Overall Study|Lost to Follow-up|1|||
48825574|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
48825575|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
48825576|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
48825577|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
48825578|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
48825579|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
48523532|NCT02212457|156107374|FG004|Overall Study|Lost to Follow-up|8|||
48523533|NCT02212457|156107375|FG005|Overall Study|Lost to Follow-up|4|||
48523534|NCT02212457|156107370|FG000|Overall Study|Protocol Violation|2|||
48523535|NCT02212457|156107371|FG001|Overall Study|Protocol Violation|1|||
48523536|NCT02212457|156107372|FG002|Overall Study|Protocol Violation|0|||
48523537|NCT02212457|156107373|FG003|Overall Study|Protocol Violation|1|||
48523538|NCT02212457|156107374|FG004|Overall Study|Protocol Violation|2|||
48523539|NCT02212457|156107375|FG005|Overall Study|Protocol Violation|3|||
48523540|NCT02212457|156107370|FG000|Overall Study|Other|2|||
48523541|NCT02212457|156107371|FG001|Overall Study|Other|1|||
48523542|NCT02212457|156107372|FG002|Overall Study|Other|2|||
48523543|NCT02212457|156107373|FG003|Overall Study|Other|1|||
48523544|NCT02212457|156107374|FG004|Overall Study|Other|0|||
48523545|NCT02212457|156107375|FG005|Overall Study|Other|1|||
48523546|NCT04405739|156107376|FG000|Overall Study|Adverse Event|0|||
48523547|NCT04405739|156107377|FG001|Overall Study|Adverse Event|1|||
48523548|NCT04405739|156107378|FG002|Overall Study|Adverse Event|0|||
48523549|NCT04405739|156107379|FG003|Overall Study|Adverse Event|0|||
48523550|NCT04405739|156107376|FG000|Overall Study|Lost to Follow-up|0|||
48523551|NCT04405739|156107377|FG001|Overall Study|Lost to Follow-up|2|||
48523552|NCT04405739|156107378|FG002|Overall Study|Lost to Follow-up|1|||
48825580|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
48825581|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
48523553|NCT04405739|156107379|FG003|Overall Study|Lost to Follow-up|3|||
48601804|NCT01325350|156399422|FG001|Overall Study|Did Not Receive Treatment|1|||
48825582|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
48825583|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
48825584|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
48825585|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
48825586|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
48825587|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
48825588|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
48601805|NCT01325350|156399423|FG002|Overall Study|Did Not Receive Treatment|1|||
48825589|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
48825590|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
48825591|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
48523554|NCT04405739|156107376|FG000|Overall Study|Withdrawal by Subject|0|||
48523555|NCT04405739|156107377|FG001|Overall Study|Withdrawal by Subject|2|||
48523556|NCT04405739|156107378|FG002|Overall Study|Withdrawal by Subject|1|||
48523557|NCT04405739|156107379|FG003|Overall Study|Withdrawal by Subject|1|||
48523558|NCT04405739|156107376|FG000|Overall Study|Death|0|||
48523559|NCT04405739|156107377|FG001|Overall Study|Death|0|||
48523560|NCT04405739|156107378|FG002|Overall Study|Death|1|||
48523561|NCT04405739|156107379|FG003|Overall Study|Death|0|||
48523562|NCT04405739|156107376|FG000|Overall Study|Transferred to rehab|0|||
48523563|NCT04405739|156107377|FG001|Overall Study|Transferred to rehab|0|||
48523564|NCT04405739|156107378|FG002|Overall Study|Transferred to rehab|0|||
48523565|NCT04405739|156107379|FG003|Overall Study|Transferred to rehab|1|||
48523566|NCT04405739|156107376|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
48523567|NCT04405739|156107377|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
48523568|NCT04405739|156107378|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
48523569|NCT04405739|156107379|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
48523570|NCT02169336|156107386|FG000|Overall Study|Lack of Efficacy|1|||
48523571|NCT02169336|156107387|FG001|Overall Study|Lack of Efficacy|1|||
48523572|NCT02169336|156107388|FG002|Overall Study|Lack of Efficacy|0|||
48523573|NCT02169336|156107386|FG000|Overall Study|Adverse Event|2|||
48523574|NCT02169336|156107387|FG001|Overall Study|Adverse Event|3|||
48523575|NCT02169336|156107388|FG002|Overall Study|Adverse Event|1|||
48523576|NCT02169336|156107386|FG000|Overall Study|Withdrawal by Subject|1|||
48523577|NCT02169336|156107387|FG001|Overall Study|Withdrawal by Subject|0|||
48523578|NCT02169336|156107388|FG002|Overall Study|Withdrawal by Subject|0|||
48523579|NCT02169336|156107386|FG000|Overall Study|Physician Decision|0|||
48523580|NCT02169336|156107387|FG001|Overall Study|Physician Decision|0|||
48523581|NCT02169336|156107388|FG002|Overall Study|Physician Decision|1|||
48523582|NCT02169336|156107386|FG000|Overall Study|Subject declined to continue dosing|0|||
48825592|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
48523583|NCT02169336|156107387|FG001|Overall Study|Subject declined to continue dosing|0|||
48523584|NCT02169336|156107388|FG002|Overall Study|Subject declined to continue dosing|1|||
48523585|NCT00434590|156107389|FG000|Overall Study|Administrative problems|5|||
48523586|NCT00434590|156107390|FG001|Overall Study|Administrative problems|5|||
48523587|NCT01148225|156107393|FG000|Overall Study|Other|185|||
48523588|NCT02028455|156107397|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
48523589|NCT02028455|156107398|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
48523590|NCT02028455|156107399|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
48601806|NCT01325350|156399424|FG003|Overall Study|Did Not Receive Treatment|0|||
48523591|NCT02028455|156107400|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
48523592|NCT02028455|156107401|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
48523593|NCT02028455|156107402|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
48523594|NCT02028455|156107403|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
48523595|NCT02028455|156107404|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
48523596|NCT02028455|156107397|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
48523597|NCT02028455|156107398|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
48523598|NCT02028455|156107399|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
48523599|NCT02028455|156107400|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
48523600|NCT02028455|156107401|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
48523601|NCT02028455|156107402|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
48523602|NCT02028455|156107403|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
48523603|NCT02028455|156107404|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
48523604|NCT02028455|156107397|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
48523605|NCT02028455|156107398|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
48523606|NCT02028455|156107399|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
48523607|NCT02028455|156107400|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
48523608|NCT02028455|156107401|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
48523609|NCT02028455|156107402|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
48523610|NCT02028455|156107403|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
48523611|NCT02028455|156107404|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
48523612|NCT02028455|156107397|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
48523613|NCT02028455|156107398|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
48523614|NCT02028455|156107399|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
48523615|NCT02028455|156107400|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
48523616|NCT02028455|156107401|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
48523617|NCT02028455|156107402|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
48523618|NCT02028455|156107403|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
48523619|NCT02028455|156107404|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
48523620|NCT03234608|156107405|FG000|Overall Study|Lost to Follow-up|23|||
48523621|NCT03234608|156107406|FG001|Overall Study|Lost to Follow-up|21|||
48523622|NCT01120691|156107407|FG000|Overall Study|Adverse Event|59|||
48523623|NCT01120691|156107408|FG001|Overall Study|Adverse Event|67|||
48523624|NCT01120691|156107409|FG002|Overall Study|Adverse Event|47|||
48523625|NCT01120691|156107407|FG000|Overall Study|Subject withdrew consent|33|||
48523626|NCT01120691|156107408|FG001|Overall Study|Subject withdrew consent|50|||
48523627|NCT01120691|156107409|FG002|Overall Study|Subject withdrew consent|44|||
48523628|NCT01120691|156107407|FG000|Overall Study|Death|21|||
48523629|NCT01120691|156107408|FG001|Overall Study|Death|22|||
48523630|NCT01120691|156107409|FG002|Overall Study|Death|24|||
48523631|NCT01120691|156107407|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
48523632|NCT01120691|156107408|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
48523633|NCT01120691|156107409|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
48523634|NCT01120691|156107407|FG000|Overall Study|Administrative problems|15|||
48523635|NCT01120691|156107408|FG001|Overall Study|Administrative problems|8|||
48523636|NCT01120691|156107409|FG002|Overall Study|Administrative problems|9|||
48523637|NCT01120691|156107407|FG000|Overall Study|Protocol deviation|13|||
48523638|NCT01120691|156107408|FG001|Overall Study|Protocol deviation|12|||
48523639|NCT01120691|156107409|FG002|Overall Study|Protocol deviation|12|||
48523640|NCT01120691|156107407|FG000|Overall Study|Lost to Follow-up|5|||
48523641|NCT01120691|156107408|FG001|Overall Study|Lost to Follow-up|6|||
48523642|NCT01120691|156107409|FG002|Overall Study|Lost to Follow-up|4|||
48523643|NCT01120691|156107407|FG000|Overall Study|Abnormal test procedure result(s)|3|||
48523644|NCT01120691|156107408|FG001|Overall Study|Abnormal test procedure result(s)|2|||
48523645|NCT01120691|156107409|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48523646|NCT01120691|156107407|FG000|Overall Study|Patient's inability to use the device|3|||
48733349|NCT02497612|156876175|FG001|Overall Study|Other unspecified|1|||
48733350|NCT02497612|156876176|FG002|Overall Study|Other unspecified|2|||
48733351|NCT02497612|156876177|FG003|Overall Study|Other unspecified|0|||
48733352|NCT02497612|156876174|FG000|Overall Study|Not eligible|1|||
48733353|NCT02497612|156876175|FG001|Overall Study|Not eligible|0|||
48733354|NCT02497612|156876176|FG002|Overall Study|Not eligible|0|||
48733355|NCT02497612|156876177|FG003|Overall Study|Not eligible|1|||
48733356|NCT02180165|156876180|FG000|Overall Study|Not Treated|0|||
48733357|NCT02180165|156876181|FG001|Overall Study|Not Treated|0|||
48733358|NCT02180165|156876182|FG002|Overall Study|Not Treated|1|||
48733359|NCT02180165|156876183|FG003|Overall Study|Not Treated|0|||
48733360|NCT02180165|156876180|FG000|Overall Study|Adverse Event|7|||
48733361|NCT02180165|156876181|FG001|Overall Study|Adverse Event|0|||
48733362|NCT02180165|156876182|FG002|Overall Study|Adverse Event|18|||
48733363|NCT02180165|156876183|FG003|Overall Study|Adverse Event|3|||
48733364|NCT02180165|156876180|FG000|Overall Study|Lack of Efficacy|0|||
48733365|NCT02180165|156876181|FG001|Overall Study|Lack of Efficacy|1|||
48733366|NCT02180165|156876182|FG002|Overall Study|Lack of Efficacy|3|||
48733367|NCT02180165|156876183|FG003|Overall Study|Lack of Efficacy|2|||
48733368|NCT02180165|156876180|FG000|Overall Study|Physician Decision|1|||
48733369|NCT02180165|156876181|FG001|Overall Study|Physician Decision|0|||
48733370|NCT02180165|156876182|FG002|Overall Study|Physician Decision|5|||
48733371|NCT02180165|156876183|FG003|Overall Study|Physician Decision|0|||
48733372|NCT02180165|156876180|FG000|Overall Study|Withdrawal by Subject|3|||
48733373|NCT02180165|156876181|FG001|Overall Study|Withdrawal by Subject|0|||
48733374|NCT02180165|156876182|FG002|Overall Study|Withdrawal by Subject|2|||
48733375|NCT02180165|156876183|FG003|Overall Study|Withdrawal by Subject|1|||
48733376|NCT01200524|156876188|FG000|Overall Study|Withdrawal by Subject|1|||
48733377|NCT01200524|156876189|FG001|Overall Study|Withdrawal by Subject|1|||
48733378|NCT01200524|156876190|FG002|Overall Study|Withdrawal by Subject|3|||
48733379|NCT01200524|156876188|FG000|Overall Study|Adverse Event|1|||
48733380|NCT01200524|156876189|FG001|Overall Study|Adverse Event|0|||
48733381|NCT01200524|156876190|FG002|Overall Study|Adverse Event|0|||
48733382|NCT01200524|156876188|FG000|Overall Study|Non availability of study nurse|0|||
48733383|NCT01200524|156876189|FG001|Overall Study|Non availability of study nurse|0|||
48733384|NCT01200524|156876190|FG002|Overall Study|Non availability of study nurse|1|||
48733385|NCT01303861|156876191|FG000|Overall Study|Lost to Follow-up|34|||
48733386|NCT01303861|156876192|FG001|Overall Study|Lost to Follow-up|14|||
48733387|NCT01303861|156876193|FG002|Overall Study|Lost to Follow-up|27|||
48733388|NCT01303861|156876194|FG003|Overall Study|Lost to Follow-up|31|||
48733389|NCT01303861|156876191|FG000|Overall Study|Lack of Efficacy|3|||
48733390|NCT01303861|156876192|FG001|Overall Study|Lack of Efficacy|2|||
48733391|NCT01303861|156876193|FG002|Overall Study|Lack of Efficacy|1|||
48733392|NCT01303861|156876194|FG003|Overall Study|Lack of Efficacy|0|||
48733393|NCT01303861|156876191|FG000|Overall Study|Withdrawal by Subject|16|||
48733394|NCT01303861|156876192|FG001|Overall Study|Withdrawal by Subject|8|||
48733395|NCT01303861|156876193|FG002|Overall Study|Withdrawal by Subject|8|||
48733396|NCT01303861|156876194|FG003|Overall Study|Withdrawal by Subject|23|||
48733397|NCT01303861|156876191|FG000|Overall Study|Adverse Event|4|||
48733398|NCT01303861|156876192|FG001|Overall Study|Adverse Event|1|||
48733399|NCT01303861|156876193|FG002|Overall Study|Adverse Event|0|||
48733400|NCT01303861|156876194|FG003|Overall Study|Adverse Event|5|||
48733401|NCT01303861|156876191|FG000|Overall Study|Pregnancy|1|||
48733402|NCT01303861|156876192|FG001|Overall Study|Pregnancy|0|||
48733403|NCT01303861|156876193|FG002|Overall Study|Pregnancy|0|||
48733404|NCT01303861|156876194|FG003|Overall Study|Pregnancy|0|||
48733405|NCT03270644|156876198|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
48733406|NCT03270644|156876198|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
48733407|NCT04676412|156876199|FG000|Overall Study|Death|17|||
48733408|NCT04676412|156876200|FG001|Overall Study|Death|23|||
48733409|NCT04676412|156876199|FG000|Overall Study|Withdrawal by Subject|0|||
48733410|NCT04676412|156876200|FG001|Overall Study|Withdrawal by Subject|2|||
48733411|NCT04676412|156876199|FG000|Overall Study|Participants ongoing|32|||
48733412|NCT04676412|156876200|FG001|Overall Study|Participants ongoing|33|||
48733413|NCT00902668|156876201|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
48733414|NCT01914757|156876202|FG000|Overall Study|Severe non-compliance to protocol|3|||
48733415|NCT01914757|156876203|FG001|Overall Study|Severe non-compliance to protocol|1|||
48733416|NCT01914757|156876204|FG002|Overall Study|Severe non-compliance to protocol|2|||
48733417|NCT01914757|156876202|FG000|Overall Study|Lost to Follow-up|5|||
48733418|NCT01914757|156876203|FG001|Overall Study|Lost to Follow-up|8|||
48733419|NCT01914757|156876204|FG002|Overall Study|Lost to Follow-up|6|||
48733420|NCT01914757|156876202|FG000|Overall Study|Withdrawal by Subject|15|||
48733421|NCT01914757|156876203|FG001|Overall Study|Withdrawal by Subject|27|||
48733422|NCT01914757|156876204|FG002|Overall Study|Withdrawal by Subject|19|||
48733423|NCT01914757|156876202|FG000|Overall Study|Death|2|||
48733424|NCT01914757|156876203|FG001|Overall Study|Death|2|||
48733425|NCT01914757|156876204|FG002|Overall Study|Death|1|||
48733426|NCT01914757|156876202|FG000|Overall Study|Adverse Event|4|||
48733427|NCT01914757|156876203|FG001|Overall Study|Adverse Event|3|||
48733428|NCT01914757|156876204|FG002|Overall Study|Adverse Event|4|||
48733429|NCT01914757|156876202|FG000|Overall Study|Study specific withdrawal criteria|0|||
48733430|NCT01914757|156876203|FG001|Overall Study|Study specific withdrawal criteria|1|||
48733431|NCT01914757|156876204|FG002|Overall Study|Study specific withdrawal criteria|0|||
48443607|NCT01617655|155812797|FG000|Overall Study|Site closure|3|||
48443608|NCT01617655|155812798|FG001|Overall Study|Site closure|5|||
48443609|NCT01617655|155812797|FG000|Overall Study|Other than specified above|1|||
48443610|NCT01617655|155812798|FG001|Overall Study|Other than specified above|2|||
48443611|NCT01175213|155812799|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
48443612|NCT01175213|155812800|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
48443613|NCT01175213|155812799|FG000|IGSC, 10%/rHuPH20|Death|1|||
48443614|NCT01175213|155812800|FG001|IGSC, 10%/rHuPH20|Death|0|||
48825593|NCT02403323|157202122|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
48825594|NCT02403323|157202123|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
48825595|NCT02403323|157202124|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
48825596|NCT04824131|157202125|FG000|CAB LA Oral Phase|Adverse Event|1|||
48825597|NCT04824131|157202125|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
48825598|NCT04824131|157202125|FG000|Step 3|Withdrawal by Subject|2|||
48825599|NCT05489224|157202126|FG000|Treatment Period I|Withdrawal by Subject|6|||
48825600|NCT05489224|157202127|FG001|Treatment Period I|Withdrawal by Subject|5|||
48825601|NCT05489224|157202128|FG002|Treatment Period I|Withdrawal by Subject|0|||
48825602|NCT05489224|157202126|FG000|Treatment Period I|Adverse Event|3|||
48825603|NCT05489224|157202127|FG001|Treatment Period I|Adverse Event|11|||
48825604|NCT05489224|157202128|FG002|Treatment Period I|Adverse Event|0|||
48825605|NCT05489224|157202126|FG000|Treatment Period I|Lost to Follow-up|0|||
48825606|NCT05489224|157202127|FG001|Treatment Period I|Lost to Follow-up|1|||
48825607|NCT05489224|157202128|FG002|Treatment Period I|Lost to Follow-up|0|||
48825608|NCT05489224|157202126|FG000|Treatment Period I|Physician Decision|0|||
48825609|NCT05489224|157202127|FG001|Treatment Period I|Physician Decision|1|||
48825610|NCT05489224|157202128|FG002|Treatment Period I|Physician Decision|0|||
48825611|NCT05489224|157202126|FG000|Treatment Period II up to Week 32|Ongoing|222|||
48825612|NCT05489224|157202127|FG001|Treatment Period II up to Week 32|Ongoing|107|||
48825613|NCT05489224|157202128|FG002|Treatment Period II up to Week 32|Ongoing|107|||
48825614|NCT05489224|157202126|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
48825615|NCT05489224|157202127|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
48825616|NCT05489224|157202128|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
48825617|NCT05489224|157202126|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
48825618|NCT05489224|157202127|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
48825619|NCT05489224|157202128|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
48825620|NCT04887285|157202130|FG000|Overall Study|Lost to Follow-up|0|||
48825621|NCT04887285|157202131|FG001|Overall Study|Lost to Follow-up|2|||
48825622|NCT04887285|157202132|FG002|Overall Study|Lost to Follow-up|3|||
48825623|NCT04269889|157202133|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
48825624|NCT04269889|157202133|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
48825625|NCT04530344|157202137|FG000|Overall Study|Lost to Follow-up|3|||
48825626|NCT04530344|157202138|FG001|Overall Study|Lost to Follow-up|3|||
48523647|NCT01120691|156107408|FG001|Overall Study|Patient's inability to use the device|1|||
48523648|NCT01120691|156107409|FG002|Overall Study|Patient's inability to use the device|0|||
48523649|NCT01120691|156107407|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48523650|NCT01120691|156107408|FG001|Overall Study|Abnormal laboratory value(s)|3|||
48523651|NCT01120691|156107409|FG002|Overall Study|Abnormal laboratory value(s)|4|||
48523652|NCT01588548|156107412|FG000|Overall Study|Withdrawal by Subject|0|||
48523653|NCT01588548|156107413|FG001|Overall Study|Withdrawal by Subject|1|||
48523654|NCT01588548|156107414|FG002|Overall Study|Withdrawal by Subject|1|||
48523655|NCT01588548|156107415|FG003|Overall Study|Withdrawal by Subject|1|||
48523656|NCT01588548|156107416|FG004|Overall Study|Withdrawal by Subject|2|||
48523657|NCT01588548|156107417|FG005|Overall Study|Withdrawal by Subject|3|||
48523658|NCT01588548|156107412|FG000|Overall Study|Adverse Event|0|||
48523659|NCT01588548|156107413|FG001|Overall Study|Adverse Event|0|||
48523660|NCT01588548|156107414|FG002|Overall Study|Adverse Event|1|||
48523661|NCT01588548|156107415|FG003|Overall Study|Adverse Event|2|||
48523662|NCT01588548|156107416|FG004|Overall Study|Adverse Event|1|||
48523663|NCT01588548|156107417|FG005|Overall Study|Adverse Event|0|||
48523664|NCT01588548|156107412|FG000|Overall Study|Condition Under Investigation Worsened|3|||
48523665|NCT01588548|156107413|FG001|Overall Study|Condition Under Investigation Worsened|6|||
48523666|NCT01588548|156107414|FG002|Overall Study|Condition Under Investigation Worsened|4|||
48523667|NCT01588548|156107415|FG003|Overall Study|Condition Under Investigation Worsened|4|||
48523668|NCT01588548|156107416|FG004|Overall Study|Condition Under Investigation Worsened|3|||
48523669|NCT01588548|156107417|FG005|Overall Study|Condition Under Investigation Worsened|3|||
48523670|NCT00787605|156107424|FG000|Overall Study|Administrative Problems|3|||
48523671|NCT00787605|156107425|FG001|Overall Study|Administrative Problems|0|||
48523672|NCT00787605|156107424|FG000|Overall Study|Adverse Event|14|||
48523673|NCT00787605|156107425|FG001|Overall Study|Adverse Event|25|||
48523674|NCT00787605|156107424|FG000|Overall Study|Lost to Follow-up|3|||
48523675|NCT00787605|156107425|FG001|Overall Study|Lost to Follow-up|6|||
48523676|NCT00787605|156107424|FG000|Overall Study|Protocol Violation|7|||
48523677|NCT00787605|156107425|FG001|Overall Study|Protocol Violation|3|||
48825627|NCT04530344|157202139|FG002|Overall Study|Lost to Follow-up|3|||
48825628|NCT04530344|157202140|FG003|Overall Study|Lost to Follow-up|10|||
48825629|NCT04530344|157202137|FG000|Overall Study|Withdrawal by Subject|14|||
48825630|NCT04530344|157202138|FG001|Overall Study|Withdrawal by Subject|5|||
48825631|NCT04530344|157202139|FG002|Overall Study|Withdrawal by Subject|18|||
48825632|NCT04530344|157202140|FG003|Overall Study|Withdrawal by Subject|33|||
48523678|NCT00787605|156107424|FG000|Overall Study|Withdrawal by Subject|6|||
48523679|NCT00787605|156107425|FG001|Overall Study|Withdrawal by Subject|13|||
48523680|NCT00787605|156107424|FG000|Overall Study|Lack of Efficacy|13|||
48523681|NCT00787605|156107425|FG001|Overall Study|Lack of Efficacy|9|||
48523682|NCT00089973|156107426|FG000|Overall Study|Adverse Event|3|||
48523683|NCT00089973|156107426|FG000|Overall Study|Withdrawal by Subject|1|||
48523684|NCT00089973|156107426|FG000|Overall Study|Disease progression|45|||
48523685|NCT00089973|156107426|FG000|Overall Study|Death|1|||
48523686|NCT01952691|156108851|FG000|Overall Study|Lost to Follow-up|2|||
48523687|NCT00274625|156108852|FG000|Overall Study|Lost to Follow-up|46|||
48523688|NCT00274625|156108853|FG001|Overall Study|Lost to Follow-up|54|||
48523689|NCT00274625|156108852|FG000|Overall Study|Excluded from analysis|14|||
48523690|NCT00274625|156108853|FG001|Overall Study|Excluded from analysis|8|||
48523691|NCT00559637|156108854|FG000|Overall Study|Adverse Event|22|||
48523692|NCT00559637|156108854|FG000|Overall Study|Withdrawal by Subject|4|||
48523693|NCT00559637|156108854|FG000|Overall Study|Protocol Violation|6|||
48523694|NCT00559637|156108854|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
48523695|NCT00559637|156108854|FG000|Overall Study|Failure to return|6|||
48523696|NCT00559637|156108854|FG000|Overall Study|Insufficient response|3|||
48523697|NCT00559637|156108854|FG000|Overall Study|Started requiring dialysis after month 7|2|||
48523698|NCT00559637|156108854|FG000|Overall Study|Suspected lung cancer|1|||
48523699|NCT00559637|156108854|FG000|Overall Study|Participation in another study|1|||
48523700|NCT00559637|156108854|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
48523701|NCT00559637|156108854|FG000|Overall Study|Change of center|1|||
48523702|NCT00559637|156108854|FG000|Overall Study|Change of home|1|||
48523703|NCT00559637|156108854|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
48523704|NCT01117987|156108855|FG000|Overall Study|Protocol deviation|0|||
48523705|NCT01117987|156108856|FG001|Overall Study|Protocol deviation|1|||
48523706|NCT01117987|156108855|FG000|Overall Study|Subject no longer requires study drug|1|||
48523707|NCT01117987|156108856|FG001|Overall Study|Subject no longer requires study drug|0|||
48733432|NCT01914757|156876202|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48733433|NCT01914757|156876203|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48733434|NCT01914757|156876204|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
48733435|NCT01914757|156876202|FG000|Overall Study|Other reasons|5|||
48733436|NCT01914757|156876203|FG001|Overall Study|Other reasons|9|||
48733437|NCT01914757|156876204|FG002|Overall Study|Other reasons|4|||
48733438|NCT05021081|156876205|FG000|Phase 2|Subject enrolled in error|1|||
48733439|NCT05021081|156876206|FG001|Phase 2|Subject enrolled in error|1|||
48733440|NCT05021081|156876207|FG002|Phase 2|Subject enrolled in error|0|||
48733441|NCT04697056|156876208|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
48733442|NCT04697056|156876209|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
48733443|NCT01925274|156876210|FG000|Overall Study|Death|1|||
48733444|NCT01925274|156876211|FG001|Overall Study|Death|0|||
48733445|NCT01925274|156876212|FG002|Overall Study|Death|0|||
48733446|NCT01925274|156876210|FG000|Overall Study|Lost to Follow-up|0|||
48733447|NCT01925274|156876211|FG001|Overall Study|Lost to Follow-up|1|||
48733448|NCT01925274|156876212|FG002|Overall Study|Lost to Follow-up|0|||
48733449|NCT01925274|156876210|FG000|Overall Study|Withdrawal by Subject|1|||
48733450|NCT01925274|156876211|FG001|Overall Study|Withdrawal by Subject|2|||
48733451|NCT01925274|156876212|FG002|Overall Study|Withdrawal by Subject|0|||
48733452|NCT01925274|156876210|FG000|Overall Study|Study terminated by sponsor|4|||
48733453|NCT01925274|156876211|FG001|Overall Study|Study terminated by sponsor|0|||
48733454|NCT01925274|156876212|FG002|Overall Study|Study terminated by sponsor|0|||
48733455|NCT01925274|156876210|FG000|Overall Study|Protocol amendment|1|||
48733456|NCT01925274|156876211|FG001|Overall Study|Protocol amendment|3|||
48733457|NCT01925274|156876212|FG002|Overall Study|Protocol amendment|6|||
48733458|NCT00057954|156876215|FG000|Overall Study|Death|1|||
48733459|NCT00057954|156876215|FG000|Overall Study|Disease progression|1|||
48733460|NCT00559754|156876217|FG000|Overall Study|Disease progression|1|||
48733461|NCT00559754|156876217|FG000|Overall Study|Adverse Event|5|||
48733462|NCT00559754|156876217|FG000|Overall Study|Protocol Violation|1|||
48733463|NCT00559754|156876217|FG000|Overall Study|Investigator criteria|2|||
48733464|NCT00559754|156876217|FG000|Overall Study|Withdrawal by Subject|2|||
48733465|NCT00369122|156876222|FG000|Overall Study|Ineligible|10|||
48733466|NCT00369122|156876222|FG000|Overall Study|No protocol treatment|1|||
48733467|NCT04327674|156876223|FG000|Overall Study|Protocol Violation|19|||
48733468|NCT01461980|156876226|FG000|Overall Study|Other|9|||
48523708|NCT01117987|156108855|FG000|Overall Study|Lost to Follow-up|1|||
48733469|NCT01461980|156876227|FG001|Overall Study|Other|8|||
48733470|NCT01461980|156876228|FG002|Overall Study|Other|6|||
48733471|NCT01461980|156876226|FG000|Overall Study|Medication error|7|||
48733472|NCT01461980|156876227|FG001|Overall Study|Medication error|5|||
48523709|NCT01117987|156108856|FG001|Overall Study|Lost to Follow-up|1|||
48523710|NCT01117987|156108855|FG000|Overall Study|Abnormal test procedure result|2|||
48523711|NCT01117987|156108856|FG001|Overall Study|Abnormal test procedure result|0|||
48523712|NCT01117987|156108855|FG000|Overall Study|Lack of Efficacy|3|||
48523713|NCT01117987|156108856|FG001|Overall Study|Lack of Efficacy|4|||
48523714|NCT01117987|156108855|FG000|Overall Study|Death|5|||
48523715|NCT01117987|156108856|FG001|Overall Study|Death|10|||
48523716|NCT01117987|156108855|FG000|Overall Study|Withdrawal by Subject|5|||
48733473|NCT01461980|156876228|FG002|Overall Study|Medication error|6|||
48733474|NCT01461980|156876226|FG000|Overall Study|Adverse Event|12|||
48733475|NCT01461980|156876227|FG001|Overall Study|Adverse Event|5|||
48733476|NCT01461980|156876228|FG002|Overall Study|Adverse Event|6|||
48733477|NCT01461980|156876226|FG000|Overall Study|Protocol Violation|12|||
48733478|NCT01461980|156876227|FG001|Overall Study|Protocol Violation|19|||
48825633|NCT04530344|157202137|FG000|Overall Study|Adverse Event|0|||
48523717|NCT01117987|156108856|FG001|Overall Study|Withdrawal by Subject|10|||
48523718|NCT01117987|156108855|FG000|Overall Study|Adverse Event|19|||
48523719|NCT01117987|156108856|FG001|Overall Study|Adverse Event|26|||
48523720|NCT01117987|156108855|FG000|Overall Study|Administrative problems|25|||
48523721|NCT01117987|156108856|FG001|Overall Study|Administrative problems|22|||
48733479|NCT01461980|156876228|FG002|Overall Study|Protocol Violation|16|||
48733480|NCT01461980|156876226|FG000|Overall Study|No longer meets eligibility criteria|18|||
48733481|NCT01461980|156876227|FG001|Overall Study|No longer meets eligibility criteria|9|||
48825634|NCT04530344|157202138|FG001|Overall Study|Adverse Event|0|||
48825635|NCT04530344|157202139|FG002|Overall Study|Adverse Event|0|||
48825636|NCT04530344|157202140|FG003|Overall Study|Adverse Event|1|||
48825637|NCT04530344|157202137|FG000|Overall Study|Lack of Efficacy|0|||
48825638|NCT04530344|157202138|FG001|Overall Study|Lack of Efficacy|0|||
48825639|NCT04530344|157202139|FG002|Overall Study|Lack of Efficacy|0|||
48523722|NCT01802216|156108857|FG000|4 Month Visit|Participant did not show to visit|3|||
48523723|NCT01802216|156108858|FG001|4 Month Visit|Participant did not show to visit|4|||
48523724|NCT01802216|156108857|FG000|8 Month Visit|Participant did not show to visit|3|||
48523725|NCT01802216|156108858|FG001|8 Month Visit|Participant did not show to visit|5|||
48523726|NCT01802216|156108857|FG000|12 Month Visit|Participant did not show to visit|3|||
48523727|NCT01802216|156108858|FG001|12 Month Visit|Participant did not show to visit|4|||
48523728|NCT05258630|156108864|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
48523729|NCT05258630|156108865|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
48523730|NCT05258630|156108864|FG000|Overall Study|Lost to Follow-up|0|||
48523731|NCT05258630|156108865|FG001|Overall Study|Lost to Follow-up|2|||
48523732|NCT00683592|156108866|FG000|Overall Study|Adverse Event|12|||
48523733|NCT00683592|156108867|FG001|Overall Study|Adverse Event|4|||
48523734|NCT00683592|156108866|FG000|Overall Study|Withdrawal by Subject|11|||
48523735|NCT00683592|156108867|FG001|Overall Study|Withdrawal by Subject|11|||
48523736|NCT00683592|156108866|FG000|Overall Study|Lost to Follow-up|17|||
48523737|NCT00683592|156108867|FG001|Overall Study|Lost to Follow-up|17|||
48523738|NCT00683592|156108866|FG000|Overall Study|Lack of Efficacy|3|||
48523739|NCT00683592|156108867|FG001|Overall Study|Lack of Efficacy|7|||
48523740|NCT00683592|156108866|FG000|Overall Study|Physician Decision|0|||
48523741|NCT00683592|156108867|FG001|Overall Study|Physician Decision|1|||
48523742|NCT00683592|156108866|FG000|Overall Study|Non-compliance|3|||
48523743|NCT00683592|156108867|FG001|Overall Study|Non-compliance|5|||
48523744|NCT00683592|156108866|FG000|Overall Study|Other|1|||
48523745|NCT00683592|156108867|FG001|Overall Study|Other|1|||
48523746|NCT01142908|156108869|FG000|Overall Study|Lost to Follow-up|19|||
48523747|NCT01142908|156108870|FG001|Overall Study|Lost to Follow-up|13|||
48523748|NCT01142908|156108869|FG000|Overall Study|Death|1|||
48523749|NCT01142908|156108870|FG001|Overall Study|Death|4|||
48523750|NCT01142908|156108869|FG000|Overall Study|Excluded - did not meet criteria|9|||
48523751|NCT01142908|156108870|FG001|Overall Study|Excluded - did not meet criteria|5|||
48523752|NCT01142908|156108869|FG000|Overall Study|Withdrawal by Subject|3|||
48523753|NCT01142908|156108870|FG001|Overall Study|Withdrawal by Subject|0|||
48523754|NCT03303417|156108878|FG000|Overall Study|Withdrawal by Subject|1|||
48523755|NCT03303417|156108879|FG001|Overall Study|Withdrawal by Subject|1|||
48523756|NCT02697617|156108880|FG000|Overall Study|Withdrawal by Subject|0|||
48523757|NCT02697617|156108881|FG001|Overall Study|Withdrawal by Subject|2|||
48523758|NCT02697617|156108880|FG000|Overall Study|Pregnancy|1|||
48523759|NCT02697617|156108881|FG001|Overall Study|Pregnancy|0|||
48523760|NCT02274558|156108884|FG000|Overall Study|Adverse Event|2|||
48523761|NCT02274558|156108885|FG001|Overall Study|Adverse Event|4|||
48523762|NCT02274558|156108886|FG002|Overall Study|Adverse Event|2|||
48523763|NCT02274558|156108884|FG000|Overall Study|Non-compliance|2|||
48733482|NCT01461980|156876228|FG002|Overall Study|No longer meets eligibility criteria|19|||
48733483|NCT01461980|156876226|FG000|Overall Study|Lost to Follow-up|52|||
48825640|NCT04530344|157202140|FG003|Overall Study|Lack of Efficacy|1|||
48523764|NCT02274558|156108885|FG001|Overall Study|Non-compliance|1|||
48825641|NCT04530344|157202137|FG000|Overall Study|Physician Decision|0|||
48825642|NCT04530344|157202138|FG001|Overall Study|Physician Decision|0|||
48825643|NCT04530344|157202139|FG002|Overall Study|Physician Decision|1|||
48523765|NCT02274558|156108886|FG002|Overall Study|Non-compliance|0|||
48523766|NCT02274558|156108884|FG000|Overall Study|Withdrawal by Subject|1|||
48523767|NCT02274558|156108885|FG001|Overall Study|Withdrawal by Subject|5|||
48523768|NCT02274558|156108886|FG002|Overall Study|Withdrawal by Subject|4|||
48523769|NCT02274558|156108884|FG000|Overall Study|Death|0|||
48523770|NCT02274558|156108885|FG001|Overall Study|Death|0|||
48523771|NCT02274558|156108886|FG002|Overall Study|Death|1|||
48523772|NCT02274558|156108884|FG000|Overall Study|Lost to Follow-up|2|||
48523773|NCT02274558|156108885|FG001|Overall Study|Lost to Follow-up|1|||
48523774|NCT02274558|156108886|FG002|Overall Study|Lost to Follow-up|1|||
48523775|NCT02274558|156108884|FG000|Overall Study|Physician Decision|0|||
48523776|NCT02274558|156108885|FG001|Overall Study|Physician Decision|2|||
48523777|NCT02274558|156108886|FG002|Overall Study|Physician Decision|1|||
48523778|NCT02460835|156108887|FG000|Overall Study|Disease progression prior to treatment|3|||
48523779|NCT02460835|156108887|FG000|Overall Study|Unable to complete planning scans|2|||
48523780|NCT02460835|156108887|FG000|Overall Study|Decrease in performance status|1|||
48523781|NCT02460835|156108887|FG000|Overall Study|Withdrawal by Subject|3|||
48523782|NCT02460835|156108887|FG000|Overall Study|Underwent fractionated RT|10|||
48523783|NCT02460835|156108887|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
48523784|NCT02655224|156108888|FG000|Overall Study|Adverse Event|1|||
48523785|NCT02655224|156108889|FG001|Overall Study|Adverse Event|1|||
48523786|NCT02219308|156108890|FG000|Overall Study|Withdrawal by Subject|1|||
48523787|NCT02219308|156108891|FG001|Overall Study|Withdrawal by Subject|2|||
48523788|NCT01157234|156108892|FG000|Overall Study|Withdrawal by Subject|1|||
48523789|NCT01157234|156108893|FG001|Overall Study|Withdrawal by Subject|0|||
48523790|NCT00381849|156108896|FG000|Wash Out|Withdrawal by Subject|0|||
48523791|NCT00381849|156108897|FG001|Wash Out|Withdrawal by Subject|1|||
48523792|NCT01332968|156108898|FG000|Induction Period|Adverse Event|23|||
48523793|NCT01332968|156108899|FG001|Induction Period|Adverse Event|26|||
48523794|NCT01332968|156108900|FG002|Induction Period|Adverse Event|0|||
48523795|NCT01332968|156108901|FG003|Induction Period|Adverse Event|0|||
48523796|NCT01332968|156108902|FG004|Induction Period|Adverse Event|0|||
48523797|NCT01332968|156108903|FG005|Induction Period|Adverse Event|0|||
48523798|NCT01332968|156108904|FG006|Induction Period|Adverse Event|0|||
48523799|NCT01332968|156108905|FG007|Induction Period|Adverse Event|0|||
48523800|NCT01332968|156108898|FG000|Induction Period|Death|1|||
48523801|NCT01332968|156108899|FG001|Induction Period|Death|4|||
48523802|NCT01332968|156108900|FG002|Induction Period|Death|0|||
48523803|NCT01332968|156108901|FG003|Induction Period|Death|0|||
48523804|NCT01332968|156108902|FG004|Induction Period|Death|0|||
48523805|NCT01332968|156108903|FG005|Induction Period|Death|0|||
48523806|NCT01332968|156108904|FG006|Induction Period|Death|0|||
48523807|NCT01332968|156108905|FG007|Induction Period|Death|0|||
48523808|NCT01332968|156108898|FG000|Induction Period|Non-compliance|1|||
48523809|NCT01332968|156108899|FG001|Induction Period|Non-compliance|0|||
48523810|NCT01332968|156108900|FG002|Induction Period|Non-compliance|0|||
48523811|NCT01332968|156108901|FG003|Induction Period|Non-compliance|0|||
48523812|NCT01332968|156108902|FG004|Induction Period|Non-compliance|0|||
48523813|NCT01332968|156108903|FG005|Induction Period|Non-compliance|0|||
48523814|NCT01332968|156108904|FG006|Induction Period|Non-compliance|0|||
48523815|NCT01332968|156108905|FG007|Induction Period|Non-compliance|0|||
48523816|NCT01332968|156108898|FG000|Induction Period|Other|2|||
48523817|NCT01332968|156108899|FG001|Induction Period|Other|2|||
48523818|NCT01332968|156108900|FG002|Induction Period|Other|0|||
48523819|NCT01332968|156108901|FG003|Induction Period|Other|0|||
48523820|NCT01332968|156108902|FG004|Induction Period|Other|0|||
48523821|NCT01332968|156108903|FG005|Induction Period|Other|0|||
48523822|NCT01332968|156108904|FG006|Induction Period|Other|0|||
48523823|NCT01332968|156108905|FG007|Induction Period|Other|0|||
48523824|NCT01332968|156108898|FG000|Induction Period|Physician Decision|6|||
48523825|NCT01332968|156108899|FG001|Induction Period|Physician Decision|1|||
48523826|NCT01332968|156108900|FG002|Induction Period|Physician Decision|0|||
48523827|NCT01332968|156108901|FG003|Induction Period|Physician Decision|0|||
48523828|NCT01332968|156108902|FG004|Induction Period|Physician Decision|0|||
48523829|NCT01332968|156108903|FG005|Induction Period|Physician Decision|0|||
48523830|NCT01332968|156108904|FG006|Induction Period|Physician Decision|0|||
48523831|NCT01332968|156108905|FG007|Induction Period|Physician Decision|0|||
48523832|NCT01332968|156108898|FG000|Induction Period|Progressive Disease|15|||
48523833|NCT01332968|156108899|FG001|Induction Period|Progressive Disease|7|||
48523834|NCT01332968|156108900|FG002|Induction Period|Progressive Disease|0|||
48733484|NCT01461980|156876227|FG001|Overall Study|Lost to Follow-up|53|||
48733485|NCT01461980|156876228|FG002|Overall Study|Lost to Follow-up|51|||
48733486|NCT01461980|156876226|FG000|Overall Study|No longer willing to participate|52|||
48733487|NCT01461980|156876227|FG001|Overall Study|No longer willing to participate|38|||
48733488|NCT01461980|156876228|FG002|Overall Study|No longer willing to participate|54|||
48733489|NCT01461980|156876226|FG000|Overall Study|Randomized but not vaccinated|4|||
48733490|NCT01461980|156876227|FG001|Overall Study|Randomized but not vaccinated|8|||
48733491|NCT01461980|156876228|FG002|Overall Study|Randomized but not vaccinated|7|||
48733492|NCT00723398|156876233|FG000|Overall Study|Withdrawal by Subject|2|||
48733493|NCT00723398|156876234|FG001|Overall Study|Withdrawal by Subject|6|||
48733494|NCT00723398|156876235|FG002|Overall Study|Withdrawal by Subject|4|||
48733495|NCT00723398|156876236|FG003|Overall Study|Withdrawal by Subject|4|||
48733496|NCT00723398|156876237|FG004|Overall Study|Withdrawal by Subject|4|||
48733497|NCT00723398|156876233|FG000|Overall Study|Protocol Violation|2|||
48733498|NCT00723398|156876234|FG001|Overall Study|Protocol Violation|1|||
48733499|NCT00723398|156876235|FG002|Overall Study|Protocol Violation|5|||
48733500|NCT00723398|156876236|FG003|Overall Study|Protocol Violation|0|||
48523835|NCT01332968|156108901|FG003|Induction Period|Progressive Disease|0|||
48523836|NCT01332968|156108902|FG004|Induction Period|Progressive Disease|0|||
48523837|NCT01332968|156108903|FG005|Induction Period|Progressive Disease|0|||
48523838|NCT01332968|156108904|FG006|Induction Period|Progressive Disease|0|||
48523839|NCT01332968|156108905|FG007|Induction Period|Progressive Disease|0|||
48523840|NCT01332968|156108898|FG000|Induction Period|Protocol Violation|3|||
48523841|NCT01332968|156108899|FG001|Induction Period|Protocol Violation|4|||
48523842|NCT01332968|156108900|FG002|Induction Period|Protocol Violation|0|||
48523843|NCT01332968|156108901|FG003|Induction Period|Protocol Violation|0|||
48523844|NCT01332968|156108902|FG004|Induction Period|Protocol Violation|0|||
48523845|NCT01332968|156108903|FG005|Induction Period|Protocol Violation|0|||
48523846|NCT01332968|156108904|FG006|Induction Period|Protocol Violation|0|||
48523847|NCT01332968|156108905|FG007|Induction Period|Protocol Violation|0|||
48523848|NCT01332968|156108898|FG000|Induction Period|Withdrawal by Subject|3|||
48523849|NCT01332968|156108899|FG001|Induction Period|Withdrawal by Subject|5|||
48523850|NCT01332968|156108900|FG002|Induction Period|Withdrawal by Subject|0|||
48523851|NCT01332968|156108901|FG003|Induction Period|Withdrawal by Subject|0|||
48601807|NCT01325350|156399425|FG004|Overall Study|Did Not Receive Treatment|1|||
48601808|NCT01484951|156399427|FG000|Overall Study|Adverse Event|3|||
48733501|NCT00723398|156876237|FG004|Overall Study|Protocol Violation|0|||
48733502|NCT00723398|156876233|FG000|Overall Study|Physician Decision|2|||
48733503|NCT00723398|156876234|FG001|Overall Study|Physician Decision|2|||
48733504|NCT00723398|156876235|FG002|Overall Study|Physician Decision|5|||
48733505|NCT00723398|156876236|FG003|Overall Study|Physician Decision|0|||
48733506|NCT00723398|156876237|FG004|Overall Study|Physician Decision|1|||
48733507|NCT00723398|156876233|FG000|Overall Study|Adverse Event|0|||
48825644|NCT04530344|157202140|FG003|Overall Study|Physician Decision|1|||
48825645|NCT04530344|157202137|FG000|Overall Study|Pregnancy|0|||
48825646|NCT04530344|157202138|FG001|Overall Study|Pregnancy|0|||
48825647|NCT04530344|157202139|FG002|Overall Study|Pregnancy|2|||
48523852|NCT01332968|156108902|FG004|Induction Period|Withdrawal by Subject|0|||
48523853|NCT01332968|156108903|FG005|Induction Period|Withdrawal by Subject|0|||
48523854|NCT01332968|156108904|FG006|Induction Period|Withdrawal by Subject|0|||
48523855|NCT01332968|156108905|FG007|Induction Period|Withdrawal by Subject|0|||
48523856|NCT01332968|156108898|FG000|Induction Period|Randomised but not treated|4|||
48523857|NCT01332968|156108899|FG001|Induction Period|Randomised but not treated|7|||
48601809|NCT01484951|156399427|FG000|Overall Study|Personal Reasons|1|||
48825648|NCT04530344|157202140|FG003|Overall Study|Pregnancy|1|||
48825649|NCT04530344|157202137|FG000|Overall Study|Protocol Violation|0|||
48825650|NCT04530344|157202138|FG001|Overall Study|Protocol Violation|0|||
48825651|NCT04530344|157202139|FG002|Overall Study|Protocol Violation|0|||
48825652|NCT04530344|157202140|FG003|Overall Study|Protocol Violation|1|||
48825653|NCT04530344|157202137|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
48825654|NCT04530344|157202138|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
48825655|NCT04530344|157202139|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
48825656|NCT04530344|157202140|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
48825657|NCT04530344|157202137|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
48523858|NCT01332968|156108900|FG002|Induction Period|Randomised but not treated|0|||
48523859|NCT01332968|156108901|FG003|Induction Period|Randomised but not treated|0|||
48601810|NCT01484951|156399427|FG000|Overall Study|Non-Compliance|1|||
48601811|NCT02224625|156399428|FG000|Irritation|Adverse Event|6|||
48601812|NCT02224625|156399428|FG000|Sensitization|Adverse Event|55|||
48601813|NCT00956839|156399430|FG000|Overall Study|Lost to Follow-up|3|||
48601814|NCT00956839|156399431|FG001|Overall Study|Lost to Follow-up|0|||
48601815|NCT00956839|156399432|FG002|Overall Study|Lost to Follow-up|3|||
48601816|NCT02121795|156399435|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
48601817|NCT02121795|156399436|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
48601818|NCT02121795|156399435|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
48601819|NCT02121795|156399436|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
48601820|NCT02121795|156399435|FG000|Double-Blind Phase|Lost to Follow-up|7|||
48601821|NCT02121795|156399436|FG001|Double-Blind Phase|Lost to Follow-up|4|||
48601822|NCT02121795|156399435|FG000|Double-Blind Phase|Physician Decision|2|||
48601823|NCT02121795|156399436|FG001|Double-Blind Phase|Physician Decision|5|||
48825658|NCT04530344|157202138|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
48601824|NCT02121795|156399435|FG000|Double-Blind Phase|Adverse Event|5|||
48601825|NCT02121795|156399436|FG001|Double-Blind Phase|Adverse Event|0|||
48601826|NCT02121795|156399435|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
48601827|NCT02121795|156399436|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
48601828|NCT02121795|156399435|FG000|Double-Blind Phase|Protocol Violation|0|||
48733508|NCT00723398|156876234|FG001|Overall Study|Adverse Event|5|||
48523860|NCT01332968|156108902|FG004|Induction Period|Randomised but not treated|0|||
48523861|NCT01332968|156108903|FG005|Induction Period|Randomised but not treated|0|||
48601829|NCT02121795|156399436|FG001|Double-Blind Phase|Protocol Violation|3|||
48601830|NCT02121795|156399435|FG000|Double-Blind Phase|Death|1|||
48733509|NCT00723398|156876235|FG002|Overall Study|Adverse Event|3|||
48523862|NCT01332968|156108904|FG006|Induction Period|Randomised but not treated|0|||
48523863|NCT01332968|156108905|FG007|Induction Period|Randomised but not treated|0|||
48733510|NCT00723398|156876236|FG003|Overall Study|Adverse Event|1|||
48523864|NCT01332968|156108898|FG000|Maintenance/Observation Period|Adverse Event|0|||
48523865|NCT01332968|156108899|FG001|Maintenance/Observation Period|Adverse Event|0|||
48523866|NCT01332968|156108900|FG002|Maintenance/Observation Period|Adverse Event|53|||
48523867|NCT01332968|156108901|FG003|Maintenance/Observation Period|Adverse Event|66|||
48523868|NCT01332968|156108902|FG004|Maintenance/Observation Period|Adverse Event|0|||
48523869|NCT01332968|156108903|FG005|Maintenance/Observation Period|Adverse Event|0|||
48523870|NCT01332968|156108904|FG006|Maintenance/Observation Period|Adverse Event|0|||
48523871|NCT01332968|156108905|FG007|Maintenance/Observation Period|Adverse Event|0|||
48523872|NCT01332968|156108898|FG000|Maintenance/Observation Period|Death|0|||
48523873|NCT01332968|156108899|FG001|Maintenance/Observation Period|Death|0|||
48523874|NCT01332968|156108900|FG002|Maintenance/Observation Period|Death|5|||
48523875|NCT01332968|156108901|FG003|Maintenance/Observation Period|Death|6|||
48523876|NCT01332968|156108902|FG004|Maintenance/Observation Period|Death|0|||
48523877|NCT01332968|156108903|FG005|Maintenance/Observation Period|Death|0|||
48523878|NCT01332968|156108904|FG006|Maintenance/Observation Period|Death|0|||
48523879|NCT01332968|156108905|FG007|Maintenance/Observation Period|Death|0|||
48523880|NCT01332968|156108898|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
48733511|NCT00723398|156876237|FG004|Overall Study|Adverse Event|4|||
48733512|NCT00723398|156876233|FG000|Overall Study|Lost to Follow-up|0|||
48733513|NCT00723398|156876234|FG001|Overall Study|Lost to Follow-up|1|||
48733514|NCT00723398|156876235|FG002|Overall Study|Lost to Follow-up|0|||
48733515|NCT00723398|156876236|FG003|Overall Study|Lost to Follow-up|0|||
48733516|NCT00723398|156876237|FG004|Overall Study|Lost to Follow-up|0|||
48733517|NCT02147184|156876238|FG000|Overall Study|Lost to Follow-up|28|||
48733518|NCT02147184|156876239|FG001|Overall Study|Lost to Follow-up|15|||
48733519|NCT02147184|156876238|FG000|Overall Study|Study Burden|11|||
48733520|NCT02147184|156876239|FG001|Overall Study|Study Burden|7|||
48733521|NCT02147184|156876238|FG000|Overall Study|Pregnancy|6|||
48733522|NCT02147184|156876239|FG001|Overall Study|Pregnancy|0|||
48733523|NCT02147184|156876238|FG000|Overall Study|Moved out of state|3|||
48733524|NCT02147184|156876239|FG001|Overall Study|Moved out of state|3|||
48733525|NCT02147184|156876238|FG000|Overall Study|Physician Decision|0|||
48733526|NCT02147184|156876239|FG001|Overall Study|Physician Decision|2|||
48733527|NCT02147184|156876238|FG000|Overall Study|Other|1|||
48733528|NCT02147184|156876239|FG001|Overall Study|Other|0|||
48733529|NCT00191906|156876240|FG000|Study Period II|Adverse Event|0|||
48733530|NCT00191906|156876241|FG001|Study Period II|Adverse Event|1|||
48733531|NCT00191906|156876242|FG002|Study Period II|Adverse Event|0|||
48733532|NCT00191906|156876243|FG003|Study Period II|Adverse Event|0|||
48733533|NCT00191906|156876240|FG000|Study Period II|Withdrawal by Subject|0|||
48733534|NCT00191906|156876241|FG001|Study Period II|Withdrawal by Subject|3|||
48733535|NCT00191906|156876242|FG002|Study Period II|Withdrawal by Subject|0|||
48733536|NCT00191906|156876243|FG003|Study Period II|Withdrawal by Subject|0|||
48733537|NCT00191906|156876240|FG000|Study Period II|Parent/Caregiver Decision|0|||
48733538|NCT00191906|156876241|FG001|Study Period II|Parent/Caregiver Decision|1|||
48733539|NCT00191906|156876242|FG002|Study Period II|Parent/Caregiver Decision|0|||
48733540|NCT00191906|156876243|FG003|Study Period II|Parent/Caregiver Decision|0|||
48733541|NCT00191906|156876240|FG000|Study Period II|Entry Criteria Exclusion|0|||
48733542|NCT00191906|156876241|FG001|Study Period II|Entry Criteria Exclusion|0|||
48733543|NCT00191906|156876242|FG002|Study Period II|Entry Criteria Exclusion|1|||
48733544|NCT00191906|156876243|FG003|Study Period II|Entry Criteria Exclusion|0|||
48733545|NCT00191906|156876240|FG000|Study Period III|Adverse Event|1|||
48733546|NCT00191906|156876241|FG001|Study Period III|Adverse Event|0|||
48733547|NCT00191906|156876242|FG002|Study Period III|Adverse Event|0|||
48733548|NCT00191906|156876243|FG003|Study Period III|Adverse Event|0|||
48733549|NCT00191906|156876240|FG000|Study Period III|Lost to Follow-up|0|||
48733550|NCT00191906|156876241|FG001|Study Period III|Lost to Follow-up|1|||
48733551|NCT00191906|156876242|FG002|Study Period III|Lost to Follow-up|0|||
48733552|NCT00191906|156876243|FG003|Study Period III|Lost to Follow-up|0|||
48733553|NCT00191906|156876240|FG000|Study Period III|Parent/Caregiver Decision|1|||
48733554|NCT00191906|156876241|FG001|Study Period III|Parent/Caregiver Decision|0|||
48733555|NCT00191906|156876242|FG002|Study Period III|Parent/Caregiver Decision|0|||
48733556|NCT00191906|156876243|FG003|Study Period III|Parent/Caregiver Decision|0|||
48733557|NCT00191906|156876240|FG000|Study Period III|Lack of Efficacy|3|||
48733558|NCT00191906|156876241|FG001|Study Period III|Lack of Efficacy|3|||
48733559|NCT00191906|156876242|FG002|Study Period III|Lack of Efficacy|0|||
48733560|NCT00191906|156876243|FG003|Study Period III|Lack of Efficacy|0|||
48733561|NCT00333801|156876244|FG000|Overall Study|Moved to another state|5|||
48733562|NCT00333801|156876245|FG001|Overall Study|Moved to another state|3|||
48733563|NCT00333801|156876244|FG000|Overall Study|Lost to Follow-up|2|||
48523881|NCT01332968|156108899|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
48733564|NCT00333801|156876245|FG001|Overall Study|Lost to Follow-up|0|||
48733565|NCT00333801|156876244|FG000|Overall Study|Incarcerated|1|||
48733566|NCT00333801|156876245|FG001|Overall Study|Incarcerated|2|||
48733567|NCT00333801|156876244|FG000|Overall Study|Withdrawal by Subject|0|||
48733568|NCT00333801|156876245|FG001|Overall Study|Withdrawal by Subject|1|||
48733569|NCT04171765|156876246|FG000|Overall Study|Adverse Event|2|||
48733570|NCT04171765|156876247|FG001|Overall Study|Adverse Event|0|||
48733571|NCT04171765|156876248|FG002|Overall Study|Adverse Event|1|||
48733572|NCT04171765|156876249|FG003|Overall Study|Adverse Event|0|||
48601831|NCT02121795|156399436|FG001|Double-Blind Phase|Death|1|||
48601832|NCT02121795|156399435|FG000|Open-Label Phase|Physician Decision|8|||
48601833|NCT02121795|156399436|FG001|Open-Label Phase|Physician Decision|8|||
48733573|NCT04171765|156876246|FG000|Overall Study|Lost to Follow-up|0|||
48601834|NCT02121795|156399435|FG000|Open-Label Phase|Withdrawal by Subject|3|||
48601835|NCT02121795|156399436|FG001|Open-Label Phase|Withdrawal by Subject|2|||
48601836|NCT02121795|156399435|FG000|Open-Label Phase|Lost to Follow-up|1|||
48601837|NCT02121795|156399436|FG001|Open-Label Phase|Lost to Follow-up|0|||
48601838|NCT01100853|156399439|FG000|Overall Study|Lost to Follow-up|11|||
48601839|NCT01100853|156399440|FG001|Overall Study|Lost to Follow-up|6|||
48601840|NCT01100853|156399439|FG000|Overall Study|Received <4 study injections|10|||
48601841|NCT01100853|156399440|FG001|Overall Study|Received <4 study injections|13|||
48601842|NCT01100853|156399439|FG000|Overall Study|Withdrawal by Subject|6|||
48601843|NCT01100853|156399440|FG001|Overall Study|Withdrawal by Subject|4|||
48733574|NCT04171765|156876247|FG001|Overall Study|Lost to Follow-up|2|||
48733575|NCT04171765|156876248|FG002|Overall Study|Lost to Follow-up|2|||
48601844|NCT01811732|156399446|FG000|Overall Study|Lost to Follow-up|24|||
48601845|NCT01811732|156399447|FG001|Overall Study|Lost to Follow-up|30|||
48601846|NCT01811732|156399446|FG000|Overall Study|Withdrawal by Subject|16|||
48601847|NCT01811732|156399447|FG001|Overall Study|Withdrawal by Subject|10|||
48601848|NCT01811732|156399446|FG000|Overall Study|Adverse Event|3|||
48601849|NCT01811732|156399447|FG001|Overall Study|Adverse Event|9|||
48733576|NCT04171765|156876249|FG003|Overall Study|Lost to Follow-up|2|||
48733577|NCT04171765|156876246|FG000|Overall Study|Week 58 visit missed|0|||
48733578|NCT04171765|156876247|FG001|Overall Study|Week 58 visit missed|0|||
48733579|NCT04171765|156876248|FG002|Overall Study|Week 58 visit missed|1|||
48733580|NCT04171765|156876249|FG003|Overall Study|Week 58 visit missed|0|||
48733581|NCT04171765|156876246|FG000|Overall Study|Study terminated by sponsor|2|||
48733582|NCT04171765|156876247|FG001|Overall Study|Study terminated by sponsor|0|||
48733583|NCT04171765|156876248|FG002|Overall Study|Study terminated by sponsor|0|||
48733584|NCT04171765|156876249|FG003|Overall Study|Study terminated by sponsor|0|||
48733585|NCT04171765|156876246|FG000|Overall Study|Withdrawal by Subject|1|||
48733586|NCT04171765|156876247|FG001|Overall Study|Withdrawal by Subject|0|||
48733587|NCT04171765|156876248|FG002|Overall Study|Withdrawal by Subject|0|||
48733588|NCT04171765|156876249|FG003|Overall Study|Withdrawal by Subject|3|||
48733589|NCT00122109|156876250|FG000|Overall Study|Did not meet criteria|6|||
48733590|NCT00122109|156876251|FG001|Overall Study|Did not meet criteria|7|||
48733591|NCT03633617|156876252|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
48733592|NCT03633617|156876253|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
48443694|NCT01624506|155812825|FG001|Overall Study|LINX explants|0|||
48443695|NCT01624506|155812824|FG000|Overall Study|Adverse Event|3|||
48443696|NCT01624506|155812825|FG001|Overall Study|Adverse Event|0|||
48443697|NCT01149343|155812826|FG000|Overall Study|Withdrawal by Subject|1|||
48443698|NCT01149343|155812827|FG001|Overall Study|Withdrawal by Subject|1|||
48443699|NCT01149343|155812828|FG002|Overall Study|Withdrawal by Subject|1|||
48443700|NCT01149343|155812829|FG003|Overall Study|Withdrawal by Subject|5|||
48443701|NCT01149343|155812826|FG000|Overall Study|Death|10|||
48443702|NCT01149343|155812827|FG001|Overall Study|Death|13|||
48443703|NCT01149343|155812828|FG002|Overall Study|Death|18|||
48443704|NCT01149343|155812829|FG003|Overall Study|Death|18|||
48443705|NCT01149343|155812826|FG000|Overall Study|Lost to Follow-up|1|||
48443706|NCT01149343|155812827|FG001|Overall Study|Lost to Follow-up|0|||
48443707|NCT01149343|155812828|FG002|Overall Study|Lost to Follow-up|0|||
48443708|NCT01149343|155812829|FG003|Overall Study|Lost to Follow-up|1|||
48443709|NCT01149343|155812826|FG000|Overall Study|Other|8|||
48443710|NCT01149343|155812827|FG001|Overall Study|Other|10|||
48443711|NCT01149343|155812828|FG002|Overall Study|Other|2|||
48443712|NCT01149343|155812829|FG003|Overall Study|Other|14|||
48443713|NCT01149343|155812826|FG000|Overall Study|Sponsor study termination|0|||
48443714|NCT01149343|155812827|FG001|Overall Study|Sponsor study termination|0|||
48443715|NCT01149343|155812828|FG002|Overall Study|Sponsor study termination|0|||
48443716|NCT01149343|155812829|FG003|Overall Study|Sponsor study termination|2|||
48443717|NCT01149343|155812826|FG000|Overall Study|Recurrence / Progressive disease|0|||
48443718|NCT01149343|155812827|FG001|Overall Study|Recurrence / Progressive disease|0|||
48443719|NCT01149343|155812828|FG002|Overall Study|Recurrence / Progressive disease|1|||
48443720|NCT01149343|155812829|FG003|Overall Study|Recurrence / Progressive disease|0|||
48443721|NCT03943446|155812830|FG000|Overall Study|Lost to Follow-up|0|||
48443722|NCT03943446|155812831|FG001|Overall Study|Lost to Follow-up|0|||
48443723|NCT03943446|155812832|FG002|Overall Study|Lost to Follow-up|1|||
48443724|NCT03943446|155812830|FG000|Overall Study|Withdrawal by Subject|1|||
48733593|NCT03633617|156876254|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733594|NCT03633617|156876255|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733595|NCT03633617|156876256|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733596|NCT03633617|156876257|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733597|NCT03633617|156876258|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733598|NCT03633617|156876259|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733599|NCT03633617|156876260|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733600|NCT03633617|156876261|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48733601|NCT03633617|156876262|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
48825659|NCT04530344|157202139|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
48825660|NCT04530344|157202140|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
48825661|NCT04530344|157202137|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
48825662|NCT04530344|157202138|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
48825663|NCT04530344|157202139|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
48825664|NCT04530344|157202140|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
48523882|NCT01332968|156108900|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
48523883|NCT01332968|156108901|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
48523884|NCT01332968|156108902|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
48523885|NCT01332968|156108903|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
48523886|NCT01332968|156108904|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
48523887|NCT01332968|156108905|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
48523888|NCT01332968|156108898|FG000|Maintenance/Observation Period|Non-compliance|0|||
48523889|NCT01332968|156108899|FG001|Maintenance/Observation Period|Non-compliance|0|||
48523890|NCT01332968|156108900|FG002|Maintenance/Observation Period|Non-compliance|4|||
48523891|NCT01332968|156108901|FG003|Maintenance/Observation Period|Non-compliance|3|||
48523892|NCT01332968|156108902|FG004|Maintenance/Observation Period|Non-compliance|0|||
48523893|NCT01332968|156108903|FG005|Maintenance/Observation Period|Non-compliance|0|||
48523894|NCT01332968|156108904|FG006|Maintenance/Observation Period|Non-compliance|0|||
48523895|NCT01332968|156108905|FG007|Maintenance/Observation Period|Non-compliance|0|||
48523896|NCT01332968|156108898|FG000|Maintenance/Observation Period|Other|0|||
48523897|NCT01332968|156108899|FG001|Maintenance/Observation Period|Other|0|||
48523898|NCT01332968|156108900|FG002|Maintenance/Observation Period|Other|4|||
48523899|NCT01332968|156108901|FG003|Maintenance/Observation Period|Other|7|||
48523900|NCT01332968|156108902|FG004|Maintenance/Observation Period|Other|0|||
48523901|NCT01332968|156108903|FG005|Maintenance/Observation Period|Other|0|||
48523902|NCT01332968|156108904|FG006|Maintenance/Observation Period|Other|0|||
48523903|NCT01332968|156108905|FG007|Maintenance/Observation Period|Other|0|||
48523904|NCT01332968|156108898|FG000|Maintenance/Observation Period|Physician Decision|0|||
48523905|NCT01332968|156108899|FG001|Maintenance/Observation Period|Physician Decision|0|||
48523906|NCT01332968|156108900|FG002|Maintenance/Observation Period|Physician Decision|14|||
48523907|NCT01332968|156108901|FG003|Maintenance/Observation Period|Physician Decision|19|||
48523908|NCT01332968|156108902|FG004|Maintenance/Observation Period|Physician Decision|0|||
48523909|NCT01332968|156108903|FG005|Maintenance/Observation Period|Physician Decision|1|||
48523910|NCT01332968|156108904|FG006|Maintenance/Observation Period|Physician Decision|0|||
48523911|NCT01332968|156108905|FG007|Maintenance/Observation Period|Physician Decision|0|||
48523912|NCT01332968|156108898|FG000|Maintenance/Observation Period|Progressive Disease|0|||
48523913|NCT01332968|156108899|FG001|Maintenance/Observation Period|Progressive Disease|0|||
48523914|NCT01332968|156108900|FG002|Maintenance/Observation Period|Progressive Disease|72|||
48523915|NCT01332968|156108901|FG003|Maintenance/Observation Period|Progressive Disease|40|||
48523916|NCT01332968|156108902|FG004|Maintenance/Observation Period|Progressive Disease|0|||
48523917|NCT01332968|156108903|FG005|Maintenance/Observation Period|Progressive Disease|0|||
48523918|NCT01332968|156108904|FG006|Maintenance/Observation Period|Progressive Disease|0|||
48601850|NCT01811732|156399446|FG000|Overall Study|Lack of Efficacy|3|||
48825665|NCT04530344|157202137|FG000|Overall Study|Personal Reasons|0|||
48825666|NCT04530344|157202138|FG001|Overall Study|Personal Reasons|0|||
48825667|NCT04530344|157202139|FG002|Overall Study|Personal Reasons|0|||
48825668|NCT04530344|157202140|FG003|Overall Study|Personal Reasons|1|||
48825669|NCT04530344|157202137|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
48825670|NCT04530344|157202138|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
48523919|NCT01332968|156108905|FG007|Maintenance/Observation Period|Progressive Disease|0|||
48523920|NCT01332968|156108898|FG000|Maintenance/Observation Period|Protocol Violation|0|||
48523921|NCT01332968|156108899|FG001|Maintenance/Observation Period|Protocol Violation|0|||
48523922|NCT01332968|156108900|FG002|Maintenance/Observation Period|Protocol Violation|1|||
48523923|NCT01332968|156108901|FG003|Maintenance/Observation Period|Protocol Violation|1|||
48523924|NCT01332968|156108902|FG004|Maintenance/Observation Period|Protocol Violation|0|||
48523925|NCT01332968|156108903|FG005|Maintenance/Observation Period|Protocol Violation|0|||
48523926|NCT01332968|156108904|FG006|Maintenance/Observation Period|Protocol Violation|0|||
48523927|NCT01332968|156108905|FG007|Maintenance/Observation Period|Protocol Violation|0|||
48523928|NCT01332968|156108898|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
48523929|NCT01332968|156108899|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
48523930|NCT01332968|156108900|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
48523931|NCT01332968|156108901|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
48523932|NCT01332968|156108902|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
48523933|NCT01332968|156108903|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
48523934|NCT01332968|156108904|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
48523935|NCT01332968|156108905|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
48523936|NCT01332968|156108898|FG000|Follow-Up Period|Adverse Event|0|||
48523937|NCT01332968|156108899|FG001|Follow-Up Period|Adverse Event|0|||
48523938|NCT01332968|156108900|FG002|Follow-Up Period|Adverse Event|0|||
48523939|NCT01332968|156108901|FG003|Follow-Up Period|Adverse Event|0|||
48523940|NCT01332968|156108902|FG004|Follow-Up Period|Adverse Event|0|||
48523941|NCT01332968|156108903|FG005|Follow-Up Period|Adverse Event|0|||
48523942|NCT01332968|156108904|FG006|Follow-Up Period|Adverse Event|0|||
48523943|NCT01332968|156108905|FG007|Follow-Up Period|Adverse Event|4|||
48523944|NCT01332968|156108898|FG000|Follow-Up Period|Death|0|||
48523945|NCT01332968|156108899|FG001|Follow-Up Period|Death|0|||
48523946|NCT01332968|156108900|FG002|Follow-Up Period|Death|0|||
48523947|NCT01332968|156108901|FG003|Follow-Up Period|Death|0|||
48523948|NCT01332968|156108902|FG004|Follow-Up Period|Death|0|||
48733602|NCT03633617|156876252|FG000|Part A|Unconfirmed early termination visit|1|||
48733603|NCT03633617|156876253|FG001|Part A|Unconfirmed early termination visit|0|||
48733604|NCT03633617|156876254|FG002|Part A|Unconfirmed early termination visit|0|||
48733605|NCT03633617|156876255|FG003|Part A|Unconfirmed early termination visit|0|||
48733606|NCT03633617|156876256|FG004|Part A|Unconfirmed early termination visit|0|||
48733607|NCT03633617|156876257|FG005|Part A|Unconfirmed early termination visit|0|||
48733608|NCT03633617|156876258|FG006|Part A|Unconfirmed early termination visit|0|||
48733609|NCT03633617|156876259|FG007|Part A|Unconfirmed early termination visit|0|||
48733610|NCT03633617|156876260|FG008|Part A|Unconfirmed early termination visit|0|||
48733611|NCT03633617|156876261|FG009|Part A|Unconfirmed early termination visit|0|||
48733612|NCT03633617|156876262|FG010|Part A|Unconfirmed early termination visit|0|||
48733613|NCT03633617|156876252|FG000|Part A|Adverse Event|0|||
48733614|NCT03633617|156876253|FG001|Part A|Adverse Event|1|||
48733615|NCT03633617|156876254|FG002|Part A|Adverse Event|0|||
48733616|NCT03633617|156876255|FG003|Part A|Adverse Event|0|||
48733617|NCT03633617|156876256|FG004|Part A|Adverse Event|0|||
48825671|NCT04530344|157202139|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
48825672|NCT04530344|157202140|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
48825673|NCT00832780|157202141|FG000|Overall Study|Death|16|||
48825674|NCT00832780|157202141|FG000|Overall Study|Lost to Follow-up|4|||
48825675|NCT00832780|157202141|FG000|Overall Study|no reason given|2|||
48825676|NCT00832780|157202141|FG000|Overall Study|other complicating condition|2|||
48825677|NCT00832780|157202141|FG000|Overall Study|Physician Decision|1|||
48825678|NCT05705167|157202146|FG000|Overall Study|Randomised but not Treated|0|||
48825679|NCT05705167|157202147|FG001|Overall Study|Randomised but not Treated|2|||
48825680|NCT05705167|157202148|FG002|Overall Study|Randomised but not Treated|0|||
48825681|NCT05705167|157202149|FG003|Overall Study|Randomised but not Treated|7|||
48825682|NCT05705167|157202150|FG004|Overall Study|Randomised but not Treated|0|||
48825683|NCT05705167|157202151|FG005|Overall Study|Randomised but not Treated|0|||
48825684|NCT05705167|157202152|FG006|Overall Study|Randomised but not Treated|0|||
48825685|NCT05705167|157202146|FG000|Overall Study|Death|0|||
48825686|NCT05705167|157202147|FG001|Overall Study|Death|0|||
48825687|NCT05705167|157202148|FG002|Overall Study|Death|3|||
48825688|NCT05705167|157202149|FG003|Overall Study|Death|0|||
48825689|NCT05705167|157202150|FG004|Overall Study|Death|1|||
48825690|NCT05705167|157202151|FG005|Overall Study|Death|1|||
48825691|NCT05705167|157202152|FG006|Overall Study|Death|1|||
48825692|NCT05705167|157202146|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
48825693|NCT05705167|157202147|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
48825694|NCT05705167|157202148|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
48825695|NCT05705167|157202149|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
48825696|NCT05705167|157202150|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
48825697|NCT05705167|157202151|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
48825698|NCT05705167|157202152|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
48825699|NCT01723774|157202153|FG000|Neoadjuvant|Ki67 > 10%|4|||
48825700|NCT01723774|157202154|FG001|Neoadjuvant|Ki67 > 10%|0|||
48523949|NCT01332968|156108903|FG005|Follow-Up Period|Death|0|||
48523950|NCT01332968|156108904|FG006|Follow-Up Period|Death|27|||
48523951|NCT01332968|156108905|FG007|Follow-Up Period|Death|30|||
48523952|NCT01332968|156108898|FG000|Follow-Up Period|Lost to Follow-up|0|||
48523953|NCT01332968|156108899|FG001|Follow-Up Period|Lost to Follow-up|0|||
48523954|NCT01332968|156108900|FG002|Follow-Up Period|Lost to Follow-up|0|||
48523955|NCT01332968|156108901|FG003|Follow-Up Period|Lost to Follow-up|0|||
48733618|NCT03633617|156876257|FG005|Part A|Adverse Event|0|||
48733619|NCT03633617|156876258|FG006|Part A|Adverse Event|0|||
48523956|NCT01332968|156108902|FG004|Follow-Up Period|Lost to Follow-up|0|||
48523957|NCT01332968|156108903|FG005|Follow-Up Period|Lost to Follow-up|0|||
48523958|NCT01332968|156108904|FG006|Follow-Up Period|Lost to Follow-up|11|||
48523959|NCT01332968|156108905|FG007|Follow-Up Period|Lost to Follow-up|15|||
48523960|NCT01332968|156108898|FG000|Follow-Up Period|Non-compliance|0|||
48523961|NCT01332968|156108899|FG001|Follow-Up Period|Non-compliance|0|||
48523962|NCT01332968|156108900|FG002|Follow-Up Period|Non-compliance|0|||
48523963|NCT01332968|156108901|FG003|Follow-Up Period|Non-compliance|0|||
48523964|NCT01332968|156108902|FG004|Follow-Up Period|Non-compliance|0|||
48523965|NCT01332968|156108903|FG005|Follow-Up Period|Non-compliance|0|||
48523966|NCT01332968|156108904|FG006|Follow-Up Period|Non-compliance|4|||
48523967|NCT01332968|156108905|FG007|Follow-Up Period|Non-compliance|9|||
48523968|NCT01332968|156108898|FG000|Follow-Up Period|Other|0|||
48523969|NCT01332968|156108899|FG001|Follow-Up Period|Other|0|||
48523970|NCT01332968|156108900|FG002|Follow-Up Period|Other|0|||
48523971|NCT01332968|156108901|FG003|Follow-Up Period|Other|0|||
48523972|NCT01332968|156108902|FG004|Follow-Up Period|Other|0|||
48523973|NCT01332968|156108903|FG005|Follow-Up Period|Other|0|||
48523974|NCT01332968|156108904|FG006|Follow-Up Period|Other|18|||
48523975|NCT01332968|156108905|FG007|Follow-Up Period|Other|21|||
48523976|NCT01332968|156108898|FG000|Follow-Up Period|Physician Decision|0|||
48523977|NCT01332968|156108899|FG001|Follow-Up Period|Physician Decision|0|||
48523978|NCT01332968|156108900|FG002|Follow-Up Period|Physician Decision|0|||
48523979|NCT01332968|156108901|FG003|Follow-Up Period|Physician Decision|0|||
48523980|NCT01332968|156108902|FG004|Follow-Up Period|Physician Decision|0|||
48523981|NCT01332968|156108903|FG005|Follow-Up Period|Physician Decision|0|||
48523982|NCT01332968|156108904|FG006|Follow-Up Period|Physician Decision|12|||
48523983|NCT01332968|156108905|FG007|Follow-Up Period|Physician Decision|15|||
48523984|NCT01332968|156108898|FG000|Follow-Up Period|Progressive Disease|0|||
48523985|NCT01332968|156108899|FG001|Follow-Up Period|Progressive Disease|0|||
48523986|NCT01332968|156108900|FG002|Follow-Up Period|Progressive Disease|0|||
48523987|NCT01332968|156108901|FG003|Follow-Up Period|Progressive Disease|0|||
48523988|NCT01332968|156108902|FG004|Follow-Up Period|Progressive Disease|0|||
48523989|NCT01332968|156108903|FG005|Follow-Up Period|Progressive Disease|0|||
48523990|NCT01332968|156108904|FG006|Follow-Up Period|Progressive Disease|126|||
48523991|NCT01332968|156108905|FG007|Follow-Up Period|Progressive Disease|106|||
48523992|NCT01332968|156108898|FG000|Follow-Up Period|Protocol Violation|0|||
48523993|NCT01332968|156108899|FG001|Follow-Up Period|Protocol Violation|0|||
48523994|NCT01332968|156108900|FG002|Follow-Up Period|Protocol Violation|0|||
48523995|NCT01332968|156108901|FG003|Follow-Up Period|Protocol Violation|0|||
48523996|NCT01332968|156108902|FG004|Follow-Up Period|Protocol Violation|0|||
48523997|NCT01332968|156108903|FG005|Follow-Up Period|Protocol Violation|0|||
48523998|NCT01332968|156108904|FG006|Follow-Up Period|Protocol Violation|1|||
48523999|NCT01332968|156108905|FG007|Follow-Up Period|Protocol Violation|0|||
48524000|NCT01332968|156108898|FG000|Follow-Up Period|Withdrawal by Subject|0|||
48524001|NCT01332968|156108899|FG001|Follow-Up Period|Withdrawal by Subject|0|||
48524002|NCT01332968|156108900|FG002|Follow-Up Period|Withdrawal by Subject|0|||
48524003|NCT01332968|156108901|FG003|Follow-Up Period|Withdrawal by Subject|0|||
48524004|NCT01332968|156108902|FG004|Follow-Up Period|Withdrawal by Subject|0|||
48524005|NCT01332968|156108903|FG005|Follow-Up Period|Withdrawal by Subject|0|||
48524006|NCT01332968|156108904|FG006|Follow-Up Period|Withdrawal by Subject|29|||
48524007|NCT01332968|156108905|FG007|Follow-Up Period|Withdrawal by Subject|32|||
48825701|NCT01723774|157202155|FG002|Neoadjuvant|Ki67 > 10%|10|||
48825702|NCT01723774|157202156|FG003|Neoadjuvant|Ki67 > 10%|0|||
48825703|NCT01723774|157202153|FG000|Neoadjuvant|Withdrawal by Subject|3|||
48825704|NCT01723774|157202154|FG001|Neoadjuvant|Withdrawal by Subject|1|||
48825705|NCT01723774|157202155|FG002|Neoadjuvant|Withdrawal by Subject|0|||
48825706|NCT01723774|157202156|FG003|Neoadjuvant|Withdrawal by Subject|0|||
48524008|NCT01332968|156108898|FG000|Follow-Up Period|No reason provided|0|||
48524009|NCT01332968|156108899|FG001|Follow-Up Period|No reason provided|0|||
48524010|NCT01332968|156108900|FG002|Follow-Up Period|No reason provided|0|||
48524011|NCT01332968|156108901|FG003|Follow-Up Period|No reason provided|0|||
48524012|NCT01332968|156108902|FG004|Follow-Up Period|No reason provided|0|||
48524013|NCT01332968|156108903|FG005|Follow-Up Period|No reason provided|0|||
48524014|NCT01332968|156108904|FG006|Follow-Up Period|No reason provided|2|||
48524015|NCT01332968|156108905|FG007|Follow-Up Period|No reason provided|3|||
48524016|NCT02351167|156108908|FG000|Overall Study|Withdrawal by Subject|19|||
48524017|NCT02351167|156108909|FG001|Overall Study|Withdrawal by Subject|18|||
48524018|NCT02351167|156108910|FG002|Overall Study|Withdrawal by Subject|21|||
48524019|NCT04117945|156108911|FG000|Overall Study|Death|1|||
48524020|NCT04117945|156108912|FG001|Overall Study|Death|0|||
48825707|NCT01723774|157202153|FG000|Neoadjuvant|Disease progression|0|||
48524021|NCT04117945|156108911|FG000|Overall Study|Withdrawal by Subject|3|||
48524022|NCT04117945|156108912|FG001|Overall Study|Withdrawal by Subject|1|||
48524023|NCT04117945|156108911|FG000|Overall Study|Disease Progression|0|||
48524024|NCT04117945|156108912|FG001|Overall Study|Disease Progression|2|||
48524025|NCT04117945|156108911|FG000|Overall Study|Ineligible|8|||
48524026|NCT04117945|156108912|FG001|Overall Study|Ineligible|7|||
48733620|NCT03633617|156876259|FG007|Part A|Adverse Event|0|||
48733621|NCT03633617|156876260|FG008|Part A|Adverse Event|0|||
48733622|NCT03633617|156876261|FG009|Part A|Adverse Event|0|||
48733623|NCT03633617|156876262|FG010|Part A|Adverse Event|0|||
48733624|NCT03633617|156876252|FG000|Part A|Pregnancy|1|||
48733625|NCT03633617|156876253|FG001|Part A|Pregnancy|0|||
48733626|NCT03633617|156876254|FG002|Part A|Pregnancy|0|||
48733627|NCT03633617|156876255|FG003|Part A|Pregnancy|0|||
48733628|NCT03633617|156876256|FG004|Part A|Pregnancy|0|||
48733629|NCT03633617|156876257|FG005|Part A|Pregnancy|0|||
48733630|NCT03633617|156876258|FG006|Part A|Pregnancy|0|||
48733631|NCT03633617|156876259|FG007|Part A|Pregnancy|0|||
48733632|NCT03633617|156876260|FG008|Part A|Pregnancy|0|||
48733633|NCT03633617|156876261|FG009|Part A|Pregnancy|0|||
48733634|NCT03633617|156876262|FG010|Part A|Pregnancy|0|||
48733635|NCT03633617|156876252|FG000|Part A|Withdrawal by Subject|0|||
48733636|NCT03633617|156876253|FG001|Part A|Withdrawal by Subject|1|||
48733637|NCT03633617|156876254|FG002|Part A|Withdrawal by Subject|0|||
48733638|NCT03633617|156876255|FG003|Part A|Withdrawal by Subject|0|||
48733639|NCT03633617|156876256|FG004|Part A|Withdrawal by Subject|0|||
48733640|NCT03633617|156876257|FG005|Part A|Withdrawal by Subject|0|||
48733641|NCT03633617|156876258|FG006|Part A|Withdrawal by Subject|0|||
48733642|NCT03633617|156876259|FG007|Part A|Withdrawal by Subject|0|||
48733643|NCT03633617|156876260|FG008|Part A|Withdrawal by Subject|0|||
48733644|NCT03633617|156876261|FG009|Part A|Withdrawal by Subject|0|||
48733645|NCT03633617|156876262|FG010|Part A|Withdrawal by Subject|0|||
48825708|NCT01723774|157202154|FG001|Neoadjuvant|Disease progression|1|||
48825709|NCT01723774|157202155|FG002|Neoadjuvant|Disease progression|1|||
48825710|NCT01723774|157202156|FG003|Neoadjuvant|Disease progression|0|||
48825711|NCT01723774|157202153|FG000|Neoadjuvant|Adverse Event|0|||
48825712|NCT01723774|157202154|FG001|Neoadjuvant|Adverse Event|1|||
48825713|NCT01723774|157202155|FG002|Neoadjuvant|Adverse Event|2|||
48825714|NCT01723774|157202156|FG003|Neoadjuvant|Adverse Event|0|||
48825715|NCT01723774|157202153|FG000|Neoadjuvant|High estradiol|0|||
48825716|NCT01723774|157202154|FG001|Neoadjuvant|High estradiol|1|||
48825717|NCT01723774|157202155|FG002|Neoadjuvant|High estradiol|0|||
48825718|NCT01723774|157202156|FG003|Neoadjuvant|High estradiol|0|||
48825719|NCT05015478|157202157|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
48733646|NCT03633617|156876252|FG000|Part B|Adverse Event|0|||
48733647|NCT03633617|156876253|FG001|Part B|Adverse Event|0|||
48733648|NCT03633617|156876254|FG002|Part B|Adverse Event|2|||
48733649|NCT03633617|156876255|FG003|Part B|Adverse Event|2|||
48733650|NCT03633617|156876256|FG004|Part B|Adverse Event|1|||
48733651|NCT03633617|156876257|FG005|Part B|Adverse Event|0|||
48733652|NCT03633617|156876258|FG006|Part B|Adverse Event|0|||
48825720|NCT05015478|157202158|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
48524027|NCT03480022|156108913|FG000|Overall Study|Pregnancy|2|||
48524028|NCT03480022|156108914|FG001|Overall Study|Pregnancy|0|||
48524029|NCT03480022|156108913|FG000|Overall Study|Adverse Event|6|||
48524030|NCT03480022|156108914|FG001|Overall Study|Adverse Event|0|||
48524031|NCT03480022|156108913|FG000|Overall Study|Lack of Efficacy|0|||
48524032|NCT03480022|156108914|FG001|Overall Study|Lack of Efficacy|2|||
48524033|NCT03480022|156108913|FG000|Overall Study|Physician Decision|0|||
48524034|NCT03480022|156108914|FG001|Overall Study|Physician Decision|1|||
48524035|NCT03480022|156108913|FG000|Overall Study|Withdrawal by Subject|2|||
48524036|NCT03480022|156108914|FG001|Overall Study|Withdrawal by Subject|0|||
48524037|NCT03480022|156108913|FG000|Overall Study|Medication concerns|1|||
48524038|NCT03480022|156108914|FG001|Overall Study|Medication concerns|0|||
48524039|NCT03480022|156108913|FG000|Overall Study|Family member COVID exposure|0|||
48524040|NCT03480022|156108914|FG001|Overall Study|Family member COVID exposure|1|||
48524041|NCT03428945|156108915|FG000|Overall Study|Lost to Follow-up|5|||
48524042|NCT03428945|156108916|FG001|Overall Study|Lost to Follow-up|3|||
48524043|NCT03428945|156108915|FG000|Overall Study|Withdrawal by Subject|10|||
48524044|NCT03428945|156108916|FG001|Overall Study|Withdrawal by Subject|10|||
48524045|NCT03496298|156108918|FG000|Overall Study|Adverse Event|49|||
48524046|NCT03496298|156108919|FG001|Overall Study|Adverse Event|68|||
48524047|NCT03496298|156108920|FG002|Overall Study|Adverse Event|79|||
48524048|NCT03496298|156108918|FG000|Overall Study|Study terminated by Sponsor|1050|||
48825721|NCT05015478|157202159|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
48825722|NCT05015478|157202160|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
48825723|NCT04939428|157202161|FG000|Overall Study|Death|0|||
48825724|NCT04939428|157202162|FG001|Overall Study|Death|1|||
48825725|NCT04939428|157202163|FG002|Overall Study|Death|0|||
48825726|NCT04939428|157202161|FG000|Overall Study|Lost to Follow-up|0|||
48825727|NCT04939428|157202162|FG001|Overall Study|Lost to Follow-up|5|||
48825728|NCT04939428|157202163|FG002|Overall Study|Lost to Follow-up|0|||
48825729|NCT04939428|157202161|FG000|Overall Study|Physician Decision|1|||
48825730|NCT04939428|157202162|FG001|Overall Study|Physician Decision|0|||
48825731|NCT04939428|157202163|FG002|Overall Study|Physician Decision|0|||
48825732|NCT04939428|157202161|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48825733|NCT04939428|157202162|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48825734|NCT04939428|157202163|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48825735|NCT04939428|157202161|FG000|Overall Study|Withdrawal by Subject|10|||
48825736|NCT04939428|157202162|FG001|Overall Study|Withdrawal by Subject|11|||
48825737|NCT04939428|157202163|FG002|Overall Study|Withdrawal by Subject|0|||
48825738|NCT04939428|157202161|FG000|Overall Study|Unkown|6|||
48825739|NCT04939428|157202162|FG001|Overall Study|Unkown|3|||
48825740|NCT04939428|157202163|FG002|Overall Study|Unkown|0|||
48825741|NCT04939428|157202161|FG000|Overall Study|Discotinued per protocol|0|||
48825742|NCT04939428|157202162|FG001|Overall Study|Discotinued per protocol|0|||
48825743|NCT04939428|157202163|FG002|Overall Study|Discotinued per protocol|902|||
48825744|NCT04639947|157202164|FG000|Overall Study|Screen fail|1|||
48825745|NCT00946192|157202172|FG000|Overall Study|Lost to Follow-up|6|||
48825746|NCT00946192|157202173|FG001|Overall Study|Lost to Follow-up|11|||
48825747|NCT00946192|157202174|FG002|Overall Study|Lost to Follow-up|9|||
48825748|NCT00946192|157202172|FG000|Overall Study|Withdrawal by Subject|10|||
48825749|NCT00946192|157202173|FG001|Overall Study|Withdrawal by Subject|7|||
48524049|NCT03496298|156108919|FG001|Overall Study|Study terminated by Sponsor|1063|||
48524050|NCT03496298|156108920|FG002|Overall Study|Study terminated by Sponsor|1071|||
48524051|NCT03496298|156108918|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
48524052|NCT03496298|156108919|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
48524053|NCT03496298|156108920|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
48524054|NCT03496298|156108918|FG000|Overall Study|Withdrawal by Subject|176|||
48524055|NCT03496298|156108919|FG001|Overall Study|Withdrawal by Subject|154|||
48524056|NCT03496298|156108920|FG002|Overall Study|Withdrawal by Subject|151|||
48524057|NCT03496298|156108918|FG000|Overall Study|Other|29|||
48524058|NCT03496298|156108919|FG001|Overall Study|Other|20|||
48524059|NCT03496298|156108920|FG002|Overall Study|Other|23|||
48524060|NCT03496298|156108918|FG000|Overall Study|Randomized and not treated|1|||
48524061|NCT03496298|156108919|FG001|Overall Study|Randomized and not treated|1|||
48524062|NCT03496298|156108920|FG002|Overall Study|Randomized and not treated|1|||
48524063|NCT01438476|156108926|FG000|Overall Study|Protocol Violation|1|||
48524064|NCT01438476|156108927|FG001|Overall Study|Protocol Violation|0|||
48825750|NCT00946192|157202174|FG002|Overall Study|Withdrawal by Subject|3|||
48825751|NCT00946192|157202172|FG000|Overall Study|Did not start medication|2|||
48825752|NCT00946192|157202173|FG001|Overall Study|Did not start medication|0|||
48825753|NCT00946192|157202174|FG002|Overall Study|Did not start medication|0|||
48825754|NCT00477412|157202175|FG000|Overall Study|Death|0|||
48524065|NCT01438476|156108926|FG000|Overall Study|Withdrawal by Subject|1|||
48524066|NCT01438476|156108927|FG001|Overall Study|Withdrawal by Subject|0|||
48524067|NCT01438476|156108926|FG000|Overall Study|No Surgery- Disease|8|||
48524068|NCT01438476|156108927|FG001|Overall Study|No Surgery- Disease|10|||
48524069|NCT01438476|156108926|FG000|Overall Study|Communication barrier|0|||
48733653|NCT03633617|156876259|FG007|Part B|Adverse Event|0|||
48733654|NCT03633617|156876260|FG008|Part B|Adverse Event|0|||
48733655|NCT03633617|156876261|FG009|Part B|Adverse Event|0|||
48733656|NCT03633617|156876262|FG010|Part B|Adverse Event|0|||
48733657|NCT03633617|156876252|FG000|Part B|Withdrawal by Subject|0|||
48733658|NCT03633617|156876253|FG001|Part B|Withdrawal by Subject|0|||
48733659|NCT03633617|156876254|FG002|Part B|Withdrawal by Subject|1|||
48825755|NCT00477412|157202176|FG001|Overall Study|Death|0|||
48524070|NCT01438476|156108927|FG001|Overall Study|Communication barrier|1|||
48524071|NCT02608476|156108928|FG000|Overall Study|Withdrawal by Subject|30|||
48524072|NCT02608476|156108929|FG001|Overall Study|Withdrawal by Subject|37|||
48524073|NCT02608476|156108928|FG000|Overall Study|Lost to Follow-up|24|||
48524074|NCT02608476|156108929|FG001|Overall Study|Lost to Follow-up|24|||
48524075|NCT02608476|156108928|FG000|Overall Study|Adverse Event|2|||
48825756|NCT00477412|157202177|FG002|Overall Study|Death|0|||
48825757|NCT00477412|157202178|FG003|Overall Study|Death|4|||
48825758|NCT00477412|157202175|FG000|Overall Study|Lost to Follow-up|0|||
48733660|NCT03633617|156876255|FG003|Part B|Withdrawal by Subject|0|||
48825759|NCT00477412|157202176|FG001|Overall Study|Lost to Follow-up|0|||
48825760|NCT00477412|157202177|FG002|Overall Study|Lost to Follow-up|0|||
48825761|NCT00477412|157202178|FG003|Overall Study|Lost to Follow-up|1|||
48825762|NCT00477412|157202175|FG000|Overall Study|Withdrawal by Subject|0|||
48825763|NCT00477412|157202176|FG001|Overall Study|Withdrawal by Subject|0|||
48825764|NCT00477412|157202177|FG002|Overall Study|Withdrawal by Subject|0|||
48825765|NCT00477412|157202178|FG003|Overall Study|Withdrawal by Subject|2|||
48825766|NCT00477412|157202175|FG000|Overall Study|Second Malignancy|0|||
48825767|NCT00477412|157202176|FG001|Overall Study|Second Malignancy|0|||
48825768|NCT00477412|157202177|FG002|Overall Study|Second Malignancy|0|||
48825769|NCT00477412|157202178|FG003|Overall Study|Second Malignancy|1|||
48825770|NCT00477412|157202175|FG000|Overall Study|Adverse Event|1|||
48825771|NCT00477412|157202176|FG001|Overall Study|Adverse Event|0|||
48825772|NCT00477412|157202177|FG002|Overall Study|Adverse Event|1|||
48825773|NCT00477412|157202178|FG003|Overall Study|Adverse Event|0|||
48825774|NCT01140347|157202183|FG000|Overall Study|Lost to Follow-up|5|||
48524076|NCT02608476|156108929|FG001|Overall Study|Adverse Event|8|||
48524077|NCT02608476|156108928|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
48524078|NCT02608476|156108929|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
48524079|NCT02608476|156108928|FG000|Overall Study|Noncompliance with treatment|1|||
48825775|NCT01140347|157202184|FG001|Overall Study|Lost to Follow-up|6|||
48825776|NCT01140347|157202183|FG000|Overall Study|Withdrawal by Subject|13|||
48524080|NCT02608476|156108929|FG001|Overall Study|Noncompliance with treatment|5|||
48524081|NCT02608476|156108928|FG000|Overall Study|Lack of Efficacy|3|||
48524082|NCT02608476|156108929|FG001|Overall Study|Lack of Efficacy|1|||
48524083|NCT02608476|156108928|FG000|Overall Study|Other|0|||
48524084|NCT02608476|156108929|FG001|Overall Study|Other|1|||
48524085|NCT02608476|156108928|FG000|Overall Study|Physician Decision|1|||
48524086|NCT02608476|156108929|FG001|Overall Study|Physician Decision|0|||
48524087|NCT02608476|156108928|FG000|Overall Study|Pregnancy|0|||
48524088|NCT02608476|156108929|FG001|Overall Study|Pregnancy|1|||
48524089|NCT02608476|156108928|FG000|Overall Study|Progressive disease|1|||
48524090|NCT02608476|156108929|FG001|Overall Study|Progressive disease|0|||
48524091|NCT02795676|156108930|FG000|Overall Study|Adverse Event|2|||
48524092|NCT02795676|156108931|FG001|Overall Study|Adverse Event|0|||
48524093|NCT02795676|156108930|FG000|Overall Study|Withdrawal by Subject|3|||
48524094|NCT02795676|156108931|FG001|Overall Study|Withdrawal by Subject|1|||
48524095|NCT00732160|156108932|FG000|Overall Study|Adverse Event|1|||
48524096|NCT00732160|156108933|FG001|Overall Study|Adverse Event|0|||
48524097|NCT00732160|156108934|FG002|Overall Study|Adverse Event|1|||
48524098|NCT00732160|156108935|FG003|Overall Study|Adverse Event|1|||
48524099|NCT00732160|156108932|FG000|Overall Study|scheduling|4|||
48524100|NCT00732160|156108933|FG001|Overall Study|scheduling|4|||
48524101|NCT00732160|156108934|FG002|Overall Study|scheduling|2|||
48524102|NCT00732160|156108935|FG003|Overall Study|scheduling|1|||
48524103|NCT03920280|156108938|FG000|Overall Study|Adverse Event|2|||
48524104|NCT03920280|156108939|FG001|Overall Study|Adverse Event|3|||
48524105|NCT03920280|156108938|FG000|Overall Study|Lost to Follow-up|0|||
48524106|NCT03920280|156108939|FG001|Overall Study|Lost to Follow-up|1|||
48524107|NCT03920280|156108938|FG000|Overall Study|Withdrawal by Subject|1|||
48524108|NCT03920280|156108939|FG001|Overall Study|Withdrawal by Subject|1|||
48825777|NCT01140347|157202184|FG001|Overall Study|Withdrawal by Subject|8|||
48825778|NCT01304147|157202185|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
48825779|NCT01304147|157202186|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
48825780|NCT01919619|157202187|FG000|Overall Study|Physician Decision|1|||
48825781|NCT01919619|157202188|FG001|Overall Study|Physician Decision|1|||
48524109|NCT03920280|156108938|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
48524110|NCT03920280|156108939|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
48524111|NCT02522780|156108940|FG000|Overall Study|Consent withdrawn by subject|5|||
48524112|NCT02522780|156108941|FG001|Overall Study|Consent withdrawn by subject|7|||
48733661|NCT03633617|156876256|FG004|Part B|Withdrawal by Subject|2|||
48825782|NCT00798265|157202189|FG000|Overall Study|Lost to Follow-up|1|||
48524113|NCT02522780|156108940|FG000|Overall Study|Protocol deviation|1|||
48524114|NCT02522780|156108941|FG001|Overall Study|Protocol deviation|3|||
48524115|NCT02522780|156108940|FG000|Overall Study|Subject refused endoscopic procedure|0|||
48524116|NCT02522780|156108941|FG001|Overall Study|Subject refused endoscopic procedure|1|||
48524117|NCT02522780|156108940|FG000|Overall Study|Adverse event, non-fatal|11|||
48524118|NCT02522780|156108941|FG001|Overall Study|Adverse event, non-fatal|16|||
48524119|NCT02058160|156108943|FG000|Overall Study|Randomized but not treated|2|||
48524120|NCT02058160|156108944|FG001|Overall Study|Randomized but not treated|4|||
48524121|NCT02058160|156108943|FG000|Overall Study|Poor compliance to protocol|4|||
48524122|NCT02058160|156108944|FG001|Overall Study|Poor compliance to protocol|1|||
48524123|NCT02058160|156108943|FG000|Overall Study|Adverse Event|12|||
48524124|NCT02058160|156108944|FG001|Overall Study|Adverse Event|3|||
48825783|NCT00798265|157202190|FG001|Overall Study|Lost to Follow-up|10|||
48825784|NCT00798265|157202189|FG000|Overall Study|Study closing|7|||
48825785|NCT00798265|157202190|FG001|Overall Study|Study closing|6|||
48825786|NCT00798265|157202189|FG000|Overall Study|Withdrawal by Subject|0|||
48825787|NCT00798265|157202190|FG001|Overall Study|Withdrawal by Subject|1|||
48825788|NCT00798265|157202189|FG000|Overall Study|Screen failure|0|||
48825789|NCT00798265|157202190|FG001|Overall Study|Screen failure|1|||
48825790|NCT01021332|157204016|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
48825791|NCT01021332|157204016|FG000|Overall Study|Adverse Event|43|||
48825792|NCT01021332|157204016|FG000|Overall Study|Lack of Efficacy|19|||
48825793|NCT01021332|157204016|FG000|Overall Study|Withdrawal of Consent|23|||
48825794|NCT01021332|157204016|FG000|Overall Study|Lost to Follow-up|4|||
48825795|NCT01021332|157204016|FG000|Overall Study|Protocol Violation|9|||
48825796|NCT01021332|157204016|FG000|Overall Study|Miscellaneous|3|||
48825797|NCT03487666|157204017|FG000|Overall Study|Disease progression|4|||
48825798|NCT03487666|157204018|FG001|Overall Study|Disease progression|2|||
48825799|NCT03487666|157204019|FG002|Overall Study|Disease progression|0|||
48825800|NCT03487666|157204017|FG000|Overall Study|Adverse Event|0|||
48825801|NCT03487666|157204018|FG001|Overall Study|Adverse Event|0|||
48825802|NCT03487666|157204019|FG002|Overall Study|Adverse Event|1|||
48825803|NCT01474538|157204020|FG000|Treatment Period 1|Death|1|||
48524125|NCT02058160|156108943|FG000|Overall Study|Lost to Follow-up|1|||
48524126|NCT02058160|156108944|FG001|Overall Study|Lost to Follow-up|0|||
48524127|NCT02058160|156108943|FG000|Overall Study|Other than specified above|12|||
48524128|NCT02058160|156108944|FG001|Overall Study|Other than specified above|6|||
48524129|NCT03253744|156108945|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
48524130|NCT03253744|156108946|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
48524131|NCT03253744|156108947|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
48524132|NCT03253744|156108948|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
48524133|NCT01264835|156108949|FG000|Overall Study|Lost to Follow-up|1|||
48524134|NCT01203917|156108950|FG000|Overall Study|Death|29|||
48524135|NCT01203917|156108950|FG000|Overall Study|Lost to Follow-up|2|||
48524136|NCT01203917|156108950|FG000|Overall Study|Withdrawal by Subject|3|||
48524137|NCT01203917|156108950|FG000|Overall Study|Due to objective disease progression|1|||
48524138|NCT01203917|156108950|FG000|Overall Study|Due to EGFR M+I patient|1|||
48524139|NCT02260635|156108951|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
48524140|NCT02260635|156108952|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
48524141|NCT02260635|156108951|FG000|Open-Label Extension|Study Termination|25|||
48524142|NCT02260635|156108952|FG001|Open-Label Extension|Study Termination|25|||
48524143|NCT02260635|156108951|FG000|Open-Label Extension|Withdrawal by Subject|1|||
48524144|NCT02260635|156108952|FG001|Open-Label Extension|Withdrawal by Subject|0|||
48524145|NCT00942734|156108953|FG000|Overall Study|Adverse Event|2|||
48524146|NCT00942734|156108953|FG000|Overall Study|Protocol Violation|3|||
48524147|NCT00942734|156108953|FG000|Overall Study|Disease Progression|2|||
48524148|NCT00942734|156108953|FG000|Overall Study|Physician Decision|1|||
48524149|NCT04106817|156108954|FG000|Overall Study|Lost to Follow-up|1|||
48524150|NCT04106817|156108955|FG001|Overall Study|Lost to Follow-up|0|||
48524151|NCT04106817|156108956|FG002|Overall Study|Lost to Follow-up|0|||
48524152|NCT04660032|156108960|FG000|Overall Study|Protocol Violation|1|||
48524153|NCT04660032|156108961|FG001|Overall Study|Protocol Violation|1|||
48524154|NCT02289820|156108970|FG000|Overall Study|Withdrawal by Subject|2|||
48524155|NCT02289820|156108971|FG001|Overall Study|Withdrawal by Subject|1|||
48524156|NCT02289820|156108972|FG002|Overall Study|Withdrawal by Subject|2|||
48524157|NCT02289820|156108973|FG003|Overall Study|Withdrawal by Subject|1|||
48524158|NCT02289820|156108974|FG004|Overall Study|Withdrawal by Subject|0|||
48524159|NCT02289820|156108975|FG005|Overall Study|Withdrawal by Subject|0|||
48524160|NCT02289820|156108976|FG006|Overall Study|Withdrawal by Subject|1|||
48825804|NCT01474538|157204021|FG001|Treatment Period 1|Death|0|||
48825805|NCT01474538|157204020|FG000|Treatment Period 1|Physician Decision|1|||
48825806|NCT01474538|157204021|FG001|Treatment Period 1|Physician Decision|0|||
48524161|NCT02289820|156108970|FG000|Overall Study|Death|0|||
48524162|NCT02289820|156108971|FG001|Overall Study|Death|0|||
48524163|NCT02289820|156108972|FG002|Overall Study|Death|1|||
48524164|NCT02289820|156108973|FG003|Overall Study|Death|0|||
48524165|NCT02289820|156108974|FG004|Overall Study|Death|0|||
48524166|NCT02289820|156108975|FG005|Overall Study|Death|0|||
48524167|NCT02289820|156108976|FG006|Overall Study|Death|0|||
48524168|NCT02289820|156108970|FG000|Overall Study|Lost to Follow-up|0|||
48524169|NCT02289820|156108971|FG001|Overall Study|Lost to Follow-up|0|||
48524170|NCT02289820|156108972|FG002|Overall Study|Lost to Follow-up|3|||
48524171|NCT02289820|156108973|FG003|Overall Study|Lost to Follow-up|1|||
48524172|NCT02289820|156108974|FG004|Overall Study|Lost to Follow-up|0|||
48524173|NCT02289820|156108975|FG005|Overall Study|Lost to Follow-up|1|||
48524174|NCT02289820|156108976|FG006|Overall Study|Lost to Follow-up|1|||
48524175|NCT02289820|156108970|FG000|Overall Study|withdrawal of consent|0|||
48524176|NCT02289820|156108971|FG001|Overall Study|withdrawal of consent|1|||
48524177|NCT02289820|156108972|FG002|Overall Study|withdrawal of consent|0|||
48524178|NCT02289820|156108973|FG003|Overall Study|withdrawal of consent|0|||
48524179|NCT02289820|156108974|FG004|Overall Study|withdrawal of consent|0|||
48524180|NCT02289820|156108975|FG005|Overall Study|withdrawal of consent|0|||
48524181|NCT02289820|156108976|FG006|Overall Study|withdrawal of consent|0|||
48524182|NCT00926367|156108977|FG000|Overall Study|Withdrawal by Subject|0|||
48524183|NCT00926367|156108978|FG001|Overall Study|Withdrawal by Subject|1|||
48524184|NCT00926367|156108977|FG000|Overall Study|Lost to Follow-up|1|||
48524185|NCT00926367|156108978|FG001|Overall Study|Lost to Follow-up|0|||
48524186|NCT00926367|156108977|FG000|Overall Study|Skin Irritation|1|||
48524187|NCT00926367|156108978|FG001|Overall Study|Skin Irritation|2|||
48524188|NCT01086969|156108982|FG000|Overall Study|Withdrawal by Subject|1|||
48524189|NCT01086969|156108983|FG001|Overall Study|Withdrawal by Subject|2|||
48524190|NCT01086969|156108984|FG002|Overall Study|Withdrawal by Subject|0|||
48524191|NCT03294317|156108985|FG000|Overall Study|Physician Decision|1|||
48524192|NCT03294317|156108985|FG000|Overall Study|Withdrawal by Subject|6|||
48524193|NCT03294317|156108985|FG000|Overall Study|Lost to Follow-up|1|||
48524194|NCT03294317|156108985|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
48524195|NCT03294317|156108985|FG000|Overall Study|Failed HB lead implant|8|||
48524196|NCT03294317|156108985|FG000|Overall Study|Received CRT instead|1|||
48524197|NCT03294317|156108985|FG000|Overall Study|Exited after lead revision|2|||
48524198|NCT00645944|156108996|FG000|Randomized|Withdrawal by Subject|1|||
48524199|NCT00645944|156108997|FG001|Randomized|Withdrawal by Subject|2|||
48524200|NCT00645944|156108996|FG000|Received Medication|Adverse Event|2|||
48524201|NCT00645944|156108997|FG001|Received Medication|Adverse Event|1|||
48524202|NCT00645944|156108996|FG000|Received Medication|Withdrawal by Subject|1|||
48524203|NCT00645944|156108997|FG001|Received Medication|Withdrawal by Subject|1|||
48524204|NCT00645944|156108996|FG000|Received Medication|Lost to Follow-up|1|||
48524205|NCT00645944|156108997|FG001|Received Medication|Lost to Follow-up|0|||
48524206|NCT00645944|156108996|FG000|Received Medication|Protocol Violation|2|||
48524207|NCT00645944|156108997|FG001|Received Medication|Protocol Violation|1|||
48524208|NCT02105701|156108998|FG000|Overall Study|Lost to Follow-up|1|||
48524209|NCT02105701|156108999|FG001|Overall Study|Lost to Follow-up|0|||
48825807|NCT01474538|157204020|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48825808|NCT01474538|157204021|FG001|Treatment Period 1|Withdrawal by Subject|3|||
48524210|NCT02105701|156109000|FG002|Overall Study|Lost to Follow-up|2|||
48524211|NCT02105701|156109001|FG003|Overall Study|Lost to Follow-up|1|||
48524212|NCT02105701|156108998|FG000|Overall Study|Protocol Violation|0|||
48524213|NCT02105701|156108999|FG001|Overall Study|Protocol Violation|0|||
48524214|NCT02105701|156109000|FG002|Overall Study|Protocol Violation|1|||
48524215|NCT02105701|156109001|FG003|Overall Study|Protocol Violation|0|||
48524216|NCT02105701|156108998|FG000|Overall Study|Withdrawal by Subject|2|||
48825809|NCT01474538|157204020|FG000|Treatment Period 1|Protocol Violation|0|||
48524217|NCT02105701|156108999|FG001|Overall Study|Withdrawal by Subject|1|||
48524218|NCT02105701|156109000|FG002|Overall Study|Withdrawal by Subject|0|||
48524219|NCT02105701|156109001|FG003|Overall Study|Withdrawal by Subject|1|||
48524220|NCT02105701|156108998|FG000|Overall Study|Death|1|||
48524221|NCT02105701|156108999|FG001|Overall Study|Death|0|||
48524222|NCT02105701|156109000|FG002|Overall Study|Death|0|||
48524223|NCT02105701|156109001|FG003|Overall Study|Death|0|||
48524224|NCT00654641|156109002|FG000|Overall Study|Lost to Follow-up|2|||
48524225|NCT00654641|156109003|FG001|Overall Study|Lost to Follow-up|3|||
48524226|NCT03108820|156109004|FG000|Overall Study|Lost to Follow-up|30|||
48524227|NCT03108820|156109005|FG001|Overall Study|Lost to Follow-up|28|||
48524228|NCT03108820|156109004|FG000|Overall Study|Withdrawal by Subject|32|||
48524229|NCT03108820|156109005|FG001|Overall Study|Withdrawal by Subject|24|||
48524230|NCT03108820|156109004|FG000|Overall Study|Death|6|||
48524231|NCT03108820|156109005|FG001|Overall Study|Death|11|||
48524232|NCT00562120|156109008|FG000|First Intervention Period|Adverse Event|1|||
48524233|NCT00562120|156109009|FG001|First Intervention Period|Adverse Event|0|||
48524234|NCT00562120|156109010|FG002|First Intervention Period|Adverse Event|0|||
48524235|NCT00562120|156109011|FG003|First Intervention Period|Adverse Event|0|||
48524236|NCT00562120|156109008|FG000|First Intervention Period|Randomized but not Treated|1|||
48524237|NCT00562120|156109009|FG001|First Intervention Period|Randomized but not Treated|0|||
48524238|NCT00562120|156109010|FG002|First Intervention Period|Randomized but not Treated|0|||
48524239|NCT00562120|156109011|FG003|First Intervention Period|Randomized but not Treated|0|||
48524240|NCT01977456|156109015|FG000|Overall Study|Death|5|||
48524241|NCT02940522|156110673|FG000|Overall Study|Lost to Follow-up|1|||
48524242|NCT02940522|156110674|FG001|Overall Study|Lost to Follow-up|2|||
48524243|NCT02940522|156110673|FG000|Overall Study|Withdrawal by Subject|1|||
48524244|NCT02940522|156110674|FG001|Overall Study|Withdrawal by Subject|0|||
48524245|NCT03086135|156110677|FG000|Overall Study|Adverse Event|1|||
48825810|NCT01474538|157204021|FG001|Treatment Period 1|Protocol Violation|1|||
48825811|NCT01474538|157204020|FG000|Treatment Period 2|Death|1|||
48825812|NCT01474538|157204021|FG001|Treatment Period 2|Death|0|||
48825813|NCT01474538|157204020|FG000|Treatment Period 2|Adverse Event|1|||
48825814|NCT01474538|157204021|FG001|Treatment Period 2|Adverse Event|1|||
48825815|NCT01474538|157204020|FG000|Treatment Period 2|Withdrawal by Subject|2|||
48825816|NCT01474538|157204021|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48825817|NCT01474538|157204020|FG000|Treatment Period 2|Sponsor decision|1|||
48825818|NCT01474538|157204021|FG001|Treatment Period 2|Sponsor decision|0|||
48825819|NCT01474538|157204020|FG000|Treatment Period 2|Physician Decision|0|||
48825820|NCT01474538|157204021|FG001|Treatment Period 2|Physician Decision|1|||
48825821|NCT01474538|157204020|FG000|Treatment Period 2|Protocol Violation|1|||
48825822|NCT01474538|157204021|FG001|Treatment Period 2|Protocol Violation|0|||
48825823|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
48825824|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
48825825|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
48825826|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
48825827|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
48825828|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
48825829|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
48825830|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
48825831|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
48825832|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
48825833|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
48825834|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
48825835|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
48825836|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
48825837|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48825838|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48825839|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
48825840|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
48825841|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825842|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825843|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825844|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825845|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
48825846|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48825847|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48825848|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48524246|NCT03086135|156110677|FG000|Overall Study|Lost to Follow-up|2|||
48825849|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48825850|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48825851|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48825852|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48825853|NCT01323660|157204023|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
48825854|NCT01323660|157204024|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48825855|NCT01323660|157204025|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48825856|NCT01323660|157204026|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48825857|NCT01323660|157204027|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
48524247|NCT03969641|156110678|FG000|Overall Study|Lost to Follow-up|5|||
48524248|NCT03969641|156110679|FG001|Overall Study|Lost to Follow-up|3|||
48524249|NCT03969641|156110678|FG000|Overall Study|Withdrawal by Subject|1|||
48825858|NCT01323660|157204028|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48825859|NCT01323660|157204023|FG000|Washout Period (14 Days)|Adverse Event|0|||
48825860|NCT01323660|157204024|FG001|Washout Period (14 Days)|Adverse Event|0|||
48825861|NCT01323660|157204025|FG002|Washout Period (14 Days)|Adverse Event|0|||
48825862|NCT01323660|157204026|FG003|Washout Period (14 Days)|Adverse Event|0|||
48825863|NCT01323660|157204027|FG004|Washout Period (14 Days)|Adverse Event|1|||
48825864|NCT01323660|157204028|FG005|Washout Period (14 Days)|Adverse Event|0|||
48825865|NCT01323660|157204023|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
48825866|NCT01323660|157204024|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
48825867|NCT01323660|157204025|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
48825868|NCT01323660|157204026|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
48825869|NCT01323660|157204027|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
48825870|NCT01323660|157204028|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
48825871|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48825872|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48825873|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48825874|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48825875|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
48825876|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
48825877|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
48825878|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
48825879|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
48825880|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
48825881|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
48825882|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
48825883|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825884|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825885|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825886|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825887|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
48825888|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
48825889|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48825890|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48825891|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48825892|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48825893|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
48825894|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
48825895|NCT01323660|157204023|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48825896|NCT01323660|157204024|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48825897|NCT01323660|157204025|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48825898|NCT01323660|157204026|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48825899|NCT01323660|157204027|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
48825900|NCT01323660|157204028|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48825901|NCT04531540|157204034|FG000|Overall Study|Adverse Event|1|||
48825902|NCT04531540|157204034|FG000|Overall Study|Protocol Violation|3|||
48825903|NCT04531540|157204034|FG000|Overall Study|Withdrawal by Subject|4|||
48825904|NCT04531540|157204034|FG000|Overall Study|Found to be Ineligible|1|||
48825905|NCT00984282|157204035|FG000|Double Blind Treatment|Adverse Event|40|||
48825906|NCT00984282|157204036|FG001|Double Blind Treatment|Adverse Event|6|||
48825907|NCT00984282|157204035|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
48825908|NCT00984282|157204036|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
48825909|NCT00984282|157204035|FG000|Double Blind Treatment|Physician Decision|1|||
48825910|NCT00984282|157204036|FG001|Double Blind Treatment|Physician Decision|2|||
48825911|NCT00984282|157204035|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
48524250|NCT03969641|156110679|FG001|Overall Study|Withdrawal by Subject|2|||
48524251|NCT03969641|156110678|FG000|Overall Study|Found to be ineligible|1|||
48825912|NCT00984282|157204036|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
48825913|NCT00984282|157204035|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
48524252|NCT03969641|156110679|FG001|Overall Study|Found to be ineligible|1|||
48524253|NCT03969641|156110678|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
48524254|NCT03969641|156110679|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
48524255|NCT03969641|156110678|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
48524256|NCT03969641|156110679|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
48524257|NCT03969641|156110678|FG000|Overall Study|Elective termination|0|||
48524258|NCT03969641|156110679|FG001|Overall Study|Elective termination|1|||
48825914|NCT00984282|157204036|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
48524259|NCT00762411|156110682|FG000|Initial Treatment|Death|7|||
48825915|NCT00984282|157204035|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
48825916|NCT00984282|157204036|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
48825917|NCT00984282|157204035|FG000|Double Blind Treatment|Lost to Follow-up|3|||
48825918|NCT00984282|157204036|FG001|Double Blind Treatment|Lost to Follow-up|0|||
48524260|NCT00762411|156110683|FG001|Initial Treatment|Death|6|||
48524261|NCT00762411|156110682|FG000|Initial Treatment|Adverse Event|132|||
48524262|NCT00762411|156110683|FG001|Initial Treatment|Adverse Event|40|||
48524263|NCT00762411|156110682|FG000|Initial Treatment|Protocol Violation|4|||
48524264|NCT00762411|156110683|FG001|Initial Treatment|Protocol Violation|1|||
48524265|NCT00762411|156110682|FG000|Initial Treatment|Withdrawal by Subject|65|||
48524266|NCT00762411|156110683|FG001|Initial Treatment|Withdrawal by Subject|52|||
48524267|NCT00762411|156110682|FG000|Initial Treatment|Physician Decision|1|||
48524268|NCT00762411|156110683|FG001|Initial Treatment|Physician Decision|0|||
48524269|NCT00762411|156110682|FG000|Initial Treatment|Sponsor Decision|293|||
48524270|NCT00762411|156110683|FG001|Initial Treatment|Sponsor Decision|401|||
48524271|NCT00762411|156110682|FG000|Initial Treatment|Lost to Follow-up|5|||
48524272|NCT00762411|156110683|FG001|Initial Treatment|Lost to Follow-up|0|||
48524273|NCT00762411|156110682|FG000|Initial Treatment|Caregiver Decision|21|||
48524274|NCT00762411|156110683|FG001|Initial Treatment|Caregiver Decision|16|||
48524275|NCT00762411|156110682|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
48524276|NCT00762411|156110683|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
48524277|NCT00762411|156110682|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
48524278|NCT00762411|156110683|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
48524279|NCT00762411|156110682|FG000|Delayed Start|Adverse Event|0|||
48524280|NCT00762411|156110683|FG001|Delayed Start|Adverse Event|4|||
48524281|NCT00762411|156110682|FG000|Delayed Start|Protocol Violation|0|||
48524282|NCT00762411|156110683|FG001|Delayed Start|Protocol Violation|1|||
48524283|NCT00762411|156110682|FG000|Delayed Start|Sponsor Decision|16|||
48524284|NCT00762411|156110683|FG001|Delayed Start|Sponsor Decision|20|||
48524285|NCT00762411|156110682|FG000|Delayed Start|Caregiver Decision|1|||
48524286|NCT00762411|156110683|FG001|Delayed Start|Caregiver Decision|1|||
48524287|NCT00762411|156110682|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
48524288|NCT00762411|156110683|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
48524289|NCT00762411|156110682|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
48524290|NCT00762411|156110683|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
48524291|NCT00762411|156110682|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
48524292|NCT00762411|156110683|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
48524293|NCT00762411|156110682|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
48601851|NCT01811732|156399447|FG001|Overall Study|Lack of Efficacy|1|||
48733662|NCT03633617|156876257|FG005|Part B|Withdrawal by Subject|0|||
48524294|NCT00762411|156110683|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
48524295|NCT00762411|156110682|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
48524296|NCT00762411|156110683|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
48524297|NCT00762411|156110682|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
48733663|NCT03633617|156876258|FG006|Part B|Withdrawal by Subject|0|||
48733664|NCT03633617|156876259|FG007|Part B|Withdrawal by Subject|0|||
48733665|NCT03633617|156876260|FG008|Part B|Withdrawal by Subject|0|||
48733666|NCT03633617|156876261|FG009|Part B|Withdrawal by Subject|0|||
48733667|NCT03633617|156876262|FG010|Part B|Withdrawal by Subject|0|||
48733668|NCT03633617|156876252|FG000|Part B|Lost to Follow-up|0|||
48733669|NCT03633617|156876253|FG001|Part B|Lost to Follow-up|0|||
48733670|NCT03633617|156876254|FG002|Part B|Lost to Follow-up|0|||
48733671|NCT03633617|156876255|FG003|Part B|Lost to Follow-up|0|||
48733672|NCT03633617|156876256|FG004|Part B|Lost to Follow-up|1|||
48524298|NCT00762411|156110683|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
48524299|NCT01023061|156110684|FG000|Overall Study|Withdrawal prior to treatment|2|||
48524300|NCT02966340|156110685|FG000|Overall Study|Adverse Event|0|||
48524301|NCT02966340|156110686|FG001|Overall Study|Adverse Event|1|||
48524302|NCT02966340|156110685|FG000|Overall Study|Lost to Follow-up|0|||
48524303|NCT02966340|156110686|FG001|Overall Study|Lost to Follow-up|1|||
48524304|NCT02966340|156110685|FG000|Overall Study|Withdrawal by Subject|1|||
48524305|NCT02966340|156110686|FG001|Overall Study|Withdrawal by Subject|0|||
48524306|NCT02966340|156110685|FG000|Overall Study|data acquisition error|1|||
48524307|NCT02966340|156110686|FG001|Overall Study|data acquisition error|0|||
48601852|NCT01811732|156399446|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
48601853|NCT01811732|156399447|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
48601854|NCT01811732|156399446|FG000|Overall Study|Physician Decision|2|||
48601855|NCT01811732|156399447|FG001|Overall Study|Physician Decision|0|||
48601856|NCT01811732|156399446|FG000|Overall Study|Death|1|||
48733673|NCT03633617|156876257|FG005|Part B|Lost to Follow-up|0|||
48733674|NCT03633617|156876258|FG006|Part B|Lost to Follow-up|0|||
48733675|NCT03633617|156876259|FG007|Part B|Lost to Follow-up|0|||
48733676|NCT03633617|156876260|FG008|Part B|Lost to Follow-up|0|||
48524308|NCT02966340|156110685|FG000|Overall Study|startle non-responder|1|||
48524309|NCT02966340|156110686|FG001|Overall Study|startle non-responder|1|||
48524310|NCT01541215|156110687|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
48524311|NCT01541215|156110688|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
48524312|NCT01541215|156110687|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
48524313|NCT01541215|156110688|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
48524314|NCT01541215|156110687|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
48524315|NCT01541215|156110688|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
48601857|NCT01811732|156399447|FG001|Overall Study|Death|1|||
48601858|NCT01811732|156399446|FG000|Overall Study|Insufficient venous access|0|||
48601859|NCT01811732|156399447|FG001|Overall Study|Insufficient venous access|1|||
48601860|NCT01811732|156399446|FG000|Overall Study|Protocol Violation|0|||
48601861|NCT01811732|156399447|FG001|Overall Study|Protocol Violation|1|||
48733677|NCT03633617|156876261|FG009|Part B|Lost to Follow-up|0|||
48733678|NCT03633617|156876262|FG010|Part B|Lost to Follow-up|0|||
48733679|NCT03633617|156876252|FG000|Part B|Physician Decision|0|||
48733680|NCT03633617|156876253|FG001|Part B|Physician Decision|0|||
48733681|NCT03633617|156876254|FG002|Part B|Physician Decision|0|||
48733682|NCT03633617|156876255|FG003|Part B|Physician Decision|0|||
48733683|NCT03633617|156876256|FG004|Part B|Physician Decision|1|||
48733684|NCT03633617|156876257|FG005|Part B|Physician Decision|0|||
48733685|NCT03633617|156876258|FG006|Part B|Physician Decision|0|||
48733686|NCT03633617|156876259|FG007|Part B|Physician Decision|0|||
48733687|NCT03633617|156876260|FG008|Part B|Physician Decision|0|||
48733688|NCT03633617|156876261|FG009|Part B|Physician Decision|0|||
48733689|NCT03633617|156876262|FG010|Part B|Physician Decision|0|||
48733690|NCT03633617|156876252|FG000|Part B|COVID-19 Restrictions|0|||
48733691|NCT03633617|156876253|FG001|Part B|COVID-19 Restrictions|0|||
48733692|NCT03633617|156876254|FG002|Part B|COVID-19 Restrictions|1|||
48733693|NCT03633617|156876255|FG003|Part B|COVID-19 Restrictions|0|||
48733694|NCT03633617|156876256|FG004|Part B|COVID-19 Restrictions|0|||
48733695|NCT03633617|156876257|FG005|Part B|COVID-19 Restrictions|0|||
48733696|NCT03633617|156876258|FG006|Part B|COVID-19 Restrictions|0|||
48733697|NCT03633617|156876259|FG007|Part B|COVID-19 Restrictions|0|||
48733698|NCT03633617|156876260|FG008|Part B|COVID-19 Restrictions|0|||
48733699|NCT03633617|156876261|FG009|Part B|COVID-19 Restrictions|0|||
48733700|NCT03633617|156876262|FG010|Part B|COVID-19 Restrictions|0|||
48733701|NCT03633617|156876252|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733702|NCT03633617|156876253|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733703|NCT03633617|156876254|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
48733704|NCT03633617|156876255|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733705|NCT03633617|156876256|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733706|NCT03633617|156876257|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733707|NCT03633617|156876258|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733708|NCT03633617|156876259|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733709|NCT03633617|156876260|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733710|NCT03633617|156876261|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48733711|NCT03633617|156876262|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
48524316|NCT01541215|156110687|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
48524317|NCT01541215|156110688|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
48524318|NCT01541215|156110687|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
48601862|NCT01811732|156399446|FG000|Overall Study|Subject incarcerated|1|||
48601863|NCT01811732|156399447|FG001|Overall Study|Subject incarcerated|2|||
48601864|NCT01811732|156399446|FG000|Overall Study|Admitted to another facility|1|||
48825919|NCT00984282|157204035|FG000|Double Blind Treatment|Death|8|||
48825920|NCT00984282|157204036|FG001|Double Blind Treatment|Death|4|||
48825921|NCT00984282|157204035|FG000|Double Blind Treatment|Not treated|0|||
48524319|NCT01541215|156110688|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
48524320|NCT01541215|156110687|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
48524321|NCT01541215|156110688|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
48524322|NCT02259348|156110690|FG000|Overall Study|Donors|6|||
48524323|NCT02259348|156110690|FG000|Overall Study|Death|4|||
48524324|NCT01622660|156110691|FG000|Overall Study|Adverse Event|1|||
48524325|NCT05135273|156110692|FG000|Overall Study|Recruited into the army|0|||
48524326|NCT05135273|156110693|FG001|Overall Study|Recruited into the army|0|||
48524327|NCT05135273|156110694|FG002|Overall Study|Recruited into the army|0|||
48524328|NCT05135273|156110695|FG003|Overall Study|Recruited into the army|0|||
48524329|NCT05135273|156110696|FG004|Overall Study|Recruited into the army|1|||
48524330|NCT05135273|156110697|FG005|Overall Study|Recruited into the army|0|||
48524331|NCT05135273|156110698|FG006|Overall Study|Recruited into the army|0|||
48524332|NCT05135273|156110699|FG007|Overall Study|Recruited into the army|0|||
48524333|NCT05135273|156110692|FG000|Overall Study|Moved away from study site|0|||
48524334|NCT05135273|156110693|FG001|Overall Study|Moved away from study site|0|||
48825922|NCT00984282|157204036|FG001|Double Blind Treatment|Not treated|1|||
48825923|NCT00984282|157204035|FG000|Double Blind Treatment|Switched to commercial drug|6|||
48825924|NCT00984282|157204036|FG001|Double Blind Treatment|Switched to commercial drug|1|||
48825925|NCT00984282|157204035|FG000|Double Blind Treatment|protocol driven decision point|1|||
48825926|NCT00984282|157204036|FG001|Double Blind Treatment|protocol driven decision point|1|||
48825927|NCT00984282|157204035|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
48825928|NCT00984282|157204036|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
48825929|NCT00984282|157204035|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
48825930|NCT00984282|157204036|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
48825931|NCT00984282|157204035|FG000|Open-label Treatment|Adverse Event|20|||
48825932|NCT00984282|157204036|FG001|Open-label Treatment|Adverse Event|30|||
48825933|NCT00984282|157204035|FG000|Open-label Treatment|Withdrawal by Subject|6|||
48825934|NCT00984282|157204036|FG001|Open-label Treatment|Withdrawal by Subject|21|||
48825935|NCT00984282|157204035|FG000|Open-label Treatment|Death|7|||
48825936|NCT00984282|157204036|FG001|Open-label Treatment|Death|15|||
48825937|NCT00984282|157204035|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
48825938|NCT00984282|157204036|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
48825939|NCT00984282|157204035|FG000|Open-label Treatment|Lost to Follow-up|1|||
48825940|NCT00984282|157204036|FG001|Open-label Treatment|Lost to Follow-up|1|||
48825941|NCT00984282|157204035|FG000|Open-label Treatment|Patient convenience|1|||
48825942|NCT00984282|157204036|FG001|Open-label Treatment|Patient convenience|0|||
48825943|NCT00984282|157204035|FG000|Open-label Treatment|Non-compliant with study medication|1|||
48825944|NCT00984282|157204036|FG001|Open-label Treatment|Non-compliant with study medication|0|||
48825945|NCT00984282|157204035|FG000|Open-label Treatment|Target lesion removed|0|||
48825946|NCT00984282|157204036|FG001|Open-label Treatment|Target lesion removed|1|||
48825947|NCT00984282|157204035|FG000|Open-label Treatment|Protocol driven decision point|1|||
48825948|NCT00984282|157204036|FG001|Open-label Treatment|Protocol driven decision point|1|||
48825949|NCT00984282|157204035|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
48825950|NCT00984282|157204036|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
48825951|NCT00984282|157204035|FG000|Open-label Treatment|Switched to commercial drug|6|||
48825952|NCT00984282|157204036|FG001|Open-label Treatment|Switched to commercial drug|7|||
48825953|NCT00984282|157204035|FG000|Open-label Treatment|Physician Decision|1|||
48825954|NCT00984282|157204036|FG001|Open-label Treatment|Physician Decision|0|||
48825955|NCT00984282|157204035|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
48825956|NCT00984282|157204036|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
48825957|NCT00984282|157204035|FG000|Long Term Follow-up|Death|27|||
48825958|NCT00984282|157204036|FG001|Long Term Follow-up|Death|68|||
48825959|NCT00984282|157204035|FG000|Long Term Follow-up|Lost to Follow-up|3|||
48825960|NCT00984282|157204036|FG001|Long Term Follow-up|Lost to Follow-up|6|||
48825961|NCT00984282|157204035|FG000|Long Term Follow-up|Protocol driven decision point|25|||
48825962|NCT00984282|157204036|FG001|Long Term Follow-up|Protocol driven decision point|26|||
48825963|NCT00984282|157204035|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
48524335|NCT05135273|156110694|FG002|Overall Study|Moved away from study site|0|||
48825964|NCT00984282|157204036|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
48825965|NCT00984282|157204035|FG000|Long Term Follow-up|Switched to commercial drug|4|||
48825966|NCT00984282|157204036|FG001|Long Term Follow-up|Switched to commercial drug|2|||
48825967|NCT00984282|157204035|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
48524336|NCT05135273|156110695|FG003|Overall Study|Moved away from study site|0|||
48524337|NCT05135273|156110696|FG004|Overall Study|Moved away from study site|0|||
48524338|NCT05135273|156110697|FG005|Overall Study|Moved away from study site|1|||
48601865|NCT01811732|156399447|FG001|Overall Study|Admitted to another facility|0|||
48601866|NCT01811732|156399446|FG000|Overall Study|Correct study drug not available on site|1|||
48524339|NCT05135273|156110698|FG006|Overall Study|Moved away from study site|1|||
48524340|NCT05135273|156110699|FG007|Overall Study|Moved away from study site|0|||
48524341|NCT05135273|156110692|FG000|Overall Study|Travel|0|||
48524342|NCT05135273|156110693|FG001|Overall Study|Travel|0|||
48524343|NCT05135273|156110694|FG002|Overall Study|Travel|0|||
48524344|NCT05135273|156110695|FG003|Overall Study|Travel|0|||
48524345|NCT05135273|156110696|FG004|Overall Study|Travel|0|||
48524346|NCT05135273|156110697|FG005|Overall Study|Travel|0|||
48524347|NCT05135273|156110698|FG006|Overall Study|Travel|0|||
48825968|NCT00984282|157204036|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
48825969|NCT02223793|157204037|FG000|Overall Study|Lost to Follow-up|10|||
48825970|NCT02223793|157204038|FG001|Overall Study|Lost to Follow-up|1|||
48825971|NCT02223793|157204039|FG002|Overall Study|Lost to Follow-up|2|||
48825972|NCT02223793|157204037|FG000|Overall Study|Withdrawal by Subject|3|||
48825973|NCT02223793|157204038|FG001|Overall Study|Withdrawal by Subject|2|||
48825974|NCT02223793|157204039|FG002|Overall Study|Withdrawal by Subject|3|||
48825975|NCT02223793|157204037|FG000|Overall Study|Moved/studycenter unable to participate|4|||
48825976|NCT02223793|157204038|FG001|Overall Study|Moved/studycenter unable to participate|6|||
48825977|NCT02223793|157204039|FG002|Overall Study|Moved/studycenter unable to participate|8|||
48825978|NCT01244984|157204040|FG000|Overall Study|Adverse Event|2|||
48825979|NCT01244984|157204041|FG001|Overall Study|Adverse Event|11|||
48825980|NCT01244984|157204042|FG002|Overall Study|Adverse Event|2|||
48825981|NCT01244984|157204040|FG000|Overall Study|Protocol Violation|1|||
48825982|NCT01244984|157204041|FG001|Overall Study|Protocol Violation|0|||
48825983|NCT01244984|157204042|FG002|Overall Study|Protocol Violation|0|||
48825984|NCT01244984|157204040|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
48825985|NCT01244984|157204041|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
48825986|NCT01244984|157204042|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
48825987|NCT01244984|157204040|FG000|Overall Study|Withdrawal by Subject|1|||
48524348|NCT05135273|156110699|FG007|Overall Study|Travel|1|||
48524349|NCT04211766|156110700|FG000|Overall Study|Withdrawal by Subject|5|||
48825988|NCT01244984|157204041|FG001|Overall Study|Withdrawal by Subject|2|||
48825989|NCT01244984|157204042|FG002|Overall Study|Withdrawal by Subject|2|||
48825990|NCT04577183|157204043|FG000|Overall Study|Death|1|||
48825991|NCT04577183|157204043|FG000|Overall Study|Withdrawal by Subject|3|||
48825992|NCT04577183|157204043|FG000|Overall Study|Early termination|2|||
48825993|NCT03566680|157204045|FG000|Overall Study|Pregnancy|1|||
48825994|NCT03566680|157204045|FG000|Overall Study|Lost to Follow-up|13|||
48825995|NCT03566680|157204045|FG000|Overall Study|Withdrawal by Subject|3|||
48825996|NCT00991276|157204049|FG000|First Intervention Period|Adverse Event|0|||
48825997|NCT00991276|157204050|FG001|First Intervention Period|Adverse Event|1|||
48825998|NCT00991276|157204051|FG002|First Intervention Period|Adverse Event|0|||
48825999|NCT00991276|157204052|FG003|First Intervention Period|Adverse Event|1|||
48826000|NCT00991276|157204053|FG004|First Intervention Period|Adverse Event|0|||
48826001|NCT00991276|157204054|FG005|First Intervention Period|Adverse Event|0|||
48826002|NCT00991276|157204049|FG000|First Intervention Period|Protocol Violation|0|||
48524350|NCT04211766|156110701|FG001|Overall Study|Withdrawal by Subject|1|||
48524351|NCT02302716|156110702|FG000|Overall Study|Adverse Event|1|||
48524352|NCT02302716|156110703|FG001|Overall Study|Adverse Event|1|||
48524353|NCT02302716|156110702|FG000|Overall Study|Death|0|||
48524354|NCT02302716|156110703|FG001|Overall Study|Death|1|||
48524355|NCT02302716|156110702|FG000|Overall Study|Lack of Efficacy|0|||
48524356|NCT02302716|156110703|FG001|Overall Study|Lack of Efficacy|1|||
48524357|NCT02302716|156110702|FG000|Overall Study|Lost to Follow-up|2|||
48601867|NCT01811732|156399447|FG001|Overall Study|Correct study drug not available on site|0|||
48601868|NCT00610168|156399449|FG000|Overall Study|Withdrawal by Subject|2|||
48601869|NCT00610168|156399450|FG001|Overall Study|Withdrawal by Subject|0|||
48826003|NCT00991276|157204050|FG001|First Intervention Period|Protocol Violation|0|||
48826004|NCT00991276|157204051|FG002|First Intervention Period|Protocol Violation|0|||
48826005|NCT00991276|157204052|FG003|First Intervention Period|Protocol Violation|0|||
48524358|NCT02302716|156110703|FG001|Overall Study|Lost to Follow-up|4|||
48524359|NCT02302716|156110702|FG000|Overall Study|Physician Decision|3|||
48524360|NCT02302716|156110703|FG001|Overall Study|Physician Decision|4|||
48524361|NCT02302716|156110702|FG000|Overall Study|Withdrawal by Subject|13|||
48524362|NCT02302716|156110703|FG001|Overall Study|Withdrawal by Subject|7|||
48601870|NCT00048035|156399451|FG000|Core Period|Early Withdrawals|4|||
48601871|NCT00048035|156399452|FG001|Core Period|Early Withdrawals|2|||
48601872|NCT00048035|156399453|FG002|Core Period|Early Withdrawals|1|||
48826006|NCT00991276|157204053|FG004|First Intervention Period|Protocol Violation|2|||
48524363|NCT02302716|156110702|FG000|Overall Study|Protocol Violation|0|||
48826007|NCT00991276|157204054|FG005|First Intervention Period|Protocol Violation|0|||
48826008|NCT00991276|157204049|FG000|First Intervention Period|Insufficient clinical response|0|||
48826009|NCT00991276|157204050|FG001|First Intervention Period|Insufficient clinical response|0|||
48826010|NCT00991276|157204051|FG002|First Intervention Period|Insufficient clinical response|0|||
48524364|NCT02302716|156110703|FG001|Overall Study|Protocol Violation|1|||
48601873|NCT00048035|156399454|FG003|Core Period|Early Withdrawals|1|||
48826011|NCT00991276|157204052|FG003|First Intervention Period|Insufficient clinical response|0|||
48826012|NCT00991276|157204053|FG004|First Intervention Period|Insufficient clinical response|1|||
48826013|NCT00991276|157204054|FG005|First Intervention Period|Insufficient clinical response|0|||
48826014|NCT00991276|157204049|FG000|First Intervention Period|Other|0|||
48826015|NCT00991276|157204050|FG001|First Intervention Period|Other|0|||
48826016|NCT00991276|157204051|FG002|First Intervention Period|Other|0|||
48826017|NCT00991276|157204052|FG003|First Intervention Period|Other|1|||
48826018|NCT00991276|157204053|FG004|First Intervention Period|Other|1|||
48826019|NCT00991276|157204054|FG005|First Intervention Period|Other|0|||
48826020|NCT00991276|157204049|FG000|First Intervention Period|Withdrawal by Subject|0|||
48826021|NCT00991276|157204050|FG001|First Intervention Period|Withdrawal by Subject|1|||
48826022|NCT00991276|157204051|FG002|First Intervention Period|Withdrawal by Subject|0|||
48826023|NCT00991276|157204052|FG003|First Intervention Period|Withdrawal by Subject|1|||
48826024|NCT00991276|157204053|FG004|First Intervention Period|Withdrawal by Subject|0|||
48826025|NCT00991276|157204054|FG005|First Intervention Period|Withdrawal by Subject|1|||
48826026|NCT00991276|157204049|FG000|First Intervention Period|Lost to Follow-up|0|||
48826027|NCT00991276|157204050|FG001|First Intervention Period|Lost to Follow-up|1|||
48826028|NCT00991276|157204051|FG002|First Intervention Period|Lost to Follow-up|0|||
48826029|NCT00991276|157204052|FG003|First Intervention Period|Lost to Follow-up|1|||
48444010|NCT02472795|155812931|FG000|Overall Study|Adverse Event|0|||
48444011|NCT02472795|155812932|FG001|Overall Study|Adverse Event|1|||
48444012|NCT02472795|155812933|FG002|Overall Study|Adverse Event|0|||
48444013|NCT02472795|155812934|FG003|Overall Study|Adverse Event|0|||
48444014|NCT02472795|155812935|FG004|Overall Study|Adverse Event|2|||
48444015|NCT02472795|155812931|FG000|Overall Study|Withdrawal by Subject|0|||
48444016|NCT02472795|155812932|FG001|Overall Study|Withdrawal by Subject|0|||
48444017|NCT02472795|155812933|FG002|Overall Study|Withdrawal by Subject|0|||
48444018|NCT02472795|155812934|FG003|Overall Study|Withdrawal by Subject|0|||
48444019|NCT02472795|155812935|FG004|Overall Study|Withdrawal by Subject|1|||
48444020|NCT05109702|155812936|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
48444021|NCT05109702|155812937|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
48444022|NCT05109702|155812938|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
48444023|NCT05109702|155812936|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
48444024|NCT05109702|155812937|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
48444025|NCT05109702|155812938|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
48444026|NCT05109702|155812936|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
48444027|NCT05109702|155812937|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
48444028|NCT05109702|155812938|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
48444029|NCT05109702|155812936|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
48444030|NCT05109702|155812937|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
48444031|NCT05109702|155812938|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
48444032|NCT05109702|155812936|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
48444033|NCT05109702|155812937|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
48444034|NCT05109702|155812938|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
48444035|NCT03094832|155812939|FG000|Overall Study|Lost to Follow-up|0|||
48444036|NCT03094832|155812940|FG001|Overall Study|Lost to Follow-up|0|||
48444037|NCT03094832|155812941|FG002|Overall Study|Lost to Follow-up|0|||
48444038|NCT03094832|155812942|FG003|Overall Study|Lost to Follow-up|1|||
48444039|NCT03094832|155812943|FG004|Overall Study|Lost to Follow-up|1|||
48444040|NCT03094832|155812939|FG000|Overall Study|Death|1|||
48444041|NCT03094832|155812940|FG001|Overall Study|Death|0|||
48444042|NCT03094832|155812941|FG002|Overall Study|Death|0|||
48444043|NCT03094832|155812942|FG003|Overall Study|Death|0|||
48444044|NCT03094832|155812943|FG004|Overall Study|Death|0|||
48444045|NCT03094832|155812939|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48444046|NCT03094832|155812940|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48444047|NCT03094832|155812941|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48444048|NCT03094832|155812942|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48444049|NCT03094832|155812943|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48444050|NCT03094832|155812939|FG000|Overall Study|Other|13|||
48444051|NCT03094832|155812940|FG001|Overall Study|Other|20|||
48444052|NCT03094832|155812941|FG002|Overall Study|Other|1|||
48444053|NCT03094832|155812942|FG003|Overall Study|Other|7|||
48444054|NCT03094832|155812943|FG004|Overall Study|Other|1|||
48444055|NCT03726333|155812944|FG000|Overall Study|Progressive Disease|0|||
48444056|NCT03726333|155812945|FG001|Overall Study|Progressive Disease|0|||
48444057|NCT03726333|155812946|FG002|Overall Study|Progressive Disease|1|||
48444058|NCT03726333|155812947|FG003|Overall Study|Progressive Disease|0|||
48444059|NCT03726333|155812948|FG004|Overall Study|Progressive Disease|0|||
48444060|NCT01392378|155812951|FG000|Infant Series|Adverse Event|0|||
48444061|NCT01392378|155812952|FG001|Infant Series|Adverse Event|0|||
48444062|NCT01392378|155812953|FG002|Infant Series|Adverse Event|0|||
48444063|NCT01392378|155812954|FG003|Infant Series|Adverse Event|1|||
48524365|NCT02710214|156110704|FG000|Overall Study|Lost to Follow-up|1|||
48524366|NCT02710214|156110705|FG001|Overall Study|Lost to Follow-up|0|||
48524367|NCT02710214|156110704|FG000|Overall Study|Lack of Efficacy|0|||
48524368|NCT02710214|156110705|FG001|Overall Study|Lack of Efficacy|1|||
48524369|NCT02710214|156110704|FG000|Overall Study|Death|0|||
48524370|NCT02710214|156110705|FG001|Overall Study|Death|1|||
48524371|NCT04264819|156110710|FG000|Overall Study|Physician Decision|19|||
48524372|NCT04264819|156110710|FG000|Overall Study|Adverse Event|12|||
48524373|NCT04264819|156110710|FG000|Overall Study|Withdrawal by Subject|11|||
48524374|NCT04264819|156110710|FG000|Overall Study|Lost to Follow-up|2|||
48601874|NCT00048035|156399455|FG004|Core Period|Early Withdrawals|1|||
48601875|NCT00048035|156399456|FG005|Core Period|Early Withdrawals|1|||
48601876|NCT00048035|156399457|FG006|Core Period|Early Withdrawals|0|||
48601877|NCT00048035|156399458|FG007|Core Period|Early Withdrawals|0|||
48601878|NCT00048035|156399451|FG000|Extension Year 1|Early Withdrawals|0|||
48601879|NCT00048035|156399452|FG001|Extension Year 1|Early Withdrawals|0|||
48826030|NCT00991276|157204053|FG004|First Intervention Period|Lost to Follow-up|0|||
48826031|NCT00991276|157204054|FG005|First Intervention Period|Lost to Follow-up|0|||
48826032|NCT00991276|157204049|FG000|Second Intervention Period|Adverse Event|0|||
48826033|NCT00991276|157204050|FG001|Second Intervention Period|Adverse Event|2|||
48524375|NCT04264819|156110710|FG000|Overall Study|Death|2|||
48524376|NCT00557245|156110712|FG000|Overall Study|Lost to Follow-up|7|||
48524377|NCT00557245|156110713|FG001|Overall Study|Lost to Follow-up|8|||
48601880|NCT00048035|156399453|FG002|Extension Year 1|Early Withdrawals|0|||
48826034|NCT00991276|157204051|FG002|Second Intervention Period|Adverse Event|0|||
48826035|NCT00991276|157204052|FG003|Second Intervention Period|Adverse Event|1|||
48826036|NCT00991276|157204053|FG004|Second Intervention Period|Adverse Event|1|||
48826037|NCT00991276|157204054|FG005|Second Intervention Period|Adverse Event|0|||
48826038|NCT00991276|157204049|FG000|Second Intervention Period|Protocol Violation|1|||
48826039|NCT00991276|157204050|FG001|Second Intervention Period|Protocol Violation|0|||
48826040|NCT00991276|157204051|FG002|Second Intervention Period|Protocol Violation|0|||
48826041|NCT00991276|157204052|FG003|Second Intervention Period|Protocol Violation|0|||
48524378|NCT00557245|156110714|FG002|Overall Study|Lost to Follow-up|10|||
48524379|NCT00557245|156110712|FG000|Overall Study|Ineligible|5|||
48524380|NCT00557245|156110713|FG001|Overall Study|Ineligible|4|||
48524381|NCT00557245|156110714|FG002|Overall Study|Ineligible|2|||
48524382|NCT01765270|156110723|FG000|Overall Study|Physician Decision|1|||
48524383|NCT01765270|156110724|FG001|Overall Study|Physician Decision|0|||
48524384|NCT01765270|156110723|FG000|Overall Study|Withdrawal by Subject|0|||
48524385|NCT01765270|156110724|FG001|Overall Study|Withdrawal by Subject|1|||
48524386|NCT02726386|156110740|FG000|Overall Study|Adverse Event|17|||
48524387|NCT02726386|156110741|FG001|Overall Study|Adverse Event|20|||
48524388|NCT02726386|156110740|FG000|Overall Study|Withdrawal by Subject|14|||
48524389|NCT02726386|156110741|FG001|Overall Study|Withdrawal by Subject|28|||
48524390|NCT02726386|156110740|FG000|Overall Study|Other reasons|7|||
48524391|NCT02726386|156110741|FG001|Overall Study|Other reasons|8|||
48524392|NCT03183141|156110745|FG000|Overall Study|Withdrawal by Subject|2|||
48524393|NCT03183141|156110746|FG001|Overall Study|Withdrawal by Subject|4|||
48524394|NCT03183141|156110745|FG000|Overall Study|Death|0|||
48524395|NCT03183141|156110746|FG001|Overall Study|Death|8|||
48524396|NCT00152516|156110749|FG000|Overall Study|Adverse Event|18|||
48524397|NCT00152516|156110749|FG000|Overall Study|Lack and Loss of Efficacy|30|||
48524398|NCT00152516|156110749|FG000|Overall Study|Lost to Follow-up|5|||
48524399|NCT00152516|156110749|FG000|Overall Study|Withdrawal by Subject|8|||
48524400|NCT00152516|156110749|FG000|Overall Study|Protocol Violation|3|||
48524401|NCT00152516|156110749|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
48524402|NCT00152516|156110749|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
48524403|NCT00152516|156110749|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
48524404|NCT00152516|156110749|FG000|Overall Study|Other: Non-Compliance|2|||
48524405|NCT00152516|156110749|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
48524406|NCT00152516|156110749|FG000|Overall Study|Other: Moved Out Of State|1|||
48601881|NCT00048035|156399454|FG003|Extension Year 1|Early Withdrawals|0|||
48601882|NCT00048035|156399455|FG004|Extension Year 1|Early Withdrawals|0|||
48601883|NCT00048035|156399456|FG005|Extension Year 1|Early Withdrawals|0|||
48601884|NCT00048035|156399457|FG006|Extension Year 1|Early Withdrawals|11|||
48826042|NCT00991276|157204053|FG004|Second Intervention Period|Protocol Violation|0|||
48826043|NCT00991276|157204054|FG005|Second Intervention Period|Protocol Violation|0|||
48826044|NCT00991276|157204049|FG000|Second Intervention Period|Other|0|||
48524407|NCT00152516|156110749|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
48601885|NCT00048035|156399458|FG007|Extension Year 1|Early Withdrawals|11|||
48524408|NCT00152516|156110749|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
48524409|NCT02427399|156110750|FG000|Overall Study|Protocol Violation|14|||
48524410|NCT02427399|156110751|FG001|Overall Study|Protocol Violation|16|||
48524411|NCT02427399|156110752|FG002|Overall Study|Protocol Violation|12|||
48524412|NCT02427399|156110753|FG003|Overall Study|Protocol Violation|18|||
48524413|NCT02427399|156110754|FG004|Overall Study|Protocol Violation|15|||
48524414|NCT00090753|156110755|FG000|First Treatment Period|Adverse Event|20|||
48524415|NCT00090753|156110756|FG001|First Treatment Period|Adverse Event|8|||
48524416|NCT00090753|156110755|FG000|First Treatment Period|Death|88|||
48524417|NCT00090753|156110756|FG001|First Treatment Period|Death|62|||
48524418|NCT00090753|156110755|FG000|First Treatment Period|Lack of Efficacy|2|||
48524419|NCT00090753|156110756|FG001|First Treatment Period|Lack of Efficacy|1|||
48524420|NCT00090753|156110755|FG000|First Treatment Period|Refused Treatment|32|||
48524421|NCT00090753|156110756|FG001|First Treatment Period|Refused Treatment|25|||
48524422|NCT00090753|156110755|FG000|First Treatment Period|Lost to Follow-up|4|||
48524423|NCT00090753|156110756|FG001|First Treatment Period|Lost to Follow-up|4|||
48524424|NCT00090753|156110755|FG000|First Treatment Period|Renal Transplant|70|||
48524425|NCT00090753|156110756|FG001|First Treatment Period|Renal Transplant|50|||
48524426|NCT00090753|156110755|FG000|First Treatment Period|Mircera Commercialization|1|||
48524427|NCT00090753|156110756|FG001|First Treatment Period|Mircera Commercialization|0|||
48524428|NCT00090753|156110755|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
48524429|NCT00090753|156110756|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
48524430|NCT00090753|156110755|FG000|Extended Treatment Period|Adverse Event|11|||
48524431|NCT00090753|156110756|FG001|Extended Treatment Period|Adverse Event|0|||
48524432|NCT00090753|156110755|FG000|Extended Treatment Period|Death|58|||
48524433|NCT00090753|156110756|FG001|Extended Treatment Period|Death|30|||
48524434|NCT00090753|156110755|FG000|Extended Treatment Period|Lack of Efficacy|1|||
48524435|NCT00090753|156110756|FG001|Extended Treatment Period|Lack of Efficacy|0|||
48524436|NCT00090753|156110755|FG000|Extended Treatment Period|Refused Treatment|18|||
48524437|NCT00090753|156110756|FG001|Extended Treatment Period|Refused Treatment|12|||
48524438|NCT00090753|156110755|FG000|Extended Treatment Period|Lost to Follow-up|3|||
48524439|NCT00090753|156110756|FG001|Extended Treatment Period|Lost to Follow-up|1|||
48524440|NCT00090753|156110755|FG000|Extended Treatment Period|Renal Transplant|15|||
48524441|NCT00090753|156110756|FG001|Extended Treatment Period|Renal Transplant|12|||
48524442|NCT00090753|156110755|FG000|Extended Treatment Period|Mircera Commercialization|188|||
48524443|NCT00090753|156110756|FG001|Extended Treatment Period|Mircera Commercialization|93|||
48524444|NCT00090753|156110755|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
48524445|NCT00090753|156110756|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
48524446|NCT00605176|156110757|FG000|Overall Study|Adverse Event|2|||
48524447|NCT00605176|156110758|FG001|Overall Study|Adverse Event|1|||
48524448|NCT00605176|156110759|FG002|Overall Study|Adverse Event|3|||
48524449|NCT00605176|156110757|FG000|Overall Study|Withdrawal by Subject|4|||
48524450|NCT00605176|156110758|FG001|Overall Study|Withdrawal by Subject|2|||
48524451|NCT00605176|156110759|FG002|Overall Study|Withdrawal by Subject|4|||
48524452|NCT00605176|156110757|FG000|Overall Study|Lost to Follow-up|2|||
48826045|NCT00991276|157204050|FG001|Second Intervention Period|Other|0|||
48826046|NCT00991276|157204051|FG002|Second Intervention Period|Other|0|||
48826047|NCT00991276|157204052|FG003|Second Intervention Period|Other|1|||
48826048|NCT00991276|157204053|FG004|Second Intervention Period|Other|0|||
48826049|NCT00991276|157204054|FG005|Second Intervention Period|Other|1|||
48826050|NCT00991276|157204049|FG000|Third Intervention Period|Protocol Violation|1|||
48826051|NCT00991276|157204050|FG001|Third Intervention Period|Protocol Violation|0|||
48826052|NCT00991276|157204051|FG002|Third Intervention Period|Protocol Violation|0|||
48826053|NCT00991276|157204052|FG003|Third Intervention Period|Protocol Violation|0|||
48826054|NCT00991276|157204053|FG004|Third Intervention Period|Protocol Violation|0|||
48826055|NCT00991276|157204054|FG005|Third Intervention Period|Protocol Violation|0|||
48826056|NCT00991276|157204049|FG000|Third Intervention Period|Other|0|||
48826057|NCT00991276|157204050|FG001|Third Intervention Period|Other|0|||
48826058|NCT00991276|157204051|FG002|Third Intervention Period|Other|0|||
48826059|NCT00991276|157204052|FG003|Third Intervention Period|Other|0|||
48826060|NCT00991276|157204053|FG004|Third Intervention Period|Other|0|||
48826061|NCT00991276|157204054|FG005|Third Intervention Period|Other|1|||
48826062|NCT00991276|157204049|FG000|Third Intervention Period|Adverse Event|0|||
48826063|NCT00991276|157204050|FG001|Third Intervention Period|Adverse Event|0|||
48826064|NCT00991276|157204051|FG002|Third Intervention Period|Adverse Event|1|||
48826065|NCT00991276|157204052|FG003|Third Intervention Period|Adverse Event|0|||
48826066|NCT00991276|157204053|FG004|Third Intervention Period|Adverse Event|0|||
48826067|NCT00991276|157204054|FG005|Third Intervention Period|Adverse Event|0|||
48826068|NCT00991276|157204049|FG000|Third Intervention Period|Withdrawal by Subject|0|||
48826069|NCT00991276|157204050|FG001|Third Intervention Period|Withdrawal by Subject|0|||
48826070|NCT00991276|157204051|FG002|Third Intervention Period|Withdrawal by Subject|0|||
48826071|NCT00991276|157204052|FG003|Third Intervention Period|Withdrawal by Subject|1|||
48826072|NCT00991276|157204053|FG004|Third Intervention Period|Withdrawal by Subject|0|||
48826073|NCT00991276|157204054|FG005|Third Intervention Period|Withdrawal by Subject|0|||
48826074|NCT00425503|157204055|FG000|Overall Study|Adverse Event|2|||
48826075|NCT00425503|157204055|FG000|Overall Study|Protocol Violation|1|||
48826076|NCT01720043|157204060|FG000|Overall Study|Withdrawal by Subject|1|||
48826077|NCT01688973|157204061|FG000|Overall Study|Ineligible|2|||
48524453|NCT00605176|156110758|FG001|Overall Study|Lost to Follow-up|2|||
48524454|NCT00605176|156110759|FG002|Overall Study|Lost to Follow-up|1|||
48826078|NCT01688973|157204062|FG001|Overall Study|Ineligible|3|||
48733712|NCT03633617|156876252|FG000|Part C (& Follow-up)|Adverse Event|0|||
48733713|NCT03633617|156876253|FG001|Part C (& Follow-up)|Adverse Event|0|||
48733714|NCT03633617|156876254|FG002|Part C (& Follow-up)|Adverse Event|0|||
48733715|NCT03633617|156876255|FG003|Part C (& Follow-up)|Adverse Event|0|||
48733716|NCT03633617|156876256|FG004|Part C (& Follow-up)|Adverse Event|0|||
48733717|NCT03633617|156876257|FG005|Part C (& Follow-up)|Adverse Event|1|||
48733718|NCT03633617|156876258|FG006|Part C (& Follow-up)|Adverse Event|0|||
48733719|NCT03633617|156876259|FG007|Part C (& Follow-up)|Adverse Event|1|||
48733720|NCT03633617|156876260|FG008|Part C (& Follow-up)|Adverse Event|0|||
48733721|NCT03633617|156876261|FG009|Part C (& Follow-up)|Adverse Event|0|||
48733722|NCT03633617|156876262|FG010|Part C (& Follow-up)|Adverse Event|0|||
48733723|NCT03633617|156876252|FG000|Part C (& Follow-up)|Pregnancy|0|||
48733724|NCT03633617|156876253|FG001|Part C (& Follow-up)|Pregnancy|0|||
48733725|NCT03633617|156876254|FG002|Part C (& Follow-up)|Pregnancy|0|||
48733726|NCT03633617|156876255|FG003|Part C (& Follow-up)|Pregnancy|0|||
48733727|NCT03633617|156876256|FG004|Part C (& Follow-up)|Pregnancy|0|||
48733728|NCT03633617|156876257|FG005|Part C (& Follow-up)|Pregnancy|0|||
48733729|NCT03633617|156876258|FG006|Part C (& Follow-up)|Pregnancy|0|||
48733730|NCT03633617|156876259|FG007|Part C (& Follow-up)|Pregnancy|0|||
48733731|NCT03633617|156876260|FG008|Part C (& Follow-up)|Pregnancy|0|||
48733732|NCT03633617|156876261|FG009|Part C (& Follow-up)|Pregnancy|1|||
48733733|NCT03633617|156876262|FG010|Part C (& Follow-up)|Pregnancy|0|||
48733734|NCT03633617|156876252|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
48826079|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
48826080|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
48826081|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
48826082|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
48826083|NCT00335153|157204063|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
48524455|NCT00605176|156110757|FG000|Overall Study|Non-complicance with study procedures|1|||
48524456|NCT00605176|156110758|FG001|Overall Study|Non-complicance with study procedures|0|||
48524457|NCT00605176|156110759|FG002|Overall Study|Non-complicance with study procedures|0|||
48524458|NCT00605176|156110757|FG000|Overall Study|Use of concomitant therapy|1|||
48524459|NCT00605176|156110758|FG001|Overall Study|Use of concomitant therapy|0|||
48733735|NCT03633617|156876253|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733736|NCT03633617|156876254|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733737|NCT03633617|156876255|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733738|NCT03633617|156876256|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733739|NCT03633617|156876257|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
48826084|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
48826085|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
48826086|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
48826087|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
48826088|NCT00335153|157204063|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
48826089|NCT01417000|157204064|FG000|Overall Study|Death|59|||
48826090|NCT01417000|157204065|FG001|Overall Study|Death|28|||
48826091|NCT01417000|157204064|FG000|Overall Study|Lost to Follow-up|1|||
48826092|NCT01417000|157204065|FG001|Overall Study|Lost to Follow-up|0|||
48826093|NCT01417000|157204064|FG000|Overall Study|Study Terminated by Sponsor|1|||
48826094|NCT01417000|157204065|FG001|Overall Study|Study Terminated by Sponsor|1|||
48826095|NCT03111095|157204066|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
48826096|NCT03111095|157204067|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
48826097|NCT03111095|157204066|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
48826098|NCT03111095|157204067|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
48826099|NCT01648283|157204068|FG000|Overall Study|Withdrawal by Subject|14|||
48826100|NCT04889118|157204069|FG000|Overall Study|Death|33|||
48826101|NCT04889118|157204070|FG001|Overall Study|Death|37|||
48826102|NCT04889118|157204069|FG000|Overall Study|Ongoing in Study|31|||
48826103|NCT04889118|157204070|FG001|Overall Study|Ongoing in Study|30|||
48826104|NCT02825043|157204073|FG000|Overall Study|Lost to Follow-up|4|||
48826105|NCT00558753|157204078|FG000|Overall Study|Lost to Follow-up|5|||
48826106|NCT00558753|157204079|FG001|Overall Study|Lost to Follow-up|7|||
48826107|NCT00601640|157204082|FG000|Overall Study|Withdrawal by Subject|3|||
48826108|NCT00601640|157204083|FG001|Overall Study|Withdrawal by Subject|0|||
48826109|NCT00601640|157204084|FG002|Overall Study|Withdrawal by Subject|7|||
48826110|NCT00601640|157204082|FG000|Overall Study|Death|1|||
48826111|NCT00601640|157204083|FG001|Overall Study|Death|0|||
48826112|NCT00601640|157204084|FG002|Overall Study|Death|0|||
48826113|NCT00601640|157204082|FG000|Overall Study|Adverse Event|0|||
48826114|NCT00601640|157204083|FG001|Overall Study|Adverse Event|4|||
48826115|NCT00601640|157204084|FG002|Overall Study|Adverse Event|2|||
48826116|NCT00601640|157204082|FG000|Overall Study|intercurrent illness|1|||
48826117|NCT00601640|157204083|FG001|Overall Study|intercurrent illness|0|||
48826118|NCT00601640|157204084|FG002|Overall Study|intercurrent illness|0|||
48826119|NCT00601640|157204082|FG000|Overall Study|change in eligibility status|0|||
48826120|NCT00601640|157204083|FG001|Overall Study|change in eligibility status|1|||
48733740|NCT03633617|156876258|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
48733741|NCT03633617|156876259|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
48733742|NCT03633617|156876260|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
48733743|NCT03633617|156876261|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
48733744|NCT03633617|156876262|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
48733745|NCT03633617|156876252|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
48733746|NCT03633617|156876253|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
48733747|NCT03633617|156876254|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
48733748|NCT03633617|156876255|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
48733749|NCT03633617|156876256|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
48733750|NCT03633617|156876257|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
48733751|NCT03633617|156876258|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
48733752|NCT03633617|156876259|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
48733753|NCT03633617|156876260|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
48826121|NCT00601640|157204084|FG002|Overall Study|change in eligibility status|1|||
48826122|NCT00530777|157204085|FG000|Overall Study|Lost to Follow-up|0|||
48826123|NCT00530777|157204086|FG001|Overall Study|Lost to Follow-up|1|||
48826124|NCT00530777|157204085|FG000|Overall Study|Death|1|||
48826125|NCT00530777|157204086|FG001|Overall Study|Death|2|||
48826126|NCT00530777|157204085|FG000|Overall Study|Physician Decision|1|||
48826127|NCT00530777|157204086|FG001|Overall Study|Physician Decision|0|||
48826128|NCT00530777|157204085|FG000|Overall Study|Withdrawal by Subject|0|||
48826129|NCT00530777|157204086|FG001|Overall Study|Withdrawal by Subject|1|||
48826130|NCT00530777|157204085|FG000|Overall Study|Unable to adhere to visit schedule|5|||
48826131|NCT00530777|157204086|FG001|Overall Study|Unable to adhere to visit schedule|1|||
48826132|NCT00282438|157204089|FG000|Overall Study|Lack of Efficacy|1|||
48826133|NCT00282438|157204090|FG001|Overall Study|Lack of Efficacy|0|||
48826134|NCT00282438|157204089|FG000|Overall Study|Death|0|||
48826135|NCT00282438|157204090|FG001|Overall Study|Death|1|||
48826136|NCT03686384|157204091|FG000|Overall Study|Lack of Efficacy|4|||
48826137|NCT03686384|157204092|FG001|Overall Study|Lack of Efficacy|13|||
48826138|NCT03686384|157204091|FG000|Overall Study|Lost to Follow-up|3|||
48524460|NCT00605176|156110759|FG002|Overall Study|Use of concomitant therapy|1|||
48524461|NCT00605176|156110757|FG000|Overall Study|Other (not due to AE)|1|||
48524462|NCT00605176|156110758|FG001|Overall Study|Other (not due to AE)|1|||
48524463|NCT00605176|156110759|FG002|Overall Study|Other (not due to AE)|0|||
48524464|NCT01256060|156110760|FG000|Overall Study|Lost to Follow-up|0|||
48524465|NCT01256060|156110761|FG001|Overall Study|Lost to Follow-up|1|||
48524466|NCT01256060|156110762|FG002|Overall Study|Lost to Follow-up|0|||
48524467|NCT01256060|156110763|FG003|Overall Study|Lost to Follow-up|0|||
48524468|NCT01517867|156110774|FG000|Overall Study|never started treatment|29|||
48733754|NCT03633617|156876261|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
48733755|NCT03633617|156876262|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
48733756|NCT03633617|156876252|FG000|Part C (& Follow-up)|Physician Decision|0|||
48733757|NCT03633617|156876253|FG001|Part C (& Follow-up)|Physician Decision|0|||
48733758|NCT03633617|156876254|FG002|Part C (& Follow-up)|Physician Decision|0|||
48733759|NCT03633617|156876255|FG003|Part C (& Follow-up)|Physician Decision|0|||
48733760|NCT03633617|156876256|FG004|Part C (& Follow-up)|Physician Decision|0|||
48733761|NCT03633617|156876257|FG005|Part C (& Follow-up)|Physician Decision|0|||
48733762|NCT03633617|156876258|FG006|Part C (& Follow-up)|Physician Decision|0|||
48733763|NCT03633617|156876259|FG007|Part C (& Follow-up)|Physician Decision|1|||
48733764|NCT03633617|156876260|FG008|Part C (& Follow-up)|Physician Decision|0|||
48733765|NCT03633617|156876261|FG009|Part C (& Follow-up)|Physician Decision|0|||
48733766|NCT03633617|156876262|FG010|Part C (& Follow-up)|Physician Decision|1|||
48733767|NCT03633617|156876252|FG000|Part C (& Follow-up)|COVID-19 related|0|||
48733768|NCT03633617|156876253|FG001|Part C (& Follow-up)|COVID-19 related|0|||
48733769|NCT03633617|156876254|FG002|Part C (& Follow-up)|COVID-19 related|0|||
48733770|NCT03633617|156876255|FG003|Part C (& Follow-up)|COVID-19 related|0|||
48733771|NCT03633617|156876256|FG004|Part C (& Follow-up)|COVID-19 related|0|||
48733772|NCT03633617|156876257|FG005|Part C (& Follow-up)|COVID-19 related|1|||
48733773|NCT03633617|156876258|FG006|Part C (& Follow-up)|COVID-19 related|0|||
48826139|NCT03686384|157204092|FG001|Overall Study|Lost to Follow-up|0|||
48826140|NCT03686384|157204091|FG000|Overall Study|Physician Decision|0|||
48826141|NCT03686384|157204092|FG001|Overall Study|Physician Decision|1|||
48826142|NCT03686384|157204091|FG000|Overall Study|Took prohibited medication|0|||
48826143|NCT03686384|157204092|FG001|Overall Study|Took prohibited medication|1|||
48826144|NCT03168438|157204094|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
48826145|NCT03168438|157204095|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
48524469|NCT01517867|156110775|FG001|Overall Study|never started treatment|32|||
48524470|NCT01517867|156110774|FG000|Overall Study|Withdrawal by Subject|34|||
48524471|NCT01517867|156110775|FG001|Overall Study|Withdrawal by Subject|30|||
48524472|NCT01517867|156110774|FG000|Overall Study|Still in treatment at study end|0|||
48733774|NCT03633617|156876259|FG007|Part C (& Follow-up)|COVID-19 related|0|||
48826146|NCT02939183|157204098|FG000|Overall Study|Death|0|||
48733775|NCT03633617|156876260|FG008|Part C (& Follow-up)|COVID-19 related|0|||
48733776|NCT03633617|156876261|FG009|Part C (& Follow-up)|COVID-19 related|0|||
48733777|NCT03633617|156876262|FG010|Part C (& Follow-up)|COVID-19 related|0|||
48733778|NCT03633617|156876252|FG000|Part C (& Follow-up)|Protocol Violation|0|||
48733779|NCT03633617|156876253|FG001|Part C (& Follow-up)|Protocol Violation|0|||
48733780|NCT03633617|156876254|FG002|Part C (& Follow-up)|Protocol Violation|0|||
48733781|NCT03633617|156876255|FG003|Part C (& Follow-up)|Protocol Violation|0|||
48826147|NCT02939183|157204099|FG001|Overall Study|Death|0|||
48826148|NCT02939183|157204100|FG002|Overall Study|Death|1|||
48826149|NCT02939183|157204101|FG003|Overall Study|Death|0|||
48826150|NCT02939183|157204102|FG004|Overall Study|Death|0|||
48826151|NCT02939183|157204103|FG005|Overall Study|Death|2|||
48826152|NCT02939183|157204104|FG006|Overall Study|Death|1|||
48826153|NCT02939183|157204105|FG007|Overall Study|Death|0|||
48826154|NCT02939183|157204106|FG008|Overall Study|Death|0|||
48524473|NCT01517867|156110775|FG001|Overall Study|Still in treatment at study end|3|||
48524474|NCT01628549|156110776|FG000|Overall Study|Adverse Event|1|||
48524475|NCT01628549|156110777|FG001|Overall Study|Adverse Event|1|||
48524476|NCT01628549|156110778|FG002|Overall Study|Adverse Event|0|||
48524477|NCT01628549|156110779|FG003|Overall Study|Adverse Event|4|||
48524478|NCT01628549|156110776|FG000|Overall Study|Lost to Follow-up|3|||
48524479|NCT01628549|156110777|FG001|Overall Study|Lost to Follow-up|4|||
48524480|NCT01628549|156110778|FG002|Overall Study|Lost to Follow-up|3|||
48826155|NCT02939183|157204098|FG000|Overall Study|Sponsor decision|0|||
48826156|NCT02939183|157204099|FG001|Overall Study|Sponsor decision|1|||
48826157|NCT02939183|157204100|FG002|Overall Study|Sponsor decision|0|||
48826158|NCT02939183|157204101|FG003|Overall Study|Sponsor decision|1|||
48826159|NCT02939183|157204102|FG004|Overall Study|Sponsor decision|2|||
48826160|NCT02939183|157204103|FG005|Overall Study|Sponsor decision|0|||
48826161|NCT02939183|157204104|FG006|Overall Study|Sponsor decision|3|||
48826162|NCT02939183|157204105|FG007|Overall Study|Sponsor decision|1|||
48826163|NCT02939183|157204106|FG008|Overall Study|Sponsor decision|4|||
48826164|NCT02939183|157204098|FG000|Overall Study|Withdrawal by Subject|0|||
48826165|NCT02939183|157204099|FG001|Overall Study|Withdrawal by Subject|2|||
48826166|NCT02939183|157204100|FG002|Overall Study|Withdrawal by Subject|0|||
48826167|NCT02939183|157204101|FG003|Overall Study|Withdrawal by Subject|1|||
48826168|NCT02939183|157204102|FG004|Overall Study|Withdrawal by Subject|0|||
48826169|NCT02939183|157204103|FG005|Overall Study|Withdrawal by Subject|0|||
48524481|NCT01628549|156110779|FG003|Overall Study|Lost to Follow-up|3|||
48524482|NCT01628549|156110776|FG000|Overall Study|Withdrawal by Subject|3|||
48733782|NCT03633617|156876256|FG004|Part C (& Follow-up)|Protocol Violation|0|||
48524483|NCT01628549|156110777|FG001|Overall Study|Withdrawal by Subject|4|||
48524484|NCT01628549|156110778|FG002|Overall Study|Withdrawal by Subject|4|||
48524485|NCT01628549|156110779|FG003|Overall Study|Withdrawal by Subject|1|||
48733783|NCT03633617|156876257|FG005|Part C (& Follow-up)|Protocol Violation|0|||
48733784|NCT03633617|156876258|FG006|Part C (& Follow-up)|Protocol Violation|0|||
48524486|NCT01628549|156110776|FG000|Overall Study|Protocol Violation|2|||
48826170|NCT02939183|157204104|FG006|Overall Study|Withdrawal by Subject|2|||
48826171|NCT02939183|157204105|FG007|Overall Study|Withdrawal by Subject|2|||
48826172|NCT02939183|157204106|FG008|Overall Study|Withdrawal by Subject|2|||
48601886|NCT00048035|156399451|FG000|Extension Year 2|Early Withdrawals|0|||
48601887|NCT00048035|156399452|FG001|Extension Year 2|Early Withdrawals|0|||
48601888|NCT00048035|156399453|FG002|Extension Year 2|Early Withdrawals|0|||
48601889|NCT00048035|156399454|FG003|Extension Year 2|Early Withdrawals|0|||
48601890|NCT00048035|156399455|FG004|Extension Year 2|Early Withdrawals|0|||
48601891|NCT00048035|156399456|FG005|Extension Year 2|Early Withdrawals|0|||
48601892|NCT00048035|156399457|FG006|Extension Year 2|Early Withdrawals|3|||
48601893|NCT00048035|156399458|FG007|Extension Year 2|Early Withdrawals|3|||
48601894|NCT01587885|156399459|FG000|Treatment Period 1|Failure to Return|0|||
48601895|NCT01587885|156399460|FG001|Treatment Period 1|Failure to Return|1|||
48601896|NCT01587885|156399459|FG000|Treatment Period 1|Protocol Violation|0|||
48601897|NCT01587885|156399460|FG001|Treatment Period 1|Protocol Violation|2|||
48601898|NCT02619617|156399461|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
48601899|NCT02619617|156399462|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
48601900|NCT02619617|156399461|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
48601901|NCT02619617|156399462|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
48601902|NCT03200548|156399463|FG000|Overall Study|Withdrawal by Subject|5|||
48601903|NCT03200548|156399464|FG001|Overall Study|Withdrawal by Subject|11|||
48601904|NCT03200548|156399465|FG002|Overall Study|Withdrawal by Subject|7|||
48601905|NCT03200548|156399466|FG003|Overall Study|Withdrawal by Subject|6|||
48601906|NCT00447772|156399467|FG000|Overall Study|Lack of Efficacy|3|||
48601907|NCT00447772|156399467|FG000|Overall Study|Insufficient compliance|6|||
48601908|NCT00447772|156399467|FG000|Overall Study|Discontinuation of drug therapy|1|||
48601909|NCT00447772|156399467|FG000|Overall Study|Lost to Follow-up|9|||
48601910|NCT00447772|156399467|FG000|Overall Study|Withdrawal by Subject|1|||
48601911|NCT00447772|156399467|FG000|Overall Study|Unable to attend all study visits|2|||
48601912|NCT00447772|156399467|FG000|Overall Study|Adverse Event|1|||
48601913|NCT00447772|156399467|FG000|Overall Study|Patient relocated|1|||
48601914|NCT00447772|156399467|FG000|Overall Study|Incomplete documentation at visit 1|1|||
48601915|NCT00447772|156399467|FG000|Overall Study|Chemotherapy for lung cancer|1|||
48601916|NCT00447772|156399467|FG000|Overall Study|Premature re-injection required|1|||
48601917|NCT00716456|156399468|FG000|Overall Study|Adverse Event|0|||
48601918|NCT00716456|156399469|FG001|Overall Study|Adverse Event|2|||
48601919|NCT00716456|156399470|FG002|Overall Study|Adverse Event|0|||
48601920|NCT02457195|156399473|FG000|Overall Study|Adverse Event|3|||
48601921|NCT02457195|156399473|FG000|Overall Study|Protocol Violation|2|||
48601922|NCT02457195|156399473|FG000|Overall Study|Withdrawal by Subject|4|||
48601923|NCT01232790|156399477|FG000|Randomization|Withdrawal by Subject|2|||
48601924|NCT01232790|156399478|FG001|Randomization|Withdrawal by Subject|0|||
48601925|NCT01232790|156399477|FG000|Randomization|Protocol Violation|0|||
48601926|NCT01232790|156399478|FG001|Randomization|Protocol Violation|1|||
48601927|NCT01232790|156399477|FG000|Randomization|Physician Decision|0|||
48601928|NCT01232790|156399478|FG001|Randomization|Physician Decision|1|||
48601929|NCT01232790|156399477|FG000|Initial Assessment|Withdrawal by Subject|0|||
48601930|NCT01232790|156399478|FG001|Initial Assessment|Withdrawal by Subject|1|||
48601931|NCT01232790|156399477|FG000|First Crossover|Withdrawal by Subject|1|||
48601932|NCT01232790|156399478|FG001|First Crossover|Withdrawal by Subject|0|||
48601933|NCT01232790|156399477|FG000|Second Crossover|Withdrawal by Subject|1|||
48601934|NCT01232790|156399478|FG001|Second Crossover|Withdrawal by Subject|2|||
48601935|NCT03769649|156399479|FG000|Overall Study|Lost to Follow-up|4|||
48601936|NCT02427841|156399480|FG000|Overall Study|Lack of Efficacy|5|||
48601937|NCT02427841|156399480|FG000|Overall Study|Physician Decision|2|||
48601938|NCT02427841|156399480|FG000|Overall Study|Withdrawal by Subject|1|||
48601939|NCT02154139|156399484|FG000|Overall Study|Injection not administered|2|||
48601940|NCT02154139|156399484|FG000|Overall Study|Other|2|||
48601941|NCT02154139|156399484|FG000|Overall Study|Investigator transferred|3|||
48601942|NCT02127658|156399488|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
48601943|NCT02127658|156399489|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
48601944|NCT02127658|156399488|FG000|Overall Study|Withdrawal by Subject|0|||
48601945|NCT02127658|156399489|FG001|Overall Study|Withdrawal by Subject|2|||
48601946|NCT02127658|156399488|FG000|Overall Study|Physician Decision|0|||
48601947|NCT02127658|156399489|FG001|Overall Study|Physician Decision|1|||
48601948|NCT01909804|156399496|FG000|Overall Study|Randomized but Never Treated|0|||
48601949|NCT01909804|156399497|FG001|Overall Study|Randomized but Never Treated|0|||
48601950|NCT01909804|156399498|FG002|Overall Study|Randomized but Never Treated|0|||
48601951|NCT01909804|156399499|FG003|Overall Study|Randomized but Never Treated|0|||
48601952|NCT01909804|156399500|FG004|Overall Study|Randomized but Never Treated|0|||
48601953|NCT01909804|156399501|FG005|Overall Study|Randomized but Never Treated|0|||
48601954|NCT01909804|156399502|FG006|Overall Study|Randomized but Never Treated|1|||
48601955|NCT01909804|156399503|FG007|Overall Study|Randomized but Never Treated|0|||
48601956|NCT01909804|156399504|FG008|Overall Study|Randomized but Never Treated|0|||
48733785|NCT03633617|156876259|FG007|Part C (& Follow-up)|Protocol Violation|0|||
48733786|NCT03633617|156876260|FG008|Part C (& Follow-up)|Protocol Violation|0|||
48733787|NCT03633617|156876261|FG009|Part C (& Follow-up)|Protocol Violation|3|||
48733788|NCT03633617|156876262|FG010|Part C (& Follow-up)|Protocol Violation|1|||
48826173|NCT02939183|157204098|FG000|Overall Study|Not treated due to adverse event|0|||
48826174|NCT02939183|157204099|FG001|Overall Study|Not treated due to adverse event|0|||
48826175|NCT02939183|157204100|FG002|Overall Study|Not treated due to adverse event|0|||
48826176|NCT02939183|157204101|FG003|Overall Study|Not treated due to adverse event|1|||
48826177|NCT02939183|157204102|FG004|Overall Study|Not treated due to adverse event|0|||
48826178|NCT02939183|157204103|FG005|Overall Study|Not treated due to adverse event|0|||
48826179|NCT02939183|157204104|FG006|Overall Study|Not treated due to adverse event|1|||
48826180|NCT02939183|157204105|FG007|Overall Study|Not treated due to adverse event|0|||
48826181|NCT02939183|157204106|FG008|Overall Study|Not treated due to adverse event|0|||
48826182|NCT04736056|157204107|FG000|Overall Study|Death|0|||
48826183|NCT04736056|157204108|FG001|Overall Study|Death|0|||
48826184|NCT04736056|157204109|FG002|Overall Study|Death|0|||
48826185|NCT04736056|157204110|FG003|Overall Study|Death|1|||
48826186|NCT04736056|157204107|FG000|Overall Study|Lost to Follow-up|1|||
48826187|NCT04736056|157204108|FG001|Overall Study|Lost to Follow-up|0|||
48826188|NCT04736056|157204109|FG002|Overall Study|Lost to Follow-up|1|||
48826189|NCT04736056|157204110|FG003|Overall Study|Lost to Follow-up|1|||
48826190|NCT04736056|157204107|FG000|Overall Study|Withdrawal by Subject|2|||
48524487|NCT01628549|156110777|FG001|Overall Study|Protocol Violation|1|||
48524488|NCT01628549|156110778|FG002|Overall Study|Protocol Violation|1|||
48524489|NCT01628549|156110779|FG003|Overall Study|Protocol Violation|0|||
48524490|NCT01628549|156110776|FG000|Overall Study|withdrawn for noncompliance|0|||
48524491|NCT01628549|156110777|FG001|Overall Study|withdrawn for noncompliance|2|||
48524492|NCT01628549|156110778|FG002|Overall Study|withdrawn for noncompliance|1|||
48524493|NCT01628549|156110779|FG003|Overall Study|withdrawn for noncompliance|0|||
48524494|NCT01628549|156110776|FG000|Overall Study|abnormal laboratory test results|0|||
48524495|NCT01628549|156110777|FG001|Overall Study|abnormal laboratory test results|0|||
48524496|NCT01628549|156110778|FG002|Overall Study|abnormal laboratory test results|1|||
48524497|NCT01628549|156110779|FG003|Overall Study|abnormal laboratory test results|0|||
48524498|NCT01628549|156110776|FG000|Overall Study|positive pregnancy test|0|||
48524499|NCT01628549|156110777|FG001|Overall Study|positive pregnancy test|0|||
48524500|NCT01628549|156110778|FG002|Overall Study|positive pregnancy test|0|||
48524501|NCT01628549|156110779|FG003|Overall Study|positive pregnancy test|1|||
48524502|NCT01436643|156110784|FG000|2-week Pre-treatment|Abnormal test result|0|||
48524503|NCT01436643|156110785|FG001|2-week Pre-treatment|Abnormal test result|0|||
48524504|NCT01436643|156110786|FG002|2-week Pre-treatment|Abnormal test result|0|||
48524505|NCT01436643|156110787|FG003|2-week Pre-treatment|Abnormal test result|1|||
48524506|NCT01436643|156110784|FG000|2-week Pre-treatment|Adverse Event|0|||
48524507|NCT01436643|156110785|FG001|2-week Pre-treatment|Adverse Event|0|||
48524508|NCT01436643|156110786|FG002|2-week Pre-treatment|Adverse Event|0|||
48524509|NCT01436643|156110787|FG003|2-week Pre-treatment|Adverse Event|5|||
48524510|NCT01436643|156110784|FG000|2-week Pre-treatment|Protocol Violation|0|||
48524511|NCT01436643|156110785|FG001|2-week Pre-treatment|Protocol Violation|0|||
48524512|NCT01436643|156110786|FG002|2-week Pre-treatment|Protocol Violation|0|||
48524513|NCT01436643|156110787|FG003|2-week Pre-treatment|Protocol Violation|4|||
48524514|NCT01436643|156110784|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
48524515|NCT01436643|156110785|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
48524516|NCT01436643|156110786|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
48524517|NCT01436643|156110787|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
48524518|NCT01436643|156110784|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
48524519|NCT01436643|156110785|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
48524520|NCT01436643|156110786|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
48524521|NCT01436643|156110787|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
48524522|NCT01436643|156110784|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
48524523|NCT01436643|156110785|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
48524524|NCT01436643|156110786|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
48524525|NCT01436643|156110787|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
48524526|NCT05766787|156110788|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
48524527|NCT05766787|156110789|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
48524528|NCT05766787|156110788|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
48524529|NCT05766787|156110789|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
48524530|NCT05766787|156110788|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
48524531|NCT05766787|156110789|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
48524532|NCT01466036|156110792|FG000|Overall Study|Death|1|||
48524533|NCT01466036|156110793|FG001|Overall Study|Death|1|||
48524534|NCT01466036|156110792|FG000|Overall Study|Physician Decision|0|||
48524535|NCT01466036|156110793|FG001|Overall Study|Physician Decision|4|||
48524536|NCT01466036|156110792|FG000|Overall Study|Adverse Event|2|||
48524537|NCT01466036|156110793|FG001|Overall Study|Adverse Event|6|||
48524538|NCT01466036|156110792|FG000|Overall Study|Withdrawal by Subject|2|||
48524539|NCT01466036|156110793|FG001|Overall Study|Withdrawal by Subject|8|||
48524540|NCT01466036|156110792|FG000|Overall Study|progression/relapse|14|||
48826191|NCT04736056|157204108|FG001|Overall Study|Withdrawal by Subject|0|||
48826192|NCT04736056|157204109|FG002|Overall Study|Withdrawal by Subject|0|||
48524541|NCT01466036|156110793|FG001|Overall Study|progression/relapse|21|||
48524542|NCT01466036|156110792|FG000|Overall Study|prolonged treatment delay|1|||
48524543|NCT01466036|156110793|FG001|Overall Study|prolonged treatment delay|1|||
48524544|NCT04499482|156110796|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
48524545|NCT02539368|156110797|FG000|Overall Study|Death|4|||
48524546|NCT02539368|156110798|FG001|Overall Study|Death|2|||
48524547|NCT02539368|156110799|FG002|Overall Study|Death|1|||
48524548|NCT02539368|156110800|FG003|Overall Study|Death|0|||
48524549|NCT02539368|156110801|FG004|Overall Study|Death|0|||
48524550|NCT02539368|156110797|FG000|Overall Study|Withdrawal by Subject|44|||
48524551|NCT02539368|156110798|FG001|Overall Study|Withdrawal by Subject|35|||
48524552|NCT02539368|156110799|FG002|Overall Study|Withdrawal by Subject|9|||
48524553|NCT02539368|156110800|FG003|Overall Study|Withdrawal by Subject|1|||
48524554|NCT02539368|156110801|FG004|Overall Study|Withdrawal by Subject|3|||
48524555|NCT02539368|156110797|FG000|Overall Study|Physician Decision|49|||
48524556|NCT02539368|156110798|FG001|Overall Study|Physician Decision|15|||
48524557|NCT02539368|156110799|FG002|Overall Study|Physician Decision|7|||
48524558|NCT02539368|156110800|FG003|Overall Study|Physician Decision|0|||
48524559|NCT02539368|156110801|FG004|Overall Study|Physician Decision|2|||
48524560|NCT02539368|156110797|FG000|Overall Study|Lost to Follow-up|96|||
48524561|NCT02539368|156110798|FG001|Overall Study|Lost to Follow-up|21|||
48524562|NCT02539368|156110799|FG002|Overall Study|Lost to Follow-up|16|||
48524563|NCT02539368|156110800|FG003|Overall Study|Lost to Follow-up|4|||
48524564|NCT02539368|156110801|FG004|Overall Study|Lost to Follow-up|3|||
48524565|NCT02539368|156110797|FG000|Overall Study|Adverse Event|44|||
48524566|NCT02539368|156110798|FG001|Overall Study|Adverse Event|5|||
48524567|NCT02539368|156110799|FG002|Overall Study|Adverse Event|9|||
48524568|NCT02539368|156110800|FG003|Overall Study|Adverse Event|0|||
48524569|NCT02539368|156110801|FG004|Overall Study|Adverse Event|3|||
48524570|NCT02539368|156110797|FG000|Overall Study|Participant Non-compliant|13|||
48524571|NCT02539368|156110798|FG001|Overall Study|Participant Non-compliant|2|||
48524572|NCT02539368|156110799|FG002|Overall Study|Participant Non-compliant|1|||
48524573|NCT02539368|156110800|FG003|Overall Study|Participant Non-compliant|1|||
48524574|NCT02539368|156110801|FG004|Overall Study|Participant Non-compliant|0|||
48524575|NCT02539368|156110797|FG000|Overall Study|Other|145|||
48524576|NCT02539368|156110798|FG001|Overall Study|Other|18|||
48524577|NCT02539368|156110799|FG002|Overall Study|Other|24|||
48524578|NCT02539368|156110800|FG003|Overall Study|Other|1|||
48733789|NCT03633617|156876252|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
48733790|NCT03633617|156876253|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
48733791|NCT03633617|156876254|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
48733792|NCT03633617|156876255|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
48733793|NCT03633617|156876256|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
48733794|NCT03633617|156876257|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
48733795|NCT03633617|156876258|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
48733796|NCT03633617|156876259|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
48733797|NCT03633617|156876260|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
48733798|NCT03633617|156876261|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
48733799|NCT03633617|156876262|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
48733800|NCT03595774|156876265|FG000|Overall Study|Adverse Event|1|||
48733801|NCT03595774|156876266|FG001|Overall Study|Adverse Event|0|||
48733802|NCT03595774|156876267|FG002|Overall Study|Adverse Event|1|||
48733803|NCT03595774|156876268|FG003|Overall Study|Adverse Event|0|||
48733804|NCT03595774|156876265|FG000|Overall Study|screen failure|0|||
48733805|NCT03595774|156876266|FG001|Overall Study|screen failure|1|||
48733806|NCT03595774|156876267|FG002|Overall Study|screen failure|0|||
48733807|NCT03595774|156876268|FG003|Overall Study|screen failure|1|||
48733808|NCT02477839|156876269|FG000|Overall Study|Adverse Event|0|||
48733809|NCT02477839|156876270|FG001|Overall Study|Adverse Event|1|||
48733810|NCT02477839|156876269|FG000|Overall Study|Protocol Violation|0|||
48733811|NCT02477839|156876270|FG001|Overall Study|Protocol Violation|2|||
48733812|NCT02477839|156876269|FG000|Overall Study|Withdrawal by Subject|3|||
48733813|NCT02477839|156876270|FG001|Overall Study|Withdrawal by Subject|3|||
48733814|NCT02477839|156876269|FG000|Overall Study|Participant had PGS during V6|0|||
48733815|NCT02477839|156876270|FG001|Overall Study|Participant had PGS during V6|1|||
48733816|NCT02477839|156876269|FG000|Overall Study|Parents decided to stop medication|0|||
48733817|NCT02477839|156876270|FG001|Overall Study|Parents decided to stop medication|1|||
48733818|NCT02477839|156876269|FG000|Overall Study|Lack of tolerability|0|||
48733819|NCT02477839|156876270|FG001|Overall Study|Lack of tolerability|1|||
48733820|NCT02477839|156876269|FG000|Overall Study|Exclusion criterion|0|||
48733821|NCT02477839|156876270|FG001|Overall Study|Exclusion criterion|1|||
48733822|NCT03198078|156876275|FG000|Overall Study|Adverse Event|0|||
48733823|NCT03198078|156876276|FG001|Overall Study|Adverse Event|1|||
48733824|NCT03198078|156876277|FG002|Overall Study|Adverse Event|2|||
48733825|NCT03198078|156876275|FG000|Overall Study|Lack of Efficacy|0|||
48733826|NCT03198078|156876276|FG001|Overall Study|Lack of Efficacy|0|||
48733827|NCT03198078|156876277|FG002|Overall Study|Lack of Efficacy|3|||
48733828|NCT03198078|156876275|FG000|Overall Study|Lost to Follow-up|1|||
48733829|NCT03198078|156876276|FG001|Overall Study|Lost to Follow-up|0|||
48733830|NCT03198078|156876277|FG002|Overall Study|Lost to Follow-up|0|||
48733831|NCT03198078|156876275|FG000|Overall Study|Pregnancy|0|||
48733832|NCT03198078|156876276|FG001|Overall Study|Pregnancy|1|||
48733833|NCT03198078|156876277|FG002|Overall Study|Pregnancy|0|||
48733834|NCT03198078|156876275|FG000|Overall Study|Withdrawal by Subject|1|||
48733835|NCT03198078|156876276|FG001|Overall Study|Withdrawal by Subject|0|||
48733836|NCT03198078|156876277|FG002|Overall Study|Withdrawal by Subject|2|||
48733837|NCT03198078|156876275|FG000|Overall Study|Withdrawal by Caregiver|1|||
48733838|NCT03198078|156876276|FG001|Overall Study|Withdrawal by Caregiver|3|||
48733839|NCT03198078|156876277|FG002|Overall Study|Withdrawal by Caregiver|5|||
48733840|NCT04137224|156876278|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
48733841|NCT04137224|156876279|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
48733842|NCT04137224|156876278|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
48733843|NCT04137224|156876279|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
48733844|NCT04137224|156876278|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
48733845|NCT04137224|156876279|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
48733846|NCT01147640|156876280|FG000|Overall Study|Adverse Event|2|||
48733847|NCT01147640|156876281|FG001|Overall Study|Adverse Event|0|||
48733848|NCT01147640|156876280|FG000|Overall Study|Physician Decision|1|||
48733849|NCT01147640|156876281|FG001|Overall Study|Physician Decision|0|||
48733850|NCT01147640|156876280|FG000|Overall Study|Withdrawal by Subject|1|||
48733851|NCT01147640|156876281|FG001|Overall Study|Withdrawal by Subject|0|||
48733852|NCT01147640|156876280|FG000|Overall Study|Lost to Follow-up|0|||
48733853|NCT01147640|156876281|FG001|Overall Study|Lost to Follow-up|1|||
48733854|NCT01147640|156876280|FG000|Overall Study|Didn't meet eligibility criteria|1|||
48733855|NCT01147640|156876281|FG001|Overall Study|Didn't meet eligibility criteria|0|||
48733856|NCT01856907|156876283|FG000|Overall Study|Pregnancy|0|||
48733857|NCT01856907|156876284|FG001|Overall Study|Pregnancy|1|||
48733858|NCT01856907|156876285|FG002|Overall Study|Pregnancy|0|||
48733859|NCT01856907|156876283|FG000|Overall Study|Pregnancy|0|||
48524579|NCT02539368|156110801|FG004|Overall Study|Other|3|||
48524580|NCT02539368|156110797|FG000|Overall Study|Missing|10|||
48524581|NCT02539368|156110798|FG001|Overall Study|Missing|3|||
48524582|NCT02539368|156110799|FG002|Overall Study|Missing|0|||
48524583|NCT02539368|156110800|FG003|Overall Study|Missing|0|||
48524584|NCT02539368|156110801|FG004|Overall Study|Missing|0|||
48524585|NCT01198873|156110802|FG000|Overall Study|Adverse Event|4|||
48524586|NCT01198873|156110803|FG001|Overall Study|Adverse Event|7|||
48524587|NCT01198873|156110802|FG000|Overall Study|Study closure|29|||
48524588|NCT01198873|156110803|FG001|Overall Study|Study closure|23|||
48524589|NCT01198873|156110802|FG000|Overall Study|Other than above|4|||
48524590|NCT01198873|156110803|FG001|Overall Study|Other than above|2|||
48524591|NCT00398073|156110804|FG000|Overall Study|Withdrawal by Subject|1|||
48524592|NCT00398073|156110805|FG001|Overall Study|Withdrawal by Subject|0|||
48524593|NCT01263561|156110806|FG000|Overall Study|Death|1|||
48524594|NCT01263561|156110807|FG001|Overall Study|Death|2|||
48524595|NCT02339740|156110808|FG000|Overall Study|Death|1|||
48524596|NCT02339740|156110809|FG001|Overall Study|Death|0|||
48524597|NCT02339740|156110808|FG000|Overall Study|Physician Decision|0|||
48733860|NCT01856907|156876284|FG001|Overall Study|Pregnancy|1|||
48733861|NCT01856907|156876285|FG002|Overall Study|Pregnancy|0|||
48733862|NCT01856907|156876283|FG000|Overall Study|Withdrawal by Subject|0|||
48733863|NCT01856907|156876284|FG001|Overall Study|Withdrawal by Subject|1|||
48733864|NCT01856907|156876285|FG002|Overall Study|Withdrawal by Subject|0|||
48733865|NCT00285818|156876296|FG000|Overall Study|Withdrawal by Subject|3|||
48733866|NCT00285818|156876297|FG001|Overall Study|Withdrawal by Subject|2|||
48733867|NCT00285818|156876296|FG000|Overall Study|Lost to Follow-up|1|||
48733868|NCT00285818|156876297|FG001|Overall Study|Lost to Follow-up|0|||
48733869|NCT01528215|156876303|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
48733870|NCT01528215|156876304|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
48733871|NCT01528215|156876303|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
48733872|NCT01528215|156876304|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
48733873|NCT01528215|156876303|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
48733874|NCT01528215|156876304|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
48733875|NCT01528215|156876303|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
48733876|NCT01528215|156876304|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
48733877|NCT04251273|156876305|FG000|Overall Study|Lost to Follow-up|331|||
48733878|NCT04251273|156876306|FG001|Overall Study|Lost to Follow-up|290|||
48733879|NCT05182125|156876309|FG000|Overall Study|Withdrawal by Subject|0|||
48733880|NCT05182125|156876310|FG001|Overall Study|Withdrawal by Subject|0|||
48733881|NCT05182125|156876311|FG002|Overall Study|Withdrawal by Subject|0|||
48733882|NCT05182125|156876312|FG003|Overall Study|Withdrawal by Subject|0|||
48733883|NCT05182125|156876313|FG004|Overall Study|Withdrawal by Subject|2|||
48524598|NCT02339740|156110809|FG001|Overall Study|Physician Decision|2|||
48733884|NCT05182125|156876314|FG005|Overall Study|Withdrawal by Subject|0|||
48733885|NCT05182125|156876309|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733886|NCT05182125|156876310|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733887|NCT05182125|156876311|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733888|NCT05182125|156876312|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
48733889|NCT05182125|156876313|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733890|NCT05182125|156876314|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
48733891|NCT05182125|156876309|FG000|Overall Study|Death|0|||
48733892|NCT05182125|156876310|FG001|Overall Study|Death|0|||
48733893|NCT05182125|156876311|FG002|Overall Study|Death|0|||
48733894|NCT05182125|156876312|FG003|Overall Study|Death|0|||
48733895|NCT05182125|156876313|FG004|Overall Study|Death|1|||
48733896|NCT05182125|156876314|FG005|Overall Study|Death|0|||
48733897|NCT05182125|156876309|FG000|Overall Study|Health Contact Follow-up|5|||
48733898|NCT05182125|156876310|FG001|Overall Study|Health Contact Follow-up|5|||
48733899|NCT05182125|156876311|FG002|Overall Study|Health Contact Follow-up|2|||
48733900|NCT05182125|156876312|FG003|Overall Study|Health Contact Follow-up|9|||
48733901|NCT05182125|156876313|FG004|Overall Study|Health Contact Follow-up|7|||
48733902|NCT05182125|156876314|FG005|Overall Study|Health Contact Follow-up|2|||
48733903|NCT02919696|156876315|FG000|Overall Study|Adverse Event|1|||
48733904|NCT02919696|156876316|FG001|Overall Study|Adverse Event|2|||
48733905|NCT02919696|156876315|FG000|Overall Study|Withdrawal by Subject|2|||
48826193|NCT04736056|157204110|FG003|Overall Study|Withdrawal by Subject|0|||
48826194|NCT04736056|157204107|FG000|Overall Study|Physician Decision|1|||
48826195|NCT04736056|157204108|FG001|Overall Study|Physician Decision|0|||
48826196|NCT04736056|157204109|FG002|Overall Study|Physician Decision|1|||
48826197|NCT04736056|157204110|FG003|Overall Study|Physician Decision|0|||
48733906|NCT02919696|156876316|FG001|Overall Study|Withdrawal by Subject|1|||
48733907|NCT02919696|156876315|FG000|Overall Study|Sponsor Decision|1|||
48733908|NCT02919696|156876316|FG001|Overall Study|Sponsor Decision|1|||
48733909|NCT02919696|156876315|FG000|Overall Study|Never Treated|0|||
48733910|NCT02919696|156876316|FG001|Overall Study|Never Treated|1|||
48733911|NCT01104701|156877626|FG000|Overall Study|Withdrawal by Subject|0|||
48733912|NCT01104701|156877627|FG001|Overall Study|Withdrawal by Subject|1|||
48733913|NCT01104701|156877628|FG002|Overall Study|Withdrawal by Subject|2|||
48733914|NCT01104701|156877629|FG003|Overall Study|Withdrawal by Subject|1|||
48733915|NCT01104701|156877626|FG000|Overall Study|Adverse Event|0|||
48733916|NCT01104701|156877627|FG001|Overall Study|Adverse Event|0|||
48733917|NCT01104701|156877628|FG002|Overall Study|Adverse Event|0|||
48733918|NCT01104701|156877629|FG003|Overall Study|Adverse Event|1|||
48733919|NCT01104701|156877626|FG000|Overall Study|Physician Decision|0|||
48733920|NCT01104701|156877627|FG001|Overall Study|Physician Decision|2|||
48733921|NCT01104701|156877628|FG002|Overall Study|Physician Decision|0|||
48733922|NCT01104701|156877629|FG003|Overall Study|Physician Decision|0|||
48733923|NCT01683019|156877630|FG000|Overall Study|Withdrawal by Subject|2|||
48733924|NCT01683019|156877631|FG001|Overall Study|Withdrawal by Subject|1|||
48733925|NCT01683019|156877632|FG002|Overall Study|Withdrawal by Subject|4|||
48733926|NCT03437512|156877633|FG000|Randomized|Withdrawal by Subject|0|||
48733927|NCT03437512|156877634|FG001|Randomized|Withdrawal by Subject|2|||
48733928|NCT03437512|156877633|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
48733929|NCT03437512|156877634|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
48733930|NCT01863953|156877637|FG000|Overall Study|Adverse Event|0|||
48733931|NCT01863953|156877638|FG001|Overall Study|Adverse Event|0|||
48733932|NCT01863953|156877639|FG002|Overall Study|Adverse Event|1|||
48733933|NCT00958789|156877640|FG000|Overall Study|Death|5|||
48733934|NCT00958789|156877640|FG000|Overall Study|Lost to Follow-up|14|||
48733935|NCT00958789|156877640|FG000|Overall Study|Withdrawal by Subject|17|||
48733936|NCT00958789|156877640|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
48826198|NCT03003962|157204117|FG000|Overall Study|Withdrawal by Subject|5|||
48601957|NCT01909804|156399505|FG009|Overall Study|Randomized but Never Treated|0|||
48733937|NCT00958789|156877640|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
48733938|NCT00958789|156877640|FG000|Overall Study|Subject terminated|2|||
48733939|NCT00958789|156877640|FG000|Overall Study|Revision|7|||
48733940|NCT00595465|156877641|FG000|Overall Study|Adverse Event|4|||
48733941|NCT00595465|156877642|FG001|Overall Study|Adverse Event|3|||
48733942|NCT00595465|156877643|FG002|Overall Study|Adverse Event|3|||
48826199|NCT03003962|157204118|FG001|Overall Study|Withdrawal by Subject|17|||
48826200|NCT03003962|157204117|FG000|Overall Study|Death|274|||
48444064|NCT01392378|155812955|FG004|Infant Series|Adverse Event|0|||
48826201|NCT03003962|157204118|FG001|Overall Study|Death|277|||
48733943|NCT00595465|156877641|FG000|Overall Study|Pregnancy|0|||
48733944|NCT00595465|156877642|FG001|Overall Study|Pregnancy|0|||
48733945|NCT00595465|156877643|FG002|Overall Study|Pregnancy|1|||
48733946|NCT00595465|156877641|FG000|Overall Study|Protocol Violation|2|||
48733947|NCT00595465|156877642|FG001|Overall Study|Protocol Violation|1|||
48733948|NCT00595465|156877643|FG002|Overall Study|Protocol Violation|0|||
48733949|NCT00595465|156877641|FG000|Overall Study|Lost to Follow-up|0|||
48733950|NCT00595465|156877642|FG001|Overall Study|Lost to Follow-up|0|||
48733951|NCT00595465|156877643|FG002|Overall Study|Lost to Follow-up|2|||
48733952|NCT00595465|156877641|FG000|Overall Study|administrative reason|0|||
48733953|NCT00595465|156877642|FG001|Overall Study|administrative reason|0|||
48733954|NCT00595465|156877643|FG002|Overall Study|administrative reason|1|||
48733955|NCT02395666|156877653|FG000|Overall Study|Physician Decision|3|||
48733956|NCT02395666|156877654|FG001|Overall Study|Physician Decision|0|||
48733957|NCT02395666|156877653|FG000|Overall Study|Lost to Follow-up|1|||
48733958|NCT02395666|156877654|FG001|Overall Study|Lost to Follow-up|0|||
48733959|NCT02395666|156877653|FG000|Overall Study|Withdrawal by Subject|2|||
48733960|NCT02395666|156877654|FG001|Overall Study|Withdrawal by Subject|1|||
48733961|NCT05061966|156877655|FG000|Overall Study|Lost to Follow-up|13|||
48733962|NCT05061966|156877656|FG001|Overall Study|Lost to Follow-up|13|||
48733963|NCT00761579|156877657|FG000|Overall Study|Adverse Event|10|||
48733964|NCT00761579|156877657|FG000|Overall Study|Death|2|||
48733965|NCT00761579|156877657|FG000|Overall Study|Lack of Efficacy|21|||
48733966|NCT00761579|156877657|FG000|Overall Study|Lost to Follow-up|16|||
48733967|NCT00761579|156877657|FG000|Overall Study|Pregnancy|1|||
48733968|NCT00761579|156877657|FG000|Overall Study|Withdrawal by Subject|34|||
48733969|NCT00761579|156877657|FG000|Overall Study|Lack of compliance|2|||
48733970|NCT00761579|156877657|FG000|Overall Study|Protocol deviation|1|||
48733971|NCT00761579|156877657|FG000|Overall Study|Drug overdose|1|||
48733972|NCT00761579|156877657|FG000|Overall Study|Aggravation of depression|1|||
48733973|NCT00761579|156877657|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
48733974|NCT00761579|156877657|FG000|Overall Study|Lost survey form|1|||
48733975|NCT00761579|156877657|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
48733976|NCT00611533|156877659|FG000|First Intervention (6 Weeks)|Never started study|0|||
48733977|NCT00611533|156877660|FG001|First Intervention (6 Weeks)|Never started study|1|||
48733978|NCT00611533|156877659|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
48733979|NCT00611533|156877660|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
48733980|NCT00611533|156877659|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
48733981|NCT00611533|156877660|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
48733982|NCT00100178|156877661|FG000|Overall Study|Lost to Follow-up|0|||
48733983|NCT00100178|156877662|FG001|Overall Study|Lost to Follow-up|6|||
48733984|NCT00100178|156877663|FG002|Overall Study|Lost to Follow-up|5|||
48733985|NCT00100178|156877661|FG000|Overall Study|Adverse Event|2|||
48733986|NCT00100178|156877662|FG001|Overall Study|Adverse Event|2|||
48733987|NCT00100178|156877663|FG002|Overall Study|Adverse Event|1|||
48733988|NCT00100178|156877661|FG000|Overall Study|Withdrawal by Subject|1|||
48733989|NCT00100178|156877662|FG001|Overall Study|Withdrawal by Subject|1|||
48733990|NCT00100178|156877663|FG002|Overall Study|Withdrawal by Subject|1|||
48733991|NCT00100178|156877661|FG000|Overall Study|Physician Decision|6|||
48733992|NCT00100178|156877662|FG001|Overall Study|Physician Decision|1|||
48733993|NCT00100178|156877663|FG002|Overall Study|Physician Decision|3|||
48733994|NCT00532155|156877672|FG000|Overall Study|Adverse Event|66|||
48733995|NCT00532155|156877673|FG001|Overall Study|Adverse Event|123|||
48733996|NCT00532155|156877672|FG000|Overall Study|Lack of Efficacy|332|||
48733997|NCT00532155|156877673|FG001|Overall Study|Lack of Efficacy|255|||
48733998|NCT00532155|156877672|FG000|Overall Study|Protocol Violation|1|||
48733999|NCT00532155|156877673|FG001|Overall Study|Protocol Violation|3|||
48734000|NCT00532155|156877672|FG000|Overall Study|Lost to Follow-up|2|||
48734001|NCT00532155|156877673|FG001|Overall Study|Lost to Follow-up|0|||
48734002|NCT00532155|156877672|FG000|Overall Study|Physician Decision|16|||
48734003|NCT00532155|156877673|FG001|Overall Study|Physician Decision|15|||
48734004|NCT00532155|156877672|FG000|Overall Study|Withdrawal by Subject|23|||
48734005|NCT00532155|156877673|FG001|Overall Study|Withdrawal by Subject|44|||
48734006|NCT00532155|156877672|FG000|Overall Study|Consent withdrawn|5|||
48734007|NCT00532155|156877673|FG001|Overall Study|Consent withdrawn|7|||
48734008|NCT00532155|156877672|FG000|Overall Study|Moved|1|||
48734009|NCT00532155|156877673|FG001|Overall Study|Moved|0|||
48734010|NCT00532155|156877672|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
48734011|NCT00532155|156877673|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
48734012|NCT00532155|156877672|FG000|Overall Study|Occurence of a second cancer|0|||
48734013|NCT00532155|156877673|FG001|Overall Study|Occurence of a second cancer|1|||
48734014|NCT00532155|156877672|FG000|Overall Study|Occurence of a secondary cancer|0|||
48734015|NCT00532155|156877673|FG001|Overall Study|Occurence of a secondary cancer|1|||
48734016|NCT00532155|156877672|FG000|Overall Study|Promotor ended study|1|||
48524599|NCT02339740|156110808|FG000|Overall Study|Withdrawal by Subject|5|||
48524600|NCT02339740|156110809|FG001|Overall Study|Withdrawal by Subject|1|||
48524601|NCT02339740|156110808|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
48524602|NCT02339740|156110809|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
48524603|NCT02260258|156110814|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
48734017|NCT00532155|156877673|FG001|Overall Study|Promotor ended study|0|||
48734018|NCT00532155|156877672|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
48734019|NCT00532155|156877673|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
48734020|NCT00532155|156877672|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
48734021|NCT00532155|156877673|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
48734022|NCT00532155|156877672|FG000|Overall Study|Study stopped|1|||
48734023|NCT00532155|156877673|FG001|Overall Study|Study stopped|0|||
48524604|NCT02260258|156110815|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
48524605|NCT00438659|156110816|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
48524606|NCT00438659|156110817|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
48524607|NCT00438659|156110816|FG000|Overall Study|Cancel|5|||
48601958|NCT01909804|156399506|FG010|Overall Study|Randomized but Never Treated|0|||
48601959|NCT01909804|156399507|FG011|Overall Study|Randomized but Never Treated|1|||
48601960|NCT01909804|156399496|FG000|Overall Study|Death|0|||
48601961|NCT01909804|156399497|FG001|Overall Study|Death|0|||
48734024|NCT00532155|156877672|FG000|Overall Study|Study terminated by sponsor|1|||
48734025|NCT00532155|156877673|FG001|Overall Study|Study terminated by sponsor|0|||
48826202|NCT03003962|157204117|FG000|Overall Study|Participants ongoing at DCO|55|||
48826203|NCT03003962|157204118|FG001|Overall Study|Participants ongoing at DCO|40|||
48826204|NCT00490555|157204119|FG000|Overall Study|noncompliant with drug administration|0|||
48826205|NCT00490555|157204120|FG001|Overall Study|noncompliant with drug administration|0|||
48826206|NCT00490555|157204121|FG002|Overall Study|noncompliant with drug administration|2|||
48826207|NCT00490555|157204122|FG003|Overall Study|noncompliant with drug administration|0|||
48826208|NCT02042443|157204123|FG000|Overall Study|Adverse Event|2|||
48826209|NCT02042443|157204124|FG001|Overall Study|Adverse Event|1|||
48826210|NCT02042443|157204123|FG000|Overall Study|Withdrawal by Subject|0|||
48826211|NCT02042443|157204124|FG001|Overall Study|Withdrawal by Subject|1|||
48524608|NCT00438659|156110817|FG001|Overall Study|Cancel|2|||
48524609|NCT01634854|156110819|FG000|Overall Study|Cesarean delivery|2|||
48601962|NCT01909804|156399498|FG002|Overall Study|Death|0|||
48601963|NCT01909804|156399499|FG003|Overall Study|Death|0|||
48601964|NCT01909804|156399500|FG004|Overall Study|Death|0|||
48601965|NCT01909804|156399501|FG005|Overall Study|Death|0|||
48601966|NCT01909804|156399502|FG006|Overall Study|Death|0|||
48601967|NCT01909804|156399503|FG007|Overall Study|Death|0|||
48601968|NCT01909804|156399504|FG008|Overall Study|Death|0|||
48601969|NCT01909804|156399505|FG009|Overall Study|Death|0|||
48601970|NCT01909804|156399506|FG010|Overall Study|Death|1|||
48601971|NCT01909804|156399507|FG011|Overall Study|Death|0|||
48601972|NCT01909804|156399496|FG000|Overall Study|Lack of Efficacy|4|||
48601973|NCT01909804|156399497|FG001|Overall Study|Lack of Efficacy|1|||
48601974|NCT01909804|156399498|FG002|Overall Study|Lack of Efficacy|0|||
48601975|NCT01909804|156399499|FG003|Overall Study|Lack of Efficacy|0|||
48601976|NCT01909804|156399500|FG004|Overall Study|Lack of Efficacy|7|||
48601977|NCT01909804|156399501|FG005|Overall Study|Lack of Efficacy|3|||
48601978|NCT01909804|156399502|FG006|Overall Study|Lack of Efficacy|1|||
48601979|NCT01909804|156399503|FG007|Overall Study|Lack of Efficacy|1|||
48601980|NCT01909804|156399504|FG008|Overall Study|Lack of Efficacy|0|||
48734026|NCT00532155|156877672|FG000|Overall Study|Study termination stop further treatment|4|||
48734027|NCT00532155|156877673|FG001|Overall Study|Study termination stop further treatment|0|||
48826212|NCT02042443|157204123|FG000|Overall Study|Progression|21|||
48826213|NCT02042443|157204124|FG001|Overall Study|Progression|17|||
48826214|NCT02042443|157204123|FG000|Overall Study|not protocol specified|1|||
48826215|NCT02042443|157204124|FG001|Overall Study|not protocol specified|1|||
48826216|NCT02042443|157204123|FG000|Overall Study|Not eligible/not analyzable|3|||
48826217|NCT02042443|157204124|FG001|Overall Study|Not eligible/not analyzable|6|||
48826218|NCT00828945|157204126|FG000|Overall Study|Death|4|||
48826219|NCT00828945|157204126|FG000|Overall Study|Participant was missing|1|||
48826220|NCT00828945|157204126|FG000|Overall Study|Other|36|||
48826221|NCT00764868|157204131|FG000|Overall Study|Adverse Event|18|||
48826222|NCT00764868|157204131|FG000|Overall Study|Withdrawal by Subject|31|||
48524610|NCT01634854|156110820|FG001|Overall Study|Cesarean delivery|7|||
48601981|NCT01909804|156399505|FG009|Overall Study|Lack of Efficacy|1|||
48601982|NCT01909804|156399506|FG010|Overall Study|Lack of Efficacy|0|||
48601983|NCT01909804|156399507|FG011|Overall Study|Lack of Efficacy|1|||
48601984|NCT01909804|156399496|FG000|Overall Study|Withdrew Consent|0|||
48601985|NCT01909804|156399497|FG001|Overall Study|Withdrew Consent|0|||
48601986|NCT01909804|156399498|FG002|Overall Study|Withdrew Consent|0|||
48601987|NCT01909804|156399499|FG003|Overall Study|Withdrew Consent|0|||
48601988|NCT01909804|156399500|FG004|Overall Study|Withdrew Consent|1|||
48601989|NCT01909804|156399501|FG005|Overall Study|Withdrew Consent|1|||
48734028|NCT00532155|156877672|FG000|Overall Study|Did not receive study medication|2|||
48734029|NCT00532155|156877673|FG001|Overall Study|Did not receive study medication|6|||
48734030|NCT03911154|156877676|FG000|Overall Study|Withdrawal by Subject|1|||
48734031|NCT02853344|156877677|FG000|Overall Study|Lost to Follow-up|1|||
48734032|NCT02853344|156877678|FG001|Overall Study|Lost to Follow-up|1|||
48734033|NCT02853344|156877677|FG000|Overall Study|Withdrawal by Subject|2|||
48734034|NCT02853344|156877678|FG001|Overall Study|Withdrawal by Subject|4|||
48734035|NCT02853344|156877677|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
48734036|NCT02853344|156877678|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
48734037|NCT02853344|156877677|FG000|Overall Study|Death|70|||
48734038|NCT02853344|156877678|FG001|Overall Study|Death|112|||
48734039|NCT00973674|156877679|FG000|Overall Study|Protocol Violation|2|||
48734040|NCT00973674|156877680|FG001|Overall Study|Protocol Violation|0|||
48734041|NCT01460368|156877681|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734042|NCT01460368|156877682|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734043|NCT01460368|156877683|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734044|NCT01460368|156877684|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734045|NCT01460368|156877685|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
48734046|NCT01460368|156877686|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734047|NCT01460368|156877687|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
48734048|NCT01460368|156877681|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734049|NCT01460368|156877682|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
48734050|NCT01460368|156877683|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734051|NCT01460368|156877684|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734052|NCT01460368|156877685|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734053|NCT01460368|156877686|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
48734054|NCT01460368|156877687|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
48734055|NCT01460368|156877681|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734056|NCT01460368|156877682|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
48734057|NCT01460368|156877683|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734058|NCT01460368|156877684|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734059|NCT01460368|156877685|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734060|NCT01460368|156877686|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734061|NCT01460368|156877687|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
48734062|NCT01460368|156877681|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734063|NCT01460368|156877682|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734064|NCT01460368|156877683|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
48734065|NCT01460368|156877684|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734066|NCT01460368|156877685|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734067|NCT01460368|156877686|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734068|NCT01460368|156877687|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
48734069|NCT01460368|156877681|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
48734070|NCT01460368|156877682|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
48734071|NCT01460368|156877683|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
48734072|NCT01460368|156877684|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
48826223|NCT00764868|157204131|FG000|Overall Study|Non-compliance|16|||
48826224|NCT00764868|157204131|FG000|Overall Study|Lost to Follow-up|25|||
48826225|NCT00764868|157204131|FG000|Overall Study|Lack of Efficacy|5|||
48826226|NCT00764868|157204131|FG000|Overall Study|Subject moved|7|||
48826227|NCT00764868|157204131|FG000|Overall Study|Pregnancy|3|||
48826228|NCT00764868|157204131|FG000|Overall Study|Prohibited medication|1|||
48826229|NCT00764868|157204131|FG000|Overall Study|Out of town|1|||
48826230|NCT00764868|157204131|FG000|Overall Study|Misuse and compliance of study drug|1|||
48826231|NCT00764868|157204131|FG000|Overall Study|Subject sent to boarding school|1|||
48826232|NCT00764868|157204131|FG000|Overall Study|Met an exclusion criteria|1|||
48826233|NCT00764868|157204131|FG000|Overall Study|Positive drug screen|2|||
48826234|NCT00764868|157204131|FG000|Overall Study|Sponsor requested withdrawal|1|||
48826235|NCT00462943|157204132|FG000|Overall Study|Failure to achieve a response|5|||
48826236|NCT00462943|157204133|FG001|Overall Study|Failure to achieve a response|5|||
48826237|NCT00462943|157204134|FG002|Overall Study|Failure to achieve a response|1|||
48826238|NCT00462943|157204132|FG000|Overall Study|Adverse Event|6|||
48826239|NCT00462943|157204133|FG001|Overall Study|Adverse Event|4|||
48826240|NCT00462943|157204134|FG002|Overall Study|Adverse Event|1|||
48826241|NCT00462943|157204132|FG000|Overall Study|Protocol Violation|1|||
48826242|NCT00462943|157204133|FG001|Overall Study|Protocol Violation|0|||
48826243|NCT00462943|157204134|FG002|Overall Study|Protocol Violation|0|||
48826244|NCT00462943|157204132|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
48826245|NCT00462943|157204133|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
48826246|NCT00462943|157204134|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
48826247|NCT00462943|157204132|FG000|Overall Study|Disease Progression|15|||
48524611|NCT03450629|156110821|FG000|Overall Study|Adverse Event|15|||
48524612|NCT03450629|156110822|FG001|Overall Study|Adverse Event|14|||
48524613|NCT03450629|156110821|FG000|Overall Study|Physician Decision|2|||
48524614|NCT03450629|156110822|FG001|Overall Study|Physician Decision|2|||
48524615|NCT03450629|156110821|FG000|Overall Study|Lack of Efficacy|2|||
48524616|NCT03450629|156110822|FG001|Overall Study|Lack of Efficacy|0|||
48524617|NCT03450629|156110821|FG000|Overall Study|Lost to Follow-up|4|||
48524618|NCT03450629|156110822|FG001|Overall Study|Lost to Follow-up|2|||
48524619|NCT03450629|156110821|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48524620|NCT03450629|156110822|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
48524621|NCT03450629|156110821|FG000|Overall Study|Non-Compliance With Study Drug|2|||
48524622|NCT03450629|156110822|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48524623|NCT03450629|156110821|FG000|Overall Study|Protocol Violation|11|||
48524624|NCT03450629|156110822|FG001|Overall Study|Protocol Violation|8|||
48524625|NCT03450629|156110821|FG000|Overall Study|Withdrawal by Subject|12|||
48524626|NCT03450629|156110822|FG001|Overall Study|Withdrawal by Subject|6|||
48524627|NCT01337596|156110823|FG000|Overall Study|Withdrawal by Subject|0|||
48524628|NCT01337596|156110824|FG001|Overall Study|Withdrawal by Subject|0|||
48524629|NCT01337596|156110825|FG002|Overall Study|Withdrawal by Subject|0|||
48524630|NCT01337596|156110826|FG003|Overall Study|Withdrawal by Subject|0|||
48524631|NCT01337596|156110827|FG004|Overall Study|Withdrawal by Subject|2|||
48524632|NCT01337596|156110828|FG005|Overall Study|Withdrawal by Subject|0|||
48524633|NCT01337596|156110829|FG006|Overall Study|Withdrawal by Subject|0|||
48524634|NCT01337596|156110830|FG007|Overall Study|Withdrawal by Subject|0|||
48524635|NCT01337596|156110831|FG008|Overall Study|Withdrawal by Subject|0|||
48524636|NCT03693950|156110832|FG000|Overall Study|Withdrawal by Subject|1|||
48524637|NCT03693950|156110833|FG001|Overall Study|Withdrawal by Subject|0|||
48524638|NCT03366194|156110834|FG000|Overall Study|Lost to Follow-up|2|||
48524639|NCT01362296|156110835|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
48524640|NCT01362296|156110836|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
48524641|NCT01362296|156110837|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
48524642|NCT01362296|156110838|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
48524643|NCT01362296|156110835|FG000|Randomized Phase (RP)|Physician Decision|1|||
48524644|NCT01362296|156110836|FG001|Randomized Phase (RP)|Physician Decision|9|||
48524645|NCT01362296|156110837|FG002|Randomized Phase (RP)|Physician Decision|0|||
48524646|NCT01362296|156110838|FG003|Randomized Phase (RP)|Physician Decision|0|||
48524647|NCT01362296|156110835|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
48524648|NCT01362296|156110836|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
48524649|NCT01362296|156110837|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
48524650|NCT01362296|156110838|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
48601990|NCT01909804|156399502|FG006|Overall Study|Withdrew Consent|0|||
48601991|NCT01909804|156399503|FG007|Overall Study|Withdrew Consent|0|||
48524651|NCT01362296|156110835|FG000|Randomized Phase (RP)|Adverse Event|20|||
48524652|NCT01362296|156110836|FG001|Randomized Phase (RP)|Adverse Event|4|||
48524653|NCT01362296|156110837|FG002|Randomized Phase (RP)|Adverse Event|0|||
48524654|NCT01362296|156110838|FG003|Randomized Phase (RP)|Adverse Event|0|||
48524655|NCT01362296|156110835|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
48524656|NCT01362296|156110836|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
48524657|NCT01362296|156110837|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
48524658|NCT01362296|156110838|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
48524659|NCT01362296|156110835|FG000|Crossover Phase|PD including Death due to PD|0|||
48524660|NCT01362296|156110836|FG001|Crossover Phase|PD including Death due to PD|0|||
48524661|NCT01362296|156110837|FG002|Crossover Phase|PD including Death due to PD|16|||
48524662|NCT01362296|156110838|FG003|Crossover Phase|PD including Death due to PD|1|||
48524663|NCT01362296|156110835|FG000|Crossover Phase|Withdrawal by Subject|0|||
48524664|NCT01362296|156110836|FG001|Crossover Phase|Withdrawal by Subject|0|||
48524665|NCT01362296|156110837|FG002|Crossover Phase|Withdrawal by Subject|2|||
48524666|NCT01362296|156110838|FG003|Crossover Phase|Withdrawal by Subject|1|||
48524667|NCT01362296|156110835|FG000|Crossover Phase|Adverse Event|0|||
48524668|NCT01362296|156110836|FG001|Crossover Phase|Adverse Event|0|||
48524669|NCT01362296|156110837|FG002|Crossover Phase|Adverse Event|4|||
48601992|NCT01909804|156399504|FG008|Overall Study|Withdrew Consent|0|||
48524670|NCT01362296|156110838|FG003|Crossover Phase|Adverse Event|0|||
48524671|NCT01362296|156110835|FG000|Crossover Phase|Study Closed/Terminated|0|||
48524672|NCT01362296|156110836|FG001|Crossover Phase|Study Closed/Terminated|0|||
48524673|NCT01362296|156110837|FG002|Crossover Phase|Study Closed/Terminated|1|||
48524674|NCT01362296|156110838|FG003|Crossover Phase|Study Closed/Terminated|0|||
48524675|NCT04230876|156110839|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
48524676|NCT04230876|156110840|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
48524677|NCT01475487|156110842|FG000|Overall Study|had to leave early for personal reasons|2|||
48524678|NCT01475487|156110843|FG001|Overall Study|had to leave early for personal reasons|1|||
48524679|NCT01475786|156110847|FG000|Overall Study|Adverse Event|0|||
48524680|NCT01475786|156110848|FG001|Overall Study|Adverse Event|1|||
48524681|NCT01475786|156110849|FG002|Overall Study|Adverse Event|0|||
48524682|NCT01475786|156110847|FG000|Overall Study|Lost to Follow-up|1|||
48524683|NCT01475786|156110848|FG001|Overall Study|Lost to Follow-up|2|||
48524684|NCT01475786|156110849|FG002|Overall Study|Lost to Follow-up|1|||
48524685|NCT01475786|156110847|FG000|Overall Study|Withdrawal by Subject|0|||
48524686|NCT01475786|156110848|FG001|Overall Study|Withdrawal by Subject|1|||
48524687|NCT01475786|156110849|FG002|Overall Study|Withdrawal by Subject|1|||
48524688|NCT01475786|156110847|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
48524689|NCT01475786|156110848|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
48524690|NCT01475786|156110849|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
48524691|NCT02093923|156110850|FG000|Overall Study|Lost to Follow-up|0|||
48524692|NCT02093923|156110851|FG001|Overall Study|Lost to Follow-up|0|||
48524693|NCT02093923|156110852|FG002|Overall Study|Lost to Follow-up|0|||
48524694|NCT02093923|156110853|FG003|Overall Study|Lost to Follow-up|1|||
48524695|NCT02093923|156110854|FG004|Overall Study|Lost to Follow-up|0|||
48524696|NCT02093923|156110850|FG000|Overall Study|Screen failure after randomization|0|||
48524697|NCT02093923|156110851|FG001|Overall Study|Screen failure after randomization|0|||
48524698|NCT02093923|156110852|FG002|Overall Study|Screen failure after randomization|0|||
48524699|NCT02093923|156110853|FG003|Overall Study|Screen failure after randomization|1|||
48524700|NCT02093923|156110854|FG004|Overall Study|Screen failure after randomization|0|||
48524701|NCT03168906|156110861|FG000|Overall Study|Lack of Efficacy|6|||
48524702|NCT03168906|156110862|FG001|Overall Study|Lack of Efficacy|6|||
48524703|NCT01321697|156110865|FG000|Overall Study|Study Terminated|7|||
48524704|NCT04556734|156112104|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
48524705|NCT04556734|156112105|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
48524706|NCT04556734|156112106|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
48524707|NCT04556734|156112107|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48524708|NCT04556734|156112108|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48524709|NCT04556734|156112109|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48524710|NCT04556734|156112110|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48524711|NCT04556734|156112111|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48524712|NCT04556734|156112104|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
48524713|NCT04556734|156112105|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48524714|NCT04556734|156112106|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48524715|NCT04556734|156112107|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48524716|NCT04556734|156112108|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48524717|NCT04556734|156112109|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48524718|NCT04556734|156112110|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48524719|NCT04556734|156112111|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48524720|NCT04556734|156112104|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48524721|NCT04556734|156112105|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48524722|NCT04556734|156112106|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48524723|NCT04556734|156112107|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48524724|NCT04556734|156112108|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48524725|NCT04556734|156112109|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48524726|NCT04556734|156112110|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48524727|NCT04556734|156112111|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48524728|NCT04556734|156112104|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
48524729|NCT04556734|156112105|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48524730|NCT04556734|156112106|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48524731|NCT04556734|156112107|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48524732|NCT04556734|156112108|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48524733|NCT04556734|156112109|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48524734|NCT04556734|156112110|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48524735|NCT04556734|156112111|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48524736|NCT04556734|156112104|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
48524737|NCT04556734|156112105|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
48524738|NCT04556734|156112106|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
48524739|NCT04556734|156112107|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
48826248|NCT00462943|157204133|FG001|Overall Study|Disease Progression|15|||
48826249|NCT00462943|157204134|FG002|Overall Study|Disease Progression|9|||
48826250|NCT00462943|157204132|FG000|Overall Study|Death|5|||
48524740|NCT04556734|156112108|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
48524741|NCT04556734|156112109|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
48524742|NCT04556734|156112110|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
48826251|NCT00462943|157204133|FG001|Overall Study|Death|2|||
48826252|NCT00462943|157204134|FG002|Overall Study|Death|7|||
48524743|NCT04556734|156112111|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
48524744|NCT04556734|156112104|FG000|OLE Period (28 Weeks)|Not reported|0|||
48524745|NCT04556734|156112105|FG001|OLE Period (28 Weeks)|Not reported|0|||
48524746|NCT04556734|156112106|FG002|OLE Period (28 Weeks)|Not reported|0|||
48524747|NCT04556734|156112107|FG003|OLE Period (28 Weeks)|Not reported|0|||
48524748|NCT04556734|156112108|FG004|OLE Period (28 Weeks)|Not reported|0|||
48524749|NCT04556734|156112109|FG005|OLE Period (28 Weeks)|Not reported|1|||
48524750|NCT04556734|156112110|FG006|OLE Period (28 Weeks)|Not reported|0|||
48524751|NCT04556734|156112111|FG007|OLE Period (28 Weeks)|Not reported|0|||
48524752|NCT04556734|156112104|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48524753|NCT04556734|156112105|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48524754|NCT04556734|156112106|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48524755|NCT04556734|156112107|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48524756|NCT04556734|156112108|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48524757|NCT04556734|156112109|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48524758|NCT04556734|156112110|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48524759|NCT04556734|156112111|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
48524760|NCT04556734|156112104|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
48524761|NCT04556734|156112105|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
48524762|NCT04556734|156112106|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
48524763|NCT04556734|156112107|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
48524764|NCT04556734|156112108|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
48524765|NCT04556734|156112109|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
48524766|NCT04556734|156112110|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
48524767|NCT04556734|156112111|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
48524768|NCT04556734|156112104|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
48524769|NCT04556734|156112105|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
48524770|NCT04556734|156112106|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
48524771|NCT04556734|156112107|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
48524772|NCT04556734|156112108|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
48524773|NCT04556734|156112109|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
48524774|NCT04556734|156112110|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
48524775|NCT04556734|156112111|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
48524776|NCT01257581|156112126|FG000|Overall Study|Early Termination|3|||
48524777|NCT01257581|156112127|FG001|Overall Study|Early Termination|1|||
48524778|NCT01257581|156112128|FG002|Overall Study|Early Termination|2|||
48524779|NCT01257581|156112126|FG000|Overall Study|Death|2|||
48524780|NCT01257581|156112127|FG001|Overall Study|Death|2|||
48524781|NCT01257581|156112128|FG002|Overall Study|Death|4|||
48524782|NCT01848210|156112129|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
48524783|NCT01848210|156112130|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
48524784|NCT01848210|156112129|FG000|Overall Study|Lost to Follow-up|24|||
48524785|NCT01848210|156112130|FG001|Overall Study|Lost to Follow-up|12|||
48524786|NCT01848210|156112129|FG000|Overall Study|Protocol Violation|3|||
48524787|NCT01848210|156112130|FG001|Overall Study|Protocol Violation|5|||
48524788|NCT01848210|156112129|FG000|Overall Study|Use of Forbidden Drugs|9|||
48826253|NCT00462943|157204132|FG000|Overall Study|Stem Cell Transplant|1|||
48826254|NCT00462943|157204133|FG001|Overall Study|Stem Cell Transplant|1|||
48826255|NCT00462943|157204134|FG002|Overall Study|Stem Cell Transplant|0|||
48826256|NCT00462943|157204132|FG000|Overall Study|Bone Marrow Transplant|1|||
48826257|NCT00462943|157204133|FG001|Overall Study|Bone Marrow Transplant|0|||
48826258|NCT00462943|157204134|FG002|Overall Study|Bone Marrow Transplant|0|||
48826259|NCT00462943|157204132|FG000|Overall Study|Required Lymphocyte Infusion|1|||
48826260|NCT00462943|157204133|FG001|Overall Study|Required Lymphocyte Infusion|0|||
48826261|NCT00462943|157204134|FG002|Overall Study|Required Lymphocyte Infusion|0|||
48826262|NCT00462943|157204132|FG000|Overall Study|Transplant - not specified|1|||
48826263|NCT00462943|157204133|FG001|Overall Study|Transplant - not specified|0|||
48524789|NCT01848210|156112130|FG001|Overall Study|Use of Forbidden Drugs|10|||
48524790|NCT01848210|156112129|FG000|Overall Study|Impedition Condition|5|||
48524791|NCT01848210|156112130|FG001|Overall Study|Impedition Condition|9|||
48524792|NCT01848210|156112129|FG000|Overall Study|Adverse Event|7|||
48826264|NCT00462943|157204134|FG002|Overall Study|Transplant - not specified|1|||
48524793|NCT01848210|156112130|FG001|Overall Study|Adverse Event|9|||
48524794|NCT01848210|156112129|FG000|Overall Study|Discontinuation Criterion|5|||
48524795|NCT01848210|156112130|FG001|Overall Study|Discontinuation Criterion|7|||
48826265|NCT00462943|157204132|FG000|Overall Study|Physician Decision|1|||
48524796|NCT01848210|156112129|FG000|Overall Study|Hypesensitivity|1|||
48524797|NCT01848210|156112130|FG001|Overall Study|Hypesensitivity|0|||
48524798|NCT01848210|156112129|FG000|Overall Study|Hepatic Function Alteration|4|||
48524799|NCT01848210|156112130|FG001|Overall Study|Hepatic Function Alteration|0|||
48524800|NCT01848210|156112129|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
48524801|NCT01848210|156112130|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
48524802|NCT01848210|156112129|FG000|Overall Study|Administrative|1|||
48524803|NCT01848210|156112130|FG001|Overall Study|Administrative|0|||
48826266|NCT00462943|157204133|FG001|Overall Study|Physician Decision|0|||
48734073|NCT01460368|156877685|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
48734074|NCT01460368|156877686|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
48734075|NCT01460368|156877687|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
48734076|NCT03452228|156877688|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48734077|NCT03452228|156877689|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
48734078|NCT03452228|156877690|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
48826267|NCT00462943|157204134|FG002|Overall Study|Physician Decision|0|||
48826268|NCT00462943|157204132|FG000|Overall Study|Withdrawal by Subject|0|||
48734079|NCT03452228|156877688|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48734080|NCT03452228|156877689|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48734081|NCT03452228|156877690|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48734082|NCT03452228|156877688|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
48826269|NCT00462943|157204133|FG001|Overall Study|Withdrawal by Subject|1|||
48826270|NCT00462943|157204134|FG002|Overall Study|Withdrawal by Subject|0|||
48524804|NCT04592419|156112131|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
48524805|NCT04592419|156112132|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
48524806|NCT04592419|156112131|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
48524807|NCT04592419|156112132|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
48524808|NCT04592419|156112131|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
48524809|NCT04592419|156112132|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
48524810|NCT04592419|156112131|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
48524811|NCT04592419|156112132|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
48524812|NCT04592419|156112131|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
48524813|NCT04592419|156112132|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
48524814|NCT04592419|156112131|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
48524815|NCT04592419|156112132|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
48524816|NCT04592419|156112131|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
48524817|NCT04592419|156112132|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
48826271|NCT00819234|157204135|FG000|Overall Study|Withdrawal by Subject|8|||
48826272|NCT00819234|157204136|FG001|Overall Study|Withdrawal by Subject|13|||
48826273|NCT00819234|157204137|FG002|Overall Study|Withdrawal by Subject|6|||
48826274|NCT00819234|157204138|FG003|Overall Study|Withdrawal by Subject|3|||
48826275|NCT00819234|157204139|FG004|Overall Study|Withdrawal by Subject|0|||
48826276|NCT00819234|157204140|FG005|Overall Study|Withdrawal by Subject|4|||
48826277|NCT00819234|157204141|FG006|Overall Study|Withdrawal by Subject|4|||
48826278|NCT00819234|157204142|FG007|Overall Study|Withdrawal by Subject|8|||
48826279|NCT00819234|157204143|FG008|Overall Study|Withdrawal by Subject|5|||
48826280|NCT00819234|157204144|FG009|Overall Study|Withdrawal by Subject|3|||
48826281|NCT00819234|157204135|FG000|Overall Study|Adverse Event|0|||
48826282|NCT00819234|157204136|FG001|Overall Study|Adverse Event|0|||
48826283|NCT00819234|157204137|FG002|Overall Study|Adverse Event|1|||
48826284|NCT00819234|157204138|FG003|Overall Study|Adverse Event|0|||
48734083|NCT03452228|156877689|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
48826285|NCT00819234|157204139|FG004|Overall Study|Adverse Event|0|||
48826286|NCT00819234|157204140|FG005|Overall Study|Adverse Event|2|||
48826287|NCT00819234|157204141|FG006|Overall Study|Adverse Event|0|||
48826288|NCT00819234|157204142|FG007|Overall Study|Adverse Event|0|||
48826289|NCT00819234|157204143|FG008|Overall Study|Adverse Event|0|||
48826290|NCT00819234|157204144|FG009|Overall Study|Adverse Event|0|||
48826291|NCT00819234|157204135|FG000|Overall Study|Physician Decision|0|||
48826292|NCT00819234|157204136|FG001|Overall Study|Physician Decision|0|||
48826293|NCT00819234|157204137|FG002|Overall Study|Physician Decision|0|||
48826294|NCT00819234|157204138|FG003|Overall Study|Physician Decision|1|||
48826295|NCT00819234|157204139|FG004|Overall Study|Physician Decision|0|||
48524818|NCT04592419|156112131|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
48524819|NCT04592419|156112132|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
48524820|NCT04592419|156112131|FG000|Open-Label Extension Period|Adverse Event|1|||
48524821|NCT04592419|156112132|FG001|Open-Label Extension Period|Adverse Event|2|||
48734084|NCT03452228|156877690|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
48734085|NCT03452228|156877688|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48734086|NCT03452228|156877689|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48734087|NCT03452228|156877690|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
48734088|NCT01986907|156877693|FG000|Overall Study|Adverse Event|11|||
48734089|NCT01986907|156877693|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
48734090|NCT01986907|156877693|FG000|Overall Study|Protocol Violation|4|||
48734091|NCT01986907|156877693|FG000|Overall Study|Withdrawal by Subject|76|||
48734092|NCT01986907|156877693|FG000|Overall Study|Lost to Follow-up|38|||
48734093|NCT01986907|156877693|FG000|Overall Study|Death|9|||
48734094|NCT01297920|156877694|FG000|Overall Study|Adverse Event|42|||
48734095|NCT01297920|156877695|FG001|Overall Study|Adverse Event|10|||
48734096|NCT01297920|156877696|FG002|Overall Study|Adverse Event|38|||
48734097|NCT01297920|156877694|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
48734098|NCT01297920|156877695|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
48734099|NCT01297920|156877696|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
48734100|NCT01297920|156877694|FG000|Overall Study|Noncompliance|1|||
48734101|NCT01297920|156877695|FG001|Overall Study|Noncompliance|0|||
48734102|NCT01297920|156877696|FG002|Overall Study|Noncompliance|0|||
48734103|NCT01297920|156877694|FG000|Overall Study|Protocol Violation|1|||
48524822|NCT04592419|156112131|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
48524823|NCT04592419|156112132|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
48524824|NCT04592419|156112131|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
48524825|NCT04592419|156112132|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
48524826|NCT04592419|156112131|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
48524827|NCT04592419|156112132|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
48524828|NCT04592419|156112131|FG000|Open-Label Extension Period|Sponsor Request|73|||
48524829|NCT04592419|156112132|FG001|Open-Label Extension Period|Sponsor Request|84|||
48524830|NCT02998541|156112135|FG000|Overall Study|Adverse Event|4|||
48524831|NCT02998541|156112136|FG001|Overall Study|Adverse Event|5|||
48524832|NCT02998541|156112137|FG002|Overall Study|Adverse Event|1|||
48524833|NCT02998541|156112135|FG000|Overall Study|Protocol Violation|1|||
48524834|NCT02998541|156112136|FG001|Overall Study|Protocol Violation|0|||
48524835|NCT02998541|156112137|FG002|Overall Study|Protocol Violation|0|||
48524836|NCT02998541|156112135|FG000|Overall Study|Withdrawal by Subject|3|||
48734104|NCT01297920|156877695|FG001|Overall Study|Protocol Violation|3|||
48734105|NCT01297920|156877696|FG002|Overall Study|Protocol Violation|0|||
48734106|NCT01297920|156877694|FG000|Overall Study|Inadequate Control of IOP|7|||
48524837|NCT02998541|156112136|FG001|Overall Study|Withdrawal by Subject|1|||
48524838|NCT02998541|156112137|FG002|Overall Study|Withdrawal by Subject|0|||
48524839|NCT02998541|156112135|FG000|Overall Study|Lost to Follow-up|0|||
48524840|NCT02998541|156112136|FG001|Overall Study|Lost to Follow-up|3|||
48524841|NCT02998541|156112137|FG002|Overall Study|Lost to Follow-up|1|||
48524842|NCT02998541|156112135|FG000|Overall Study|Physician Decision|0|||
48524843|NCT02998541|156112136|FG001|Overall Study|Physician Decision|0|||
48524844|NCT02998541|156112137|FG002|Overall Study|Physician Decision|3|||
48524845|NCT02998541|156112135|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48524846|NCT02998541|156112136|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48524847|NCT02998541|156112137|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
48524848|NCT00517192|156112140|FG000|Overall Study|Adverse Event|1|||
48524849|NCT00517192|156112141|FG001|Overall Study|Adverse Event|1|||
48524850|NCT00517192|156112140|FG000|Overall Study|Lost to Follow-up|1|||
48524851|NCT00517192|156112141|FG001|Overall Study|Lost to Follow-up|1|||
48524852|NCT00517192|156112140|FG000|Overall Study|Withdrawal by Subject|1|||
48524853|NCT00517192|156112141|FG001|Overall Study|Withdrawal by Subject|0|||
48524854|NCT00517192|156112140|FG000|Overall Study|Early termination of the trial|16|||
48524855|NCT00517192|156112141|FG001|Overall Study|Early termination of the trial|18|||
48524856|NCT04129944|156112142|FG000|Overall Study|Death|0|||
48524857|NCT04129944|156112143|FG001|Overall Study|Death|0|||
48524858|NCT04129944|156112144|FG002|Overall Study|Death|0|||
48524859|NCT04129944|156112145|FG003|Overall Study|Death|1|||
48524860|NCT04129944|156112142|FG000|Overall Study|Lost to Follow-up|1|||
48524861|NCT04129944|156112143|FG001|Overall Study|Lost to Follow-up|0|||
48524862|NCT04129944|156112144|FG002|Overall Study|Lost to Follow-up|0|||
48524863|NCT04129944|156112145|FG003|Overall Study|Lost to Follow-up|0|||
48524864|NCT04129944|156112142|FG000|Overall Study|Withdrawal by Subject|1|||
48524865|NCT04129944|156112143|FG001|Overall Study|Withdrawal by Subject|0|||
48734107|NCT01297920|156877695|FG001|Overall Study|Inadequate Control of IOP|9|||
48734108|NCT01297920|156877696|FG002|Overall Study|Inadequate Control of IOP|17|||
48734109|NCT01297920|156877694|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
48826296|NCT00819234|157204140|FG005|Overall Study|Physician Decision|0|||
48524866|NCT04129944|156112144|FG002|Overall Study|Withdrawal by Subject|1|||
48524867|NCT04129944|156112145|FG003|Overall Study|Withdrawal by Subject|2|||
48524868|NCT04102345|156112153|FG000|Overall Study|Withdrawal by Subject|1|||
48524869|NCT04102345|156112154|FG001|Overall Study|Withdrawal by Subject|0|||
48524870|NCT04205162|156112155|FG000|Overall Study|Lost to Follow-up|1|||
48734110|NCT01297920|156877695|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
48734111|NCT01297920|156877696|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
48734112|NCT01090973|156877697|FG000|Overall Study|Disease progression|1|||
48734113|NCT02507973|156877698|FG000|Overall Study|Adverse Event|1|||
48734114|NCT01565642|156877699|FG000|Overall Study|Withdrawal by Subject|2|||
48734115|NCT01565642|156877700|FG001|Overall Study|Withdrawal by Subject|1|||
48734116|NCT02770170|156877703|FG000|Overall Study|Withdrawal by Subject|0|||
48734117|NCT02770170|156877704|FG001|Overall Study|Withdrawal by Subject|0|||
48734118|NCT02770170|156877705|FG002|Overall Study|Withdrawal by Subject|0|||
48734119|NCT02770170|156877706|FG003|Overall Study|Withdrawal by Subject|2|||
48734120|NCT02770170|156877703|FG000|Overall Study|due to pregnancy|1|||
48734121|NCT02770170|156877704|FG001|Overall Study|due to pregnancy|0|||
48734122|NCT02770170|156877705|FG002|Overall Study|due to pregnancy|0|||
48734123|NCT02770170|156877706|FG003|Overall Study|due to pregnancy|0|||
48734124|NCT02770170|156877703|FG000|Overall Study|Lack of Efficacy|2|||
48734125|NCT02770170|156877704|FG001|Overall Study|Lack of Efficacy|0|||
48734126|NCT02770170|156877705|FG002|Overall Study|Lack of Efficacy|0|||
48734127|NCT02770170|156877706|FG003|Overall Study|Lack of Efficacy|1|||
48734128|NCT02770170|156877703|FG000|Overall Study|Adverse Event|4|||
48734129|NCT02770170|156877704|FG001|Overall Study|Adverse Event|3|||
48734130|NCT02770170|156877705|FG002|Overall Study|Adverse Event|5|||
48734131|NCT02770170|156877706|FG003|Overall Study|Adverse Event|3|||
48734132|NCT02770170|156877703|FG000|Overall Study|due to disease worsening|0|||
48734133|NCT02770170|156877704|FG001|Overall Study|due to disease worsening|0|||
48734134|NCT02770170|156877705|FG002|Overall Study|due to disease worsening|0|||
48734135|NCT02770170|156877706|FG003|Overall Study|due to disease worsening|1|||
48734136|NCT01710046|156877709|FG000|Overall Study|Lost to Follow-up|1|||
48734137|NCT01710046|156877710|FG001|Overall Study|Lost to Follow-up|0|||
48734138|NCT00467857|156877711|FG000|Overall Study|Adverse Event|1|||
48734139|NCT00467857|156877712|FG001|Overall Study|Adverse Event|0|||
48734140|NCT00467857|156877711|FG000|Overall Study|Withdrew consent|2|||
48734141|NCT00467857|156877712|FG001|Overall Study|Withdrew consent|0|||
48734142|NCT00467857|156877711|FG000|Overall Study|Death|0|||
48734143|NCT00467857|156877712|FG001|Overall Study|Death|1|||
48734144|NCT00467857|156877711|FG000|Overall Study|Discharged from court service|0|||
48734145|NCT00467857|156877712|FG001|Overall Study|Discharged from court service|1|||
48734146|NCT00467857|156877711|FG000|Overall Study|Emergency care required|0|||
48734147|NCT00467857|156877712|FG001|Overall Study|Emergency care required|1|||
48734148|NCT00467857|156877711|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
48734149|NCT00467857|156877712|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
48734150|NCT00467857|156877711|FG000|Overall Study|Discontinuation reason missing|0|||
48734151|NCT00467857|156877712|FG001|Overall Study|Discontinuation reason missing|3|||
48734152|NCT02349542|156877713|FG000|Overall Study|Withdrawal by Subject|5|||
48734153|NCT00543543|156877714|FG000|Base Study|Adverse Event|1|||
48734154|NCT00543543|156877715|FG001|Base Study|Adverse Event|11|||
48734155|NCT00543543|156877716|FG002|Base Study|Adverse Event|0|||
48734156|NCT00543543|156877717|FG003|Base Study|Adverse Event|5|||
48734157|NCT00543543|156877714|FG000|Base Study|Lost to Follow-up|12|||
48734158|NCT00543543|156877715|FG001|Base Study|Lost to Follow-up|749|||
48734159|NCT00543543|156877716|FG002|Base Study|Lost to Follow-up|9|||
48734160|NCT00543543|156877717|FG003|Base Study|Lost to Follow-up|701|||
48734161|NCT00543543|156877714|FG000|Base Study|Physician Decision|0|||
48734162|NCT00543543|156877715|FG001|Base Study|Physician Decision|4|||
48734163|NCT00543543|156877716|FG002|Base Study|Physician Decision|0|||
48734164|NCT00543543|156877717|FG003|Base Study|Physician Decision|7|||
48734165|NCT00543543|156877714|FG000|Base Study|Protocol Violation|0|||
48734166|NCT00543543|156877715|FG001|Base Study|Protocol Violation|6|||
48734167|NCT00543543|156877716|FG002|Base Study|Protocol Violation|0|||
48734168|NCT00543543|156877717|FG003|Base Study|Protocol Violation|6|||
48734169|NCT00543543|156877714|FG000|Base Study|Withdrawal by Subject|7|||
48734170|NCT00543543|156877715|FG001|Base Study|Withdrawal by Subject|482|||
48734171|NCT00543543|156877716|FG002|Base Study|Withdrawal by Subject|5|||
48734172|NCT00543543|156877717|FG003|Base Study|Withdrawal by Subject|503|||
48734173|NCT00543543|156877714|FG000|Extension Study|Adverse Event|0|||
48734174|NCT00543543|156877715|FG001|Extension Study|Adverse Event|0|||
48826297|NCT00819234|157204141|FG006|Overall Study|Physician Decision|0|||
48826298|NCT00819234|157204142|FG007|Overall Study|Physician Decision|0|||
48826299|NCT00819234|157204143|FG008|Overall Study|Physician Decision|0|||
48826300|NCT00819234|157204144|FG009|Overall Study|Physician Decision|2|||
48601993|NCT01909804|156399505|FG009|Overall Study|Withdrew Consent|0|||
48734175|NCT00543543|156877716|FG002|Extension Study|Adverse Event|0|||
48734176|NCT00543543|156877717|FG003|Extension Study|Adverse Event|5|||
48734177|NCT00543543|156877714|FG000|Extension Study|Lost to Follow-up|0|||
48734178|NCT00543543|156877715|FG001|Extension Study|Lost to Follow-up|0|||
48734179|NCT00543543|156877716|FG002|Extension Study|Lost to Follow-up|0|||
48734180|NCT00543543|156877717|FG003|Extension Study|Lost to Follow-up|77|||
48734181|NCT00543543|156877714|FG000|Extension Study|Physician Decision|0|||
48734182|NCT00543543|156877715|FG001|Extension Study|Physician Decision|0|||
48734183|NCT00543543|156877716|FG002|Extension Study|Physician Decision|0|||
48734184|NCT00543543|156877717|FG003|Extension Study|Physician Decision|7|||
48734185|NCT00543543|156877714|FG000|Extension Study|Pregnancy|0|||
48734186|NCT00543543|156877715|FG001|Extension Study|Pregnancy|0|||
48734187|NCT00543543|156877716|FG002|Extension Study|Pregnancy|0|||
48734188|NCT00543543|156877717|FG003|Extension Study|Pregnancy|6|||
48734189|NCT00543543|156877714|FG000|Extension Study|Protocol Violation|0|||
48734190|NCT00543543|156877715|FG001|Extension Study|Protocol Violation|0|||
48734191|NCT00543543|156877716|FG002|Extension Study|Protocol Violation|0|||
48734192|NCT00543543|156877717|FG003|Extension Study|Protocol Violation|11|||
48734193|NCT00543543|156877714|FG000|Extension Study|Withdrawal by Subject|0|||
48734194|NCT00543543|156877715|FG001|Extension Study|Withdrawal by Subject|0|||
48734195|NCT00543543|156877716|FG002|Extension Study|Withdrawal by Subject|0|||
48734196|NCT00543543|156877717|FG003|Extension Study|Withdrawal by Subject|120|||
48734197|NCT04122534|156877721|FG000|Overall Study|Lost to Follow-up|4|||
48734198|NCT02959983|156877726|FG000|Overall Study|Protocol Violation|0|||
48734199|NCT02959983|156877727|FG001|Overall Study|Protocol Violation|1|||
48734200|NCT02959983|156877726|FG000|Overall Study|Lack of Efficacy|0|||
48734201|NCT02959983|156877727|FG001|Overall Study|Lack of Efficacy|1|||
48734202|NCT02959983|156877726|FG000|Overall Study|Lost to Follow-up|12|||
48734203|NCT02959983|156877727|FG001|Overall Study|Lost to Follow-up|9|||
48826301|NCT00819234|157204135|FG000|Overall Study|Protocol Violation|0|||
48826302|NCT00819234|157204136|FG001|Overall Study|Protocol Violation|0|||
48826303|NCT00819234|157204137|FG002|Overall Study|Protocol Violation|1|||
48826304|NCT00819234|157204138|FG003|Overall Study|Protocol Violation|0|||
48826305|NCT00819234|157204139|FG004|Overall Study|Protocol Violation|0|||
48826306|NCT00819234|157204140|FG005|Overall Study|Protocol Violation|0|||
48826307|NCT00819234|157204141|FG006|Overall Study|Protocol Violation|0|||
48826308|NCT00819234|157204142|FG007|Overall Study|Protocol Violation|0|||
48826309|NCT00819234|157204143|FG008|Overall Study|Protocol Violation|0|||
48826310|NCT00819234|157204144|FG009|Overall Study|Protocol Violation|0|||
48826311|NCT00819234|157204135|FG000|Overall Study|Lost to Follow-up|2|||
48826312|NCT00819234|157204136|FG001|Overall Study|Lost to Follow-up|2|||
48826313|NCT00819234|157204137|FG002|Overall Study|Lost to Follow-up|0|||
48826314|NCT00819234|157204138|FG003|Overall Study|Lost to Follow-up|2|||
48826315|NCT00819234|157204139|FG004|Overall Study|Lost to Follow-up|1|||
48826316|NCT00819234|157204140|FG005|Overall Study|Lost to Follow-up|1|||
48826317|NCT00819234|157204141|FG006|Overall Study|Lost to Follow-up|1|||
48826318|NCT00819234|157204142|FG007|Overall Study|Lost to Follow-up|1|||
48826319|NCT00819234|157204143|FG008|Overall Study|Lost to Follow-up|1|||
48826320|NCT00819234|157204144|FG009|Overall Study|Lost to Follow-up|2|||
48826321|NCT01096056|157204145|FG000|Overall Study|Lost to Follow-up|0|||
48826322|NCT01096056|157204146|FG001|Overall Study|Lost to Follow-up|1|||
48826323|NCT04438785|157204147|FG000|Overall Study|change of weight, give up intervention|2|||
48826324|NCT04438785|157204148|FG001|Overall Study|change of weight, give up intervention|10|||
48826325|NCT02027935|157204152|FG000|Overall Study|Death|1|||
48524871|NCT04205162|156112156|FG001|Overall Study|Lost to Follow-up|0|||
48524872|NCT04205162|156112155|FG000|Overall Study|Withdrawal by Subject|2|||
48734204|NCT02959983|156877726|FG000|Overall Study|Other|1|||
48734205|NCT02959983|156877727|FG001|Overall Study|Other|1|||
48734206|NCT02959983|156877726|FG000|Overall Study|Physician Decision|1|||
48734207|NCT02959983|156877727|FG001|Overall Study|Physician Decision|0|||
48734208|NCT02959983|156877726|FG000|Overall Study|Adverse Event|5|||
48734209|NCT02959983|156877727|FG001|Overall Study|Adverse Event|1|||
48734210|NCT02959983|156877726|FG000|Overall Study|Withdrawal by Subject|7|||
48734211|NCT02959983|156877727|FG001|Overall Study|Withdrawal by Subject|12|||
48734212|NCT02020577|156877728|FG000|Overall Study|Progressive disease|3|||
48826326|NCT02027935|157204152|FG000|Overall Study|Lack of Efficacy|5|||
48826327|NCT02027935|157204152|FG000|Overall Study|Study Closure|1|||
48524873|NCT04205162|156112156|FG001|Overall Study|Withdrawal by Subject|0|||
48524874|NCT04205162|156112155|FG000|Overall Study|University closure due to COVID-19|1|||
48524875|NCT04205162|156112156|FG001|Overall Study|University closure due to COVID-19|0|||
48524876|NCT02985398|156112157|FG000|Overall Study|Adverse Event|1|||
48524877|NCT02985398|156112157|FG000|Overall Study|Lost to Follow-up|4|||
48524878|NCT02985398|156112157|FG000|Overall Study|Withdrawal by Subject|8|||
48524879|NCT02985398|156112157|FG000|Overall Study|Study Burden|9|||
48734213|NCT02020577|156877729|FG001|Overall Study|Progressive disease|38|||
48734214|NCT02020577|156877728|FG000|Overall Study|Other AE or clinical progression|0|||
48734215|NCT02020577|156877729|FG001|Overall Study|Other AE or clinical progression|15|||
48734216|NCT02020577|156877728|FG000|Overall Study|Withdrawal by Subject|0|||
48826328|NCT03115346|157204153|FG000|Overall Study|Did not have AAA surgery|28|||
48734217|NCT02020577|156877729|FG001|Overall Study|Withdrawal by Subject|1|||
48734218|NCT02020577|156877728|FG000|Overall Study|Other than stated above|0|||
48826329|NCT03115346|157204154|FG001|Overall Study|Did not have AAA surgery|15|||
48826330|NCT03115346|157204153|FG000|Overall Study|Death|3|||
48826331|NCT03115346|157204154|FG001|Overall Study|Death|1|||
48826332|NCT03115346|157204153|FG000|Overall Study|Withdrawal by Subject|0|||
48524880|NCT01266603|156112169|FG000|Overall Study|Adverse Event|1|||
48826333|NCT03115346|157204154|FG001|Overall Study|Withdrawal by Subject|3|||
48826334|NCT03115346|157204153|FG000|Overall Study|Lost to Follow-up|0|||
48601994|NCT01909804|156399506|FG010|Overall Study|Withdrew Consent|0|||
48601995|NCT01909804|156399507|FG011|Overall Study|Withdrew Consent|0|||
48601996|NCT01909804|156399496|FG000|Overall Study|Protocol Violation|0|||
48601997|NCT01909804|156399497|FG001|Overall Study|Protocol Violation|0|||
48601998|NCT01909804|156399498|FG002|Overall Study|Protocol Violation|0|||
48601999|NCT01909804|156399499|FG003|Overall Study|Protocol Violation|0|||
48602000|NCT01909804|156399500|FG004|Overall Study|Protocol Violation|0|||
48602001|NCT01909804|156399501|FG005|Overall Study|Protocol Violation|0|||
48602002|NCT01909804|156399502|FG006|Overall Study|Protocol Violation|0|||
48602003|NCT01909804|156399503|FG007|Overall Study|Protocol Violation|0|||
48602004|NCT01909804|156399504|FG008|Overall Study|Protocol Violation|0|||
48602005|NCT01909804|156399505|FG009|Overall Study|Protocol Violation|0|||
48602006|NCT01909804|156399506|FG010|Overall Study|Protocol Violation|0|||
48602007|NCT01909804|156399507|FG011|Overall Study|Protocol Violation|1|||
48602008|NCT03804268|156399510|FG000|Overall Study|Adverse Event|2|||
48602009|NCT03804268|156399511|FG001|Overall Study|Adverse Event|2|||
48602010|NCT03804268|156399510|FG000|Overall Study|Withdrawal by Subject|2|||
48602011|NCT03804268|156399511|FG001|Overall Study|Withdrawal by Subject|0|||
48602012|NCT03804268|156399510|FG000|Overall Study|Lost to Follow-up|1|||
48602013|NCT03804268|156399511|FG001|Overall Study|Lost to Follow-up|0|||
48602014|NCT03804268|156399510|FG000|Overall Study|Physician Decision|2|||
48602015|NCT03804268|156399511|FG001|Overall Study|Physician Decision|0|||
48602016|NCT00128661|156399514|FG000|Overall Study|Adverse Event|14|||
48602017|NCT00128661|156399515|FG001|Overall Study|Adverse Event|11|||
48602018|NCT00128661|156399514|FG000|Overall Study|Lost to Follow-up|10|||
48602019|NCT00128661|156399515|FG001|Overall Study|Lost to Follow-up|7|||
48602020|NCT00128661|156399514|FG000|Overall Study|Withdrawal by Subject|243|||
48602021|NCT00128661|156399515|FG001|Overall Study|Withdrawal by Subject|232|||
48602022|NCT00128661|156399514|FG000|Overall Study|Other|7|||
48602023|NCT00128661|156399515|FG001|Overall Study|Other|8|||
48602024|NCT02616783|156399516|FG000|Overall Study|Randomized but Not Treated|1|||
48602025|NCT02616783|156399517|FG001|Overall Study|Randomized but Not Treated|0|||
48602026|NCT02616783|156399516|FG000|Overall Study|Adverse Event|1|||
48602027|NCT02616783|156399517|FG001|Overall Study|Adverse Event|0|||
48602028|NCT02616783|156399516|FG000|Overall Study|Death|1|||
48602029|NCT02616783|156399517|FG001|Overall Study|Death|0|||
48602030|NCT02616783|156399516|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48602031|NCT02616783|156399517|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48602032|NCT02616783|156399516|FG000|Overall Study|Protocol Violation|1|||
48602033|NCT02616783|156399517|FG001|Overall Study|Protocol Violation|1|||
48602034|NCT02616783|156399516|FG000|Overall Study|Withdrew Consent|1|||
48602035|NCT02616783|156399517|FG001|Overall Study|Withdrew Consent|1|||
48602036|NCT03327324|156399519|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602037|NCT03327324|156399520|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
48602038|NCT03327324|156399521|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602039|NCT03327324|156399522|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
48602040|NCT03327324|156399523|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602041|NCT03327324|156399524|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
48602042|NCT03327324|156399519|FG000|Baseline (Month 0-Month 3)|Refused|0|||
48602043|NCT03327324|156399520|FG001|Baseline (Month 0-Month 3)|Refused|0|||
48602044|NCT03327324|156399521|FG002|Baseline (Month 0-Month 3)|Refused|0|||
48602045|NCT03327324|156399522|FG003|Baseline (Month 0-Month 3)|Refused|0|||
48602046|NCT03327324|156399523|FG004|Baseline (Month 0-Month 3)|Refused|1|||
48602047|NCT03327324|156399524|FG005|Baseline (Month 0-Month 3)|Refused|0|||
48602048|NCT03327324|156399519|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
48602049|NCT03327324|156399520|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
48602050|NCT03327324|156399521|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
48602051|NCT03327324|156399522|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
48602052|NCT03327324|156399523|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
48602053|NCT03327324|156399524|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
48602054|NCT03327324|156399519|FG000|Baseline (Month 0-Month 3)|Death|0|||
48602055|NCT03327324|156399520|FG001|Baseline (Month 0-Month 3)|Death|0|||
48602056|NCT03327324|156399521|FG002|Baseline (Month 0-Month 3)|Death|0|||
48602057|NCT03327324|156399522|FG003|Baseline (Month 0-Month 3)|Death|0|||
48602058|NCT03327324|156399523|FG004|Baseline (Month 0-Month 3)|Death|1|||
48602059|NCT03327324|156399524|FG005|Baseline (Month 0-Month 3)|Death|0|||
48602060|NCT03327324|156399519|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602061|NCT03327324|156399520|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602062|NCT03327324|156399521|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602063|NCT03327324|156399522|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48630289|NCT00867334|156504910|FG001|Overall Study|Withdrawal by Subject|0|||
48734219|NCT02020577|156877729|FG001|Overall Study|Other than stated above|1|||
48734220|NCT00484094|156877730|FG000|Overall Study|Discontinued|39|||
48734221|NCT00484094|156877730|FG000|Overall Study|Other|3|||
48734222|NCT00621959|156877734|FG000|Overall Study|Adverse Event|4|||
48734223|NCT00621959|156877735|FG001|Overall Study|Adverse Event|2|||
48734224|NCT00621959|156877734|FG000|Overall Study|Lack of Efficacy|1|||
48734225|NCT00621959|156877735|FG001|Overall Study|Lack of Efficacy|1|||
48734226|NCT00621959|156877734|FG000|Overall Study|Lost to Follow-up|0|||
48734227|NCT00621959|156877735|FG001|Overall Study|Lost to Follow-up|2|||
48734228|NCT00621959|156877734|FG000|Overall Study|Withdrawal by Subject|1|||
48734229|NCT00621959|156877735|FG001|Overall Study|Withdrawal by Subject|1|||
48734230|NCT00621959|156877734|FG000|Overall Study|Other|1|||
48524881|NCT01266603|156112169|FG000|Overall Study|Lack of Efficacy|14|||
48524882|NCT01266603|156112169|FG000|Overall Study|Withdrawal by Subject|1|||
48524883|NCT01266603|156112169|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
48524884|NCT00179673|156112172|FG000|Overall Study|Adverse Event|7|||
48524885|NCT00179673|156112172|FG000|Overall Study|Lack of Efficacy|15|||
48734231|NCT00621959|156877735|FG001|Overall Study|Other|3|||
48734232|NCT00590135|156877736|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
48734233|NCT01414608|156877737|FG000|Overall Study|Ineligible|5|||
48826335|NCT03115346|157204154|FG001|Overall Study|Lost to Follow-up|3|||
48826336|NCT00630864|157204156|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
48826337|NCT00630864|157204156|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
48826338|NCT02014558|157204157|FG000|Overall Study|Never Received Study Drug|0|||
48826339|NCT02014558|157204158|FG001|Overall Study|Never Received Study Drug|0|||
48826340|NCT02014558|157204159|FG002|Overall Study|Never Received Study Drug|0|||
48826341|NCT02014558|157204160|FG003|Overall Study|Never Received Study Drug|0|||
48826342|NCT02014558|157204161|FG004|Overall Study|Never Received Study Drug|1|||
48826343|NCT02014558|157204162|FG005|Overall Study|Never Received Study Drug|0|||
48826344|NCT02014558|157204163|FG006|Overall Study|Never Received Study Drug|1|||
48826345|NCT02014558|157204164|FG007|Overall Study|Never Received Study Drug|0|||
48826346|NCT02014558|157204165|FG008|Overall Study|Never Received Study Drug|2|||
48826347|NCT02014558|157204166|FG009|Overall Study|Never Received Study Drug|0|||
48826348|NCT02014558|157204167|FG010|Overall Study|Never Received Study Drug|2|||
48826349|NCT02014558|157204168|FG011|Overall Study|Never Received Study Drug|2|||
48826350|NCT02014558|157204169|FG012|Overall Study|Never Received Study Drug|0|||
48826351|NCT02014558|157204157|FG000|Overall Study|Adverse Event|0|||
48826352|NCT02014558|157204158|FG001|Overall Study|Adverse Event|0|||
48826353|NCT02014558|157204159|FG002|Overall Study|Adverse Event|0|||
48826354|NCT02014558|157204160|FG003|Overall Study|Adverse Event|0|||
48826355|NCT02014558|157204161|FG004|Overall Study|Adverse Event|1|||
48826356|NCT02014558|157204162|FG005|Overall Study|Adverse Event|0|||
48826357|NCT02014558|157204163|FG006|Overall Study|Adverse Event|0|||
48826358|NCT02014558|157204164|FG007|Overall Study|Adverse Event|0|||
48826359|NCT02014558|157204165|FG008|Overall Study|Adverse Event|2|||
48826360|NCT02014558|157204166|FG009|Overall Study|Adverse Event|2|||
48826361|NCT02014558|157204167|FG010|Overall Study|Adverse Event|5|||
48524886|NCT00179673|156112172|FG000|Overall Study|Withdrawal by Subject|3|||
48826362|NCT02014558|157204168|FG011|Overall Study|Adverse Event|21|||
48826363|NCT02014558|157204169|FG012|Overall Study|Adverse Event|3|||
48826364|NCT02014558|157204157|FG000|Overall Study|Death|1|||
48826365|NCT02014558|157204158|FG001|Overall Study|Death|0|||
48524887|NCT00179673|156112172|FG000|Overall Study|Death|4|||
48524888|NCT00179673|156112172|FG000|Overall Study|Other Observations and options|14|||
48524889|NCT03847974|156112173|FG000|Overall Study|relocated out of region|3|||
48524890|NCT03847974|156112173|FG000|Overall Study|Withdrawal by Subject|2|||
48524891|NCT03847974|156112173|FG000|Overall Study|Adverse Event|1|||
48524892|NCT01801917|156112174|FG000|Period 1 - Randomized|Adverse Event|1|||
48630290|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
48524893|NCT01801917|156112175|FG001|Period 1 - Randomized|Adverse Event|0|||
48524894|NCT01801917|156112176|FG002|Period 1 - Randomized|Adverse Event|1|||
48630291|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
48630292|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
48630293|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
48630294|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
48630295|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
48630296|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
48630352|NCT02082977|156504931|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48524895|NCT01801917|156112177|FG003|Period 1 - Randomized|Adverse Event|0|||
48524896|NCT04307849|156112178|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
48524897|NCT04307849|156112179|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
48524898|NCT04307849|156112180|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
48524899|NCT04307849|156112181|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
48524900|NCT04307849|156112182|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
48524901|NCT04307849|156112183|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
48524902|NCT04307849|156112178|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
48734234|NCT01414608|156877738|FG001|Overall Study|Ineligible|2|||
48734235|NCT03331250|156877739|FG000|Overall Study|Withdrawal by Subject|1|||
48734236|NCT03344796|156877742|FG000|Overall Study|Lost to Follow-up|0|||
48734237|NCT03344796|156877743|FG001|Overall Study|Lost to Follow-up|0|||
48734238|NCT03344796|156877744|FG002|Overall Study|Lost to Follow-up|0|||
48734239|NCT03344796|156877745|FG003|Overall Study|Lost to Follow-up|0|||
48734240|NCT03344796|156877746|FG004|Overall Study|Lost to Follow-up|0|||
48734241|NCT03344796|156877747|FG005|Overall Study|Lost to Follow-up|2|||
48734242|NCT01736124|156877748|FG000|Post-intervention Assessment|Death|2|||
48734243|NCT01736124|156877749|FG001|Post-intervention Assessment|Death|2|||
48734244|NCT01736124|156877748|FG000|Post-intervention Assessment|lost computer access|1|||
48734245|NCT01736124|156877749|FG001|Post-intervention Assessment|lost computer access|1|||
48734246|NCT01736124|156877748|FG000|Post-intervention Assessment|Moved away|3|||
48734247|NCT01736124|156877749|FG001|Post-intervention Assessment|Moved away|1|||
48734248|NCT01736124|156877748|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
48734249|NCT01736124|156877749|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
48734250|NCT01736124|156877748|FG000|Post-intervention Assessment|Illness|3|||
48734251|NCT01736124|156877749|FG001|Post-intervention Assessment|Illness|2|||
48734252|NCT01736124|156877748|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
48734253|NCT01736124|156877749|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
48734254|NCT01736124|156877748|FG000|Post-intervention Assessment|Temporarily away|3|||
48734255|NCT01736124|156877749|FG001|Post-intervention Assessment|Temporarily away|1|||
48734256|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
48734257|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
48734258|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
48734259|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
48734260|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
48734261|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
48734262|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
48734263|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
48734264|NCT01736124|156877748|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
48734265|NCT01736124|156877749|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
48734266|NCT01736124|156877748|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
48734267|NCT01736124|156877749|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
48734268|NCT01736124|156877748|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
48734269|NCT01736124|156877749|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
48734270|NCT01736124|156877748|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
48734271|NCT01736124|156877749|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
48734272|NCT01736124|156877748|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
48734273|NCT01736124|156877749|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
48734274|NCT02130024|156877751|FG000|Overall Study|Adverse Event|10|||
48734275|NCT02130024|156877752|FG001|Overall Study|Adverse Event|11|||
48734276|NCT02130024|156877751|FG000|Overall Study|Death|2|||
48734277|NCT02130024|156877752|FG001|Overall Study|Death|2|||
48734278|NCT02130024|156877751|FG000|Overall Study|Lost to Follow-up|1|||
48734279|NCT02130024|156877752|FG001|Overall Study|Lost to Follow-up|1|||
48734280|NCT02130024|156877751|FG000|Overall Study|Physician Decision|1|||
48734281|NCT02130024|156877752|FG001|Overall Study|Physician Decision|3|||
48734282|NCT02130024|156877751|FG000|Overall Study|Protocol Deviation|4|||
48734283|NCT02130024|156877752|FG001|Overall Study|Protocol Deviation|0|||
48734284|NCT02130024|156877751|FG000|Overall Study|Site Administration Problems|1|||
48734285|NCT02130024|156877752|FG001|Overall Study|Site Administration Problems|0|||
48734286|NCT02130024|156877751|FG000|Overall Study|Subject Withdrew Consent|6|||
48734287|NCT02130024|156877752|FG001|Overall Study|Subject Withdrew Consent|14|||
48734288|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
48734289|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734290|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48743060|NCT00968201|156910496|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
48734291|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734292|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734293|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734294|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
48734295|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
48734296|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734297|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734298|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734299|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734300|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734301|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
48734302|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
48734303|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734304|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734305|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734306|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734307|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48734308|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
48826366|NCT02014558|157204159|FG002|Overall Study|Death|0|||
48826367|NCT02014558|157204160|FG003|Overall Study|Death|0|||
48826368|NCT02014558|157204161|FG004|Overall Study|Death|0|||
48826369|NCT02014558|157204162|FG005|Overall Study|Death|0|||
48826370|NCT02014558|157204163|FG006|Overall Study|Death|1|||
48826371|NCT02014558|157204164|FG007|Overall Study|Death|1|||
48826372|NCT02014558|157204165|FG008|Overall Study|Death|2|||
48826373|NCT02014558|157204166|FG009|Overall Study|Death|5|||
48826374|NCT02014558|157204167|FG010|Overall Study|Death|5|||
48826375|NCT02014558|157204168|FG011|Overall Study|Death|19|||
48826376|NCT02014558|157204169|FG012|Overall Study|Death|2|||
48524903|NCT04307849|156112179|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
48524904|NCT04307849|156112180|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
48524905|NCT04307849|156112181|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
48524906|NCT04307849|156112182|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
48524907|NCT04307849|156112183|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
48524908|NCT04307849|156112178|FG000|Overall Study|Family member did not want them to continue|0|||
48524909|NCT04307849|156112179|FG001|Overall Study|Family member did not want them to continue|0|||
48524910|NCT04307849|156112180|FG002|Overall Study|Family member did not want them to continue|1|||
48524911|NCT04307849|156112181|FG003|Overall Study|Family member did not want them to continue|0|||
48524912|NCT04307849|156112182|FG004|Overall Study|Family member did not want them to continue|0|||
48524913|NCT04307849|156112183|FG005|Overall Study|Family member did not want them to continue|0|||
48524914|NCT04307849|156112178|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
48524915|NCT04307849|156112179|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
48524916|NCT04307849|156112180|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
48524917|NCT04307849|156112181|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
48524918|NCT04307849|156112182|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
48524919|NCT04307849|156112183|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
48524920|NCT04220775|156112186|FG000|Overall Study|Adverse Event|1|||
48524921|NCT04220775|156112187|FG001|Overall Study|Adverse Event|0|||
48524922|NCT04220775|156112186|FG000|Overall Study|Disease Progression|1|||
48602064|NCT03327324|156399523|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602065|NCT03327324|156399524|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
48602066|NCT03327324|156399519|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602067|NCT03327324|156399520|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602068|NCT03327324|156399521|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
48734309|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
48734310|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734311|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734312|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734313|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734314|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734315|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
48734316|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
48734317|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734318|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734319|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734320|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734321|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734322|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
48734323|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
48734324|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734325|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734326|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734327|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734328|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734329|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
48734330|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
48734331|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734332|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734333|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734334|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734335|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734336|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
48734337|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
48734338|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734339|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734340|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734341|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734342|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48734343|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
48743061|NCT00968201|156910494|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
48743062|NCT00968201|156910495|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
48743063|NCT00968201|156910496|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
48743064|NCT00968201|156910494|FG000|Base Study - (Period II)|Protocol Violation|12|||
48743065|NCT00968201|156910495|FG001|Base Study - (Period II)|Protocol Violation|0|||
48743066|NCT00968201|156910496|FG002|Base Study - (Period II)|Protocol Violation|12|||
48743067|NCT00968201|156910494|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
48743068|NCT00968201|156910495|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
48743069|NCT00968201|156910496|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
48743070|NCT00968201|156910494|FG000|Base Study - (Period II)|Site Error|0|||
48743071|NCT00968201|156910495|FG001|Base Study - (Period II)|Site Error|0|||
48743072|NCT00968201|156910496|FG002|Base Study - (Period II)|Site Error|1|||
48524923|NCT04220775|156112187|FG001|Overall Study|Disease Progression|0|||
48524924|NCT02654015|156112188|FG000|Overall Study|Death|12|||
48743073|NCT00968201|156910494|FG000|Extension Study - (Period III)|Adverse Event|0|||
48524925|NCT02654015|156112188|FG000|Overall Study|Lost to Follow-up|3|||
48524926|NCT01896505|156112192|FG000|Overall Study|Adverse Event|1|||
48826377|NCT02014558|157204157|FG000|Overall Study|Lack of Efficacy|1|||
48826378|NCT02014558|157204158|FG001|Overall Study|Lack of Efficacy|2|||
48826379|NCT02014558|157204159|FG002|Overall Study|Lack of Efficacy|1|||
48826380|NCT02014558|157204160|FG003|Overall Study|Lack of Efficacy|1|||
48826381|NCT02014558|157204161|FG004|Overall Study|Lack of Efficacy|0|||
48826382|NCT02014558|157204162|FG005|Overall Study|Lack of Efficacy|0|||
48826383|NCT02014558|157204163|FG006|Overall Study|Lack of Efficacy|1|||
48524927|NCT01896505|156112193|FG001|Overall Study|Adverse Event|0|||
48524928|NCT01896505|156112194|FG002|Overall Study|Adverse Event|2|||
48524929|NCT01896505|156112195|FG003|Overall Study|Adverse Event|1|||
48524930|NCT01896505|156112196|FG004|Overall Study|Adverse Event|1|||
48524931|NCT01896505|156112197|FG005|Overall Study|Adverse Event|0|||
48524932|NCT01896505|156112192|FG000|Overall Study|Physician Decision|1|||
48524933|NCT01896505|156112193|FG001|Overall Study|Physician Decision|3|||
48524934|NCT01896505|156112194|FG002|Overall Study|Physician Decision|2|||
48524935|NCT01896505|156112195|FG003|Overall Study|Physician Decision|0|||
48524936|NCT01896505|156112196|FG004|Overall Study|Physician Decision|0|||
48524937|NCT01896505|156112197|FG005|Overall Study|Physician Decision|1|||
48524938|NCT01896505|156112192|FG000|Overall Study|Withdrawal by Subject|1|||
48524939|NCT01896505|156112193|FG001|Overall Study|Withdrawal by Subject|0|||
48524940|NCT01896505|156112194|FG002|Overall Study|Withdrawal by Subject|3|||
48524941|NCT01896505|156112195|FG003|Overall Study|Withdrawal by Subject|1|||
48524942|NCT01896505|156112196|FG004|Overall Study|Withdrawal by Subject|0|||
48524943|NCT01896505|156112197|FG005|Overall Study|Withdrawal by Subject|0|||
48524944|NCT01896505|156112192|FG000|Overall Study|Disease Progression|7|||
48524945|NCT01896505|156112193|FG001|Overall Study|Disease Progression|5|||
48524946|NCT01896505|156112194|FG002|Overall Study|Disease Progression|8|||
48524947|NCT01896505|156112195|FG003|Overall Study|Disease Progression|4|||
48524948|NCT01896505|156112196|FG004|Overall Study|Disease Progression|4|||
48524949|NCT01896505|156112197|FG005|Overall Study|Disease Progression|4|||
48524950|NCT01896505|156112192|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
48524951|NCT01896505|156112193|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
48524952|NCT01896505|156112194|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
48524953|NCT01896505|156112195|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
48524954|NCT01896505|156112196|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
48524955|NCT01896505|156112197|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
48524956|NCT01896505|156112192|FG000|Overall Study|Intercurrent illness|0|||
48524957|NCT01896505|156112193|FG001|Overall Study|Intercurrent illness|1|||
48630297|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
48630298|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
48630299|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
48630300|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
48630301|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
48630302|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
48630303|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
48630304|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
48630305|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
48630306|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
48630307|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
48630308|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
48630309|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
48630310|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
48630311|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
48630312|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
48630313|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
48630314|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
48630315|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
48630316|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
48630317|NCT03093415|156504915|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
48630318|NCT03093415|156504916|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
48630319|NCT03093415|156504917|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
48630320|NCT03093415|156504915|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
48630321|NCT03093415|156504916|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
48630322|NCT03093415|156504917|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
48630323|NCT03331354|156504918|FG000|Overall Study|Withdrawal by Subject|1|||
48630324|NCT03331354|156504919|FG001|Overall Study|Withdrawal by Subject|3|||
48630325|NCT03331354|156504918|FG000|Overall Study|Lost to Follow-up|3|||
48524958|NCT01896505|156112194|FG002|Overall Study|Intercurrent illness|0|||
48524959|NCT01896505|156112195|FG003|Overall Study|Intercurrent illness|0|||
48524960|NCT01896505|156112196|FG004|Overall Study|Intercurrent illness|0|||
48524961|NCT01896505|156112197|FG005|Overall Study|Intercurrent illness|0|||
48524962|NCT01896505|156112192|FG000|Overall Study|Death|0|||
48524963|NCT01896505|156112193|FG001|Overall Study|Death|0|||
48524964|NCT01896505|156112194|FG002|Overall Study|Death|1|||
48734344|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
48734345|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48524965|NCT01896505|156112195|FG003|Overall Study|Death|1|||
48524966|NCT01896505|156112196|FG004|Overall Study|Death|0|||
48524967|NCT01896505|156112197|FG005|Overall Study|Death|1|||
48524968|NCT02418754|156112198|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
48524969|NCT02418754|156112199|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
48524970|NCT02418754|156112200|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
48524971|NCT02418754|156112201|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
48524972|NCT02418754|156112202|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
48524973|NCT02418754|156112198|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
48524974|NCT02418754|156112199|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
48524975|NCT02418754|156112200|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
48524976|NCT02418754|156112201|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
48602069|NCT03327324|156399522|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602070|NCT03327324|156399523|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602071|NCT03327324|156399524|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48734346|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734347|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734348|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734349|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734350|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
48734351|NCT04526509|156877755|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
48734352|NCT04526509|156877756|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734353|NCT04526509|156877757|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734354|NCT04526509|156877758|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734355|NCT04526509|156877759|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734356|NCT04526509|156877760|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734357|NCT04526509|156877761|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
48734358|NCT04526509|156877755|FG000|Enrolled|Study Terminated by Sponsor|0|||
48734359|NCT04526509|156877756|FG001|Enrolled|Study Terminated by Sponsor|0|||
48734360|NCT04526509|156877757|FG002|Enrolled|Study Terminated by Sponsor|0|||
48734361|NCT04526509|156877758|FG003|Enrolled|Study Terminated by Sponsor|0|||
48734362|NCT04526509|156877759|FG004|Enrolled|Study Terminated by Sponsor|0|||
48734363|NCT04526509|156877760|FG005|Enrolled|Study Terminated by Sponsor|0|||
48734364|NCT04526509|156877761|FG006|Enrolled|Study Terminated by Sponsor|1|||
48734365|NCT04526509|156877755|FG000|Enrolled|Death prior to lymphodepletion|0|||
48734366|NCT04526509|156877756|FG001|Enrolled|Death prior to lymphodepletion|0|||
48734367|NCT04526509|156877757|FG002|Enrolled|Death prior to lymphodepletion|0|||
48734368|NCT04526509|156877758|FG003|Enrolled|Death prior to lymphodepletion|1|||
48734369|NCT04526509|156877759|FG004|Enrolled|Death prior to lymphodepletion|0|||
48734370|NCT04526509|156877760|FG005|Enrolled|Death prior to lymphodepletion|0|||
48734371|NCT04526509|156877761|FG006|Enrolled|Death prior to lymphodepletion|0|||
48734372|NCT04526509|156877755|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734373|NCT04526509|156877756|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734374|NCT04526509|156877757|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734375|NCT04526509|156877758|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
48734376|NCT04526509|156877759|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734377|NCT04526509|156877760|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734378|NCT04526509|156877761|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
48734379|NCT04526509|156877755|FG000|Enrolled|Physician Decision|0|||
48734380|NCT04526509|156877756|FG001|Enrolled|Physician Decision|1|||
48524977|NCT02418754|156112202|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
48524978|NCT02418754|156112198|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
48524979|NCT02418754|156112199|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
48826384|NCT02014558|157204164|FG007|Overall Study|Lack of Efficacy|3|||
48826385|NCT02014558|157204165|FG008|Overall Study|Lack of Efficacy|3|||
48826386|NCT02014558|157204166|FG009|Overall Study|Lack of Efficacy|3|||
48826387|NCT02014558|157204167|FG010|Overall Study|Lack of Efficacy|16|||
48826388|NCT02014558|157204168|FG011|Overall Study|Lack of Efficacy|8|||
48826389|NCT02014558|157204169|FG012|Overall Study|Lack of Efficacy|5|||
48826390|NCT02014558|157204157|FG000|Overall Study|Lost to Follow-up|0|||
48826391|NCT02014558|157204158|FG001|Overall Study|Lost to Follow-up|0|||
48826392|NCT02014558|157204159|FG002|Overall Study|Lost to Follow-up|0|||
48826393|NCT02014558|157204160|FG003|Overall Study|Lost to Follow-up|0|||
48826394|NCT02014558|157204161|FG004|Overall Study|Lost to Follow-up|0|||
48826395|NCT02014558|157204162|FG005|Overall Study|Lost to Follow-up|0|||
48826396|NCT02014558|157204163|FG006|Overall Study|Lost to Follow-up|0|||
48826397|NCT02014558|157204164|FG007|Overall Study|Lost to Follow-up|0|||
48826398|NCT02014558|157204165|FG008|Overall Study|Lost to Follow-up|0|||
48826399|NCT02014558|157204166|FG009|Overall Study|Lost to Follow-up|0|||
48602072|NCT03327324|156399519|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
48602073|NCT03327324|156399520|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
48826400|NCT02014558|157204167|FG010|Overall Study|Lost to Follow-up|1|||
48826401|NCT02014558|157204168|FG011|Overall Study|Lost to Follow-up|0|||
48826402|NCT02014558|157204169|FG012|Overall Study|Lost to Follow-up|0|||
48826403|NCT02014558|157204157|FG000|Overall Study|Progressive Disease|1|||
48826404|NCT02014558|157204158|FG001|Overall Study|Progressive Disease|0|||
48826405|NCT02014558|157204159|FG002|Overall Study|Progressive Disease|1|||
48826406|NCT02014558|157204160|FG003|Overall Study|Progressive Disease|1|||
48826407|NCT02014558|157204161|FG004|Overall Study|Progressive Disease|1|||
48826408|NCT02014558|157204162|FG005|Overall Study|Progressive Disease|2|||
48826409|NCT02014558|157204163|FG006|Overall Study|Progressive Disease|1|||
48826410|NCT02014558|157204164|FG007|Overall Study|Progressive Disease|6|||
48826411|NCT02014558|157204165|FG008|Overall Study|Progressive Disease|5|||
48826412|NCT02014558|157204166|FG009|Overall Study|Progressive Disease|6|||
48826413|NCT02014558|157204167|FG010|Overall Study|Progressive Disease|22|||
48826414|NCT02014558|157204168|FG011|Overall Study|Progressive Disease|31|||
48826415|NCT02014558|157204169|FG012|Overall Study|Progressive Disease|6|||
48826416|NCT02014558|157204157|FG000|Overall Study|Withdrawal by Subject|0|||
48826417|NCT02014558|157204158|FG001|Overall Study|Withdrawal by Subject|0|||
48826418|NCT02014558|157204159|FG002|Overall Study|Withdrawal by Subject|0|||
48826419|NCT02014558|157204160|FG003|Overall Study|Withdrawal by Subject|0|||
48826420|NCT02014558|157204161|FG004|Overall Study|Withdrawal by Subject|1|||
48826421|NCT02014558|157204162|FG005|Overall Study|Withdrawal by Subject|0|||
48826422|NCT02014558|157204163|FG006|Overall Study|Withdrawal by Subject|0|||
48826423|NCT02014558|157204164|FG007|Overall Study|Withdrawal by Subject|0|||
48826424|NCT02014558|157204165|FG008|Overall Study|Withdrawal by Subject|0|||
48826425|NCT02014558|157204166|FG009|Overall Study|Withdrawal by Subject|2|||
48826426|NCT02014558|157204167|FG010|Overall Study|Withdrawal by Subject|6|||
48826427|NCT02014558|157204168|FG011|Overall Study|Withdrawal by Subject|10|||
48826428|NCT02014558|157204169|FG012|Overall Study|Withdrawal by Subject|0|||
48826429|NCT02014558|157204157|FG000|Overall Study|Miscellaneous|2|||
48826430|NCT02014558|157204158|FG001|Overall Study|Miscellaneous|1|||
48826431|NCT02014558|157204159|FG002|Overall Study|Miscellaneous|1|||
48826432|NCT02014558|157204160|FG003|Overall Study|Miscellaneous|1|||
48826433|NCT02014558|157204161|FG004|Overall Study|Miscellaneous|0|||
48826434|NCT02014558|157204162|FG005|Overall Study|Miscellaneous|1|||
48826435|NCT02014558|157204163|FG006|Overall Study|Miscellaneous|0|||
48602074|NCT03327324|156399521|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
48602075|NCT03327324|156399522|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
48602076|NCT03327324|156399523|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
48826436|NCT02014558|157204164|FG007|Overall Study|Miscellaneous|1|||
48826437|NCT02014558|157204165|FG008|Overall Study|Miscellaneous|1|||
48826438|NCT02014558|157204166|FG009|Overall Study|Miscellaneous|3|||
48826439|NCT02014558|157204167|FG010|Overall Study|Miscellaneous|12|||
48826440|NCT02014558|157204168|FG011|Overall Study|Miscellaneous|11|||
48826441|NCT02014558|157204169|FG012|Overall Study|Miscellaneous|1|||
48826442|NCT04580407|157204170|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
48602077|NCT03327324|156399524|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
48826443|NCT05296629|157205669|FG000|Overall Study|Withdrawal by Subject|3|||
48826444|NCT05296629|157205670|FG001|Overall Study|Withdrawal by Subject|10|||
48826445|NCT05296629|157205671|FG002|Overall Study|Withdrawal by Subject|4|||
48826446|NCT05296629|157205669|FG000|Overall Study|Lost to Follow-up|2|||
48826447|NCT05296629|157205670|FG001|Overall Study|Lost to Follow-up|7|||
48826448|NCT05296629|157205671|FG002|Overall Study|Lost to Follow-up|1|||
48826449|NCT05296629|157205669|FG000|Overall Study|Adverse Event|0|||
48826450|NCT05296629|157205670|FG001|Overall Study|Adverse Event|4|||
48826451|NCT05296629|157205671|FG002|Overall Study|Adverse Event|2|||
48826452|NCT05296629|157205669|FG000|Overall Study|Protocol Violation|0|||
48826453|NCT05296629|157205670|FG001|Overall Study|Protocol Violation|2|||
48826454|NCT05296629|157205671|FG002|Overall Study|Protocol Violation|0|||
48826455|NCT04034238|157205679|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
48826456|NCT04034238|157205680|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48826457|NCT04034238|157205681|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48826458|NCT04034238|157205682|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48826459|NCT04034238|157205679|FG000|Dose Escalation Phase|Screen failures|0|||
48826460|NCT04034238|157205680|FG001|Dose Escalation Phase|Screen failures|0|||
48826461|NCT04034238|157205681|FG002|Dose Escalation Phase|Screen failures|0|||
48826462|NCT04034238|157205682|FG003|Dose Escalation Phase|Screen failures|2|||
48826463|NCT04034238|157205679|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
48826464|NCT04034238|157205680|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
48826465|NCT04034238|157205681|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
48524980|NCT02418754|156112200|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
48524981|NCT02418754|156112201|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
48602078|NCT03327324|156399519|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
48602079|NCT03327324|156399520|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
48602080|NCT03327324|156399521|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
48826466|NCT04034238|157205682|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
48524982|NCT02418754|156112202|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
48524983|NCT02418754|156112198|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
48524984|NCT02418754|156112199|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
48524985|NCT02418754|156112200|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
48524986|NCT02418754|156112201|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
48524987|NCT02418754|156112202|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
48524988|NCT02418754|156112198|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
48524989|NCT02418754|156112199|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
48524990|NCT02418754|156112200|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
48602081|NCT03327324|156399522|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
48826467|NCT04034238|157205679|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
48826468|NCT04034238|157205680|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
48826469|NCT04034238|157205681|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
48826470|NCT04034238|157205682|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
48826471|NCT05310084|157205683|FG000|Overall Study|Withdrawal by Subject|2|||
48826472|NCT05310084|157205684|FG001|Overall Study|Withdrawal by Subject|3|||
48826473|NCT05310084|157205683|FG000|Overall Study|Participant availability|0|||
48826474|NCT05310084|157205684|FG001|Overall Study|Participant availability|4|||
48826475|NCT05310084|157205683|FG000|Overall Study|Lost to Follow-up|1|||
48826476|NCT05310084|157205684|FG001|Overall Study|Lost to Follow-up|1|||
48826477|NCT05310084|157205683|FG000|Overall Study|Adverse Event|1|||
48826478|NCT05310084|157205684|FG001|Overall Study|Adverse Event|1|||
48826479|NCT05310084|157205683|FG000|Overall Study|Randomized but not vaccinated|4|||
48826480|NCT05310084|157205684|FG001|Overall Study|Randomized but not vaccinated|2|||
48826481|NCT01518257|157205687|FG000|Overall Study|Lost to Follow-up|1|||
48826482|NCT01518257|157205688|FG001|Overall Study|Lost to Follow-up|0|||
48826483|NCT01518257|157205687|FG000|Overall Study|Other Miscellaneous Reason|1|||
48826484|NCT01518257|157205688|FG001|Overall Study|Other Miscellaneous Reason|0|||
48826485|NCT00797862|157205689|FG000|Overall Study|Adverse Event|86|||
48826486|NCT00797862|157205690|FG001|Overall Study|Adverse Event|44|||
48826487|NCT00797862|157205691|FG002|Overall Study|Adverse Event|58|||
48826488|NCT00797862|157205689|FG000|Overall Study|Abnormal Test Procedure Result|0|||
48524991|NCT02418754|156112201|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
48524992|NCT02418754|156112202|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
48524993|NCT02418754|156112198|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
48524994|NCT02418754|156112199|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
48524995|NCT02418754|156112200|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
48524996|NCT02418754|156112201|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
48524997|NCT02418754|156112202|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
48524998|NCT02418754|156112198|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
48524999|NCT02418754|156112199|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
48525000|NCT02418754|156112200|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
48525001|NCT02418754|156112201|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
48525002|NCT02418754|156112202|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
48525003|NCT02418754|156112198|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
48525004|NCT02418754|156112199|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
48525005|NCT02418754|156112200|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
48525006|NCT02418754|156112201|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
48525007|NCT02418754|156112202|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
48525008|NCT02418754|156112198|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
48525009|NCT02418754|156112199|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
48525010|NCT02418754|156112200|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
48525011|NCT02418754|156112201|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
48525012|NCT02418754|156112202|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
48525013|NCT02418754|156112198|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
48525014|NCT02418754|156112199|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
48525015|NCT02418754|156112200|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
48525016|NCT02418754|156112201|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
48525017|NCT02418754|156112202|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
48525018|NCT02418754|156112198|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
48525019|NCT02418754|156112199|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
48525020|NCT02418754|156112200|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
48525021|NCT02418754|156112201|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
48525022|NCT02418754|156112202|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
48525023|NCT05467982|156112203|FG000|Overall Study|Death|0|||
48525024|NCT05467982|156112204|FG001|Overall Study|Death|1|||
48525025|NCT05467982|156112203|FG000|Overall Study|Lost to Follow-up|3|||
48525026|NCT05467982|156112204|FG001|Overall Study|Lost to Follow-up|1|||
48525027|NCT02412722|156112209|FG000|Overall Study|Adverse Event|0|||
48525028|NCT02412722|156112210|FG001|Overall Study|Adverse Event|2|||
48525029|NCT02412722|156112211|FG002|Overall Study|Adverse Event|0|||
48525030|NCT02412722|156112212|FG003|Overall Study|Adverse Event|3|||
48525031|NCT02412722|156112213|FG004|Overall Study|Adverse Event|0|||
48525032|NCT02412722|156112214|FG005|Overall Study|Adverse Event|3|||
48525033|NCT02412722|156112209|FG000|Overall Study|Progressive Disease|6|||
48525034|NCT02412722|156112210|FG001|Overall Study|Progressive Disease|4|||
48525035|NCT02412722|156112211|FG002|Overall Study|Progressive Disease|4|||
48525036|NCT02412722|156112212|FG003|Overall Study|Progressive Disease|9|||
48826489|NCT00797862|157205690|FG001|Overall Study|Abnormal Test Procedure Result|1|||
48826490|NCT00797862|157205691|FG002|Overall Study|Abnormal Test Procedure Result|1|||
48826491|NCT00797862|157205689|FG000|Overall Study|Lack of Efficacy|1|||
48826492|NCT00797862|157205690|FG001|Overall Study|Lack of Efficacy|7|||
48826493|NCT00797862|157205691|FG002|Overall Study|Lack of Efficacy|6|||
48826494|NCT00797862|157205689|FG000|Overall Study|No longer required study medication|1|||
48826495|NCT00797862|157205690|FG001|Overall Study|No longer required study medication|0|||
48826496|NCT00797862|157205691|FG002|Overall Study|No longer required study medication|0|||
48826497|NCT00797862|157205689|FG000|Overall Study|Withdrawal by Subject|14|||
48826498|NCT00797862|157205690|FG001|Overall Study|Withdrawal by Subject|7|||
48826499|NCT00797862|157205691|FG002|Overall Study|Withdrawal by Subject|7|||
48826500|NCT00797862|157205689|FG000|Overall Study|Lost to Follow-up|11|||
48826501|NCT00797862|157205690|FG001|Overall Study|Lost to Follow-up|0|||
48826502|NCT00797862|157205691|FG002|Overall Study|Lost to Follow-up|5|||
48826503|NCT00797862|157205689|FG000|Overall Study|Administrative Problem|4|||
48826504|NCT00797862|157205690|FG001|Overall Study|Administrative Problem|0|||
48826505|NCT00797862|157205691|FG002|Overall Study|Administrative Problem|0|||
48525037|NCT02412722|156112213|FG004|Overall Study|Progressive Disease|3|||
48525038|NCT02412722|156112214|FG005|Overall Study|Progressive Disease|3|||
48525039|NCT02412722|156112209|FG000|Overall Study|Withdrawal by Subject|2|||
48525040|NCT02412722|156112210|FG001|Overall Study|Withdrawal by Subject|0|||
48525041|NCT02412722|156112211|FG002|Overall Study|Withdrawal by Subject|1|||
48525042|NCT02412722|156112212|FG003|Overall Study|Withdrawal by Subject|2|||
48525043|NCT02412722|156112213|FG004|Overall Study|Withdrawal by Subject|1|||
48525044|NCT02412722|156112214|FG005|Overall Study|Withdrawal by Subject|1|||
48826506|NCT00797862|157205689|FG000|Overall Study|Protocol Violation|4|||
48826507|NCT00797862|157205690|FG001|Overall Study|Protocol Violation|6|||
48826508|NCT00797862|157205691|FG002|Overall Study|Protocol Violation|8|||
48826509|NCT00797862|157205689|FG000|Overall Study|Mis-randomized|3|||
48826510|NCT00797862|157205690|FG001|Overall Study|Mis-randomized|3|||
48826511|NCT00797862|157205691|FG002|Overall Study|Mis-randomized|1|||
48826512|NCT00531479|157205692|FG000|Overall Study|Death|68|||
48826513|NCT00531479|157205693|FG001|Overall Study|Death|71|||
48826514|NCT00531479|157205692|FG000|Overall Study|Lost to Follow-up|0|||
48525045|NCT02412722|156112209|FG000|Overall Study|Lost to Follow-up|0|||
48525046|NCT02412722|156112210|FG001|Overall Study|Lost to Follow-up|0|||
48525047|NCT02412722|156112211|FG002|Overall Study|Lost to Follow-up|0|||
48525048|NCT02412722|156112212|FG003|Overall Study|Lost to Follow-up|0|||
48525049|NCT02412722|156112213|FG004|Overall Study|Lost to Follow-up|1|||
48525050|NCT02412722|156112214|FG005|Overall Study|Lost to Follow-up|0|||
48525051|NCT02412722|156112209|FG000|Overall Study|Received drug in run-in and discontinued|0|||
48525052|NCT02412722|156112210|FG001|Overall Study|Received drug in run-in and discontinued|2|||
48525053|NCT02412722|156112211|FG002|Overall Study|Received drug in run-in and discontinued|0|||
48525054|NCT02412722|156112212|FG003|Overall Study|Received drug in run-in and discontinued|0|||
48525055|NCT02412722|156112213|FG004|Overall Study|Received drug in run-in and discontinued|0|||
48525056|NCT02412722|156112214|FG005|Overall Study|Received drug in run-in and discontinued|0|||
48525057|NCT02412722|156112209|FG000|Overall Study|Reason not Specified|3|||
48525058|NCT02412722|156112210|FG001|Overall Study|Reason not Specified|0|||
48525059|NCT02412722|156112211|FG002|Overall Study|Reason not Specified|2|||
48525060|NCT02412722|156112212|FG003|Overall Study|Reason not Specified|1|||
48525061|NCT02412722|156112213|FG004|Overall Study|Reason not Specified|2|||
48525062|NCT02412722|156112214|FG005|Overall Study|Reason not Specified|6|||
48525063|NCT04330157|156112215|FG000|Overall Study|Protocol Violation|4|||
48525064|NCT04330157|156112215|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
48525065|NCT03365791|156112220|FG000|Overall Study|Adverse Event|5|||
48525066|NCT03365791|156112220|FG000|Overall Study|Death|1|||
48525067|NCT03365791|156112220|FG000|Overall Study|Lost to Follow-up|1|||
48525068|NCT03365791|156112220|FG000|Overall Study|Physician Decision|9|||
48525069|NCT03365791|156112220|FG000|Overall Study|Progressive disease|51|||
48525070|NCT03365791|156112220|FG000|Overall Study|Subject/guardian decision|5|||
48525071|NCT01754376|156113580|FG000|Overall Study|Adverse Event|1|||
48525072|NCT01754376|156113580|FG000|Overall Study|Lack of Efficacy|2|||
48525073|NCT04590781|156113581|FG000|Overall Study|Death|0|||
48525074|NCT04590781|156113582|FG001|Overall Study|Death|2|||
48525075|NCT04590781|156113581|FG000|Overall Study|Withdrawal by Subject|2|||
48525076|NCT04590781|156113582|FG001|Overall Study|Withdrawal by Subject|0|||
48525077|NCT00754052|156113586|FG000|Overall Study|Study terminated by Sponsor|5|||
48525078|NCT00754052|156113587|FG001|Overall Study|Study terminated by Sponsor|3|||
48525079|NCT01680016|156113588|FG000|Overall Study|Adverse Event|0|||
48525080|NCT01680016|156113589|FG001|Overall Study|Adverse Event|0|||
48826515|NCT00531479|157205693|FG001|Overall Study|Lost to Follow-up|2|||
48826516|NCT00531479|157205692|FG000|Overall Study|Other|0|||
48826517|NCT00531479|157205693|FG001|Overall Study|Other|1|||
48826518|NCT00531479|157205692|FG000|Overall Study|Withdrawal by Subject|6|||
48630326|NCT03331354|156504919|FG001|Overall Study|Lost to Follow-up|3|||
48525081|NCT01680016|156113590|FG002|Overall Study|Adverse Event|1|||
48525082|NCT01680016|156113591|FG003|Overall Study|Adverse Event|4|||
48525083|NCT01680016|156113588|FG000|Overall Study|The Subject went out of The Trial|1|||
48826519|NCT00531479|157205693|FG001|Overall Study|Withdrawal by Subject|6|||
48525084|NCT01680016|156113589|FG001|Overall Study|The Subject went out of The Trial|0|||
48826520|NCT00531479|157205692|FG000|Overall Study|Did not receive treatment|2|||
48826521|NCT00531479|157205693|FG001|Overall Study|Did not receive treatment|3|||
48826522|NCT03404960|157205698|FG000|Overall Study|Adverse Event|0|||
48826523|NCT03404960|157205699|FG001|Overall Study|Adverse Event|2|||
48826524|NCT03404960|157205698|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
48826525|NCT03404960|157205699|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
48826526|NCT03404960|157205698|FG000|Overall Study|Bowel obstruction|0|||
48826527|NCT03404960|157205699|FG001|Overall Study|Bowel obstruction|1|||
48826528|NCT03404960|157205698|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
48826529|NCT03404960|157205699|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
48826530|NCT01636362|157205702|FG000|Overall Study|Physician Decision|6|||
48826531|NCT01636362|157205702|FG000|Overall Study|Subject healed, not returning|1|||
48826532|NCT01636362|157205702|FG000|Overall Study|Withdrawal by Subject|1|||
48826533|NCT00498186|157205703|FG000|Overall Study|Protocol Violation|10|||
48826534|NCT00498186|157205703|FG000|Overall Study|Lack of Efficacy|31|||
48826535|NCT00498186|157205703|FG000|Overall Study|Adverse Event|89|||
48826536|NCT00498186|157205703|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
48826537|NCT00498186|157205703|FG000|Overall Study|Withdrawal by Subject|18|||
48826538|NCT00498186|157205703|FG000|Overall Study|Lost to Follow-up|3|||
48826539|NCT00498186|157205703|FG000|Overall Study|Other|10|||
48826540|NCT00088465|157205704|FG000|Overall Study|Withdrawal by Subject|290|||
48826541|NCT00088465|157205704|FG000|Overall Study|Adverse Event|77|||
48826542|NCT00088465|157205704|FG000|Overall Study|Lost to Follow-up|57|||
48826543|NCT00088465|157205704|FG000|Overall Study|Physician Decision|45|||
48826544|NCT00088465|157205704|FG000|Overall Study|Sponsor Decision|37|||
48826545|NCT00088465|157205704|FG000|Overall Study|Lack of Efficacy|27|||
48826546|NCT00088465|157205704|FG000|Overall Study|Protocol Violation|17|||
48826547|NCT00088465|157205704|FG000|Overall Study|Death|11|||
48826548|NCT02459964|157205705|FG000|Overall Study|Withdrawal by Subject|0|||
48826549|NCT02459964|157205706|FG001|Overall Study|Withdrawal by Subject|0|||
48826550|NCT02459964|157205707|FG002|Overall Study|Withdrawal by Subject|1|||
48826551|NCT02459964|157205705|FG000|Overall Study|Abnormal EKG changes|0|||
48826552|NCT02459964|157205706|FG001|Overall Study|Abnormal EKG changes|0|||
48826553|NCT02459964|157205707|FG002|Overall Study|Abnormal EKG changes|1|||
48826554|NCT01456780|157205709|FG000|Overall Study|Lost to Follow-up|3|||
48826555|NCT01456780|157205710|FG001|Overall Study|Lost to Follow-up|3|||
48826556|NCT01456780|157205711|FG002|Overall Study|Lost to Follow-up|0|||
48826557|NCT00886613|157205718|FG000|Overall Study|Protocol deviation (Part B)|1|||
48826558|NCT00886613|157205719|FG001|Overall Study|Protocol deviation (Part B)|0|||
48826559|NCT00886613|157205720|FG002|Overall Study|Protocol deviation (Part B)|0|||
48826560|NCT00886613|157205718|FG000|Overall Study|Lost to follow-up (Part B)|1|||
48826561|NCT00886613|157205719|FG001|Overall Study|Lost to follow-up (Part B)|0|||
48826562|NCT00886613|157205720|FG002|Overall Study|Lost to follow-up (Part B)|1|||
48826563|NCT00886613|157205718|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
48826564|NCT00886613|157205719|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
48826565|NCT00886613|157205720|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
48826566|NCT00751790|157205721|FG000|Overall Study|Lost to Follow-up|1|||
48826567|NCT00751790|157205721|FG000|Overall Study|Death|3|||
48826568|NCT00751790|157205721|FG000|Overall Study|Withdrawal by Subject|1|||
48826569|NCT00151996|157205722|FG000|Overall Study|Adverse Event|3|||
48826570|NCT00151996|157205723|FG001|Overall Study|Adverse Event|2|||
48826571|NCT00151996|157205722|FG000|Overall Study|Withdrawal by Subject|1|||
48826572|NCT00151996|157205723|FG001|Overall Study|Withdrawal by Subject|1|||
48525085|NCT01680016|156113590|FG002|Overall Study|The Subject went out of The Trial|3|||
48525086|NCT01680016|156113591|FG003|Overall Study|The Subject went out of The Trial|0|||
48525087|NCT01680016|156113588|FG000|Overall Study|Protocol Violation|0|||
48525088|NCT01680016|156113589|FG001|Overall Study|Protocol Violation|1|||
48525089|NCT01680016|156113590|FG002|Overall Study|Protocol Violation|0|||
48525090|NCT01680016|156113591|FG003|Overall Study|Protocol Violation|0|||
48525091|NCT01680016|156113588|FG000|Overall Study|Withdrawal by Subject|5|||
48525092|NCT01680016|156113589|FG001|Overall Study|Withdrawal by Subject|7|||
48826573|NCT00151996|157205722|FG000|Overall Study|Protocol Violation|1|||
48826574|NCT00151996|157205723|FG001|Overall Study|Protocol Violation|2|||
48826575|NCT00151996|157205722|FG000|Overall Study|Sponsor's decision|0|||
48826576|NCT00151996|157205723|FG001|Overall Study|Sponsor's decision|2|||
48826577|NCT01168401|157205725|FG000|Overall Study|Lost to Follow-up|1|||
48826578|NCT01168401|157205726|FG001|Overall Study|Lost to Follow-up|1|||
48826579|NCT01168401|157205727|FG002|Overall Study|Lost to Follow-up|2|||
48826580|NCT01168401|157205728|FG003|Overall Study|Lost to Follow-up|1|||
48826581|NCT01168401|157205729|FG004|Overall Study|Lost to Follow-up|0|||
48826582|NCT01168401|157205730|FG005|Overall Study|Lost to Follow-up|0|||
48826583|NCT01168401|157205731|FG006|Overall Study|Lost to Follow-up|0|||
48826584|NCT01168401|157205732|FG007|Overall Study|Lost to Follow-up|0|||
48525093|NCT01680016|156113590|FG002|Overall Study|Withdrawal by Subject|1|||
48525094|NCT01680016|156113591|FG003|Overall Study|Withdrawal by Subject|1|||
48826585|NCT01168401|157205733|FG008|Overall Study|Lost to Follow-up|0|||
48826586|NCT01168401|157205734|FG009|Overall Study|Lost to Follow-up|0|||
48826587|NCT01168401|157205735|FG010|Overall Study|Lost to Follow-up|0|||
48826588|NCT01168401|157205725|FG000|Overall Study|Withdrawal by Subject|0|||
48826589|NCT01168401|157205726|FG001|Overall Study|Withdrawal by Subject|0|||
48826590|NCT01168401|157205727|FG002|Overall Study|Withdrawal by Subject|0|||
48826591|NCT01168401|157205728|FG003|Overall Study|Withdrawal by Subject|1|||
48826592|NCT01168401|157205729|FG004|Overall Study|Withdrawal by Subject|0|||
48826593|NCT01168401|157205730|FG005|Overall Study|Withdrawal by Subject|0|||
48826594|NCT01168401|157205731|FG006|Overall Study|Withdrawal by Subject|0|||
48826595|NCT01168401|157205732|FG007|Overall Study|Withdrawal by Subject|0|||
48826596|NCT01168401|157205733|FG008|Overall Study|Withdrawal by Subject|0|||
48826597|NCT01168401|157205734|FG009|Overall Study|Withdrawal by Subject|0|||
48826598|NCT01168401|157205735|FG010|Overall Study|Withdrawal by Subject|0|||
48826599|NCT00303303|157205738|FG000|Overall Study|Withdrawal by Subject|0|||
48826600|NCT00303303|157205739|FG001|Overall Study|Withdrawal by Subject|0|||
48826601|NCT00303303|157205740|FG002|Overall Study|Withdrawal by Subject|1|||
48826602|NCT00672256|157205741|FG000|Overall Study|PI dropped, bad data|44|||
48826603|NCT00945477|157205757|FG000|Overall Study|Adverse Event|3|||
48826604|NCT00945477|157205757|FG000|Overall Study|Lack of Efficacy|2|||
48826605|NCT00945477|157205757|FG000|Overall Study|Withdrawal by Subject|1|||
48826606|NCT01878890|157205767|FG000|Overall Study|Protocol Violation|0|||
48826607|NCT01878890|157205768|FG001|Overall Study|Protocol Violation|1|||
48826608|NCT01878890|157205769|FG002|Overall Study|Protocol Violation|0|||
48826609|NCT01878890|157205770|FG003|Overall Study|Protocol Violation|0|||
48826610|NCT00916006|157205772|FG000|Overall Study|Adverse Event|1|||
48826611|NCT00916006|157205773|FG001|Overall Study|Adverse Event|1|||
48826612|NCT00916006|157205772|FG000|Overall Study|Withdrawal by Subject|2|||
48826613|NCT00916006|157205773|FG001|Overall Study|Withdrawal by Subject|5|||
48826614|NCT00916006|157205772|FG000|Overall Study|Protocol Violation|0|||
48826615|NCT00916006|157205773|FG001|Overall Study|Protocol Violation|1|||
48826616|NCT02929108|157205776|FG000|Overall Study|Hospice patient death|100|||
48826617|NCT02929108|157205777|FG001|Overall Study|Hospice patient death|64|||
48826618|NCT02929108|157205778|FG002|Overall Study|Hospice patient death|28|||
48826619|NCT02929108|157205779|FG003|Overall Study|Hospice patient death|46|||
48826620|NCT02929108|157205780|FG004|Overall Study|Hospice patient death|55|||
48826621|NCT02929108|157205781|FG005|Overall Study|Hospice patient death|28|||
48826622|NCT02929108|157205782|FG006|Overall Study|Hospice patient death|78|||
48826623|NCT03441984|157205783|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826624|NCT03441984|157205784|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826625|NCT03441984|157205785|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
48826626|NCT03441984|157205786|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826627|NCT03441984|157205787|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826628|NCT03441984|157205788|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826629|NCT03441984|157205789|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826630|NCT03441984|157205790|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826631|NCT03441984|157205791|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826632|NCT03441984|157205792|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48525095|NCT02658019|156113592|FG000|Overall Study|Adverse Event|1|||
48525096|NCT02722616|156113594|FG000|Overall Study|Sponsor closed study after one month|2|||
48525097|NCT02722616|156113595|FG001|Overall Study|Sponsor closed study after one month|0|||
48525098|NCT02722616|156113596|FG002|Overall Study|Sponsor closed study after one month|0|||
48525099|NCT01958060|156113598|FG000|Overall Study|Not treated|2|||
48826633|NCT03441984|157205793|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826634|NCT03441984|157205794|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
48826635|NCT04088188|157205795|FG000|Overall Study|Withdrawal by Subject|2|||
48826636|NCT04088188|157205796|FG001|Overall Study|Withdrawal by Subject|0|||
48826637|NCT04088188|157205795|FG000|Overall Study|Adverse Event|2|||
48826638|NCT04088188|157205796|FG001|Overall Study|Adverse Event|0|||
48826639|NCT01414166|157205797|FG000|Overall Study|Adverse Event|10|||
48525100|NCT01958060|156113599|FG001|Overall Study|Not treated|0|||
48826640|NCT01414166|157205798|FG001|Overall Study|Adverse Event|2|||
48826641|NCT01414166|157205797|FG000|Overall Study|Lost to Follow-up|4|||
48826642|NCT01414166|157205798|FG001|Overall Study|Lost to Follow-up|1|||
48826643|NCT01414166|157205797|FG000|Overall Study|Non-compliance with study drug|2|||
48826644|NCT01414166|157205798|FG001|Overall Study|Non-compliance with study drug|0|||
48826645|NCT01414166|157205797|FG000|Overall Study|Physician Decision|2|||
48826646|NCT01414166|157205798|FG001|Overall Study|Physician Decision|0|||
48826647|NCT01414166|157205797|FG000|Overall Study|Protocol Violation|2|||
48826648|NCT01414166|157205798|FG001|Overall Study|Protocol Violation|0|||
48826649|NCT01414166|157205797|FG000|Overall Study|Study terminated by Sponsor|68|||
48826650|NCT01414166|157205798|FG001|Overall Study|Study terminated by Sponsor|75|||
48525101|NCT01958060|156113600|FG002|Overall Study|Not treated|0|||
48826651|NCT01414166|157205797|FG000|Overall Study|Withdrawal by Subject|3|||
48826652|NCT01414166|157205798|FG001|Overall Study|Withdrawal by Subject|5|||
48826653|NCT05027971|157205799|FG000|Overall Study|Physician Decision|7|||
48826654|NCT05027971|157205800|FG001|Overall Study|Physician Decision|3|||
48826655|NCT05027971|157205799|FG000|Overall Study|Lost to Follow-up|1|||
48826656|NCT05027971|157205800|FG001|Overall Study|Lost to Follow-up|1|||
48826657|NCT05027971|157205799|FG000|Overall Study|Withdrawal by Subject|0|||
48826658|NCT05027971|157205800|FG001|Overall Study|Withdrawal by Subject|2|||
48826659|NCT05027971|157205799|FG000|Overall Study|Non-study fiber used.|0|||
48826660|NCT05027971|157205800|FG001|Overall Study|Non-study fiber used.|1|||
48826661|NCT05027971|157205799|FG000|Overall Study|Protocol Violation|0|||
48826662|NCT05027971|157205800|FG001|Overall Study|Protocol Violation|2|||
48826663|NCT04423393|157207281|FG000|Overall Study|Withdrawal by Subject|0|||
48826664|NCT04423393|157207282|FG001|Overall Study|Withdrawal by Subject|0|||
48826665|NCT04423393|157207283|FG002|Overall Study|Withdrawal by Subject|0|||
48826666|NCT04423393|157207284|FG003|Overall Study|Withdrawal by Subject|0|||
48826667|NCT04423393|157207285|FG004|Overall Study|Withdrawal by Subject|0|||
48525102|NCT01958060|156113601|FG003|Overall Study|Not treated|0|||
48525103|NCT01958060|156113602|FG004|Overall Study|Not treated|1|||
48525104|NCT01958060|156113603|FG005|Overall Study|Not treated|0|||
48525105|NCT01120899|156113606|FG000|Overall Study|Withdrawal by Subject|3|||
48525106|NCT00820599|156113607|FG000|Overall Study|Death|129|||
48525107|NCT00820599|156113607|FG000|Overall Study|Withdrawal by Subject|2|||
48525108|NCT00799708|156113608|FG000|Overall Study|non-compliance|1|||
48525109|NCT00799708|156113609|FG001|Overall Study|non-compliance|0|||
48525110|NCT00799708|156113610|FG002|Overall Study|non-compliance|0|||
48525111|NCT00880334|156113611|FG000|Randomized Phase|Physician Decision|1|||
48525112|NCT00880334|156113612|FG001|Randomized Phase|Physician Decision|0|||
48525113|NCT00880334|156113611|FG000|Randomized Phase|Withdrawal by Subject|2|||
48525114|NCT00880334|156113612|FG001|Randomized Phase|Withdrawal by Subject|1|||
48525115|NCT00880334|156113611|FG000|Randomized Phase|Inadequate Labs|1|||
48525116|NCT00880334|156113612|FG001|Randomized Phase|Inadequate Labs|1|||
48525117|NCT00880334|156113611|FG000|Randomized Phase|Brain Metastasis|0|||
48525118|NCT00880334|156113612|FG001|Randomized Phase|Brain Metastasis|1|||
48525119|NCT00880334|156113611|FG000|Randomized Phase|Crossover Participants|0|||
48525120|NCT00880334|156113612|FG001|Randomized Phase|Crossover Participants|37|||
48525121|NCT00329160|156113613|FG000|Overall Study|Adverse Event|27|||
48525122|NCT00329160|156113613|FG000|Overall Study|Withdrawal by Subject|13|||
48525123|NCT00329160|156113613|FG000|Overall Study|Protocol Violation|2|||
48525124|NCT00329160|156113613|FG000|Overall Study|Did not Receive Study Drug|1|||
48525125|NCT00329160|156113613|FG000|Overall Study|Incomplete IVUS|45|||
48525126|NCT00493792|156113614|FG000|Overall Study|Death|55|||
48525127|NCT00493792|156113615|FG001|Overall Study|Death|50|||
48525128|NCT00493792|156113614|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
48525129|NCT00493792|156113615|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
48525130|NCT04501094|156113616|FG000|Overall Study|Death (unrelated to research)|1|||
48525131|NCT04501094|156113617|FG001|Overall Study|Death (unrelated to research)|0|||
48525132|NCT01841073|156113633|FG000|Overall Study|Adverse Event|1|||
48525133|NCT01841073|156113634|FG001|Overall Study|Adverse Event|1|||
48525134|NCT01841073|156113633|FG000|Overall Study|Physician Decision|1|||
48525135|NCT01841073|156113634|FG001|Overall Study|Physician Decision|0|||
48525136|NCT01841073|156113633|FG000|Overall Study|Lost to Follow-up|0|||
48525137|NCT01841073|156113634|FG001|Overall Study|Lost to Follow-up|2|||
48525138|NCT03343639|156113638|FG000|Overall Study|Withdrawal by Subject|10|||
48525139|NCT03343639|156113639|FG001|Overall Study|Withdrawal by Subject|6|||
48525140|NCT03343639|156113638|FG000|Overall Study|Lost to Follow-up|4|||
48525141|NCT03343639|156113639|FG001|Overall Study|Lost to Follow-up|5|||
48525142|NCT03343639|156113638|FG000|Overall Study|Protocol Violation|0|||
48525143|NCT03343639|156113639|FG001|Overall Study|Protocol Violation|1|||
48525144|NCT03110380|156113640|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
48525145|NCT03110380|156113641|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
48525146|NCT03110380|156113642|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
48826668|NCT04423393|157207286|FG005|Overall Study|Withdrawal by Subject|1|||
48826669|NCT04423393|157207287|FG006|Overall Study|Withdrawal by Subject|0|||
48826670|NCT04423393|157207288|FG007|Overall Study|Withdrawal by Subject|0|||
48525147|NCT03110380|156113643|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
48525148|NCT03110380|156113640|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
48525149|NCT03110380|156113641|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
48525150|NCT03110380|156113642|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48826671|NCT04423393|157207289|FG008|Overall Study|Withdrawal by Subject|0|||
48383822|NCT03239483|155601445|FG000|Overall Study|Withdrawal by Subject|1|||
48525151|NCT03110380|156113643|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48525152|NCT03110380|156113640|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
48525153|NCT03110380|156113641|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
48826672|NCT04423393|157207290|FG009|Overall Study|Withdrawal by Subject|0|||
48826673|NCT04423393|157207291|FG010|Overall Study|Withdrawal by Subject|0|||
48525154|NCT03110380|156113642|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
48734381|NCT04526509|156877757|FG002|Enrolled|Physician Decision|0|||
48734382|NCT04526509|156877758|FG003|Enrolled|Physician Decision|0|||
48734383|NCT04526509|156877759|FG004|Enrolled|Physician Decision|0|||
48734384|NCT04526509|156877760|FG005|Enrolled|Physician Decision|0|||
48734385|NCT04526509|156877761|FG006|Enrolled|Physician Decision|0|||
48734386|NCT01066000|156877764|FG000|Overall Study|Protocol Violation|4|||
48734387|NCT01066000|156877764|FG000|Overall Study|Death|3|||
48734388|NCT01066000|156877764|FG000|Overall Study|Withdrawal by Subject|1|||
48734389|NCT01066000|156877764|FG000|Overall Study|Adverse Event|1|||
48734390|NCT03001882|156877765|FG000|Overall Study|Death|1|||
48734391|NCT03001882|156877766|FG001|Overall Study|Death|0|||
48734392|NCT03001882|156877767|FG002|Overall Study|Death|0|||
48734393|NCT03001882|156877768|FG003|Overall Study|Death|3|||
48734394|NCT03001882|156877765|FG000|Overall Study|Participant withdrew consent|0|||
48734395|NCT03001882|156877766|FG001|Overall Study|Participant withdrew consent|1|||
48734396|NCT03001882|156877767|FG002|Overall Study|Participant withdrew consent|0|||
48826674|NCT04423393|157207292|FG011|Overall Study|Withdrawal by Subject|0|||
48826675|NCT04423393|157207293|FG012|Overall Study|Withdrawal by Subject|0|||
48826676|NCT04423393|157207294|FG013|Overall Study|Withdrawal by Subject|1|||
48826677|NCT04423393|157207295|FG014|Overall Study|Withdrawal by Subject|0|||
48826678|NCT04423393|157207296|FG015|Overall Study|Withdrawal by Subject|0|||
48826679|NCT04423393|157207297|FG016|Overall Study|Withdrawal by Subject|0|||
48826680|NCT04423393|157207298|FG017|Overall Study|Withdrawal by Subject|0|||
48826681|NCT04423393|157207281|FG000|Overall Study|Sponsor Decision|0|||
48826682|NCT04423393|157207282|FG001|Overall Study|Sponsor Decision|0|||
48826683|NCT04423393|157207283|FG002|Overall Study|Sponsor Decision|0|||
48826684|NCT04423393|157207284|FG003|Overall Study|Sponsor Decision|0|||
48826685|NCT04423393|157207285|FG004|Overall Study|Sponsor Decision|0|||
48826686|NCT04423393|157207286|FG005|Overall Study|Sponsor Decision|0|||
48826687|NCT04423393|157207287|FG006|Overall Study|Sponsor Decision|0|||
48826688|NCT04423393|157207288|FG007|Overall Study|Sponsor Decision|0|||
48525155|NCT03110380|156113643|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
48525156|NCT03110380|156113640|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
48525157|NCT03110380|156113641|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
48525158|NCT03110380|156113642|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
48525159|NCT03110380|156113643|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
48525160|NCT03110380|156113640|FG000|Double-Blind Treatment Phase|Death|2|||
48525161|NCT03110380|156113641|FG001|Double-Blind Treatment Phase|Death|1|||
48525162|NCT03110380|156113642|FG002|Double-Blind Treatment Phase|Death|0|||
48734397|NCT03001882|156877768|FG003|Overall Study|Participant withdrew consent|5|||
48734398|NCT03001882|156877765|FG000|Overall Study|Other reasons|1|||
48734399|NCT03001882|156877766|FG001|Overall Study|Other reasons|2|||
48734400|NCT03001882|156877767|FG002|Overall Study|Other reasons|0|||
48734401|NCT03001882|156877768|FG003|Overall Study|Other reasons|5|||
48525163|NCT03110380|156113643|FG003|Double-Blind Treatment Phase|Death|0|||
48525164|NCT03110380|156113640|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
48525165|NCT03110380|156113641|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
48525166|NCT03110380|156113642|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
48525167|NCT03110380|156113643|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
48525168|NCT03110380|156113640|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
48525169|NCT03110380|156113641|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
48525170|NCT03110380|156113642|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
48734402|NCT03001882|156877765|FG000|Overall Study|Administrative reason by sponsor|0|||
48734403|NCT03001882|156877766|FG001|Overall Study|Administrative reason by sponsor|0|||
48734404|NCT03001882|156877767|FG002|Overall Study|Administrative reason by sponsor|0|||
48734405|NCT03001882|156877768|FG003|Overall Study|Administrative reason by sponsor|1|||
48826689|NCT04423393|157207289|FG008|Overall Study|Sponsor Decision|0|||
48826690|NCT04423393|157207290|FG009|Overall Study|Sponsor Decision|0|||
48826691|NCT04423393|157207291|FG010|Overall Study|Sponsor Decision|0|||
48826692|NCT04423393|157207292|FG011|Overall Study|Sponsor Decision|0|||
48525171|NCT03110380|156113643|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
48734406|NCT03001882|156877765|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
48826693|NCT04423393|157207293|FG012|Overall Study|Sponsor Decision|0|||
48602082|NCT03327324|156399523|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
48602083|NCT03327324|156399524|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
48602084|NCT03327324|156399519|FG000|Intervention (Month 3-Month 6)|Death|1|||
48602085|NCT03327324|156399520|FG001|Intervention (Month 3-Month 6)|Death|0|||
48602086|NCT03327324|156399521|FG002|Intervention (Month 3-Month 6)|Death|1|||
48602087|NCT03327324|156399522|FG003|Intervention (Month 3-Month 6)|Death|1|||
48602088|NCT03327324|156399523|FG004|Intervention (Month 3-Month 6)|Death|1|||
48602089|NCT03327324|156399524|FG005|Intervention (Month 3-Month 6)|Death|0|||
48602090|NCT03327324|156399519|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602091|NCT03327324|156399520|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602092|NCT03327324|156399521|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48826694|NCT04423393|157207294|FG013|Overall Study|Sponsor Decision|1|||
48826695|NCT04423393|157207295|FG014|Overall Study|Sponsor Decision|0|||
48826696|NCT04423393|157207296|FG015|Overall Study|Sponsor Decision|0|||
48826697|NCT04423393|157207297|FG016|Overall Study|Sponsor Decision|0|||
48826698|NCT04423393|157207298|FG017|Overall Study|Sponsor Decision|0|||
48826699|NCT03531905|157207304|FG000|Overall Study|Withdrawal by Subject|3|||
48826700|NCT03531905|157207305|FG001|Overall Study|Withdrawal by Subject|3|||
48826701|NCT03531905|157207306|FG002|Overall Study|Withdrawal by Subject|2|||
48826702|NCT03531905|157207304|FG000|Overall Study|Lost to Follow-up|2|||
48826703|NCT03531905|157207305|FG001|Overall Study|Lost to Follow-up|2|||
48602093|NCT03327324|156399522|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602094|NCT03327324|156399523|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48826704|NCT03531905|157207306|FG002|Overall Study|Lost to Follow-up|1|||
48826705|NCT03531905|157207304|FG000|Overall Study|Participant was out of town|1|||
48826706|NCT03531905|157207305|FG001|Overall Study|Participant was out of town|0|||
48826707|NCT03531905|157207306|FG002|Overall Study|Participant was out of town|0|||
48444065|NCT01392378|155812951|FG000|Infant Series|Lost to Follow-up|0|||
48444066|NCT01392378|155812952|FG001|Infant Series|Lost to Follow-up|0|||
48444067|NCT01392378|155812953|FG002|Infant Series|Lost to Follow-up|0|||
48444068|NCT01392378|155812954|FG003|Infant Series|Lost to Follow-up|1|||
48444069|NCT01392378|155812955|FG004|Infant Series|Lost to Follow-up|0|||
48444070|NCT01392378|155812951|FG000|Infant Series|Protocol Violation|0|||
48444071|NCT01392378|155812952|FG001|Infant Series|Protocol Violation|1|||
48444072|NCT01392378|155812953|FG002|Infant Series|Protocol Violation|0|||
48444073|NCT01392378|155812954|FG003|Infant Series|Protocol Violation|0|||
48444074|NCT01392378|155812955|FG004|Infant Series|Protocol Violation|0|||
48444075|NCT01392378|155812951|FG000|Infant Series|Withdrawal by Parent|4|||
48444076|NCT01392378|155812952|FG001|Infant Series|Withdrawal by Parent|1|||
48444077|NCT01392378|155812953|FG002|Infant Series|Withdrawal by Parent|0|||
48444078|NCT01392378|155812954|FG003|Infant Series|Withdrawal by Parent|0|||
48444079|NCT01392378|155812955|FG004|Infant Series|Withdrawal by Parent|0|||
48525172|NCT03110380|156113640|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
48525173|NCT03110380|156113641|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
48525174|NCT03110380|156113642|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
48525175|NCT03110380|156113643|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
48525176|NCT03110380|156113640|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
48525177|NCT03110380|156113641|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
48525178|NCT03110380|156113642|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
48525179|NCT03110380|156113643|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
48525180|NCT03110380|156113640|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
48525181|NCT03110380|156113641|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
48525182|NCT03110380|156113642|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
48525183|NCT03110380|156113643|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
48525184|NCT03110380|156113640|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
48525185|NCT03110380|156113641|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
48525186|NCT03110380|156113642|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
48525187|NCT03110380|156113643|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
48525188|NCT01231373|156113644|FG000|Overall Study|Withdrew consent prior to randomization|2|||
48525189|NCT01231373|156113645|FG001|Overall Study|Withdrew consent prior to randomization|1|||
48525190|NCT01231373|156113646|FG002|Overall Study|Withdrew consent prior to randomization|0|||
48525191|NCT01231373|156113647|FG003|Overall Study|Withdrew consent prior to randomization|0|||
48525192|NCT01231373|156113644|FG000|Overall Study|Lost to Follow-up|0|||
48525193|NCT01231373|156113645|FG001|Overall Study|Lost to Follow-up|0|||
48525194|NCT01231373|156113646|FG002|Overall Study|Lost to Follow-up|0|||
48525195|NCT01231373|156113647|FG003|Overall Study|Lost to Follow-up|1|||
48525196|NCT01231373|156113644|FG000|Overall Study|Withdrew Consent|1|||
48525197|NCT01231373|156113645|FG001|Overall Study|Withdrew Consent|0|||
48525198|NCT01231373|156113646|FG002|Overall Study|Withdrew Consent|0|||
48525199|NCT01231373|156113647|FG003|Overall Study|Withdrew Consent|0|||
48525200|NCT02725411|156113648|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
48525201|NCT02725411|156113649|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
48525202|NCT02725411|156113650|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
48525203|NCT02725411|156113648|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
48525204|NCT02725411|156113649|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
48525205|NCT02725411|156113650|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
48525206|NCT02725411|156113648|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
48525207|NCT02725411|156113649|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
48525208|NCT02725411|156113650|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
48525209|NCT02725411|156113648|FG000|Treatment Period (56 Weeks)|Other|1|||
48525210|NCT02725411|156113649|FG001|Treatment Period (56 Weeks)|Other|4|||
48525211|NCT02725411|156113650|FG002|Treatment Period (56 Weeks)|Other|5|||
48525212|NCT02725411|156113648|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
48525213|NCT02725411|156113649|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
48525214|NCT02725411|156113650|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
48525215|NCT02725411|156113648|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
48525216|NCT02725411|156113649|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
48525217|NCT02725411|156113650|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
48525218|NCT02725411|156113648|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
48525219|NCT02725411|156113649|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
48525220|NCT02725411|156113650|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
48525221|NCT02725411|156113648|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
48525222|NCT02725411|156113649|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
48525223|NCT02725411|156113650|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
48525224|NCT02725411|156113648|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
48525225|NCT02725411|156113649|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
48525226|NCT02725411|156113650|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
48525227|NCT02725411|156113648|FG000|Follow-up Period (24 Weeks)|Other|1|||
48525228|NCT02725411|156113649|FG001|Follow-up Period (24 Weeks)|Other|4|||
48525229|NCT02725411|156113650|FG002|Follow-up Period (24 Weeks)|Other|2|||
48525230|NCT02725411|156113648|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
48525231|NCT02725411|156113649|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
48525232|NCT02725411|156113650|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
48525233|NCT02786927|156113651|FG000|Overall Study|Adverse Event|1|||
48525234|NCT02786927|156113651|FG000|Overall Study|Protocol Violation|4|||
48525235|NCT01557920|156113652|FG000|Overall Study|Withdrawal by Subject|2|||
48525236|NCT01557920|156113653|FG001|Overall Study|Withdrawal by Subject|3|||
48525237|NCT01557920|156113652|FG000|Overall Study|Lack of Efficacy|1|||
48525238|NCT01557920|156113653|FG001|Overall Study|Lack of Efficacy|0|||
48525239|NCT02329431|156113654|FG000|Overall Study|Lost to Follow-up|20|||
48525240|NCT02329431|156113655|FG001|Overall Study|Lost to Follow-up|13|||
48525241|NCT01924364|156113660|FG000|Overall Study|Physician Decision|3|||
48525242|NCT01294449|156113661|FG000|Overall Study|Death|11|||
48525243|NCT01294449|156113662|FG001|Overall Study|Death|12|||
48525244|NCT01294449|156113661|FG000|Overall Study|Withdrawal by Subject|1|||
48525245|NCT01294449|156113662|FG001|Overall Study|Withdrawal by Subject|3|||
48525246|NCT04599166|156113663|FG000|Overall Study|Technological failure connecting to study app|80|||
48525247|NCT00265785|156113664|FG000|Overall Study|Adverse Event|4|||
48525248|NCT00265785|156113664|FG000|Overall Study|Withdrawal by Subject|3|||
48525249|NCT00265785|156113664|FG000|Overall Study|Progression/Relapse|15|||
48525250|NCT00265785|156113664|FG000|Overall Study|Not protocol specified|2|||
48525251|NCT00265785|156113664|FG000|Overall Study|Ineligible|1|||
48525252|NCT00265785|156113664|FG000|Overall Study|Did not receive protocol treatment|2|||
48525253|NCT00250705|156113665|FG000|Overall Study|Lack of Efficacy|2|||
48525254|NCT01609582|156113672|FG000|Overall Study|Adverse Event|20|||
48525255|NCT01609582|156113673|FG001|Overall Study|Adverse Event|18|||
48525256|NCT01609582|156113672|FG000|Overall Study|Lost to Follow-up|10|||
48525257|NCT01609582|156113673|FG001|Overall Study|Lost to Follow-up|10|||
48525258|NCT01609582|156113672|FG000|Overall Study|Withdrawal by Subject|21|||
48525259|NCT01609582|156113673|FG001|Overall Study|Withdrawal by Subject|15|||
48525260|NCT01609582|156113672|FG000|Overall Study|Study Terminated by Sponsor|1543|||
48525261|NCT01609582|156113673|FG001|Overall Study|Study Terminated by Sponsor|1548|||
48525262|NCT01609582|156113672|FG000|Overall Study|Other|9|||
48525263|NCT01609582|156113673|FG001|Overall Study|Other|10|||
48525264|NCT01609582|156113672|FG000|Overall Study|Randomized, but not treated|0|||
48525265|NCT01609582|156113673|FG001|Overall Study|Randomized, but not treated|3|||
48525266|NCT01740791|156113674|FG000|Overall Study|Randomized but never treated|5|||
48525267|NCT01740791|156113675|FG001|Overall Study|Randomized but never treated|3|||
48525268|NCT01740791|156113676|FG002|Overall Study|Randomized but never treated|2|||
48602095|NCT03327324|156399524|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
48602096|NCT03327324|156399519|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
48602097|NCT03327324|156399520|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602098|NCT03327324|156399521|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48734407|NCT03001882|156877766|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
48734408|NCT03001882|156877767|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
48734409|NCT03001882|156877768|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
48525269|NCT01740791|156113677|FG003|Overall Study|Randomized but never treated|2|||
48525270|NCT01740791|156113678|FG004|Overall Study|Randomized but never treated|1|||
48525271|NCT01740791|156113679|FG005|Overall Study|Randomized but never treated|3|||
48525272|NCT01740791|156113674|FG000|Overall Study|Lost to Follow-up|2|||
48525273|NCT01740791|156113675|FG001|Overall Study|Lost to Follow-up|0|||
48525274|NCT01740791|156113676|FG002|Overall Study|Lost to Follow-up|2|||
48525275|NCT01740791|156113677|FG003|Overall Study|Lost to Follow-up|3|||
48734410|NCT03001882|156877765|FG000|Overall Study|Not reported|0|||
48734411|NCT03001882|156877766|FG001|Overall Study|Not reported|0|||
48734412|NCT03001882|156877767|FG002|Overall Study|Not reported|0|||
48734413|NCT03001882|156877768|FG003|Overall Study|Not reported|6|||
48734414|NCT03001882|156877765|FG000|Overall Study|Maximum clinical benefit|2|||
48734415|NCT03001882|156877766|FG001|Overall Study|Maximum clinical benefit|3|||
48734416|NCT03001882|156877767|FG002|Overall Study|Maximum clinical benefit|0|||
48734417|NCT03001882|156877768|FG003|Overall Study|Maximum clinical benefit|10|||
48734418|NCT03001882|156877765|FG000|Overall Study|AE unrelated to study drug|3|||
48734419|NCT03001882|156877766|FG001|Overall Study|AE unrelated to study drug|3|||
48734420|NCT03001882|156877767|FG002|Overall Study|AE unrelated to study drug|0|||
48734421|NCT03001882|156877768|FG003|Overall Study|AE unrelated to study drug|11|||
48734422|NCT03001882|156877765|FG000|Overall Study|Study Drug Toxicity|8|||
48734423|NCT03001882|156877766|FG001|Overall Study|Study Drug Toxicity|5|||
48734424|NCT03001882|156877767|FG002|Overall Study|Study Drug Toxicity|0|||
48734425|NCT03001882|156877768|FG003|Overall Study|Study Drug Toxicity|37|||
48734426|NCT03001882|156877765|FG000|Overall Study|Disease progression|16|||
48734427|NCT03001882|156877766|FG001|Overall Study|Disease progression|14|||
48734428|NCT03001882|156877767|FG002|Overall Study|Disease progression|1|||
48734429|NCT03001882|156877768|FG003|Overall Study|Disease progression|90|||
48734430|NCT01386008|156877769|FG000|Overall Study|exited w/o incident /study discontinued|17|||
48734431|NCT01386008|156877769|FG000|Overall Study|Adverse Event|3|||
48734432|NCT04449861|156877770|FG000|Overall Study|Withdrawal by Subject|4|||
48734433|NCT04449861|156877770|FG000|Overall Study|Lost to Follow-up|5|||
48734434|NCT04449861|156877770|FG000|Overall Study|Death|112|||
48734435|NCT04635059|156877771|FG000|Overall Study|Study terminated early.|4|||
48734436|NCT01083485|156879458|FG000|Overall Study|Adverse Event|0|||
48734437|NCT01083485|156879459|FG001|Overall Study|Adverse Event|1|||
48525276|NCT01740791|156113678|FG004|Overall Study|Lost to Follow-up|2|||
48525277|NCT01740791|156113679|FG005|Overall Study|Lost to Follow-up|3|||
48525278|NCT01740791|156113674|FG000|Overall Study|Withdrew Consent|4|||
48525279|NCT01740791|156113675|FG001|Overall Study|Withdrew Consent|0|||
48525280|NCT01740791|156113676|FG002|Overall Study|Withdrew Consent|1|||
48525281|NCT01740791|156113677|FG003|Overall Study|Withdrew Consent|2|||
48525282|NCT01740791|156113678|FG004|Overall Study|Withdrew Consent|0|||
48525283|NCT01740791|156113679|FG005|Overall Study|Withdrew Consent|3|||
48525284|NCT01740791|156113674|FG000|Overall Study|Investigator's discretion|1|||
48525285|NCT01740791|156113675|FG001|Overall Study|Investigator's discretion|0|||
48734438|NCT01083485|156879458|FG000|Overall Study|Protocol Violation|1|||
48734439|NCT01083485|156879459|FG001|Overall Study|Protocol Violation|0|||
48734440|NCT01083485|156879458|FG000|Overall Study|Withdrawal by Subject|5|||
48734441|NCT01083485|156879459|FG001|Overall Study|Withdrawal by Subject|2|||
48734442|NCT01083485|156879458|FG000|Overall Study|Other|1|||
48734443|NCT01083485|156879459|FG001|Overall Study|Other|0|||
48734444|NCT04879225|156879460|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
48734445|NCT04879225|156879460|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
48734446|NCT01824342|156879464|FG000|Overall Study|Withdrawal by Subject|0|||
48734447|NCT01824342|156879465|FG001|Overall Study|Withdrawal by Subject|3|||
48444233|NCT01281189|155815020|FG001|Overall Study|Other|12|||
48444234|NCT01563107|155815021|FG000|Overall Study|Physician Decision|0|||
48444235|NCT01563107|155815022|FG001|Overall Study|Physician Decision|1|||
48444236|NCT01563107|155815023|FG002|Overall Study|Physician Decision|1|||
48444237|NCT01563107|155815024|FG003|Overall Study|Physician Decision|3|||
48444238|NCT01563107|155815021|FG000|Overall Study|Withdrawal by Subject|1|||
48444239|NCT01563107|155815022|FG001|Overall Study|Withdrawal by Subject|2|||
48444240|NCT01563107|155815023|FG002|Overall Study|Withdrawal by Subject|1|||
48444241|NCT01563107|155815024|FG003|Overall Study|Withdrawal by Subject|2|||
48444242|NCT01019252|155815029|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
48444243|NCT01019252|155815030|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
48444244|NCT01019252|155815029|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
48444245|NCT01019252|155815030|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
48444246|NCT01019252|155815029|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
48444247|NCT01019252|155815030|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
48444248|NCT01019252|155815029|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
48444249|NCT01019252|155815030|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
48444250|NCT02514772|155815031|FG000|Overall Study|Adverse Event|1|||
48444251|NCT02514772|155815032|FG001|Overall Study|Adverse Event|0|||
48444252|NCT02514772|155815031|FG000|Overall Study|Death|0|||
48444253|NCT02514772|155815032|FG001|Overall Study|Death|1|||
48444254|NCT02514772|155815031|FG000|Overall Study|Withdrawal by Subject|2|||
48444255|NCT02514772|155815032|FG001|Overall Study|Withdrawal by Subject|1|||
48444256|NCT03024255|155815033|FG000|Overall Study|Adverse Event|1|||
48444257|NCT03024255|155815034|FG001|Overall Study|Adverse Event|4|||
48444258|NCT03024255|155815035|FG002|Overall Study|Adverse Event|8|||
48444259|NCT03024255|155815036|FG003|Overall Study|Adverse Event|0|||
48444260|NCT03024255|155815033|FG000|Overall Study|Withdrawal by Subject|3|||
48444261|NCT03024255|155815034|FG001|Overall Study|Withdrawal by Subject|1|||
48444262|NCT03024255|155815035|FG002|Overall Study|Withdrawal by Subject|0|||
48444263|NCT03024255|155815036|FG003|Overall Study|Withdrawal by Subject|3|||
48444264|NCT03024255|155815033|FG000|Overall Study|Protocol Violation|0|||
48444265|NCT03024255|155815034|FG001|Overall Study|Protocol Violation|0|||
48444266|NCT03024255|155815035|FG002|Overall Study|Protocol Violation|2|||
48444267|NCT03024255|155815036|FG003|Overall Study|Protocol Violation|0|||
48444268|NCT03024255|155815033|FG000|Overall Study|Lost to Follow-up|1|||
48444269|NCT03024255|155815034|FG001|Overall Study|Lost to Follow-up|2|||
48444270|NCT03024255|155815035|FG002|Overall Study|Lost to Follow-up|1|||
48444271|NCT03024255|155815036|FG003|Overall Study|Lost to Follow-up|1|||
48444272|NCT03024255|155815033|FG000|Overall Study|Lack of Efficacy|1|||
48444273|NCT03024255|155815034|FG001|Overall Study|Lack of Efficacy|0|||
48444274|NCT03024255|155815035|FG002|Overall Study|Lack of Efficacy|0|||
48444275|NCT03024255|155815036|FG003|Overall Study|Lack of Efficacy|0|||
48444276|NCT03024255|155815033|FG000|Overall Study|Protocol Noncompliance|1|||
48444277|NCT03024255|155815034|FG001|Overall Study|Protocol Noncompliance|1|||
48444278|NCT03024255|155815035|FG002|Overall Study|Protocol Noncompliance|0|||
48444279|NCT03024255|155815036|FG003|Overall Study|Protocol Noncompliance|1|||
48444280|NCT02685995|155815037|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
48444281|NCT02685995|155815038|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
48444282|NCT03625141|155815039|FG000|Overall Study|Adverse Event|0|||
48444283|NCT03625141|155815040|FG001|Overall Study|Adverse Event|2|||
48444284|NCT03625141|155815039|FG000|Overall Study|Study Terminated By Sponsor|1|||
48444285|NCT03625141|155815040|FG001|Overall Study|Study Terminated By Sponsor|13|||
48444286|NCT03625141|155815039|FG000|Overall Study|Withdrawal by Subject|3|||
48444287|NCT03625141|155815040|FG001|Overall Study|Withdrawal by Subject|0|||
48444288|NCT03625141|155815039|FG000|Overall Study|Withdrawal Of Consent|0|||
48444289|NCT03625141|155815040|FG001|Overall Study|Withdrawal Of Consent|1|||
48444290|NCT03625141|155815039|FG000|Overall Study|Death|11|||
48444291|NCT03625141|155815040|FG001|Overall Study|Death|47|||
48444292|NCT03625141|155815039|FG000|Overall Study|Progressive Disease|0|||
48826708|NCT03531905|157207304|FG000|Overall Study|Could not speak with the participant|1|||
48826709|NCT03531905|157207305|FG001|Overall Study|Could not speak with the participant|0|||
48826710|NCT03531905|157207306|FG002|Overall Study|Could not speak with the participant|0|||
48826711|NCT04978363|157207309|FG000|Overall Study|Other medical issues unrelated to the study|0|||
48826712|NCT04978363|157207310|FG001|Overall Study|Other medical issues unrelated to the study|0|||
48826713|NCT04978363|157207311|FG002|Overall Study|Other medical issues unrelated to the study|0|||
48826714|NCT04978363|157207312|FG003|Overall Study|Other medical issues unrelated to the study|0|||
48826715|NCT04978363|157207313|FG004|Overall Study|Other medical issues unrelated to the study|1|||
48826716|NCT04978363|157207314|FG005|Overall Study|Other medical issues unrelated to the study|0|||
48826717|NCT04978363|157207315|FG006|Overall Study|Other medical issues unrelated to the study|0|||
48826718|NCT04978363|157207316|FG007|Overall Study|Other medical issues unrelated to the study|0|||
48826719|NCT04978363|157207317|FG008|Overall Study|Other medical issues unrelated to the study|0|||
48826720|NCT04978363|157207318|FG009|Overall Study|Other medical issues unrelated to the study|0|||
48826721|NCT04978363|157207319|FG010|Overall Study|Other medical issues unrelated to the study|0|||
48826722|NCT04978363|157207309|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
48826723|NCT04978363|157207310|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
48826724|NCT04978363|157207311|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
48826725|NCT04978363|157207312|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
48826726|NCT04978363|157207313|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
48826727|NCT04978363|157207314|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
48826728|NCT04978363|157207315|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
48826729|NCT04978363|157207316|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
48826730|NCT04978363|157207317|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
48826731|NCT04978363|157207318|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
48826732|NCT04978363|157207319|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
48826733|NCT04978363|157207309|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826734|NCT04978363|157207310|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
48826735|NCT04978363|157207311|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826736|NCT04978363|157207312|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826737|NCT04978363|157207313|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826738|NCT04978363|157207314|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826739|NCT04978363|157207315|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826740|NCT04978363|157207316|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826741|NCT04978363|157207317|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826742|NCT04978363|157207318|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826743|NCT04978363|157207319|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
48826744|NCT01251614|157207320|FG000|Overall Study|Adverse Event|1|||
48826745|NCT01251614|157207321|FG001|Overall Study|Adverse Event|0|||
48826746|NCT01251614|157207322|FG002|Overall Study|Adverse Event|1|||
48826747|NCT01251614|157207320|FG000|Overall Study|Lack of Efficacy|1|||
48826748|NCT01251614|157207321|FG001|Overall Study|Lack of Efficacy|9|||
48826749|NCT01251614|157207322|FG002|Overall Study|Lack of Efficacy|4|||
48826750|NCT01251614|157207320|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
48826751|NCT01251614|157207321|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
48525286|NCT01740791|156113676|FG002|Overall Study|Investigator's discretion|1|||
48525287|NCT01740791|156113677|FG003|Overall Study|Investigator's discretion|0|||
48525288|NCT01740791|156113678|FG004|Overall Study|Investigator's discretion|0|||
48525289|NCT01740791|156113679|FG005|Overall Study|Investigator's discretion|1|||
48525290|NCT01740791|156113674|FG000|Overall Study|Adverse Event|0|||
48525291|NCT01740791|156113675|FG001|Overall Study|Adverse Event|0|||
48525292|NCT01740791|156113676|FG002|Overall Study|Adverse Event|0|||
48525293|NCT01740791|156113677|FG003|Overall Study|Adverse Event|0|||
48525294|NCT01740791|156113678|FG004|Overall Study|Adverse Event|0|||
48525295|NCT01740791|156113679|FG005|Overall Study|Adverse Event|1|||
48525296|NCT00985231|156113680|FG000|Overall Study|ineligible|1|||
48525297|NCT00985231|156113681|FG001|Overall Study|ineligible|0|||
48525298|NCT00985231|156113680|FG000|Overall Study|Protocol Violation|1|||
48525299|NCT00985231|156113681|FG001|Overall Study|Protocol Violation|0|||
48525300|NCT00985231|156113680|FG000|Overall Study|Withdrawal by Subject|1|||
48525301|NCT00985231|156113681|FG001|Overall Study|Withdrawal by Subject|0|||
48525302|NCT00985231|156113680|FG000|Overall Study|Lost to Follow-up|0|||
48525303|NCT00985231|156113681|FG001|Overall Study|Lost to Follow-up|1|||
48525304|NCT00985231|156113680|FG000|Overall Study|Study related symptoms & complaints|0|||
48525305|NCT00985231|156113681|FG001|Overall Study|Study related symptoms & complaints|2|||
48525306|NCT01808248|156113683|FG000|Overall Study|Lack of Efficacy|3|||
48525307|NCT01808248|156113683|FG000|Overall Study|Withdrawal by Subject|1|||
48525308|NCT01808248|156113683|FG000|Overall Study|Lost to Follow-up|1|||
48826752|NCT01251614|157207322|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
48826753|NCT01251614|157207320|FG000|Overall Study|Pregnancy|0|||
48826754|NCT01251614|157207321|FG001|Overall Study|Pregnancy|0|||
48826755|NCT01251614|157207322|FG002|Overall Study|Pregnancy|2|||
48826756|NCT01251614|157207320|FG000|Overall Study|Loss of Disease Control|0|||
48826757|NCT01251614|157207321|FG001|Overall Study|Loss of Disease Control|1|||
48826758|NCT01251614|157207322|FG002|Overall Study|Loss of Disease Control|0|||
48826759|NCT01251614|157207320|FG000|Overall Study|Withdrawal by Subject|0|||
48525309|NCT00819767|156113684|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48525310|NCT00819767|156113685|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48525311|NCT00603512|156113688|FG000|Overall Study|Adverse Event|0|||
48525312|NCT00603512|156113689|FG001|Overall Study|Adverse Event|2|||
48525313|NCT00603512|156113690|FG002|Overall Study|Adverse Event|4|||
48525314|NCT00603512|156113691|FG003|Overall Study|Adverse Event|4|||
48525315|NCT00603512|156113692|FG004|Overall Study|Adverse Event|2|||
48525316|NCT00603512|156113688|FG000|Overall Study|Lack of Efficacy|0|||
48525317|NCT00603512|156113689|FG001|Overall Study|Lack of Efficacy|1|||
48525318|NCT00603512|156113690|FG002|Overall Study|Lack of Efficacy|0|||
48525319|NCT00603512|156113691|FG003|Overall Study|Lack of Efficacy|0|||
48525320|NCT00603512|156113692|FG004|Overall Study|Lack of Efficacy|1|||
48525321|NCT00603512|156113688|FG000|Overall Study|Other|2|||
48525322|NCT00603512|156113689|FG001|Overall Study|Other|1|||
48525323|NCT00603512|156113690|FG002|Overall Study|Other|0|||
48525324|NCT00603512|156113691|FG003|Overall Study|Other|1|||
48525325|NCT00603512|156113692|FG004|Overall Study|Other|1|||
48525326|NCT00603512|156113688|FG000|Overall Study|Withdrawal by Subject|0|||
48525327|NCT00603512|156113689|FG001|Overall Study|Withdrawal by Subject|0|||
48525328|NCT00603512|156113690|FG002|Overall Study|Withdrawal by Subject|0|||
48525329|NCT00603512|156113691|FG003|Overall Study|Withdrawal by Subject|0|||
48525330|NCT00603512|156113692|FG004|Overall Study|Withdrawal by Subject|1|||
48525331|NCT00603512|156113688|FG000|Overall Study|Randomized but not treated|0|||
48525332|NCT00603512|156113689|FG001|Overall Study|Randomized but not treated|1|||
48525333|NCT00603512|156113690|FG002|Overall Study|Randomized but not treated|1|||
48525334|NCT00603512|156113691|FG003|Overall Study|Randomized but not treated|2|||
48525335|NCT00603512|156113692|FG004|Overall Study|Randomized but not treated|0|||
48525336|NCT00756717|156113695|FG000|Overall Study|Withdrawal by Subject|2|||
48525337|NCT04979858|156113699|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
48525338|NCT04979858|156113700|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
48525339|NCT04253236|156113701|FG000|Overall Study|Adverse Event|1|||
48525340|NCT04253236|156113702|FG001|Overall Study|Adverse Event|0|||
48525341|NCT04253236|156113701|FG000|Overall Study|Safety Concerns|1|||
48525342|NCT04253236|156113702|FG001|Overall Study|Safety Concerns|0|||
48525343|NCT04253236|156113701|FG000|Overall Study|Study Terminated by Sponsor|1|||
48525344|NCT04253236|156113702|FG001|Overall Study|Study Terminated by Sponsor|0|||
48525345|NCT02169791|156113707|FG000|Overall Study|Death|6|||
48525346|NCT02169791|156113707|FG000|Overall Study|patient withdrew consent|1|||
48525347|NCT03170869|156113708|FG000|Overall Study|Protocol Violation|5|||
48525348|NCT03170869|156113708|FG000|Overall Study|Early study termination|3|||
48525349|NCT01142661|156113717|FG000|Overall Study|Adverse Event|2|||
48525350|NCT01142661|156113717|FG000|Overall Study|Withdrawal by Subject|1|||
48525351|NCT01142661|156113717|FG000|Overall Study|Physician Decision|1|||
48525352|NCT02875028|156113718|FG000|Washout Period|Withdrawal by Subject|0|||
48525353|NCT02875028|156113719|FG001|Washout Period|Withdrawal by Subject|1|||
48525354|NCT03689894|156113720|FG000|Overall Study|Adverse Event|1|||
48525355|NCT02832167|156115216|FG000|Treatment Period 1|Disease progression|90|||
48525356|NCT02832167|156115216|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
48525357|NCT02832167|156115216|FG000|Treatment Period 1|Death|2|||
48525358|NCT02832167|156115216|FG000|Treatment Period 1|Study Drug Toxicity|6|||
48525359|NCT02832167|156115216|FG000|Treatment Period 1|Participant request to discontinue|9|||
48525360|NCT02832167|156115216|FG000|Treatment Period 1|No longer meet study criteria|1|||
48525361|NCT02832167|156115216|FG000|Treatment Period 1|Participant withdrew consent|3|||
48525362|NCT02832167|156115216|FG000|Treatment Period 1|Other reasons|6|||
48525363|NCT02832167|156115216|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
48630327|NCT03331354|156504918|FG000|Overall Study|Found employment before initiated active intervention|0|||
48826760|NCT01251614|157207321|FG001|Overall Study|Withdrawal by Subject|2|||
48826761|NCT01251614|157207322|FG002|Overall Study|Withdrawal by Subject|1|||
48826762|NCT01251614|157207320|FG000|Overall Study|Lost to Follow-up|0|||
48525364|NCT02832167|156115216|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
48525365|NCT02832167|156115216|FG000|Transition From Period 1 to Period 2|Death|2|||
48525366|NCT02832167|156115216|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
48525367|NCT02832167|156115216|FG000|Treatment Period 2|Disease progression|69|||
48826763|NCT01251614|157207321|FG001|Overall Study|Lost to Follow-up|1|||
48630353|NCT02082977|156504932|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48630354|NCT02082977|156504933|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48630355|NCT02082977|156504934|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48630356|NCT02082977|156504935|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48630357|NCT02082977|156504936|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48630358|NCT02082977|156504937|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
48630359|NCT02082977|156504938|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48630360|NCT02082977|156504939|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48630361|NCT02082977|156504930|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630362|NCT02082977|156504931|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630363|NCT02082977|156504932|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630364|NCT02082977|156504933|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630365|NCT02082977|156504934|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630366|NCT02082977|156504935|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
48630367|NCT02082977|156504936|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630368|NCT02082977|156504937|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630369|NCT02082977|156504938|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630370|NCT02082977|156504939|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
48630371|NCT02082977|156504930|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
48630372|NCT02082977|156504931|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
48630373|NCT02082977|156504932|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
48630374|NCT02082977|156504933|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
48630375|NCT02082977|156504934|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
48630376|NCT02082977|156504935|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
48630377|NCT02082977|156504936|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
48630378|NCT02082977|156504937|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
48630379|NCT02082977|156504938|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
48630380|NCT02082977|156504939|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
48630381|NCT02082977|156504930|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630382|NCT02082977|156504931|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630383|NCT02082977|156504932|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630384|NCT02082977|156504933|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630385|NCT02082977|156504934|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630386|NCT02082977|156504935|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630387|NCT02082977|156504936|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630388|NCT02082977|156504937|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
48630389|NCT02082977|156504938|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630390|NCT02082977|156504939|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
48630391|NCT02495883|156504940|FG000|Overall Study|Excessive head motion|1|||
48630392|NCT02495883|156504941|FG001|Overall Study|Excessive head motion|0|||
48630393|NCT00105066|156504942|FG000|Overall Study|Adverse Event|2|||
48630394|NCT00105066|156504943|FG001|Overall Study|Adverse Event|5|||
48630395|NCT02796651|156504944|FG000|Overall Study|Adverse Event|6|||
48630396|NCT02796651|156504944|FG000|Overall Study|Lost to Follow-up|1|||
48630397|NCT02796651|156504944|FG000|Overall Study|Withdrawal by Subject|4|||
48630398|NCT02796651|156504944|FG000|Overall Study|Protocol Violation|4|||
48630399|NCT02796651|156504944|FG000|Overall Study|Lack of Efficacy|1|||
48630400|NCT02796651|156504944|FG000|Overall Study|Other|10|||
48630401|NCT05014919|156504945|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
48630402|NCT05014919|156504946|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
48630403|NCT05014919|156504947|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
48630404|NCT05014919|156504945|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
48630405|NCT05014919|156504946|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
48630406|NCT05014919|156504947|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
48630407|NCT05014919|156504945|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
48630408|NCT05014919|156504946|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
48630409|NCT05014919|156504947|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
48630410|NCT05014919|156504945|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
48630411|NCT05014919|156504946|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
48630412|NCT05014919|156504947|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
48630413|NCT05014919|156504945|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
48630414|NCT05014919|156504946|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
48630415|NCT05014919|156504947|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
48630416|NCT05014919|156504945|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
48630417|NCT05014919|156504946|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
48630418|NCT05014919|156504947|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
48630419|NCT05014919|156504945|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
48630420|NCT05014919|156504946|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
48734448|NCT01824342|156879464|FG000|Overall Study|Adverse Event|1|||
48734449|NCT01824342|156879465|FG001|Overall Study|Adverse Event|1|||
48734450|NCT01824342|156879464|FG000|Overall Study|Disease Progression|1|||
48734451|NCT01824342|156879465|FG001|Overall Study|Disease Progression|1|||
48826764|NCT01251614|157207322|FG002|Overall Study|Lost to Follow-up|0|||
48826765|NCT02153788|157207323|FG000|Overall Study|Physician Decision|2|||
48826766|NCT02153788|157207324|FG001|Overall Study|Physician Decision|1|||
48826767|NCT05305040|157207327|FG000|Overall Study|Not Dosed|37|||
48826768|NCT05305040|157207328|FG001|Overall Study|Not Dosed|37|||
48826769|NCT05305040|157207327|FG000|Overall Study|Study Closure|34|||
48826770|NCT05305040|157207328|FG001|Overall Study|Study Closure|46|||
48826771|NCT05305040|157207327|FG000|Overall Study|Death|14|||
48826772|NCT05305040|157207328|FG001|Overall Study|Death|13|||
48826773|NCT05305040|157207327|FG000|Overall Study|Withdrawal by Subject|15|||
48826774|NCT05305040|157207328|FG001|Overall Study|Withdrawal by Subject|10|||
48826775|NCT05305040|157207327|FG000|Overall Study|Other|13|||
48826776|NCT05305040|157207328|FG001|Overall Study|Other|10|||
48826777|NCT05305040|157207327|FG000|Overall Study|Primary Malignancy Relapse|3|||
48826778|NCT05305040|157207328|FG001|Overall Study|Primary Malignancy Relapse|4|||
48525368|NCT02832167|156115216|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
48525369|NCT02832167|156115216|FG000|Treatment Period 2|Maximum clinical benefit|1|||
48525370|NCT02832167|156115216|FG000|Treatment Period 2|Study Drug Toxicity|5|||
48525371|NCT02832167|156115216|FG000|Treatment Period 2|Participant request to discontinue|2|||
48525372|NCT02832167|156115216|FG000|Treatment Period 2|Participant withdrew consent|3|||
48525373|NCT02832167|156115216|FG000|Treatment Period 2|Other reasons|3|||
48525374|NCT01705717|156115224|FG000|Overall Study|Adverse Event|2|||
48525375|NCT01705717|156115225|FG001|Overall Study|Adverse Event|2|||
48525376|NCT01705717|156115224|FG000|Overall Study|Lack of Efficacy|0|||
48525377|NCT01705717|156115225|FG001|Overall Study|Lack of Efficacy|1|||
48525378|NCT01705717|156115224|FG000|Overall Study|Other|0|||
48525379|NCT01705717|156115225|FG001|Overall Study|Other|2|||
48525380|NCT03686215|156115226|FG000|Overall Study|Adverse Event|0|||
48525381|NCT03686215|156115227|FG001|Overall Study|Adverse Event|0|||
48525382|NCT03686215|156115228|FG002|Overall Study|Adverse Event|7|||
48525383|NCT03686215|156115226|FG000|Overall Study|Physician Decision|0|||
48525384|NCT03686215|156115227|FG001|Overall Study|Physician Decision|0|||
48525385|NCT03686215|156115228|FG002|Overall Study|Physician Decision|1|||
48525386|NCT03686215|156115226|FG000|Overall Study|Protocol Violation|0|||
48525387|NCT03686215|156115227|FG001|Overall Study|Protocol Violation|0|||
48525388|NCT03686215|156115228|FG002|Overall Study|Protocol Violation|4|||
48525389|NCT03686215|156115226|FG000|Overall Study|Device issue|1|||
48525390|NCT03686215|156115227|FG001|Overall Study|Device issue|0|||
48525391|NCT03686215|156115228|FG002|Overall Study|Device issue|2|||
48525392|NCT01188226|156115233|FG000|Overall Study|Withdrawal by Subject|4|||
48525393|NCT00202839|156115236|FG000|Overall Study|Adverse Event|1|||
48525394|NCT00202839|156115237|FG001|Overall Study|Adverse Event|5|||
48525395|NCT00202839|156115236|FG000|Overall Study|Physician Decision|12|||
48525396|NCT00202839|156115237|FG001|Overall Study|Physician Decision|0|||
48525397|NCT00202839|156115236|FG000|Overall Study|Withdrawal by Subject|6|||
48525398|NCT00202839|156115237|FG001|Overall Study|Withdrawal by Subject|2|||
48525399|NCT00202839|156115236|FG000|Overall Study|Protocol Violation|2|||
48525400|NCT00202839|156115237|FG001|Overall Study|Protocol Violation|1|||
48525401|NCT00202839|156115236|FG000|Overall Study|Lost to Follow-up|3|||
48525402|NCT00202839|156115237|FG001|Overall Study|Lost to Follow-up|2|||
48525403|NCT04832971|156115239|FG000|Overall Study|Death|1|||
48525404|NCT04832971|156115240|FG001|Overall Study|Death|0|||
48734452|NCT01824342|156879464|FG000|Overall Study|Physician Decision|5|||
48734453|NCT01824342|156879465|FG001|Overall Study|Physician Decision|0|||
48734454|NCT01824342|156879464|FG000|Overall Study|Death|2|||
48734455|NCT01824342|156879465|FG001|Overall Study|Death|0|||
48826779|NCT05305040|157207327|FG000|Overall Study|Adverse Event|3|||
48826780|NCT05305040|157207328|FG001|Overall Study|Adverse Event|3|||
48826781|NCT05305040|157207327|FG000|Overall Study|Lost to Follow-up|2|||
48826782|NCT05305040|157207328|FG001|Overall Study|Lost to Follow-up|1|||
48525405|NCT04832971|156115241|FG002|Overall Study|Death|0|||
48525406|NCT04832971|156115242|FG003|Overall Study|Death|0|||
48525407|NCT04832971|156115239|FG000|Overall Study|Lost to Follow-up|1|||
48525408|NCT04832971|156115240|FG001|Overall Study|Lost to Follow-up|1|||
48525409|NCT04832971|156115241|FG002|Overall Study|Lost to Follow-up|1|||
48525410|NCT04832971|156115242|FG003|Overall Study|Lost to Follow-up|0|||
48525411|NCT04832971|156115239|FG000|Overall Study|Withdrawal by Subject|1|||
48826783|NCT05305040|157207327|FG000|Overall Study|Graft versus host disease|2|||
48525412|NCT04832971|156115240|FG001|Overall Study|Withdrawal by Subject|3|||
48525413|NCT04832971|156115241|FG002|Overall Study|Withdrawal by Subject|2|||
48525414|NCT04832971|156115242|FG003|Overall Study|Withdrawal by Subject|2|||
48525415|NCT04832971|156115239|FG000|Overall Study|Other, Not Specified|0|||
48525416|NCT04832971|156115240|FG001|Overall Study|Other, Not Specified|0|||
48826784|NCT05305040|157207328|FG001|Overall Study|Graft versus host disease|0|||
48525417|NCT04832971|156115241|FG002|Overall Study|Other, Not Specified|1|||
48525418|NCT04832971|156115242|FG003|Overall Study|Other, Not Specified|0|||
48525419|NCT00927251|156115243|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
48525420|NCT01098851|156115244|FG000|Overall Study|Equipment failure|1|||
48525421|NCT01098851|156115245|FG001|Overall Study|Equipment failure|0|||
48525422|NCT03431337|156115246|FG000|Overall Study|Lost to Follow-up|21|||
48525423|NCT03431337|156115247|FG001|Overall Study|Lost to Follow-up|19|||
48525424|NCT03431337|156115246|FG000|Overall Study|Withdrawal by Subject|8|||
48525425|NCT03431337|156115247|FG001|Overall Study|Withdrawal by Subject|3|||
48525426|NCT02419573|156115248|FG000|Overall Study|Lost to Follow-up|3|||
48826785|NCT05305040|157207327|FG000|Overall Study|Investigator's Decision|1|||
48826786|NCT05305040|157207328|FG001|Overall Study|Investigator's Decision|1|||
48826787|NCT05305040|157207327|FG000|Overall Study|COVID-19 Reasons|1|||
48826788|NCT05305040|157207328|FG001|Overall Study|COVID-19 Reasons|0|||
48826789|NCT00049517|157207329|FG000|Induction|Disease progression|0|||
48826790|NCT00049517|157207330|FG001|Induction|Disease progression|0|||
48826791|NCT00049517|157207331|FG002|Induction|Disease progression|0|||
48826792|NCT00049517|157207332|FG003|Induction|Disease progression|0|||
48826793|NCT00049517|157207333|FG004|Induction|Disease progression|18|||
48826794|NCT00049517|157207334|FG005|Induction|Disease progression|11|||
48826795|NCT00049517|157207329|FG000|Induction|Adverse Event|0|||
48826796|NCT00049517|157207330|FG001|Induction|Adverse Event|0|||
48826797|NCT00049517|157207331|FG002|Induction|Adverse Event|0|||
48826798|NCT00049517|157207332|FG003|Induction|Adverse Event|0|||
48826799|NCT00049517|157207333|FG004|Induction|Adverse Event|5|||
48826800|NCT00049517|157207334|FG005|Induction|Adverse Event|7|||
48826801|NCT00049517|157207329|FG000|Induction|Death|0|||
48826802|NCT00049517|157207330|FG001|Induction|Death|0|||
48826803|NCT00049517|157207331|FG002|Induction|Death|0|||
48826804|NCT00049517|157207332|FG003|Induction|Death|0|||
48826805|NCT00049517|157207333|FG004|Induction|Death|9|||
48826806|NCT00049517|157207334|FG005|Induction|Death|6|||
48826807|NCT00049517|157207329|FG000|Induction|Withdrawal by Subject|0|||
48826808|NCT00049517|157207330|FG001|Induction|Withdrawal by Subject|0|||
48826809|NCT00049517|157207331|FG002|Induction|Withdrawal by Subject|0|||
48826810|NCT00049517|157207332|FG003|Induction|Withdrawal by Subject|0|||
48826811|NCT00049517|157207333|FG004|Induction|Withdrawal by Subject|1|||
48826812|NCT00049517|157207334|FG005|Induction|Withdrawal by Subject|3|||
48525427|NCT02419573|156115249|FG001|Overall Study|Lost to Follow-up|0|||
48525428|NCT02419573|156115248|FG000|Overall Study|Withdrawal by Subject|1|||
48525429|NCT02419573|156115249|FG001|Overall Study|Withdrawal by Subject|0|||
48826813|NCT00049517|157207329|FG000|Induction|Alternative therapy|0|||
48826814|NCT00049517|157207330|FG001|Induction|Alternative therapy|0|||
48826815|NCT00049517|157207331|FG002|Induction|Alternative therapy|0|||
48826816|NCT00049517|157207332|FG003|Induction|Alternative therapy|0|||
48826817|NCT00049517|157207333|FG004|Induction|Alternative therapy|2|||
48826818|NCT00049517|157207334|FG005|Induction|Alternative therapy|2|||
48525430|NCT00401245|156115250|FG000|Double Blind Titration Phase|Adverse Event|3|||
48525431|NCT00401245|156115251|FG001|Double Blind Titration Phase|Adverse Event|2|||
48826819|NCT00049517|157207329|FG000|Induction|Other complicating disease|0|||
48826820|NCT00049517|157207330|FG001|Induction|Other complicating disease|0|||
48826821|NCT00049517|157207331|FG002|Induction|Other complicating disease|0|||
48826822|NCT00049517|157207332|FG003|Induction|Other complicating disease|0|||
48826823|NCT00049517|157207333|FG004|Induction|Other complicating disease|3|||
48826824|NCT00049517|157207334|FG005|Induction|Other complicating disease|0|||
48826825|NCT00049517|157207329|FG000|Induction|Reasons not reported|0|||
48826826|NCT00049517|157207330|FG001|Induction|Reasons not reported|0|||
48826827|NCT00049517|157207331|FG002|Induction|Reasons not reported|0|||
48826828|NCT00049517|157207332|FG003|Induction|Reasons not reported|0|||
48826829|NCT00049517|157207333|FG004|Induction|Reasons not reported|22|||
48826830|NCT00049517|157207334|FG005|Induction|Reasons not reported|25|||
48826831|NCT00049517|157207329|FG000|Conditioning/Transplant|Disease progression|14|||
48826832|NCT00049517|157207330|FG001|Conditioning/Transplant|Disease progression|6|||
48826833|NCT00049517|157207331|FG002|Conditioning/Transplant|Disease progression|10|||
48826834|NCT00049517|157207332|FG003|Conditioning/Transplant|Disease progression|6|||
48826835|NCT00049517|157207333|FG004|Conditioning/Transplant|Disease progression|0|||
48826836|NCT00049517|157207334|FG005|Conditioning/Transplant|Disease progression|0|||
48826837|NCT00049517|157207329|FG000|Conditioning/Transplant|Adverse Event|2|||
48826838|NCT00049517|157207330|FG001|Conditioning/Transplant|Adverse Event|1|||
48826839|NCT00049517|157207331|FG002|Conditioning/Transplant|Adverse Event|4|||
48826840|NCT00049517|157207332|FG003|Conditioning/Transplant|Adverse Event|8|||
48826841|NCT00049517|157207333|FG004|Conditioning/Transplant|Adverse Event|0|||
48826842|NCT00049517|157207334|FG005|Conditioning/Transplant|Adverse Event|0|||
48826843|NCT00049517|157207329|FG000|Conditioning/Transplant|Death|1|||
48826844|NCT00049517|157207330|FG001|Conditioning/Transplant|Death|0|||
48826845|NCT00049517|157207331|FG002|Conditioning/Transplant|Death|0|||
48826846|NCT00049517|157207332|FG003|Conditioning/Transplant|Death|2|||
48826847|NCT00049517|157207333|FG004|Conditioning/Transplant|Death|0|||
48826848|NCT00049517|157207334|FG005|Conditioning/Transplant|Death|0|||
48826849|NCT00049517|157207329|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
48826850|NCT00049517|157207330|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
48826851|NCT00049517|157207331|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
48826852|NCT00049517|157207332|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
48826853|NCT00049517|157207333|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
48826854|NCT00049517|157207334|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
48826855|NCT00049517|157207329|FG000|Conditioning/Transplant|Alternative therapy|4|||
48826856|NCT00049517|157207330|FG001|Conditioning/Transplant|Alternative therapy|4|||
48826857|NCT00049517|157207331|FG002|Conditioning/Transplant|Alternative therapy|2|||
48826858|NCT00049517|157207332|FG003|Conditioning/Transplant|Alternative therapy|1|||
48826859|NCT00049517|157207333|FG004|Conditioning/Transplant|Alternative therapy|1|||
48826860|NCT00049517|157207334|FG005|Conditioning/Transplant|Alternative therapy|0|||
48826861|NCT00049517|157207329|FG000|Conditioning/Transplant|Other complicating disease|2|||
48826862|NCT00049517|157207330|FG001|Conditioning/Transplant|Other complicating disease|0|||
48826863|NCT00049517|157207331|FG002|Conditioning/Transplant|Other complicating disease|0|||
48826864|NCT00049517|157207332|FG003|Conditioning/Transplant|Other complicating disease|4|||
48826865|NCT00049517|157207333|FG004|Conditioning/Transplant|Other complicating disease|0|||
48826866|NCT00049517|157207334|FG005|Conditioning/Transplant|Other complicating disease|1|||
48826867|NCT00049517|157207329|FG000|Conditioning/Transplant|Reasons not reported|25|||
48826868|NCT00049517|157207330|FG001|Conditioning/Transplant|Reasons not reported|31|||
48826869|NCT00049517|157207331|FG002|Conditioning/Transplant|Reasons not reported|18|||
48826870|NCT00049517|157207332|FG003|Conditioning/Transplant|Reasons not reported|15|||
48826871|NCT00049517|157207333|FG004|Conditioning/Transplant|Reasons not reported|5|||
48826872|NCT00049517|157207334|FG005|Conditioning/Transplant|Reasons not reported|5|||
48826873|NCT00256308|157207335|FG000|Overall Study|Death|2|||
48826874|NCT02206685|157207336|FG000|Overall Study|Surgery cancelled/changed|2|||
48826875|NCT02206685|157207337|FG001|Overall Study|Surgery cancelled/changed|3|||
48826876|NCT02206685|157207336|FG000|Overall Study|Withdrawal by Subject|1|||
48826877|NCT02206685|157207337|FG001|Overall Study|Withdrawal by Subject|2|||
48826878|NCT02206685|157207336|FG000|Overall Study|Protocol Violation|2|||
48826879|NCT02206685|157207337|FG001|Overall Study|Protocol Violation|2|||
48826880|NCT01106287|157207338|FG000|Overall Study|Adverse Event|1|||
48525432|NCT00401245|156115252|FG002|Double Blind Titration Phase|Adverse Event|5|||
48826881|NCT01106287|157207339|FG001|Overall Study|Adverse Event|0|||
48826882|NCT01106287|157207340|FG002|Overall Study|Adverse Event|0|||
48826883|NCT01106287|157207341|FG003|Overall Study|Adverse Event|0|||
48826884|NCT00072475|157207342|FG000|Overall Study|Adverse Event|44|||
48826885|NCT00072475|157207342|FG000|Overall Study|Death|3|||
48826886|NCT00072475|157207342|FG000|Overall Study|Withdrawal by Subject|46|||
48826887|NCT00072475|157207342|FG000|Overall Study|Patient/Investigator Decision|4|||
48826888|NCT04730947|157207343|FG000|Overall Study|Withdrawal by Subject|0|||
48826889|NCT04730947|157207344|FG001|Overall Study|Withdrawal by Subject|1|||
48826890|NCT04476043|157207345|FG000|Overall Study|Withdrawal by Subject|1|||
48826891|NCT04476043|157207346|FG001|Overall Study|Withdrawal by Subject|3|||
48525433|NCT00401245|156115253|FG003|Double Blind Titration Phase|Adverse Event|12|||
48525434|NCT00401245|156115254|FG004|Double Blind Titration Phase|Adverse Event|0|||
48525435|NCT00401245|156115255|FG005|Double Blind Titration Phase|Adverse Event|0|||
48525436|NCT00401245|156115256|FG006|Double Blind Titration Phase|Adverse Event|0|||
48525437|NCT00401245|156115257|FG007|Double Blind Titration Phase|Adverse Event|0|||
48525438|NCT00401245|156115250|FG000|Double Blind Titration Phase|Other|0|||
48525439|NCT00401245|156115251|FG001|Double Blind Titration Phase|Other|0|||
48525440|NCT00401245|156115252|FG002|Double Blind Titration Phase|Other|1|||
48525441|NCT00401245|156115253|FG003|Double Blind Titration Phase|Other|0|||
48525442|NCT00401245|156115254|FG004|Double Blind Titration Phase|Other|0|||
48525443|NCT00401245|156115255|FG005|Double Blind Titration Phase|Other|0|||
48525444|NCT00401245|156115256|FG006|Double Blind Titration Phase|Other|0|||
48525445|NCT00401245|156115257|FG007|Double Blind Titration Phase|Other|0|||
48525446|NCT00401245|156115250|FG000|Double Blind Titration Phase|Protocol Violation|0|||
48525447|NCT00401245|156115251|FG001|Double Blind Titration Phase|Protocol Violation|0|||
48525448|NCT00401245|156115252|FG002|Double Blind Titration Phase|Protocol Violation|0|||
48525449|NCT00401245|156115253|FG003|Double Blind Titration Phase|Protocol Violation|1|||
48525450|NCT00401245|156115254|FG004|Double Blind Titration Phase|Protocol Violation|0|||
48525451|NCT00401245|156115255|FG005|Double Blind Titration Phase|Protocol Violation|0|||
48525452|NCT00401245|156115256|FG006|Double Blind Titration Phase|Protocol Violation|0|||
48525453|NCT00401245|156115257|FG007|Double Blind Titration Phase|Protocol Violation|0|||
48525454|NCT00401245|156115250|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
48525455|NCT00401245|156115251|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
48525456|NCT00401245|156115252|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
48525457|NCT00401245|156115253|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
48525458|NCT00401245|156115254|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
48525459|NCT00401245|156115255|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
48525460|NCT00401245|156115256|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
48525461|NCT00401245|156115257|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
48525462|NCT00401245|156115250|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
48525463|NCT00401245|156115251|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
48525464|NCT00401245|156115252|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
48525465|NCT00401245|156115253|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
48525466|NCT00401245|156115254|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
48525467|NCT00401245|156115255|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
48525468|NCT00401245|156115256|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
48525469|NCT00401245|156115257|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
48525470|NCT00401245|156115250|FG000|Open Label Phase|Adverse Event|5|||
48525471|NCT00401245|156115251|FG001|Open Label Phase|Adverse Event|14|||
48525472|NCT00401245|156115252|FG002|Open Label Phase|Adverse Event|6|||
48525473|NCT00401245|156115253|FG003|Open Label Phase|Adverse Event|7|||
48525474|NCT00401245|156115254|FG004|Open Label Phase|Adverse Event|0|||
48525475|NCT00401245|156115255|FG005|Open Label Phase|Adverse Event|0|||
48734456|NCT01229371|156879470|FG000|Overall Study|Withdrawal by Subject|0|||
48734457|NCT01229371|156879471|FG001|Overall Study|Withdrawal by Subject|1|||
48734458|NCT01229371|156879472|FG002|Overall Study|Withdrawal by Subject|0|||
48525476|NCT00401245|156115256|FG006|Open Label Phase|Adverse Event|0|||
48525477|NCT00401245|156115257|FG007|Open Label Phase|Adverse Event|0|||
48525478|NCT00401245|156115250|FG000|Open Label Phase|Lost to Follow-up|5|||
48525479|NCT00401245|156115251|FG001|Open Label Phase|Lost to Follow-up|7|||
48525480|NCT00401245|156115252|FG002|Open Label Phase|Lost to Follow-up|5|||
48525481|NCT00401245|156115253|FG003|Open Label Phase|Lost to Follow-up|4|||
48525482|NCT00401245|156115254|FG004|Open Label Phase|Lost to Follow-up|0|||
48734459|NCT01229371|156879473|FG003|Overall Study|Withdrawal by Subject|0|||
48734460|NCT03491215|156879480|FG000|Overall Study|Death|6|||
48734461|NCT03491215|156879481|FG001|Overall Study|Death|2|||
48734462|NCT03491215|156879482|FG002|Overall Study|Death|1|||
48734463|NCT03491215|156879483|FG003|Overall Study|Death|0|||
48826892|NCT04476043|157207347|FG002|Overall Study|Withdrawal by Subject|4|||
48525483|NCT00401245|156115255|FG005|Open Label Phase|Lost to Follow-up|0|||
48525484|NCT00401245|156115256|FG006|Open Label Phase|Lost to Follow-up|0|||
48525485|NCT00401245|156115257|FG007|Open Label Phase|Lost to Follow-up|0|||
48525486|NCT00401245|156115250|FG000|Open Label Phase|Other|4|||
48525487|NCT00401245|156115251|FG001|Open Label Phase|Other|8|||
48525488|NCT00401245|156115252|FG002|Open Label Phase|Other|7|||
48826893|NCT04476043|157207348|FG003|Overall Study|Withdrawal by Subject|1|||
48826894|NCT04476043|157207345|FG000|Overall Study|Lost to Follow-up|1|||
48826895|NCT04476043|157207346|FG001|Overall Study|Lost to Follow-up|1|||
48826896|NCT04476043|157207347|FG002|Overall Study|Lost to Follow-up|2|||
48734464|NCT03491215|156879480|FG000|Overall Study|Physician Decision|1|||
48383823|NCT03239483|155601446|FG001|Overall Study|Withdrawal by Subject|0|||
48734465|NCT03491215|156879481|FG001|Overall Study|Physician Decision|0|||
48826897|NCT04476043|157207348|FG003|Overall Study|Lost to Follow-up|1|||
48734466|NCT03491215|156879482|FG002|Overall Study|Physician Decision|0|||
48734467|NCT03491215|156879483|FG003|Overall Study|Physician Decision|0|||
48734468|NCT00617851|156879484|FG000|Overall Study|Death|0|||
48734469|NCT00617851|156879485|FG001|Overall Study|Death|0|||
48734470|NCT00617851|156879486|FG002|Overall Study|Death|0|||
48734471|NCT00617851|156879487|FG003|Overall Study|Death|1|||
48734472|NCT00617851|156879484|FG000|Overall Study|Withdrawal by Subject|14|||
48734473|NCT00617851|156879485|FG001|Overall Study|Withdrawal by Subject|7|||
48734474|NCT00617851|156879486|FG002|Overall Study|Withdrawal by Subject|12|||
48734475|NCT00617851|156879487|FG003|Overall Study|Withdrawal by Subject|4|||
48734476|NCT00617851|156879484|FG000|Overall Study|Lost to Follow-up|27|||
48734477|NCT00617851|156879485|FG001|Overall Study|Lost to Follow-up|29|||
48734478|NCT00617851|156879486|FG002|Overall Study|Lost to Follow-up|31|||
48734479|NCT00617851|156879487|FG003|Overall Study|Lost to Follow-up|19|||
48734480|NCT00617851|156879484|FG000|Overall Study|Inappropriate Enrollment|5|||
48734481|NCT00617851|156879485|FG001|Overall Study|Inappropriate Enrollment|4|||
48734482|NCT00617851|156879486|FG002|Overall Study|Inappropriate Enrollment|1|||
48734483|NCT00617851|156879487|FG003|Overall Study|Inappropriate Enrollment|1|||
48734484|NCT00617851|156879484|FG000|Overall Study|Unable to classify|1|||
48734485|NCT00617851|156879485|FG001|Overall Study|Unable to classify|0|||
48734486|NCT00617851|156879486|FG002|Overall Study|Unable to classify|1|||
48734487|NCT00617851|156879487|FG003|Overall Study|Unable to classify|0|||
48734488|NCT05246397|156879488|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
48734489|NCT01676727|156879501|FG000|Overall Study|Death|18|||
48734490|NCT01676727|156879501|FG000|Overall Study|Withdrawal by Subject|6|||
48734491|NCT01676727|156879501|FG000|Overall Study|Screening failure|5|||
48734492|NCT01676727|156879501|FG000|Overall Study|Not willing to attend 1-year visit|2|||
48734493|NCT01676727|156879501|FG000|Overall Study|Valve explanted|1|||
48734494|NCT01578330|156879502|FG000|Overall Study|Adverse Event|2|||
48734495|NCT01578330|156879502|FG000|Overall Study|Protocol Violation|5|||
48734496|NCT01134731|156879503|FG000|Overall Study|Adverse Event|3|||
48734497|NCT01134731|156879504|FG001|Overall Study|Adverse Event|2|||
48734498|NCT01134731|156879505|FG002|Overall Study|Adverse Event|1|||
48734499|NCT01134731|156879503|FG000|Overall Study|Physician Decision|2|||
48734500|NCT01134731|156879504|FG001|Overall Study|Physician Decision|2|||
48734501|NCT01134731|156879505|FG002|Overall Study|Physician Decision|2|||
48734502|NCT01134731|156879503|FG000|Overall Study|Lack of Efficacy|0|||
48734503|NCT01134731|156879504|FG001|Overall Study|Lack of Efficacy|0|||
48734504|NCT01134731|156879505|FG002|Overall Study|Lack of Efficacy|1|||
48734505|NCT01134731|156879503|FG000|Overall Study|Withdrawal by Subject|3|||
48734506|NCT01134731|156879504|FG001|Overall Study|Withdrawal by Subject|3|||
48734507|NCT01134731|156879505|FG002|Overall Study|Withdrawal by Subject|1|||
48734508|NCT01134731|156879503|FG000|Overall Study|Lost to Follow-up|5|||
48734509|NCT01134731|156879504|FG001|Overall Study|Lost to Follow-up|4|||
48734510|NCT01134731|156879505|FG002|Overall Study|Lost to Follow-up|3|||
48734511|NCT01050543|156879506|FG000|Overall Study|Withdrawal by Subject|0|||
48734512|NCT01050543|156879507|FG001|Overall Study|Withdrawal by Subject|2|||
48734513|NCT01050543|156879506|FG000|Overall Study|Protocol Violation|0|||
48734514|NCT01050543|156879507|FG001|Overall Study|Protocol Violation|1|||
48734515|NCT01050543|156879506|FG000|Overall Study|Administrative|4|||
48734516|NCT01050543|156879507|FG001|Overall Study|Administrative|1|||
48734517|NCT03161093|156879508|FG000|Overall Study|Protocol Violation|11|||
48734518|NCT03161093|156879509|FG001|Overall Study|Protocol Violation|14|||
48734519|NCT03161093|156879510|FG002|Overall Study|Protocol Violation|6|||
48734520|NCT03161093|156879511|FG003|Overall Study|Protocol Violation|13|||
48734521|NCT03161093|156879512|FG004|Overall Study|Protocol Violation|1|||
48734522|NCT03161093|156879513|FG005|Overall Study|Protocol Violation|0|||
48734523|NCT03161093|156879508|FG000|Overall Study|Adverse Event|5|||
48826898|NCT04476043|157207345|FG000|Overall Study|Adverse Event|2|||
48826899|NCT04476043|157207346|FG001|Overall Study|Adverse Event|0|||
48826900|NCT04476043|157207347|FG002|Overall Study|Adverse Event|1|||
48525489|NCT00401245|156115253|FG003|Open Label Phase|Other|8|||
48525490|NCT00401245|156115254|FG004|Open Label Phase|Other|0|||
48734524|NCT03161093|156879509|FG001|Overall Study|Adverse Event|21|||
48734525|NCT03161093|156879510|FG002|Overall Study|Adverse Event|16|||
48734526|NCT03161093|156879511|FG003|Overall Study|Adverse Event|35|||
48734527|NCT03161093|156879512|FG004|Overall Study|Adverse Event|2|||
48734528|NCT03161093|156879513|FG005|Overall Study|Adverse Event|1|||
48734529|NCT03161093|156879508|FG000|Overall Study|Lack of Efficacy|9|||
48734530|NCT03161093|156879509|FG001|Overall Study|Lack of Efficacy|13|||
48734531|NCT03161093|156879510|FG002|Overall Study|Lack of Efficacy|9|||
48734532|NCT03161093|156879511|FG003|Overall Study|Lack of Efficacy|24|||
48734533|NCT03161093|156879512|FG004|Overall Study|Lack of Efficacy|4|||
48734534|NCT03161093|156879513|FG005|Overall Study|Lack of Efficacy|1|||
48826901|NCT04476043|157207348|FG003|Overall Study|Adverse Event|0|||
48525491|NCT00401245|156115255|FG005|Open Label Phase|Other|0|||
48734535|NCT03161093|156879508|FG000|Overall Study|Physician Decision|0|||
48734536|NCT03161093|156879509|FG001|Overall Study|Physician Decision|1|||
48734537|NCT03161093|156879510|FG002|Overall Study|Physician Decision|0|||
48826902|NCT04476043|157207345|FG000|Overall Study|Protocol Violation|0|||
48525492|NCT00401245|156115256|FG006|Open Label Phase|Other|0|||
48525493|NCT00401245|156115257|FG007|Open Label Phase|Other|0|||
48525494|NCT00401245|156115250|FG000|Open Label Phase|Protocol Violation|0|||
48525495|NCT00401245|156115251|FG001|Open Label Phase|Protocol Violation|1|||
48525496|NCT00401245|156115252|FG002|Open Label Phase|Protocol Violation|0|||
48826903|NCT04476043|157207346|FG001|Overall Study|Protocol Violation|1|||
48826904|NCT04476043|157207347|FG002|Overall Study|Protocol Violation|0|||
48826905|NCT04476043|157207348|FG003|Overall Study|Protocol Violation|0|||
48826906|NCT00940017|157207349|FG000|Overall Study|did not meet entrance criteria|3|||
48525497|NCT00401245|156115253|FG003|Open Label Phase|Protocol Violation|1|||
48525498|NCT00401245|156115254|FG004|Open Label Phase|Protocol Violation|0|||
48525499|NCT00401245|156115255|FG005|Open Label Phase|Protocol Violation|0|||
48525500|NCT00401245|156115256|FG006|Open Label Phase|Protocol Violation|0|||
48525501|NCT00401245|156115257|FG007|Open Label Phase|Protocol Violation|0|||
48525502|NCT00401245|156115250|FG000|Open Label Phase|Withdrawal by Subject|3|||
48525503|NCT00401245|156115251|FG001|Open Label Phase|Withdrawal by Subject|3|||
48525504|NCT00401245|156115252|FG002|Open Label Phase|Withdrawal by Subject|2|||
48525505|NCT00401245|156115253|FG003|Open Label Phase|Withdrawal by Subject|1|||
48525506|NCT00401245|156115254|FG004|Open Label Phase|Withdrawal by Subject|0|||
48525507|NCT00401245|156115255|FG005|Open Label Phase|Withdrawal by Subject|0|||
48525508|NCT00401245|156115256|FG006|Open Label Phase|Withdrawal by Subject|0|||
48525509|NCT00401245|156115257|FG007|Open Label Phase|Withdrawal by Subject|0|||
48525510|NCT00401245|156115250|FG000|Open Label Phase|Lack of Efficacy|4|||
48525511|NCT00401245|156115251|FG001|Open Label Phase|Lack of Efficacy|2|||
48525512|NCT00401245|156115252|FG002|Open Label Phase|Lack of Efficacy|3|||
48525513|NCT00401245|156115253|FG003|Open Label Phase|Lack of Efficacy|0|||
48525514|NCT00401245|156115254|FG004|Open Label Phase|Lack of Efficacy|0|||
48525515|NCT00401245|156115255|FG005|Open Label Phase|Lack of Efficacy|0|||
48525516|NCT00401245|156115256|FG006|Open Label Phase|Lack of Efficacy|0|||
48525517|NCT00401245|156115257|FG007|Open Label Phase|Lack of Efficacy|0|||
48525518|NCT00401245|156115250|FG000|Double Blind Tapering Phase|Adverse Event|0|||
48525519|NCT00401245|156115251|FG001|Double Blind Tapering Phase|Adverse Event|0|||
48525520|NCT00401245|156115252|FG002|Double Blind Tapering Phase|Adverse Event|0|||
48525521|NCT00401245|156115253|FG003|Double Blind Tapering Phase|Adverse Event|0|||
48525522|NCT00401245|156115254|FG004|Double Blind Tapering Phase|Adverse Event|1|||
48525523|NCT00401245|156115255|FG005|Double Blind Tapering Phase|Adverse Event|1|||
48525524|NCT00401245|156115256|FG006|Double Blind Tapering Phase|Adverse Event|2|||
48525525|NCT00401245|156115257|FG007|Double Blind Tapering Phase|Adverse Event|4|||
48525526|NCT00401245|156115250|FG000|Double Blind Tapering Phase|Investigator request|0|||
48525527|NCT00401245|156115251|FG001|Double Blind Tapering Phase|Investigator request|0|||
48525528|NCT00401245|156115252|FG002|Double Blind Tapering Phase|Investigator request|0|||
48525529|NCT00401245|156115253|FG003|Double Blind Tapering Phase|Investigator request|0|||
48525530|NCT00401245|156115254|FG004|Double Blind Tapering Phase|Investigator request|0|||
48525531|NCT00401245|156115255|FG005|Double Blind Tapering Phase|Investigator request|0|||
48525532|NCT00401245|156115256|FG006|Double Blind Tapering Phase|Investigator request|0|||
48525533|NCT00401245|156115257|FG007|Double Blind Tapering Phase|Investigator request|1|||
48525534|NCT00401245|156115250|FG000|Double Blind Tapering Phase|Other|0|||
48525535|NCT00401245|156115251|FG001|Double Blind Tapering Phase|Other|0|||
48525536|NCT00401245|156115252|FG002|Double Blind Tapering Phase|Other|0|||
48525537|NCT00401245|156115253|FG003|Double Blind Tapering Phase|Other|0|||
48525538|NCT00401245|156115254|FG004|Double Blind Tapering Phase|Other|1|||
48525539|NCT00401245|156115255|FG005|Double Blind Tapering Phase|Other|0|||
48525540|NCT00401245|156115256|FG006|Double Blind Tapering Phase|Other|2|||
48525541|NCT00401245|156115257|FG007|Double Blind Tapering Phase|Other|2|||
48525542|NCT00401245|156115250|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
48525543|NCT00401245|156115251|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
48525544|NCT00401245|156115252|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
48525545|NCT00401245|156115253|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
48525546|NCT00401245|156115254|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
48525547|NCT00401245|156115255|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
48525548|NCT00401245|156115256|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
48525549|NCT00401245|156115257|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
48525550|NCT00401245|156115250|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
48525551|NCT00401245|156115251|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
48826907|NCT00940017|157207349|FG000|Overall Study|Adverse Event|1|||
48826908|NCT01450943|157207352|FG000|Overall Study|Screen failure, loss to follow-up|2|||
48826909|NCT01450943|157207353|FG001|Overall Study|Screen failure, loss to follow-up|7|||
48525552|NCT00401245|156115252|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
48525553|NCT00401245|156115253|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
48525554|NCT00401245|156115254|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
48525555|NCT00401245|156115255|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
48525556|NCT00401245|156115256|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
48525557|NCT00401245|156115257|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
48826910|NCT01450943|157207354|FG002|Overall Study|Screen failure, loss to follow-up|6|||
48525558|NCT00685035|156115259|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
48525559|NCT00685035|156115260|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
48525560|NCT01463982|156115261|FG000|Overall Study|Withdrawal by Subject|0|||
48525561|NCT01463982|156115262|FG001|Overall Study|Withdrawal by Subject|1|||
48525562|NCT01463982|156115263|FG002|Overall Study|Withdrawal by Subject|1|||
48525563|NCT01463982|156115264|FG003|Overall Study|Withdrawal by Subject|0|||
48525564|NCT01463982|156115261|FG000|Overall Study|Treatment delay over 5 week|0|||
48734538|NCT03161093|156879511|FG003|Overall Study|Physician Decision|2|||
48734539|NCT03161093|156879512|FG004|Overall Study|Physician Decision|17|||
48734540|NCT03161093|156879513|FG005|Overall Study|Physician Decision|15|||
48734541|NCT03161093|156879508|FG000|Overall Study|Withdrawal by Subject|24|||
48734542|NCT03161093|156879509|FG001|Overall Study|Withdrawal by Subject|73|||
48734543|NCT03161093|156879510|FG002|Overall Study|Withdrawal by Subject|44|||
48734544|NCT03161093|156879511|FG003|Overall Study|Withdrawal by Subject|97|||
48734545|NCT03161093|156879512|FG004|Overall Study|Withdrawal by Subject|11|||
48734546|NCT03161093|156879513|FG005|Overall Study|Withdrawal by Subject|10|||
48734547|NCT03161093|156879508|FG000|Overall Study|Lost to Follow-up|3|||
48734548|NCT03161093|156879509|FG001|Overall Study|Lost to Follow-up|12|||
48734549|NCT03161093|156879510|FG002|Overall Study|Lost to Follow-up|4|||
48734550|NCT03161093|156879511|FG003|Overall Study|Lost to Follow-up|7|||
48734551|NCT03161093|156879512|FG004|Overall Study|Lost to Follow-up|8|||
48734552|NCT03161093|156879513|FG005|Overall Study|Lost to Follow-up|13|||
48734553|NCT03161093|156879508|FG000|Overall Study|Death|3|||
48734554|NCT03161093|156879509|FG001|Overall Study|Death|9|||
48734555|NCT03161093|156879510|FG002|Overall Study|Death|7|||
48734556|NCT03161093|156879511|FG003|Overall Study|Death|9|||
48734557|NCT03161093|156879512|FG004|Overall Study|Death|0|||
48734558|NCT03161093|156879513|FG005|Overall Study|Death|0|||
48734559|NCT03161093|156879508|FG000|Overall Study|Unknown - Not reported|0|||
48734560|NCT03161093|156879509|FG001|Overall Study|Unknown - Not reported|1|||
48734561|NCT03161093|156879510|FG002|Overall Study|Unknown - Not reported|0|||
48734562|NCT03161093|156879511|FG003|Overall Study|Unknown - Not reported|0|||
48734563|NCT03161093|156879512|FG004|Overall Study|Unknown - Not reported|0|||
48734564|NCT03161093|156879513|FG005|Overall Study|Unknown - Not reported|1|||
48734565|NCT01031706|156879514|FG000|Overall Study|Adverse Event|1|||
48734566|NCT01031706|156879515|FG001|Overall Study|Adverse Event|0|||
48734567|NCT01031706|156879514|FG000|Overall Study|Withdrawal by Subject|1|||
48734568|NCT01031706|156879515|FG001|Overall Study|Withdrawal by Subject|1|||
48734569|NCT02758171|156879520|FG000|Wash-out|Withdrawal by Subject|1|||
48734570|NCT02758171|156879521|FG001|Wash-out|Withdrawal by Subject|0|||
48734571|NCT02758171|156879520|FG000|Wash-out|Other reason|1|||
48734572|NCT02758171|156879521|FG001|Wash-out|Other reason|0|||
48734573|NCT01309165|156879522|FG000|Overall Study|Lost to Follow-up|4|||
48734574|NCT01309165|156879523|FG001|Overall Study|Lost to Follow-up|3|||
48734575|NCT01309165|156879522|FG000|Overall Study|Return to work|1|||
48734576|NCT01309165|156879523|FG001|Overall Study|Return to work|2|||
48734577|NCT01309165|156879522|FG000|Overall Study|Left country|0|||
48734578|NCT01309165|156879523|FG001|Overall Study|Left country|1|||
48734579|NCT01309165|156879522|FG000|Overall Study|No transportation|0|||
48734580|NCT01309165|156879523|FG001|Overall Study|No transportation|1|||
48734581|NCT01309165|156879522|FG000|Overall Study|Admitted to hospital for second stroke|1|||
48734582|NCT01309165|156879523|FG001|Overall Study|Admitted to hospital for second stroke|0|||
48734583|NCT01497275|156879524|FG000|Overall Study|Death|1|||
48734584|NCT01497275|156879524|FG000|Overall Study|Adverse Event|1|||
48734585|NCT00437320|156879525|FG000|Overall Study|Participant request|2|||
48734586|NCT00437320|156879526|FG001|Overall Study|Participant request|1|||
48734587|NCT00437320|156879527|FG002|Overall Study|Participant request|4|||
48734588|NCT01495975|156879528|FG000|Overall Study|Lost to Follow-up|1|||
48734589|NCT01495975|156879529|FG001|Overall Study|Lost to Follow-up|0|||
48734590|NCT00808483|156879530|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
48734591|NCT00808483|156879531|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
48734592|NCT00808483|156879530|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
48734593|NCT00808483|156879531|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
48826911|NCT02790606|157207361|FG000|Overall Study|Death|27|||
48826912|NCT02790606|157207361|FG000|Overall Study|Lost to Follow-up|4|||
48734594|NCT00808483|156879530|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
48734595|NCT00808483|156879531|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
48525565|NCT01463982|156115262|FG001|Overall Study|Treatment delay over 5 week|0|||
48734596|NCT02357979|156879532|FG000|Overall Study|Lost to Follow-up|5|||
48826913|NCT02790606|157207361|FG000|Overall Study|Physician Decision|3|||
48734597|NCT02357979|156879533|FG001|Overall Study|Lost to Follow-up|5|||
48734598|NCT04810481|156879538|FG000|Overall Study|Disqualified data sets|10|||
48734599|NCT04810481|156879539|FG001|Overall Study|Disqualified data sets|28|||
48734600|NCT01123850|156879540|FG000|Overall Study|Slow enrollment|45|||
48734601|NCT01024231|156879546|FG000|Overall Study|Other Reasons|1|||
48734602|NCT01024231|156879547|FG001|Overall Study|Other Reasons|2|||
48734603|NCT01024231|156879548|FG002|Overall Study|Other Reasons|0|||
48826914|NCT02790606|157207361|FG000|Overall Study|Withdrawal by Subject|1|||
48734604|NCT01024231|156879549|FG003|Overall Study|Other Reasons|0|||
48734605|NCT01024231|156879550|FG004|Overall Study|Other Reasons|2|||
48734606|NCT01024231|156879551|FG005|Overall Study|Other Reasons|0|||
48734607|NCT01024231|156879552|FG006|Overall Study|Other Reasons|1|||
48734608|NCT01024231|156879546|FG000|Overall Study|Maximum Clinical Benefit|1|||
48734609|NCT01024231|156879547|FG001|Overall Study|Maximum Clinical Benefit|2|||
48734610|NCT01024231|156879548|FG002|Overall Study|Maximum Clinical Benefit|0|||
48734611|NCT01024231|156879549|FG003|Overall Study|Maximum Clinical Benefit|1|||
48734612|NCT01024231|156879550|FG004|Overall Study|Maximum Clinical Benefit|1|||
48734613|NCT01024231|156879551|FG005|Overall Study|Maximum Clinical Benefit|0|||
48734614|NCT01024231|156879552|FG006|Overall Study|Maximum Clinical Benefit|0|||
48734615|NCT01024231|156879546|FG000|Overall Study|Disease Progression|3|||
48734616|NCT01024231|156879547|FG001|Overall Study|Disease Progression|1|||
48734617|NCT01024231|156879548|FG002|Overall Study|Disease Progression|3|||
48734618|NCT01024231|156879549|FG003|Overall Study|Disease Progression|0|||
48734619|NCT01024231|156879550|FG004|Overall Study|Disease Progression|4|||
48525566|NCT01463982|156115263|FG002|Overall Study|Treatment delay over 5 week|1|||
48525567|NCT01463982|156115264|FG003|Overall Study|Treatment delay over 5 week|0|||
48525568|NCT03069417|156115269|FG000|Overall Study|Lost to Follow-up|2|||
48525569|NCT03069417|156115270|FG001|Overall Study|Lost to Follow-up|0|||
48525570|NCT03069417|156115269|FG000|Overall Study|Reason Unknown|4|||
48525571|NCT03069417|156115270|FG001|Overall Study|Reason Unknown|7|||
48525572|NCT00685750|156115271|FG000|Overall Study|Tumor sampling failure|0|||
48525573|NCT00685750|156115272|FG001|Overall Study|Tumor sampling failure|0|||
48525574|NCT00685750|156115273|FG002|Overall Study|Tumor sampling failure|1|||
48525575|NCT00685750|156115274|FG003|Overall Study|Tumor sampling failure|0|||
48525576|NCT00685750|156115275|FG004|Overall Study|Tumor sampling failure|0|||
48525577|NCT00685750|156115276|FG005|Overall Study|Tumor sampling failure|0|||
48525578|NCT00685750|156115277|FG006|Overall Study|Tumor sampling failure|0|||
48525579|NCT00685750|156115271|FG000|Overall Study|Patient didn't receive the treatment|0|||
48525580|NCT00685750|156115272|FG001|Overall Study|Patient didn't receive the treatment|0|||
48525581|NCT00685750|156115273|FG002|Overall Study|Patient didn't receive the treatment|0|||
48525582|NCT00685750|156115274|FG003|Overall Study|Patient didn't receive the treatment|0|||
48525583|NCT00685750|156115275|FG004|Overall Study|Patient didn't receive the treatment|0|||
48525584|NCT00685750|156115276|FG005|Overall Study|Patient didn't receive the treatment|0|||
48525585|NCT00685750|156115277|FG006|Overall Study|Patient didn't receive the treatment|1|||
48525586|NCT00685750|156115271|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48525587|NCT00685750|156115272|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48525588|NCT00685750|156115273|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
48525589|NCT00685750|156115274|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
48525590|NCT00685750|156115275|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
48525591|NCT00685750|156115276|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
48525592|NCT00685750|156115277|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
48525593|NCT00587431|156115280|FG000|Overall Study|Adverse Event|1|||
48525594|NCT00587431|156115281|FG001|Overall Study|Adverse Event|0|||
48525595|NCT00587431|156115280|FG000|Overall Study|Withdrawal by Subject|0|||
48525596|NCT00587431|156115281|FG001|Overall Study|Withdrawal by Subject|1|||
48525597|NCT02297841|156115290|FG000|Overall Study|Withdrawal by Subject|1|||
48525598|NCT02297841|156115290|FG000|Overall Study|Protocol Violation|7|||
48525599|NCT02466386|156115291|FG000|Overall Study|Adverse Event|5|||
48525600|NCT02466386|156115291|FG000|Overall Study|Protocol Violation|2|||
48525601|NCT02466386|156115291|FG000|Overall Study|Withdrawal by Subject|14|||
48525602|NCT02466386|156115291|FG000|Overall Study|Lost to Follow-up|5|||
48602099|NCT03327324|156399522|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602100|NCT03327324|156399523|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602101|NCT03327324|156399524|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
48602102|NCT03327324|156399519|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
48602103|NCT03327324|156399520|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
48602104|NCT03327324|156399521|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
48602105|NCT03327324|156399522|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
48734620|NCT01024231|156879551|FG005|Overall Study|Disease Progression|11|||
48734621|NCT01024231|156879552|FG006|Overall Study|Disease Progression|6|||
48734622|NCT01024231|156879546|FG000|Overall Study|AE unrelated to Study Drug|0|||
48734623|NCT01024231|156879547|FG001|Overall Study|AE unrelated to Study Drug|1|||
48525603|NCT02466386|156115291|FG000|Overall Study|Lack of Efficacy|8|||
48525604|NCT02466386|156115291|FG000|Overall Study|Other|10|||
48525605|NCT05317195|156115306|FG000|Randomization|Withdrawal by Subject|1|||
48525606|NCT05317195|156115306|FG000|Randomization|Discontinued|6|||
48734624|NCT01024231|156879548|FG002|Overall Study|AE unrelated to Study Drug|0|||
48734625|NCT01024231|156879549|FG003|Overall Study|AE unrelated to Study Drug|0|||
48734626|NCT01024231|156879550|FG004|Overall Study|AE unrelated to Study Drug|0|||
48734627|NCT01024231|156879551|FG005|Overall Study|AE unrelated to Study Drug|0|||
48734628|NCT01024231|156879552|FG006|Overall Study|AE unrelated to Study Drug|0|||
48734629|NCT01024231|156879546|FG000|Overall Study|No longer meets criteria|0|||
48734630|NCT01024231|156879547|FG001|Overall Study|No longer meets criteria|0|||
48734631|NCT01024231|156879548|FG002|Overall Study|No longer meets criteria|0|||
48734632|NCT01024231|156879549|FG003|Overall Study|No longer meets criteria|0|||
48734633|NCT01024231|156879550|FG004|Overall Study|No longer meets criteria|1|||
48734634|NCT01024231|156879551|FG005|Overall Study|No longer meets criteria|0|||
48734635|NCT01024231|156879552|FG006|Overall Study|No longer meets criteria|1|||
48734636|NCT01024231|156879546|FG000|Overall Study|Study Drug Toxicity|1|||
48734637|NCT01024231|156879547|FG001|Overall Study|Study Drug Toxicity|6|||
48734638|NCT01024231|156879548|FG002|Overall Study|Study Drug Toxicity|6|||
48734639|NCT01024231|156879549|FG003|Overall Study|Study Drug Toxicity|4|||
48734640|NCT01024231|156879550|FG004|Overall Study|Study Drug Toxicity|2|||
48734641|NCT01024231|156879551|FG005|Overall Study|Study Drug Toxicity|0|||
48734642|NCT01024231|156879552|FG006|Overall Study|Study Drug Toxicity|7|||
48734643|NCT01024231|156879546|FG000|Overall Study|Death|6|||
48734644|NCT01024231|156879547|FG001|Overall Study|Death|2|||
48734645|NCT01024231|156879548|FG002|Overall Study|Death|1|||
48734646|NCT01024231|156879549|FG003|Overall Study|Death|0|||
48734647|NCT01024231|156879550|FG004|Overall Study|Death|4|||
48734648|NCT01024231|156879551|FG005|Overall Study|Death|3|||
48734649|NCT01024231|156879552|FG006|Overall Study|Death|5|||
48734650|NCT01024231|156879546|FG000|Overall Study|Lost to Follow-up|0|||
48734651|NCT01024231|156879547|FG001|Overall Study|Lost to Follow-up|0|||
48734652|NCT01024231|156879548|FG002|Overall Study|Lost to Follow-up|0|||
48734653|NCT01024231|156879549|FG003|Overall Study|Lost to Follow-up|0|||
48734654|NCT01024231|156879550|FG004|Overall Study|Lost to Follow-up|0|||
48734655|NCT01024231|156879551|FG005|Overall Study|Lost to Follow-up|0|||
48734656|NCT01024231|156879552|FG006|Overall Study|Lost to Follow-up|1|||
48734657|NCT01024231|156879546|FG000|Overall Study|Withdrew Consent|0|||
48734658|NCT01024231|156879547|FG001|Overall Study|Withdrew Consent|1|||
48734659|NCT01024231|156879548|FG002|Overall Study|Withdrew Consent|0|||
48734660|NCT01024231|156879549|FG003|Overall Study|Withdrew Consent|0|||
48734661|NCT01024231|156879550|FG004|Overall Study|Withdrew Consent|0|||
48734662|NCT01024231|156879551|FG005|Overall Study|Withdrew Consent|0|||
48734663|NCT01024231|156879552|FG006|Overall Study|Withdrew Consent|0|||
48734664|NCT01024231|156879546|FG000|Overall Study|Continuing on Treatment|0|||
48734665|NCT01024231|156879547|FG001|Overall Study|Continuing on Treatment|0|||
48734666|NCT01024231|156879548|FG002|Overall Study|Continuing on Treatment|0|||
48734667|NCT01024231|156879549|FG003|Overall Study|Continuing on Treatment|0|||
48734668|NCT01024231|156879550|FG004|Overall Study|Continuing on Treatment|3|||
48734669|NCT01024231|156879551|FG005|Overall Study|Continuing on Treatment|2|||
48734670|NCT01024231|156879552|FG006|Overall Study|Continuing on Treatment|0|||
48734671|NCT02435147|156879553|FG000|Overall Study|non-evaluable DXA scan|11|||
48734672|NCT04439344|156879554|FG000|Overall Study|Never started threapy|3|||
48734673|NCT04439344|156879554|FG000|Overall Study|Ineligible|3|||
48734674|NCT04439344|156879554|FG000|Overall Study|Adverse Event|13|||
48734675|NCT04439344|156879554|FG000|Overall Study|Death|2|||
48734676|NCT04439344|156879554|FG000|Overall Study|Disease progression|29|||
48734677|NCT04439344|156879554|FG000|Overall Study|Withdrawal by Subject|2|||
48734678|NCT04439344|156879554|FG000|Overall Study|Alternative therapy|1|||
48734679|NCT01281137|156879557|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
48734680|NCT01281137|156879558|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
48734681|NCT01281137|156879557|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
48734682|NCT01281137|156879558|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
48734683|NCT01281137|156879557|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
48734684|NCT01281137|156879558|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
48734685|NCT01281137|156879557|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
48826915|NCT02652130|157207362|FG000|Overall Study|Death|1|||
48826916|NCT01941316|157207363|FG000|Overall Study|Adverse Event|0|||
48826917|NCT01941316|157207364|FG001|Overall Study|Adverse Event|1|||
48826918|NCT01941316|157207365|FG002|Overall Study|Adverse Event|0|||
48826919|NCT01941316|157207366|FG003|Overall Study|Adverse Event|7|||
48826920|NCT01941316|157207363|FG000|Overall Study|Progressive Disease|3|||
48826921|NCT01941316|157207364|FG001|Overall Study|Progressive Disease|6|||
48525607|NCT05317195|156115306|FG000|Admission|Withdrawal by Subject|2|||
48826922|NCT01941316|157207365|FG002|Overall Study|Progressive Disease|2|||
48525608|NCT01009515|156115308|FG000|Overall Study|Withdrawal by Subject|3|||
48826923|NCT01941316|157207366|FG003|Overall Study|Progressive Disease|29|||
48826924|NCT01941316|157207363|FG000|Overall Study|Withdrawal by Subject|0|||
48734686|NCT01281137|156879558|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
48525609|NCT00983476|156115314|FG000|Overall Study|Did not receive intervention|17|||
48525610|NCT00983476|156115315|FG001|Overall Study|Did not receive intervention|22|||
48525611|NCT00983476|156115316|FG002|Overall Study|Did not receive intervention|0|||
48525612|NCT00761176|156115317|FG000|Overall Study|Death|1|||
48525613|NCT00761176|156115318|FG001|Overall Study|Death|0|||
48525614|NCT00761176|156115317|FG000|Overall Study|Withdrawal by Subject|1|||
48525615|NCT00761176|156115318|FG001|Overall Study|Withdrawal by Subject|1|||
48525616|NCT02762994|156115321|FG000|Overall Study|Withdrawal by Subject|0|||
48525617|NCT02762994|156115322|FG001|Overall Study|Withdrawal by Subject|1|||
48525618|NCT02762994|156115323|FG002|Overall Study|Withdrawal by Subject|2|||
48525619|NCT02762994|156115324|FG003|Overall Study|Withdrawal by Subject|0|||
48525620|NCT02762994|156115321|FG000|Overall Study|Protocol Violation|1|||
48525621|NCT02762994|156115322|FG001|Overall Study|Protocol Violation|0|||
48525622|NCT02762994|156115323|FG002|Overall Study|Protocol Violation|0|||
48525623|NCT02762994|156115324|FG003|Overall Study|Protocol Violation|2|||
48525624|NCT05103657|156115325|FG000|Overall Study|Other reasons than listed|9|||
48525625|NCT05103657|156115326|FG001|Overall Study|Other reasons than listed|8|||
48525626|NCT05103657|156115325|FG000|Overall Study|Protocol deviation|2|||
48525627|NCT05103657|156115326|FG001|Overall Study|Protocol deviation|2|||
48525628|NCT05103657|156115325|FG000|Overall Study|No reason available|5|||
48525629|NCT05103657|156115326|FG001|Overall Study|No reason available|4|||
48525630|NCT05103657|156115325|FG000|Overall Study|Burden of study procedures|3|||
48525631|NCT05103657|156115326|FG001|Overall Study|Burden of study procedures|1|||
48525632|NCT05103657|156115325|FG000|Overall Study|Perceived lack of efficacy|1|||
48525633|NCT05103657|156115326|FG001|Overall Study|Perceived lack of efficacy|1|||
48525634|NCT05103657|156115325|FG000|Overall Study|Adverse Event|6|||
48525635|NCT05103657|156115326|FG001|Overall Study|Adverse Event|14|||
48525636|NCT05103657|156115325|FG000|Overall Study|Not Treated|1|||
48525637|NCT05103657|156115326|FG001|Overall Study|Not Treated|1|||
48525638|NCT01175473|156115327|FG000|Overall Study|Adverse Event|2|||
48525639|NCT01175473|156115328|FG001|Overall Study|Adverse Event|2|||
48525640|NCT02020967|156115331|FG000|Overall Study|Withdrawal by Subject|51|||
48525641|NCT02674386|156115332|FG000|Overall Study|Lost to Follow-up|0|||
48525642|NCT02674386|156115333|FG001|Overall Study|Lost to Follow-up|1|||
48525643|NCT02674386|156115334|FG002|Overall Study|Lost to Follow-up|1|||
48525644|NCT02674386|156115332|FG000|Overall Study|Withdrawal by Subject|0|||
48525645|NCT02674386|156115333|FG001|Overall Study|Withdrawal by Subject|4|||
48525646|NCT02674386|156115334|FG002|Overall Study|Withdrawal by Subject|0|||
48525647|NCT02674386|156115332|FG000|Overall Study|Other|0|||
48525648|NCT02674386|156115333|FG001|Overall Study|Other|1|||
48525649|NCT02674386|156115334|FG002|Overall Study|Other|0|||
48525650|NCT02674386|156115332|FG000|Overall Study|Enrolled but not evaluated|0|||
48525651|NCT02674386|156115333|FG001|Overall Study|Enrolled but not evaluated|4|||
48525652|NCT02674386|156115334|FG002|Overall Study|Enrolled but not evaluated|0|||
48734687|NCT01281137|156879557|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
48734688|NCT01281137|156879558|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
48734689|NCT00299182|156879559|FG000|Overall Study|Withdrawal by Subject|0|||
48734690|NCT00299182|156879560|FG001|Overall Study|Withdrawal by Subject|0|||
48734691|NCT00299182|156879561|FG002|Overall Study|Withdrawal by Subject|1|||
48734692|NCT00299182|156879562|FG003|Overall Study|Withdrawal by Subject|0|||
48734693|NCT00299182|156879563|FG004|Overall Study|Withdrawal by Subject|1|||
48734694|NCT00299182|156879564|FG005|Overall Study|Withdrawal by Subject|2|||
48734695|NCT00299182|156879565|FG006|Overall Study|Withdrawal by Subject|0|||
48734696|NCT00299182|156879559|FG000|Overall Study|Chemotherapy Changed|0|||
48734697|NCT00299182|156879560|FG001|Overall Study|Chemotherapy Changed|0|||
48734698|NCT00299182|156879561|FG002|Overall Study|Chemotherapy Changed|1|||
48734699|NCT00299182|156879562|FG003|Overall Study|Chemotherapy Changed|0|||
48734700|NCT00299182|156879563|FG004|Overall Study|Chemotherapy Changed|1|||
48734701|NCT00299182|156879564|FG005|Overall Study|Chemotherapy Changed|0|||
48734702|NCT00299182|156879565|FG006|Overall Study|Chemotherapy Changed|1|||
48734703|NCT00299182|156879559|FG000|Overall Study|Adverse Event|0|||
48525653|NCT02462486|156115335|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
48525654|NCT02462486|156115336|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
48525655|NCT02462486|156115337|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
48525656|NCT02462486|156115335|FG000|Overall Study|Adverse Event|53|||
48525657|NCT02462486|156115336|FG001|Overall Study|Adverse Event|48|||
48525658|NCT02462486|156115337|FG002|Overall Study|Adverse Event|21|||
48525659|NCT02462486|156115335|FG000|Overall Study|Lack of Efficacy|6|||
48525660|NCT02462486|156115336|FG001|Overall Study|Lack of Efficacy|12|||
48525661|NCT02462486|156115337|FG002|Overall Study|Lack of Efficacy|3|||
48525662|NCT02462486|156115335|FG000|Overall Study|Lost to Follow-up|3|||
48525663|NCT02462486|156115336|FG001|Overall Study|Lost to Follow-up|4|||
48525664|NCT02462486|156115337|FG002|Overall Study|Lost to Follow-up|2|||
48525665|NCT02462486|156115335|FG000|Overall Study|Withdrawal by Subject|25|||
48525666|NCT02462486|156115336|FG001|Overall Study|Withdrawal by Subject|22|||
48525667|NCT02462486|156115337|FG002|Overall Study|Withdrawal by Subject|19|||
48734704|NCT00299182|156879560|FG001|Overall Study|Adverse Event|0|||
48734705|NCT00299182|156879561|FG002|Overall Study|Adverse Event|0|||
48826925|NCT01941316|157207364|FG001|Overall Study|Withdrawal by Subject|2|||
48826926|NCT01941316|157207365|FG002|Overall Study|Withdrawal by Subject|1|||
48826927|NCT01941316|157207366|FG003|Overall Study|Withdrawal by Subject|8|||
48826928|NCT01941316|157207363|FG000|Overall Study|Death|0|||
48826929|NCT01941316|157207364|FG001|Overall Study|Death|0|||
48826930|NCT01941316|157207365|FG002|Overall Study|Death|0|||
48826931|NCT01941316|157207366|FG003|Overall Study|Death|3|||
48826932|NCT01941316|157207363|FG000|Overall Study|Physician Decision|0|||
48826933|NCT01941316|157207364|FG001|Overall Study|Physician Decision|0|||
48826934|NCT01941316|157207365|FG002|Overall Study|Physician Decision|0|||
48826935|NCT01941316|157207366|FG003|Overall Study|Physician Decision|3|||
48826936|NCT01941316|157207363|FG000|Overall Study|Protocol Violation|0|||
48525668|NCT02462486|156115335|FG000|Overall Study|Protocol Violation|3|||
48525669|NCT02462486|156115336|FG001|Overall Study|Protocol Violation|1|||
48525670|NCT02462486|156115337|FG002|Overall Study|Protocol Violation|1|||
48525671|NCT02462486|156115335|FG000|Overall Study|Reason not Specified|3|||
48525672|NCT02462486|156115336|FG001|Overall Study|Reason not Specified|4|||
48525673|NCT02462486|156115337|FG002|Overall Study|Reason not Specified|3|||
48525674|NCT00585312|156115338|FG000|Overall Study|Adverse Event|3|||
48525675|NCT00585312|156115339|FG001|Overall Study|Adverse Event|0|||
48525676|NCT00585312|156115338|FG000|Overall Study|Lack of Efficacy|6|||
48525677|NCT00585312|156115339|FG001|Overall Study|Lack of Efficacy|11|||
48525678|NCT00585312|156115338|FG000|Overall Study|Lost to Follow-up|1|||
48525679|NCT00585312|156115339|FG001|Overall Study|Lost to Follow-up|1|||
48525680|NCT00585312|156115338|FG000|Overall Study|Reason not specified|2|||
48525681|NCT00585312|156115339|FG001|Overall Study|Reason not specified|0|||
48525682|NCT00585312|156115338|FG000|Overall Study|Withdrawal by Subject|5|||
48525683|NCT00585312|156115339|FG001|Overall Study|Withdrawal by Subject|1|||
48525684|NCT00585312|156115338|FG000|Overall Study|Study terminated by the sponsor|34|||
48525685|NCT00585312|156115339|FG001|Overall Study|Study terminated by the sponsor|31|||
48525686|NCT00109850|156115346|FG000|Overall Study|Adverse Event|1|||
48525687|NCT00109850|156115346|FG000|Overall Study|Death|2|||
48525688|NCT00109850|156115346|FG000|Overall Study|Ineligible|1|||
48525689|NCT02310763|156115349|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
48734706|NCT00299182|156879562|FG003|Overall Study|Adverse Event|0|||
48734707|NCT00299182|156879563|FG004|Overall Study|Adverse Event|0|||
48734708|NCT00299182|156879564|FG005|Overall Study|Adverse Event|1|||
48734709|NCT00299182|156879565|FG006|Overall Study|Adverse Event|0|||
48734710|NCT00299182|156879559|FG000|Overall Study|Not Eligible|0|||
48734711|NCT00299182|156879560|FG001|Overall Study|Not Eligible|0|||
48734712|NCT00299182|156879561|FG002|Overall Study|Not Eligible|0|||
48734713|NCT00299182|156879562|FG003|Overall Study|Not Eligible|0|||
48734714|NCT00299182|156879563|FG004|Overall Study|Not Eligible|1|||
48734715|NCT00299182|156879564|FG005|Overall Study|Not Eligible|0|||
48734716|NCT00299182|156879565|FG006|Overall Study|Not Eligible|0|||
48734717|NCT00669396|156879568|FG000|Overall Study|Lost to Follow-up|10|||
48734718|NCT00669396|156879569|FG001|Overall Study|Lost to Follow-up|12|||
48734719|NCT02635776|156879577|FG000|Overall Study|Physician Decision|1|||
48734720|NCT02635776|156879578|FG001|Overall Study|Physician Decision|0|||
48734721|NCT02635776|156879577|FG000|Overall Study|Adverse Event|51|||
48734722|NCT02635776|156879578|FG001|Overall Study|Adverse Event|3|||
48734723|NCT02635776|156879577|FG000|Overall Study|Withdrawal by Subject|41|||
48734724|NCT02635776|156879578|FG001|Overall Study|Withdrawal by Subject|7|||
48734725|NCT02635776|156879577|FG000|Overall Study|Lost to Follow-up|4|||
48734726|NCT02635776|156879578|FG001|Overall Study|Lost to Follow-up|0|||
48734727|NCT02635776|156879577|FG000|Overall Study|Other reasons|5|||
48734728|NCT02635776|156879578|FG001|Overall Study|Other reasons|1|||
48734729|NCT00910273|156879579|FG000|Overall Study|Lack of Efficacy|6|||
48734730|NCT00910273|156879580|FG001|Overall Study|Lack of Efficacy|9|||
48734731|NCT00910273|156879579|FG000|Overall Study|Adverse Event|1|||
48734732|NCT00910273|156879580|FG001|Overall Study|Adverse Event|1|||
48734733|NCT00910273|156879579|FG000|Overall Study|Withdrawal by Subject|1|||
48734734|NCT00910273|156879580|FG001|Overall Study|Withdrawal by Subject|0|||
48734735|NCT00910273|156879579|FG000|Overall Study|Discontinuation of study by sponsor|8|||
48734736|NCT00910273|156879580|FG001|Overall Study|Discontinuation of study by sponsor|2|||
48734737|NCT00910273|156879579|FG000|Overall Study|Protocol Violation|1|||
48826937|NCT01941316|157207364|FG001|Overall Study|Protocol Violation|0|||
48826938|NCT01941316|157207365|FG002|Overall Study|Protocol Violation|0|||
48525690|NCT02310763|156115350|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
48525691|NCT02310763|156115351|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
48525692|NCT02310763|156115349|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
48525693|NCT02310763|156115350|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
48734738|NCT00910273|156879580|FG001|Overall Study|Protocol Violation|0|||
48734739|NCT00910273|156879579|FG000|Overall Study|Lost to Follow-up|1|||
48734740|NCT00910273|156879580|FG001|Overall Study|Lost to Follow-up|1|||
48734741|NCT02030938|156879581|FG000|Overall Study|Lost to Follow-up|4|||
48734742|NCT02030938|156879581|FG000|Overall Study|Withdrawal by Subject|1|||
48826939|NCT01941316|157207366|FG003|Overall Study|Protocol Violation|3|||
48826940|NCT01941316|157207363|FG000|Overall Study|Intercurrent illness|0|||
48826941|NCT01941316|157207364|FG001|Overall Study|Intercurrent illness|0|||
48826942|NCT01941316|157207365|FG002|Overall Study|Intercurrent illness|0|||
48525694|NCT02310763|156115351|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
48525695|NCT02310763|156115349|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
48525696|NCT02310763|156115350|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
48525697|NCT02310763|156115351|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
48525698|NCT02310763|156115349|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
48525699|NCT02310763|156115350|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
48525700|NCT02310763|156115351|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
48525701|NCT02310763|156115349|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
48525702|NCT02310763|156115350|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
48525703|NCT02310763|156115351|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
48525704|NCT03433703|156115352|FG000|Overall Study|Study terminated by Sponsor|2|||
48525705|NCT00979212|156115359|FG000|Overall Study|Protocol Violation|1|||
48525706|NCT00979212|156115360|FG001|Overall Study|Protocol Violation|8|||
48525707|NCT00979212|156115359|FG000|Overall Study|No protocol therapy received|1|||
48525708|NCT00979212|156115360|FG001|Overall Study|No protocol therapy received|0|||
48525709|NCT00569777|156115365|FG000|Overall Study|Withdrawal by Subject|4|||
48525710|NCT00569777|156115366|FG001|Overall Study|Withdrawal by Subject|0|||
48525711|NCT00569777|156115365|FG000|Overall Study|Adverse Event|3|||
48525712|NCT00569777|156115366|FG001|Overall Study|Adverse Event|0|||
48525713|NCT00569777|156115365|FG000|Overall Study|Lost to Follow-up|1|||
48525714|NCT00569777|156115366|FG001|Overall Study|Lost to Follow-up|0|||
48525715|NCT00569777|156115365|FG000|Overall Study|scheduled eye surgery|0|||
48525716|NCT00569777|156115366|FG001|Overall Study|scheduled eye surgery|1|||
48525717|NCT00569777|156115365|FG000|Overall Study|did not meet exclusion criteria|1|||
48525718|NCT00569777|156115366|FG001|Overall Study|did not meet exclusion criteria|2|||
48826943|NCT01941316|157207366|FG003|Overall Study|Intercurrent illness|1|||
48826944|NCT01941316|157207363|FG000|Overall Study|Other, not specified|0|||
48826945|NCT01941316|157207364|FG001|Overall Study|Other, not specified|0|||
48826946|NCT01941316|157207365|FG002|Overall Study|Other, not specified|0|||
48826947|NCT01941316|157207366|FG003|Overall Study|Other, not specified|1|||
48826948|NCT02469064|157207367|FG000|Overall Study|Request not to receive intervention.|1|||
48826949|NCT02469064|157207368|FG001|Overall Study|Request not to receive intervention.|3|||
48826950|NCT05650333|157207369|FG000|Treatment Period (7 Days)|Adverse Event|1|||
48826951|NCT02616263|157207370|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
48826952|NCT02616263|157207371|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
48826953|NCT02616263|157207370|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
48826954|NCT02616263|157207371|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
48826955|NCT02616263|157207370|FG000|6 Month to 1.5 Year|Death|1|||
48826956|NCT02616263|157207371|FG001|6 Month to 1.5 Year|Death|0|||
48826957|NCT02616263|157207370|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
48826958|NCT02616263|157207371|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
48826959|NCT02616263|157207370|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
48826960|NCT02616263|157207371|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
48826961|NCT02616263|157207370|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
48826962|NCT02616263|157207371|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
48826963|NCT02820051|157207373|FG000|Overall Study|Lost to Follow-up|7|||
48826964|NCT02820051|157207374|FG001|Overall Study|Lost to Follow-up|4|||
48826965|NCT01018511|157207379|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
48826966|NCT01018511|157207380|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
48826967|NCT01018511|157207381|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
48826968|NCT01018511|157207382|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
48826969|NCT01018511|157207379|FG000|Overall Study|Adverse Event|5|||
48826970|NCT01018511|157207380|FG001|Overall Study|Adverse Event|9|||
48826971|NCT01018511|157207381|FG002|Overall Study|Adverse Event|13|||
48826972|NCT01018511|157207382|FG003|Overall Study|Adverse Event|10|||
48826973|NCT01018511|157207379|FG000|Overall Study|Lack of Efficacy|4|||
48826974|NCT01018511|157207380|FG001|Overall Study|Lack of Efficacy|1|||
48525719|NCT00569777|156115365|FG000|Overall Study|pregnant|1|||
48525720|NCT00569777|156115366|FG001|Overall Study|pregnant|0|||
48826975|NCT01018511|157207381|FG002|Overall Study|Lack of Efficacy|1|||
48826976|NCT01018511|157207382|FG003|Overall Study|Lack of Efficacy|2|||
48525721|NCT00537017|156115369|FG000|Treatment Phase|Adverse Event|19|||
48826977|NCT01018511|157207379|FG000|Overall Study|Withdrawal by Subject|6|||
48826978|NCT01018511|157207380|FG001|Overall Study|Withdrawal by Subject|5|||
48525722|NCT00537017|156115369|FG000|Treatment Phase|Withdrawal by Subject|13|||
48525723|NCT00537017|156115369|FG000|Treatment Phase|Protocol Violation|2|||
48826979|NCT01018511|157207381|FG002|Overall Study|Withdrawal by Subject|11|||
48826980|NCT01018511|157207382|FG003|Overall Study|Withdrawal by Subject|9|||
48525724|NCT00537017|156115369|FG000|Follow-up Phase|Withdrawal by Subject|9|||
48525725|NCT01923311|156116511|FG000|Overall Study|Pregnancy|1|||
48525726|NCT01923311|156116512|FG001|Overall Study|Pregnancy|0|||
48525727|NCT01923311|156116511|FG000|Overall Study|Investigator's Discretion|1|||
48734743|NCT04308304|156879582|FG000|Overall Study|Withdrawal by Subject|4|||
48734744|NCT04308304|156879583|FG001|Overall Study|Withdrawal by Subject|0|||
48734745|NCT04308304|156879582|FG000|Overall Study|Protocol Violation|1|||
48734746|NCT04308304|156879583|FG001|Overall Study|Protocol Violation|0|||
48734747|NCT03181893|156879584|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734748|NCT03181893|156879585|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
48734749|NCT03181893|156879586|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734750|NCT03181893|156879587|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734751|NCT03181893|156879588|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734752|NCT03181893|156879589|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734753|NCT03181893|156879590|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734754|NCT03181893|156879591|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734755|NCT03181893|156879592|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734756|NCT03181893|156879593|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734757|NCT03181893|156879594|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
48734758|NCT03181893|156879584|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
48734759|NCT03181893|156879585|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
48734760|NCT03181893|156879586|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734761|NCT03181893|156879587|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734762|NCT03181893|156879588|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734763|NCT03181893|156879589|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734764|NCT03181893|156879590|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734765|NCT03181893|156879591|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734766|NCT03181893|156879592|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734767|NCT03181893|156879593|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734768|NCT03181893|156879594|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
48734769|NCT03181893|156879584|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734770|NCT03181893|156879585|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734771|NCT03181893|156879586|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734772|NCT03181893|156879587|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734773|NCT03181893|156879588|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734774|NCT03181893|156879589|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734775|NCT03181893|156879590|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734776|NCT03181893|156879591|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
48734777|NCT03181893|156879592|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
48734778|NCT03181893|156879593|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734779|NCT03181893|156879594|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
48734780|NCT03181893|156879584|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48525728|NCT01923311|156116512|FG001|Overall Study|Investigator's Discretion|0|||
48525729|NCT01923311|156116511|FG000|Overall Study|Non-Compliance with Study Drug|2|||
48826981|NCT01018511|157207379|FG000|Overall Study|Lost to Follow-up|0|||
48826982|NCT01018511|157207380|FG001|Overall Study|Lost to Follow-up|0|||
48826983|NCT01018511|157207381|FG002|Overall Study|Lost to Follow-up|1|||
48826984|NCT01018511|157207382|FG003|Overall Study|Lost to Follow-up|0|||
48826985|NCT01018511|157207379|FG000|Overall Study|Protocol Violation|5|||
48826986|NCT01018511|157207380|FG001|Overall Study|Protocol Violation|8|||
48826987|NCT01018511|157207381|FG002|Overall Study|Protocol Violation|7|||
48826988|NCT01018511|157207382|FG003|Overall Study|Protocol Violation|9|||
48826989|NCT01018511|157207379|FG000|Overall Study|Miscellaneous|0|||
48826990|NCT01018511|157207380|FG001|Overall Study|Miscellaneous|2|||
48826991|NCT01018511|157207381|FG002|Overall Study|Miscellaneous|0|||
48826992|NCT01018511|157207382|FG003|Overall Study|Miscellaneous|0|||
48826993|NCT03282123|157207383|FG000|Overall Study|Withdrawal by Subject|5|||
48826994|NCT03905135|157207387|FG000|Dose Escalation|Adverse Event|1|||
48826995|NCT03905135|157207388|FG001|Dose Escalation|Adverse Event|1|||
48826996|NCT03905135|157207387|FG000|Dose Escalation|Progressive disease|3|||
48826997|NCT03905135|157207388|FG001|Dose Escalation|Progressive disease|1|||
48826998|NCT03905135|157207387|FG000|Dose Escalation|Intercurrent illness|1|||
48826999|NCT03905135|157207388|FG001|Dose Escalation|Intercurrent illness|0|||
48827000|NCT04523181|157207390|FG000|Overall Study|Withdrawal by Subject|4|||
48827001|NCT04523181|157207391|FG001|Overall Study|Withdrawal by Subject|5|||
48827002|NCT04523181|157207390|FG000|Overall Study|Lost to Follow-up|2|||
48827003|NCT04523181|157207391|FG001|Overall Study|Lost to Follow-up|3|||
48827004|NCT04523181|157207390|FG000|Overall Study|Physician Decision|1|||
48444293|NCT03625141|155815040|FG001|Overall Study|Progressive Disease|2|||
48444294|NCT01188096|155815041|FG000|Overall Study|progression of disease|4|||
48444295|NCT01188096|155815041|FG000|Overall Study|Withdrawal by Subject|2|||
48602106|NCT03327324|156399523|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
48734781|NCT03181893|156879585|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734782|NCT03181893|156879586|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734783|NCT03181893|156879587|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734784|NCT03181893|156879588|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734785|NCT03181893|156879589|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734786|NCT03181893|156879590|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734787|NCT03181893|156879591|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734788|NCT03181893|156879592|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48444296|NCT04209530|155815045|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
48444297|NCT04209530|155815046|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
48734789|NCT03181893|156879593|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
48734790|NCT03181893|156879594|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
48734791|NCT03181893|156879584|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734792|NCT03181893|156879585|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734793|NCT03181893|156879586|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734794|NCT03181893|156879587|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734795|NCT03181893|156879588|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48827005|NCT04523181|157207391|FG001|Overall Study|Physician Decision|0|||
48827006|NCT04523181|157207390|FG000|Overall Study|Transferred to external facility.|1|||
48827007|NCT04523181|157207391|FG001|Overall Study|Transferred to external facility.|1|||
48827008|NCT04391309|157207395|FG000|Overall Study|Death|1|||
48827009|NCT04391309|157207396|FG001|Overall Study|Death|1|||
48444298|NCT04209530|155815045|FG000|Overall Study|Withdrawal by Subject|0|||
48444299|NCT04209530|155815046|FG001|Overall Study|Withdrawal by Subject|1|||
48444300|NCT02680587|155815047|FG000|Overall Study|Withdrawal by Subject|1|||
48444301|NCT02680587|155815048|FG001|Overall Study|Withdrawal by Subject|0|||
48444302|NCT01188538|155815049|FG000|Overall Study|Lost to Follow-up|0|||
48444303|NCT01188538|155815050|FG001|Overall Study|Lost to Follow-up|1|||
48444304|NCT02273037|155815051|FG000|Overall Study|Lost to Follow-up|1|||
48444305|NCT02273037|155815052|FG001|Overall Study|Lost to Follow-up|0|||
48444306|NCT02273037|155815051|FG000|Overall Study|Delivered before monitoring initiated|1|||
48444307|NCT02273037|155815052|FG001|Overall Study|Delivered before monitoring initiated|3|||
48444308|NCT02273037|155815051|FG000|Overall Study|Breech delivery|2|||
48444309|NCT02273037|155815052|FG001|Overall Study|Breech delivery|3|||
48444310|NCT02273037|155815051|FG000|Overall Study|Multiple delivery|2|||
48444311|NCT02273037|155815052|FG001|Overall Study|Multiple delivery|2|||
48525730|NCT01923311|156116512|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48525731|NCT01923311|156116511|FG000|Overall Study|Withdrew Consent|1|||
48525732|NCT01923311|156116512|FG001|Overall Study|Withdrew Consent|0|||
48525733|NCT01923311|156116511|FG000|Overall Study|Study Terminated by Sponsor|12|||
48525734|NCT01923311|156116512|FG001|Overall Study|Study Terminated by Sponsor|0|||
48525735|NCT02485158|156116513|FG000|Overall Study|Withdrawal by Subject|3|||
48525736|NCT02485158|156116513|FG000|Overall Study|expected drug side effect|1|||
48525737|NCT01662024|156116516|FG000|Overall Study|Pregnancy|2|||
48525738|NCT01662024|156116516|FG000|Overall Study|Withdrawal by Subject|3|||
48525739|NCT02031237|156116517|FG000|Overall Study|Death|1|||
48525740|NCT02031237|156116518|FG001|Overall Study|Death|5|||
48525741|NCT02031237|156116519|FG002|Overall Study|Death|0|||
48525742|NCT02031237|156116517|FG000|Overall Study|Physician Decision|0|||
48525743|NCT02031237|156116518|FG001|Overall Study|Physician Decision|1|||
48525744|NCT02031237|156116519|FG002|Overall Study|Physician Decision|0|||
48525745|NCT02031237|156116517|FG000|Overall Study|Withdrawal by Subject|2|||
48525746|NCT02031237|156116518|FG001|Overall Study|Withdrawal by Subject|2|||
48525747|NCT02031237|156116519|FG002|Overall Study|Withdrawal by Subject|0|||
48525748|NCT02031237|156116517|FG000|Overall Study|Protocol Violation|2|||
48525749|NCT02031237|156116518|FG001|Overall Study|Protocol Violation|6|||
48525750|NCT02031237|156116519|FG002|Overall Study|Protocol Violation|0|||
48525751|NCT02031237|156116517|FG000|Overall Study|Alternate Treatment Given|0|||
48525752|NCT02031237|156116518|FG001|Overall Study|Alternate Treatment Given|0|||
48525753|NCT02031237|156116519|FG002|Overall Study|Alternate Treatment Given|3|||
48525754|NCT04980456|156116520|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
48525755|NCT04980456|156116521|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
48525756|NCT04980456|156116520|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
48525757|NCT04980456|156116521|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
48525758|NCT04980456|156116520|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
48525759|NCT04980456|156116521|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
48525760|NCT04980456|156116520|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
48525761|NCT04980456|156116521|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
48525762|NCT02846883|156116522|FG000|Overall Study|Death|0|||
48525763|NCT02846883|156116523|FG001|Overall Study|Death|1|||
48525764|NCT02846883|156116524|FG002|Overall Study|Death|1|||
48525765|NCT02846883|156116522|FG000|Overall Study|Lost to Follow-up|0|||
48525766|NCT02846883|156116523|FG001|Overall Study|Lost to Follow-up|0|||
48525767|NCT02846883|156116524|FG002|Overall Study|Lost to Follow-up|1|||
48525768|NCT02846883|156116522|FG000|Overall Study|Withdrawal by Subject|1|||
48525769|NCT02846883|156116523|FG001|Overall Study|Withdrawal by Subject|0|||
48525770|NCT02846883|156116524|FG002|Overall Study|Withdrawal by Subject|0|||
48525771|NCT02846883|156116522|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
48525772|NCT02846883|156116523|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
48525773|NCT02846883|156116524|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
48525774|NCT02846883|156116522|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
48525775|NCT02846883|156116523|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
48525776|NCT02846883|156116524|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
48525777|NCT04768296|156116528|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
48525778|NCT04768296|156116529|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
48525779|NCT00442351|156116530|FG000|Overall Study|Administrative|6|||
48525780|NCT00442351|156116531|FG001|Overall Study|Administrative|5|||
48525781|NCT00442351|156116530|FG000|Overall Study|Did not meet protocol eligibility|1|||
48525782|NCT00442351|156116531|FG001|Overall Study|Did not meet protocol eligibility|0|||
48525783|NCT00442351|156116530|FG000|Overall Study|Other|0|||
48525784|NCT00442351|156116531|FG001|Overall Study|Other|1|||
48525785|NCT03087786|156116532|FG000|Overall Study|Withdrawal by Subject|2|||
48525786|NCT03087786|156116533|FG001|Overall Study|Withdrawal by Subject|0|||
48525787|NCT00063258|156116558|FG000|Overall Study|Physician Decision|2|||
48525788|NCT00063258|156116559|FG001|Overall Study|Physician Decision|0|||
48525789|NCT00063258|156116558|FG000|Overall Study|Lack of Efficacy|2|||
48525790|NCT00063258|156116559|FG001|Overall Study|Lack of Efficacy|0|||
48525791|NCT00035555|156116560|FG000|Overall Study|Adverse Event|5|||
48525792|NCT00035555|156116561|FG001|Overall Study|Adverse Event|8|||
48525793|NCT00035555|156116562|FG002|Overall Study|Adverse Event|9|||
48525794|NCT00035555|156116560|FG000|Overall Study|Allograft loss|1|||
48734796|NCT03181893|156879589|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48525795|NCT00035555|156116561|FG001|Overall Study|Allograft loss|1|||
48525796|NCT00035555|156116562|FG002|Overall Study|Allograft loss|2|||
48525797|NCT00035555|156116560|FG000|Overall Study|Death|0|||
48525798|NCT00035555|156116561|FG001|Overall Study|Death|0|||
48525799|NCT00035555|156116562|FG002|Overall Study|Death|2|||
48525800|NCT00035555|156116560|FG000|Overall Study|Lost to Follow-up|0|||
48525801|NCT00035555|156116561|FG001|Overall Study|Lost to Follow-up|0|||
48525802|NCT00035555|156116562|FG002|Overall Study|Lost to Follow-up|1|||
48525803|NCT00035555|156116560|FG000|Overall Study|Noncompliance|0|||
48525804|NCT00035555|156116561|FG001|Overall Study|Noncompliance|1|||
48525805|NCT00035555|156116562|FG002|Overall Study|Noncompliance|1|||
48525806|NCT00035555|156116560|FG000|Overall Study|Prohibited medication|1|||
48525807|NCT00035555|156116561|FG001|Overall Study|Prohibited medication|1|||
48525808|NCT00035555|156116562|FG002|Overall Study|Prohibited medication|0|||
48525809|NCT00035555|156116560|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
48525810|NCT00035555|156116561|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
48525811|NCT00035555|156116562|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
48525812|NCT00035555|156116560|FG000|Overall Study|Withdrawal by Subject|2|||
48525813|NCT00035555|156116561|FG001|Overall Study|Withdrawal by Subject|0|||
48525814|NCT00035555|156116562|FG002|Overall Study|Withdrawal by Subject|2|||
48525815|NCT00035555|156116560|FG000|Overall Study|Investigator deemed not a good candidate|0|||
48525816|NCT00035555|156116561|FG001|Overall Study|Investigator deemed not a good candidate|0|||
48525817|NCT00035555|156116562|FG002|Overall Study|Investigator deemed not a good candidate|1|||
48602107|NCT03327324|156399524|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
48734797|NCT03181893|156879590|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48525818|NCT00035555|156116560|FG000|Overall Study|Received cyclosporin in error|0|||
48525819|NCT00035555|156116561|FG001|Overall Study|Received cyclosporin in error|0|||
48525820|NCT00035555|156116562|FG002|Overall Study|Received cyclosporin in error|1|||
48525821|NCT01957150|156116563|FG000|Overall Study|Adverse Event|23|||
48525822|NCT01957150|156116564|FG001|Overall Study|Adverse Event|20|||
48602108|NCT03327324|156399519|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
48734798|NCT03181893|156879591|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734799|NCT03181893|156879592|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734800|NCT03181893|156879593|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
48734801|NCT03181893|156879594|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
48734802|NCT02298023|156879595|FG000|Overall Study|Withdrawal by Subject|1|||
48734803|NCT02298023|156879596|FG001|Overall Study|Withdrawal by Subject|0|||
48734804|NCT02298023|156879597|FG002|Overall Study|Withdrawal by Subject|0|||
48734805|NCT03540030|156879600|FG000|Overall Study|Withdrawal by Subject|2|||
48734806|NCT03540030|156879601|FG001|Overall Study|Withdrawal by Subject|1|||
48734807|NCT03540030|156879600|FG000|Overall Study|screen fail|7|||
48734808|NCT03540030|156879601|FG001|Overall Study|screen fail|1|||
48734809|NCT03540030|156879600|FG000|Overall Study|never had surgery after signing consent|9|||
48734810|NCT03540030|156879601|FG001|Overall Study|never had surgery after signing consent|1|||
48734811|NCT03021304|156879602|FG000|Overall Study|Lack of Efficacy|1|||
48734812|NCT00569270|156879603|FG000|Period: First Intervention|Protocol Violation|0|||
48734813|NCT00569270|156879604|FG001|Period: First Intervention|Protocol Violation|1|||
48734814|NCT00451451|156880754|FG000|Overall Study|Adverse Event|11|||
48734815|NCT00451451|156880755|FG001|Overall Study|Adverse Event|21|||
48734816|NCT00451451|156880756|FG002|Overall Study|Adverse Event|26|||
48734817|NCT00451451|156880757|FG003|Overall Study|Adverse Event|10|||
48734818|NCT00451451|156880754|FG000|Overall Study|Lost to Follow-up|11|||
48734819|NCT00451451|156880755|FG001|Overall Study|Lost to Follow-up|9|||
48734820|NCT00451451|156880756|FG002|Overall Study|Lost to Follow-up|8|||
48734821|NCT00451451|156880757|FG003|Overall Study|Lost to Follow-up|11|||
48734822|NCT00451451|156880754|FG000|Overall Study|Consent Withdrawn|14|||
48734823|NCT00451451|156880755|FG001|Overall Study|Consent Withdrawn|9|||
48734824|NCT00451451|156880756|FG002|Overall Study|Consent Withdrawn|17|||
48734825|NCT00451451|156880757|FG003|Overall Study|Consent Withdrawn|17|||
48734826|NCT00451451|156880754|FG000|Overall Study|Investigator Decision|6|||
48734827|NCT00451451|156880755|FG001|Overall Study|Investigator Decision|2|||
48734828|NCT00451451|156880756|FG002|Overall Study|Investigator Decision|1|||
48734829|NCT00451451|156880757|FG003|Overall Study|Investigator Decision|2|||
48734830|NCT00451451|156880754|FG000|Overall Study|Subject Non-Compliance|8|||
48734831|NCT00451451|156880755|FG001|Overall Study|Subject Non-Compliance|4|||
48734832|NCT00451451|156880756|FG002|Overall Study|Subject Non-Compliance|3|||
48734833|NCT00451451|156880757|FG003|Overall Study|Subject Non-Compliance|3|||
48734834|NCT00451451|156880754|FG000|Overall Study|Death|1|||
48734835|NCT00451451|156880755|FG001|Overall Study|Death|0|||
48734836|NCT00451451|156880756|FG002|Overall Study|Death|0|||
48734837|NCT00451451|156880757|FG003|Overall Study|Death|1|||
48734838|NCT00451451|156880754|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
48734839|NCT00451451|156880755|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
48734840|NCT00451451|156880756|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
48734841|NCT00451451|156880757|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
48734842|NCT02095223|156880758|FG000|Overall Study|Withdrawal by Subject|1|||
48734843|NCT02095223|156880759|FG001|Overall Study|Withdrawal by Subject|0|||
48734844|NCT03911713|156880760|FG000|Overall Study|Lost to Follow-up|0|||
48734845|NCT03911713|156880761|FG001|Overall Study|Lost to Follow-up|2|||
48525823|NCT01957150|156116563|FG000|Overall Study|Withdrawal by Subject|13|||
48734846|NCT03911713|156880762|FG002|Overall Study|Lost to Follow-up|0|||
48734847|NCT03911713|156880763|FG003|Overall Study|Lost to Follow-up|0|||
48734848|NCT03911713|156880764|FG004|Overall Study|Lost to Follow-up|0|||
48734849|NCT03911713|156880760|FG000|Overall Study|Other|0|||
48734850|NCT03911713|156880761|FG001|Overall Study|Other|0|||
48827010|NCT04391309|157207395|FG000|Overall Study|Lost to Follow-up|3|||
48827011|NCT04391309|157207396|FG001|Overall Study|Lost to Follow-up|2|||
48827012|NCT04391309|157207395|FG000|Overall Study|Withdrawal by Subject|2|||
48827013|NCT04391309|157207396|FG001|Overall Study|Withdrawal by Subject|2|||
48827014|NCT05576662|157207397|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
48827015|NCT05576662|157207398|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
48827016|NCT05576662|157207397|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
48827017|NCT05576662|157207398|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
48827018|NCT05576662|157207397|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
48827019|NCT05576662|157207398|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
48827020|NCT05576662|157207397|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
48827021|NCT05576662|157207398|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
48827022|NCT04739423|157207403|FG000|Overall Study|Protocol Violation|0|||
48827023|NCT04739423|157207404|FG001|Overall Study|Protocol Violation|1|||
48827024|NCT04739423|157207405|FG002|Overall Study|Protocol Violation|0|||
48827025|NCT04739423|157207406|FG003|Overall Study|Protocol Violation|0|||
48827026|NCT04739423|157207407|FG004|Overall Study|Protocol Violation|0|||
48827027|NCT04739423|157207408|FG005|Overall Study|Protocol Violation|0|||
48827028|NCT04739423|157207403|FG000|Overall Study|Adverse Event|0|||
48827029|NCT04739423|157207404|FG001|Overall Study|Adverse Event|0|||
48827030|NCT04739423|157207405|FG002|Overall Study|Adverse Event|1|||
48827031|NCT04739423|157207406|FG003|Overall Study|Adverse Event|0|||
48827032|NCT04739423|157207407|FG004|Overall Study|Adverse Event|1|||
48827033|NCT04739423|157207408|FG005|Overall Study|Adverse Event|0|||
48827034|NCT04739423|157207403|FG000|Overall Study|Withdrawal by Subject|0|||
48827035|NCT04739423|157207404|FG001|Overall Study|Withdrawal by Subject|0|||
48827036|NCT04739423|157207405|FG002|Overall Study|Withdrawal by Subject|0|||
48827037|NCT04739423|157207406|FG003|Overall Study|Withdrawal by Subject|0|||
48827038|NCT04739423|157207407|FG004|Overall Study|Withdrawal by Subject|0|||
48827039|NCT04739423|157207408|FG005|Overall Study|Withdrawal by Subject|1|||
48827040|NCT03971357|157207411|FG000|Overall Study|Lack of Efficacy|0|||
48827041|NCT03971357|157207412|FG001|Overall Study|Lack of Efficacy|1|||
48827042|NCT00124982|157207413|FG000|Short-term Period|Death|1|||
48827043|NCT00124982|157207414|FG001|Short-term Period|Death|1|||
48827044|NCT00124982|157207415|FG002|Short-term Period|Death|0|||
48827045|NCT00124982|157207413|FG000|Short-term Period|Adverse Event|17|||
48827046|NCT00124982|157207414|FG001|Short-term Period|Adverse Event|22|||
48525824|NCT01957150|156116564|FG001|Overall Study|Withdrawal by Subject|17|||
48525825|NCT01957150|156116563|FG000|Overall Study|Physician Decision|3|||
48525826|NCT01957150|156116564|FG001|Overall Study|Physician Decision|6|||
48525827|NCT01957150|156116563|FG000|Overall Study|Lost to Follow-up|4|||
48525828|NCT01957150|156116564|FG001|Overall Study|Lost to Follow-up|4|||
48525829|NCT01957150|156116563|FG000|Overall Study|Protocol Violation|1|||
48525830|NCT01957150|156116564|FG001|Overall Study|Protocol Violation|0|||
48827047|NCT00124982|157207415|FG002|Short-term Period|Adverse Event|0|||
48827048|NCT00124982|157207413|FG000|Short-term Period|Lack of Efficacy|32|||
48827049|NCT00124982|157207414|FG001|Short-term Period|Lack of Efficacy|73|||
48827050|NCT00124982|157207415|FG002|Short-term Period|Lack of Efficacy|0|||
48827051|NCT00124982|157207413|FG000|Short-term Period|Lost to Follow-up|8|||
48827052|NCT00124982|157207414|FG001|Short-term Period|Lost to Follow-up|5|||
48827053|NCT00124982|157207415|FG002|Short-term Period|Lost to Follow-up|0|||
48525831|NCT01957150|156116563|FG000|Overall Study|Lack of Efficacy|11|||
48525832|NCT01957150|156116564|FG001|Overall Study|Lack of Efficacy|11|||
48525833|NCT04164758|156116568|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
48525834|NCT04164758|156116569|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
48525835|NCT04164758|156116570|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
48525836|NCT04164758|156116568|FG000|Overall Study|Adverse Event|0|||
48525837|NCT04164758|156116569|FG001|Overall Study|Adverse Event|1|||
48525838|NCT04164758|156116570|FG002|Overall Study|Adverse Event|0|||
48525839|NCT01011556|156116575|FG000|Overall Study|Adverse Event|1|||
48525840|NCT01011556|156116576|FG001|Overall Study|Adverse Event|3|||
48525841|NCT01011556|156116577|FG002|Overall Study|Adverse Event|2|||
48525842|NCT01011556|156116578|FG003|Overall Study|Adverse Event|1|||
48525843|NCT01011556|156116575|FG000|Overall Study|Lost to Follow-up|1|||
48525844|NCT01011556|156116576|FG001|Overall Study|Lost to Follow-up|0|||
48525845|NCT01011556|156116577|FG002|Overall Study|Lost to Follow-up|0|||
48525846|NCT01011556|156116578|FG003|Overall Study|Lost to Follow-up|0|||
48525847|NCT01011556|156116575|FG000|Overall Study|Physician Decision|1|||
48525848|NCT01011556|156116576|FG001|Overall Study|Physician Decision|0|||
48525849|NCT01011556|156116577|FG002|Overall Study|Physician Decision|0|||
48525850|NCT01011556|156116578|FG003|Overall Study|Physician Decision|1|||
48525851|NCT01011556|156116575|FG000|Overall Study|Protocol Violation|0|||
48525852|NCT01011556|156116576|FG001|Overall Study|Protocol Violation|1|||
48525853|NCT01011556|156116577|FG002|Overall Study|Protocol Violation|0|||
48525854|NCT01011556|156116578|FG003|Overall Study|Protocol Violation|0|||
48525855|NCT01011556|156116575|FG000|Overall Study|Withdrawal by Subject|1|||
48525856|NCT01011556|156116576|FG001|Overall Study|Withdrawal by Subject|2|||
48525857|NCT01011556|156116577|FG002|Overall Study|Withdrawal by Subject|4|||
48525858|NCT01011556|156116578|FG003|Overall Study|Withdrawal by Subject|4|||
48525859|NCT01011556|156116575|FG000|Overall Study|Sponsor decision|0|||
48525860|NCT01011556|156116576|FG001|Overall Study|Sponsor decision|1|||
48525861|NCT01011556|156116577|FG002|Overall Study|Sponsor decision|1|||
48525862|NCT01011556|156116578|FG003|Overall Study|Sponsor decision|2|||
48525863|NCT01011556|156116575|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
48525864|NCT01011556|156116576|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
48525865|NCT01011556|156116577|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
48525866|NCT01011556|156116578|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
48525867|NCT04149535|156116580|FG000|Overall Study|Death|11|||
48525868|NCT04149535|156116581|FG001|Overall Study|Death|7|||
48525869|NCT04149535|156116580|FG000|Overall Study|Physician Decision|10|||
48827054|NCT00124982|157207413|FG000|Short-term Period|Withdrawal of Consent|7|||
48525870|NCT04149535|156116581|FG001|Overall Study|Physician Decision|4|||
48525871|NCT04149535|156116580|FG000|Overall Study|Withdrawal by Subject|6|||
48525872|NCT04149535|156116581|FG001|Overall Study|Withdrawal by Subject|7|||
48827055|NCT00124982|157207414|FG001|Short-term Period|Withdrawal of Consent|9|||
48827056|NCT00124982|157207415|FG002|Short-term Period|Withdrawal of Consent|0|||
48827057|NCT00124982|157207413|FG000|Short-term Period|Poor/Non-compliance|3|||
48827058|NCT00124982|157207414|FG001|Short-term Period|Poor/Non-compliance|1|||
48827059|NCT00124982|157207415|FG002|Short-term Period|Poor/Non-compliance|0|||
48827060|NCT00124982|157207413|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
48827061|NCT00124982|157207414|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
48827062|NCT00124982|157207415|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
48827063|NCT00124982|157207413|FG000|Short-term Period|Participant Decision|1|||
48827064|NCT00124982|157207414|FG001|Short-term Period|Participant Decision|0|||
48827065|NCT00124982|157207415|FG002|Short-term Period|Participant Decision|0|||
48827066|NCT00124982|157207413|FG000|Short-term Period|Participant Chose Own Doctor|0|||
48827067|NCT00124982|157207414|FG001|Short-term Period|Participant Chose Own Doctor|1|||
48827068|NCT00124982|157207415|FG002|Short-term Period|Participant Chose Own Doctor|0|||
48827069|NCT00124982|157207413|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
48827070|NCT00124982|157207414|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
48827071|NCT00124982|157207415|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
48525873|NCT04149535|156116580|FG000|Overall Study|Not described|2|||
48525874|NCT04149535|156116581|FG001|Overall Study|Not described|0|||
48525875|NCT00220727|156116584|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
48525876|NCT00220727|156116585|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
48525877|NCT02056652|156116599|FG000|Overall Study|Withdrawal by Subject|1|||
48525878|NCT02056652|156116600|FG001|Overall Study|Withdrawal by Subject|0|||
48525879|NCT02056652|156116599|FG000|Overall Study|Lost to Follow-up|0|||
48525880|NCT02056652|156116600|FG001|Overall Study|Lost to Follow-up|3|||
48525881|NCT00476593|156116601|FG000|Overall Study|Lost to Follow-up|10|||
48525882|NCT00476593|156116602|FG001|Overall Study|Lost to Follow-up|2|||
48525883|NCT00476593|156116603|FG002|Overall Study|Lost to Follow-up|8|||
48525884|NCT00476593|156116604|FG003|Overall Study|Lost to Follow-up|22|||
48602109|NCT03327324|156399520|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
48525885|NCT03430011|156116607|FG000|Pre-Treatment|Death|1|||
48827072|NCT00124982|157207413|FG000|Short-term Period|Participant Had Lymphopenia|1|||
48827073|NCT00124982|157207414|FG001|Short-term Period|Participant Had Lymphopenia|0|||
48525886|NCT03430011|156116608|FG001|Pre-Treatment|Death|0|||
48525887|NCT03430011|156116609|FG002|Pre-Treatment|Death|0|||
48525888|NCT03430011|156116610|FG003|Pre-Treatment|Death|0|||
48525889|NCT03430011|156116611|FG004|Pre-Treatment|Death|1|||
48525890|NCT03430011|156116612|FG005|Pre-Treatment|Death|0|||
48525891|NCT03430011|156116613|FG006|Pre-Treatment|Death|1|||
48525892|NCT03430011|156116614|FG007|Pre-Treatment|Death|0|||
48525893|NCT03430011|156116607|FG000|Pre-Treatment|Screen Fail|0|||
48525894|NCT03430011|156116608|FG001|Pre-Treatment|Screen Fail|0|||
48525895|NCT03430011|156116609|FG002|Pre-Treatment|Screen Fail|0|||
48525896|NCT03430011|156116610|FG003|Pre-Treatment|Screen Fail|0|||
48827074|NCT00124982|157207415|FG002|Short-term Period|Participant Had Lymphopenia|0|||
48827075|NCT00124982|157207413|FG000|Long-term Period|Death|0|||
48827076|NCT00124982|157207414|FG001|Long-term Period|Death|0|||
48827077|NCT00124982|157207415|FG002|Long-term Period|Death|1|||
48827078|NCT00124982|157207413|FG000|Long-term Period|Adverse Event|0|||
48827079|NCT00124982|157207414|FG001|Long-term Period|Adverse Event|0|||
48827080|NCT00124982|157207415|FG002|Long-term Period|Adverse Event|17|||
48827081|NCT00124982|157207413|FG000|Long-term Period|Lack of Efficacy|0|||
48827082|NCT00124982|157207414|FG001|Long-term Period|Lack of Efficacy|0|||
48827083|NCT00124982|157207415|FG002|Long-term Period|Lack of Efficacy|46|||
48827084|NCT00124982|157207413|FG000|Long-term Period|Lost to Follow-up|0|||
48827085|NCT00124982|157207414|FG001|Long-term Period|Lost to Follow-up|0|||
48827086|NCT00124982|157207415|FG002|Long-term Period|Lost to Follow-up|4|||
48827087|NCT00124982|157207413|FG000|Long-term Period|Withdrawal by Subject|0|||
48525897|NCT03430011|156116611|FG004|Pre-Treatment|Screen Fail|1|||
48525898|NCT03430011|156116612|FG005|Pre-Treatment|Screen Fail|0|||
48525899|NCT03430011|156116613|FG006|Pre-Treatment|Screen Fail|0|||
48525900|NCT03430011|156116614|FG007|Pre-Treatment|Screen Fail|0|||
48525901|NCT03430011|156116607|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
48525902|NCT03430011|156116608|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
48525903|NCT03430011|156116609|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
48525904|NCT03430011|156116610|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
48525905|NCT03430011|156116611|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
48525906|NCT03430011|156116612|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
48525907|NCT03430011|156116613|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
48525908|NCT03430011|156116614|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
48525909|NCT03430011|156116607|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
48525910|NCT03430011|156116608|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
48525911|NCT03430011|156116609|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
48525912|NCT03430011|156116610|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
48525913|NCT03430011|156116611|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
48525914|NCT03430011|156116612|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
48525915|NCT03430011|156116613|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
48525916|NCT03430011|156116614|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
48525917|NCT03430011|156116607|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
48525918|NCT03430011|156116608|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
48525919|NCT03430011|156116609|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
48525920|NCT03430011|156116610|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
48525921|NCT03430011|156116611|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
48525922|NCT03430011|156116612|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
48525923|NCT03430011|156116613|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
48525924|NCT03430011|156116614|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
48525925|NCT03430011|156116607|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
48827088|NCT00124982|157207414|FG001|Long-term Period|Withdrawal by Subject|0|||
48525926|NCT03430011|156116608|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
48525927|NCT03430011|156116609|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
48827089|NCT00124982|157207415|FG002|Long-term Period|Withdrawal by Subject|16|||
48827090|NCT00124982|157207413|FG000|Long-term Period|Pregnancy|0|||
48827091|NCT00124982|157207414|FG001|Long-term Period|Pregnancy|0|||
48827092|NCT00124982|157207415|FG002|Long-term Period|Pregnancy|1|||
48827093|NCT00124982|157207413|FG000|Long-term Period|Poor/Non-compliance|0|||
48525928|NCT03430011|156116610|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
48525929|NCT03430011|156116611|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
48525930|NCT03430011|156116612|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
48525931|NCT03430011|156116613|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
48525932|NCT03430011|156116614|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
48525933|NCT03430011|156116607|FG000|JCARH125 Treatment|Death|4|||
48525934|NCT03430011|156116608|FG001|JCARH125 Treatment|Death|19|||
48525935|NCT03430011|156116609|FG002|JCARH125 Treatment|Death|10|||
48525936|NCT03430011|156116610|FG003|JCARH125 Treatment|Death|8|||
48525937|NCT03430011|156116611|FG004|JCARH125 Treatment|Death|5|||
48525938|NCT03430011|156116612|FG005|JCARH125 Treatment|Death|3|||
48827094|NCT00124982|157207414|FG001|Long-term Period|Poor/Non-compliance|0|||
48827095|NCT00124982|157207415|FG002|Long-term Period|Poor/Non-compliance|2|||
48827096|NCT00124982|157207413|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
48827097|NCT00124982|157207414|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
48525939|NCT03430011|156116613|FG006|JCARH125 Treatment|Death|4|||
48525940|NCT03430011|156116614|FG007|JCARH125 Treatment|Death|2|||
48525941|NCT03430011|156116607|FG000|JCARH125 Treatment|Other reasons|1|||
48525942|NCT03430011|156116608|FG001|JCARH125 Treatment|Other reasons|0|||
48525943|NCT03430011|156116609|FG002|JCARH125 Treatment|Other reasons|4|||
48525944|NCT03430011|156116610|FG003|JCARH125 Treatment|Other reasons|2|||
48525945|NCT03430011|156116611|FG004|JCARH125 Treatment|Other reasons|2|||
48525946|NCT03430011|156116612|FG005|JCARH125 Treatment|Other reasons|1|||
48525947|NCT03430011|156116613|FG006|JCARH125 Treatment|Other reasons|3|||
48525948|NCT03430011|156116614|FG007|JCARH125 Treatment|Other reasons|2|||
48525949|NCT00402025|156116615|FG000|Overall Study|Adverse Event|0|||
48525950|NCT00402025|156116616|FG001|Overall Study|Adverse Event|0|||
48525951|NCT00402025|156116617|FG002|Overall Study|Adverse Event|2|||
48525952|NCT00402025|156116615|FG000|Overall Study|Death|0|||
48525953|NCT00402025|156116616|FG001|Overall Study|Death|1|||
48525954|NCT00402025|156116617|FG002|Overall Study|Death|5|||
48525955|NCT00402025|156116615|FG000|Overall Study|Disease Progression|1|||
48525956|NCT00402025|156116616|FG001|Overall Study|Disease Progression|1|||
48525957|NCT00402025|156116617|FG002|Overall Study|Disease Progression|2|||
48525958|NCT00402025|156116615|FG000|Overall Study|Physician Decision|1|||
48525959|NCT00402025|156116616|FG001|Overall Study|Physician Decision|1|||
48525960|NCT00402025|156116617|FG002|Overall Study|Physician Decision|0|||
48525961|NCT00402025|156116615|FG000|Overall Study|Participant Decision|0|||
48525962|NCT00402025|156116616|FG001|Overall Study|Participant Decision|0|||
48525963|NCT00402025|156116617|FG002|Overall Study|Participant Decision|1|||
48525964|NCT02063217|156116619|FG000|Overall Study|Withdrawal by Subject|1|||
48525965|NCT02063217|156116620|FG001|Overall Study|Withdrawal by Subject|0|||
48525966|NCT02063217|156116621|FG002|Overall Study|Withdrawal by Subject|0|||
48525967|NCT00869440|156116623|FG000|Overall Study|Withdrawal by Subject|1|||
48525968|NCT00869440|156116624|FG001|Overall Study|Withdrawal by Subject|0|||
48525969|NCT00869440|156116625|FG002|Overall Study|Withdrawal by Subject|0|||
48525970|NCT00869440|156116626|FG003|Overall Study|Withdrawal by Subject|0|||
48525971|NCT00869440|156116623|FG000|Overall Study|Physician Decision|1|||
48525972|NCT00869440|156116624|FG001|Overall Study|Physician Decision|1|||
48525973|NCT00869440|156116625|FG002|Overall Study|Physician Decision|0|||
48525974|NCT00869440|156116626|FG003|Overall Study|Physician Decision|0|||
48525975|NCT01899326|156116627|FG000|Overall Study|Withdrawal by Subject|1|||
48525976|NCT01899326|156116627|FG000|Overall Study|Adverse Event|2|||
48525977|NCT01899326|156116627|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
48525978|NCT03139240|156116628|FG000|Overall Study|Lost to Follow-up|0|||
48525979|NCT03139240|156116629|FG001|Overall Study|Lost to Follow-up|1|||
48525980|NCT03139240|156116630|FG002|Overall Study|Lost to Follow-up|1|||
48525981|NCT03139240|156116631|FG003|Overall Study|Lost to Follow-up|0|||
48525982|NCT00104247|156116641|FG000|Overall Study|Withdrawal by Subject|1|||
48525983|NCT00104247|156116642|FG001|Overall Study|Withdrawal by Subject|0|||
48525984|NCT00104247|156116641|FG000|Overall Study|Noncompliant with dosing|0|||
48525985|NCT00104247|156116642|FG001|Overall Study|Noncompliant with dosing|1|||
48525986|NCT02415387|156118043|FG000|Overall Study|Withdrawal by Subject|6|||
48525987|NCT02415387|156118044|FG001|Overall Study|Withdrawal by Subject|1|||
48525988|NCT02415387|156118043|FG000|Overall Study|blood draw problem|0|||
48525989|NCT02415387|156118044|FG001|Overall Study|blood draw problem|1|||
48525990|NCT02415387|156118043|FG000|Overall Study|Protocol Violation|1|||
48525991|NCT02415387|156118044|FG001|Overall Study|Protocol Violation|0|||
48525992|NCT02426541|156118049|FG000|Overall Study|Protocol Violation|1|||
48525993|NCT02426541|156118050|FG001|Overall Study|Protocol Violation|0|||
48525994|NCT00784979|156118053|FG000|Overall Study|incomplete data|6|||
48525995|NCT00894933|156118063|FG000|Overall Study|Lost to Follow-up|2|||
48525996|NCT00894933|156118063|FG000|Overall Study|Cancelled Procedure|1|||
48525997|NCT00894933|156118063|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
48525998|NCT01867606|156118065|FG000|Overall Study|Withdrawal by Subject|10|||
48602110|NCT03327324|156399521|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
48602111|NCT03327324|156399522|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
48525999|NCT01867606|156118066|FG001|Overall Study|Withdrawal by Subject|14|||
48526000|NCT01867606|156118065|FG000|Overall Study|Protocol Violation|0|||
48526001|NCT01867606|156118066|FG001|Overall Study|Protocol Violation|1|||
48526002|NCT04252287|156118068|FG000|Overall Study|Death|5|||
48526003|NCT04252287|156118069|FG001|Overall Study|Death|3|||
48526004|NCT04252287|156118068|FG000|Overall Study|Lost to Follow-up|4|||
48526005|NCT04252287|156118069|FG001|Overall Study|Lost to Follow-up|6|||
48526006|NCT04252287|156118068|FG000|Overall Study|Withdrawal by Subject|19|||
48526007|NCT04252287|156118069|FG001|Overall Study|Withdrawal by Subject|16|||
48526008|NCT04252287|156118068|FG000|Overall Study|Protocol Violation|3|||
48526009|NCT04252287|156118069|FG001|Overall Study|Protocol Violation|4|||
48526010|NCT01908205|156118070|FG000|Overall Study|Lost to Follow-up|2|||
48526011|NCT01908205|156118071|FG001|Overall Study|Lost to Follow-up|0|||
48526012|NCT01908205|156118070|FG000|Overall Study|Withdrawal by Subject|3|||
48526013|NCT01908205|156118071|FG001|Overall Study|Withdrawal by Subject|1|||
48526014|NCT00440115|156118072|FG000|Overall Study|Death|7|||
48526015|NCT00440115|156118073|FG001|Overall Study|Death|9|||
48526016|NCT00440115|156118074|FG002|Overall Study|Death|5|||
48526017|NCT00440115|156118072|FG000|Overall Study|Incarceration|0|||
48526018|NCT00440115|156118073|FG001|Overall Study|Incarceration|2|||
48526019|NCT00440115|156118074|FG002|Overall Study|Incarceration|1|||
48526020|NCT00529217|156118076|FG000|Overall Study|Lack of Efficacy|2|||
48526021|NCT00529217|156118076|FG000|Overall Study|Unable to adhere to study schedule|2|||
48526022|NCT03507686|156118077|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
48526023|NCT03507686|156118078|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
48526024|NCT03507686|156118077|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
48827098|NCT00124982|157207415|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
48827099|NCT00124982|157207413|FG000|Long-term Period|Neurologist Recommendation|0|||
48827100|NCT00124982|157207414|FG001|Long-term Period|Neurologist Recommendation|0|||
48827101|NCT00124982|157207415|FG002|Long-term Period|Neurologist Recommendation|1|||
48827102|NCT01773122|157207416|FG000|Overall Study|Due to amended age eligibility criteria|3|||
48827103|NCT01773122|157207417|FG001|Overall Study|Due to amended age eligibility criteria|1|||
48827104|NCT01773122|157207418|FG002|Overall Study|Due to amended age eligibility criteria|0|||
48827105|NCT01773122|157207419|FG003|Overall Study|Due to amended age eligibility criteria|1|||
48827106|NCT00871429|157207420|FG000|Overall Study|Lost to Follow-up|6|||
48827107|NCT00871429|157207420|FG000|Overall Study|Withdrawal by Subject|17|||
48827108|NCT00871429|157207420|FG000|Overall Study|Questionnaire not completed|1|||
48827109|NCT03425539|157207421|FG000|Overall Study|Randomized but not treated|0|||
48827110|NCT03425539|157207422|FG001|Overall Study|Randomized but not treated|1|||
48827111|NCT03425539|157207421|FG000|Overall Study|Adverse Event|2|||
48827112|NCT03425539|157207422|FG001|Overall Study|Adverse Event|2|||
48827113|NCT03425539|157207421|FG000|Overall Study|Withdrawal by Subject|3|||
48827114|NCT03425539|157207422|FG001|Overall Study|Withdrawal by Subject|0|||
48827115|NCT03425539|157207421|FG000|Overall Study|Lost to Follow-up|0|||
48827116|NCT03425539|157207422|FG001|Overall Study|Lost to Follow-up|1|||
48827117|NCT02040844|157207423|FG000|Overall Study|Adverse Event|0|||
48827118|NCT02040844|157207424|FG001|Overall Study|Adverse Event|0|||
48827119|NCT02040844|157207425|FG002|Overall Study|Adverse Event|1|||
48827120|NCT02040844|157207423|FG000|Overall Study|Withdrawal by Subject|16|||
48827121|NCT02040844|157207424|FG001|Overall Study|Withdrawal by Subject|22|||
48827122|NCT02040844|157207425|FG002|Overall Study|Withdrawal by Subject|25|||
48827123|NCT02040844|157207423|FG000|Overall Study|Lost to Follow-up|12|||
48827124|NCT02040844|157207424|FG001|Overall Study|Lost to Follow-up|9|||
48827125|NCT02040844|157207425|FG002|Overall Study|Lost to Follow-up|13|||
48827126|NCT02040844|157207423|FG000|Overall Study|Missing|13|||
48827127|NCT02040844|157207424|FG001|Overall Study|Missing|3|||
48827128|NCT02040844|157207425|FG002|Overall Study|Missing|2|||
48827129|NCT02040844|157207423|FG000|Overall Study|Non-specified|8|||
48827130|NCT02040844|157207424|FG001|Overall Study|Non-specified|2|||
48827131|NCT02040844|157207425|FG002|Overall Study|Non-specified|5|||
48827132|NCT02040844|157207423|FG000|Overall Study|Concomitant medication|1|||
48827133|NCT02040844|157207424|FG001|Overall Study|Concomitant medication|3|||
48827134|NCT02040844|157207425|FG002|Overall Study|Concomitant medication|1|||
48827135|NCT01772719|157207426|FG000|Overall Study|Withdrawal by Subject|3|||
48827136|NCT01772719|157207426|FG000|Overall Study|Adverse Event|2|||
48827137|NCT01772719|157207426|FG000|Overall Study|Protocol Violation|1|||
48827138|NCT01772719|157207426|FG000|Overall Study|Lost to Follow-up|1|||
48827139|NCT04159506|157207427|FG000|Overall Study|Lost to Follow-up|2|||
48827140|NCT04159506|157207428|FG001|Overall Study|Lost to Follow-up|5|||
48827141|NCT02949271|157208846|FG000|Overall Study|Lack of Efficacy|5|||
48827142|NCT02949271|157208847|FG001|Overall Study|Lack of Efficacy|4|||
48827143|NCT02949271|157208846|FG000|Overall Study|Lost to Follow-up|3|||
48827144|NCT02949271|157208847|FG001|Overall Study|Lost to Follow-up|6|||
48827145|NCT02949271|157208846|FG000|Overall Study|Physician Decision|5|||
48526025|NCT03507686|156118078|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
48526026|NCT03507686|156118077|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
48526027|NCT03507686|156118078|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
48526028|NCT03507686|156118077|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
48526029|NCT03507686|156118078|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
48827146|NCT02949271|157208847|FG001|Overall Study|Physician Decision|5|||
48827147|NCT02949271|157208846|FG000|Overall Study|Protocol Violation|6|||
48827148|NCT02949271|157208847|FG001|Overall Study|Protocol Violation|3|||
48827149|NCT02949271|157208846|FG000|Overall Study|Withdrawal by Subject|1|||
48827150|NCT02949271|157208847|FG001|Overall Study|Withdrawal by Subject|0|||
48827151|NCT02949271|157208846|FG000|Overall Study|Delivered prior to intervention|7|||
48827152|NCT02949271|157208847|FG001|Overall Study|Delivered prior to intervention|9|||
48827153|NCT02949271|157208846|FG000|Overall Study|Outside the window for cervical dilation|2|||
48526030|NCT03507686|156118077|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
48526031|NCT03507686|156118078|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
48526032|NCT03507686|156118077|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
48526033|NCT03507686|156118078|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
48526034|NCT01439724|156118085|FG000|Overall Study|missing consultation|9|||
48526035|NCT01439724|156118086|FG001|Overall Study|missing consultation|8|||
48526036|NCT02508116|156118087|FG000|Overall Study|Lost to Follow-up|2|||
48526037|NCT02508116|156118088|FG001|Overall Study|Lost to Follow-up|3|||
48526038|NCT02508116|156118087|FG000|Overall Study|Withdrawal by Subject|3|||
48526039|NCT02508116|156118088|FG001|Overall Study|Withdrawal by Subject|2|||
48526040|NCT02508116|156118087|FG000|Overall Study|Protocol Violation|1|||
48526041|NCT02508116|156118088|FG001|Overall Study|Protocol Violation|2|||
48526042|NCT02508116|156118087|FG000|Overall Study|Physician Decision|2|||
48526043|NCT02508116|156118088|FG001|Overall Study|Physician Decision|0|||
48526044|NCT03429049|156118092|FG000|Overall Study|Adverse Event|2|||
48526045|NCT03429049|156118093|FG001|Overall Study|Adverse Event|3|||
48526046|NCT03429049|156118092|FG000|Overall Study|Death|0|||
48526047|NCT03429049|156118093|FG001|Overall Study|Death|1|||
48526048|NCT03429049|156118092|FG000|Overall Study|Lack of Efficacy|4|||
48526049|NCT03429049|156118093|FG001|Overall Study|Lack of Efficacy|2|||
48526050|NCT03429049|156118092|FG000|Overall Study|Lost to Follow-up|9|||
48526051|NCT03429049|156118093|FG001|Overall Study|Lost to Follow-up|8|||
48526052|NCT03429049|156118092|FG000|Overall Study|Physician Decision|1|||
48526053|NCT03429049|156118093|FG001|Overall Study|Physician Decision|0|||
48734851|NCT03911713|156880762|FG002|Overall Study|Other|0|||
48734852|NCT03911713|156880763|FG003|Overall Study|Other|1|||
48734853|NCT03911713|156880764|FG004|Overall Study|Other|0|||
48734854|NCT03911713|156880760|FG000|Overall Study|Randomized, Never Dosed|1|||
48734855|NCT03911713|156880761|FG001|Overall Study|Randomized, Never Dosed|0|||
48734856|NCT03911713|156880762|FG002|Overall Study|Randomized, Never Dosed|0|||
48734857|NCT03911713|156880763|FG003|Overall Study|Randomized, Never Dosed|1|||
48734858|NCT03911713|156880764|FG004|Overall Study|Randomized, Never Dosed|0|||
48734859|NCT04447417|156880765|FG000|Overall Study|Withdrawal by Subject|1|||
48734860|NCT04447417|156880766|FG001|Overall Study|Withdrawal by Subject|0|||
48734861|NCT04447417|156880765|FG000|Overall Study|Failure to meet inclusion criteria|1|||
48734862|NCT04447417|156880766|FG001|Overall Study|Failure to meet inclusion criteria|0|||
48734863|NCT04447417|156880765|FG000|Overall Study|Lost to Follow-up|1|||
48734864|NCT04447417|156880766|FG001|Overall Study|Lost to Follow-up|0|||
48734865|NCT02423109|156880768|FG000|Lens 1|Adverse Event|1|||
48734866|NCT02423109|156880769|FG001|Lens 1|Adverse Event|0|||
48734867|NCT02203071|156880770|FG000|Overall Study|Lost to Follow-up|3|||
48734868|NCT02203071|156880771|FG001|Overall Study|Lost to Follow-up|1|||
48734869|NCT02186873|156880772|FG000|Overall Study|Adverse Event|1|||
48827154|NCT02949271|157208847|FG001|Overall Study|Outside the window for cervical dilation|3|||
48526054|NCT03429049|156118092|FG000|Overall Study|Protocol Violation|3|||
48526055|NCT03429049|156118093|FG001|Overall Study|Protocol Violation|0|||
48526056|NCT03429049|156118092|FG000|Overall Study|Sponsor Decision|2|||
48526057|NCT03429049|156118093|FG001|Overall Study|Sponsor Decision|0|||
48526058|NCT03429049|156118092|FG000|Overall Study|Withdrawal by Subject|4|||
48526059|NCT03429049|156118093|FG001|Overall Study|Withdrawal by Subject|20|||
48526060|NCT03429049|156118092|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
48526061|NCT03429049|156118093|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
48526062|NCT04234464|156118095|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
48526063|NCT04234464|156118096|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
48526064|NCT01857206|156118101|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
48526065|NCT01857206|156118102|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
48526066|NCT01857206|156118101|FG000|Overall Study|Lost to Follow-up|9|||
48526067|NCT01857206|156118102|FG001|Overall Study|Lost to Follow-up|6|||
48526068|NCT01857206|156118101|FG000|Overall Study|Unclassified|3|||
48526069|NCT01857206|156118102|FG001|Overall Study|Unclassified|3|||
48526070|NCT01857206|156118101|FG000|Overall Study|Withdrawal by Subject|1|||
48734870|NCT02186873|156880773|FG001|Overall Study|Adverse Event|3|||
48734871|NCT02186873|156880772|FG000|Overall Study|Lack of Efficacy|0|||
48734872|NCT02186873|156880773|FG001|Overall Study|Lack of Efficacy|1|||
48734873|NCT02186873|156880772|FG000|Overall Study|Lost to Follow-up|1|||
48734874|NCT02186873|156880773|FG001|Overall Study|Lost to Follow-up|2|||
48526071|NCT01857206|156118102|FG001|Overall Study|Withdrawal by Subject|0|||
48526072|NCT00983528|156118103|FG000|Overall Study|Death|4|||
48526073|NCT00983528|156118103|FG000|Overall Study|Lost to Follow-up|1|||
48526074|NCT00983528|156118103|FG000|Overall Study|Study Terminated|1|||
48526075|NCT03635983|156118104|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
48526076|NCT03635983|156118105|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
48526077|NCT03635983|156118104|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
48526078|NCT03635983|156118105|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
48526079|NCT03635983|156118104|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
48526080|NCT03635983|156118105|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48526081|NCT03635983|156118104|FG000|Pre-Treatment Period|Other reasons|1|||
48734875|NCT02186873|156880772|FG000|Overall Study|Withdrawal by Subject|7|||
48734876|NCT02186873|156880773|FG001|Overall Study|Withdrawal by Subject|2|||
48734877|NCT01973569|156880777|FG000|Overall Study|Adverse Event|9|||
48734878|NCT01973569|156880778|FG001|Overall Study|Adverse Event|2|||
48734879|NCT01973569|156880779|FG002|Overall Study|Adverse Event|4|||
48734880|NCT01973569|156880777|FG000|Overall Study|Protocol Violation|2|||
48734881|NCT01973569|156880778|FG001|Overall Study|Protocol Violation|1|||
48734882|NCT01973569|156880779|FG002|Overall Study|Protocol Violation|3|||
48734883|NCT01973569|156880777|FG000|Overall Study|Withdrawal by Subject|7|||
48734884|NCT01973569|156880778|FG001|Overall Study|Withdrawal by Subject|5|||
48734885|NCT01973569|156880779|FG002|Overall Study|Withdrawal by Subject|2|||
48734886|NCT01973569|156880777|FG000|Overall Study|Invasive dental treatment|3|||
48734887|NCT01973569|156880778|FG001|Overall Study|Invasive dental treatment|5|||
48734888|NCT01973569|156880779|FG002|Overall Study|Invasive dental treatment|6|||
48734889|NCT01973569|156880777|FG000|Overall Study|Prohibited concomitant d|1|||
48734890|NCT01973569|156880778|FG001|Overall Study|Prohibited concomitant d|5|||
48734891|NCT01973569|156880779|FG002|Overall Study|Prohibited concomitant d|0|||
48734892|NCT01973569|156880777|FG000|Overall Study|Disease progression|0|||
48734893|NCT01973569|156880778|FG001|Overall Study|Disease progression|3|||
48734894|NCT01973569|156880779|FG002|Overall Study|Disease progression|0|||
48734895|NCT01973569|156880777|FG000|Overall Study|Other|1|||
48734896|NCT01973569|156880778|FG001|Overall Study|Other|1|||
48734897|NCT01973569|156880779|FG002|Overall Study|Other|0|||
48734898|NCT01973569|156880777|FG000|Overall Study|Did not receive study drug|6|||
48734899|NCT01973569|156880778|FG001|Overall Study|Did not receive study drug|3|||
48734900|NCT01973569|156880779|FG002|Overall Study|Did not receive study drug|3|||
48734901|NCT00137631|156880783|FG000|Overall Study|Lost to Follow-up|37|||
48734902|NCT00137631|156880784|FG001|Overall Study|Lost to Follow-up|41|||
48734903|NCT04087213|156880789|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
48734904|NCT04087213|156880789|FG000|In-Facility Introduction|Adverse Event|1|||
48734905|NCT04087213|156880789|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
48734906|NCT04087213|156880789|FG000|Assisted Evaluable Period|Personal reasons|3|||
48827155|NCT01460381|157208848|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
48827156|NCT01460381|157208849|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
48827157|NCT01097655|157208850|FG000|Overall Study|Withdrawal by Subject|1|||
48827158|NCT01097655|157208850|FG000|Overall Study|Subject Documented Twice|1|||
48827159|NCT01097655|157208850|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
48526082|NCT03635983|156118105|FG001|Pre-Treatment Period|Other reasons|2|||
48734907|NCT04087213|156880789|FG000|Transition Period B|Renal Transplantation|1|||
48734908|NCT02024529|156880790|FG000|Overall Study|Withdrawal by Subject|11|||
48734909|NCT02024529|156880791|FG001|Overall Study|Withdrawal by Subject|21|||
48827160|NCT01345292|157208851|FG000|Overall Study|Withdrawal by Subject|2|||
48827161|NCT01345292|157208852|FG001|Overall Study|Withdrawal by Subject|0|||
48526083|NCT03635983|156118104|FG000|Pre-Treatment Period|Disease Progression|0|||
48526084|NCT03635983|156118105|FG001|Pre-Treatment Period|Disease Progression|1|||
48526085|NCT03635983|156118104|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
48526086|NCT03635983|156118105|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
48526087|NCT03635983|156118104|FG000|Treatment Period|Completed treatment period|13|||
48526088|NCT03635983|156118105|FG001|Treatment Period|Completed treatment period|20|||
48526089|NCT03635983|156118104|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
48526090|NCT03635983|156118105|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
48526091|NCT03635983|156118104|FG000|Treatment Period|Withdrawal by Subject|2|||
48526092|NCT03635983|156118105|FG001|Treatment Period|Withdrawal by Subject|4|||
48526093|NCT03635983|156118104|FG000|Treatment Period|Death|3|||
48526094|NCT03635983|156118105|FG001|Treatment Period|Death|4|||
48526095|NCT03635983|156118104|FG000|Treatment Period|Poor/Non-compliance|1|||
48526096|NCT03635983|156118105|FG001|Treatment Period|Poor/Non-compliance|0|||
48526097|NCT03635983|156118104|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
48526098|NCT03635983|156118105|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
48526099|NCT03635983|156118104|FG000|Treatment Period|Other reasons|5|||
48526100|NCT03635983|156118105|FG001|Treatment Period|Other reasons|2|||
48526101|NCT03635983|156118104|FG000|Treatment Period|Disease progression|184|||
48526102|NCT03635983|156118105|FG001|Treatment Period|Disease progression|168|||
48526103|NCT03635983|156118104|FG000|Treatment Period|Study drug toxicity|26|||
48526104|NCT03635983|156118105|FG001|Treatment Period|Study drug toxicity|29|||
48526105|NCT03635983|156118104|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
48526106|NCT03635983|156118105|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
48526107|NCT03635983|156118104|FG000|Treatment Period|Maximum clinical benefit|3|||
48526108|NCT03635983|156118105|FG001|Treatment Period|Maximum clinical benefit|2|||
48526109|NCT01483625|156118107|FG000|Overall Study|Adverse Event|1|||
48526110|NCT01483625|156118108|FG001|Overall Study|Adverse Event|1|||
48526111|NCT01483625|156118107|FG000|Overall Study|Refused to continue medication|2|||
48526112|NCT01483625|156118108|FG001|Overall Study|Refused to continue medication|1|||
48526113|NCT01483625|156118107|FG000|Overall Study|Due to other reason|1|||
48734910|NCT02024529|156880790|FG000|Overall Study|Lost to Follow-up|2|||
48734911|NCT02024529|156880791|FG001|Overall Study|Lost to Follow-up|4|||
48734912|NCT01788046|156880793|FG000|Overall Study|Withdrawal by Subject|12|||
48734913|NCT01788046|156880794|FG001|Overall Study|Withdrawal by Subject|12|||
48734914|NCT01788046|156880793|FG000|Overall Study|Lost to Follow-up|12|||
48734915|NCT01788046|156880794|FG001|Overall Study|Lost to Follow-up|19|||
48734916|NCT01788046|156880793|FG000|Overall Study|Death|7|||
48734917|NCT01788046|156880794|FG001|Overall Study|Death|5|||
48734918|NCT01788046|156880793|FG000|Overall Study|Protocol Specified Criteria|25|||
48734919|NCT01788046|156880794|FG001|Overall Study|Protocol Specified Criteria|1|||
48734920|NCT02124161|156880795|FG000|Overall Study|Other unspecified|0|||
48734921|NCT02124161|156880796|FG001|Overall Study|Other unspecified|1|||
48734922|NCT02124161|156880795|FG000|Overall Study|Death|1|||
48734923|NCT02124161|156880796|FG001|Overall Study|Death|0|||
48734924|NCT02124161|156880795|FG000|Overall Study|Protocol Violation|2|||
48734925|NCT02124161|156880796|FG001|Overall Study|Protocol Violation|1|||
48734926|NCT02124161|156880795|FG000|Overall Study|Withdrawal by Subject|1|||
48734927|NCT02124161|156880796|FG001|Overall Study|Withdrawal by Subject|2|||
48734928|NCT02124161|156880795|FG000|Overall Study|Adverse Event|2|||
48734929|NCT02124161|156880796|FG001|Overall Study|Adverse Event|0|||
48734930|NCT02124161|156880795|FG000|Overall Study|Does not meet entrance criteria|2|||
48734931|NCT02124161|156880796|FG001|Overall Study|Does not meet entrance criteria|3|||
48734932|NCT02124161|156880795|FG000|Overall Study|No longer meets eligibility criteria|5|||
48734933|NCT02124161|156880796|FG001|Overall Study|No longer meets eligibility criteria|4|||
48734934|NCT02124161|156880795|FG000|Overall Study|Lost to Follow-up|3|||
48734935|NCT02124161|156880796|FG001|Overall Study|Lost to Follow-up|4|||
48734936|NCT01332331|156880802|FG000|Overall Study|Lost to Follow-up|0|||
48734937|NCT01332331|156880803|FG001|Overall Study|Lost to Follow-up|1|||
48734938|NCT01332331|156880802|FG000|Overall Study|Adverse Event|1|||
48734939|NCT01332331|156880803|FG001|Overall Study|Adverse Event|1|||
48734940|NCT01332331|156880802|FG000|Overall Study|Physician Decision|1|||
48734941|NCT01332331|156880803|FG001|Overall Study|Physician Decision|0|||
48734942|NCT03605212|156880804|FG000|Treatment Period|Adverse Event|1|||
48734943|NCT03605212|156880805|FG001|Treatment Period|Adverse Event|0|||
48734944|NCT03605212|156880806|FG002|Treatment Period|Adverse Event|0|||
48734945|NCT03605212|156880807|FG003|Treatment Period|Adverse Event|0|||
48734946|NCT03605212|156880808|FG004|Treatment Period|Adverse Event|0|||
48734947|NCT03605212|156880804|FG000|Treatment Period|Physician Decision|0|||
48734948|NCT03605212|156880805|FG001|Treatment Period|Physician Decision|0|||
48734949|NCT03605212|156880806|FG002|Treatment Period|Physician Decision|0|||
48734950|NCT03605212|156880807|FG003|Treatment Period|Physician Decision|0|||
48734951|NCT03605212|156880808|FG004|Treatment Period|Physician Decision|1|||
48734952|NCT02019277|156880809|FG000|Overall Study|Withdrawal by Subject|3|||
48734953|NCT02019277|156880809|FG000|Overall Study|Death|7|||
48734954|NCT02019277|156880809|FG000|Overall Study|Did no Cooperate|1|||
48734955|NCT02019277|156880809|FG000|Overall Study|Adverse Event|1|||
48734956|NCT00071396|156880812|FG000|Overall Study|Withdrawal by Subject|1|||
48734957|NCT00071396|156880812|FG000|Overall Study|Physician Decision|2|||
48734958|NCT00839852|156880813|FG000|Overall Study|Adverse Event|10|||
48734959|NCT00839852|156880813|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48734960|NCT00839852|156880813|FG000|Overall Study|Protocol Violation|9|||
48734961|NCT00839852|156880813|FG000|Overall Study|Withdrawal of Consent|16|||
48734962|NCT00839852|156880813|FG000|Overall Study|Lost to Follow-up|7|||
48734963|NCT00839852|156880813|FG000|Overall Study|Lack of Compliance While in Jail|1|||
48734964|NCT00839852|156880813|FG000|Overall Study|Pregnancy|1|||
48734965|NCT02149875|156880814|FG000|Overall Study|Lost to Follow-up|3|||
48734966|NCT02149875|156880815|FG001|Overall Study|Lost to Follow-up|4|||
48734967|NCT02149875|156880816|FG002|Overall Study|Lost to Follow-up|5|||
48734968|NCT02149875|156880814|FG000|Overall Study|Withdrawal by Subject|3|||
48734969|NCT02149875|156880815|FG001|Overall Study|Withdrawal by Subject|2|||
48602112|NCT03327324|156399523|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
48734970|NCT02149875|156880816|FG002|Overall Study|Withdrawal by Subject|2|||
48602113|NCT03327324|156399524|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
48734971|NCT02149875|156880814|FG000|Overall Study|Physician Decision|1|||
48734972|NCT02149875|156880815|FG001|Overall Study|Physician Decision|2|||
48734973|NCT02149875|156880816|FG002|Overall Study|Physician Decision|2|||
48734974|NCT00702689|156880829|FG000|Overall Study|Withdrawal by Subject|4|||
48734975|NCT00702689|156880829|FG000|Overall Study|Recurrent malignancy|1|||
48734976|NCT00702689|156880829|FG000|Overall Study|Adverse Event|1|||
48734977|NCT01262573|156880830|FG000|Overall Study|Withdrawal by Subject|0|||
48734978|NCT01262573|156880831|FG001|Overall Study|Withdrawal by Subject|1|||
48734979|NCT04043728|156880840|FG000|Overall Study|Lost to Follow-up|1|||
48734980|NCT04043728|156880841|FG001|Overall Study|Lost to Follow-up|2|||
48734981|NCT04043728|156880842|FG002|Overall Study|Lost to Follow-up|0|||
48734982|NCT00331422|156880845|FG000|Overall Study|Did not receive entire study regimen|5|||
48734983|NCT03643159|156880852|FG000|Overall Study|Adverse Event|1|||
48734984|NCT03643159|156880852|FG000|Overall Study|Withdrawal by Subject|1|||
48734985|NCT02081183|156880855|FG000|Overall Study|Lost to Follow-up|0|||
48734986|NCT02081183|156880856|FG001|Overall Study|Lost to Follow-up|1|||
48734987|NCT02081183|156880855|FG000|Overall Study|Protocol Violation|1|||
48734988|NCT02081183|156880856|FG001|Overall Study|Protocol Violation|0|||
48734989|NCT02081183|156880855|FG000|Overall Study|Other|3|||
48734990|NCT02081183|156880856|FG001|Overall Study|Other|3|||
48734991|NCT03386474|156880857|FG000|Overall Study|Death|1|||
48734992|NCT03386474|156880858|FG001|Overall Study|Death|0|||
48734993|NCT03386474|156880857|FG000|Overall Study|Adverse Event|0|||
48734994|NCT03386474|156880858|FG001|Overall Study|Adverse Event|1|||
48734995|NCT00788073|156880863|FG000|STX209 Then Placebo|Adverse Event|1|||
48734996|NCT00788073|156880864|FG001|STX209 Then Placebo|Adverse Event|0|||
48734997|NCT00788073|156880863|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
48734998|NCT00788073|156880864|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
48734999|NCT00788073|156880863|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
48735000|NCT00788073|156880864|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
48735001|NCT00788073|156880863|FG000|STX209 Then Placebo|unable to return due to travel|0|||
48735002|NCT00788073|156880864|FG001|STX209 Then Placebo|unable to return due to travel|1|||
48735003|NCT00788073|156880863|FG000|Placebo Then STX209|Adverse Event|2|||
48735004|NCT00788073|156880864|FG001|Placebo Then STX209|Adverse Event|0|||
48735005|NCT00788073|156880863|FG000|Placebo Then STX209|Protocol Violation|0|||
48735006|NCT00788073|156880864|FG001|Placebo Then STX209|Protocol Violation|1|||
48735007|NCT02282358|156880866|FG000|Overall Study|Nonevaluable|1|||
48735008|NCT02155881|156880867|FG000|Overall Study|Withdrawal by Subject|0|||
48735009|NCT02155881|156880868|FG001|Overall Study|Withdrawal by Subject|2|||
48735010|NCT02155881|156880867|FG000|Overall Study|Inappropriately randomized|2|||
48526114|NCT01483625|156118108|FG001|Overall Study|Due to other reason|0|||
48735011|NCT02155881|156880868|FG001|Overall Study|Inappropriately randomized|2|||
48735012|NCT04357782|156880869|FG000|Overall Study|Discharged from hospital|1|||
48735013|NCT04357782|156880870|FG001|Overall Study|Discharged from hospital|0|||
48735014|NCT04357782|156880869|FG000|Overall Study|Death|0|||
48735015|NCT04357782|156880870|FG001|Overall Study|Death|2|||
48735016|NCT00579098|156880873|FG000|Overall Study|Lost to Follow-up|2|||
48735017|NCT00579098|156880874|FG001|Overall Study|Lost to Follow-up|0|||
48735018|NCT00579098|156880873|FG000|Overall Study|Adverse Event|2|||
48735019|NCT00579098|156880874|FG001|Overall Study|Adverse Event|3|||
48735020|NCT00579098|156880873|FG000|Overall Study|Withdrawal by Subject|2|||
48735021|NCT00579098|156880874|FG001|Overall Study|Withdrawal by Subject|3|||
48735022|NCT00579098|156880873|FG000|Overall Study|AF returned after ablation|3|||
48735023|NCT00579098|156880874|FG001|Overall Study|AF returned after ablation|2|||
48735024|NCT02436681|156880875|FG000|Overall Study|Lost to Follow-up|10|||
48735025|NCT02436681|156880875|FG000|Overall Study|Withdrawal by Subject|2|||
48735026|NCT02436681|156880875|FG000|Overall Study|Death|2|||
48735027|NCT00406718|156880878|FG000|Overall Study|Withdrawal by Subject|2|||
48735028|NCT00406718|156880879|FG001|Overall Study|Withdrawal by Subject|9|||
48735029|NCT00406718|156880880|FG002|Overall Study|Withdrawal by Subject|4|||
48735030|NCT00406718|156880878|FG000|Overall Study|Lost to Follow-up|2|||
48735031|NCT00406718|156880879|FG001|Overall Study|Lost to Follow-up|5|||
48735032|NCT00406718|156880880|FG002|Overall Study|Lost to Follow-up|4|||
48735033|NCT00287365|156880881|FG000|Overall Study|sample not acquired|13|||
48735034|NCT00447005|156880883|FG000|Overall Study|Adverse Event|1|||
48735035|NCT00447005|156880883|FG000|Overall Study|Lack of Efficacy|11|||
48735036|NCT02628938|156880884|FG000|Overall Study|Did not attend the follow up recall|2|||
48526115|NCT00575380|156118112|FG000|Overall Study|Withdrawal by Subject|1|||
48735037|NCT02628938|156880885|FG001|Overall Study|Did not attend the follow up recall|2|||
48735038|NCT02628938|156880886|FG002|Overall Study|Did not attend the follow up recall|1|||
48735039|NCT02628938|156880884|FG000|Overall Study|Failure to comply with the instructions|3|||
48735040|NCT02628938|156880885|FG001|Overall Study|Failure to comply with the instructions|0|||
48735041|NCT02628938|156880886|FG002|Overall Study|Failure to comply with the instructions|3|||
48735042|NCT00165984|156880887|FG000|Overall Study|Death|15|||
48735043|NCT00398411|156882169|FG000|Overall Study|Death|0|||
48735044|NCT00398411|156882170|FG001|Overall Study|Death|1|||
48735045|NCT01614600|156882171|FG000|Overall Study|Unacceptable fit|1|||
48735046|NCT01614600|156882171|FG000|Overall Study|Discomfort|1|||
48735047|NCT01614600|156882171|FG000|Overall Study|Unable to remove lens at the end of day|1|||
48735048|NCT01614600|156882171|FG000|Overall Study|Protocol deviation|1|||
48735049|NCT01858376|156882172|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
48735050|NCT01680965|156882173|FG000|Overall Study|Death|0|||
48735051|NCT01680965|156882174|FG001|Overall Study|Death|0|||
48526116|NCT00575380|156118113|FG001|Overall Study|Withdrawal by Subject|0|||
48735052|NCT01680965|156882175|FG002|Overall Study|Death|0|||
48735053|NCT01680965|156882176|FG003|Overall Study|Death|6|||
48735054|NCT00195273|156882177|FG000|Overall Study|Adverse Event|9|||
48735055|NCT00195273|156882178|FG001|Overall Study|Adverse Event|9|||
48735056|NCT00195273|156882177|FG000|Overall Study|Protocol deviation|0|||
48735057|NCT00195273|156882178|FG001|Overall Study|Protocol deviation|1|||
48735058|NCT00195273|156882177|FG000|Overall Study|Lack of Efficacy|3|||
48735059|NCT00195273|156882178|FG001|Overall Study|Lack of Efficacy|1|||
48735060|NCT00195273|156882177|FG000|Overall Study|Procedural complications|9|||
48735061|NCT00195273|156882178|FG001|Overall Study|Procedural complications|3|||
48735062|NCT04587271|156882179|FG000|Overall Study|Lost to Follow-up|2|||
48735063|NCT04587271|156882180|FG001|Overall Study|Lost to Follow-up|2|||
48735064|NCT04587271|156882181|FG002|Overall Study|Lost to Follow-up|0|||
48735065|NCT04587271|156882182|FG003|Overall Study|Lost to Follow-up|2|||
48735066|NCT04587271|156882183|FG004|Overall Study|Lost to Follow-up|2|||
48735067|NCT04587271|156882184|FG005|Overall Study|Lost to Follow-up|0|||
48735068|NCT04587271|156882179|FG000|Overall Study|Caregiver brought child to visits|0|||
48735069|NCT04587271|156882180|FG001|Overall Study|Caregiver brought child to visits|0|||
48735070|NCT04587271|156882181|FG002|Overall Study|Caregiver brought child to visits|0|||
48735071|NCT04587271|156882182|FG003|Overall Study|Caregiver brought child to visits|1|||
48735072|NCT04587271|156882183|FG004|Overall Study|Caregiver brought child to visits|0|||
48735073|NCT04587271|156882184|FG005|Overall Study|Caregiver brought child to visits|0|||
48735074|NCT04622306|156882185|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
48735075|NCT04622306|156882186|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
48735076|NCT04622306|156882187|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
48735077|NCT04622306|156882188|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
48735078|NCT04622306|156882189|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
48735079|NCT04622306|156882190|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
48735080|NCT04622306|156882185|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
48735081|NCT04622306|156882186|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
48735082|NCT04622306|156882187|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
48735083|NCT04622306|156882188|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
48735084|NCT04622306|156882189|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
48735085|NCT04622306|156882190|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
48735086|NCT00354614|156882191|FG000|Overall Study|Lack of Efficacy|28|||
48735087|NCT01601132|156882194|FG000|Overall Study|Patient withdrew consent|1|||
48735088|NCT01601132|156882194|FG000|Overall Study|Protocol deviation|1|||
48735089|NCT02601027|156882199|FG000|Registration to Surgery|Withdrawal by Subject|20|||
48735090|NCT02601027|156882200|FG001|Registration to Surgery|Withdrawal by Subject|10|||
48735091|NCT00737438|156882206|FG000|Overall Study|Withdrawal by Subject|2|||
48735092|NCT00737438|156882206|FG000|Overall Study|Patient ineligible|1|||
48735093|NCT03626168|156882207|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48735094|NCT03626168|156882208|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
48827162|NCT01345292|157208853|FG002|Overall Study|Withdrawal by Subject|1|||
48827163|NCT05458102|157208854|FG000|Overall Study|Withdrew consent|2|||
48827164|NCT05458102|157208855|FG001|Overall Study|Withdrew consent|0|||
48827165|NCT05458102|157208854|FG000|Overall Study|Adverse Event|1|||
48827166|NCT05458102|157208855|FG001|Overall Study|Adverse Event|0|||
48827167|NCT05458102|157208854|FG000|Overall Study|Enrolled but never treated|1|||
48827168|NCT05458102|157208855|FG001|Overall Study|Enrolled but never treated|0|||
48827169|NCT05458102|157208854|FG000|Overall Study|Protocol Violation|1|||
48827170|NCT05458102|157208855|FG001|Overall Study|Protocol Violation|0|||
48827171|NCT04454567|157208862|FG000|Overall Study|Study Terminated by Sponsor|1|||
48827172|NCT04454567|157208863|FG001|Overall Study|Study Terminated by Sponsor|1|||
48827173|NCT01516892|157208865|FG000|Overall Study|Adverse Event|25|||
48827174|NCT01516892|157208865|FG000|Overall Study|Lack of Efficacy|35|||
48827175|NCT01516892|157208865|FG000|Overall Study|Pregnancy|5|||
48827176|NCT01516892|157208865|FG000|Overall Study|Lost to Follow-up|82|||
48827177|NCT01516892|157208865|FG000|Overall Study|Subject Withdrew Consent|92|||
48827178|NCT01516892|157208865|FG000|Overall Study|Protocol Violation|60|||
48526117|NCT00575380|156118112|FG000|Overall Study|Adverse Event|0|||
48526118|NCT00575380|156118113|FG001|Overall Study|Adverse Event|1|||
48526119|NCT00575380|156118112|FG000|Overall Study|Various|0|||
48526120|NCT00575380|156118113|FG001|Overall Study|Various|2|||
48526121|NCT00559364|156118114|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
48526122|NCT00559364|156118115|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
48735095|NCT03626168|156882207|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
48735096|NCT03626168|156882208|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
48735097|NCT03626168|156882207|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48735098|NCT03626168|156882208|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
48735099|NCT04289623|156882209|FG000|Wave 1 Emails|Email was not delivered|268|||
48735100|NCT04289623|156882210|FG001|Wave 1 Emails|Email was not delivered|257|||
48735101|NCT04289623|156882211|FG002|Wave 1 Emails|Email was not delivered|0|||
48735102|NCT04289623|156882212|FG003|Wave 1 Emails|Email was not delivered|0|||
48735103|NCT04289623|156882213|FG004|Wave 1 Emails|Email was not delivered|0|||
48735104|NCT04289623|156882214|FG005|Wave 1 Emails|Email was not delivered|0|||
48735105|NCT03758443|156882215|FG000|Induction Period|Adverse Event|2|||
48735106|NCT03758443|156882216|FG001|Induction Period|Adverse Event|4|||
48526123|NCT04126343|156118116|FG000|Overall Study|Adverse Event|0|||
48526124|NCT04126343|156118117|FG001|Overall Study|Adverse Event|0|||
48735107|NCT03758443|156882217|FG002|Induction Period|Adverse Event|2|||
48735108|NCT03758443|156882218|FG003|Induction Period|Adverse Event|3|||
48735109|NCT03758443|156882215|FG000|Induction Period|Physician Decision|1|||
48735110|NCT03758443|156882216|FG001|Induction Period|Physician Decision|1|||
48735111|NCT03758443|156882217|FG002|Induction Period|Physician Decision|3|||
48735112|NCT03758443|156882218|FG003|Induction Period|Physician Decision|0|||
48735113|NCT03758443|156882215|FG000|Induction Period|Protocol Violation|0|||
48735114|NCT03758443|156882216|FG001|Induction Period|Protocol Violation|0|||
48735115|NCT03758443|156882217|FG002|Induction Period|Protocol Violation|0|||
48735116|NCT03758443|156882218|FG003|Induction Period|Protocol Violation|1|||
48735117|NCT03758443|156882215|FG000|Induction Period|Withdrawal by Subject|3|||
48735118|NCT03758443|156882216|FG001|Induction Period|Withdrawal by Subject|2|||
48735119|NCT03758443|156882217|FG002|Induction Period|Withdrawal by Subject|2|||
48735120|NCT03758443|156882218|FG003|Induction Period|Withdrawal by Subject|4|||
48735121|NCT03758443|156882215|FG000|Extended Induction Period|Adverse Event|1|||
48735122|NCT03758443|156882216|FG001|Extended Induction Period|Adverse Event|1|||
48735123|NCT03758443|156882217|FG002|Extended Induction Period|Adverse Event|0|||
48735124|NCT03758443|156882218|FG003|Extended Induction Period|Adverse Event|1|||
48735125|NCT03758443|156882215|FG000|Extended Induction Period|Lost to Follow-up|1|||
48735126|NCT03758443|156882216|FG001|Extended Induction Period|Lost to Follow-up|0|||
48735127|NCT03758443|156882217|FG002|Extended Induction Period|Lost to Follow-up|0|||
48735128|NCT03758443|156882218|FG003|Extended Induction Period|Lost to Follow-up|0|||
48735129|NCT03758443|156882215|FG000|Extended Induction Period|Physician Decision|2|||
48735130|NCT03758443|156882216|FG001|Extended Induction Period|Physician Decision|1|||
48735131|NCT03758443|156882217|FG002|Extended Induction Period|Physician Decision|2|||
48735132|NCT03758443|156882218|FG003|Extended Induction Period|Physician Decision|2|||
48735133|NCT03758443|156882215|FG000|Extended Induction Period|Protocol Violation|0|||
48735134|NCT03758443|156882216|FG001|Extended Induction Period|Protocol Violation|0|||
48735135|NCT03758443|156882217|FG002|Extended Induction Period|Protocol Violation|0|||
48735136|NCT03758443|156882218|FG003|Extended Induction Period|Protocol Violation|1|||
48735137|NCT03758443|156882215|FG000|Extended Induction Period|Withdrawal by Subject|8|||
48735138|NCT03758443|156882216|FG001|Extended Induction Period|Withdrawal by Subject|1|||
48735139|NCT03758443|156882217|FG002|Extended Induction Period|Withdrawal by Subject|7|||
48735140|NCT03758443|156882218|FG003|Extended Induction Period|Withdrawal by Subject|3|||
48735141|NCT03758443|156882215|FG000|Extended Induction Period|Miscellaneous|1|||
48735142|NCT03758443|156882216|FG001|Extended Induction Period|Miscellaneous|0|||
48735143|NCT03758443|156882217|FG002|Extended Induction Period|Miscellaneous|0|||
48735144|NCT03758443|156882218|FG003|Extended Induction Period|Miscellaneous|0|||
48735145|NCT03758443|156882215|FG000|Maintenance Period|Adverse Event|1|||
48735146|NCT03758443|156882216|FG001|Maintenance Period|Adverse Event|2|||
48735147|NCT03758443|156882217|FG002|Maintenance Period|Adverse Event|0|||
48735148|NCT03758443|156882218|FG003|Maintenance Period|Adverse Event|0|||
48735149|NCT03758443|156882215|FG000|Maintenance Period|Lost to Follow-up|0|||
48735150|NCT03758443|156882216|FG001|Maintenance Period|Lost to Follow-up|0|||
48735151|NCT03758443|156882217|FG002|Maintenance Period|Lost to Follow-up|0|||
48444312|NCT02273037|155815051|FG000|Overall Study|Other complication|2|||
48735152|NCT03758443|156882218|FG003|Maintenance Period|Lost to Follow-up|1|||
48735153|NCT03758443|156882215|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
48735154|NCT03758443|156882216|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
48735155|NCT03758443|156882217|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
48735156|NCT03758443|156882218|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
48735157|NCT03758443|156882215|FG000|Maintenance Period|Protocol Violation|0|||
48735158|NCT03758443|156882216|FG001|Maintenance Period|Protocol Violation|1|||
48735159|NCT03758443|156882217|FG002|Maintenance Period|Protocol Violation|0|||
48735160|NCT03758443|156882218|FG003|Maintenance Period|Protocol Violation|0|||
48735161|NCT03758443|156882215|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
48735162|NCT03758443|156882216|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
48735163|NCT03758443|156882217|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
48735164|NCT03758443|156882218|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
48735165|NCT03758443|156882215|FG000|Maintenance Period|Withdrawal by Subject|1|||
48735166|NCT03758443|156882216|FG001|Maintenance Period|Withdrawal by Subject|0|||
48735167|NCT03758443|156882217|FG002|Maintenance Period|Withdrawal by Subject|1|||
48735168|NCT03758443|156882218|FG003|Maintenance Period|Withdrawal by Subject|1|||
48735169|NCT03758443|156882215|FG000|Maintenance Period|Miscellaneous|0|||
48735170|NCT03758443|156882216|FG001|Maintenance Period|Miscellaneous|0|||
48735171|NCT03758443|156882217|FG002|Maintenance Period|Miscellaneous|1|||
48735172|NCT03758443|156882218|FG003|Maintenance Period|Miscellaneous|0|||
48735173|NCT03080454|156882219|FG000|Baseline|Adverse Event|2|||
48735174|NCT03080454|156882219|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
48735175|NCT03080454|156882219|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
48735176|NCT01649804|156882221|FG000|Overall Study|Administrative/Other|8|||
48735177|NCT01772160|156882222|FG000|Overall Study|Death|3|||
48735178|NCT01772160|156882222|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
48735179|NCT01772160|156882222|FG000|Overall Study|Consent withdrawal|3|||
48735180|NCT01772160|156882222|FG000|Overall Study|Migrated / moved from the study area|4|||
48735181|NCT01772160|156882222|FG000|Overall Study|Lost to Follow-up|30|||
48735182|NCT01772160|156882222|FG000|Overall Study|Other|5|||
48735183|NCT01904058|156882227|FG000|Overall Study|Adverse Event|2|||
48735184|NCT01904058|156882228|FG001|Overall Study|Adverse Event|0|||
48735185|NCT01904058|156882229|FG002|Overall Study|Adverse Event|0|||
48735186|NCT01904058|156882230|FG003|Overall Study|Adverse Event|0|||
48735187|NCT01904058|156882227|FG000|Overall Study|Withdrawal by Subject|1|||
48735188|NCT01904058|156882228|FG001|Overall Study|Withdrawal by Subject|0|||
48735189|NCT01904058|156882229|FG002|Overall Study|Withdrawal by Subject|1|||
48735190|NCT01904058|156882230|FG003|Overall Study|Withdrawal by Subject|0|||
48735191|NCT01904058|156882227|FG000|Overall Study|Pregnancy|0|||
48735192|NCT01904058|156882228|FG001|Overall Study|Pregnancy|0|||
48735193|NCT01904058|156882229|FG002|Overall Study|Pregnancy|0|||
48735194|NCT01904058|156882230|FG003|Overall Study|Pregnancy|1|||
48735195|NCT03096483|156882232|FG000|Overall Study|Withdrawal by site|1|||
48735196|NCT00369707|156882233|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
48735197|NCT00369707|156882233|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
48827179|NCT01516892|157208865|FG000|Overall Study|Other Miscellaneous Reasons|43|||
48827180|NCT01516892|157208865|FG000|Overall Study|Missing|1|||
48827181|NCT02334306|157208866|FG000|Double-blind Period|Adverse Event|0|||
48827182|NCT02334306|157208867|FG001|Double-blind Period|Adverse Event|1|||
48827183|NCT02334306|157208866|FG000|Double-blind Period|Withdrawal by Subject|1|||
48827184|NCT02334306|157208867|FG001|Double-blind Period|Withdrawal by Subject|1|||
48827185|NCT00465985|157208868|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
48827186|NCT00465985|157208869|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
48735198|NCT00369707|156882233|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
48735199|NCT00369707|156882233|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
48735200|NCT00369707|156882233|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
48735201|NCT00369707|156882233|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
48735202|NCT00369707|156882233|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
48735203|NCT00369707|156882233|FG000|Follow up for 2 Years After Treatment|Death|1|||
48735204|NCT00369707|156882233|FG000|Follow up for 2 Years After Treatment|Other|2|||
48735205|NCT02083081|156882236|FG000|Overall Study|Lost to Follow-up|31|||
48735206|NCT02083081|156882237|FG001|Overall Study|Lost to Follow-up|9|||
48735207|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
48735208|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
48827187|NCT00465985|157208868|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
48827188|NCT00465985|157208869|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
48827189|NCT00465985|157208868|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
48827190|NCT00465985|157208869|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
48827191|NCT00465985|157208868|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
48827192|NCT00465985|157208869|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
48735209|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Physician Decision|1|||
48735210|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Physician Decision|0|||
48827193|NCT02534896|157208870|FG000|Overall Study|Adverse Event|2|||
48827194|NCT02534896|157208871|FG001|Overall Study|Adverse Event|1|||
48827195|NCT02534896|157208872|FG002|Overall Study|Adverse Event|1|||
48827196|NCT02534896|157208870|FG000|Overall Study|Insufficient therapeutic response|2|||
48827197|NCT02534896|157208871|FG001|Overall Study|Insufficient therapeutic response|0|||
48827198|NCT02534896|157208872|FG002|Overall Study|Insufficient therapeutic response|0|||
48827199|NCT01313182|157208873|FG000|Overall Study|Protocol Violation|66|||
48827200|NCT01313182|157208874|FG001|Overall Study|Protocol Violation|92|||
48827201|NCT03686683|157208878|FG000|Overall Study|Withdrawal by Subject|52|||
48827202|NCT03686683|157208879|FG001|Overall Study|Withdrawal by Subject|32|||
48827203|NCT03686683|157208878|FG000|Overall Study|Lost to Follow-up|23|||
48827204|NCT03686683|157208879|FG001|Overall Study|Lost to Follow-up|19|||
48827205|NCT03686683|157208878|FG000|Overall Study|Adverse Event|1|||
48827206|NCT03686683|157208879|FG001|Overall Study|Adverse Event|0|||
48827207|NCT03686683|157208878|FG000|Overall Study|Death|10|||
48827208|NCT03686683|157208879|FG001|Overall Study|Death|5|||
48827209|NCT03686683|157208878|FG000|Overall Study|Progressive Disease|1|||
48827210|NCT03686683|157208879|FG001|Overall Study|Progressive Disease|1|||
48827211|NCT03686683|157208878|FG000|Overall Study|Noncompliance|1|||
48735211|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
48735212|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
48735213|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
48735214|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
48735215|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Adverse Event|15|||
48735216|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Adverse Event|0|||
48735217|NCT03277690|156882242|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
48735218|NCT03277690|156882243|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
48735219|NCT03277690|156882242|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
48735220|NCT03277690|156882243|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
48735221|NCT01691898|156882244|FG000|Overall Study|Death|34|||
48735222|NCT01691898|156882245|FG001|Overall Study|Death|32|||
48735223|NCT01691898|156882246|FG002|Overall Study|Death|6|||
48735224|NCT01691898|156882247|FG003|Overall Study|Death|3|||
48735225|NCT01691898|156882248|FG004|Overall Study|Death|8|||
48735226|NCT01691898|156882249|FG005|Overall Study|Death|31|||
48735227|NCT01691898|156882244|FG000|Overall Study|Adverse Event|0|||
48735228|NCT01691898|156882245|FG001|Overall Study|Adverse Event|1|||
48735229|NCT01691898|156882246|FG002|Overall Study|Adverse Event|0|||
48735230|NCT01691898|156882247|FG003|Overall Study|Adverse Event|1|||
48735231|NCT01691898|156882248|FG004|Overall Study|Adverse Event|1|||
48735232|NCT01691898|156882249|FG005|Overall Study|Adverse Event|0|||
48735233|NCT01691898|156882244|FG000|Overall Study|Progression of Disease|1|||
48735234|NCT01691898|156882245|FG001|Overall Study|Progression of Disease|2|||
48735235|NCT01691898|156882246|FG002|Overall Study|Progression of Disease|1|||
48735236|NCT01691898|156882247|FG003|Overall Study|Progression of Disease|0|||
48735237|NCT01691898|156882248|FG004|Overall Study|Progression of Disease|0|||
48735238|NCT01691898|156882249|FG005|Overall Study|Progression of Disease|1|||
48735239|NCT01691898|156882244|FG000|Overall Study|Lost to Follow-up|3|||
48735240|NCT01691898|156882245|FG001|Overall Study|Lost to Follow-up|1|||
48735241|NCT01691898|156882246|FG002|Overall Study|Lost to Follow-up|0|||
48735242|NCT01691898|156882247|FG003|Overall Study|Lost to Follow-up|0|||
48735243|NCT01691898|156882248|FG004|Overall Study|Lost to Follow-up|1|||
48735244|NCT01691898|156882249|FG005|Overall Study|Lost to Follow-up|0|||
48735245|NCT01691898|156882244|FG000|Overall Study|Withdrawal by Subject|9|||
48735246|NCT01691898|156882245|FG001|Overall Study|Withdrawal by Subject|8|||
48735247|NCT01691898|156882246|FG002|Overall Study|Withdrawal by Subject|2|||
48827212|NCT03686683|157208879|FG001|Overall Study|Noncompliance|0|||
48827213|NCT03686683|157208878|FG000|Overall Study|Physician Decision|1|||
48827214|NCT03686683|157208879|FG001|Overall Study|Physician Decision|1|||
48735248|NCT01691898|156882247|FG003|Overall Study|Withdrawal by Subject|1|||
48735249|NCT01691898|156882248|FG004|Overall Study|Withdrawal by Subject|3|||
48735250|NCT01691898|156882249|FG005|Overall Study|Withdrawal by Subject|3|||
48735251|NCT01691898|156882244|FG000|Overall Study|Non-Compliance|0|||
48735252|NCT01691898|156882245|FG001|Overall Study|Non-Compliance|0|||
48735253|NCT01691898|156882246|FG002|Overall Study|Non-Compliance|0|||
48735254|NCT01691898|156882247|FG003|Overall Study|Non-Compliance|0|||
48526125|NCT04126343|156118118|FG002|Overall Study|Adverse Event|0|||
48735255|NCT01691898|156882248|FG004|Overall Study|Non-Compliance|1|||
48735256|NCT01691898|156882249|FG005|Overall Study|Non-Compliance|0|||
48827215|NCT03686683|157208878|FG000|Overall Study|Screen fail post-randomization|1|||
48827216|NCT03686683|157208879|FG001|Overall Study|Screen fail post-randomization|0|||
48827217|NCT03686683|157208878|FG000|Overall Study|Protocol Violation|3|||
48827218|NCT03686683|157208879|FG001|Overall Study|Protocol Violation|0|||
48827219|NCT03686683|157208878|FG000|Overall Study|No data available|1|||
48735257|NCT01013350|156882250|FG000|Overall Study|Lost to Follow-up|15|||
48735258|NCT01013350|156882251|FG001|Overall Study|Lost to Follow-up|95|||
48735259|NCT01013350|156882250|FG000|Overall Study|Adverse Event|0|||
48827220|NCT03686683|157208879|FG001|Overall Study|No data available|0|||
48827221|NCT01101165|157208882|FG000|Period 1|Adverse Event|1|||
48827222|NCT01101165|157208883|FG001|Period 1|Adverse Event|2|||
48735260|NCT01013350|156882251|FG001|Overall Study|Adverse Event|1|||
48735261|NCT01013350|156882250|FG000|Overall Study|Physician Decision|4|||
48735262|NCT01013350|156882251|FG001|Overall Study|Physician Decision|20|||
48735263|NCT01013350|156882250|FG000|Overall Study|Withdrawal by Subject|15|||
48735264|NCT01013350|156882251|FG001|Overall Study|Withdrawal by Subject|38|||
48827223|NCT01101165|157208882|FG000|Period 1|Withdrawal by Subject|0|||
48827224|NCT01101165|157208883|FG001|Period 1|Withdrawal by Subject|2|||
48827225|NCT01101165|157208882|FG000|Period 1|Positive Drug Screen|0|||
48827226|NCT01101165|157208883|FG001|Period 1|Positive Drug Screen|1|||
48827227|NCT01101165|157208882|FG000|Period 1|Lost to Follow-up|1|||
48827228|NCT01101165|157208883|FG001|Period 1|Lost to Follow-up|0|||
48827229|NCT01101165|157208882|FG000|Period 2|Withdrawal by Subject|3|||
48827230|NCT01101165|157208883|FG001|Period 2|Withdrawal by Subject|1|||
48827231|NCT01101165|157208882|FG000|Period 2|Adverse Event|1|||
48827232|NCT01101165|157208883|FG001|Period 2|Adverse Event|0|||
48827233|NCT02397889|157208894|FG000|Overall Study|Physician Decision|1|||
48526126|NCT04126343|156118119|FG003|Overall Study|Adverse Event|0|||
48526127|NCT04126343|156118120|FG004|Overall Study|Adverse Event|0|||
48526128|NCT04126343|156118121|FG005|Overall Study|Adverse Event|1|||
48526129|NCT04126343|156118116|FG000|Overall Study|Withdrawal by Subject|0|||
48526130|NCT04126343|156118117|FG001|Overall Study|Withdrawal by Subject|0|||
48526131|NCT04126343|156118118|FG002|Overall Study|Withdrawal by Subject|0|||
48526132|NCT04126343|156118119|FG003|Overall Study|Withdrawal by Subject|1|||
48602114|NCT03327324|156399519|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602115|NCT03327324|156399520|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48630421|NCT05014919|156504947|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
48827234|NCT02397889|157208895|FG001|Overall Study|Physician Decision|0|||
48827235|NCT03670602|157208896|FG000|Overall Study|Lost to Follow-up|1|||
48827236|NCT03670602|157208897|FG001|Overall Study|Lost to Follow-up|0|||
48526133|NCT04126343|156118120|FG004|Overall Study|Withdrawal by Subject|0|||
48526134|NCT04126343|156118121|FG005|Overall Study|Withdrawal by Subject|0|||
48526135|NCT04126343|156118116|FG000|Overall Study|Related to COVID-19 pandemic|3|||
48526136|NCT04126343|156118117|FG001|Overall Study|Related to COVID-19 pandemic|4|||
48526137|NCT04126343|156118118|FG002|Overall Study|Related to COVID-19 pandemic|3|||
48526138|NCT04126343|156118119|FG003|Overall Study|Related to COVID-19 pandemic|3|||
48526139|NCT04126343|156118120|FG004|Overall Study|Related to COVID-19 pandemic|3|||
48526140|NCT04126343|156118121|FG005|Overall Study|Related to COVID-19 pandemic|3|||
48526141|NCT01235442|156118122|FG000|Overall Study|Lost to Follow-up|12|||
48526142|NCT01235442|156118123|FG001|Overall Study|Lost to Follow-up|10|||
48526143|NCT01235442|156118122|FG000|Overall Study|Death|0|||
48526144|NCT01235442|156118123|FG001|Overall Study|Death|2|||
48526145|NCT01235442|156118122|FG000|Overall Study|Pregnancy|1|||
48526146|NCT01235442|156118123|FG001|Overall Study|Pregnancy|1|||
48526147|NCT01235442|156118122|FG000|Overall Study|Ineligibility determined|5|||
48526148|NCT01235442|156118123|FG001|Overall Study|Ineligibility determined|4|||
48526149|NCT01235442|156118122|FG000|Overall Study|Protocol Violation|3|||
48526150|NCT01235442|156118123|FG001|Overall Study|Protocol Violation|3|||
48526151|NCT01235442|156118122|FG000|Overall Study|Adverse Event|4|||
48602116|NCT03327324|156399521|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602117|NCT03327324|156399522|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
48526152|NCT01235442|156118123|FG001|Overall Study|Adverse Event|6|||
48526153|NCT01235442|156118122|FG000|Overall Study|Withdrawal by Subject|15|||
48526154|NCT01235442|156118123|FG001|Overall Study|Withdrawal by Subject|9|||
48526155|NCT01235442|156118122|FG000|Overall Study|Lack of Efficacy|1|||
48526156|NCT01235442|156118123|FG001|Overall Study|Lack of Efficacy|3|||
48526157|NCT01235442|156118122|FG000|Overall Study|Noncompliance|1|||
48526158|NCT01235442|156118123|FG001|Overall Study|Noncompliance|2|||
48526159|NCT01235442|156118122|FG000|Overall Study|Administrative decision|1|||
48526160|NCT01235442|156118123|FG001|Overall Study|Administrative decision|2|||
48526161|NCT01235442|156118122|FG000|Overall Study|Other unspecified|1|||
48526162|NCT01235442|156118123|FG001|Overall Study|Other unspecified|2|||
48526163|NCT00084799|156118124|FG000|Overall Study|Disease Progression|1|||
48526164|NCT00084799|156118125|FG001|Overall Study|Disease Progression|0|||
48526165|NCT00889252|156118126|FG000|Overall Study|Adverse Event|2|||
48526166|NCT00889252|156118127|FG001|Overall Study|Adverse Event|4|||
48526167|NCT00889252|156118126|FG000|Overall Study|Withdrawal by Subject|3|||
48602118|NCT03327324|156399523|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
48602119|NCT03327324|156399524|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
48602120|NCT03327324|156399519|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
48602121|NCT03327324|156399520|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
48602122|NCT03327324|156399521|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
48602123|NCT03327324|156399522|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
48602124|NCT03327324|156399523|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
48602125|NCT03327324|156399524|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
48602126|NCT03327324|156399519|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
48735265|NCT01013350|156882250|FG000|Overall Study|Death|3|||
48735266|NCT01013350|156882251|FG001|Overall Study|Death|5|||
48735267|NCT01013350|156882250|FG000|Overall Study|Participant entered interventional study|0|||
48827237|NCT03670602|157208896|FG000|Overall Study|Withdrawal by Subject|0|||
48383824|NCT00436618|155601447|FG000|Overall Study|Withdrawal by Subject|5|||
48526168|NCT00889252|156118127|FG001|Overall Study|Withdrawal by Subject|0|||
48526169|NCT00889252|156118126|FG000|Overall Study|Protocol Violation|2|||
48526170|NCT00889252|156118127|FG001|Overall Study|Protocol Violation|0|||
48526171|NCT04019054|156118130|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
48526172|NCT04019054|156118131|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
48526173|NCT04019054|156118130|FG000|Overall Study|Withdrawal by Subject|3|||
48526174|NCT04019054|156118131|FG001|Overall Study|Withdrawal by Subject|1|||
48526175|NCT00330460|156118139|FG000|Overall Study|Physician Decision|1|||
48526176|NCT00330460|156118140|FG001|Overall Study|Physician Decision|0|||
48526177|NCT00330460|156118139|FG000|Overall Study|Adverse Event|10|||
48526178|NCT00330460|156118140|FG001|Overall Study|Adverse Event|8|||
48526179|NCT00330460|156118139|FG000|Overall Study|Withdrawal by Subject|18|||
48526180|NCT00330460|156118140|FG001|Overall Study|Withdrawal by Subject|17|||
48526181|NCT00330460|156118139|FG000|Overall Study|Death|1|||
48735268|NCT01013350|156882251|FG001|Overall Study|Participant entered interventional study|8|||
48735269|NCT01013350|156882250|FG000|Overall Study|Other|1|||
48735270|NCT01013350|156882251|FG001|Overall Study|Other|25|||
48735271|NCT00413244|156882252|FG000|Overall Study|Withdrawal by Subject|10|||
48735272|NCT00413244|156882253|FG001|Overall Study|Withdrawal by Subject|1|||
48735273|NCT02633501|156882255|FG000|Overall Study|Adverse Event|0|||
48735274|NCT02633501|156882256|FG001|Overall Study|Adverse Event|0|||
48735275|NCT02633501|156882257|FG002|Overall Study|Adverse Event|1|||
48735276|NCT02633501|156882258|FG003|Overall Study|Adverse Event|0|||
48735277|NCT02633501|156882259|FG004|Overall Study|Adverse Event|1|||
48735278|NCT02633501|156882260|FG005|Overall Study|Adverse Event|1|||
48735279|NCT02633501|156882255|FG000|Overall Study|Withdrawal by Subject|2|||
48735280|NCT02633501|156882256|FG001|Overall Study|Withdrawal by Subject|1|||
48735281|NCT02633501|156882257|FG002|Overall Study|Withdrawal by Subject|2|||
48735282|NCT02633501|156882258|FG003|Overall Study|Withdrawal by Subject|2|||
48602127|NCT03327324|156399520|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
48602128|NCT03327324|156399521|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
48602129|NCT03327324|156399522|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
48383825|NCT00436618|155601448|FG001|Overall Study|Withdrawal by Subject|8|||
48602130|NCT03327324|156399523|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
48602131|NCT03327324|156399524|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
48602132|NCT00072410|156399525|FG000|Overall Study|Progressive disease|0|||
48602133|NCT00072410|156399526|FG001|Overall Study|Progressive disease|3|||
48602134|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
48602135|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
48602136|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
48602137|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
48602138|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
48602139|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
48735283|NCT02633501|156882259|FG004|Overall Study|Withdrawal by Subject|1|||
48735284|NCT02633501|156882260|FG005|Overall Study|Withdrawal by Subject|3|||
48735285|NCT02633501|156882255|FG000|Overall Study|Various other reasons|0|||
48735286|NCT02633501|156882256|FG001|Overall Study|Various other reasons|2|||
48735287|NCT02633501|156882257|FG002|Overall Study|Various other reasons|4|||
48735288|NCT02633501|156882258|FG003|Overall Study|Various other reasons|1|||
48735289|NCT02633501|156882259|FG004|Overall Study|Various other reasons|7|||
48735290|NCT02633501|156882260|FG005|Overall Study|Various other reasons|11|||
48735291|NCT02633501|156882255|FG000|Overall Study|Lost to Follow-up|0|||
48735292|NCT02633501|156882256|FG001|Overall Study|Lost to Follow-up|0|||
48735293|NCT02633501|156882257|FG002|Overall Study|Lost to Follow-up|0|||
48735294|NCT02633501|156882258|FG003|Overall Study|Lost to Follow-up|1|||
48735295|NCT02633501|156882259|FG004|Overall Study|Lost to Follow-up|2|||
48735296|NCT02633501|156882260|FG005|Overall Study|Lost to Follow-up|0|||
48735297|NCT05055128|156882268|FG000|Overall Study|Adverse Event|0|||
48735298|NCT05055128|156882269|FG001|Overall Study|Adverse Event|0|||
48735299|NCT05055128|156882270|FG002|Overall Study|Adverse Event|0|||
48735300|NCT05055128|156882271|FG003|Overall Study|Adverse Event|1|||
48735301|NCT05055128|156882272|FG004|Overall Study|Adverse Event|1|||
48735302|NCT05055128|156882268|FG000|Overall Study|Protocol Violation|0|||
48735303|NCT05055128|156882269|FG001|Overall Study|Protocol Violation|0|||
48735304|NCT05055128|156882270|FG002|Overall Study|Protocol Violation|0|||
48735305|NCT05055128|156882271|FG003|Overall Study|Protocol Violation|1|||
48735306|NCT05055128|156882272|FG004|Overall Study|Protocol Violation|0|||
48735307|NCT05055128|156882268|FG000|Overall Study|Withdrawal by Subject|5|||
48735308|NCT05055128|156882269|FG001|Overall Study|Withdrawal by Subject|2|||
48735309|NCT05055128|156882270|FG002|Overall Study|Withdrawal by Subject|2|||
48735310|NCT05055128|156882271|FG003|Overall Study|Withdrawal by Subject|4|||
48735311|NCT05055128|156882272|FG004|Overall Study|Withdrawal by Subject|2|||
48735312|NCT05055128|156882268|FG000|Overall Study|Randomized By Mistake|0|||
48735313|NCT05055128|156882269|FG001|Overall Study|Randomized By Mistake|1|||
48735314|NCT05055128|156882270|FG002|Overall Study|Randomized By Mistake|0|||
48735315|NCT05055128|156882271|FG003|Overall Study|Randomized By Mistake|0|||
48735316|NCT05055128|156882272|FG004|Overall Study|Randomized By Mistake|0|||
48735317|NCT05055128|156882268|FG000|Overall Study|Other|1|||
48735318|NCT05055128|156882269|FG001|Overall Study|Other|0|||
48735319|NCT05055128|156882270|FG002|Overall Study|Other|0|||
48735320|NCT05055128|156882271|FG003|Overall Study|Other|0|||
48735321|NCT05055128|156882272|FG004|Overall Study|Other|0|||
48735322|NCT00753766|156882273|FG000|Overall Study|Physician Decision|1|||
48735323|NCT00753766|156882274|FG001|Overall Study|Physician Decision|0|||
48735324|NCT00747461|156882275|FG000|Overall Study|study terminated by sponsor|5|||
48735325|NCT02478372|156882276|FG000|Overall Study|Protocol Violation|12|||
48735326|NCT02478372|156882277|FG001|Overall Study|Protocol Violation|8|||
48735327|NCT02478372|156882276|FG000|Overall Study|Lost to Follow-up|1|||
48735328|NCT02478372|156882277|FG001|Overall Study|Lost to Follow-up|4|||
48735329|NCT02478372|156882276|FG000|Overall Study|Death|0|||
48735330|NCT02478372|156882277|FG001|Overall Study|Death|2|||
48735331|NCT04295772|156882278|FG000|Overall Study|Protocol Violation|1|||
48735332|NCT04295772|156882279|FG001|Overall Study|Protocol Violation|0|||
48735333|NCT04295772|156882278|FG000|Overall Study|Ongoing for safety monitoring|14|||
48526182|NCT00330460|156118140|FG001|Overall Study|Death|1|||
48526183|NCT00330460|156118139|FG000|Overall Study|Ineligibility determined|1|||
48526184|NCT00330460|156118140|FG001|Overall Study|Ineligibility determined|3|||
48526185|NCT00330460|156118139|FG000|Overall Study|Lost to Follow-up|8|||
48827238|NCT03670602|157208897|FG001|Overall Study|Withdrawal by Subject|3|||
48526186|NCT00330460|156118140|FG001|Overall Study|Lost to Follow-up|3|||
48526187|NCT00330460|156118139|FG000|Overall Study|Noncompliance|2|||
48526188|NCT00330460|156118140|FG001|Overall Study|Noncompliance|1|||
48526189|NCT00330460|156118139|FG000|Overall Study|Other|1|||
48526190|NCT00330460|156118140|FG001|Overall Study|Other|0|||
48526191|NCT00089076|156118141|FG000|Overall Study|Alternate Therapy|1|||
48526192|NCT00089076|156118141|FG000|Overall Study|Withdrawal by Subject|2|||
48526193|NCT00089076|156118141|FG000|Overall Study|Progression|7|||
48526194|NCT01857973|156118142|FG000|Overall Study|Subject did not meet required BG range|3|||
48526195|NCT01857973|156118142|FG000|Overall Study|drop out after 3 failed attempts|1|||
48526196|NCT01857973|156118142|FG000|Overall Study|Physician Decision|1|||
48526197|NCT02413294|156118143|FG000|Overall Study|Withdrawal by Subject|1|||
48526198|NCT02663882|156118144|FG000|Overall Study|Lost to Follow-up|4|||
48526199|NCT02663882|156118145|FG001|Overall Study|Lost to Follow-up|2|||
48526200|NCT05444543|156118148|FG000|Overall Study|Withdrawal by Subject|1|||
48526201|NCT05444543|156118149|FG001|Overall Study|Withdrawal by Subject|0|||
48526202|NCT05444543|156118148|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
48526203|NCT05444543|156118149|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
48526204|NCT05444543|156118148|FG000|Overall Study|Adverse Event|0|||
48526205|NCT05444543|156118149|FG001|Overall Study|Adverse Event|1|||
48526206|NCT05444543|156118148|FG000|Overall Study|Family relocating at a distance from study site|0|||
48526207|NCT05444543|156118149|FG001|Overall Study|Family relocating at a distance from study site|1|||
48526208|NCT03712124|156118152|FG000|Overall Study|Protocol Violation|1|||
48526209|NCT03712124|156118153|FG001|Overall Study|Protocol Violation|0|||
48526210|NCT01040793|156118157|FG000|Overall Study|Adverse Event|5|||
48526211|NCT01040793|156118158|FG001|Overall Study|Adverse Event|3|||
48526212|NCT01040793|156118159|FG002|Overall Study|Adverse Event|0|||
48526213|NCT01040793|156118160|FG003|Overall Study|Adverse Event|2|||
48526214|NCT01040793|156118161|FG004|Overall Study|Adverse Event|2|||
48827239|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
48827240|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
48827241|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
48827242|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
48827243|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
48827244|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
48827245|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
48827246|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
48827247|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
48827248|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
48827249|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
48827250|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
48827251|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
48827252|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
48526215|NCT01040793|156118162|FG005|Overall Study|Adverse Event|1|||
48526216|NCT01040793|156118157|FG000|Overall Study|Protocol Violation|1|||
48526217|NCT01040793|156118158|FG001|Overall Study|Protocol Violation|1|||
48526218|NCT01040793|156118159|FG002|Overall Study|Protocol Violation|1|||
48526219|NCT01040793|156118160|FG003|Overall Study|Protocol Violation|0|||
48526220|NCT01040793|156118161|FG004|Overall Study|Protocol Violation|1|||
48827253|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
48827254|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
48827255|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
48827256|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
48827257|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
48827258|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
48827259|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
48526221|NCT01040793|156118162|FG005|Overall Study|Protocol Violation|0|||
48827260|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
48827261|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
48827262|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
48827263|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
48827264|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
48827265|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
48827266|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
48827267|NCT00241644|157208898|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
48827268|NCT00241644|157208899|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
48526222|NCT01040793|156118157|FG000|Overall Study|Lost to Follow-up|0|||
48526223|NCT01040793|156118158|FG001|Overall Study|Lost to Follow-up|1|||
48526224|NCT01040793|156118159|FG002|Overall Study|Lost to Follow-up|1|||
48526225|NCT01040793|156118160|FG003|Overall Study|Lost to Follow-up|0|||
48526226|NCT01040793|156118161|FG004|Overall Study|Lost to Follow-up|0|||
48526227|NCT01040793|156118162|FG005|Overall Study|Lost to Follow-up|0|||
48526228|NCT01040793|156118157|FG000|Overall Study|Withdrawal by Subject|0|||
48827269|NCT00241644|157208900|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
48827270|NCT00241644|157208901|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
48827271|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
48827272|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
48827273|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
48827274|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
48827275|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
48827276|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
48827277|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
48827278|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
48526229|NCT01040793|156118158|FG001|Overall Study|Withdrawal by Subject|0|||
48526230|NCT01040793|156118159|FG002|Overall Study|Withdrawal by Subject|0|||
48526231|NCT01040793|156118160|FG003|Overall Study|Withdrawal by Subject|2|||
48526232|NCT01040793|156118161|FG004|Overall Study|Withdrawal by Subject|0|||
48526233|NCT01040793|156118162|FG005|Overall Study|Withdrawal by Subject|0|||
48526234|NCT01040793|156118157|FG000|Overall Study|Other reasons not listed above|0|||
48526235|NCT01040793|156118158|FG001|Overall Study|Other reasons not listed above|0|||
48526236|NCT01040793|156118159|FG002|Overall Study|Other reasons not listed above|1|||
48526237|NCT01040793|156118160|FG003|Overall Study|Other reasons not listed above|0|||
48526238|NCT01040793|156118161|FG004|Overall Study|Other reasons not listed above|1|||
48526239|NCT01040793|156118162|FG005|Overall Study|Other reasons not listed above|0|||
48526240|NCT00602537|156118165|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
48526241|NCT00602537|156118166|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
48526242|NCT00602537|156118165|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
48526243|NCT00602537|156118166|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
48526244|NCT00602537|156118165|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
48526245|NCT00602537|156118166|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
48526246|NCT00602537|156118165|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
48526247|NCT00602537|156118166|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
48526248|NCT00602537|156118165|FG000|Follow Up Study Comparison|Adverse Event|1|||
48526249|NCT00602537|156118166|FG001|Follow Up Study Comparison|Adverse Event|0|||
48526250|NCT00602537|156118165|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
48526251|NCT00602537|156118166|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
48602140|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
48602141|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
48827279|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
48526252|NCT00602537|156118165|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
48526253|NCT00602537|156118166|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
48526254|NCT00388037|156118167|FG000|Overall Study|Protocol Violation|1|||
48526255|NCT02094261|156118168|FG000|Overall Study|Death|24|||
48526256|NCT02094261|156118168|FG000|Overall Study|Lost to Follow-up|1|||
48827280|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
48827281|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
48827282|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
48827283|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
48827284|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
48827285|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
48827286|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
48827287|NCT00241644|157208898|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
48827288|NCT00241644|157208899|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
48827289|NCT00241644|157208900|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
48827290|NCT00241644|157208901|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
48827291|NCT02317705|157208902|FG000|Overall Study|Withdrawal by Subject|3|||
48827292|NCT02317705|157208902|FG000|Overall Study|Physician Decision|1|||
48827293|NCT02317705|157208902|FG000|Overall Study|Drug not usable|1|||
48827294|NCT00335556|157208903|FG000|Overall Study|Death|0|||
48827295|NCT00335556|157208904|FG001|Overall Study|Death|5|||
48827296|NCT00335556|157208905|FG002|Overall Study|Death|0|||
48827297|NCT00335556|157208906|FG003|Overall Study|Death|0|||
48827298|NCT00335556|157208907|FG004|Overall Study|Death|1|||
48827299|NCT00335556|157208908|FG005|Overall Study|Death|0|||
48827300|NCT00335556|157208903|FG000|Overall Study|Lack of Efficacy|0|||
48827301|NCT00335556|157208904|FG001|Overall Study|Lack of Efficacy|19|||
48827302|NCT00335556|157208905|FG002|Overall Study|Lack of Efficacy|3|||
48827303|NCT00335556|157208906|FG003|Overall Study|Lack of Efficacy|3|||
48827304|NCT00335556|157208907|FG004|Overall Study|Lack of Efficacy|0|||
48827305|NCT00335556|157208908|FG005|Overall Study|Lack of Efficacy|1|||
48827306|NCT00335556|157208903|FG000|Overall Study|Physician Decision|0|||
48827307|NCT00335556|157208904|FG001|Overall Study|Physician Decision|6|||
48827308|NCT00335556|157208905|FG002|Overall Study|Physician Decision|2|||
48827309|NCT00335556|157208906|FG003|Overall Study|Physician Decision|1|||
48827310|NCT00335556|157208907|FG004|Overall Study|Physician Decision|0|||
48827311|NCT00335556|157208908|FG005|Overall Study|Physician Decision|0|||
48827312|NCT00335556|157208903|FG000|Overall Study|Ineligible|2|||
48827313|NCT00335556|157208904|FG001|Overall Study|Ineligible|0|||
48827314|NCT00335556|157208905|FG002|Overall Study|Ineligible|0|||
48827315|NCT00335556|157208906|FG003|Overall Study|Ineligible|0|||
48827316|NCT00335556|157208907|FG004|Overall Study|Ineligible|0|||
48827317|NCT00335556|157208908|FG005|Overall Study|Ineligible|0|||
48827318|NCT00335556|157208903|FG000|Overall Study|Refusal of further protocol therapy|0|||
48827319|NCT00335556|157208904|FG001|Overall Study|Refusal of further protocol therapy|4|||
48827320|NCT00335556|157208905|FG002|Overall Study|Refusal of further protocol therapy|0|||
48827321|NCT00335556|157208906|FG003|Overall Study|Refusal of further protocol therapy|1|||
48827322|NCT00335556|157208907|FG004|Overall Study|Refusal of further protocol therapy|0|||
48526257|NCT02094261|156118168|FG000|Overall Study|Withdrawal by Subject|4|||
48526258|NCT02094261|156118168|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
48526259|NCT00885677|156118169|FG000|Overall Study|Death|40|||
48526260|NCT00885677|156118170|FG001|Overall Study|Death|34|||
48526261|NCT00885677|156118169|FG000|Overall Study|Lost to Follow-up|15|||
48526262|NCT00885677|156118170|FG001|Overall Study|Lost to Follow-up|13|||
48526263|NCT00885677|156118169|FG000|Overall Study|Protocol Violation|54|||
48526264|NCT00885677|156118170|FG001|Overall Study|Protocol Violation|54|||
48526265|NCT00885677|156118169|FG000|Overall Study|premature study closure|41|||
48526266|NCT00885677|156118170|FG001|Overall Study|premature study closure|44|||
48526267|NCT00885677|156118169|FG000|Overall Study|device/lead revision or replacement|7|||
48526268|NCT00885677|156118170|FG001|Overall Study|device/lead revision or replacement|6|||
48526269|NCT00885677|156118169|FG000|Overall Study|Heart transplantation|1|||
48602142|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48827323|NCT00335556|157208908|FG005|Overall Study|Refusal of further protocol therapy|0|||
48827324|NCT01599325|157208911|FG000|Primary Parent Phase|Adverse Event|5|||
48827325|NCT01599325|157208911|FG000|Primary Parent Phase|Disease Progression|7|||
48602143|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48827326|NCT01599325|157208911|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
48827327|NCT01599325|157208911|FG000|Primary Parent Phase|Death|13|||
48827328|NCT01599325|157208911|FG000|Primary Parent Phase|Protocol Violation|1|||
48827329|NCT01599325|157208911|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
48827330|NCT01599325|157208911|FG000|Primary Parent Phase|Other|2|||
48827331|NCT01599325|157208911|FG000|Extension Phase|Study Closure|1|||
48827332|NCT01599325|157208911|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
48827333|NCT01599325|157208911|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
48827334|NCT01599325|157208911|FG000|Extension Phase|Disease Progression|1|||
48827335|NCT01599325|157208911|FG000|Extension Phase|Withdrawal by Subject|8|||
48827336|NCT02952261|157208913|FG000|Overall Study|Withdrawal by Subject|4|||
48827337|NCT02952261|157208914|FG001|Overall Study|Withdrawal by Subject|5|||
48526270|NCT00885677|156118170|FG001|Overall Study|Heart transplantation|0|||
48526271|NCT00885677|156118169|FG000|Overall Study|Inclusion/exclusion not met|25|||
48526272|NCT00885677|156118170|FG001|Overall Study|Inclusion/exclusion not met|27|||
48526273|NCT04314843|156118171|FG000|Overall Study|Death|2|||
48526274|NCT04314843|156118172|FG001|Overall Study|Death|2|||
48526275|NCT04314843|156118171|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
48526276|NCT04314843|156118172|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
48526277|NCT01020526|156118173|FG000|Overall Study|Withdrawal by Subject|5|||
48526278|NCT01020526|156118173|FG000|Overall Study|Other reasons|3|||
48526279|NCT01020526|156118173|FG000|Overall Study|Insufficient clinical response|3|||
48526280|NCT01020526|156118173|FG000|Overall Study|Lost to Follow-up|1|||
48526281|NCT01020526|156118173|FG000|Overall Study|Adverse Event|2|||
48526282|NCT01644149|156118174|FG000|Overall Study|Withdrawal by Subject|1|||
48526283|NCT01644149|156118175|FG001|Overall Study|Withdrawal by Subject|0|||
48526284|NCT01644149|156118174|FG000|Overall Study|Lost to Follow-up|3|||
48526285|NCT01644149|156118175|FG001|Overall Study|Lost to Follow-up|1|||
48526286|NCT02148445|156118193|FG000|Overall Study|Death|1|||
48526287|NCT02148445|156118194|FG001|Overall Study|Death|3|||
48526288|NCT03078478|156118198|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
48526289|NCT03078478|156118199|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
48526290|NCT03078478|156118198|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
48526291|NCT03078478|156118199|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
48526292|NCT03078478|156118198|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
48526293|NCT03078478|156118199|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
48526294|NCT03078478|156118198|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
48526295|NCT03078478|156118199|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
48526296|NCT03078478|156118198|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
48526297|NCT03078478|156118199|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
48526298|NCT03078478|156118198|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
48526299|NCT03078478|156118199|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
48526300|NCT03078478|156118198|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
48526301|NCT03078478|156118199|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
48526302|NCT03078478|156118198|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
48526303|NCT03078478|156118199|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
48526304|NCT00810602|156118206|FG000|Overall Study|Withdrawal by Subject|8|||
48827338|NCT02952261|157208913|FG000|Overall Study|Protocol Violation|1|||
48827339|NCT02952261|157208914|FG001|Overall Study|Protocol Violation|0|||
48827340|NCT01763047|157208915|FG000|Period 1|Test Article Not Available|4|||
48827341|NCT01763047|157208916|FG001|Period 1|Test Article Not Available|1|||
48827342|NCT01763047|157208915|FG000|Period 1|Protocol Violation|4|||
48827343|NCT01763047|157208916|FG001|Period 1|Protocol Violation|4|||
48827344|NCT01763047|157208915|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
48827345|NCT01763047|157208916|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
48827346|NCT01763047|157208915|FG000|Period 1|Adverse Event|0|||
48827347|NCT01763047|157208916|FG001|Period 1|Adverse Event|1|||
48827348|NCT01763047|157208915|FG000|Period 1|Unsatisfactory Visual Response|0|||
48827349|NCT01763047|157208916|FG001|Period 1|Unsatisfactory Visual Response|3|||
48827350|NCT01763047|157208915|FG000|Period 1|Lens Power Not Available|0|||
48827351|NCT01763047|157208916|FG001|Period 1|Lens Power Not Available|1|||
48827352|NCT01763047|157208915|FG000|Period 1|Study Site office Closed|0|||
48827353|NCT01763047|157208916|FG001|Period 1|Study Site office Closed|1|||
48827354|NCT01763047|157208915|FG000|Period 2|Lens Discomfort|1|||
48827355|NCT01763047|157208916|FG001|Period 2|Lens Discomfort|0|||
48827356|NCT01763047|157208915|FG000|Period 2|No longer meets Eligibility Criteria|1|||
48827357|NCT01763047|157208916|FG001|Period 2|No longer meets Eligibility Criteria|0|||
48526305|NCT00810602|156118207|FG001|Overall Study|Withdrawal by Subject|3|||
48526306|NCT00442546|156118208|FG000|Overall Study|Adverse Event|11|||
48526307|NCT00442546|156118209|FG001|Overall Study|Adverse Event|17|||
48526308|NCT00442546|156118210|FG002|Overall Study|Adverse Event|13|||
48526309|NCT00442546|156118208|FG000|Overall Study|Lost to Follow-up|1|||
48526310|NCT00442546|156118209|FG001|Overall Study|Lost to Follow-up|2|||
48602144|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48827358|NCT01763047|157208915|FG000|Period 2|Study Site office Closed|1|||
48827359|NCT01763047|157208916|FG001|Period 2|Study Site office Closed|1|||
48827360|NCT01763047|157208915|FG000|Period 2|Unsatisfactory Visual Response|1|||
48827361|NCT01763047|157208916|FG001|Period 2|Unsatisfactory Visual Response|1|||
48827362|NCT01763047|157208915|FG000|Period 2|Protocol Violation|0|||
48526311|NCT00442546|156118210|FG002|Overall Study|Lost to Follow-up|1|||
48827363|NCT01763047|157208916|FG001|Period 2|Protocol Violation|2|||
48827364|NCT01763047|157208915|FG000|Period 2|Unsatisfactory lens Fitting|0|||
48827365|NCT01763047|157208916|FG001|Period 2|Unsatisfactory lens Fitting|1|||
48827366|NCT03404843|157208917|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
48827367|NCT03404843|157208918|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
48827368|NCT01605136|157208926|FG000|Study Period|Withdrawal by Subject|2|||
48526312|NCT00442546|156118208|FG000|Overall Study|Other|4|||
48526313|NCT00442546|156118209|FG001|Overall Study|Other|9|||
48526314|NCT00442546|156118210|FG002|Overall Study|Other|6|||
48526315|NCT00442546|156118208|FG000|Overall Study|Withdrawal by Subject|5|||
48526316|NCT00442546|156118209|FG001|Overall Study|Withdrawal by Subject|5|||
48526317|NCT00442546|156118210|FG002|Overall Study|Withdrawal by Subject|7|||
48526318|NCT00442546|156118208|FG000|Overall Study|Randomized But Not Treated|5|||
48526319|NCT00442546|156118209|FG001|Overall Study|Randomized But Not Treated|4|||
48526320|NCT00442546|156118210|FG002|Overall Study|Randomized But Not Treated|6|||
48526321|NCT02293460|156120436|FG000|Overall Study|Protocol Violation|1|||
48526322|NCT02293460|156120436|FG000|Overall Study|Lack of Efficacy|2|||
48526323|NCT02293460|156120436|FG000|Overall Study|Adverse Event|2|||
48526324|NCT02293460|156120436|FG000|Overall Study|Withdrawal by Subject|1|||
48526325|NCT00500318|156120438|FG000|Overall Study|Adverse Event|3|||
48526326|NCT00500318|156120439|FG001|Overall Study|Adverse Event|8|||
48526327|NCT00500318|156120438|FG000|Overall Study|Protocol Violation|1|||
48827369|NCT01605136|157208927|FG001|Study Period|Withdrawal by Subject|0|||
48827370|NCT01605136|157208926|FG000|Study Period|Physician Decision|1|||
48827371|NCT01605136|157208927|FG001|Study Period|Physician Decision|1|||
48827372|NCT01605136|157208926|FG000|Study Period|Lost to Follow-up|0|||
48827373|NCT01605136|157208927|FG001|Study Period|Lost to Follow-up|2|||
48827374|NCT01605136|157208926|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
48827375|NCT01605136|157208927|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
48827376|NCT01093534|157208937|FG000|Overall Study|Adverse Event|2|||
48827377|NCT01093534|157208938|FG001|Overall Study|Adverse Event|5|||
48827378|NCT01093534|157208939|FG002|Overall Study|Adverse Event|2|||
48827379|NCT01093534|157208937|FG000|Overall Study|Lack of Efficacy|2|||
48827380|NCT01093534|157208938|FG001|Overall Study|Lack of Efficacy|1|||
48827381|NCT01093534|157208939|FG002|Overall Study|Lack of Efficacy|1|||
48827382|NCT01093534|157208937|FG000|Overall Study|Withdrawal by Subject|5|||
48827383|NCT01093534|157208938|FG001|Overall Study|Withdrawal by Subject|7|||
48827384|NCT01093534|157208939|FG002|Overall Study|Withdrawal by Subject|2|||
48827385|NCT01093534|157208937|FG000|Overall Study|Other|1|||
48827386|NCT01093534|157208938|FG001|Overall Study|Other|3|||
48827387|NCT01093534|157208939|FG002|Overall Study|Other|4|||
48827388|NCT04831775|157208943|FG000|Overall Study|Lost to Follow-up|11|||
48827389|NCT04831775|157208944|FG001|Overall Study|Lost to Follow-up|13|||
48827390|NCT03563053|157208945|FG000|Overall Study|Withdrawal by Subject|17|||
48827391|NCT03563053|157208945|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
48827392|NCT03563053|157208945|FG000|Overall Study|Adverse Event|3|||
48827393|NCT03563053|157208945|FG000|Overall Study|Physician Decision|1|||
48827394|NCT03563053|157208945|FG000|Overall Study|study terminated by sponsor|71|||
48827395|NCT01729871|157208946|FG000|Overall Study|Adverse Event|7|||
48827396|NCT01729871|157208947|FG001|Overall Study|Adverse Event|7|||
48827397|NCT01729871|157208946|FG000|Overall Study|Death|0|||
48526328|NCT00500318|156120439|FG001|Overall Study|Protocol Violation|3|||
48526329|NCT00500318|156120438|FG000|Overall Study|Withdrawal by Subject|1|||
48526330|NCT00500318|156120439|FG001|Overall Study|Withdrawal by Subject|2|||
48602145|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48827398|NCT01729871|157208947|FG001|Overall Study|Death|1|||
48827399|NCT01729871|157208946|FG000|Overall Study|Lack of Efficacy|0|||
48827400|NCT01729871|157208947|FG001|Overall Study|Lack of Efficacy|1|||
48827401|NCT01729871|157208946|FG000|Overall Study|Physician Decision|0|||
48827402|NCT01729871|157208947|FG001|Overall Study|Physician Decision|2|||
48827403|NCT01729871|157208946|FG000|Overall Study|Protocol Violation|1|||
48827404|NCT01729871|157208947|FG001|Overall Study|Protocol Violation|0|||
48526331|NCT00500318|156120438|FG000|Overall Study|Lack of Efficacy|0|||
48827405|NCT01729871|157208946|FG000|Overall Study|Withdrawal by Subject|0|||
48526332|NCT00500318|156120439|FG001|Overall Study|Lack of Efficacy|3|||
48526333|NCT00500318|156120438|FG000|Overall Study|Other Reason|0|||
48602146|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48827406|NCT01729871|157208947|FG001|Overall Study|Withdrawal by Subject|3|||
48827407|NCT01729871|157208946|FG000|Overall Study|Other|4|||
48827408|NCT01729871|157208947|FG001|Overall Study|Other|9|||
48827409|NCT00819910|157208949|FG000|Overall Study|Adverse Event|0|||
48827410|NCT00819910|157208950|FG001|Overall Study|Adverse Event|0|||
48827411|NCT00819910|157208951|FG002|Overall Study|Adverse Event|2|||
48827412|NCT00819910|157208952|FG003|Overall Study|Adverse Event|1|||
48827413|NCT00819910|157208949|FG000|Overall Study|Withdrawal by Subject|1|||
48526334|NCT00500318|156120439|FG001|Overall Study|Other Reason|1|||
48526335|NCT01074008|156120449|FG000|Overall Study|Adverse Event|0|||
48526336|NCT01074008|156120450|FG001|Overall Study|Adverse Event|1|||
48526337|NCT01074008|156120451|FG002|Overall Study|Adverse Event|0|||
48526338|NCT01074008|156120452|FG003|Overall Study|Adverse Event|0|||
48526339|NCT01074008|156120453|FG004|Overall Study|Adverse Event|0|||
48526340|NCT01074008|156120454|FG005|Overall Study|Adverse Event|0|||
48526341|NCT01074008|156120455|FG006|Overall Study|Adverse Event|0|||
48526342|NCT01074008|156120456|FG007|Overall Study|Adverse Event|0|||
48526343|NCT01074008|156120457|FG008|Overall Study|Adverse Event|0|||
48526344|NCT01074008|156120449|FG000|Overall Study|Withdrawal by Subject|1|||
48526345|NCT01074008|156120450|FG001|Overall Study|Withdrawal by Subject|1|||
48827414|NCT00819910|157208950|FG001|Overall Study|Withdrawal by Subject|1|||
48827415|NCT00819910|157208951|FG002|Overall Study|Withdrawal by Subject|1|||
48827416|NCT00819910|157208952|FG003|Overall Study|Withdrawal by Subject|0|||
48827417|NCT00819910|157208949|FG000|Overall Study|Lost to Follow-up|1|||
48827418|NCT00819910|157208950|FG001|Overall Study|Lost to Follow-up|0|||
48827419|NCT00819910|157208951|FG002|Overall Study|Lost to Follow-up|0|||
48827420|NCT00819910|157208952|FG003|Overall Study|Lost to Follow-up|0|||
48827421|NCT05273801|157208955|FG000|Overall Study|Physician Decision|1|||
48827422|NCT03820986|157208956|FG000|Overall Study|Death|177|||
48827423|NCT03820986|157208957|FG001|Overall Study|Death|156|||
48827424|NCT03820986|157208956|FG000|Overall Study|Lost to Follow-up|0|||
48526346|NCT01074008|156120451|FG002|Overall Study|Withdrawal by Subject|1|||
48526347|NCT01074008|156120452|FG003|Overall Study|Withdrawal by Subject|0|||
48526348|NCT01074008|156120453|FG004|Overall Study|Withdrawal by Subject|1|||
48526349|NCT01074008|156120454|FG005|Overall Study|Withdrawal by Subject|0|||
48526350|NCT01074008|156120455|FG006|Overall Study|Withdrawal by Subject|0|||
48526351|NCT01074008|156120456|FG007|Overall Study|Withdrawal by Subject|0|||
48526352|NCT01074008|156120457|FG008|Overall Study|Withdrawal by Subject|0|||
48827425|NCT03820986|157208957|FG001|Overall Study|Lost to Follow-up|1|||
48827426|NCT03820986|157208956|FG000|Overall Study|Withdrawal by Subject|8|||
48827427|NCT03820986|157208957|FG001|Overall Study|Withdrawal by Subject|3|||
48827428|NCT03820986|157208956|FG000|Overall Study|Ongoing|149|||
48827429|NCT03820986|157208957|FG001|Overall Study|Ongoing|180|||
48827430|NCT00828919|157208958|FG000|Overall Study|Death|0|||
48827431|NCT00828919|157208959|FG001|Overall Study|Death|1|||
48827432|NCT00828919|157208960|FG002|Overall Study|Death|2|||
48827433|NCT00828919|157208961|FG003|Overall Study|Death|0|||
48827434|NCT00828919|157208962|FG004|Overall Study|Death|0|||
48827435|NCT00828919|157208958|FG000|Overall Study|Adverse Event|2|||
48827436|NCT00828919|157208959|FG001|Overall Study|Adverse Event|2|||
48827437|NCT00828919|157208960|FG002|Overall Study|Adverse Event|2|||
48827438|NCT00828919|157208961|FG003|Overall Study|Adverse Event|1|||
48827439|NCT00828919|157208962|FG004|Overall Study|Adverse Event|3|||
48827440|NCT00828919|157208958|FG000|Overall Study|Objective progression or relapse|4|||
48827441|NCT00828919|157208959|FG001|Overall Study|Objective progression or relapse|4|||
48827442|NCT00828919|157208960|FG002|Overall Study|Objective progression or relapse|11|||
48827443|NCT00828919|157208961|FG003|Overall Study|Objective progression or relapse|0|||
48827444|NCT00828919|157208962|FG004|Overall Study|Objective progression or relapse|5|||
48827445|NCT00828919|157208958|FG000|Overall Study|No longer willing to participate in study|0|||
48827446|NCT00828919|157208959|FG001|Overall Study|No longer willing to participate in study|0|||
48827447|NCT00828919|157208960|FG002|Overall Study|No longer willing to participate in study|2|||
48827448|NCT00828919|157208961|FG003|Overall Study|No longer willing to participate in study|0|||
48827449|NCT00828919|157208962|FG004|Overall Study|No longer willing to participate in study|0|||
48827450|NCT00828919|157208958|FG000|Overall Study|Insufficient Clinical Response|0|||
48827451|NCT00828919|157208959|FG001|Overall Study|Insufficient Clinical Response|1|||
48827452|NCT00828919|157208960|FG002|Overall Study|Insufficient Clinical Response|2|||
48827453|NCT00828919|157208961|FG003|Overall Study|Insufficient Clinical Response|0|||
48827454|NCT00828919|157208962|FG004|Overall Study|Insufficient Clinical Response|0|||
48526353|NCT01074008|156120449|FG000|Overall Study|Lost to Follow-up|0|||
48526354|NCT01074008|156120450|FG001|Overall Study|Lost to Follow-up|1|||
48526355|NCT01074008|156120451|FG002|Overall Study|Lost to Follow-up|1|||
48526356|NCT01074008|156120452|FG003|Overall Study|Lost to Follow-up|1|||
48526357|NCT01074008|156120453|FG004|Overall Study|Lost to Follow-up|1|||
48827455|NCT00828919|157208958|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
48827456|NCT00828919|157208959|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
48526358|NCT01074008|156120454|FG005|Overall Study|Lost to Follow-up|0|||
48827457|NCT00828919|157208960|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
48827458|NCT00828919|157208961|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
48827459|NCT00828919|157208962|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
48827460|NCT00828919|157208958|FG000|Overall Study|Other|1|||
48827461|NCT00828919|157208959|FG001|Overall Study|Other|0|||
48827462|NCT00828919|157208960|FG002|Overall Study|Other|1|||
48827463|NCT00828919|157208961|FG003|Overall Study|Other|1|||
48827464|NCT00828919|157208962|FG004|Overall Study|Other|0|||
48526359|NCT01074008|156120455|FG006|Overall Study|Lost to Follow-up|1|||
48526360|NCT01074008|156120456|FG007|Overall Study|Lost to Follow-up|0|||
48526361|NCT01074008|156120457|FG008|Overall Study|Lost to Follow-up|4|||
48827465|NCT00828919|157208958|FG000|Overall Study|Lost to Follow-up|0|||
48526362|NCT00224484|156120460|FG000|Overall Study|Serious Adverse Event|1|||
48526363|NCT00224484|156120461|FG001|Overall Study|Serious Adverse Event|1|||
48526364|NCT00224484|156120462|FG002|Overall Study|Serious Adverse Event|0|||
48526365|NCT00224484|156120460|FG000|Overall Study|Non-Serious Adverse Event|5|||
48526366|NCT00224484|156120461|FG001|Overall Study|Non-Serious Adverse Event|7|||
48526367|NCT00224484|156120462|FG002|Overall Study|Non-Serious Adverse Event|3|||
48526368|NCT00224484|156120460|FG000|Overall Study|Protocol Violation|2|||
48526369|NCT00224484|156120461|FG001|Overall Study|Protocol Violation|2|||
48526370|NCT00224484|156120462|FG002|Overall Study|Protocol Violation|0|||
48827466|NCT00828919|157208959|FG001|Overall Study|Lost to Follow-up|1|||
48827467|NCT00828919|157208960|FG002|Overall Study|Lost to Follow-up|0|||
48827468|NCT00828919|157208961|FG003|Overall Study|Lost to Follow-up|0|||
48827469|NCT00828919|157208962|FG004|Overall Study|Lost to Follow-up|0|||
48827470|NCT05567159|157208963|FG000|Overall Study|Adverse Event|4|||
48827471|NCT05567159|157208963|FG000|Overall Study|Physician Decision|3|||
48827472|NCT05567159|157208963|FG000|Overall Study|Protocol deviation|1|||
48827473|NCT05355805|157208964|FG000|Overall Study|Lost to Follow-up|6|||
48827474|NCT05355805|157208965|FG001|Overall Study|Lost to Follow-up|5|||
48827475|NCT05355805|157208966|FG002|Overall Study|Lost to Follow-up|6|||
48827476|NCT05355805|157208967|FG003|Overall Study|Lost to Follow-up|2|||
48827477|NCT05355805|157208964|FG000|Overall Study|Decision by Sponsor|0|||
48827478|NCT05355805|157208965|FG001|Overall Study|Decision by Sponsor|0|||
48827479|NCT05355805|157208966|FG002|Overall Study|Decision by Sponsor|0|||
48827480|NCT05355805|157208967|FG003|Overall Study|Decision by Sponsor|1|||
48827481|NCT05355805|157208964|FG000|Overall Study|Withdrawal by Subject|7|||
48827482|NCT05355805|157208965|FG001|Overall Study|Withdrawal by Subject|10|||
48827483|NCT05355805|157208966|FG002|Overall Study|Withdrawal by Subject|9|||
48827484|NCT05355805|157208967|FG003|Overall Study|Withdrawal by Subject|2|||
48827485|NCT05355805|157208964|FG000|Overall Study|Missing|0|||
48827486|NCT05355805|157208965|FG001|Overall Study|Missing|0|||
48827487|NCT05355805|157208966|FG002|Overall Study|Missing|1|||
48827488|NCT05355805|157208967|FG003|Overall Study|Missing|0|||
48827489|NCT05355805|157208964|FG000|Overall Study|Ongoing|0|||
48827490|NCT05355805|157208965|FG001|Overall Study|Ongoing|41|||
48827491|NCT05355805|157208966|FG002|Overall Study|Ongoing|38|||
48827492|NCT05355805|157208967|FG003|Overall Study|Ongoing|48|||
48827493|NCT05052983|157208968|FG000|Overall Study|Lack of Efficacy|3|||
48827494|NCT05052983|157208969|FG001|Overall Study|Lack of Efficacy|12|||
48827495|NCT05052983|157208968|FG000|Overall Study|Adverse Event|1|||
48827496|NCT05052983|157208969|FG001|Overall Study|Adverse Event|0|||
48827497|NCT03425643|157208970|FG000|Overall Study|Withdrawal by Subject|10|||
48827498|NCT03425643|157208971|FG001|Overall Study|Withdrawal by Subject|12|||
48827499|NCT03425643|157208970|FG000|Overall Study|Lost to Follow-up|2|||
48827500|NCT03425643|157208971|FG001|Overall Study|Lost to Follow-up|0|||
48827501|NCT03425643|157208970|FG000|Overall Study|Death|109|||
48827502|NCT03425643|157208971|FG001|Overall Study|Death|141|||
48827503|NCT03425643|157208970|FG000|Overall Study|Ongoing in study|276|||
48827504|NCT03425643|157208971|FG001|Overall Study|Ongoing in study|247|||
48827505|NCT01304706|157210973|FG000|Overall Study|Adverse Event|2|||
48827506|NCT01304706|157210973|FG000|Overall Study|Lack of Efficacy|1|||
48827507|NCT01304706|157210973|FG000|Overall Study|Death|3|||
48827508|NCT01304706|157210973|FG000|Overall Study|Withdrawal by Subject|3|||
48827509|NCT01304706|157210973|FG000|Overall Study|Lost to Follow-up|7|||
48526371|NCT00224484|156120460|FG000|Overall Study|Withdrawal by Subject|49|||
48526372|NCT00224484|156120461|FG001|Overall Study|Withdrawal by Subject|18|||
48526373|NCT00224484|156120462|FG002|Overall Study|Withdrawal by Subject|16|||
48526374|NCT00224484|156120460|FG000|Overall Study|Migrated/moved from study area|18|||
48526375|NCT00224484|156120461|FG001|Overall Study|Migrated/moved from study area|5|||
48526376|NCT00224484|156120462|FG002|Overall Study|Migrated/moved from study area|5|||
48526377|NCT00224484|156120460|FG000|Overall Study|Lost to Follow-up|66|||
48526378|NCT00224484|156120461|FG001|Overall Study|Lost to Follow-up|28|||
48526379|NCT00224484|156120462|FG002|Overall Study|Lost to Follow-up|36|||
48526380|NCT00224484|156120460|FG000|Overall Study|Reason not specified|5|||
48526381|NCT00224484|156120461|FG001|Overall Study|Reason not specified|4|||
48827510|NCT01304706|157210973|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
48526382|NCT00224484|156120462|FG002|Overall Study|Reason not specified|2|||
48827511|NCT03303105|157210981|FG000|Overall Study|Adverse Event|0|||
48827512|NCT03303105|157210982|FG001|Overall Study|Adverse Event|2|||
48827513|NCT03303105|157210981|FG000|Overall Study|Lack of Efficacy|1|||
48827514|NCT03303105|157210982|FG001|Overall Study|Lack of Efficacy|0|||
48827515|NCT03303105|157210981|FG000|Overall Study|Protocol Violation|1|||
48827516|NCT03303105|157210982|FG001|Overall Study|Protocol Violation|0|||
48827517|NCT03303105|157210981|FG000|Overall Study|Withdrawal by Subject|0|||
48827518|NCT03303105|157210982|FG001|Overall Study|Withdrawal by Subject|2|||
48827519|NCT01240356|157210985|FG000|Overall Study|Withdrawal by Subject|2|||
48827520|NCT01240356|157210986|FG001|Overall Study|Withdrawal by Subject|0|||
48526383|NCT02805309|156120463|FG000|Overall Study|Lost to Follow-up|2|||
48526384|NCT02805309|156120464|FG001|Overall Study|Lost to Follow-up|2|||
48526385|NCT02805309|156120465|FG002|Overall Study|Lost to Follow-up|2|||
48526386|NCT02805309|156120463|FG000|Overall Study|Post-Randomization Exclusion|0|||
48526387|NCT02805309|156120464|FG001|Overall Study|Post-Randomization Exclusion|2|||
48526388|NCT02805309|156120465|FG002|Overall Study|Post-Randomization Exclusion|1|||
48526389|NCT00108628|156120473|FG000|Overall Study|Withdrawal by Subject|17|||
48526390|NCT00108628|156120474|FG001|Overall Study|Withdrawal by Subject|9|||
48526391|NCT00108628|156120473|FG000|Overall Study|Lack of Efficacy|2|||
48526392|NCT00108628|156120474|FG001|Overall Study|Lack of Efficacy|1|||
48526393|NCT00108628|156120473|FG000|Overall Study|Death|1|||
48526394|NCT00108628|156120474|FG001|Overall Study|Death|0|||
48526395|NCT01453153|156120475|FG000|Overall Study|Physician Decision|0|||
48526396|NCT01453153|156120476|FG001|Overall Study|Physician Decision|0|||
48526397|NCT01453153|156120477|FG002|Overall Study|Physician Decision|1|||
48526398|NCT01453153|156120475|FG000|Overall Study|Progressive Disease|3|||
48526399|NCT01453153|156120476|FG001|Overall Study|Progressive Disease|2|||
48526400|NCT01453153|156120477|FG002|Overall Study|Progressive Disease|16|||
48526401|NCT01453153|156120475|FG000|Overall Study|Withdrawal by Subject|0|||
48526402|NCT01453153|156120476|FG001|Overall Study|Withdrawal by Subject|1|||
48526403|NCT01453153|156120477|FG002|Overall Study|Withdrawal by Subject|2|||
48526404|NCT01453153|156120475|FG000|Overall Study|Adverse Event|1|||
48526405|NCT01453153|156120476|FG001|Overall Study|Adverse Event|1|||
48526406|NCT01453153|156120477|FG002|Overall Study|Adverse Event|1|||
48526407|NCT01350934|156120478|FG000|Base Study|Adverse Event|6|||
48526408|NCT01350934|156120479|FG001|Base Study|Adverse Event|0|||
48526409|NCT01350934|156120478|FG000|Base Study|Lost to Follow-up|1|||
48526410|NCT01350934|156120479|FG001|Base Study|Lost to Follow-up|0|||
48735334|NCT04295772|156882279|FG001|Overall Study|Ongoing for safety monitoring|1|||
48526411|NCT01350934|156120478|FG000|Base Study|Protocol Violation|1|||
48526412|NCT01350934|156120479|FG001|Base Study|Protocol Violation|1|||
48526413|NCT01350934|156120478|FG000|Base Study|Withdrawal by Subject|1|||
48526414|NCT01350934|156120479|FG001|Base Study|Withdrawal by Subject|2|||
48526415|NCT01350934|156120478|FG000|Base Study|Non-Compliance With Study Drug|2|||
48526416|NCT01350934|156120479|FG001|Base Study|Non-Compliance With Study Drug|0|||
48526417|NCT01350934|156120478|FG000|Extension Study|Adverse Event|2|||
48526418|NCT01350934|156120479|FG001|Extension Study|Adverse Event|1|||
48526419|NCT01350934|156120478|FG000|Extension Study|Lost to Follow-up|2|||
48526420|NCT01350934|156120479|FG001|Extension Study|Lost to Follow-up|0|||
48526421|NCT01350934|156120478|FG000|Extension Study|Protocol Violation|1|||
48526422|NCT01350934|156120479|FG001|Extension Study|Protocol Violation|1|||
48526423|NCT01350934|156120478|FG000|Extension Study|Lack of Efficacy|0|||
48526424|NCT01350934|156120479|FG001|Extension Study|Lack of Efficacy|1|||
48526425|NCT01350934|156120478|FG000|Extension Study|Withdrawal by Subject|0|||
48526426|NCT01350934|156120479|FG001|Extension Study|Withdrawal by Subject|1|||
48526427|NCT03547635|156120482|FG000|Overall Study|Adverse Event|5|||
48526428|NCT03547635|156120483|FG001|Overall Study|Adverse Event|2|||
48735335|NCT04295772|156882278|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
48735336|NCT04295772|156882279|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
48735337|NCT02805972|156882284|FG000|Washout Period|Lost to Follow-up|3|||
48735338|NCT02805972|156882285|FG001|Washout Period|Lost to Follow-up|0|||
48735339|NCT01927627|156882288|FG000|Overall Study|Adverse Event|3|||
48735340|NCT01927627|156882288|FG000|Overall Study|Lack of Efficacy|1|||
48735341|NCT01927627|156882288|FG000|Overall Study|Financial Concerns|1|||
48735342|NCT03608254|156882289|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
48735343|NCT03608254|156882289|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
48735344|NCT03511664|156882290|FG000|Overall Study|Death|457|||
48735345|NCT03511664|156882291|FG001|Overall Study|Death|201|||
48827521|NCT01240356|157210985|FG000|Overall Study|MRI contraindication|1|||
48827522|NCT01240356|157210986|FG001|Overall Study|MRI contraindication|0|||
48526429|NCT03547635|156120484|FG002|Overall Study|Adverse Event|3|||
48526430|NCT03547635|156120482|FG000|Overall Study|Lost to Follow-up|1|||
48526431|NCT03547635|156120483|FG001|Overall Study|Lost to Follow-up|3|||
48526432|NCT03547635|156120484|FG002|Overall Study|Lost to Follow-up|4|||
48526433|NCT03547635|156120482|FG000|Overall Study|Withdrawal by Subject|1|||
48526434|NCT03547635|156120483|FG001|Overall Study|Withdrawal by Subject|0|||
48526435|NCT03547635|156120484|FG002|Overall Study|Withdrawal by Subject|0|||
48526436|NCT03547635|156120482|FG000|Overall Study|Withdrawal By PI|0|||
48526437|NCT03547635|156120483|FG001|Overall Study|Withdrawal By PI|1|||
48526438|NCT03547635|156120484|FG002|Overall Study|Withdrawal By PI|0|||
48526439|NCT03547635|156120482|FG000|Overall Study|Withdrawal by Sponsor|0|||
48526440|NCT03547635|156120483|FG001|Overall Study|Withdrawal by Sponsor|0|||
48526441|NCT03547635|156120484|FG002|Overall Study|Withdrawal by Sponsor|1|||
48602147|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
48735346|NCT03511664|156882292|FG002|Overall Study|Death|21|||
48735347|NCT03511664|156882290|FG000|Overall Study|Withdrew consent|40|||
48735348|NCT03511664|156882291|FG001|Overall Study|Withdrew consent|63|||
48735349|NCT03511664|156882292|FG002|Overall Study|Withdrew consent|3|||
48735350|NCT03511664|156882290|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
48735351|NCT03511664|156882291|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
48735352|NCT03511664|156882292|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
48735353|NCT03511664|156882290|FG000|Overall Study|Lost to Follow-up|8|||
48735354|NCT03511664|156882291|FG001|Overall Study|Lost to Follow-up|5|||
48735355|NCT03511664|156882292|FG002|Overall Study|Lost to Follow-up|0|||
48735356|NCT03511664|156882290|FG000|Overall Study|Physician Decision|2|||
48735357|NCT03511664|156882291|FG001|Overall Study|Physician Decision|1|||
48735358|NCT03511664|156882292|FG002|Overall Study|Physician Decision|0|||
48735359|NCT03511664|156882290|FG000|Overall Study|Patient non-compliance|1|||
48735360|NCT03511664|156882291|FG001|Overall Study|Patient non-compliance|0|||
48735361|NCT03511664|156882292|FG002|Overall Study|Patient non-compliance|0|||
48735362|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
48735363|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
48735364|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
48735365|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
48735366|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|Death|2|||
48735367|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|Death|2|||
48735368|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
48735369|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
48735370|NCT01528033|156882293|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
48735371|NCT01528033|156882294|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
48735372|NCT01528033|156882293|FG000|Follow Up|No data available|46|||
48735373|NCT01528033|156882294|FG001|Follow Up|No data available|44|||
48735374|NCT02121522|156882295|FG000|Overall Study|Adverse Event|1|||
48735375|NCT00338104|156882297|FG000|Overall Study|Protocol Violation|2|||
48735376|NCT00338104|156882298|FG001|Overall Study|Protocol Violation|1|||
48735377|NCT00338104|156882299|FG002|Overall Study|Protocol Violation|3|||
48735378|NCT03855228|156882300|FG000|Overall Study|Adverse Event|2|||
48526442|NCT03547635|156120482|FG000|Overall Study|Errant Randomization before Treatment|0|||
48526443|NCT03547635|156120483|FG001|Overall Study|Errant Randomization before Treatment|1|||
48526444|NCT03547635|156120484|FG002|Overall Study|Errant Randomization before Treatment|0|||
48526445|NCT03547635|156120482|FG000|Overall Study|Withdrawal by Subject|1|||
48526446|NCT03547635|156120483|FG001|Overall Study|Withdrawal by Subject|0|||
48526447|NCT03547635|156120484|FG002|Overall Study|Withdrawal by Subject|0|||
48526448|NCT01813435|156120485|FG000|Overall Study|did not finish experimental regimen|1902|||
48526449|NCT01813435|156120486|FG001|Overall Study|did not finish experimental regimen|770|||
48526450|NCT01813435|156120485|FG000|Overall Study|Lost to Follow-up|268|||
48526451|NCT01813435|156120486|FG001|Overall Study|Lost to Follow-up|237|||
48526452|NCT01011335|156120487|FG000|Overall Study|Lost to Follow-up|0|||
48526453|NCT01011335|156120488|FG001|Overall Study|Lost to Follow-up|0|||
48526454|NCT01011335|156120489|FG002|Overall Study|Lost to Follow-up|1|||
48526455|NCT01011335|156120490|FG003|Overall Study|Lost to Follow-up|1|||
48526456|NCT01011335|156120491|FG004|Overall Study|Lost to Follow-up|1|||
48526457|NCT01011335|156120492|FG005|Overall Study|Lost to Follow-up|1|||
48526458|NCT01011335|156120493|FG006|Overall Study|Lost to Follow-up|2|||
48526459|NCT01011335|156120494|FG007|Overall Study|Lost to Follow-up|2|||
48526460|NCT01011335|156120495|FG008|Overall Study|Lost to Follow-up|1|||
48526461|NCT01011335|156120496|FG009|Overall Study|Lost to Follow-up|0|||
48526462|NCT01011335|156120497|FG010|Overall Study|Lost to Follow-up|0|||
48526463|NCT01011335|156120498|FG011|Overall Study|Lost to Follow-up|1|||
48526464|NCT01011335|156120499|FG012|Overall Study|Lost to Follow-up|2|||
48526465|NCT01011335|156120487|FG000|Overall Study|Protocol Violation|0|||
48526466|NCT01011335|156120488|FG001|Overall Study|Protocol Violation|1|||
48526467|NCT01011335|156120489|FG002|Overall Study|Protocol Violation|0|||
48526468|NCT01011335|156120490|FG003|Overall Study|Protocol Violation|0|||
48526469|NCT01011335|156120491|FG004|Overall Study|Protocol Violation|0|||
48526470|NCT01011335|156120492|FG005|Overall Study|Protocol Violation|0|||
48526471|NCT01011335|156120493|FG006|Overall Study|Protocol Violation|0|||
48526472|NCT01011335|156120494|FG007|Overall Study|Protocol Violation|0|||
48735379|NCT03855228|156882301|FG001|Overall Study|Adverse Event|4|||
48735380|NCT03855228|156882302|FG002|Overall Study|Adverse Event|4|||
48735381|NCT03855228|156882303|FG003|Overall Study|Adverse Event|8|||
48735382|NCT03855228|156882300|FG000|Overall Study|Treatment Failure|1|||
48735383|NCT03855228|156882301|FG001|Overall Study|Treatment Failure|2|||
48735384|NCT03855228|156882302|FG002|Overall Study|Treatment Failure|1|||
48735385|NCT03855228|156882303|FG003|Overall Study|Treatment Failure|8|||
48735386|NCT03855228|156882300|FG000|Overall Study|Lost to Follow-up|0|||
48735387|NCT03855228|156882301|FG001|Overall Study|Lost to Follow-up|0|||
48735388|NCT03855228|156882302|FG002|Overall Study|Lost to Follow-up|0|||
48735389|NCT03855228|156882303|FG003|Overall Study|Lost to Follow-up|1|||
48735390|NCT03855228|156882300|FG000|Overall Study|Protocol Violation|0|||
48735391|NCT03855228|156882301|FG001|Overall Study|Protocol Violation|1|||
48735392|NCT03855228|156882302|FG002|Overall Study|Protocol Violation|2|||
48735393|NCT03855228|156882303|FG003|Overall Study|Protocol Violation|1|||
48735394|NCT03855228|156882300|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
48735395|NCT03855228|156882301|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
48602148|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
48602149|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
48735396|NCT03855228|156882302|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
48735397|NCT03855228|156882303|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
48735398|NCT00761631|156882316|FG000|Overall Study|Parent/legal guardian request|8|||
48735399|NCT00761631|156882317|FG001|Overall Study|Parent/legal guardian request|3|||
48735400|NCT00761631|156882318|FG002|Overall Study|Parent/legal guardian request|8|||
48735401|NCT00761631|156882319|FG003|Overall Study|Parent/legal guardian request|0|||
48735402|NCT00761631|156882320|FG004|Overall Study|Parent/legal guardian request|5|||
48735403|NCT00761631|156882321|FG005|Overall Study|Parent/legal guardian request|0|||
48735404|NCT00761631|156882316|FG000|Overall Study|Lost to Follow-up|2|||
48735405|NCT00761631|156882317|FG001|Overall Study|Lost to Follow-up|4|||
48735406|NCT00761631|156882318|FG002|Overall Study|Lost to Follow-up|7|||
48735407|NCT00761631|156882319|FG003|Overall Study|Lost to Follow-up|1|||
48735408|NCT00761631|156882320|FG004|Overall Study|Lost to Follow-up|6|||
48827523|NCT02735915|157210996|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
48827524|NCT02735915|157210996|FG000|Overall Study|Withdrawal following SAE|2|||
48827525|NCT02735915|157210996|FG000|Overall Study|Withdrawal by Subject|1|||
48827526|NCT05328973|157210997|FG000|Overall Study|Withdrawal by Subject|0|||
48827527|NCT05328973|157210998|FG001|Overall Study|Withdrawal by Subject|1|||
48827528|NCT00515086|157210999|FG000|Overall Study|Adverse Event|1|||
48827529|NCT00515086|157211000|FG001|Overall Study|Adverse Event|1|||
48827530|NCT00515086|157211001|FG002|Overall Study|Adverse Event|2|||
48827531|NCT00515086|157211002|FG003|Overall Study|Adverse Event|3|||
48827532|NCT00515086|157210999|FG000|Overall Study|Administrative|1|||
48827533|NCT00515086|157211000|FG001|Overall Study|Administrative|1|||
48827534|NCT00515086|157211001|FG002|Overall Study|Administrative|0|||
48827535|NCT00515086|157211002|FG003|Overall Study|Administrative|0|||
48827536|NCT00515086|157210999|FG000|Overall Study|Withdrawal by Subject|1|||
48827537|NCT00515086|157211000|FG001|Overall Study|Withdrawal by Subject|0|||
48827538|NCT00515086|157211001|FG002|Overall Study|Withdrawal by Subject|0|||
48827539|NCT00515086|157211002|FG003|Overall Study|Withdrawal by Subject|1|||
48827540|NCT00515086|157210999|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
48827541|NCT00515086|157211000|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48827542|NCT00515086|157211001|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
48827543|NCT00515086|157211002|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
48827544|NCT00515086|157210999|FG000|Overall Study|Lost to Follow-up|1|||
48827545|NCT00515086|157211000|FG001|Overall Study|Lost to Follow-up|0|||
48827546|NCT00515086|157211001|FG002|Overall Study|Lost to Follow-up|0|||
48827547|NCT00515086|157211002|FG003|Overall Study|Lost to Follow-up|0|||
48827548|NCT00515086|157210999|FG000|Overall Study|Study drug no longer required|0|||
48827549|NCT00515086|157211000|FG001|Overall Study|Study drug no longer required|1|||
48827550|NCT00515086|157211001|FG002|Overall Study|Study drug no longer required|0|||
48827551|NCT00515086|157211002|FG003|Overall Study|Study drug no longer required|0|||
48827552|NCT00515086|157210999|FG000|Overall Study|Death|2|||
48827553|NCT00515086|157211000|FG001|Overall Study|Death|0|||
48827554|NCT00515086|157211001|FG002|Overall Study|Death|0|||
48827555|NCT00515086|157211002|FG003|Overall Study|Death|0|||
48827556|NCT00868231|157211003|FG000|Treatment Period 1|Adverse Event|0|||
48827557|NCT00868231|157211004|FG001|Treatment Period 1|Adverse Event|0|||
48827558|NCT00868231|157211005|FG002|Treatment Period 1|Adverse Event|0|||
48827559|NCT00868231|157211006|FG003|Treatment Period 1|Adverse Event|0|||
48827560|NCT00868231|157211007|FG004|Treatment Period 1|Adverse Event|1|||
48827561|NCT00868231|157211008|FG005|Treatment Period 1|Adverse Event|0|||
48827562|NCT00868231|157211003|FG000|Treatment Period 2|Adverse Event|1|||
48827563|NCT00868231|157211004|FG001|Treatment Period 2|Adverse Event|0|||
48827564|NCT00868231|157211005|FG002|Treatment Period 2|Adverse Event|0|||
48827565|NCT00868231|157211006|FG003|Treatment Period 2|Adverse Event|0|||
48827566|NCT00868231|157211007|FG004|Treatment Period 2|Adverse Event|0|||
48827567|NCT00868231|157211008|FG005|Treatment Period 2|Adverse Event|0|||
48827568|NCT00868231|157211003|FG000|Treatment Period 3|Adverse Event|0|||
48827569|NCT00868231|157211004|FG001|Treatment Period 3|Adverse Event|0|||
48827570|NCT00868231|157211005|FG002|Treatment Period 3|Adverse Event|1|||
48827571|NCT00868231|157211006|FG003|Treatment Period 3|Adverse Event|0|||
48827572|NCT00868231|157211007|FG004|Treatment Period 3|Adverse Event|0|||
48827573|NCT00868231|157211008|FG005|Treatment Period 3|Adverse Event|0|||
48827574|NCT03120676|157211011|FG000|Overall Study|Not treated|1|||
48827575|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
48827576|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
48827577|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
48827578|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
48827579|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Adverse Event|198|||
48827580|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Adverse Event|0|||
48827581|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Adverse Event|0|||
48827582|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Adverse Event|0|||
48827583|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Death|62|||
48827584|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Death|0|||
48827585|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Death|0|||
48827586|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Death|0|||
48827587|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
48827588|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
48827589|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
48827590|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
48827591|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Complicating disease|13|||
48827592|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Complicating disease|0|||
48526473|NCT01011335|156120495|FG008|Overall Study|Protocol Violation|0|||
48526474|NCT01011335|156120496|FG009|Overall Study|Protocol Violation|0|||
48526475|NCT01011335|156120497|FG010|Overall Study|Protocol Violation|0|||
48526476|NCT01011335|156120498|FG011|Overall Study|Protocol Violation|0|||
48526477|NCT01011335|156120499|FG012|Overall Study|Protocol Violation|0|||
48526478|NCT01011335|156120487|FG000|Overall Study|Moved/deployed or no booster|1|||
48526479|NCT01011335|156120488|FG001|Overall Study|Moved/deployed or no booster|0|||
48526480|NCT01011335|156120489|FG002|Overall Study|Moved/deployed or no booster|0|||
48526481|NCT01011335|156120490|FG003|Overall Study|Moved/deployed or no booster|1|||
48526482|NCT01011335|156120491|FG004|Overall Study|Moved/deployed or no booster|0|||
48526483|NCT01011335|156120492|FG005|Overall Study|Moved/deployed or no booster|0|||
48526484|NCT01011335|156120493|FG006|Overall Study|Moved/deployed or no booster|1|||
48526485|NCT01011335|156120494|FG007|Overall Study|Moved/deployed or no booster|0|||
48526486|NCT01011335|156120495|FG008|Overall Study|Moved/deployed or no booster|1|||
48526487|NCT01011335|156120496|FG009|Overall Study|Moved/deployed or no booster|0|||
48526488|NCT01011335|156120497|FG010|Overall Study|Moved/deployed or no booster|2|||
48526489|NCT01011335|156120498|FG011|Overall Study|Moved/deployed or no booster|0|||
48526490|NCT01011335|156120499|FG012|Overall Study|Moved/deployed or no booster|0|||
48827593|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Complicating disease|0|||
48827594|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Complicating disease|0|||
48827595|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
48827596|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
48827597|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
48827598|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
48827599|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
48827600|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
48827601|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
48827602|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
48827603|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Non-compliance|4|||
48827604|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Non-compliance|0|||
48827605|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Non-compliance|0|||
48827606|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Non-compliance|0|||
48827607|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Pain|4|||
48827608|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Pain|0|||
48827609|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Pain|0|||
48526491|NCT01011335|156120487|FG000|Overall Study|Adverse Event|0|||
48526492|NCT01011335|156120488|FG001|Overall Study|Adverse Event|0|||
48827610|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Pain|0|||
48827611|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
48526493|NCT01011335|156120489|FG002|Overall Study|Adverse Event|0|||
48526494|NCT01011335|156120490|FG003|Overall Study|Adverse Event|0|||
48526495|NCT01011335|156120491|FG004|Overall Study|Adverse Event|0|||
48827612|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
48827613|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
48827614|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
48827615|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Hospice care|1|||
48827616|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Hospice care|0|||
48827617|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Hospice care|0|||
48827618|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Hospice care|0|||
48827619|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Physician Decision|1|||
48827620|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Physician Decision|0|||
48827621|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Physician Decision|0|||
48526496|NCT01011335|156120492|FG005|Overall Study|Adverse Event|0|||
48526497|NCT01011335|156120493|FG006|Overall Study|Adverse Event|0|||
48526498|NCT01011335|156120494|FG007|Overall Study|Adverse Event|0|||
48526499|NCT01011335|156120495|FG008|Overall Study|Adverse Event|0|||
48827622|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Physician Decision|0|||
48827623|NCT01107626|157211012|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
48827624|NCT01107626|157211013|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
48827625|NCT01107626|157211014|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
48827626|NCT01107626|157211015|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
48526500|NCT01011335|156120496|FG009|Overall Study|Adverse Event|0|||
48526501|NCT01011335|156120497|FG010|Overall Study|Adverse Event|4|||
48526502|NCT01011335|156120498|FG011|Overall Study|Adverse Event|0|||
48526503|NCT01011335|156120499|FG012|Overall Study|Adverse Event|1|||
48526504|NCT03180528|156120509|FG000|Overall Study|Adverse Event|1|||
48526505|NCT03180528|156120509|FG000|Overall Study|Withdrawal by Subject|1|||
48526506|NCT03180528|156120509|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
48526507|NCT01989676|156120510|FG000|Overall Study|Death|52|||
48526508|NCT01989676|156120511|FG001|Overall Study|Death|60|||
48526509|NCT01989676|156120510|FG000|Overall Study|Protocol Violation|2|||
48526510|NCT01989676|156120511|FG001|Overall Study|Protocol Violation|1|||
48526511|NCT01989676|156120510|FG000|Overall Study|Lost to Follow-up|8|||
48526512|NCT01989676|156120511|FG001|Overall Study|Lost to Follow-up|18|||
48526513|NCT01989676|156120510|FG000|Overall Study|No longer willing to participate in study|26|||
48526514|NCT01989676|156120511|FG001|Overall Study|No longer willing to participate in study|26|||
48526515|NCT01989676|156120510|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
48526516|NCT01989676|156120511|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
48526517|NCT01989676|156120510|FG000|Overall Study|Other|4|||
48526518|NCT01989676|156120511|FG001|Overall Study|Other|3|||
48526519|NCT03941834|156120512|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
48526520|NCT03941834|156120513|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
48526521|NCT03941834|156120514|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
48526522|NCT03941834|156120512|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
48526523|NCT03941834|156120513|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
48526524|NCT03941834|156120514|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
48526525|NCT03941834|156120512|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
48526526|NCT03941834|156120513|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
48526527|NCT03941834|156120514|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
48526528|NCT03941834|156120512|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
48526529|NCT03941834|156120513|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
48526530|NCT03941834|156120514|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
48526531|NCT03941834|156120512|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
48526532|NCT03941834|156120513|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
48526533|NCT03941834|156120514|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
48526534|NCT03941834|156120512|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
48526535|NCT03941834|156120513|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
48526536|NCT03941834|156120514|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
48526537|NCT01560819|156120515|FG000|Overall Study|Physician Decision|1|||
48526538|NCT01560819|156120516|FG001|Overall Study|Physician Decision|0|||
48526539|NCT04241133|156120519|FG000|Overall Study|COVID19 Precautions|14|||
48526540|NCT04241133|156120520|FG001|Overall Study|COVID19 Precautions|34|||
48526541|NCT00595335|156120521|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
48526542|NCT00595335|156120522|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
48526543|NCT00595335|156120521|FG000|Baseline to Six Months|Disease Progression|1|||
48526544|NCT00595335|156120522|FG001|Baseline to Six Months|Disease Progression|1|||
48526545|NCT00595335|156120521|FG000|Baseline to Six Months|Adverse Event|1|||
48526546|NCT00595335|156120522|FG001|Baseline to Six Months|Adverse Event|0|||
48526547|NCT00595335|156120521|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
48526548|NCT00595335|156120522|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
48526549|NCT00595335|156120521|FG000|Six Months to Twelve Months|Disease Progression|1|||
48526550|NCT00595335|156120522|FG001|Six Months to Twelve Months|Disease Progression|0|||
48526551|NCT00631007|156120527|FG000|Overall Study|Adverse Event|0|||
48526552|NCT00631007|156120528|FG001|Overall Study|Adverse Event|2|||
48526553|NCT00631007|156120529|FG002|Overall Study|Adverse Event|0|||
48526554|NCT00631007|156120530|FG003|Overall Study|Adverse Event|2|||
48526555|NCT00631007|156120531|FG004|Overall Study|Adverse Event|3|||
48526556|NCT00631007|156120532|FG005|Overall Study|Adverse Event|2|||
48526557|NCT00631007|156120527|FG000|Overall Study|Lost to Follow-up|2|||
48526558|NCT00631007|156120528|FG001|Overall Study|Lost to Follow-up|1|||
48526559|NCT00631007|156120529|FG002|Overall Study|Lost to Follow-up|2|||
48526560|NCT00631007|156120530|FG003|Overall Study|Lost to Follow-up|4|||
48526561|NCT00631007|156120531|FG004|Overall Study|Lost to Follow-up|5|||
48526562|NCT00631007|156120532|FG005|Overall Study|Lost to Follow-up|3|||
48526563|NCT00631007|156120527|FG000|Overall Study|Physician Decision|1|||
48526564|NCT00631007|156120528|FG001|Overall Study|Physician Decision|0|||
48526565|NCT00631007|156120529|FG002|Overall Study|Physician Decision|1|||
48602150|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
48526566|NCT00631007|156120530|FG003|Overall Study|Physician Decision|0|||
48526567|NCT00631007|156120531|FG004|Overall Study|Physician Decision|0|||
48526568|NCT00631007|156120532|FG005|Overall Study|Physician Decision|2|||
48526569|NCT00631007|156120527|FG000|Overall Study|Persistent Hyperglycemia|2|||
48526570|NCT00631007|156120528|FG001|Overall Study|Persistent Hyperglycemia|2|||
48526571|NCT00631007|156120529|FG002|Overall Study|Persistent Hyperglycemia|5|||
48526572|NCT00631007|156120530|FG003|Overall Study|Persistent Hyperglycemia|1|||
48827627|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
48827628|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
48827629|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
48827630|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
48827631|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
48827632|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
48827633|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
48827634|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
48827635|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Death|0|||
48827636|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Death|8|||
48827637|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Death|2|||
48827638|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Death|13|||
48827639|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
48827640|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
48827641|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
48827642|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
48827643|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
48827644|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
48827645|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
48827646|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
48827647|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
48827648|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
48827649|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
48827650|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
48827651|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
48827652|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
48827653|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
48827654|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
48827655|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
48827656|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
48827657|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
48827658|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
48827659|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
48827660|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
48827661|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
48827662|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
48827663|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
48827664|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
48827665|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
48827666|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
48827667|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
48827668|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
48827669|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
48827670|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
48827671|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
48827672|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
48827673|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
48827674|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
48827675|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
48827676|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
48827677|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
48827678|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
48827679|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Pain|0|||
48827680|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Pain|0|||
48827681|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Pain|0|||
48827682|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Pain|1|||
48827683|NCT01107626|157211012|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
48827684|NCT01107626|157211013|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
48827685|NCT01107626|157211014|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
48827686|NCT01107626|157211015|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
48827687|NCT00711646|157211016|FG000|Overall Study|Adverse Event|6|||
48827688|NCT00711646|157211017|FG001|Overall Study|Adverse Event|1|||
48827689|NCT00711646|157211016|FG000|Overall Study|Withdrawal by Subject|4|||
48827690|NCT00711646|157211017|FG001|Overall Study|Withdrawal by Subject|0|||
48827691|NCT00711646|157211016|FG000|Overall Study|Protocol Violation|0|||
48827692|NCT00711646|157211017|FG001|Overall Study|Protocol Violation|1|||
48827693|NCT00711646|157211016|FG000|Overall Study|Lost to Follow-up|1|||
48827694|NCT00711646|157211017|FG001|Overall Study|Lost to Follow-up|0|||
48827695|NCT00711646|157211016|FG000|Overall Study|administrative decision|0|||
48602151|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
48526573|NCT00631007|156120531|FG004|Overall Study|Persistent Hyperglycemia|2|||
48526574|NCT00631007|156120532|FG005|Overall Study|Persistent Hyperglycemia|5|||
48526575|NCT00631007|156120527|FG000|Overall Study|Withdrawal by Subject|4|||
48526576|NCT00631007|156120528|FG001|Overall Study|Withdrawal by Subject|5|||
48526577|NCT00631007|156120529|FG002|Overall Study|Withdrawal by Subject|2|||
48526578|NCT00631007|156120530|FG003|Overall Study|Withdrawal by Subject|2|||
48526579|NCT00631007|156120531|FG004|Overall Study|Withdrawal by Subject|1|||
48526580|NCT00631007|156120532|FG005|Overall Study|Withdrawal by Subject|3|||
48827696|NCT00711646|157211017|FG001|Overall Study|administrative decision|1|||
48827697|NCT00711646|157211016|FG000|Overall Study|patient non-compliance|1|||
48827698|NCT00711646|157211017|FG001|Overall Study|patient non-compliance|0|||
48827699|NCT03302156|157211018|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
48827700|NCT03302156|157211019|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
48827701|NCT03302156|157211020|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
48827702|NCT01280591|157211021|FG000|Overall Study|Withdrawal by Subject|0|||
48827703|NCT01280591|157211022|FG001|Overall Study|Withdrawal by Subject|0|||
48827704|NCT01280591|157211023|FG002|Overall Study|Withdrawal by Subject|0|||
48827705|NCT01280591|157211024|FG003|Overall Study|Withdrawal by Subject|2|||
48526581|NCT00631007|156120527|FG000|Overall Study|Other|2|||
48526582|NCT00631007|156120528|FG001|Overall Study|Other|1|||
48526583|NCT00631007|156120529|FG002|Overall Study|Other|0|||
48526584|NCT00631007|156120530|FG003|Overall Study|Other|0|||
48526585|NCT00631007|156120531|FG004|Overall Study|Other|1|||
48526586|NCT00631007|156120532|FG005|Overall Study|Other|0|||
48526587|NCT02674633|156120533|FG000|Overall Study|Lost to Follow-up|3|||
48526588|NCT02674633|156120534|FG001|Overall Study|Lost to Follow-up|2|||
48526589|NCT02674633|156120533|FG000|Overall Study|Physician Decision|1|||
48526590|NCT02674633|156120534|FG001|Overall Study|Physician Decision|0|||
48526591|NCT02674633|156120533|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48526592|NCT02674633|156120534|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48827706|NCT01280591|157211021|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
48526593|NCT00683787|156120535|FG000|Overall Study|Progression|3|||
48526594|NCT00683787|156120536|FG001|Overall Study|Progression|3|||
48526595|NCT00683787|156120537|FG002|Overall Study|Progression|0|||
48827707|NCT01280591|157211022|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
48827708|NCT01280591|157211023|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
48827709|NCT01280591|157211024|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
48827710|NCT02390557|157211025|FG000|Wave 2|Survey non-respondent|72|||
48827711|NCT02390557|157211026|FG001|Wave 2|Survey non-respondent|41|||
48827712|NCT02390557|157211027|FG002|Wave 2|Survey non-respondent|23|||
48827713|NCT05419557|157211030|FG000|Overall Study|Lost to Follow-up|11|||
48827714|NCT05419557|157211031|FG001|Overall Study|Lost to Follow-up|4|||
48827715|NCT04582877|157211032|FG000|Overall Study|Did not use device measurement|5|||
48827716|NCT04582877|157211032|FG000|Overall Study|No fractional flow reserve test results|2|||
48827717|NCT04582877|157211032|FG000|Overall Study|Protocol Violation|1|||
48827718|NCT01833065|157211034|FG000|Overall Study|Adverse Event|6|||
48827719|NCT01833065|157211035|FG001|Overall Study|Adverse Event|1|||
48827720|NCT01833065|157211036|FG002|Overall Study|Adverse Event|0|||
48827721|NCT01833065|157211037|FG003|Overall Study|Adverse Event|2|||
48827722|NCT01833065|157211038|FG004|Overall Study|Adverse Event|3|||
48827723|NCT01833065|157211034|FG000|Overall Study|Protocol Violation|1|||
48827724|NCT01833065|157211035|FG001|Overall Study|Protocol Violation|0|||
48827725|NCT01833065|157211036|FG002|Overall Study|Protocol Violation|0|||
48827726|NCT01833065|157211037|FG003|Overall Study|Protocol Violation|0|||
48827727|NCT01833065|157211038|FG004|Overall Study|Protocol Violation|2|||
48827728|NCT01833065|157211034|FG000|Overall Study|Lost to Follow-up|1|||
48827729|NCT01833065|157211035|FG001|Overall Study|Lost to Follow-up|0|||
48827730|NCT01833065|157211036|FG002|Overall Study|Lost to Follow-up|0|||
48827731|NCT01833065|157211037|FG003|Overall Study|Lost to Follow-up|0|||
48827732|NCT01833065|157211038|FG004|Overall Study|Lost to Follow-up|3|||
48827733|NCT01833065|157211034|FG000|Overall Study|Withdrawal by Subject|6|||
48827734|NCT01833065|157211035|FG001|Overall Study|Withdrawal by Subject|2|||
48827735|NCT01833065|157211036|FG002|Overall Study|Withdrawal by Subject|4|||
48827736|NCT01833065|157211037|FG003|Overall Study|Withdrawal by Subject|3|||
48827737|NCT01833065|157211038|FG004|Overall Study|Withdrawal by Subject|11|||
48827738|NCT01833065|157211034|FG000|Overall Study|Subject's substantial non-compliance|0|||
48602152|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
48827739|NCT01833065|157211035|FG001|Overall Study|Subject's substantial non-compliance|1|||
48827740|NCT01833065|157211036|FG002|Overall Study|Subject's substantial non-compliance|0|||
48827741|NCT01833065|157211037|FG003|Overall Study|Subject's substantial non-compliance|0|||
48827742|NCT01833065|157211038|FG004|Overall Study|Subject's substantial non-compliance|0|||
48526596|NCT00683787|156120535|FG000|Overall Study|Adverse Event|0|||
48526597|NCT00683787|156120536|FG001|Overall Study|Adverse Event|0|||
48526598|NCT00683787|156120537|FG002|Overall Study|Adverse Event|2|||
48526599|NCT04167618|156120538|FG000|Overall Study|Trial terminated by sponsor|1|||
48526600|NCT04167618|156120539|FG001|Overall Study|Trial terminated by sponsor|1|||
48526601|NCT00460109|156120540|FG000|Overall Study|Death|1|||
48526602|NCT01235715|156120541|FG000|Overall Study|Physician Decision|0|||
48526603|NCT01235715|156120542|FG001|Overall Study|Physician Decision|2|||
48526604|NCT02994394|156120543|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
48526605|NCT02994394|156120544|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
48526606|NCT02994394|156120545|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
48526607|NCT02994394|156120546|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
48526608|NCT02994394|156120547|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
48526609|NCT02994394|156120548|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
48526610|NCT02994394|156120543|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
48692901|NCT03137992|156724646|FG000|Washout Period 1|Principal Investigator Discretion|0|||
48827743|NCT01833065|157211034|FG000|Overall Study|Trial terminated by sponsor|8|||
48827744|NCT01833065|157211035|FG001|Overall Study|Trial terminated by sponsor|8|||
48827745|NCT01833065|157211036|FG002|Overall Study|Trial terminated by sponsor|7|||
48827746|NCT01833065|157211037|FG003|Overall Study|Trial terminated by sponsor|3|||
48827747|NCT01833065|157211038|FG004|Overall Study|Trial terminated by sponsor|13|||
48827748|NCT01833065|157211034|FG000|Overall Study|Others|2|||
48827749|NCT01833065|157211035|FG001|Overall Study|Others|1|||
48827750|NCT01833065|157211036|FG002|Overall Study|Others|1|||
48827751|NCT01833065|157211037|FG003|Overall Study|Others|1|||
48827752|NCT01833065|157211038|FG004|Overall Study|Others|4|||
48827753|NCT00567164|157211040|FG000|Overall Study|Withdrawal by Subject|171|||
48827754|NCT00567164|157211041|FG001|Overall Study|Withdrawal by Subject|21|||
48827755|NCT00567164|157211042|FG002|Overall Study|Withdrawal by Subject|17|||
48827756|NCT00567164|157211040|FG000|Overall Study|Protocol Violation|23|||
48827757|NCT00567164|157211041|FG001|Overall Study|Protocol Violation|4|||
48827758|NCT00567164|157211042|FG002|Overall Study|Protocol Violation|2|||
48827759|NCT00567164|157211040|FG000|Overall Study|Adverse Event|92|||
48827760|NCT00567164|157211041|FG001|Overall Study|Adverse Event|13|||
48827761|NCT00567164|157211042|FG002|Overall Study|Adverse Event|9|||
48827762|NCT00567164|157211040|FG000|Overall Study|Death|0|||
48526611|NCT02994394|156120544|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
48526612|NCT02994394|156120545|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
48526613|NCT02994394|156120546|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
48827763|NCT00567164|157211041|FG001|Overall Study|Death|0|||
48827764|NCT00567164|157211042|FG002|Overall Study|Death|1|||
48602153|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
48735409|NCT00761631|156882321|FG005|Overall Study|Lost to Follow-up|1|||
48735410|NCT00761631|156882316|FG000|Overall Study|Protocol Violation|2|||
48735411|NCT00761631|156882317|FG001|Overall Study|Protocol Violation|0|||
48735412|NCT00761631|156882318|FG002|Overall Study|Protocol Violation|0|||
48735413|NCT00761631|156882319|FG003|Overall Study|Protocol Violation|1|||
48735414|NCT00761631|156882320|FG004|Overall Study|Protocol Violation|5|||
48735415|NCT00761631|156882321|FG005|Overall Study|Protocol Violation|1|||
48735416|NCT00761631|156882316|FG000|Overall Study|Randomized, not treated|1|||
48735417|NCT00761631|156882317|FG001|Overall Study|Randomized, not treated|0|||
48735418|NCT00761631|156882318|FG002|Overall Study|Randomized, not treated|0|||
48735419|NCT00761631|156882319|FG003|Overall Study|Randomized, not treated|0|||
48735420|NCT00761631|156882320|FG004|Overall Study|Randomized, not treated|0|||
48827765|NCT00567164|157211040|FG000|Overall Study|Lost to Follow-up|202|||
48827766|NCT00567164|157211041|FG001|Overall Study|Lost to Follow-up|23|||
48827767|NCT00567164|157211042|FG002|Overall Study|Lost to Follow-up|21|||
48827768|NCT00567164|157211040|FG000|Overall Study|Pregnancy|20|||
48827769|NCT00567164|157211041|FG001|Overall Study|Pregnancy|4|||
48827770|NCT00567164|157211042|FG002|Overall Study|Pregnancy|6|||
48827771|NCT00567164|157211040|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
48827772|NCT00567164|157211041|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
48827773|NCT00567164|157211042|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
48827774|NCT00567164|157211040|FG000|Overall Study|Missing|1|||
48827775|NCT00567164|157211041|FG001|Overall Study|Missing|0|||
48827776|NCT00567164|157211042|FG002|Overall Study|Missing|0|||
48827777|NCT02282527|157211044|FG000|Overall Study|Lost to Follow-up|0|||
48827778|NCT02282527|157211045|FG001|Overall Study|Lost to Follow-up|1|||
48827779|NCT02282527|157211044|FG000|Overall Study|Lack of home health aid|1|||
48827780|NCT02282527|157211045|FG001|Overall Study|Lack of home health aid|0|||
48827781|NCT00941031|157211046|FG000|Induction Period|Lack of Efficacy|2|||
48827782|NCT00941031|157211047|FG001|Induction Period|Lack of Efficacy|1|||
48827783|NCT00941031|157211048|FG002|Induction Period|Lack of Efficacy|0|||
48827784|NCT00941031|157211049|FG003|Induction Period|Lack of Efficacy|5|||
48827785|NCT00941031|157211050|FG004|Induction Period|Lack of Efficacy|0|||
48827786|NCT00941031|157211051|FG005|Induction Period|Lack of Efficacy|0|||
48827787|NCT00941031|157211052|FG006|Induction Period|Lack of Efficacy|0|||
48827788|NCT00941031|157211046|FG000|Induction Period|Withdrawal by Subject|1|||
48827789|NCT00941031|157211047|FG001|Induction Period|Withdrawal by Subject|2|||
48827790|NCT00941031|157211048|FG002|Induction Period|Withdrawal by Subject|2|||
48827791|NCT00941031|157211049|FG003|Induction Period|Withdrawal by Subject|2|||
48827792|NCT00941031|157211050|FG004|Induction Period|Withdrawal by Subject|0|||
48827793|NCT00941031|157211051|FG005|Induction Period|Withdrawal by Subject|0|||
48827794|NCT00941031|157211052|FG006|Induction Period|Withdrawal by Subject|0|||
48827795|NCT00941031|157211046|FG000|Induction Period|Adminstative Problems|1|||
48827796|NCT00941031|157211047|FG001|Induction Period|Adminstative Problems|1|||
48827797|NCT00941031|157211048|FG002|Induction Period|Adminstative Problems|1|||
48827798|NCT00941031|157211049|FG003|Induction Period|Adminstative Problems|0|||
48827799|NCT00941031|157211050|FG004|Induction Period|Adminstative Problems|0|||
48827800|NCT00941031|157211051|FG005|Induction Period|Adminstative Problems|0|||
48827801|NCT00941031|157211052|FG006|Induction Period|Adminstative Problems|0|||
48827802|NCT00941031|157211046|FG000|Induction Period|Adverse Event|1|||
48827803|NCT00941031|157211047|FG001|Induction Period|Adverse Event|0|||
48827804|NCT00941031|157211048|FG002|Induction Period|Adverse Event|3|||
48827805|NCT00941031|157211049|FG003|Induction Period|Adverse Event|2|||
48827806|NCT00941031|157211050|FG004|Induction Period|Adverse Event|0|||
48827807|NCT00941031|157211051|FG005|Induction Period|Adverse Event|0|||
48444313|NCT02273037|155815052|FG001|Overall Study|Other complication|0|||
48444314|NCT00851253|155815056|FG000|Overall Study|Disease Progression|1|||
48444315|NCT00851253|155815057|FG001|Overall Study|Disease Progression|0|||
48827808|NCT00941031|157211052|FG006|Induction Period|Adverse Event|0|||
48444316|NCT02899377|155815058|FG000|Overall Study|Adverse Event|1|||
48444317|NCT02899377|155815059|FG001|Overall Study|Adverse Event|0|||
48444318|NCT04154943|155815060|FG000|Overall Study|Study Ongoing|68|||
48444319|NCT04154943|155815060|FG000|Overall Study|Lost to Follow-up|1|||
48444320|NCT04154943|155815060|FG000|Overall Study|Decision by the Investigator|1|||
48444321|NCT04154943|155815060|FG000|Overall Study|Death|5|||
48444322|NCT04154943|155815060|FG000|Overall Study|Withdrawal by Subject|4|||
48444323|NCT02227849|155815067|FG000|Overall Study|Adverse Event|4|||
48444324|NCT02227849|155815067|FG000|Overall Study|Physician Decision|1|||
48444325|NCT02227849|155815067|FG000|Overall Study|Withdrawal by Subject|3|||
48444326|NCT00776555|155815068|FG000|Overall Study|Study terminated|3|||
48444327|NCT00776555|155815069|FG001|Overall Study|Study terminated|0|||
48444328|NCT01335698|155815070|FG000|Treatment Stage 1|Lack of Efficacy|3|||
48444329|NCT01335698|155815071|FG001|Treatment Stage 1|Lack of Efficacy|1|||
48444330|NCT01335698|155815072|FG002|Treatment Stage 1|Lack of Efficacy|3|||
48444331|NCT01335698|155815073|FG003|Treatment Stage 1|Lack of Efficacy|3|||
48444332|NCT01335698|155815074|FG004|Treatment Stage 1|Lack of Efficacy|1|||
48526614|NCT02994394|156120547|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
48526615|NCT02994394|156120548|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
48526616|NCT03619876|156120549|FG000|Overall Study|Withdrawal by Subject|1|||
48526617|NCT03619876|156120550|FG001|Overall Study|Withdrawal by Subject|2|||
48526618|NCT03619876|156120549|FG000|Overall Study|Withdrawal due to incidental finding|0|||
48526619|NCT03619876|156120550|FG001|Overall Study|Withdrawal due to incidental finding|2|||
48526620|NCT01396421|156120551|FG000|Overall Study|Lost to Follow-up|0|||
48602154|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
48526621|NCT01396421|156120552|FG001|Overall Study|Lost to Follow-up|0|||
48526622|NCT01396421|156120553|FG002|Overall Study|Lost to Follow-up|0|||
48526623|NCT01396421|156120554|FG003|Overall Study|Lost to Follow-up|1|||
48526624|NCT01396421|156120551|FG000|Overall Study|Adverse Event|17|||
48602155|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
48602156|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
48602157|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
48735421|NCT00761631|156882321|FG005|Overall Study|Randomized, not treated|0|||
48735422|NCT00761631|156882316|FG000|Overall Study|Failed to return|1|||
48735423|NCT00761631|156882317|FG001|Overall Study|Failed to return|0|||
48735424|NCT00761631|156882318|FG002|Overall Study|Failed to return|1|||
48735425|NCT00761631|156882319|FG003|Overall Study|Failed to return|1|||
48735426|NCT00761631|156882320|FG004|Overall Study|Failed to return|5|||
48735427|NCT00761631|156882321|FG005|Overall Study|Failed to return|2|||
48735428|NCT00761631|156882316|FG000|Overall Study|Physician Decision|1|||
48735429|NCT00761631|156882317|FG001|Overall Study|Physician Decision|0|||
48735430|NCT00761631|156882318|FG002|Overall Study|Physician Decision|0|||
48735431|NCT00761631|156882319|FG003|Overall Study|Physician Decision|0|||
48735432|NCT00761631|156882320|FG004|Overall Study|Physician Decision|0|||
48735433|NCT00761631|156882321|FG005|Overall Study|Physician Decision|0|||
48735434|NCT00761631|156882316|FG000|Overall Study|Other|0|||
48735435|NCT00761631|156882317|FG001|Overall Study|Other|0|||
48735436|NCT00761631|156882318|FG002|Overall Study|Other|0|||
48735437|NCT00761631|156882319|FG003|Overall Study|Other|0|||
48735438|NCT00761631|156882320|FG004|Overall Study|Other|1|||
48735439|NCT00761631|156882321|FG005|Overall Study|Other|1|||
48735440|NCT00289016|156882322|FG000|Overall Study|Disease Progression|29|||
48735441|NCT00289016|156882322|FG000|Overall Study|Death|2|||
48735442|NCT00289016|156882322|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
48735443|NCT00289016|156882322|FG000|Overall Study|Withdrawal by Subject|2|||
48735444|NCT00289016|156882322|FG000|Overall Study|Adverse Event|1|||
48735445|NCT00289016|156882322|FG000|Overall Study|Other|1|||
48735446|NCT01558739|156882325|FG000|Overall Study|Adverse Event|7|||
48735447|NCT01558739|156882325|FG000|Overall Study|Withdrawal by Subject|2|||
48735448|NCT01558739|156882325|FG000|Overall Study|Death|3|||
48735449|NCT01558739|156882325|FG000|Overall Study|Disease Progression|4|||
48735450|NCT01558739|156882325|FG000|Overall Study|Protocol Violation|1|||
48735451|NCT01759511|156882326|FG000|Overall Study|Adverse Event|4|||
48735452|NCT01759511|156882326|FG000|Overall Study|Death|2|||
48827809|NCT00941031|157211046|FG000|Maintenance Period|Withdrawal by Subject|0|||
48827810|NCT00941031|157211047|FG001|Maintenance Period|Withdrawal by Subject|0|||
48827811|NCT00941031|157211048|FG002|Maintenance Period|Withdrawal by Subject|0|||
48827812|NCT00941031|157211049|FG003|Maintenance Period|Withdrawal by Subject|0|||
48827813|NCT00941031|157211050|FG004|Maintenance Period|Withdrawal by Subject|6|||
48827814|NCT00941031|157211051|FG005|Maintenance Period|Withdrawal by Subject|2|||
48827815|NCT00941031|157211052|FG006|Maintenance Period|Withdrawal by Subject|13|||
48827816|NCT00941031|157211046|FG000|Maintenance Period|Administrative Problems|0|||
48827817|NCT00941031|157211047|FG001|Maintenance Period|Administrative Problems|0|||
48827818|NCT00941031|157211048|FG002|Maintenance Period|Administrative Problems|0|||
48827819|NCT00941031|157211049|FG003|Maintenance Period|Administrative Problems|0|||
48827820|NCT00941031|157211050|FG004|Maintenance Period|Administrative Problems|1|||
48827821|NCT00941031|157211051|FG005|Maintenance Period|Administrative Problems|0|||
48827822|NCT00941031|157211052|FG006|Maintenance Period|Administrative Problems|1|||
48827823|NCT00941031|157211046|FG000|Maintenance Period|Protocol Violation|0|||
48827824|NCT00941031|157211047|FG001|Maintenance Period|Protocol Violation|0|||
48827825|NCT00941031|157211048|FG002|Maintenance Period|Protocol Violation|0|||
48827826|NCT00941031|157211049|FG003|Maintenance Period|Protocol Violation|0|||
48827827|NCT00941031|157211050|FG004|Maintenance Period|Protocol Violation|0|||
48827828|NCT00941031|157211051|FG005|Maintenance Period|Protocol Violation|0|||
48827829|NCT00941031|157211052|FG006|Maintenance Period|Protocol Violation|1|||
48827830|NCT00941031|157211046|FG000|Maintenance Period|Adverse Event|0|||
48827831|NCT00941031|157211047|FG001|Maintenance Period|Adverse Event|0|||
48827832|NCT00941031|157211048|FG002|Maintenance Period|Adverse Event|0|||
48827833|NCT00941031|157211049|FG003|Maintenance Period|Adverse Event|0|||
48526625|NCT01396421|156120552|FG001|Overall Study|Adverse Event|15|||
48526626|NCT01396421|156120553|FG002|Overall Study|Adverse Event|12|||
48526627|NCT01396421|156120554|FG003|Overall Study|Adverse Event|32|||
48602158|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
48735453|NCT01759511|156882326|FG000|Overall Study|Lack of Efficacy|2|||
48735454|NCT01759511|156882326|FG000|Overall Study|Physician Decision|1|||
48827834|NCT00941031|157211050|FG004|Maintenance Period|Adverse Event|0|||
48827835|NCT00941031|157211051|FG005|Maintenance Period|Adverse Event|2|||
48827836|NCT00941031|157211052|FG006|Maintenance Period|Adverse Event|8|||
48827837|NCT00941031|157211046|FG000|Maintenance Period|Lost to Follow-up|0|||
48827838|NCT00941031|157211047|FG001|Maintenance Period|Lost to Follow-up|0|||
48827839|NCT00941031|157211048|FG002|Maintenance Period|Lost to Follow-up|0|||
48827840|NCT00941031|157211049|FG003|Maintenance Period|Lost to Follow-up|0|||
48827841|NCT00941031|157211050|FG004|Maintenance Period|Lost to Follow-up|2|||
48827842|NCT00941031|157211051|FG005|Maintenance Period|Lost to Follow-up|2|||
48827843|NCT00941031|157211052|FG006|Maintenance Period|Lost to Follow-up|7|||
48827844|NCT00941031|157211046|FG000|Maintenance Period|Lack of Efficacy|0|||
48827845|NCT00941031|157211047|FG001|Maintenance Period|Lack of Efficacy|0|||
48827846|NCT00941031|157211048|FG002|Maintenance Period|Lack of Efficacy|0|||
48827847|NCT00941031|157211049|FG003|Maintenance Period|Lack of Efficacy|0|||
48827848|NCT00941031|157211050|FG004|Maintenance Period|Lack of Efficacy|0|||
48827849|NCT00941031|157211051|FG005|Maintenance Period|Lack of Efficacy|0|||
48827850|NCT00941031|157211052|FG006|Maintenance Period|Lack of Efficacy|13|||
48827851|NCT03124108|157211054|FG000|Overall Study|Adverse Event|0|||
48827852|NCT03124108|157211055|FG001|Overall Study|Adverse Event|1|||
48827853|NCT03124108|157211056|FG002|Overall Study|Adverse Event|0|||
48827854|NCT00631917|157211059|FG000|Overall Study|Adverse Event|34|||
48827855|NCT00631917|157211060|FG001|Overall Study|Adverse Event|45|||
48827856|NCT00631917|157211059|FG000|Overall Study|Abnormal laboratory value(s)|2|||
48827857|NCT00631917|157211060|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48827858|NCT00631917|157211059|FG000|Overall Study|Abnormal test procedure result(s)|3|||
48827859|NCT00631917|157211060|FG001|Overall Study|Abnormal test procedure result(s)|2|||
48827860|NCT00631917|157211059|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
48827861|NCT00631917|157211060|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
48827862|NCT00631917|157211059|FG000|Overall Study|No longer required study drug|0|||
48827863|NCT00631917|157211060|FG001|Overall Study|No longer required study drug|1|||
48827864|NCT00631917|157211059|FG000|Overall Study|Protocol deviation|6|||
48735455|NCT01759511|156882326|FG000|Overall Study|Progressive Disease|5|||
48735456|NCT01759511|156882326|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
48735457|NCT01759511|156882326|FG000|Overall Study|Study Terminated by Sponsor|13|||
48735458|NCT01759511|156882326|FG000|Overall Study|Withdrawal by Subject|3|||
48735459|NCT02024555|156882327|FG000|Overall Study|Lost to Follow-up|1|||
48735460|NCT02024555|156882328|FG001|Overall Study|Lost to Follow-up|1|||
48735461|NCT02024555|156882327|FG000|Overall Study|Withdrawal by Subject|5|||
48735462|NCT02024555|156882328|FG001|Overall Study|Withdrawal by Subject|1|||
48735463|NCT00810108|156883616|FG000|Overall Study|Withdrawal by Subject|1|||
48735464|NCT00810108|156883617|FG001|Overall Study|Withdrawal by Subject|0|||
48735465|NCT04806503|156883618|FG000|Overall Study|Lost to Follow-up|0|||
48735466|NCT04806503|156883619|FG001|Overall Study|Lost to Follow-up|0|||
48735467|NCT04806503|156883620|FG002|Overall Study|Lost to Follow-up|1|||
48735468|NCT04806503|156883621|FG003|Overall Study|Lost to Follow-up|0|||
48735469|NCT04806503|156883622|FG004|Overall Study|Lost to Follow-up|0|||
48735470|NCT04806503|156883618|FG000|Overall Study|Withdrawal by Subject|1|||
48735471|NCT04806503|156883619|FG001|Overall Study|Withdrawal by Subject|0|||
48735472|NCT04806503|156883620|FG002|Overall Study|Withdrawal by Subject|1|||
48735473|NCT04806503|156883621|FG003|Overall Study|Withdrawal by Subject|1|||
48735474|NCT04806503|156883622|FG004|Overall Study|Withdrawal by Subject|1|||
48735475|NCT04806503|156883618|FG000|Overall Study|Adverse Event|1|||
48735476|NCT04806503|156883619|FG001|Overall Study|Adverse Event|1|||
48735477|NCT04806503|156883620|FG002|Overall Study|Adverse Event|0|||
48735478|NCT04806503|156883621|FG003|Overall Study|Adverse Event|1|||
48735479|NCT04806503|156883622|FG004|Overall Study|Adverse Event|0|||
48735480|NCT01871142|156883623|FG000|Overall Study|Adverse Event|1|||
48735481|NCT01409434|156883624|FG000|Overall Study|Protocol Violation|4|||
48735482|NCT02336373|156883629|FG000|Overall Study|Protocol closed early|4|||
48735483|NCT02336373|156883629|FG000|Overall Study|Physician Decision|14|||
48735484|NCT01031381|156883640|FG000|Overall Study|Physician Decision|3|||
48735485|NCT01031381|156883640|FG000|Overall Study|Withdrawal by Subject|6|||
48735486|NCT03257371|156883641|FG000|Overall Study|Lost to Follow-up|1|||
48735487|NCT00631696|156883642|FG000|Overall Study|Entered, not randomized to treatment|1|||
48735488|NCT00631696|156883643|FG001|Overall Study|Entered, not randomized to treatment|1|||
48735489|NCT00631696|156883642|FG000|Overall Study|Discontinued after database release date|1|||
48735490|NCT00631696|156883643|FG001|Overall Study|Discontinued after database release date|0|||
48735491|NCT00631696|156883642|FG000|Overall Study|Follow up after database release date|1|||
48735492|NCT00631696|156883643|FG001|Overall Study|Follow up after database release date|0|||
48735493|NCT00631696|156883642|FG000|Overall Study|Lost to Follow-up|7|||
48735494|NCT00631696|156883643|FG001|Overall Study|Lost to Follow-up|10|||
48735495|NCT00631696|156883642|FG000|Overall Study|Withdrawal by Subject|2|||
48735496|NCT00631696|156883643|FG001|Overall Study|Withdrawal by Subject|9|||
48827865|NCT00631917|157211060|FG001|Overall Study|Protocol deviation|5|||
48827866|NCT00631917|157211059|FG000|Overall Study|Subject withdrew consent|25|||
48827867|NCT00631917|157211060|FG001|Overall Study|Subject withdrew consent|33|||
48827868|NCT00631917|157211059|FG000|Overall Study|Lost to Follow-up|7|||
48827869|NCT00631917|157211060|FG001|Overall Study|Lost to Follow-up|7|||
48827870|NCT00631917|157211059|FG000|Overall Study|Administrative problems|2|||
48827871|NCT00631917|157211060|FG001|Overall Study|Administrative problems|0|||
48827872|NCT00631917|157211059|FG000|Overall Study|Death|1|||
48827873|NCT00631917|157211060|FG001|Overall Study|Death|0|||
48827874|NCT00502593|157211063|FG000|Overall Study|Withdrawn unspecified reason|1|||
48827875|NCT00502593|157211064|FG001|Overall Study|Withdrawn unspecified reason|1|||
48827876|NCT00502593|157211065|FG002|Overall Study|Withdrawn unspecified reason|3|||
48827877|NCT00502593|157211066|FG003|Overall Study|Withdrawn unspecified reason|1|||
48827878|NCT00502593|157211067|FG004|Overall Study|Withdrawn unspecified reason|2|||
48827879|NCT00502593|157211068|FG005|Overall Study|Withdrawn unspecified reason|0|||
48827880|NCT00502593|157211069|FG006|Overall Study|Withdrawn unspecified reason|2|||
48827881|NCT00502593|157211070|FG007|Overall Study|Withdrawn unspecified reason|0|||
48827882|NCT00502593|157211071|FG008|Overall Study|Withdrawn unspecified reason|0|||
48827883|NCT00502593|157211072|FG009|Overall Study|Withdrawn unspecified reason|0|||
48827884|NCT00502593|157211073|FG010|Overall Study|Withdrawn unspecified reason|0|||
48827885|NCT00502593|157211074|FG011|Overall Study|Withdrawn unspecified reason|0|||
48827886|NCT00502593|157211063|FG000|Overall Study|Withdrawal by Subject|0|||
48827887|NCT00502593|157211064|FG001|Overall Study|Withdrawal by Subject|0|||
48827888|NCT00502593|157211065|FG002|Overall Study|Withdrawal by Subject|6|||
48827889|NCT00502593|157211066|FG003|Overall Study|Withdrawal by Subject|2|||
48827890|NCT00502593|157211067|FG004|Overall Study|Withdrawal by Subject|2|||
48827891|NCT00502593|157211068|FG005|Overall Study|Withdrawal by Subject|0|||
48827892|NCT00502593|157211069|FG006|Overall Study|Withdrawal by Subject|3|||
48827893|NCT00502593|157211070|FG007|Overall Study|Withdrawal by Subject|0|||
48827894|NCT00502593|157211071|FG008|Overall Study|Withdrawal by Subject|3|||
48827895|NCT00502593|157211072|FG009|Overall Study|Withdrawal by Subject|0|||
48827896|NCT00502593|157211073|FG010|Overall Study|Withdrawal by Subject|1|||
48827897|NCT00502593|157211074|FG011|Overall Study|Withdrawal by Subject|0|||
48827898|NCT00502593|157211063|FG000|Overall Study|Lost to Follow-up|2|||
48827899|NCT00502593|157211064|FG001|Overall Study|Lost to Follow-up|1|||
48827900|NCT00502593|157211065|FG002|Overall Study|Lost to Follow-up|1|||
48827901|NCT00502593|157211066|FG003|Overall Study|Lost to Follow-up|1|||
48827902|NCT00502593|157211067|FG004|Overall Study|Lost to Follow-up|0|||
48827903|NCT00502593|157211068|FG005|Overall Study|Lost to Follow-up|0|||
48827904|NCT00502593|157211069|FG006|Overall Study|Lost to Follow-up|0|||
48827905|NCT00502593|157211070|FG007|Overall Study|Lost to Follow-up|0|||
48827906|NCT00502593|157211071|FG008|Overall Study|Lost to Follow-up|3|||
48827907|NCT00502593|157211072|FG009|Overall Study|Lost to Follow-up|0|||
48827908|NCT00502593|157211073|FG010|Overall Study|Lost to Follow-up|1|||
48827909|NCT00502593|157211074|FG011|Overall Study|Lost to Follow-up|0|||
48827910|NCT01664104|157211075|FG000|Overall Study|Adverse Event|6|||
48827911|NCT01664104|157211075|FG000|Overall Study|Lack of Efficacy|2|||
48827912|NCT01664104|157211075|FG000|Overall Study|Withdrawal by Subject|1|||
48827913|NCT01664104|157211075|FG000|Overall Study|Lost to Follow-up|4|||
48827914|NCT01664104|157211075|FG000|Overall Study|Other|1|||
48827915|NCT01664104|157211075|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
48827916|NCT03761784|157211078|FG000|Overall Study|Adverse Event|4|||
48827917|NCT03761784|157211079|FG001|Overall Study|Adverse Event|0|||
48827918|NCT03761784|157211078|FG000|Overall Study|Lost to Follow-up|10|||
48827919|NCT03761784|157211079|FG001|Overall Study|Lost to Follow-up|7|||
48827920|NCT03761784|157211078|FG000|Overall Study|Pregnancy|1|||
48827921|NCT03761784|157211079|FG001|Overall Study|Pregnancy|0|||
48444333|NCT01335698|155815070|FG000|Treatment Stage 1|Adverse Event|1|||
48444334|NCT01335698|155815071|FG001|Treatment Stage 1|Adverse Event|2|||
48444335|NCT01335698|155815072|FG002|Treatment Stage 1|Adverse Event|2|||
48444336|NCT01335698|155815073|FG003|Treatment Stage 1|Adverse Event|1|||
48444337|NCT01335698|155815074|FG004|Treatment Stage 1|Adverse Event|1|||
48444338|NCT01335698|155815070|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
48444339|NCT01335698|155815071|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
48444340|NCT01335698|155815072|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
48444341|NCT01335698|155815073|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
48444342|NCT01335698|155815074|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
48444343|NCT01335698|155815070|FG000|Treatment Stage 1|Lost to Follow-up|1|||
48444344|NCT01335698|155815071|FG001|Treatment Stage 1|Lost to Follow-up|1|||
48444345|NCT01335698|155815072|FG002|Treatment Stage 1|Lost to Follow-up|0|||
48444346|NCT01335698|155815073|FG003|Treatment Stage 1|Lost to Follow-up|0|||
48444347|NCT01335698|155815074|FG004|Treatment Stage 1|Lost to Follow-up|0|||
48444348|NCT01335698|155815070|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
48444349|NCT01335698|155815071|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
48444350|NCT01335698|155815072|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
48444351|NCT01335698|155815073|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
48526628|NCT01396421|156120551|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
48526629|NCT01396421|156120552|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
48526630|NCT01396421|156120553|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
48526631|NCT01396421|156120554|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
48526632|NCT01396421|156120551|FG000|Overall Study|Physician Decision|1|||
48526633|NCT01396421|156120552|FG001|Overall Study|Physician Decision|1|||
48526634|NCT01396421|156120553|FG002|Overall Study|Physician Decision|0|||
48526635|NCT01396421|156120554|FG003|Overall Study|Physician Decision|3|||
48526636|NCT01396421|156120551|FG000|Overall Study|Withdrawal by Subject|31|||
48526637|NCT01396421|156120552|FG001|Overall Study|Withdrawal by Subject|24|||
48526638|NCT01396421|156120553|FG002|Overall Study|Withdrawal by Subject|13|||
48526639|NCT01396421|156120554|FG003|Overall Study|Withdrawal by Subject|21|||
48526640|NCT01396421|156120551|FG000|Overall Study|Protocol Deviation|2|||
48526641|NCT01396421|156120552|FG001|Overall Study|Protocol Deviation|1|||
48526642|NCT01396421|156120553|FG002|Overall Study|Protocol Deviation|1|||
48526643|NCT01396421|156120554|FG003|Overall Study|Protocol Deviation|0|||
48526644|NCT01396421|156120551|FG000|Overall Study|Lack of Efficacy|7|||
48526645|NCT01396421|156120552|FG001|Overall Study|Lack of Efficacy|17|||
48526646|NCT01396421|156120553|FG002|Overall Study|Lack of Efficacy|7|||
48526647|NCT01396421|156120554|FG003|Overall Study|Lack of Efficacy|18|||
48526648|NCT02576717|156120555|FG000|Overall Study|Other Reasons|16|||
48526649|NCT02576717|156120556|FG001|Overall Study|Other Reasons|18|||
48526650|NCT02576717|156120557|FG002|Overall Study|Other Reasons|15|||
48526651|NCT02576717|156120555|FG000|Overall Study|Covid-19 Pandemic|0|||
48526652|NCT02576717|156120556|FG001|Overall Study|Covid-19 Pandemic|1|||
48526653|NCT02576717|156120557|FG002|Overall Study|Covid-19 Pandemic|1|||
48526654|NCT02576717|156120555|FG000|Overall Study|Sponsor Decision|0|||
48526655|NCT02576717|156120556|FG001|Overall Study|Sponsor Decision|0|||
48526656|NCT02576717|156120557|FG002|Overall Study|Sponsor Decision|1|||
48526657|NCT02576717|156120555|FG000|Overall Study|Physician Decision|3|||
48526658|NCT02576717|156120556|FG001|Overall Study|Physician Decision|8|||
48526659|NCT02576717|156120557|FG002|Overall Study|Physician Decision|9|||
48526660|NCT02576717|156120555|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
48526661|NCT02576717|156120556|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
48526662|NCT02576717|156120557|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
48526663|NCT02576717|156120555|FG000|Overall Study|Death|3|||
48526664|NCT02576717|156120556|FG001|Overall Study|Death|5|||
48526665|NCT02576717|156120557|FG002|Overall Study|Death|3|||
48526666|NCT02576717|156120555|FG000|Overall Study|Lost to Follow-up|9|||
48526667|NCT02576717|156120556|FG001|Overall Study|Lost to Follow-up|10|||
48526668|NCT02576717|156120557|FG002|Overall Study|Lost to Follow-up|19|||
48526669|NCT02576717|156120555|FG000|Overall Study|Protocol Violation|4|||
48526670|NCT02576717|156120556|FG001|Overall Study|Protocol Violation|0|||
48526671|NCT02576717|156120557|FG002|Overall Study|Protocol Violation|5|||
48526672|NCT02576717|156120555|FG000|Overall Study|Lack of Efficacy|24|||
48526673|NCT02576717|156120556|FG001|Overall Study|Lack of Efficacy|28|||
48526674|NCT02576717|156120557|FG002|Overall Study|Lack of Efficacy|20|||
48526675|NCT02576717|156120555|FG000|Overall Study|Adverse Event|26|||
48526676|NCT02576717|156120556|FG001|Overall Study|Adverse Event|32|||
48526677|NCT02576717|156120557|FG002|Overall Study|Adverse Event|26|||
48526678|NCT01755975|156120558|FG000|Overall Study|Adverse Event|0|||
48526679|NCT01755975|156120559|FG001|Overall Study|Adverse Event|0|||
48526680|NCT01755975|156120560|FG002|Overall Study|Adverse Event|1|||
48526681|NCT01755975|156120561|FG003|Overall Study|Adverse Event|0|||
48526682|NCT01755975|156120562|FG004|Overall Study|Adverse Event|2|||
48526683|NCT01098110|156120563|FG000|Overall Study|Withdrawal by Subject|14|||
48526684|NCT01098110|156120564|FG001|Overall Study|Withdrawal by Subject|24|||
48526685|NCT01098110|156120565|FG002|Overall Study|Withdrawal by Subject|19|||
48526686|NCT01098110|156120563|FG000|Overall Study|Adverse Event|30|||
48526687|NCT01098110|156120564|FG001|Overall Study|Adverse Event|32|||
48526688|NCT01098110|156120565|FG002|Overall Study|Adverse Event|43|||
48526689|NCT01098110|156120563|FG000|Overall Study|Lack of Efficacy|13|||
48526690|NCT01098110|156120564|FG001|Overall Study|Lack of Efficacy|9|||
48526691|NCT01098110|156120565|FG002|Overall Study|Lack of Efficacy|27|||
48526692|NCT01098110|156120563|FG000|Overall Study|Other|4|||
48526693|NCT01098110|156120564|FG001|Overall Study|Other|7|||
48526694|NCT01098110|156120565|FG002|Overall Study|Other|5|||
48526695|NCT01098110|156120563|FG000|Overall Study|Untreated|1|||
48526696|NCT01098110|156120564|FG001|Overall Study|Untreated|1|||
48526697|NCT01098110|156120565|FG002|Overall Study|Untreated|0|||
48526698|NCT01999894|156120566|FG000|Overall Study|Adverse Event|9|||
48602159|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
48526699|NCT01999894|156120566|FG000|Overall Study|Lack of Efficacy|5|||
48526700|NCT01999894|156120566|FG000|Overall Study|Protocol Violation|1|||
48526701|NCT01999894|156120566|FG000|Overall Study|Withdrawal by Subject|7|||
48526702|NCT01999894|156120566|FG000|Overall Study|Lost to Follow-up|10|||
48526703|NCT01999894|156120566|FG000|Overall Study|Other Reason|3|||
48526704|NCT01999894|156120566|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
48526705|NCT02147587|156120567|FG000|Overall Study|Adverse Event|9|||
48735497|NCT00631696|156883642|FG000|Overall Study|Other|8|||
48526706|NCT02147587|156120568|FG001|Overall Study|Adverse Event|4|||
48526707|NCT02147587|156120567|FG000|Overall Study|Lack of Efficacy|2|||
48526708|NCT02147587|156120568|FG001|Overall Study|Lack of Efficacy|1|||
48526709|NCT01546519|156120570|FG000|Overall Study|Adverse Event|0|||
48526710|NCT01546519|156120571|FG001|Overall Study|Adverse Event|0|||
48526711|NCT01546519|156120572|FG002|Overall Study|Adverse Event|1|||
48526712|NCT01546519|156120573|FG003|Overall Study|Adverse Event|1|||
48526713|NCT01546519|156120570|FG000|Overall Study|Death|0|||
48526714|NCT01546519|156120571|FG001|Overall Study|Death|1|||
48526715|NCT01546519|156120572|FG002|Overall Study|Death|3|||
48526716|NCT01546519|156120573|FG003|Overall Study|Death|1|||
48526717|NCT01546519|156120570|FG000|Overall Study|related to disease progression|2|||
48526718|NCT01546519|156120571|FG001|Overall Study|related to disease progression|2|||
48526719|NCT01546519|156120572|FG002|Overall Study|related to disease progression|2|||
48526720|NCT01546519|156120573|FG003|Overall Study|related to disease progression|1|||
48526721|NCT01546519|156120570|FG000|Overall Study|Physician Decision|6|||
48526722|NCT01546519|156120571|FG001|Overall Study|Physician Decision|5|||
48526723|NCT01546519|156120572|FG002|Overall Study|Physician Decision|2|||
48526724|NCT01546519|156120573|FG003|Overall Study|Physician Decision|3|||
48526725|NCT01546519|156120570|FG000|Overall Study|Withdrawal by Subject|1|||
48526726|NCT01546519|156120571|FG001|Overall Study|Withdrawal by Subject|0|||
48526727|NCT01546519|156120572|FG002|Overall Study|Withdrawal by Subject|0|||
48526728|NCT01546519|156120573|FG003|Overall Study|Withdrawal by Subject|0|||
48526729|NCT01355302|156120574|FG000|Phase 1b|Death|4|||
48526730|NCT01355302|156120575|FG001|Phase 1b|Death|0|||
48526731|NCT01355302|156120576|FG002|Phase 1b|Death|0|||
48526732|NCT01355302|156120574|FG000|Phase 1b|Study terminated by sponsor|2|||
48526733|NCT01355302|156120575|FG001|Phase 1b|Study terminated by sponsor|0|||
48526734|NCT01355302|156120576|FG002|Phase 1b|Study terminated by sponsor|0|||
48526735|NCT03259789|156120577|FG000|Overall Study|Adverse Event|3|||
48526736|NCT03259789|156120578|FG001|Overall Study|Adverse Event|2|||
48526737|NCT03259789|156120579|FG002|Overall Study|Adverse Event|1|||
48526738|NCT03259789|156120577|FG000|Overall Study|Withdrawal by Subject|9|||
48526739|NCT03259789|156120578|FG001|Overall Study|Withdrawal by Subject|5|||
48526740|NCT03259789|156120579|FG002|Overall Study|Withdrawal by Subject|1|||
48526741|NCT03259789|156120577|FG000|Overall Study|Lost to Follow-up|5|||
48526742|NCT03259789|156120578|FG001|Overall Study|Lost to Follow-up|9|||
48526743|NCT03259789|156120579|FG002|Overall Study|Lost to Follow-up|4|||
48526744|NCT03259789|156120577|FG000|Overall Study|Physician Decision|0|||
48526745|NCT03259789|156120578|FG001|Overall Study|Physician Decision|1|||
48526746|NCT03259789|156120579|FG002|Overall Study|Physician Decision|0|||
48526747|NCT01701973|156120580|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
48526748|NCT01701973|156120581|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
48526749|NCT01701973|156120582|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
48827922|NCT03761784|157211078|FG000|Overall Study|Protocol Violation|2|||
48827923|NCT03761784|157211079|FG001|Overall Study|Protocol Violation|0|||
48827924|NCT03761784|157211078|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
48827925|NCT03761784|157211079|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
48827926|NCT03761784|157211078|FG000|Overall Study|Withdrawal by Subject|9|||
48827927|NCT03761784|157211079|FG001|Overall Study|Withdrawal by Subject|4|||
48827928|NCT03761784|157211078|FG000|Overall Study|Physician Decision|1|||
48827929|NCT03761784|157211079|FG001|Overall Study|Physician Decision|0|||
48827930|NCT03761784|157211078|FG000|Overall Study|Other Than Specified|1|||
48827931|NCT03761784|157211079|FG001|Overall Study|Other Than Specified|0|||
48827932|NCT02596035|157211082|FG000|Overall Study|Disease Progression|64|||
48827933|NCT02596035|157211083|FG001|Overall Study|Disease Progression|32|||
48827934|NCT02596035|157211084|FG002|Overall Study|Disease Progression|1|||
48827935|NCT02596035|157211082|FG000|Overall Study|study drug toxicity|12|||
48827936|NCT02596035|157211083|FG001|Overall Study|study drug toxicity|3|||
48827937|NCT02596035|157211084|FG002|Overall Study|study drug toxicity|0|||
48827938|NCT02596035|157211082|FG000|Overall Study|AE unrelated to study drug|5|||
48827939|NCT02596035|157211083|FG001|Overall Study|AE unrelated to study drug|2|||
48827940|NCT02596035|157211084|FG002|Overall Study|AE unrelated to study drug|0|||
48827941|NCT02596035|157211082|FG000|Overall Study|participant request to discontinue study treatment|2|||
48827942|NCT02596035|157211083|FG001|Overall Study|participant request to discontinue study treatment|0|||
48827943|NCT02596035|157211084|FG002|Overall Study|participant request to discontinue study treatment|0|||
48827944|NCT02596035|157211082|FG000|Overall Study|participant withdrew consent|2|||
48827945|NCT02596035|157211083|FG001|Overall Study|participant withdrew consent|2|||
48827946|NCT02596035|157211084|FG002|Overall Study|participant withdrew consent|0|||
48827947|NCT02596035|157211082|FG000|Overall Study|Poor/Non Comlpiance|0|||
48827948|NCT02596035|157211083|FG001|Overall Study|Poor/Non Comlpiance|1|||
48827949|NCT02596035|157211084|FG002|Overall Study|Poor/Non Comlpiance|0|||
48827950|NCT02596035|157211082|FG000|Overall Study|participant no longer meets study criteria|1|||
48827951|NCT02596035|157211083|FG001|Overall Study|participant no longer meets study criteria|0|||
48526750|NCT01701973|156120583|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
48526751|NCT01701973|156120584|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
48526752|NCT01701973|156120585|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
48526753|NCT01701973|156120586|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
48526754|NCT01701973|156120587|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
48526755|NCT01876368|156120588|FG000|Overall Study|Adverse Event|2|||
48526756|NCT01876368|156120589|FG001|Overall Study|Adverse Event|5|||
48526757|NCT01876368|156120588|FG000|Overall Study|Lack of Efficacy|1|||
48526758|NCT01876368|156120589|FG001|Overall Study|Lack of Efficacy|0|||
48526759|NCT01876368|156120588|FG000|Overall Study|Lost to Follow-up|0|||
48526760|NCT01876368|156120589|FG001|Overall Study|Lost to Follow-up|1|||
48526761|NCT01876368|156120588|FG000|Overall Study|Non-compliance with study treatment|0|||
48526762|NCT01876368|156120589|FG001|Overall Study|Non-compliance with study treatment|1|||
48526763|NCT01876368|156120588|FG000|Overall Study|Physician Decision|0|||
48526764|NCT01876368|156120589|FG001|Overall Study|Physician Decision|2|||
48526765|NCT01876368|156120588|FG000|Overall Study|Protocol deviation|3|||
48526766|NCT01876368|156120589|FG001|Overall Study|Protocol deviation|3|||
48526767|NCT01876368|156120588|FG000|Overall Study|Subject/guardian decision|3|||
48526768|NCT01876368|156120589|FG001|Overall Study|Subject/guardian decision|1|||
48526769|NCT01731886|156120590|FG000|Overall Study|Death|1|||
48526770|NCT01731886|156120591|FG001|Overall Study|Death|0|||
48526771|NCT01731886|156120590|FG000|Overall Study|Never started treatment|0|||
48526772|NCT01731886|156120591|FG001|Overall Study|Never started treatment|1|||
48526773|NCT01731886|156120590|FG000|Overall Study|Non-compliant|1|||
48526774|NCT01731886|156120591|FG001|Overall Study|Non-compliant|0|||
48526775|NCT00271024|156120592|FG000|Overall Study|Lost Interest|3|||
48526776|NCT00271024|156120593|FG001|Overall Study|Lost Interest|4|||
48526777|NCT00271024|156120594|FG002|Overall Study|Lost Interest|2|||
48526778|NCT00271024|156120595|FG003|Overall Study|Lost Interest|3|||
48526779|NCT00271024|156120592|FG000|Overall Study|Unknown/Unspecified|11|||
48526780|NCT00271024|156120593|FG001|Overall Study|Unknown/Unspecified|11|||
48526781|NCT00271024|156120594|FG002|Overall Study|Unknown/Unspecified|8|||
48526782|NCT00271024|156120595|FG003|Overall Study|Unknown/Unspecified|4|||
48526783|NCT00271024|156120592|FG000|Overall Study|Protocol Violation|1|||
48526784|NCT00271024|156120593|FG001|Overall Study|Protocol Violation|6|||
48526785|NCT00271024|156120594|FG002|Overall Study|Protocol Violation|5|||
48526786|NCT00271024|156120595|FG003|Overall Study|Protocol Violation|11|||
48526787|NCT00271024|156120592|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
48526788|NCT00271024|156120593|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
48526789|NCT00271024|156120594|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
48526790|NCT00271024|156120595|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
48526791|NCT00271024|156120592|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
48526792|NCT00271024|156120593|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
48526793|NCT00271024|156120594|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
48526794|NCT00271024|156120595|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
48526795|NCT00129116|156120596|FG000|Primary Phase|Lost to Follow-up|1|||
48526796|NCT00129116|156120597|FG001|Primary Phase|Lost to Follow-up|1|||
48526797|NCT00129116|156120598|FG002|Primary Phase|Lost to Follow-up|0|||
48526798|NCT00129116|156120599|FG003|Primary Phase|Lost to Follow-up|1|||
48827952|NCT02596035|157211084|FG002|Overall Study|participant no longer meets study criteria|0|||
48827953|NCT02596035|157211082|FG000|Overall Study|other reasons|11|||
48827954|NCT02596035|157211083|FG001|Overall Study|other reasons|4|||
48526799|NCT00129116|156120600|FG004|Primary Phase|Lost to Follow-up|1|||
48526800|NCT00129116|156120596|FG000|Primary Phase|Protocol Violation|0|||
48526801|NCT00129116|156120597|FG001|Primary Phase|Protocol Violation|1|||
48526802|NCT00129116|156120598|FG002|Primary Phase|Protocol Violation|0|||
48526803|NCT00129116|156120599|FG003|Primary Phase|Protocol Violation|0|||
48526804|NCT00129116|156120600|FG004|Primary Phase|Protocol Violation|0|||
48526805|NCT00129116|156120596|FG000|Primary Phase|Adverse Event|1|||
48526806|NCT00129116|156120597|FG001|Primary Phase|Adverse Event|1|||
48526807|NCT00129116|156120598|FG002|Primary Phase|Adverse Event|0|||
48526808|NCT00129116|156120599|FG003|Primary Phase|Adverse Event|0|||
48526809|NCT00129116|156120600|FG004|Primary Phase|Adverse Event|0|||
48526810|NCT00129116|156120596|FG000|Primary Phase|Withdrawal by Subject|0|||
48526811|NCT00129116|156120597|FG001|Primary Phase|Withdrawal by Subject|1|||
48827955|NCT02596035|157211084|FG002|Overall Study|other reasons|0|||
48827956|NCT03852433|157211085|FG000|Overall Study|Withdrawal of consent|5|||
48526812|NCT00129116|156120598|FG002|Primary Phase|Withdrawal by Subject|0|||
48526813|NCT00129116|156120599|FG003|Primary Phase|Withdrawal by Subject|0|||
48526814|NCT00129116|156120600|FG004|Primary Phase|Withdrawal by Subject|0|||
48526815|NCT00129116|156120596|FG000|Primary Phase|Other|0|||
48526816|NCT00129116|156120597|FG001|Primary Phase|Other|0|||
48526817|NCT00129116|156120598|FG002|Primary Phase|Other|1|||
48526818|NCT00129116|156120599|FG003|Primary Phase|Other|0|||
48526819|NCT00129116|156120600|FG004|Primary Phase|Other|0|||
48526820|NCT00129116|156120596|FG000|Booster Phase|Lost to Follow-up|2|||
48526821|NCT00129116|156120597|FG001|Booster Phase|Lost to Follow-up|0|||
48526822|NCT00129116|156120598|FG002|Booster Phase|Lost to Follow-up|0|||
48526823|NCT00129116|156120599|FG003|Booster Phase|Lost to Follow-up|0|||
48526824|NCT00129116|156120600|FG004|Booster Phase|Lost to Follow-up|1|||
48526825|NCT01261624|156120601|FG000|Week 0 to Week 12|Disease Progression|1|||
48602160|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
48827957|NCT03852433|157211086|FG001|Overall Study|Withdrawal of consent|8|||
48827958|NCT03852433|157211087|FG002|Overall Study|Withdrawal of consent|1|||
48827959|NCT03852433|157211088|FG003|Overall Study|Withdrawal of consent|1|||
48827960|NCT03852433|157211085|FG000|Overall Study|Adverse Event|1|||
48827961|NCT03852433|157211086|FG001|Overall Study|Adverse Event|1|||
48827962|NCT03852433|157211087|FG002|Overall Study|Adverse Event|1|||
48827963|NCT03852433|157211088|FG003|Overall Study|Adverse Event|1|||
48827964|NCT03852433|157211085|FG000|Overall Study|Lost to Follow-up|0|||
48827965|NCT03852433|157211086|FG001|Overall Study|Lost to Follow-up|1|||
48827966|NCT03852433|157211087|FG002|Overall Study|Lost to Follow-up|0|||
48827967|NCT03852433|157211088|FG003|Overall Study|Lost to Follow-up|1|||
48827968|NCT03852433|157211085|FG000|Overall Study|Pregnancy|0|||
48827969|NCT03852433|157211086|FG001|Overall Study|Pregnancy|1|||
48827970|NCT03852433|157211087|FG002|Overall Study|Pregnancy|1|||
48827971|NCT03852433|157211088|FG003|Overall Study|Pregnancy|0|||
48827972|NCT03852433|157211085|FG000|Overall Study|Protocol Violation|0|||
48827973|NCT03852433|157211086|FG001|Overall Study|Protocol Violation|0|||
48827974|NCT03852433|157211087|FG002|Overall Study|Protocol Violation|1|||
48827975|NCT03852433|157211088|FG003|Overall Study|Protocol Violation|1|||
48827976|NCT03852433|157211085|FG000|Overall Study|Death|0|||
48827977|NCT03852433|157211086|FG001|Overall Study|Death|0|||
48827978|NCT03852433|157211087|FG002|Overall Study|Death|1|||
48827979|NCT03852433|157211088|FG003|Overall Study|Death|0|||
48444567|NCT02807844|155815113|FG009|Overall Study|Physician Decision|2|||
48444568|NCT02807844|155815104|FG000|Overall Study|Death|0|||
48444569|NCT02807844|155815105|FG001|Overall Study|Death|0|||
48444570|NCT02807844|155815106|FG002|Overall Study|Death|2|||
48444571|NCT02807844|155815107|FG003|Overall Study|Death|4|||
48444572|NCT02807844|155815108|FG004|Overall Study|Death|1|||
48444573|NCT02807844|155815109|FG005|Overall Study|Death|2|||
48444574|NCT02807844|155815110|FG006|Overall Study|Death|1|||
48444575|NCT02807844|155815111|FG007|Overall Study|Death|2|||
48444576|NCT02807844|155815112|FG008|Overall Study|Death|0|||
48444577|NCT02807844|155815113|FG009|Overall Study|Death|1|||
48444578|NCT02807844|155815104|FG000|Overall Study|Withdrawal by Subject|0|||
48444579|NCT02807844|155815105|FG001|Overall Study|Withdrawal by Subject|0|||
48444580|NCT02807844|155815106|FG002|Overall Study|Withdrawal by Subject|2|||
48444581|NCT02807844|155815107|FG003|Overall Study|Withdrawal by Subject|1|||
48444582|NCT02807844|155815108|FG004|Overall Study|Withdrawal by Subject|1|||
48444583|NCT02807844|155815109|FG005|Overall Study|Withdrawal by Subject|0|||
48444584|NCT02807844|155815110|FG006|Overall Study|Withdrawal by Subject|1|||
48444585|NCT02807844|155815111|FG007|Overall Study|Withdrawal by Subject|0|||
48444586|NCT02807844|155815112|FG008|Overall Study|Withdrawal by Subject|0|||
48444587|NCT02807844|155815113|FG009|Overall Study|Withdrawal by Subject|0|||
48444588|NCT02807844|155815104|FG000|Overall Study|Progressive disease|5|||
48444589|NCT02807844|155815105|FG001|Overall Study|Progressive disease|12|||
48444590|NCT02807844|155815106|FG002|Overall Study|Progressive disease|8|||
48444591|NCT02807844|155815107|FG003|Overall Study|Progressive disease|8|||
48444592|NCT02807844|155815108|FG004|Overall Study|Progressive disease|3|||
48444593|NCT02807844|155815109|FG005|Overall Study|Progressive disease|8|||
48444594|NCT02807844|155815110|FG006|Overall Study|Progressive disease|14|||
48444595|NCT02807844|155815111|FG007|Overall Study|Progressive disease|17|||
48444596|NCT02807844|155815112|FG008|Overall Study|Progressive disease|19|||
48444597|NCT02807844|155815113|FG009|Overall Study|Progressive disease|15|||
48444598|NCT02807844|155815104|FG000|Overall Study|Adverse Event|1|||
48444599|NCT02807844|155815105|FG001|Overall Study|Adverse Event|0|||
48444600|NCT02807844|155815106|FG002|Overall Study|Adverse Event|0|||
48444601|NCT02807844|155815107|FG003|Overall Study|Adverse Event|0|||
48444602|NCT02807844|155815108|FG004|Overall Study|Adverse Event|1|||
48444603|NCT02807844|155815109|FG005|Overall Study|Adverse Event|1|||
48444604|NCT02807844|155815110|FG006|Overall Study|Adverse Event|1|||
48444605|NCT02807844|155815111|FG007|Overall Study|Adverse Event|1|||
48444606|NCT02807844|155815112|FG008|Overall Study|Adverse Event|1|||
48444607|NCT02807844|155815113|FG009|Overall Study|Adverse Event|2|||
48444608|NCT00709124|155815115|FG000|Overall Study|Death|3|||
48444609|NCT00709124|155815116|FG001|Overall Study|Death|1|||
48444610|NCT00709124|155815115|FG000|Overall Study|encephalopathy; can't do assessment|1|||
48444611|NCT00709124|155815116|FG001|Overall Study|encephalopathy; can't do assessment|0|||
48444612|NCT00373490|155815117|FG000|Overall Study|Adverse Event|0|||
48444613|NCT00373490|155815118|FG001|Overall Study|Adverse Event|1|||
48444614|NCT00373490|155815117|FG000|Overall Study|Lack of Efficacy|9|||
48444615|NCT00373490|155815118|FG001|Overall Study|Lack of Efficacy|4|||
48444616|NCT00373490|155815117|FG000|Overall Study|Withdrawal by Subject|0|||
48444617|NCT00373490|155815118|FG001|Overall Study|Withdrawal by Subject|1|||
48444618|NCT00004732|155815120|FG000|Overall Study|Withdrawal by Subject|36|||
48444619|NCT00004732|155815121|FG001|Overall Study|Withdrawal by Subject|64|||
48444620|NCT00004732|155815120|FG000|Overall Study|Lost to Follow-up|33|||
48444621|NCT00004732|155815121|FG001|Overall Study|Lost to Follow-up|47|||
48526826|NCT01261624|156120602|FG001|Week 0 to Week 12|Disease Progression|1|||
48526827|NCT01261624|156120601|FG000|Week 0 to Week 12|Insufficient Response|0|||
48526828|NCT01261624|156120602|FG001|Week 0 to Week 12|Insufficient Response|2|||
48526829|NCT01261624|156120601|FG000|Week 13 to Week 24|Insufficient Response|0|||
48526830|NCT01261624|156120602|FG001|Week 13 to Week 24|Insufficient Response|1|||
48526831|NCT03566238|156120605|FG000|Overall Study|Adverse Event|0|||
48526832|NCT03566238|156120606|FG001|Overall Study|Adverse Event|1|||
48526833|NCT03566238|156120607|FG002|Overall Study|Adverse Event|0|||
48526834|NCT03566238|156120605|FG000|Overall Study|Lack of Efficacy|4|||
48602161|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
48827980|NCT03852433|157211085|FG000|Overall Study|Lack of Efficacy|0|||
48827981|NCT03852433|157211086|FG001|Overall Study|Lack of Efficacy|1|||
48526835|NCT03566238|156120606|FG001|Overall Study|Lack of Efficacy|2|||
48526836|NCT03566238|156120607|FG002|Overall Study|Lack of Efficacy|5|||
48526837|NCT03566238|156120605|FG000|Overall Study|Other|1|||
48526838|NCT03566238|156120606|FG001|Overall Study|Other|0|||
48526839|NCT03566238|156120607|FG002|Overall Study|Other|0|||
48526840|NCT04034355|156120619|FG000|Overall Study|Study terminated by Sponsor|10|||
48526841|NCT04034355|156120620|FG001|Overall Study|Study terminated by Sponsor|17|||
48526842|NCT04034355|156120619|FG000|Overall Study|Withdrawal by Subject|12|||
48526843|NCT04034355|156120620|FG001|Overall Study|Withdrawal by Subject|11|||
48526844|NCT04034355|156120619|FG000|Overall Study|Site terminated by Sponsor|4|||
48526845|NCT04034355|156120620|FG001|Overall Study|Site terminated by Sponsor|5|||
48526846|NCT04034355|156120619|FG000|Overall Study|Adverse Event|2|||
48526847|NCT04034355|156120620|FG001|Overall Study|Adverse Event|0|||
48526848|NCT04034355|156120619|FG000|Overall Study|Death|1|||
48526849|NCT04034355|156120620|FG001|Overall Study|Death|1|||
48526850|NCT04034355|156120619|FG000|Overall Study|Not reported|2|||
48526851|NCT04034355|156120620|FG001|Overall Study|Not reported|0|||
48526852|NCT04034355|156120619|FG000|Overall Study|Lost to Follow-up|1|||
48526853|NCT04034355|156120620|FG001|Overall Study|Lost to Follow-up|0|||
48526854|NCT04034355|156120619|FG000|Overall Study|Physician Decision|1|||
48526855|NCT04034355|156120620|FG001|Overall Study|Physician Decision|0|||
48526856|NCT04034355|156120619|FG000|Overall Study|Protocol Violation|0|||
48526857|NCT04034355|156120620|FG001|Overall Study|Protocol Violation|1|||
48526858|NCT04034355|156120619|FG000|Overall Study|Progressive disease|1|||
48526859|NCT04034355|156120620|FG001|Overall Study|Progressive disease|0|||
48526860|NCT03573817|156120621|FG000|Overall Study|Adverse Event|0|||
48526861|NCT03573817|156120622|FG001|Overall Study|Adverse Event|2|||
48526862|NCT03573817|156120621|FG000|Overall Study|Protocol Violation|0|||
48526863|NCT03573817|156120622|FG001|Overall Study|Protocol Violation|1|||
48526864|NCT03573817|156120621|FG000|Overall Study|Withdrawal by Subject|1|||
48526865|NCT03573817|156120622|FG001|Overall Study|Withdrawal by Subject|1|||
48526866|NCT02010255|156120623|FG000|Overall Study|Death|0|||
48526867|NCT02010255|156120624|FG001|Overall Study|Death|1|||
48526868|NCT02010255|156120625|FG002|Overall Study|Death|4|||
48827982|NCT03852433|157211087|FG002|Overall Study|Lack of Efficacy|0|||
48827983|NCT03852433|157211088|FG003|Overall Study|Lack of Efficacy|0|||
48827984|NCT03852433|157211085|FG000|Overall Study|Non-compliance with study drug|0|||
48827985|NCT03852433|157211086|FG001|Overall Study|Non-compliance with study drug|0|||
48827986|NCT03852433|157211087|FG002|Overall Study|Non-compliance with study drug|0|||
48827987|NCT03852433|157211088|FG003|Overall Study|Non-compliance with study drug|1|||
48827988|NCT03852433|157211085|FG000|Overall Study|Physician Decision|1|||
48526869|NCT02010255|156120626|FG003|Overall Study|Death|4|||
48526870|NCT02010255|156120627|FG004|Overall Study|Death|2|||
48827989|NCT03852433|157211086|FG001|Overall Study|Physician Decision|0|||
48827990|NCT03852433|157211087|FG002|Overall Study|Physician Decision|0|||
48827991|NCT03852433|157211088|FG003|Overall Study|Physician Decision|0|||
48827992|NCT03852433|157211085|FG000|Overall Study|Randomized but never treated|1|||
48526871|NCT02010255|156120628|FG005|Overall Study|Death|0|||
48526872|NCT02010255|156120629|FG006|Overall Study|Death|1|||
48526873|NCT02010255|156120630|FG007|Overall Study|Death|1|||
48526874|NCT02010255|156120631|FG008|Overall Study|Death|1|||
48526875|NCT02010255|156120632|FG009|Overall Study|Death|0|||
48526876|NCT02010255|156120633|FG010|Overall Study|Death|1|||
48526877|NCT02010255|156120634|FG011|Overall Study|Death|1|||
48827993|NCT03852433|157211086|FG001|Overall Study|Randomized but never treated|0|||
48827994|NCT03852433|157211087|FG002|Overall Study|Randomized but never treated|0|||
48526878|NCT02010255|156120635|FG012|Overall Study|Death|0|||
48827995|NCT03852433|157211088|FG003|Overall Study|Randomized but never treated|0|||
48526879|NCT02010255|156120636|FG013|Overall Study|Death|0|||
48526880|NCT02010255|156120623|FG000|Overall Study|Lack of Efficacy|4|||
48526881|NCT02010255|156120624|FG001|Overall Study|Lack of Efficacy|1|||
48526882|NCT02010255|156120625|FG002|Overall Study|Lack of Efficacy|2|||
48526883|NCT02010255|156120626|FG003|Overall Study|Lack of Efficacy|1|||
48526884|NCT02010255|156120627|FG004|Overall Study|Lack of Efficacy|1|||
48526885|NCT02010255|156120628|FG005|Overall Study|Lack of Efficacy|0|||
48526886|NCT02010255|156120629|FG006|Overall Study|Lack of Efficacy|0|||
48526887|NCT02010255|156120630|FG007|Overall Study|Lack of Efficacy|0|||
48526888|NCT02010255|156120631|FG008|Overall Study|Lack of Efficacy|0|||
48526889|NCT02010255|156120632|FG009|Overall Study|Lack of Efficacy|0|||
48526890|NCT02010255|156120633|FG010|Overall Study|Lack of Efficacy|1|||
48526891|NCT02010255|156120634|FG011|Overall Study|Lack of Efficacy|0|||
48526892|NCT02010255|156120635|FG012|Overall Study|Lack of Efficacy|0|||
48526893|NCT02010255|156120636|FG013|Overall Study|Lack of Efficacy|0|||
48526894|NCT02010255|156120623|FG000|Overall Study|Withdrew Consent|1|||
48526895|NCT02010255|156120624|FG001|Overall Study|Withdrew Consent|0|||
48526896|NCT02010255|156120625|FG002|Overall Study|Withdrew Consent|0|||
48526897|NCT02010255|156120626|FG003|Overall Study|Withdrew Consent|1|||
48526898|NCT02010255|156120627|FG004|Overall Study|Withdrew Consent|0|||
48526899|NCT02010255|156120628|FG005|Overall Study|Withdrew Consent|0|||
48526900|NCT02010255|156120629|FG006|Overall Study|Withdrew Consent|0|||
48526901|NCT02010255|156120630|FG007|Overall Study|Withdrew Consent|0|||
48526902|NCT02010255|156120631|FG008|Overall Study|Withdrew Consent|0|||
48526903|NCT02010255|156120632|FG009|Overall Study|Withdrew Consent|0|||
48526904|NCT02010255|156120633|FG010|Overall Study|Withdrew Consent|0|||
48526905|NCT02010255|156120634|FG011|Overall Study|Withdrew Consent|0|||
48526906|NCT02010255|156120635|FG012|Overall Study|Withdrew Consent|0|||
48526907|NCT02010255|156120636|FG013|Overall Study|Withdrew Consent|0|||
48526908|NCT02010255|156120623|FG000|Overall Study|Adverse Event|1|||
48526909|NCT02010255|156120624|FG001|Overall Study|Adverse Event|0|||
48526910|NCT02010255|156120625|FG002|Overall Study|Adverse Event|0|||
48526911|NCT02010255|156120626|FG003|Overall Study|Adverse Event|0|||
48526912|NCT02010255|156120627|FG004|Overall Study|Adverse Event|0|||
48526913|NCT02010255|156120628|FG005|Overall Study|Adverse Event|0|||
48526914|NCT02010255|156120629|FG006|Overall Study|Adverse Event|0|||
48526915|NCT02010255|156120630|FG007|Overall Study|Adverse Event|0|||
48526916|NCT02010255|156120631|FG008|Overall Study|Adverse Event|0|||
48526917|NCT02010255|156120632|FG009|Overall Study|Adverse Event|0|||
48526918|NCT02010255|156120633|FG010|Overall Study|Adverse Event|0|||
48526919|NCT02010255|156120634|FG011|Overall Study|Adverse Event|0|||
48526920|NCT02010255|156120635|FG012|Overall Study|Adverse Event|0|||
48526921|NCT02010255|156120636|FG013|Overall Study|Adverse Event|0|||
48526922|NCT02010255|156120623|FG000|Overall Study|Lost to Follow-up|0|||
48526923|NCT02010255|156120624|FG001|Overall Study|Lost to Follow-up|0|||
48526924|NCT02010255|156120625|FG002|Overall Study|Lost to Follow-up|1|||
48526925|NCT02010255|156120626|FG003|Overall Study|Lost to Follow-up|0|||
48526926|NCT02010255|156120627|FG004|Overall Study|Lost to Follow-up|1|||
48526927|NCT02010255|156120628|FG005|Overall Study|Lost to Follow-up|0|||
48526928|NCT02010255|156120629|FG006|Overall Study|Lost to Follow-up|0|||
48526929|NCT02010255|156120630|FG007|Overall Study|Lost to Follow-up|0|||
48526930|NCT02010255|156120631|FG008|Overall Study|Lost to Follow-up|0|||
48526931|NCT02010255|156120632|FG009|Overall Study|Lost to Follow-up|0|||
48526932|NCT02010255|156120633|FG010|Overall Study|Lost to Follow-up|0|||
48526933|NCT02010255|156120634|FG011|Overall Study|Lost to Follow-up|0|||
48526934|NCT02010255|156120635|FG012|Overall Study|Lost to Follow-up|0|||
48526935|NCT02010255|156120636|FG013|Overall Study|Lost to Follow-up|0|||
48526936|NCT02010255|156120623|FG000|Overall Study|Randomized but Not Treated|0|||
48526937|NCT02010255|156120624|FG001|Overall Study|Randomized but Not Treated|0|||
48526938|NCT02010255|156120625|FG002|Overall Study|Randomized but Not Treated|0|||
48526939|NCT02010255|156120626|FG003|Overall Study|Randomized but Not Treated|0|||
48526940|NCT02010255|156120627|FG004|Overall Study|Randomized but Not Treated|0|||
48526941|NCT02010255|156120628|FG005|Overall Study|Randomized but Not Treated|0|||
48526942|NCT02010255|156120629|FG006|Overall Study|Randomized but Not Treated|0|||
48526943|NCT02010255|156120630|FG007|Overall Study|Randomized but Not Treated|0|||
48602162|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
48827996|NCT03199469|157211090|FG000|Overall Study|Randomized, not treated|0|||
48444622|NCT00753688|155815122|FG000|Overall Study|Death|102|||
48444623|NCT00753688|155815123|FG001|Overall Study|Death|203|||
48444624|NCT00753688|155815122|FG000|Overall Study|Missing|4|||
48444625|NCT00753688|155815123|FG001|Overall Study|Missing|9|||
48444626|NCT00753688|155815122|FG000|Overall Study|Participant Withdrew Consent|2|||
48444627|NCT00753688|155815123|FG001|Overall Study|Participant Withdrew Consent|2|||
48444628|NCT00753688|155815122|FG000|Overall Study|Ongoing - in Follow-up|15|||
48444629|NCT00753688|155815123|FG001|Overall Study|Ongoing - in Follow-up|31|||
48444630|NCT00753688|155815122|FG000|Overall Study|Adverse Event|0|||
48444631|NCT00753688|155815123|FG001|Overall Study|Adverse Event|1|||
48444632|NCT01250756|155815124|FG000|Infant Series|Withdrawal by Subject|4|||
48444633|NCT01250756|155815125|FG001|Infant Series|Withdrawal by Subject|5|||
48444634|NCT01250756|155815124|FG000|Infant Series|Randomized, Not Vaccinated|2|||
48444635|NCT01250756|155815125|FG001|Infant Series|Randomized, Not Vaccinated|2|||
48444636|NCT01250756|155815124|FG000|Infant Series|Other|22|||
48444637|NCT01250756|155815125|FG001|Infant Series|Other|0|||
48444638|NCT01250756|155815124|FG000|After Infant Series|Adverse Event|5|||
48444639|NCT01250756|155815125|FG001|After Infant Series|Adverse Event|2|||
48444640|NCT01250756|155815124|FG000|After Infant Series|Withdrawal by Subject|4|||
48444641|NCT01250756|155815125|FG001|After Infant Series|Withdrawal by Subject|1|||
48444642|NCT01250756|155815124|FG000|After Infant Series|Other|2|||
48444643|NCT01250756|155815125|FG001|After Infant Series|Other|1|||
48526944|NCT02010255|156120631|FG008|Overall Study|Randomized but Not Treated|0|||
48526945|NCT02010255|156120632|FG009|Overall Study|Randomized but Not Treated|0|||
48526946|NCT02010255|156120633|FG010|Overall Study|Randomized but Not Treated|0|||
48526947|NCT02010255|156120634|FG011|Overall Study|Randomized but Not Treated|0|||
48526948|NCT02010255|156120635|FG012|Overall Study|Randomized but Not Treated|0|||
48526949|NCT02010255|156120636|FG013|Overall Study|Randomized but Not Treated|1|||
48526950|NCT01192399|156120637|FG000|Overall Study|Lack of Efficacy|2|||
48526951|NCT01029392|156120639|FG000|Overall Study|Withdrawal by Subject|18|||
48526952|NCT01029392|156120640|FG001|Overall Study|Withdrawal by Subject|11|||
48526953|NCT01029392|156120639|FG000|Overall Study|Physician Decision|2|||
48526954|NCT01029392|156120640|FG001|Overall Study|Physician Decision|0|||
48526955|NCT00436917|156120641|FG000|Overall Study|Withdrawal by Subject|13|||
48526956|NCT00436917|156120641|FG000|Overall Study|Adverse Event|2|||
48526957|NCT00436917|156120641|FG000|Overall Study|Physician Decision|1|||
48526958|NCT00436917|156120641|FG000|Overall Study|Death|1|||
48526959|NCT00436917|156120641|FG000|Overall Study|Lost to Follow-up|1|||
48526960|NCT00436917|156120641|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
48526961|NCT00436917|156120641|FG000|Overall Study|Increased creatinine|1|||
48526962|NCT00436917|156120641|FG000|Overall Study|Personal conflicts of patient|1|||
48526963|NCT02339090|156120642|FG000|Overall Study|Adverse Event|1|||
48526964|NCT02339090|156120643|FG001|Overall Study|Adverse Event|0|||
48526965|NCT02339090|156120642|FG000|Overall Study|Lost to Follow-up|0|||
48526966|NCT02339090|156120643|FG001|Overall Study|Lost to Follow-up|1|||
48526967|NCT02339090|156120642|FG000|Overall Study|Non-compliance With Study Drug|0|||
48526968|NCT02339090|156120643|FG001|Overall Study|Non-compliance With Study Drug|1|||
48526969|NCT02339090|156120642|FG000|Overall Study|Withdrawal by Subject|2|||
48526970|NCT02339090|156120643|FG001|Overall Study|Withdrawal by Subject|1|||
48526971|NCT02339090|156120642|FG000|Overall Study|Poor Growth|3|||
48526972|NCT02339090|156120643|FG001|Overall Study|Poor Growth|0|||
48526973|NCT02339090|156120642|FG000|Overall Study|Randomized but not treated|0|||
48526974|NCT02339090|156120643|FG001|Overall Study|Randomized but not treated|2|||
48526975|NCT01636934|156122456|FG000|Overall Study|Withdrawal by Subject|3|||
48526976|NCT01636934|156122457|FG001|Overall Study|Withdrawal by Subject|2|||
48526977|NCT01636934|156122456|FG000|Overall Study|Chemo cancel|1|||
48526978|NCT01636934|156122457|FG001|Overall Study|Chemo cancel|0|||
48526979|NCT01636934|156122456|FG000|Overall Study|Too ill to continue|1|||
48526980|NCT01636934|156122457|FG001|Overall Study|Too ill to continue|0|||
48526981|NCT01636934|156122456|FG000|Overall Study|Never started study medication|1|||
48526982|NCT01636934|156122457|FG001|Overall Study|Never started study medication|1|||
48526983|NCT04974619|156122460|FG000|Overall Study|Lost to Follow-up|0|||
48526984|NCT04974619|156122461|FG001|Overall Study|Lost to Follow-up|0|||
48526985|NCT04974619|156122462|FG002|Overall Study|Lost to Follow-up|1|||
48526986|NCT04974619|156122460|FG000|Overall Study|Withdrawal by Subject|0|||
48526987|NCT04974619|156122461|FG001|Overall Study|Withdrawal by Subject|0|||
48526988|NCT04974619|156122462|FG002|Overall Study|Withdrawal by Subject|1|||
48526989|NCT04974619|156122460|FG000|Overall Study|Protocol Violation|0|||
48526990|NCT04974619|156122461|FG001|Overall Study|Protocol Violation|1|||
48526991|NCT04974619|156122462|FG002|Overall Study|Protocol Violation|0|||
48526992|NCT02447887|156122480|FG000|Overall Study|Study was terminated|3|||
48526993|NCT02839798|156122481|FG000|Overall Study|Withdrawal by Subject|2|||
48526994|NCT01765751|156122482|FG000|Overall Study|Lost to Follow-up|0|||
48526995|NCT01765751|156122483|FG001|Overall Study|Lost to Follow-up|2|||
48526996|NCT01765751|156122484|FG002|Overall Study|Lost to Follow-up|1|||
48526997|NCT02733627|156122485|FG000|Overall Study|Adverse Event|0|||
48526998|NCT02733627|156122486|FG001|Overall Study|Adverse Event|1|||
48526999|NCT02733627|156122487|FG002|Overall Study|Adverse Event|1|||
48527000|NCT02733627|156122488|FG003|Overall Study|Adverse Event|0|||
48527001|NCT02733627|156122485|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
48527002|NCT02733627|156122486|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
48527003|NCT02733627|156122487|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
48527004|NCT02733627|156122488|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
48527005|NCT01619579|156122489|FG000|Overall Study|Withdrawal by Subject|0|||
48527006|NCT01619579|156122490|FG001|Overall Study|Withdrawal by Subject|3|||
48527007|NCT02344745|156122491|FG000|Overall Study|Data collection sheets were lost|2|||
48527008|NCT02344745|156122492|FG001|Overall Study|Data collection sheets were lost|0|||
48527009|NCT00183196|156122493|FG000|Overall Study|Withdrawal by Subject|18|||
48527010|NCT00183196|156122494|FG001|Overall Study|Withdrawal by Subject|11|||
48527011|NCT00183196|156122495|FG002|Overall Study|Withdrawal by Subject|13|||
48527012|NCT00183196|156122493|FG000|Overall Study|Adverse Event|1|||
48527013|NCT00183196|156122494|FG001|Overall Study|Adverse Event|2|||
48527014|NCT00183196|156122495|FG002|Overall Study|Adverse Event|2|||
48527015|NCT00183196|156122493|FG000|Overall Study|Legal event|1|||
48527016|NCT00183196|156122494|FG001|Overall Study|Legal event|1|||
48527017|NCT00183196|156122495|FG002|Overall Study|Legal event|1|||
48527018|NCT00183196|156122493|FG000|Overall Study|Required more intensive care|0|||
48527019|NCT00183196|156122494|FG001|Overall Study|Required more intensive care|1|||
48527020|NCT00183196|156122495|FG002|Overall Study|Required more intensive care|2|||
48527021|NCT02788513|156122496|FG000|Overall Study|Withdrawal by Subject|3|||
48527022|NCT02788513|156122497|FG001|Overall Study|Withdrawal by Subject|0|||
48527023|NCT02788513|156122498|FG002|Overall Study|Withdrawal by Subject|2|||
48527024|NCT02788513|156122499|FG003|Overall Study|Withdrawal by Subject|3|||
48527025|NCT02788513|156122500|FG004|Overall Study|Withdrawal by Subject|1|||
48527026|NCT02788513|156122496|FG000|Overall Study|Lost to Follow-up|1|||
48527027|NCT02788513|156122497|FG001|Overall Study|Lost to Follow-up|0|||
48527028|NCT02788513|156122498|FG002|Overall Study|Lost to Follow-up|0|||
48527029|NCT02788513|156122499|FG003|Overall Study|Lost to Follow-up|0|||
48527030|NCT02788513|156122500|FG004|Overall Study|Lost to Follow-up|1|||
48527031|NCT02788513|156122496|FG000|Overall Study|Adverse Event|5|||
48527032|NCT02788513|156122497|FG001|Overall Study|Adverse Event|8|||
48527033|NCT02788513|156122498|FG002|Overall Study|Adverse Event|4|||
48527034|NCT02788513|156122499|FG003|Overall Study|Adverse Event|2|||
48527035|NCT02788513|156122500|FG004|Overall Study|Adverse Event|2|||
48527036|NCT02788513|156122496|FG000|Overall Study|Protocol Violation|0|||
48527037|NCT02788513|156122497|FG001|Overall Study|Protocol Violation|0|||
48527038|NCT02788513|156122498|FG002|Overall Study|Protocol Violation|1|||
48602163|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
48602164|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
48602165|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
48602166|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
48602167|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
48602168|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
48602169|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
48602170|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
48602171|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
48527039|NCT02788513|156122499|FG003|Overall Study|Protocol Violation|1|||
48527040|NCT02788513|156122500|FG004|Overall Study|Protocol Violation|0|||
48527041|NCT02788513|156122496|FG000|Overall Study|Subject decided to stop taking treatment|0|||
48527042|NCT02788513|156122497|FG001|Overall Study|Subject decided to stop taking treatment|0|||
48527043|NCT02788513|156122498|FG002|Overall Study|Subject decided to stop taking treatment|1|||
48527044|NCT02788513|156122499|FG003|Overall Study|Subject decided to stop taking treatment|0|||
48527045|NCT02788513|156122500|FG004|Overall Study|Subject decided to stop taking treatment|0|||
48527046|NCT02788513|156122496|FG000|Overall Study|Decision by the study team|0|||
48527047|NCT02788513|156122497|FG001|Overall Study|Decision by the study team|0|||
48527048|NCT02788513|156122498|FG002|Overall Study|Decision by the study team|0|||
48527049|NCT02788513|156122499|FG003|Overall Study|Decision by the study team|0|||
48527050|NCT02788513|156122500|FG004|Overall Study|Decision by the study team|1|||
48602172|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
48527051|NCT02246764|156122501|FG000|Overall Study|Adverse Event|15|||
48527052|NCT02246764|156122502|FG001|Overall Study|Adverse Event|29|||
48527053|NCT02246764|156122503|FG002|Overall Study|Adverse Event|1|||
48527054|NCT02246764|156122501|FG000|Overall Study|Withdrawal by Subject|0|||
48527055|NCT02246764|156122502|FG001|Overall Study|Withdrawal by Subject|0|||
48602173|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
48602174|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
48602175|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
48602176|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
48602177|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
48602178|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
48602179|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
48602180|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
48602181|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
48602182|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
48602183|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
48602184|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
48602185|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
48602186|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
48602187|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
48602188|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
48602189|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
48827997|NCT03199469|157211091|FG001|Overall Study|Randomized, not treated|3|||
48527056|NCT02246764|156122503|FG002|Overall Study|Withdrawal by Subject|1|||
48527057|NCT02246764|156122501|FG000|Overall Study|Disallowed Concomitant Medication|1|||
48527058|NCT02246764|156122502|FG001|Overall Study|Disallowed Concomitant Medication|0|||
48527059|NCT02246764|156122503|FG002|Overall Study|Disallowed Concomitant Medication|0|||
48527060|NCT02246764|156122501|FG000|Overall Study|Physician Decision|0|||
48827998|NCT03199469|157211090|FG000|Overall Study|Withdrawal by Subject|1|||
48827999|NCT03199469|157211091|FG001|Overall Study|Withdrawal by Subject|0|||
48828000|NCT03199469|157211090|FG000|Overall Study|Death|1|||
48828001|NCT03199469|157211091|FG001|Overall Study|Death|3|||
48828002|NCT03199469|157211090|FG000|Overall Study|Ongoing|5|||
48828003|NCT03199469|157211091|FG001|Overall Study|Ongoing|14|||
48828004|NCT04109118|157211096|FG000|Overall Study|Lost to Follow-up|3|||
48828005|NCT01268566|157211100|FG000|Overall Study|Lost to Follow-up|1|||
48828006|NCT01268566|157211100|FG000|Overall Study|Withdrawal by Subject|12|||
48828007|NCT01268566|157211100|FG000|Overall Study|Death|30|||
48828008|NCT05824351|157211103|FG000|Overall Study|Adverse Event|6|||
48828009|NCT03568162|157211106|FG000|Overall Study|Adverse Event|0|||
48828010|NCT03568162|157211107|FG001|Overall Study|Adverse Event|1|||
48828011|NCT03568162|157211108|FG002|Overall Study|Adverse Event|2|||
48828012|NCT03568162|157211109|FG003|Overall Study|Adverse Event|0|||
48828013|NCT03568162|157211110|FG004|Overall Study|Adverse Event|0|||
48828014|NCT03568162|157211111|FG005|Overall Study|Adverse Event|1|||
48828015|NCT03568162|157211106|FG000|Overall Study|Death|0|||
48828016|NCT03568162|157211107|FG001|Overall Study|Death|0|||
48828017|NCT03568162|157211108|FG002|Overall Study|Death|0|||
48828018|NCT03568162|157211109|FG003|Overall Study|Death|0|||
48828019|NCT03568162|157211110|FG004|Overall Study|Death|1|||
48828020|NCT03568162|157211111|FG005|Overall Study|Death|0|||
48828021|NCT03568162|157211106|FG000|Overall Study|Lost to Follow-up|3|||
48828022|NCT03568162|157211107|FG001|Overall Study|Lost to Follow-up|2|||
48828023|NCT03568162|157211108|FG002|Overall Study|Lost to Follow-up|4|||
48828024|NCT03568162|157211109|FG003|Overall Study|Lost to Follow-up|2|||
48828025|NCT03568162|157211110|FG004|Overall Study|Lost to Follow-up|3|||
48828026|NCT03568162|157211111|FG005|Overall Study|Lost to Follow-up|2|||
48828027|NCT03568162|157211106|FG000|Overall Study|Physician Decision|0|||
48828028|NCT03568162|157211107|FG001|Overall Study|Physician Decision|1|||
48828029|NCT03568162|157211108|FG002|Overall Study|Physician Decision|1|||
48828030|NCT03568162|157211109|FG003|Overall Study|Physician Decision|0|||
48828031|NCT03568162|157211110|FG004|Overall Study|Physician Decision|1|||
48828032|NCT03568162|157211111|FG005|Overall Study|Physician Decision|0|||
48828033|NCT03568162|157211106|FG000|Overall Study|Pregnancy|0|||
48828034|NCT03568162|157211107|FG001|Overall Study|Pregnancy|0|||
48828035|NCT03568162|157211108|FG002|Overall Study|Pregnancy|0|||
48828036|NCT03568162|157211109|FG003|Overall Study|Pregnancy|1|||
48828037|NCT03568162|157211110|FG004|Overall Study|Pregnancy|0|||
48828038|NCT03568162|157211111|FG005|Overall Study|Pregnancy|0|||
48828039|NCT03568162|157211106|FG000|Overall Study|Protocol Violation|1|||
48828040|NCT03568162|157211107|FG001|Overall Study|Protocol Violation|0|||
48828041|NCT03568162|157211108|FG002|Overall Study|Protocol Violation|1|||
48828042|NCT03568162|157211109|FG003|Overall Study|Protocol Violation|1|||
48828043|NCT03568162|157211110|FG004|Overall Study|Protocol Violation|1|||
48828044|NCT03568162|157211111|FG005|Overall Study|Protocol Violation|1|||
48828045|NCT03568162|157211106|FG000|Overall Study|Withdrawal by Subject|15|||
48828046|NCT03568162|157211107|FG001|Overall Study|Withdrawal by Subject|15|||
48828047|NCT03568162|157211108|FG002|Overall Study|Withdrawal by Subject|26|||
48828048|NCT03568162|157211109|FG003|Overall Study|Withdrawal by Subject|22|||
48828049|NCT03568162|157211110|FG004|Overall Study|Withdrawal by Subject|6|||
48828050|NCT03568162|157211111|FG005|Overall Study|Withdrawal by Subject|9|||
48828051|NCT03568162|157211106|FG000|Overall Study|Others|3|||
48828052|NCT03568162|157211107|FG001|Overall Study|Others|4|||
48828053|NCT03568162|157211108|FG002|Overall Study|Others|1|||
48828054|NCT03568162|157211109|FG003|Overall Study|Others|4|||
48828055|NCT03568162|157211110|FG004|Overall Study|Others|2|||
48828056|NCT03568162|157211111|FG005|Overall Study|Others|1|||
48828057|NCT01838551|157211112|FG000|Overall Study|Adverse Event|16|||
48828058|NCT01838551|157211112|FG000|Overall Study|Death|1|||
48828059|NCT01838551|157211112|FG000|Overall Study|Lack of Efficacy|10|||
48828060|NCT01838551|157211112|FG000|Overall Study|Physician Decision|4|||
48828061|NCT01838551|157211112|FG000|Overall Study|Withdrawal by Subject|10|||
48828062|NCT01838551|157211112|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
48828063|NCT03722446|157211113|FG000|Overall Study|Protocol Violation|15|||
48828064|NCT03722446|157211114|FG001|Overall Study|Protocol Violation|2|||
48828065|NCT02931396|157211115|FG000|Overall Study|Lost to Follow-up|3|||
48828066|NCT02931396|157211116|FG001|Overall Study|Lost to Follow-up|0|||
48828067|NCT02931396|157211115|FG000|Overall Study|Withdrawal by Subject|2|||
48828068|NCT02931396|157211116|FG001|Overall Study|Withdrawal by Subject|0|||
48828069|NCT00315055|157212377|FG000|Overall Study|Protocol Violation|2|||
48828070|NCT00315055|157212378|FG001|Overall Study|Protocol Violation|4|||
48828071|NCT00315055|157212377|FG000|Overall Study|Lost to Follow-up|1|||
48828072|NCT00315055|157212378|FG001|Overall Study|Lost to Follow-up|1|||
48828073|NCT00530335|157212379|FG000|Overall Study|Adverse Event|3|||
48828074|NCT00530335|157212379|FG000|Overall Study|Protocol Violation|1|||
48828075|NCT00530335|157212379|FG000|Overall Study|Withdrawal by Subject|1|||
48828076|NCT00530335|157212379|FG000|Overall Study|Physician Decision|1|||
48828077|NCT01649791|157212380|FG000|Overall Study|Disease Progression|2|||
48828078|NCT01649791|157212380|FG000|Overall Study|Adverse Event|1|||
48828079|NCT03646669|157212381|FG000|Overall Study|Withdrawal by Subject|5|||
48828080|NCT03646669|157212382|FG001|Overall Study|Withdrawal by Subject|0|||
48527061|NCT02246764|156122502|FG001|Overall Study|Physician Decision|2|||
48527062|NCT02246764|156122503|FG002|Overall Study|Physician Decision|1|||
48527063|NCT02246764|156122501|FG000|Overall Study|Protocol Violation|2|||
48527064|NCT02246764|156122502|FG001|Overall Study|Protocol Violation|1|||
48828081|NCT02680756|157212386|FG000|Overall Study|Adverse Event|10|||
48828082|NCT02680756|157212387|FG001|Overall Study|Adverse Event|2|||
48828083|NCT02680756|157212386|FG000|Overall Study|Lost to Follow-up|7|||
48527065|NCT02246764|156122503|FG002|Overall Study|Protocol Violation|1|||
48828084|NCT02680756|157212387|FG001|Overall Study|Lost to Follow-up|6|||
48828085|NCT02680756|157212386|FG000|Overall Study|Withdrawal by Subject|5|||
48828086|NCT02680756|157212387|FG001|Overall Study|Withdrawal by Subject|5|||
48828087|NCT02680756|157212386|FG000|Overall Study|Physician Decision|4|||
48828088|NCT02680756|157212387|FG001|Overall Study|Physician Decision|1|||
48828089|NCT02680756|157212386|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
48828090|NCT02680756|157212387|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
48828091|NCT02680756|157212386|FG000|Overall Study|Blood transfusion for any reason|0|||
48828092|NCT02680756|157212387|FG001|Overall Study|Blood transfusion for any reason|1|||
48828093|NCT02680756|157212386|FG000|Overall Study|Death|1|||
48828094|NCT02680756|157212387|FG001|Overall Study|Death|0|||
48828095|NCT02680756|157212386|FG000|Overall Study|Protocol Violation|1|||
48828096|NCT02680756|157212387|FG001|Overall Study|Protocol Violation|0|||
48828097|NCT02680756|157212386|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
48828098|NCT02680756|157212387|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
48828099|NCT02680756|157212386|FG000|Overall Study|None of above or not recorded|3|||
48828100|NCT02680756|157212387|FG001|Overall Study|None of above or not recorded|2|||
48828101|NCT03681691|157212388|FG000|Overall Study|COVID|1|||
48828102|NCT03681691|157212389|FG001|Overall Study|COVID|0|||
48828103|NCT03681691|157212388|FG000|Overall Study|prolonged bleeding|1|||
48828104|NCT03681691|157212389|FG001|Overall Study|prolonged bleeding|0|||
48828105|NCT03681691|157212388|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
48828106|NCT03681691|157212389|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
48828107|NCT01670019|157212394|FG000|Overall Study|Adverse Event|3|||
48828108|NCT01670019|157212395|FG001|Overall Study|Adverse Event|0|||
48828109|NCT01670019|157212394|FG000|Overall Study|Withdrawal by Subject|6|||
48828110|NCT01670019|157212395|FG001|Overall Study|Withdrawal by Subject|0|||
48828111|NCT00371566|157212398|FG000|Treatment Phase|Withdrawal by Subject|0|||
48828112|NCT00371566|157212399|FG001|Treatment Phase|Withdrawal by Subject|1|||
48828113|NCT00371566|157212398|FG000|Treatment Phase|Adverse Event|0|||
48828114|NCT00371566|157212399|FG001|Treatment Phase|Adverse Event|1|||
48828115|NCT00371566|157212398|FG000|Treatment Phase|Protocol Violation|0|||
48828116|NCT00371566|157212399|FG001|Treatment Phase|Protocol Violation|1|||
48828117|NCT00371566|157212398|FG000|Chemoradiation Phase|Physician Decision|2|||
48828118|NCT00371566|157212399|FG001|Chemoradiation Phase|Physician Decision|0|||
48828119|NCT00371566|157212398|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
48828120|NCT00371566|157212399|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
48828121|NCT00371566|157212398|FG000|Chemoradiation Phase|Non compliant|0|||
48828122|NCT00371566|157212399|FG001|Chemoradiation Phase|Non compliant|1|||
48828123|NCT00371566|157212398|FG000|Chemoradiation Phase|Progressive Disease|1|||
48828124|NCT00371566|157212399|FG001|Chemoradiation Phase|Progressive Disease|1|||
48828125|NCT00371566|157212398|FG000|Chemoradiation Phase|Death|2|||
48828126|NCT00371566|157212399|FG001|Chemoradiation Phase|Death|0|||
48828127|NCT00371566|157212398|FG000|Follow Up Phase|Death|0|||
48828128|NCT00371566|157212399|FG001|Follow Up Phase|Death|5|||
48828129|NCT00371566|157212398|FG000|Follow Up Phase|Disease progression|1|||
48828130|NCT00371566|157212399|FG001|Follow Up Phase|Disease progression|0|||
48828131|NCT00371566|157212398|FG000|Follow Up Phase|Withdrawal by Subject|0|||
48828132|NCT00371566|157212399|FG001|Follow Up Phase|Withdrawal by Subject|1|||
48828133|NCT00371566|157212398|FG000|Follow Up Phase|Physician Decision|1|||
48828134|NCT00371566|157212399|FG001|Follow Up Phase|Physician Decision|1|||
48828135|NCT00371566|157212398|FG000|Follow Up Phase|Lost to Follow-up|1|||
48828136|NCT00371566|157212399|FG001|Follow Up Phase|Lost to Follow-up|0|||
48828137|NCT01467700|157212400|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
48828138|NCT01467700|157212401|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
48828139|NCT01467700|157212402|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
48828140|NCT01467700|157212403|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
48527066|NCT02124902|156122504|FG000|Overall Study|Adverse Event|7|||
48828141|NCT01467700|157212400|FG000|Overall Study|Major Protocol Deviation|3|||
48828142|NCT01467700|157212401|FG001|Overall Study|Major Protocol Deviation|3|||
48828143|NCT01467700|157212402|FG002|Overall Study|Major Protocol Deviation|2|||
48828144|NCT01467700|157212403|FG003|Overall Study|Major Protocol Deviation|3|||
48828145|NCT01467700|157212400|FG000|Overall Study|Lost to Follow-up|6|||
48828146|NCT01467700|157212401|FG001|Overall Study|Lost to Follow-up|5|||
48828147|NCT01467700|157212402|FG002|Overall Study|Lost to Follow-up|2|||
48828148|NCT01467700|157212403|FG003|Overall Study|Lost to Follow-up|3|||
48527067|NCT02124902|156122505|FG001|Overall Study|Adverse Event|2|||
48828149|NCT01467700|157212400|FG000|Overall Study|Voluntary Withdrawal|5|||
48828150|NCT01467700|157212401|FG001|Overall Study|Voluntary Withdrawal|7|||
48527068|NCT02124902|156122504|FG000|Overall Study|Went to alternative treatment|4|||
48527069|NCT02124902|156122505|FG001|Overall Study|Went to alternative treatment|0|||
48828151|NCT01467700|157212402|FG002|Overall Study|Voluntary Withdrawal|6|||
48828152|NCT01467700|157212403|FG003|Overall Study|Voluntary Withdrawal|2|||
48828153|NCT01467700|157212400|FG000|Overall Study|Study Termination|6|||
48828154|NCT01467700|157212401|FG001|Overall Study|Study Termination|5|||
48828155|NCT01467700|157212402|FG002|Overall Study|Study Termination|10|||
48828156|NCT01467700|157212403|FG003|Overall Study|Study Termination|7|||
48828157|NCT01467700|157212400|FG000|Overall Study|Pregnancy|0|||
48828158|NCT01467700|157212401|FG001|Overall Study|Pregnancy|1|||
48828159|NCT01467700|157212402|FG002|Overall Study|Pregnancy|1|||
48828160|NCT01467700|157212403|FG003|Overall Study|Pregnancy|0|||
48828161|NCT01467700|157212400|FG000|Overall Study|Lack of Efficacy|2|||
48828162|NCT01467700|157212401|FG001|Overall Study|Lack of Efficacy|0|||
48828163|NCT01467700|157212402|FG002|Overall Study|Lack of Efficacy|2|||
48828164|NCT01467700|157212403|FG003|Overall Study|Lack of Efficacy|1|||
48828165|NCT01467700|157212400|FG000|Overall Study|Reason not Specified|1|||
48828166|NCT01467700|157212401|FG001|Overall Study|Reason not Specified|3|||
48828167|NCT01467700|157212402|FG002|Overall Study|Reason not Specified|2|||
48828168|NCT01467700|157212403|FG003|Overall Study|Reason not Specified|8|||
48828169|NCT03732820|157212404|FG000|Overall Study|Death|168|||
48828170|NCT03732820|157212405|FG001|Overall Study|Death|203|||
48828171|NCT03732820|157212404|FG000|Overall Study|Other|2|||
48828172|NCT03732820|157212405|FG001|Overall Study|Other|2|||
48828173|NCT03732820|157212404|FG000|Overall Study|Failure to meet randomisation criteria|1|||
48828174|NCT03732820|157212405|FG001|Overall Study|Failure to meet randomisation criteria|1|||
48828175|NCT03732820|157212404|FG000|Overall Study|Patient decision|14|||
48828176|NCT03732820|157212405|FG001|Overall Study|Patient decision|10|||
48828177|NCT03732820|157212404|FG000|Overall Study|Screen failure|0|||
48828178|NCT03732820|157212405|FG001|Overall Study|Screen failure|1|||
48828179|NCT03732820|157212404|FG000|Overall Study|Patients ongoing study at data cut off|210|||
48828180|NCT03732820|157212405|FG001|Overall Study|Patients ongoing study at data cut off|178|||
48828181|NCT03732820|157212404|FG000|Overall Study|Lost to Follow-up|4|||
48828182|NCT03732820|157212405|FG001|Overall Study|Lost to Follow-up|2|||
48828183|NCT05030311|157212406|FG000|Overall Study|Technical problems|0|||
48828184|NCT05030311|157212407|FG001|Overall Study|Technical problems|1|||
48828185|NCT05030311|157212406|FG000|Overall Study|Withdrawal by Subject|31|||
48828186|NCT05030311|157212407|FG001|Overall Study|Withdrawal by Subject|17|||
48828187|NCT05030311|157212406|FG000|Overall Study|Adverse Event|13|||
48527070|NCT02124902|156122504|FG000|Overall Study|Withdrawal by Subject|2|||
48527071|NCT02124902|156122505|FG001|Overall Study|Withdrawal by Subject|1|||
48527072|NCT02124902|156122504|FG000|Overall Study|Physician Decision|2|||
48527073|NCT02124902|156122505|FG001|Overall Study|Physician Decision|0|||
48527074|NCT02124902|156122504|FG000|Overall Study|Not eligible|1|||
48527075|NCT02124902|156122505|FG001|Overall Study|Not eligible|0|||
48527076|NCT02124902|156122504|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
48527077|NCT02124902|156122505|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
48527078|NCT01937351|156122506|FG000|Overall Study|Withdrawal by Subject|4|||
48527079|NCT01937351|156122507|FG001|Overall Study|Withdrawal by Subject|2|||
48527080|NCT01937351|156122506|FG000|Overall Study|Death|1|||
48527081|NCT01937351|156122507|FG001|Overall Study|Death|0|||
48527082|NCT01937351|156122506|FG000|Overall Study|Not treated w device, per protocol fail|4|||
48527083|NCT01937351|156122507|FG001|Overall Study|Not treated w device, per protocol fail|0|||
48527084|NCT01961687|156122509|FG000|Overall Study|Lost to Follow-up|19|||
48527085|NCT01961687|156122509|FG000|Overall Study|Re-operation|17|||
48527086|NCT01961687|156122509|FG000|Overall Study|Death|7|||
48527087|NCT01961687|156122509|FG000|Overall Study|Withdrawal by Subject|6|||
48527088|NCT01961687|156122509|FG000|Overall Study|Adverse Event|6|||
48602190|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
48602191|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
48527089|NCT01961687|156122509|FG000|Overall Study|Moved to area without study site|2|||
48527090|NCT01961687|156122509|FG000|Overall Study|Sponsor decision|2|||
48527091|NCT01961687|156122509|FG000|Overall Study|Physician Decision|1|||
48828188|NCT05030311|157212407|FG001|Overall Study|Adverse Event|5|||
48527092|NCT01961687|156122509|FG000|Overall Study|Unable to meet follow-up requirements|1|||
48527093|NCT00808509|156122510|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
48527094|NCT00808509|156122511|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
48828189|NCT05030311|157212406|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48828190|NCT05030311|157212407|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48828191|NCT05030311|157212406|FG000|Overall Study|Physician Decision|5|||
48828192|NCT05030311|157212407|FG001|Overall Study|Physician Decision|2|||
48828193|NCT05030311|157212406|FG000|Overall Study|Lost to Follow-up|5|||
48828194|NCT05030311|157212407|FG001|Overall Study|Lost to Follow-up|1|||
48828195|NCT05030311|157212406|FG000|Overall Study|Protocol Violation|4|||
48828196|NCT05030311|157212407|FG001|Overall Study|Protocol Violation|4|||
48828209|NCT02734004|157212411|FG000|Overall Study|Death|36|||
48828210|NCT02734004|157212412|FG001|Overall Study|Death|24|||
48828211|NCT02734004|157212413|FG002|Overall Study|Death|26|||
48828212|NCT02734004|157212414|FG003|Overall Study|Death|35|||
48828213|NCT02734004|157212415|FG004|Overall Study|Death|13|||
48828214|NCT02734004|157212416|FG005|Overall Study|Death|17|||
48828215|NCT02734004|157212417|FG006|Overall Study|Death|20|||
48828216|NCT02734004|157212411|FG000|Overall Study|Lost to Follow-up|1|||
48828217|NCT02734004|157212412|FG001|Overall Study|Lost to Follow-up|1|||
48828218|NCT02734004|157212413|FG002|Overall Study|Lost to Follow-up|0|||
48828219|NCT02734004|157212414|FG003|Overall Study|Lost to Follow-up|0|||
48828220|NCT02734004|157212415|FG004|Overall Study|Lost to Follow-up|1|||
48828221|NCT02734004|157212416|FG005|Overall Study|Lost to Follow-up|0|||
48828222|NCT02734004|157212417|FG006|Overall Study|Lost to Follow-up|0|||
48828223|NCT02734004|157212411|FG000|Overall Study|Withdrawal by Subject|3|||
48828224|NCT02734004|157212412|FG001|Overall Study|Withdrawal by Subject|1|||
48828225|NCT02734004|157212413|FG002|Overall Study|Withdrawal by Subject|1|||
48828226|NCT02734004|157212414|FG003|Overall Study|Withdrawal by Subject|1|||
48828227|NCT02734004|157212415|FG004|Overall Study|Withdrawal by Subject|3|||
48828228|NCT02734004|157212416|FG005|Overall Study|Withdrawal by Subject|0|||
48828229|NCT02734004|157212417|FG006|Overall Study|Withdrawal by Subject|2|||
48828230|NCT02734004|157212411|FG000|Overall Study|Other|0|||
48828231|NCT02734004|157212412|FG001|Overall Study|Other|8|||
48828232|NCT02734004|157212413|FG002|Overall Study|Other|7|||
48828233|NCT02734004|157212414|FG003|Overall Study|Other|4|||
48828234|NCT02734004|157212415|FG004|Overall Study|Other|34|||
48828235|NCT02734004|157212416|FG005|Overall Study|Other|14|||
48828236|NCT02734004|157212417|FG006|Overall Study|Other|10|||
48828237|NCT03098030|157212418|FG000|Overall Study|Death|10|||
48828238|NCT03098030|157212419|FG001|Overall Study|Death|156|||
48828239|NCT03098030|157212420|FG002|Overall Study|Death|156|||
48828240|NCT03098030|157212421|FG003|Overall Study|Death|82|||
48828241|NCT03098030|157212418|FG000|Overall Study|Withdrawal by Subject|0|||
48828242|NCT03098030|157212419|FG001|Overall Study|Withdrawal by Subject|7|||
48828243|NCT03098030|157212420|FG002|Overall Study|Withdrawal by Subject|8|||
48828244|NCT03098030|157212421|FG003|Overall Study|Withdrawal by Subject|2|||
48828245|NCT03098030|157212418|FG000|Overall Study|Lost to Follow-up|0|||
48828246|NCT03098030|157212419|FG001|Overall Study|Lost to Follow-up|0|||
48828247|NCT03098030|157212420|FG002|Overall Study|Lost to Follow-up|2|||
48828248|NCT03098030|157212421|FG003|Overall Study|Lost to Follow-up|1|||
48828249|NCT02062827|157212422|FG000|Overall Study|Death|1|||
48828250|NCT02062827|157212423|FG001|Overall Study|Death|0|||
48828251|NCT02062827|157212424|FG002|Overall Study|Death|0|||
48828252|NCT02062827|157212425|FG003|Overall Study|Death|0|||
48828253|NCT02062827|157212426|FG004|Overall Study|Death|0|||
48828254|NCT02062827|157212427|FG005|Overall Study|Death|0|||
48828255|NCT02062827|157212428|FG006|Overall Study|Death|0|||
48828256|NCT02062827|157212429|FG007|Overall Study|Death|0|||
48828257|NCT02062827|157212422|FG000|Overall Study|Withdrawal by Subject|3|||
48828258|NCT02062827|157212423|FG001|Overall Study|Withdrawal by Subject|1|||
48828259|NCT02062827|157212424|FG002|Overall Study|Withdrawal by Subject|1|||
48828260|NCT02062827|157212425|FG003|Overall Study|Withdrawal by Subject|2|||
48828261|NCT02062827|157212426|FG004|Overall Study|Withdrawal by Subject|6|||
48828262|NCT02062827|157212427|FG005|Overall Study|Withdrawal by Subject|0|||
48828263|NCT02062827|157212428|FG006|Overall Study|Withdrawal by Subject|5|||
48828264|NCT02062827|157212429|FG007|Overall Study|Withdrawal by Subject|0|||
48828265|NCT02062827|157212422|FG000|Overall Study|Screen Fail|0|||
48828266|NCT02062827|157212423|FG001|Overall Study|Screen Fail|0|||
48828267|NCT02062827|157212424|FG002|Overall Study|Screen Fail|0|||
48828268|NCT02062827|157212425|FG003|Overall Study|Screen Fail|0|||
48828269|NCT02062827|157212426|FG004|Overall Study|Screen Fail|0|||
48828270|NCT02062827|157212427|FG005|Overall Study|Screen Fail|0|||
48828271|NCT02062827|157212428|FG006|Overall Study|Screen Fail|0|||
48828272|NCT02062827|157212429|FG007|Overall Study|Screen Fail|8|||
48828273|NCT03586544|157212433|FG000|First Intervention|Adverse Event|0|||
48828274|NCT03586544|157212434|FG001|First Intervention|Adverse Event|1|||
48828275|NCT03586544|157212433|FG000|Second Intervention|Withdrawal by Subject|0|||
48828276|NCT03586544|157212434|FG001|Second Intervention|Withdrawal by Subject|1|||
48828277|NCT02781584|157212435|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
48828278|NCT02781584|157212436|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
48828279|NCT02781584|157212437|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
48828280|NCT02781584|157212438|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
48828281|NCT02781584|157212439|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
48828282|NCT02781584|157212440|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
48828283|NCT02781584|157212441|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
48828284|NCT02781584|157212442|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
48828285|NCT02781584|157212443|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
48828286|NCT02781584|157212444|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
48828287|NCT02781584|157212445|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
48828288|NCT02781584|157212446|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
48828289|NCT02781584|157212447|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
48828290|NCT02781584|157212435|FG000|Pre-treatment Phase|Adverse Event|0|||
48828291|NCT02781584|157212436|FG001|Pre-treatment Phase|Adverse Event|0|||
48828292|NCT02781584|157212437|FG002|Pre-treatment Phase|Adverse Event|0|||
48828293|NCT02781584|157212438|FG003|Pre-treatment Phase|Adverse Event|0|||
48828294|NCT02781584|157212439|FG004|Pre-treatment Phase|Adverse Event|0|||
48828295|NCT02781584|157212440|FG005|Pre-treatment Phase|Adverse Event|0|||
48828296|NCT02781584|157212441|FG006|Pre-treatment Phase|Adverse Event|0|||
48828297|NCT02781584|157212442|FG007|Pre-treatment Phase|Adverse Event|0|||
48828298|NCT02781584|157212443|FG008|Pre-treatment Phase|Adverse Event|0|||
48828299|NCT02781584|157212444|FG009|Pre-treatment Phase|Adverse Event|0|||
48828300|NCT02781584|157212445|FG010|Pre-treatment Phase|Adverse Event|0|||
48828301|NCT02781584|157212446|FG011|Pre-treatment Phase|Adverse Event|1|||
48828302|NCT02781584|157212447|FG012|Pre-treatment Phase|Adverse Event|0|||
48828303|NCT02781584|157212435|FG000|Treatment Phase|Withdrew Consent|0|||
48828304|NCT02781584|157212436|FG001|Treatment Phase|Withdrew Consent|0|||
48828305|NCT02781584|157212437|FG002|Treatment Phase|Withdrew Consent|0|||
48828306|NCT02781584|157212438|FG003|Treatment Phase|Withdrew Consent|0|||
48828307|NCT02781584|157212439|FG004|Treatment Phase|Withdrew Consent|0|||
48828308|NCT02781584|157212440|FG005|Treatment Phase|Withdrew Consent|1|||
48828309|NCT02781584|157212441|FG006|Treatment Phase|Withdrew Consent|0|||
48828310|NCT02781584|157212442|FG007|Treatment Phase|Withdrew Consent|0|||
48828311|NCT02781584|157212443|FG008|Treatment Phase|Withdrew Consent|0|||
48828312|NCT02781584|157212444|FG009|Treatment Phase|Withdrew Consent|0|||
48828313|NCT02781584|157212445|FG010|Treatment Phase|Withdrew Consent|1|||
48828314|NCT02781584|157212446|FG011|Treatment Phase|Withdrew Consent|2|||
48828315|NCT02781584|157212447|FG012|Treatment Phase|Withdrew Consent|0|||
48828316|NCT02781584|157212435|FG000|Treatment Phase|Adverse Event|0|||
48828317|NCT02781584|157212436|FG001|Treatment Phase|Adverse Event|0|||
48828318|NCT02781584|157212437|FG002|Treatment Phase|Adverse Event|0|||
48828319|NCT02781584|157212438|FG003|Treatment Phase|Adverse Event|0|||
48828320|NCT02781584|157212439|FG004|Treatment Phase|Adverse Event|0|||
48828321|NCT02781584|157212440|FG005|Treatment Phase|Adverse Event|0|||
48828322|NCT02781584|157212441|FG006|Treatment Phase|Adverse Event|0|||
48828323|NCT02781584|157212442|FG007|Treatment Phase|Adverse Event|1|||
48828324|NCT02781584|157212443|FG008|Treatment Phase|Adverse Event|0|||
48828325|NCT02781584|157212444|FG009|Treatment Phase|Adverse Event|0|||
48828326|NCT02781584|157212445|FG010|Treatment Phase|Adverse Event|0|||
48828327|NCT02781584|157212446|FG011|Treatment Phase|Adverse Event|0|||
48828328|NCT02781584|157212447|FG012|Treatment Phase|Adverse Event|0|||
48828329|NCT00881335|157212448|FG000|Overall Study|Lost to Follow-up|3|||
48828330|NCT00881335|157212449|FG001|Overall Study|Lost to Follow-up|2|||
48828331|NCT01007149|157212452|FG000|Overall Study|Administrative problems|0|||
48828332|NCT01007149|157212453|FG001|Overall Study|Administrative problems|1|||
48828333|NCT01348087|157212454|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
48828334|NCT01348087|157212454|FG000|Overall Study|Administrative problems|79|||
48828335|NCT01348087|157212454|FG000|Overall Study|protocol deviation|1|||
48828336|NCT01348087|157212454|FG000|Overall Study|Lost to Follow-up|1|||
48828337|NCT01348087|157212454|FG000|Overall Study|Subject withdrew consent|7|||
48828338|NCT01348087|157212454|FG000|Overall Study|Adverse Event|25|||
48828339|NCT04886596|157212457|FG000|Overall Study|Adverse Event|73|||
48828340|NCT04886596|157212458|FG001|Overall Study|Adverse Event|78|||
48828341|NCT04886596|157212457|FG000|Overall Study|Lost to Follow-up|104|||
48828342|NCT04886596|157212458|FG001|Overall Study|Lost to Follow-up|104|||
48828343|NCT04886596|157212457|FG000|Overall Study|Ongoing|12095|||
48828344|NCT04886596|157212458|FG001|Overall Study|Ongoing|12107|||
48828345|NCT04886596|157212457|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
48828346|NCT04886596|157212458|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
48828347|NCT04886596|157212457|FG000|Overall Study|Migrated / Moved from the study area|17|||
48828348|NCT04886596|157212458|FG001|Overall Study|Migrated / Moved from the study area|14|||
48828349|NCT04886596|157212457|FG000|Overall Study|Unknown reason|16|||
48828350|NCT04886596|157212458|FG001|Overall Study|Unknown reason|23|||
48828351|NCT00603538|157212459|FG000|Overall Study|Adverse Event|0|||
48828352|NCT00603538|157212460|FG001|Overall Study|Adverse Event|4|||
48828353|NCT00603538|157212461|FG002|Overall Study|Adverse Event|2|||
48828354|NCT00603538|157212459|FG000|Overall Study|Objective progression or relapse|3|||
48828355|NCT00603538|157212460|FG001|Overall Study|Objective progression or relapse|0|||
48828356|NCT00603538|157212461|FG002|Overall Study|Objective progression or relapse|0|||
48828357|NCT04771273|157212462|FG000|Dose Escalation Period|Not treated with trial medication|0|||
48828358|NCT04771273|157212463|FG001|Dose Escalation Period|Not treated with trial medication|1|||
48828359|NCT04771273|157212464|FG002|Dose Escalation Period|Not treated with trial medication|1|||
48828360|NCT04771273|157212465|FG003|Dose Escalation Period|Not treated with trial medication|0|||
48828361|NCT04771273|157212462|FG000|Dose Escalation Period|Other reasons than listed|2|||
48828362|NCT04771273|157212463|FG001|Dose Escalation Period|Other reasons than listed|0|||
48828363|NCT04771273|157212464|FG002|Dose Escalation Period|Other reasons than listed|2|||
48828364|NCT04771273|157212465|FG003|Dose Escalation Period|Other reasons than listed|1|||
48828365|NCT04771273|157212462|FG000|Dose Escalation Period|Protocol Violation|0|||
48828366|NCT04771273|157212463|FG001|Dose Escalation Period|Protocol Violation|0|||
48828367|NCT04771273|157212464|FG002|Dose Escalation Period|Protocol Violation|3|||
48828368|NCT04771273|157212465|FG003|Dose Escalation Period|Protocol Violation|1|||
48828369|NCT04771273|157212462|FG000|Dose Escalation Period|Burden of study procedures|1|||
48828370|NCT04771273|157212463|FG001|Dose Escalation Period|Burden of study procedures|0|||
48828371|NCT04771273|157212464|FG002|Dose Escalation Period|Burden of study procedures|0|||
48828372|NCT04771273|157212465|FG003|Dose Escalation Period|Burden of study procedures|0|||
48828373|NCT04771273|157212462|FG000|Dose Escalation Period|Change of residence|0|||
48828374|NCT04771273|157212463|FG001|Dose Escalation Period|Change of residence|0|||
48828375|NCT04771273|157212464|FG002|Dose Escalation Period|Change of residence|0|||
48828376|NCT04771273|157212465|FG003|Dose Escalation Period|Change of residence|1|||
48828377|NCT04771273|157212462|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
48828378|NCT04771273|157212463|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
48828379|NCT04771273|157212464|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
48828380|NCT04771273|157212465|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
48828381|NCT04771273|157212462|FG000|Dose Escalation Period|Adverse Event|8|||
48828382|NCT04771273|157212463|FG001|Dose Escalation Period|Adverse Event|9|||
48828383|NCT04771273|157212464|FG002|Dose Escalation Period|Adverse Event|12|||
48828384|NCT04771273|157212465|FG003|Dose Escalation Period|Adverse Event|2|||
48828385|NCT04771273|157212462|FG000|Maintenance Period|Other than listed|4|||
48828386|NCT04771273|157212463|FG001|Maintenance Period|Other than listed|2|||
48828387|NCT04771273|157212464|FG002|Maintenance Period|Other than listed|0|||
48828388|NCT04771273|157212465|FG003|Maintenance Period|Other than listed|3|||
48828389|NCT04771273|157212462|FG000|Maintenance Period|Burden of study procedures|1|||
48828390|NCT04771273|157212463|FG001|Maintenance Period|Burden of study procedures|0|||
48828391|NCT04771273|157212464|FG002|Maintenance Period|Burden of study procedures|0|||
48527095|NCT00808509|156122510|FG000|Randomized Phase|Reduced methotrexate dose|1|||
48527096|NCT00808509|156122511|FG001|Randomized Phase|Reduced methotrexate dose|2|||
48527097|NCT00808509|156122510|FG000|Randomized Phase|Patient refused rescue therapy|0|||
48527098|NCT00808509|156122511|FG001|Randomized Phase|Patient refused rescue therapy|3|||
48527099|NCT02012452|156122514|FG000|Overall Study|Lost to Follow-up|2|||
48527100|NCT02012452|156122515|FG001|Overall Study|Lost to Follow-up|1|||
48527101|NCT02012452|156122514|FG000|Overall Study|Withdrawal by Subject|4|||
48527102|NCT02012452|156122515|FG001|Overall Study|Withdrawal by Subject|0|||
48828392|NCT04771273|157212465|FG003|Maintenance Period|Burden of study procedures|0|||
48828393|NCT04771273|157212462|FG000|Maintenance Period|Change of residence|0|||
48828394|NCT04771273|157212463|FG001|Maintenance Period|Change of residence|1|||
48527103|NCT02190279|156122516|FG000|Overall Study|Withdrawal consent|1|||
48828395|NCT04771273|157212464|FG002|Maintenance Period|Change of residence|3|||
48828396|NCT04771273|157212465|FG003|Maintenance Period|Change of residence|0|||
48828397|NCT04771273|157212462|FG000|Maintenance Period|Perceived lack of efficacy|0|||
48828398|NCT04771273|157212463|FG001|Maintenance Period|Perceived lack of efficacy|0|||
48527104|NCT02190279|156122517|FG001|Overall Study|Withdrawal consent|0|||
48828399|NCT04771273|157212464|FG002|Maintenance Period|Perceived lack of efficacy|0|||
48828400|NCT04771273|157212465|FG003|Maintenance Period|Perceived lack of efficacy|1|||
48828401|NCT04771273|157212462|FG000|Maintenance Period|Adverse Event|4|||
48828402|NCT04771273|157212463|FG001|Maintenance Period|Adverse Event|5|||
48828403|NCT04771273|157212464|FG002|Maintenance Period|Adverse Event|5|||
48828404|NCT04771273|157212465|FG003|Maintenance Period|Adverse Event|0|||
48828405|NCT05096884|157212466|FG000|Overall Study|Excluded based on negative tilt table test|4|||
48527105|NCT02190279|156122518|FG002|Overall Study|Withdrawal consent|1|||
48527106|NCT02190279|156122516|FG000|Overall Study|Lost to Follow-up|2|||
48527107|NCT02190279|156122517|FG001|Overall Study|Lost to Follow-up|0|||
48527108|NCT02190279|156122518|FG002|Overall Study|Lost to Follow-up|0|||
48828406|NCT04011033|157212470|FG000|Overall Study|Physician Decision|2|||
48828407|NCT04011033|157212471|FG001|Overall Study|Physician Decision|3|||
48527109|NCT02190279|156122516|FG000|Overall Study|Refused further treatment|0|||
48527110|NCT02190279|156122517|FG001|Overall Study|Refused further treatment|0|||
48828408|NCT04011033|157212470|FG000|Overall Study|Withdrawal by Subject|1|||
48828409|NCT04011033|157212471|FG001|Overall Study|Withdrawal by Subject|0|||
48828410|NCT01333514|157212478|FG000|Overall Study|Withdrawal by Subject|1|||
48828411|NCT01333514|157212479|FG001|Overall Study|Withdrawal by Subject|0|||
48828412|NCT02289560|157212480|FG000|Overall Study|Lost to Follow-up|6|||
48828413|NCT02289560|157212480|FG000|Overall Study|Alternative Treatment|4|||
48828414|NCT02289560|157212480|FG000|Overall Study|Inadequate Treatment|2|||
48828415|NCT02289560|157212480|FG000|Overall Study|Withdrawal by Subject|23|||
48828416|NCT02540213|157212482|FG000|Overall Study|Death/adverse event|18|||
48828417|NCT02540213|157212482|FG000|Overall Study|Administrative reasons|3|||
48828418|NCT02540213|157212482|FG000|Overall Study|Kidney transplant|3|||
48828419|NCT02540213|157212482|FG000|Overall Study|Lack of Efficacy|6|||
48828420|NCT02540213|157212482|FG000|Overall Study|Consent withdrawn|7|||
48828421|NCT02540213|157212482|FG000|Overall Study|Enrolled but not treated|2|||
48828422|NCT00389519|157212483|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
48828423|NCT00389519|157212484|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
48828424|NCT00389519|157212485|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
48828425|NCT00389519|157212486|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
48828426|NCT00389519|157212483|FG000|Placebo Run-In|Withdrawal by Subject|19|||
48828427|NCT00389519|157212484|FG001|Placebo Run-In|Withdrawal by Subject|0|||
48828428|NCT00389519|157212485|FG002|Placebo Run-In|Withdrawal by Subject|0|||
48828429|NCT00389519|157212486|FG003|Placebo Run-In|Withdrawal by Subject|0|||
48828430|NCT00389519|157212483|FG000|Placebo Run-In|Reason not specified|40|||
48828431|NCT00389519|157212484|FG001|Placebo Run-In|Reason not specified|0|||
48828432|NCT00389519|157212485|FG002|Placebo Run-In|Reason not specified|0|||
48828433|NCT00389519|157212486|FG003|Placebo Run-In|Reason not specified|0|||
48828434|NCT00389519|157212483|FG000|Randomized|Did not receive study drug|2|||
48828435|NCT00389519|157212484|FG001|Randomized|Did not receive study drug|0|||
48828436|NCT00389519|157212485|FG002|Randomized|Did not receive study drug|0|||
48828437|NCT00389519|157212486|FG003|Randomized|Did not receive study drug|0|||
48828438|NCT00389519|157212483|FG000|Treated|Adverse Event|1|||
48828439|NCT00389519|157212484|FG001|Treated|Adverse Event|0|||
48828440|NCT00389519|157212485|FG002|Treated|Adverse Event|0|||
48828441|NCT00389519|157212486|FG003|Treated|Adverse Event|2|||
48828442|NCT00389519|157212483|FG000|Treated|Reason not specified|1|||
48828443|NCT00389519|157212484|FG001|Treated|Reason not specified|1|||
48828444|NCT00389519|157212485|FG002|Treated|Reason not specified|0|||
48828445|NCT00389519|157212486|FG003|Treated|Reason not specified|2|||
48828446|NCT01981356|157212493|FG000|Overall Study|Lost to Follow-up|4|||
48828447|NCT01981356|157212494|FG001|Overall Study|Lost to Follow-up|1|||
48828448|NCT01981356|157212493|FG000|Overall Study|Withdrawal by Subject|1|||
48828449|NCT01981356|157212494|FG001|Overall Study|Withdrawal by Subject|1|||
48828450|NCT01981356|157212493|FG000|Overall Study|Protocol Violation|2|||
48828451|NCT01981356|157212494|FG001|Overall Study|Protocol Violation|0|||
48828452|NCT00536380|157212495|FG000|Overall Study|Adverse Event|0|||
48828453|NCT00536380|157212496|FG001|Overall Study|Adverse Event|2|||
48828454|NCT00536380|157212497|FG002|Overall Study|Adverse Event|2|||
48828455|NCT00536380|157212495|FG000|Overall Study|Lost to Follow-up|0|||
48828456|NCT00536380|157212496|FG001|Overall Study|Lost to Follow-up|0|||
48828457|NCT00536380|157212497|FG002|Overall Study|Lost to Follow-up|1|||
48828458|NCT00536380|157212495|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
48828459|NCT00536380|157212496|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
48828460|NCT00536380|157212497|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
48527111|NCT02190279|156122518|FG002|Overall Study|Refused further treatment|1|||
48527112|NCT02190279|156122516|FG000|Overall Study|Screening failure|0|||
48828461|NCT00536380|157212495|FG000|Overall Study|Withdrawal related to study drug|7|||
48828462|NCT00536380|157212496|FG001|Overall Study|Withdrawal related to study drug|5|||
48828463|NCT00536380|157212497|FG002|Overall Study|Withdrawal related to study drug|2|||
48828464|NCT00536380|157212495|FG000|Overall Study|Noncompliance with protocol|3|||
48828465|NCT00536380|157212496|FG001|Overall Study|Noncompliance with protocol|2|||
48828466|NCT00536380|157212497|FG002|Overall Study|Noncompliance with protocol|2|||
48828467|NCT00536380|157212495|FG000|Overall Study|Did not meet protocol eligibility|0|||
48828468|NCT00536380|157212496|FG001|Overall Study|Did not meet protocol eligibility|0|||
48828469|NCT00536380|157212497|FG002|Overall Study|Did not meet protocol eligibility|1|||
48828470|NCT00536380|157212495|FG000|Overall Study|Administrative|0|||
48828471|NCT00536380|157212496|FG001|Overall Study|Administrative|0|||
48828472|NCT00536380|157212497|FG002|Overall Study|Administrative|1|||
48828473|NCT00299702|157212498|FG000|Overall Study|Death|1|||
48828474|NCT00299702|157212499|FG001|Overall Study|Death|0|||
48828475|NCT00299702|157212498|FG000|Overall Study|Adverse Event|0|||
48828476|NCT00299702|157212499|FG001|Overall Study|Adverse Event|4|||
48828477|NCT00299702|157212498|FG000|Overall Study|Lost to Follow-up|18|||
48828478|NCT00299702|157212499|FG001|Overall Study|Lost to Follow-up|10|||
48828479|NCT00299702|157212498|FG000|Overall Study|Withdrawal by Subject|25|||
48828480|NCT00299702|157212499|FG001|Overall Study|Withdrawal by Subject|23|||
48828481|NCT00299702|157212498|FG000|Overall Study|Pregnancy|0|||
48828482|NCT00299702|157212499|FG001|Overall Study|Pregnancy|1|||
48828483|NCT00299702|157212498|FG000|Overall Study|Insufficient Response|4|||
48828484|NCT00299702|157212499|FG001|Overall Study|Insufficient Response|3|||
48828485|NCT00299702|157212498|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
48828486|NCT00299702|157212499|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
48828487|NCT02013037|157212501|FG000|Overall Study|Death|6|||
48828488|NCT02013037|157212501|FG000|Overall Study|Withdrawal by Subject|1|||
48828489|NCT02013037|157212501|FG000|Overall Study|Awaiting Transplantation|7|||
48828490|NCT02013037|157212501|FG000|Overall Study|Transplanted without DSA|2|||
48828491|NCT02465359|157212502|FG000|Overall Study|Lack of Efficacy|1|||
48828492|NCT02465359|157212502|FG000|Overall Study|Withdrawal by Subject|1|||
48828493|NCT02465359|157212502|FG000|Overall Study|Adverse Event|1|||
48828494|NCT03141788|157212506|FG000|Overall Study|Lost to Follow-up|1|||
48828495|NCT03141788|157212506|FG000|Overall Study|Protocol Violation|3|||
48828496|NCT03141788|157212506|FG000|Overall Study|Withdrawal by Subject|4|||
48828497|NCT02812966|157212507|FG000|Overall Study|Death|1|||
48828498|NCT02812966|157212508|FG001|Overall Study|Death|0|||
48828499|NCT03354390|157212509|FG000|Level 1|Death|2|||
48828500|NCT03354390|157212510|FG001|Level 1|Death|0|||
48828501|NCT03354390|157212511|FG002|Level 1|Death|0|||
48828502|NCT03354390|157212512|FG003|Level 1|Death|0|||
48828503|NCT03354390|157212509|FG000|Level 1|Physician Decision|1|||
48828504|NCT03354390|157212510|FG001|Level 1|Physician Decision|0|||
48828505|NCT03354390|157212511|FG002|Level 1|Physician Decision|0|||
48828506|NCT03354390|157212512|FG003|Level 1|Physician Decision|0|||
48828507|NCT03354390|157212509|FG000|Level 2|Physician Decision|0|||
48828508|NCT03354390|157212510|FG001|Level 2|Physician Decision|2|||
48828509|NCT03354390|157212511|FG002|Level 2|Physician Decision|0|||
48828510|NCT03354390|157212512|FG003|Level 2|Physician Decision|0|||
48828511|NCT03354390|157212509|FG000|Level 2|Lack of Efficacy|0|||
48828512|NCT03354390|157212510|FG001|Level 2|Lack of Efficacy|1|||
48828513|NCT03354390|157212511|FG002|Level 2|Lack of Efficacy|0|||
48828514|NCT03354390|157212512|FG003|Level 2|Lack of Efficacy|0|||
48828515|NCT03354390|157212509|FG000|Level 2|Lost to Follow-up|0|||
48828516|NCT03354390|157212510|FG001|Level 2|Lost to Follow-up|1|||
48828517|NCT03354390|157212511|FG002|Level 2|Lost to Follow-up|0|||
48828518|NCT03354390|157212512|FG003|Level 2|Lost to Follow-up|0|||
48828519|NCT03354390|157212509|FG000|Level 3|Death|0|||
48828520|NCT03354390|157212510|FG001|Level 3|Death|0|||
48828521|NCT03354390|157212511|FG002|Level 3|Death|1|||
48828522|NCT03354390|157212512|FG003|Level 3|Death|0|||
48828523|NCT03354390|157212509|FG000|Level 3|Physician Decision|0|||
48828524|NCT03354390|157212510|FG001|Level 3|Physician Decision|0|||
48828525|NCT03354390|157212511|FG002|Level 3|Physician Decision|2|||
48828526|NCT03354390|157212512|FG003|Level 3|Physician Decision|0|||
48828527|NCT03354390|157212509|FG000|Level 4|Death|0|||
48828528|NCT03354390|157212510|FG001|Level 4|Death|0|||
48828529|NCT03354390|157212511|FG002|Level 4|Death|0|||
48828530|NCT03354390|157212512|FG003|Level 4|Death|3|||
48828531|NCT03481777|157214016|FG000|Overall Study|Withdrawal by Subject|36|||
48828532|NCT03481777|157214017|FG001|Overall Study|Withdrawal by Subject|31|||
48828533|NCT03481777|157214016|FG000|Overall Study|Non stroke = non target population|277|||
48828534|NCT03481777|157214017|FG001|Overall Study|Non stroke = non target population|254|||
48828535|NCT04091672|157214019|FG000|Overall Study|Death|6|||
48828536|NCT04091672|157214020|FG001|Overall Study|Death|6|||
48828537|NCT04091672|157214019|FG000|Overall Study|Lost to Follow-up|7|||
48828538|NCT04091672|157214020|FG001|Overall Study|Lost to Follow-up|7|||
48828539|NCT04091672|157214019|FG000|Overall Study|Withdrawal by Subject|3|||
48828540|NCT04091672|157214020|FG001|Overall Study|Withdrawal by Subject|3|||
48828541|NCT04091672|157214019|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
48828542|NCT04091672|157214020|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
48828543|NCT01939158|157214021|FG000|Overall Study|Adverse Event|1|||
48828544|NCT01939158|157214022|FG001|Overall Study|Adverse Event|0|||
48828545|NCT01939158|157214023|FG002|Overall Study|Adverse Event|0|||
48828546|NCT01939158|157214024|FG003|Overall Study|Adverse Event|0|||
48828547|NCT01939158|157214021|FG000|Overall Study|Withdrawal by Subject|22|||
48828548|NCT01939158|157214022|FG001|Overall Study|Withdrawal by Subject|25|||
48828549|NCT01939158|157214023|FG002|Overall Study|Withdrawal by Subject|15|||
48828550|NCT01939158|157214024|FG003|Overall Study|Withdrawal by Subject|17|||
48828551|NCT01939158|157214021|FG000|Overall Study|Migrated/moved from study area|5|||
48828552|NCT01939158|157214022|FG001|Overall Study|Migrated/moved from study area|7|||
48828553|NCT01939158|157214023|FG002|Overall Study|Migrated/moved from study area|3|||
48828554|NCT01939158|157214024|FG003|Overall Study|Migrated/moved from study area|6|||
48828555|NCT01939158|157214021|FG000|Overall Study|Lost to Follow-up|18|||
48828556|NCT01939158|157214022|FG001|Overall Study|Lost to Follow-up|17|||
48828557|NCT01939158|157214023|FG002|Overall Study|Lost to Follow-up|17|||
48828558|NCT01939158|157214024|FG003|Overall Study|Lost to Follow-up|17|||
48828559|NCT01939158|157214021|FG000|Overall Study|Death|0|||
48828560|NCT01939158|157214022|FG001|Overall Study|Death|0|||
48828561|NCT01939158|157214023|FG002|Overall Study|Death|1|||
48828562|NCT01939158|157214024|FG003|Overall Study|Death|1|||
48828563|NCT01939158|157214021|FG000|Overall Study|No longer meets eligibility criteria|0|||
48828564|NCT01939158|157214022|FG001|Overall Study|No longer meets eligibility criteria|0|||
48828565|NCT01939158|157214023|FG002|Overall Study|No longer meets eligibility criteria|1|||
48828566|NCT01939158|157214024|FG003|Overall Study|No longer meets eligibility criteria|0|||
48828567|NCT01939158|157214021|FG000|Overall Study|Other|1|||
48828568|NCT01939158|157214022|FG001|Overall Study|Other|3|||
48828569|NCT01939158|157214023|FG002|Overall Study|Other|4|||
48828570|NCT01939158|157214024|FG003|Overall Study|Other|3|||
48828571|NCT01684046|157214025|FG000|Period 1, First 30 Days|Adverse Event|0|||
48828572|NCT01684046|157214026|FG001|Period 1, First 30 Days|Adverse Event|2|||
48828573|NCT05074498|157214027|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828574|NCT05074498|157214028|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828575|NCT05074498|157214029|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828576|NCT05074498|157214030|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
48828577|NCT05074498|157214031|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828578|NCT05074498|157214032|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
48828579|NCT05074498|157214027|FG000|Part 1 (Upto Day 104)|Other|1|||
48828580|NCT05074498|157214028|FG001|Part 1 (Upto Day 104)|Other|0|||
48828581|NCT05074498|157214029|FG002|Part 1 (Upto Day 104)|Other|0|||
48828582|NCT05074498|157214030|FG003|Part 1 (Upto Day 104)|Other|0|||
48828583|NCT05074498|157214031|FG004|Part 1 (Upto Day 104)|Other|0|||
48828584|NCT05074498|157214032|FG005|Part 1 (Upto Day 104)|Other|0|||
48828585|NCT05074498|157214027|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828586|NCT05074498|157214028|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828587|NCT05074498|157214029|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828588|NCT05074498|157214030|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828589|NCT05074498|157214031|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
48828590|NCT05074498|157214032|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
48828591|NCT05074498|157214027|FG000|Part 2 (Upto Day 104)|Death|0|||
48828592|NCT05074498|157214028|FG001|Part 2 (Upto Day 104)|Death|0|||
48828593|NCT05074498|157214029|FG002|Part 2 (Upto Day 104)|Death|0|||
48828594|NCT05074498|157214030|FG003|Part 2 (Upto Day 104)|Death|0|||
48828595|NCT05074498|157214031|FG004|Part 2 (Upto Day 104)|Death|1|||
48828596|NCT05074498|157214032|FG005|Part 2 (Upto Day 104)|Death|0|||
48828597|NCT05074498|157214027|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
48828598|NCT05074498|157214028|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
48828599|NCT05074498|157214029|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
48828600|NCT05074498|157214030|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
48828601|NCT05074498|157214031|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
48828602|NCT05074498|157214032|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
48828603|NCT05074498|157214027|FG000|Part 2 (Upto Day 104)|Other|0|||
48828604|NCT05074498|157214028|FG001|Part 2 (Upto Day 104)|Other|0|||
48828605|NCT05074498|157214029|FG002|Part 2 (Upto Day 104)|Other|0|||
48828606|NCT05074498|157214030|FG003|Part 2 (Upto Day 104)|Other|0|||
48828607|NCT05074498|157214031|FG004|Part 2 (Upto Day 104)|Other|1|||
48828608|NCT05074498|157214032|FG005|Part 2 (Upto Day 104)|Other|0|||
48828609|NCT02028884|157214033|FG000|Double-blind Period|Adverse Event|5|||
48828610|NCT02028884|157214034|FG001|Double-blind Period|Adverse Event|3|||
48828611|NCT02028884|157214035|FG002|Double-blind Period|Adverse Event|0|||
48828612|NCT02028884|157214033|FG000|Double-blind Period|Eligibility Violation|1|||
48828613|NCT02028884|157214034|FG001|Double-blind Period|Eligibility Violation|0|||
48828614|NCT02028884|157214035|FG002|Double-blind Period|Eligibility Violation|0|||
48828615|NCT02028884|157214033|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
48828616|NCT02028884|157214034|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
48828617|NCT02028884|157214035|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
48527113|NCT02190279|156122517|FG001|Overall Study|Screening failure|0|||
48527114|NCT02190279|156122518|FG002|Overall Study|Screening failure|1|||
48527115|NCT02688387|156122519|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527116|NCT02688387|156122520|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527117|NCT02688387|156122521|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
48527118|NCT02688387|156122522|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48828618|NCT02028884|157214033|FG000|Double-blind Period|Withdrawal by Subject|2|||
48828619|NCT02028884|157214034|FG001|Double-blind Period|Withdrawal by Subject|0|||
48828620|NCT02028884|157214035|FG002|Double-blind Period|Withdrawal by Subject|0|||
48828621|NCT02028884|157214033|FG000|Open-label Extension Period|Adverse Event|3|||
48828622|NCT02028884|157214034|FG001|Open-label Extension Period|Adverse Event|1|||
48828623|NCT02028884|157214035|FG002|Open-label Extension Period|Adverse Event|0|||
48828624|NCT02028884|157214033|FG000|Open-label Extension Period|Lack of Efficacy|3|||
48828625|NCT02028884|157214034|FG001|Open-label Extension Period|Lack of Efficacy|0|||
48828626|NCT02028884|157214035|FG002|Open-label Extension Period|Lack of Efficacy|0|||
48828627|NCT02028884|157214033|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
48828628|NCT02028884|157214034|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
48828629|NCT02028884|157214035|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
48828630|NCT02028884|157214033|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
48828631|NCT02028884|157214034|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
48828632|NCT02028884|157214035|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
48828633|NCT02028884|157214033|FG000|Open-label Extension Period|Switched to another treatment option|3|||
48828634|NCT02028884|157214034|FG001|Open-label Extension Period|Switched to another treatment option|0|||
48828635|NCT02028884|157214035|FG002|Open-label Extension Period|Switched to another treatment option|0|||
48828636|NCT00849147|157214038|FG000|Overall Study|Withdrawal by Subject|1|||
48828637|NCT00849147|157214038|FG000|Overall Study|Protocol Violation|2|||
48828638|NCT00849147|157214038|FG000|Overall Study|Disease Relapse/Progression|2|||
48828639|NCT01257503|157214041|FG000|Overall Study|Lost to Follow-up|7|||
48828640|NCT01257503|157214042|FG001|Overall Study|Lost to Follow-up|10|||
48828641|NCT01257503|157214041|FG000|Overall Study|Over 5 years old at enrollment|0|||
48828642|NCT01257503|157214042|FG001|Overall Study|Over 5 years old at enrollment|1|||
48828643|NCT01257503|157214041|FG000|Overall Study|strep culture positive at enrollment|1|||
48828644|NCT01257503|157214042|FG001|Overall Study|strep culture positive at enrollment|0|||
48828645|NCT03201757|157214043|FG000|Overall Study|Withdrawal by Subject|133|||
48828646|NCT03201757|157214043|FG000|Overall Study|Adverse Event|44|||
48828647|NCT03201757|157214043|FG000|Overall Study|Lost to Follow-up|37|||
48828648|NCT03201757|157214043|FG000|Overall Study|Pregnancy|2|||
48828649|NCT03201757|157214043|FG000|Overall Study|Lack of Efficacy|1|||
48828650|NCT03201757|157214043|FG000|Overall Study|Protocol Violation|20|||
48828651|NCT03201757|157214043|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
48828652|NCT03201757|157214043|FG000|Overall Study|Not Yet Determined|5|||
48828653|NCT03201757|157214043|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
48828654|NCT03201757|157214043|FG000|Overall Study|Other|20|||
48828655|NCT00495469|157214046|FG000|Overall Study|Adverse Event|0|||
48828656|NCT00495469|157214047|FG001|Overall Study|Adverse Event|1|||
48828657|NCT00495469|157214048|FG002|Overall Study|Adverse Event|3|||
48828658|NCT00495469|157214049|FG003|Overall Study|Adverse Event|0|||
48828659|NCT00495469|157214050|FG004|Overall Study|Adverse Event|1|||
48828660|NCT00495469|157214051|FG005|Overall Study|Adverse Event|1|||
48828661|NCT00495469|157214052|FG006|Overall Study|Adverse Event|1|||
48828662|NCT00495469|157214046|FG000|Overall Study|Lost to Follow-up|1|||
48828663|NCT00495469|157214047|FG001|Overall Study|Lost to Follow-up|1|||
48828664|NCT00495469|157214048|FG002|Overall Study|Lost to Follow-up|3|||
48828665|NCT00495469|157214049|FG003|Overall Study|Lost to Follow-up|1|||
48828666|NCT00495469|157214050|FG004|Overall Study|Lost to Follow-up|0|||
48828667|NCT00495469|157214051|FG005|Overall Study|Lost to Follow-up|0|||
48828668|NCT00495469|157214052|FG006|Overall Study|Lost to Follow-up|0|||
48828669|NCT00495469|157214046|FG000|Overall Study|Protocol Violation|0|||
48828670|NCT00495469|157214047|FG001|Overall Study|Protocol Violation|0|||
48828671|NCT00495469|157214048|FG002|Overall Study|Protocol Violation|0|||
48828672|NCT00495469|157214049|FG003|Overall Study|Protocol Violation|0|||
48828673|NCT00495469|157214050|FG004|Overall Study|Protocol Violation|1|||
48828674|NCT00495469|157214051|FG005|Overall Study|Protocol Violation|2|||
48828675|NCT00495469|157214052|FG006|Overall Study|Protocol Violation|0|||
48828676|NCT00495469|157214046|FG000|Overall Study|Withdrawal by Subject|5|||
48828677|NCT00495469|157214047|FG001|Overall Study|Withdrawal by Subject|3|||
48828678|NCT00495469|157214048|FG002|Overall Study|Withdrawal by Subject|1|||
48527119|NCT02688387|156122523|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48828679|NCT00495469|157214049|FG003|Overall Study|Withdrawal by Subject|3|||
48828680|NCT00495469|157214050|FG004|Overall Study|Withdrawal by Subject|3|||
48828681|NCT00495469|157214051|FG005|Overall Study|Withdrawal by Subject|2|||
48828682|NCT00495469|157214052|FG006|Overall Study|Withdrawal by Subject|3|||
48828683|NCT00495469|157214046|FG000|Overall Study|Lack of Efficacy|0|||
48828684|NCT00495469|157214047|FG001|Overall Study|Lack of Efficacy|0|||
48527120|NCT02688387|156122524|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527121|NCT02688387|156122525|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527122|NCT02688387|156122526|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527123|NCT02688387|156122527|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527124|NCT02688387|156122528|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527125|NCT02688387|156122529|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527126|NCT02688387|156122530|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527127|NCT02688387|156122531|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527128|NCT02688387|156122532|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527129|NCT02688387|156122533|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527130|NCT02688387|156122534|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527131|NCT02688387|156122535|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527132|NCT02688387|156122536|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527133|NCT02688387|156122537|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527134|NCT02688387|156122538|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527135|NCT02688387|156122539|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527136|NCT02688387|156122540|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
48527137|NCT02688387|156122519|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527138|NCT02688387|156122520|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48602192|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
48602193|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
48602194|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
48602195|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
48602196|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
48602197|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
48602198|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
48602199|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
48602200|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
48602201|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
48602202|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
48602203|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
48602204|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
48602205|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
48602206|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
48735498|NCT00631696|156883643|FG001|Overall Study|Other|8|||
48735499|NCT00631696|156883642|FG000|Overall Study|Protocol Violation|9|||
48735500|NCT00631696|156883643|FG001|Overall Study|Protocol Violation|9|||
48735501|NCT00631696|156883642|FG000|Overall Study|Study terminated by sponsor|3|||
48735502|NCT00631696|156883643|FG001|Overall Study|Study terminated by sponsor|3|||
48735503|NCT00631696|156883642|FG000|Overall Study|Adverse Event|5|||
48735504|NCT00631696|156883643|FG001|Overall Study|Adverse Event|0|||
48735505|NCT01160211|156883644|FG000|Overall Study|ongoing|90|||
48735506|NCT01160211|156883645|FG001|Overall Study|ongoing|75|||
48735507|NCT01160211|156883646|FG002|Overall Study|ongoing|79|||
48735508|NCT01160211|156883644|FG000|Overall Study|Withdrawal by Subject|3|||
48735509|NCT01160211|156883645|FG001|Overall Study|Withdrawal by Subject|5|||
48735510|NCT01160211|156883646|FG002|Overall Study|Withdrawal by Subject|3|||
48735511|NCT01160211|156883644|FG000|Overall Study|Physician Decision|2|||
48735512|NCT01160211|156883645|FG001|Overall Study|Physician Decision|0|||
48735513|NCT01160211|156883646|FG002|Overall Study|Physician Decision|0|||
48735514|NCT01160211|156883644|FG000|Overall Study|Lost to Follow-up|4|||
48735515|NCT01160211|156883645|FG001|Overall Study|Lost to Follow-up|7|||
48735516|NCT01160211|156883646|FG002|Overall Study|Lost to Follow-up|5|||
48735517|NCT00676338|156883647|FG000|Overall Study|Adverse Event|6|||
48735518|NCT00676338|156883648|FG001|Overall Study|Adverse Event|6|||
48735519|NCT00676338|156883649|FG002|Overall Study|Adverse Event|5|||
48735520|NCT00676338|156883650|FG003|Overall Study|Adverse Event|1|||
48735521|NCT00676338|156883647|FG000|Overall Study|Lost to Follow-up|4|||
48735522|NCT00676338|156883648|FG001|Overall Study|Lost to Follow-up|1|||
48735523|NCT00676338|156883649|FG002|Overall Study|Lost to Follow-up|3|||
48735524|NCT00676338|156883650|FG003|Overall Study|Lost to Follow-up|4|||
48735525|NCT00676338|156883647|FG000|Overall Study|Physician Decision|3|||
48735526|NCT00676338|156883648|FG001|Overall Study|Physician Decision|3|||
48735527|NCT00676338|156883649|FG002|Overall Study|Physician Decision|2|||
48735528|NCT00676338|156883650|FG003|Overall Study|Physician Decision|3|||
48735529|NCT00676338|156883647|FG000|Overall Study|Protocol Violation|5|||
48735530|NCT00676338|156883648|FG001|Overall Study|Protocol Violation|9|||
48527139|NCT02688387|156122521|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527140|NCT02688387|156122522|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
48527141|NCT02688387|156122523|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48735531|NCT00676338|156883649|FG002|Overall Study|Protocol Violation|2|||
48602207|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
48602208|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
48602209|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
48602210|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
48602211|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
48602212|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
48602213|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
48602214|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
48602215|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
48602216|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
48602217|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
48602218|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
48602219|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
48602220|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
48828685|NCT00495469|157214048|FG002|Overall Study|Lack of Efficacy|0|||
48828686|NCT00495469|157214049|FG003|Overall Study|Lack of Efficacy|0|||
48828687|NCT00495469|157214050|FG004|Overall Study|Lack of Efficacy|0|||
48828688|NCT00495469|157214051|FG005|Overall Study|Lack of Efficacy|0|||
48828689|NCT00495469|157214052|FG006|Overall Study|Lack of Efficacy|1|||
48828690|NCT00495469|157214046|FG000|Overall Study|Liver function test abnormality|0|||
48828691|NCT00495469|157214047|FG001|Overall Study|Liver function test abnormality|1|||
48828692|NCT00495469|157214048|FG002|Overall Study|Liver function test abnormality|0|||
48828693|NCT00495469|157214049|FG003|Overall Study|Liver function test abnormality|0|||
48828694|NCT00495469|157214050|FG004|Overall Study|Liver function test abnormality|0|||
48828695|NCT00495469|157214051|FG005|Overall Study|Liver function test abnormality|0|||
48828696|NCT00495469|157214052|FG006|Overall Study|Liver function test abnormality|0|||
48828697|NCT00495469|157214046|FG000|Overall Study|ST depression at randomisation in ECG|0|||
48828698|NCT00495469|157214047|FG001|Overall Study|ST depression at randomisation in ECG|1|||
48828699|NCT00495469|157214048|FG002|Overall Study|ST depression at randomisation in ECG|0|||
48828700|NCT00495469|157214049|FG003|Overall Study|ST depression at randomisation in ECG|0|||
48828701|NCT00495469|157214050|FG004|Overall Study|ST depression at randomisation in ECG|0|||
48828702|NCT00495469|157214051|FG005|Overall Study|ST depression at randomisation in ECG|0|||
48828703|NCT00495469|157214052|FG006|Overall Study|ST depression at randomisation in ECG|0|||
48828704|NCT01390857|157214053|FG000|Overall Study|Protocol Violation|2|||
48828705|NCT01390857|157214053|FG000|Overall Study|Lost to Follow-up|1|||
48828706|NCT01390857|157214053|FG000|Overall Study|No Visit after the First Visit|7|||
48602221|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
48602222|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
48602223|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
48602224|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
48602225|NCT01791595|156399527|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
48602226|NCT01791595|156399528|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
48602227|NCT01791595|156399529|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
48602228|NCT01791595|156399530|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
48602229|NCT01791595|156399531|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
48602230|NCT01791595|156399532|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
48602231|NCT01791595|156399533|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
48602232|NCT01791595|156399527|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
48602233|NCT01791595|156399528|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
48828707|NCT00603447|157214054|FG000|Overall Study|Adverse Event|0|||
48828708|NCT00603447|157214055|FG001|Overall Study|Adverse Event|1|||
48828709|NCT00603447|157214056|FG002|Overall Study|Adverse Event|1|||
48828710|NCT00603447|157214057|FG003|Overall Study|Adverse Event|2|||
48828711|NCT00603447|157214058|FG004|Overall Study|Adverse Event|1|||
48828712|NCT00603447|157214059|FG005|Overall Study|Adverse Event|2|||
48828713|NCT00603447|157214060|FG006|Overall Study|Adverse Event|10|||
48828714|NCT00603447|157214054|FG000|Overall Study|Other|0|||
48828715|NCT00603447|157214055|FG001|Overall Study|Other|0|||
48828716|NCT00603447|157214056|FG002|Overall Study|Other|1|||
48828717|NCT00603447|157214057|FG003|Overall Study|Other|0|||
48828718|NCT00603447|157214058|FG004|Overall Study|Other|3|||
48828719|NCT00603447|157214059|FG005|Overall Study|Other|0|||
48828720|NCT00603447|157214060|FG006|Overall Study|Other|13|||
48828721|NCT00603447|157214054|FG000|Overall Study|Withdrew Consent|0|||
48828722|NCT00603447|157214055|FG001|Overall Study|Withdrew Consent|2|||
48828723|NCT00603447|157214056|FG002|Overall Study|Withdrew Consent|0|||
48828724|NCT00603447|157214057|FG003|Overall Study|Withdrew Consent|0|||
48828725|NCT00603447|157214058|FG004|Overall Study|Withdrew Consent|1|||
48828726|NCT00603447|157214059|FG005|Overall Study|Withdrew Consent|0|||
48828727|NCT00603447|157214060|FG006|Overall Study|Withdrew Consent|1|||
48828728|NCT01123161|157214061|FG000|Overall Study|Lost to Follow-up|1|||
48828729|NCT01123161|157214062|FG001|Overall Study|Lost to Follow-up|0|||
48828730|NCT01123161|157214061|FG000|Overall Study|Withdrawal by Subject|1|||
48828731|NCT01123161|157214062|FG001|Overall Study|Withdrawal by Subject|0|||
48828732|NCT03085017|157214067|FG000|Overall Study|Death|0|||
48828733|NCT03085017|157214068|FG001|Overall Study|Death|3|||
48828734|NCT01268891|157214071|FG000|Overall Study|Adverse Event|3|||
48527142|NCT02688387|156122524|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527143|NCT02688387|156122525|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527144|NCT02688387|156122526|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527145|NCT02688387|156122527|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527146|NCT02688387|156122528|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48602234|NCT01791595|156399529|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
48602235|NCT01791595|156399530|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
48602236|NCT01791595|156399531|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
48602237|NCT01791595|156399532|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
48828735|NCT01268891|157214072|FG001|Overall Study|Adverse Event|7|||
48828736|NCT01268891|157214071|FG000|Overall Study|Lack of Efficacy|1|||
48828737|NCT01268891|157214072|FG001|Overall Study|Lack of Efficacy|0|||
48527147|NCT02688387|156122529|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527148|NCT02688387|156122530|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527149|NCT02688387|156122531|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527150|NCT02688387|156122532|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527151|NCT02688387|156122533|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527152|NCT02688387|156122534|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527153|NCT02688387|156122535|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48828738|NCT01268891|157214071|FG000|Overall Study|Withdrawal of Consent|3|||
48828739|NCT01268891|157214072|FG001|Overall Study|Withdrawal of Consent|1|||
48828740|NCT01268891|157214071|FG000|Overall Study|Administrative or other reason(s)|1|||
48828741|NCT01268891|157214072|FG001|Overall Study|Administrative or other reason(s)|0|||
48828742|NCT03255018|157214075|FG000|Overall Study|Death on study|0|||
48527154|NCT02688387|156122536|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48828743|NCT03255018|157214076|FG001|Overall Study|Death on study|5|||
48828744|NCT03255018|157214075|FG000|Overall Study|Withdrawal by Subject|0|||
48828745|NCT03255018|157214076|FG001|Overall Study|Withdrawal by Subject|2|||
48828746|NCT04759131|157214077|FG000|Overall Study|Investigator's discretion|1|||
48527155|NCT02688387|156122537|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527156|NCT02688387|156122538|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527157|NCT02688387|156122539|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527158|NCT02688387|156122540|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527159|NCT02688387|156122519|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527160|NCT02688387|156122520|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
48527161|NCT02688387|156122521|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527162|NCT02688387|156122522|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48602238|NCT01791595|156399533|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
48602239|NCT01791595|156399527|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
48828747|NCT04759131|157214078|FG001|Overall Study|Investigator's discretion|0|||
48828748|NCT04759131|157214077|FG000|Overall Study|Subject withdrawal|1|||
48828749|NCT04759131|157214078|FG001|Overall Study|Subject withdrawal|0|||
48828750|NCT01124162|157214079|FG000|First Intervention|Adverse Event|2|||
48828751|NCT01124162|157214080|FG001|First Intervention|Adverse Event|0|||
48828752|NCT01124162|157214079|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48828753|NCT01124162|157214080|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48602240|NCT01791595|156399528|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
48602241|NCT01791595|156399529|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
48602242|NCT01791595|156399530|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
48602243|NCT01791595|156399531|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
48602244|NCT01791595|156399532|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
48602245|NCT01791595|156399533|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
48602246|NCT01791595|156399527|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48602247|NCT01791595|156399528|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48602248|NCT01791595|156399529|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48602249|NCT01791595|156399530|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48602250|NCT01791595|156399531|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48602251|NCT01791595|156399532|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
48828754|NCT01360840|157214083|FG000|Overall Study|Ongoing at data cut-off|10|||
48602252|NCT01791595|156399533|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
48602253|NCT01791595|156399527|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
48828755|NCT01360840|157214084|FG001|Overall Study|Ongoing at data cut-off|10|||
48828756|NCT01360840|157214085|FG002|Overall Study|Ongoing at data cut-off|9|||
48828757|NCT02846415|157214087|FG000|Overall Study|Lost to Follow-up|2|||
48828758|NCT02846415|157214088|FG001|Overall Study|Lost to Follow-up|0|||
48828759|NCT02846415|157214087|FG000|Overall Study|Withdrawal by Subject|1|||
48828760|NCT02846415|157214088|FG001|Overall Study|Withdrawal by Subject|1|||
48828761|NCT03736785|157214089|FG000|Overall Study|Adverse Event|1|||
48828762|NCT03736785|157214090|FG001|Overall Study|Adverse Event|1|||
48828763|NCT03736785|157214091|FG002|Overall Study|Adverse Event|1|||
48828764|NCT03736785|157214089|FG000|Overall Study|Death|1|||
48828765|NCT03736785|157214090|FG001|Overall Study|Death|0|||
48828766|NCT03736785|157214091|FG002|Overall Study|Death|1|||
48828767|NCT03736785|157214089|FG000|Overall Study|Lost to Follow-up|0|||
48828768|NCT03736785|157214090|FG001|Overall Study|Lost to Follow-up|2|||
48828769|NCT03736785|157214091|FG002|Overall Study|Lost to Follow-up|3|||
48828770|NCT03736785|157214089|FG000|Overall Study|Non compliance with study drug|1|||
48828771|NCT03736785|157214090|FG001|Overall Study|Non compliance with study drug|1|||
48828772|NCT03736785|157214091|FG002|Overall Study|Non compliance with study drug|0|||
48828773|NCT03736785|157214089|FG000|Overall Study|Physician Decision|0|||
48828774|NCT03736785|157214090|FG001|Overall Study|Physician Decision|1|||
48828775|NCT03736785|157214091|FG002|Overall Study|Physician Decision|1|||
48527163|NCT02688387|156122523|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527164|NCT02688387|156122524|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527165|NCT02688387|156122525|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527166|NCT02688387|156122526|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527167|NCT02688387|156122527|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527168|NCT02688387|156122528|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527169|NCT02688387|156122529|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527170|NCT02688387|156122530|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527171|NCT02688387|156122531|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527172|NCT02688387|156122532|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527173|NCT02688387|156122533|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527174|NCT02688387|156122534|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527175|NCT02688387|156122535|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527176|NCT02688387|156122536|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527177|NCT02688387|156122537|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527178|NCT02688387|156122538|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527179|NCT02688387|156122539|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527180|NCT02688387|156122540|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
48527181|NCT02688387|156122519|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527182|NCT02688387|156122520|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527183|NCT02688387|156122521|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
48527184|NCT02688387|156122522|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527185|NCT02688387|156122523|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
48527186|NCT02688387|156122524|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527187|NCT02688387|156122525|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527188|NCT02688387|156122526|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48602254|NCT01791595|156399528|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
48602255|NCT01791595|156399529|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
48602256|NCT01791595|156399530|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
48828776|NCT03736785|157214089|FG000|Overall Study|Protocol Violation|1|||
48828777|NCT03736785|157214090|FG001|Overall Study|Protocol Violation|4|||
48828778|NCT03736785|157214091|FG002|Overall Study|Protocol Violation|3|||
48828779|NCT03736785|157214089|FG000|Overall Study|Sponsor Decision|1|||
48828780|NCT03736785|157214090|FG001|Overall Study|Sponsor Decision|0|||
48828781|NCT03736785|157214091|FG002|Overall Study|Sponsor Decision|0|||
48828782|NCT03736785|157214089|FG000|Overall Study|Unknown/Missing data|3|||
48828783|NCT03736785|157214090|FG001|Overall Study|Unknown/Missing data|2|||
48828784|NCT03736785|157214091|FG002|Overall Study|Unknown/Missing data|1|||
48828785|NCT03736785|157214089|FG000|Overall Study|Withdrawal by Subject|9|||
48828786|NCT03736785|157214090|FG001|Overall Study|Withdrawal by Subject|6|||
48828787|NCT03736785|157214091|FG002|Overall Study|Withdrawal by Subject|4|||
48828788|NCT01744691|157214092|FG000|Overall Study|Progressive Disease|18|||
48828789|NCT01744691|157214092|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
48527189|NCT02688387|156122527|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527190|NCT02688387|156122528|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527191|NCT02688387|156122529|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527192|NCT02688387|156122530|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527193|NCT02688387|156122531|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527194|NCT02688387|156122532|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527195|NCT02688387|156122533|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527196|NCT02688387|156122534|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527197|NCT02688387|156122535|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48735532|NCT00676338|156883650|FG003|Overall Study|Protocol Violation|5|||
48735533|NCT00676338|156883647|FG000|Overall Study|Withdrawal by Subject|17|||
48735534|NCT00676338|156883648|FG001|Overall Study|Withdrawal by Subject|9|||
48735535|NCT00676338|156883649|FG002|Overall Study|Withdrawal by Subject|12|||
48735536|NCT00676338|156883650|FG003|Overall Study|Withdrawal by Subject|6|||
48735537|NCT00676338|156883647|FG000|Overall Study|Entry Criteria Not Met|0|||
48735538|NCT00676338|156883648|FG001|Overall Study|Entry Criteria Not Met|2|||
48735539|NCT00676338|156883649|FG002|Overall Study|Entry Criteria Not Met|1|||
48735540|NCT00676338|156883650|FG003|Overall Study|Entry Criteria Not Met|1|||
48735541|NCT00676338|156883647|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
48735542|NCT00676338|156883648|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
48735543|NCT00676338|156883649|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
48735544|NCT00676338|156883650|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
48735545|NCT00697788|156883651|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735546|NCT00697788|156883652|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
48735547|NCT00697788|156883653|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735548|NCT00697788|156883654|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735549|NCT00697788|156883655|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735550|NCT00697788|156883656|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48735551|NCT00697788|156883657|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48527198|NCT02688387|156122536|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527199|NCT02688387|156122537|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527200|NCT02688387|156122538|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527201|NCT02688387|156122539|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527202|NCT02688387|156122540|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
48527203|NCT02688387|156122519|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
48527204|NCT02688387|156122520|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527205|NCT02688387|156122521|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527206|NCT02688387|156122522|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527207|NCT02688387|156122523|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527208|NCT02688387|156122524|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527209|NCT02688387|156122525|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48602257|NCT01791595|156399531|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
48602258|NCT01791595|156399532|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
48602259|NCT01791595|156399533|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
48828790|NCT01744691|157214092|FG000|Overall Study|Withdrawal of consent for treatment|3|||
48828791|NCT01744691|157214092|FG000|Overall Study|Physician Decision|4|||
48828792|NCT02095158|157214094|FG000|Overall Study|Adverse Event|14|||
48828793|NCT02095158|157214094|FG000|Overall Study|Lack of Efficacy|3|||
48828794|NCT02095158|157214094|FG000|Overall Study|Pregnancy|1|||
48828795|NCT02095158|157214094|FG000|Overall Study|Lost to Follow-up|20|||
48828796|NCT02095158|157214094|FG000|Overall Study|Personal Reasons|35|||
48828797|NCT02095158|157214094|FG000|Overall Study|Protocol Violation|1|||
48828798|NCT02095158|157214094|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48828799|NCT04555044|157214095|FG000|Overall Study|Adverse Event|0|||
48828800|NCT04555044|157214096|FG001|Overall Study|Adverse Event|1|||
48828801|NCT00542386|157214101|FG000|Overall Study|Adverse Event|1|||
48828802|NCT00542386|157214102|FG001|Overall Study|Adverse Event|7|||
48828803|NCT00542386|157214103|FG002|Overall Study|Adverse Event|7|||
48828804|NCT00542386|157214104|FG003|Overall Study|Adverse Event|8|||
48828805|NCT00542386|157214105|FG004|Overall Study|Adverse Event|13|||
48828806|NCT00542386|157214106|FG005|Overall Study|Adverse Event|4|||
48828807|NCT00542386|157214101|FG000|Overall Study|Death|0|||
48828808|NCT00542386|157214102|FG001|Overall Study|Death|0|||
48828809|NCT00542386|157214103|FG002|Overall Study|Death|1|||
48828810|NCT00542386|157214104|FG003|Overall Study|Death|2|||
48828811|NCT00542386|157214105|FG004|Overall Study|Death|1|||
48828812|NCT00542386|157214106|FG005|Overall Study|Death|2|||
48828813|NCT00542386|157214101|FG000|Overall Study|Lack of Efficacy|32|||
48828814|NCT00542386|157214102|FG001|Overall Study|Lack of Efficacy|12|||
48527210|NCT02688387|156122526|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527211|NCT02688387|156122527|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527212|NCT02688387|156122528|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527213|NCT02688387|156122529|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527214|NCT02688387|156122530|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527215|NCT02688387|156122531|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527216|NCT02688387|156122532|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527217|NCT02688387|156122533|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527218|NCT02688387|156122534|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527219|NCT02688387|156122535|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527220|NCT02688387|156122536|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527221|NCT02688387|156122537|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527222|NCT02688387|156122538|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527223|NCT02688387|156122539|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527224|NCT02688387|156122540|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
48527225|NCT02688387|156122519|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527226|NCT02688387|156122520|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527227|NCT02688387|156122521|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527228|NCT02688387|156122522|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527229|NCT02688387|156122523|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527230|NCT02688387|156122524|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527231|NCT02688387|156122525|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527232|NCT02688387|156122526|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527233|NCT02688387|156122527|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48602260|NCT02287038|156399537|FG000|Overall Study|Stopped attending appointments|3|||
48828815|NCT00542386|157214103|FG002|Overall Study|Lack of Efficacy|10|||
48828816|NCT00542386|157214104|FG003|Overall Study|Lack of Efficacy|13|||
48828817|NCT00542386|157214105|FG004|Overall Study|Lack of Efficacy|7|||
48828818|NCT00542386|157214106|FG005|Overall Study|Lack of Efficacy|31|||
48828819|NCT00542386|157214101|FG000|Overall Study|Physician Decision|1|||
48828820|NCT00542386|157214102|FG001|Overall Study|Physician Decision|0|||
48527234|NCT02688387|156122528|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527235|NCT02688387|156122529|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
48527236|NCT02688387|156122530|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527237|NCT02688387|156122531|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527238|NCT02688387|156122532|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527239|NCT02688387|156122533|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527240|NCT02688387|156122534|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527241|NCT02688387|156122535|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527242|NCT02688387|156122536|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527243|NCT02688387|156122537|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527244|NCT02688387|156122538|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527245|NCT02688387|156122539|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527246|NCT02688387|156122540|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
48527247|NCT02688387|156122519|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527248|NCT02688387|156122520|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527249|NCT02688387|156122521|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527250|NCT02688387|156122522|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527251|NCT02688387|156122523|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527252|NCT02688387|156122524|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527253|NCT02688387|156122525|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527254|NCT02688387|156122526|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527255|NCT02688387|156122527|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527256|NCT02688387|156122528|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527257|NCT02688387|156122529|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527258|NCT02688387|156122530|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527259|NCT02688387|156122531|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527260|NCT02688387|156122532|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48602261|NCT02287038|156399538|FG001|Overall Study|Stopped attending appointments|2|||
48828821|NCT00542386|157214103|FG002|Overall Study|Physician Decision|0|||
48828822|NCT00542386|157214104|FG003|Overall Study|Physician Decision|1|||
48828823|NCT00542386|157214105|FG004|Overall Study|Physician Decision|0|||
48828824|NCT00542386|157214106|FG005|Overall Study|Physician Decision|0|||
48828825|NCT00542386|157214101|FG000|Overall Study|Protocol Violation|0|||
48828826|NCT00542386|157214102|FG001|Overall Study|Protocol Violation|0|||
48828827|NCT00542386|157214103|FG002|Overall Study|Protocol Violation|1|||
48828828|NCT00542386|157214104|FG003|Overall Study|Protocol Violation|0|||
48828829|NCT00542386|157214105|FG004|Overall Study|Protocol Violation|0|||
48828830|NCT00542386|157214106|FG005|Overall Study|Protocol Violation|4|||
48828831|NCT00542386|157214101|FG000|Overall Study|Withdrawal by Subject|5|||
48828832|NCT00542386|157214102|FG001|Overall Study|Withdrawal by Subject|8|||
48527261|NCT02688387|156122533|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
48527262|NCT02688387|156122534|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527263|NCT02688387|156122535|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527264|NCT02688387|156122536|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527265|NCT02688387|156122537|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527266|NCT02688387|156122538|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527267|NCT02688387|156122539|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527268|NCT02688387|156122540|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
48527269|NCT02688387|156122519|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527270|NCT02688387|156122520|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527271|NCT02688387|156122521|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527272|NCT02688387|156122522|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527273|NCT02688387|156122523|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527274|NCT02688387|156122524|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527275|NCT02688387|156122525|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527276|NCT02688387|156122526|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527277|NCT02688387|156122527|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527278|NCT02688387|156122528|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48444644|NCT01250756|155815124|FG000|Toddler Dose|Adverse Event|0|||
48444645|NCT01250756|155815125|FG001|Toddler Dose|Adverse Event|1|||
48444646|NCT01250756|155815124|FG000|After Toddler Dose|Adverse Event|0|||
48444647|NCT01250756|155815125|FG001|After Toddler Dose|Adverse Event|1|||
48444648|NCT04294095|155815128|FG000|Overall Study|Adverse Event|1|||
48444649|NCT04294095|155815129|FG001|Overall Study|Adverse Event|0|||
48444650|NCT02674685|155815130|FG000|Overall Study|Withdrawal by Subject|4|||
48444651|NCT02148211|155815133|FG000|Overall Study|Lost to Follow-up|352|||
48444652|NCT04126031|155815136|FG000|Part A|Withdrawal by Subject|0|||
48444653|NCT04126031|155815137|FG001|Part A|Withdrawal by Subject|0|||
48444654|NCT04126031|155815138|FG002|Part A|Withdrawal by Subject|1|||
48444655|NCT04126031|155815139|FG003|Part A|Withdrawal by Subject|0|||
48444656|NCT04126031|155815140|FG004|Part A|Withdrawal by Subject|0|||
48444657|NCT04126031|155815141|FG005|Part A|Withdrawal by Subject|0|||
48444658|NCT04126031|155815136|FG000|Part A|Other|1|||
48444659|NCT04126031|155815137|FG001|Part A|Other|0|||
48444660|NCT04126031|155815138|FG002|Part A|Other|0|||
48444661|NCT04126031|155815139|FG003|Part A|Other|0|||
48444662|NCT04126031|155815140|FG004|Part A|Other|0|||
48444663|NCT04126031|155815141|FG005|Part A|Other|0|||
48444664|NCT04126031|155815136|FG000|Part B|Adverse Event|0|||
48444665|NCT04126031|155815137|FG001|Part B|Adverse Event|0|||
48444666|NCT04126031|155815138|FG002|Part B|Adverse Event|0|||
48444667|NCT04126031|155815139|FG003|Part B|Adverse Event|0|||
48444668|NCT04126031|155815140|FG004|Part B|Adverse Event|0|||
48444669|NCT04126031|155815141|FG005|Part B|Adverse Event|2|||
48444670|NCT04126031|155815136|FG000|Part B|Pre-existing hypertransaminasemia|0|||
48444671|NCT04126031|155815137|FG001|Part B|Pre-existing hypertransaminasemia|0|||
48444672|NCT04126031|155815138|FG002|Part B|Pre-existing hypertransaminasemia|0|||
48444673|NCT04126031|155815139|FG003|Part B|Pre-existing hypertransaminasemia|0|||
48444674|NCT04126031|155815140|FG004|Part B|Pre-existing hypertransaminasemia|1|||
48444675|NCT04126031|155815141|FG005|Part B|Pre-existing hypertransaminasemia|0|||
48444676|NCT02713789|155815142|FG000|Overall Study|Lost to Follow-up|0|||
48444677|NCT02713789|155815143|FG001|Overall Study|Lost to Follow-up|1|||
48444678|NCT02713789|155815144|FG002|Overall Study|Lost to Follow-up|1|||
48444679|NCT01410799|155815145|FG000|Overall Study|PI decision|13|||
48444680|NCT02017899|155815147|FG000|Overall Study|Withdrawal by Subject|0|||
48444681|NCT02017899|155815148|FG001|Overall Study|Withdrawal by Subject|0|||
48444682|NCT02017899|155815149|FG002|Overall Study|Withdrawal by Subject|0|||
48444683|NCT02017899|155815150|FG003|Overall Study|Withdrawal by Subject|1|||
48444684|NCT02017899|155815151|FG004|Overall Study|Withdrawal by Subject|1|||
48444685|NCT02017899|155815152|FG005|Overall Study|Withdrawal by Subject|0|||
48444686|NCT02999100|155815153|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
48444687|NCT02999100|155815154|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
48444688|NCT02999100|155815155|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
48444689|NCT02999100|155815156|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
48444690|NCT02999100|155815157|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
48444691|NCT02999100|155815158|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
48444692|NCT02999100|155815153|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48444693|NCT02999100|155815154|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48444694|NCT02999100|155815155|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48444695|NCT02999100|155815156|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48444696|NCT02999100|155815157|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
48444697|NCT02999100|155815158|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
48444698|NCT02999100|155815153|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48828833|NCT00542386|157214103|FG002|Overall Study|Withdrawal by Subject|10|||
48828834|NCT00542386|157214104|FG003|Overall Study|Withdrawal by Subject|11|||
48828835|NCT00542386|157214105|FG004|Overall Study|Withdrawal by Subject|15|||
48828836|NCT00542386|157214106|FG005|Overall Study|Withdrawal by Subject|7|||
48527279|NCT02688387|156122529|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527280|NCT02688387|156122530|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527281|NCT02688387|156122531|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527282|NCT02688387|156122532|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527283|NCT02688387|156122533|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527284|NCT02688387|156122534|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527285|NCT02688387|156122535|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527286|NCT02688387|156122536|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527287|NCT02688387|156122537|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527288|NCT02688387|156122538|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527289|NCT02688387|156122539|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
48527290|NCT02688387|156122540|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
48527291|NCT02688387|156122519|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527292|NCT02688387|156122520|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527293|NCT02688387|156122521|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527294|NCT02688387|156122522|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527295|NCT02688387|156122523|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527296|NCT02688387|156122524|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527297|NCT02688387|156122525|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527298|NCT02688387|156122526|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527299|NCT02688387|156122527|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527300|NCT02688387|156122528|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527301|NCT02688387|156122529|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527302|NCT02688387|156122530|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527303|NCT02688387|156122531|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527304|NCT02688387|156122532|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527305|NCT02688387|156122533|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527306|NCT02688387|156122534|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48828837|NCT00542386|157214101|FG000|Overall Study|Other Reasons|4|||
48828838|NCT00542386|157214102|FG001|Overall Study|Other Reasons|1|||
48828839|NCT00542386|157214103|FG002|Overall Study|Other Reasons|4|||
48828840|NCT00542386|157214104|FG003|Overall Study|Other Reasons|3|||
48828841|NCT00542386|157214105|FG004|Overall Study|Other Reasons|4|||
48828842|NCT00542386|157214106|FG005|Overall Study|Other Reasons|2|||
48828843|NCT01839877|157214113|FG000|Overall Study|Protocol Violation|1|||
48828844|NCT03593070|157214114|FG000|Overall Study|administrative withdrawal|1|||
48828845|NCT03593070|157214115|FG001|Overall Study|administrative withdrawal|1|||
48828846|NCT03643211|157214116|FG000|Overall Study|Contract violation/deficiency|12|||
48828847|NCT03643211|157214116|FG000|Overall Study|Invalid registration|3|||
48828848|NCT03643211|157214116|FG000|Overall Study|No treatment information|2|||
48828849|NCT03643211|157214116|FG000|Overall Study|No adverse event information - No revisit|4|||
48828850|NCT02197234|157214121|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
48828851|NCT02197234|157214121|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
48828852|NCT02197234|157214121|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
48527307|NCT02688387|156122535|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48828853|NCT02197234|157214121|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
48527308|NCT02688387|156122536|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527309|NCT02688387|156122537|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
48527310|NCT02688387|156122538|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527311|NCT02688387|156122539|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
48828854|NCT02197234|157214121|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
48828855|NCT02197234|157214121|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
48828856|NCT01740557|157214123|FG000|Overall Study|Ineligible|1|||
48828857|NCT01740557|157214123|FG000|Overall Study|Screen failure|1|||
48828858|NCT05826431|157214124|FG000|Overall Study|Withdrawal by Subject|1|||
48828859|NCT01913340|157214125|FG000|Overall Study|Death|2|||
48828860|NCT01913340|157214126|FG001|Overall Study|Death|5|||
48828861|NCT01913340|157214125|FG000|Overall Study|Lost to Follow-up|1|||
48828862|NCT01913340|157214126|FG001|Overall Study|Lost to Follow-up|1|||
48828863|NCT01823341|157214127|FG000|Overall Study|Failed run-in|7|||
48828864|NCT01823341|157214127|FG000|Overall Study|Withdrawal by Subject|7|||
48828865|NCT01823341|157214127|FG000|Overall Study|Adverse Event|1|||
48828866|NCT00751036|157214128|FG000|Overall Study|Disease Progression|28|||
48828867|NCT00751036|157214129|FG001|Overall Study|Disease Progression|29|||
48828868|NCT00751036|157214128|FG000|Overall Study|Adverse Event|6|||
48828869|NCT00751036|157214129|FG001|Overall Study|Adverse Event|4|||
48828870|NCT00751036|157214128|FG000|Overall Study|Administrative Problems|3|||
48828871|NCT00751036|157214129|FG001|Overall Study|Administrative Problems|4|||
48828872|NCT00751036|157214128|FG000|Overall Study|Withdrawal by Subject|5|||
48828873|NCT00751036|157214129|FG001|Overall Study|Withdrawal by Subject|2|||
48828874|NCT00751036|157214128|FG000|Overall Study|Death|3|||
48828875|NCT00751036|157214129|FG001|Overall Study|Death|3|||
48828876|NCT00751036|157214128|FG000|Overall Study|Lost to Follow-up|0|||
48828877|NCT00751036|157214129|FG001|Overall Study|Lost to Follow-up|1|||
48828878|NCT00751036|157214128|FG000|Overall Study|Protocol Violation|1|||
48828879|NCT00751036|157214129|FG001|Overall Study|Protocol Violation|0|||
48828880|NCT00751036|157214128|FG000|Overall Study|Missing end of Treatment Page|2|||
48828881|NCT00751036|157214129|FG001|Overall Study|Missing end of Treatment Page|3|||
48828882|NCT04248829|157214130|FG000|Overall Study|Disease progression|44|||
48828883|NCT04248829|157214131|FG001|Overall Study|Disease progression|109|||
48828884|NCT04248829|157214130|FG000|Overall Study|Adverse Event|19|||
48828885|NCT04248829|157214131|FG001|Overall Study|Adverse Event|18|||
48828886|NCT04248829|157214130|FG000|Overall Study|Withdrawal by Subject|11|||
48828887|NCT04248829|157214131|FG001|Overall Study|Withdrawal by Subject|2|||
48828888|NCT04248829|157214130|FG000|Overall Study|Lost to Follow-up|0|||
48828889|NCT04248829|157214131|FG001|Overall Study|Lost to Follow-up|1|||
48828890|NCT04248829|157214130|FG000|Overall Study|Death|12|||
48828891|NCT04248829|157214131|FG001|Overall Study|Death|14|||
48828892|NCT04248829|157214130|FG000|Overall Study|Physician Decision|2|||
48828893|NCT04248829|157214131|FG001|Overall Study|Physician Decision|4|||
48828894|NCT04248829|157214130|FG000|Overall Study|Any reason not specifically recorded|0|||
48828895|NCT04248829|157214131|FG001|Overall Study|Any reason not specifically recorded|2|||
48828896|NCT05460663|157214132|FG000|Overall Study|Withdrawal by Subject|2|||
48828897|NCT05460663|157214133|FG001|Overall Study|Withdrawal by Subject|5|||
48828898|NCT01867580|157214134|FG000|Overall Study|Withdrawal by Subject|2|||
48828899|NCT01867580|157214135|FG001|Overall Study|Withdrawal by Subject|3|||
48527312|NCT02688387|156122540|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
48527313|NCT02688387|156122519|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527314|NCT02688387|156122520|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527315|NCT02688387|156122521|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527316|NCT02688387|156122522|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527317|NCT02688387|156122523|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527318|NCT02688387|156122524|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527319|NCT02688387|156122525|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527320|NCT02688387|156122526|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527321|NCT02688387|156122527|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527322|NCT02688387|156122528|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527323|NCT02688387|156122529|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527324|NCT02688387|156122530|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527325|NCT02688387|156122531|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527326|NCT02688387|156122532|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527327|NCT02688387|156122533|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527328|NCT02688387|156122534|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527329|NCT02688387|156122535|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527330|NCT02688387|156122536|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48828900|NCT01867580|157214134|FG000|Overall Study|Physician Decision|17|||
48828901|NCT01867580|157214135|FG001|Overall Study|Physician Decision|12|||
48828902|NCT01867580|157214134|FG000|Overall Study|Lost to Follow-up|3|||
48828903|NCT01867580|157214135|FG001|Overall Study|Lost to Follow-up|5|||
48828904|NCT01867580|157214134|FG000|Overall Study|Sponsor terminated study|1|||
48527331|NCT02688387|156122537|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527332|NCT02688387|156122538|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
48527333|NCT02688387|156122539|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527334|NCT02688387|156122540|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
48527335|NCT00493779|156122541|FG000|Overall Study|Logistical issue at site|1|||
48527336|NCT00895037|156122542|FG000|Overall Study|Death|0|||
48527337|NCT00895037|156122543|FG001|Overall Study|Death|2|||
48527338|NCT00895037|156122544|FG002|Overall Study|Death|1|||
48527339|NCT04403399|156122545|FG000|Period 2|Physician Decision|0|||
48527340|NCT04403399|156122546|FG001|Period 2|Physician Decision|1|||
48527341|NCT00802178|156122548|FG000|Overall Study|Lack of Efficacy|36|||
48527342|NCT00802178|156122548|FG000|Overall Study|Insufficient tolerability (IT)|17|||
48527343|NCT00802178|156122548|FG000|Overall Study|Withdrawal by Subject|18|||
48527344|NCT00802178|156122548|FG000|Overall Study|Other|32|||
48527345|NCT00802178|156122548|FG000|Overall Study|Lack of efficacy and patient wish|1|||
48527346|NCT00802178|156122548|FG000|Overall Study|IT and patient wish|8|||
48527347|NCT00802178|156122548|FG000|Overall Study|Patients wish and other reason|1|||
48828905|NCT01867580|157214135|FG001|Overall Study|Sponsor terminated study|0|||
48828906|NCT01867580|157214134|FG000|Overall Study|Missed follow-up assessment|2|||
48828907|NCT01867580|157214135|FG001|Overall Study|Missed follow-up assessment|1|||
48828908|NCT01867580|157214134|FG000|Overall Study|Interruption to therapy|3|||
48828909|NCT01867580|157214135|FG001|Overall Study|Interruption to therapy|0|||
48828910|NCT01867580|157214134|FG000|Overall Study|Osteomyelitis|0|||
48828911|NCT01867580|157214135|FG001|Overall Study|Osteomyelitis|1|||
48828912|NCT01867580|157214134|FG000|Overall Study|Continuation of therapy|0|||
48828913|NCT01867580|157214135|FG001|Overall Study|Continuation of therapy|1|||
48828914|NCT01867580|157214134|FG000|Overall Study|Wound recurrence|0|||
48828915|NCT01867580|157214135|FG001|Overall Study|Wound recurrence|1|||
48828916|NCT02451943|157215863|FG000|Overall Study|On Treatment|4|||
48828917|NCT02451943|157215864|FG001|Overall Study|On Treatment|4|||
48828918|NCT02451943|157215863|FG000|Overall Study|Withdrawal by Subject|13|||
48828919|NCT02451943|157215864|FG001|Overall Study|Withdrawal by Subject|16|||
48828920|NCT02451943|157215863|FG000|Overall Study|Lost to Follow-up|3|||
48828921|NCT02451943|157215864|FG001|Overall Study|Lost to Follow-up|4|||
48828922|NCT02624778|157215865|FG000|Overall Study|Lost to Follow-up|0|||
48828923|NCT02624778|157215866|FG001|Overall Study|Lost to Follow-up|0|||
48828924|NCT02624778|157215867|FG002|Overall Study|Lost to Follow-up|1|||
48828925|NCT02624778|157215868|FG003|Overall Study|Lost to Follow-up|0|||
48828926|NCT02624778|157215869|FG004|Overall Study|Lost to Follow-up|0|||
48828927|NCT02624778|157215870|FG005|Overall Study|Lost to Follow-up|0|||
48828928|NCT02624778|157215871|FG006|Overall Study|Lost to Follow-up|0|||
48828929|NCT02624778|157215872|FG007|Overall Study|Lost to Follow-up|0|||
48828930|NCT02624778|157215873|FG008|Overall Study|Lost to Follow-up|0|||
48527348|NCT04099641|156122549|FG000|Overall Study|Death|46|||
48527349|NCT04099641|156122550|FG001|Overall Study|Death|12|||
48527350|NCT04099641|156122549|FG000|Overall Study|Lost to Follow-up|1|||
48828931|NCT02624778|157215865|FG000|Overall Study|Withdrawal by Subject|0|||
48527351|NCT04099641|156122550|FG001|Overall Study|Lost to Follow-up|0|||
48527352|NCT04099641|156122549|FG000|Overall Study|Withdrawal by Subject|2|||
48828932|NCT02624778|157215866|FG001|Overall Study|Withdrawal by Subject|1|||
48828933|NCT02624778|157215867|FG002|Overall Study|Withdrawal by Subject|0|||
48828934|NCT02624778|157215868|FG003|Overall Study|Withdrawal by Subject|0|||
48828935|NCT02624778|157215869|FG004|Overall Study|Withdrawal by Subject|0|||
48828936|NCT02624778|157215870|FG005|Overall Study|Withdrawal by Subject|1|||
48828937|NCT02624778|157215871|FG006|Overall Study|Withdrawal by Subject|1|||
48527353|NCT04099641|156122550|FG001|Overall Study|Withdrawal by Subject|0|||
48527354|NCT01115855|156122551|FG000|Overall Study|Adverse Event|16|||
48527355|NCT01115855|156122552|FG001|Overall Study|Adverse Event|18|||
48527356|NCT01115855|156122551|FG000|Overall Study|Death|6|||
48527357|NCT01115855|156122552|FG001|Overall Study|Death|5|||
48527358|NCT01115855|156122551|FG000|Overall Study|Lab Abnormality|1|||
48527359|NCT01115855|156122552|FG001|Overall Study|Lab Abnormality|1|||
48527360|NCT01115855|156122551|FG000|Overall Study|Protocol Violation|0|||
48527361|NCT01115855|156122552|FG001|Overall Study|Protocol Violation|1|||
48527362|NCT01115855|156122551|FG000|Overall Study|Withdrawal by Subject|5|||
48527363|NCT01115855|156122552|FG001|Overall Study|Withdrawal by Subject|5|||
48527364|NCT01115855|156122551|FG000|Overall Study|Other|8|||
48527365|NCT01115855|156122552|FG001|Overall Study|Other|6|||
48527366|NCT00399893|156122553|FG000|Overall Study|Withdrawal by Subject|1|||
48527367|NCT00399893|156122554|FG001|Overall Study|Withdrawal by Subject|0|||
48527368|NCT01363011|156122555|FG000|Main Study|Adverse Event|2|||
48527369|NCT01363011|156122556|FG001|Main Study|Adverse Event|3|||
48527370|NCT01363011|156122555|FG000|Main Study|Investigator's Discretion|1|||
48527371|NCT01363011|156122556|FG001|Main Study|Investigator's Discretion|1|||
48527372|NCT01363011|156122555|FG000|Main Study|Withdrew Consent|1|||
48527373|NCT01363011|156122556|FG001|Main Study|Withdrew Consent|4|||
48527374|NCT01363011|156122555|FG000|Main Study|Protocol Violation|0|||
48527375|NCT01363011|156122556|FG001|Main Study|Protocol Violation|1|||
48527376|NCT01363011|156122555|FG000|Extension Phase|Adverse Event|1|||
48527377|NCT01363011|156122556|FG001|Extension Phase|Adverse Event|1|||
48527378|NCT01363011|156122555|FG000|Extension Phase|Lack of Efficacy|0|||
48527379|NCT01363011|156122556|FG001|Extension Phase|Lack of Efficacy|1|||
48527380|NCT01363011|156122555|FG000|Extension Phase|Investigator's Discretion|2|||
48527381|NCT01363011|156122556|FG001|Extension Phase|Investigator's Discretion|2|||
48527382|NCT01363011|156122555|FG000|Extension Phase|Withdrew Consent|0|||
48527383|NCT01363011|156122556|FG001|Extension Phase|Withdrew Consent|1|||
48527384|NCT01363011|156122555|FG000|Extension Phase|Lost to Follow-up|0|||
48527385|NCT01363011|156122556|FG001|Extension Phase|Lost to Follow-up|2|||
48527386|NCT01363011|156122555|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
48527387|NCT01363011|156122556|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
48527388|NCT02284347|156122566|FG000|Overall Study|Lost to Follow-up|2|||
48527389|NCT02284347|156122566|FG000|Overall Study|Withdrawn prior to treatment|1|||
48527390|NCT00433329|156122567|FG000|Overall Study|Adverse Event|9|||
48527391|NCT00433329|156122567|FG000|Overall Study|Death|4|||
48527392|NCT00433329|156122567|FG000|Overall Study|Withdrew consent|3|||
48527393|NCT00433329|156122567|FG000|Overall Study|Discontinued sildenafil|2|||
48527394|NCT00433329|156122567|FG000|Overall Study|Moved out of state|1|||
48527395|NCT00433329|156122567|FG000|Overall Study|Lost to Follow-up|1|||
48527396|NCT00433329|156122567|FG000|Overall Study|Physician Decision|1|||
48527397|NCT01790113|156122570|FG000|Overall Study|Adverse Event|2|||
48527398|NCT01790113|156122571|FG001|Overall Study|Adverse Event|7|||
48527399|NCT01790113|156122570|FG000|Overall Study|Study ended due to FDA clearance|1|||
48527400|NCT01790113|156122571|FG001|Overall Study|Study ended due to FDA clearance|68|||
48527401|NCT00263887|156122574|FG000|Overall Study|Withdrawal by Subject|1|||
48527402|NCT00263887|156122575|FG001|Overall Study|Withdrawal by Subject|1|||
48527403|NCT00263887|156122574|FG000|Overall Study|Lung transplantation|1|||
48527404|NCT00263887|156122575|FG001|Overall Study|Lung transplantation|2|||
48828938|NCT02624778|157215872|FG007|Overall Study|Withdrawal by Subject|1|||
48828939|NCT02624778|157215873|FG008|Overall Study|Withdrawal by Subject|1|||
48828940|NCT02624778|157215865|FG000|Overall Study|Adverse Event|0|||
48828941|NCT02624778|157215866|FG001|Overall Study|Adverse Event|0|||
48828942|NCT02624778|157215867|FG002|Overall Study|Adverse Event|0|||
48828943|NCT02624778|157215868|FG003|Overall Study|Adverse Event|0|||
48828944|NCT02624778|157215869|FG004|Overall Study|Adverse Event|0|||
48828945|NCT02624778|157215870|FG005|Overall Study|Adverse Event|0|||
48828946|NCT02624778|157215871|FG006|Overall Study|Adverse Event|0|||
48828947|NCT02624778|157215872|FG007|Overall Study|Adverse Event|0|||
48828948|NCT02624778|157215873|FG008|Overall Study|Adverse Event|2|||
48828949|NCT02624778|157215865|FG000|Overall Study|Death|0|||
48828950|NCT02624778|157215866|FG001|Overall Study|Death|0|||
48828951|NCT02624778|157215867|FG002|Overall Study|Death|0|||
48828952|NCT02624778|157215868|FG003|Overall Study|Death|0|||
48527405|NCT00263887|156122574|FG000|Overall Study|Too ill to attend visit|1|||
48527406|NCT00263887|156122575|FG001|Overall Study|Too ill to attend visit|0|||
48527407|NCT00263887|156122574|FG000|Overall Study|Adverse Event|0|||
48527408|NCT00263887|156122575|FG001|Overall Study|Adverse Event|2|||
48527409|NCT00263887|156122574|FG000|Overall Study|Disease progression|0|||
48527410|NCT00263887|156122575|FG001|Overall Study|Disease progression|1|||
48527411|NCT00263887|156122574|FG000|Overall Study|Lack of Efficacy|0|||
48527412|NCT00263887|156122575|FG001|Overall Study|Lack of Efficacy|1|||
48828953|NCT02624778|157215869|FG004|Overall Study|Death|0|||
48828954|NCT02624778|157215870|FG005|Overall Study|Death|0|||
48828955|NCT02624778|157215871|FG006|Overall Study|Death|1|||
48828956|NCT02624778|157215872|FG007|Overall Study|Death|0|||
48828957|NCT02624778|157215873|FG008|Overall Study|Death|0|||
48828958|NCT02624778|157215865|FG000|Overall Study|Physician Decision|0|||
48828959|NCT02624778|157215866|FG001|Overall Study|Physician Decision|0|||
48828960|NCT02624778|157215867|FG002|Overall Study|Physician Decision|0|||
48828961|NCT02624778|157215868|FG003|Overall Study|Physician Decision|0|||
48828962|NCT02624778|157215869|FG004|Overall Study|Physician Decision|0|||
48828963|NCT02624778|157215870|FG005|Overall Study|Physician Decision|0|||
48828964|NCT02624778|157215871|FG006|Overall Study|Physician Decision|0|||
48828965|NCT02624778|157215872|FG007|Overall Study|Physician Decision|3|||
48828966|NCT02624778|157215873|FG008|Overall Study|Physician Decision|3|||
48527413|NCT01688882|156122576|FG000|Overall Study|Adverse Event|1|||
48527414|NCT01688882|156122577|FG001|Overall Study|Adverse Event|0|||
48527415|NCT01688882|156122576|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48527416|NCT01688882|156122577|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48527417|NCT01688882|156122576|FG000|Overall Study|Administrative problems|1|||
48527418|NCT01688882|156122577|FG001|Overall Study|Administrative problems|0|||
48527419|NCT04291508|156122578|FG000|Overall Study|Withdrawal by Subject|1|||
48527420|NCT04291508|156122579|FG001|Overall Study|Withdrawal by Subject|0|||
48527421|NCT04291508|156122580|FG002|Overall Study|Withdrawal by Subject|1|||
48828967|NCT03158948|157215874|FG000|Overall Study|Death|1|||
48828968|NCT03158948|157215875|FG001|Overall Study|Death|1|||
48828969|NCT03158948|157215876|FG002|Overall Study|Death|3|||
48828970|NCT03158948|157215877|FG003|Overall Study|Death|2|||
48828971|NCT03158948|157215874|FG000|Overall Study|Physician Decision|0|||
48828972|NCT03158948|157215875|FG001|Overall Study|Physician Decision|0|||
48828973|NCT03158948|157215876|FG002|Overall Study|Physician Decision|0|||
48828974|NCT03158948|157215877|FG003|Overall Study|Physician Decision|1|||
48828975|NCT05025449|157215880|FG000|Overall Study|Withdrawal by Subject|1|||
48828976|NCT05025449|157215880|FG000|Overall Study|Patient emergently taken to operating room|1|||
48828977|NCT00093795|157215881|FG000|Overall Study|No follow up data|20|||
48828978|NCT00093795|157215882|FG001|Overall Study|No follow up data|16|||
48828979|NCT00093795|157215883|FG002|Overall Study|No follow up data|17|||
48828980|NCT01195675|157215884|FG000|Overall Study|Adverse Event|1|||
48828981|NCT01195675|157215884|FG000|Overall Study|Withdrawal by Subject|2|||
48828982|NCT02501629|157215894|FG000|Overall Study|Death|0|||
48828983|NCT02501629|157215895|FG001|Overall Study|Death|1|||
48828984|NCT02501629|157215894|FG000|Overall Study|Withdrawn from study by sponsor|1|||
48828985|NCT02501629|157215895|FG001|Overall Study|Withdrawn from study by sponsor|0|||
48828986|NCT02501629|157215894|FG000|Overall Study|Early termination by sponsor|1|||
48828987|NCT02501629|157215895|FG001|Overall Study|Early termination by sponsor|0|||
48828988|NCT02501629|157215894|FG000|Overall Study|Withdrawal by Subject|3|||
48828989|NCT02501629|157215895|FG001|Overall Study|Withdrawal by Subject|5|||
48828990|NCT02501629|157215894|FG000|Overall Study|Subject did not return to site|0|||
48828991|NCT02501629|157215895|FG001|Overall Study|Subject did not return to site|1|||
48828992|NCT00349908|157215898|FG000|Overall Study|Withdrawal by Subject|0|||
48828993|NCT00349908|157215899|FG001|Overall Study|Withdrawal by Subject|4|||
48828994|NCT04565249|157215900|FG000|Overall Study|Death|0|||
48828995|NCT04565249|157215901|FG001|Overall Study|Death|0|||
48828996|NCT04565249|157215902|FG002|Overall Study|Death|0|||
48828997|NCT04565249|157215903|FG003|Overall Study|Death|1|||
48828998|NCT00926393|157215904|FG000|Overall Study|Withdrawal by Subject|1|||
48828999|NCT00926393|157215905|FG001|Overall Study|Withdrawal by Subject|2|||
48829000|NCT00926393|157215904|FG000|Overall Study|Adverse Event|1|||
48829001|NCT00926393|157215905|FG001|Overall Study|Adverse Event|1|||
48829002|NCT02333630|157215906|FG000|Overall Study|Lost to Follow-up|5|||
48829003|NCT02333630|157215907|FG001|Overall Study|Lost to Follow-up|2|||
48829004|NCT05349864|157215908|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
48829005|NCT05349864|157215909|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
48829006|NCT01704846|157215910|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48829007|NCT01704846|157215911|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48829008|NCT00058058|157215912|FG000|Overall Study|Withdrawal by Subject|4|||
48829009|NCT00058058|157215912|FG000|Overall Study|Ineligible|20|||
48527422|NCT04291508|156122581|FG003|Overall Study|Withdrawal by Subject|0|||
48829010|NCT00058058|157215912|FG000|Overall Study|Claustrophobic|5|||
48829011|NCT00058058|157215912|FG000|Overall Study|technical issues|6|||
48829012|NCT00058058|157215912|FG000|Overall Study|Poor positioning, illness,pain|3|||
48829013|NCT03613129|157215914|FG000|Pre-treatment Assessment|Protocol Violation|2|||
48829014|NCT03613129|157215915|FG001|Pre-treatment Assessment|Protocol Violation|0|||
48829015|NCT03613129|157215916|FG002|Pre-treatment Assessment|Protocol Violation|0|||
48829016|NCT03613129|157215917|FG003|Pre-treatment Assessment|Protocol Violation|0|||
48829017|NCT03613129|157215918|FG004|Pre-treatment Assessment|Protocol Violation|0|||
48829018|NCT03613129|157215914|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
48829019|NCT03613129|157215915|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
48829020|NCT03613129|157215916|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
48829021|NCT03613129|157215917|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
48829022|NCT03613129|157215918|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
48527423|NCT04291508|156122578|FG000|Overall Study|lost to follow up|4|||
48527424|NCT04291508|156122579|FG001|Overall Study|lost to follow up|0|||
48527425|NCT04291508|156122580|FG002|Overall Study|lost to follow up|1|||
48527426|NCT04291508|156122581|FG003|Overall Study|lost to follow up|0|||
48527427|NCT01955044|156122582|FG000|Overall Study|Death|1|||
48527428|NCT01955044|156122583|FG001|Overall Study|Death|1|||
48527429|NCT01955044|156122584|FG002|Overall Study|Death|0|||
48527430|NCT02280187|156122589|FG000|Overall Study|Lost to Follow-up|218|||
48527431|NCT03840382|156122592|FG000|Overall Study|Lost to Follow-up|11|||
48527432|NCT04668274|156122595|FG000|Part 1 Study Period 1|Adverse Event|3|||
48527433|NCT04668274|156122596|FG001|Part 1 Study Period 1|Adverse Event|0|||
48527434|NCT04668274|156122597|FG002|Part 1 Study Period 1|Adverse Event|0|||
48527435|NCT04668274|156122598|FG003|Part 1 Study Period 1|Adverse Event|0|||
48527436|NCT04668274|156122595|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
48527437|NCT04668274|156122596|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
48527438|NCT04668274|156122597|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
48527439|NCT04668274|156122598|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
48527440|NCT04668274|156122595|FG000|Part 1 Study Period 2|Other|0|||
48527441|NCT04668274|156122596|FG001|Part 1 Study Period 2|Other|1|||
48527442|NCT04668274|156122597|FG002|Part 1 Study Period 2|Other|0|||
48527443|NCT04668274|156122598|FG003|Part 1 Study Period 2|Other|0|||
48527444|NCT04668274|156122595|FG000|Part 1 Study Period 3|Adverse Event|0|||
48527445|NCT04668274|156122596|FG001|Part 1 Study Period 3|Adverse Event|0|||
48527446|NCT04668274|156122597|FG002|Part 1 Study Period 3|Adverse Event|1|||
48527447|NCT04668274|156122598|FG003|Part 1 Study Period 3|Adverse Event|0|||
48527448|NCT04668274|156122595|FG000|Part 1 Study Period 3|Other|0|||
48527449|NCT04668274|156122596|FG001|Part 1 Study Period 3|Other|0|||
48527450|NCT04668274|156122597|FG002|Part 1 Study Period 3|Other|2|||
48527451|NCT04668274|156122598|FG003|Part 1 Study Period 3|Other|0|||
48527452|NCT04668274|156122595|FG000|Part 2 Study Period 4|Other|0|||
48527453|NCT04668274|156122596|FG001|Part 2 Study Period 4|Other|0|||
48527454|NCT04668274|156122597|FG002|Part 2 Study Period 4|Other|0|||
48527455|NCT04668274|156122598|FG003|Part 2 Study Period 4|Other|1|||
48527456|NCT00551616|156122603|FG000|Overall Study|Lost to Follow-up|48|||
48527457|NCT00551616|156122604|FG001|Overall Study|Lost to Follow-up|40|||
48527458|NCT02808819|156122605|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
48527459|NCT02808819|156122606|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
48527460|NCT02808819|156122605|FG000|Overall Study|Withdrawal by Subject|10|||
48527461|NCT02808819|156122606|FG001|Overall Study|Withdrawal by Subject|13|||
48527462|NCT02808819|156122605|FG000|Overall Study|Site terminated by sponsor|2|||
48527463|NCT02808819|156122606|FG001|Overall Study|Site terminated by sponsor|0|||
48527464|NCT02808819|156122605|FG000|Overall Study|Pregnancy|1|||
48527465|NCT02808819|156122606|FG001|Overall Study|Pregnancy|0|||
48527466|NCT02808819|156122605|FG000|Overall Study|Lost to Follow-up|1|||
48527467|NCT02808819|156122606|FG001|Overall Study|Lost to Follow-up|6|||
48527468|NCT02808819|156122605|FG000|Overall Study|Protocol Violation|0|||
48527469|NCT02808819|156122606|FG001|Overall Study|Protocol Violation|1|||
48527470|NCT02808819|156122605|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
48527471|NCT02808819|156122606|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
48527472|NCT02808819|156122605|FG000|Overall Study|Death|1|||
48527473|NCT02808819|156122606|FG001|Overall Study|Death|0|||
48527474|NCT02808819|156122605|FG000|Overall Study|Adverse Event|3|||
48527475|NCT02808819|156122606|FG001|Overall Study|Adverse Event|4|||
48527476|NCT02752802|156122607|FG000|Overall Study|Contrast Volume Not Collected|1|||
48527477|NCT02752802|156122608|FG001|Overall Study|Contrast Volume Not Collected|0|||
48527478|NCT01937117|156122611|FG000|Overall Study|Disease Progression|7|||
48527479|NCT01937117|156122611|FG000|Overall Study|Physician Decision|4|||
48527480|NCT01937117|156122611|FG000|Overall Study|Adverse Event|2|||
48527481|NCT00931463|156122614|FG000|Overall Study|Death|8|||
48527482|NCT00931463|156122615|FG001|Overall Study|Death|4|||
48527483|NCT00931463|156122614|FG000|Overall Study|Withdrawal by Subject|5|||
48602262|NCT02287038|156399537|FG000|Overall Study|Anxiety after starting medication|0|||
48527484|NCT00931463|156122615|FG001|Overall Study|Withdrawal by Subject|0|||
48527485|NCT00931463|156122614|FG000|Overall Study|Lost to Follow-up|4|||
48527486|NCT00931463|156122615|FG001|Overall Study|Lost to Follow-up|1|||
48527487|NCT03438006|156122616|FG000|Overall Study|Adverse Event|1|||
48527488|NCT03438006|156122616|FG000|Overall Study|Lost to Follow-up|67|||
48527489|NCT03438006|156122616|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
48527490|NCT03438006|156122616|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
48527491|NCT00857818|156122627|FG000|Overall Study|Lack of Efficacy|1|||
48602263|NCT02287038|156399538|FG001|Overall Study|Anxiety after starting medication|1|||
48602264|NCT02287038|156399537|FG000|Overall Study|Nausea after starting medication|1|||
48527492|NCT00857818|156122628|FG001|Overall Study|Lack of Efficacy|0|||
48527493|NCT00857818|156122627|FG000|Overall Study|Adverse Event|3|||
48527494|NCT00857818|156122628|FG001|Overall Study|Adverse Event|0|||
48527495|NCT00857818|156122627|FG000|Overall Study|Withdrawal by Subject|0|||
48527496|NCT00857818|156122628|FG001|Overall Study|Withdrawal by Subject|4|||
48527497|NCT00857818|156122627|FG000|Overall Study|Sponsor terminated study|6|||
48527498|NCT00857818|156122628|FG001|Overall Study|Sponsor terminated study|4|||
48527499|NCT00857818|156122627|FG000|Overall Study|Investigator decision|1|||
48527500|NCT00857818|156122628|FG001|Overall Study|Investigator decision|0|||
48527501|NCT01392326|156122629|FG000|Overall Study|Death|2|||
48527502|NCT01392326|156122630|FG001|Overall Study|Death|0|||
48527503|NCT01392326|156122631|FG002|Overall Study|Death|0|||
48527504|NCT01392326|156122629|FG000|Overall Study|Withdrawal by Subject|12|||
48527505|NCT01392326|156122630|FG001|Overall Study|Withdrawal by Subject|11|||
48527506|NCT01392326|156122631|FG002|Overall Study|Withdrawal by Subject|15|||
48527507|NCT01392326|156122629|FG000|Overall Study|Protocol Violation|2|||
48527508|NCT01392326|156122630|FG001|Overall Study|Protocol Violation|0|||
48527509|NCT01392326|156122631|FG002|Overall Study|Protocol Violation|0|||
48527510|NCT01392326|156122629|FG000|Overall Study|Pregnancy|0|||
48527511|NCT01392326|156122630|FG001|Overall Study|Pregnancy|0|||
48527512|NCT01392326|156122631|FG002|Overall Study|Pregnancy|1|||
48527513|NCT01392326|156122629|FG000|Overall Study|Physician Decision|7|||
48527514|NCT01392326|156122630|FG001|Overall Study|Physician Decision|5|||
48527515|NCT01392326|156122631|FG002|Overall Study|Physician Decision|2|||
48527516|NCT01392326|156122629|FG000|Overall Study|Lost to Follow-up|1|||
48527517|NCT01392326|156122630|FG001|Overall Study|Lost to Follow-up|3|||
48527518|NCT01392326|156122631|FG002|Overall Study|Lost to Follow-up|4|||
48527519|NCT01392326|156122629|FG000|Overall Study|Lack of Efficacy|14|||
48527520|NCT01392326|156122630|FG001|Overall Study|Lack of Efficacy|10|||
48527521|NCT01392326|156122631|FG002|Overall Study|Lack of Efficacy|15|||
48527522|NCT01392326|156122629|FG000|Overall Study|Adverse Event|9|||
48527523|NCT01392326|156122630|FG001|Overall Study|Adverse Event|6|||
48527524|NCT01392326|156122631|FG002|Overall Study|Adverse Event|11|||
48527525|NCT05816200|156122634|FG000|Overall Study|Lost to Follow-up|2|||
48527526|NCT05816200|156122635|FG001|Overall Study|Lost to Follow-up|1|||
48527527|NCT01557582|156122639|FG000|Overall Study|Protocol Violation|4|||
48527528|NCT01557582|156122639|FG000|Overall Study|Operator error|2|||
48527529|NCT03756883|156124185|FG000|Overall Study|Adverse Event|2|||
48527530|NCT03756883|156124186|FG001|Overall Study|Adverse Event|2|||
48829023|NCT04381494|157215921|FG000|Overall Study|Early termination of trial|19|||
48829024|NCT04381494|157215921|FG000|Overall Study|Investigator's discretion|1|||
48829025|NCT04381494|157215921|FG000|Overall Study|Withdrawal by Subject|9|||
48829026|NCT04381494|157215921|FG000|Overall Study|NSCLC disease progression|4|||
48829027|NCT04381494|157215921|FG000|Overall Study|Device-Related Adverse Event|2|||
48829028|NCT03278028|157215924|FG000|Overall Study|Lost to Follow-up|1|||
48829029|NCT03278028|157215925|FG001|Overall Study|Lost to Follow-up|0|||
48829030|NCT03278028|157215924|FG000|Overall Study|Withdrawal by Subject|3|||
48829031|NCT03278028|157215925|FG001|Overall Study|Withdrawal by Subject|1|||
48829032|NCT03278028|157215924|FG000|Overall Study|Pregnancy|0|||
48829033|NCT03278028|157215925|FG001|Overall Study|Pregnancy|1|||
48829034|NCT03635567|157215926|FG000|Overall Study|Lost to Follow-up|0|||
48829035|NCT03635567|157215927|FG001|Overall Study|Lost to Follow-up|2|||
48829036|NCT03635567|157215926|FG000|Overall Study|Withdrawal by Subject|9|||
48829037|NCT03635567|157215927|FG001|Overall Study|Withdrawal by Subject|10|||
48829038|NCT03635567|157215926|FG000|Overall Study|Ongoing in Study|125|||
48829039|NCT03635567|157215927|FG001|Overall Study|Ongoing in Study|76|||
48829040|NCT03635567|157215926|FG000|Overall Study|Death|174|||
48527531|NCT03756883|156124187|FG002|Overall Study|Adverse Event|2|||
48527532|NCT03756883|156124185|FG000|Overall Study|Lack of Efficacy|0|||
48527533|NCT03756883|156124186|FG001|Overall Study|Lack of Efficacy|1|||
48527534|NCT03756883|156124187|FG002|Overall Study|Lack of Efficacy|2|||
48527535|NCT03756883|156124185|FG000|Overall Study|Lost to Follow-up|3|||
48527536|NCT03756883|156124186|FG001|Overall Study|Lost to Follow-up|3|||
48527537|NCT03756883|156124187|FG002|Overall Study|Lost to Follow-up|0|||
48527538|NCT03756883|156124185|FG000|Overall Study|Protocol Violation|2|||
48527539|NCT03756883|156124186|FG001|Overall Study|Protocol Violation|0|||
48527540|NCT03756883|156124187|FG002|Overall Study|Protocol Violation|1|||
48527541|NCT03756883|156124185|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
48527542|NCT03756883|156124186|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
48527543|NCT03756883|156124187|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
48527544|NCT03756883|156124185|FG000|Overall Study|Withdrawal by Subject|4|||
48527545|NCT03756883|156124186|FG001|Overall Study|Withdrawal by Subject|1|||
48829041|NCT03635567|157215927|FG001|Overall Study|Death|221|||
48829042|NCT01720446|157215928|FG000|Overall Study|Lost to Follow-up|12|||
48527546|NCT03756883|156124187|FG002|Overall Study|Withdrawal by Subject|0|||
48527547|NCT03756883|156124185|FG000|Overall Study|Other Reasons|2|||
48527548|NCT03756883|156124186|FG001|Overall Study|Other Reasons|4|||
48527549|NCT03756883|156124187|FG002|Overall Study|Other Reasons|0|||
48527550|NCT00337428|156124188|FG000|Overall Study|Withdrawal by Subject|1|||
48527551|NCT00337428|156124189|FG001|Overall Study|Withdrawal by Subject|2|||
48829043|NCT01720446|157215929|FG001|Overall Study|Lost to Follow-up|6|||
48829044|NCT01720446|157215930|FG002|Overall Study|Lost to Follow-up|16|||
48829045|NCT01720446|157215931|FG003|Overall Study|Lost to Follow-up|16|||
48829046|NCT01720446|157215928|FG000|Overall Study|Withdrawal by Subject|2|||
48527552|NCT00337428|156124188|FG000|Overall Study|Lack of Time|1|||
48527553|NCT00337428|156124189|FG001|Overall Study|Lack of Time|1|||
48527554|NCT00337428|156124188|FG000|Overall Study|Unwilling to Continue|1|||
48527555|NCT00337428|156124189|FG001|Overall Study|Unwilling to Continue|0|||
48527556|NCT00337428|156124188|FG000|Overall Study|Anorexia|1|||
48527557|NCT00337428|156124189|FG001|Overall Study|Anorexia|0|||
48527558|NCT02938442|156124190|FG000|Overall Study|Death|0|||
48527559|NCT02938442|156124191|FG001|Overall Study|Death|1|||
48527560|NCT02938442|156124190|FG000|Overall Study|Lost to Follow-up|0|||
48527561|NCT02938442|156124191|FG001|Overall Study|Lost to Follow-up|1|||
48527562|NCT02938442|156124190|FG000|Overall Study|Physician Decision|0|||
48527563|NCT02938442|156124191|FG001|Overall Study|Physician Decision|1|||
48527564|NCT02938442|156124190|FG000|Overall Study|Withdrawal by Subject|2|||
48527565|NCT02938442|156124191|FG001|Overall Study|Withdrawal by Subject|0|||
48527566|NCT02014441|156124192|FG000|Overall Study|Withdrawal by Subject|12|||
48527567|NCT01606228|156124195|FG000|Overall Study|Lost to Follow-up|20|||
48527568|NCT01606228|156124195|FG000|Overall Study|Withdrawal by Subject|3|||
48527569|NCT01606228|156124195|FG000|Overall Study|Non-compliant|3|||
48527570|NCT01606228|156124195|FG000|Overall Study|Lack of Efficacy|2|||
48527571|NCT01606228|156124195|FG000|Overall Study|Adverse Event|1|||
48527572|NCT00546910|156124198|FG000|Overall Study|Adverse Event|2|||
48527573|NCT00546910|156124199|FG001|Overall Study|Adverse Event|3|||
48527574|NCT00546910|156124198|FG000|Overall Study|Lack of Efficacy|5|||
48527575|NCT00546910|156124199|FG001|Overall Study|Lack of Efficacy|7|||
48527576|NCT00546910|156124198|FG000|Overall Study|Physician Decision|0|||
48527577|NCT00546910|156124199|FG001|Overall Study|Physician Decision|1|||
48527578|NCT00546910|156124198|FG000|Overall Study|Withdrawal by Subject|2|||
48527579|NCT00546910|156124199|FG001|Overall Study|Withdrawal by Subject|0|||
48527580|NCT04412057|156124200|FG000|Overall Study|Death|3|||
48527581|NCT04412057|156124201|FG001|Overall Study|Death|7|||
48829047|NCT01720446|157215929|FG001|Overall Study|Withdrawal by Subject|5|||
48829048|NCT01720446|157215930|FG002|Overall Study|Withdrawal by Subject|4|||
48829049|NCT01720446|157215931|FG003|Overall Study|Withdrawal by Subject|4|||
48829050|NCT00015457|157215935|FG000|First Intervention|Adverse Event|0|||
48829051|NCT00015457|157215936|FG001|First Intervention|Adverse Event|2|||
48829052|NCT00015457|157215935|FG000|First Intervention|Lack of Efficacy|0|||
48829053|NCT00015457|157215936|FG001|First Intervention|Lack of Efficacy|1|||
48829054|NCT00015457|157215935|FG000|Second Intervention|Withdrawal by Subject|1|||
48829055|NCT00015457|157215936|FG001|Second Intervention|Withdrawal by Subject|0|||
48829056|NCT01027286|157215937|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
48829057|NCT01027286|157215938|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
48829058|NCT01027286|157215937|FG000|Overall Study|Lost to Follow-up|0|||
48829059|NCT01027286|157215938|FG001|Overall Study|Lost to Follow-up|1|||
48829060|NCT03178201|157215939|FG000|Overall Study|Off study|5|||
48829061|NCT03201809|157215940|FG000|Overall Study|Lost to Follow-up|2|||
48829062|NCT03201809|157215941|FG001|Overall Study|Lost to Follow-up|0|||
48829063|NCT00864682|157215947|FG000|Overall Study|Protocol Violation|2|||
48829064|NCT00864682|157215948|FG001|Overall Study|Protocol Violation|1|||
48829065|NCT00864682|157215949|FG002|Overall Study|Protocol Violation|2|||
48527582|NCT04412057|156124200|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
48527583|NCT04412057|156124201|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
48527584|NCT03653026|156124202|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
48527585|NCT03653026|156124203|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
48829066|NCT00545844|157215950|FG000|Overall Study|Lost to Follow-up|9|||
48829067|NCT00545844|157215950|FG000|Overall Study|Protocol Violation|1|||
48829068|NCT00545844|157215950|FG000|Overall Study|Withdrawal by Subject|2|||
48829069|NCT00001575|157215951|FG000|Overall Study|Screening failures-Ph I portion|22|||
48829070|NCT00001575|157215951|FG000|Overall Study|Withdrawn/deaths|23|||
48527586|NCT03653026|156124204|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
48527587|NCT03653026|156124205|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
48527588|NCT03653026|156124202|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
48527589|NCT03653026|156124203|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
48527590|NCT03653026|156124204|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
48527591|NCT03653026|156124205|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
48829071|NCT01242085|157215952|FG000|Overall Study|Withdrawal by Subject|4|||
48829072|NCT01242085|157215953|FG001|Overall Study|Withdrawal by Subject|2|||
48829073|NCT01242085|157215954|FG002|Overall Study|Withdrawal by Subject|0|||
48527592|NCT03653026|156124202|FG000|Part 1: Placebo-controlled Period|Other|0|||
48527593|NCT03653026|156124203|FG001|Part 1: Placebo-controlled Period|Other|3|||
48527594|NCT03653026|156124204|FG002|Part 1: Placebo-controlled Period|Other|0|||
48527595|NCT03653026|156124205|FG003|Part 1: Placebo-controlled Period|Other|0|||
48527596|NCT03653026|156124202|FG000|Part 2: Open-label Extension|Adverse Event|0|||
48527597|NCT03653026|156124203|FG001|Part 2: Open-label Extension|Adverse Event|0|||
48829074|NCT01242085|157215952|FG000|Overall Study|medically unable to have surgery|4|||
48527598|NCT03653026|156124204|FG002|Part 2: Open-label Extension|Adverse Event|1|||
48527599|NCT03653026|156124205|FG003|Part 2: Open-label Extension|Adverse Event|1|||
48527600|NCT03653026|156124202|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
48527601|NCT03653026|156124203|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
48527602|NCT03653026|156124204|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
48527603|NCT03653026|156124205|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
48527604|NCT03653026|156124202|FG000|Part 2: Open-label Extension|Other|0|||
48527605|NCT03653026|156124203|FG001|Part 2: Open-label Extension|Other|0|||
48527606|NCT03653026|156124204|FG002|Part 2: Open-label Extension|Other|1|||
48527607|NCT03653026|156124205|FG003|Part 2: Open-label Extension|Other|2|||
48527608|NCT04300023|156124206|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
48527609|NCT04300023|156124207|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
48527610|NCT03275285|156124208|FG000|Overall Study|Ongoing|45|||
48527611|NCT03275285|156124209|FG001|Overall Study|Ongoing|69|||
48527612|NCT01730040|156124210|FG000|Overall Study|Randomized but not treated|0|||
48527613|NCT01730040|156124211|FG001|Overall Study|Randomized but not treated|0|||
48527614|NCT01730040|156124212|FG002|Overall Study|Randomized but not treated|0|||
48829075|NCT01242085|157215953|FG001|Overall Study|medically unable to have surgery|5|||
48829076|NCT01242085|157215954|FG002|Overall Study|medically unable to have surgery|0|||
48829077|NCT00094809|157215955|FG000|Overall Study|Protocol deviation|2|||
48829078|NCT00094809|157215956|FG001|Overall Study|Protocol deviation|2|||
48829079|NCT00094809|157215955|FG000|Overall Study|Noncompliance|1|||
48829080|NCT00094809|157215956|FG001|Overall Study|Noncompliance|0|||
48829081|NCT00094809|157215955|FG000|Overall Study|Adverse Event|3|||
48829082|NCT00094809|157215956|FG001|Overall Study|Adverse Event|1|||
48829083|NCT00094809|157215955|FG000|Overall Study|Withdrawal by Subject|8|||
48829084|NCT00094809|157215956|FG001|Overall Study|Withdrawal by Subject|9|||
48829085|NCT00094809|157215955|FG000|Overall Study|Disease progression|3|||
48829086|NCT00094809|157215956|FG001|Overall Study|Disease progression|3|||
48829087|NCT00094809|157215955|FG000|Overall Study|Physician Decision|3|||
48829088|NCT00094809|157215956|FG001|Overall Study|Physician Decision|5|||
48829089|NCT00094809|157215955|FG000|Overall Study|Lost to Follow-up|6|||
48829090|NCT00094809|157215956|FG001|Overall Study|Lost to Follow-up|6|||
48829091|NCT00094809|157215955|FG000|Overall Study|Death|19|||
48829092|NCT00094809|157215956|FG001|Overall Study|Death|25|||
48829093|NCT00094809|157215955|FG000|Overall Study|Protocol-specified criteria|1|||
48829094|NCT00094809|157215956|FG001|Overall Study|Protocol-specified criteria|1|||
48829095|NCT00094809|157215955|FG000|Overall Study|Other|2|||
48829096|NCT00094809|157215956|FG001|Overall Study|Other|4|||
48829097|NCT00094809|157215955|FG000|Overall Study|Informed consent signed after treatment|1|||
48829098|NCT00094809|157215956|FG001|Overall Study|Informed consent signed after treatment|0|||
48829099|NCT00094809|157215955|FG000|Overall Study|Study drug not received|2|||
48829100|NCT00094809|157215956|FG001|Overall Study|Study drug not received|8|||
48829101|NCT00094809|157215955|FG000|Overall Study|Other|1|||
48829102|NCT00094809|157215956|FG001|Overall Study|Other|1|||
48829103|NCT02430532|157215964|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
48829104|NCT02430532|157215965|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
48829105|NCT02430532|157215964|FG000|Overall Study|Consent Withdrawn|0|||
48829106|NCT02430532|157215965|FG001|Overall Study|Consent Withdrawn|2|||
48829107|NCT02430532|157215964|FG000|Overall Study|Adverse Event|0|||
48829108|NCT02430532|157215965|FG001|Overall Study|Adverse Event|1|||
48829109|NCT02750709|157215966|FG000|Treatment Period 1|Adverse Event|0|||
48829110|NCT02750709|157215967|FG001|Treatment Period 1|Adverse Event|0|||
48829111|NCT02750709|157215968|FG002|Treatment Period 1|Adverse Event|0|||
48829112|NCT02750709|157215969|FG003|Treatment Period 1|Adverse Event|0|||
48829113|NCT02750709|157215970|FG004|Treatment Period 1|Adverse Event|0|||
48829114|NCT02750709|157215971|FG005|Treatment Period 1|Adverse Event|1|||
48829115|NCT03256344|157215972|FG000|Overall Study|Death|6|||
48829116|NCT03256344|157215973|FG001|Overall Study|Death|22|||
48829117|NCT03256344|157215972|FG000|Overall Study|Withdrawal by Subject|3|||
48829118|NCT03256344|157215973|FG001|Overall Study|Withdrawal by Subject|3|||
48829119|NCT03256344|157215972|FG000|Overall Study|Sponsor Decision|1|||
48829120|NCT03256344|157215973|FG001|Overall Study|Sponsor Decision|0|||
48829121|NCT00404079|157215974|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
48829122|NCT00404079|157215975|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
48829123|NCT01120275|157215976|FG000|Overall Study|Adverse Event|3|||
48829124|NCT01120275|157215976|FG000|Overall Study|Progression|27|||
48527615|NCT01730040|156124213|FG003|Overall Study|Randomized but not treated|0|||
48829125|NCT01120275|157215976|FG000|Overall Study|Ineligible|3|||
48829126|NCT01120275|157215976|FG000|Overall Study|Withdrawal by Subject|1|||
48829127|NCT01120275|157215976|FG000|Overall Study|Refusal|1|||
48829128|NCT01120275|157215976|FG000|Overall Study|Not specific|1|||
48829129|NCT04511650|157215982|FG000|Overall Study|Lost to Follow-up|1|||
48829130|NCT04511650|157215983|FG001|Overall Study|Lost to Follow-up|0|||
48829131|NCT04511650|157215984|FG002|Overall Study|Lost to Follow-up|0|||
48602265|NCT02287038|156399538|FG001|Overall Study|Nausea after starting medication|0|||
48829132|NCT04511650|157215982|FG000|Overall Study|Withdrawal by Subject|1|||
48829133|NCT04511650|157215983|FG001|Overall Study|Withdrawal by Subject|0|||
48829134|NCT04511650|157215984|FG002|Overall Study|Withdrawal by Subject|0|||
48829135|NCT04511650|157215982|FG000|Overall Study|reason not provided|0|||
48829136|NCT04511650|157215983|FG001|Overall Study|reason not provided|0|||
48829137|NCT04511650|157215984|FG002|Overall Study|reason not provided|1|||
48829138|NCT04511650|157215982|FG000|Overall Study|Death|1|||
48829139|NCT04511650|157215983|FG001|Overall Study|Death|1|||
48829140|NCT04511650|157215984|FG002|Overall Study|Death|1|||
48602266|NCT02287038|156399537|FG000|Overall Study|Abnormal ECG after starting medication|1|||
48829141|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Death|1|||
48829142|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Death|1|||
48829143|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Death|0|||
48829144|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Death|0|||
48829145|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Death|0|||
48829146|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
48829147|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
48829148|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
48829149|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
48829150|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
48829151|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Physician Decision|0|||
48829152|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Physician Decision|0|||
48829153|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Physician Decision|0|||
48829154|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Physician Decision|0|||
48829155|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Physician Decision|1|||
48829156|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
48602267|NCT02287038|156399538|FG001|Overall Study|Abnormal ECG after starting medication|0|||
48602268|NCT03177148|156399541|FG000|Overall Study|Lost to Follow-up|50|||
48602269|NCT03177148|156399542|FG001|Overall Study|Lost to Follow-up|1|||
48602270|NCT03177148|156399541|FG000|Overall Study|Death|1|||
48602271|NCT03177148|156399542|FG001|Overall Study|Death|0|||
48602272|NCT02848664|156399543|FG000|Overall Study|Withdrawal by Subject|2|||
48602273|NCT02848664|156399543|FG000|Overall Study|Adverse Event|1|||
48602274|NCT02848664|156399543|FG000|Overall Study|no assistance for device training|1|||
48602275|NCT00931632|156399546|FG000|Overall Study|Withdrawal by Subject|2|||
48602276|NCT00931632|156399547|FG001|Overall Study|Withdrawal by Subject|3|||
48602277|NCT00931632|156399546|FG000|Overall Study|Adverse Event|19|||
48602278|NCT00931632|156399547|FG001|Overall Study|Adverse Event|15|||
48602279|NCT01819727|156399549|FG000|Overall Study|Adverse Event|8|||
48602280|NCT01819727|156399550|FG001|Overall Study|Adverse Event|9|||
48602281|NCT01819727|156399549|FG000|Overall Study|Death|1|||
48602282|NCT01819727|156399550|FG001|Overall Study|Death|0|||
48602283|NCT01819727|156399549|FG000|Overall Study|Lost to Follow-up|1|||
48602284|NCT01819727|156399550|FG001|Overall Study|Lost to Follow-up|1|||
48602285|NCT01819727|156399549|FG000|Overall Study|Physician Decision|3|||
48602286|NCT01819727|156399550|FG001|Overall Study|Physician Decision|2|||
48602287|NCT01819727|156399549|FG000|Overall Study|Pregnancy|1|||
48602288|NCT01819727|156399550|FG001|Overall Study|Pregnancy|0|||
48602289|NCT01819727|156399549|FG000|Overall Study|Protocol Violation|0|||
48602290|NCT01819727|156399550|FG001|Overall Study|Protocol Violation|2|||
48602291|NCT01819727|156399549|FG000|Overall Study|Study Terminated by Sponsor|0|||
48602292|NCT01819727|156399550|FG001|Overall Study|Study Terminated by Sponsor|1|||
48602293|NCT01819727|156399549|FG000|Overall Study|Withdrawal by Subject|6|||
48602294|NCT01819727|156399550|FG001|Overall Study|Withdrawal by Subject|11|||
48602295|NCT01819727|156399549|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
48602296|NCT01819727|156399550|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
48602297|NCT01819727|156399549|FG000|Overall Study|Quit due to lack of health benifits|0|||
48602298|NCT01819727|156399550|FG001|Overall Study|Quit due to lack of health benifits|1|||
48829157|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
48602299|NCT00715403|156399556|FG000|Overall Study|Progressive disease|0|||
48602300|NCT00715403|156399557|FG001|Overall Study|Progressive disease|1|||
48829158|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
48829159|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
48829160|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
48602301|NCT00715403|156399558|FG002|Overall Study|Progressive disease|3|||
48602302|NCT00715403|156399559|FG003|Overall Study|Progressive disease|9|||
48602303|NCT00715403|156399560|FG004|Overall Study|Progressive disease|5|||
48602304|NCT00715403|156399561|FG005|Overall Study|Progressive disease|14|||
48602305|NCT00715403|156399562|FG006|Overall Study|Progressive disease|1|||
48602306|NCT00715403|156399556|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
48602307|NCT00715403|156399557|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
48829161|NCT02503202|157215986|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
48829162|NCT02503202|157215987|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
48829163|NCT02503202|157215988|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
48829164|NCT02503202|157215989|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
48829165|NCT02503202|157215990|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
48829166|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
48829167|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
48829168|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
48829169|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
48829170|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
48829171|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Death|1|||
48829172|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Death|0|||
48829173|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Death|0|||
48829174|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Death|0|||
48829175|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Death|0|||
48829176|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
48829177|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
48829178|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
48829179|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
48829180|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
48829181|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Physician Decision|1|||
48829182|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Physician Decision|0|||
48829183|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Physician Decision|1|||
48829184|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Physician Decision|3|||
48829185|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Physician Decision|0|||
48829186|NCT02503202|157215986|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
48829187|NCT02503202|157215987|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
48829188|NCT02503202|157215988|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
48829189|NCT02503202|157215989|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
48829190|NCT02503202|157215990|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
48829191|NCT01549652|157215991|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
48829192|NCT01549652|157215992|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
48829193|NCT01549652|157215993|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
48829194|NCT01549652|157215994|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
48829195|NCT01549652|157215991|FG000|Overall Study|Study Drug Titration Failure|5|||
48829196|NCT01549652|157215992|FG001|Overall Study|Study Drug Titration Failure|6|||
48829197|NCT01549652|157215993|FG002|Overall Study|Study Drug Titration Failure|0|||
48829198|NCT01549652|157215994|FG003|Overall Study|Study Drug Titration Failure|0|||
48829199|NCT01549652|157215991|FG000|Overall Study|Withdrawal Effect|0|||
48829200|NCT01549652|157215992|FG001|Overall Study|Withdrawal Effect|2|||
48829201|NCT01549652|157215993|FG002|Overall Study|Withdrawal Effect|0|||
48829202|NCT01549652|157215994|FG003|Overall Study|Withdrawal Effect|0|||
48829203|NCT01549652|157215991|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
48829204|NCT01549652|157215992|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
48829205|NCT01549652|157215993|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
48829206|NCT01549652|157215994|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
48602308|NCT00715403|156399558|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
48602309|NCT00715403|156399559|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
48602310|NCT00715403|156399560|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
48602311|NCT00715403|156399561|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
48602312|NCT00715403|156399562|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
48602313|NCT00715403|156399556|FG000|Overall Study|Other Adverse Event than DLT|1|||
48602314|NCT00715403|156399557|FG001|Overall Study|Other Adverse Event than DLT|0|||
48602315|NCT00715403|156399558|FG002|Overall Study|Other Adverse Event than DLT|0|||
48602316|NCT00715403|156399559|FG003|Overall Study|Other Adverse Event than DLT|0|||
48602317|NCT00715403|156399560|FG004|Overall Study|Other Adverse Event than DLT|0|||
48602318|NCT00715403|156399561|FG005|Overall Study|Other Adverse Event than DLT|2|||
48602319|NCT00715403|156399562|FG006|Overall Study|Other Adverse Event than DLT|0|||
48602320|NCT00715403|156399556|FG000|Overall Study|Protocol Violation|0|||
48602321|NCT00715403|156399557|FG001|Overall Study|Protocol Violation|0|||
48602322|NCT00715403|156399558|FG002|Overall Study|Protocol Violation|0|||
48602323|NCT00715403|156399559|FG003|Overall Study|Protocol Violation|0|||
48602324|NCT00715403|156399560|FG004|Overall Study|Protocol Violation|0|||
48602325|NCT00715403|156399561|FG005|Overall Study|Protocol Violation|1|||
48602326|NCT00715403|156399562|FG006|Overall Study|Protocol Violation|0|||
48602327|NCT00715403|156399556|FG000|Overall Study|Other reason not defined above|0|||
48602328|NCT00715403|156399557|FG001|Overall Study|Other reason not defined above|0|||
48829207|NCT01549652|157215991|FG000|Overall Study|Problem with Infusion|1|||
48829208|NCT01549652|157215992|FG001|Overall Study|Problem with Infusion|0|||
48602329|NCT00715403|156399558|FG002|Overall Study|Other reason not defined above|1|||
48829209|NCT01549652|157215993|FG002|Overall Study|Problem with Infusion|0|||
48829210|NCT01549652|157215994|FG003|Overall Study|Problem with Infusion|0|||
48829211|NCT01549652|157215991|FG000|Overall Study|Titration Non-Compliance|1|||
48829212|NCT01549652|157215992|FG001|Overall Study|Titration Non-Compliance|3|||
48829213|NCT01549652|157215993|FG002|Overall Study|Titration Non-Compliance|4|||
48829214|NCT01549652|157215994|FG003|Overall Study|Titration Non-Compliance|5|||
48829215|NCT01549652|157215991|FG000|Overall Study|Titration Side Effects|0|||
48829216|NCT01549652|157215992|FG001|Overall Study|Titration Side Effects|0|||
48829217|NCT01549652|157215993|FG002|Overall Study|Titration Side Effects|6|||
48829218|NCT01549652|157215994|FG003|Overall Study|Titration Side Effects|3|||
48829219|NCT01549652|157215991|FG000|Overall Study|Withdrawal by Subject|0|||
48829220|NCT01549652|157215992|FG001|Overall Study|Withdrawal by Subject|0|||
48829221|NCT01549652|157215993|FG002|Overall Study|Withdrawal by Subject|5|||
48829222|NCT01549652|157215994|FG003|Overall Study|Withdrawal by Subject|3|||
48829223|NCT00586339|157215995|FG000|Overall Study|Withdrawal by Subject|1|||
48829224|NCT00586339|157215996|FG001|Overall Study|Withdrawal by Subject|3|||
48829225|NCT00586339|157215997|FG002|Overall Study|Withdrawal by Subject|1|||
48829226|NCT00586339|157215995|FG000|Overall Study|Migrated/moved from study area|3|||
48829227|NCT00586339|157215996|FG001|Overall Study|Migrated/moved from study area|2|||
48829228|NCT00586339|157215997|FG002|Overall Study|Migrated/moved from study area|4|||
48829229|NCT00586339|157215995|FG000|Overall Study|Lost to Follow-up|3|||
48829230|NCT00586339|157215996|FG001|Overall Study|Lost to Follow-up|2|||
48829231|NCT00586339|157215997|FG002|Overall Study|Lost to Follow-up|1|||
48829232|NCT01972152|157215998|FG000|First Treatment Visit|Lost to Follow-up|0|||
48829233|NCT01972152|157215999|FG001|First Treatment Visit|Lost to Follow-up|1|||
48829234|NCT01972152|157216000|FG002|First Treatment Visit|Lost to Follow-up|0|||
48829235|NCT01972152|157216001|FG003|First Treatment Visit|Lost to Follow-up|0|||
48829236|NCT01972152|157216002|FG004|First Treatment Visit|Lost to Follow-up|0|||
48829237|NCT01972152|157216003|FG005|First Treatment Visit|Lost to Follow-up|0|||
48829238|NCT01972152|157215998|FG000|Second Treatment Visit|Protocol Violation|0|||
48829239|NCT01972152|157215999|FG001|Second Treatment Visit|Protocol Violation|1|||
48829240|NCT01972152|157216000|FG002|Second Treatment Visit|Protocol Violation|0|||
48829241|NCT01972152|157216001|FG003|Second Treatment Visit|Protocol Violation|0|||
48829242|NCT01972152|157216002|FG004|Second Treatment Visit|Protocol Violation|0|||
48829243|NCT01972152|157216003|FG005|Second Treatment Visit|Protocol Violation|0|||
48829244|NCT01959412|157216004|FG000|Overall Study|Protocol deviation|1|||
48829245|NCT01959412|157216005|FG001|Overall Study|Protocol deviation|1|||
48829246|NCT01959412|157216006|FG002|Overall Study|Protocol deviation|0|||
48829247|NCT01959412|157216007|FG003|Overall Study|Protocol deviation|1|||
48829248|NCT01959412|157216008|FG004|Overall Study|Protocol deviation|3|||
48829249|NCT01959412|157216009|FG005|Overall Study|Protocol deviation|0|||
48829250|NCT01959412|157216004|FG000|Overall Study|Adverse Event|0|||
48829251|NCT01959412|157216005|FG001|Overall Study|Adverse Event|0|||
48829252|NCT01959412|157216006|FG002|Overall Study|Adverse Event|0|||
48829253|NCT01959412|157216007|FG003|Overall Study|Adverse Event|1|||
48829254|NCT01959412|157216008|FG004|Overall Study|Adverse Event|0|||
48829255|NCT01959412|157216009|FG005|Overall Study|Adverse Event|0|||
48829256|NCT04163458|157216010|FG000|Overall Study|Protocol Deviation|7|||
48829257|NCT04163458|157216011|FG001|Overall Study|Protocol Deviation|13|||
48829258|NCT04163458|157216010|FG000|Overall Study|Adverse Event|5|||
48829259|NCT04163458|157216011|FG001|Overall Study|Adverse Event|8|||
48829260|NCT04163458|157216010|FG000|Overall Study|Due to COVID-19 pandemic|4|||
48829261|NCT04163458|157216011|FG001|Overall Study|Due to COVID-19 pandemic|2|||
48829262|NCT04163458|157216010|FG000|Overall Study|Participant withdrew consent|2|||
48829263|NCT04163458|157216011|FG001|Overall Study|Participant withdrew consent|3|||
48829264|NCT04163458|157216010|FG000|Overall Study|Randomization failure|2|||
48829265|NCT04163458|157216011|FG001|Overall Study|Randomization failure|2|||
48829266|NCT04163458|157216010|FG000|Overall Study|Other|4|||
48829267|NCT04163458|157216011|FG001|Overall Study|Other|2|||
48829268|NCT05487703|157216013|FG000|Overall Study|Other|19|||
48829269|NCT05487703|157216013|FG000|Overall Study|Participant not well|5|||
48829270|NCT05487703|157216013|FG000|Overall Study|Insurance Reasons|6|||
48829271|NCT05487703|157216013|FG000|Overall Study|Physician Decision|19|||
48829272|NCT05487703|157216013|FG000|Overall Study|Lack of Efficacy|60|||
48829273|NCT03631199|157216014|FG000|Overall Study|Progressive disease|9|||
48829274|NCT03631199|157216015|FG001|Overall Study|Progressive disease|5|||
48829275|NCT03631199|157216016|FG002|Overall Study|Progressive disease|5|||
48829276|NCT03631199|157216017|FG003|Overall Study|Progressive disease|149|||
48829277|NCT03631199|157216018|FG004|Overall Study|Progressive disease|148|||
48829278|NCT03631199|157216014|FG000|Overall Study|Physician Decision|0|||
48829279|NCT03631199|157216015|FG001|Overall Study|Physician Decision|2|||
48829280|NCT03631199|157216016|FG002|Overall Study|Physician Decision|3|||
48829281|NCT03631199|157216017|FG003|Overall Study|Physician Decision|19|||
48829282|NCT03631199|157216018|FG004|Overall Study|Physician Decision|13|||
48829283|NCT03631199|157216014|FG000|Overall Study|Adverse Event|1|||
48829284|NCT03631199|157216015|FG001|Overall Study|Adverse Event|1|||
48829285|NCT03631199|157216016|FG002|Overall Study|Adverse Event|0|||
48829286|NCT03631199|157216017|FG003|Overall Study|Adverse Event|28|||
48829287|NCT03631199|157216018|FG004|Overall Study|Adverse Event|29|||
48829288|NCT03631199|157216014|FG000|Overall Study|Death|0|||
48829289|NCT03631199|157216015|FG001|Overall Study|Death|1|||
48829290|NCT03631199|157216016|FG002|Overall Study|Death|0|||
48829291|NCT03631199|157216017|FG003|Overall Study|Death|35|||
48829292|NCT03631199|157216018|FG004|Overall Study|Death|48|||
48829293|NCT03631199|157216014|FG000|Overall Study|Subject decision|0|||
48829294|NCT03631199|157216015|FG001|Overall Study|Subject decision|1|||
48829295|NCT03631199|157216016|FG002|Overall Study|Subject decision|0|||
48829296|NCT03631199|157216017|FG003|Overall Study|Subject decision|12|||
48829297|NCT03631199|157216018|FG004|Overall Study|Subject decision|12|||
48829298|NCT03631199|157216014|FG000|Overall Study|No treated|0|||
48829299|NCT03631199|157216015|FG001|Overall Study|No treated|0|||
48829300|NCT03631199|157216016|FG002|Overall Study|No treated|0|||
48829301|NCT03631199|157216017|FG003|Overall Study|No treated|0|||
48829302|NCT03631199|157216018|FG004|Overall Study|No treated|1|||
48829303|NCT03631199|157216014|FG000|Overall Study|Treatment ongoing|0|||
48829304|NCT03631199|157216015|FG001|Overall Study|Treatment ongoing|1|||
48829305|NCT03631199|157216016|FG002|Overall Study|Treatment ongoing|1|||
48829306|NCT03631199|157216017|FG003|Overall Study|Treatment ongoing|76|||
48829307|NCT03631199|157216018|FG004|Overall Study|Treatment ongoing|71|||
48829308|NCT03631199|157216014|FG000|Overall Study|Guardian decision|0|||
48829309|NCT03631199|157216015|FG001|Overall Study|Guardian decision|0|||
48829310|NCT03631199|157216016|FG002|Overall Study|Guardian decision|0|||
48829311|NCT03631199|157216017|FG003|Overall Study|Guardian decision|1|||
48829312|NCT03631199|157216018|FG004|Overall Study|Guardian decision|1|||
48829313|NCT03310983|157216019|FG000|Overall Study|Lost to Follow-up|15|||
48829314|NCT03310983|157216020|FG001|Overall Study|Lost to Follow-up|17|||
48829315|NCT03368001|157216022|FG000|Allocation|Lost to Pretest|16|||
48829316|NCT03368001|157216023|FG001|Allocation|Lost to Pretest|25|||
48829317|NCT03368001|157216022|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
48829318|NCT03368001|157216023|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
48829319|NCT03368001|157216022|FG000|Posttest|Lost to Posttest|7|||
48829320|NCT03368001|157216023|FG001|Posttest|Lost to Posttest|11|||
48829321|NCT03368001|157216022|FG000|Posttest|Discontinued Intervention|6|||
48829322|NCT03368001|157216023|FG001|Posttest|Discontinued Intervention|19|||
48829323|NCT03368001|157216022|FG000|Follow-up|Lost to Follow-up|6|||
48829324|NCT03368001|157216023|FG001|Follow-up|Lost to Follow-up|3|||
48829325|NCT01656304|157216024|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
48829326|NCT02824432|157216025|FG000|Overall Study|Major Protocol Deviation|1|||
48829327|NCT02824432|157216026|FG001|Overall Study|Major Protocol Deviation|0|||
48829328|NCT04436120|157216027|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829329|NCT04436120|157216028|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829330|NCT04436120|157216029|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829331|NCT04436120|157216030|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
48829332|NCT04436120|157216031|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829333|NCT04436120|157216032|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
48829334|NCT04436120|157216033|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
48829335|NCT01068249|157216034|FG000|Overall Study|Death|1|||
48829336|NCT01068249|157216034|FG000|Overall Study|Withdrawal by Subject|3|||
48829337|NCT03822351|157216035|FG000|Overall Study|Death|27|||
48829338|NCT03822351|157216036|FG001|Overall Study|Death|23|||
48829339|NCT03822351|157216037|FG002|Overall Study|Death|24|||
48829340|NCT03822351|157216035|FG000|Overall Study|Lost to Follow-up|6|||
48829341|NCT03822351|157216036|FG001|Overall Study|Lost to Follow-up|2|||
48829342|NCT03822351|157216037|FG002|Overall Study|Lost to Follow-up|1|||
48829343|NCT03822351|157216035|FG000|Overall Study|Withdrawal by Subject|10|||
48829344|NCT03822351|157216036|FG001|Overall Study|Withdrawal by Subject|4|||
48527616|NCT01730040|156124214|FG004|Overall Study|Randomized but not treated|0|||
48527617|NCT01730040|156124215|FG005|Overall Study|Randomized but not treated|1|||
48527618|NCT01730040|156124216|FG006|Overall Study|Randomized but not treated|0|||
48829345|NCT03822351|157216037|FG002|Overall Study|Withdrawal by Subject|6|||
48829346|NCT03822351|157216035|FG000|Overall Study|Progressive Disease|2|||
48829347|NCT03822351|157216036|FG001|Overall Study|Progressive Disease|1|||
48829348|NCT03822351|157216037|FG002|Overall Study|Progressive Disease|0|||
48829349|NCT03822351|157216035|FG000|Overall Study|Not Treated|1|||
48829350|NCT03822351|157216036|FG001|Overall Study|Not Treated|1|||
48829351|NCT03822351|157216037|FG002|Overall Study|Not Treated|1|||
48829352|NCT01311713|157216038|FG000|Overall Study|Death|0|||
48829353|NCT01311713|157216039|FG001|Overall Study|Death|0|||
48829354|NCT01311713|157216040|FG002|Overall Study|Death|1|||
48527619|NCT01730040|156124210|FG000|Overall Study|Subject moved|0|||
48829355|NCT01311713|157216041|FG003|Overall Study|Death|1|||
48829356|NCT01311713|157216042|FG004|Overall Study|Death|0|||
48829357|NCT01311713|157216043|FG005|Overall Study|Death|1|||
48829358|NCT01311713|157216044|FG006|Overall Study|Death|0|||
48829359|NCT01311713|157216038|FG000|Overall Study|Adverse Event|0|||
48829360|NCT01311713|157216039|FG001|Overall Study|Adverse Event|1|||
48829361|NCT01311713|157216040|FG002|Overall Study|Adverse Event|0|||
48829362|NCT01311713|157216041|FG003|Overall Study|Adverse Event|2|||
48829363|NCT01311713|157216042|FG004|Overall Study|Adverse Event|0|||
48829364|NCT01311713|157216043|FG005|Overall Study|Adverse Event|0|||
48527620|NCT01730040|156124211|FG001|Overall Study|Subject moved|0|||
48527621|NCT01730040|156124212|FG002|Overall Study|Subject moved|1|||
48527622|NCT01730040|156124213|FG003|Overall Study|Subject moved|0|||
48527623|NCT01730040|156124214|FG004|Overall Study|Subject moved|0|||
48527624|NCT01730040|156124215|FG005|Overall Study|Subject moved|0|||
48527625|NCT01730040|156124216|FG006|Overall Study|Subject moved|1|||
48527626|NCT01730040|156124210|FG000|Overall Study|Physician Decision|0|||
48527627|NCT01730040|156124211|FG001|Overall Study|Physician Decision|0|||
48527628|NCT01730040|156124212|FG002|Overall Study|Physician Decision|0|||
48527629|NCT01730040|156124213|FG003|Overall Study|Physician Decision|0|||
48527630|NCT01730040|156124214|FG004|Overall Study|Physician Decision|0|||
48527631|NCT01730040|156124215|FG005|Overall Study|Physician Decision|1|||
48527632|NCT01730040|156124216|FG006|Overall Study|Physician Decision|1|||
48527633|NCT01730040|156124210|FG000|Overall Study|Other than specified|7|||
48527634|NCT01730040|156124211|FG001|Overall Study|Other than specified|8|||
48527635|NCT01730040|156124212|FG002|Overall Study|Other than specified|5|||
48527636|NCT01730040|156124213|FG003|Overall Study|Other than specified|5|||
48527637|NCT01730040|156124214|FG004|Overall Study|Other than specified|5|||
48527638|NCT01730040|156124215|FG005|Overall Study|Other than specified|4|||
48527639|NCT01730040|156124216|FG006|Overall Study|Other than specified|4|||
48527640|NCT01730040|156124210|FG000|Overall Study|Adverse Event|4|||
48527641|NCT01730040|156124211|FG001|Overall Study|Adverse Event|3|||
48527642|NCT01730040|156124212|FG002|Overall Study|Adverse Event|5|||
48527643|NCT01730040|156124213|FG003|Overall Study|Adverse Event|3|||
48527644|NCT01730040|156124214|FG004|Overall Study|Adverse Event|1|||
48527645|NCT01730040|156124215|FG005|Overall Study|Adverse Event|1|||
48527646|NCT01730040|156124216|FG006|Overall Study|Adverse Event|2|||
48527647|NCT01730040|156124210|FG000|Overall Study|Poor compliance to protocol|2|||
48527648|NCT01730040|156124211|FG001|Overall Study|Poor compliance to protocol|4|||
48527649|NCT01730040|156124212|FG002|Overall Study|Poor compliance to protocol|0|||
48527650|NCT01730040|156124213|FG003|Overall Study|Poor compliance to protocol|0|||
48527651|NCT01730040|156124214|FG004|Overall Study|Poor compliance to protocol|0|||
48527652|NCT01730040|156124215|FG005|Overall Study|Poor compliance to protocol|0|||
48527653|NCT01730040|156124216|FG006|Overall Study|Poor compliance to protocol|1|||
48527654|NCT02457819|156124223|FG000|Overall Study|reason not given|8|||
48527655|NCT02457819|156124223|FG000|Overall Study|Withdrawal by Subject|24|||
48527656|NCT02457819|156124223|FG000|Overall Study|Protocol Violation|1|||
48527657|NCT02457819|156124223|FG000|Overall Study|non compliance with study drug|4|||
48527658|NCT02457819|156124223|FG000|Overall Study|Lost to Follow-up|10|||
48527659|NCT02457819|156124223|FG000|Overall Study|Lack of Efficacy|19|||
48527660|NCT02457819|156124223|FG000|Overall Study|Adverse Event|33|||
48527661|NCT00969124|156124224|FG000|Overall Study|Protocol Violation|2|||
48527662|NCT00969124|156124224|FG000|Overall Study|Inadequate bowel preparation|15|||
48527663|NCT00969124|156124224|FG000|Overall Study|Inability to reach cecum|9|||
48527664|NCT00969124|156124224|FG000|Overall Study|Previously unrecognized disease|3|||
48527665|NCT00969124|156124224|FG000|Overall Study|Technical error|1|||
48527666|NCT01478828|156124226|FG000|Overall Study|Adverse Event|1|||
48527667|NCT03379675|156124227|FG000|Overall Study|Lost to Follow-up|0|||
48527668|NCT03379675|156124228|FG001|Overall Study|Lost to Follow-up|1|||
48527669|NCT03379675|156124229|FG002|Overall Study|Lost to Follow-up|0|||
48527670|NCT03379675|156124227|FG000|Overall Study|Adverse Event|2|||
48527671|NCT03379675|156124228|FG001|Overall Study|Adverse Event|0|||
48527672|NCT03379675|156124229|FG002|Overall Study|Adverse Event|0|||
48527673|NCT03379675|156124227|FG000|Overall Study|Withdrawal by Subject|2|||
48527674|NCT03379675|156124228|FG001|Overall Study|Withdrawal by Subject|1|||
48527675|NCT03379675|156124229|FG002|Overall Study|Withdrawal by Subject|2|||
48527676|NCT04625283|156124230|FG000|Overall Study|post randomization exclusion|28|||
48602330|NCT00715403|156399559|FG003|Overall Study|Other reason not defined above|0|||
48602331|NCT00715403|156399560|FG004|Overall Study|Other reason not defined above|1|||
48527677|NCT04625283|156124231|FG001|Overall Study|post randomization exclusion|20|||
48527678|NCT00779402|156124232|FG000|Treatment Phase 1|Disease Progression|1|||
48527679|NCT00779402|156124233|FG001|Treatment Phase 1|Disease Progression|0|||
48527680|NCT00779402|156124232|FG000|Treatment Phase 1|Adverse Event|2|||
48527681|NCT00779402|156124233|FG001|Treatment Phase 1|Adverse Event|0|||
48527682|NCT00779402|156124232|FG000|Treatment Phase 1|Protocol Violation|1|||
48527683|NCT00779402|156124233|FG001|Treatment Phase 1|Protocol Violation|0|||
48527684|NCT00779402|156124232|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
48527685|NCT00779402|156124233|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
48527686|NCT00779402|156124232|FG000|Treatment Phase 1|Lost to Follow-up|0|||
48527687|NCT00779402|156124233|FG001|Treatment Phase 1|Lost to Follow-up|1|||
48527688|NCT00779402|156124232|FG000|Treatment Phase 1|Death|0|||
48527689|NCT00779402|156124233|FG001|Treatment Phase 1|Death|1|||
48527690|NCT00779402|156124232|FG000|Treatment Phase 1|Intercurrent Illness|1|||
48829365|NCT01311713|157216044|FG006|Overall Study|Adverse Event|2|||
48527691|NCT00779402|156124233|FG001|Treatment Phase 1|Intercurrent Illness|1|||
48527692|NCT00779402|156124232|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
48527693|NCT00779402|156124233|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
48527694|NCT00779402|156124232|FG000|Treatment Phase 1|Other|4|||
48829366|NCT01311713|157216038|FG000|Overall Study|Withdrawal by Subject|0|||
48829367|NCT01311713|157216039|FG001|Overall Study|Withdrawal by Subject|1|||
48829368|NCT01311713|157216040|FG002|Overall Study|Withdrawal by Subject|1|||
48829369|NCT01311713|157216041|FG003|Overall Study|Withdrawal by Subject|0|||
48829370|NCT01311713|157216042|FG004|Overall Study|Withdrawal by Subject|0|||
48829371|NCT01311713|157216043|FG005|Overall Study|Withdrawal by Subject|1|||
48829372|NCT01311713|157216044|FG006|Overall Study|Withdrawal by Subject|2|||
48829373|NCT01311713|157216038|FG000|Overall Study|Disease progression|3|||
48829374|NCT01311713|157216039|FG001|Overall Study|Disease progression|4|||
48829375|NCT01311713|157216040|FG002|Overall Study|Disease progression|3|||
48829376|NCT01311713|157216041|FG003|Overall Study|Disease progression|2|||
48829377|NCT01311713|157216042|FG004|Overall Study|Disease progression|4|||
48829378|NCT01311713|157216043|FG005|Overall Study|Disease progression|4|||
48829379|NCT01311713|157216044|FG006|Overall Study|Disease progression|5|||
48829380|NCT01311713|157216038|FG000|Overall Study|Lost to Follow-up|0|||
48829381|NCT01311713|157216039|FG001|Overall Study|Lost to Follow-up|0|||
48829382|NCT01311713|157216040|FG002|Overall Study|Lost to Follow-up|1|||
48829383|NCT01311713|157216041|FG003|Overall Study|Lost to Follow-up|0|||
48829384|NCT01311713|157216042|FG004|Overall Study|Lost to Follow-up|0|||
48829385|NCT01311713|157216043|FG005|Overall Study|Lost to Follow-up|0|||
48829386|NCT01311713|157216044|FG006|Overall Study|Lost to Follow-up|0|||
48829387|NCT01311713|157216038|FG000|Overall Study|Stopped taking study medication|0|||
48829388|NCT01311713|157216039|FG001|Overall Study|Stopped taking study medication|0|||
48829389|NCT01311713|157216040|FG002|Overall Study|Stopped taking study medication|0|||
48829390|NCT01311713|157216041|FG003|Overall Study|Stopped taking study medication|1|||
48829391|NCT01311713|157216042|FG004|Overall Study|Stopped taking study medication|1|||
48829392|NCT01311713|157216043|FG005|Overall Study|Stopped taking study medication|0|||
48829393|NCT01311713|157216044|FG006|Overall Study|Stopped taking study medication|0|||
48829394|NCT01311713|157216038|FG000|Overall Study|Enrolled but not treated|0|||
48829395|NCT01311713|157216039|FG001|Overall Study|Enrolled but not treated|0|||
48829396|NCT01311713|157216040|FG002|Overall Study|Enrolled but not treated|1|||
48829397|NCT01311713|157216041|FG003|Overall Study|Enrolled but not treated|0|||
48829398|NCT01311713|157216042|FG004|Overall Study|Enrolled but not treated|0|||
48829399|NCT01311713|157216043|FG005|Overall Study|Enrolled but not treated|0|||
48829400|NCT01311713|157216044|FG006|Overall Study|Enrolled but not treated|0|||
48829401|NCT01311713|157216038|FG000|Overall Study|Other than specified|0|||
48829402|NCT01311713|157216039|FG001|Overall Study|Other than specified|1|||
48829403|NCT01311713|157216040|FG002|Overall Study|Other than specified|2|||
48829404|NCT01311713|157216041|FG003|Overall Study|Other than specified|0|||
48829405|NCT01311713|157216042|FG004|Overall Study|Other than specified|0|||
48829406|NCT01311713|157216043|FG005|Overall Study|Other than specified|0|||
48829407|NCT01311713|157216044|FG006|Overall Study|Other than specified|0|||
48829408|NCT01560949|157216045|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
48829409|NCT01560949|157216045|FG000|Surgery Phase|Physician Decision|3|||
48829410|NCT05526911|157217448|FG000|Overall Study|Adverse Event|2|||
48829411|NCT00946114|157217454|FG000|Overall Study|Death|5|||
48829412|NCT00946114|157217455|FG001|Overall Study|Death|2|||
48829413|NCT00946114|157217454|FG000|Overall Study|Other|1|||
48829414|NCT00946114|157217455|FG001|Overall Study|Other|0|||
48829415|NCT00946114|157217454|FG000|Overall Study|Withdrawal by Subject|2|||
48829416|NCT00946114|157217455|FG001|Overall Study|Withdrawal by Subject|0|||
48829417|NCT02380742|157217456|FG000|Overall Study|Withdrawal by Subject|1|||
48829418|NCT02380742|157217457|FG001|Overall Study|Withdrawal by Subject|0|||
48444852|NCT04019795|155816976|FG002|Overall Study|Physician Decision|1|||
48444853|NCT04019795|155816977|FG003|Overall Study|Physician Decision|0|||
48444854|NCT04019795|155816974|FG000|Overall Study|Adverse Event|1|||
48444855|NCT04019795|155816975|FG001|Overall Study|Adverse Event|0|||
48444856|NCT04019795|155816976|FG002|Overall Study|Adverse Event|0|||
48444857|NCT04019795|155816977|FG003|Overall Study|Adverse Event|0|||
48444858|NCT04671342|155816978|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
48444859|NCT04671342|155816978|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
48444860|NCT04671342|155816978|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
48444861|NCT04671342|155816978|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
48444862|NCT04671342|155816978|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
48444863|NCT04671342|155816978|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
48444864|NCT01231607|155816981|FG000|Overall Study|Adverse Event|0|||
48444865|NCT01231607|155816982|FG001|Overall Study|Adverse Event|8|||
48444866|NCT01231607|155816983|FG002|Overall Study|Adverse Event|4|||
48444867|NCT01231607|155816984|FG003|Overall Study|Adverse Event|4|||
48444868|NCT01231607|155816985|FG004|Overall Study|Adverse Event|5|||
48444869|NCT01231607|155816981|FG000|Overall Study|Lost to Follow-up|13|||
48444870|NCT01231607|155816982|FG001|Overall Study|Lost to Follow-up|11|||
48444871|NCT01231607|155816983|FG002|Overall Study|Lost to Follow-up|10|||
48444872|NCT01231607|155816984|FG003|Overall Study|Lost to Follow-up|10|||
48444873|NCT01231607|155816985|FG004|Overall Study|Lost to Follow-up|4|||
48444874|NCT01231607|155816981|FG000|Overall Study|Physician Decision|4|||
48527695|NCT00779402|156124233|FG001|Treatment Phase 1|Other|2|||
48527696|NCT00779402|156124232|FG000|Treatment Phase 1|Closure of Study|3|||
48527697|NCT00779402|156124233|FG001|Treatment Phase 1|Closure of Study|2|||
48527698|NCT00779402|156124232|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
48527699|NCT00779402|156124233|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
48527700|NCT00779402|156124232|FG000|Surveillance Phase|Protocol Violation|0|||
48527701|NCT00779402|156124233|FG001|Surveillance Phase|Protocol Violation|1|||
48527702|NCT00779402|156124232|FG000|Surveillance Phase|Patient refused to continue|22|||
48527703|NCT00779402|156124233|FG001|Surveillance Phase|Patient refused to continue|14|||
48527704|NCT00779402|156124232|FG000|Surveillance Phase|Lost to Follow-up|2|||
48527705|NCT00779402|156124233|FG001|Surveillance Phase|Lost to Follow-up|1|||
48527706|NCT00779402|156124232|FG000|Surveillance Phase|Death|0|||
48527707|NCT00779402|156124233|FG001|Surveillance Phase|Death|1|||
48527708|NCT00779402|156124232|FG000|Surveillance Phase|Intercurrent Illness|2|||
48527709|NCT00779402|156124233|FG001|Surveillance Phase|Intercurrent Illness|0|||
48527710|NCT00779402|156124232|FG000|Surveillance Phase|Other|5|||
48527711|NCT00779402|156124233|FG001|Surveillance Phase|Other|5|||
48527712|NCT00779402|156124232|FG000|Surveillance Phase|Withdrawal by Subject|4|||
48527713|NCT00779402|156124233|FG001|Surveillance Phase|Withdrawal by Subject|1|||
48527714|NCT00779402|156124232|FG000|Surveillance Phase|Closure of study|5|||
48527715|NCT00779402|156124233|FG001|Surveillance Phase|Closure of study|6|||
48527716|NCT00779402|156124232|FG000|Surveillance Phase|Completed Protocol Visits|3|||
48527717|NCT00779402|156124233|FG001|Surveillance Phase|Completed Protocol Visits|2|||
48527718|NCT00779402|156124232|FG000|Long-term Follow-up|Patient refused to continue|2|||
48527719|NCT00779402|156124233|FG001|Long-term Follow-up|Patient refused to continue|0|||
48527720|NCT00779402|156124232|FG000|Long-term Follow-up|Other|5|||
48527721|NCT00779402|156124233|FG001|Long-term Follow-up|Other|0|||
48527722|NCT00779402|156124232|FG000|Long-term Follow-up|Closure of Study|8|||
48527723|NCT00779402|156124233|FG001|Long-term Follow-up|Closure of Study|4|||
48527724|NCT00779402|156124232|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
48527725|NCT00779402|156124233|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
48527726|NCT03847194|156124239|FG000|Overall Study|Lost to Follow-up|2|||
48527727|NCT03847194|156124240|FG001|Overall Study|Lost to Follow-up|5|||
48527728|NCT03847194|156124239|FG000|Overall Study|Withdrawal by Subject|1|||
48527729|NCT03847194|156124240|FG001|Overall Study|Withdrawal by Subject|2|||
48527730|NCT03847194|156124239|FG000|Overall Study|Death|0|||
48527731|NCT03847194|156124240|FG001|Overall Study|Death|1|||
48527732|NCT04084574|156124243|FG000|Overall Study|Lost to Follow-up|1|||
48527733|NCT04084574|156124244|FG001|Overall Study|Lost to Follow-up|0|||
48527734|NCT04084574|156124243|FG000|Overall Study|Physician Decision|1|||
48527735|NCT04084574|156124244|FG001|Overall Study|Physician Decision|0|||
48527736|NCT04084574|156124243|FG000|Overall Study|Relocated out of state|1|||
48527737|NCT04084574|156124244|FG001|Overall Study|Relocated out of state|0|||
48527738|NCT02408120|156124245|FG000|Overall Study|Withdrawal by Subject|0|||
48527739|NCT02408120|156124246|FG001|Overall Study|Withdrawal by Subject|1|||
48527740|NCT02408120|156124245|FG000|Overall Study|Treatment Refusal|1|||
48527741|NCT02408120|156124246|FG001|Overall Study|Treatment Refusal|0|||
48527742|NCT02408120|156124245|FG000|Overall Study|Received Steroids|1|||
48527743|NCT02408120|156124246|FG001|Overall Study|Received Steroids|1|||
48527744|NCT02408120|156124245|FG000|Overall Study|Discharged same day|1|||
48527745|NCT02408120|156124246|FG001|Overall Study|Discharged same day|1|||
48527746|NCT02408120|156124245|FG000|Overall Study|Did not receive insulin|1|||
48527747|NCT02408120|156124246|FG001|Overall Study|Did not receive insulin|2|||
48527748|NCT00373425|156124247|FG000|Overall Study|Relapse of NSCLC|116|||
48527749|NCT00373425|156124248|FG001|Overall Study|Relapse of NSCLC|104|||
48527750|NCT00373425|156124249|FG002|Overall Study|Relapse of NSCLC|19|||
48527751|NCT00373425|156124250|FG003|Overall Study|Relapse of NSCLC|2|||
48527752|NCT00373425|156124251|FG004|Overall Study|Relapse of NSCLC|26|||
48829419|NCT02955069|157217461|FG000|Overall Study|Adverse Event|7|||
48829420|NCT02955069|157217462|FG001|Overall Study|Adverse Event|2|||
48829421|NCT02955069|157217461|FG000|Overall Study|Death|7|||
48829422|NCT02955069|157217462|FG001|Overall Study|Death|3|||
48829423|NCT02955069|157217461|FG000|Overall Study|Physician Decision|10|||
48829424|NCT02955069|157217462|FG001|Overall Study|Physician Decision|2|||
48829425|NCT02955069|157217461|FG000|Overall Study|Progressive disease|64|||
48829426|NCT02955069|157217462|FG001|Overall Study|Progressive disease|13|||
48829427|NCT02955069|157217461|FG000|Overall Study|Study terminated by sponsor|4|||
48829428|NCT02955069|157217462|FG001|Overall Study|Study terminated by sponsor|0|||
48829429|NCT02955069|157217461|FG000|Overall Study|Subject/Guardian decision|3|||
48829430|NCT02955069|157217462|FG001|Overall Study|Subject/Guardian decision|1|||
48829431|NCT01149681|157217464|FG000|Overall Study|Withdrawal by Subject|7|||
48829432|NCT01149681|157217464|FG000|Overall Study|Progressive disease|1|||
48829433|NCT01149681|157217464|FG000|Overall Study|Physician Decision|2|||
48829434|NCT01149681|157217464|FG000|Overall Study|adverse events nonrelated study drug|2|||
48527753|NCT00373425|156124247|FG000|Overall Study|Adverse Event|191|||
48829435|NCT02232178|157217465|FG000|Overall Study|Lost to Follow-up|0|||
48527754|NCT00373425|156124248|FG001|Overall Study|Adverse Event|22|||
48527755|NCT00373425|156124249|FG002|Overall Study|Adverse Event|59|||
48527756|NCT00373425|156124250|FG003|Overall Study|Adverse Event|0|||
48527757|NCT00373425|156124251|FG004|Overall Study|Adverse Event|34|||
48527758|NCT00373425|156124247|FG000|Overall Study|Patient request|35|||
48527759|NCT00373425|156124248|FG001|Overall Study|Patient request|18|||
48829436|NCT02232178|157217466|FG001|Overall Study|Lost to Follow-up|1|||
48829437|NCT02232178|157217467|FG002|Overall Study|Lost to Follow-up|0|||
48829438|NCT02232178|157217465|FG000|Overall Study|ineligibility|0|||
48829439|NCT02232178|157217466|FG001|Overall Study|ineligibility|0|||
48829440|NCT02232178|157217467|FG002|Overall Study|ineligibility|1|||
48829441|NCT02232178|157217465|FG000|Overall Study|surgical complication|1|||
48829442|NCT02232178|157217466|FG001|Overall Study|surgical complication|0|||
48829443|NCT02232178|157217467|FG002|Overall Study|surgical complication|0|||
48829444|NCT03357341|157217468|FG000|Overall Study|Withdrawal by Subject|3|||
48829445|NCT03357341|157217469|FG001|Overall Study|Withdrawal by Subject|6|||
48829446|NCT03357341|157217468|FG000|Overall Study|Lost to Follow-up|4|||
48829447|NCT03357341|157217469|FG001|Overall Study|Lost to Follow-up|5|||
48829448|NCT03357341|157217468|FG000|Overall Study|Death|0|||
48829449|NCT03357341|157217469|FG001|Overall Study|Death|1|||
48829450|NCT03107611|157217470|FG000|Overall Study|Adverse Event|1|||
48829451|NCT03107611|157217471|FG001|Overall Study|Adverse Event|0|||
48829452|NCT03107611|157217472|FG002|Overall Study|Adverse Event|2|||
48829453|NCT03107611|157217470|FG000|Overall Study|Lost to Follow-up|3|||
48829454|NCT03107611|157217471|FG001|Overall Study|Lost to Follow-up|3|||
48829455|NCT03107611|157217472|FG002|Overall Study|Lost to Follow-up|3|||
48829456|NCT03107611|157217470|FG000|Overall Study|Protocol Violation|0|||
48829457|NCT03107611|157217471|FG001|Overall Study|Protocol Violation|0|||
48829458|NCT03107611|157217472|FG002|Overall Study|Protocol Violation|1|||
48829459|NCT03107611|157217470|FG000|Overall Study|Withdrawal by Subject|1|||
48829460|NCT03107611|157217471|FG001|Overall Study|Withdrawal by Subject|0|||
48527760|NCT00373425|156124249|FG002|Overall Study|Patient request|43|||
48527761|NCT00373425|156124250|FG003|Overall Study|Patient request|6|||
48527762|NCT00373425|156124251|FG004|Overall Study|Patient request|7|||
48527763|NCT00373425|156124247|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
48527764|NCT00373425|156124248|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
48527765|NCT00373425|156124249|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
48527766|NCT00373425|156124250|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
48527767|NCT00373425|156124251|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
48527768|NCT00373425|156124247|FG000|Overall Study|Death|7|||
48527769|NCT00373425|156124248|FG001|Overall Study|Death|0|||
48527770|NCT00373425|156124249|FG002|Overall Study|Death|3|||
48527771|NCT00373425|156124250|FG003|Overall Study|Death|1|||
48829461|NCT03107611|157217472|FG002|Overall Study|Withdrawal by Subject|1|||
48829462|NCT03107611|157217470|FG000|Overall Study|Worsening signs/symptoms|2|||
48829463|NCT03107611|157217471|FG001|Overall Study|Worsening signs/symptoms|1|||
48829464|NCT03107611|157217472|FG002|Overall Study|Worsening signs/symptoms|2|||
48829465|NCT03635112|157217473|FG000|Overall Study|Adverse Event|5|||
48829466|NCT03635112|157217474|FG001|Overall Study|Adverse Event|9|||
48829467|NCT03635112|157217475|FG002|Overall Study|Adverse Event|14|||
48829468|NCT03635112|157217473|FG000|Overall Study|Lost to Follow-up|1|||
48829469|NCT03635112|157217474|FG001|Overall Study|Lost to Follow-up|0|||
48829470|NCT03635112|157217475|FG002|Overall Study|Lost to Follow-up|1|||
48829471|NCT03635112|157217473|FG000|Overall Study|Physician Decision|5|||
48829472|NCT03635112|157217474|FG001|Overall Study|Physician Decision|7|||
48829473|NCT03635112|157217475|FG002|Overall Study|Physician Decision|5|||
48829474|NCT03635112|157217473|FG000|Overall Study|Protocol Violation|0|||
48829475|NCT03635112|157217474|FG001|Overall Study|Protocol Violation|0|||
48829476|NCT03635112|157217475|FG002|Overall Study|Protocol Violation|1|||
48829477|NCT03635112|157217473|FG000|Overall Study|Study Terminated by Sponsor|11|||
48829478|NCT03635112|157217474|FG001|Overall Study|Study Terminated by Sponsor|17|||
48829479|NCT03635112|157217475|FG002|Overall Study|Study Terminated by Sponsor|21|||
48829480|NCT03635112|157217473|FG000|Overall Study|Withdrawal by Subject|4|||
48829481|NCT03635112|157217474|FG001|Overall Study|Withdrawal by Subject|9|||
48829482|NCT03635112|157217475|FG002|Overall Study|Withdrawal by Subject|7|||
48829483|NCT03635112|157217473|FG000|Overall Study|Miscellaneous|0|||
48829484|NCT03635112|157217474|FG001|Overall Study|Miscellaneous|0|||
48829485|NCT03635112|157217475|FG002|Overall Study|Miscellaneous|1|||
48527772|NCT00373425|156124251|FG004|Overall Study|Death|0|||
48829486|NCT00930813|157217476|FG000|Overall Study|Death|4|||
48829487|NCT00930813|157217477|FG001|Overall Study|Death|5|||
48829488|NCT00930813|157217476|FG000|Overall Study|Withdrawal by Subject|2|||
48829489|NCT00930813|157217477|FG001|Overall Study|Withdrawal by Subject|5|||
48829490|NCT00930813|157217476|FG000|Overall Study|Lost to Follow-up|2|||
48829491|NCT00930813|157217477|FG001|Overall Study|Lost to Follow-up|4|||
48829492|NCT01876511|157217478|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
48829493|NCT01876511|157217479|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
48829494|NCT01876511|157217480|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
48829495|NCT01876511|157217478|FG000|Overall Study|Death (unrelated)|3|||
48829496|NCT01876511|157217479|FG001|Overall Study|Death (unrelated)|0|||
48829497|NCT01876511|157217480|FG002|Overall Study|Death (unrelated)|2|||
48829498|NCT01876511|157217478|FG000|Overall Study|Drug-related Toxicity|5|||
48829499|NCT01876511|157217479|FG001|Overall Study|Drug-related Toxicity|1|||
48829500|NCT01876511|157217480|FG002|Overall Study|Drug-related Toxicity|6|||
48829501|NCT01876511|157217478|FG000|Overall Study|Patient Decision|3|||
48829502|NCT01876511|157217479|FG001|Overall Study|Patient Decision|0|||
48829503|NCT01876511|157217480|FG002|Overall Study|Patient Decision|6|||
48829504|NCT01876511|157217478|FG000|Overall Study|Physician Decision|1|||
48829505|NCT01876511|157217479|FG001|Overall Study|Physician Decision|0|||
48829506|NCT01876511|157217480|FG002|Overall Study|Physician Decision|1|||
48829507|NCT02145182|157217485|FG000|Overall Study|Adverse Event|4|||
48829508|NCT02145182|157217486|FG001|Overall Study|Adverse Event|1|||
48829509|NCT02145182|157217485|FG000|Overall Study|Death|7|||
48829510|NCT02145182|157217486|FG001|Overall Study|Death|7|||
48829511|NCT02145182|157217485|FG000|Overall Study|Lost to Follow-up|2|||
48829512|NCT02145182|157217486|FG001|Overall Study|Lost to Follow-up|2|||
48829513|NCT02145182|157217485|FG000|Overall Study|Pre-transplant Withdrawal|0|||
48829514|NCT02145182|157217486|FG001|Overall Study|Pre-transplant Withdrawal|2|||
48829515|NCT02145182|157217485|FG000|Overall Study|Withdrawal by Subject|5|||
48829516|NCT02145182|157217486|FG001|Overall Study|Withdrawal by Subject|4|||
48829517|NCT03999554|157217488|FG000|Overall Study|Lost to Follow-up|4|||
48829518|NCT03999554|157217489|FG001|Overall Study|Lost to Follow-up|5|||
48829519|NCT03999554|157217490|FG002|Overall Study|Lost to Follow-up|4|||
48829520|NCT03999554|157217491|FG003|Overall Study|Lost to Follow-up|5|||
48829521|NCT03999554|157217492|FG004|Overall Study|Lost to Follow-up|8|||
48829522|NCT03999554|157217488|FG000|Overall Study|Protocol Violation|0|||
48829523|NCT03999554|157217489|FG001|Overall Study|Protocol Violation|0|||
48829524|NCT03999554|157217490|FG002|Overall Study|Protocol Violation|5|||
48829525|NCT03999554|157217491|FG003|Overall Study|Protocol Violation|0|||
48829526|NCT03999554|157217492|FG004|Overall Study|Protocol Violation|0|||
48829527|NCT03999554|157217488|FG000|Overall Study|Pregnancy|0|||
48829528|NCT03999554|157217489|FG001|Overall Study|Pregnancy|0|||
48829529|NCT03999554|157217490|FG002|Overall Study|Pregnancy|1|||
48829530|NCT03999554|157217491|FG003|Overall Study|Pregnancy|0|||
48829531|NCT03999554|157217492|FG004|Overall Study|Pregnancy|0|||
48829532|NCT03999554|157217488|FG000|Overall Study|Withdrawal by Subject|2|||
48829533|NCT03999554|157217489|FG001|Overall Study|Withdrawal by Subject|2|||
48829534|NCT03999554|157217490|FG002|Overall Study|Withdrawal by Subject|2|||
48829535|NCT03999554|157217491|FG003|Overall Study|Withdrawal by Subject|1|||
48829536|NCT03999554|157217492|FG004|Overall Study|Withdrawal by Subject|1|||
48829537|NCT03999554|157217488|FG000|Overall Study|failure to comply with protocol requirements|0|||
48829538|NCT03999554|157217489|FG001|Overall Study|failure to comply with protocol requirements|0|||
48829539|NCT03999554|157217490|FG002|Overall Study|failure to comply with protocol requirements|0|||
48829540|NCT03999554|157217491|FG003|Overall Study|failure to comply with protocol requirements|1|||
48829541|NCT03999554|157217492|FG004|Overall Study|failure to comply with protocol requirements|0|||
48829542|NCT03006341|157217493|FG000|Overall Study|Not linked in the EMR|25069|||
48829543|NCT03006341|157217494|FG001|Overall Study|Not linked in the EMR|67505|||
48829544|NCT03006341|157217495|FG002|Overall Study|Not linked in the EMR|30993|||
48829545|NCT03006341|157217496|FG003|Overall Study|Not linked in the EMR|10685|||
48829546|NCT04337489|157217497|FG000|Overall Study|Withdrawal by Subject|1|||
48829547|NCT01695317|157217498|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
48527773|NCT03558139|156124252|FG000|Overall Study|Consent Withdrawn|1|||
48527774|NCT03558139|156124253|FG001|Overall Study|Consent Withdrawn|1|||
48527775|NCT03558139|156124254|FG002|Overall Study|Consent Withdrawn|4|||
48527776|NCT03558139|156124252|FG000|Overall Study|Death|5|||
48527777|NCT03558139|156124253|FG001|Overall Study|Death|3|||
48527778|NCT03558139|156124254|FG002|Overall Study|Death|8|||
48829548|NCT01695317|157217499|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
48829549|NCT01695317|157217498|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
48829550|NCT01695317|157217499|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
48829551|NCT03055767|157217500|FG000|Open-Label Period|Lost to Follow-up|0|||
48829552|NCT03055767|157217501|FG001|Open-Label Period|Lost to Follow-up|0|||
48829553|NCT03055767|157217502|FG002|Open-Label Period|Lost to Follow-up|2|||
48527779|NCT03558139|156124252|FG000|Overall Study|Lost to Follow-up|0|||
48527780|NCT03558139|156124253|FG001|Overall Study|Lost to Follow-up|0|||
48829554|NCT03055767|157217503|FG003|Open-Label Period|Lost to Follow-up|0|||
48829555|NCT03055767|157217500|FG000|Open-Label Period|Withdrawal by Subject|0|||
48829556|NCT03055767|157217501|FG001|Open-Label Period|Withdrawal by Subject|0|||
48829557|NCT03055767|157217502|FG002|Open-Label Period|Withdrawal by Subject|0|||
48829558|NCT03055767|157217503|FG003|Open-Label Period|Withdrawal by Subject|1|||
48829559|NCT02759731|157217504|FG000|Overall Study|Did not complete treatment.|8|||
48829560|NCT00957229|157217508|FG000|Study Start|Adverse Event|0|||
48829561|NCT00957229|157217509|FG001|Study Start|Adverse Event|3|||
48829562|NCT00957229|157217508|FG000|Study Start|Disease Progression|1|||
48829563|NCT00957229|157217509|FG001|Study Start|Disease Progression|0|||
48829564|NCT00957229|157217508|FG000|Reallocated to or Continued Vismodegib|Death|1|||
48527781|NCT03558139|156124254|FG002|Overall Study|Lost to Follow-up|3|||
48602332|NCT00715403|156399561|FG005|Overall Study|Other reason not defined above|1|||
48602333|NCT00715403|156399562|FG006|Overall Study|Other reason not defined above|0|||
48602334|NCT02700048|156399563|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
48602335|NCT02700048|156399564|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
48602336|NCT01316224|156399565|FG000|Overall Study|Protocol Violation|3|||
48602337|NCT01316224|156399565|FG000|Overall Study|Adverse Event|3|||
48602338|NCT01316224|156399565|FG000|Overall Study|Lack of Efficacy|1|||
48602339|NCT01316224|156399565|FG000|Overall Study|Withdrawal by Subject|1|||
48602340|NCT01316224|156399565|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
48602341|NCT01316224|156399565|FG000|Overall Study|Other|1|||
48602342|NCT02175225|156399566|FG000|Overall Study|Withdrawal by Subject|1|||
48602343|NCT02175225|156399567|FG001|Overall Study|Withdrawal by Subject|2|||
48829565|NCT00957229|157217509|FG001|Reallocated to or Continued Vismodegib|Death|1|||
48829566|NCT00957229|157217508|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
48829567|NCT00957229|157217509|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
48829568|NCT05193318|157217510|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
48527782|NCT03558139|156124252|FG000|Overall Study|Study Ended Per Protocol|0|||
48527783|NCT03558139|156124253|FG001|Overall Study|Study Ended Per Protocol|3|||
48829569|NCT05193318|157217510|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
48829570|NCT02299635|157217511|FG000|Overall Study|Adverse Event|2|||
48829571|NCT02299635|157217511|FG000|Overall Study|Death|1|||
48829572|NCT02299635|157217511|FG000|Overall Study|Global deterioration of health status|1|||
48829573|NCT02299635|157217511|FG000|Overall Study|Objective progression or relapse|10|||
48829574|NCT02299635|157217511|FG000|Overall Study|Withdrawal by Subject|2|||
48829575|NCT02299635|157217511|FG000|Overall Study|Other|3|||
48527784|NCT03558139|156124254|FG002|Overall Study|Study Ended Per Protocol|6|||
48829576|NCT00927823|157217512|FG000|Continuous Dosing Period|Death|0|||
48829577|NCT00927823|157217513|FG001|Continuous Dosing Period|Death|0|||
48829578|NCT00927823|157217514|FG002|Continuous Dosing Period|Death|6|||
48527785|NCT02363439|156124255|FG000|Overall Study|Lack of Efficacy|4|||
48527786|NCT04439110|156124256|FG000|Overall Study|Ineligible|2|||
48527787|NCT04439110|156124256|FG000|Overall Study|Adverse Event|4|||
48602344|NCT02175225|156399566|FG000|Overall Study|Lost to Follow-up|6|||
48602345|NCT02175225|156399567|FG001|Overall Study|Lost to Follow-up|7|||
48527788|NCT04439110|156124256|FG000|Overall Study|Death|2|||
48527789|NCT04439110|156124256|FG000|Overall Study|Disease proression|25|||
48527790|NCT04439110|156124256|FG000|Overall Study|Withdrawal by Subject|1|||
48527791|NCT04439110|156124256|FG000|Overall Study|Alternative therapy|1|||
48527792|NCT04439110|156124256|FG000|Overall Study|Other complicating disease|1|||
48527793|NCT04439110|156124256|FG000|Overall Study|Personal reasons|1|||
48527794|NCT04439110|156124256|FG000|Overall Study|Still on treatment|1|||
48527795|NCT01134627|156124267|FG000|Overall Study|Adverse Event|47|||
48527796|NCT01134627|156124268|FG001|Overall Study|Adverse Event|31|||
48527797|NCT01134627|156124267|FG000|Overall Study|Lost to Follow-up|1|||
48527798|NCT01134627|156124268|FG001|Overall Study|Lost to Follow-up|2|||
48527799|NCT01134627|156124267|FG000|Overall Study|Protocol Violation|3|||
48527800|NCT01134627|156124268|FG001|Overall Study|Protocol Violation|5|||
48602346|NCT02175225|156399566|FG000|Overall Study|Study drug not administered|1|||
48602347|NCT02175225|156399567|FG001|Overall Study|Study drug not administered|2|||
48829579|NCT00927823|157217515|FG003|Continuous Dosing Period|Death|0|||
48829580|NCT00927823|157217512|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
48829581|NCT00927823|157217513|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
48829582|NCT00927823|157217514|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
48829583|NCT00927823|157217515|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
48602348|NCT02340000|156399568|FG000|Time Period 1|Withdrawal by Subject|6|||
48602349|NCT02340000|156399569|FG001|Time Period 1|Withdrawal by Subject|8|||
48829584|NCT00927823|157217512|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
48829585|NCT00927823|157217513|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
48829586|NCT00927823|157217514|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
48829587|NCT00927823|157217515|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
48829588|NCT00927823|157217512|FG000|Continuous Dosing Period|Other|1|||
48829589|NCT00927823|157217513|FG001|Continuous Dosing Period|Other|2|||
48527801|NCT01134627|156124267|FG000|Overall Study|Lack of Efficacy|2|||
48527802|NCT01134627|156124268|FG001|Overall Study|Lack of Efficacy|12|||
48527803|NCT01134627|156124267|FG000|Overall Study|Withdrawal by Subject|4|||
48527804|NCT01134627|156124268|FG001|Overall Study|Withdrawal by Subject|3|||
48527805|NCT01134627|156124267|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
48602350|NCT02340000|156399568|FG000|Time Period 1|Lost to Follow-up|6|||
48602351|NCT02340000|156399569|FG001|Time Period 1|Lost to Follow-up|7|||
48829590|NCT00927823|157217514|FG002|Continuous Dosing Period|Other|9|||
48829591|NCT00927823|157217515|FG003|Continuous Dosing Period|Other|3|||
48829592|NCT00543725|157217516|FG000|Overall Study|Adverse Event|18|||
48829593|NCT00543725|157217517|FG001|Overall Study|Adverse Event|27|||
48602352|NCT02340000|156399568|FG000|Time Period 2|Withdrawal by Subject|9|||
48602353|NCT02340000|156399569|FG001|Time Period 2|Withdrawal by Subject|7|||
48602354|NCT02340000|156399568|FG000|Time Period 2|Lost to Follow-up|10|||
48829594|NCT00543725|157217516|FG000|Overall Study|Sponsor's Decision|0|||
48829595|NCT00543725|157217517|FG001|Overall Study|Sponsor's Decision|1|||
48829596|NCT00543725|157217516|FG000|Overall Study|Subject Non-Compliant|4|||
48829597|NCT00543725|157217517|FG001|Overall Study|Subject Non-Compliant|4|||
48829598|NCT00543725|157217516|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
48829599|NCT00543725|157217517|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
48829600|NCT00543725|157217516|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
48829601|NCT00543725|157217517|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
48829602|NCT00543725|157217516|FG000|Overall Study|Protocol Violation|0|||
48829603|NCT00543725|157217517|FG001|Overall Study|Protocol Violation|1|||
48829604|NCT00543725|157217516|FG000|Overall Study|Withdrawal by Subject|4|||
48527806|NCT01134627|156124268|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
48527807|NCT01134627|156124267|FG000|Overall Study|Other|11|||
48602355|NCT02340000|156399569|FG001|Time Period 2|Lost to Follow-up|8|||
48602356|NCT00449163|156399572|FG000|Overall Study|Physician Decision|3|||
48602357|NCT00606307|156399573|FG000|Overall Study|Adverse Event|2|||
48602358|NCT00606307|156399573|FG000|Overall Study|Withdrawal by Subject|2|||
48602359|NCT00606307|156399573|FG000|Overall Study|Disease progression|6|||
48602360|NCT00606307|156399573|FG000|Overall Study|QTc prolongation|1|||
48602361|NCT02563899|156399574|FG000|Overall Study|Protocol Violation|1|||
48602362|NCT02563899|156399575|FG001|Overall Study|Protocol Violation|0|||
48602363|NCT02563899|156399576|FG002|Overall Study|Protocol Violation|0|||
48602364|NCT02563899|156399577|FG003|Overall Study|Protocol Violation|0|||
48602365|NCT02563899|156399574|FG000|Overall Study|Withdrawal by Subject|0|||
48602366|NCT02563899|156399575|FG001|Overall Study|Withdrawal by Subject|0|||
48602367|NCT02563899|156399576|FG002|Overall Study|Withdrawal by Subject|1|||
48602368|NCT02563899|156399577|FG003|Overall Study|Withdrawal by Subject|0|||
48602369|NCT01107925|156399579|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
48527808|NCT01134627|156124268|FG001|Overall Study|Other|14|||
48527809|NCT02618382|156124269|FG000|Overall Study|Physician Decision|1|||
48527810|NCT02618382|156124269|FG000|Overall Study|Withdrawal by Subject|1|||
48527811|NCT02618382|156124269|FG000|Overall Study|Protocol Violation|1|||
48527812|NCT01341587|156124270|FG000|Overall Study|Lost to Follow-up|2|||
48527813|NCT01341587|156124271|FG001|Overall Study|Lost to Follow-up|0|||
48527814|NCT01341587|156124270|FG000|Overall Study|stopped using the meters|2|||
48527815|NCT01341587|156124271|FG001|Overall Study|stopped using the meters|10|||
48527816|NCT00351351|156124272|FG000|Overall Study|surgical access pbs; device issues|9|||
48527817|NCT00351351|156124273|FG001|Overall Study|surgical access pbs; device issues|4|||
48527818|NCT01719562|156124274|FG000|Overall Study|Lost to Follow-up|1|||
48527819|NCT01719562|156124275|FG001|Overall Study|Lost to Follow-up|0|||
48527820|NCT01719562|156124274|FG000|Overall Study|Death|1|||
48527821|NCT01719562|156124275|FG001|Overall Study|Death|0|||
48527822|NCT01719562|156124274|FG000|Overall Study|New cancer diagnosis|1|||
48527823|NCT01719562|156124275|FG001|Overall Study|New cancer diagnosis|0|||
48527824|NCT00508027|156124276|FG000|Dose Level 1|Lost to Follow-up|4|||
48527825|NCT00508027|156124276|FG000|Dose Level 1|Withdrawal by Subject|2|||
48527826|NCT00508027|156124276|FG000|Dose Level 1|Physician Decision|2|||
48527827|NCT00508027|156124276|FG000|Dose Level 2|Lost to Follow-up|2|||
48527828|NCT00508027|156124276|FG000|Dose Level 2|Withdrawal by Subject|2|||
48527829|NCT01083680|156124277|FG000|Overall Study|Lost to Follow-up|2758|||
48527830|NCT01083680|156124277|FG000|Overall Study|Withdrawal by Subject|1086|||
48527831|NCT02013531|156124284|FG000|Overall Study|Lost to Follow-up|3|||
48527832|NCT02013531|156124284|FG000|Overall Study|Met Withdrawal Criteria|1|||
48527833|NCT02013531|156124284|FG000|Overall Study|Withdrawal by Subject|1|||
48527834|NCT03554317|156124285|FG000|Overall Study|Withdrawal by Subject|1|||
48527835|NCT03554317|156124285|FG000|Overall Study|PSA Progression|3|||
48527836|NCT03554317|156124285|FG000|Overall Study|Radiographic Progression|4|||
48527837|NCT02400476|156124286|FG000|Overall Study|Adverse Event|57|||
48527838|NCT02400476|156124287|FG001|Overall Study|Adverse Event|10|||
48527839|NCT02400476|156124288|FG002|Overall Study|Adverse Event|22|||
48527840|NCT02400476|156124289|FG003|Overall Study|Adverse Event|19|||
48527841|NCT02400476|156124290|FG004|Overall Study|Adverse Event|5|||
48527842|NCT02400476|156124291|FG005|Overall Study|Adverse Event|8|||
48527843|NCT02400476|156124286|FG000|Overall Study|Withdrawal by Subject|4|||
48527844|NCT02400476|156124287|FG001|Overall Study|Withdrawal by Subject|1|||
48527845|NCT02400476|156124288|FG002|Overall Study|Withdrawal by Subject|12|||
48527846|NCT02400476|156124289|FG003|Overall Study|Withdrawal by Subject|7|||
48527847|NCT02400476|156124290|FG004|Overall Study|Withdrawal by Subject|5|||
48527848|NCT02400476|156124291|FG005|Overall Study|Withdrawal by Subject|5|||
48527849|NCT02400476|156124286|FG000|Overall Study|Lost to Follow-up|0|||
48602370|NCT01107925|156399580|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
48602371|NCT01107925|156399581|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
48602372|NCT01107925|156399582|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
48829605|NCT00543725|157217517|FG001|Overall Study|Withdrawal by Subject|13|||
48829606|NCT00543725|157217516|FG000|Overall Study|Lost to Follow-up|15|||
48829607|NCT00543725|157217517|FG001|Overall Study|Lost to Follow-up|11|||
48829608|NCT00543725|157217516|FG000|Overall Study|Other|3|||
48829609|NCT00543725|157217517|FG001|Overall Study|Other|3|||
48829610|NCT00906698|157217518|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
48829611|NCT00906698|157217519|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
48829612|NCT00906698|157217520|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
48829613|NCT00906698|157217521|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
48829614|NCT00906698|157217522|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
48829615|NCT00906698|157217523|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
48829616|NCT00906698|157217518|FG000|Overall Study|Adverse Event|0|||
48829617|NCT00906698|157217519|FG001|Overall Study|Adverse Event|0|||
48829618|NCT00906698|157217520|FG002|Overall Study|Adverse Event|2|||
48829619|NCT00906698|157217521|FG003|Overall Study|Adverse Event|0|||
48829620|NCT00906698|157217522|FG004|Overall Study|Adverse Event|4|||
48829621|NCT00906698|157217523|FG005|Overall Study|Adverse Event|1|||
48829622|NCT00906698|157217518|FG000|Overall Study|Disease progression|3|||
48829623|NCT00906698|157217519|FG001|Overall Study|Disease progression|12|||
48829624|NCT00906698|157217520|FG002|Overall Study|Disease progression|4|||
48829625|NCT00906698|157217521|FG003|Overall Study|Disease progression|4|||
48829626|NCT00906698|157217522|FG004|Overall Study|Disease progression|12|||
48829627|NCT00906698|157217523|FG005|Overall Study|Disease progression|4|||
48829628|NCT00906698|157217518|FG000|Overall Study|Withdrawal by Subject|0|||
48829629|NCT00906698|157217519|FG001|Overall Study|Withdrawal by Subject|0|||
48829630|NCT00906698|157217520|FG002|Overall Study|Withdrawal by Subject|0|||
48829631|NCT00906698|157217521|FG003|Overall Study|Withdrawal by Subject|0|||
48829632|NCT00906698|157217522|FG004|Overall Study|Withdrawal by Subject|1|||
48829633|NCT00906698|157217523|FG005|Overall Study|Withdrawal by Subject|0|||
48829634|NCT00906698|157217518|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
48829635|NCT00906698|157217519|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
48829636|NCT00906698|157217520|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
48829637|NCT00906698|157217521|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
48829638|NCT00906698|157217522|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
48829639|NCT00906698|157217523|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
48829640|NCT01250002|157217524|FG000|Overall Study|Change to open surgical procedure|4|||
48829641|NCT01250002|157217525|FG001|Overall Study|Change to open surgical procedure|3|||
48829642|NCT02219490|157217526|FG000|Overall Study|Adverse Event|24|||
48829643|NCT02219490|157217526|FG000|Overall Study|Withdrew consent|96|||
48829644|NCT02219490|157217526|FG000|Overall Study|Lost to Follow-up|126|||
48829645|NCT02219490|157217526|FG000|Overall Study|COVID-19 infection|2|||
48829646|NCT02219490|157217526|FG000|Overall Study|COVID-19 logistical restrictions|33|||
48829647|NCT02219490|157217526|FG000|Overall Study|Other, not specified|57|||
48829648|NCT01674569|157217527|FG000|Overall Study|Adverse Event|0|||
48829649|NCT01674569|157217528|FG001|Overall Study|Adverse Event|2|||
48829650|NCT01674569|157217529|FG002|Overall Study|Adverse Event|0|||
48829651|NCT01674569|157217530|FG003|Overall Study|Adverse Event|1|||
48829652|NCT01674569|157217531|FG004|Overall Study|Adverse Event|2|||
48829653|NCT01674569|157217532|FG005|Overall Study|Adverse Event|2|||
48829654|NCT01674569|157217527|FG000|Overall Study|Protocol Violation|0|||
48829655|NCT01674569|157217528|FG001|Overall Study|Protocol Violation|1|||
48829656|NCT01674569|157217529|FG002|Overall Study|Protocol Violation|1|||
48829657|NCT01674569|157217530|FG003|Overall Study|Protocol Violation|0|||
48829658|NCT01674569|157217531|FG004|Overall Study|Protocol Violation|0|||
48829659|NCT01674569|157217532|FG005|Overall Study|Protocol Violation|0|||
48829660|NCT01674569|157217527|FG000|Overall Study|Withdrawal by Subject|0|||
48829661|NCT01674569|157217528|FG001|Overall Study|Withdrawal by Subject|0|||
48829662|NCT01674569|157217529|FG002|Overall Study|Withdrawal by Subject|1|||
48829663|NCT01674569|157217530|FG003|Overall Study|Withdrawal by Subject|0|||
48829664|NCT01674569|157217531|FG004|Overall Study|Withdrawal by Subject|0|||
48829665|NCT01674569|157217532|FG005|Overall Study|Withdrawal by Subject|0|||
48829666|NCT01119703|157217535|FG000|Overall Study|Adverse Event|0|||
48829667|NCT01119703|157217536|FG001|Overall Study|Adverse Event|1|||
48829668|NCT02974010|157217538|FG000|Overall Study|Lost to Follow-up|3|||
48829669|NCT02974010|157217539|FG001|Overall Study|Lost to Follow-up|1|||
48829670|NCT02974010|157217540|FG002|Overall Study|Lost to Follow-up|0|||
48829671|NCT02974010|157217541|FG003|Overall Study|Lost to Follow-up|0|||
48829672|NCT02974010|157217538|FG000|Overall Study|Withdrawal by Subject|2|||
48829673|NCT02974010|157217539|FG001|Overall Study|Withdrawal by Subject|1|||
48829674|NCT02974010|157217540|FG002|Overall Study|Withdrawal by Subject|0|||
48829675|NCT02974010|157217541|FG003|Overall Study|Withdrawal by Subject|0|||
48829676|NCT02974010|157217538|FG000|Overall Study|Adverse Event|0|||
48829677|NCT02974010|157217539|FG001|Overall Study|Adverse Event|1|||
48829678|NCT02974010|157217540|FG002|Overall Study|Adverse Event|0|||
48829679|NCT02974010|157217541|FG003|Overall Study|Adverse Event|0|||
48829680|NCT02974010|157217538|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
48829681|NCT02974010|157217539|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
48829682|NCT02974010|157217540|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
48829683|NCT02974010|157217541|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
48829684|NCT02974010|157217538|FG000|Overall Study|Lack of Efficacy|0|||
48829685|NCT02974010|157217539|FG001|Overall Study|Lack of Efficacy|0|||
48829686|NCT02974010|157217540|FG002|Overall Study|Lack of Efficacy|1|||
48829687|NCT02974010|157217541|FG003|Overall Study|Lack of Efficacy|0|||
48829688|NCT01178762|157217542|FG000|Overall Study|Lost to Follow-up|15|||
48829689|NCT02377362|157217543|FG000|Part A Second Treatment|Protocol Violation|0|||
48829690|NCT02377362|157217544|FG001|Part A Second Treatment|Protocol Violation|0|||
48829691|NCT02377362|157217545|FG002|Part A Second Treatment|Protocol Violation|0|||
48829692|NCT02377362|157217546|FG003|Part A Second Treatment|Protocol Violation|0|||
48829693|NCT02377362|157217547|FG004|Part A Second Treatment|Protocol Violation|1|||
48829694|NCT02377362|157217548|FG005|Part A Second Treatment|Protocol Violation|0|||
48829695|NCT02377362|157217549|FG006|Part A Second Treatment|Protocol Violation|0|||
48829696|NCT02377362|157217550|FG007|Part A Second Treatment|Protocol Violation|0|||
48829697|NCT02377362|157217551|FG008|Part A Second Treatment|Protocol Violation|0|||
48829698|NCT02377362|157217552|FG009|Part A Second Treatment|Protocol Violation|0|||
48829699|NCT02377362|157217553|FG010|Part A Second Treatment|Protocol Violation|0|||
48829700|NCT02377362|157217554|FG011|Part A Second Treatment|Protocol Violation|0|||
48829701|NCT02377362|157217555|FG012|Part A Second Treatment|Protocol Violation|0|||
48829702|NCT02377362|157217543|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829703|NCT02377362|157217544|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829704|NCT02377362|157217545|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829705|NCT02377362|157217546|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
48829706|NCT02377362|157217547|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
48829707|NCT02377362|157217548|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
48829708|NCT02377362|157217549|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829709|NCT02377362|157217550|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829710|NCT02377362|157217551|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829711|NCT02377362|157217552|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829712|NCT02377362|157217553|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829713|NCT02377362|157217554|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829714|NCT02377362|157217555|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
48829715|NCT02377362|157217543|FG000|Part B Overall|Protocol Violation|0|||
48829716|NCT02377362|157217544|FG001|Part B Overall|Protocol Violation|0|||
48829717|NCT02377362|157217545|FG002|Part B Overall|Protocol Violation|0|||
48829718|NCT02377362|157217546|FG003|Part B Overall|Protocol Violation|0|||
48829719|NCT02377362|157217547|FG004|Part B Overall|Protocol Violation|0|||
48829720|NCT02377362|157217548|FG005|Part B Overall|Protocol Violation|0|||
48829721|NCT02377362|157217549|FG006|Part B Overall|Protocol Violation|0|||
48829722|NCT02377362|157217550|FG007|Part B Overall|Protocol Violation|0|||
48829723|NCT02377362|157217551|FG008|Part B Overall|Protocol Violation|0|||
48829724|NCT02377362|157217552|FG009|Part B Overall|Protocol Violation|1|||
48829725|NCT02377362|157217553|FG010|Part B Overall|Protocol Violation|0|||
48829726|NCT02377362|157217554|FG011|Part B Overall|Protocol Violation|0|||
48829727|NCT02377362|157217555|FG012|Part B Overall|Protocol Violation|0|||
48829728|NCT02377362|157217543|FG000|Part B Overall|Adverse Event|0|||
48829729|NCT02377362|157217544|FG001|Part B Overall|Adverse Event|0|||
48829730|NCT02377362|157217545|FG002|Part B Overall|Adverse Event|0|||
48829731|NCT02377362|157217546|FG003|Part B Overall|Adverse Event|0|||
48829732|NCT02377362|157217547|FG004|Part B Overall|Adverse Event|0|||
48829733|NCT02377362|157217548|FG005|Part B Overall|Adverse Event|0|||
48829734|NCT02377362|157217549|FG006|Part B Overall|Adverse Event|1|||
48829735|NCT02377362|157217550|FG007|Part B Overall|Adverse Event|1|||
48829736|NCT02377362|157217551|FG008|Part B Overall|Adverse Event|0|||
48829737|NCT02377362|157217552|FG009|Part B Overall|Adverse Event|0|||
48829738|NCT02377362|157217553|FG010|Part B Overall|Adverse Event|0|||
48829739|NCT02377362|157217554|FG011|Part B Overall|Adverse Event|0|||
48829740|NCT02377362|157217555|FG012|Part B Overall|Adverse Event|0|||
48829741|NCT02377362|157217543|FG000|Part B Overall|Withdrawal by Subject|0|||
48829742|NCT02377362|157217544|FG001|Part B Overall|Withdrawal by Subject|0|||
48829743|NCT02377362|157217545|FG002|Part B Overall|Withdrawal by Subject|0|||
48829744|NCT02377362|157217546|FG003|Part B Overall|Withdrawal by Subject|0|||
48829745|NCT02377362|157217547|FG004|Part B Overall|Withdrawal by Subject|0|||
48829746|NCT02377362|157217548|FG005|Part B Overall|Withdrawal by Subject|0|||
48829747|NCT02377362|157217549|FG006|Part B Overall|Withdrawal by Subject|1|||
48829748|NCT02377362|157217550|FG007|Part B Overall|Withdrawal by Subject|0|||
48829749|NCT02377362|157217551|FG008|Part B Overall|Withdrawal by Subject|0|||
48829750|NCT02377362|157217552|FG009|Part B Overall|Withdrawal by Subject|0|||
48829751|NCT02377362|157217553|FG010|Part B Overall|Withdrawal by Subject|0|||
48829752|NCT02377362|157217554|FG011|Part B Overall|Withdrawal by Subject|1|||
48829753|NCT02377362|157217555|FG012|Part B Overall|Withdrawal by Subject|0|||
48829754|NCT02140554|157217557|FG000|Overall Study|Withdrawal of consent|1|||
48829755|NCT02140554|157217558|FG001|Overall Study|Withdrawal of consent|0|||
48829756|NCT02140554|157217559|FG002|Overall Study|Withdrawal of consent|4|||
48829757|NCT02140554|157217557|FG000|Overall Study|Physician Decision|1|||
48829758|NCT02140554|157217558|FG001|Overall Study|Physician Decision|0|||
48829759|NCT02140554|157217559|FG002|Overall Study|Physician Decision|2|||
48829760|NCT02140554|157217557|FG000|Overall Study|Death|0|||
48829761|NCT02140554|157217558|FG001|Overall Study|Death|0|||
48829762|NCT02140554|157217559|FG002|Overall Study|Death|1|||
48829763|NCT02140554|157217557|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
48829764|NCT02140554|157217558|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
48829765|NCT02140554|157217559|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
48829766|NCT03601507|157217560|FG000|Overall Study|Adverse Event|1|||
48527850|NCT02400476|156124287|FG001|Overall Study|Lost to Follow-up|0|||
48527851|NCT02400476|156124288|FG002|Overall Study|Lost to Follow-up|0|||
48527852|NCT02400476|156124289|FG003|Overall Study|Lost to Follow-up|1|||
48527853|NCT02400476|156124290|FG004|Overall Study|Lost to Follow-up|3|||
48527854|NCT02400476|156124291|FG005|Overall Study|Lost to Follow-up|1|||
48527855|NCT02400476|156124286|FG000|Overall Study|Physician Decision|0|||
48527856|NCT02400476|156124287|FG001|Overall Study|Physician Decision|0|||
48527857|NCT02400476|156124288|FG002|Overall Study|Physician Decision|1|||
48527858|NCT02400476|156124289|FG003|Overall Study|Physician Decision|1|||
48527859|NCT02400476|156124290|FG004|Overall Study|Physician Decision|0|||
48527860|NCT02400476|156124291|FG005|Overall Study|Physician Decision|1|||
48527861|NCT02400476|156124286|FG000|Overall Study|Other, Disease Progression|0|||
48602373|NCT01107925|156399583|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
48602374|NCT01107925|156399584|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
48602375|NCT01107925|156399579|FG000|Period 2|Withdrawal by Subject|0|||
48602376|NCT01107925|156399580|FG001|Period 2|Withdrawal by Subject|1|||
48602377|NCT01107925|156399581|FG002|Period 2|Withdrawal by Subject|0|||
48602378|NCT01107925|156399582|FG003|Period 2|Withdrawal by Subject|0|||
48602379|NCT01107925|156399583|FG004|Period 2|Withdrawal by Subject|0|||
48602380|NCT01107925|156399584|FG005|Period 2|Withdrawal by Subject|1|||
48602381|NCT02322749|156399587|FG000|Period 2|Adverse Event|0|||
48829767|NCT03586167|157217561|FG000|Overall Study|Other|1|||
48829768|NCT03586167|157217562|FG001|Overall Study|Other|0|||
48829769|NCT00517933|157217563|FG000|Period 1|Death|2|||
48527862|NCT02400476|156124287|FG001|Overall Study|Other, Disease Progression|1|||
48527863|NCT02400476|156124288|FG002|Overall Study|Other, Disease Progression|2|||
48527864|NCT02400476|156124289|FG003|Overall Study|Other, Disease Progression|1|||
48527865|NCT02400476|156124290|FG004|Overall Study|Other, Disease Progression|2|||
48527866|NCT02400476|156124291|FG005|Overall Study|Other, Disease Progression|1|||
48527867|NCT02400476|156124286|FG000|Overall Study|Other, Decreased Quality of Life|0|||
48527868|NCT02400476|156124287|FG001|Overall Study|Other, Decreased Quality of Life|0|||
48527869|NCT02400476|156124288|FG002|Overall Study|Other, Decreased Quality of Life|2|||
48527870|NCT02400476|156124289|FG003|Overall Study|Other, Decreased Quality of Life|0|||
48527871|NCT02400476|156124290|FG004|Overall Study|Other, Decreased Quality of Life|0|||
48527872|NCT02400476|156124291|FG005|Overall Study|Other, Decreased Quality of Life|0|||
48527873|NCT02400476|156124286|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
48527874|NCT02400476|156124287|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
48527875|NCT02400476|156124288|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
48527876|NCT02400476|156124289|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
48829770|NCT00517933|157217564|FG001|Period 1|Death|1|||
48829771|NCT00517933|157217563|FG000|Period 1|Adverse Event|4|||
48829772|NCT00517933|157217564|FG001|Period 1|Adverse Event|4|||
48829773|NCT00517933|157217563|FG000|Period 1|Lost to Follow-up|2|||
48527877|NCT02400476|156124290|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
48527878|NCT02400476|156124291|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
48527879|NCT02487082|156124295|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
48527880|NCT02487082|156124296|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
48829774|NCT00517933|157217564|FG001|Period 1|Lost to Follow-up|0|||
48527881|NCT02487082|156124295|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
48527882|NCT02487082|156124296|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
48527883|NCT00251316|156124297|FG000|Overall Study|Physician Decision|2|||
48527884|NCT00251316|156124298|FG001|Overall Study|Physician Decision|3|||
48527885|NCT00955721|156124302|FG000|Overall Study|Physician Decision|1|||
48602382|NCT02322749|156399588|FG001|Period 2|Adverse Event|0|||
48829775|NCT00517933|157217563|FG000|Period 1|Underwent lung transplant|0|||
48527886|NCT00955721|156124303|FG001|Overall Study|Physician Decision|0|||
48602383|NCT02322749|156399589|FG002|Period 2|Adverse Event|0|||
48829776|NCT00517933|157217564|FG001|Period 1|Underwent lung transplant|1|||
48829777|NCT00517933|157217563|FG000|Period 2|Death|2|||
48829778|NCT00517933|157217564|FG001|Period 2|Death|4|||
48829779|NCT00517933|157217563|FG000|Period 2|Adverse Event|2|||
48829780|NCT00517933|157217564|FG001|Period 2|Adverse Event|4|||
48829781|NCT00517933|157217563|FG000|Period 2|Physician Decision|1|||
48829782|NCT00517933|157217564|FG001|Period 2|Physician Decision|0|||
48829783|NCT00517933|157217563|FG000|Period 2|Withdrawal by Subject|1|||
48829784|NCT00517933|157217564|FG001|Period 2|Withdrawal by Subject|3|||
48829785|NCT00517933|157217563|FG000|Period 2|Underwent lung transplant|0|||
48602384|NCT02322749|156399590|FG003|Period 2|Adverse Event|1|||
48829786|NCT00517933|157217564|FG001|Period 2|Underwent lung transplant|2|||
48829787|NCT03523962|157217565|FG000|Closed Fractures|Death|86|||
48829788|NCT03523962|157217566|FG001|Closed Fractures|Death|71|||
48829789|NCT03523962|157217567|FG002|Closed Fractures|Death|0|||
48829790|NCT03523962|157217568|FG003|Closed Fractures|Death|0|||
48829791|NCT03523962|157217565|FG000|Closed Fractures|Lost to Follow-up|62|||
48829792|NCT03523962|157217566|FG001|Closed Fractures|Lost to Follow-up|36|||
48829793|NCT03523962|157217567|FG002|Closed Fractures|Lost to Follow-up|0|||
48829794|NCT03523962|157217568|FG003|Closed Fractures|Lost to Follow-up|0|||
48829795|NCT03523962|157217565|FG000|Closed Fractures|Withdrawal by Subject|19|||
48527887|NCT00955721|156124302|FG000|Overall Study|Death|1|||
48527888|NCT00955721|156124303|FG001|Overall Study|Death|0|||
48527889|NCT00955721|156124302|FG000|Overall Study|Withdrawal by Subject|1|||
48527890|NCT00955721|156124303|FG001|Overall Study|Withdrawal by Subject|0|||
48527891|NCT01144403|156124304|FG000|Overall Study|Lost to Follow-up|3|||
48527892|NCT01144403|156124304|FG000|Overall Study|Death|1|||
48527893|NCT01144403|156124304|FG000|Overall Study|Adverse Event|1|||
48527894|NCT00346164|156124305|FG000|Overall Study|Adverse Event|0|||
48527895|NCT00346164|156124306|FG001|Overall Study|Adverse Event|0|||
48527896|NCT00346164|156124307|FG002|Overall Study|Adverse Event|0|||
48829796|NCT03523962|157217566|FG001|Closed Fractures|Withdrawal by Subject|29|||
48829797|NCT03523962|157217567|FG002|Closed Fractures|Withdrawal by Subject|0|||
48527897|NCT00346164|156124308|FG003|Overall Study|Adverse Event|1|||
48527898|NCT00346164|156124305|FG000|Overall Study|Lack of Efficacy|0|||
48527899|NCT00346164|156124306|FG001|Overall Study|Lack of Efficacy|1|||
48527900|NCT00346164|156124307|FG002|Overall Study|Lack of Efficacy|7|||
48527901|NCT00346164|156124308|FG003|Overall Study|Lack of Efficacy|25|||
48527902|NCT00346164|156124305|FG000|Overall Study|Physician Decision|0|||
48527903|NCT00346164|156124306|FG001|Overall Study|Physician Decision|1|||
48527904|NCT00346164|156124307|FG002|Overall Study|Physician Decision|2|||
48527905|NCT00346164|156124308|FG003|Overall Study|Physician Decision|27|||
48527906|NCT00346164|156124305|FG000|Overall Study|Protocol Violation|6|||
48527907|NCT00346164|156124306|FG001|Overall Study|Protocol Violation|2|||
48527908|NCT00346164|156124307|FG002|Overall Study|Protocol Violation|10|||
48527909|NCT00346164|156124308|FG003|Overall Study|Protocol Violation|4|||
48527910|NCT00346164|156124305|FG000|Overall Study|Withdrawal by Subject|0|||
48527911|NCT00346164|156124306|FG001|Overall Study|Withdrawal by Subject|0|||
48527912|NCT00346164|156124307|FG002|Overall Study|Withdrawal by Subject|2|||
48527913|NCT00346164|156124308|FG003|Overall Study|Withdrawal by Subject|0|||
48527914|NCT00346164|156124305|FG000|Overall Study|Ineligible|11|||
48527915|NCT00346164|156124306|FG001|Overall Study|Ineligible|2|||
48527916|NCT00346164|156124307|FG002|Overall Study|Ineligible|2|||
48527917|NCT00346164|156124308|FG003|Overall Study|Ineligible|23|||
48527918|NCT00346164|156124305|FG000|Overall Study|Refusal of further protocol therapy|0|||
48527919|NCT00346164|156124306|FG001|Overall Study|Refusal of further protocol therapy|1|||
48527920|NCT00346164|156124307|FG002|Overall Study|Refusal of further protocol therapy|3|||
48527921|NCT00346164|156124308|FG003|Overall Study|Refusal of further protocol therapy|15|||
48527922|NCT00346164|156124305|FG000|Overall Study|Inability to start week 16 tx on time|0|||
48527923|NCT00346164|156124306|FG001|Overall Study|Inability to start week 16 tx on time|0|||
48527924|NCT00346164|156124307|FG002|Overall Study|Inability to start week 16 tx on time|0|||
48527925|NCT00346164|156124308|FG003|Overall Study|Inability to start week 16 tx on time|11|||
48527926|NCT02457611|156124309|FG000|Overall Study|Lost to Follow-up|3|||
48527927|NCT02001051|156124312|FG000|Overall Study|Deemed not eligible following enrollment|0|||
48527928|NCT02001051|156124313|FG001|Overall Study|Deemed not eligible following enrollment|1|||
48527929|NCT02756637|156124314|FG000|Overall Study|Not eligible for initial SWOG study|10|||
48527930|NCT02756637|156124315|FG001|Overall Study|Not eligible for initial SWOG study|10|||
48829798|NCT03523962|157217568|FG003|Closed Fractures|Withdrawal by Subject|0|||
48527931|NCT02756637|156124314|FG000|Overall Study|No available NLR value|44|||
48527932|NCT02756637|156124315|FG001|Overall Study|No available NLR value|44|||
48527933|NCT02756637|156124314|FG000|Overall Study|Did not complete curative therapy|33|||
48527934|NCT02756637|156124315|FG001|Overall Study|Did not complete curative therapy|0|||
48527935|NCT00063882|156124318|FG000|Overall Study|Protocol Violation|3|||
48829799|NCT03523962|157217565|FG000|Closed Fractures|Incarceration|1|||
48829800|NCT03523962|157217566|FG001|Closed Fractures|Incarceration|4|||
48829801|NCT03523962|157217567|FG002|Closed Fractures|Incarceration|0|||
48829802|NCT03523962|157217568|FG003|Closed Fractures|Incarceration|0|||
48829803|NCT03523962|157217565|FG000|Open Fractures|Death|0|||
48829804|NCT03523962|157217566|FG001|Open Fractures|Death|0|||
48829805|NCT03523962|157217567|FG002|Open Fractures|Death|11|||
48829806|NCT03523962|157217568|FG003|Open Fractures|Death|6|||
48829807|NCT03523962|157217565|FG000|Open Fractures|Lost to Follow-up|0|||
48829808|NCT03523962|157217566|FG001|Open Fractures|Lost to Follow-up|0|||
48829809|NCT03523962|157217567|FG002|Open Fractures|Lost to Follow-up|15|||
48829810|NCT03523962|157217568|FG003|Open Fractures|Lost to Follow-up|8|||
48829811|NCT03523962|157217565|FG000|Open Fractures|Withdrawal by Subject|0|||
48527936|NCT00063882|156124319|FG001|Overall Study|Protocol Violation|3|||
48527937|NCT00063882|156124318|FG000|Overall Study|Withdrawal by Subject|2|||
48527938|NCT00063882|156124319|FG001|Overall Study|Withdrawal by Subject|1|||
48527939|NCT02820740|156124320|FG000|Overall Study|Did not have procedure|2|||
48829812|NCT03523962|157217566|FG001|Open Fractures|Withdrawal by Subject|0|||
48829813|NCT03523962|157217567|FG002|Open Fractures|Withdrawal by Subject|6|||
48829814|NCT03523962|157217568|FG003|Open Fractures|Withdrawal by Subject|2|||
48829815|NCT03523962|157217565|FG000|Open Fractures|Incarceration|0|||
48829816|NCT03523962|157217566|FG001|Open Fractures|Incarceration|0|||
48829817|NCT03523962|157217567|FG002|Open Fractures|Incarceration|1|||
48829818|NCT03523962|157217568|FG003|Open Fractures|Incarceration|0|||
48829819|NCT01835899|157217569|FG000|Overall Study|Adverse Event|0|||
48829820|NCT01835899|157217570|FG001|Overall Study|Adverse Event|0|||
48829821|NCT01835899|157217571|FG002|Overall Study|Adverse Event|1|||
48829822|NCT01835899|157217569|FG000|Overall Study|Other than stated above|0|||
48829823|NCT01835899|157217570|FG001|Overall Study|Other than stated above|1|||
48829824|NCT01835899|157217571|FG002|Overall Study|Other than stated above|0|||
48829825|NCT04716933|157217574|FG000|Overall Study|Ongoing|46|||
48829826|NCT04716933|157217575|FG001|Overall Study|Ongoing|37|||
48829827|NCT04716933|157217574|FG000|Overall Study|Sponsor Decision|55|||
48829828|NCT04716933|157217575|FG001|Overall Study|Sponsor Decision|63|||
48829829|NCT05484726|157217576|FG000|Overall Study|Protocol Violation|3|||
48527940|NCT04542694|156125917|FG000|Overall Study|The need for prohibited therapy|2|||
48527941|NCT04542694|156125918|FG001|Overall Study|The need for prohibited therapy|0|||
48527942|NCT04542694|156125917|FG000|Overall Study|Adverse Event|1|||
48527943|NCT04542694|156125918|FG001|Overall Study|Adverse Event|0|||
48527944|NCT04542694|156125917|FG000|Overall Study|Protocol Violation|1|||
48527945|NCT04542694|156125918|FG001|Overall Study|Protocol Violation|0|||
48527946|NCT00996437|156125919|FG000|Overall Study|Death|1|||
48527947|NCT00996437|156125920|FG001|Overall Study|Death|0|||
48602385|NCT02322749|156399591|FG004|Period 2|Adverse Event|0|||
48829830|NCT05484726|157217577|FG001|Overall Study|Protocol Violation|3|||
48829831|NCT05484726|157217576|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
48829832|NCT05484726|157217577|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
48829833|NCT05484726|157217576|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
48829834|NCT05484726|157217577|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
48829835|NCT05484726|157217576|FG000|Overall Study|continued need of mechanical ventilation|2|||
48829836|NCT05484726|157217577|FG001|Overall Study|continued need of mechanical ventilation|3|||
48829837|NCT05484726|157217576|FG000|Overall Study|Withdrawal by Subject|2|||
48829838|NCT05484726|157217577|FG001|Overall Study|Withdrawal by Subject|3|||
48829839|NCT05484726|157217576|FG000|Overall Study|IVH (G III & IV)|2|||
48829840|NCT05484726|157217577|FG001|Overall Study|IVH (G III & IV)|1|||
48829841|NCT05484726|157217576|FG000|Overall Study|NEC (stage II & III)|2|||
48829842|NCT05484726|157217577|FG001|Overall Study|NEC (stage II & III)|3|||
48829843|NCT02357784|157217579|FG000|Overall Study|Withdrawal by Subject|1|||
48829844|NCT00768066|157217580|FG000|Overall Study|Did not receive study product injection.|3|||
48829845|NCT00768066|157217581|FG001|Overall Study|Did not receive study product injection.|3|||
48829846|NCT00768066|157217582|FG002|Overall Study|Did not receive study product injection.|0|||
48829847|NCT03538054|157217583|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
48527948|NCT00996437|156125919|FG000|Overall Study|Dropped|2|||
48602386|NCT02322749|156399592|FG005|Period 2|Adverse Event|0|||
48602387|NCT02322749|156399587|FG000|Period 2|Withdrawal by Subject|0|||
48602388|NCT02322749|156399588|FG001|Period 2|Withdrawal by Subject|0|||
48602389|NCT02322749|156399589|FG002|Period 2|Withdrawal by Subject|0|||
48602390|NCT02322749|156399590|FG003|Period 2|Withdrawal by Subject|1|||
48602391|NCT02322749|156399591|FG004|Period 2|Withdrawal by Subject|0|||
48602392|NCT02322749|156399592|FG005|Period 2|Withdrawal by Subject|0|||
48602393|NCT02322749|156399587|FG000|Period 3|Withdrawal by Subject|0|||
48602394|NCT02322749|156399588|FG001|Period 3|Withdrawal by Subject|0|||
48602395|NCT02322749|156399589|FG002|Period 3|Withdrawal by Subject|1|||
48602396|NCT02322749|156399590|FG003|Period 3|Withdrawal by Subject|0|||
48602397|NCT02322749|156399591|FG004|Period 3|Withdrawal by Subject|0|||
48602398|NCT02322749|156399592|FG005|Period 3|Withdrawal by Subject|0|||
48602399|NCT03641508|156399593|FG000|First Injection|Lost to Follow-up|2|||
48602400|NCT03641508|156399594|FG001|First Injection|Lost to Follow-up|0|||
48602401|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
48602402|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
48602403|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
48602404|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
48602405|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
48602406|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
48602407|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
48829848|NCT03538054|157217583|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
48829849|NCT03538054|157217583|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
48527949|NCT00996437|156125920|FG001|Overall Study|Dropped|2|||
48527950|NCT00996437|156125919|FG000|Overall Study|Missed|2|||
48829850|NCT02132702|157217587|FG000|Overall Study|Protocol Violation|2|||
48527951|NCT00996437|156125920|FG001|Overall Study|Missed|5|||
48527952|NCT03333915|156125921|FG000|Overall Study|Lost to Follow-up|0|||
48602408|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48527953|NCT03333915|156125922|FG001|Overall Study|Lost to Follow-up|0|||
48527954|NCT03333915|156125923|FG002|Overall Study|Lost to Follow-up|1|||
48527955|NCT03333915|156125924|FG003|Overall Study|Lost to Follow-up|0|||
48527956|NCT03333915|156125925|FG004|Overall Study|Lost to Follow-up|0|||
48527957|NCT03333915|156125921|FG000|Overall Study|Disease Progression|0|||
48527958|NCT03333915|156125922|FG001|Overall Study|Disease Progression|1|||
48527959|NCT03333915|156125923|FG002|Overall Study|Disease Progression|0|||
48527960|NCT03333915|156125924|FG003|Overall Study|Disease Progression|0|||
48527961|NCT03333915|156125925|FG004|Overall Study|Disease Progression|0|||
48527962|NCT03333915|156125921|FG000|Overall Study|Death|0|||
48527963|NCT03333915|156125922|FG001|Overall Study|Death|0|||
48527964|NCT03333915|156125923|FG002|Overall Study|Death|0|||
48527965|NCT03333915|156125924|FG003|Overall Study|Death|37|||
48527966|NCT03333915|156125925|FG004|Overall Study|Death|18|||
48527967|NCT03333915|156125921|FG000|Overall Study|Sponsor's Decision|0|||
48527968|NCT03333915|156125922|FG001|Overall Study|Sponsor's Decision|0|||
48527969|NCT03333915|156125923|FG002|Overall Study|Sponsor's Decision|0|||
48527970|NCT03333915|156125924|FG003|Overall Study|Sponsor's Decision|48|||
48527971|NCT03333915|156125925|FG004|Overall Study|Sponsor's Decision|4|||
48527972|NCT03333915|156125921|FG000|Overall Study|Withdrawal by Subject|0|||
48527973|NCT03333915|156125922|FG001|Overall Study|Withdrawal by Subject|0|||
48527974|NCT03333915|156125923|FG002|Overall Study|Withdrawal by Subject|0|||
48527975|NCT03333915|156125924|FG003|Overall Study|Withdrawal by Subject|5|||
48527976|NCT03333915|156125925|FG004|Overall Study|Withdrawal by Subject|1|||
48527977|NCT04505722|156125926|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
48527978|NCT04505722|156125927|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
48602409|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48602410|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
48602411|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
48602412|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
48829851|NCT02132702|157217587|FG000|Overall Study|Adverse Event|3|||
48829852|NCT02132702|157217587|FG000|Overall Study|Withdrawal by Subject|3|||
48829853|NCT04697069|157217588|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
48829854|NCT04697069|157217589|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
48829855|NCT04697069|157217588|FG000|Overall Study|Study termination|2|||
48829856|NCT04697069|157217589|FG001|Overall Study|Study termination|1|||
48829857|NCT04133363|157217592|FG000|Overall Study|Lost to Follow-up|2|||
48829858|NCT04133363|157217593|FG001|Overall Study|Lost to Follow-up|1|||
48829859|NCT04133363|157217594|FG002|Overall Study|Lost to Follow-up|4|||
48829860|NCT01306331|157219344|FG000|Overall Study|Adverse Event|28|||
48829861|NCT01306331|157219345|FG001|Overall Study|Adverse Event|25|||
48829862|NCT01306331|157219344|FG000|Overall Study|Lost to Follow-up|321|||
48829863|NCT01306331|157219345|FG001|Overall Study|Lost to Follow-up|323|||
48829864|NCT01306331|157219344|FG000|Overall Study|Physician Decision|26|||
48829865|NCT01306331|157219345|FG001|Overall Study|Physician Decision|22|||
48527979|NCT04505722|156125928|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
48527980|NCT04505722|156125926|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
48527981|NCT04505722|156125927|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
48527982|NCT04505722|156125928|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
48527983|NCT04505722|156125926|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
48527984|NCT04505722|156125927|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
48602413|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
48602414|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
48602415|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
48602416|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
48602417|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
48602418|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
48602419|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
48602420|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
48602421|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
48602422|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
48602423|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
48829866|NCT01306331|157219344|FG000|Overall Study|Pregnancy|136|||
48829867|NCT01306331|157219345|FG001|Overall Study|Pregnancy|151|||
48829868|NCT01306331|157219344|FG000|Overall Study|Protocol Violation|154|||
48829869|NCT01306331|157219345|FG001|Overall Study|Protocol Violation|124|||
48829870|NCT01306331|157219344|FG000|Overall Study|Withdrawal by Subject|163|||
48829871|NCT01306331|157219345|FG001|Overall Study|Withdrawal by Subject|152|||
48829872|NCT01306331|157219344|FG000|Overall Study|Not sexually active|29|||
48829873|NCT01306331|157219345|FG001|Overall Study|Not sexually active|28|||
48829874|NCT01306331|157219344|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
48527985|NCT04505722|156125928|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
48527986|NCT04505722|156125926|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
48527987|NCT04505722|156125927|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
48829875|NCT01306331|157219345|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
48829876|NCT01306331|157219344|FG000|Overall Study|Other|34|||
48829877|NCT01306331|157219345|FG001|Overall Study|Other|32|||
48829878|NCT01211665|157219346|FG000|Overall Study|Withdrawal by Subject|1|||
48829879|NCT01211665|157219347|FG001|Overall Study|Withdrawal by Subject|0|||
48829880|NCT01211665|157219346|FG000|Overall Study|Death|1|||
48829881|NCT01211665|157219347|FG001|Overall Study|Death|0|||
48829882|NCT00567879|157219348|FG000|Overall Study|Adverse Event|2|||
48829883|NCT00567879|157219349|FG001|Overall Study|Adverse Event|0|||
48829884|NCT00567879|157219350|FG002|Overall Study|Adverse Event|1|||
48829885|NCT00567879|157219351|FG003|Overall Study|Adverse Event|0|||
48829886|NCT00567879|157219352|FG004|Overall Study|Adverse Event|1|||
48829887|NCT00567879|157219353|FG005|Overall Study|Adverse Event|0|||
48829888|NCT00567879|157219348|FG000|Overall Study|Abnormal test procedure(s)|0|||
48829889|NCT00567879|157219349|FG001|Overall Study|Abnormal test procedure(s)|0|||
48829890|NCT00567879|157219350|FG002|Overall Study|Abnormal test procedure(s)|1|||
48829891|NCT00567879|157219351|FG003|Overall Study|Abnormal test procedure(s)|0|||
48829892|NCT00567879|157219352|FG004|Overall Study|Abnormal test procedure(s)|0|||
48829893|NCT00567879|157219353|FG005|Overall Study|Abnormal test procedure(s)|0|||
48829894|NCT00567879|157219348|FG000|Overall Study|Withdrawal by Subject|0|||
48829895|NCT00567879|157219349|FG001|Overall Study|Withdrawal by Subject|0|||
48829896|NCT00567879|157219350|FG002|Overall Study|Withdrawal by Subject|3|||
48829897|NCT00567879|157219351|FG003|Overall Study|Withdrawal by Subject|1|||
48829898|NCT00567879|157219352|FG004|Overall Study|Withdrawal by Subject|0|||
48829899|NCT00567879|157219353|FG005|Overall Study|Withdrawal by Subject|0|||
48829900|NCT00567879|157219348|FG000|Overall Study|New cancer therapy|0|||
48829901|NCT00567879|157219349|FG001|Overall Study|New cancer therapy|0|||
48829902|NCT00567879|157219350|FG002|Overall Study|New cancer therapy|1|||
48829903|NCT00567879|157219351|FG003|Overall Study|New cancer therapy|0|||
48829904|NCT00567879|157219352|FG004|Overall Study|New cancer therapy|0|||
48829905|NCT00567879|157219353|FG005|Overall Study|New cancer therapy|0|||
48829906|NCT00567879|157219348|FG000|Overall Study|Disease progression|5|||
48829907|NCT00567879|157219349|FG001|Overall Study|Disease progression|7|||
48829908|NCT00567879|157219350|FG002|Overall Study|Disease progression|15|||
48829909|NCT00567879|157219351|FG003|Overall Study|Disease progression|5|||
48829910|NCT00567879|157219352|FG004|Overall Study|Disease progression|11|||
48829911|NCT00567879|157219353|FG005|Overall Study|Disease progression|3|||
48829912|NCT00938340|157219355|FG000|Overall Study|Withdrawal by Subject|3|||
48829913|NCT00938340|157219355|FG000|Overall Study|Protocol Violation|1|||
48829914|NCT00938340|157219355|FG000|Overall Study|Adverse Event|1|||
48829915|NCT03396835|157219356|FG000|Overall Study|Withdrawn prior to completion|1|||
48829916|NCT03396835|157219356|FG000|Overall Study|Did not meet criteria for data analysis|1|||
48829917|NCT04310579|157219357|FG000|Overall Study|Adverse Event|0|||
48829918|NCT04310579|157219358|FG001|Overall Study|Adverse Event|0|||
48829919|NCT04310579|157219359|FG002|Overall Study|Adverse Event|0|||
48829920|NCT04310579|157219360|FG003|Overall Study|Adverse Event|0|||
48829921|NCT04310579|157219361|FG004|Overall Study|Adverse Event|0|||
48829922|NCT04310579|157219362|FG005|Overall Study|Adverse Event|0|||
48829923|NCT04310579|157219363|FG006|Overall Study|Adverse Event|2|||
48829924|NCT04310579|157219364|FG007|Overall Study|Adverse Event|0|||
48829925|NCT04310579|157219365|FG008|Overall Study|Adverse Event|1|||
48829926|NCT04310579|157219366|FG009|Overall Study|Adverse Event|1|||
48829927|NCT04310579|157219367|FG010|Overall Study|Adverse Event|0|||
48829928|NCT04310579|157219357|FG000|Overall Study|Withdrawal by Subject|0|||
48829929|NCT04310579|157219358|FG001|Overall Study|Withdrawal by Subject|0|||
48829930|NCT04310579|157219359|FG002|Overall Study|Withdrawal by Subject|0|||
48829931|NCT04310579|157219360|FG003|Overall Study|Withdrawal by Subject|0|||
48829932|NCT04310579|157219361|FG004|Overall Study|Withdrawal by Subject|0|||
48829933|NCT04310579|157219362|FG005|Overall Study|Withdrawal by Subject|1|||
48829934|NCT04310579|157219363|FG006|Overall Study|Withdrawal by Subject|0|||
48829935|NCT04310579|157219364|FG007|Overall Study|Withdrawal by Subject|0|||
48829936|NCT04310579|157219365|FG008|Overall Study|Withdrawal by Subject|0|||
48829937|NCT04310579|157219366|FG009|Overall Study|Withdrawal by Subject|0|||
48829938|NCT04310579|157219367|FG010|Overall Study|Withdrawal by Subject|0|||
48829939|NCT04310579|157219357|FG000|Overall Study|Positive COVID-19 test|0|||
48829940|NCT04310579|157219358|FG001|Overall Study|Positive COVID-19 test|0|||
48829941|NCT04310579|157219359|FG002|Overall Study|Positive COVID-19 test|0|||
48527988|NCT04505722|156125928|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
48829942|NCT04310579|157219360|FG003|Overall Study|Positive COVID-19 test|0|||
48829943|NCT04310579|157219361|FG004|Overall Study|Positive COVID-19 test|0|||
48829944|NCT04310579|157219362|FG005|Overall Study|Positive COVID-19 test|0|||
48829945|NCT04310579|157219363|FG006|Overall Study|Positive COVID-19 test|0|||
48829946|NCT04310579|157219364|FG007|Overall Study|Positive COVID-19 test|0|||
48829947|NCT04310579|157219365|FG008|Overall Study|Positive COVID-19 test|0|||
48829948|NCT04310579|157219366|FG009|Overall Study|Positive COVID-19 test|0|||
48829949|NCT04310579|157219367|FG010|Overall Study|Positive COVID-19 test|1|||
48829950|NCT03721016|157219370|FG000|Overall Study|Adverse Event|0|||
48829951|NCT03721016|157219371|FG001|Overall Study|Adverse Event|1|||
48829952|NCT03721016|157219372|FG002|Overall Study|Adverse Event|1|||
48829953|NCT03721016|157219370|FG000|Overall Study|Withdrawal by Subject|8|||
48829954|NCT03721016|157219371|FG001|Overall Study|Withdrawal by Subject|16|||
48829955|NCT03721016|157219372|FG002|Overall Study|Withdrawal by Subject|13|||
48829956|NCT03721016|157219370|FG000|Overall Study|Lost to Follow-up|4|||
48829957|NCT03721016|157219371|FG001|Overall Study|Lost to Follow-up|6|||
48829958|NCT03721016|157219372|FG002|Overall Study|Lost to Follow-up|5|||
48829959|NCT03721016|157219370|FG000|Overall Study|Physician Decision|0|||
48829960|NCT03721016|157219371|FG001|Overall Study|Physician Decision|1|||
48829961|NCT03721016|157219372|FG002|Overall Study|Physician Decision|2|||
48829962|NCT03721016|157219370|FG000|Overall Study|Protocol Violation|0|||
48829963|NCT03721016|157219371|FG001|Overall Study|Protocol Violation|1|||
48829964|NCT03721016|157219372|FG002|Overall Study|Protocol Violation|0|||
48829965|NCT03721016|157219370|FG000|Overall Study|Site terminated by sponsor|3|||
48829966|NCT03721016|157219371|FG001|Overall Study|Site terminated by sponsor|7|||
48829967|NCT03721016|157219372|FG002|Overall Study|Site terminated by sponsor|6|||
48829968|NCT03721016|157219370|FG000|Overall Study|Subject exited early due to COVID-19|1|||
48829969|NCT03721016|157219371|FG001|Overall Study|Subject exited early due to COVID-19|0|||
48829970|NCT03721016|157219372|FG002|Overall Study|Subject exited early due to COVID-19|0|||
48829971|NCT04148937|157219375|FG000|Overall Study|Withdrawal by Subject|0|||
48829972|NCT04148937|157219376|FG001|Overall Study|Withdrawal by Subject|0|||
48829973|NCT04148937|157219377|FG002|Overall Study|Withdrawal by Subject|0|||
48829974|NCT04148937|157219378|FG003|Overall Study|Withdrawal by Subject|1|||
48829975|NCT04148937|157219379|FG004|Overall Study|Withdrawal by Subject|0|||
48829976|NCT04148937|157219380|FG005|Overall Study|Withdrawal by Subject|1|||
48829977|NCT04148937|157219381|FG006|Overall Study|Withdrawal by Subject|1|||
48829978|NCT04148937|157219382|FG007|Overall Study|Withdrawal by Subject|0|||
48829979|NCT04148937|157219375|FG000|Overall Study|Lost to Follow-up|0|||
48829980|NCT04148937|157219376|FG001|Overall Study|Lost to Follow-up|0|||
48829981|NCT04148937|157219377|FG002|Overall Study|Lost to Follow-up|1|||
48829982|NCT04148937|157219378|FG003|Overall Study|Lost to Follow-up|0|||
48829983|NCT04148937|157219379|FG004|Overall Study|Lost to Follow-up|0|||
48829984|NCT04148937|157219380|FG005|Overall Study|Lost to Follow-up|2|||
48829985|NCT04148937|157219381|FG006|Overall Study|Lost to Follow-up|0|||
48829986|NCT04148937|157219382|FG007|Overall Study|Lost to Follow-up|0|||
48829987|NCT01803646|157219383|FG000|Overall Study|Protocol Violation|1|||
48829988|NCT01803646|157219384|FG001|Overall Study|Protocol Violation|0|||
48829989|NCT01803646|157219383|FG000|Overall Study|Adverse Event|1|||
48829990|NCT01803646|157219384|FG001|Overall Study|Adverse Event|1|||
48829991|NCT01803646|157219383|FG000|Overall Study|Withdrawal by Subject|9|||
48829992|NCT01803646|157219384|FG001|Overall Study|Withdrawal by Subject|6|||
48829993|NCT01803646|157219383|FG000|Overall Study|Randomization error|1|||
48829994|NCT01803646|157219384|FG001|Overall Study|Randomization error|2|||
48829995|NCT01803646|157219383|FG000|Overall Study|Lost to Follow-up|5|||
48829996|NCT01803646|157219384|FG001|Overall Study|Lost to Follow-up|1|||
48829997|NCT01020838|157219385|FG000|Overall Study|Death|90|||
48829998|NCT01020838|157219385|FG000|Overall Study|Adverse Event|1|||
48829999|NCT01020838|157219385|FG000|Overall Study|Withdrawal by Subject|9|||
48830000|NCT01020838|157219385|FG000|Overall Study|Lost to Follow-up|6|||
48830001|NCT01020838|157219385|FG000|Overall Study|Most common: Study ended by sponsor|77|||
48830002|NCT01167426|157219386|FG000|Overall Study|Lost to Follow-up|6|||
48830003|NCT01167426|157219386|FG000|Overall Study|Protocol Violation|1|||
48830004|NCT01167426|157219386|FG000|Overall Study|Withdrawal by Subject|2|||
48830005|NCT01167426|157219386|FG000|Overall Study|Sponsor Decision|1|||
48830006|NCT00003656|157219389|FG000|Overall Study|Adverse Event|0|||
48830007|NCT00003656|157219390|FG001|Overall Study|Adverse Event|1|||
48830008|NCT03095508|157219396|FG000|Overall Study|Adverse Event|0|||
48830009|NCT03095508|157219397|FG001|Overall Study|Adverse Event|1|||
48527989|NCT04505722|156125926|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
48527990|NCT04505722|156125927|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
48527991|NCT04505722|156125928|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
48527992|NCT04505722|156125926|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
48830010|NCT02954055|157219407|FG000|Overall Study|Did not initiate therapy|6|||
48830011|NCT02954055|157219408|FG001|Overall Study|Did not initiate therapy|1|||
48830012|NCT01511250|157219409|FG000|Overall Study|Withdrawal of Consent|1|||
48830013|NCT01511250|157219410|FG001|Overall Study|Withdrawal of Consent|0|||
48527993|NCT04505722|156125927|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
48527994|NCT04505722|156125928|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
48830014|NCT01511250|157219411|FG002|Overall Study|Withdrawal of Consent|0|||
48830015|NCT01511250|157219412|FG003|Overall Study|Withdrawal of Consent|0|||
48830016|NCT01511250|157219413|FG004|Overall Study|Withdrawal of Consent|0|||
48527995|NCT04505722|156125926|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
48830017|NCT01511250|157219414|FG005|Overall Study|Withdrawal of Consent|0|||
48830018|NCT01511250|157219415|FG006|Overall Study|Withdrawal of Consent|0|||
48830019|NCT01511250|157219416|FG007|Overall Study|Withdrawal of Consent|1|||
48830020|NCT01511250|157219417|FG008|Overall Study|Withdrawal of Consent|1|||
48830021|NCT01511250|157219418|FG009|Overall Study|Withdrawal of Consent|0|||
48830022|NCT01511250|157219409|FG000|Overall Study|Sponsor/Investigator Decision|1|||
48830023|NCT01511250|157219410|FG001|Overall Study|Sponsor/Investigator Decision|0|||
48830024|NCT01511250|157219411|FG002|Overall Study|Sponsor/Investigator Decision|0|||
48830025|NCT01511250|157219412|FG003|Overall Study|Sponsor/Investigator Decision|0|||
48830026|NCT01511250|157219413|FG004|Overall Study|Sponsor/Investigator Decision|0|||
48830027|NCT01511250|157219414|FG005|Overall Study|Sponsor/Investigator Decision|0|||
48830028|NCT01511250|157219415|FG006|Overall Study|Sponsor/Investigator Decision|0|||
48830029|NCT01511250|157219416|FG007|Overall Study|Sponsor/Investigator Decision|0|||
48830030|NCT01511250|157219417|FG008|Overall Study|Sponsor/Investigator Decision|0|||
48830031|NCT01511250|157219418|FG009|Overall Study|Sponsor/Investigator Decision|0|||
48830032|NCT01511250|157219409|FG000|Overall Study|Lost to Follow-up|7|||
48830033|NCT01511250|157219410|FG001|Overall Study|Lost to Follow-up|3|||
48830034|NCT01511250|157219411|FG002|Overall Study|Lost to Follow-up|3|||
48830035|NCT01511250|157219412|FG003|Overall Study|Lost to Follow-up|3|||
48830036|NCT01511250|157219413|FG004|Overall Study|Lost to Follow-up|0|||
48830037|NCT01511250|157219414|FG005|Overall Study|Lost to Follow-up|0|||
48830038|NCT01511250|157219415|FG006|Overall Study|Lost to Follow-up|2|||
48830039|NCT01511250|157219416|FG007|Overall Study|Lost to Follow-up|3|||
48830040|NCT01511250|157219417|FG008|Overall Study|Lost to Follow-up|13|||
48830041|NCT01511250|157219418|FG009|Overall Study|Lost to Follow-up|5|||
48830042|NCT01511250|157219409|FG000|Overall Study|Protocol Violation|0|||
48830043|NCT01511250|157219410|FG001|Overall Study|Protocol Violation|2|||
48830044|NCT01511250|157219411|FG002|Overall Study|Protocol Violation|1|||
48830045|NCT01511250|157219412|FG003|Overall Study|Protocol Violation|0|||
48830046|NCT01511250|157219413|FG004|Overall Study|Protocol Violation|0|||
48830047|NCT01511250|157219414|FG005|Overall Study|Protocol Violation|0|||
48830048|NCT01511250|157219415|FG006|Overall Study|Protocol Violation|0|||
48830049|NCT01511250|157219416|FG007|Overall Study|Protocol Violation|0|||
48830050|NCT01511250|157219417|FG008|Overall Study|Protocol Violation|0|||
48830051|NCT01511250|157219418|FG009|Overall Study|Protocol Violation|0|||
48830052|NCT01710514|157219419|FG000|Overall Study|Adverse Event|6|||
48830053|NCT01710514|157219420|FG001|Overall Study|Adverse Event|7|||
48830054|NCT01710514|157219419|FG000|Overall Study|Withdrawal by Subject|1|||
48830055|NCT01710514|157219420|FG001|Overall Study|Withdrawal by Subject|0|||
48830056|NCT04044664|157219423|FG000|Stage 1|Adverse Event|3|||
48830057|NCT04044664|157219424|FG001|Stage 1|Adverse Event|3|||
48830058|NCT04044664|157219425|FG002|Stage 1|Adverse Event|1|||
48830059|NCT04044664|157219423|FG000|Stage 1|Lost to Follow-up|3|||
48830060|NCT04044664|157219424|FG001|Stage 1|Lost to Follow-up|2|||
48830061|NCT04044664|157219425|FG002|Stage 1|Lost to Follow-up|2|||
48830062|NCT04044664|157219423|FG000|Stage 1|Withdrawal by Subject|9|||
48830063|NCT04044664|157219424|FG001|Stage 1|Withdrawal by Subject|1|||
48830064|NCT04044664|157219425|FG002|Stage 1|Withdrawal by Subject|0|||
48830065|NCT04044664|157219423|FG000|Stage 1|noncompliance, personal reason|2|||
48830066|NCT04044664|157219424|FG001|Stage 1|noncompliance, personal reason|0|||
48830067|NCT04044664|157219425|FG002|Stage 1|noncompliance, personal reason|0|||
48830068|NCT04044664|157219423|FG000|Stage 1|randomization error|0|||
48830069|NCT04044664|157219424|FG001|Stage 1|randomization error|1|||
48830070|NCT04044664|157219425|FG002|Stage 1|randomization error|0|||
48830071|NCT04044664|157219423|FG000|Stage 2|Adverse Event|2|||
48830072|NCT04044664|157219424|FG001|Stage 2|Adverse Event|0|||
48830073|NCT04044664|157219425|FG002|Stage 2|Adverse Event|0|||
48830074|NCT04044664|157219423|FG000|Stage 2|Lost to Follow-up|3|||
48830075|NCT04044664|157219424|FG001|Stage 2|Lost to Follow-up|2|||
48830076|NCT04044664|157219425|FG002|Stage 2|Lost to Follow-up|1|||
48830077|NCT04044664|157219423|FG000|Stage 2|Withdrawal by Subject|3|||
48830078|NCT04044664|157219424|FG001|Stage 2|Withdrawal by Subject|0|||
48830079|NCT04044664|157219425|FG002|Stage 2|Withdrawal by Subject|0|||
48830080|NCT04044664|157219423|FG000|Stage 2|protocol deviation|1|||
48830081|NCT04044664|157219424|FG001|Stage 2|protocol deviation|0|||
48830082|NCT04044664|157219425|FG002|Stage 2|protocol deviation|0|||
48830083|NCT00320489|157219426|FG000|Overall Study|Adverse Event|26|||
48830084|NCT00320489|157219427|FG001|Overall Study|Adverse Event|25|||
48830085|NCT00320489|157219426|FG000|Overall Study|Clinical Relapse|26|||
48830086|NCT00320489|157219427|FG001|Overall Study|Clinical Relapse|20|||
48830087|NCT00320489|157219426|FG000|Overall Study|Death|0|||
48830088|NCT00320489|157219427|FG001|Overall Study|Death|2|||
48830089|NCT00320489|157219426|FG000|Overall Study|Entry Criteria Exclusion|2|||
48830090|NCT00320489|157219427|FG001|Overall Study|Entry Criteria Exclusion|4|||
48830091|NCT00320489|157219426|FG000|Overall Study|Lack of Efficacy|16|||
48830092|NCT00320489|157219427|FG001|Overall Study|Lack of Efficacy|7|||
48830093|NCT00320489|157219426|FG000|Overall Study|Lost to Follow-up|21|||
48830094|NCT00320489|157219427|FG001|Overall Study|Lost to Follow-up|22|||
48830095|NCT00320489|157219426|FG000|Overall Study|Physician Decision|8|||
48830096|NCT00320489|157219427|FG001|Overall Study|Physician Decision|8|||
48830097|NCT00320489|157219426|FG000|Overall Study|Protocol Violation|4|||
48830098|NCT00320489|157219427|FG001|Overall Study|Protocol Violation|4|||
48830099|NCT00320489|157219426|FG000|Overall Study|Sponsor Decision|3|||
48830100|NCT00320489|157219427|FG001|Overall Study|Sponsor Decision|3|||
48830101|NCT00320489|157219426|FG000|Overall Study|Withdrawal by Subject|39|||
48527996|NCT04505722|156125927|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
48527997|NCT04505722|156125928|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
48830102|NCT00320489|157219427|FG001|Overall Study|Withdrawal by Subject|41|||
48527998|NCT04505722|156125926|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
48527999|NCT04505722|156125927|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
48528000|NCT04505722|156125928|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
48528001|NCT04505722|156125926|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
48528002|NCT04505722|156125927|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
48528003|NCT04505722|156125928|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
48528004|NCT04505722|156125926|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
48528005|NCT04505722|156125927|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
48528006|NCT04505722|156125928|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
48528007|NCT04505722|156125926|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
48528008|NCT04505722|156125927|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
48528009|NCT04505722|156125928|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
48528010|NCT04505722|156125926|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
48528011|NCT04505722|156125927|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
48528012|NCT04505722|156125928|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
48528013|NCT04505722|156125926|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
48528014|NCT04505722|156125927|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
48528015|NCT04505722|156125928|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
48528016|NCT04505722|156125926|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
48528017|NCT04505722|156125927|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
48528018|NCT04505722|156125928|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
48528019|NCT04505722|156125926|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
48528020|NCT04505722|156125927|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
48528021|NCT04505722|156125928|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
48528022|NCT03442569|156125929|FG000|Overall Study|Subject was ineligible after enrollment|1|||
48528023|NCT01961882|156125935|FG000|Overall Study|Adverse Event|3|||
48528024|NCT01961882|156125936|FG001|Overall Study|Adverse Event|2|||
48528025|NCT01961882|156125935|FG000|Overall Study|Physician Decision|1|||
48528026|NCT01961882|156125936|FG001|Overall Study|Physician Decision|0|||
48528027|NCT01961882|156125935|FG000|Overall Study|Withdrawal by Subject|4|||
48528028|NCT01961882|156125936|FG001|Overall Study|Withdrawal by Subject|1|||
48528029|NCT01961882|156125935|FG000|Overall Study|Relapse of AML|39|||
48528030|NCT01961882|156125936|FG001|Overall Study|Relapse of AML|37|||
48528031|NCT01961882|156125935|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
48528032|NCT01961882|156125936|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
48528033|NCT01961882|156125935|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
48528034|NCT01961882|156125936|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
48528035|NCT01301482|156125937|FG000|Overall Study|Withdrawal by Subject|1|||
48528036|NCT01901848|156125941|FG000|Randomized and Treated|Lost to Follow-up|3|||
48528037|NCT01901848|156125942|FG001|Randomized and Treated|Lost to Follow-up|6|||
48528038|NCT01901848|156125941|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
48528039|NCT01901848|156125942|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
48528040|NCT00763555|156125946|FG000|Overall Study|Adverse Event|2|||
48528041|NCT00763555|156125947|FG001|Overall Study|Adverse Event|1|||
48528042|NCT00763555|156125946|FG000|Overall Study|Withdrawal by Subject|2|||
48528043|NCT00763555|156125947|FG001|Overall Study|Withdrawal by Subject|6|||
48528044|NCT00763555|156125946|FG000|Overall Study|Lost to Follow-up|0|||
48528045|NCT00763555|156125947|FG001|Overall Study|Lost to Follow-up|3|||
48528046|NCT01647958|156125948|FG000|Initial Study|Lost to Follow-up|2|||
48528047|NCT01647958|156125949|FG001|Initial Study|Lost to Follow-up|3|||
48528048|NCT01647958|156125948|FG000|Continuation Phase|treatment received during Overall Study|39|||
48528049|NCT01647958|156125949|FG001|Continuation Phase|treatment received during Overall Study|0|||
48528050|NCT01647958|156125948|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
48528051|NCT01647958|156125949|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
48528052|NCT06424236|156125950|FG000|Overall Study|Adverse Event|0|||
48528053|NCT06424236|156125951|FG001|Overall Study|Adverse Event|1|||
48528054|NCT06424236|156125952|FG002|Overall Study|Adverse Event|0|||
48528055|NCT06424236|156125950|FG000|Overall Study|Withdrawal by Subject|3|||
48528056|NCT06424236|156125951|FG001|Overall Study|Withdrawal by Subject|1|||
48528057|NCT06424236|156125952|FG002|Overall Study|Withdrawal by Subject|2|||
48528058|NCT06424236|156125950|FG000|Overall Study|Physician Decision|0|||
48528059|NCT06424236|156125951|FG001|Overall Study|Physician Decision|1|||
48528060|NCT06424236|156125952|FG002|Overall Study|Physician Decision|0|||
48528061|NCT06424236|156125950|FG000|Overall Study|Study Terminated by Sponsor|11|||
48528062|NCT06424236|156125951|FG001|Overall Study|Study Terminated by Sponsor|20|||
48528063|NCT06424236|156125952|FG002|Overall Study|Study Terminated by Sponsor|16|||
48528064|NCT06424236|156125950|FG000|Overall Study|Lost to Follow-up|0|||
48528065|NCT06424236|156125951|FG001|Overall Study|Lost to Follow-up|1|||
48830103|NCT02322216|157219430|FG000|Overall Study|Adverse Event|1|||
48830104|NCT02322216|157219431|FG001|Overall Study|Adverse Event|0|||
48830105|NCT02322216|157219430|FG000|Overall Study|Withdrawal by Subject|1|||
48830106|NCT02322216|157219431|FG001|Overall Study|Withdrawal by Subject|4|||
48830107|NCT02954848|157219434|FG000|Overall Study|Randomized but Not Treated|0|||
48830108|NCT02954848|157219435|FG001|Overall Study|Randomized but Not Treated|1|||
48528066|NCT06424236|156125952|FG002|Overall Study|Lost to Follow-up|0|||
48528067|NCT06424236|156125950|FG000|Overall Study|Disease Progression|0|||
48528068|NCT06424236|156125951|FG001|Overall Study|Disease Progression|1|||
48830109|NCT02954848|157219434|FG000|Overall Study|Adverse Event|2|||
48830110|NCT02954848|157219435|FG001|Overall Study|Adverse Event|3|||
48830111|NCT02954848|157219434|FG000|Overall Study|Withdrawal by Participant|0|||
48830112|NCT02954848|157219435|FG001|Overall Study|Withdrawal by Participant|1|||
48830113|NCT01253226|157219437|FG000|Overall Study|Adverse Event|0|||
48830114|NCT01253226|157219438|FG001|Overall Study|Adverse Event|0|||
48830115|NCT01253226|157219439|FG002|Overall Study|Adverse Event|1|||
48830116|NCT01253226|157219440|FG003|Overall Study|Adverse Event|0|||
48830117|NCT01253226|157219441|FG004|Overall Study|Adverse Event|0|||
48830118|NCT01253226|157219437|FG000|Overall Study|Death|0|||
48830119|NCT01253226|157219438|FG001|Overall Study|Death|1|||
48830120|NCT01253226|157219439|FG002|Overall Study|Death|0|||
48830121|NCT01253226|157219440|FG003|Overall Study|Death|0|||
48830122|NCT01253226|157219441|FG004|Overall Study|Death|0|||
48830123|NCT01253226|157219437|FG000|Overall Study|Physician Decision|0|||
48830124|NCT01253226|157219438|FG001|Overall Study|Physician Decision|0|||
48602424|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
48602425|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
48602426|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
48602427|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
48602428|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
48602429|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
48602430|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
48830125|NCT01253226|157219439|FG002|Overall Study|Physician Decision|0|||
48830126|NCT01253226|157219440|FG003|Overall Study|Physician Decision|0|||
48830127|NCT01253226|157219441|FG004|Overall Study|Physician Decision|2|||
48830128|NCT01253226|157219437|FG000|Overall Study|Withdrawal by Subject|0|||
48830129|NCT01253226|157219438|FG001|Overall Study|Withdrawal by Subject|0|||
48830130|NCT01253226|157219439|FG002|Overall Study|Withdrawal by Subject|0|||
48830131|NCT01253226|157219440|FG003|Overall Study|Withdrawal by Subject|1|||
48830132|NCT01253226|157219441|FG004|Overall Study|Withdrawal by Subject|0|||
48830133|NCT03235349|157219442|FG000|Overall Study|Adverse Event|1|||
48830134|NCT03235349|157219442|FG000|Overall Study|Other|1|||
48830135|NCT01227707|157219443|FG000|Overall Study|Adverse Event|10|||
48830136|NCT01227707|157219443|FG000|Overall Study|Progression of disease|3|||
48830137|NCT01227707|157219443|FG000|Overall Study|Withdrawal by Subject|1|||
48830138|NCT01227707|157219443|FG000|Overall Study|Patient non-compliance|3|||
48830139|NCT01227707|157219443|FG000|Overall Study|Medical decision|6|||
48830140|NCT01227707|157219443|FG000|Overall Study|Death|1|||
48830141|NCT03210402|157219446|FG000|Overall Study|Withdrawal by Subject|0|||
48830142|NCT03210402|157219447|FG001|Overall Study|Withdrawal by Subject|1|||
48830143|NCT04858425|157219448|FG000|Overall Study|Adverse Event|2|||
48830144|NCT04858425|157219449|FG001|Overall Study|Adverse Event|2|||
48830145|NCT04858425|157219448|FG000|Overall Study|Withdrawal by Subject|3|||
48830146|NCT04858425|157219449|FG001|Overall Study|Withdrawal by Subject|1|||
48830147|NCT04858425|157219448|FG000|Overall Study|Lost to Follow-up|4|||
48830148|NCT04858425|157219449|FG001|Overall Study|Lost to Follow-up|2|||
48830149|NCT04858425|157219448|FG000|Overall Study|Lost to Follow-up|1|||
48528069|NCT06424236|156125952|FG002|Overall Study|Disease Progression|2|||
48528070|NCT06424236|156125950|FG000|Overall Study|Other|0|||
48830150|NCT04858425|157219449|FG001|Overall Study|Lost to Follow-up|0|||
48528071|NCT06424236|156125951|FG001|Overall Study|Other|0|||
48528072|NCT06424236|156125952|FG002|Overall Study|Other|1|||
48528073|NCT04823130|156125955|FG000|Overall Study|Withdrawal by Subject|2|||
48528074|NCT04823130|156125956|FG001|Overall Study|Withdrawal by Subject|3|||
48830151|NCT00823979|157219464|FG000|Overall Study|Lack of Efficacy|13|||
48830152|NCT00823979|157219465|FG001|Overall Study|Lack of Efficacy|16|||
48830153|NCT00823979|157219466|FG002|Overall Study|Lack of Efficacy|9|||
48830154|NCT00823979|157219464|FG000|Overall Study|Lost to Follow-up|2|||
48830155|NCT00823979|157219465|FG001|Overall Study|Lost to Follow-up|1|||
48830156|NCT00823979|157219466|FG002|Overall Study|Lost to Follow-up|0|||
48830157|NCT00823979|157219464|FG000|Overall Study|Withdrawal by Subject|2|||
48830158|NCT00823979|157219465|FG001|Overall Study|Withdrawal by Subject|3|||
48528075|NCT04823130|156125955|FG000|Overall Study|Failure to meet inclusion criteria|6|||
48830159|NCT00823979|157219466|FG002|Overall Study|Withdrawal by Subject|2|||
48830160|NCT00823979|157219464|FG000|Overall Study|Protocol Violation|1|||
48830161|NCT00823979|157219465|FG001|Overall Study|Protocol Violation|1|||
48830162|NCT00823979|157219466|FG002|Overall Study|Protocol Violation|0|||
48528076|NCT04823130|156125956|FG001|Overall Study|Failure to meet inclusion criteria|4|||
48830163|NCT00823979|157219464|FG000|Overall Study|Pregnancy|0|||
48830164|NCT00823979|157219465|FG001|Overall Study|Pregnancy|1|||
48830165|NCT00823979|157219466|FG002|Overall Study|Pregnancy|0|||
48830166|NCT00823979|157219464|FG000|Overall Study|Adverse Event|0|||
48830167|NCT00823979|157219465|FG001|Overall Study|Adverse Event|2|||
48830168|NCT00823979|157219466|FG002|Overall Study|Adverse Event|4|||
48830169|NCT00823979|157219464|FG000|Overall Study|Other|2|||
48830170|NCT00823979|157219465|FG001|Overall Study|Other|0|||
48830171|NCT00823979|157219466|FG002|Overall Study|Other|1|||
48830172|NCT00823979|157219464|FG000|Overall Study|Randomized but not Treated|4|||
48830173|NCT00823979|157219465|FG001|Overall Study|Randomized but not Treated|3|||
48830174|NCT00823979|157219466|FG002|Overall Study|Randomized but not Treated|1|||
48830175|NCT00823979|157219464|FG000|Overall Study|Study Terminated by Sponsor|5|||
48830176|NCT00823979|157219465|FG001|Overall Study|Study Terminated by Sponsor|5|||
48830177|NCT00823979|157219466|FG002|Overall Study|Study Terminated by Sponsor|7|||
48830178|NCT03396913|157219467|FG000|Overall Study|Lost to Follow-up|0|||
48830179|NCT03396913|157219468|FG001|Overall Study|Lost to Follow-up|6|||
48830180|NCT00554801|157219469|FG000|Overall Study|left area before completion|5|||
48830181|NCT00554801|157219470|FG001|Overall Study|left area before completion|0|||
48830182|NCT00554801|157219469|FG000|Overall Study|Withdrawal by Subject|14|||
48830183|NCT00554801|157219470|FG001|Overall Study|Withdrawal by Subject|0|||
48830184|NCT03503773|157219471|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
48830185|NCT03503773|157219472|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
48830186|NCT03503773|157219471|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
48830187|NCT03503773|157219472|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
48830188|NCT03503773|157219471|FG000|Overall Study|Not completing the primary ABPM|3|||
48830189|NCT03503773|157219472|FG001|Overall Study|Not completing the primary ABPM|1|||
48830190|NCT03503773|157219471|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
48830191|NCT03503773|157219472|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48830192|NCT00117988|157219475|FG000|Overall Study|Death|3|||
48830193|NCT00117988|157219475|FG000|Overall Study|Adverse Event|1|||
48830194|NCT00995709|157219480|FG000|Overall Study|Adverse Event|4|||
48830195|NCT00995709|157219481|FG001|Overall Study|Adverse Event|2|||
48830196|NCT00995709|157219482|FG002|Overall Study|Adverse Event|0|||
48830197|NCT00995709|157219480|FG000|Overall Study|Lack of Efficacy|0|||
48830198|NCT00995709|157219481|FG001|Overall Study|Lack of Efficacy|1|||
48830199|NCT00995709|157219482|FG002|Overall Study|Lack of Efficacy|4|||
48830200|NCT00995709|157219480|FG000|Overall Study|Withdrawal by Subject|0|||
48830201|NCT00995709|157219481|FG001|Overall Study|Withdrawal by Subject|4|||
48830202|NCT00995709|157219482|FG002|Overall Study|Withdrawal by Subject|1|||
48830203|NCT00995709|157219480|FG000|Overall Study|Lost to Follow-up|1|||
48830204|NCT00995709|157219481|FG001|Overall Study|Lost to Follow-up|0|||
48830205|NCT00995709|157219482|FG002|Overall Study|Lost to Follow-up|0|||
48830206|NCT00995709|157219480|FG000|Overall Study|Death|0|||
48528077|NCT04823130|156125955|FG000|Overall Study|Other-unspecified|1|||
48528078|NCT04823130|156125956|FG001|Overall Study|Other-unspecified|0|||
48528079|NCT00408005|156125957|FG000|Induction|Adverse Event|19|||
48830207|NCT00995709|157219481|FG001|Overall Study|Death|1|||
48830208|NCT00995709|157219482|FG002|Overall Study|Death|0|||
48830209|NCT00995709|157219480|FG000|Overall Study|Protocol Violation|2|||
48830210|NCT00995709|157219481|FG001|Overall Study|Protocol Violation|1|||
48830211|NCT00995709|157219482|FG002|Overall Study|Protocol Violation|0|||
48830212|NCT03781804|157219483|FG000|Overall Study|Adverse Event|2|||
48830213|NCT03781804|157219484|FG001|Overall Study|Adverse Event|2|||
48830214|NCT03781804|157219485|FG002|Overall Study|Adverse Event|3|||
48830215|NCT03781804|157219483|FG000|Overall Study|Lost to Follow-up|1|||
48830216|NCT03781804|157219484|FG001|Overall Study|Lost to Follow-up|1|||
48830217|NCT03781804|157219485|FG002|Overall Study|Lost to Follow-up|2|||
48528080|NCT00408005|156125958|FG001|Induction|Adverse Event|3|||
48528081|NCT00408005|156125959|FG002|Induction|Adverse Event|0|||
48528082|NCT00408005|156125960|FG003|Induction|Adverse Event|0|||
48528083|NCT00408005|156125961|FG004|Induction|Adverse Event|0|||
48528084|NCT00408005|156125962|FG005|Induction|Adverse Event|0|||
48528085|NCT00408005|156125963|FG006|Induction|Adverse Event|0|||
48528086|NCT00408005|156125964|FG007|Induction|Adverse Event|0|||
48528087|NCT00408005|156125957|FG000|Induction|Death|6|||
48528088|NCT00408005|156125958|FG001|Induction|Death|0|||
48528089|NCT00408005|156125959|FG002|Induction|Death|0|||
48528090|NCT00408005|156125960|FG003|Induction|Death|0|||
48528091|NCT00408005|156125961|FG004|Induction|Death|0|||
48528092|NCT00408005|156125962|FG005|Induction|Death|0|||
48528093|NCT00408005|156125963|FG006|Induction|Death|0|||
48528094|NCT00408005|156125964|FG007|Induction|Death|0|||
48528095|NCT00408005|156125957|FG000|Induction|Physician Decision|83|||
48528096|NCT00408005|156125958|FG001|Induction|Physician Decision|9|||
48528097|NCT00408005|156125959|FG002|Induction|Physician Decision|0|||
48528098|NCT00408005|156125960|FG003|Induction|Physician Decision|0|||
48528099|NCT00408005|156125961|FG004|Induction|Physician Decision|0|||
48528100|NCT00408005|156125962|FG005|Induction|Physician Decision|0|||
48528101|NCT00408005|156125963|FG006|Induction|Physician Decision|0|||
48830218|NCT03781804|157219483|FG000|Overall Study|Lack of Efficacy|4|||
48830219|NCT03781804|157219484|FG001|Overall Study|Lack of Efficacy|2|||
48830220|NCT03781804|157219485|FG002|Overall Study|Lack of Efficacy|9|||
48830221|NCT03781804|157219483|FG000|Overall Study|Protocol Violation|0|||
48830222|NCT03781804|157219484|FG001|Overall Study|Protocol Violation|0|||
48830223|NCT03781804|157219485|FG002|Overall Study|Protocol Violation|1|||
48830224|NCT03781804|157219483|FG000|Overall Study|Withdrawal by Subject|0|||
48830225|NCT03781804|157219484|FG001|Overall Study|Withdrawal by Subject|1|||
48830226|NCT03781804|157219485|FG002|Overall Study|Withdrawal by Subject|1|||
48830227|NCT03781804|157219483|FG000|Overall Study|Reason not provided|2|||
48830228|NCT03781804|157219484|FG001|Overall Study|Reason not provided|2|||
48830229|NCT03781804|157219485|FG002|Overall Study|Reason not provided|0|||
48830230|NCT00906282|157219493|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
48830231|NCT00906282|157219493|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
48830232|NCT00906282|157219493|FG000|Preoperative Chemotherapy|Progressive disease|6|||
48830233|NCT00906282|157219493|FG000|Preoperative Chemotherapy|Toxicity|1|||
48830234|NCT00712166|157219494|FG000|Overall Study|Noncompliance|0|||
48830235|NCT00712166|157219495|FG001|Overall Study|Noncompliance|1|||
48830236|NCT03102242|157219496|FG000|Overall Study|Adverse Event|2|||
48830237|NCT01264718|157219497|FG000|Overall Study|Lost to Follow-up|3|||
48830238|NCT01264718|157219498|FG001|Overall Study|Lost to Follow-up|2|||
48528102|NCT00408005|156125964|FG007|Induction|Physician Decision|0|||
48528103|NCT00408005|156125957|FG000|Induction|Withdrawal by Subject|2|||
48528104|NCT00408005|156125958|FG001|Induction|Withdrawal by Subject|4|||
48528105|NCT00408005|156125959|FG002|Induction|Withdrawal by Subject|0|||
48528106|NCT00408005|156125960|FG003|Induction|Withdrawal by Subject|0|||
48528107|NCT00408005|156125961|FG004|Induction|Withdrawal by Subject|0|||
48528108|NCT00408005|156125962|FG005|Induction|Withdrawal by Subject|0|||
48528109|NCT00408005|156125963|FG006|Induction|Withdrawal by Subject|0|||
48528110|NCT00408005|156125964|FG007|Induction|Withdrawal by Subject|0|||
48528111|NCT00408005|156125957|FG000|Induction|Ineligible|33|||
48528112|NCT00408005|156125958|FG001|Induction|Ineligible|14|||
48528113|NCT00408005|156125959|FG002|Induction|Ineligible|0|||
48528114|NCT00408005|156125960|FG003|Induction|Ineligible|0|||
48528115|NCT00408005|156125961|FG004|Induction|Ineligible|0|||
48528116|NCT00408005|156125962|FG005|Induction|Ineligible|0|||
48528117|NCT00408005|156125963|FG006|Induction|Ineligible|0|||
48528118|NCT00408005|156125964|FG007|Induction|Ineligible|0|||
48528119|NCT00408005|156125957|FG000|Induction|Refusal of Further Protocol Therapy|225|||
48528120|NCT00408005|156125958|FG001|Induction|Refusal of Further Protocol Therapy|44|||
48830239|NCT01264718|157219497|FG000|Overall Study|Withdrawal by Subject|9|||
48528121|NCT00408005|156125959|FG002|Induction|Refusal of Further Protocol Therapy|0|||
48528122|NCT00408005|156125960|FG003|Induction|Refusal of Further Protocol Therapy|0|||
48528123|NCT00408005|156125961|FG004|Induction|Refusal of Further Protocol Therapy|0|||
48528124|NCT00408005|156125962|FG005|Induction|Refusal of Further Protocol Therapy|0|||
48528125|NCT00408005|156125963|FG006|Induction|Refusal of Further Protocol Therapy|0|||
48528126|NCT00408005|156125964|FG007|Induction|Refusal of Further Protocol Therapy|0|||
48528127|NCT00408005|156125957|FG000|Induction|Entered another COG therapeutic protocol|4|||
48528128|NCT00408005|156125958|FG001|Induction|Entered another COG therapeutic protocol|0|||
48528129|NCT00408005|156125959|FG002|Induction|Entered another COG therapeutic protocol|0|||
48528130|NCT00408005|156125960|FG003|Induction|Entered another COG therapeutic protocol|0|||
48528131|NCT00408005|156125961|FG004|Induction|Entered another COG therapeutic protocol|0|||
48528132|NCT00408005|156125962|FG005|Induction|Entered another COG therapeutic protocol|0|||
48528133|NCT00408005|156125963|FG006|Induction|Entered another COG therapeutic protocol|0|||
48528134|NCT00408005|156125964|FG007|Induction|Entered another COG therapeutic protocol|0|||
48528135|NCT00408005|156125957|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
48528136|NCT00408005|156125958|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
48528137|NCT00408005|156125959|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
48528138|NCT00408005|156125960|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
48528139|NCT00408005|156125961|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
48528140|NCT00408005|156125962|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
48528141|NCT00408005|156125963|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
48528142|NCT00408005|156125964|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
48528143|NCT00408005|156125957|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
48528144|NCT00408005|156125958|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
48528145|NCT00408005|156125959|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
48528146|NCT00408005|156125960|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
48528147|NCT00408005|156125961|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
48830240|NCT01264718|157219498|FG001|Overall Study|Withdrawal by Subject|15|||
48830241|NCT01264718|157219497|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
48830242|NCT01264718|157219498|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
48830243|NCT02908464|157219499|FG000|Overall Study|Withdrawal by Subject|2|||
48830244|NCT02908464|157219500|FG001|Overall Study|Withdrawal by Subject|1|||
48830245|NCT02908464|157219499|FG000|Overall Study|Found ineligible after randomization|0|||
48830246|NCT02908464|157219500|FG001|Overall Study|Found ineligible after randomization|2|||
48830247|NCT04084769|157219501|FG000|Overall Study|Protocol Violation|1|||
48830248|NCT04084769|157219502|FG001|Overall Study|Protocol Violation|3|||
48830249|NCT04084769|157219503|FG002|Overall Study|Protocol Violation|0|||
48830250|NCT04084769|157219504|FG003|Overall Study|Protocol Violation|1|||
48830251|NCT04084769|157219501|FG000|Overall Study|Withdrawal by Subject|0|||
48830252|NCT04084769|157219502|FG001|Overall Study|Withdrawal by Subject|1|||
48830253|NCT04084769|157219503|FG002|Overall Study|Withdrawal by Subject|0|||
48830254|NCT04084769|157219504|FG003|Overall Study|Withdrawal by Subject|0|||
48830255|NCT04084769|157219501|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48830256|NCT04084769|157219502|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48830257|NCT04084769|157219503|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48830258|NCT04084769|157219504|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48830259|NCT04084769|157219501|FG000|Overall Study|Lost to Follow-up|2|||
48830260|NCT04084769|157219502|FG001|Overall Study|Lost to Follow-up|0|||
48830261|NCT04084769|157219503|FG002|Overall Study|Lost to Follow-up|0|||
48830262|NCT04084769|157219504|FG003|Overall Study|Lost to Follow-up|0|||
48830263|NCT01278862|157219505|FG000|Overall Study|Lost to Follow-up|1|||
48830264|NCT01278862|157219506|FG001|Overall Study|Lost to Follow-up|1|||
48830265|NCT05512949|157220661|FG000|Overall Study|Lost to Follow-up|4|||
48830266|NCT05512949|157220662|FG001|Overall Study|Lost to Follow-up|6|||
48830267|NCT05512949|157220663|FG002|Overall Study|Lost to Follow-up|2|||
48830268|NCT05512949|157220661|FG000|Overall Study|Protocol Violation|0|||
48830269|NCT05512949|157220662|FG001|Overall Study|Protocol Violation|0|||
48830270|NCT05512949|157220663|FG002|Overall Study|Protocol Violation|1|||
48830271|NCT05512949|157220661|FG000|Overall Study|Withdrawal by Subject|1|||
48830272|NCT05512949|157220662|FG001|Overall Study|Withdrawal by Subject|1|||
48830273|NCT05512949|157220663|FG002|Overall Study|Withdrawal by Subject|2|||
48830274|NCT05512949|157220661|FG000|Overall Study|Completion status unknown|1|||
48830275|NCT05512949|157220662|FG001|Overall Study|Completion status unknown|3|||
48830276|NCT05512949|157220663|FG002|Overall Study|Completion status unknown|0|||
48830277|NCT00777556|157220665|FG000|Overall Study|Inappropriate self-selection|34|||
48830278|NCT00777556|157220665|FG000|Overall Study|Dispensed but did not use product|12|||
48830279|NCT00777556|157220665|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
48830280|NCT01249092|157220666|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
48830281|NCT01249092|157220666|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
48830282|NCT01729819|157220671|FG000|Overall Study|Adverse Event|2|||
48830283|NCT01729819|157220672|FG001|Overall Study|Adverse Event|4|||
48830284|NCT01729819|157220671|FG000|Overall Study|Lack of Efficacy|1|||
48830285|NCT01729819|157220672|FG001|Overall Study|Lack of Efficacy|0|||
48830286|NCT01729819|157220671|FG000|Overall Study|Lost to Follow-up|2|||
48830287|NCT01729819|157220672|FG001|Overall Study|Lost to Follow-up|0|||
48830288|NCT01729819|157220671|FG000|Overall Study|Other reason|1|||
48830289|NCT01729819|157220672|FG001|Overall Study|Other reason|0|||
48830290|NCT01729819|157220671|FG000|Overall Study|Protocol Violation|0|||
48830291|NCT01729819|157220672|FG001|Overall Study|Protocol Violation|1|||
48830292|NCT01729819|157220671|FG000|Overall Study|Withdrawal by Subject|0|||
48528148|NCT00408005|156125962|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
48528149|NCT00408005|156125963|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
48528150|NCT00408005|156125964|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
48528151|NCT00408005|156125957|FG000|Induction|Progressive Disease|0|||
48528152|NCT00408005|156125958|FG001|Induction|Progressive Disease|1|||
48528153|NCT00408005|156125959|FG002|Induction|Progressive Disease|0|||
48528154|NCT00408005|156125960|FG003|Induction|Progressive Disease|0|||
48528155|NCT00408005|156125961|FG004|Induction|Progressive Disease|0|||
48830293|NCT01729819|157220672|FG001|Overall Study|Withdrawal by Subject|2|||
48830294|NCT00309452|157220674|FG000|Overall Study|Withdrawal by Subject|3|||
48830295|NCT00309452|157220675|FG001|Overall Study|Withdrawal by Subject|0|||
48830296|NCT02943993|157220676|FG000|Overall Study|Withdrawal by Subject|52|||
48528156|NCT00408005|156125962|FG005|Induction|Progressive Disease|0|||
48528157|NCT00408005|156125963|FG006|Induction|Progressive Disease|0|||
48528158|NCT00408005|156125964|FG007|Induction|Progressive Disease|0|||
48528159|NCT00408005|156125957|FG000|Induction|Inevaluable|18|||
48830297|NCT02943993|157220676|FG000|Overall Study|Transfer to another institution|6|||
48830298|NCT02943993|157220676|FG000|Overall Study|Lost to Follow-up|135|||
48830299|NCT02943993|157220676|FG000|Overall Study|Death|98|||
48830300|NCT02943993|157220676|FG000|Overall Study|Other reason for premature termination|32|||
48830301|NCT02943993|157220676|FG000|Overall Study|Missing reason for termination|7|||
48830302|NCT00109967|157220677|FG000|Overall Study|Cancel Prior to Treatment|2|||
48830303|NCT00109967|157220678|FG001|Overall Study|Cancel Prior to Treatment|0|||
48830304|NCT00109967|157220677|FG000|Overall Study|Adverse Event|12|||
48830305|NCT00109967|157220678|FG001|Overall Study|Adverse Event|1|||
48830306|NCT00109967|157220677|FG000|Overall Study|Withdrawal by Subject|5|||
48830307|NCT00109967|157220678|FG001|Overall Study|Withdrawal by Subject|0|||
48830308|NCT00109967|157220677|FG000|Overall Study|Physician Decision|1|||
48830309|NCT00109967|157220678|FG001|Overall Study|Physician Decision|3|||
48830310|NCT00109967|157220677|FG000|Overall Study|Death|0|||
48830311|NCT00109967|157220678|FG001|Overall Study|Death|2|||
48830312|NCT02993471|157220679|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
48830313|NCT02993471|157220679|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
48830314|NCT01693614|157220680|FG000|Overall Study|Adverse Event|7|||
48830315|NCT01693614|157220681|FG001|Overall Study|Adverse Event|11|||
48830316|NCT01693614|157220682|FG002|Overall Study|Adverse Event|5|||
48830317|NCT01693614|157220680|FG000|Overall Study|Disease progression|11|||
48830318|NCT01693614|157220681|FG001|Overall Study|Disease progression|8|||
48830319|NCT01693614|157220682|FG002|Overall Study|Disease progression|7|||
48830320|NCT01693614|157220680|FG000|Overall Study|Protocol Violation|5|||
48830321|NCT01693614|157220681|FG001|Overall Study|Protocol Violation|2|||
48830322|NCT01693614|157220682|FG002|Overall Study|Protocol Violation|1|||
48830323|NCT01693614|157220680|FG000|Overall Study|Death|1|||
48830324|NCT01693614|157220681|FG001|Overall Study|Death|0|||
48830325|NCT01693614|157220682|FG002|Overall Study|Death|0|||
48830326|NCT01693614|157220680|FG000|Overall Study|Physician Decision|1|||
48830327|NCT01693614|157220681|FG001|Overall Study|Physician Decision|1|||
48830328|NCT01693614|157220682|FG002|Overall Study|Physician Decision|4|||
48830329|NCT01693614|157220680|FG000|Overall Study|Withdrawal by subject/guardian|0|||
48830330|NCT01693614|157220681|FG001|Overall Study|Withdrawal by subject/guardian|0|||
48830331|NCT01693614|157220682|FG002|Overall Study|Withdrawal by subject/guardian|2|||
48830332|NCT01693614|157220680|FG000|Overall Study|Withdrawal by Subject|1|||
48830333|NCT01693614|157220681|FG001|Overall Study|Withdrawal by Subject|0|||
48830334|NCT01693614|157220682|FG002|Overall Study|Withdrawal by Subject|5|||
48830335|NCT04649359|157220683|FG000|Overall Study|Withdrawal by Subject|7|||
48830336|NCT04649359|157220684|FG001|Overall Study|Withdrawal by Subject|7|||
48830337|NCT04649359|157220683|FG000|Overall Study|Death|41|||
48830338|NCT04649359|157220684|FG001|Overall Study|Death|26|||
48830339|NCT04649359|157220683|FG000|Overall Study|Ongoing in the study|75|||
48830340|NCT04649359|157220684|FG001|Overall Study|Ongoing in the study|31|||
48830341|NCT03383887|157220686|FG000|Overall Study|Lost to Follow-up|0|||
48830342|NCT03383887|157220687|FG001|Overall Study|Lost to Follow-up|1|||
48830343|NCT00831792|157220688|FG000|Overall Study|Not Eligible|3|||
48830344|NCT00831792|157220688|FG000|Overall Study|Adverse Event|1|||
48830345|NCT00831792|157220688|FG000|Overall Study|Death|1|||
48830346|NCT00831792|157220688|FG000|Overall Study|Lack of Efficacy|1|||
48830347|NCT01190150|157220699|FG000|First Treatment|Withdrawal by Subject|1|||
48830348|NCT01190150|157220700|FG001|First Treatment|Withdrawal by Subject|0|||
48830349|NCT01190150|157220699|FG000|Washout|Withdrawal by Subject|0|||
48830350|NCT01190150|157220700|FG001|Washout|Withdrawal by Subject|1|||
48830351|NCT01190150|157220699|FG000|Washout|Difficulty in adherence|0|||
48830352|NCT01190150|157220700|FG001|Washout|Difficulty in adherence|1|||
48830353|NCT00580801|157220702|FG000|Overall Study|Physician Decision|1|||
48830354|NCT00580801|157220703|FG001|Overall Study|Physician Decision|0|||
48830355|NCT00580801|157220704|FG002|Overall Study|Physician Decision|0|||
48830356|NCT00580801|157220702|FG000|Overall Study|Adverse Event|2|||
48528160|NCT00408005|156125958|FG001|Induction|Inevaluable|14|||
48528161|NCT00408005|156125959|FG002|Induction|Inevaluable|0|||
48528162|NCT00408005|156125960|FG003|Induction|Inevaluable|0|||
48830357|NCT00580801|157220703|FG001|Overall Study|Adverse Event|0|||
48528163|NCT00408005|156125961|FG004|Induction|Inevaluable|0|||
48830358|NCT00580801|157220704|FG002|Overall Study|Adverse Event|0|||
48830359|NCT00580801|157220702|FG000|Overall Study|Lost to Follow-up|2|||
48830360|NCT00580801|157220703|FG001|Overall Study|Lost to Follow-up|0|||
48830361|NCT00580801|157220704|FG002|Overall Study|Lost to Follow-up|0|||
48830362|NCT00580801|157220702|FG000|Overall Study|Reached a virologic endpoint|0|||
48830363|NCT00580801|157220703|FG001|Overall Study|Reached a virologic endpoint|1|||
48830364|NCT00580801|157220704|FG002|Overall Study|Reached a virologic endpoint|2|||
48830365|NCT00580801|157220702|FG000|Overall Study|Participant non-compliant|0|||
48830366|NCT00580801|157220703|FG001|Overall Study|Participant non-compliant|0|||
48528164|NCT00408005|156125962|FG005|Induction|Inevaluable|0|||
48830367|NCT00580801|157220704|FG002|Overall Study|Participant non-compliant|1|||
48830368|NCT00580801|157220702|FG000|Overall Study|Travel|1|||
48830369|NCT00580801|157220703|FG001|Overall Study|Travel|0|||
48830370|NCT00580801|157220704|FG002|Overall Study|Travel|0|||
48830371|NCT01833832|157220705|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
48830372|NCT01191788|157220709|FG000|Overall Study|Lost to Follow-up|21|||
48830373|NCT01191788|157220710|FG001|Overall Study|Lost to Follow-up|22|||
48830374|NCT02512042|157220713|FG000|Overall Study|Adverse Event|0|||
48830375|NCT02512042|157220714|FG001|Overall Study|Adverse Event|4|||
48830376|NCT02512042|157220713|FG000|Overall Study|Withdrawal by Subject|6|||
48830377|NCT02512042|157220714|FG001|Overall Study|Withdrawal by Subject|6|||
48830378|NCT02512042|157220713|FG000|Overall Study|Non-compliance with study drug|1|||
48830379|NCT02512042|157220714|FG001|Overall Study|Non-compliance with study drug|2|||
48830380|NCT02512042|157220713|FG000|Overall Study|Lost to Follow-up|5|||
48830381|NCT02512042|157220714|FG001|Overall Study|Lost to Follow-up|2|||
48830382|NCT02512042|157220713|FG000|Overall Study|Other|11|||
48830383|NCT02512042|157220714|FG001|Overall Study|Other|11|||
48830384|NCT01194258|157220717|FG000|Titration Period|Withdrawal by Subject|6|||
48830385|NCT01194258|157220718|FG001|Titration Period|Withdrawal by Subject|0|||
48830386|NCT01194258|157220719|FG002|Titration Period|Withdrawal by Subject|0|||
48830387|NCT01194258|157220720|FG003|Titration Period|Withdrawal by Subject|0|||
48830388|NCT01194258|157220721|FG004|Titration Period|Withdrawal by Subject|0|||
48830389|NCT01194258|157220717|FG000|Titration Period|Lost to Follow-up|2|||
48830390|NCT01194258|157220718|FG001|Titration Period|Lost to Follow-up|0|||
48830391|NCT01194258|157220719|FG002|Titration Period|Lost to Follow-up|0|||
48830392|NCT01194258|157220720|FG003|Titration Period|Lost to Follow-up|0|||
48830393|NCT01194258|157220721|FG004|Titration Period|Lost to Follow-up|0|||
48830394|NCT01194258|157220717|FG000|Titration Period|Titration failure|3|||
48830395|NCT01194258|157220718|FG001|Titration Period|Titration failure|0|||
48830396|NCT01194258|157220719|FG002|Titration Period|Titration failure|0|||
48528165|NCT00408005|156125963|FG006|Induction|Inevaluable|0|||
48528166|NCT00408005|156125964|FG007|Induction|Inevaluable|0|||
48528167|NCT00408005|156125957|FG000|Induction|Failed to Complete Randomization|3|||
48528168|NCT00408005|156125958|FG001|Induction|Failed to Complete Randomization|2|||
48528169|NCT00408005|156125959|FG002|Induction|Failed to Complete Randomization|0|||
48528170|NCT00408005|156125960|FG003|Induction|Failed to Complete Randomization|0|||
48528171|NCT00408005|156125961|FG004|Induction|Failed to Complete Randomization|0|||
48528172|NCT00408005|156125962|FG005|Induction|Failed to Complete Randomization|0|||
48528173|NCT00408005|156125963|FG006|Induction|Failed to Complete Randomization|0|||
48528174|NCT00408005|156125964|FG007|Induction|Failed to Complete Randomization|0|||
48528175|NCT00408005|156125957|FG000|Induction|Protocol Deviation|3|||
48528176|NCT00408005|156125958|FG001|Induction|Protocol Deviation|1|||
48528177|NCT00408005|156125959|FG002|Induction|Protocol Deviation|0|||
48528178|NCT00408005|156125960|FG003|Induction|Protocol Deviation|0|||
48528179|NCT00408005|156125961|FG004|Induction|Protocol Deviation|0|||
48528180|NCT00408005|156125962|FG005|Induction|Protocol Deviation|0|||
48528181|NCT00408005|156125963|FG006|Induction|Protocol Deviation|0|||
48528182|NCT00408005|156125964|FG007|Induction|Protocol Deviation|0|||
48528183|NCT00408005|156125957|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
48528184|NCT00408005|156125958|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
48528185|NCT00408005|156125959|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
48528186|NCT00408005|156125960|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
48528187|NCT00408005|156125961|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
48528188|NCT00408005|156125962|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
48528189|NCT00408005|156125963|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
48528190|NCT00408005|156125964|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
48528191|NCT00408005|156125957|FG000|Induction|Recurrent leukemia|1|||
48528192|NCT00408005|156125958|FG001|Induction|Recurrent leukemia|0|||
48528193|NCT00408005|156125959|FG002|Induction|Recurrent leukemia|0|||
48528194|NCT00408005|156125960|FG003|Induction|Recurrent leukemia|0|||
48528195|NCT00408005|156125961|FG004|Induction|Recurrent leukemia|0|||
48528196|NCT00408005|156125962|FG005|Induction|Recurrent leukemia|0|||
48528197|NCT00408005|156125963|FG006|Induction|Recurrent leukemia|0|||
48528198|NCT00408005|156125964|FG007|Induction|Recurrent leukemia|0|||
48830397|NCT01194258|157220720|FG003|Titration Period|Titration failure|0|||
48830398|NCT01194258|157220721|FG004|Titration Period|Titration failure|0|||
48830399|NCT01194258|157220717|FG000|Period 1 (12 Weeks)|Death|0|||
48528199|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
48528200|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
48528201|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
48830400|NCT01194258|157220718|FG001|Period 1 (12 Weeks)|Death|0|||
48830401|NCT01194258|157220719|FG002|Period 1 (12 Weeks)|Death|0|||
48830402|NCT01194258|157220720|FG003|Period 1 (12 Weeks)|Death|0|||
48830403|NCT01194258|157220721|FG004|Period 1 (12 Weeks)|Death|1|||
48830404|NCT01194258|157220717|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48830405|NCT01194258|157220718|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48830406|NCT01194258|157220719|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48528202|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
48528203|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
48528204|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
48528205|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
48528206|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
48528207|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
48528208|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
48528209|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
48602431|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
48830407|NCT01194258|157220720|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
48528210|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
48528211|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
48528212|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
48602432|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
48602433|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
48602434|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
48602435|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
48602436|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
48602437|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
48602438|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
48602439|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
48602440|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
48602441|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
48602442|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
48602443|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
48602444|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
48602445|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
48602446|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
48602447|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
48602448|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
48602449|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
48602450|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
48602451|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
48602452|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
48602453|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
48602454|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
48602455|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
48602456|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
48602457|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
48830408|NCT01194258|157220721|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
48830409|NCT01194258|157220717|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
48830410|NCT01194258|157220718|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
48830411|NCT01194258|157220719|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
48830412|NCT01194258|157220720|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
48830413|NCT01194258|157220721|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
48528213|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
48528214|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
48528215|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
48528216|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
48528217|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
48528218|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
48528219|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
48528220|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
48528221|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
48528222|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
48528223|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
48528224|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
48528225|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
48528226|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
48830414|NCT01194258|157220717|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48830415|NCT01194258|157220718|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48830416|NCT01194258|157220719|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48830417|NCT01194258|157220720|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48830418|NCT01194258|157220721|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48830419|NCT00197236|157220722|FG000|Overall Study|Adverse Event|1|||
48528227|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
48528228|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
48528229|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
48528230|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
48830420|NCT00197236|157220723|FG001|Overall Study|Adverse Event|0|||
48830421|NCT00197236|157220724|FG002|Overall Study|Adverse Event|1|||
48830422|NCT00197236|157220722|FG000|Overall Study|Lost to Follow-up|5|||
48830423|NCT00197236|157220723|FG001|Overall Study|Lost to Follow-up|14|||
48830424|NCT00197236|157220724|FG002|Overall Study|Lost to Follow-up|6|||
48830425|NCT00197236|157220722|FG000|Overall Study|Protocol Violation|0|||
48830426|NCT00197236|157220723|FG001|Overall Study|Protocol Violation|0|||
48830427|NCT00197236|157220724|FG002|Overall Study|Protocol Violation|1|||
48830428|NCT00197236|157220722|FG000|Overall Study|Withdrawal by Subject|7|||
48830429|NCT00197236|157220723|FG001|Overall Study|Withdrawal by Subject|3|||
48830430|NCT00197236|157220724|FG002|Overall Study|Withdrawal by Subject|11|||
48830431|NCT00197236|157220722|FG000|Overall Study|Study drug/medication expiration|1|||
48830432|NCT00197236|157220723|FG001|Overall Study|Study drug/medication expiration|0|||
48830433|NCT00197236|157220724|FG002|Overall Study|Study drug/medication expiration|3|||
48830434|NCT00197236|157220722|FG000|Overall Study|Returned out of specified time window|0|||
48830435|NCT00197236|157220723|FG001|Overall Study|Returned out of specified time window|0|||
48830436|NCT00197236|157220724|FG002|Overall Study|Returned out of specified time window|1|||
48528231|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
48528232|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
48528233|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
48528234|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
48528235|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
48528236|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
48528237|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
48528238|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
48528239|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
48528240|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
48528241|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
48528242|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
48528243|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
48528244|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
48528245|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
48528246|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
48528247|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
48528248|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
48528249|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
48528250|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
48528251|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
48528252|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
48528253|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
48528254|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
48528255|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
48528256|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
48528257|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
48602458|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
48602459|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
48602460|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
48602461|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
48602462|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
48602463|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
48602464|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
48830437|NCT03885596|157220725|FG000|Overall Study|Withdrawal by Subject|2|||
48830438|NCT03885596|157220726|FG001|Overall Study|Withdrawal by Subject|1|||
48830439|NCT03885596|157220727|FG002|Overall Study|Withdrawal by Subject|0|||
48830440|NCT03885596|157220728|FG003|Overall Study|Withdrawal by Subject|0|||
48830441|NCT00383188|157220729|FG000|Overall Study|Adverse Event|4|||
48830442|NCT00383188|157220730|FG001|Overall Study|Adverse Event|7|||
48830443|NCT00383188|157220731|FG002|Overall Study|Adverse Event|9|||
48830444|NCT00383188|157220732|FG003|Overall Study|Adverse Event|8|||
48830445|NCT00383188|157220733|FG004|Overall Study|Adverse Event|8|||
48830446|NCT00383188|157220729|FG000|Overall Study|Lack of Efficacy|9|||
48830447|NCT00383188|157220730|FG001|Overall Study|Lack of Efficacy|3|||
48830448|NCT00383188|157220731|FG002|Overall Study|Lack of Efficacy|3|||
48830449|NCT00383188|157220732|FG003|Overall Study|Lack of Efficacy|2|||
48830450|NCT00383188|157220733|FG004|Overall Study|Lack of Efficacy|6|||
48830451|NCT00383188|157220729|FG000|Overall Study|Other|3|||
48830452|NCT00383188|157220730|FG001|Overall Study|Other|1|||
48830453|NCT00383188|157220731|FG002|Overall Study|Other|0|||
48830454|NCT00383188|157220732|FG003|Overall Study|Other|2|||
48830455|NCT00383188|157220733|FG004|Overall Study|Other|6|||
48830456|NCT00383188|157220729|FG000|Overall Study|No longer willing to participate|1|||
48830457|NCT00383188|157220730|FG001|Overall Study|No longer willing to participate|0|||
48830458|NCT00383188|157220731|FG002|Overall Study|No longer willing to participate|1|||
48830459|NCT00383188|157220732|FG003|Overall Study|No longer willing to participate|0|||
48830460|NCT00383188|157220733|FG004|Overall Study|No longer willing to participate|2|||
48830461|NCT00383188|157220729|FG000|Overall Study|Lost to Follow-up|0|||
48830462|NCT00383188|157220730|FG001|Overall Study|Lost to Follow-up|0|||
48830463|NCT00383188|157220731|FG002|Overall Study|Lost to Follow-up|0|||
48830464|NCT00383188|157220732|FG003|Overall Study|Lost to Follow-up|0|||
48830465|NCT00383188|157220733|FG004|Overall Study|Lost to Follow-up|1|||
48830466|NCT01076335|157220734|FG000|Overall Study|Withdrawal by Subject|3|||
48830467|NCT01076335|157220734|FG000|Overall Study|Withdrawal without treatment|1|||
48830468|NCT01582945|157220735|FG000|Overall Study|Intolerable side-effects|1|||
48830469|NCT01582945|157220735|FG000|Overall Study|Scheduling conflicts|1|||
48830470|NCT02784704|157220737|FG000|Overall Study|Adverse Event|4|||
48830471|NCT02784704|157220738|FG001|Overall Study|Adverse Event|2|||
48830472|NCT02784704|157220737|FG000|Overall Study|Lost to Follow-up|6|||
48830473|NCT02784704|157220738|FG001|Overall Study|Lost to Follow-up|4|||
48830474|NCT02784704|157220737|FG000|Overall Study|Withdrawal by Subject|1|||
48830475|NCT02784704|157220738|FG001|Overall Study|Withdrawal by Subject|3|||
48830476|NCT02784704|157220737|FG000|Overall Study|Subject Non Compliance|2|||
48830477|NCT02784704|157220738|FG001|Overall Study|Subject Non Compliance|0|||
48830478|NCT00741988|157220739|FG000|Overall Study|Adverse Event|2|||
48830479|NCT00741988|157220740|FG001|Overall Study|Adverse Event|4|||
48830480|NCT00741988|157220739|FG000|Overall Study|Lack of Efficacy|2|||
48528258|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
48528259|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
48528260|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
48528261|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
48528262|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
48528263|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
48528264|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
48528265|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
48830481|NCT00741988|157220740|FG001|Overall Study|Lack of Efficacy|0|||
48830482|NCT00768651|157220741|FG000|Overall Study|Withdrawal by Subject|1|||
48830483|NCT03523572|157220742|FG000|Dose Escalation|Progressive disease|1|||
48830484|NCT03523572|157220743|FG001|Dose Escalation|Progressive disease|0|||
48830485|NCT03523572|157220744|FG002|Dose Escalation|Progressive disease|0|||
48830486|NCT03523572|157220745|FG003|Dose Escalation|Progressive disease|0|||
48830487|NCT03523572|157220746|FG004|Dose Escalation|Progressive disease|0|||
48830488|NCT03523572|157220747|FG005|Dose Escalation|Progressive disease|0|||
48830489|NCT03523572|157220742|FG000|Dose Escalation|Clinical Progression|0|||
48830490|NCT03523572|157220743|FG001|Dose Escalation|Clinical Progression|1|||
48830491|NCT03523572|157220744|FG002|Dose Escalation|Clinical Progression|0|||
48830492|NCT03523572|157220745|FG003|Dose Escalation|Clinical Progression|0|||
48830493|NCT03523572|157220746|FG004|Dose Escalation|Clinical Progression|0|||
48830494|NCT03523572|157220747|FG005|Dose Escalation|Clinical Progression|0|||
48830495|NCT03523572|157220742|FG000|Dose Escalation|Adverse Event|2|||
48830496|NCT03523572|157220743|FG001|Dose Escalation|Adverse Event|0|||
48830497|NCT03523572|157220744|FG002|Dose Escalation|Adverse Event|0|||
48830498|NCT03523572|157220745|FG003|Dose Escalation|Adverse Event|0|||
48830499|NCT03523572|157220746|FG004|Dose Escalation|Adverse Event|0|||
48830500|NCT03523572|157220747|FG005|Dose Escalation|Adverse Event|0|||
48830501|NCT03523572|157220742|FG000|Dose Escalation|Physician Decision|1|||
48830502|NCT03523572|157220743|FG001|Dose Escalation|Physician Decision|1|||
48830503|NCT03523572|157220744|FG002|Dose Escalation|Physician Decision|0|||
48830504|NCT03523572|157220745|FG003|Dose Escalation|Physician Decision|0|||
48830505|NCT03523572|157220746|FG004|Dose Escalation|Physician Decision|0|||
48830506|NCT03523572|157220747|FG005|Dose Escalation|Physician Decision|0|||
48830507|NCT03523572|157220742|FG000|Dose Expansion|Progressive Disease|0|||
48830508|NCT03523572|157220743|FG001|Dose Expansion|Progressive Disease|0|||
48830509|NCT03523572|157220744|FG002|Dose Expansion|Progressive Disease|9|||
48830510|NCT03523572|157220745|FG003|Dose Expansion|Progressive Disease|11|||
48830511|NCT03523572|157220746|FG004|Dose Expansion|Progressive Disease|15|||
48830512|NCT03523572|157220747|FG005|Dose Expansion|Progressive Disease|2|||
48830513|NCT03523572|157220742|FG000|Dose Expansion|Clinical Progression|0|||
48830514|NCT03523572|157220743|FG001|Dose Expansion|Clinical Progression|0|||
48830515|NCT03523572|157220744|FG002|Dose Expansion|Clinical Progression|2|||
48830516|NCT03523572|157220745|FG003|Dose Expansion|Clinical Progression|2|||
48830517|NCT03523572|157220746|FG004|Dose Expansion|Clinical Progression|2|||
48830518|NCT03523572|157220747|FG005|Dose Expansion|Clinical Progression|0|||
48830519|NCT03523572|157220742|FG000|Dose Expansion|Adverse Event|0|||
48830520|NCT03523572|157220743|FG001|Dose Expansion|Adverse Event|0|||
48830521|NCT03523572|157220744|FG002|Dose Expansion|Adverse Event|10|||
48830522|NCT03523572|157220745|FG003|Dose Expansion|Adverse Event|1|||
48830523|NCT03523572|157220746|FG004|Dose Expansion|Adverse Event|5|||
48830524|NCT03523572|157220747|FG005|Dose Expansion|Adverse Event|2|||
48830525|NCT03523572|157220742|FG000|Dose Expansion|Withdrawal by Subject|0|||
48830526|NCT03523572|157220743|FG001|Dose Expansion|Withdrawal by Subject|0|||
48830527|NCT03523572|157220744|FG002|Dose Expansion|Withdrawal by Subject|1|||
48830528|NCT03523572|157220745|FG003|Dose Expansion|Withdrawal by Subject|1|||
48830529|NCT03523572|157220746|FG004|Dose Expansion|Withdrawal by Subject|0|||
48830530|NCT03523572|157220747|FG005|Dose Expansion|Withdrawal by Subject|0|||
48830531|NCT03523572|157220742|FG000|Dose Expansion|Physician Decision|0|||
48528266|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
48830532|NCT03523572|157220743|FG001|Dose Expansion|Physician Decision|0|||
48830533|NCT03523572|157220744|FG002|Dose Expansion|Physician Decision|1|||
48830534|NCT03523572|157220745|FG003|Dose Expansion|Physician Decision|0|||
48830535|NCT03523572|157220746|FG004|Dose Expansion|Physician Decision|1|||
48830536|NCT03523572|157220747|FG005|Dose Expansion|Physician Decision|0|||
48830537|NCT03523572|157220742|FG000|Dose Expansion|Miscellaneous|0|||
48830538|NCT03523572|157220743|FG001|Dose Expansion|Miscellaneous|0|||
48830539|NCT03523572|157220744|FG002|Dose Expansion|Miscellaneous|0|||
48830540|NCT03523572|157220745|FG003|Dose Expansion|Miscellaneous|0|||
48830541|NCT03523572|157220746|FG004|Dose Expansion|Miscellaneous|3|||
48830542|NCT03523572|157220747|FG005|Dose Expansion|Miscellaneous|0|||
48830543|NCT04888585|157220748|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
48830544|NCT04888585|157220749|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
48830545|NCT04888585|157220750|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
48830546|NCT04888585|157220751|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
48830547|NCT04888585|157220752|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
48830548|NCT04888585|157220753|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830549|NCT04888585|157220754|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830550|NCT04888585|157220755|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830551|NCT04888585|157220756|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830552|NCT04888585|157220757|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830553|NCT04888585|157220758|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
48830554|NCT04888585|157220748|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48528267|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
48528268|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
48528269|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
48528270|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
48528271|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
48528272|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
48830555|NCT04888585|157220749|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
48528273|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
48528274|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
48528275|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
48528276|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
48830556|NCT04888585|157220750|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
48830557|NCT04888585|157220751|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
48830558|NCT04888585|157220752|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
48830559|NCT04888585|157220753|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830560|NCT04888585|157220754|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830561|NCT04888585|157220755|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830562|NCT04888585|157220756|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830563|NCT04888585|157220757|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830564|NCT04888585|157220758|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
48830565|NCT04888585|157220748|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830566|NCT04888585|157220749|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830567|NCT04888585|157220750|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
48830568|NCT04888585|157220751|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830569|NCT04888585|157220752|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
48830570|NCT04888585|157220753|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830571|NCT04888585|157220754|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830572|NCT04888585|157220755|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830573|NCT04888585|157220756|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830574|NCT04888585|157220757|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830575|NCT04888585|157220758|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
48830576|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830577|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830578|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830579|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830580|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830581|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830582|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830583|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
48830584|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830585|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
48830586|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
48830587|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48830588|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48830589|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48528277|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
48528278|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
48528279|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
48528280|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
48602465|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
48830590|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48830591|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
48830592|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
48830593|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
48602466|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
48602467|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
48602468|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
48602469|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
48602470|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
48602471|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
48830594|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
48830595|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
48830596|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
48830597|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
48830598|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830599|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830600|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830601|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830602|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
48830603|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
48830604|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
48830605|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
48830606|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
48830607|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
48830608|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
48830609|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830610|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830611|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830612|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830613|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
48830614|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
48830615|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
48830616|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
48830617|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
48830618|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
48830619|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
48830620|NCT04888585|157220748|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830621|NCT04888585|157220749|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830622|NCT04888585|157220750|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830623|NCT04888585|157220751|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830624|NCT04888585|157220752|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830625|NCT04888585|157220753|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830626|NCT04888585|157220754|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
48830627|NCT04888585|157220755|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
48830628|NCT04888585|157220756|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
48830629|NCT04888585|157220757|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
48830630|NCT04888585|157220758|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
48830631|NCT04927975|157220759|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
48830632|NCT04927975|157220760|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
48830633|NCT04927975|157220761|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
48830634|NCT04927975|157220762|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
48830635|NCT04927975|157220763|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
48528281|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
48528282|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
48528283|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
48528284|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
48528285|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
48528286|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
48528287|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
48528288|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
48528289|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
48602472|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
48830636|NCT04927975|157220764|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
48830637|NCT04927975|157220759|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
48830638|NCT04927975|157220760|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
48830639|NCT04927975|157220761|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
48830640|NCT04927975|157220762|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
48830641|NCT04927975|157220763|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
48830642|NCT04927975|157220764|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
48830643|NCT04927975|157220759|FG000|Period 1 (Baseline-Week 24)|Death|0|||
48830644|NCT04927975|157220760|FG001|Period 1 (Baseline-Week 24)|Death|0|||
48830645|NCT04927975|157220761|FG002|Period 1 (Baseline-Week 24)|Death|0|||
48830646|NCT04927975|157220762|FG003|Period 1 (Baseline-Week 24)|Death|0|||
48830647|NCT04927975|157220763|FG004|Period 1 (Baseline-Week 24)|Death|0|||
48830648|NCT04927975|157220764|FG005|Period 1 (Baseline-Week 24)|Death|1|||
48830649|NCT04927975|157220759|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
48830650|NCT04927975|157220760|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
48830651|NCT04927975|157220761|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
48830652|NCT04927975|157220762|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
48830653|NCT04927975|157220763|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
48830654|NCT04927975|157220764|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
48830655|NCT04927975|157220759|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
48830656|NCT04927975|157220760|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
48830657|NCT04927975|157220761|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
48830658|NCT04927975|157220762|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
48830659|NCT04927975|157220763|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
48830660|NCT04927975|157220764|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
48830661|NCT03213665|157220769|FG000|Overall Study|Adverse Event|1|||
48830662|NCT03213665|157220769|FG000|Overall Study|Physician Decision|2|||
48830663|NCT03213665|157220769|FG000|Overall Study|Withdrawal by Subject|3|||
48830664|NCT03213665|157220769|FG000|Overall Study|Progressive Disease|13|||
48830665|NCT01769391|157220771|FG000|Overall Study|Death|10|||
48830666|NCT01769391|157220772|FG001|Overall Study|Death|1|||
48528290|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
48528291|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
48528292|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
48528293|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
48528294|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
48528295|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
48528296|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
48528297|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
48528298|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
48528299|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
48528300|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
48830667|NCT01769391|157220771|FG000|Overall Study|Adverse Event|0|||
48830668|NCT01769391|157220772|FG001|Overall Study|Adverse Event|3|||
48830669|NCT01769391|157220771|FG000|Overall Study|Progressive Disease|1|||
48830670|NCT01769391|157220772|FG001|Overall Study|Progressive Disease|2|||
48830671|NCT01769391|157220771|FG000|Overall Study|Withdrawal by Subject|4|||
48830672|NCT01769391|157220772|FG001|Overall Study|Withdrawal by Subject|3|||
48830673|NCT01769391|157220771|FG000|Overall Study|Investigator Decision|2|||
48830674|NCT01769391|157220772|FG001|Overall Study|Investigator Decision|0|||
48830675|NCT03603717|157220773|FG000|Overall Study|Lost to Follow-up|20|||
48830676|NCT03603717|157220774|FG001|Overall Study|Lost to Follow-up|20|||
48830677|NCT03603717|157220773|FG000|Overall Study|Withdrawal by Subject|16|||
48830678|NCT03603717|157220774|FG001|Overall Study|Withdrawal by Subject|10|||
48830679|NCT00290706|157220777|FG000|Overall Study|Withdrawal by Subject|2|||
48830680|NCT00290706|157220778|FG001|Overall Study|Withdrawal by Subject|0|||
48830681|NCT00290706|157220779|FG002|Overall Study|Withdrawal by Subject|0|||
48528301|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
48528302|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
48528303|NCT00408005|156125957|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
48528304|NCT00408005|156125958|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
48528305|NCT00408005|156125959|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
48830682|NCT00290706|157220780|FG003|Overall Study|Withdrawal by Subject|0|||
48830683|NCT00290706|157220777|FG000|Overall Study|Progressive Disease|3|||
48830684|NCT00290706|157220778|FG001|Overall Study|Progressive Disease|5|||
48830685|NCT00290706|157220779|FG002|Overall Study|Progressive Disease|4|||
48830686|NCT00290706|157220780|FG003|Overall Study|Progressive Disease|10|||
48830687|NCT00290706|157220777|FG000|Overall Study|Adverse Event|0|||
48830688|NCT00290706|157220778|FG001|Overall Study|Adverse Event|1|||
48830689|NCT00290706|157220779|FG002|Overall Study|Adverse Event|2|||
48830690|NCT00290706|157220780|FG003|Overall Study|Adverse Event|0|||
48830691|NCT00290706|157220777|FG000|Overall Study|Receive auto transplant or radiation|0|||
48830692|NCT00290706|157220778|FG001|Overall Study|Receive auto transplant or radiation|0|||
48528306|NCT00408005|156125960|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
48602473|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
48528307|NCT00408005|156125961|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
48528308|NCT00408005|156125962|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
48528309|NCT00408005|156125963|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
48528310|NCT00408005|156125964|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
48528311|NCT01959425|156125965|FG000|Overall Study|Withdrawal by Subject|5|||
48528312|NCT01959425|156125966|FG001|Overall Study|Withdrawal by Subject|4|||
48528313|NCT01959425|156125965|FG000|Overall Study|Lost to Follow-up|1|||
48528314|NCT01959425|156125966|FG001|Overall Study|Lost to Follow-up|0|||
48528315|NCT01959425|156125965|FG000|Overall Study|Discontinued Subjects|6|||
48528316|NCT01959425|156125966|FG001|Overall Study|Discontinued Subjects|4|||
48528317|NCT02575339|156125967|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
48528318|NCT02575339|156125968|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
48528319|NCT02575339|156125969|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
48528320|NCT02575339|156125967|FG000|Study Treatment|Disease Progression|5|||
48528321|NCT02575339|156125968|FG001|Study Treatment|Disease Progression|2|||
48528322|NCT02575339|156125969|FG002|Study Treatment|Disease Progression|0|||
48528323|NCT02575339|156125967|FG000|Study Treatment|Adverse Event|1|||
48528324|NCT02575339|156125968|FG001|Study Treatment|Adverse Event|2|||
48528325|NCT02575339|156125969|FG002|Study Treatment|Adverse Event|0|||
48528326|NCT02575339|156125967|FG000|Follow up|Death|6|||
48528327|NCT02575339|156125968|FG001|Follow up|Death|2|||
48528328|NCT02575339|156125969|FG002|Follow up|Death|0|||
48528329|NCT02575339|156125967|FG000|Follow up|Study Terminated|0|||
48528330|NCT02575339|156125968|FG001|Follow up|Study Terminated|2|||
48602474|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
48602475|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
48735552|NCT00697788|156883658|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
48602476|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
48830693|NCT00290706|157220779|FG002|Overall Study|Receive auto transplant or radiation|0|||
48830694|NCT00290706|157220780|FG003|Overall Study|Receive auto transplant or radiation|1|||
48830695|NCT00290706|157220777|FG000|Overall Study|Physician Decision|0|||
48830696|NCT00290706|157220778|FG001|Overall Study|Physician Decision|0|||
48830697|NCT00290706|157220779|FG002|Overall Study|Physician Decision|0|||
48830698|NCT00290706|157220780|FG003|Overall Study|Physician Decision|1|||
48735553|NCT00697788|156883651|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735554|NCT00697788|156883652|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735555|NCT00697788|156883653|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735556|NCT00697788|156883654|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735557|NCT00697788|156883655|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
48735558|NCT00697788|156883656|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735559|NCT00697788|156883657|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735560|NCT00697788|156883658|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
48735561|NCT05447897|156883663|FG000|Overall Study|Did not participate in survey|2|||
48735562|NCT00850070|156883664|FG000|Overall Study|Lack of Efficacy|1|||
48735563|NCT00850070|156883665|FG001|Overall Study|Lack of Efficacy|1|||
48602477|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
48602478|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
48602479|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
48602480|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
48735564|NCT00850070|156883664|FG000|Overall Study|Adverse Event|2|||
48735565|NCT00850070|156883665|FG001|Overall Study|Adverse Event|0|||
48830699|NCT00546871|157220781|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
48830700|NCT00546871|157220782|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
48830701|NCT00546871|157220781|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
48830702|NCT00546871|157220782|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
48830703|NCT00546871|157220781|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
48830704|NCT00546871|157220782|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
48830705|NCT00546871|157220781|FG000|Study Extension Period|Protocol Violation|1|||
48830706|NCT00546871|157220782|FG001|Study Extension Period|Protocol Violation|0|||
48830707|NCT00546871|157220781|FG000|Study Extension Period|Withdrawal by Subject|0|||
48830708|NCT00546871|157220782|FG001|Study Extension Period|Withdrawal by Subject|1|||
48830709|NCT05567952|157221860|FG000|Overall Study|Lost to Follow-up|3|||
48830710|NCT05567952|157221861|FG001|Overall Study|Lost to Follow-up|2|||
48830711|NCT05567952|157221860|FG000|Overall Study|Withdrawal by Subject|6|||
48528331|NCT02575339|156125969|FG002|Follow up|Study Terminated|0|||
48528332|NCT02575339|156125967|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
48830712|NCT05567952|157221861|FG001|Overall Study|Withdrawal by Subject|3|||
48830713|NCT05567952|157221860|FG000|Overall Study|Other|3|||
48830714|NCT05567952|157221861|FG001|Overall Study|Other|1|||
48830715|NCT02152137|157221862|FG000|Overall Study|Withdrawal by Subject|1|||
48830716|NCT02152137|157221862|FG000|Overall Study|Originally assigned to Arm B|3|||
48830717|NCT01311648|157221863|FG000|Main Study|Protocol Violation|0|||
48830718|NCT01311648|157221864|FG001|Main Study|Protocol Violation|1|||
48830719|NCT01311648|157221863|FG000|Main Study|Adverse Event|0|||
48830720|NCT01311648|157221864|FG001|Main Study|Adverse Event|1|||
48830721|NCT01311648|157221863|FG000|Main Study|Inhibitor management|0|||
48830722|NCT01311648|157221864|FG001|Main Study|Inhibitor management|17|||
48830723|NCT01311648|157221863|FG000|Main Study|Withdrawal by Subject|0|||
48830724|NCT01311648|157221864|FG001|Main Study|Withdrawal by Subject|2|||
48528333|NCT02575339|156125968|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
48528334|NCT02575339|156125969|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
48528335|NCT02244424|156125970|FG000|Overall Study|Lost to Follow-up|20|||
48528336|NCT02244424|156125971|FG001|Overall Study|Lost to Follow-up|10|||
48528337|NCT01253317|156125972|FG000|Overall Study|Adverse Event|2|||
48528338|NCT00480324|156125973|FG000|Overall Study|Adverse Event|1|||
48528339|NCT00480324|156125974|FG001|Overall Study|Adverse Event|1|||
48528340|NCT00480324|156125973|FG000|Overall Study|Protocol Violation|0|||
48528341|NCT00480324|156125974|FG001|Overall Study|Protocol Violation|1|||
48528342|NCT00480324|156125973|FG000|Overall Study|Withdrawal by Subject|14|||
48528343|NCT00480324|156125974|FG001|Overall Study|Withdrawal by Subject|5|||
48528344|NCT00480324|156125973|FG000|Overall Study|Lost to Follow-up|17|||
48528345|NCT00480324|156125974|FG001|Overall Study|Lost to Follow-up|8|||
48528346|NCT00480324|156125973|FG000|Overall Study|Subject's mother pregnant|0|||
48528347|NCT00480324|156125974|FG001|Overall Study|Subject's mother pregnant|1|||
48528348|NCT02488824|156125975|FG000|Overall Study|Adverse Event|1|||
48528349|NCT02488824|156125976|FG001|Overall Study|Adverse Event|1|||
48528350|NCT00784134|156125982|FG000|Overall Study|Lost to Follow-up|3|||
48528351|NCT00784134|156125983|FG001|Overall Study|Lost to Follow-up|6|||
48528352|NCT04675775|156125984|FG000|Overall Study|Withdrawal by Subject|7|||
48528353|NCT01983683|156125985|FG000|Overall Study|Withdrawal by Subject|14|||
48528354|NCT01983683|156125986|FG001|Overall Study|Withdrawal by Subject|18|||
48528355|NCT01983683|156125985|FG000|Overall Study|Death|11|||
48528356|NCT01983683|156125986|FG001|Overall Study|Death|15|||
48528357|NCT01983683|156125985|FG000|Overall Study|Physician Decision|8|||
48528358|NCT01983683|156125986|FG001|Overall Study|Physician Decision|9|||
48602481|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
48602482|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
48602483|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
48602484|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
48830725|NCT01311648|157221863|FG000|Extension Study|Physician Decision|0|||
48830726|NCT01311648|157221864|FG001|Extension Study|Physician Decision|1|||
48528359|NCT01983683|156125985|FG000|Overall Study|Lost to Follow-up|4|||
48528360|NCT01983683|156125986|FG001|Overall Study|Lost to Follow-up|8|||
48528361|NCT01983683|156125985|FG000|Overall Study|Sponsor Decision|1|||
48528362|NCT01983683|156125986|FG001|Overall Study|Sponsor Decision|1|||
48528363|NCT02817776|156125987|FG000|Overall Study|Excluded|33|||
48528364|NCT02817776|156125987|FG000|Overall Study|Lost to Follow-up|20|||
48528365|NCT02817776|156125987|FG000|Overall Study|Withdrawal by Subject|33|||
48528366|NCT02817776|156125987|FG000|Overall Study|Death|2|||
48528367|NCT03546647|156125999|FG000|Overall Study|Adverse Event|1|||
48528368|NCT03546647|156126000|FG001|Overall Study|Adverse Event|0|||
48528369|NCT00939627|156126001|FG000|Overall Study|Disease Progression|16|||
48528370|NCT00939627|156126002|FG001|Overall Study|Disease Progression|12|||
48528371|NCT00939627|156126003|FG002|Overall Study|Disease Progression|0|||
48528372|NCT00939627|156126001|FG000|Overall Study|Adverse Event|6|||
48528373|NCT00939627|156126002|FG001|Overall Study|Adverse Event|7|||
48528374|NCT00939627|156126003|FG002|Overall Study|Adverse Event|0|||
48528375|NCT00939627|156126001|FG000|Overall Study|Death|0|||
48528376|NCT00939627|156126002|FG001|Overall Study|Death|2|||
48602485|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
48602486|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
48602487|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
48602488|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
48602489|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
48602490|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
48602491|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
48602492|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
48602493|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
48602494|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
48602495|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
48830727|NCT01311648|157221863|FG000|Extension Study|ITI therapy with marketed product|0|||
48528377|NCT00939627|156126003|FG002|Overall Study|Death|0|||
48528378|NCT00939627|156126001|FG000|Overall Study|Withdrawal by Subject|2|||
48528379|NCT00939627|156126002|FG001|Overall Study|Withdrawal by Subject|4|||
48528380|NCT00939627|156126003|FG002|Overall Study|Withdrawal by Subject|0|||
48528381|NCT00939627|156126001|FG000|Overall Study|Other complicating disease|1|||
48528382|NCT00939627|156126002|FG001|Overall Study|Other complicating disease|1|||
48528383|NCT00939627|156126003|FG002|Overall Study|Other complicating disease|0|||
48528384|NCT00939627|156126001|FG000|Overall Study|Not compliant|2|||
48528385|NCT00939627|156126002|FG001|Overall Study|Not compliant|0|||
48528386|NCT00939627|156126003|FG002|Overall Study|Not compliant|0|||
48528387|NCT00939627|156126001|FG000|Overall Study|No off-tx reason given|0|||
48528388|NCT00939627|156126002|FG001|Overall Study|No off-tx reason given|2|||
48528389|NCT00939627|156126003|FG002|Overall Study|No off-tx reason given|0|||
48528390|NCT04339062|156126004|FG000|Overall Study|Death|0|||
48528391|NCT04339062|156126005|FG001|Overall Study|Death|1|||
48528392|NCT00124462|156126006|FG000|Overall Study|Lost to Follow-up|3|||
48830728|NCT01311648|157221864|FG001|Extension Study|ITI therapy with marketed product|1|||
48830729|NCT01311648|157221863|FG000|Extension Study|Incorrect visit planning|0|||
48830730|NCT01311648|157221864|FG001|Extension Study|Incorrect visit planning|1|||
48830731|NCT01311648|157221863|FG000|Extension Study|Family's decision|0|||
48830732|NCT01311648|157221864|FG001|Extension Study|Family's decision|1|||
48830733|NCT01311648|157221863|FG000|Extension Study|Failure of ITI therapy|0|||
48830734|NCT01311648|157221864|FG001|Extension Study|Failure of ITI therapy|3|||
48528393|NCT00124462|156126007|FG001|Overall Study|Lost to Follow-up|3|||
48528394|NCT00124462|156126006|FG000|Overall Study|Physician Decision|3|||
48528395|NCT00124462|156126007|FG001|Overall Study|Physician Decision|4|||
48830735|NCT01311648|157221863|FG000|Extension Study|Long travel|0|||
48830736|NCT01311648|157221864|FG001|Extension Study|Long travel|1|||
48830737|NCT01311648|157221863|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
48830738|NCT01311648|157221864|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
48830739|NCT01311648|157221863|FG000|Extension Study|Withdrawal by Subject|0|||
48830740|NCT01311648|157221864|FG001|Extension Study|Withdrawal by Subject|1|||
48830741|NCT01311648|157221863|FG000|Extension Study|Inhibitor management|0|||
48830742|NCT01311648|157221864|FG001|Extension Study|Inhibitor management|2|||
48830743|NCT01645111|157221865|FG000|Overall Study|Did not require Clevidipine|15|||
48830744|NCT03103321|157221866|FG000|Overall Study|Protocol Violation|1|||
48830745|NCT03103321|157221867|FG001|Overall Study|Protocol Violation|1|||
48830746|NCT03103321|157221868|FG002|Overall Study|Protocol Violation|1|||
48830747|NCT03103321|157221869|FG003|Overall Study|Protocol Violation|0|||
48830748|NCT01419717|157221870|FG000|Overall Study|Protocol-specified Criteria|62|||
48830749|NCT01419717|157221870|FG000|Overall Study|Adverse Event|19|||
48830750|NCT01419717|157221870|FG000|Overall Study|Death|17|||
48830751|NCT01419717|157221870|FG000|Overall Study|Withdrawal by Subject|10|||
48830752|NCT01419717|157221870|FG000|Overall Study|Disease Progression|9|||
48830753|NCT01419717|157221870|FG000|Overall Study|Other|4|||
48830754|NCT01419717|157221870|FG000|Overall Study|Lost to Follow-up|2|||
48830755|NCT01419717|157221870|FG000|Overall Study|Administrative Decision|1|||
48830756|NCT01419717|157221870|FG000|Overall Study|Noncompliance|1|||
48830757|NCT02857283|157221871|FG000|First Exposure|Withdrawal by Subject|1|||
48830758|NCT02857283|157221872|FG001|First Exposure|Withdrawal by Subject|0|||
48830759|NCT02728557|157221873|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
48830760|NCT02728557|157221874|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
48528396|NCT00124462|156126006|FG000|Overall Study|Withdrawal by Subject|4|||
48528397|NCT00124462|156126007|FG001|Overall Study|Withdrawal by Subject|5|||
48528398|NCT00124462|156126006|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
48528399|NCT00124462|156126007|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
48528400|NCT00003531|156126009|FG000|Overall Study|Not evaluable|10|||
48528401|NCT02944968|156126010|FG000|Overall Study|Subject excluded before study procedure|1|||
48528402|NCT02944968|156126010|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
48528403|NCT02563769|156126011|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
48830761|NCT02728557|157221873|FG000|Overall Study|Dissatisfaction with research tasks|0|||
48830762|NCT02728557|157221874|FG001|Overall Study|Dissatisfaction with research tasks|1|||
48528404|NCT02563769|156126012|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
48528405|NCT02563769|156126013|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
48528406|NCT01470417|156126014|FG000|Overall Study|Disease progression|0|||
48528407|NCT01470417|156126015|FG001|Overall Study|Disease progression|2|||
48830763|NCT02728557|157221873|FG000|Overall Study|Scheduling or change in availability|1|||
48830764|NCT02728557|157221874|FG001|Overall Study|Scheduling or change in availability|1|||
48830765|NCT01537133|157221875|FG000|Overall Study|Withdrawal by Subject|2|||
48830766|NCT01537133|157221876|FG001|Overall Study|Withdrawal by Subject|0|||
48830767|NCT01537133|157221877|FG002|Overall Study|Withdrawal by Subject|0|||
48528408|NCT03823287|156126016|FG000|Overall Study|Withdrawal by Subject|25|||
48528409|NCT03823287|156126017|FG001|Overall Study|Withdrawal by Subject|17|||
48528410|NCT03823287|156126016|FG000|Overall Study|Death|13|||
48528411|NCT03823287|156126017|FG001|Overall Study|Death|7|||
48528412|NCT03823287|156126016|FG000|Overall Study|Lost to Follow-up|7|||
48528413|NCT03823287|156126017|FG001|Overall Study|Lost to Follow-up|8|||
48528414|NCT03823287|156126016|FG000|Overall Study|Adverse Event|6|||
48528415|NCT03823287|156126017|FG001|Overall Study|Adverse Event|8|||
48528416|NCT03823287|156126016|FG000|Overall Study|Physician Decision|5|||
48528417|NCT03823287|156126017|FG001|Overall Study|Physician Decision|2|||
48528418|NCT03823287|156126016|FG000|Overall Study|Lack of Efficacy|2|||
48528419|NCT03823287|156126017|FG001|Overall Study|Lack of Efficacy|0|||
48528420|NCT03823287|156126016|FG000|Overall Study|Other|2|||
48830768|NCT01537133|157221878|FG003|Overall Study|Withdrawal by Subject|0|||
48830769|NCT01537133|157221875|FG000|Overall Study|Lost to Follow-up|1|||
48830770|NCT01537133|157221876|FG001|Overall Study|Lost to Follow-up|0|||
48528421|NCT03823287|156126017|FG001|Overall Study|Other|4|||
48528422|NCT00749411|156126018|FG000|Overall Study|Adverse Event|0|||
48528423|NCT00749411|156126019|FG001|Overall Study|Adverse Event|2|||
48528424|NCT00749411|156126018|FG000|Overall Study|Lack of Efficacy|0|||
48528425|NCT00749411|156126019|FG001|Overall Study|Lack of Efficacy|1|||
48528426|NCT00749411|156126018|FG000|Overall Study|Protocol Violation|1|||
48528427|NCT00749411|156126019|FG001|Overall Study|Protocol Violation|1|||
48528428|NCT00749411|156126018|FG000|Overall Study|Protocol-defined stopping criteria|0|||
48528429|NCT00749411|156126019|FG001|Overall Study|Protocol-defined stopping criteria|1|||
48528430|NCT01385202|156126020|FG000|Overall Study|Lost to Follow-up|6|||
48528431|NCT01385202|156126020|FG000|Overall Study|Not Eligible|11|||
48528432|NCT01385202|156126020|FG000|Overall Study|Withdrawn|1|||
48528433|NCT03891329|156126021|FG000|Overall Study|Death|5|||
48528434|NCT03891329|156126021|FG000|Overall Study|Lost to Follow-up|4|||
48528435|NCT03891329|156126021|FG000|Overall Study|Physician Decision|4|||
48528436|NCT03891329|156126021|FG000|Overall Study|Device explanted|3|||
48528437|NCT03891329|156126021|FG000|Overall Study|No study device implanted|3|||
48528438|NCT02039063|156126029|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
48528439|NCT02039063|156126030|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
48528440|NCT02039063|156126031|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
48528441|NCT02039063|156126032|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
48528442|NCT02039063|156126029|FG000|Treatment Phase|Progression of disease|0|||
48528443|NCT02039063|156126030|FG001|Treatment Phase|Progression of disease|0|||
48528444|NCT02039063|156126031|FG002|Treatment Phase|Progression of disease|1|||
48528445|NCT02039063|156126032|FG003|Treatment Phase|Progression of disease|1|||
48528446|NCT02039063|156126029|FG000|Extension Phase|Inadequate therapeutic effect|0|||
48528447|NCT02039063|156126030|FG001|Extension Phase|Inadequate therapeutic effect|1|||
48528448|NCT02039063|156126031|FG002|Extension Phase|Inadequate therapeutic effect|2|||
48528449|NCT02039063|156126032|FG003|Extension Phase|Inadequate therapeutic effect|0|||
48528450|NCT02039063|156126029|FG000|Extension Phase|Progression of disease|0|||
48830771|NCT01537133|157221877|FG002|Overall Study|Lost to Follow-up|0|||
48830772|NCT01537133|157221878|FG003|Overall Study|Lost to Follow-up|0|||
48830773|NCT00613301|157221879|FG000|Overall Study|Adverse Event|49|||
48830774|NCT00613301|157221879|FG000|Overall Study|Lost to Follow-up|88|||
48830775|NCT00613301|157221879|FG000|Overall Study|Withdrawal by Subject|5|||
48830776|NCT00613301|157221879|FG000|Overall Study|Death|6|||
48830777|NCT00613301|157221879|FG000|Overall Study|Lack of Efficacy|13|||
48830778|NCT00613301|157221879|FG000|Overall Study|Physician Decision|2|||
48830779|NCT00613301|157221879|FG000|Overall Study|No data was collected|53|||
48830780|NCT00613301|157221879|FG000|Overall Study|Irregularly enrolled patients|12|||
48830781|NCT00762463|157221880|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
48830782|NCT00762463|157221881|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
48830783|NCT00762463|157221882|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
48830784|NCT00762463|157221883|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
48830785|NCT00762463|157221880|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
48830786|NCT00762463|157221881|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
48830787|NCT00762463|157221882|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
48830788|NCT00762463|157221883|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
48830789|NCT00762463|157221880|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
48830790|NCT00762463|157221881|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
48830791|NCT00762463|157221882|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
48830792|NCT00762463|157221883|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
48830793|NCT00762463|157221880|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
48830794|NCT00762463|157221881|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
48830795|NCT00762463|157221882|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
48830796|NCT00762463|157221883|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
48830797|NCT00762463|157221880|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
48830798|NCT00762463|157221881|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
48830799|NCT00762463|157221882|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
48830800|NCT00762463|157221883|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
48528451|NCT02039063|156126030|FG001|Extension Phase|Progression of disease|0|||
48528452|NCT02039063|156126031|FG002|Extension Phase|Progression of disease|0|||
48528453|NCT02039063|156126032|FG003|Extension Phase|Progression of disease|1|||
48528454|NCT02039063|156126029|FG000|Extension Phase|Adverse Event|0|||
48528455|NCT02039063|156126030|FG001|Extension Phase|Adverse Event|0|||
48528456|NCT02039063|156126031|FG002|Extension Phase|Adverse Event|1|||
48528457|NCT02039063|156126032|FG003|Extension Phase|Adverse Event|0|||
48528458|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
48528459|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
48528460|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
48528461|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
48528462|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
48830801|NCT00762463|157221880|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
48528463|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
48528464|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
48528465|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
48528466|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
48528467|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
48528468|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
48528469|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
48528470|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
48528471|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
48528472|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
48528473|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
48528474|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
48528475|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
48528476|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
48528477|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
48528478|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
48528479|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
48528480|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
48528481|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
48528482|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
48528483|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
48528484|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
48528485|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
48528486|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Death|0|||
48528487|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Death|1|||
48528488|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Death|0|||
48528489|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Death|0|||
48528490|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
48528491|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
48528492|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
48528493|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
48528494|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
48528495|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
48528496|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
48528497|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
48528498|NCT02990806|156126034|FG000|Stage 1 (22 Weeks)|Other|1|||
48528499|NCT02990806|156126035|FG001|Stage 1 (22 Weeks)|Other|3|||
48528500|NCT02990806|156126036|FG002|Stage 1 (22 Weeks)|Other|0|||
48528501|NCT02990806|156126037|FG003|Stage 1 (22 Weeks)|Other|0|||
48528502|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
48528503|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
48528504|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
48528505|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
48528506|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Death|1|||
48528507|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Death|0|||
48528508|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Death|0|||
48528509|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Death|0|||
48830802|NCT00762463|157221881|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
48830803|NCT00762463|157221882|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
48830804|NCT00762463|157221883|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
48528510|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
48528511|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
48528512|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
48528513|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
48528514|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
48528515|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
48528516|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
48528517|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
48602496|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
48602497|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
48444875|NCT01231607|155816982|FG001|Overall Study|Physician Decision|4|||
48830805|NCT00762463|157221880|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
48830806|NCT00762463|157221881|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
48830807|NCT00762463|157221882|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
48830808|NCT00762463|157221883|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
48830809|NCT00762463|157221880|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
48830810|NCT00762463|157221881|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
48830811|NCT00762463|157221882|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
48830812|NCT00762463|157221883|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
48830813|NCT03784963|157221884|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
48830814|NCT03784963|157221885|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
48830815|NCT03784963|157221886|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
48830816|NCT03784963|157221887|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
48830817|NCT01362491|157221888|FG000|Overall Study|Ineligible|1|||
48830818|NCT01362491|157221889|FG001|Overall Study|Ineligible|0|||
48830819|NCT01362491|157221890|FG002|Overall Study|Ineligible|0|||
48830820|NCT00149630|157221891|FG000|Overall Study|Incarceration|2|||
48830821|NCT00149630|157221892|FG001|Overall Study|Incarceration|0|||
48830822|NCT00149630|157221891|FG000|Overall Study|Treatment Programs|4|||
48830823|NCT00149630|157221892|FG001|Overall Study|Treatment Programs|5|||
48830824|NCT00149630|157221891|FG000|Overall Study|Adverse Event|2|||
48830825|NCT00149630|157221892|FG001|Overall Study|Adverse Event|0|||
48830826|NCT01175707|157221894|FG000|Overall Study|Adverse Event|4|||
48830827|NCT01175707|157221895|FG001|Overall Study|Adverse Event|6|||
48830828|NCT03771898|157221896|FG000|Overall Study|Adverse Event|1|||
48830829|NCT03771898|157221897|FG001|Overall Study|Adverse Event|0|||
48830830|NCT03771898|157221898|FG002|Overall Study|Adverse Event|0|||
48830831|NCT03771898|157221899|FG003|Overall Study|Adverse Event|0|||
48830832|NCT03771898|157221900|FG004|Overall Study|Adverse Event|0|||
48830833|NCT03771898|157221896|FG000|Overall Study|Lost to Follow-up|1|||
48830834|NCT03771898|157221897|FG001|Overall Study|Lost to Follow-up|1|||
48830835|NCT03771898|157221898|FG002|Overall Study|Lost to Follow-up|1|||
48830836|NCT03771898|157221899|FG003|Overall Study|Lost to Follow-up|0|||
48830837|NCT03771898|157221900|FG004|Overall Study|Lost to Follow-up|0|||
48830838|NCT03771898|157221896|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48830839|NCT03771898|157221897|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48830840|NCT03771898|157221898|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48830841|NCT03771898|157221899|FG003|Overall Study|Withdrawal by parent/guardian|0|||
48830842|NCT03771898|157221900|FG004|Overall Study|Withdrawal by parent/guardian|0|||
48830843|NCT03771898|157221896|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
48830844|NCT03771898|157221897|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
48830845|NCT03771898|157221898|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
48830846|NCT03771898|157221899|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
48830847|NCT03771898|157221900|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
48830848|NCT02962674|157221901|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
48830849|NCT01897233|157221902|FG000|Part B (24 Weeks)|Adverse Event|1|||
48444876|NCT01231607|155816983|FG002|Overall Study|Physician Decision|3|||
48444877|NCT01231607|155816984|FG003|Overall Study|Physician Decision|5|||
48444878|NCT01231607|155816985|FG004|Overall Study|Physician Decision|4|||
48444879|NCT01231607|155816981|FG000|Overall Study|Protocol Violation|3|||
48444880|NCT01231607|155816982|FG001|Overall Study|Protocol Violation|2|||
48444881|NCT01231607|155816983|FG002|Overall Study|Protocol Violation|0|||
48444882|NCT01231607|155816984|FG003|Overall Study|Protocol Violation|2|||
48444883|NCT01231607|155816985|FG004|Overall Study|Protocol Violation|2|||
48444884|NCT01231607|155816981|FG000|Overall Study|Withdrawal by Subject|9|||
48444885|NCT01231607|155816982|FG001|Overall Study|Withdrawal by Subject|9|||
48444886|NCT01231607|155816983|FG002|Overall Study|Withdrawal by Subject|14|||
48444887|NCT01231607|155816984|FG003|Overall Study|Withdrawal by Subject|17|||
48444888|NCT01231607|155816985|FG004|Overall Study|Withdrawal by Subject|9|||
48444889|NCT02197897|155816986|FG000|Overall Study|not eligible|1|||
48444890|NCT02062398|155816987|FG000|Overall Study|Implant removal|1|||
48444891|NCT01705587|155816988|FG000|Overall Study|Withdrawal by Subject|0|||
48444892|NCT01705587|155816989|FG001|Overall Study|Withdrawal by Subject|1|||
48444893|NCT01280266|155816990|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
48444894|NCT01280266|155816991|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
48444895|NCT01280266|155816990|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
48444896|NCT01280266|155816991|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
48444897|NCT02137837|155816992|FG000|Overall Study|Adverse Event|0|||
48444898|NCT02137837|155816993|FG001|Overall Study|Adverse Event|2|||
48444899|NCT02137837|155816994|FG002|Overall Study|Adverse Event|1|||
48528518|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
48528519|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
48528520|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
48528521|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
48528522|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
48528523|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
48528524|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
48528525|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
48528526|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
48528527|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
48830850|NCT01897233|157221902|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
48830851|NCT01897233|157221902|FG000|Part B (24 Weeks)|Physician Decision|1|||
48830852|NCT00269399|157221903|FG000|Overall Study|Lack of Efficacy|27|||
48830853|NCT00269399|157221904|FG001|Overall Study|Lack of Efficacy|10|||
48528528|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
48528529|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
48528530|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
48528531|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
48528532|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
48528533|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
48528534|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
48528535|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
48528536|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
48528537|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
48528538|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
48528539|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
48528540|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
48528541|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
48528542|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
48528543|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
48528544|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
48528545|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
48528546|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Other|3|||
48528547|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Other|0|||
48528548|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Other|4|||
48528549|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Other|1|||
48528550|NCT02990806|156126034|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
48528551|NCT02990806|156126035|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
48528552|NCT02990806|156126036|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
48528553|NCT02990806|156126037|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
48528554|NCT02990806|156126034|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
48528555|NCT02990806|156126035|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
48528556|NCT02990806|156126036|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
48528557|NCT02990806|156126037|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
48528558|NCT02990806|156126034|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
48528559|NCT02990806|156126035|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
48528560|NCT02990806|156126036|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
48528561|NCT02990806|156126037|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
48830854|NCT00269399|157221903|FG000|Overall Study|Adverse Event|10|||
48830855|NCT00269399|157221904|FG001|Overall Study|Adverse Event|4|||
48830856|NCT00269399|157221903|FG000|Overall Study|Withdrawal by Subject|2|||
48830857|NCT00269399|157221904|FG001|Overall Study|Withdrawal by Subject|5|||
48830858|NCT00269399|157221903|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
48830859|NCT00269399|157221904|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
48830860|NCT00269399|157221903|FG000|Overall Study|Other|0|||
48830861|NCT00269399|157221904|FG001|Overall Study|Other|4|||
48830862|NCT00269399|157221903|FG000|Overall Study|Development of exclusion criteria|0|||
48830863|NCT00269399|157221904|FG001|Overall Study|Development of exclusion criteria|1|||
48830864|NCT01048788|157221905|FG000|Overall Study|Adverse Event|5|||
48830865|NCT01048788|157221906|FG001|Overall Study|Adverse Event|1|||
48830866|NCT01048788|157221907|FG002|Overall Study|Adverse Event|1|||
48528562|NCT02990806|156126034|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
48528563|NCT02990806|156126035|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
48528564|NCT02990806|156126036|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
48528565|NCT02990806|156126037|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
48602498|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
48830867|NCT01048788|157221905|FG000|Overall Study|Lack of Efficacy|0|||
48830868|NCT01048788|157221906|FG001|Overall Study|Lack of Efficacy|0|||
48830869|NCT01048788|157221907|FG002|Overall Study|Lack of Efficacy|1|||
48528566|NCT02990806|156126034|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
48528567|NCT02990806|156126035|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
48528568|NCT02990806|156126036|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
48528569|NCT02990806|156126037|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
48528570|NCT02990806|156126034|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
48528571|NCT02990806|156126035|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
48528572|NCT02990806|156126036|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
48528573|NCT02990806|156126037|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
48528574|NCT02990806|156126034|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
48528575|NCT02990806|156126035|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
48528576|NCT02990806|156126036|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
48528577|NCT02990806|156126037|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
48528578|NCT02990806|156126034|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
48528579|NCT02990806|156126035|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
48528580|NCT02990806|156126036|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
48528581|NCT02990806|156126037|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
48528582|NCT02990806|156126034|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
48528583|NCT02990806|156126035|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
48528584|NCT02990806|156126036|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
48528585|NCT02990806|156126037|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
48528586|NCT01210807|156126038|FG000|Overall Study|Lost to Follow-up|1|||
48528587|NCT01210807|156126039|FG001|Overall Study|Lost to Follow-up|2|||
48528588|NCT01210807|156126038|FG000|Overall Study|Not implanted bilaterally|2|||
48528589|NCT01210807|156126039|FG001|Overall Study|Not implanted bilaterally|1|||
48528590|NCT04102111|156126040|FG000|Overall Study|Withdrawal by Subject|2|||
48528591|NCT04102111|156126041|FG001|Overall Study|Withdrawal by Subject|3|||
48528592|NCT04102111|156126040|FG000|Overall Study|Adverse Event|1|||
48830870|NCT01048788|157221905|FG000|Overall Study|Withdrawal by Subject|0|||
48528593|NCT04102111|156126041|FG001|Overall Study|Adverse Event|1|||
48528594|NCT04102111|156126040|FG000|Overall Study|Study terminated by sponsor|1|||
48528595|NCT04102111|156126041|FG001|Overall Study|Study terminated by sponsor|3|||
48528596|NCT00887198|156126042|FG000|Randomized Period|Ongoing|42|||
48528597|NCT00887198|156126043|FG001|Randomized Period|Ongoing|0|||
48528598|NCT00887198|156126044|FG002|Randomized Period|Ongoing|0|||
48528599|NCT00887198|156126042|FG000|Randomized Period|Adverse Event|50|||
48528600|NCT00887198|156126043|FG001|Randomized Period|Adverse Event|33|||
48528601|NCT00887198|156126044|FG002|Randomized Period|Adverse Event|0|||
48528602|NCT00887198|156126042|FG000|Randomized Period|Lost to Follow-up|1|||
48528603|NCT00887198|156126043|FG001|Randomized Period|Lost to Follow-up|0|||
48528604|NCT00887198|156126044|FG002|Randomized Period|Lost to Follow-up|0|||
48528605|NCT00887198|156126042|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
48528606|NCT00887198|156126043|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
48528607|NCT00887198|156126044|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
48528608|NCT00887198|156126042|FG000|Randomized Period|Withdrawal by Subject|41|||
48528609|NCT00887198|156126043|FG001|Randomized Period|Withdrawal by Subject|56|||
48528610|NCT00887198|156126044|FG002|Randomized Period|Withdrawal by Subject|0|||
48528611|NCT00887198|156126042|FG000|Randomized Period|Progressive disease|366|||
48528612|NCT00887198|156126043|FG001|Randomized Period|Progressive disease|370|||
48528613|NCT00887198|156126044|FG002|Randomized Period|Progressive disease|0|||
48528614|NCT00887198|156126042|FG000|Randomized Period|Other|42|||
48528615|NCT00887198|156126043|FG001|Randomized Period|Other|30|||
48528616|NCT00887198|156126044|FG002|Randomized Period|Other|0|||
48602499|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
48830871|NCT01048788|157221906|FG001|Overall Study|Withdrawal by Subject|1|||
48830872|NCT01048788|157221907|FG002|Overall Study|Withdrawal by Subject|0|||
48830873|NCT01196988|157221908|FG000|Overall Study|Adverse Event|1|||
48830874|NCT01196988|157221909|FG001|Overall Study|Adverse Event|2|||
48830875|NCT01196988|157221910|FG002|Overall Study|Adverse Event|0|||
48830876|NCT01196988|157221911|FG003|Overall Study|Adverse Event|0|||
48830877|NCT01196988|157221908|FG000|Overall Study|Withdrawal by Subject|5|||
48830878|NCT01196988|157221909|FG001|Overall Study|Withdrawal by Subject|1|||
48830879|NCT01196988|157221910|FG002|Overall Study|Withdrawal by Subject|4|||
48528617|NCT00887198|156126042|FG000|Randomized Period|Randomized, Not treated|4|||
48528618|NCT00887198|156126043|FG001|Randomized Period|Randomized, Not treated|2|||
48528619|NCT00887198|156126044|FG002|Randomized Period|Randomized, Not treated|0|||
48528620|NCT00887198|156126042|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
48528621|NCT00887198|156126043|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
48528622|NCT00887198|156126044|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
48602500|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
48830880|NCT01196988|157221911|FG003|Overall Study|Withdrawal by Subject|0|||
48830881|NCT01196988|157221908|FG000|Overall Study|Lost to Follow-up|16|||
48830882|NCT01196988|157221909|FG001|Overall Study|Lost to Follow-up|29|||
48830883|NCT01196988|157221910|FG002|Overall Study|Lost to Follow-up|21|||
48830884|NCT01196988|157221911|FG003|Overall Study|Lost to Follow-up|1|||
48830885|NCT01196988|157221908|FG000|Overall Study|Other|2|||
48830886|NCT01196988|157221909|FG001|Overall Study|Other|0|||
48830887|NCT01196988|157221910|FG002|Overall Study|Other|0|||
48830888|NCT01196988|157221911|FG003|Overall Study|Other|0|||
48383826|NCT00436618|155601449|FG002|Overall Study|Withdrawal by Subject|11|||
48528623|NCT00887198|156126042|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
48528624|NCT00887198|156126043|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
48528625|NCT00887198|156126044|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
48528626|NCT00887198|156126042|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
48528627|NCT00887198|156126043|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
48528628|NCT00887198|156126044|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
48528629|NCT00887198|156126042|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
48528630|NCT00887198|156126043|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
48528631|NCT00887198|156126044|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
48528632|NCT00887198|156126042|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
48528633|NCT00887198|156126043|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
48528634|NCT00887198|156126044|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
48528635|NCT00887198|156126042|FG000|Cross Over (Placebo to AA)|Other|0|||
48528636|NCT00887198|156126043|FG001|Cross Over (Placebo to AA)|Other|0|||
48528637|NCT00887198|156126044|FG002|Cross Over (Placebo to AA)|Other|19|||
48528638|NCT01610063|156126045|FG000|Overall Study|Lost to Follow-up|42|||
48528639|NCT01610063|156126046|FG001|Overall Study|Lost to Follow-up|20|||
48528640|NCT03166124|156126047|FG000|Treatment Period 1|Adverse Event|0|||
48528641|NCT03166124|156126048|FG001|Treatment Period 1|Adverse Event|0|||
48528642|NCT03166124|156126049|FG002|Treatment Period 1|Adverse Event|1|||
48528643|NCT03166124|156126050|FG003|Treatment Period 1|Adverse Event|0|||
48528644|NCT03166124|156126047|FG000|Wash-out Period|Withdrawal by Subject|0|||
48528645|NCT03166124|156126048|FG001|Wash-out Period|Withdrawal by Subject|1|||
48528646|NCT03166124|156126049|FG002|Wash-out Period|Withdrawal by Subject|0|||
48528647|NCT03166124|156126050|FG003|Wash-out Period|Withdrawal by Subject|1|||
48528648|NCT03166124|156126047|FG000|Wash-out Period|Adverse Event|0|||
48528649|NCT03166124|156126048|FG001|Wash-out Period|Adverse Event|1|||
48528650|NCT03166124|156126049|FG002|Wash-out Period|Adverse Event|1|||
48528651|NCT03166124|156126050|FG003|Wash-out Period|Adverse Event|0|||
48528652|NCT01662362|156126051|FG000|Overall Study|Lost to Follow-up|38|||
48528653|NCT01181531|156126053|FG000|Overall Study|Other|17|||
48528654|NCT01181531|156126054|FG001|Overall Study|Other|12|||
48528655|NCT01181531|156126053|FG000|Overall Study|Partial consent by subject withdrawn|0|||
48528656|NCT01181531|156126054|FG001|Overall Study|Partial consent by subject withdrawn|1|||
48528657|NCT01181531|156126053|FG000|Overall Study|Physician Decision|3|||
48528658|NCT01181531|156126054|FG001|Overall Study|Physician Decision|1|||
48528659|NCT01181531|156126053|FG000|Overall Study|Noncompliance|2|||
48528660|NCT01181531|156126054|FG001|Overall Study|Noncompliance|2|||
48528661|NCT01181531|156126053|FG000|Overall Study|Ineligibility determined|1|||
48528662|NCT01181531|156126054|FG001|Overall Study|Ineligibility determined|2|||
48528663|NCT01181531|156126053|FG000|Overall Study|Protocol Specified Criteria|15|||
48528664|NCT01181531|156126054|FG001|Overall Study|Protocol Specified Criteria|8|||
48830889|NCT04304534|157221913|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
48830890|NCT04304534|157221914|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
48830891|NCT04304534|157221915|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
48830892|NCT04304534|157221916|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
48830893|NCT04304534|157221913|FG000|Overall Study|Non-Compliance with study drug|0|||
48830894|NCT04304534|157221914|FG001|Overall Study|Non-Compliance with study drug|1|||
48830895|NCT04304534|157221915|FG002|Overall Study|Non-Compliance with study drug|1|||
48830896|NCT04304534|157221916|FG003|Overall Study|Non-Compliance with study drug|1|||
48830897|NCT04304534|157221913|FG000|Overall Study|Lost to Follow-up|0|||
48830898|NCT04304534|157221914|FG001|Overall Study|Lost to Follow-up|1|||
48830899|NCT04304534|157221915|FG002|Overall Study|Lost to Follow-up|2|||
48830900|NCT04304534|157221916|FG003|Overall Study|Lost to Follow-up|3|||
48830901|NCT04304534|157221913|FG000|Overall Study|Unspecific|4|||
48830902|NCT04304534|157221914|FG001|Overall Study|Unspecific|2|||
48830903|NCT04304534|157221915|FG002|Overall Study|Unspecific|2|||
48830904|NCT04304534|157221916|FG003|Overall Study|Unspecific|2|||
48830905|NCT04304534|157221913|FG000|Overall Study|Technical Problems|2|||
48830906|NCT04304534|157221914|FG001|Overall Study|Technical Problems|2|||
48830907|NCT04304534|157221915|FG002|Overall Study|Technical Problems|3|||
48830908|NCT04304534|157221916|FG003|Overall Study|Technical Problems|4|||
48830909|NCT04304534|157221913|FG000|Overall Study|Death|7|||
48830910|NCT04304534|157221914|FG001|Overall Study|Death|2|||
48528665|NCT01181531|156126053|FG000|Overall Study|Pregnancy|0|||
48528666|NCT01181531|156126054|FG001|Overall Study|Pregnancy|1|||
48528667|NCT01181531|156126053|FG000|Overall Study|Withdrawal by Subject|8|||
48528668|NCT01181531|156126054|FG001|Overall Study|Withdrawal by Subject|7|||
48528669|NCT01181531|156126053|FG000|Overall Study|Protocol Violation|6|||
48528670|NCT01181531|156126054|FG001|Overall Study|Protocol Violation|6|||
48528671|NCT01181531|156126053|FG000|Overall Study|Death|9|||
48830911|NCT04304534|157221915|FG002|Overall Study|Death|4|||
48830912|NCT04304534|157221916|FG003|Overall Study|Death|3|||
48830913|NCT04304534|157221913|FG000|Overall Study|Withdrawal by Subject|7|||
48830914|NCT04304534|157221914|FG001|Overall Study|Withdrawal by Subject|2|||
48830915|NCT04304534|157221915|FG002|Overall Study|Withdrawal by Subject|7|||
48528672|NCT01181531|156126054|FG001|Overall Study|Death|12|||
48830916|NCT04304534|157221916|FG003|Overall Study|Withdrawal by Subject|4|||
48830917|NCT04304534|157221913|FG000|Overall Study|Physician Decision|4|||
48830918|NCT04304534|157221914|FG001|Overall Study|Physician Decision|9|||
48830919|NCT04304534|157221915|FG002|Overall Study|Physician Decision|9|||
48830920|NCT04304534|157221916|FG003|Overall Study|Physician Decision|5|||
48830921|NCT04304534|157221913|FG000|Overall Study|Subject Decision|34|||
48830922|NCT04304534|157221914|FG001|Overall Study|Subject Decision|25|||
48830923|NCT04304534|157221915|FG002|Overall Study|Subject Decision|25|||
48830924|NCT04304534|157221916|FG003|Overall Study|Subject Decision|26|||
48830925|NCT04304534|157221913|FG000|Overall Study|Adverse Event|35|||
48830926|NCT04304534|157221914|FG001|Overall Study|Adverse Event|40|||
48830927|NCT04304534|157221915|FG002|Overall Study|Adverse Event|39|||
48830928|NCT04304534|157221916|FG003|Overall Study|Adverse Event|44|||
48528673|NCT01181531|156126053|FG000|Overall Study|Adverse Event|0|||
48528674|NCT01181531|156126054|FG001|Overall Study|Adverse Event|1|||
48528675|NCT00545688|156126055|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
48528676|NCT00545688|156126056|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
48528677|NCT00545688|156126057|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
48528678|NCT00545688|156126058|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
48528679|NCT00545688|156126055|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
48528680|NCT00545688|156126056|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
48528681|NCT00545688|156126057|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
48528682|NCT00545688|156126058|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
48528683|NCT00545688|156126055|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
48528684|NCT00545688|156126056|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
48528685|NCT00545688|156126057|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
48830929|NCT00763282|157221917|FG000|Overall Study|Withdrawal by Subject|6|||
48830930|NCT00763282|157221918|FG001|Overall Study|Withdrawal by Subject|5|||
48830931|NCT00763282|157221917|FG000|Overall Study|Death|4|||
48830932|NCT00763282|157221918|FG001|Overall Study|Death|3|||
48830933|NCT00763282|157221917|FG000|Overall Study|Lost to Follow-up|22|||
48830934|NCT00763282|157221918|FG001|Overall Study|Lost to Follow-up|26|||
48830935|NCT00828672|157221919|FG000|Study Treatment|Lost to Follow-up|1|||
48830936|NCT00828672|157221920|FG001|Study Treatment|Lost to Follow-up|0|||
48830937|NCT00828672|157221919|FG000|Study Treatment|Adverse Event|0|||
48830938|NCT00828672|157221920|FG001|Study Treatment|Adverse Event|1|||
48830939|NCT00828672|157221919|FG000|Study Treatment|Complete response, no surgery|1|||
48830940|NCT00828672|157221920|FG001|Study Treatment|Complete response, no surgery|1|||
48830941|NCT00828672|157221919|FG000|Post-surgery (<30 Days)|No central review materials|0|||
48830942|NCT00828672|157221920|FG001|Post-surgery (<30 Days)|No central review materials|1|||
48830943|NCT04107805|157221921|FG000|Overall Study|Adverse Event|0|||
48830944|NCT04107805|157221922|FG001|Overall Study|Adverse Event|0|||
48830945|NCT04107805|157221923|FG002|Overall Study|Adverse Event|0|||
48830946|NCT04107805|157221924|FG003|Overall Study|Adverse Event|1|||
48830947|NCT04107805|157221925|FG004|Overall Study|Adverse Event|0|||
48830948|NCT04107805|157221926|FG005|Overall Study|Adverse Event|1|||
48830949|NCT04107805|157221927|FG006|Overall Study|Adverse Event|0|||
48830950|NCT04107805|157221928|FG007|Overall Study|Adverse Event|0|||
48830951|NCT04107805|157221929|FG008|Overall Study|Adverse Event|1|||
48830952|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
48830953|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
48830954|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
48830955|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
48830956|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
48830957|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
48830958|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
48830959|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
48830960|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
48830961|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
48383827|NCT00436618|155601447|FG000|Overall Study|Adverse Event|8|||
48528686|NCT00545688|156126058|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
48528687|NCT00545688|156126055|FG000|Neo-Adjuvant Treatment Period|Death|0|||
48528688|NCT00545688|156126056|FG001|Neo-Adjuvant Treatment Period|Death|1|||
48830962|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
48830963|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
48830964|NCT02057718|157221934|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
48830965|NCT02057718|157221935|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
48528689|NCT00545688|156126057|FG002|Neo-Adjuvant Treatment Period|Death|0|||
48528690|NCT00545688|156126058|FG003|Neo-Adjuvant Treatment Period|Death|0|||
48528691|NCT00545688|156126055|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
48528692|NCT00545688|156126056|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
48830966|NCT02057718|157221934|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
48830967|NCT02057718|157221935|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
48830968|NCT02057718|157221934|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
48830969|NCT02057718|157221935|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
48830970|NCT02057718|157221934|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
48830971|NCT02057718|157221935|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
48830972|NCT02057718|157221934|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
48830973|NCT02057718|157221935|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
48830974|NCT01565928|157221938|FG000|Overall Study|Adverse Event|3|||
48830975|NCT01565928|157221938|FG000|Overall Study|Other|3|||
48830976|NCT01565928|157221938|FG000|Overall Study|Progressive Disease|13|||
48830977|NCT01565928|157221938|FG000|Overall Study|Withdrawal by Subject|1|||
48830978|NCT01565928|157221938|FG000|Overall Study|Death|2|||
48528693|NCT00545688|156126057|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
48528694|NCT00545688|156126058|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
48528695|NCT00545688|156126055|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
48528696|NCT00545688|156126056|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
48528697|NCT00545688|156126057|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
48528698|NCT00545688|156126058|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
48528699|NCT00545688|156126055|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
48528700|NCT00545688|156126056|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
48528701|NCT00545688|156126057|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
48528702|NCT00545688|156126058|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
48528703|NCT00545688|156126055|FG000|Adjuvant Treatment Period|Disease Progression|3|||
48528704|NCT00545688|156126056|FG001|Adjuvant Treatment Period|Disease Progression|3|||
48528705|NCT00545688|156126057|FG002|Adjuvant Treatment Period|Disease Progression|0|||
48528706|NCT00545688|156126058|FG003|Adjuvant Treatment Period|Disease Progression|7|||
48528707|NCT00545688|156126055|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
48528708|NCT00545688|156126056|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
48528709|NCT00545688|156126057|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
48528710|NCT00545688|156126058|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
48528711|NCT00545688|156126055|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
48528712|NCT00545688|156126056|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
48528713|NCT00545688|156126057|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
48528714|NCT00545688|156126058|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
48528715|NCT00545688|156126055|FG000|Adjuvant Treatment Period|Adverse Event|0|||
48528716|NCT00545688|156126056|FG001|Adjuvant Treatment Period|Adverse Event|3|||
48528717|NCT00545688|156126057|FG002|Adjuvant Treatment Period|Adverse Event|2|||
48528718|NCT00545688|156126058|FG003|Adjuvant Treatment Period|Adverse Event|2|||
48528719|NCT00545688|156126055|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
48528720|NCT00545688|156126056|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
48528721|NCT00545688|156126057|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
48528722|NCT00545688|156126058|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
48830979|NCT00608907|157221939|FG000|Overall Study|Adverse Event|6|||
48830980|NCT00608907|157221940|FG001|Overall Study|Adverse Event|0|||
48528723|NCT00545688|156126055|FG000|Follow-Up Period|Death|4|||
48528724|NCT00545688|156126056|FG001|Follow-Up Period|Death|2|||
48528725|NCT00545688|156126057|FG002|Follow-Up Period|Death|2|||
48528726|NCT00545688|156126058|FG003|Follow-Up Period|Death|6|||
48528727|NCT00545688|156126055|FG000|Follow-Up Period|Disease Progression|6|||
48528728|NCT00545688|156126056|FG001|Follow-Up Period|Disease Progression|5|||
48528729|NCT00545688|156126057|FG002|Follow-Up Period|Disease Progression|9|||
48528730|NCT00545688|156126058|FG003|Follow-Up Period|Disease Progression|9|||
48528731|NCT00545688|156126055|FG000|Follow-Up Period|Refused Treatment|6|||
48528732|NCT00545688|156126056|FG001|Follow-Up Period|Refused Treatment|2|||
48528733|NCT00545688|156126057|FG002|Follow-Up Period|Refused Treatment|0|||
48528734|NCT00545688|156126058|FG003|Follow-Up Period|Refused Treatment|2|||
48830981|NCT00608907|157221941|FG002|Overall Study|Adverse Event|1|||
48830982|NCT00608907|157221939|FG000|Overall Study|Death|1|||
48830983|NCT00608907|157221940|FG001|Overall Study|Death|0|||
48830984|NCT00608907|157221941|FG002|Overall Study|Death|0|||
48830985|NCT00608907|157221939|FG000|Overall Study|Withdrawal by Subject|4|||
48830986|NCT00608907|157221940|FG001|Overall Study|Withdrawal by Subject|0|||
48830987|NCT00608907|157221941|FG002|Overall Study|Withdrawal by Subject|0|||
48830988|NCT00608907|157221939|FG000|Overall Study|Progressive Disease|1|||
48830989|NCT00608907|157221940|FG001|Overall Study|Progressive Disease|0|||
48830990|NCT00608907|157221941|FG002|Overall Study|Progressive Disease|0|||
48830991|NCT00130637|157221942|FG000|Overall Study|Adverse Event|2|||
48830992|NCT00130637|157221942|FG000|Overall Study|Withdrawal by Subject|1|||
48830993|NCT02982213|157221944|FG000|Overall Study|Did not complete follow up questionnaire|5|||
48830994|NCT02982213|157221945|FG001|Overall Study|Did not complete follow up questionnaire|1|||
48830995|NCT03537651|157221946|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
48830996|NCT03537651|157221946|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
48830997|NCT03537651|157221946|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
48528735|NCT00545688|156126055|FG000|Follow-Up Period|Lost to Follow-up|3|||
48528736|NCT00545688|156126056|FG001|Follow-Up Period|Lost to Follow-up|3|||
48528737|NCT00545688|156126057|FG002|Follow-Up Period|Lost to Follow-up|3|||
48528738|NCT00545688|156126058|FG003|Follow-Up Period|Lost to Follow-up|1|||
48528739|NCT00545688|156126055|FG000|Follow-Up Period|Unspecified Reason|2|||
48528740|NCT00545688|156126056|FG001|Follow-Up Period|Unspecified Reason|5|||
48528741|NCT00545688|156126057|FG002|Follow-Up Period|Unspecified Reason|6|||
48528742|NCT00545688|156126058|FG003|Follow-Up Period|Unspecified Reason|8|||
48528743|NCT00545688|156126055|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
48528744|NCT00545688|156126056|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
48528745|NCT00545688|156126057|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
48528746|NCT00545688|156126058|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
48830998|NCT03537651|157221946|FG000|Part A (Up to 96 Weeks)|Other|1|||
48830999|NCT03537651|157221946|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
48831000|NCT03537651|157221946|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
48831001|NCT03537651|157221946|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
48528747|NCT00515034|156126061|FG000|Overall Study|Adverse Event|2|||
48528748|NCT00515034|156126062|FG001|Overall Study|Adverse Event|0|||
48528749|NCT00515034|156126063|FG002|Overall Study|Adverse Event|1|||
48528750|NCT00515034|156126064|FG003|Overall Study|Adverse Event|0|||
48528751|NCT00515034|156126061|FG000|Overall Study|Death|4|||
48528752|NCT00515034|156126062|FG001|Overall Study|Death|2|||
48528753|NCT00515034|156126063|FG002|Overall Study|Death|1|||
48528754|NCT00515034|156126064|FG003|Overall Study|Death|3|||
48528755|NCT00515034|156126061|FG000|Overall Study|Withdrawal by Subject|1|||
48528756|NCT00515034|156126062|FG001|Overall Study|Withdrawal by Subject|0|||
48528757|NCT00515034|156126063|FG002|Overall Study|Withdrawal by Subject|3|||
48528758|NCT00515034|156126064|FG003|Overall Study|Withdrawal by Subject|0|||
48528759|NCT00515034|156126061|FG000|Overall Study|Physician Decision|0|||
48528760|NCT00515034|156126062|FG001|Overall Study|Physician Decision|0|||
48528761|NCT00515034|156126063|FG002|Overall Study|Physician Decision|1|||
48528762|NCT00515034|156126064|FG003|Overall Study|Physician Decision|1|||
48528763|NCT00515034|156126061|FG000|Overall Study|Other|1|||
48528764|NCT00515034|156126062|FG001|Overall Study|Other|0|||
48528765|NCT00515034|156126063|FG002|Overall Study|Other|2|||
48528766|NCT00515034|156126064|FG003|Overall Study|Other|1|||
48528767|NCT03253094|156126065|FG000|Overall Study|Adverse Event|2|||
48528768|NCT03253094|156126066|FG001|Overall Study|Adverse Event|0|||
48528769|NCT03253094|156126067|FG002|Overall Study|Adverse Event|0|||
48528770|NCT03253094|156126068|FG003|Overall Study|Adverse Event|0|||
48528771|NCT03253094|156126069|FG004|Overall Study|Adverse Event|0|||
48528772|NCT03253094|156126070|FG005|Overall Study|Adverse Event|0|||
48528773|NCT03253094|156126065|FG000|Overall Study|Lack of Efficacy|0|||
48528774|NCT03253094|156126066|FG001|Overall Study|Lack of Efficacy|0|||
48528775|NCT03253094|156126067|FG002|Overall Study|Lack of Efficacy|2|||
48528776|NCT03253094|156126068|FG003|Overall Study|Lack of Efficacy|1|||
48528777|NCT03253094|156126069|FG004|Overall Study|Lack of Efficacy|2|||
48528778|NCT03253094|156126070|FG005|Overall Study|Lack of Efficacy|1|||
48528779|NCT03253094|156126065|FG000|Overall Study|Lost to Follow-up|0|||
48528780|NCT03253094|156126066|FG001|Overall Study|Lost to Follow-up|0|||
48602501|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
48528781|NCT03253094|156126067|FG002|Overall Study|Lost to Follow-up|1|||
48528782|NCT03253094|156126068|FG003|Overall Study|Lost to Follow-up|1|||
48528783|NCT03253094|156126069|FG004|Overall Study|Lost to Follow-up|0|||
48528784|NCT03253094|156126070|FG005|Overall Study|Lost to Follow-up|1|||
48528785|NCT03253094|156126065|FG000|Overall Study|Physician Decision|1|||
48528786|NCT03253094|156126066|FG001|Overall Study|Physician Decision|0|||
48528787|NCT03253094|156126067|FG002|Overall Study|Physician Decision|0|||
48528788|NCT03253094|156126068|FG003|Overall Study|Physician Decision|1|||
48528789|NCT03253094|156126069|FG004|Overall Study|Physician Decision|0|||
48528790|NCT03253094|156126070|FG005|Overall Study|Physician Decision|2|||
48831002|NCT03537651|157221946|FG000|Part B (Up to 192 Weeks)|Other|1|||
48831003|NCT01186848|157221947|FG000|Overall Study|Lost to Follow-up|4|||
48528791|NCT03253094|156126065|FG000|Overall Study|Withdrawal by Subject|1|||
48528792|NCT03253094|156126066|FG001|Overall Study|Withdrawal by Subject|2|||
48528793|NCT03253094|156126067|FG002|Overall Study|Withdrawal by Subject|1|||
48528794|NCT03253094|156126068|FG003|Overall Study|Withdrawal by Subject|0|||
48528795|NCT03253094|156126069|FG004|Overall Study|Withdrawal by Subject|3|||
48528796|NCT03253094|156126070|FG005|Overall Study|Withdrawal by Subject|0|||
48528797|NCT03253094|156126065|FG000|Overall Study|Other|0|||
48528798|NCT03253094|156126066|FG001|Overall Study|Other|1|||
48528799|NCT03253094|156126067|FG002|Overall Study|Other|2|||
48528800|NCT03253094|156126068|FG003|Overall Study|Other|1|||
48602502|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
48602503|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
48602504|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
48602505|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
48602506|NCT02717195|156399595|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
48602507|NCT02717195|156399596|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
48602508|NCT02717195|156399597|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
48602509|NCT02717195|156399598|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
48602510|NCT02717195|156399599|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
48602511|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
48602512|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
48602513|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
48602514|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
48602515|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
48602516|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
48602517|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
48602518|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
48602519|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
48602520|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
48602521|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
48602522|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
48602523|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
48602524|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
48602525|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
48602526|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
48602527|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
48602528|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
48602529|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
48602530|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
48602531|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48602532|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48602533|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
48602534|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
48602535|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
48528801|NCT03253094|156126069|FG004|Overall Study|Other|0|||
48528802|NCT03253094|156126070|FG005|Overall Study|Other|0|||
48528803|NCT02858726|156126071|FG000|Overall Study|Adverse Event|4|||
48528804|NCT02858726|156126072|FG001|Overall Study|Adverse Event|4|||
48528805|NCT02858726|156126073|FG002|Overall Study|Adverse Event|9|||
48528806|NCT02858726|156126074|FG003|Overall Study|Adverse Event|1|||
48528807|NCT02858726|156126071|FG000|Overall Study|Physician Decision|0|||
48528808|NCT02858726|156126072|FG001|Overall Study|Physician Decision|0|||
48528809|NCT02858726|156126073|FG002|Overall Study|Physician Decision|1|||
48528810|NCT02858726|156126074|FG003|Overall Study|Physician Decision|0|||
48528811|NCT02858726|156126071|FG000|Overall Study|Protocol Violation|0|||
48528812|NCT02858726|156126072|FG001|Overall Study|Protocol Violation|0|||
48528813|NCT02858726|156126073|FG002|Overall Study|Protocol Violation|0|||
48528814|NCT02858726|156126074|FG003|Overall Study|Protocol Violation|1|||
48528815|NCT02858726|156126071|FG000|Overall Study|Study Terminated by Sponsor|0|||
48528816|NCT02858726|156126072|FG001|Overall Study|Study Terminated by Sponsor|0|||
48528817|NCT02858726|156126073|FG002|Overall Study|Study Terminated by Sponsor|0|||
48528818|NCT02858726|156126074|FG003|Overall Study|Study Terminated by Sponsor|1|||
48528819|NCT02858726|156126071|FG000|Overall Study|Withdrawal by Subject|1|||
48528820|NCT02858726|156126072|FG001|Overall Study|Withdrawal by Subject|2|||
48528821|NCT02858726|156126073|FG002|Overall Study|Withdrawal by Subject|1|||
48602536|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
48602537|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
48602538|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
48735566|NCT04674644|156883668|FG000|Overall Study|with missing data|37|||
48602539|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
48602540|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
48602541|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
48602542|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
48602543|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
48602544|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
48602545|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
48602546|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
48602547|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
48602548|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
48602549|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
48602550|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
48602551|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
48602552|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
48602553|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
48602554|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
48602555|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
48602556|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
48602557|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
48602558|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
48602559|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
48602560|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
48602561|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
48602562|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
48602563|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
48602564|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
48602565|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
48602566|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
48602567|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
48602568|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
48528822|NCT02858726|156126074|FG003|Overall Study|Withdrawal by Subject|0|||
48528823|NCT02858726|156126071|FG000|Overall Study|Noncompliance|0|||
48528824|NCT02858726|156126072|FG001|Overall Study|Noncompliance|1|||
48528825|NCT02858726|156126073|FG002|Overall Study|Noncompliance|0|||
48528826|NCT02858726|156126074|FG003|Overall Study|Noncompliance|0|||
48528827|NCT00576303|156126075|FG000|Dose Titration Period|Early withdrawal|17|||
48528828|NCT00576303|156126075|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
48528829|NCT00576303|156126075|FG000|Long Term Safety Period|Early withdrawal|16|||
48528830|NCT01467479|156128983|FG000|Overall Study|No Study Medication|1|||
48528831|NCT01467479|156128984|FG001|Overall Study|No Study Medication|0|||
48528832|NCT01467479|156128985|FG002|Overall Study|No Study Medication|2|||
48528833|NCT01467479|156128983|FG000|Overall Study|Adverse Event|1|||
48528834|NCT01467479|156128984|FG001|Overall Study|Adverse Event|2|||
48528835|NCT01467479|156128985|FG002|Overall Study|Adverse Event|0|||
48528836|NCT01467479|156128983|FG000|Overall Study|Death|0|||
48528837|NCT01467479|156128984|FG001|Overall Study|Death|0|||
48528838|NCT01467479|156128985|FG002|Overall Study|Death|1|||
48528839|NCT01467479|156128983|FG000|Overall Study|Lost to Follow-up|2|||
48528840|NCT01467479|156128984|FG001|Overall Study|Lost to Follow-up|5|||
48528841|NCT01467479|156128985|FG002|Overall Study|Lost to Follow-up|3|||
48528842|NCT01467479|156128983|FG000|Overall Study|Withdrawal of Consent|3|||
48528843|NCT01467479|156128984|FG001|Overall Study|Withdrawal of Consent|7|||
48528844|NCT01467479|156128985|FG002|Overall Study|Withdrawal of Consent|7|||
48528845|NCT01467479|156128983|FG000|Overall Study|Study Terminated by Sponsor|1|||
48528846|NCT01467479|156128984|FG001|Overall Study|Study Terminated by Sponsor|3|||
48528847|NCT01467479|156128985|FG002|Overall Study|Study Terminated by Sponsor|3|||
48528848|NCT01467479|156128983|FG000|Overall Study|Other|1|||
48528849|NCT01467479|156128984|FG001|Overall Study|Other|0|||
48528850|NCT01467479|156128985|FG002|Overall Study|Other|0|||
48528851|NCT04100096|156128989|FG000|Overall Study|Adverse Event|19|||
48528852|NCT04100096|156128990|FG001|Overall Study|Adverse Event|7|||
48528853|NCT04100096|156128989|FG000|Overall Study|Lack of Efficacy|0|||
48528854|NCT04100096|156128990|FG001|Overall Study|Lack of Efficacy|1|||
48528855|NCT04100096|156128989|FG000|Overall Study|Lost to Follow-up|13|||
48528856|NCT04100096|156128990|FG001|Overall Study|Lost to Follow-up|11|||
48528857|NCT04100096|156128989|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48528858|NCT04100096|156128990|FG001|Overall Study|Non-Compliance With Study Drug|3|||
48528859|NCT04100096|156128989|FG000|Overall Study|Protocol Deviation|1|||
48602569|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
48735567|NCT00395733|156883669|FG000|Period 2|Withdrawal by Subject|1|||
48528860|NCT04100096|156128990|FG001|Overall Study|Protocol Deviation|1|||
48528861|NCT04100096|156128989|FG000|Overall Study|Withdrawal by Participant|13|||
48528862|NCT04100096|156128990|FG001|Overall Study|Withdrawal by Participant|15|||
48528863|NCT02104817|156128991|FG000|Overall Study|Death|363|||
48528864|NCT02104817|156128992|FG001|Overall Study|Death|330|||
48528865|NCT02104817|156128991|FG000|Overall Study|Lost to Follow-up|3|||
48528866|NCT02104817|156128992|FG001|Overall Study|Lost to Follow-up|2|||
48528867|NCT02104817|156128991|FG000|Overall Study|Protocol Violation|0|||
48528868|NCT02104817|156128992|FG001|Overall Study|Protocol Violation|1|||
48528869|NCT02104817|156128991|FG000|Overall Study|Study terminated by sponsor|5854|||
48528870|NCT02104817|156128992|FG001|Overall Study|Study terminated by sponsor|5901|||
48528871|NCT02104817|156128991|FG000|Overall Study|Withdrawal by Subject|111|||
48528872|NCT02104817|156128992|FG001|Overall Study|Withdrawal by Subject|78|||
48528873|NCT02104817|156128991|FG000|Overall Study|Other reasons|128|||
48528874|NCT02104817|156128992|FG001|Overall Study|Other reasons|135|||
48528875|NCT02919306|156128996|FG000|Overall Study|Withdrawal by Subject|1|||
48831004|NCT01186848|157221947|FG000|Overall Study|Withdrawal by Subject|2|||
48831005|NCT01186848|157221947|FG000|Overall Study|Adverse Event|2|||
48528876|NCT02919306|156128997|FG001|Overall Study|Withdrawal by Subject|0|||
48528877|NCT02919306|156128996|FG000|Overall Study|Protocol Violation|1|||
48831006|NCT02698241|157221951|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
48831007|NCT02698241|157221951|FG000|Overall Study|Screening not met|7|||
48831008|NCT02698241|157221951|FG000|Overall Study|Withdrawal by Subject|7|||
48831009|NCT02698241|157221951|FG000|Overall Study|Physician Decision|2|||
48831010|NCT02698241|157221951|FG000|Overall Study|Subject underwent system modification|2|||
48831011|NCT02698241|157221951|FG000|Overall Study|Lost to Follow-up|3|||
48831012|NCT02698241|157221951|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
48831013|NCT02698241|157221951|FG000|Overall Study|geographic and licensing issue|1|||
48831014|NCT02698241|157221951|FG000|Overall Study|Death|2|||
48831015|NCT01837641|157221952|FG000|Overall Study|Sponsor decision|1|||
48831016|NCT01837641|157221953|FG001|Overall Study|Sponsor decision|0|||
48831017|NCT01837641|157221954|FG002|Overall Study|Sponsor decision|0|||
48831018|NCT01837641|157221955|FG003|Overall Study|Sponsor decision|0|||
48831019|NCT01837641|157221956|FG004|Overall Study|Sponsor decision|0|||
48831020|NCT01837641|157221957|FG005|Overall Study|Sponsor decision|1|||
48831021|NCT01837641|157221958|FG006|Overall Study|Sponsor decision|0|||
48831022|NCT01837641|157221959|FG007|Overall Study|Sponsor decision|0|||
48831023|NCT01837641|157221952|FG000|Overall Study|Adverse Event|0|||
48831024|NCT01837641|157221953|FG001|Overall Study|Adverse Event|0|||
48831025|NCT01837641|157221954|FG002|Overall Study|Adverse Event|0|||
48831026|NCT01837641|157221955|FG003|Overall Study|Adverse Event|0|||
48831027|NCT01837641|157221956|FG004|Overall Study|Adverse Event|0|||
48831028|NCT01837641|157221957|FG005|Overall Study|Adverse Event|1|||
48831029|NCT01837641|157221958|FG006|Overall Study|Adverse Event|0|||
48831030|NCT01837641|157221959|FG007|Overall Study|Adverse Event|0|||
48831031|NCT01837641|157221952|FG000|Overall Study|Withdrawal by Subject|0|||
48831032|NCT01837641|157221953|FG001|Overall Study|Withdrawal by Subject|0|||
48831033|NCT01837641|157221954|FG002|Overall Study|Withdrawal by Subject|0|||
48831034|NCT01837641|157221955|FG003|Overall Study|Withdrawal by Subject|0|||
48831035|NCT01837641|157221956|FG004|Overall Study|Withdrawal by Subject|1|||
48831036|NCT01837641|157221957|FG005|Overall Study|Withdrawal by Subject|0|||
48831037|NCT01837641|157221958|FG006|Overall Study|Withdrawal by Subject|1|||
48831038|NCT01837641|157221959|FG007|Overall Study|Withdrawal by Subject|0|||
48831039|NCT03386929|157221964|FG000|Overall Study|Death|0|||
48831040|NCT03386929|157221965|FG001|Overall Study|Death|0|||
48831041|NCT03386929|157221966|FG002|Overall Study|Death|1|||
48831042|NCT03386929|157221964|FG000|Overall Study|Withdrawal by Subject|0|||
48831043|NCT03386929|157221965|FG001|Overall Study|Withdrawal by Subject|1|||
48831044|NCT03386929|157221966|FG002|Overall Study|Withdrawal by Subject|0|||
48831045|NCT03386929|157221964|FG000|Overall Study|Physician Decision|0|||
48831046|NCT03386929|157221965|FG001|Overall Study|Physician Decision|0|||
48831047|NCT03386929|157221966|FG002|Overall Study|Physician Decision|1|||
48831048|NCT03386929|157221964|FG000|Overall Study|Progression|4|||
48831049|NCT03386929|157221965|FG001|Overall Study|Progression|4|||
48831050|NCT03386929|157221966|FG002|Overall Study|Progression|0|||
48831051|NCT03386929|157221964|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
48831052|NCT03386929|157221965|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
48831053|NCT03386929|157221966|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
48831054|NCT03386929|157221964|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
48831055|NCT03386929|157221965|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
48831056|NCT03386929|157221966|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
48831057|NCT01137292|157221967|FG000|Overall Study|Death|30|||
48831058|NCT01137292|157221967|FG000|Overall Study|Adverse Event|3|||
48831059|NCT01137292|157221967|FG000|Overall Study|Lack of Efficacy|13|||
48831060|NCT01137292|157221967|FG000|Overall Study|Lost to Follow-up|1|||
48831061|NCT01137292|157221967|FG000|Overall Study|Other|7|||
48528878|NCT02919306|156128997|FG001|Overall Study|Protocol Violation|0|||
48528879|NCT00831233|156128998|FG000|Overall Study|Adverse Event|0|||
48528880|NCT00831233|156128999|FG001|Overall Study|Adverse Event|1|||
48528881|NCT00831233|156128998|FG000|Overall Study|Protocol Violation|1|||
48528882|NCT00831233|156128999|FG001|Overall Study|Protocol Violation|0|||
48528883|NCT00831233|156128998|FG000|Overall Study|Selection Criteria Not Met|2|||
48528884|NCT00831233|156128999|FG001|Overall Study|Selection Criteria Not Met|0|||
48528885|NCT04908722|156129002|FG000|Overall Study|Protocol deviation|1|||
48528886|NCT04908722|156129003|FG001|Overall Study|Protocol deviation|0|||
48528887|NCT04908722|156129004|FG002|Overall Study|Protocol deviation|0|||
48528888|NCT04908722|156129005|FG003|Overall Study|Protocol deviation|0|||
48528889|NCT04908722|156129006|FG004|Overall Study|Protocol deviation|0|||
48528890|NCT04908722|156129007|FG005|Overall Study|Protocol deviation|1|||
48528891|NCT04908722|156129002|FG000|Overall Study|Lost to Follow-up|33|||
48528892|NCT04908722|156129003|FG001|Overall Study|Lost to Follow-up|33|||
48528893|NCT04908722|156129004|FG002|Overall Study|Lost to Follow-up|36|||
48528894|NCT04908722|156129005|FG003|Overall Study|Lost to Follow-up|30|||
48528895|NCT04908722|156129006|FG004|Overall Study|Lost to Follow-up|32|||
48528896|NCT04908722|156129007|FG005|Overall Study|Lost to Follow-up|34|||
48528897|NCT04908722|156129002|FG000|Overall Study|Physician Decision|1|||
48528898|NCT04908722|156129003|FG001|Overall Study|Physician Decision|1|||
48528899|NCT04908722|156129004|FG002|Overall Study|Physician Decision|1|||
48528900|NCT04908722|156129005|FG003|Overall Study|Physician Decision|2|||
48528901|NCT04908722|156129006|FG004|Overall Study|Physician Decision|0|||
48528902|NCT04908722|156129007|FG005|Overall Study|Physician Decision|0|||
48528903|NCT04908722|156129002|FG000|Overall Study|Death|1|||
48528904|NCT04908722|156129003|FG001|Overall Study|Death|0|||
48528905|NCT04908722|156129004|FG002|Overall Study|Death|0|||
48528906|NCT04908722|156129005|FG003|Overall Study|Death|0|||
48528907|NCT04908722|156129006|FG004|Overall Study|Death|0|||
48528908|NCT04908722|156129007|FG005|Overall Study|Death|1|||
48528909|NCT04908722|156129002|FG000|Overall Study|Withdrawal by Subject|12|||
48528910|NCT04908722|156129003|FG001|Overall Study|Withdrawal by Subject|8|||
48528911|NCT04908722|156129004|FG002|Overall Study|Withdrawal by Subject|7|||
48528912|NCT04908722|156129005|FG003|Overall Study|Withdrawal by Subject|6|||
48528913|NCT04908722|156129006|FG004|Overall Study|Withdrawal by Subject|12|||
48528914|NCT04908722|156129007|FG005|Overall Study|Withdrawal by Subject|14|||
48528915|NCT04908722|156129002|FG000|Overall Study|Other|3|||
48528916|NCT04908722|156129003|FG001|Overall Study|Other|1|||
48528917|NCT04908722|156129004|FG002|Overall Study|Other|3|||
48831062|NCT03264456|157221969|FG000|Overall Study|Withdrawal by Subject|3|||
48831063|NCT03264456|157221969|FG000|Overall Study|Lost to Follow-up|1|||
48831064|NCT00837616|157221975|FG000|Overall Study|Withdrawal by Subject|0|||
48831065|NCT00837616|157221976|FG001|Overall Study|Withdrawal by Subject|1|||
48831066|NCT03254394|157221977|FG000|Overall Study|Withdrawal by Subject|0|||
48831067|NCT03254394|157221978|FG001|Overall Study|Withdrawal by Subject|2|||
48831068|NCT02317016|157221979|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
48831069|NCT02317016|157221979|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
48831070|NCT02317016|157221979|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
48528918|NCT04908722|156129005|FG003|Overall Study|Other|2|||
48528919|NCT04908722|156129006|FG004|Overall Study|Other|4|||
48528920|NCT04908722|156129007|FG005|Overall Study|Other|1|||
48528921|NCT04908722|156129002|FG000|Overall Study|Initiated prohibited medication|0|||
48735568|NCT00395733|156883670|FG001|Period 2|Withdrawal by Subject|2|||
48735569|NCT00395733|156883669|FG000|Period 2|Protocol Violation|0|||
48735570|NCT00395733|156883670|FG001|Period 2|Protocol Violation|1|||
48735571|NCT00395733|156883669|FG000|Period 2|Adverse Event|0|||
48735572|NCT00395733|156883670|FG001|Period 2|Adverse Event|2|||
48735573|NCT00395733|156883669|FG000|Period 2|Technical problems|1|||
48735574|NCT00395733|156883670|FG001|Period 2|Technical problems|0|||
48735575|NCT00471146|156883671|FG000|Overall Study|Adverse Event|32|||
48735576|NCT00471146|156883672|FG001|Overall Study|Adverse Event|33|||
48735577|NCT00471146|156883671|FG000|Overall Study|Withdrawal by Subject|14|||
48735578|NCT00471146|156883672|FG001|Overall Study|Withdrawal by Subject|11|||
48735579|NCT00471146|156883671|FG000|Overall Study|Death|11|||
48735580|NCT00471146|156883672|FG001|Overall Study|Death|12|||
48735581|NCT00471146|156883671|FG000|Overall Study|Lost to Follow-up|4|||
48735582|NCT00471146|156883672|FG001|Overall Study|Lost to Follow-up|2|||
48735583|NCT00471146|156883671|FG000|Overall Study|Protocol Violation|2|||
48735584|NCT00471146|156883672|FG001|Overall Study|Protocol Violation|2|||
48735585|NCT00471146|156883671|FG000|Overall Study|Objective progression or relapse|84|||
48735586|NCT00471146|156883672|FG001|Overall Study|Objective progression or relapse|87|||
48735587|NCT00471146|156883671|FG000|Overall Study|Global deterioration of health status|12|||
48831071|NCT02317016|157221979|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
48831072|NCT02317016|157221979|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
48831073|NCT02317016|157221979|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
48831074|NCT02317016|157221979|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
48831075|NCT03418324|157221980|FG000|Overall Study|Death|0|||
48831076|NCT03418324|157221981|FG001|Overall Study|Death|1|||
48831077|NCT03418324|157221980|FG000|Overall Study|Physician Decision|1|||
48831078|NCT03418324|157221981|FG001|Overall Study|Physician Decision|1|||
48831079|NCT00605033|157221983|FG000|Overall Study|Adverse Event|2|||
48831080|NCT00605033|157221984|FG001|Overall Study|Adverse Event|2|||
48831081|NCT00605033|157221983|FG000|Overall Study|Lost to Follow-up|1|||
48831082|NCT00605033|157221984|FG001|Overall Study|Lost to Follow-up|1|||
48528922|NCT04908722|156129003|FG001|Overall Study|Initiated prohibited medication|0|||
48528923|NCT04908722|156129004|FG002|Overall Study|Initiated prohibited medication|0|||
48528924|NCT04908722|156129005|FG003|Overall Study|Initiated prohibited medication|1|||
48528925|NCT04908722|156129006|FG004|Overall Study|Initiated prohibited medication|0|||
48528926|NCT04908722|156129007|FG005|Overall Study|Initiated prohibited medication|1|||
48528927|NCT04908722|156129002|FG000|Overall Study|Randomized but not vaccinated|3|||
48528928|NCT04908722|156129003|FG001|Overall Study|Randomized but not vaccinated|1|||
48831083|NCT00605033|157221983|FG000|Overall Study|Withdrawal by Subject|3|||
48831084|NCT00605033|157221984|FG001|Overall Study|Withdrawal by Subject|4|||
48831085|NCT00605033|157221983|FG000|Overall Study|Protocol Violation|1|||
48831086|NCT00605033|157221984|FG001|Overall Study|Protocol Violation|1|||
48831087|NCT02041104|157221985|FG000|Overall Study|Lost to Follow-up|1|||
48831088|NCT02041104|157221986|FG001|Overall Study|Lost to Follow-up|4|||
48831089|NCT02041104|157221985|FG000|Overall Study|discomfort during OGTT|0|||
48831090|NCT02041104|157221986|FG001|Overall Study|discomfort during OGTT|3|||
48831091|NCT04688450|157223532|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
48831092|NCT04688450|157223532|FG000|Overall Study|Withdrawal by Subject|1|||
48831093|NCT05057897|157223533|FG000|Overall Study|Site closure|2|||
48831094|NCT05057897|157223534|FG001|Overall Study|Site closure|2|||
48831095|NCT05057897|157223533|FG000|Overall Study|Death|1|||
48831096|NCT05057897|157223534|FG001|Overall Study|Death|0|||
48831097|NCT02662062|157223535|FG000|Overall Study|Withdrawal by Subject|1|||
48831098|NCT02249949|157223536|FG000|Overall Study|Cancelled prior to treatment|2|||
48831099|NCT03653507|157223537|FG000|Overall Study|Miscellaneous|26|||
48831100|NCT03653507|157223538|FG001|Overall Study|Miscellaneous|16|||
48831101|NCT03653507|157223537|FG000|Overall Study|Withdrawal by Subject|35|||
48831102|NCT03653507|157223538|FG001|Overall Study|Withdrawal by Subject|23|||
48831103|NCT03653507|157223537|FG000|Overall Study|Protocol Deviation|2|||
48831104|NCT03653507|157223538|FG001|Overall Study|Protocol Deviation|1|||
48831105|NCT03653507|157223537|FG000|Overall Study|Progressive disease|102|||
48831106|NCT03653507|157223538|FG001|Overall Study|Progressive disease|157|||
48831107|NCT03653507|157223537|FG000|Overall Study|Lost to Follow-up|1|||
48831108|NCT03653507|157223538|FG001|Overall Study|Lost to Follow-up|1|||
48831109|NCT03653507|157223537|FG000|Overall Study|Death|24|||
48831110|NCT03653507|157223538|FG001|Overall Study|Death|22|||
48831111|NCT03653507|157223537|FG000|Overall Study|Adverse Event|34|||
48831112|NCT03653507|157223538|FG001|Overall Study|Adverse Event|15|||
48831113|NCT01090024|157223539|FG000|Period 1|Met exclusion criteria|0|||
48831114|NCT01090024|157223540|FG001|Period 1|Met exclusion criteria|0|||
48831115|NCT01090024|157223541|FG002|Period 1|Met exclusion criteria|0|||
48831116|NCT01090024|157223542|FG003|Period 1|Met exclusion criteria|0|||
48831117|NCT01090024|157223543|FG004|Period 1|Met exclusion criteria|0|||
48831118|NCT01090024|157223544|FG005|Period 1|Met exclusion criteria|0|||
48831119|NCT01090024|157223545|FG006|Period 1|Met exclusion criteria|0|||
48831120|NCT01090024|157223546|FG007|Period 1|Met exclusion criteria|0|||
48831121|NCT01090024|157223547|FG008|Period 1|Met exclusion criteria|0|||
48831122|NCT01090024|157223548|FG009|Period 1|Met exclusion criteria|0|||
48831123|NCT01090024|157223549|FG010|Period 1|Met exclusion criteria|0|||
48831124|NCT01090024|157223550|FG011|Period 1|Met exclusion criteria|0|||
48831125|NCT01090024|157223551|FG012|Period 1|Met exclusion criteria|0|||
48831126|NCT01090024|157223552|FG013|Period 1|Met exclusion criteria|0|||
48831127|NCT01090024|157223553|FG014|Period 1|Met exclusion criteria|1|||
48831128|NCT01090024|157223554|FG015|Period 1|Met exclusion criteria|0|||
48831129|NCT01090024|157223555|FG016|Period 1|Met exclusion criteria|0|||
48831130|NCT01090024|157223556|FG017|Period 1|Met exclusion criteria|0|||
48831131|NCT01090024|157223539|FG000|Period 1|Adverse Event|0|||
48831132|NCT01090024|157223540|FG001|Period 1|Adverse Event|0|||
48831133|NCT01090024|157223541|FG002|Period 1|Adverse Event|0|||
48831134|NCT01090024|157223542|FG003|Period 1|Adverse Event|0|||
48831135|NCT01090024|157223543|FG004|Period 1|Adverse Event|0|||
48831136|NCT01090024|157223544|FG005|Period 1|Adverse Event|0|||
48831137|NCT01090024|157223545|FG006|Period 1|Adverse Event|0|||
48831138|NCT01090024|157223546|FG007|Period 1|Adverse Event|0|||
48831139|NCT01090024|157223547|FG008|Period 1|Adverse Event|0|||
48831140|NCT01090024|157223548|FG009|Period 1|Adverse Event|1|||
48831141|NCT01090024|157223549|FG010|Period 1|Adverse Event|0|||
48831142|NCT01090024|157223550|FG011|Period 1|Adverse Event|1|||
48831143|NCT01090024|157223551|FG012|Period 1|Adverse Event|0|||
48831144|NCT01090024|157223552|FG013|Period 1|Adverse Event|0|||
48831145|NCT01090024|157223553|FG014|Period 1|Adverse Event|0|||
48831146|NCT01090024|157223554|FG015|Period 1|Adverse Event|0|||
48831147|NCT01090024|157223555|FG016|Period 1|Adverse Event|0|||
48831148|NCT01090024|157223556|FG017|Period 1|Adverse Event|1|||
48831149|NCT01090024|157223539|FG000|Period 1|Withdrawal by Subject|0|||
48831150|NCT01090024|157223540|FG001|Period 1|Withdrawal by Subject|0|||
48831151|NCT01090024|157223541|FG002|Period 1|Withdrawal by Subject|0|||
48831152|NCT01090024|157223542|FG003|Period 1|Withdrawal by Subject|1|||
48831153|NCT01090024|157223543|FG004|Period 1|Withdrawal by Subject|0|||
48831154|NCT01090024|157223544|FG005|Period 1|Withdrawal by Subject|0|||
48831155|NCT01090024|157223545|FG006|Period 1|Withdrawal by Subject|0|||
48831156|NCT01090024|157223546|FG007|Period 1|Withdrawal by Subject|0|||
48831157|NCT01090024|157223547|FG008|Period 1|Withdrawal by Subject|0|||
48831158|NCT01090024|157223548|FG009|Period 1|Withdrawal by Subject|0|||
48831159|NCT01090024|157223549|FG010|Period 1|Withdrawal by Subject|0|||
48831160|NCT01090024|157223550|FG011|Period 1|Withdrawal by Subject|0|||
48831161|NCT01090024|157223551|FG012|Period 1|Withdrawal by Subject|0|||
48831162|NCT01090024|157223552|FG013|Period 1|Withdrawal by Subject|0|||
48831163|NCT01090024|157223553|FG014|Period 1|Withdrawal by Subject|0|||
48831164|NCT01090024|157223554|FG015|Period 1|Withdrawal by Subject|0|||
48831165|NCT01090024|157223555|FG016|Period 1|Withdrawal by Subject|0|||
48831166|NCT01090024|157223556|FG017|Period 1|Withdrawal by Subject|0|||
48831167|NCT01090024|157223539|FG000|Period 1|Lost to Follow-up|0|||
48831168|NCT01090024|157223540|FG001|Period 1|Lost to Follow-up|1|||
48831169|NCT01090024|157223541|FG002|Period 1|Lost to Follow-up|0|||
48831170|NCT01090024|157223542|FG003|Period 1|Lost to Follow-up|0|||
48831171|NCT01090024|157223543|FG004|Period 1|Lost to Follow-up|0|||
48831172|NCT01090024|157223544|FG005|Period 1|Lost to Follow-up|0|||
48528929|NCT04908722|156129004|FG002|Overall Study|Randomized but not vaccinated|2|||
48528930|NCT04908722|156129005|FG003|Overall Study|Randomized but not vaccinated|2|||
48528931|NCT04908722|156129006|FG004|Overall Study|Randomized but not vaccinated|3|||
48528932|NCT04908722|156129007|FG005|Overall Study|Randomized but not vaccinated|4|||
48528933|NCT00544817|156129008|FG000|Combined Modality|Lack of Efficacy|2|||
48528934|NCT00544817|156129008|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
48528935|NCT00544817|156129008|FG000|Combined Modality|Adverse Event|2|||
48528936|NCT00544817|156129008|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
48528937|NCT00544817|156129008|FG000|No Treatment Interval|Lack of Efficacy|8|||
48528938|NCT00544817|156129008|FG000|No Treatment Interval|Physician Decision|3|||
48528939|NCT00544817|156129008|FG000|No Treatment Interval|Adverse Event|1|||
48528940|NCT00544817|156129008|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
48528941|NCT00544817|156129008|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
48528942|NCT00544817|156129008|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
48528943|NCT04633642|156129012|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
48528944|NCT04633642|156129013|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
48528945|NCT01131299|156129014|FG000|Overall Study|Withdrawal by Subject|4|||
48528946|NCT01131299|156129015|FG001|Overall Study|Withdrawal by Subject|7|||
48528947|NCT04191499|156129017|FG000|Overall Study|Adverse Event|1|||
48528948|NCT04191499|156129018|FG001|Overall Study|Adverse Event|0|||
48528949|NCT04191499|156129017|FG000|Overall Study|Death|42|||
48528950|NCT04191499|156129018|FG001|Overall Study|Death|55|||
48528951|NCT04191499|156129017|FG000|Overall Study|Lost to Follow-up|4|||
48528952|NCT04191499|156129018|FG001|Overall Study|Lost to Follow-up|1|||
48528953|NCT04191499|156129017|FG000|Overall Study|Physician Decision|1|||
48528954|NCT04191499|156129018|FG001|Overall Study|Physician Decision|0|||
48528955|NCT04191499|156129017|FG000|Overall Study|Progressive Disease|1|||
48528956|NCT04191499|156129018|FG001|Overall Study|Progressive Disease|0|||
48528957|NCT04191499|156129017|FG000|Overall Study|Symptomatic Deterioration|1|||
48528958|NCT04191499|156129018|FG001|Overall Study|Symptomatic Deterioration|0|||
48528959|NCT04191499|156129017|FG000|Overall Study|Withdrawal by Subject|7|||
48528960|NCT04191499|156129018|FG001|Overall Study|Withdrawal by Subject|11|||
48528961|NCT04191499|156129017|FG000|Overall Study|Ongoing in the study|104|||
48528962|NCT04191499|156129018|FG001|Overall Study|Ongoing in the study|97|||
48831173|NCT01090024|157223545|FG006|Period 1|Lost to Follow-up|0|||
48528963|NCT01976728|156129020|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
48831174|NCT01090024|157223546|FG007|Period 1|Lost to Follow-up|0|||
48528964|NCT01976728|156129021|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
48831175|NCT01090024|157223547|FG008|Period 1|Lost to Follow-up|0|||
48831176|NCT01090024|157223548|FG009|Period 1|Lost to Follow-up|0|||
48831177|NCT01090024|157223549|FG010|Period 1|Lost to Follow-up|0|||
48831178|NCT01090024|157223550|FG011|Period 1|Lost to Follow-up|0|||
48831179|NCT01090024|157223551|FG012|Period 1|Lost to Follow-up|0|||
48831180|NCT01090024|157223552|FG013|Period 1|Lost to Follow-up|0|||
48831181|NCT01090024|157223553|FG014|Period 1|Lost to Follow-up|0|||
48831182|NCT01090024|157223554|FG015|Period 1|Lost to Follow-up|0|||
48831183|NCT01090024|157223555|FG016|Period 1|Lost to Follow-up|0|||
48831184|NCT01090024|157223556|FG017|Period 1|Lost to Follow-up|0|||
48831185|NCT01090024|157223539|FG000|Period 2|Lost to Follow-up|0|||
48831186|NCT01090024|157223540|FG001|Period 2|Lost to Follow-up|0|||
48831187|NCT01090024|157223541|FG002|Period 2|Lost to Follow-up|0|||
48831188|NCT01090024|157223542|FG003|Period 2|Lost to Follow-up|1|||
48831189|NCT01090024|157223543|FG004|Period 2|Lost to Follow-up|0|||
48831190|NCT01090024|157223544|FG005|Period 2|Lost to Follow-up|0|||
48831191|NCT01090024|157223545|FG006|Period 2|Lost to Follow-up|0|||
48831192|NCT01090024|157223546|FG007|Period 2|Lost to Follow-up|0|||
48831193|NCT01090024|157223547|FG008|Period 2|Lost to Follow-up|0|||
48831194|NCT01090024|157223548|FG009|Period 2|Lost to Follow-up|0|||
48831195|NCT01090024|157223549|FG010|Period 2|Lost to Follow-up|0|||
48831196|NCT01090024|157223550|FG011|Period 2|Lost to Follow-up|0|||
48831197|NCT01090024|157223551|FG012|Period 2|Lost to Follow-up|0|||
48831198|NCT01090024|157223552|FG013|Period 2|Lost to Follow-up|0|||
48831199|NCT01090024|157223553|FG014|Period 2|Lost to Follow-up|0|||
48831200|NCT01090024|157223554|FG015|Period 2|Lost to Follow-up|0|||
48831201|NCT01090024|157223555|FG016|Period 2|Lost to Follow-up|0|||
48831202|NCT01090024|157223556|FG017|Period 2|Lost to Follow-up|0|||
48831203|NCT01090024|157223539|FG000|Period 2|Adverse Event|1|||
48831204|NCT01090024|157223540|FG001|Period 2|Adverse Event|0|||
48831205|NCT01090024|157223541|FG002|Period 2|Adverse Event|0|||
48831206|NCT01090024|157223542|FG003|Period 2|Adverse Event|0|||
48831207|NCT01090024|157223543|FG004|Period 2|Adverse Event|0|||
48831208|NCT01090024|157223544|FG005|Period 2|Adverse Event|0|||
48831209|NCT01090024|157223545|FG006|Period 2|Adverse Event|0|||
48831210|NCT01090024|157223546|FG007|Period 2|Adverse Event|0|||
48831211|NCT01090024|157223547|FG008|Period 2|Adverse Event|0|||
48831212|NCT01090024|157223548|FG009|Period 2|Adverse Event|0|||
48831213|NCT01090024|157223549|FG010|Period 2|Adverse Event|0|||
48831214|NCT01090024|157223550|FG011|Period 2|Adverse Event|0|||
48831215|NCT01090024|157223551|FG012|Period 2|Adverse Event|0|||
48831216|NCT01090024|157223552|FG013|Period 2|Adverse Event|0|||
48831217|NCT01090024|157223553|FG014|Period 2|Adverse Event|0|||
48831218|NCT01090024|157223554|FG015|Period 2|Adverse Event|0|||
48831219|NCT01090024|157223555|FG016|Period 2|Adverse Event|0|||
48831220|NCT01090024|157223556|FG017|Period 2|Adverse Event|0|||
48831221|NCT01090024|157223539|FG000|Period 3|Withdrawal by Subject|0|||
48831222|NCT01090024|157223540|FG001|Period 3|Withdrawal by Subject|0|||
48831223|NCT01090024|157223541|FG002|Period 3|Withdrawal by Subject|0|||
48831224|NCT01090024|157223542|FG003|Period 3|Withdrawal by Subject|0|||
48831225|NCT01090024|157223543|FG004|Period 3|Withdrawal by Subject|0|||
48831226|NCT01090024|157223544|FG005|Period 3|Withdrawal by Subject|0|||
48831227|NCT01090024|157223545|FG006|Period 3|Withdrawal by Subject|0|||
48831228|NCT01090024|157223546|FG007|Period 3|Withdrawal by Subject|0|||
48831229|NCT01090024|157223547|FG008|Period 3|Withdrawal by Subject|0|||
48831230|NCT01090024|157223548|FG009|Period 3|Withdrawal by Subject|0|||
48831231|NCT01090024|157223549|FG010|Period 3|Withdrawal by Subject|0|||
48831232|NCT01090024|157223550|FG011|Period 3|Withdrawal by Subject|0|||
48528965|NCT01976728|156129022|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
48528966|NCT01976728|156129023|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
48528967|NCT02262728|156129024|FG000|Follow-up Phase (3 Years)|Death|0|||
48528968|NCT02262728|156129025|FG001|Follow-up Phase (3 Years)|Death|1|||
48831233|NCT01090024|157223551|FG012|Period 3|Withdrawal by Subject|0|||
48831234|NCT01090024|157223552|FG013|Period 3|Withdrawal by Subject|0|||
48528969|NCT02262728|156129024|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
48528970|NCT02262728|156129025|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
48528971|NCT02262728|156129024|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
48528972|NCT02262728|156129025|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
48528973|NCT02953678|156129026|FG000|Overall Study|Adverse Event|20|||
48528974|NCT02953678|156129026|FG000|Overall Study|Death|7|||
48528975|NCT02953678|156129026|FG000|Overall Study|Physician Decision|23|||
48528976|NCT02953678|156129026|FG000|Overall Study|Progressive Disease of GVHD|7|||
48528977|NCT02953678|156129026|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
48528978|NCT02953678|156129026|FG000|Overall Study|Withdrawal by participant|3|||
48528979|NCT02953678|156129026|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
48528980|NCT02953678|156129026|FG000|Overall Study|Participants were transferred to commercial product.|3|||
48692902|NCT03137992|156724647|FG001|Washout Period 1|Principal Investigator Discretion|1|||
48831235|NCT01090024|157223553|FG014|Period 3|Withdrawal by Subject|0|||
48831236|NCT01090024|157223554|FG015|Period 3|Withdrawal by Subject|1|||
48528981|NCT02356211|156129027|FG000|Overall Study|Withdrawal by Subject|2|||
48831237|NCT01090024|157223555|FG016|Period 3|Withdrawal by Subject|0|||
48831238|NCT01090024|157223556|FG017|Period 3|Withdrawal by Subject|0|||
48831239|NCT01090024|157223539|FG000|Period 3|Protocol Violation|0|||
48831240|NCT01090024|157223540|FG001|Period 3|Protocol Violation|0|||
48831241|NCT01090024|157223541|FG002|Period 3|Protocol Violation|0|||
48831242|NCT01090024|157223542|FG003|Period 3|Protocol Violation|0|||
48831243|NCT01090024|157223543|FG004|Period 3|Protocol Violation|0|||
48831244|NCT01090024|157223544|FG005|Period 3|Protocol Violation|0|||
48831245|NCT01090024|157223545|FG006|Period 3|Protocol Violation|0|||
48528982|NCT02356211|156129028|FG001|Overall Study|Withdrawal by Subject|2|||
48831246|NCT01090024|157223546|FG007|Period 3|Protocol Violation|0|||
48831247|NCT01090024|157223547|FG008|Period 3|Protocol Violation|1|||
48831248|NCT01090024|157223548|FG009|Period 3|Protocol Violation|0|||
48831249|NCT01090024|157223549|FG010|Period 3|Protocol Violation|0|||
48831250|NCT01090024|157223550|FG011|Period 3|Protocol Violation|0|||
48831251|NCT01090024|157223551|FG012|Period 3|Protocol Violation|0|||
48831252|NCT01090024|157223552|FG013|Period 3|Protocol Violation|0|||
48831253|NCT01090024|157223553|FG014|Period 3|Protocol Violation|0|||
48831254|NCT01090024|157223554|FG015|Period 3|Protocol Violation|0|||
48831255|NCT01090024|157223555|FG016|Period 3|Protocol Violation|0|||
48831256|NCT01090024|157223556|FG017|Period 3|Protocol Violation|0|||
48831257|NCT01090024|157223539|FG000|Period 3|Adverse Event|0|||
48831258|NCT01090024|157223540|FG001|Period 3|Adverse Event|0|||
48831259|NCT01090024|157223541|FG002|Period 3|Adverse Event|0|||
48831260|NCT01090024|157223542|FG003|Period 3|Adverse Event|0|||
48831261|NCT01090024|157223543|FG004|Period 3|Adverse Event|0|||
48831262|NCT01090024|157223544|FG005|Period 3|Adverse Event|1|||
48831263|NCT01090024|157223545|FG006|Period 3|Adverse Event|0|||
48831264|NCT01090024|157223546|FG007|Period 3|Adverse Event|0|||
48831265|NCT01090024|157223547|FG008|Period 3|Adverse Event|0|||
48831266|NCT01090024|157223548|FG009|Period 3|Adverse Event|0|||
48831267|NCT01090024|157223549|FG010|Period 3|Adverse Event|0|||
48831268|NCT01090024|157223550|FG011|Period 3|Adverse Event|0|||
48831269|NCT01090024|157223551|FG012|Period 3|Adverse Event|0|||
48831270|NCT01090024|157223552|FG013|Period 3|Adverse Event|0|||
48831271|NCT01090024|157223553|FG014|Period 3|Adverse Event|0|||
48831272|NCT01090024|157223554|FG015|Period 3|Adverse Event|0|||
48831273|NCT01090024|157223555|FG016|Period 3|Adverse Event|0|||
48831274|NCT01090024|157223556|FG017|Period 3|Adverse Event|0|||
48831275|NCT02757885|157223557|FG000|Overall Study|Screen Failures|4|||
48831276|NCT00470626|157223560|FG000|Overall Study|Lost to Follow-up|10|||
48831277|NCT00470626|157223560|FG000|Overall Study|Withdrawal by Subject|7|||
48831278|NCT05298111|157223561|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
48831279|NCT05298111|157223562|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
48831280|NCT02689349|157223563|FG000|Overall Study|Not implanted|4|||
48831281|NCT02689349|157223564|FG001|Overall Study|Not implanted|0|||
48831282|NCT02689349|157223563|FG000|Overall Study|Withdrawal by Subject|9|||
48831283|NCT02689349|157223564|FG001|Overall Study|Withdrawal by Subject|0|||
48831284|NCT02987543|157223565|FG000|Overall Study|Ongoing study at data cut off|49|||
48831285|NCT02987543|157223566|FG001|Overall Study|Ongoing study at data cut off|21|||
48831286|NCT02987543|157223567|FG002|Overall Study|Ongoing study at data cut off|19|||
48831287|NCT02987543|157223568|FG003|Overall Study|Ongoing study at data cut off|12|||
48831288|NCT02987543|157223565|FG000|Overall Study|Death|88|||
48831289|NCT02987543|157223566|FG001|Overall Study|Death|54|||
48831290|NCT02987543|157223567|FG002|Overall Study|Death|67|||
48831291|NCT02987543|157223568|FG003|Overall Study|Death|28|||
48831292|NCT02987543|157223565|FG000|Overall Study|Lost to Follow-up|3|||
48831293|NCT02987543|157223566|FG001|Overall Study|Lost to Follow-up|0|||
48831294|NCT02987543|157223567|FG002|Overall Study|Lost to Follow-up|1|||
48831295|NCT02987543|157223568|FG003|Overall Study|Lost to Follow-up|0|||
48831296|NCT02987543|157223565|FG000|Overall Study|Screen failure|0|||
48831297|NCT02987543|157223566|FG001|Overall Study|Screen failure|0|||
48831298|NCT02987543|157223567|FG002|Overall Study|Screen failure|0|||
48831299|NCT02987543|157223568|FG003|Overall Study|Screen failure|1|||
48528983|NCT02356211|156129027|FG000|Overall Study|ineligible|1|||
48528984|NCT02356211|156129028|FG001|Overall Study|ineligible|8|||
48528985|NCT03785145|156129033|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
48528986|NCT03785145|156129034|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
48528987|NCT03785145|156129033|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
48831300|NCT02987543|157223565|FG000|Overall Study|Withdrawal by Subject|21|||
48831301|NCT02987543|157223566|FG001|Overall Study|Withdrawal by Subject|7|||
48831302|NCT02987543|157223567|FG002|Overall Study|Withdrawal by Subject|7|||
48831303|NCT02987543|157223568|FG003|Overall Study|Withdrawal by Subject|6|||
48831304|NCT02987543|157223565|FG000|Overall Study|Study terminated by sponsor|1|||
48831305|NCT02987543|157223566|FG001|Overall Study|Study terminated by sponsor|0|||
48831306|NCT02987543|157223567|FG002|Overall Study|Study terminated by sponsor|0|||
48831307|NCT02987543|157223568|FG003|Overall Study|Study terminated by sponsor|0|||
48831308|NCT02987543|157223565|FG000|Overall Study|Investigator decision|0|||
48831309|NCT02987543|157223566|FG001|Overall Study|Investigator decision|1|||
48528988|NCT03785145|156129034|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
48831310|NCT02987543|157223567|FG002|Overall Study|Investigator decision|0|||
48831311|NCT02987543|157223568|FG003|Overall Study|Investigator decision|0|||
48831312|NCT02987543|157223565|FG000|Overall Study|Disease progression|0|||
48831313|NCT02987543|157223566|FG001|Overall Study|Disease progression|0|||
48831314|NCT02987543|157223567|FG002|Overall Study|Disease progression|0|||
48831315|NCT02987543|157223568|FG003|Overall Study|Disease progression|1|||
48831316|NCT04012853|157223575|FG000|Overall Study|Withdrawal by Subject|1|||
48831317|NCT04012853|157223576|FG001|Overall Study|Withdrawal by Subject|1|||
48528989|NCT03785145|156129033|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
48528990|NCT03785145|156129034|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
48528991|NCT03785145|156129033|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
48528992|NCT03785145|156129034|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
48528993|NCT03785145|156129033|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
48528994|NCT03785145|156129034|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
48528995|NCT03785145|156129033|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
48528996|NCT03785145|156129034|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
48528997|NCT03785145|156129033|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
48528998|NCT03785145|156129034|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
48528999|NCT03785145|156129033|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
48529000|NCT03785145|156129034|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
48529001|NCT03785145|156129033|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
48529002|NCT03785145|156129034|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
48529003|NCT03785145|156129033|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
48529004|NCT03785145|156129034|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
48529005|NCT03785145|156129033|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
48529006|NCT03785145|156129034|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
48529007|NCT01824394|156129035|FG000|Overall Study|Early Termination|1|||
48529008|NCT01824394|156129036|FG001|Overall Study|Early Termination|1|||
48529009|NCT01824394|156129037|FG002|Overall Study|Early Termination|3|||
48529010|NCT01824394|156129035|FG000|Overall Study|Withdrawn due to Study Termination|91|||
48529011|NCT01824394|156129036|FG001|Overall Study|Withdrawn due to Study Termination|83|||
48529012|NCT01824394|156129037|FG002|Overall Study|Withdrawn due to Study Termination|41|||
48529013|NCT01824394|156129035|FG000|Overall Study|Lost to Follow-up|0|||
48529014|NCT01824394|156129036|FG001|Overall Study|Lost to Follow-up|9|||
48529015|NCT01824394|156129037|FG002|Overall Study|Lost to Follow-up|3|||
48529016|NCT01824394|156129035|FG000|Overall Study|Death|3|||
48529017|NCT01824394|156129036|FG001|Overall Study|Death|2|||
48529018|NCT01824394|156129037|FG002|Overall Study|Death|4|||
48831318|NCT04012853|157223575|FG000|Overall Study|Protocol Violation|1|||
48831319|NCT04012853|157223576|FG001|Overall Study|Protocol Violation|0|||
48529019|NCT01824394|156129035|FG000|Overall Study|Discontinued Subjects|1|||
48529020|NCT01824394|156129036|FG001|Overall Study|Discontinued Subjects|1|||
48831320|NCT04012853|157223575|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
48831321|NCT04012853|157223576|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
48831322|NCT04613375|157223577|FG000|Overall Study|Death|198|||
48831323|NCT04613375|157223577|FG000|Overall Study|Withdrawal by Subject|3|||
48831324|NCT00464672|157223580|FG000|Overall Study|withdrawal of consent|0|||
48831325|NCT00464672|157223581|FG001|Overall Study|withdrawal of consent|0|||
48831326|NCT00464672|157223582|FG002|Overall Study|withdrawal of consent|0|||
48831327|NCT00464672|157223583|FG003|Overall Study|withdrawal of consent|1|||
48831328|NCT00464672|157223584|FG004|Overall Study|withdrawal of consent|9|||
48831329|NCT00464672|157223585|FG005|Overall Study|withdrawal of consent|4|||
48831330|NCT00464672|157223580|FG000|Overall Study|Lost to Follow-up|25|||
48831331|NCT00464672|157223581|FG001|Overall Study|Lost to Follow-up|10|||
48831332|NCT00464672|157223582|FG002|Overall Study|Lost to Follow-up|0|||
48831333|NCT00464672|157223583|FG003|Overall Study|Lost to Follow-up|0|||
48831334|NCT00464672|157223584|FG004|Overall Study|Lost to Follow-up|1|||
48831335|NCT00464672|157223585|FG005|Overall Study|Lost to Follow-up|0|||
48831336|NCT00217672|157223586|FG000|Allocation|Ineligible|2|||
48831337|NCT00217672|157223587|FG001|Allocation|Ineligible|0|||
48831338|NCT00217672|157223586|FG000|Treatment|disease progression|33|||
48831339|NCT00217672|157223587|FG001|Treatment|disease progression|4|||
48831340|NCT00217672|157223586|FG000|Treatment|Adverse Event|18|||
48831341|NCT00217672|157223587|FG001|Treatment|Adverse Event|2|||
48831342|NCT00217672|157223586|FG000|Treatment|reqd treatment not permitted by protocol|6|||
48831343|NCT00217672|157223587|FG001|Treatment|reqd treatment not permitted by protocol|0|||
48831344|NCT00217672|157223586|FG000|Treatment|Physician Decision|6|||
48831345|NCT00217672|157223587|FG001|Treatment|Physician Decision|0|||
48831346|NCT00217672|157223586|FG000|Treatment|insurance issues|1|||
48831347|NCT00217672|157223587|FG001|Treatment|insurance issues|1|||
48831348|NCT00217672|157223586|FG000|Treatment|Death|2|||
48831349|NCT00217672|157223587|FG001|Treatment|Death|0|||
48831350|NCT00217672|157223586|FG000|Treatment|secondary malignancy|1|||
48831351|NCT00217672|157223587|FG001|Treatment|secondary malignancy|0|||
48831352|NCT00217672|157223586|FG000|Follow-up|Withdrawal by Subject|4|||
48831353|NCT00217672|157223587|FG001|Follow-up|Withdrawal by Subject|0|||
48831354|NCT00217672|157223586|FG000|Follow-up|Lost to Follow-up|1|||
48831355|NCT00217672|157223587|FG001|Follow-up|Lost to Follow-up|0|||
48831356|NCT01235949|157223591|FG000|Primary Phase|Migrated/moved from study area|1|||
48831357|NCT01235949|157223592|FG001|Primary Phase|Migrated/moved from study area|1|||
48831358|NCT01235949|157223593|FG002|Primary Phase|Migrated/moved from study area|0|||
48831359|NCT01235949|157223594|FG003|Primary Phase|Migrated/moved from study area|0|||
48529021|NCT01824394|156129037|FG002|Overall Study|Discontinued Subjects|2|||
48529022|NCT01824394|156129035|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
48529023|NCT01824394|156129036|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
48529024|NCT01824394|156129037|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
48529025|NCT02566889|156129038|FG000|Overall Study|Withdrawal by Subject|3|||
48529026|NCT02566889|156129039|FG001|Overall Study|Withdrawal by Subject|1|||
48529027|NCT02566889|156129038|FG000|Overall Study|Adverse Event|4|||
48529028|NCT02566889|156129039|FG001|Overall Study|Adverse Event|2|||
48529029|NCT02566889|156129038|FG000|Overall Study|Other|6|||
48529030|NCT02566889|156129039|FG001|Overall Study|Other|2|||
48529031|NCT02510261|156129042|FG000|Overall Study|Adverse Event|5|||
48529032|NCT02510261|156129043|FG001|Overall Study|Adverse Event|8|||
48529033|NCT02510261|156129044|FG002|Overall Study|Adverse Event|0|||
48529034|NCT02510261|156129042|FG000|Overall Study|Physician Decision|1|||
48529035|NCT02510261|156129043|FG001|Overall Study|Physician Decision|5|||
48529036|NCT02510261|156129044|FG002|Overall Study|Physician Decision|0|||
48529037|NCT02510261|156129042|FG000|Overall Study|Death|19|||
48529038|NCT02510261|156129043|FG001|Overall Study|Death|19|||
48602570|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
48602571|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
48602572|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
48602573|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
48831360|NCT01235949|157223595|FG004|Primary Phase|Migrated/moved from study area|1|||
48529039|NCT02510261|156129044|FG002|Overall Study|Death|0|||
48529040|NCT02510261|156129042|FG000|Overall Study|Withdrawal by Subject|3|||
48529041|NCT02510261|156129043|FG001|Overall Study|Withdrawal by Subject|10|||
48529042|NCT02510261|156129044|FG002|Overall Study|Withdrawal by Subject|3|||
48529043|NCT03519178|156129046|FG000|PF-06873600 Treatment|Adverse Event|0|||
48529044|NCT03519178|156129047|FG001|PF-06873600 Treatment|Adverse Event|0|||
48831361|NCT01235949|157223596|FG005|Primary Phase|Migrated/moved from study area|2|||
48831362|NCT01235949|157223597|FG006|Primary Phase|Migrated/moved from study area|0|||
48831363|NCT01235949|157223598|FG007|Primary Phase|Migrated/moved from study area|0|||
48831364|NCT01235949|157223599|FG008|Primary Phase|Migrated/moved from study area|0|||
48831365|NCT01235949|157223600|FG009|Primary Phase|Migrated/moved from study area|0|||
48831366|NCT01235949|157223601|FG010|Primary Phase|Migrated/moved from study area|0|||
48529045|NCT03519178|156129048|FG002|PF-06873600 Treatment|Adverse Event|0|||
48529046|NCT03519178|156129049|FG003|PF-06873600 Treatment|Adverse Event|0|||
48529047|NCT03519178|156129050|FG004|PF-06873600 Treatment|Adverse Event|0|||
48529048|NCT03519178|156129051|FG005|PF-06873600 Treatment|Adverse Event|0|||
48529049|NCT03519178|156129052|FG006|PF-06873600 Treatment|Adverse Event|0|||
48529050|NCT03519178|156129053|FG007|PF-06873600 Treatment|Adverse Event|2|||
48529051|NCT03519178|156129054|FG008|PF-06873600 Treatment|Adverse Event|1|||
48529052|NCT03519178|156129055|FG009|PF-06873600 Treatment|Adverse Event|0|||
48602574|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
48831367|NCT01235949|157223602|FG011|Primary Phase|Migrated/moved from study area|0|||
48831368|NCT01235949|157223603|FG012|Primary Phase|Migrated/moved from study area|0|||
48831369|NCT01235949|157223604|FG013|Primary Phase|Migrated/moved from study area|0|||
48831370|NCT01235949|157223605|FG014|Primary Phase|Migrated/moved from study area|0|||
48831371|NCT01235949|157223606|FG015|Primary Phase|Migrated/moved from study area|0|||
48831372|NCT01235949|157223607|FG016|Primary Phase|Migrated/moved from study area|0|||
48831373|NCT01235949|157223608|FG017|Primary Phase|Migrated/moved from study area|0|||
48831374|NCT01235949|157223591|FG000|Primary Phase|Adverse Event|0|||
48831375|NCT01235949|157223592|FG001|Primary Phase|Adverse Event|0|||
48831376|NCT01235949|157223593|FG002|Primary Phase|Adverse Event|0|||
48831377|NCT01235949|157223594|FG003|Primary Phase|Adverse Event|1|||
48831378|NCT01235949|157223595|FG004|Primary Phase|Adverse Event|0|||
48831379|NCT01235949|157223596|FG005|Primary Phase|Adverse Event|0|||
48831380|NCT01235949|157223597|FG006|Primary Phase|Adverse Event|0|||
48831381|NCT01235949|157223598|FG007|Primary Phase|Adverse Event|0|||
48831382|NCT01235949|157223599|FG008|Primary Phase|Adverse Event|0|||
48831383|NCT01235949|157223600|FG009|Primary Phase|Adverse Event|0|||
48831384|NCT01235949|157223601|FG010|Primary Phase|Adverse Event|0|||
48831385|NCT01235949|157223602|FG011|Primary Phase|Adverse Event|0|||
48529053|NCT03519178|156129056|FG010|PF-06873600 Treatment|Adverse Event|0|||
48529054|NCT03519178|156129057|FG011|PF-06873600 Treatment|Adverse Event|0|||
48529055|NCT03519178|156129058|FG012|PF-06873600 Treatment|Adverse Event|1|||
48529056|NCT03519178|156129059|FG013|PF-06873600 Treatment|Adverse Event|3|||
48529057|NCT03519178|156129060|FG014|PF-06873600 Treatment|Adverse Event|2|||
48529058|NCT03519178|156129046|FG000|PF-06873600 Treatment|Death|0|||
48831386|NCT01235949|157223603|FG012|Primary Phase|Adverse Event|0|||
48831387|NCT01235949|157223604|FG013|Primary Phase|Adverse Event|0|||
48529059|NCT03519178|156129047|FG001|PF-06873600 Treatment|Death|0|||
48529060|NCT03519178|156129048|FG002|PF-06873600 Treatment|Death|0|||
48529061|NCT03519178|156129049|FG003|PF-06873600 Treatment|Death|0|||
48529062|NCT03519178|156129050|FG004|PF-06873600 Treatment|Death|0|||
48529063|NCT03519178|156129051|FG005|PF-06873600 Treatment|Death|0|||
48529064|NCT03519178|156129052|FG006|PF-06873600 Treatment|Death|0|||
48529065|NCT03519178|156129053|FG007|PF-06873600 Treatment|Death|0|||
48529066|NCT03519178|156129054|FG008|PF-06873600 Treatment|Death|1|||
48831388|NCT01235949|157223605|FG014|Primary Phase|Adverse Event|0|||
48831389|NCT01235949|157223606|FG015|Primary Phase|Adverse Event|0|||
48831390|NCT01235949|157223607|FG016|Primary Phase|Adverse Event|0|||
48831391|NCT01235949|157223608|FG017|Primary Phase|Adverse Event|0|||
48529067|NCT03519178|156129055|FG009|PF-06873600 Treatment|Death|1|||
48529068|NCT03519178|156129056|FG010|PF-06873600 Treatment|Death|0|||
48529069|NCT03519178|156129057|FG011|PF-06873600 Treatment|Death|0|||
48529070|NCT03519178|156129058|FG012|PF-06873600 Treatment|Death|0|||
48529071|NCT03519178|156129059|FG013|PF-06873600 Treatment|Death|0|||
48529072|NCT03519178|156129060|FG014|PF-06873600 Treatment|Death|1|||
48529073|NCT03519178|156129046|FG000|PF-06873600 Treatment|Physician Decision|0|||
48529074|NCT03519178|156129047|FG001|PF-06873600 Treatment|Physician Decision|0|||
48529075|NCT03519178|156129048|FG002|PF-06873600 Treatment|Physician Decision|0|||
48529076|NCT03519178|156129049|FG003|PF-06873600 Treatment|Physician Decision|0|||
48529077|NCT03519178|156129050|FG004|PF-06873600 Treatment|Physician Decision|0|||
48529078|NCT03519178|156129051|FG005|PF-06873600 Treatment|Physician Decision|0|||
48529079|NCT03519178|156129052|FG006|PF-06873600 Treatment|Physician Decision|0|||
48529080|NCT03519178|156129053|FG007|PF-06873600 Treatment|Physician Decision|1|||
48529081|NCT03519178|156129054|FG008|PF-06873600 Treatment|Physician Decision|0|||
48529082|NCT03519178|156129055|FG009|PF-06873600 Treatment|Physician Decision|0|||
48529083|NCT03519178|156129056|FG010|PF-06873600 Treatment|Physician Decision|1|||
48529084|NCT03519178|156129057|FG011|PF-06873600 Treatment|Physician Decision|0|||
48529085|NCT03519178|156129058|FG012|PF-06873600 Treatment|Physician Decision|0|||
48529086|NCT03519178|156129059|FG013|PF-06873600 Treatment|Physician Decision|4|||
48831392|NCT01235949|157223591|FG000|Primary Phase|Withdrawal by Subject|3|||
48831393|NCT01235949|157223592|FG001|Primary Phase|Withdrawal by Subject|2|||
48831394|NCT01235949|157223593|FG002|Primary Phase|Withdrawal by Subject|2|||
48831395|NCT01235949|157223594|FG003|Primary Phase|Withdrawal by Subject|0|||
48831396|NCT01235949|157223595|FG004|Primary Phase|Withdrawal by Subject|0|||
48831397|NCT01235949|157223596|FG005|Primary Phase|Withdrawal by Subject|3|||
48831398|NCT01235949|157223597|FG006|Primary Phase|Withdrawal by Subject|0|||
48831399|NCT01235949|157223598|FG007|Primary Phase|Withdrawal by Subject|0|||
48831400|NCT01235949|157223599|FG008|Primary Phase|Withdrawal by Subject|0|||
48831401|NCT01235949|157223600|FG009|Primary Phase|Withdrawal by Subject|0|||
48831402|NCT01235949|157223601|FG010|Primary Phase|Withdrawal by Subject|0|||
48831403|NCT01235949|157223602|FG011|Primary Phase|Withdrawal by Subject|0|||
48831404|NCT01235949|157223603|FG012|Primary Phase|Withdrawal by Subject|0|||
48831405|NCT01235949|157223604|FG013|Primary Phase|Withdrawal by Subject|0|||
48831406|NCT01235949|157223605|FG014|Primary Phase|Withdrawal by Subject|0|||
48831407|NCT01235949|157223606|FG015|Primary Phase|Withdrawal by Subject|0|||
48831408|NCT01235949|157223607|FG016|Primary Phase|Withdrawal by Subject|0|||
48831409|NCT01235949|157223608|FG017|Primary Phase|Withdrawal by Subject|0|||
48831410|NCT01235949|157223591|FG000|Primary Phase|Lost to Follow-up|0|||
48831411|NCT01235949|157223592|FG001|Primary Phase|Lost to Follow-up|0|||
48831412|NCT01235949|157223593|FG002|Primary Phase|Lost to Follow-up|1|||
48831413|NCT01235949|157223594|FG003|Primary Phase|Lost to Follow-up|1|||
48831414|NCT01235949|157223595|FG004|Primary Phase|Lost to Follow-up|0|||
48831415|NCT01235949|157223596|FG005|Primary Phase|Lost to Follow-up|2|||
48831416|NCT01235949|157223597|FG006|Primary Phase|Lost to Follow-up|0|||
48831417|NCT01235949|157223598|FG007|Primary Phase|Lost to Follow-up|0|||
48831418|NCT01235949|157223599|FG008|Primary Phase|Lost to Follow-up|0|||
48831419|NCT01235949|157223600|FG009|Primary Phase|Lost to Follow-up|0|||
48831420|NCT01235949|157223601|FG010|Primary Phase|Lost to Follow-up|0|||
48831421|NCT01235949|157223602|FG011|Primary Phase|Lost to Follow-up|0|||
48831422|NCT01235949|157223603|FG012|Primary Phase|Lost to Follow-up|0|||
48831423|NCT01235949|157223604|FG013|Primary Phase|Lost to Follow-up|0|||
48831424|NCT01235949|157223605|FG014|Primary Phase|Lost to Follow-up|0|||
48831425|NCT01235949|157223606|FG015|Primary Phase|Lost to Follow-up|0|||
48529087|NCT03519178|156129060|FG014|PF-06873600 Treatment|Physician Decision|1|||
48529088|NCT03519178|156129046|FG000|PF-06873600 Treatment|Progressive disease|1|||
48529089|NCT03519178|156129047|FG001|PF-06873600 Treatment|Progressive disease|1|||
48529090|NCT03519178|156129048|FG002|PF-06873600 Treatment|Progressive disease|1|||
48529091|NCT03519178|156129049|FG003|PF-06873600 Treatment|Progressive disease|1|||
48529092|NCT03519178|156129050|FG004|PF-06873600 Treatment|Progressive disease|6|||
48831426|NCT01235949|157223607|FG016|Primary Phase|Lost to Follow-up|0|||
48831427|NCT01235949|157223608|FG017|Primary Phase|Lost to Follow-up|0|||
48831428|NCT01235949|157223591|FG000|Booster Phase|Migrated/moved from study area|0|||
48831429|NCT01235949|157223592|FG001|Booster Phase|Migrated/moved from study area|0|||
48831430|NCT01235949|157223593|FG002|Booster Phase|Migrated/moved from study area|0|||
48831431|NCT01235949|157223594|FG003|Booster Phase|Migrated/moved from study area|0|||
48529093|NCT03519178|156129051|FG005|PF-06873600 Treatment|Progressive disease|7|||
48529094|NCT03519178|156129052|FG006|PF-06873600 Treatment|Progressive disease|3|||
48529095|NCT03519178|156129053|FG007|PF-06873600 Treatment|Progressive disease|7|||
48529096|NCT03519178|156129054|FG008|PF-06873600 Treatment|Progressive disease|3|||
48529097|NCT03519178|156129055|FG009|PF-06873600 Treatment|Progressive disease|5|||
48529098|NCT03519178|156129056|FG010|PF-06873600 Treatment|Progressive disease|4|||
48529099|NCT03519178|156129057|FG011|PF-06873600 Treatment|Progressive disease|3|||
48529100|NCT03519178|156129058|FG012|PF-06873600 Treatment|Progressive disease|4|||
48529101|NCT03519178|156129059|FG013|PF-06873600 Treatment|Progressive disease|28|||
48529102|NCT03519178|156129060|FG014|PF-06873600 Treatment|Progressive disease|7|||
48529103|NCT03519178|156129046|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
48529104|NCT03519178|156129047|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
48602575|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
48602576|NCT02717195|156399595|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
48831432|NCT01235949|157223595|FG004|Booster Phase|Migrated/moved from study area|0|||
48529105|NCT03519178|156129048|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
48529106|NCT03519178|156129049|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
48529107|NCT03519178|156129050|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
48529108|NCT03519178|156129051|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
48831433|NCT01235949|157223596|FG005|Booster Phase|Migrated/moved from study area|0|||
48831434|NCT01235949|157223597|FG006|Booster Phase|Migrated/moved from study area|0|||
48831435|NCT01235949|157223598|FG007|Booster Phase|Migrated/moved from study area|0|||
48831436|NCT01235949|157223599|FG008|Booster Phase|Migrated/moved from study area|0|||
48831437|NCT01235949|157223600|FG009|Booster Phase|Migrated/moved from study area|0|||
48831438|NCT01235949|157223601|FG010|Booster Phase|Migrated/moved from study area|0|||
48831439|NCT01235949|157223602|FG011|Booster Phase|Migrated/moved from study area|1|||
48831440|NCT01235949|157223603|FG012|Booster Phase|Migrated/moved from study area|1|||
48831441|NCT01235949|157223604|FG013|Booster Phase|Migrated/moved from study area|0|||
48831442|NCT01235949|157223605|FG014|Booster Phase|Migrated/moved from study area|0|||
48831443|NCT01235949|157223606|FG015|Booster Phase|Migrated/moved from study area|0|||
48831444|NCT01235949|157223607|FG016|Booster Phase|Migrated/moved from study area|0|||
48831445|NCT01235949|157223608|FG017|Booster Phase|Migrated/moved from study area|1|||
48831446|NCT01235949|157223591|FG000|Booster Phase|Adverse Event|0|||
48831447|NCT01235949|157223592|FG001|Booster Phase|Adverse Event|0|||
48831448|NCT01235949|157223593|FG002|Booster Phase|Adverse Event|0|||
48831449|NCT01235949|157223594|FG003|Booster Phase|Adverse Event|0|||
48831450|NCT01235949|157223595|FG004|Booster Phase|Adverse Event|0|||
48831451|NCT01235949|157223596|FG005|Booster Phase|Adverse Event|0|||
48831452|NCT01235949|157223597|FG006|Booster Phase|Adverse Event|0|||
48831453|NCT01235949|157223598|FG007|Booster Phase|Adverse Event|0|||
48831454|NCT01235949|157223599|FG008|Booster Phase|Adverse Event|0|||
48831455|NCT01235949|157223600|FG009|Booster Phase|Adverse Event|0|||
48831456|NCT01235949|157223601|FG010|Booster Phase|Adverse Event|0|||
48831457|NCT01235949|157223602|FG011|Booster Phase|Adverse Event|0|||
48831458|NCT01235949|157223603|FG012|Booster Phase|Adverse Event|0|||
48831459|NCT01235949|157223604|FG013|Booster Phase|Adverse Event|0|||
48831460|NCT01235949|157223605|FG014|Booster Phase|Adverse Event|0|||
48831461|NCT01235949|157223606|FG015|Booster Phase|Adverse Event|1|||
48831462|NCT01235949|157223607|FG016|Booster Phase|Adverse Event|0|||
48831463|NCT01235949|157223608|FG017|Booster Phase|Adverse Event|0|||
48529109|NCT03519178|156129052|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
48529110|NCT03519178|156129053|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
48529111|NCT03519178|156129054|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
48529112|NCT03519178|156129055|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
48529113|NCT03519178|156129056|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
48529114|NCT03519178|156129057|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
48529115|NCT03519178|156129058|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
48529116|NCT03519178|156129059|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
48529117|NCT03519178|156129060|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
48602577|NCT02717195|156399596|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
48831464|NCT01235949|157223591|FG000|Booster Phase|Withdrawal by Subject|0|||
48831465|NCT01235949|157223592|FG001|Booster Phase|Withdrawal by Subject|0|||
48831466|NCT01235949|157223593|FG002|Booster Phase|Withdrawal by Subject|0|||
48831467|NCT01235949|157223594|FG003|Booster Phase|Withdrawal by Subject|0|||
48831468|NCT01235949|157223595|FG004|Booster Phase|Withdrawal by Subject|0|||
48831469|NCT01235949|157223596|FG005|Booster Phase|Withdrawal by Subject|0|||
48831470|NCT01235949|157223597|FG006|Booster Phase|Withdrawal by Subject|0|||
48831471|NCT01235949|157223598|FG007|Booster Phase|Withdrawal by Subject|1|||
48831472|NCT01235949|157223599|FG008|Booster Phase|Withdrawal by Subject|1|||
48831473|NCT01235949|157223600|FG009|Booster Phase|Withdrawal by Subject|0|||
48529118|NCT03519178|156129046|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
48529119|NCT03519178|156129047|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
48529120|NCT03519178|156129048|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
48529121|NCT03519178|156129049|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
48529122|NCT03519178|156129050|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
48529123|NCT03519178|156129051|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
48529124|NCT03519178|156129052|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
48529125|NCT03519178|156129053|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
48529126|NCT03519178|156129054|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
48529127|NCT03519178|156129055|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
48529128|NCT03519178|156129056|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
48529129|NCT03519178|156129057|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
48529130|NCT03519178|156129058|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
48831474|NCT01235949|157223601|FG010|Booster Phase|Withdrawal by Subject|1|||
48831475|NCT01235949|157223602|FG011|Booster Phase|Withdrawal by Subject|1|||
48831476|NCT01235949|157223603|FG012|Booster Phase|Withdrawal by Subject|2|||
48831477|NCT01235949|157223604|FG013|Booster Phase|Withdrawal by Subject|0|||
48831478|NCT01235949|157223605|FG014|Booster Phase|Withdrawal by Subject|2|||
48831479|NCT01235949|157223606|FG015|Booster Phase|Withdrawal by Subject|0|||
48831480|NCT01235949|157223607|FG016|Booster Phase|Withdrawal by Subject|0|||
48831481|NCT01235949|157223608|FG017|Booster Phase|Withdrawal by Subject|0|||
48831482|NCT01235949|157223591|FG000|Booster Phase|Lost to Follow-up|0|||
48831483|NCT01235949|157223592|FG001|Booster Phase|Lost to Follow-up|0|||
48831484|NCT01235949|157223593|FG002|Booster Phase|Lost to Follow-up|0|||
48831485|NCT01235949|157223594|FG003|Booster Phase|Lost to Follow-up|0|||
48831486|NCT01235949|157223595|FG004|Booster Phase|Lost to Follow-up|0|||
48529131|NCT03519178|156129059|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
48831487|NCT01235949|157223596|FG005|Booster Phase|Lost to Follow-up|0|||
48831488|NCT01235949|157223597|FG006|Booster Phase|Lost to Follow-up|0|||
48831489|NCT01235949|157223598|FG007|Booster Phase|Lost to Follow-up|0|||
48831490|NCT01235949|157223599|FG008|Booster Phase|Lost to Follow-up|1|||
48831491|NCT01235949|157223600|FG009|Booster Phase|Lost to Follow-up|1|||
48831492|NCT01235949|157223601|FG010|Booster Phase|Lost to Follow-up|1|||
48831493|NCT01235949|157223602|FG011|Booster Phase|Lost to Follow-up|1|||
48831494|NCT01235949|157223603|FG012|Booster Phase|Lost to Follow-up|0|||
48831495|NCT01235949|157223604|FG013|Booster Phase|Lost to Follow-up|0|||
48831496|NCT01235949|157223605|FG014|Booster Phase|Lost to Follow-up|0|||
48831497|NCT01235949|157223606|FG015|Booster Phase|Lost to Follow-up|0|||
48831498|NCT01235949|157223607|FG016|Booster Phase|Lost to Follow-up|0|||
48831499|NCT01235949|157223608|FG017|Booster Phase|Lost to Follow-up|1|||
48831500|NCT04173572|157223609|FG000|Overall Study|Withdrawal by Subject|1|||
48831501|NCT04173572|157223610|FG001|Overall Study|Withdrawal by Subject|5|||
48831502|NCT04173572|157223609|FG000|Overall Study|Lost to Follow-up|3|||
48831503|NCT04173572|157223610|FG001|Overall Study|Lost to Follow-up|1|||
48831504|NCT04059484|157223621|FG000|Overall Study|Adverse Event|2|||
48831505|NCT04059484|157223622|FG001|Overall Study|Adverse Event|5|||
48831506|NCT04059484|157223621|FG000|Overall Study|Withdrawal by Subject|5|||
48831507|NCT04059484|157223622|FG001|Overall Study|Withdrawal by Subject|3|||
48831508|NCT04059484|157223621|FG000|Overall Study|Progressive disease|112|||
48831509|NCT04059484|157223622|FG001|Overall Study|Progressive disease|112|||
48831510|NCT04059484|157223621|FG000|Overall Study|Other|8|||
48831511|NCT04059484|157223622|FG001|Overall Study|Other|3|||
48831512|NCT04059484|157223621|FG000|Overall Study|Ongoing|20|||
48831513|NCT04059484|157223622|FG001|Overall Study|Ongoing|20|||
48831514|NCT05949788|157223625|FG000|Overall Study|severe birth deformity|2|||
48831515|NCT05949788|157223626|FG001|Overall Study|severe birth deformity|7|||
48831516|NCT05949788|157223625|FG000|Overall Study|twin-twin transfusion syndrome|2|||
48831517|NCT05949788|157223626|FG001|Overall Study|twin-twin transfusion syndrome|7|||
48831518|NCT05949788|157223625|FG000|Overall Study|neonatal hemolytic disease|3|||
48831519|NCT05949788|157223626|FG001|Overall Study|neonatal hemolytic disease|8|||
48831520|NCT05949788|157223625|FG000|Overall Study|death within 14 days after birth|2|||
48831521|NCT05949788|157223626|FG001|Overall Study|death within 14 days after birth|6|||
48831522|NCT05949788|157223625|FG000|Overall Study|transfer to another hospital|2|||
48831523|NCT05949788|157223626|FG001|Overall Study|transfer to another hospital|6|||
48831524|NCT06181760|157223635|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
48831525|NCT06181760|157223636|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
48831526|NCT06181760|157223637|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
48831527|NCT06181760|157223638|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
48831528|NCT05125679|157223645|FG000|Overall Study|Study Terminated by Sponsor|2|||
48831529|NCT05125679|157223646|FG001|Overall Study|Study Terminated by Sponsor|5|||
48831530|NCT03483038|157223647|FG000|Overall Study|Subjects still in follow-up|18|||
48831531|NCT01155869|157223648|FG000|Overall Study|Lost to Follow-up|3|||
48831532|NCT01155869|157223649|FG001|Overall Study|Lost to Follow-up|1|||
48831533|NCT04678830|157223652|FG000|Overall Study|Lack of Efficacy|2|||
48831534|NCT04678830|157223653|FG001|Overall Study|Lack of Efficacy|0|||
48831535|NCT04678830|157223652|FG000|Overall Study|Withdrawal by Subject|0|||
48831536|NCT04678830|157223653|FG001|Overall Study|Withdrawal by Subject|1|||
48831537|NCT00324038|157223658|FG000|Overall Study|Adverse Event|38|||
48831538|NCT00324038|157223659|FG001|Overall Study|Adverse Event|23|||
48831539|NCT00324038|157223658|FG000|Overall Study|Lack of Efficacy|5|||
48831540|NCT00324038|157223659|FG001|Overall Study|Lack of Efficacy|13|||
48529132|NCT03519178|156129060|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
48529133|NCT03519178|156129046|FG000|PF-06873600 Treatment|Refused further treatment|0|||
48529134|NCT03519178|156129047|FG001|PF-06873600 Treatment|Refused further treatment|1|||
48529135|NCT03519178|156129048|FG002|PF-06873600 Treatment|Refused further treatment|0|||
48831541|NCT00324038|157223658|FG000|Overall Study|Lost to Follow-up|0|||
48831542|NCT00324038|157223659|FG001|Overall Study|Lost to Follow-up|2|||
48831543|NCT00324038|157223658|FG000|Overall Study|Other|6|||
48831544|NCT00324038|157223659|FG001|Overall Study|Other|13|||
48831545|NCT00038103|157223662|FG000|Overall Study|Adverse Event|5|||
48831546|NCT00038103|157223663|FG001|Overall Study|Adverse Event|6|||
48831547|NCT00038103|157223662|FG000|Overall Study|Lack of Efficacy|48|||
48831548|NCT00038103|157223663|FG001|Overall Study|Lack of Efficacy|41|||
48831549|NCT00038103|157223662|FG000|Overall Study|Withdrawal by Subject|0|||
48831550|NCT00038103|157223663|FG001|Overall Study|Withdrawal by Subject|3|||
48831551|NCT00038103|157223662|FG000|Overall Study|Lost to Follow-up|0|||
48831552|NCT00038103|157223663|FG001|Overall Study|Lost to Follow-up|3|||
48831553|NCT00038103|157223662|FG000|Overall Study|Protocol Violation|0|||
48831554|NCT00038103|157223663|FG001|Overall Study|Protocol Violation|2|||
48831555|NCT00038103|157223662|FG000|Overall Study|Sponsor Decision|0|||
48831556|NCT00038103|157223663|FG001|Overall Study|Sponsor Decision|1|||
48831557|NCT00038103|157223662|FG000|Overall Study|Randomized/never treated|2|||
48831558|NCT00038103|157223663|FG001|Overall Study|Randomized/never treated|0|||
48831559|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
48831560|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
48831561|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
48831562|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
48831563|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
48831564|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
48831565|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
48831566|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
48831567|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Death|1|||
48831568|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Death|0|||
48831569|NCT01080131|157223666|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
48831570|NCT01080131|157223667|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
48831571|NCT01080131|157223666|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
48831572|NCT01080131|157223667|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
48831573|NCT01080131|157223666|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
48831574|NCT01080131|157223667|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
48831575|NCT01080131|157223666|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
48831576|NCT01080131|157223667|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
48831577|NCT01080131|157223666|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
48831578|NCT01080131|157223667|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
48831579|NCT01080131|157223666|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
48831580|NCT01080131|157223667|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
48831581|NCT01080131|157223666|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
48831582|NCT01080131|157223667|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
48831583|NCT01080131|157223666|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
48831584|NCT01080131|157223667|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
48831585|NCT00387465|157223668|FG000|Overall Study|Withdrawal by Subject|0|||
48831586|NCT00387465|157223669|FG001|Overall Study|Withdrawal by Subject|1|||
48831587|NCT00387465|157223670|FG002|Overall Study|Withdrawal by Subject|0|||
48831588|NCT03545984|157223671|FG000|Overall Study|CSF cases not present during rotation|11|||
48831589|NCT03545984|157223672|FG001|Overall Study|CSF cases not present during rotation|9|||
48831590|NCT03768206|157223674|FG000|Overall Study|Lost to Follow-up|2|||
48831591|NCT03768206|157223675|FG001|Overall Study|Lost to Follow-up|1|||
48831592|NCT03768206|157223674|FG000|Overall Study|Withdrawal by Subject|0|||
48831593|NCT03768206|157223675|FG001|Overall Study|Withdrawal by Subject|1|||
48831594|NCT01390402|157223676|FG000|Overall Study|Death|1|||
48831595|NCT01390402|157223676|FG000|Overall Study|Disease Progression|4|||
48831596|NCT03121950|157223677|FG000|Overall Study|Withdrawal by Subject|11|||
48831597|NCT03121950|157223678|FG001|Overall Study|Withdrawal by Subject|2|||
48831598|NCT04167553|157223681|FG000|Overall Study|Withdrawal by Subject|1|||
48831599|NCT04167553|157223682|FG001|Overall Study|Withdrawal by Subject|0|||
48831600|NCT04167553|157223683|FG002|Overall Study|Withdrawal by Subject|1|||
48831601|NCT04167553|157223684|FG003|Overall Study|Withdrawal by Subject|2|||
48831602|NCT04167553|157223685|FG004|Overall Study|Withdrawal by Subject|1|||
48831603|NCT04167553|157223686|FG005|Overall Study|Withdrawal by Subject|0|||
48831604|NCT04167553|157223687|FG006|Overall Study|Withdrawal by Subject|0|||
48831605|NCT04167553|157223681|FG000|Overall Study|Physician Decision|0|||
48529136|NCT03519178|156129049|FG003|PF-06873600 Treatment|Refused further treatment|0|||
48831606|NCT04167553|157223682|FG001|Overall Study|Physician Decision|0|||
48831607|NCT04167553|157223683|FG002|Overall Study|Physician Decision|0|||
48831608|NCT04167553|157223684|FG003|Overall Study|Physician Decision|0|||
48831609|NCT04167553|157223685|FG004|Overall Study|Physician Decision|2|||
48831610|NCT04167553|157223686|FG005|Overall Study|Physician Decision|2|||
48831611|NCT04167553|157223687|FG006|Overall Study|Physician Decision|0|||
48831612|NCT04167553|157223681|FG000|Overall Study|Lost to Follow-up|0|||
48831613|NCT04167553|157223682|FG001|Overall Study|Lost to Follow-up|0|||
48831614|NCT04167553|157223683|FG002|Overall Study|Lost to Follow-up|2|||
48831615|NCT04167553|157223684|FG003|Overall Study|Lost to Follow-up|0|||
48831616|NCT04167553|157223685|FG004|Overall Study|Lost to Follow-up|0|||
48831617|NCT04167553|157223686|FG005|Overall Study|Lost to Follow-up|0|||
48831618|NCT04167553|157223687|FG006|Overall Study|Lost to Follow-up|0|||
48831619|NCT02685033|157223688|FG000|Overall Study|Withdrawal of Consent|0|||
48831620|NCT02685033|157223689|FG001|Overall Study|Withdrawal of Consent|1|||
48831621|NCT02685033|157223688|FG000|Overall Study|Lost to Follow-up|2|||
48831622|NCT02685033|157223689|FG001|Overall Study|Lost to Follow-up|1|||
48831623|NCT02685033|157223688|FG000|Overall Study|Adverse Event|1|||
48831624|NCT02685033|157223689|FG001|Overall Study|Adverse Event|0|||
48831625|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
48831626|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
48831627|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
48831628|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831629|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831630|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831631|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831632|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831633|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48831634|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
48831635|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
48831636|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
48831637|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831638|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831639|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831640|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831641|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831642|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48831643|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
48831644|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
48831645|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
48831646|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831647|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831648|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831649|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48529137|NCT03519178|156129050|FG004|PF-06873600 Treatment|Refused further treatment|1|||
48529138|NCT03519178|156129051|FG005|PF-06873600 Treatment|Refused further treatment|0|||
48529139|NCT03519178|156129052|FG006|PF-06873600 Treatment|Refused further treatment|0|||
48831650|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831651|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48831652|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
48831653|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831654|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
48831655|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831656|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48529140|NCT03519178|156129053|FG007|PF-06873600 Treatment|Refused further treatment|0|||
48529141|NCT03519178|156129054|FG008|PF-06873600 Treatment|Refused further treatment|0|||
48529142|NCT03519178|156129055|FG009|PF-06873600 Treatment|Refused further treatment|0|||
48529143|NCT03519178|156129056|FG010|PF-06873600 Treatment|Refused further treatment|0|||
48529144|NCT03519178|156129057|FG011|PF-06873600 Treatment|Refused further treatment|0|||
48529145|NCT03519178|156129058|FG012|PF-06873600 Treatment|Refused further treatment|0|||
48831657|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831658|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831659|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48831660|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48529146|NCT03519178|156129059|FG013|PF-06873600 Treatment|Refused further treatment|0|||
48529147|NCT03519178|156129060|FG014|PF-06873600 Treatment|Refused further treatment|1|||
48529148|NCT03519178|156129046|FG000|PF-06873600 Treatment|Other|0|||
48529149|NCT03519178|156129047|FG001|PF-06873600 Treatment|Other|0|||
48529150|NCT03519178|156129048|FG002|PF-06873600 Treatment|Other|0|||
48529151|NCT03519178|156129049|FG003|PF-06873600 Treatment|Other|0|||
48529152|NCT03519178|156129050|FG004|PF-06873600 Treatment|Other|0|||
48831661|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48831662|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48831663|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
48529153|NCT03519178|156129051|FG005|PF-06873600 Treatment|Other|0|||
48529154|NCT03519178|156129052|FG006|PF-06873600 Treatment|Other|0|||
48529155|NCT03519178|156129053|FG007|PF-06873600 Treatment|Other|0|||
48529156|NCT03519178|156129054|FG008|PF-06873600 Treatment|Other|1|||
48529157|NCT03519178|156129055|FG009|PF-06873600 Treatment|Other|0|||
48831664|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48529158|NCT03519178|156129056|FG010|PF-06873600 Treatment|Other|0|||
48529159|NCT03519178|156129057|FG011|PF-06873600 Treatment|Other|0|||
48529160|NCT03519178|156129058|FG012|PF-06873600 Treatment|Other|0|||
48529161|NCT03519178|156129059|FG013|PF-06873600 Treatment|Other|1|||
48529162|NCT03519178|156129060|FG014|PF-06873600 Treatment|Other|3|||
48529163|NCT03519178|156129046|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
48529164|NCT03519178|156129047|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
48529165|NCT03519178|156129048|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
48529166|NCT03519178|156129049|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
48529167|NCT03519178|156129050|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
48529168|NCT03519178|156129051|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
48529169|NCT03519178|156129052|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
48529170|NCT03519178|156129053|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
48529171|NCT03519178|156129054|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
48831665|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831666|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831667|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831668|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831669|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48831670|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831671|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
48831672|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
48831673|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831674|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831675|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831676|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831677|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831678|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48831679|NCT01212757|157223692|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
48831680|NCT01212757|157223693|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
48831681|NCT01212757|157223694|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831682|NCT01212757|157223695|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831683|NCT01212757|157223696|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831684|NCT01212757|157223697|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831685|NCT01212757|157223698|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831686|NCT01212757|157223699|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831687|NCT01212757|157223700|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48831688|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831689|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
48831690|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
48831691|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
48831692|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831693|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
48831694|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831695|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831696|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
48831697|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48831698|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
48831699|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
48831700|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
48831701|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48831702|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
48831703|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48831704|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48529172|NCT03519178|156129055|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
48529173|NCT03519178|156129056|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
48529174|NCT03519178|156129057|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
48529175|NCT03519178|156129058|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
48529176|NCT03519178|156129059|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
48529177|NCT03519178|156129060|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
48529178|NCT03519178|156129046|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529179|NCT03519178|156129047|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529180|NCT03519178|156129048|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529181|NCT03519178|156129049|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529182|NCT03519178|156129050|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529183|NCT03519178|156129051|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529184|NCT03519178|156129052|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529185|NCT03519178|156129053|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529186|NCT03519178|156129054|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529187|NCT03519178|156129055|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529188|NCT03519178|156129056|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529189|NCT03519178|156129057|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529190|NCT03519178|156129058|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
48529191|NCT03519178|156129059|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
48529192|NCT03519178|156129060|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
48529193|NCT03519178|156129046|FG000|PF-06873600 Treatment|Ongoing|0|||
48529194|NCT03519178|156129047|FG001|PF-06873600 Treatment|Ongoing|0|||
48529195|NCT03519178|156129048|FG002|PF-06873600 Treatment|Ongoing|0|||
48529196|NCT03519178|156129049|FG003|PF-06873600 Treatment|Ongoing|0|||
48529197|NCT03519178|156129050|FG004|PF-06873600 Treatment|Ongoing|0|||
48529198|NCT03519178|156129051|FG005|PF-06873600 Treatment|Ongoing|0|||
48831705|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
48831706|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831707|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831708|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
48831709|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831710|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831711|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831712|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831713|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831714|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
48831715|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48831716|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
48831717|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
48831718|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
48831719|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
48831720|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
48831721|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48831722|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48831723|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48831724|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48529199|NCT03519178|156129052|FG006|PF-06873600 Treatment|Ongoing|0|||
48529200|NCT03519178|156129053|FG007|PF-06873600 Treatment|Ongoing|0|||
48529201|NCT03519178|156129054|FG008|PF-06873600 Treatment|Ongoing|0|||
48529202|NCT03519178|156129055|FG009|PF-06873600 Treatment|Ongoing|0|||
48529203|NCT03519178|156129056|FG010|PF-06873600 Treatment|Ongoing|0|||
48529204|NCT03519178|156129057|FG011|PF-06873600 Treatment|Ongoing|0|||
48529205|NCT03519178|156129058|FG012|PF-06873600 Treatment|Ongoing|0|||
48529206|NCT03519178|156129059|FG013|PF-06873600 Treatment|Ongoing|1|||
48529207|NCT03519178|156129060|FG014|PF-06873600 Treatment|Ongoing|6|||
48529208|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529209|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529210|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529211|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529212|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529213|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529214|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48692903|NCT03137992|156724648|FG002|Washout Period 1|Principal Investigator Discretion|0|||
48529215|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529216|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529217|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529218|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529219|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529220|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529221|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
48529222|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
48529223|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Death|0|||
48529224|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Death|0|||
48529225|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Death|0|||
48529226|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Death|0|||
48529227|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Death|0|||
48529228|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Death|0|||
48529229|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Death|0|||
48529230|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Death|0|||
48529231|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Death|0|||
48831725|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
48831726|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48529232|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Death|1|||
48529233|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Death|0|||
48529234|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Death|0|||
48529235|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Death|0|||
48529236|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Death|0|||
48529237|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Death|1|||
48529238|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48602578|NCT02717195|156399597|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
48602579|NCT02717195|156399598|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
48831727|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48831728|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
48831729|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48831730|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48831731|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48831732|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48529239|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529240|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529241|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529242|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529243|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529244|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529245|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529246|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529247|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529248|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529249|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529250|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529251|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
48529252|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
48529253|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529254|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529255|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529256|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529257|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529258|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529259|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529260|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529261|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529262|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529263|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48602580|NCT02717195|156399599|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
48831733|NCT01212757|157223692|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48529264|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48602581|NCT01441973|156399600|FG000|Overall Study|Disease progression|8|||
48602582|NCT01441973|156399601|FG001|Overall Study|Disease progression|6|||
48831734|NCT01212757|157223693|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
48831735|NCT01212757|157223694|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
48831736|NCT01212757|157223695|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831737|NCT01212757|157223696|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48529265|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
48529266|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
48831738|NCT01212757|157223697|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831739|NCT01212757|157223698|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831740|NCT01212757|157223699|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831741|NCT01212757|157223700|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
48831742|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831743|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831744|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831745|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831746|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831747|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831748|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831749|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
48831750|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
48831751|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831752|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
48831753|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
48831754|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831755|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831756|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831757|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
48831758|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
48529267|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
48529268|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529269|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529270|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529271|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529272|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529273|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529274|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529275|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529276|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529277|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
48529278|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529279|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529280|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
48529281|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
48529282|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
48529283|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529284|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529285|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529286|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529287|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529288|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529289|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529290|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529291|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529292|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529293|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48831759|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
48529294|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529295|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
48529296|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
48529297|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
48529298|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529299|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529300|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529301|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529302|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529303|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529304|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529305|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529306|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529307|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
48529308|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529309|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529310|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
48529311|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
48529312|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
48529313|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529314|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529315|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529316|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529317|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529318|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529319|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529320|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529321|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529322|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
48529323|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529324|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529325|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529326|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
48529327|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
48529328|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529329|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529330|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529331|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529332|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529333|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529334|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529335|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529336|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529337|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529338|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529339|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48831760|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831761|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
48831762|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
48831763|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831764|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831765|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831766|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831767|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
48831768|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
48831769|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831770|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
48831771|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
48831772|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831773|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831774|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831775|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48831776|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
48831777|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
48831778|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831779|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831780|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
48831781|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831782|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831783|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831784|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831785|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48529340|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48529341|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
48831786|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
48831787|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831788|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
48831789|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
48831790|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831791|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831792|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831793|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831794|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
48831795|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
48831796|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831797|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
48831798|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
48831799|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831800|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831801|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831802|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
48831803|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
48831804|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
48831805|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831806|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831807|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
48831808|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831809|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831810|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831811|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831812|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831813|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
48831814|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831815|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
48831816|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48831817|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831818|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831819|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831820|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48831821|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48831822|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48831823|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831824|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831825|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831826|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831827|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831828|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831829|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831830|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
48831831|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
48831832|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831833|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
48831834|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831835|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831836|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831837|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831838|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831839|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831840|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
48831841|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831842|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831843|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
48831844|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831845|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831846|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831847|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831848|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
48831849|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
48831850|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831851|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
48831852|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831853|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831854|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831855|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831856|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831857|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
48831858|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
48831859|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831860|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
48831861|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
48831862|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831863|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831864|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831865|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
48831866|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
48831867|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
48831868|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831869|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
48831870|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
48831871|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831872|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831873|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831874|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
48831875|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
48831876|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
48831877|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831878|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
48831879|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
48831880|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831881|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831882|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831883|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48831884|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
48529342|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
48831885|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
48529343|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Other|0|||
48831886|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
48831887|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
48831888|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
48831889|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
48831890|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
48831891|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
48831892|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
48831893|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
48831894|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
48831895|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48529344|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Other|0|||
48529345|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Other|0|||
48529346|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Other|0|||
48529347|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Other|0|||
48529348|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Other|0|||
48529349|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Other|0|||
48529350|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Other|0|||
48529351|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Other|0|||
48529352|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Other|0|||
48529353|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Other|0|||
48529354|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Other|0|||
48529355|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Other|0|||
48529356|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Other|1|||
48529357|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Other|3|||
48529358|NCT03519178|156129046|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529359|NCT03519178|156129047|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529360|NCT03519178|156129048|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529361|NCT03519178|156129049|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529362|NCT03519178|156129050|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529363|NCT03519178|156129051|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529364|NCT03519178|156129052|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529365|NCT03519178|156129053|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529366|NCT03519178|156129054|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529367|NCT03519178|156129055|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529368|NCT03519178|156129056|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529369|NCT03519178|156129057|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
48529370|NCT03519178|156129058|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
48602583|NCT01441973|156399600|FG000|Overall Study|Adverse event unrelated to study drug|3|||
48831896|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831897|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831898|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831899|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831900|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831901|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831902|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
48831903|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
48831904|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831905|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
48831906|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
48831907|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831908|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831909|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831910|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48831911|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48831912|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48831913|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831914|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
48831915|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
48831916|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831917|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831918|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831919|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831920|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
48831921|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
48831922|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48831923|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
48831924|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
48831925|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48529371|NCT03519178|156129059|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
48529372|NCT03519178|156129060|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
48529373|NCT03519178|156129046|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
48529374|NCT03519178|156129047|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
48529375|NCT03519178|156129048|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
48529376|NCT03519178|156129049|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
48529377|NCT03519178|156129050|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
48529378|NCT03519178|156129051|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
48529379|NCT03519178|156129052|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
48529380|NCT03519178|156129053|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
48529381|NCT03519178|156129054|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
48529382|NCT03519178|156129055|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
48529383|NCT03519178|156129056|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
48529384|NCT03519178|156129057|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
48529385|NCT03519178|156129058|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
48529386|NCT03519178|156129059|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
48529387|NCT03519178|156129060|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
48529388|NCT03519178|156129046|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
48529389|NCT03519178|156129047|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
48529390|NCT03519178|156129048|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
48529391|NCT03519178|156129049|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
48529392|NCT03519178|156129050|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
48529393|NCT03519178|156129051|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
48529394|NCT03519178|156129052|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
48529395|NCT03519178|156129053|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
48602584|NCT01441973|156399601|FG001|Overall Study|Adverse event unrelated to study drug|2|||
48602585|NCT01441973|156399600|FG000|Overall Study|Participant request to discontinue|1|||
48602586|NCT01441973|156399601|FG001|Overall Study|Participant request to discontinue|1|||
48602587|NCT01441973|156399600|FG000|Overall Study|Poor compliance/noncompliance|0|||
48602588|NCT01441973|156399601|FG001|Overall Study|Poor compliance/noncompliance|1|||
48602589|NCT01441973|156399600|FG000|Overall Study|Administrative reason by sponsor|3|||
48831926|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48831927|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48831928|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
48831929|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
48831930|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
48831931|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831932|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
48831933|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831934|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831935|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831936|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831937|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831938|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831939|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
48831940|NCT01212757|157223692|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831941|NCT01212757|157223693|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
48831942|NCT01212757|157223694|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
48831943|NCT01212757|157223695|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831944|NCT01212757|157223696|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831945|NCT01212757|157223697|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831946|NCT01212757|157223698|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831947|NCT01212757|157223699|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831948|NCT01212757|157223700|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
48831949|NCT00359619|157224991|FG000|Overall Study|Adverse Event|0|||
48831950|NCT00359619|157224992|FG001|Overall Study|Adverse Event|0|||
48831951|NCT00359619|157224993|FG002|Overall Study|Adverse Event|1|||
48831952|NCT00359619|157224994|FG003|Overall Study|Adverse Event|0|||
48831953|NCT00359619|157224995|FG004|Overall Study|Adverse Event|0|||
48831954|NCT00359619|157224996|FG005|Overall Study|Adverse Event|0|||
48831955|NCT00359619|157224997|FG006|Overall Study|Adverse Event|1|||
48831956|NCT00359619|157224991|FG000|Overall Study|Withdrawal by Subject|3|||
48602590|NCT01441973|156399601|FG001|Overall Study|Administrative reason by sponsor|5|||
48831957|NCT00359619|157224992|FG001|Overall Study|Withdrawal by Subject|1|||
48831958|NCT00359619|157224993|FG002|Overall Study|Withdrawal by Subject|4|||
48831959|NCT00359619|157224994|FG003|Overall Study|Withdrawal by Subject|2|||
48831960|NCT00359619|157224995|FG004|Overall Study|Withdrawal by Subject|2|||
48831961|NCT00359619|157224996|FG005|Overall Study|Withdrawal by Subject|0|||
48831962|NCT00359619|157224997|FG006|Overall Study|Withdrawal by Subject|3|||
48831963|NCT00359619|157224991|FG000|Overall Study|Other|1|||
48831964|NCT00359619|157224992|FG001|Overall Study|Other|0|||
48831965|NCT00359619|157224993|FG002|Overall Study|Other|0|||
48831966|NCT00359619|157224994|FG003|Overall Study|Other|0|||
48831967|NCT00359619|157224995|FG004|Overall Study|Other|0|||
48831968|NCT00359619|157224996|FG005|Overall Study|Other|0|||
48831969|NCT00359619|157224997|FG006|Overall Study|Other|0|||
48831970|NCT00359619|157224991|FG000|Overall Study|Lost to Follow-up|4|||
48831971|NCT00359619|157224992|FG001|Overall Study|Lost to Follow-up|4|||
48831972|NCT00359619|157224993|FG002|Overall Study|Lost to Follow-up|2|||
48831973|NCT00359619|157224994|FG003|Overall Study|Lost to Follow-up|1|||
48831974|NCT00359619|157224995|FG004|Overall Study|Lost to Follow-up|1|||
48831975|NCT00359619|157224996|FG005|Overall Study|Lost to Follow-up|5|||
48831976|NCT00359619|157224997|FG006|Overall Study|Lost to Follow-up|0|||
48831977|NCT00569946|157224998|FG000|Overall Study|Adverse Event|16|||
48831978|NCT00569946|157224998|FG000|Overall Study|Objective Progression or Relapse|42|||
48831979|NCT00569946|157224998|FG000|Overall Study|Global Deterioration of Health Status|1|||
48831980|NCT00587288|157225000|FG000|Overall Study|Adverse Event|0|||
48831981|NCT00587288|157225001|FG001|Overall Study|Adverse Event|1|||
48831982|NCT00587288|157225000|FG000|Overall Study|Lack of Efficacy|2|||
48831983|NCT00587288|157225001|FG001|Overall Study|Lack of Efficacy|8|||
48831984|NCT00587288|157225000|FG000|Overall Study|Protocol Violation|1|||
48831985|NCT00587288|157225001|FG001|Overall Study|Protocol Violation|0|||
48831986|NCT03584516|157225002|FG000|Part 1|Death|2|||
48831987|NCT03584516|157225003|FG001|Part 1|Death|3|||
48831988|NCT03584516|157225004|FG002|Part 1|Death|0|||
48831989|NCT03584516|157225005|FG003|Part 1|Death|0|||
48831990|NCT03584516|157225006|FG004|Part 1|Death|0|||
48831991|NCT03584516|157225007|FG005|Part 1|Death|0|||
48831992|NCT03584516|157225002|FG000|Part 1|Withdrawal by Subject|2|||
48831993|NCT03584516|157225003|FG001|Part 1|Withdrawal by Subject|0|||
48831994|NCT03584516|157225004|FG002|Part 1|Withdrawal by Subject|0|||
48831995|NCT03584516|157225005|FG003|Part 1|Withdrawal by Subject|0|||
48831996|NCT03584516|157225006|FG004|Part 1|Withdrawal by Subject|0|||
48831997|NCT03584516|157225007|FG005|Part 1|Withdrawal by Subject|0|||
48529396|NCT03519178|156129054|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
48529397|NCT03519178|156129055|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
48529398|NCT03519178|156129056|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
48529399|NCT03519178|156129057|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
48529400|NCT03519178|156129058|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
48529401|NCT03519178|156129059|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
48529402|NCT03519178|156129060|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
48831998|NCT03584516|157225002|FG000|Part 1|Lost to Follow-up|1|||
48831999|NCT03584516|157225003|FG001|Part 1|Lost to Follow-up|0|||
48832000|NCT03584516|157225004|FG002|Part 1|Lost to Follow-up|0|||
48832001|NCT03584516|157225005|FG003|Part 1|Lost to Follow-up|0|||
48832002|NCT03584516|157225006|FG004|Part 1|Lost to Follow-up|0|||
48832003|NCT03584516|157225007|FG005|Part 1|Lost to Follow-up|0|||
48832004|NCT03584516|157225002|FG000|Part 1|Study Terminated by Sponsor|0|||
48832005|NCT03584516|157225003|FG001|Part 1|Study Terminated by Sponsor|2|||
48832006|NCT03584516|157225004|FG002|Part 1|Study Terminated by Sponsor|0|||
48832007|NCT03584516|157225005|FG003|Part 1|Study Terminated by Sponsor|0|||
48832008|NCT03584516|157225006|FG004|Part 1|Study Terminated by Sponsor|0|||
48832009|NCT03584516|157225007|FG005|Part 1|Study Terminated by Sponsor|0|||
48832010|NCT03584516|157225002|FG000|Part 1 Expansion|Death|0|||
48832011|NCT03584516|157225003|FG001|Part 1 Expansion|Death|0|||
48832012|NCT03584516|157225004|FG002|Part 1 Expansion|Death|9|||
48832013|NCT03584516|157225005|FG003|Part 1 Expansion|Death|8|||
48832014|NCT03584516|157225006|FG004|Part 1 Expansion|Death|4|||
48832015|NCT03584516|157225007|FG005|Part 1 Expansion|Death|5|||
48832016|NCT03584516|157225002|FG000|Part 1 Expansion|Lost to Follow-up|0|||
48832017|NCT03584516|157225003|FG001|Part 1 Expansion|Lost to Follow-up|0|||
48832018|NCT03584516|157225004|FG002|Part 1 Expansion|Lost to Follow-up|0|||
48832019|NCT03584516|157225005|FG003|Part 1 Expansion|Lost to Follow-up|1|||
48832020|NCT03584516|157225006|FG004|Part 1 Expansion|Lost to Follow-up|0|||
48832021|NCT03584516|157225007|FG005|Part 1 Expansion|Lost to Follow-up|0|||
48832022|NCT03584516|157225002|FG000|Part 1 Expansion|Physician Decision|0|||
48832023|NCT03584516|157225003|FG001|Part 1 Expansion|Physician Decision|0|||
48832024|NCT03584516|157225004|FG002|Part 1 Expansion|Physician Decision|4|||
48832025|NCT03584516|157225005|FG003|Part 1 Expansion|Physician Decision|3|||
48832026|NCT03584516|157225006|FG004|Part 1 Expansion|Physician Decision|2|||
48832027|NCT03584516|157225007|FG005|Part 1 Expansion|Physician Decision|3|||
48832028|NCT03584516|157225002|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
48832029|NCT03584516|157225003|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
48832030|NCT03584516|157225004|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
48832031|NCT03584516|157225005|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
48832032|NCT03584516|157225006|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
48832033|NCT03584516|157225007|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
48529403|NCT03519178|156129046|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529404|NCT03519178|156129047|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529405|NCT03519178|156129048|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529406|NCT03519178|156129049|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529407|NCT03519178|156129050|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529408|NCT03519178|156129051|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529409|NCT03519178|156129052|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529410|NCT03519178|156129053|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529411|NCT03519178|156129054|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529412|NCT03519178|156129055|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529413|NCT03519178|156129056|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
48529414|NCT03519178|156129057|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529415|NCT03519178|156129058|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529416|NCT03519178|156129059|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529417|NCT03519178|156129060|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
48529418|NCT03519178|156129046|FG000|Follow-Up|Death|0|||
48529419|NCT03519178|156129047|FG001|Follow-Up|Death|0|||
48529420|NCT03519178|156129048|FG002|Follow-Up|Death|1|||
48529421|NCT03519178|156129049|FG003|Follow-Up|Death|0|||
48529422|NCT03519178|156129050|FG004|Follow-Up|Death|0|||
48529423|NCT03519178|156129051|FG005|Follow-Up|Death|0|||
48529424|NCT03519178|156129052|FG006|Follow-Up|Death|0|||
48529425|NCT03519178|156129053|FG007|Follow-Up|Death|0|||
48529426|NCT03519178|156129054|FG008|Follow-Up|Death|3|||
48529427|NCT03519178|156129055|FG009|Follow-Up|Death|1|||
48529428|NCT03519178|156129056|FG010|Follow-Up|Death|0|||
48529429|NCT03519178|156129057|FG011|Follow-Up|Death|0|||
48529430|NCT03519178|156129058|FG012|Follow-Up|Death|2|||
48529431|NCT03519178|156129059|FG013|Follow-Up|Death|0|||
48529432|NCT03519178|156129060|FG014|Follow-Up|Death|0|||
48529433|NCT03519178|156129046|FG000|Follow-Up|Lost to Follow-up|0|||
48832034|NCT03584516|157225002|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
48832035|NCT03584516|157225003|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
48832036|NCT03584516|157225004|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
48832037|NCT03584516|157225005|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
48832038|NCT03584516|157225006|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
48832039|NCT03584516|157225007|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
48832040|NCT03584516|157225002|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48529434|NCT03519178|156129047|FG001|Follow-Up|Lost to Follow-up|0|||
48529435|NCT03519178|156129048|FG002|Follow-Up|Lost to Follow-up|0|||
48529436|NCT03519178|156129049|FG003|Follow-Up|Lost to Follow-up|0|||
48529437|NCT03519178|156129050|FG004|Follow-Up|Lost to Follow-up|0|||
48529438|NCT03519178|156129051|FG005|Follow-Up|Lost to Follow-up|3|||
48529439|NCT03519178|156129052|FG006|Follow-Up|Lost to Follow-up|1|||
48529440|NCT03519178|156129053|FG007|Follow-Up|Lost to Follow-up|4|||
48529441|NCT03519178|156129054|FG008|Follow-Up|Lost to Follow-up|1|||
48529442|NCT03519178|156129055|FG009|Follow-Up|Lost to Follow-up|0|||
48529443|NCT03519178|156129056|FG010|Follow-Up|Lost to Follow-up|0|||
48529444|NCT03519178|156129057|FG011|Follow-Up|Lost to Follow-up|0|||
48529445|NCT03519178|156129058|FG012|Follow-Up|Lost to Follow-up|0|||
48529446|NCT03519178|156129059|FG013|Follow-Up|Lost to Follow-up|0|||
48529447|NCT03519178|156129060|FG014|Follow-Up|Lost to Follow-up|0|||
48529448|NCT03519178|156129046|FG000|Follow-Up|Withdrawal by Subject|1|||
48529449|NCT03519178|156129047|FG001|Follow-Up|Withdrawal by Subject|2|||
48529450|NCT03519178|156129048|FG002|Follow-Up|Withdrawal by Subject|2|||
48529451|NCT03519178|156129049|FG003|Follow-Up|Withdrawal by Subject|3|||
48529452|NCT03519178|156129050|FG004|Follow-Up|Withdrawal by Subject|5|||
48529453|NCT03519178|156129051|FG005|Follow-Up|Withdrawal by Subject|1|||
48529454|NCT03519178|156129052|FG006|Follow-Up|Withdrawal by Subject|2|||
48529455|NCT03519178|156129053|FG007|Follow-Up|Withdrawal by Subject|6|||
48529456|NCT03519178|156129054|FG008|Follow-Up|Withdrawal by Subject|5|||
48529457|NCT03519178|156129055|FG009|Follow-Up|Withdrawal by Subject|2|||
48529458|NCT03519178|156129056|FG010|Follow-Up|Withdrawal by Subject|3|||
48832041|NCT03584516|157225003|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48529459|NCT03519178|156129057|FG011|Follow-Up|Withdrawal by Subject|5|||
48529460|NCT03519178|156129058|FG012|Follow-Up|Withdrawal by Subject|2|||
48832042|NCT03584516|157225004|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48832043|NCT03584516|157225005|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
48529461|NCT03519178|156129059|FG013|Follow-Up|Withdrawal by Subject|0|||
48529462|NCT03519178|156129060|FG014|Follow-Up|Withdrawal by Subject|0|||
48529463|NCT03519178|156129046|FG000|Follow-Up|Other|0|||
48529464|NCT03519178|156129047|FG001|Follow-Up|Other|0|||
48529465|NCT03519178|156129048|FG002|Follow-Up|Other|0|||
48529466|NCT03519178|156129049|FG003|Follow-Up|Other|0|||
48529467|NCT03519178|156129050|FG004|Follow-Up|Other|0|||
48529468|NCT03519178|156129051|FG005|Follow-Up|Other|0|||
48529469|NCT03519178|156129052|FG006|Follow-Up|Other|0|||
48529470|NCT03519178|156129053|FG007|Follow-Up|Other|1|||
48529471|NCT03519178|156129054|FG008|Follow-Up|Other|0|||
48529472|NCT03519178|156129055|FG009|Follow-Up|Other|0|||
48529473|NCT03519178|156129056|FG010|Follow-Up|Other|0|||
48529474|NCT03519178|156129057|FG011|Follow-Up|Other|0|||
48529475|NCT03519178|156129058|FG012|Follow-Up|Other|0|||
48529476|NCT03519178|156129059|FG013|Follow-Up|Other|0|||
48529477|NCT03519178|156129060|FG014|Follow-Up|Other|0|||
48529478|NCT03519178|156129046|FG000|Long-term Follow-up|Death|0|||
48529479|NCT03519178|156129047|FG001|Long-term Follow-up|Death|0|||
48529480|NCT03519178|156129048|FG002|Long-term Follow-up|Death|0|||
48529481|NCT03519178|156129049|FG003|Long-term Follow-up|Death|0|||
48529482|NCT03519178|156129050|FG004|Long-term Follow-up|Death|0|||
48529483|NCT03519178|156129051|FG005|Long-term Follow-up|Death|0|||
48529484|NCT03519178|156129052|FG006|Long-term Follow-up|Death|0|||
48529485|NCT03519178|156129053|FG007|Long-term Follow-up|Death|0|||
48529486|NCT03519178|156129054|FG008|Long-term Follow-up|Death|0|||
48529487|NCT03519178|156129055|FG009|Long-term Follow-up|Death|0|||
48529488|NCT03519178|156129056|FG010|Long-term Follow-up|Death|0|||
48529489|NCT03519178|156129057|FG011|Long-term Follow-up|Death|0|||
48529490|NCT03519178|156129058|FG012|Long-term Follow-up|Death|0|||
48529491|NCT03519178|156129059|FG013|Long-term Follow-up|Death|4|||
48529492|NCT03519178|156129060|FG014|Long-term Follow-up|Death|4|||
48529493|NCT03519178|156129046|FG000|Long-term Follow-up|Lost to Follow-up|0|||
48529494|NCT03519178|156129047|FG001|Long-term Follow-up|Lost to Follow-up|0|||
48529495|NCT03519178|156129048|FG002|Long-term Follow-up|Lost to Follow-up|0|||
48529496|NCT03519178|156129049|FG003|Long-term Follow-up|Lost to Follow-up|0|||
48529497|NCT03519178|156129050|FG004|Long-term Follow-up|Lost to Follow-up|0|||
48832044|NCT03584516|157225006|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48832045|NCT03584516|157225007|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
48832046|NCT03584516|157225002|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832047|NCT03584516|157225003|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832048|NCT03584516|157225004|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832049|NCT03584516|157225005|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832050|NCT03584516|157225006|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
48832051|NCT03584516|157225007|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
48832052|NCT04868110|157225008|FG000|Overall Study|Withdrawal by Subject|3|||
48832053|NCT04868110|157225009|FG001|Overall Study|Withdrawal by Subject|4|||
48832054|NCT03068468|157225010|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
48832055|NCT03068468|157225011|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
48832056|NCT03068468|157225012|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
48832057|NCT03068468|157225013|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
48832058|NCT03068468|157225010|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
48832059|NCT03068468|157225011|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
48832060|NCT03068468|157225012|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
48832061|NCT03068468|157225013|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
48832062|NCT03068468|157225010|FG000|Placebo-Controlled Period|Adverse Event|16|||
48832063|NCT03068468|157225011|FG001|Placebo-Controlled Period|Adverse Event|21|||
48832064|NCT03068468|157225012|FG002|Placebo-Controlled Period|Adverse Event|0|||
48832065|NCT03068468|157225013|FG003|Placebo-Controlled Period|Adverse Event|0|||
48832066|NCT03068468|157225010|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
48832067|NCT03068468|157225011|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
48832068|NCT03068468|157225012|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
48832069|NCT03068468|157225013|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
48529498|NCT03519178|156129051|FG005|Long-term Follow-up|Lost to Follow-up|0|||
48529499|NCT03519178|156129052|FG006|Long-term Follow-up|Lost to Follow-up|0|||
48529500|NCT03519178|156129053|FG007|Long-term Follow-up|Lost to Follow-up|0|||
48529501|NCT03519178|156129054|FG008|Long-term Follow-up|Lost to Follow-up|0|||
48529502|NCT03519178|156129055|FG009|Long-term Follow-up|Lost to Follow-up|0|||
48529503|NCT03519178|156129056|FG010|Long-term Follow-up|Lost to Follow-up|0|||
48529504|NCT03519178|156129057|FG011|Long-term Follow-up|Lost to Follow-up|0|||
48529505|NCT03519178|156129058|FG012|Long-term Follow-up|Lost to Follow-up|0|||
48529506|NCT03519178|156129059|FG013|Long-term Follow-up|Lost to Follow-up|1|||
48602591|NCT01441973|156399600|FG000|Overall Study|Participant withdrew consent|0|||
48602592|NCT01441973|156399601|FG001|Overall Study|Participant withdrew consent|1|||
48832070|NCT03068468|157225010|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
48832071|NCT03068468|157225011|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
48832072|NCT03068468|157225012|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48832073|NCT03068468|157225013|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48832074|NCT03068468|157225010|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
48832075|NCT03068468|157225011|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
48832076|NCT03068468|157225012|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
48832077|NCT03068468|157225013|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
48832078|NCT03068468|157225010|FG000|Placebo-Controlled Period|Death|0|||
48832079|NCT03068468|157225011|FG001|Placebo-Controlled Period|Death|1|||
48832080|NCT03068468|157225012|FG002|Placebo-Controlled Period|Death|0|||
48832081|NCT03068468|157225013|FG003|Placebo-Controlled Period|Death|0|||
48832082|NCT03068468|157225010|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
48832083|NCT03068468|157225011|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
48832084|NCT03068468|157225012|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
48832085|NCT03068468|157225013|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
48832086|NCT03068468|157225010|FG000|Open-Label Extension Period|Adverse Event|0|||
48832087|NCT03068468|157225011|FG001|Open-Label Extension Period|Adverse Event|0|||
48832088|NCT03068468|157225012|FG002|Open-Label Extension Period|Adverse Event|13|||
48529507|NCT03519178|156129060|FG014|Long-term Follow-up|Lost to Follow-up|1|||
48529508|NCT03519178|156129046|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
48832089|NCT03068468|157225013|FG003|Open-Label Extension Period|Adverse Event|17|||
48832090|NCT03068468|157225010|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
48529509|NCT03519178|156129047|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
48529510|NCT03519178|156129048|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
48529511|NCT03519178|156129049|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
48529512|NCT03519178|156129050|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
48529513|NCT03519178|156129051|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
48529514|NCT03519178|156129052|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
48529515|NCT03519178|156129053|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
48529516|NCT03519178|156129054|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
48529517|NCT03519178|156129055|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
48529518|NCT03519178|156129056|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
48529519|NCT03519178|156129057|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
48529520|NCT03519178|156129058|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
48529521|NCT03519178|156129059|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
48529522|NCT03519178|156129060|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
48529523|NCT03519178|156129046|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
48529524|NCT03519178|156129047|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
48529525|NCT03519178|156129048|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
48529526|NCT03519178|156129049|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
48529527|NCT03519178|156129050|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
48529528|NCT03519178|156129051|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
48529529|NCT03519178|156129052|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
48529530|NCT03519178|156129053|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
48529531|NCT03519178|156129054|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
48529532|NCT03519178|156129055|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
48602593|NCT05117060|156399606|FG000|Overall Study|Adverse Event|3|||
48832091|NCT03068468|157225011|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
48832092|NCT03068468|157225012|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
48529533|NCT03519178|156129056|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
48832093|NCT03068468|157225013|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
48832094|NCT03068468|157225010|FG000|Open-Label Extension Period|Death|0|||
48832095|NCT03068468|157225011|FG001|Open-Label Extension Period|Death|0|||
48832096|NCT03068468|157225012|FG002|Open-Label Extension Period|Death|0|||
48832097|NCT03068468|157225013|FG003|Open-Label Extension Period|Death|1|||
48832098|NCT03068468|157225010|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
48832099|NCT03068468|157225011|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
48832100|NCT03068468|157225012|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
48832101|NCT03068468|157225013|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
48832102|NCT03068468|157225010|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
48832103|NCT03068468|157225011|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
48832104|NCT03068468|157225012|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
48832105|NCT03068468|157225013|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
48832106|NCT03068468|157225010|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
48832107|NCT03068468|157225011|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
48832108|NCT03068468|157225012|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
48529534|NCT03519178|156129057|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
48529535|NCT03519178|156129058|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
48529536|NCT03519178|156129059|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
48529537|NCT03519178|156129060|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
48529538|NCT03519178|156129046|FG000|Long-term Follow-up|Other|0|||
48529539|NCT03519178|156129047|FG001|Long-term Follow-up|Other|0|||
48529540|NCT03519178|156129048|FG002|Long-term Follow-up|Other|0|||
48529541|NCT03519178|156129049|FG003|Long-term Follow-up|Other|0|||
48529542|NCT03519178|156129050|FG004|Long-term Follow-up|Other|0|||
48529543|NCT03519178|156129051|FG005|Long-term Follow-up|Other|0|||
48529544|NCT03519178|156129052|FG006|Long-term Follow-up|Other|0|||
48529545|NCT03519178|156129053|FG007|Long-term Follow-up|Other|0|||
48529546|NCT03519178|156129054|FG008|Long-term Follow-up|Other|0|||
48529547|NCT03519178|156129055|FG009|Long-term Follow-up|Other|0|||
48529548|NCT03519178|156129056|FG010|Long-term Follow-up|Other|0|||
48529549|NCT03519178|156129057|FG011|Long-term Follow-up|Other|0|||
48529550|NCT03519178|156129058|FG012|Long-term Follow-up|Other|0|||
48529551|NCT03519178|156129059|FG013|Long-term Follow-up|Other|0|||
48529552|NCT03519178|156129060|FG014|Long-term Follow-up|Other|1|||
48529553|NCT03519178|156129046|FG000|Long-term Follow-up|Ongoing|0|||
48529554|NCT03519178|156129047|FG001|Long-term Follow-up|Ongoing|0|||
48529555|NCT03519178|156129048|FG002|Long-term Follow-up|Ongoing|0|||
48529556|NCT03519178|156129049|FG003|Long-term Follow-up|Ongoing|0|||
48529557|NCT03519178|156129050|FG004|Long-term Follow-up|Ongoing|0|||
48529558|NCT03519178|156129051|FG005|Long-term Follow-up|Ongoing|0|||
48529559|NCT03519178|156129052|FG006|Long-term Follow-up|Ongoing|0|||
48529560|NCT03519178|156129053|FG007|Long-term Follow-up|Ongoing|0|||
48529561|NCT03519178|156129054|FG008|Long-term Follow-up|Ongoing|0|||
48529562|NCT03519178|156129055|FG009|Long-term Follow-up|Ongoing|0|||
48529563|NCT03519178|156129056|FG010|Long-term Follow-up|Ongoing|0|||
48529564|NCT03519178|156129057|FG011|Long-term Follow-up|Ongoing|0|||
48529565|NCT03519178|156129058|FG012|Long-term Follow-up|Ongoing|0|||
48529566|NCT03519178|156129059|FG013|Long-term Follow-up|Ongoing|1|||
48529567|NCT03519178|156129060|FG014|Long-term Follow-up|Ongoing|0|||
48529568|NCT00108082|156129061|FG000|Overall Study|Adverse Event|14|||
48529569|NCT00108082|156129062|FG001|Overall Study|Adverse Event|12|||
48529570|NCT00108082|156129063|FG002|Overall Study|Adverse Event|17|||
48529571|NCT00108082|156129061|FG000|Overall Study|Lost to Follow-up|6|||
48529572|NCT00108082|156129062|FG001|Overall Study|Lost to Follow-up|3|||
48529573|NCT00108082|156129063|FG002|Overall Study|Lost to Follow-up|7|||
48529574|NCT00108082|156129061|FG000|Overall Study|Consent Withdrawn|3|||
48529575|NCT00108082|156129062|FG001|Overall Study|Consent Withdrawn|3|||
48529576|NCT00108082|156129063|FG002|Overall Study|Consent Withdrawn|5|||
48529577|NCT00108082|156129061|FG000|Overall Study|Protocol Violation|1|||
48529578|NCT00108082|156129062|FG001|Overall Study|Protocol Violation|2|||
48529579|NCT00108082|156129063|FG002|Overall Study|Protocol Violation|0|||
48529580|NCT00108082|156129061|FG000|Overall Study|Lack of Efficacy|3|||
48529581|NCT00108082|156129062|FG001|Overall Study|Lack of Efficacy|1|||
48529582|NCT00108082|156129063|FG002|Overall Study|Lack of Efficacy|2|||
48529583|NCT00108082|156129061|FG000|Overall Study|Amendment 4: > Month 12|5|||
48832109|NCT03068468|157225013|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
48832110|NCT03068468|157225010|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
48529584|NCT00108082|156129062|FG001|Overall Study|Amendment 4: > Month 12|7|||
48529585|NCT00108082|156129063|FG002|Overall Study|Amendment 4: > Month 12|5|||
48832111|NCT03068468|157225011|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
48529586|NCT00108082|156129061|FG000|Overall Study|Woman of Child-bearing Potential|2|||
48529587|NCT00108082|156129062|FG001|Overall Study|Woman of Child-bearing Potential|0|||
48529588|NCT00108082|156129063|FG002|Overall Study|Woman of Child-bearing Potential|2|||
48529589|NCT00108082|156129061|FG000|Overall Study|Incorrectly Randomized|0|||
48529590|NCT00108082|156129062|FG001|Overall Study|Incorrectly Randomized|0|||
48602594|NCT05117060|156399607|FG001|Overall Study|Adverse Event|5|||
48529591|NCT00108082|156129063|FG002|Overall Study|Incorrectly Randomized|2|||
48529592|NCT00108082|156129061|FG000|Overall Study|Non-compliance|1|||
48529593|NCT00108082|156129062|FG001|Overall Study|Non-compliance|0|||
48529594|NCT00108082|156129063|FG002|Overall Study|Non-compliance|2|||
48529595|NCT00108082|156129061|FG000|Overall Study|Stopped Study Medication|0|||
48529596|NCT00108082|156129062|FG001|Overall Study|Stopped Study Medication|0|||
48529597|NCT00108082|156129063|FG002|Overall Study|Stopped Study Medication|1|||
48529598|NCT00108082|156129061|FG000|Overall Study|Site Closed Study|0|||
48529599|NCT00108082|156129062|FG001|Overall Study|Site Closed Study|2|||
48529600|NCT00108082|156129063|FG002|Overall Study|Site Closed Study|0|||
48529601|NCT00108082|156129061|FG000|Overall Study|Protocol Amendment|0|||
48529602|NCT00108082|156129062|FG001|Overall Study|Protocol Amendment|1|||
48529603|NCT00108082|156129063|FG002|Overall Study|Protocol Amendment|0|||
48529604|NCT00108082|156129061|FG000|Overall Study|Study Medication Not Tapered|0|||
48529605|NCT00108082|156129062|FG001|Overall Study|Study Medication Not Tapered|1|||
48529606|NCT00108082|156129063|FG002|Overall Study|Study Medication Not Tapered|0|||
48832112|NCT03068468|157225012|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
48832113|NCT03068468|157225013|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
48832114|NCT03068468|157225010|FG000|Open-Label Extension Period|Reason not Specified|0|||
48832115|NCT03068468|157225011|FG001|Open-Label Extension Period|Reason not Specified|0|||
48832116|NCT03068468|157225012|FG002|Open-Label Extension Period|Reason not Specified|1|||
48529607|NCT00108082|156129061|FG000|Overall Study|Subject Left Site Location|1|||
48529608|NCT00108082|156129062|FG001|Overall Study|Subject Left Site Location|0|||
48529609|NCT00108082|156129063|FG002|Overall Study|Subject Left Site Location|0|||
48529610|NCT00108082|156129061|FG000|Overall Study|Investigator Not at Site|1|||
48529611|NCT00108082|156129062|FG001|Overall Study|Investigator Not at Site|0|||
48529612|NCT00108082|156129063|FG002|Overall Study|Investigator Not at Site|0|||
48529613|NCT00108082|156129061|FG000|Overall Study|Blood Pressure Not Controlled|1|||
48529614|NCT00108082|156129062|FG001|Overall Study|Blood Pressure Not Controlled|0|||
48529615|NCT00108082|156129063|FG002|Overall Study|Blood Pressure Not Controlled|0|||
48529616|NCT04021862|156129064|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
48602595|NCT05117060|156399608|FG002|Overall Study|Adverse Event|6|||
48529617|NCT04021862|156129065|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
48529618|NCT04021862|156129066|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
48529619|NCT04021862|156129067|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
48529620|NCT04021862|156129068|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
48529621|NCT04021862|156129069|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
48529622|NCT04021862|156129064|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
48529623|NCT04021862|156129065|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
48529624|NCT04021862|156129066|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
48529625|NCT04021862|156129067|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
48529626|NCT04021862|156129068|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
48602596|NCT05117060|156399609|FG003|Overall Study|Adverse Event|1|||
48832117|NCT03068468|157225013|FG003|Open-Label Extension Period|Reason not Specified|4|||
48832118|NCT00739102|157225015|FG000|Overall Study|Death|5|||
48832119|NCT00739102|157225015|FG000|Overall Study|Withdrawal by Subject|10|||
48832120|NCT00646451|157225016|FG000|Overall Study|Adverse Event|3|||
48529627|NCT04021862|156129069|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
48529628|NCT04021862|156129064|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
48529629|NCT04021862|156129065|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
48832121|NCT00646451|157225017|FG001|Overall Study|Adverse Event|0|||
48529630|NCT04021862|156129066|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
48529631|NCT04021862|156129067|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
48529632|NCT04021862|156129068|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
48529633|NCT04021862|156129069|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
48602597|NCT05117060|156399606|FG000|Overall Study|Lost to Follow-up|0|||
48832122|NCT00646451|157225016|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
48832123|NCT00646451|157225017|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
48529634|NCT04021862|156129064|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
48529635|NCT04021862|156129065|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
48832124|NCT01510912|157225018|FG000|Overall Study|Adverse Event|99|||
48832125|NCT01510912|157225018|FG000|Overall Study|Lack of Efficacy|12|||
48832126|NCT01510912|157225018|FG000|Overall Study|Non-compliance with trial drug|23|||
48832127|NCT01510912|157225018|FG000|Overall Study|Withdrawal by Subject|49|||
48832128|NCT01510912|157225018|FG000|Overall Study|Physician Decision|1|||
48832129|NCT01510912|157225018|FG000|Overall Study|Protocol Violation|27|||
48832130|NCT01510912|157225018|FG000|Overall Study|Lost to Follow-up|26|||
48832131|NCT01510912|157225018|FG000|Overall Study|Other, including joint replacement|5|||
48832132|NCT03179787|157225019|FG000|Overall Study|Lost to Follow-up|15|||
48832133|NCT03179787|157225019|FG000|Overall Study|Case report failures|2|||
48832134|NCT03179787|157225019|FG000|Overall Study|Treatment not administered|1|||
48832135|NCT04335591|157225023|FG000|Overall Study|Adverse Event|5|||
48832136|NCT04335591|157225024|FG001|Overall Study|Adverse Event|2|||
48832137|NCT04335591|157225025|FG002|Overall Study|Adverse Event|3|||
48832138|NCT04335591|157225026|FG003|Overall Study|Adverse Event|2|||
48832139|NCT04335591|157225023|FG000|Overall Study|Protocol Violation|1|||
48832140|NCT04335591|157225024|FG001|Overall Study|Protocol Violation|0|||
48832141|NCT04335591|157225025|FG002|Overall Study|Protocol Violation|0|||
48832142|NCT04335591|157225026|FG003|Overall Study|Protocol Violation|0|||
48832143|NCT04335591|157225023|FG000|Overall Study|Withdrawal by Subject|8|||
48832144|NCT04335591|157225024|FG001|Overall Study|Withdrawal by Subject|4|||
48832145|NCT04335591|157225025|FG002|Overall Study|Withdrawal by Subject|4|||
48832146|NCT04335591|157225026|FG003|Overall Study|Withdrawal by Subject|5|||
48832147|NCT04335591|157225023|FG000|Overall Study|Subject planning pregnancy|0|||
48832148|NCT04335591|157225024|FG001|Overall Study|Subject planning pregnancy|1|||
48832149|NCT04335591|157225025|FG002|Overall Study|Subject planning pregnancy|0|||
48832150|NCT04335591|157225026|FG003|Overall Study|Subject planning pregnancy|0|||
48832151|NCT04335591|157225023|FG000|Overall Study|Ukrainian Russian war conflict|4|||
48832152|NCT04335591|157225024|FG001|Overall Study|Ukrainian Russian war conflict|5|||
48832153|NCT04335591|157225025|FG002|Overall Study|Ukrainian Russian war conflict|2|||
48832154|NCT04335591|157225026|FG003|Overall Study|Ukrainian Russian war conflict|0|||
48832155|NCT03518112|157225029|FG000|Overall Study|Withdrawal by Subject|1|||
48832156|NCT01546155|157225030|FG000|Overall Study|could not tolerate long scan duration|3|||
48832157|NCT02930343|157225031|FG000|Overall Study|Lost to Follow-up|9|||
48832158|NCT02930343|157225032|FG001|Overall Study|Lost to Follow-up|7|||
48832159|NCT01289119|157225033|FG000|Overall Study|Adverse Event|2|||
48832160|NCT01289119|157225034|FG001|Overall Study|Adverse Event|1|||
48832161|NCT01289119|157225035|FG002|Overall Study|Adverse Event|0|||
48832162|NCT01289119|157225036|FG003|Overall Study|Adverse Event|2|||
48832163|NCT01289119|157225037|FG004|Overall Study|Adverse Event|1|||
48832164|NCT01289119|157225038|FG005|Overall Study|Adverse Event|0|||
48832165|NCT01289119|157225033|FG000|Overall Study|Major Protocol Deviation|2|||
48832166|NCT01289119|157225034|FG001|Overall Study|Major Protocol Deviation|1|||
48529636|NCT04021862|156129066|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
48529637|NCT04021862|156129067|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
48529638|NCT04021862|156129068|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
48529639|NCT04021862|156129069|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
48529640|NCT04021862|156129064|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
48529641|NCT04021862|156129065|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
48529642|NCT04021862|156129066|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
48529643|NCT04021862|156129067|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
48529644|NCT04021862|156129068|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
48832167|NCT01289119|157225035|FG002|Overall Study|Major Protocol Deviation|3|||
48832168|NCT01289119|157225036|FG003|Overall Study|Major Protocol Deviation|0|||
48832169|NCT01289119|157225037|FG004|Overall Study|Major Protocol Deviation|2|||
48832170|NCT01289119|157225038|FG005|Overall Study|Major Protocol Deviation|1|||
48832171|NCT01289119|157225033|FG000|Overall Study|Lost to Follow-up|0|||
48832172|NCT01289119|157225034|FG001|Overall Study|Lost to Follow-up|3|||
48832173|NCT01289119|157225035|FG002|Overall Study|Lost to Follow-up|0|||
48832174|NCT01289119|157225036|FG003|Overall Study|Lost to Follow-up|0|||
48529645|NCT04021862|156129069|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
48529646|NCT03223909|156129070|FG000|Overall Study|Protocol Violation|48|||
48529647|NCT03223909|156129071|FG001|Overall Study|Protocol Violation|45|||
48529648|NCT03223909|156129072|FG002|Overall Study|Protocol Violation|16|||
48529649|NCT01470144|156129073|FG000|Overall Study|Adverse Event|2|||
48529650|NCT01470144|156129073|FG000|Overall Study|Death|1|||
48529651|NCT01470144|156129073|FG000|Overall Study|Lung transplant|6|||
48529652|NCT01470144|156129073|FG000|Overall Study|Patient's and investigator's decision|1|||
48529653|NCT04767373|156129074|FG000|Overall Study|Death|6|||
48832175|NCT01289119|157225037|FG004|Overall Study|Lost to Follow-up|0|||
48832176|NCT01289119|157225038|FG005|Overall Study|Lost to Follow-up|1|||
48832177|NCT01289119|157225033|FG000|Overall Study|Withdrawal by Subject|4|||
48832178|NCT01289119|157225034|FG001|Overall Study|Withdrawal by Subject|2|||
48832179|NCT01289119|157225035|FG002|Overall Study|Withdrawal by Subject|4|||
48832180|NCT01289119|157225036|FG003|Overall Study|Withdrawal by Subject|3|||
48832181|NCT01289119|157225037|FG004|Overall Study|Withdrawal by Subject|1|||
48832182|NCT01289119|157225038|FG005|Overall Study|Withdrawal by Subject|1|||
48832183|NCT01289119|157225033|FG000|Overall Study|Pregnancy|0|||
48832184|NCT01289119|157225034|FG001|Overall Study|Pregnancy|1|||
48832185|NCT01289119|157225035|FG002|Overall Study|Pregnancy|0|||
48832186|NCT01289119|157225036|FG003|Overall Study|Pregnancy|0|||
48832187|NCT01289119|157225037|FG004|Overall Study|Pregnancy|0|||
48832188|NCT01289119|157225038|FG005|Overall Study|Pregnancy|0|||
48832189|NCT01289119|157225033|FG000|Overall Study|Lack of Efficacy|0|||
48832190|NCT01289119|157225034|FG001|Overall Study|Lack of Efficacy|1|||
48832191|NCT01289119|157225035|FG002|Overall Study|Lack of Efficacy|1|||
48832192|NCT01289119|157225036|FG003|Overall Study|Lack of Efficacy|1|||
48832193|NCT01289119|157225037|FG004|Overall Study|Lack of Efficacy|1|||
48832194|NCT01289119|157225038|FG005|Overall Study|Lack of Efficacy|1|||
48832195|NCT01289119|157225033|FG000|Overall Study|Other|1|||
48832196|NCT01289119|157225034|FG001|Overall Study|Other|0|||
48832197|NCT01289119|157225035|FG002|Overall Study|Other|1|||
48832198|NCT01289119|157225036|FG003|Overall Study|Other|0|||
48832199|NCT01289119|157225037|FG004|Overall Study|Other|0|||
48832200|NCT01289119|157225038|FG005|Overall Study|Other|0|||
48832201|NCT01801930|157225043|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
48832202|NCT01801930|157225044|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
48832203|NCT01801930|157225045|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
48832204|NCT01801930|157225046|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
48832205|NCT01801930|157225043|FG000|Overall Study|DLT occurs|0|||
48832206|NCT01801930|157225044|FG001|Overall Study|DLT occurs|1|||
48832207|NCT01801930|157225045|FG002|Overall Study|DLT occurs|0|||
48832208|NCT01801930|157225046|FG003|Overall Study|DLT occurs|0|||
48832209|NCT00377455|157225049|FG000|Overall Study|Withdrawal by Subject|1|||
48832210|NCT00771667|157225050|FG000|Induction Phase|Adverse Event|5|||
48832211|NCT00771667|157225051|FG001|Induction Phase|Adverse Event|2|||
48832212|NCT00771667|157225052|FG002|Induction Phase|Adverse Event|4|||
48832213|NCT00771667|157225053|FG003|Induction Phase|Adverse Event|1|||
48832214|NCT00771667|157225054|FG004|Induction Phase|Adverse Event|0|||
48832215|NCT00771667|157225055|FG005|Induction Phase|Adverse Event|0|||
48832216|NCT00771667|157225056|FG006|Induction Phase|Adverse Event|0|||
48832217|NCT00771667|157225057|FG007|Induction Phase|Adverse Event|0|||
48832218|NCT00771667|157225058|FG008|Induction Phase|Adverse Event|0|||
48832219|NCT00771667|157225059|FG009|Induction Phase|Adverse Event|0|||
48832220|NCT00771667|157225050|FG000|Induction Phase|Lack of Efficacy|9|||
48832221|NCT00771667|157225051|FG001|Induction Phase|Lack of Efficacy|2|||
48832222|NCT00771667|157225052|FG002|Induction Phase|Lack of Efficacy|4|||
48832223|NCT00771667|157225053|FG003|Induction Phase|Lack of Efficacy|3|||
48832224|NCT00771667|157225054|FG004|Induction Phase|Lack of Efficacy|0|||
48832225|NCT00771667|157225055|FG005|Induction Phase|Lack of Efficacy|0|||
48832226|NCT00771667|157225056|FG006|Induction Phase|Lack of Efficacy|0|||
48832227|NCT00771667|157225057|FG007|Induction Phase|Lack of Efficacy|0|||
48832228|NCT00771667|157225058|FG008|Induction Phase|Lack of Efficacy|0|||
48832229|NCT00771667|157225059|FG009|Induction Phase|Lack of Efficacy|0|||
48832230|NCT00771667|157225050|FG000|Induction Phase|Lost to Follow-up|1|||
48832231|NCT00771667|157225051|FG001|Induction Phase|Lost to Follow-up|0|||
48832232|NCT00771667|157225052|FG002|Induction Phase|Lost to Follow-up|1|||
48832233|NCT00771667|157225053|FG003|Induction Phase|Lost to Follow-up|0|||
48832234|NCT00771667|157225054|FG004|Induction Phase|Lost to Follow-up|0|||
48529654|NCT04767373|156129075|FG001|Overall Study|Death|3|||
48832235|NCT00771667|157225055|FG005|Induction Phase|Lost to Follow-up|0|||
48832236|NCT00771667|157225056|FG006|Induction Phase|Lost to Follow-up|0|||
48832237|NCT00771667|157225057|FG007|Induction Phase|Lost to Follow-up|0|||
48832238|NCT00771667|157225058|FG008|Induction Phase|Lost to Follow-up|0|||
48832239|NCT00771667|157225059|FG009|Induction Phase|Lost to Follow-up|0|||
48832240|NCT00771667|157225050|FG000|Induction Phase|Other|4|||
48832241|NCT00771667|157225051|FG001|Induction Phase|Other|6|||
48832242|NCT00771667|157225052|FG002|Induction Phase|Other|3|||
48832243|NCT00771667|157225053|FG003|Induction Phase|Other|4|||
48832244|NCT00771667|157225054|FG004|Induction Phase|Other|0|||
48529655|NCT04767373|156129074|FG000|Overall Study|Lost to Follow-up|67|||
48529656|NCT04767373|156129075|FG001|Overall Study|Lost to Follow-up|35|||
48529657|NCT04767373|156129074|FG000|Overall Study|Physician Decision|15|||
48529658|NCT04767373|156129075|FG001|Overall Study|Physician Decision|4|||
48529659|NCT04767373|156129074|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48832245|NCT00771667|157225055|FG005|Induction Phase|Other|0|||
48832246|NCT00771667|157225056|FG006|Induction Phase|Other|0|||
48832247|NCT00771667|157225057|FG007|Induction Phase|Other|0|||
48832248|NCT00771667|157225058|FG008|Induction Phase|Other|0|||
48832249|NCT00771667|157225059|FG009|Induction Phase|Other|0|||
48832250|NCT00771667|157225050|FG000|Maintenance Phase|Adverse Event|0|||
48832251|NCT00771667|157225051|FG001|Maintenance Phase|Adverse Event|0|||
48832252|NCT00771667|157225052|FG002|Maintenance Phase|Adverse Event|0|||
48832253|NCT00771667|157225053|FG003|Maintenance Phase|Adverse Event|0|||
48832254|NCT00771667|157225054|FG004|Maintenance Phase|Adverse Event|1|||
48832255|NCT00771667|157225055|FG005|Maintenance Phase|Adverse Event|3|||
48529660|NCT04767373|156129075|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48529661|NCT04767373|156129074|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
48832256|NCT00771667|157225056|FG006|Maintenance Phase|Adverse Event|5|||
48832257|NCT00771667|157225057|FG007|Maintenance Phase|Adverse Event|1|||
48832258|NCT00771667|157225058|FG008|Maintenance Phase|Adverse Event|8|||
48832259|NCT00771667|157225059|FG009|Maintenance Phase|Adverse Event|7|||
48832260|NCT00771667|157225050|FG000|Maintenance Phase|Lack of Efficacy|0|||
48832261|NCT00771667|157225051|FG001|Maintenance Phase|Lack of Efficacy|0|||
48832262|NCT00771667|157225052|FG002|Maintenance Phase|Lack of Efficacy|0|||
48832263|NCT00771667|157225053|FG003|Maintenance Phase|Lack of Efficacy|0|||
48832264|NCT00771667|157225054|FG004|Maintenance Phase|Lack of Efficacy|1|||
48832265|NCT00771667|157225055|FG005|Maintenance Phase|Lack of Efficacy|3|||
48832266|NCT00771667|157225056|FG006|Maintenance Phase|Lack of Efficacy|3|||
48832267|NCT00771667|157225057|FG007|Maintenance Phase|Lack of Efficacy|2|||
48832268|NCT00771667|157225058|FG008|Maintenance Phase|Lack of Efficacy|11|||
48832269|NCT00771667|157225059|FG009|Maintenance Phase|Lack of Efficacy|7|||
48832270|NCT00771667|157225050|FG000|Maintenance Phase|Other|0|||
48832271|NCT00771667|157225051|FG001|Maintenance Phase|Other|0|||
48832272|NCT00771667|157225052|FG002|Maintenance Phase|Other|0|||
48832273|NCT00771667|157225053|FG003|Maintenance Phase|Other|0|||
48832274|NCT00771667|157225054|FG004|Maintenance Phase|Other|0|||
48832275|NCT00771667|157225055|FG005|Maintenance Phase|Other|1|||
48832276|NCT00771667|157225056|FG006|Maintenance Phase|Other|2|||
48832277|NCT00771667|157225057|FG007|Maintenance Phase|Other|2|||
48529662|NCT04767373|156129075|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
48529663|NCT04767373|156129074|FG000|Overall Study|Other|1|||
48529664|NCT04767373|156129075|FG001|Overall Study|Other|2|||
48529665|NCT04436276|156129076|FG000|Overall Study|Adverse Event|0|||
48529666|NCT04436276|156129077|FG001|Overall Study|Adverse Event|0|||
48529667|NCT04436276|156129078|FG002|Overall Study|Adverse Event|0|||
48529668|NCT04436276|156129079|FG003|Overall Study|Adverse Event|0|||
48529669|NCT04436276|156129080|FG004|Overall Study|Adverse Event|0|||
48832278|NCT00771667|157225058|FG008|Maintenance Phase|Other|3|||
48832279|NCT00771667|157225059|FG009|Maintenance Phase|Other|3|||
48832280|NCT03467724|157225060|FG000|Overall Study|Lost to Follow-up|5|||
48529670|NCT04436276|156129081|FG005|Overall Study|Adverse Event|0|||
48529671|NCT04436276|156129082|FG006|Overall Study|Adverse Event|0|||
48529672|NCT04436276|156129083|FG007|Overall Study|Adverse Event|0|||
48529673|NCT04436276|156129084|FG008|Overall Study|Adverse Event|0|||
48529674|NCT04436276|156129085|FG009|Overall Study|Adverse Event|0|||
48529675|NCT04436276|156129086|FG010|Overall Study|Adverse Event|0|||
48529676|NCT04436276|156129087|FG011|Overall Study|Adverse Event|0|||
48529677|NCT04436276|156129088|FG012|Overall Study|Adverse Event|0|||
48529678|NCT04436276|156129089|FG013|Overall Study|Adverse Event|0|||
48529679|NCT04436276|156129090|FG014|Overall Study|Adverse Event|0|||
48529680|NCT04436276|156129091|FG015|Overall Study|Adverse Event|0|||
48529681|NCT04436276|156129092|FG016|Overall Study|Adverse Event|1|||
48832281|NCT03467724|157225060|FG000|Overall Study|Withdrawal by Subject|1|||
48832282|NCT03467724|157225060|FG000|Overall Study|Protocol Violation|1|||
48832283|NCT03467724|157225060|FG000|Overall Study|Adverse Event|1|||
48832284|NCT01368406|157225064|FG000|Overall Study|Lost to Follow-up|8|||
48832285|NCT01368406|157225065|FG001|Overall Study|Lost to Follow-up|4|||
48832286|NCT01368406|157225064|FG000|Overall Study|Withdrawal by Subject|8|||
48832287|NCT01368406|157225065|FG001|Overall Study|Withdrawal by Subject|4|||
48529682|NCT04436276|156129093|FG017|Overall Study|Adverse Event|0|||
48529683|NCT04436276|156129094|FG018|Overall Study|Adverse Event|0|||
48529684|NCT04436276|156129095|FG019|Overall Study|Adverse Event|0|||
48529685|NCT04436276|156129096|FG020|Overall Study|Adverse Event|0|||
48529686|NCT04436276|156129097|FG021|Overall Study|Adverse Event|0|||
48529687|NCT04436276|156129098|FG022|Overall Study|Adverse Event|0|||
48529688|NCT04436276|156129076|FG000|Overall Study|Death|0|||
48832288|NCT01368406|157225064|FG000|Overall Study|relapse of the disease|3|||
48529689|NCT04436276|156129077|FG001|Overall Study|Death|0|||
48529690|NCT04436276|156129078|FG002|Overall Study|Death|0|||
48529691|NCT04436276|156129079|FG003|Overall Study|Death|0|||
48529692|NCT04436276|156129080|FG004|Overall Study|Death|0|||
48529693|NCT04436276|156129081|FG005|Overall Study|Death|0|||
48529694|NCT04436276|156129082|FG006|Overall Study|Death|0|||
48529695|NCT04436276|156129083|FG007|Overall Study|Death|0|||
48529696|NCT04436276|156129084|FG008|Overall Study|Death|0|||
48529697|NCT04436276|156129085|FG009|Overall Study|Death|0|||
48529698|NCT04436276|156129086|FG010|Overall Study|Death|0|||
48602598|NCT05117060|156399607|FG001|Overall Study|Lost to Follow-up|0|||
48602599|NCT05117060|156399608|FG002|Overall Study|Lost to Follow-up|0|||
48602600|NCT05117060|156399609|FG003|Overall Study|Lost to Follow-up|1|||
48602601|NCT05117060|156399606|FG000|Overall Study|Lack of Efficacy|4|||
48602602|NCT05117060|156399607|FG001|Overall Study|Lack of Efficacy|5|||
48602603|NCT05117060|156399608|FG002|Overall Study|Lack of Efficacy|2|||
48602604|NCT05117060|156399609|FG003|Overall Study|Lack of Efficacy|6|||
48602605|NCT05117060|156399606|FG000|Overall Study|Withdrawal by Subject|8|||
48602606|NCT05117060|156399607|FG001|Overall Study|Withdrawal by Subject|5|||
48602607|NCT05117060|156399608|FG002|Overall Study|Withdrawal by Subject|5|||
48602608|NCT05117060|156399609|FG003|Overall Study|Withdrawal by Subject|6|||
48602609|NCT05117060|156399606|FG000|Overall Study|Other|2|||
48602610|NCT05117060|156399607|FG001|Overall Study|Other|1|||
48602611|NCT05117060|156399608|FG002|Overall Study|Other|3|||
48602612|NCT05117060|156399609|FG003|Overall Study|Other|1|||
48529699|NCT04436276|156129087|FG011|Overall Study|Death|0|||
48602613|NCT01081626|156399612|FG000|Overall Study|Dosing error|1|||
48602614|NCT01081626|156399613|FG001|Overall Study|Dosing error|1|||
48529700|NCT04436276|156129088|FG012|Overall Study|Death|1|||
48529701|NCT04436276|156129089|FG013|Overall Study|Death|0|||
48529702|NCT04436276|156129090|FG014|Overall Study|Death|1|||
48529703|NCT04436276|156129091|FG015|Overall Study|Death|0|||
48529704|NCT04436276|156129092|FG016|Overall Study|Death|0|||
48529705|NCT04436276|156129093|FG017|Overall Study|Death|0|||
48529706|NCT04436276|156129094|FG018|Overall Study|Death|0|||
48529707|NCT04436276|156129095|FG019|Overall Study|Death|2|||
48602615|NCT01081626|156399612|FG000|Overall Study|Missing Estradiol|25|||
48832289|NCT01368406|157225065|FG001|Overall Study|relapse of the disease|2|||
48529708|NCT04436276|156129096|FG020|Overall Study|Death|0|||
48529709|NCT04436276|156129097|FG021|Overall Study|Death|1|||
48529710|NCT04436276|156129098|FG022|Overall Study|Death|0|||
48529711|NCT04436276|156129076|FG000|Overall Study|Lost to Follow-up|0|||
48529712|NCT04436276|156129077|FG001|Overall Study|Lost to Follow-up|2|||
48529713|NCT04436276|156129078|FG002|Overall Study|Lost to Follow-up|2|||
48529714|NCT04436276|156129079|FG003|Overall Study|Lost to Follow-up|1|||
48529715|NCT04436276|156129080|FG004|Overall Study|Lost to Follow-up|4|||
48529716|NCT04436276|156129081|FG005|Overall Study|Lost to Follow-up|1|||
48529717|NCT04436276|156129082|FG006|Overall Study|Lost to Follow-up|0|||
48529718|NCT04436276|156129083|FG007|Overall Study|Lost to Follow-up|0|||
48529719|NCT04436276|156129084|FG008|Overall Study|Lost to Follow-up|1|||
48529720|NCT04436276|156129085|FG009|Overall Study|Lost to Follow-up|0|||
48529721|NCT04436276|156129086|FG010|Overall Study|Lost to Follow-up|5|||
48529722|NCT04436276|156129087|FG011|Overall Study|Lost to Follow-up|5|||
48529723|NCT04436276|156129088|FG012|Overall Study|Lost to Follow-up|4|||
48529724|NCT04436276|156129089|FG013|Overall Study|Lost to Follow-up|1|||
48529725|NCT04436276|156129090|FG014|Overall Study|Lost to Follow-up|7|||
48529726|NCT04436276|156129091|FG015|Overall Study|Lost to Follow-up|7|||
48529727|NCT04436276|156129092|FG016|Overall Study|Lost to Follow-up|1|||
48529728|NCT04436276|156129093|FG017|Overall Study|Lost to Follow-up|0|||
48529729|NCT04436276|156129094|FG018|Overall Study|Lost to Follow-up|1|||
48529730|NCT04436276|156129095|FG019|Overall Study|Lost to Follow-up|1|||
48602616|NCT01081626|156399613|FG001|Overall Study|Missing Estradiol|28|||
48832290|NCT01368406|157225064|FG000|Overall Study|started working|2|||
48832291|NCT01368406|157225065|FG001|Overall Study|started working|3|||
48529731|NCT04436276|156129096|FG020|Overall Study|Lost to Follow-up|2|||
48529732|NCT04436276|156129097|FG021|Overall Study|Lost to Follow-up|1|||
48529733|NCT04436276|156129098|FG022|Overall Study|Lost to Follow-up|1|||
48529734|NCT04436276|156129076|FG000|Overall Study|Physician Decision|1|||
48602617|NCT01081626|156399612|FG000|Overall Study|Low antral follicle count|1|||
48602618|NCT01081626|156399613|FG001|Overall Study|Low antral follicle count|0|||
48602619|NCT01081626|156399612|FG000|Overall Study|Overstimulation|0|||
48529735|NCT04436276|156129077|FG001|Overall Study|Physician Decision|0|||
48529736|NCT04436276|156129078|FG002|Overall Study|Physician Decision|2|||
48529737|NCT04436276|156129079|FG003|Overall Study|Physician Decision|1|||
48529738|NCT04436276|156129080|FG004|Overall Study|Physician Decision|0|||
48529739|NCT04436276|156129081|FG005|Overall Study|Physician Decision|0|||
48529740|NCT04436276|156129082|FG006|Overall Study|Physician Decision|0|||
48529741|NCT04436276|156129083|FG007|Overall Study|Physician Decision|0|||
48529742|NCT04436276|156129084|FG008|Overall Study|Physician Decision|0|||
48529743|NCT04436276|156129085|FG009|Overall Study|Physician Decision|0|||
48602620|NCT01081626|156399613|FG001|Overall Study|Overstimulation|1|||
48602621|NCT01081626|156399612|FG000|Overall Study|Lost to Follow-up|0|||
48602622|NCT01081626|156399613|FG001|Overall Study|Lost to Follow-up|1|||
48529744|NCT04436276|156129086|FG010|Overall Study|Physician Decision|0|||
48529745|NCT04436276|156129087|FG011|Overall Study|Physician Decision|1|||
48529746|NCT04436276|156129088|FG012|Overall Study|Physician Decision|2|||
48529747|NCT04436276|156129089|FG013|Overall Study|Physician Decision|0|||
48529748|NCT04436276|156129090|FG014|Overall Study|Physician Decision|0|||
48529749|NCT04436276|156129091|FG015|Overall Study|Physician Decision|0|||
48529750|NCT04436276|156129092|FG016|Overall Study|Physician Decision|0|||
48832292|NCT01806714|157225070|FG000|Overall Study|No functioning phone number|200|||
48832293|NCT01806714|157225071|FG001|Overall Study|No functioning phone number|170|||
48832294|NCT02155829|157225072|FG000|Overall Study|Adverse Event|1|||
48832295|NCT02155829|157225073|FG001|Overall Study|Adverse Event|0|||
48832296|NCT02155829|157225072|FG000|Overall Study|Withdrawal by Subject|3|||
48832297|NCT02155829|157225073|FG001|Overall Study|Withdrawal by Subject|3|||
48832298|NCT02155829|157225072|FG000|Overall Study|Protocol Violation|2|||
48832299|NCT02155829|157225073|FG001|Overall Study|Protocol Violation|0|||
48832300|NCT00678795|157225074|FG000|Overall Study|Adverse Event|7|||
48832301|NCT00678795|157225075|FG001|Overall Study|Adverse Event|3|||
48832302|NCT00678795|157225074|FG000|Overall Study|Withdrawal by Subject|3|||
48832303|NCT00678795|157225075|FG001|Overall Study|Withdrawal by Subject|0|||
48832304|NCT00678795|157225074|FG000|Overall Study|Protocol Violation|0|||
48832305|NCT00678795|157225075|FG001|Overall Study|Protocol Violation|1|||
48832306|NCT00678795|157225074|FG000|Overall Study|Lost to Follow-up|0|||
48832307|NCT00678795|157225075|FG001|Overall Study|Lost to Follow-up|1|||
48832308|NCT00678795|157225074|FG000|Overall Study|Lack of Efficacy|1|||
48832309|NCT00678795|157225075|FG001|Overall Study|Lack of Efficacy|1|||
48832310|NCT00197015|157225084|FG000|Overall Study|Adverse Event|3|||
48832311|NCT00197015|157225085|FG001|Overall Study|Adverse Event|0|||
48832312|NCT00197015|157225086|FG002|Overall Study|Adverse Event|1|||
48832313|NCT00197015|157225084|FG000|Overall Study|Protocol Violation|0|||
48832314|NCT00197015|157225085|FG001|Overall Study|Protocol Violation|3|||
48832315|NCT00197015|157225086|FG002|Overall Study|Protocol Violation|3|||
48832316|NCT00197015|157225084|FG000|Overall Study|Withdrawal by Subject|17|||
48832317|NCT00197015|157225085|FG001|Overall Study|Withdrawal by Subject|37|||
48832318|NCT00197015|157225086|FG002|Overall Study|Withdrawal by Subject|34|||
48832319|NCT00197015|157225084|FG000|Overall Study|Lost to Follow-up|28|||
48832320|NCT00197015|157225085|FG001|Overall Study|Lost to Follow-up|46|||
48832321|NCT00197015|157225086|FG002|Overall Study|Lost to Follow-up|37|||
48832322|NCT00197015|157225084|FG000|Overall Study|Other|2|||
48832323|NCT00197015|157225085|FG001|Overall Study|Other|3|||
48832324|NCT00197015|157225086|FG002|Overall Study|Other|2|||
48832325|NCT04011722|157225089|FG000|30 Days|Death|5|||
48832326|NCT04011722|157225090|FG001|30 Days|Death|1|||
48832327|NCT04011722|157225089|FG000|1 Year|Death|13|||
48832328|NCT04011722|157225090|FG001|1 Year|Death|5|||
48832329|NCT04011722|157225089|FG000|1 Year|Withdrawal by Subject|8|||
48832330|NCT04011722|157225090|FG001|1 Year|Withdrawal by Subject|2|||
48832331|NCT04011722|157225089|FG000|1 Year|Missed Visit|6|||
48832332|NCT04011722|157225090|FG001|1 Year|Missed Visit|1|||
48832333|NCT04011722|157225089|FG000|1 Year|Pending Visit|0|||
48832334|NCT04011722|157225090|FG001|1 Year|Pending Visit|11|||
48832335|NCT04011722|157225089|FG000|1 Year|Not Yet Due|0|||
48832336|NCT04011722|157225090|FG001|1 Year|Not Yet Due|9|||
48832337|NCT04011722|157225089|FG000|2 Year|Death|16|||
48832338|NCT04011722|157225090|FG001|2 Year|Death|1|||
48832339|NCT04011722|157225089|FG000|2 Year|Withdrawal by Subject|10|||
48832340|NCT04011722|157225090|FG001|2 Year|Withdrawal by Subject|1|||
48832341|NCT04011722|157225089|FG000|2 Year|Missed Visit|9|||
48832342|NCT04011722|157225090|FG001|2 Year|Missed Visit|0|||
48832343|NCT04011722|157225089|FG000|2 Year|Visit Pending|1|||
48832344|NCT04011722|157225090|FG001|2 Year|Visit Pending|3|||
48832345|NCT04011722|157225089|FG000|2 Year|Not Yet Due|43|||
48832346|NCT04011722|157225090|FG001|2 Year|Not Yet Due|54|||
48832347|NCT04011722|157225089|FG000|3 Year|Death|10|||
48832348|NCT04011722|157225090|FG001|3 Year|Death|0|||
48832349|NCT04011722|157225089|FG000|3 Year|Withdrawal by Subject|2|||
48832350|NCT04011722|157225090|FG001|3 Year|Withdrawal by Subject|0|||
48832351|NCT04011722|157225089|FG000|3 Year|Missed Visit|2|||
48529751|NCT04436276|156129093|FG017|Overall Study|Physician Decision|0|||
48529752|NCT04436276|156129094|FG018|Overall Study|Physician Decision|0|||
48529753|NCT04436276|156129095|FG019|Overall Study|Physician Decision|0|||
48832352|NCT04011722|157225090|FG001|3 Year|Missed Visit|0|||
48832353|NCT04011722|157225089|FG000|3 Year|Pending Visit|34|||
48832354|NCT04011722|157225090|FG001|3 Year|Pending Visit|0|||
48832355|NCT04011722|157225089|FG000|3 Year|Not Yet Due|99|||
48832356|NCT04011722|157225090|FG001|3 Year|Not Yet Due|0|||
48832357|NCT03220035|157225093|FG000|Overall Study|Adverse Event|1|||
48832358|NCT03220035|157225093|FG000|Overall Study|Protocol Violation|1|||
48832359|NCT03220035|157225093|FG000|Overall Study|Progressive Disease|2|||
48832360|NCT03523091|157225096|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
48832361|NCT03523091|157225097|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
48832362|NCT03523091|157225096|FG000|Overall Study|Withdrawal by Subject|0|||
48832363|NCT03523091|157225097|FG001|Overall Study|Withdrawal by Subject|3|||
48832364|NCT03523091|157225096|FG000|Overall Study|Increase Botox dose|0|||
48602623|NCT01081626|156399612|FG000|Overall Study|Other|33|||
48602624|NCT01081626|156399613|FG001|Overall Study|Other|30|||
48602625|NCT02003144|156399614|FG000|Open Label Maintenance Phase|Other than specified|2|||
48832365|NCT03523091|157225097|FG001|Overall Study|Increase Botox dose|1|||
48529754|NCT04436276|156129096|FG020|Overall Study|Physician Decision|1|||
48529755|NCT04436276|156129097|FG021|Overall Study|Physician Decision|2|||
48529756|NCT04436276|156129098|FG022|Overall Study|Physician Decision|0|||
48529757|NCT04436276|156129076|FG000|Overall Study|Protocol Violation|0|||
48529758|NCT04436276|156129077|FG001|Overall Study|Protocol Violation|0|||
48529759|NCT04436276|156129078|FG002|Overall Study|Protocol Violation|0|||
48529760|NCT04436276|156129079|FG003|Overall Study|Protocol Violation|0|||
48832366|NCT04340362|157225098|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
48832367|NCT02711826|157225099|FG000|Overall Study|Physician Decision|0|||
48529761|NCT04436276|156129080|FG004|Overall Study|Protocol Violation|0|||
48529762|NCT04436276|156129081|FG005|Overall Study|Protocol Violation|0|||
48529763|NCT04436276|156129082|FG006|Overall Study|Protocol Violation|0|||
48529764|NCT04436276|156129083|FG007|Overall Study|Protocol Violation|0|||
48529765|NCT04436276|156129084|FG008|Overall Study|Protocol Violation|0|||
48529766|NCT04436276|156129085|FG009|Overall Study|Protocol Violation|0|||
48529767|NCT04436276|156129086|FG010|Overall Study|Protocol Violation|0|||
48529768|NCT04436276|156129087|FG011|Overall Study|Protocol Violation|0|||
48529769|NCT04436276|156129088|FG012|Overall Study|Protocol Violation|0|||
48529770|NCT04436276|156129089|FG013|Overall Study|Protocol Violation|1|||
48529771|NCT04436276|156129090|FG014|Overall Study|Protocol Violation|0|||
48529772|NCT04436276|156129091|FG015|Overall Study|Protocol Violation|1|||
48529773|NCT04436276|156129092|FG016|Overall Study|Protocol Violation|0|||
48529774|NCT04436276|156129093|FG017|Overall Study|Protocol Violation|0|||
48529775|NCT04436276|156129094|FG018|Overall Study|Protocol Violation|0|||
48529776|NCT04436276|156129095|FG019|Overall Study|Protocol Violation|0|||
48832368|NCT02711826|157225100|FG001|Overall Study|Physician Decision|0|||
48832369|NCT02711826|157225101|FG002|Overall Study|Physician Decision|0|||
48832370|NCT02711826|157225102|FG003|Overall Study|Physician Decision|1|||
48832371|NCT02711826|157225103|FG004|Overall Study|Physician Decision|0|||
48832372|NCT02711826|157225099|FG000|Overall Study|Withdrawal by Subject|0|||
48832373|NCT02711826|157225100|FG001|Overall Study|Withdrawal by Subject|1|||
48832374|NCT02711826|157225101|FG002|Overall Study|Withdrawal by Subject|0|||
48832375|NCT02711826|157225102|FG003|Overall Study|Withdrawal by Subject|4|||
48832376|NCT02711826|157225103|FG004|Overall Study|Withdrawal by Subject|0|||
48832377|NCT02711826|157225099|FG000|Overall Study|Failure to manufacture cellular product|0|||
48832378|NCT02711826|157225100|FG001|Overall Study|Failure to manufacture cellular product|0|||
48832379|NCT02711826|157225101|FG002|Overall Study|Failure to manufacture cellular product|5|||
48832380|NCT02711826|157225102|FG003|Overall Study|Failure to manufacture cellular product|0|||
48832381|NCT02711826|157225103|FG004|Overall Study|Failure to manufacture cellular product|0|||
48832382|NCT02711826|157225099|FG000|Overall Study|Infusion canceled for active infection|0|||
48832383|NCT02711826|157225100|FG001|Overall Study|Infusion canceled for active infection|1|||
48832384|NCT02711826|157225101|FG002|Overall Study|Infusion canceled for active infection|0|||
48832385|NCT02711826|157225102|FG003|Overall Study|Infusion canceled for active infection|0|||
48832386|NCT02711826|157225103|FG004|Overall Study|Infusion canceled for active infection|0|||
48832387|NCT02711826|157225099|FG000|Overall Study|Screen failures|0|||
48832388|NCT02711826|157225100|FG001|Overall Study|Screen failures|0|||
48832389|NCT02711826|157225101|FG002|Overall Study|Screen failures|0|||
48832390|NCT02711826|157225102|FG003|Overall Study|Screen failures|4|||
48832391|NCT02711826|157225103|FG004|Overall Study|Screen failures|0|||
48832392|NCT03952559|157225104|FG000|Double Blind Treatment Period|Adverse Event|0|||
48832393|NCT03952559|157225105|FG001|Double Blind Treatment Period|Adverse Event|2|||
48832394|NCT03952559|157225106|FG002|Double Blind Treatment Period|Adverse Event|1|||
48832395|NCT03952559|157225107|FG003|Double Blind Treatment Period|Adverse Event|0|||
48832396|NCT03952559|157225108|FG004|Double Blind Treatment Period|Adverse Event|1|||
48832397|NCT03952559|157225104|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
48832398|NCT03952559|157225105|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
48832399|NCT03952559|157225106|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
48832400|NCT03952559|157225107|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
48832401|NCT03952559|157225108|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
48832402|NCT03952559|157225104|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
48832403|NCT03952559|157225105|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
48832404|NCT03952559|157225106|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
48529777|NCT04436276|156129096|FG020|Overall Study|Protocol Violation|0|||
48529778|NCT04436276|156129097|FG021|Overall Study|Protocol Violation|0|||
48529779|NCT04436276|156129098|FG022|Overall Study|Protocol Violation|0|||
48602626|NCT02003144|156399615|FG001|Open Label Maintenance Phase|Other than specified|4|||
48832405|NCT03952559|157225107|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
48832406|NCT03952559|157225108|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
48832407|NCT03952559|157225104|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
48832408|NCT03952559|157225105|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
48832409|NCT03952559|157225106|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
48832410|NCT03952559|157225107|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
48832411|NCT03952559|157225108|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
48832412|NCT02968004|157227550|FG000|Overall Study|Adverse Event|1|||
48832413|NCT02968004|157227551|FG001|Overall Study|Adverse Event|0|||
48832414|NCT02968004|157227550|FG000|Overall Study|Withdrawal by Subject|0|||
48832415|NCT02968004|157227551|FG001|Overall Study|Withdrawal by Subject|1|||
48832416|NCT01838200|157227554|FG000|Overall Study|Adverse Event|0|||
48832417|NCT01838200|157227555|FG001|Overall Study|Adverse Event|2|||
48832418|NCT01838200|157227554|FG000|Overall Study|Progressive disease|3|||
48832419|NCT01838200|157227555|FG001|Overall Study|Progressive disease|0|||
48832420|NCT00686517|157227560|FG000|Treatment|Serious Adverse Event|1|||
48832421|NCT00686517|157227561|FG001|Treatment|Serious Adverse Event|2|||
48832422|NCT00686517|157227562|FG002|Treatment|Serious Adverse Event|1|||
48832423|NCT00686517|157227560|FG000|Treatment|Adverse Event|2|||
48832424|NCT00686517|157227561|FG001|Treatment|Adverse Event|0|||
48832425|NCT00686517|157227562|FG002|Treatment|Adverse Event|0|||
48832426|NCT00686517|157227560|FG000|Treatment|Poor Protocol Compliance|1|||
48832427|NCT00686517|157227561|FG001|Treatment|Poor Protocol Compliance|0|||
48832428|NCT00686517|157227562|FG002|Treatment|Poor Protocol Compliance|0|||
48832429|NCT00686517|157227560|FG000|Treatment|Protocol Violation|2|||
48832430|NCT00686517|157227561|FG001|Treatment|Protocol Violation|1|||
48832431|NCT00686517|157227562|FG002|Treatment|Protocol Violation|0|||
48832432|NCT03710564|157227563|FG000|Overall Study|Study Terminated by Sponsor|104|||
48832433|NCT03710564|157227564|FG001|Overall Study|Study Terminated by Sponsor|55|||
48832434|NCT03710564|157227563|FG000|Overall Study|Withdrawal by Subject|57|||
48832435|NCT03710564|157227564|FG001|Overall Study|Withdrawal by Subject|25|||
48832436|NCT03710564|157227563|FG000|Overall Study|Death|10|||
48832437|NCT03710564|157227564|FG001|Overall Study|Death|4|||
48832438|NCT03710564|157227563|FG000|Overall Study|Lost to Follow-up|5|||
48832439|NCT03710564|157227564|FG001|Overall Study|Lost to Follow-up|4|||
48832440|NCT03710564|157227563|FG000|Overall Study|Protocol Violation|3|||
48832441|NCT03710564|157227564|FG001|Overall Study|Protocol Violation|2|||
48832442|NCT03710564|157227563|FG000|Overall Study|Adverse Event|3|||
48832443|NCT03710564|157227564|FG001|Overall Study|Adverse Event|0|||
48832444|NCT03710564|157227563|FG000|Overall Study|Physician Decision|2|||
48832445|NCT03710564|157227564|FG001|Overall Study|Physician Decision|3|||
48832446|NCT01908634|157227565|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
48832447|NCT01908634|157227565|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
48832448|NCT04176458|157227566|FG000|Overall Study|Covid 19|4|||
48832449|NCT01072357|157227567|FG000|Overall Study|Lost to Follow-up|0|||
48832450|NCT01072357|157227568|FG001|Overall Study|Lost to Follow-up|1|||
48832451|NCT01352507|157227573|FG000|Treatment Period 1|Adverse Event|3|||
48832452|NCT01352507|157227574|FG001|Treatment Period 1|Adverse Event|0|||
48832453|NCT01352507|157227573|FG000|Treatment Period 1|Lost to Follow-up|3|||
48832454|NCT01352507|157227574|FG001|Treatment Period 1|Lost to Follow-up|4|||
48832455|NCT01352507|157227573|FG000|Treatment Period 1|Withdrawal by Subject|7|||
48832456|NCT01352507|157227574|FG001|Treatment Period 1|Withdrawal by Subject|5|||
48832457|NCT01352507|157227573|FG000|Treatment Period 1|Physician Decision|1|||
48832458|NCT01352507|157227574|FG001|Treatment Period 1|Physician Decision|0|||
48832459|NCT01352507|157227573|FG000|Washout Period|Withdrawal by Subject|0|||
48832460|NCT01352507|157227574|FG001|Washout Period|Withdrawal by Subject|1|||
48832461|NCT01352507|157227573|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
48832462|NCT01352507|157227574|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
48832463|NCT01352507|157227573|FG000|Treatment Period 2|Withdrawal by Subject|4|||
48832464|NCT01352507|157227574|FG001|Treatment Period 2|Withdrawal by Subject|3|||
48832465|NCT01352507|157227573|FG000|Treatment Period 2|Lack of Efficacy|1|||
48832466|NCT01352507|157227574|FG001|Treatment Period 2|Lack of Efficacy|0|||
48832467|NCT02701361|157227575|FG000|Overall Study|Lost to Follow-up|5|||
48832468|NCT02701361|157227576|FG001|Overall Study|Lost to Follow-up|2|||
48832469|NCT02701361|157227577|FG002|Overall Study|Lost to Follow-up|1|||
48832470|NCT02701361|157227575|FG000|Overall Study|Withdrawal by Subject|4|||
48832471|NCT02701361|157227576|FG001|Overall Study|Withdrawal by Subject|0|||
48832472|NCT02701361|157227577|FG002|Overall Study|Withdrawal by Subject|0|||
48832473|NCT02701361|157227575|FG000|Overall Study|timed out in rehab center|0|||
48832474|NCT02701361|157227576|FG001|Overall Study|timed out in rehab center|1|||
48832475|NCT02701361|157227577|FG002|Overall Study|timed out in rehab center|0|||
48832476|NCT02701361|157227575|FG000|Overall Study|incarceration|0|||
48832477|NCT02701361|157227576|FG001|Overall Study|incarceration|0|||
48832478|NCT02701361|157227577|FG002|Overall Study|incarceration|1|||
48832479|NCT00975806|157227578|FG000|Overall Study|Adverse Event|2|||
48832480|NCT00975806|157227579|FG001|Overall Study|Adverse Event|1|||
48832481|NCT00975806|157227580|FG002|Overall Study|Adverse Event|2|||
48602627|NCT02003144|156399614|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
48832482|NCT00975806|157227578|FG000|Overall Study|Disease Progression|1|||
48832483|NCT00975806|157227579|FG001|Overall Study|Disease Progression|5|||
48832484|NCT00975806|157227580|FG002|Overall Study|Disease Progression|1|||
48832485|NCT00975806|157227578|FG000|Overall Study|Withdrawal by Subject|1|||
48832486|NCT00975806|157227579|FG001|Overall Study|Withdrawal by Subject|0|||
48832487|NCT00975806|157227580|FG002|Overall Study|Withdrawal by Subject|0|||
48832488|NCT00975806|157227578|FG000|Overall Study|Death|0|||
48832489|NCT00975806|157227579|FG001|Overall Study|Death|1|||
48832490|NCT00975806|157227580|FG002|Overall Study|Death|0|||
48832491|NCT00975806|157227578|FG000|Overall Study|Physician decision and disease related|1|||
48832492|NCT00975806|157227579|FG001|Overall Study|Physician decision and disease related|0|||
48832493|NCT00975806|157227580|FG002|Overall Study|Physician decision and disease related|1|||
48832494|NCT00290732|157227583|FG000|Overall Study|Inability to instill drug intraductally.|0|||
48832495|NCT00290732|157227584|FG001|Overall Study|Inability to instill drug intraductally.|1|||
48832496|NCT00290732|157227585|FG002|Overall Study|Inability to instill drug intraductally.|1|||
48832497|NCT00290732|157227586|FG003|Overall Study|Inability to instill drug intraductally.|0|||
48832498|NCT00290732|157227587|FG004|Overall Study|Inability to instill drug intraductally.|0|||
48832499|NCT00964366|157227588|FG000|Overall Study|Did not qualify at Day 1|1|||
48832500|NCT00964366|157227589|FG001|Overall Study|Did not qualify at Day 1|0|||
48832501|NCT00964366|157227588|FG000|Overall Study|Withdrawal by Subject|0|||
48832502|NCT00964366|157227589|FG001|Overall Study|Withdrawal by Subject|1|||
48832503|NCT02046616|157227591|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
48832504|NCT02046616|157227591|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
48832505|NCT02046616|157227591|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
48832506|NCT02046616|157227591|FG000|24-Week Treatment Period|Physician Decision|3|||
48832507|NCT02046616|157227591|FG000|24-Week Treatment Period|Other|1|||
48832508|NCT02046616|157227591|FG000|8-Week FU Period|Lost to Follow-up|1|||
48832509|NCT00344019|157227592|FG000|Overall Study|did not meet final inclusion criteria|0|||
48832510|NCT00344019|157227593|FG001|Overall Study|did not meet final inclusion criteria|0|||
48832511|NCT00344019|157227594|FG002|Overall Study|did not meet final inclusion criteria|74|||
48832512|NCT00843193|157227595|FG000|Overall Study|Adverse Event|2|||
48529780|NCT04436276|156129076|FG000|Overall Study|Withdrawal by Subject|25|||
48529781|NCT04436276|156129077|FG001|Overall Study|Withdrawal by Subject|22|||
48529782|NCT04436276|156129078|FG002|Overall Study|Withdrawal by Subject|24|||
48529783|NCT04436276|156129079|FG003|Overall Study|Withdrawal by Subject|23|||
48529784|NCT04436276|156129080|FG004|Overall Study|Withdrawal by Subject|14|||
48529785|NCT04436276|156129081|FG005|Overall Study|Withdrawal by Subject|0|||
48529786|NCT04436276|156129082|FG006|Overall Study|Withdrawal by Subject|0|||
48529787|NCT04436276|156129083|FG007|Overall Study|Withdrawal by Subject|1|||
48529788|NCT04436276|156129084|FG008|Overall Study|Withdrawal by Subject|0|||
48529789|NCT04436276|156129085|FG009|Overall Study|Withdrawal by Subject|1|||
48529790|NCT04436276|156129086|FG010|Overall Study|Withdrawal by Subject|17|||
48529791|NCT04436276|156129087|FG011|Overall Study|Withdrawal by Subject|7|||
48529792|NCT04436276|156129088|FG012|Overall Study|Withdrawal by Subject|10|||
48529793|NCT04436276|156129089|FG013|Overall Study|Withdrawal by Subject|6|||
48529794|NCT04436276|156129090|FG014|Overall Study|Withdrawal by Subject|20|||
48529795|NCT04436276|156129091|FG015|Overall Study|Withdrawal by Subject|6|||
48529796|NCT04436276|156129092|FG016|Overall Study|Withdrawal by Subject|11|||
48529797|NCT04436276|156129093|FG017|Overall Study|Withdrawal by Subject|4|||
48529798|NCT04436276|156129094|FG018|Overall Study|Withdrawal by Subject|14|||
48529799|NCT04436276|156129095|FG019|Overall Study|Withdrawal by Subject|24|||
48529800|NCT04436276|156129096|FG020|Overall Study|Withdrawal by Subject|24|||
48529801|NCT04436276|156129097|FG021|Overall Study|Withdrawal by Subject|16|||
48529802|NCT04436276|156129098|FG022|Overall Study|Withdrawal by Subject|14|||
48529803|NCT04436276|156129076|FG000|Overall Study|Other|3|||
48529804|NCT04436276|156129077|FG001|Overall Study|Other|2|||
48529805|NCT04436276|156129078|FG002|Overall Study|Other|5|||
48529806|NCT04436276|156129079|FG003|Overall Study|Other|9|||
48529807|NCT04436276|156129080|FG004|Overall Study|Other|23|||
48529808|NCT04436276|156129081|FG005|Overall Study|Other|1|||
48529809|NCT04436276|156129082|FG006|Overall Study|Other|0|||
48832513|NCT00843193|157227596|FG001|Overall Study|Adverse Event|4|||
48832514|NCT00843193|157227595|FG000|Overall Study|Lack of Efficacy|1|||
48832515|NCT00843193|157227596|FG001|Overall Study|Lack of Efficacy|1|||
48529810|NCT04436276|156129083|FG007|Overall Study|Other|0|||
48529811|NCT04436276|156129084|FG008|Overall Study|Other|0|||
48529812|NCT04436276|156129085|FG009|Overall Study|Other|0|||
48529813|NCT04436276|156129086|FG010|Overall Study|Other|3|||
48529814|NCT04436276|156129087|FG011|Overall Study|Other|1|||
48529815|NCT04436276|156129088|FG012|Overall Study|Other|1|||
48529816|NCT04436276|156129089|FG013|Overall Study|Other|2|||
48529817|NCT04436276|156129090|FG014|Overall Study|Other|3|||
48529818|NCT04436276|156129091|FG015|Overall Study|Other|0|||
48529819|NCT04436276|156129092|FG016|Overall Study|Other|0|||
48529820|NCT04436276|156129093|FG017|Overall Study|Other|6|||
48529821|NCT04436276|156129094|FG018|Overall Study|Other|1|||
48529822|NCT04436276|156129095|FG019|Overall Study|Other|0|||
48529823|NCT04436276|156129096|FG020|Overall Study|Other|2|||
48529824|NCT04436276|156129097|FG021|Overall Study|Other|2|||
48529825|NCT04436276|156129098|FG022|Overall Study|Other|60|||
48529826|NCT03150862|156129099|FG000|Overall Study|Death|2|||
48832516|NCT00843193|157227595|FG000|Overall Study|Protocol Violation|1|||
48832517|NCT00843193|157227596|FG001|Overall Study|Protocol Violation|2|||
48832518|NCT00843193|157227595|FG000|Overall Study|Lost to Follow-up|1|||
48832519|NCT00843193|157227596|FG001|Overall Study|Lost to Follow-up|0|||
48832520|NCT00843193|157227595|FG000|Overall Study|Physician Decision|0|||
48832521|NCT00843193|157227596|FG001|Overall Study|Physician Decision|1|||
48832522|NCT00843193|157227595|FG000|Overall Study|Withdrawal by Subject|3|||
48832523|NCT00843193|157227596|FG001|Overall Study|Withdrawal by Subject|3|||
48832524|NCT01648140|157227597|FG000|Overall Study|Physician Decision|1|||
48832525|NCT01648140|157227598|FG001|Overall Study|Physician Decision|0|||
48832526|NCT01648140|157227599|FG002|Overall Study|Physician Decision|0|||
48832527|NCT01648140|157227600|FG003|Overall Study|Physician Decision|0|||
48832528|NCT01648140|157227597|FG000|Overall Study|Lack of Efficacy|4|||
48832529|NCT01648140|157227598|FG001|Overall Study|Lack of Efficacy|7|||
48832530|NCT01648140|157227599|FG002|Overall Study|Lack of Efficacy|1|||
48832531|NCT01648140|157227600|FG003|Overall Study|Lack of Efficacy|0|||
48832532|NCT01648140|157227597|FG000|Overall Study|Adverse Event|3|||
48832533|NCT01648140|157227598|FG001|Overall Study|Adverse Event|1|||
48832534|NCT01648140|157227599|FG002|Overall Study|Adverse Event|2|||
48832535|NCT01648140|157227600|FG003|Overall Study|Adverse Event|0|||
48832536|NCT01648140|157227597|FG000|Overall Study|Withdrawal by Subject|2|||
48832537|NCT01648140|157227598|FG001|Overall Study|Withdrawal by Subject|3|||
48832538|NCT01648140|157227599|FG002|Overall Study|Withdrawal by Subject|3|||
48832539|NCT01648140|157227600|FG003|Overall Study|Withdrawal by Subject|2|||
48832540|NCT01648140|157227597|FG000|Overall Study|Lost to Follow-up|2|||
48832541|NCT01648140|157227598|FG001|Overall Study|Lost to Follow-up|1|||
48832542|NCT01648140|157227599|FG002|Overall Study|Lost to Follow-up|2|||
48832543|NCT01648140|157227600|FG003|Overall Study|Lost to Follow-up|0|||
48832544|NCT00880906|157227601|FG000|Overall Study|Lost to Follow-up|0|||
48832545|NCT00880906|157227602|FG001|Overall Study|Lost to Follow-up|1|||
48832546|NCT00880906|157227601|FG000|Overall Study|Did not meet criteria following patholog|12|||
48832547|NCT00880906|157227602|FG001|Overall Study|Did not meet criteria following patholog|6|||
48832548|NCT01119950|157227603|FG000|Overall Study|Adverse Event|25|||
48832549|NCT01119950|157227603|FG000|Overall Study|Withdrawal by Subject|9|||
48832550|NCT01119950|157227603|FG000|Overall Study|Protocol Violation|5|||
48832551|NCT01119950|157227603|FG000|Overall Study|Lost to Follow-up|4|||
48832552|NCT01119950|157227603|FG000|Overall Study|Administrative|2|||
48832553|NCT01119950|157227603|FG000|Overall Study|Abnormal lab value|1|||
48832554|NCT01119950|157227603|FG000|Overall Study|Death|1|||
48832555|NCT00906035|157227606|FG000|Overall Study|Withdrawal by Subject|2|||
48832556|NCT00906035|157227607|FG001|Overall Study|Withdrawal by Subject|3|||
48832557|NCT00906035|157227608|FG002|Overall Study|Withdrawal by Subject|0|||
48529827|NCT03150862|156129100|FG001|Overall Study|Death|7|||
48529828|NCT03150862|156129101|FG002|Overall Study|Death|8|||
48832558|NCT03621761|157227609|FG000|Overall Study|Lost to Follow-up|1|||
48832559|NCT03621761|157227610|FG001|Overall Study|Lost to Follow-up|1|||
48832560|NCT03621761|157227611|FG002|Overall Study|Lost to Follow-up|2|||
48529829|NCT03150862|156129102|FG003|Overall Study|Death|27|||
48529830|NCT03150862|156129103|FG004|Overall Study|Death|4|||
48529831|NCT03150862|156129104|FG005|Overall Study|Death|8|||
48832561|NCT03621761|157227609|FG000|Overall Study|Withdrawal by Subject|2|||
48832562|NCT03621761|157227610|FG001|Overall Study|Withdrawal by Subject|1|||
48832563|NCT03621761|157227611|FG002|Overall Study|Withdrawal by Subject|1|||
48832564|NCT03621761|157227609|FG000|Overall Study|Became Ineligible|0|||
48832565|NCT03621761|157227610|FG001|Overall Study|Became Ineligible|2|||
48832566|NCT03621761|157227611|FG002|Overall Study|Became Ineligible|0|||
48832567|NCT02107014|157227614|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
48832568|NCT00591838|157227615|FG000|Overall Study|Withdrawal by Subject|0|||
48832569|NCT00591838|157227616|FG001|Overall Study|Withdrawal by Subject|0|||
48832570|NCT00591838|157227617|FG002|Overall Study|Withdrawal by Subject|0|||
48832571|NCT00591838|157227618|FG003|Overall Study|Withdrawal by Subject|1|||
48832572|NCT00591838|157227619|FG004|Overall Study|Withdrawal by Subject|0|||
48832573|NCT01591616|157227620|FG000|Overall Study|Withdrawal by Subject|1|||
48832574|NCT01909336|157227624|FG000|Overall Study|Lost to Follow-up|4|||
48832575|NCT01909336|157227625|FG001|Overall Study|Lost to Follow-up|2|||
48832576|NCT01909336|157227626|FG002|Overall Study|Lost to Follow-up|2|||
48832577|NCT01909336|157227624|FG000|Overall Study|Physician Decision|0|||
48832578|NCT01909336|157227625|FG001|Overall Study|Physician Decision|1|||
48832579|NCT01909336|157227626|FG002|Overall Study|Physician Decision|1|||
48832580|NCT00619645|157227627|FG000|Overall Study|Adverse Event|1|||
48832581|NCT04364269|157227628|FG000|Overall Study|Adverse Event|1|||
48832582|NCT04364269|157227629|FG001|Overall Study|Adverse Event|0|||
48832583|NCT04364269|157227630|FG002|Overall Study|Adverse Event|0|||
48832584|NCT04364269|157227628|FG000|Overall Study|Withdrawal by Subject|0|||
48832585|NCT04364269|157227629|FG001|Overall Study|Withdrawal by Subject|1|||
48832586|NCT04364269|157227630|FG002|Overall Study|Withdrawal by Subject|0|||
48832587|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
48832588|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
48832589|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
48832590|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
48832591|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
48832592|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
48832593|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
48832594|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
48832595|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
48832596|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
48832597|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
48832598|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
48529832|NCT03150862|156129105|FG006|Overall Study|Death|6|||
48832599|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
48832600|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
48602628|NCT02003144|156399615|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
48602629|NCT02003144|156399614|FG000|Open Label Maintenance Phase|Pregnancy|0|||
48602630|NCT02003144|156399615|FG001|Open Label Maintenance Phase|Pregnancy|2|||
48602631|NCT02003144|156399614|FG000|Open Label Maintenance Phase|Physician Decision|1|||
48602632|NCT02003144|156399615|FG001|Open Label Maintenance Phase|Physician Decision|1|||
48602633|NCT02003144|156399614|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
48602634|NCT02003144|156399615|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
48602635|NCT02003144|156399614|FG000|Open Label Maintenance Phase|Adverse Event|2|||
48529833|NCT03150862|156129106|FG007|Overall Study|Death|21|||
48529834|NCT03150862|156129099|FG000|Overall Study|Withdrawal by Subject|1|||
48529835|NCT03150862|156129100|FG001|Overall Study|Withdrawal by Subject|1|||
48529836|NCT03150862|156129101|FG002|Overall Study|Withdrawal by Subject|0|||
48529837|NCT03150862|156129102|FG003|Overall Study|Withdrawal by Subject|3|||
48529838|NCT03150862|156129103|FG004|Overall Study|Withdrawal by Subject|1|||
48529839|NCT03150862|156129104|FG005|Overall Study|Withdrawal by Subject|1|||
48529840|NCT03150862|156129105|FG006|Overall Study|Withdrawal by Subject|1|||
48529841|NCT03150862|156129106|FG007|Overall Study|Withdrawal by Subject|3|||
48529842|NCT03150862|156129099|FG000|Overall Study|Lost to Follow-up|0|||
48529843|NCT03150862|156129100|FG001|Overall Study|Lost to Follow-up|0|||
48529844|NCT03150862|156129101|FG002|Overall Study|Lost to Follow-up|1|||
48529845|NCT03150862|156129102|FG003|Overall Study|Lost to Follow-up|0|||
48529846|NCT03150862|156129103|FG004|Overall Study|Lost to Follow-up|0|||
48529847|NCT03150862|156129104|FG005|Overall Study|Lost to Follow-up|0|||
48529848|NCT03150862|156129105|FG006|Overall Study|Lost to Follow-up|0|||
48529849|NCT03150862|156129106|FG007|Overall Study|Lost to Follow-up|2|||
48529850|NCT03150862|156129099|FG000|Overall Study|Sponsor's decision|0|||
48529851|NCT03150862|156129100|FG001|Overall Study|Sponsor's decision|0|||
48529852|NCT03150862|156129101|FG002|Overall Study|Sponsor's decision|0|||
48529853|NCT03150862|156129102|FG003|Overall Study|Sponsor's decision|10|||
48529854|NCT03150862|156129103|FG004|Overall Study|Sponsor's decision|3|||
48529855|NCT03150862|156129104|FG005|Overall Study|Sponsor's decision|0|||
48529856|NCT03150862|156129105|FG006|Overall Study|Sponsor's decision|1|||
48529857|NCT03150862|156129106|FG007|Overall Study|Sponsor's decision|1|||
48529858|NCT03150862|156129099|FG000|Overall Study|Change in Methylation status|0|||
48602636|NCT02003144|156399615|FG001|Open Label Maintenance Phase|Adverse Event|1|||
48602637|NCT01814007|156399617|FG000|Overall Study|Withdrawal by Subject|1|||
48602638|NCT01919164|156401506|FG000|Overall Study|Adverse Event|6|||
48602639|NCT01919164|156401507|FG001|Overall Study|Adverse Event|4|||
48832601|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
48832602|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
48832603|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
48832604|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832605|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832606|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832607|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832608|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
48832609|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
48832610|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
48832611|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
48832612|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
48832613|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
48832614|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
48832615|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
48832616|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
48832617|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
48832618|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
48832619|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
48832620|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832621|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
48832622|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
48832623|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
48832624|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832625|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832626|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48529859|NCT03150862|156129100|FG001|Overall Study|Change in Methylation status|0|||
48529860|NCT03150862|156129101|FG002|Overall Study|Change in Methylation status|0|||
48529861|NCT03150862|156129102|FG003|Overall Study|Change in Methylation status|0|||
48529862|NCT03150862|156129103|FG004|Overall Study|Change in Methylation status|1|||
48529863|NCT03150862|156129104|FG005|Overall Study|Change in Methylation status|0|||
48602640|NCT01919164|156401508|FG002|Overall Study|Adverse Event|9|||
48529864|NCT03150862|156129105|FG006|Overall Study|Change in Methylation status|0|||
48529865|NCT03150862|156129106|FG007|Overall Study|Change in Methylation status|0|||
48602641|NCT01919164|156401509|FG003|Overall Study|Adverse Event|3|||
48832627|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832628|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832629|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832630|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
48832631|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832632|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832633|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832634|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832635|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
48832636|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832637|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48529866|NCT03150862|156129099|FG000|Overall Study|Roll over in to Long Term Extension|0|||
48529867|NCT03150862|156129100|FG001|Overall Study|Roll over in to Long Term Extension|0|||
48529868|NCT03150862|156129101|FG002|Overall Study|Roll over in to Long Term Extension|0|||
48529869|NCT03150862|156129102|FG003|Overall Study|Roll over in to Long Term Extension|0|||
48529870|NCT03150862|156129103|FG004|Overall Study|Roll over in to Long Term Extension|0|||
48529871|NCT03150862|156129104|FG005|Overall Study|Roll over in to Long Term Extension|0|||
48529872|NCT03150862|156129105|FG006|Overall Study|Roll over in to Long Term Extension|0|||
48602642|NCT01919164|156401510|FG004|Overall Study|Adverse Event|2|||
48602643|NCT01919164|156401506|FG000|Overall Study|Lost to Follow-up|2|||
48529873|NCT03150862|156129106|FG007|Overall Study|Roll over in to Long Term Extension|1|||
48529874|NCT03150862|156129099|FG000|Overall Study|Progressive Disease|0|||
48529875|NCT03150862|156129100|FG001|Overall Study|Progressive Disease|0|||
48529876|NCT03150862|156129101|FG002|Overall Study|Progressive Disease|0|||
48529877|NCT03150862|156129102|FG003|Overall Study|Progressive Disease|0|||
48529878|NCT03150862|156129103|FG004|Overall Study|Progressive Disease|0|||
48529879|NCT03150862|156129104|FG005|Overall Study|Progressive Disease|0|||
48529880|NCT03150862|156129105|FG006|Overall Study|Progressive Disease|0|||
48602644|NCT01919164|156401507|FG001|Overall Study|Lost to Follow-up|2|||
48832638|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48529881|NCT03150862|156129106|FG007|Overall Study|Progressive Disease|2|||
48529882|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
48529883|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
48529884|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
48529885|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
48529886|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
48529887|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
48529888|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
48529889|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
48529890|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
48529891|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
48529892|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
48529893|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
48529894|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
48529895|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
48529896|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
48602645|NCT01919164|156401508|FG002|Overall Study|Lost to Follow-up|2|||
48832639|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832640|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832641|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
48832642|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
48832643|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832644|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832645|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48602646|NCT01919164|156401509|FG003|Overall Study|Lost to Follow-up|0|||
48602647|NCT01919164|156401510|FG004|Overall Study|Lost to Follow-up|4|||
48602648|NCT01919164|156401506|FG000|Overall Study|Death|1|||
48602649|NCT01919164|156401507|FG001|Overall Study|Death|0|||
48602650|NCT01919164|156401508|FG002|Overall Study|Death|0|||
48602651|NCT01919164|156401509|FG003|Overall Study|Death|0|||
48602652|NCT01919164|156401510|FG004|Overall Study|Death|0|||
48832646|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832647|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48529897|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
48602653|NCT01919164|156401506|FG000|Overall Study|Protocol Violation|6|||
48602654|NCT01919164|156401507|FG001|Overall Study|Protocol Violation|0|||
48602655|NCT01919164|156401508|FG002|Overall Study|Protocol Violation|3|||
48602656|NCT01919164|156401509|FG003|Overall Study|Protocol Violation|2|||
48602657|NCT01919164|156401510|FG004|Overall Study|Protocol Violation|2|||
48602658|NCT01919164|156401506|FG000|Overall Study|Disease progression|2|||
48602659|NCT01919164|156401507|FG001|Overall Study|Disease progression|2|||
48602660|NCT01919164|156401508|FG002|Overall Study|Disease progression|1|||
48602661|NCT01919164|156401509|FG003|Overall Study|Disease progression|2|||
48602662|NCT01919164|156401510|FG004|Overall Study|Disease progression|1|||
48529898|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
48529899|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
48529900|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
48529901|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
48529902|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
48529903|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
48529904|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
48529905|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
48529906|NCT01715285|156129110|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
48529907|NCT01715285|156129111|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
48529908|NCT01715285|156129112|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
48529909|NCT01715285|156129110|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
48529910|NCT01715285|156129111|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
48529911|NCT01715285|156129112|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
48529912|NCT01715285|156129110|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
48529913|NCT01715285|156129111|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
48529914|NCT01715285|156129112|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
48529915|NCT01715285|156129110|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
48529916|NCT01715285|156129111|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
48529917|NCT01715285|156129112|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
48529918|NCT01715285|156129110|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
48602663|NCT01919164|156401506|FG000|Overall Study|Withdrew consent|13|||
48832648|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832649|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832650|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832651|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832652|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
48832653|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
48832654|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
48832655|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
48832656|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
48832657|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
48832658|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
48832659|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
48832660|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
48529919|NCT01715285|156129111|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
48832661|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
48832662|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
48832663|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
48832664|NCT02914522|157227633|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832665|NCT02914522|157227634|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
48832666|NCT02914522|157227635|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832667|NCT02914522|157227636|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832668|NCT02914522|157227637|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
48832669|NCT02914522|157227638|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
48832670|NCT02914522|157227639|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832671|NCT02914522|157227640|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832672|NCT02914522|157227641|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832673|NCT02914522|157227642|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832674|NCT02914522|157227643|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
48832675|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832676|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832677|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832678|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832679|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48832680|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
48602664|NCT01919164|156401507|FG001|Overall Study|Withdrew consent|13|||
48832681|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
48832682|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
48832683|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
48832684|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
48832685|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
48832686|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832687|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832688|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832689|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832690|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832691|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
48832692|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
48832693|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
48832694|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
48832695|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
48832696|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
48832697|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832698|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832699|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832700|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832701|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832702|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832703|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
48832704|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
48832705|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
48832706|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
48832707|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
48832708|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832709|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832710|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832711|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832712|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832713|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
48832714|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
48832715|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
48832716|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
48832717|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
48832718|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
48832719|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
48832720|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
48832721|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
48832722|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
48832723|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
48529920|NCT01715285|156129112|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
48529921|NCT01715285|156129110|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
48529922|NCT01715285|156129111|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
48529923|NCT01715285|156129112|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
48529924|NCT02675751|156129113|FG000|Overall Study|Lost to Follow-up|16|||
48529925|NCT03656510|156129117|FG000|Overall Study|Lost to Follow-up|1|||
48529926|NCT03656510|156129118|FG001|Overall Study|Lost to Follow-up|0|||
48529927|NCT03656510|156129119|FG002|Overall Study|Lost to Follow-up|0|||
48529928|NCT03656510|156129120|FG003|Overall Study|Lost to Follow-up|0|||
48529929|NCT03656510|156129121|FG004|Overall Study|Lost to Follow-up|0|||
48529930|NCT03656510|156129122|FG005|Overall Study|Lost to Follow-up|0|||
48529931|NCT03656510|156129117|FG000|Overall Study|Withdrawal by Subject|1|||
48529932|NCT03656510|156129118|FG001|Overall Study|Withdrawal by Subject|1|||
48529933|NCT03656510|156129119|FG002|Overall Study|Withdrawal by Subject|0|||
48529934|NCT03656510|156129120|FG003|Overall Study|Withdrawal by Subject|1|||
48529935|NCT03656510|156129121|FG004|Overall Study|Withdrawal by Subject|0|||
48529936|NCT03656510|156129122|FG005|Overall Study|Withdrawal by Subject|0|||
48529937|NCT00693225|156129123|FG000|Overall Study|Lost to Follow-up|1|||
48529938|NCT00693225|156129124|FG001|Overall Study|Lost to Follow-up|2|||
48529939|NCT00693225|156129123|FG000|Overall Study|Adverse Event|1|||
48529940|NCT00693225|156129124|FG001|Overall Study|Adverse Event|3|||
48529941|NCT02418455|156129125|FG000|48-Week Treatment Period|Other- Not Specified|1|||
48529942|NCT02418455|156129125|FG000|Continuation Period|Sponsor Decision|7|||
48832724|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
48832725|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
48832726|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
48832727|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
48832728|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
48832729|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
48832730|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832731|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832732|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832733|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832734|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832735|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832736|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832737|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
48832738|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
48832739|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832740|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
48832741|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832742|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832743|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832744|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832745|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48529943|NCT04599634|156129126|FG000|Overall Study|Dose limiting toxicity|0|||
48529944|NCT04599634|156129127|FG001|Overall Study|Dose limiting toxicity|0|||
48529945|NCT04599634|156129128|FG002|Overall Study|Dose limiting toxicity|2|||
48529946|NCT04599634|156129129|FG003|Overall Study|Dose limiting toxicity|0|||
48529951|NCT03451006|156129131|FG000|Overall Study|Withdrawal by Subject|2|||
48529952|NCT03451006|156129132|FG001|Overall Study|Withdrawal by Subject|2|||
48529953|NCT03990883|156129133|FG000|Blinded Treatment Phase|Adverse Event|1|||
48529954|NCT03990883|156129134|FG001|Blinded Treatment Phase|Adverse Event|1|||
48529955|NCT03990883|156129135|FG002|Blinded Treatment Phase|Adverse Event|0|||
48529956|NCT03990883|156129133|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
48529957|NCT03990883|156129134|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
48832746|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832747|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48529958|NCT03990883|156129135|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
48529959|NCT03990883|156129133|FG000|Blinded Treatment Phase|Physician Decision|1|||
48529960|NCT03990883|156129134|FG001|Blinded Treatment Phase|Physician Decision|0|||
48529961|NCT03990883|156129135|FG002|Blinded Treatment Phase|Physician Decision|0|||
48529962|NCT03990883|156129133|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
48529963|NCT03990883|156129134|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
48529964|NCT03990883|156129135|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
48529965|NCT03990883|156129133|FG000|Blinded Treatment Phase|COVID-19|3|||
48529966|NCT03990883|156129134|FG001|Blinded Treatment Phase|COVID-19|2|||
48529967|NCT03990883|156129135|FG002|Blinded Treatment Phase|COVID-19|0|||
48529968|NCT03990883|156129133|FG000|Blinded Treatment Phase|Personal Reasons|6|||
48529969|NCT03990883|156129134|FG001|Blinded Treatment Phase|Personal Reasons|3|||
48529970|NCT03990883|156129135|FG002|Blinded Treatment Phase|Personal Reasons|0|||
48529971|NCT03990883|156129133|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
48529972|NCT03990883|156129134|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
48529973|NCT03990883|156129135|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
48529974|NCT03990883|156129133|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
48529975|NCT03990883|156129134|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
48529976|NCT03990883|156129135|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
48529977|NCT03990883|156129133|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
48529978|NCT03990883|156129134|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
48529979|NCT03990883|156129135|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
48529980|NCT01315028|156129136|FG000|Overall Study|Lost to Follow-up|1|||
48529981|NCT01315028|156129137|FG001|Overall Study|Lost to Follow-up|0|||
48529982|NCT01315028|156129136|FG000|Overall Study|Death|0|||
48529983|NCT01315028|156129137|FG001|Overall Study|Death|1|||
48529984|NCT00194792|156129138|FG000|Overall Study|Withdrawal by Subject|1|||
48529985|NCT00493454|156129143|FG000|Overall Study|Withdrawal by Subject|1|||
48529986|NCT03877926|156129144|FG000|Overall Study|Adverse Event|1|||
48832748|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48529987|NCT03877926|156129145|FG001|Overall Study|Adverse Event|0|||
48529988|NCT03877926|156129146|FG002|Overall Study|Adverse Event|0|||
48832749|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
48832750|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
48832751|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
48832752|NCT02914522|157227633|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832753|NCT02914522|157227634|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832754|NCT02914522|157227635|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832755|NCT02914522|157227636|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832756|NCT02914522|157227637|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832757|NCT02914522|157227638|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832758|NCT02914522|157227639|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832759|NCT02914522|157227640|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832760|NCT02914522|157227641|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832761|NCT02914522|157227642|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
48832762|NCT02914522|157227643|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
48832763|NCT02537522|157227644|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
48832764|NCT02537522|157227645|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
48832765|NCT02537522|157227646|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
48832766|NCT02537522|157227647|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
48832767|NCT02537522|157227644|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
48832768|NCT02537522|157227645|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
48832769|NCT02537522|157227646|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
48832770|NCT02537522|157227647|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
48832771|NCT02537522|157227644|FG000|Phase I - Contralateral|incorrect randomization|0|||
48832772|NCT02537522|157227645|FG001|Phase I - Contralateral|incorrect randomization|1|||
48832773|NCT02537522|157227646|FG002|Phase I - Contralateral|incorrect randomization|0|||
48832774|NCT02537522|157227647|FG003|Phase I - Contralateral|incorrect randomization|0|||
48832775|NCT02537522|157227644|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
48832776|NCT02537522|157227645|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
48832777|NCT02537522|157227646|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
48832778|NCT02537522|157227647|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
48832779|NCT02537522|157227644|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
48832780|NCT02537522|157227645|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
48832781|NCT02537522|157227646|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
48832782|NCT02537522|157227647|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
48832783|NCT01726023|157227654|FG000|Overall Study|Death|1|||
48832784|NCT01726023|157227655|FG001|Overall Study|Death|1|||
48832785|NCT01726023|157227654|FG000|Overall Study|Lost to Follow-up|5|||
48832786|NCT01726023|157227655|FG001|Overall Study|Lost to Follow-up|10|||
48832787|NCT01726023|157227654|FG000|Overall Study|Other Eligibility criteria|7|||
48832788|NCT01726023|157227655|FG001|Overall Study|Other Eligibility criteria|7|||
48832789|NCT01726023|157227654|FG000|Overall Study|Withdrawal by Subject|16|||
48832790|NCT01726023|157227655|FG001|Overall Study|Withdrawal by Subject|8|||
48832791|NCT04770402|157227662|FG000|Overall Study|Lost to Follow-up|1|||
48832792|NCT04770402|157227663|FG001|Overall Study|Lost to Follow-up|2|||
48832793|NCT04770402|157227662|FG000|Overall Study|Non-compliance|1|||
48832794|NCT04770402|157227663|FG001|Overall Study|Non-compliance|0|||
48832795|NCT04770402|157227662|FG000|Overall Study|Withdrawal by Subject|0|||
48832796|NCT04770402|157227663|FG001|Overall Study|Withdrawal by Subject|1|||
48832797|NCT04811040|157227664|FG000|Overall Study|Lost to Follow-up|2|||
48832798|NCT04811040|157227665|FG001|Overall Study|Lost to Follow-up|0|||
48832799|NCT04811040|157227666|FG002|Overall Study|Lost to Follow-up|0|||
48832800|NCT04811040|157227667|FG003|Overall Study|Lost to Follow-up|0|||
48832801|NCT04811040|157227664|FG000|Overall Study|Withdrew consent|1|||
48832802|NCT04811040|157227665|FG001|Overall Study|Withdrew consent|1|||
48832803|NCT04811040|157227666|FG002|Overall Study|Withdrew consent|0|||
48832804|NCT04811040|157227667|FG003|Overall Study|Withdrew consent|0|||
48832805|NCT03612804|157227668|FG000|Overall Study|Death|0|||
48832806|NCT03612804|157227669|FG001|Overall Study|Death|7|||
48832807|NCT03612804|157227670|FG002|Overall Study|Death|0|||
48832808|NCT03612804|157227671|FG003|Overall Study|Death|8|||
48832809|NCT03612804|157227668|FG000|Overall Study|Medication copay coverage issues|0|||
48832810|NCT03612804|157227669|FG001|Overall Study|Medication copay coverage issues|0|||
48832811|NCT03612804|157227670|FG002|Overall Study|Medication copay coverage issues|0|||
48832812|NCT03612804|157227671|FG003|Overall Study|Medication copay coverage issues|17|||
48832813|NCT03612804|157227668|FG000|Overall Study|Not current smoker at time of screening|0|||
48832814|NCT03612804|157227669|FG001|Overall Study|Not current smoker at time of screening|1|||
48832815|NCT03612804|157227670|FG002|Overall Study|Not current smoker at time of screening|0|||
48832816|NCT03612804|157227671|FG003|Overall Study|Not current smoker at time of screening|3|||
48832817|NCT03612804|157227668|FG000|Overall Study|Non-veteran status|0|||
48832818|NCT03612804|157227669|FG001|Overall Study|Non-veteran status|1|||
48832819|NCT03612804|157227670|FG002|Overall Study|Non-veteran status|0|||
48529989|NCT03877926|156129147|FG003|Overall Study|Adverse Event|0|||
48529990|NCT03877926|156129144|FG000|Overall Study|Death|2|||
48529991|NCT03877926|156129145|FG001|Overall Study|Death|2|||
48529992|NCT03877926|156129146|FG002|Overall Study|Death|2|||
48529993|NCT03877926|156129147|FG003|Overall Study|Death|0|||
48529994|NCT03877926|156129144|FG000|Overall Study|Lost to Follow-up|41|||
48529995|NCT03877926|156129145|FG001|Overall Study|Lost to Follow-up|52|||
48529996|NCT03877926|156129146|FG002|Overall Study|Lost to Follow-up|45|||
48529997|NCT03877926|156129147|FG003|Overall Study|Lost to Follow-up|17|||
48529998|NCT03877926|156129144|FG000|Overall Study|Physician Decision|2|||
48529999|NCT03877926|156129145|FG001|Overall Study|Physician Decision|0|||
48530000|NCT03877926|156129146|FG002|Overall Study|Physician Decision|2|||
48530001|NCT03877926|156129147|FG003|Overall Study|Physician Decision|0|||
48530002|NCT03877926|156129144|FG000|Overall Study|Withdrawal by Subject|18|||
48832820|NCT03612804|157227671|FG003|Overall Study|Non-veteran status|0|||
48832821|NCT03612804|157227668|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
48832822|NCT03612804|157227669|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
48530003|NCT03877926|156129145|FG001|Overall Study|Withdrawal by Subject|21|||
48530004|NCT03877926|156129146|FG002|Overall Study|Withdrawal by Subject|12|||
48530005|NCT03877926|156129147|FG003|Overall Study|Withdrawal by Subject|4|||
48530006|NCT03877926|156129144|FG000|Overall Study|Other - Various|4|||
48530007|NCT03877926|156129145|FG001|Overall Study|Other - Various|1|||
48530008|NCT03877926|156129146|FG002|Overall Study|Other - Various|1|||
48530009|NCT03877926|156129147|FG003|Overall Study|Other - Various|0|||
48530010|NCT03877926|156129144|FG000|Overall Study|Not Treated|3|||
48530011|NCT03877926|156129145|FG001|Overall Study|Not Treated|1|||
48530012|NCT03877926|156129146|FG002|Overall Study|Not Treated|1|||
48530013|NCT03877926|156129147|FG003|Overall Study|Not Treated|0|||
48530014|NCT00588731|156129148|FG000|Overall Study|Withdrawal by Subject|3|||
48530015|NCT00588731|156129149|FG001|Overall Study|Withdrawal by Subject|2|||
48832823|NCT03612804|157227670|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
48832824|NCT03612804|157227671|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
48832825|NCT03612804|157227668|FG000|Overall Study|Provider retired from VA|0|||
48832826|NCT03612804|157227669|FG001|Overall Study|Provider retired from VA|0|||
48832827|NCT03612804|157227670|FG002|Overall Study|Provider retired from VA|2|||
48832828|NCT03612804|157227671|FG003|Overall Study|Provider retired from VA|0|||
48832829|NCT03612804|157227668|FG000|Overall Study|Withdrawal by Subject|0|||
48832830|NCT03612804|157227669|FG001|Overall Study|Withdrawal by Subject|0|||
48832831|NCT03612804|157227670|FG002|Overall Study|Withdrawal by Subject|7|||
48832832|NCT03612804|157227671|FG003|Overall Study|Withdrawal by Subject|0|||
48832833|NCT03612804|157227668|FG000|Overall Study|Provider involved with study activities|1|||
48832834|NCT03612804|157227669|FG001|Overall Study|Provider involved with study activities|0|||
48832835|NCT03612804|157227670|FG002|Overall Study|Provider involved with study activities|0|||
48832836|NCT03612804|157227671|FG003|Overall Study|Provider involved with study activities|0|||
48530016|NCT01118117|156129150|FG000|Overall Study|Death|8|||
48530017|NCT01118117|156129151|FG001|Overall Study|Death|0|||
48530018|NCT01118117|156129150|FG000|Overall Study|Lost to Follow-up|6|||
48530019|NCT01118117|156129151|FG001|Overall Study|Lost to Follow-up|0|||
48832837|NCT00256243|157227679|FG000|Overall Study|Lost to Follow-up|2|||
48530020|NCT01118117|156129150|FG000|Overall Study|Missed 12 Month Visit|7|||
48530021|NCT01118117|156129151|FG001|Overall Study|Missed 12 Month Visit|0|||
48530022|NCT00537199|156129154|FG000|Overall Study|Study Terminated|1|||
48530023|NCT02905331|156129155|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
48530024|NCT02905331|156129156|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
48602665|NCT01919164|156401508|FG002|Overall Study|Withdrew consent|14|||
48602666|NCT01919164|156401509|FG003|Overall Study|Withdrew consent|14|||
48602667|NCT01919164|156401510|FG004|Overall Study|Withdrew consent|9|||
48602668|NCT01919164|156401506|FG000|Overall Study|Other Un-specified|13|||
48602669|NCT01919164|156401507|FG001|Overall Study|Other Un-specified|9|||
48602670|NCT01919164|156401508|FG002|Overall Study|Other Un-specified|8|||
48602671|NCT01919164|156401509|FG003|Overall Study|Other Un-specified|7|||
48602672|NCT01919164|156401510|FG004|Overall Study|Other Un-specified|15|||
48602673|NCT03638128|156401517|FG000|Overall Study|Withdrawal by Subject|1|||
48602674|NCT03638128|156401518|FG001|Overall Study|Withdrawal by Subject|7|||
48602675|NCT03638128|156401519|FG002|Overall Study|Withdrawal by Subject|6|||
48602676|NCT03638128|156401517|FG000|Overall Study|Sponsor Decision|15|||
48602677|NCT03638128|156401518|FG001|Overall Study|Sponsor Decision|12|||
48602678|NCT03638128|156401519|FG002|Overall Study|Sponsor Decision|19|||
48602679|NCT03638128|156401517|FG000|Overall Study|Lost to Follow-up|0|||
48602680|NCT03638128|156401518|FG001|Overall Study|Lost to Follow-up|0|||
48602681|NCT03638128|156401519|FG002|Overall Study|Lost to Follow-up|1|||
48602682|NCT01228591|156401521|FG000|Baseline|Lack of Efficacy|1|||
48602683|NCT01228591|156401522|FG001|Baseline|Lack of Efficacy|2|||
48602684|NCT04980014|156401523|FG000|Overall Study|Participants who are Duplicated|1|||
48602685|NCT04980014|156401523|FG000|Overall Study|Follow-up Failure|13|||
48602686|NCT04980014|156401523|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
48602687|NCT04980014|156401523|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
48602688|NCT04980014|156401523|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
48602689|NCT03569098|156401524|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
48602690|NCT03569098|156401525|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
48602691|NCT03569098|156401526|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
48602692|NCT03569098|156401524|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
48602693|NCT03569098|156401525|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
48602694|NCT03569098|156401526|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
48602695|NCT03569098|156401524|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
48602696|NCT03569098|156401525|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
48602697|NCT03569098|156401526|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
48602698|NCT03569098|156401524|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
48832838|NCT00256243|157227679|FG000|Overall Study|Death|7|||
48530025|NCT02905331|156129157|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
48530026|NCT02905331|156129155|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
48530027|NCT02905331|156129156|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
48530028|NCT02905331|156129157|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
48530029|NCT02905331|156129155|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
48530030|NCT02905331|156129156|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
48530031|NCT02905331|156129157|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
48530032|NCT02905331|156129155|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
48530033|NCT02905331|156129156|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
48530034|NCT02905331|156129157|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
48530035|NCT02905331|156129155|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
48530036|NCT02905331|156129156|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
48530037|NCT02905331|156129157|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
48530038|NCT01675492|156129158|FG000|Overall Study|study completed early - product approval|42|||
48530039|NCT01371981|156129159|FG000|Overall Study|Adverse Event|12|||
48530040|NCT01371981|156129160|FG001|Overall Study|Adverse Event|17|||
48530041|NCT01371981|156129161|FG002|Overall Study|Adverse Event|0|||
48530042|NCT01371981|156129162|FG003|Overall Study|Adverse Event|4|||
48602699|NCT03569098|156401525|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
48602700|NCT03569098|156401526|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
48602701|NCT03569098|156401524|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
48602702|NCT03569098|156401525|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
48602703|NCT03569098|156401526|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
48832839|NCT00256243|157227679|FG000|Overall Study|Not treated|1|||
48530043|NCT01371981|156129163|FG004|Overall Study|Adverse Event|1|||
48530044|NCT01371981|156129164|FG005|Overall Study|Adverse Event|0|||
48530045|NCT01371981|156129159|FG000|Overall Study|Death|22|||
48530046|NCT01371981|156129160|FG001|Overall Study|Death|16|||
48530047|NCT01371981|156129161|FG002|Overall Study|Death|0|||
48530048|NCT01371981|156129162|FG003|Overall Study|Death|0|||
48530049|NCT01371981|156129163|FG004|Overall Study|Death|2|||
48602704|NCT03569098|156401524|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
48832840|NCT00811057|157227680|FG000|Overall Study|Protocol Violation|5|||
48602705|NCT03569098|156401525|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
48602706|NCT03569098|156401526|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
48602707|NCT03569098|156401524|FG000|Double-Blind Treatment Cycle 1|Other|1|||
48602708|NCT03569098|156401525|FG001|Double-Blind Treatment Cycle 1|Other|0|||
48530050|NCT01371981|156129164|FG005|Overall Study|Death|2|||
48530051|NCT01371981|156129159|FG000|Overall Study|Lack of Efficacy|69|||
48530052|NCT01371981|156129160|FG001|Overall Study|Lack of Efficacy|61|||
48530053|NCT01371981|156129161|FG002|Overall Study|Lack of Efficacy|4|||
48530054|NCT01371981|156129162|FG003|Overall Study|Lack of Efficacy|8|||
48530055|NCT01371981|156129163|FG004|Overall Study|Lack of Efficacy|5|||
48530056|NCT01371981|156129164|FG005|Overall Study|Lack of Efficacy|0|||
48530057|NCT01371981|156129159|FG000|Overall Study|Physician Decision|48|||
48530058|NCT01371981|156129160|FG001|Overall Study|Physician Decision|63|||
48530059|NCT01371981|156129161|FG002|Overall Study|Physician Decision|1|||
48530060|NCT01371981|156129162|FG003|Overall Study|Physician Decision|7|||
48530061|NCT01371981|156129163|FG004|Overall Study|Physician Decision|14|||
48530062|NCT01371981|156129164|FG005|Overall Study|Physician Decision|3|||
48530063|NCT01371981|156129159|FG000|Overall Study|Withdrawal by Subject|12|||
48530064|NCT01371981|156129160|FG001|Overall Study|Withdrawal by Subject|19|||
48530065|NCT01371981|156129161|FG002|Overall Study|Withdrawal by Subject|1|||
48530066|NCT01371981|156129162|FG003|Overall Study|Withdrawal by Subject|2|||
48530067|NCT01371981|156129163|FG004|Overall Study|Withdrawal by Subject|10|||
48530068|NCT01371981|156129164|FG005|Overall Study|Withdrawal by Subject|3|||
48530069|NCT01371981|156129159|FG000|Overall Study|Ineligible|19|||
48530070|NCT01371981|156129160|FG001|Overall Study|Ineligible|13|||
48530071|NCT01371981|156129161|FG002|Overall Study|Ineligible|0|||
48530072|NCT01371981|156129162|FG003|Overall Study|Ineligible|0|||
48530073|NCT01371981|156129163|FG004|Overall Study|Ineligible|0|||
48530074|NCT01371981|156129164|FG005|Overall Study|Ineligible|4|||
48530075|NCT01371981|156129159|FG000|Overall Study|Did not start treatment|2|||
48530076|NCT01371981|156129160|FG001|Overall Study|Did not start treatment|3|||
48530077|NCT01371981|156129161|FG002|Overall Study|Did not start treatment|0|||
48530078|NCT01371981|156129162|FG003|Overall Study|Did not start treatment|0|||
48530079|NCT01371981|156129163|FG004|Overall Study|Did not start treatment|0|||
48530080|NCT01371981|156129164|FG005|Overall Study|Did not start treatment|2|||
48530081|NCT02095691|156129165|FG000|Overall Study|Physician Decision|1|||
48530082|NCT03681262|156129166|FG000|Overall Study|Continuing on study|3|||
48530083|NCT03681262|156129167|FG001|Overall Study|Continuing on study|3|||
48530084|NCT03681262|156129166|FG000|Overall Study|Lost to Follow-up|1|||
48530085|NCT03681262|156129167|FG001|Overall Study|Lost to Follow-up|0|||
48530086|NCT04535544|156129169|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
48530087|NCT04535544|156129170|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
48530088|NCT04535544|156129171|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
48530089|NCT04535544|156129172|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
48530090|NCT04535544|156129169|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
48530091|NCT04535544|156129170|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
48530092|NCT04535544|156129171|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
48530093|NCT04535544|156129172|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
48530094|NCT04535544|156129169|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
48530095|NCT04535544|156129170|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
48530096|NCT04535544|156129171|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
48530097|NCT04535544|156129172|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
48530098|NCT04535544|156129169|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
48530099|NCT04535544|156129170|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
48530100|NCT04535544|156129171|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
48530101|NCT04535544|156129172|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
48832841|NCT00811057|157227681|FG001|Overall Study|Protocol Violation|10|||
48832842|NCT00811057|157227682|FG002|Overall Study|Protocol Violation|10|||
48832843|NCT02747004|157227688|FG000|Overall Study|Withdrawal by Subject|8|||
48832844|NCT02747004|157227689|FG001|Overall Study|Withdrawal by Subject|5|||
48832845|NCT02747004|157227690|FG002|Overall Study|Withdrawal by Subject|4|||
48832846|NCT02747004|157227688|FG000|Overall Study|Lost to Follow-up|1|||
48832847|NCT02747004|157227689|FG001|Overall Study|Lost to Follow-up|2|||
48530102|NCT04535544|156129169|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
48530103|NCT04535544|156129170|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
48602709|NCT03569098|156401526|FG002|Double-Blind Treatment Cycle 1|Other|1|||
48530104|NCT04535544|156129171|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
48530105|NCT04535544|156129172|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
48530106|NCT04535544|156129169|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
48530107|NCT04535544|156129170|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
48530108|NCT04535544|156129171|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
48530109|NCT04535544|156129172|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
48530110|NCT04535544|156129169|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
48832848|NCT02747004|157227690|FG002|Overall Study|Lost to Follow-up|2|||
48530111|NCT04535544|156129170|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
48530112|NCT04535544|156129171|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
48530113|NCT04535544|156129172|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
48530114|NCT04535544|156129169|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
48530115|NCT04535544|156129170|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
48530116|NCT04535544|156129171|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
48530117|NCT04535544|156129172|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
48832849|NCT02747004|157227688|FG000|Overall Study|on study treatment/follow-up|48|||
48832850|NCT02747004|157227689|FG001|Overall Study|on study treatment/follow-up|42|||
48832851|NCT02747004|157227690|FG002|Overall Study|on study treatment/follow-up|41|||
48832852|NCT05019729|157227691|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832853|NCT05019729|157227692|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832854|NCT05019729|157227693|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832855|NCT05019729|157227694|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832856|NCT05019729|157227695|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
48832857|NCT05019729|157227696|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
48832858|NCT02482233|157227697|FG000|Overall Study|Lost to Follow-up|1|||
48832859|NCT02482233|157227698|FG001|Overall Study|Lost to Follow-up|1|||
48832860|NCT01144182|157227701|FG000|Overall Study|Death|5|||
48832861|NCT01144182|157227702|FG001|Overall Study|Death|6|||
48530118|NCT03176784|156129174|FG000|Overall Study|Lost to Follow-up|77|||
48530119|NCT03176784|156129175|FG001|Overall Study|Lost to Follow-up|79|||
48530120|NCT03176784|156129176|FG002|Overall Study|Lost to Follow-up|79|||
48530121|NCT03176784|156129177|FG003|Overall Study|Lost to Follow-up|49|||
48530122|NCT03176784|156129174|FG000|Overall Study|Withdrawal by Subject|28|||
48530123|NCT03176784|156129175|FG001|Overall Study|Withdrawal by Subject|34|||
48530124|NCT03176784|156129176|FG002|Overall Study|Withdrawal by Subject|34|||
48530125|NCT03176784|156129177|FG003|Overall Study|Withdrawal by Subject|21|||
48530126|NCT03334695|156129178|FG000|Overall Study|Lost to Follow-up|3|||
48530127|NCT03334695|156129179|FG001|Overall Study|Lost to Follow-up|3|||
48530128|NCT03334695|156129178|FG000|Overall Study|Physician Decision|1|||
48530129|NCT03334695|156129179|FG001|Overall Study|Physician Decision|2|||
48530130|NCT03334695|156129178|FG000|Overall Study|Protocol Violation|0|||
48530131|NCT03334695|156129179|FG001|Overall Study|Protocol Violation|1|||
48530132|NCT00026312|156129180|FG000|Overall Study|Adverse Event|0|||
48530133|NCT00026312|156129181|FG001|Overall Study|Adverse Event|32|||
48530134|NCT00026312|156129180|FG000|Overall Study|Death|1|||
48530135|NCT00026312|156129181|FG001|Overall Study|Death|7|||
48530136|NCT00026312|156129180|FG000|Overall Study|Lack of Efficacy|19|||
48530137|NCT00026312|156129181|FG001|Overall Study|Lack of Efficacy|114|||
48530138|NCT00026312|156129180|FG000|Overall Study|Lost to Follow-up|0|||
48530139|NCT00026312|156129181|FG001|Overall Study|Lost to Follow-up|5|||
48530140|NCT00026312|156129180|FG000|Overall Study|Physician Decision|1|||
48530141|NCT00026312|156129181|FG001|Overall Study|Physician Decision|37|||
48530142|NCT00026312|156129180|FG000|Overall Study|Protocol Violation|0|||
48530143|NCT00026312|156129181|FG001|Overall Study|Protocol Violation|3|||
48530144|NCT00026312|156129180|FG000|Overall Study|Withdrawal by Subject|1|||
48530145|NCT00026312|156129181|FG001|Overall Study|Withdrawal by Subject|6|||
48530146|NCT00026312|156129180|FG000|Overall Study|Ineligible|4|||
48530147|NCT00026312|156129181|FG001|Overall Study|Ineligible|5|||
48530148|NCT00026312|156129180|FG000|Overall Study|Entry onto another COG study|0|||
48530149|NCT00026312|156129181|FG001|Overall Study|Entry onto another COG study|1|||
48530150|NCT00026312|156129180|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
48530151|NCT00026312|156129181|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
48530152|NCT02413489|156129182|FG000|Overall Study|Death|11|||
48530153|NCT02413489|156129183|FG001|Overall Study|Death|3|||
48530154|NCT02413489|156129184|FG002|Overall Study|Death|4|||
48530155|NCT02413489|156129182|FG000|Overall Study|Withdrawal by Subject|2|||
48602710|NCT03569098|156401524|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
48602711|NCT03569098|156401525|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
48602712|NCT03569098|156401526|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
48832862|NCT01144182|157227701|FG000|Overall Study|Withdrawal by Subject|3|||
48832863|NCT01144182|157227702|FG001|Overall Study|Withdrawal by Subject|6|||
48832864|NCT01144182|157227701|FG000|Overall Study|Lost to Follow-up|9|||
48832865|NCT01144182|157227702|FG001|Overall Study|Lost to Follow-up|9|||
48832866|NCT02351180|157227709|FG000|Overall Study|Withdrawal by Subject|1|||
48832867|NCT02351180|157227710|FG001|Overall Study|Withdrawal by Subject|0|||
48530156|NCT02413489|156129183|FG001|Overall Study|Withdrawal by Subject|0|||
48530157|NCT02413489|156129184|FG002|Overall Study|Withdrawal by Subject|0|||
48530158|NCT02413489|156129182|FG000|Overall Study|Study Terminated By Sponsor|2|||
48602713|NCT03569098|156401524|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
48530159|NCT02413489|156129183|FG001|Overall Study|Study Terminated By Sponsor|13|||
48530160|NCT02413489|156129184|FG002|Overall Study|Study Terminated By Sponsor|1|||
48530161|NCT05158140|156129185|FG000|Overall Study|Death|0|||
48530162|NCT05158140|156129186|FG001|Overall Study|Death|0|||
48530163|NCT05158140|156129187|FG002|Overall Study|Death|0|||
48530164|NCT05158140|156129188|FG003|Overall Study|Death|1|||
48530165|NCT05158140|156129185|FG000|Overall Study|Lost to Follow-up|3|||
48530166|NCT05158140|156129186|FG001|Overall Study|Lost to Follow-up|6|||
48530167|NCT05158140|156129187|FG002|Overall Study|Lost to Follow-up|4|||
48530168|NCT05158140|156129188|FG003|Overall Study|Lost to Follow-up|3|||
48530169|NCT05158140|156129185|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48530170|NCT05158140|156129186|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48832868|NCT02163915|157227717|FG000|Overall Study|Withdrawal by Subject|2|||
48832869|NCT02163915|157227718|FG001|Overall Study|Withdrawal by Subject|0|||
48832870|NCT02163915|157227719|FG002|Overall Study|Withdrawal by Subject|2|||
48832871|NCT02163915|157227720|FG003|Overall Study|Withdrawal by Subject|2|||
48832872|NCT02163915|157227721|FG004|Overall Study|Withdrawal by Subject|2|||
48832873|NCT02163915|157227717|FG000|Overall Study|Study termination|1|||
48832874|NCT02163915|157227718|FG001|Overall Study|Study termination|0|||
48832875|NCT02163915|157227719|FG002|Overall Study|Study termination|0|||
48832876|NCT02163915|157227720|FG003|Overall Study|Study termination|0|||
48832877|NCT02163915|157227721|FG004|Overall Study|Study termination|2|||
48530171|NCT05158140|156129187|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
48530172|NCT05158140|156129188|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48530173|NCT05158140|156129185|FG000|Overall Study|Withdrawal by Subject|3|||
48530174|NCT05158140|156129186|FG001|Overall Study|Withdrawal by Subject|7|||
48530175|NCT05158140|156129187|FG002|Overall Study|Withdrawal by Subject|3|||
48530176|NCT05158140|156129188|FG003|Overall Study|Withdrawal by Subject|7|||
48530177|NCT00977431|156129193|FG000|Overall Study|Other than listed|1|||
48530178|NCT00977431|156129194|FG001|Overall Study|Other than listed|0|||
48530179|NCT00977431|156129195|FG002|Overall Study|Other than listed|0|||
48530180|NCT00977431|156129196|FG003|Overall Study|Other than listed|0|||
48530181|NCT00977431|156129197|FG004|Overall Study|Other than listed|2|||
48530182|NCT00977431|156129193|FG000|Overall Study|Protocol Violation|0|||
48530183|NCT00977431|156129194|FG001|Overall Study|Protocol Violation|0|||
48602714|NCT03569098|156401525|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
48602715|NCT03569098|156401526|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
48602716|NCT03569098|156401524|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
48602717|NCT03569098|156401525|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
48602718|NCT03569098|156401526|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
48602719|NCT03569098|156401524|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
48602720|NCT03569098|156401525|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
48602721|NCT03569098|156401526|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
48602722|NCT03569098|156401524|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
48832878|NCT02163915|157227717|FG000|Overall Study|Physician Decision|0|||
48832879|NCT02163915|157227718|FG001|Overall Study|Physician Decision|0|||
48530184|NCT00977431|156129195|FG002|Overall Study|Protocol Violation|1|||
48530185|NCT00977431|156129196|FG003|Overall Study|Protocol Violation|0|||
48530186|NCT00977431|156129197|FG004|Overall Study|Protocol Violation|0|||
48530187|NCT00977431|156129193|FG000|Overall Study|Adverse Event|3|||
48530188|NCT00977431|156129194|FG001|Overall Study|Adverse Event|0|||
48530189|NCT00977431|156129195|FG002|Overall Study|Adverse Event|4|||
48530190|NCT00977431|156129196|FG003|Overall Study|Adverse Event|0|||
48530191|NCT00977431|156129197|FG004|Overall Study|Adverse Event|6|||
48530192|NCT00977431|156129193|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
48530193|NCT00977431|156129194|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
48530194|NCT00977431|156129195|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
48530195|NCT00977431|156129196|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
48530196|NCT00977431|156129197|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
48530197|NCT00977431|156129193|FG000|Overall Study|Progressive disease|2|||
48530198|NCT00977431|156129194|FG001|Overall Study|Progressive disease|6|||
48530199|NCT00977431|156129195|FG002|Overall Study|Progressive disease|1|||
48530200|NCT00977431|156129196|FG003|Overall Study|Progressive disease|3|||
48530201|NCT00977431|156129197|FG004|Overall Study|Progressive disease|5|||
48530202|NCT02806726|156129198|FG000|Overall Study|Lost to Follow-up|1|||
48530203|NCT05007080|156129199|FG000|Overall Study|Lost to Follow-up|0|||
48530204|NCT05007080|156129200|FG001|Overall Study|Lost to Follow-up|1|||
48530205|NCT05007080|156129201|FG002|Overall Study|Lost to Follow-up|0|||
48530206|NCT05007080|156129202|FG003|Overall Study|Lost to Follow-up|1|||
48602723|NCT03569098|156401525|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
48530207|NCT05007080|156129203|FG004|Overall Study|Lost to Follow-up|1|||
48530208|NCT05007080|156129204|FG005|Overall Study|Lost to Follow-up|1|||
48530209|NCT05007080|156129199|FG000|Overall Study|Death|0|||
48530210|NCT05007080|156129200|FG001|Overall Study|Death|1|||
48530211|NCT05007080|156129201|FG002|Overall Study|Death|0|||
48832880|NCT02163915|157227719|FG002|Overall Study|Physician Decision|0|||
48832881|NCT02163915|157227720|FG003|Overall Study|Physician Decision|1|||
48530212|NCT05007080|156129202|FG003|Overall Study|Death|0|||
48530213|NCT05007080|156129203|FG004|Overall Study|Death|0|||
48832882|NCT02163915|157227721|FG004|Overall Study|Physician Decision|0|||
48832883|NCT03395353|157227724|FG000|Overall Study|Adverse Event|20|||
48530214|NCT05007080|156129204|FG005|Overall Study|Death|0|||
48530215|NCT05007080|156129199|FG000|Overall Study|Withdrawal by Subject|1|||
48530216|NCT05007080|156129200|FG001|Overall Study|Withdrawal by Subject|2|||
48530217|NCT05007080|156129201|FG002|Overall Study|Withdrawal by Subject|0|||
48530218|NCT05007080|156129202|FG003|Overall Study|Withdrawal by Subject|2|||
48530219|NCT05007080|156129203|FG004|Overall Study|Withdrawal by Subject|1|||
48530220|NCT05007080|156129204|FG005|Overall Study|Withdrawal by Subject|1|||
48530221|NCT05007080|156129199|FG000|Overall Study|Other|1|||
48530222|NCT05007080|156129200|FG001|Overall Study|Other|0|||
48530223|NCT05007080|156129201|FG002|Overall Study|Other|1|||
48530224|NCT05007080|156129202|FG003|Overall Study|Other|1|||
48530225|NCT05007080|156129203|FG004|Overall Study|Other|0|||
48530226|NCT05007080|156129204|FG005|Overall Study|Other|2|||
48530227|NCT05007080|156129199|FG000|Overall Study|Randomized not vaccinated|0|||
48530228|NCT05007080|156129200|FG001|Overall Study|Randomized not vaccinated|0|||
48530229|NCT05007080|156129201|FG002|Overall Study|Randomized not vaccinated|0|||
48530230|NCT05007080|156129202|FG003|Overall Study|Randomized not vaccinated|0|||
48530231|NCT05007080|156129203|FG004|Overall Study|Randomized not vaccinated|0|||
48530232|NCT05007080|156129204|FG005|Overall Study|Randomized not vaccinated|1|||
48530233|NCT01527188|156129214|FG000|Overall Study|Adverse Event|5|||
48530234|NCT01527188|156129215|FG001|Overall Study|Adverse Event|5|||
48530235|NCT01527188|156129216|FG002|Overall Study|Adverse Event|11|||
48530236|NCT01527188|156129217|FG003|Overall Study|Adverse Event|0|||
48530237|NCT01527188|156129214|FG000|Overall Study|Withdrawal by Subject|3|||
48530238|NCT01527188|156129215|FG001|Overall Study|Withdrawal by Subject|6|||
48530239|NCT01527188|156129216|FG002|Overall Study|Withdrawal by Subject|4|||
48530240|NCT01527188|156129217|FG003|Overall Study|Withdrawal by Subject|4|||
48530241|NCT01527188|156129214|FG000|Overall Study|Any other reason not above-mentioned|6|||
48530242|NCT01527188|156129215|FG001|Overall Study|Any other reason not above-mentioned|7|||
48530243|NCT01527188|156129216|FG002|Overall Study|Any other reason not above-mentioned|8|||
48530244|NCT01527188|156129217|FG003|Overall Study|Any other reason not above-mentioned|8|||
48530245|NCT00233987|156129219|FG000|Overall Study|Withdrawal by Subject|1|||
48530246|NCT00233987|156129219|FG000|Overall Study|Lack of Efficacy|2|||
48530247|NCT00233987|156129219|FG000|Overall Study|Reason Under Review|1|||
48530248|NCT00233987|156129219|FG000|Overall Study|Other - Not Protocol Specified|5|||
48530249|NCT00233987|156129219|FG000|Overall Study|Eligible but No Treatment Received|2|||
48530250|NCT00233987|156129219|FG000|Overall Study|Ineligible|4|||
48530251|NCT00114231|156131219|FG000|Overall Study|No consent|2|||
48530252|NCT00114231|156131220|FG001|Overall Study|No consent|0|||
48530253|NCT00114231|156131219|FG000|Overall Study|QARC requirement not met|1|||
48530254|NCT00114231|156131220|FG001|Overall Study|QARC requirement not met|0|||
48530255|NCT00114231|156131219|FG000|Overall Study|Suspected metastatic disease|1|||
48530256|NCT00114231|156131220|FG001|Overall Study|Suspected metastatic disease|0|||
48530257|NCT00114231|156131219|FG000|Overall Study|No adenocarcinoma|1|||
48530258|NCT00114231|156131220|FG001|Overall Study|No adenocarcinoma|0|||
48530259|NCT00114231|156131219|FG000|Overall Study|Low creatinine clearance|0|||
48530260|NCT00114231|156131220|FG001|Overall Study|Low creatinine clearance|1|||
48530261|NCT00114231|156131219|FG000|Overall Study|Tumor size > 4cm|1|||
48530262|NCT00114231|156131220|FG001|Overall Study|Tumor size > 4cm|0|||
48530263|NCT00114231|156131219|FG000|Overall Study|Tumor fixed on digital exam|0|||
48530264|NCT00114231|156131220|FG001|Overall Study|Tumor fixed on digital exam|1|||
48530265|NCT00114231|156131219|FG000|Overall Study|No Absolute Neutrophil Count|2|||
48530266|NCT00114231|156131220|FG001|Overall Study|No Absolute Neutrophil Count|0|||
48530267|NCT00114231|156131219|FG000|Overall Study|Biopsy done after registration|1|||
48530268|NCT00114231|156131220|FG001|Overall Study|Biopsy done after registration|0|||
48530269|NCT02310672|156131221|FG000|Overall Study|Death|1|||
48530270|NCT02310672|156131221|FG000|Overall Study|Lost to Follow-up|1|||
48530271|NCT02310672|156131221|FG000|Overall Study|Withdrawal by Subject|1|||
48530272|NCT02310672|156131221|FG000|Overall Study|Sponsor's decision|12|||
48530273|NCT01098812|156131222|FG000|Overall Study|Death|2|||
48530274|NCT01098812|156131223|FG001|Overall Study|Death|0|||
48530275|NCT01098812|156131224|FG002|Overall Study|Death|1|||
48832884|NCT03395353|157227724|FG000|Overall Study|Protocol Violation|1|||
48832885|NCT03395353|157227724|FG000|Overall Study|Lack of Efficacy|3|||
48530276|NCT01098812|156131222|FG000|Overall Study|Lost to Follow-up|0|||
48530277|NCT01098812|156131223|FG001|Overall Study|Lost to Follow-up|1|||
48530278|NCT01098812|156131224|FG002|Overall Study|Lost to Follow-up|0|||
48530279|NCT01855750|156131228|FG000|Overall Study|Death|78|||
48832886|NCT03395353|157227724|FG000|Overall Study|Withdrawal by Subject|24|||
48832887|NCT03395353|157227724|FG000|Overall Study|Discontinued visit|1|||
48832888|NCT03395353|157227724|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
48832889|NCT03395353|157227724|FG000|Overall Study|Physician Decision|4|||
48832890|NCT03395353|157227724|FG000|Overall Study|Early termination of overall study|33|||
48530280|NCT01855750|156131229|FG001|Overall Study|Death|78|||
48530281|NCT01855750|156131228|FG000|Overall Study|Lost to Follow-up|9|||
48530282|NCT01855750|156131229|FG001|Overall Study|Lost to Follow-up|23|||
48530283|NCT01855750|156131228|FG000|Overall Study|Withdrawal by Subject|35|||
48530284|NCT01855750|156131229|FG001|Overall Study|Withdrawal by Subject|28|||
48530285|NCT01855750|156131228|FG000|Overall Study|Sponsor ends the study|297|||
48530286|NCT01855750|156131229|FG001|Overall Study|Sponsor ends the study|290|||
48530287|NCT01933919|156131230|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
48530288|NCT01933919|156131231|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
48530289|NCT01933919|156131230|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
48530290|NCT01933919|156131231|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
48530291|NCT01933919|156131230|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
48530292|NCT01933919|156131231|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
48530293|NCT01933919|156131230|FG000|Open-label Long-term Phase|Adverse Event|2|||
48530294|NCT01933919|156131231|FG001|Open-label Long-term Phase|Adverse Event|0|||
48530295|NCT01933919|156131230|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
48530296|NCT01933919|156131231|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
48530297|NCT01933919|156131230|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
48530298|NCT01933919|156131231|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
48530299|NCT01933919|156131230|FG000|Open-label Long-term Phase|Other|1|||
48530300|NCT01933919|156131231|FG001|Open-label Long-term Phase|Other|2|||
48530301|NCT03330236|156131232|FG000|Overall Study|Death|2|||
48530302|NCT03330236|156131233|FG001|Overall Study|Death|1|||
48530303|NCT03330236|156131232|FG000|Overall Study|Withdrawal by Subject|2|||
48530304|NCT03330236|156131233|FG001|Overall Study|Withdrawal by Subject|4|||
48530305|NCT03330236|156131232|FG000|Overall Study|Lost to Follow-up|0|||
48530306|NCT03330236|156131233|FG001|Overall Study|Lost to Follow-up|2|||
48530307|NCT03330236|156131232|FG000|Overall Study|Physician Decision|2|||
48530308|NCT03330236|156131233|FG001|Overall Study|Physician Decision|0|||
48832891|NCT03213678|157227726|FG000|Overall Study|Death|1|||
48832892|NCT03213678|157227726|FG000|Overall Study|Physician Decision|1|||
48832893|NCT03213678|157227726|FG000|Overall Study|Progressive disease|16|||
48832894|NCT04369911|157227727|FG000|Overall Study|Lost to Follow-up|3|||
48832895|NCT04369911|157227728|FG001|Overall Study|Lost to Follow-up|3|||
48832896|NCT04369911|157227727|FG000|Overall Study|Withdrawal by Subject|1|||
48832897|NCT04369911|157227728|FG001|Overall Study|Withdrawal by Subject|2|||
48832898|NCT03140176|157229205|FG000|Overall Study|Reason missing|23|||
48832899|NCT03140176|157229205|FG000|Overall Study|Death|33|||
48832900|NCT03140176|157229205|FG000|Overall Study|Disease progression|1|||
48832901|NCT03140176|157229205|FG000|Overall Study|Physician Decision|1|||
48832902|NCT03140176|157229205|FG000|Overall Study|Withdrawal by Subject|1|||
48832903|NCT03140176|157229205|FG000|Overall Study|Lost to Follow-up|15|||
48832904|NCT03181958|157229206|FG000|Overall Study|Lost to Follow-up|17|||
48832905|NCT03181958|157229207|FG001|Overall Study|Lost to Follow-up|21|||
48832906|NCT03181958|157229208|FG002|Overall Study|Lost to Follow-up|15|||
48832907|NCT00408928|157229209|FG000|Overall Study|Withdrawal by Subject|1|||
48832908|NCT00408928|157229209|FG000|Overall Study|Death|1|||
48832909|NCT00408928|157229209|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
48832910|NCT02030028|157229210|FG000|Overall Study|Withdrawal by Subject|4|||
48832911|NCT02030028|157229210|FG000|Overall Study|lack of transportation|1|||
48832912|NCT01185522|157229211|FG000|Overall Study|Lack of Efficacy|28|||
48832913|NCT01185522|157229211|FG000|Overall Study|Lost to Follow-up|19|||
48832914|NCT01185522|157229211|FG000|Overall Study|Withdrawal by Subject|10|||
48832915|NCT01185522|157229211|FG000|Overall Study|Poor tolerance|39|||
48832916|NCT01185522|157229211|FG000|Overall Study|Other reasons|12|||
48832917|NCT00954707|157229212|FG000|Overall Study|Death|34|||
48832918|NCT00954707|157229212|FG000|Overall Study|Withdrawal by Subject|100|||
48832919|NCT00954707|157229212|FG000|Overall Study|Lost to Follow-up|33|||
48832920|NCT02072226|157229213|FG000|Overall Study|Lost to Follow-up|11|||
48832921|NCT02072226|157229214|FG001|Overall Study|Lost to Follow-up|7|||
48832922|NCT02072226|157229213|FG000|Overall Study|Patient Non-compliance|2|||
48530309|NCT03330236|156131232|FG000|Overall Study|Protocol Violation|4|||
48530310|NCT03330236|156131233|FG001|Overall Study|Protocol Violation|3|||
48832923|NCT02072226|157229214|FG001|Overall Study|Patient Non-compliance|3|||
48832924|NCT02072226|157229213|FG000|Overall Study|Death|1|||
48832925|NCT02072226|157229214|FG001|Overall Study|Death|0|||
48832926|NCT02072226|157229213|FG000|Overall Study|Patient Withdrawal of Consent|1|||
48530311|NCT03330236|156131232|FG000|Overall Study|SedLine malfunction/blinding|19|||
48832927|NCT02072226|157229214|FG001|Overall Study|Patient Withdrawal of Consent|0|||
48832928|NCT03441360|157229227|FG000|Overall Study|Radiological disease progression|5|||
48832929|NCT03441360|157229228|FG001|Overall Study|Radiological disease progression|6|||
48530312|NCT03330236|156131233|FG001|Overall Study|SedLine malfunction/blinding|14|||
48530313|NCT03330236|156131232|FG000|Overall Study|Volatile anesthetics used|11|||
48530314|NCT03330236|156131233|FG001|Overall Study|Volatile anesthetics used|8|||
48530315|NCT03330236|156131232|FG000|Overall Study|Surgery aborted/converted to open|60|||
48530316|NCT03330236|156131233|FG001|Overall Study|Surgery aborted/converted to open|52|||
48832930|NCT03441360|157229229|FG002|Overall Study|Radiological disease progression|4|||
48832931|NCT03441360|157229227|FG000|Overall Study|Clinical disease progression|2|||
48832932|NCT03441360|157229228|FG001|Overall Study|Clinical disease progression|2|||
48832933|NCT03441360|157229229|FG002|Overall Study|Clinical disease progression|0|||
48832934|NCT03441360|157229227|FG000|Overall Study|Adverse Event|1|||
48832935|NCT03441360|157229228|FG001|Overall Study|Adverse Event|0|||
48832936|NCT03441360|157229229|FG002|Overall Study|Adverse Event|1|||
48832937|NCT01977612|157229230|FG000|Overall Study|Lost to Follow-up|1|||
48832938|NCT01977612|157229231|FG001|Overall Study|Lost to Follow-up|1|||
48832939|NCT02236559|157229238|FG000|Overall Study|Met Exclusion|3|||
48832940|NCT02236559|157229239|FG001|Overall Study|Met Exclusion|6|||
48832941|NCT02236559|157229238|FG000|Overall Study|Did not Meet Inclusion|3|||
48832942|NCT02236559|157229239|FG001|Overall Study|Did not Meet Inclusion|3|||
48832943|NCT02236559|157229238|FG000|Overall Study|Subject Did Not Consent|4|||
48832944|NCT02236559|157229239|FG001|Overall Study|Subject Did Not Consent|2|||
48832945|NCT02236559|157229238|FG000|Overall Study|Physician Decision|1|||
48832946|NCT02236559|157229239|FG001|Overall Study|Physician Decision|1|||
48832947|NCT02236559|157229238|FG000|Overall Study|Withdrawal by Subject|1|||
48832948|NCT02236559|157229239|FG001|Overall Study|Withdrawal by Subject|0|||
48530317|NCT01684215|156131234|FG000|Phase 1, Part 1|Adverse Event|1|||
48530318|NCT01684215|156131235|FG001|Phase 1, Part 1|Adverse Event|0|||
48530319|NCT01684215|156131236|FG002|Phase 1, Part 1|Adverse Event|0|||
48530320|NCT01684215|156131237|FG003|Phase 1, Part 1|Adverse Event|0|||
48530321|NCT01684215|156131234|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
48530322|NCT01684215|156131235|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
48832949|NCT04860258|157229241|FG000|Overall Study|Withdrawal by Subject|0|||
48832950|NCT04860258|157229242|FG001|Overall Study|Withdrawal by Subject|0|||
48832951|NCT04860258|157229243|FG002|Overall Study|Withdrawal by Subject|4|||
48832952|NCT04860258|157229244|FG003|Overall Study|Withdrawal by Subject|1|||
48832953|NCT04860258|157229245|FG004|Overall Study|Withdrawal by Subject|4|||
48832954|NCT04860258|157229246|FG005|Overall Study|Withdrawal by Subject|1|||
48832955|NCT04860258|157229247|FG006|Overall Study|Withdrawal by Subject|0|||
48832956|NCT00420316|157229248|FG000|Overall Study|Withdrawal by Subject|0|||
48832957|NCT00420316|157229249|FG001|Overall Study|Withdrawal by Subject|1|||
48832958|NCT00420316|157229248|FG000|Overall Study|Lost to Follow-up|12|||
48832959|NCT00420316|157229249|FG001|Overall Study|Lost to Follow-up|8|||
48832960|NCT00588666|157229250|FG000|Overall Study|Adverse Event|4|||
48832961|NCT01233050|157229251|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
48832962|NCT01233050|157229252|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
48832963|NCT02174562|157229256|FG000|Overall Study|Withdrawal by Subject|7|||
48832964|NCT02174562|157229257|FG001|Overall Study|Withdrawal by Subject|2|||
48832965|NCT02174562|157229256|FG000|Overall Study|Death|2|||
48832966|NCT02174562|157229257|FG001|Overall Study|Death|0|||
48832967|NCT02174562|157229256|FG000|Overall Study|Lost to Follow-up|0|||
48832968|NCT02174562|157229257|FG001|Overall Study|Lost to Follow-up|3|||
48832969|NCT00606580|157229260|FG000|Overall Study|Lost to Follow-up|1|||
48832970|NCT00606580|157229261|FG001|Overall Study|Lost to Follow-up|1|||
48832971|NCT00606580|157229262|FG002|Overall Study|Lost to Follow-up|4|||
48832972|NCT00606580|157229260|FG000|Overall Study|Clinical failures|1|||
48832973|NCT00606580|157229261|FG001|Overall Study|Clinical failures|0|||
48832974|NCT00606580|157229262|FG002|Overall Study|Clinical failures|12|||
48832975|NCT00606580|157229260|FG000|Overall Study|Withdrawal by investigator|0|||
48832976|NCT00606580|157229261|FG001|Overall Study|Withdrawal by investigator|1|||
48832977|NCT00606580|157229262|FG002|Overall Study|Withdrawal by investigator|6|||
48832978|NCT00606580|157229260|FG000|Overall Study|Withdrawal by Subject|0|||
48832979|NCT00606580|157229261|FG001|Overall Study|Withdrawal by Subject|1|||
48832980|NCT00606580|157229262|FG002|Overall Study|Withdrawal by Subject|0|||
48832981|NCT00798096|157229263|FG000|Overall Study|Ongoing|2|||
48832982|NCT01156116|157229277|FG000|Overall Study|Withdrawal by Subject|3|||
48832983|NCT01156116|157229278|FG001|Overall Study|Withdrawal by Subject|1|||
48530323|NCT01684215|156131236|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
48530324|NCT01684215|156131237|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
48602724|NCT03569098|156401526|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
48832984|NCT01156116|157229277|FG000|Overall Study|CPAP intolerance|2|||
48832985|NCT01156116|157229278|FG001|Overall Study|CPAP intolerance|0|||
48832986|NCT01193153|157229279|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
48832987|NCT01193153|157229280|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
48832988|NCT01193153|157229279|FG000|Open-label Lead in Period|Pregnancy|1|||
48832989|NCT01193153|157229280|FG001|Open-label Lead in Period|Pregnancy|0|||
48832990|NCT01193153|157229279|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
48832991|NCT01193153|157229280|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
48832992|NCT01193153|157229279|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
48832993|NCT01193153|157229280|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
48832994|NCT01193153|157229279|FG000|Open-label Lead in Period|Other|14|||
48832995|NCT01193153|157229280|FG001|Open-label Lead in Period|Other|0|||
48530325|NCT01684215|156131234|FG000|Phase 1, Part 2|Adverse Event|0|||
48832996|NCT01193153|157229279|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
48832997|NCT01193153|157229280|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
48530326|NCT01684215|156131235|FG001|Phase 1, Part 2|Adverse Event|0|||
48530327|NCT01684215|156131236|FG002|Phase 1, Part 2|Adverse Event|1|||
48530328|NCT01684215|156131237|FG003|Phase 1, Part 2|Adverse Event|0|||
48530329|NCT01684215|156131234|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
48530330|NCT01684215|156131235|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
48530331|NCT01684215|156131236|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
48530332|NCT01684215|156131237|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
48530333|NCT01684215|156131234|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
48530334|NCT01684215|156131235|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
48530335|NCT01684215|156131236|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
48530336|NCT01684215|156131237|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
48530337|NCT01684215|156131234|FG000|Phase 2|Death|0|||
48530338|NCT01684215|156131235|FG001|Phase 2|Death|0|||
48530339|NCT01684215|156131236|FG002|Phase 2|Death|0|||
48530340|NCT01684215|156131237|FG003|Phase 2|Death|8|||
48530341|NCT01684215|156131234|FG000|Phase 2|Study terminated by sponsor|0|||
48530342|NCT01684215|156131235|FG001|Phase 2|Study terminated by sponsor|0|||
48832998|NCT01193153|157229279|FG000|Open-label Lead in Period|Adverse Event|41|||
48832999|NCT01193153|157229280|FG001|Open-label Lead in Period|Adverse Event|0|||
48833000|NCT01193153|157229279|FG000|Open-label Lead in Period|Death|1|||
48833001|NCT01193153|157229280|FG001|Open-label Lead in Period|Death|0|||
48833002|NCT01193153|157229279|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
48833003|NCT01193153|157229280|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
48833004|NCT01193153|157229279|FG000|Open-label Stabilization Period|Adverse Event|9|||
48833005|NCT01193153|157229280|FG001|Open-label Stabilization Period|Adverse Event|0|||
48833006|NCT01193153|157229279|FG000|Open-label Stabilization Period|Death|2|||
48833007|NCT01193153|157229280|FG001|Open-label Stabilization Period|Death|0|||
48833008|NCT01193153|157229279|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
48833009|NCT01193153|157229280|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
48833010|NCT01193153|157229279|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
48833011|NCT01193153|157229280|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
48833012|NCT01193153|157229279|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
48833013|NCT01193153|157229280|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
48833014|NCT01193153|157229279|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
48833015|NCT01193153|157229280|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
48833016|NCT01193153|157229279|FG000|Open-label Stabilization Period|Other|8|||
48833017|NCT01193153|157229280|FG001|Open-label Stabilization Period|Other|0|||
48833018|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Other|2|||
48833019|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Other|3|||
48833020|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
48833021|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
48833022|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Death|2|||
48833023|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Death|0|||
48833024|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
48833025|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
48833026|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
48833027|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
48833028|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
48833029|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
48833030|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
48833031|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
48833032|NCT01193153|157229279|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
48833033|NCT01193153|157229280|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
48833034|NCT01460342|157229281|FG000|Overall Study|Adverse Event|5|||
48833035|NCT01460342|157229282|FG001|Overall Study|Adverse Event|4|||
48833036|NCT01460342|157229281|FG000|Overall Study|Lost to Follow-up|1|||
48833037|NCT01460342|157229282|FG001|Overall Study|Lost to Follow-up|2|||
48833038|NCT01460342|157229281|FG000|Overall Study|Protocol Violation|0|||
48833039|NCT01460342|157229282|FG001|Overall Study|Protocol Violation|1|||
48833040|NCT01460342|157229281|FG000|Overall Study|Withdrawal by Subject|3|||
48833041|NCT01460342|157229282|FG001|Overall Study|Withdrawal by Subject|4|||
48833042|NCT01460342|157229281|FG000|Overall Study|Physician Decision|1|||
48530343|NCT01684215|156131236|FG002|Phase 2|Study terminated by sponsor|0|||
48530344|NCT01684215|156131237|FG003|Phase 2|Study terminated by sponsor|30|||
48530345|NCT01684215|156131234|FG000|Phase 2|Enrolled but not treated|0|||
48530346|NCT01684215|156131235|FG001|Phase 2|Enrolled but not treated|0|||
48530347|NCT01684215|156131236|FG002|Phase 2|Enrolled but not treated|0|||
48833043|NCT01460342|157229282|FG001|Overall Study|Physician Decision|3|||
48833044|NCT01460342|157229281|FG000|Overall Study|Lack of Efficacy|1|||
48833045|NCT01460342|157229282|FG001|Overall Study|Lack of Efficacy|0|||
48833046|NCT01689519|157229283|FG000|Intent to Treat|Death|157|||
48833047|NCT01689519|157229284|FG001|Intent to Treat|Death|167|||
48833048|NCT01689519|157229283|FG000|Intent to Treat|Lost to Follow-up|4|||
48833049|NCT01689519|157229284|FG001|Intent to Treat|Lost to Follow-up|8|||
48833050|NCT01689519|157229283|FG000|Intent to Treat|Other|2|||
48833051|NCT01689519|157229284|FG001|Intent to Treat|Other|4|||
48833052|NCT01689519|157229283|FG000|Intent to Treat|Physician Decision|4|||
48833053|NCT01689519|157229284|FG001|Intent to Treat|Physician Decision|1|||
48530348|NCT01684215|156131237|FG003|Phase 2|Enrolled but not treated|1|||
48530349|NCT01684215|156131234|FG000|Phase 2|Lost to Follow-up|0|||
48530350|NCT01684215|156131235|FG001|Phase 2|Lost to Follow-up|0|||
48530351|NCT01684215|156131236|FG002|Phase 2|Lost to Follow-up|0|||
48530352|NCT01684215|156131237|FG003|Phase 2|Lost to Follow-up|4|||
48530353|NCT04288778|156131238|FG000|Overall Study|Withdrawal by Subject|2|||
48530354|NCT04288778|156131238|FG000|Overall Study|Adverse Event|5|||
48530355|NCT04288778|156131238|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48530356|NCT04288778|156131238|FG000|Overall Study|Other|1|||
48530357|NCT04288778|156131238|FG000|Overall Study|Started but not treated|2|||
48530358|NCT01660022|156131239|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
48530359|NCT01660022|156131240|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
48530360|NCT01660022|156131241|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
48530361|NCT01660022|156131242|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
48530362|NCT01660022|156131243|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
48530363|NCT01660022|156131244|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
48530364|NCT01660022|156131239|FG000|First Sequence (7 Days)|Adverse Event|0|||
48530365|NCT01660022|156131240|FG001|First Sequence (7 Days)|Adverse Event|0|||
48530366|NCT01660022|156131241|FG002|First Sequence (7 Days)|Adverse Event|0|||
48530367|NCT01660022|156131242|FG003|First Sequence (7 Days)|Adverse Event|0|||
48530368|NCT01660022|156131243|FG004|First Sequence (7 Days)|Adverse Event|1|||
48530369|NCT01660022|156131244|FG005|First Sequence (7 Days)|Adverse Event|3|||
48530370|NCT01660022|156131239|FG000|First Sequence (7 Days)|Protocol Violation|0|||
48530371|NCT01660022|156131240|FG001|First Sequence (7 Days)|Protocol Violation|0|||
48530372|NCT01660022|156131241|FG002|First Sequence (7 Days)|Protocol Violation|0|||
48530373|NCT01660022|156131242|FG003|First Sequence (7 Days)|Protocol Violation|0|||
48530374|NCT01660022|156131243|FG004|First Sequence (7 Days)|Protocol Violation|0|||
48530375|NCT01660022|156131244|FG005|First Sequence (7 Days)|Protocol Violation|1|||
48530376|NCT02879695|156131245|FG000|Overall Study|Did not start study treatment|2|||
48530377|NCT02879695|156131246|FG001|Overall Study|Did not start study treatment|0|||
48530378|NCT02879695|156131247|FG002|Overall Study|Did not start study treatment|3|||
48530379|NCT02879695|156131248|FG003|Overall Study|Did not start study treatment|0|||
48530380|NCT03462030|156131249|FG000|Overall Study|Withdrawal by Subject|1|||
48530381|NCT03462030|156131250|FG001|Overall Study|Withdrawal by Subject|1|||
48530382|NCT03381196|156131251|FG000|Overall Study|Withdrawal by Subject|7|||
48530383|NCT03381196|156131252|FG001|Overall Study|Withdrawal by Subject|7|||
48530384|NCT03381196|156131251|FG000|Overall Study|Other|0|||
48530385|NCT03381196|156131252|FG001|Overall Study|Other|1|||
48530386|NCT03381196|156131251|FG000|Overall Study|Lost to Follow-up|5|||
48530387|NCT03381196|156131252|FG001|Overall Study|Lost to Follow-up|4|||
48530388|NCT03381196|156131251|FG000|Overall Study|Death|0|||
48530389|NCT03381196|156131252|FG001|Overall Study|Death|1|||
48530390|NCT03381196|156131251|FG000|Overall Study|Adverse Event|1|||
48530391|NCT03381196|156131252|FG001|Overall Study|Adverse Event|0|||
48530392|NCT03381196|156131251|FG000|Overall Study|Randomized, not treated|3|||
48530393|NCT03381196|156131252|FG001|Overall Study|Randomized, not treated|6|||
48530394|NCT01885182|156131253|FG000|Overall Study|Adverse Event|11|||
48530395|NCT01885182|156131254|FG001|Overall Study|Adverse Event|13|||
48530396|NCT01885182|156131253|FG000|Overall Study|Withdrawal by Subject|13|||
48530397|NCT01885182|156131254|FG001|Overall Study|Withdrawal by Subject|6|||
48530398|NCT01885182|156131253|FG000|Overall Study|Lost to Follow-up|2|||
48530399|NCT01885182|156131254|FG001|Overall Study|Lost to Follow-up|2|||
48530400|NCT01885182|156131253|FG000|Overall Study|Lack of Efficacy|8|||
48530401|NCT01885182|156131254|FG001|Overall Study|Lack of Efficacy|1|||
48833054|NCT01689519|157229283|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
48530407|NCT00227344|156131256|FG000|Overall Study|study terminated early|12|||
48530408|NCT00227344|156131257|FG001|Overall Study|study terminated early|5|||
48530409|NCT01915940|156131258|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
48833055|NCT01689519|157229284|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
48530410|NCT01915940|156131259|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
48530411|NCT01915940|156131260|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
48530412|NCT01915940|156131258|FG000|Treatment Period|Decision of Participant|0|||
48530413|NCT01915940|156131259|FG001|Treatment Period|Decision of Participant|1|||
48833056|NCT01689519|157229283|FG000|Intent to Treat|Withdrawal by Subject|21|||
48833057|NCT01689519|157229284|FG001|Intent to Treat|Withdrawal by Subject|20|||
48833058|NCT01689519|157229283|FG000|Safety Population|Death|158|||
48833059|NCT01689519|157229284|FG001|Safety Population|Death|165|||
48833060|NCT01689519|157229283|FG000|Safety Population|Lost to Follow-up|4|||
48833061|NCT01689519|157229284|FG001|Safety Population|Lost to Follow-up|8|||
48833062|NCT01689519|157229283|FG000|Safety Population|Other|2|||
48833063|NCT01689519|157229284|FG001|Safety Population|Other|4|||
48530414|NCT01915940|156131260|FG002|Treatment Period|Decision of Participant|3|||
48530415|NCT01915940|156131258|FG000|Treatment Period|Adverse Event|0|||
48530416|NCT01915940|156131259|FG001|Treatment Period|Adverse Event|9|||
48833064|NCT01689519|157229283|FG000|Safety Population|Physician Decision|4|||
48833065|NCT01689519|157229284|FG001|Safety Population|Physician Decision|1|||
48833066|NCT01689519|157229283|FG000|Safety Population|Study Terminated By Sponsor|60|||
48833067|NCT01689519|157229284|FG001|Safety Population|Study Terminated By Sponsor|47|||
48530417|NCT01915940|156131260|FG002|Treatment Period|Adverse Event|1|||
48530418|NCT01915940|156131258|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
48530419|NCT01915940|156131259|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
48530420|NCT01915940|156131260|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
48530421|NCT00097786|156131263|FG000|Overall Study|lost to follow-up for all-cause death|296|||
48530422|NCT00097786|156131264|FG001|Overall Study|lost to follow-up for all-cause death|292|||
48530423|NCT00097786|156131265|FG002|Overall Study|lost to follow-up for all-cause death|313|||
48530424|NCT00097786|156131266|FG003|Overall Study|lost to follow-up for all-cause death|310|||
48833068|NCT01689519|157229283|FG000|Safety Population|Withdrawal by Subject|20|||
48833069|NCT01689519|157229284|FG001|Safety Population|Withdrawal by Subject|20|||
48833070|NCT00612586|157229285|FG000|Overall Study|Adverse Event|6|||
48833071|NCT00612586|157229286|FG001|Overall Study|Adverse Event|2|||
48833072|NCT00612586|157229285|FG000|Overall Study|Death|1|||
48833073|NCT00612586|157229286|FG001|Overall Study|Death|0|||
48833074|NCT00612586|157229285|FG000|Overall Study|Entry Criteria Not Met|0|||
48833075|NCT00612586|157229286|FG001|Overall Study|Entry Criteria Not Met|2|||
48833076|NCT00612586|157229285|FG000|Overall Study|Withdrawal by Subject|7|||
48833077|NCT00612586|157229286|FG001|Overall Study|Withdrawal by Subject|9|||
48833078|NCT00612586|157229285|FG000|Overall Study|Physician Decision|1|||
48833079|NCT00612586|157229286|FG001|Overall Study|Physician Decision|2|||
48833080|NCT00612586|157229285|FG000|Overall Study|Sponsor Decision|1|||
48833081|NCT00612586|157229286|FG001|Overall Study|Sponsor Decision|1|||
48833082|NCT00612586|157229285|FG000|Overall Study|Progressive Disease|26|||
48833083|NCT00612586|157229286|FG001|Overall Study|Progressive Disease|24|||
48833084|NCT00612586|157229285|FG000|Overall Study|Randomized and Not Treated|1|||
48833085|NCT00612586|157229286|FG001|Overall Study|Randomized and Not Treated|1|||
48833086|NCT00762606|157229289|FG000|Overall Study|Lost to Follow-up|18|||
48833087|NCT00762606|157229290|FG001|Overall Study|Lost to Follow-up|13|||
48833088|NCT00436644|157229291|FG000|Overall Study|Adverse Event|2|||
48833089|NCT00436644|157229291|FG000|Overall Study|Death|1|||
48833090|NCT01596504|157229293|FG000|Overall Study|Participant's Private Reason|0|||
48833091|NCT01596504|157229294|FG001|Overall Study|Participant's Private Reason|1|||
48833092|NCT01596504|157229295|FG002|Overall Study|Participant's Private Reason|0|||
48833093|NCT01596504|157229293|FG000|Overall Study|Adverse Event|1|||
48833094|NCT01596504|157229294|FG001|Overall Study|Adverse Event|2|||
48833095|NCT01596504|157229295|FG002|Overall Study|Adverse Event|1|||
48833096|NCT01596504|157229293|FG000|Overall Study|Withdrawal by Subject|1|||
48833097|NCT01596504|157229294|FG001|Overall Study|Withdrawal by Subject|0|||
48833098|NCT01596504|157229295|FG002|Overall Study|Withdrawal by Subject|0|||
48833099|NCT01069341|157229296|FG000|Overall Study|Lost to Follow-up|1|||
48833100|NCT00922207|157229297|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
48833101|NCT00922207|157229298|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
48833102|NCT00922207|157229299|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
48833103|NCT00922207|157229297|FG000|Overall Study|Insufficient Therapeutic Response|0|||
48833104|NCT00922207|157229298|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48833105|NCT00922207|157229299|FG002|Overall Study|Insufficient Therapeutic Response|1|||
48833106|NCT00922207|157229297|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
48833107|NCT00922207|157229298|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48833108|NCT00922207|157229299|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
48833109|NCT00922207|157229297|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
48833110|NCT00922207|157229298|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
48833111|NCT00922207|157229299|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
48833112|NCT00922207|157229297|FG000|Overall Study|Withdrew Consent|2|||
48833113|NCT00922207|157229298|FG001|Overall Study|Withdrew Consent|5|||
48833114|NCT00922207|157229299|FG002|Overall Study|Withdrew Consent|2|||
48833115|NCT00922207|157229297|FG000|Overall Study|Abnormality of Laboratory Test|0|||
48833116|NCT00922207|157229298|FG001|Overall Study|Abnormality of Laboratory Test|1|||
48833117|NCT00922207|157229299|FG002|Overall Study|Abnormality of Laboratory Test|1|||
48833118|NCT03299816|157229304|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
48833119|NCT03299816|157229305|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
48833120|NCT03299816|157229304|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
48530425|NCT03371381|156131267|FG000|Overall Study|Death|5|||
48833121|NCT03299816|157229305|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
48833122|NCT03299816|157229304|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
48530426|NCT03371381|156131267|FG000|Overall Study|Study terminated by sponsor|3|||
48530427|NCT03371381|156131267|FG000|Overall Study|Other|4|||
48530428|NCT01987895|156131268|FG000|Overall Study|Withdrawal by Subject|12|||
48530429|NCT01987895|156131269|FG001|Overall Study|Withdrawal by Subject|7|||
48530430|NCT01987895|156131268|FG000|Overall Study|Physician Decision|8|||
48833123|NCT03299816|157229305|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
48833124|NCT04536077|157229310|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
48833125|NCT04536077|157229311|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
48833126|NCT04536077|157229310|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
48530431|NCT01987895|156131269|FG001|Overall Study|Physician Decision|10|||
48530432|NCT01987895|156131268|FG000|Overall Study|Death|7|||
48530433|NCT01987895|156131269|FG001|Overall Study|Death|7|||
48530434|NCT01987895|156131268|FG000|Overall Study|Lost to Follow-up|3|||
48530435|NCT01987895|156131269|FG001|Overall Study|Lost to Follow-up|5|||
48530436|NCT01987895|156131268|FG000|Overall Study|randomized before giving IC|0|||
48530437|NCT01987895|156131269|FG001|Overall Study|randomized before giving IC|1|||
48530438|NCT01106014|156131270|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
48530439|NCT01106014|156131271|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
48530440|NCT01106014|156131270|FG000|Overall Study|Adverse Event|78|||
48530441|NCT01106014|156131271|FG001|Overall Study|Adverse Event|42|||
48530442|NCT01106014|156131270|FG000|Overall Study|Withdrawal by Subject|43|||
48530443|NCT01106014|156131271|FG001|Overall Study|Withdrawal by Subject|37|||
48530444|NCT01106014|156131270|FG000|Overall Study|Administrative reason|7|||
48530445|NCT01106014|156131271|FG001|Overall Study|Administrative reason|6|||
48530446|NCT01106014|156131270|FG000|Overall Study|Lost to Follow-up|2|||
48530447|NCT01106014|156131271|FG001|Overall Study|Lost to Follow-up|3|||
48530448|NCT02598388|156131272|FG000|Overall Study|Lost to Follow-up|1|||
48530449|NCT02598388|156131273|FG001|Overall Study|Lost to Follow-up|0|||
48833127|NCT04536077|157229311|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
48833128|NCT03803774|157229312|FG000|Dose Escalation|Withdrawal by Subject|0|||
48833129|NCT03803774|157229313|FG001|Dose Escalation|Withdrawal by Subject|0|||
48833130|NCT03803774|157229314|FG002|Dose Escalation|Withdrawal by Subject|0|||
48833131|NCT03803774|157229315|FG003|Dose Escalation|Withdrawal by Subject|1|||
48833132|NCT03803774|157229316|FG004|Dose Escalation|Withdrawal by Subject|0|||
48833133|NCT00208767|157229318|FG000|Overall Study|Adverse Event|9|||
48833134|NCT00208767|157229319|FG001|Overall Study|Adverse Event|1|||
48833135|NCT00208767|157229318|FG000|Overall Study|Withdrawal by Subject|14|||
48833136|NCT00208767|157229319|FG001|Overall Study|Withdrawal by Subject|3|||
48833137|NCT00208767|157229318|FG000|Overall Study|Death|1|||
48833138|NCT00208767|157229319|FG001|Overall Study|Death|0|||
48833139|NCT00208767|157229318|FG000|Overall Study|Lost to Follow-up|3|||
48530450|NCT02598388|156131274|FG002|Overall Study|Lost to Follow-up|1|||
48530451|NCT02598388|156131275|FG003|Overall Study|Lost to Follow-up|0|||
48530452|NCT02598388|156131276|FG004|Overall Study|Lost to Follow-up|5|||
48833140|NCT00208767|157229319|FG001|Overall Study|Lost to Follow-up|3|||
48833141|NCT01751724|157229322|FG000|Overall Study|extubated bef.start assigned treatment|1|||
48530453|NCT02598388|156131277|FG005|Overall Study|Lost to Follow-up|1|||
48530454|NCT02598388|156131278|FG006|Overall Study|Lost to Follow-up|2|||
48530455|NCT02598388|156131279|FG007|Overall Study|Lost to Follow-up|1|||
48530456|NCT02598388|156131280|FG008|Overall Study|Lost to Follow-up|0|||
48530457|NCT02598388|156131281|FG009|Overall Study|Lost to Follow-up|0|||
48530458|NCT02598388|156131282|FG010|Overall Study|Lost to Follow-up|1|||
48530459|NCT02598388|156131283|FG011|Overall Study|Lost to Follow-up|0|||
48530460|NCT02598388|156131272|FG000|Overall Study|Withdrawal by Subject|0|||
48530461|NCT02598388|156131273|FG001|Overall Study|Withdrawal by Subject|0|||
48530462|NCT02598388|156131274|FG002|Overall Study|Withdrawal by Subject|0|||
48530463|NCT02598388|156131275|FG003|Overall Study|Withdrawal by Subject|0|||
48530464|NCT02598388|156131276|FG004|Overall Study|Withdrawal by Subject|2|||
48530465|NCT02598388|156131277|FG005|Overall Study|Withdrawal by Subject|0|||
48530466|NCT02598388|156131278|FG006|Overall Study|Withdrawal by Subject|2|||
48530467|NCT02598388|156131279|FG007|Overall Study|Withdrawal by Subject|0|||
48530468|NCT02598388|156131280|FG008|Overall Study|Withdrawal by Subject|0|||
48530469|NCT02598388|156131281|FG009|Overall Study|Withdrawal by Subject|1|||
48530470|NCT02598388|156131282|FG010|Overall Study|Withdrawal by Subject|0|||
48530471|NCT02598388|156131283|FG011|Overall Study|Withdrawal by Subject|0|||
48530472|NCT02598388|156131272|FG000|Overall Study|Other|0|||
48530473|NCT02598388|156131273|FG001|Overall Study|Other|0|||
48530474|NCT02598388|156131274|FG002|Overall Study|Other|1|||
48530475|NCT02598388|156131275|FG003|Overall Study|Other|0|||
48530476|NCT02598388|156131276|FG004|Overall Study|Other|3|||
48530477|NCT02598388|156131277|FG005|Overall Study|Other|0|||
48530478|NCT02598388|156131278|FG006|Overall Study|Other|1|||
48530479|NCT02598388|156131279|FG007|Overall Study|Other|0|||
48530480|NCT02598388|156131280|FG008|Overall Study|Other|0|||
48530481|NCT02598388|156131281|FG009|Overall Study|Other|0|||
48530482|NCT02598388|156131282|FG010|Overall Study|Other|0|||
48530483|NCT02598388|156131283|FG011|Overall Study|Other|0|||
48530496|NCT02443324|156131289|FG000|Overall Study|Death|4|||
48530497|NCT02443324|156131290|FG001|Overall Study|Death|1|||
48530498|NCT02443324|156131291|FG002|Overall Study|Death|0|||
48530499|NCT02443324|156131292|FG003|Overall Study|Death|3|||
48530500|NCT02443324|156131293|FG004|Overall Study|Death|1|||
48530501|NCT02443324|156131294|FG005|Overall Study|Death|3|||
48530502|NCT02443324|156131295|FG006|Overall Study|Death|2|||
48530503|NCT02443324|156131289|FG000|Overall Study|Lost to Follow-up|0|||
48530504|NCT02443324|156131290|FG001|Overall Study|Lost to Follow-up|0|||
48530505|NCT02443324|156131291|FG002|Overall Study|Lost to Follow-up|0|||
48530506|NCT02443324|156131292|FG003|Overall Study|Lost to Follow-up|1|||
48530507|NCT02443324|156131293|FG004|Overall Study|Lost to Follow-up|0|||
48530508|NCT02443324|156131294|FG005|Overall Study|Lost to Follow-up|1|||
48530509|NCT02443324|156131295|FG006|Overall Study|Lost to Follow-up|0|||
48530510|NCT02443324|156131289|FG000|Overall Study|Physician Decision|0|||
48530511|NCT02443324|156131290|FG001|Overall Study|Physician Decision|3|||
48530512|NCT02443324|156131291|FG002|Overall Study|Physician Decision|5|||
48530513|NCT02443324|156131292|FG003|Overall Study|Physician Decision|1|||
48833142|NCT01751724|157229323|FG001|Overall Study|extubated bef.start assigned treatment|0|||
48833143|NCT01751724|157229322|FG000|Overall Study|withdrawn by parent|0|||
48530514|NCT02443324|156131293|FG004|Overall Study|Physician Decision|1|||
48530515|NCT02443324|156131294|FG005|Overall Study|Physician Decision|0|||
48530516|NCT02443324|156131295|FG006|Overall Study|Physician Decision|2|||
48530517|NCT02443324|156131289|FG000|Overall Study|Progressive Disease|20|||
48530518|NCT02443324|156131290|FG001|Overall Study|Progressive Disease|20|||
48530519|NCT02443324|156131291|FG002|Overall Study|Progressive Disease|13|||
48530520|NCT02443324|156131292|FG003|Overall Study|Progressive Disease|10|||
48530521|NCT02443324|156131293|FG004|Overall Study|Progressive Disease|13|||
48530522|NCT02443324|156131294|FG005|Overall Study|Progressive Disease|17|||
48530523|NCT02443324|156131295|FG006|Overall Study|Progressive Disease|10|||
48530524|NCT02443324|156131289|FG000|Overall Study|Withdrawal by Subject|0|||
48530525|NCT02443324|156131290|FG001|Overall Study|Withdrawal by Subject|0|||
48530526|NCT02443324|156131291|FG002|Overall Study|Withdrawal by Subject|3|||
48530527|NCT02443324|156131292|FG003|Overall Study|Withdrawal by Subject|1|||
48530528|NCT02443324|156131293|FG004|Overall Study|Withdrawal by Subject|1|||
48530529|NCT02443324|156131294|FG005|Overall Study|Withdrawal by Subject|0|||
48530530|NCT02443324|156131295|FG006|Overall Study|Withdrawal by Subject|1|||
48530531|NCT02443324|156131289|FG000|Overall Study|Adverse Event|0|||
48530532|NCT02443324|156131290|FG001|Overall Study|Adverse Event|1|||
48530533|NCT02443324|156131291|FG002|Overall Study|Adverse Event|3|||
48530534|NCT02443324|156131292|FG003|Overall Study|Adverse Event|0|||
48530535|NCT02443324|156131293|FG004|Overall Study|Adverse Event|4|||
48530536|NCT02443324|156131294|FG005|Overall Study|Adverse Event|3|||
48530537|NCT02443324|156131295|FG006|Overall Study|Adverse Event|3|||
48530538|NCT02443324|156131289|FG000|Overall Study|Enrolled but Never Treated|0|||
48530539|NCT02443324|156131290|FG001|Overall Study|Enrolled but Never Treated|0|||
48530540|NCT02443324|156131291|FG002|Overall Study|Enrolled but Never Treated|1|||
48530541|NCT02443324|156131292|FG003|Overall Study|Enrolled but Never Treated|0|||
48530542|NCT02443324|156131293|FG004|Overall Study|Enrolled but Never Treated|1|||
48530543|NCT02443324|156131294|FG005|Overall Study|Enrolled but Never Treated|0|||
48530544|NCT02443324|156131295|FG006|Overall Study|Enrolled but Never Treated|1|||
48530559|NCT00949988|156131300|FG000|Overall Study|Withdrawal by Subject|3|||
48833144|NCT01751724|157229323|FG001|Overall Study|withdrawn by parent|2|||
48833145|NCT01690624|157229326|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
48530560|NCT03714815|156131301|FG000|Overall Study|Physician Decision|2|||
48530561|NCT03714815|156131301|FG000|Overall Study|Withdrawal by Subject|2|||
48530562|NCT03714815|156131301|FG000|Overall Study|Death|11|||
48530563|NCT04999111|156131302|FG000|Overall Study|Lost to Follow-up|21|||
48530564|NCT04999111|156131303|FG001|Overall Study|Lost to Follow-up|16|||
48530565|NCT04999111|156131304|FG002|Overall Study|Lost to Follow-up|2|||
48530566|NCT04999111|156131305|FG003|Overall Study|Lost to Follow-up|26|||
48530567|NCT04999111|156131306|FG004|Overall Study|Lost to Follow-up|30|||
48530568|NCT04999111|156131307|FG005|Overall Study|Lost to Follow-up|6|||
48530569|NCT04999111|156131302|FG000|Overall Study|Physician Decision|1|||
48530570|NCT04999111|156131303|FG001|Overall Study|Physician Decision|3|||
48530571|NCT04999111|156131304|FG002|Overall Study|Physician Decision|0|||
48530572|NCT04999111|156131305|FG003|Overall Study|Physician Decision|1|||
48530573|NCT04999111|156131306|FG004|Overall Study|Physician Decision|2|||
48530574|NCT04999111|156131307|FG005|Overall Study|Physician Decision|0|||
48530575|NCT04999111|156131302|FG000|Overall Study|Withdrawal by Subject|23|||
48530576|NCT04999111|156131303|FG001|Overall Study|Withdrawal by Subject|29|||
48530577|NCT04999111|156131304|FG002|Overall Study|Withdrawal by Subject|15|||
48530578|NCT04999111|156131305|FG003|Overall Study|Withdrawal by Subject|30|||
48530579|NCT04999111|156131306|FG004|Overall Study|Withdrawal by Subject|35|||
48530580|NCT04999111|156131307|FG005|Overall Study|Withdrawal by Subject|10|||
48530581|NCT04999111|156131302|FG000|Overall Study|Other|6|||
48530582|NCT04999111|156131303|FG001|Overall Study|Other|6|||
48530583|NCT04999111|156131304|FG002|Overall Study|Other|3|||
48833146|NCT01690624|157229327|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
48530584|NCT04999111|156131305|FG003|Overall Study|Other|8|||
48530585|NCT04999111|156131306|FG004|Overall Study|Other|8|||
48530586|NCT04999111|156131307|FG005|Overall Study|Other|5|||
48833147|NCT01690624|157229328|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
48530587|NCT04999111|156131302|FG000|Overall Study|Non-compliance with study schedule|1|||
48530588|NCT04999111|156131303|FG001|Overall Study|Non-compliance with study schedule|0|||
48530589|NCT04999111|156131304|FG002|Overall Study|Non-compliance with study schedule|0|||
48530590|NCT04999111|156131305|FG003|Overall Study|Non-compliance with study schedule|1|||
48530591|NCT04999111|156131306|FG004|Overall Study|Non-compliance with study schedule|1|||
48530592|NCT04999111|156131307|FG005|Overall Study|Non-compliance with study schedule|1|||
48530593|NCT04999111|156131302|FG000|Overall Study|Randomized but not vaccinated|1|||
48833148|NCT01690624|157229329|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
48530594|NCT04999111|156131303|FG001|Overall Study|Randomized but not vaccinated|2|||
48530595|NCT04999111|156131304|FG002|Overall Study|Randomized but not vaccinated|0|||
48530596|NCT04999111|156131305|FG003|Overall Study|Randomized but not vaccinated|3|||
48530597|NCT04999111|156131306|FG004|Overall Study|Randomized but not vaccinated|3|||
48530598|NCT04999111|156131307|FG005|Overall Study|Randomized but not vaccinated|0|||
48530599|NCT04999111|156131302|FG000|Overall Study|Adverse Event|1|||
48530600|NCT04999111|156131303|FG001|Overall Study|Adverse Event|1|||
48530601|NCT04999111|156131304|FG002|Overall Study|Adverse Event|0|||
48530602|NCT04999111|156131305|FG003|Overall Study|Adverse Event|0|||
48530603|NCT04999111|156131306|FG004|Overall Study|Adverse Event|0|||
48530604|NCT04999111|156131307|FG005|Overall Study|Adverse Event|0|||
48530605|NCT04999111|156131302|FG000|Overall Study|Initiated prohibited medication|0|||
48530606|NCT04999111|156131303|FG001|Overall Study|Initiated prohibited medication|0|||
48530607|NCT04999111|156131304|FG002|Overall Study|Initiated prohibited medication|0|||
48530608|NCT04999111|156131305|FG003|Overall Study|Initiated prohibited medication|0|||
48530609|NCT04999111|156131306|FG004|Overall Study|Initiated prohibited medication|1|||
48530610|NCT04999111|156131307|FG005|Overall Study|Initiated prohibited medication|0|||
48530611|NCT04703855|156131311|FG000|Overall Study|Heart Transplant|1|||
48530612|NCT01714739|156131314|FG000|Overall Study|Disease progression|3|||
48530613|NCT01714739|156131315|FG001|Overall Study|Disease progression|5|||
48530614|NCT01714739|156131316|FG002|Overall Study|Disease progression|5|||
48530615|NCT01714739|156131317|FG003|Overall Study|Disease progression|204|||
48530616|NCT01714739|156131318|FG004|Overall Study|Disease progression|1|||
48530617|NCT01714739|156131319|FG005|Overall Study|Disease progression|3|||
48530618|NCT01714739|156131320|FG006|Overall Study|Disease progression|5|||
48530619|NCT01714739|156131314|FG000|Overall Study|Study drug toxicity|1|||
48530620|NCT01714739|156131315|FG001|Overall Study|Study drug toxicity|1|||
48530621|NCT01714739|156131316|FG002|Overall Study|Study drug toxicity|1|||
48530622|NCT01714739|156131317|FG003|Overall Study|Study drug toxicity|15|||
48833149|NCT01690624|157229326|FG000|Overall Study|Adverse event (other than DLT)|3|||
48833150|NCT01690624|157229327|FG001|Overall Study|Adverse event (other than DLT)|1|||
48833151|NCT01690624|157229328|FG002|Overall Study|Adverse event (other than DLT)|1|||
48530623|NCT01714739|156131318|FG004|Overall Study|Study drug toxicity|0|||
48530624|NCT01714739|156131319|FG005|Overall Study|Study drug toxicity|0|||
48530625|NCT01714739|156131320|FG006|Overall Study|Study drug toxicity|5|||
48530626|NCT01714739|156131314|FG000|Overall Study|Death|0|||
48530627|NCT01714739|156131315|FG001|Overall Study|Death|0|||
48530628|NCT01714739|156131316|FG002|Overall Study|Death|0|||
48530629|NCT01714739|156131317|FG003|Overall Study|Death|1|||
48530630|NCT01714739|156131318|FG004|Overall Study|Death|0|||
48530631|NCT01714739|156131319|FG005|Overall Study|Death|0|||
48530632|NCT01714739|156131320|FG006|Overall Study|Death|0|||
48530633|NCT01714739|156131314|FG000|Overall Study|Adverse Event unrelated to drug|0|||
48530634|NCT01714739|156131315|FG001|Overall Study|Adverse Event unrelated to drug|0|||
48530635|NCT01714739|156131316|FG002|Overall Study|Adverse Event unrelated to drug|3|||
48530636|NCT01714739|156131317|FG003|Overall Study|Adverse Event unrelated to drug|21|||
48530637|NCT01714739|156131318|FG004|Overall Study|Adverse Event unrelated to drug|0|||
48530638|NCT01714739|156131319|FG005|Overall Study|Adverse Event unrelated to drug|0|||
48530639|NCT01714739|156131320|FG006|Overall Study|Adverse Event unrelated to drug|0|||
48530640|NCT01714739|156131314|FG000|Overall Study|Participant request to stop therapy|0|||
48530641|NCT01714739|156131315|FG001|Overall Study|Participant request to stop therapy|1|||
48530642|NCT01714739|156131316|FG002|Overall Study|Participant request to stop therapy|0|||
48530643|NCT01714739|156131317|FG003|Overall Study|Participant request to stop therapy|6|||
48530644|NCT01714739|156131318|FG004|Overall Study|Participant request to stop therapy|0|||
48530645|NCT01714739|156131319|FG005|Overall Study|Participant request to stop therapy|0|||
48530646|NCT01714739|156131320|FG006|Overall Study|Participant request to stop therapy|0|||
48530647|NCT01714739|156131314|FG000|Overall Study|Participant withdrew consent|0|||
48530648|NCT01714739|156131315|FG001|Overall Study|Participant withdrew consent|1|||
48530649|NCT01714739|156131316|FG002|Overall Study|Participant withdrew consent|0|||
48833152|NCT01690624|157229329|FG003|Overall Study|Adverse event (other than DLT)|1|||
48833153|NCT01690624|157229326|FG000|Overall Study|Withdrawal by Subject|0|||
48833154|NCT01690624|157229327|FG001|Overall Study|Withdrawal by Subject|0|||
48833155|NCT01690624|157229328|FG002|Overall Study|Withdrawal by Subject|1|||
48833156|NCT01690624|157229329|FG003|Overall Study|Withdrawal by Subject|0|||
48833157|NCT01690624|157229326|FG000|Overall Study|Sponsor is ending trial|0|||
48833158|NCT01690624|157229327|FG001|Overall Study|Sponsor is ending trial|0|||
48833159|NCT01690624|157229328|FG002|Overall Study|Sponsor is ending trial|0|||
48833160|NCT01690624|157229329|FG003|Overall Study|Sponsor is ending trial|1|||
48833161|NCT01690624|157229326|FG000|Overall Study|Physician Decision|0|||
48833162|NCT01690624|157229327|FG001|Overall Study|Physician Decision|0|||
48833163|NCT01690624|157229328|FG002|Overall Study|Physician Decision|0|||
48833164|NCT01690624|157229329|FG003|Overall Study|Physician Decision|1|||
48833165|NCT01690624|157229326|FG000|Overall Study|Withdrawal by Subject|0|||
48833166|NCT01690624|157229327|FG001|Overall Study|Withdrawal by Subject|1|||
48833167|NCT01690624|157229328|FG002|Overall Study|Withdrawal by Subject|0|||
48833168|NCT01690624|157229329|FG003|Overall Study|Withdrawal by Subject|0|||
48530650|NCT01714739|156131317|FG003|Overall Study|Participant withdrew consent|8|||
48530651|NCT01714739|156131318|FG004|Overall Study|Participant withdrew consent|0|||
48530652|NCT01714739|156131319|FG005|Overall Study|Participant withdrew consent|0|||
48530653|NCT01714739|156131320|FG006|Overall Study|Participant withdrew consent|0|||
48530654|NCT01714739|156131314|FG000|Overall Study|Lost to Follow-up|0|||
48833169|NCT01690624|157229326|FG000|Overall Study|Lack of Efficacy|1|||
48833170|NCT01690624|157229327|FG001|Overall Study|Lack of Efficacy|1|||
48833171|NCT01690624|157229328|FG002|Overall Study|Lack of Efficacy|3|||
48833172|NCT01690624|157229329|FG003|Overall Study|Lack of Efficacy|0|||
48833173|NCT05355116|157231024|FG000|Overall Study|Withdrawal by Subject|2|||
48833174|NCT01025843|157231028|FG000|Washout 4|Withdrawal by Subject|0|||
48833175|NCT01025843|157231029|FG001|Washout 4|Withdrawal by Subject|0|||
48530655|NCT01714739|156131315|FG001|Overall Study|Lost to Follow-up|0|||
48530656|NCT01714739|156131316|FG002|Overall Study|Lost to Follow-up|0|||
48530657|NCT01714739|156131317|FG003|Overall Study|Lost to Follow-up|1|||
48530658|NCT01714739|156131318|FG004|Overall Study|Lost to Follow-up|0|||
48530659|NCT01714739|156131319|FG005|Overall Study|Lost to Follow-up|0|||
48530660|NCT01714739|156131320|FG006|Overall Study|Lost to Follow-up|0|||
48530661|NCT01714739|156131314|FG000|Overall Study|Maximum clinical benefit|0|||
48530662|NCT01714739|156131315|FG001|Overall Study|Maximum clinical benefit|1|||
48530663|NCT01714739|156131316|FG002|Overall Study|Maximum clinical benefit|1|||
48530664|NCT01714739|156131317|FG003|Overall Study|Maximum clinical benefit|3|||
48530665|NCT01714739|156131318|FG004|Overall Study|Maximum clinical benefit|0|||
48530666|NCT01714739|156131319|FG005|Overall Study|Maximum clinical benefit|0|||
48833176|NCT01025843|157231030|FG002|Washout 4|Withdrawal by Subject|1|||
48833177|NCT01025843|157231031|FG003|Washout 4|Withdrawal by Subject|1|||
48833178|NCT01025843|157231032|FG004|Washout 4|Withdrawal by Subject|0|||
48833179|NCT01025843|157231033|FG005|Washout 4|Withdrawal by Subject|0|||
48833180|NCT01025843|157231034|FG006|Washout 4|Withdrawal by Subject|0|||
48833181|NCT01025843|157231035|FG007|Washout 4|Withdrawal by Subject|0|||
48833182|NCT01025843|157231036|FG008|Washout 4|Withdrawal by Subject|0|||
48833183|NCT01025843|157231037|FG009|Washout 4|Withdrawal by Subject|0|||
48833184|NCT01883492|157231040|FG000|Overall Study|Lost to Follow-up|3|||
48833185|NCT01883492|157231041|FG001|Overall Study|Lost to Follow-up|4|||
48833186|NCT01883492|157231040|FG000|Overall Study|Surgery on contra-lateral hip|0|||
48833187|NCT01883492|157231041|FG001|Overall Study|Surgery on contra-lateral hip|1|||
48833188|NCT01883492|157231040|FG000|Overall Study|Poor X-ray quality|7|||
48833189|NCT01883492|157231041|FG001|Overall Study|Poor X-ray quality|4|||
48833190|NCT01883492|157231040|FG000|Overall Study|Withdrawal by Subject|1|||
48833191|NCT01883492|157231041|FG001|Overall Study|Withdrawal by Subject|0|||
48833192|NCT01883492|157231040|FG000|Overall Study|inappropriate implant used|1|||
48833193|NCT01883492|157231041|FG001|Overall Study|inappropriate implant used|1|||
48833194|NCT01883492|157231040|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
48833195|NCT01883492|157231041|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
48833196|NCT03265210|157231042|FG000|Overall Study|Withdrawal by Subject|7|||
48833197|NCT03265210|157231043|FG001|Overall Study|Withdrawal by Subject|9|||
48833198|NCT03265210|157231042|FG000|Overall Study|Lost to Follow-up|2|||
48833199|NCT03265210|157231043|FG001|Overall Study|Lost to Follow-up|0|||
48833200|NCT03265210|157231042|FG000|Overall Study|Physician Decision|2|||
48833201|NCT03265210|157231043|FG001|Overall Study|Physician Decision|0|||
48833202|NCT03265210|157231042|FG000|Overall Study|Adverse Event|1|||
48833203|NCT03265210|157231043|FG001|Overall Study|Adverse Event|0|||
48833204|NCT04353037|157231046|FG000|Overall Study|Lost to Follow-up|0|||
48833205|NCT04353037|157231047|FG001|Overall Study|Lost to Follow-up|1|||
48833206|NCT04353037|157231048|FG002|Overall Study|Lost to Follow-up|2|||
48833207|NCT04353037|157231049|FG003|Overall Study|Lost to Follow-up|3|||
48833208|NCT04353037|157231046|FG000|Overall Study|Withdrawal by Subject|0|||
48833209|NCT04353037|157231047|FG001|Overall Study|Withdrawal by Subject|2|||
48833210|NCT04353037|157231048|FG002|Overall Study|Withdrawal by Subject|3|||
48833211|NCT04353037|157231049|FG003|Overall Study|Withdrawal by Subject|5|||
48833212|NCT04353037|157231046|FG000|Overall Study|Adverse Event|0|||
48833213|NCT04353037|157231047|FG001|Overall Study|Adverse Event|0|||
48833214|NCT04353037|157231048|FG002|Overall Study|Adverse Event|2|||
48833215|NCT04353037|157231049|FG003|Overall Study|Adverse Event|0|||
48833216|NCT04353037|157231046|FG000|Overall Study|Exposure Change|0|||
48833217|NCT04353037|157231047|FG001|Overall Study|Exposure Change|0|||
48833218|NCT04353037|157231048|FG002|Overall Study|Exposure Change|0|||
48833219|NCT04353037|157231049|FG003|Overall Study|Exposure Change|2|||
48833220|NCT00357396|157231051|FG000|Overall Study|Adverse Event|1|||
48833221|NCT00357396|157231052|FG001|Overall Study|Adverse Event|0|||
48833222|NCT02274493|157231053|FG000|Overall Study|Withdrawal by Subject|1|||
48833223|NCT00920686|157231054|FG000|Overall Study|Lost to Follow-up|2|||
48833224|NCT00920686|157231055|FG001|Overall Study|Lost to Follow-up|3|||
48833225|NCT00920686|157231056|FG002|Overall Study|Lost to Follow-up|1|||
48833226|NCT00920686|157231054|FG000|Overall Study|Study drug dosing criteria not met|17|||
48833227|NCT00920686|157231055|FG001|Overall Study|Study drug dosing criteria not met|19|||
48833228|NCT00920686|157231056|FG002|Overall Study|Study drug dosing criteria not met|12|||
48833229|NCT01494662|157231061|FG000|Overall Study|Withdrawal by Subject|0|||
48530667|NCT01714739|156131320|FG006|Overall Study|Maximum clinical benefit|0|||
48530668|NCT01714739|156131314|FG000|Overall Study|Poor/non-comliance|0|||
48530669|NCT01714739|156131315|FG001|Overall Study|Poor/non-comliance|1|||
48833230|NCT01494662|157231062|FG001|Overall Study|Withdrawal by Subject|0|||
48833231|NCT01494662|157231063|FG002|Overall Study|Withdrawal by Subject|1|||
48833232|NCT01494662|157231064|FG003|Overall Study|Withdrawal by Subject|0|||
48833233|NCT01494662|157231065|FG004|Overall Study|Withdrawal by Subject|0|||
48530670|NCT01714739|156131316|FG002|Overall Study|Poor/non-comliance|0|||
48530671|NCT01714739|156131317|FG003|Overall Study|Poor/non-comliance|1|||
48530672|NCT01714739|156131318|FG004|Overall Study|Poor/non-comliance|0|||
48530673|NCT01714739|156131319|FG005|Overall Study|Poor/non-comliance|0|||
48530674|NCT01714739|156131320|FG006|Overall Study|Poor/non-comliance|0|||
48833234|NCT01494662|157231066|FG005|Overall Study|Withdrawal by Subject|0|||
48833235|NCT01494662|157231067|FG006|Overall Study|Withdrawal by Subject|0|||
48833236|NCT01494662|157231061|FG000|Overall Study|Physician Decision|0|||
48833237|NCT01494662|157231062|FG001|Overall Study|Physician Decision|0|||
48530675|NCT01714739|156131314|FG000|Overall Study|No longer meets study criteria|0|||
48530676|NCT01714739|156131315|FG001|Overall Study|No longer meets study criteria|0|||
48530677|NCT01714739|156131316|FG002|Overall Study|No longer meets study criteria|0|||
48530678|NCT01714739|156131317|FG003|Overall Study|No longer meets study criteria|1|||
48833238|NCT01494662|157231063|FG002|Overall Study|Physician Decision|1|||
48833239|NCT01494662|157231064|FG003|Overall Study|Physician Decision|0|||
48833240|NCT01494662|157231065|FG004|Overall Study|Physician Decision|0|||
48833241|NCT01494662|157231066|FG005|Overall Study|Physician Decision|0|||
48833242|NCT01494662|157231067|FG006|Overall Study|Physician Decision|0|||
48833243|NCT01329328|157231068|FG000|Overall Study|Withdrawal by Subject|2|||
48833244|NCT01329328|157231069|FG001|Overall Study|Withdrawal by Subject|4|||
48833245|NCT01329328|157231070|FG002|Overall Study|Withdrawal by Subject|3|||
48833246|NCT01651949|157231071|FG000|Overall Study|Unknown status|4|||
48833247|NCT01651949|157231072|FG001|Overall Study|Unknown status|4|||
48833248|NCT01651949|157231073|FG002|Overall Study|Unknown status|0|||
48833249|NCT01651949|157231071|FG000|Overall Study|Lost to Follow-up|30|||
48833250|NCT01651949|157231072|FG001|Overall Study|Lost to Follow-up|56|||
48833251|NCT01651949|157231073|FG002|Overall Study|Lost to Follow-up|20|||
48833252|NCT01651949|157231071|FG000|Overall Study|Protocol Violation|0|||
48833253|NCT01651949|157231072|FG001|Overall Study|Protocol Violation|2|||
48833254|NCT01651949|157231073|FG002|Overall Study|Protocol Violation|1|||
48833255|NCT01651949|157231071|FG000|Overall Study|Physician Decision|0|||
48833256|NCT01651949|157231072|FG001|Overall Study|Physician Decision|2|||
48833257|NCT01651949|157231073|FG002|Overall Study|Physician Decision|0|||
48833258|NCT01651949|157231071|FG000|Overall Study|Adverse Event|0|||
48833259|NCT01651949|157231072|FG001|Overall Study|Adverse Event|2|||
48833260|NCT01651949|157231073|FG002|Overall Study|Adverse Event|1|||
48833261|NCT01651949|157231071|FG000|Overall Study|Screen failure|2|||
48833262|NCT01651949|157231072|FG001|Overall Study|Screen failure|2|||
48833263|NCT01651949|157231073|FG002|Overall Study|Screen failure|0|||
48833264|NCT01651949|157231071|FG000|Overall Study|Withdrawal by Subject|17|||
48833265|NCT01651949|157231072|FG001|Overall Study|Withdrawal by Subject|18|||
48833266|NCT01651949|157231073|FG002|Overall Study|Withdrawal by Subject|9|||
48833267|NCT02595398|157231074|FG000|Overall Study|Non-compliance|1|||
48833268|NCT02595398|157231075|FG001|Overall Study|Non-compliance|0|||
48833269|NCT02595398|157231074|FG000|Overall Study|Withdrawal by Subject|2|||
48833270|NCT02595398|157231075|FG001|Overall Study|Withdrawal by Subject|1|||
48833271|NCT02595398|157231074|FG000|Overall Study|Lost to Follow-up|1|||
48833272|NCT02595398|157231075|FG001|Overall Study|Lost to Follow-up|0|||
48833273|NCT00544440|157231076|FG000|Overall Study|Other|1|||
48833274|NCT00544440|157231076|FG000|Overall Study|Adverse Event|1|||
48833275|NCT00544440|157231076|FG000|Overall Study|Withdrawal by Subject|2|||
48833276|NCT00544440|157231076|FG000|Overall Study|Subject Non-compliance|1|||
48833277|NCT00544440|157231076|FG000|Overall Study|Progressive Disease|47|||
48833278|NCT00544440|157231076|FG000|Overall Study|Other|5|||
48833279|NCT03525119|157231078|FG000|Overall Study|Adverse Event|0|||
48833280|NCT03525119|157231079|FG001|Overall Study|Adverse Event|1|||
48833281|NCT03525119|157231080|FG002|Overall Study|Adverse Event|0|||
48833282|NCT03525119|157231078|FG000|Overall Study|Lost to Follow-up|32|||
48833283|NCT03525119|157231079|FG001|Overall Study|Lost to Follow-up|33|||
48833284|NCT03525119|157231080|FG002|Overall Study|Lost to Follow-up|37|||
48833285|NCT03525119|157231078|FG000|Overall Study|Withdrawal by Subject|5|||
48833286|NCT03525119|157231079|FG001|Overall Study|Withdrawal by Subject|4|||
48833287|NCT03525119|157231080|FG002|Overall Study|Withdrawal by Subject|2|||
48833288|NCT03525119|157231078|FG000|Overall Study|Reason not Specified|2|||
48833289|NCT03525119|157231079|FG001|Overall Study|Reason not Specified|1|||
48530679|NCT01714739|156131318|FG004|Overall Study|No longer meets study criteria|0|||
48833290|NCT03525119|157231080|FG002|Overall Study|Reason not Specified|2|||
48833291|NCT03525119|157231078|FG000|Overall Study|Randomized but not Vaccinated|1|||
48833292|NCT03525119|157231079|FG001|Overall Study|Randomized but not Vaccinated|0|||
48833293|NCT03525119|157231080|FG002|Overall Study|Randomized but not Vaccinated|2|||
48833294|NCT03987451|157231081|FG000|Overall Study|Lost to Follow-up|1|||
48833295|NCT03987451|157231082|FG001|Overall Study|Lost to Follow-up|0|||
48833296|NCT03987451|157231081|FG000|Overall Study|Withdrawal by Subject|1|||
48833297|NCT03987451|157231082|FG001|Overall Study|Withdrawal by Subject|1|||
48833298|NCT00770965|157231096|FG000|Safety Set|Withdrawal by Subject|0|||
48833299|NCT00770965|157231097|FG001|Safety Set|Withdrawal by Subject|0|||
48833300|NCT00770965|157231098|FG002|Safety Set|Withdrawal by Subject|0|||
48530680|NCT01714739|156131319|FG005|Overall Study|No longer meets study criteria|0|||
48833301|NCT00770965|157231099|FG003|Safety Set|Withdrawal by Subject|1|||
48833302|NCT00770965|157231096|FG000|Safety Set|Protocol deviation|0|||
48833303|NCT00770965|157231097|FG001|Safety Set|Protocol deviation|0|||
48833304|NCT00770965|157231098|FG002|Safety Set|Protocol deviation|1|||
48833305|NCT00770965|157231099|FG003|Safety Set|Protocol deviation|0|||
48833306|NCT00770965|157231096|FG000|Excluded Set|Administrative problems|14|||
48833307|NCT00770965|157231097|FG001|Excluded Set|Administrative problems|12|||
48833308|NCT00770965|157231098|FG002|Excluded Set|Administrative problems|12|||
48833309|NCT00770965|157231099|FG003|Excluded Set|Administrative problems|10|||
48833310|NCT00770965|157231096|FG000|Excluded Set|Withdrawal by Subject|1|||
48833311|NCT00770965|157231097|FG001|Excluded Set|Withdrawal by Subject|1|||
48833312|NCT00770965|157231098|FG002|Excluded Set|Withdrawal by Subject|2|||
48833313|NCT00770965|157231099|FG003|Excluded Set|Withdrawal by Subject|3|||
48833314|NCT00509769|157231100|FG000|Overall Study|Progressive disease|77|||
48833315|NCT00509769|157231100|FG000|Overall Study|Adverse Event|4|||
48833316|NCT00509769|157231100|FG000|Overall Study|Patient's decision|1|||
48833317|NCT00509769|157231100|FG000|Overall Study|Physician Decision|8|||
48833318|NCT00509769|157231100|FG000|Overall Study|Use of prohibited therapies during study|1|||
48833319|NCT02371746|157231101|FG000|Overall Study|Consent withdrawn|0|||
48833320|NCT02371746|157231102|FG001|Overall Study|Consent withdrawn|0|||
48833321|NCT02371746|157231103|FG002|Overall Study|Consent withdrawn|0|||
48833322|NCT02371746|157231104|FG003|Overall Study|Consent withdrawn|0|||
48833323|NCT02371746|157231105|FG004|Overall Study|Consent withdrawn|0|||
48833324|NCT02371746|157231106|FG005|Overall Study|Consent withdrawn|0|||
48833325|NCT02371746|157231107|FG006|Overall Study|Consent withdrawn|1|||
48833326|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
48833327|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
48833328|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
48833329|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
48833330|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
48833331|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
48833332|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
48833333|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
48833334|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
48530681|NCT01714739|156131320|FG006|Overall Study|No longer meets study criteria|0|||
48833335|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
48833336|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
48833337|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
48833338|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Death|7|||
48833339|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Death|4|||
48833340|NCT00410124|157231109|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
48833341|NCT00410124|157231110|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
48833342|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
48833343|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
48833344|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
48833345|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
48833346|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
48530682|NCT01714739|156131314|FG000|Overall Study|Other reason|0|||
48602725|NCT03569098|156401524|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
48602726|NCT03569098|156401525|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
48602727|NCT03569098|156401526|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
48602728|NCT02317991|156401527|FG000|Overall Study|Adverse Event|12|||
48602729|NCT02317991|156401527|FG000|Overall Study|Death|4|||
48833347|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
48833348|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
48833349|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
48833350|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
48833351|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
48833352|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
48530683|NCT01714739|156131315|FG001|Overall Study|Other reason|0|||
48530684|NCT01714739|156131316|FG002|Overall Study|Other reason|0|||
48530685|NCT01714739|156131317|FG003|Overall Study|Other reason|3|||
48530686|NCT01714739|156131318|FG004|Overall Study|Other reason|1|||
48530687|NCT01714739|156131319|FG005|Overall Study|Other reason|0|||
48530688|NCT01714739|156131320|FG006|Overall Study|Other reason|0|||
48530689|NCT03297294|156131328|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
48530690|NCT03297294|156131329|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
48530691|NCT03297294|156131330|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48530692|NCT03297294|156131331|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48530693|NCT03297294|156131332|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48833353|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
48833354|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
48833355|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
48833356|NCT00410124|157231109|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
48833357|NCT00410124|157231110|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
48833358|NCT00909363|157231111|FG000|Overall Study|Withdrawal by Subject|1|||
48833359|NCT00909363|157231112|FG001|Overall Study|Withdrawal by Subject|0|||
48833360|NCT00909363|157231113|FG002|Overall Study|Withdrawal by Subject|0|||
48833361|NCT00909363|157231111|FG000|Overall Study|Lack of Efficacy|1|||
48833362|NCT00909363|157231112|FG001|Overall Study|Lack of Efficacy|0|||
48833363|NCT00909363|157231113|FG002|Overall Study|Lack of Efficacy|0|||
48833364|NCT05179837|157231115|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
48833365|NCT05179837|157231115|FG000|Overall Study|Device malfunctioned|1|||
48833366|NCT05179837|157231115|FG000|Overall Study|Image quality too low|2|||
48833367|NCT01802632|157231116|FG000|Overall Study|Death|28|||
48833368|NCT01802632|157231117|FG001|Overall Study|Death|1|||
48833369|NCT01802632|157231118|FG002|Overall Study|Death|38|||
48833370|NCT01802632|157231119|FG003|Overall Study|Death|0|||
48833371|NCT01802632|157231120|FG004|Overall Study|Death|2|||
48833372|NCT01802632|157231121|FG005|Overall Study|Death|0|||
48833373|NCT01802632|157231116|FG000|Overall Study|Withdrawal by Subject|4|||
48833374|NCT01802632|157231117|FG001|Overall Study|Withdrawal by Subject|2|||
48833375|NCT01802632|157231118|FG002|Overall Study|Withdrawal by Subject|7|||
48833376|NCT01802632|157231119|FG003|Overall Study|Withdrawal by Subject|3|||
48833377|NCT01802632|157231120|FG004|Overall Study|Withdrawal by Subject|0|||
48833378|NCT01802632|157231121|FG005|Overall Study|Withdrawal by Subject|1|||
48530694|NCT03297294|156131328|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
48530695|NCT03297294|156131329|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
48530696|NCT03297294|156131330|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48530697|NCT03297294|156131331|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48530698|NCT03297294|156131332|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48530699|NCT03297294|156131328|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
48530700|NCT03297294|156131329|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
48530701|NCT03297294|156131330|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48530702|NCT03297294|156131331|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48530703|NCT03297294|156131332|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48530704|NCT03297294|156131328|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
48530705|NCT03297294|156131329|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
48530706|NCT03297294|156131330|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48530707|NCT03297294|156131331|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48530708|NCT03297294|156131332|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48833379|NCT01802632|157231116|FG000|Overall Study|Objective Disease Progression|1|||
48833380|NCT01802632|157231117|FG001|Overall Study|Objective Disease Progression|12|||
48833381|NCT01802632|157231118|FG002|Overall Study|Objective Disease Progression|104|||
48833382|NCT01802632|157231119|FG003|Overall Study|Objective Disease Progression|6|||
48833383|NCT01802632|157231120|FG004|Overall Study|Objective Disease Progression|4|||
48833384|NCT01802632|157231121|FG005|Overall Study|Objective Disease Progression|4|||
48530709|NCT03297294|156131328|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
48530710|NCT03297294|156131329|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
48530711|NCT03297294|156131330|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
48530712|NCT03297294|156131331|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
48530713|NCT03297294|156131332|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
48530714|NCT05147584|156131336|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
48530715|NCT02938923|156131337|FG000|Overall Study|Death|1|||
48530716|NCT02938923|156131338|FG001|Overall Study|Death|0|||
48530717|NCT02938923|156131339|FG002|Overall Study|Death|0|||
48530718|NCT02938923|156131337|FG000|Overall Study|Physician Decision|0|||
48530719|NCT02938923|156131338|FG001|Overall Study|Physician Decision|2|||
48530720|NCT02938923|156131339|FG002|Overall Study|Physician Decision|0|||
48530721|NCT02938923|156131337|FG000|Overall Study|Withdrawal by Subject|0|||
48530722|NCT02938923|156131338|FG001|Overall Study|Withdrawal by Subject|1|||
48530723|NCT02938923|156131339|FG002|Overall Study|Withdrawal by Subject|1|||
48530724|NCT02671903|156131340|FG000|Period 0 (Run-In)|Death|0|||
48530725|NCT02671903|156131341|FG001|Period 0 (Run-In)|Death|0|||
48530726|NCT02671903|156131342|FG002|Period 0 (Run-In)|Death|3|||
48530727|NCT02671903|156131340|FG000|Period 0 (Run-In)|Physician Decision|0|||
48530728|NCT02671903|156131341|FG001|Period 0 (Run-In)|Physician Decision|0|||
48530729|NCT02671903|156131342|FG002|Period 0 (Run-In)|Physician Decision|4|||
48833385|NCT01802632|157231116|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
48833386|NCT01802632|157231117|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
48833387|NCT01802632|157231118|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
48833388|NCT01802632|157231119|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
48530730|NCT02671903|156131340|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
48530731|NCT02671903|156131341|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
48530732|NCT02671903|156131342|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
48530733|NCT02671903|156131340|FG000|Period 0 (Run-In)|Protocol Violation|0|||
48530734|NCT02671903|156131341|FG001|Period 0 (Run-In)|Protocol Violation|0|||
48530735|NCT02671903|156131342|FG002|Period 0 (Run-In)|Protocol Violation|1|||
48530736|NCT02671903|156131340|FG000|Period 0 (Run-In)|Adverse Event|0|||
48530737|NCT02671903|156131341|FG001|Period 0 (Run-In)|Adverse Event|0|||
48530738|NCT02671903|156131342|FG002|Period 0 (Run-In)|Adverse Event|1|||
48530739|NCT02671903|156131340|FG000|Period 0 (Run-In)|Implantation Failure|0|||
48530740|NCT02671903|156131341|FG001|Period 0 (Run-In)|Implantation Failure|0|||
48530741|NCT02671903|156131342|FG002|Period 0 (Run-In)|Implantation Failure|2|||
48530742|NCT02671903|156131340|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
48530743|NCT02671903|156131341|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
48530744|NCT02671903|156131342|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
48530745|NCT00721149|156131343|FG000|Overall Study|Physician Decision|1|||
48530746|NCT02315703|156131344|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
48530747|NCT02315703|156131345|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
48530748|NCT02315703|156131346|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
48530749|NCT02315703|156131347|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
48530750|NCT02315703|156131348|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
48530751|NCT02315703|156131349|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
48530752|NCT02315703|156131350|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
48530753|NCT02315703|156131351|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
48530754|NCT02315703|156131344|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
48530755|NCT02315703|156131345|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
48530756|NCT02315703|156131346|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
48530757|NCT02315703|156131347|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
48530758|NCT02315703|156131348|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
48530759|NCT02315703|156131349|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
48530760|NCT02315703|156131350|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
48530761|NCT02315703|156131351|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
48530762|NCT02315703|156131344|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
48530763|NCT02315703|156131345|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
48530764|NCT02315703|156131346|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
48530765|NCT02315703|156131347|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
48530766|NCT02315703|156131348|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
48530767|NCT02315703|156131349|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
48530768|NCT02315703|156131350|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
48530769|NCT02315703|156131351|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
48530770|NCT02315703|156131344|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
48530771|NCT02315703|156131345|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
48530772|NCT02315703|156131346|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
48530773|NCT02315703|156131347|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
48530774|NCT02315703|156131348|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
48530775|NCT02315703|156131349|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
48530776|NCT02315703|156131350|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
48530777|NCT02315703|156131351|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
48833389|NCT01802632|157231120|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
48833390|NCT01802632|157231121|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
48833391|NCT01802632|157231116|FG000|Overall Study|Other (not specified)|0|||
48833392|NCT01802632|157231117|FG001|Overall Study|Other (not specified)|0|||
48833393|NCT01802632|157231118|FG002|Overall Study|Other (not specified)|7|||
48833394|NCT01802632|157231119|FG003|Overall Study|Other (not specified)|1|||
48833395|NCT01802632|157231120|FG004|Overall Study|Other (not specified)|0|||
48833396|NCT01802632|157231121|FG005|Overall Study|Other (not specified)|1|||
48833397|NCT00545077|157231129|FG000|Overall Study|Treatment not received|5|||
48833398|NCT00545077|157231130|FG001|Overall Study|Treatment not received|1|||
48833399|NCT00545077|157231129|FG000|Overall Study|Disease Progression|131|||
48833400|NCT00545077|157231130|FG001|Overall Study|Disease Progression|98|||
48833401|NCT00545077|157231129|FG000|Overall Study|Withdrawal by Subject|3|||
48833402|NCT00545077|157231130|FG001|Overall Study|Withdrawal by Subject|14|||
48833403|NCT00545077|157231129|FG000|Overall Study|Physician Decision|6|||
48833404|NCT00545077|157231130|FG001|Overall Study|Physician Decision|3|||
48833405|NCT00545077|157231129|FG000|Overall Study|Lost to Follow-up|2|||
48383828|NCT00436618|155601448|FG001|Overall Study|Adverse Event|8|||
48530778|NCT02315703|156131344|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
48530779|NCT02315703|156131345|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
48833406|NCT00545077|157231130|FG001|Overall Study|Lost to Follow-up|0|||
48833407|NCT00545077|157231129|FG000|Overall Study|Protocol Violation|1|||
48833408|NCT00545077|157231130|FG001|Overall Study|Protocol Violation|0|||
48530780|NCT02315703|156131346|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
48530781|NCT02315703|156131347|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
48530782|NCT02315703|156131348|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
48530783|NCT02315703|156131349|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
48530784|NCT02315703|156131350|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
48530785|NCT02315703|156131351|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
48530786|NCT02315703|156131344|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
48530787|NCT02315703|156131345|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
48530788|NCT02315703|156131346|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
48530789|NCT02315703|156131347|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
48530790|NCT02315703|156131348|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
48530791|NCT02315703|156131349|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
48530792|NCT02315703|156131350|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
48530793|NCT02315703|156131351|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
48530794|NCT02315703|156131344|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
48530795|NCT02315703|156131345|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
48530796|NCT02315703|156131346|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
48530797|NCT02315703|156131347|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
48530798|NCT02315703|156131348|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
48530799|NCT02315703|156131349|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
48530800|NCT02315703|156131350|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
48530801|NCT02315703|156131351|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
48530802|NCT02315703|156131344|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
48530803|NCT02315703|156131345|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
48530804|NCT02315703|156131346|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
48530805|NCT02315703|156131347|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
48530806|NCT02315703|156131348|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
48530807|NCT02315703|156131349|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
48530808|NCT02315703|156131350|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
48530809|NCT02315703|156131351|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
48530810|NCT02315703|156131344|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
48530811|NCT02315703|156131345|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
48530812|NCT02315703|156131346|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
48530813|NCT02315703|156131347|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
48530814|NCT02315703|156131348|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
48530815|NCT02315703|156131349|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
48530816|NCT02315703|156131350|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
48530817|NCT02315703|156131351|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
48530818|NCT03376321|156131352|FG000|Overall Study|Other|5|||
48530819|NCT03376321|156131353|FG001|Overall Study|Other|1|||
48530820|NCT03376321|156131352|FG000|Overall Study|Withdrawal by Subject|8|||
48530821|NCT03376321|156131353|FG001|Overall Study|Withdrawal by Subject|14|||
48530822|NCT03376321|156131352|FG000|Overall Study|Lost to Follow-up|1|||
48530823|NCT03376321|156131353|FG001|Overall Study|Lost to Follow-up|7|||
48530824|NCT03376321|156131352|FG000|Overall Study|Death|4|||
48530825|NCT03376321|156131353|FG001|Overall Study|Death|0|||
48530826|NCT03376321|156131352|FG000|Overall Study|Randomized, not treated|5|||
48602730|NCT02317991|156401527|FG000|Overall Study|Withdrawal by Subject|8|||
48530827|NCT03376321|156131353|FG001|Overall Study|Randomized, not treated|3|||
48530828|NCT02874742|156131354|FG000|Overall Study|Death|0|||
48530829|NCT02874742|156131355|FG001|Overall Study|Death|1|||
48530830|NCT02874742|156131356|FG002|Overall Study|Death|0|||
48530831|NCT02874742|156131354|FG000|Overall Study|Lost to Follow-up|5|||
48530832|NCT02874742|156131355|FG001|Overall Study|Lost to Follow-up|4|||
48530833|NCT02874742|156131356|FG002|Overall Study|Lost to Follow-up|1|||
48530834|NCT02874742|156131354|FG000|Overall Study|Withdrawal by Subject|17|||
48530835|NCT02874742|156131355|FG001|Overall Study|Withdrawal by Subject|8|||
48530836|NCT02874742|156131356|FG002|Overall Study|Withdrawal by Subject|0|||
48530837|NCT02874742|156131354|FG000|Overall Study|Other|4|||
48530838|NCT02874742|156131355|FG001|Overall Study|Other|1|||
48530839|NCT02874742|156131356|FG002|Overall Study|Other|0|||
48530840|NCT02874742|156131354|FG000|Overall Study|Progressive Disease|1|||
48602731|NCT02317991|156401527|FG000|Overall Study|Progressive Disease|41|||
48602732|NCT04069715|156401530|FG000|Overall Study|Lost to Follow-up|1|||
48602733|NCT04069715|156401531|FG001|Overall Study|Lost to Follow-up|1|||
48602734|NCT04069715|156401530|FG000|Overall Study|Physician Decision|1|||
48530841|NCT02874742|156131355|FG001|Overall Study|Progressive Disease|0|||
48530842|NCT02874742|156131356|FG002|Overall Study|Progressive Disease|0|||
48530843|NCT02874742|156131354|FG000|Overall Study|Screen Failure|0|||
48530844|NCT02874742|156131355|FG001|Overall Study|Screen Failure|2|||
48530845|NCT02874742|156131356|FG002|Overall Study|Screen Failure|0|||
48602735|NCT04069715|156401531|FG001|Overall Study|Physician Decision|1|||
48602736|NCT04069715|156401530|FG000|Overall Study|Withdrawal by Subject|3|||
48602737|NCT04069715|156401531|FG001|Overall Study|Withdrawal by Subject|3|||
48530846|NCT00612677|156131363|FG000|Overall Study|study closed before treatment started|1|||
48833409|NCT00545077|157231129|FG000|Overall Study|Adverse Event|0|||
48833410|NCT00545077|157231130|FG001|Overall Study|Adverse Event|31|||
48833411|NCT00545077|157231129|FG000|Overall Study|Death|0|||
48833412|NCT00545077|157231130|FG001|Overall Study|Death|8|||
48833413|NCT00919763|157231136|FG000|Overall Study|Adverse Event|7|||
48833414|NCT00919763|157231137|FG001|Overall Study|Adverse Event|1|||
48833415|NCT00919763|157231136|FG000|Overall Study|Lost to Follow-up|1|||
48833416|NCT00919763|157231137|FG001|Overall Study|Lost to Follow-up|0|||
48833417|NCT00919763|157231136|FG000|Overall Study|Protocol Violation|1|||
48833418|NCT00919763|157231137|FG001|Overall Study|Protocol Violation|1|||
48833419|NCT00919763|157231136|FG000|Overall Study|Withdrawal by Subject|3|||
48833420|NCT00919763|157231137|FG001|Overall Study|Withdrawal by Subject|1|||
48833421|NCT00919763|157231136|FG000|Overall Study|Non-compliance|0|||
48833422|NCT00919763|157231137|FG001|Overall Study|Non-compliance|1|||
48833423|NCT02739035|157231138|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
48833424|NCT02739035|157231139|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
48833425|NCT02739035|157231138|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
48833426|NCT02739035|157231139|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
48833427|NCT02739035|157231138|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
48833428|NCT02739035|157231139|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
48833429|NCT02739035|157231138|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
48833430|NCT02739035|157231139|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
48833431|NCT00940992|157231140|FG000|Overall Study|Adverse Event|2|||
48833432|NCT00940992|157231141|FG001|Overall Study|Adverse Event|0|||
48833433|NCT00940992|157231142|FG002|Overall Study|Adverse Event|1|||
48833434|NCT00940992|157231140|FG000|Overall Study|subject request|2|||
48833435|NCT00940992|157231141|FG001|Overall Study|subject request|1|||
48833436|NCT00940992|157231142|FG002|Overall Study|subject request|0|||
48833437|NCT00940992|157231140|FG000|Overall Study|Lost to Follow-up|0|||
48833438|NCT00940992|157231141|FG001|Overall Study|Lost to Follow-up|1|||
48833439|NCT00940992|157231142|FG002|Overall Study|Lost to Follow-up|1|||
48833440|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
48833441|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
48833442|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
48833443|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
48833444|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
48833445|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
48833446|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
48833447|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
48833448|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
48833449|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
48833450|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
48833451|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
48833452|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
48833453|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
48833454|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
48833455|NCT01254864|157231145|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
48833456|NCT01254864|157231146|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
48833457|NCT01254864|157231147|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
48833458|NCT01254864|157231145|FG000|Randomization Phase|Adverse Event|0|||
48530847|NCT04583280|156131366|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
48530848|NCT04583280|156131367|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
48530849|NCT00964392|156131370|FG000|Overall Study|Withdrawal by Subject|4|||
48530850|NCT00964392|156131371|FG001|Overall Study|Withdrawal by Subject|6|||
48530851|NCT00964392|156131370|FG000|Overall Study|Lost to Follow-up|4|||
48530852|NCT00964392|156131371|FG001|Overall Study|Lost to Follow-up|10|||
48530853|NCT00964392|156131370|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
48530854|NCT00964392|156131371|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
48530855|NCT00964392|156131370|FG000|Overall Study|Not completed|44|||
48530856|NCT00964392|156131371|FG001|Overall Study|Not completed|168|||
48530857|NCT00860743|156131375|FG000|Overall Study|Withdrawal by Subject|3|||
48530858|NCT00860743|156131376|FG001|Overall Study|Withdrawal by Subject|0|||
48530859|NCT04129554|156131377|FG000|Overall Study|Withdrawal by Subject|4|||
48833459|NCT01254864|157231146|FG001|Randomization Phase|Adverse Event|5|||
48833460|NCT01254864|157231147|FG002|Randomization Phase|Adverse Event|17|||
48833461|NCT01254864|157231145|FG000|Randomization Phase|Death|0|||
48530860|NCT04129554|156131378|FG001|Overall Study|Withdrawal by Subject|3|||
48530861|NCT04129554|156131377|FG000|Overall Study|Other|0|||
48530862|NCT04129554|156131378|FG001|Overall Study|Other|2|||
48833462|NCT01254864|157231146|FG001|Randomization Phase|Death|1|||
48530863|NCT01570361|156131379|FG000|Overall Study|Subject discontinued|1|||
48530864|NCT01570361|156131380|FG001|Overall Study|Subject discontinued|2|||
48530865|NCT01570361|156131379|FG000|Overall Study|Sponsor closing the study|51|||
48530866|NCT01570361|156131380|FG001|Overall Study|Sponsor closing the study|50|||
48530867|NCT01570361|156131379|FG000|Overall Study|Subject excluded|5|||
48530868|NCT01570361|156131380|FG001|Overall Study|Subject excluded|3|||
48530869|NCT01570361|156131379|FG000|Overall Study|Subject withdrew consent|14|||
48530870|NCT01570361|156131380|FG001|Overall Study|Subject withdrew consent|9|||
48530871|NCT01570361|156131379|FG000|Overall Study|Adverse Event|2|||
48530872|NCT01570361|156131380|FG001|Overall Study|Adverse Event|1|||
48530873|NCT01570361|156131379|FG000|Overall Study|Lost to Follow-up|4|||
48530874|NCT01570361|156131380|FG001|Overall Study|Lost to Follow-up|4|||
48530875|NCT01570361|156131379|FG000|Overall Study|Death|5|||
48530876|NCT01570361|156131380|FG001|Overall Study|Death|4|||
48530877|NCT01570361|156131379|FG000|Overall Study|Other|0|||
48530878|NCT01570361|156131380|FG001|Overall Study|Other|2|||
48530879|NCT01998243|156131381|FG000|Overall Study|Pregnancy|0|||
48530880|NCT01998243|156131382|FG001|Overall Study|Pregnancy|1|||
48530881|NCT01998243|156131381|FG000|Overall Study|Protocol Violation|5|||
48530882|NCT01998243|156131382|FG001|Overall Study|Protocol Violation|2|||
48530883|NCT01998243|156131381|FG000|Overall Study|Withdrawal by Subject|3|||
48530884|NCT01998243|156131382|FG001|Overall Study|Withdrawal by Subject|4|||
48530885|NCT02846545|156131383|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
48530886|NCT02846545|156131384|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
48530887|NCT02846545|156131383|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
48530888|NCT02846545|156131384|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
48530889|NCT02846545|156131383|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
48530890|NCT02846545|156131384|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
48530891|NCT02846545|156131383|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
48530892|NCT02846545|156131384|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
48530893|NCT02846545|156131383|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
48530894|NCT02846545|156131384|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
48530895|NCT02181296|156131385|FG000|Overall Study|Lost to Follow-up|7|||
48530896|NCT02181296|156131386|FG001|Overall Study|Lost to Follow-up|6|||
48530897|NCT02461134|156131387|FG000|Overall Study|Adverse Event|1|||
48530898|NCT02427984|156131388|FG000|Overall Study|Lost to Follow-up|13|||
48530899|NCT02427984|156131389|FG001|Overall Study|Lost to Follow-up|5|||
48530900|NCT02427984|156131390|FG002|Overall Study|Lost to Follow-up|18|||
48530901|NCT01338415|156133934|FG000|Core + Extension|Adverse Event|8|||
48530902|NCT01338415|156133935|FG001|Core + Extension|Adverse Event|6|||
48530903|NCT01338415|156133936|FG002|Core + Extension|Adverse Event|0|||
48530904|NCT01338415|156133934|FG000|Core + Extension|Withdrawal by Subject|1|||
48530905|NCT01338415|156133935|FG001|Core + Extension|Withdrawal by Subject|1|||
48530906|NCT01338415|156133936|FG002|Core + Extension|Withdrawal by Subject|0|||
48530907|NCT01338415|156133934|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
48530908|NCT01338415|156133935|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
48530909|NCT01338415|156133936|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
48530910|NCT01338415|156133934|FG000|Core + Extension|Other (administrative reason)|1|||
48530911|NCT01338415|156133935|FG001|Core + Extension|Other (administrative reason)|0|||
48530912|NCT01338415|156133936|FG002|Core + Extension|Other (administrative reason)|0|||
48530913|NCT01338415|156133934|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
48530914|NCT01338415|156133935|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
48530915|NCT01338415|156133936|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
48530916|NCT01338415|156133934|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
48530917|NCT01338415|156133935|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
48530918|NCT01338415|156133936|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
48530919|NCT01338415|156133934|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
48530920|NCT01338415|156133935|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
48530921|NCT01338415|156133936|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
48530922|NCT01338415|156133934|FG000|Exceptional Use Treatment Period|Death|0|||
48602738|NCT00823134|156401533|FG000|Overall Study|Invalid measurement|1|||
48602739|NCT02723188|156401534|FG000|Overall Study|Withdrawal by Subject|1|||
48530923|NCT01338415|156133935|FG001|Exceptional Use Treatment Period|Death|0|||
48530924|NCT01338415|156133936|FG002|Exceptional Use Treatment Period|Death|1|||
48833463|NCT01254864|157231147|FG002|Randomization Phase|Death|0|||
48833464|NCT01254864|157231145|FG000|Randomization Phase|Lost to Follow-up|0|||
48833465|NCT01254864|157231146|FG001|Randomization Phase|Lost to Follow-up|0|||
48530925|NCT04774380|156133940|FG000|Overall Study|Patients ongoing study at data cut-off|75|||
48530926|NCT01105091|156133941|FG000|Overall Study|Death|2|||
48530927|NCT01105091|156133942|FG001|Overall Study|Death|0|||
48530928|NCT00709956|156133943|FG000|Overall Study|Withdrawal by Subject|1|||
48530929|NCT00709956|156133944|FG001|Overall Study|Withdrawal by Subject|1|||
48833466|NCT01254864|157231147|FG002|Randomization Phase|Lost to Follow-up|1|||
48833467|NCT01254864|157231145|FG000|Randomization Phase|Physician Decision|0|||
48530930|NCT00709956|156133943|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
48530931|NCT00709956|156133944|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
48530932|NCT01369355|156133945|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
48530933|NCT01369355|156133946|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
48530934|NCT01369355|156133947|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
48530935|NCT01369355|156133948|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
48530936|NCT01369355|156133949|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
48530937|NCT01369355|156133950|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
48530938|NCT01369355|156133951|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
48530939|NCT01369355|156133952|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
48530940|NCT01369355|156133953|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
48530941|NCT01369355|156133945|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
48530942|NCT01369355|156133946|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
48530943|NCT01369355|156133947|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
48530944|NCT01369355|156133948|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
48530945|NCT01369355|156133949|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
48530946|NCT01369355|156133950|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
48530947|NCT01369355|156133951|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
48530948|NCT01369355|156133952|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
48530949|NCT01369355|156133953|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
48530950|NCT01369355|156133945|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
48530951|NCT01369355|156133946|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
48530952|NCT01369355|156133947|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
48530953|NCT01369355|156133948|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
48530954|NCT01369355|156133949|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
48530955|NCT01369355|156133950|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
48530956|NCT01369355|156133951|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
48530957|NCT01369355|156133952|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
48530958|NCT01369355|156133953|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
48530959|NCT01369355|156133945|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
48530960|NCT01369355|156133946|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
48530961|NCT01369355|156133947|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
48530962|NCT01369355|156133948|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
48530963|NCT01369355|156133949|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
48530964|NCT01369355|156133950|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
48530965|NCT01369355|156133951|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
48530966|NCT01369355|156133952|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
48530967|NCT01369355|156133953|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
48530968|NCT01369355|156133945|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
48530969|NCT01369355|156133946|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
48530970|NCT01369355|156133947|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
48530971|NCT01369355|156133948|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
48530972|NCT01369355|156133949|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
48530973|NCT01369355|156133950|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
48530974|NCT01369355|156133951|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
48530975|NCT01369355|156133952|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
48530976|NCT01369355|156133953|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
48530977|NCT01369355|156133945|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
48530978|NCT01369355|156133946|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
48530979|NCT01369355|156133947|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
48530980|NCT01369355|156133948|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
48530981|NCT01369355|156133949|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
48530982|NCT01369355|156133950|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
48530983|NCT01369355|156133951|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
48530984|NCT01369355|156133952|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
48530985|NCT01369355|156133953|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
48530986|NCT01369355|156133945|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
48530987|NCT01369355|156133946|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
48530988|NCT01369355|156133947|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
48530989|NCT01369355|156133948|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
48530990|NCT01369355|156133949|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
48530991|NCT01369355|156133950|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
48530992|NCT01369355|156133951|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
48530993|NCT01369355|156133952|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
48530994|NCT01369355|156133953|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
48530995|NCT01369355|156133945|FG000|Long-term Extension (Week 44-272)|Death|0|||
48530996|NCT01369355|156133946|FG001|Long-term Extension (Week 44-272)|Death|0|||
48530997|NCT01369355|156133947|FG002|Long-term Extension (Week 44-272)|Death|0|||
48530998|NCT01369355|156133948|FG003|Long-term Extension (Week 44-272)|Death|0|||
48530999|NCT01369355|156133949|FG004|Long-term Extension (Week 44-272)|Death|0|||
48531000|NCT01369355|156133950|FG005|Long-term Extension (Week 44-272)|Death|0|||
48531001|NCT01369355|156133951|FG006|Long-term Extension (Week 44-272)|Death|0|||
48531002|NCT01369355|156133952|FG007|Long-term Extension (Week 44-272)|Death|1|||
48531003|NCT01369355|156133953|FG008|Long-term Extension (Week 44-272)|Death|3|||
48531004|NCT01369355|156133945|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
48531005|NCT01369355|156133946|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
48531006|NCT01369355|156133947|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
48531007|NCT01369355|156133948|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
48531008|NCT01369355|156133949|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
48531009|NCT01369355|156133950|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
48531010|NCT01369355|156133951|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
48531011|NCT01369355|156133952|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
48531012|NCT01369355|156133953|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
48531013|NCT01369355|156133945|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
48531014|NCT01369355|156133946|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
48531015|NCT01369355|156133947|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
48531016|NCT01369355|156133948|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
48531017|NCT01369355|156133949|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
48531018|NCT01369355|156133950|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
48531019|NCT01369355|156133951|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
48531020|NCT01369355|156133952|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
48531021|NCT01369355|156133953|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
48531022|NCT01369355|156133945|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
48531023|NCT01369355|156133946|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
48531024|NCT01369355|156133947|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
48531025|NCT01369355|156133948|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
48531026|NCT01369355|156133949|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
48531027|NCT01369355|156133950|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
48531028|NCT01369355|156133951|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
48531029|NCT01369355|156133952|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
48531030|NCT01369355|156133953|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
48531031|NCT01369355|156133945|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
48531032|NCT01369355|156133946|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
48531033|NCT01369355|156133947|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
48531034|NCT01369355|156133948|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
48531035|NCT01369355|156133949|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
48531036|NCT01369355|156133950|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
48531037|NCT01369355|156133951|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
48531038|NCT01369355|156133952|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
48531039|NCT01369355|156133953|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
48531040|NCT01369355|156133945|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
48531041|NCT01369355|156133946|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
48531042|NCT01369355|156133947|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
48531043|NCT01369355|156133948|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
48531044|NCT01369355|156133949|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
48531045|NCT01369355|156133950|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
48531046|NCT01369355|156133951|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
48531047|NCT01369355|156133952|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
48531048|NCT01369355|156133953|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
48531049|NCT01369355|156133945|FG000|Long-term Extension (Week 44-272)|Other|0|||
48531050|NCT01369355|156133946|FG001|Long-term Extension (Week 44-272)|Other|0|||
48531051|NCT01369355|156133947|FG002|Long-term Extension (Week 44-272)|Other|0|||
48531052|NCT01369355|156133948|FG003|Long-term Extension (Week 44-272)|Other|0|||
48531053|NCT01369355|156133949|FG004|Long-term Extension (Week 44-272)|Other|0|||
48531054|NCT01369355|156133950|FG005|Long-term Extension (Week 44-272)|Other|0|||
48531055|NCT01369355|156133951|FG006|Long-term Extension (Week 44-272)|Other|110|||
48531056|NCT01369355|156133952|FG007|Long-term Extension (Week 44-272)|Other|9|||
48531057|NCT01369355|156133953|FG008|Long-term Extension (Week 44-272)|Other|17|||
48531058|NCT00991510|156133954|FG000|Period I (Days 1-14)|Adverse Event|1|||
48531059|NCT00991510|156133955|FG001|Period I (Days 1-14)|Adverse Event|0|||
48833468|NCT01254864|157231146|FG001|Randomization Phase|Physician Decision|20|||
48833469|NCT01254864|157231147|FG002|Randomization Phase|Physician Decision|25|||
48833470|NCT01254864|157231145|FG000|Randomization Phase|Withdrawal by Subject|0|||
48833471|NCT01254864|157231146|FG001|Randomization Phase|Withdrawal by Subject|4|||
48833472|NCT01254864|157231147|FG002|Randomization Phase|Withdrawal by Subject|2|||
48833473|NCT01254864|157231145|FG000|Randomization Phase|Non-Compliance|0|||
48531060|NCT00991510|156133954|FG000|Period III (Days 29-112)|Adverse Event|1|||
48531061|NCT00991510|156133955|FG001|Period III (Days 29-112)|Adverse Event|1|||
48531062|NCT02319759|156133956|FG000|Week 0 - 16|Lack of Efficacy|1|||
48531063|NCT02319759|156133957|FG001|Week 0 - 16|Lack of Efficacy|0|||
48833474|NCT01254864|157231146|FG001|Randomization Phase|Non-Compliance|1|||
48833475|NCT01254864|157231147|FG002|Randomization Phase|Non-Compliance|0|||
48833476|NCT01254864|157231145|FG000|Randomization Phase|Comorbidities|0|||
48833477|NCT01254864|157231146|FG001|Randomization Phase|Comorbidities|2|||
48833478|NCT01254864|157231147|FG002|Randomization Phase|Comorbidities|1|||
48833479|NCT00337818|157231148|FG000|Overall Study|Lost to Follow-up|289|||
48833480|NCT00337818|157231149|FG001|Overall Study|Lost to Follow-up|91|||
48833481|NCT00337818|157231150|FG002|Overall Study|Lost to Follow-up|107|||
48833482|NCT02770248|157231156|FG000|Overall Study|Adverse Event|0|||
48833483|NCT02770248|157231157|FG001|Overall Study|Adverse Event|1|||
48531064|NCT02319759|156133958|FG002|Week 0 - 16|Lack of Efficacy|0|||
48531065|NCT02319759|156133959|FG003|Week 0 - 16|Lack of Efficacy|0|||
48531066|NCT02319759|156133960|FG004|Week 0 - 16|Lack of Efficacy|0|||
48531067|NCT02319759|156133956|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
48531068|NCT02319759|156133957|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
48531069|NCT02319759|156133958|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
48531070|NCT02319759|156133959|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
48531071|NCT02319759|156133960|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
48531072|NCT02319759|156133956|FG000|Week 16 - 24|Lack of Efficacy|1|||
48833484|NCT02770248|157231156|FG000|Overall Study|Randomized in error, prior to treatment|0|||
48531073|NCT02319759|156133957|FG001|Week 16 - 24|Lack of Efficacy|0|||
48531074|NCT02319759|156133958|FG002|Week 16 - 24|Lack of Efficacy|1|||
48531075|NCT02319759|156133959|FG003|Week 16 - 24|Lack of Efficacy|0|||
48833485|NCT02770248|157231157|FG001|Overall Study|Randomized in error, prior to treatment|1|||
48833486|NCT00094575|157231165|FG000|Overall Study|Death|146|||
48531076|NCT02319759|156133960|FG004|Week 16 - 24|Lack of Efficacy|0|||
48531077|NCT02319759|156133956|FG000|Week 16 - 24|Lost to Follow-up|1|||
48531078|NCT02319759|156133957|FG001|Week 16 - 24|Lost to Follow-up|0|||
48531079|NCT02319759|156133958|FG002|Week 16 - 24|Lost to Follow-up|0|||
48531080|NCT02319759|156133959|FG003|Week 16 - 24|Lost to Follow-up|0|||
48531081|NCT02319759|156133960|FG004|Week 16 - 24|Lost to Follow-up|0|||
48531082|NCT02319759|156133956|FG000|Week 16 - 24|Withdrawal by Subject|0|||
48531083|NCT02319759|156133957|FG001|Week 16 - 24|Withdrawal by Subject|0|||
48531084|NCT02319759|156133958|FG002|Week 16 - 24|Withdrawal by Subject|2|||
48531085|NCT02319759|156133959|FG003|Week 16 - 24|Withdrawal by Subject|0|||
48531086|NCT02319759|156133960|FG004|Week 16 - 24|Withdrawal by Subject|0|||
48833487|NCT00094575|157231166|FG001|Overall Study|Death|146|||
48833488|NCT04679935|157231170|FG000|Overall Study|Death|0|||
48833489|NCT04679935|157231171|FG001|Overall Study|Death|1|||
48833490|NCT00961636|157231172|FG000|Overall Study|Adverse Event|35|||
48833491|NCT00961636|157231173|FG001|Overall Study|Adverse Event|54|||
48833492|NCT00961636|157231174|FG002|Overall Study|Adverse Event|13|||
48735588|NCT00471146|156883672|FG001|Overall Study|Global deterioration of health status|14|||
48833493|NCT00961636|157231172|FG000|Overall Study|Flushing Symptoms|29|||
48833494|NCT00961636|157231173|FG001|Overall Study|Flushing Symptoms|46|||
48833495|NCT00961636|157231174|FG002|Overall Study|Flushing Symptoms|3|||
48531087|NCT02319759|156133956|FG000|Week 24 - 56|Adverse Event|0|||
48735589|NCT00471146|156883671|FG000|Overall Study|Randomized but not treated|9|||
48735590|NCT00471146|156883672|FG001|Overall Study|Randomized but not treated|8|||
48735591|NCT00471146|156883671|FG000|Overall Study|Other|4|||
48735592|NCT00471146|156883672|FG001|Overall Study|Other|5|||
48735593|NCT03800173|156883684|FG000|Overall Study|Lost to Follow-up|0|||
48735594|NCT03800173|156883685|FG001|Overall Study|Lost to Follow-up|0|||
48735595|NCT03800173|156883686|FG002|Overall Study|Lost to Follow-up|0|||
48735596|NCT03800173|156883687|FG003|Overall Study|Lost to Follow-up|0|||
48735597|NCT03800173|156883688|FG004|Overall Study|Lost to Follow-up|1|||
48735598|NCT01934972|156883689|FG000|Overall Study|Withdrawal by Subject|9|||
48735599|NCT01934972|156883690|FG001|Overall Study|Withdrawal by Subject|6|||
48735600|NCT02345226|156883691|FG000|Double-Blind Phase|Adverse Event|5|||
48531088|NCT02319759|156133957|FG001|Week 24 - 56|Adverse Event|0|||
48531089|NCT02319759|156133958|FG002|Week 24 - 56|Adverse Event|2|||
48531090|NCT02319759|156133959|FG003|Week 24 - 56|Adverse Event|0|||
48531091|NCT02319759|156133960|FG004|Week 24 - 56|Adverse Event|0|||
48531092|NCT02319759|156133956|FG000|Week 24 - 56|Lack of Efficacy|0|||
48531093|NCT02319759|156133957|FG001|Week 24 - 56|Lack of Efficacy|0|||
48531094|NCT02319759|156133958|FG002|Week 24 - 56|Lack of Efficacy|0|||
48531095|NCT02319759|156133959|FG003|Week 24 - 56|Lack of Efficacy|2|||
48531096|NCT02319759|156133960|FG004|Week 24 - 56|Lack of Efficacy|1|||
48531097|NCT02319759|156133956|FG000|Week 24 - 56|Withdrawal by Subject|0|||
48531098|NCT02319759|156133957|FG001|Week 24 - 56|Withdrawal by Subject|1|||
48531099|NCT02319759|156133958|FG002|Week 24 - 56|Withdrawal by Subject|0|||
48531100|NCT02319759|156133959|FG003|Week 24 - 56|Withdrawal by Subject|0|||
48833496|NCT00961636|157231172|FG000|Overall Study|Lost to Follow-up|2|||
48531101|NCT02319759|156133960|FG004|Week 24 - 56|Withdrawal by Subject|0|||
48531102|NCT02319759|156133956|FG000|Week 24 - 56|Lost to Follow-up|0|||
48531103|NCT02319759|156133957|FG001|Week 24 - 56|Lost to Follow-up|0|||
48531104|NCT02319759|156133958|FG002|Week 24 - 56|Lost to Follow-up|0|||
48531105|NCT02319759|156133959|FG003|Week 24 - 56|Lost to Follow-up|0|||
48531106|NCT02319759|156133960|FG004|Week 24 - 56|Lost to Follow-up|1|||
48531107|NCT03339713|156133961|FG000|Overall Study|Lost to Follow-up|2|||
48531108|NCT03339713|156133962|FG001|Overall Study|Lost to Follow-up|1|||
48531109|NCT03339713|156133961|FG000|Overall Study|Protocol Violation|1|||
48531110|NCT03339713|156133962|FG001|Overall Study|Protocol Violation|0|||
48531111|NCT03339713|156133961|FG000|Overall Study|Withdrawal by Subject|1|||
48531112|NCT03339713|156133962|FG001|Overall Study|Withdrawal by Subject|1|||
48531113|NCT00852917|156133963|FG000|Overall Study|Adverse Event|13|||
48531114|NCT00852917|156133964|FG001|Overall Study|Adverse Event|20|||
48531115|NCT00852917|156133965|FG002|Overall Study|Adverse Event|35|||
48531116|NCT00852917|156133966|FG003|Overall Study|Adverse Event|17|||
48531117|NCT00852917|156133963|FG000|Overall Study|Lack of Efficacy|21|||
48531118|NCT00852917|156133964|FG001|Overall Study|Lack of Efficacy|11|||
48531119|NCT00852917|156133965|FG002|Overall Study|Lack of Efficacy|11|||
48531120|NCT00852917|156133966|FG003|Overall Study|Lack of Efficacy|47|||
48531121|NCT00852917|156133963|FG000|Overall Study|Withdrawal by Subject|4|||
48531122|NCT00852917|156133964|FG001|Overall Study|Withdrawal by Subject|8|||
48531123|NCT00852917|156133965|FG002|Overall Study|Withdrawal by Subject|10|||
48531124|NCT00852917|156133966|FG003|Overall Study|Withdrawal by Subject|9|||
48531125|NCT00852917|156133963|FG000|Overall Study|Physician Decision|6|||
48531126|NCT00852917|156133964|FG001|Overall Study|Physician Decision|7|||
48833497|NCT00961636|157231173|FG001|Overall Study|Lost to Follow-up|3|||
48833498|NCT00961636|157231174|FG002|Overall Study|Lost to Follow-up|1|||
48833499|NCT00961636|157231172|FG000|Overall Study|Physician Decision|3|||
48833500|NCT00961636|157231173|FG001|Overall Study|Physician Decision|1|||
48833501|NCT00961636|157231174|FG002|Overall Study|Physician Decision|1|||
48833502|NCT00961636|157231172|FG000|Overall Study|Protocol Violation|9|||
48833503|NCT00961636|157231173|FG001|Overall Study|Protocol Violation|5|||
48833504|NCT00961636|157231174|FG002|Overall Study|Protocol Violation|1|||
48531127|NCT00852917|156133965|FG002|Overall Study|Physician Decision|2|||
48531128|NCT00852917|156133966|FG003|Overall Study|Physician Decision|19|||
48531129|NCT00852917|156133963|FG000|Overall Study|Death|0|||
48531130|NCT00852917|156133964|FG001|Overall Study|Death|0|||
48531131|NCT00852917|156133965|FG002|Overall Study|Death|0|||
48531132|NCT00852917|156133966|FG003|Overall Study|Death|1|||
48531133|NCT02365597|156133967|FG000|Overall Study|Lost to Follow-up|0|||
48531134|NCT02365597|156133968|FG001|Overall Study|Lost to Follow-up|1|||
48531135|NCT02365597|156133969|FG002|Overall Study|Lost to Follow-up|0|||
48833505|NCT00961636|157231172|FG000|Overall Study|Withdrawal by Subject|29|||
48531136|NCT02365597|156133970|FG003|Overall Study|Lost to Follow-up|1|||
48531137|NCT02365597|156133967|FG000|Overall Study|Withdrawal by Subject|1|||
48531138|NCT02365597|156133968|FG001|Overall Study|Withdrawal by Subject|8|||
48531139|NCT02365597|156133969|FG002|Overall Study|Withdrawal by Subject|5|||
48531140|NCT02365597|156133970|FG003|Overall Study|Withdrawal by Subject|1|||
48531141|NCT02365597|156133967|FG000|Overall Study|Sponsor's decision|1|||
48531142|NCT02365597|156133968|FG001|Overall Study|Sponsor's decision|3|||
48531143|NCT02365597|156133969|FG002|Overall Study|Sponsor's decision|13|||
48531144|NCT02365597|156133970|FG003|Overall Study|Sponsor's decision|0|||
48531145|NCT02365597|156133967|FG000|Overall Study|Other|0|||
48531146|NCT02365597|156133968|FG001|Overall Study|Other|4|||
48531147|NCT02365597|156133969|FG002|Overall Study|Other|0|||
48531148|NCT02365597|156133970|FG003|Overall Study|Other|0|||
48531149|NCT02365597|156133967|FG000|Overall Study|Enrolled but not treated|0|||
48531150|NCT02365597|156133968|FG001|Overall Study|Enrolled but not treated|1|||
48833506|NCT00961636|157231173|FG001|Overall Study|Withdrawal by Subject|22|||
48531151|NCT02365597|156133969|FG002|Overall Study|Enrolled but not treated|1|||
48531152|NCT02365597|156133970|FG003|Overall Study|Enrolled but not treated|0|||
48833507|NCT00961636|157231174|FG002|Overall Study|Withdrawal by Subject|13|||
48833508|NCT01768676|157231182|FG000|Overall Study|Adverse Event|3|||
48531153|NCT02365597|156133967|FG000|Overall Study|Ongoing|0|||
48531154|NCT02365597|156133968|FG001|Overall Study|Ongoing|0|||
48531155|NCT02365597|156133969|FG002|Overall Study|Ongoing|0|||
48531156|NCT02365597|156133970|FG003|Overall Study|Ongoing|17|||
48531157|NCT05364671|156133971|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
48531158|NCT05364671|156133972|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
48531159|NCT05364671|156133971|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
48531160|NCT05364671|156133972|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
48531161|NCT05364671|156133971|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
48531162|NCT05364671|156133972|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
48531163|NCT05364671|156133971|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
48531164|NCT05364671|156133972|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
48531165|NCT05364671|156133971|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
48833509|NCT01768676|157231183|FG001|Overall Study|Adverse Event|3|||
48833510|NCT01768676|157231182|FG000|Overall Study|Lost to Follow-up|13|||
48833511|NCT01768676|157231183|FG001|Overall Study|Lost to Follow-up|16|||
48531166|NCT05364671|156133972|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
48531167|NCT01647711|156133973|FG000|Overall Study|Progressive disease|6|||
48531168|NCT01647711|156133974|FG001|Overall Study|Progressive disease|2|||
48531169|NCT01647711|156133975|FG002|Overall Study|Progressive disease|6|||
48531170|NCT01647711|156133976|FG003|Overall Study|Progressive disease|8|||
48531171|NCT01647711|156133977|FG004|Overall Study|Progressive disease|2|||
48531172|NCT01647711|156133973|FG000|Overall Study|Other adverse event|0|||
48531173|NCT01647711|156133974|FG001|Overall Study|Other adverse event|0|||
48531174|NCT01647711|156133975|FG002|Overall Study|Other adverse event|2|||
48531175|NCT01647711|156133976|FG003|Overall Study|Other adverse event|0|||
48531176|NCT01647711|156133977|FG004|Overall Study|Other adverse event|2|||
48531177|NCT01647711|156133973|FG000|Overall Study|Protocol Violation|0|||
48531178|NCT01647711|156133974|FG001|Overall Study|Protocol Violation|0|||
48531179|NCT01647711|156133975|FG002|Overall Study|Protocol Violation|0|||
48531180|NCT01647711|156133976|FG003|Overall Study|Protocol Violation|0|||
48531181|NCT01647711|156133977|FG004|Overall Study|Protocol Violation|1|||
48531182|NCT01647711|156133973|FG000|Overall Study|Refused to continue taking medication|0|||
48531183|NCT01647711|156133974|FG001|Overall Study|Refused to continue taking medication|0|||
48531184|NCT01647711|156133975|FG002|Overall Study|Refused to continue taking medication|0|||
48531185|NCT01647711|156133976|FG003|Overall Study|Refused to continue taking medication|2|||
48531186|NCT01647711|156133977|FG004|Overall Study|Refused to continue taking medication|1|||
48531187|NCT01647711|156133973|FG000|Overall Study|Other reason not defined|0|||
48531188|NCT01647711|156133974|FG001|Overall Study|Other reason not defined|1|||
48531189|NCT01647711|156133975|FG002|Overall Study|Other reason not defined|1|||
48531190|NCT01647711|156133976|FG003|Overall Study|Other reason not defined|1|||
48531191|NCT01647711|156133977|FG004|Overall Study|Other reason not defined|0|||
48531192|NCT04281498|156133980|FG000|Overall Study|Progression of disease|1|||
48531193|NCT04281498|156133980|FG000|Overall Study|Planned SCT|1|||
48531194|NCT04281498|156133980|FG000|Overall Study|Alternative Treatment|1|||
48531195|NCT02359890|156133981|FG000|Overall Study|Not meeting eligibility|4|||
48531196|NCT02359890|156133981|FG000|Overall Study|Never treated with study catheter|6|||
48531197|NCT03628924|156133982|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
48531198|NCT03628924|156133983|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
48531199|NCT03628924|156133984|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
48531200|NCT03628924|156133985|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
48531201|NCT03628924|156133986|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
48531202|NCT03628924|156133987|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
48531203|NCT03628924|156133988|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
48531204|NCT03628924|156133982|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48531205|NCT03628924|156133983|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48531206|NCT03628924|156133984|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
48531207|NCT03628924|156133985|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48531208|NCT03628924|156133986|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48833512|NCT01768676|157231182|FG000|Overall Study|Protocol Violation|1|||
48833513|NCT01768676|157231183|FG001|Overall Study|Protocol Violation|1|||
48531209|NCT03628924|156133987|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48531210|NCT03628924|156133988|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48531211|NCT03628924|156133982|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
48531212|NCT03628924|156133983|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
48531213|NCT03628924|156133984|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
48531214|NCT03628924|156133985|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
48833514|NCT01768676|157231182|FG000|Overall Study|Physician Decision|4|||
48833515|NCT01768676|157231183|FG001|Overall Study|Physician Decision|1|||
48833516|NCT01768676|157231182|FG000|Overall Study|Withdrawal by Subject|3|||
48833517|NCT01768676|157231183|FG001|Overall Study|Withdrawal by Subject|10|||
48833518|NCT00457691|157231187|FG000|Overall Study|Adverse Event|4|||
48531215|NCT03628924|156133986|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
48531216|NCT03628924|156133987|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
48531217|NCT03628924|156133988|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
48531218|NCT03628924|156133982|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
48531219|NCT03628924|156133983|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
48531220|NCT03628924|156133984|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
48531221|NCT03628924|156133985|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
48531222|NCT03628924|156133986|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
48602740|NCT02723188|156401535|FG001|Overall Study|Withdrawal by Subject|0|||
48602741|NCT02723188|156401536|FG002|Overall Study|Withdrawal by Subject|0|||
48531223|NCT03628924|156133987|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
48531224|NCT03628924|156133988|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
48531225|NCT03628924|156133982|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
48531226|NCT03628924|156133983|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
48531227|NCT03628924|156133984|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
48531228|NCT03628924|156133985|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
48531229|NCT03628924|156133986|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
48531230|NCT03628924|156133987|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
48531231|NCT03628924|156133988|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
48531232|NCT03628924|156133982|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
48531233|NCT03628924|156133983|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
48602742|NCT01051921|156401537|FG000|Overall Study|Physician Decision|9|||
48602743|NCT01051921|156401537|FG000|Overall Study|Adverse Event|8|||
48602744|NCT01051921|156401537|FG000|Overall Study|Withdrawal by Subject|7|||
48602745|NCT01051921|156401537|FG000|Overall Study|Lost to Follow-up|4|||
48602746|NCT01051921|156401537|FG000|Overall Study|virological failure|1|||
48602747|NCT01051921|156401537|FG000|Overall Study|patient moved|1|||
48602748|NCT00377637|156401538|FG000|Induction Phase|Adverse Event|12|||
48602749|NCT00377637|156401539|FG001|Induction Phase|Adverse Event|21|||
48602750|NCT00377637|156401540|FG002|Induction Phase|Adverse Event|0|||
48602751|NCT00377637|156401541|FG003|Induction Phase|Adverse Event|0|||
48602752|NCT00377637|156401538|FG000|Induction Phase|Deterioration/serum creatinine|2|||
48602753|NCT00377637|156401539|FG001|Induction Phase|Deterioration/serum creatinine|0|||
48602754|NCT00377637|156401540|FG002|Induction Phase|Deterioration/serum creatinine|0|||
48602755|NCT00377637|156401541|FG003|Induction Phase|Deterioration/serum creatinine|0|||
48602756|NCT00377637|156401538|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
48602757|NCT00377637|156401539|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
48602758|NCT00377637|156401540|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
48602759|NCT00377637|156401541|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
48602760|NCT00377637|156401538|FG000|Induction Phase|Lost to Follow-up|2|||
48602761|NCT00377637|156401539|FG001|Induction Phase|Lost to Follow-up|1|||
48602762|NCT00377637|156401540|FG002|Induction Phase|Lost to Follow-up|0|||
48602763|NCT00377637|156401541|FG003|Induction Phase|Lost to Follow-up|0|||
48602764|NCT00377637|156401538|FG000|Induction Phase|Death|1|||
48833519|NCT00457691|157231188|FG001|Overall Study|Adverse Event|1|||
48602765|NCT00377637|156401539|FG001|Induction Phase|Death|3|||
48602766|NCT00377637|156401540|FG002|Induction Phase|Death|0|||
48602767|NCT00377637|156401541|FG003|Induction Phase|Death|0|||
48602768|NCT00377637|156401538|FG000|Induction Phase|Withdrawal by Subject|5|||
48833520|NCT00457691|157231187|FG000|Overall Study|Death|163|||
48833521|NCT00457691|157231188|FG001|Overall Study|Death|148|||
48833522|NCT00457691|157231187|FG000|Overall Study|Protocol Violation|1|||
48833523|NCT00457691|157231188|FG001|Overall Study|Protocol Violation|3|||
48833524|NCT00457691|157231187|FG000|Overall Study|Lost to Follow-up|23|||
48833525|NCT00457691|157231188|FG001|Overall Study|Lost to Follow-up|14|||
48833526|NCT00457691|157231187|FG000|Overall Study|Study terminated by Sponsor|1|||
48833527|NCT00457691|157231188|FG001|Overall Study|Study terminated by Sponsor|1|||
48833528|NCT00457691|157231187|FG000|Overall Study|Subject refused (reason other than AE)|14|||
48833529|NCT00457691|157231188|FG001|Overall Study|Subject refused (reason other than AE)|19|||
48833530|NCT00457691|157231187|FG000|Overall Study|Disease progression, study terminated|180|||
48833531|NCT00457691|157231188|FG001|Overall Study|Disease progression, study terminated|196|||
48833532|NCT02486588|157231191|FG000|Overall Study|Randomized in error- ineligible|738|||
48833533|NCT02486588|157231192|FG001|Overall Study|Randomized in error- ineligible|750|||
48833534|NCT02486588|157231193|FG002|Overall Study|Randomized in error- ineligible|755|||
48833535|NCT02486588|157231194|FG003|Overall Study|Randomized in error- ineligible|738|||
48833536|NCT02486588|157231195|FG004|Overall Study|Randomized in error- ineligible|746|||
48833537|NCT02486588|157231196|FG005|Overall Study|Randomized in error- ineligible|746|||
48833538|NCT02551055|157231201|FG000|Overall Study|Death|2|||
48833539|NCT02551055|157231202|FG001|Overall Study|Death|4|||
48833540|NCT02551055|157231203|FG002|Overall Study|Death|2|||
48833541|NCT02551055|157231204|FG003|Overall Study|Death|2|||
48833542|NCT02551055|157231205|FG004|Overall Study|Death|2|||
48833543|NCT02551055|157231206|FG005|Overall Study|Death|1|||
48531234|NCT03628924|156133984|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
48531235|NCT03628924|156133985|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
48531236|NCT03628924|156133986|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
48531237|NCT03628924|156133987|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
48531238|NCT03628924|156133988|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
48531239|NCT03628924|156133982|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
48531240|NCT03628924|156133983|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
48531241|NCT03628924|156133984|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
48531242|NCT03628924|156133985|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
48531243|NCT03628924|156133986|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
48531244|NCT03628924|156133987|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
48531245|NCT03628924|156133988|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
48531246|NCT03628924|156133982|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
48531247|NCT03628924|156133983|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
48531248|NCT03628924|156133984|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
48531249|NCT03628924|156133985|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
48531250|NCT03628924|156133986|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
48531251|NCT03628924|156133987|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
48531252|NCT03628924|156133988|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
48531253|NCT03628924|156133982|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
48531254|NCT03628924|156133983|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
48531255|NCT03628924|156133984|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
48531256|NCT03628924|156133985|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
48531257|NCT03628924|156133986|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
48531258|NCT03628924|156133987|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
48531259|NCT03628924|156133988|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
48531260|NCT03628924|156133982|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
48531261|NCT03628924|156133983|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
48531262|NCT03628924|156133984|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
48531263|NCT03628924|156133985|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
48531264|NCT03628924|156133986|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
48531265|NCT03628924|156133987|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
48531266|NCT03628924|156133988|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
48531267|NCT02999984|156133989|FG000|Overall Study|Treatment Failure|1|||
48531268|NCT03524092|156133992|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
48531269|NCT03524092|156133993|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
48531270|NCT03524092|156133994|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
48531271|NCT03524092|156133995|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
48531272|NCT03524092|156133996|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
48531273|NCT03524092|156133997|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
48531274|NCT03524092|156133992|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
48531275|NCT03524092|156133993|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
48531276|NCT03524092|156133994|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
48531277|NCT03524092|156133995|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
48531278|NCT03524092|156133996|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
48531279|NCT03524092|156133997|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
48531280|NCT03524092|156133992|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
48531281|NCT03524092|156133993|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
48531282|NCT03524092|156133994|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
48531283|NCT03524092|156133995|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
48531284|NCT03524092|156133996|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
48531285|NCT03524092|156133997|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
48531286|NCT03524092|156133992|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
48531287|NCT03524092|156133993|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
48531288|NCT03524092|156133994|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
48531289|NCT03524092|156133995|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
48531290|NCT03524092|156133996|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
48531291|NCT03524092|156133997|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
48531292|NCT03524092|156133992|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
48531293|NCT03524092|156133993|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
48531294|NCT03524092|156133994|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
48531295|NCT03524092|156133995|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
48531296|NCT03524092|156133996|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
48531297|NCT03524092|156133997|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
48833544|NCT02551055|157231207|FG006|Overall Study|Death|2|||
48833545|NCT02551055|157231208|FG007|Overall Study|Death|0|||
48531298|NCT03524092|156133992|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
48531299|NCT03524092|156133993|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
48531300|NCT03524092|156133994|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
48531301|NCT03524092|156133995|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
48531302|NCT03524092|156133996|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
48531303|NCT03524092|156133997|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
48531304|NCT03524092|156133992|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
48531305|NCT03524092|156133993|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
48531306|NCT03524092|156133994|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
48531307|NCT03524092|156133995|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
48531308|NCT03524092|156133996|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
48531309|NCT03524092|156133997|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
48531310|NCT03524092|156133992|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
48531311|NCT03524092|156133993|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
48531312|NCT03524092|156133994|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
48531313|NCT03524092|156133995|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
48531314|NCT03524092|156133996|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
48531315|NCT03524092|156133997|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
48531316|NCT03524092|156133992|FG000|Loss of Response Rescue Period|Adverse Event|0|||
48531317|NCT03524092|156133993|FG001|Loss of Response Rescue Period|Adverse Event|0|||
48531318|NCT03524092|156133994|FG002|Loss of Response Rescue Period|Adverse Event|0|||
48531319|NCT03524092|156133995|FG003|Loss of Response Rescue Period|Adverse Event|2|||
48833546|NCT02551055|157231201|FG000|Overall Study|Study Terminated by Sponsor|1|||
48833547|NCT02551055|157231202|FG001|Overall Study|Study Terminated by Sponsor|1|||
48833548|NCT02551055|157231203|FG002|Overall Study|Study Terminated by Sponsor|0|||
48531320|NCT03524092|156133996|FG004|Loss of Response Rescue Period|Adverse Event|0|||
48833549|NCT02551055|157231204|FG003|Overall Study|Study Terminated by Sponsor|2|||
48833550|NCT02551055|157231205|FG004|Overall Study|Study Terminated by Sponsor|2|||
48833551|NCT02551055|157231206|FG005|Overall Study|Study Terminated by Sponsor|0|||
48833552|NCT02551055|157231207|FG006|Overall Study|Study Terminated by Sponsor|0|||
48833553|NCT02551055|157231208|FG007|Overall Study|Study Terminated by Sponsor|0|||
48833554|NCT02551055|157231201|FG000|Overall Study|Withdrawal by Subject|1|||
48833555|NCT02551055|157231202|FG001|Overall Study|Withdrawal by Subject|1|||
48833556|NCT02551055|157231203|FG002|Overall Study|Withdrawal by Subject|0|||
48833557|NCT02551055|157231204|FG003|Overall Study|Withdrawal by Subject|1|||
48833558|NCT02551055|157231205|FG004|Overall Study|Withdrawal by Subject|2|||
48833559|NCT02551055|157231206|FG005|Overall Study|Withdrawal by Subject|0|||
48833560|NCT02551055|157231207|FG006|Overall Study|Withdrawal by Subject|0|||
48833561|NCT02551055|157231208|FG007|Overall Study|Withdrawal by Subject|0|||
48833562|NCT02551055|157231201|FG000|Overall Study|Reason not specified|0|||
48833563|NCT02551055|157231202|FG001|Overall Study|Reason not specified|0|||
48833564|NCT02551055|157231203|FG002|Overall Study|Reason not specified|0|||
48833565|NCT02551055|157231204|FG003|Overall Study|Reason not specified|0|||
48833566|NCT02551055|157231205|FG004|Overall Study|Reason not specified|1|||
48833567|NCT02551055|157231206|FG005|Overall Study|Reason not specified|0|||
48833568|NCT02551055|157231207|FG006|Overall Study|Reason not specified|1|||
48833569|NCT02551055|157231208|FG007|Overall Study|Reason not specified|0|||
48833570|NCT00430300|157231209|FG000|Overall Study|Adverse Event|0|||
48833571|NCT00430300|157231210|FG001|Overall Study|Adverse Event|2|||
48833572|NCT00430300|157231211|FG002|Overall Study|Adverse Event|1|||
48833573|NCT00430300|157231212|FG003|Overall Study|Adverse Event|1|||
48833574|NCT00430300|157231209|FG000|Overall Study|Withdrawal by Subject|1|||
48833575|NCT00430300|157231210|FG001|Overall Study|Withdrawal by Subject|0|||
48531321|NCT03524092|156133997|FG005|Loss of Response Rescue Period|Adverse Event|0|||
48531322|NCT03524092|156133992|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
48531323|NCT03524092|156133993|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
48531324|NCT03524092|156133994|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
48531325|NCT03524092|156133995|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
48531326|NCT03524092|156133996|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
48531327|NCT03524092|156133997|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
48531328|NCT03524092|156133992|FG000|Loss of Response Rescue Period|Pregnancy|0|||
48531329|NCT03524092|156133993|FG001|Loss of Response Rescue Period|Pregnancy|0|||
48531330|NCT03524092|156133994|FG002|Loss of Response Rescue Period|Pregnancy|0|||
48531331|NCT03524092|156133995|FG003|Loss of Response Rescue Period|Pregnancy|1|||
48531332|NCT03524092|156133996|FG004|Loss of Response Rescue Period|Pregnancy|0|||
48833576|NCT00430300|157231211|FG002|Overall Study|Withdrawal by Subject|5|||
48833577|NCT00430300|157231212|FG003|Overall Study|Withdrawal by Subject|0|||
48833578|NCT00430300|157231209|FG000|Overall Study|Laboratory abnormality|1|||
48833579|NCT00430300|157231210|FG001|Overall Study|Laboratory abnormality|0|||
48833580|NCT00430300|157231211|FG002|Overall Study|Laboratory abnormality|0|||
48833581|NCT00430300|157231212|FG003|Overall Study|Laboratory abnormality|0|||
48833582|NCT00430300|157231209|FG000|Overall Study|Other|0|||
48833583|NCT00430300|157231210|FG001|Overall Study|Other|0|||
48833584|NCT00430300|157231211|FG002|Overall Study|Other|0|||
48833585|NCT00430300|157231212|FG003|Overall Study|Other|1|||
48833586|NCT02577523|157232642|FG000|Overall Study|Adverse Event|1|||
48833587|NCT02577523|157232643|FG001|Overall Study|Adverse Event|1|||
48833588|NCT02577523|157232642|FG000|Overall Study|Lack of Efficacy|1|||
48833589|NCT02577523|157232643|FG001|Overall Study|Lack of Efficacy|1|||
48833590|NCT02577523|157232642|FG000|Overall Study|Withdrawal by Subject|1|||
48833591|NCT02577523|157232643|FG001|Overall Study|Withdrawal by Subject|0|||
48833592|NCT00943605|157232644|FG000|Overall Study|Study termination|30|||
48833593|NCT00943605|157232645|FG001|Overall Study|Study termination|30|||
48833594|NCT03646123|157232648|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
48833595|NCT03646123|157232649|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
48833596|NCT03646123|157232650|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
48833597|NCT03646123|157232648|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
48833598|NCT03646123|157232649|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
48833599|NCT03646123|157232650|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
48833600|NCT03646123|157232648|FG000|Overall Study|Non-compliance to study protocol|1|||
48833601|NCT03646123|157232649|FG001|Overall Study|Non-compliance to study protocol|0|||
48833602|NCT03646123|157232650|FG002|Overall Study|Non-compliance to study protocol|0|||
48833603|NCT03646123|157232648|FG000|Overall Study|Ineligible due to progression during screening|0|||
48833604|NCT03646123|157232649|FG001|Overall Study|Ineligible due to progression during screening|0|||
48833605|NCT03646123|157232650|FG002|Overall Study|Ineligible due to progression during screening|1|||
48833606|NCT03646123|157232648|FG000|Overall Study|Withdrawal by Subject|2|||
48833607|NCT03646123|157232649|FG001|Overall Study|Withdrawal by Subject|1|||
48833608|NCT03646123|157232650|FG002|Overall Study|Withdrawal by Subject|3|||
48833609|NCT03646123|157232648|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
48833610|NCT03646123|157232649|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
48833611|NCT03646123|157232650|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
48833612|NCT03646123|157232648|FG000|Overall Study|Death|2|||
48833613|NCT03646123|157232649|FG001|Overall Study|Death|1|||
48833614|NCT03646123|157232650|FG002|Overall Study|Death|1|||
48833615|NCT03646123|157232648|FG000|Overall Study|Lost to Follow-up|4|||
48833616|NCT03646123|157232649|FG001|Overall Study|Lost to Follow-up|7|||
48833617|NCT03646123|157232650|FG002|Overall Study|Lost to Follow-up|6|||
48833618|NCT03646123|157232648|FG000|Overall Study|Participants in long term follow-up|0|||
48833619|NCT03646123|157232649|FG001|Overall Study|Participants in long term follow-up|48|||
48833620|NCT03646123|157232650|FG002|Overall Study|Participants in long term follow-up|144|||
48833621|NCT01956669|157232652|FG000|Overall Study|Disease Progression|12|||
48833622|NCT01956669|157232653|FG001|Overall Study|Disease Progression|7|||
48833623|NCT01956669|157232654|FG002|Overall Study|Disease Progression|7|||
48833624|NCT01956669|157232655|FG003|Overall Study|Disease Progression|8|||
48833625|NCT01956669|157232656|FG004|Overall Study|Disease Progression|4|||
48833626|NCT01956669|157232657|FG005|Overall Study|Disease Progression|3|||
48833627|NCT01956669|157232658|FG006|Overall Study|Disease Progression|5|||
48833628|NCT01956669|157232652|FG000|Overall Study|Adverse Event|0|||
48531333|NCT03524092|156133997|FG005|Loss of Response Rescue Period|Pregnancy|0|||
48531334|NCT03524092|156133992|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
48531335|NCT03524092|156133993|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
48531336|NCT03524092|156133994|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
48531337|NCT03524092|156133995|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
48531338|NCT03524092|156133996|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
48531339|NCT03524092|156133997|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
48531340|NCT03524092|156133992|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
48531341|NCT03524092|156133993|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
48602769|NCT00377637|156401539|FG001|Induction Phase|Withdrawal by Subject|6|||
48602770|NCT00377637|156401540|FG002|Induction Phase|Withdrawal by Subject|0|||
48602771|NCT00377637|156401541|FG003|Induction Phase|Withdrawal by Subject|0|||
48602772|NCT00377637|156401538|FG000|Induction Phase|Physician Decision|3|||
48602773|NCT00377637|156401539|FG001|Induction Phase|Physician Decision|1|||
48602774|NCT00377637|156401540|FG002|Induction Phase|Physician Decision|0|||
48602775|NCT00377637|156401541|FG003|Induction Phase|Physician Decision|0|||
48602776|NCT00377637|156401538|FG000|Induction Phase|Sponsor decision|1|||
48602777|NCT00377637|156401539|FG001|Induction Phase|Sponsor decision|2|||
48602778|NCT00377637|156401540|FG002|Induction Phase|Sponsor decision|0|||
48602779|NCT00377637|156401541|FG003|Induction Phase|Sponsor decision|0|||
48602780|NCT00377637|156401538|FG000|Induction Phase|Non-Compliance|1|||
48602781|NCT00377637|156401539|FG001|Induction Phase|Non-Compliance|0|||
48602782|NCT00377637|156401540|FG002|Induction Phase|Non-Compliance|0|||
48602783|NCT00377637|156401541|FG003|Induction Phase|Non-Compliance|0|||
48602784|NCT00377637|156401538|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
48602785|NCT00377637|156401539|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
48602786|NCT00377637|156401540|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
48602787|NCT00377637|156401541|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
48602788|NCT00377637|156401538|FG000|Maintenance Phase|Adverse Event|0|||
48602789|NCT00377637|156401539|FG001|Maintenance Phase|Adverse Event|0|||
48602790|NCT00377637|156401540|FG002|Maintenance Phase|Adverse Event|29|||
48602791|NCT00377637|156401541|FG003|Maintenance Phase|Adverse Event|43|||
48602792|NCT00377637|156401538|FG000|Maintenance Phase|Physician Decision|0|||
48602793|NCT00377637|156401539|FG001|Maintenance Phase|Physician Decision|0|||
48602794|NCT00377637|156401540|FG002|Maintenance Phase|Physician Decision|5|||
48602795|NCT00377637|156401541|FG003|Maintenance Phase|Physician Decision|4|||
48602796|NCT00377637|156401538|FG000|Maintenance Phase|Lost to Follow-up|0|||
48602797|NCT00377637|156401539|FG001|Maintenance Phase|Lost to Follow-up|0|||
48602798|NCT00377637|156401540|FG002|Maintenance Phase|Lost to Follow-up|3|||
48602799|NCT00377637|156401541|FG003|Maintenance Phase|Lost to Follow-up|1|||
48602800|NCT00377637|156401538|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48602801|NCT00377637|156401539|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48602802|NCT00377637|156401540|FG002|Maintenance Phase|Withdrawal by Subject|3|||
48602803|NCT00377637|156401541|FG003|Maintenance Phase|Withdrawal by Subject|3|||
48602804|NCT00377637|156401538|FG000|Maintenance Phase|Sponsor decision|0|||
48833629|NCT01956669|157232653|FG001|Overall Study|Adverse Event|2|||
48833630|NCT01956669|157232654|FG002|Overall Study|Adverse Event|2|||
48833631|NCT01956669|157232655|FG003|Overall Study|Adverse Event|1|||
48833632|NCT01956669|157232656|FG004|Overall Study|Adverse Event|0|||
48833633|NCT01956669|157232657|FG005|Overall Study|Adverse Event|0|||
48833634|NCT01956669|157232658|FG006|Overall Study|Adverse Event|0|||
48833635|NCT01956669|157232652|FG000|Overall Study|Physician Decision|0|||
48833636|NCT01956669|157232653|FG001|Overall Study|Physician Decision|2|||
48833637|NCT01956669|157232654|FG002|Overall Study|Physician Decision|0|||
48833638|NCT01956669|157232655|FG003|Overall Study|Physician Decision|0|||
48833639|NCT01956669|157232656|FG004|Overall Study|Physician Decision|0|||
48833640|NCT01956669|157232657|FG005|Overall Study|Physician Decision|1|||
48833641|NCT01956669|157232658|FG006|Overall Study|Physician Decision|0|||
48531342|NCT03524092|156133994|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
48531343|NCT03524092|156133995|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
48531344|NCT03524092|156133996|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
48531345|NCT03524092|156133997|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
48531346|NCT03524092|156133992|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
48531347|NCT03524092|156133993|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
48531348|NCT03524092|156133994|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
48531349|NCT03524092|156133995|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
48602805|NCT00377637|156401539|FG001|Maintenance Phase|Sponsor decision|0|||
48602806|NCT00377637|156401540|FG002|Maintenance Phase|Sponsor decision|2|||
48602807|NCT00377637|156401541|FG003|Maintenance Phase|Sponsor decision|3|||
48602808|NCT00377637|156401538|FG000|Maintenance Phase|Non-compliance|0|||
48602809|NCT00377637|156401539|FG001|Maintenance Phase|Non-compliance|0|||
48602810|NCT00377637|156401540|FG002|Maintenance Phase|Non-compliance|1|||
48833642|NCT01956669|157232652|FG000|Overall Study|Withdrawal by Subject|0|||
48833643|NCT01956669|157232653|FG001|Overall Study|Withdrawal by Subject|0|||
48833644|NCT01956669|157232654|FG002|Overall Study|Withdrawal by Subject|1|||
48383829|NCT00436618|155601449|FG002|Overall Study|Adverse Event|9|||
48833645|NCT01956669|157232655|FG003|Overall Study|Withdrawal by Subject|1|||
48833646|NCT01956669|157232656|FG004|Overall Study|Withdrawal by Subject|0|||
48833647|NCT01956669|157232657|FG005|Overall Study|Withdrawal by Subject|0|||
48833648|NCT01956669|157232658|FG006|Overall Study|Withdrawal by Subject|1|||
48833649|NCT00891618|157232659|FG000|Overall Study|Withdrawal by Subject|1|||
48833650|NCT03125382|157232664|FG000|Randomization|screening failure|1|||
48833651|NCT03125382|157232665|FG001|Randomization|screening failure|4|||
48833652|NCT03125382|157232666|FG002|Randomization|screening failure|2|||
48833653|NCT03125382|157232667|FG003|Randomization|screening failure|0|||
48833654|NCT03125382|157232664|FG000|Follow-up|Death|1|||
48833655|NCT03125382|157232665|FG001|Follow-up|Death|2|||
48833656|NCT03125382|157232666|FG002|Follow-up|Death|1|||
48833657|NCT03125382|157232667|FG003|Follow-up|Death|2|||
48833658|NCT03125382|157232664|FG000|Follow-up|Lost to Follow-up|1|||
48833659|NCT03125382|157232665|FG001|Follow-up|Lost to Follow-up|4|||
48833660|NCT03125382|157232666|FG002|Follow-up|Lost to Follow-up|3|||
48833661|NCT03125382|157232667|FG003|Follow-up|Lost to Follow-up|1|||
48833662|NCT04889664|157232670|FG000|Screen|Lost to Follow-up|1|||
48833663|NCT04889664|157232670|FG000|Screen|Failed to meet screening criteria|1|||
48833664|NCT04889664|157232670|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
48833665|NCT01585038|157232671|FG000|Overall Study|Adverse Event|2|||
48833666|NCT01585038|157232672|FG001|Overall Study|Adverse Event|2|||
48833667|NCT01145885|157232673|FG000|Overall Study|Progressive Disease|7|||
48833668|NCT01988233|157232679|FG000|Overall Study|Lost to Follow-up|64|||
48833669|NCT01988233|157232680|FG001|Overall Study|Lost to Follow-up|51|||
48833670|NCT02613364|157232681|FG000|Overall Study|Other|19|||
48833671|NCT02613364|157232682|FG001|Overall Study|Other|29|||
48833672|NCT02613364|157232683|FG002|Overall Study|Other|17|||
48833673|NCT02613364|157232681|FG000|Overall Study|Too time consuming|21|||
48833674|NCT02613364|157232682|FG001|Overall Study|Too time consuming|26|||
48833675|NCT02613364|157232683|FG002|Overall Study|Too time consuming|26|||
48833676|NCT02613364|157232681|FG000|Overall Study|Withdrawal by Subject|13|||
48833677|NCT02613364|157232682|FG001|Overall Study|Withdrawal by Subject|18|||
48833678|NCT02613364|157232683|FG002|Overall Study|Withdrawal by Subject|17|||
48833679|NCT02613364|157232681|FG000|Overall Study|Medical|12|||
48833680|NCT02613364|157232682|FG001|Overall Study|Medical|13|||
48833681|NCT02613364|157232683|FG002|Overall Study|Medical|9|||
48833682|NCT02613364|157232681|FG000|Overall Study|Disliked Study Procedure|1|||
48833683|NCT02613364|157232682|FG001|Overall Study|Disliked Study Procedure|1|||
48833684|NCT02613364|157232683|FG002|Overall Study|Disliked Study Procedure|4|||
48833685|NCT02613364|157232681|FG000|Overall Study|Disliked Intervention|0|||
48833686|NCT02613364|157232682|FG001|Overall Study|Disliked Intervention|3|||
48833687|NCT02613364|157232683|FG002|Overall Study|Disliked Intervention|3|||
48833688|NCT03743246|157232684|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
48833689|NCT03743246|157232685|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
48833690|NCT03743246|157232686|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
48833691|NCT03743246|157232687|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
48833692|NCT03743246|157232684|FG000|Pre-Treatment Period|Death|0|||
48833693|NCT03743246|157232685|FG001|Pre-Treatment Period|Death|1|||
48833694|NCT03743246|157232686|FG002|Pre-Treatment Period|Death|0|||
48833695|NCT03743246|157232687|FG003|Pre-Treatment Period|Death|1|||
48833696|NCT03743246|157232684|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
48833697|NCT03743246|157232685|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
48833698|NCT03743246|157232686|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
48833699|NCT03743246|157232687|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
48833700|NCT03743246|157232684|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
48833701|NCT03743246|157232685|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
48833702|NCT03743246|157232686|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
48833703|NCT03743246|157232687|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
48833704|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
48833705|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
48833706|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
48833707|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
48833708|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
48833709|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
48833710|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
48833711|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
48833712|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
48833713|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
48833714|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
48833715|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
48833716|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
48602811|NCT00377637|156401541|FG003|Maintenance Phase|Non-compliance|1|||
48602812|NCT00377637|156401538|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
48602813|NCT00377637|156401539|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
48602814|NCT00377637|156401540|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
48602815|NCT00377637|156401541|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
48602816|NCT00377637|156401538|FG000|Maintenance Phase|Death|0|||
48602817|NCT00377637|156401539|FG001|Maintenance Phase|Death|0|||
48602818|NCT00377637|156401540|FG002|Maintenance Phase|Death|0|||
48602819|NCT00377637|156401541|FG003|Maintenance Phase|Death|1|||
48602820|NCT03028142|156401542|FG000|Overall Study|Adverse Event|1|||
48602821|NCT03028142|156401543|FG001|Overall Study|Adverse Event|1|||
48602822|NCT03028142|156401544|FG002|Overall Study|Adverse Event|0|||
48602823|NCT03028142|156401545|FG003|Overall Study|Adverse Event|0|||
48602824|NCT03028142|156401546|FG004|Overall Study|Adverse Event|0|||
48602825|NCT03028142|156401547|FG005|Overall Study|Adverse Event|1|||
48833717|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
48531350|NCT03524092|156133996|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
48531351|NCT03524092|156133997|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
48531352|NCT03524092|156133992|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
48531353|NCT03524092|156133993|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
48531354|NCT03524092|156133994|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
48531355|NCT03524092|156133995|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
48531356|NCT03524092|156133996|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
48531357|NCT03524092|156133997|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
48531358|NCT03524092|156133992|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
48531359|NCT03524092|156133993|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
48531360|NCT03524092|156133994|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
48531361|NCT03524092|156133995|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
48531362|NCT03524092|156133996|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
48531363|NCT03524092|156133997|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
48531364|NCT03524092|156133992|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
48531365|NCT03524092|156133993|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
48531366|NCT03524092|156133994|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
48531367|NCT03524092|156133995|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
48531368|NCT03524092|156133996|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
48531369|NCT03524092|156133997|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
48531370|NCT03524092|156133992|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
48531371|NCT03524092|156133993|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
48531372|NCT03524092|156133994|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
48531373|NCT03524092|156133995|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
48531374|NCT03524092|156133996|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
48531375|NCT03524092|156133997|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
48531376|NCT03524092|156133992|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
48531377|NCT03524092|156133993|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
48531378|NCT03524092|156133994|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
48531379|NCT03524092|156133995|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
48531380|NCT03524092|156133996|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
48531381|NCT03524092|156133997|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
48531382|NCT03524092|156133992|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
48531383|NCT03524092|156133993|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
48531384|NCT03524092|156133994|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
48531385|NCT03524092|156133995|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
48531386|NCT03524092|156133996|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
48833718|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
48833719|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
48833720|NCT03743246|157232684|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
48833721|NCT03743246|157232685|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
48602826|NCT03028142|156401542|FG000|Overall Study|Withdrawal by Subject|0|||
48602827|NCT03028142|156401543|FG001|Overall Study|Withdrawal by Subject|0|||
48602828|NCT03028142|156401544|FG002|Overall Study|Withdrawal by Subject|0|||
48602829|NCT03028142|156401545|FG003|Overall Study|Withdrawal by Subject|0|||
48602830|NCT03028142|156401546|FG004|Overall Study|Withdrawal by Subject|1|||
48602831|NCT03028142|156401547|FG005|Overall Study|Withdrawal by Subject|0|||
48602832|NCT04085601|156401552|FG000|Overall Study|Lost to Follow-up|1|||
48602833|NCT04085601|156401553|FG001|Overall Study|Lost to Follow-up|0|||
48602834|NCT04085601|156401552|FG000|Overall Study|Death|1|||
48602835|NCT04085601|156401553|FG001|Overall Study|Death|1|||
48602836|NCT02810418|156401554|FG000|Arm A Dose Escalation|Adverse Event|2|||
48602837|NCT02810418|156401555|FG001|Arm A Dose Escalation|Adverse Event|1|||
48602838|NCT02810418|156401556|FG002|Arm A Dose Escalation|Adverse Event|0|||
48602839|NCT02810418|156401557|FG003|Arm A Dose Escalation|Adverse Event|0|||
48602840|NCT02810418|156401558|FG004|Arm A Dose Escalation|Adverse Event|0|||
48602841|NCT02810418|156401559|FG005|Arm A Dose Escalation|Adverse Event|0|||
48602842|NCT02810418|156401560|FG006|Arm A Dose Escalation|Adverse Event|0|||
48602843|NCT02810418|156401554|FG000|Dose Expansion|Adverse Event|0|||
48602844|NCT02810418|156401555|FG001|Dose Expansion|Adverse Event|1|||
48602845|NCT02810418|156401556|FG002|Dose Expansion|Adverse Event|1|||
48602846|NCT02810418|156401557|FG003|Dose Expansion|Adverse Event|0|||
48602847|NCT02810418|156401558|FG004|Dose Expansion|Adverse Event|0|||
48602848|NCT02810418|156401559|FG005|Dose Expansion|Adverse Event|0|||
48531387|NCT03524092|156133997|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
48531388|NCT03524092|156133992|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
48531389|NCT03524092|156133993|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
48531390|NCT03524092|156133994|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
48531391|NCT03524092|156133995|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
48602849|NCT02810418|156401560|FG006|Dose Expansion|Adverse Event|0|||
48531392|NCT03524092|156133996|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
48531393|NCT03524092|156133997|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
48602850|NCT02810418|156401554|FG000|Dose Expansion|Physician Decision|0|||
48602851|NCT02810418|156401555|FG001|Dose Expansion|Physician Decision|0|||
48602852|NCT02810418|156401556|FG002|Dose Expansion|Physician Decision|2|||
48602853|NCT02810418|156401557|FG003|Dose Expansion|Physician Decision|0|||
48602854|NCT02810418|156401558|FG004|Dose Expansion|Physician Decision|0|||
48602855|NCT02810418|156401559|FG005|Dose Expansion|Physician Decision|0|||
48833722|NCT03743246|157232686|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
48833723|NCT03743246|157232687|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
48833724|NCT01490580|157232688|FG000|Overall Study|Parents withdrew consent|0|||
48531394|NCT03524092|156133992|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
48531395|NCT03524092|156133993|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
48833725|NCT01490580|157232689|FG001|Overall Study|Parents withdrew consent|2|||
48833726|NCT00972504|157232690|FG000|Overall Study|Adverse Event|2|||
48531396|NCT03524092|156133994|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
48833727|NCT00972504|157232690|FG000|Overall Study|Investigator discretion|1|||
48833728|NCT03478696|157232703|FG000|Overall Study|Adverse Event|1|||
48833729|NCT03478696|157232704|FG001|Overall Study|Adverse Event|5|||
48833730|NCT03478696|157232703|FG000|Overall Study|Lost to Follow-up|1|||
48833731|NCT03478696|157232704|FG001|Overall Study|Lost to Follow-up|0|||
48833732|NCT03478696|157232703|FG000|Overall Study|Physician Decision|6|||
48833733|NCT03478696|157232704|FG001|Overall Study|Physician Decision|3|||
48531397|NCT03524092|156133995|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
48531398|NCT03524092|156133996|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
48531399|NCT03524092|156133997|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
48531400|NCT03524092|156133992|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
48531401|NCT03524092|156133993|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
48531402|NCT03524092|156133994|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
48531403|NCT03524092|156133995|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
48531404|NCT03524092|156133996|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
48531405|NCT03524092|156133997|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
48531406|NCT03449199|156134001|FG000|Overall Study|Lost to Follow-up|1|||
48531407|NCT03449199|156134002|FG001|Overall Study|Lost to Follow-up|1|||
48602856|NCT02810418|156401560|FG006|Dose Expansion|Physician Decision|0|||
48602857|NCT02810418|156401554|FG000|Arm B Dose Escalation|Adverse Event|0|||
48602858|NCT02810418|156401555|FG001|Arm B Dose Escalation|Adverse Event|0|||
48602859|NCT02810418|156401556|FG002|Arm B Dose Escalation|Adverse Event|0|||
48602860|NCT02810418|156401557|FG003|Arm B Dose Escalation|Adverse Event|0|||
48602861|NCT02810418|156401558|FG004|Arm B Dose Escalation|Adverse Event|1|||
48602862|NCT02810418|156401559|FG005|Arm B Dose Escalation|Adverse Event|2|||
48602863|NCT02810418|156401560|FG006|Arm B Dose Escalation|Adverse Event|0|||
48602864|NCT00010257|156401561|FG000|Overall Study|Withdrawal by Subject|1|||
48602865|NCT00010257|156401562|FG001|Overall Study|Withdrawal by Subject|0|||
48602866|NCT03506438|156401563|FG000|Overall Study|Lost to Follow-up|8|||
48602867|NCT03506438|156401564|FG001|Overall Study|Lost to Follow-up|7|||
48833734|NCT03478696|157232703|FG000|Overall Study|Withdrawal by Subject|9|||
48833735|NCT03478696|157232704|FG001|Overall Study|Withdrawal by Subject|4|||
48833736|NCT04246762|157232705|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
48833737|NCT00597519|157232706|FG000|Overall Study|Death|1|||
48833738|NCT01981850|157232707|FG000|Main Phase Stage 1|Death|2|||
48833739|NCT01981850|157232708|FG001|Main Phase Stage 1|Death|0|||
48833740|NCT01981850|157232709|FG002|Main Phase Stage 1|Death|0|||
48833741|NCT01981850|157232710|FG003|Main Phase Stage 1|Death|0|||
48833742|NCT01981850|157232711|FG004|Main Phase Stage 1|Death|0|||
48833743|NCT01981850|157232712|FG005|Main Phase Stage 1|Death|0|||
48833744|NCT01981850|157232713|FG006|Main Phase Stage 1|Death|0|||
48833745|NCT01981850|157232714|FG007|Main Phase Stage 1|Death|0|||
48833746|NCT01981850|157232715|FG008|Main Phase Stage 1|Death|0|||
48833747|NCT01981850|157232716|FG009|Main Phase Stage 1|Death|0|||
48833748|NCT01981850|157232707|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
48833749|NCT01981850|157232708|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833750|NCT01981850|157232709|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833751|NCT01981850|157232710|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833752|NCT01981850|157232711|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833753|NCT01981850|157232712|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833754|NCT01981850|157232713|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833755|NCT01981850|157232714|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833756|NCT01981850|157232715|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833757|NCT01981850|157232716|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
48833758|NCT01981850|157232707|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
48833759|NCT01981850|157232708|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
48833760|NCT01981850|157232709|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
48833761|NCT01981850|157232710|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
48602868|NCT03506438|156401565|FG002|Overall Study|Lost to Follow-up|8|||
48833762|NCT01981850|157232711|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
48833763|NCT01981850|157232712|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
48833764|NCT01981850|157232713|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
48833765|NCT01981850|157232714|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
48833766|NCT01981850|157232715|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
48833767|NCT01981850|157232716|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
48602869|NCT03506438|156401566|FG003|Overall Study|Lost to Follow-up|7|||
48602870|NCT03506438|156401567|FG004|Overall Study|Lost to Follow-up|0|||
48602871|NCT03506438|156401568|FG005|Overall Study|Lost to Follow-up|0|||
48602872|NCT03234036|156401575|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
48602873|NCT03234036|156401576|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
48602874|NCT03234036|156401577|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
48602875|NCT03234036|156401578|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
48602876|NCT00368108|156401595|FG000|Overall Study|Adverse Event|38|||
48602877|NCT00368108|156401596|FG001|Overall Study|Adverse Event|26|||
48602878|NCT00368108|156401597|FG002|Overall Study|Adverse Event|44|||
48602879|NCT00368108|156401595|FG000|Overall Study|Abnormal Laboratory Value|0|||
48602880|NCT00368108|156401596|FG001|Overall Study|Abnormal Laboratory Value|0|||
48602881|NCT00368108|156401597|FG002|Overall Study|Abnormal Laboratory Value|3|||
48602882|NCT00368108|156401595|FG000|Overall Study|Protocol Violation|5|||
48602883|NCT00368108|156401596|FG001|Overall Study|Protocol Violation|9|||
48602884|NCT00368108|156401597|FG002|Overall Study|Protocol Violation|9|||
48602885|NCT00368108|156401595|FG000|Overall Study|Withdrawal by Subject|9|||
48602886|NCT00368108|156401596|FG001|Overall Study|Withdrawal by Subject|3|||
48602887|NCT00368108|156401597|FG002|Overall Study|Withdrawal by Subject|5|||
48602888|NCT00368108|156401595|FG000|Overall Study|Lack of Efficacy|7|||
48602889|NCT00368108|156401596|FG001|Overall Study|Lack of Efficacy|8|||
48602890|NCT00368108|156401597|FG002|Overall Study|Lack of Efficacy|5|||
48602891|NCT00368108|156401595|FG000|Overall Study|Physician Decision|2|||
48602892|NCT00368108|156401596|FG001|Overall Study|Physician Decision|0|||
48602893|NCT00368108|156401597|FG002|Overall Study|Physician Decision|1|||
48602894|NCT00368108|156401595|FG000|Overall Study|Other|3|||
48602895|NCT00368108|156401596|FG001|Overall Study|Other|7|||
48602896|NCT00368108|156401597|FG002|Overall Study|Other|1|||
48602897|NCT01241279|156401598|FG000|Overall Study|Lost to Follow-up|0|||
48602898|NCT01241279|156401599|FG001|Overall Study|Lost to Follow-up|1|||
48602899|NCT02302846|156401602|FG000|Overall Study|Withdrawal by Subject|1|||
48602900|NCT02948829|156401603|FG000|Overall Study|Lost to Follow-up|2|||
48833768|NCT01981850|157232707|FG000|Main Phase Stage 1|Various reasons|0|||
48833769|NCT01981850|157232708|FG001|Main Phase Stage 1|Various reasons|0|||
48833770|NCT01981850|157232709|FG002|Main Phase Stage 1|Various reasons|2|||
48833771|NCT01981850|157232710|FG003|Main Phase Stage 1|Various reasons|0|||
48833772|NCT01981850|157232711|FG004|Main Phase Stage 1|Various reasons|0|||
48833773|NCT01981850|157232712|FG005|Main Phase Stage 1|Various reasons|0|||
48833774|NCT01981850|157232713|FG006|Main Phase Stage 1|Various reasons|0|||
48833775|NCT01981850|157232714|FG007|Main Phase Stage 1|Various reasons|0|||
48833776|NCT01981850|157232715|FG008|Main Phase Stage 1|Various reasons|0|||
48833777|NCT01981850|157232716|FG009|Main Phase Stage 1|Various reasons|0|||
48833778|NCT01981850|157232707|FG000|Main Phase Stage 2|Adverse Event|0|||
48833779|NCT01981850|157232708|FG001|Main Phase Stage 2|Adverse Event|0|||
48833780|NCT01981850|157232709|FG002|Main Phase Stage 2|Adverse Event|0|||
48833781|NCT01981850|157232710|FG003|Main Phase Stage 2|Adverse Event|0|||
48833782|NCT01981850|157232711|FG004|Main Phase Stage 2|Adverse Event|6|||
48833783|NCT01981850|157232712|FG005|Main Phase Stage 2|Adverse Event|5|||
48833784|NCT01981850|157232713|FG006|Main Phase Stage 2|Adverse Event|7|||
48833785|NCT01981850|157232714|FG007|Main Phase Stage 2|Adverse Event|0|||
48833786|NCT01981850|157232715|FG008|Main Phase Stage 2|Adverse Event|0|||
48833787|NCT01981850|157232716|FG009|Main Phase Stage 2|Adverse Event|0|||
48833788|NCT01981850|157232707|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833789|NCT01981850|157232708|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833790|NCT01981850|157232709|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833791|NCT01981850|157232710|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833792|NCT01981850|157232711|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
48833793|NCT01981850|157232712|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
48833794|NCT01981850|157232713|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
48833795|NCT01981850|157232714|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833796|NCT01981850|157232715|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833797|NCT01981850|157232716|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
48833798|NCT01981850|157232707|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
48833799|NCT01981850|157232708|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
48833800|NCT01981850|157232709|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
48833801|NCT01981850|157232710|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
48833802|NCT01981850|157232711|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
48833803|NCT01981850|157232712|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
48833804|NCT01981850|157232713|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
48833805|NCT01981850|157232714|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
48833806|NCT01981850|157232715|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
48602901|NCT02948829|156401603|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
48602902|NCT02948829|156401603|FG000|Overall Study|Pregnancy|1|||
48602903|NCT02948829|156401603|FG000|Overall Study|Other: Reason not Specified|8|||
48602904|NCT01450813|156401606|FG000|Overall Study|Physician Decision|1|||
48602905|NCT01450813|156401607|FG001|Overall Study|Physician Decision|1|||
48833807|NCT01981850|157232716|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
48833808|NCT01981850|157232707|FG000|Main Phase Stage 2|Various reasons|0|||
48833809|NCT01981850|157232708|FG001|Main Phase Stage 2|Various reasons|0|||
48833810|NCT01981850|157232709|FG002|Main Phase Stage 2|Various reasons|0|||
48833811|NCT01981850|157232710|FG003|Main Phase Stage 2|Various reasons|0|||
48833812|NCT01981850|157232711|FG004|Main Phase Stage 2|Various reasons|2|||
48833813|NCT01981850|157232712|FG005|Main Phase Stage 2|Various reasons|0|||
48531408|NCT03449199|156134003|FG002|Overall Study|Lost to Follow-up|0|||
48531409|NCT03449199|156134001|FG000|Overall Study|Protocol Deviation|0|||
48531410|NCT03449199|156134002|FG001|Overall Study|Protocol Deviation|0|||
48531411|NCT03449199|156134003|FG002|Overall Study|Protocol Deviation|1|||
48531412|NCT03449199|156134001|FG000|Overall Study|Withdrawal by Subject|0|||
48531413|NCT03449199|156134002|FG001|Overall Study|Withdrawal by Subject|0|||
48531414|NCT03449199|156134003|FG002|Overall Study|Withdrawal by Subject|1|||
48602906|NCT01450813|156401608|FG002|Overall Study|Physician Decision|0|||
48602907|NCT01450813|156401609|FG003|Overall Study|Physician Decision|3|||
48602908|NCT00917124|156401610|FG000|Overall Study|Protocol Violation|4|||
48602909|NCT00917124|156401611|FG001|Overall Study|Protocol Violation|6|||
48602910|NCT01935089|156401612|FG000|Overall Study|Adverse Event|2|||
48602911|NCT01935089|156401612|FG000|Overall Study|Withdrawal by Subject|1|||
48602912|NCT00737100|156401625|FG000|Overall Study|Adverse Event|6|||
48602913|NCT00737100|156401626|FG001|Overall Study|Adverse Event|5|||
48602914|NCT00737100|156401627|FG002|Overall Study|Adverse Event|3|||
48602915|NCT00737100|156401625|FG000|Overall Study|Lost to Follow-up|0|||
48602916|NCT00737100|156401626|FG001|Overall Study|Lost to Follow-up|1|||
48602917|NCT00737100|156401627|FG002|Overall Study|Lost to Follow-up|0|||
48602918|NCT00737100|156401625|FG000|Overall Study|Withdrawal by Subject|0|||
48602919|NCT00737100|156401626|FG001|Overall Study|Withdrawal by Subject|0|||
48602920|NCT00737100|156401627|FG002|Overall Study|Withdrawal by Subject|3|||
48602921|NCT00737100|156401625|FG000|Overall Study|Reason discontinued not explained above|1|||
48602922|NCT00737100|156401626|FG001|Overall Study|Reason discontinued not explained above|1|||
48602923|NCT00737100|156401627|FG002|Overall Study|Reason discontinued not explained above|1|||
48602924|NCT00232557|156401628|FG000|Overall Study|Lost to Follow-up|3|||
48602925|NCT00232557|156401629|FG001|Overall Study|Lost to Follow-up|5|||
48602926|NCT01447407|156401630|FG000|Overall Study|Withdrawal by Subject|2|||
48602927|NCT01447407|156401631|FG001|Overall Study|Withdrawal by Subject|0|||
48602928|NCT01447407|156401632|FG002|Overall Study|Withdrawal by Subject|0|||
48602929|NCT01447407|156401633|FG003|Overall Study|Withdrawal by Subject|1|||
48602930|NCT01447407|156401630|FG000|Overall Study|Physician Decision|0|||
48602931|NCT01447407|156401631|FG001|Overall Study|Physician Decision|0|||
48602932|NCT01447407|156401632|FG002|Overall Study|Physician Decision|1|||
48602933|NCT01447407|156401633|FG003|Overall Study|Physician Decision|1|||
48602934|NCT01783743|156401636|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
48602935|NCT01783743|156401637|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
48833814|NCT01981850|157232713|FG006|Main Phase Stage 2|Various reasons|1|||
48531415|NCT04442737|156134004|FG000|Overall Study|Lost to Follow-up|1|||
48531416|NCT04442737|156134005|FG001|Overall Study|Lost to Follow-up|3|||
48531417|NCT04442737|156134004|FG000|Overall Study|Withdrawal by Subject|3|||
48531418|NCT04442737|156134005|FG001|Overall Study|Withdrawal by Subject|2|||
48531419|NCT04442737|156134004|FG000|Overall Study|Adverse Event|3|||
48531420|NCT04442737|156134005|FG001|Overall Study|Adverse Event|2|||
48531421|NCT04442737|156134004|FG000|Overall Study|Death|0|||
48531422|NCT04442737|156134005|FG001|Overall Study|Death|1|||
48531423|NCT04442737|156134004|FG000|Overall Study|Protocol Violation|0|||
48531424|NCT04442737|156134005|FG001|Overall Study|Protocol Violation|2|||
48531425|NCT04442737|156134004|FG000|Overall Study|Other|1|||
48531426|NCT04442737|156134005|FG001|Overall Study|Other|1|||
48531427|NCT05780437|156134006|FG000|Overall Study|Withdrawal by Subject|22|||
48531428|NCT05780437|156134007|FG001|Overall Study|Withdrawal by Subject|16|||
48531429|NCT01756300|156134010|FG000|Overall Study|Death|1|||
48531430|NCT01756300|156134010|FG000|Overall Study|Withdrawal by Subject|1|||
48531431|NCT02096588|156134011|FG000|Overall Study|Lack of Efficacy|2|||
48531432|NCT02096588|156134012|FG001|Overall Study|Lack of Efficacy|0|||
48531433|NCT02096588|156134011|FG000|Overall Study|Withdrawal by Subject|0|||
48531434|NCT02096588|156134012|FG001|Overall Study|Withdrawal by Subject|1|||
48531435|NCT00384293|156134013|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
48602936|NCT01783743|156401636|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
48383830|NCT00436618|155601447|FG000|Overall Study|Alternate Treatment|3|||
48531436|NCT00384293|156134014|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
48531437|NCT00384293|156134015|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
48531438|NCT00384293|156134013|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
48602937|NCT01783743|156401637|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
48833815|NCT01981850|157232714|FG007|Main Phase Stage 2|Various reasons|0|||
48602938|NCT01783743|156401636|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
48602939|NCT01783743|156401637|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
48833816|NCT01981850|157232715|FG008|Main Phase Stage 2|Various reasons|0|||
48833817|NCT01981850|157232716|FG009|Main Phase Stage 2|Various reasons|0|||
48833818|NCT01981850|157232707|FG000|Main Phase Stage 2|Progressive Disease|0|||
48833819|NCT01981850|157232708|FG001|Main Phase Stage 2|Progressive Disease|0|||
48833820|NCT01981850|157232709|FG002|Main Phase Stage 2|Progressive Disease|0|||
48833821|NCT01981850|157232710|FG003|Main Phase Stage 2|Progressive Disease|0|||
48833822|NCT01981850|157232711|FG004|Main Phase Stage 2|Progressive Disease|0|||
48833823|NCT01981850|157232712|FG005|Main Phase Stage 2|Progressive Disease|6|||
48833824|NCT01981850|157232713|FG006|Main Phase Stage 2|Progressive Disease|6|||
48833825|NCT01981850|157232714|FG007|Main Phase Stage 2|Progressive Disease|0|||
48833826|NCT01981850|157232715|FG008|Main Phase Stage 2|Progressive Disease|0|||
48833827|NCT01981850|157232716|FG009|Main Phase Stage 2|Progressive Disease|0|||
48833828|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Adverse Event|0|||
48833829|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Adverse Event|0|||
48833830|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Adverse Event|0|||
48833831|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Adverse Event|0|||
48531439|NCT00384293|156134014|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
48531440|NCT00384293|156134015|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
48531441|NCT00384293|156134013|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
48531442|NCT00384293|156134014|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
48833832|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Adverse Event|0|||
48833833|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Adverse Event|0|||
48833834|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Adverse Event|0|||
48833835|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Adverse Event|2|||
48833836|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Adverse Event|1|||
48833837|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Adverse Event|8|||
48531443|NCT00384293|156134015|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
48531444|NCT00384293|156134013|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
48531445|NCT00384293|156134014|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
48531446|NCT00384293|156134015|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
48531447|NCT00384293|156134013|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
48531448|NCT00384293|156134014|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
48531449|NCT00384293|156134015|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
48531450|NCT00384293|156134013|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
48531451|NCT00384293|156134014|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
48531452|NCT00384293|156134015|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
48531453|NCT00384293|156134013|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
48531454|NCT00384293|156134014|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
48531455|NCT00384293|156134015|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
48531456|NCT00384293|156134013|FG000|Post-randomization Period|Adverse Event|0|||
48531457|NCT00384293|156134014|FG001|Post-randomization Period|Adverse Event|23|||
48531458|NCT00384293|156134015|FG002|Post-randomization Period|Adverse Event|7|||
48531459|NCT00384293|156134013|FG000|Post-randomization Period|Lost to Follow-up|0|||
48531460|NCT00384293|156134014|FG001|Post-randomization Period|Lost to Follow-up|2|||
48531461|NCT00384293|156134015|FG002|Post-randomization Period|Lost to Follow-up|1|||
48531462|NCT00384293|156134013|FG000|Post-randomization Period|Protocol Violation|0|||
48531463|NCT00384293|156134014|FG001|Post-randomization Period|Protocol Violation|1|||
48531464|NCT00384293|156134015|FG002|Post-randomization Period|Protocol Violation|0|||
48531465|NCT00384293|156134013|FG000|Post-randomization Period|Withdrawal by Subject|0|||
48531466|NCT00384293|156134014|FG001|Post-randomization Period|Withdrawal by Subject|8|||
48531467|NCT00384293|156134015|FG002|Post-randomization Period|Withdrawal by Subject|6|||
48531468|NCT00384293|156134013|FG000|Post-randomization Period|Trial Termination|0|||
48531469|NCT00384293|156134014|FG001|Post-randomization Period|Trial Termination|180|||
48531470|NCT00384293|156134015|FG002|Post-randomization Period|Trial Termination|204|||
48531471|NCT00384293|156134013|FG000|Post-randomization Period|Patient Randomized in Error|0|||
48531472|NCT00384293|156134014|FG001|Post-randomization Period|Patient Randomized in Error|0|||
48531473|NCT00384293|156134015|FG002|Post-randomization Period|Patient Randomized in Error|1|||
48531474|NCT03227861|156134016|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
48531475|NCT03227861|156134016|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
48531476|NCT03227861|156134016|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
48531477|NCT03227861|156134016|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
48531478|NCT03227861|156134016|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
48531479|NCT03227861|156134016|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
48531480|NCT03227861|156134016|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
48531481|NCT03227861|156134016|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
48833838|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833839|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
48531482|NCT03227861|156134016|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
48531483|NCT03227861|156134016|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
48531484|NCT04056611|156134017|FG000|Overall Study|Physician Decision|1|||
48531485|NCT03153111|156134018|FG000|Overall Study|Death|2|||
48531486|NCT03153111|156134019|FG001|Overall Study|Death|5|||
48531487|NCT03153111|156134018|FG000|Overall Study|Lost to Follow-up|1|||
48531488|NCT03153111|156134019|FG001|Overall Study|Lost to Follow-up|0|||
48531489|NCT03153111|156134018|FG000|Overall Study|Physician Decision|5|||
48531490|NCT03153111|156134019|FG001|Overall Study|Physician Decision|1|||
48531491|NCT03153111|156134018|FG000|Overall Study|Withdrawal by Subject|3|||
48531492|NCT03153111|156134019|FG001|Overall Study|Withdrawal by Subject|3|||
48531493|NCT02782676|156134021|FG000|Overall Study|Lost to Follow-up|0|||
48531494|NCT02782676|156134022|FG001|Overall Study|Lost to Follow-up|1|||
48531495|NCT01093326|156134023|FG000|Overall Study|Death|0|||
48531496|NCT01093326|156134024|FG001|Overall Study|Death|1|||
48531497|NCT01093326|156134025|FG002|Overall Study|Death|0|||
48602940|NCT01607593|156401638|FG000|Overall Study|Adverse Event|15|||
48602941|NCT01607593|156401638|FG000|Overall Study|Lack of Efficacy|16|||
48531498|NCT01093326|156134023|FG000|Overall Study|Lack of Efficacy|7|||
48531499|NCT01093326|156134024|FG001|Overall Study|Lack of Efficacy|6|||
48531500|NCT01093326|156134025|FG002|Overall Study|Lack of Efficacy|3|||
48531501|NCT01093326|156134023|FG000|Overall Study|Lost to Follow-up|2|||
48531502|NCT01093326|156134024|FG001|Overall Study|Lost to Follow-up|5|||
48531503|NCT01093326|156134025|FG002|Overall Study|Lost to Follow-up|4|||
48531504|NCT01093326|156134023|FG000|Overall Study|Physician Decision|3|||
48602942|NCT01607593|156401638|FG000|Overall Study|Lost to Follow-up|25|||
48602943|NCT01607593|156401638|FG000|Overall Study|Continuation|33|||
48602944|NCT01607593|156401638|FG000|Overall Study|Other|4|||
48602945|NCT00458003|156401641|FG000|Overall Study|Non protocol spinal anesthesia|1|||
48833840|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833841|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833842|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833843|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833844|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
48833845|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
48833846|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
48833847|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
48833848|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Various reasons|0|||
48833849|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Various reasons|0|||
48833850|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Various reasons|0|||
48833851|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Various reasons|0|||
48833852|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Various reasons|0|||
48833853|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Various reasons|0|||
48833854|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Various reasons|0|||
48833855|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Various reasons|3|||
48833856|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Various reasons|1|||
48833857|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Various reasons|3|||
48833858|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
48833859|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
48833860|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
48833861|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
48833862|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
48833863|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
48833864|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
48833865|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
48833866|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
48833867|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
48833868|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833869|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833870|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833871|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833872|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833873|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833874|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833875|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833876|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
48833877|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
48833878|NCT01981850|157232707|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833879|NCT01981850|157232708|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833880|NCT01981850|157232709|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833881|NCT01981850|157232710|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
48531505|NCT01093326|156134024|FG001|Overall Study|Physician Decision|1|||
48602946|NCT00458003|156401642|FG001|Overall Study|Non protocol spinal anesthesia|1|||
48602947|NCT01348139|156401643|FG000|Period 1|Adverse Event|1|||
48602948|NCT01348139|156401644|FG001|Period 1|Adverse Event|0|||
48602949|NCT01348139|156401645|FG002|Period 1|Adverse Event|0|||
48602950|NCT01348139|156401646|FG003|Period 1|Adverse Event|0|||
48602951|NCT01348139|156401647|FG004|Period 1|Adverse Event|0|||
48602952|NCT01348139|156401648|FG005|Period 1|Adverse Event|0|||
48602953|NCT01249131|156401652|FG000|Washout Period of 10 Days|Adverse Event|0|||
48602954|NCT01249131|156401653|FG001|Washout Period of 10 Days|Adverse Event|0|||
48602955|NCT01249131|156401654|FG002|Washout Period of 10 Days|Adverse Event|0|||
48602956|NCT01249131|156401655|FG003|Washout Period of 10 Days|Adverse Event|0|||
48602957|NCT01249131|156401656|FG004|Washout Period of 10 Days|Adverse Event|1|||
48602958|NCT01249131|156401657|FG005|Washout Period of 10 Days|Adverse Event|0|||
48602959|NCT02087774|156401658|FG000|Overall Study|Were absent day of data collection|8|||
48833882|NCT01981850|157232711|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833883|NCT01981850|157232712|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833884|NCT01981850|157232713|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833885|NCT01981850|157232714|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833886|NCT01981850|157232715|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
48833887|NCT01981850|157232716|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
48602960|NCT02087774|156401659|FG001|Overall Study|Were absent day of data collection|20|||
48602961|NCT02659943|156401660|FG000|Overall Study|Switched to alternative treatment|1|||
48602962|NCT02659943|156401661|FG001|Overall Study|Switched to alternative treatment|1|||
48602963|NCT02659943|156401662|FG002|Overall Study|Switched to alternative treatment|0|||
48602964|NCT02659943|156401663|FG003|Overall Study|Switched to alternative treatment|2|||
48602965|NCT02659943|156401664|FG004|Overall Study|Switched to alternative treatment|1|||
48602966|NCT02659943|156401665|FG005|Overall Study|Switched to alternative treatment|0|||
48602967|NCT02659943|156401666|FG006|Overall Study|Switched to alternative treatment|1|||
48833888|NCT05641311|157232721|FG000|Dosing Period 1|Adverse Event|1|||
48833889|NCT05641311|157232722|FG001|Dosing Period 1|Adverse Event|0|||
48833890|NCT02524288|157232725|FG000|Overall Study|Adverse Event|115|||
48833891|NCT02524288|157232725|FG000|Overall Study|Lost to Follow-up|216|||
48833892|NCT02524288|157232725|FG000|Overall Study|Non-Compliance With Protocol|32|||
48833893|NCT02524288|157232725|FG000|Overall Study|Non-Compliance With Study Drug|14|||
48833894|NCT02524288|157232725|FG000|Overall Study|Pregnancy Wish|6|||
48833895|NCT02524288|157232725|FG000|Overall Study|Protocol Violation|6|||
48833896|NCT02524288|157232725|FG000|Overall Study|Screen Failure|2|||
48833897|NCT02524288|157232725|FG000|Overall Study|Site Discontinued Study Participation|1|||
48833898|NCT02524288|157232725|FG000|Overall Study|Study Terminated By Sponsor|1417|||
48833899|NCT02524288|157232725|FG000|Overall Study|Subject Moved|32|||
48833900|NCT02524288|157232725|FG000|Overall Study|Withdrawal by Subject|76|||
48833901|NCT02524288|157232725|FG000|Overall Study|Pregnancy|22|||
48833902|NCT02524288|157232725|FG000|Overall Study|Physician Decision|2|||
48833903|NCT02459899|157232741|FG000|Overall Study|Adverse Event|1|||
48833904|NCT02459899|157232742|FG001|Overall Study|Adverse Event|1|||
48833905|NCT02459899|157232743|FG002|Overall Study|Adverse Event|0|||
48833906|NCT02459899|157232744|FG003|Overall Study|Adverse Event|0|||
48833907|NCT02459899|157232741|FG000|Overall Study|Lost to Follow-up|1|||
48833908|NCT02459899|157232742|FG001|Overall Study|Lost to Follow-up|2|||
48602968|NCT02659943|156401660|FG000|Overall Study|Disease progression on study|0|||
48602969|NCT02659943|156401661|FG001|Overall Study|Disease progression on study|1|||
48602970|NCT02659943|156401662|FG002|Overall Study|Disease progression on study|1|||
48602971|NCT02659943|156401663|FG003|Overall Study|Disease progression on study|1|||
48602972|NCT02659943|156401664|FG004|Overall Study|Disease progression on study|1|||
48602973|NCT02659943|156401665|FG005|Overall Study|Disease progression on study|4|||
48602974|NCT02659943|156401666|FG006|Overall Study|Disease progression on study|0|||
48602975|NCT02659943|156401660|FG000|Overall Study|Patient's condition per principal investigator|0|||
48602976|NCT02659943|156401661|FG001|Overall Study|Patient's condition per principal investigator|0|||
48602977|NCT02659943|156401662|FG002|Overall Study|Patient's condition per principal investigator|0|||
48602978|NCT02659943|156401663|FG003|Overall Study|Patient's condition per principal investigator|0|||
48602979|NCT02659943|156401664|FG004|Overall Study|Patient's condition per principal investigator|0|||
48602980|NCT02659943|156401665|FG005|Overall Study|Patient's condition per principal investigator|1|||
48602981|NCT02659943|156401666|FG006|Overall Study|Patient's condition per principal investigator|0|||
48602982|NCT02659943|156401660|FG000|Overall Study|Ineligible|0|||
48602983|NCT02659943|156401661|FG001|Overall Study|Ineligible|0|||
48833909|NCT02459899|157232743|FG002|Overall Study|Lost to Follow-up|0|||
48602984|NCT02659943|156401662|FG002|Overall Study|Ineligible|0|||
48602985|NCT02659943|156401663|FG003|Overall Study|Ineligible|0|||
48602986|NCT02659943|156401664|FG004|Overall Study|Ineligible|0|||
48602987|NCT02659943|156401665|FG005|Overall Study|Ineligible|0|||
48833910|NCT02459899|157232744|FG003|Overall Study|Lost to Follow-up|1|||
48833911|NCT02459899|157232741|FG000|Overall Study|Non-compliance with the treatment|0|||
48833912|NCT02459899|157232742|FG001|Overall Study|Non-compliance with the treatment|0|||
48602988|NCT02659943|156401666|FG006|Overall Study|Ineligible|1|||
48833913|NCT02459899|157232743|FG002|Overall Study|Non-compliance with the treatment|0|||
48833914|NCT02459899|157232744|FG003|Overall Study|Non-compliance with the treatment|1|||
48833915|NCT02459899|157232741|FG000|Overall Study|Withdrawal by Subject|1|||
48531506|NCT01093326|156134025|FG002|Overall Study|Physician Decision|3|||
48531507|NCT01093326|156134023|FG000|Overall Study|Withdrawal by Subject|30|||
48531508|NCT01093326|156134024|FG001|Overall Study|Withdrawal by Subject|27|||
48531509|NCT01093326|156134025|FG002|Overall Study|Withdrawal by Subject|26|||
48531510|NCT01093326|156134023|FG000|Overall Study|Adverse Event|2|||
48531511|NCT01093326|156134024|FG001|Overall Study|Adverse Event|1|||
48531512|NCT01093326|156134025|FG002|Overall Study|Adverse Event|4|||
48531513|NCT01093326|156134023|FG000|Overall Study|Other|0|||
48833916|NCT02459899|157232742|FG001|Overall Study|Withdrawal by Subject|3|||
48833917|NCT02459899|157232743|FG002|Overall Study|Withdrawal by Subject|0|||
48833918|NCT02459899|157232744|FG003|Overall Study|Withdrawal by Subject|0|||
48833919|NCT03394027|157232747|FG000|Overall Study|Ineligible|3|||
48833920|NCT03394027|157232748|FG001|Overall Study|Ineligible|1|||
48833921|NCT03394027|157232749|FG002|Overall Study|Ineligible|3|||
48833922|NCT03394027|157232747|FG000|Overall Study|Participant declined to participate before treatment started|0|||
48833923|NCT03394027|157232748|FG001|Overall Study|Participant declined to participate before treatment started|0|||
48833924|NCT03394027|157232749|FG002|Overall Study|Participant declined to participate before treatment started|1|||
48833925|NCT02248480|157232753|FG000|Overall Study|Lack of Efficacy|4|||
48833926|NCT02248480|157232754|FG001|Overall Study|Lack of Efficacy|6|||
48833927|NCT02248480|157232753|FG000|Overall Study|Adverse Event|11|||
48833928|NCT02248480|157232754|FG001|Overall Study|Adverse Event|2|||
48833929|NCT02248480|157232753|FG000|Overall Study|Withdrawal by Subject|2|||
48833930|NCT02248480|157232754|FG001|Overall Study|Withdrawal by Subject|4|||
48833931|NCT02248480|157232753|FG000|Overall Study|Entry Criteria Not Met|0|||
48833932|NCT02248480|157232754|FG001|Overall Study|Entry Criteria Not Met|1|||
48833933|NCT02248480|157232753|FG000|Overall Study|Other:Physician Decision|0|||
48531514|NCT01093326|156134024|FG001|Overall Study|Other|0|||
48531515|NCT01093326|156134025|FG002|Overall Study|Other|1|||
48531516|NCT02641730|156134026|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
48531517|NCT02641730|156134027|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
48833934|NCT02248480|157232754|FG001|Overall Study|Other:Physician Decision|1|||
48833935|NCT03942042|157232755|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
48833936|NCT03942042|157232756|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
48833937|NCT03942042|157232755|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
48833938|NCT03942042|157232756|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
48833939|NCT01196429|157232757|FG000|Overall Study|Ineligible - inadequate pathology|1|||
48833940|NCT01196429|157232758|FG001|Overall Study|Ineligible - inadequate pathology|0|||
48833941|NCT01196429|157232757|FG000|Overall Study|Ineligible - wrong cell type|1|||
48833942|NCT01196429|157232758|FG001|Overall Study|Ineligible - wrong cell type|0|||
48833943|NCT01196429|157232757|FG000|Overall Study|Refused - Never Treated|1|||
48833944|NCT01196429|157232758|FG001|Overall Study|Refused - Never Treated|0|||
48833945|NCT01121549|157232759|FG000|Overall Study|Adverse Event|10|||
48833946|NCT01121549|157232759|FG000|Overall Study|Lack of Efficacy|11|||
48833947|NCT01121549|157232759|FG000|Overall Study|Lost to Follow-up|12|||
48833948|NCT01121549|157232759|FG000|Overall Study|Did not meet entrance criteria|9|||
48531518|NCT02641730|156134028|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
48531519|NCT02641730|156134029|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
48531520|NCT02641730|156134030|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
48531521|NCT02641730|156134026|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
48531522|NCT02641730|156134027|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
48531523|NCT02641730|156134028|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
48531524|NCT02641730|156134029|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
48531525|NCT02641730|156134030|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
48531526|NCT02641730|156134026|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
48531527|NCT02641730|156134027|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
48531528|NCT02641730|156134028|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
48833949|NCT01121549|157232759|FG000|Overall Study|Study terminated by sponsor|197|||
48833950|NCT01121549|157232759|FG000|Overall Study|Pregnancy|1|||
48833951|NCT01121549|157232759|FG000|Overall Study|Protocol Violation|33|||
48833952|NCT01121549|157232759|FG000|Overall Study|Withdrawal by Subject|16|||
48833953|NCT01121549|157232759|FG000|Overall Study|Other|58|||
48833954|NCT02299336|157232762|FG000|Overall Study|Withdrawal by Subject|11|||
48833955|NCT02299336|157232762|FG000|Overall Study|Adverse Event|1|||
48833956|NCT02299336|157232762|FG000|Overall Study|Death|1|||
48833957|NCT02299336|157232762|FG000|Overall Study|Lost to Follow-up|1|||
48833958|NCT03993392|157232765|FG000|Overall Study|Withdrawal by Subject|3|||
48833959|NCT03993392|157232765|FG000|Overall Study|Lost to Follow-up|2|||
48833960|NCT03993392|157232765|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
48833961|NCT00573833|157232766|FG000|Overall Study|Not Treated|2|||
48602989|NCT02659943|156401660|FG000|Overall Study|No longer meets eligibility|0|||
48602990|NCT02659943|156401661|FG001|Overall Study|No longer meets eligibility|0|||
48602991|NCT02659943|156401662|FG002|Overall Study|No longer meets eligibility|0|||
48602992|NCT02659943|156401663|FG003|Overall Study|No longer meets eligibility|0|||
48602993|NCT02659943|156401664|FG004|Overall Study|No longer meets eligibility|0|||
48602994|NCT02659943|156401665|FG005|Overall Study|No longer meets eligibility|0|||
48833962|NCT01451814|157234108|FG000|Overall Study|Withdrawal by Subject|1|||
48531529|NCT02641730|156134029|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
48531530|NCT02641730|156134030|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
48531531|NCT02641730|156134026|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48531532|NCT02641730|156134027|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48531533|NCT02641730|156134028|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48531534|NCT02641730|156134029|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
48531535|NCT02641730|156134030|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
48531536|NCT02641730|156134026|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
48531537|NCT02641730|156134027|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
48531538|NCT02641730|156134028|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
48531539|NCT02641730|156134029|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
48531540|NCT02641730|156134030|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
48531541|NCT02641730|156134026|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
48531542|NCT02641730|156134027|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
48531543|NCT02641730|156134028|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
48531544|NCT02641730|156134029|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
48531545|NCT02641730|156134030|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
48531546|NCT00319046|156134031|FG000|Overall Study|withdrawal of subject's consent|7|||
48531547|NCT00319046|156134031|FG000|Overall Study|administrative reason|1|||
48833963|NCT01451814|157234109|FG001|Overall Study|Withdrawal by Subject|1|||
48833964|NCT01451814|157234108|FG000|Overall Study|Lost to Follow-up|5|||
48833965|NCT01451814|157234109|FG001|Overall Study|Lost to Follow-up|4|||
48833966|NCT02049866|157234110|FG000|Overall Study|Withdrawal by Subject|1|||
48833967|NCT01570751|157234112|FG000|Period A (16 Weeks)|Protocol Violation|1|||
48833968|NCT01570751|157234113|FG001|Period A (16 Weeks)|Protocol Violation|1|||
48833969|NCT01570751|157234112|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
48833970|NCT01570751|157234113|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
48833971|NCT01570751|157234112|FG000|Period A (16 Weeks)|Unclassified|2|||
48531548|NCT01010750|156134032|FG000|Second Intervention|Adverse Event|0|||
48531549|NCT01010750|156134033|FG001|Second Intervention|Adverse Event|1|||
48531550|NCT01010750|156134034|FG002|Second Intervention|Adverse Event|0|||
48531551|NCT01010750|156134035|FG003|Second Intervention|Adverse Event|0|||
48531552|NCT01010750|156134036|FG004|Second Intervention|Adverse Event|0|||
48531553|NCT01010750|156134037|FG005|Second Intervention|Adverse Event|0|||
48531554|NCT01832402|156134038|FG000|Overall Study|Lost to Follow-up|2|||
48531555|NCT01832402|156134039|FG001|Overall Study|Lost to Follow-up|0|||
48531556|NCT01832402|156134038|FG000|Overall Study|Withdrawal by Subject|3|||
48531557|NCT01832402|156134039|FG001|Overall Study|Withdrawal by Subject|3|||
48531558|NCT01832402|156134038|FG000|Overall Study|Declining Performance status|2|||
48531559|NCT01832402|156134039|FG001|Overall Study|Declining Performance status|1|||
48602995|NCT02659943|156401666|FG006|Overall Study|No longer meets eligibility|1|||
48602996|NCT02659943|156401660|FG000|Overall Study|No treatment, per protocol|0|||
48833972|NCT01570751|157234113|FG001|Period A (16 Weeks)|Unclassified|3|||
48833973|NCT01570751|157234112|FG000|Period B (16 Weeks)|Adverse Event|1|||
48602997|NCT02659943|156401661|FG001|Overall Study|No treatment, per protocol|0|||
48833974|NCT01570751|157234113|FG001|Period B (16 Weeks)|Adverse Event|0|||
48833975|NCT01570751|157234112|FG000|Period B (16 Weeks)|Protocol Violation|0|||
48833976|NCT01570751|157234113|FG001|Period B (16 Weeks)|Protocol Violation|1|||
48833977|NCT02131324|157234114|FG000|Overall Study|Withdrawal by Subject|1|||
48833978|NCT02131324|157234115|FG001|Overall Study|Withdrawal by Subject|2|||
48531564|NCT00412607|156134042|FG000|Overall Study|Withdrawal by Subject|9|||
48531565|NCT00412607|156134042|FG000|Overall Study|Lost to Follow-up|19|||
48531566|NCT00412607|156134042|FG000|Overall Study|Death|61|||
48531567|NCT00412607|156134042|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
48531568|NCT00319020|156134044|FG000|Overall Study|Death|2|||
48531569|NCT00319020|156134045|FG001|Overall Study|Death|2|||
48531570|NCT00319020|156134044|FG000|Overall Study|Withdrawal by Subject|4|||
48531571|NCT00319020|156134045|FG001|Overall Study|Withdrawal by Subject|1|||
48531572|NCT00319020|156134044|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
48531573|NCT00319020|156134045|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
48531574|NCT00319020|156134044|FG000|Overall Study|Administrative reason|0|||
48531575|NCT00319020|156134045|FG001|Overall Study|Administrative reason|5|||
48531576|NCT00319020|156134044|FG000|Overall Study|Disease progression|0|||
48531577|NCT00319020|156134045|FG001|Overall Study|Disease progression|2|||
48602998|NCT02659943|156401662|FG002|Overall Study|No treatment, per protocol|0|||
48531578|NCT00319020|156134044|FG000|Overall Study|Transplant|0|||
48602999|NCT02659943|156401663|FG003|Overall Study|No treatment, per protocol|0|||
48603000|NCT02659943|156401664|FG004|Overall Study|No treatment, per protocol|0|||
48833979|NCT02131324|157234114|FG000|Overall Study|Lost to Follow-up|1|||
48833980|NCT02131324|157234115|FG001|Overall Study|Lost to Follow-up|1|||
48833981|NCT05790408|157234116|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
48603001|NCT02659943|156401665|FG005|Overall Study|No treatment, per protocol|0|||
48603002|NCT02659943|156401666|FG006|Overall Study|No treatment, per protocol|3|||
48603003|NCT01408706|156401667|FG000|Overall Study|Physician Decision|1|||
48603004|NCT01408706|156401668|FG001|Overall Study|Physician Decision|0|||
48603005|NCT02157519|156401673|FG000|Overall Study|Death|3|||
48603006|NCT02157519|156401674|FG001|Overall Study|Death|1|||
48603007|NCT02157519|156401673|FG000|Overall Study|Withdrawal by Subject|7|||
48603008|NCT02157519|156401674|FG001|Overall Study|Withdrawal by Subject|0|||
48531579|NCT00319020|156134045|FG001|Overall Study|Transplant|1|||
48531580|NCT00319020|156134044|FG000|Overall Study|Treatment failure|0|||
48531581|NCT00319020|156134045|FG001|Overall Study|Treatment failure|1|||
48531582|NCT00319020|156134044|FG000|Overall Study|Adverse Event|0|||
48531583|NCT00319020|156134045|FG001|Overall Study|Adverse Event|1|||
48603009|NCT02157519|156401673|FG000|Overall Study|Lost to Follow-up|1|||
48603010|NCT02157519|156401674|FG001|Overall Study|Lost to Follow-up|0|||
48603011|NCT01825200|156401677|FG000|Overall Study|Lost to Follow-up|5|||
48603012|NCT01825200|156401678|FG001|Overall Study|Lost to Follow-up|6|||
48603013|NCT01825200|156401677|FG000|Overall Study|Withdrawal by Subject|0|||
48603014|NCT01825200|156401678|FG001|Overall Study|Withdrawal by Subject|1|||
48603015|NCT01443858|156401679|FG000|Overall Study|Withdrawal by Subject|9|||
48603016|NCT01443858|156401680|FG001|Overall Study|Withdrawal by Subject|8|||
48603017|NCT01443858|156401681|FG002|Overall Study|Withdrawal by Subject|5|||
48603018|NCT01443858|156401679|FG000|Overall Study|Lack of Efficacy|1|||
48603019|NCT01443858|156401680|FG001|Overall Study|Lack of Efficacy|0|||
48603020|NCT01443858|156401681|FG002|Overall Study|Lack of Efficacy|0|||
48603021|NCT01443858|156401679|FG000|Overall Study|Lost to Follow-up|5|||
48833982|NCT02281318|157234122|FG000|Overall Study|Adverse Event|2|||
48833983|NCT02281318|157234123|FG001|Overall Study|Adverse Event|2|||
48833984|NCT02281318|157234122|FG000|Overall Study|Lack of Efficacy|2|||
48833985|NCT02281318|157234123|FG001|Overall Study|Lack of Efficacy|0|||
48833986|NCT02281318|157234122|FG000|Overall Study|Lost to Follow-up|2|||
48833987|NCT02281318|157234123|FG001|Overall Study|Lost to Follow-up|1|||
48833988|NCT02281318|157234122|FG000|Overall Study|Physician Decision|2|||
48833989|NCT02281318|157234123|FG001|Overall Study|Physician Decision|0|||
48833990|NCT02281318|157234122|FG000|Overall Study|Withdrawal by Subject|6|||
48833991|NCT02281318|157234123|FG001|Overall Study|Withdrawal by Subject|2|||
48833992|NCT01281813|157234131|FG000|Overall Study|Adverse Event|0|||
48833993|NCT01281813|157234132|FG001|Overall Study|Adverse Event|0|||
48833994|NCT01281813|157234133|FG002|Overall Study|Adverse Event|10|||
48833995|NCT01281813|157234131|FG000|Overall Study|Lost to Follow-up|0|||
48833996|NCT01281813|157234132|FG001|Overall Study|Lost to Follow-up|0|||
48833997|NCT01281813|157234133|FG002|Overall Study|Lost to Follow-up|31|||
48833998|NCT01281813|157234131|FG000|Overall Study|Withdrawal by Subject|0|||
48833999|NCT01281813|157234132|FG001|Overall Study|Withdrawal by Subject|0|||
48834000|NCT01281813|157234133|FG002|Overall Study|Withdrawal by Subject|13|||
48834001|NCT01281813|157234131|FG000|Overall Study|Subject Non-Compliant|0|||
48834002|NCT01281813|157234132|FG001|Overall Study|Subject Non-Compliant|0|||
48834003|NCT01281813|157234133|FG002|Overall Study|Subject Non-Compliant|6|||
48834004|NCT01281813|157234131|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
48834005|NCT01281813|157234132|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
48834006|NCT01281813|157234133|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
48531584|NCT00747565|156134051|FG000|Overall Study|Withdrawal by Subject|10|||
48531585|NCT00747565|156134052|FG001|Overall Study|Withdrawal by Subject|6|||
48531586|NCT00747565|156134051|FG000|Overall Study|Lost to Follow-up|4|||
48531587|NCT00747565|156134052|FG001|Overall Study|Lost to Follow-up|1|||
48531588|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
48834007|NCT01281813|157234131|FG000|Overall Study|Sponsor's Decision|4|||
48834008|NCT01281813|157234132|FG001|Overall Study|Sponsor's Decision|3|||
48834009|NCT01281813|157234133|FG002|Overall Study|Sponsor's Decision|7|||
48834010|NCT01281813|157234131|FG000|Overall Study|Switched to Commercially Available Medication|0|||
48834011|NCT01281813|157234132|FG001|Overall Study|Switched to Commercially Available Medication|0|||
48531589|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
48531590|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
48531591|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
48531592|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
48531593|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
48531594|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
48531595|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
48531596|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
48531597|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
48531598|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
48531599|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
48531600|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
48531601|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
48531602|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
48531603|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
48531604|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
48531605|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
48531606|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
48531607|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
48531608|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
48531609|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
48531610|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
48531611|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
48531612|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
48531613|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
48531614|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
48531615|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
48531616|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
48531617|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
48531618|NCT04614948|156134053|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
48531619|NCT04614948|156134054|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
48531620|NCT04614948|156134055|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
48531621|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
48531622|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
48531623|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
48531624|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
48531625|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
48531626|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
48531627|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
48531628|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
48531629|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
48531630|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
48531631|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
48531632|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
48531633|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
48531634|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
48531635|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
48531636|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
48531637|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
48531638|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
48834012|NCT01281813|157234133|FG002|Overall Study|Switched to Commercially Available Medication|26|||
48834013|NCT01281813|157234131|FG000|Overall Study|Other|0|||
48834014|NCT01281813|157234132|FG001|Overall Study|Other|1|||
48834015|NCT01281813|157234133|FG002|Overall Study|Other|39|||
48834016|NCT00970307|157234134|FG000|Overall Study|Serious Adverse Event|1|||
48834017|NCT00970307|157234135|FG001|Overall Study|Serious Adverse Event|0|||
48834018|NCT00970307|157234136|FG002|Overall Study|Serious Adverse Event|0|||
48834019|NCT00970307|157234134|FG000|Overall Study|Withdrawal by Subject|2|||
48531639|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
48531640|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
48531641|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
48531642|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
48834020|NCT00970307|157234135|FG001|Overall Study|Withdrawal by Subject|3|||
48531643|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
48531644|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
48834021|NCT00970307|157234136|FG002|Overall Study|Withdrawal by Subject|2|||
48531645|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
48531646|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
48531647|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
48531648|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
48531649|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
48531650|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
48531651|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
48531652|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
48531653|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
48531654|NCT04614948|156134053|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
48531655|NCT04614948|156134054|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
48531656|NCT04614948|156134055|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
48531657|NCT03417830|156134056|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
48531658|NCT03417830|156134057|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
48531659|NCT00319696|156134058|FG000|Overall Study|Adverse Event|36|||
48531660|NCT00319696|156134058|FG000|Overall Study|withdrawal of consent|14|||
48531661|NCT00319696|156134058|FG000|Overall Study|administrative|7|||
48531662|NCT00319696|156134058|FG000|Overall Study|Lost to Follow-up|3|||
48531663|NCT03498521|156134059|FG000|Overall Study|Death|191|||
48531664|NCT03498521|156134060|FG001|Overall Study|Death|64|||
48531665|NCT03498521|156134061|FG002|Overall Study|Death|72|||
48531666|NCT03498521|156134059|FG000|Overall Study|Exclusion criteria|1|||
48531667|NCT03498521|156134060|FG001|Overall Study|Exclusion criteria|0|||
48531668|NCT03498521|156134061|FG002|Overall Study|Exclusion criteria|0|||
48531669|NCT03498521|156134059|FG000|Overall Study|Lost to Follow-up|3|||
48531670|NCT03498521|156134060|FG001|Overall Study|Lost to Follow-up|3|||
48531671|NCT03498521|156134061|FG002|Overall Study|Lost to Follow-up|3|||
48531672|NCT03498521|156134059|FG000|Overall Study|No profile due to technical failure|1|||
48531673|NCT03498521|156134060|FG001|Overall Study|No profile due to technical failure|0|||
48531674|NCT03498521|156134061|FG002|Overall Study|No profile due to technical failure|0|||
48531675|NCT03498521|156134059|FG000|Overall Study|Physician Decision|0|||
48531676|NCT03498521|156134060|FG001|Overall Study|Physician Decision|1|||
48531677|NCT03498521|156134061|FG002|Overall Study|Physician Decision|0|||
48531678|NCT03498521|156134059|FG000|Overall Study|Withdrawal by Subject|9|||
48531679|NCT03498521|156134060|FG001|Overall Study|Withdrawal by Subject|6|||
48531680|NCT03498521|156134061|FG002|Overall Study|Withdrawal by Subject|2|||
48603022|NCT01443858|156401680|FG001|Overall Study|Lost to Follow-up|5|||
48603023|NCT01443858|156401681|FG002|Overall Study|Lost to Follow-up|2|||
48603024|NCT02277028|156401682|FG000|Overall Study|Lost to Follow-up|1|||
48603025|NCT02277028|156401683|FG001|Overall Study|Lost to Follow-up|0|||
48603026|NCT02277028|156401682|FG000|Overall Study|Withdrawal by Subject|0|||
48603027|NCT02277028|156401683|FG001|Overall Study|Withdrawal by Subject|1|||
48603028|NCT02983045|156401687|FG000|Overall Study|Withdrawal by Subject|0|||
48603029|NCT02983045|156401688|FG001|Overall Study|Withdrawal by Subject|1|||
48531681|NCT03498521|156134059|FG000|Overall Study|Study ongoing|121|||
48531682|NCT03498521|156134060|FG001|Overall Study|Study ongoing|36|||
48531683|NCT03498521|156134061|FG002|Overall Study|Study ongoing|15|||
48531684|NCT02654587|156134062|FG000|Overall Study|patient alive at end of study|22|||
48531685|NCT02654587|156134063|FG001|Overall Study|patient alive at end of study|8|||
48603030|NCT02983045|156401689|FG002|Overall Study|Withdrawal by Subject|0|||
48603031|NCT02983045|156401690|FG003|Overall Study|Withdrawal by Subject|5|||
48735601|NCT02345226|156883692|FG001|Double-Blind Phase|Adverse Event|6|||
48735602|NCT02345226|156883691|FG000|Double-Blind Phase|Death|3|||
48735603|NCT02345226|156883692|FG001|Double-Blind Phase|Death|0|||
48735604|NCT02345226|156883691|FG000|Double-Blind Phase|Pregnancy|0|||
48735605|NCT02345226|156883692|FG001|Double-Blind Phase|Pregnancy|1|||
48735606|NCT02345226|156883691|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48735607|NCT02345226|156883692|FG001|Double-Blind Phase|Lack of Efficacy|0|||
48735608|NCT02345226|156883691|FG000|Double-Blind Phase|Investigator's Discretion|4|||
48735609|NCT02345226|156883692|FG001|Double-Blind Phase|Investigator's Discretion|3|||
48735610|NCT02345226|156883691|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
48735611|NCT02345226|156883692|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
48735612|NCT02345226|156883691|FG000|Double-Blind Phase|Withdrew Consent|41|||
48735613|NCT02345226|156883692|FG001|Double-Blind Phase|Withdrew Consent|39|||
48735614|NCT02345226|156883691|FG000|Double-Blind Phase|Lost to Follow-up|12|||
48735615|NCT02345226|156883692|FG001|Double-Blind Phase|Lost to Follow-up|16|||
48735616|NCT02345226|156883691|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
48735617|NCT02345226|156883692|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
48735618|NCT02345226|156883691|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
48735619|NCT02345226|156883692|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
48735620|NCT00304239|156883693|FG000|Overall Study|Protocol Deviations/Violations|15|||
48735621|NCT00304239|156883694|FG001|Overall Study|Protocol Deviations/Violations|0|||
48735622|NCT00304239|156883693|FG000|Overall Study|Adverse Event|2|||
48834022|NCT02614560|157234137|FG000|Overall Study|Death|6|||
48834023|NCT02614560|157234138|FG001|Overall Study|Death|2|||
48834024|NCT00558363|157234139|FG000|Overall Study|Physician Decision|18|||
48834025|NCT00558363|157234140|FG001|Overall Study|Physician Decision|4|||
48834026|NCT00558363|157234139|FG000|Overall Study|Withdrawal by Subject|11|||
48834027|NCT00558363|157234140|FG001|Overall Study|Withdrawal by Subject|4|||
48834028|NCT00558363|157234139|FG000|Overall Study|Adverse Event|5|||
48834029|NCT00558363|157234140|FG001|Overall Study|Adverse Event|5|||
48834030|NCT00558363|157234139|FG000|Overall Study|Lack of Efficacy|2|||
48834031|NCT00558363|157234140|FG001|Overall Study|Lack of Efficacy|2|||
48834032|NCT00558363|157234139|FG000|Overall Study|Protocol Violation|2|||
48834033|NCT00558363|157234140|FG001|Overall Study|Protocol Violation|1|||
48834034|NCT00558363|157234139|FG000|Overall Study|Lost to Follow-up|0|||
48834035|NCT00558363|157234140|FG001|Overall Study|Lost to Follow-up|1|||
48834036|NCT00558363|157234139|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
48834037|NCT00558363|157234140|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
48834038|NCT00558363|157234139|FG000|Overall Study|Randomized in Error|1|||
48834039|NCT00558363|157234140|FG001|Overall Study|Randomized in Error|2|||
48834040|NCT00558363|157234139|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
48834041|NCT00558363|157234140|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
48834042|NCT03102710|157234141|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
48834043|NCT03102710|157234142|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
48834044|NCT03102710|157234143|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
48834045|NCT03102710|157234141|FG000|Overall Study|Technical issues during final MRI scan|0|||
48834046|NCT03102710|157234142|FG001|Overall Study|Technical issues during final MRI scan|1|||
48834047|NCT03102710|157234143|FG002|Overall Study|Technical issues during final MRI scan|0|||
48834048|NCT03102710|157234141|FG000|Overall Study|Nausea during MRI scan|0|||
48834049|NCT03102710|157234142|FG001|Overall Study|Nausea during MRI scan|1|||
48834050|NCT03102710|157234143|FG002|Overall Study|Nausea during MRI scan|0|||
48531686|NCT02654587|156134062|FG000|Overall Study|Withdrawal by Subject|1|||
48531687|NCT02654587|156134063|FG001|Overall Study|Withdrawal by Subject|7|||
48531688|NCT03357952|156134064|FG000|Overall Study|Withdrawal by Subject|0|||
48531689|NCT03357952|156134065|FG001|Overall Study|Withdrawal by Subject|1|||
48531690|NCT03357952|156134064|FG000|Overall Study|Sponsor Decision|9|||
48834051|NCT03102710|157234141|FG000|Overall Study|Subject unable to attend final session|0|||
48834052|NCT03102710|157234142|FG001|Overall Study|Subject unable to attend final session|1|||
48834053|NCT03102710|157234143|FG002|Overall Study|Subject unable to attend final session|0|||
48834054|NCT02517307|157234144|FG000|Overall Study|Withdrawal by Subject|1|||
48834055|NCT02517307|157234145|FG001|Overall Study|Withdrawal by Subject|0|||
48834056|NCT02517307|157234146|FG002|Overall Study|Withdrawal by Subject|1|||
48531691|NCT03357952|156134065|FG001|Overall Study|Sponsor Decision|0|||
48531692|NCT00303459|156134066|FG000|Overall Study|Death|33|||
48531693|NCT00303459|156134067|FG001|Overall Study|Death|44|||
48531694|NCT00303459|156134066|FG000|Overall Study|Withdrawal of consent|32|||
48531695|NCT00303459|156134067|FG001|Overall Study|Withdrawal of consent|26|||
48834057|NCT02517307|157234147|FG003|Overall Study|Withdrawal by Subject|0|||
48834058|NCT02517307|157234144|FG000|Overall Study|Protocol Violation|0|||
48834059|NCT02517307|157234145|FG001|Overall Study|Protocol Violation|0|||
48834060|NCT02517307|157234146|FG002|Overall Study|Protocol Violation|1|||
48834061|NCT02517307|157234147|FG003|Overall Study|Protocol Violation|1|||
48834062|NCT03058991|157234154|FG000|Overall Study|Lost to Follow-up|17|||
48834063|NCT03058991|157234155|FG001|Overall Study|Lost to Follow-up|12|||
48834064|NCT03058991|157234156|FG002|Overall Study|Lost to Follow-up|12|||
48834065|NCT03058991|157234154|FG000|Overall Study|Withdrawal by Subject|1|||
48603032|NCT02983045|156401691|FG004|Overall Study|Withdrawal by Subject|0|||
48603033|NCT02983045|156401692|FG005|Overall Study|Withdrawal by Subject|72|||
48603034|NCT02983045|156401693|FG006|Overall Study|Withdrawal by Subject|0|||
48603035|NCT02983045|156401694|FG007|Overall Study|Withdrawal by Subject|0|||
48603036|NCT02983045|156401695|FG008|Overall Study|Withdrawal by Subject|0|||
48603037|NCT02983045|156401696|FG009|Overall Study|Withdrawal by Subject|2|||
48603038|NCT02983045|156401687|FG000|Overall Study|Lost to Follow-up|0|||
48603039|NCT02983045|156401688|FG001|Overall Study|Lost to Follow-up|0|||
48603040|NCT02983045|156401689|FG002|Overall Study|Lost to Follow-up|0|||
48603041|NCT02983045|156401690|FG003|Overall Study|Lost to Follow-up|0|||
48603042|NCT02983045|156401691|FG004|Overall Study|Lost to Follow-up|0|||
48603043|NCT02983045|156401692|FG005|Overall Study|Lost to Follow-up|10|||
48603044|NCT02983045|156401693|FG006|Overall Study|Lost to Follow-up|0|||
48603045|NCT02983045|156401694|FG007|Overall Study|Lost to Follow-up|0|||
48834066|NCT03058991|157234155|FG001|Overall Study|Withdrawal by Subject|0|||
48834067|NCT03058991|157234156|FG002|Overall Study|Withdrawal by Subject|0|||
48834068|NCT00139737|157234157|FG000|Overall Study|Withdrawal by Subject|190|||
48834069|NCT00139737|157234157|FG000|Overall Study|Adverse Event|58|||
48834070|NCT00139737|157234157|FG000|Overall Study|Lack of Efficacy|40|||
48834071|NCT00139737|157234157|FG000|Overall Study|Lost to Follow-up|8|||
48834072|NCT00139737|157234157|FG000|Overall Study|Death|3|||
48834073|NCT00139737|157234157|FG000|Overall Study|Laboratory Abnormality|2|||
48834074|NCT00139737|157234157|FG000|Overall Study|Protocol Violation|18|||
48834075|NCT00139737|157234157|FG000|Overall Study|Withdrew During Screening Phase|8|||
48834076|NCT00139737|157234157|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
48834077|NCT00139737|157234157|FG000|Overall Study|Screened, Not Treated|13|||
48834078|NCT00758602|157234165|FG000|Overall Study|Adverse Event|11|||
48834079|NCT00758602|157234166|FG001|Overall Study|Adverse Event|10|||
48834080|NCT00758602|157234165|FG000|Overall Study|Lost to Follow-up|4|||
48834081|NCT00758602|157234166|FG001|Overall Study|Lost to Follow-up|3|||
48834082|NCT00758602|157234165|FG000|Overall Study|Withdrawal by Subject|1|||
48834083|NCT00758602|157234166|FG001|Overall Study|Withdrawal by Subject|3|||
48834084|NCT00758602|157234165|FG000|Overall Study|Protocol Violation|0|||
48834085|NCT00758602|157234166|FG001|Overall Study|Protocol Violation|2|||
48834086|NCT00758602|157234165|FG000|Overall Study|Death|0|||
48834087|NCT00758602|157234166|FG001|Overall Study|Death|1|||
48834088|NCT00758602|157234165|FG000|Overall Study|Reason not specified|3|||
48834089|NCT00758602|157234166|FG001|Overall Study|Reason not specified|3|||
48834090|NCT04379713|157234174|FG000|Overall Study|Adverse Event|2|||
48834091|NCT04379713|157234175|FG001|Overall Study|Adverse Event|0|||
48834092|NCT04379713|157234174|FG000|Overall Study|Physician Decision|2|||
48834093|NCT04379713|157234175|FG001|Overall Study|Physician Decision|1|||
48834094|NCT04379713|157234174|FG000|Overall Study|Protocol Violation|11|||
48834095|NCT04379713|157234175|FG001|Overall Study|Protocol Violation|6|||
48834096|NCT04379713|157234174|FG000|Overall Study|No longer met eligibility criteria|14|||
48834097|NCT04379713|157234175|FG001|Overall Study|No longer met eligibility criteria|11|||
48834098|NCT04379713|157234174|FG000|Overall Study|Withdrawal by parent/guardian|36|||
48834099|NCT04379713|157234175|FG001|Overall Study|Withdrawal by parent/guardian|15|||
48834100|NCT04379713|157234174|FG000|Overall Study|Lost to Follow-up|31|||
48834101|NCT04379713|157234175|FG001|Overall Study|Lost to Follow-up|21|||
48834102|NCT02148133|157234176|FG000|Overall Study|Investigator discretion|1|||
48834103|NCT02148133|157234176|FG000|Overall Study|Lack of Efficacy|1|||
48834104|NCT02148133|157234176|FG000|Overall Study|Protocol deviation|1|||
48531696|NCT00303459|156134066|FG000|Overall Study|Lost to Follow-up|5|||
48531697|NCT00303459|156134067|FG001|Overall Study|Lost to Follow-up|4|||
48531698|NCT00303459|156134066|FG000|Overall Study|Administrative reason|7|||
48531699|NCT00303459|156134067|FG001|Overall Study|Administrative reason|7|||
48531700|NCT00303459|156134066|FG000|Overall Study|Decision by the investigator|5|||
48531701|NCT00303459|156134067|FG001|Overall Study|Decision by the investigator|7|||
48531702|NCT00303459|156134066|FG000|Overall Study|Lung transplantation|1|||
48531703|NCT00303459|156134067|FG001|Overall Study|Lung transplantation|1|||
48531704|NCT02776553|156134068|FG000|Overall Study|Lost to Follow-up|1|||
48531705|NCT02776553|156134069|FG001|Overall Study|Lost to Follow-up|0|||
48531706|NCT02776553|156134068|FG000|Overall Study|got liver transplant|1|||
48834105|NCT02148133|157234176|FG000|Overall Study|Protocol-defined stopping criteria|2|||
48834106|NCT03808883|157234177|FG000|Overall Study|Withdrawal by Subject|2|||
48834107|NCT03808883|157234178|FG001|Overall Study|Withdrawal by Subject|0|||
48531707|NCT02776553|156134069|FG001|Overall Study|got liver transplant|2|||
48603046|NCT02983045|156401695|FG008|Overall Study|Lost to Follow-up|0|||
48834108|NCT03808883|157234177|FG000|Overall Study|Did not complete pre test or post test survey|4|||
48834109|NCT03808883|157234178|FG001|Overall Study|Did not complete pre test or post test survey|3|||
48834110|NCT04567888|157234185|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
48834111|NCT04567888|157234186|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
48531708|NCT02776553|156134068|FG000|Overall Study|had other surgery|1|||
48603047|NCT02983045|156401696|FG009|Overall Study|Lost to Follow-up|0|||
48531709|NCT02776553|156134069|FG001|Overall Study|had other surgery|0|||
48603048|NCT00791999|156401697|FG000|Overall Study|Protocol planed withdrawal|14|||
48834112|NCT04567888|157234185|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
48834113|NCT04567888|157234186|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
48834114|NCT04567888|157234185|FG000|Overall Study|Reported Unusual Birth Year|2|||
48834115|NCT04567888|157234186|FG001|Overall Study|Reported Unusual Birth Year|3|||
48834116|NCT04567888|157234185|FG000|Overall Study|Duplicate Responses|0|||
48834117|NCT04567888|157234186|FG001|Overall Study|Duplicate Responses|1|||
48834118|NCT00414648|157234187|FG000|Overall Study|Adverse Event|5|||
48834119|NCT00414648|157234188|FG001|Overall Study|Adverse Event|5|||
48834120|NCT00414648|157234187|FG000|Overall Study|Death|0|||
48834121|NCT00414648|157234188|FG001|Overall Study|Death|1|||
48834122|NCT00414648|157234187|FG000|Overall Study|Lack of Efficacy|0|||
48834123|NCT00414648|157234188|FG001|Overall Study|Lack of Efficacy|2|||
48834124|NCT00414648|157234187|FG000|Overall Study|Withdrawal by Subject|0|||
48834125|NCT00414648|157234188|FG001|Overall Study|Withdrawal by Subject|1|||
48834126|NCT00746330|157234190|FG000|Period 1|Abnormal test procedure result|0|||
48834127|NCT00746330|157234191|FG001|Period 1|Abnormal test procedure result|0|||
48834128|NCT00746330|157234192|FG002|Period 1|Abnormal test procedure result|1|||
48834129|NCT00746330|157234193|FG003|Period 1|Abnormal test procedure result|0|||
48834130|NCT00949975|157234194|FG000|Overall Study|Voluntary discontinuation|6|||
48834131|NCT00949975|157234195|FG001|Overall Study|Voluntary discontinuation|5|||
48834132|NCT00949975|157234196|FG002|Overall Study|Voluntary discontinuation|3|||
48834133|NCT00949975|157234197|FG003|Overall Study|Voluntary discontinuation|6|||
48834134|NCT00949975|157234194|FG000|Overall Study|Adverse Event|11|||
48834135|NCT00949975|157234195|FG001|Overall Study|Adverse Event|11|||
48834136|NCT00949975|157234196|FG002|Overall Study|Adverse Event|10|||
48834137|NCT00949975|157234197|FG003|Overall Study|Adverse Event|10|||
48834138|NCT00949975|157234194|FG000|Overall Study|Safety reason|0|||
48834139|NCT00949975|157234195|FG001|Overall Study|Safety reason|1|||
48834140|NCT00949975|157234196|FG002|Overall Study|Safety reason|0|||
48834141|NCT00949975|157234197|FG003|Overall Study|Safety reason|0|||
48834142|NCT00949975|157234194|FG000|Overall Study|Study-specific criteria|0|||
48834143|NCT00949975|157234195|FG001|Overall Study|Study-specific criteria|1|||
48834144|NCT00949975|157234196|FG002|Overall Study|Study-specific criteria|1|||
48834145|NCT00949975|157234197|FG003|Overall Study|Study-specific criteria|0|||
48834146|NCT00949975|157234194|FG000|Overall Study|Incorrect enrolment|5|||
48834147|NCT00949975|157234195|FG001|Overall Study|Incorrect enrolment|10|||
48834148|NCT00949975|157234196|FG002|Overall Study|Incorrect enrolment|4|||
48834149|NCT00949975|157234197|FG003|Overall Study|Incorrect enrolment|7|||
48834150|NCT00949975|157234194|FG000|Overall Study|Severe non-compliance|3|||
48834151|NCT00949975|157234195|FG001|Overall Study|Severe non-compliance|1|||
48834152|NCT00949975|157234196|FG002|Overall Study|Severe non-compliance|0|||
48834153|NCT00949975|157234197|FG003|Overall Study|Severe non-compliance|2|||
48834154|NCT00949975|157234194|FG000|Overall Study|Lost to Follow-up|1|||
48834155|NCT00949975|157234195|FG001|Overall Study|Lost to Follow-up|0|||
48834156|NCT00949975|157234196|FG002|Overall Study|Lost to Follow-up|1|||
48834157|NCT00949975|157234197|FG003|Overall Study|Lost to Follow-up|3|||
48834158|NCT00949975|157234194|FG000|Overall Study|Other|1|||
48834159|NCT00949975|157234195|FG001|Overall Study|Other|0|||
48834160|NCT00949975|157234196|FG002|Overall Study|Other|0|||
48834161|NCT00949975|157234197|FG003|Overall Study|Other|0|||
48834162|NCT02873754|157234198|FG000|Overall Study|Lost to Follow-up|5|||
48834163|NCT02873754|157234198|FG000|Overall Study|Couldn't complete study procedures|1|||
48834164|NCT00082810|157234199|FG000|Overall Study|Adverse Event|3|||
48834165|NCT00082810|157234199|FG000|Overall Study|Progressive disease|24|||
48834166|NCT00082810|157234199|FG000|Overall Study|Withdrawal by Subject|4|||
48834167|NCT00367055|157234200|FG000|Overall Study|Adverse Event|6|||
48834168|NCT00367055|157234201|FG001|Overall Study|Adverse Event|3|||
48834169|NCT00367055|157234200|FG000|Overall Study|Patient's Willing|3|||
48531710|NCT02776553|156134068|FG000|Overall Study|Protocol Violation|0|||
48531711|NCT02776553|156134069|FG001|Overall Study|Protocol Violation|1|||
48531712|NCT02746627|156134070|FG000|Overall Study|Withdrawal by Subject|1|||
48834170|NCT00367055|157234201|FG001|Overall Study|Patient's Willing|2|||
48834171|NCT00367055|157234200|FG000|Overall Study|Lack of Efficacy|1|||
48834172|NCT00367055|157234201|FG001|Overall Study|Lack of Efficacy|2|||
48834173|NCT00367055|157234200|FG000|Overall Study|Lost to Follow-up|1|||
48834174|NCT00367055|157234201|FG001|Overall Study|Lost to Follow-up|1|||
48834175|NCT00367055|157234200|FG000|Overall Study|Protocol Violation|0|||
48834176|NCT00367055|157234201|FG001|Overall Study|Protocol Violation|1|||
48834177|NCT00367055|157234200|FG000|Overall Study|Stopping Criterion Met|0|||
48834178|NCT00367055|157234201|FG001|Overall Study|Stopping Criterion Met|1|||
48834179|NCT00367055|157234200|FG000|Overall Study|Participant Living too Far from Hospital|0|||
48834180|NCT00367055|157234201|FG001|Overall Study|Participant Living too Far from Hospital|1|||
48834181|NCT01585558|157234202|FG000|Overall Study|Withdrawal by Subject|4|||
48834182|NCT01585558|157234203|FG001|Overall Study|Withdrawal by Subject|5|||
48834183|NCT01585558|157234204|FG002|Overall Study|Withdrawal by Subject|8|||
48531713|NCT02746627|156134071|FG001|Overall Study|Withdrawal by Subject|1|||
48531714|NCT02746627|156134072|FG002|Overall Study|Withdrawal by Subject|1|||
48834184|NCT01585558|157234202|FG000|Overall Study|Lost to Follow-up|2|||
48834185|NCT01585558|157234203|FG001|Overall Study|Lost to Follow-up|0|||
48834186|NCT01585558|157234204|FG002|Overall Study|Lost to Follow-up|3|||
48834187|NCT01585558|157234202|FG000|Overall Study|Adverse Event|3|||
48834188|NCT01585558|157234203|FG001|Overall Study|Adverse Event|4|||
48834189|NCT01585558|157234204|FG002|Overall Study|Adverse Event|1|||
48834190|NCT01585558|157234202|FG000|Overall Study|Protocol Violation|4|||
48834191|NCT01585558|157234203|FG001|Overall Study|Protocol Violation|3|||
48834192|NCT01585558|157234204|FG002|Overall Study|Protocol Violation|2|||
48834193|NCT01585558|157234202|FG000|Overall Study|Lack of Efficacy|0|||
48834194|NCT01585558|157234203|FG001|Overall Study|Lack of Efficacy|0|||
48531715|NCT00171340|156134077|FG000|Overall Study|Adverse Event|46|||
48531716|NCT00171340|156134078|FG001|Overall Study|Adverse Event|42|||
48834195|NCT01585558|157234204|FG002|Overall Study|Lack of Efficacy|1|||
48834196|NCT02994654|157234205|FG000|Overall Study|Lost to Follow-up|1|||
48834197|NCT01123083|157234210|FG000|Overall Study|Investigator recommendation|1|||
48834198|NCT01123083|157234211|FG001|Overall Study|Investigator recommendation|1|||
48834199|NCT01123083|157234210|FG000|Overall Study|Administrative reasons|0|||
48834200|NCT01123083|157234211|FG001|Overall Study|Administrative reasons|4|||
48834201|NCT01123083|157234210|FG000|Overall Study|Lost to Follow-up|2|||
48834202|NCT01123083|157234211|FG001|Overall Study|Lost to Follow-up|6|||
48834203|NCT01123083|157234210|FG000|Overall Study|Adverse Event|1|||
48834204|NCT01123083|157234211|FG001|Overall Study|Adverse Event|0|||
48834205|NCT01123083|157234210|FG000|Overall Study|Withdrew for another reason not covered|0|||
48834206|NCT01123083|157234211|FG001|Overall Study|Withdrew for another reason not covered|1|||
48834207|NCT01123083|157234210|FG000|Overall Study|Participant/legal representative request|7|||
48834208|NCT01123083|157234211|FG001|Overall Study|Participant/legal representative request|3|||
48834209|NCT02674750|157234214|FG000|Overall Study|Death|4|||
48834210|NCT02674750|157234215|FG001|Overall Study|Death|5|||
48834211|NCT02674750|157234216|FG002|Overall Study|Death|8|||
48834212|NCT02674750|157234214|FG000|Overall Study|Lost to Follow-up|0|||
48834213|NCT02674750|157234215|FG001|Overall Study|Lost to Follow-up|8|||
48834214|NCT02674750|157234216|FG002|Overall Study|Lost to Follow-up|0|||
48834215|NCT02674750|157234214|FG000|Overall Study|Lack of Efficacy|1|||
48834216|NCT02674750|157234215|FG001|Overall Study|Lack of Efficacy|17|||
48834217|NCT02674750|157234216|FG002|Overall Study|Lack of Efficacy|3|||
48834218|NCT02674750|157234214|FG000|Overall Study|Withdrawal by Subject|0|||
48834219|NCT02674750|157234215|FG001|Overall Study|Withdrawal by Subject|7|||
48834220|NCT02674750|157234216|FG002|Overall Study|Withdrawal by Subject|1|||
48834221|NCT02674750|157234214|FG000|Overall Study|Other|0|||
48834222|NCT02674750|157234215|FG001|Overall Study|Other|8|||
48834223|NCT02674750|157234216|FG002|Overall Study|Other|0|||
48834224|NCT01063517|157234219|FG000|Overall Study|Consent withdrawal|1|||
48834225|NCT01063517|157234220|FG001|Overall Study|Consent withdrawal|0|||
48834226|NCT01063517|157234219|FG000|Overall Study|Study reached data cut-off|19|||
48531717|NCT00171340|156134077|FG000|Overall Study|Lack of Efficacy|29|||
48531718|NCT00171340|156134078|FG001|Overall Study|Lack of Efficacy|41|||
48531719|NCT00171340|156134077|FG000|Overall Study|Protocol Violation|7|||
48531720|NCT00171340|156134078|FG001|Overall Study|Protocol Violation|8|||
48531721|NCT00171340|156134077|FG000|Overall Study|Withdrawal by Subject|22|||
48531722|NCT00171340|156134078|FG001|Overall Study|Withdrawal by Subject|19|||
48531723|NCT00171340|156134077|FG000|Overall Study|Lost to Follow-up|0|||
48531724|NCT00171340|156134078|FG001|Overall Study|Lost to Follow-up|5|||
48531725|NCT00171340|156134077|FG000|Overall Study|Abnormal Laboratory Results|2|||
48531726|NCT00171340|156134078|FG001|Overall Study|Abnormal Laboratory Results|0|||
48531727|NCT00171340|156134077|FG000|Overall Study|Abnormal Test Procedure Results|6|||
48531728|NCT00171340|156134078|FG001|Overall Study|Abnormal Test Procedure Results|11|||
48531729|NCT00171340|156134077|FG000|Overall Study|No Longer Required Study Drug|1|||
48531730|NCT00171340|156134078|FG001|Overall Study|No Longer Required Study Drug|1|||
48531731|NCT00171340|156134077|FG000|Overall Study|Administrative Problems|5|||
48531732|NCT00171340|156134078|FG001|Overall Study|Administrative Problems|2|||
48531733|NCT00171340|156134077|FG000|Overall Study|Death|6|||
48531734|NCT00171340|156134078|FG001|Overall Study|Death|6|||
48531735|NCT03606512|156134081|FG000|Overall Study|Lost to Follow-up|0|||
48531736|NCT03606512|156134082|FG001|Overall Study|Lost to Follow-up|1|||
48531737|NCT03606512|156134081|FG000|Overall Study|'moved from study area|0|||
48531738|NCT03606512|156134082|FG001|Overall Study|'moved from study area|1|||
48531739|NCT03827018|156134088|FG000|Overall Study|Adverse Event|1|||
48531740|NCT03827018|156134089|FG001|Overall Study|Adverse Event|0|||
48834227|NCT01063517|157234220|FG001|Overall Study|Study reached data cut-off|7|||
48834228|NCT01063517|157234219|FG000|Overall Study|Lost to Follow-up|4|||
48834229|NCT01063517|157234220|FG001|Overall Study|Lost to Follow-up|3|||
48834230|NCT01063517|157234219|FG000|Overall Study|Withdrawal by Subject|1|||
48531741|NCT03827018|156134088|FG000|Overall Study|Withdrawal by Subject|2|||
48531742|NCT03827018|156134089|FG001|Overall Study|Withdrawal by Subject|2|||
48531743|NCT03827018|156134088|FG000|Overall Study|Lack of Efficacy|0|||
48531744|NCT03827018|156134089|FG001|Overall Study|Lack of Efficacy|1|||
48584946|NCT00743288|156333716|FG002|Overall Study|Progressive disease (PD)|1|||
48834231|NCT01063517|157234220|FG001|Overall Study|Withdrawal by Subject|2|||
48834232|NCT01063517|157234219|FG000|Overall Study|Death|33|||
48531745|NCT05513937|156134090|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
48603049|NCT00791999|156401698|FG001|Overall Study|Protocol planed withdrawal|11|||
48603050|NCT00791999|156401699|FG002|Overall Study|Protocol planed withdrawal|11|||
48603051|NCT00791999|156401700|FG003|Overall Study|Protocol planed withdrawal|45|||
48603052|NCT00791999|156401697|FG000|Overall Study|Withdrawal by Subject|0|||
48603053|NCT00791999|156401698|FG001|Overall Study|Withdrawal by Subject|1|||
48531746|NCT05513937|156134091|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
48531747|NCT05513937|156134092|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
48531748|NCT05513937|156134093|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
48531749|NCT05513937|156134090|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
48531750|NCT05513937|156134091|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
48531751|NCT05513937|156134092|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
48531752|NCT05513937|156134093|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
48531753|NCT05513937|156134090|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
48531754|NCT05513937|156134091|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
48531755|NCT05513937|156134092|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
48531756|NCT05513937|156134093|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
48531757|NCT05513937|156134090|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
48531758|NCT05513937|156134091|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
48531759|NCT05513937|156134092|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
48834233|NCT01063517|157234220|FG001|Overall Study|Death|48|||
48834234|NCT01239316|157234221|FG000|Overall Study|Progression/Relapse|11|||
48834235|NCT01239316|157234221|FG000|Overall Study|Adverse Event|1|||
48834236|NCT02106442|157234222|FG000|Overall Study|Case Report Forms Uncollected|7|||
48834237|NCT02106442|157234222|FG000|Overall Study|Protocol Deviation|30|||
48834238|NCT01331824|157235665|FG000|Overall Study|Adverse Event|2|||
48531760|NCT05513937|156134093|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
48531761|NCT05513937|156134090|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
48531762|NCT05513937|156134091|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
48531763|NCT05513937|156134092|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
48531764|NCT05513937|156134093|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
48531765|NCT05513937|156134090|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
48531766|NCT05513937|156134091|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
48531767|NCT05513937|156134092|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
48834239|NCT01331824|157235665|FG000|Overall Study|Death|1|||
48834240|NCT01331824|157235665|FG000|Overall Study|Disease Progression|9|||
48834241|NCT01331824|157235665|FG000|Overall Study|Withdrawal by Subject|1|||
48834242|NCT01393119|157235666|FG000|Overall Study|Adverse Event|1|||
48531768|NCT05513937|156134093|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
48531769|NCT01065454|156134094|FG000|Treatment|Adverse Event|7|||
48603054|NCT00791999|156401699|FG002|Overall Study|Withdrawal by Subject|0|||
48603055|NCT00791999|156401700|FG003|Overall Study|Withdrawal by Subject|2|||
48531770|NCT01065454|156134095|FG001|Treatment|Adverse Event|4|||
48531771|NCT01065454|156134096|FG002|Treatment|Adverse Event|3|||
48531772|NCT01065454|156134097|FG003|Treatment|Adverse Event|6|||
48531773|NCT01065454|156134094|FG000|Treatment|Death|1|||
48531774|NCT01065454|156134095|FG001|Treatment|Death|0|||
48531775|NCT01065454|156134096|FG002|Treatment|Death|0|||
48531776|NCT01065454|156134097|FG003|Treatment|Death|0|||
48531777|NCT01065454|156134094|FG000|Treatment|Non-compliance|1|||
48531778|NCT01065454|156134095|FG001|Treatment|Non-compliance|0|||
48531779|NCT01065454|156134096|FG002|Treatment|Non-compliance|0|||
48531780|NCT01065454|156134097|FG003|Treatment|Non-compliance|1|||
48531781|NCT01065454|156134094|FG000|Treatment|Protocol Decision|0|||
48531782|NCT01065454|156134095|FG001|Treatment|Protocol Decision|0|||
48531783|NCT01065454|156134096|FG002|Treatment|Protocol Decision|3|||
48531784|NCT01065454|156134097|FG003|Treatment|Protocol Decision|2|||
48531785|NCT01065454|156134094|FG000|Treatment|Protocol Violation|1|||
48531786|NCT01065454|156134095|FG001|Treatment|Protocol Violation|0|||
48531787|NCT01065454|156134096|FG002|Treatment|Protocol Violation|1|||
48531788|NCT01065454|156134097|FG003|Treatment|Protocol Violation|0|||
48531789|NCT01065454|156134094|FG000|Treatment|Withdrawal by Subject|3|||
48531790|NCT01065454|156134095|FG001|Treatment|Withdrawal by Subject|1|||
48531791|NCT01065454|156134096|FG002|Treatment|Withdrawal by Subject|2|||
48531792|NCT01065454|156134097|FG003|Treatment|Withdrawal by Subject|3|||
48603056|NCT00791999|156401697|FG000|Overall Study|Protocol Violation|3|||
48603057|NCT00791999|156401698|FG001|Overall Study|Protocol Violation|0|||
48603058|NCT00791999|156401699|FG002|Overall Study|Protocol Violation|1|||
48603059|NCT00791999|156401700|FG003|Overall Study|Protocol Violation|0|||
48603060|NCT00791999|156401697|FG000|Overall Study|Adverse Event|3|||
48834243|NCT01393119|157235667|FG001|Overall Study|Adverse Event|1|||
48834244|NCT01393119|157235668|FG002|Overall Study|Adverse Event|0|||
48834245|NCT01393119|157235669|FG003|Overall Study|Adverse Event|1|||
48834246|NCT01393119|157235666|FG000|Overall Study|Withdrawal by Subject|0|||
48834247|NCT01393119|157235667|FG001|Overall Study|Withdrawal by Subject|1|||
48834248|NCT01393119|157235668|FG002|Overall Study|Withdrawal by Subject|1|||
48834249|NCT01393119|157235669|FG003|Overall Study|Withdrawal by Subject|0|||
48834250|NCT01393119|157235666|FG000|Overall Study|Lack of Efficacy|1|||
48834251|NCT01393119|157235667|FG001|Overall Study|Lack of Efficacy|0|||
48834252|NCT01393119|157235668|FG002|Overall Study|Lack of Efficacy|2|||
48834253|NCT01393119|157235669|FG003|Overall Study|Lack of Efficacy|1|||
48834254|NCT01393119|157235666|FG000|Overall Study|Protocol Violation|0|||
48834255|NCT01393119|157235667|FG001|Overall Study|Protocol Violation|0|||
48834256|NCT01393119|157235668|FG002|Overall Study|Protocol Violation|1|||
48834257|NCT01393119|157235669|FG003|Overall Study|Protocol Violation|0|||
48834258|NCT01393119|157235666|FG000|Overall Study|Death|0|||
48834259|NCT01393119|157235667|FG001|Overall Study|Death|0|||
48834260|NCT01393119|157235668|FG002|Overall Study|Death|0|||
48834261|NCT01393119|157235669|FG003|Overall Study|Death|1|||
48531793|NCT01065454|156134094|FG000|Follow up|Adverse Event|1|||
48531794|NCT01065454|156134095|FG001|Follow up|Adverse Event|0|||
48531795|NCT01065454|156134096|FG002|Follow up|Adverse Event|0|||
48531796|NCT01065454|156134097|FG003|Follow up|Adverse Event|1|||
48531797|NCT01065454|156134094|FG000|Follow up|Death|0|||
48531798|NCT01065454|156134095|FG001|Follow up|Death|1|||
48531799|NCT01065454|156134096|FG002|Follow up|Death|1|||
48531800|NCT01065454|156134097|FG003|Follow up|Death|0|||
48531801|NCT01065454|156134094|FG000|Follow up|Lost to Follow-up|0|||
48531802|NCT01065454|156134095|FG001|Follow up|Lost to Follow-up|0|||
48531803|NCT01065454|156134096|FG002|Follow up|Lost to Follow-up|0|||
48531804|NCT01065454|156134097|FG003|Follow up|Lost to Follow-up|1|||
48531805|NCT01065454|156134094|FG000|Follow up|Progressive disease|0|||
48531806|NCT01065454|156134095|FG001|Follow up|Progressive disease|0|||
48531807|NCT01065454|156134096|FG002|Follow up|Progressive disease|0|||
48531808|NCT01065454|156134097|FG003|Follow up|Progressive disease|1|||
48531809|NCT01065454|156134094|FG000|Follow up|Withdrawal by Subject|1|||
48531810|NCT01065454|156134095|FG001|Follow up|Withdrawal by Subject|1|||
48531811|NCT01065454|156134096|FG002|Follow up|Withdrawal by Subject|1|||
48531812|NCT01065454|156134097|FG003|Follow up|Withdrawal by Subject|0|||
48531813|NCT01065454|156134094|FG000|Follow up|study ongoing|37|||
48531814|NCT01065454|156134095|FG001|Follow up|study ongoing|22|||
48531815|NCT01065454|156134096|FG002|Follow up|study ongoing|15|||
48531816|NCT01065454|156134097|FG003|Follow up|study ongoing|41|||
48531817|NCT03691298|156134098|FG000|Overall Study|Lost to Follow-up|8|||
48531818|NCT03691298|156134098|FG000|Overall Study|Sponsor terminated study|2|||
48531819|NCT03982186|156134100|FG000|Overall Study|Lost to Follow-up|0|||
48531820|NCT03982186|156134101|FG001|Overall Study|Lost to Follow-up|1|||
48531821|NCT03982186|156134102|FG002|Overall Study|Lost to Follow-up|2|||
48531822|NCT03982186|156134103|FG003|Overall Study|Lost to Follow-up|1|||
48531823|NCT03982186|156134104|FG004|Overall Study|Lost to Follow-up|1|||
48531824|NCT03982186|156134105|FG005|Overall Study|Lost to Follow-up|0|||
48531825|NCT03982186|156134100|FG000|Overall Study|Physician Decision|0|||
48531826|NCT03982186|156134101|FG001|Overall Study|Physician Decision|1|||
48531827|NCT03982186|156134102|FG002|Overall Study|Physician Decision|0|||
48531828|NCT03982186|156134103|FG003|Overall Study|Physician Decision|0|||
48531829|NCT03982186|156134104|FG004|Overall Study|Physician Decision|0|||
48531830|NCT03982186|156134105|FG005|Overall Study|Physician Decision|0|||
48531831|NCT03982186|156134100|FG000|Overall Study|Withdrawal by Subject|3|||
48531832|NCT03982186|156134101|FG001|Overall Study|Withdrawal by Subject|4|||
48531833|NCT03982186|156134102|FG002|Overall Study|Withdrawal by Subject|1|||
48531834|NCT03982186|156134103|FG003|Overall Study|Withdrawal by Subject|7|||
48531835|NCT03982186|156134104|FG004|Overall Study|Withdrawal by Subject|2|||
48531836|NCT03982186|156134105|FG005|Overall Study|Withdrawal by Subject|0|||
48531837|NCT03982186|156134100|FG000|Overall Study|Randomized and not treated|0|||
48531838|NCT03982186|156134101|FG001|Overall Study|Randomized and not treated|0|||
48531839|NCT03982186|156134102|FG002|Overall Study|Randomized and not treated|0|||
48531840|NCT03982186|156134103|FG003|Overall Study|Randomized and not treated|1|||
48531841|NCT03982186|156134104|FG004|Overall Study|Randomized and not treated|0|||
48531842|NCT03982186|156134105|FG005|Overall Study|Randomized and not treated|0|||
48531843|NCT00739973|156134106|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
48531844|NCT00739973|156134107|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
48531845|NCT00739973|156134108|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
48531846|NCT00739973|156134109|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
48531847|NCT00739973|156134110|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
48531848|NCT00739973|156134111|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
48531849|NCT00739973|156134112|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
48531850|NCT00739973|156134113|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
48531851|NCT00739973|156134114|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
48834262|NCT01393119|157235666|FG000|Overall Study|Randomized but Not treated|1|||
48834263|NCT01393119|157235667|FG001|Overall Study|Randomized but Not treated|0|||
48531852|NCT00739973|156134106|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
48603061|NCT00791999|156401698|FG001|Overall Study|Adverse Event|3|||
48834264|NCT01393119|157235668|FG002|Overall Study|Randomized but Not treated|1|||
48834265|NCT01393119|157235669|FG003|Overall Study|Randomized but Not treated|1|||
48834266|NCT01393119|157235666|FG000|Overall Study|Sponsor Termination of Study|11|||
48603062|NCT00791999|156401699|FG002|Overall Study|Adverse Event|7|||
48603063|NCT00791999|156401700|FG003|Overall Study|Adverse Event|3|||
48603064|NCT00791999|156401697|FG000|Overall Study|Lack of Efficacy|0|||
48603065|NCT00791999|156401698|FG001|Overall Study|Lack of Efficacy|1|||
48603066|NCT00791999|156401699|FG002|Overall Study|Lack of Efficacy|0|||
48603067|NCT00791999|156401700|FG003|Overall Study|Lack of Efficacy|2|||
48603068|NCT00791999|156401697|FG000|Overall Study|Reason other than those above|1|||
48603069|NCT00791999|156401698|FG001|Overall Study|Reason other than those above|0|||
48603070|NCT00791999|156401699|FG002|Overall Study|Reason other than those above|1|||
48834267|NCT01393119|157235667|FG001|Overall Study|Sponsor Termination of Study|12|||
48834268|NCT01393119|157235668|FG002|Overall Study|Sponsor Termination of Study|9|||
48834269|NCT01393119|157235669|FG003|Overall Study|Sponsor Termination of Study|12|||
48834270|NCT00817635|157235670|FG000|Overall Study|Adverse Event|1|||
48834271|NCT00817635|157235671|FG001|Overall Study|Adverse Event|0|||
48834272|NCT00817635|157235672|FG002|Overall Study|Adverse Event|0|||
48834273|NCT00817635|157235673|FG003|Overall Study|Adverse Event|1|||
48834274|NCT00817635|157235674|FG004|Overall Study|Adverse Event|1|||
48603071|NCT00791999|156401700|FG003|Overall Study|Reason other than those above|0|||
48603072|NCT02417753|156401701|FG000|Overall Study|Death|1|||
48603073|NCT04805671|156401702|FG000|Overall Study|Death|2|||
48603074|NCT04805671|156401703|FG001|Overall Study|Death|7|||
48603075|NCT04805671|156401702|FG000|Overall Study|Lost to Follow-up|1|||
48603076|NCT04805671|156401703|FG001|Overall Study|Lost to Follow-up|0|||
48603077|NCT04805671|156401702|FG000|Overall Study|Withdrawal by Subject|9|||
48603078|NCT04805671|156401703|FG001|Overall Study|Withdrawal by Subject|7|||
48603079|NCT04805671|156401702|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
48603080|NCT04805671|156401703|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
48834275|NCT00817635|157235670|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
48834276|NCT00817635|157235671|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
48834277|NCT00817635|157235672|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
48834278|NCT00817635|157235673|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
48834279|NCT00817635|157235674|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
48834280|NCT00817635|157235670|FG000|Overall Study|Withdrawal by Subject|2|||
48834281|NCT00817635|157235671|FG001|Overall Study|Withdrawal by Subject|1|||
48834282|NCT00817635|157235672|FG002|Overall Study|Withdrawal by Subject|0|||
48834283|NCT00817635|157235673|FG003|Overall Study|Withdrawal by Subject|1|||
48834284|NCT00817635|157235674|FG004|Overall Study|Withdrawal by Subject|2|||
48834285|NCT00817635|157235670|FG000|Overall Study|Lost to Follow-up|0|||
48834286|NCT00817635|157235671|FG001|Overall Study|Lost to Follow-up|1|||
48834287|NCT00817635|157235672|FG002|Overall Study|Lost to Follow-up|0|||
48834288|NCT00817635|157235673|FG003|Overall Study|Lost to Follow-up|1|||
48834289|NCT00817635|157235674|FG004|Overall Study|Lost to Follow-up|0|||
48834290|NCT00817635|157235670|FG000|Overall Study|Administrative Problems|0|||
48834291|NCT00817635|157235671|FG001|Overall Study|Administrative Problems|0|||
48531853|NCT00739973|156134107|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
48531854|NCT00739973|156134108|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
48531855|NCT00739973|156134109|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
48531856|NCT00739973|156134110|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
48531857|NCT00739973|156134111|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
48531858|NCT00739973|156134112|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
48531859|NCT00739973|156134113|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
48531860|NCT00739973|156134114|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
48531861|NCT00739973|156134106|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
48531862|NCT00739973|156134107|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
48531863|NCT00739973|156134108|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
48531864|NCT00739973|156134109|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
48531865|NCT00739973|156134110|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
48531866|NCT00739973|156134111|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
48603081|NCT01657162|156401704|FG000|Overall Study|Adverse Event|26|||
48603082|NCT01657162|156401705|FG001|Overall Study|Adverse Event|36|||
48603083|NCT01657162|156401704|FG000|Overall Study|Withdrawal by Subject|13|||
48603084|NCT01657162|156401705|FG001|Overall Study|Withdrawal by Subject|13|||
48603085|NCT01657162|156401704|FG000|Overall Study|Continuing Significant Deterioration|9|||
48834292|NCT00817635|157235672|FG002|Overall Study|Administrative Problems|0|||
48834293|NCT00817635|157235673|FG003|Overall Study|Administrative Problems|0|||
48834294|NCT00817635|157235674|FG004|Overall Study|Administrative Problems|1|||
48834295|NCT00817635|157235670|FG000|Overall Study|Protocol Violation|5|||
48383831|NCT00436618|155601448|FG001|Overall Study|Alternate Treatment|4|||
48603086|NCT01657162|156401705|FG001|Overall Study|Continuing Significant Deterioration|3|||
48603087|NCT01657162|156401704|FG000|Overall Study|Refusal of Treatment|4|||
48603088|NCT01657162|156401705|FG001|Overall Study|Refusal of Treatment|6|||
48603089|NCT01657162|156401704|FG000|Overall Study|Lost to Follow-up|3|||
48603090|NCT01657162|156401705|FG001|Overall Study|Lost to Follow-up|4|||
48603091|NCT01657162|156401704|FG000|Overall Study|Death|2|||
48603092|NCT01657162|156401705|FG001|Overall Study|Death|3|||
48603093|NCT01657162|156401704|FG000|Overall Study|Inability to Complete Study Procedures|1|||
48603094|NCT01657162|156401705|FG001|Overall Study|Inability to Complete Study Procedures|7|||
48603095|NCT01657162|156401704|FG000|Overall Study|Protocol Violation|1|||
48834296|NCT00817635|157235671|FG001|Overall Study|Protocol Violation|1|||
48834297|NCT00817635|157235672|FG002|Overall Study|Protocol Violation|3|||
48834298|NCT00817635|157235673|FG003|Overall Study|Protocol Violation|2|||
48834299|NCT00817635|157235674|FG004|Overall Study|Protocol Violation|3|||
48834300|NCT01131494|157235676|FG000|Overall Study|Withdrawal by Subject|2|||
48834301|NCT02385669|157235678|FG000|Overall Study|Adverse Event|2|||
48834302|NCT02082158|157235679|FG000|Overall Study|Withdrawal by Subject|0|||
48834303|NCT02082158|157235680|FG001|Overall Study|Withdrawal by Subject|0|||
48834304|NCT02082158|157235681|FG002|Overall Study|Withdrawal by Subject|0|||
48834305|NCT02082158|157235682|FG003|Overall Study|Withdrawal by Subject|0|||
48834306|NCT02082158|157235683|FG004|Overall Study|Withdrawal by Subject|1|||
48834307|NCT02082158|157235684|FG005|Overall Study|Withdrawal by Subject|0|||
48834308|NCT02082158|157235679|FG000|Overall Study|Failed Fit-testing|8|||
48834309|NCT02082158|157235680|FG001|Overall Study|Failed Fit-testing|8|||
48834310|NCT02082158|157235681|FG002|Overall Study|Failed Fit-testing|14|||
48834311|NCT02082158|157235682|FG003|Overall Study|Failed Fit-testing|4|||
48834312|NCT02082158|157235683|FG004|Overall Study|Failed Fit-testing|3|||
48834313|NCT02082158|157235684|FG005|Overall Study|Failed Fit-testing|7|||
48834314|NCT00868192|157235685|FG000|Overall Study|Ineligible|4|||
48834315|NCT01616654|157235686|FG000|Overall Study|Lack of Efficacy|1|||
48834316|NCT01616654|157235687|FG001|Overall Study|Lack of Efficacy|0|||
48834317|NCT01616654|157235688|FG002|Overall Study|Lack of Efficacy|0|||
48834318|NCT01616654|157235689|FG003|Overall Study|Lack of Efficacy|0|||
48834319|NCT01616654|157235690|FG004|Overall Study|Lack of Efficacy|1|||
48834320|NCT01616654|157235686|FG000|Overall Study|Adverse Event|0|||
48834321|NCT01616654|157235687|FG001|Overall Study|Adverse Event|1|||
48834322|NCT01616654|157235688|FG002|Overall Study|Adverse Event|2|||
48834323|NCT01616654|157235689|FG003|Overall Study|Adverse Event|1|||
48834324|NCT01616654|157235690|FG004|Overall Study|Adverse Event|0|||
48834325|NCT01616654|157235686|FG000|Overall Study|Withdrawal by Subject|2|||
48834326|NCT01616654|157235687|FG001|Overall Study|Withdrawal by Subject|2|||
48834327|NCT01616654|157235688|FG002|Overall Study|Withdrawal by Subject|3|||
48834328|NCT01616654|157235689|FG003|Overall Study|Withdrawal by Subject|1|||
48834329|NCT01616654|157235690|FG004|Overall Study|Withdrawal by Subject|5|||
48834330|NCT01616654|157235686|FG000|Overall Study|Protocol Violation|0|||
48834331|NCT01616654|157235687|FG001|Overall Study|Protocol Violation|5|||
48834332|NCT01616654|157235688|FG002|Overall Study|Protocol Violation|2|||
48834333|NCT01616654|157235689|FG003|Overall Study|Protocol Violation|4|||
48834334|NCT01616654|157235690|FG004|Overall Study|Protocol Violation|4|||
48834335|NCT01616654|157235686|FG000|Overall Study|Lost to Follow-up|1|||
48834336|NCT01616654|157235687|FG001|Overall Study|Lost to Follow-up|0|||
48834337|NCT01616654|157235688|FG002|Overall Study|Lost to Follow-up|3|||
48834338|NCT01616654|157235689|FG003|Overall Study|Lost to Follow-up|2|||
48834339|NCT01616654|157235690|FG004|Overall Study|Lost to Follow-up|1|||
48834340|NCT01616654|157235686|FG000|Overall Study|Pregnancy|1|||
48603096|NCT01657162|156401705|FG001|Overall Study|Protocol Violation|0|||
48834341|NCT01616654|157235687|FG001|Overall Study|Pregnancy|0|||
48834342|NCT01616654|157235688|FG002|Overall Study|Pregnancy|0|||
48834343|NCT01616654|157235689|FG003|Overall Study|Pregnancy|0|||
48603097|NCT01657162|156401704|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
48834344|NCT01616654|157235690|FG004|Overall Study|Pregnancy|1|||
48834345|NCT02057692|157235691|FG000|Overall Study|Adverse Event|1|||
48834346|NCT02057692|157235692|FG001|Overall Study|Adverse Event|0|||
48834347|NCT02057692|157235693|FG002|Overall Study|Adverse Event|0|||
48834348|NCT02057692|157235694|FG003|Overall Study|Adverse Event|0|||
48834349|NCT02057692|157235691|FG000|Overall Study|Lost to Follow-up|0|||
48834350|NCT02057692|157235692|FG001|Overall Study|Lost to Follow-up|0|||
48834351|NCT02057692|157235693|FG002|Overall Study|Lost to Follow-up|0|||
48834352|NCT02057692|157235694|FG003|Overall Study|Lost to Follow-up|1|||
48834353|NCT01466881|157235696|FG000|Overall Study|Ineligible|5|||
48834354|NCT01466881|157235696|FG000|Overall Study|Adverse Event|6|||
48834355|NCT01466881|157235696|FG000|Overall Study|Progression/relapse|20|||
48834356|NCT01466881|157235696|FG000|Overall Study|Death|4|||
48834357|NCT01466881|157235696|FG000|Overall Study|Other reason not protocol specified|5|||
48834358|NCT01456936|157235699|FG000|Overall Study|Other reason|41|||
48834359|NCT01456936|157235700|FG001|Overall Study|Other reason|30|||
48834360|NCT01456936|157235701|FG002|Overall Study|Other reason|36|||
48531867|NCT00739973|156134112|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
48531868|NCT00739973|156134113|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
48531869|NCT00739973|156134114|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
48834361|NCT01456936|157235702|FG003|Overall Study|Other reason|33|||
48834362|NCT01456936|157235699|FG000|Overall Study|No longer meets eligibility criteria|4|||
48834363|NCT01456936|157235700|FG001|Overall Study|No longer meets eligibility criteria|8|||
48834364|NCT01456936|157235701|FG002|Overall Study|No longer meets eligibility criteria|6|||
48834365|NCT01456936|157235702|FG003|Overall Study|No longer meets eligibility criteria|5|||
48834366|NCT01456936|157235699|FG000|Overall Study|Protocol Violation|4|||
48834367|NCT01456936|157235700|FG001|Overall Study|Protocol Violation|2|||
48834368|NCT01456936|157235701|FG002|Overall Study|Protocol Violation|5|||
48834369|NCT01456936|157235702|FG003|Overall Study|Protocol Violation|5|||
48834370|NCT01456936|157235699|FG000|Overall Study|Pregnancy|1|||
48834371|NCT01456936|157235700|FG001|Overall Study|Pregnancy|0|||
48834372|NCT01456936|157235701|FG002|Overall Study|Pregnancy|0|||
48834373|NCT01456936|157235702|FG003|Overall Study|Pregnancy|1|||
48834374|NCT01456936|157235699|FG000|Overall Study|Insufficient clinical response|4|||
48834375|NCT01456936|157235700|FG001|Overall Study|Insufficient clinical response|4|||
48834376|NCT01456936|157235701|FG002|Overall Study|Insufficient clinical response|14|||
48834377|NCT01456936|157235702|FG003|Overall Study|Insufficient clinical response|13|||
48834378|NCT01456936|157235699|FG000|Overall Study|No longer willing to participate|195|||
48834379|NCT01456936|157235700|FG001|Overall Study|No longer willing to participate|218|||
48834380|NCT01456936|157235701|FG002|Overall Study|No longer willing to participate|224|||
48834381|NCT01456936|157235702|FG003|Overall Study|No longer willing to participate|248|||
48834382|NCT01456936|157235699|FG000|Overall Study|Lost to Follow-up|135|||
48834383|NCT01456936|157235700|FG001|Overall Study|Lost to Follow-up|126|||
48834384|NCT01456936|157235701|FG002|Overall Study|Lost to Follow-up|144|||
48834385|NCT01456936|157235702|FG003|Overall Study|Lost to Follow-up|127|||
48834386|NCT01456936|157235699|FG000|Overall Study|Medication error|0|||
48834387|NCT01456936|157235700|FG001|Overall Study|Medication error|1|||
48834388|NCT01456936|157235701|FG002|Overall Study|Medication error|0|||
48834389|NCT01456936|157235702|FG003|Overall Study|Medication error|1|||
48834390|NCT01456936|157235699|FG000|Overall Study|Adverse event (study drug)|25|||
48834391|NCT01456936|157235700|FG001|Overall Study|Adverse event (study drug)|21|||
48834392|NCT01456936|157235701|FG002|Overall Study|Adverse event (study drug)|26|||
48383832|NCT00436618|155601449|FG002|Overall Study|Alternate Treatment|12|||
48834393|NCT01456936|157235702|FG003|Overall Study|Adverse event (study drug)|17|||
48603098|NCT01657162|156401705|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
48603099|NCT01657162|156401704|FG000|Overall Study|Other than Specified|0|||
48603100|NCT01657162|156401705|FG001|Overall Study|Other than Specified|2|||
48603101|NCT02849587|156401706|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
48603102|NCT02849587|156401707|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
48603103|NCT02849587|156401708|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
48603104|NCT02849587|156401706|FG000|Overall Study|Withdrawal by Subject|0|||
48834394|NCT01456936|157235699|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
48834395|NCT01456936|157235700|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
48834396|NCT01456936|157235701|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
48834397|NCT01456936|157235702|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
48834398|NCT01456936|157235699|FG000|Overall Study|Death|0|||
48834399|NCT01456936|157235700|FG001|Overall Study|Death|3|||
48834400|NCT01456936|157235701|FG002|Overall Study|Death|1|||
48834401|NCT01456936|157235702|FG003|Overall Study|Death|3|||
48603105|NCT02849587|156401707|FG001|Overall Study|Withdrawal by Subject|1|||
48834402|NCT01456936|157235699|FG000|Overall Study|Randomized but not treated|21|||
48834403|NCT01456936|157235700|FG001|Overall Study|Randomized but not treated|28|||
48834404|NCT01456936|157235701|FG002|Overall Study|Randomized but not treated|16|||
48834405|NCT01456936|157235702|FG003|Overall Study|Randomized but not treated|21|||
48834406|NCT01786564|157235703|FG000|Overall Study|Lost to Follow-up|47|||
48834407|NCT01786564|157235703|FG000|Overall Study|Ineligible|17|||
48834408|NCT00494442|157235704|FG000|Overall Study|Death|1|||
48834409|NCT00494442|157235705|FG001|Overall Study|Death|1|||
48834410|NCT00494442|157235704|FG000|Overall Study|Lack of Efficacy|16|||
48834411|NCT00494442|157235705|FG001|Overall Study|Lack of Efficacy|10|||
48834412|NCT00494442|157235704|FG000|Overall Study|Adverse Event|0|||
48834413|NCT00494442|157235705|FG001|Overall Study|Adverse Event|2|||
48531870|NCT00739973|156134106|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
48531871|NCT00739973|156134107|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
48531872|NCT00739973|156134108|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
48531873|NCT00739973|156134109|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
48531874|NCT00739973|156134110|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
48531875|NCT00739973|156134111|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
48531876|NCT00739973|156134112|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
48531877|NCT00739973|156134113|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
48834414|NCT00494442|157235704|FG000|Overall Study|Physician Decision|0|||
48834415|NCT00494442|157235705|FG001|Overall Study|Physician Decision|1|||
48834416|NCT00494442|157235704|FG000|Overall Study|Non-compliance|0|||
48834417|NCT00494442|157235705|FG001|Overall Study|Non-compliance|1|||
48834418|NCT00494442|157235704|FG000|Overall Study|Intercurrent illness|0|||
48834419|NCT00494442|157235705|FG001|Overall Study|Intercurrent illness|1|||
48531878|NCT00739973|156134114|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
48531879|NCT00739973|156134106|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
48531880|NCT00739973|156134107|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
48531881|NCT00739973|156134108|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
48531882|NCT00739973|156134109|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
48531883|NCT00739973|156134110|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
48531884|NCT00739973|156134111|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
48531885|NCT00739973|156134112|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
48531886|NCT00739973|156134113|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
48531887|NCT00739973|156134114|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
48531888|NCT00739973|156134106|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
48531889|NCT00739973|156134107|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
48531890|NCT00739973|156134108|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
48531891|NCT00739973|156134109|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
48531892|NCT00739973|156134110|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
48531893|NCT00739973|156134111|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
48531894|NCT00739973|156134112|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
48531895|NCT00739973|156134113|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
48531896|NCT00739973|156134114|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
48531897|NCT00739973|156134106|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
48531898|NCT00739973|156134107|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
48531899|NCT00739973|156134108|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
48834420|NCT00486330|157235706|FG000|Overall Study|Adverse Event|2|||
48834421|NCT01241292|157235707|FG000|Overall Study|Administrative Reason by Sponsor|1|||
48834422|NCT01241292|157235708|FG001|Overall Study|Administrative Reason by Sponsor|0|||
48834423|NCT01241292|157235707|FG000|Overall Study|Disease Progression|2|||
48834424|NCT01241292|157235708|FG001|Overall Study|Disease Progression|0|||
48834425|NCT01241292|157235707|FG000|Overall Study|Study Drug Toxicity|0|||
48834426|NCT01241292|157235708|FG001|Overall Study|Study Drug Toxicity|1|||
48834427|NCT01241292|157235707|FG000|Overall Study|Participant Discontinued Treatment|0|||
48834428|NCT01241292|157235708|FG001|Overall Study|Participant Discontinued Treatment|2|||
48834429|NCT03034915|157235709|FG000|Overall Study|Adverse Event|29|||
48834430|NCT03034915|157235710|FG001|Overall Study|Adverse Event|32|||
48834431|NCT03034915|157235711|FG002|Overall Study|Adverse Event|22|||
48834432|NCT03034915|157235709|FG000|Overall Study|Lost to Follow-up|5|||
48834433|NCT03034915|157235710|FG001|Overall Study|Lost to Follow-up|13|||
48531900|NCT00739973|156134109|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
48531901|NCT00739973|156134110|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
48531902|NCT00739973|156134111|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
48531903|NCT00739973|156134112|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
48531904|NCT00739973|156134113|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
48531905|NCT00739973|156134114|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
48531906|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
48531907|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
48834434|NCT03034915|157235711|FG002|Overall Study|Lost to Follow-up|3|||
48834435|NCT03034915|157235709|FG000|Overall Study|Withdrawal by Subject|29|||
48834436|NCT03034915|157235710|FG001|Overall Study|Withdrawal by Subject|46|||
48834437|NCT03034915|157235711|FG002|Overall Study|Withdrawal by Subject|41|||
48834438|NCT03034915|157235709|FG000|Overall Study|Protocol Deviation|2|||
48834439|NCT03034915|157235710|FG001|Overall Study|Protocol Deviation|14|||
48834440|NCT03034915|157235711|FG002|Overall Study|Protocol Deviation|7|||
48834441|NCT03034915|157235709|FG000|Overall Study|Lack of Efficacy|8|||
48834442|NCT03034915|157235710|FG001|Overall Study|Lack of Efficacy|16|||
48834443|NCT03034915|157235711|FG002|Overall Study|Lack of Efficacy|18|||
48834444|NCT03034915|157235709|FG000|Overall Study|Site closed|2|||
48834445|NCT03034915|157235710|FG001|Overall Study|Site closed|2|||
48834446|NCT03034915|157235711|FG002|Overall Study|Site closed|4|||
48834447|NCT03034915|157235709|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
48834448|NCT03034915|157235710|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
48531908|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
48531909|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
48531910|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
48531911|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
48531912|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
48531913|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
48531914|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
48531915|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
48531916|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
48531917|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
48531918|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
48531919|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
48531920|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
48531921|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
48531922|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
48531923|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
48531924|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
48531925|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
48531926|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
48531927|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
48531928|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
48531929|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
48531930|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
48531931|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
48531932|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
48531933|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
48531934|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
48834449|NCT03034915|157235711|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
48834450|NCT03034915|157235709|FG000|Overall Study|Physician Decision|1|||
48834451|NCT03034915|157235710|FG001|Overall Study|Physician Decision|5|||
48603106|NCT02849587|156401708|FG002|Overall Study|Withdrawal by Subject|0|||
48603107|NCT04202497|156401709|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
48603108|NCT04202497|156401710|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
48603109|NCT04202497|156401711|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
48603110|NCT04202497|156401712|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
48603111|NCT02100839|156402924|FG000|Multiple Ascending Dose|Adverse Event|2|||
48834452|NCT03034915|157235711|FG002|Overall Study|Physician Decision|2|||
48603112|NCT02100839|156402925|FG001|Multiple Ascending Dose|Adverse Event|0|||
48603113|NCT02100839|156402924|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
48531935|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
48531936|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
48531937|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
48531938|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
48531939|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
48531940|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
48531941|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
48531942|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
48531943|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
48531944|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
48834453|NCT00957658|157235712|FG000|Overall Study|Death|1|||
48834454|NCT00957658|157235712|FG000|Overall Study|Lost to Follow-up|4|||
48834455|NCT00957658|157235712|FG000|Overall Study|Withdrawal by Subject|12|||
48834456|NCT00957658|157235712|FG000|Overall Study|Revision|1|||
48834457|NCT00957658|157235712|FG000|Overall Study|Incomplete 2 yr data|28|||
48834458|NCT00957658|157235712|FG000|Overall Study|Site termination|10|||
48834459|NCT00957658|157235712|FG000|Overall Study|unwilling/unable to return|2|||
48834460|NCT00957658|157235712|FG000|Overall Study|surgery cancelled|2|||
48834461|NCT00957658|157235712|FG000|Overall Study|Protocol Violation|5|||
48531945|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
48531946|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
48531947|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
48531948|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
48531949|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
48531950|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
48531951|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
48531952|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
48531953|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
48531954|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
48531955|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
48531956|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
48531957|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
48531958|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
48531959|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
48531960|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
48531961|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
48531962|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
48531963|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
48531964|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
48531965|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
48531966|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
48531967|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
48531968|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
48531969|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
48531970|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
48531971|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
48531972|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
48834462|NCT00424762|157235713|FG000|Overall Study|Withdrawal by Subject|18|||
48531973|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
48531974|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
48531975|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
48531976|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
48531977|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
48531978|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
48531979|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
48531980|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
48531981|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
48531982|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
48531983|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
48531984|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
48531985|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
48531986|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
48531987|NCT00739973|156134106|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
48531988|NCT00739973|156134107|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
48531989|NCT00739973|156134108|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
48531990|NCT00739973|156134109|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
48531991|NCT00739973|156134110|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
48531992|NCT00739973|156134111|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
48531993|NCT00739973|156134112|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
48531994|NCT00739973|156134113|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
48531995|NCT00739973|156134114|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
48531996|NCT02792218|156134117|FG000|Overall Study|Patient/guardian decision|15|||
48531997|NCT02792218|156134118|FG001|Overall Study|Patient/guardian decision|42|||
48531998|NCT02792218|156134117|FG000|Overall Study|Adverse Event|15|||
48531999|NCT02792218|156134118|FG001|Overall Study|Adverse Event|14|||
48532000|NCT02792218|156134117|FG000|Overall Study|Lost to Follow-up|10|||
48532001|NCT02792218|156134118|FG001|Overall Study|Lost to Follow-up|5|||
48532002|NCT02792218|156134117|FG000|Overall Study|Lack of Efficacy|1|||
48532003|NCT02792218|156134118|FG001|Overall Study|Lack of Efficacy|12|||
48532004|NCT02792218|156134117|FG000|Overall Study|Physician Decision|4|||
48532005|NCT02792218|156134118|FG001|Overall Study|Physician Decision|4|||
48532006|NCT02792218|156134117|FG000|Overall Study|Protocol deviation|3|||
48532007|NCT02792218|156134118|FG001|Overall Study|Protocol deviation|2|||
48532008|NCT02792218|156134117|FG000|Overall Study|New therapy for study indication|0|||
48532009|NCT02792218|156134118|FG001|Overall Study|New therapy for study indication|1|||
48532010|NCT02792218|156134117|FG000|Overall Study|Non-compliance with study treatment|0|||
48532011|NCT02792218|156134118|FG001|Overall Study|Non-compliance with study treatment|1|||
48532012|NCT02792218|156134117|FG000|Overall Study|Pregnancy|1|||
48532013|NCT02792218|156134118|FG001|Overall Study|Pregnancy|0|||
48532014|NCT03610581|156134119|FG000|Overall Study|Study terminated by sponsor|2|||
48532015|NCT03610581|156134120|FG001|Overall Study|Study terminated by sponsor|0|||
48532016|NCT03610581|156134119|FG000|Overall Study|Other|0|||
48532017|NCT03610581|156134120|FG001|Overall Study|Other|1|||
48532018|NCT03610581|156134119|FG000|Overall Study|Withdrawal by Subject|1|||
48532019|NCT03610581|156134120|FG001|Overall Study|Withdrawal by Subject|0|||
48532020|NCT02485925|156134122|FG000|Overall Study|Withdrawal by Subject|3|||
48532021|NCT02485925|156134122|FG000|Overall Study|Death|1|||
48532022|NCT02485925|156134122|FG000|Overall Study|Lost to Follow-up|11|||
48532023|NCT00980460|156134123|FG000|Overall Study|Death|0|||
48532024|NCT00980460|156134124|FG001|Overall Study|Death|0|||
48532025|NCT00980460|156134125|FG002|Overall Study|Death|1|||
48532026|NCT00980460|156134126|FG003|Overall Study|Death|2|||
48532027|NCT00980460|156134127|FG004|Overall Study|Death|1|||
48532028|NCT00980460|156134123|FG000|Overall Study|Lack of Efficacy|0|||
48532029|NCT00980460|156134124|FG001|Overall Study|Lack of Efficacy|0|||
48532030|NCT00980460|156134125|FG002|Overall Study|Lack of Efficacy|10|||
48532031|NCT00980460|156134126|FG003|Overall Study|Lack of Efficacy|6|||
48532032|NCT00980460|156134127|FG004|Overall Study|Lack of Efficacy|8|||
48532033|NCT00980460|156134123|FG000|Overall Study|Lost to Follow-up|0|||
48532034|NCT00980460|156134124|FG001|Overall Study|Lost to Follow-up|0|||
48532035|NCT00980460|156134125|FG002|Overall Study|Lost to Follow-up|0|||
48532036|NCT00980460|156134126|FG003|Overall Study|Lost to Follow-up|1|||
48532037|NCT00980460|156134127|FG004|Overall Study|Lost to Follow-up|0|||
48532038|NCT00980460|156134123|FG000|Overall Study|Physician Decision|0|||
48532039|NCT00980460|156134124|FG001|Overall Study|Physician Decision|0|||
48532040|NCT00980460|156134125|FG002|Overall Study|Physician Decision|11|||
48532041|NCT00980460|156134126|FG003|Overall Study|Physician Decision|5|||
48532042|NCT00980460|156134127|FG004|Overall Study|Physician Decision|3|||
48532043|NCT00980460|156134123|FG000|Overall Study|Withdrawal by Subject|0|||
48532044|NCT00980460|156134124|FG001|Overall Study|Withdrawal by Subject|0|||
48532045|NCT00980460|156134125|FG002|Overall Study|Withdrawal by Subject|1|||
48532046|NCT00980460|156134126|FG003|Overall Study|Withdrawal by Subject|0|||
48532047|NCT00980460|156134127|FG004|Overall Study|Withdrawal by Subject|0|||
48532048|NCT00980460|156134123|FG000|Overall Study|Ineligible|0|||
48532049|NCT00980460|156134124|FG001|Overall Study|Ineligible|2|||
48532050|NCT00980460|156134125|FG002|Overall Study|Ineligible|3|||
48532051|NCT00980460|156134126|FG003|Overall Study|Ineligible|1|||
48834463|NCT00424762|157235714|FG001|Overall Study|Withdrawal by Subject|19|||
48834464|NCT00424762|157235713|FG000|Overall Study|Lost to Follow-up|2|||
48834465|NCT00424762|157235714|FG001|Overall Study|Lost to Follow-up|3|||
48834466|NCT04588480|157235715|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
48834467|NCT04588480|157235716|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
48834468|NCT04588480|157235717|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
48834469|NCT04588480|157235715|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
48834470|NCT04588480|157235716|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
48834471|NCT04588480|157235717|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
48834472|NCT01405924|157235718|FG000|Overall Study|Protocol Violation|8|||
48834473|NCT01405924|157235718|FG000|Overall Study|Missing/Incomplete Data|2|||
48834474|NCT01191086|157235720|FG000|Overall Study|Adverse Event|20|||
48834475|NCT01191086|157235720|FG000|Overall Study|Lack of Efficacy|10|||
48834476|NCT01191086|157235720|FG000|Overall Study|Lost to Follow-up|4|||
48834477|NCT01191086|157235720|FG000|Overall Study|Physician Decision|2|||
48834478|NCT01191086|157235720|FG000|Overall Study|Withdrawal by Subject|24|||
48834479|NCT01191086|157235720|FG000|Overall Study|Discontinuation criterion met|1|||
48834480|NCT01191086|157235720|FG000|Overall Study|Other|1|||
48532052|NCT00980460|156134127|FG004|Overall Study|Ineligible|4|||
48532053|NCT00980460|156134123|FG000|Overall Study|Refusal of further therapy|0|||
48532054|NCT00980460|156134124|FG001|Overall Study|Refusal of further therapy|2|||
48532055|NCT00980460|156134125|FG002|Overall Study|Refusal of further therapy|3|||
48532056|NCT00980460|156134126|FG003|Overall Study|Refusal of further therapy|2|||
48532057|NCT00980460|156134127|FG004|Overall Study|Refusal of further therapy|0|||
48532058|NCT00980460|156134123|FG000|Overall Study|No therapy within 42 days of resection|0|||
48532059|NCT00980460|156134124|FG001|Overall Study|No therapy within 42 days of resection|0|||
48532060|NCT00980460|156134125|FG002|Overall Study|No therapy within 42 days of resection|3|||
48532061|NCT00980460|156134126|FG003|Overall Study|No therapy within 42 days of resection|1|||
48532062|NCT00980460|156134127|FG004|Overall Study|No therapy within 42 days of resection|0|||
48532063|NCT00980460|156134123|FG000|Overall Study|No transplant by protocol timepoints|0|||
48532064|NCT00980460|156134124|FG001|Overall Study|No transplant by protocol timepoints|0|||
48532065|NCT00980460|156134125|FG002|Overall Study|No transplant by protocol timepoints|3|||
48532066|NCT00980460|156134126|FG003|Overall Study|No transplant by protocol timepoints|0|||
48532067|NCT00980460|156134127|FG004|Overall Study|No transplant by protocol timepoints|0|||
48532074|NCT04376827|156134131|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
48532075|NCT04376827|156134132|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
48532076|NCT04376827|156134131|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
48532077|NCT04376827|156134132|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
48532078|NCT04376827|156134131|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
48532079|NCT04376827|156134132|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
48532080|NCT04376827|156134131|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
48532081|NCT04376827|156134132|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
48532082|NCT04376827|156134131|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
48532083|NCT04376827|156134132|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
48532084|NCT00302211|156134133|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
48532085|NCT00302211|156134134|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
48532086|NCT00302211|156134135|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
48532087|NCT00302211|156134136|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
48532088|NCT00302211|156134137|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
48532089|NCT00302211|156134133|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
48532090|NCT00302211|156134134|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
48532091|NCT00302211|156134135|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
48834481|NCT03691428|157235721|FG000|Overall Study|Withdrawal by Subject|6|||
48834482|NCT03691428|157235722|FG001|Overall Study|Withdrawal by Subject|8|||
48834483|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Other|4|||
48532092|NCT00302211|156134136|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
48532093|NCT00302211|156134137|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
48532094|NCT00302211|156134133|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
48532095|NCT00302211|156134134|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
48532096|NCT00302211|156134135|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
48532097|NCT00302211|156134136|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
48532098|NCT00302211|156134137|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
48532099|NCT00302211|156134133|FG000|Double Blind Period (New Patients)|Disease progression|0|||
48532100|NCT00302211|156134134|FG001|Double Blind Period (New Patients)|Disease progression|1|||
48532101|NCT00302211|156134135|FG002|Double Blind Period (New Patients)|Disease progression|1|||
48532102|NCT00302211|156134136|FG003|Double Blind Period (New Patients)|Disease progression|0|||
48532103|NCT00302211|156134137|FG004|Double Blind Period (New Patients)|Disease progression|0|||
48532104|NCT00302211|156134133|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
48532105|NCT00302211|156134134|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
48532106|NCT00302211|156134135|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
48532107|NCT00302211|156134136|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
48532108|NCT00302211|156134137|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
48532109|NCT00302211|156134133|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
48532110|NCT00302211|156134134|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
48532111|NCT00302211|156134135|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
48532112|NCT00302211|156134136|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
48532113|NCT00302211|156134137|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
48532114|NCT00302211|156134133|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
48532115|NCT00302211|156134134|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
48532116|NCT00302211|156134135|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
48532117|NCT00302211|156134136|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
48532118|NCT00302211|156134137|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
48532119|NCT00302211|156134133|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
48532120|NCT00302211|156134134|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
48532121|NCT00302211|156134135|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
48532122|NCT00302211|156134136|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
48532123|NCT00302211|156134137|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
48532124|NCT00302211|156134133|FG000|Open Label-Patients From Double-Blind|Death|0|||
48532125|NCT00302211|156134134|FG001|Open Label-Patients From Double-Blind|Death|0|||
48532126|NCT00302211|156134135|FG002|Open Label-Patients From Double-Blind|Death|0|||
48532127|NCT00302211|156134136|FG003|Open Label-Patients From Double-Blind|Death|1|||
48532128|NCT00302211|156134137|FG004|Open Label-Patients From Double-Blind|Death|1|||
48532129|NCT00302211|156134133|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
48532130|NCT00302211|156134134|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
48532131|NCT00302211|156134135|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
48532132|NCT00302211|156134136|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
48532133|NCT00302211|156134137|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
48532134|NCT00302211|156134133|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
48532135|NCT00302211|156134134|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
48532136|NCT00302211|156134135|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
48532137|NCT00302211|156134136|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
48532138|NCT00302211|156134137|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
48532139|NCT00302211|156134133|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
48532140|NCT00302211|156134134|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
48532141|NCT00302211|156134135|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
48532142|NCT00302211|156134136|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
48532143|NCT00302211|156134137|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
48532144|NCT01729026|156136124|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
48532145|NCT01729026|156136125|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
48532146|NCT01729026|156136124|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
48532147|NCT01729026|156136125|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
48532148|NCT03710590|156136131|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
48532149|NCT03710590|156136132|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
48532150|NCT00407745|156136133|FG000|Overall Study|Lack of Efficacy|1|||
48532151|NCT00407745|156136134|FG001|Overall Study|Lack of Efficacy|2|||
48532152|NCT00407745|156136133|FG000|Overall Study|Withdrawal by Subject|3|||
48532153|NCT00407745|156136134|FG001|Overall Study|Withdrawal by Subject|3|||
48834484|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Other|0|||
48834485|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
48834486|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
48834487|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
48532154|NCT00407745|156136133|FG000|Overall Study|Protocol Violation|5|||
48532155|NCT00407745|156136134|FG001|Overall Study|Protocol Violation|3|||
48532156|NCT00407745|156136133|FG000|Overall Study|Adverse Event|8|||
48532157|NCT00407745|156136134|FG001|Overall Study|Adverse Event|8|||
48532158|NCT00407745|156136133|FG000|Overall Study|Other|2|||
48532159|NCT00407745|156136134|FG001|Overall Study|Other|0|||
48532160|NCT00407745|156136133|FG000|Overall Study|Randomized, unknown if treated|0|||
48532161|NCT00407745|156136134|FG001|Overall Study|Randomized, unknown if treated|1|||
48532162|NCT03042468|156136144|FG000|Overall Study|Death|0|||
48532163|NCT03042468|156136145|FG001|Overall Study|Death|1|||
48532164|NCT03042468|156136146|FG002|Overall Study|Death|1|||
48532165|NCT03042468|156136147|FG003|Overall Study|Death|0|||
48532166|NCT03042468|156136148|FG004|Overall Study|Death|0|||
48532167|NCT03042468|156136149|FG005|Overall Study|Death|0|||
48532168|NCT03042468|156136144|FG000|Overall Study|Withdrawal by Subject|0|||
48532169|NCT03042468|156136145|FG001|Overall Study|Withdrawal by Subject|0|||
48532170|NCT03042468|156136146|FG002|Overall Study|Withdrawal by Subject|0|||
48532171|NCT03042468|156136147|FG003|Overall Study|Withdrawal by Subject|0|||
48532172|NCT03042468|156136148|FG004|Overall Study|Withdrawal by Subject|0|||
48532173|NCT03042468|156136149|FG005|Overall Study|Withdrawal by Subject|1|||
48532174|NCT03042468|156136144|FG000|Overall Study|Lost to Follow-up|0|||
48532175|NCT03042468|156136145|FG001|Overall Study|Lost to Follow-up|0|||
48532176|NCT03042468|156136146|FG002|Overall Study|Lost to Follow-up|0|||
48532177|NCT03042468|156136147|FG003|Overall Study|Lost to Follow-up|0|||
48532178|NCT03042468|156136148|FG004|Overall Study|Lost to Follow-up|1|||
48532179|NCT03042468|156136149|FG005|Overall Study|Lost to Follow-up|1|||
48532180|NCT01592721|156136150|FG000|Long-term Follow-up|Death|1|||
48834488|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
48532181|NCT01073566|156136151|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
48532182|NCT01073566|156136152|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
48532183|NCT00298740|156136158|FG000|Overall Study|Lack of Efficacy|6|||
48532184|NCT00298740|156136158|FG000|Overall Study|Withdrawal by Subject|3|||
48532185|NCT01270620|156136161|FG000|Overall Study|Withdrawal by Subject|1|||
48532186|NCT01270620|156136162|FG001|Overall Study|Withdrawal by Subject|3|||
48532187|NCT04015167|156136163|FG000|Overall Study|Lost to Follow-up|40|||
48532188|NCT04015167|156136163|FG000|Overall Study|Adverse Event|5|||
48532189|NCT04015167|156136163|FG000|Overall Study|Withdrawal by Subject|2|||
48532190|NCT04015167|156136163|FG000|Overall Study|Subject went to jail|1|||
48532191|NCT00684567|156136164|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
48532192|NCT00684567|156136164|FG000|Monotherapy Period|Adverse Event|2|||
48532193|NCT00684567|156136164|FG000|Monotherapy Period|Death|1|||
48532194|NCT00684567|156136164|FG000|Monotherapy Period|Progression of primary disease|11|||
48532195|NCT05132569|156136165|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
48532196|NCT05132569|156136166|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
48532197|NCT05132569|156136165|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
48532198|NCT05132569|156136166|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
48532199|NCT05132569|156136165|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
48532200|NCT05132569|156136166|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
48532201|NCT03382652|156136179|FG000|Overall Study|Lost to Follow-up|6|||
48532202|NCT03382652|156136179|FG000|Overall Study|Death|4|||
48532203|NCT03382652|156136179|FG000|Overall Study|Revision|5|||
48532204|NCT03382652|156136179|FG000|Overall Study|Patient withdrew|3|||
48834489|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
48834490|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
48834491|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
48834492|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
48834493|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
48834494|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
48834495|NCT00853827|157235723|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
48834496|NCT00853827|157235724|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
48834497|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
48834498|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
48834499|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
48532205|NCT03382652|156136179|FG000|Overall Study|Other reasons|21|||
48532206|NCT00977548|156136183|FG000|Overall Study|Ineligible|4|||
48532207|NCT00977548|156136183|FG000|Overall Study|Adverse Event|8|||
48532208|NCT00977548|156136183|FG000|Overall Study|Withdrawal by Subject|1|||
48532209|NCT00988208|156136184|FG000|Overall Study|Adverse Event|71|||
48532210|NCT00988208|156136185|FG001|Overall Study|Adverse Event|122|||
48532211|NCT00988208|156136184|FG000|Overall Study|Disease Progression|103|||
48532212|NCT00988208|156136185|FG001|Overall Study|Disease Progression|89|||
48532213|NCT00988208|156136184|FG000|Overall Study|Withdrawal by Subject|50|||
48532214|NCT00988208|156136185|FG001|Overall Study|Withdrawal by Subject|57|||
48532215|NCT00988208|156136184|FG000|Overall Study|Death|9|||
48532216|NCT00988208|156136185|FG001|Overall Study|Death|15|||
48532217|NCT00988208|156136184|FG000|Overall Study|Lost to Follow-up|2|||
48834500|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
48834501|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
48834502|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
48834503|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
48834504|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
48834505|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
48834506|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
48834507|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
48834508|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
48834509|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
48834510|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
48834511|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
48834512|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
48834513|NCT00853827|157235723|FG000|Double Blind Period (103 Weeks)|Death|1|||
48532218|NCT00988208|156136185|FG001|Overall Study|Lost to Follow-up|3|||
48834514|NCT00853827|157235724|FG001|Double Blind Period (103 Weeks)|Death|6|||
48834515|NCT00771849|157235725|FG000|Overall Study|Lost to Follow-up|1|||
48834516|NCT00771849|157235726|FG001|Overall Study|Lost to Follow-up|2|||
48834517|NCT00771849|157235725|FG000|Overall Study|Withdrawal by Subject|1|||
48834518|NCT00771849|157235726|FG001|Overall Study|Withdrawal by Subject|1|||
48532219|NCT00988208|156136184|FG000|Overall Study|Protocol Violation|9|||
48532220|NCT00988208|156136185|FG001|Overall Study|Protocol Violation|2|||
48532221|NCT00988208|156136184|FG000|Overall Study|Sponsor Decision|102|||
48532222|NCT00988208|156136185|FG001|Overall Study|Sponsor Decision|78|||
48532223|NCT00988208|156136184|FG000|Overall Study|Clinical Progression|17|||
48532224|NCT00988208|156136185|FG001|Overall Study|Clinical Progression|16|||
48532225|NCT00988208|156136184|FG000|Overall Study|Biochemical Progression|21|||
48532226|NCT00988208|156136185|FG001|Overall Study|Biochemical Progression|7|||
48532227|NCT00988208|156136184|FG000|Overall Study|Clinical Deterioration|7|||
48532228|NCT00988208|156136185|FG001|Overall Study|Clinical Deterioration|14|||
48532229|NCT00988208|156136184|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
48532230|NCT00988208|156136185|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
48532231|NCT00988208|156136184|FG000|Overall Study|Other|8|||
48532232|NCT00988208|156136185|FG001|Overall Study|Other|3|||
48532233|NCT01796964|156136186|FG000|Overall Study|Adverse Event|1|||
48532234|NCT01796964|156136187|FG001|Overall Study|Adverse Event|1|||
48532235|NCT01796964|156136186|FG000|Overall Study|Death|1|||
48532236|NCT01796964|156136187|FG001|Overall Study|Death|0|||
48532237|NCT01796964|156136186|FG000|Overall Study|Protocol Violation|0|||
48532238|NCT01796964|156136187|FG001|Overall Study|Protocol Violation|1|||
48532239|NCT01796964|156136186|FG000|Overall Study|Withdrawal by Subject|1|||
48532240|NCT01796964|156136187|FG001|Overall Study|Withdrawal by Subject|1|||
48532241|NCT04858321|156136188|FG000|Overall Study|Withdrawal by Subject|3|||
48532242|NCT04025684|156136189|FG000|Overall Study|Withdrawal by Subject|1|||
48532243|NCT04025684|156136190|FG001|Overall Study|Withdrawal by Subject|1|||
48532244|NCT04025684|156136191|FG002|Overall Study|Withdrawal by Subject|0|||
48532245|NCT04025684|156136192|FG003|Overall Study|Withdrawal by Subject|0|||
48532246|NCT04025684|156136189|FG000|Overall Study|Multiple reasons|1|||
48532247|NCT04025684|156136190|FG001|Overall Study|Multiple reasons|3|||
48532248|NCT04025684|156136191|FG002|Overall Study|Multiple reasons|0|||
48532249|NCT04025684|156136192|FG003|Overall Study|Multiple reasons|1|||
48532250|NCT00981799|156136193|FG000|Overall Study|Adverse Event|1|||
48532251|NCT00981799|156136194|FG001|Overall Study|Adverse Event|1|||
48532252|NCT00981799|156136195|FG002|Overall Study|Adverse Event|0|||
48532253|NCT00981799|156136196|FG003|Overall Study|Adverse Event|0|||
48532254|NCT01201759|156136197|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
48532255|NCT01201759|156136198|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
48532256|NCT01201759|156136197|FG000|Visit 3 - Washout|Adverse Event|0|||
48532257|NCT01201759|156136198|FG001|Visit 3 - Washout|Adverse Event|3|||
48532258|NCT01201759|156136197|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
48532259|NCT01201759|156136198|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
48532260|NCT01201759|156136197|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
48532261|NCT01201759|156136198|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
48735623|NCT00304239|156883694|FG001|Overall Study|Adverse Event|0|||
48735624|NCT03576495|156883695|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
48735625|NCT03576495|156883696|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
48735626|NCT00961649|156883697|FG000|Overall Study|Adverse Event|4|||
48735627|NCT00961649|156883698|FG001|Overall Study|Adverse Event|0|||
48735628|NCT00961649|156883699|FG002|Overall Study|Adverse Event|0|||
48735629|NCT00961649|156883700|FG003|Overall Study|Adverse Event|2|||
48735630|NCT00961649|156883697|FG000|Overall Study|Inadequate control of IOP|0|||
48735631|NCT00961649|156883698|FG001|Overall Study|Inadequate control of IOP|0|||
48735632|NCT00961649|156883699|FG002|Overall Study|Inadequate control of IOP|0|||
48735633|NCT00961649|156883700|FG003|Overall Study|Inadequate control of IOP|1|||
48735634|NCT00961649|156883697|FG000|Overall Study|Patient has travel plans during holidays|0|||
48603114|NCT02100839|156402925|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
48603115|NCT04155463|156402926|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
48603116|NCT04155463|156402927|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
48603117|NCT01307787|156402929|FG000|Overall Study|Withdrawal by Subject|2|||
48603118|NCT01307787|156402930|FG001|Overall Study|Withdrawal by Subject|0|||
48603119|NCT01573000|156402933|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
48603120|NCT01573000|156402934|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
48603121|NCT01573000|156402933|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
48603122|NCT01573000|156402934|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
48603123|NCT01573000|156402933|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
48603124|NCT01573000|156402934|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
48603125|NCT01573000|156402933|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
48603126|NCT01573000|156402934|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
48603127|NCT01573000|156402933|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
48834519|NCT00771849|157235725|FG000|Overall Study|Not vaccinated|0|||
48834520|NCT00771849|157235726|FG001|Overall Study|Not vaccinated|1|||
48834521|NCT01370694|157235727|FG000|Overall Study|Switched to rituximab|4|||
48834522|NCT01370694|157235727|FG000|Overall Study|Progressive disease|2|||
48834523|NCT02736799|157235728|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
48834524|NCT02736799|157235729|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
48834525|NCT02736799|157235730|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
48834526|NCT02736799|157235731|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
48834527|NCT04842604|157235735|FG000|Overall Study|Death|1|||
48834528|NCT04842604|157235736|FG001|Overall Study|Death|0|||
48834529|NCT04842604|157235735|FG000|Overall Study|Other|4|||
48834530|NCT04842604|157235736|FG001|Overall Study|Other|4|||
48834531|NCT04842604|157235735|FG000|Overall Study|Randomized but not treated|1|||
48834532|NCT04842604|157235736|FG001|Overall Study|Randomized but not treated|0|||
48834533|NCT05046132|157235738|FG000|Overall Study|Adverse Event|4|||
48834534|NCT05046132|157235739|FG001|Overall Study|Adverse Event|0|||
48834535|NCT05046132|157235740|FG002|Overall Study|Adverse Event|0|||
48834536|NCT05046132|157235738|FG000|Overall Study|Withdrawal by Subject|3|||
48834537|NCT05046132|157235739|FG001|Overall Study|Withdrawal by Subject|0|||
48834538|NCT05046132|157235740|FG002|Overall Study|Withdrawal by Subject|0|||
48834539|NCT05046132|157235738|FG000|Overall Study|Positive Covid19 Result.|0|||
48834540|NCT05046132|157235739|FG001|Overall Study|Positive Covid19 Result.|1|||
48834541|NCT05046132|157235740|FG002|Overall Study|Positive Covid19 Result.|0|||
48834542|NCT00559949|157235741|FG000|Overall Study|Progressive Disease during cycle 1|1|||
48834543|NCT00559949|157235741|FG000|Overall Study|Adverse Event|1|||
48834544|NCT00559949|157235741|FG000|Overall Study|Withdrawal by Subject|4|||
48834545|NCT00559949|157235741|FG000|Overall Study|No disease evaluation per protocol|1|||
48834546|NCT01183780|157235742|FG000|Overall Study|Withdrawal by Subject|25|||
48834547|NCT01183780|157235743|FG001|Overall Study|Withdrawal by Subject|14|||
48834548|NCT01183780|157235742|FG000|Overall Study|Lost to Follow-up|6|||
48834549|NCT01183780|157235743|FG001|Overall Study|Lost to Follow-up|11|||
48834550|NCT04493242|157235744|FG000|Overall Study|Death|10|||
48834551|NCT04493242|157235745|FG001|Overall Study|Death|14|||
48834552|NCT04493242|157235746|FG002|Overall Study|Death|16|||
48834553|NCT04493242|157235744|FG000|Overall Study|Lost to Follow-up|1|||
48834554|NCT04493242|157235745|FG001|Overall Study|Lost to Follow-up|1|||
48834555|NCT04493242|157235746|FG002|Overall Study|Lost to Follow-up|0|||
48834556|NCT04493242|157235744|FG000|Overall Study|Withdrawal by Subject|1|||
48445109|NCT00168064|155817023|FG001|Overall Study|Lack of Efficacy|4|||
48445110|NCT00168064|155817022|FG000|Overall Study|Lost to Follow-up|4|||
48445111|NCT00168064|155817023|FG001|Overall Study|Lost to Follow-up|3|||
48445112|NCT00168064|155817022|FG000|Overall Study|Non-compliance|2|||
48445113|NCT00168064|155817023|FG001|Overall Study|Non-compliance|3|||
48445114|NCT00168064|155817022|FG000|Overall Study|Concurrent Illness|4|||
48445115|NCT00168064|155817023|FG001|Overall Study|Concurrent Illness|3|||
48445116|NCT00168064|155817022|FG000|Overall Study|Subject's Best interest|2|||
48445117|NCT00168064|155817023|FG001|Overall Study|Subject's Best interest|2|||
48445118|NCT00168064|155817022|FG000|Overall Study|Various|4|||
48445119|NCT00168064|155817023|FG001|Overall Study|Various|3|||
48603128|NCT01573000|156402934|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
48603129|NCT01573000|156402933|FG000|Crossover Phase|Lack of Efficacy|0|||
48603130|NCT01573000|156402934|FG001|Crossover Phase|Lack of Efficacy|13|||
48603131|NCT01573000|156402933|FG000|Crossover Phase|Lost to Follow-up|0|||
48603132|NCT01573000|156402934|FG001|Crossover Phase|Lost to Follow-up|2|||
48603133|NCT01573000|156402933|FG000|Crossover Phase|Death|0|||
48603134|NCT01573000|156402934|FG001|Crossover Phase|Death|3|||
48603135|NCT01573000|156402933|FG000|Long-Term Follow-Up|Death|3|||
48603136|NCT01573000|156402934|FG001|Long-Term Follow-Up|Death|0|||
48603137|NCT01573000|156402933|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
48603138|NCT01573000|156402934|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
48603139|NCT02999789|156402939|FG000|Overall Study|Withdrawal by Subject|0|||
48603140|NCT02999789|156402940|FG001|Overall Study|Withdrawal by Subject|1|||
48603141|NCT02999789|156402939|FG000|Overall Study|Became ineligible|1|||
48603142|NCT02999789|156402940|FG001|Overall Study|Became ineligible|2|||
48603143|NCT03713684|156402942|FG000|Overall Study|Adverse Event|1|||
48603144|NCT03713684|156402943|FG001|Overall Study|Adverse Event|3|||
48603145|NCT03713684|156402944|FG002|Overall Study|Adverse Event|1|||
48603146|NCT03713684|156402945|FG003|Overall Study|Adverse Event|0|||
48603147|NCT03713684|156402942|FG000|Overall Study|Poor compliance to protocol|2|||
48603148|NCT03713684|156402943|FG001|Overall Study|Poor compliance to protocol|1|||
48603149|NCT03713684|156402944|FG002|Overall Study|Poor compliance to protocol|0|||
48603150|NCT03713684|156402945|FG003|Overall Study|Poor compliance to protocol|1|||
48603151|NCT03713684|156402942|FG000|Overall Study|Withdrawal by Subject|14|||
48603152|NCT03713684|156402943|FG001|Overall Study|Withdrawal by Subject|6|||
48603153|NCT03713684|156402944|FG002|Overall Study|Withdrawal by Subject|14|||
48603154|NCT03713684|156402945|FG003|Overall Study|Withdrawal by Subject|16|||
48603155|NCT03713684|156402942|FG000|Overall Study|Other than specified|69|||
48603156|NCT03713684|156402943|FG001|Overall Study|Other than specified|77|||
48603157|NCT03713684|156402944|FG002|Overall Study|Other than specified|73|||
48603158|NCT03713684|156402945|FG003|Overall Study|Other than specified|70|||
48603159|NCT00249873|156402946|FG000|Overall Study|Not treated|7|||
48603160|NCT00249873|156402947|FG001|Overall Study|Not treated|8|||
48603161|NCT00249873|156402946|FG000|Overall Study|Significant thrombocytopenia|9|||
48603162|NCT00249873|156402947|FG001|Overall Study|Significant thrombocytopenia|8|||
48603163|NCT00249873|156402946|FG000|Overall Study|Severe allergic reaction|8|||
48603164|NCT00249873|156402947|FG001|Overall Study|Severe allergic reaction|1|||
48603165|NCT00249873|156402946|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
48603166|NCT00249873|156402947|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
48603167|NCT00249873|156402946|FG000|Overall Study|Other Serious Adverse Event|86|||
48603168|NCT00249873|156402947|FG001|Overall Study|Other Serious Adverse Event|97|||
48603169|NCT00249873|156402946|FG000|Overall Study|Qualifying condition not present|20|||
48603170|NCT00249873|156402947|FG001|Overall Study|Qualifying condition not present|23|||
48603171|NCT00249873|156402946|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
48603172|NCT00249873|156402947|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
48603173|NCT00249873|156402946|FG000|Overall Study|Withdrawal by Subject|504|||
48603174|NCT00249873|156402947|FG001|Overall Study|Withdrawal by Subject|466|||
48603175|NCT00249873|156402946|FG000|Overall Study|Lost to Follow-up|4|||
48603176|NCT00249873|156402947|FG001|Overall Study|Lost to Follow-up|7|||
48603177|NCT00249873|156402946|FG000|Overall Study|Minor bleeding|99|||
48603178|NCT00249873|156402947|FG001|Overall Study|Minor bleeding|37|||
48603179|NCT00249873|156402946|FG000|Overall Study|Non-compliance|41|||
48603180|NCT00249873|156402947|FG001|Overall Study|Non-compliance|46|||
48603181|NCT00249873|156402946|FG000|Overall Study|Other non serious Adverse Event|112|||
48603182|NCT00249873|156402947|FG001|Overall Study|Other non serious Adverse Event|108|||
48603183|NCT00249873|156402946|FG000|Overall Study|Other contraindicated medication|1|||
48603184|NCT00249873|156402947|FG001|Overall Study|Other contraindicated medication|0|||
48603185|NCT00249873|156402946|FG000|Overall Study|Patient not wish to continue after May08|3|||
48603186|NCT00249873|156402947|FG001|Overall Study|Patient not wish to continue after May08|4|||
48603187|NCT00249873|156402946|FG000|Overall Study|Physician withdrew consent|59|||
48603188|NCT00249873|156402947|FG001|Overall Study|Physician withdrew consent|60|||
48603189|NCT00249873|156402946|FG000|Overall Study|Open label clopidogrel required|31|||
48603190|NCT00249873|156402947|FG001|Overall Study|Open label clopidogrel required|42|||
48603191|NCT00249873|156402946|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
48603192|NCT00249873|156402947|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
48603193|NCT00249873|156402946|FG000|Overall Study|Oral anticoagulant required|159|||
48603194|NCT00249873|156402947|FG001|Overall Study|Oral anticoagulant required|157|||
48603195|NCT00249873|156402946|FG000|Overall Study|Study drug intolerance|5|||
48603196|NCT00249873|156402947|FG001|Overall Study|Study drug intolerance|0|||
48603197|NCT00249873|156402946|FG000|Overall Study|Surgery/ procedure|9|||
48603198|NCT00249873|156402947|FG001|Overall Study|Surgery/ procedure|9|||
48834557|NCT04493242|157235745|FG001|Overall Study|Withdrawal by Subject|0|||
48603199|NCT00249873|156402946|FG000|Overall Study|Event related to cardiac condition|12|||
48603200|NCT00249873|156402947|FG001|Overall Study|Event related to cardiac condition|21|||
48603201|NCT00249873|156402946|FG000|Overall Study|Thromboembolic/outcome event|82|||
48834558|NCT04493242|157235746|FG002|Overall Study|Withdrawal by Subject|0|||
48834559|NCT04493242|157235744|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
48834560|NCT04493242|157235745|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
48834561|NCT04493242|157235746|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
48834562|NCT04493242|157235744|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
48834563|NCT04493242|157235745|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
48834564|NCT04493242|157235746|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
48834565|NCT00754936|157235749|FG000|Overall Study|Lost to Follow-up|3|||
48834566|NCT00754936|157235749|FG000|Overall Study|Physician Decision|1|||
48834567|NCT00754936|157235749|FG000|Overall Study|Withdrawal by Subject|2|||
48834568|NCT00754936|157235749|FG000|Overall Study|Side Effects|3|||
48834569|NCT00754936|157235749|FG000|Overall Study|Inter-current medical events|3|||
48834570|NCT00530842|157235752|FG000|Overall Study|Adverse Event|10|||
48834571|NCT00530842|157235753|FG001|Overall Study|Adverse Event|6|||
48834572|NCT00530842|157235752|FG000|Overall Study|Lack of Efficacy|2|||
48834573|NCT00530842|157235753|FG001|Overall Study|Lack of Efficacy|1|||
48834574|NCT00530842|157235752|FG000|Overall Study|Lost to Follow-up|0|||
48834575|NCT00530842|157235753|FG001|Overall Study|Lost to Follow-up|4|||
48834576|NCT00530842|157235752|FG000|Overall Study|Protocol Violation|3|||
48834577|NCT00530842|157235753|FG001|Overall Study|Protocol Violation|2|||
48834578|NCT00530842|157235752|FG000|Overall Study|Withdrawal by Subject|4|||
48834579|NCT00530842|157235753|FG001|Overall Study|Withdrawal by Subject|5|||
48834580|NCT00530842|157235752|FG000|Overall Study|Individual different reasons|4|||
48834581|NCT00530842|157235753|FG001|Overall Study|Individual different reasons|3|||
48834582|NCT00530842|157235752|FG000|Period 1|Adverse Event|7|||
48834583|NCT00530842|157235753|FG001|Period 1|Adverse Event|3|||
48834584|NCT00530842|157235752|FG000|Period 1|Lack of Efficacy|1|||
48834585|NCT00530842|157235753|FG001|Period 1|Lack of Efficacy|1|||
48834586|NCT00530842|157235752|FG000|Period 1|Protocol Violation|2|||
48834587|NCT00530842|157235753|FG001|Period 1|Protocol Violation|1|||
48834588|NCT00530842|157235752|FG000|Period 1|Withdrawal by Subject|2|||
48834589|NCT00530842|157235753|FG001|Period 1|Withdrawal by Subject|3|||
48834590|NCT00530842|157235752|FG000|Period 1|Individual different reasons|2|||
48834591|NCT00530842|157235753|FG001|Period 1|Individual different reasons|3|||
48834592|NCT00530842|157235752|FG000|Period 2|Adverse Event|3|||
48834593|NCT00530842|157235753|FG001|Period 2|Adverse Event|3|||
48834594|NCT00530842|157235752|FG000|Period 2|Lack of Efficacy|1|||
48834595|NCT00530842|157235753|FG001|Period 2|Lack of Efficacy|0|||
48834596|NCT00530842|157235752|FG000|Period 2|Lost to Follow-up|0|||
48834597|NCT00530842|157235753|FG001|Period 2|Lost to Follow-up|4|||
48834598|NCT00530842|157235752|FG000|Period 2|Protocol Violation|1|||
48834599|NCT00530842|157235753|FG001|Period 2|Protocol Violation|0|||
48834600|NCT00530842|157235752|FG000|Period 2|Withdrawal by Subject|1|||
48834601|NCT00530842|157235753|FG001|Period 2|Withdrawal by Subject|2|||
48834602|NCT00530842|157235752|FG000|Period 2|Individual different reasons|2|||
48834603|NCT00530842|157235753|FG001|Period 2|Individual different reasons|0|||
48834604|NCT00835380|157235756|FG000|Overall Study|Withdrawal by Subject|2|||
48834605|NCT02950558|157235758|FG000|Overall Study|Lost to Follow-up|2|||
48834606|NCT02950558|157235759|FG001|Overall Study|Lost to Follow-up|0|||
48834607|NCT00319436|157235762|FG000|Overall Study|Withdrawal by Subject|6|||
48834608|NCT00319436|157235763|FG001|Overall Study|Withdrawal by Subject|7|||
48834609|NCT02000817|157235768|FG000|Overall Study|Withdrawal by Subject|2|||
48834610|NCT02000817|157235769|FG001|Overall Study|Withdrawal by Subject|0|||
48834611|NCT02000817|157235770|FG002|Overall Study|Withdrawal by Subject|0|||
48834612|NCT02000817|157235771|FG003|Overall Study|Withdrawal by Subject|0|||
48834613|NCT02000817|157235768|FG000|Overall Study|Adverse Event|0|||
48834614|NCT02000817|157235769|FG001|Overall Study|Adverse Event|1|||
48834615|NCT02000817|157235770|FG002|Overall Study|Adverse Event|0|||
48834616|NCT02000817|157235771|FG003|Overall Study|Adverse Event|0|||
48834617|NCT02000817|157235768|FG000|Overall Study|Lost to Follow-up|0|||
48834618|NCT02000817|157235769|FG001|Overall Study|Lost to Follow-up|0|||
48834619|NCT02000817|157235770|FG002|Overall Study|Lost to Follow-up|1|||
48532262|NCT01539083|156136201|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
48834620|NCT02000817|157235771|FG003|Overall Study|Lost to Follow-up|0|||
48834621|NCT01792830|157235775|FG000|Overall Study|Withdrawal by Subject|22|||
48532263|NCT01539083|156136202|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
48532264|NCT01539083|156136203|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
48532265|NCT01539083|156136201|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
48532266|NCT01539083|156136202|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
48532267|NCT01539083|156136203|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
48532268|NCT01539083|156136201|FG000|Before Randomization (VCD Induction)|Death|6|||
48532269|NCT01539083|156136202|FG001|Before Randomization (VCD Induction)|Death|0|||
48532270|NCT01539083|156136203|FG002|Before Randomization (VCD Induction)|Death|0|||
48532271|NCT01539083|156136201|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
48532272|NCT01539083|156136202|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
48532273|NCT01539083|156136203|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
48834622|NCT01792830|157235776|FG001|Overall Study|Withdrawal by Subject|0|||
48834623|NCT01792830|157235777|FG002|Overall Study|Withdrawal by Subject|0|||
48834624|NCT01792830|157235778|FG003|Overall Study|Withdrawal by Subject|2|||
48834625|NCT01792830|157235779|FG004|Overall Study|Withdrawal by Subject|1|||
48834626|NCT01792830|157235780|FG005|Overall Study|Withdrawal by Subject|1|||
48834627|NCT01792830|157235781|FG006|Overall Study|Withdrawal by Subject|1|||
48834628|NCT01792830|157235782|FG007|Overall Study|Withdrawal by Subject|1|||
48834629|NCT01792830|157235783|FG008|Overall Study|Withdrawal by Subject|7|||
48834630|NCT01792830|157235784|FG009|Overall Study|Withdrawal by Subject|0|||
48834631|NCT01792830|157235785|FG010|Overall Study|Withdrawal by Subject|2|||
48532274|NCT01539083|156136201|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
48532275|NCT01539083|156136202|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
48532276|NCT01539083|156136203|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
48532277|NCT01539083|156136201|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
48532278|NCT01539083|156136202|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
48532279|NCT01539083|156136203|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
48532280|NCT01539083|156136201|FG000|Before Randomization (VCD Induction)|Other|5|||
48532281|NCT01539083|156136202|FG001|Before Randomization (VCD Induction)|Other|0|||
48834632|NCT01792830|157235775|FG000|Overall Study|Death|3|||
48834633|NCT01792830|157235776|FG001|Overall Study|Death|0|||
48834634|NCT01792830|157235777|FG002|Overall Study|Death|0|||
48834635|NCT01792830|157235778|FG003|Overall Study|Death|1|||
48834636|NCT01792830|157235779|FG004|Overall Study|Death|0|||
48834637|NCT01792830|157235780|FG005|Overall Study|Death|0|||
48834638|NCT01792830|157235781|FG006|Overall Study|Death|1|||
48834639|NCT01792830|157235782|FG007|Overall Study|Death|0|||
48834640|NCT01792830|157235783|FG008|Overall Study|Death|1|||
48834641|NCT01792830|157235784|FG009|Overall Study|Death|0|||
48834642|NCT01792830|157235785|FG010|Overall Study|Death|1|||
48834643|NCT01792830|157235775|FG000|Overall Study|Adverse Event|0|||
48834644|NCT01792830|157235776|FG001|Overall Study|Adverse Event|0|||
48834645|NCT01792830|157235777|FG002|Overall Study|Adverse Event|0|||
48834646|NCT01792830|157235778|FG003|Overall Study|Adverse Event|0|||
48834647|NCT01792830|157235779|FG004|Overall Study|Adverse Event|0|||
48834648|NCT01792830|157235780|FG005|Overall Study|Adverse Event|0|||
48834649|NCT01792830|157235781|FG006|Overall Study|Adverse Event|0|||
48834650|NCT01792830|157235782|FG007|Overall Study|Adverse Event|0|||
48834651|NCT01792830|157235783|FG008|Overall Study|Adverse Event|1|||
48834652|NCT01792830|157235784|FG009|Overall Study|Adverse Event|0|||
48834653|NCT01792830|157235785|FG010|Overall Study|Adverse Event|0|||
48834654|NCT00547118|157235786|FG000|Overall Study|Did not qualify prior to starting drug|1|||
48834655|NCT00547118|157235787|FG001|Overall Study|Did not qualify prior to starting drug|1|||
48834656|NCT00547118|157235786|FG000|Overall Study|Study suspended|7|||
48834657|NCT00547118|157235787|FG001|Overall Study|Study suspended|8|||
48834658|NCT00539292|157235788|FG000|Overall Study|Physician Decision|1|||
48834659|NCT00539292|157235789|FG001|Overall Study|Physician Decision|0|||
48834660|NCT02685488|157235793|FG000|Overall Study|Withdrawal by Subject|0|||
48834661|NCT02685488|157235794|FG001|Overall Study|Withdrawal by Subject|1|||
48834662|NCT02621424|157235795|FG000|Overall Study|Withdrawal by Subject|1|||
48834663|NCT02621424|157235796|FG001|Overall Study|Withdrawal by Subject|2|||
48834664|NCT00305695|157235799|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
48834665|NCT00305695|157235800|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
48834666|NCT00305695|157235799|FG000|Overall Study|Did not have baseline scan|1|||
48834667|NCT00305695|157235800|FG001|Overall Study|Did not have baseline scan|1|||
48834668|NCT01697319|157235802|FG000|Primary Phase|Withdrawal by Subject|1|||
48834669|NCT01697319|157235802|FG000|Extension Phase|Terminated by Sponsor|15|||
48834670|NCT04222959|157235806|FG000|Overall Study|Lost to Follow-up|76|||
48834671|NCT04222959|157235807|FG001|Overall Study|Lost to Follow-up|28|||
48834672|NCT00794118|157235808|FG000|Overall Study|Lost to Follow-up|16|||
48834673|NCT00794118|157235808|FG000|Overall Study|Withdrawal by Subject|9|||
48834674|NCT00794118|157235808|FG000|Overall Study|Changed hospital center|2|||
48834675|NCT02918071|157235809|FG000|Overall Study|Withdrawal by Subject|2|||
48834676|NCT02918071|157235809|FG000|Overall Study|Lost to Follow-up|1|||
48834677|NCT01251354|157235816|FG000|Overall Study|Adverse Event|1|||
48834678|NCT01251354|157235816|FG000|Overall Study|Investigator's Decision|1|||
48834679|NCT01251354|157235816|FG000|Overall Study|Disease Progression|4|||
48834680|NCT04057196|157237042|FG000|Overall Study|Withdrawal by Subject|3|||
48834681|NCT04057196|157237042|FG000|Overall Study|Death|3|||
48834682|NCT03439124|157237043|FG000|Overall Study|Adverse Event|2|||
48834683|NCT03439124|157237044|FG001|Overall Study|Adverse Event|0|||
48834684|NCT03439124|157237043|FG000|Overall Study|Lost to Follow-up|1|||
48834685|NCT03439124|157237044|FG001|Overall Study|Lost to Follow-up|0|||
48834686|NCT03439124|157237043|FG000|Overall Study|Other reasons|1|||
48834687|NCT03439124|157237044|FG001|Overall Study|Other reasons|0|||
48834688|NCT00918957|157237047|FG000|Overall Study|Adverse Event|2|||
48834689|NCT00918957|157237048|FG001|Overall Study|Adverse Event|0|||
48532282|NCT01539083|156136203|FG002|Before Randomization (VCD Induction)|Other|0|||
48532283|NCT01539083|156136201|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
48532284|NCT01539083|156136202|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
48532285|NCT01539083|156136203|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
48532286|NCT01539083|156136201|FG000|After Randomization (TP and VTP)|Other|0|||
48532287|NCT01539083|156136202|FG001|After Randomization (TP and VTP)|Other|1|||
48603202|NCT00249873|156402947|FG001|Overall Study|Thromboembolic/outcome event|122|||
48603203|NCT00928434|156402954|FG000|Overall Study|Adverse Event|14|||
48603204|NCT00928434|156402955|FG001|Overall Study|Adverse Event|5|||
48603205|NCT00928434|156402956|FG002|Overall Study|Adverse Event|18|||
48603206|NCT00928434|156402954|FG000|Overall Study|Protocol Violation|5|||
48603207|NCT00928434|156402955|FG001|Overall Study|Protocol Violation|0|||
48603208|NCT00928434|156402956|FG002|Overall Study|Protocol Violation|8|||
48603209|NCT00928434|156402954|FG000|Overall Study|Physician Decision|2|||
48603210|NCT00928434|156402955|FG001|Overall Study|Physician Decision|0|||
48603211|NCT00928434|156402956|FG002|Overall Study|Physician Decision|3|||
48603212|NCT00928434|156402954|FG000|Overall Study|Lost to Follow-up|1|||
48603213|NCT00928434|156402955|FG001|Overall Study|Lost to Follow-up|0|||
48603214|NCT00928434|156402956|FG002|Overall Study|Lost to Follow-up|3|||
48603215|NCT00928434|156402954|FG000|Overall Study|Withdrawal by Subject|5|||
48603216|NCT00928434|156402955|FG001|Overall Study|Withdrawal by Subject|3|||
48603217|NCT00928434|156402956|FG002|Overall Study|Withdrawal by Subject|2|||
48603218|NCT00928434|156402954|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
48603219|NCT00928434|156402955|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
48603220|NCT00928434|156402956|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
48603221|NCT00928434|156402954|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
48603222|NCT00928434|156402955|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
48603223|NCT00928434|156402956|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
48603224|NCT00928434|156402954|FG000|Overall Study|Other (not meeting above criteria)|5|||
48603225|NCT00928434|156402955|FG001|Overall Study|Other (not meeting above criteria)|1|||
48603226|NCT00928434|156402956|FG002|Overall Study|Other (not meeting above criteria)|2|||
48603227|NCT00752089|156402961|FG000|Overall Study|Adverse Event|1|||
48603228|NCT00752089|156402961|FG000|Overall Study|Protocol Deviation|2|||
48603229|NCT00752089|156402961|FG000|Overall Study|Could not attend visit 9|1|||
48603230|NCT00752089|156402961|FG000|Overall Study|Not capable of wearing partial denture|1|||
48603231|NCT00752089|156402961|FG000|Overall Study|Cannot continue the study|1|||
48603232|NCT00468585|156402964|FG000|Overall Study|Patient not treated|1|||
48603233|NCT00468585|156402965|FG001|Overall Study|Patient not treated|0|||
48603234|NCT00468585|156402966|FG002|Overall Study|Patient not treated|1|||
48834690|NCT00918957|157237047|FG000|Overall Study|Withdrawal by Subject|1|||
48834691|NCT00918957|157237048|FG001|Overall Study|Withdrawal by Subject|0|||
48532288|NCT01539083|156136203|FG002|After Randomization (TP and VTP)|Other|1|||
48532289|NCT01539083|156136201|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
48532290|NCT01539083|156136202|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
48532291|NCT01539083|156136203|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
48532292|NCT01539083|156136201|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
48532293|NCT01539083|156136202|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
48532294|NCT01539083|156136203|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
48532295|NCT01539083|156136201|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
48532296|NCT01539083|156136202|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
48532297|NCT01539083|156136203|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
48532298|NCT01539083|156136201|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
48532299|NCT01539083|156136202|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
48834692|NCT04464421|157237049|FG000|Overall Study|Lost to Follow-up|2|||
48834693|NCT04464421|157237050|FG001|Overall Study|Lost to Follow-up|2|||
48834694|NCT00487578|157237051|FG000|Overall Study|Adverse Event|1|||
48834695|NCT00487578|157237052|FG001|Overall Study|Adverse Event|2|||
48834696|NCT00487578|157237051|FG000|Overall Study|Lack of Efficacy|0|||
48834697|NCT00487578|157237052|FG001|Overall Study|Lack of Efficacy|1|||
48834698|NCT00487578|157237051|FG000|Overall Study|Lost to Follow-up|0|||
48532300|NCT01539083|156136203|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
48532301|NCT01539083|156136201|FG000|After Randomization (TP and VTP)|Death|0|||
48603235|NCT00468585|156402967|FG003|Overall Study|Patient not treated|0|||
48603236|NCT00468585|156402964|FG000|Overall Study|Patient found to be ineligible|0|||
48603237|NCT00468585|156402965|FG001|Overall Study|Patient found to be ineligible|0|||
48603238|NCT00468585|156402966|FG002|Overall Study|Patient found to be ineligible|1|||
48603239|NCT00468585|156402967|FG003|Overall Study|Patient found to be ineligible|0|||
48603240|NCT00468585|156402964|FG000|Overall Study|Adverse Event|0|||
48603241|NCT00468585|156402965|FG001|Overall Study|Adverse Event|0|||
48603242|NCT00468585|156402966|FG002|Overall Study|Adverse Event|1|||
48834699|NCT00487578|157237052|FG001|Overall Study|Lost to Follow-up|1|||
48834700|NCT00768664|157237053|FG000|Overall Study|Death|57|||
48834701|NCT00768664|157237053|FG000|Overall Study|Lost to Follow-up|2|||
48532302|NCT01539083|156136202|FG001|After Randomization (TP and VTP)|Death|6|||
48834702|NCT00768664|157237053|FG000|Overall Study|Other|9|||
48834703|NCT00768664|157237053|FG000|Overall Study|Participant refused|1|||
48834704|NCT00726999|157237058|FG000|Overall Study|Physician Decision|0|||
48834705|NCT00726999|157237059|FG001|Overall Study|Physician Decision|1|||
48834706|NCT00726999|157237058|FG000|Overall Study|Withdrawal by Subject|2|||
48834707|NCT00726999|157237059|FG001|Overall Study|Withdrawal by Subject|0|||
48834708|NCT00726999|157237058|FG000|Overall Study|Protocol Violation|1|||
48834709|NCT00726999|157237059|FG001|Overall Study|Protocol Violation|0|||
48834710|NCT04480827|157237060|FG000|Overall Study|Adverse Event|0|||
48834711|NCT04480827|157237061|FG001|Overall Study|Adverse Event|0|||
48834712|NCT04480827|157237062|FG002|Overall Study|Adverse Event|0|||
48834713|NCT04480827|157237063|FG003|Overall Study|Adverse Event|0|||
48834714|NCT04480827|157237064|FG004|Overall Study|Adverse Event|0|||
48834715|NCT04480827|157237065|FG005|Overall Study|Adverse Event|1|||
48834716|NCT04480827|157237066|FG006|Overall Study|Adverse Event|0|||
48834717|NCT05257798|157237067|FG000|Follow-up Phase|Lost to Follow-up|1|||
48834718|NCT05257798|157237068|FG001|Follow-up Phase|Lost to Follow-up|0|||
48532303|NCT01539083|156136203|FG002|After Randomization (TP and VTP)|Death|11|||
48532304|NCT00906373|156136204|FG000|Overall Study|Withdrawal by Subject|0|||
48532305|NCT00906373|156136205|FG001|Overall Study|Withdrawal by Subject|5|||
48532306|NCT00906373|156136204|FG000|Overall Study|Other|0|||
48532307|NCT00906373|156136205|FG001|Overall Study|Other|1|||
48532308|NCT00906373|156136204|FG000|Overall Study|Still on treatment at cutoff date|0|||
48532309|NCT00906373|156136205|FG001|Overall Study|Still on treatment at cutoff date|2|||
48532310|NCT01844531|156136206|FG000|Overall Study|Withdrawal by Subject|0|||
48532311|NCT01844531|156136207|FG001|Overall Study|Withdrawal by Subject|1|||
48532312|NCT01844531|156136208|FG002|Overall Study|Withdrawal by Subject|0|||
48532313|NCT01844531|156136209|FG003|Overall Study|Withdrawal by Subject|0|||
48532314|NCT02070757|156136210|FG000|Overall Study|Adverse Event|107|||
48532315|NCT02070757|156136211|FG001|Overall Study|Adverse Event|99|||
48532316|NCT02070757|156136210|FG000|Overall Study|Lost to Follow-up|7|||
48532317|NCT02070757|156136211|FG001|Overall Study|Lost to Follow-up|4|||
48532318|NCT02070757|156136210|FG000|Overall Study|Protocol Violation|0|||
48532319|NCT02070757|156136211|FG001|Overall Study|Protocol Violation|4|||
48532320|NCT02070757|156136210|FG000|Overall Study|Withdrawal by Subject|1|||
48532321|NCT02070757|156136211|FG001|Overall Study|Withdrawal by Subject|3|||
48532322|NCT02070757|156136210|FG000|Overall Study|Investigator Decision|0|||
48532323|NCT02070757|156136211|FG001|Overall Study|Investigator Decision|2|||
48532324|NCT02070757|156136210|FG000|Overall Study|Discharged from Study Hospital|2|||
48532325|NCT02070757|156136211|FG001|Overall Study|Discharged from Study Hospital|2|||
48532326|NCT03733925|156136216|FG000|Overall Study|Lost to Follow-up|1|||
48532327|NCT03733925|156136216|FG000|Overall Study|Withdrawal by Subject|2|||
48532328|NCT03733925|156136216|FG000|Overall Study|Adverse Event|2|||
48532329|NCT03733925|156136216|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48532330|NCT04780581|156136219|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
48532331|NCT04780581|156136220|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
48532332|NCT04780581|156136219|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
48532333|NCT04780581|156136220|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
48532334|NCT01501110|156136221|FG000|Overall Study|Death|0|||
48532335|NCT01501110|156136222|FG001|Overall Study|Death|1|||
48532336|NCT02274948|156136223|FG000|Overall Study|Lost to Follow-up|28|||
48532337|NCT02274948|156136224|FG001|Overall Study|Lost to Follow-up|25|||
48532338|NCT02274948|156136223|FG000|Overall Study|Withdrawal by Subject|64|||
48532339|NCT02274948|156136224|FG001|Overall Study|Withdrawal by Subject|58|||
48532340|NCT02274948|156136223|FG000|Overall Study|Stopped on family Practitioner advice|2|||
48532341|NCT02274948|156136224|FG001|Overall Study|Stopped on family Practitioner advice|5|||
48532342|NCT02274948|156136223|FG000|Overall Study|Left the area|4|||
48532343|NCT02274948|156136224|FG001|Overall Study|Left the area|3|||
48532344|NCT02751827|156136225|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
48532345|NCT02751827|156136226|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
48834719|NCT00419094|157237072|FG000|Overall Study|Adverse Event|3|||
48532346|NCT02751827|156136227|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
48532347|NCT02542631|156136230|FG000|Overall Study|Adverse Event|1|||
48532348|NCT02542631|156136231|FG001|Overall Study|Adverse Event|1|||
48532349|NCT02542631|156136230|FG000|Overall Study|Sponsor Termination|1|||
48532350|NCT02542631|156136231|FG001|Overall Study|Sponsor Termination|0|||
48532351|NCT02542631|156136230|FG000|Overall Study|Withdrawal by Subject|11|||
48532352|NCT02542631|156136231|FG001|Overall Study|Withdrawal by Subject|16|||
48532353|NCT02542631|156136230|FG000|Overall Study|Protocol Violation|1|||
48834720|NCT00419094|157237073|FG001|Overall Study|Adverse Event|7|||
48834721|NCT00419094|157237072|FG000|Overall Study|Lack of Efficacy|1|||
48834722|NCT00419094|157237073|FG001|Overall Study|Lack of Efficacy|0|||
48834723|NCT00419094|157237072|FG000|Overall Study|Lost to Follow-up|0|||
48834724|NCT00419094|157237073|FG001|Overall Study|Lost to Follow-up|2|||
48834725|NCT00419094|157237072|FG000|Overall Study|Protocol Violation|1|||
48834726|NCT00419094|157237073|FG001|Overall Study|Protocol Violation|14|||
48532354|NCT02542631|156136231|FG001|Overall Study|Protocol Violation|1|||
48532355|NCT02542631|156136230|FG000|Overall Study|Physician Decision|6|||
48532356|NCT02542631|156136231|FG001|Overall Study|Physician Decision|4|||
48532357|NCT02542631|156136230|FG000|Overall Study|Lost to Follow-up|6|||
48532358|NCT02542631|156136231|FG001|Overall Study|Lost to Follow-up|5|||
48532359|NCT02542631|156136230|FG000|Overall Study|Death|1|||
48532360|NCT02542631|156136231|FG001|Overall Study|Death|2|||
48532361|NCT02542631|156136230|FG000|Overall Study|Other|2|||
48532362|NCT02542631|156136231|FG001|Overall Study|Other|1|||
48532363|NCT02542631|156136230|FG000|Overall Study|Used Prohibited Medication|2|||
48532364|NCT02542631|156136231|FG001|Overall Study|Used Prohibited Medication|1|||
48834727|NCT00419094|157237072|FG000|Overall Study|Withdrawal of consent|1|||
48834728|NCT00419094|157237073|FG001|Overall Study|Withdrawal of consent|5|||
48834729|NCT00419094|157237072|FG000|Overall Study|Other: Error determining exit criteria|1|||
48834730|NCT00419094|157237073|FG001|Overall Study|Other: Error determining exit criteria|0|||
48834731|NCT00419094|157237072|FG000|Overall Study|Other: Patient non-compliant|0|||
48834732|NCT00419094|157237073|FG001|Overall Study|Other: Patient non-compliant|1|||
48834733|NCT00419094|157237072|FG000|Overall Study|Other: No contact for extended period|0|||
48834734|NCT00419094|157237073|FG001|Overall Study|Other: No contact for extended period|1|||
48834735|NCT00814346|157237074|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
48834736|NCT00814346|157237075|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
48532365|NCT00467831|156136232|FG000|Overall Study|Death|2|||
48532366|NCT00467831|156136232|FG000|Overall Study|Withdrawal by Subject|1|||
48532367|NCT04271046|156136235|FG000|Overall Study|Death|0|||
48532368|NCT04271046|156136236|FG001|Overall Study|Death|2|||
48532369|NCT04271046|156136237|FG002|Overall Study|Death|0|||
48532370|NCT04271046|156136238|FG003|Overall Study|Death|2|||
48532371|NCT04271046|156136235|FG000|Overall Study|Lost to Follow-up|12|||
48532372|NCT04271046|156136236|FG001|Overall Study|Lost to Follow-up|12|||
48532373|NCT04271046|156136237|FG002|Overall Study|Lost to Follow-up|11|||
48532374|NCT04271046|156136238|FG003|Overall Study|Lost to Follow-up|11|||
48532375|NCT04271046|156136235|FG000|Overall Study|Patient with Dementia Died|2|||
48532376|NCT04271046|156136236|FG001|Overall Study|Patient with Dementia Died|0|||
48532377|NCT04271046|156136237|FG002|Overall Study|Patient with Dementia Died|2|||
48532378|NCT04271046|156136238|FG003|Overall Study|Patient with Dementia Died|0|||
48532379|NCT04271046|156136235|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
48834737|NCT00814346|157237074|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
48834738|NCT00814346|157237075|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
48834739|NCT00814346|157237074|FG000|Open Phase (17 Months)|Adverse Event|5|||
48834740|NCT00814346|157237075|FG001|Open Phase (17 Months)|Adverse Event|0|||
48834741|NCT00814346|157237074|FG000|Open Phase (17 Months)|Consent|2|||
48834742|NCT00814346|157237075|FG001|Open Phase (17 Months)|Consent|0|||
48834743|NCT00814346|157237074|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
48834744|NCT00814346|157237075|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
48834745|NCT00814346|157237074|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
48834746|NCT00814346|157237075|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
48532380|NCT04271046|156136236|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
48532381|NCT04271046|156136237|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
48532382|NCT04271046|156136238|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
48532383|NCT03739138|156136239|FG000|Overall Study|Death|0|||
48532384|NCT03739138|156136240|FG001|Overall Study|Death|7|||
48532385|NCT03739138|156136241|FG002|Overall Study|Death|4|||
48532386|NCT03739138|156136242|FG003|Overall Study|Death|13|||
48532387|NCT03739138|156136243|FG004|Overall Study|Death|0|||
48532388|NCT03739138|156136239|FG000|Overall Study|Lost to Follow-up|0|||
48532389|NCT03739138|156136240|FG001|Overall Study|Lost to Follow-up|0|||
48532390|NCT03739138|156136241|FG002|Overall Study|Lost to Follow-up|1|||
48532391|NCT03739138|156136242|FG003|Overall Study|Lost to Follow-up|0|||
48532392|NCT03739138|156136243|FG004|Overall Study|Lost to Follow-up|0|||
48532393|NCT03739138|156136239|FG000|Overall Study|Study Terminated By Sponsor|0|||
48532394|NCT03739138|156136240|FG001|Overall Study|Study Terminated By Sponsor|0|||
48532395|NCT03739138|156136241|FG002|Overall Study|Study Terminated By Sponsor|0|||
48532396|NCT03739138|156136242|FG003|Overall Study|Study Terminated By Sponsor|4|||
48532397|NCT03739138|156136243|FG004|Overall Study|Study Terminated By Sponsor|0|||
48532398|NCT03739138|156136239|FG000|Overall Study|Withdrawal by Subject|0|||
48532399|NCT03739138|156136240|FG001|Overall Study|Withdrawal by Subject|0|||
48532400|NCT03739138|156136241|FG002|Overall Study|Withdrawal by Subject|0|||
48532401|NCT03739138|156136242|FG003|Overall Study|Withdrawal by Subject|1|||
48532402|NCT03739138|156136243|FG004|Overall Study|Withdrawal by Subject|0|||
48834747|NCT05136443|157237078|FG000|Overall Study|Lost to Follow-up|2|||
48834748|NCT05136443|157237078|FG000|Overall Study|Adverse Event|2|||
48834749|NCT04580303|157237080|FG000|Overall Study|Adverse Event|0|||
48532403|NCT00631475|156136244|FG000|Overall Study|Death|18|||
48532404|NCT00631475|156136244|FG000|Overall Study|Adverse Event|14|||
48532405|NCT00631475|156136244|FG000|Overall Study|Withdrew consent|5|||
48532406|NCT00631475|156136244|FG000|Overall Study|Preparation for lung transplant|8|||
48532407|NCT00823199|156136245|FG000|Overall Study|Withdrawal by Subject|2|||
48603243|NCT00468585|156402967|FG003|Overall Study|Adverse Event|0|||
48603244|NCT00468585|156402964|FG000|Overall Study|Withdrawal by Subject|0|||
48834750|NCT04580303|157237081|FG001|Overall Study|Adverse Event|1|||
48834751|NCT04580303|157237082|FG002|Overall Study|Adverse Event|0|||
48834752|NCT04580303|157237083|FG003|Overall Study|Adverse Event|0|||
48834753|NCT04580303|157237080|FG000|Overall Study|Withdrawal by Subject|0|||
48834754|NCT04580303|157237081|FG001|Overall Study|Withdrawal by Subject|0|||
48834755|NCT04580303|157237082|FG002|Overall Study|Withdrawal by Subject|1|||
48834756|NCT04580303|157237083|FG003|Overall Study|Withdrawal by Subject|0|||
48834757|NCT00753012|157237084|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
48834758|NCT00753012|157237085|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
48834759|NCT00753012|157237084|FG000|Overall Study|Adverse Event|2|||
48834760|NCT00753012|157237085|FG001|Overall Study|Adverse Event|0|||
48834761|NCT00753012|157237084|FG000|Overall Study|Withdrawal by Subject|0|||
48834762|NCT00753012|157237085|FG001|Overall Study|Withdrawal by Subject|1|||
48834763|NCT00753012|157237084|FG000|Overall Study|Lost to Follow-up|4|||
48834764|NCT00753012|157237085|FG001|Overall Study|Lost to Follow-up|0|||
48834765|NCT00753012|157237084|FG000|Overall Study|Confounded endpoint data|1|||
48834766|NCT00753012|157237085|FG001|Overall Study|Confounded endpoint data|0|||
48834767|NCT01290224|157237086|FG000|Overall Study|Adverse Event|1|||
48532408|NCT01825837|156136249|FG000|PART I|Withdrawal by Subject|0|||
48532409|NCT01825837|156136250|FG001|PART I|Withdrawal by Subject|0|||
48532410|NCT01825837|156136251|FG002|PART I|Withdrawal by Subject|0|||
48532411|NCT01825837|156136252|FG003|PART I|Withdrawal by Subject|6|||
48532412|NCT01825837|156136249|FG000|PART I|Patient non-compliance|0|||
48532413|NCT01825837|156136250|FG001|PART I|Patient non-compliance|0|||
48532414|NCT01825837|156136251|FG002|PART I|Patient non-compliance|0|||
48532415|NCT01825837|156136252|FG003|PART I|Patient non-compliance|1|||
48532416|NCT01825837|156136249|FG000|PART I|Treatment failure|0|||
48532417|NCT01825837|156136250|FG001|PART I|Treatment failure|0|||
48532418|NCT01825837|156136251|FG002|PART I|Treatment failure|0|||
48532419|NCT01825837|156136252|FG003|PART I|Treatment failure|7|||
48532420|NCT01825837|156136249|FG000|PART I|reason unspecified|0|||
48532421|NCT01825837|156136250|FG001|PART I|reason unspecified|0|||
48532422|NCT01825837|156136251|FG002|PART I|reason unspecified|0|||
48532423|NCT01825837|156136252|FG003|PART I|reason unspecified|3|||
48532424|NCT01825837|156136249|FG000|PART II|Withdrawal by Subject|3|||
48532425|NCT01825837|156136250|FG001|PART II|Withdrawal by Subject|3|||
48532426|NCT01825837|156136251|FG002|PART II|Withdrawal by Subject|7|||
48532427|NCT01825837|156136252|FG003|PART II|Withdrawal by Subject|0|||
48532428|NCT01825837|156136249|FG000|PART II|Patient non-compliance|5|||
48532429|NCT01825837|156136250|FG001|PART II|Patient non-compliance|2|||
48532430|NCT01825837|156136251|FG002|PART II|Patient non-compliance|4|||
48532431|NCT01825837|156136252|FG003|PART II|Patient non-compliance|0|||
48532432|NCT01825837|156136249|FG000|PART II|Adverse Event|3|||
48532433|NCT01825837|156136250|FG001|PART II|Adverse Event|3|||
48532434|NCT01825837|156136251|FG002|PART II|Adverse Event|1|||
48532435|NCT01825837|156136252|FG003|PART II|Adverse Event|0|||
48532436|NCT01825837|156136249|FG000|PART II|Treatment failure|6|||
48532437|NCT01825837|156136250|FG001|PART II|Treatment failure|4|||
48532438|NCT01825837|156136251|FG002|PART II|Treatment failure|5|||
48532439|NCT01825837|156136252|FG003|PART II|Treatment failure|0|||
48532440|NCT01825837|156136249|FG000|PART II|reason unspecified|2|||
48532441|NCT01825837|156136250|FG001|PART II|reason unspecified|2|||
48532442|NCT01825837|156136251|FG002|PART II|reason unspecified|2|||
48532443|NCT01825837|156136252|FG003|PART II|reason unspecified|0|||
48834768|NCT01290224|157237086|FG000|Overall Study|Refused Further Treatment|4|||
48603245|NCT00468585|156402965|FG001|Overall Study|Withdrawal by Subject|0|||
48603246|NCT00468585|156402966|FG002|Overall Study|Withdrawal by Subject|2|||
48603247|NCT00468585|156402967|FG003|Overall Study|Withdrawal by Subject|1|||
48603248|NCT00511810|156402968|FG000|Overall Study|Lost to Follow-up|1|||
48603249|NCT00511810|156402969|FG001|Overall Study|Lost to Follow-up|2|||
48603250|NCT00511810|156402968|FG000|Overall Study|Lack of Efficacy|0|||
48603251|NCT00511810|156402969|FG001|Overall Study|Lack of Efficacy|2|||
48603252|NCT00511810|156402968|FG000|Overall Study|Refused second scn|0|||
48603253|NCT00511810|156402969|FG001|Overall Study|Refused second scn|1|||
48603254|NCT03322293|156402970|FG000|Overall Study|Lost to Follow-up|0|||
48603255|NCT03322293|156402971|FG001|Overall Study|Lost to Follow-up|0|||
48603256|NCT03322293|156402972|FG002|Overall Study|Lost to Follow-up|1|||
48603257|NCT00230048|156402973|FG000|Overall Study|Lost to Follow-up|13|||
48603258|NCT00230048|156402974|FG001|Overall Study|Lost to Follow-up|18|||
48603259|NCT00297648|156402975|FG000|Overall Study|Adverse Event|13|||
48603260|NCT00297648|156402975|FG000|Overall Study|Lack of Efficacy|18|||
48603261|NCT00297648|156402975|FG000|Overall Study|Lost to Follow-up|1|||
48603262|NCT00297648|156402975|FG000|Overall Study|Withdrawal by Subject|3|||
48603263|NCT00297648|156402975|FG000|Overall Study|Other: Incompliance|1|||
48603264|NCT03810183|156402976|FG000|Overall Study|Study terminated by Sponsor|2|||
48603265|NCT03810183|156402977|FG001|Overall Study|Study terminated by Sponsor|1|||
48603266|NCT03167242|156402979|FG000|Overall Study|Patient/Guardian Decision|0|||
48603267|NCT03167242|156402980|FG001|Overall Study|Patient/Guardian Decision|1|||
48603268|NCT03167242|156402981|FG002|Overall Study|Patient/Guardian Decision|2|||
48603269|NCT03167242|156402982|FG003|Overall Study|Patient/Guardian Decision|1|||
48603270|NCT03167242|156402983|FG004|Overall Study|Patient/Guardian Decision|1|||
48603271|NCT03167242|156402984|FG005|Overall Study|Patient/Guardian Decision|1|||
48603272|NCT03167242|156402985|FG006|Overall Study|Patient/Guardian Decision|0|||
48603273|NCT03167242|156402986|FG007|Overall Study|Patient/Guardian Decision|0|||
48603274|NCT03167242|156402987|FG008|Overall Study|Patient/Guardian Decision|0|||
48603275|NCT03167242|156402988|FG009|Overall Study|Patient/Guardian Decision|0|||
48603276|NCT03167242|156402989|FG010|Overall Study|Patient/Guardian Decision|1|||
48603277|NCT03167242|156402990|FG011|Overall Study|Patient/Guardian Decision|0|||
48603278|NCT03167242|156402979|FG000|Overall Study|Lost to Follow-up|0|||
48603279|NCT03167242|156402980|FG001|Overall Study|Lost to Follow-up|0|||
48603280|NCT03167242|156402981|FG002|Overall Study|Lost to Follow-up|1|||
48603281|NCT03167242|156402982|FG003|Overall Study|Lost to Follow-up|0|||
48603282|NCT03167242|156402983|FG004|Overall Study|Lost to Follow-up|0|||
48603283|NCT03167242|156402984|FG005|Overall Study|Lost to Follow-up|1|||
48603284|NCT03167242|156402985|FG006|Overall Study|Lost to Follow-up|2|||
48603285|NCT03167242|156402986|FG007|Overall Study|Lost to Follow-up|1|||
48603286|NCT03167242|156402987|FG008|Overall Study|Lost to Follow-up|0|||
48603287|NCT03167242|156402988|FG009|Overall Study|Lost to Follow-up|0|||
48603288|NCT03167242|156402989|FG010|Overall Study|Lost to Follow-up|1|||
48603289|NCT03167242|156402990|FG011|Overall Study|Lost to Follow-up|1|||
48603290|NCT03167242|156402979|FG000|Overall Study|Reason not provided|0|||
48603291|NCT03167242|156402980|FG001|Overall Study|Reason not provided|0|||
48603292|NCT03167242|156402981|FG002|Overall Study|Reason not provided|0|||
48603293|NCT03167242|156402982|FG003|Overall Study|Reason not provided|0|||
48603294|NCT03167242|156402983|FG004|Overall Study|Reason not provided|0|||
48603295|NCT03167242|156402984|FG005|Overall Study|Reason not provided|0|||
48603296|NCT03167242|156402985|FG006|Overall Study|Reason not provided|0|||
48603297|NCT03167242|156402986|FG007|Overall Study|Reason not provided|0|||
48603298|NCT03167242|156402987|FG008|Overall Study|Reason not provided|1|||
48603299|NCT03167242|156402988|FG009|Overall Study|Reason not provided|0|||
48603300|NCT03167242|156402989|FG010|Overall Study|Reason not provided|0|||
48603301|NCT03167242|156402990|FG011|Overall Study|Reason not provided|0|||
48603302|NCT01411852|156402991|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
48603303|NCT01411852|156402992|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
48603304|NCT01411852|156402991|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
48603305|NCT01411852|156402992|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
48603306|NCT01411852|156402991|FG000|Prehospital Intervention Phase|Found to be under age|0|||
48603307|NCT01411852|156402992|FG001|Prehospital Intervention Phase|Found to be under age|1|||
48603308|NCT01411852|156402991|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
48603309|NCT01411852|156402992|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
48603310|NCT01411852|156402991|FG000|Hospital Intervention Phase|Severe head injury|5|||
48603311|NCT01411852|156402992|FG001|Hospital Intervention Phase|Severe head injury|4|||
48603312|NCT01411852|156402991|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
48603313|NCT01411852|156402992|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
48603314|NCT01411852|156402991|FG000|Hospital Intervention Phase|Miscommunication error|1|||
48603315|NCT01411852|156402992|FG001|Hospital Intervention Phase|Miscommunication error|2|||
48603316|NCT01411852|156402991|FG000|Hospital Intervention Phase|CPR administered|3|||
48603317|NCT01411852|156402992|FG001|Hospital Intervention Phase|CPR administered|1|||
48603318|NCT01411852|156402991|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
48603319|NCT01411852|156402992|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
48603320|NCT01411852|156402991|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
48603321|NCT01411852|156402992|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
48603322|NCT01411852|156402991|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
48603323|NCT01411852|156402992|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
48603324|NCT01411852|156402991|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
48603325|NCT01411852|156402992|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
48603326|NCT01411852|156402991|FG000|Hospital Intervention Phase|Other ineligible|2|||
48603327|NCT01411852|156402992|FG001|Hospital Intervention Phase|Other ineligible|2|||
48603328|NCT01411852|156402991|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
48603329|NCT01411852|156402992|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
48603330|NCT01411852|156402991|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
48603331|NCT01411852|156402992|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
48603332|NCT01411852|156402991|FG000|Hospital Intervention Phase|Vascular access failed|1|||
48603333|NCT01411852|156402992|FG001|Hospital Intervention Phase|Vascular access failed|0|||
48603334|NCT04817332|156402993|FG000|Overall Study|Lost to Follow-up|3|||
48834769|NCT03184558|157237087|FG000|Overall Study|Withdrawal by Subject|2|||
48834770|NCT03184558|157237087|FG000|Overall Study|Death|16|||
48834771|NCT03184558|157237087|FG000|Overall Study|Lost to Follow-up|2|||
48834772|NCT03184558|157237087|FG000|Overall Study|Other|9|||
48834773|NCT02393716|157237088|FG000|Overall Study|Death|29|||
48834774|NCT02393716|157237088|FG000|Overall Study|Withdrawal by Subject|8|||
48834775|NCT02393716|157237088|FG000|Overall Study|Device Explanted|8|||
48834776|NCT02393716|157237088|FG000|Overall Study|Missed visit|16|||
48834777|NCT02957539|157237089|FG000|Baseline to Week 16|Lost to Follow-up|8|||
48834778|NCT02957539|157237090|FG001|Baseline to Week 16|Lost to Follow-up|10|||
48834779|NCT02957539|157237091|FG002|Baseline to Week 16|Lost to Follow-up|16|||
48834780|NCT02957539|157237089|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
48834781|NCT02957539|157237090|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
48834782|NCT02957539|157237091|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
48834783|NCT02957539|157237089|FG000|Week 16 to 32|Withdrawal by Subject|3|||
48834784|NCT02957539|157237090|FG001|Week 16 to 32|Withdrawal by Subject|3|||
48834785|NCT02957539|157237091|FG002|Week 16 to 32|Withdrawal by Subject|1|||
48834786|NCT02957539|157237089|FG000|Week 16 to 32|Lost to Follow-up|8|||
48834787|NCT02957539|157237090|FG001|Week 16 to 32|Lost to Follow-up|7|||
48834788|NCT02957539|157237091|FG002|Week 16 to 32|Lost to Follow-up|5|||
48834789|NCT02957539|157237089|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
48834790|NCT02957539|157237090|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
48834791|NCT02957539|157237091|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
48834792|NCT02957539|157237089|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
48834793|NCT02957539|157237090|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
48834794|NCT02957539|157237091|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
48834795|NCT00079183|157237100|FG000|Overall Study|Withdrawal by Subject|4|||
48834796|NCT00079183|157237100|FG000|Overall Study|Study medication non-compliance|2|||
48834797|NCT00079183|157237100|FG000|Overall Study|Specimen collection non-compliance|1|||
48834798|NCT00878722|157237101|FG000|Overall Study|Progressive disease|3|||
48834799|NCT00878722|157237102|FG001|Overall Study|Progressive disease|3|||
48834800|NCT00878722|157237103|FG002|Overall Study|Progressive disease|3|||
48834801|NCT00878722|157237104|FG003|Overall Study|Progressive disease|7|||
48834802|NCT00878722|157237105|FG004|Overall Study|Progressive disease|7|||
48834803|NCT00878722|157237106|FG005|Overall Study|Progressive disease|1|||
48834804|NCT00878722|157237107|FG006|Overall Study|Progressive disease|4|||
48834805|NCT00878722|157237108|FG007|Overall Study|Progressive disease|3|||
48834806|NCT00878722|157237101|FG000|Overall Study|Death|0|||
48834807|NCT00878722|157237102|FG001|Overall Study|Death|0|||
48834808|NCT00878722|157237103|FG002|Overall Study|Death|0|||
48834809|NCT00878722|157237104|FG003|Overall Study|Death|1|||
48834810|NCT00878722|157237105|FG004|Overall Study|Death|0|||
48834811|NCT00878722|157237106|FG005|Overall Study|Death|1|||
48834812|NCT00878722|157237107|FG006|Overall Study|Death|0|||
48834813|NCT00878722|157237108|FG007|Overall Study|Death|2|||
48834814|NCT00878722|157237101|FG000|Overall Study|Adverse Event|0|||
48834815|NCT00878722|157237102|FG001|Overall Study|Adverse Event|0|||
48834816|NCT00878722|157237103|FG002|Overall Study|Adverse Event|0|||
48834817|NCT00878722|157237104|FG003|Overall Study|Adverse Event|0|||
48834818|NCT00878722|157237105|FG004|Overall Study|Adverse Event|0|||
48834819|NCT00878722|157237106|FG005|Overall Study|Adverse Event|0|||
48834820|NCT00878722|157237107|FG006|Overall Study|Adverse Event|2|||
48834821|NCT00878722|157237108|FG007|Overall Study|Adverse Event|0|||
48834822|NCT00878722|157237101|FG000|Overall Study|Withdrawal by Subject|0|||
48834823|NCT00878722|157237102|FG001|Overall Study|Withdrawal by Subject|0|||
48834824|NCT00878722|157237103|FG002|Overall Study|Withdrawal by Subject|0|||
48834825|NCT00878722|157237104|FG003|Overall Study|Withdrawal by Subject|0|||
48834826|NCT00878722|157237105|FG004|Overall Study|Withdrawal by Subject|0|||
48834827|NCT00878722|157237106|FG005|Overall Study|Withdrawal by Subject|0|||
48834828|NCT00878722|157237107|FG006|Overall Study|Withdrawal by Subject|0|||
48834829|NCT00878722|157237108|FG007|Overall Study|Withdrawal by Subject|2|||
48834830|NCT00878722|157237101|FG000|Overall Study|Relapse|0|||
48834831|NCT00878722|157237102|FG001|Overall Study|Relapse|0|||
48834832|NCT00878722|157237103|FG002|Overall Study|Relapse|0|||
48834833|NCT00878722|157237104|FG003|Overall Study|Relapse|1|||
48834834|NCT00878722|157237105|FG004|Overall Study|Relapse|0|||
48834835|NCT00878722|157237106|FG005|Overall Study|Relapse|0|||
48834836|NCT00878722|157237107|FG006|Overall Study|Relapse|0|||
48834837|NCT00878722|157237108|FG007|Overall Study|Relapse|0|||
48834838|NCT03920215|157237109|FG000|Overall Study|Lost to Follow-up|1|||
48834839|NCT03920215|157237110|FG001|Overall Study|Lost to Follow-up|2|||
48834840|NCT03920215|157237111|FG002|Overall Study|Lost to Follow-up|0|||
48834841|NCT03920215|157237112|FG003|Overall Study|Lost to Follow-up|0|||
48834842|NCT03920215|157237109|FG000|Overall Study|Death|0|||
48834843|NCT03920215|157237110|FG001|Overall Study|Death|0|||
48834844|NCT03920215|157237111|FG002|Overall Study|Death|0|||
48834845|NCT03920215|157237112|FG003|Overall Study|Death|1|||
48834846|NCT03621696|157237117|FG000|Overall Study|Not eligible|0|||
48834847|NCT03621696|157237118|FG001|Overall Study|Not eligible|0|||
48834848|NCT03621696|157237119|FG002|Overall Study|Not eligible|0|||
48834849|NCT03621696|157237120|FG003|Overall Study|Not eligible|5|||
48603335|NCT04817332|156402994|FG001|Overall Study|Lost to Follow-up|3|||
48532582|NCT00941720|156136263|FG000|Overall Study|Withdrawal by Subject|1|||
48532583|NCT00941720|156136263|FG000|Overall Study|Insurance denied participation|11|||
48532584|NCT00941720|156136263|FG000|Overall Study|ineligible|2|||
48532585|NCT00904748|156136264|FG000|Overall Study|Withdrawal by Subject|1|||
48532586|NCT00904748|156136265|FG001|Overall Study|Withdrawal by Subject|1|||
48532587|NCT00904748|156136266|FG002|Overall Study|Withdrawal by Subject|1|||
48532588|NCT00904748|156136267|FG003|Overall Study|Withdrawal by Subject|2|||
48532589|NCT00904748|156136268|FG004|Overall Study|Withdrawal by Subject|0|||
48532590|NCT00904748|156136269|FG005|Overall Study|Withdrawal by Subject|0|||
48532591|NCT00904748|156136264|FG000|Overall Study|Adverse Event|0|||
48532592|NCT00904748|156136265|FG001|Overall Study|Adverse Event|0|||
48532593|NCT00904748|156136266|FG002|Overall Study|Adverse Event|0|||
48532594|NCT00904748|156136267|FG003|Overall Study|Adverse Event|0|||
48532595|NCT00904748|156136268|FG004|Overall Study|Adverse Event|1|||
48532596|NCT00904748|156136269|FG005|Overall Study|Adverse Event|0|||
48532597|NCT03218826|156136270|FG000|Overall Study|Non-compliance with protocol|1|||
48532598|NCT03218826|156136271|FG001|Overall Study|Non-compliance with protocol|0|||
48532599|NCT03218826|156136272|FG002|Overall Study|Non-compliance with protocol|2|||
48532600|NCT03218826|156136273|FG003|Overall Study|Non-compliance with protocol|1|||
48532601|NCT03218826|156136274|FG004|Overall Study|Non-compliance with protocol|1|||
48532602|NCT01682148|156136275|FG000|Overall Study|Withdrawal by Subject|2|||
48532603|NCT01682148|156136276|FG001|Overall Study|Withdrawal by Subject|0|||
48532604|NCT01682148|156136275|FG000|Overall Study|Lost to Follow-up|1|||
48532605|NCT01682148|156136276|FG001|Overall Study|Lost to Follow-up|2|||
48532606|NCT01682148|156136275|FG000|Overall Study|Protocol Violation|1|||
48532607|NCT01682148|156136276|FG001|Overall Study|Protocol Violation|1|||
48532608|NCT04569786|156136279|FG000|Overall Study|Lost to Follow-up|1|||
48532609|NCT04569786|156136280|FG001|Overall Study|Lost to Follow-up|0|||
48532610|NCT04569786|156136281|FG002|Overall Study|Lost to Follow-up|4|||
48532611|NCT04569786|156136282|FG003|Overall Study|Lost to Follow-up|1|||
48532612|NCT04569786|156136283|FG004|Overall Study|Lost to Follow-up|0|||
48532613|NCT04569786|156136279|FG000|Overall Study|Withdrawal by Subject|0|||
48532614|NCT04569786|156136280|FG001|Overall Study|Withdrawal by Subject|0|||
48532615|NCT04569786|156136281|FG002|Overall Study|Withdrawal by Subject|0|||
48532616|NCT04569786|156136282|FG003|Overall Study|Withdrawal by Subject|5|||
48532617|NCT04569786|156136283|FG004|Overall Study|Withdrawal by Subject|1|||
48532618|NCT04569786|156136279|FG000|Overall Study|Physician Decision|0|||
48532619|NCT04569786|156136280|FG001|Overall Study|Physician Decision|0|||
48532620|NCT04569786|156136281|FG002|Overall Study|Physician Decision|0|||
48532621|NCT04569786|156136282|FG003|Overall Study|Physician Decision|1|||
48532622|NCT04569786|156136283|FG004|Overall Study|Physician Decision|0|||
48532623|NCT03164616|156136290|FG000|Overall Study|Death|250|||
48532624|NCT03164616|156136291|FG001|Overall Study|Death|264|||
48532625|NCT03164616|156136292|FG002|Overall Study|Death|279|||
48532626|NCT03164616|156136290|FG000|Overall Study|Lost to Follow-up|2|||
48532627|NCT03164616|156136291|FG001|Overall Study|Lost to Follow-up|2|||
48532628|NCT03164616|156136292|FG002|Overall Study|Lost to Follow-up|2|||
48532629|NCT03164616|156136290|FG000|Overall Study|Withdrawal by Subject|6|||
48532630|NCT03164616|156136291|FG001|Overall Study|Withdrawal by Subject|7|||
48532631|NCT03164616|156136292|FG002|Overall Study|Withdrawal by Subject|16|||
48532632|NCT01640184|156136294|FG000|Overall Study|Death|1|||
48532633|NCT01640184|156136295|FG001|Overall Study|Death|0|||
48532634|NCT01640184|156136296|FG002|Overall Study|Death|0|||
48532635|NCT01640184|156136294|FG000|Overall Study|Lost to Follow-up|4|||
48532636|NCT01640184|156136295|FG001|Overall Study|Lost to Follow-up|1|||
48532637|NCT01640184|156136296|FG002|Overall Study|Lost to Follow-up|0|||
48532638|NCT01640184|156136294|FG000|Overall Study|Physician Decision|3|||
48532639|NCT01640184|156136295|FG001|Overall Study|Physician Decision|0|||
48532640|NCT01640184|156136296|FG002|Overall Study|Physician Decision|0|||
48532641|NCT01640184|156136294|FG000|Overall Study|Withdrawal by Subject|0|||
48532642|NCT01640184|156136295|FG001|Overall Study|Withdrawal by Subject|1|||
48532643|NCT01640184|156136296|FG002|Overall Study|Withdrawal by Subject|1|||
48532644|NCT01640184|156136294|FG000|Overall Study|Protocol Violation|0|||
48532645|NCT01640184|156136295|FG001|Overall Study|Protocol Violation|0|||
48532646|NCT01640184|156136296|FG002|Overall Study|Protocol Violation|1|||
48532647|NCT00605917|156136297|FG000|Overall Study|Protocol Violation|79|||
48532648|NCT00319111|156136298|FG000|Overall Study|Adverse Event|20|||
48532649|NCT00319111|156136298|FG000|Overall Study|Withdrawal of consent|11|||
48532650|NCT00319111|156136298|FG000|Overall Study|Death|9|||
48532651|NCT00319111|156136298|FG000|Overall Study|Lack of clinical improvement|4|||
48532652|NCT00319111|156136298|FG000|Overall Study|Administrative|2|||
48532653|NCT00319111|156136298|FG000|Overall Study|Treatment failure|1|||
48532654|NCT02310789|156138389|FG000|Overall Study|Adverse Event|1|||
48532655|NCT03474679|156138396|FG000|Overall Study|Death|7|||
48532656|NCT03474679|156138396|FG000|Overall Study|Withdrawal by Subject|1|||
48532657|NCT03136406|156138397|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
48532658|NCT00611884|156138401|FG000|Overall Study|Adverse Event|1|||
48532659|NCT00611884|156138402|FG001|Overall Study|Adverse Event|0|||
48532660|NCT00611884|156138403|FG002|Overall Study|Adverse Event|0|||
48532661|NCT00611884|156138404|FG003|Overall Study|Adverse Event|1|||
48834850|NCT03621696|157237117|FG000|Overall Study|Withdrawal by Subject|1|||
48834851|NCT03621696|157237118|FG001|Overall Study|Withdrawal by Subject|1|||
48834852|NCT03621696|157237119|FG002|Overall Study|Withdrawal by Subject|1|||
48834853|NCT03621696|157237120|FG003|Overall Study|Withdrawal by Subject|0|||
48834854|NCT03621696|157237117|FG000|Overall Study|Physician Decision|0|||
48532662|NCT00611884|156138401|FG000|Overall Study|Non-Compliance|1|||
48532663|NCT00611884|156138402|FG001|Overall Study|Non-Compliance|4|||
48532664|NCT00611884|156138403|FG002|Overall Study|Non-Compliance|2|||
48532665|NCT00611884|156138404|FG003|Overall Study|Non-Compliance|2|||
48532666|NCT00611884|156138401|FG000|Overall Study|Lack of Efficacy|0|||
48532667|NCT00611884|156138402|FG001|Overall Study|Lack of Efficacy|1|||
48532668|NCT00611884|156138403|FG002|Overall Study|Lack of Efficacy|0|||
48532669|NCT00611884|156138404|FG003|Overall Study|Lack of Efficacy|0|||
48532670|NCT00611884|156138401|FG000|Overall Study|Unclassified|7|||
48532671|NCT00611884|156138402|FG001|Overall Study|Unclassified|4|||
48532672|NCT00611884|156138403|FG002|Overall Study|Unclassified|2|||
48532673|NCT00611884|156138404|FG003|Overall Study|Unclassified|3|||
48532674|NCT04142242|156138405|FG000|Stage I|Non-compliance with the protocol|1|||
48532675|NCT04142242|156138406|FG001|Stage I|Non-compliance with the protocol|0|||
48532676|NCT04142242|156138407|FG002|Stage I|Non-compliance with the protocol|0|||
48532677|NCT04142242|156138408|FG003|Stage I|Non-compliance with the protocol|0|||
48532678|NCT04142242|156138409|FG004|Stage I|Non-compliance with the protocol|0|||
48532679|NCT04142242|156138410|FG005|Stage I|Non-compliance with the protocol|1|||
48532680|NCT04142242|156138405|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
48532681|NCT04142242|156138406|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
48532682|NCT04142242|156138407|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
48532683|NCT04142242|156138408|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
48532684|NCT04142242|156138409|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
48532685|NCT04142242|156138410|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
48532686|NCT04142242|156138405|FG000|Stage II|Non-compliance with the protocol|0|||
48532687|NCT04142242|156138406|FG001|Stage II|Non-compliance with the protocol|0|||
48532688|NCT04142242|156138407|FG002|Stage II|Non-compliance with the protocol|0|||
48532689|NCT04142242|156138408|FG003|Stage II|Non-compliance with the protocol|2|||
48532690|NCT04142242|156138409|FG004|Stage II|Non-compliance with the protocol|0|||
48532691|NCT04142242|156138410|FG005|Stage II|Non-compliance with the protocol|0|||
48532692|NCT04142242|156138405|FG000|Stage II|Lost to Follow-up|0|||
48532693|NCT04142242|156138406|FG001|Stage II|Lost to Follow-up|0|||
48532694|NCT04142242|156138407|FG002|Stage II|Lost to Follow-up|1|||
48532695|NCT04142242|156138408|FG003|Stage II|Lost to Follow-up|2|||
48532696|NCT04142242|156138409|FG004|Stage II|Lost to Follow-up|0|||
48532697|NCT04142242|156138410|FG005|Stage II|Lost to Follow-up|0|||
48532698|NCT04142242|156138405|FG000|Stage II|Withdrawal by Subject|0|||
48532699|NCT04142242|156138406|FG001|Stage II|Withdrawal by Subject|0|||
48532700|NCT04142242|156138407|FG002|Stage II|Withdrawal by Subject|5|||
48532701|NCT04142242|156138408|FG003|Stage II|Withdrawal by Subject|9|||
48532702|NCT04142242|156138409|FG004|Stage II|Withdrawal by Subject|0|||
48532703|NCT04142242|156138410|FG005|Stage II|Withdrawal by Subject|0|||
48532704|NCT03135899|156138411|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
48532705|NCT03135899|156138412|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
48532706|NCT03135899|156138413|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
48532707|NCT03135899|156138414|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
48532708|NCT03135899|156138415|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
48532709|NCT03135899|156138416|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
48532710|NCT03135899|156138417|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
48532711|NCT03135899|156138418|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
48532712|NCT03135899|156138411|FG000|Overall Study|Withdrawal by Subject|0|||
48532713|NCT03135899|156138412|FG001|Overall Study|Withdrawal by Subject|0|||
48532714|NCT03135899|156138413|FG002|Overall Study|Withdrawal by Subject|0|||
48532715|NCT03135899|156138414|FG003|Overall Study|Withdrawal by Subject|0|||
48532716|NCT03135899|156138415|FG004|Overall Study|Withdrawal by Subject|0|||
48532717|NCT03135899|156138416|FG005|Overall Study|Withdrawal by Subject|2|||
48532718|NCT03135899|156138417|FG006|Overall Study|Withdrawal by Subject|0|||
48532719|NCT03135899|156138418|FG007|Overall Study|Withdrawal by Subject|0|||
48532720|NCT04889209|156138421|FG000|All Cohorts Except 15E|Adverse Event|0|||
48834855|NCT03621696|157237118|FG001|Overall Study|Physician Decision|0|||
48834856|NCT03621696|157237119|FG002|Overall Study|Physician Decision|1|||
48834857|NCT03621696|157237120|FG003|Overall Study|Physician Decision|0|||
48834858|NCT05149313|157237125|FG000|Overall Study|Adverse Event|2|||
48532721|NCT04889209|156138422|FG001|All Cohorts Except 15E|Adverse Event|0|||
48532722|NCT04889209|156138423|FG002|All Cohorts Except 15E|Adverse Event|0|||
48532723|NCT04889209|156138424|FG003|All Cohorts Except 15E|Adverse Event|0|||
48532724|NCT04889209|156138425|FG004|All Cohorts Except 15E|Adverse Event|0|||
48834859|NCT05149313|157237126|FG001|Overall Study|Adverse Event|2|||
48834860|NCT05149313|157237125|FG000|Overall Study|Lost to Follow-up|2|||
48834861|NCT05149313|157237126|FG001|Overall Study|Lost to Follow-up|3|||
48834862|NCT05149313|157237125|FG000|Overall Study|Pregnancy|1|||
48834863|NCT05149313|157237126|FG001|Overall Study|Pregnancy|0|||
48834864|NCT05149313|157237125|FG000|Overall Study|Withdrawal by Subject|2|||
48603336|NCT04817332|156402993|FG000|Overall Study|Protocol Violation|2|||
48603337|NCT04817332|156402994|FG001|Overall Study|Protocol Violation|0|||
48603338|NCT01172873|156402997|FG000|Overall Study|Withdrawal by Subject|3|||
48603339|NCT01172873|156402998|FG001|Overall Study|Withdrawal by Subject|2|||
48834865|NCT05149313|157237126|FG001|Overall Study|Withdrawal by Subject|5|||
48603340|NCT00338741|156403000|FG000|Overall Study|Lost to Follow-up|2|||
48603341|NCT00338741|156403001|FG001|Overall Study|Lost to Follow-up|0|||
48603342|NCT01534273|156403002|FG000|Period 1|Physician Decision|0|||
48603343|NCT01534273|156403003|FG001|Period 1|Physician Decision|0|||
48603344|NCT01534273|156403004|FG002|Period 1|Physician Decision|0|||
48603345|NCT01534273|156403005|FG003|Period 1|Physician Decision|1|||
48603346|NCT01534273|156403006|FG004|Period 1|Physician Decision|0|||
48603347|NCT01534273|156403007|FG005|Period 1|Physician Decision|0|||
48603348|NCT01534273|156403008|FG006|Period 1|Physician Decision|0|||
48603349|NCT01710020|156403013|FG000|Period 1|Protocol Violation|1|||
48603350|NCT00467519|156403014|FG000|Overall Study|Protocol Violation|8|||
48603351|NCT00467519|156403015|FG001|Overall Study|Protocol Violation|4|||
48603352|NCT00467519|156403014|FG000|Overall Study|Lost to Follow-up|2|||
48603353|NCT00467519|156403015|FG001|Overall Study|Lost to Follow-up|9|||
48603354|NCT00467519|156403014|FG000|Overall Study|Withdrawal by Subject|4|||
48603355|NCT00467519|156403015|FG001|Overall Study|Withdrawal by Subject|10|||
48603356|NCT01791985|156403016|FG000|Overall Study|Adverse Event|7|||
48603357|NCT01791985|156403016|FG000|Overall Study|Withdrawal by Subject|1|||
48603358|NCT00372424|156403017|FG000|Overall Study|Adverse Event|2|||
48603359|NCT00372424|156403017|FG000|Overall Study|Withdrawal by Subject|1|||
48603360|NCT00372424|156403017|FG000|Overall Study|Death|1|||
48603361|NCT00372424|156403017|FG000|Overall Study|Objective Progression or Relapse|14|||
48603362|NCT00372424|156403017|FG000|Overall Study|Other|7|||
48603363|NCT00372424|156403017|FG000|Overall Study|Enrolled, Not Treated|1|||
48603364|NCT03118934|156403018|FG000|Overall Study|Adverse Event|0|||
48603365|NCT03118934|156403019|FG001|Overall Study|Adverse Event|0|||
48603366|NCT03118934|156403020|FG002|Overall Study|Adverse Event|0|||
48603367|NCT03118934|156403021|FG003|Overall Study|Adverse Event|0|||
48603368|NCT03118934|156403022|FG004|Overall Study|Adverse Event|0|||
48603369|NCT03118934|156403023|FG005|Overall Study|Adverse Event|1|||
48603370|NCT03118934|156403018|FG000|Overall Study|Physician Decision|0|||
48603371|NCT03118934|156403019|FG001|Overall Study|Physician Decision|0|||
48603372|NCT03118934|156403020|FG002|Overall Study|Physician Decision|0|||
48603373|NCT03118934|156403021|FG003|Overall Study|Physician Decision|0|||
48603374|NCT03118934|156403022|FG004|Overall Study|Physician Decision|0|||
48603375|NCT03118934|156403023|FG005|Overall Study|Physician Decision|1|||
48603376|NCT03118934|156403018|FG000|Overall Study|Discontinued prior to exposure|0|||
48603377|NCT03118934|156403019|FG001|Overall Study|Discontinued prior to exposure|1|||
48603378|NCT03118934|156403020|FG002|Overall Study|Discontinued prior to exposure|1|||
48603379|NCT03118934|156403021|FG003|Overall Study|Discontinued prior to exposure|1|||
48603380|NCT03118934|156403022|FG004|Overall Study|Discontinued prior to exposure|2|||
48603381|NCT03118934|156403023|FG005|Overall Study|Discontinued prior to exposure|0|||
48603382|NCT03080935|156403024|FG000|Overall Study|Death|34|||
48603383|NCT03080935|156403025|FG001|Overall Study|Death|50|||
48603384|NCT03080935|156403024|FG000|Overall Study|Lost to Follow-up|5|||
48603385|NCT03080935|156403025|FG001|Overall Study|Lost to Follow-up|4|||
48603386|NCT03080935|156403024|FG000|Overall Study|Withdrawal by Subject|11|||
48603387|NCT03080935|156403025|FG001|Overall Study|Withdrawal by Subject|15|||
48603388|NCT01614470|156403027|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
48603389|NCT01614470|156403028|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48603390|NCT01614470|156403029|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48603391|NCT01614470|156403027|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
48603392|NCT01614470|156403028|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
48603393|NCT01614470|156403029|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
48603394|NCT04249427|156403031|FG000|Overall Study|Adverse Event|3|||
48603395|NCT04249427|156403032|FG001|Overall Study|Adverse Event|1|||
48603396|NCT04249427|156403031|FG000|Overall Study|Lack of Efficacy|0|||
48603397|NCT04249427|156403032|FG001|Overall Study|Lack of Efficacy|1|||
48603398|NCT04249427|156403031|FG000|Overall Study|Withdrawal by Subject|1|||
48603399|NCT04249427|156403032|FG001|Overall Study|Withdrawal by Subject|2|||
48603400|NCT02557399|156403033|FG000|Overall Study|Adverse Event|6|||
48603401|NCT02557399|156403034|FG001|Overall Study|Adverse Event|5|||
48603402|NCT02557399|156403033|FG000|Overall Study|Protocol Violation|0|||
48834866|NCT05149313|157237125|FG000|Overall Study|Physician Decision|1|||
48834867|NCT05149313|157237126|FG001|Overall Study|Physician Decision|0|||
48603403|NCT02557399|156403034|FG001|Overall Study|Protocol Violation|1|||
48834868|NCT05149313|157237125|FG000|Overall Study|Other|0|||
48834869|NCT05149313|157237126|FG001|Overall Study|Other|1|||
48445120|NCT00290589|155817024|FG000|Overall Study|Lost to Follow-up|2|||
48445121|NCT00290589|155817025|FG001|Overall Study|Lost to Follow-up|2|||
48445122|NCT01896856|155817033|FG000|Overall Study|Transportation issues / Non-compliance|0|||
48445123|NCT01896856|155817034|FG001|Overall Study|Transportation issues / Non-compliance|0|||
48445124|NCT01896856|155817035|FG002|Overall Study|Transportation issues / Non-compliance|1|||
48445125|NCT01896856|155817036|FG003|Overall Study|Transportation issues / Non-compliance|0|||
48445126|NCT01896856|155817037|FG004|Overall Study|Transportation issues / Non-compliance|0|||
48445127|NCT01896856|155817038|FG005|Overall Study|Transportation issues / Non-compliance|0|||
48445128|NCT02378883|155817039|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
48445129|NCT02378883|155817039|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
48445130|NCT02378883|155817039|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
48445131|NCT02378883|155817039|FG000|30 Day Follow-Up|Physician Decision|2|||
48445132|NCT02378883|155817039|FG000|30 Day Follow-Up|Missed Visit|2|||
48445133|NCT02378883|155817039|FG000|30 Day Follow-Up|Death|1|||
48445134|NCT02378883|155817039|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
48445135|NCT02378883|155817039|FG000|12 Months Follow-Up|Death|2|||
48445136|NCT00416312|155817042|FG000|Overall Study|tumors not visible on imaging|2|||
48445137|NCT02031432|155817043|FG000|Overall Study|Protocol Violation|1|||
48445138|NCT02031432|155817043|FG000|Overall Study|Lack of Efficacy|5|||
48445139|NCT02031432|155817043|FG000|Overall Study|Cancer Progression|2|||
48445140|NCT02031432|155817043|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
48445141|NCT02031432|155817043|FG000|Overall Study|Adverse Event|8|||
48445142|NCT02031432|155817043|FG000|Overall Study|Withdrawal by Subject|5|||
48445143|NCT02031432|155817043|FG000|Overall Study|Lost to Follow-up|1|||
48445144|NCT02031432|155817043|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
48445145|NCT02031432|155817043|FG000|Overall Study|Death|10|||
48445146|NCT00108953|155817055|FG000|Follow-up|Death|18|||
48445147|NCT00108953|155817056|FG001|Follow-up|Death|26|||
48445148|NCT00108953|155817055|FG000|Follow-up|Lost to Follow-up|1|||
48445149|NCT00108953|155817056|FG001|Follow-up|Lost to Follow-up|1|||
48445150|NCT00108953|155817055|FG000|Follow-up|Study terminated by sponsor|10|||
48445151|NCT00108953|155817056|FG001|Follow-up|Study terminated by sponsor|6|||
48445152|NCT01688635|155817061|FG000|Washout 1|Withdrawal by Subject|1|||
48445153|NCT01688635|155817062|FG001|Washout 1|Withdrawal by Subject|0|||
48445154|NCT01688635|155817061|FG000|Washout 1|Adverse Event|0|||
48445155|NCT01688635|155817062|FG001|Washout 1|Adverse Event|1|||
48445156|NCT01688635|155817061|FG000|Washout 1|Physician Decision|0|||
48445157|NCT01688635|155817062|FG001|Washout 1|Physician Decision|1|||
48445158|NCT01688635|155817061|FG000|Washout 2|Physician Decision|1|||
48445159|NCT01688635|155817062|FG001|Washout 2|Physician Decision|0|||
48445160|NCT01688635|155817061|FG000|Washout 2|Withdrawal by Subject|1|||
48445161|NCT01688635|155817062|FG001|Washout 2|Withdrawal by Subject|0|||
48445162|NCT01688635|155817061|FG000|Washout 2|Sponsor Decision|1|||
48445163|NCT01688635|155817062|FG001|Washout 2|Sponsor Decision|2|||
48445164|NCT01688635|155817061|FG000|Washout 3|Withdrawal by Subject|1|||
48445165|NCT01688635|155817062|FG001|Washout 3|Withdrawal by Subject|0|||
48445166|NCT01181778|155817064|FG000|Overall Study|Physician Decision|48|||
48445167|NCT01602549|155817066|FG000|Overall Study|Protocol Violation|0|||
48445168|NCT01602549|155817067|FG001|Overall Study|Protocol Violation|1|||
48445169|NCT01602549|155817066|FG000|Overall Study|Withdrawal by Subject|1|||
48445170|NCT01602549|155817067|FG001|Overall Study|Withdrawal by Subject|0|||
48445171|NCT00367432|155817068|FG000|First Period (16 Weeks)|Adverse Event|6|||
48445172|NCT00367432|155817069|FG001|First Period (16 Weeks)|Adverse Event|0|||
48445173|NCT00367432|155817068|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
48445174|NCT00367432|155817069|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
48445175|NCT00367432|155817068|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
48445176|NCT00367432|155817069|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
48445177|NCT00367432|155817068|FG000|First Period (16 Weeks)|Other Reason|2|||
48445178|NCT00367432|155817069|FG001|First Period (16 Weeks)|Other Reason|0|||
48445179|NCT00367432|155817068|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
48445180|NCT00367432|155817069|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
48445181|NCT00367432|155817068|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
48445182|NCT00367432|155817069|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
48445183|NCT00367432|155817068|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
48445184|NCT00367432|155817069|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
48445185|NCT00367432|155817068|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
48445186|NCT00367432|155817069|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
48445187|NCT00367432|155817068|FG000|Second Period (up to 54 Months)|Other Reason|6|||
48445188|NCT00367432|155817069|FG001|Second Period (up to 54 Months)|Other Reason|2|||
48445189|NCT01125293|155817070|FG000|Overall Study|Disease Progression|1|||
48445190|NCT01125293|155817071|FG001|Overall Study|Disease Progression|3|||
48445191|NCT01125293|155817072|FG002|Overall Study|Disease Progression|4|||
48532725|NCT04889209|156138426|FG005|All Cohorts Except 15E|Adverse Event|0|||
48532726|NCT04889209|156138427|FG006|All Cohorts Except 15E|Adverse Event|1|||
48532727|NCT04889209|156138428|FG007|All Cohorts Except 15E|Adverse Event|0|||
48532728|NCT04889209|156138429|FG008|All Cohorts Except 15E|Adverse Event|0|||
48532729|NCT04889209|156138430|FG009|All Cohorts Except 15E|Adverse Event|0|||
48532730|NCT04889209|156138431|FG010|All Cohorts Except 15E|Adverse Event|0|||
48834870|NCT01152190|157237127|FG000|Overall Study|Adverse Event|2|||
48834871|NCT01152190|157237128|FG001|Overall Study|Adverse Event|4|||
48834872|NCT01152190|157237127|FG000|Overall Study|Death|1|||
48834873|NCT01152190|157237128|FG001|Overall Study|Death|0|||
48834874|NCT01152190|157237127|FG000|Overall Study|Protocol Violation|1|||
48834875|NCT01152190|157237128|FG001|Overall Study|Protocol Violation|1|||
48834876|NCT01152190|157237127|FG000|Overall Study|Withdrawal by Subject|1|||
48834877|NCT01152190|157237128|FG001|Overall Study|Withdrawal by Subject|3|||
48834878|NCT01595321|157237129|FG000|Overall Study|Adverse Event|1|||
48532731|NCT04889209|156138432|FG011|All Cohorts Except 15E|Adverse Event|0|||
48532732|NCT04889209|156138433|FG012|All Cohorts Except 15E|Adverse Event|0|||
48532733|NCT04889209|156138434|FG013|All Cohorts Except 15E|Adverse Event|0|||
48532734|NCT04889209|156138435|FG014|All Cohorts Except 15E|Adverse Event|0|||
48532735|NCT04889209|156138436|FG015|All Cohorts Except 15E|Adverse Event|0|||
48532736|NCT04889209|156138437|FG016|All Cohorts Except 15E|Adverse Event|0|||
48532737|NCT04889209|156138438|FG017|All Cohorts Except 15E|Adverse Event|0|||
48532738|NCT04889209|156138421|FG000|All Cohorts Except 15E|Death|0|||
48532739|NCT04889209|156138422|FG001|All Cohorts Except 15E|Death|1|||
48532740|NCT04889209|156138423|FG002|All Cohorts Except 15E|Death|0|||
48532741|NCT04889209|156138424|FG003|All Cohorts Except 15E|Death|0|||
48532742|NCT04889209|156138425|FG004|All Cohorts Except 15E|Death|0|||
48603404|NCT02557399|156403033|FG000|Overall Study|Protocol-defined stopping criteria|0|||
48603405|NCT02557399|156403034|FG001|Overall Study|Protocol-defined stopping criteria|1|||
48603406|NCT02557399|156403033|FG000|Overall Study|Withdrawal by Subject|1|||
48603407|NCT02557399|156403034|FG001|Overall Study|Withdrawal by Subject|1|||
48603408|NCT00577317|156403041|FG000|Overall Study|Study Terminated|0|||
48603409|NCT00577317|156403042|FG001|Overall Study|Study Terminated|2|||
48603410|NCT03160716|156403044|FG000|Overall Study|Lost to Follow-up|1|||
48603411|NCT02033759|156403052|FG000|Overall Study|Withdrawal by Subject|2|||
48603412|NCT02033759|156403053|FG001|Overall Study|Withdrawal by Subject|1|||
48603413|NCT02033759|156403052|FG000|Overall Study|Protocol Violation|1|||
48834879|NCT01595321|157237130|FG001|Overall Study|Adverse Event|1|||
48834880|NCT01595321|157237131|FG002|Overall Study|Adverse Event|1|||
48834881|NCT01595321|157237129|FG000|Overall Study|Lack of Efficacy|0|||
48834882|NCT01595321|157237130|FG001|Overall Study|Lack of Efficacy|0|||
48532743|NCT04889209|156138426|FG005|All Cohorts Except 15E|Death|0|||
48532744|NCT04889209|156138427|FG006|All Cohorts Except 15E|Death|0|||
48532745|NCT04889209|156138428|FG007|All Cohorts Except 15E|Death|0|||
48603414|NCT02033759|156403053|FG001|Overall Study|Protocol Violation|1|||
48834883|NCT01595321|157237131|FG002|Overall Study|Lack of Efficacy|4|||
48834884|NCT01943799|157237132|FG000|Overall Study|Lost to Follow-up|0|||
48834885|NCT01943799|157237133|FG001|Overall Study|Lost to Follow-up|1|||
48834886|NCT01943799|157237134|FG002|Overall Study|Lost to Follow-up|1|||
48834887|NCT01943799|157237135|FG003|Overall Study|Lost to Follow-up|0|||
48834888|NCT01943799|157237132|FG000|Overall Study|Protocol Violation|1|||
48834889|NCT01943799|157237133|FG001|Overall Study|Protocol Violation|0|||
48834890|NCT01943799|157237134|FG002|Overall Study|Protocol Violation|0|||
48834891|NCT01943799|157237135|FG003|Overall Study|Protocol Violation|0|||
48834892|NCT01943799|157237132|FG000|Overall Study|Withdrawal by Subject|4|||
48834893|NCT01943799|157237133|FG001|Overall Study|Withdrawal by Subject|2|||
48834894|NCT01943799|157237134|FG002|Overall Study|Withdrawal by Subject|1|||
48834895|NCT01943799|157237135|FG003|Overall Study|Withdrawal by Subject|0|||
48834896|NCT03070483|157237138|FG000|Overall Study|Lost to Follow-up|2|||
48834897|NCT03008915|157237148|FG000|Treatment 1|Withdrawal by Subject|0|||
48834898|NCT03008915|157237149|FG001|Treatment 1|Withdrawal by Subject|1|||
48834899|NCT00361283|157237150|FG000|Overall Study|Lost to Follow-up|27|||
48834900|NCT01810263|157237154|FG000|Overall Study|Lost to Follow-up|8|||
48834901|NCT01810263|157237155|FG001|Overall Study|Lost to Follow-up|7|||
48834902|NCT00688519|157237156|FG000|Overall Study|Adverse Event|2|||
48834903|NCT00688519|157237157|FG001|Overall Study|Adverse Event|3|||
48834904|NCT00688519|157237156|FG000|Overall Study|Lost to Follow-up|3|||
48834905|NCT00688519|157237157|FG001|Overall Study|Lost to Follow-up|3|||
48834906|NCT00688519|157237156|FG000|Overall Study|Lack of Efficacy|3|||
48834907|NCT00688519|157237157|FG001|Overall Study|Lack of Efficacy|1|||
48834908|NCT00688519|157237156|FG000|Overall Study|Withdrawal by Subject|7|||
48834909|NCT00688519|157237157|FG001|Overall Study|Withdrawal by Subject|6|||
48834910|NCT00688519|157237156|FG000|Overall Study|Prohibited medication|1|||
48532746|NCT04889209|156138429|FG008|All Cohorts Except 15E|Death|0|||
48532747|NCT04889209|156138430|FG009|All Cohorts Except 15E|Death|0|||
48603415|NCT00764790|156403054|FG000|Overall Study|Protocol Violation|0|||
48603416|NCT00764790|156403055|FG001|Overall Study|Protocol Violation|0|||
48834911|NCT00688519|157237157|FG001|Overall Study|Prohibited medication|0|||
48834912|NCT00688519|157237156|FG000|Overall Study|Non-compliance|0|||
48603417|NCT00764790|156403056|FG002|Overall Study|Protocol Violation|1|||
48603418|NCT00764790|156403054|FG000|Overall Study|Withdrawal by Subject|10|||
48603419|NCT00764790|156403055|FG001|Overall Study|Withdrawal by Subject|12|||
48603420|NCT00764790|156403056|FG002|Overall Study|Withdrawal by Subject|6|||
48603421|NCT00764790|156403054|FG000|Overall Study|Lost to Follow-up|28|||
48603422|NCT00764790|156403055|FG001|Overall Study|Lost to Follow-up|29|||
48603423|NCT00764790|156403056|FG002|Overall Study|Lost to Follow-up|23|||
48834913|NCT00688519|157237157|FG001|Overall Study|Non-compliance|1|||
48834914|NCT00688519|157237156|FG000|Overall Study|Subject moved out of state|1|||
48834915|NCT00688519|157237157|FG001|Overall Study|Subject moved out of state|0|||
48834916|NCT00688519|157237156|FG000|Overall Study|Investigator decision|1|||
48834917|NCT00688519|157237157|FG001|Overall Study|Investigator decision|0|||
48834918|NCT00688519|157237156|FG000|Overall Study|Subject moved out of area|1|||
48834919|NCT00688519|157237157|FG001|Overall Study|Subject moved out of area|0|||
48834920|NCT00688519|157237156|FG000|Overall Study|Pregnancy|0|||
48834921|NCT00688519|157237157|FG001|Overall Study|Pregnancy|1|||
48834922|NCT03512756|157237158|FG000|Part 1|Death|23|||
48834923|NCT03512756|157237159|FG001|Part 1|Death|18|||
48834924|NCT03512756|157237160|FG002|Part 1|Death|0|||
48834925|NCT03512756|157237161|FG003|Part 1|Death|0|||
48834926|NCT03512756|157237158|FG000|Part 1|Lost to Follow-up|0|||
48834927|NCT03512756|157237159|FG001|Part 1|Lost to Follow-up|3|||
48834928|NCT03512756|157237160|FG002|Part 1|Lost to Follow-up|0|||
48834929|NCT03512756|157237161|FG003|Part 1|Lost to Follow-up|0|||
48834930|NCT03512756|157237158|FG000|Part 1|Physician Decision|0|||
48834931|NCT03512756|157237159|FG001|Part 1|Physician Decision|1|||
48834932|NCT03512756|157237160|FG002|Part 1|Physician Decision|0|||
48834933|NCT03512756|157237161|FG003|Part 1|Physician Decision|0|||
48834934|NCT03512756|157237158|FG000|Part 1|Withdrawal by Subject|2|||
48834935|NCT03512756|157237159|FG001|Part 1|Withdrawal by Subject|2|||
48834936|NCT03512756|157237160|FG002|Part 1|Withdrawal by Subject|0|||
48834937|NCT03512756|157237161|FG003|Part 1|Withdrawal by Subject|0|||
48834938|NCT03512756|157237158|FG000|Part 2|Death|0|||
48834939|NCT03512756|157237159|FG001|Part 2|Death|0|||
48834940|NCT03512756|157237160|FG002|Part 2|Death|32|||
48834941|NCT03512756|157237161|FG003|Part 2|Death|21|||
48834942|NCT03512756|157237158|FG000|Part 2|Lost to Follow-up|0|||
48834943|NCT03512756|157237159|FG001|Part 2|Lost to Follow-up|0|||
48834944|NCT03512756|157237160|FG002|Part 2|Lost to Follow-up|1|||
48834945|NCT03512756|157237161|FG003|Part 2|Lost to Follow-up|0|||
48532748|NCT04889209|156138431|FG010|All Cohorts Except 15E|Death|0|||
48532749|NCT04889209|156138432|FG011|All Cohorts Except 15E|Death|0|||
48532750|NCT04889209|156138433|FG012|All Cohorts Except 15E|Death|0|||
48532751|NCT04889209|156138434|FG013|All Cohorts Except 15E|Death|0|||
48532752|NCT04889209|156138435|FG014|All Cohorts Except 15E|Death|0|||
48532753|NCT04889209|156138436|FG015|All Cohorts Except 15E|Death|0|||
48532754|NCT04889209|156138437|FG016|All Cohorts Except 15E|Death|0|||
48532755|NCT04889209|156138438|FG017|All Cohorts Except 15E|Death|0|||
48532756|NCT04889209|156138421|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
48532757|NCT04889209|156138422|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
48532758|NCT04889209|156138423|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
48532759|NCT04889209|156138424|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
48532760|NCT04889209|156138425|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
48532761|NCT04889209|156138426|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
48532762|NCT04889209|156138427|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
48532763|NCT04889209|156138428|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
48532764|NCT04889209|156138429|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
48532765|NCT04889209|156138430|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
48532766|NCT04889209|156138431|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
48532767|NCT04889209|156138432|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
48532768|NCT04889209|156138433|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
48532769|NCT04889209|156138434|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
48532770|NCT04889209|156138435|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
48532771|NCT04889209|156138436|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
48532772|NCT04889209|156138437|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
48532773|NCT04889209|156138438|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
48532774|NCT04889209|156138421|FG000|All Cohorts Except 15E|Physician Decision|0|||
48532775|NCT04889209|156138422|FG001|All Cohorts Except 15E|Physician Decision|0|||
48603424|NCT02404545|156403061|FG000|Overall Study|Sponsor Termination|6|||
48834946|NCT03512756|157237158|FG000|Part 2|Physician Decision|0|||
48834947|NCT03512756|157237159|FG001|Part 2|Physician Decision|0|||
48532776|NCT04889209|156138423|FG002|All Cohorts Except 15E|Physician Decision|0|||
48532777|NCT04889209|156138424|FG003|All Cohorts Except 15E|Physician Decision|0|||
48532778|NCT04889209|156138425|FG004|All Cohorts Except 15E|Physician Decision|1|||
48532779|NCT04889209|156138426|FG005|All Cohorts Except 15E|Physician Decision|0|||
48603425|NCT02404545|156403062|FG001|Overall Study|Sponsor Termination|6|||
48834948|NCT03512756|157237160|FG002|Part 2|Physician Decision|2|||
48834949|NCT03512756|157237161|FG003|Part 2|Physician Decision|4|||
48834950|NCT03512756|157237158|FG000|Part 2|Study Terminated by Sponsor|0|||
48834951|NCT03512756|157237159|FG001|Part 2|Study Terminated by Sponsor|0|||
48834952|NCT03512756|157237160|FG002|Part 2|Study Terminated by Sponsor|2|||
48834953|NCT03512756|157237161|FG003|Part 2|Study Terminated by Sponsor|6|||
48834954|NCT03512756|157237158|FG000|Part 2|Protocol Violation|0|||
48834955|NCT03512756|157237159|FG001|Part 2|Protocol Violation|0|||
48834956|NCT03512756|157237160|FG002|Part 2|Protocol Violation|1|||
48834957|NCT03512756|157237161|FG003|Part 2|Protocol Violation|0|||
48834958|NCT03512756|157237158|FG000|Part 2|Withdrawal by Subject|0|||
48834959|NCT03512756|157237159|FG001|Part 2|Withdrawal by Subject|0|||
48834960|NCT03512756|157237160|FG002|Part 2|Withdrawal by Subject|3|||
48834961|NCT03512756|157237161|FG003|Part 2|Withdrawal by Subject|9|||
48834962|NCT00943735|157238646|FG000|Overall Study|Adverse Event|12|||
48834963|NCT00943735|157238646|FG000|Overall Study|Withdrawal by Subject|8|||
48834964|NCT00943735|157238646|FG000|Overall Study|Death|1|||
48834965|NCT00943735|157238646|FG000|Overall Study|Other|8|||
48834966|NCT00943735|157238646|FG000|Overall Study|Other|3|||
48834967|NCT00831415|157238649|FG000|Overall Study|Adverse Event|14|||
48834968|NCT00831415|157238649|FG000|Overall Study|Failed to return|3|||
48834969|NCT00831415|157238649|FG000|Overall Study|Physician Decision|6|||
48834970|NCT00831415|157238649|FG000|Overall Study|Lost to Follow-up|9|||
48834971|NCT00831415|157238649|FG000|Overall Study|Protocol Violation|3|||
48834972|NCT00831415|157238649|FG000|Overall Study|Withdrawal by Subject|35|||
48834973|NCT00831415|157238649|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
48834974|NCT00831415|157238649|FG000|Overall Study|Death|1|||
48834975|NCT00246012|157238651|FG000|Overall Study|Adverse Event|0|||
48834976|NCT00246012|157238652|FG001|Overall Study|Adverse Event|0|||
48834977|NCT00246012|157238653|FG002|Overall Study|Adverse Event|0|||
48834978|NCT00246012|157238654|FG003|Overall Study|Adverse Event|0|||
48834979|NCT00246012|157238655|FG004|Overall Study|Adverse Event|0|||
48834980|NCT00246012|157238656|FG005|Overall Study|Adverse Event|1|||
48834981|NCT00246012|157238657|FG006|Overall Study|Adverse Event|0|||
48834982|NCT00246012|157238658|FG007|Overall Study|Adverse Event|0|||
48834983|NCT00246012|157238659|FG008|Overall Study|Adverse Event|2|||
48834984|NCT00246012|157238651|FG000|Overall Study|Withdrawal by Subject|0|||
48834985|NCT00246012|157238652|FG001|Overall Study|Withdrawal by Subject|0|||
48834986|NCT00246012|157238653|FG002|Overall Study|Withdrawal by Subject|0|||
48834987|NCT00246012|157238654|FG003|Overall Study|Withdrawal by Subject|0|||
48834988|NCT00246012|157238655|FG004|Overall Study|Withdrawal by Subject|0|||
48834989|NCT00246012|157238656|FG005|Overall Study|Withdrawal by Subject|1|||
48834990|NCT00246012|157238657|FG006|Overall Study|Withdrawal by Subject|0|||
48834991|NCT00246012|157238658|FG007|Overall Study|Withdrawal by Subject|0|||
48834992|NCT00246012|157238659|FG008|Overall Study|Withdrawal by Subject|0|||
48834993|NCT00246012|157238651|FG000|Overall Study|Disease progression|3|||
48834994|NCT00246012|157238652|FG001|Overall Study|Disease progression|1|||
48834995|NCT00246012|157238653|FG002|Overall Study|Disease progression|2|||
48834996|NCT00246012|157238654|FG003|Overall Study|Disease progression|3|||
48834997|NCT00246012|157238655|FG004|Overall Study|Disease progression|3|||
48834998|NCT00246012|157238656|FG005|Overall Study|Disease progression|25|||
48834999|NCT00246012|157238657|FG006|Overall Study|Disease progression|30|||
48835000|NCT00246012|157238658|FG007|Overall Study|Disease progression|27|||
48835001|NCT00246012|157238659|FG008|Overall Study|Disease progression|26|||
48835002|NCT00246012|157238651|FG000|Overall Study|Other|0|||
48835003|NCT00246012|157238652|FG001|Overall Study|Other|0|||
48835004|NCT00246012|157238653|FG002|Overall Study|Other|0|||
48835005|NCT00246012|157238654|FG003|Overall Study|Other|0|||
48835006|NCT00246012|157238655|FG004|Overall Study|Other|0|||
48835007|NCT00246012|157238656|FG005|Overall Study|Other|0|||
48835008|NCT00246012|157238657|FG006|Overall Study|Other|0|||
48835009|NCT00246012|157238658|FG007|Overall Study|Other|1|||
48835010|NCT00246012|157238659|FG008|Overall Study|Other|0|||
48835011|NCT00246012|157238651|FG000|Overall Study|Randomly assigned but not treated|0|||
48835012|NCT00246012|157238652|FG001|Overall Study|Randomly assigned but not treated|0|||
48835013|NCT00246012|157238653|FG002|Overall Study|Randomly assigned but not treated|0|||
48835014|NCT00246012|157238654|FG003|Overall Study|Randomly assigned but not treated|0|||
48835015|NCT00246012|157238655|FG004|Overall Study|Randomly assigned but not treated|0|||
48835016|NCT00246012|157238656|FG005|Overall Study|Randomly assigned but not treated|1|||
48835017|NCT00246012|157238657|FG006|Overall Study|Randomly assigned but not treated|1|||
48835018|NCT00246012|157238658|FG007|Overall Study|Randomly assigned but not treated|0|||
48835019|NCT00246012|157238659|FG008|Overall Study|Randomly assigned but not treated|0|||
48835020|NCT00855465|157238670|FG000|Treatment Period|Adverse Event|4|||
48835021|NCT00855465|157238671|FG001|Treatment Period|Adverse Event|2|||
48835022|NCT00855465|157238670|FG000|Treatment Period|Death|2|||
48835023|NCT00855465|157238671|FG001|Treatment Period|Death|2|||
48835024|NCT00855465|157238670|FG000|Treatment Period|Lack of Efficacy|2|||
48835025|NCT00855465|157238671|FG001|Treatment Period|Lack of Efficacy|1|||
48835026|NCT00855465|157238670|FG000|Treatment Period|Non-compliance|1|||
48835027|NCT00855465|157238671|FG001|Treatment Period|Non-compliance|0|||
48835028|NCT00855465|157238670|FG000|Treatment Period|Protocol Violation|2|||
48835029|NCT00855465|157238671|FG001|Treatment Period|Protocol Violation|0|||
48835030|NCT00855465|157238670|FG000|Treatment Period|Withdrawal by Subject|2|||
48835031|NCT00855465|157238671|FG001|Treatment Period|Withdrawal by Subject|0|||
48835032|NCT00855465|157238670|FG000|Treatment Period|Not treated|1|||
48532780|NCT04889209|156138427|FG006|All Cohorts Except 15E|Physician Decision|0|||
48532781|NCT04889209|156138428|FG007|All Cohorts Except 15E|Physician Decision|1|||
48532782|NCT04889209|156138429|FG008|All Cohorts Except 15E|Physician Decision|0|||
48532783|NCT04889209|156138430|FG009|All Cohorts Except 15E|Physician Decision|1|||
48532784|NCT04889209|156138431|FG010|All Cohorts Except 15E|Physician Decision|0|||
48532785|NCT04889209|156138432|FG011|All Cohorts Except 15E|Physician Decision|1|||
48532786|NCT04889209|156138433|FG012|All Cohorts Except 15E|Physician Decision|1|||
48532787|NCT04889209|156138434|FG013|All Cohorts Except 15E|Physician Decision|0|||
48532788|NCT04889209|156138435|FG014|All Cohorts Except 15E|Physician Decision|0|||
48532789|NCT04889209|156138436|FG015|All Cohorts Except 15E|Physician Decision|0|||
48532790|NCT04889209|156138437|FG016|All Cohorts Except 15E|Physician Decision|0|||
48532791|NCT04889209|156138438|FG017|All Cohorts Except 15E|Physician Decision|0|||
48532792|NCT04889209|156138421|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
48532793|NCT04889209|156138422|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
48532794|NCT04889209|156138423|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
48532795|NCT04889209|156138424|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
48532796|NCT04889209|156138425|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
48532797|NCT04889209|156138426|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
48532798|NCT04889209|156138427|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
48532799|NCT04889209|156138428|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
48532800|NCT04889209|156138429|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
48532801|NCT04889209|156138430|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
48532802|NCT04889209|156138431|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
48532803|NCT04889209|156138432|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
48532804|NCT04889209|156138433|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
48532805|NCT04889209|156138434|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
48532806|NCT04889209|156138435|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
48532807|NCT04889209|156138436|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
48532808|NCT04889209|156138437|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
48532809|NCT04889209|156138438|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
48532810|NCT04889209|156138421|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
48532811|NCT04889209|156138422|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
48532812|NCT04889209|156138423|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532813|NCT04889209|156138424|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532814|NCT04889209|156138425|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532815|NCT04889209|156138426|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
48532816|NCT04889209|156138427|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532817|NCT04889209|156138428|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
48532818|NCT04889209|156138429|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532819|NCT04889209|156138430|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
48532820|NCT04889209|156138431|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532821|NCT04889209|156138432|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532822|NCT04889209|156138433|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532823|NCT04889209|156138434|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532824|NCT04889209|156138435|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532825|NCT04889209|156138436|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532826|NCT04889209|156138437|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
48532827|NCT04889209|156138438|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
48532828|NCT04889209|156138421|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532829|NCT04889209|156138422|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532830|NCT04889209|156138423|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532831|NCT04889209|156138424|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
48532832|NCT04889209|156138425|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532833|NCT04889209|156138426|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532834|NCT04889209|156138427|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532835|NCT04889209|156138428|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532836|NCT04889209|156138429|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532837|NCT04889209|156138430|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48603426|NCT00103285|156404246|FG000|Induction|Adverse Event|14|||
48603427|NCT00103285|156404247|FG001|Induction|Adverse Event|0|||
48835033|NCT00855465|157238671|FG001|Treatment Period|Not treated|0|||
48835034|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Adverse Event|0|||
48835035|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Adverse Event|1|||
48835036|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Death|0|||
48835037|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Death|1|||
48532838|NCT04889209|156138431|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532839|NCT04889209|156138432|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532840|NCT04889209|156138433|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532841|NCT04889209|156138434|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48603428|NCT00103285|156404248|FG002|Induction|Adverse Event|0|||
48603429|NCT00103285|156404249|FG003|Induction|Adverse Event|0|||
48603430|NCT00103285|156404250|FG004|Induction|Adverse Event|0|||
48603431|NCT00103285|156404251|FG005|Induction|Adverse Event|0|||
48835038|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
48835039|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
48532842|NCT04889209|156138435|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532843|NCT04889209|156138436|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48603432|NCT00103285|156404252|FG006|Induction|Adverse Event|0|||
48603433|NCT00103285|156404253|FG007|Induction|Adverse Event|0|||
48603434|NCT00103285|156404246|FG000|Induction|Death|24|||
48603435|NCT00103285|156404247|FG001|Induction|Death|0|||
48603436|NCT00103285|156404248|FG002|Induction|Death|0|||
48603437|NCT00103285|156404249|FG003|Induction|Death|0|||
48835040|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
48835041|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
48835042|NCT00855465|157238670|FG000|Follow-up Period (FUP)|Missing|1|||
48835043|NCT00855465|157238671|FG001|Follow-up Period (FUP)|Missing|0|||
48835044|NCT00880048|157238674|FG000|Overall Study|Adverse Event|2|||
48835045|NCT00880048|157238675|FG001|Overall Study|Adverse Event|3|||
48835046|NCT00880048|157238676|FG002|Overall Study|Adverse Event|5|||
48835047|NCT00880048|157238674|FG000|Overall Study|Lack of Efficacy|1|||
48835048|NCT00880048|157238675|FG001|Overall Study|Lack of Efficacy|2|||
48835049|NCT00880048|157238676|FG002|Overall Study|Lack of Efficacy|2|||
48532844|NCT04889209|156138437|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532845|NCT04889209|156138438|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
48532846|NCT04889209|156138421|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532847|NCT04889209|156138422|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532848|NCT04889209|156138423|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532849|NCT04889209|156138424|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532850|NCT04889209|156138425|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
48532851|NCT04889209|156138426|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532852|NCT04889209|156138427|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
48532853|NCT04889209|156138428|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
48532854|NCT04889209|156138429|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532855|NCT04889209|156138430|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
48532856|NCT04889209|156138431|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
48532857|NCT04889209|156138432|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532858|NCT04889209|156138433|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
48532859|NCT04889209|156138434|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532860|NCT04889209|156138435|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532861|NCT04889209|156138436|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532862|NCT04889209|156138437|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
48532863|NCT04889209|156138438|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
48532864|NCT04889209|156138421|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532865|NCT04889209|156138422|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532866|NCT04889209|156138423|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532867|NCT04889209|156138424|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532868|NCT04889209|156138425|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532869|NCT04889209|156138426|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532870|NCT04889209|156138427|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532871|NCT04889209|156138428|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532872|NCT04889209|156138429|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532873|NCT04889209|156138430|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532874|NCT04889209|156138431|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532875|NCT04889209|156138432|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48603438|NCT00103285|156404250|FG004|Induction|Death|0|||
48603439|NCT00103285|156404251|FG005|Induction|Death|0|||
48603440|NCT00103285|156404252|FG006|Induction|Death|0|||
48835050|NCT00880048|157238674|FG000|Overall Study|Protocol Violation|4|||
48835051|NCT00880048|157238675|FG001|Overall Study|Protocol Violation|6|||
48835052|NCT00880048|157238676|FG002|Overall Study|Protocol Violation|5|||
48835053|NCT00880048|157238674|FG000|Overall Study|Lost to Follow-up|6|||
48835054|NCT00880048|157238675|FG001|Overall Study|Lost to Follow-up|6|||
48603441|NCT00103285|156404253|FG007|Induction|Death|0|||
48603442|NCT00103285|156404246|FG000|Induction|Physician Decision|103|||
48603443|NCT00103285|156404247|FG001|Induction|Physician Decision|0|||
48603444|NCT00103285|156404248|FG002|Induction|Physician Decision|0|||
48603445|NCT00103285|156404249|FG003|Induction|Physician Decision|0|||
48603446|NCT00103285|156404250|FG004|Induction|Physician Decision|0|||
48603447|NCT00103285|156404251|FG005|Induction|Physician Decision|0|||
48603448|NCT00103285|156404252|FG006|Induction|Physician Decision|0|||
48603449|NCT00103285|156404253|FG007|Induction|Physician Decision|0|||
48603450|NCT00103285|156404246|FG000|Induction|Withdrawal by Subject|1|||
48603451|NCT00103285|156404247|FG001|Induction|Withdrawal by Subject|0|||
48603452|NCT00103285|156404248|FG002|Induction|Withdrawal by Subject|0|||
48603453|NCT00103285|156404249|FG003|Induction|Withdrawal by Subject|0|||
48603454|NCT00103285|156404250|FG004|Induction|Withdrawal by Subject|0|||
48603455|NCT00103285|156404251|FG005|Induction|Withdrawal by Subject|0|||
48603456|NCT00103285|156404252|FG006|Induction|Withdrawal by Subject|0|||
48603457|NCT00103285|156404253|FG007|Induction|Withdrawal by Subject|0|||
48603458|NCT00103285|156404246|FG000|Induction|Ineligible|43|||
48603459|NCT00103285|156404247|FG001|Induction|Ineligible|0|||
48603460|NCT00103285|156404248|FG002|Induction|Ineligible|0|||
48603461|NCT00103285|156404249|FG003|Induction|Ineligible|0|||
48603462|NCT00103285|156404250|FG004|Induction|Ineligible|0|||
48603463|NCT00103285|156404251|FG005|Induction|Ineligible|0|||
48603464|NCT00103285|156404252|FG006|Induction|Ineligible|0|||
48603465|NCT00103285|156404253|FG007|Induction|Ineligible|0|||
48603466|NCT00103285|156404246|FG000|Induction|Refusal|906|||
48603467|NCT00103285|156404247|FG001|Induction|Refusal|0|||
48603468|NCT00103285|156404248|FG002|Induction|Refusal|0|||
48603469|NCT00103285|156404249|FG003|Induction|Refusal|0|||
48603470|NCT00103285|156404250|FG004|Induction|Refusal|0|||
48603471|NCT00103285|156404251|FG005|Induction|Refusal|0|||
48603472|NCT00103285|156404252|FG006|Induction|Refusal|0|||
48603473|NCT00103285|156404253|FG007|Induction|Refusal|0|||
48603474|NCT00103285|156404246|FG000|Induction|Other|258|||
48603475|NCT00103285|156404247|FG001|Induction|Other|0|||
48603476|NCT00103285|156404248|FG002|Induction|Other|0|||
48603477|NCT00103285|156404249|FG003|Induction|Other|0|||
48603478|NCT00103285|156404250|FG004|Induction|Other|0|||
48603479|NCT00103285|156404251|FG005|Induction|Other|0|||
48835055|NCT00880048|157238676|FG002|Overall Study|Lost to Follow-up|5|||
48835056|NCT00880048|157238674|FG000|Overall Study|Physician Decision|1|||
48835057|NCT00880048|157238675|FG001|Overall Study|Physician Decision|1|||
48835058|NCT00880048|157238676|FG002|Overall Study|Physician Decision|7|||
48835059|NCT00880048|157238674|FG000|Overall Study|Withdrawal by Subject|5|||
48835060|NCT00880048|157238675|FG001|Overall Study|Withdrawal by Subject|8|||
48835061|NCT00880048|157238676|FG002|Overall Study|Withdrawal by Subject|5|||
48532876|NCT04889209|156138433|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532877|NCT04889209|156138434|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532878|NCT04889209|156138435|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532879|NCT04889209|156138436|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532880|NCT04889209|156138437|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
48532881|NCT04889209|156138438|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
48532882|NCT04889209|156138421|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532883|NCT04889209|156138422|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532884|NCT04889209|156138423|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532885|NCT04889209|156138424|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532886|NCT04889209|156138425|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532887|NCT04889209|156138426|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532888|NCT04889209|156138427|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532889|NCT04889209|156138428|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532890|NCT04889209|156138429|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532891|NCT04889209|156138430|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532892|NCT04889209|156138431|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532893|NCT04889209|156138432|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532894|NCT04889209|156138433|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532895|NCT04889209|156138434|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48603480|NCT00103285|156404252|FG006|Induction|Other|0|||
48603481|NCT00103285|156404253|FG007|Induction|Other|0|||
48603482|NCT00103285|156404246|FG000|Response Assignment|Adverse Event|0|||
48603483|NCT00103285|156404247|FG001|Response Assignment|Adverse Event|8|||
48835062|NCT00880048|157238674|FG000|Overall Study|Study closed/terminated|9|||
48603484|NCT00103285|156404248|FG002|Response Assignment|Adverse Event|3|||
48603485|NCT00103285|156404249|FG003|Response Assignment|Adverse Event|2|||
48603486|NCT00103285|156404250|FG004|Response Assignment|Adverse Event|3|||
48603487|NCT00103285|156404251|FG005|Response Assignment|Adverse Event|1|||
48603488|NCT00103285|156404252|FG006|Response Assignment|Adverse Event|1|||
48603489|NCT00103285|156404253|FG007|Response Assignment|Adverse Event|2|||
48603490|NCT00103285|156404246|FG000|Response Assignment|Death|0|||
48603491|NCT00103285|156404247|FG001|Response Assignment|Death|5|||
48603492|NCT00103285|156404248|FG002|Response Assignment|Death|2|||
48603493|NCT00103285|156404249|FG003|Response Assignment|Death|2|||
48603494|NCT00103285|156404250|FG004|Response Assignment|Death|3|||
48603495|NCT00103285|156404251|FG005|Response Assignment|Death|1|||
48603496|NCT00103285|156404252|FG006|Response Assignment|Death|0|||
48603497|NCT00103285|156404253|FG007|Response Assignment|Death|8|||
48603498|NCT00103285|156404246|FG000|Response Assignment|Lost to Follow-up|0|||
48603499|NCT00103285|156404247|FG001|Response Assignment|Lost to Follow-up|9|||
48603500|NCT00103285|156404248|FG002|Response Assignment|Lost to Follow-up|5|||
48603501|NCT00103285|156404249|FG003|Response Assignment|Lost to Follow-up|5|||
48603502|NCT00103285|156404250|FG004|Response Assignment|Lost to Follow-up|1|||
48603503|NCT00103285|156404251|FG005|Response Assignment|Lost to Follow-up|2|||
48603504|NCT00103285|156404252|FG006|Response Assignment|Lost to Follow-up|2|||
48603505|NCT00103285|156404253|FG007|Response Assignment|Lost to Follow-up|5|||
48603506|NCT00103285|156404246|FG000|Response Assignment|Physician Decision|0|||
48603507|NCT00103285|156404247|FG001|Response Assignment|Physician Decision|13|||
48603508|NCT00103285|156404248|FG002|Response Assignment|Physician Decision|14|||
48603509|NCT00103285|156404249|FG003|Response Assignment|Physician Decision|9|||
48603510|NCT00103285|156404250|FG004|Response Assignment|Physician Decision|13|||
48603511|NCT00103285|156404251|FG005|Response Assignment|Physician Decision|7|||
48603512|NCT00103285|156404252|FG006|Response Assignment|Physician Decision|4|||
48603513|NCT00103285|156404253|FG007|Response Assignment|Physician Decision|35|||
48603514|NCT00103285|156404246|FG000|Response Assignment|Protocol Violation|0|||
48603515|NCT00103285|156404247|FG001|Response Assignment|Protocol Violation|2|||
48603516|NCT00103285|156404248|FG002|Response Assignment|Protocol Violation|0|||
48603517|NCT00103285|156404249|FG003|Response Assignment|Protocol Violation|0|||
48603518|NCT00103285|156404250|FG004|Response Assignment|Protocol Violation|0|||
48603519|NCT00103285|156404251|FG005|Response Assignment|Protocol Violation|0|||
48603520|NCT00103285|156404252|FG006|Response Assignment|Protocol Violation|0|||
48603521|NCT00103285|156404253|FG007|Response Assignment|Protocol Violation|0|||
48603522|NCT00103285|156404246|FG000|Response Assignment|Withdrawal by Subject|0|||
48603523|NCT00103285|156404247|FG001|Response Assignment|Withdrawal by Subject|4|||
48603524|NCT00103285|156404248|FG002|Response Assignment|Withdrawal by Subject|1|||
48603525|NCT00103285|156404249|FG003|Response Assignment|Withdrawal by Subject|1|||
48603526|NCT00103285|156404250|FG004|Response Assignment|Withdrawal by Subject|2|||
48603527|NCT00103285|156404251|FG005|Response Assignment|Withdrawal by Subject|2|||
48603528|NCT00103285|156404252|FG006|Response Assignment|Withdrawal by Subject|0|||
48603529|NCT00103285|156404253|FG007|Response Assignment|Withdrawal by Subject|2|||
48835063|NCT00880048|157238675|FG001|Overall Study|Study closed/terminated|7|||
48835064|NCT00880048|157238676|FG002|Overall Study|Study closed/terminated|6|||
48835065|NCT00367991|157238684|FG000|Overall Study|Withdrawal by Subject|1|||
48835066|NCT00367991|157238685|FG001|Overall Study|Withdrawal by Subject|1|||
48835067|NCT00367991|157238684|FG000|Overall Study|Adverse Event|1|||
48835068|NCT00367991|157238685|FG001|Overall Study|Adverse Event|1|||
48835069|NCT03247543|157238688|FG000|Overall Study|Adverse Event|3|||
48835070|NCT03247543|157238689|FG001|Overall Study|Adverse Event|6|||
48835071|NCT03247543|157238690|FG002|Overall Study|Adverse Event|4|||
48835072|NCT03247543|157238688|FG000|Overall Study|Lost to Follow-up|10|||
48835073|NCT03247543|157238689|FG001|Overall Study|Lost to Follow-up|7|||
48835074|NCT03247543|157238690|FG002|Overall Study|Lost to Follow-up|8|||
48835075|NCT03247543|157238688|FG000|Overall Study|Consent withdrawn by caregiver|2|||
48835076|NCT03247543|157238689|FG001|Overall Study|Consent withdrawn by caregiver|2|||
48835077|NCT03247543|157238690|FG002|Overall Study|Consent withdrawn by caregiver|9|||
48835078|NCT03247543|157238688|FG000|Overall Study|Withdrawal by Subject|0|||
48835079|NCT03247543|157238689|FG001|Overall Study|Withdrawal by Subject|0|||
48835080|NCT03247543|157238690|FG002|Overall Study|Withdrawal by Subject|1|||
48835081|NCT03247543|157238688|FG000|Overall Study|Failure to Follow study procedures|1|||
48835082|NCT03247543|157238689|FG001|Overall Study|Failure to Follow study procedures|3|||
48835083|NCT03247543|157238690|FG002|Overall Study|Failure to Follow study procedures|1|||
48835084|NCT03247543|157238688|FG000|Overall Study|Lack of Efficacy|1|||
48835085|NCT03247543|157238689|FG001|Overall Study|Lack of Efficacy|0|||
48835086|NCT03247543|157238690|FG002|Overall Study|Lack of Efficacy|0|||
48835087|NCT03247543|157238688|FG000|Overall Study|Non-compliance with study visits|0|||
48835088|NCT03247543|157238689|FG001|Overall Study|Non-compliance with study visits|1|||
48835089|NCT03247543|157238690|FG002|Overall Study|Non-compliance with study visits|0|||
48835090|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
48835091|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
48835092|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
48835093|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
48835094|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
48835095|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
48835096|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
48835097|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
48835098|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
48835099|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
48603530|NCT00103285|156404246|FG000|Response Assignment|Ineligible|0|||
48603531|NCT00103285|156404247|FG001|Response Assignment|Ineligible|8|||
48603532|NCT00103285|156404248|FG002|Response Assignment|Ineligible|6|||
48603533|NCT00103285|156404249|FG003|Response Assignment|Ineligible|2|||
48603534|NCT00103285|156404250|FG004|Response Assignment|Ineligible|0|||
48835100|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48532896|NCT04889209|156138435|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532897|NCT04889209|156138436|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532898|NCT04889209|156138437|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
48532899|NCT04889209|156138438|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
48532900|NCT04889209|156138421|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532901|NCT04889209|156138422|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532902|NCT04889209|156138423|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532903|NCT04889209|156138424|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532904|NCT04889209|156138425|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532905|NCT04889209|156138426|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532906|NCT04889209|156138427|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532907|NCT04889209|156138428|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532908|NCT04889209|156138429|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532909|NCT04889209|156138430|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532910|NCT04889209|156138431|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532911|NCT04889209|156138432|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532912|NCT04889209|156138433|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532913|NCT04889209|156138434|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532914|NCT04889209|156138435|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
48532915|NCT04889209|156138436|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532916|NCT04889209|156138437|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532917|NCT04889209|156138438|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
48532918|NCT02000531|156138444|FG000|Overall Study|Lost to Follow-up|1|||
48532919|NCT02000531|156138445|FG001|Overall Study|Lost to Follow-up|0|||
48603535|NCT00103285|156404251|FG005|Response Assignment|Ineligible|3|||
48603536|NCT00103285|156404252|FG006|Response Assignment|Ineligible|1|||
48835101|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
48835102|NCT00790790|157238691|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
48835103|NCT00790790|157238692|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
48835104|NCT00790790|157238693|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
48835105|NCT02059980|157238700|FG000|Overall Study|Lost to Follow-up|2|||
48835106|NCT02059980|157238701|FG001|Overall Study|Lost to Follow-up|1|||
48835107|NCT01321606|157238702|FG000|Overall Study|Lost to Follow-up|0|||
48835108|NCT01321606|157238703|FG001|Overall Study|Lost to Follow-up|0|||
48835109|NCT01321606|157238704|FG002|Overall Study|Lost to Follow-up|0|||
48835110|NCT01321606|157238705|FG003|Overall Study|Lost to Follow-up|1|||
48835111|NCT02808338|157238706|FG000|Screening|Screen Failure|10|||
48835112|NCT02808338|157238706|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
48835113|NCT02808338|157238706|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
48835114|NCT02194933|157238710|FG000|Overall Study|Lost to Follow-up|1|||
48835115|NCT02194933|157238711|FG001|Overall Study|Lost to Follow-up|2|||
48835116|NCT02194933|157238710|FG000|Overall Study|Participant met withdrawal criteria|1|||
48835117|NCT02194933|157238711|FG001|Overall Study|Participant met withdrawal criteria|3|||
48835118|NCT02194933|157238710|FG000|Overall Study|Withdrawal by Subject|0|||
48835119|NCT02194933|157238711|FG001|Overall Study|Withdrawal by Subject|2|||
48835120|NCT02194933|157238710|FG000|Overall Study|Lack of Efficacy|1|||
48835121|NCT02194933|157238711|FG001|Overall Study|Lack of Efficacy|2|||
48835122|NCT01104415|157238712|FG000|Core Phase|Consent withdrawn by subjects|1|||
48835123|NCT01104415|157238713|FG001|Core Phase|Consent withdrawn by subjects|0|||
48835124|NCT01104415|157238712|FG000|Extension Period|Progressive disease|0|||
48835125|NCT01104415|157238713|FG001|Extension Period|Progressive disease|4|||
48835126|NCT01104415|157238712|FG000|Extension Period|Death|0|||
48835127|NCT01104415|157238713|FG001|Extension Period|Death|1|||
48835128|NCT01104415|157238712|FG000|Extension Period|Physician Decision|0|||
48835129|NCT01104415|157238713|FG001|Extension Period|Physician Decision|1|||
48835130|NCT01104415|157238712|FG000|Extension Period|Transition to Study LX1606.302|0|||
48835131|NCT01104415|157238713|FG001|Extension Period|Transition to Study LX1606.302|4|||
48835132|NCT01104415|157238712|FG000|Extension Period|Heart surgery/feeling miserable|0|||
48835133|NCT01104415|157238713|FG001|Extension Period|Heart surgery/feeling miserable|1|||
48835134|NCT00057837|157238721|FG000|Overall Study|Progression/relapse|12|||
48603537|NCT00103285|156404253|FG007|Response Assignment|Ineligible|5|||
48835135|NCT00057837|157238722|FG001|Overall Study|Progression/relapse|14|||
48835136|NCT00057837|157238721|FG000|Overall Study|Adverse Event|2|||
48532920|NCT02000531|156138444|FG000|Overall Study|Discontinued due to data cut-off|3|||
48532921|NCT02000531|156138445|FG001|Overall Study|Discontinued due to data cut-off|8|||
48835137|NCT00057837|157238722|FG001|Overall Study|Adverse Event|12|||
48835138|NCT00057837|157238721|FG000|Overall Study|Death|5|||
48835139|NCT00057837|157238722|FG001|Overall Study|Death|4|||
48835140|NCT00057837|157238721|FG000|Overall Study|Withdrawal by Subject|5|||
48835141|NCT00057837|157238722|FG001|Overall Study|Withdrawal by Subject|3|||
48835142|NCT00057837|157238721|FG000|Overall Study|Alternative therapy|0|||
48835143|NCT00057837|157238722|FG001|Overall Study|Alternative therapy|1|||
48835144|NCT00057837|157238721|FG000|Overall Study|Other complicating disease|2|||
48835145|NCT00057837|157238722|FG001|Overall Study|Other complicating disease|1|||
48835146|NCT00057837|157238721|FG000|Overall Study|Physician Decision|1|||
48835147|NCT00057837|157238722|FG001|Overall Study|Physician Decision|0|||
48835148|NCT00057837|157238721|FG000|Overall Study|Ineligible|3|||
48835149|NCT00057837|157238722|FG001|Overall Study|Ineligible|3|||
48835150|NCT00057837|157238721|FG000|Overall Study|Never started treatment|1|||
48835151|NCT00057837|157238722|FG001|Overall Study|Never started treatment|1|||
48835152|NCT05001945|157238725|FG000|Overall Study|Adverse Event|0|||
48835153|NCT05001945|157238726|FG001|Overall Study|Adverse Event|0|||
48835154|NCT05001945|157238727|FG002|Overall Study|Adverse Event|0|||
48835155|NCT05001945|157238728|FG003|Overall Study|Adverse Event|1|||
48835156|NCT05001945|157238729|FG004|Overall Study|Adverse Event|0|||
48835157|NCT05001945|157238730|FG005|Overall Study|Adverse Event|0|||
48835158|NCT05001945|157238731|FG006|Overall Study|Adverse Event|0|||
48835159|NCT05001945|157238732|FG007|Overall Study|Adverse Event|0|||
48835160|NCT05001945|157238725|FG000|Overall Study|Lost to Follow-up|0|||
48835161|NCT05001945|157238726|FG001|Overall Study|Lost to Follow-up|1|||
48835162|NCT05001945|157238727|FG002|Overall Study|Lost to Follow-up|1|||
48835163|NCT05001945|157238728|FG003|Overall Study|Lost to Follow-up|2|||
48835164|NCT05001945|157238729|FG004|Overall Study|Lost to Follow-up|0|||
48835165|NCT05001945|157238730|FG005|Overall Study|Lost to Follow-up|1|||
48835166|NCT05001945|157238731|FG006|Overall Study|Lost to Follow-up|0|||
48835167|NCT05001945|157238732|FG007|Overall Study|Lost to Follow-up|0|||
48835168|NCT05001945|157238725|FG000|Overall Study|Protocol Violation|1|||
48835169|NCT05001945|157238726|FG001|Overall Study|Protocol Violation|0|||
48835170|NCT05001945|157238727|FG002|Overall Study|Protocol Violation|1|||
48835171|NCT05001945|157238728|FG003|Overall Study|Protocol Violation|1|||
48835172|NCT05001945|157238729|FG004|Overall Study|Protocol Violation|0|||
48835173|NCT05001945|157238730|FG005|Overall Study|Protocol Violation|1|||
48835174|NCT05001945|157238731|FG006|Overall Study|Protocol Violation|0|||
48835175|NCT05001945|157238732|FG007|Overall Study|Protocol Violation|0|||
48835176|NCT05001945|157238725|FG000|Overall Study|Withdrawal by Subject|0|||
48835177|NCT05001945|157238726|FG001|Overall Study|Withdrawal by Subject|0|||
48835178|NCT05001945|157238727|FG002|Overall Study|Withdrawal by Subject|0|||
48835179|NCT05001945|157238728|FG003|Overall Study|Withdrawal by Subject|1|||
48835180|NCT05001945|157238729|FG004|Overall Study|Withdrawal by Subject|1|||
48835181|NCT05001945|157238730|FG005|Overall Study|Withdrawal by Subject|1|||
48532922|NCT00794417|156138446|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
48532923|NCT00794417|156138447|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
48532924|NCT00794417|156138448|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
48532925|NCT00794417|156138449|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
48532926|NCT00794417|156138446|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
48532927|NCT00794417|156138447|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
48532928|NCT00794417|156138448|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
48532929|NCT00794417|156138449|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
48532930|NCT00794417|156138446|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
48532931|NCT00794417|156138447|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
48532932|NCT00794417|156138448|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
48532933|NCT00794417|156138449|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
48532934|NCT00794417|156138446|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
48532935|NCT00794417|156138447|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
48532936|NCT00794417|156138448|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
48532937|NCT00794417|156138449|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
48532938|NCT00794417|156138446|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
48532939|NCT00794417|156138447|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
48532940|NCT00794417|156138448|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
48532941|NCT00794417|156138449|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
48532942|NCT00794417|156138446|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
48532943|NCT00794417|156138447|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
48835182|NCT05001945|157238731|FG006|Overall Study|Withdrawal by Subject|0|||
48835183|NCT05001945|157238732|FG007|Overall Study|Withdrawal by Subject|1|||
48835184|NCT05001945|157238725|FG000|Overall Study|Not specified by Investigator|0|||
48835185|NCT05001945|157238726|FG001|Overall Study|Not specified by Investigator|3|||
48835186|NCT05001945|157238727|FG002|Overall Study|Not specified by Investigator|0|||
48532944|NCT00794417|156138448|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
48532945|NCT00794417|156138449|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
48532946|NCT00348816|156138454|FG000|Overall Study|Noncompliance with radiation treatment|1|||
48532947|NCT01042535|156138457|FG000|Overall Study|disease progression prior to treatment|3|||
48532948|NCT01042535|156138457|FG000|Overall Study|disease progression during treatment|3|||
48532949|NCT01042535|156138457|FG000|Overall Study|complications from other disease|2|||
48532950|NCT01345318|156138461|FG000|Overall Study|Adverse Event|16|||
48532951|NCT01345318|156138461|FG000|Overall Study|Lack of Efficacy|17|||
48532952|NCT01345318|156138461|FG000|Overall Study|Lost to Follow-up|2|||
48532953|NCT01345318|156138461|FG000|Overall Study|Protocol Violation|1|||
48532954|NCT01345318|156138461|FG000|Overall Study|Withdrawal by Subject|41|||
48603538|NCT00103285|156404246|FG000|Response Assignment|Refusal|0|||
48835187|NCT05001945|157238728|FG003|Overall Study|Not specified by Investigator|0|||
48835188|NCT05001945|157238729|FG004|Overall Study|Not specified by Investigator|1|||
48835189|NCT05001945|157238730|FG005|Overall Study|Not specified by Investigator|0|||
48835190|NCT05001945|157238731|FG006|Overall Study|Not specified by Investigator|0|||
48532955|NCT01345318|156138461|FG000|Overall Study|Other|3|||
48532956|NCT00317642|156138462|FG000|Overall Study|Not Received Either Study Drug|1|||
48532957|NCT00317642|156138463|FG001|Overall Study|Not Received Either Study Drug|3|||
48532958|NCT00317642|156138462|FG000|Overall Study|Physician Decision|15|||
48532959|NCT00317642|156138463|FG001|Overall Study|Physician Decision|7|||
48532960|NCT00317642|156138462|FG000|Overall Study|Participant declined treatment|14|||
48532961|NCT00317642|156138463|FG001|Overall Study|Participant declined treatment|3|||
48532962|NCT00317642|156138462|FG000|Overall Study|Adverse Event|17|||
48532963|NCT00317642|156138463|FG001|Overall Study|Adverse Event|5|||
48532964|NCT00317642|156138462|FG000|Overall Study|Treatment Failure|56|||
48532965|NCT00317642|156138463|FG001|Overall Study|Treatment Failure|102|||
48532966|NCT00317642|156138462|FG000|Overall Study|Disease Recurrence|1|||
48532967|NCT00317642|156138463|FG001|Overall Study|Disease Recurrence|2|||
48532968|NCT00317642|156138462|FG000|Overall Study|Death|14|||
48532969|NCT00317642|156138463|FG001|Overall Study|Death|7|||
48532970|NCT00317642|156138462|FG000|Overall Study|Not Continue to Consolidation|2|||
48532971|NCT00317642|156138463|FG001|Overall Study|Not Continue to Consolidation|0|||
48532972|NCT00317642|156138462|FG000|Overall Study|Withdrawal by Subject|0|||
48532973|NCT00317642|156138463|FG001|Overall Study|Withdrawal by Subject|1|||
48532974|NCT00317642|156138462|FG000|Overall Study|Referred For Transplantation|1|||
48532975|NCT00317642|156138463|FG001|Overall Study|Referred For Transplantation|0|||
48532976|NCT00317642|156138462|FG000|Overall Study|AML Not Centrally Confirmed|1|||
48532977|NCT00317642|156138463|FG001|Overall Study|AML Not Centrally Confirmed|5|||
48532978|NCT01546142|156138464|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
48532979|NCT01546142|156138465|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
48532980|NCT01546142|156138464|FG000|Overall Study|Subject Noncompliance|1|||
48532981|NCT01546142|156138465|FG001|Overall Study|Subject Noncompliance|1|||
48603539|NCT00103285|156404247|FG001|Response Assignment|Refusal|53|||
48603540|NCT00103285|156404248|FG002|Response Assignment|Refusal|5|||
48835191|NCT05001945|157238732|FG007|Overall Study|Not specified by Investigator|0|||
48835192|NCT00756730|157238733|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
48835193|NCT00756730|157238734|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
48835194|NCT00756730|157238733|FG000|Overall Study|persistent low-level viremmia|0|||
48835195|NCT00756730|157238734|FG001|Overall Study|persistent low-level viremmia|1|||
48835196|NCT02798835|157238736|FG000|Overall Study|Protocol Violation|0|||
48835197|NCT02798835|157238737|FG001|Overall Study|Protocol Violation|0|||
48835198|NCT02798835|157238738|FG002|Overall Study|Protocol Violation|3|||
48835199|NCT01081145|157238739|FG000|Open-Label Phase|Lack of Efficacy|56|||
48835200|NCT01081145|157238740|FG001|Open-Label Phase|Lack of Efficacy|0|||
48835201|NCT01081145|157238739|FG000|Open-Label Phase|Response criteria not met|46|||
48835202|NCT01081145|157238740|FG001|Open-Label Phase|Response criteria not met|0|||
48835203|NCT01081145|157238739|FG000|Open-Label Phase|Adverse Event|42|||
48603541|NCT00103285|156404249|FG003|Response Assignment|Refusal|3|||
48603542|NCT00103285|156404250|FG004|Response Assignment|Refusal|25|||
48835204|NCT01081145|157238740|FG001|Open-Label Phase|Adverse Event|0|||
48835205|NCT01081145|157238739|FG000|Open-Label Phase|Withdrawal by Subject|41|||
48835206|NCT01081145|157238740|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48835207|NCT01081145|157238739|FG000|Open-Label Phase|Other|12|||
48532982|NCT01546142|156138464|FG000|Overall Study|Adverse Event|6|||
48532983|NCT01546142|156138465|FG001|Overall Study|Adverse Event|3|||
48532984|NCT01546142|156138464|FG000|Overall Study|Lost to Follow-up|20|||
48532985|NCT01546142|156138465|FG001|Overall Study|Lost to Follow-up|15|||
48532986|NCT01546142|156138464|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
48603543|NCT00103285|156404251|FG005|Response Assignment|Refusal|15|||
48532987|NCT01546142|156138465|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
48532988|NCT01546142|156138464|FG000|Overall Study|Subject Randomized but Not Treated|1|||
48532989|NCT01546142|156138465|FG001|Overall Study|Subject Randomized but Not Treated|0|||
48532990|NCT00848042|156138468|FG000|Overall Study|Death|1|||
48603544|NCT00103285|156404252|FG006|Response Assignment|Refusal|30|||
48603545|NCT00103285|156404253|FG007|Response Assignment|Refusal|10|||
48603546|NCT00103285|156404246|FG000|Response Assignment|Other|0|||
48532991|NCT00848042|156138469|FG001|Overall Study|Death|2|||
48532992|NCT00848042|156138470|FG002|Overall Study|Death|0|||
48532993|NCT00848042|156138468|FG000|Overall Study|Other Therapy|3|||
48532994|NCT00848042|156138469|FG001|Overall Study|Other Therapy|0|||
48532995|NCT00848042|156138470|FG002|Overall Study|Other Therapy|0|||
48532996|NCT00707434|156138474|FG000|Overall Study|Adverse Event|1|||
48532997|NCT03585959|156138475|FG000|Overall Study|Physician Decision|1|||
48532998|NCT03585959|156138475|FG000|Overall Study|Unsuccessful Procedure|2|||
48532999|NCT02531594|156138476|FG000|Overall Study|Withdrawal by Subject|7|||
48533000|NCT02531594|156138477|FG001|Overall Study|Withdrawal by Subject|8|||
48533001|NCT00775606|156138483|FG000|Overall Study|Study sponsor terminated funding|3|||
48533002|NCT00775606|156138484|FG001|Overall Study|Study sponsor terminated funding|0|||
48533003|NCT04435782|156138485|FG000|Overall Study|Study terminated by sponsor|4|||
48533004|NCT05158504|156138486|FG000|Overall Study|Lost to Follow-up|2|||
48533005|NCT05158504|156138487|FG001|Overall Study|Lost to Follow-up|3|||
48603547|NCT00103285|156404247|FG001|Response Assignment|Other|30|||
48603548|NCT00103285|156404248|FG002|Response Assignment|Other|48|||
48603549|NCT00103285|156404249|FG003|Response Assignment|Other|38|||
48603550|NCT00103285|156404250|FG004|Response Assignment|Other|37|||
48603551|NCT00103285|156404251|FG005|Response Assignment|Other|17|||
48603552|NCT00103285|156404252|FG006|Response Assignment|Other|11|||
48603553|NCT00103285|156404253|FG007|Response Assignment|Other|53|||
48603554|NCT00452439|156404256|FG000|Overall Study|Lost to Follow-up|1|||
48603555|NCT00452439|156404257|FG001|Overall Study|Lost to Follow-up|1|||
48603556|NCT00452439|156404256|FG000|Overall Study|Refused Treatment|4|||
48603557|NCT00452439|156404257|FG001|Overall Study|Refused Treatment|3|||
48603558|NCT00452439|156404256|FG000|Overall Study|Death|3|||
48603559|NCT00452439|156404257|FG001|Overall Study|Death|1|||
48835208|NCT01081145|157238740|FG001|Open-Label Phase|Other|0|||
48835209|NCT01081145|157238739|FG000|Open-Label Phase|Lost to Follow-up|11|||
48603560|NCT00452439|156404256|FG000|Overall Study|Bone Marrow Transplant|0|||
48603561|NCT00452439|156404257|FG001|Overall Study|Bone Marrow Transplant|1|||
48603562|NCT00452439|156404256|FG000|Overall Study|Too Ill to Continue|0|||
48603563|NCT00452439|156404257|FG001|Overall Study|Too Ill to Continue|1|||
48835210|NCT01081145|157238740|FG001|Open-Label Phase|Lost to Follow-up|0|||
48533062|NCT01056640|156138495|FG000|Overall Study|Withdrawal by Subject|11|||
48533063|NCT01056640|156138496|FG001|Overall Study|Withdrawal by Subject|8|||
48533064|NCT01056640|156138495|FG000|Overall Study|Death|15|||
48533065|NCT01056640|156138496|FG001|Overall Study|Death|4|||
48533066|NCT03718117|156138497|FG000|Overall Study|Death|12|||
48533067|NCT03718117|156138498|FG001|Overall Study|Death|11|||
48533068|NCT03718117|156138499|FG002|Overall Study|Death|0|||
48603564|NCT00452439|156404256|FG000|Overall Study|Failed to achieve complete response|2|||
48835211|NCT01081145|157238739|FG000|Open-Label Phase|Protocol Violation|4|||
48835212|NCT01081145|157238740|FG001|Open-Label Phase|Protocol Violation|0|||
48835213|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
48835214|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
48835215|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
48835216|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
48835217|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
48835218|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
48835219|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
48835220|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
48835221|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
48835222|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
48835223|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
48835224|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
48835225|NCT01081145|157238739|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
48835226|NCT01081145|157238740|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
48835227|NCT00639002|157238744|FG000|Overall Study|Death|1|||
48835228|NCT00639002|157238744|FG000|Overall Study|Adverse Event|1|||
48835229|NCT00639002|157238744|FG000|Overall Study|Protocol Violation|1|||
48835230|NCT00639002|157238744|FG000|Overall Study|Disease progression|3|||
48835231|NCT00639002|157238744|FG000|Overall Study|Physician Decision|6|||
48835232|NCT00639002|157238744|FG000|Overall Study|Lack of Efficacy|1|||
48835233|NCT01430611|157238748|FG000|Overall Study|Adverse Event|0|||
48835234|NCT01430611|157238749|FG001|Overall Study|Adverse Event|1|||
48835235|NCT01430611|157238748|FG000|Overall Study|Protocol Violation|1|||
48835236|NCT01430611|157238749|FG001|Overall Study|Protocol Violation|0|||
48835237|NCT01430611|157238748|FG000|Overall Study|Lost to Follow-up|1|||
48835238|NCT01430611|157238749|FG001|Overall Study|Lost to Follow-up|0|||
48835239|NCT01430611|157238748|FG000|Overall Study|Withdrawal by Subject|15|||
48835240|NCT01430611|157238749|FG001|Overall Study|Withdrawal by Subject|14|||
48835241|NCT01968226|157238750|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
48835242|NCT01909778|157238753|FG000|Overall Study|failed screening|1|||
48835243|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
48835244|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
48835245|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
48835246|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
48835247|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
48835248|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
48835249|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
48835250|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
48835251|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
48835252|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
48835253|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
48835254|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
48533069|NCT03718117|156138497|FG000|Overall Study|Other|0|||
48533070|NCT03718117|156138498|FG001|Overall Study|Other|1|||
48533071|NCT03718117|156138499|FG002|Overall Study|Other|0|||
48533072|NCT03718117|156138497|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
48533073|NCT03718117|156138498|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
48533074|NCT03718117|156138499|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
48533075|NCT03718117|156138497|FG000|Overall Study|Participant not met eligibility criteria|0|||
48533076|NCT03718117|156138498|FG001|Overall Study|Participant not met eligibility criteria|0|||
48533077|NCT03718117|156138499|FG002|Overall Study|Participant not met eligibility criteria|2|||
48533078|NCT03663205|156138500|FG000|Overall Study|Death|144|||
48533079|NCT03663205|156138501|FG001|Overall Study|Death|69|||
48533080|NCT03663205|156138500|FG000|Overall Study|Sponsor decision|53|||
48533081|NCT03663205|156138501|FG001|Overall Study|Sponsor decision|19|||
48533082|NCT03663205|156138500|FG000|Overall Study|Withdrawal by Subject|8|||
48533083|NCT03663205|156138501|FG001|Overall Study|Withdrawal by Subject|11|||
48533084|NCT03663205|156138500|FG000|Overall Study|Lost to Follow-up|7|||
48533085|NCT03663205|156138501|FG001|Overall Study|Lost to Follow-up|9|||
48533086|NCT03663205|156138500|FG000|Overall Study|Transferred to long term extension study|11|||
48533087|NCT03663205|156138501|FG001|Overall Study|Transferred to long term extension study|3|||
48533088|NCT01202877|156138502|FG000|Overall Study|Disease Progression|0|||
48533089|NCT01202877|156138503|FG001|Overall Study|Disease Progression|1|||
48533090|NCT01202877|156138504|FG002|Overall Study|Disease Progression|2|||
48533091|NCT01202877|156138502|FG000|Overall Study|Adverse Event|0|||
48603565|NCT00452439|156404257|FG001|Overall Study|Failed to achieve complete response|0|||
48603566|NCT00452439|156404256|FG000|Overall Study|Relapse|3|||
48603567|NCT00452439|156404257|FG001|Overall Study|Relapse|0|||
48603568|NCT00452439|156404256|FG000|Overall Study|Fracture|1|||
48603569|NCT00452439|156404257|FG001|Overall Study|Fracture|0|||
48603570|NCT00715559|156404258|FG000|Overall Study|medication not tolerated - nausea|1|||
48603571|NCT02291029|156404263|FG000|Overall Study|Withdrawal by Subject|0|||
48603572|NCT02291029|156404264|FG001|Overall Study|Withdrawal by Subject|0|||
48603573|NCT02291029|156404265|FG002|Overall Study|Withdrawal by Subject|1|||
48835255|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
48835256|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
48533092|NCT01202877|156138503|FG001|Overall Study|Adverse Event|0|||
48533093|NCT01202877|156138504|FG002|Overall Study|Adverse Event|2|||
48533094|NCT01202877|156138502|FG000|Overall Study|Withdrawal by Subject|0|||
48533095|NCT01202877|156138503|FG001|Overall Study|Withdrawal by Subject|0|||
48533096|NCT01202877|156138504|FG002|Overall Study|Withdrawal by Subject|1|||
48533097|NCT01202877|156138502|FG000|Overall Study|Death|0|||
48533098|NCT01202877|156138503|FG001|Overall Study|Death|0|||
48533099|NCT01202877|156138504|FG002|Overall Study|Death|1|||
48533100|NCT04647383|156138509|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
48835257|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
48835258|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835259|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835260|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
48835261|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835262|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835263|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835264|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835265|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835266|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835267|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835268|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
48835269|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
48835270|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
48835271|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
48835272|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
48533101|NCT04647383|156138510|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
48533102|NCT04647383|156138511|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
48533103|NCT04647383|156138512|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
48533104|NCT01435031|156138517|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
48533105|NCT01435031|156138517|FG000|ITT at 1 Month|Death|1|||
48533106|NCT01435031|156138517|FG000|ITT at 1 Month|Lost to Follow-up|4|||
48533107|NCT01435031|156138517|FG000|ITT at 6 Months|Death|2|||
48603574|NCT02291029|156404266|FG003|Overall Study|Withdrawal by Subject|0|||
48603575|NCT02291029|156404267|FG004|Overall Study|Withdrawal by Subject|0|||
48533108|NCT01435031|156138517|FG000|ITT at 6 Months|Lost to Follow-up|3|||
48533109|NCT01435031|156138517|FG000|ITT at 1 Year|Death|1|||
48533110|NCT01435031|156138517|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
48533111|NCT01435031|156138517|FG000|ITT at 1 Year|Lost to Follow-up|6|||
48533112|NCT01435031|156138517|FG000|ITT at 2 Years|Death|7|||
48533113|NCT01435031|156138517|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
48533114|NCT01435031|156138517|FG000|ITT at 2 Years|Lost to Follow-up|4|||
48533115|NCT01435031|156138517|FG000|ITT at 3 Years|Death|5|||
48533116|NCT01435031|156138517|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
48533117|NCT01435031|156138517|FG000|ITT at 3 Years|Lost to Follow-up|4|||
48533118|NCT01435031|156138517|FG000|ITT at 4 Years|Death|4|||
48533119|NCT01435031|156138517|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
48533120|NCT01435031|156138517|FG000|ITT at 4 Years|Lost to Follow-up|1|||
48533121|NCT02087176|156138518|FG000|Overall Study|Withdrawal by Subject|1|||
48533122|NCT02087176|156138518|FG000|Overall Study|Death|10|||
48533123|NCT02087176|156138518|FG000|Overall Study|Censored|19|||
48533124|NCT02087176|156138518|FG000|Overall Study|Study Terminated by Sponsor|2|||
48533125|NCT02326974|156138519|FG000|Overall Study|Withdrawal by Subject|2|||
48533126|NCT02326974|156138519|FG000|Overall Study|failed heterogenity evaluation|5|||
48603576|NCT02291029|156404268|FG005|Overall Study|Withdrawal by Subject|0|||
48603577|NCT02291029|156404263|FG000|Overall Study|Adverse Event|0|||
48603578|NCT02291029|156404264|FG001|Overall Study|Adverse Event|1|||
48603579|NCT02291029|156404265|FG002|Overall Study|Adverse Event|0|||
48603580|NCT02291029|156404266|FG003|Overall Study|Adverse Event|0|||
48603581|NCT02291029|156404267|FG004|Overall Study|Adverse Event|0|||
48603582|NCT02291029|156404268|FG005|Overall Study|Adverse Event|0|||
48603583|NCT01095835|156404269|FG000|Overall Study|Adverse Event|8|||
48603584|NCT01095835|156404270|FG001|Overall Study|Adverse Event|6|||
48603585|NCT01095835|156404271|FG002|Overall Study|Adverse Event|6|||
48603586|NCT01095835|156404269|FG000|Overall Study|Lack of Efficacy|0|||
48603587|NCT01095835|156404270|FG001|Overall Study|Lack of Efficacy|1|||
48603588|NCT01095835|156404271|FG002|Overall Study|Lack of Efficacy|0|||
48603589|NCT01095835|156404269|FG000|Overall Study|Physician Decision|0|||
48603590|NCT01095835|156404270|FG001|Overall Study|Physician Decision|0|||
48603591|NCT01095835|156404271|FG002|Overall Study|Physician Decision|1|||
48603592|NCT01095835|156404269|FG000|Overall Study|Withdrawal by Subject|1|||
48603593|NCT01095835|156404270|FG001|Overall Study|Withdrawal by Subject|3|||
48603594|NCT01095835|156404271|FG002|Overall Study|Withdrawal by Subject|0|||
48603595|NCT01095835|156404269|FG000|Overall Study|Non study compliance|0|||
48603596|NCT01095835|156404270|FG001|Overall Study|Non study compliance|0|||
48603597|NCT01095835|156404271|FG002|Overall Study|Non study compliance|1|||
48603598|NCT01095835|156404269|FG000|Overall Study|Protocol Violation|1|||
48603599|NCT01095835|156404270|FG001|Overall Study|Protocol Violation|2|||
48603600|NCT01095835|156404271|FG002|Overall Study|Protocol Violation|0|||
48603601|NCT02498678|156404276|FG000|Overall Study|interference from the surgical team|0|||
48603602|NCT02498678|156404277|FG001|Overall Study|interference from the surgical team|2|||
48603603|NCT00521365|156404280|FG000|Overall Study|Adverse Event|3|||
48603604|NCT00521365|156404280|FG000|Overall Study|Lost to Follow-up|6|||
48603605|NCT00521365|156404280|FG000|Overall Study|Protocol deviation|2|||
48603606|NCT00521365|156404280|FG000|Overall Study|Drug compliance|3|||
48603607|NCT00521365|156404280|FG000|Overall Study|Usage of not allowed drugs|6|||
48603608|NCT03627832|156404283|FG000|Overall Study|Withdrawal by Subject|10|||
48603609|NCT03627832|156404284|FG001|Overall Study|Withdrawal by Subject|1|||
48603610|NCT01190891|156404285|FG000|Overall Study|Protocol Violation|1|||
48603611|NCT01190891|156404286|FG001|Overall Study|Protocol Violation|0|||
48603612|NCT01190891|156404285|FG000|Overall Study|Withdrawal by Subject|5|||
48603613|NCT01190891|156404286|FG001|Overall Study|Withdrawal by Subject|0|||
48603614|NCT01926028|156404287|FG000|Overall Study|Lost to Follow-up|7|||
48603615|NCT01926028|156404288|FG001|Overall Study|Lost to Follow-up|6|||
48603616|NCT01926028|156404289|FG002|Overall Study|Lost to Follow-up|0|||
48603617|NCT01926028|156404287|FG000|Overall Study|Physician Decision|1|||
48603618|NCT01926028|156404288|FG001|Overall Study|Physician Decision|5|||
48603619|NCT01926028|156404289|FG002|Overall Study|Physician Decision|0|||
48603620|NCT01926028|156404287|FG000|Overall Study|Withdrawal by Subject|9|||
48603621|NCT01926028|156404288|FG001|Overall Study|Withdrawal by Subject|9|||
48603622|NCT01926028|156404289|FG002|Overall Study|Withdrawal by Subject|2|||
48603623|NCT01926028|156404287|FG000|Overall Study|Non compliance or other reasons|4|||
48603624|NCT01926028|156404288|FG001|Overall Study|Non compliance or other reasons|2|||
48603625|NCT01926028|156404289|FG002|Overall Study|Non compliance or other reasons|0|||
48603626|NCT03150082|156404290|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
48603627|NCT03150082|156404291|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
48603628|NCT01718483|156404292|FG000|Overall Study|Withdrawal by Subject|14|||
48603629|NCT01718483|156404293|FG001|Overall Study|Withdrawal by Subject|12|||
48603630|NCT01718483|156404292|FG000|Overall Study|Adverse Event|5|||
48603631|NCT01718483|156404293|FG001|Overall Study|Adverse Event|12|||
48603632|NCT01718483|156404292|FG000|Overall Study|Lost to Follow-up|8|||
48603633|NCT01718483|156404293|FG001|Overall Study|Lost to Follow-up|3|||
48603634|NCT01718483|156404292|FG000|Overall Study|Protocol Violation|4|||
48603635|NCT01718483|156404293|FG001|Overall Study|Protocol Violation|2|||
48603636|NCT01718483|156404292|FG000|Overall Study|Other|1|||
48603637|NCT01718483|156404293|FG001|Overall Study|Other|4|||
48603638|NCT01718483|156404292|FG000|Overall Study|Pregnancy|1|||
48603639|NCT01718483|156404293|FG001|Overall Study|Pregnancy|1|||
48603640|NCT01718483|156404292|FG000|Overall Study|Lack of Efficacy|1|||
48603641|NCT01718483|156404293|FG001|Overall Study|Lack of Efficacy|0|||
48603642|NCT01405560|156404300|FG000|Overall Study|Physician Decision|1|||
48603643|NCT02683109|156404301|FG000|Overall Study|Adverse Event|1|||
48603644|NCT02683109|156404302|FG001|Overall Study|Adverse Event|0|||
48603645|NCT00003537|156404305|FG000|Overall Study|Not evalauable|1|||
48603646|NCT02419807|156404306|FG000|Overall Study|Withdrawal by Subject|4|||
48603647|NCT02419807|156404306|FG000|Overall Study|Physician Decision|1|||
48603648|NCT02419807|156404306|FG000|Overall Study|Protocol Violation|5|||
48603649|NCT01065818|156404308|FG000|Overall Study|Withdrawal by Subject|1|||
48603650|NCT01065818|156404308|FG000|Overall Study|Not a candidate for surgery|1|||
48533127|NCT02927834|156138523|FG000|Overall Study|Lost to Follow-up|1|||
48533128|NCT02927834|156138524|FG001|Overall Study|Lost to Follow-up|2|||
48533129|NCT02927834|156138525|FG002|Overall Study|Lost to Follow-up|2|||
48533130|NCT00206102|156138527|FG000|Overall Study|Adverse Event|119|||
48533131|NCT00206102|156138528|FG001|Overall Study|Adverse Event|82|||
48533132|NCT00206102|156138527|FG000|Overall Study|Protocol Violation|0|||
48533133|NCT00206102|156138528|FG001|Overall Study|Protocol Violation|2|||
48533134|NCT00206102|156138527|FG000|Overall Study|Lack of therapeutic response|16|||
48533135|NCT00206102|156138528|FG001|Overall Study|Lack of therapeutic response|11|||
48533136|NCT00206102|156138527|FG000|Overall Study|Lost to Follow-up|95|||
48533137|NCT00206102|156138528|FG001|Overall Study|Lost to Follow-up|66|||
48533138|NCT00206102|156138527|FG000|Overall Study|Withdrawal by Subject|118|||
48533139|NCT00206102|156138528|FG001|Overall Study|Withdrawal by Subject|101|||
48533140|NCT00206102|156138527|FG000|Overall Study|Study-specific discontinuation criteria|18|||
48533141|NCT00206102|156138528|FG001|Overall Study|Study-specific discontinuation criteria|17|||
48533142|NCT00206102|156138527|FG000|Overall Study|None of those categories|42|||
48533143|NCT00206102|156138528|FG001|Overall Study|None of those categories|36|||
48533144|NCT02903238|156138529|FG000|Overall Study|Lost to Follow-up|4|||
48533145|NCT02985879|156138531|FG000|Overall Study|Adverse Event|7|||
48533146|NCT02985879|156138532|FG001|Overall Study|Adverse Event|9|||
48533147|NCT02985879|156138533|FG002|Overall Study|Adverse Event|7|||
48533148|NCT02985879|156138531|FG000|Overall Study|Withdrew consent|6|||
48603651|NCT01309386|156404312|FG000|Overall Study|Other|2|||
48603652|NCT01309386|156404313|FG001|Overall Study|Other|0|||
48603653|NCT01309386|156404312|FG000|Overall Study|Withdrawal by Subject|2|||
48603654|NCT01309386|156404313|FG001|Overall Study|Withdrawal by Subject|0|||
48603655|NCT01309386|156404312|FG000|Overall Study|Progressive disease|9|||
48603656|NCT01309386|156404313|FG001|Overall Study|Progressive disease|11|||
48603657|NCT01309386|156404312|FG000|Overall Study|Physician Decision|1|||
48835273|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
48835274|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
48603658|NCT01309386|156404313|FG001|Overall Study|Physician Decision|1|||
48835275|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
48835276|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
48835277|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
48835278|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
48603659|NCT01309386|156404312|FG000|Overall Study|Lack of Efficacy|3|||
48835279|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
48533149|NCT02985879|156138532|FG001|Overall Study|Withdrew consent|8|||
48533150|NCT02985879|156138533|FG002|Overall Study|Withdrew consent|10|||
48603660|NCT01309386|156404313|FG001|Overall Study|Lack of Efficacy|1|||
48603661|NCT01309386|156404312|FG000|Overall Study|Adverse Event|5|||
48533151|NCT02985879|156138531|FG000|Overall Study|Lost to Follow-up|1|||
48533152|NCT02985879|156138532|FG001|Overall Study|Lost to Follow-up|0|||
48533153|NCT02985879|156138533|FG002|Overall Study|Lost to Follow-up|2|||
48533154|NCT02985879|156138531|FG000|Overall Study|Other, not specified|62|||
48533155|NCT02985879|156138532|FG001|Overall Study|Other, not specified|58|||
48533156|NCT02985879|156138533|FG002|Overall Study|Other, not specified|58|||
48533157|NCT00890552|156138534|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
48533158|NCT00890552|156138534|FG000|On-treatment|Early prog disease/ death|10|||
48533159|NCT02220725|156138537|FG000|Overall Study|Lost to Follow-up|0|||
48533160|NCT02220725|156138538|FG001|Overall Study|Lost to Follow-up|0|||
48533161|NCT02220725|156138539|FG002|Overall Study|Lost to Follow-up|0|||
48533162|NCT02220725|156138540|FG003|Overall Study|Lost to Follow-up|1|||
48533163|NCT02220725|156138537|FG000|Overall Study|Withdrawal by Subject|0|||
48603662|NCT01309386|156404313|FG001|Overall Study|Adverse Event|8|||
48835280|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
48835281|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
48835282|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835283|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
48835284|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
48835285|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835286|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
48835287|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835288|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835289|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835290|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835291|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835292|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835293|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835294|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
48835295|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
48835296|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
48835297|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
48835298|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
48835299|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
48835300|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48533164|NCT02220725|156138538|FG001|Overall Study|Withdrawal by Subject|0|||
48533165|NCT02220725|156138539|FG002|Overall Study|Withdrawal by Subject|0|||
48533166|NCT02220725|156138540|FG003|Overall Study|Withdrawal by Subject|1|||
48533167|NCT00987831|156138541|FG000|Overall Study|Never flared in 12 months|1|||
48533168|NCT00987831|156138542|FG001|Overall Study|Never flared in 12 months|0|||
48533169|NCT00987831|156138543|FG002|Overall Study|Never flared in 12 months|0|||
48533170|NCT00987831|156138541|FG000|Overall Study|Lost to Follow-up|0|||
48533171|NCT00987831|156138542|FG001|Overall Study|Lost to Follow-up|3|||
48533172|NCT00987831|156138543|FG002|Overall Study|Lost to Follow-up|0|||
48533173|NCT00518622|156138544|FG000|Overall Study|Lost to Follow-up|0|||
48533174|NCT00518622|156138545|FG001|Overall Study|Lost to Follow-up|0|||
48533175|NCT00518622|156138546|FG002|Overall Study|Lost to Follow-up|1|||
48533176|NCT00518622|156138547|FG003|Overall Study|Lost to Follow-up|0|||
48533177|NCT00518622|156138548|FG004|Overall Study|Lost to Follow-up|0|||
48533178|NCT00518622|156138549|FG005|Overall Study|Lost to Follow-up|0|||
48533179|NCT00518622|156138550|FG006|Overall Study|Lost to Follow-up|0|||
48533180|NCT00518622|156138551|FG007|Overall Study|Lost to Follow-up|0|||
48533181|NCT00518622|156138544|FG000|Overall Study|Study medication taken incorrectly|0|||
48533182|NCT00518622|156138545|FG001|Overall Study|Study medication taken incorrectly|1|||
48533183|NCT00518622|156138546|FG002|Overall Study|Study medication taken incorrectly|0|||
48533184|NCT00518622|156138547|FG003|Overall Study|Study medication taken incorrectly|0|||
48533185|NCT00518622|156138548|FG004|Overall Study|Study medication taken incorrectly|0|||
48533186|NCT00518622|156138549|FG005|Overall Study|Study medication taken incorrectly|0|||
48533187|NCT00518622|156138550|FG006|Overall Study|Study medication taken incorrectly|0|||
48533188|NCT00518622|156138551|FG007|Overall Study|Study medication taken incorrectly|0|||
48533189|NCT01688726|156138552|FG000|Overall Study|Adverse Event|1|||
48533190|NCT01688726|156138553|FG001|Overall Study|Adverse Event|0|||
48533191|NCT01688726|156138552|FG000|Overall Study|Relocated abroad|0|||
48533192|NCT01688726|156138553|FG001|Overall Study|Relocated abroad|1|||
48533193|NCT00824369|156138554|FG000|Overall Study|Nolonger willing to participate in study|1|||
48533194|NCT00824369|156138555|FG001|Overall Study|Nolonger willing to participate in study|0|||
48533195|NCT00824369|156138556|FG002|Overall Study|Nolonger willing to participate in study|1|||
48533196|NCT00824369|156138557|FG003|Overall Study|Nolonger willing to participate in study|2|||
48533197|NCT00824369|156138558|FG004|Overall Study|Nolonger willing to participate in study|0|||
48835301|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48533198|NCT00824369|156138559|FG005|Overall Study|Nolonger willing to participate in study|1|||
48533199|NCT00824369|156138554|FG000|Overall Study|Lost to Follow-up|0|||
48533200|NCT00824369|156138555|FG001|Overall Study|Lost to Follow-up|0|||
48533201|NCT00824369|156138556|FG002|Overall Study|Lost to Follow-up|0|||
48533202|NCT00824369|156138557|FG003|Overall Study|Lost to Follow-up|0|||
48533203|NCT00824369|156138558|FG004|Overall Study|Lost to Follow-up|1|||
48533204|NCT00824369|156138559|FG005|Overall Study|Lost to Follow-up|0|||
48533205|NCT01563237|156140038|FG000|Overall Study|Lost to Follow-up|6|||
48533206|NCT01563237|156140039|FG001|Overall Study|Lost to Follow-up|0|||
48533207|NCT01563237|156140038|FG000|Overall Study|Withdrawal by Subject|1|||
48533208|NCT01563237|156140039|FG001|Overall Study|Withdrawal by Subject|0|||
48835302|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48835303|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
48533209|NCT01563237|156140038|FG000|Overall Study|Adverse Event|1|||
48533210|NCT01563237|156140039|FG001|Overall Study|Adverse Event|0|||
48533211|NCT01563237|156140038|FG000|Overall Study|Medical Reasons|1|||
48533212|NCT01563237|156140039|FG001|Overall Study|Medical Reasons|0|||
48533213|NCT01563237|156140038|FG000|Overall Study|Death|1|||
48533214|NCT01563237|156140039|FG001|Overall Study|Death|0|||
48533215|NCT01552369|156140040|FG000|Overall Study|Did not consent to extended follow up|8|||
48533216|NCT01552369|156140041|FG001|Overall Study|Did not consent to extended follow up|9|||
48533217|NCT01546922|156140043|FG000|First Period of 10 Weeks|Protocol Violation|3|||
48533218|NCT01546922|156140044|FG001|First Period of 10 Weeks|Protocol Violation|1|||
48533219|NCT01546922|156140043|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
48533220|NCT01546922|156140044|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
48533221|NCT01546922|156140043|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
48533222|NCT01546922|156140044|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
48533223|NCT01546922|156140043|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
48533224|NCT01546922|156140044|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
48533225|NCT01546922|156140043|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
48533226|NCT01546922|156140044|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
48533227|NCT04086641|156140045|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
48533228|NCT04086641|156140046|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
48533229|NCT01597479|156140047|FG000|Overall Study|Protocol Violation|1|||
48533230|NCT01597479|156140048|FG001|Overall Study|Protocol Violation|0|||
48533231|NCT01597479|156140047|FG000|Overall Study|Lost to Follow-up|1|||
48533232|NCT01597479|156140048|FG001|Overall Study|Lost to Follow-up|0|||
48533233|NCT01045707|156140052|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
48533234|NCT01045707|156140053|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
48533235|NCT01045707|156140052|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
48533236|NCT01045707|156140053|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
48533237|NCT01045707|156140052|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
48533238|NCT01045707|156140053|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
48533239|NCT01045707|156140052|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
48533240|NCT01045707|156140053|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
48533241|NCT01045707|156140052|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
48533242|NCT01045707|156140053|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
48533243|NCT01045707|156140052|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
48533244|NCT01045707|156140053|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
48533245|NCT01045707|156140052|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
48603663|NCT02062437|156404314|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
48533246|NCT01045707|156140053|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
48533247|NCT01045707|156140052|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
48533248|NCT01045707|156140053|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
48533249|NCT01045707|156140052|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
48533250|NCT01045707|156140053|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
48533251|NCT01613378|156140054|FG000|Overall Study|Lack of Efficacy|13|||
48533252|NCT01613378|156140054|FG000|Overall Study|Adverse Event|11|||
48603664|NCT02062437|156404314|FG000|Overall Study|Patient not available for the 2y visit|18|||
48603665|NCT02062437|156404314|FG000|Overall Study|Death|2|||
48603666|NCT02062437|156404314|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
48603667|NCT02515630|156404315|FG000|Overall Study|Withdrawal by Subject|5|||
48603668|NCT02515630|156404315|FG000|Overall Study|Adverse Event|4|||
48603669|NCT02515630|156404315|FG000|Overall Study|Physician Decision|4|||
48603670|NCT02515630|156404315|FG000|Overall Study|Death|2|||
48835304|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48835305|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48835306|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48835307|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
48533253|NCT01613378|156140054|FG000|Overall Study|Withdrawal by Subject|8|||
48533254|NCT01613378|156140054|FG000|Overall Study|Death|2|||
48533255|NCT01613378|156140054|FG000|Overall Study|Lost to Follow-up|1|||
48533256|NCT01613378|156140054|FG000|Overall Study|Other Reason|4|||
48533257|NCT01213836|156140055|FG000|Period 1, First Intervention|Adverse Event|2|||
48603671|NCT02515630|156404315|FG000|Overall Study|Disease Progression|1|||
48603672|NCT02976519|156404316|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
48603673|NCT02976519|156404317|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
48603674|NCT02976519|156404318|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
48603675|NCT02976519|156404319|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
48603676|NCT02976519|156404320|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
48603677|NCT02976519|156404321|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
48603678|NCT02976519|156404322|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
48603679|NCT02976519|156404316|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
48603680|NCT02976519|156404317|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
48603681|NCT02976519|156404318|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
48603682|NCT02976519|156404319|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
48603683|NCT02976519|156404320|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
48603684|NCT02976519|156404321|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
48603685|NCT02976519|156404322|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
48603686|NCT02976519|156404316|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
48603687|NCT02976519|156404317|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
48603688|NCT02976519|156404318|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
48603689|NCT02976519|156404319|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
48603690|NCT02976519|156404320|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
48603691|NCT02976519|156404321|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
48603692|NCT02976519|156404322|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
48603693|NCT02976519|156404316|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
48603694|NCT02976519|156404317|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
48603695|NCT02976519|156404318|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
48603696|NCT02976519|156404319|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
48603697|NCT02976519|156404320|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
48603698|NCT02976519|156404321|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
48603699|NCT02976519|156404322|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
48533258|NCT01213836|156140056|FG001|Period 1, First Intervention|Adverse Event|1|||
48533259|NCT01213836|156140055|FG000|Period 1, First Intervention|Protocol Violation|0|||
48533260|NCT01213836|156140056|FG001|Period 1, First Intervention|Protocol Violation|1|||
48533261|NCT01213836|156140055|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
48533262|NCT01213836|156140056|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
48533263|NCT00255151|156140057|FG000|Overall Study|Adverse Event|10|||
48533264|NCT00255151|156140058|FG001|Overall Study|Adverse Event|6|||
48533265|NCT00255151|156140059|FG002|Overall Study|Adverse Event|9|||
48533266|NCT00255151|156140057|FG000|Overall Study|Lost to Follow-up|4|||
48533267|NCT00255151|156140058|FG001|Overall Study|Lost to Follow-up|3|||
48533268|NCT00255151|156140059|FG002|Overall Study|Lost to Follow-up|4|||
48533269|NCT00255151|156140057|FG000|Overall Study|Withdrawal by Subject|18|||
48533270|NCT00255151|156140058|FG001|Overall Study|Withdrawal by Subject|17|||
48533271|NCT00255151|156140059|FG002|Overall Study|Withdrawal by Subject|8|||
48533272|NCT00255151|156140057|FG000|Overall Study|Noncompliance|0|||
48533273|NCT00255151|156140058|FG001|Overall Study|Noncompliance|1|||
48533274|NCT00255151|156140059|FG002|Overall Study|Noncompliance|2|||
48533275|NCT00255151|156140057|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
48533276|NCT00255151|156140058|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
48533277|NCT00255151|156140059|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
48533278|NCT00255151|156140057|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
48533279|NCT00255151|156140058|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
48533280|NCT00255151|156140059|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
48533281|NCT00255151|156140057|FG000|Overall Study|Possible Barrett's Esophagus|1|||
48533282|NCT00255151|156140058|FG001|Overall Study|Possible Barrett's Esophagus|3|||
48533283|NCT00255151|156140059|FG002|Overall Study|Possible Barrett's Esophagus|8|||
48533284|NCT00255151|156140057|FG000|Overall Study|Esophageal Stricture|0|||
48533285|NCT00255151|156140058|FG001|Overall Study|Esophageal Stricture|0|||
48533286|NCT00255151|156140059|FG002|Overall Study|Esophageal Stricture|1|||
48533287|NCT00255151|156140057|FG000|Overall Study|Therapeutic Failure|11|||
48533288|NCT00255151|156140058|FG001|Overall Study|Therapeutic Failure|2|||
48603700|NCT02976519|156404316|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
48603701|NCT02976519|156404317|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
48603702|NCT02976519|156404318|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
48603703|NCT02976519|156404319|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
48603704|NCT02976519|156404320|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
48533289|NCT00255151|156140059|FG002|Overall Study|Therapeutic Failure|3|||
48533290|NCT02744755|156140060|FG000|Study Period 1|Protocol Violation|2|||
48533291|NCT02744755|156140061|FG001|Study Period 1|Protocol Violation|1|||
48533292|NCT02744755|156140060|FG000|Study Period 1|not defined|0|||
48533293|NCT02744755|156140061|FG001|Study Period 1|not defined|1|||
48533294|NCT02744755|156140060|FG000|Study Period 1|Pregnancy|1|||
48533295|NCT02744755|156140061|FG001|Study Period 1|Pregnancy|0|||
48533296|NCT02744755|156140060|FG000|Study Period 1|Adverse Event|1|||
48533297|NCT02744755|156140061|FG001|Study Period 1|Adverse Event|1|||
48533298|NCT02744755|156140060|FG000|Study Period 1|Lost to Follow-up|1|||
48533299|NCT02744755|156140061|FG001|Study Period 1|Lost to Follow-up|1|||
48533300|NCT02744755|156140060|FG000|Study Period 1|Lack of Efficacy|1|||
48533301|NCT02744755|156140061|FG001|Study Period 1|Lack of Efficacy|0|||
48533302|NCT02744755|156140060|FG000|Study Period 1|Withdrawal by Subject|8|||
48533303|NCT02744755|156140061|FG001|Study Period 1|Withdrawal by Subject|4|||
48533304|NCT02744755|156140060|FG000|Study Period 2|Adverse Event|5|||
48533305|NCT02744755|156140061|FG001|Study Period 2|Adverse Event|0|||
48533306|NCT02744755|156140060|FG000|Study Period 2|Protocol Violation|1|||
48603705|NCT02976519|156404321|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
48603706|NCT02976519|156404322|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
48603707|NCT00095979|156404326|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
48603708|NCT00785356|156404327|FG000|Overall Study|Study prematurely terminated|8|||
48603709|NCT00313846|156404328|FG000|Overall Study|Withdrawal by Subject|2|||
48603710|NCT00313846|156404329|FG001|Overall Study|Withdrawal by Subject|0|||
48603711|NCT00313846|156404328|FG000|Overall Study|Adverse Event|1|||
48603712|NCT00313846|156404329|FG001|Overall Study|Adverse Event|8|||
48603713|NCT00313846|156404328|FG000|Overall Study|Administrative|2|||
48603714|NCT00313846|156404329|FG001|Overall Study|Administrative|3|||
48603715|NCT01663402|156404341|FG000|Overall Study|Randomized but not treated|19|||
48603716|NCT01663402|156404342|FG001|Overall Study|Randomized but not treated|11|||
48603717|NCT01663402|156404341|FG000|Overall Study|Adverse Event|347|||
48603718|NCT01663402|156404342|FG001|Overall Study|Adverse Event|362|||
48603719|NCT01663402|156404341|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
48603720|NCT01663402|156404342|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
48603721|NCT01663402|156404341|FG000|Overall Study|Poor compliance to protocol|529|||
48603722|NCT01663402|156404342|FG001|Overall Study|Poor compliance to protocol|454|||
48603723|NCT01663402|156404341|FG000|Overall Study|Physician Decision|77|||
48603724|NCT01663402|156404342|FG001|Overall Study|Physician Decision|62|||
48603725|NCT01663402|156404341|FG000|Overall Study|Site terminated by sponsor|1|||
48603726|NCT01663402|156404342|FG001|Overall Study|Site terminated by sponsor|3|||
48603727|NCT01663402|156404341|FG000|Overall Study|Participant moved|139|||
48603728|NCT01663402|156404342|FG001|Overall Study|Participant moved|104|||
48603729|NCT01663402|156404341|FG000|Overall Study|Withdrawal by Subject|118|||
48603730|NCT01663402|156404342|FG001|Overall Study|Withdrawal by Subject|91|||
48603731|NCT01663402|156404341|FG000|Overall Study|Related to study drug administration|96|||
48603732|NCT01663402|156404342|FG001|Overall Study|Related to study drug administration|105|||
48603733|NCT01663402|156404341|FG000|Overall Study|Lost to Follow-up|17|||
48603734|NCT01663402|156404342|FG001|Overall Study|Lost to Follow-up|15|||
48603735|NCT01663402|156404341|FG000|Overall Study|Other than specified above|172|||
48603736|NCT01663402|156404342|FG001|Overall Study|Other than specified above|147|||
48603737|NCT01774591|156404345|FG000|Overall Study|Physician Decision|1|||
48603738|NCT01774591|156404346|FG001|Overall Study|Physician Decision|1|||
48603739|NCT01774591|156404345|FG000|Overall Study|Withdrawal by Subject|0|||
48603740|NCT01774591|156404346|FG001|Overall Study|Withdrawal by Subject|1|||
48603741|NCT01774591|156404345|FG000|Overall Study|Adverse Event|0|||
48603742|NCT01774591|156404346|FG001|Overall Study|Adverse Event|2|||
48603743|NCT00274742|156404347|FG000|Overall Study|Adverse Event|0|||
48603744|NCT00274742|156404348|FG001|Overall Study|Adverse Event|4|||
48603745|NCT00274742|156404349|FG002|Overall Study|Adverse Event|1|||
48603746|NCT00274742|156404350|FG003|Overall Study|Adverse Event|4|||
48603747|NCT00274742|156404351|FG004|Overall Study|Adverse Event|12|||
48603748|NCT00274742|156404352|FG005|Overall Study|Adverse Event|3|||
48603749|NCT00274742|156404347|FG000|Overall Study|Lost to Follow-up|0|||
48603750|NCT00274742|156404348|FG001|Overall Study|Lost to Follow-up|0|||
48603751|NCT00274742|156404349|FG002|Overall Study|Lost to Follow-up|0|||
48603752|NCT00274742|156404350|FG003|Overall Study|Lost to Follow-up|0|||
48603753|NCT00274742|156404351|FG004|Overall Study|Lost to Follow-up|1|||
48533307|NCT02744755|156140061|FG001|Study Period 2|Protocol Violation|0|||
48533308|NCT02744755|156140060|FG000|Study Period 2|not defined|3|||
48603754|NCT00274742|156404352|FG005|Overall Study|Lost to Follow-up|0|||
48603755|NCT00274742|156404347|FG000|Overall Study|End of Study|0|||
48603756|NCT00274742|156404348|FG001|Overall Study|End of Study|0|||
48603757|NCT00274742|156404349|FG002|Overall Study|End of Study|0|||
48603758|NCT00274742|156404350|FG003|Overall Study|End of Study|1|||
48603759|NCT00274742|156404351|FG004|Overall Study|End of Study|0|||
48533309|NCT02744755|156140061|FG001|Study Period 2|not defined|2|||
48533310|NCT02744755|156140060|FG000|Study Period 2|Lost to Follow-up|0|||
48533311|NCT02744755|156140061|FG001|Study Period 2|Lost to Follow-up|2|||
48533312|NCT02744755|156140060|FG000|Study Period 2|Withdrawal by Subject|2|||
48603760|NCT00274742|156404352|FG005|Overall Study|End of Study|0|||
48603761|NCT00274742|156404347|FG000|Overall Study|Disease Progression|0|||
48603762|NCT00274742|156404348|FG001|Overall Study|Disease Progression|1|||
48603763|NCT00274742|156404349|FG002|Overall Study|Disease Progression|1|||
48603764|NCT00274742|156404350|FG003|Overall Study|Disease Progression|0|||
48603765|NCT00274742|156404351|FG004|Overall Study|Disease Progression|1|||
48533313|NCT02744755|156140061|FG001|Study Period 2|Withdrawal by Subject|2|||
48533314|NCT02744755|156140060|FG000|Study Period 2|Lack of Efficacy|3|||
48533315|NCT02744755|156140061|FG001|Study Period 2|Lack of Efficacy|2|||
48533316|NCT00792623|156140062|FG000|Overall Study|Adverse Event|2|||
48533317|NCT00792623|156140062|FG000|Overall Study|Withdrawal by Subject|5|||
48533318|NCT01559935|156140063|FG000|Car Phase|Toxicity|4|||
48533319|NCT01559935|156140063|FG000|Car Phase|Death|1|||
48533320|NCT01559935|156140063|FG000|Car Phase|Lack of Efficacy|2|||
48533321|NCT01559935|156140063|FG000|Car Phase|Lost to Follow-up|1|||
48533322|NCT01559935|156140063|FG000|Car Phase|Physician Decision|1|||
48533323|NCT01559935|156140063|FG000|Car Phase|Withdrawal by Subject|2|||
48533324|NCT01559935|156140063|FG000|Car Phase|Per protocol|1|||
48533325|NCT01559935|156140063|FG000|Car Phase|Insurance|1|||
48533326|NCT01559935|156140063|FG000|Car Phase|non-compliance|1|||
48533327|NCT01559935|156140063|FG000|BiRD Phase|Toxicity|1|||
48533328|NCT01559935|156140063|FG000|BiRD Phase|Lack of Efficacy|1|||
48533329|NCT01559935|156140063|FG000|BiRD Phase|Withdrawal by Subject|2|||
48533330|NCT01559935|156140063|FG000|Maintenance Phase|Remains on study|28|||
48533331|NCT01559935|156140063|FG000|Maintenance Phase|Toxicity|1|||
48533332|NCT01559935|156140063|FG000|Maintenance Phase|Lack of Efficacy|18|||
48533333|NCT01559935|156140063|FG000|Maintenance Phase|Withdrawal by Subject|5|||
48533334|NCT01559935|156140063|FG000|Maintenance Phase|Non-compliance|2|||
48533335|NCT04317599|156140066|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
48533336|NCT04317599|156140066|FG000|Overall Study|treatment outside standard of care|4|||
48533337|NCT04059549|156140067|FG000|Overall Study|Withdrawal by Subject|2|||
48533338|NCT04059549|156140068|FG001|Overall Study|Withdrawal by Subject|0|||
48533339|NCT03919448|156140071|FG000|Overall Study|Withdrawal by Subject|1|||
48533340|NCT03919448|156140072|FG001|Overall Study|Withdrawal by Subject|0|||
48533341|NCT03919448|156140073|FG002|Overall Study|Withdrawal by Subject|0|||
48533342|NCT03438539|156140078|FG000|Overall Study|Lost to Follow-up|8|||
48533343|NCT03438539|156140079|FG001|Overall Study|Lost to Follow-up|4|||
48533344|NCT03438539|156140080|FG002|Overall Study|Lost to Follow-up|10|||
48533345|NCT03438539|156140081|FG003|Overall Study|Lost to Follow-up|9|||
48533346|NCT03438539|156140082|FG004|Overall Study|Lost to Follow-up|3|||
48533347|NCT03438539|156140083|FG005|Overall Study|Lost to Follow-up|8|||
48533348|NCT01221090|156140084|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
48533349|NCT01221090|156140085|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
48533350|NCT01221090|156140086|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
48533351|NCT01221090|156140087|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
48603766|NCT00274742|156404352|FG005|Overall Study|Disease Progression|0|||
48603767|NCT00274742|156404347|FG000|Overall Study|Other|0|||
48603768|NCT00274742|156404348|FG001|Overall Study|Other|3|||
48603769|NCT00274742|156404349|FG002|Overall Study|Other|0|||
48603770|NCT00274742|156404350|FG003|Overall Study|Other|0|||
48603771|NCT00274742|156404351|FG004|Overall Study|Other|2|||
48603772|NCT00274742|156404352|FG005|Overall Study|Other|0|||
48603773|NCT00731822|156404353|FG000|Overall Study|Adverse Event|2|||
48603774|NCT00731822|156404354|FG001|Overall Study|Adverse Event|1|||
48603775|NCT00731822|156404353|FG000|Overall Study|Protocol Violation|1|||
48533352|NCT01221090|156140084|FG000|Overall Study|Withdrawal by Subject|0|||
48533353|NCT01221090|156140085|FG001|Overall Study|Withdrawal by Subject|22|||
48533354|NCT01221090|156140086|FG002|Overall Study|Withdrawal by Subject|27|||
48533355|NCT01221090|156140087|FG003|Overall Study|Withdrawal by Subject|2|||
48533356|NCT00708708|156140090|FG000|Overall Study|Another therapy instead of Enbrel|141|||
48533357|NCT00708708|156140090|FG000|Overall Study|Lost to Follow-up|52|||
48603776|NCT00731822|156404354|FG001|Overall Study|Protocol Violation|0|||
48533358|NCT00708708|156140090|FG000|Overall Study|Withdrawal by Subject|51|||
48533359|NCT00708708|156140090|FG000|Overall Study|Intolerance|42|||
48533360|NCT00708708|156140090|FG000|Overall Study|Another therapy along with Enbrel|15|||
48603777|NCT00731822|156404353|FG000|Overall Study|Lost to Follow-up|1|||
48603778|NCT00731822|156404354|FG001|Overall Study|Lost to Follow-up|0|||
48533361|NCT00708708|156140090|FG000|Overall Study|Other unspecified|11|||
48603779|NCT03585270|156404355|FG000|Overall Study|Withdrawal by Subject|2|||
48835308|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
48533362|NCT00708708|156140090|FG000|Overall Study|Good effectiveness|9|||
48533363|NCT00708708|156140090|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
48533364|NCT00708708|156140090|FG000|Overall Study|Administrative reasons|7|||
48533365|NCT00708708|156140090|FG000|Overall Study|Lack of effectiveness|4|||
48533366|NCT00708708|156140090|FG000|Overall Study|Lack of compliance|3|||
48835309|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835310|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835311|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835312|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835313|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
48835314|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
48835315|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
48835316|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835317|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48533367|NCT00708708|156140090|FG000|Overall Study|Pregnancy|3|||
48835318|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835319|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835320|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
48835321|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
48835322|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
48835323|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
48835324|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
48533368|NCT00708708|156140090|FG000|Overall Study|Adverse Event|3|||
48533369|NCT00708708|156140090|FG000|Overall Study|Missing values|392|||
48533370|NCT04213209|156140091|FG000|Overall Study|Protocol Violation|1|||
48533371|NCT04213209|156140092|FG001|Overall Study|Protocol Violation|0|||
48533372|NCT04213209|156140093|FG002|Overall Study|Protocol Violation|0|||
48533373|NCT04213209|156140094|FG003|Overall Study|Protocol Violation|0|||
48533374|NCT04213209|156140095|FG004|Overall Study|Protocol Violation|0|||
48533375|NCT04213209|156140096|FG005|Overall Study|Protocol Violation|0|||
48533376|NCT00743509|156140100|FG000|Overall Study|Withdrawal by Subject|2|||
48533377|NCT02278718|156140102|FG000|Overall Study|Adverse Event|1|||
48533378|NCT02278718|156140103|FG001|Overall Study|Adverse Event|0|||
48533379|NCT02278718|156140102|FG000|Overall Study|Lost to Follow-up|2|||
48533380|NCT02278718|156140103|FG001|Overall Study|Lost to Follow-up|4|||
48533381|NCT02278718|156140102|FG000|Overall Study|Withdrawal by Subject|1|||
48533382|NCT02278718|156140103|FG001|Overall Study|Withdrawal by Subject|4|||
48533383|NCT02278718|156140102|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
48533384|NCT02278718|156140103|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
48533385|NCT02278718|156140102|FG000|Overall Study|Missing|0|||
48533386|NCT02278718|156140103|FG001|Overall Study|Missing|1|||
48533387|NCT01615263|156140109|FG000|Overall Study|Post-randomization exclusion|0|||
48533388|NCT01615263|156140110|FG001|Overall Study|Post-randomization exclusion|2|||
48533389|NCT01546649|156140111|FG000|Overall Study|Adverse Event|4|||
48533390|NCT01546649|156140112|FG001|Overall Study|Adverse Event|5|||
48533391|NCT01546649|156140111|FG000|Overall Study|Protocol Violation|1|||
48533392|NCT01546649|156140112|FG001|Overall Study|Protocol Violation|0|||
48533393|NCT01546649|156140111|FG000|Overall Study|Lack of Efficacy|1|||
48533394|NCT01546649|156140112|FG001|Overall Study|Lack of Efficacy|0|||
48533395|NCT01546649|156140111|FG000|Overall Study|Recurrence|1|||
48533396|NCT01546649|156140112|FG001|Overall Study|Recurrence|1|||
48533397|NCT01546649|156140111|FG000|Overall Study|Discovery of secondary cancer|0|||
48835325|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
48835326|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
48835327|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
48835328|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
48835329|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
48835330|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
48533398|NCT01546649|156140112|FG001|Overall Study|Discovery of secondary cancer|1|||
48533399|NCT01546649|156140111|FG000|Overall Study|Withdrawal by Subject|1|||
48533400|NCT01546649|156140112|FG001|Overall Study|Withdrawal by Subject|2|||
48533401|NCT04440449|156140114|FG000|Overall Study|Lost to Follow-up|2|||
48533402|NCT04440449|156140115|FG001|Overall Study|Lost to Follow-up|0|||
48533403|NCT00857259|156140116|FG000|Overall Study|Protocol Violation|1|||
48533404|NCT00857259|156140117|FG001|Overall Study|Protocol Violation|0|||
48533405|NCT00857259|156140118|FG002|Overall Study|Protocol Violation|1|||
48533406|NCT02075606|156140119|FG000|Overall Study|Adverse Event|5|||
48533407|NCT02075606|156140119|FG000|Overall Study|Withdrawal by Subject|1|||
48533408|NCT02075606|156140119|FG000|Overall Study|Death|1|||
48533409|NCT02075606|156140119|FG000|Overall Study|Investigator's decision|1|||
48533410|NCT02075606|156140119|FG000|Overall Study|Symptom management|1|||
48533411|NCT02075606|156140119|FG000|Overall Study|Increasing Symptoms|1|||
48533412|NCT01929395|156140120|FG000|Overall Study|Did not complete - non-related toxicity|1|||
48533413|NCT01929395|156140121|FG001|Overall Study|Did not complete - non-related toxicity|0|||
48533414|NCT01929395|156140122|FG002|Overall Study|Did not complete - non-related toxicity|0|||
48533415|NCT01929395|156140120|FG000|Overall Study|Withdrawal by Subject|0|||
48533416|NCT01929395|156140121|FG001|Overall Study|Withdrawal by Subject|1|||
48533417|NCT01929395|156140122|FG002|Overall Study|Withdrawal by Subject|0|||
48533418|NCT01929395|156140120|FG000|Overall Study|Screen Fail|0|||
48533419|NCT01929395|156140121|FG001|Overall Study|Screen Fail|0|||
48533420|NCT01929395|156140122|FG002|Overall Study|Screen Fail|1|||
48533421|NCT01803269|156140125|FG000|Overall Study|Withdrawal by Subject|3|||
48533422|NCT01803269|156140126|FG001|Overall Study|Withdrawal by Subject|0|||
48835331|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
48835332|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
48835333|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
48835334|NCT04707313|157238754|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835335|NCT04707313|157238755|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835336|NCT04707313|157238756|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
48835337|NCT04707313|157238757|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835338|NCT04707313|157238758|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835339|NCT04707313|157238759|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835340|NCT04707313|157238760|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835341|NCT04707313|157238761|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
48835342|NCT04707313|157238762|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835343|NCT04707313|157238763|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835344|NCT04707313|157238764|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835345|NCT04707313|157238765|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835346|NCT04707313|157238766|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
48835347|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835348|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835349|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835350|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835351|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835352|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835353|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835354|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835355|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835356|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
48835357|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
48835358|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
48835359|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
48835360|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835361|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835362|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835363|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835364|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835365|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835366|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835367|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835368|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835369|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
48835370|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
48835371|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
48835372|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
48835373|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835374|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835375|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835376|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48533423|NCT01803269|156140127|FG002|Overall Study|Withdrawal by Subject|0|||
48533424|NCT00268892|156140131|FG000|Overall Study|Adverse Event|14|||
48533425|NCT00268892|156140132|FG001|Overall Study|Adverse Event|17|||
48533426|NCT00268892|156140133|FG002|Overall Study|Adverse Event|20|||
48835377|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835378|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48533427|NCT00268892|156140131|FG000|Overall Study|Lack of Efficacy|1|||
48533428|NCT00268892|156140132|FG001|Overall Study|Lack of Efficacy|3|||
48533429|NCT00268892|156140133|FG002|Overall Study|Lack of Efficacy|0|||
48603780|NCT03585270|156404356|FG001|Overall Study|Withdrawal by Subject|6|||
48603781|NCT03585270|156404355|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
48603782|NCT03585270|156404356|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
48603783|NCT03585270|156404355|FG000|Overall Study|Adverse Event|5|||
48835379|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835380|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835381|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
48835382|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
48603784|NCT03585270|156404356|FG001|Overall Study|Adverse Event|2|||
48603785|NCT03585270|156404355|FG000|Overall Study|Lost to Follow-up|1|||
48603786|NCT03585270|156404356|FG001|Overall Study|Lost to Follow-up|4|||
48603787|NCT03585270|156404355|FG000|Overall Study|Death|5|||
48603788|NCT03585270|156404356|FG001|Overall Study|Death|3|||
48603789|NCT03585270|156404355|FG000|Overall Study|Other reasons|2|||
48603790|NCT03585270|156404356|FG001|Overall Study|Other reasons|2|||
48603791|NCT01802385|156404357|FG000|Overall Study|Death|106|||
48603792|NCT01802385|156404358|FG001|Overall Study|Death|120|||
48603793|NCT03786380|156404359|FG000|Overall Study|Adverse Event|1|||
48603794|NCT03786380|156404360|FG001|Overall Study|Adverse Event|0|||
48603795|NCT03786380|156404361|FG002|Overall Study|Adverse Event|0|||
48835383|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
48835384|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
48835385|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
48835386|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
48603796|NCT03786380|156404362|FG003|Overall Study|Adverse Event|3|||
48603797|NCT03786380|156404363|FG004|Overall Study|Adverse Event|1|||
48603798|NCT03786380|156404359|FG000|Overall Study|Lack of Efficacy|0|||
48603799|NCT03786380|156404360|FG001|Overall Study|Lack of Efficacy|0|||
48603800|NCT03786380|156404361|FG002|Overall Study|Lack of Efficacy|0|||
48603801|NCT03786380|156404362|FG003|Overall Study|Lack of Efficacy|0|||
48603802|NCT03786380|156404363|FG004|Overall Study|Lack of Efficacy|1|||
48603803|NCT03786380|156404359|FG000|Overall Study|Withdrawal by Subject|1|||
48603804|NCT03786380|156404360|FG001|Overall Study|Withdrawal by Subject|2|||
48603805|NCT03786380|156404361|FG002|Overall Study|Withdrawal by Subject|2|||
48603806|NCT03786380|156404362|FG003|Overall Study|Withdrawal by Subject|1|||
48603807|NCT03786380|156404363|FG004|Overall Study|Withdrawal by Subject|2|||
48603808|NCT03786380|156404359|FG000|Overall Study|Lost to Follow-up|3|||
48603809|NCT03786380|156404360|FG001|Overall Study|Lost to Follow-up|0|||
48603810|NCT03786380|156404361|FG002|Overall Study|Lost to Follow-up|1|||
48603811|NCT03786380|156404362|FG003|Overall Study|Lost to Follow-up|2|||
48603812|NCT03786380|156404363|FG004|Overall Study|Lost to Follow-up|0|||
48603813|NCT03786380|156404359|FG000|Overall Study|Physician Decision|0|||
48603814|NCT03786380|156404360|FG001|Overall Study|Physician Decision|0|||
48603815|NCT03786380|156404361|FG002|Overall Study|Physician Decision|1|||
48603816|NCT03786380|156404362|FG003|Overall Study|Physician Decision|0|||
48603817|NCT03786380|156404363|FG004|Overall Study|Physician Decision|0|||
48603818|NCT03786380|156404359|FG000|Overall Study|Study Terminated by the Sponsor|30|||
48603819|NCT03786380|156404360|FG001|Overall Study|Study Terminated by the Sponsor|20|||
48603820|NCT03786380|156404361|FG002|Overall Study|Study Terminated by the Sponsor|50|||
48603821|NCT03786380|156404362|FG003|Overall Study|Study Terminated by the Sponsor|57|||
48603822|NCT03786380|156404363|FG004|Overall Study|Study Terminated by the Sponsor|23|||
48603823|NCT03786380|156404359|FG000|Overall Study|Reason Not Specified|0|||
48603824|NCT03786380|156404360|FG001|Overall Study|Reason Not Specified|0|||
48603825|NCT03786380|156404361|FG002|Overall Study|Reason Not Specified|0|||
48835387|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835388|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835389|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835390|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835391|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
48603826|NCT03786380|156404362|FG003|Overall Study|Reason Not Specified|0|||
48603827|NCT03786380|156404363|FG004|Overall Study|Reason Not Specified|1|||
48835392|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
48603828|NCT01494818|156404365|FG000|Overall Study|Relocation|1|||
48603829|NCT01494818|156404366|FG001|Overall Study|Relocation|2|||
48603830|NCT01494818|156404365|FG000|Overall Study|Lost to Follow-up|1|||
48603831|NCT01494818|156404366|FG001|Overall Study|Lost to Follow-up|0|||
48835393|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835394|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835395|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835396|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
48533430|NCT00268892|156140131|FG000|Overall Study|Withdrawal by Subject|14|||
48533431|NCT00268892|156140132|FG001|Overall Study|Withdrawal by Subject|15|||
48533432|NCT00268892|156140133|FG002|Overall Study|Withdrawal by Subject|13|||
48533433|NCT00268892|156140131|FG000|Overall Study|Physician Decision|0|||
48533434|NCT00268892|156140132|FG001|Overall Study|Physician Decision|1|||
48533435|NCT00268892|156140133|FG002|Overall Study|Physician Decision|0|||
48533436|NCT00268892|156140131|FG000|Overall Study|Lost to Follow-up|5|||
48533437|NCT00268892|156140132|FG001|Overall Study|Lost to Follow-up|2|||
48533438|NCT00268892|156140133|FG002|Overall Study|Lost to Follow-up|4|||
48533439|NCT00268892|156140131|FG000|Overall Study|Protocol Violation|0|||
48533440|NCT00268892|156140132|FG001|Overall Study|Protocol Violation|1|||
48533441|NCT00268892|156140133|FG002|Overall Study|Protocol Violation|0|||
48533442|NCT00268892|156140131|FG000|Overall Study|Disease Progression|1|||
48533443|NCT00268892|156140132|FG001|Overall Study|Disease Progression|1|||
48533444|NCT00268892|156140133|FG002|Overall Study|Disease Progression|0|||
48533445|NCT00268892|156140131|FG000|Overall Study|Trial Site Closed|4|||
48533446|NCT00268892|156140132|FG001|Overall Study|Trial Site Closed|2|||
48533447|NCT00268892|156140133|FG002|Overall Study|Trial Site Closed|2|||
48533448|NCT05830799|156140139|FG000|Overall Study|Withdrawal by Subject|1|||
48533449|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
48533450|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
48533451|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
48533452|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
48533453|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
48533454|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
48533455|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
48533456|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
48533457|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
48533458|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
48533459|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Subject decision|1|||
48533460|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Subject decision|1|||
48533461|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
48533462|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
48533463|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
48533464|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
48533465|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
48533466|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
48533467|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
48533468|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
48533469|NCT00518882|156140140|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
48533470|NCT00518882|156140141|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
48533471|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
48533472|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
48533473|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
48533474|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
48533475|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
48533476|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
48603832|NCT00617357|156404369|FG000|Overall Study|Lost to Follow-up|7|||
48603833|NCT00617357|156404369|FG000|Overall Study|Death|5|||
48603834|NCT00617357|156404369|FG000|Overall Study|insurance concerns|2|||
48603835|NCT00617357|156404369|FG000|Overall Study|Withdrawal by Subject|1|||
48603836|NCT00617357|156404369|FG000|Overall Study|Physician Decision|1|||
48603837|NCT04350827|156404372|FG000|Overall Study|Lost to Follow-up|1|||
48603838|NCT04350827|156404373|FG001|Overall Study|Lost to Follow-up|2|||
48603839|NCT01775670|156406605|FG000|Overall Study|Lost to Follow-up|1|||
48603840|NCT01775670|156406606|FG001|Overall Study|Lost to Follow-up|1|||
48603841|NCT01111565|156406612|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
48603842|NCT01111565|156406613|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
48835397|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
48835398|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
48835399|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835400|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835401|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835402|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835403|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835404|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835405|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835406|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835407|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835408|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
48835409|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
48603843|NCT01111565|156406614|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
48603844|NCT01111565|156406615|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
48603845|NCT01111565|156406616|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
48603846|NCT01111565|156406612|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
48603847|NCT01111565|156406613|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
48603848|NCT01111565|156406614|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
48603849|NCT01111565|156406615|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
48603850|NCT01111565|156406616|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
48603851|NCT01111565|156406612|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
48603852|NCT01111565|156406613|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
48603853|NCT01111565|156406614|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
48603854|NCT01111565|156406615|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
48603855|NCT01111565|156406616|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
48603856|NCT01111565|156406612|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
48603857|NCT01111565|156406613|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
48603858|NCT01111565|156406614|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
48603859|NCT01111565|156406615|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
48603860|NCT01111565|156406616|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
48603861|NCT01111565|156406612|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
48603862|NCT01111565|156406613|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
48603863|NCT01111565|156406614|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
48603864|NCT01111565|156406615|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
48603865|NCT01111565|156406616|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
48603866|NCT01111565|156406612|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
48603867|NCT01111565|156406613|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
48603868|NCT01111565|156406614|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
48603869|NCT01111565|156406615|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
48603870|NCT01111565|156406616|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
48603871|NCT01111565|156406612|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
48603872|NCT01111565|156406613|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
48603873|NCT01111565|156406614|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
48603874|NCT01111565|156406615|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
48603875|NCT01111565|156406616|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
48603876|NCT01111565|156406612|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48603877|NCT01111565|156406613|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48603878|NCT01111565|156406614|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48603879|NCT01111565|156406615|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
48603880|NCT01111565|156406616|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48835410|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835411|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
48835412|NCT04707313|157238754|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835413|NCT04707313|157238755|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48533477|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
48533478|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
48533479|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
48533480|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
48533481|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
48533482|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
48533483|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
48835414|NCT04707313|157238756|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835415|NCT04707313|157238757|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48533484|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
48533485|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
48533486|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
48533487|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
48533488|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
48533489|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
48533490|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
48533491|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
48533492|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
48533493|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
48533494|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
48533495|NCT00518882|156140140|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
48533496|NCT00518882|156140141|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
48603881|NCT01111565|156406612|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48603882|NCT01111565|156406613|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48835416|NCT04707313|157238758|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48533497|NCT00396331|156140142|FG000|Overall Study|Failed to mobilize - no transplant|8|||
48533498|NCT00396331|156140142|FG000|Overall Study|Did not go on to transplant|5|||
48533499|NCT00396331|156140142|FG000|Overall Study|Lost to Follow-up|3|||
48533500|NCT00396331|156140142|FG000|Overall Study|Death|16|||
48835417|NCT04707313|157238759|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835418|NCT04707313|157238760|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835419|NCT04707313|157238761|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48533501|NCT03395639|156140143|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
48533502|NCT03395639|156140144|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
48533503|NCT03395639|156140145|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
48533504|NCT03395639|156140143|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
48533505|NCT03395639|156140144|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
48533506|NCT03395639|156140145|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
48533507|NCT03395639|156140143|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
48533508|NCT03395639|156140144|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
48533509|NCT03395639|156140145|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
48533510|NCT03395639|156140143|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
48533511|NCT03395639|156140144|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
48533512|NCT03395639|156140145|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
48533513|NCT03395639|156140143|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
48533514|NCT03395639|156140144|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
48533515|NCT03395639|156140145|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
48533516|NCT00680186|156140146|FG000|Overall Study|Adverse Event|47|||
48533517|NCT00680186|156140147|FG001|Overall Study|Adverse Event|44|||
48533518|NCT00680186|156140146|FG000|Overall Study|Protocol Violation|31|||
48533519|NCT00680186|156140147|FG001|Overall Study|Protocol Violation|26|||
48835420|NCT04707313|157238762|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
48835421|NCT04707313|157238763|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
48835422|NCT04707313|157238764|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
48835423|NCT04707313|157238765|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
48835424|NCT04707313|157238766|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
48835425|NCT03823911|157238769|FG000|Overall Study|Lost to Follow-up|1|||
48835426|NCT03823911|157238770|FG001|Overall Study|Lost to Follow-up|5|||
48835427|NCT03823911|157238771|FG002|Overall Study|Lost to Follow-up|2|||
48835428|NCT03823911|157238769|FG000|Overall Study|Did not meet eligibility criteria|13|||
48835429|NCT03823911|157238770|FG001|Overall Study|Did not meet eligibility criteria|7|||
48835430|NCT03823911|157238771|FG002|Overall Study|Did not meet eligibility criteria|4|||
48835431|NCT03823911|157238769|FG000|Overall Study|Death|0|||
48835432|NCT03823911|157238770|FG001|Overall Study|Death|1|||
48835433|NCT03823911|157238771|FG002|Overall Study|Death|0|||
48835434|NCT00834834|157238774|FG000|Overall Study|Withdrawal by Subject|4|||
48835435|NCT00834834|157238775|FG001|Overall Study|Withdrawal by Subject|3|||
48835436|NCT01692730|157238776|FG000|Overall Study|Lost to Follow-up|225|||
48835437|NCT01692730|157238777|FG001|Overall Study|Lost to Follow-up|227|||
48835438|NCT04199728|157240646|FG000|Overall Study|Adverse Event|1|||
48835439|NCT04199728|157240647|FG001|Overall Study|Adverse Event|0|||
48835440|NCT04199728|157240646|FG000|Overall Study|Withdrawal by Subject|8|||
48835441|NCT04199728|157240647|FG001|Overall Study|Withdrawal by Subject|3|||
48835442|NCT04199728|157240646|FG000|Overall Study|Screen fail after consent|0|||
48835443|NCT04199728|157240647|FG001|Overall Study|Screen fail after consent|1|||
48835444|NCT04199728|157240646|FG000|Overall Study|Early withdraw criteria met|0|||
48835445|NCT04199728|157240647|FG001|Overall Study|Early withdraw criteria met|1|||
48835446|NCT04199728|157240646|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
48835447|NCT04199728|157240647|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
48835448|NCT04048135|157240648|FG000|Overall Study|Withdrawal by Subject|1|||
48835449|NCT04048135|157240649|FG001|Overall Study|Withdrawal by Subject|1|||
48835450|NCT04048135|157240650|FG002|Overall Study|Withdrawal by Subject|1|||
48835451|NCT04048135|157240651|FG003|Overall Study|Withdrawal by Subject|2|||
48835452|NCT04048135|157240652|FG004|Overall Study|Withdrawal by Subject|0|||
48835453|NCT04048135|157240653|FG005|Overall Study|Withdrawal by Subject|0|||
48835454|NCT04048135|157240654|FG006|Overall Study|Withdrawal by Subject|1|||
48603883|NCT01111565|156406614|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
48603884|NCT01111565|156406615|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48603885|NCT01111565|156406616|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48603886|NCT01111565|156406612|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
48603887|NCT01111565|156406613|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
48603888|NCT01111565|156406614|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
48603889|NCT01111565|156406615|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
48603890|NCT01111565|156406616|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
48603891|NCT01111565|156406612|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
48603892|NCT01111565|156406613|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
48835455|NCT04048135|157240655|FG007|Overall Study|Withdrawal by Subject|1|||
48835456|NCT04048135|157240648|FG000|Overall Study|Adverse Event|0|||
48533520|NCT00680186|156140146|FG000|Overall Study|Lost to Follow-up|11|||
48533521|NCT00680186|156140147|FG001|Overall Study|Lost to Follow-up|6|||
48533522|NCT00680186|156140146|FG000|Overall Study|Withdrawal by Subject|32|||
48533523|NCT00680186|156140147|FG001|Overall Study|Withdrawal by Subject|39|||
48533524|NCT00680186|156140146|FG000|Overall Study|Other|4|||
48533525|NCT00680186|156140147|FG001|Overall Study|Other|1|||
48533526|NCT01351350|156140150|FG000|Overall Study|Disease Progression|5|||
48533527|NCT01351350|156140151|FG001|Overall Study|Disease Progression|13|||
48533528|NCT01351350|156140152|FG002|Overall Study|Disease Progression|6|||
48533529|NCT01351350|156140153|FG003|Overall Study|Disease Progression|8|||
48533530|NCT01351350|156140154|FG004|Overall Study|Disease Progression|5|||
48533531|NCT01351350|156140150|FG000|Overall Study|Adverse Event|1|||
48533532|NCT01351350|156140151|FG001|Overall Study|Adverse Event|10|||
48533533|NCT01351350|156140152|FG002|Overall Study|Adverse Event|1|||
48533534|NCT01351350|156140153|FG003|Overall Study|Adverse Event|2|||
48533535|NCT01351350|156140154|FG004|Overall Study|Adverse Event|0|||
48533536|NCT01351350|156140150|FG000|Overall Study|Participant Decision|2|||
48533537|NCT01351350|156140151|FG001|Overall Study|Participant Decision|6|||
48533538|NCT01351350|156140152|FG002|Overall Study|Participant Decision|3|||
48533539|NCT01351350|156140153|FG003|Overall Study|Participant Decision|3|||
48533540|NCT01351350|156140154|FG004|Overall Study|Participant Decision|2|||
48533541|NCT01351350|156140150|FG000|Overall Study|Enrolled but not Treated|0|||
48533542|NCT01351350|156140151|FG001|Overall Study|Enrolled but not Treated|0|||
48533543|NCT01351350|156140152|FG002|Overall Study|Enrolled but not Treated|1|||
48533544|NCT01351350|156140153|FG003|Overall Study|Enrolled but not Treated|0|||
48533545|NCT01351350|156140154|FG004|Overall Study|Enrolled but not Treated|0|||
48533546|NCT01684878|156140155|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
48533547|NCT01684878|156140156|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
48533548|NCT01684878|156140157|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
48533549|NCT01684878|156140158|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
48533550|NCT01684878|156140155|FG000|Part 1: Safety Run in Phase|Death|15|||
48533551|NCT01684878|156140156|FG001|Part 1: Safety Run in Phase|Death|20|||
48533552|NCT01684878|156140157|FG002|Part 1: Safety Run in Phase|Death|0|||
48533553|NCT01684878|156140158|FG003|Part 1: Safety Run in Phase|Death|0|||
48533554|NCT01684878|156140155|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
48533555|NCT01684878|156140156|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
48533556|NCT01684878|156140157|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
48533557|NCT01684878|156140158|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
48533558|NCT01684878|156140155|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
48533559|NCT01684878|156140156|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
48533560|NCT01684878|156140157|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
48533561|NCT01684878|156140158|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
48533562|NCT01684878|156140155|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
48533563|NCT01684878|156140156|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
48533564|NCT01684878|156140157|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
48533565|NCT01684878|156140158|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
48533566|NCT01684878|156140155|FG000|Part 2: Randomized Phase|Death|0|||
48533567|NCT01684878|156140156|FG001|Part 2: Randomized Phase|Death|0|||
48533568|NCT01684878|156140157|FG002|Part 2: Randomized Phase|Death|62|||
48603893|NCT01111565|156406614|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
48692904|NCT03137992|156724649|FG003|Washout Period 1|Principal Investigator Discretion|0|||
48835457|NCT04048135|157240649|FG001|Overall Study|Adverse Event|0|||
48835458|NCT04048135|157240650|FG002|Overall Study|Adverse Event|0|||
48835459|NCT04048135|157240651|FG003|Overall Study|Adverse Event|1|||
48533569|NCT01684878|156140158|FG003|Part 2: Randomized Phase|Death|68|||
48533570|NCT01684878|156140155|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
48533571|NCT01684878|156140156|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
48533572|NCT01684878|156140157|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
48533573|NCT01684878|156140158|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
48533574|NCT01684878|156140155|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
48533575|NCT01684878|156140156|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
48533576|NCT01684878|156140157|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
48533577|NCT01684878|156140158|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
48533578|NCT02492841|156140162|FG000|Overall Study|Lost to Follow-up|34|||
48533579|NCT02492841|156140163|FG001|Overall Study|Lost to Follow-up|31|||
48533580|NCT02492841|156140164|FG002|Overall Study|Lost to Follow-up|35|||
48533581|NCT01917968|156140167|FG000|Overall Study|Death|3|||
48533582|NCT01917968|156140168|FG001|Overall Study|Death|2|||
48533583|NCT01917968|156140167|FG000|Overall Study|Lost to Follow-up|21|||
48533584|NCT01917968|156140168|FG001|Overall Study|Lost to Follow-up|39|||
48533585|NCT01917968|156140167|FG000|Overall Study|Physician Decision|1|||
48533586|NCT01917968|156140168|FG001|Overall Study|Physician Decision|2|||
48533587|NCT01917968|156140167|FG000|Overall Study|Withdrawal by Subject|20|||
48533588|NCT01917968|156140168|FG001|Overall Study|Withdrawal by Subject|35|||
48533589|NCT01917968|156140167|FG000|Overall Study|Subject Relocation|5|||
48533590|NCT01917968|156140168|FG001|Overall Study|Subject Relocation|1|||
48533591|NCT01917968|156140167|FG000|Overall Study|36M Missed Visit|3|||
48533592|NCT01917968|156140168|FG001|Overall Study|36M Missed Visit|2|||
48533593|NCT01917968|156140167|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
48533594|NCT01917968|156140168|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
48533595|NCT01917968|156140167|FG000|Overall Study|Change in Family Circumstances|0|||
48533596|NCT01917968|156140168|FG001|Overall Study|Change in Family Circumstances|1|||
48533597|NCT01917968|156140167|FG000|Overall Study|No Data Available|0|||
48533598|NCT01917968|156140168|FG001|Overall Study|No Data Available|2|||
48533599|NCT00966381|156141362|FG000|Overall Study|Withdrawal by Subject|2|||
48533600|NCT00966381|156141363|FG001|Overall Study|Withdrawal by Subject|2|||
48533601|NCT02211014|156141364|FG000|Overall Study|Adverse Event|0|||
48533602|NCT02211014|156141365|FG001|Overall Study|Adverse Event|2|||
48533603|NCT02211014|156141364|FG000|Overall Study|Physician Decision|1|||
48533604|NCT02211014|156141365|FG001|Overall Study|Physician Decision|2|||
48533605|NCT02211014|156141364|FG000|Overall Study|Started another cancer therapy|1|||
48533606|NCT02211014|156141365|FG001|Overall Study|Started another cancer therapy|0|||
48533607|NCT02211014|156141364|FG000|Overall Study|Withdrawal by Subject|0|||
48533608|NCT02211014|156141365|FG001|Overall Study|Withdrawal by Subject|1|||
48533609|NCT02211014|156141364|FG000|Overall Study|In agreement with patient, no benefit|0|||
48533610|NCT02211014|156141365|FG001|Overall Study|In agreement with patient, no benefit|1|||
48533611|NCT03581188|156141366|FG000|Overall Study|Inclusion criteria not met|3|||
48533612|NCT03581188|156141367|FG001|Overall Study|Inclusion criteria not met|2|||
48533613|NCT03581188|156141366|FG000|Overall Study|Lost to Follow-up|5|||
48533614|NCT03581188|156141367|FG001|Overall Study|Lost to Follow-up|5|||
48533615|NCT03581188|156141366|FG000|Overall Study|Discontinued intervention|11|||
48533616|NCT03581188|156141367|FG001|Overall Study|Discontinued intervention|8|||
48533617|NCT01124695|156141371|FG000|Overall Study|Disease progression|77|||
48533618|NCT01124695|156141371|FG000|Overall Study|Adverse Event|11|||
48533619|NCT01124695|156141371|FG000|Overall Study|Death|1|||
48533620|NCT01124695|156141371|FG000|Overall Study|Withdrawal by Subject|7|||
48533621|NCT01124695|156141371|FG000|Overall Study|Physician Decision|3|||
48533622|NCT01124695|156141371|FG000|Overall Study|Alternative therapy|9|||
48533623|NCT01124695|156141371|FG000|Overall Study|No documentation that patient went off treatment|4|||
48533624|NCT01124695|156141371|FG000|Overall Study|Ineligible|9|||
48533625|NCT01124695|156141371|FG000|Overall Study|Ineligible and never start treatment|2|||
48533626|NCT00115934|156141380|FG000|Overall Study|Lost to Follow-up|1|||
48533627|NCT00115934|156141381|FG001|Overall Study|Lost to Follow-up|0|||
48533628|NCT00115934|156141380|FG000|Overall Study|Did not receive intervention|3|||
48533629|NCT00115934|156141381|FG001|Overall Study|Did not receive intervention|2|||
48533630|NCT03891758|156141382|FG000|Overall Study|Adverse Event|2|||
48533631|NCT03891758|156141383|FG001|Overall Study|Adverse Event|0|||
48533632|NCT03891758|156141382|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48533633|NCT03891758|156141383|FG001|Overall Study|Withdrawal by parent/guardian|2|||
48533634|NCT02676284|156141384|FG000|Overall Study|Withdrawal by Subject|1|||
48533635|NCT00107042|156141385|FG000|Overall Study|Lost to Follow-up|9|||
48533636|NCT00107042|156141386|FG001|Overall Study|Lost to Follow-up|7|||
48533637|NCT00107042|156141385|FG000|Overall Study|Withdrawal by Subject|6|||
48533638|NCT00107042|156141386|FG001|Overall Study|Withdrawal by Subject|1|||
48533639|NCT00107042|156141385|FG000|Overall Study|Moved out of area|5|||
48533640|NCT00107042|156141386|FG001|Overall Study|Moved out of area|3|||
48533641|NCT00107042|156141385|FG000|Overall Study|Pregnancy|1|||
48533642|NCT00107042|156141386|FG001|Overall Study|Pregnancy|1|||
48533643|NCT00107042|156141385|FG000|Overall Study|Inadvertent enrollment|0|||
48533644|NCT00107042|156141386|FG001|Overall Study|Inadvertent enrollment|1|||
48533645|NCT00107042|156141385|FG000|Overall Study|vaccinated outside window|1|||
48533646|NCT00107042|156141386|FG001|Overall Study|vaccinated outside window|1|||
48533647|NCT00107042|156141385|FG000|Overall Study|Disallowed medications|0|||
48533648|NCT00107042|156141386|FG001|Overall Study|Disallowed medications|2|||
48533649|NCT00880087|156141391|FG000|Overall Study|Lost to Follow-up|0|||
48533650|NCT00880087|156141392|FG001|Overall Study|Lost to Follow-up|2|||
48533651|NCT00754442|156141393|FG000|Overall Study|Withdrawal by Subject|5|||
48533652|NCT00754442|156141394|FG001|Overall Study|Withdrawal by Subject|3|||
48603894|NCT01111565|156406615|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
48603895|NCT01111565|156406616|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
48533653|NCT01557842|156141395|FG000|Overall Study|Lost to Follow-up|0|||
48533654|NCT01557842|156141396|FG001|Overall Study|Lost to Follow-up|1|||
48533655|NCT01557842|156141395|FG000|Overall Study|Death|1|||
48603896|NCT01111565|156406612|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
48603897|NCT01111565|156406613|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
48603898|NCT01111565|156406614|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
48603899|NCT01111565|156406615|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
48603900|NCT01111565|156406616|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
48603901|NCT00723229|156406619|FG000|First Intervention|Lost to Follow-up|7|||
48603902|NCT00723229|156406620|FG001|First Intervention|Lost to Follow-up|3|||
48603903|NCT01719380|156406621|FG000|Overall Study|Adverse Event|0|||
48603904|NCT01719380|156406622|FG001|Overall Study|Adverse Event|0|||
48603905|NCT01719380|156406623|FG002|Overall Study|Adverse Event|1|||
48603906|NCT01719380|156406624|FG003|Overall Study|Adverse Event|2|||
48603907|NCT01719380|156406625|FG004|Overall Study|Adverse Event|0|||
48533656|NCT01557842|156141396|FG001|Overall Study|Death|0|||
48533657|NCT01557842|156141395|FG000|Overall Study|Lack of Efficacy|0|||
48533658|NCT01557842|156141396|FG001|Overall Study|Lack of Efficacy|1|||
48533659|NCT01557842|156141395|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
48533660|NCT01557842|156141396|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
48533661|NCT01557842|156141395|FG000|Overall Study|Study Terminated by Sponsor|3|||
48533662|NCT01557842|156141396|FG001|Overall Study|Study Terminated by Sponsor|4|||
48533663|NCT01557842|156141395|FG000|Overall Study|Not Ablated|2|||
48533664|NCT01557842|156141396|FG001|Overall Study|Not Ablated|0|||
48533665|NCT02065713|156141401|FG000|Overall Study|Adverse Event|0|||
48533666|NCT02065713|156141402|FG001|Overall Study|Adverse Event|1|||
48533667|NCT02065713|156141401|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48533668|NCT02065713|156141402|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48533669|NCT02780167|156141404|FG000|Overall Study|Adverse Event|9|||
48533670|NCT02780167|156141405|FG001|Overall Study|Adverse Event|8|||
48603908|NCT01719380|156406626|FG005|Overall Study|Adverse Event|1|||
48835460|NCT04048135|157240652|FG004|Overall Study|Adverse Event|1|||
48835461|NCT04048135|157240653|FG005|Overall Study|Adverse Event|0|||
48835462|NCT04048135|157240654|FG006|Overall Study|Adverse Event|0|||
48533671|NCT02780167|156141406|FG002|Overall Study|Adverse Event|8|||
48533672|NCT02780167|156141407|FG003|Overall Study|Adverse Event|12|||
48533673|NCT02780167|156141408|FG004|Overall Study|Adverse Event|8|||
48533674|NCT02780167|156141404|FG000|Overall Study|Lack of Efficacy|6|||
48533675|NCT02780167|156141405|FG001|Overall Study|Lack of Efficacy|5|||
48533676|NCT02780167|156141406|FG002|Overall Study|Lack of Efficacy|6|||
48533677|NCT02780167|156141407|FG003|Overall Study|Lack of Efficacy|1|||
48533678|NCT02780167|156141408|FG004|Overall Study|Lack of Efficacy|0|||
48835463|NCT04048135|157240655|FG007|Overall Study|Adverse Event|0|||
48835464|NCT04048135|157240648|FG000|Overall Study|Protocol Violation|0|||
48835465|NCT04048135|157240649|FG001|Overall Study|Protocol Violation|0|||
48835466|NCT04048135|157240650|FG002|Overall Study|Protocol Violation|0|||
48835467|NCT04048135|157240651|FG003|Overall Study|Protocol Violation|0|||
48835468|NCT04048135|157240652|FG004|Overall Study|Protocol Violation|0|||
48835469|NCT04048135|157240653|FG005|Overall Study|Protocol Violation|1|||
48835470|NCT04048135|157240654|FG006|Overall Study|Protocol Violation|0|||
48835471|NCT04048135|157240655|FG007|Overall Study|Protocol Violation|0|||
48835472|NCT00172185|157240656|FG000|Overall Study|Adverse Event|0|||
48835473|NCT00172185|157240657|FG001|Overall Study|Adverse Event|1|||
48835474|NCT00172185|157240658|FG002|Overall Study|Adverse Event|3|||
48835475|NCT00172185|157240659|FG003|Overall Study|Adverse Event|4|||
48835476|NCT00172185|157240656|FG000|Overall Study|Physician Decision|0|||
48835477|NCT00172185|157240657|FG001|Overall Study|Physician Decision|0|||
48835478|NCT00172185|157240658|FG002|Overall Study|Physician Decision|1|||
48835479|NCT00172185|157240659|FG003|Overall Study|Physician Decision|0|||
48835480|NCT00172185|157240656|FG000|Overall Study|SPONSOR Decision|0|||
48835481|NCT00172185|157240657|FG001|Overall Study|SPONSOR Decision|1|||
48835482|NCT00172185|157240658|FG002|Overall Study|SPONSOR Decision|0|||
48835483|NCT00172185|157240659|FG003|Overall Study|SPONSOR Decision|0|||
48835484|NCT00172185|157240656|FG000|Overall Study|Withdrawal by Subject|0|||
48835485|NCT00172185|157240657|FG001|Overall Study|Withdrawal by Subject|0|||
48835486|NCT00172185|157240658|FG002|Overall Study|Withdrawal by Subject|1|||
48835487|NCT00172185|157240659|FG003|Overall Study|Withdrawal by Subject|0|||
48533679|NCT02780167|156141404|FG000|Overall Study|Lost to Follow-up|2|||
48603909|NCT01719380|156406627|FG006|Overall Study|Adverse Event|0|||
48603910|NCT01719380|156406628|FG007|Overall Study|Adverse Event|1|||
48603911|NCT01719380|156406629|FG008|Overall Study|Adverse Event|4|||
48835488|NCT04358549|157240667|FG000|Overall Study|Adverse Event|0|||
48835489|NCT04358549|157240668|FG001|Overall Study|Adverse Event|1|||
48835490|NCT04358549|157240667|FG000|Overall Study|Death|1|||
48603912|NCT01719380|156406630|FG009|Overall Study|Adverse Event|3|||
48603913|NCT01719380|156406621|FG000|Overall Study|Death|0|||
48603914|NCT01719380|156406622|FG001|Overall Study|Death|1|||
48533680|NCT02780167|156141405|FG001|Overall Study|Lost to Follow-up|0|||
48533681|NCT02780167|156141406|FG002|Overall Study|Lost to Follow-up|1|||
48533682|NCT02780167|156141407|FG003|Overall Study|Lost to Follow-up|0|||
48533683|NCT02780167|156141408|FG004|Overall Study|Lost to Follow-up|0|||
48533684|NCT02780167|156141404|FG000|Overall Study|Does not meet entrance criteria|0|||
48533685|NCT02780167|156141405|FG001|Overall Study|Does not meet entrance criteria|0|||
48533686|NCT02780167|156141406|FG002|Overall Study|Does not meet entrance criteria|1|||
48533687|NCT02780167|156141407|FG003|Overall Study|Does not meet entrance criteria|0|||
48533688|NCT02780167|156141408|FG004|Overall Study|Does not meet entrance criteria|0|||
48533689|NCT02780167|156141404|FG000|Overall Study|No longer meets eligibility criteria|0|||
48533690|NCT02780167|156141405|FG001|Overall Study|No longer meets eligibility criteria|0|||
48533691|NCT02780167|156141406|FG002|Overall Study|No longer meets eligibility criteria|0|||
48533692|NCT02780167|156141407|FG003|Overall Study|No longer meets eligibility criteria|1|||
48533693|NCT02780167|156141408|FG004|Overall Study|No longer meets eligibility criteria|1|||
48533694|NCT02780167|156141404|FG000|Overall Study|Protocol Violation|5|||
48533695|NCT02780167|156141405|FG001|Overall Study|Protocol Violation|5|||
48533696|NCT02780167|156141406|FG002|Overall Study|Protocol Violation|1|||
48533697|NCT02780167|156141407|FG003|Overall Study|Protocol Violation|1|||
48533698|NCT02780167|156141408|FG004|Overall Study|Protocol Violation|2|||
48533699|NCT02780167|156141404|FG000|Overall Study|Withdrawal by Subject|6|||
48603915|NCT01719380|156406623|FG002|Overall Study|Death|0|||
48603916|NCT01719380|156406624|FG003|Overall Study|Death|0|||
48603917|NCT01719380|156406625|FG004|Overall Study|Death|0|||
48533700|NCT02780167|156141405|FG001|Overall Study|Withdrawal by Subject|4|||
48533701|NCT02780167|156141406|FG002|Overall Study|Withdrawal by Subject|4|||
48533702|NCT02780167|156141407|FG003|Overall Study|Withdrawal by Subject|3|||
48533703|NCT02780167|156141408|FG004|Overall Study|Withdrawal by Subject|4|||
48533704|NCT02780167|156141404|FG000|Overall Study|Other|0|||
48533705|NCT02780167|156141405|FG001|Overall Study|Other|0|||
48533706|NCT02780167|156141406|FG002|Overall Study|Other|3|||
48533707|NCT02780167|156141407|FG003|Overall Study|Other|1|||
48533708|NCT02780167|156141408|FG004|Overall Study|Other|2|||
48533709|NCT00126126|156141411|FG000|Overall Study|Lost to Follow-up|0|||
48533710|NCT00126126|156141412|FG001|Overall Study|Lost to Follow-up|2|||
48533711|NCT02547766|156141413|FG000|Overall Study|Withdrawal by Subject|1|||
48533712|NCT03212794|156141414|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
48533713|NCT03212794|156141415|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
48533714|NCT03212794|156141414|FG000|Overall Study|Lost to Follow-up|5|||
48533715|NCT03212794|156141415|FG001|Overall Study|Lost to Follow-up|6|||
48533716|NCT03212794|156141414|FG000|Overall Study|Incarcerated; unable to participate|2|||
48533717|NCT03212794|156141415|FG001|Overall Study|Incarcerated; unable to participate|0|||
48533718|NCT03212794|156141414|FG000|Overall Study|Withdrawal by Subject|1|||
48533719|NCT03212794|156141415|FG001|Overall Study|Withdrawal by Subject|0|||
48533720|NCT03212794|156141414|FG000|Overall Study|Death|0|||
48533721|NCT03212794|156141415|FG001|Overall Study|Death|1|||
48533722|NCT03212794|156141414|FG000|Overall Study|Found to be ineligible after allocation|0|||
48533723|NCT03212794|156141415|FG001|Overall Study|Found to be ineligible after allocation|1|||
48533724|NCT03212794|156141414|FG000|Overall Study|Relocated out of area|2|||
48603918|NCT01719380|156406626|FG005|Overall Study|Death|0|||
48603919|NCT01719380|156406627|FG006|Overall Study|Death|0|||
48603920|NCT01719380|156406628|FG007|Overall Study|Death|0|||
48603921|NCT01719380|156406629|FG008|Overall Study|Death|3|||
48603922|NCT01719380|156406630|FG009|Overall Study|Death|3|||
48603923|NCT01719380|156406621|FG000|Overall Study|Participant/Guardian Decision|0|||
48603924|NCT01719380|156406622|FG001|Overall Study|Participant/Guardian Decision|0|||
48603925|NCT01719380|156406623|FG002|Overall Study|Participant/Guardian Decision|1|||
48603926|NCT01719380|156406624|FG003|Overall Study|Participant/Guardian Decision|0|||
48603927|NCT01719380|156406625|FG004|Overall Study|Participant/Guardian Decision|0|||
48603928|NCT01719380|156406626|FG005|Overall Study|Participant/Guardian Decision|0|||
48603929|NCT01719380|156406627|FG006|Overall Study|Participant/Guardian Decision|0|||
48533725|NCT03212794|156141415|FG001|Overall Study|Relocated out of area|0|||
48533726|NCT00103038|156141421|FG000|Overall Study|Withdrawal by Subject|8|||
48533727|NCT00103038|156141421|FG000|Overall Study|Screen failure|3|||
48533728|NCT00103038|156141421|FG000|Overall Study|Death|1|||
48533729|NCT00103038|156141421|FG000|Overall Study|Physician Decision|1|||
48533730|NCT00775528|156141425|FG000|Overall Study|Protocol Violation|1|||
48603930|NCT01719380|156406628|FG007|Overall Study|Participant/Guardian Decision|0|||
48603931|NCT01719380|156406629|FG008|Overall Study|Participant/Guardian Decision|2|||
48603932|NCT01719380|156406630|FG009|Overall Study|Participant/Guardian Decision|2|||
48603933|NCT01719380|156406621|FG000|Overall Study|Physician Decision|0|||
48603934|NCT01719380|156406622|FG001|Overall Study|Physician Decision|0|||
48603935|NCT01719380|156406623|FG002|Overall Study|Physician Decision|2|||
48603936|NCT01719380|156406624|FG003|Overall Study|Physician Decision|0|||
48533731|NCT00942331|156141426|FG000|Overall Study|Did not start treatment|15|||
48533732|NCT00942331|156141427|FG001|Overall Study|Did not start treatment|22|||
48533733|NCT00873119|156141429|FG000|Overall Study|Patient request|4|||
48533734|NCT00873119|156141430|FG001|Overall Study|Patient request|2|||
48533735|NCT00873119|156141429|FG000|Overall Study|Adverse Event|8|||
48533736|NCT00873119|156141430|FG001|Overall Study|Adverse Event|0|||
48533737|NCT00873119|156141429|FG000|Overall Study|Progressive disease|26|||
48533738|NCT00873119|156141430|FG001|Overall Study|Progressive disease|18|||
48533739|NCT00873119|156141429|FG000|Overall Study|Death|2|||
48533740|NCT00873119|156141430|FG001|Overall Study|Death|1|||
48533741|NCT00873119|156141429|FG000|Overall Study|Other|2|||
48533742|NCT00873119|156141430|FG001|Overall Study|Other|5|||
48533743|NCT00873119|156141429|FG000|Overall Study|Not treated|2|||
48533744|NCT00873119|156141430|FG001|Overall Study|Not treated|0|||
48533745|NCT03648879|156141435|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
48533746|NCT00285584|156141438|FG000|Month 3|Lost to Follow-up|3|||
48533747|NCT00285584|156141439|FG001|Month 3|Lost to Follow-up|3|||
48533748|NCT00285584|156141438|FG000|Month 3|Withdrawal by Subject|1|||
48533749|NCT00285584|156141439|FG001|Month 3|Withdrawal by Subject|0|||
48533750|NCT00285584|156141438|FG000|Month 6|Lost to Follow-up|0|||
48533751|NCT00285584|156141439|FG001|Month 6|Lost to Follow-up|1|||
48533752|NCT03812991|156141440|FG000|Overall Study|Lost to Follow-up|3|||
48533753|NCT03812991|156141441|FG001|Overall Study|Lost to Follow-up|1|||
48533754|NCT04740931|156141442|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
48533755|NCT04740931|156141443|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
48533756|NCT04740931|156141442|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
48533757|NCT04740931|156141443|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
48533758|NCT04740931|156141442|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
48533759|NCT04740931|156141443|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
48533760|NCT04740931|156141442|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
48533761|NCT04740931|156141443|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
48533762|NCT04740931|156141442|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
48533763|NCT04740931|156141443|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
48533764|NCT04740931|156141442|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
48533765|NCT04740931|156141443|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
48533766|NCT04740931|156141442|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
48533767|NCT04740931|156141443|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
48533768|NCT04740931|156141442|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
48533769|NCT04740931|156141443|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
48533770|NCT04740931|156141442|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
48533771|NCT04740931|156141443|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
48533772|NCT04740931|156141442|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
48533773|NCT04740931|156141443|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
48533774|NCT04740931|156141442|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
48533775|NCT04740931|156141443|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
48533776|NCT04740931|156141442|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
48533777|NCT04740931|156141443|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
48603937|NCT01719380|156406625|FG004|Overall Study|Physician Decision|0|||
48603938|NCT01719380|156406626|FG005|Overall Study|Physician Decision|0|||
48603939|NCT01719380|156406627|FG006|Overall Study|Physician Decision|0|||
48603940|NCT01719380|156406628|FG007|Overall Study|Physician Decision|0|||
48603941|NCT01719380|156406629|FG008|Overall Study|Physician Decision|1|||
48603942|NCT01719380|156406630|FG009|Overall Study|Physician Decision|1|||
48603943|NCT01719380|156406621|FG000|Overall Study|Lack of Efficacy|2|||
48603944|NCT01719380|156406622|FG001|Overall Study|Lack of Efficacy|6|||
48603945|NCT01719380|156406623|FG002|Overall Study|Lack of Efficacy|5|||
48603946|NCT01719380|156406624|FG003|Overall Study|Lack of Efficacy|6|||
48603947|NCT01719380|156406625|FG004|Overall Study|Lack of Efficacy|3|||
48603948|NCT01719380|156406626|FG005|Overall Study|Lack of Efficacy|7|||
48603949|NCT01719380|156406627|FG006|Overall Study|Lack of Efficacy|10|||
48603950|NCT01719380|156406628|FG007|Overall Study|Lack of Efficacy|6|||
48603951|NCT01719380|156406629|FG008|Overall Study|Lack of Efficacy|39|||
48603952|NCT01719380|156406630|FG009|Overall Study|Lack of Efficacy|42|||
48835491|NCT04358549|157240668|FG001|Overall Study|Death|0|||
48603953|NCT01719380|156406621|FG000|Overall Study|Progressive Disease|0|||
48835492|NCT04358549|157240667|FG000|Overall Study|Lost to Follow-up|2|||
48835493|NCT04358549|157240668|FG001|Overall Study|Lost to Follow-up|1|||
48835494|NCT04358549|157240667|FG000|Overall Study|Withdrawal by Subject|6|||
48533778|NCT04740931|156141442|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
48533779|NCT04740931|156141443|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
48533780|NCT04740931|156141442|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
48533781|NCT04740931|156141443|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
48533782|NCT04740931|156141442|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
48533783|NCT04740931|156141443|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
48603954|NCT01719380|156406622|FG001|Overall Study|Progressive Disease|0|||
48603955|NCT01719380|156406623|FG002|Overall Study|Progressive Disease|0|||
48603956|NCT01719380|156406624|FG003|Overall Study|Progressive Disease|0|||
48603957|NCT01719380|156406625|FG004|Overall Study|Progressive Disease|0|||
48603958|NCT01719380|156406626|FG005|Overall Study|Progressive Disease|0|||
48603959|NCT01719380|156406627|FG006|Overall Study|Progressive Disease|0|||
48603960|NCT01719380|156406628|FG007|Overall Study|Progressive Disease|0|||
48603961|NCT01719380|156406629|FG008|Overall Study|Progressive Disease|1|||
48603962|NCT01719380|156406630|FG009|Overall Study|Progressive Disease|0|||
48603963|NCT00528424|156406631|FG000|Overall Study|Lost to Follow-up|13|||
48603964|NCT00528424|156406631|FG000|Overall Study|Withdrew consent|2|||
48603965|NCT00528424|156406631|FG000|Overall Study|Administrative reason|2|||
48603966|NCT00528424|156406631|FG000|Overall Study|Other|12|||
48835495|NCT04358549|157240668|FG001|Overall Study|Withdrawal by Subject|6|||
48533784|NCT04403763|156141444|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
48533785|NCT04403763|156141445|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
48533786|NCT04403763|156141446|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
48533787|NCT04403763|156141447|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
48533788|NCT04403763|156141448|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
48533789|NCT04403763|156141449|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
48533790|NCT04403763|156141450|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
48533791|NCT04403763|156141444|FG000|Stage 1|Early termination due to PK tube failure|0|||
48533792|NCT04403763|156141445|FG001|Stage 1|Early termination due to PK tube failure|0|||
48533793|NCT04403763|156141446|FG002|Stage 1|Early termination due to PK tube failure|1|||
48533794|NCT04403763|156141447|FG003|Stage 1|Early termination due to PK tube failure|0|||
48533795|NCT04403763|156141448|FG004|Stage 1|Early termination due to PK tube failure|0|||
48533796|NCT04403763|156141449|FG005|Stage 1|Early termination due to PK tube failure|0|||
48533797|NCT04403763|156141450|FG006|Stage 1|Early termination due to PK tube failure|0|||
48533798|NCT04403763|156141444|FG000|Stage 2A|Adverse Event|0|||
48533799|NCT04403763|156141445|FG001|Stage 2A|Adverse Event|0|||
48533800|NCT04403763|156141446|FG002|Stage 2A|Adverse Event|0|||
48533801|NCT04403763|156141447|FG003|Stage 2A|Adverse Event|0|||
48533802|NCT04403763|156141448|FG004|Stage 2A|Adverse Event|0|||
48533803|NCT04403763|156141449|FG005|Stage 2A|Adverse Event|0|||
48533804|NCT04403763|156141450|FG006|Stage 2A|Adverse Event|1|||
48533805|NCT00227266|156141451|FG000|Overall Study|Withdrawal by Subject|0|||
48533806|NCT00227266|156141452|FG001|Overall Study|Withdrawal by Subject|0|||
48533807|NCT00227266|156141453|FG002|Overall Study|Withdrawal by Subject|1|||
48533808|NCT00227266|156141451|FG000|Overall Study|Protocol Violation|1|||
48533809|NCT00227266|156141452|FG001|Overall Study|Protocol Violation|0|||
48533810|NCT00227266|156141453|FG002|Overall Study|Protocol Violation|1|||
48533811|NCT00227266|156141451|FG000|Overall Study|Excessive weight gain|0|||
48533812|NCT00227266|156141452|FG001|Overall Study|Excessive weight gain|0|||
48533813|NCT00227266|156141453|FG002|Overall Study|Excessive weight gain|2|||
48533814|NCT00479388|156141467|FG000|Overall Study|Adverse Event|90|||
48533815|NCT00479388|156141468|FG001|Overall Study|Adverse Event|45|||
48533816|NCT00479388|156141467|FG000|Overall Study|Lost to Follow-up|0|||
48533817|NCT00479388|156141468|FG001|Overall Study|Lost to Follow-up|2|||
48533818|NCT00479388|156141467|FG000|Overall Study|Protocol Violation|10|||
48533819|NCT00479388|156141468|FG001|Overall Study|Protocol Violation|9|||
48533820|NCT00479388|156141467|FG000|Overall Study|Withdrawal by Subject|32|||
48533821|NCT00479388|156141468|FG001|Overall Study|Withdrawal by Subject|17|||
48533822|NCT02843659|156141470|FG000|Overall Study|Subject Withdrew Consent|0|||
48533823|NCT02843659|156141471|FG001|Overall Study|Subject Withdrew Consent|0|||
48533824|NCT02843659|156141472|FG002|Overall Study|Subject Withdrew Consent|1|||
48533825|NCT02843659|156141470|FG000|Overall Study|Administrative Reason by Sponsor|4|||
48533826|NCT02843659|156141471|FG001|Overall Study|Administrative Reason by Sponsor|5|||
48533827|NCT02843659|156141472|FG002|Overall Study|Administrative Reason by Sponsor|4|||
48533828|NCT02843659|156141470|FG000|Overall Study|Adverse Event|0|||
48533829|NCT02843659|156141471|FG001|Overall Study|Adverse Event|1|||
48533830|NCT02843659|156141472|FG002|Overall Study|Adverse Event|0|||
48603967|NCT02254772|156406634|FG000|Overall Study|Ineligible|1|||
48835496|NCT04358549|157240667|FG000|Overall Study|Start remdesivir|1|||
48835497|NCT04358549|157240668|FG001|Overall Study|Start remdesivir|0|||
48835498|NCT03895034|157240669|FG000|Overall Study|Lost to Follow-up|2|||
48835499|NCT01118377|157240673|FG000|Overall Study|Did Not Receive Study Medication|1|||
48533831|NCT03351231|156141481|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
48533832|NCT03351231|156141481|FG000|Combination Therapy Period|Disease progression|2|||
48533833|NCT03351231|156141481|FG000|Combination Therapy Period|Study drug toxicity|1|||
48533834|NCT03351231|156141481|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
48533835|NCT03351231|156141481|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
48533836|NCT03351231|156141481|FG000|Safety Follow-Up Period|Other reason|2|||
48835500|NCT01118377|157240673|FG000|Overall Study|Death|38|||
48835501|NCT01118377|157240673|FG000|Overall Study|Failure to Return|3|||
48533837|NCT00248170|156141482|FG000|Overall Study|Withdrawal by Subject|71|||
48603968|NCT02254772|156406634|FG000|Overall Study|Withdrawal by Subject|1|||
48603969|NCT03102762|156406635|FG000|Overall Study|Lost to Follow-up|1|||
48603970|NCT03102762|156406636|FG001|Overall Study|Lost to Follow-up|0|||
48533838|NCT00248170|156141483|FG001|Overall Study|Withdrawal by Subject|79|||
48533839|NCT00248170|156141482|FG000|Overall Study|Protocol Violation|35|||
48533840|NCT00248170|156141483|FG001|Overall Study|Protocol Violation|30|||
48533841|NCT00248170|156141482|FG000|Overall Study|Lost to Follow-up|28|||
48533842|NCT00248170|156141483|FG001|Overall Study|Lost to Follow-up|35|||
48533843|NCT00248170|156141482|FG000|Overall Study|Disease progression|196|||
48533844|NCT00248170|156141483|FG001|Overall Study|Disease progression|216|||
48533845|NCT00248170|156141482|FG000|Overall Study|Death|28|||
48533846|NCT00248170|156141483|FG001|Overall Study|Death|47|||
48533847|NCT00248170|156141482|FG000|Overall Study|Adverse Event|311|||
48533848|NCT00248170|156141483|FG001|Overall Study|Adverse Event|296|||
48533849|NCT00248170|156141482|FG000|Overall Study|Administrative problems|22|||
48533850|NCT00248170|156141483|FG001|Overall Study|Administrative problems|25|||
48533851|NCT00248170|156141482|FG000|Overall Study|Abnormal test procedure(s) result|49|||
48533852|NCT00248170|156141483|FG001|Overall Study|Abnormal test procedure(s) result|61|||
48533853|NCT00248170|156141482|FG000|Overall Study|Abnormal laboratory values|4|||
48533854|NCT00248170|156141483|FG001|Overall Study|Abnormal laboratory values|0|||
48533855|NCT00248170|156141482|FG000|Overall Study|Protocol deviation|17|||
48533856|NCT00248170|156141483|FG001|Overall Study|Protocol deviation|19|||
48533857|NCT02333487|156141484|FG000|Overall Study|Adverse Event|0|||
48533858|NCT02333487|156141485|FG001|Overall Study|Adverse Event|2|||
48533859|NCT02333487|156141486|FG002|Overall Study|Adverse Event|0|||
48533860|NCT04553913|156141487|FG000|Overall Study|patient's block resolved prior to PACU|1|||
48533861|NCT04553913|156141487|FG000|Overall Study|did not use the device properly|5|||
48533862|NCT03123783|156141488|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
48533863|NCT03123783|156141489|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
48533864|NCT03123783|156141490|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
48533865|NCT03123783|156141491|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
48533866|NCT03123783|156141492|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
48533867|NCT03123783|156141493|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
48533868|NCT03123783|156141494|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
48533869|NCT03123783|156141488|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
48533870|NCT03123783|156141489|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
48533871|NCT03123783|156141490|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
48533872|NCT03123783|156141491|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
48533873|NCT03123783|156141492|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
48533874|NCT03123783|156141493|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
48533875|NCT03123783|156141494|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
48533876|NCT03123783|156141488|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
48533877|NCT03123783|156141489|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
48533878|NCT03123783|156141490|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
48533879|NCT03123783|156141491|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
48533880|NCT03123783|156141492|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
48533881|NCT03123783|156141493|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
48533882|NCT03123783|156141494|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
48533883|NCT03123783|156141488|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
48533884|NCT03123783|156141489|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
48533885|NCT03123783|156141490|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
48533886|NCT03123783|156141491|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
48533887|NCT03123783|156141492|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
48533888|NCT03123783|156141493|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
48533889|NCT03123783|156141494|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
48533890|NCT02450526|156143173|FG000|DB Period (Cycle 1)|Adverse Event|0|||
48533891|NCT02450526|156143174|FG001|DB Period (Cycle 1)|Adverse Event|0|||
48533892|NCT02450526|156143175|FG002|DB Period (Cycle 1)|Adverse Event|2|||
48533893|NCT02450526|156143176|FG003|DB Period (Cycle 1)|Adverse Event|0|||
48533894|NCT02450526|156143177|FG004|DB Period (Cycle 1)|Adverse Event|0|||
48533895|NCT02450526|156143173|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
48533896|NCT02450526|156143174|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
48533897|NCT02450526|156143175|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
48533898|NCT02450526|156143176|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
48533899|NCT02450526|156143177|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
48533900|NCT02450526|156143173|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
48533901|NCT02450526|156143174|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
48533902|NCT02450526|156143175|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
48533903|NCT02450526|156143176|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
48533904|NCT02450526|156143177|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
48533905|NCT02450526|156143173|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
48533906|NCT02450526|156143174|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
48533907|NCT02450526|156143175|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
48533908|NCT02450526|156143176|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
48533909|NCT02450526|156143177|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
48533910|NCT02450526|156143173|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
48533911|NCT02450526|156143174|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
48533912|NCT02450526|156143175|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
48533913|NCT02450526|156143176|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
48533914|NCT02450526|156143177|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
48533915|NCT02450526|156143173|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
48533916|NCT02450526|156143174|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
48533917|NCT02450526|156143175|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
48533918|NCT02450526|156143176|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
48533919|NCT02450526|156143177|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
48533920|NCT02450526|156143173|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
48533921|NCT02450526|156143174|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
48533922|NCT02450526|156143175|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
48533923|NCT02450526|156143176|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
48533924|NCT02450526|156143177|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
48533925|NCT02450526|156143173|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
48533926|NCT02450526|156143174|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
48533927|NCT02450526|156143175|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
48533928|NCT02450526|156143176|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
48533929|NCT02450526|156143177|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
48533930|NCT02940730|156143178|FG000|Intervention 2|Physician Decision|7|||
48533931|NCT02940730|156143179|FG001|Intervention 2|Physician Decision|0|||
48533932|NCT02737592|156143180|FG000|Overall Study|Withdrawal by Subject|1|||
48533933|NCT02668822|156143181|FG000|Overall Study|Protocol Violation|2|||
48533934|NCT02668822|156143182|FG001|Overall Study|Protocol Violation|0|||
48533935|NCT02668822|156143181|FG000|Overall Study|Study Terminated by Sponsor|7|||
48533936|NCT02668822|156143182|FG001|Overall Study|Study Terminated by Sponsor|9|||
48533937|NCT02960438|156143183|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
48533938|NCT02960438|156143184|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
48533939|NCT02960438|156143185|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
48533940|NCT02960438|156143186|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
48533941|NCT02960438|156143183|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
48533942|NCT02960438|156143184|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
48533943|NCT02960438|156143185|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
48533944|NCT02960438|156143186|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
48533945|NCT02960438|156143183|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
48533946|NCT02960438|156143184|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
48533947|NCT02960438|156143185|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
48533948|NCT02960438|156143186|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
48533949|NCT02960438|156143183|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
48533950|NCT02960438|156143184|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
48533951|NCT02960438|156143185|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
48533952|NCT02960438|156143186|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
48533953|NCT02960438|156143183|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
48533954|NCT02960438|156143184|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
48533955|NCT02960438|156143185|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
48533956|NCT02960438|156143186|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
48533957|NCT02960438|156143183|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
48533958|NCT02960438|156143184|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
48533959|NCT02960438|156143185|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
48533960|NCT02960438|156143186|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
48533961|NCT02960438|156143183|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
48603971|NCT02900352|156406637|FG000|Overall Study|Lost to Follow-up|28|||
48603972|NCT02900352|156406638|FG001|Overall Study|Lost to Follow-up|17|||
48835502|NCT01091454|157240677|FG000|Overall Study|Ineligible|1|||
48835503|NCT00157014|157240678|FG000|Overall Study|Death|4|||
48835504|NCT00157014|157240679|FG001|Overall Study|Death|2|||
48835505|NCT00157014|157240680|FG002|Overall Study|Death|1|||
48835506|NCT00157014|157240681|FG003|Overall Study|Death|1|||
48603973|NCT00960193|156406639|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
48533962|NCT02960438|156143184|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
48533963|NCT02960438|156143185|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
48533964|NCT02960438|156143186|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
48603974|NCT00728494|156406640|FG000|Overall Study|Adverse Event|7|||
48603975|NCT00728494|156406641|FG001|Overall Study|Adverse Event|0|||
48603976|NCT00728494|156406640|FG000|Overall Study|Withdrawal by Subject|0|||
48603977|NCT00728494|156406641|FG001|Overall Study|Withdrawal by Subject|2|||
48835507|NCT00157014|157240678|FG000|Overall Study|Physician Decision|0|||
48603978|NCT00728494|156406640|FG000|Overall Study|Lack of Efficacy|2|||
48603979|NCT00728494|156406641|FG001|Overall Study|Lack of Efficacy|4|||
48603980|NCT00728494|156406640|FG000|Overall Study|No data available|0|||
48603981|NCT00728494|156406641|FG001|Overall Study|No data available|1|||
48603982|NCT00902577|156406642|FG000|Overall Study|Withdrawal by Subject|6|||
48603983|NCT00902577|156406642|FG000|Overall Study|FMISO production failure|2|||
48603984|NCT01290718|156406647|FG000|Overall Study|Early termination of the study|4|||
48603985|NCT02869789|156406649|FG000|Overall Study|Disease progression|184|||
48603986|NCT02869789|156406650|FG001|Overall Study|Disease progression|109|||
48603987|NCT02869789|156406651|FG002|Overall Study|Disease progression|260|||
48603988|NCT02869789|156406652|FG003|Overall Study|Disease progression|19|||
48603989|NCT02869789|156406649|FG000|Overall Study|Study drug toxicity|90|||
48603990|NCT02869789|156406650|FG001|Overall Study|Study drug toxicity|32|||
48603991|NCT02869789|156406651|FG002|Overall Study|Study drug toxicity|55|||
48603992|NCT02869789|156406652|FG003|Overall Study|Study drug toxicity|14|||
48603993|NCT02869789|156406649|FG000|Overall Study|Death|7|||
48603994|NCT02869789|156406650|FG001|Overall Study|Death|3|||
48603995|NCT02869789|156406651|FG002|Overall Study|Death|5|||
48603996|NCT02869789|156406652|FG003|Overall Study|Death|1|||
48603997|NCT02869789|156406649|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
48603998|NCT02869789|156406650|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
48603999|NCT02869789|156406651|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
48604000|NCT02869789|156406652|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
48604001|NCT02869789|156406649|FG000|Overall Study|Participant request to discontinue study treatment|10|||
48604002|NCT02869789|156406650|FG001|Overall Study|Participant request to discontinue study treatment|5|||
48604003|NCT02869789|156406651|FG002|Overall Study|Participant request to discontinue study treatment|5|||
48604004|NCT02869789|156406652|FG003|Overall Study|Participant request to discontinue study treatment|3|||
48604005|NCT02869789|156406649|FG000|Overall Study|Withdrawal by Subject|5|||
48604006|NCT02869789|156406650|FG001|Overall Study|Withdrawal by Subject|2|||
48604007|NCT02869789|156406651|FG002|Overall Study|Withdrawal by Subject|7|||
48604008|NCT02869789|156406652|FG003|Overall Study|Withdrawal by Subject|2|||
48604009|NCT02869789|156406649|FG000|Overall Study|Lost to Follow-up|0|||
48604010|NCT02869789|156406650|FG001|Overall Study|Lost to Follow-up|0|||
48604011|NCT02869789|156406651|FG002|Overall Study|Lost to Follow-up|2|||
48604012|NCT02869789|156406652|FG003|Overall Study|Lost to Follow-up|0|||
48604013|NCT02869789|156406649|FG000|Overall Study|Maximum clinical benefit|5|||
48604014|NCT02869789|156406650|FG001|Overall Study|Maximum clinical benefit|2|||
48604015|NCT02869789|156406651|FG002|Overall Study|Maximum clinical benefit|1|||
48604016|NCT02869789|156406652|FG003|Overall Study|Maximum clinical benefit|0|||
48835508|NCT00157014|157240679|FG001|Overall Study|Physician Decision|1|||
48835509|NCT00157014|157240680|FG002|Overall Study|Physician Decision|0|||
48533965|NCT02960438|156143183|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
48835510|NCT00157014|157240681|FG003|Overall Study|Physician Decision|0|||
48533966|NCT02960438|156143184|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
48533967|NCT02960438|156143185|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
48533968|NCT02960438|156143186|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
48533969|NCT02960438|156143183|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
48533970|NCT02960438|156143184|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
48533971|NCT02960438|156143185|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
48533972|NCT02960438|156143186|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
48533973|NCT02960438|156143183|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
48533974|NCT02960438|156143184|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
48533975|NCT02960438|156143185|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
48533976|NCT02960438|156143186|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
48533977|NCT02960438|156143183|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
48533978|NCT02960438|156143184|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
48533979|NCT02960438|156143185|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
48533980|NCT02960438|156143186|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
48533981|NCT02960438|156143183|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
48533982|NCT02960438|156143184|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
48533983|NCT02960438|156143185|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
48604017|NCT02869789|156406649|FG000|Overall Study|Poor/Non-compliance|0|||
48604018|NCT02869789|156406650|FG001|Overall Study|Poor/Non-compliance|2|||
48604019|NCT02869789|156406651|FG002|Overall Study|Poor/Non-compliance|1|||
48604020|NCT02869789|156406652|FG003|Overall Study|Poor/Non-compliance|0|||
48604021|NCT02869789|156406649|FG000|Overall Study|Participant no longer meets study criteria|0|||
48604022|NCT02869789|156406650|FG001|Overall Study|Participant no longer meets study criteria|1|||
48604023|NCT02869789|156406651|FG002|Overall Study|Participant no longer meets study criteria|1|||
48835511|NCT00157014|157240678|FG000|Overall Study|Medications withdrawn on family request|0|||
48835512|NCT00157014|157240679|FG001|Overall Study|Medications withdrawn on family request|1|||
48835513|NCT00157014|157240680|FG002|Overall Study|Medications withdrawn on family request|0|||
48835514|NCT00157014|157240681|FG003|Overall Study|Medications withdrawn on family request|0|||
48835515|NCT00157014|157240678|FG000|Overall Study|Patient withdrawn by investigator|1|||
48835516|NCT00157014|157240679|FG001|Overall Study|Patient withdrawn by investigator|0|||
48835517|NCT00157014|157240680|FG002|Overall Study|Patient withdrawn by investigator|0|||
48835518|NCT00157014|157240681|FG003|Overall Study|Patient withdrawn by investigator|0|||
48835519|NCT00157014|157240678|FG000|Overall Study|Patient unable to return in nursing home|1|||
48835520|NCT00157014|157240679|FG001|Overall Study|Patient unable to return in nursing home|0|||
48835521|NCT00157014|157240680|FG002|Overall Study|Patient unable to return in nursing home|0|||
48835522|NCT00157014|157240681|FG003|Overall Study|Patient unable to return in nursing home|0|||
48835523|NCT00157014|157240678|FG000|Overall Study|Patient would not receive transplant|0|||
48835524|NCT00157014|157240679|FG001|Overall Study|Patient would not receive transplant|1|||
48835525|NCT00157014|157240680|FG002|Overall Study|Patient would not receive transplant|0|||
48835526|NCT00157014|157240681|FG003|Overall Study|Patient would not receive transplant|0|||
48835527|NCT00157014|157240678|FG000|Overall Study|Withdrawal by Subject|1|||
48835528|NCT00157014|157240679|FG001|Overall Study|Withdrawal by Subject|0|||
48835529|NCT00157014|157240680|FG002|Overall Study|Withdrawal by Subject|0|||
48835530|NCT00157014|157240681|FG003|Overall Study|Withdrawal by Subject|0|||
48835531|NCT00661778|157240686|FG000|Overall Study|Disease Progression|23|||
48835532|NCT00661778|157240686|FG000|Overall Study|Adverse Event|18|||
48835533|NCT00661778|157240686|FG000|Overall Study|Reason not Specified|6|||
48835534|NCT00661778|157240686|FG000|Overall Study|Protocol Violation|2|||
48835535|NCT00661778|157240686|FG000|Overall Study|Withdrawal of Consent|1|||
48835536|NCT00486759|157240692|FG000|Treatment|Adverse event/intercurrent illness|86|||
48835537|NCT00486759|157240693|FG001|Treatment|Adverse event/intercurrent illness|39|||
48835538|NCT00486759|157240692|FG000|Treatment|Insufficient therapeutic response|37|||
48835539|NCT00486759|157240693|FG001|Treatment|Insufficient therapeutic response|39|||
48835540|NCT00486759|157240692|FG000|Treatment|Death|17|||
48835541|NCT00486759|157240693|FG001|Treatment|Death|10|||
48835542|NCT00486759|157240692|FG000|Treatment|Withdrew consent|15|||
48835543|NCT00486759|157240693|FG001|Treatment|Withdrew consent|12|||
48835544|NCT00486759|157240692|FG000|Treatment|Administrative/reason not specified|17|||
48835545|NCT00486759|157240693|FG001|Treatment|Administrative/reason not specified|21|||
48835546|NCT00486759|157240692|FG000|Treatment|Refused treatment|10|||
48835547|NCT00486759|157240693|FG001|Treatment|Refused treatment|7|||
48835548|NCT00486759|157240692|FG000|Treatment|Violation of selection criteria at entry|3|||
48835549|NCT00486759|157240693|FG001|Treatment|Violation of selection criteria at entry|3|||
48835550|NCT00486759|157240692|FG000|Treatment|Other protocol violation|1|||
48835551|NCT00486759|157240693|FG001|Treatment|Other protocol violation|5|||
48835552|NCT00486759|157240692|FG000|Treatment|Failure to return|1|||
48835553|NCT00486759|157240693|FG001|Treatment|Failure to return|1|||
48835554|NCT00486759|157240692|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
48835555|NCT00486759|157240693|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
48835556|NCT00486759|157240692|FG000|Safety Follow-up|Death|40|||
48835557|NCT00486759|157240693|FG001|Safety Follow-up|Death|29|||
48835558|NCT00486759|157240692|FG000|Safety Follow-up|Withdrew consent|32|||
48835559|NCT00486759|157240693|FG001|Safety Follow-up|Withdrew consent|23|||
48835560|NCT00486759|157240692|FG000|Safety Follow-up|Failure to return|9|||
48835561|NCT00486759|157240693|FG001|Safety Follow-up|Failure to return|6|||
48835562|NCT00486759|157240692|FG000|Safety Follow-up|Administrative/not specified|8|||
48835563|NCT00486759|157240693|FG001|Safety Follow-up|Administrative/not specified|6|||
48533984|NCT02960438|156143186|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
48533985|NCT04776746|156143192|FG000|Overall Study|Study terminated by sponsor|61|||
48533986|NCT04776746|156143192|FG000|Overall Study|Adverse Event|5|||
48533987|NCT04776746|156143192|FG000|Overall Study|Death|4|||
48533988|NCT04776746|156143192|FG000|Overall Study|Lack of Efficacy|3|||
48533989|NCT04776746|156143192|FG000|Overall Study|Noncompliance with study drug|2|||
48533990|NCT04776746|156143192|FG000|Overall Study|Not related to COVID-19|2|||
48533991|NCT00809965|156143198|FG000|Overall Study|Death|194|||
48533992|NCT00809965|156143199|FG001|Overall Study|Death|147|||
48533993|NCT00809965|156143200|FG002|Overall Study|Death|196|||
48533994|NCT00809965|156143198|FG000|Overall Study|Lost to Follow-up|17|||
48533995|NCT00809965|156143199|FG001|Overall Study|Lost to Follow-up|10|||
48533996|NCT00809965|156143200|FG002|Overall Study|Lost to Follow-up|18|||
48533997|NCT00809965|156143198|FG000|Overall Study|Withdrawal by Subject|405|||
48533998|NCT00809965|156143199|FG001|Overall Study|Withdrawal by Subject|448|||
48533999|NCT00809965|156143200|FG002|Overall Study|Withdrawal by Subject|441|||
48534000|NCT00809965|156143198|FG000|Overall Study|Other Reason|167|||
48534001|NCT00809965|156143199|FG001|Overall Study|Other Reason|170|||
48534002|NCT00809965|156143200|FG002|Overall Study|Other Reason|189|||
48534003|NCT02133001|156143203|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
48534004|NCT02133001|156143204|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
48534005|NCT02133001|156143203|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
48604024|NCT02869789|156406652|FG003|Overall Study|Participant no longer meets study criteria|0|||
48534006|NCT02133001|156143204|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
48534007|NCT02133001|156143203|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
48835564|NCT00486759|157240692|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
48835565|NCT00486759|157240693|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
48835566|NCT00486759|157240692|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
48835567|NCT00486759|157240693|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
48835568|NCT02496702|157240694|FG000|Overall Study|Lost to Follow-up|8|||
48835569|NCT02496702|157240695|FG001|Overall Study|Lost to Follow-up|6|||
48835570|NCT02496702|157240694|FG000|Overall Study|Only partially tested|0|||
48835571|NCT02496702|157240695|FG001|Overall Study|Only partially tested|2|||
48835572|NCT01499134|157240696|FG000|Overall Study|Withdrawal by Subject|0|||
48835573|NCT01499134|157240697|FG001|Overall Study|Withdrawal by Subject|1|||
48835574|NCT00708032|157240698|FG000|Overall Study|Adverse Event|0|||
48835575|NCT00708032|157240699|FG001|Overall Study|Adverse Event|2|||
48835576|NCT00708032|157240698|FG000|Overall Study|Lost to Follow-up|1|||
48835577|NCT00708032|157240699|FG001|Overall Study|Lost to Follow-up|2|||
48835578|NCT00708032|157240698|FG000|Overall Study|Pregnancy|0|||
48835579|NCT00708032|157240699|FG001|Overall Study|Pregnancy|1|||
48835580|NCT00708032|157240698|FG000|Overall Study|Poor vision|0|||
48835581|NCT00708032|157240699|FG001|Overall Study|Poor vision|6|||
48835582|NCT00708032|157240698|FG000|Overall Study|Visit out of range at month 12|4|||
48835583|NCT00708032|157240699|FG001|Overall Study|Visit out of range at month 12|1|||
48835584|NCT00708032|157240698|FG000|Overall Study|Did not meet protocol criteria|1|||
48835585|NCT00708032|157240699|FG001|Overall Study|Did not meet protocol criteria|2|||
48835586|NCT00708032|157240698|FG000|Overall Study|Protocol Violation|4|||
48835587|NCT00708032|157240699|FG001|Overall Study|Protocol Violation|1|||
48835588|NCT00708032|157240698|FG000|Overall Study|Withdrawal by Subject|0|||
48835589|NCT00708032|157240699|FG001|Overall Study|Withdrawal by Subject|1|||
48835590|NCT00516386|157240711|FG000|Overall Study|not interested in the study|4|||
48835591|NCT00516386|157240711|FG000|Overall Study|Lost to Follow-up|2|||
48835592|NCT04033432|157240712|FG000|Overall Study|Progressive Disease|8|||
48835593|NCT04033432|157240712|FG000|Overall Study|Adverse Event|4|||
48835594|NCT04033432|157240712|FG000|Overall Study|Death|1|||
48835595|NCT00854906|157240717|FG000|Overall Study|One person had no ocular history|1|||
48835596|NCT03804918|157240724|FG000|Overall Study|Participant did not use the app|1|||
48835597|NCT03861767|157240727|FG000|Overall Study|Withdrawal by Subject|2|||
48835598|NCT03861767|157240728|FG001|Overall Study|Withdrawal by Subject|1|||
48835599|NCT03861767|157240729|FG002|Overall Study|Withdrawal by Subject|0|||
48835600|NCT03861767|157240730|FG003|Overall Study|Withdrawal by Subject|5|||
48835601|NCT03861767|157240731|FG004|Overall Study|Withdrawal by Subject|2|||
48835602|NCT03861767|157240732|FG005|Overall Study|Withdrawal by Subject|1|||
48835603|NCT03861767|157240733|FG006|Overall Study|Withdrawal by Subject|3|||
48835604|NCT03861767|157240734|FG007|Overall Study|Withdrawal by Subject|1|||
48835605|NCT03861767|157240735|FG008|Overall Study|Withdrawal by Subject|0|||
48835606|NCT03861767|157240736|FG009|Overall Study|Withdrawal by Subject|5|||
48835607|NCT01460290|157240744|FG000|Overall Study|Adverse Event|3|||
48835608|NCT01460290|157240744|FG000|Overall Study|Elevated liver function|1|||
48835609|NCT02506257|157240745|FG000|Overall Study|Adverse Event|0|||
48835610|NCT02506257|157240746|FG001|Overall Study|Adverse Event|2|||
48835611|NCT02506257|157240747|FG002|Overall Study|Adverse Event|3|||
48835612|NCT02506257|157240748|FG003|Overall Study|Adverse Event|0|||
48835613|NCT02506257|157240745|FG000|Overall Study|Protocol Violation|0|||
48835614|NCT02506257|157240746|FG001|Overall Study|Protocol Violation|0|||
48835615|NCT02506257|157240747|FG002|Overall Study|Protocol Violation|1|||
48534008|NCT02133001|156143204|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
48835616|NCT02506257|157240748|FG003|Overall Study|Protocol Violation|0|||
48835617|NCT01924767|157240749|FG000|Overall Study|Adverse Event|1|||
48835618|NCT01924767|157240750|FG001|Overall Study|Adverse Event|0|||
48835619|NCT01924767|157240751|FG002|Overall Study|Adverse Event|1|||
48835620|NCT01924767|157240752|FG003|Overall Study|Adverse Event|0|||
48835621|NCT01924767|157240753|FG004|Overall Study|Adverse Event|0|||
48835622|NCT01563354|157240754|FG000|Core Phase|Adverse Event|5|||
48835623|NCT01563354|157240755|FG001|Core Phase|Adverse Event|15|||
48835624|NCT01563354|157240756|FG002|Core Phase|Adverse Event|13|||
48534009|NCT02133001|156143203|FG000|Double Blind (Day 1-25)|Other|2|||
48534010|NCT02133001|156143204|FG001|Double Blind (Day 1-25)|Other|2|||
48534011|NCT02133001|156143203|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
48835625|NCT01563354|157240754|FG000|Core Phase|Withdrawal by Subject|1|||
48835626|NCT01563354|157240755|FG001|Core Phase|Withdrawal by Subject|0|||
48835627|NCT01563354|157240756|FG002|Core Phase|Withdrawal by Subject|3|||
48835628|NCT01563354|157240754|FG000|Core Phase|Lost to Follow-up|1|||
48534012|NCT02133001|156143204|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
48534013|NCT02133001|156143203|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
48534014|NCT02133001|156143204|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
48534015|NCT02133001|156143203|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
48835629|NCT01563354|157240755|FG001|Core Phase|Lost to Follow-up|0|||
48835630|NCT01563354|157240756|FG002|Core Phase|Lost to Follow-up|0|||
48835631|NCT01563354|157240754|FG000|Core Phase|Death|1|||
48835632|NCT01563354|157240755|FG001|Core Phase|Death|5|||
48534016|NCT02133001|156143204|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
48534017|NCT02133001|156143203|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
48534018|NCT02133001|156143204|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
48534019|NCT01239472|156143205|FG000|Overall Study|Withdrawal by Subject|5|||
48534020|NCT01239472|156143206|FG001|Overall Study|Withdrawal by Subject|1|||
48534021|NCT01239472|156143205|FG000|Overall Study|Adverse Event|0|||
48534022|NCT01239472|156143206|FG001|Overall Study|Adverse Event|1|||
48534023|NCT01239472|156143205|FG000|Overall Study|Lack of Efficacy|0|||
48534024|NCT01239472|156143206|FG001|Overall Study|Lack of Efficacy|1|||
48534025|NCT01286558|156143207|FG000|Overall Study|Adverse Event|1|||
48534026|NCT01286558|156143208|FG001|Overall Study|Adverse Event|1|||
48534027|NCT01286558|156143207|FG000|Overall Study|Withdrawal by Subject|0|||
48534028|NCT01286558|156143208|FG001|Overall Study|Withdrawal by Subject|1|||
48534029|NCT00094458|156143209|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
48835633|NCT01563354|157240756|FG002|Core Phase|Death|2|||
48835634|NCT01563354|157240754|FG000|Core Phase|Diseasse progression|18|||
48835635|NCT01563354|157240755|FG001|Core Phase|Diseasse progression|7|||
48835636|NCT01563354|157240756|FG002|Core Phase|Diseasse progression|8|||
48835637|NCT01563354|157240754|FG000|Core Phase|Protocol deviation|2|||
48835638|NCT01563354|157240755|FG001|Core Phase|Protocol deviation|0|||
48534030|NCT00094458|156143210|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
48534031|NCT00094458|156143211|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
48534032|NCT00094458|156143212|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
48534033|NCT00094458|156143213|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
48534034|NCT00094458|156143214|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
48534035|NCT00094458|156143209|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
48534036|NCT00094458|156143210|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
48534037|NCT00094458|156143211|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
48534038|NCT00094458|156143212|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
48534039|NCT00094458|156143213|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
48534040|NCT00094458|156143214|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
48534041|NCT00094458|156143209|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
48534042|NCT00094458|156143210|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
48534043|NCT00094458|156143211|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
48534044|NCT00094458|156143212|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
48835639|NCT01563354|157240756|FG002|Core Phase|Protocol deviation|0|||
48835640|NCT01563354|157240754|FG000|Core Phase|PI decision - did not enter extension|0|||
48835641|NCT01563354|157240755|FG001|Core Phase|PI decision - did not enter extension|1|||
48835642|NCT01563354|157240756|FG002|Core Phase|PI decision - did not enter extension|0|||
48835643|NCT01563354|157240754|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
48835644|NCT01563354|157240755|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
48835645|NCT01563354|157240756|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
48835646|NCT01563354|157240754|FG000|Extension Phase|Adverse Event|0|||
48835647|NCT01563354|157240755|FG001|Extension Phase|Adverse Event|3|||
48835648|NCT01563354|157240756|FG002|Extension Phase|Adverse Event|2|||
48835649|NCT01563354|157240754|FG000|Extension Phase|Withdrawal by Subject|0|||
48835650|NCT01563354|157240755|FG001|Extension Phase|Withdrawal by Subject|1|||
48835651|NCT01563354|157240756|FG002|Extension Phase|Withdrawal by Subject|0|||
48835652|NCT01563354|157240754|FG000|Extension Phase|Administration problems|3|||
48835653|NCT01563354|157240755|FG001|Extension Phase|Administration problems|2|||
48835654|NCT01563354|157240756|FG002|Extension Phase|Administration problems|3|||
48835655|NCT01563354|157240754|FG000|Extension Phase|Disease progression|9|||
48835656|NCT01563354|157240755|FG001|Extension Phase|Disease progression|8|||
48835657|NCT01563354|157240756|FG002|Extension Phase|Disease progression|10|||
48835658|NCT01050569|157240760|FG000|Overall Study|Lost to Follow-up|20|||
48835659|NCT01050569|157240761|FG001|Overall Study|Lost to Follow-up|14|||
48835660|NCT01050569|157240762|FG002|Overall Study|Lost to Follow-up|16|||
48835661|NCT01050569|157240760|FG000|Overall Study|Withdrawal by Subject|9|||
48835662|NCT01050569|157240761|FG001|Overall Study|Withdrawal by Subject|3|||
48835663|NCT01050569|157240762|FG002|Overall Study|Withdrawal by Subject|11|||
48604025|NCT02869789|156406649|FG000|Overall Study|Administrative reason by sponsor|0|||
48604026|NCT02869789|156406650|FG001|Overall Study|Administrative reason by sponsor|0|||
48604027|NCT02869789|156406651|FG002|Overall Study|Administrative reason by sponsor|1|||
48534045|NCT00094458|156143213|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
48534046|NCT00094458|156143214|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
48534047|NCT00094458|156143209|FG000|Main Study: Through Week 30|Adverse Event|38|||
48534048|NCT00094458|156143210|FG001|Main Study: Through Week 30|Adverse Event|20|||
48534049|NCT00094458|156143211|FG002|Main Study: Through Week 30|Adverse Event|28|||
48534050|NCT00094458|156143212|FG003|Main Study: Through Week 30|Adverse Event|0|||
48534051|NCT00094458|156143213|FG004|Main Study: Through Week 30|Adverse Event|0|||
48604028|NCT02869789|156406652|FG003|Overall Study|Administrative reason by sponsor|0|||
48604029|NCT02869789|156406649|FG000|Overall Study|Other reasons|4|||
48604030|NCT02869789|156406650|FG001|Overall Study|Other reasons|8|||
48604031|NCT02869789|156406651|FG002|Overall Study|Other reasons|6|||
48604032|NCT02869789|156406652|FG003|Overall Study|Other reasons|0|||
48604033|NCT00749398|156406653|FG000|Overall Study|Lack of Efficacy|7|||
48604034|NCT00749398|156406653|FG000|Overall Study|Adverse Event|4|||
48604035|NCT00749398|156406653|FG000|Overall Study|Serious adverse event|11|||
48604036|NCT00749398|156406653|FG000|Overall Study|Withdrawal by Subject|17|||
48604037|NCT00749398|156406653|FG000|Overall Study|Lost to Follow-up|11|||
48604038|NCT00749398|156406653|FG000|Overall Study|Reason not specified|2|||
48604039|NCT00749398|156406653|FG000|Overall Study|Unknown reason|1|||
48604040|NCT00846053|156406654|FG000|Overall Study|Physician Decision|3|||
48604041|NCT00846053|156406655|FG001|Overall Study|Physician Decision|0|||
48604042|NCT00570401|156406658|FG000|Overall Study|Adverse Event|2|||
48604043|NCT03902613|156406660|FG000|Overall Study|Physician Decision|1|||
48534052|NCT00094458|156143214|FG005|Main Study: Through Week 30|Adverse Event|0|||
48534053|NCT00094458|156143209|FG000|Main Study: Through Week 30|Death|1|||
48534054|NCT00094458|156143210|FG001|Main Study: Through Week 30|Death|0|||
48534055|NCT00094458|156143211|FG002|Main Study: Through Week 30|Death|0|||
48534056|NCT00094458|156143212|FG003|Main Study: Through Week 30|Death|0|||
48534057|NCT00094458|156143213|FG004|Main Study: Through Week 30|Death|0|||
48534058|NCT00094458|156143214|FG005|Main Study: Through Week 30|Death|0|||
48534059|NCT00094458|156143209|FG000|Main Study: Through Week 30|Other|19|||
48534060|NCT00094458|156143210|FG001|Main Study: Through Week 30|Other|16|||
48534061|NCT00094458|156143211|FG002|Main Study: Through Week 30|Other|9|||
48534062|NCT00094458|156143212|FG003|Main Study: Through Week 30|Other|0|||
48604044|NCT00069264|156406665|FG000|Overall Study|Adverse Event|3|||
48604045|NCT00069264|156406665|FG000|Overall Study|Progressive Disease|23|||
48604046|NCT00069264|156406665|FG000|Overall Study|Withdrawal by Subject|3|||
48835664|NCT01050569|157240760|FG000|Overall Study|Lack of Efficacy|5|||
48835665|NCT01050569|157240761|FG001|Overall Study|Lack of Efficacy|4|||
48835666|NCT01050569|157240762|FG002|Overall Study|Lack of Efficacy|3|||
48835667|NCT01050569|157240760|FG000|Overall Study|Adverse Event|1|||
48835668|NCT01050569|157240761|FG001|Overall Study|Adverse Event|0|||
48835669|NCT01050569|157240762|FG002|Overall Study|Adverse Event|0|||
48835670|NCT01050569|157240760|FG000|Overall Study|Physician Decision|3|||
48835671|NCT01050569|157240761|FG001|Overall Study|Physician Decision|3|||
48835672|NCT01050569|157240762|FG002|Overall Study|Physician Decision|3|||
48835673|NCT01713530|157240767|FG000|Overall Study|Adverse Event|0|||
48835674|NCT01713530|157240768|FG001|Overall Study|Adverse Event|5|||
48835675|NCT01713530|157240767|FG000|Overall Study|Withdrawal criteria|21|||
48835676|NCT01713530|157240768|FG001|Overall Study|Withdrawal criteria|12|||
48835677|NCT01713530|157240767|FG000|Overall Study|Unclassified|4|||
48835678|NCT01713530|157240768|FG001|Overall Study|Unclassified|2|||
48835679|NCT03939819|157240769|FG000|Overall Study|Death|2|||
48534063|NCT00094458|156143213|FG004|Main Study: Through Week 30|Other|0|||
48534064|NCT00094458|156143214|FG005|Main Study: Through Week 30|Other|0|||
48534065|NCT00094458|156143209|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
48534066|NCT00094458|156143210|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
48534067|NCT00094458|156143211|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
48534068|NCT00094458|156143212|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
48604047|NCT00069264|156406665|FG000|Overall Study|Discon Therapy|3|||
48835680|NCT03939819|157240770|FG001|Overall Study|Death|0|||
48835681|NCT03781336|157240771|FG000|Overall Study|Withdrawal by Subject|2|||
48534069|NCT00094458|156143213|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
48534070|NCT00094458|156143214|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
48534071|NCT00094458|156143209|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
48534072|NCT00094458|156143210|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
48534073|NCT00094458|156143211|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
48604048|NCT00732069|156406677|FG000|Washout After First Study Drug|Adverse Event|1|||
48604049|NCT00732069|156406678|FG001|Washout After First Study Drug|Adverse Event|0|||
48604050|NCT00732069|156406679|FG002|Washout After First Study Drug|Adverse Event|0|||
48835682|NCT03781336|157240772|FG001|Overall Study|Withdrawal by Subject|2|||
48835683|NCT01831791|157240773|FG000|Overall Study|Withdrawal by Subject|10|||
48835684|NCT00158054|157240776|FG000|Overall Study|Refused to continue|3|||
48835685|NCT00158054|157240777|FG001|Overall Study|Refused to continue|0|||
48835686|NCT00158054|157240776|FG000|Overall Study|Unavailable for follow up|7|||
48835687|NCT00158054|157240777|FG001|Overall Study|Unavailable for follow up|3|||
48835688|NCT03192046|157240778|FG000|Overall Study|Withdrawal by Subject|1|||
48835689|NCT03192046|157240779|FG001|Overall Study|Withdrawal by Subject|1|||
48835690|NCT01194154|157240782|FG000|Overall Study|Adverse Event|12|||
48835691|NCT01194154|157240783|FG001|Overall Study|Adverse Event|7|||
48835692|NCT01194154|157240782|FG000|Overall Study|Lost to Follow-up|2|||
48835693|NCT01194154|157240783|FG001|Overall Study|Lost to Follow-up|3|||
48835694|NCT01194154|157240782|FG000|Overall Study|Protocol Violation|0|||
48835695|NCT01194154|157240783|FG001|Overall Study|Protocol Violation|1|||
48835696|NCT01194154|157240782|FG000|Overall Study|Withdrawal by Subject|5|||
48835697|NCT01194154|157240783|FG001|Overall Study|Withdrawal by Subject|6|||
48835698|NCT01194154|157240782|FG000|Overall Study|Blood pressure increase|5|||
48835699|NCT01194154|157240783|FG001|Overall Study|Blood pressure increase|3|||
48835700|NCT01194154|157240782|FG000|Overall Study|Hemoglobin decrease|0|||
48835701|NCT01194154|157240783|FG001|Overall Study|Hemoglobin decrease|1|||
48835702|NCT01194154|157240782|FG000|Overall Study|Hemoglobin increase|12|||
48835703|NCT01194154|157240783|FG001|Overall Study|Hemoglobin increase|3|||
48835704|NCT01194154|157240782|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
48835705|NCT01194154|157240783|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
48835706|NCT01194154|157240782|FG000|Overall Study|Treatment with prohibited medication|4|||
48835707|NCT01194154|157240783|FG001|Overall Study|Treatment with prohibited medication|5|||
48835708|NCT01194154|157240782|FG000|Overall Study|Other|4|||
48835709|NCT01194154|157240783|FG001|Overall Study|Other|0|||
48835710|NCT01194154|157240782|FG000|Overall Study|Did not receive study medication|2|||
48835711|NCT01194154|157240783|FG001|Overall Study|Did not receive study medication|4|||
48835712|NCT01157182|157240788|FG000|Washout of 28 Days|Adverse Event|2|||
48835713|NCT01157182|157240789|FG001|Washout of 28 Days|Adverse Event|0|||
48835714|NCT01901276|157240790|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
48835715|NCT01901276|157240791|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
48835716|NCT02888080|157240792|FG000|Overall Study|Subject / Guardian decision|1|||
48835717|NCT02888080|157240793|FG001|Overall Study|Subject / Guardian decision|3|||
48835718|NCT02888080|157240792|FG000|Overall Study|New Therapy for study indication|1|||
48835719|NCT02888080|157240793|FG001|Overall Study|New Therapy for study indication|0|||
48835720|NCT02888080|157240792|FG000|Overall Study|Lack of Efficacy|0|||
48835721|NCT02888080|157240793|FG001|Overall Study|Lack of Efficacy|1|||
48835722|NCT02888080|157240792|FG000|Overall Study|Adverse Event|0|||
48835723|NCT02888080|157240793|FG001|Overall Study|Adverse Event|1|||
48835724|NCT00395018|157240794|FG000|On-Treatment|Death|4|||
48835725|NCT00395018|157240794|FG000|On-Treatment|Other Reason|2|||
48835726|NCT00395018|157240794|FG000|On-Treatment|Poor/non-compliance|2|||
48835727|NCT00395018|157240794|FG000|On-Treatment|Subject no longer meets study criteria|2|||
48835728|NCT00395018|157240794|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
48835729|NCT00395018|157240794|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
48835730|NCT00395018|157240794|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
48835731|NCT02026258|157240795|FG000|Randomized|Did not start treatment|2|||
48835732|NCT02026258|157240796|FG001|Randomized|Did not start treatment|1|||
48835733|NCT02026258|157240795|FG000|Randomized|Change in treatment plan|1|||
48835734|NCT02026258|157240796|FG001|Randomized|Change in treatment plan|0|||
48835735|NCT02026258|157240795|FG000|Randomized|Presence of periodontal disease|1|||
48835736|NCT02026258|157240796|FG001|Randomized|Presence of periodontal disease|1|||
48835737|NCT02026258|157240795|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
48835738|NCT02026258|157240796|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
48835739|NCT02026258|157240795|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
48835740|NCT02026258|157240796|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
48534074|NCT00094458|156143212|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
48534075|NCT00094458|156143213|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
48534076|NCT00094458|156143214|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
48534077|NCT00094458|156143209|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
48534078|NCT00094458|156143210|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
48534079|NCT00094458|156143211|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
48835741|NCT04439799|157240797|FG000|Overall Study|Lost to Follow-up|6|||
48835742|NCT04439799|157240798|FG001|Overall Study|Lost to Follow-up|6|||
48835743|NCT04439799|157240797|FG000|Overall Study|Withdrawal by Subject|2|||
48534080|NCT00094458|156143212|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
48835744|NCT04439799|157240798|FG001|Overall Study|Withdrawal by Subject|6|||
48835745|NCT04439799|157240797|FG000|Overall Study|Adverse Event|2|||
48835746|NCT04439799|157240798|FG001|Overall Study|Adverse Event|5|||
48835747|NCT00845832|157240799|FG000|Treatment Period|Adverse Event|0|||
48835748|NCT00845832|157240800|FG001|Treatment Period|Adverse Event|2|||
48835749|NCT00845832|157240801|FG002|Treatment Period|Adverse Event|0|||
48835750|NCT00845832|157240799|FG000|Treatment Period|Protocol Violation|1|||
48835751|NCT00845832|157240800|FG001|Treatment Period|Protocol Violation|1|||
48835752|NCT00845832|157240801|FG002|Treatment Period|Protocol Violation|0|||
48835753|NCT00845832|157240799|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
48835754|NCT00845832|157240800|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
48835755|NCT00845832|157240801|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
48835756|NCT00845832|157240799|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
48835757|NCT00845832|157240800|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
48604051|NCT00732069|156406680|FG003|Washout After First Study Drug|Adverse Event|0|||
48604052|NCT00732069|156406681|FG004|Washout After First Study Drug|Adverse Event|0|||
48604053|NCT00732069|156406682|FG005|Washout After First Study Drug|Adverse Event|0|||
48604054|NCT04460326|156406683|FG000|Completed at Least 4 Meals|Early discharge|5|||
48604055|NCT04460326|156406684|FG001|Completed at Least 4 Meals|Early discharge|5|||
48604056|NCT04460326|156406683|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
48604057|NCT04460326|156406684|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
48604058|NCT04460326|156406683|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
48604059|NCT04460326|156406684|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
48534081|NCT00094458|156143213|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
48534082|NCT00094458|156143214|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
48534083|NCT00094458|156143209|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
48534084|NCT00094458|156143210|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
48534085|NCT00094458|156143211|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
48835758|NCT00845832|157240801|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
48835759|NCT01391130|157240803|FG000|Overall Study|Withdrawal by Subject|3|||
48835760|NCT01391130|157240804|FG001|Overall Study|Withdrawal by Subject|2|||
48835761|NCT01391130|157240803|FG000|Overall Study|Physician Decision|2|||
48835762|NCT01391130|157240804|FG001|Overall Study|Physician Decision|3|||
48604060|NCT04460326|156406683|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
48835763|NCT01391130|157240803|FG000|Overall Study|Did not Receive Drug|1|||
48534086|NCT00094458|156143212|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
48534087|NCT00094458|156143213|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
48534088|NCT00094458|156143214|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
48534089|NCT00094458|156143209|FG000|OLE: Open-Label Extension|Adverse Event|0|||
48534090|NCT00094458|156143210|FG001|OLE: Open-Label Extension|Adverse Event|0|||
48534091|NCT00094458|156143211|FG002|OLE: Open-Label Extension|Adverse Event|0|||
48534092|NCT00094458|156143212|FG003|OLE: Open-Label Extension|Adverse Event|0|||
48534093|NCT00094458|156143213|FG004|OLE: Open-Label Extension|Adverse Event|3|||
48534094|NCT00094458|156143214|FG005|OLE: Open-Label Extension|Adverse Event|4|||
48534095|NCT00094458|156143209|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
48534096|NCT00094458|156143210|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
48534097|NCT00094458|156143211|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
48534098|NCT00094458|156143212|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
48534099|NCT00094458|156143213|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
48534100|NCT00094458|156143214|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
48534101|NCT00094458|156143209|FG000|OLE: Open-Label Extension|Patient decision|0|||
48534102|NCT00094458|156143210|FG001|OLE: Open-Label Extension|Patient decision|0|||
48534103|NCT00094458|156143211|FG002|OLE: Open-Label Extension|Patient decision|0|||
48534104|NCT00094458|156143212|FG003|OLE: Open-Label Extension|Patient decision|0|||
48534105|NCT00094458|156143213|FG004|OLE: Open-Label Extension|Patient decision|1|||
48534106|NCT00094458|156143214|FG005|OLE: Open-Label Extension|Patient decision|0|||
48534107|NCT04376502|156143216|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
48534108|NCT01787279|156143217|FG000|Overall Study|Lost to Follow-up|2|||
48534109|NCT01787279|156143217|FG000|Overall Study|Lack of Efficacy|1|||
48534110|NCT04035499|156143221|FG000|Overall Study|Death|2|||
48534111|NCT04035499|156143221|FG000|Overall Study|Withdrawal by Subject|1|||
48534112|NCT02268253|156143225|FG000|Stage 1|Withdrawal by Subject|1|||
48534113|NCT02268253|156143226|FG001|Stage 1|Withdrawal by Subject|0|||
48534114|NCT02268253|156143227|FG002|Stage 1|Withdrawal by Subject|0|||
48534115|NCT02268253|156143228|FG003|Stage 1|Withdrawal by Subject|0|||
48534116|NCT02268253|156143229|FG004|Stage 1|Withdrawal by Subject|0|||
48534117|NCT02268253|156143230|FG005|Stage 1|Withdrawal by Subject|0|||
48534118|NCT02268253|156143231|FG006|Stage 1|Withdrawal by Subject|0|||
48534119|NCT02268253|156143225|FG000|Stage 1|Death|0|||
48534120|NCT02268253|156143226|FG001|Stage 1|Death|2|||
48604061|NCT04460326|156406684|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
48835764|NCT01391130|157240804|FG001|Overall Study|Did not Receive Drug|1|||
48835765|NCT04347954|157240805|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
48835766|NCT04347954|157240806|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
48835767|NCT04347954|157240807|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
48835768|NCT04347954|157240805|FG000|Overall Study|Lost to Follow-up|0|||
48835769|NCT04347954|157240806|FG001|Overall Study|Lost to Follow-up|1|||
48835770|NCT04347954|157240807|FG002|Overall Study|Lost to Follow-up|0|||
48835771|NCT02534350|157240808|FG000|Overall Study|Randomized But Not Treated|1|||
48534121|NCT02268253|156143227|FG002|Stage 1|Death|2|||
48534122|NCT02268253|156143228|FG003|Stage 1|Death|2|||
48534123|NCT02268253|156143229|FG004|Stage 1|Death|1|||
48534124|NCT02268253|156143230|FG005|Stage 1|Death|1|||
48534125|NCT02268253|156143231|FG006|Stage 1|Death|0|||
48534126|NCT02268253|156143225|FG000|Stage 2|Disease Recurrence/ Progression|0|||
48534127|NCT02268253|156143226|FG001|Stage 2|Disease Recurrence/ Progression|0|||
48604062|NCT04460326|156406683|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
48604063|NCT04460326|156406684|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
48604064|NCT04460326|156406683|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
48604065|NCT04460326|156406684|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
48604066|NCT01499810|156406685|FG000|Overall Study|Lost to Follow-up|10|||
48604067|NCT01499810|156406685|FG000|Overall Study|Protocol Violation|1|||
48604068|NCT01499810|156406685|FG000|Overall Study|Withdrawal by Subject|1|||
48604069|NCT00887484|156406696|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
48604070|NCT00887484|156406696|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
48604071|NCT00887484|156406696|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
48604072|NCT01939314|156406697|FG000|Overall Study|Withdrawal by Subject|3|||
48604073|NCT01939314|156406698|FG001|Overall Study|Withdrawal by Subject|1|||
48604074|NCT01939314|156406697|FG000|Overall Study|Protocol Violation|1|||
48604075|NCT01939314|156406698|FG001|Overall Study|Protocol Violation|0|||
48604076|NCT01939314|156406697|FG000|Overall Study|Pregnancy|0|||
48604077|NCT01939314|156406698|FG001|Overall Study|Pregnancy|1|||
48604078|NCT01939314|156406697|FG000|Overall Study|Lost to Follow-up|5|||
48604079|NCT01939314|156406698|FG001|Overall Study|Lost to Follow-up|6|||
48604080|NCT01061606|156406699|FG000|Overall Study|Adverse Event|1|||
48604081|NCT01061606|156406699|FG000|Overall Study|Death|1|||
48534128|NCT02268253|156143227|FG002|Stage 2|Disease Recurrence/ Progression|1|||
48534129|NCT02268253|156143228|FG003|Stage 2|Disease Recurrence/ Progression|0|||
48534130|NCT02268253|156143229|FG004|Stage 2|Disease Recurrence/ Progression|0|||
48534131|NCT02268253|156143230|FG005|Stage 2|Disease Recurrence/ Progression|0|||
48534132|NCT02268253|156143231|FG006|Stage 2|Disease Recurrence/ Progression|0|||
48835772|NCT02534350|157240809|FG001|Overall Study|Randomized But Not Treated|0|||
48604082|NCT01061606|156406699|FG000|Overall Study|Disease Progression|4|||
48604083|NCT01061606|156406699|FG000|Overall Study|alternative therapy|2|||
48604084|NCT00735007|156406700|FG000|Overall Study|Adverse Event|4|||
48604085|NCT00735007|156406700|FG000|Overall Study|Protocol Violation|1|||
48604086|NCT03044314|156406702|FG000|Overall Study|Physician Decision|2|||
48604087|NCT03044314|156406702|FG000|Overall Study|Withdrawal by Subject|1|||
48604088|NCT03044314|156406702|FG000|Overall Study|Connector tubing not available|1|||
48604089|NCT00830765|156406703|FG000|Overall Study|Protocol Violation|3|||
48604090|NCT00830765|156406704|FG001|Overall Study|Protocol Violation|2|||
48604091|NCT03644017|156406705|FG000|Overall Study|Access Abandonment|5|||
48604092|NCT03644017|156406705|FG000|Overall Study|Kidney Transplant|2|||
48604093|NCT01204671|156406706|FG000|Overall Study|Adverse Event|4|||
48604094|NCT01204671|156406707|FG001|Overall Study|Adverse Event|3|||
48604095|NCT01204671|156406708|FG002|Overall Study|Adverse Event|3|||
48604096|NCT01204671|156406709|FG003|Overall Study|Adverse Event|3|||
48604097|NCT01204671|156406710|FG004|Overall Study|Adverse Event|1|||
48604098|NCT01204671|156406706|FG000|Overall Study|Withdrawal by Subject|2|||
48534133|NCT02268253|156143225|FG000|Stage 2|Withdrawal by Subject|0|||
48534134|NCT02268253|156143226|FG001|Stage 2|Withdrawal by Subject|0|||
48534135|NCT02268253|156143227|FG002|Stage 2|Withdrawal by Subject|2|||
48534136|NCT02268253|156143228|FG003|Stage 2|Withdrawal by Subject|0|||
48835773|NCT02534350|157240808|FG000|Overall Study|Protocol Violation|1|||
48835774|NCT02534350|157240809|FG001|Overall Study|Protocol Violation|0|||
48835775|NCT02534350|157240808|FG000|Overall Study|Withdrew Consent|2|||
48835776|NCT02534350|157240809|FG001|Overall Study|Withdrew Consent|0|||
48835777|NCT00716144|157240813|FG000|Overall Study|Withdrawal by Subject|4|||
48534137|NCT02268253|156143229|FG004|Stage 2|Withdrawal by Subject|0|||
48534138|NCT02268253|156143230|FG005|Stage 2|Withdrawal by Subject|2|||
48534139|NCT02268253|156143231|FG006|Stage 2|Withdrawal by Subject|0|||
48534140|NCT02268253|156143225|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
48604099|NCT01204671|156406707|FG001|Overall Study|Withdrawal by Subject|3|||
48835778|NCT00716144|157240814|FG001|Overall Study|Withdrawal by Subject|2|||
48534141|NCT02268253|156143226|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
48534142|NCT02268253|156143227|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
48534143|NCT02268253|156143228|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
48534144|NCT02268253|156143229|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
48534145|NCT02268253|156143230|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
48604100|NCT01204671|156406708|FG002|Overall Study|Withdrawal by Subject|4|||
48604101|NCT01204671|156406709|FG003|Overall Study|Withdrawal by Subject|5|||
48604102|NCT01204671|156406710|FG004|Overall Study|Withdrawal by Subject|3|||
48604103|NCT01204671|156406706|FG000|Overall Study|Lost to Follow-up|7|||
48534146|NCT02268253|156143231|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
48835779|NCT00716144|157240815|FG002|Overall Study|Withdrawal by Subject|6|||
48604104|NCT01204671|156406707|FG001|Overall Study|Lost to Follow-up|8|||
48604105|NCT01204671|156406708|FG002|Overall Study|Lost to Follow-up|6|||
48534147|NCT02268253|156143225|FG000|Stage 2|Death|0|||
48534148|NCT02268253|156143226|FG001|Stage 2|Death|0|||
48534149|NCT02268253|156143227|FG002|Stage 2|Death|19|||
48534150|NCT02268253|156143228|FG003|Stage 2|Death|0|||
48534151|NCT02268253|156143229|FG004|Stage 2|Death|0|||
48534152|NCT02268253|156143230|FG005|Stage 2|Death|20|||
48534153|NCT02268253|156143231|FG006|Stage 2|Death|1|||
48534154|NCT02268253|156143225|FG000|Stage 2|Lost to Follow-up|0|||
48534155|NCT02268253|156143226|FG001|Stage 2|Lost to Follow-up|0|||
48534156|NCT02268253|156143227|FG002|Stage 2|Lost to Follow-up|0|||
48534157|NCT02268253|156143228|FG003|Stage 2|Lost to Follow-up|0|||
48534158|NCT02268253|156143229|FG004|Stage 2|Lost to Follow-up|0|||
48534159|NCT02268253|156143230|FG005|Stage 2|Lost to Follow-up|4|||
48534160|NCT02268253|156143231|FG006|Stage 2|Lost to Follow-up|0|||
48534161|NCT02268253|156143225|FG000|Stage 2|Transferred to Hospice|0|||
48534162|NCT02268253|156143226|FG001|Stage 2|Transferred to Hospice|0|||
48534163|NCT02268253|156143227|FG002|Stage 2|Transferred to Hospice|0|||
48604106|NCT01204671|156406709|FG003|Overall Study|Lost to Follow-up|4|||
48604107|NCT01204671|156406710|FG004|Overall Study|Lost to Follow-up|0|||
48604108|NCT01204671|156406706|FG000|Overall Study|Unknown Completion Status|1|||
48604109|NCT01204671|156406707|FG001|Overall Study|Unknown Completion Status|1|||
48604110|NCT01204671|156406708|FG002|Overall Study|Unknown Completion Status|0|||
48604111|NCT01204671|156406709|FG003|Overall Study|Unknown Completion Status|0|||
48604112|NCT01204671|156406710|FG004|Overall Study|Unknown Completion Status|0|||
48604113|NCT01204671|156406706|FG000|Overall Study|Physician Decision|0|||
48604114|NCT01204671|156406707|FG001|Overall Study|Physician Decision|0|||
48604115|NCT01204671|156406708|FG002|Overall Study|Physician Decision|0|||
48604116|NCT01204671|156406709|FG003|Overall Study|Physician Decision|1|||
48604117|NCT01204671|156406710|FG004|Overall Study|Physician Decision|0|||
48604118|NCT00264147|156406711|FG000|Treatment I Period|Adverse Event|3|||
48604119|NCT00264147|156406712|FG001|Treatment I Period|Adverse Event|6|||
48604120|NCT00264147|156406713|FG002|Treatment I Period|Adverse Event|3|||
48604121|NCT00264147|156406714|FG003|Treatment I Period|Adverse Event|5|||
48604122|NCT00264147|156406715|FG004|Treatment I Period|Adverse Event|7|||
48604123|NCT00264147|156406716|FG005|Treatment I Period|Adverse Event|0|||
48604124|NCT00264147|156406711|FG000|Treatment I Period|Laboratory Adverse Event|0|||
48604125|NCT00264147|156406712|FG001|Treatment I Period|Laboratory Adverse Event|0|||
48604126|NCT00264147|156406713|FG002|Treatment I Period|Laboratory Adverse Event|0|||
48604127|NCT00264147|156406714|FG003|Treatment I Period|Laboratory Adverse Event|1|||
48604128|NCT00264147|156406715|FG004|Treatment I Period|Laboratory Adverse Event|0|||
48604129|NCT00264147|156406716|FG005|Treatment I Period|Laboratory Adverse Event|0|||
48604130|NCT00264147|156406711|FG000|Treatment I Period|Lack of Efficacy|6|||
48604131|NCT00264147|156406712|FG001|Treatment I Period|Lack of Efficacy|2|||
48604132|NCT00264147|156406713|FG002|Treatment I Period|Lack of Efficacy|8|||
48604133|NCT00264147|156406714|FG003|Treatment I Period|Lack of Efficacy|0|||
48534164|NCT02268253|156143228|FG003|Stage 2|Transferred to Hospice|0|||
48534165|NCT02268253|156143229|FG004|Stage 2|Transferred to Hospice|0|||
48534166|NCT02268253|156143230|FG005|Stage 2|Transferred to Hospice|2|||
48534167|NCT02268253|156143231|FG006|Stage 2|Transferred to Hospice|0|||
48534168|NCT02268253|156143225|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
48534169|NCT02268253|156143226|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
48534170|NCT02268253|156143227|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
48534171|NCT02268253|156143228|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
48534172|NCT02268253|156143229|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
48534173|NCT02268253|156143230|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
48534174|NCT02268253|156143231|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
48534175|NCT02268253|156143225|FG000|Stage 3A|Withdrawal by Subject|0|||
48534176|NCT02268253|156143226|FG001|Stage 3A|Withdrawal by Subject|0|||
48534177|NCT02268253|156143227|FG002|Stage 3A|Withdrawal by Subject|2|||
48534178|NCT02268253|156143228|FG003|Stage 3A|Withdrawal by Subject|0|||
48534179|NCT02268253|156143229|FG004|Stage 3A|Withdrawal by Subject|0|||
48534180|NCT02268253|156143230|FG005|Stage 3A|Withdrawal by Subject|0|||
48534181|NCT02268253|156143231|FG006|Stage 3A|Withdrawal by Subject|0|||
48534182|NCT02268253|156143225|FG000|Stage 3A|Physician Decision|0|||
48534183|NCT02268253|156143226|FG001|Stage 3A|Physician Decision|0|||
48534184|NCT02268253|156143227|FG002|Stage 3A|Physician Decision|2|||
48534185|NCT02268253|156143228|FG003|Stage 3A|Physician Decision|0|||
48534186|NCT02268253|156143229|FG004|Stage 3A|Physician Decision|0|||
48534187|NCT02268253|156143230|FG005|Stage 3A|Physician Decision|0|||
48534188|NCT02268253|156143231|FG006|Stage 3A|Physician Decision|0|||
48534189|NCT02268253|156143225|FG000|Stage 3A|Study Terminated by Sponsor|0|||
48534190|NCT02268253|156143226|FG001|Stage 3A|Study Terminated by Sponsor|0|||
48534191|NCT02268253|156143227|FG002|Stage 3A|Study Terminated by Sponsor|2|||
48604134|NCT00264147|156406715|FG004|Treatment I Period|Lack of Efficacy|1|||
48604135|NCT00264147|156406716|FG005|Treatment I Period|Lack of Efficacy|0|||
48604136|NCT00264147|156406711|FG000|Treatment I Period|Lost to Follow-up|1|||
48604137|NCT00264147|156406712|FG001|Treatment I Period|Lost to Follow-up|0|||
48604138|NCT00264147|156406713|FG002|Treatment I Period|Lost to Follow-up|0|||
48534192|NCT02268253|156143228|FG003|Stage 3A|Study Terminated by Sponsor|0|||
48534193|NCT02268253|156143229|FG004|Stage 3A|Study Terminated by Sponsor|0|||
48534194|NCT02268253|156143230|FG005|Stage 3A|Study Terminated by Sponsor|0|||
48534195|NCT02268253|156143231|FG006|Stage 3A|Study Terminated by Sponsor|0|||
48534196|NCT02268253|156143225|FG000|Stage 3A|Lost to Follow-up|0|||
48534197|NCT02268253|156143226|FG001|Stage 3A|Lost to Follow-up|0|||
48534198|NCT02268253|156143227|FG002|Stage 3A|Lost to Follow-up|1|||
48534199|NCT02268253|156143228|FG003|Stage 3A|Lost to Follow-up|0|||
48534200|NCT02268253|156143229|FG004|Stage 3A|Lost to Follow-up|0|||
48534201|NCT02268253|156143230|FG005|Stage 3A|Lost to Follow-up|0|||
48534202|NCT02268253|156143231|FG006|Stage 3A|Lost to Follow-up|0|||
48534203|NCT02268253|156143225|FG000|Stage 3A|Death|0|||
48534204|NCT02268253|156143226|FG001|Stage 3A|Death|0|||
48604139|NCT00264147|156406714|FG003|Treatment I Period|Lost to Follow-up|1|||
48604140|NCT00264147|156406715|FG004|Treatment I Period|Lost to Follow-up|1|||
48604141|NCT00264147|156406716|FG005|Treatment I Period|Lost to Follow-up|0|||
48604142|NCT00264147|156406711|FG000|Treatment I Period|Protocol Violation|2|||
48604143|NCT00264147|156406712|FG001|Treatment I Period|Protocol Violation|2|||
48604144|NCT00264147|156406713|FG002|Treatment I Period|Protocol Violation|0|||
48604145|NCT00264147|156406714|FG003|Treatment I Period|Protocol Violation|0|||
48604146|NCT00264147|156406715|FG004|Treatment I Period|Protocol Violation|0|||
48604147|NCT00264147|156406716|FG005|Treatment I Period|Protocol Violation|0|||
48604148|NCT00264147|156406711|FG000|Treatment I Period|Withdrawal by Subject|2|||
48604149|NCT00264147|156406712|FG001|Treatment I Period|Withdrawal by Subject|0|||
48604150|NCT00264147|156406713|FG002|Treatment I Period|Withdrawal by Subject|0|||
48604151|NCT00264147|156406714|FG003|Treatment I Period|Withdrawal by Subject|2|||
48604152|NCT00264147|156406715|FG004|Treatment I Period|Withdrawal by Subject|2|||
48604153|NCT00264147|156406716|FG005|Treatment I Period|Withdrawal by Subject|0|||
48604154|NCT00264147|156406711|FG000|Treatment I Period|Patient out of town for an extended time|0|||
48604155|NCT00264147|156406712|FG001|Treatment I Period|Patient out of town for an extended time|1|||
48604156|NCT00264147|156406713|FG002|Treatment I Period|Patient out of town for an extended time|0|||
48604157|NCT00264147|156406714|FG003|Treatment I Period|Patient out of town for an extended time|0|||
48604158|NCT00264147|156406715|FG004|Treatment I Period|Patient out of town for an extended time|0|||
48604159|NCT00264147|156406716|FG005|Treatment I Period|Patient out of town for an extended time|0|||
48604160|NCT00264147|156406711|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
48604161|NCT00264147|156406712|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
48604162|NCT00264147|156406713|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
48604163|NCT00264147|156406714|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
48604164|NCT00264147|156406715|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
48604165|NCT00264147|156406716|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
48604166|NCT00264147|156406711|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
48604167|NCT00264147|156406712|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
48604168|NCT00264147|156406713|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
48604169|NCT00264147|156406714|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
48604170|NCT00264147|156406715|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
48604171|NCT00264147|156406716|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
48604172|NCT00264147|156406711|FG000|Treatment II Period|Adverse Event|0|||
48604173|NCT00264147|156406712|FG001|Treatment II Period|Adverse Event|0|||
48604174|NCT00264147|156406713|FG002|Treatment II Period|Adverse Event|0|||
48604175|NCT00264147|156406714|FG003|Treatment II Period|Adverse Event|0|||
48604176|NCT00264147|156406715|FG004|Treatment II Period|Adverse Event|9|||
48604177|NCT00264147|156406716|FG005|Treatment II Period|Adverse Event|9|||
48604178|NCT00264147|156406711|FG000|Treatment II Period|Laboratory Adverse Event|0|||
48604179|NCT00264147|156406712|FG001|Treatment II Period|Laboratory Adverse Event|0|||
48604180|NCT00264147|156406713|FG002|Treatment II Period|Laboratory Adverse Event|0|||
48604181|NCT00264147|156406714|FG003|Treatment II Period|Laboratory Adverse Event|0|||
48604182|NCT00264147|156406715|FG004|Treatment II Period|Laboratory Adverse Event|0|||
48604183|NCT00264147|156406716|FG005|Treatment II Period|Laboratory Adverse Event|1|||
48604184|NCT00264147|156406711|FG000|Treatment II Period|Lack of Efficacy|0|||
48604185|NCT00264147|156406712|FG001|Treatment II Period|Lack of Efficacy|0|||
48604186|NCT00264147|156406713|FG002|Treatment II Period|Lack of Efficacy|0|||
48604187|NCT00264147|156406714|FG003|Treatment II Period|Lack of Efficacy|0|||
48604188|NCT00264147|156406715|FG004|Treatment II Period|Lack of Efficacy|20|||
48604189|NCT00264147|156406716|FG005|Treatment II Period|Lack of Efficacy|19|||
48604190|NCT00264147|156406711|FG000|Treatment II Period|Lost to Follow-up|0|||
48604191|NCT00264147|156406712|FG001|Treatment II Period|Lost to Follow-up|0|||
48604192|NCT00264147|156406713|FG002|Treatment II Period|Lost to Follow-up|0|||
48604193|NCT00264147|156406714|FG003|Treatment II Period|Lost to Follow-up|0|||
48604194|NCT00264147|156406715|FG004|Treatment II Period|Lost to Follow-up|1|||
48604195|NCT00264147|156406716|FG005|Treatment II Period|Lost to Follow-up|1|||
48604196|NCT00264147|156406711|FG000|Treatment II Period|Withdrawal by Subject|0|||
48604197|NCT00264147|156406712|FG001|Treatment II Period|Withdrawal by Subject|0|||
48604198|NCT00264147|156406713|FG002|Treatment II Period|Withdrawal by Subject|0|||
48534205|NCT02268253|156143227|FG002|Stage 3A|Death|5|||
48534206|NCT02268253|156143228|FG003|Stage 3A|Death|0|||
48534207|NCT02268253|156143229|FG004|Stage 3A|Death|0|||
48534208|NCT02268253|156143230|FG005|Stage 3A|Death|0|||
48604199|NCT00264147|156406714|FG003|Treatment II Period|Withdrawal by Subject|0|||
48604200|NCT00264147|156406715|FG004|Treatment II Period|Withdrawal by Subject|3|||
48604201|NCT00264147|156406716|FG005|Treatment II Period|Withdrawal by Subject|2|||
48604202|NCT00264147|156406711|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
48604203|NCT00264147|156406712|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
48604204|NCT00264147|156406713|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
48604205|NCT00264147|156406714|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
48604206|NCT00264147|156406715|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
48604207|NCT00264147|156406716|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
48604208|NCT01316575|156406719|FG000|Overall Study|Withdrawal by Subject|2|||
48604209|NCT01316575|156406720|FG001|Overall Study|Withdrawal by Subject|0|||
48604210|NCT01316575|156406719|FG000|Overall Study|Required alternate treatment|0|||
48604211|NCT01316575|156406720|FG001|Overall Study|Required alternate treatment|1|||
48604212|NCT00315445|156406721|FG000|Overall Study|Adverse Event|7|||
48604213|NCT00315445|156406722|FG001|Overall Study|Adverse Event|12|||
48604214|NCT00315445|156406723|FG002|Overall Study|Adverse Event|15|||
48604215|NCT00315445|156406721|FG000|Overall Study|Lack of Efficacy|16|||
48604216|NCT00315445|156406722|FG001|Overall Study|Lack of Efficacy|1|||
48604217|NCT00315445|156406723|FG002|Overall Study|Lack of Efficacy|7|||
48604218|NCT00315445|156406721|FG000|Overall Study|Lost to Follow-up|1|||
48534209|NCT02268253|156143231|FG006|Stage 3A|Death|0|||
48534210|NCT02315066|156143232|FG000|Overall Study|Lost to Follow-up|0|||
48534211|NCT02315066|156143233|FG001|Overall Study|Lost to Follow-up|1|||
48534212|NCT02315066|156143234|FG002|Overall Study|Lost to Follow-up|1|||
48534213|NCT02315066|156143235|FG003|Overall Study|Lost to Follow-up|0|||
48534214|NCT02315066|156143236|FG004|Overall Study|Lost to Follow-up|1|||
48534215|NCT02315066|156143237|FG005|Overall Study|Lost to Follow-up|0|||
48534216|NCT02315066|156143238|FG006|Overall Study|Lost to Follow-up|2|||
48534217|NCT02315066|156143239|FG007|Overall Study|Lost to Follow-up|1|||
48534218|NCT02315066|156143240|FG008|Overall Study|Lost to Follow-up|0|||
48534219|NCT02315066|156143241|FG009|Overall Study|Lost to Follow-up|0|||
48534220|NCT02315066|156143242|FG010|Overall Study|Lost to Follow-up|1|||
48534221|NCT02315066|156143243|FG011|Overall Study|Lost to Follow-up|2|||
48534222|NCT02315066|156143244|FG012|Overall Study|Lost to Follow-up|0|||
48534223|NCT02315066|156143245|FG013|Overall Study|Lost to Follow-up|4|||
48534224|NCT02315066|156143232|FG000|Overall Study|Death|2|||
48534225|NCT02315066|156143233|FG001|Overall Study|Death|7|||
48534226|NCT02315066|156143234|FG002|Overall Study|Death|6|||
48534227|NCT02315066|156143235|FG003|Overall Study|Death|11|||
48534228|NCT02315066|156143236|FG004|Overall Study|Death|10|||
48534229|NCT02315066|156143237|FG005|Overall Study|Death|3|||
48534230|NCT02315066|156143238|FG006|Overall Study|Death|9|||
48534231|NCT02315066|156143239|FG007|Overall Study|Death|9|||
48534232|NCT02315066|156143240|FG008|Overall Study|Death|10|||
48534233|NCT02315066|156143241|FG009|Overall Study|Death|8|||
48534234|NCT02315066|156143242|FG010|Overall Study|Death|10|||
48534235|NCT02315066|156143243|FG011|Overall Study|Death|7|||
48534236|NCT02315066|156143244|FG012|Overall Study|Death|8|||
48534237|NCT02315066|156143245|FG013|Overall Study|Death|21|||
48534238|NCT02315066|156143232|FG000|Overall Study|Other|0|||
48534239|NCT02315066|156143233|FG001|Overall Study|Other|0|||
48534240|NCT02315066|156143234|FG002|Overall Study|Other|0|||
48534241|NCT02315066|156143235|FG003|Overall Study|Other|0|||
48534242|NCT02315066|156143236|FG004|Overall Study|Other|0|||
48534243|NCT02315066|156143237|FG005|Overall Study|Other|0|||
48534244|NCT02315066|156143238|FG006|Overall Study|Other|0|||
48534245|NCT02315066|156143239|FG007|Overall Study|Other|1|||
48534246|NCT02315066|156143240|FG008|Overall Study|Other|1|||
48534247|NCT02315066|156143241|FG009|Overall Study|Other|2|||
48534248|NCT02315066|156143242|FG010|Overall Study|Other|0|||
48534249|NCT02315066|156143243|FG011|Overall Study|Other|0|||
48534250|NCT02315066|156143244|FG012|Overall Study|Other|0|||
48534251|NCT02315066|156143245|FG013|Overall Study|Other|0|||
48534252|NCT02315066|156143232|FG000|Overall Study|Subject refused further follow-up|0|||
48534253|NCT02315066|156143233|FG001|Overall Study|Subject refused further follow-up|2|||
48534254|NCT02315066|156143234|FG002|Overall Study|Subject refused further follow-up|2|||
48534255|NCT02315066|156143235|FG003|Overall Study|Subject refused further follow-up|0|||
48534256|NCT02315066|156143236|FG004|Overall Study|Subject refused further follow-up|0|||
48534257|NCT02315066|156143237|FG005|Overall Study|Subject refused further follow-up|0|||
48534258|NCT02315066|156143238|FG006|Overall Study|Subject refused further follow-up|2|||
48534259|NCT02315066|156143239|FG007|Overall Study|Subject refused further follow-up|3|||
48534260|NCT02315066|156143240|FG008|Overall Study|Subject refused further follow-up|0|||
48534261|NCT02315066|156143241|FG009|Overall Study|Subject refused further follow-up|1|||
48534262|NCT02315066|156143242|FG010|Overall Study|Subject refused further follow-up|1|||
48534263|NCT02315066|156143243|FG011|Overall Study|Subject refused further follow-up|2|||
48534264|NCT02315066|156143244|FG012|Overall Study|Subject refused further follow-up|2|||
48534265|NCT02315066|156143245|FG013|Overall Study|Subject refused further follow-up|4|||
48534266|NCT02315066|156143232|FG000|Overall Study|Study ongoing at date of cut-off|0|||
48534267|NCT02315066|156143233|FG001|Overall Study|Study ongoing at date of cut-off|0|||
48534268|NCT02315066|156143234|FG002|Overall Study|Study ongoing at date of cut-off|0|||
48534269|NCT02315066|156143235|FG003|Overall Study|Study ongoing at date of cut-off|0|||
48534270|NCT02315066|156143236|FG004|Overall Study|Study ongoing at date of cut-off|0|||
48534271|NCT02315066|156143237|FG005|Overall Study|Study ongoing at date of cut-off|0|||
48534272|NCT02315066|156143238|FG006|Overall Study|Study ongoing at date of cut-off|0|||
48534273|NCT02315066|156143239|FG007|Overall Study|Study ongoing at date of cut-off|0|||
48534274|NCT02315066|156143240|FG008|Overall Study|Study ongoing at date of cut-off|0|||
48534275|NCT02315066|156143241|FG009|Overall Study|Study ongoing at date of cut-off|0|||
48534276|NCT02315066|156143242|FG010|Overall Study|Study ongoing at date of cut-off|0|||
48534277|NCT02315066|156143243|FG011|Overall Study|Study ongoing at date of cut-off|0|||
48534278|NCT02315066|156143244|FG012|Overall Study|Study ongoing at date of cut-off|0|||
48534279|NCT02315066|156143245|FG013|Overall Study|Study ongoing at date of cut-off|1|||
48534280|NCT02459665|156143246|FG000|Overall Study|Withdrawal by Subject|0|||
48534281|NCT02459665|156143247|FG001|Overall Study|Withdrawal by Subject|1|||
48534282|NCT02459665|156143248|FG002|Overall Study|Withdrawal by Subject|1|||
48534283|NCT02459665|156143249|FG003|Overall Study|Withdrawal by Subject|2|||
48534284|NCT01567826|156143250|FG000|Overall Study|Lost to Follow-up|3|||
48534285|NCT01567826|156143251|FG001|Overall Study|Lost to Follow-up|2|||
48534286|NCT00567476|156143261|FG000|Overall Study|Adverse Event|2|||
48534287|NCT00567476|156143262|FG001|Overall Study|Adverse Event|0|||
48534288|NCT00567476|156143261|FG000|Overall Study|Pregnancy|1|||
48534289|NCT00567476|156143262|FG001|Overall Study|Pregnancy|0|||
48534290|NCT00567476|156143261|FG000|Overall Study|Protocol Violation|4|||
48534291|NCT00567476|156143262|FG001|Overall Study|Protocol Violation|1|||
48534292|NCT00567476|156143261|FG000|Overall Study|Lost to Follow-up|0|||
48534293|NCT00567476|156143262|FG001|Overall Study|Lost to Follow-up|1|||
48604219|NCT00315445|156406722|FG001|Overall Study|Lost to Follow-up|0|||
48604220|NCT00315445|156406723|FG002|Overall Study|Lost to Follow-up|1|||
48604221|NCT00315445|156406721|FG000|Overall Study|Protocol Violation|2|||
48604222|NCT00315445|156406722|FG001|Overall Study|Protocol Violation|0|||
48604223|NCT00315445|156406723|FG002|Overall Study|Protocol Violation|1|||
48604224|NCT00315445|156406721|FG000|Overall Study|Other|1|||
48604225|NCT00315445|156406722|FG001|Overall Study|Other|3|||
48604226|NCT00315445|156406723|FG002|Overall Study|Other|0|||
48604227|NCT00969228|156406724|FG000|Overall Study|Adverse Event|1|||
48604228|NCT00969228|156406725|FG001|Overall Study|Adverse Event|0|||
48604229|NCT00969228|156406724|FG000|Overall Study|Withdrawal by Subject|4|||
48604230|NCT00969228|156406725|FG001|Overall Study|Withdrawal by Subject|0|||
48604231|NCT00969228|156406724|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
48604232|NCT00969228|156406725|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
48604233|NCT01677741|156406742|FG000|Overall Study|Death|0|||
48604234|NCT01677741|156406743|FG001|Overall Study|Death|0|||
48604235|NCT01677741|156406744|FG002|Overall Study|Death|0|||
48604236|NCT01677741|156406745|FG003|Overall Study|Death|1|||
48604237|NCT01677741|156406746|FG004|Overall Study|Death|0|||
48604238|NCT01677741|156406747|FG005|Overall Study|Death|1|||
48604239|NCT01677741|156406748|FG006|Overall Study|Death|0|||
48604240|NCT01677741|156406749|FG007|Overall Study|Death|0|||
48604241|NCT01677741|156406742|FG000|Overall Study|Withdrawal by Subject|2|||
48604242|NCT01677741|156406743|FG001|Overall Study|Withdrawal by Subject|7|||
48604243|NCT01677741|156406744|FG002|Overall Study|Withdrawal by Subject|5|||
48604244|NCT01677741|156406745|FG003|Overall Study|Withdrawal by Subject|4|||
48604245|NCT01677741|156406746|FG004|Overall Study|Withdrawal by Subject|11|||
48835780|NCT00716144|157240816|FG003|Overall Study|Withdrawal by Subject|6|||
48835781|NCT00716144|157240813|FG000|Overall Study|Lost to Follow-up|2|||
48835782|NCT00716144|157240814|FG001|Overall Study|Lost to Follow-up|2|||
48835783|NCT00716144|157240815|FG002|Overall Study|Lost to Follow-up|1|||
48835784|NCT00716144|157240816|FG003|Overall Study|Lost to Follow-up|2|||
48835785|NCT00716144|157240813|FG000|Overall Study|Adverse Event|0|||
48835786|NCT00716144|157240814|FG001|Overall Study|Adverse Event|0|||
48835787|NCT00716144|157240815|FG002|Overall Study|Adverse Event|0|||
48835788|NCT00716144|157240816|FG003|Overall Study|Adverse Event|2|||
48835789|NCT00716144|157240813|FG000|Overall Study|Non-compliance|1|||
48835790|NCT00716144|157240814|FG001|Overall Study|Non-compliance|0|||
48835791|NCT00716144|157240815|FG002|Overall Study|Non-compliance|0|||
48835792|NCT00716144|157240816|FG003|Overall Study|Non-compliance|0|||
48835793|NCT00716144|157240813|FG000|Overall Study|Protocol Violation|2|||
48835794|NCT00716144|157240814|FG001|Overall Study|Protocol Violation|0|||
48835795|NCT00716144|157240815|FG002|Overall Study|Protocol Violation|1|||
48835796|NCT00716144|157240816|FG003|Overall Study|Protocol Violation|0|||
48835797|NCT00716144|157240813|FG000|Overall Study|Physician Decision|0|||
48835798|NCT00716144|157240814|FG001|Overall Study|Physician Decision|1|||
48835799|NCT00716144|157240815|FG002|Overall Study|Physician Decision|2|||
48835800|NCT00716144|157240816|FG003|Overall Study|Physician Decision|2|||
48835801|NCT00716144|157240813|FG000|Overall Study|Intercurrent illness|0|||
48534294|NCT00567476|156143261|FG000|Overall Study|Administrative issues|1|||
48534295|NCT00567476|156143262|FG001|Overall Study|Administrative issues|0|||
48534296|NCT00567476|156143261|FG000|Overall Study|Medical Decision|0|||
48534297|NCT00567476|156143262|FG001|Overall Study|Medical Decision|1|||
48534298|NCT00567476|156143261|FG000|Overall Study|Non-adherence to protocol|0|||
48534299|NCT00567476|156143262|FG001|Overall Study|Non-adherence to protocol|1|||
48534300|NCT02696031|156143263|FG000|Up to Week 24|Adverse Event|2|||
48534301|NCT02696031|156143264|FG001|Up to Week 24|Adverse Event|4|||
48534302|NCT02696031|156143265|FG002|Up to Week 24|Adverse Event|2|||
48534303|NCT02696031|156143266|FG003|Up to Week 24|Adverse Event|0|||
48534304|NCT02696031|156143267|FG004|Up to Week 24|Adverse Event|0|||
48534305|NCT02696031|156143268|FG005|Up to Week 24|Adverse Event|0|||
48534306|NCT02696031|156143263|FG000|Up to Week 24|Lack of Efficacy|2|||
48534307|NCT02696031|156143264|FG001|Up to Week 24|Lack of Efficacy|1|||
48534308|NCT02696031|156143265|FG002|Up to Week 24|Lack of Efficacy|2|||
48534309|NCT02696031|156143266|FG003|Up to Week 24|Lack of Efficacy|0|||
48534310|NCT02696031|156143267|FG004|Up to Week 24|Lack of Efficacy|0|||
48534311|NCT02696031|156143268|FG005|Up to Week 24|Lack of Efficacy|0|||
48534312|NCT02696031|156143263|FG000|Up to Week 24|Lost to Follow-up|0|||
48604246|NCT01677741|156406747|FG005|Overall Study|Withdrawal by Subject|20|||
48604247|NCT01677741|156406748|FG006|Overall Study|Withdrawal by Subject|4|||
48604248|NCT01677741|156406749|FG007|Overall Study|Withdrawal by Subject|2|||
48604249|NCT01677741|156406742|FG000|Overall Study|Enrolled in a rollover study|0|||
48604250|NCT01677741|156406743|FG001|Overall Study|Enrolled in a rollover study|3|||
48604251|NCT01677741|156406744|FG002|Overall Study|Enrolled in a rollover study|2|||
48604252|NCT01677741|156406745|FG003|Overall Study|Enrolled in a rollover study|1|||
48604253|NCT01677741|156406746|FG004|Overall Study|Enrolled in a rollover study|6|||
48604254|NCT01677741|156406747|FG005|Overall Study|Enrolled in a rollover study|6|||
48534313|NCT02696031|156143264|FG001|Up to Week 24|Lost to Follow-up|1|||
48534314|NCT02696031|156143265|FG002|Up to Week 24|Lost to Follow-up|1|||
48604255|NCT01677741|156406748|FG006|Overall Study|Enrolled in a rollover study|7|||
48604256|NCT01677741|156406749|FG007|Overall Study|Enrolled in a rollover study|0|||
48534315|NCT02696031|156143266|FG003|Up to Week 24|Lost to Follow-up|0|||
48534316|NCT02696031|156143267|FG004|Up to Week 24|Lost to Follow-up|0|||
48604257|NCT01677741|156406742|FG000|Overall Study|Progressive disease|1|||
48604258|NCT01677741|156406743|FG001|Overall Study|Progressive disease|0|||
48534317|NCT02696031|156143268|FG005|Up to Week 24|Lost to Follow-up|0|||
48534318|NCT02696031|156143263|FG000|Up to Week 24|Physician Decision|1|||
48835802|NCT00716144|157240814|FG001|Overall Study|Intercurrent illness|0|||
48534319|NCT02696031|156143264|FG001|Up to Week 24|Physician Decision|0|||
48835803|NCT00716144|157240815|FG002|Overall Study|Intercurrent illness|1|||
48835804|NCT00716144|157240816|FG003|Overall Study|Intercurrent illness|0|||
48835805|NCT00716144|157240813|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
48835806|NCT00716144|157240814|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
48835807|NCT00716144|157240815|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
48835808|NCT00716144|157240816|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
48835809|NCT00716144|157240813|FG000|Overall Study|Adverse event: left foot pain|0|||
48835810|NCT00716144|157240814|FG001|Overall Study|Adverse event: left foot pain|1|||
48835811|NCT00716144|157240815|FG002|Overall Study|Adverse event: left foot pain|0|||
48835812|NCT00716144|157240816|FG003|Overall Study|Adverse event: left foot pain|0|||
48534320|NCT02696031|156143265|FG002|Up to Week 24|Physician Decision|1|||
48534321|NCT02696031|156143266|FG003|Up to Week 24|Physician Decision|0|||
48835813|NCT00716144|157240813|FG000|Overall Study|Clinical Depression|0|||
48534322|NCT02696031|156143267|FG004|Up to Week 24|Physician Decision|0|||
48534323|NCT02696031|156143268|FG005|Up to Week 24|Physician Decision|0|||
48534324|NCT02696031|156143263|FG000|Up to Week 24|Protocol Violation|1|||
48534325|NCT02696031|156143264|FG001|Up to Week 24|Protocol Violation|0|||
48534326|NCT02696031|156143265|FG002|Up to Week 24|Protocol Violation|0|||
48604259|NCT01677741|156406744|FG002|Overall Study|Progressive disease|1|||
48604260|NCT01677741|156406745|FG003|Overall Study|Progressive disease|0|||
48604261|NCT01677741|156406746|FG004|Overall Study|Progressive disease|0|||
48604262|NCT01677741|156406747|FG005|Overall Study|Progressive disease|1|||
48604263|NCT01677741|156406748|FG006|Overall Study|Progressive disease|0|||
48604264|NCT01677741|156406749|FG007|Overall Study|Progressive disease|0|||
48604265|NCT01883895|156406750|FG000|Overall Study|Lost to Follow-up|2|||
48604266|NCT04386902|156406755|FG000|Overall Study|Withdrawal by Subject|5|||
48604267|NCT04386902|156406755|FG000|Overall Study|Technical problems in the recording|5|||
48604268|NCT03054428|156406756|FG000|Overall Study|Physician Decision|0|||
48604269|NCT03054428|156406757|FG001|Overall Study|Physician Decision|1|||
48604270|NCT03054428|156406758|FG002|Overall Study|Physician Decision|1|||
48604271|NCT03054428|156406756|FG000|Overall Study|Lack of Efficacy|3|||
48604272|NCT03054428|156406757|FG001|Overall Study|Lack of Efficacy|1|||
48604273|NCT03054428|156406758|FG002|Overall Study|Lack of Efficacy|0|||
48604274|NCT03054428|156406756|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
48604275|NCT03054428|156406757|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
48604276|NCT03054428|156406758|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
48604277|NCT03054428|156406756|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
48604278|NCT03054428|156406757|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
48604279|NCT03054428|156406758|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
48604280|NCT03054428|156406756|FG000|Overall Study|Transitioned to OLE study|76|||
48604281|NCT03054428|156406757|FG001|Overall Study|Transitioned to OLE study|76|||
48604282|NCT03054428|156406758|FG002|Overall Study|Transitioned to OLE study|73|||
48604283|NCT03054428|156406756|FG000|Overall Study|Withdrawal by Subject|3|||
48604284|NCT03054428|156406757|FG001|Overall Study|Withdrawal by Subject|2|||
48604285|NCT03054428|156406758|FG002|Overall Study|Withdrawal by Subject|3|||
48604286|NCT03054428|156406756|FG000|Overall Study|Lost to Follow-up|0|||
48604287|NCT03054428|156406757|FG001|Overall Study|Lost to Follow-up|0|||
48604288|NCT03054428|156406758|FG002|Overall Study|Lost to Follow-up|1|||
48604289|NCT01884597|156406759|FG000|Overall Study|Adverse Event|0|||
48604290|NCT01884597|156406760|FG001|Overall Study|Adverse Event|0|||
48604291|NCT01884597|156406761|FG002|Overall Study|Adverse Event|1|||
48604292|NCT01884597|156406759|FG000|Overall Study|Lack of Efficacy|1|||
48604293|NCT01884597|156406760|FG001|Overall Study|Lack of Efficacy|0|||
48604294|NCT01884597|156406761|FG002|Overall Study|Lack of Efficacy|0|||
48604295|NCT01884597|156406759|FG000|Overall Study|Death|0|||
48604296|NCT01884597|156406760|FG001|Overall Study|Death|1|||
48835814|NCT00716144|157240814|FG001|Overall Study|Clinical Depression|1|||
48835815|NCT00716144|157240815|FG002|Overall Study|Clinical Depression|0|||
48835816|NCT00716144|157240816|FG003|Overall Study|Clinical Depression|0|||
48835817|NCT02425111|157240822|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
48835818|NCT02425111|157240822|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
48835819|NCT02425111|157240822|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
48835820|NCT02425111|157240822|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
48835821|NCT02425111|157240822|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
48835822|NCT02425111|157240822|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
48835823|NCT03383146|157240823|FG000|Overall Study|Screen Failure|1|||
48835824|NCT03383146|157240824|FG001|Overall Study|Screen Failure|0|||
48835825|NCT03383146|157240823|FG000|Overall Study|Adverse Event|6|||
48835826|NCT03383146|157240824|FG001|Overall Study|Adverse Event|18|||
48835827|NCT03383146|157240823|FG000|Overall Study|Lack of Efficacy|0|||
48835828|NCT03383146|157240824|FG001|Overall Study|Lack of Efficacy|3|||
48835829|NCT03383146|157240823|FG000|Overall Study|Withdrawal by Subject|20|||
48835830|NCT03383146|157240824|FG001|Overall Study|Withdrawal by Subject|36|||
48835831|NCT03383146|157240823|FG000|Overall Study|Lost to Follow-up|5|||
48835832|NCT03383146|157240824|FG001|Overall Study|Lost to Follow-up|15|||
48445192|NCT01125293|155817073|FG003|Overall Study|Disease Progression|3|||
48445193|NCT01125293|155817074|FG004|Overall Study|Disease Progression|5|||
48445194|NCT01125293|155817075|FG005|Overall Study|Disease Progression|12|||
48445195|NCT01125293|155817070|FG000|Overall Study|Adverse Event|1|||
48445196|NCT01125293|155817071|FG001|Overall Study|Adverse Event|0|||
48445197|NCT01125293|155817072|FG002|Overall Study|Adverse Event|0|||
48445198|NCT01125293|155817073|FG003|Overall Study|Adverse Event|0|||
48445199|NCT01125293|155817074|FG004|Overall Study|Adverse Event|2|||
48445200|NCT01125293|155817075|FG005|Overall Study|Adverse Event|8|||
48445201|NCT01125293|155817070|FG000|Overall Study|Symptomatic Deterioration|1|||
48445202|NCT01125293|155817071|FG001|Overall Study|Symptomatic Deterioration|0|||
48445203|NCT01125293|155817072|FG002|Overall Study|Symptomatic Deterioration|0|||
48445204|NCT01125293|155817073|FG003|Overall Study|Symptomatic Deterioration|0|||
48445205|NCT01125293|155817074|FG004|Overall Study|Symptomatic Deterioration|0|||
48445206|NCT01125293|155817075|FG005|Overall Study|Symptomatic Deterioration|0|||
48445207|NCT01125293|155817070|FG000|Overall Study|Death|0|||
48445208|NCT01125293|155817071|FG001|Overall Study|Death|0|||
48445209|NCT01125293|155817072|FG002|Overall Study|Death|0|||
48445210|NCT01125293|155817073|FG003|Overall Study|Death|0|||
48445211|NCT01125293|155817074|FG004|Overall Study|Death|1|||
48534327|NCT02696031|156143266|FG003|Up to Week 24|Protocol Violation|0|||
48534328|NCT02696031|156143267|FG004|Up to Week 24|Protocol Violation|0|||
48534329|NCT02696031|156143268|FG005|Up to Week 24|Protocol Violation|0|||
48534330|NCT02696031|156143263|FG000|Up to Week 24|Withdrawal by Subject|4|||
48534331|NCT02696031|156143264|FG001|Up to Week 24|Withdrawal by Subject|1|||
48534332|NCT02696031|156143265|FG002|Up to Week 24|Withdrawal by Subject|5|||
48534333|NCT02696031|156143266|FG003|Up to Week 24|Withdrawal by Subject|0|||
48534334|NCT02696031|156143267|FG004|Up to Week 24|Withdrawal by Subject|0|||
48534335|NCT02696031|156143268|FG005|Up to Week 24|Withdrawal by Subject|0|||
48534336|NCT02696031|156143263|FG000|Up to Week 52|Adverse Event|4|||
48534337|NCT02696031|156143264|FG001|Up to Week 52|Adverse Event|5|||
48534338|NCT02696031|156143265|FG002|Up to Week 52|Adverse Event|3|||
48534339|NCT02696031|156143266|FG003|Up to Week 52|Adverse Event|0|||
48534340|NCT02696031|156143267|FG004|Up to Week 52|Adverse Event|0|||
48534341|NCT02696031|156143268|FG005|Up to Week 52|Adverse Event|0|||
48534342|NCT02696031|156143263|FG000|Up to Week 52|Lack of Efficacy|10|||
48534343|NCT02696031|156143264|FG001|Up to Week 52|Lack of Efficacy|7|||
48835833|NCT03383146|157240823|FG000|Overall Study|Death|0|||
48835834|NCT03383146|157240824|FG001|Overall Study|Death|2|||
48835835|NCT03383146|157240823|FG000|Overall Study|Physician Decision|0|||
48835836|NCT03383146|157240824|FG001|Overall Study|Physician Decision|1|||
48835837|NCT03383146|157240823|FG000|Overall Study|Protocol Deviation|1|||
48534344|NCT02696031|156143265|FG002|Up to Week 52|Lack of Efficacy|11|||
48534345|NCT02696031|156143266|FG003|Up to Week 52|Lack of Efficacy|0|||
48534346|NCT02696031|156143267|FG004|Up to Week 52|Lack of Efficacy|0|||
48534347|NCT02696031|156143268|FG005|Up to Week 52|Lack of Efficacy|0|||
48604297|NCT01884597|156406761|FG002|Overall Study|Death|0|||
48604298|NCT01265498|156406762|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
48604299|NCT01265498|156406763|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
48604300|NCT00269152|156406764|FG000|Overall Study|Adverse Event|9|||
48604301|NCT00269152|156406765|FG001|Overall Study|Adverse Event|3|||
48604302|NCT00269152|156406764|FG000|Overall Study|Withdrawal by Subject|7|||
48534348|NCT02696031|156143263|FG000|Up to Week 52|Lost to Follow-up|1|||
48534349|NCT02696031|156143264|FG001|Up to Week 52|Lost to Follow-up|1|||
48534350|NCT02696031|156143265|FG002|Up to Week 52|Lost to Follow-up|1|||
48534351|NCT02696031|156143266|FG003|Up to Week 52|Lost to Follow-up|0|||
48534352|NCT02696031|156143267|FG004|Up to Week 52|Lost to Follow-up|0|||
48534353|NCT02696031|156143268|FG005|Up to Week 52|Lost to Follow-up|0|||
48534354|NCT02696031|156143263|FG000|Up to Week 52|Physician Decision|1|||
48534355|NCT02696031|156143264|FG001|Up to Week 52|Physician Decision|1|||
48534356|NCT02696031|156143265|FG002|Up to Week 52|Physician Decision|2|||
48534357|NCT02696031|156143266|FG003|Up to Week 52|Physician Decision|0|||
48534358|NCT02696031|156143267|FG004|Up to Week 52|Physician Decision|0|||
48534359|NCT02696031|156143268|FG005|Up to Week 52|Physician Decision|0|||
48534360|NCT02696031|156143263|FG000|Up to Week 52|Pregnancy|0|||
48534361|NCT02696031|156143264|FG001|Up to Week 52|Pregnancy|2|||
48604303|NCT00269152|156406765|FG001|Overall Study|Withdrawal by Subject|3|||
48604304|NCT00269152|156406764|FG000|Overall Study|Physician Decision|2|||
48604305|NCT00269152|156406765|FG001|Overall Study|Physician Decision|3|||
48604306|NCT00269152|156406764|FG000|Overall Study|Protocol Violation|0|||
48604307|NCT00269152|156406765|FG001|Overall Study|Protocol Violation|1|||
48835838|NCT03383146|157240824|FG001|Overall Study|Protocol Deviation|8|||
48835839|NCT03383146|157240823|FG000|Overall Study|Study Terminated by the Sponsor|48|||
48835840|NCT03383146|157240824|FG001|Overall Study|Study Terminated by the Sponsor|95|||
48835841|NCT03383146|157240823|FG000|Overall Study|Reason not Specified|4|||
48835842|NCT03383146|157240824|FG001|Overall Study|Reason not Specified|6|||
48835843|NCT00988637|157240831|FG000|Overall Study|Lost to Follow-up|2|||
48835844|NCT00988637|157240832|FG001|Overall Study|Lost to Follow-up|1|||
48835845|NCT00988637|157240831|FG000|Overall Study|Withdrawal by Subject|1|||
48835846|NCT00988637|157240832|FG001|Overall Study|Withdrawal by Subject|1|||
48835847|NCT00988637|157240831|FG000|Overall Study|non-compliance with study drug|0|||
48534362|NCT02696031|156143265|FG002|Up to Week 52|Pregnancy|0|||
48534363|NCT02696031|156143266|FG003|Up to Week 52|Pregnancy|0|||
48534364|NCT02696031|156143267|FG004|Up to Week 52|Pregnancy|0|||
48835848|NCT00988637|157240832|FG001|Overall Study|non-compliance with study drug|1|||
48835849|NCT02104765|157240835|FG000|Overall Study|Lost to Follow-up|0|||
48534365|NCT02696031|156143268|FG005|Up to Week 52|Pregnancy|0|||
48534366|NCT02696031|156143263|FG000|Up to Week 52|Protocol Violation|1|||
48534367|NCT02696031|156143264|FG001|Up to Week 52|Protocol Violation|0|||
48534368|NCT02696031|156143265|FG002|Up to Week 52|Protocol Violation|0|||
48534369|NCT02696031|156143266|FG003|Up to Week 52|Protocol Violation|0|||
48534370|NCT02696031|156143267|FG004|Up to Week 52|Protocol Violation|0|||
48534371|NCT02696031|156143268|FG005|Up to Week 52|Protocol Violation|0|||
48534372|NCT02696031|156143263|FG000|Up to Week 52|Withdrawal by Subject|12|||
48534373|NCT02696031|156143264|FG001|Up to Week 52|Withdrawal by Subject|3|||
48534374|NCT02696031|156143265|FG002|Up to Week 52|Withdrawal by Subject|9|||
48835850|NCT02104765|157240836|FG001|Overall Study|Lost to Follow-up|0|||
48835851|NCT02104765|157240837|FG002|Overall Study|Lost to Follow-up|1|||
48835852|NCT02104765|157240838|FG003|Overall Study|Lost to Follow-up|0|||
48835853|NCT02104765|157240839|FG004|Overall Study|Lost to Follow-up|0|||
48534375|NCT02696031|156143266|FG003|Up to Week 52|Withdrawal by Subject|0|||
48534376|NCT02696031|156143267|FG004|Up to Week 52|Withdrawal by Subject|0|||
48534377|NCT02696031|156143268|FG005|Up to Week 52|Withdrawal by Subject|0|||
48534378|NCT02696031|156143263|FG000|Up to Week 104|Pregnancy|0|||
48534379|NCT02696031|156143264|FG001|Up to Week 104|Pregnancy|2|||
48534380|NCT02696031|156143265|FG002|Up to Week 104|Pregnancy|1|||
48534381|NCT02696031|156143266|FG003|Up to Week 104|Pregnancy|0|||
48534382|NCT02696031|156143267|FG004|Up to Week 104|Pregnancy|0|||
48534383|NCT02696031|156143268|FG005|Up to Week 104|Pregnancy|0|||
48534384|NCT02696031|156143263|FG000|Up to Week 104|Withdrawal by Subject|15|||
48534385|NCT02696031|156143264|FG001|Up to Week 104|Withdrawal by Subject|10|||
48534386|NCT02696031|156143265|FG002|Up to Week 104|Withdrawal by Subject|16|||
48534387|NCT02696031|156143266|FG003|Up to Week 104|Withdrawal by Subject|0|||
48534388|NCT02696031|156143267|FG004|Up to Week 104|Withdrawal by Subject|0|||
48835854|NCT02104765|157240840|FG005|Overall Study|Lost to Follow-up|0|||
48835855|NCT02104765|157240841|FG006|Overall Study|Lost to Follow-up|0|||
48835856|NCT02104765|157240835|FG000|Overall Study|Withdrawal by Subject|0|||
48835857|NCT02104765|157240836|FG001|Overall Study|Withdrawal by Subject|0|||
48835858|NCT02104765|157240837|FG002|Overall Study|Withdrawal by Subject|0|||
48835859|NCT02104765|157240838|FG003|Overall Study|Withdrawal by Subject|1|||
48534389|NCT02696031|156143268|FG005|Up to Week 104|Withdrawal by Subject|0|||
48534390|NCT02696031|156143263|FG000|Up to Week 104|Protocol Violation|1|||
48534391|NCT02696031|156143264|FG001|Up to Week 104|Protocol Violation|0|||
48534392|NCT02696031|156143265|FG002|Up to Week 104|Protocol Violation|0|||
48534393|NCT02696031|156143266|FG003|Up to Week 104|Protocol Violation|0|||
48534394|NCT02696031|156143267|FG004|Up to Week 104|Protocol Violation|0|||
48534395|NCT02696031|156143268|FG005|Up to Week 104|Protocol Violation|0|||
48534396|NCT02696031|156143263|FG000|Up to Week 104|Physician Decision|1|||
48534397|NCT02696031|156143264|FG001|Up to Week 104|Physician Decision|2|||
48534398|NCT02696031|156143265|FG002|Up to Week 104|Physician Decision|3|||
48534399|NCT02696031|156143266|FG003|Up to Week 104|Physician Decision|0|||
48534400|NCT02696031|156143267|FG004|Up to Week 104|Physician Decision|0|||
48534401|NCT02696031|156143268|FG005|Up to Week 104|Physician Decision|0|||
48534402|NCT02696031|156143263|FG000|Up to Week 104|Lost to Follow-up|2|||
48534403|NCT02696031|156143264|FG001|Up to Week 104|Lost to Follow-up|3|||
48534404|NCT02696031|156143265|FG002|Up to Week 104|Lost to Follow-up|1|||
48534405|NCT02696031|156143266|FG003|Up to Week 104|Lost to Follow-up|0|||
48534406|NCT02696031|156143267|FG004|Up to Week 104|Lost to Follow-up|0|||
48534407|NCT02696031|156143268|FG005|Up to Week 104|Lost to Follow-up|0|||
48534408|NCT02696031|156143263|FG000|Up to Week 104|Lack of Efficacy|13|||
48534409|NCT02696031|156143264|FG001|Up to Week 104|Lack of Efficacy|12|||
48534410|NCT02696031|156143265|FG002|Up to Week 104|Lack of Efficacy|11|||
48534411|NCT02696031|156143266|FG003|Up to Week 104|Lack of Efficacy|0|||
48534412|NCT02696031|156143267|FG004|Up to Week 104|Lack of Efficacy|0|||
48534413|NCT02696031|156143268|FG005|Up to Week 104|Lack of Efficacy|0|||
48534414|NCT02696031|156143263|FG000|Up to Week 104|Adverse Event|7|||
48534415|NCT02696031|156143264|FG001|Up to Week 104|Adverse Event|11|||
48534416|NCT02696031|156143265|FG002|Up to Week 104|Adverse Event|5|||
48534417|NCT02696031|156143266|FG003|Up to Week 104|Adverse Event|0|||
48534418|NCT02696031|156143267|FG004|Up to Week 104|Adverse Event|0|||
48534419|NCT02696031|156143268|FG005|Up to Week 104|Adverse Event|0|||
48534420|NCT02696031|156143263|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
48604308|NCT03533751|156406766|FG000|Overall Study|Withdrawal by Subject|12|||
48835860|NCT02104765|157240839|FG004|Overall Study|Withdrawal by Subject|1|||
48835861|NCT02104765|157240840|FG005|Overall Study|Withdrawal by Subject|0|||
48534421|NCT02696031|156143264|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
48534422|NCT02696031|156143265|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
48534423|NCT02696031|156143266|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
48534424|NCT02696031|156143267|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
48534425|NCT02696031|156143268|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
48534426|NCT02696031|156143263|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
48534427|NCT02696031|156143264|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
48534428|NCT02696031|156143265|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
48534429|NCT02696031|156143266|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
48534430|NCT02696031|156143267|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
48534431|NCT02696031|156143268|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
48604309|NCT03533751|156406767|FG001|Overall Study|Withdrawal by Subject|6|||
48534432|NCT02696031|156143263|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
48534433|NCT02696031|156143264|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
48534434|NCT02696031|156143265|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
48534435|NCT02696031|156143266|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
48534436|NCT02696031|156143267|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
48534437|NCT02696031|156143268|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
48835862|NCT02104765|157240841|FG006|Overall Study|Withdrawal by Subject|1|||
48604310|NCT03533751|156406768|FG002|Overall Study|Withdrawal by Subject|11|||
48604311|NCT03533751|156406769|FG003|Overall Study|Withdrawal by Subject|9|||
48604312|NCT03533751|156406770|FG004|Overall Study|Withdrawal by Subject|10|||
48604313|NCT03533751|156406766|FG000|Overall Study|Adverse Event|4|||
48534438|NCT02696031|156143263|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
48534439|NCT02696031|156143264|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
48534440|NCT02696031|156143265|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
48534441|NCT02696031|156143266|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
48534442|NCT02696031|156143267|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
48534443|NCT02696031|156143268|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
48534444|NCT02696031|156143263|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
48534445|NCT02696031|156143264|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
48534446|NCT02696031|156143265|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
48534447|NCT02696031|156143266|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
48534448|NCT02696031|156143267|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
48534449|NCT02696031|156143268|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
48534450|NCT02696031|156143263|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
48534451|NCT02696031|156143264|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
48534452|NCT02696031|156143265|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
48534453|NCT02696031|156143266|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
48534454|NCT02696031|156143267|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
48534455|NCT02696031|156143268|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
48534456|NCT02696031|156143263|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
48534457|NCT02696031|156143264|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
48534458|NCT02696031|156143265|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
48534459|NCT02696031|156143266|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
48534460|NCT02696031|156143267|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
48534461|NCT02696031|156143268|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
48604314|NCT03533751|156406767|FG001|Overall Study|Adverse Event|7|||
48604315|NCT03533751|156406768|FG002|Overall Study|Adverse Event|2|||
48604316|NCT03533751|156406769|FG003|Overall Study|Adverse Event|4|||
48604317|NCT03533751|156406770|FG004|Overall Study|Adverse Event|5|||
48604318|NCT03533751|156406766|FG000|Overall Study|Physician Decision|0|||
48604319|NCT03533751|156406767|FG001|Overall Study|Physician Decision|2|||
48604320|NCT03533751|156406768|FG002|Overall Study|Physician Decision|1|||
48604321|NCT03533751|156406769|FG003|Overall Study|Physician Decision|2|||
48604322|NCT03533751|156406770|FG004|Overall Study|Physician Decision|1|||
48604323|NCT03533751|156406766|FG000|Overall Study|Sponsor Decision|0|||
48604324|NCT03533751|156406767|FG001|Overall Study|Sponsor Decision|0|||
48604325|NCT03533751|156406768|FG002|Overall Study|Sponsor Decision|1|||
48604326|NCT03533751|156406769|FG003|Overall Study|Sponsor Decision|1|||
48604327|NCT03533751|156406770|FG004|Overall Study|Sponsor Decision|0|||
48604328|NCT03533751|156406766|FG000|Overall Study|Lost to Follow-up|3|||
48604329|NCT03533751|156406767|FG001|Overall Study|Lost to Follow-up|7|||
48604330|NCT03533751|156406768|FG002|Overall Study|Lost to Follow-up|6|||
48604331|NCT03533751|156406769|FG003|Overall Study|Lost to Follow-up|4|||
48604332|NCT03533751|156406770|FG004|Overall Study|Lost to Follow-up|3|||
48604333|NCT03533751|156406766|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
48604334|NCT03533751|156406767|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
48604335|NCT03533751|156406768|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
48604336|NCT03533751|156406769|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
48604337|NCT03533751|156406770|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
48604338|NCT03533751|156406766|FG000|Overall Study|Other|0|||
48604339|NCT03533751|156406767|FG001|Overall Study|Other|2|||
48604340|NCT03533751|156406768|FG002|Overall Study|Other|1|||
48604341|NCT03533751|156406769|FG003|Overall Study|Other|0|||
48604342|NCT03533751|156406770|FG004|Overall Study|Other|3|||
48604343|NCT03225287|156406771|FG000|Overall Study|Adverse Event|0|||
48604344|NCT03225287|156406772|FG001|Overall Study|Adverse Event|0|||
48604345|NCT03225287|156406773|FG002|Overall Study|Adverse Event|1|||
48835863|NCT00442117|157240842|FG000|Overall Study|Adverse Event|3|||
48835864|NCT00442117|157240843|FG001|Overall Study|Adverse Event|2|||
48604346|NCT03225287|156406771|FG000|Overall Study|Protocol non-compliance|0|||
48604347|NCT03225287|156406772|FG001|Overall Study|Protocol non-compliance|0|||
48604348|NCT03225287|156406773|FG002|Overall Study|Protocol non-compliance|1|||
48604349|NCT03225287|156406771|FG000|Overall Study|Subject withdraws consent|3|||
48604350|NCT03225287|156406772|FG001|Overall Study|Subject withdraws consent|0|||
48604351|NCT03225287|156406773|FG002|Overall Study|Subject withdraws consent|0|||
48604352|NCT03225287|156406771|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
48604353|NCT03225287|156406772|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
48604354|NCT03225287|156406773|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
48604355|NCT03225287|156406771|FG000|Overall Study|Trial drug not effective|0|||
48835865|NCT00442117|157240842|FG000|Overall Study|Lack of Efficacy|2|||
48835866|NCT00442117|157240843|FG001|Overall Study|Lack of Efficacy|6|||
48835867|NCT00442117|157240842|FG000|Overall Study|Lost to Follow-up|1|||
48835868|NCT00442117|157240843|FG001|Overall Study|Lost to Follow-up|2|||
48835869|NCT00442117|157240842|FG000|Overall Study|Withdrawal by Subject|2|||
48835870|NCT00442117|157240843|FG001|Overall Study|Withdrawal by Subject|2|||
48835871|NCT00442117|157240842|FG000|Overall Study|Major Deviation|25|||
48534462|NCT00597116|156143269|FG000|Overall Study|Adverse Event|2|||
48534463|NCT00597116|156143270|FG001|Overall Study|Adverse Event|1|||
48534464|NCT00597116|156143269|FG000|Overall Study|Withdrawal by Subject|0|||
48534465|NCT00597116|156143270|FG001|Overall Study|Withdrawal by Subject|2|||
48534466|NCT00597116|156143269|FG000|Overall Study|Physician Decision|0|||
48534467|NCT00597116|156143270|FG001|Overall Study|Physician Decision|1|||
48534468|NCT00597116|156143269|FG000|Overall Study|Death|0|||
48534469|NCT00597116|156143270|FG001|Overall Study|Death|1|||
48534470|NCT00597116|156143269|FG000|Overall Study|Lost to Follow-up|1|||
48534471|NCT00597116|156143270|FG001|Overall Study|Lost to Follow-up|0|||
48534472|NCT00597116|156143269|FG000|Overall Study|Progressive disease|11|||
48534473|NCT00597116|156143270|FG001|Overall Study|Progressive disease|6|||
48534474|NCT00350402|156143273|FG000|Overall Study|Lost to Follow-up|1|||
48534475|NCT00350402|156143274|FG001|Overall Study|Lost to Follow-up|1|||
48534476|NCT01884688|156143277|FG000|Overall Study|Screen Failure|2|||
48534477|NCT04349631|156143280|FG000|Overall Study|Lost to Follow-up|3|||
48534478|NCT04349631|156143280|FG000|Overall Study|Withdrawal by Subject|7|||
48534479|NCT00690482|156143282|FG000|Overall Study|Adverse Event|2|||
48534480|NCT00690482|156143283|FG001|Overall Study|Adverse Event|1|||
48534481|NCT00690482|156143282|FG000|Overall Study|Incorrect enrolment|0|||
48534482|NCT00690482|156143283|FG001|Overall Study|Incorrect enrolment|1|||
48534483|NCT00690482|156143282|FG000|Overall Study|Study-specific discontinuation criteria|1|||
48534484|NCT00690482|156143283|FG001|Overall Study|Study-specific discontinuation criteria|0|||
48534485|NCT00690482|156143282|FG000|Overall Study|Intake of prohibited medicine|1|||
48534486|NCT00690482|156143283|FG001|Overall Study|Intake of prohibited medicine|0|||
48534487|NCT00690482|156143282|FG000|Overall Study|withdrew consent at rand.day|0|||
48534488|NCT00690482|156143283|FG001|Overall Study|withdrew consent at rand.day|1|||
48534489|NCT04798482|156143284|FG000|Overall Study|Physician Decision|1|||
48534490|NCT04798482|156143284|FG000|Overall Study|Lost eligibility|1|||
48534491|NCT01258101|156143286|FG000|Overall Study|Adverse Event|5|||
48534492|NCT01258101|156143287|FG001|Overall Study|Adverse Event|6|||
48534493|NCT01258101|156143288|FG002|Overall Study|Adverse Event|0|||
48534494|NCT01258101|156143289|FG003|Overall Study|Adverse Event|0|||
48534495|NCT01258101|156143286|FG000|Overall Study|Extra exclusion criterion amended|2|||
48534496|NCT01258101|156143287|FG001|Overall Study|Extra exclusion criterion amended|1|||
48534497|NCT01258101|156143288|FG002|Overall Study|Extra exclusion criterion amended|1|||
48534498|NCT01258101|156143289|FG003|Overall Study|Extra exclusion criterion amended|1|||
48534499|NCT01258101|156143286|FG000|Overall Study|Informed consent has been withdrawn|2|||
48534500|NCT01258101|156143287|FG001|Overall Study|Informed consent has been withdrawn|2|||
48534501|NCT01258101|156143288|FG002|Overall Study|Informed consent has been withdrawn|1|||
48534502|NCT01258101|156143289|FG003|Overall Study|Informed consent has been withdrawn|1|||
48534503|NCT01258101|156143286|FG000|Overall Study|Patient is not able to attend visits|8|||
48534504|NCT01258101|156143287|FG001|Overall Study|Patient is not able to attend visits|9|||
48534505|NCT01258101|156143288|FG002|Overall Study|Patient is not able to attend visits|7|||
48534506|NCT01258101|156143289|FG003|Overall Study|Patient is not able to attend visits|6|||
48534507|NCT01258101|156143286|FG000|Overall Study|Patient´s compliance|4|||
48534508|NCT01258101|156143287|FG001|Overall Study|Patient´s compliance|3|||
48534509|NCT01258101|156143288|FG002|Overall Study|Patient´s compliance|1|||
48534510|NCT01258101|156143289|FG003|Overall Study|Patient´s compliance|2|||
48604356|NCT03225287|156406772|FG001|Overall Study|Trial drug not effective|1|||
48604357|NCT03225287|156406773|FG002|Overall Study|Trial drug not effective|0|||
48604358|NCT03225287|156406771|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
48604359|NCT03225287|156406772|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
48604360|NCT03225287|156406773|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
48604361|NCT03225287|156406771|FG000|Overall Study|Stem cell transplantation|0|||
48534511|NCT01258101|156143286|FG000|Overall Study|Lost to Follow-up|5|||
48534512|NCT01258101|156143287|FG001|Overall Study|Lost to Follow-up|5|||
48534513|NCT01258101|156143288|FG002|Overall Study|Lost to Follow-up|0|||
48835872|NCT00442117|157240843|FG001|Overall Study|Major Deviation|20|||
48835873|NCT00442117|157240842|FG000|Overall Study|Non compliance with protocol|3|||
48534514|NCT01258101|156143289|FG003|Overall Study|Lost to Follow-up|6|||
48534515|NCT01258101|156143286|FG000|Overall Study|PCR positive at week 24|0|||
48835874|NCT00442117|157240843|FG001|Overall Study|Non compliance with protocol|5|||
48835875|NCT00442117|157240842|FG000|Overall Study|Met Withdrawal Criteria|2|||
48835876|NCT00442117|157240843|FG001|Overall Study|Met Withdrawal Criteria|1|||
48835877|NCT03863834|157240844|FG000|Overall Study|Lost to Follow-up|3|||
48835878|NCT04009577|157240845|FG000|Core Study|Adverse Event|1|||
48835879|NCT04009577|157240846|FG001|Core Study|Adverse Event|0|||
48835880|NCT04009577|157240847|FG002|Core Study|Adverse Event|2|||
48534516|NCT01258101|156143287|FG001|Overall Study|PCR positive at week 24|0|||
48534517|NCT01258101|156143288|FG002|Overall Study|PCR positive at week 24|0|||
48534518|NCT01258101|156143289|FG003|Overall Study|PCR positive at week 24|1|||
48534519|NCT01258101|156143286|FG000|Overall Study|Other reason|7|||
48534520|NCT01258101|156143287|FG001|Overall Study|Other reason|8|||
48534521|NCT01258101|156143288|FG002|Overall Study|Other reason|1|||
48534522|NCT01258101|156143289|FG003|Overall Study|Other reason|8|||
48534523|NCT00303667|156143290|FG000|Overall Study|Death|0|||
48534524|NCT00303667|156143291|FG001|Overall Study|Death|4|||
48534525|NCT00058214|156143293|FG000|Overall Study|Adverse Event|1|||
48534526|NCT00606502|156143294|FG000|Randomization|Randomized but not treated|3|||
48534527|NCT00606502|156143295|FG001|Randomization|Randomized but not treated|0|||
48534528|NCT00606502|156143294|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
48534529|NCT00606502|156143295|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
48534530|NCT02377921|156143296|FG000|Overall Study|Subject non-compliance|1|||
48534531|NCT02377921|156143297|FG001|Overall Study|Subject non-compliance|1|||
48534532|NCT03903159|156143300|FG000|Overall Study|Discharged with Staff Approval|2|||
48534533|NCT03903159|156143300|FG000|Overall Study|Discharged at Staff Request|2|||
48534534|NCT03903159|156143300|FG000|Overall Study|Discharged Against Staff Advice|1|||
48534535|NCT01297322|156143314|FG000|Overall Study|Lost to Follow-up|1|||
48534536|NCT01297322|156143315|FG001|Overall Study|Lost to Follow-up|0|||
48534537|NCT01297322|156143314|FG000|Overall Study|Withdrawal by Subject|0|||
48534538|NCT01297322|156143315|FG001|Overall Study|Withdrawal by Subject|1|||
48534539|NCT01297322|156143314|FG000|Overall Study|Protocol Violation|0|||
48534540|NCT01297322|156143315|FG001|Overall Study|Protocol Violation|3|||
48534541|NCT03686150|156144845|FG000|Overall Study|Withdrawal by Subject|1|||
48534542|NCT03686150|156144846|FG001|Overall Study|Withdrawal by Subject|1|||
48534543|NCT03686150|156144847|FG002|Overall Study|Withdrawal by Subject|1|||
48534544|NCT03686150|156144848|FG003|Overall Study|Withdrawal by Subject|0|||
48534545|NCT03686150|156144849|FG004|Overall Study|Withdrawal by Subject|1|||
48534546|NCT03686150|156144850|FG005|Overall Study|Withdrawal by Subject|2|||
48534547|NCT03686150|156144845|FG000|Overall Study|Physician Decision|1|||
48534548|NCT03686150|156144846|FG001|Overall Study|Physician Decision|0|||
48534549|NCT03686150|156144847|FG002|Overall Study|Physician Decision|0|||
48534550|NCT03686150|156144848|FG003|Overall Study|Physician Decision|0|||
48534551|NCT03686150|156144849|FG004|Overall Study|Physician Decision|0|||
48534552|NCT03686150|156144850|FG005|Overall Study|Physician Decision|1|||
48534553|NCT03686150|156144845|FG000|Overall Study|Lost to Follow-up|0|||
48534554|NCT03686150|156144846|FG001|Overall Study|Lost to Follow-up|1|||
48534555|NCT03686150|156144847|FG002|Overall Study|Lost to Follow-up|0|||
48534556|NCT03686150|156144848|FG003|Overall Study|Lost to Follow-up|0|||
48534557|NCT03686150|156144849|FG004|Overall Study|Lost to Follow-up|0|||
48534558|NCT03686150|156144850|FG005|Overall Study|Lost to Follow-up|0|||
48534559|NCT01522950|156144851|FG000|Overall Study|Withdrawal by Subject|3|||
48534560|NCT01522950|156144852|FG001|Overall Study|Withdrawal by Subject|2|||
48534561|NCT01522950|156144853|FG002|Overall Study|Withdrawal by Subject|1|||
48534562|NCT01522950|156144851|FG000|Overall Study|Adverse Event|3|||
48534563|NCT01522950|156144852|FG001|Overall Study|Adverse Event|1|||
48534564|NCT01522950|156144853|FG002|Overall Study|Adverse Event|1|||
48534565|NCT01522950|156144851|FG000|Overall Study|Protocol Violation|0|||
48534566|NCT01522950|156144852|FG001|Overall Study|Protocol Violation|0|||
48534567|NCT01522950|156144853|FG002|Overall Study|Protocol Violation|2|||
48534568|NCT01522950|156144851|FG000|Overall Study|Death|0|||
48534569|NCT01522950|156144852|FG001|Overall Study|Death|1|||
48534570|NCT01522950|156144853|FG002|Overall Study|Death|1|||
48534571|NCT01522950|156144851|FG000|Overall Study|Study Medication Sensitivity|0|||
48534572|NCT01522950|156144852|FG001|Overall Study|Study Medication Sensitivity|1|||
48534573|NCT01522950|156144853|FG002|Overall Study|Study Medication Sensitivity|0|||
48534574|NCT06191679|156144861|FG000|Baseline|Lost to Follow-up|1|||
48534575|NCT06191679|156144862|FG001|Baseline|Lost to Follow-up|0|||
48534576|NCT06191679|156144863|FG002|Baseline|Lost to Follow-up|1|||
48534577|NCT06191679|156144864|FG003|Baseline|Lost to Follow-up|0|||
48534578|NCT06191679|156144861|FG000|Allocation to Group|Withdrawal by Subject|0|||
48534579|NCT06191679|156144862|FG001|Allocation to Group|Withdrawal by Subject|1|||
48534580|NCT06191679|156144863|FG002|Allocation to Group|Withdrawal by Subject|2|||
48534581|NCT06191679|156144864|FG003|Allocation to Group|Withdrawal by Subject|0|||
48534582|NCT06191679|156144861|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
48534583|NCT06191679|156144862|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
48534584|NCT06191679|156144863|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
48534585|NCT06191679|156144864|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
48534586|NCT06191679|156144861|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
48534587|NCT06191679|156144862|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
48534588|NCT06191679|156144863|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
48534589|NCT06191679|156144864|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
48534590|NCT06191679|156144861|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
48835881|NCT04009577|157240848|FG003|Core Study|Adverse Event|4|||
48835882|NCT04009577|157240845|FG000|Core Study|Withdrawal by Subject|0|||
48835883|NCT04009577|157240846|FG001|Core Study|Withdrawal by Subject|0|||
48835884|NCT04009577|157240847|FG002|Core Study|Withdrawal by Subject|2|||
48835885|NCT04009577|157240848|FG003|Core Study|Withdrawal by Subject|0|||
48835886|NCT04009577|157240845|FG000|Core Study|Other|0|||
48835887|NCT04009577|157240846|FG001|Core Study|Other|0|||
48835888|NCT04009577|157240847|FG002|Core Study|Other|0|||
48835889|NCT04009577|157240848|FG003|Core Study|Other|1|||
48835890|NCT04009577|157240845|FG000|Extension Phase|Adverse Event|0|||
48835891|NCT04009577|157240846|FG001|Extension Phase|Adverse Event|0|||
48835892|NCT04009577|157240847|FG002|Extension Phase|Adverse Event|0|||
48835893|NCT04009577|157240848|FG003|Extension Phase|Adverse Event|1|||
48835894|NCT04009577|157240845|FG000|Extension Phase|Inadequate therapeutic effect|0|||
48835895|NCT04009577|157240846|FG001|Extension Phase|Inadequate therapeutic effect|0|||
48835896|NCT04009577|157240847|FG002|Extension Phase|Inadequate therapeutic effect|1|||
48835897|NCT04009577|157240848|FG003|Extension Phase|Inadequate therapeutic effect|0|||
48835898|NCT04009577|157240845|FG000|Extension Phase|Withdrawal by Subject|0|||
48835899|NCT04009577|157240846|FG001|Extension Phase|Withdrawal by Subject|0|||
48835900|NCT04009577|157240847|FG002|Extension Phase|Withdrawal by Subject|1|||
48835901|NCT04009577|157240848|FG003|Extension Phase|Withdrawal by Subject|0|||
48835902|NCT04009577|157240845|FG000|Extension Phase|Not Treated|0|||
48835903|NCT04009577|157240846|FG001|Extension Phase|Not Treated|0|||
48835904|NCT04009577|157240847|FG002|Extension Phase|Not Treated|2|||
48835905|NCT04009577|157240848|FG003|Extension Phase|Not Treated|0|||
48835906|NCT01685606|157240859|FG000|Overall Study|Withdrawal by Subject|1|||
48835907|NCT01787760|157240860|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
48835908|NCT01787760|157240861|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
48835909|NCT01787760|157240862|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
48835910|NCT01787760|157240860|FG000|Overall Study|Decompensated on left exotropia|0|||
48835911|NCT01787760|157240861|FG001|Overall Study|Decompensated on left exotropia|0|||
48835912|NCT01787760|157240862|FG002|Overall Study|Decompensated on left exotropia|1|||
48835913|NCT01787760|157240860|FG000|Overall Study|Dryness|0|||
48835914|NCT01787760|157240861|FG001|Overall Study|Dryness|1|||
48835915|NCT01787760|157240862|FG002|Overall Study|Dryness|0|||
48835916|NCT01787760|157240860|FG000|Overall Study|Relocation|1|||
48835917|NCT01787760|157240861|FG001|Overall Study|Relocation|1|||
48835918|NCT01787760|157240862|FG002|Overall Study|Relocation|0|||
48835919|NCT01787760|157240860|FG000|Overall Study|Lens discomfort|3|||
48835920|NCT01787760|157240861|FG001|Overall Study|Lens discomfort|0|||
48835921|NCT01787760|157240862|FG002|Overall Study|Lens discomfort|0|||
48835922|NCT01787760|157240860|FG000|Overall Study|Lens handling difficulty|1|||
48835923|NCT01787760|157240861|FG001|Overall Study|Lens handling difficulty|2|||
48835924|NCT01787760|157240862|FG002|Overall Study|Lens handling difficulty|0|||
48835925|NCT01787760|157240860|FG000|Overall Study|Protocol Violation|6|||
48835926|NCT01787760|157240861|FG001|Overall Study|Protocol Violation|0|||
48835927|NCT01787760|157240862|FG002|Overall Study|Protocol Violation|1|||
48835928|NCT01787760|157240860|FG000|Overall Study|Withdrawal by Subject|5|||
48835929|NCT01787760|157240861|FG001|Overall Study|Withdrawal by Subject|1|||
48835930|NCT01787760|157240862|FG002|Overall Study|Withdrawal by Subject|2|||
48835931|NCT01787760|157240860|FG000|Overall Study|Lost to Follow-up|1|||
48835932|NCT01787760|157240861|FG001|Overall Study|Lost to Follow-up|0|||
48835933|NCT01787760|157240862|FG002|Overall Study|Lost to Follow-up|1|||
48835934|NCT01787760|157240860|FG000|Overall Study|Stroke|1|||
48835935|NCT01787760|157240861|FG001|Overall Study|Stroke|0|||
48835936|NCT01787760|157240862|FG002|Overall Study|Stroke|0|||
48835937|NCT01787760|157240860|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
48835938|NCT01787760|157240861|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
48835939|NCT01787760|157240862|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
48835940|NCT01787760|157240860|FG000|Overall Study|Unsatisfactory physiological response|2|||
48835941|NCT01787760|157240861|FG001|Overall Study|Unsatisfactory physiological response|4|||
48835942|NCT01787760|157240862|FG002|Overall Study|Unsatisfactory physiological response|0|||
48835943|NCT01787760|157240860|FG000|Overall Study|Unsatisfactory visual response|1|||
48835944|NCT01787760|157240861|FG001|Overall Study|Unsatisfactory visual response|1|||
48835945|NCT01787760|157240862|FG002|Overall Study|Unsatisfactory visual response|0|||
48835946|NCT01787760|157240860|FG000|Overall Study|Near vision blur|1|||
48835947|NCT01787760|157240861|FG001|Overall Study|Near vision blur|0|||
48835948|NCT01787760|157240862|FG002|Overall Study|Near vision blur|0|||
48835949|NCT02754479|157240863|FG000|Overall Study|Lost to Follow-up|1|||
48835950|NCT01199705|157240864|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
48835951|NCT01849055|157240865|FG000|Overall Study|Withdrawal by Subject|0|||
48835952|NCT01849055|157240866|FG001|Overall Study|Withdrawal by Subject|0|||
48835953|NCT01849055|157240867|FG002|Overall Study|Withdrawal by Subject|1|||
48835954|NCT01849055|157240868|FG003|Overall Study|Withdrawal by Subject|0|||
48835955|NCT01849055|157240869|FG004|Overall Study|Withdrawal by Subject|0|||
48835956|NCT01849055|157240870|FG005|Overall Study|Withdrawal by Subject|0|||
48835957|NCT00223795|157240871|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
48835958|NCT00223795|157240872|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
48835959|NCT00223795|157240871|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
48835960|NCT00223795|157240872|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
48835961|NCT00801983|157240873|FG000|Period 1|Lost to Follow-up|2|||
48835962|NCT00801983|157240874|FG001|Period 1|Lost to Follow-up|0|||
48835963|NCT00801983|157240873|FG000|Period 1|Withdrawal by Subject|2|||
48835964|NCT00801983|157240874|FG001|Period 1|Withdrawal by Subject|8|||
48835965|NCT00801983|157240873|FG000|Period 2|Withdrawal by Subject|2|||
48835966|NCT00801983|157240874|FG001|Period 2|Withdrawal by Subject|1|||
48835967|NCT02999477|157240875|FG000|Overall Study|found ineligible after first dose|0|||
48835968|NCT02999477|157240876|FG001|Overall Study|found ineligible after first dose|1|||
48835969|NCT02999477|157240875|FG000|Overall Study|Withdrawal by Subject|1|||
48835970|NCT02999477|157240876|FG001|Overall Study|Withdrawal by Subject|1|||
48835971|NCT02738840|157242701|FG000|Overall Study|MRI Scan not Performed|5|||
48835972|NCT02738840|157242701|FG000|Overall Study|Lost to Follow-up|1|||
48835973|NCT02738840|157242701|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
48835974|NCT02738840|157242701|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
48835975|NCT02960659|157242702|FG000|Overall Study|Withdrawal by Subject|1|||
48835976|NCT02960659|157242703|FG001|Overall Study|Withdrawal by Subject|0|||
48835977|NCT02960659|157242702|FG000|Overall Study|Poor compliance|0|||
48835978|NCT02960659|157242703|FG001|Overall Study|Poor compliance|1|||
48835979|NCT03712930|157242708|FG000|Overall Study|Death|7|||
48835980|NCT03712930|157242708|FG000|Overall Study|Physician Decision|1|||
48835981|NCT03712930|157242708|FG000|Overall Study|Study Terminated by Sponsor|3|||
48835982|NCT03712930|157242708|FG000|Overall Study|Progressive Disease|2|||
48835983|NCT01062126|157242711|FG000|Overall Study|Death|209|||
48835984|NCT01062126|157242711|FG000|Overall Study|All Withdrawals|324|||
48835985|NCT03837028|157242712|FG000|Overall Study|Lost to Follow-up|4|||
48835986|NCT03837028|157242713|FG001|Overall Study|Lost to Follow-up|0|||
48835987|NCT03837028|157242714|FG002|Overall Study|Lost to Follow-up|2|||
48835988|NCT03837028|157242715|FG003|Overall Study|Lost to Follow-up|0|||
48835989|NCT03837028|157242712|FG000|Overall Study|Withdrawal by Subject|12|||
48835990|NCT03837028|157242713|FG001|Overall Study|Withdrawal by Subject|11|||
48835991|NCT03837028|157242714|FG002|Overall Study|Withdrawal by Subject|11|||
48835992|NCT03837028|157242715|FG003|Overall Study|Withdrawal by Subject|7|||
48835993|NCT02001623|157242723|FG000|Overall Study|Disease Progression|2|||
48835994|NCT02001623|157242724|FG001|Overall Study|Disease Progression|2|||
48835995|NCT02001623|157242725|FG002|Overall Study|Disease Progression|3|||
48835996|NCT02001623|157242726|FG003|Overall Study|Disease Progression|2|||
48835997|NCT02001623|157242727|FG004|Overall Study|Disease Progression|3|||
48835998|NCT02001623|157242728|FG005|Overall Study|Disease Progression|2|||
48835999|NCT02001623|157242729|FG006|Overall Study|Disease Progression|3|||
48836000|NCT02001623|157242730|FG007|Overall Study|Disease Progression|3|||
48836001|NCT02001623|157242731|FG008|Overall Study|Disease Progression|7|||
48836002|NCT02001623|157242732|FG009|Overall Study|Disease Progression|40|||
48836003|NCT02001623|157242733|FG010|Overall Study|Disease Progression|5|||
48836004|NCT02001623|157242734|FG011|Overall Study|Disease Progression|9|||
48836005|NCT02001623|157242735|FG012|Overall Study|Disease Progression|9|||
48836006|NCT02001623|157242736|FG013|Overall Study|Disease Progression|20|||
48836007|NCT02001623|157242737|FG014|Overall Study|Disease Progression|9|||
48836008|NCT02001623|157242723|FG000|Overall Study|Physician Decision|0|||
48836009|NCT02001623|157242724|FG001|Overall Study|Physician Decision|0|||
48836010|NCT02001623|157242725|FG002|Overall Study|Physician Decision|0|||
48836011|NCT02001623|157242726|FG003|Overall Study|Physician Decision|0|||
48836012|NCT02001623|157242727|FG004|Overall Study|Physician Decision|0|||
48836013|NCT02001623|157242728|FG005|Overall Study|Physician Decision|0|||
48836014|NCT02001623|157242729|FG006|Overall Study|Physician Decision|0|||
48836015|NCT02001623|157242730|FG007|Overall Study|Physician Decision|0|||
48836016|NCT02001623|157242731|FG008|Overall Study|Physician Decision|3|||
48836017|NCT02001623|157242732|FG009|Overall Study|Physician Decision|2|||
48534591|NCT06191679|156144862|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
48534592|NCT06191679|156144863|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
48534593|NCT06191679|156144864|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
48836018|NCT02001623|157242733|FG010|Overall Study|Physician Decision|3|||
48836019|NCT02001623|157242734|FG011|Overall Study|Physician Decision|3|||
48836020|NCT02001623|157242735|FG012|Overall Study|Physician Decision|1|||
48836021|NCT02001623|157242736|FG013|Overall Study|Physician Decision|2|||
48836022|NCT02001623|157242737|FG014|Overall Study|Physician Decision|1|||
48836023|NCT02001623|157242723|FG000|Overall Study|Death|0|||
48836024|NCT02001623|157242724|FG001|Overall Study|Death|1|||
48836025|NCT02001623|157242725|FG002|Overall Study|Death|0|||
48836026|NCT02001623|157242726|FG003|Overall Study|Death|0|||
48836027|NCT02001623|157242727|FG004|Overall Study|Death|0|||
48836028|NCT02001623|157242728|FG005|Overall Study|Death|0|||
48836029|NCT02001623|157242729|FG006|Overall Study|Death|0|||
48836030|NCT02001623|157242730|FG007|Overall Study|Death|0|||
48836031|NCT02001623|157242731|FG008|Overall Study|Death|0|||
48836032|NCT02001623|157242732|FG009|Overall Study|Death|0|||
48836033|NCT02001623|157242733|FG010|Overall Study|Death|0|||
48836034|NCT02001623|157242734|FG011|Overall Study|Death|0|||
48836035|NCT02001623|157242735|FG012|Overall Study|Death|0|||
48836036|NCT02001623|157242736|FG013|Overall Study|Death|0|||
48836037|NCT02001623|157242737|FG014|Overall Study|Death|0|||
48836038|NCT02001623|157242723|FG000|Overall Study|Adverse Event|0|||
48836039|NCT02001623|157242724|FG001|Overall Study|Adverse Event|0|||
48836040|NCT02001623|157242725|FG002|Overall Study|Adverse Event|0|||
48604362|NCT03225287|156406772|FG001|Overall Study|Stem cell transplantation|1|||
48604363|NCT03225287|156406773|FG002|Overall Study|Stem cell transplantation|0|||
48604364|NCT02097823|156406774|FG000|Overall Study|Withdrawal by Subject|1|||
48604365|NCT02097823|156406775|FG001|Overall Study|Withdrawal by Subject|1|||
48604366|NCT03082729|156406776|FG000|Overall Study|Lost to Follow-up|7|||
48604367|NCT03082729|156406776|FG000|Overall Study|Physician Decision|2|||
48604368|NCT03082729|156406776|FG000|Overall Study|Withdrawal by Subject|1|||
48604369|NCT03082729|156406776|FG000|Overall Study|Lack of Efficacy|9|||
48604370|NCT03082729|156406776|FG000|Overall Study|Adverse Event|4|||
48604371|NCT03082729|156406776|FG000|Overall Study|Protocol Violation|6|||
48604372|NCT03082729|156406776|FG000|Overall Study|Fear of study procedure|1|||
48604373|NCT03082729|156406776|FG000|Overall Study|Scheduling conflict|1|||
48604374|NCT01274351|156406777|FG000|Overall Study|Lost to Follow-up|1|||
48604375|NCT01274351|156406777|FG000|Overall Study|patient not compliant with the protocol|1|||
48604376|NCT01274351|156406777|FG000|Overall Study|Pregnancy|1|||
48604377|NCT01274351|156406777|FG000|Overall Study|Death|2|||
48604378|NCT01274351|156406777|FG000|Overall Study|Withdrawal by Subject|3|||
48604379|NCT01274351|156406777|FG000|Overall Study|Adverse Event|8|||
48604380|NCT01274351|156406777|FG000|Overall Study|progression of disease|3|||
48604381|NCT01274351|156406777|FG000|Overall Study|hospitalization|1|||
48604382|NCT02783170|156408920|FG000|Overall Study|Randomized but not Vaccinated|1|||
48604383|NCT02783170|156408921|FG001|Overall Study|Randomized but not Vaccinated|0|||
48604384|NCT01251952|156408922|FG000|Overall Study|Adverse Event|1|||
48604385|NCT03110354|156408923|FG000|Overall Study|Death|1|||
48604386|NCT03110354|156408924|FG001|Overall Study|Death|0|||
48604387|NCT03110354|156408925|FG002|Overall Study|Death|0|||
48604388|NCT03110354|156408926|FG003|Overall Study|Death|1|||
48604389|NCT03110354|156408927|FG004|Overall Study|Death|0|||
48604390|NCT03110354|156408923|FG000|Overall Study|Start of new therapy|0|||
48604391|NCT03110354|156408924|FG001|Overall Study|Start of new therapy|0|||
48604392|NCT03110354|156408925|FG002|Overall Study|Start of new therapy|0|||
48604393|NCT03110354|156408926|FG003|Overall Study|Start of new therapy|0|||
48604394|NCT03110354|156408927|FG004|Overall Study|Start of new therapy|1|||
48604395|NCT03110354|156408923|FG000|Overall Study|Failure to achieve response|2|||
48604396|NCT03110354|156408924|FG001|Overall Study|Failure to achieve response|3|||
48604397|NCT03110354|156408925|FG002|Overall Study|Failure to achieve response|0|||
48604398|NCT03110354|156408926|FG003|Overall Study|Failure to achieve response|2|||
48604399|NCT03110354|156408927|FG004|Overall Study|Failure to achieve response|1|||
48604400|NCT03110354|156408923|FG000|Overall Study|Progressive disease|1|||
48604401|NCT03110354|156408924|FG001|Overall Study|Progressive disease|1|||
48604402|NCT03110354|156408925|FG002|Overall Study|Progressive disease|3|||
48836041|NCT02001623|157242726|FG003|Overall Study|Adverse Event|0|||
48836042|NCT02001623|157242727|FG004|Overall Study|Adverse Event|0|||
48836043|NCT02001623|157242728|FG005|Overall Study|Adverse Event|1|||
48836044|NCT02001623|157242729|FG006|Overall Study|Adverse Event|0|||
48836045|NCT02001623|157242730|FG007|Overall Study|Adverse Event|3|||
48445212|NCT01125293|155817075|FG005|Overall Study|Death|0|||
48445213|NCT01125293|155817070|FG000|Overall Study|Withdrawal by Subject|0|||
48445214|NCT01125293|155817071|FG001|Overall Study|Withdrawal by Subject|0|||
48445215|NCT01125293|155817072|FG002|Overall Study|Withdrawal by Subject|0|||
48445216|NCT01125293|155817073|FG003|Overall Study|Withdrawal by Subject|0|||
48445217|NCT01125293|155817074|FG004|Overall Study|Withdrawal by Subject|2|||
48445218|NCT01125293|155817075|FG005|Overall Study|Withdrawal by Subject|1|||
48445219|NCT01125293|155817070|FG000|Overall Study|Physician Decision|0|||
48445220|NCT01125293|155817071|FG001|Overall Study|Physician Decision|0|||
48445221|NCT01125293|155817072|FG002|Overall Study|Physician Decision|0|||
48445222|NCT01125293|155817073|FG003|Overall Study|Physician Decision|0|||
48445223|NCT01125293|155817074|FG004|Overall Study|Physician Decision|0|||
48445224|NCT01125293|155817075|FG005|Overall Study|Physician Decision|2|||
48445225|NCT00014911|155817076|FG000|Overall Study|Adverse Event|1|||
48445226|NCT00014911|155817076|FG000|Overall Study|Lost to Follow-up|1|||
48445227|NCT00014911|155817076|FG000|Overall Study|Withdrawal by Subject|6|||
48445228|NCT00014911|155817076|FG000|Overall Study|Unknown Reasons|2|||
48445229|NCT00014911|155817076|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
48445230|NCT00719862|155817078|FG000|Overall Study|Adverse Event|1|||
48445231|NCT00719862|155817079|FG001|Overall Study|Adverse Event|2|||
48445232|NCT00719862|155817078|FG000|Overall Study|Lack of Efficacy|3|||
48445233|NCT00719862|155817079|FG001|Overall Study|Lack of Efficacy|0|||
48445234|NCT00719862|155817078|FG000|Overall Study|Non-Compliance|1|||
48445235|NCT00719862|155817079|FG001|Overall Study|Non-Compliance|0|||
48836046|NCT02001623|157242731|FG008|Overall Study|Adverse Event|4|||
48836047|NCT02001623|157242732|FG009|Overall Study|Adverse Event|6|||
48836048|NCT02001623|157242733|FG010|Overall Study|Adverse Event|4|||
48836049|NCT02001623|157242734|FG011|Overall Study|Adverse Event|0|||
48836050|NCT02001623|157242735|FG012|Overall Study|Adverse Event|3|||
48836051|NCT02001623|157242736|FG013|Overall Study|Adverse Event|5|||
48836052|NCT02001623|157242737|FG014|Overall Study|Adverse Event|6|||
48836053|NCT02001623|157242723|FG000|Overall Study|Other - Miscellaneous|0|||
48836054|NCT02001623|157242724|FG001|Overall Study|Other - Miscellaneous|0|||
48836055|NCT02001623|157242725|FG002|Overall Study|Other - Miscellaneous|0|||
48836056|NCT02001623|157242726|FG003|Overall Study|Other - Miscellaneous|0|||
48836057|NCT02001623|157242727|FG004|Overall Study|Other - Miscellaneous|0|||
48836058|NCT02001623|157242728|FG005|Overall Study|Other - Miscellaneous|0|||
48836059|NCT02001623|157242729|FG006|Overall Study|Other - Miscellaneous|0|||
48836060|NCT02001623|157242730|FG007|Overall Study|Other - Miscellaneous|0|||
48836061|NCT02001623|157242731|FG008|Overall Study|Other - Miscellaneous|0|||
48836062|NCT02001623|157242732|FG009|Overall Study|Other - Miscellaneous|1|||
48836063|NCT02001623|157242733|FG010|Overall Study|Other - Miscellaneous|0|||
48836064|NCT02001623|157242734|FG011|Overall Study|Other - Miscellaneous|0|||
48836065|NCT02001623|157242735|FG012|Overall Study|Other - Miscellaneous|0|||
48836066|NCT02001623|157242736|FG013|Overall Study|Other - Miscellaneous|1|||
48836067|NCT02001623|157242737|FG014|Overall Study|Other - Miscellaneous|0|||
48534594|NCT05020249|156144865|FG000|Overall Study|Protocol Violation|1|||
48534595|NCT05020249|156144866|FG001|Overall Study|Protocol Violation|0|||
48534596|NCT00614926|156144867|FG000|Overall Study|Burden of travel|1|||
48534597|NCT00614926|156144868|FG001|Overall Study|Burden of travel|0|||
48534598|NCT00614926|156144867|FG000|Overall Study|Adverse Event|3|||
48534599|NCT00614926|156144868|FG001|Overall Study|Adverse Event|0|||
48534600|NCT01207440|156144875|FG000|Overall Study|Adverse Event|46|||
48534601|NCT01207440|156144876|FG001|Overall Study|Adverse Event|11|||
48534602|NCT01207440|156144877|FG002|Overall Study|Adverse Event|7|||
48534603|NCT01207440|156144878|FG003|Overall Study|Adverse Event|2|||
48534604|NCT01207440|156144879|FG004|Overall Study|Adverse Event|6|||
48534605|NCT01207440|156144880|FG005|Overall Study|Adverse Event|6|||
48534606|NCT01207440|156144881|FG006|Overall Study|Adverse Event|2|||
48534607|NCT01207440|156144875|FG000|Overall Study|Death|6|||
48534608|NCT01207440|156144876|FG001|Overall Study|Death|3|||
48534609|NCT01207440|156144877|FG002|Overall Study|Death|2|||
48534610|NCT01207440|156144878|FG003|Overall Study|Death|2|||
48534611|NCT01207440|156144879|FG004|Overall Study|Death|7|||
48534612|NCT01207440|156144880|FG005|Overall Study|Death|5|||
48534613|NCT01207440|156144881|FG006|Overall Study|Death|1|||
48534614|NCT01207440|156144875|FG000|Overall Study|Lack of Efficacy|13|||
48534615|NCT01207440|156144876|FG001|Overall Study|Lack of Efficacy|2|||
48534616|NCT01207440|156144877|FG002|Overall Study|Lack of Efficacy|5|||
48534617|NCT01207440|156144878|FG003|Overall Study|Lack of Efficacy|1|||
48534618|NCT01207440|156144879|FG004|Overall Study|Lack of Efficacy|2|||
48534619|NCT01207440|156144880|FG005|Overall Study|Lack of Efficacy|3|||
48534620|NCT01207440|156144881|FG006|Overall Study|Lack of Efficacy|0|||
48534621|NCT01207440|156144875|FG000|Overall Study|Lost to Follow-up|0|||
48534622|NCT01207440|156144876|FG001|Overall Study|Lost to Follow-up|0|||
48534623|NCT01207440|156144877|FG002|Overall Study|Lost to Follow-up|2|||
48534624|NCT01207440|156144878|FG003|Overall Study|Lost to Follow-up|1|||
48534625|NCT01207440|156144879|FG004|Overall Study|Lost to Follow-up|0|||
48534626|NCT01207440|156144880|FG005|Overall Study|Lost to Follow-up|0|||
48534627|NCT01207440|156144881|FG006|Overall Study|Lost to Follow-up|0|||
48534628|NCT01207440|156144875|FG000|Overall Study|Non-compliance with Study Drug|3|||
48534629|NCT01207440|156144876|FG001|Overall Study|Non-compliance with Study Drug|0|||
48534630|NCT01207440|156144877|FG002|Overall Study|Non-compliance with Study Drug|1|||
48534631|NCT01207440|156144878|FG003|Overall Study|Non-compliance with Study Drug|0|||
48534632|NCT01207440|156144879|FG004|Overall Study|Non-compliance with Study Drug|0|||
48534633|NCT01207440|156144880|FG005|Overall Study|Non-compliance with Study Drug|0|||
48534634|NCT01207440|156144881|FG006|Overall Study|Non-compliance with Study Drug|0|||
48534635|NCT01207440|156144875|FG000|Overall Study|Physician Decision|6|||
48534636|NCT01207440|156144876|FG001|Overall Study|Physician Decision|5|||
48534637|NCT01207440|156144877|FG002|Overall Study|Physician Decision|5|||
48534638|NCT01207440|156144878|FG003|Overall Study|Physician Decision|0|||
48534639|NCT01207440|156144879|FG004|Overall Study|Physician Decision|1|||
48534640|NCT01207440|156144880|FG005|Overall Study|Physician Decision|0|||
48534641|NCT01207440|156144881|FG006|Overall Study|Physician Decision|0|||
48534642|NCT01207440|156144875|FG000|Overall Study|Progressive Disease|19|||
48534643|NCT01207440|156144876|FG001|Overall Study|Progressive Disease|10|||
48836068|NCT02001623|157242723|FG000|Overall Study|Withdrawal by Subject|1|||
48836069|NCT02001623|157242724|FG001|Overall Study|Withdrawal by Subject|0|||
48836070|NCT02001623|157242725|FG002|Overall Study|Withdrawal by Subject|0|||
48534644|NCT01207440|156144877|FG002|Overall Study|Progressive Disease|19|||
48534645|NCT01207440|156144878|FG003|Overall Study|Progressive Disease|7|||
48534646|NCT01207440|156144879|FG004|Overall Study|Progressive Disease|23|||
48534647|NCT01207440|156144880|FG005|Overall Study|Progressive Disease|27|||
48836071|NCT02001623|157242726|FG003|Overall Study|Withdrawal by Subject|0|||
48836072|NCT02001623|157242727|FG004|Overall Study|Withdrawal by Subject|0|||
48836073|NCT02001623|157242728|FG005|Overall Study|Withdrawal by Subject|0|||
48836074|NCT02001623|157242729|FG006|Overall Study|Withdrawal by Subject|0|||
48836075|NCT02001623|157242730|FG007|Overall Study|Withdrawal by Subject|0|||
48836076|NCT02001623|157242731|FG008|Overall Study|Withdrawal by Subject|1|||
48836077|NCT02001623|157242732|FG009|Overall Study|Withdrawal by Subject|3|||
48836078|NCT02001623|157242733|FG010|Overall Study|Withdrawal by Subject|2|||
48836079|NCT02001623|157242734|FG011|Overall Study|Withdrawal by Subject|2|||
48836080|NCT02001623|157242735|FG012|Overall Study|Withdrawal by Subject|1|||
48836081|NCT02001623|157242736|FG013|Overall Study|Withdrawal by Subject|5|||
48836082|NCT02001623|157242737|FG014|Overall Study|Withdrawal by Subject|2|||
48836083|NCT02001623|157242723|FG000|Overall Study|Lost to Follow-up|0|||
48836084|NCT02001623|157242724|FG001|Overall Study|Lost to Follow-up|0|||
48836085|NCT02001623|157242725|FG002|Overall Study|Lost to Follow-up|0|||
48836086|NCT02001623|157242726|FG003|Overall Study|Lost to Follow-up|0|||
48604403|NCT03110354|156408926|FG003|Overall Study|Progressive disease|4|||
48604404|NCT03110354|156408927|FG004|Overall Study|Progressive disease|2|||
48604405|NCT03110354|156408923|FG000|Overall Study|Adverse Event|0|||
48604406|NCT03110354|156408924|FG001|Overall Study|Adverse Event|0|||
48604407|NCT03110354|156408925|FG002|Overall Study|Adverse Event|0|||
48604408|NCT03110354|156408926|FG003|Overall Study|Adverse Event|2|||
48604409|NCT03110354|156408927|FG004|Overall Study|Adverse Event|2|||
48604410|NCT03110354|156408923|FG000|Overall Study|Other|0|||
48604411|NCT03110354|156408924|FG001|Overall Study|Other|0|||
48604412|NCT03110354|156408925|FG002|Overall Study|Other|0|||
48604413|NCT03110354|156408926|FG003|Overall Study|Other|1|||
48604414|NCT03110354|156408927|FG004|Overall Study|Other|1|||
48604415|NCT02456727|156408945|FG000|Overall Study|Lost to Follow-up|63|||
48604416|NCT02456727|156408946|FG001|Overall Study|Lost to Follow-up|65|||
48604417|NCT02456727|156408945|FG000|Overall Study|Death|2|||
48604418|NCT02456727|156408946|FG001|Overall Study|Death|1|||
48836087|NCT02001623|157242727|FG004|Overall Study|Lost to Follow-up|0|||
48836088|NCT02001623|157242728|FG005|Overall Study|Lost to Follow-up|0|||
48836089|NCT02001623|157242729|FG006|Overall Study|Lost to Follow-up|0|||
48836090|NCT02001623|157242730|FG007|Overall Study|Lost to Follow-up|0|||
48836091|NCT02001623|157242731|FG008|Overall Study|Lost to Follow-up|0|||
48836092|NCT02001623|157242732|FG009|Overall Study|Lost to Follow-up|1|||
48836093|NCT02001623|157242733|FG010|Overall Study|Lost to Follow-up|0|||
48836094|NCT02001623|157242734|FG011|Overall Study|Lost to Follow-up|0|||
48836095|NCT02001623|157242735|FG012|Overall Study|Lost to Follow-up|0|||
48836096|NCT02001623|157242736|FG013|Overall Study|Lost to Follow-up|0|||
48836097|NCT02001623|157242737|FG014|Overall Study|Lost to Follow-up|0|||
48836098|NCT02001623|157242723|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
48836099|NCT02001623|157242724|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
48836100|NCT02001623|157242725|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
48836101|NCT02001623|157242726|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
48836102|NCT02001623|157242727|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
48836103|NCT02001623|157242728|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
48836104|NCT02001623|157242729|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
48836105|NCT02001623|157242730|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
48604419|NCT02456727|156408945|FG000|Overall Study|Withdrawal by Subject|1|||
48836106|NCT02001623|157242731|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
48836107|NCT02001623|157242732|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
48836108|NCT02001623|157242733|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
48836109|NCT02001623|157242734|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
48836110|NCT02001623|157242735|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
48836111|NCT02001623|157242736|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
48836112|NCT02001623|157242737|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
48836113|NCT02001623|157242723|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
48836114|NCT02001623|157242724|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
48836115|NCT02001623|157242725|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
48836116|NCT02001623|157242726|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
48836117|NCT02001623|157242727|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
48836118|NCT02001623|157242728|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
48836119|NCT02001623|157242729|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
48836120|NCT02001623|157242730|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
48836121|NCT02001623|157242731|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
48604420|NCT02456727|156408946|FG001|Overall Study|Withdrawal by Subject|10|||
48604421|NCT02456727|156408945|FG000|Overall Study|Never Initiated Treatment|43|||
48604422|NCT02456727|156408946|FG001|Overall Study|Never Initiated Treatment|30|||
48604423|NCT02446691|156408947|FG000|Overall Study|Withdrawal by Subject|2|||
48604424|NCT02446691|156408947|FG000|Overall Study|Lost to Follow-up|8|||
48604425|NCT02446691|156408947|FG000|Overall Study|Protocol Violation|1|||
48836122|NCT02001623|157242732|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
48604426|NCT00243919|156408948|FG000|Overall Study|Death|3|||
48604427|NCT00243919|156408949|FG001|Overall Study|Death|4|||
48836123|NCT02001623|157242733|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
48836124|NCT02001623|157242734|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
48836125|NCT02001623|157242735|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
48836126|NCT02001623|157242736|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
48836127|NCT02001623|157242737|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
48836128|NCT01070888|157242738|FG000|First Intervention (14 Days)|Adverse Event|0|||
48836129|NCT01070888|157242739|FG001|First Intervention (14 Days)|Adverse Event|1|||
48836130|NCT01070888|157242738|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
48836131|NCT01070888|157242739|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
48836132|NCT01070888|157242738|FG000|Washout (14 Days)|Physician Decision|1|||
48836133|NCT01070888|157242739|FG001|Washout (14 Days)|Physician Decision|0|||
48836134|NCT00364286|157242740|FG000|Overall Study|Withdrawal by Subject|1|||
48836135|NCT00364286|157242740|FG000|Overall Study|Adverse Event|2|||
48836136|NCT00628862|157242741|FG000|Overall Study|Adverse Event|6|||
48836137|NCT00628862|157242742|FG001|Overall Study|Adverse Event|8|||
48836138|NCT00628862|157242743|FG002|Overall Study|Adverse Event|10|||
48836139|NCT00628862|157242741|FG000|Overall Study|Withdrawal by Subject|4|||
48836140|NCT00628862|157242742|FG001|Overall Study|Withdrawal by Subject|6|||
48836141|NCT00628862|157242743|FG002|Overall Study|Withdrawal by Subject|11|||
48836142|NCT00628862|157242741|FG000|Overall Study|Lost to Follow-up|0|||
48836143|NCT00628862|157242742|FG001|Overall Study|Lost to Follow-up|2|||
48836144|NCT00628862|157242743|FG002|Overall Study|Lost to Follow-up|1|||
48836145|NCT00628862|157242741|FG000|Overall Study|Protocol Violation|1|||
48836146|NCT00628862|157242742|FG001|Overall Study|Protocol Violation|0|||
48836147|NCT00628862|157242743|FG002|Overall Study|Protocol Violation|0|||
48836148|NCT00628862|157242741|FG000|Overall Study|COPD Exacerbation|0|||
48836149|NCT00628862|157242742|FG001|Overall Study|COPD Exacerbation|1|||
48836150|NCT00628862|157242743|FG002|Overall Study|COPD Exacerbation|0|||
48836151|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Adverse Event|1|||
48836152|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
48836153|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
48836154|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
48836155|NCT01063036|157242744|FG000|Participants Treated With Study Drug|Pregnancy|1|||
48836156|NCT01063036|157242744|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
48836157|NCT01063036|157242744|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
48836158|NCT01063036|157242744|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
48836159|NCT02715258|157242745|FG000|Overall Study|Withdrawal by Subject|6|||
48836160|NCT02715258|157242746|FG001|Overall Study|Withdrawal by Subject|1|||
48836161|NCT02715258|157242745|FG000|Overall Study|Lost to Follow-up|7|||
48836162|NCT02715258|157242746|FG001|Overall Study|Lost to Follow-up|1|||
48836163|NCT02715258|157242745|FG000|Overall Study|Terminated by Sponsor|0|||
48836164|NCT02715258|157242746|FG001|Overall Study|Terminated by Sponsor|1|||
48836165|NCT02715258|157242745|FG000|Overall Study|Death|0|||
48836166|NCT02715258|157242746|FG001|Overall Study|Death|1|||
48836167|NCT02715258|157242745|FG000|Overall Study|Subject non-compliant|1|||
48836168|NCT02715258|157242746|FG001|Overall Study|Subject non-compliant|1|||
48836169|NCT02715258|157242745|FG000|Overall Study|GCP violation|2|||
48836170|NCT02715258|157242746|FG001|Overall Study|GCP violation|1|||
48836171|NCT00178399|157242747|FG000|Overall Study|Physician Decision|4|||
48836172|NCT00178399|157242747|FG000|Overall Study|Withdrawal by Subject|8|||
48836173|NCT00178399|157242747|FG000|Overall Study|Lost to Follow-up|1|||
48836174|NCT02814643|157242748|FG000|Overall Study|Lost to Follow-up|0|||
48836175|NCT02814643|157242749|FG001|Overall Study|Lost to Follow-up|1|||
48836176|NCT02814643|157242748|FG000|Overall Study|Withdrawal by Subject|1|||
48836177|NCT02814643|157242749|FG001|Overall Study|Withdrawal by Subject|2|||
48836178|NCT02631148|157242752|FG000|Overall Study|8 were ineligible|8|||
48836179|NCT02631148|157242753|FG001|Overall Study|8 were ineligible|0|||
48836180|NCT02631148|157242752|FG000|Overall Study|Withdrawal by Subject|1|||
48836181|NCT02631148|157242753|FG001|Overall Study|Withdrawal by Subject|0|||
48836182|NCT02631148|157242752|FG000|Overall Study|PAH not available to study participant|1|||
48836183|NCT02631148|157242753|FG001|Overall Study|PAH not available to study participant|0|||
48836184|NCT01134562|157242754|FG000|Overall Study|Adverse Event|0|||
48836185|NCT01134562|157242755|FG001|Overall Study|Adverse Event|1|||
48836186|NCT01134562|157242756|FG002|Overall Study|Adverse Event|0|||
48836187|NCT01134562|157242757|FG003|Overall Study|Adverse Event|0|||
48836188|NCT01134562|157242758|FG004|Overall Study|Adverse Event|0|||
48836189|NCT01400776|157242759|FG000|Overall Study|Adverse Event|7|||
48836190|NCT01400776|157242760|FG001|Overall Study|Adverse Event|2|||
48836191|NCT01400776|157242761|FG002|Overall Study|Adverse Event|9|||
48604428|NCT00243919|156408950|FG002|Overall Study|Death|6|||
48836192|NCT01400776|157242762|FG003|Overall Study|Adverse Event|2|||
48836193|NCT01400776|157242759|FG000|Overall Study|Lost to Follow-up|1|||
48836194|NCT01400776|157242760|FG001|Overall Study|Lost to Follow-up|0|||
48836195|NCT01400776|157242761|FG002|Overall Study|Lost to Follow-up|4|||
48836196|NCT01400776|157242762|FG003|Overall Study|Lost to Follow-up|1|||
48836197|NCT01400776|157242759|FG000|Overall Study|Withdrew Consent|4|||
48534648|NCT01207440|156144881|FG006|Overall Study|Progressive Disease|0|||
48534649|NCT01207440|156144875|FG000|Overall Study|Protocol Violation|2|||
48534650|NCT01207440|156144876|FG001|Overall Study|Protocol Violation|0|||
48534651|NCT01207440|156144877|FG002|Overall Study|Protocol Violation|0|||
48534652|NCT01207440|156144878|FG003|Overall Study|Protocol Violation|0|||
48836198|NCT01400776|157242760|FG001|Overall Study|Withdrew Consent|2|||
48836199|NCT01400776|157242761|FG002|Overall Study|Withdrew Consent|6|||
48836200|NCT01400776|157242762|FG003|Overall Study|Withdrew Consent|1|||
48836201|NCT01400776|157242759|FG000|Overall Study|Protocol Deviation|6|||
48836202|NCT01400776|157242760|FG001|Overall Study|Protocol Deviation|1|||
48836203|NCT01400776|157242761|FG002|Overall Study|Protocol Deviation|5|||
48836204|NCT01400776|157242762|FG003|Overall Study|Protocol Deviation|2|||
48836205|NCT01400776|157242759|FG000|Overall Study|Reason not Specified|3|||
48836206|NCT01400776|157242760|FG001|Overall Study|Reason not Specified|0|||
48836207|NCT01400776|157242761|FG002|Overall Study|Reason not Specified|4|||
48836208|NCT01400776|157242762|FG003|Overall Study|Reason not Specified|3|||
48836209|NCT02320123|157242763|FG000|Overall Study|Lost to Follow-up|4|||
48836210|NCT02320123|157242764|FG001|Overall Study|Lost to Follow-up|6|||
48836211|NCT02320123|157242763|FG000|Overall Study|Death|6|||
48836212|NCT02320123|157242764|FG001|Overall Study|Death|5|||
48836213|NCT02477670|157242768|FG000|Stage 1|Adverse Event|2|||
48836214|NCT02477670|157242769|FG001|Stage 1|Adverse Event|7|||
48836215|NCT02477670|157242770|FG002|Stage 1|Adverse Event|0|||
48836216|NCT02477670|157242771|FG003|Stage 1|Adverse Event|0|||
48836217|NCT02477670|157242772|FG004|Stage 1|Adverse Event|0|||
48836218|NCT02477670|157242773|FG005|Stage 1|Adverse Event|0|||
48836219|NCT02477670|157242774|FG006|Stage 1|Adverse Event|0|||
48836220|NCT02477670|157242768|FG000|Stage 1|Lost to Follow-up|0|||
48836221|NCT02477670|157242769|FG001|Stage 1|Lost to Follow-up|2|||
48836222|NCT02477670|157242770|FG002|Stage 1|Lost to Follow-up|0|||
48836223|NCT02477670|157242771|FG003|Stage 1|Lost to Follow-up|0|||
48836224|NCT02477670|157242772|FG004|Stage 1|Lost to Follow-up|0|||
48836225|NCT02477670|157242773|FG005|Stage 1|Lost to Follow-up|0|||
48836226|NCT02477670|157242774|FG006|Stage 1|Lost to Follow-up|0|||
48836227|NCT02477670|157242768|FG000|Stage 1|Withdrawal by Subject|1|||
48836228|NCT02477670|157242769|FG001|Stage 1|Withdrawal by Subject|2|||
48836229|NCT02477670|157242770|FG002|Stage 1|Withdrawal by Subject|0|||
48836230|NCT02477670|157242771|FG003|Stage 1|Withdrawal by Subject|0|||
48836231|NCT02477670|157242772|FG004|Stage 1|Withdrawal by Subject|0|||
48836232|NCT02477670|157242773|FG005|Stage 1|Withdrawal by Subject|0|||
48836233|NCT02477670|157242774|FG006|Stage 1|Withdrawal by Subject|0|||
48836234|NCT02477670|157242768|FG000|Stage 1|Non-compliance with Study Drug|1|||
48836235|NCT02477670|157242769|FG001|Stage 1|Non-compliance with Study Drug|2|||
48836236|NCT02477670|157242770|FG002|Stage 1|Non-compliance with Study Drug|0|||
48836237|NCT02477670|157242771|FG003|Stage 1|Non-compliance with Study Drug|0|||
48836238|NCT02477670|157242772|FG004|Stage 1|Non-compliance with Study Drug|0|||
48836239|NCT02477670|157242773|FG005|Stage 1|Non-compliance with Study Drug|0|||
48836240|NCT02477670|157242774|FG006|Stage 1|Non-compliance with Study Drug|0|||
48836241|NCT02477670|157242768|FG000|Stage 2|Adverse Event|0|||
48836242|NCT02477670|157242769|FG001|Stage 2|Adverse Event|0|||
48836243|NCT02477670|157242770|FG002|Stage 2|Adverse Event|1|||
48836244|NCT02477670|157242771|FG003|Stage 2|Adverse Event|0|||
48836245|NCT02477670|157242772|FG004|Stage 2|Adverse Event|0|||
48836246|NCT02477670|157242773|FG005|Stage 2|Adverse Event|0|||
48836247|NCT02477670|157242774|FG006|Stage 2|Adverse Event|0|||
48836248|NCT02477670|157242768|FG000|Stage 2|Antipsychotic Medication Changed|0|||
48534653|NCT01207440|156144879|FG004|Overall Study|Protocol Violation|0|||
48836249|NCT02477670|157242769|FG001|Stage 2|Antipsychotic Medication Changed|0|||
48836250|NCT02477670|157242770|FG002|Stage 2|Antipsychotic Medication Changed|1|||
48836251|NCT02477670|157242771|FG003|Stage 2|Antipsychotic Medication Changed|0|||
48836252|NCT02477670|157242772|FG004|Stage 2|Antipsychotic Medication Changed|0|||
48836253|NCT02477670|157242773|FG005|Stage 2|Antipsychotic Medication Changed|0|||
48836254|NCT02477670|157242774|FG006|Stage 2|Antipsychotic Medication Changed|0|||
48836255|NCT02477670|157242768|FG000|Stage 2|Withdrawal by Subject|0|||
48836256|NCT02477670|157242769|FG001|Stage 2|Withdrawal by Subject|0|||
48836257|NCT02477670|157242770|FG002|Stage 2|Withdrawal by Subject|0|||
48836258|NCT02477670|157242771|FG003|Stage 2|Withdrawal by Subject|1|||
48534654|NCT01207440|156144880|FG005|Overall Study|Protocol Violation|0|||
48836259|NCT02477670|157242772|FG004|Stage 2|Withdrawal by Subject|0|||
48836260|NCT02477670|157242773|FG005|Stage 2|Withdrawal by Subject|0|||
48836261|NCT02477670|157242774|FG006|Stage 2|Withdrawal by Subject|0|||
48836262|NCT00004124|157242775|FG000|Overall Study|Received no protocol therapy|12|||
48836263|NCT00004124|157242776|FG001|Overall Study|Received no protocol therapy|20|||
48836264|NCT02139046|157242780|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48534655|NCT01207440|156144881|FG006|Overall Study|Protocol Violation|0|||
48836265|NCT02139046|157242781|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
48604429|NCT00243919|156408948|FG000|Overall Study|Withdrawal by Subject|6|||
48836266|NCT02139046|157242782|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
48836267|NCT02139046|157242783|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
48836268|NCT02139046|157242784|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
48836269|NCT02139046|157242780|FG000|Overall Study|Major Protocol Deviation|9|||
48836270|NCT02139046|157242781|FG001|Overall Study|Major Protocol Deviation|10|||
48836271|NCT02139046|157242782|FG002|Overall Study|Major Protocol Deviation|16|||
48836272|NCT02139046|157242783|FG003|Overall Study|Major Protocol Deviation|12|||
48836273|NCT02139046|157242784|FG004|Overall Study|Major Protocol Deviation|6|||
48836274|NCT02139046|157242780|FG000|Overall Study|Lost to Follow-up|13|||
48836275|NCT02139046|157242781|FG001|Overall Study|Lost to Follow-up|16|||
48836276|NCT02139046|157242782|FG002|Overall Study|Lost to Follow-up|16|||
48836277|NCT02139046|157242783|FG003|Overall Study|Lost to Follow-up|18|||
48836278|NCT02139046|157242784|FG004|Overall Study|Lost to Follow-up|13|||
48836279|NCT02139046|157242780|FG000|Overall Study|Voluntary Withdrawal|20|||
48836280|NCT02139046|157242781|FG001|Overall Study|Voluntary Withdrawal|8|||
48534656|NCT01207440|156144875|FG000|Overall Study|Site Terminated by Sponsor|69|||
48534657|NCT01207440|156144876|FG001|Overall Study|Site Terminated by Sponsor|19|||
48534658|NCT01207440|156144877|FG002|Overall Study|Site Terminated by Sponsor|12|||
48534659|NCT01207440|156144878|FG003|Overall Study|Site Terminated by Sponsor|2|||
48534660|NCT01207440|156144879|FG004|Overall Study|Site Terminated by Sponsor|3|||
48534661|NCT01207440|156144880|FG005|Overall Study|Site Terminated by Sponsor|0|||
48534662|NCT01207440|156144881|FG006|Overall Study|Site Terminated by Sponsor|2|||
48534663|NCT01207440|156144875|FG000|Overall Study|Withdrawal by Subject|29|||
48534664|NCT01207440|156144876|FG001|Overall Study|Withdrawal by Subject|4|||
48604430|NCT00243919|156408949|FG001|Overall Study|Withdrawal by Subject|6|||
48836281|NCT02139046|157242782|FG002|Overall Study|Voluntary Withdrawal|10|||
48836282|NCT02139046|157242783|FG003|Overall Study|Voluntary Withdrawal|15|||
48836283|NCT02139046|157242784|FG004|Overall Study|Voluntary Withdrawal|16|||
48836284|NCT02139046|157242780|FG000|Overall Study|Lack of Efficacy|0|||
48836285|NCT02139046|157242781|FG001|Overall Study|Lack of Efficacy|1|||
48836286|NCT02139046|157242782|FG002|Overall Study|Lack of Efficacy|2|||
48836287|NCT02139046|157242783|FG003|Overall Study|Lack of Efficacy|1|||
48836288|NCT02139046|157242784|FG004|Overall Study|Lack of Efficacy|2|||
48836289|NCT02139046|157242780|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
48836290|NCT02139046|157242781|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
48836291|NCT02139046|157242782|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
48836292|NCT02139046|157242783|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
48836293|NCT02139046|157242784|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
48836294|NCT02139046|157242780|FG000|Overall Study|Other Miscellaneous Reasons|10|||
48836295|NCT02139046|157242781|FG001|Overall Study|Other Miscellaneous Reasons|9|||
48836296|NCT02139046|157242782|FG002|Overall Study|Other Miscellaneous Reasons|4|||
48836297|NCT02139046|157242783|FG003|Overall Study|Other Miscellaneous Reasons|9|||
48836298|NCT02139046|157242784|FG004|Overall Study|Other Miscellaneous Reasons|12|||
48836299|NCT00244855|157242792|FG000|Overall Study|Withdrawal by Subject|0|||
48836300|NCT00244855|157242793|FG001|Overall Study|Withdrawal by Subject|1|||
48836301|NCT02441036|157242796|FG000|Overall Study|No tissue resected|0|||
48836302|NCT02441036|157242797|FG001|Overall Study|No tissue resected|1|||
48836303|NCT02441036|157242798|FG002|Overall Study|No tissue resected|0|||
48836304|NCT02441036|157242799|FG003|Overall Study|No tissue resected|1|||
48836305|NCT02441036|157242800|FG004|Overall Study|No tissue resected|0|||
48836306|NCT01254019|157242801|FG000|Overall Study|Adverse Event|0|||
48836307|NCT01254019|157242802|FG001|Overall Study|Adverse Event|2|||
48836308|NCT01254019|157242801|FG000|Overall Study|Protocol Violation|1|||
48836309|NCT01254019|157242802|FG001|Overall Study|Protocol Violation|0|||
48836310|NCT01254019|157242801|FG000|Overall Study|Withdrawal by Subject|0|||
48836311|NCT01254019|157242802|FG001|Overall Study|Withdrawal by Subject|2|||
48836312|NCT03061474|157242803|FG000|Overall Study|Adverse Event|2|||
48836313|NCT03061474|157242804|FG001|Overall Study|Adverse Event|0|||
48836314|NCT03061474|157242803|FG000|Overall Study|Safety Risk|0|||
48836315|NCT03061474|157242804|FG001|Overall Study|Safety Risk|1|||
48836316|NCT03061474|157242803|FG000|Overall Study|Participant unwilling or unable to participate|0|||
48836317|NCT03061474|157242804|FG001|Overall Study|Participant unwilling or unable to participate|2|||
48836318|NCT03061474|157242803|FG000|Overall Study|Lost to Follow-up|0|||
48836319|NCT03061474|157242804|FG001|Overall Study|Lost to Follow-up|1|||
48836320|NCT01505881|157242805|FG000|Overall Study|Adverse Event|0|||
48836321|NCT01505881|157242806|FG001|Overall Study|Adverse Event|1|||
48836322|NCT01505881|157242805|FG000|Overall Study|Lost to Follow-up|2|||
48836323|NCT01505881|157242806|FG001|Overall Study|Lost to Follow-up|0|||
48836324|NCT01505881|157242805|FG000|Overall Study|Withdrawal by Subject|2|||
48836325|NCT01505881|157242806|FG001|Overall Study|Withdrawal by Subject|0|||
48836326|NCT00842257|157242807|FG000|Overall Study|Adverse Event|1|||
48836327|NCT01147341|157242808|FG000|Double Blind Period|Lack of Efficacy|1|||
48836328|NCT01147341|157242809|FG001|Double Blind Period|Lack of Efficacy|1|||
48836329|NCT01147341|157242808|FG000|Double Blind Period|Withdrawal by Subject|0|||
48836330|NCT01147341|157242809|FG001|Double Blind Period|Withdrawal by Subject|1|||
48836331|NCT01147341|157242808|FG000|Open Label Period|Lack of Efficacy|3|||
48836332|NCT01147341|157242809|FG001|Open Label Period|Lack of Efficacy|0|||
48836333|NCT01147341|157242808|FG000|Open Label Period|Subject moved|1|||
48836334|NCT01147341|157242809|FG001|Open Label Period|Subject moved|0|||
48836335|NCT03257813|157242810|FG000|Overall Study|Protocol Violation|6|||
48836336|NCT03257813|157242811|FG001|Overall Study|Protocol Violation|3|||
48836337|NCT00177216|157242812|FG000|Overall Study|Withdrawal by Subject|6|||
48836338|NCT00177216|157242813|FG001|Overall Study|Withdrawal by Subject|3|||
48836339|NCT00177216|157242814|FG002|Overall Study|Withdrawal by Subject|1|||
48836340|NCT03024606|157242817|FG000|Overall Study|Withdrawal by Subject|9|||
48836341|NCT03024606|157242818|FG001|Overall Study|Withdrawal by Subject|10|||
48836342|NCT01161498|157242825|FG000|Overall Study|Disease Progression|0|||
48836343|NCT01161498|157242826|FG001|Overall Study|Disease Progression|1|||
48836344|NCT00258895|157242830|FG000|Overall Study|Lost to Follow-up|3|||
48836345|NCT00258895|157242831|FG001|Overall Study|Lost to Follow-up|1|||
48836346|NCT00258895|157242830|FG000|Overall Study|Protocol Violation|6|||
48836347|NCT00258895|157242831|FG001|Overall Study|Protocol Violation|2|||
48836348|NCT00258895|157242830|FG000|Overall Study|Withdrawal by Subject|1|||
48836349|NCT00258895|157242831|FG001|Overall Study|Withdrawal by Subject|0|||
48836350|NCT05609032|157242832|FG000|Overall Study|Lost to Follow-up|3|||
48836351|NCT05609032|157242833|FG001|Overall Study|Lost to Follow-up|1|||
48836352|NCT05609032|157242832|FG000|Overall Study|Withdrawal by Subject|1|||
48836353|NCT05609032|157242833|FG001|Overall Study|Withdrawal by Subject|0|||
48836354|NCT02031471|157242836|FG000|24 Week Treatment Period|Adverse Event|6|||
48836355|NCT02031471|157242836|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
48836356|NCT02031471|157242836|FG000|24 Week Treatment Period|Protocol Violation|1|||
48836357|NCT02031471|157242836|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
48534665|NCT01207440|156144877|FG002|Overall Study|Withdrawal by Subject|5|||
48534666|NCT01207440|156144878|FG003|Overall Study|Withdrawal by Subject|3|||
48534667|NCT01207440|156144879|FG004|Overall Study|Withdrawal by Subject|2|||
48534668|NCT01207440|156144880|FG005|Overall Study|Withdrawal by Subject|2|||
48534669|NCT01207440|156144881|FG006|Overall Study|Withdrawal by Subject|0|||
48534670|NCT01207440|156144875|FG000|Overall Study|Reason Not Specified|10|||
48534671|NCT01207440|156144876|FG001|Overall Study|Reason Not Specified|10|||
48534672|NCT01207440|156144877|FG002|Overall Study|Reason Not Specified|7|||
48534673|NCT01207440|156144878|FG003|Overall Study|Reason Not Specified|0|||
48534674|NCT01207440|156144879|FG004|Overall Study|Reason Not Specified|4|||
48534675|NCT01207440|156144880|FG005|Overall Study|Reason Not Specified|3|||
48534676|NCT01207440|156144881|FG006|Overall Study|Reason Not Specified|0|||
48534677|NCT02698865|156144882|FG000|Overall Study|Other|11|||
48534678|NCT02698865|156144883|FG001|Overall Study|Other|11|||
48534679|NCT02698865|156144882|FG000|Overall Study|Withdrawal by Subject|20|||
48534680|NCT02698865|156144883|FG001|Overall Study|Withdrawal by Subject|16|||
48534681|NCT02698865|156144882|FG000|Overall Study|Physician Decision|0|||
48534682|NCT02698865|156144883|FG001|Overall Study|Physician Decision|4|||
48534683|NCT02698865|156144882|FG000|Overall Study|Lost to Follow-up|4|||
48534684|NCT02698865|156144883|FG001|Overall Study|Lost to Follow-up|2|||
48534685|NCT00418522|156144886|FG000|Overall Study|Adverse Event|7|||
48534686|NCT00418522|156144887|FG001|Overall Study|Adverse Event|1|||
48534687|NCT00418522|156144886|FG000|Overall Study|Lack of Efficacy|1|||
48534688|NCT00418522|156144887|FG001|Overall Study|Lack of Efficacy|3|||
48534689|NCT00418522|156144886|FG000|Overall Study|Lost to Follow-up|10|||
48534690|NCT00418522|156144887|FG001|Overall Study|Lost to Follow-up|4|||
48534691|NCT00418522|156144886|FG000|Overall Study|Withdrawal by Subject|31|||
48534692|NCT00418522|156144887|FG001|Overall Study|Withdrawal by Subject|7|||
48534693|NCT00418522|156144886|FG000|Overall Study|Other|27|||
48534694|NCT00418522|156144887|FG001|Overall Study|Other|23|||
48534695|NCT00418522|156144886|FG000|Overall Study|Randomized but did not receive treatment|7|||
48534696|NCT00418522|156144887|FG001|Overall Study|Randomized but did not receive treatment|4|||
48534697|NCT02695719|156144888|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
48534698|NCT02695719|156144889|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
48534699|NCT02695719|156144888|FG000|Overall Study|Significant Protocol Deviation|0|||
48534700|NCT02695719|156144889|FG001|Overall Study|Significant Protocol Deviation|1|||
48534701|NCT02695719|156144888|FG000|Overall Study|Voluntary Withdrawal|1|||
48604431|NCT00243919|156408950|FG002|Overall Study|Withdrawal by Subject|2|||
48604432|NCT00243919|156408948|FG000|Overall Study|Lost to Follow-up|6|||
48604433|NCT00243919|156408949|FG001|Overall Study|Lost to Follow-up|7|||
48604434|NCT00243919|156408950|FG002|Overall Study|Lost to Follow-up|3|||
48604435|NCT00243919|156408948|FG000|Overall Study|Administrative Error|1|||
48604436|NCT00243919|156408949|FG001|Overall Study|Administrative Error|0|||
48604437|NCT00243919|156408950|FG002|Overall Study|Administrative Error|0|||
48604438|NCT00243919|156408948|FG000|Overall Study|Physician Decision|1|||
48604439|NCT00243919|156408949|FG001|Overall Study|Physician Decision|1|||
48604440|NCT00243919|156408950|FG002|Overall Study|Physician Decision|0|||
48604441|NCT00192114|156408951|FG000|Overall Study|Objective Tumor Progression|19|||
48836358|NCT02031471|157242836|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
48836359|NCT02031471|157242836|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
48836360|NCT02031471|157242836|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
48836361|NCT00732381|157242837|FG000|Overall Study|Adverse Event|1|||
48836362|NCT00732381|157242838|FG001|Overall Study|Adverse Event|0|||
48836363|NCT00732381|157242837|FG000|Overall Study|Treatment Failure|1|||
48836364|NCT00732381|157242838|FG001|Overall Study|Treatment Failure|1|||
48836365|NCT01353963|157242841|FG000|Overall Study|Adverse Event|2|||
48836366|NCT00617201|157242842|FG000|Overall Study|Lost to Follow-up|9|||
48836367|NCT00617201|157242843|FG001|Overall Study|Lost to Follow-up|13|||
48836368|NCT02670525|157242849|FG000|Overall Study|Death|94|||
48836369|NCT02670525|157242850|FG001|Overall Study|Death|14|||
48836370|NCT02670525|157242849|FG000|Overall Study|Lost to Follow-up|4|||
48836371|NCT02670525|157242850|FG001|Overall Study|Lost to Follow-up|1|||
48836372|NCT02670525|157242849|FG000|Overall Study|Subject withdrew consent|1|||
48836373|NCT02670525|157242850|FG001|Overall Study|Subject withdrew consent|0|||
48836374|NCT02670525|157242849|FG000|Overall Study|Unknown, data entry delayed|123|||
48836375|NCT02670525|157242850|FG001|Overall Study|Unknown, data entry delayed|78|||
48836376|NCT03227757|157244041|FG000|Overall Study|Death|25|||
48836377|NCT03227757|157244041|FG000|Overall Study|Withdrawal|10|||
48836378|NCT03227757|157244041|FG000|Overall Study|Missed visits|1|||
48836379|NCT03227757|157244041|FG000|Overall Study|Lost to Follow-up|2|||
48836380|NCT02263508|157244043|FG000|Overall Study|Withdrawal by Subject|1|||
48534702|NCT02695719|156144889|FG001|Overall Study|Voluntary Withdrawal|0|||
48534703|NCT02148913|156144890|FG000|Overall Study|Death|0|||
48534704|NCT02148913|156144891|FG001|Overall Study|Death|1|||
48534705|NCT02148913|156144892|FG002|Overall Study|Death|0|||
48534706|NCT02148913|156144893|FG003|Overall Study|Death|0|||
48534707|NCT01005329|156144897|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
48534708|NCT01652729|156144898|FG000|Overall Study|Withdrawal by Subject|14|||
48836381|NCT02263508|157244044|FG001|Overall Study|Withdrawal by Subject|23|||
48836382|NCT02263508|157244045|FG002|Overall Study|Withdrawal by Subject|17|||
48836383|NCT02263508|157244043|FG000|Overall Study|Sponsor Decision|12|||
48836384|NCT02263508|157244044|FG001|Overall Study|Sponsor Decision|165|||
48836385|NCT02263508|157244045|FG002|Overall Study|Sponsor Decision|182|||
48836386|NCT02263508|157244043|FG000|Overall Study|Lost to Follow-up|2|||
48836387|NCT02263508|157244044|FG001|Overall Study|Lost to Follow-up|7|||
48836388|NCT02263508|157244045|FG002|Overall Study|Lost to Follow-up|7|||
48836389|NCT02263508|157244043|FG000|Overall Study|Death|6|||
48836390|NCT02263508|157244044|FG001|Overall Study|Death|151|||
48836391|NCT02263508|157244045|FG002|Overall Study|Death|140|||
48836392|NCT01259102|157244046|FG000|Overall Study|Adverse Event|1|||
48836393|NCT01259102|157244047|FG001|Overall Study|Adverse Event|0|||
48836394|NCT01259102|157244048|FG002|Overall Study|Adverse Event|1|||
48836395|NCT01259102|157244049|FG003|Overall Study|Adverse Event|1|||
48836396|NCT01259102|157244050|FG004|Overall Study|Adverse Event|0|||
48836397|NCT01259102|157244046|FG000|Overall Study|Other|0|||
48836398|NCT01259102|157244047|FG001|Overall Study|Other|0|||
48836399|NCT01259102|157244048|FG002|Overall Study|Other|1|||
48836400|NCT01259102|157244049|FG003|Overall Study|Other|1|||
48836401|NCT01259102|157244050|FG004|Overall Study|Other|1|||
48836402|NCT02488980|157244053|FG000|Overall Study|Protocol Violation|2|||
48836403|NCT02488980|157244054|FG001|Overall Study|Protocol Violation|2|||
48836404|NCT02488980|157244055|FG002|Overall Study|Protocol Violation|2|||
48836405|NCT03546907|157244056|FG000|Overall Study|Lack of Efficacy|1|||
48836406|NCT03546907|157244057|FG001|Overall Study|Lack of Efficacy|1|||
48836407|NCT03546907|157244056|FG000|Overall Study|Withdrawal by Subject|8|||
48836408|NCT03546907|157244057|FG001|Overall Study|Withdrawal by Subject|9|||
48836409|NCT03546907|157244056|FG000|Overall Study|Adverse events (AEs)|7|||
48836410|NCT03546907|157244057|FG001|Overall Study|Adverse events (AEs)|10|||
48836411|NCT03546907|157244056|FG000|Overall Study|Other-unspecified|1|||
48836412|NCT03546907|157244057|FG001|Overall Study|Other-unspecified|1|||
48836413|NCT02810080|157244058|FG000|Overall Study|Adverse Event|3|||
48836414|NCT02810080|157244059|FG001|Overall Study|Adverse Event|0|||
48836415|NCT02810080|157244058|FG000|Overall Study|Death|0|||
48836416|NCT02810080|157244059|FG001|Overall Study|Death|2|||
48836417|NCT02810080|157244058|FG000|Overall Study|Physician Decision|4|||
48836418|NCT02810080|157244059|FG001|Overall Study|Physician Decision|0|||
48836419|NCT02810080|157244058|FG000|Overall Study|Withdrawal by Subject|0|||
48836420|NCT02810080|157244059|FG001|Overall Study|Withdrawal by Subject|2|||
48836421|NCT02027558|157244066|FG000|Overall Study|Death|0|||
48836422|NCT02027558|157244067|FG001|Overall Study|Death|1|||
48836423|NCT02027558|157244066|FG000|Overall Study|Withdrawal by Subject|2|||
48836424|NCT02027558|157244067|FG001|Overall Study|Withdrawal by Subject|0|||
48836425|NCT02027558|157244066|FG000|Overall Study|Lost to Follow-up|4|||
48836426|NCT02027558|157244067|FG001|Overall Study|Lost to Follow-up|1|||
48836427|NCT02027558|157244066|FG000|Overall Study|Refused assessment|3|||
48836428|NCT02027558|157244067|FG001|Overall Study|Refused assessment|0|||
48836429|NCT00114244|157244072|FG000|Overall Study|Adverse Event|2|||
48836430|NCT00114244|157244073|FG001|Overall Study|Adverse Event|5|||
48836431|NCT00114244|157244072|FG000|Overall Study|Withdrawal by Subject|0|||
48836432|NCT00114244|157244073|FG001|Overall Study|Withdrawal by Subject|2|||
48836433|NCT02698891|157244074|FG000|Overall Study|Withdrawal by Subject|2|||
48836434|NCT02698891|157244074|FG000|Overall Study|deemed ineligible|1|||
48836435|NCT02698891|157244074|FG000|Overall Study|Adverse Event|9|||
48836436|NCT00711958|157244075|FG000|Overall Study|Withdrawal by Subject|6|||
48836437|NCT00711958|157244076|FG001|Overall Study|Withdrawal by Subject|8|||
48836438|NCT00711958|157244075|FG000|Overall Study|Lack of Efficacy|3|||
48836439|NCT00711958|157244076|FG001|Overall Study|Lack of Efficacy|1|||
48836440|NCT00711958|157244075|FG000|Overall Study|Clinical deterioration|1|||
48836441|NCT00711958|157244076|FG001|Overall Study|Clinical deterioration|0|||
48836442|NCT00711958|157244075|FG000|Overall Study|Adverse Event|9|||
48836443|NCT00711958|157244076|FG001|Overall Study|Adverse Event|7|||
48836444|NCT00711958|157244075|FG000|Overall Study|Protocol Violation|1|||
48836445|NCT00711958|157244076|FG001|Overall Study|Protocol Violation|0|||
48836446|NCT00711958|157244075|FG000|Overall Study|Lost to Follow-up|2|||
48836447|NCT00711958|157244076|FG001|Overall Study|Lost to Follow-up|2|||
48836448|NCT00711958|157244075|FG000|Overall Study|Death|10|||
48836449|NCT00711958|157244076|FG001|Overall Study|Death|5|||
48836450|NCT00711958|157244075|FG000|Overall Study|Progression of disease|1|||
48836451|NCT00711958|157244076|FG001|Overall Study|Progression of disease|0|||
48836452|NCT00738699|157244077|FG000|Overall Study|Withdrawal by Subject|5|||
48836453|NCT00738699|157244078|FG001|Overall Study|Withdrawal by Subject|0|||
48836454|NCT00738699|157244077|FG000|Overall Study|Lost to Follow-up|1|||
48836455|NCT00738699|157244078|FG001|Overall Study|Lost to Follow-up|0|||
48836456|NCT00738699|157244077|FG000|Overall Study|Death|144|||
48836457|NCT00738699|157244078|FG001|Overall Study|Death|68|||
48836458|NCT00738699|157244077|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
48836459|NCT00738699|157244078|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
48604442|NCT00192114|156408951|FG000|Overall Study|Adverse Event|2|||
48604443|NCT00192114|156408951|FG000|Overall Study|Clinical Progression|2|||
48604444|NCT00192114|156408951|FG000|Overall Study|Death|1|||
48604445|NCT01222104|156408954|FG000|Overall Study|Lost to Follow-up|37|||
48604446|NCT01222104|156408954|FG000|Overall Study|Death|10|||
48604447|NCT01418339|156408961|FG000|Overall Study|Adverse Event|5|||
48604448|NCT01418339|156408962|FG001|Overall Study|Adverse Event|2|||
48604449|NCT01418339|156408961|FG000|Overall Study|Subject Withdrew Consent|1|||
48604450|NCT01418339|156408962|FG001|Overall Study|Subject Withdrew Consent|2|||
48604451|NCT01418339|156408961|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
48604452|NCT01418339|156408962|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
48604453|NCT02204917|156408963|FG000|Overall Study|Protocol Violation|1|||
48604454|NCT01401322|156408964|FG000|Overall Study|Withdrawal by Subject|1|||
48604455|NCT01401322|156408964|FG000|Overall Study|Physician Decision|1|||
48604456|NCT02974868|156408965|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
48604457|NCT02974868|156408966|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
48604458|NCT02974868|156408967|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
48836460|NCT00738699|157244077|FG000|Overall Study|Other|2|||
48836461|NCT00738699|157244078|FG001|Overall Study|Other|0|||
48836462|NCT01458210|157244081|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
48836463|NCT01458210|157244081|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
48836464|NCT01458210|157244081|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
48836465|NCT01458210|157244081|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
48836466|NCT03020745|157244082|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836467|NCT03020745|157244083|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836468|NCT03020745|157244084|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836469|NCT03020745|157244085|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836470|NCT03020745|157244086|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836471|NCT03020745|157244087|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836472|NCT03020745|157244088|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836473|NCT03020745|157244089|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836474|NCT03020745|157244090|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
48836475|NCT03020745|157244091|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
48836476|NCT03020745|157244082|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836477|NCT03020745|157244083|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836478|NCT03020745|157244084|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836479|NCT03020745|157244085|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836480|NCT03020745|157244086|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836481|NCT03020745|157244087|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836482|NCT03020745|157244088|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836483|NCT03020745|157244089|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
48836484|NCT03020745|157244090|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836485|NCT03020745|157244091|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
48836486|NCT03020745|157244082|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836487|NCT03020745|157244083|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836488|NCT03020745|157244084|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836489|NCT03020745|157244085|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836490|NCT03020745|157244086|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836491|NCT03020745|157244087|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
48836492|NCT03020745|157244088|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836493|NCT03020745|157244089|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836494|NCT03020745|157244090|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
48836495|NCT03020745|157244091|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
48836496|NCT03020745|157244082|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836497|NCT03020745|157244083|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836498|NCT03020745|157244084|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836499|NCT03020745|157244085|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836500|NCT03020745|157244086|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836501|NCT03020745|157244087|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836502|NCT03020745|157244088|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836503|NCT03020745|157244089|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48836504|NCT03020745|157244090|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
48836505|NCT03020745|157244091|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
48604459|NCT02974868|156408968|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
48604460|NCT02974868|156408965|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
48604461|NCT02974868|156408966|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
48604462|NCT02974868|156408967|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
48604463|NCT02974868|156408968|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
48604464|NCT02974868|156408965|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
48445457|NCT03803202|155818740|FG003|Overall Study|Death|0|||
48604465|NCT02974868|156408966|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
48604466|NCT02974868|156408967|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
48604467|NCT02974868|156408968|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
48604468|NCT02974868|156408965|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
48604469|NCT02974868|156408966|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
48604470|NCT02974868|156408967|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
48604471|NCT02974868|156408968|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
48604472|NCT03154086|156408971|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604473|NCT03154086|156408972|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604474|NCT03154086|156408973|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604475|NCT03154086|156408974|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
48604476|NCT03154086|156408975|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604477|NCT03154086|156408976|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604478|NCT03154086|156408977|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604479|NCT03154086|156408978|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604480|NCT03154086|156408979|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604481|NCT03154086|156408980|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604482|NCT03154086|156408981|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604483|NCT03154086|156408982|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604484|NCT03154086|156408983|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48836506|NCT02296424|157244092|FG000|Part 1|New therapy for study indication|0|||
48836507|NCT02296424|157244093|FG001|Part 1|New therapy for study indication|1|||
48836508|NCT02296424|157244094|FG002|Part 1|New therapy for study indication|0|||
48836509|NCT02296424|157244095|FG003|Part 1|New therapy for study indication|0|||
48836510|NCT02296424|157244092|FG000|Part 1|Protocol Violation|0|||
48836511|NCT02296424|157244093|FG001|Part 1|Protocol Violation|1|||
48836512|NCT02296424|157244094|FG002|Part 1|Protocol Violation|0|||
48836513|NCT02296424|157244095|FG003|Part 1|Protocol Violation|0|||
48836514|NCT02296424|157244092|FG000|Part 1|Withdrawal by Subject|0|||
48604485|NCT03154086|156408984|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604486|NCT03154086|156408985|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
48604487|NCT03154086|156408971|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604488|NCT03154086|156408972|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
48836515|NCT02296424|157244093|FG001|Part 1|Withdrawal by Subject|2|||
48836516|NCT02296424|157244094|FG002|Part 1|Withdrawal by Subject|0|||
48836517|NCT02296424|157244095|FG003|Part 1|Withdrawal by Subject|0|||
48836518|NCT02296424|157244092|FG000|Part 1|Study terminated by sponsor|0|||
48836519|NCT02296424|157244093|FG001|Part 1|Study terminated by sponsor|1|||
48836520|NCT02296424|157244094|FG002|Part 1|Study terminated by sponsor|0|||
48836521|NCT02296424|157244095|FG003|Part 1|Study terminated by sponsor|0|||
48836522|NCT02296424|157244092|FG000|Part 1|Adverse Event|2|||
48836523|NCT02296424|157244093|FG001|Part 1|Adverse Event|11|||
48836524|NCT02296424|157244094|FG002|Part 1|Adverse Event|0|||
48836525|NCT02296424|157244095|FG003|Part 1|Adverse Event|0|||
48836526|NCT02296424|157244092|FG000|Part 1|Lack of Efficacy|5|||
48836527|NCT02296424|157244093|FG001|Part 1|Lack of Efficacy|17|||
48836528|NCT02296424|157244094|FG002|Part 1|Lack of Efficacy|0|||
48836529|NCT02296424|157244095|FG003|Part 1|Lack of Efficacy|0|||
48836530|NCT02296424|157244092|FG000|Part 1|16 directly started part II|16|||
48836531|NCT02296424|157244093|FG001|Part 1|16 directly started part II|0|||
48836532|NCT02296424|157244094|FG002|Part 1|16 directly started part II|0|||
48836533|NCT02296424|157244095|FG003|Part 1|16 directly started part II|0|||
48836534|NCT02296424|157244092|FG000|Part 2|Lack of Efficacy|0|||
48836535|NCT02296424|157244093|FG001|Part 2|Lack of Efficacy|0|||
48836536|NCT02296424|157244094|FG002|Part 2|Lack of Efficacy|1|||
48836537|NCT02296424|157244095|FG003|Part 2|Lack of Efficacy|0|||
48836538|NCT02296424|157244092|FG000|Part 2|Adverse Event|0|||
48836539|NCT02296424|157244093|FG001|Part 2|Adverse Event|0|||
48836540|NCT02296424|157244094|FG002|Part 2|Adverse Event|1|||
48836541|NCT02296424|157244095|FG003|Part 2|Adverse Event|0|||
48836542|NCT02296424|157244092|FG000|Part 2|Lost to Follow-up|0|||
48836543|NCT02296424|157244093|FG001|Part 2|Lost to Follow-up|0|||
48836544|NCT02296424|157244094|FG002|Part 2|Lost to Follow-up|1|||
48836545|NCT02296424|157244095|FG003|Part 2|Lost to Follow-up|0|||
48836546|NCT02613871|157244105|FG000|Overall Study|Death|2|||
48836547|NCT02613871|157244105|FG000|Overall Study|Withdrew Consent|1|||
48836548|NCT01930045|157244108|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836549|NCT01930045|157244109|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836550|NCT01930045|157244110|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836551|NCT01930045|157244111|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836552|NCT01930045|157244112|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
48836553|NCT01930045|157244113|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
48836554|NCT01930045|157244108|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
48836555|NCT01930045|157244109|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
48836556|NCT01930045|157244110|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
48836557|NCT01930045|157244111|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
48836558|NCT01930045|157244112|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
48836559|NCT01930045|157244113|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
48836560|NCT00813904|157244114|FG000|Overall Study|Death|1|||
48836561|NCT01140048|157244117|FG000|Overall Study|Physician Decision|1|||
48836562|NCT01140048|157244117|FG000|Overall Study|Withdrawal by Subject|13|||
48836563|NCT01140048|157244117|FG000|Overall Study|Lost to Follow-up|31|||
48836564|NCT03615924|157244120|FG000|Overall Study|Withdrawal by Subject|2|||
48836565|NCT03615924|157244121|FG001|Overall Study|Withdrawal by Subject|5|||
48836566|NCT03615924|157244120|FG000|Overall Study|Death|3|||
48836567|NCT03615924|157244121|FG001|Overall Study|Death|1|||
48836568|NCT03615924|157244120|FG000|Overall Study|Lost to Follow-up|1|||
48836569|NCT03615924|157244121|FG001|Overall Study|Lost to Follow-up|0|||
48836570|NCT03615924|157244120|FG000|Overall Study|Randomized in error|1|||
48836571|NCT03615924|157244121|FG001|Overall Study|Randomized in error|0|||
48836572|NCT03615924|157244120|FG000|Overall Study|Study termination by Sponsor|94|||
48836573|NCT03615924|157244121|FG001|Overall Study|Study termination by Sponsor|86|||
48836574|NCT02880241|157244122|FG000|Overall Study|Lack of Efficacy|1|||
48836575|NCT02880241|157244123|FG001|Overall Study|Lack of Efficacy|0|||
48836576|NCT02880241|157244124|FG002|Overall Study|Lack of Efficacy|0|||
48836577|NCT02880241|157244125|FG003|Overall Study|Lack of Efficacy|0|||
48836578|NCT02880241|157244126|FG004|Overall Study|Lack of Efficacy|0|||
48836579|NCT02880241|157244127|FG005|Overall Study|Lack of Efficacy|0|||
48836580|NCT00102063|157244129|FG000|Overall Study|Lack of Efficacy|5|||
48836581|NCT00102063|157244130|FG001|Overall Study|Lack of Efficacy|1|||
48836582|NCT00102063|157244131|FG002|Overall Study|Lack of Efficacy|1|||
48836583|NCT00102063|157244129|FG000|Overall Study|Adverse Event|7|||
48836584|NCT00102063|157244130|FG001|Overall Study|Adverse Event|4|||
48836585|NCT00102063|157244131|FG002|Overall Study|Adverse Event|2|||
48836586|NCT00102063|157244129|FG000|Overall Study|Withdrawal by Subject|4|||
48836587|NCT00102063|157244130|FG001|Overall Study|Withdrawal by Subject|12|||
48836588|NCT00102063|157244131|FG002|Overall Study|Withdrawal by Subject|5|||
48836589|NCT00102063|157244129|FG000|Overall Study|Lost to Follow-up|0|||
48836590|NCT00102063|157244130|FG001|Overall Study|Lost to Follow-up|0|||
48836591|NCT00102063|157244131|FG002|Overall Study|Lost to Follow-up|1|||
48836592|NCT00102063|157244129|FG000|Overall Study|Protocol Violation|0|||
48836593|NCT00102063|157244130|FG001|Overall Study|Protocol Violation|1|||
48836594|NCT00102063|157244131|FG002|Overall Study|Protocol Violation|1|||
48836595|NCT01692938|157244134|FG000|Overall Study|Protocol Deviation|1|||
48836596|NCT01692938|157244135|FG001|Overall Study|Protocol Deviation|1|||
48836597|NCT01692938|157244134|FG000|Overall Study|Study completed prior to site completion|3|||
48836598|NCT01692938|157244135|FG001|Overall Study|Study completed prior to site completion|3|||
48836599|NCT05686421|157244136|FG000|Overall Study|Screen failure|22|||
48836600|NCT05686421|157244137|FG001|Overall Study|Screen failure|0|||
48836601|NCT05686421|157244138|FG002|Overall Study|Screen failure|0|||
48836602|NCT05686421|157244139|FG003|Overall Study|Screen failure|0|||
48836603|NCT02471755|157244140|FG000|Overall Study|Withdrawal by Subject|1|||
48836604|NCT02471755|157244141|FG001|Overall Study|Withdrawal by Subject|0|||
48836605|NCT02471755|157244140|FG000|Overall Study|Lost to Follow-up|0|||
48836606|NCT02471755|157244141|FG001|Overall Study|Lost to Follow-up|1|||
48836607|NCT02020616|157244144|FG000|Overall Study|Adverse Event|0|||
48836608|NCT02020616|157244145|FG001|Overall Study|Adverse Event|0|||
48836609|NCT02020616|157244146|FG002|Overall Study|Adverse Event|0|||
48836610|NCT02020616|157244147|FG003|Overall Study|Adverse Event|0|||
48836611|NCT02020616|157244148|FG004|Overall Study|Adverse Event|0|||
48836612|NCT02020616|157244149|FG005|Overall Study|Adverse Event|1|||
48836613|NCT02020616|157244150|FG006|Overall Study|Adverse Event|1|||
48836614|NCT02020616|157244144|FG000|Overall Study|Physician Decision|0|||
48836615|NCT02020616|157244145|FG001|Overall Study|Physician Decision|0|||
48836616|NCT02020616|157244146|FG002|Overall Study|Physician Decision|0|||
48836617|NCT02020616|157244147|FG003|Overall Study|Physician Decision|0|||
48836618|NCT02020616|157244148|FG004|Overall Study|Physician Decision|0|||
48836619|NCT02020616|157244149|FG005|Overall Study|Physician Decision|1|||
48534709|NCT01652729|156144899|FG001|Overall Study|Withdrawal by Subject|7|||
48534710|NCT01652729|156144900|FG002|Overall Study|Withdrawal by Subject|7|||
48836620|NCT02020616|157244150|FG006|Overall Study|Physician Decision|2|||
48836621|NCT02020616|157244144|FG000|Overall Study|Withdrawal by Subject|0|||
48836622|NCT02020616|157244145|FG001|Overall Study|Withdrawal by Subject|0|||
48836623|NCT02020616|157244146|FG002|Overall Study|Withdrawal by Subject|1|||
48836624|NCT02020616|157244147|FG003|Overall Study|Withdrawal by Subject|0|||
48836625|NCT02020616|157244148|FG004|Overall Study|Withdrawal by Subject|0|||
48836626|NCT02020616|157244149|FG005|Overall Study|Withdrawal by Subject|1|||
48836627|NCT02020616|157244150|FG006|Overall Study|Withdrawal by Subject|1|||
48836628|NCT02020616|157244144|FG000|Overall Study|Lost to Follow-up|0|||
48836629|NCT02020616|157244145|FG001|Overall Study|Lost to Follow-up|1|||
48836630|NCT02020616|157244146|FG002|Overall Study|Lost to Follow-up|0|||
48836631|NCT02020616|157244147|FG003|Overall Study|Lost to Follow-up|1|||
48836632|NCT02020616|157244148|FG004|Overall Study|Lost to Follow-up|1|||
48534711|NCT01652729|156144898|FG000|Overall Study|Adverse Event|4|||
48836633|NCT02020616|157244149|FG005|Overall Study|Lost to Follow-up|1|||
48836634|NCT02020616|157244150|FG006|Overall Study|Lost to Follow-up|0|||
48836635|NCT02020616|157244144|FG000|Overall Study|Early Termination Criteria Met|0|||
48836636|NCT02020616|157244145|FG001|Overall Study|Early Termination Criteria Met|0|||
48836637|NCT02020616|157244146|FG002|Overall Study|Early Termination Criteria Met|1|||
48836638|NCT02020616|157244147|FG003|Overall Study|Early Termination Criteria Met|0|||
48836639|NCT02020616|157244148|FG004|Overall Study|Early Termination Criteria Met|0|||
48836640|NCT02020616|157244149|FG005|Overall Study|Early Termination Criteria Met|1|||
48836641|NCT02020616|157244150|FG006|Overall Study|Early Termination Criteria Met|0|||
48836642|NCT02020616|157244144|FG000|Overall Study|Randomized in Error|0|||
48836643|NCT02020616|157244145|FG001|Overall Study|Randomized in Error|0|||
48836644|NCT02020616|157244146|FG002|Overall Study|Randomized in Error|0|||
48836645|NCT02020616|157244147|FG003|Overall Study|Randomized in Error|1|||
48836646|NCT02020616|157244148|FG004|Overall Study|Randomized in Error|0|||
48836647|NCT02020616|157244149|FG005|Overall Study|Randomized in Error|0|||
48836648|NCT02020616|157244150|FG006|Overall Study|Randomized in Error|0|||
48836649|NCT02020616|157244144|FG000|Overall Study|Lack of Efficacy|0|||
48836650|NCT02020616|157244145|FG001|Overall Study|Lack of Efficacy|0|||
48836651|NCT02020616|157244146|FG002|Overall Study|Lack of Efficacy|0|||
48836652|NCT02020616|157244147|FG003|Overall Study|Lack of Efficacy|0|||
48836653|NCT02020616|157244148|FG004|Overall Study|Lack of Efficacy|1|||
48836654|NCT02020616|157244149|FG005|Overall Study|Lack of Efficacy|0|||
48836655|NCT02020616|157244150|FG006|Overall Study|Lack of Efficacy|0|||
48836656|NCT01597258|157244151|FG000|Overall Study|No Drug Administration|1|||
48836657|NCT01580293|157245555|FG000|Part A_Main Trial|Adverse Event|0|||
48836658|NCT01580293|157245556|FG001|Part A_Main Trial|Adverse Event|2|||
48836659|NCT01580293|157245557|FG002|Part A_Main Trial|Adverse Event|0|||
48836660|NCT01580293|157245555|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
48836661|NCT01580293|157245556|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
48836662|NCT01580293|157245557|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
48836663|NCT01580293|157245555|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
48836664|NCT01580293|157245556|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
48836665|NCT01580293|157245557|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
48836666|NCT01580293|157245555|FG000|Part A_Extension|Adverse Event|0|||
48836667|NCT01580293|157245556|FG001|Part A_Extension|Adverse Event|2|||
48836668|NCT01580293|157245557|FG002|Part A_Extension|Adverse Event|0|||
48836669|NCT01580293|157245555|FG000|Part A_Extension|Withdrawal by Subject|0|||
48836670|NCT01580293|157245556|FG001|Part A_Extension|Withdrawal by Subject|3|||
48836671|NCT01580293|157245557|FG002|Part A_Extension|Withdrawal by Subject|0|||
48836672|NCT01580293|157245555|FG000|Part A_Extension|Lost to Follow-up|0|||
48836673|NCT01580293|157245556|FG001|Part A_Extension|Lost to Follow-up|1|||
48836674|NCT01580293|157245557|FG002|Part A_Extension|Lost to Follow-up|0|||
48836675|NCT01580293|157245555|FG000|Part A_Extension|Other Reason|0|||
48534712|NCT01652729|156144899|FG001|Overall Study|Adverse Event|0|||
48534713|NCT01652729|156144900|FG002|Overall Study|Adverse Event|3|||
48534714|NCT01652729|156144898|FG000|Overall Study|Physician Decision|1|||
48534715|NCT01652729|156144899|FG001|Overall Study|Physician Decision|0|||
48534716|NCT01652729|156144900|FG002|Overall Study|Physician Decision|1|||
48534717|NCT01652729|156144898|FG000|Overall Study|Protocol Violation|1|||
48534718|NCT01652729|156144899|FG001|Overall Study|Protocol Violation|0|||
48534719|NCT01652729|156144900|FG002|Overall Study|Protocol Violation|0|||
48534720|NCT01652729|156144898|FG000|Overall Study|Lost to Follow-up|6|||
48534721|NCT01652729|156144899|FG001|Overall Study|Lost to Follow-up|6|||
48534722|NCT01652729|156144900|FG002|Overall Study|Lost to Follow-up|3|||
48534723|NCT01652729|156144898|FG000|Overall Study|Administrative|1|||
48836676|NCT01580293|157245556|FG001|Part A_Extension|Other Reason|1|||
48836677|NCT01580293|157245557|FG002|Part A_Extension|Other Reason|0|||
48836678|NCT01580293|157245555|FG000|Part A_Extension|Completed Japan only|0|||
48836679|NCT01580293|157245556|FG001|Part A_Extension|Completed Japan only|5|||
48836680|NCT01580293|157245557|FG002|Part A_Extension|Completed Japan only|0|||
48836681|NCT01580293|157245555|FG000|Part B|Withdrawal by Subject|0|||
48836682|NCT01580293|157245556|FG001|Part B|Withdrawal by Subject|0|||
48836683|NCT01580293|157245557|FG002|Part B|Withdrawal by Subject|1|||
48836684|NCT01580293|157245555|FG000|Part B|Other reason|0|||
48836685|NCT01580293|157245556|FG001|Part B|Other reason|0|||
48836686|NCT01580293|157245557|FG002|Part B|Other reason|1|||
48836687|NCT02525796|157245558|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
48836688|NCT02525796|157245559|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
48836689|NCT02525796|157245560|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
48836690|NCT02525796|157245558|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
48836691|NCT02525796|157245559|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
48836692|NCT02525796|157245560|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
48836693|NCT02525796|157245558|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
48836694|NCT02525796|157245559|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
48836695|NCT02525796|157245560|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
48836696|NCT02525796|157245558|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
48836697|NCT02525796|157245559|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
48836698|NCT02525796|157245560|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
48836699|NCT02525796|157245558|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
48836700|NCT02525796|157245559|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
48836701|NCT02525796|157245560|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
48836702|NCT02937831|157245563|FG000|Overall Study|Protocol Violation|4|||
48836703|NCT02983617|157245564|FG000|Overall Study|Adverse Event|0|||
48836704|NCT02983617|157245565|FG001|Overall Study|Adverse Event|7|||
48836705|NCT02983617|157245564|FG000|Overall Study|Death|0|||
48836706|NCT02983617|157245565|FG001|Overall Study|Death|1|||
48836707|NCT02983617|157245564|FG000|Overall Study|Investigator's Discretion|0|||
48836708|NCT02983617|157245565|FG001|Overall Study|Investigator's Discretion|1|||
48836709|NCT03720210|157245566|FG000|Overall Study|Lost to Follow-up|1|||
48836710|NCT02013830|157245567|FG000|Overall Study|Adverse Event|3|||
48836711|NCT02013830|157245567|FG000|Overall Study|Death|1|||
48836712|NCT02013830|157245567|FG000|Overall Study|Insufficient therapeutic response|25|||
48836713|NCT02013830|157245567|FG000|Overall Study|Refused treatment|1|||
48836714|NCT00393848|157245568|FG000|Overall Study|Surgical schedule|0|||
48836715|NCT00393848|157245569|FG001|Overall Study|Surgical schedule|0|||
48836716|NCT00393848|157245570|FG002|Overall Study|Surgical schedule|0|||
48836717|NCT00393848|157245571|FG003|Overall Study|Surgical schedule|1|||
48836718|NCT00393848|157245568|FG000|Overall Study|Personal reasons|0|||
48836719|NCT00393848|157245569|FG001|Overall Study|Personal reasons|0|||
48836720|NCT00393848|157245570|FG002|Overall Study|Personal reasons|2|||
48836721|NCT00393848|157245571|FG003|Overall Study|Personal reasons|0|||
48836722|NCT01064817|157245573|FG000|Study Completion|Physician Decision|1|||
48836723|NCT01064817|157245574|FG001|Study Completion|Physician Decision|0|||
48836724|NCT01064817|157245573|FG000|Study Completion|Withdrawal by Subject|1|||
48836725|NCT01064817|157245574|FG001|Study Completion|Withdrawal by Subject|0|||
48836726|NCT02694978|157245577|FG000|Overall Study|Adverse Event|10|||
48836727|NCT02694978|157245578|FG001|Overall Study|Adverse Event|9|||
48836728|NCT02694978|157245577|FG000|Overall Study|Withdrawal by Subject|22|||
48836729|NCT02694978|157245578|FG001|Overall Study|Withdrawal by Subject|19|||
48836730|NCT02694978|157245577|FG000|Overall Study|Lost to Follow-up|14|||
48836731|NCT02694978|157245578|FG001|Overall Study|Lost to Follow-up|17|||
48534724|NCT01652729|156144899|FG001|Overall Study|Administrative|0|||
48534725|NCT01652729|156144900|FG002|Overall Study|Administrative|0|||
48534726|NCT01272921|156144906|FG000|Overall Study|Protocol Violation|2|||
48534727|NCT01272921|156144907|FG001|Overall Study|Protocol Violation|1|||
48534728|NCT01132664|156144908|FG000|Phase lb|Adverse Event|0|||
48534729|NCT01132664|156144909|FG001|Phase lb|Adverse Event|1|||
48534730|NCT01132664|156144910|FG002|Phase lb|Adverse Event|0|||
48534731|NCT01132664|156144911|FG003|Phase lb|Adverse Event|0|||
48534732|NCT01132664|156144912|FG004|Phase lb|Adverse Event|0|||
48534733|NCT01132664|156144908|FG000|Phase lb|Withdrawal by Subject|1|||
48534734|NCT01132664|156144909|FG001|Phase lb|Withdrawal by Subject|2|||
48534735|NCT01132664|156144910|FG002|Phase lb|Withdrawal by Subject|0|||
48534736|NCT01132664|156144911|FG003|Phase lb|Withdrawal by Subject|0|||
48534737|NCT01132664|156144912|FG004|Phase lb|Withdrawal by Subject|0|||
48534738|NCT01132664|156144908|FG000|Phase lb|Disease Progression|4|||
48534739|NCT01132664|156144909|FG001|Phase lb|Disease Progression|9|||
48534740|NCT01132664|156144910|FG002|Phase lb|Disease Progression|0|||
48534741|NCT01132664|156144911|FG003|Phase lb|Disease Progression|0|||
48534742|NCT01132664|156144912|FG004|Phase lb|Disease Progression|0|||
48534743|NCT01132664|156144908|FG000|Phase ll|Death|0|||
48534744|NCT01132664|156144909|FG001|Phase ll|Death|0|||
48534745|NCT01132664|156144910|FG002|Phase ll|Death|2|||
48534746|NCT01132664|156144911|FG003|Phase ll|Death|0|||
48534747|NCT01132664|156144912|FG004|Phase ll|Death|0|||
48534748|NCT01132664|156144908|FG000|Phase ll|Adverse Event|0|||
48534749|NCT01132664|156144909|FG001|Phase ll|Adverse Event|0|||
48534750|NCT01132664|156144910|FG002|Phase ll|Adverse Event|10|||
48534751|NCT01132664|156144911|FG003|Phase ll|Adverse Event|0|||
48836732|NCT02694978|157245577|FG000|Overall Study|Death|4|||
48836733|NCT02694978|157245578|FG001|Overall Study|Death|1|||
48534752|NCT01132664|156144912|FG004|Phase ll|Adverse Event|0|||
48836734|NCT02694978|157245577|FG000|Overall Study|Other-Decision of Participant|6|||
48836735|NCT02694978|157245578|FG001|Overall Study|Other-Decision of Participant|1|||
48836736|NCT02694978|157245577|FG000|Overall Study|Other-Investigator's decision|1|||
48836737|NCT02694978|157245578|FG001|Overall Study|Other-Investigator's decision|0|||
48836738|NCT02694978|157245577|FG000|Overall Study|Other-Unable to be reached|0|||
48836739|NCT02694978|157245578|FG001|Overall Study|Other-Unable to be reached|1|||
48836740|NCT02694978|157245577|FG000|Overall Study|Other-Protocol noncompliant|2|||
48836741|NCT02694978|157245578|FG001|Overall Study|Other-Protocol noncompliant|1|||
48836742|NCT02694978|157245577|FG000|Overall Study|Other-Personal reasons|3|||
48836743|NCT02694978|157245578|FG001|Overall Study|Other-Personal reasons|3|||
48836744|NCT02694978|157245577|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
48836745|NCT02694978|157245578|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
48836746|NCT03923491|157245580|FG000|Overall Study|Lost to Follow-up|5|||
48836747|NCT03923491|157245581|FG001|Overall Study|Lost to Follow-up|8|||
48836748|NCT03923491|157245580|FG000|Overall Study|Withdrawal by Subject|4|||
48836749|NCT03923491|157245581|FG001|Overall Study|Withdrawal by Subject|6|||
48836750|NCT03959241|157245582|FG000|Overall Study|Withdrawal by Subject|7|||
48836751|NCT03959241|157245583|FG001|Overall Study|Withdrawal by Subject|8|||
48836752|NCT03959241|157245582|FG000|Overall Study|Lost to Follow-up|1|||
48836753|NCT03959241|157245583|FG001|Overall Study|Lost to Follow-up|0|||
48836754|NCT03959241|157245582|FG000|Overall Study|Move to Hospice Care|1|||
48836755|NCT03959241|157245583|FG001|Overall Study|Move to Hospice Care|0|||
48836756|NCT03959241|157245582|FG000|Overall Study|Screen Failure|1|||
48836757|NCT03959241|157245583|FG001|Overall Study|Screen Failure|0|||
48836758|NCT03959241|157245582|FG000|Overall Study|Disease Relapse|0|||
48836759|NCT03959241|157245583|FG001|Overall Study|Disease Relapse|1|||
48836760|NCT03959241|157245582|FG000|Overall Study|Off Study|1|||
48836761|NCT03959241|157245583|FG001|Overall Study|Off Study|0|||
48836762|NCT04833855|157245586|FG000|Overall Study|Decision by sponsor|0|||
48836763|NCT04833855|157245587|FG001|Overall Study|Decision by sponsor|1|||
48836764|NCT04833855|157245588|FG002|Overall Study|Decision by sponsor|0|||
48836765|NCT04833855|157245589|FG003|Overall Study|Decision by sponsor|0|||
48534753|NCT01132664|156144908|FG000|Phase ll|Withdrawal by Subject|0|||
48534754|NCT01132664|156144909|FG001|Phase ll|Withdrawal by Subject|0|||
48534755|NCT01132664|156144910|FG002|Phase ll|Withdrawal by Subject|3|||
48534756|NCT01132664|156144911|FG003|Phase ll|Withdrawal by Subject|0|||
48534757|NCT01132664|156144912|FG004|Phase ll|Withdrawal by Subject|0|||
48534758|NCT01132664|156144908|FG000|Phase ll|Disease progression|0|||
48836766|NCT04833855|157245586|FG000|Overall Study|Withdrawal by Subject|4|||
48836767|NCT04833855|157245587|FG001|Overall Study|Withdrawal by Subject|1|||
48836768|NCT04833855|157245588|FG002|Overall Study|Withdrawal by Subject|3|||
48836769|NCT04833855|157245589|FG003|Overall Study|Withdrawal by Subject|1|||
48836770|NCT04833855|157245586|FG000|Overall Study|Lost to Follow-up|1|||
48836771|NCT04833855|157245587|FG001|Overall Study|Lost to Follow-up|0|||
48836772|NCT04833855|157245588|FG002|Overall Study|Lost to Follow-up|2|||
48836773|NCT04833855|157245589|FG003|Overall Study|Lost to Follow-up|2|||
48836774|NCT04833855|157245586|FG000|Overall Study|Protocol specified criteria|0|||
48836775|NCT04833855|157245587|FG001|Overall Study|Protocol specified criteria|0|||
48836776|NCT04833855|157245588|FG002|Overall Study|Protocol specified criteria|2|||
48836777|NCT04833855|157245589|FG003|Overall Study|Protocol specified criteria|1|||
48836778|NCT03460756|157245596|FG000|Overall Study|Adverse Event|0|||
48836779|NCT03460756|157245597|FG001|Overall Study|Adverse Event|0|||
48836780|NCT03460756|157245598|FG002|Overall Study|Adverse Event|0|||
48836781|NCT03460756|157245599|FG003|Overall Study|Adverse Event|1|||
48836782|NCT03460756|157245596|FG000|Overall Study|Lack of Efficacy|0|||
48836783|NCT03460756|157245597|FG001|Overall Study|Lack of Efficacy|0|||
48836784|NCT03460756|157245598|FG002|Overall Study|Lack of Efficacy|0|||
48836785|NCT03460756|157245599|FG003|Overall Study|Lack of Efficacy|2|||
48836786|NCT03460756|157245596|FG000|Overall Study|Lost to Follow-up|0|||
48836787|NCT03460756|157245597|FG001|Overall Study|Lost to Follow-up|1|||
48836788|NCT03460756|157245598|FG002|Overall Study|Lost to Follow-up|2|||
48836789|NCT03460756|157245599|FG003|Overall Study|Lost to Follow-up|1|||
48836790|NCT03460756|157245596|FG000|Overall Study|Pregnancy|0|||
48836791|NCT03460756|157245597|FG001|Overall Study|Pregnancy|0|||
48534759|NCT01132664|156144909|FG001|Phase ll|Disease progression|0|||
48534760|NCT01132664|156144910|FG002|Phase ll|Disease progression|35|||
48534761|NCT01132664|156144911|FG003|Phase ll|Disease progression|0|||
48836792|NCT03460756|157245598|FG002|Overall Study|Pregnancy|0|||
48836793|NCT03460756|157245599|FG003|Overall Study|Pregnancy|1|||
48836794|NCT03460756|157245596|FG000|Overall Study|Protocol Violation|0|||
48836795|NCT03460756|157245597|FG001|Overall Study|Protocol Violation|0|||
48836796|NCT03460756|157245598|FG002|Overall Study|Protocol Violation|0|||
48836797|NCT03460756|157245599|FG003|Overall Study|Protocol Violation|1|||
48534762|NCT01132664|156144912|FG004|Phase ll|Disease progression|0|||
48534763|NCT01132664|156144908|FG000|BM Cohort|Disease progression|0|||
48534764|NCT01132664|156144909|FG001|BM Cohort|Disease progression|0|||
48836798|NCT03460756|157245596|FG000|Overall Study|Withdrawal by Subject|0|||
48836799|NCT03460756|157245597|FG001|Overall Study|Withdrawal by Subject|4|||
48836800|NCT03460756|157245598|FG002|Overall Study|Withdrawal by Subject|7|||
48836801|NCT03460756|157245599|FG003|Overall Study|Withdrawal by Subject|3|||
48836802|NCT02878330|157245601|FG000|Overall Study|Death|3|||
48604489|NCT03154086|156408973|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604490|NCT03154086|156408974|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604491|NCT03154086|156408975|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48836803|NCT02878330|157245602|FG001|Overall Study|Death|2|||
48836804|NCT02878330|157245601|FG000|Overall Study|Lost to Follow-up|11|||
48534765|NCT01132664|156144910|FG002|BM Cohort|Disease progression|0|||
48534766|NCT01132664|156144911|FG003|BM Cohort|Disease progression|3|||
48534767|NCT01132664|156144912|FG004|BM Cohort|Disease progression|4|||
48534768|NCT01132664|156144908|FG000|BM Cohort|Adverse Event|0|||
48534769|NCT01132664|156144909|FG001|BM Cohort|Adverse Event|0|||
48534770|NCT01132664|156144910|FG002|BM Cohort|Adverse Event|0|||
48534771|NCT01132664|156144911|FG003|BM Cohort|Adverse Event|0|||
48534772|NCT01132664|156144912|FG004|BM Cohort|Adverse Event|1|||
48534773|NCT01132664|156144908|FG000|BM Cohort|Withdrawal by Subject|0|||
48534774|NCT01132664|156144909|FG001|BM Cohort|Withdrawal by Subject|0|||
48534775|NCT01132664|156144910|FG002|BM Cohort|Withdrawal by Subject|0|||
48534776|NCT01132664|156144911|FG003|BM Cohort|Withdrawal by Subject|0|||
48534777|NCT01132664|156144912|FG004|BM Cohort|Withdrawal by Subject|1|||
48534778|NCT00655850|156144913|FG000|Overall Study|Death|2|||
48534779|NCT00655850|156144913|FG000|Overall Study|Withdrawal by Subject|1|||
48534780|NCT00140413|156144914|FG000|Overall Study|Lost to Follow-up|1|||
48534781|NCT00140413|156144915|FG001|Overall Study|Lost to Follow-up|0|||
48534782|NCT00140413|156144914|FG000|Overall Study|Withdrawal by Subject|2|||
48534783|NCT00140413|156144915|FG001|Overall Study|Withdrawal by Subject|0|||
48534784|NCT02694549|156144918|FG000|Overall Study|screen failures|2|||
48534785|NCT01534078|156144919|FG000|Overall Study|Death|1|||
48534786|NCT01534078|156144919|FG000|Overall Study|Withdrawal by Subject|1|||
48534787|NCT02916693|156144920|FG000|Overall Study|Lost to Follow-up|7|||
48534788|NCT03180801|156144923|FG000|Overall Study|Physician Decision|3|||
48534789|NCT03180801|156144924|FG001|Overall Study|Physician Decision|3|||
48534790|NCT03180801|156144925|FG002|Overall Study|Physician Decision|1|||
48534791|NCT03180801|156144923|FG000|Overall Study|Non-compliance|1|||
48836805|NCT02878330|157245602|FG001|Overall Study|Lost to Follow-up|26|||
48836806|NCT02878330|157245601|FG000|Overall Study|Withdrawal by Subject|11|||
48836807|NCT02878330|157245602|FG001|Overall Study|Withdrawal by Subject|21|||
48836808|NCT02878330|157245601|FG000|Overall Study|Other|4|||
48836809|NCT02878330|157245602|FG001|Overall Study|Other|7|||
48836810|NCT00980330|157245603|FG000|Overall Study|Adverse Event|0|||
48836811|NCT00980330|157245604|FG001|Overall Study|Adverse Event|0|||
48836812|NCT00980330|157245605|FG002|Overall Study|Adverse Event|0|||
48836813|NCT00980330|157245606|FG003|Overall Study|Adverse Event|1|||
48836814|NCT00980330|157245607|FG004|Overall Study|Adverse Event|0|||
48836815|NCT00980330|157245608|FG005|Overall Study|Adverse Event|0|||
48836816|NCT00980330|157245609|FG006|Overall Study|Adverse Event|0|||
48836817|NCT00980330|157245603|FG000|Overall Study|Lost to Follow-up|1|||
48836818|NCT00980330|157245604|FG001|Overall Study|Lost to Follow-up|1|||
48836819|NCT00980330|157245605|FG002|Overall Study|Lost to Follow-up|4|||
48836820|NCT00980330|157245606|FG003|Overall Study|Lost to Follow-up|2|||
48836821|NCT00980330|157245607|FG004|Overall Study|Lost to Follow-up|1|||
48836822|NCT00980330|157245608|FG005|Overall Study|Lost to Follow-up|1|||
48836823|NCT00980330|157245609|FG006|Overall Study|Lost to Follow-up|2|||
48836824|NCT00980330|157245603|FG000|Overall Study|Withdrawal by Subject|2|||
48836825|NCT00980330|157245604|FG001|Overall Study|Withdrawal by Subject|4|||
48836826|NCT00980330|157245605|FG002|Overall Study|Withdrawal by Subject|4|||
48604492|NCT03154086|156408976|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48836827|NCT00980330|157245606|FG003|Overall Study|Withdrawal by Subject|1|||
48534792|NCT03180801|156144924|FG001|Overall Study|Non-compliance|4|||
48534793|NCT03180801|156144925|FG002|Overall Study|Non-compliance|0|||
48534794|NCT03180801|156144923|FG000|Overall Study|Inoculation Target Reached|1|||
48604493|NCT03154086|156408977|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48534795|NCT03180801|156144924|FG001|Overall Study|Inoculation Target Reached|1|||
48534796|NCT03180801|156144925|FG002|Overall Study|Inoculation Target Reached|3|||
48534797|NCT03180801|156144923|FG000|Overall Study|Adverse Event|1|||
48534798|NCT03180801|156144924|FG001|Overall Study|Adverse Event|0|||
48534799|NCT03180801|156144925|FG002|Overall Study|Adverse Event|2|||
48534800|NCT03180801|156144923|FG000|Overall Study|Withdrawal by Subject|2|||
48836828|NCT00980330|157245607|FG004|Overall Study|Withdrawal by Subject|3|||
48836829|NCT00980330|157245608|FG005|Overall Study|Withdrawal by Subject|2|||
48836830|NCT00980330|157245609|FG006|Overall Study|Withdrawal by Subject|5|||
48836831|NCT00980330|157245603|FG000|Overall Study|(not specified)|2|||
48836832|NCT00980330|157245604|FG001|Overall Study|(not specified)|0|||
48836833|NCT00980330|157245605|FG002|Overall Study|(not specified)|0|||
48836834|NCT00980330|157245606|FG003|Overall Study|(not specified)|1|||
48836835|NCT00980330|157245607|FG004|Overall Study|(not specified)|1|||
48836836|NCT00980330|157245608|FG005|Overall Study|(not specified)|1|||
48836837|NCT00980330|157245609|FG006|Overall Study|(not specified)|0|||
48534801|NCT03180801|156144924|FG001|Overall Study|Withdrawal by Subject|2|||
48534802|NCT03180801|156144925|FG002|Overall Study|Withdrawal by Subject|1|||
48534803|NCT03180801|156144923|FG000|Overall Study|Lost to Follow-up|0|||
48534804|NCT03180801|156144924|FG001|Overall Study|Lost to Follow-up|2|||
48534805|NCT03180801|156144925|FG002|Overall Study|Lost to Follow-up|3|||
48534806|NCT01049412|156144926|FG000|Period I|Withdrawal by Subject|4|||
48534807|NCT01049412|156144927|FG001|Period I|Withdrawal by Subject|6|||
48534808|NCT01049412|156144926|FG000|Period I|Lost to Follow-up|2|||
48534809|NCT01049412|156144927|FG001|Period I|Lost to Follow-up|2|||
48534810|NCT01049412|156144926|FG000|Period I|Physician Decision|0|||
48836838|NCT01039688|157245614|FG000|Overall Study|Adverse Event|38|||
48836839|NCT01039688|157245615|FG001|Overall Study|Adverse Event|39|||
48836840|NCT01039688|157245616|FG002|Overall Study|Adverse Event|24|||
48836841|NCT01039688|157245614|FG000|Overall Study|Lack of Efficacy|20|||
48836842|NCT01039688|157245615|FG001|Overall Study|Lack of Efficacy|11|||
48836843|NCT01039688|157245616|FG002|Overall Study|Lack of Efficacy|26|||
48836844|NCT01039688|157245614|FG000|Overall Study|Lost to Follow-up|11|||
48836845|NCT01039688|157245615|FG001|Overall Study|Lost to Follow-up|9|||
48836846|NCT01039688|157245616|FG002|Overall Study|Lost to Follow-up|5|||
48836847|NCT01039688|157245614|FG000|Overall Study|Other|13|||
48534811|NCT01049412|156144927|FG001|Period I|Physician Decision|3|||
48534812|NCT01049412|156144926|FG000|Period I|Protocol Violation|1|||
48604494|NCT03154086|156408978|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604495|NCT03154086|156408979|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604496|NCT03154086|156408980|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604497|NCT03154086|156408981|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604498|NCT03154086|156408982|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604499|NCT03154086|156408983|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604500|NCT03154086|156408984|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604501|NCT03154086|156408985|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
48604502|NCT03154086|156408971|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604503|NCT03154086|156408972|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48836848|NCT01039688|157245615|FG001|Overall Study|Other|25|||
48604504|NCT03154086|156408973|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
48604505|NCT03154086|156408974|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604506|NCT03154086|156408975|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604507|NCT03154086|156408976|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604508|NCT03154086|156408977|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604509|NCT03154086|156408978|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604510|NCT03154086|156408979|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604511|NCT03154086|156408980|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604512|NCT03154086|156408981|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604513|NCT03154086|156408982|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604514|NCT03154086|156408983|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604515|NCT03154086|156408984|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604516|NCT03154086|156408985|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
48604517|NCT03154086|156408971|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
48604518|NCT03154086|156408972|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48836849|NCT01039688|157245616|FG002|Overall Study|Other|12|||
48836850|NCT01039688|157245614|FG000|Overall Study|Withdrawal by Subject|23|||
48836851|NCT01039688|157245615|FG001|Overall Study|Withdrawal by Subject|27|||
48836852|NCT01039688|157245616|FG002|Overall Study|Withdrawal by Subject|13|||
48836853|NCT01039688|157245614|FG000|Overall Study|Death|2|||
48836854|NCT01039688|157245615|FG001|Overall Study|Death|0|||
48836855|NCT01039688|157245616|FG002|Overall Study|Death|0|||
48836856|NCT00346151|157245623|FG000|Overall Study|Withdrawal by Subject|3|||
48534813|NCT01049412|156144927|FG001|Period I|Protocol Violation|2|||
48604519|NCT03154086|156408973|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604520|NCT03154086|156408974|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604521|NCT03154086|156408975|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604522|NCT03154086|156408976|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604523|NCT03154086|156408977|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48836857|NCT02705586|157245630|FG000|Overall Study|Health Issues|2|||
48534814|NCT01049412|156144926|FG000|Period I|Adverse Event|1|||
48534815|NCT01049412|156144927|FG001|Period I|Adverse Event|0|||
48836858|NCT02705586|157245630|FG000|Overall Study|Transportation Difficulties|5|||
48836859|NCT02705586|157245630|FG000|Overall Study|Vacation/Planned Absence|1|||
48836860|NCT02448446|157245631|FG000|Overall Study|Withdrawal by Subject|1|||
48836861|NCT02448446|157245632|FG001|Overall Study|Withdrawal by Subject|0|||
48534816|NCT01049412|156144926|FG000|Period II|Withdrawal by Subject|2|||
48534817|NCT01049412|156144927|FG001|Period II|Withdrawal by Subject|3|||
48534818|NCT01049412|156144926|FG000|Period II|Adverse Event|1|||
48836862|NCT02547922|157245634|FG000|Overall Study|Withdrawal by Subject|9|||
48534819|NCT01049412|156144927|FG001|Period II|Adverse Event|0|||
48836863|NCT02547922|157245635|FG001|Overall Study|Withdrawal by Subject|6|||
48836864|NCT02547922|157245636|FG002|Overall Study|Withdrawal by Subject|10|||
48836865|NCT02547922|157245634|FG000|Overall Study|Adverse Event|3|||
48836866|NCT02547922|157245635|FG001|Overall Study|Adverse Event|1|||
48836867|NCT02547922|157245636|FG002|Overall Study|Adverse Event|2|||
48836868|NCT02547922|157245634|FG000|Overall Study|Lost to Follow-up|1|||
48836869|NCT02547922|157245635|FG001|Overall Study|Lost to Follow-up|0|||
48836870|NCT02547922|157245636|FG002|Overall Study|Lost to Follow-up|0|||
48836871|NCT02547922|157245634|FG000|Overall Study|Lack of Efficacy|5|||
48836872|NCT02547922|157245635|FG001|Overall Study|Lack of Efficacy|7|||
48836873|NCT02547922|157245636|FG002|Overall Study|Lack of Efficacy|4|||
48836874|NCT02547922|157245634|FG000|Overall Study|Death|1|||
48836875|NCT02547922|157245635|FG001|Overall Study|Death|0|||
48836876|NCT02547922|157245636|FG002|Overall Study|Death|0|||
48836877|NCT02547922|157245634|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
48836878|NCT02547922|157245635|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
48836879|NCT02547922|157245636|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
48836880|NCT02547922|157245634|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
48836881|NCT02547922|157245635|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
48836882|NCT02547922|157245636|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
48836883|NCT02547922|157245634|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
48836884|NCT02547922|157245635|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
48836885|NCT02547922|157245636|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
48836886|NCT02547922|157245634|FG000|Overall Study|Physician Decision|2|||
48836887|NCT02547922|157245635|FG001|Overall Study|Physician Decision|1|||
48836888|NCT02547922|157245636|FG002|Overall Study|Physician Decision|2|||
48836889|NCT02547922|157245634|FG000|Overall Study|Patients did not receive IP|1|||
48836890|NCT02547922|157245635|FG001|Overall Study|Patients did not receive IP|1|||
48836891|NCT02547922|157245636|FG002|Overall Study|Patients did not receive IP|0|||
48836892|NCT05283395|157245637|FG000|Overall Study|Adverse Event|4|||
48836893|NCT05283395|157245638|FG001|Overall Study|Adverse Event|4|||
48836894|NCT05283395|157245639|FG002|Overall Study|Adverse Event|0|||
48836895|NCT05283395|157245637|FG000|Overall Study|Patient Lost to Follow-Up|0|||
48534820|NCT01049412|156144926|FG000|Period II|Lost to Follow-up|1|||
48534821|NCT01049412|156144927|FG001|Period II|Lost to Follow-up|0|||
48534822|NCT01223235|156144929|FG000|Overall Study|Withdrawal by Subject|1|||
48534823|NCT04364737|156144930|FG000|Overall Study|Withdrawal by Subject|4|||
48534824|NCT04364737|156144931|FG001|Overall Study|Withdrawal by Subject|9|||
48534825|NCT04364737|156144930|FG000|Overall Study|Lost to Follow-up|1|||
48534826|NCT04364737|156144931|FG001|Overall Study|Lost to Follow-up|1|||
48534827|NCT01507090|156144932|FG000|Overall Study|incomplete dataset|18|||
48534828|NCT03604341|156144933|FG000|Overall Study|Withdrawal by Subject|1|||
48534829|NCT03604341|156144934|FG001|Overall Study|Withdrawal by Subject|1|||
48534830|NCT03604341|156144933|FG000|Overall Study|Adverse Event|1|||
48534831|NCT03604341|156144934|FG001|Overall Study|Adverse Event|0|||
48534832|NCT03604341|156144933|FG000|Overall Study|Protocol Violation|0|||
48534833|NCT03604341|156144934|FG001|Overall Study|Protocol Violation|1|||
48534834|NCT00484419|156144935|FG000|Overall Study|Adverse Event|3|||
48534835|NCT00484419|156144936|FG001|Overall Study|Adverse Event|0|||
48534836|NCT00484419|156144937|FG002|Overall Study|Adverse Event|0|||
48534837|NCT00484419|156144935|FG000|Overall Study|Lost to Follow-up|1|||
48534838|NCT00484419|156144936|FG001|Overall Study|Lost to Follow-up|0|||
48534839|NCT00484419|156144937|FG002|Overall Study|Lost to Follow-up|2|||
48534840|NCT00484419|156144935|FG000|Overall Study|Withdrawal by Subject|3|||
48534841|NCT00484419|156144936|FG001|Overall Study|Withdrawal by Subject|1|||
48534842|NCT00484419|156144937|FG002|Overall Study|Withdrawal by Subject|1|||
48534843|NCT00484419|156144935|FG000|Overall Study|subject met discontinuation criteria|2|||
48534844|NCT00484419|156144936|FG001|Overall Study|subject met discontinuation criteria|2|||
48534845|NCT00484419|156144937|FG002|Overall Study|subject met discontinuation criteria|4|||
48534846|NCT00484419|156144935|FG000|Overall Study|required restricted medication|1|||
48534847|NCT00484419|156144936|FG001|Overall Study|required restricted medication|0|||
48534848|NCT00484419|156144937|FG002|Overall Study|required restricted medication|1|||
48534849|NCT00484419|156144935|FG000|Overall Study|Physician Decision|1|||
48534850|NCT00484419|156144936|FG001|Overall Study|Physician Decision|1|||
48534851|NCT00484419|156144937|FG002|Overall Study|Physician Decision|1|||
48534852|NCT00484419|156144935|FG000|Overall Study|subject unable to receive medication|1|||
48534853|NCT00484419|156144936|FG001|Overall Study|subject unable to receive medication|0|||
48534854|NCT00484419|156144937|FG002|Overall Study|subject unable to receive medication|0|||
48534855|NCT00484419|156144935|FG000|Overall Study|subject relocated|0|||
48836896|NCT05283395|157245638|FG001|Overall Study|Patient Lost to Follow-Up|0|||
48836897|NCT05283395|157245639|FG002|Overall Study|Patient Lost to Follow-Up|1|||
48836898|NCT05283395|157245637|FG000|Overall Study|Patient Withdrawal|2|||
48836899|NCT05283395|157245638|FG001|Overall Study|Patient Withdrawal|4|||
48836900|NCT05283395|157245639|FG002|Overall Study|Patient Withdrawal|2|||
48836901|NCT05283395|157245637|FG000|Overall Study|Investigator Decision|1|||
48836902|NCT05283395|157245638|FG001|Overall Study|Investigator Decision|0|||
48836903|NCT05283395|157245639|FG002|Overall Study|Investigator Decision|1|||
48836904|NCT05283395|157245637|FG000|Overall Study|Enrolled in error|0|||
48836905|NCT05283395|157245638|FG001|Overall Study|Enrolled in error|0|||
48836906|NCT05283395|157245639|FG002|Overall Study|Enrolled in error|1|||
48836907|NCT00712335|157245640|FG000|Overall Study|Withdrawal by Subject|0|||
48836908|NCT00712335|157245641|FG001|Overall Study|Withdrawal by Subject|7|||
48836909|NCT00712335|157245642|FG002|Overall Study|Withdrawal by Subject|2|||
48836910|NCT00712335|157245643|FG003|Overall Study|Withdrawal by Subject|3|||
48836911|NCT00712335|157245644|FG004|Overall Study|Withdrawal by Subject|0|||
48836912|NCT00712335|157245640|FG000|Overall Study|Lost to Follow-up|2|||
48836913|NCT00712335|157245641|FG001|Overall Study|Lost to Follow-up|5|||
48836914|NCT00712335|157245642|FG002|Overall Study|Lost to Follow-up|0|||
48836915|NCT00712335|157245643|FG003|Overall Study|Lost to Follow-up|1|||
48836916|NCT00712335|157245644|FG004|Overall Study|Lost to Follow-up|0|||
48836917|NCT00712335|157245640|FG000|Overall Study|Protocol Violation|1|||
48836918|NCT00712335|157245641|FG001|Overall Study|Protocol Violation|2|||
48836919|NCT00712335|157245642|FG002|Overall Study|Protocol Violation|1|||
48836920|NCT00712335|157245643|FG003|Overall Study|Protocol Violation|0|||
48836921|NCT00712335|157245644|FG004|Overall Study|Protocol Violation|0|||
48836922|NCT00712335|157245640|FG000|Overall Study|Lack of Efficacy|0|||
48836923|NCT00712335|157245641|FG001|Overall Study|Lack of Efficacy|0|||
48836924|NCT00712335|157245642|FG002|Overall Study|Lack of Efficacy|1|||
48836925|NCT00712335|157245643|FG003|Overall Study|Lack of Efficacy|1|||
48836926|NCT00712335|157245644|FG004|Overall Study|Lack of Efficacy|0|||
48604524|NCT03154086|156408978|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48836927|NCT00712335|157245640|FG000|Overall Study|Other Reason|0|||
48836928|NCT00712335|157245641|FG001|Overall Study|Other Reason|3|||
48836929|NCT00712335|157245642|FG002|Overall Study|Other Reason|1|||
48836930|NCT00712335|157245643|FG003|Overall Study|Other Reason|0|||
48836931|NCT00712335|157245644|FG004|Overall Study|Other Reason|0|||
48836932|NCT03194958|157245649|FG000|Overall Study|Death|0|||
48836933|NCT03194958|157245650|FG001|Overall Study|Death|1|||
48836934|NCT03194958|157245651|FG002|Overall Study|Death|1|||
48836935|NCT03194958|157245652|FG003|Overall Study|Death|1|||
48836936|NCT03194958|157245649|FG000|Overall Study|Withdrawal by Subject|24|||
48836937|NCT03194958|157245650|FG001|Overall Study|Withdrawal by Subject|27|||
48836938|NCT03194958|157245651|FG002|Overall Study|Withdrawal by Subject|7|||
48836939|NCT03194958|157245652|FG003|Overall Study|Withdrawal by Subject|22|||
48836940|NCT03194958|157245649|FG000|Overall Study|Lost to Follow-up|168|||
48836941|NCT03194958|157245650|FG001|Overall Study|Lost to Follow-up|196|||
48836942|NCT03194958|157245651|FG002|Overall Study|Lost to Follow-up|174|||
48836943|NCT03194958|157245652|FG003|Overall Study|Lost to Follow-up|186|||
48836944|NCT00959946|157245654|FG000|Overall Study|Adverse Event|0|||
48836945|NCT00959946|157245655|FG001|Overall Study|Adverse Event|0|||
48604525|NCT03154086|156408979|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48836946|NCT00959946|157245656|FG002|Overall Study|Adverse Event|2|||
48836947|NCT00959946|157245657|FG003|Overall Study|Adverse Event|1|||
48836948|NCT00959946|157245658|FG004|Overall Study|Adverse Event|0|||
48836949|NCT00959946|157245659|FG005|Overall Study|Adverse Event|1|||
48836950|NCT00959946|157245660|FG006|Overall Study|Adverse Event|0|||
48836951|NCT00959946|157245661|FG007|Overall Study|Adverse Event|0|||
48836952|NCT00959946|157245654|FG000|Overall Study|Death|0|||
48836953|NCT00959946|157245655|FG001|Overall Study|Death|0|||
48836954|NCT00959946|157245656|FG002|Overall Study|Death|0|||
48836955|NCT00959946|157245657|FG003|Overall Study|Death|0|||
48836956|NCT00959946|157245658|FG004|Overall Study|Death|0|||
48836957|NCT00959946|157245659|FG005|Overall Study|Death|1|||
48836958|NCT00959946|157245660|FG006|Overall Study|Death|0|||
48836959|NCT00959946|157245661|FG007|Overall Study|Death|0|||
48836960|NCT00959946|157245654|FG000|Overall Study|Disease Progression|2|||
48836961|NCT00959946|157245655|FG001|Overall Study|Disease Progression|4|||
48836962|NCT00959946|157245656|FG002|Overall Study|Disease Progression|2|||
48836963|NCT00959946|157245657|FG003|Overall Study|Disease Progression|4|||
48604526|NCT03154086|156408980|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48836964|NCT00959946|157245658|FG004|Overall Study|Disease Progression|4|||
48836965|NCT00959946|157245659|FG005|Overall Study|Disease Progression|6|||
48836966|NCT00959946|157245660|FG006|Overall Study|Disease Progression|2|||
48836967|NCT00959946|157245661|FG007|Overall Study|Disease Progression|2|||
48836968|NCT00959946|157245654|FG000|Overall Study|Withdrawal by Subject|0|||
48836969|NCT00959946|157245655|FG001|Overall Study|Withdrawal by Subject|0|||
48836970|NCT00959946|157245656|FG002|Overall Study|Withdrawal by Subject|0|||
48836971|NCT00959946|157245657|FG003|Overall Study|Withdrawal by Subject|0|||
48836972|NCT00959946|157245658|FG004|Overall Study|Withdrawal by Subject|0|||
48836973|NCT00959946|157245659|FG005|Overall Study|Withdrawal by Subject|1|||
48836974|NCT00959946|157245660|FG006|Overall Study|Withdrawal by Subject|0|||
48836975|NCT00959946|157245661|FG007|Overall Study|Withdrawal by Subject|0|||
48836976|NCT01202955|157245664|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
48836977|NCT01202955|157245665|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
48836978|NCT00159783|157245666|FG000|Overall Study|Adverse Event|5|||
48836979|NCT00159783|157245667|FG001|Overall Study|Adverse Event|7|||
48836980|NCT00159783|157245668|FG002|Overall Study|Adverse Event|9|||
48836981|NCT00159783|157245666|FG000|Overall Study|Lack of Efficacy|1|||
48836982|NCT00159783|157245667|FG001|Overall Study|Lack of Efficacy|2|||
48836983|NCT00159783|157245668|FG002|Overall Study|Lack of Efficacy|3|||
48836984|NCT00159783|157245666|FG000|Overall Study|Withdrawal by Subject|7|||
48836985|NCT00159783|157245667|FG001|Overall Study|Withdrawal by Subject|11|||
48836986|NCT00159783|157245668|FG002|Overall Study|Withdrawal by Subject|12|||
48836987|NCT00159783|157245666|FG000|Overall Study|Lost to Follow-up|6|||
48836988|NCT00159783|157245667|FG001|Overall Study|Lost to Follow-up|5|||
48836989|NCT00159783|157245668|FG002|Overall Study|Lost to Follow-up|11|||
48836990|NCT00159783|157245666|FG000|Overall Study|Other|0|||
48836991|NCT00159783|157245667|FG001|Overall Study|Other|2|||
48836992|NCT00159783|157245668|FG002|Overall Study|Other|4|||
48836993|NCT00658996|157245671|FG000|First Intervention|Positive slit lamp finding|1|||
48836994|NCT00658996|157245672|FG001|First Intervention|Positive slit lamp finding|0|||
48836995|NCT00658996|157245671|FG000|First Intervention|Lack of lenses|0|||
48836996|NCT00658996|157245672|FG001|First Intervention|Lack of lenses|1|||
48836997|NCT00658996|157245671|FG000|Crossover Period|Physician Decision|1|||
48534856|NCT00484419|156144936|FG001|Overall Study|subject relocated|1|||
48836998|NCT00658996|157245672|FG001|Crossover Period|Physician Decision|0|||
48836999|NCT00658996|157245671|FG000|Crossover Period|Ineligible|1|||
48837000|NCT00658996|157245672|FG001|Crossover Period|Ineligible|1|||
48837001|NCT00658996|157245671|FG000|Second Intervention|Developed a stye on upper lid|1|||
48837002|NCT00658996|157245672|FG001|Second Intervention|Developed a stye on upper lid|0|||
48837003|NCT00658996|157245671|FG000|Second Intervention|Positive slit lamp finding|0|||
48837004|NCT00658996|157245672|FG001|Second Intervention|Positive slit lamp finding|1|||
48837005|NCT00997386|157245673|FG000|Overall Study|Death|7|||
48837006|NCT01041417|157245674|FG000|Overall Study|Adverse Event|5|||
48534857|NCT00484419|156144937|FG002|Overall Study|subject relocated|0|||
48534858|NCT00484419|156144935|FG000|Overall Study|sponsor decision, randomized in error|0|||
48534859|NCT00484419|156144936|FG001|Overall Study|sponsor decision, randomized in error|0|||
48534860|NCT00484419|156144937|FG002|Overall Study|sponsor decision, randomized in error|2|||
48534861|NCT00466726|156144938|FG000|Overall Study|Not evaluable for response|14|||
48534862|NCT01376310|156144940|FG000|Overall Study|Study closed/terminated|1|||
48534863|NCT01376310|156144941|FG001|Overall Study|Study closed/terminated|2|||
48534864|NCT01376310|156144940|FG000|Overall Study|Withdrawal by Subject|8|||
48534865|NCT01376310|156144941|FG001|Overall Study|Withdrawal by Subject|2|||
48837007|NCT01041417|157245675|FG001|Overall Study|Adverse Event|2|||
48534866|NCT01376310|156144940|FG000|Overall Study|Physician Decision|26|||
48534867|NCT01376310|156144941|FG001|Overall Study|Physician Decision|7|||
48534868|NCT01376310|156144940|FG000|Overall Study|Lost to Follow-up|1|||
48534869|NCT01376310|156144941|FG001|Overall Study|Lost to Follow-up|0|||
48534870|NCT00296491|156144942|FG000|Overall Study|Low Pollen Counts|18|||
48534871|NCT00296491|156144943|FG001|Overall Study|Low Pollen Counts|26|||
48534872|NCT00296491|156144944|FG002|Overall Study|Low Pollen Counts|25|||
48534873|NCT00296491|156144945|FG003|Overall Study|Low Pollen Counts|16|||
48534874|NCT00296491|156144942|FG000|Overall Study|Protocol Violation|4|||
48534875|NCT00296491|156144943|FG001|Overall Study|Protocol Violation|6|||
48534876|NCT00296491|156144944|FG002|Overall Study|Protocol Violation|2|||
48534877|NCT00296491|156144945|FG003|Overall Study|Protocol Violation|3|||
48534878|NCT00296491|156144942|FG000|Overall Study|Adverse Event|1|||
48534879|NCT00296491|156144943|FG001|Overall Study|Adverse Event|3|||
48534880|NCT00296491|156144944|FG002|Overall Study|Adverse Event|1|||
48534881|NCT00296491|156144945|FG003|Overall Study|Adverse Event|4|||
48534882|NCT00296491|156144942|FG000|Overall Study|Withdrawn due to Asthma|0|||
48534883|NCT00296491|156144943|FG001|Overall Study|Withdrawn due to Asthma|0|||
48534884|NCT00296491|156144944|FG002|Overall Study|Withdrawn due to Asthma|0|||
48534885|NCT00296491|156144945|FG003|Overall Study|Withdrawn due to Asthma|4|||
48534886|NCT00296491|156144942|FG000|Overall Study|Withdrawal by Subject|7|||
48534887|NCT00296491|156144943|FG001|Overall Study|Withdrawal by Subject|3|||
48534888|NCT00296491|156144944|FG002|Overall Study|Withdrawal by Subject|3|||
48534889|NCT00296491|156144945|FG003|Overall Study|Withdrawal by Subject|2|||
48534890|NCT00296491|156144942|FG000|Overall Study|Non-Compliance|12|||
48534891|NCT00296491|156144943|FG001|Overall Study|Non-Compliance|13|||
48534892|NCT00296491|156144944|FG002|Overall Study|Non-Compliance|10|||
48837008|NCT01041417|157245674|FG000|Overall Study|Lost to Follow-up|1|||
48534893|NCT00296491|156144945|FG003|Overall Study|Non-Compliance|14|||
48534894|NCT00296491|156144942|FG000|Overall Study|Lost to Follow-up|0|||
48837009|NCT01041417|157245675|FG001|Overall Study|Lost to Follow-up|1|||
48837010|NCT01041417|157245674|FG000|Overall Study|Death|1|||
48534895|NCT00296491|156144943|FG001|Overall Study|Lost to Follow-up|2|||
48534896|NCT00296491|156144944|FG002|Overall Study|Lost to Follow-up|2|||
48534897|NCT00296491|156144945|FG003|Overall Study|Lost to Follow-up|0|||
48837011|NCT01041417|157245675|FG001|Overall Study|Death|0|||
48837012|NCT03201562|157245678|FG000|Overall Study|Physician Decision|0|||
48534898|NCT03005067|156144948|FG000|Overall Study|Withdrawal by Subject|3|||
48534899|NCT03005067|156144949|FG001|Overall Study|Withdrawal by Subject|2|||
48534900|NCT03005067|156144948|FG000|Overall Study|Adverse Event|4|||
48534901|NCT03005067|156144949|FG001|Overall Study|Adverse Event|3|||
48534902|NCT03005067|156144948|FG000|Overall Study|Other (reason not specified)|3|||
48534903|NCT03005067|156144949|FG001|Overall Study|Other (reason not specified)|1|||
48534904|NCT03005067|156144948|FG000|Overall Study|Protocol Violation|0|||
48534905|NCT03005067|156144949|FG001|Overall Study|Protocol Violation|1|||
48534906|NCT01807117|156144950|FG000|Overall Study|Physician Decision|2|||
48534907|NCT01807117|156144950|FG000|Overall Study|Disease diagnosis not a study disease|1|||
48534908|NCT01355159|156144953|FG000|Overall Study|Withdrew consent|39|||
48534909|NCT01355159|156144954|FG001|Overall Study|Withdrew consent|47|||
48534910|NCT01355159|156144953|FG000|Overall Study|No primary outcome data|17|||
48534911|NCT01355159|156144954|FG001|Overall Study|No primary outcome data|11|||
48534912|NCT01355159|156144953|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
48534913|NCT01355159|156144954|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
48534914|NCT01355159|156144953|FG000|Overall Study|Early intrauterine fetal death|6|||
48534915|NCT01355159|156144954|FG001|Overall Study|Early intrauterine fetal death|6|||
48534916|NCT01930175|156144955|FG000|Core Study|Lost to Follow-up|0|||
48534917|NCT01930175|156144956|FG001|Core Study|Lost to Follow-up|1|||
48534918|NCT01930175|156144957|FG002|Core Study|Lost to Follow-up|0|||
48837013|NCT03201562|157245679|FG001|Overall Study|Physician Decision|0|||
48837014|NCT03201562|157245680|FG002|Overall Study|Physician Decision|1|||
48837015|NCT03201562|157245678|FG000|Overall Study|Adverse Event|0|||
48837016|NCT03201562|157245679|FG001|Overall Study|Adverse Event|0|||
48837017|NCT03201562|157245680|FG002|Overall Study|Adverse Event|1|||
48837018|NCT03201562|157245678|FG000|Overall Study|Lost to Follow-up|0|||
48837019|NCT03201562|157245679|FG001|Overall Study|Lost to Follow-up|1|||
48837020|NCT03201562|157245680|FG002|Overall Study|Lost to Follow-up|2|||
48534919|NCT01930175|156144955|FG000|Core Study|Adverse Event|0|||
48534920|NCT01930175|156144956|FG001|Core Study|Adverse Event|0|||
48534921|NCT01930175|156144957|FG002|Core Study|Adverse Event|1|||
48534922|NCT01103479|156144958|FG000|Overall Study|Up to date with CRC screening|1|||
48534923|NCT01103479|156144959|FG001|Overall Study|Up to date with CRC screening|9|||
48534924|NCT01103479|156144960|FG002|Overall Study|Up to date with CRC screening|12|||
48534925|NCT01103479|156144958|FG000|Overall Study|Family history of CRC|1|||
48534926|NCT01103479|156144959|FG001|Overall Study|Family history of CRC|0|||
48534927|NCT01103479|156144960|FG002|Overall Study|Family history of CRC|2|||
48534928|NCT01103479|156144958|FG000|Overall Study|Active cancer|1|||
48534929|NCT01103479|156144959|FG001|Overall Study|Active cancer|0|||
48534930|NCT01103479|156144960|FG002|Overall Study|Active cancer|0|||
48534931|NCT01103479|156144958|FG000|Overall Study|Saw non-study physician|2|||
48534932|NCT01103479|156144959|FG001|Overall Study|Saw non-study physician|0|||
48837021|NCT01117480|157247048|FG000|Overall Study|Protocol Violation|8|||
48837022|NCT01117480|157247048|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
48837023|NCT01266265|157247049|FG000|Overall Study|Death|95|||
48837024|NCT01266265|157247050|FG001|Overall Study|Death|73|||
48837025|NCT01266265|157247049|FG000|Overall Study|Lost to Follow-up|23|||
48837026|NCT01266265|157247050|FG001|Overall Study|Lost to Follow-up|28|||
48534933|NCT01103479|156144960|FG002|Overall Study|Saw non-study physician|0|||
48534934|NCT00834899|156144961|FG000|Overall Study|Withdrawal by Subject|1|||
48534935|NCT00834899|156144962|FG001|Overall Study|Withdrawal by Subject|1|||
48534936|NCT01534637|156144963|FG000|Overall Study|Physician Decision|3|||
48534937|NCT01534637|156144963|FG000|Overall Study|Lack of Efficacy|3|||
48534938|NCT01534637|156144963|FG000|Overall Study|Withdrawal by Subject|1|||
48534939|NCT01534637|156144963|FG000|Overall Study|Adverse Event|1|||
48534940|NCT01534637|156144963|FG000|Overall Study|Liver Mets before treatment|1|||
48534941|NCT01523587|156144964|FG000|Overall Study|Other than listed|5|||
48534942|NCT01523587|156144965|FG001|Overall Study|Other than listed|5|||
48534943|NCT01523587|156144964|FG000|Overall Study|Worsening of underlying cancer disease|19|||
48534944|NCT01523587|156144965|FG001|Overall Study|Worsening of underlying cancer disease|34|||
48534945|NCT01523587|156144964|FG000|Overall Study|Adverse Event|68|||
48534946|NCT01523587|156144965|FG001|Overall Study|Adverse Event|52|||
48534947|NCT01523587|156144964|FG000|Overall Study|Protocol Violation|5|||
48534948|NCT01523587|156144965|FG001|Overall Study|Protocol Violation|3|||
48534949|NCT01523587|156144964|FG000|Overall Study|Lost to Follow-up|2|||
48534950|NCT01523587|156144965|FG001|Overall Study|Lost to Follow-up|2|||
48534951|NCT01523587|156144964|FG000|Overall Study|Withdrawal by Subject|28|||
48534952|NCT01523587|156144965|FG001|Overall Study|Withdrawal by Subject|20|||
48837027|NCT01266265|157247049|FG000|Overall Study|Withdrawal by Subject|13|||
48837028|NCT01266265|157247050|FG001|Overall Study|Withdrawal by Subject|11|||
48837029|NCT01266265|157247049|FG000|Overall Study|Respiratory-related adverse event|2|||
48534953|NCT01523587|156144964|FG000|Overall Study|Withdrew due to Progressive disease|265|||
48604527|NCT03154086|156408981|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604528|NCT03154086|156408982|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604529|NCT03154086|156408983|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604530|NCT03154086|156408984|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604531|NCT03154086|156408985|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
48604532|NCT03154086|156408971|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604533|NCT03154086|156408972|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604534|NCT03154086|156408973|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604535|NCT03154086|156408974|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48534954|NCT01523587|156144965|FG001|Overall Study|Withdrew due to Progressive disease|279|||
48534955|NCT01523587|156144964|FG000|Overall Study|Randomised but bot treated|6|||
48534956|NCT01523587|156144965|FG001|Overall Study|Randomised but bot treated|2|||
48534957|NCT01298778|156144967|FG000|Overall Study|Lost to Follow-up|2|||
48534958|NCT01298778|156144968|FG001|Overall Study|Lost to Follow-up|3|||
48534959|NCT01298778|156144967|FG000|Overall Study|Incorrect use of VAS|1|||
48534960|NCT01298778|156144968|FG001|Overall Study|Incorrect use of VAS|0|||
48534961|NCT01298778|156144967|FG000|Overall Study|Withdrawal by Subject|0|||
48534962|NCT01298778|156144968|FG001|Overall Study|Withdrawal by Subject|1|||
48534963|NCT01298778|156144967|FG000|Overall Study|Protocol Violation|0|||
48534964|NCT01298778|156144968|FG001|Overall Study|Protocol Violation|1|||
48534965|NCT01298778|156144967|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
48534966|NCT01298778|156144968|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
48534967|NCT00767520|156144969|FG000|Overall Study|Participants still on treatment|11|||
48534968|NCT00767520|156144970|FG001|Overall Study|Participants still on treatment|15|||
48534969|NCT00767520|156144969|FG000|Overall Study|Randomized in error and Never treated|0|||
48534970|NCT00767520|156144970|FG001|Overall Study|Randomized in error and Never treated|2|||
48534971|NCT00094094|156144971|FG000|Overall Study|Death|2|||
48534972|NCT00094094|156144971|FG000|Overall Study|Lack of Efficacy|23|||
48837030|NCT01266265|157247050|FG001|Overall Study|Respiratory-related adverse event|1|||
48837031|NCT01266265|157247049|FG000|Overall Study|Transferred care to another provider|22|||
48534973|NCT00094094|156144971|FG000|Overall Study|Adverse Event|7|||
48534974|NCT04965389|156144972|FG000|Overall Study|Other reasons|1|||
48534975|NCT04965389|156144973|FG001|Overall Study|Other reasons|0|||
48534976|NCT04965389|156144974|FG002|Overall Study|Other reasons|0|||
48534977|NCT04965389|156144975|FG003|Overall Study|Other reasons|0|||
48534978|NCT04965389|156144972|FG000|Overall Study|Participant withdrew consent|0|||
48534979|NCT04965389|156144973|FG001|Overall Study|Participant withdrew consent|1|||
48534980|NCT04965389|156144974|FG002|Overall Study|Participant withdrew consent|0|||
48534981|NCT04965389|156144975|FG003|Overall Study|Participant withdrew consent|0|||
48534982|NCT04965389|156144972|FG000|Overall Study|Poor/Non-compliance|0|||
48534983|NCT04965389|156144973|FG001|Overall Study|Poor/Non-compliance|1|||
48534984|NCT04965389|156144974|FG002|Overall Study|Poor/Non-compliance|0|||
48534985|NCT04965389|156144975|FG003|Overall Study|Poor/Non-compliance|0|||
48534986|NCT02709486|156144976|FG000|Overall Study|Adverse Event|2|||
48534987|NCT02709486|156144977|FG001|Overall Study|Adverse Event|5|||
48534988|NCT02709486|156144978|FG002|Overall Study|Adverse Event|3|||
48534989|NCT02709486|156144976|FG000|Overall Study|Death|0|||
48534990|NCT02709486|156144977|FG001|Overall Study|Death|0|||
48534991|NCT02709486|156144978|FG002|Overall Study|Death|2|||
48534992|NCT02709486|156144976|FG000|Overall Study|Insufficient clinical response|7|||
48534993|NCT02709486|156144977|FG001|Overall Study|Insufficient clinical response|3|||
48534994|NCT02709486|156144978|FG002|Overall Study|Insufficient clinical response|3|||
48534995|NCT02709486|156144976|FG000|Overall Study|Lost to Follow-up|3|||
48534996|NCT02709486|156144977|FG001|Overall Study|Lost to Follow-up|2|||
48534997|NCT02709486|156144978|FG002|Overall Study|Lost to Follow-up|2|||
48534998|NCT02709486|156144976|FG000|Overall Study|Other|0|||
48534999|NCT02709486|156144977|FG001|Overall Study|Other|2|||
48535000|NCT02709486|156144978|FG002|Overall Study|Other|3|||
48535001|NCT02709486|156144976|FG000|Overall Study|Withdrawal by Subject|32|||
48535002|NCT02709486|156144977|FG001|Overall Study|Withdrawal by Subject|22|||
48535003|NCT02709486|156144978|FG002|Overall Study|Withdrawal by Subject|32|||
48604536|NCT03154086|156408975|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604537|NCT03154086|156408976|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604538|NCT03154086|156408977|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604539|NCT03154086|156408978|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48837032|NCT01266265|157247050|FG001|Overall Study|Transferred care to another provider|28|||
48837033|NCT01266265|157247049|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
48535004|NCT02443545|156144981|FG000|Overall Study|Adverse Event|1|||
48535005|NCT02443545|156144982|FG001|Overall Study|Adverse Event|1|||
48535006|NCT02443545|156144981|FG000|Overall Study|Lost to Follow-up|0|||
48535007|NCT02443545|156144982|FG001|Overall Study|Lost to Follow-up|2|||
48535008|NCT02443545|156144981|FG000|Overall Study|Physician Decision|3|||
48535009|NCT02443545|156144982|FG001|Overall Study|Physician Decision|0|||
48535010|NCT02443545|156144981|FG000|Overall Study|Protocol Violation|8|||
48837034|NCT01266265|157247050|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
48837035|NCT01266265|157247049|FG000|Overall Study|Enrolled in another clinical study|15|||
48837036|NCT01266265|157247050|FG001|Overall Study|Enrolled in another clinical study|26|||
48535011|NCT02443545|156144982|FG001|Overall Study|Protocol Violation|1|||
48535012|NCT02443545|156144981|FG000|Overall Study|Pregnancy|1|||
48535013|NCT02443545|156144982|FG001|Overall Study|Pregnancy|1|||
48535014|NCT02443545|156144981|FG000|Overall Study|Withdrawal by Subject|6|||
48535015|NCT02443545|156144982|FG001|Overall Study|Withdrawal by Subject|3|||
48535016|NCT02443545|156144981|FG000|Overall Study|Termination of study|20|||
48535017|NCT02443545|156144982|FG001|Overall Study|Termination of study|11|||
48535018|NCT03499119|156144983|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
48535019|NCT03499119|156144984|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
48535020|NCT03499119|156144985|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
48535021|NCT03499119|156144986|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
48535022|NCT03499119|156144983|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
48535023|NCT03499119|156144984|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
48535024|NCT03499119|156144985|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
48535025|NCT03499119|156144986|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
48535026|NCT03499119|156144983|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
48535027|NCT03499119|156144984|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
48535028|NCT03499119|156144985|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
48535029|NCT03499119|156144986|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
48535030|NCT03499119|156144983|FG000|Optional Extension Phase|Lost to Follow-up|0|||
48535031|NCT03499119|156144984|FG001|Optional Extension Phase|Lost to Follow-up|0|||
48535032|NCT03499119|156144985|FG002|Optional Extension Phase|Lost to Follow-up|0|||
48535033|NCT03499119|156144986|FG003|Optional Extension Phase|Lost to Follow-up|1|||
48535034|NCT03499119|156144983|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
48535035|NCT03499119|156144984|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
48535036|NCT03499119|156144985|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
48535037|NCT03499119|156144986|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
48535038|NCT03499119|156144983|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
48535039|NCT03499119|156144984|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
48535040|NCT03499119|156144985|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
48535041|NCT03499119|156144986|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
48535042|NCT02459418|156146641|FG000|Overall Study|Exclusion Criteria|4|||
48535043|NCT02459418|156146642|FG001|Overall Study|Exclusion Criteria|0|||
48535044|NCT02459418|156146641|FG000|Overall Study|Protocol Violation|0|||
48535045|NCT02459418|156146642|FG001|Overall Study|Protocol Violation|2|||
48535046|NCT02459418|156146641|FG000|Overall Study|Physician Decision|0|||
48535047|NCT02459418|156146642|FG001|Overall Study|Physician Decision|2|||
48535048|NCT02459418|156146641|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
48535049|NCT02459418|156146642|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
48535050|NCT02459418|156146641|FG000|Overall Study|Adverse Event|0|||
48535051|NCT02459418|156146642|FG001|Overall Study|Adverse Event|1|||
48535052|NCT02459418|156146641|FG000|Overall Study|Withdrawal by Subject|1|||
48535053|NCT02459418|156146642|FG001|Overall Study|Withdrawal by Subject|1|||
48535054|NCT02459418|156146641|FG000|Overall Study|Elevated Creatine Kinase|1|||
48535055|NCT02459418|156146642|FG001|Overall Study|Elevated Creatine Kinase|0|||
48535056|NCT02459418|156146641|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
48837037|NCT01266265|157247049|FG000|Overall Study|Non-compliance|8|||
48837038|NCT01266265|157247050|FG001|Overall Study|Non-compliance|5|||
48837039|NCT01266265|157247049|FG000|Overall Study|Lung transplant|6|||
48837040|NCT01266265|157247050|FG001|Overall Study|Lung transplant|5|||
48837041|NCT01266265|157247049|FG000|Overall Study|Site closed early|4|||
48837042|NCT01266265|157247050|FG001|Overall Study|Site closed early|3|||
48535057|NCT02459418|156146642|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
48535058|NCT02973321|156146643|FG000|Overall Study|Other than specified|0|||
48535059|NCT02973321|156146644|FG001|Overall Study|Other than specified|5|||
48535060|NCT02973321|156146645|FG002|Overall Study|Other than specified|3|||
48535061|NCT02973321|156146646|FG003|Overall Study|Other than specified|3|||
48535062|NCT02973321|156146647|FG004|Overall Study|Other than specified|1|||
48837043|NCT01266265|157247049|FG000|Overall Study|Clinical worsening|1|||
48837044|NCT01266265|157247050|FG001|Overall Study|Clinical worsening|1|||
48535063|NCT02973321|156146643|FG000|Overall Study|Lack of Efficacy|0|||
48535064|NCT02973321|156146644|FG001|Overall Study|Lack of Efficacy|0|||
48535065|NCT02973321|156146645|FG002|Overall Study|Lack of Efficacy|0|||
48535066|NCT02973321|156146646|FG003|Overall Study|Lack of Efficacy|0|||
48535067|NCT02973321|156146647|FG004|Overall Study|Lack of Efficacy|1|||
48535068|NCT02973321|156146643|FG000|Overall Study|Adverse Event|1|||
48535069|NCT02973321|156146644|FG001|Overall Study|Adverse Event|10|||
48604540|NCT03154086|156408979|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
48837045|NCT00028769|157247051|FG000|Overall Study|Adverse Event|2|||
48837046|NCT00028769|157247051|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
48837047|NCT00028769|157247051|FG000|Overall Study|Progression or Death|31|||
48837048|NCT00028769|157247051|FG000|Overall Study|Other - Not Protocol Specified|1|||
48837049|NCT00028769|157247051|FG000|Overall Study|Ineligible|5|||
48837050|NCT00028769|157247051|FG000|Overall Study|Not Analyzable|1|||
48837051|NCT02015546|157247058|FG000|Overall Study|Withdrawal by Subject|1|||
48837052|NCT02015546|157247059|FG001|Overall Study|Withdrawal by Subject|1|||
48837053|NCT02015546|157247060|FG002|Overall Study|Withdrawal by Subject|1|||
48837054|NCT02015546|157247058|FG000|Overall Study|Screem Failure|2|||
48837055|NCT02015546|157247059|FG001|Overall Study|Screem Failure|1|||
48837056|NCT02015546|157247060|FG002|Overall Study|Screem Failure|3|||
48535070|NCT02973321|156146645|FG002|Overall Study|Adverse Event|11|||
48535071|NCT02973321|156146646|FG003|Overall Study|Adverse Event|13|||
48535072|NCT02973321|156146647|FG004|Overall Study|Adverse Event|3|||
48535073|NCT00685802|156146648|FG000|Washout Period of 7 Days|Protocol Violation|2|||
48535074|NCT00685802|156146649|FG001|Washout Period of 7 Days|Protocol Violation|0|||
48535075|NCT00685802|156146648|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
48535076|NCT00685802|156146649|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48535077|NCT01048502|156146650|FG000|Overall Study|Lost to Follow-up|2|||
48837057|NCT00507689|157247065|FG000|Pre-Randomization Period|Adverse Event|1|||
48837058|NCT00507689|157247066|FG001|Pre-Randomization Period|Adverse Event|0|||
48837059|NCT00507689|157247065|FG000|Pre-Randomization Period|Physician Decision|1|||
48837060|NCT00507689|157247066|FG001|Pre-Randomization Period|Physician Decision|0|||
48837061|NCT00507689|157247065|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
48837062|NCT00507689|157247066|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
48837063|NCT00507689|157247065|FG000|Randomized Period|Adverse Event|1|||
48837064|NCT00507689|157247066|FG001|Randomized Period|Adverse Event|1|||
48837065|NCT00507689|157247065|FG000|Randomized Period|Withdrawal by Subject|0|||
48837066|NCT00507689|157247066|FG001|Randomized Period|Withdrawal by Subject|1|||
48837067|NCT00346333|157247067|FG000|Overall Study|Death|1|||
48837068|NCT00346333|157247068|FG001|Overall Study|Death|0|||
48837069|NCT00346333|157247067|FG000|Overall Study|unwilling or unable to continue|4|||
48837070|NCT00346333|157247068|FG001|Overall Study|unwilling or unable to continue|8|||
48837071|NCT00494780|157247069|FG000|Overall Study|Adverse Event|1|||
48837072|NCT00494780|157247070|FG001|Overall Study|Adverse Event|0|||
48837073|NCT00494780|157247069|FG000|Overall Study|Withdrew before Dosed|0|||
48837074|NCT00494780|157247070|FG001|Overall Study|Withdrew before Dosed|1|||
48837075|NCT00494780|157247069|FG000|Overall Study|Progression of Study Disease|7|||
48837076|NCT00494780|157247070|FG001|Overall Study|Progression of Study Disease|8|||
48837077|NCT00494780|157247069|FG000|Overall Study|New Treatment|2|||
48837078|NCT00494780|157247070|FG001|Overall Study|New Treatment|2|||
48837079|NCT00494780|157247069|FG000|Overall Study|Non-compliance|1|||
48837080|NCT00494780|157247070|FG001|Overall Study|Non-compliance|0|||
48837081|NCT00494780|157247069|FG000|Overall Study|Residual Tumour Mass|0|||
48837082|NCT00494780|157247070|FG001|Overall Study|Residual Tumour Mass|1|||
48837083|NCT00494780|157247069|FG000|Overall Study|Insurance Issues|0|||
48837084|NCT00494780|157247070|FG001|Overall Study|Insurance Issues|1|||
48535078|NCT01048502|156146651|FG001|Overall Study|Lost to Follow-up|0|||
48535079|NCT01048502|156146652|FG002|Overall Study|Lost to Follow-up|0|||
48535080|NCT01048502|156146653|FG003|Overall Study|Lost to Follow-up|0|||
48535081|NCT01048502|156146650|FG000|Overall Study|Adverse Event|1|||
48535082|NCT01048502|156146651|FG001|Overall Study|Adverse Event|0|||
48535083|NCT01048502|156146652|FG002|Overall Study|Adverse Event|0|||
48535084|NCT01048502|156146653|FG003|Overall Study|Adverse Event|0|||
48535085|NCT01048502|156146650|FG000|Overall Study|Withdrawal by Subject|1|||
48535086|NCT01048502|156146651|FG001|Overall Study|Withdrawal by Subject|4|||
48535087|NCT01048502|156146652|FG002|Overall Study|Withdrawal by Subject|5|||
48535088|NCT01048502|156146653|FG003|Overall Study|Withdrawal by Subject|3|||
48535089|NCT01048502|156146650|FG000|Overall Study|Physician Decision|0|||
48535090|NCT01048502|156146651|FG001|Overall Study|Physician Decision|3|||
48535091|NCT01048502|156146652|FG002|Overall Study|Physician Decision|0|||
48535092|NCT01048502|156146653|FG003|Overall Study|Physician Decision|1|||
48837085|NCT00723450|157247071|FG000|Open-Label Phase|Adverse Event|26|||
48837086|NCT00723450|157247072|FG001|Open-Label Phase|Adverse Event|0|||
48837087|NCT00723450|157247073|FG002|Open-Label Phase|Adverse Event|0|||
48837088|NCT00723450|157247071|FG000|Open-Label Phase|Lack of Efficacy|18|||
48837089|NCT00723450|157247072|FG001|Open-Label Phase|Lack of Efficacy|0|||
48837090|NCT00723450|157247073|FG002|Open-Label Phase|Lack of Efficacy|0|||
48837091|NCT00723450|157247071|FG000|Open-Label Phase|Protocol Violation|35|||
48837092|NCT00723450|157247072|FG001|Open-Label Phase|Protocol Violation|0|||
48837093|NCT00723450|157247073|FG002|Open-Label Phase|Protocol Violation|0|||
48837094|NCT00723450|157247071|FG000|Open-Label Phase|Lost to Follow-up|7|||
48837095|NCT00723450|157247072|FG001|Open-Label Phase|Lost to Follow-up|0|||
48535093|NCT03235479|156146656|FG000|Overall Study|Lost to Follow-up|8|||
48535094|NCT03235479|156146657|FG001|Overall Study|Lost to Follow-up|11|||
48837096|NCT00723450|157247073|FG002|Open-Label Phase|Lost to Follow-up|0|||
48837097|NCT00723450|157247071|FG000|Open-Label Phase|Physician Decision|2|||
48837098|NCT00723450|157247072|FG001|Open-Label Phase|Physician Decision|0|||
48837099|NCT00723450|157247073|FG002|Open-Label Phase|Physician Decision|0|||
48837100|NCT00723450|157247071|FG000|Open-Label Phase|Withdrawal by Subject|37|||
48837101|NCT00723450|157247072|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48837102|NCT00723450|157247073|FG002|Open-Label Phase|Withdrawal by Subject|0|||
48837103|NCT00723450|157247071|FG000|Randomized Phase|Adverse Event|0|||
48837104|NCT00723450|157247072|FG001|Randomized Phase|Adverse Event|26|||
48837105|NCT00723450|157247073|FG002|Randomized Phase|Adverse Event|17|||
48837106|NCT00723450|157247071|FG000|Randomized Phase|Lack of Efficacy|0|||
48837107|NCT00723450|157247072|FG001|Randomized Phase|Lack of Efficacy|11|||
48837108|NCT00723450|157247073|FG002|Randomized Phase|Lack of Efficacy|11|||
48837109|NCT00723450|157247071|FG000|Randomized Phase|Protocol Violation|0|||
48837110|NCT00723450|157247072|FG001|Randomized Phase|Protocol Violation|9|||
48837111|NCT00723450|157247073|FG002|Randomized Phase|Protocol Violation|13|||
48837112|NCT00723450|157247071|FG000|Randomized Phase|Lost to Follow-up|0|||
48837113|NCT00723450|157247072|FG001|Randomized Phase|Lost to Follow-up|2|||
48837114|NCT00723450|157247073|FG002|Randomized Phase|Lost to Follow-up|3|||
48837115|NCT00723450|157247071|FG000|Randomized Phase|Physician Decision|0|||
48837116|NCT00723450|157247072|FG001|Randomized Phase|Physician Decision|3|||
48837117|NCT00723450|157247073|FG002|Randomized Phase|Physician Decision|1|||
48837118|NCT00723450|157247071|FG000|Randomized Phase|Withdrawal by Subject|0|||
48837119|NCT00723450|157247072|FG001|Randomized Phase|Withdrawal by Subject|14|||
48837120|NCT00723450|157247073|FG002|Randomized Phase|Withdrawal by Subject|22|||
48535095|NCT03235479|156146656|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
48535096|NCT03235479|156146657|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
48535097|NCT03235479|156146656|FG000|Overall Study|Pregnancy|1|||
48535098|NCT03235479|156146657|FG001|Overall Study|Pregnancy|0|||
48535099|NCT03235479|156146656|FG000|Overall Study|Protocol Deviation|1|||
48535100|NCT03235479|156146657|FG001|Overall Study|Protocol Deviation|3|||
48535101|NCT03235479|156146656|FG000|Overall Study|Technical Problems|3|||
48535102|NCT03235479|156146657|FG001|Overall Study|Technical Problems|2|||
48535103|NCT03235479|156146656|FG000|Overall Study|Withdrawal by Subject|2|||
48535104|NCT03235479|156146657|FG001|Overall Study|Withdrawal by Subject|2|||
48535105|NCT03235479|156146656|FG000|Overall Study|Other Reasons|3|||
48535106|NCT03235479|156146657|FG001|Overall Study|Other Reasons|5|||
48535107|NCT00653159|156146658|FG000|Overall Study|Adverse Event|4|||
48535108|NCT00653159|156146659|FG001|Overall Study|Adverse Event|1|||
48535109|NCT00653159|156146658|FG000|Overall Study|Lost to Follow-up|1|||
48535110|NCT00653159|156146659|FG001|Overall Study|Lost to Follow-up|2|||
48535111|NCT01333072|156146660|FG000|Overall Study|Lost to Follow-up|3|||
48535112|NCT01333072|156146661|FG001|Overall Study|Lost to Follow-up|0|||
48535113|NCT01333072|156146660|FG000|Overall Study|Adverse Event|2|||
48535114|NCT01333072|156146661|FG001|Overall Study|Adverse Event|4|||
48535115|NCT01333072|156146660|FG000|Overall Study|Physician Decision|1|||
48535116|NCT01333072|156146661|FG001|Overall Study|Physician Decision|0|||
48535117|NCT03036839|156146662|FG000|Overall Study|Adverse Event|0|||
48535118|NCT03036839|156146663|FG001|Overall Study|Adverse Event|0|||
48535119|NCT03036839|156146664|FG002|Overall Study|Adverse Event|1|||
48535120|NCT03036839|156146662|FG000|Overall Study|Death|3|||
48535121|NCT03036839|156146663|FG001|Overall Study|Death|0|||
48535122|NCT03036839|156146664|FG002|Overall Study|Death|3|||
48535123|NCT03036839|156146662|FG000|Overall Study|Withdrew Consent|0|||
48535124|NCT03036839|156146663|FG001|Overall Study|Withdrew Consent|0|||
48535125|NCT03036839|156146664|FG002|Overall Study|Withdrew Consent|1|||
48535126|NCT01316419|156146665|FG000|Overall Study|Not treated|103|||
48535127|NCT01316419|156146665|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
48535128|NCT01316419|156146665|FG000|Overall Study|Lost to Follow-up|19|||
48535129|NCT00412737|156146668|FG000|Overall Study|Death|1|||
48535130|NCT00412737|156146669|FG001|Overall Study|Death|0|||
48535131|NCT00412737|156146668|FG000|Overall Study|Adverse Event|3|||
48535132|NCT00412737|156146669|FG001|Overall Study|Adverse Event|2|||
48535133|NCT00412737|156146668|FG000|Overall Study|Refused Treatment|6|||
48535134|NCT00412737|156146669|FG001|Overall Study|Refused Treatment|2|||
48535135|NCT00412737|156146668|FG000|Overall Study|Failure to Return|6|||
48535136|NCT00412737|156146669|FG001|Overall Study|Failure to Return|2|||
48837121|NCT02314117|157247074|FG000|Overall Study|Lost to Follow-up|9|||
48837122|NCT02314117|157247075|FG001|Overall Study|Lost to Follow-up|14|||
48837123|NCT02314117|157247074|FG000|Overall Study|Withdrawal by Subject|3|||
48837124|NCT02314117|157247075|FG001|Overall Study|Withdrawal by Subject|2|||
48837125|NCT00189202|157247076|FG000|Overall Study|Physician Decision|5|||
48837126|NCT00869323|157247077|FG000|Maintenance Therapy|concurrent illness|1|||
48837127|NCT04054635|157247078|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
48535137|NCT03341000|156146670|FG000|Overall Study|Adverse Event|1|||
48535138|NCT01064531|156146673|FG000|Overall Study|Lost to Follow-up|0|||
48535139|NCT01064531|156146674|FG001|Overall Study|Lost to Follow-up|2|||
48535140|NCT01064531|156146673|FG000|Overall Study|Physician Decision|0|||
48535141|NCT01064531|156146674|FG001|Overall Study|Physician Decision|1|||
48535142|NCT01064531|156146673|FG000|Overall Study|Withdrawal by Subject|2|||
48535143|NCT01064531|156146674|FG001|Overall Study|Withdrawal by Subject|2|||
48604541|NCT03154086|156408980|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604542|NCT03154086|156408981|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604543|NCT03154086|156408982|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604544|NCT03154086|156408983|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604545|NCT03154086|156408984|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604546|NCT03154086|156408985|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
48604547|NCT03154086|156408971|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604548|NCT03154086|156408972|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604549|NCT03154086|156408973|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604550|NCT03154086|156408974|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604551|NCT03154086|156408975|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604552|NCT03154086|156408976|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604553|NCT03154086|156408977|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604554|NCT03154086|156408978|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
48604555|NCT03154086|156408979|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604556|NCT03154086|156408980|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604557|NCT03154086|156408981|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604558|NCT03154086|156408982|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604559|NCT03154086|156408983|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48837128|NCT04054635|157247079|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
48837129|NCT04054635|157247080|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
48837130|NCT04054635|157247078|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
48837131|NCT04054635|157247079|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
48837132|NCT04054635|157247080|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
48837133|NCT00566527|157247084|FG000|Overall Study|Reason not provided|3|||
48837134|NCT00566527|157247085|FG001|Overall Study|Reason not provided|11|||
48837135|NCT00566527|157247086|FG002|Overall Study|Reason not provided|10|||
48837136|NCT00566527|157247084|FG000|Overall Study|Adverse Event|2|||
48837137|NCT00566527|157247085|FG001|Overall Study|Adverse Event|0|||
48837138|NCT00566527|157247086|FG002|Overall Study|Adverse Event|1|||
48837139|NCT00566527|157247084|FG000|Overall Study|Physician Decision|3|||
48837140|NCT00566527|157247085|FG001|Overall Study|Physician Decision|8|||
48837141|NCT00566527|157247086|FG002|Overall Study|Physician Decision|20|||
48837142|NCT00566527|157247084|FG000|Overall Study|Lost to Follow-up|3|||
48837143|NCT00566527|157247085|FG001|Overall Study|Lost to Follow-up|4|||
48837144|NCT00566527|157247086|FG002|Overall Study|Lost to Follow-up|4|||
48445458|NCT03803202|155818741|FG004|Overall Study|Death|0|||
48445459|NCT03803202|155818742|FG005|Overall Study|Death|1|||
48445460|NCT03803202|155818743|FG006|Overall Study|Death|0|||
48445461|NCT03803202|155818744|FG007|Overall Study|Death|0|||
48445462|NCT03803202|155818745|FG008|Overall Study|Death|0|||
48445463|NCT03803202|155818737|FG000|Overall Study|Withdrawal by Subject|0|||
48445464|NCT03803202|155818738|FG001|Overall Study|Withdrawal by Subject|0|||
48445465|NCT03803202|155818739|FG002|Overall Study|Withdrawal by Subject|1|||
48445466|NCT03803202|155818740|FG003|Overall Study|Withdrawal by Subject|0|||
48445467|NCT03803202|155818741|FG004|Overall Study|Withdrawal by Subject|0|||
48445468|NCT03803202|155818742|FG005|Overall Study|Withdrawal by Subject|0|||
48445469|NCT03803202|155818743|FG006|Overall Study|Withdrawal by Subject|0|||
48445470|NCT03803202|155818744|FG007|Overall Study|Withdrawal by Subject|1|||
48445471|NCT03803202|155818745|FG008|Overall Study|Withdrawal by Subject|0|||
48445472|NCT03803202|155818737|FG000|Overall Study|Lost to Follow-up|0|||
48445473|NCT03803202|155818738|FG001|Overall Study|Lost to Follow-up|0|||
48445474|NCT03803202|155818739|FG002|Overall Study|Lost to Follow-up|0|||
48445475|NCT03803202|155818740|FG003|Overall Study|Lost to Follow-up|1|||
48445476|NCT03803202|155818741|FG004|Overall Study|Lost to Follow-up|1|||
48445477|NCT03803202|155818742|FG005|Overall Study|Lost to Follow-up|0|||
48445478|NCT03803202|155818743|FG006|Overall Study|Lost to Follow-up|1|||
48445479|NCT03803202|155818744|FG007|Overall Study|Lost to Follow-up|0|||
48445480|NCT03803202|155818745|FG008|Overall Study|Lost to Follow-up|0|||
48445481|NCT03595384|155818746|FG000|Overall Study|Other time commitments|8|||
48445482|NCT03595384|155818746|FG000|Overall Study|Changes to session time|7|||
48445483|NCT03595384|155818746|FG000|Overall Study|Relocation out of country|1|||
48445484|NCT01601470|155818747|FG000|Period 2 - LCZ696|Physician Decision|1|||
48445485|NCT02661464|155818748|FG000|Overall Study|Lost to Follow-up|28|||
48445486|NCT02661464|155818749|FG001|Overall Study|Lost to Follow-up|0|||
48445487|NCT02661464|155818750|FG002|Overall Study|Lost to Follow-up|0|||
48445488|NCT02661464|155818751|FG003|Overall Study|Lost to Follow-up|0|||
48445489|NCT02661464|155818748|FG000|Overall Study|Withdrawal by Subject|3|||
48445490|NCT02661464|155818749|FG001|Overall Study|Withdrawal by Subject|1|||
48445491|NCT02661464|155818750|FG002|Overall Study|Withdrawal by Subject|0|||
48445492|NCT02661464|155818751|FG003|Overall Study|Withdrawal by Subject|0|||
48445493|NCT02661464|155818748|FG000|Overall Study|Participants terminated prematurely|288|||
48604560|NCT03154086|156408984|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604561|NCT03154086|156408985|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
48604562|NCT03154086|156408971|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
48604563|NCT03154086|156408972|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
48604564|NCT03154086|156408973|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
48604565|NCT03154086|156408974|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
48604566|NCT03154086|156408975|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
48604567|NCT03154086|156408976|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
48604568|NCT03154086|156408977|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
48604569|NCT03154086|156408978|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
48604570|NCT03154086|156408979|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
48604571|NCT03154086|156408980|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
48604572|NCT03154086|156408981|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
48604573|NCT03154086|156408982|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
48445571|NCT04095442|155820456|FG001|Overall Study|Screen failure|0|||
48837145|NCT00566527|157247084|FG000|Overall Study|Withdrawal by Subject|6|||
48837146|NCT00566527|157247085|FG001|Overall Study|Withdrawal by Subject|43|||
48837147|NCT00566527|157247086|FG002|Overall Study|Withdrawal by Subject|43|||
48604574|NCT03154086|156408983|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
48604575|NCT03154086|156408984|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
48604576|NCT03154086|156408985|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
48604577|NCT03575702|156408988|FG000|Overall Study|Withdrawal by Subject|1|||
48604578|NCT03575702|156408989|FG001|Overall Study|Withdrawal by Subject|1|||
48604579|NCT03575702|156408988|FG000|Overall Study|Lost to Follow-up|1|||
48604580|NCT03575702|156408989|FG001|Overall Study|Lost to Follow-up|2|||
48604581|NCT03575702|156408988|FG000|Overall Study|Protocol Violation|0|||
48604582|NCT03575702|156408989|FG001|Overall Study|Protocol Violation|1|||
48604583|NCT03575702|156408988|FG000|Overall Study|Patient non compliance|4|||
48604584|NCT03575702|156408989|FG001|Overall Study|Patient non compliance|0|||
48604585|NCT04210986|156408990|FG000|Overall Study|Lost to Follow-up|5|||
48837148|NCT00356265|157247087|FG000|Overall Study|Withdrawal by Subject|0|||
48445572|NCT03363919|155820457|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
48445573|NCT03363919|155820458|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
48837149|NCT00356265|157247088|FG001|Overall Study|Withdrawal by Subject|0|||
48837150|NCT00356265|157247089|FG002|Overall Study|Withdrawal by Subject|1|||
48837151|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
48837152|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
48837153|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
48837154|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
48837155|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
48837156|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
48837157|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
48837158|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
48837159|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
48604586|NCT04210986|156408991|FG001|Overall Study|Lost to Follow-up|2|||
48837160|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
48837161|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
48445574|NCT03363919|155820457|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
48445575|NCT03363919|155820458|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
48445576|NCT00424346|155820461|FG000|Core Study|Adverse Event|5|||
48445577|NCT00424346|155820462|FG001|Core Study|Adverse Event|3|||
48445578|NCT00424346|155820463|FG002|Core Study|Adverse Event|1|||
48445579|NCT00424346|155820464|FG003|Core Study|Adverse Event|1|||
48445580|NCT00424346|155820461|FG000|Core Study|Abnormal Laboratory Values|0|||
48445581|NCT00424346|155820462|FG001|Core Study|Abnormal Laboratory Values|1|||
48445582|NCT00424346|155820463|FG002|Core Study|Abnormal Laboratory Values|0|||
48445583|NCT00424346|155820464|FG003|Core Study|Abnormal Laboratory Values|0|||
48445584|NCT00424346|155820461|FG000|Core Study|Lack of Efficacy|1|||
48445585|NCT00424346|155820462|FG001|Core Study|Lack of Efficacy|3|||
48445586|NCT00424346|155820463|FG002|Core Study|Lack of Efficacy|0|||
48445587|NCT00424346|155820464|FG003|Core Study|Lack of Efficacy|4|||
48604587|NCT04210986|156408990|FG000|Overall Study|Withdrawal by Subject|3|||
48604588|NCT04210986|156408991|FG001|Overall Study|Withdrawal by Subject|1|||
48604589|NCT04210986|156408990|FG000|Overall Study|Protocol Violation|1|||
48604590|NCT04210986|156408991|FG001|Overall Study|Protocol Violation|1|||
48837162|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
48837163|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
48837164|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
48837165|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
48535144|NCT01064531|156146673|FG000|Overall Study|Revision due to femoral stem loosening|1|||
48535145|NCT01064531|156146674|FG001|Overall Study|Revision due to femoral stem loosening|0|||
48604591|NCT04210986|156408990|FG000|Overall Study|Physician Decision|0|||
48604592|NCT04210986|156408991|FG001|Overall Study|Physician Decision|1|||
48604593|NCT01529606|156409006|FG000|Overall Study|Lost to Follow-up|21|||
48604594|NCT01529606|156409007|FG001|Overall Study|Lost to Follow-up|18|||
48604595|NCT03555149|156409008|FG000|Overall Study|Death|18|||
48604596|NCT03555149|156409009|FG001|Overall Study|Death|15|||
48604597|NCT03555149|156409010|FG002|Overall Study|Death|15|||
48604598|NCT03555149|156409011|FG003|Overall Study|Death|4|||
48604599|NCT03555149|156409012|FG004|Overall Study|Death|4|||
48604600|NCT03555149|156409013|FG005|Overall Study|Death|11|||
48604601|NCT03555149|156409014|FG006|Overall Study|Death|12|||
48604602|NCT03555149|156409015|FG007|Overall Study|Death|1|||
48604603|NCT03555149|156409008|FG000|Overall Study|Lost to Follow-up|1|||
48604604|NCT03555149|156409009|FG001|Overall Study|Lost to Follow-up|0|||
48604605|NCT03555149|156409010|FG002|Overall Study|Lost to Follow-up|0|||
48604606|NCT03555149|156409011|FG003|Overall Study|Lost to Follow-up|0|||
48604607|NCT03555149|156409012|FG004|Overall Study|Lost to Follow-up|0|||
48604608|NCT03555149|156409013|FG005|Overall Study|Lost to Follow-up|1|||
48604609|NCT03555149|156409014|FG006|Overall Study|Lost to Follow-up|0|||
48837166|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
48837167|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
48837168|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
48837169|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
48837170|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
48837171|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
48837172|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
48837173|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
48837174|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
48837175|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
48837176|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
48837177|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
48837178|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
48837179|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
48837180|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
48837181|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
48837182|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
48837183|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
48837184|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
48837185|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
48837186|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
48837187|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
48837188|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
48837189|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
48535146|NCT01064531|156146673|FG000|Overall Study|Revision due to dislocation|0|||
48535147|NCT01064531|156146674|FG001|Overall Study|Revision due to dislocation|1|||
48535148|NCT01064531|156146673|FG000|Overall Study|Death|0|||
48535149|NCT01064531|156146674|FG001|Overall Study|Death|1|||
48535150|NCT00754013|156146675|FG000|Overall Study|Lost to Follow-up|1|||
48535151|NCT00754013|156146676|FG001|Overall Study|Lost to Follow-up|1|||
48535152|NCT00754013|156146675|FG000|Overall Study|didn't return after study termed|3|||
48535153|NCT00754013|156146676|FG001|Overall Study|didn't return after study termed|4|||
48535154|NCT01091103|156146677|FG000|Overall Study|Adverse Event|1|||
48604610|NCT03555149|156409015|FG007|Overall Study|Lost to Follow-up|0|||
48837190|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
48837191|NCT02709655|157247090|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
48604611|NCT03555149|156409008|FG000|Overall Study|Physician Decision|1|||
48837192|NCT02709655|157247091|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
48837193|NCT02709655|157247092|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
48604612|NCT03555149|156409009|FG001|Overall Study|Physician Decision|0|||
48837194|NCT02709655|157247093|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
48535155|NCT01091103|156146677|FG000|Overall Study|Progressive Disease|3|||
48604613|NCT03555149|156409010|FG002|Overall Study|Physician Decision|0|||
48604614|NCT03555149|156409011|FG003|Overall Study|Physician Decision|0|||
48604615|NCT03555149|156409012|FG004|Overall Study|Physician Decision|0|||
48604616|NCT03555149|156409013|FG005|Overall Study|Physician Decision|0|||
48604617|NCT03555149|156409014|FG006|Overall Study|Physician Decision|0|||
48604618|NCT03555149|156409015|FG007|Overall Study|Physician Decision|0|||
48604619|NCT03555149|156409008|FG000|Overall Study|Study Terminated By Sponsor|1|||
48604620|NCT03555149|156409009|FG001|Overall Study|Study Terminated By Sponsor|0|||
48604621|NCT03555149|156409010|FG002|Overall Study|Study Terminated By Sponsor|0|||
48604622|NCT03555149|156409011|FG003|Overall Study|Study Terminated By Sponsor|0|||
48604623|NCT03555149|156409012|FG004|Overall Study|Study Terminated By Sponsor|0|||
48604624|NCT03555149|156409013|FG005|Overall Study|Study Terminated By Sponsor|2|||
48604625|NCT03555149|156409014|FG006|Overall Study|Study Terminated By Sponsor|3|||
48604626|NCT03555149|156409015|FG007|Overall Study|Study Terminated By Sponsor|1|||
48604627|NCT03555149|156409008|FG000|Overall Study|Withdrawal by Subject|3|||
48604628|NCT03555149|156409009|FG001|Overall Study|Withdrawal by Subject|0|||
48604629|NCT03555149|156409010|FG002|Overall Study|Withdrawal by Subject|0|||
48604630|NCT03555149|156409011|FG003|Overall Study|Withdrawal by Subject|2|||
48604631|NCT03555149|156409012|FG004|Overall Study|Withdrawal by Subject|0|||
48604632|NCT03555149|156409013|FG005|Overall Study|Withdrawal by Subject|1|||
48604633|NCT03555149|156409014|FG006|Overall Study|Withdrawal by Subject|0|||
48604634|NCT03555149|156409015|FG007|Overall Study|Withdrawal by Subject|0|||
48604635|NCT01746862|156409018|FG000|Overall Study|Withdrawal by Subject|1|||
48604636|NCT01746862|156409019|FG001|Overall Study|Withdrawal by Subject|1|||
48604637|NCT01746862|156409018|FG000|Overall Study|Protocol Violation|1|||
48604638|NCT01746862|156409019|FG001|Overall Study|Protocol Violation|0|||
48604639|NCT01746862|156409018|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
48604640|NCT01746862|156409019|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
48604641|NCT01746862|156409018|FG000|Overall Study|Entered puberty during the study|1|||
48604642|NCT01746862|156409019|FG001|Overall Study|Entered puberty during the study|0|||
48604643|NCT02785939|156409020|FG000|Overall Study|Progression|25|||
48604644|NCT02785939|156409021|FG001|Overall Study|Progression|8|||
48837195|NCT02709655|157247094|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
48837196|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
48837197|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
48837198|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
48837199|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
48837200|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
48837201|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
48837202|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
48837203|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
48837204|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
48837205|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
48837206|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
48837207|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
48837208|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
48837209|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
48837210|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
48837211|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
48837212|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
48837213|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
48837214|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
48837215|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
48837216|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
48837217|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
48837218|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
48837219|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
48837220|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
48837221|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
48837222|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
48604645|NCT02785939|156409020|FG000|Overall Study|Adverse Event|3|||
48604646|NCT02785939|156409021|FG001|Overall Study|Adverse Event|1|||
48604647|NCT02785939|156409020|FG000|Overall Study|Death|1|||
48604648|NCT02785939|156409021|FG001|Overall Study|Death|0|||
48604649|NCT02785939|156409020|FG000|Overall Study|Refusal|1|||
48604650|NCT02785939|156409021|FG001|Overall Study|Refusal|0|||
48604651|NCT02785939|156409020|FG000|Overall Study|Deteriorating health|1|||
48604652|NCT02785939|156409021|FG001|Overall Study|Deteriorating health|0|||
48604653|NCT02785939|156409020|FG000|Overall Study|Not protocol specified|0|||
48837223|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
48837224|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
48837225|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
48837226|NCT02709655|157247090|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
48837227|NCT02709655|157247091|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
48837228|NCT02709655|157247092|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
48837229|NCT02709655|157247093|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
48837230|NCT02709655|157247094|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
48837231|NCT04210180|157247095|FG000|Overall Study|Withdrawal by Subject|2|||
48837232|NCT00468910|157247096|FG000|Overall Study|Lost to Follow-up|2|||
48837233|NCT00468910|157247097|FG001|Overall Study|Lost to Follow-up|1|||
48837234|NCT00468910|157247096|FG000|Overall Study|Withdrawal by Subject|2|||
48837235|NCT00468910|157247097|FG001|Overall Study|Withdrawal by Subject|1|||
48837236|NCT00468910|157247096|FG000|Overall Study|Medical Contraindication|0|||
48837237|NCT00468910|157247097|FG001|Overall Study|Medical Contraindication|1|||
48837238|NCT05190419|157247098|FG000|Overall Study|Lack of Efficacy|8|||
48837239|NCT05190419|157247099|FG001|Overall Study|Lack of Efficacy|0|||
48837240|NCT05190419|157247100|FG002|Overall Study|Lack of Efficacy|1|||
48837241|NCT05190419|157247101|FG003|Overall Study|Lack of Efficacy|0|||
48837242|NCT05190419|157247098|FG000|Overall Study|Withdrawal by Subject|7|||
48837243|NCT05190419|157247099|FG001|Overall Study|Withdrawal by Subject|1|||
48837244|NCT05190419|157247100|FG002|Overall Study|Withdrawal by Subject|2|||
48837245|NCT05190419|157247101|FG003|Overall Study|Withdrawal by Subject|2|||
48837246|NCT05190419|157247098|FG000|Overall Study|Adverse Event|2|||
48837247|NCT05190419|157247099|FG001|Overall Study|Adverse Event|10|||
48837248|NCT05190419|157247100|FG002|Overall Study|Adverse Event|11|||
48837249|NCT05190419|157247101|FG003|Overall Study|Adverse Event|21|||
48837250|NCT05190419|157247098|FG000|Overall Study|Lost to Follow-up|1|||
48837251|NCT05190419|157247099|FG001|Overall Study|Lost to Follow-up|2|||
48837252|NCT05190419|157247100|FG002|Overall Study|Lost to Follow-up|3|||
48837253|NCT05190419|157247101|FG003|Overall Study|Lost to Follow-up|1|||
48837254|NCT05190419|157247098|FG000|Overall Study|Other|1|||
48837255|NCT05190419|157247099|FG001|Overall Study|Other|1|||
48837256|NCT05190419|157247100|FG002|Overall Study|Other|0|||
48837257|NCT05190419|157247101|FG003|Overall Study|Other|3|||
48837258|NCT01576484|157247104|FG000|Overall Study|Adverse Event|1|||
48535156|NCT04039919|156146678|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48837259|NCT01576484|157247105|FG001|Overall Study|Adverse Event|1|||
48837260|NCT01576484|157247104|FG000|Overall Study|Protocol Violation|0|||
48837261|NCT01576484|157247105|FG001|Overall Study|Protocol Violation|2|||
48837262|NCT01576484|157247104|FG000|Overall Study|Sponsor Decision|2|||
48837263|NCT01576484|157247105|FG001|Overall Study|Sponsor Decision|8|||
48837264|NCT01576484|157247104|FG000|Overall Study|Withdrawal by Subject|0|||
48837265|NCT01576484|157247105|FG001|Overall Study|Withdrawal by Subject|3|||
48837266|NCT01576484|157247104|FG000|Overall Study|Other|2|||
48535157|NCT04039919|156146679|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48535158|NCT04039919|156146680|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48535159|NCT04039919|156146681|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48535160|NCT04039919|156146682|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48535161|NCT04039919|156146678|FG000|Treatment Period 1|Sponsor's decision|0|||
48535162|NCT04039919|156146679|FG001|Treatment Period 1|Sponsor's decision|0|||
48535163|NCT04039919|156146680|FG002|Treatment Period 1|Sponsor's decision|0|||
48535164|NCT04039919|156146681|FG003|Treatment Period 1|Sponsor's decision|0|||
48535165|NCT04039919|156146682|FG004|Treatment Period 1|Sponsor's decision|16|||
48535166|NCT04039919|156146678|FG000|Treatment Period 5|Withdrawal by Subject|1|||
48535167|NCT04039919|156146679|FG001|Treatment Period 5|Withdrawal by Subject|0|||
48535168|NCT04039919|156146680|FG002|Treatment Period 5|Withdrawal by Subject|0|||
48535169|NCT04039919|156146681|FG003|Treatment Period 5|Withdrawal by Subject|0|||
48535170|NCT04039919|156146682|FG004|Treatment Period 5|Withdrawal by Subject|0|||
48535171|NCT00483548|156146683|FG000|Overall Study|Randomized; not treated with study drug|1|||
48535172|NCT00483548|156146684|FG001|Overall Study|Randomized; not treated with study drug|3|||
48535173|NCT00483548|156146683|FG000|Overall Study|Adverse Event|25|||
48535174|NCT00483548|156146684|FG001|Overall Study|Adverse Event|14|||
48535175|NCT00483548|156146683|FG000|Overall Study|Laboratory abnormality|1|||
48535176|NCT00483548|156146684|FG001|Overall Study|Laboratory abnormality|2|||
48535177|NCT00483548|156146683|FG000|Overall Study|Lack of Efficacy|4|||
48535178|NCT00483548|156146684|FG001|Overall Study|Lack of Efficacy|8|||
48535179|NCT00483548|156146683|FG000|Overall Study|Protocol Violation|11|||
48535180|NCT00483548|156146684|FG001|Overall Study|Protocol Violation|7|||
48535181|NCT00483548|156146683|FG000|Overall Study|Pregnancy|1|||
48535182|NCT00483548|156146684|FG001|Overall Study|Pregnancy|0|||
48535183|NCT00483548|156146683|FG000|Overall Study|Protocol required discontinuation|6|||
48535184|NCT00483548|156146684|FG001|Overall Study|Protocol required discontinuation|6|||
48535185|NCT00483548|156146683|FG000|Overall Study|Unable to comply with protocol schedule|1|||
48535186|NCT00483548|156146684|FG001|Overall Study|Unable to comply with protocol schedule|0|||
48535187|NCT00483548|156146683|FG000|Overall Study|Non-compliance with medication|2|||
48535188|NCT00483548|156146684|FG001|Overall Study|Non-compliance with medication|0|||
48535189|NCT00483548|156146683|FG000|Overall Study|Lost to Follow-up|3|||
48535190|NCT00483548|156146684|FG001|Overall Study|Lost to Follow-up|4|||
48604654|NCT02785939|156409021|FG001|Overall Study|Not protocol specified|1|||
48837267|NCT01576484|157247105|FG001|Overall Study|Other|5|||
48837268|NCT05274217|157247106|FG000|Overall Study|Study terminated.|11|||
48837269|NCT05274217|157247107|FG001|Overall Study|Study terminated.|0|||
48837270|NCT02261467|157247108|FG000|Overall Study|Enrolled in Error|1|||
48837271|NCT02261467|157247109|FG001|Overall Study|Enrolled in Error|0|||
48837272|NCT02261467|157247108|FG000|Overall Study|Protocol Violation|0|||
48837273|NCT02261467|157247109|FG001|Overall Study|Protocol Violation|1|||
48837274|NCT02261467|157247108|FG000|Overall Study|Personal Reasons|17|||
48837275|NCT02261467|157247109|FG001|Overall Study|Personal Reasons|22|||
48837276|NCT02261467|157247108|FG000|Overall Study|Lost to Follow-up|2|||
48604655|NCT03292016|156409029|FG000|Second Washout|Adverse Event|0|||
48837277|NCT02261467|157247109|FG001|Overall Study|Lost to Follow-up|13|||
48837278|NCT02261467|157247108|FG000|Overall Study|Adverse Event|1|||
48837279|NCT02261467|157247109|FG001|Overall Study|Adverse Event|1|||
48837280|NCT00841035|157247115|FG000|Phase 1 Overall Study|Physician Decision|13|||
48837281|NCT04305405|157247116|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48535191|NCT00483548|156146683|FG000|Overall Study|Withdrawal by Subject|5|||
48535192|NCT00483548|156146684|FG001|Overall Study|Withdrawal by Subject|2|||
48535193|NCT04109313|156146685|FG000|Overall Study|Pregnancy|1|||
48535194|NCT04109313|156146685|FG000|Overall Study|Adverse Event|11|||
48535195|NCT04109313|156146685|FG000|Overall Study|Lack of Efficacy|11|||
48535196|NCT04109313|156146685|FG000|Overall Study|Lost to Follow-up|1|||
48535197|NCT04109313|156146685|FG000|Overall Study|Physician Decision|2|||
48535198|NCT04109313|156146685|FG000|Overall Study|Subject Decision|13|||
48535199|NCT04109313|156146685|FG000|Overall Study|Covid-19 situation|2|||
48535200|NCT00892281|156146686|FG000|Overall Study|Adverse Event|65|||
48535201|NCT00892281|156146687|FG001|Overall Study|Adverse Event|8|||
48535202|NCT00892281|156146686|FG000|Overall Study|Lost to Follow-up|81|||
48535203|NCT00892281|156146687|FG001|Overall Study|Lost to Follow-up|8|||
48535204|NCT00892281|156146686|FG000|Overall Study|Pregnancy|1|||
48535205|NCT00892281|156146687|FG001|Overall Study|Pregnancy|0|||
48535206|NCT00892281|156146686|FG000|Overall Study|Protocol Violation|7|||
48535207|NCT00892281|156146687|FG001|Overall Study|Protocol Violation|2|||
48535208|NCT00892281|156146686|FG000|Overall Study|Withdrawal by Subject|86|||
48535209|NCT00892281|156146687|FG001|Overall Study|Withdrawal by Subject|14|||
48535210|NCT00892281|156146686|FG000|Overall Study|Subject failed to return for final visit|2|||
48535211|NCT00892281|156146687|FG001|Overall Study|Subject failed to return for final visit|0|||
48535212|NCT00892281|156146686|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
48535213|NCT00892281|156146687|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
48535214|NCT00892281|156146686|FG000|Overall Study|Final visit completed 4 weeks late|0|||
48535215|NCT00892281|156146687|FG001|Overall Study|Final visit completed 4 weeks late|1|||
48535216|NCT00892281|156146686|FG000|Overall Study|Subject completed day after study closed|1|||
48535217|NCT00892281|156146687|FG001|Overall Study|Subject completed day after study closed|0|||
48535218|NCT00892281|156146686|FG000|Overall Study|Family emergency|1|||
48535219|NCT00892281|156146687|FG001|Overall Study|Family emergency|0|||
48535220|NCT00892281|156146686|FG000|Overall Study|Last visit not done - death in family|1|||
48535221|NCT00892281|156146687|FG001|Overall Study|Last visit not done - death in family|0|||
48535222|NCT00892281|156146686|FG000|Overall Study|Did not meet incl/excl criteria|1|||
48535223|NCT00892281|156146687|FG001|Overall Study|Did not meet incl/excl criteria|0|||
48535224|NCT00892281|156146686|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
48535225|NCT00892281|156146687|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
48535226|NCT00892281|156146686|FG000|Overall Study|Unable to redeem the drug voucher|1|||
48535227|NCT00892281|156146687|FG001|Overall Study|Unable to redeem the drug voucher|0|||
48535228|NCT00892281|156146686|FG000|Overall Study|Subject not good candidate for study|1|||
48535229|NCT00892281|156146687|FG001|Overall Study|Subject not good candidate for study|0|||
48535230|NCT00892281|156146686|FG000|Overall Study|Subject did not return for any visits|1|||
48535231|NCT00892281|156146687|FG001|Overall Study|Subject did not return for any visits|0|||
48535232|NCT00892281|156146686|FG000|Overall Study|Subject missed several visits/lost meds|1|||
48535233|NCT00892281|156146687|FG001|Overall Study|Subject missed several visits/lost meds|0|||
48535234|NCT00892281|156146686|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
48535235|NCT00892281|156146687|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
48535236|NCT00892281|156146686|FG000|Overall Study|Scheduled for knee replacement|0|||
48535237|NCT00892281|156146687|FG001|Overall Study|Scheduled for knee replacement|1|||
48535238|NCT00892281|156146686|FG000|Overall Study|PI complained of inadequate compensation|3|||
48535239|NCT00892281|156146687|FG001|Overall Study|PI complained of inadequate compensation|0|||
48535240|NCT00892281|156146686|FG000|Overall Study|Subject lost interest in program|0|||
48535241|NCT00892281|156146687|FG001|Overall Study|Subject lost interest in program|1|||
48535242|NCT00892281|156146686|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
48535243|NCT00892281|156146687|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
48535244|NCT00892281|156146686|FG000|Overall Study|Death in family|1|||
48535245|NCT00892281|156146687|FG001|Overall Study|Death in family|0|||
48535246|NCT00892281|156146686|FG000|Overall Study|Lack of efficacy of study product|2|||
48535247|NCT00892281|156146687|FG001|Overall Study|Lack of efficacy of study product|0|||
48837282|NCT04305405|157247117|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48837283|NCT00736853|157247121|FG000|Open-Label Period|Physician Decision|2|||
48837284|NCT00736853|157247122|FG001|Open-Label Period|Physician Decision|0|||
48837285|NCT00736853|157247123|FG002|Open-Label Period|Physician Decision|0|||
48837286|NCT00736853|157247121|FG000|Open-Label Period|Adverse Event|31|||
48837287|NCT00736853|157247122|FG001|Open-Label Period|Adverse Event|0|||
48837288|NCT00736853|157247123|FG002|Open-Label Period|Adverse Event|0|||
48837289|NCT00736853|157247121|FG000|Open-Label Period|Withdrawal by Subject|16|||
48837290|NCT00736853|157247122|FG001|Open-Label Period|Withdrawal by Subject|0|||
48837291|NCT00736853|157247123|FG002|Open-Label Period|Withdrawal by Subject|0|||
48837292|NCT00736853|157247121|FG000|Open-Label Period|Started but not treated|42|||
48837293|NCT00736853|157247122|FG001|Open-Label Period|Started but not treated|0|||
48837294|NCT00736853|157247123|FG002|Open-Label Period|Started but not treated|0|||
48837295|NCT00736853|157247121|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
48837296|NCT00736853|157247122|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
48837297|NCT00736853|157247123|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
48837298|NCT00736853|157247121|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
48837299|NCT00736853|157247122|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
48837300|NCT00736853|157247123|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
48837301|NCT00736853|157247121|FG000|Double-Blind Period|Lack of Efficacy|0|||
48837302|NCT00736853|157247122|FG001|Double-Blind Period|Lack of Efficacy|19|||
48837303|NCT00736853|157247123|FG002|Double-Blind Period|Lack of Efficacy|42|||
48837304|NCT00736853|157247121|FG000|Double-Blind Period|Adverse Event|0|||
48837305|NCT00736853|157247122|FG001|Double-Blind Period|Adverse Event|3|||
48837306|NCT00736853|157247123|FG002|Double-Blind Period|Adverse Event|2|||
48837307|NCT00736853|157247121|FG000|Double-Blind Period|Withdrawal by Subject|0|||
48837308|NCT00736853|157247122|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48837309|NCT00736853|157247123|FG002|Double-Blind Period|Withdrawal by Subject|4|||
48837310|NCT00736853|157247121|FG000|Double-Blind Period|Ineligible to participate the study|0|||
48837311|NCT00736853|157247122|FG001|Double-Blind Period|Ineligible to participate the study|1|||
48837312|NCT00736853|157247123|FG002|Double-Blind Period|Ineligible to participate the study|0|||
48837313|NCT01415349|157247128|FG000|Treatment Period 1|Adverse Event|0|||
48837314|NCT01415349|157247129|FG001|Treatment Period 1|Adverse Event|1|||
48837315|NCT01415349|157247128|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48837316|NCT01415349|157247129|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48837317|NCT01350804|157247130|FG000|Core Study|Withdrawal by Subject|11|||
48837318|NCT01350804|157247131|FG001|Core Study|Withdrawal by Subject|17|||
48837319|NCT01350804|157247132|FG002|Core Study|Withdrawal by Subject|16|||
48837320|NCT01350804|157247133|FG003|Core Study|Withdrawal by Subject|7|||
48837321|NCT01350804|157247130|FG000|Core Study|Study terminated by Sponsor|0|||
48837322|NCT01350804|157247131|FG001|Core Study|Study terminated by Sponsor|0|||
48837323|NCT01350804|157247132|FG002|Core Study|Study terminated by Sponsor|0|||
48837324|NCT01350804|157247133|FG003|Core Study|Study terminated by Sponsor|2|||
48837325|NCT01350804|157247130|FG000|Core Study|Protocol deviation|1|||
48837326|NCT01350804|157247131|FG001|Core Study|Protocol deviation|0|||
48837327|NCT01350804|157247132|FG002|Core Study|Protocol deviation|1|||
48837328|NCT01350804|157247133|FG003|Core Study|Protocol deviation|0|||
48837329|NCT01350804|157247130|FG000|Core Study|Physician Decision|1|||
48837330|NCT01350804|157247131|FG001|Core Study|Physician Decision|0|||
48837331|NCT01350804|157247132|FG002|Core Study|Physician Decision|1|||
48837332|NCT01350804|157247133|FG003|Core Study|Physician Decision|3|||
48837333|NCT01350804|157247130|FG000|Core Study|Lost to Follow-up|3|||
48837334|NCT01350804|157247131|FG001|Core Study|Lost to Follow-up|0|||
48837335|NCT01350804|157247132|FG002|Core Study|Lost to Follow-up|2|||
48837336|NCT01350804|157247133|FG003|Core Study|Lost to Follow-up|1|||
48837337|NCT01350804|157247130|FG000|Core Study|Lack of Efficacy|16|||
48837338|NCT01350804|157247131|FG001|Core Study|Lack of Efficacy|19|||
48837339|NCT01350804|157247132|FG002|Core Study|Lack of Efficacy|18|||
48837340|NCT01350804|157247133|FG003|Core Study|Lack of Efficacy|5|||
48837341|NCT01350804|157247130|FG000|Core Study|Death|1|||
48837342|NCT01350804|157247131|FG001|Core Study|Death|1|||
48837343|NCT01350804|157247132|FG002|Core Study|Death|1|||
48837344|NCT01350804|157247133|FG003|Core Study|Death|0|||
48837345|NCT01350804|157247130|FG000|Core Study|Adverse Event|8|||
48837346|NCT01350804|157247131|FG001|Core Study|Adverse Event|10|||
48837347|NCT01350804|157247132|FG002|Core Study|Adverse Event|8|||
48837348|NCT01350804|157247133|FG003|Core Study|Adverse Event|8|||
48837349|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
48837350|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
48837351|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
48837352|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
48837353|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
48837354|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
48837355|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
48837356|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
48837357|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
48837358|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
48837359|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
48837360|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
48837361|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
48837362|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
48837363|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
48837364|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
48837365|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
48837366|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
48837367|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
48837368|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
48837369|NCT01350804|157247130|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
48837370|NCT01350804|157247131|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
48837371|NCT01350804|157247132|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
48837372|NCT01350804|157247133|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
48837373|NCT02139943|157247134|FG000|Overall Study|Adverse Event|0|||
48837374|NCT02139943|157247135|FG001|Overall Study|Adverse Event|1|||
48837375|NCT02139943|157247136|FG002|Overall Study|Adverse Event|2|||
48837376|NCT02139943|157247134|FG000|Overall Study|Lost to Follow-up|3|||
48837377|NCT02139943|157247135|FG001|Overall Study|Lost to Follow-up|2|||
48837378|NCT02139943|157247136|FG002|Overall Study|Lost to Follow-up|2|||
48837379|NCT02139943|157247134|FG000|Overall Study|Withdrawal by Subject|4|||
48837380|NCT02139943|157247135|FG001|Overall Study|Withdrawal by Subject|3|||
48837381|NCT02139943|157247136|FG002|Overall Study|Withdrawal by Subject|0|||
48837382|NCT02139943|157247134|FG000|Overall Study|Other|0|||
48837383|NCT02139943|157247135|FG001|Overall Study|Other|0|||
48837384|NCT02139943|157247136|FG002|Overall Study|Other|1|||
48837385|NCT02139943|157247134|FG000|Overall Study|Participant wishes to discontinue|2|||
48837386|NCT02139943|157247135|FG001|Overall Study|Participant wishes to discontinue|0|||
48837387|NCT02139943|157247136|FG002|Overall Study|Participant wishes to discontinue|0|||
48837388|NCT02139943|157247134|FG000|Overall Study|Participant in Poor Compliance|1|||
48837389|NCT02139943|157247135|FG001|Overall Study|Participant in Poor Compliance|0|||
48837390|NCT02139943|157247136|FG002|Overall Study|Participant in Poor Compliance|1|||
48837391|NCT02139943|157247134|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
48837392|NCT02139943|157247135|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
48837393|NCT02139943|157247136|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
48837394|NCT01713946|157247139|FG000|Overall Study|Death|0|||
48837395|NCT01713946|157247140|FG001|Overall Study|Death|2|||
48837396|NCT01713946|157247141|FG002|Overall Study|Death|2|||
48837397|NCT01713946|157247139|FG000|Overall Study|Adverse Event|19|||
48837398|NCT01713946|157247140|FG001|Overall Study|Adverse Event|14|||
48837399|NCT01713946|157247141|FG002|Overall Study|Adverse Event|13|||
48837400|NCT01713946|157247139|FG000|Overall Study|Withdrawal by Subject|12|||
48837401|NCT01713946|157247140|FG001|Overall Study|Withdrawal by Subject|12|||
48837402|NCT01713946|157247141|FG002|Overall Study|Withdrawal by Subject|8|||
48837403|NCT01713946|157247139|FG000|Overall Study|Lack of Efficacy|8|||
48837404|NCT01713946|157247140|FG001|Overall Study|Lack of Efficacy|8|||
48837405|NCT01713946|157247141|FG002|Overall Study|Lack of Efficacy|14|||
48837406|NCT01713946|157247139|FG000|Overall Study|Protocol Violation|2|||
48837407|NCT01713946|157247140|FG001|Overall Study|Protocol Violation|4|||
48604656|NCT03292016|156409030|FG001|Second Washout|Adverse Event|1|||
48837408|NCT01713946|157247141|FG002|Overall Study|Protocol Violation|1|||
48837409|NCT01713946|157247139|FG000|Overall Study|Lost to Follow-up|0|||
48837410|NCT01713946|157247140|FG001|Overall Study|Lost to Follow-up|0|||
48837411|NCT01713946|157247141|FG002|Overall Study|Lost to Follow-up|1|||
48837412|NCT01713946|157247139|FG000|Overall Study|Administrative problems|1|||
48837413|NCT01713946|157247140|FG001|Overall Study|Administrative problems|0|||
48837414|NCT01713946|157247141|FG002|Overall Study|Administrative problems|0|||
48837415|NCT01713946|157247139|FG000|Overall Study|Did not continue in Ext|0|||
48837416|NCT01713946|157247140|FG001|Overall Study|Did not continue in Ext|3|||
48837417|NCT01713946|157247141|FG002|Overall Study|Did not continue in Ext|0|||
48837418|NCT01713946|157247139|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
48837419|NCT01713946|157247140|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
48837420|NCT01713946|157247141|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
48837421|NCT01713946|157247139|FG000|Overall Study|Patients never switched to everolimus|0|||
48837422|NCT01713946|157247140|FG001|Overall Study|Patients never switched to everolimus|0|||
48604657|NCT03292016|156409031|FG002|Second Washout|Adverse Event|0|||
48837423|NCT01713946|157247141|FG002|Overall Study|Patients never switched to everolimus|5|||
48837424|NCT03183518|157247142|FG000|Overall Study|Other (Not specified)|2|||
48837425|NCT03183518|157247142|FG000|Overall Study|Other (Withdrawal of consent)|1|||
48837426|NCT01803555|157247145|FG000|Overall Study|Adverse Event|3|||
48837427|NCT01803555|157247146|FG001|Overall Study|Adverse Event|2|||
48837428|NCT01803555|157247145|FG000|Overall Study|Withdrawal by Subject|3|||
48837429|NCT01803555|157247146|FG001|Overall Study|Withdrawal by Subject|3|||
48837430|NCT01803555|157247145|FG000|Overall Study|Non-compliance|1|||
48837431|NCT01803555|157247146|FG001|Overall Study|Non-compliance|1|||
48837432|NCT01803555|157247145|FG000|Overall Study|Protocol Violation|3|||
48837433|NCT01803555|157247146|FG001|Overall Study|Protocol Violation|5|||
48837434|NCT01803555|157247145|FG000|Overall Study|Lost to Follow-up|0|||
48837435|NCT01803555|157247146|FG001|Overall Study|Lost to Follow-up|2|||
48837436|NCT01803555|157247145|FG000|Overall Study|Other than specified|3|||
48837437|NCT01803555|157247146|FG001|Overall Study|Other than specified|5|||
48837438|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
48837439|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
48837440|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
48837441|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
48837442|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
48837443|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
48837444|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
48837445|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
48837446|NCT00393484|157247147|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
48837447|NCT00393484|157247148|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
48837448|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
48837449|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
48837450|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
48837451|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
48837452|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
48837453|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
48604658|NCT03292016|156409032|FG003|Second Washout|Adverse Event|0|||
48604659|NCT03292016|156409033|FG004|Second Washout|Adverse Event|0|||
48604660|NCT03292016|156409034|FG005|Second Washout|Adverse Event|0|||
48604661|NCT00465517|156409035|FG000|Overall Study|Adverse Event|7|||
48604662|NCT00465517|156409036|FG001|Overall Study|Adverse Event|3|||
48604663|NCT00465517|156409035|FG000|Overall Study|Lost to Follow-up|1|||
48604664|NCT00465517|156409036|FG001|Overall Study|Lost to Follow-up|0|||
48604665|NCT00465517|156409035|FG000|Overall Study|Withdrawal by Subject|4|||
48837454|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
48837455|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
48837456|NCT00393484|157247147|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
48837457|NCT00393484|157247148|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
48837458|NCT01764464|157247149|FG000|First Intervention|Withdrawal by Subject|1|||
48837459|NCT01764464|157247150|FG001|First Intervention|Withdrawal by Subject|0|||
48837460|NCT01764464|157247149|FG000|First Intervention|Lost to Follow-up|1|||
48837461|NCT01764464|157247150|FG001|First Intervention|Lost to Follow-up|0|||
48837462|NCT01764464|157247149|FG000|First Intervention|Adverse Event|0|||
48837463|NCT01764464|157247150|FG001|First Intervention|Adverse Event|2|||
48837464|NCT01764464|157247149|FG000|First Intervention|did not receive study drug|0|||
48837465|NCT01764464|157247150|FG001|First Intervention|did not receive study drug|1|||
48837466|NCT01764464|157247149|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
48837467|NCT01764464|157247150|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
48837468|NCT00065260|157247151|FG000|Overall Study|Death|0|||
48837469|NCT00065260|157247152|FG001|Overall Study|Death|1|||
48837470|NCT03473340|157247158|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
48837471|NCT03473340|157247159|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
48837472|NCT03473340|157247158|FG000|Overall Study|Withdrawal by Subject|1|||
48837473|NCT03473340|157247159|FG001|Overall Study|Withdrawal by Subject|0|||
48837474|NCT03473340|157247158|FG000|Overall Study|Lost to Follow-up|1|||
48604666|NCT00465517|156409036|FG001|Overall Study|Withdrawal by Subject|1|||
48604667|NCT05222880|156409037|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
48604668|NCT05222880|156409037|FG000|Overall Study|Withdrew Consent during Study|1|||
48604669|NCT05222880|156409037|FG000|Overall Study|COVID-19 Related|1|||
48604670|NCT00830128|156409038|FG000|Overall Study|Adverse Event|5|||
48604671|NCT00830128|156409038|FG000|Overall Study|Lack of Efficacy|7|||
48604672|NCT00830128|156409038|FG000|Overall Study|Protocol Violation|1|||
48604673|NCT00830128|156409038|FG000|Overall Study|Withdrawal by Subject|2|||
48604674|NCT00830128|156409038|FG000|Overall Study|Family obligation|1|||
48837475|NCT03473340|157247159|FG001|Overall Study|Lost to Follow-up|2|||
48837476|NCT01420549|157247160|FG000|Overall Study|Adverse Event|1|||
48604675|NCT00830128|156409038|FG000|Overall Study|Relocation|1|||
48604676|NCT00830128|156409038|FG000|Overall Study|Work obligation|1|||
48604677|NCT00830128|156409038|FG000|Overall Study|Operating a vehicle|1|||
48604678|NCT05401565|156409039|FG000|Overall Study|Lost to Follow-up|1|||
48604679|NCT05401565|156409040|FG001|Overall Study|Lost to Follow-up|0|||
48604680|NCT05401565|156409039|FG000|Overall Study|Adverse Event|2|||
48604681|NCT05401565|156409040|FG001|Overall Study|Adverse Event|0|||
48604682|NCT02984982|156409046|FG000|Overall Study|Adverse Event|2|||
48837477|NCT01420549|157247161|FG001|Overall Study|Adverse Event|1|||
48837478|NCT01420549|157247160|FG000|Overall Study|Lost to Follow-up|2|||
48837479|NCT01420549|157247161|FG001|Overall Study|Lost to Follow-up|2|||
48604683|NCT02984982|156409047|FG001|Overall Study|Adverse Event|5|||
48535248|NCT00892281|156146686|FG000|Overall Study|Subject not seen by PI at final visit|1|||
48535249|NCT00892281|156146687|FG001|Overall Study|Subject not seen by PI at final visit|0|||
48535250|NCT00892281|156146686|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
48535251|NCT00892281|156146687|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
48535252|NCT00892281|156146686|FG000|Overall Study|Missed multiple visits|1|||
48535253|NCT00892281|156146687|FG001|Overall Study|Missed multiple visits|0|||
48535254|NCT00892281|156146686|FG000|Overall Study|Missed visits rescheduled out of window|1|||
48535255|NCT00892281|156146687|FG001|Overall Study|Missed visits rescheduled out of window|0|||
48535256|NCT00892281|156146686|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
48535257|NCT00892281|156146687|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
48535258|NCT00892281|156146686|FG000|Overall Study|Subject had history of drug abuse|1|||
48535259|NCT00892281|156146687|FG001|Overall Study|Subject had history of drug abuse|0|||
48535260|NCT00892281|156146686|FG000|Overall Study|Rash on hand|1|||
48535261|NCT00892281|156146687|FG001|Overall Study|Rash on hand|0|||
48535262|NCT00892281|156146686|FG000|Overall Study|Visit 4 date out of window|1|||
48535263|NCT00892281|156146687|FG001|Overall Study|Visit 4 date out of window|0|||
48535264|NCT05212883|156146693|FG000|Overall Study|Invalid test result|125|||
48535265|NCT02470091|156146696|FG000|Overall Study|Withdrawal by Subject|1|||
48535266|NCT02470091|156146697|FG001|Overall Study|Withdrawal by Subject|0|||
48535267|NCT02470091|156146696|FG000|Overall Study|Ineligible|0|||
48535268|NCT02470091|156146697|FG001|Overall Study|Ineligible|2|||
48535269|NCT01663727|156146703|FG000|Overall Study|Death|161|||
48535270|NCT01663727|156146704|FG001|Overall Study|Death|155|||
48837480|NCT01420549|157247160|FG000|Overall Study|Protocol Violation|0|||
48837481|NCT01420549|157247161|FG001|Overall Study|Protocol Violation|1|||
48837482|NCT01420549|157247160|FG000|Overall Study|Non-adherence to medication|4|||
48837483|NCT01420549|157247161|FG001|Overall Study|Non-adherence to medication|1|||
48837484|NCT01212991|157247162|FG000|Double-blind|Lost to Follow-up|8|||
48837485|NCT01212991|157247163|FG001|Double-blind|Lost to Follow-up|4|||
48837486|NCT01212991|157247164|FG002|Double-blind|Lost to Follow-up|0|||
48604684|NCT02984982|156409046|FG000|Overall Study|Poor Compliance to Protocol|4|||
48604685|NCT02984982|156409047|FG001|Overall Study|Poor Compliance to Protocol|4|||
48604686|NCT02984982|156409046|FG000|Overall Study|Withdrawal by Subject|2|||
48604687|NCT02984982|156409047|FG001|Overall Study|Withdrawal by Subject|0|||
48604688|NCT02984982|156409046|FG000|Overall Study|Randomized but not treated|0|||
48604689|NCT02984982|156409047|FG001|Overall Study|Randomized but not treated|1|||
48604690|NCT03217591|156409048|FG000|Overall Study|Adverse Event|1|||
48604691|NCT03217591|156409049|FG001|Overall Study|Adverse Event|2|||
48604692|NCT03217591|156409050|FG002|Overall Study|Adverse Event|6|||
48604693|NCT03217591|156409048|FG000|Overall Study|Withdrawal by Subject|0|||
48604694|NCT03217591|156409049|FG001|Overall Study|Withdrawal by Subject|1|||
48604695|NCT03217591|156409050|FG002|Overall Study|Withdrawal by Subject|3|||
48604696|NCT03217591|156409048|FG000|Overall Study|Lost to Follow-up|1|||
48604697|NCT03217591|156409049|FG001|Overall Study|Lost to Follow-up|0|||
48604698|NCT03217591|156409050|FG002|Overall Study|Lost to Follow-up|0|||
48604699|NCT03217591|156409048|FG000|Overall Study|Protocol Violation|1|||
48604700|NCT03217591|156409049|FG001|Overall Study|Protocol Violation|0|||
48604701|NCT03217591|156409050|FG002|Overall Study|Protocol Violation|1|||
48604702|NCT02175121|156409051|FG000|Overall Study|Lack of Efficacy|1|||
48604703|NCT02175121|156409052|FG001|Overall Study|Lack of Efficacy|0|||
48604704|NCT02175121|156409053|FG002|Overall Study|Lack of Efficacy|0|||
48604705|NCT02175121|156409054|FG003|Overall Study|Lack of Efficacy|0|||
48604706|NCT02175121|156409055|FG004|Overall Study|Lack of Efficacy|0|||
48604707|NCT02175121|156409051|FG000|Overall Study|Lost to Follow-up|0|||
48604708|NCT02175121|156409052|FG001|Overall Study|Lost to Follow-up|1|||
48604709|NCT02175121|156409053|FG002|Overall Study|Lost to Follow-up|0|||
48604710|NCT02175121|156409054|FG003|Overall Study|Lost to Follow-up|1|||
48535271|NCT01663727|156146703|FG000|Overall Study|Lost to Follow-up|10|||
48604711|NCT02175121|156409055|FG004|Overall Study|Lost to Follow-up|0|||
48604712|NCT02175121|156409051|FG000|Overall Study|Personal emergency|0|||
48604713|NCT02175121|156409052|FG001|Overall Study|Personal emergency|0|||
48604714|NCT02175121|156409053|FG002|Overall Study|Personal emergency|0|||
48604715|NCT02175121|156409054|FG003|Overall Study|Personal emergency|0|||
48604716|NCT02175121|156409055|FG004|Overall Study|Personal emergency|1|||
48604717|NCT02175121|156409051|FG000|Overall Study|Schedule conflict|0|||
48604718|NCT02175121|156409052|FG001|Overall Study|Schedule conflict|0|||
48604719|NCT02175121|156409053|FG002|Overall Study|Schedule conflict|1|||
48604720|NCT02175121|156409054|FG003|Overall Study|Schedule conflict|0|||
48837487|NCT01212991|157247162|FG000|Double-blind|Death|699|||
48837488|NCT01212991|157247163|FG001|Double-blind|Death|550|||
48535272|NCT01663727|156146704|FG001|Overall Study|Lost to Follow-up|8|||
48535273|NCT01663727|156146703|FG000|Overall Study|Withdrawal by Subject|18|||
48535274|NCT01663727|156146704|FG001|Overall Study|Withdrawal by Subject|25|||
48535275|NCT01663727|156146703|FG000|Overall Study|Study Terminated|51|||
48604721|NCT02175121|156409055|FG004|Overall Study|Schedule conflict|0|||
48604722|NCT02175121|156409051|FG000|Overall Study|Time issues|0|||
48604723|NCT02175121|156409052|FG001|Overall Study|Time issues|0|||
48604724|NCT02175121|156409053|FG002|Overall Study|Time issues|1|||
48604725|NCT02175121|156409054|FG003|Overall Study|Time issues|0|||
48604726|NCT02175121|156409055|FG004|Overall Study|Time issues|0|||
48604727|NCT02027025|156409056|FG000|Overall Study|Adverse Event|0|||
48604728|NCT02027025|156409057|FG001|Overall Study|Adverse Event|1|||
48604729|NCT02027025|156409058|FG002|Overall Study|Adverse Event|1|||
48604730|NCT02027025|156409056|FG000|Overall Study|Protocol Violation|1|||
48604731|NCT02027025|156409057|FG001|Overall Study|Protocol Violation|0|||
48604732|NCT02027025|156409058|FG002|Overall Study|Protocol Violation|0|||
48604733|NCT02027025|156409056|FG000|Overall Study|Lost to Follow-up|0|||
48604734|NCT02027025|156409057|FG001|Overall Study|Lost to Follow-up|2|||
48604735|NCT02027025|156409058|FG002|Overall Study|Lost to Follow-up|0|||
48604736|NCT02027025|156409056|FG000|Overall Study|Withdrawal by Subject|0|||
48604737|NCT02027025|156409057|FG001|Overall Study|Withdrawal by Subject|1|||
48604738|NCT02027025|156409058|FG002|Overall Study|Withdrawal by Subject|0|||
48604739|NCT02027025|156409056|FG000|Overall Study|Sponsor's decision|0|||
48604740|NCT02027025|156409057|FG001|Overall Study|Sponsor's decision|1|||
48604741|NCT02027025|156409058|FG002|Overall Study|Sponsor's decision|0|||
48604742|NCT01232283|156409064|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
48604743|NCT01232283|156409065|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
48604744|NCT01232283|156409066|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
48604745|NCT01232283|156409067|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
48604746|NCT01232283|156409068|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
48604747|NCT01232283|156409069|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
48604748|NCT01232283|156409070|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
48604749|NCT01232283|156409071|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
48604750|NCT01232283|156409072|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
48604751|NCT01232283|156409073|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
48604752|NCT01232283|156409064|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
48604753|NCT01232283|156409065|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
48604754|NCT01232283|156409066|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48604755|NCT01232283|156409067|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48604756|NCT01232283|156409068|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48604757|NCT01232283|156409069|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48604758|NCT01232283|156409070|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48604759|NCT01232283|156409071|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48604760|NCT01232283|156409072|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48604761|NCT01232283|156409073|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
48604762|NCT01232283|156409064|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
48604763|NCT01232283|156409065|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48604764|NCT01232283|156409066|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48604765|NCT01232283|156409067|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48837489|NCT01212991|157247164|FG002|Double-blind|Death|0|||
48837490|NCT01212991|157247162|FG000|Double-blind|Withdrawal by Subject|16|||
48837491|NCT01212991|157247163|FG001|Double-blind|Withdrawal by Subject|19|||
48837492|NCT01212991|157247164|FG002|Double-blind|Withdrawal by Subject|0|||
48837493|NCT01212991|157247162|FG000|Double-blind|Other|7|||
48837494|NCT01212991|157247163|FG001|Double-blind|Other|0|||
48604766|NCT01232283|156409068|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48604767|NCT01232283|156409069|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48604768|NCT01232283|156409070|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48604769|NCT01232283|156409071|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48604770|NCT01232283|156409072|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48604771|NCT01232283|156409073|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
48604772|NCT01232283|156409064|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
48837495|NCT01212991|157247164|FG002|Double-blind|Other|0|||
48837496|NCT01212991|157247162|FG000|Double-blind|Sponsor decision|142|||
48837497|NCT01212991|157247163|FG001|Double-blind|Sponsor decision|38|||
48837498|NCT01212991|157247164|FG002|Double-blind|Sponsor decision|0|||
48837499|NCT01212991|157247162|FG000|Open-label|Death|0|||
48837500|NCT01212991|157247163|FG001|Open-label|Death|0|||
48837501|NCT01212991|157247164|FG002|Open-label|Death|166|||
48837502|NCT01212991|157247162|FG000|Open-label|Lost to Follow-up|0|||
48837503|NCT01212991|157247163|FG001|Open-label|Lost to Follow-up|0|||
48837504|NCT01212991|157247164|FG002|Open-label|Lost to Follow-up|5|||
48837505|NCT01212991|157247162|FG000|Open-label|Withdrawal by Subject|0|||
48604773|NCT01232283|156409065|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
48837506|NCT01212991|157247163|FG001|Open-label|Withdrawal by Subject|0|||
48837507|NCT01212991|157247164|FG002|Open-label|Withdrawal by Subject|7|||
48837508|NCT01212991|157247162|FG000|Open-label|Sponsor decision|0|||
48837509|NCT01212991|157247163|FG001|Open-label|Sponsor decision|0|||
48837510|NCT01212991|157247164|FG002|Open-label|Sponsor decision|53|||
48837511|NCT01212991|157247162|FG000|Open-label|Other|0|||
48837512|NCT01212991|157247163|FG001|Open-label|Other|0|||
48837513|NCT01212991|157247164|FG002|Open-label|Other|3|||
48837514|NCT01677936|157248678|FG000|Overall Study|Lost to Follow-up|4|||
48837515|NCT01677936|157248679|FG001|Overall Study|Lost to Follow-up|1|||
48837516|NCT01677936|157248678|FG000|Overall Study|Protocol Violation|3|||
48837517|NCT01677936|157248679|FG001|Overall Study|Protocol Violation|0|||
48837518|NCT01677936|157248678|FG000|Overall Study|Adverse Event|1|||
48837519|NCT01677936|157248679|FG001|Overall Study|Adverse Event|0|||
48837520|NCT01677936|157248678|FG000|Overall Study|Lost to Follow-up|1|||
48837521|NCT01677936|157248679|FG001|Overall Study|Lost to Follow-up|0|||
48837522|NCT01677936|157248678|FG000|Overall Study|Protocol Violation|0|||
48837523|NCT01677936|157248679|FG001|Overall Study|Protocol Violation|4|||
48837524|NCT01359592|157248682|FG000|Initial Registration|Adverse Event|1|||
48837525|NCT01359592|157248683|FG001|Initial Registration|Adverse Event|0|||
48837526|NCT01359592|157248684|FG002|Initial Registration|Adverse Event|0|||
48837527|NCT01359592|157248685|FG003|Initial Registration|Adverse Event|0|||
48837528|NCT01359592|157248682|FG000|Initial Registration|Death|1|||
48837529|NCT01359592|157248683|FG001|Initial Registration|Death|0|||
48837530|NCT01359592|157248684|FG002|Initial Registration|Death|0|||
48837531|NCT01359592|157248685|FG003|Initial Registration|Death|0|||
48837532|NCT01359592|157248682|FG000|Initial Registration|Other reason not protocol specified|1|||
48837533|NCT01359592|157248683|FG001|Initial Registration|Other reason not protocol specified|0|||
48837534|NCT01359592|157248684|FG002|Initial Registration|Other reason not protocol specified|0|||
48837535|NCT01359592|157248685|FG003|Initial Registration|Other reason not protocol specified|0|||
48837536|NCT01359592|157248682|FG000|Initial Registration|Ineligible|26|||
48837537|NCT01359592|157248683|FG001|Initial Registration|Ineligible|0|||
48837538|NCT01359592|157248684|FG002|Initial Registration|Ineligible|0|||
48837539|NCT01359592|157248685|FG003|Initial Registration|Ineligible|0|||
48837540|NCT01359592|157248682|FG000|PET-Directed Therapy|Adverse Event|0|||
48837541|NCT01359592|157248683|FG001|PET-Directed Therapy|Adverse Event|0|||
48837542|NCT01359592|157248684|FG002|PET-Directed Therapy|Adverse Event|1|||
48837543|NCT01359592|157248685|FG003|PET-Directed Therapy|Adverse Event|0|||
48837544|NCT01359592|157248682|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
48837545|NCT01359592|157248683|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
48837546|NCT01359592|157248684|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
48837547|NCT01359592|157248685|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
48837548|NCT01359592|157248682|FG000|PET-Directed Therapy|Ineligible|0|||
48837549|NCT01359592|157248683|FG001|PET-Directed Therapy|Ineligible|0|||
48837550|NCT01359592|157248684|FG002|PET-Directed Therapy|Ineligible|24|||
48837551|NCT01359592|157248685|FG003|PET-Directed Therapy|Ineligible|0|||
48837552|NCT00150176|157248690|FG000|Overall Study|Adverse Event|16|||
48837553|NCT00150176|157248691|FG001|Overall Study|Adverse Event|53|||
48837554|NCT00150176|157248690|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
48837555|NCT00150176|157248691|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
48837556|NCT00150176|157248690|FG000|Overall Study|Withdrawal by Subject|19|||
48837557|NCT00150176|157248691|FG001|Overall Study|Withdrawal by Subject|12|||
48837558|NCT00150176|157248690|FG000|Overall Study|Lost to Follow-up|3|||
48837559|NCT00150176|157248691|FG001|Overall Study|Lost to Follow-up|3|||
48837560|NCT00150176|157248690|FG000|Overall Study|OTHER|11|||
48837561|NCT00150176|157248691|FG001|Overall Study|OTHER|13|||
48535276|NCT01663727|156146704|FG001|Overall Study|Study Terminated|50|||
48535277|NCT01663727|156146703|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
48535278|NCT01663727|156146704|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
48535279|NCT01663727|156146703|FG000|Overall Study|Withdrawal prior to dosing.|1|||
48535280|NCT01663727|156146704|FG001|Overall Study|Withdrawal prior to dosing.|0|||
48535281|NCT01194973|156146705|FG000|Screening Period|Screen Failure|3|||
48535282|NCT01194973|156146705|FG000|26 Week Treatment Period|Adverse Event|1|||
48535283|NCT01194973|156146705|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
48535284|NCT01194973|156146705|FG000|26 Week Treatment Period|Pregnancy|1|||
48535285|NCT02631876|156146706|FG000|Overall Study|Death|96|||
48535286|NCT02631876|156146707|FG001|Overall Study|Death|50|||
48535287|NCT02631876|156146706|FG000|Overall Study|Investigator's discretion|1|||
48535288|NCT02631876|156146707|FG001|Overall Study|Investigator's discretion|0|||
48535289|NCT02631876|156146706|FG000|Overall Study|Lost to Follow-up|2|||
48535290|NCT02631876|156146707|FG001|Overall Study|Lost to Follow-up|0|||
48535291|NCT02631876|156146706|FG000|Overall Study|Withdrawal by Subject|16|||
48535292|NCT02631876|156146707|FG001|Overall Study|Withdrawal by Subject|9|||
48535293|NCT02631876|156146706|FG000|Overall Study|Other than specified|4|||
48535294|NCT02631876|156146707|FG001|Overall Study|Other than specified|4|||
48535295|NCT00375492|156146710|FG000|Overall Study|Adverse Event|4|||
48535296|NCT00375492|156146711|FG001|Overall Study|Adverse Event|5|||
48535297|NCT00375492|156146710|FG000|Overall Study|Entry Criteria Not Met|0|||
48535298|NCT00375492|156146711|FG001|Overall Study|Entry Criteria Not Met|1|||
48604774|NCT01232283|156409066|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48837562|NCT04035668|157248692|FG000|Overall Study|Adverse Event|3|||
48837563|NCT04035668|157248693|FG001|Overall Study|Adverse Event|4|||
48837564|NCT04035668|157248694|FG002|Overall Study|Adverse Event|2|||
48837565|NCT04035668|157248692|FG000|Overall Study|Lost to Follow-up|0|||
48837566|NCT04035668|157248693|FG001|Overall Study|Lost to Follow-up|1|||
48837567|NCT04035668|157248694|FG002|Overall Study|Lost to Follow-up|0|||
48837568|NCT04035668|157248692|FG000|Overall Study|Physician Decision|2|||
48837569|NCT04035668|157248693|FG001|Overall Study|Physician Decision|1|||
48837570|NCT04035668|157248694|FG002|Overall Study|Physician Decision|1|||
48837571|NCT04035668|157248692|FG000|Overall Study|Subject Decision|2|||
48837572|NCT04035668|157248693|FG001|Overall Study|Subject Decision|2|||
48837573|NCT04035668|157248694|FG002|Overall Study|Subject Decision|0|||
48837574|NCT00703911|157248695|FG000|Overall Study|Death|1|||
48535299|NCT00375492|156146710|FG000|Overall Study|Loss of Glucose Control|0|||
48535300|NCT00375492|156146711|FG001|Overall Study|Loss of Glucose Control|1|||
48535301|NCT00375492|156146710|FG000|Overall Study|Lost to Follow-up|10|||
48535302|NCT00375492|156146711|FG001|Overall Study|Lost to Follow-up|5|||
48535303|NCT00375492|156146710|FG000|Overall Study|Physician Decision|0|||
48535304|NCT00375492|156146711|FG001|Overall Study|Physician Decision|4|||
48535305|NCT00375492|156146710|FG000|Overall Study|Protocol Violation|6|||
48535306|NCT00375492|156146711|FG001|Overall Study|Protocol Violation|3|||
48535307|NCT00375492|156146710|FG000|Overall Study|Sponsor Decision|0|||
48535308|NCT00375492|156146711|FG001|Overall Study|Sponsor Decision|1|||
48535309|NCT00375492|156146710|FG000|Overall Study|Withdrawal by Subject|6|||
48535310|NCT00375492|156146711|FG001|Overall Study|Withdrawal by Subject|6|||
48535311|NCT01232491|156146718|FG000|Overall Study|Adverse Event|13|||
48535312|NCT01232491|156146719|FG001|Overall Study|Adverse Event|8|||
48535313|NCT01232491|156146718|FG000|Overall Study|Lack of Efficacy|1|||
48535314|NCT01232491|156146719|FG001|Overall Study|Lack of Efficacy|5|||
48535315|NCT01232491|156146718|FG000|Overall Study|Protocol Violation|13|||
48535316|NCT01232491|156146719|FG001|Overall Study|Protocol Violation|11|||
48535317|NCT01232491|156146718|FG000|Overall Study|Withdrawal Criteria|12|||
48535318|NCT01232491|156146719|FG001|Overall Study|Withdrawal Criteria|21|||
48535319|NCT01232491|156146718|FG000|Overall Study|Other|21|||
48535320|NCT01232491|156146719|FG001|Overall Study|Other|18|||
48535321|NCT01640873|156146726|FG000|Overall Study|Protocol Violation|2|||
48535322|NCT01640873|156146727|FG001|Overall Study|Protocol Violation|1|||
48535323|NCT02924376|156146728|FG000|Overall Study|Progressive Disease|4|||
48535324|NCT02924376|156146729|FG001|Overall Study|Progressive Disease|0|||
48535325|NCT02924376|156146730|FG002|Overall Study|Progressive Disease|1|||
48535326|NCT02924376|156146731|FG003|Overall Study|Progressive Disease|0|||
48535327|NCT02924376|156146728|FG000|Overall Study|Death|73|||
48535328|NCT02924376|156146729|FG001|Overall Study|Death|18|||
48535329|NCT02924376|156146730|FG002|Overall Study|Death|15|||
48535330|NCT02924376|156146731|FG003|Overall Study|Death|2|||
48535331|NCT02924376|156146728|FG000|Overall Study|Lost to Follow-up|3|||
48535332|NCT02924376|156146729|FG001|Overall Study|Lost to Follow-up|0|||
48837575|NCT00703911|157248695|FG000|Overall Study|Physician Decision|6|||
48837576|NCT00703911|157248695|FG000|Overall Study|Lost to Follow-up|1|||
48837577|NCT00703911|157248695|FG000|Overall Study|Withdrawal by Subject|2|||
48837578|NCT02192606|157248696|FG000|Overall Study|surgery type was changed|1|||
48837579|NCT02192606|157248697|FG001|Overall Study|surgery type was changed|1|||
48535333|NCT02924376|156146730|FG002|Overall Study|Lost to Follow-up|0|||
48535334|NCT02924376|156146731|FG003|Overall Study|Lost to Follow-up|0|||
48535335|NCT02924376|156146728|FG000|Overall Study|Study Terminated by Sponsor|19|||
48535336|NCT02924376|156146729|FG001|Overall Study|Study Terminated by Sponsor|0|||
48535337|NCT02924376|156146730|FG002|Overall Study|Study Terminated by Sponsor|0|||
48535338|NCT02924376|156146731|FG003|Overall Study|Study Terminated by Sponsor|0|||
48535339|NCT02924376|156146728|FG000|Overall Study|Physician Decision|1|||
48535340|NCT02924376|156146729|FG001|Overall Study|Physician Decision|0|||
48535341|NCT02924376|156146730|FG002|Overall Study|Physician Decision|0|||
48535342|NCT02924376|156146731|FG003|Overall Study|Physician Decision|0|||
48535343|NCT02924376|156146728|FG000|Overall Study|Withdrawal by Subject|7|||
48837580|NCT02192606|157248696|FG000|Overall Study|Physician Decision|1|||
48837581|NCT02192606|157248697|FG001|Overall Study|Physician Decision|2|||
48837582|NCT02192606|157248696|FG000|Overall Study|3D equipment rep unable to join|0|||
48837583|NCT02192606|157248697|FG001|Overall Study|3D equipment rep unable to join|1|||
48837584|NCT04956575|157248698|FG000|Overall Study|Death|1|||
48837585|NCT04956575|157248699|FG001|Overall Study|Death|0|||
48837586|NCT04956575|157248700|FG002|Overall Study|Death|0|||
48837587|NCT04956575|157248701|FG003|Overall Study|Death|0|||
48837588|NCT04956575|157248702|FG004|Overall Study|Death|0|||
48837589|NCT04956575|157248703|FG005|Overall Study|Death|0|||
48837590|NCT04956575|157248704|FG006|Overall Study|Death|0|||
48535344|NCT02924376|156146729|FG001|Overall Study|Withdrawal by Subject|2|||
48535345|NCT02924376|156146730|FG002|Overall Study|Withdrawal by Subject|1|||
48535346|NCT02924376|156146731|FG003|Overall Study|Withdrawal by Subject|0|||
48535347|NCT02924376|156146728|FG000|Overall Study|Rolled Over to Another Study|1|||
48535348|NCT02924376|156146729|FG001|Overall Study|Rolled Over to Another Study|0|||
48535349|NCT02924376|156146730|FG002|Overall Study|Rolled Over to Another Study|0|||
48535350|NCT02924376|156146731|FG003|Overall Study|Rolled Over to Another Study|0|||
48535351|NCT00842530|156146732|FG000|Overall Study|Serious adverse event|0|||
48535352|NCT00842530|156146733|FG001|Overall Study|Serious adverse event|6|||
48535353|NCT00842530|156146732|FG000|Overall Study|Other adverse event|6|||
48535354|NCT00842530|156146733|FG001|Overall Study|Other adverse event|1|||
48535355|NCT00842530|156146732|FG000|Overall Study|Protocol Violation|32|||
48535356|NCT00842530|156146733|FG001|Overall Study|Protocol Violation|14|||
48535357|NCT00842530|156146732|FG000|Overall Study|Lost to Follow-up|6|||
48535358|NCT00842530|156146733|FG001|Overall Study|Lost to Follow-up|8|||
48535359|NCT00842530|156146732|FG000|Overall Study|Withdrawal by Subject|73|||
48535360|NCT00842530|156146733|FG001|Overall Study|Withdrawal by Subject|28|||
48535361|NCT00720226|156146734|FG000|Overall Study|Withdrawal by Subject|7|||
48535362|NCT00720226|156146735|FG001|Overall Study|Withdrawal by Subject|4|||
48837591|NCT04956575|157248705|FG007|Overall Study|Death|1|||
48837592|NCT04956575|157248706|FG008|Overall Study|Death|0|||
48837593|NCT04956575|157248707|FG009|Overall Study|Death|1|||
48837594|NCT04956575|157248708|FG010|Overall Study|Death|0|||
48837595|NCT04956575|157248709|FG011|Overall Study|Death|0|||
48535363|NCT00958126|156146736|FG000|Overall Study|Serious Adverse Event|0|||
48535364|NCT00958126|156146737|FG001|Overall Study|Serious Adverse Event|2|||
48535365|NCT00958126|156146738|FG002|Overall Study|Serious Adverse Event|0|||
48535366|NCT00958126|156146739|FG003|Overall Study|Serious Adverse Event|0|||
48535367|NCT00958126|156146740|FG004|Overall Study|Serious Adverse Event|0|||
48535368|NCT00958126|156146741|FG005|Overall Study|Serious Adverse Event|0|||
48535369|NCT00958126|156146742|FG006|Overall Study|Serious Adverse Event|1|||
48535370|NCT00958126|156146743|FG007|Overall Study|Serious Adverse Event|0|||
48535371|NCT00958126|156146736|FG000|Overall Study|Withdrawal by Subject|0|||
48535372|NCT00958126|156146737|FG001|Overall Study|Withdrawal by Subject|2|||
48535373|NCT00958126|156146738|FG002|Overall Study|Withdrawal by Subject|0|||
48535374|NCT00958126|156146739|FG003|Overall Study|Withdrawal by Subject|0|||
48535375|NCT00958126|156146740|FG004|Overall Study|Withdrawal by Subject|0|||
48535376|NCT00958126|156146741|FG005|Overall Study|Withdrawal by Subject|0|||
48535377|NCT00958126|156146742|FG006|Overall Study|Withdrawal by Subject|0|||
48535378|NCT00958126|156146743|FG007|Overall Study|Withdrawal by Subject|0|||
48535379|NCT00958126|156146736|FG000|Overall Study|Moved away from study area|0|||
48535380|NCT00958126|156146737|FG001|Overall Study|Moved away from study area|0|||
48535381|NCT00958126|156146738|FG002|Overall Study|Moved away from study area|1|||
48535382|NCT00958126|156146739|FG003|Overall Study|Moved away from study area|1|||
48535383|NCT00958126|156146740|FG004|Overall Study|Moved away from study area|0|||
48535384|NCT00958126|156146741|FG005|Overall Study|Moved away from study area|0|||
48837596|NCT04956575|157248698|FG000|Overall Study|Lost to Follow-up|3|||
48837597|NCT04956575|157248699|FG001|Overall Study|Lost to Follow-up|4|||
48837598|NCT04956575|157248700|FG002|Overall Study|Lost to Follow-up|2|||
48837599|NCT04956575|157248701|FG003|Overall Study|Lost to Follow-up|3|||
48837600|NCT04956575|157248702|FG004|Overall Study|Lost to Follow-up|1|||
48837601|NCT04956575|157248703|FG005|Overall Study|Lost to Follow-up|10|||
48837602|NCT04956575|157248704|FG006|Overall Study|Lost to Follow-up|11|||
48837603|NCT04956575|157248705|FG007|Overall Study|Lost to Follow-up|7|||
48837604|NCT04956575|157248706|FG008|Overall Study|Lost to Follow-up|4|||
48535385|NCT00958126|156146742|FG006|Overall Study|Moved away from study area|0|||
48535386|NCT00958126|156146743|FG007|Overall Study|Moved away from study area|0|||
48535387|NCT00958126|156146736|FG000|Overall Study|Lost to Follow-up|1|||
48535388|NCT00958126|156146737|FG001|Overall Study|Lost to Follow-up|5|||
48535389|NCT00958126|156146738|FG002|Overall Study|Lost to Follow-up|9|||
48535390|NCT00958126|156146739|FG003|Overall Study|Lost to Follow-up|8|||
48535391|NCT00958126|156146740|FG004|Overall Study|Lost to Follow-up|0|||
48604775|NCT01232283|156409067|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48837605|NCT04956575|157248707|FG009|Overall Study|Lost to Follow-up|2|||
48837606|NCT04956575|157248708|FG010|Overall Study|Lost to Follow-up|3|||
48837607|NCT04956575|157248709|FG011|Overall Study|Lost to Follow-up|8|||
48837608|NCT04956575|157248698|FG000|Overall Study|Withdrawal by Subject|1|||
48535392|NCT00958126|156146741|FG005|Overall Study|Lost to Follow-up|0|||
48837609|NCT04956575|157248699|FG001|Overall Study|Withdrawal by Subject|2|||
48837610|NCT04956575|157248700|FG002|Overall Study|Withdrawal by Subject|1|||
48837611|NCT04956575|157248701|FG003|Overall Study|Withdrawal by Subject|4|||
48837612|NCT04956575|157248702|FG004|Overall Study|Withdrawal by Subject|2|||
48837613|NCT04956575|157248703|FG005|Overall Study|Withdrawal by Subject|8|||
48837614|NCT04956575|157248704|FG006|Overall Study|Withdrawal by Subject|5|||
48837615|NCT04956575|157248705|FG007|Overall Study|Withdrawal by Subject|1|||
48837616|NCT04956575|157248706|FG008|Overall Study|Withdrawal by Subject|1|||
48837617|NCT04956575|157248707|FG009|Overall Study|Withdrawal by Subject|0|||
48837618|NCT04956575|157248708|FG010|Overall Study|Withdrawal by Subject|3|||
48837619|NCT04956575|157248709|FG011|Overall Study|Withdrawal by Subject|1|||
48837620|NCT00668863|157248716|FG000|Overall Study|Objective Progression or Relapse|42|||
48837621|NCT00668863|157248716|FG000|Overall Study|Adverse Event|13|||
48837622|NCT00668863|157248716|FG000|Overall Study|Study Terminated by Sponsor|8|||
48837623|NCT00668863|157248716|FG000|Overall Study|Global Deterioration of Health Status|4|||
48837624|NCT00668863|157248716|FG000|Overall Study|Withdrawal by Subject|1|||
48837625|NCT00668863|157248716|FG000|Overall Study|Surgery|1|||
48837626|NCT00668863|157248716|FG000|Overall Study|Subject's work scheduling problem|1|||
48837627|NCT00668863|157248716|FG000|Overall Study|Physician Decision|1|||
48837628|NCT03520413|157248717|FG000|Overall Study|Lost to Follow-up|1|||
48837629|NCT03520413|157248718|FG001|Overall Study|Lost to Follow-up|1|||
48837630|NCT03520413|157248717|FG000|Overall Study|Withdrawal by Subject|1|||
48837631|NCT03520413|157248718|FG001|Overall Study|Withdrawal by Subject|2|||
48837632|NCT03520413|157248717|FG000|Overall Study|Death|0|||
48837633|NCT03520413|157248718|FG001|Overall Study|Death|1|||
48535393|NCT00958126|156146742|FG006|Overall Study|Lost to Follow-up|0|||
48837634|NCT03520413|157248717|FG000|Overall Study|Physician Decision|3|||
48837635|NCT03520413|157248718|FG001|Overall Study|Physician Decision|3|||
48535394|NCT00958126|156146743|FG007|Overall Study|Lost to Follow-up|0|||
48535395|NCT00958126|156146736|FG000|Overall Study|Sponsor/Investigator decision|0|||
48837636|NCT03520413|157248717|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
48837637|NCT03520413|157248718|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
48837638|NCT01184508|157248719|FG000|Overall Study|Adverse Event|4|||
48535396|NCT00958126|156146737|FG001|Overall Study|Sponsor/Investigator decision|0|||
48535397|NCT00958126|156146738|FG002|Overall Study|Sponsor/Investigator decision|0|||
48535398|NCT00958126|156146739|FG003|Overall Study|Sponsor/Investigator decision|1|||
48535399|NCT00958126|156146740|FG004|Overall Study|Sponsor/Investigator decision|0|||
48535400|NCT00958126|156146741|FG005|Overall Study|Sponsor/Investigator decision|0|||
48535401|NCT00958126|156146742|FG006|Overall Study|Sponsor/Investigator decision|0|||
48535402|NCT00958126|156146743|FG007|Overall Study|Sponsor/Investigator decision|0|||
48535403|NCT00958126|156146736|FG000|Overall Study|Other Reason|0|||
48535404|NCT00958126|156146737|FG001|Overall Study|Other Reason|0|||
48535405|NCT00958126|156146738|FG002|Overall Study|Other Reason|0|||
48837639|NCT01184508|157248720|FG001|Overall Study|Adverse Event|6|||
48837640|NCT01184508|157248719|FG000|Overall Study|Lack of Efficacy|1|||
48535406|NCT00958126|156146739|FG003|Overall Study|Other Reason|1|||
48535407|NCT00958126|156146740|FG004|Overall Study|Other Reason|0|||
48604776|NCT01232283|156409068|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48604777|NCT01232283|156409069|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48604778|NCT01232283|156409070|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48604779|NCT01232283|156409071|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48604780|NCT01232283|156409072|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48604781|NCT01232283|156409073|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
48535408|NCT00958126|156146741|FG005|Overall Study|Other Reason|1|||
48535409|NCT00958126|156146742|FG006|Overall Study|Other Reason|0|||
48535410|NCT00958126|156146743|FG007|Overall Study|Other Reason|0|||
48535411|NCT00733369|156146747|FG000|Overall Study|Lost to Follow-up|2|||
48535412|NCT00733369|156146748|FG001|Overall Study|Lost to Follow-up|1|||
48535413|NCT00733369|156146747|FG000|Overall Study|Adverse Event|4|||
48535414|NCT00733369|156146748|FG001|Overall Study|Adverse Event|4|||
48535415|NCT00733369|156146747|FG000|Overall Study|Protocol Violation|4|||
48535416|NCT00733369|156146748|FG001|Overall Study|Protocol Violation|4|||
48535417|NCT03401073|156146749|FG000|Overall Study|Lost to Follow-up|1|||
48535418|NCT03401073|156146750|FG001|Overall Study|Lost to Follow-up|2|||
48604782|NCT01232283|156409064|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
48604783|NCT01232283|156409065|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
48837641|NCT01184508|157248720|FG001|Overall Study|Lack of Efficacy|1|||
48837642|NCT01184508|157248719|FG000|Overall Study|Lost to Follow-up|1|||
48837643|NCT01184508|157248720|FG001|Overall Study|Lost to Follow-up|1|||
48535419|NCT01470612|156146751|FG000|Overall Study|Adverse Event|20|||
48535420|NCT01470612|156146752|FG001|Overall Study|Adverse Event|80|||
48535421|NCT01470612|156146751|FG000|Overall Study|Death|0|||
48535422|NCT01470612|156146752|FG001|Overall Study|Death|1|||
48535423|NCT01470612|156146751|FG000|Overall Study|Lack of Efficacy|20|||
48535424|NCT01470612|156146752|FG001|Overall Study|Lack of Efficacy|326|||
48535425|NCT01470612|156146751|FG000|Overall Study|Lost to Follow-up|2|||
48837644|NCT01184508|157248719|FG000|Overall Study|Physician Decision|1|||
48837645|NCT01184508|157248720|FG001|Overall Study|Physician Decision|0|||
48837646|NCT01184508|157248719|FG000|Overall Study|Protocol Violation|3|||
48837647|NCT01184508|157248720|FG001|Overall Study|Protocol Violation|1|||
48837648|NCT01184508|157248719|FG000|Overall Study|Sponsor Decision|5|||
48535426|NCT01470612|156146752|FG001|Overall Study|Lost to Follow-up|5|||
48535427|NCT01470612|156146751|FG000|Overall Study|Did not meet entrance criteria|0|||
48535428|NCT01470612|156146752|FG001|Overall Study|Did not meet entrance criteria|1|||
48535429|NCT01470612|156146751|FG000|Overall Study|Pregnancy|2|||
48535430|NCT01470612|156146752|FG001|Overall Study|Pregnancy|10|||
48535431|NCT01470612|156146751|FG000|Overall Study|Protocol Violation|2|||
48535432|NCT01470612|156146752|FG001|Overall Study|Protocol Violation|7|||
48535433|NCT01470612|156146751|FG000|Overall Study|Withdrawal by Subject|24|||
48535434|NCT01470612|156146752|FG001|Overall Study|Withdrawal by Subject|79|||
48535435|NCT01470612|156146751|FG000|Overall Study|Other|14|||
48535436|NCT01470612|156146752|FG001|Overall Study|Other|156|||
48535437|NCT00706355|156146753|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
48535438|NCT00706355|156146754|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
48535439|NCT00706355|156146755|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
48535440|NCT00706355|156146756|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
48535441|NCT00706355|156146753|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
48535442|NCT00706355|156146754|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
48535443|NCT00706355|156146755|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
48535444|NCT00706355|156146756|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
48535445|NCT00706355|156146753|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
48535446|NCT00706355|156146754|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
48535447|NCT00706355|156146755|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
48535448|NCT00706355|156146756|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
48535449|NCT00706355|156146753|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
48535450|NCT00706355|156146754|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
48535451|NCT00706355|156146755|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
48535452|NCT00706355|156146756|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
48535453|NCT00706355|156146753|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
48535454|NCT00706355|156146754|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
48535455|NCT00706355|156146755|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
48535456|NCT00706355|156146756|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
48535457|NCT00706355|156146753|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
48535458|NCT00706355|156146754|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
48535459|NCT00706355|156146755|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
48535460|NCT00706355|156146756|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
48535461|NCT00706355|156146753|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
48535462|NCT00706355|156146754|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
48535463|NCT00706355|156146755|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
48535464|NCT00706355|156146756|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
48535465|NCT00706355|156146753|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
48535466|NCT00706355|156146754|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
48535467|NCT00706355|156146755|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
48535468|NCT00706355|156146756|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
48535469|NCT00706355|156146753|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
48535470|NCT00706355|156146754|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
48535471|NCT00706355|156146755|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
48535472|NCT00706355|156146756|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
48535473|NCT01506908|156146757|FG000|Overall Study|Adverse Event|1|||
48535474|NCT01506908|156146758|FG001|Overall Study|Adverse Event|0|||
48535475|NCT02510014|156146759|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
48535476|NCT02510014|156146760|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
48535477|NCT02510014|156146759|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
48535478|NCT02510014|156146760|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
48535479|NCT02510014|156146759|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
48535480|NCT02510014|156146760|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
48535481|NCT02510014|156146759|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
48535482|NCT02510014|156146760|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
48535483|NCT02510014|156146759|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
48535484|NCT02510014|156146760|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
48535485|NCT02510014|156146759|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
48535486|NCT02510014|156146760|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
48535487|NCT02510014|156146759|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
48535488|NCT02510014|156146760|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
48837649|NCT01184508|157248720|FG001|Overall Study|Sponsor Decision|2|||
48837650|NCT01184508|157248719|FG000|Overall Study|Withdrawal by Subject|1|||
48837651|NCT01184508|157248720|FG001|Overall Study|Withdrawal by Subject|3|||
48837652|NCT01184508|157248719|FG000|Overall Study|Randomized, Not Treated|0|||
48837653|NCT01184508|157248720|FG001|Overall Study|Randomized, Not Treated|1|||
48837654|NCT01075217|157248721|FG000|Overall Study|Adverse Event|1|||
48837655|NCT01075217|157248722|FG001|Overall Study|Adverse Event|1|||
48837656|NCT01075217|157248721|FG000|Overall Study|Physician Decision|1|||
48837657|NCT01075217|157248722|FG001|Overall Study|Physician Decision|0|||
48837658|NCT00891930|157248727|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
48837659|NCT00891930|157248727|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
48837660|NCT00891930|157248727|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
48837661|NCT00891930|157248727|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
48837662|NCT00891930|157248727|FG000|Part 2 Panitumumab + AMG479|Death|30|||
48837663|NCT02045836|157248728|FG000|Overall Study|Adverse Event|4|||
48837664|NCT02045836|157248729|FG001|Overall Study|Adverse Event|4|||
48837665|NCT02045836|157248728|FG000|Overall Study|Withdrawal by Subject|1|||
48837666|NCT02045836|157248729|FG001|Overall Study|Withdrawal by Subject|1|||
48837667|NCT02045836|157248728|FG000|Overall Study|Lost to Follow-up|4|||
48837668|NCT02045836|157248729|FG001|Overall Study|Lost to Follow-up|7|||
48837669|NCT02045836|157248728|FG000|Overall Study|Migrated from study area|0|||
48837670|NCT02045836|157248729|FG001|Overall Study|Migrated from study area|2|||
48837671|NCT02341625|157248730|FG000|Overall Study|Disease Progression|2|||
48837672|NCT02341625|157248731|FG001|Overall Study|Disease Progression|2|||
48837673|NCT02341625|157248732|FG002|Overall Study|Disease Progression|3|||
48837674|NCT02341625|157248733|FG003|Overall Study|Disease Progression|6|||
48837675|NCT02341625|157248734|FG004|Overall Study|Disease Progression|7|||
48837676|NCT02341625|157248735|FG005|Overall Study|Disease Progression|7|||
48837677|NCT02341625|157248736|FG006|Overall Study|Disease Progression|28|||
48837678|NCT02341625|157248737|FG007|Overall Study|Disease Progression|5|||
48535489|NCT02510014|156146759|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
48535490|NCT02510014|156146760|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
48837679|NCT02341625|157248738|FG008|Overall Study|Disease Progression|4|||
48837680|NCT02341625|157248739|FG009|Overall Study|Disease Progression|19|||
48837681|NCT02341625|157248730|FG000|Overall Study|Study Drug Toxicity|0|||
48837682|NCT02341625|157248731|FG001|Overall Study|Study Drug Toxicity|0|||
48837683|NCT02341625|157248732|FG002|Overall Study|Study Drug Toxicity|0|||
48445588|NCT00424346|155820461|FG000|Core Study|Withdrawal by Subject|1|||
48535491|NCT02510014|156146759|FG000|Treatment Period|Adverse Event|11|||
48535492|NCT02510014|156146760|FG001|Treatment Period|Adverse Event|4|||
48535493|NCT02510014|156146759|FG000|Treatment Period|Withdrawal symptoms|3|||
48535494|NCT02510014|156146760|FG001|Treatment Period|Withdrawal symptoms|0|||
48837684|NCT02341625|157248733|FG003|Overall Study|Study Drug Toxicity|1|||
48445589|NCT00424346|155820462|FG001|Core Study|Withdrawal by Subject|0|||
48445590|NCT00424346|155820463|FG002|Core Study|Withdrawal by Subject|0|||
48445591|NCT00424346|155820464|FG003|Core Study|Withdrawal by Subject|2|||
48445592|NCT00424346|155820461|FG000|Core Study|Lost to Follow-up|1|||
48445593|NCT00424346|155820462|FG001|Core Study|Lost to Follow-up|1|||
48445594|NCT00424346|155820463|FG002|Core Study|Lost to Follow-up|0|||
48445595|NCT00424346|155820464|FG003|Core Study|Lost to Follow-up|0|||
48445596|NCT00424346|155820461|FG000|Core Study|Administrative Problems|1|||
48445597|NCT00424346|155820462|FG001|Core Study|Administrative Problems|0|||
48445598|NCT00424346|155820463|FG002|Core Study|Administrative Problems|1|||
48445599|NCT00424346|155820464|FG003|Core Study|Administrative Problems|0|||
48445600|NCT00424346|155820461|FG000|Core Study|Protocol Violation|0|||
48445601|NCT00424346|155820462|FG001|Core Study|Protocol Violation|0|||
48445602|NCT00424346|155820463|FG002|Core Study|Protocol Violation|2|||
48445603|NCT00424346|155820464|FG003|Core Study|Protocol Violation|0|||
48445604|NCT00424346|155820461|FG000|Extension Phase|Adverse Event|0|||
48445605|NCT00424346|155820462|FG001|Extension Phase|Adverse Event|9|||
48445606|NCT00424346|155820463|FG002|Extension Phase|Adverse Event|5|||
48445607|NCT00424346|155820464|FG003|Extension Phase|Adverse Event|4|||
48445608|NCT00424346|155820461|FG000|Extension Phase|Lack of Efficacy|0|||
48445609|NCT00424346|155820462|FG001|Extension Phase|Lack of Efficacy|16|||
48445610|NCT00424346|155820463|FG002|Extension Phase|Lack of Efficacy|14|||
48445611|NCT00424346|155820464|FG003|Extension Phase|Lack of Efficacy|11|||
48445612|NCT00424346|155820461|FG000|Extension Phase|Withdrawal by Subject|0|||
48445613|NCT00424346|155820462|FG001|Extension Phase|Withdrawal by Subject|5|||
48445614|NCT00424346|155820463|FG002|Extension Phase|Withdrawal by Subject|3|||
48445615|NCT00424346|155820464|FG003|Extension Phase|Withdrawal by Subject|4|||
48445616|NCT00424346|155820461|FG000|Extension Phase|Lost to Follow-up|0|||
48445617|NCT00424346|155820462|FG001|Extension Phase|Lost to Follow-up|2|||
48445618|NCT00424346|155820463|FG002|Extension Phase|Lost to Follow-up|0|||
48445619|NCT00424346|155820464|FG003|Extension Phase|Lost to Follow-up|0|||
48445620|NCT00424346|155820461|FG000|Extension Phase|Administrative Problems|0|||
48837685|NCT02341625|157248734|FG004|Overall Study|Study Drug Toxicity|0|||
48837686|NCT02341625|157248735|FG005|Overall Study|Study Drug Toxicity|3|||
48837687|NCT02341625|157248736|FG006|Overall Study|Study Drug Toxicity|10|||
48837688|NCT02341625|157248737|FG007|Overall Study|Study Drug Toxicity|0|||
48837689|NCT02341625|157248738|FG008|Overall Study|Study Drug Toxicity|0|||
48837690|NCT02341625|157248739|FG009|Overall Study|Study Drug Toxicity|3|||
48837691|NCT02341625|157248730|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837692|NCT02341625|157248731|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837693|NCT02341625|157248732|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837694|NCT02341625|157248733|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837695|NCT02341625|157248734|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837696|NCT02341625|157248735|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837697|NCT02341625|157248736|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
48837698|NCT02341625|157248737|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
48837699|NCT02341625|157248738|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48837700|NCT02341625|157248739|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
48837701|NCT02341625|157248730|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837702|NCT02341625|157248731|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837703|NCT02341625|157248732|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837704|NCT02341625|157248733|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837705|NCT02341625|157248734|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837706|NCT02341625|157248735|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837707|NCT02341625|157248736|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
48837708|NCT02341625|157248737|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
48837709|NCT02341625|157248738|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837710|NCT02341625|157248739|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
48837711|NCT02341625|157248730|FG000|Overall Study|Participant Withdrew Consent|0|||
48837712|NCT02341625|157248731|FG001|Overall Study|Participant Withdrew Consent|0|||
48837713|NCT02341625|157248732|FG002|Overall Study|Participant Withdrew Consent|0|||
48837714|NCT02341625|157248733|FG003|Overall Study|Participant Withdrew Consent|1|||
48837715|NCT02341625|157248734|FG004|Overall Study|Participant Withdrew Consent|0|||
48837716|NCT02341625|157248735|FG005|Overall Study|Participant Withdrew Consent|0|||
48837717|NCT02341625|157248736|FG006|Overall Study|Participant Withdrew Consent|0|||
48837718|NCT02341625|157248737|FG007|Overall Study|Participant Withdrew Consent|0|||
48837719|NCT02341625|157248738|FG008|Overall Study|Participant Withdrew Consent|0|||
48837720|NCT02341625|157248739|FG009|Overall Study|Participant Withdrew Consent|0|||
48837721|NCT02341625|157248730|FG000|Overall Study|Completed Treatment as per Protocol|0|||
48837722|NCT02341625|157248731|FG001|Overall Study|Completed Treatment as per Protocol|0|||
48837723|NCT02341625|157248732|FG002|Overall Study|Completed Treatment as per Protocol|0|||
48837724|NCT02341625|157248733|FG003|Overall Study|Completed Treatment as per Protocol|0|||
48837725|NCT02341625|157248734|FG004|Overall Study|Completed Treatment as per Protocol|0|||
48837726|NCT02341625|157248735|FG005|Overall Study|Completed Treatment as per Protocol|0|||
48837727|NCT02341625|157248736|FG006|Overall Study|Completed Treatment as per Protocol|0|||
48837728|NCT02341625|157248737|FG007|Overall Study|Completed Treatment as per Protocol|0|||
48837729|NCT02341625|157248738|FG008|Overall Study|Completed Treatment as per Protocol|0|||
48837730|NCT02341625|157248739|FG009|Overall Study|Completed Treatment as per Protocol|1|||
48837731|NCT02341625|157248730|FG000|Overall Study|Other Reasons|0|||
48837732|NCT02341625|157248731|FG001|Overall Study|Other Reasons|0|||
48837733|NCT02341625|157248732|FG002|Overall Study|Other Reasons|0|||
48837734|NCT02341625|157248733|FG003|Overall Study|Other Reasons|0|||
48837735|NCT02341625|157248734|FG004|Overall Study|Other Reasons|1|||
48837736|NCT02341625|157248735|FG005|Overall Study|Other Reasons|0|||
48837737|NCT02341625|157248736|FG006|Overall Study|Other Reasons|5|||
48837738|NCT02341625|157248737|FG007|Overall Study|Other Reasons|0|||
48837739|NCT02341625|157248738|FG008|Overall Study|Other Reasons|0|||
48837740|NCT02341625|157248739|FG009|Overall Study|Other Reasons|2|||
48837741|NCT02341625|157248730|FG000|Overall Study|Not Reported|0|||
48837742|NCT02341625|157248731|FG001|Overall Study|Not Reported|0|||
48837743|NCT02341625|157248732|FG002|Overall Study|Not Reported|0|||
48837744|NCT02341625|157248733|FG003|Overall Study|Not Reported|0|||
48837745|NCT02341625|157248734|FG004|Overall Study|Not Reported|0|||
48837746|NCT02341625|157248735|FG005|Overall Study|Not Reported|0|||
48445911|NCT00050960|155820548|FG001|Overall Study|Partial Response|19|||
48445912|NCT00050960|155820547|FG000|Overall Study|Complete Response|0|||
48445913|NCT00050960|155820548|FG001|Overall Study|Complete Response|2|||
48445914|NCT00050960|155820547|FG000|Overall Study|Adverse Event|62|||
48445915|NCT00050960|155820548|FG001|Overall Study|Adverse Event|61|||
48445916|NCT00050960|155820547|FG000|Overall Study|Lost to Follow-up|0|||
48445917|NCT00050960|155820548|FG001|Overall Study|Lost to Follow-up|1|||
48445918|NCT00050960|155820547|FG000|Overall Study|Withdrawal by Subject|23|||
48445919|NCT00050960|155820548|FG001|Overall Study|Withdrawal by Subject|18|||
48445920|NCT00050960|155820547|FG000|Overall Study|Administrative|31|||
48837747|NCT02341625|157248736|FG006|Overall Study|Not Reported|0|||
48837748|NCT02341625|157248737|FG007|Overall Study|Not Reported|0|||
48837749|NCT02341625|157248738|FG008|Overall Study|Not Reported|0|||
48837750|NCT02341625|157248739|FG009|Overall Study|Not Reported|3|||
48837751|NCT02570711|157248743|FG000|Overall Study|Death|1|||
48837752|NCT02570711|157248744|FG001|Overall Study|Death|0|||
48837753|NCT02570711|157248743|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
48837754|NCT02570711|157248744|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
48837755|NCT01490086|157248757|FG000|Overall Study|Consent withdrawn|4|||
48837756|NCT01490086|157248758|FG001|Overall Study|Consent withdrawn|4|||
48837757|NCT01490086|157248759|FG002|Overall Study|Consent withdrawn|3|||
48837758|NCT01490086|157248760|FG003|Overall Study|Consent withdrawn|0|||
48837759|NCT01490086|157248761|FG004|Overall Study|Consent withdrawn|1|||
48837760|NCT01490086|157248757|FG000|Overall Study|Non-compliance|0|||
48837761|NCT01490086|157248758|FG001|Overall Study|Non-compliance|1|||
48837762|NCT01490086|157248759|FG002|Overall Study|Non-compliance|0|||
48837763|NCT01490086|157248760|FG003|Overall Study|Non-compliance|0|||
48837764|NCT01490086|157248761|FG004|Overall Study|Non-compliance|0|||
48837765|NCT01490086|157248757|FG000|Overall Study|Abnormal laboratory findings|1|||
48837766|NCT01490086|157248758|FG001|Overall Study|Abnormal laboratory findings|0|||
48837767|NCT01490086|157248759|FG002|Overall Study|Abnormal laboratory findings|0|||
48837768|NCT01490086|157248760|FG003|Overall Study|Abnormal laboratory findings|0|||
48837769|NCT01490086|157248761|FG004|Overall Study|Abnormal laboratory findings|0|||
48837770|NCT01490086|157248757|FG000|Overall Study|Lost to Follow-up|0|||
48837771|NCT01490086|157248758|FG001|Overall Study|Lost to Follow-up|0|||
48837772|NCT01490086|157248759|FG002|Overall Study|Lost to Follow-up|0|||
48837773|NCT01490086|157248760|FG003|Overall Study|Lost to Follow-up|0|||
48837774|NCT01490086|157248761|FG004|Overall Study|Lost to Follow-up|1|||
48837775|NCT01490086|157248757|FG000|Overall Study|Physician Decision|3|||
48837776|NCT01490086|157248758|FG001|Overall Study|Physician Decision|4|||
48837777|NCT01490086|157248759|FG002|Overall Study|Physician Decision|2|||
48837778|NCT01490086|157248760|FG003|Overall Study|Physician Decision|3|||
48837779|NCT01490086|157248761|FG004|Overall Study|Physician Decision|1|||
48837780|NCT01490086|157248757|FG000|Overall Study|Adverse Event|0|||
48837781|NCT01490086|157248758|FG001|Overall Study|Adverse Event|0|||
48837782|NCT01490086|157248759|FG002|Overall Study|Adverse Event|1|||
48837783|NCT01490086|157248760|FG003|Overall Study|Adverse Event|2|||
48837784|NCT01490086|157248761|FG004|Overall Study|Adverse Event|0|||
48837785|NCT01490086|157248757|FG000|Overall Study|Lack of Efficacy|0|||
48837786|NCT01490086|157248758|FG001|Overall Study|Lack of Efficacy|3|||
48837787|NCT01490086|157248759|FG002|Overall Study|Lack of Efficacy|1|||
48837788|NCT01490086|157248760|FG003|Overall Study|Lack of Efficacy|0|||
48837789|NCT01490086|157248761|FG004|Overall Study|Lack of Efficacy|8|||
48837790|NCT01490086|157248757|FG000|Overall Study|Worsening of symptoms|0|||
48837791|NCT01490086|157248758|FG001|Overall Study|Worsening of symptoms|1|||
48837792|NCT01490086|157248759|FG002|Overall Study|Worsening of symptoms|0|||
48837793|NCT01490086|157248760|FG003|Overall Study|Worsening of symptoms|1|||
48837794|NCT01490086|157248761|FG004|Overall Study|Worsening of symptoms|0|||
48837795|NCT01490086|157248757|FG000|Overall Study|Subject uncontrollable and abusive|0|||
48837796|NCT01490086|157248758|FG001|Overall Study|Subject uncontrollable and abusive|1|||
48837797|NCT01490086|157248759|FG002|Overall Study|Subject uncontrollable and abusive|0|||
48837798|NCT01490086|157248760|FG003|Overall Study|Subject uncontrollable and abusive|0|||
48837799|NCT01490086|157248761|FG004|Overall Study|Subject uncontrollable and abusive|0|||
48837800|NCT01490086|157248757|FG000|Overall Study|Subject left hospital|0|||
48837801|NCT01490086|157248758|FG001|Overall Study|Subject left hospital|1|||
48837802|NCT01490086|157248759|FG002|Overall Study|Subject left hospital|0|||
48535495|NCT02510014|156146759|FG000|Treatment Period|Lost to Follow-up|80|||
48535496|NCT02510014|156146760|FG001|Treatment Period|Lost to Follow-up|19|||
48535497|NCT02510014|156146759|FG000|Treatment Period|Physician Decision|5|||
48535498|NCT02510014|156146760|FG001|Treatment Period|Physician Decision|0|||
48535499|NCT02510014|156146759|FG000|Treatment Period|Withdrawal by Subject|67|||
48837803|NCT01490086|157248760|FG003|Overall Study|Subject left hospital|1|||
48837804|NCT01490086|157248761|FG004|Overall Study|Subject left hospital|0|||
48837805|NCT02549170|157248762|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
48837806|NCT02549170|157248763|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
48837807|NCT02549170|157248764|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
48837808|NCT02549170|157248765|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
48837809|NCT02549170|157248766|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
48837810|NCT02549170|157248762|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
48837811|NCT02549170|157248763|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
48837812|NCT02549170|157248764|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
48535500|NCT02510014|156146760|FG001|Treatment Period|Withdrawal by Subject|24|||
48837813|NCT02549170|157248765|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
48837814|NCT02549170|157248766|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
48837815|NCT02549170|157248762|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
48837816|NCT02549170|157248763|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
48837817|NCT02549170|157248764|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
48837818|NCT02549170|157248765|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
48837819|NCT02549170|157248766|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
48837820|NCT01124734|157248767|FG000|Overall Study|Disease progression|13|||
48837821|NCT01124734|157248767|FG000|Overall Study|Adverse Event|1|||
48837822|NCT01124734|157248767|FG000|Overall Study|Withdrawal by Subject|1|||
48837823|NCT01124734|157248767|FG000|Overall Study|Elected for alternative treatment|2|||
48837824|NCT02807493|157248769|FG000|Overall Study|Adverse Event|5|||
48837825|NCT02807493|157248770|FG001|Overall Study|Adverse Event|2|||
48837826|NCT02807493|157248769|FG000|Overall Study|Lost to Follow-up|6|||
48837827|NCT02807493|157248770|FG001|Overall Study|Lost to Follow-up|0|||
48837828|NCT02807493|157248769|FG000|Overall Study|Physician Decision|4|||
48837829|NCT02807493|157248770|FG001|Overall Study|Physician Decision|1|||
48837830|NCT02807493|157248769|FG000|Overall Study|Protocol Violation|7|||
48837831|NCT02807493|157248770|FG001|Overall Study|Protocol Violation|0|||
48837832|NCT02807493|157248769|FG000|Overall Study|Withdrawal by Subject|17|||
48837833|NCT02807493|157248770|FG001|Overall Study|Withdrawal by Subject|10|||
48837834|NCT02807493|157248769|FG000|Overall Study|Other withdrawal|17|||
48837835|NCT02807493|157248770|FG001|Overall Study|Other withdrawal|0|||
48837836|NCT02807493|157248769|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
48837837|NCT02807493|157248770|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
48837838|NCT04504916|157248771|FG000|Overall Study|Study terminated|7|||
48837839|NCT04504916|157248772|FG001|Overall Study|Study terminated|8|||
48837840|NCT04504916|157248771|FG000|Overall Study|Death|54|||
48837841|NCT04504916|157248772|FG001|Overall Study|Death|18|||
48837842|NCT04504916|157248771|FG000|Overall Study|Lost to Follow-up|1|||
48837843|NCT04504916|157248772|FG001|Overall Study|Lost to Follow-up|1|||
48837844|NCT04504916|157248771|FG000|Overall Study|Withdrawal by Subject|8|||
48837845|NCT04504916|157248772|FG001|Overall Study|Withdrawal by Subject|4|||
48837846|NCT04504916|157248771|FG000|Overall Study|Did not agree to follow-up|0|||
48837847|NCT04504916|157248772|FG001|Overall Study|Did not agree to follow-up|1|||
48837848|NCT04594759|157248773|FG000|Overall Study|Lost to Follow-up|3|||
48837849|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
48837850|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
48837851|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
48837852|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
48837853|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
48837854|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
48837855|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
48837856|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
48837857|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
48837858|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
48837859|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
48837860|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
48837861|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
48837862|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
48837863|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
48837864|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
48837865|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
48535501|NCT02510014|156146759|FG000|Treatment Period|Withdrawn by the investigator|7|||
48535502|NCT02510014|156146760|FG001|Treatment Period|Withdrawn by the investigator|1|||
48604784|NCT01232283|156409066|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
48535503|NCT02510014|156146759|FG000|Treatment Period|Protocol Violation|4|||
48535504|NCT02510014|156146760|FG001|Treatment Period|Protocol Violation|4|||
48535505|NCT02510014|156146759|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
48535506|NCT02510014|156146760|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
48535507|NCT03336242|156146763|FG000|Overall Study|Adverse Event|0|||
48535508|NCT03336242|156146764|FG001|Overall Study|Adverse Event|1|||
48535509|NCT00359632|156146765|FG000|Overall Study|Death|2|||
48535510|NCT00359632|156146766|FG001|Overall Study|Death|0|||
48604785|NCT01232283|156409067|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
48604786|NCT01232283|156409068|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
48604787|NCT01232283|156409069|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
48837866|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
48604788|NCT01232283|156409070|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
48535511|NCT00359632|156146765|FG000|Overall Study|Adverse Event|1|||
48535512|NCT00359632|156146766|FG001|Overall Study|Adverse Event|0|||
48535513|NCT00359632|156146765|FG000|Overall Study|Non-compliance with visit schedule|1|||
48535514|NCT00359632|156146766|FG001|Overall Study|Non-compliance with visit schedule|0|||
48535515|NCT01875471|156146769|FG000|Overall Study|Adverse Event|0|||
48535516|NCT01875471|156146770|FG001|Overall Study|Adverse Event|1|||
48535517|NCT01875471|156146769|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
48535518|NCT01875471|156146770|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
48837867|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
48837868|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
48837869|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
48837870|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
48837871|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
48837872|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
48837873|NCT00311363|157248776|FG000|24-Week Single-Blind Treatment Period|Death|1|||
48837874|NCT00311363|157248777|FG001|24-Week Single-Blind Treatment Period|Death|0|||
48837875|NCT00311363|157248778|FG002|24-Week Single-Blind Treatment Period|Death|0|||
48837876|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
48837877|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
48837878|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
48837879|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
48837880|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
48837881|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
48837882|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
48837883|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
48837884|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
48837885|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
48837886|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
48837887|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
48837888|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
48837889|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
48837890|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
48837891|NCT00311363|157248776|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
48837892|NCT00311363|157248777|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
48837893|NCT00311363|157248778|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
48837894|NCT00630786|157248779|FG000|Overall Study|Physician Decision|0|||
48837895|NCT00630786|157248780|FG001|Overall Study|Physician Decision|0|||
48837896|NCT00630786|157248781|FG002|Overall Study|Physician Decision|1|||
48837897|NCT00630786|157248779|FG000|Overall Study|Withdrawal by Subject|0|||
48837898|NCT00630786|157248780|FG001|Overall Study|Withdrawal by Subject|1|||
48837899|NCT00630786|157248781|FG002|Overall Study|Withdrawal by Subject|1|||
48837900|NCT00630786|157248779|FG000|Overall Study|Lost to Follow-up|0|||
48837901|NCT00630786|157248780|FG001|Overall Study|Lost to Follow-up|1|||
48837902|NCT00630786|157248781|FG002|Overall Study|Lost to Follow-up|0|||
48837903|NCT00630786|157248779|FG000|Overall Study|Other|1|||
48837904|NCT00630786|157248780|FG001|Overall Study|Other|0|||
48837905|NCT00630786|157248781|FG002|Overall Study|Other|0|||
48837906|NCT02568683|157248782|FG000|Overall Study|Death|0|||
48837907|NCT02568683|157248783|FG001|Overall Study|Death|2|||
48837908|NCT02568683|157248782|FG000|Overall Study|Withdrew Consent|1|||
48837909|NCT02568683|157248783|FG001|Overall Study|Withdrew Consent|0|||
48837910|NCT02568683|157248782|FG000|Overall Study|Study Terminated By Sponsor|5|||
48837911|NCT02568683|157248783|FG001|Overall Study|Study Terminated By Sponsor|2|||
48837912|NCT05510245|157248784|FG000|Overall Study|Withdrawal by Subject|1|||
48837913|NCT05510245|157248785|FG001|Overall Study|Withdrawal by Subject|0|||
48837914|NCT05510245|157248786|FG002|Overall Study|Withdrawal by Subject|0|||
48837915|NCT01373346|157248787|FG000|Overall Study|Death|1|||
48837916|NCT01395758|157248788|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
48837917|NCT01395758|157248789|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48837918|NCT01395758|157248790|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
48837919|NCT00433199|157248791|FG000|Double-Blind Period|Adverse Event|0|||
48837920|NCT00433199|157248792|FG001|Double-Blind Period|Adverse Event|25|||
48837921|NCT00433199|157248791|FG000|Double-Blind Period|Lack of Efficacy|0|||
48837922|NCT00433199|157248792|FG001|Double-Blind Period|Lack of Efficacy|2|||
48837923|NCT00433199|157248791|FG000|Double-Blind Period|Lost to Follow-up|2|||
48837924|NCT00433199|157248792|FG001|Double-Blind Period|Lost to Follow-up|5|||
48837925|NCT00433199|157248791|FG000|Double-Blind Period|Withdrawal by Subject|8|||
48837926|NCT00433199|157248792|FG001|Double-Blind Period|Withdrawal by Subject|19|||
48837927|NCT00433199|157248791|FG000|Double-Blind Period|Protocol Violation|1|||
48535519|NCT02610816|156146776|FG000|Phase 1|Withdrawal by Subject|2|||
48535520|NCT02610816|156146777|FG001|Phase 1|Withdrawal by Subject|6|||
48535521|NCT02610816|156146778|FG002|Phase 1|Withdrawal by Subject|0|||
48535522|NCT02610816|156146779|FG003|Phase 1|Withdrawal by Subject|0|||
48535523|NCT02610816|156146776|FG000|Phase 1|Lost to Follow-up|2|||
48837928|NCT00433199|157248792|FG001|Double-Blind Period|Protocol Violation|10|||
48837929|NCT00433199|157248791|FG000|Double-Blind Period|Administrative|1|||
48837930|NCT00433199|157248792|FG001|Double-Blind Period|Administrative|5|||
48837931|NCT00433199|157248791|FG000|Open-Label Period|Adverse Event|0|||
48837932|NCT00433199|157248792|FG001|Open-Label Period|Adverse Event|19|||
48837933|NCT00433199|157248791|FG000|Open-Label Period|Lack of Efficacy|0|||
48837934|NCT00433199|157248792|FG001|Open-Label Period|Lack of Efficacy|2|||
48837935|NCT00433199|157248791|FG000|Open-Label Period|Lost to Follow-up|0|||
48837936|NCT00433199|157248792|FG001|Open-Label Period|Lost to Follow-up|3|||
48837937|NCT00433199|157248791|FG000|Open-Label Period|Withdrawal by Subject|0|||
48837938|NCT00433199|157248792|FG001|Open-Label Period|Withdrawal by Subject|7|||
48837939|NCT00433199|157248791|FG000|Open-Label Period|Protocol Violation|0|||
48837940|NCT00433199|157248792|FG001|Open-Label Period|Protocol Violation|2|||
48837941|NCT00433199|157248791|FG000|Open-Label Period|Administrative|0|||
48837942|NCT00433199|157248792|FG001|Open-Label Period|Administrative|1|||
48837943|NCT02794480|157248793|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
48837944|NCT02794480|157248794|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
48837945|NCT02794480|157248795|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
48837946|NCT02794480|157248796|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
48837947|NCT02794480|157248793|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
48837948|NCT02794480|157248794|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
48837949|NCT02794480|157248795|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
48837950|NCT02794480|157248796|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
48837951|NCT02794480|157248793|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48837952|NCT02794480|157248794|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48837953|NCT02794480|157248795|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48837954|NCT02794480|157248796|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
48837955|NCT02794480|157248793|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48837956|NCT02794480|157248794|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
48837957|NCT02794480|157248795|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48837958|NCT02794480|157248796|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48837959|NCT02794480|157248793|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
48837960|NCT02794480|157248794|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48837961|NCT02794480|157248795|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48837962|NCT02794480|157248796|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
48837963|NCT00206375|157248798|FG000|Overall Study|Lost to Follow-up|1|||
48837964|NCT00206375|157248799|FG001|Overall Study|Lost to Follow-up|0|||
48837965|NCT00206375|157248800|FG002|Overall Study|Lost to Follow-up|0|||
48837966|NCT00206375|157248798|FG000|Overall Study|Withdrawal by Subject|2|||
48535524|NCT02610816|156146777|FG001|Phase 1|Lost to Follow-up|1|||
48535525|NCT02610816|156146778|FG002|Phase 1|Lost to Follow-up|0|||
48837967|NCT00206375|157248799|FG001|Overall Study|Withdrawal by Subject|1|||
48837968|NCT00206375|157248800|FG002|Overall Study|Withdrawal by Subject|3|||
48837969|NCT00206375|157248798|FG000|Overall Study|Study terminated due to lack of funds|0|||
48837970|NCT00206375|157248799|FG001|Overall Study|Study terminated due to lack of funds|1|||
48837971|NCT00206375|157248800|FG002|Overall Study|Study terminated due to lack of funds|1|||
48837972|NCT01170962|157248801|FG000|Treatment Period|Lack of Efficacy|96|||
48837973|NCT01170962|157248802|FG001|Treatment Period|Lack of Efficacy|91|||
48837974|NCT01170962|157248803|FG002|Treatment Period|Lack of Efficacy|7|||
48837975|NCT01170962|157248801|FG000|Treatment Period|Adverse Event|11|||
48837976|NCT01170962|157248802|FG001|Treatment Period|Adverse Event|12|||
48837977|NCT01170962|157248803|FG002|Treatment Period|Adverse Event|3|||
48837978|NCT01170962|157248801|FG000|Treatment Period|Withdrawal by Subject|2|||
48837979|NCT01170962|157248802|FG001|Treatment Period|Withdrawal by Subject|1|||
48535526|NCT02610816|156146779|FG003|Phase 1|Lost to Follow-up|0|||
48535527|NCT02610816|156146776|FG000|Phase 1|Physician Decision|0|||
48535528|NCT02610816|156146777|FG001|Phase 1|Physician Decision|1|||
48535529|NCT02610816|156146778|FG002|Phase 1|Physician Decision|0|||
48535530|NCT02610816|156146779|FG003|Phase 1|Physician Decision|0|||
48535531|NCT02610816|156146776|FG000|Phase 2|Withdrawal by Subject|0|||
48535532|NCT02610816|156146777|FG001|Phase 2|Withdrawal by Subject|0|||
48535533|NCT02610816|156146778|FG002|Phase 2|Withdrawal by Subject|9|||
48535534|NCT02610816|156146779|FG003|Phase 2|Withdrawal by Subject|3|||
48535535|NCT02610816|156146776|FG000|Phase 2|Lost to Follow-up|0|||
48535536|NCT02610816|156146777|FG001|Phase 2|Lost to Follow-up|0|||
48535537|NCT02610816|156146778|FG002|Phase 2|Lost to Follow-up|2|||
48535538|NCT02610816|156146779|FG003|Phase 2|Lost to Follow-up|0|||
48535539|NCT02610816|156146776|FG000|Phase 2|Physician Decision|0|||
48535540|NCT02610816|156146777|FG001|Phase 2|Physician Decision|0|||
48535541|NCT02610816|156146778|FG002|Phase 2|Physician Decision|0|||
48535542|NCT02610816|156146779|FG003|Phase 2|Physician Decision|2|||
48837980|NCT01170962|157248803|FG002|Treatment Period|Withdrawal by Subject|0|||
48535543|NCT02610816|156146776|FG000|Phase 2|Pregnancy|0|||
48837981|NCT01170962|157248801|FG000|Treatment Period|Lost to Follow-up|1|||
48837982|NCT01170962|157248802|FG001|Treatment Period|Lost to Follow-up|1|||
48837983|NCT01170962|157248803|FG002|Treatment Period|Lost to Follow-up|1|||
48837984|NCT01170962|157248801|FG000|Treatment Period|Participant no longer meets criteria|0|||
48837985|NCT01170962|157248802|FG001|Treatment Period|Participant no longer meets criteria|1|||
48837986|NCT01170962|157248803|FG002|Treatment Period|Participant no longer meets criteria|0|||
48837987|NCT01170962|157248801|FG000|Treatment Period|Request to discontinue treatment|7|||
48837988|NCT01170962|157248802|FG001|Treatment Period|Request to discontinue treatment|3|||
48837989|NCT01170962|157248803|FG002|Treatment Period|Request to discontinue treatment|1|||
48837990|NCT01170962|157248801|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
48837991|NCT01170962|157248802|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
48837992|NCT01170962|157248803|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
48837993|NCT01170962|157248801|FG000|Follow up Period|Withdrawal by Subject|14|||
48837994|NCT01170962|157248802|FG001|Follow up Period|Withdrawal by Subject|10|||
48837995|NCT01170962|157248803|FG002|Follow up Period|Withdrawal by Subject|2|||
48837996|NCT01170962|157248801|FG000|Follow up Period|Lost to Follow-up|13|||
48837997|NCT01170962|157248802|FG001|Follow up Period|Lost to Follow-up|8|||
48837998|NCT01170962|157248803|FG002|Follow up Period|Lost to Follow-up|1|||
48837999|NCT01170962|157248801|FG000|Follow up Period|Death|2|||
48838000|NCT01170962|157248802|FG001|Follow up Period|Death|2|||
48838001|NCT01170962|157248803|FG002|Follow up Period|Death|0|||
48838002|NCT01170962|157248801|FG000|Follow up Period|Others|10|||
48838003|NCT01170962|157248802|FG001|Follow up Period|Others|7|||
48838004|NCT01170962|157248803|FG002|Follow up Period|Others|3|||
48838005|NCT03887650|157248804|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
48838006|NCT03887650|157248805|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
48838007|NCT03887650|157248804|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
48838008|NCT03887650|157248805|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
48838009|NCT03887650|157248804|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
48838010|NCT03887650|157248805|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
48838011|NCT01579916|157248806|FG000|Overall Study|Lost to Follow-up|6|||
48838012|NCT01579916|157248807|FG001|Overall Study|Lost to Follow-up|1|||
48838013|NCT01579916|157248806|FG000|Overall Study|Withdrawal by Subject|1|||
48838014|NCT01579916|157248807|FG001|Overall Study|Withdrawal by Subject|1|||
48838015|NCT01579916|157248806|FG000|Overall Study|Death|1|||
48838016|NCT01579916|157248807|FG001|Overall Study|Death|0|||
48838017|NCT00933400|157248813|FG000|Overall Study|Withdrawal by Subject|21|||
48838018|NCT00933400|157248814|FG001|Overall Study|Withdrawal by Subject|1|||
48838019|NCT02299375|157248815|FG000|Overall Study|Adverse Event, serious fatal|1|||
48838020|NCT02299375|157248816|FG001|Overall Study|Adverse Event, serious fatal|3|||
48838021|NCT02299375|157248815|FG000|Overall Study|Adverse Event, non-fatal|8|||
48838022|NCT02299375|157248816|FG001|Overall Study|Adverse Event, non-fatal|9|||
48838023|NCT02299375|157248815|FG000|Overall Study|Lack of Efficacy|1|||
48838024|NCT02299375|157248816|FG001|Overall Study|Lack of Efficacy|3|||
48838025|NCT02299375|157248815|FG000|Overall Study|Protocol Violation|1|||
48838026|NCT02299375|157248816|FG001|Overall Study|Protocol Violation|3|||
48838027|NCT02299375|157248815|FG000|Overall Study|Other: Met stopping criteria|1|||
48838028|NCT02299375|157248816|FG001|Overall Study|Other: Met stopping criteria|0|||
48838029|NCT02299375|157248815|FG000|Overall Study|Other: Study closed/terminated|66|||
48838030|NCT02299375|157248816|FG001|Overall Study|Other: Study closed/terminated|55|||
48535544|NCT02610816|156146777|FG001|Phase 2|Pregnancy|0|||
48535545|NCT02610816|156146778|FG002|Phase 2|Pregnancy|0|||
48535546|NCT02610816|156146779|FG003|Phase 2|Pregnancy|1|||
48535547|NCT03629028|156146782|FG000|Overall Study|Lost to Follow-up|26|||
48535548|NCT03629028|156146783|FG001|Overall Study|Lost to Follow-up|23|||
48535549|NCT03629028|156146782|FG000|Overall Study|Pregnancy|4|||
48535550|NCT03629028|156146783|FG001|Overall Study|Pregnancy|2|||
48535551|NCT03629028|156146782|FG000|Overall Study|intolerance to examination|2|||
48535552|NCT03629028|156146783|FG001|Overall Study|intolerance to examination|0|||
48535553|NCT00766831|156146784|FG000|Overall Study|Withdrawal by Subject|4|||
48535554|NCT00766831|156146784|FG000|Overall Study|Lost to Follow-up|3|||
48535555|NCT00766831|156146784|FG000|Overall Study|Adverse Event|20|||
48838031|NCT02299375|157248815|FG000|Overall Study|Lost to Follow-up|0|||
48838032|NCT02299375|157248816|FG001|Overall Study|Lost to Follow-up|2|||
48838033|NCT02299375|157248815|FG000|Overall Study|Physician Decision|1|||
48838034|NCT02299375|157248816|FG001|Overall Study|Physician Decision|1|||
48838035|NCT02299375|157248815|FG000|Overall Study|Withdrawal by Subject|1|||
48838036|NCT02299375|157248816|FG001|Overall Study|Withdrawal by Subject|4|||
48838037|NCT02539225|157248817|FG000|Part A|Adverse Event|13|||
48838038|NCT02539225|157248818|FG001|Part A|Adverse Event|4|||
48838039|NCT02539225|157248817|FG000|Part A|Withdrawal by Subject|2|||
48838040|NCT02539225|157248818|FG001|Part A|Withdrawal by Subject|4|||
48838041|NCT02539225|157248817|FG000|Part A|Physician Decision|4|||
48838042|NCT02539225|157248818|FG001|Part A|Physician Decision|7|||
48838043|NCT02539225|157248817|FG000|Part A|Did Not Receive study Drug|1|||
48838044|NCT02539225|157248818|FG001|Part A|Did Not Receive study Drug|1|||
48838045|NCT02539225|157248817|FG000|Pre Treatment for Part B|Progressive disease|1|||
48604789|NCT01232283|156409071|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
48604790|NCT01232283|156409072|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
48535556|NCT00766831|156146784|FG000|Overall Study|Protocol Violation|15|||
48535557|NCT00766831|156146784|FG000|Overall Study|Physician Decision|5|||
48535558|NCT00766831|156146784|FG000|Overall Study|Withdrawal of consent|26|||
48535559|NCT00766831|156146784|FG000|Overall Study|Non cooperation by participants|14|||
48535560|NCT00766831|156146784|FG000|Overall Study|Other|28|||
48604791|NCT01232283|156409073|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
48604792|NCT01232283|156409064|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
48604793|NCT01232283|156409065|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
48604794|NCT01232283|156409066|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
48604795|NCT01232283|156409067|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
48604796|NCT01232283|156409068|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
48604797|NCT01232283|156409069|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
48604798|NCT01232283|156409070|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
48604799|NCT01232283|156409071|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
48604800|NCT01232283|156409072|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
48604801|NCT01232283|156409073|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
48604802|NCT01232283|156409064|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
48604803|NCT01232283|156409065|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
48604804|NCT01232283|156409066|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
48604805|NCT01232283|156409067|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
48604806|NCT01232283|156409068|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
48604807|NCT01232283|156409069|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
48604808|NCT01232283|156409070|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
48604809|NCT01232283|156409071|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
48604810|NCT01232283|156409072|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
48604811|NCT01232283|156409073|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
48604812|NCT01232283|156409064|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48604813|NCT01232283|156409065|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48604814|NCT01232283|156409066|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
48604815|NCT01232283|156409067|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
48604816|NCT01232283|156409068|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48604817|NCT01232283|156409069|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48604818|NCT01232283|156409070|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48604819|NCT01232283|156409071|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48604820|NCT01232283|156409072|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48604821|NCT01232283|156409073|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
48604822|NCT01232283|156409064|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
48604823|NCT01232283|156409065|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
48604824|NCT01232283|156409066|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
48604825|NCT01232283|156409067|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
48604826|NCT01232283|156409068|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
48604827|NCT01232283|156409069|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
48604828|NCT01232283|156409070|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
48604829|NCT01232283|156409071|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
48604830|NCT01232283|156409072|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
48604831|NCT01232283|156409073|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
48604832|NCT01232283|156409064|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604833|NCT01232283|156409065|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604834|NCT01232283|156409066|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
48604835|NCT01232283|156409067|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604836|NCT01232283|156409068|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604837|NCT01232283|156409069|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604838|NCT01232283|156409070|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604839|NCT01232283|156409071|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604840|NCT01232283|156409072|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604841|NCT01232283|156409073|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
48604842|NCT01232283|156409064|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48604843|NCT01232283|156409065|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48604844|NCT01232283|156409066|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
48604845|NCT01232283|156409067|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
48535561|NCT00502801|156146787|FG000|Treatment Period|Withdrawal by Subject|3|||
48535562|NCT00502801|156146787|FG000|Treatment Period|Adverse Event|7|||
48535563|NCT00502801|156146787|FG000|Treatment Period|Death|14|||
48535564|NCT00502801|156146787|FG000|Treatment Period|OTHER|30|||
48535565|NCT00502801|156146787|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
48535566|NCT00502801|156146787|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
48838046|NCT02539225|157248818|FG001|Pre Treatment for Part B|Progressive disease|1|||
48838047|NCT02539225|157248817|FG000|Pre Treatment for Part B|Adverse Event|1|||
48838048|NCT02539225|157248818|FG001|Pre Treatment for Part B|Adverse Event|1|||
48838049|NCT02539225|157248817|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
48838050|NCT02539225|157248818|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
48838051|NCT02539225|157248817|FG000|Pre Treatment for Part B|Physician Decision|2|||
48838052|NCT02539225|157248818|FG001|Pre Treatment for Part B|Physician Decision|0|||
48838053|NCT02539225|157248817|FG000|Part B|Adverse Event|4|||
48838054|NCT02539225|157248818|FG001|Part B|Adverse Event|4|||
48838055|NCT02539225|157248817|FG000|Part B|Withdrawal by Subject|0|||
48838056|NCT02539225|157248818|FG001|Part B|Withdrawal by Subject|3|||
48838057|NCT02539225|157248817|FG000|Part B|Physician Decision|0|||
48838058|NCT02539225|157248818|FG001|Part B|Physician Decision|9|||
48838059|NCT01551355|157248819|FG000|Overall Study|Lost to Follow-up|51|||
48838060|NCT01551355|157248820|FG001|Overall Study|Lost to Follow-up|49|||
48838061|NCT01551355|157248821|FG002|Overall Study|Lost to Follow-up|34|||
48838062|NCT01551355|157248822|FG003|Overall Study|Lost to Follow-up|24|||
48838063|NCT01551355|157248823|FG004|Overall Study|Lost to Follow-up|9|||
48838064|NCT01551355|157248824|FG005|Overall Study|Lost to Follow-up|6|||
48838065|NCT01538719|157248829|FG000|Overall Study|Lost to Follow-up|2|||
48838066|NCT01538719|157248830|FG001|Overall Study|Lost to Follow-up|0|||
48838067|NCT03997916|157248831|FG000|Overall Study|Protocol Violation|35|||
48838068|NCT01274338|157250179|FG000|Overall Study|Lack of Efficacy|72|||
48838069|NCT01274338|157250180|FG001|Overall Study|Lack of Efficacy|108|||
48838070|NCT01274338|157250181|FG002|Overall Study|Lack of Efficacy|116|||
48838071|NCT01274338|157250182|FG003|Overall Study|Lack of Efficacy|0|||
48838072|NCT01274338|157250183|FG004|Overall Study|Lack of Efficacy|0|||
48838073|NCT01274338|157250184|FG005|Overall Study|Lack of Efficacy|0|||
48838074|NCT01274338|157250179|FG000|Overall Study|Adverse Event|272|||
48838075|NCT01274338|157250180|FG001|Overall Study|Adverse Event|105|||
48838076|NCT01274338|157250181|FG002|Overall Study|Adverse Event|180|||
48838077|NCT01274338|157250182|FG003|Overall Study|Adverse Event|1|||
48838078|NCT01274338|157250183|FG004|Overall Study|Adverse Event|0|||
48838079|NCT01274338|157250184|FG005|Overall Study|Adverse Event|0|||
48838080|NCT01274338|157250179|FG000|Overall Study|Death|8|||
48838081|NCT01274338|157250180|FG001|Overall Study|Death|1|||
48838082|NCT01274338|157250181|FG002|Overall Study|Death|0|||
48838083|NCT01274338|157250182|FG003|Overall Study|Death|0|||
48838084|NCT01274338|157250183|FG004|Overall Study|Death|0|||
48838085|NCT01274338|157250184|FG005|Overall Study|Death|0|||
48838086|NCT01274338|157250179|FG000|Overall Study|Withdrawal by Subject|27|||
48838087|NCT01274338|157250180|FG001|Overall Study|Withdrawal by Subject|99|||
48838088|NCT01274338|157250181|FG002|Overall Study|Withdrawal by Subject|17|||
48838089|NCT01274338|157250182|FG003|Overall Study|Withdrawal by Subject|0|||
48838090|NCT01274338|157250183|FG004|Overall Study|Withdrawal by Subject|0|||
48838091|NCT01274338|157250184|FG005|Overall Study|Withdrawal by Subject|0|||
48838092|NCT01274338|157250179|FG000|Overall Study|Did not start treatment|8|||
48838093|NCT01274338|157250180|FG001|Overall Study|Did not start treatment|116|||
48838094|NCT01274338|157250181|FG002|Overall Study|Did not start treatment|7|||
48838095|NCT01274338|157250182|FG003|Overall Study|Did not start treatment|0|||
48838096|NCT01274338|157250183|FG004|Overall Study|Did not start treatment|0|||
48838097|NCT01274338|157250184|FG005|Overall Study|Did not start treatment|0|||
48838098|NCT01274338|157250179|FG000|Overall Study|Alternative therapy|0|||
48838099|NCT01274338|157250180|FG001|Overall Study|Alternative therapy|1|||
48838100|NCT01274338|157250181|FG002|Overall Study|Alternative therapy|0|||
48838101|NCT01274338|157250182|FG003|Overall Study|Alternative therapy|0|||
48838102|NCT01274338|157250183|FG004|Overall Study|Alternative therapy|0|||
48838103|NCT01274338|157250184|FG005|Overall Study|Alternative therapy|0|||
48535567|NCT00502801|156146787|FG000|End of Therapy to Test of Cure|Death|3|||
48535568|NCT00502801|156146787|FG000|End of Therapy to Test of Cure|OTHER|2|||
48535569|NCT00731549|156146788|FG000|Overall Study|Lost to Follow-up|19|||
48535570|NCT00731549|156146788|FG000|Overall Study|Met withdrawal criteria|24|||
48535571|NCT00731549|156146788|FG000|Overall Study|Physician Decision|16|||
48535572|NCT00731549|156146788|FG000|Overall Study|Withdrawal by Subject|89|||
48535573|NCT00731549|156146788|FG000|Overall Study|Protocol deviation|1|||
48535574|NCT00731549|156146788|FG000|Overall Study|Adverse Event|31|||
48535575|NCT00731549|156146788|FG000|Overall Study|Lack of efficacy with AE|37|||
48838104|NCT01274338|157250179|FG000|Overall Study|Other complicating diseases|0|||
48838105|NCT01274338|157250180|FG001|Overall Study|Other complicating diseases|3|||
48838106|NCT01274338|157250181|FG002|Overall Study|Other complicating diseases|1|||
48838107|NCT01274338|157250182|FG003|Overall Study|Other complicating diseases|0|||
48838108|NCT01274338|157250183|FG004|Overall Study|Other complicating diseases|0|||
48838109|NCT01274338|157250184|FG005|Overall Study|Other complicating diseases|0|||
48838110|NCT01274338|157250179|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
48838111|NCT01274338|157250180|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
48838112|NCT01274338|157250181|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
48838113|NCT01274338|157250182|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
48838114|NCT01274338|157250183|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
48535576|NCT00731549|156146788|FG000|Overall Study|Lack of efficacy without AE|6|||
48535577|NCT01393730|156146789|FG000|Overall Study|Withdrawal by Subject|3|||
48535578|NCT01393730|156146789|FG000|Overall Study|Other|2|||
48535579|NCT01393730|156146789|FG000|Overall Study|Adverse Event|1|||
48838115|NCT01274338|157250184|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
48838116|NCT01274338|157250179|FG000|Overall Study|Pregnancy|0|||
48838117|NCT01274338|157250180|FG001|Overall Study|Pregnancy|0|||
48838118|NCT01274338|157250181|FG002|Overall Study|Pregnancy|1|||
48838119|NCT01274338|157250182|FG003|Overall Study|Pregnancy|0|||
48838120|NCT01274338|157250183|FG004|Overall Study|Pregnancy|0|||
48838121|NCT01274338|157250184|FG005|Overall Study|Pregnancy|0|||
48838122|NCT01274338|157250179|FG000|Overall Study|Reason not reported|12|||
48838123|NCT01274338|157250180|FG001|Overall Study|Reason not reported|21|||
48838124|NCT01274338|157250181|FG002|Overall Study|Reason not reported|3|||
48838125|NCT01274338|157250182|FG003|Overall Study|Reason not reported|0|||
48838126|NCT01274338|157250183|FG004|Overall Study|Reason not reported|1|||
48838127|NCT01274338|157250184|FG005|Overall Study|Reason not reported|0|||
48838128|NCT01386385|157250185|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
48838129|NCT01386385|157250186|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
48838130|NCT01386385|157250187|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
48838131|NCT01386385|157250188|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
48838132|NCT01386385|157250189|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
48838133|NCT01386385|157250190|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
48535580|NCT00103402|156146790|FG000|Overall Study|Adverse Event|3|||
48535581|NCT00103402|156146791|FG001|Overall Study|Adverse Event|4|||
48535582|NCT00103402|156146790|FG000|Overall Study|Lost to Follow-up|8|||
48535583|NCT00103402|156146791|FG001|Overall Study|Lost to Follow-up|7|||
48535584|NCT00103402|156146790|FG000|Overall Study|Dissatisfied/No longer interested|6|||
48535585|NCT00103402|156146791|FG001|Overall Study|Dissatisfied/No longer interested|6|||
48535586|NCT00103402|156146790|FG000|Overall Study|Personal constraints/Other|5|||
48535587|NCT00103402|156146791|FG001|Overall Study|Personal constraints/Other|0|||
48535588|NCT05810285|156146794|FG000|Overall Study|Death|4|||
48535589|NCT05810285|156146795|FG001|Overall Study|Death|21|||
48535590|NCT05810285|156146794|FG000|Overall Study|Adverse Event|18|||
48535591|NCT05810285|156146795|FG001|Overall Study|Adverse Event|16|||
48535592|NCT01000610|156148341|FG000|Overall Study|Adverse Event|1|||
48838134|NCT01386385|157250191|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
48838135|NCT01386385|157250192|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
48838136|NCT01386385|157250185|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
48838137|NCT01386385|157250186|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
48838138|NCT01386385|157250187|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
48838139|NCT01386385|157250188|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
48838140|NCT01386385|157250189|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
48838141|NCT01386385|157250190|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
48838142|NCT01386385|157250191|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
48838143|NCT01386385|157250192|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
48838144|NCT01386385|157250185|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
48838145|NCT01386385|157250186|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
48838146|NCT01386385|157250187|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
48838147|NCT01386385|157250188|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
48838148|NCT01386385|157250189|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
48838149|NCT01386385|157250190|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
48838150|NCT01386385|157250191|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
48838151|NCT01386385|157250192|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
48838152|NCT01386385|157250185|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
48838153|NCT01386385|157250186|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
48838154|NCT01386385|157250187|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
48535593|NCT01000610|156148341|FG000|Overall Study|Lost to Follow-up|4|||
48535594|NCT01000610|156148341|FG000|Overall Study|Treatment failure|1|||
48838155|NCT01386385|157250188|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
48535595|NCT00109837|156148342|FG000|Overall Study|Adverse Event|2|||
48535596|NCT00109837|156148342|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
48535597|NCT00109837|156148342|FG000|Overall Study|Death|1|||
48535598|NCT00109837|156148342|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
48535599|NCT00109837|156148342|FG000|Overall Study|Not treated|1|||
48535600|NCT00109837|156148342|FG000|Overall Study|Ineligible|1|||
48838156|NCT01386385|157250189|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
48838157|NCT01386385|157250190|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
48838158|NCT01386385|157250191|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
48838159|NCT01386385|157250192|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
48838160|NCT01386385|157250185|FG000|Phase II Concurrent CRT|Adverse Event|0|||
48838161|NCT01386385|157250186|FG001|Phase II Concurrent CRT|Adverse Event|0|||
48838162|NCT01386385|157250187|FG002|Phase II Concurrent CRT|Adverse Event|0|||
48838163|NCT01386385|157250188|FG003|Phase II Concurrent CRT|Adverse Event|0|||
48838164|NCT01386385|157250189|FG004|Phase II Concurrent CRT|Adverse Event|0|||
48838165|NCT01386385|157250190|FG005|Phase II Concurrent CRT|Adverse Event|0|||
48838166|NCT01386385|157250191|FG006|Phase II Concurrent CRT|Adverse Event|3|||
48838167|NCT01386385|157250192|FG007|Phase II Concurrent CRT|Adverse Event|3|||
48838168|NCT01386385|157250185|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
48838169|NCT01386385|157250186|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
48838170|NCT01386385|157250187|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
48838171|NCT01386385|157250188|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
48838172|NCT01386385|157250189|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
48838173|NCT01386385|157250190|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
48838174|NCT01386385|157250191|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
48838175|NCT01386385|157250192|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
48838176|NCT01386385|157250185|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
48838177|NCT01386385|157250186|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
48838178|NCT01386385|157250187|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
48838179|NCT01386385|157250188|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
48838180|NCT01386385|157250189|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
48838181|NCT01386385|157250190|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
48535601|NCT01220609|156148346|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
48535602|NCT01220609|156148346|FG000|Overall Study|Ineligible- Wrong cell type|1|||
48535603|NCT01220609|156148346|FG000|Overall Study|Ineligible-Never treated|1|||
48535604|NCT00865098|156148350|FG000|Overall Study|Progressive disease|1|||
48535605|NCT00868296|156148358|FG000|Overall Study|Adverse Event|0|||
48535606|NCT00868296|156148359|FG001|Overall Study|Adverse Event|2|||
48535607|NCT00868296|156148358|FG000|Overall Study|Withdrawal by Subject|0|||
48535608|NCT00868296|156148359|FG001|Overall Study|Withdrawal by Subject|1|||
48535609|NCT00112294|156148360|FG000|Overall Study|Still on study|5|||
48535610|NCT00112294|156148361|FG001|Overall Study|Still on study|0|||
48535611|NCT01360866|156148362|FG000|Overall Study|Lost to Follow-up|11|||
48535612|NCT01360866|156148363|FG001|Overall Study|Lost to Follow-up|28|||
48535613|NCT01360866|156148364|FG002|Overall Study|Lost to Follow-up|41|||
48535614|NCT01360866|156148365|FG003|Overall Study|Lost to Follow-up|0|||
48535615|NCT01360866|156148362|FG000|Overall Study|Adverse Event|56|||
48535616|NCT01360866|156148363|FG001|Overall Study|Adverse Event|61|||
48535617|NCT01360866|156148364|FG002|Overall Study|Adverse Event|134|||
48535618|NCT01360866|156148365|FG003|Overall Study|Adverse Event|6|||
48535619|NCT01360866|156148362|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
48535620|NCT01360866|156148363|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
48535621|NCT01360866|156148364|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
48535622|NCT01360866|156148365|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
48838182|NCT01386385|157250191|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
48838183|NCT01386385|157250192|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
48838184|NCT01386385|157250185|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
48838185|NCT01386385|157250186|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
48838186|NCT01386385|157250187|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
48838187|NCT01386385|157250188|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
48838188|NCT01386385|157250189|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
48838189|NCT01386385|157250190|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
48838190|NCT01386385|157250191|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
48838191|NCT01386385|157250192|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
48838192|NCT01386385|157250185|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
48838193|NCT01386385|157250186|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
48838194|NCT01386385|157250187|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
48838195|NCT01386385|157250188|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
48838196|NCT01386385|157250189|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
48838197|NCT01386385|157250190|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
48535623|NCT01360866|156148362|FG000|Overall Study|Withdrawn by Investigator|9|||
48535624|NCT01360866|156148363|FG001|Overall Study|Withdrawn by Investigator|8|||
48535625|NCT01360866|156148364|FG002|Overall Study|Withdrawn by Investigator|31|||
48535626|NCT01360866|156148365|FG003|Overall Study|Withdrawn by Investigator|2|||
48838198|NCT01386385|157250191|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
48838199|NCT01386385|157250192|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
48838200|NCT03889925|157250193|FG000|Overall Study|Lost to Follow-up|11|||
48838201|NCT03889925|157250194|FG001|Overall Study|Lost to Follow-up|10|||
48838202|NCT01643070|157250201|FG000|Overall Study|Withdrawal by Subject|3|||
48838203|NCT01643070|157250202|FG001|Overall Study|Withdrawal by Subject|1|||
48838204|NCT01643070|157250201|FG000|Overall Study|Death|1|||
48838205|NCT01643070|157250202|FG001|Overall Study|Death|0|||
48838206|NCT01643070|157250201|FG000|Overall Study|Pregressive disease|0|||
48838207|NCT01643070|157250202|FG001|Overall Study|Pregressive disease|2|||
48838208|NCT01259401|157250203|FG000|4-month Follow-up|Death|0|||
48838209|NCT01259401|157250204|FG001|4-month Follow-up|Death|1|||
48838210|NCT01259401|157250203|FG000|4-month Follow-up|Lost to Follow-up|0|||
48604846|NCT01232283|156409068|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48604847|NCT01232283|156409069|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48604848|NCT01232283|156409070|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48604849|NCT01232283|156409071|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48604850|NCT01232283|156409072|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48604851|NCT01232283|156409073|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
48604852|NCT01232283|156409064|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
48604853|NCT01232283|156409065|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
48838211|NCT01259401|157250204|FG001|4-month Follow-up|Lost to Follow-up|1|||
48838212|NCT04770753|157250205|FG000|Overall Study|Randomized, never treated|1|||
48838213|NCT04770753|157250206|FG001|Overall Study|Randomized, never treated|1|||
48838214|NCT04770753|157250205|FG000|Overall Study|Withdrawal by Subject|3|||
48838215|NCT04770753|157250206|FG001|Overall Study|Withdrawal by Subject|1|||
48838216|NCT04770753|157250205|FG000|Overall Study|Adverse Event|2|||
48838217|NCT04770753|157250206|FG001|Overall Study|Adverse Event|0|||
48838218|NCT04770753|157250205|FG000|Overall Study|Pregnancy|1|||
48838219|NCT04770753|157250206|FG001|Overall Study|Pregnancy|0|||
48838220|NCT04770753|157250205|FG000|Overall Study|Other un-specified|1|||
48838221|NCT04770753|157250206|FG001|Overall Study|Other un-specified|0|||
48838222|NCT02775851|157250207|FG000|Overall Study|Adverse Event|1|||
48838223|NCT02775851|157250208|FG001|Overall Study|Adverse Event|10|||
48838224|NCT02775851|157250207|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
48838225|NCT02775851|157250208|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
48838226|NCT02775851|157250207|FG000|Overall Study|Progression/Relapse|0|||
48838227|NCT02775851|157250208|FG001|Overall Study|Progression/Relapse|4|||
48838228|NCT02775851|157250207|FG000|Overall Study|Other - Not Protocol Specified|0|||
48838229|NCT02775851|157250208|FG001|Overall Study|Other - Not Protocol Specified|7|||
48838230|NCT02775851|157250207|FG000|Overall Study|Withdrawal by Subject|1|||
48838231|NCT02775851|157250208|FG001|Overall Study|Withdrawal by Subject|0|||
48535627|NCT01360866|156148362|FG000|Overall Study|Withdrawal by participant|79|||
48535628|NCT01360866|156148363|FG001|Overall Study|Withdrawal by participant|89|||
48535629|NCT01360866|156148364|FG002|Overall Study|Withdrawal by participant|168|||
48535630|NCT01360866|156148365|FG003|Overall Study|Withdrawal by participant|8|||
48535631|NCT01360866|156148362|FG000|Overall Study|Protocol Deviation|25|||
48535632|NCT01360866|156148363|FG001|Overall Study|Protocol Deviation|33|||
48535633|NCT01360866|156148364|FG002|Overall Study|Protocol Deviation|61|||
48535634|NCT01360866|156148365|FG003|Overall Study|Protocol Deviation|2|||
48535635|NCT01360866|156148362|FG000|Overall Study|Lack of Efficacy|30|||
48535636|NCT01360866|156148363|FG001|Overall Study|Lack of Efficacy|40|||
48535637|NCT01360866|156148364|FG002|Overall Study|Lack of Efficacy|30|||
48604854|NCT01232283|156409066|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
48604855|NCT01232283|156409067|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
48604856|NCT01232283|156409068|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
48604857|NCT01232283|156409069|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
48604858|NCT01232283|156409070|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
48604859|NCT01232283|156409071|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
48604860|NCT01232283|156409072|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
48604861|NCT01232283|156409073|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
48604862|NCT01232283|156409064|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
48604863|NCT01232283|156409065|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
48604864|NCT01232283|156409066|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
48604865|NCT01232283|156409067|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
48604866|NCT01232283|156409068|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
48604867|NCT01232283|156409069|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
48604868|NCT01232283|156409070|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
48604869|NCT01232283|156409071|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
48838232|NCT05696080|157250211|FG000|Overall Study|Lost to Follow-up|2|||
48838233|NCT05696080|157250212|FG001|Overall Study|Lost to Follow-up|1|||
48838234|NCT05696080|157250211|FG000|Overall Study|Physician Decision|1|||
48838235|NCT05696080|157250212|FG001|Overall Study|Physician Decision|0|||
48838236|NCT05696080|157250211|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48838237|NCT05696080|157250212|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48838238|NCT05696080|157250211|FG000|Overall Study|Withdrawal by Subject|12|||
48838239|NCT05696080|157250212|FG001|Overall Study|Withdrawal by Subject|0|||
48838240|NCT05644002|157250213|FG000|Overall Study|Lost to Follow-up|1|||
48838241|NCT05644002|157250214|FG001|Overall Study|Lost to Follow-up|2|||
48838242|NCT05644002|157250213|FG000|Overall Study|Withdrawal by Subject|0|||
48838243|NCT05644002|157250214|FG001|Overall Study|Withdrawal by Subject|1|||
48838244|NCT05056246|157250217|FG000|Overall Study|Adverse Event|0|||
48838245|NCT05056246|157250218|FG001|Overall Study|Adverse Event|0|||
48838246|NCT05056246|157250219|FG002|Overall Study|Adverse Event|0|||
48838247|NCT05056246|157250220|FG003|Overall Study|Adverse Event|0|||
48838248|NCT05056246|157250221|FG004|Overall Study|Adverse Event|1|||
48838249|NCT05056246|157250217|FG000|Overall Study|Lost to Follow-up|0|||
48838250|NCT05056246|157250218|FG001|Overall Study|Lost to Follow-up|0|||
48838251|NCT05056246|157250219|FG002|Overall Study|Lost to Follow-up|0|||
48838252|NCT05056246|157250220|FG003|Overall Study|Lost to Follow-up|2|||
48838253|NCT05056246|157250221|FG004|Overall Study|Lost to Follow-up|0|||
48838254|NCT05056246|157250217|FG000|Overall Study|Withdrawal by Subject|0|||
48838255|NCT05056246|157250218|FG001|Overall Study|Withdrawal by Subject|1|||
48838256|NCT05056246|157250219|FG002|Overall Study|Withdrawal by Subject|0|||
48604870|NCT01232283|156409072|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
48838257|NCT05056246|157250220|FG003|Overall Study|Withdrawal by Subject|0|||
48838258|NCT05056246|157250221|FG004|Overall Study|Withdrawal by Subject|0|||
48838259|NCT05307978|157250224|FG000|Overall Study|Lost to Follow-up|0|||
48838260|NCT05307978|157250225|FG001|Overall Study|Lost to Follow-up|1|||
48535638|NCT01360866|156148365|FG003|Overall Study|Lack of Efficacy|4|||
48535639|NCT00099268|156148366|FG000|Overall Study|Withdrawal by Subject|46|||
48838261|NCT05307978|157250226|FG002|Overall Study|Lost to Follow-up|0|||
48838262|NCT05307978|157250227|FG003|Overall Study|Lost to Follow-up|4|||
48838263|NCT05307978|157250228|FG004|Overall Study|Lost to Follow-up|0|||
48535640|NCT00099268|156148367|FG001|Overall Study|Withdrawal by Subject|28|||
48604871|NCT01232283|156409073|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
48604872|NCT01232283|156409064|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
48604873|NCT01232283|156409065|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
48604874|NCT01232283|156409066|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
48604875|NCT01232283|156409067|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
48604876|NCT01232283|156409068|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
48604877|NCT01232283|156409069|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
48535641|NCT00099268|156148366|FG000|Overall Study|Adverse Event|19|||
48604878|NCT01232283|156409070|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
48535642|NCT00099268|156148367|FG001|Overall Study|Adverse Event|19|||
48535643|NCT00099268|156148366|FG000|Overall Study|Protocol Violation|9|||
48535644|NCT00099268|156148367|FG001|Overall Study|Protocol Violation|8|||
48535645|NCT00099268|156148366|FG000|Overall Study|Lost to Follow-up|6|||
48535646|NCT00099268|156148367|FG001|Overall Study|Lost to Follow-up|4|||
48535647|NCT00099268|156148366|FG000|Overall Study|Lack of Efficacy|5|||
48535648|NCT00099268|156148367|FG001|Overall Study|Lack of Efficacy|18|||
48604879|NCT01232283|156409071|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
48604880|NCT01232283|156409072|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
48535649|NCT00099268|156148366|FG000|Overall Study|Administrative problems|4|||
48535650|NCT00099268|156148367|FG001|Overall Study|Administrative problems|4|||
48535651|NCT00099268|156148366|FG000|Overall Study|Death|3|||
48535652|NCT00099268|156148367|FG001|Overall Study|Death|1|||
48535653|NCT03702049|156148371|FG000|Overall Study|Lost to Follow-up|4|||
48535654|NCT03702049|156148371|FG000|Overall Study|Physician Decision|1|||
48535655|NCT01280617|156148372|FG000|Overall Study|Adverse Event|0|||
48535656|NCT01280617|156148373|FG001|Overall Study|Adverse Event|1|||
48535657|NCT03197558|156148374|FG000|Overall Study|Tubes not placed|1|||
48535658|NCT00573170|156148385|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
48535659|NCT00573170|156148386|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
48535660|NCT00573170|156148387|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
48604881|NCT01232283|156409073|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
48604882|NCT01232283|156409064|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
48535661|NCT00573170|156148388|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
48535662|NCT00573170|156148389|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
48535663|NCT00573170|156148390|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
48604883|NCT01232283|156409065|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
48604884|NCT01232283|156409066|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
48838264|NCT05307978|157250229|FG005|Overall Study|Lost to Follow-up|0|||
48535664|NCT00573170|156148385|FG000|First Washout Period|Adverse Event|1|||
48838265|NCT05307978|157250230|FG006|Overall Study|Lost to Follow-up|1|||
48838266|NCT01353313|157250234|FG000|Overall Study|Lost to Follow-up|22|||
48838267|NCT01353313|157250235|FG001|Overall Study|Lost to Follow-up|23|||
48838268|NCT01353313|157250234|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
48838269|NCT01353313|157250235|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
48838270|NCT03737994|157250236|FG000|Overall Study|Withdrawal by Subject|0|||
48838271|NCT03737994|157250237|FG001|Overall Study|Withdrawal by Subject|0|||
48535665|NCT00573170|156148386|FG001|First Washout Period|Adverse Event|1|||
48535666|NCT00573170|156148387|FG002|First Washout Period|Adverse Event|0|||
48604885|NCT01232283|156409067|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
48604886|NCT01232283|156409068|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
48604887|NCT01232283|156409069|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
48604888|NCT01232283|156409070|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
48604889|NCT01232283|156409071|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
48604890|NCT01232283|156409072|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
48604891|NCT01232283|156409073|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
48604892|NCT01232283|156409064|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
48604893|NCT01232283|156409065|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
48604894|NCT01232283|156409066|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
48604895|NCT01232283|156409067|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
48604896|NCT01232283|156409068|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
48604897|NCT01232283|156409069|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
48604898|NCT01232283|156409070|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
48604899|NCT01232283|156409071|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
48604900|NCT01232283|156409072|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
48604901|NCT01232283|156409073|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
48604902|NCT01232283|156409064|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604903|NCT01232283|156409065|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604904|NCT01232283|156409066|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604905|NCT01232283|156409067|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604906|NCT01232283|156409068|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
48604907|NCT01232283|156409069|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604908|NCT01232283|156409070|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604909|NCT01232283|156409071|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604910|NCT01232283|156409072|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604911|NCT01232283|156409073|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
48604912|NCT01232283|156409064|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
48604913|NCT01232283|156409065|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
48604914|NCT01232283|156409066|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
48604915|NCT01232283|156409067|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
48604916|NCT01232283|156409068|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
48604917|NCT01232283|156409069|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
48604918|NCT01232283|156409070|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
48604919|NCT01232283|156409071|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
48604920|NCT01232283|156409072|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
48604921|NCT01232283|156409073|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
48604922|NCT01232283|156409064|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604923|NCT01232283|156409065|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604924|NCT01232283|156409066|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604925|NCT01232283|156409067|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604926|NCT01232283|156409068|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604927|NCT01232283|156409069|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604928|NCT01232283|156409070|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604929|NCT01232283|156409071|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
48604930|NCT01232283|156409072|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604931|NCT01232283|156409073|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
48604932|NCT01232283|156409064|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48604933|NCT01232283|156409065|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48604934|NCT01232283|156409066|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48604935|NCT01232283|156409067|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48604936|NCT01232283|156409068|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48604937|NCT01232283|156409069|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
48604938|NCT01232283|156409070|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48604939|NCT01232283|156409071|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48838272|NCT03737994|157250238|FG002|Overall Study|Withdrawal by Subject|0|||
48838273|NCT03737994|157250239|FG003|Overall Study|Withdrawal by Subject|0|||
48604940|NCT01232283|156409072|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48604941|NCT01232283|156409073|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
48604942|NCT01232283|156409064|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
48604943|NCT01232283|156409065|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
48604944|NCT01232283|156409066|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
48604945|NCT01232283|156409067|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
48604946|NCT01232283|156409068|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
48838274|NCT03737994|157250240|FG004|Overall Study|Withdrawal by Subject|0|||
48838275|NCT03737994|157250241|FG005|Overall Study|Withdrawal by Subject|0|||
48838276|NCT03737994|157250242|FG006|Overall Study|Withdrawal by Subject|1|||
48838277|NCT03382561|157250243|FG000|Overall Study|Disease progression|47|||
48838278|NCT03382561|157250244|FG001|Overall Study|Disease progression|6|||
48838279|NCT03382561|157250243|FG000|Overall Study|Adverse Event|10|||
48838280|NCT03382561|157250244|FG001|Overall Study|Adverse Event|2|||
48838281|NCT03382561|157250243|FG000|Overall Study|Death|8|||
48535667|NCT00573170|156148388|FG003|First Washout Period|Adverse Event|0|||
48535668|NCT00573170|156148389|FG004|First Washout Period|Adverse Event|0|||
48535669|NCT00573170|156148390|FG005|First Washout Period|Adverse Event|1|||
48535670|NCT00573170|156148385|FG000|First Washout Period|Lack of Efficacy|0|||
48535671|NCT00573170|156148386|FG001|First Washout Period|Lack of Efficacy|0|||
48535672|NCT00573170|156148387|FG002|First Washout Period|Lack of Efficacy|0|||
48535673|NCT00573170|156148388|FG003|First Washout Period|Lack of Efficacy|0|||
48535674|NCT00573170|156148389|FG004|First Washout Period|Lack of Efficacy|0|||
48535675|NCT00573170|156148390|FG005|First Washout Period|Lack of Efficacy|1|||
48535676|NCT00573170|156148385|FG000|First Washout Period|Lost to Follow-up|1|||
48535677|NCT00573170|156148386|FG001|First Washout Period|Lost to Follow-up|1|||
48535678|NCT00573170|156148387|FG002|First Washout Period|Lost to Follow-up|0|||
48535679|NCT00573170|156148388|FG003|First Washout Period|Lost to Follow-up|2|||
48535680|NCT00573170|156148389|FG004|First Washout Period|Lost to Follow-up|0|||
48535681|NCT00573170|156148390|FG005|First Washout Period|Lost to Follow-up|2|||
48535682|NCT00573170|156148385|FG000|First Washout Period|Withdrawal by Subject|2|||
48535683|NCT00573170|156148386|FG001|First Washout Period|Withdrawal by Subject|0|||
48535684|NCT00573170|156148387|FG002|First Washout Period|Withdrawal by Subject|0|||
48535685|NCT00573170|156148388|FG003|First Washout Period|Withdrawal by Subject|2|||
48535686|NCT00573170|156148389|FG004|First Washout Period|Withdrawal by Subject|3|||
48535687|NCT00573170|156148390|FG005|First Washout Period|Withdrawal by Subject|3|||
48535688|NCT00573170|156148385|FG000|First Washout Period|Other|4|||
48535689|NCT00573170|156148386|FG001|First Washout Period|Other|0|||
48535690|NCT00573170|156148387|FG002|First Washout Period|Other|1|||
48535691|NCT00573170|156148388|FG003|First Washout Period|Other|1|||
48535692|NCT00573170|156148389|FG004|First Washout Period|Other|0|||
48535693|NCT00573170|156148390|FG005|First Washout Period|Other|0|||
48535694|NCT00573170|156148385|FG000|Second Washout Period|Adverse Event|1|||
48535695|NCT00573170|156148386|FG001|Second Washout Period|Adverse Event|0|||
48535696|NCT00573170|156148387|FG002|Second Washout Period|Adverse Event|0|||
48535697|NCT00573170|156148388|FG003|Second Washout Period|Adverse Event|0|||
48535698|NCT00573170|156148389|FG004|Second Washout Period|Adverse Event|1|||
48535699|NCT00573170|156148390|FG005|Second Washout Period|Adverse Event|0|||
48535700|NCT00573170|156148385|FG000|Second Washout Period|Protocol Violation|2|||
48535701|NCT00573170|156148386|FG001|Second Washout Period|Protocol Violation|1|||
48535702|NCT00573170|156148387|FG002|Second Washout Period|Protocol Violation|1|||
48535703|NCT00573170|156148388|FG003|Second Washout Period|Protocol Violation|0|||
48535704|NCT00573170|156148389|FG004|Second Washout Period|Protocol Violation|0|||
48535705|NCT00573170|156148390|FG005|Second Washout Period|Protocol Violation|0|||
48535706|NCT00573170|156148385|FG000|Second Washout Period|Withdrawal by Subject|1|||
48535707|NCT00573170|156148386|FG001|Second Washout Period|Withdrawal by Subject|1|||
48535708|NCT00573170|156148387|FG002|Second Washout Period|Withdrawal by Subject|2|||
48535709|NCT00573170|156148388|FG003|Second Washout Period|Withdrawal by Subject|0|||
48535710|NCT00573170|156148389|FG004|Second Washout Period|Withdrawal by Subject|1|||
48535711|NCT00573170|156148390|FG005|Second Washout Period|Withdrawal by Subject|0|||
48535712|NCT00573170|156148385|FG000|Second Washout Period|Lost to Follow-up|0|||
48535713|NCT00573170|156148386|FG001|Second Washout Period|Lost to Follow-up|0|||
48535714|NCT00573170|156148387|FG002|Second Washout Period|Lost to Follow-up|0|||
48535715|NCT00573170|156148388|FG003|Second Washout Period|Lost to Follow-up|1|||
48535716|NCT00573170|156148389|FG004|Second Washout Period|Lost to Follow-up|0|||
48535717|NCT00573170|156148390|FG005|Second Washout Period|Lost to Follow-up|0|||
48535718|NCT00573170|156148385|FG000|Second Washout Period|Other|1|||
48535719|NCT00573170|156148386|FG001|Second Washout Period|Other|2|||
48535720|NCT00573170|156148387|FG002|Second Washout Period|Other|1|||
48535721|NCT00573170|156148388|FG003|Second Washout Period|Other|4|||
48838282|NCT03382561|157250244|FG001|Overall Study|Death|3|||
48838283|NCT03382561|157250243|FG000|Overall Study|Withdrawal by Subject|6|||
48535722|NCT00573170|156148389|FG004|Second Washout Period|Other|6|||
48535723|NCT00573170|156148390|FG005|Second Washout Period|Other|2|||
48535724|NCT00573170|156148385|FG000|Third Treatment Period|Withdrawal by Subject|1|||
48535725|NCT00573170|156148386|FG001|Third Treatment Period|Withdrawal by Subject|0|||
48535726|NCT00573170|156148387|FG002|Third Treatment Period|Withdrawal by Subject|0|||
48535727|NCT00573170|156148388|FG003|Third Treatment Period|Withdrawal by Subject|0|||
48535728|NCT00573170|156148389|FG004|Third Treatment Period|Withdrawal by Subject|0|||
48535729|NCT00573170|156148390|FG005|Third Treatment Period|Withdrawal by Subject|0|||
48535730|NCT00573170|156148385|FG000|Third Treatment Period|Lost to Follow-up|0|||
48535731|NCT00573170|156148386|FG001|Third Treatment Period|Lost to Follow-up|0|||
48535732|NCT00573170|156148387|FG002|Third Treatment Period|Lost to Follow-up|0|||
48604947|NCT01232283|156409069|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
48604948|NCT01232283|156409070|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
48838284|NCT03382561|157250244|FG001|Overall Study|Withdrawal by Subject|5|||
48838285|NCT03382561|157250243|FG000|Overall Study|Alternative therapy|2|||
48838286|NCT03382561|157250244|FG001|Overall Study|Alternative therapy|8|||
48838287|NCT03382561|157250243|FG000|Overall Study|Never started treatment|3|||
48838288|NCT03382561|157250244|FG001|Overall Study|Never started treatment|6|||
48838289|NCT03382561|157250243|FG000|Overall Study|Lack of Efficacy|0|||
48838290|NCT03382561|157250244|FG001|Overall Study|Lack of Efficacy|1|||
48838291|NCT03382561|157250243|FG000|Overall Study|Physician Decision|0|||
48838292|NCT03382561|157250244|FG001|Overall Study|Physician Decision|1|||
48838293|NCT03382561|157250243|FG000|Overall Study|Other complicating disease|0|||
48838294|NCT03382561|157250244|FG001|Overall Study|Other complicating disease|1|||
48838295|NCT04468776|157250245|FG000|Overall Study|Lost to Follow-up|4|||
48838296|NCT04468776|157250246|FG001|Overall Study|Lost to Follow-up|3|||
48838297|NCT04468776|157250247|FG002|Overall Study|Lost to Follow-up|4|||
48838298|NCT04468776|157250245|FG000|Overall Study|Withdrawal by Subject|1|||
48838299|NCT04468776|157250246|FG001|Overall Study|Withdrawal by Subject|10|||
48838300|NCT04468776|157250247|FG002|Overall Study|Withdrawal by Subject|4|||
48838301|NCT04468776|157250245|FG000|Overall Study|Physician Decision|0|||
48838302|NCT04468776|157250246|FG001|Overall Study|Physician Decision|1|||
48838303|NCT04468776|157250247|FG002|Overall Study|Physician Decision|1|||
48838304|NCT02143414|157250248|FG000|Induction|Adverse Event|1|||
48838305|NCT02143414|157250249|FG001|Induction|Adverse Event|2|||
48838306|NCT02143414|157250248|FG000|Induction|Death|1|||
48838307|NCT02143414|157250249|FG001|Induction|Death|2|||
48838308|NCT02143414|157250248|FG000|Induction|Patient refusal|1|||
48838309|NCT02143414|157250249|FG001|Induction|Patient refusal|1|||
48838310|NCT02143414|157250248|FG000|Induction|Refractory|1|||
48838311|NCT02143414|157250249|FG001|Induction|Refractory|0|||
48838312|NCT02143414|157250248|FG000|Induction|Began alternative treatment|1|||
48838313|NCT02143414|157250249|FG001|Induction|Began alternative treatment|0|||
48838314|NCT02143414|157250248|FG000|Induction|Ineligible for postremission|5|||
48838315|NCT02143414|157250249|FG001|Induction|Ineligible for postremission|1|||
48838316|NCT02143414|157250248|FG000|Post-remission|Adverse Event|0|||
48604949|NCT01232283|156409071|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
48604950|NCT01232283|156409072|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
48604951|NCT01232283|156409073|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
48838317|NCT02143414|157250249|FG001|Post-remission|Adverse Event|2|||
48838318|NCT02143414|157250248|FG000|Post-remission|Disease progression/relapse|5|||
48838319|NCT02143414|157250249|FG001|Post-remission|Disease progression/relapse|0|||
48838320|NCT02143414|157250248|FG000|Maintenance|Adverse Event|4|||
48604952|NCT01232283|156409064|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
48604953|NCT01232283|156409065|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
48604954|NCT01232283|156409066|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
48604955|NCT01232283|156409067|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
48604956|NCT01232283|156409068|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
48604957|NCT01232283|156409069|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
48604958|NCT01232283|156409070|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
48604959|NCT01232283|156409071|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
48604960|NCT01232283|156409072|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
48604961|NCT01232283|156409073|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
48604962|NCT01232283|156409064|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48604963|NCT01232283|156409065|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48604964|NCT01232283|156409066|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48604965|NCT01232283|156409067|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48604966|NCT01232283|156409068|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48604967|NCT01232283|156409069|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48604968|NCT01232283|156409070|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48604969|NCT01232283|156409071|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
48604970|NCT01232283|156409072|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
48838321|NCT02143414|157250249|FG001|Maintenance|Adverse Event|6|||
48838322|NCT02143414|157250248|FG000|Maintenance|Disease progression/relapse|3|||
48838323|NCT02143414|157250249|FG001|Maintenance|Disease progression/relapse|2|||
48838324|NCT02143414|157250248|FG000|Maintenance|Patient refusal|2|||
48838325|NCT02143414|157250249|FG001|Maintenance|Patient refusal|1|||
48838326|NCT02143414|157250248|FG000|Maintenance|Physician Decision|1|||
48838327|NCT02143414|157250249|FG001|Maintenance|Physician Decision|0|||
48838328|NCT02143414|157250248|FG000|Maintenance|Death|0|||
48838329|NCT02143414|157250249|FG001|Maintenance|Death|1|||
48838330|NCT02143414|157250248|FG000|Maintenance|On protocol treatment|0|||
48838331|NCT02143414|157250249|FG001|Maintenance|On protocol treatment|6|||
48838332|NCT04847999|157250254|FG000|Overall Study|Lost to Follow-up|0|||
48838333|NCT04847999|157250255|FG001|Overall Study|Lost to Follow-up|1|||
48838334|NCT02879448|157250256|FG000|Overall Study|Death|251|||
48535733|NCT00573170|156148388|FG003|Third Treatment Period|Lost to Follow-up|0|||
48535734|NCT00573170|156148389|FG004|Third Treatment Period|Lost to Follow-up|0|||
48535735|NCT00573170|156148390|FG005|Third Treatment Period|Lost to Follow-up|2|||
48535736|NCT02129647|156148391|FG000|Overall Study|Adverse Event|2|||
48535737|NCT02129647|156148391|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
48535738|NCT01715896|156148393|FG000|Overall Study|Lost to Follow-up|0|||
48535739|NCT01715896|156148394|FG001|Overall Study|Lost to Follow-up|2|||
48535740|NCT01715896|156148393|FG000|Overall Study|Withdrawal by Subject|1|||
48535741|NCT01715896|156148394|FG001|Overall Study|Withdrawal by Subject|4|||
48535742|NCT01715896|156148393|FG000|Overall Study|Other|2|||
48535743|NCT01715896|156148394|FG001|Overall Study|Other|5|||
48535744|NCT02502734|156148398|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
48535745|NCT02502734|156148399|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
48535746|NCT02502734|156148398|FG000|Washout Period|Adverse Event|1|||
48535747|NCT02502734|156148399|FG001|Washout Period|Adverse Event|0|||
48535748|NCT03064438|156148400|FG000|Overall Study|Lost to Follow-up|1|||
48535749|NCT03064438|156148401|FG001|Overall Study|Lost to Follow-up|0|||
48535750|NCT03064438|156148400|FG000|Overall Study|Withdrawal by Subject|0|||
48535751|NCT03064438|156148401|FG001|Overall Study|Withdrawal by Subject|1|||
48535752|NCT00614822|156148402|FG000|Overall Study|Adverse Event|3|||
48535753|NCT00700817|156148414|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
48535754|NCT00700817|156148415|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
48535755|NCT00700817|156148416|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
48535756|NCT00700817|156148417|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
48604971|NCT01232283|156409073|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
48535757|NCT00700817|156148418|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
48535758|NCT00700817|156148414|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
48838335|NCT02879448|157250257|FG001|Overall Study|Death|263|||
48838336|NCT02879448|157250256|FG000|Overall Study|Lost to Follow-up|23|||
48838337|NCT02879448|157250257|FG001|Overall Study|Lost to Follow-up|28|||
48838338|NCT02879448|157250256|FG000|Overall Study|Withdrawal by Subject|42|||
48838339|NCT02879448|157250257|FG001|Overall Study|Withdrawal by Subject|79|||
48838340|NCT02879448|157250256|FG000|Overall Study|Other Reasons|8|||
48838341|NCT02879448|157250257|FG001|Overall Study|Other Reasons|12|||
48838342|NCT01286272|157250259|FG000|Overall Study|Ineligible after beginning treatment|1|||
48535759|NCT00700817|156148415|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
48535760|NCT00700817|156148416|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
48535761|NCT00700817|156148417|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
48535762|NCT00700817|156148418|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
48535763|NCT00700817|156148414|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
48838343|NCT01286272|157250260|FG001|Overall Study|Ineligible after beginning treatment|3|||
48838344|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
48838345|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
48838346|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
48838347|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
48838348|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
48838349|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
48535764|NCT00700817|156148415|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
48838350|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
48838351|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
48838352|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
48838353|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
48838354|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
48838355|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
48838356|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
48838357|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
48535765|NCT00700817|156148416|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
48838358|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
48838359|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
48838360|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
48838361|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
48535766|NCT00700817|156148417|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
48838362|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
48838363|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
48838364|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
48838365|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
48838366|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
48838367|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
48838368|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
48838369|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
48838370|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
48838371|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
48838372|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
48838373|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
48838374|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
48838375|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
48838376|NCT03818035|157250261|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
48838377|NCT03818035|157250262|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
48838378|NCT03818035|157250263|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
48838379|NCT03818035|157250264|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
48838380|NCT03818035|157250261|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
48838381|NCT03818035|157250262|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
48838382|NCT03818035|157250263|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
48838383|NCT03818035|157250264|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
48838384|NCT03818035|157250261|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
48838385|NCT03818035|157250262|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
48838386|NCT03818035|157250263|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
48838387|NCT03818035|157250264|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
48838388|NCT03818035|157250261|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
48838389|NCT03818035|157250262|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
48838390|NCT03818035|157250263|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
48838391|NCT03818035|157250264|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
48838392|NCT03818035|157250261|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
48838393|NCT03818035|157250262|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
48838394|NCT03818035|157250263|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
48838395|NCT03818035|157250264|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
48838396|NCT03818035|157250261|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
48838397|NCT03818035|157250262|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
48838398|NCT03818035|157250263|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
48838399|NCT03818035|157250264|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
48838400|NCT03818035|157250261|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
48838401|NCT03818035|157250262|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
48838402|NCT03818035|157250263|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
48838403|NCT03818035|157250264|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
48838404|NCT04905407|157250267|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
48838405|NCT04905407|157250268|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
48838406|NCT04905407|157250269|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
48838407|NCT04905407|157250270|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
48838408|NCT04905407|157250267|FG000|Part 1 and Part 2|Death|7|||
48838409|NCT04905407|157250268|FG001|Part 1 and Part 2|Death|7|||
48535767|NCT00700817|156148418|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
48838410|NCT04905407|157250269|FG002|Part 1 and Part 2|Death|7|||
48838411|NCT04905407|157250270|FG003|Part 1 and Part 2|Death|0|||
48838412|NCT04905407|157250267|FG000|Part 1 and Part 2|Other than specified|0|||
48535768|NCT00700817|156148414|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
48535769|NCT00700817|156148415|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
48838413|NCT04905407|157250268|FG001|Part 1 and Part 2|Other than specified|0|||
48838414|NCT04905407|157250269|FG002|Part 1 and Part 2|Other than specified|1|||
48838415|NCT04905407|157250270|FG003|Part 1 and Part 2|Other than specified|0|||
48838416|NCT04905407|157250267|FG000|Part 3|Death|0|||
48838417|NCT04905407|157250268|FG001|Part 3|Death|0|||
48535770|NCT00700817|156148416|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
48838418|NCT04905407|157250269|FG002|Part 3|Death|0|||
48838419|NCT04905407|157250270|FG003|Part 3|Death|2|||
48838420|NCT05320432|157250274|FG000|Overall Study|Withdrawal by Subject|0|||
48838421|NCT05320432|157250275|FG001|Overall Study|Withdrawal by Subject|2|||
48838422|NCT03261271|157250284|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
48838423|NCT03261271|157250285|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
48838424|NCT02287311|157250289|FG000|Cohort 1: Dose Level 1|Death|2|||
48838425|NCT02287311|157250290|FG001|Cohort 1: Dose Level 1|Death|0|||
48838426|NCT02287311|157250291|FG002|Cohort 1: Dose Level 1|Death|0|||
48838427|NCT02287311|157250292|FG003|Cohort 1: Dose Level 1|Death|3|||
48838428|NCT02287311|157250293|FG004|Cohort 1: Dose Level 1|Death|0|||
48838429|NCT02287311|157250294|FG005|Cohort 1: Dose Level 1|Death|0|||
48604972|NCT01232283|156409064|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48604973|NCT01232283|156409065|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48604974|NCT01232283|156409066|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48604975|NCT01232283|156409067|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48604976|NCT01232283|156409068|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48604977|NCT01232283|156409069|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48604978|NCT01232283|156409070|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48604979|NCT01232283|156409071|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
48604980|NCT01232283|156409072|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
48604981|NCT01232283|156409073|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
48604982|NCT01232283|156409064|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
48604983|NCT01232283|156409065|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
48604984|NCT01232283|156409066|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
48604985|NCT01232283|156409067|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
48604986|NCT01232283|156409068|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
48604987|NCT01232283|156409069|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
48604988|NCT01232283|156409070|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
48604989|NCT01232283|156409071|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
48604990|NCT01232283|156409072|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
48604991|NCT01232283|156409073|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
48604992|NCT01232283|156409064|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48604993|NCT01232283|156409065|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48604994|NCT01232283|156409066|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48604995|NCT01232283|156409067|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48604996|NCT01232283|156409068|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48604997|NCT01232283|156409069|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48604998|NCT01232283|156409070|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48604999|NCT01232283|156409071|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48605000|NCT01232283|156409072|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
48605001|NCT01232283|156409073|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
48605002|NCT01232283|156409064|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605003|NCT01232283|156409065|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605004|NCT01232283|156409066|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605005|NCT01232283|156409067|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605006|NCT01232283|156409068|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605007|NCT01232283|156409069|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605008|NCT01232283|156409070|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605009|NCT01232283|156409071|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605010|NCT01232283|156409072|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
48605011|NCT01232283|156409073|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
48605012|NCT01232283|156409064|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
48605013|NCT01232283|156409065|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
48605014|NCT01232283|156409066|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
48605015|NCT01232283|156409067|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
48838430|NCT02287311|157250295|FG006|Cohort 1: Dose Level 1|Death|1|||
48838431|NCT02287311|157250296|FG007|Cohort 1: Dose Level 1|Death|0|||
48838432|NCT02287311|157250297|FG008|Cohort 1: Dose Level 1|Death|0|||
48838433|NCT02287311|157250289|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
48838434|NCT02287311|157250290|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
48838435|NCT02287311|157250291|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
48838436|NCT02287311|157250292|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
48838437|NCT02287311|157250293|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
48838438|NCT02287311|157250294|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
48838439|NCT02287311|157250295|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
48838440|NCT02287311|157250296|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
48838441|NCT02287311|157250297|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
48605016|NCT01232283|156409068|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
48605017|NCT01232283|156409069|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
48838442|NCT02287311|157250289|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
48838443|NCT02287311|157250290|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
48838444|NCT02287311|157250291|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
48838445|NCT02287311|157250292|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
48838446|NCT02287311|157250293|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
48838447|NCT02287311|157250294|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
48838448|NCT02287311|157250295|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
48838449|NCT02287311|157250296|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
48838450|NCT02287311|157250297|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
48838451|NCT02287311|157250289|FG000|Cohort 2: Dose Level 2|Death|0|||
48605018|NCT01232283|156409070|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
48605019|NCT01232283|156409071|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
48605020|NCT01232283|156409072|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
48605021|NCT01232283|156409073|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
48605022|NCT03106077|156409074|FG000|Overall Study|Screen Failure|94|||
48605023|NCT03106077|156409075|FG001|Overall Study|Screen Failure|0|||
48605024|NCT01274533|156409078|FG000|Overall Study|Withdrawal by Subject|1|||
48605025|NCT01274533|156409078|FG000|Overall Study|Non-compliance|1|||
48605026|NCT01274533|156409078|FG000|Overall Study|Disease progression|2|||
48605027|NCT03368807|156409079|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
48605028|NCT03368807|156409079|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
48605029|NCT03368807|156409079|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
48605030|NCT03368807|156409079|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
48605031|NCT03669588|156409087|FG000|Overall Study|Adverse Event|1|||
48605032|NCT03669588|156409088|FG001|Overall Study|Adverse Event|0|||
48605033|NCT03669588|156409087|FG000|Overall Study|Physician Decision|0|||
48605034|NCT03669588|156409088|FG001|Overall Study|Physician Decision|1|||
48605035|NCT03669588|156409087|FG000|Overall Study|Protocol Violation|1|||
48605036|NCT03669588|156409088|FG001|Overall Study|Protocol Violation|0|||
48605037|NCT03669588|156409087|FG000|Overall Study|Sponsor Decision|1|||
48605038|NCT03669588|156409088|FG001|Overall Study|Sponsor Decision|1|||
48605039|NCT03669588|156409087|FG000|Overall Study|Withdrawal by Subject|1|||
48605040|NCT03669588|156409088|FG001|Overall Study|Withdrawal by Subject|4|||
48605041|NCT03669588|156409087|FG000|Overall Study|Rescue Therapy Needed|0|||
48605042|NCT03669588|156409088|FG001|Overall Study|Rescue Therapy Needed|1|||
48605043|NCT01118052|156409089|FG000|Overall Study|Never treated|2|||
48605044|NCT00828711|156409091|FG000|Overall Study|Lost to Follow-up|1|||
48605045|NCT00828711|156409092|FG001|Overall Study|Lost to Follow-up|0|||
48605046|NCT00828711|156409093|FG002|Overall Study|Lost to Follow-up|0|||
48838452|NCT02287311|157250290|FG001|Cohort 2: Dose Level 2|Death|2|||
48838453|NCT02287311|157250291|FG002|Cohort 2: Dose Level 2|Death|0|||
48838454|NCT02287311|157250292|FG003|Cohort 2: Dose Level 2|Death|0|||
48838455|NCT02287311|157250293|FG004|Cohort 2: Dose Level 2|Death|2|||
48838456|NCT02287311|157250294|FG005|Cohort 2: Dose Level 2|Death|0|||
48838457|NCT02287311|157250295|FG006|Cohort 2: Dose Level 2|Death|0|||
48838458|NCT02287311|157250296|FG007|Cohort 2: Dose Level 2|Death|2|||
48838459|NCT02287311|157250297|FG008|Cohort 2: Dose Level 2|Death|0|||
48838460|NCT02287311|157250289|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
48838461|NCT02287311|157250290|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
48838462|NCT02287311|157250291|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
48838463|NCT02287311|157250292|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
48838464|NCT02287311|157250293|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
48838465|NCT02287311|157250294|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
48838466|NCT02287311|157250295|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
48838467|NCT02287311|157250296|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
48838468|NCT02287311|157250297|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
48838469|NCT02287311|157250289|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
48838470|NCT02287311|157250290|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
48838471|NCT02287311|157250291|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
48838472|NCT02287311|157250292|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
48838473|NCT02287311|157250293|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
48838474|NCT02287311|157250294|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
48838475|NCT02287311|157250295|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
48838476|NCT02287311|157250296|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
48605047|NCT04356937|156409095|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
48838477|NCT02287311|157250297|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
48838478|NCT02287311|157250289|FG000|Cohort 3: Dose Level 3|Death|0|||
48838479|NCT02287311|157250290|FG001|Cohort 3: Dose Level 3|Death|0|||
48838480|NCT02287311|157250291|FG002|Cohort 3: Dose Level 3|Death|4|||
48838481|NCT02287311|157250292|FG003|Cohort 3: Dose Level 3|Death|0|||
48605048|NCT04356937|156409096|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
48605049|NCT03092752|156409097|FG000|Overall Study|Aged <40 years|14209|||
48605050|NCT03092752|156409097|FG000|Overall Study|At least one claim with T2DM|61299|||
48838482|NCT02287311|157250293|FG004|Cohort 3: Dose Level 3|Death|0|||
48838483|NCT02287311|157250294|FG005|Cohort 3: Dose Level 3|Death|4|||
48838484|NCT02287311|157250295|FG006|Cohort 3: Dose Level 3|Death|0|||
48838485|NCT02287311|157250296|FG007|Cohort 3: Dose Level 3|Death|0|||
48838486|NCT02287311|157250297|FG008|Cohort 3: Dose Level 3|Death|2|||
48838487|NCT02287311|157250289|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
48838488|NCT02287311|157250290|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
48838489|NCT02287311|157250291|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
48838490|NCT02287311|157250292|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
48838491|NCT02287311|157250293|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
48838492|NCT02287311|157250294|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
48838493|NCT02287311|157250295|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
48838494|NCT02287311|157250296|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
48838495|NCT02287311|157250297|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
48838496|NCT02287311|157250289|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
48838497|NCT02287311|157250290|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
48838498|NCT02287311|157250291|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
48838499|NCT02287311|157250292|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
48838500|NCT02287311|157250293|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
48838501|NCT02287311|157250294|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
48838502|NCT02287311|157250295|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
48838503|NCT02287311|157250296|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
48838504|NCT02287311|157250297|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
48838505|NCT03648840|157250298|FG000|First IV Infusion Session|Adverse Event|0|||
48838506|NCT03648840|157250299|FG001|First IV Infusion Session|Adverse Event|2|||
48605051|NCT03092752|156409097|FG000|Overall Study|Having no claim of study drugs|29282|||
48605052|NCT03092752|156409097|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
48605053|NCT03092752|156409097|FG000|Overall Study|<6 month history|245900|||
48605054|NCT00617279|156409099|FG000|Overall Study|Study terminated by Sponsor|10|||
48838507|NCT03648840|157250298|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
48838508|NCT03648840|157250299|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
48838509|NCT03648840|157250298|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
48838510|NCT03648840|157250299|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
48838511|NCT03648840|157250298|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
48838512|NCT03648840|157250299|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
48838513|NCT03055013|157250300|FG000|Overall Study|Adverse Event|78|||
48838514|NCT03055013|157250301|FG001|Overall Study|Adverse Event|0|||
48838515|NCT03055013|157250300|FG000|Overall Study|Death|6|||
48838516|NCT03055013|157250301|FG001|Overall Study|Death|0|||
48838517|NCT03055013|157250300|FG000|Overall Study|Disease relapse|33|||
48838518|NCT03055013|157250301|FG001|Overall Study|Disease relapse|0|||
48838519|NCT03055013|157250300|FG000|Overall Study|Withdrawal by Subject|28|||
48838520|NCT03055013|157250301|FG001|Overall Study|Withdrawal by Subject|0|||
48605055|NCT00617279|156409100|FG001|Overall Study|Study terminated by Sponsor|15|||
48838521|NCT03055013|157250300|FG000|Overall Study|Other complicating disease|5|||
48838522|NCT03055013|157250301|FG001|Overall Study|Other complicating disease|0|||
48838523|NCT03055013|157250300|FG000|Overall Study|Physician Decision|1|||
48838524|NCT03055013|157250301|FG001|Overall Study|Physician Decision|0|||
48838525|NCT03055013|157250300|FG000|Overall Study|Benign mass/non-RCC|4|||
48838526|NCT03055013|157250301|FG001|Overall Study|Benign mass/non-RCC|0|||
48838527|NCT03055013|157250300|FG000|Overall Study|Enrolled in another trial|1|||
48838528|NCT03055013|157250301|FG001|Overall Study|Enrolled in another trial|0|||
48838529|NCT03055013|157250300|FG000|Overall Study|Non-protocol therapy|1|||
48838530|NCT03055013|157250301|FG001|Overall Study|Non-protocol therapy|0|||
48838531|NCT03055013|157250300|FG000|Overall Study|Incompliance|1|||
48838532|NCT03055013|157250301|FG001|Overall Study|Incompliance|0|||
48838533|NCT03055013|157250300|FG000|Overall Study|Insurance issues|1|||
48838534|NCT03055013|157250301|FG001|Overall Study|Insurance issues|0|||
48605056|NCT00617279|156409099|FG000|Overall Study|Graft abandonment|2|||
48838535|NCT03055013|157250300|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
48838536|NCT03055013|157250301|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
48838537|NCT03055013|157250300|FG000|Overall Study|Did not receive nivolumab|10|||
48838538|NCT03055013|157250301|FG001|Overall Study|Did not receive nivolumab|0|||
48838539|NCT03055013|157250300|FG000|Overall Study|Did not receive surgery|0|||
48838540|NCT03055013|157250301|FG001|Overall Study|Did not receive surgery|28|||
48838541|NCT05063994|157250302|FG000|Cortef Run-In|Withdrawal of Consent|1|||
48838542|NCT05063994|157250303|FG001|Cortef Run-In|Withdrawal of Consent|0|||
48838543|NCT05063994|157250304|FG002|Cortef Run-In|Withdrawal of Consent|0|||
48838544|NCT05063994|157250302|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
48535771|NCT00700817|156148417|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
48535772|NCT00700817|156148418|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
48535773|NCT00700817|156148414|FG000|Week 0-26 (Main Period)|Unclassified|14|||
48535774|NCT00700817|156148415|FG001|Week 0-26 (Main Period)|Unclassified|4|||
48838545|NCT05063994|157250303|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
48838546|NCT05063994|157250304|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
48838547|NCT05063994|157250302|FG000|Treatment|Physician Decision|0|||
48838548|NCT05063994|157250303|FG001|Treatment|Physician Decision|0|||
48838549|NCT05063994|157250304|FG002|Treatment|Physician Decision|1|||
48838550|NCT05063994|157250302|FG000|Treatment|Withdrawal by Subject|0|||
48838551|NCT05063994|157250303|FG001|Treatment|Withdrawal by Subject|0|||
48838552|NCT05063994|157250304|FG002|Treatment|Withdrawal by Subject|1|||
48838553|NCT05063994|157250302|FG000|Treatment|Withdrawal of Consent|0|||
48838554|NCT05063994|157250303|FG001|Treatment|Withdrawal of Consent|0|||
48838555|NCT05063994|157250304|FG002|Treatment|Withdrawal of Consent|1|||
48838556|NCT03101904|157250307|FG000|Wash Out (10 Days)|Adverse Event|1|||
48838557|NCT03101904|157250308|FG001|Wash Out (10 Days)|Adverse Event|0|||
48838558|NCT03101904|157250307|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
48838559|NCT03101904|157250308|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
48838560|NCT00861705|157250313|FG000|Overall Study|Never Began Treatment|7|||
48838561|NCT00861705|157250314|FG001|Overall Study|Never Began Treatment|3|||
48605057|NCT00617279|156409100|FG001|Overall Study|Graft abandonment|0|||
48838562|NCT00861705|157250315|FG002|Overall Study|Never Began Treatment|0|||
48838563|NCT00861705|157250316|FG003|Overall Study|Never Began Treatment|1|||
48838564|NCT00616967|157250317|FG000|Overall Study|Withdrawal by Subject|0|||
48535775|NCT00700817|156148416|FG002|Week 0-26 (Main Period)|Unclassified|8|||
48535776|NCT00700817|156148417|FG003|Week 0-26 (Main Period)|Unclassified|0|||
48535777|NCT00700817|156148418|FG004|Week 0-26 (Main Period)|Unclassified|0|||
48535778|NCT00700817|156148414|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
48605058|NCT00617279|156409099|FG000|Overall Study|Lost to Follow-up|1|||
48605059|NCT00617279|156409100|FG001|Overall Study|Lost to Follow-up|0|||
48605060|NCT00617279|156409099|FG000|Overall Study|Death|1|||
48605061|NCT00617279|156409100|FG001|Overall Study|Death|2|||
48605062|NCT01324947|156409105|FG000|Overall Study|Adverse Event|7|||
48605063|NCT01324947|156409105|FG000|Overall Study|Death|10|||
48605064|NCT01324947|156409105|FG000|Overall Study|Other|3|||
48605065|NCT01324947|156409105|FG000|Overall Study|Progressive Disease|50|||
48605066|NCT01324947|156409105|FG000|Overall Study|Withdrawal by Subject|3|||
48605067|NCT01324947|156409105|FG000|Overall Study|1 discontinued before starting drug|1|||
48605068|NCT02100124|156409109|FG000|Overall Study|Lost to Follow-up|5|||
48605069|NCT02100124|156409110|FG001|Overall Study|Lost to Follow-up|11|||
48605070|NCT02100124|156409111|FG002|Overall Study|Lost to Follow-up|3|||
48605071|NCT02100124|156409109|FG000|Overall Study|Withdrawal by Subject|1|||
48605072|NCT02100124|156409110|FG001|Overall Study|Withdrawal by Subject|0|||
48605073|NCT02100124|156409111|FG002|Overall Study|Withdrawal by Subject|0|||
48605074|NCT03321721|156409112|FG000|Overall Study|Lost to Follow-up|4|||
48605075|NCT03321721|156409113|FG001|Overall Study|Lost to Follow-up|8|||
48605076|NCT03321721|156409114|FG002|Overall Study|Lost to Follow-up|11|||
48605077|NCT02481050|156411568|FG000|Overall Study|Adverse Event|1|||
48838565|NCT00616967|157250318|FG001|Overall Study|Withdrawal by Subject|0|||
48838566|NCT00616967|157250319|FG002|Overall Study|Withdrawal by Subject|1|||
48838567|NCT05059262|157251963|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
48838568|NCT05059262|157251964|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
48838569|NCT05059262|157251963|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
48838570|NCT05059262|157251964|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
48838571|NCT05059262|157251963|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
48838572|NCT05059262|157251964|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
48838573|NCT05059262|157251963|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
48838574|NCT05059262|157251964|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
48838575|NCT05059262|157251963|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
48838576|NCT05059262|157251964|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
48838577|NCT05059262|157251963|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
48838578|NCT05059262|157251964|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
48838579|NCT05059262|157251963|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
48838580|NCT05059262|157251964|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
48605078|NCT02481050|156411568|FG000|Overall Study|Disease Progression|47|||
48838581|NCT05059262|157251963|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
48838582|NCT05059262|157251964|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
48838583|NCT05059262|157251963|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
48838584|NCT05059262|157251964|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
48838585|NCT05818137|157251965|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
48838586|NCT05818137|157251965|FG000|Extension Treatment Period|Ongoing participants|44|||
48838587|NCT02029443|157251966|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
48535779|NCT00700817|156148415|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
48535780|NCT00700817|156148416|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
48535781|NCT00700817|156148417|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
48535782|NCT00700817|156148418|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
48535783|NCT00700817|156148414|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
48535784|NCT00700817|156148415|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
48535785|NCT00700817|156148416|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
48535786|NCT00700817|156148417|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
48535787|NCT00700817|156148418|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
48535788|NCT00700817|156148414|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
48535789|NCT00700817|156148415|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
48535790|NCT00700817|156148416|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
48535791|NCT00700817|156148417|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
48535792|NCT00700817|156148418|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
48535793|NCT00700817|156148414|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
48535794|NCT00700817|156148415|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
48535795|NCT00700817|156148416|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
48535796|NCT00700817|156148417|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
48535797|NCT00700817|156148418|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
48535798|NCT00700817|156148414|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
48535799|NCT00700817|156148415|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
48535800|NCT00700817|156148416|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
48535801|NCT00700817|156148417|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
48838588|NCT02029443|157251967|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
48838589|NCT02029443|157251968|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
48838590|NCT02029443|157251969|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
48838591|NCT02029443|157251970|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
48605079|NCT02481050|156411568|FG000|Overall Study|Withdrawal by Subject|7|||
48605080|NCT02481050|156411568|FG000|Overall Study|Other|3|||
48605081|NCT01386606|156411569|FG000|Overall Study|Adverse Event|0|||
48605082|NCT01386606|156411570|FG001|Overall Study|Adverse Event|1|||
48605083|NCT01386606|156411571|FG002|Overall Study|Adverse Event|0|||
48605084|NCT01386606|156411572|FG003|Overall Study|Adverse Event|0|||
48605085|NCT01386606|156411569|FG000|Overall Study|Withdrawal by Subject|0|||
48605086|NCT01386606|156411570|FG001|Overall Study|Withdrawal by Subject|1|||
48838592|NCT02029443|157251966|FG000|Overall Study|Death|13|||
48838593|NCT02029443|157251967|FG001|Overall Study|Death|2|||
48838594|NCT02029443|157251968|FG002|Overall Study|Death|2|||
48838595|NCT02029443|157251969|FG003|Overall Study|Death|11|||
48838596|NCT02029443|157251970|FG004|Overall Study|Death|2|||
48838597|NCT02029443|157251966|FG000|Overall Study|Lost to Follow-up|1|||
48838598|NCT02029443|157251967|FG001|Overall Study|Lost to Follow-up|0|||
48838599|NCT02029443|157251968|FG002|Overall Study|Lost to Follow-up|1|||
48838600|NCT02029443|157251969|FG003|Overall Study|Lost to Follow-up|1|||
48838601|NCT02029443|157251970|FG004|Overall Study|Lost to Follow-up|0|||
48838602|NCT02029443|157251966|FG000|Overall Study|Started other anti-cancer therapy|17|||
48838603|NCT02029443|157251967|FG001|Overall Study|Started other anti-cancer therapy|4|||
48838604|NCT02029443|157251968|FG002|Overall Study|Started other anti-cancer therapy|7|||
48838605|NCT02029443|157251969|FG003|Overall Study|Started other anti-cancer therapy|9|||
48838606|NCT02029443|157251970|FG004|Overall Study|Started other anti-cancer therapy|3|||
48838607|NCT02029443|157251966|FG000|Overall Study|Withdrawal by Subject|3|||
48838608|NCT02029443|157251967|FG001|Overall Study|Withdrawal by Subject|1|||
48838609|NCT02029443|157251968|FG002|Overall Study|Withdrawal by Subject|1|||
48838610|NCT02029443|157251969|FG003|Overall Study|Withdrawal by Subject|1|||
48535802|NCT00700817|156148418|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
48838611|NCT02029443|157251970|FG004|Overall Study|Withdrawal by Subject|0|||
48838612|NCT02029443|157251966|FG000|Overall Study|Other|6|||
48535803|NCT00700817|156148414|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
48535804|NCT00700817|156148415|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
48535805|NCT00700817|156148416|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
48535806|NCT00700817|156148417|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
48605087|NCT01386606|156411571|FG002|Overall Study|Withdrawal by Subject|1|||
48535807|NCT00700817|156148418|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
48838613|NCT02029443|157251967|FG001|Overall Study|Other|6|||
48535808|NCT00700817|156148414|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
48535809|NCT00700817|156148415|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
48535810|NCT00700817|156148416|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
48838614|NCT02029443|157251968|FG002|Overall Study|Other|4|||
48838615|NCT02029443|157251969|FG003|Overall Study|Other|2|||
48838616|NCT02029443|157251970|FG004|Overall Study|Other|0|||
48838617|NCT04737772|157251972|FG000|Phase 2 Study|Lost to Follow-up|15|||
48838618|NCT04737772|157251973|FG001|Phase 2 Study|Lost to Follow-up|15|||
48838619|NCT04737772|157251972|FG000|Phase 2 Study|Withdrawal by Subject|0|||
48838620|NCT04737772|157251973|FG001|Phase 2 Study|Withdrawal by Subject|1|||
48838621|NCT04737772|157251972|FG000|Phase 2 Study|Did not take any coaching calls|4|||
48838622|NCT04737772|157251973|FG001|Phase 2 Study|Did not take any coaching calls|0|||
48838623|NCT04737772|157251972|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
48838624|NCT04737772|157251973|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
48838625|NCT04737772|157251972|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
48838626|NCT04737772|157251973|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
48838627|NCT04083235|157251974|FG000|Overall Study|Death|252|||
48838628|NCT04083235|157251975|FG001|Overall Study|Death|277|||
48535811|NCT00700817|156148417|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
48535812|NCT00700817|156148418|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
48535813|NCT00700817|156148414|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
48535814|NCT00700817|156148415|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
48535815|NCT00700817|156148416|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
48535816|NCT00700817|156148417|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
48535817|NCT00700817|156148418|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
48535818|NCT00700817|156148414|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
48535819|NCT00700817|156148415|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
48535820|NCT00700817|156148416|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
48535821|NCT00700817|156148417|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
48535822|NCT00700817|156148418|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
48535823|NCT00700817|156148414|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
48838629|NCT04083235|157251974|FG000|Overall Study|Withdrawal by Subject|13|||
48838630|NCT04083235|157251975|FG001|Overall Study|Withdrawal by Subject|17|||
48535824|NCT00700817|156148415|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
48535825|NCT00700817|156148416|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
48535826|NCT00700817|156148417|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
48535827|NCT00700817|156148418|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
48535828|NCT02100319|156148419|FG000|Overall Study|Case Report Forms Uncollected|11|||
48535829|NCT02100319|156148419|FG000|Overall Study|Protocol Deviation|5|||
48838631|NCT04083235|157251974|FG000|Overall Study|Lost to Follow-up|1|||
48838632|NCT04083235|157251975|FG001|Overall Study|Lost to Follow-up|1|||
48838633|NCT04083235|157251974|FG000|Overall Study|Does not meet entry criteria|1|||
48535830|NCT03463993|156148420|FG000|Overall Study|Lost to Follow-up|7|||
48838634|NCT04083235|157251975|FG001|Overall Study|Does not meet entry criteria|0|||
48838635|NCT04083235|157251974|FG000|Overall Study|Did not receive treatment|13|||
48838636|NCT04083235|157251975|FG001|Overall Study|Did not receive treatment|8|||
48838637|NCT04083235|157251974|FG000|Overall Study|Ongoing at the time of DCO|44|||
48535831|NCT03463993|156148421|FG001|Overall Study|Lost to Follow-up|8|||
48535832|NCT03463993|156148420|FG000|Overall Study|Withdrawal by Subject|2|||
48535833|NCT03463993|156148421|FG001|Overall Study|Withdrawal by Subject|0|||
48535834|NCT03463993|156148420|FG000|Overall Study|Protocol Violation|4|||
48535835|NCT03463993|156148421|FG001|Overall Study|Protocol Violation|1|||
48535836|NCT03463993|156148420|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
48535837|NCT03463993|156148421|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
48535838|NCT03463993|156148420|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
48535839|NCT03463993|156148421|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
48535840|NCT00724373|156148422|FG000|Overall Study|Adverse Event|41|||
48535841|NCT00724373|156148422|FG000|Overall Study|Lack of Efficacy|82|||
48535842|NCT00724373|156148422|FG000|Overall Study|Lost to Follow-up|7|||
48535843|NCT00724373|156148422|FG000|Overall Study|Non-compliance|2|||
48535844|NCT00724373|156148422|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
48535845|NCT00724373|156148422|FG000|Overall Study|Participant moved away|1|||
48535846|NCT00724373|156148422|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
48535847|NCT00724373|156148422|FG000|Overall Study|Only to have 24 week regimen|1|||
48838638|NCT04083235|157251975|FG001|Overall Study|Ongoing at the time of DCO|7|||
48838639|NCT04270760|157251979|FG000|Overall Study|Withdrawal by Subject|0|||
48838640|NCT04270760|157251980|FG001|Overall Study|Withdrawal by Subject|1|||
48838641|NCT04270760|157251981|FG002|Overall Study|Withdrawal by Subject|3|||
48535848|NCT00724373|156148422|FG000|Overall Study|Viral Relapse|1|||
48838642|NCT04270760|157251982|FG003|Overall Study|Withdrawal by Subject|0|||
48838643|NCT04270760|157251983|FG004|Overall Study|Withdrawal by Subject|0|||
48535849|NCT00724373|156148422|FG000|Overall Study|Acute HCV infection|1|||
48838644|NCT04270760|157251979|FG000|Overall Study|Lost to Follow-up|1|||
48838645|NCT04270760|157251980|FG001|Overall Study|Lost to Follow-up|2|||
48535850|NCT00724373|156148422|FG000|Overall Study|Drug Relapse|1|||
48535851|NCT00724373|156148422|FG000|Overall Study|Tolerability|23|||
48535852|NCT00536484|156148425|FG000|Overall Study|Adverse Event|21|||
48535853|NCT00536484|156148426|FG001|Overall Study|Adverse Event|34|||
48838646|NCT04270760|157251981|FG002|Overall Study|Lost to Follow-up|1|||
48838647|NCT04270760|157251982|FG003|Overall Study|Lost to Follow-up|0|||
48838648|NCT04270760|157251983|FG004|Overall Study|Lost to Follow-up|0|||
48838649|NCT04270760|157251979|FG000|Overall Study|Death|0|||
48535854|NCT00536484|156148425|FG000|Overall Study|Withdrawal by Subject|11|||
48535855|NCT00536484|156148426|FG001|Overall Study|Withdrawal by Subject|11|||
48535856|NCT00536484|156148425|FG000|Overall Study|Lost to Follow-up|8|||
48535857|NCT00536484|156148426|FG001|Overall Study|Lost to Follow-up|6|||
48535858|NCT00536484|156148425|FG000|Overall Study|Lack of Efficacy|16|||
48535859|NCT00536484|156148426|FG001|Overall Study|Lack of Efficacy|5|||
48535860|NCT00536484|156148425|FG000|Overall Study|Other|4|||
48535861|NCT00536484|156148426|FG001|Overall Study|Other|0|||
48838650|NCT04270760|157251980|FG001|Overall Study|Death|0|||
48535862|NCT01334710|156148427|FG000|Overall Study|Trial was terminated|3|||
48535863|NCT00710749|156148437|FG000|First Intervention|Withdrawal by Subject|1|||
48535864|NCT00710749|156148438|FG001|First Intervention|Withdrawal by Subject|0|||
48535865|NCT01020799|156148442|FG000|Overall Study|Adverse Event|4|||
48535866|NCT01020799|156148443|FG001|Overall Study|Adverse Event|3|||
48535867|NCT01020799|156148444|FG002|Overall Study|Adverse Event|2|||
48535868|NCT01020799|156148442|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
48535869|NCT01020799|156148443|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
48535870|NCT01020799|156148444|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
48838651|NCT04270760|157251981|FG002|Overall Study|Death|0|||
48838652|NCT04270760|157251982|FG003|Overall Study|Death|0|||
48838653|NCT04270760|157251983|FG004|Overall Study|Death|1|||
48838654|NCT00433511|157251988|FG000|Step 1|Adverse Event|50|||
48838655|NCT00433511|157251989|FG001|Step 1|Adverse Event|157|||
48838656|NCT00433511|157251990|FG002|Step 1|Adverse Event|153|||
48838657|NCT00433511|157251988|FG000|Step 1|Withdrawal by Subject|45|||
48838658|NCT00433511|157251989|FG001|Step 1|Withdrawal by Subject|143|||
48838659|NCT00433511|157251990|FG002|Step 1|Withdrawal by Subject|154|||
48838660|NCT00433511|157251988|FG000|Step 1|Death|3|||
48535871|NCT01020799|156148442|FG000|Overall Study|Protocol Violation|3|||
48535872|NCT01020799|156148443|FG001|Overall Study|Protocol Violation|2|||
48535873|NCT01020799|156148444|FG002|Overall Study|Protocol Violation|0|||
48535874|NCT01020799|156148442|FG000|Overall Study|Withdrawal by Subject|2|||
48535875|NCT01020799|156148443|FG001|Overall Study|Withdrawal by Subject|2|||
48535876|NCT01020799|156148444|FG002|Overall Study|Withdrawal by Subject|3|||
48535877|NCT01020799|156148442|FG000|Overall Study|Lost to Follow-up|6|||
48535878|NCT01020799|156148443|FG001|Overall Study|Lost to Follow-up|4|||
48535879|NCT01020799|156148444|FG002|Overall Study|Lost to Follow-up|2|||
48535880|NCT03856593|156148445|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
48535881|NCT03856593|156148446|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
48535882|NCT02370914|156148448|FG000|Overall Study|Protocol Violation|2|||
48535883|NCT02595008|156148449|FG000|Overall Study|Enrolled In Error|1|||
48535884|NCT02595008|156148450|FG001|Overall Study|Enrolled In Error|0|||
48535885|NCT03407118|156148454|FG000|Period 2|Withdrawal by Subject|1|||
48838661|NCT00433511|157251989|FG001|Step 1|Death|1|||
48838662|NCT00433511|157251990|FG002|Step 1|Death|1|||
48838663|NCT00433511|157251988|FG000|Step 1|Physician Decision|1|||
48838664|NCT00433511|157251989|FG001|Step 1|Physician Decision|4|||
48838665|NCT00433511|157251990|FG002|Step 1|Physician Decision|3|||
48838666|NCT00433511|157251988|FG000|Step 1|Never started protocol therapy|28|||
48838667|NCT00433511|157251989|FG001|Step 1|Never started protocol therapy|64|||
48838668|NCT00433511|157251990|FG002|Step 1|Never started protocol therapy|66|||
48838669|NCT00433511|157251988|FG000|Step 1|Alternative therapy|2|||
48838670|NCT00433511|157251989|FG001|Step 1|Alternative therapy|1|||
48838671|NCT00433511|157251990|FG002|Step 1|Alternative therapy|3|||
48838672|NCT00433511|157251988|FG000|Step 1|Disease progression, relapse|5|||
48838673|NCT00433511|157251989|FG001|Step 1|Disease progression, relapse|3|||
48838674|NCT00433511|157251990|FG002|Step 1|Disease progression, relapse|3|||
48838675|NCT00433511|157251988|FG000|Step 1|Other complicating disease|2|||
48838676|NCT00433511|157251989|FG001|Step 1|Other complicating disease|6|||
48838677|NCT00433511|157251990|FG002|Step 1|Other complicating disease|3|||
48838678|NCT00433511|157251988|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
48838679|NCT00433511|157251989|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
48838680|NCT00433511|157251990|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
48535886|NCT03407118|156148455|FG001|Period 2|Withdrawal by Subject|0|||
48535887|NCT00619359|156148459|FG000|Overall Study|Adverse Event|32|||
48535888|NCT00619359|156148460|FG001|Overall Study|Adverse Event|36|||
48535889|NCT00619359|156148459|FG000|Overall Study|Lost to Follow-up|12|||
48535890|NCT00619359|156148460|FG001|Overall Study|Lost to Follow-up|16|||
48838681|NCT00433511|157251988|FG000|Step 1|Suspected recurrence|0|||
48838682|NCT00433511|157251989|FG001|Step 1|Suspected recurrence|1|||
48838683|NCT00433511|157251990|FG002|Step 1|Suspected recurrence|0|||
48838684|NCT00433511|157251988|FG000|Step 1|Insurance/drug distribution issues|0|||
48535891|NCT00619359|156148459|FG000|Overall Study|Physician Decision|0|||
48535892|NCT00619359|156148460|FG001|Overall Study|Physician Decision|7|||
48535893|NCT00619359|156148459|FG000|Overall Study|Protocol Violation|1|||
48535894|NCT00619359|156148460|FG001|Overall Study|Protocol Violation|1|||
48838685|NCT00433511|157251989|FG001|Step 1|Insurance/drug distribution issues|1|||
48838686|NCT00433511|157251990|FG002|Step 1|Insurance/drug distribution issues|2|||
48838687|NCT00433511|157251988|FG000|Step 1|Patient moved|0|||
48838688|NCT00433511|157251989|FG001|Step 1|Patient moved|0|||
48838689|NCT00433511|157251990|FG002|Step 1|Patient moved|1|||
48838690|NCT00433511|157251988|FG000|Step 2 (Arm D)|Adverse Event|0|||
48838691|NCT00433511|157251989|FG001|Step 2 (Arm D)|Adverse Event|0|||
48838692|NCT00433511|157251990|FG002|Step 2 (Arm D)|Adverse Event|135|||
48838693|NCT00433511|157251988|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
48838694|NCT00433511|157251989|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
48838695|NCT00433511|157251990|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
48838696|NCT00433511|157251988|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
48838697|NCT00433511|157251989|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
48838698|NCT00433511|157251990|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
48838699|NCT00433511|157251988|FG000|Step 2 (Arm D)|Physician Decision|0|||
48838700|NCT00433511|157251989|FG001|Step 2 (Arm D)|Physician Decision|0|||
48838701|NCT00433511|157251990|FG002|Step 2 (Arm D)|Physician Decision|9|||
48838702|NCT00433511|157251988|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
48838703|NCT00433511|157251989|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
48838704|NCT00433511|157251990|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
48838705|NCT00433511|157251988|FG000|Step 2 (Arm D)|Other complicating disease|0|||
48838706|NCT00433511|157251989|FG001|Step 2 (Arm D)|Other complicating disease|0|||
48838707|NCT00433511|157251990|FG002|Step 2 (Arm D)|Other complicating disease|3|||
48838708|NCT00433511|157251988|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
48838709|NCT00433511|157251989|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
48838710|NCT00433511|157251990|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
48838711|NCT00433511|157251988|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
48838712|NCT00433511|157251989|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
48838713|NCT00433511|157251990|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
48838714|NCT00433511|157251988|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
48838715|NCT00433511|157251989|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
48838716|NCT00433511|157251990|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
48838717|NCT00433511|157251988|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
48838718|NCT00433511|157251989|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
48838719|NCT00433511|157251990|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
48838720|NCT00602641|157251991|FG000|Overall Study|Never started protocol therapy|6|||
48838721|NCT00602641|157251992|FG001|Overall Study|Never started protocol therapy|2|||
48838722|NCT00602641|157251991|FG000|Overall Study|Still on treatment at time of analysis|8|||
48838723|NCT00602641|157251992|FG001|Overall Study|Still on treatment at time of analysis|15|||
48838724|NCT00602641|157251991|FG000|Overall Study|Adverse Event|62|||
48838725|NCT00602641|157251992|FG001|Overall Study|Adverse Event|53|||
48838726|NCT00602641|157251991|FG000|Overall Study|Disease progression|38|||
48838727|NCT00602641|157251992|FG001|Overall Study|Disease progression|55|||
48838728|NCT00602641|157251991|FG000|Overall Study|Death|6|||
48838729|NCT00602641|157251992|FG001|Overall Study|Death|5|||
48838730|NCT00602641|157251991|FG000|Overall Study|Withdrawal by Subject|15|||
48838731|NCT00602641|157251992|FG001|Overall Study|Withdrawal by Subject|12|||
48838732|NCT00602641|157251991|FG000|Overall Study|Alternative therapy|5|||
48838733|NCT00602641|157251992|FG001|Overall Study|Alternative therapy|2|||
48838734|NCT00602641|157251991|FG000|Overall Study|Other Complicating Disease|5|||
48838735|NCT00602641|157251992|FG001|Overall Study|Other Complicating Disease|2|||
48535895|NCT00619359|156148459|FG000|Overall Study|Withdrawal by Subject|19|||
48838736|NCT00602641|157251991|FG000|Overall Study|Physician Decision|5|||
48535896|NCT00619359|156148460|FG001|Overall Study|Withdrawal by Subject|20|||
48535897|NCT00619359|156148459|FG000|Overall Study|Progressive Disease|3|||
48535898|NCT00619359|156148460|FG001|Overall Study|Progressive Disease|1|||
48535899|NCT02556307|156148461|FG000|Overall Study|Premature treatment interruption|11|||
48535900|NCT02556307|156148461|FG000|Overall Study|Lost to Follow-up|36|||
48535901|NCT02556307|156148461|FG000|Overall Study|Change to triple therapy|4|||
48535902|NCT02556307|156148461|FG000|Overall Study|Enrolled but not treated|2|||
48535903|NCT00384176|156148463|FG000|Overall Study|Death|239|||
48535904|NCT00384176|156148464|FG001|Overall Study|Death|247|||
48535905|NCT00384176|156148465|FG002|Overall Study|Death|105|||
48535906|NCT00384176|156148463|FG000|Overall Study|Withdrawal by Subject|52|||
48535907|NCT00384176|156148464|FG001|Overall Study|Withdrawal by Subject|48|||
48535908|NCT00384176|156148465|FG002|Overall Study|Withdrawal by Subject|22|||
48535909|NCT00384176|156148463|FG000|Overall Study|Lost to Follow-up|16|||
48535910|NCT00384176|156148464|FG001|Overall Study|Lost to Follow-up|18|||
48535911|NCT00384176|156148465|FG002|Overall Study|Lost to Follow-up|4|||
48535912|NCT00384176|156148463|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
48838737|NCT00602641|157251992|FG001|Overall Study|Physician Decision|4|||
48838738|NCT00602641|157251991|FG000|Overall Study|Administrative Closure|1|||
48838739|NCT00602641|157251992|FG001|Overall Study|Administrative Closure|1|||
48838740|NCT00602641|157251991|FG000|Overall Study|Other|3|||
48838741|NCT00602641|157251992|FG001|Overall Study|Other|1|||
48838742|NCT02807636|157251993|FG000|Overall Study|Lost to Follow-up|10|||
48838743|NCT02807636|157251994|FG001|Overall Study|Lost to Follow-up|13|||
48838744|NCT02807636|157251995|FG002|Overall Study|Lost to Follow-up|6|||
48838745|NCT02807636|157251993|FG000|Overall Study|Protocol Deviation|1|||
48838746|NCT02807636|157251994|FG001|Overall Study|Protocol Deviation|0|||
48838747|NCT02807636|157251995|FG002|Overall Study|Protocol Deviation|0|||
48838748|NCT02807636|157251993|FG000|Overall Study|Symptomatic Deterioration|0|||
48838749|NCT02807636|157251994|FG001|Overall Study|Symptomatic Deterioration|1|||
48838750|NCT02807636|157251995|FG002|Overall Study|Symptomatic Deterioration|0|||
48838751|NCT02807636|157251993|FG000|Overall Study|Withdrawal by Subject|39|||
48838752|NCT02807636|157251994|FG001|Overall Study|Withdrawal by Subject|28|||
48838753|NCT02807636|157251995|FG002|Overall Study|Withdrawal by Subject|24|||
48838754|NCT02807636|157251993|FG000|Overall Study|Death|303|||
48838755|NCT02807636|157251994|FG001|Overall Study|Death|332|||
48838756|NCT02807636|157251995|FG002|Overall Study|Death|272|||
48535913|NCT00384176|156148464|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
48535914|NCT00384176|156148465|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
48535915|NCT00384176|156148463|FG000|Overall Study|Longer QTC as Visit 1|1|||
48535916|NCT00384176|156148464|FG001|Overall Study|Longer QTC as Visit 1|0|||
48838757|NCT02807636|157251993|FG000|Overall Study|Study Terminated By Sponsor|47|||
48838758|NCT02807636|157251994|FG001|Overall Study|Study Terminated By Sponsor|76|||
48838759|NCT02807636|157251995|FG002|Overall Study|Study Terminated By Sponsor|60|||
48838760|NCT02807636|157251993|FG000|Overall Study|Physician Decision|0|||
48838761|NCT02807636|157251994|FG001|Overall Study|Physician Decision|1|||
48535917|NCT00384176|156148465|FG002|Overall Study|Longer QTC as Visit 1|0|||
48838762|NCT02807636|157251995|FG002|Overall Study|Physician Decision|0|||
48838763|NCT02954341|157251996|FG000|Overall Study|Attempted Implant unsuccessful|5|||
48838764|NCT02954341|157251996|FG000|Overall Study|Death|90|||
48838765|NCT02954341|157251996|FG000|Overall Study|Withdrawal by Subject|4|||
48838766|NCT02954341|157251996|FG000|Overall Study|Physician Decision|13|||
48838767|NCT02954341|157251996|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
48838768|NCT02954341|157251996|FG000|Overall Study|Not implanted due to physician's decision|1|||
48838769|NCT02954341|157251996|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
48838770|NCT04233879|157252003|FG000|Overall Study|Death|2|||
48535918|NCT00384176|156148463|FG000|Overall Study|Toxicity of treatment|1|||
48838771|NCT04233879|157252004|FG001|Overall Study|Death|0|||
48535919|NCT00384176|156148464|FG001|Overall Study|Toxicity of treatment|0|||
48535920|NCT00384176|156148465|FG002|Overall Study|Toxicity of treatment|0|||
48535921|NCT00384176|156148463|FG000|Overall Study|Did not receive study treatment|0|||
48535922|NCT00384176|156148464|FG001|Overall Study|Did not receive study treatment|1|||
48535923|NCT00384176|156148465|FG002|Overall Study|Did not receive study treatment|1|||
48535924|NCT00384176|156148463|FG000|Overall Study|Physician Decision|0|||
48535925|NCT00384176|156148464|FG001|Overall Study|Physician Decision|2|||
48535926|NCT00384176|156148465|FG002|Overall Study|Physician Decision|0|||
48535927|NCT00384176|156148463|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
48535928|NCT00384176|156148464|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
48535929|NCT00384176|156148465|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
48535930|NCT03438227|156148467|FG000|Overall Study|Withdrawal by Subject|10|||
48535931|NCT03438227|156148468|FG001|Overall Study|Withdrawal by Subject|5|||
48535932|NCT01010126|156150348|FG000|Overall Study|Withdrawal by Subject|1|||
48535933|NCT01010126|156150349|FG001|Overall Study|Withdrawal by Subject|0|||
48535934|NCT01010126|156150350|FG002|Overall Study|Withdrawal by Subject|1|||
48535935|NCT01010126|156150351|FG003|Overall Study|Withdrawal by Subject|0|||
48535936|NCT01010126|156150352|FG004|Overall Study|Withdrawal by Subject|3|||
48535937|NCT01010126|156150353|FG005|Overall Study|Withdrawal by Subject|0|||
48535938|NCT00493246|156150354|FG000|Overall Study|Withdrawal by Subject|0|||
48535939|NCT00493246|156150355|FG001|Overall Study|Withdrawal by Subject|0|||
48535940|NCT00493246|156150356|FG002|Overall Study|Withdrawal by Subject|0|||
48535941|NCT00493246|156150357|FG003|Overall Study|Withdrawal by Subject|0|||
48535942|NCT00493246|156150358|FG004|Overall Study|Withdrawal by Subject|1|||
48535943|NCT00493246|156150359|FG005|Overall Study|Withdrawal by Subject|0|||
48535944|NCT00493246|156150360|FG006|Overall Study|Withdrawal by Subject|0|||
48535945|NCT00493246|156150361|FG007|Overall Study|Withdrawal by Subject|0|||
48535946|NCT00493246|156150354|FG000|Overall Study|No access to draw blood|0|||
48535947|NCT00493246|156150355|FG001|Overall Study|No access to draw blood|0|||
48535948|NCT00493246|156150356|FG002|Overall Study|No access to draw blood|0|||
48535949|NCT00493246|156150357|FG003|Overall Study|No access to draw blood|0|||
48535950|NCT00493246|156150358|FG004|Overall Study|No access to draw blood|0|||
48535951|NCT00493246|156150359|FG005|Overall Study|No access to draw blood|1|||
48535952|NCT00493246|156150360|FG006|Overall Study|No access to draw blood|0|||
48535953|NCT00493246|156150361|FG007|Overall Study|No access to draw blood|0|||
48535954|NCT00493246|156150354|FG000|Overall Study|Lost to Follow-up|0|||
48535955|NCT00493246|156150355|FG001|Overall Study|Lost to Follow-up|0|||
48838772|NCT04233879|157252003|FG000|Overall Study|Lost to Follow-up|3|||
48838773|NCT04233879|157252004|FG001|Overall Study|Lost to Follow-up|8|||
48838774|NCT04233879|157252003|FG000|Overall Study|Physician Decision|4|||
48838775|NCT04233879|157252004|FG001|Overall Study|Physician Decision|4|||
48838776|NCT04233879|157252003|FG000|Overall Study|Withdrawal by Subject|7|||
48838777|NCT04233879|157252004|FG001|Overall Study|Withdrawal by Subject|10|||
48838778|NCT04233879|157252003|FG000|Overall Study|Other|281|||
48838779|NCT04233879|157252004|FG001|Overall Study|Other|279|||
48838780|NCT04774926|157252007|FG000|Overall Study|Adverse Event|15|||
48838781|NCT04774926|157252007|FG000|Overall Study|Lost to Follow-up|3|||
48838782|NCT04774926|157252007|FG000|Overall Study|Physician Decision|6|||
48838783|NCT04774926|157252007|FG000|Overall Study|Withdrawal by Subject|3|||
48838784|NCT04774926|157252007|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
48838785|NCT03143153|157252008|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
48838786|NCT03143153|157252009|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
48838787|NCT03143153|157252010|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
48838788|NCT03143153|157252008|FG000|Pre-Treatment|Participant withdrew consent|0|||
48838789|NCT03143153|157252009|FG001|Pre-Treatment|Participant withdrew consent|1|||
48838790|NCT03143153|157252010|FG002|Pre-Treatment|Participant withdrew consent|12|||
48838791|NCT03143153|157252008|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
48838792|NCT03143153|157252009|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
48838793|NCT03143153|157252010|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
48838794|NCT03143153|157252008|FG000|Pre-Treatment|Other Reasons|1|||
48838795|NCT03143153|157252009|FG001|Pre-Treatment|Other Reasons|2|||
48838796|NCT03143153|157252010|FG002|Pre-Treatment|Other Reasons|1|||
48838797|NCT03143153|157252008|FG000|Pre-Treatment|Disease Progression|1|||
48535956|NCT00493246|156150356|FG002|Overall Study|Lost to Follow-up|0|||
48535957|NCT00493246|156150357|FG003|Overall Study|Lost to Follow-up|0|||
48535958|NCT00493246|156150358|FG004|Overall Study|Lost to Follow-up|0|||
48535959|NCT00493246|156150359|FG005|Overall Study|Lost to Follow-up|0|||
48535960|NCT00493246|156150360|FG006|Overall Study|Lost to Follow-up|1|||
48535961|NCT00493246|156150361|FG007|Overall Study|Lost to Follow-up|0|||
48535962|NCT00983918|156150366|FG000|Overall Study|conversion to open cholecystectomy|0|||
48535963|NCT00983918|156150367|FG001|Overall Study|conversion to open cholecystectomy|2|||
48535964|NCT00983918|156150368|FG002|Overall Study|conversion to open cholecystectomy|2|||
48535965|NCT00983918|156150369|FG003|Overall Study|conversion to open cholecystectomy|2|||
48535966|NCT05016622|156150376|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
48535967|NCT05016622|156150376|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
48535968|NCT01304693|156150381|FG000|Overall Study|Adverse Event|0|||
48535969|NCT01304693|156150382|FG001|Overall Study|Adverse Event|0|||
48535970|NCT01304693|156150383|FG002|Overall Study|Adverse Event|0|||
48535971|NCT01304693|156150384|FG003|Overall Study|Adverse Event|0|||
48535972|NCT01304693|156150385|FG004|Overall Study|Adverse Event|1|||
48535973|NCT01304693|156150381|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
48535974|NCT01304693|156150382|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
48535975|NCT01304693|156150383|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
48535976|NCT01304693|156150384|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
48535977|NCT01304693|156150385|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
48535978|NCT01829113|156150387|FG000|Overall Study|Disease Progression|37|||
48535979|NCT01829113|156150388|FG001|Overall Study|Disease Progression|48|||
48535980|NCT01829113|156150387|FG000|Overall Study|Adverse Event|14|||
48535981|NCT01829113|156150388|FG001|Overall Study|Adverse Event|10|||
48535982|NCT01829113|156150387|FG000|Overall Study|Withdrawal by Subject|17|||
48535983|NCT01829113|156150388|FG001|Overall Study|Withdrawal by Subject|10|||
48535984|NCT01829113|156150387|FG000|Overall Study|Death|4|||
48535985|NCT01829113|156150388|FG001|Overall Study|Death|6|||
48535986|NCT01829113|156150387|FG000|Overall Study|Sponsor Decision|1|||
48838798|NCT03143153|157252009|FG001|Pre-Treatment|Disease Progression|1|||
48838799|NCT03143153|157252010|FG002|Pre-Treatment|Disease Progression|2|||
48838800|NCT03143153|157252008|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
48838801|NCT03143153|157252009|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
48535987|NCT01829113|156150388|FG001|Overall Study|Sponsor Decision|1|||
48535988|NCT01829113|156150387|FG000|Overall Study|No Study Treatment Received|3|||
48535989|NCT01829113|156150388|FG001|Overall Study|No Study Treatment Received|2|||
48535990|NCT01829113|156150387|FG000|Overall Study|Physician Decision|1|||
48535991|NCT01829113|156150388|FG001|Overall Study|Physician Decision|1|||
48535992|NCT01370213|156150394|FG000|Overall Study|Early Death|1|||
48535993|NCT01370213|156150395|FG001|Overall Study|Early Death|0|||
48535994|NCT01370213|156150396|FG002|Overall Study|Early Death|0|||
48535995|NCT01370213|156150394|FG000|Overall Study|Not evaluable|0|||
48535996|NCT01370213|156150395|FG001|Overall Study|Not evaluable|2|||
48535997|NCT01370213|156150396|FG002|Overall Study|Not evaluable|0|||
48838802|NCT03143153|157252010|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
48838803|NCT03143153|157252008|FG000|Treatment|Disease progression|174|||
48838804|NCT03143153|157252009|FG001|Treatment|Disease progression|184|||
48535998|NCT02701413|156150397|FG000|Overall Study|Withdrawal by Subject|7|||
48535999|NCT02701413|156150398|FG001|Overall Study|Withdrawal by Subject|11|||
48838805|NCT03143153|157252010|FG002|Treatment|Disease progression|193|||
48838806|NCT03143153|157252008|FG000|Treatment|Study drug toxicity|59|||
48838807|NCT03143153|157252009|FG001|Treatment|Study drug toxicity|33|||
48838808|NCT03143153|157252010|FG002|Treatment|Study drug toxicity|40|||
48838809|NCT03143153|157252008|FG000|Treatment|Death|5|||
48838810|NCT03143153|157252009|FG001|Treatment|Death|3|||
48838811|NCT03143153|157252010|FG002|Treatment|Death|4|||
48838812|NCT03143153|157252008|FG000|Treatment|Adverse event unrelated to study drug|19|||
48838813|NCT03143153|157252009|FG001|Treatment|Adverse event unrelated to study drug|28|||
48838814|NCT03143153|157252010|FG002|Treatment|Adverse event unrelated to study drug|12|||
48838815|NCT03143153|157252008|FG000|Treatment|Participant request to discontinue study treatment|13|||
48838816|NCT03143153|157252009|FG001|Treatment|Participant request to discontinue study treatment|15|||
48838817|NCT03143153|157252010|FG002|Treatment|Participant request to discontinue study treatment|20|||
48838818|NCT03143153|157252008|FG000|Treatment|Participant withdrew consent|3|||
48838819|NCT03143153|157252009|FG001|Treatment|Participant withdrew consent|4|||
48838820|NCT03143153|157252010|FG002|Treatment|Participant withdrew consent|12|||
48838821|NCT03143153|157252008|FG000|Treatment|Pregnancy|1|||
48838822|NCT03143153|157252009|FG001|Treatment|Pregnancy|0|||
48838823|NCT03143153|157252010|FG002|Treatment|Pregnancy|0|||
48838824|NCT03143153|157252008|FG000|Treatment|Maximum clinical benefit|1|||
48838825|NCT03143153|157252009|FG001|Treatment|Maximum clinical benefit|3|||
48838826|NCT03143153|157252010|FG002|Treatment|Maximum clinical benefit|4|||
48838827|NCT03143153|157252008|FG000|Treatment|Completed treatment as per Protocol|13|||
48838828|NCT03143153|157252009|FG001|Treatment|Completed treatment as per Protocol|8|||
48838829|NCT03143153|157252010|FG002|Treatment|Completed treatment as per Protocol|0|||
48838830|NCT03143153|157252008|FG000|Treatment|Other reasons|12|||
48838831|NCT03143153|157252009|FG001|Treatment|Other reasons|7|||
48838832|NCT03143153|157252010|FG002|Treatment|Other reasons|15|||
48838833|NCT03143153|157252008|FG000|Treatment|Not reported|1|||
48838834|NCT03143153|157252009|FG001|Treatment|Not reported|0|||
48838835|NCT03143153|157252010|FG002|Treatment|Not reported|0|||
48838836|NCT04083976|157252014|FG000|Overall Study|Lost to Follow-up|3|||
48838837|NCT04083976|157252015|FG001|Overall Study|Lost to Follow-up|0|||
48445921|NCT00050960|155820548|FG001|Overall Study|Administrative|46|||
48445922|NCT00050960|155820547|FG000|Overall Study|Non-compliance|3|||
48445923|NCT00050960|155820548|FG001|Overall Study|Non-compliance|1|||
48445924|NCT00050960|155820547|FG000|Overall Study|Death|13|||
48445925|NCT00050960|155820548|FG001|Overall Study|Death|15|||
48445926|NCT02727660|155820549|FG000|Overall Study|Lack of Efficacy|40|||
48445927|NCT02727660|155820550|FG001|Overall Study|Lack of Efficacy|40|||
48445928|NCT02727660|155820551|FG002|Overall Study|Lack of Efficacy|70|||
48445929|NCT02727660|155820549|FG000|Overall Study|Adverse Event|28|||
48445930|NCT02727660|155820550|FG001|Overall Study|Adverse Event|21|||
48445931|NCT02727660|155820551|FG002|Overall Study|Adverse Event|32|||
48445932|NCT02727660|155820549|FG000|Overall Study|Withdrawal by Subject|26|||
48445933|NCT02727660|155820550|FG001|Overall Study|Withdrawal by Subject|25|||
48445934|NCT02727660|155820551|FG002|Overall Study|Withdrawal by Subject|30|||
48445935|NCT02727660|155820549|FG000|Overall Study|Physician Decision|3|||
48445936|NCT02727660|155820550|FG001|Overall Study|Physician Decision|8|||
48445937|NCT02727660|155820551|FG002|Overall Study|Physician Decision|14|||
48445938|NCT02727660|155820549|FG000|Overall Study|Lost to Follow-up|5|||
48445939|NCT02727660|155820550|FG001|Overall Study|Lost to Follow-up|9|||
48445940|NCT02727660|155820551|FG002|Overall Study|Lost to Follow-up|8|||
48445941|NCT02727660|155820549|FG000|Overall Study|Protocol Violation|7|||
48445942|NCT02727660|155820550|FG001|Overall Study|Protocol Violation|5|||
48445943|NCT02727660|155820551|FG002|Overall Study|Protocol Violation|5|||
48445944|NCT02727660|155820549|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
48445945|NCT02727660|155820550|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
48445946|NCT02727660|155820551|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
48445947|NCT02727660|155820549|FG000|Overall Study|Administrative Reasons|2|||
48445948|NCT02727660|155820550|FG001|Overall Study|Administrative Reasons|3|||
48445949|NCT02727660|155820551|FG002|Overall Study|Administrative Reasons|4|||
48445950|NCT01248364|155820552|FG000|Overall Study|Adverse Event|0|||
48445951|NCT01248364|155820553|FG001|Overall Study|Adverse Event|1|||
48445952|NCT01248364|155820554|FG002|Overall Study|Adverse Event|0|||
48445953|NCT01248364|155820555|FG003|Overall Study|Adverse Event|0|||
48445954|NCT03379376|155820556|FG000|Overall Study|Lost to Follow-up|2|||
48445955|NCT03379376|155820556|FG000|Overall Study|Did not wish to complete follow up|1|||
48445956|NCT03379376|155820556|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
48445957|NCT03379376|155820556|FG000|Overall Study|Death|1|||
48445958|NCT01576406|155820561|FG000|Overall Study|Lost to Follow-up|1|||
48445959|NCT01576406|155820562|FG001|Overall Study|Lost to Follow-up|2|||
48445960|NCT01576406|155820563|FG002|Overall Study|Lost to Follow-up|0|||
48445961|NCT01576406|155820564|FG003|Overall Study|Lost to Follow-up|0|||
48445962|NCT01576406|155820565|FG004|Overall Study|Lost to Follow-up|0|||
48536000|NCT01763918|156150399|FG000|Overall Study|Withdrawal by Subject|2|||
48536001|NCT01763918|156150400|FG001|Overall Study|Withdrawal by Subject|1|||
48536002|NCT01763918|156150401|FG002|Overall Study|Withdrawal by Subject|1|||
48536003|NCT01763918|156150402|FG003|Overall Study|Withdrawal by Subject|2|||
48536004|NCT01763918|156150399|FG000|Overall Study|Sponsor Decision|4|||
48536005|NCT01763918|156150400|FG001|Overall Study|Sponsor Decision|0|||
48536006|NCT01763918|156150401|FG002|Overall Study|Sponsor Decision|9|||
48536007|NCT01763918|156150402|FG003|Overall Study|Sponsor Decision|0|||
48536008|NCT00897949|156150403|FG000|Overall Study|Adverse Event|1|||
48536009|NCT00897949|156150404|FG001|Overall Study|Adverse Event|1|||
48536010|NCT00897949|156150405|FG002|Overall Study|Adverse Event|0|||
48536011|NCT00897949|156150403|FG000|Overall Study|Lost to Follow-up|0|||
48536012|NCT00897949|156150404|FG001|Overall Study|Lost to Follow-up|2|||
48536013|NCT00897949|156150405|FG002|Overall Study|Lost to Follow-up|1|||
48536014|NCT00897949|156150403|FG000|Overall Study|Protocol Violation|6|||
48536015|NCT00897949|156150404|FG001|Overall Study|Protocol Violation|3|||
48536016|NCT00897949|156150405|FG002|Overall Study|Protocol Violation|1|||
48536017|NCT00897949|156150403|FG000|Overall Study|Withdrawal by Subject|1|||
48536018|NCT00897949|156150404|FG001|Overall Study|Withdrawal by Subject|2|||
48536019|NCT00897949|156150405|FG002|Overall Study|Withdrawal by Subject|0|||
48536020|NCT00897949|156150403|FG000|Overall Study|Patient Uncoorperative|0|||
48536021|NCT00897949|156150404|FG001|Overall Study|Patient Uncoorperative|2|||
48536022|NCT00897949|156150405|FG002|Overall Study|Patient Uncoorperative|1|||
48536023|NCT00897949|156150403|FG000|Overall Study|Lost to Follow-up|30|||
48536024|NCT00897949|156150404|FG001|Overall Study|Lost to Follow-up|23|||
48838838|NCT04083976|157252016|FG002|Overall Study|Lost to Follow-up|0|||
48838839|NCT04083976|157252017|FG003|Overall Study|Lost to Follow-up|1|||
48536025|NCT00897949|156150405|FG002|Overall Study|Lost to Follow-up|17|||
48536026|NCT00897949|156150403|FG000|Overall Study|Withdrawal by Subject|24|||
48536027|NCT00897949|156150404|FG001|Overall Study|Withdrawal by Subject|31|||
48536028|NCT00897949|156150405|FG002|Overall Study|Withdrawal by Subject|17|||
48536029|NCT00897949|156150403|FG000|Overall Study|Abnormal Prestudy Labs|2|||
48536030|NCT00897949|156150404|FG001|Overall Study|Abnormal Prestudy Labs|3|||
48536031|NCT00897949|156150405|FG002|Overall Study|Abnormal Prestudy Labs|4|||
48536032|NCT00897949|156150403|FG000|Overall Study|Abnormal Baseline ECG|2|||
48536033|NCT00897949|156150404|FG001|Overall Study|Abnormal Baseline ECG|2|||
48536034|NCT00897949|156150405|FG002|Overall Study|Abnormal Baseline ECG|4|||
48536035|NCT00897949|156150403|FG000|Overall Study|Need for Concom. Med.|0|||
48536036|NCT00897949|156150404|FG001|Overall Study|Need for Concom. Med.|1|||
48536037|NCT00897949|156150405|FG002|Overall Study|Need for Concom. Med.|1|||
48536038|NCT00897949|156150403|FG000|Overall Study|Lack of Migraine Attack|29|||
48536039|NCT00897949|156150404|FG001|Overall Study|Lack of Migraine Attack|30|||
48536040|NCT00897949|156150405|FG002|Overall Study|Lack of Migraine Attack|19|||
48536041|NCT00897949|156150403|FG000|Overall Study|Did not take study drug|9|||
48536042|NCT00897949|156150404|FG001|Overall Study|Did not take study drug|3|||
48536043|NCT00897949|156150405|FG002|Overall Study|Did not take study drug|4|||
48536044|NCT01553747|156150406|FG000|Overall Study|Protocol Violation|0|||
48536045|NCT01553747|156150407|FG001|Overall Study|Protocol Violation|2|||
48536046|NCT01553747|156150408|FG002|Overall Study|Protocol Violation|0|||
48536047|NCT01553747|156150406|FG000|Overall Study|Voluntarily withdrew|70|||
48536048|NCT01553747|156150407|FG001|Overall Study|Voluntarily withdrew|66|||
48536049|NCT01553747|156150408|FG002|Overall Study|Voluntarily withdrew|74|||
48536050|NCT01553747|156150406|FG000|Overall Study|Adverse event or SAE|32|||
48536051|NCT01553747|156150407|FG001|Overall Study|Adverse event or SAE|28|||
48536052|NCT01553747|156150408|FG002|Overall Study|Adverse event or SAE|19|||
48536053|NCT01553747|156150406|FG000|Overall Study|Physician decision: other|10|||
48536054|NCT01553747|156150407|FG001|Overall Study|Physician decision: other|8|||
48536055|NCT01553747|156150408|FG002|Overall Study|Physician decision: other|7|||
48536056|NCT01553747|156150406|FG000|Overall Study|Lost to Follow-up|11|||
48536057|NCT01553747|156150407|FG001|Overall Study|Lost to Follow-up|5|||
48536058|NCT01553747|156150408|FG002|Overall Study|Lost to Follow-up|6|||
48536059|NCT01553747|156150406|FG000|Overall Study|Sponsor decision, specify|7|||
48536060|NCT01553747|156150407|FG001|Overall Study|Sponsor decision, specify|5|||
48536061|NCT01553747|156150408|FG002|Overall Study|Sponsor decision, specify|0|||
48536062|NCT01553747|156150406|FG000|Overall Study|Physician decision: lack of efficacy|1|||
48536063|NCT01553747|156150407|FG001|Overall Study|Physician decision: lack of efficacy|5|||
48536064|NCT01553747|156150408|FG002|Overall Study|Physician decision: lack of efficacy|3|||
48536065|NCT02938520|156150409|FG000|Overall Study|On-going at the time of analysis|258|||
48536066|NCT02938520|156150410|FG001|Overall Study|On-going at the time of analysis|261|||
48536067|NCT02938520|156150409|FG000|Overall Study|Physician Decision|2|||
48536068|NCT02938520|156150410|FG001|Overall Study|Physician Decision|5|||
48838840|NCT04083976|157252014|FG000|Overall Study|Withdrawal by Subject|16|||
48536069|NCT02938520|156150409|FG000|Overall Study|Lost to Follow-up|2|||
48536070|NCT02938520|156150410|FG001|Overall Study|Lost to Follow-up|2|||
48536071|NCT02938520|156150409|FG000|Overall Study|Withdrawal by Subject|7|||
48536072|NCT02938520|156150410|FG001|Overall Study|Withdrawal by Subject|7|||
48536073|NCT02938520|156150409|FG000|Overall Study|Protocol Violation|0|||
48536074|NCT02938520|156150410|FG001|Overall Study|Protocol Violation|1|||
48536075|NCT02938520|156150409|FG000|Overall Study|Lack of Efficacy|5|||
48536076|NCT02938520|156150410|FG001|Overall Study|Lack of Efficacy|3|||
48536077|NCT02938520|156150409|FG000|Overall Study|Adverse Event|9|||
48536078|NCT02938520|156150410|FG001|Overall Study|Adverse Event|4|||
48536079|NCT01901874|156150411|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
48536080|NCT01901874|156150411|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
48536081|NCT01901874|156150411|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
48536082|NCT01901874|156150411|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
48536083|NCT01901874|156150411|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
48536084|NCT01901874|156150411|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
48536085|NCT03314662|156150412|FG000|Overall Study|Withdrawal by Subject|1|||
48536086|NCT03314662|156150413|FG001|Overall Study|Withdrawal by Subject|1|||
48536087|NCT03314662|156150414|FG002|Overall Study|Withdrawal by Subject|1|||
48536088|NCT03314662|156150412|FG000|Overall Study|Lost to Follow-up|5|||
48838841|NCT04083976|157252015|FG001|Overall Study|Withdrawal by Subject|1|||
48838842|NCT04083976|157252016|FG002|Overall Study|Withdrawal by Subject|9|||
48838843|NCT04083976|157252017|FG003|Overall Study|Withdrawal by Subject|0|||
48536089|NCT03314662|156150413|FG001|Overall Study|Lost to Follow-up|4|||
48536090|NCT03314662|156150414|FG002|Overall Study|Lost to Follow-up|4|||
48536091|NCT03314662|156150412|FG000|Overall Study|Death|2|||
48536092|NCT03314662|156150413|FG001|Overall Study|Death|0|||
48536093|NCT03314662|156150414|FG002|Overall Study|Death|0|||
48536094|NCT03978091|156150415|FG000|Overall Study|Lost to Follow-up|0|||
48605088|NCT01386606|156411572|FG003|Overall Study|Withdrawal by Subject|0|||
48605089|NCT01386606|156411569|FG000|Overall Study|Protocol Violation|1|||
48605090|NCT01386606|156411570|FG001|Overall Study|Protocol Violation|0|||
48605091|NCT01386606|156411571|FG002|Overall Study|Protocol Violation|1|||
48605092|NCT01386606|156411572|FG003|Overall Study|Protocol Violation|1|||
48605093|NCT01386606|156411569|FG000|Overall Study|Lost to Follow-up|2|||
48605094|NCT01386606|156411570|FG001|Overall Study|Lost to Follow-up|0|||
48605095|NCT01386606|156411571|FG002|Overall Study|Lost to Follow-up|0|||
48605096|NCT01386606|156411572|FG003|Overall Study|Lost to Follow-up|0|||
48605097|NCT01386606|156411569|FG000|Overall Study|Subject incarcerated|0|||
48605098|NCT01386606|156411570|FG001|Overall Study|Subject incarcerated|1|||
48605099|NCT01386606|156411571|FG002|Overall Study|Subject incarcerated|0|||
48605100|NCT01386606|156411572|FG003|Overall Study|Subject incarcerated|0|||
48605101|NCT01386606|156411569|FG000|Overall Study|Unable to draw PK|1|||
48605102|NCT01386606|156411570|FG001|Overall Study|Unable to draw PK|0|||
48605103|NCT01386606|156411571|FG002|Overall Study|Unable to draw PK|0|||
48605104|NCT01386606|156411572|FG003|Overall Study|Unable to draw PK|0|||
48605105|NCT01386606|156411569|FG000|Overall Study|T levels too high|0|||
48605106|NCT01386606|156411570|FG001|Overall Study|T levels too high|1|||
48605107|NCT01386606|156411571|FG002|Overall Study|T levels too high|1|||
48605108|NCT01386606|156411572|FG003|Overall Study|T levels too high|0|||
48605109|NCT03101150|156411573|FG000|Overall Study|Lost to Follow-up|2|||
48605110|NCT03101150|156411574|FG001|Overall Study|Lost to Follow-up|4|||
48605111|NCT03101150|156411573|FG000|Overall Study|Miscarriage|3|||
48605112|NCT03101150|156411574|FG001|Overall Study|Miscarriage|6|||
48605113|NCT01022203|156411576|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
48605114|NCT01022203|156411577|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
48605115|NCT01022203|156411576|FG000|Post Treatment Assessment|Physician Decision|2|||
48605116|NCT01022203|156411577|FG001|Post Treatment Assessment|Physician Decision|0|||
48605117|NCT01022203|156411576|FG000|Post Treatment Assessment|Adverse Event|0|||
48605118|NCT01022203|156411577|FG001|Post Treatment Assessment|Adverse Event|2|||
48605119|NCT01022203|156411576|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
48605120|NCT01022203|156411577|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
48605121|NCT03163446|156411578|FG000|Overall Study|Unable to return for Day 180 visit|2|||
48605122|NCT03163446|156411579|FG001|Overall Study|Unable to return for Day 180 visit|0|||
48605123|NCT03163446|156411578|FG000|Overall Study|Withdrawal by Subject|2|||
48838844|NCT04083976|157252014|FG000|Overall Study|Sponsor Decision|14|||
48838845|NCT04083976|157252015|FG001|Overall Study|Sponsor Decision|0|||
48838846|NCT04083976|157252016|FG002|Overall Study|Sponsor Decision|0|||
48838847|NCT04083976|157252017|FG003|Overall Study|Sponsor Decision|7|||
48838848|NCT04083976|157252014|FG000|Overall Study|Other|1|||
48838849|NCT04083976|157252015|FG001|Overall Study|Other|0|||
48838850|NCT04083976|157252016|FG002|Overall Study|Other|1|||
48838851|NCT04083976|157252017|FG003|Overall Study|Other|0|||
48536095|NCT03978091|156150416|FG001|Overall Study|Lost to Follow-up|0|||
48536096|NCT03978091|156150417|FG002|Overall Study|Lost to Follow-up|1|||
48536097|NCT03978091|156150418|FG003|Overall Study|Lost to Follow-up|0|||
48605124|NCT03163446|156411579|FG001|Overall Study|Withdrawal by Subject|6|||
48605125|NCT03163446|156411578|FG000|Overall Study|Death|16|||
48838852|NCT04918147|157252018|FG000|Overall Study|Disease flare as defined in protocol|0|||
48536098|NCT03978091|156150419|FG004|Overall Study|Lost to Follow-up|0|||
48536099|NCT03978091|156150420|FG005|Overall Study|Lost to Follow-up|0|||
48536100|NCT03978091|156150415|FG000|Overall Study|Withdrawal by Subject|0|||
48838853|NCT04918147|157252019|FG001|Overall Study|Disease flare as defined in protocol|2|||
48536101|NCT03978091|156150416|FG001|Overall Study|Withdrawal by Subject|0|||
48536102|NCT03978091|156150417|FG002|Overall Study|Withdrawal by Subject|0|||
48536103|NCT03978091|156150418|FG003|Overall Study|Withdrawal by Subject|1|||
48536104|NCT03978091|156150419|FG004|Overall Study|Withdrawal by Subject|1|||
48536105|NCT03978091|156150420|FG005|Overall Study|Withdrawal by Subject|0|||
48536106|NCT00252174|156150421|FG000|Overall Study|Withdrawal by Subject|0|||
48536107|NCT00252174|156150422|FG001|Overall Study|Withdrawal by Subject|1|||
48536108|NCT00252174|156150423|FG002|Overall Study|Withdrawal by Subject|0|||
48536109|NCT02224573|156150427|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
48584947|NCT00743288|156333717|FG003|Overall Study|Progressive disease (PD)|4|||
48838854|NCT04849416|157252020|FG000|Overall Study|Ongoing Treatment|12|||
48838855|NCT04849416|157252021|FG001|Overall Study|Ongoing Treatment|5|||
48838856|NCT04849416|157252022|FG002|Overall Study|Ongoing Treatment|3|||
48838857|NCT04849416|157252020|FG000|Overall Study|On Post-Treatment Follow-up|8|||
48838858|NCT04849416|157252021|FG001|Overall Study|On Post-Treatment Follow-up|9|||
48838859|NCT04849416|157252022|FG002|Overall Study|On Post-Treatment Follow-up|10|||
48838860|NCT04849416|157252020|FG000|Overall Study|Withdrawal by Subject|0|||
48838861|NCT04849416|157252021|FG001|Overall Study|Withdrawal by Subject|0|||
48838862|NCT04849416|157252022|FG002|Overall Study|Withdrawal by Subject|1|||
48838863|NCT04849416|157252020|FG000|Overall Study|Lost to Follow-up|1|||
48838864|NCT04849416|157252021|FG001|Overall Study|Lost to Follow-up|0|||
48838865|NCT04849416|157252022|FG002|Overall Study|Lost to Follow-up|0|||
48838866|NCT02890355|157252028|FG000|Overall Study|Adverse Event|5|||
48838867|NCT02890355|157252029|FG001|Overall Study|Adverse Event|5|||
48838868|NCT02890355|157252028|FG000|Overall Study|Refusal unrelated to adverse event|5|||
48838869|NCT02890355|157252029|FG001|Overall Study|Refusal unrelated to adverse event|10|||
48838870|NCT02890355|157252028|FG000|Overall Study|Progression/relapse|46|||
48838871|NCT02890355|157252029|FG001|Overall Study|Progression/relapse|39|||
48838872|NCT02890355|157252028|FG000|Overall Study|Not protocol specified|3|||
48838873|NCT02890355|157252029|FG001|Overall Study|Not protocol specified|4|||
48838874|NCT03406780|157252030|FG000|Overall Study|Withdrawal by Subject|1|||
48838875|NCT03406780|157252031|FG001|Overall Study|Withdrawal by Subject|1|||
48838876|NCT03406780|157252030|FG000|Overall Study|Other|0|||
48838877|NCT03406780|157252031|FG001|Overall Study|Other|2|||
48838878|NCT03898180|157252032|FG000|Overall Study|Ongoing in Study|133|||
48838879|NCT03898180|157252033|FG001|Overall Study|Ongoing in Study|134|||
48838880|NCT03898180|157252032|FG000|Overall Study|Withdrawal by Subject|3|||
48838881|NCT03898180|157252033|FG001|Overall Study|Withdrawal by Subject|2|||
48838882|NCT03898180|157252032|FG000|Overall Study|Death|109|||
48838883|NCT03898180|157252033|FG001|Overall Study|Death|106|||
48838884|NCT00334815|157252040|FG000|Overall Study|Adverse Event|3|||
48838885|NCT00334815|157252041|FG001|Overall Study|Adverse Event|2|||
48838886|NCT00334815|157252040|FG000|Overall Study|Death|0|||
48838887|NCT00334815|157252041|FG001|Overall Study|Death|2|||
48838888|NCT00334815|157252040|FG000|Overall Study|Progression|1|||
48838889|NCT00334815|157252041|FG001|Overall Study|Progression|0|||
48838890|NCT00334815|157252040|FG000|Overall Study|ineligible|1|||
48838891|NCT00334815|157252041|FG001|Overall Study|ineligible|1|||
48838892|NCT00334815|157252040|FG000|Overall Study|patient refused treatment|0|||
48838893|NCT00334815|157252041|FG001|Overall Study|patient refused treatment|1|||
48584948|NCT00743288|156333718|FG004|Overall Study|Progressive disease (PD)|5|||
48584949|NCT00743288|156333719|FG005|Overall Study|Progressive disease (PD)|3|||
48584950|NCT00743288|156333720|FG006|Overall Study|Progressive disease (PD)|6|||
48584951|NCT00743288|156333714|FG000|Overall Study|Worsening of condition (Not PD)|0|||
48584952|NCT00743288|156333715|FG001|Overall Study|Worsening of condition (Not PD)|2|||
48584953|NCT00743288|156333716|FG002|Overall Study|Worsening of condition (Not PD)|1|||
48584954|NCT00743288|156333717|FG003|Overall Study|Worsening of condition (Not PD)|1|||
48584955|NCT00743288|156333718|FG004|Overall Study|Worsening of condition (Not PD)|0|||
48584956|NCT00743288|156333719|FG005|Overall Study|Worsening of condition (Not PD)|0|||
48584957|NCT00743288|156333720|FG006|Overall Study|Worsening of condition (Not PD)|0|||
48584958|NCT03235115|156333721|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
48584959|NCT03235115|156333722|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
48584960|NCT03235115|156333723|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
48584961|NCT03235115|156333724|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
48584962|NCT03235115|156333725|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
48584963|NCT03235115|156333726|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
48584964|NCT02093390|156333729|FG000|Overall Study|Withdrawal by Subject|0|||
48584965|NCT02093390|156333730|FG001|Overall Study|Withdrawal by Subject|1|||
48584966|NCT01092637|156333734|FG000|Overall Study|Death|47|||
48584967|NCT01092637|156333735|FG001|Overall Study|Death|49|||
48584968|NCT01179737|156333738|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
48584969|NCT01179737|156333739|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
48584970|NCT01179737|156333740|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
48584971|NCT01179737|156333741|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
48838894|NCT00334815|157252040|FG000|Overall Study|Physician Decision|2|||
48838895|NCT00334815|157252041|FG001|Overall Study|Physician Decision|4|||
48838896|NCT02152982|157252043|FG000|Overall Study|Ineligible|4|||
48838897|NCT02152982|157252044|FG001|Overall Study|Ineligible|4|||
48838898|NCT02152982|157252043|FG000|Overall Study|Did not start treatment|12|||
48838899|NCT02152982|157252044|FG001|Overall Study|Did not start treatment|6|||
48838900|NCT01169337|157252045|FG000|Overall Study|Lack of Efficacy|5|||
48838901|NCT01169337|157252046|FG001|Overall Study|Lack of Efficacy|7|||
48838902|NCT01169337|157252047|FG002|Overall Study|Lack of Efficacy|0|||
48838903|NCT01169337|157252045|FG000|Overall Study|Adverse Event|12|||
48838904|NCT01169337|157252046|FG001|Overall Study|Adverse Event|18|||
48838905|NCT01169337|157252047|FG002|Overall Study|Adverse Event|0|||
48838906|NCT01169337|157252045|FG000|Overall Study|Death|2|||
48536110|NCT02224573|156150428|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
48536111|NCT02224573|156150427|FG000|Treatment Phase|Started on Other IMP|1|||
48536112|NCT02224573|156150428|FG001|Treatment Phase|Started on Other IMP|0|||
48536113|NCT02224573|156150427|FG000|Treatment Phase|Participant Discontinued IMP|0|||
48536114|NCT02224573|156150428|FG001|Treatment Phase|Participant Discontinued IMP|1|||
48536115|NCT02224573|156150427|FG000|Treatment Phase|Lack of Efficacy|15|||
48536116|NCT02224573|156150428|FG001|Treatment Phase|Lack of Efficacy|8|||
48536117|NCT02224573|156150427|FG000|Treatment Phase|Began Commercial Product|1|||
48536118|NCT02224573|156150428|FG001|Treatment Phase|Began Commercial Product|0|||
48536119|NCT02224573|156150427|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
48536120|NCT02224573|156150428|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
48536121|NCT02224573|156150427|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
48536122|NCT02224573|156150428|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
48536123|NCT02224573|156150427|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
48536124|NCT02224573|156150428|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
48536125|NCT02224573|156150427|FG000|Treatment Phase|Continued Compassionate Use|1|||
48536126|NCT02224573|156150428|FG001|Treatment Phase|Continued Compassionate Use|0|||
48536127|NCT02224573|156150427|FG000|Treatment Phase|Lack of Efficiency|2|||
48536128|NCT02224573|156150428|FG001|Treatment Phase|Lack of Efficiency|1|||
48536129|NCT02224573|156150427|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
48536130|NCT02224573|156150428|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
48536131|NCT02224573|156150427|FG000|Treatment Phase|Participant Moved|2|||
48536132|NCT02224573|156150428|FG001|Treatment Phase|Participant Moved|0|||
48536133|NCT02224573|156150427|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
48536134|NCT02224573|156150428|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
48536135|NCT02224573|156150427|FG000|Treatment Phase|Refused Medication|1|||
48536136|NCT02224573|156150428|FG001|Treatment Phase|Refused Medication|1|||
48536137|NCT02224573|156150427|FG000|Treatment Phase|Adverse Event|26|||
48536138|NCT02224573|156150428|FG001|Treatment Phase|Adverse Event|38|||
48536139|NCT02224573|156150427|FG000|Treatment Phase|Placed in Group Home|0|||
48536140|NCT02224573|156150428|FG001|Treatment Phase|Placed in Group Home|1|||
48536141|NCT02224573|156150427|FG000|Treatment Phase|Pursued Other Trials|1|||
48536142|NCT02224573|156150428|FG001|Treatment Phase|Pursued Other Trials|0|||
48536143|NCT02224573|156150427|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
48536144|NCT02224573|156150428|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
48536145|NCT02224573|156150427|FG000|Treatment Phase|Lost to Follow-up|2|||
48536146|NCT02224573|156150428|FG001|Treatment Phase|Lost to Follow-up|1|||
48536147|NCT02224573|156150427|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
48536148|NCT02224573|156150428|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
48536149|NCT02224573|156150427|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
48536150|NCT02224573|156150428|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
48536151|NCT02224573|156150427|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
48536152|NCT02224573|156150428|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
48536153|NCT02224573|156150427|FG000|Taper Phase|Adverse Event|1|||
48536154|NCT02224573|156150428|FG001|Taper Phase|Adverse Event|1|||
48536155|NCT02549573|156150431|FG000|Overall Study|Withdrawal by Subject|0|||
48536156|NCT02549573|156150432|FG001|Overall Study|Withdrawal by Subject|2|||
48536157|NCT02549573|156150431|FG000|Overall Study|Protocol Violation|0|||
48536158|NCT02549573|156150432|FG001|Overall Study|Protocol Violation|1|||
48536159|NCT02083926|156150437|FG000|Overall Study|Withdrawal by Subject|1|||
48536160|NCT02083926|156150438|FG001|Overall Study|Withdrawal by Subject|0|||
48536161|NCT01949116|156150447|FG000|Overall Study|Death|2|||
48536162|NCT01949116|156150448|FG001|Overall Study|Death|0|||
48536163|NCT01949116|156150447|FG000|Overall Study|Lost to Follow-up|1|||
48536164|NCT01949116|156150448|FG001|Overall Study|Lost to Follow-up|3|||
48536165|NCT01949116|156150447|FG000|Overall Study|Withdrawal by Subject|5|||
48536166|NCT01949116|156150448|FG001|Overall Study|Withdrawal by Subject|3|||
48536167|NCT02201290|156150449|FG000|Overall Study|Withdrawal by Subject|2|||
48536168|NCT02201290|156150449|FG000|Overall Study|Lack of Efficacy|2|||
48838907|NCT01169337|157252046|FG001|Overall Study|Death|0|||
48838908|NCT01169337|157252047|FG002|Overall Study|Death|0|||
48838909|NCT01169337|157252045|FG000|Overall Study|Withdrawal by Subject|11|||
48838910|NCT01169337|157252046|FG001|Overall Study|Withdrawal by Subject|11|||
48838911|NCT01169337|157252047|FG002|Overall Study|Withdrawal by Subject|6|||
48838912|NCT01169337|157252045|FG000|Overall Study|Noncompliance|2|||
48838913|NCT01169337|157252046|FG001|Overall Study|Noncompliance|0|||
48838914|NCT01169337|157252047|FG002|Overall Study|Noncompliance|0|||
48838915|NCT01169337|157252045|FG000|Overall Study|Other complicating disease|1|||
48838916|NCT01169337|157252046|FG001|Overall Study|Other complicating disease|1|||
48838917|NCT01169337|157252047|FG002|Overall Study|Other complicating disease|0|||
48838918|NCT01169337|157252045|FG000|Overall Study|Physician Decision|1|||
48838919|NCT01169337|157252046|FG001|Overall Study|Physician Decision|5|||
48838920|NCT01169337|157252047|FG002|Overall Study|Physician Decision|0|||
48838921|NCT01169337|157252045|FG000|Overall Study|Alternative therapy|0|||
48838922|NCT01169337|157252046|FG001|Overall Study|Alternative therapy|2|||
48838923|NCT01169337|157252047|FG002|Overall Study|Alternative therapy|0|||
48838924|NCT01169337|157252045|FG000|Overall Study|Changed hospital|0|||
48838925|NCT01169337|157252046|FG001|Overall Study|Changed hospital|1|||
48838926|NCT01169337|157252047|FG002|Overall Study|Changed hospital|0|||
48838927|NCT01169337|157252045|FG000|Overall Study|Never started treatment|0|||
48838928|NCT01169337|157252046|FG001|Overall Study|Never started treatment|2|||
48838929|NCT01169337|157252047|FG002|Overall Study|Never started treatment|0|||
48838930|NCT01169337|157252045|FG000|Overall Study|Reason not reported|1|||
48838931|NCT01169337|157252046|FG001|Overall Study|Reason not reported|0|||
48536169|NCT02201290|156150449|FG000|Overall Study|Adverse Event|1|||
48536170|NCT01564459|156150450|FG000|Run-In|Adverse Event|7|||
48536171|NCT01564459|156150451|FG001|Run-In|Adverse Event|0|||
48536172|NCT01564459|156150452|FG002|Run-In|Adverse Event|0|||
48536173|NCT01564459|156150450|FG000|Run-In|Lost to Follow-up|1|||
48536174|NCT01564459|156150451|FG001|Run-In|Lost to Follow-up|0|||
48536175|NCT01564459|156150452|FG002|Run-In|Lost to Follow-up|0|||
48536176|NCT01564459|156150450|FG000|Run-In|Non-compliance with study drug|2|||
48536177|NCT01564459|156150451|FG001|Run-In|Non-compliance with study drug|0|||
48536178|NCT01564459|156150452|FG002|Run-In|Non-compliance with study drug|0|||
48536179|NCT01564459|156150450|FG000|Run-In|Protocol Violation|1|||
48838932|NCT01169337|157252047|FG002|Overall Study|Reason not reported|0|||
48838933|NCT01169337|157252045|FG000|Overall Study|Continuing lenalidomide|9|||
48838934|NCT01169337|157252046|FG001|Overall Study|Continuing lenalidomide|43|||
48838935|NCT01169337|157252047|FG002|Overall Study|Continuing lenalidomide|0|||
48838936|NCT02306161|157252052|FG000|Overall Study|Death|1|||
48838937|NCT02306161|157252053|FG001|Overall Study|Death|3|||
48838938|NCT02306161|157252052|FG000|Overall Study|Lack of Efficacy|20|||
48838939|NCT02306161|157252053|FG001|Overall Study|Lack of Efficacy|43|||
48838940|NCT02306161|157252052|FG000|Overall Study|Physician Decision|30|||
48838941|NCT02306161|157252053|FG001|Overall Study|Physician Decision|18|||
48838942|NCT02306161|157252052|FG000|Overall Study|Withdrawal by Subject|4|||
48838943|NCT02306161|157252053|FG001|Overall Study|Withdrawal by Subject|0|||
48838944|NCT02306161|157252052|FG000|Overall Study|Ineligible|9|||
48838945|NCT02306161|157252053|FG001|Overall Study|Ineligible|5|||
48838946|NCT02921230|157252056|FG000|Overall Study|Withdrawal by Subject|20|||
48838947|NCT02921230|157252057|FG001|Overall Study|Withdrawal by Subject|8|||
48838948|NCT02921230|157252056|FG000|Overall Study|Death|12|||
48838949|NCT02921230|157252057|FG001|Overall Study|Death|3|||
48838950|NCT02921230|157252056|FG000|Overall Study|Protocol Violation|17|||
48838951|NCT02921230|157252057|FG001|Overall Study|Protocol Violation|6|||
48838952|NCT02921230|157252056|FG000|Overall Study|Early completion|5|||
48838953|NCT02921230|157252057|FG001|Overall Study|Early completion|1|||
48838954|NCT02921230|157252056|FG000|Overall Study|Pending data entry|1|||
48838955|NCT02921230|157252057|FG001|Overall Study|Pending data entry|0|||
48838956|NCT04130438|157252058|FG000|Overall Study|Lost to Follow-up|0|||
48838957|NCT04130438|157252059|FG001|Overall Study|Lost to Follow-up|0|||
48838958|NCT04130438|157252060|FG002|Overall Study|Lost to Follow-up|1|||
48838959|NCT04280081|157252061|FG000|Overall Study|Adverse Event|4|||
48838960|NCT04280081|157252061|FG000|Overall Study|Death|2|||
48838961|NCT04280081|157252061|FG000|Overall Study|Progressive Disease|6|||
48838962|NCT05155306|157252062|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
48536180|NCT01564459|156150451|FG001|Run-In|Protocol Violation|0|||
48536181|NCT01564459|156150452|FG002|Run-In|Protocol Violation|0|||
48536182|NCT01564459|156150450|FG000|Run-In|Withdrawal by Subject|1|||
48536183|NCT01564459|156150451|FG001|Run-In|Withdrawal by Subject|0|||
48536184|NCT01564459|156150452|FG002|Run-In|Withdrawal by Subject|0|||
48838963|NCT05155306|157252063|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
48838964|NCT05155306|157252064|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
48536185|NCT01564459|156150450|FG000|Double-blind Treatment|Adverse Event|0|||
48838965|NCT05155306|157252065|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
48838966|NCT05155306|157252062|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
48838967|NCT05155306|157252063|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
48838968|NCT05155306|157252064|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
48536186|NCT01564459|156150451|FG001|Double-blind Treatment|Adverse Event|0|||
48838969|NCT05155306|157252065|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
48838970|NCT02476916|157252066|FG000|Core Period|Adverse Event|2|||
48536187|NCT01564459|156150452|FG002|Double-blind Treatment|Adverse Event|1|||
48838971|NCT02476916|157252067|FG001|Core Period|Adverse Event|2|||
48838972|NCT02476916|157252066|FG000|Core Period|Investigator decision|1|||
48838973|NCT02476916|157252067|FG001|Core Period|Investigator decision|1|||
48838974|NCT02476916|157252066|FG000|Core Period|Withdrawal by Subject|3|||
48838975|NCT02476916|157252067|FG001|Core Period|Withdrawal by Subject|0|||
48605126|NCT03163446|156411579|FG001|Overall Study|Death|5|||
48605127|NCT03163446|156411578|FG000|Overall Study|Lost to Follow-up|6|||
48605128|NCT03163446|156411579|FG001|Overall Study|Lost to Follow-up|5|||
48605129|NCT03163446|156411578|FG000|Overall Study|Physician Decision|1|||
48605130|NCT03163446|156411579|FG001|Overall Study|Physician Decision|1|||
48605131|NCT03163446|156411578|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
48605132|NCT03163446|156411579|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
48605133|NCT00611806|156411580|FG000|Overall Study|Withdrawal by Subject|8|||
48605134|NCT00611806|156411581|FG001|Overall Study|Withdrawal by Subject|2|||
48605135|NCT00611806|156411580|FG000|Overall Study|Adverse Event|2|||
48605136|NCT00611806|156411581|FG001|Overall Study|Adverse Event|1|||
48605137|NCT00611806|156411580|FG000|Overall Study|Lost to Follow-up|6|||
48605138|NCT00611806|156411581|FG001|Overall Study|Lost to Follow-up|0|||
48605139|NCT02611882|156411584|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
48605140|NCT02611882|156411585|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
48605141|NCT02611882|156411586|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
48605142|NCT01317940|156411587|FG000|Overall Study|Death|1|||
48605143|NCT01317940|156411588|FG001|Overall Study|Death|0|||
48605144|NCT01317940|156411589|FG002|Overall Study|Death|1|||
48605145|NCT01317940|156411590|FG003|Overall Study|Death|0|||
48605146|NCT01317940|156411591|FG004|Overall Study|Death|0|||
48605147|NCT01317940|156411592|FG005|Overall Study|Death|0|||
48605148|NCT01317940|156411587|FG000|Overall Study|Lost to Follow-up|0|||
48605149|NCT01317940|156411588|FG001|Overall Study|Lost to Follow-up|0|||
48605150|NCT01317940|156411589|FG002|Overall Study|Lost to Follow-up|1|||
48605151|NCT01317940|156411590|FG003|Overall Study|Lost to Follow-up|1|||
48605152|NCT01317940|156411591|FG004|Overall Study|Lost to Follow-up|1|||
48605153|NCT01317940|156411592|FG005|Overall Study|Lost to Follow-up|0|||
48605154|NCT01317940|156411587|FG000|Overall Study|Change in therapy plan|0|||
48605155|NCT01317940|156411588|FG001|Overall Study|Change in therapy plan|0|||
48605156|NCT01317940|156411589|FG002|Overall Study|Change in therapy plan|3|||
48605157|NCT01317940|156411590|FG003|Overall Study|Change in therapy plan|0|||
48605158|NCT01317940|156411591|FG004|Overall Study|Change in therapy plan|0|||
48605159|NCT01317940|156411592|FG005|Overall Study|Change in therapy plan|0|||
48605160|NCT02990000|156411593|FG000|Overall Study|Failed to provide data beyond baseline|36|||
48605161|NCT02990000|156411594|FG001|Overall Study|Failed to provide data beyond baseline|34|||
48605162|NCT00922636|156411596|FG000|Overall Study|Adverse Event|3|||
48605163|NCT00922636|156411597|FG001|Overall Study|Adverse Event|3|||
48605164|NCT00922636|156411598|FG002|Overall Study|Adverse Event|2|||
48605165|NCT00922636|156411599|FG003|Overall Study|Adverse Event|3|||
48605166|NCT00922636|156411600|FG004|Overall Study|Adverse Event|2|||
48605167|NCT00922636|156411596|FG000|Overall Study|Lack of Efficacy|1|||
48605168|NCT00922636|156411597|FG001|Overall Study|Lack of Efficacy|7|||
48605169|NCT00922636|156411598|FG002|Overall Study|Lack of Efficacy|3|||
48605170|NCT00922636|156411599|FG003|Overall Study|Lack of Efficacy|2|||
48605171|NCT00922636|156411600|FG004|Overall Study|Lack of Efficacy|4|||
48605172|NCT00922636|156411596|FG000|Overall Study|Sponsor Decision|0|||
48605173|NCT00922636|156411597|FG001|Overall Study|Sponsor Decision|0|||
48605174|NCT00922636|156411598|FG002|Overall Study|Sponsor Decision|2|||
48605175|NCT00922636|156411599|FG003|Overall Study|Sponsor Decision|0|||
48605176|NCT00922636|156411600|FG004|Overall Study|Sponsor Decision|0|||
48605177|NCT00922636|156411596|FG000|Overall Study|Withdrawal by Subject|0|||
48605178|NCT00922636|156411597|FG001|Overall Study|Withdrawal by Subject|0|||
48838976|NCT02476916|157252066|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
48838977|NCT02476916|157252067|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
48605179|NCT00922636|156411598|FG002|Overall Study|Withdrawal by Subject|5|||
48605180|NCT00922636|156411599|FG003|Overall Study|Withdrawal by Subject|2|||
48605181|NCT00922636|156411600|FG004|Overall Study|Withdrawal by Subject|4|||
48605182|NCT00922636|156411596|FG000|Overall Study|Protocol Violation|0|||
48605183|NCT00922636|156411597|FG001|Overall Study|Protocol Violation|0|||
48605184|NCT00922636|156411598|FG002|Overall Study|Protocol Violation|2|||
48605185|NCT00922636|156411599|FG003|Overall Study|Protocol Violation|2|||
48838978|NCT02476916|157252066|FG000|Extension Period|On Treatment|12|||
48838979|NCT02476916|157252067|FG001|Extension Period|On Treatment|17|||
48605186|NCT00922636|156411600|FG004|Overall Study|Protocol Violation|0|||
48605187|NCT00922636|156411596|FG000|Overall Study|Entry Criteria Not Met|0|||
48605188|NCT00922636|156411597|FG001|Overall Study|Entry Criteria Not Met|0|||
48605189|NCT00922636|156411598|FG002|Overall Study|Entry Criteria Not Met|1|||
48838980|NCT04322643|157252070|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
48605190|NCT00922636|156411599|FG003|Overall Study|Entry Criteria Not Met|1|||
48605191|NCT00922636|156411600|FG004|Overall Study|Entry Criteria Not Met|0|||
48605192|NCT00922636|156411596|FG000|Overall Study|Parent/Caregiver Decision|2|||
48838981|NCT04055090|157252074|FG000|Overall Study|screen failure|1|||
48838982|NCT04055090|157252075|FG001|Overall Study|screen failure|0|||
48838983|NCT04055090|157252074|FG000|Overall Study|Withdrawal by Subject|1|||
48838984|NCT04055090|157252075|FG001|Overall Study|Withdrawal by Subject|0|||
48838985|NCT05071807|157252076|FG000|Overall Study|Withdrawal by Subject|4|||
48838986|NCT05071807|157252077|FG001|Overall Study|Withdrawal by Subject|0|||
48838987|NCT05071807|157252076|FG000|Overall Study|Unrelated medical issues|3|||
48838988|NCT05071807|157252077|FG001|Overall Study|Unrelated medical issues|0|||
48838989|NCT05071807|157252076|FG000|Overall Study|Relocated|0|||
48838990|NCT05071807|157252077|FG001|Overall Study|Relocated|1|||
48838991|NCT03936322|157252078|FG000|Overall Study|Lost to Follow-up|1|||
48838992|NCT03936322|157252078|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
48838993|NCT04175912|157252079|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
48838994|NCT04175912|157252080|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
48838995|NCT04175912|157252079|FG000|Overall Study|Adverse Event|0|||
48838996|NCT04175912|157252080|FG001|Overall Study|Adverse Event|3|||
48605193|NCT00922636|156411597|FG001|Overall Study|Parent/Caregiver Decision|4|||
48605194|NCT00922636|156411598|FG002|Overall Study|Parent/Caregiver Decision|3|||
48605195|NCT00922636|156411599|FG003|Overall Study|Parent/Caregiver Decision|5|||
48838997|NCT04175912|157252079|FG000|Overall Study|Never started treatment|3|||
48838998|NCT04175912|157252080|FG001|Overall Study|Never started treatment|3|||
48838999|NCT04175912|157252079|FG000|Overall Study|Death|0|||
48839000|NCT04175912|157252080|FG001|Overall Study|Death|1|||
48839001|NCT04852302|157252081|FG000|Overall Study|Withdrawal by Subject|2|||
48839002|NCT04852302|157252081|FG000|Overall Study|Did not complete CALM therapy.|2|||
48839003|NCT04437511|157252082|FG000|Overall Study|Adverse Event|50|||
48839004|NCT04437511|157252083|FG001|Overall Study|Adverse Event|21|||
48839005|NCT04437511|157252082|FG000|Overall Study|Death|15|||
48839006|NCT04437511|157252083|FG001|Overall Study|Death|10|||
48839007|NCT04437511|157252082|FG000|Overall Study|Lost to Follow-up|11|||
48839008|NCT04437511|157252083|FG001|Overall Study|Lost to Follow-up|11|||
48839009|NCT04437511|157252082|FG000|Overall Study|Physician Decision|19|||
48839010|NCT04437511|157252083|FG001|Overall Study|Physician Decision|10|||
48839011|NCT04437511|157252082|FG000|Overall Study|Progressive Disease|4|||
48839012|NCT04437511|157252083|FG001|Overall Study|Progressive Disease|7|||
48839013|NCT04437511|157252082|FG000|Overall Study|Withdrawal by Subject|111|||
48839014|NCT04437511|157252083|FG001|Overall Study|Withdrawal by Subject|94|||
48839015|NCT04437511|157252082|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
48839016|NCT04437511|157252083|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
48839017|NCT04437511|157252082|FG000|Overall Study|Continuing Study|7|||
48839018|NCT04437511|157252083|FG001|Overall Study|Continuing Study|5|||
48839019|NCT02985957|157252084|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48839020|NCT02985957|157252085|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48839021|NCT02985957|157252086|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48839022|NCT02985957|157252087|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48839023|NCT02985957|157252088|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
48839024|NCT02985957|157252089|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48839025|NCT02985957|157252090|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48839026|NCT02985957|157252084|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
48839027|NCT02985957|157252085|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
48839028|NCT02985957|157252086|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
48839029|NCT02985957|157252087|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
48839030|NCT02985957|157252088|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
48839031|NCT02985957|157252089|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
48839032|NCT02985957|157252090|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
48605196|NCT00922636|156411600|FG004|Overall Study|Parent/Caregiver Decision|2|||
48605197|NCT00922636|156411596|FG000|Overall Study|Lost to Follow-up|1|||
48605198|NCT00922636|156411597|FG001|Overall Study|Lost to Follow-up|2|||
48605199|NCT00922636|156411598|FG002|Overall Study|Lost to Follow-up|2|||
48605200|NCT00922636|156411599|FG003|Overall Study|Lost to Follow-up|2|||
48605201|NCT00922636|156411600|FG004|Overall Study|Lost to Follow-up|4|||
48605202|NCT00379834|156411603|FG000|Overall Study|Time constraints|2|||
48839033|NCT02985957|157252084|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48839034|NCT02985957|157252085|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48839035|NCT02985957|157252086|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48839036|NCT02985957|157252087|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48605203|NCT00116688|156411608|FG000|Overall Study|Protocol deviation|1|||
48605204|NCT00116688|156411609|FG001|Overall Study|Protocol deviation|0|||
48605205|NCT00116688|156411608|FG000|Overall Study|Noncompliance|3|||
48839037|NCT02985957|157252088|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48839038|NCT02985957|157252089|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48839039|NCT02985957|157252090|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
48839040|NCT02985957|157252084|FG000|Treatment Period|Death|0|||
48839041|NCT02985957|157252085|FG001|Treatment Period|Death|0|||
48839042|NCT02985957|157252086|FG002|Treatment Period|Death|0|||
48839043|NCT02985957|157252087|FG003|Treatment Period|Death|0|||
48536188|NCT04969861|156150459|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
48536189|NCT04969861|156150460|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
48536190|NCT00290251|156150461|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
48536191|NCT00290251|156150462|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
48536192|NCT00290251|156150463|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
48536193|NCT00290251|156150464|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
48536194|NCT00290251|156150465|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
48536195|NCT00290251|156150466|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
48536196|NCT00290251|156150461|FG000|Treatment 1 (Months 2-4)|headache|0|||
48839044|NCT02985957|157252088|FG004|Treatment Period|Death|1|||
48839045|NCT02985957|157252089|FG005|Treatment Period|Death|0|||
48839046|NCT02985957|157252090|FG006|Treatment Period|Death|0|||
48839047|NCT02985957|157252084|FG000|Treatment Period|Participant withdrew consent|0|||
48839048|NCT02985957|157252085|FG001|Treatment Period|Participant withdrew consent|0|||
48839049|NCT02985957|157252086|FG002|Treatment Period|Participant withdrew consent|0|||
48839050|NCT02985957|157252087|FG003|Treatment Period|Participant withdrew consent|1|||
48536197|NCT00290251|156150462|FG001|Treatment 1 (Months 2-4)|headache|0|||
48536198|NCT00290251|156150463|FG002|Treatment 1 (Months 2-4)|headache|0|||
48536199|NCT00290251|156150464|FG003|Treatment 1 (Months 2-4)|headache|0|||
48536200|NCT00290251|156150465|FG004|Treatment 1 (Months 2-4)|headache|1|||
48536201|NCT00290251|156150466|FG005|Treatment 1 (Months 2-4)|headache|0|||
48536202|NCT00290251|156150461|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
48536203|NCT00290251|156150462|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
48536204|NCT00290251|156150463|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
48536205|NCT00290251|156150464|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
48536206|NCT00290251|156150465|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
48536207|NCT00290251|156150466|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
48536208|NCT04700280|156150467|FG000|Overall Study|Adverse Event|4|||
48839051|NCT02985957|157252088|FG004|Treatment Period|Participant withdrew consent|3|||
48536209|NCT04700280|156150468|FG001|Overall Study|Adverse Event|0|||
48536210|NCT04700280|156150467|FG000|Overall Study|Lack of Efficacy|1|||
48536211|NCT04700280|156150468|FG001|Overall Study|Lack of Efficacy|0|||
48536212|NCT04700280|156150467|FG000|Overall Study|Study terminated by sponsor|5|||
48536213|NCT04700280|156150468|FG001|Overall Study|Study terminated by sponsor|3|||
48536214|NCT04700280|156150467|FG000|Overall Study|Other than specified|1|||
48536215|NCT04700280|156150468|FG001|Overall Study|Other than specified|0|||
48536216|NCT02458092|156150471|FG000|Overall Study|Withdrawal by Subject|1|||
48536217|NCT02458092|156150472|FG001|Overall Study|Withdrawal by Subject|0|||
48536218|NCT01843348|156150473|FG000|Overall Study|Withdrawal by Subject|4|||
48605206|NCT00116688|156411609|FG001|Overall Study|Noncompliance|1|||
48605207|NCT00116688|156411608|FG000|Overall Study|Adverse Event|11|||
48605208|NCT00116688|156411609|FG001|Overall Study|Adverse Event|0|||
48605209|NCT00116688|156411608|FG000|Overall Study|Withdrawal by Subject|26|||
48605210|NCT00116688|156411609|FG001|Overall Study|Withdrawal by Subject|2|||
48605211|NCT00116688|156411608|FG000|Overall Study|Requirement for alternative therapy|11|||
48605212|NCT00116688|156411609|FG001|Overall Study|Requirement for alternative therapy|1|||
48605213|NCT00116688|156411608|FG000|Overall Study|Physician Decision|7|||
48605214|NCT00116688|156411609|FG001|Overall Study|Physician Decision|0|||
48605215|NCT00116688|156411608|FG000|Overall Study|Lost to Follow-up|3|||
48605216|NCT00116688|156411609|FG001|Overall Study|Lost to Follow-up|0|||
48605217|NCT00116688|156411608|FG000|Overall Study|Death|15|||
48605218|NCT00116688|156411609|FG001|Overall Study|Death|0|||
48605219|NCT00116688|156411608|FG000|Overall Study|Protocol-specified criteria|3|||
48605220|NCT00116688|156411609|FG001|Overall Study|Protocol-specified criteria|0|||
48605221|NCT00116688|156411608|FG000|Overall Study|Pregnancy|1|||
48605222|NCT00116688|156411609|FG001|Overall Study|Pregnancy|0|||
48605223|NCT00116688|156411608|FG000|Overall Study|Other|11|||
48605224|NCT00116688|156411609|FG001|Overall Study|Other|0|||
48605225|NCT02812186|156411610|FG000|Period 1|Post randomization screen failure|5|||
48605226|NCT02812186|156411611|FG001|Period 1|Post randomization screen failure|9|||
48605227|NCT02812186|156411610|FG000|Period 1|nonevaluable data sets|6|||
48605228|NCT02812186|156411611|FG001|Period 1|nonevaluable data sets|6|||
48605229|NCT03316586|156411614|FG000|Overall Study|Adverse Event|2|||
48839052|NCT02985957|157252089|FG005|Treatment Period|Participant withdrew consent|0|||
48839053|NCT02985957|157252090|FG006|Treatment Period|Participant withdrew consent|1|||
48605230|NCT03316586|156411614|FG000|Overall Study|Physician Decision|3|||
48605231|NCT03316586|156411614|FG000|Overall Study|Lack of Efficacy|10|||
48605232|NCT03316586|156411614|FG000|Overall Study|still on treatment|1|||
48605233|NCT03316586|156411614|FG000|Overall Study|Patient needed radiation therapy|1|||
48605234|NCT03316586|156411614|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
48839054|NCT02985957|157252084|FG000|Treatment Period|Lost to Follow-up|0|||
48839055|NCT02985957|157252085|FG001|Treatment Period|Lost to Follow-up|0|||
48536219|NCT01843348|156150474|FG001|Overall Study|Withdrawal by Subject|16|||
48536220|NCT01843348|156150475|FG002|Overall Study|Withdrawal by Subject|18|||
48536221|NCT01843348|156150473|FG000|Overall Study|Lost to Follow-up|5|||
48536222|NCT01843348|156150474|FG001|Overall Study|Lost to Follow-up|4|||
48536223|NCT01843348|156150475|FG002|Overall Study|Lost to Follow-up|2|||
48536224|NCT01843348|156150473|FG000|Overall Study|Death|5|||
48536225|NCT01843348|156150474|FG001|Overall Study|Death|3|||
48536226|NCT01843348|156150475|FG002|Overall Study|Death|4|||
48536227|NCT01843348|156150473|FG000|Overall Study|Graft loss/retransplantation|5|||
48839056|NCT02985957|157252086|FG002|Treatment Period|Lost to Follow-up|0|||
48839057|NCT02985957|157252087|FG003|Treatment Period|Lost to Follow-up|0|||
48536228|NCT01843348|156150474|FG001|Overall Study|Graft loss/retransplantation|8|||
48536229|NCT01843348|156150475|FG002|Overall Study|Graft loss/retransplantation|11|||
48536230|NCT01843348|156150473|FG000|Overall Study|Various reasons|4|||
48536231|NCT01843348|156150474|FG001|Overall Study|Various reasons|9|||
48536232|NCT01843348|156150475|FG002|Overall Study|Various reasons|6|||
48536233|NCT01855048|156150477|FG000|Overall Study|Withdrawal by Subject|0|||
48536234|NCT01855048|156150478|FG001|Overall Study|Withdrawal by Subject|1|||
48536235|NCT01855048|156150479|FG002|Overall Study|Withdrawal by Subject|0|||
48536236|NCT01855048|156150480|FG003|Overall Study|Withdrawal by Subject|0|||
48536237|NCT01855048|156150481|FG004|Overall Study|Withdrawal by Subject|1|||
48536238|NCT01855048|156150482|FG005|Overall Study|Withdrawal by Subject|0|||
48536239|NCT00876018|156150489|FG000|Overall Study|Lost to Follow-up|0|||
48536240|NCT00876018|156150490|FG001|Overall Study|Lost to Follow-up|1|||
48536241|NCT00876018|156150491|FG002|Overall Study|Lost to Follow-up|1|||
48536242|NCT00876018|156150489|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
48536243|NCT00876018|156150490|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
48536244|NCT00876018|156150491|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
48536245|NCT02692482|156150492|FG000|Overall Study|Death|2|||
48536246|NCT02692482|156150493|FG001|Overall Study|Death|2|||
48536247|NCT02692482|156150492|FG000|Overall Study|Withdrawal by Subject|1|||
48536248|NCT02692482|156150493|FG001|Overall Study|Withdrawal by Subject|2|||
48536249|NCT00257920|156150494|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
48536250|NCT00257920|156150495|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
48839058|NCT02985957|157252088|FG004|Treatment Period|Lost to Follow-up|1|||
48839059|NCT02985957|157252089|FG005|Treatment Period|Lost to Follow-up|0|||
48839060|NCT02985957|157252090|FG006|Treatment Period|Lost to Follow-up|0|||
48839061|NCT02985957|157252084|FG000|Treatment Period|Other reasons|0|||
48839062|NCT02985957|157252085|FG001|Treatment Period|Other reasons|0|||
48839063|NCT02985957|157252086|FG002|Treatment Period|Other reasons|1|||
48839064|NCT02985957|157252087|FG003|Treatment Period|Other reasons|3|||
48839065|NCT02985957|157252088|FG004|Treatment Period|Other reasons|6|||
48839066|NCT02985957|157252089|FG005|Treatment Period|Other reasons|0|||
48839067|NCT02985957|157252090|FG006|Treatment Period|Other reasons|1|||
48839068|NCT02985957|157252084|FG000|Treatment Period|Not reported|0|||
48536251|NCT00257920|156150494|FG000|Period: Second Intervention|Other|2|||
48536252|NCT00257920|156150495|FG001|Period: Second Intervention|Other|1|||
48536253|NCT00925301|156150496|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
48536254|NCT00925301|156150497|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
48536255|NCT00925301|156150498|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
48536256|NCT00925301|156150499|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
48839069|NCT02985957|157252085|FG001|Treatment Period|Not reported|1|||
48839070|NCT02985957|157252086|FG002|Treatment Period|Not reported|2|||
48839071|NCT02985957|157252087|FG003|Treatment Period|Not reported|5|||
48839072|NCT02985957|157252088|FG004|Treatment Period|Not reported|0|||
48839073|NCT02985957|157252089|FG005|Treatment Period|Not reported|0|||
48839074|NCT02985957|157252090|FG006|Treatment Period|Not reported|0|||
48839075|NCT02985957|157252084|FG000|Treatment Period|Maximum clinical benefit|0|||
48839076|NCT02985957|157252085|FG001|Treatment Period|Maximum clinical benefit|0|||
48839077|NCT02985957|157252086|FG002|Treatment Period|Maximum clinical benefit|1|||
48839078|NCT02985957|157252087|FG003|Treatment Period|Maximum clinical benefit|1|||
48839079|NCT02985957|157252088|FG004|Treatment Period|Maximum clinical benefit|0|||
48839080|NCT02985957|157252089|FG005|Treatment Period|Maximum clinical benefit|0|||
48536257|NCT00925301|156150496|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
48839081|NCT02985957|157252090|FG006|Treatment Period|Maximum clinical benefit|2|||
48839082|NCT02985957|157252084|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
48839083|NCT02985957|157252085|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
48839084|NCT02985957|157252086|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
48536258|NCT00925301|156150497|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
48839085|NCT02985957|157252087|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
48839086|NCT02985957|157252088|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
48839087|NCT02985957|157252089|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
48536259|NCT00925301|156150498|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
48536260|NCT00925301|156150499|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
48839088|NCT02985957|157252090|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
48839089|NCT02985957|157252084|FG000|Treatment Period|Study drug toxicity|1|||
48839090|NCT02985957|157252085|FG001|Treatment Period|Study drug toxicity|23|||
48839091|NCT02985957|157252086|FG002|Treatment Period|Study drug toxicity|20|||
48536261|NCT00925301|156150496|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
48536262|NCT00925301|156150497|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
48536263|NCT00925301|156150498|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
48536264|NCT00925301|156150499|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
48536265|NCT00925301|156150496|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
48536266|NCT00925301|156150497|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
48536267|NCT00925301|156150498|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
48839092|NCT02985957|157252087|FG003|Treatment Period|Study drug toxicity|11|||
48839093|NCT02985957|157252088|FG004|Treatment Period|Study drug toxicity|19|||
48839094|NCT02985957|157252089|FG005|Treatment Period|Study drug toxicity|3|||
48839095|NCT02985957|157252090|FG006|Treatment Period|Study drug toxicity|5|||
48839096|NCT02985957|157252084|FG000|Treatment Period|Disease progression|0|||
48839097|NCT02985957|157252085|FG001|Treatment Period|Disease progression|16|||
48839098|NCT02985957|157252086|FG002|Treatment Period|Disease progression|20|||
48839099|NCT02985957|157252087|FG003|Treatment Period|Disease progression|39|||
48839100|NCT02985957|157252088|FG004|Treatment Period|Disease progression|29|||
48839101|NCT02985957|157252089|FG005|Treatment Period|Disease progression|11|||
48839102|NCT02985957|157252090|FG006|Treatment Period|Disease progression|28|||
48839103|NCT02985957|157252084|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
48839104|NCT02985957|157252085|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
48839105|NCT02985957|157252086|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
48839106|NCT02985957|157252087|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
48839107|NCT02985957|157252088|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
48839108|NCT02985957|157252089|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
48839109|NCT02985957|157252090|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
48839110|NCT02985957|157252084|FG000|Treatment Period|Poor/Non-Compliance|0|||
48839111|NCT02985957|157252085|FG001|Treatment Period|Poor/Non-Compliance|0|||
48839112|NCT02985957|157252086|FG002|Treatment Period|Poor/Non-Compliance|0|||
48839113|NCT02985957|157252087|FG003|Treatment Period|Poor/Non-Compliance|0|||
48839114|NCT02985957|157252088|FG004|Treatment Period|Poor/Non-Compliance|1|||
48839115|NCT02985957|157252089|FG005|Treatment Period|Poor/Non-Compliance|1|||
48839116|NCT02985957|157252090|FG006|Treatment Period|Poor/Non-Compliance|0|||
48839117|NCT02985957|157252084|FG000|Treatment Period|Continuing in Treatment Period|0|||
48839118|NCT02985957|157252085|FG001|Treatment Period|Continuing in Treatment Period|1|||
48839119|NCT02985957|157252086|FG002|Treatment Period|Continuing in Treatment Period|0|||
48839120|NCT02985957|157252087|FG003|Treatment Period|Continuing in Treatment Period|4|||
48839121|NCT02985957|157252088|FG004|Treatment Period|Continuing in Treatment Period|4|||
48839122|NCT02985957|157252089|FG005|Treatment Period|Continuing in Treatment Period|0|||
48839123|NCT02985957|157252090|FG006|Treatment Period|Continuing in Treatment Period|0|||
48839124|NCT04225039|157252091|FG000|Overall Study|Withdrawal by Subject|1|||
48839125|NCT04225039|157252092|FG001|Overall Study|Withdrawal by Subject|0|||
48839126|NCT04225039|157252093|FG002|Overall Study|Withdrawal by Subject|0|||
48839127|NCT04225039|157252094|FG003|Overall Study|Withdrawal by Subject|1|||
48839128|NCT04225039|157252091|FG000|Overall Study|Currently active on study treatment|0|||
48839129|NCT04225039|157252092|FG001|Overall Study|Currently active on study treatment|1|||
48839130|NCT04225039|157252093|FG002|Overall Study|Currently active on study treatment|0|||
48839131|NCT04225039|157252094|FG003|Overall Study|Currently active on study treatment|0|||
48839132|NCT04225039|157252091|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
48839133|NCT04225039|157252092|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
48839134|NCT04225039|157252093|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
48839135|NCT04225039|157252094|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
48839136|NCT04225039|157252091|FG000|Overall Study|Ineligible for treatment|0|||
48839137|NCT04225039|157252092|FG001|Overall Study|Ineligible for treatment|0|||
48839138|NCT04225039|157252093|FG002|Overall Study|Ineligible for treatment|0|||
48839139|NCT04225039|157252094|FG003|Overall Study|Ineligible for treatment|4|||
48839140|NCT01248130|157252095|FG000|Overall Study|Protocol Violation|1|||
48839141|NCT01248130|157252096|FG001|Overall Study|Protocol Violation|0|||
48839142|NCT01248130|157252095|FG000|Overall Study|Ineligible|1|||
48839143|NCT01248130|157252096|FG001|Overall Study|Ineligible|0|||
48839144|NCT04676022|157252097|FG000|Overall Study|Screen Failure/|1|||
48839145|NCT04676022|157252098|FG001|Overall Study|Screen Failure/|1|||
48839146|NCT04676022|157252099|FG002|Overall Study|Screen Failure/|85|||
48839147|NCT04676022|157252097|FG000|Overall Study|Lost to Follow-up|1|||
48839148|NCT04676022|157252098|FG001|Overall Study|Lost to Follow-up|1|||
48839149|NCT04676022|157252099|FG002|Overall Study|Lost to Follow-up|0|||
48839150|NCT04676022|157252097|FG000|Overall Study|Adverse Event|2|||
48839151|NCT04676022|157252098|FG001|Overall Study|Adverse Event|0|||
48839152|NCT04676022|157252099|FG002|Overall Study|Adverse Event|1|||
48839153|NCT04676022|157252097|FG000|Overall Study|Physician Decision|2|||
48839154|NCT04676022|157252098|FG001|Overall Study|Physician Decision|0|||
48839155|NCT04676022|157252099|FG002|Overall Study|Physician Decision|1|||
48839156|NCT04676022|157252097|FG000|Overall Study|Withdrawal by Subject|3|||
48839157|NCT04676022|157252098|FG001|Overall Study|Withdrawal by Subject|1|||
48839158|NCT04676022|157252099|FG002|Overall Study|Withdrawal by Subject|6|||
48839159|NCT04676022|157252097|FG000|Overall Study|Will not move forward with permanent implant|6|||
48839160|NCT04676022|157252098|FG001|Overall Study|Will not move forward with permanent implant|0|||
48839161|NCT04676022|157252099|FG002|Overall Study|Will not move forward with permanent implant|0|||
48839162|NCT04676022|157252097|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
48839163|NCT04676022|157252098|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
48839164|NCT04676022|157252099|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
48839165|NCT06161012|157252118|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
48536268|NCT00925301|156150499|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
48536269|NCT00925301|156150496|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
48536270|NCT00925301|156150497|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
48536271|NCT00925301|156150498|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
48536272|NCT00925301|156150499|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
48839166|NCT06161012|157252119|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
48839167|NCT01522976|157252126|FG000|Overall Study|Ineligible|4|||
48839168|NCT01522976|157252127|FG001|Overall Study|Ineligible|0|||
48839169|NCT01522976|157252128|FG002|Overall Study|Ineligible|1|||
48839170|NCT01522976|157252126|FG000|Overall Study|Death|7|||
48839171|NCT01522976|157252127|FG001|Overall Study|Death|6|||
48839172|NCT01522976|157252128|FG002|Overall Study|Death|2|||
48839173|NCT01522976|157252126|FG000|Overall Study|Still on treatment|9|||
48839174|NCT01522976|157252127|FG001|Overall Study|Still on treatment|9|||
48839175|NCT01522976|157252128|FG002|Overall Study|Still on treatment|6|||
48839176|NCT01522976|157252126|FG000|Overall Study|Disease progression|28|||
48605235|NCT00643760|156411617|FG000|Overall Study|Adverse Event|11|||
48605236|NCT00643760|156411618|FG001|Overall Study|Adverse Event|5|||
48605237|NCT00643760|156411619|FG002|Overall Study|Adverse Event|12|||
48605238|NCT00643760|156411620|FG003|Overall Study|Adverse Event|21|||
48605239|NCT00643760|156411621|FG004|Overall Study|Adverse Event|6|||
48605240|NCT00643760|156411617|FG000|Overall Study|Lack of Efficacy|3|||
48839177|NCT01522976|157252127|FG001|Overall Study|Disease progression|30|||
48839178|NCT01522976|157252128|FG002|Overall Study|Disease progression|25|||
48839179|NCT01522976|157252126|FG000|Overall Study|Adverse Event|17|||
48839180|NCT01522976|157252127|FG001|Overall Study|Adverse Event|7|||
48839181|NCT01522976|157252128|FG002|Overall Study|Adverse Event|18|||
48536273|NCT00925301|156150496|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
48605241|NCT00643760|156411618|FG001|Overall Study|Lack of Efficacy|1|||
48605242|NCT00643760|156411619|FG002|Overall Study|Lack of Efficacy|0|||
48605243|NCT00643760|156411620|FG003|Overall Study|Lack of Efficacy|4|||
48605244|NCT00643760|156411621|FG004|Overall Study|Lack of Efficacy|3|||
48605245|NCT00643760|156411617|FG000|Overall Study|Protocol Violation|7|||
48536274|NCT00925301|156150497|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
48536275|NCT00925301|156150498|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
48536276|NCT00925301|156150499|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
48536277|NCT00925301|156150496|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
48605246|NCT00643760|156411618|FG001|Overall Study|Protocol Violation|6|||
48605247|NCT00643760|156411619|FG002|Overall Study|Protocol Violation|4|||
48605248|NCT00643760|156411620|FG003|Overall Study|Protocol Violation|4|||
48605249|NCT00643760|156411621|FG004|Overall Study|Protocol Violation|6|||
48839182|NCT01522976|157252126|FG000|Overall Study|Refusal unrelated to adverse event|10|||
48839183|NCT01522976|157252127|FG001|Overall Study|Refusal unrelated to adverse event|13|||
48536278|NCT00925301|156150497|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
48536279|NCT00925301|156150498|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
48605250|NCT00643760|156411617|FG000|Overall Study|Lost to Follow-up|6|||
48839184|NCT01522976|157252128|FG002|Overall Study|Refusal unrelated to adverse event|14|||
48839185|NCT01522976|157252126|FG000|Overall Study|Not protocol specified|22|||
48605251|NCT00643760|156411618|FG001|Overall Study|Lost to Follow-up|2|||
48605252|NCT00643760|156411619|FG002|Overall Study|Lost to Follow-up|1|||
48839186|NCT01522976|157252127|FG001|Overall Study|Not protocol specified|27|||
48839187|NCT01522976|157252128|FG002|Overall Study|Not protocol specified|27|||
48839188|NCT01798498|157252131|FG000|Overall Study|Lost to Follow-up|1|||
48605253|NCT00643760|156411620|FG003|Overall Study|Lost to Follow-up|3|||
48605254|NCT00643760|156411621|FG004|Overall Study|Lost to Follow-up|3|||
48605255|NCT00643760|156411617|FG000|Overall Study|Investigator Discretion|0|||
48605256|NCT00643760|156411618|FG001|Overall Study|Investigator Discretion|0|||
48605257|NCT00643760|156411619|FG002|Overall Study|Investigator Discretion|0|||
48605258|NCT00643760|156411620|FG003|Overall Study|Investigator Discretion|2|||
48605259|NCT00643760|156411621|FG004|Overall Study|Investigator Discretion|0|||
48605260|NCT00643760|156411617|FG000|Overall Study|Withdrawal by Subject|3|||
48605261|NCT00643760|156411618|FG001|Overall Study|Withdrawal by Subject|1|||
48605262|NCT00643760|156411619|FG002|Overall Study|Withdrawal by Subject|2|||
48605263|NCT00643760|156411620|FG003|Overall Study|Withdrawal by Subject|4|||
48605264|NCT00643760|156411621|FG004|Overall Study|Withdrawal by Subject|1|||
48605265|NCT02063672|156411624|FG000|Overall Study|Ongoing Follow-up|27|||
48605266|NCT02063672|156411625|FG001|Overall Study|Ongoing Follow-up|14|||
48605267|NCT02063672|156411624|FG000|Overall Study|Death|5|||
48605268|NCT02063672|156411625|FG001|Overall Study|Death|3|||
48605269|NCT02063672|156411624|FG000|Overall Study|Lost to Follow-up|1|||
48605270|NCT02063672|156411625|FG001|Overall Study|Lost to Follow-up|3|||
48605271|NCT02063672|156411624|FG000|Overall Study|Withdrawal by Subject|2|||
48605272|NCT02063672|156411625|FG001|Overall Study|Withdrawal by Subject|2|||
48605273|NCT01053741|156411626|FG000|2nd Study Intervention|Physician Decision|0|||
48605274|NCT01053741|156411627|FG001|2nd Study Intervention|Physician Decision|1|||
48605275|NCT01914393|156411629|FG000|Overall Study|Protocol Violation|11|||
48605276|NCT01914393|156411630|FG001|Overall Study|Protocol Violation|3|||
48605277|NCT01914393|156411631|FG002|Overall Study|Protocol Violation|19|||
48605278|NCT01914393|156411629|FG000|Overall Study|Lack of Efficacy|11|||
48605279|NCT01914393|156411630|FG001|Overall Study|Lack of Efficacy|16|||
48605280|NCT01914393|156411631|FG002|Overall Study|Lack of Efficacy|5|||
48605281|NCT01914393|156411629|FG000|Overall Study|no reason given|14|||
48605282|NCT01914393|156411630|FG001|Overall Study|no reason given|8|||
48605283|NCT01914393|156411631|FG002|Overall Study|no reason given|16|||
48605284|NCT01914393|156411629|FG000|Overall Study|Adverse Event|29|||
48605285|NCT01914393|156411630|FG001|Overall Study|Adverse Event|18|||
48605286|NCT01914393|156411631|FG002|Overall Study|Adverse Event|31|||
48605287|NCT01914393|156411629|FG000|Overall Study|Withdrawal by Subject|38|||
48605288|NCT01914393|156411630|FG001|Overall Study|Withdrawal by Subject|20|||
48605289|NCT01914393|156411631|FG002|Overall Study|Withdrawal by Subject|47|||
48605290|NCT01914393|156411629|FG000|Overall Study|Lost to Follow-up|12|||
48605291|NCT01914393|156411630|FG001|Overall Study|Lost to Follow-up|6|||
48605292|NCT01914393|156411631|FG002|Overall Study|Lost to Follow-up|19|||
48605293|NCT01914393|156411629|FG000|Overall Study|subject never dosed|0|||
48605294|NCT01914393|156411630|FG001|Overall Study|subject never dosed|0|||
48839189|NCT04624633|157254235|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
48839190|NCT04624633|157254236|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
48839191|NCT04624633|157254235|FG000|Overall Study|Death|1|||
48536280|NCT00925301|156150499|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
48536281|NCT03977701|156150500|FG000|Overall Study|COVID-19 pandemic|0|||
48536282|NCT03977701|156150501|FG001|Overall Study|COVID-19 pandemic|0|||
48536283|NCT03977701|156150502|FG002|Overall Study|COVID-19 pandemic|0|||
48536284|NCT03977701|156150503|FG003|Overall Study|COVID-19 pandemic|0|||
48536285|NCT03977701|156150504|FG004|Overall Study|COVID-19 pandemic|0|||
48536286|NCT03977701|156150505|FG005|Overall Study|COVID-19 pandemic|1|||
48536287|NCT03977701|156150506|FG006|Overall Study|COVID-19 pandemic|0|||
48536288|NCT03977701|156150507|FG007|Overall Study|COVID-19 pandemic|1|||
48536289|NCT03977701|156150508|FG008|Overall Study|COVID-19 pandemic|0|||
48536290|NCT03977701|156150509|FG009|Overall Study|COVID-19 pandemic|0|||
48536291|NCT00770692|156150510|FG000|Overall Study|Withdrawal by Subject|7|||
48536292|NCT00770692|156150511|FG001|Overall Study|Withdrawal by Subject|9|||
48536293|NCT00770692|156150512|FG002|Overall Study|Withdrawal by Subject|9|||
48536294|NCT00770692|156150513|FG003|Overall Study|Withdrawal by Subject|6|||
48536295|NCT00770692|156150510|FG000|Overall Study|Adverse Event|3|||
48536296|NCT00770692|156150511|FG001|Overall Study|Adverse Event|0|||
48536297|NCT00770692|156150512|FG002|Overall Study|Adverse Event|4|||
48536298|NCT00770692|156150513|FG003|Overall Study|Adverse Event|4|||
48536299|NCT00770692|156150510|FG000|Overall Study|Investigator judgment|2|||
48536300|NCT00770692|156150511|FG001|Overall Study|Investigator judgment|0|||
48536301|NCT00770692|156150512|FG002|Overall Study|Investigator judgment|1|||
48536302|NCT00770692|156150513|FG003|Overall Study|Investigator judgment|1|||
48536303|NCT03043560|156150514|FG000|Overall Study|Discontinued Intervention|1|||
48536304|NCT03043560|156150515|FG001|Overall Study|Discontinued Intervention|2|||
48536305|NCT03043560|156150514|FG000|Overall Study|Lost to Follow-up|0|||
48536306|NCT03043560|156150515|FG001|Overall Study|Lost to Follow-up|1|||
48536307|NCT00293202|156150516|FG000|Overall Study|Withdrawal by Subject|1|||
48536308|NCT00293202|156150517|FG001|Overall Study|Withdrawal by Subject|2|||
48536309|NCT00293202|156150516|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
48536310|NCT00293202|156150517|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
48536311|NCT00293202|156150516|FG000|Overall Study|on-hold due to fistula maturation time|1|||
48605295|NCT01914393|156411631|FG002|Overall Study|subject never dosed|1|||
48605296|NCT00619827|156411635|FG000|Overall Study|Adverse Event|1|||
48839192|NCT04624633|157254236|FG001|Overall Study|Death|0|||
48839193|NCT04091750|157254237|FG000|Overall Study|Adverse Event|4|||
48839194|NCT04091750|157254237|FG000|Overall Study|Withdrawal by Subject|1|||
48839195|NCT03698994|157254240|FG000|Overall Study|Adverse Event|2|||
48839196|NCT03698994|157254240|FG000|Overall Study|Death|1|||
48839197|NCT03698994|157254240|FG000|Overall Study|Physician Decision|1|||
48839198|NCT03698994|157254240|FG000|Overall Study|Withdrawal by Subject|3|||
48839199|NCT03698994|157254240|FG000|Overall Study|Progressive Disease|12|||
48839200|NCT02567435|157254241|FG000|Overall Study|Death|1|||
48839201|NCT02567435|157254242|FG001|Overall Study|Death|1|||
48839202|NCT02567435|157254243|FG002|Overall Study|Death|0|||
48839203|NCT02567435|157254244|FG003|Overall Study|Death|0|||
48839204|NCT02567435|157254241|FG000|Overall Study|Ineligible|1|||
48839205|NCT02567435|157254242|FG001|Overall Study|Ineligible|3|||
48839206|NCT02567435|157254243|FG002|Overall Study|Ineligible|0|||
48839207|NCT02567435|157254244|FG003|Overall Study|Ineligible|0|||
48839208|NCT02567435|157254241|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
48839209|NCT02567435|157254242|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
48839210|NCT02567435|157254243|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
48839211|NCT02567435|157254244|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
48839212|NCT02166463|157254245|FG000|Overall Study|Lost to Follow-up|0|||
48839213|NCT02166463|157254246|FG001|Overall Study|Lost to Follow-up|1|||
48839214|NCT02166463|157254245|FG000|Overall Study|Physician Decision|10|||
48839215|NCT02166463|157254246|FG001|Overall Study|Physician Decision|10|||
48839216|NCT02166463|157254245|FG000|Overall Study|Ineligible|11|||
48839217|NCT02166463|157254246|FG001|Overall Study|Ineligible|2|||
48839218|NCT02166463|157254245|FG000|Overall Study|Progressive Disease|9|||
48839219|NCT02166463|157254246|FG001|Overall Study|Progressive Disease|6|||
48536312|NCT00293202|156150517|FG001|Overall Study|on-hold due to fistula maturation time|0|||
48536313|NCT00831623|156150522|FG000|Overall Study|Withdrawal by Subject|9|||
48839220|NCT02166463|157254245|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
48839221|NCT02166463|157254246|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
48839222|NCT02166463|157254245|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
48839223|NCT02166463|157254246|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
48839224|NCT02166463|157254245|FG000|Overall Study|Refusal of further protocol therapy|5|||
48839225|NCT02166463|157254246|FG001|Overall Study|Refusal of further protocol therapy|6|||
48536314|NCT00831623|156150522|FG000|Overall Study|Lost to Follow-up|1|||
48536315|NCT00831623|156150522|FG000|Overall Study|Not 2 years post-treatment|12|||
48536316|NCT04932941|156150523|FG000|Overall Study|Lost to Follow-up|3|||
48536317|NCT04932941|156150524|FG001|Overall Study|Lost to Follow-up|1|||
48536318|NCT04932941|156150523|FG000|Overall Study|Withdrawal by Subject|7|||
48536319|NCT04932941|156150524|FG001|Overall Study|Withdrawal by Subject|4|||
48536320|NCT04932941|156150523|FG000|Overall Study|Other|4|||
48536321|NCT04932941|156150524|FG001|Overall Study|Other|2|||
48536322|NCT01408563|156152837|FG000|Overall Study|Ineligible after consent/ registration|2|||
48536323|NCT01197417|156152838|FG000|Overall Study|Physician Decision|3|||
48536324|NCT01197417|156152839|FG001|Overall Study|Physician Decision|2|||
48536325|NCT01197417|156152838|FG000|Overall Study|Withdrawal by Subject|2|||
48536326|NCT01197417|156152839|FG001|Overall Study|Withdrawal by Subject|4|||
48536327|NCT01197417|156152838|FG000|Overall Study|Site miscommunication|0|||
48536328|NCT01197417|156152839|FG001|Overall Study|Site miscommunication|1|||
48536329|NCT01197417|156152838|FG000|Overall Study|Subject transferred to intensive care|0|||
48536330|NCT01197417|156152839|FG001|Overall Study|Subject transferred to intensive care|1|||
48536331|NCT01197417|156152838|FG000|Overall Study|Not consented in time to receive drug|0|||
48536332|NCT01197417|156152839|FG001|Overall Study|Not consented in time to receive drug|1|||
48536333|NCT01197417|156152838|FG000|Overall Study|Hypotension|1|||
48536334|NCT01197417|156152839|FG001|Overall Study|Hypotension|2|||
48536335|NCT01197417|156152838|FG000|Overall Study|Found to be ineligible|2|||
48536336|NCT01197417|156152839|FG001|Overall Study|Found to be ineligible|5|||
48536337|NCT01197417|156152838|FG000|Overall Study|No 25-hour magnesium level|0|||
48536338|NCT01197417|156152839|FG001|Overall Study|No 25-hour magnesium level|2|||
48536339|NCT01432574|156152840|FG000|Overall Study|Moved|2|||
48536340|NCT01432574|156152840|FG000|Overall Study|Not interested|1|||
48536341|NCT02516410|156152841|FG000|Overall Study|Adverse Event|0|||
48536342|NCT02516410|156152842|FG001|Overall Study|Adverse Event|1|||
48536343|NCT02516410|156152841|FG000|Overall Study|Withdrawal by Subject|0|||
48839226|NCT02101775|157254247|FG000|Overall Study|Adverse Event|4|||
48839227|NCT02101775|157254248|FG001|Overall Study|Adverse Event|0|||
48839228|NCT02101775|157254249|FG002|Overall Study|Adverse Event|0|||
48839229|NCT02101775|157254247|FG000|Overall Study|Admission to Hospital|0|||
48839230|NCT02101775|157254248|FG001|Overall Study|Admission to Hospital|1|||
48839231|NCT02101775|157254249|FG002|Overall Study|Admission to Hospital|0|||
48839232|NCT02242942|157254250|FG000|Overall Study|Death|17|||
48839233|NCT02242942|157254251|FG001|Overall Study|Death|20|||
48839234|NCT02242942|157254252|FG002|Overall Study|Death|2|||
48839235|NCT02242942|157254250|FG000|Overall Study|Physician Decision|1|||
48605297|NCT00619827|156411636|FG001|Overall Study|Adverse Event|2|||
48605298|NCT00619827|156411635|FG000|Overall Study|Withdrawal by Subject|2|||
48605299|NCT00619827|156411636|FG001|Overall Study|Withdrawal by Subject|2|||
48605300|NCT01165307|156411638|FG000|Overall Study|Lost to Follow-up|11|||
48536344|NCT02516410|156152842|FG001|Overall Study|Withdrawal by Subject|1|||
48536345|NCT00918463|156152843|FG000|Overall Study|Death|1|||
48536346|NCT00918463|156152843|FG000|Overall Study|Lack of Efficacy|1|||
48605301|NCT01165307|156411639|FG001|Overall Study|Lost to Follow-up|3|||
48605302|NCT01165307|156411638|FG000|Overall Study|Withdrawal by Subject|2|||
48605303|NCT01165307|156411639|FG001|Overall Study|Withdrawal by Subject|0|||
48605304|NCT01165307|156411638|FG000|Overall Study|Subject not available for contact|1|||
48605305|NCT01165307|156411639|FG001|Overall Study|Subject not available for contact|0|||
48605306|NCT00104052|156411640|FG000|Overall Study|Adverse Event|1|||
48605307|NCT00104052|156411640|FG000|Overall Study|Lack of Efficacy|26|||
48605308|NCT00104052|156411640|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
48605309|NCT04644029|156411641|FG000|Overall Study|Death|1|||
48605310|NCT04644029|156411642|FG001|Overall Study|Death|0|||
48605311|NCT04644029|156411641|FG000|Overall Study|Physician Decision|1|||
48605312|NCT04644029|156411642|FG001|Overall Study|Physician Decision|2|||
48605313|NCT04644029|156411641|FG000|Overall Study|Withdrawal by Subject|21|||
48605314|NCT04644029|156411642|FG001|Overall Study|Withdrawal by Subject|19|||
48605315|NCT04644029|156411641|FG000|Overall Study|Lost to Follow-up|31|||
48605316|NCT04644029|156411642|FG001|Overall Study|Lost to Follow-up|34|||
48605317|NCT04644029|156411641|FG000|Overall Study|Study Terminated by Sponsor|305|||
48605318|NCT04644029|156411642|FG001|Overall Study|Study Terminated by Sponsor|301|||
48605319|NCT04644029|156411641|FG000|Overall Study|Status Not Recorded|3|||
48605320|NCT04644029|156411642|FG001|Overall Study|Status Not Recorded|8|||
48605321|NCT04644029|156411641|FG000|Overall Study|Randomized in Error|2|||
48605322|NCT04644029|156411642|FG001|Overall Study|Randomized in Error|1|||
48605323|NCT04644029|156411641|FG000|Overall Study|Other|0|||
48605324|NCT04644029|156411642|FG001|Overall Study|Other|1|||
48605325|NCT03652818|156411644|FG000|Overall Study|Adverse Event|1|||
48605326|NCT03652818|156411645|FG001|Overall Study|Adverse Event|0|||
48605327|NCT03652818|156411646|FG002|Overall Study|Adverse Event|0|||
48605328|NCT03652818|156411647|FG003|Overall Study|Adverse Event|0|||
48605329|NCT03652818|156411648|FG004|Overall Study|Adverse Event|0|||
48605330|NCT03652818|156411644|FG000|Overall Study|Physician Decision|1|||
48605331|NCT03652818|156411645|FG001|Overall Study|Physician Decision|0|||
48605332|NCT03652818|156411646|FG002|Overall Study|Physician Decision|0|||
48605333|NCT03652818|156411647|FG003|Overall Study|Physician Decision|0|||
48605334|NCT03652818|156411648|FG004|Overall Study|Physician Decision|0|||
48605335|NCT03652818|156411644|FG000|Overall Study|Lost to Follow-up|0|||
48605336|NCT03652818|156411645|FG001|Overall Study|Lost to Follow-up|1|||
48605337|NCT03652818|156411646|FG002|Overall Study|Lost to Follow-up|2|||
48605338|NCT03652818|156411647|FG003|Overall Study|Lost to Follow-up|1|||
48536347|NCT01014624|156152847|FG000|Overall Study|Adverse Event|0|||
48536348|NCT01014624|156152848|FG001|Overall Study|Adverse Event|1|||
48536349|NCT01014624|156152847|FG000|Overall Study|Protocol Violation|1|||
48536350|NCT01014624|156152848|FG001|Overall Study|Protocol Violation|0|||
48536351|NCT01014624|156152847|FG000|Overall Study|Withdrawal by Subject|1|||
48605339|NCT03652818|156411648|FG004|Overall Study|Lost to Follow-up|1|||
48605340|NCT01855958|156411649|FG000|Overall Study|Withdrawal by Subject|1|||
48605341|NCT01855958|156411650|FG001|Overall Study|Withdrawal by Subject|0|||
48605342|NCT00239720|156411658|FG000|Overall Study|Adverse Event|1|||
48605343|NCT00239720|156411659|FG001|Overall Study|Adverse Event|0|||
48605344|NCT00239720|156411658|FG000|Overall Study|Lost to Follow-up|0|||
48839236|NCT02242942|157254251|FG001|Overall Study|Physician Decision|0|||
48536352|NCT01014624|156152848|FG001|Overall Study|Withdrawal by Subject|0|||
48536353|NCT02954159|156152849|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
48536354|NCT02954159|156152850|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
48536355|NCT02954159|156152849|FG000|Overall Study|Withdrawal by Subject|0|||
48536356|NCT02954159|156152850|FG001|Overall Study|Withdrawal by Subject|1|||
48536357|NCT00706992|156152856|FG000|Overall Study|Study termination|5|||
48536358|NCT00706992|156152857|FG001|Overall Study|Study termination|5|||
48536359|NCT00706992|156152858|FG002|Overall Study|Study termination|6|||
48605345|NCT00239720|156411659|FG001|Overall Study|Lost to Follow-up|1|||
48605346|NCT02791269|156411660|FG000|Overall Study|Lost to Follow-up|0|||
48605347|NCT02791269|156411661|FG001|Overall Study|Lost to Follow-up|1|||
48605348|NCT00368251|156411662|FG000|Overall Study|SAE, non-fatal|1|||
48605349|NCT00368251|156411663|FG001|Overall Study|SAE, non-fatal|0|||
48605350|NCT00368251|156411664|FG002|Overall Study|SAE, non-fatal|0|||
48605351|NCT00368251|156411662|FG000|Overall Study|AE, non-serious non-fatal|0|||
48605352|NCT00368251|156411663|FG001|Overall Study|AE, non-serious non-fatal|0|||
48605353|NCT00368251|156411664|FG002|Overall Study|AE, non-serious non-fatal|1|||
48605354|NCT01218308|156411668|FG000|Overall Study|Adverse Event|1|||
48605355|NCT01218308|156411669|FG001|Overall Study|Adverse Event|2|||
48605356|NCT01218308|156411668|FG000|Overall Study|Protocol Violation|0|||
48605357|NCT01218308|156411669|FG001|Overall Study|Protocol Violation|2|||
48839237|NCT02242942|157254252|FG002|Overall Study|Physician Decision|0|||
48605358|NCT01218308|156411668|FG000|Overall Study|Withdrawal by Subject|61|||
48605359|NCT01218308|156411669|FG001|Overall Study|Withdrawal by Subject|64|||
48605360|NCT01218308|156411668|FG000|Overall Study|Lost to Follow-up|27|||
48605361|NCT01218308|156411669|FG001|Overall Study|Lost to Follow-up|31|||
48605362|NCT01218308|156411668|FG000|Overall Study|Other|14|||
48536360|NCT00706992|156152859|FG003|Overall Study|Study termination|2|||
48605363|NCT01218308|156411669|FG001|Overall Study|Other|21|||
48605364|NCT00974311|156411672|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
48536361|NCT00706992|156152860|FG004|Overall Study|Study termination|3|||
48536362|NCT00706992|156152861|FG005|Overall Study|Study termination|2|||
48839238|NCT02242942|157254250|FG000|Overall Study|Withdrawal by Subject|8|||
48839239|NCT02242942|157254251|FG001|Overall Study|Withdrawal by Subject|10|||
48605365|NCT00974311|156411673|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
48605366|NCT00974311|156411672|FG000|DB Phase (up to 24 Months)|Death|561|||
48605367|NCT00974311|156411673|FG001|DB Phase (up to 24 Months)|Death|298|||
48605368|NCT00974311|156411672|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
48605369|NCT00974311|156411673|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
48605370|NCT00974311|156411672|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
48605371|NCT00974311|156411673|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
48605372|NCT00974311|156411672|FG000|DB Phase (up to 24 Months)|Other|1|||
48605373|NCT00974311|156411673|FG001|DB Phase (up to 24 Months)|Other|0|||
48605374|NCT00974311|156411672|FG000|OLE Phase (up to 77 Months)|Death|14|||
48605375|NCT00974311|156411673|FG001|OLE Phase (up to 77 Months)|Death|21|||
48605376|NCT00974311|156411672|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
48605377|NCT00974311|156411673|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
48605378|NCT00974311|156411672|FG000|OLE Phase (up to 77 Months)|Other|15|||
48605379|NCT00974311|156411673|FG001|OLE Phase (up to 77 Months)|Other|2|||
48605380|NCT00974311|156411672|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
48605381|NCT00974311|156411673|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
48605382|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Death|20|||
48605383|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Death|26|||
48605384|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
48605385|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
48605386|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
48605387|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
48605388|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
48605389|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
48605390|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
48839240|NCT02242942|157254252|FG002|Overall Study|Withdrawal by Subject|0|||
48839241|NCT02242942|157254250|FG000|Overall Study|On-going in Study|190|||
48839242|NCT02242942|157254251|FG001|Overall Study|On-going in Study|186|||
48839243|NCT02242942|157254252|FG002|Overall Study|On-going in Study|11|||
48605391|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
48605392|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
48605393|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
48839244|NCT03668236|157254253|FG000|90-day Follow-up|Withdrawal by Subject|3|||
48536363|NCT00706992|156152862|FG006|Overall Study|Study termination|3|||
48536364|NCT00706992|156152856|FG000|Overall Study|Disease progression before treatment|0|||
48536365|NCT00706992|156152857|FG001|Overall Study|Disease progression before treatment|0|||
48536366|NCT00706992|156152858|FG002|Overall Study|Disease progression before treatment|0|||
48536367|NCT00706992|156152859|FG003|Overall Study|Disease progression before treatment|0|||
48536368|NCT00706992|156152860|FG004|Overall Study|Disease progression before treatment|1|||
48536369|NCT00706992|156152861|FG005|Overall Study|Disease progression before treatment|0|||
48536370|NCT00706992|156152862|FG006|Overall Study|Disease progression before treatment|0|||
48536371|NCT02777918|156152863|FG000|Overall Study|Medical reasons|1|||
48536372|NCT02777918|156152864|FG001|Overall Study|Medical reasons|2|||
48536373|NCT02777918|156152863|FG000|Overall Study|Too busy / stressed|1|||
48536374|NCT02777918|156152864|FG001|Overall Study|Too busy / stressed|1|||
48536375|NCT02777918|156152863|FG000|Overall Study|Withdrawal by Subject|1|||
48536376|NCT02777918|156152864|FG001|Overall Study|Withdrawal by Subject|1|||
48605394|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
48605395|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
48605396|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
48605397|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
48605398|NCT00643201|156411674|FG000|Randomized, Completed 6 Months of Study|Other|107|||
48605399|NCT00643201|156411675|FG001|Randomized, Completed 6 Months of Study|Other|107|||
48605400|NCT00643201|156411674|FG000|Completed Study Follow Up|Death|28|||
48839245|NCT03668236|157254254|FG001|90-day Follow-up|Withdrawal by Subject|2|||
48839246|NCT03668236|157254253|FG000|90-day Follow-up|Lost to Follow-up|3|||
48839247|NCT03668236|157254254|FG001|90-day Follow-up|Lost to Follow-up|1|||
48839248|NCT03668236|157254253|FG000|Baseline Characteristics|Lost to Follow-up|9|||
48839249|NCT03668236|157254254|FG001|Baseline Characteristics|Lost to Follow-up|5|||
48605401|NCT00643201|156411675|FG001|Completed Study Follow Up|Death|34|||
48605402|NCT00643201|156411674|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
48605403|NCT00643201|156411675|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
48605404|NCT00643201|156411674|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
48605405|NCT00643201|156411675|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
48605406|NCT00643201|156411674|FG000|Completed Study Follow Up|non-specified|1|||
48605407|NCT00643201|156411675|FG001|Completed Study Follow Up|non-specified|0|||
48605408|NCT00483652|156411676|FG000|Double-blind Treatment Period|Protocol Violation|2|||
48605409|NCT00483652|156411677|FG001|Double-blind Treatment Period|Protocol Violation|1|||
48605410|NCT00483652|156411676|FG000|Double-blind Treatment Period|Adverse Event|3|||
48605411|NCT00483652|156411677|FG001|Double-blind Treatment Period|Adverse Event|4|||
48605412|NCT00483652|156411676|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
48605413|NCT00483652|156411677|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
48605414|NCT00483652|156411676|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
48605415|NCT00483652|156411677|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
48605416|NCT01245101|156411678|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
48605417|NCT01245101|156411679|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
48605418|NCT01245101|156411678|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
48605419|NCT01245101|156411679|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
48605420|NCT01245101|156411678|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
48605421|NCT01245101|156411679|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
48605422|NCT02858401|156411682|FG000|Overall Study|Withdrew Consent|0|||
48605423|NCT02858401|156411683|FG001|Overall Study|Withdrew Consent|0|||
48605424|NCT02858401|156411684|FG002|Overall Study|Withdrew Consent|0|||
48605425|NCT02858401|156411685|FG003|Overall Study|Withdrew Consent|0|||
48605426|NCT02858401|156411686|FG004|Overall Study|Withdrew Consent|0|||
48605427|NCT02858401|156411687|FG005|Overall Study|Withdrew Consent|1|||
48605428|NCT02858401|156411688|FG006|Overall Study|Withdrew Consent|0|||
48605429|NCT02858401|156411682|FG000|Overall Study|Lost to Follow-up|0|||
48605430|NCT02858401|156411683|FG001|Overall Study|Lost to Follow-up|1|||
48605431|NCT02858401|156411684|FG002|Overall Study|Lost to Follow-up|0|||
48605432|NCT02858401|156411685|FG003|Overall Study|Lost to Follow-up|0|||
48605433|NCT02858401|156411686|FG004|Overall Study|Lost to Follow-up|0|||
48605434|NCT02858401|156411687|FG005|Overall Study|Lost to Follow-up|0|||
48605435|NCT02858401|156411688|FG006|Overall Study|Lost to Follow-up|0|||
48605436|NCT01723072|156411689|FG000|Overall Study|Withdrawal by Subject|7|||
48605437|NCT01723072|156411690|FG001|Overall Study|Withdrawal by Subject|13|||
48605438|NCT01723072|156411689|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
48605439|NCT01723072|156411690|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
48605440|NCT01723072|156411689|FG000|Overall Study|Other|4|||
48839250|NCT03668236|157254253|FG000|1-year Follow-up|Withdrawal by Subject|17|||
48605441|NCT01723072|156411690|FG001|Overall Study|Other|3|||
48605442|NCT04556760|156411696|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
48605443|NCT04556760|156411697|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
48605444|NCT04556760|156411698|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
48605445|NCT04556760|156411699|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
48605446|NCT04556760|156411700|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
48605447|NCT04556760|156411701|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
48605448|NCT04556760|156411696|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
48605449|NCT04556760|156411697|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
48605450|NCT04556760|156411698|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
48605451|NCT04556760|156411699|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
48605452|NCT04556760|156411700|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
48605453|NCT04556760|156411701|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
48605454|NCT05081388|156411702|FG000|Overall Study|Adverse Event|1|||
48605455|NCT05081388|156411703|FG001|Overall Study|Adverse Event|0|||
48605456|NCT05081388|156411704|FG002|Overall Study|Adverse Event|0|||
48605457|NCT05081388|156411705|FG003|Overall Study|Adverse Event|0|||
48605458|NCT05081388|156411706|FG004|Overall Study|Adverse Event|0|||
48605459|NCT05081388|156411702|FG000|Overall Study|Lost to Follow-up|0|||
48839251|NCT03668236|157254254|FG001|1-year Follow-up|Withdrawal by Subject|15|||
48839252|NCT04788511|157254255|FG000|Overall Study|Withdrawal by Subject|2|||
48605460|NCT05081388|156411703|FG001|Overall Study|Lost to Follow-up|1|||
48839253|NCT04788511|157254256|FG001|Overall Study|Withdrawal by Subject|1|||
48605461|NCT05081388|156411704|FG002|Overall Study|Lost to Follow-up|0|||
48605462|NCT05081388|156411705|FG003|Overall Study|Lost to Follow-up|0|||
48605463|NCT05081388|156411706|FG004|Overall Study|Lost to Follow-up|0|||
48605464|NCT05081388|156411702|FG000|Overall Study|Subject decision|0|||
48839254|NCT04788511|157254255|FG000|Overall Study|Lost to Follow-up|2|||
48839255|NCT04788511|157254256|FG001|Overall Study|Lost to Follow-up|7|||
48839256|NCT04788511|157254255|FG000|Overall Study|Death|3|||
48839257|NCT04788511|157254256|FG001|Overall Study|Death|4|||
48536377|NCT00952276|156152867|FG000|Overall Study|Withdrawal by Subject|1|||
48536378|NCT00952276|156152868|FG001|Overall Study|Withdrawal by Subject|0|||
48536379|NCT00952276|156152869|FG002|Overall Study|Withdrawal by Subject|0|||
48536380|NCT00952276|156152870|FG003|Overall Study|Withdrawal by Subject|1|||
48536381|NCT00952276|156152871|FG004|Overall Study|Withdrawal by Subject|0|||
48536382|NCT03078582|156152872|FG000|Overall Study|Adverse Event|0|||
48536383|NCT03078582|156152873|FG001|Overall Study|Adverse Event|8|||
48536384|NCT01230892|156152874|FG000|Overall Study|Withdrawal by Subject|1|||
48536385|NCT01230892|156152875|FG001|Overall Study|Withdrawal by Subject|1|||
48536386|NCT01230892|156152874|FG000|Overall Study|Lost to Follow-up|2|||
48536387|NCT01230892|156152875|FG001|Overall Study|Lost to Follow-up|0|||
48536388|NCT00251641|156152876|FG000|Overall Study|Adverse Event|80|||
48536389|NCT00251641|156152877|FG001|Overall Study|Adverse Event|8|||
48536390|NCT00251641|156152876|FG000|Overall Study|Lack of Efficacy|2|||
48536391|NCT00251641|156152877|FG001|Overall Study|Lack of Efficacy|1|||
48536392|NCT00251641|156152876|FG000|Overall Study|Progression of Disease|0|||
48536393|NCT00251641|156152877|FG001|Overall Study|Progression of Disease|2|||
48536394|NCT00251641|156152876|FG000|Overall Study|Lost to Follow-up|3|||
48536395|NCT00251641|156152877|FG001|Overall Study|Lost to Follow-up|3|||
48536396|NCT00251641|156152876|FG000|Overall Study|Withdrawal by Subject|6|||
48536397|NCT00251641|156152877|FG001|Overall Study|Withdrawal by Subject|8|||
48536398|NCT00251641|156152876|FG000|Overall Study|Protocol Violation|10|||
48536399|NCT00251641|156152877|FG001|Overall Study|Protocol Violation|2|||
48536400|NCT00251641|156152876|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
48536401|NCT00251641|156152877|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
48536402|NCT00251641|156152876|FG000|Overall Study|Switched Treatment|9|||
48536403|NCT00251641|156152877|FG001|Overall Study|Switched Treatment|63|||
48536404|NCT02691741|156152878|FG000|Overall Study|Adverse Event|0|||
48536405|NCT02691741|156152879|FG001|Overall Study|Adverse Event|2|||
48536406|NCT02691741|156152878|FG000|Overall Study|Lost to Follow-up|1|||
48536407|NCT02691741|156152879|FG001|Overall Study|Lost to Follow-up|0|||
48536408|NCT02691741|156152878|FG000|Overall Study|Physician Decision|0|||
48536409|NCT02691741|156152879|FG001|Overall Study|Physician Decision|1|||
48536410|NCT02691741|156152878|FG000|Overall Study|Withdrawal by Subject|0|||
48536411|NCT02691741|156152879|FG001|Overall Study|Withdrawal by Subject|4|||
48536412|NCT02139124|156152880|FG000|Overall Study|Adverse Event|2|||
48536413|NCT02139124|156152881|FG001|Overall Study|Adverse Event|0|||
48536414|NCT02139124|156152882|FG002|Overall Study|Adverse Event|1|||
48536415|NCT02139124|156152883|FG003|Overall Study|Adverse Event|2|||
48536416|NCT02139124|156152884|FG004|Overall Study|Adverse Event|5|||
48536417|NCT02139124|156152880|FG000|Overall Study|Withdrawal by Subject|2|||
48536418|NCT02139124|156152881|FG001|Overall Study|Withdrawal by Subject|2|||
48536419|NCT02139124|156152882|FG002|Overall Study|Withdrawal by Subject|2|||
48536420|NCT02139124|156152883|FG003|Overall Study|Withdrawal by Subject|2|||
48536421|NCT02139124|156152884|FG004|Overall Study|Withdrawal by Subject|3|||
48536422|NCT02139124|156152880|FG000|Overall Study|Protocol Violation|0|||
48536423|NCT02139124|156152881|FG001|Overall Study|Protocol Violation|0|||
48536424|NCT02139124|156152882|FG002|Overall Study|Protocol Violation|0|||
48536425|NCT02139124|156152883|FG003|Overall Study|Protocol Violation|1|||
48536426|NCT02139124|156152884|FG004|Overall Study|Protocol Violation|1|||
48536427|NCT02139124|156152880|FG000|Overall Study|non-compliant|1|||
48536428|NCT02139124|156152881|FG001|Overall Study|non-compliant|0|||
48536429|NCT02139124|156152882|FG002|Overall Study|non-compliant|0|||
48536430|NCT02139124|156152883|FG003|Overall Study|non-compliant|2|||
48536431|NCT02139124|156152884|FG004|Overall Study|non-compliant|0|||
48536432|NCT02139124|156152880|FG000|Overall Study|incarceration|0|||
48536433|NCT02139124|156152881|FG001|Overall Study|incarceration|0|||
48536434|NCT02139124|156152882|FG002|Overall Study|incarceration|1|||
48536435|NCT02139124|156152883|FG003|Overall Study|incarceration|0|||
48536436|NCT02139124|156152884|FG004|Overall Study|incarceration|0|||
48536437|NCT02139124|156152880|FG000|Overall Study|subject moved|1|||
48536438|NCT02139124|156152881|FG001|Overall Study|subject moved|0|||
48536439|NCT02139124|156152882|FG002|Overall Study|subject moved|0|||
48536440|NCT02139124|156152883|FG003|Overall Study|subject moved|0|||
48536441|NCT02139124|156152884|FG004|Overall Study|subject moved|0|||
48536442|NCT02139124|156152880|FG000|Overall Study|Lost to Follow-up|3|||
48536443|NCT02139124|156152881|FG001|Overall Study|Lost to Follow-up|2|||
48536444|NCT02139124|156152882|FG002|Overall Study|Lost to Follow-up|0|||
48536445|NCT02139124|156152883|FG003|Overall Study|Lost to Follow-up|5|||
48536446|NCT02139124|156152884|FG004|Overall Study|Lost to Follow-up|4|||
48536447|NCT02039414|156152887|FG000|Overall Study|Delivered|1|||
48536448|NCT02039414|156152888|FG001|Overall Study|Delivered|1|||
48536449|NCT02039414|156152887|FG000|Overall Study|Lost to Follow-up|2|||
48536450|NCT02039414|156152888|FG001|Overall Study|Lost to Follow-up|0|||
48536451|NCT02039414|156152887|FG000|Overall Study|Protocol Violation|3|||
48536452|NCT02039414|156152888|FG001|Overall Study|Protocol Violation|1|||
48536453|NCT02093221|156152889|FG000|Overall Study|Adverse Event|1|||
48536454|NCT02093221|156152890|FG001|Overall Study|Adverse Event|0|||
48536455|NCT02093221|156152891|FG002|Overall Study|Adverse Event|0|||
48536456|NCT02093221|156152892|FG003|Overall Study|Adverse Event|0|||
48605465|NCT05081388|156411703|FG001|Overall Study|Subject decision|0|||
48605466|NCT05081388|156411704|FG002|Overall Study|Subject decision|0|||
48605467|NCT05081388|156411705|FG003|Overall Study|Subject decision|1|||
48605468|NCT05081388|156411706|FG004|Overall Study|Subject decision|0|||
48605469|NCT00706004|156411710|FG000|Overall Study|Did not meet eligibility criteria|2|||
48605470|NCT01064479|156411713|FG000|Overall Study|Death|10|||
48605471|NCT01064479|156411714|FG001|Overall Study|Death|11|||
48605472|NCT01064479|156411713|FG000|Overall Study|Withdrawal by Subject|2|||
48605473|NCT01064479|156411714|FG001|Overall Study|Withdrawal by Subject|2|||
48605474|NCT01064479|156411713|FG000|Overall Study|Disease progression|1|||
48605475|NCT01064479|156411714|FG001|Overall Study|Disease progression|1|||
48605476|NCT01064479|156411713|FG000|Overall Study|Toxicity|1|||
48605477|NCT01064479|156411714|FG001|Overall Study|Toxicity|1|||
48605478|NCT01064479|156411713|FG000|Overall Study|Other|1|||
48605479|NCT01064479|156411714|FG001|Overall Study|Other|2|||
48605480|NCT01474486|156411718|FG000|Overall Study|Death|2|||
48605481|NCT01474486|156411718|FG000|Overall Study|Withdrawal by Subject|4|||
48605482|NCT01474486|156411718|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
48605483|NCT01255163|156411719|FG000|Overall Study|Withdrawal by Subject|1|||
48605484|NCT01255163|156411720|FG001|Overall Study|Withdrawal by Subject|0|||
48605485|NCT01255163|156411719|FG000|Overall Study|Lost to Follow-up|2|||
48605486|NCT01255163|156411720|FG001|Overall Study|Lost to Follow-up|0|||
48605487|NCT01255163|156411719|FG000|Overall Study|Adverse Event|0|||
48605488|NCT01255163|156411720|FG001|Overall Study|Adverse Event|2|||
48605489|NCT01255163|156411719|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
48605490|NCT01255163|156411720|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
48605491|NCT00490035|156411721|FG000|Overall Study|AE, non-serious non-fatal|3|||
48605492|NCT00490035|156411722|FG001|Overall Study|AE, non-serious non-fatal|4|||
48605493|NCT00490035|156411723|FG002|Overall Study|AE, non-serious non-fatal|4|||
48605494|NCT00490035|156411724|FG003|Overall Study|AE, non-serious non-fatal|5|||
48605495|NCT00490035|156411721|FG000|Overall Study|Lost to Follow-up|2|||
48605496|NCT00490035|156411722|FG001|Overall Study|Lost to Follow-up|0|||
48605497|NCT00490035|156411723|FG002|Overall Study|Lost to Follow-up|1|||
48605498|NCT00490035|156411724|FG003|Overall Study|Lost to Follow-up|0|||
48605499|NCT00490035|156411721|FG000|Overall Study|Withdrawal by Subject|2|||
48605500|NCT00490035|156411722|FG001|Overall Study|Withdrawal by Subject|1|||
48605501|NCT00490035|156411723|FG002|Overall Study|Withdrawal by Subject|1|||
48605502|NCT00490035|156411724|FG003|Overall Study|Withdrawal by Subject|0|||
48605503|NCT00490035|156411721|FG000|Overall Study|Other reason|0|||
48605504|NCT00490035|156411722|FG001|Overall Study|Other reason|1|||
48605505|NCT00490035|156411723|FG002|Overall Study|Other reason|3|||
48605506|NCT00490035|156411724|FG003|Overall Study|Other reason|1|||
48605507|NCT00490035|156411721|FG000|Overall Study|AE, serious fatal|1|||
48605508|NCT00490035|156411722|FG001|Overall Study|AE, serious fatal|0|||
48605509|NCT00490035|156411723|FG002|Overall Study|AE, serious fatal|0|||
48605510|NCT00490035|156411724|FG003|Overall Study|AE, serious fatal|0|||
48605511|NCT00490035|156411721|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
48605512|NCT00490035|156411722|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
48605513|NCT00490035|156411723|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
48839258|NCT04458922|157254260|FG000|Overall Study|Withdrawal by Subject|1|||
48839259|NCT04458922|157254261|FG001|Overall Study|Withdrawal by Subject|0|||
48839260|NCT04458922|157254262|FG002|Overall Study|Withdrawal by Subject|2|||
48839261|NCT04458922|157254260|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
48839262|NCT04458922|157254261|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
48839263|NCT04458922|157254262|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
48839264|NCT04458922|157254260|FG000|Overall Study|Adverse Event|1|||
48839265|NCT04458922|157254261|FG001|Overall Study|Adverse Event|0|||
48839266|NCT04458922|157254262|FG002|Overall Study|Adverse Event|0|||
48445963|NCT01576406|155820566|FG005|Overall Study|Lost to Follow-up|0|||
48605514|NCT00490035|156411724|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
48605515|NCT00490035|156411721|FG000|Overall Study|AE of unknown type|0|||
48605516|NCT00490035|156411722|FG001|Overall Study|AE of unknown type|0|||
48605517|NCT00490035|156411723|FG002|Overall Study|AE of unknown type|2|||
48605518|NCT00490035|156411724|FG003|Overall Study|AE of unknown type|0|||
48605519|NCT02295644|156411725|FG000|Overall Study|Did not meet inclusion criterion|0|||
48605520|NCT02295644|156411726|FG001|Overall Study|Did not meet inclusion criterion|0|||
48605521|NCT02295644|156411727|FG002|Overall Study|Did not meet inclusion criterion|1|||
48605522|NCT02295644|156411728|FG003|Overall Study|Did not meet inclusion criterion|2|||
48605523|NCT01103323|156411729|FG000|Without/Before Drug Switch|Adverse Event|50|||
48605524|NCT01103323|156411730|FG001|Without/Before Drug Switch|Adverse Event|7|||
48605525|NCT01103323|156411729|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
48839267|NCT04458922|157254260|FG000|Overall Study|Started new study|0|||
48839268|NCT04458922|157254261|FG001|Overall Study|Started new study|0|||
48839269|NCT04458922|157254262|FG002|Overall Study|Started new study|1|||
48839270|NCT04458922|157254260|FG000|Overall Study|Progressive disease|6|||
48839271|NCT04458922|157254261|FG001|Overall Study|Progressive disease|8|||
48839272|NCT04458922|157254262|FG002|Overall Study|Progressive disease|2|||
48839273|NCT04458922|157254260|FG000|Overall Study|Death|1|||
48839274|NCT04458922|157254261|FG001|Overall Study|Death|0|||
48839275|NCT04458922|157254262|FG002|Overall Study|Death|2|||
48839276|NCT04458922|157254260|FG000|Overall Study|Participant started chemotherapy|0|||
48839277|NCT04458922|157254261|FG001|Overall Study|Participant started chemotherapy|1|||
48839278|NCT04458922|157254262|FG002|Overall Study|Participant started chemotherapy|0|||
48839279|NCT02003222|157254263|FG000|Induction|Never started treatment|0|||
48839280|NCT02003222|157254264|FG001|Induction|Never started treatment|0|||
48839281|NCT02003222|157254265|FG002|Induction|Never started treatment|0|||
48839282|NCT02003222|157254266|FG003|Induction|Never started treatment|0|||
48839283|NCT02003222|157254267|FG004|Induction|Never started treatment|8|||
48839284|NCT02003222|157254263|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
48839285|NCT02003222|157254264|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
48839286|NCT02003222|157254265|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
48839287|NCT02003222|157254266|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
48839288|NCT02003222|157254267|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
48839289|NCT02003222|157254263|FG000|Induction|Adverse Event|0|||
48839290|NCT02003222|157254264|FG001|Induction|Adverse Event|0|||
48839291|NCT02003222|157254265|FG002|Induction|Adverse Event|0|||
48839292|NCT02003222|157254266|FG003|Induction|Adverse Event|0|||
48839293|NCT02003222|157254267|FG004|Induction|Adverse Event|13|||
48839294|NCT02003222|157254263|FG000|Induction|Alternative therapy|0|||
48839295|NCT02003222|157254264|FG001|Induction|Alternative therapy|0|||
48839296|NCT02003222|157254265|FG002|Induction|Alternative therapy|0|||
48839297|NCT02003222|157254266|FG003|Induction|Alternative therapy|0|||
48839298|NCT02003222|157254267|FG004|Induction|Alternative therapy|12|||
48839299|NCT02003222|157254263|FG000|Induction|Disease progression|0|||
48839300|NCT02003222|157254264|FG001|Induction|Disease progression|0|||
48839301|NCT02003222|157254265|FG002|Induction|Disease progression|0|||
48839302|NCT02003222|157254266|FG003|Induction|Disease progression|0|||
48536457|NCT02093221|156152893|FG004|Overall Study|Adverse Event|0|||
48536458|NCT02093221|156152889|FG000|Overall Study|Withdrawal by Subject|1|||
48536459|NCT02093221|156152890|FG001|Overall Study|Withdrawal by Subject|1|||
48536460|NCT02093221|156152891|FG002|Overall Study|Withdrawal by Subject|4|||
48536461|NCT02093221|156152892|FG003|Overall Study|Withdrawal by Subject|1|||
48536462|NCT02093221|156152893|FG004|Overall Study|Withdrawal by Subject|1|||
48536463|NCT02093221|156152889|FG000|Overall Study|Lost to Follow-up|2|||
48536464|NCT02093221|156152890|FG001|Overall Study|Lost to Follow-up|0|||
48536465|NCT02093221|156152891|FG002|Overall Study|Lost to Follow-up|1|||
48536466|NCT02093221|156152892|FG003|Overall Study|Lost to Follow-up|1|||
48536467|NCT02093221|156152893|FG004|Overall Study|Lost to Follow-up|0|||
48536468|NCT02093221|156152889|FG000|Overall Study|Death|0|||
48536469|NCT02093221|156152890|FG001|Overall Study|Death|1|||
48536470|NCT02093221|156152891|FG002|Overall Study|Death|0|||
48839303|NCT02003222|157254267|FG004|Induction|Disease progression|22|||
48839304|NCT02003222|157254263|FG000|Induction|Death|0|||
48839305|NCT02003222|157254264|FG001|Induction|Death|0|||
48839306|NCT02003222|157254265|FG002|Induction|Death|0|||
48839307|NCT02003222|157254266|FG003|Induction|Death|0|||
48839308|NCT02003222|157254267|FG004|Induction|Death|3|||
48839309|NCT02003222|157254263|FG000|Induction|Withdrawal by Subject|0|||
48839310|NCT02003222|157254264|FG001|Induction|Withdrawal by Subject|0|||
48839311|NCT02003222|157254265|FG002|Induction|Withdrawal by Subject|0|||
48839312|NCT02003222|157254266|FG003|Induction|Withdrawal by Subject|0|||
48839313|NCT02003222|157254267|FG004|Induction|Withdrawal by Subject|8|||
48839314|NCT02003222|157254263|FG000|Induction|Other reasons|0|||
48839315|NCT02003222|157254264|FG001|Induction|Other reasons|0|||
48839316|NCT02003222|157254265|FG002|Induction|Other reasons|0|||
48839317|NCT02003222|157254266|FG003|Induction|Other reasons|0|||
48536471|NCT02093221|156152892|FG003|Overall Study|Death|0|||
48536472|NCT02093221|156152893|FG004|Overall Study|Death|0|||
48536473|NCT02093221|156152889|FG000|Overall Study|Protocol Violation|0|||
48536474|NCT02093221|156152890|FG001|Overall Study|Protocol Violation|1|||
48536475|NCT02093221|156152891|FG002|Overall Study|Protocol Violation|0|||
48536476|NCT02093221|156152892|FG003|Overall Study|Protocol Violation|0|||
48536477|NCT02093221|156152893|FG004|Overall Study|Protocol Violation|0|||
48536478|NCT02093221|156152889|FG000|Overall Study|Study termination|6|||
48839318|NCT02003222|157254267|FG004|Induction|Other reasons|22|||
48839319|NCT02003222|157254263|FG000|Intensification|Never started treatment|0|||
48839320|NCT02003222|157254264|FG001|Intensification|Never started treatment|0|||
48839321|NCT02003222|157254265|FG002|Intensification|Never started treatment|0|||
48839322|NCT02003222|157254266|FG003|Intensification|Never started treatment|0|||
48839323|NCT02003222|157254267|FG004|Intensification|Never started treatment|2|||
48839324|NCT02003222|157254263|FG000|Intensification|Adverse Event|0|||
48839325|NCT02003222|157254264|FG001|Intensification|Adverse Event|0|||
48839326|NCT02003222|157254265|FG002|Intensification|Adverse Event|0|||
48536479|NCT02093221|156152890|FG001|Overall Study|Study termination|5|||
48536480|NCT02093221|156152891|FG002|Overall Study|Study termination|4|||
48536481|NCT02093221|156152892|FG003|Overall Study|Study termination|6|||
48536482|NCT02093221|156152893|FG004|Overall Study|Study termination|7|||
48536483|NCT03465436|156152894|FG000|Period 1|Protocol Violation|0|||
48536484|NCT03465436|156152895|FG001|Period 1|Protocol Violation|0|||
48536485|NCT03465436|156152896|FG002|Period 1|Protocol Violation|1|||
48536486|NCT03465436|156152897|FG003|Period 1|Protocol Violation|0|||
48839327|NCT02003222|157254266|FG003|Intensification|Adverse Event|0|||
48839328|NCT02003222|157254267|FG004|Intensification|Adverse Event|6|||
48839329|NCT02003222|157254263|FG000|Intensification|Alternative therapy|0|||
48839330|NCT02003222|157254264|FG001|Intensification|Alternative therapy|0|||
48839331|NCT02003222|157254265|FG002|Intensification|Alternative therapy|0|||
48839332|NCT02003222|157254266|FG003|Intensification|Alternative therapy|0|||
48839333|NCT02003222|157254267|FG004|Intensification|Alternative therapy|8|||
48839334|NCT02003222|157254263|FG000|Intensification|Disease progression|0|||
48839335|NCT02003222|157254264|FG001|Intensification|Disease progression|0|||
48839336|NCT02003222|157254265|FG002|Intensification|Disease progression|0|||
48839337|NCT02003222|157254266|FG003|Intensification|Disease progression|0|||
48839338|NCT02003222|157254267|FG004|Intensification|Disease progression|18|||
48839339|NCT02003222|157254263|FG000|Intensification|Withdrawal by Subject|0|||
48839340|NCT02003222|157254264|FG001|Intensification|Withdrawal by Subject|0|||
48839341|NCT02003222|157254265|FG002|Intensification|Withdrawal by Subject|0|||
48839342|NCT02003222|157254266|FG003|Intensification|Withdrawal by Subject|0|||
48839343|NCT02003222|157254267|FG004|Intensification|Withdrawal by Subject|5|||
48536487|NCT03465436|156152894|FG000|Period 2|Protocol Violation|0|||
48536488|NCT03465436|156152895|FG001|Period 2|Protocol Violation|1|||
48536489|NCT03465436|156152896|FG002|Period 2|Protocol Violation|0|||
48536490|NCT03465436|156152897|FG003|Period 2|Protocol Violation|0|||
48536491|NCT03465436|156152894|FG000|Period 3|Protocol Violation|1|||
48536492|NCT03465436|156152895|FG001|Period 3|Protocol Violation|1|||
48536493|NCT03465436|156152896|FG002|Period 3|Protocol Violation|0|||
48536494|NCT03465436|156152897|FG003|Period 3|Protocol Violation|0|||
48839344|NCT02003222|157254263|FG000|Intensification|Other reasons|0|||
48839345|NCT02003222|157254264|FG001|Intensification|Other reasons|0|||
48839346|NCT02003222|157254265|FG002|Intensification|Other reasons|0|||
48839347|NCT02003222|157254266|FG003|Intensification|Other reasons|0|||
48839348|NCT02003222|157254267|FG004|Intensification|Other reasons|8|||
48839349|NCT06019559|157254268|FG000|Overall Study|Withdrawal by Subject|7|||
48839350|NCT06019559|157254269|FG001|Overall Study|Withdrawal by Subject|6|||
48839351|NCT06019559|157254270|FG002|Overall Study|Withdrawal by Subject|5|||
48839352|NCT06019559|157254268|FG000|Overall Study|Lost to Follow-up|2|||
48839353|NCT06019559|157254269|FG001|Overall Study|Lost to Follow-up|0|||
48839354|NCT06019559|157254270|FG002|Overall Study|Lost to Follow-up|3|||
48536495|NCT03465436|156152894|FG000|Period 4|Protocol Violation|0|||
48536496|NCT03465436|156152895|FG001|Period 4|Protocol Violation|0|||
48536497|NCT03465436|156152896|FG002|Period 4|Protocol Violation|1|||
48605526|NCT01103323|156411730|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
48605527|NCT01103323|156411729|FG000|Without/Before Drug Switch|Protocol Violation|2|||
48536498|NCT03465436|156152897|FG003|Period 4|Protocol Violation|0|||
48536499|NCT02340221|156152900|FG000|Overall Study|Death|100|||
48536500|NCT02340221|156152901|FG001|Overall Study|Death|197|||
48536501|NCT02340221|156152900|FG000|Overall Study|Withdrawal by Participant|24|||
48536502|NCT02340221|156152901|FG001|Overall Study|Withdrawal by Participant|37|||
48536503|NCT02340221|156152900|FG000|Overall Study|Lost to Follow-up|4|||
48536504|NCT02340221|156152901|FG001|Overall Study|Lost to Follow-up|15|||
48536505|NCT02340221|156152900|FG000|Overall Study|Reason Not Specified|85|||
48536506|NCT02340221|156152901|FG001|Overall Study|Reason Not Specified|165|||
48536507|NCT02340221|156152900|FG000|Overall Study|Study Terminated by Sponsor|1|||
48536508|NCT02340221|156152901|FG001|Overall Study|Study Terminated by Sponsor|3|||
48536509|NCT02972502|156152902|FG000|Overall Study|Lost to Follow-up|3|||
48536510|NCT02972502|156152903|FG001|Overall Study|Lost to Follow-up|1|||
48536511|NCT02972502|156152902|FG000|Overall Study|Withdrawal by Subject|1|||
48536512|NCT02972502|156152903|FG001|Overall Study|Withdrawal by Subject|1|||
48536513|NCT03832738|156152904|FG000|Overall Study|Withdrawal by Subject|6|||
48536514|NCT03832738|156152905|FG001|Overall Study|Withdrawal by Subject|7|||
48605528|NCT01103323|156411730|FG001|Without/Before Drug Switch|Protocol Violation|0|||
48605529|NCT01103323|156411729|FG000|Without/Before Drug Switch|Physician Decision|2|||
48605530|NCT01103323|156411730|FG001|Without/Before Drug Switch|Physician Decision|0|||
48605531|NCT01103323|156411729|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
48605532|NCT01103323|156411730|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
48605533|NCT01103323|156411729|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
48605534|NCT01103323|156411730|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
48536515|NCT03832738|156152906|FG002|Overall Study|Withdrawal by Subject|16|||
48536516|NCT03832738|156152904|FG000|Overall Study|Physician Decision|0|||
48536517|NCT03832738|156152905|FG001|Overall Study|Physician Decision|1|||
48536518|NCT03832738|156152906|FG002|Overall Study|Physician Decision|2|||
48536519|NCT03832738|156152904|FG000|Overall Study|Adverse Event|2|||
48536520|NCT03832738|156152905|FG001|Overall Study|Adverse Event|3|||
48536521|NCT03832738|156152906|FG002|Overall Study|Adverse Event|1|||
48536522|NCT03832738|156152904|FG000|Overall Study|Pregnancy|0|||
48536523|NCT03832738|156152905|FG001|Overall Study|Pregnancy|1|||
48536524|NCT03832738|156152906|FG002|Overall Study|Pregnancy|0|||
48536525|NCT03852459|156152909|FG000|Overall Study|Adverse Event|2|||
48536526|NCT03852459|156152910|FG001|Overall Study|Adverse Event|2|||
48536527|NCT03852459|156152909|FG000|Overall Study|Withdrawal by Subject|1|||
48536528|NCT03852459|156152910|FG001|Overall Study|Withdrawal by Subject|1|||
48536529|NCT01079832|156152911|FG000|Overall Study|Withdrawal by Subject|1|||
48536530|NCT00049842|156152912|FG000|Treatment Phase|Adverse Event|47|||
48536531|NCT00049842|156152913|FG001|Treatment Phase|Adverse Event|12|||
48536532|NCT00049842|156152912|FG000|Treatment Phase|Withdrawal by Subject|35|||
48536533|NCT00049842|156152913|FG001|Treatment Phase|Withdrawal by Subject|46|||
48536534|NCT00049842|156152912|FG000|Treatment Phase|Non-compliance with protocol|7|||
48536535|NCT00049842|156152913|FG001|Treatment Phase|Non-compliance with protocol|8|||
48536536|NCT00049842|156152912|FG000|Treatment Phase|Lost to Follow-up|4|||
48536537|NCT00049842|156152913|FG001|Treatment Phase|Lost to Follow-up|8|||
48536538|NCT00049842|156152912|FG000|Treatment Phase|Administrative|0|||
48536539|NCT00049842|156152913|FG001|Treatment Phase|Administrative|3|||
48536540|NCT00049842|156152912|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
48536541|NCT00049842|156152913|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
48536542|NCT00049842|156152912|FG000|Follow-up Phase|Adverse Event|6|||
48536543|NCT00049842|156152913|FG001|Follow-up Phase|Adverse Event|1|||
48605535|NCT01103323|156411729|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
48839355|NCT03975647|157254271|FG000|Overall Study|Death|71|||
48839356|NCT03975647|157254272|FG001|Overall Study|Death|63|||
48839357|NCT03975647|157254271|FG000|Overall Study|Lost to Follow-up|2|||
48839358|NCT03975647|157254272|FG001|Overall Study|Lost to Follow-up|2|||
48839359|NCT03975647|157254271|FG000|Overall Study|Subject withdrawal of consent|7|||
48536544|NCT00049842|156152912|FG000|Follow-up Phase|Other|1|||
48536545|NCT00049842|156152913|FG001|Follow-up Phase|Other|4|||
48536546|NCT02442271|156152914|FG000|Overall Study|Adverse Event|1|||
48536547|NCT02442271|156152914|FG000|Overall Study|Withdrew Consent|1|||
48536548|NCT02442271|156152914|FG000|Overall Study|Lost to Follow-up|1|||
48536549|NCT02442271|156152914|FG000|Overall Study|Other|1|||
48536550|NCT01813071|156152915|FG000|Overall Study|Protocol Violation|0|||
48536551|NCT01813071|156152916|FG001|Overall Study|Protocol Violation|0|||
48536552|NCT01813071|156152917|FG002|Overall Study|Protocol Violation|0|||
48536553|NCT01813071|156152918|FG003|Overall Study|Protocol Violation|0|||
48536554|NCT01813071|156152919|FG004|Overall Study|Protocol Violation|1|||
48536555|NCT01813071|156152920|FG005|Overall Study|Protocol Violation|4|||
48536556|NCT01813071|156152921|FG006|Overall Study|Protocol Violation|2|||
48536557|NCT01813071|156152922|FG007|Overall Study|Protocol Violation|4|||
48536558|NCT01813071|156152923|FG008|Overall Study|Protocol Violation|2|||
48536559|NCT01813071|156152915|FG000|Overall Study|Withdrawal by Subject|0|||
48536560|NCT01813071|156152916|FG001|Overall Study|Withdrawal by Subject|0|||
48536561|NCT01813071|156152917|FG002|Overall Study|Withdrawal by Subject|0|||
48536562|NCT01813071|156152918|FG003|Overall Study|Withdrawal by Subject|0|||
48536563|NCT01813071|156152919|FG004|Overall Study|Withdrawal by Subject|0|||
48536564|NCT01813071|156152920|FG005|Overall Study|Withdrawal by Subject|1|||
48536565|NCT01813071|156152921|FG006|Overall Study|Withdrawal by Subject|0|||
48536566|NCT01813071|156152922|FG007|Overall Study|Withdrawal by Subject|0|||
48536567|NCT01813071|156152923|FG008|Overall Study|Withdrawal by Subject|0|||
48536568|NCT01813071|156152915|FG000|Overall Study|Adverse Event|0|||
48536569|NCT01813071|156152916|FG001|Overall Study|Adverse Event|0|||
48536570|NCT01813071|156152917|FG002|Overall Study|Adverse Event|0|||
48536571|NCT01813071|156152918|FG003|Overall Study|Adverse Event|0|||
48536572|NCT01813071|156152919|FG004|Overall Study|Adverse Event|0|||
48536573|NCT01813071|156152920|FG005|Overall Study|Adverse Event|1|||
48536574|NCT01813071|156152921|FG006|Overall Study|Adverse Event|0|||
48536575|NCT01813071|156152922|FG007|Overall Study|Adverse Event|0|||
48536576|NCT01813071|156152923|FG008|Overall Study|Adverse Event|0|||
48536577|NCT01813071|156152915|FG000|Overall Study|Physician Decision|0|||
48536578|NCT01813071|156152916|FG001|Overall Study|Physician Decision|0|||
48536579|NCT01813071|156152917|FG002|Overall Study|Physician Decision|0|||
48536580|NCT01813071|156152918|FG003|Overall Study|Physician Decision|0|||
48536581|NCT01813071|156152919|FG004|Overall Study|Physician Decision|0|||
48536582|NCT01813071|156152920|FG005|Overall Study|Physician Decision|0|||
48536583|NCT01813071|156152921|FG006|Overall Study|Physician Decision|1|||
48536584|NCT01813071|156152922|FG007|Overall Study|Physician Decision|0|||
48536585|NCT01813071|156152923|FG008|Overall Study|Physician Decision|0|||
48536586|NCT01813071|156152915|FG000|Overall Study|Met inc/exc criteria|0|||
48536587|NCT01813071|156152916|FG001|Overall Study|Met inc/exc criteria|0|||
48536588|NCT01813071|156152917|FG002|Overall Study|Met inc/exc criteria|0|||
48536589|NCT01813071|156152918|FG003|Overall Study|Met inc/exc criteria|0|||
48536590|NCT01813071|156152919|FG004|Overall Study|Met inc/exc criteria|0|||
48536591|NCT01813071|156152920|FG005|Overall Study|Met inc/exc criteria|1|||
48536592|NCT01813071|156152921|FG006|Overall Study|Met inc/exc criteria|0|||
48536593|NCT01813071|156152922|FG007|Overall Study|Met inc/exc criteria|1|||
48536594|NCT01813071|156152923|FG008|Overall Study|Met inc/exc criteria|1|||
48536595|NCT02615171|156152927|FG000|Overall Study|Lost to Follow-up|2|||
48536596|NCT02615171|156152928|FG001|Overall Study|Lost to Follow-up|1|||
48605536|NCT01103323|156411730|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
48839360|NCT03975647|157254272|FG001|Overall Study|Subject withdrawal of consent|11|||
48839361|NCT05362487|157254273|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
48839362|NCT06215521|157254274|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
48839363|NCT06215521|157254275|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
48839364|NCT06215521|157254276|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
48839365|NCT06215521|157254277|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
48839366|NCT06215521|157254278|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
48839367|NCT06215521|157254279|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
48536597|NCT01902628|156152929|FG000|Overall Study|Withdrawal of participant's consent|7|||
48605537|NCT00086190|156411743|FG000|Overall Study|Adverse Event|6|||
48605538|NCT00086190|156411744|FG001|Overall Study|Adverse Event|2|||
48605539|NCT00086190|156411745|FG002|Overall Study|Adverse Event|2|||
48605540|NCT00086190|156411743|FG000|Overall Study|Withdrawal by Subject|0|||
48605541|NCT00086190|156411744|FG001|Overall Study|Withdrawal by Subject|2|||
48605542|NCT00086190|156411745|FG002|Overall Study|Withdrawal by Subject|2|||
48605543|NCT00086190|156411743|FG000|Overall Study|Protocol Violation|1|||
48605544|NCT00086190|156411744|FG001|Overall Study|Protocol Violation|0|||
48605545|NCT00086190|156411745|FG002|Overall Study|Protocol Violation|0|||
48605546|NCT00086190|156411743|FG000|Overall Study|Moved|1|||
48605547|NCT00086190|156411744|FG001|Overall Study|Moved|0|||
48839368|NCT05170009|157254280|FG000|Overall Study|Physician Decision|0|||
48536598|NCT01902628|156152929|FG000|Overall Study|Adverse Event|41|||
48536599|NCT01902628|156152929|FG000|Overall Study|Lost to Follow-up|35|||
48536600|NCT01347866|156152932|FG000|Overall Study|Death|0|||
48536601|NCT01347866|156152933|FG001|Overall Study|Death|0|||
48536602|NCT01347866|156152934|FG002|Overall Study|Death|0|||
48536603|NCT01347866|156152935|FG003|Overall Study|Death|1|||
48605548|NCT00086190|156411745|FG002|Overall Study|Moved|0|||
48536604|NCT01347866|156152936|FG004|Overall Study|Death|2|||
48536605|NCT01347866|156152937|FG005|Overall Study|Death|2|||
48536606|NCT01347866|156152938|FG006|Overall Study|Death|1|||
48536607|NCT01347866|156152939|FG007|Overall Study|Death|0|||
48536608|NCT01347866|156152940|FG008|Overall Study|Death|4|||
48536609|NCT01347866|156152941|FG009|Overall Study|Death|1|||
48536610|NCT01347866|156152942|FG010|Overall Study|Death|3|||
48536611|NCT01347866|156152943|FG011|Overall Study|Death|1|||
48536612|NCT01347866|156152944|FG012|Overall Study|Death|2|||
48536613|NCT01347866|156152945|FG013|Overall Study|Death|0|||
48536614|NCT01347866|156152946|FG014|Overall Study|Death|0|||
48536615|NCT01347866|156152947|FG015|Overall Study|Death|1|||
48536616|NCT01347866|156152948|FG016|Overall Study|Death|0|||
48839369|NCT05170009|157254281|FG001|Overall Study|Physician Decision|1|||
48536617|NCT01347866|156152932|FG000|Overall Study|Lost to Follow-up|0|||
48536618|NCT01347866|156152933|FG001|Overall Study|Lost to Follow-up|0|||
48536619|NCT01347866|156152934|FG002|Overall Study|Lost to Follow-up|0|||
48536620|NCT01347866|156152935|FG003|Overall Study|Lost to Follow-up|0|||
48536621|NCT01347866|156152936|FG004|Overall Study|Lost to Follow-up|0|||
48536622|NCT01347866|156152937|FG005|Overall Study|Lost to Follow-up|0|||
48536623|NCT01347866|156152938|FG006|Overall Study|Lost to Follow-up|0|||
48536624|NCT01347866|156152939|FG007|Overall Study|Lost to Follow-up|1|||
48536625|NCT01347866|156152940|FG008|Overall Study|Lost to Follow-up|1|||
48536626|NCT01347866|156152941|FG009|Overall Study|Lost to Follow-up|0|||
48536627|NCT01347866|156152942|FG010|Overall Study|Lost to Follow-up|0|||
48536628|NCT01347866|156152943|FG011|Overall Study|Lost to Follow-up|0|||
48839370|NCT02296125|157254284|FG000|Overall Study|Withdrawal by Subject|18|||
48839371|NCT02296125|157254285|FG001|Overall Study|Withdrawal by Subject|8|||
48536629|NCT01347866|156152944|FG012|Overall Study|Lost to Follow-up|0|||
48536630|NCT01347866|156152945|FG013|Overall Study|Lost to Follow-up|0|||
48536631|NCT01347866|156152946|FG014|Overall Study|Lost to Follow-up|0|||
48536632|NCT01347866|156152947|FG015|Overall Study|Lost to Follow-up|0|||
48536633|NCT01347866|156152948|FG016|Overall Study|Lost to Follow-up|0|||
48536634|NCT01347866|156152932|FG000|Overall Study|Other|3|||
48536635|NCT01347866|156152933|FG001|Overall Study|Other|1|||
48536636|NCT01347866|156152934|FG002|Overall Study|Other|1|||
48536637|NCT01347866|156152935|FG003|Overall Study|Other|4|||
48605549|NCT00086190|156411743|FG000|Overall Study|Worsening depression|0|||
48839372|NCT02296125|157254286|FG002|Overall Study|Withdrawal by Subject|6|||
48839373|NCT02296125|157254287|FG003|Overall Study|Withdrawal by Subject|2|||
48839374|NCT02296125|157254284|FG000|Overall Study|Adverse Event|41|||
48839375|NCT02296125|157254285|FG001|Overall Study|Adverse Event|52|||
48839376|NCT02296125|157254286|FG002|Overall Study|Adverse Event|9|||
48839377|NCT02296125|157254287|FG003|Overall Study|Adverse Event|4|||
48839378|NCT02296125|157254284|FG000|Overall Study|Severe non-compliance to protocol|0|||
48839379|NCT02296125|157254285|FG001|Overall Study|Severe non-compliance to protocol|1|||
48839380|NCT02296125|157254286|FG002|Overall Study|Severe non-compliance to protocol|0|||
48605550|NCT00086190|156411744|FG001|Overall Study|Worsening depression|0|||
48605551|NCT00086190|156411745|FG002|Overall Study|Worsening depression|2|||
48605552|NCT00249834|156411746|FG000|Overall Study|Ovarian stimulation failed|1|||
48605553|NCT00249834|156411747|FG001|Overall Study|Ovarian stimulation failed|0|||
48605554|NCT00249834|156411748|FG002|Overall Study|Ovarian stimulation failed|0|||
48839381|NCT02296125|157254287|FG003|Overall Study|Severe non-compliance to protocol|0|||
48839382|NCT02296125|157254284|FG000|Overall Study|Condition under investigation worsened|153|||
48839383|NCT02296125|157254285|FG001|Overall Study|Condition under investigation worsened|199|||
48839384|NCT02296125|157254286|FG002|Overall Study|Condition under investigation worsened|39|||
48839385|NCT02296125|157254287|FG003|Overall Study|Condition under investigation worsened|56|||
48839386|NCT02296125|157254284|FG000|Overall Study|Any reason not specifically recorded|6|||
48839387|NCT02296125|157254285|FG001|Overall Study|Any reason not specifically recorded|4|||
48839388|NCT02296125|157254286|FG002|Overall Study|Any reason not specifically recorded|2|||
48839389|NCT02296125|157254287|FG003|Overall Study|Any reason not specifically recorded|0|||
48839390|NCT03448107|157254288|FG000|Overall Study|Lost to Follow-up|229|||
48839391|NCT03448107|157254289|FG001|Overall Study|Lost to Follow-up|258|||
48839392|NCT01648023|157254290|FG000|Overall Study|Screen Fail Post Randomization|1|||
48839393|NCT01648023|157254291|FG001|Overall Study|Screen Fail Post Randomization|2|||
48839394|NCT01272037|157254292|FG000|Overall Study|Death|25|||
48839395|NCT01272037|157254293|FG001|Overall Study|Death|28|||
48839396|NCT01272037|157254292|FG000|Overall Study|Adverse Event|12|||
48839397|NCT01272037|157254293|FG001|Overall Study|Adverse Event|7|||
48839398|NCT01272037|157254292|FG000|Overall Study|Withdrawal by Subject|175|||
48839399|NCT01272037|157254293|FG001|Overall Study|Withdrawal by Subject|93|||
48839400|NCT01272037|157254292|FG000|Overall Study|Disease progression|70|||
48839401|NCT01272037|157254293|FG001|Overall Study|Disease progression|111|||
48839402|NCT01272037|157254292|FG000|Overall Study|Other reason|42|||
48839403|NCT01272037|157254293|FG001|Overall Study|Other reason|41|||
48839404|NCT01272037|157254292|FG000|Overall Study|Delinquent data|24|||
48839405|NCT01272037|157254293|FG001|Overall Study|Delinquent data|19|||
48839406|NCT01272037|157254292|FG000|Overall Study|Reason under review|33|||
48536638|NCT01347866|156152936|FG004|Overall Study|Other|5|||
48536639|NCT01347866|156152937|FG005|Overall Study|Other|0|||
48536640|NCT01347866|156152938|FG006|Overall Study|Other|5|||
48536641|NCT01347866|156152939|FG007|Overall Study|Other|3|||
48536642|NCT01347866|156152940|FG008|Overall Study|Other|22|||
48536643|NCT01347866|156152941|FG009|Overall Study|Other|5|||
48536644|NCT01347866|156152942|FG010|Overall Study|Other|0|||
48536645|NCT01347866|156152943|FG011|Overall Study|Other|3|||
48536646|NCT01347866|156152944|FG012|Overall Study|Other|4|||
48536647|NCT01347866|156152945|FG013|Overall Study|Other|4|||
48536648|NCT01347866|156152946|FG014|Overall Study|Other|2|||
48536649|NCT01347866|156152947|FG015|Overall Study|Other|3|||
48536650|NCT01347866|156152948|FG016|Overall Study|Other|0|||
48536651|NCT01347866|156152932|FG000|Overall Study|Subject refused further follow-up|2|||
48536652|NCT01347866|156152933|FG001|Overall Study|Subject refused further follow-up|0|||
48536653|NCT01347866|156152934|FG002|Overall Study|Subject refused further follow-up|0|||
48536654|NCT01347866|156152935|FG003|Overall Study|Subject refused further follow-up|2|||
48536655|NCT01347866|156152936|FG004|Overall Study|Subject refused further follow-up|0|||
48536656|NCT01347866|156152937|FG005|Overall Study|Subject refused further follow-up|1|||
48536657|NCT01347866|156152938|FG006|Overall Study|Subject refused further follow-up|0|||
48536658|NCT01347866|156152939|FG007|Overall Study|Subject refused further follow-up|0|||
48536659|NCT01347866|156152940|FG008|Overall Study|Subject refused further follow-up|4|||
48536660|NCT01347866|156152941|FG009|Overall Study|Subject refused further follow-up|1|||
48536661|NCT01347866|156152942|FG010|Overall Study|Subject refused further follow-up|0|||
48536662|NCT01347866|156152943|FG011|Overall Study|Subject refused further follow-up|0|||
48536663|NCT01347866|156152944|FG012|Overall Study|Subject refused further follow-up|1|||
48536664|NCT01347866|156152945|FG013|Overall Study|Subject refused further follow-up|3|||
48605555|NCT00249834|156411749|FG003|Overall Study|Ovarian stimulation failed|0|||
48605556|NCT00249834|156411750|FG004|Overall Study|Ovarian stimulation failed|0|||
48839407|NCT01272037|157254293|FG001|Overall Study|Reason under review|29|||
48839408|NCT01272037|157254292|FG000|Overall Study|On treatment|626|||
48839409|NCT01272037|157254293|FG001|Overall Study|On treatment|632|||
48839410|NCT04948697|157254296|FG000|Overall Study|Progressive disease|27|||
48839411|NCT04948697|157254297|FG001|Overall Study|Progressive disease|18|||
48839412|NCT04948697|157254296|FG000|Overall Study|Adverse Event|14|||
48839413|NCT04948697|157254297|FG001|Overall Study|Adverse Event|4|||
48839414|NCT04948697|157254296|FG000|Overall Study|Participant moved to long term extension study|7|||
48839415|NCT04948697|157254297|FG001|Overall Study|Participant moved to long term extension study|4|||
48839416|NCT04948697|157254296|FG000|Overall Study|Withdrawal by Subject|10|||
48839417|NCT04948697|157254297|FG001|Overall Study|Withdrawal by Subject|0|||
48839418|NCT04948697|157254296|FG000|Overall Study|Closed by Sponsor|3|||
48839419|NCT04948697|157254297|FG001|Overall Study|Closed by Sponsor|2|||
48839420|NCT04948697|157254296|FG000|Overall Study|Physician Decision|0|||
48839421|NCT04948697|157254297|FG001|Overall Study|Physician Decision|2|||
48839422|NCT04948697|157254296|FG000|Overall Study|Lost to Follow-up|0|||
48839423|NCT04948697|157254297|FG001|Overall Study|Lost to Follow-up|1|||
48839424|NCT04948697|157254296|FG000|Overall Study|Other-Miscellaneous|1|||
48839425|NCT04948697|157254297|FG001|Overall Study|Other-Miscellaneous|0|||
48839426|NCT04948697|157254296|FG000|Overall Study|Randomized but not treated|0|||
48839427|NCT04948697|157254297|FG001|Overall Study|Randomized but not treated|1|||
48839428|NCT05329220|157254302|FG000|Active Trial Period|Adverse Event|0|||
48839429|NCT05329220|157254303|FG001|Active Trial Period|Adverse Event|0|||
48839430|NCT05329220|157254304|FG002|Active Trial Period|Adverse Event|0|||
48839431|NCT05329220|157254305|FG003|Active Trial Period|Adverse Event|0|||
48839432|NCT05329220|157254306|FG004|Active Trial Period|Adverse Event|1|||
48839433|NCT05329220|157254307|FG005|Active Trial Period|Adverse Event|0|||
48839434|NCT05329220|157254302|FG000|Active Trial Period|Lost to Follow-up|0|||
48839435|NCT05329220|157254303|FG001|Active Trial Period|Lost to Follow-up|0|||
48839436|NCT05329220|157254304|FG002|Active Trial Period|Lost to Follow-up|0|||
48839437|NCT05329220|157254305|FG003|Active Trial Period|Lost to Follow-up|0|||
48839438|NCT05329220|157254306|FG004|Active Trial Period|Lost to Follow-up|32|||
48605557|NCT00249834|156411751|FG005|Overall Study|Ovarian stimulation failed|0|||
48605558|NCT00249834|156411752|FG006|Overall Study|Ovarian stimulation failed|0|||
48605559|NCT00249834|156411753|FG007|Overall Study|Ovarian stimulation failed|0|||
48605560|NCT00249834|156411746|FG000|Overall Study|Failure of down-regulation|0|||
48605561|NCT00249834|156411747|FG001|Overall Study|Failure of down-regulation|0|||
48605562|NCT00249834|156411748|FG002|Overall Study|Failure of down-regulation|0|||
48605563|NCT00249834|156411749|FG003|Overall Study|Failure of down-regulation|0|||
48605564|NCT00249834|156411750|FG004|Overall Study|Failure of down-regulation|0|||
48605565|NCT00249834|156411751|FG005|Overall Study|Failure of down-regulation|0|||
48605566|NCT00249834|156411752|FG006|Overall Study|Failure of down-regulation|1|||
48839439|NCT05329220|157254307|FG005|Active Trial Period|Lost to Follow-up|28|||
48839440|NCT05329220|157254302|FG000|Active Trial Period|Physician Decision|0|||
48839441|NCT05329220|157254303|FG001|Active Trial Period|Physician Decision|0|||
48839442|NCT05329220|157254304|FG002|Active Trial Period|Physician Decision|0|||
48839443|NCT05329220|157254305|FG003|Active Trial Period|Physician Decision|0|||
48839444|NCT05329220|157254306|FG004|Active Trial Period|Physician Decision|2|||
48839445|NCT05329220|157254307|FG005|Active Trial Period|Physician Decision|0|||
48839446|NCT05329220|157254302|FG000|Active Trial Period|Protocol Violation|0|||
48839447|NCT05329220|157254303|FG001|Active Trial Period|Protocol Violation|0|||
48839448|NCT05329220|157254304|FG002|Active Trial Period|Protocol Violation|0|||
48536665|NCT01347866|156152946|FG014|Overall Study|Subject refused further follow-up|1|||
48605567|NCT00249834|156411753|FG007|Overall Study|Failure of down-regulation|0|||
48605568|NCT00249834|156411746|FG000|Overall Study|Protocol Violation|0|||
48839449|NCT05329220|157254305|FG003|Active Trial Period|Protocol Violation|0|||
48839450|NCT05329220|157254306|FG004|Active Trial Period|Protocol Violation|1|||
48839451|NCT05329220|157254307|FG005|Active Trial Period|Protocol Violation|3|||
48839452|NCT05329220|157254302|FG000|Active Trial Period|Withdrawal by Subject|0|||
48839453|NCT05329220|157254303|FG001|Active Trial Period|Withdrawal by Subject|0|||
48839454|NCT05329220|157254304|FG002|Active Trial Period|Withdrawal by Subject|0|||
48839455|NCT05329220|157254305|FG003|Active Trial Period|Withdrawal by Subject|1|||
48839456|NCT05329220|157254306|FG004|Active Trial Period|Withdrawal by Subject|12|||
48839457|NCT05329220|157254307|FG005|Active Trial Period|Withdrawal by Subject|13|||
48839458|NCT05329220|157254302|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
48839459|NCT05329220|157254303|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
48839460|NCT05329220|157254304|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
48839461|NCT05329220|157254305|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
48536666|NCT01347866|156152947|FG015|Overall Study|Subject refused further follow-up|0|||
48536667|NCT01347866|156152948|FG016|Overall Study|Subject refused further follow-up|2|||
48536668|NCT01117766|156152950|FG000|First Intervention|Adverse Event|0|||
48536669|NCT01117766|156152951|FG001|First Intervention|Adverse Event|1|||
48536670|NCT01117766|156152950|FG000|First Intervention|Protocol Violation|1|||
48536671|NCT01117766|156152951|FG001|First Intervention|Protocol Violation|0|||
48536672|NCT01117766|156152950|FG000|Washout Period|Protocol Violation|0|||
48536673|NCT01117766|156152951|FG001|Washout Period|Protocol Violation|2|||
48536674|NCT01117766|156152950|FG000|Second Intervention|Lost to Follow-up|1|||
48536675|NCT01117766|156152951|FG001|Second Intervention|Lost to Follow-up|0|||
48536676|NCT01117766|156152950|FG000|Second Intervention|Other|1|||
48536677|NCT01117766|156152951|FG001|Second Intervention|Other|2|||
48536678|NCT01117766|156152950|FG000|Second Intervention|Adverse Event|0|||
48536679|NCT01117766|156152951|FG001|Second Intervention|Adverse Event|2|||
48536680|NCT01117766|156152950|FG000|Second Intervention|Withdrawal by Subject|0|||
48536681|NCT01117766|156152951|FG001|Second Intervention|Withdrawal by Subject|1|||
48536682|NCT00854373|156152952|FG000|Overall Study|Withdrawal by Subject|1|||
48536683|NCT00854373|156152953|FG001|Overall Study|Withdrawal by Subject|3|||
48536684|NCT00854373|156152952|FG000|Overall Study|Forgot to take study drug|1|||
48536685|NCT00854373|156152953|FG001|Overall Study|Forgot to take study drug|1|||
48536686|NCT00307931|156152954|FG000|Overall Study|Adverse Event|1|||
48536687|NCT02429934|156152955|FG000|Overall Study|Withdrawal by Subject|0|||
48536688|NCT02429934|156152956|FG001|Overall Study|Withdrawal by Subject|2|||
48536689|NCT02429934|156152955|FG000|Overall Study|Adverse Event|2|||
48536690|NCT02429934|156152956|FG001|Overall Study|Adverse Event|0|||
48536691|NCT02429934|156152955|FG000|Overall Study|Lost to Follow-up|1|||
48536692|NCT02429934|156152956|FG001|Overall Study|Lost to Follow-up|1|||
48536693|NCT02429934|156152955|FG000|Overall Study|Physician Decision|1|||
48536694|NCT02429934|156152956|FG001|Overall Study|Physician Decision|0|||
48536695|NCT00869024|156152957|FG000|Overall Study|Death|2|||
48536696|NCT00869024|156152958|FG001|Overall Study|Death|3|||
48536697|NCT00869024|156152957|FG000|Overall Study|Lost to Follow-up|0|||
48536698|NCT00869024|156152958|FG001|Overall Study|Lost to Follow-up|1|||
48536699|NCT00869024|156152957|FG000|Overall Study|Protocol Violation|0|||
48536700|NCT00869024|156152958|FG001|Overall Study|Protocol Violation|1|||
48536701|NCT02939950|156152959|FG000|Overall Study|Lost to Follow-up|13|||
48536702|NCT02939950|156152960|FG001|Overall Study|Lost to Follow-up|16|||
48536703|NCT02939950|156152959|FG000|Overall Study|Positive slit lamp findings|0|||
48536704|NCT02939950|156152960|FG001|Overall Study|Positive slit lamp findings|1|||
48536705|NCT02939950|156152959|FG000|Overall Study|Chalazion upper lid|0|||
48536706|NCT02939950|156152960|FG001|Overall Study|Chalazion upper lid|1|||
48536707|NCT02939950|156152959|FG000|Overall Study|Lack of motivation|0|||
48536708|NCT02939950|156152960|FG001|Overall Study|Lack of motivation|2|||
48536709|NCT02939950|156152959|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
48536710|NCT02939950|156152960|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
48536711|NCT02939950|156152959|FG000|Overall Study|Military orders|1|||
48536712|NCT02939950|156152960|FG001|Overall Study|Military orders|0|||
48536713|NCT02939950|156152959|FG000|Overall Study|Participant Relocated|5|||
48536714|NCT02939950|156152960|FG001|Overall Study|Participant Relocated|3|||
48536715|NCT02939950|156152959|FG000|Overall Study|Study related symptoms|8|||
48536716|NCT02939950|156152960|FG001|Overall Study|Study related symptoms|8|||
48536717|NCT02939950|156152959|FG000|Overall Study|Unacceptable lens movement|2|||
48536718|NCT02939950|156152960|FG001|Overall Study|Unacceptable lens movement|0|||
48536719|NCT02939950|156152959|FG000|Overall Study|Protocol Violation|6|||
48536720|NCT02939950|156152960|FG001|Overall Study|Protocol Violation|3|||
48536721|NCT02939950|156152959|FG000|Overall Study|Physician Decision|2|||
48536722|NCT02939950|156152960|FG001|Overall Study|Physician Decision|0|||
48536723|NCT02939950|156152959|FG000|Overall Study|Pregnancy|6|||
48536724|NCT02939950|156152960|FG001|Overall Study|Pregnancy|7|||
48536725|NCT02939950|156152959|FG000|Overall Study|Withdrawal by Subject|12|||
48536726|NCT02939950|156152960|FG001|Overall Study|Withdrawal by Subject|28|||
48839462|NCT05329220|157254306|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
48839463|NCT05329220|157254307|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
48839464|NCT05329220|157254302|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
48839465|NCT05329220|157254303|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
48839466|NCT05329220|157254304|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
48839467|NCT05329220|157254305|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
48839468|NCT05329220|157254306|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
48839469|NCT05329220|157254307|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
48839470|NCT05329220|157254302|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
48839471|NCT05329220|157254303|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
48839472|NCT05329220|157254304|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
48839473|NCT05329220|157254305|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
48839474|NCT05329220|157254306|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
48839475|NCT05329220|157254307|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
48839476|NCT05329220|157254302|FG000|Follow-up Period|Adverse Event|0|||
48839477|NCT05329220|157254303|FG001|Follow-up Period|Adverse Event|0|||
48839478|NCT05329220|157254304|FG002|Follow-up Period|Adverse Event|0|||
48839479|NCT05329220|157254305|FG003|Follow-up Period|Adverse Event|0|||
48839480|NCT05329220|157254306|FG004|Follow-up Period|Adverse Event|2|||
48839481|NCT05329220|157254307|FG005|Follow-up Period|Adverse Event|1|||
48839482|NCT05329220|157254302|FG000|Follow-up Period|Death|0|||
48839483|NCT05329220|157254303|FG001|Follow-up Period|Death|0|||
48839484|NCT05329220|157254304|FG002|Follow-up Period|Death|1|||
48839485|NCT05329220|157254305|FG003|Follow-up Period|Death|1|||
48839486|NCT05329220|157254306|FG004|Follow-up Period|Death|0|||
48839487|NCT05329220|157254307|FG005|Follow-up Period|Death|1|||
48839488|NCT05329220|157254302|FG000|Follow-up Period|Lost to Follow-up|0|||
48839489|NCT05329220|157254303|FG001|Follow-up Period|Lost to Follow-up|1|||
48839490|NCT05329220|157254304|FG002|Follow-up Period|Lost to Follow-up|2|||
48839491|NCT05329220|157254305|FG003|Follow-up Period|Lost to Follow-up|2|||
48839492|NCT05329220|157254306|FG004|Follow-up Period|Lost to Follow-up|113|||
48839493|NCT05329220|157254307|FG005|Follow-up Period|Lost to Follow-up|89|||
48536727|NCT02939950|156152959|FG000|Overall Study|Adverse Event|7|||
48839494|NCT05329220|157254302|FG000|Follow-up Period|Physician Decision|0|||
48839495|NCT05329220|157254303|FG001|Follow-up Period|Physician Decision|0|||
48839496|NCT05329220|157254304|FG002|Follow-up Period|Physician Decision|0|||
48839497|NCT05329220|157254305|FG003|Follow-up Period|Physician Decision|0|||
48839498|NCT05329220|157254306|FG004|Follow-up Period|Physician Decision|2|||
48839499|NCT05329220|157254307|FG005|Follow-up Period|Physician Decision|2|||
48536728|NCT02939950|156152960|FG001|Overall Study|Adverse Event|3|||
48536729|NCT02939950|156152959|FG000|Overall Study|Randomized, not dispensed|1|||
48536730|NCT02939950|156152960|FG001|Overall Study|Randomized, not dispensed|0|||
48536731|NCT02939950|156152959|FG000|Overall Study|Ineligible at Baseline|2|||
48536732|NCT02939950|156152960|FG001|Overall Study|Ineligible at Baseline|8|||
48536733|NCT00679913|156152965|FG000|Overall Study|Protocol Violation|18|||
48536734|NCT00679913|156152966|FG001|Overall Study|Protocol Violation|13|||
48536735|NCT00038649|156152972|FG000|Overall Study|Adverse Event|9|||
48536736|NCT00975286|156152978|FG000|Overall Study|Adverse Event|9|||
48536737|NCT00975286|156152979|FG001|Overall Study|Adverse Event|19|||
48536738|NCT00975286|156152978|FG000|Overall Study|Protocol Violation|1|||
48536739|NCT00975286|156152979|FG001|Overall Study|Protocol Violation|2|||
48536740|NCT00975286|156152978|FG000|Overall Study|Withdrawal by Subject|0|||
48536741|NCT00975286|156152979|FG001|Overall Study|Withdrawal by Subject|2|||
48536742|NCT00975286|156152978|FG000|Overall Study|Familial and Personal Reasons|2|||
48536743|NCT00975286|156152979|FG001|Overall Study|Familial and Personal Reasons|2|||
48536744|NCT00975286|156152978|FG000|Overall Study|Poor Compliance to Protocol|0|||
48536745|NCT00975286|156152979|FG001|Overall Study|Poor Compliance to Protocol|2|||
48536746|NCT00975286|156152978|FG000|Overall Study|Sponsor Decision|0|||
48536747|NCT00975286|156152979|FG001|Overall Study|Sponsor Decision|2|||
48536748|NCT00725621|156152980|FG000|Overall Study|Adverse Event|25|||
48536749|NCT00725621|156152980|FG000|Overall Study|Lack of Efficacy|46|||
48536750|NCT00725621|156152980|FG000|Overall Study|Withdrawal by Subject|57|||
48536751|NCT00725621|156152980|FG000|Overall Study|Physician Decision|19|||
48536752|NCT00725621|156152980|FG000|Overall Study|Lost to Follow-up|52|||
48536753|NCT00725621|156152980|FG000|Overall Study|Non-compliance|8|||
48536754|NCT00725621|156152980|FG000|Overall Study|Continued treatment by other physician|6|||
48536755|NCT00725621|156152980|FG000|Overall Study|Switched to other study|1|||
48536756|NCT00725621|156152980|FG000|Overall Study|Switched to other drug|1|||
48536757|NCT00725621|156152980|FG000|Overall Study|Prepared for elective surgery|1|||
48536758|NCT00725621|156152980|FG000|Overall Study|Reason not specified|55|||
48536759|NCT01560507|156152984|FG000|Overall Study|Lost to Follow-up|3|||
48536760|NCT01560507|156152985|FG001|Overall Study|Lost to Follow-up|1|||
48536761|NCT01560507|156152986|FG002|Overall Study|Lost to Follow-up|2|||
48536762|NCT01560507|156152984|FG000|Overall Study|Withdrawal by Subject|1|||
48536763|NCT01560507|156152985|FG001|Overall Study|Withdrawal by Subject|1|||
48536764|NCT01560507|156152986|FG002|Overall Study|Withdrawal by Subject|0|||
48536765|NCT02080832|156152990|FG000|Overall Study|Excluded from analysis by MRI|9|||
48536766|NCT02080832|156152991|FG001|Overall Study|Excluded from analysis by MRI|10|||
48536767|NCT02080832|156152992|FG002|Overall Study|Excluded from analysis by MRI|14|||
48536768|NCT02080832|156152990|FG000|Overall Study|Lost to Follow-up|0|||
48536769|NCT02080832|156152991|FG001|Overall Study|Lost to Follow-up|2|||
48536770|NCT02080832|156152992|FG002|Overall Study|Lost to Follow-up|2|||
48536771|NCT01000493|156152993|FG000|Overall Study|Adverse Event|3|||
48536772|NCT01000493|156152994|FG001|Overall Study|Adverse Event|6|||
48536773|NCT01000493|156152993|FG000|Overall Study|Lack of Efficacy|1|||
48536774|NCT01000493|156152994|FG001|Overall Study|Lack of Efficacy|1|||
48605569|NCT00249834|156411747|FG001|Overall Study|Protocol Violation|19|||
48605570|NCT00249834|156411748|FG002|Overall Study|Protocol Violation|14|||
48605571|NCT00249834|156411749|FG003|Overall Study|Protocol Violation|8|||
48605572|NCT00249834|156411750|FG004|Overall Study|Protocol Violation|5|||
48605573|NCT00249834|156411751|FG005|Overall Study|Protocol Violation|2|||
48536775|NCT01000493|156152993|FG000|Overall Study|Protocol Violation|1|||
48536776|NCT01000493|156152994|FG001|Overall Study|Protocol Violation|8|||
48536777|NCT01000493|156152993|FG000|Overall Study|Study closed/terminated|25|||
48536778|NCT01000493|156152994|FG001|Overall Study|Study closed/terminated|23|||
48605574|NCT00249834|156411752|FG006|Overall Study|Protocol Violation|0|||
48605575|NCT00249834|156411753|FG007|Overall Study|Protocol Violation|0|||
48605576|NCT02187783|156411754|FG000|Overall Study|Adverse Event|8|||
48839500|NCT05329220|157254302|FG000|Follow-up Period|Protocol Violation|0|||
48839501|NCT05329220|157254303|FG001|Follow-up Period|Protocol Violation|0|||
48839502|NCT05329220|157254304|FG002|Follow-up Period|Protocol Violation|0|||
48839503|NCT05329220|157254305|FG003|Follow-up Period|Protocol Violation|0|||
48839504|NCT05329220|157254306|FG004|Follow-up Period|Protocol Violation|0|||
48839505|NCT05329220|157254307|FG005|Follow-up Period|Protocol Violation|1|||
48839506|NCT05329220|157254302|FG000|Follow-up Period|Withdrawal by Subject|0|||
48839507|NCT05329220|157254303|FG001|Follow-up Period|Withdrawal by Subject|0|||
48839508|NCT05329220|157254304|FG002|Follow-up Period|Withdrawal by Subject|1|||
48839509|NCT05329220|157254305|FG003|Follow-up Period|Withdrawal by Subject|1|||
48839510|NCT05329220|157254306|FG004|Follow-up Period|Withdrawal by Subject|34|||
48839511|NCT05329220|157254307|FG005|Follow-up Period|Withdrawal by Subject|35|||
48839512|NCT05329220|157254302|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
48839513|NCT05329220|157254303|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
48839514|NCT05329220|157254304|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
48839515|NCT05329220|157254305|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
48839516|NCT05329220|157254306|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
48839517|NCT05329220|157254307|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
48839518|NCT05329220|157254302|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
48839519|NCT05329220|157254303|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
48839520|NCT05329220|157254304|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
48839521|NCT05329220|157254305|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
48839522|NCT05329220|157254306|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
48605577|NCT02187783|156411754|FG000|Overall Study|Death|3|||
48605578|NCT02187783|156411754|FG000|Overall Study|Progressive disease|80|||
48605579|NCT02187783|156411754|FG000|Overall Study|Protocol Violation|3|||
48605580|NCT02187783|156411754|FG000|Overall Study|Physician Decision|2|||
48605581|NCT02187783|156411754|FG000|Overall Study|Withdrawal by Subject|9|||
48605582|NCT02187783|156411754|FG000|Overall Study|Study terminated by sponsor|1|||
48605583|NCT02801331|156411755|FG000|Overall Study|Transferred to another hospital|8|||
48839523|NCT05329220|157254307|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
48839524|NCT05329220|157254302|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
48839525|NCT05329220|157254303|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
48839526|NCT05329220|157254304|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
48605584|NCT02801331|156411756|FG001|Overall Study|Transferred to another hospital|7|||
48605585|NCT02801331|156411755|FG000|Overall Study|Withdrawal by Subject|0|||
48605586|NCT02801331|156411756|FG001|Overall Study|Withdrawal by Subject|4|||
48605587|NCT02801331|156411755|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
48536779|NCT01000493|156152993|FG000|Overall Study|Lost to Follow-up|5|||
48536780|NCT01000493|156152994|FG001|Overall Study|Lost to Follow-up|9|||
48536781|NCT01000493|156152993|FG000|Overall Study|Physician Decision|1|||
48536782|NCT01000493|156152994|FG001|Overall Study|Physician Decision|1|||
48536783|NCT01000493|156152993|FG000|Overall Study|Withdrawal by Subject|3|||
48536784|NCT01000493|156152994|FG001|Overall Study|Withdrawal by Subject|7|||
48536785|NCT02243293|156152995|FG000|Overall Study|Adverse Event|1|||
48536786|NCT02243293|156152996|FG001|Overall Study|Adverse Event|0|||
48536787|NCT02243293|156152997|FG002|Overall Study|Adverse Event|0|||
48536788|NCT02243293|156152998|FG003|Overall Study|Adverse Event|0|||
48605588|NCT02801331|156411756|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
48605589|NCT00875810|156411757|FG000|Overall Study|Withdrawal by Subject|1|||
48839527|NCT05329220|157254305|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
48839528|NCT05329220|157254306|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
48839529|NCT05329220|157254307|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
48839530|NCT05329220|157254302|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
48839531|NCT05329220|157254303|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
48839532|NCT05329220|157254304|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
48839533|NCT05329220|157254305|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
48839534|NCT05329220|157254306|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
48839535|NCT05329220|157254307|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
48839536|NCT05329220|157254302|FG000|Follow-up Period|EARLY TERMINATION|0|||
48839537|NCT05329220|157254303|FG001|Follow-up Period|EARLY TERMINATION|0|||
48839538|NCT05329220|157254304|FG002|Follow-up Period|EARLY TERMINATION|0|||
48839539|NCT05329220|157254305|FG003|Follow-up Period|EARLY TERMINATION|0|||
48839540|NCT05329220|157254306|FG004|Follow-up Period|EARLY TERMINATION|0|||
48536789|NCT02243293|156152999|FG004|Overall Study|Adverse Event|0|||
48605590|NCT00875810|156411757|FG000|Overall Study|Physician Decision|3|||
48839541|NCT05329220|157254307|FG005|Follow-up Period|EARLY TERMINATION|1|||
48839542|NCT05329220|157254302|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
48839543|NCT05329220|157254303|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
48839544|NCT05329220|157254304|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
48839545|NCT05329220|157254305|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
48839546|NCT05329220|157254306|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
48839547|NCT05329220|157254307|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
48839548|NCT05329220|157254302|FG000|Follow-up Period|DROPPED|0|||
48839549|NCT05329220|157254303|FG001|Follow-up Period|DROPPED|0|||
48839550|NCT05329220|157254304|FG002|Follow-up Period|DROPPED|0|||
48839551|NCT05329220|157254305|FG003|Follow-up Period|DROPPED|0|||
48839552|NCT05329220|157254306|FG004|Follow-up Period|DROPPED|0|||
48839553|NCT05329220|157254307|FG005|Follow-up Period|DROPPED|1|||
48839554|NCT05329220|157254302|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
48839555|NCT05329220|157254303|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
48839556|NCT05329220|157254304|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
48839557|NCT05329220|157254305|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
48839558|NCT05329220|157254306|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
48839559|NCT05329220|157254307|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
48839560|NCT03504397|157254309|FG000|Overall Study|Progressive Disease|133|||
48839561|NCT03504397|157254310|FG001|Overall Study|Progressive Disease|177|||
48839562|NCT03504397|157254309|FG000|Overall Study|Withdrawal by Subject|29|||
48839563|NCT03504397|157254310|FG001|Overall Study|Withdrawal by Subject|18|||
48839564|NCT03504397|157254309|FG000|Overall Study|Lost to Follow-up|1|||
48605591|NCT00875810|156411757|FG000|Overall Study|Lost to Follow-up|39|||
48605592|NCT00875810|156411757|FG000|Overall Study|Patient enroled but not implanted|2|||
48605593|NCT00875810|156411757|FG000|Overall Study|Device explanted|1|||
48605594|NCT03234465|156411758|FG000|Overall Study|Adverse Event|4|||
48605595|NCT03234465|156411759|FG001|Overall Study|Adverse Event|2|||
48605596|NCT03234465|156411758|FG000|Overall Study|Death|0|||
48605597|NCT03234465|156411759|FG001|Overall Study|Death|1|||
48839565|NCT03504397|157254310|FG001|Overall Study|Lost to Follow-up|0|||
48839566|NCT03504397|157254309|FG000|Overall Study|Death|13|||
48839567|NCT03504397|157254310|FG001|Overall Study|Death|16|||
48839568|NCT03504397|157254309|FG000|Overall Study|Adverse Event|42|||
48839569|NCT03504397|157254310|FG001|Overall Study|Adverse Event|14|||
48839570|NCT03504397|157254309|FG000|Overall Study|miscellaneous|17|||
48839571|NCT03504397|157254310|FG001|Overall Study|miscellaneous|15|||
48536790|NCT02243293|156153000|FG005|Overall Study|Adverse Event|0|||
48536791|NCT02243293|156153001|FG006|Overall Study|Adverse Event|0|||
48605598|NCT03234465|156411758|FG000|Overall Study|Lost to Follow-up|1|||
48605599|NCT03234465|156411759|FG001|Overall Study|Lost to Follow-up|1|||
48605600|NCT03234465|156411758|FG000|Overall Study|Withdrawal by Subject|12|||
48605601|NCT03234465|156411759|FG001|Overall Study|Withdrawal by Subject|27|||
48839572|NCT03504397|157254309|FG000|Overall Study|Protocol deviation|1|||
48839573|NCT03504397|157254310|FG001|Overall Study|Protocol deviation|0|||
48839574|NCT02427464|157254312|FG000|Overall Study|Adverse Event|6|||
48839575|NCT02427464|157254313|FG001|Overall Study|Adverse Event|1|||
48839576|NCT02427464|157254312|FG000|Overall Study|Lost to Follow-up|16|||
48839577|NCT02427464|157254313|FG001|Overall Study|Lost to Follow-up|5|||
48839578|NCT02427464|157254312|FG000|Overall Study|Physician Decision|2|||
48839579|NCT02427464|157254313|FG001|Overall Study|Physician Decision|0|||
48839580|NCT02427464|157254312|FG000|Overall Study|Withdrawal by Subject|10|||
48839581|NCT02427464|157254313|FG001|Overall Study|Withdrawal by Subject|8|||
48839582|NCT02427464|157254312|FG000|Overall Study|Noncompliance|16|||
48839583|NCT02427464|157254313|FG001|Overall Study|Noncompliance|10|||
48839584|NCT04103580|157254314|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
48839585|NCT04103580|157254315|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
48536792|NCT02243293|156153002|FG007|Overall Study|Adverse Event|0|||
48536793|NCT02243293|156153003|FG008|Overall Study|Adverse Event|0|||
48536794|NCT02243293|156153004|FG009|Overall Study|Adverse Event|0|||
48536795|NCT02243293|156153005|FG010|Overall Study|Adverse Event|0|||
48536796|NCT02243293|156153006|FG011|Overall Study|Adverse Event|0|||
48536797|NCT02243293|156153007|FG012|Overall Study|Adverse Event|0|||
48536798|NCT02243293|156153008|FG013|Overall Study|Adverse Event|0|||
48839586|NCT04103580|157254314|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
48839587|NCT04103580|157254315|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
48839588|NCT04103580|157254314|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
48839589|NCT04103580|157254315|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
48839590|NCT04103580|157254314|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
48839591|NCT04103580|157254315|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
48839592|NCT04103580|157254314|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
48839593|NCT04103580|157254315|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
48839594|NCT04103580|157254314|FG000|Phase 1 Active Caregiving|Other|3|||
48839595|NCT04103580|157254315|FG001|Phase 1 Active Caregiving|Other|3|||
48839596|NCT04103580|157254314|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
48839597|NCT04103580|157254315|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
48839598|NCT04103580|157254314|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
48839599|NCT04103580|157254315|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
48839600|NCT04103580|157254314|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
48839601|NCT04103580|157254315|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
48839602|NCT04103580|157254314|FG000|Phase 2 Bereavement|Other|8|||
48839603|NCT04103580|157254315|FG001|Phase 2 Bereavement|Other|6|||
48839604|NCT04145440|157254316|FG000|Overall Study|Physician Decision|3|||
48839605|NCT04145440|157254317|FG001|Overall Study|Physician Decision|0|||
48839606|NCT04145440|157254316|FG000|Overall Study|Use of prohibited therapy|2|||
48839607|NCT04145440|157254317|FG001|Overall Study|Use of prohibited therapy|3|||
48839608|NCT02927236|157254320|FG000|Characterization Phase|Physician Decision|0|||
48839609|NCT02927236|157254321|FG001|Characterization Phase|Physician Decision|3|||
48839610|NCT02927236|157254322|FG002|Characterization Phase|Physician Decision|0|||
48839611|NCT02927236|157254323|FG003|Characterization Phase|Physician Decision|2|||
48839612|NCT02927236|157254320|FG000|Characterization Phase|Lost to Follow-up|0|||
48839613|NCT02927236|157254321|FG001|Characterization Phase|Lost to Follow-up|0|||
48839614|NCT02927236|157254322|FG002|Characterization Phase|Lost to Follow-up|0|||
48839615|NCT02927236|157254323|FG003|Characterization Phase|Lost to Follow-up|3|||
48839616|NCT02927236|157254320|FG000|Characterization Phase|Withdrawal by Subject|1|||
48839617|NCT02927236|157254321|FG001|Characterization Phase|Withdrawal by Subject|0|||
48839618|NCT02927236|157254322|FG002|Characterization Phase|Withdrawal by Subject|0|||
48839619|NCT02927236|157254323|FG003|Characterization Phase|Withdrawal by Subject|1|||
48839620|NCT02927236|157254320|FG000|Treatment Phase|Adverse Event|1|||
48839621|NCT02927236|157254321|FG001|Treatment Phase|Adverse Event|0|||
48536799|NCT02243293|156153009|FG014|Overall Study|Adverse Event|0|||
48536800|NCT02243293|156153010|FG015|Overall Study|Adverse Event|1|||
48605602|NCT03234465|156411758|FG000|Overall Study|Symptomatic deterioration|0|||
48605603|NCT03234465|156411759|FG001|Overall Study|Symptomatic deterioration|1|||
48839622|NCT02927236|157254322|FG002|Treatment Phase|Adverse Event|1|||
48839623|NCT02927236|157254323|FG003|Treatment Phase|Adverse Event|1|||
48839624|NCT02927236|157254320|FG000|Treatment Phase|Protocol Violation|3|||
48839625|NCT02927236|157254321|FG001|Treatment Phase|Protocol Violation|0|||
48536801|NCT02243293|156153011|FG016|Overall Study|Adverse Event|0|||
48536802|NCT02243293|156153012|FG017|Overall Study|Adverse Event|0|||
48839626|NCT02927236|157254322|FG002|Treatment Phase|Protocol Violation|0|||
48839627|NCT02927236|157254323|FG003|Treatment Phase|Protocol Violation|1|||
48839628|NCT02927236|157254320|FG000|Treatment Phase|Lost to Follow-up|1|||
48839629|NCT02927236|157254321|FG001|Treatment Phase|Lost to Follow-up|0|||
48839630|NCT02927236|157254322|FG002|Treatment Phase|Lost to Follow-up|0|||
48839631|NCT02927236|157254323|FG003|Treatment Phase|Lost to Follow-up|0|||
48605604|NCT03234465|156411758|FG000|Overall Study|Non-compliance|2|||
48605605|NCT03234465|156411759|FG001|Overall Study|Non-compliance|0|||
48605606|NCT03234465|156411758|FG000|Overall Study|Other|14|||
48605607|NCT03234465|156411759|FG001|Overall Study|Other|8|||
48605608|NCT03368664|156411760|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
48839632|NCT02927236|157254320|FG000|Follow-up Phase|Lost to Follow-up|1|||
48839633|NCT02927236|157254321|FG001|Follow-up Phase|Lost to Follow-up|0|||
48839634|NCT02927236|157254322|FG002|Follow-up Phase|Lost to Follow-up|1|||
48839635|NCT02927236|157254323|FG003|Follow-up Phase|Lost to Follow-up|0|||
48839636|NCT03698019|157254324|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
48839637|NCT03698019|157254325|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
48839638|NCT03698019|157254324|FG000|Step 1: Registration|Withdrawal by Subject|7|||
48839639|NCT03698019|157254325|FG001|Step 1: Registration|Withdrawal by Subject|2|||
48839640|NCT03698019|157254324|FG000|Step 1: Registration|Toxicity|0|||
48839641|NCT03698019|157254325|FG001|Step 1: Registration|Toxicity|1|||
48839642|NCT03698019|157254324|FG000|Step 1: Registration|Disease Progression|0|||
48839643|NCT03698019|157254325|FG001|Step 1: Registration|Disease Progression|12|||
48839644|NCT03698019|157254324|FG000|Step 1: Registration|Co-morbidities|0|||
48839645|NCT03698019|157254325|FG001|Step 1: Registration|Co-morbidities|1|||
48839646|NCT03698019|157254324|FG000|Step 1: Registration|Scheduling Issues|1|||
48839647|NCT03698019|157254325|FG001|Step 1: Registration|Scheduling Issues|0|||
48839648|NCT03698019|157254324|FG000|Step 1: Registration|Participant Refusal|0|||
48839649|NCT03698019|157254325|FG001|Step 1: Registration|Participant Refusal|1|||
48839650|NCT03698019|157254324|FG000|Step 2: Surgery|Participant Refusal|2|||
48839651|NCT03698019|157254325|FG001|Step 2: Surgery|Participant Refusal|1|||
48839652|NCT03698019|157254324|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
48839653|NCT03698019|157254325|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
48839654|NCT03698019|157254324|FG000|Step 2: Surgery|Metastatic Disease|16|||
48839655|NCT03698019|157254325|FG001|Step 2: Surgery|Metastatic Disease|9|||
48839656|NCT03698019|157254324|FG000|Step 2: Surgery|Residual Disease|2|||
48839657|NCT03698019|157254325|FG001|Step 2: Surgery|Residual Disease|1|||
48839658|NCT03698019|157254324|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
48839659|NCT03698019|157254325|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
48839660|NCT03698019|157254324|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
48839661|NCT03698019|157254325|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
48839662|NCT03698019|157254324|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
48839663|NCT03698019|157254325|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
48839664|NCT03698019|157254324|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
48839665|NCT03698019|157254325|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
48839666|NCT03698019|157254324|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
48839667|NCT03698019|157254325|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
48839668|NCT03698019|157254324|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
48839669|NCT03698019|157254325|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
48839670|NCT03698019|157254324|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
48839671|NCT03698019|157254325|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
48839672|NCT03698019|157254324|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
48839673|NCT03698019|157254325|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
48839674|NCT01856192|157254326|FG000|Overall Study|Adverse Event|12|||
48605609|NCT03368664|156411760|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
48605610|NCT03368664|156411760|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
48605611|NCT03368664|156411760|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
48605612|NCT00843492|156411767|FG000|Overall Study|Adverse Event|0|||
48605613|NCT00843492|156411768|FG001|Overall Study|Adverse Event|3|||
48605614|NCT00843492|156411767|FG000|Overall Study|Lost to Follow-up|4|||
48605615|NCT00843492|156411768|FG001|Overall Study|Lost to Follow-up|4|||
48605616|NCT00843492|156411767|FG000|Overall Study|Withdrawal by Subject|0|||
48839675|NCT01856192|157254327|FG001|Overall Study|Adverse Event|4|||
48839676|NCT01856192|157254326|FG000|Overall Study|Alternative therapy|0|||
48839677|NCT01856192|157254327|FG001|Overall Study|Alternative therapy|3|||
48605617|NCT00843492|156411768|FG001|Overall Study|Withdrawal by Subject|4|||
48839678|NCT01856192|157254326|FG000|Overall Study|Death|3|||
48839679|NCT01856192|157254327|FG001|Overall Study|Death|5|||
48839680|NCT01856192|157254326|FG000|Overall Study|Lack of Efficacy|0|||
48605618|NCT00843492|156411767|FG000|Overall Study|Immobilization Stopped|1|||
48839681|NCT01856192|157254327|FG001|Overall Study|Lack of Efficacy|5|||
48839682|NCT01856192|157254326|FG000|Overall Study|Withdrawal by Subject|1|||
48839683|NCT01856192|157254327|FG001|Overall Study|Withdrawal by Subject|1|||
48839684|NCT01856192|157254326|FG000|Overall Study|Other diseases|1|||
48839685|NCT01856192|157254327|FG001|Overall Study|Other diseases|0|||
48839686|NCT01856192|157254326|FG000|Overall Study|Never started treatment|7|||
48839687|NCT01856192|157254327|FG001|Overall Study|Never started treatment|5|||
48839688|NCT01856192|157254326|FG000|Overall Study|Path ineligible|20|||
48839689|NCT01856192|157254327|FG001|Overall Study|Path ineligible|34|||
48839690|NCT01856192|157254326|FG000|Overall Study|Non-path ineligible|2|||
48839691|NCT01856192|157254327|FG001|Overall Study|Non-path ineligible|2|||
48839692|NCT01856192|157254326|FG000|Overall Study|Physician Decision|1|||
48839693|NCT01856192|157254327|FG001|Overall Study|Physician Decision|1|||
48839694|NCT01856192|157254326|FG000|Overall Study|Suspicion of progressive disease|1|||
48839695|NCT01856192|157254327|FG001|Overall Study|Suspicion of progressive disease|0|||
48839696|NCT01856192|157254326|FG000|Overall Study|Non-compliance|1|||
48839697|NCT01856192|157254327|FG001|Overall Study|Non-compliance|0|||
48839698|NCT05297565|157254328|FG000|Overall Study|Other Reasons|0|||
48839699|NCT05297565|157254329|FG001|Overall Study|Other Reasons|1|||
48839700|NCT05297565|157254328|FG000|Overall Study|Physician Decision|0|||
48839701|NCT05297565|157254329|FG001|Overall Study|Physician Decision|1|||
48839702|NCT05297565|157254328|FG000|Overall Study|Disease recurrence|1|||
48839703|NCT05297565|157254329|FG001|Overall Study|Disease recurrence|0|||
48839704|NCT03375320|157254330|FG000|Overall Study|Adverse Event|34|||
48839705|NCT03375320|157254331|FG001|Overall Study|Adverse Event|9|||
48839706|NCT03375320|157254332|FG002|Overall Study|Adverse Event|10|||
48839707|NCT03375320|157254333|FG003|Overall Study|Adverse Event|0|||
48839708|NCT03375320|157254330|FG000|Overall Study|Death|6|||
48839709|NCT03375320|157254331|FG001|Overall Study|Death|3|||
48839710|NCT03375320|157254332|FG002|Overall Study|Death|0|||
48839711|NCT03375320|157254333|FG003|Overall Study|Death|0|||
48839712|NCT03375320|157254330|FG000|Overall Study|Withdrawal by Subject|7|||
48839713|NCT03375320|157254331|FG001|Overall Study|Withdrawal by Subject|4|||
48839714|NCT03375320|157254332|FG002|Overall Study|Withdrawal by Subject|5|||
48839715|NCT03375320|157254333|FG003|Overall Study|Withdrawal by Subject|4|||
48839716|NCT03375320|157254330|FG000|Overall Study|Progressive disease|55|||
48839717|NCT03375320|157254331|FG001|Overall Study|Progressive disease|41|||
48839718|NCT03375320|157254332|FG002|Overall Study|Progressive disease|29|||
48839719|NCT03375320|157254333|FG003|Overall Study|Progressive disease|24|||
48839720|NCT03375320|157254330|FG000|Overall Study|Alternative treatment|6|||
48839721|NCT03375320|157254331|FG001|Overall Study|Alternative treatment|1|||
48839722|NCT03375320|157254332|FG002|Overall Study|Alternative treatment|1|||
48839723|NCT03375320|157254333|FG003|Overall Study|Alternative treatment|0|||
48839724|NCT03375320|157254330|FG000|Overall Study|Other disease|1|||
48839725|NCT03375320|157254331|FG001|Overall Study|Other disease|1|||
48839726|NCT03375320|157254332|FG002|Overall Study|Other disease|3|||
48839727|NCT03375320|157254333|FG003|Overall Study|Other disease|0|||
48839728|NCT03375320|157254330|FG000|Overall Study|Withdrawal prior to initiation|2|||
48839729|NCT03375320|157254331|FG001|Overall Study|Withdrawal prior to initiation|2|||
48839730|NCT03375320|157254332|FG002|Overall Study|Withdrawal prior to initiation|1|||
48839731|NCT03375320|157254333|FG003|Overall Study|Withdrawal prior to initiation|0|||
48839732|NCT03375320|157254330|FG000|Overall Study|Physician Decision|1|||
48839733|NCT03375320|157254331|FG001|Overall Study|Physician Decision|1|||
48839734|NCT03375320|157254332|FG002|Overall Study|Physician Decision|1|||
48839735|NCT03375320|157254333|FG003|Overall Study|Physician Decision|1|||
48839736|NCT03375320|157254330|FG000|Overall Study|Non-compliance|1|||
48839737|NCT03375320|157254331|FG001|Overall Study|Non-compliance|0|||
48839738|NCT03375320|157254332|FG002|Overall Study|Non-compliance|0|||
48839739|NCT03375320|157254333|FG003|Overall Study|Non-compliance|0|||
48839740|NCT03058289|157254334|FG000|Overall Study|Radiographic Deterioration|0|||
48839741|NCT03058289|157254335|FG001|Overall Study|Radiographic Deterioration|3|||
48839742|NCT03058289|157254336|FG002|Overall Study|Radiographic Deterioration|1|||
48839743|NCT03058289|157254337|FG003|Overall Study|Radiographic Deterioration|2|||
48839744|NCT03058289|157254338|FG004|Overall Study|Radiographic Deterioration|6|||
48839745|NCT03058289|157254339|FG005|Overall Study|Radiographic Deterioration|3|||
48839746|NCT03058289|157254340|FG006|Overall Study|Radiographic Deterioration|0|||
48839747|NCT03058289|157254341|FG007|Overall Study|Radiographic Deterioration|4|||
48839748|NCT03058289|157254342|FG008|Overall Study|Radiographic Deterioration|2|||
48839749|NCT03058289|157254334|FG000|Overall Study|Adverse Event|2|||
48839750|NCT03058289|157254335|FG001|Overall Study|Adverse Event|0|||
48839751|NCT03058289|157254336|FG002|Overall Study|Adverse Event|1|||
48839752|NCT03058289|157254337|FG003|Overall Study|Adverse Event|3|||
48839753|NCT03058289|157254338|FG004|Overall Study|Adverse Event|1|||
48839754|NCT03058289|157254339|FG005|Overall Study|Adverse Event|0|||
48839755|NCT03058289|157254340|FG006|Overall Study|Adverse Event|1|||
48839756|NCT03058289|157254341|FG007|Overall Study|Adverse Event|3|||
48839757|NCT03058289|157254342|FG008|Overall Study|Adverse Event|0|||
48839758|NCT03058289|157254334|FG000|Overall Study|Withdrawal by Subject|0|||
48839759|NCT03058289|157254335|FG001|Overall Study|Withdrawal by Subject|0|||
48839760|NCT03058289|157254336|FG002|Overall Study|Withdrawal by Subject|0|||
48839761|NCT03058289|157254337|FG003|Overall Study|Withdrawal by Subject|2|||
48839762|NCT03058289|157254338|FG004|Overall Study|Withdrawal by Subject|0|||
48839763|NCT03058289|157254339|FG005|Overall Study|Withdrawal by Subject|2|||
48839764|NCT03058289|157254340|FG006|Overall Study|Withdrawal by Subject|0|||
48839765|NCT03058289|157254341|FG007|Overall Study|Withdrawal by Subject|4|||
48839766|NCT03058289|157254342|FG008|Overall Study|Withdrawal by Subject|1|||
48839767|NCT03058289|157254334|FG000|Overall Study|Physician Decision|1|||
48839768|NCT03058289|157254335|FG001|Overall Study|Physician Decision|0|||
48839769|NCT03058289|157254336|FG002|Overall Study|Physician Decision|0|||
48839770|NCT03058289|157254337|FG003|Overall Study|Physician Decision|2|||
48839771|NCT03058289|157254338|FG004|Overall Study|Physician Decision|1|||
48839772|NCT03058289|157254339|FG005|Overall Study|Physician Decision|0|||
48839773|NCT03058289|157254340|FG006|Overall Study|Physician Decision|2|||
48839774|NCT03058289|157254341|FG007|Overall Study|Physician Decision|3|||
48839775|NCT03058289|157254342|FG008|Overall Study|Physician Decision|0|||
48839776|NCT03058289|157254334|FG000|Overall Study|Clinical Deterioration|2|||
48839777|NCT03058289|157254335|FG001|Overall Study|Clinical Deterioration|0|||
48839778|NCT03058289|157254336|FG002|Overall Study|Clinical Deterioration|0|||
48839779|NCT03058289|157254337|FG003|Overall Study|Clinical Deterioration|2|||
48839780|NCT03058289|157254338|FG004|Overall Study|Clinical Deterioration|1|||
48839781|NCT03058289|157254339|FG005|Overall Study|Clinical Deterioration|1|||
48839782|NCT03058289|157254340|FG006|Overall Study|Clinical Deterioration|0|||
48839783|NCT03058289|157254341|FG007|Overall Study|Clinical Deterioration|3|||
48605619|NCT00843492|156411768|FG001|Overall Study|Immobilization Stopped|0|||
48605620|NCT00843492|156411767|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
48839784|NCT03058289|157254342|FG008|Overall Study|Clinical Deterioration|2|||
48839785|NCT03058289|157254334|FG000|Overall Study|Lost to Follow-up|0|||
48839786|NCT03058289|157254335|FG001|Overall Study|Lost to Follow-up|0|||
48839787|NCT03058289|157254336|FG002|Overall Study|Lost to Follow-up|0|||
48839788|NCT03058289|157254337|FG003|Overall Study|Lost to Follow-up|0|||
48605621|NCT00843492|156411768|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
48605622|NCT00843492|156411767|FG000|Overall Study|Orthopedic Surgery|0|||
48605623|NCT00843492|156411768|FG001|Overall Study|Orthopedic Surgery|2|||
48605624|NCT00843492|156411767|FG000|Overall Study|Visit Not Performed|1|||
48536803|NCT02243293|156153013|FG018|Overall Study|Adverse Event|0|||
48536804|NCT02243293|156153014|FG019|Overall Study|Adverse Event|0|||
48839789|NCT03058289|157254338|FG004|Overall Study|Lost to Follow-up|1|||
48839790|NCT03058289|157254339|FG005|Overall Study|Lost to Follow-up|0|||
48605625|NCT00843492|156411768|FG001|Overall Study|Visit Not Performed|0|||
48605626|NCT00843492|156411767|FG000|Overall Study|Deep-vein Thrombosis|1|||
48605627|NCT00843492|156411768|FG001|Overall Study|Deep-vein Thrombosis|0|||
48605628|NCT01100502|156411770|FG000|Overall Study|Withdrawal by Subject|18|||
48605629|NCT01100502|156411771|FG001|Overall Study|Withdrawal by Subject|25|||
48605630|NCT01100502|156411770|FG000|Overall Study|Lost to Follow-up|13|||
48605631|NCT01100502|156411771|FG001|Overall Study|Lost to Follow-up|28|||
48605632|NCT01100502|156411770|FG000|Overall Study|Site request to end participation in study|0|||
48605633|NCT01100502|156411771|FG001|Overall Study|Site request to end participation in study|1|||
48605634|NCT01100502|156411770|FG000|Overall Study|Death|45|||
48605635|NCT01100502|156411771|FG001|Overall Study|Death|40|||
48605636|NCT01618968|156411772|FG000|Overall Study|Adverse Event|1|||
48605637|NCT01618968|156411773|FG001|Overall Study|Adverse Event|0|||
48605638|NCT01618968|156411774|FG002|Overall Study|Adverse Event|0|||
48605639|NCT01618968|156411775|FG003|Overall Study|Adverse Event|0|||
48605640|NCT01618968|156411772|FG000|Overall Study|Death|0|||
48605641|NCT01618968|156411773|FG001|Overall Study|Death|0|||
48605642|NCT01618968|156411774|FG002|Overall Study|Death|0|||
48605643|NCT01618968|156411775|FG003|Overall Study|Death|1|||
48839791|NCT03058289|157254340|FG006|Overall Study|Lost to Follow-up|0|||
48839792|NCT03058289|157254341|FG007|Overall Study|Lost to Follow-up|0|||
48839793|NCT03058289|157254342|FG008|Overall Study|Lost to Follow-up|0|||
48839794|NCT03058289|157254334|FG000|Overall Study|Refused Further Treatment|0|||
48839795|NCT03058289|157254335|FG001|Overall Study|Refused Further Treatment|0|||
48839796|NCT03058289|157254336|FG002|Overall Study|Refused Further Treatment|1|||
48839797|NCT03058289|157254337|FG003|Overall Study|Refused Further Treatment|0|||
48839798|NCT03058289|157254338|FG004|Overall Study|Refused Further Treatment|1|||
48839799|NCT03058289|157254339|FG005|Overall Study|Refused Further Treatment|0|||
48839800|NCT03058289|157254340|FG006|Overall Study|Refused Further Treatment|0|||
48839801|NCT03058289|157254341|FG007|Overall Study|Refused Further Treatment|0|||
48839802|NCT03058289|157254342|FG008|Overall Study|Refused Further Treatment|0|||
48839803|NCT03058289|157254334|FG000|Overall Study|Rapid Progression of Disease|0|||
48536805|NCT02243293|156153015|FG020|Overall Study|Adverse Event|1|||
48536806|NCT02243293|156153016|FG021|Overall Study|Adverse Event|0|||
48536807|NCT02243293|156152995|FG000|Overall Study|Withdrawal by Subject|1|||
48536808|NCT02243293|156152996|FG001|Overall Study|Withdrawal by Subject|0|||
48536809|NCT02243293|156152997|FG002|Overall Study|Withdrawal by Subject|0|||
48536810|NCT02243293|156152998|FG003|Overall Study|Withdrawal by Subject|0|||
48536811|NCT02243293|156152999|FG004|Overall Study|Withdrawal by Subject|0|||
48536812|NCT02243293|156153000|FG005|Overall Study|Withdrawal by Subject|0|||
48536813|NCT02243293|156153001|FG006|Overall Study|Withdrawal by Subject|0|||
48536814|NCT02243293|156153002|FG007|Overall Study|Withdrawal by Subject|0|||
48536815|NCT02243293|156153003|FG008|Overall Study|Withdrawal by Subject|0|||
48536816|NCT02243293|156153004|FG009|Overall Study|Withdrawal by Subject|1|||
48536817|NCT02243293|156153005|FG010|Overall Study|Withdrawal by Subject|0|||
48536818|NCT02243293|156153006|FG011|Overall Study|Withdrawal by Subject|1|||
48536819|NCT02243293|156153007|FG012|Overall Study|Withdrawal by Subject|0|||
48536820|NCT02243293|156153008|FG013|Overall Study|Withdrawal by Subject|0|||
48605644|NCT00073918|156411777|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
48839804|NCT03058289|157254335|FG001|Overall Study|Rapid Progression of Disease|0|||
48839805|NCT03058289|157254336|FG002|Overall Study|Rapid Progression of Disease|0|||
48605645|NCT00073918|156411777|FG000|Overall Study|Rapid disease progression|2|||
48839806|NCT03058289|157254337|FG003|Overall Study|Rapid Progression of Disease|1|||
48536821|NCT02243293|156153009|FG014|Overall Study|Withdrawal by Subject|0|||
48536822|NCT02243293|156153010|FG015|Overall Study|Withdrawal by Subject|0|||
48536823|NCT02243293|156153011|FG016|Overall Study|Withdrawal by Subject|0|||
48536824|NCT02243293|156153012|FG017|Overall Study|Withdrawal by Subject|0|||
48536825|NCT02243293|156153013|FG018|Overall Study|Withdrawal by Subject|0|||
48536826|NCT02243293|156153014|FG019|Overall Study|Withdrawal by Subject|0|||
48536827|NCT02243293|156153015|FG020|Overall Study|Withdrawal by Subject|0|||
48536828|NCT02243293|156153016|FG021|Overall Study|Withdrawal by Subject|1|||
48536829|NCT02243293|156152995|FG000|Overall Study|Lost to Follow-up|0|||
48536830|NCT02243293|156152996|FG001|Overall Study|Lost to Follow-up|1|||
48536831|NCT02243293|156152997|FG002|Overall Study|Lost to Follow-up|1|||
48536832|NCT02243293|156152998|FG003|Overall Study|Lost to Follow-up|1|||
48536833|NCT02243293|156152999|FG004|Overall Study|Lost to Follow-up|0|||
48839807|NCT03058289|157254338|FG004|Overall Study|Rapid Progression of Disease|0|||
48839808|NCT03058289|157254339|FG005|Overall Study|Rapid Progression of Disease|0|||
48839809|NCT03058289|157254340|FG006|Overall Study|Rapid Progression of Disease|0|||
48839810|NCT03058289|157254341|FG007|Overall Study|Rapid Progression of Disease|0|||
48839811|NCT03058289|157254342|FG008|Overall Study|Rapid Progression of Disease|0|||
48839812|NCT02319837|157254351|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
48839813|NCT02319837|157254352|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
48839814|NCT02319837|157254353|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
48839815|NCT02319837|157254351|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
48839816|NCT02319837|157254352|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
48839817|NCT02319837|157254353|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
48839818|NCT02319837|157254351|FG000|Study Treatment Phase|Adverse Event|73|||
48839819|NCT02319837|157254352|FG001|Study Treatment Phase|Adverse Event|36|||
48839820|NCT02319837|157254353|FG002|Study Treatment Phase|Adverse Event|63|||
48839821|NCT02319837|157254351|FG000|Study Treatment Phase|Development of castration resistance|0|||
48839822|NCT02319837|157254352|FG001|Study Treatment Phase|Development of castration resistance|2|||
48839823|NCT02319837|157254353|FG002|Study Treatment Phase|Development of castration resistance|0|||
48839824|NCT02319837|157254351|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
48839825|NCT02319837|157254352|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
48839826|NCT02319837|157254353|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
48839827|NCT02319837|157254351|FG000|Study Treatment Phase|Protocol Violation|2|||
48839828|NCT02319837|157254352|FG001|Study Treatment Phase|Protocol Violation|2|||
48839829|NCT02319837|157254353|FG002|Study Treatment Phase|Protocol Violation|1|||
48839830|NCT02319837|157254351|FG000|Study Treatment Phase|Lost to Follow-up|0|||
48839831|NCT02319837|157254352|FG001|Study Treatment Phase|Lost to Follow-up|1|||
48839832|NCT02319837|157254353|FG002|Study Treatment Phase|Lost to Follow-up|0|||
48839833|NCT02319837|157254351|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
48839834|NCT02319837|157254352|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
48839835|NCT02319837|157254353|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
48839836|NCT02319837|157254351|FG000|Study Treatment Phase|Other|0|||
48839837|NCT02319837|157254352|FG001|Study Treatment Phase|Other|1|||
48536834|NCT02243293|156153000|FG005|Overall Study|Lost to Follow-up|0|||
48536835|NCT02243293|156153001|FG006|Overall Study|Lost to Follow-up|3|||
48536836|NCT02243293|156153002|FG007|Overall Study|Lost to Follow-up|0|||
48536837|NCT02243293|156153003|FG008|Overall Study|Lost to Follow-up|0|||
48536838|NCT02243293|156153004|FG009|Overall Study|Lost to Follow-up|0|||
48536839|NCT02243293|156153005|FG010|Overall Study|Lost to Follow-up|0|||
48536840|NCT02243293|156153006|FG011|Overall Study|Lost to Follow-up|2|||
48536841|NCT02243293|156153007|FG012|Overall Study|Lost to Follow-up|0|||
48536842|NCT02243293|156153008|FG013|Overall Study|Lost to Follow-up|0|||
48536843|NCT02243293|156153009|FG014|Overall Study|Lost to Follow-up|0|||
48536844|NCT02243293|156153010|FG015|Overall Study|Lost to Follow-up|0|||
48536845|NCT02243293|156153011|FG016|Overall Study|Lost to Follow-up|3|||
48536846|NCT02243293|156153012|FG017|Overall Study|Lost to Follow-up|1|||
48536847|NCT02243293|156153013|FG018|Overall Study|Lost to Follow-up|0|||
48536848|NCT02243293|156153014|FG019|Overall Study|Lost to Follow-up|0|||
48839838|NCT02319837|157254353|FG002|Study Treatment Phase|Other|0|||
48839839|NCT02319837|157254351|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
48839840|NCT02319837|157254352|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
48839841|NCT02319837|157254353|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
48839842|NCT02319837|157254351|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
48839843|NCT02319837|157254352|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
48839844|NCT02319837|157254353|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
48536849|NCT02243293|156153015|FG020|Overall Study|Lost to Follow-up|1|||
48536850|NCT02243293|156153016|FG021|Overall Study|Lost to Follow-up|2|||
48536851|NCT02243293|156152995|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
48536852|NCT02243293|156152996|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
48536853|NCT02243293|156152997|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
48536854|NCT02243293|156152998|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
48536855|NCT02243293|156152999|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
48536856|NCT02243293|156153000|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
48536857|NCT02243293|156153001|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
48536858|NCT02243293|156153002|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
48536859|NCT02243293|156153003|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
48536860|NCT02243293|156153004|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
48536861|NCT02243293|156153005|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
48536862|NCT02243293|156153006|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
48536863|NCT02243293|156153007|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
48536864|NCT02243293|156153008|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
48536865|NCT02243293|156153009|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
48536866|NCT02243293|156153010|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
48536867|NCT02243293|156153011|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
48605646|NCT00073918|156411777|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
48605647|NCT00496769|156413534|FG000|Double Blind|>=1 reason assigned per patient|558|||
48605648|NCT00496769|156413535|FG001|Double Blind|>=1 reason assigned per patient|649|||
48605649|NCT00496769|156413536|FG002|Double Blind|>=1 reason assigned per patient|0|||
48605650|NCT00496769|156413534|FG000|Open Label|>=1 reason assigned per patient|0|||
48605651|NCT00496769|156413535|FG001|Open Label|>=1 reason assigned per patient|0|||
48605652|NCT00496769|156413536|FG002|Open Label|>=1 reason assigned per patient|1011|||
48605653|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
48605654|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
48605655|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
48605656|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
48536868|NCT02243293|156153012|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
48605657|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
48605658|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
48605659|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
48605660|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
48605661|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
48839845|NCT02319837|157254351|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
48839846|NCT02319837|157254352|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
48536869|NCT02243293|156153013|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
48536870|NCT02243293|156153014|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
48536871|NCT02243293|156153015|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
48536872|NCT02243293|156153016|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
48536873|NCT02243293|156152995|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
48536874|NCT02243293|156152996|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
48605662|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
48839847|NCT02319837|157254353|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
48839848|NCT02319837|157254351|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
48839849|NCT02319837|157254352|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
48839850|NCT02319837|157254353|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
48839851|NCT02319837|157254351|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
48839852|NCT02319837|157254352|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
48839853|NCT02319837|157254353|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
48839854|NCT02319837|157254351|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
48839855|NCT02319837|157254352|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
48839856|NCT02319837|157254353|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
48839857|NCT02319837|157254351|FG000|Long-Term Follow-Up Phase|Death|33|||
48839858|NCT02319837|157254352|FG001|Long-Term Follow-Up Phase|Death|54|||
48839859|NCT02319837|157254353|FG002|Long-Term Follow-Up Phase|Death|42|||
48839860|NCT04159415|157254354|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
48839861|NCT04159415|157254355|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
48839862|NCT04159415|157254356|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
48839863|NCT04159415|157254357|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
48839864|NCT04159415|157254358|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
48839865|NCT04159415|157254359|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
48839866|NCT04159415|157254360|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
48839867|NCT04159415|157254361|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
48839868|NCT03941860|157254362|FG000|Overall Study|Withdrawal by Subject|0|||
48839869|NCT03941860|157254363|FG001|Overall Study|Withdrawal by Subject|1|||
48839870|NCT02505984|157254368|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
48839871|NCT02505984|157254369|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
48839872|NCT02505984|157254368|FG000|Overall Study|Unreliable self-report data|1|||
48839873|NCT02505984|157254369|FG001|Overall Study|Unreliable self-report data|0|||
48839874|NCT02505984|157254368|FG000|Overall Study|Study blind opened during assessment|0|||
48839875|NCT02505984|157254369|FG001|Overall Study|Study blind opened during assessment|1|||
48839876|NCT02505984|157254368|FG000|Overall Study|Noncompliance with study protocol|0|||
48839877|NCT02505984|157254369|FG001|Overall Study|Noncompliance with study protocol|1|||
48839878|NCT02421939|157254376|FG000|Overall Study|Progressive disease|70|||
48839879|NCT02421939|157254377|FG001|Overall Study|Progressive disease|16|||
48839880|NCT02421939|157254376|FG000|Overall Study|Lack of Efficacy|21|||
48839881|NCT02421939|157254377|FG001|Overall Study|Lack of Efficacy|31|||
48839882|NCT02421939|157254376|FG000|Overall Study|Death|36|||
48839883|NCT02421939|157254377|FG001|Overall Study|Death|10|||
48839884|NCT02421939|157254376|FG000|Overall Study|Disease relapse|33|||
48839885|NCT02421939|157254377|FG001|Overall Study|Disease relapse|2|||
48839886|NCT02421939|157254376|FG000|Overall Study|Adverse Event|28|||
48839887|NCT02421939|157254377|FG001|Overall Study|Adverse Event|5|||
48839888|NCT02421939|157254376|FG000|Overall Study|Withdrawal by Subject|5|||
48536875|NCT02243293|156152997|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
48536876|NCT02243293|156152998|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
48536877|NCT02243293|156152999|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
48536878|NCT02243293|156153000|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
48536879|NCT02243293|156153001|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
48536880|NCT02243293|156153002|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
48536881|NCT02243293|156153003|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
48536882|NCT02243293|156153004|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
48536883|NCT02243293|156153005|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
48536884|NCT02243293|156153006|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
48536885|NCT02243293|156153007|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
48536886|NCT02243293|156153008|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
48536887|NCT02243293|156153009|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
48536888|NCT02243293|156153010|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
48536889|NCT02243293|156153011|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
48536890|NCT02243293|156153012|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
48536891|NCT02243293|156153013|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
48536892|NCT02243293|156153014|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
48536893|NCT02243293|156153015|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
48536894|NCT02243293|156153016|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
48536895|NCT01138111|156153017|FG000|Overall Study|Withdrawal by Subject|5|||
48536896|NCT01138111|156153017|FG000|Overall Study|Adverse Event|1|||
48536897|NCT01138111|156153017|FG000|Overall Study|Death|1|||
48536898|NCT01138111|156153017|FG000|Overall Study|Lost to Follow-up|2|||
48536899|NCT00560937|156153020|FG000|Overall Study|Withdrawal by Subject|0|||
48536900|NCT00560937|156153021|FG001|Overall Study|Withdrawal by Subject|1|||
48536901|NCT00560937|156153020|FG000|Overall Study|Physician Decision|1|||
48536902|NCT00560937|156153021|FG001|Overall Study|Physician Decision|1|||
48536903|NCT01558297|156153022|FG000|Overall Study|Withdrawal by Subject|2|||
48536904|NCT01558297|156153023|FG001|Overall Study|Withdrawal by Subject|2|||
48536905|NCT01558297|156153024|FG002|Overall Study|Withdrawal by Subject|1|||
48536906|NCT03870477|156153025|FG000|Overall Study|Early Study Termination|1|||
48536907|NCT01674647|156153026|FG000|Treatment Period|Death|4|||
48536908|NCT01674647|156153027|FG001|Treatment Period|Death|1|||
48536909|NCT01674647|156153026|FG000|Treatment Period|Efficacy outcome reached|0|||
48536910|NCT01674647|156153027|FG001|Treatment Period|Efficacy outcome reached|1|||
48536911|NCT01674647|156153026|FG000|Treatment Period|Physician Decision|3|||
48536912|NCT01674647|156153027|FG001|Treatment Period|Physician Decision|1|||
48839889|NCT02421939|157254377|FG001|Overall Study|Withdrawal by Subject|24|||
48839890|NCT02421939|157254376|FG000|Overall Study|Physician Decision|11|||
48839891|NCT02421939|157254377|FG001|Overall Study|Physician Decision|11|||
48839892|NCT02421939|157254376|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
48839893|NCT02421939|157254377|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
48839894|NCT02421939|157254376|FG000|Overall Study|Miscellaneous|4|||
48839895|NCT02421939|157254377|FG001|Overall Study|Miscellaneous|5|||
48839896|NCT02421939|157254376|FG000|Overall Study|Protocol deviation|1|||
48839897|NCT02421939|157254377|FG001|Overall Study|Protocol deviation|1|||
48839898|NCT05934942|157254378|FG000|Run-in Period|Not treated|1|||
48839899|NCT05934942|157254378|FG000|Run-in Period|Withdrawal by Subject|1|||
48839900|NCT04362254|157254381|FG000|Overall Study|Adverse Event|1|||
48839901|NCT04362254|157254381|FG000|Overall Study|Protocol Violation|1|||
48839902|NCT04362254|157254381|FG000|Overall Study|Due to early termination of the trial|10|||
48839903|NCT02003209|157254382|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
48839904|NCT02003209|157254383|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
48839905|NCT04707625|157254386|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
48839906|NCT02038777|157254387|FG000|Overall Study|Death|0|||
48839907|NCT02038777|157254388|FG001|Overall Study|Death|2|||
48839908|NCT02038777|157254389|FG002|Overall Study|Death|0|||
48839909|NCT02038777|157254390|FG003|Overall Study|Death|1|||
48839910|NCT02038777|157254391|FG004|Overall Study|Death|2|||
48839911|NCT02038777|157254392|FG005|Overall Study|Death|4|||
48839912|NCT02038777|157254393|FG006|Overall Study|Death|0|||
48839913|NCT02038777|157254394|FG007|Overall Study|Death|11|||
48839914|NCT02038777|157254387|FG000|Overall Study|Lost to Follow-up|0|||
48839915|NCT02038777|157254388|FG001|Overall Study|Lost to Follow-up|0|||
48839916|NCT02038777|157254389|FG002|Overall Study|Lost to Follow-up|0|||
48839917|NCT02038777|157254390|FG003|Overall Study|Lost to Follow-up|1|||
48839918|NCT02038777|157254391|FG004|Overall Study|Lost to Follow-up|0|||
48839919|NCT02038777|157254392|FG005|Overall Study|Lost to Follow-up|0|||
48839920|NCT02038777|157254393|FG006|Overall Study|Lost to Follow-up|0|||
48839921|NCT02038777|157254394|FG007|Overall Study|Lost to Follow-up|0|||
48839922|NCT02038777|157254387|FG000|Overall Study|Other|0|||
48839923|NCT02038777|157254388|FG001|Overall Study|Other|1|||
48839924|NCT02038777|157254389|FG002|Overall Study|Other|0|||
48839925|NCT02038777|157254390|FG003|Overall Study|Other|2|||
48839926|NCT02038777|157254391|FG004|Overall Study|Other|1|||
48839927|NCT02038777|157254392|FG005|Overall Study|Other|0|||
48839928|NCT02038777|157254393|FG006|Overall Study|Other|0|||
48536913|NCT01674647|156153026|FG000|Treatment Period|Adverse Event|60|||
48536914|NCT01674647|156153027|FG001|Treatment Period|Adverse Event|22|||
48536915|NCT01674647|156153026|FG000|Treatment Period|Non-compliance with study drug|3|||
48536916|NCT01674647|156153027|FG001|Treatment Period|Non-compliance with study drug|0|||
48839929|NCT02038777|157254394|FG007|Overall Study|Other|0|||
48839930|NCT02038777|157254387|FG000|Overall Study|Randomized but not treated|0|||
48839931|NCT02038777|157254388|FG001|Overall Study|Randomized but not treated|1|||
48839932|NCT02038777|157254389|FG002|Overall Study|Randomized but not treated|0|||
48839933|NCT02038777|157254390|FG003|Overall Study|Randomized but not treated|0|||
48839934|NCT02038777|157254391|FG004|Overall Study|Randomized but not treated|0|||
48839935|NCT02038777|157254392|FG005|Overall Study|Randomized but not treated|0|||
48839936|NCT02038777|157254393|FG006|Overall Study|Randomized but not treated|0|||
48839937|NCT02038777|157254394|FG007|Overall Study|Randomized but not treated|0|||
48839938|NCT02038777|157254387|FG000|Overall Study|Started Chemotherapy|1|||
48839939|NCT02038777|157254388|FG001|Overall Study|Started Chemotherapy|0|||
48839940|NCT02038777|157254389|FG002|Overall Study|Started Chemotherapy|3|||
48839941|NCT02038777|157254390|FG003|Overall Study|Started Chemotherapy|0|||
48839942|NCT02038777|157254391|FG004|Overall Study|Started Chemotherapy|0|||
48839943|NCT02038777|157254392|FG005|Overall Study|Started Chemotherapy|0|||
48839944|NCT02038777|157254393|FG006|Overall Study|Started Chemotherapy|0|||
48839945|NCT02038777|157254394|FG007|Overall Study|Started Chemotherapy|0|||
48839946|NCT02038777|157254387|FG000|Overall Study|participation terminated by sponsor|0|||
48839947|NCT02038777|157254388|FG001|Overall Study|participation terminated by sponsor|0|||
48839948|NCT02038777|157254389|FG002|Overall Study|participation terminated by sponsor|0|||
48839949|NCT02038777|157254390|FG003|Overall Study|participation terminated by sponsor|0|||
48839950|NCT02038777|157254391|FG004|Overall Study|participation terminated by sponsor|0|||
48839951|NCT02038777|157254392|FG005|Overall Study|participation terminated by sponsor|0|||
48839952|NCT02038777|157254393|FG006|Overall Study|participation terminated by sponsor|1|||
48839953|NCT02038777|157254394|FG007|Overall Study|participation terminated by sponsor|1|||
48839954|NCT02115282|157254395|FG000|Overall Study|Disease progression during treatment|216|||
48839955|NCT02115282|157254396|FG001|Overall Study|Disease progression during treatment|229|||
48839956|NCT02115282|157254395|FG000|Overall Study|Adverse Event|49|||
48839957|NCT02115282|157254396|FG001|Overall Study|Adverse Event|23|||
48839958|NCT02115282|157254395|FG000|Overall Study|Death|1|||
48839959|NCT02115282|157254396|FG001|Overall Study|Death|3|||
48839960|NCT02115282|157254395|FG000|Overall Study|Alternative therapy|1|||
48839961|NCT02115282|157254396|FG001|Overall Study|Alternative therapy|1|||
48839962|NCT02115282|157254395|FG000|Overall Study|Complicating disease|0|||
48839963|NCT02115282|157254396|FG001|Overall Study|Complicating disease|3|||
48839964|NCT02115282|157254395|FG000|Overall Study|Withdrawal by Subject|12|||
48839965|NCT02115282|157254396|FG001|Overall Study|Withdrawal by Subject|10|||
48839966|NCT02115282|157254395|FG000|Overall Study|Symptomatic progression/deterioration|7|||
48839967|NCT02115282|157254396|FG001|Overall Study|Symptomatic progression/deterioration|18|||
48839968|NCT02115282|157254395|FG000|Overall Study|Non-compliance|5|||
48839969|NCT02115282|157254396|FG001|Overall Study|Non-compliance|1|||
48839970|NCT02115282|157254395|FG000|Overall Study|Protocol Violation|2|||
48839971|NCT02115282|157254396|FG001|Overall Study|Protocol Violation|2|||
48839972|NCT02115282|157254395|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
48839973|NCT02115282|157254396|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
48839974|NCT02115282|157254395|FG000|Overall Study|Not start protocol therapy|9|||
48839975|NCT02115282|157254396|FG001|Overall Study|Not start protocol therapy|10|||
48839976|NCT04590963|157254397|FG000|Overall Study|Death|118|||
48839977|NCT04590963|157254398|FG001|Overall Study|Death|59|||
48839978|NCT04590963|157254397|FG000|Overall Study|Lost to Follow-up|1|||
48839979|NCT04590963|157254398|FG001|Overall Study|Lost to Follow-up|1|||
48839980|NCT04590963|157254397|FG000|Overall Study|Progressive disease|0|||
48839981|NCT04590963|157254398|FG001|Overall Study|Progressive disease|1|||
48839982|NCT04590963|157254397|FG000|Overall Study|Study terminated by sponsor|103|||
48839983|NCT04590963|157254398|FG001|Overall Study|Study terminated by sponsor|50|||
48839984|NCT04590963|157254397|FG000|Overall Study|Withdrawal by Subject|15|||
48839985|NCT04590963|157254398|FG001|Overall Study|Withdrawal by Subject|8|||
48839986|NCT04590963|157254397|FG000|Overall Study|Ongoing at data cut-off|9|||
48839987|NCT04590963|157254398|FG001|Overall Study|Ongoing at data cut-off|4|||
48839988|NCT04590963|157254397|FG000|Overall Study|Screen failure|1|||
48839989|NCT04590963|157254398|FG001|Overall Study|Screen failure|0|||
48839990|NCT02424617|157254399|FG000|Overall Study|Adverse Event|0|||
48839991|NCT02424617|157254400|FG001|Overall Study|Adverse Event|1|||
48839992|NCT02424617|157254401|FG002|Overall Study|Adverse Event|0|||
48839993|NCT02424617|157254402|FG003|Overall Study|Adverse Event|0|||
48839994|NCT02424617|157254399|FG000|Overall Study|Investigator Decision|0|||
48839995|NCT02424617|157254400|FG001|Overall Study|Investigator Decision|0|||
48839996|NCT02424617|157254401|FG002|Overall Study|Investigator Decision|0|||
48839997|NCT02424617|157254402|FG003|Overall Study|Investigator Decision|1|||
48839998|NCT02424617|157254399|FG000|Overall Study|Withdrawal by Subject|1|||
48839999|NCT02424617|157254400|FG001|Overall Study|Withdrawal by Subject|1|||
48840000|NCT02424617|157254401|FG002|Overall Study|Withdrawal by Subject|0|||
48840001|NCT02424617|157254402|FG003|Overall Study|Withdrawal by Subject|1|||
48840002|NCT02424617|157254399|FG000|Overall Study|Progressive Disease|7|||
48840003|NCT02424617|157254400|FG001|Overall Study|Progressive Disease|6|||
48840004|NCT02424617|157254401|FG002|Overall Study|Progressive Disease|11|||
48605663|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
48605664|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
48840005|NCT02424617|157254402|FG003|Overall Study|Progressive Disease|10|||
48840006|NCT02424617|157254399|FG000|Overall Study|Other|0|||
48840007|NCT02424617|157254400|FG001|Overall Study|Other|0|||
48840008|NCT02424617|157254401|FG002|Overall Study|Other|0|||
48840009|NCT02424617|157254402|FG003|Overall Study|Other|1|||
48840010|NCT04414722|157254403|FG000|Overall Study|Lost to Follow-up|3|||
48840011|NCT04414722|157254404|FG001|Overall Study|Lost to Follow-up|4|||
48840012|NCT04414722|157254405|FG002|Overall Study|Lost to Follow-up|3|||
48840013|NCT04414722|157254406|FG003|Overall Study|Lost to Follow-up|2|||
48840014|NCT04414722|157254407|FG004|Overall Study|Lost to Follow-up|3|||
48840015|NCT04414722|157254403|FG000|Overall Study|Withdrawal by Subject|6|||
48840016|NCT04414722|157254404|FG001|Overall Study|Withdrawal by Subject|3|||
48840017|NCT04414722|157254405|FG002|Overall Study|Withdrawal by Subject|1|||
48840018|NCT04414722|157254406|FG003|Overall Study|Withdrawal by Subject|5|||
48840019|NCT04414722|157254407|FG004|Overall Study|Withdrawal by Subject|1|||
48840020|NCT04414722|157254403|FG000|Overall Study|Physician Decision|0|||
48840021|NCT04414722|157254404|FG001|Overall Study|Physician Decision|1|||
48840022|NCT04414722|157254405|FG002|Overall Study|Physician Decision|2|||
48840023|NCT04414722|157254406|FG003|Overall Study|Physician Decision|0|||
48840024|NCT04414722|157254407|FG004|Overall Study|Physician Decision|0|||
48840025|NCT04414722|157254403|FG000|Overall Study|Non-participatory|0|||
48840026|NCT04414722|157254404|FG001|Overall Study|Non-participatory|1|||
48840027|NCT04414722|157254405|FG002|Overall Study|Non-participatory|1|||
48840028|NCT04414722|157254406|FG003|Overall Study|Non-participatory|0|||
48840029|NCT04414722|157254407|FG004|Overall Study|Non-participatory|0|||
48840030|NCT00769379|157254408|FG000|Overall Study|No follow up data mapped to Other.|3|||
48840031|NCT00769379|157254409|FG001|Overall Study|No follow up data mapped to Other.|13|||
48840032|NCT01275677|157254410|FG000|Overall Study|Not at risk for recurrence.|1|||
48840033|NCT01275677|157254411|FG001|Overall Study|Not at risk for recurrence.|1|||
48840034|NCT01275677|157254410|FG000|Overall Study|No follow-up|26|||
48605665|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
48840035|NCT01275677|157254411|FG001|Overall Study|No follow-up|37|||
48840036|NCT01275677|157254410|FG000|Overall Study|No clinical follow up.|1|||
48840037|NCT01275677|157254411|FG001|Overall Study|No clinical follow up.|4|||
48840038|NCT01627574|157254412|FG000|Overall Study|Withdrawal by Subject|8|||
48840039|NCT01627574|157254413|FG001|Overall Study|Withdrawal by Subject|5|||
48840040|NCT01627574|157254412|FG000|Overall Study|Lost to Follow-up|13|||
48840041|NCT01627574|157254413|FG001|Overall Study|Lost to Follow-up|13|||
48840042|NCT00792948|157254414|FG000|Overall Study|Adverse Event|6|||
48605666|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
48605667|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
48605668|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
48605669|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
48605670|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
48605671|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
48605672|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
48605673|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
48605674|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
48605675|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
48605676|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
48605677|NCT01198002|156413537|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
48605678|NCT01198002|156413538|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
48605679|NCT01198002|156413539|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
48605680|NCT01198002|156413537|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
48605681|NCT01198002|156413538|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
48605682|NCT01198002|156413539|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
48605683|NCT01198002|156413537|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
48605684|NCT01198002|156413538|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
48605685|NCT01198002|156413539|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
48605686|NCT01198002|156413537|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
48605687|NCT01198002|156413538|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
48605688|NCT01198002|156413539|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
48605689|NCT01198002|156413537|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
48605690|NCT01198002|156413538|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
48605691|NCT01198002|156413539|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
48605692|NCT01198002|156413537|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
48605693|NCT01198002|156413538|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
48605694|NCT01198002|156413539|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
48840043|NCT00792948|157254414|FG000|Overall Study|Death|4|||
48840044|NCT00792948|157254414|FG000|Overall Study|Withdrawal by Subject|3|||
48840045|NCT00792948|157254414|FG000|Overall Study|Ineligible|2|||
48840046|NCT00792948|157254414|FG000|Overall Study|Insurance denial - not treated|1|||
48840047|NCT00792948|157254414|FG000|Overall Study|Physician Decision|11|||
48840048|NCT00792948|157254414|FG000|Overall Study|Protocol Violation|1|||
48840049|NCT02446600|157254415|FG000|Overall Study|Never treated|20|||
48840050|NCT02446600|157254416|FG001|Overall Study|Never treated|2|||
48840051|NCT02446600|157254417|FG002|Overall Study|Never treated|6|||
48840052|NCT02446600|157254418|FG003|Overall Study|Never treated|0|||
48840053|NCT02446600|157254415|FG000|Overall Study|Withdrawal by Subject|19|||
48840054|NCT02446600|157254416|FG001|Overall Study|Withdrawal by Subject|5|||
48840055|NCT02446600|157254417|FG002|Overall Study|Withdrawal by Subject|17|||
48840056|NCT02446600|157254418|FG003|Overall Study|Withdrawal by Subject|0|||
48840057|NCT02446600|157254415|FG000|Overall Study|Ineligible|1|||
48840058|NCT02446600|157254416|FG001|Overall Study|Ineligible|4|||
48840059|NCT02446600|157254417|FG002|Overall Study|Ineligible|4|||
48840060|NCT02446600|157254418|FG003|Overall Study|Ineligible|1|||
48840061|NCT02446600|157254415|FG000|Overall Study|Duplicate Enrollment|0|||
48840062|NCT02446600|157254416|FG001|Overall Study|Duplicate Enrollment|1|||
48840063|NCT02446600|157254417|FG002|Overall Study|Duplicate Enrollment|0|||
48840064|NCT02446600|157254418|FG003|Overall Study|Duplicate Enrollment|0|||
48840065|NCT02152995|157254419|FG000|Overall Study|Withdrawal by Subject|1|||
48840066|NCT02152995|157254420|FG001|Overall Study|Withdrawal by Subject|0|||
48840067|NCT03692052|157254424|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
48840068|NCT03692052|157254424|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
48840069|NCT03692052|157254424|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
48840070|NCT03692052|157254424|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
48840071|NCT03442309|157254425|FG000|Overall Study|Lost to Follow-up|1676|||
48840072|NCT03442309|157254426|FG001|Overall Study|Lost to Follow-up|1642|||
48840073|NCT04428476|157254427|FG000|Overall Study|Withdrawal by Subject|1|||
48840074|NCT04428476|157254427|FG000|Overall Study|Still on treatment|12|||
48840075|NCT02466971|157254428|FG000|Overall Study|eligible and never treated|14|||
48840076|NCT02466971|157254429|FG001|Overall Study|eligible and never treated|20|||
48840077|NCT02466971|157254428|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
48840078|NCT02466971|157254429|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
48840079|NCT02466971|157254428|FG000|Overall Study|ineligible and treated|1|||
48840080|NCT02466971|157254429|FG001|Overall Study|ineligible and treated|0|||
48840081|NCT02466971|157254428|FG000|Overall Study|ineligible and never treated|0|||
48840082|NCT02466971|157254429|FG001|Overall Study|ineligible and never treated|1|||
48840083|NCT03362190|157254430|FG000|Overall Study|Adverse Event|0|||
48840084|NCT03362190|157254431|FG001|Overall Study|Adverse Event|0|||
48840085|NCT03362190|157254432|FG002|Overall Study|Adverse Event|0|||
48840086|NCT03362190|157254433|FG003|Overall Study|Adverse Event|1|||
48840087|NCT03362190|157254430|FG000|Overall Study|Withdrawal by Subject|0|||
48840088|NCT03362190|157254431|FG001|Overall Study|Withdrawal by Subject|0|||
48840089|NCT03362190|157254432|FG002|Overall Study|Withdrawal by Subject|0|||
48840090|NCT03362190|157254433|FG003|Overall Study|Withdrawal by Subject|1|||
48840091|NCT04295512|157254434|FG000|Overall Study|Lack of family response to schedule assessment|0|||
48840092|NCT04295512|157254435|FG001|Overall Study|Lack of family response to schedule assessment|0|||
48840093|NCT04295512|157254436|FG002|Overall Study|Lack of family response to schedule assessment|0|||
48840094|NCT04295512|157254437|FG003|Overall Study|Lack of family response to schedule assessment|2|||
48840095|NCT04295512|157254434|FG000|Overall Study|Therapist did not refer eligible family|7|||
48840096|NCT04295512|157254435|FG001|Overall Study|Therapist did not refer eligible family|7|||
48840097|NCT04295512|157254436|FG002|Overall Study|Therapist did not refer eligible family|0|||
48840098|NCT04295512|157254437|FG003|Overall Study|Therapist did not refer eligible family|0|||
48840099|NCT01309672|157254439|FG000|Overall Study|Lack of Efficacy|20|||
48840100|NCT01309672|157254439|FG000|Overall Study|Other|9|||
48840101|NCT01309672|157254439|FG000|Overall Study|Adverse Event|5|||
48840102|NCT01309672|157254439|FG000|Overall Study|Withdrawal by Subject|3|||
48840103|NCT04076059|157254440|FG000|Double Blind Phase|Progressive disease|22|||
48840104|NCT04076059|157254441|FG001|Double Blind Phase|Progressive disease|26|||
48840105|NCT04076059|157254442|FG002|Double Blind Phase|Progressive disease|0|||
48840106|NCT04076059|157254440|FG000|Double Blind Phase|Withdrawal by Subject|4|||
48840107|NCT04076059|157254441|FG001|Double Blind Phase|Withdrawal by Subject|11|||
48840108|NCT04076059|157254442|FG002|Double Blind Phase|Withdrawal by Subject|0|||
48840109|NCT04076059|157254440|FG000|Double Blind Phase|Death|1|||
48840110|NCT04076059|157254441|FG001|Double Blind Phase|Death|1|||
48840111|NCT04076059|157254442|FG002|Double Blind Phase|Death|0|||
48840112|NCT04076059|157254440|FG000|Double Blind Phase|Lost to Follow-up|1|||
48840113|NCT04076059|157254441|FG001|Double Blind Phase|Lost to Follow-up|0|||
48840114|NCT04076059|157254442|FG002|Double Blind Phase|Lost to Follow-up|0|||
48840115|NCT04076059|157254440|FG000|Double Blind Phase|Adverse Event|5|||
48840116|NCT04076059|157254441|FG001|Double Blind Phase|Adverse Event|1|||
48840117|NCT04076059|157254442|FG002|Double Blind Phase|Adverse Event|0|||
48840118|NCT04076059|157254440|FG000|Double Blind Phase|Ongoing Participants|82|||
48840119|NCT04076059|157254441|FG001|Double Blind Phase|Ongoing Participants|18|||
48840120|NCT04076059|157254442|FG002|Double Blind Phase|Ongoing Participants|0|||
48840121|NCT04076059|157254440|FG000|Double Blind Phase|Miscellaneous|3|||
48840122|NCT04076059|157254441|FG001|Double Blind Phase|Miscellaneous|1|||
48840123|NCT04076059|157254442|FG002|Double Blind Phase|Miscellaneous|0|||
48840124|NCT04076059|157254440|FG000|Double Blind Phase|Protocol Deviation|1|||
48840125|NCT04076059|157254441|FG001|Double Blind Phase|Protocol Deviation|1|||
48840126|NCT04076059|157254442|FG002|Double Blind Phase|Protocol Deviation|0|||
48840127|NCT04076059|157254440|FG000|Double Blind Phase|Did not take study drug|1|||
48840128|NCT04076059|157254441|FG001|Double Blind Phase|Did not take study drug|1|||
48840129|NCT04076059|157254442|FG002|Double Blind Phase|Did not take study drug|0|||
48840130|NCT04076059|157254440|FG000|Open Label Phase|Progressive disease|0|||
48840131|NCT04076059|157254441|FG001|Open Label Phase|Progressive disease|0|||
48840132|NCT04076059|157254442|FG002|Open Label Phase|Progressive disease|7|||
48840133|NCT04076059|157254440|FG000|Open Label Phase|Withdrawal by Subject|0|||
48840134|NCT04076059|157254441|FG001|Open Label Phase|Withdrawal by Subject|0|||
48840135|NCT04076059|157254442|FG002|Open Label Phase|Withdrawal by Subject|3|||
48840136|NCT04076059|157254440|FG000|Open Label Phase|Death|0|||
48840137|NCT04076059|157254441|FG001|Open Label Phase|Death|0|||
48840138|NCT04076059|157254442|FG002|Open Label Phase|Death|2|||
48840139|NCT04076059|157254440|FG000|Open Label Phase|Ongoing Participants|0|||
48840140|NCT04076059|157254441|FG001|Open Label Phase|Ongoing Participants|0|||
48840141|NCT04076059|157254442|FG002|Open Label Phase|Ongoing Participants|11|||
48840142|NCT04886154|157254443|FG000|Overall Study|Adverse Event|0|||
48840143|NCT04886154|157254444|FG001|Overall Study|Adverse Event|0|||
48840144|NCT04886154|157254445|FG002|Overall Study|Adverse Event|0|||
48840145|NCT04886154|157254446|FG003|Overall Study|Adverse Event|0|||
48840146|NCT04886154|157254447|FG004|Overall Study|Adverse Event|1|||
48840147|NCT04886154|157254448|FG005|Overall Study|Adverse Event|0|||
48840148|NCT04886154|157254449|FG006|Overall Study|Adverse Event|0|||
48840149|NCT04886154|157254450|FG007|Overall Study|Adverse Event|1|||
48840150|NCT04886154|157254451|FG008|Overall Study|Adverse Event|1|||
48840151|NCT04886154|157254452|FG009|Overall Study|Adverse Event|0|||
48840152|NCT04886154|157254453|FG010|Overall Study|Adverse Event|0|||
48840153|NCT04886154|157254454|FG011|Overall Study|Adverse Event|1|||
48840154|NCT04886154|157254455|FG012|Overall Study|Adverse Event|0|||
48840155|NCT04886154|157254456|FG013|Overall Study|Adverse Event|0|||
48840156|NCT04886154|157254457|FG014|Overall Study|Adverse Event|3|||
48840157|NCT04886154|157254443|FG000|Overall Study|Lost to Follow-up|1|||
48840158|NCT04886154|157254444|FG001|Overall Study|Lost to Follow-up|0|||
48840159|NCT04886154|157254445|FG002|Overall Study|Lost to Follow-up|2|||
48840160|NCT04886154|157254446|FG003|Overall Study|Lost to Follow-up|0|||
48840161|NCT04886154|157254447|FG004|Overall Study|Lost to Follow-up|17|||
48840162|NCT04886154|157254448|FG005|Overall Study|Lost to Follow-up|7|||
48840163|NCT04886154|157254449|FG006|Overall Study|Lost to Follow-up|8|||
48840164|NCT04886154|157254450|FG007|Overall Study|Lost to Follow-up|7|||
48840165|NCT04886154|157254451|FG008|Overall Study|Lost to Follow-up|8|||
48840166|NCT04886154|157254452|FG009|Overall Study|Lost to Follow-up|0|||
48840167|NCT04886154|157254453|FG010|Overall Study|Lost to Follow-up|2|||
48840168|NCT04886154|157254454|FG011|Overall Study|Lost to Follow-up|0|||
48840169|NCT04886154|157254455|FG012|Overall Study|Lost to Follow-up|0|||
48840170|NCT04886154|157254456|FG013|Overall Study|Lost to Follow-up|0|||
48840171|NCT04886154|157254457|FG014|Overall Study|Lost to Follow-up|0|||
48840172|NCT04886154|157254443|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840173|NCT04886154|157254444|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840174|NCT04886154|157254445|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840175|NCT04886154|157254446|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840176|NCT04886154|157254447|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840177|NCT04886154|157254448|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840178|NCT04886154|157254449|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
48840179|NCT04886154|157254450|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840180|NCT04886154|157254451|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840181|NCT04886154|157254452|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840182|NCT04886154|157254453|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840183|NCT04886154|157254454|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840184|NCT04886154|157254455|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840185|NCT04886154|157254456|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840186|NCT04886154|157254457|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
48840187|NCT04886154|157254443|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840188|NCT04886154|157254444|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840189|NCT04886154|157254445|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840190|NCT04886154|157254446|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840191|NCT04886154|157254447|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48840192|NCT04886154|157254448|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840193|NCT04886154|157254449|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
48840194|NCT04886154|157254450|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48840195|NCT04886154|157254451|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840196|NCT04886154|157254452|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840197|NCT04886154|157254453|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840198|NCT04886154|157254454|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840199|NCT04886154|157254455|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840200|NCT04886154|157254456|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48840201|NCT04886154|157254457|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48840202|NCT04886154|157254443|FG000|Overall Study|Other, Not Specified|0|||
48840203|NCT04886154|157254444|FG001|Overall Study|Other, Not Specified|0|||
48840204|NCT04886154|157254445|FG002|Overall Study|Other, Not Specified|0|||
48840205|NCT04886154|157254446|FG003|Overall Study|Other, Not Specified|0|||
48840206|NCT04886154|157254447|FG004|Overall Study|Other, Not Specified|11|||
48840207|NCT04886154|157254448|FG005|Overall Study|Other, Not Specified|8|||
48840208|NCT04886154|157254449|FG006|Overall Study|Other, Not Specified|9|||
48840209|NCT04886154|157254450|FG007|Overall Study|Other, Not Specified|10|||
48840210|NCT04886154|157254451|FG008|Overall Study|Other, Not Specified|6|||
48840211|NCT04886154|157254452|FG009|Overall Study|Other, Not Specified|1|||
48536917|NCT01674647|156153026|FG000|Treatment Period|Lost to Follow-up|1|||
48536918|NCT01674647|156153027|FG001|Treatment Period|Lost to Follow-up|1|||
48536919|NCT01674647|156153026|FG000|Treatment Period|Withdrawal by Subject|19|||
48536920|NCT01674647|156153027|FG001|Treatment Period|Withdrawal by Subject|16|||
48840212|NCT04886154|157254453|FG010|Overall Study|Other, Not Specified|1|||
48840213|NCT04886154|157254454|FG011|Overall Study|Other, Not Specified|2|||
48840214|NCT04886154|157254455|FG012|Overall Study|Other, Not Specified|1|||
48840215|NCT04886154|157254456|FG013|Overall Study|Other, Not Specified|2|||
48840216|NCT04886154|157254457|FG014|Overall Study|Other, Not Specified|3|||
48536921|NCT01674647|156153026|FG000|Treatment Period|Switching to other therapy|5|||
48840217|NCT04308681|157254459|FG000|Pre-Treatment|Not reported|1|||
48840218|NCT04308681|157254460|FG001|Pre-Treatment|Not reported|1|||
48840219|NCT04308681|157254461|FG002|Pre-Treatment|Not reported|0|||
48840220|NCT04308681|157254462|FG003|Pre-Treatment|Not reported|0|||
48840221|NCT04308681|157254463|FG004|Pre-Treatment|Not reported|0|||
48840222|NCT04308681|157254464|FG005|Pre-Treatment|Not reported|2|||
48840223|NCT04308681|157254465|FG006|Pre-Treatment|Not reported|0|||
48840224|NCT04308681|157254466|FG007|Pre-Treatment|Not reported|0|||
48840225|NCT04308681|157254459|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
48840226|NCT04308681|157254460|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
48840227|NCT04308681|157254461|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
48840228|NCT04308681|157254462|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
48840229|NCT04308681|157254463|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
48840230|NCT04308681|157254464|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
48840231|NCT04308681|157254465|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
48840232|NCT04308681|157254466|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
48840233|NCT04308681|157254459|FG000|Treatment up to Week 26|Other reasons|2|||
48840234|NCT04308681|157254460|FG001|Treatment up to Week 26|Other reasons|0|||
48840235|NCT04308681|157254461|FG002|Treatment up to Week 26|Other reasons|0|||
48840236|NCT04308681|157254462|FG003|Treatment up to Week 26|Other reasons|0|||
48840237|NCT04308681|157254463|FG004|Treatment up to Week 26|Other reasons|1|||
48840238|NCT04308681|157254464|FG005|Treatment up to Week 26|Other reasons|1|||
48840239|NCT04308681|157254465|FG006|Treatment up to Week 26|Other reasons|0|||
48840240|NCT04308681|157254466|FG007|Treatment up to Week 26|Other reasons|0|||
48840241|NCT04308681|157254459|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
48840242|NCT04308681|157254460|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
48840243|NCT04308681|157254461|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
48840244|NCT04308681|157254462|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
48840245|NCT04308681|157254463|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
48445964|NCT01576406|155820561|FG000|Overall Study|Death|3|||
48840246|NCT04308681|157254464|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
48840247|NCT04308681|157254465|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
48840248|NCT04308681|157254466|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
48536922|NCT01674647|156153027|FG001|Treatment Period|Switching to other therapy|2|||
48536923|NCT01674647|156153026|FG000|Treatment Period|Logistical difficulties|5|||
48840249|NCT04308681|157254459|FG000|Treatment up to Week 26|Adverse Event|6|||
48840250|NCT04308681|157254460|FG001|Treatment up to Week 26|Adverse Event|5|||
48840251|NCT04308681|157254461|FG002|Treatment up to Week 26|Adverse Event|5|||
48840252|NCT04308681|157254462|FG003|Treatment up to Week 26|Adverse Event|0|||
48840253|NCT04308681|157254463|FG004|Treatment up to Week 26|Adverse Event|6|||
48840254|NCT04308681|157254464|FG005|Treatment up to Week 26|Adverse Event|1|||
48840255|NCT04308681|157254465|FG006|Treatment up to Week 26|Adverse Event|0|||
48840256|NCT04308681|157254466|FG007|Treatment up to Week 26|Adverse Event|0|||
48536924|NCT01674647|156153027|FG001|Treatment Period|Logistical difficulties|8|||
48536925|NCT01674647|156153026|FG000|Treatment Period|Treatment failure|0|||
48536926|NCT01674647|156153027|FG001|Treatment Period|Treatment failure|14|||
48536927|NCT01674647|156153026|FG000|Treatment Period|Protocol Violation|56|||
48536928|NCT01674647|156153027|FG001|Treatment Period|Protocol Violation|36|||
48536929|NCT01674647|156153026|FG000|30-day Safety Follow-up Period|Death|3|||
48536930|NCT01674647|156153027|FG001|30-day Safety Follow-up Period|Death|2|||
48536931|NCT01674647|156153026|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
48536932|NCT01674647|156153027|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
48536933|NCT01674647|156153026|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
48536934|NCT01674647|156153027|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
48536935|NCT01674647|156153026|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
48536936|NCT01674647|156153027|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
48536937|NCT01674647|156153026|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
48536938|NCT01674647|156153027|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
48536939|NCT01674647|156153026|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
48536940|NCT01674647|156153027|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
48536941|NCT01382251|156153028|FG000|Overall Study|Surgeries cancelled or delayed|16|||
48536942|NCT01382251|156153029|FG001|Overall Study|Surgeries cancelled or delayed|16|||
48536943|NCT01382251|156153028|FG000|Overall Study|Lost to Follow-up|4|||
48536944|NCT01382251|156153029|FG001|Overall Study|Lost to Follow-up|4|||
48536945|NCT01382251|156153028|FG000|Overall Study|Contacted after study closed|1|||
48536946|NCT01382251|156153029|FG001|Overall Study|Contacted after study closed|1|||
48536947|NCT00788593|156153030|FG000|Placebo Run-in Phase|Adverse Event|2|||
48840257|NCT04308681|157254459|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
48840258|NCT04308681|157254460|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
48840259|NCT04308681|157254461|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
48840260|NCT04308681|157254462|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
48840261|NCT04308681|157254463|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
48840262|NCT04308681|157254464|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
48840263|NCT04308681|157254465|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
48840264|NCT04308681|157254466|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
48840265|NCT04308681|157254459|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
48840266|NCT04308681|157254460|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
48840267|NCT04308681|157254461|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
48840268|NCT04308681|157254462|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
48840269|NCT04308681|157254463|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
48840270|NCT04308681|157254464|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
48840271|NCT04308681|157254465|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
48840272|NCT04308681|157254466|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
48840273|NCT04308681|157254459|FG000|OTE - 26 Weeks|Death|0|||
48840274|NCT04308681|157254460|FG001|OTE - 26 Weeks|Death|1|||
48840275|NCT04308681|157254461|FG002|OTE - 26 Weeks|Death|0|||
48840276|NCT04308681|157254462|FG003|OTE - 26 Weeks|Death|0|||
48840277|NCT04308681|157254463|FG004|OTE - 26 Weeks|Death|0|||
48840278|NCT04308681|157254464|FG005|OTE - 26 Weeks|Death|0|||
48840279|NCT04308681|157254465|FG006|OTE - 26 Weeks|Death|1|||
48840280|NCT04308681|157254466|FG007|OTE - 26 Weeks|Death|0|||
48840281|NCT04308681|157254459|FG000|OTE - 26 Weeks|Adverse Event|0|||
48840282|NCT04308681|157254460|FG001|OTE - 26 Weeks|Adverse Event|2|||
48840283|NCT04308681|157254461|FG002|OTE - 26 Weeks|Adverse Event|8|||
48840284|NCT04308681|157254462|FG003|OTE - 26 Weeks|Adverse Event|3|||
48840285|NCT04308681|157254463|FG004|OTE - 26 Weeks|Adverse Event|0|||
48840286|NCT04308681|157254464|FG005|OTE - 26 Weeks|Adverse Event|1|||
48840287|NCT04308681|157254465|FG006|OTE - 26 Weeks|Adverse Event|2|||
48840288|NCT04308681|157254466|FG007|OTE - 26 Weeks|Adverse Event|0|||
48840289|NCT04308681|157254459|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
48840290|NCT04308681|157254460|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
48840291|NCT04308681|157254461|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
48840292|NCT04308681|157254462|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
48840293|NCT04308681|157254463|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
48840294|NCT04308681|157254464|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
48840295|NCT04308681|157254465|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
48840296|NCT04308681|157254466|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
48840297|NCT05565820|157254467|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
48840298|NCT05565820|157254468|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
48840299|NCT05565820|157254467|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
48840300|NCT05565820|157254468|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
48840301|NCT02257736|157254473|FG000|Overall Study|Progressive disease|365|||
48840302|NCT02257736|157254474|FG001|Overall Study|Progressive disease|327|||
48840303|NCT02257736|157254473|FG000|Overall Study|Adverse Event|45|||
48840304|NCT02257736|157254474|FG001|Overall Study|Adverse Event|56|||
48840305|NCT02257736|157254473|FG000|Overall Study|Withdrawal by Subject|21|||
48840306|NCT02257736|157254474|FG001|Overall Study|Withdrawal by Subject|38|||
48840307|NCT02257736|157254473|FG000|Overall Study|Death|11|||
48840308|NCT02257736|157254474|FG001|Overall Study|Death|6|||
48840309|NCT02257736|157254473|FG000|Overall Study|Physician Decision|5|||
48840310|NCT02257736|157254474|FG001|Overall Study|Physician Decision|9|||
48840311|NCT02257736|157254473|FG000|Overall Study|Non-Compliance with study drug|1|||
48840312|NCT02257736|157254474|FG001|Overall Study|Non-Compliance with study drug|2|||
48840313|NCT02257736|157254473|FG000|Overall Study|Protocol Violation|1|||
48840314|NCT02257736|157254474|FG001|Overall Study|Protocol Violation|0|||
48840315|NCT02257736|157254473|FG000|Overall Study|Other|1|||
48840316|NCT02257736|157254474|FG001|Overall Study|Other|7|||
48840317|NCT02257736|157254473|FG000|Overall Study|Randomized, not treated|1|||
48840318|NCT02257736|157254474|FG001|Overall Study|Randomized, not treated|2|||
48840319|NCT01796197|157256301|FG000|Overall Study|Lost to Follow-up|1|||
48445965|NCT01576406|155820562|FG001|Overall Study|Death|4|||
48840320|NCT01796197|157256301|FG000|Overall Study|Lack of Efficacy|1|||
48840321|NCT02142803|157256305|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
48840322|NCT02142803|157256306|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
48840323|NCT02142803|157256307|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
48840324|NCT02142803|157256308|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
48840325|NCT04471428|157256309|FG000|Overall Study|Withdrawal by Subject|29|||
48445966|NCT01576406|155820563|FG002|Overall Study|Death|8|||
48445967|NCT01576406|155820564|FG003|Overall Study|Death|5|||
48840326|NCT04471428|157256310|FG001|Overall Study|Withdrawal by Subject|1|||
48840327|NCT04471428|157256309|FG000|Overall Study|Physician Decision|0|||
48840328|NCT04471428|157256310|FG001|Overall Study|Physician Decision|1|||
48840329|NCT04471428|157256309|FG000|Overall Study|Reason Not Specified|0|||
48840330|NCT04471428|157256310|FG001|Overall Study|Reason Not Specified|2|||
48840331|NCT04471428|157256309|FG000|Overall Study|Death|106|||
48840332|NCT04471428|157256310|FG001|Overall Study|Death|114|||
48840333|NCT04471428|157256309|FG000|Overall Study|Ongoing in the study|45|||
48840334|NCT04471428|157256310|FG001|Overall Study|Ongoing in the study|68|||
48840335|NCT05280574|157256311|FG000|Overall Study|Withdrawal by Subject|0|||
48840336|NCT05280574|157256312|FG001|Overall Study|Withdrawal by Subject|2|||
48840337|NCT05280574|157256313|FG002|Overall Study|Withdrawal by Subject|0|||
48840338|NCT02686658|157256314|FG000|Overall Study|Adverse Event|0|||
48840339|NCT02686658|157256315|FG001|Overall Study|Adverse Event|0|||
48840340|NCT02686658|157256316|FG002|Overall Study|Adverse Event|1|||
48840341|NCT02686658|157256317|FG003|Overall Study|Adverse Event|1|||
48840342|NCT02686658|157256318|FG004|Overall Study|Adverse Event|2|||
48840343|NCT02686658|157256319|FG005|Overall Study|Adverse Event|1|||
48840344|NCT02686658|157256314|FG000|Overall Study|Investigator decision|0|||
48840345|NCT02686658|157256315|FG001|Overall Study|Investigator decision|0|||
48840346|NCT02686658|157256316|FG002|Overall Study|Investigator decision|0|||
48840347|NCT02686658|157256317|FG003|Overall Study|Investigator decision|1|||
48840348|NCT02686658|157256318|FG004|Overall Study|Investigator decision|2|||
48840349|NCT02686658|157256319|FG005|Overall Study|Investigator decision|1|||
48840350|NCT02686658|157256314|FG000|Overall Study|Sponsor decision|1|||
48840351|NCT02686658|157256315|FG001|Overall Study|Sponsor decision|2|||
48840352|NCT02686658|157256316|FG002|Overall Study|Sponsor decision|1|||
48840353|NCT02686658|157256317|FG003|Overall Study|Sponsor decision|5|||
48840354|NCT02686658|157256318|FG004|Overall Study|Sponsor decision|13|||
48840355|NCT02686658|157256319|FG005|Overall Study|Sponsor decision|2|||
48840356|NCT02686658|157256314|FG000|Overall Study|Lost to Follow-up|0|||
48840357|NCT02686658|157256315|FG001|Overall Study|Lost to Follow-up|0|||
48840358|NCT02686658|157256316|FG002|Overall Study|Lost to Follow-up|2|||
48840359|NCT02686658|157256317|FG003|Overall Study|Lost to Follow-up|0|||
48840360|NCT02686658|157256318|FG004|Overall Study|Lost to Follow-up|0|||
48605695|NCT01198002|156413537|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
48605696|NCT01198002|156413538|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
48605697|NCT01198002|156413539|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
48605698|NCT01001429|156413545|FG000|Overall Study|surgery cancelled|0|||
48605699|NCT01001429|156413546|FG001|Overall Study|surgery cancelled|1|||
48605700|NCT03353792|156413549|FG000|Overall Study|Lost to Follow-up|1|||
48605701|NCT03353792|156413550|FG001|Overall Study|Lost to Follow-up|0|||
48605702|NCT03353792|156413549|FG000|Overall Study|Participant Unable to Manage Device|1|||
48605703|NCT03353792|156413550|FG001|Overall Study|Participant Unable to Manage Device|0|||
48605704|NCT00735709|156413551|FG000|Overall Study|Adverse Event|2|||
48605705|NCT00735709|156413552|FG001|Overall Study|Adverse Event|3|||
48605706|NCT00735709|156413553|FG002|Overall Study|Adverse Event|1|||
48605707|NCT00735709|156413554|FG003|Overall Study|Adverse Event|5|||
48605708|NCT00735709|156413551|FG000|Overall Study|Lack of Efficacy|8|||
48605709|NCT00735709|156413552|FG001|Overall Study|Lack of Efficacy|4|||
48605710|NCT00735709|156413553|FG002|Overall Study|Lack of Efficacy|2|||
48605711|NCT00735709|156413554|FG003|Overall Study|Lack of Efficacy|3|||
48605712|NCT00735709|156413551|FG000|Overall Study|Noncompliance|0|||
48605713|NCT00735709|156413552|FG001|Overall Study|Noncompliance|0|||
48605714|NCT00735709|156413553|FG002|Overall Study|Noncompliance|1|||
48605715|NCT00735709|156413554|FG003|Overall Study|Noncompliance|0|||
48605716|NCT00735709|156413551|FG000|Overall Study|Protocol deviations|1|||
48605717|NCT00735709|156413552|FG001|Overall Study|Protocol deviations|2|||
48605718|NCT00735709|156413553|FG002|Overall Study|Protocol deviations|1|||
48605719|NCT00735709|156413554|FG003|Overall Study|Protocol deviations|1|||
48605720|NCT00735709|156413551|FG000|Overall Study|Voluntary Withdrawal|1|||
48840361|NCT02686658|157256319|FG005|Overall Study|Lost to Follow-up|1|||
48605721|NCT00735709|156413552|FG001|Overall Study|Voluntary Withdrawal|3|||
48605722|NCT00735709|156413553|FG002|Overall Study|Voluntary Withdrawal|5|||
48605723|NCT00735709|156413554|FG003|Overall Study|Voluntary Withdrawal|7|||
48840362|NCT02686658|157256314|FG000|Overall Study|Death|1|||
48840363|NCT02686658|157256315|FG001|Overall Study|Death|0|||
48840364|NCT02686658|157256316|FG002|Overall Study|Death|0|||
48536948|NCT00788593|156153031|FG001|Placebo Run-in Phase|Adverse Event|0|||
48840365|NCT02686658|157256317|FG003|Overall Study|Death|1|||
48840366|NCT02686658|157256318|FG004|Overall Study|Death|1|||
48840367|NCT02686658|157256319|FG005|Overall Study|Death|1|||
48840368|NCT02686658|157256314|FG000|Overall Study|Withdrawal by Subject|2|||
48840369|NCT02686658|157256315|FG001|Overall Study|Withdrawal by Subject|5|||
48840370|NCT02686658|157256316|FG002|Overall Study|Withdrawal by Subject|4|||
48840371|NCT02686658|157256317|FG003|Overall Study|Withdrawal by Subject|4|||
48840372|NCT02686658|157256318|FG004|Overall Study|Withdrawal by Subject|17|||
48840373|NCT02686658|157256319|FG005|Overall Study|Withdrawal by Subject|8|||
48840374|NCT02686658|157256314|FG000|Overall Study|Placed in hospice care|0|||
48840375|NCT02686658|157256315|FG001|Overall Study|Placed in hospice care|0|||
48840376|NCT02686658|157256316|FG002|Overall Study|Placed in hospice care|1|||
48840377|NCT02686658|157256317|FG003|Overall Study|Placed in hospice care|0|||
48840378|NCT02686658|157256318|FG004|Overall Study|Placed in hospice care|0|||
48840379|NCT02686658|157256319|FG005|Overall Study|Placed in hospice care|0|||
48840380|NCT02686658|157256314|FG000|Overall Study|Participant non-compliance|0|||
48840381|NCT02686658|157256315|FG001|Overall Study|Participant non-compliance|0|||
48840382|NCT02686658|157256316|FG002|Overall Study|Participant non-compliance|0|||
48840383|NCT02686658|157256317|FG003|Overall Study|Participant non-compliance|0|||
48840384|NCT02686658|157256318|FG004|Overall Study|Participant non-compliance|0|||
48840385|NCT02686658|157256319|FG005|Overall Study|Participant non-compliance|1|||
48840386|NCT02686658|157256314|FG000|Overall Study|Concern over coronavirus disease care|0|||
48840387|NCT02686658|157256315|FG001|Overall Study|Concern over coronavirus disease care|0|||
48840388|NCT02686658|157256316|FG002|Overall Study|Concern over coronavirus disease care|0|||
48840389|NCT02686658|157256317|FG003|Overall Study|Concern over coronavirus disease care|0|||
48840390|NCT02686658|157256318|FG004|Overall Study|Concern over coronavirus disease care|2|||
48840391|NCT02686658|157256319|FG005|Overall Study|Concern over coronavirus disease care|1|||
48840392|NCT05169567|157256320|FG000|Overall Study|On study treatment|116|||
48840393|NCT05169567|157256321|FG001|Overall Study|On study treatment|128|||
48840394|NCT05169567|157256320|FG000|Overall Study|Lost to Follow-up|1|||
48840395|NCT05169567|157256321|FG001|Overall Study|Lost to Follow-up|0|||
48840396|NCT05169567|157256320|FG000|Overall Study|Withdrawal by Subject|25|||
48840397|NCT05169567|157256321|FG001|Overall Study|Withdrawal by Subject|21|||
48840398|NCT03210714|157256322|FG000|Overall Study|Adverse Event|6|||
48840399|NCT03210714|157256322|FG000|Overall Study|Physician Decision|1|||
48840400|NCT03210714|157256322|FG000|Overall Study|Progressive disease|11|||
48840401|NCT03210714|157256322|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
48840402|NCT04186845|157256330|FG000|Overall Study|Death|2|||
48840403|NCT04186845|157256330|FG000|Overall Study|Lost to Follow-up|1|||
48840404|NCT04186845|157256330|FG000|Overall Study|Physician Decision|1|||
48840405|NCT04186845|157256330|FG000|Overall Study|Protocol Violation|1|||
48536949|NCT00788593|156153032|FG002|Placebo Run-in Phase|Adverse Event|0|||
48536950|NCT00788593|156153030|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
48536951|NCT00788593|156153031|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
48536952|NCT00788593|156153032|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
48536953|NCT00788593|156153030|FG000|Placebo Run-in Phase|Protocol Violation|2|||
48536954|NCT00788593|156153031|FG001|Placebo Run-in Phase|Protocol Violation|0|||
48536955|NCT00788593|156153032|FG002|Placebo Run-in Phase|Protocol Violation|0|||
48840406|NCT04186845|157256330|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
48840407|NCT04186845|157256330|FG000|Overall Study|Biopsy ordered but not done|1|||
48840408|NCT04186845|157256330|FG000|Overall Study|It was previously confirmed|1|||
48840409|NCT04186845|157256330|FG000|Overall Study|Patient cancelled scheduled scans|2|||
48840410|NCT04186845|157256330|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
48840411|NCT04186845|157256330|FG000|Overall Study|Subject refused confirmatory imaging|1|||
48536956|NCT00788593|156153030|FG000|First Intervention Period|Adverse Event|0|||
48536957|NCT00788593|156153031|FG001|First Intervention Period|Adverse Event|1|||
48536958|NCT00788593|156153032|FG002|First Intervention Period|Adverse Event|0|||
48536959|NCT00788593|156153030|FG000|Second Intervention Period|Lost to Follow-up|0|||
48536960|NCT00788593|156153031|FG001|Second Intervention Period|Lost to Follow-up|1|||
48536961|NCT00788593|156153032|FG002|Second Intervention Period|Lost to Follow-up|0|||
48536962|NCT00788593|156153030|FG000|Second Intervention Period|Other|0|||
48840412|NCT04186845|157256330|FG000|Overall Study|Too small to biopsy|1|||
48840413|NCT04086121|157256332|FG000|Overall Study|Other than listed|8|||
48536963|NCT00788593|156153031|FG001|Second Intervention Period|Other|0|||
48536964|NCT00788593|156153032|FG002|Second Intervention Period|Other|1|||
48536965|NCT01366443|156153033|FG000|Overall Study|Lost to Follow-up|2|||
48536966|NCT01366443|156153033|FG000|Overall Study|Under 18 yo|1|||
48536967|NCT00911807|156153034|FG000|Overall Study|Adverse Event|2|||
48536968|NCT00911807|156153035|FG001|Overall Study|Adverse Event|1|||
48536969|NCT00911807|156153036|FG002|Overall Study|Adverse Event|5|||
48840414|NCT04086121|157256332|FG000|Overall Study|Withdrawal by Subject|3|||
48840415|NCT04086121|157256332|FG000|Overall Study|Lost to Follow-up|2|||
48840416|NCT04086121|157256332|FG000|Overall Study|Adverse Event|1|||
48840417|NCT04880733|157256333|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
48840418|NCT04880733|157256334|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
48840419|NCT04880733|157256335|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
48840420|NCT04880733|157256333|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
48840421|NCT04880733|157256334|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
48840422|NCT04880733|157256335|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
48840423|NCT04880733|157256333|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
48840424|NCT04880733|157256334|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
48840425|NCT04880733|157256335|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
48840426|NCT04880733|157256333|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
48840427|NCT04880733|157256334|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
48840428|NCT04880733|157256335|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
48840429|NCT04880733|157256333|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
48840430|NCT04880733|157256334|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
48840431|NCT04880733|157256335|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
48840432|NCT04311632|157256336|FG000|Overall Study|Withdrawal by Subject|0|||
48840433|NCT04311632|157256337|FG001|Overall Study|Withdrawal by Subject|0|||
48840434|NCT04311632|157256338|FG002|Overall Study|Withdrawal by Subject|1|||
48840435|NCT04934072|157256339|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
48840436|NCT04934072|157256340|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
48840437|NCT04934072|157256341|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
48840438|NCT04934072|157256342|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
48840439|NCT04934072|157256343|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
48840440|NCT04934072|157256339|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
48840441|NCT04934072|157256340|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
48840442|NCT04934072|157256341|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
48840443|NCT04934072|157256342|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
48840444|NCT04934072|157256343|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
48840445|NCT04934072|157256339|FG000|Day 0 to Week 52|Other|3|||
48840446|NCT04934072|157256340|FG001|Day 0 to Week 52|Other|1|||
48840447|NCT04934072|157256341|FG002|Day 0 to Week 52|Other|0|||
48840448|NCT04934072|157256342|FG003|Day 0 to Week 52|Other|0|||
48840449|NCT04934072|157256343|FG004|Day 0 to Week 52|Other|0|||
48840450|NCT04934072|157256339|FG000|Day 0 to Week 52|Adverse Event|1|||
48840451|NCT04934072|157256340|FG001|Day 0 to Week 52|Adverse Event|3|||
48840452|NCT04934072|157256341|FG002|Day 0 to Week 52|Adverse Event|0|||
48840453|NCT04934072|157256342|FG003|Day 0 to Week 52|Adverse Event|0|||
48840454|NCT04934072|157256343|FG004|Day 0 to Week 52|Adverse Event|0|||
48840455|NCT04934072|157256339|FG000|Week 52 to Week 78|Adverse Event|0|||
48840456|NCT04934072|157256340|FG001|Week 52 to Week 78|Adverse Event|0|||
48840457|NCT04934072|157256341|FG002|Week 52 to Week 78|Adverse Event|0|||
48840458|NCT04934072|157256342|FG003|Week 52 to Week 78|Adverse Event|1|||
48840459|NCT04934072|157256343|FG004|Week 52 to Week 78|Adverse Event|1|||
48840460|NCT04934072|157256339|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
48840461|NCT04934072|157256340|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
48840462|NCT04934072|157256341|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
48536970|NCT00911807|156153034|FG000|Overall Study|Death|0|||
48536971|NCT00911807|156153035|FG001|Overall Study|Death|0|||
48536972|NCT00911807|156153036|FG002|Overall Study|Death|1|||
48536973|NCT00911807|156153034|FG000|Overall Study|Protocol Violation|6|||
48536974|NCT00911807|156153035|FG001|Overall Study|Protocol Violation|4|||
48536975|NCT00911807|156153036|FG002|Overall Study|Protocol Violation|9|||
48536976|NCT00911807|156153034|FG000|Overall Study|Withdrawal by Subject|8|||
48536977|NCT00911807|156153035|FG001|Overall Study|Withdrawal by Subject|10|||
48536978|NCT00911807|156153036|FG002|Overall Study|Withdrawal by Subject|7|||
48536979|NCT00911807|156153034|FG000|Overall Study|Organizational reasons|1|||
48536980|NCT00911807|156153035|FG001|Overall Study|Organizational reasons|3|||
48840463|NCT04934072|157256342|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
48840464|NCT04934072|157256343|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
48840465|NCT04934072|157256339|FG000|Week 52 to Week 78|Other|0|||
48840466|NCT04934072|157256340|FG001|Week 52 to Week 78|Other|0|||
48536981|NCT00911807|156153036|FG002|Overall Study|Organizational reasons|1|||
48536982|NCT03346070|156154903|FG000|Overall Study|Death|0|||
48840467|NCT04934072|157256341|FG002|Week 52 to Week 78|Other|1|||
48840468|NCT04934072|157256342|FG003|Week 52 to Week 78|Other|0|||
48840469|NCT04934072|157256343|FG004|Week 52 to Week 78|Other|0|||
48536983|NCT03346070|156154904|FG001|Overall Study|Death|0|||
48536984|NCT03346070|156154905|FG002|Overall Study|Death|0|||
48840470|NCT02828358|157256344|FG000|Overall Study|Physician Decision|7|||
48840471|NCT02828358|157256345|FG001|Overall Study|Physician Decision|1|||
48840472|NCT02828358|157256344|FG000|Overall Study|Treatment Failure|6|||
48840473|NCT02828358|157256345|FG001|Overall Study|Treatment Failure|0|||
48840474|NCT02828358|157256344|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
48536985|NCT03346070|156154906|FG003|Overall Study|Death|0|||
48536986|NCT03346070|156154907|FG004|Overall Study|Death|1|||
48536987|NCT03346070|156154903|FG000|Overall Study|Lost to Follow-up|0|||
48536988|NCT03346070|156154904|FG001|Overall Study|Lost to Follow-up|1|||
48840475|NCT02828358|157256345|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
48840476|NCT02828358|157256344|FG000|Overall Study|Refusal of further protocol therapy|2|||
48840477|NCT02828358|157256345|FG001|Overall Study|Refusal of further protocol therapy|0|||
48840478|NCT02828358|157256344|FG000|Overall Study|Relapse|25|||
48840479|NCT02828358|157256345|FG001|Overall Study|Relapse|0|||
48840480|NCT02828358|157256344|FG000|Overall Study|Still on therapy|5|||
48840481|NCT02828358|157256345|FG001|Overall Study|Still on therapy|0|||
48840482|NCT05285137|157256348|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
48840483|NCT05285137|157256349|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
48840484|NCT05285137|157256350|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
48840485|NCT05285137|157256351|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
48840486|NCT05285137|157256352|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
48840487|NCT05285137|157256353|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
48840488|NCT05285137|157256354|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
48840489|NCT05285137|157256355|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
48840490|NCT05285137|157256356|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
48840491|NCT05285137|157256348|FG000|Overall Study|Lost to Follow-up|0|||
48840492|NCT05285137|157256349|FG001|Overall Study|Lost to Follow-up|0|||
48840493|NCT05285137|157256350|FG002|Overall Study|Lost to Follow-up|1|||
48840494|NCT05285137|157256351|FG003|Overall Study|Lost to Follow-up|3|||
48840495|NCT05285137|157256352|FG004|Overall Study|Lost to Follow-up|0|||
48840496|NCT05285137|157256353|FG005|Overall Study|Lost to Follow-up|0|||
48840497|NCT05285137|157256354|FG006|Overall Study|Lost to Follow-up|1|||
48840498|NCT05285137|157256355|FG007|Overall Study|Lost to Follow-up|0|||
48840499|NCT05285137|157256356|FG008|Overall Study|Lost to Follow-up|0|||
48840500|NCT05285137|157256348|FG000|Overall Study|Physician Decision|0|||
48840501|NCT05285137|157256349|FG001|Overall Study|Physician Decision|1|||
48840502|NCT05285137|157256350|FG002|Overall Study|Physician Decision|0|||
48840503|NCT05285137|157256351|FG003|Overall Study|Physician Decision|0|||
48840504|NCT05285137|157256352|FG004|Overall Study|Physician Decision|0|||
48605724|NCT00735709|156413551|FG000|Overall Study|Lost to Follow-up|0|||
48605725|NCT00735709|156413552|FG001|Overall Study|Lost to Follow-up|1|||
48605726|NCT00735709|156413553|FG002|Overall Study|Lost to Follow-up|1|||
48605727|NCT00735709|156413554|FG003|Overall Study|Lost to Follow-up|1|||
48605728|NCT00735709|156413551|FG000|Overall Study|Excluded medication|1|||
48605729|NCT00735709|156413552|FG001|Overall Study|Excluded medication|0|||
48605730|NCT00735709|156413553|FG002|Overall Study|Excluded medication|0|||
48605731|NCT00735709|156413554|FG003|Overall Study|Excluded medication|1|||
48605732|NCT00789321|156413555|FG000|Overall Study|Adverse Event|0|||
48605733|NCT00789321|156413556|FG001|Overall Study|Adverse Event|1|||
48605734|NCT02163395|156413560|FG000|Overall Study|Withdrawal by Subject|1|||
48605735|NCT02163395|156413560|FG000|Overall Study|Lost to Follow-up|3|||
48605736|NCT02163395|156413560|FG000|Overall Study|Adverse Event|1|||
48605737|NCT01965327|156413561|FG000|Overall Study|Physician Decision|2|||
48840505|NCT05285137|157256353|FG005|Overall Study|Physician Decision|0|||
48840506|NCT05285137|157256354|FG006|Overall Study|Physician Decision|0|||
48840507|NCT05285137|157256355|FG007|Overall Study|Physician Decision|0|||
48840508|NCT05285137|157256356|FG008|Overall Study|Physician Decision|0|||
48605738|NCT03342001|156413562|FG000|Overall Study|Adverse Event|1|||
48605739|NCT03342001|156413562|FG000|Overall Study|Lost to Follow-up|1|||
48840509|NCT05285137|157256348|FG000|Overall Study|Pregnancy|0|||
48840510|NCT05285137|157256349|FG001|Overall Study|Pregnancy|0|||
48840511|NCT05285137|157256350|FG002|Overall Study|Pregnancy|0|||
48840512|NCT05285137|157256351|FG003|Overall Study|Pregnancy|0|||
48840513|NCT05285137|157256352|FG004|Overall Study|Pregnancy|0|||
48840514|NCT05285137|157256353|FG005|Overall Study|Pregnancy|0|||
48840515|NCT05285137|157256354|FG006|Overall Study|Pregnancy|1|||
48605740|NCT01930539|156413576|FG000|Overall Study|Withdrawal by Subject|2|||
48605741|NCT01930539|156413577|FG001|Overall Study|Withdrawal by Subject|2|||
48840516|NCT05285137|157256355|FG007|Overall Study|Pregnancy|0|||
48840517|NCT05285137|157256356|FG008|Overall Study|Pregnancy|0|||
48840518|NCT05285137|157256348|FG000|Overall Study|Withdrawal by Subject|0|||
48840519|NCT05285137|157256349|FG001|Overall Study|Withdrawal by Subject|1|||
48840520|NCT05285137|157256350|FG002|Overall Study|Withdrawal by Subject|2|||
48840521|NCT05285137|157256351|FG003|Overall Study|Withdrawal by Subject|1|||
48840522|NCT05285137|157256352|FG004|Overall Study|Withdrawal by Subject|0|||
48840523|NCT05285137|157256353|FG005|Overall Study|Withdrawal by Subject|0|||
48840524|NCT05285137|157256354|FG006|Overall Study|Withdrawal by Subject|0|||
48840525|NCT05285137|157256355|FG007|Overall Study|Withdrawal by Subject|0|||
48840526|NCT05285137|157256356|FG008|Overall Study|Withdrawal by Subject|1|||
48536989|NCT03346070|156154905|FG002|Overall Study|Lost to Follow-up|2|||
48536990|NCT03346070|156154906|FG003|Overall Study|Lost to Follow-up|0|||
48536991|NCT03346070|156154907|FG004|Overall Study|Lost to Follow-up|0|||
48536992|NCT03346070|156154903|FG000|Overall Study|Physician Decision|0|||
48536993|NCT03346070|156154904|FG001|Overall Study|Physician Decision|0|||
48605742|NCT00896493|156413578|FG000|Overall Study|Early disease relapse|3|||
48840527|NCT04186819|157256358|FG000|Overall Study|Adverse Event|1|||
48605743|NCT02737358|156413579|FG000|Overall Study|Withdrawal by Subject|7|||
48605744|NCT02737358|156413580|FG001|Overall Study|Withdrawal by Subject|12|||
48605745|NCT02737358|156413579|FG000|Overall Study|Lost to Follow-up|2|||
48605746|NCT02737358|156413580|FG001|Overall Study|Lost to Follow-up|3|||
48605747|NCT01868646|156413582|FG000|Overall Study|Do not meet inclusion criteria|3|||
48605748|NCT01868646|156413583|FG001|Overall Study|Do not meet inclusion criteria|5|||
48605749|NCT01863771|156413592|FG000|Induction Phase|Adverse Event|9|||
48605750|NCT01863771|156413593|FG001|Induction Phase|Adverse Event|0|||
48840528|NCT04186819|157256358|FG000|Overall Study|Lost to Follow-up|1|||
48536994|NCT03346070|156154905|FG002|Overall Study|Physician Decision|0|||
48536995|NCT03346070|156154906|FG003|Overall Study|Physician Decision|1|||
48536996|NCT03346070|156154907|FG004|Overall Study|Physician Decision|1|||
48536997|NCT03346070|156154903|FG000|Overall Study|Withdrawal by Subject|1|||
48536998|NCT03346070|156154904|FG001|Overall Study|Withdrawal by Subject|0|||
48536999|NCT03346070|156154905|FG002|Overall Study|Withdrawal by Subject|0|||
48537000|NCT03346070|156154906|FG003|Overall Study|Withdrawal by Subject|1|||
48537001|NCT03346070|156154907|FG004|Overall Study|Withdrawal by Subject|0|||
48537002|NCT03346070|156154903|FG000|Overall Study|Study medication not received as planned|2|||
48537003|NCT03346070|156154904|FG001|Overall Study|Study medication not received as planned|3|||
48537004|NCT03346070|156154905|FG002|Overall Study|Study medication not received as planned|2|||
48537005|NCT03346070|156154906|FG003|Overall Study|Study medication not received as planned|3|||
48537006|NCT03346070|156154907|FG004|Overall Study|Study medication not received as planned|2|||
48537007|NCT03346070|156154903|FG000|Overall Study|Screen Failure|0|||
48537008|NCT03346070|156154904|FG001|Overall Study|Screen Failure|0|||
48537009|NCT03346070|156154905|FG002|Overall Study|Screen Failure|0|||
48537010|NCT03346070|156154906|FG003|Overall Study|Screen Failure|1|||
48537011|NCT03346070|156154907|FG004|Overall Study|Screen Failure|1|||
48537012|NCT00986570|156154908|FG000|Overall Study|Lost to Follow-up|6|||
48537013|NCT00986570|156154908|FG000|Overall Study|Potential bias for objective assessment|1|||
48537014|NCT02225665|156154909|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
48537015|NCT02225665|156154910|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
48537016|NCT02225665|156154909|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
48537017|NCT02225665|156154910|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
48537018|NCT02546362|156154923|FG000|4-week Treatment Period|Lost to Follow-up|1|||
48537019|NCT02546362|156154923|FG000|4-week Treatment Period|Change in medication|2|||
48537020|NCT02546362|156154923|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
48537021|NCT02546362|156154923|FG000|12-week Treatment Period|Lost to Follow-up|2|||
48537022|NCT02546362|156154923|FG000|12-week Treatment Period|Change in medication|1|||
48537023|NCT02932228|156154924|FG000|Overall Study|Death|8|||
48537024|NCT02932228|156154925|FG001|Overall Study|Death|23|||
48537025|NCT02932228|156154924|FG000|Overall Study|not eligible upon chart review|2|||
48537026|NCT02932228|156154925|FG001|Overall Study|not eligible upon chart review|5|||
48537027|NCT01311557|156154929|FG000|Overall Study|Serious adverse event|0|||
48537028|NCT01311557|156154930|FG001|Overall Study|Serious adverse event|1|||
48537029|NCT01311557|156154929|FG000|Overall Study|Protocol Violation|4|||
48537030|NCT01311557|156154930|FG001|Overall Study|Protocol Violation|2|||
48537031|NCT01311557|156154929|FG000|Overall Study|Lost to Follow-up|0|||
48605751|NCT01863771|156413594|FG002|Induction Phase|Adverse Event|0|||
48840529|NCT04186819|157256358|FG000|Overall Study|Opted for EBRT|1|||
48537032|NCT01311557|156154930|FG001|Overall Study|Lost to Follow-up|1|||
48840530|NCT04186819|157256358|FG000|Overall Study|Opted SBRT|1|||
48537033|NCT01311557|156154929|FG000|Overall Study|Withdrawal by Subject|1|||
48537034|NCT01311557|156154930|FG001|Overall Study|Withdrawal by Subject|2|||
48537035|NCT05855616|156154931|FG000|Overall Study|Lost to Follow-up|1|||
48605752|NCT01863771|156413595|FG003|Induction Phase|Adverse Event|0|||
48840531|NCT04186819|157256358|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
48537036|NCT05855616|156154932|FG001|Overall Study|Lost to Follow-up|2|||
48537037|NCT04032158|156154935|FG000|Overall Study|Study Termination|2|||
48537038|NCT04032158|156154936|FG001|Overall Study|Study Termination|1|||
48537039|NCT04322149|156154937|FG000|Overall Study|Adverse Event|1|||
48840532|NCT04186819|157256358|FG000|Overall Study|Physician Decision|1|||
48840533|NCT04186819|157256358|FG000|Overall Study|RP Delayed|1|||
48840534|NCT04186819|157256358|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
48840535|NCT04186819|157256358|FG000|Overall Study|Subject declined for financial reasons|1|||
48840536|NCT04186819|157256358|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
48840537|NCT04186819|157256358|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
48840538|NCT04186819|157256358|FG000|Overall Study|The subject opted for other treatment option|2|||
48840539|NCT04186819|157256358|FG000|Overall Study|The subject opted for other treatment options|1|||
48537040|NCT04322149|156154938|FG001|Overall Study|Adverse Event|1|||
48537041|NCT04322149|156154939|FG002|Overall Study|Adverse Event|0|||
48537042|NCT04322149|156154940|FG003|Overall Study|Adverse Event|0|||
48537043|NCT04322149|156154937|FG000|Overall Study|Withdrawal by Subject|0|||
48537044|NCT04322149|156154938|FG001|Overall Study|Withdrawal by Subject|0|||
48537045|NCT04322149|156154939|FG002|Overall Study|Withdrawal by Subject|0|||
48537046|NCT04322149|156154940|FG003|Overall Study|Withdrawal by Subject|2|||
48537047|NCT04322149|156154937|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
48537048|NCT04322149|156154938|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
48537049|NCT04322149|156154939|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
48537050|NCT04322149|156154940|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
48537051|NCT00652028|156154941|FG000|Overall Study|Adverse Event|1|||
48537052|NCT00652028|156154942|FG001|Overall Study|Adverse Event|0|||
48537053|NCT00652028|156154943|FG002|Overall Study|Adverse Event|0|||
48537054|NCT00652028|156154944|FG003|Overall Study|Adverse Event|0|||
48537055|NCT00652028|156154941|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
48537056|NCT00652028|156154942|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
48537057|NCT00652028|156154943|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
48537058|NCT00652028|156154944|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
48537059|NCT00652028|156154941|FG000|Overall Study|Physician Decision|0|||
48537060|NCT00652028|156154942|FG001|Overall Study|Physician Decision|0|||
48537061|NCT00652028|156154943|FG002|Overall Study|Physician Decision|1|||
48537062|NCT00652028|156154944|FG003|Overall Study|Physician Decision|0|||
48537063|NCT00102687|156154946|FG000|Initial Period|Withdrawal by Subject|6|||
48537064|NCT00102687|156154947|FG001|Initial Period|Withdrawal by Subject|3|||
48537065|NCT00102687|156154948|FG002|Initial Period|Withdrawal by Subject|5|||
48537066|NCT00102687|156154949|FG003|Initial Period|Withdrawal by Subject|0|||
48537067|NCT00102687|156154950|FG004|Initial Period|Withdrawal by Subject|0|||
48537068|NCT00102687|156154946|FG000|Initial Period|Adverse Event|4|||
48537069|NCT00102687|156154947|FG001|Initial Period|Adverse Event|7|||
48537070|NCT00102687|156154948|FG002|Initial Period|Adverse Event|9|||
48537071|NCT00102687|156154949|FG003|Initial Period|Adverse Event|0|||
48537072|NCT00102687|156154950|FG004|Initial Period|Adverse Event|0|||
48605753|NCT01863771|156413592|FG000|Induction Phase|Lack of Efficacy|10|||
48605754|NCT01863771|156413593|FG001|Induction Phase|Lack of Efficacy|0|||
48605755|NCT01863771|156413594|FG002|Induction Phase|Lack of Efficacy|0|||
48605756|NCT01863771|156413595|FG003|Induction Phase|Lack of Efficacy|0|||
48605757|NCT01863771|156413592|FG000|Induction Phase|Withdrawal by Subject|2|||
48605758|NCT01863771|156413593|FG001|Induction Phase|Withdrawal by Subject|0|||
48605759|NCT01863771|156413594|FG002|Induction Phase|Withdrawal by Subject|0|||
48605760|NCT01863771|156413595|FG003|Induction Phase|Withdrawal by Subject|0|||
48605761|NCT01863771|156413592|FG000|Maintenance Phase|Adverse Event|0|||
48605762|NCT01863771|156413593|FG001|Maintenance Phase|Adverse Event|0|||
48605763|NCT01863771|156413594|FG002|Maintenance Phase|Adverse Event|1|||
48605764|NCT01863771|156413595|FG003|Maintenance Phase|Adverse Event|1|||
48605765|NCT01863771|156413592|FG000|Maintenance Phase|Lack of Efficacy|0|||
48605766|NCT01863771|156413593|FG001|Maintenance Phase|Lack of Efficacy|3|||
48605767|NCT01863771|156413594|FG002|Maintenance Phase|Lack of Efficacy|7|||
48605768|NCT01863771|156413595|FG003|Maintenance Phase|Lack of Efficacy|38|||
48605769|NCT01863771|156413592|FG000|Maintenance Phase|Physician Decision|0|||
48537073|NCT00102687|156154946|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
48537074|NCT00102687|156154947|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
48537075|NCT00102687|156154948|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
48537076|NCT00102687|156154949|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
48537077|NCT00102687|156154950|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
48537078|NCT00102687|156154946|FG000|Initial Period|Protocol Violation|0|||
48537079|NCT00102687|156154947|FG001|Initial Period|Protocol Violation|0|||
48537080|NCT00102687|156154948|FG002|Initial Period|Protocol Violation|2|||
48605770|NCT01863771|156413593|FG001|Maintenance Phase|Physician Decision|0|||
48605771|NCT01863771|156413594|FG002|Maintenance Phase|Physician Decision|2|||
48605772|NCT01863771|156413595|FG003|Maintenance Phase|Physician Decision|1|||
48537081|NCT00102687|156154949|FG003|Initial Period|Protocol Violation|0|||
48537082|NCT00102687|156154950|FG004|Initial Period|Protocol Violation|0|||
48537083|NCT00102687|156154946|FG000|Initial Period|Physician Decision|2|||
48605773|NCT01863771|156413592|FG000|Maintenance Phase|Pregnancy|0|||
48537084|NCT00102687|156154947|FG001|Initial Period|Physician Decision|9|||
48537085|NCT00102687|156154948|FG002|Initial Period|Physician Decision|6|||
48537086|NCT00102687|156154949|FG003|Initial Period|Physician Decision|0|||
48537087|NCT00102687|156154950|FG004|Initial Period|Physician Decision|0|||
48537088|NCT00102687|156154946|FG000|Initial Period|Sponsor's decision|0|||
48537089|NCT00102687|156154947|FG001|Initial Period|Sponsor's decision|1|||
48605774|NCT01863771|156413593|FG001|Maintenance Phase|Pregnancy|1|||
48605775|NCT01863771|156413594|FG002|Maintenance Phase|Pregnancy|0|||
48605776|NCT01863771|156413595|FG003|Maintenance Phase|Pregnancy|0|||
48605777|NCT01863771|156413592|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48605778|NCT01863771|156413593|FG001|Maintenance Phase|Withdrawal by Subject|1|||
48840540|NCT04186819|157256358|FG000|Overall Study|Withdrawal by Subject|3|||
48840541|NCT04186819|157256358|FG000|Overall Study|Reason not specified|1|||
48840542|NCT05013385|157256359|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
48537090|NCT00102687|156154948|FG002|Initial Period|Sponsor's decision|1|||
48537091|NCT00102687|156154949|FG003|Initial Period|Sponsor's decision|0|||
48537092|NCT00102687|156154950|FG004|Initial Period|Sponsor's decision|0|||
48537093|NCT00102687|156154946|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
48537094|NCT00102687|156154947|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
48537095|NCT00102687|156154948|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
48537096|NCT00102687|156154949|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
48537097|NCT00102687|156154950|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
48537098|NCT00102687|156154946|FG000|Initial Period|Death|1|||
48537099|NCT00102687|156154947|FG001|Initial Period|Death|1|||
48537100|NCT00102687|156154948|FG002|Initial Period|Death|1|||
48537101|NCT00102687|156154949|FG003|Initial Period|Death|0|||
48537102|NCT00102687|156154950|FG004|Initial Period|Death|0|||
48537103|NCT00102687|156154946|FG000|Maintenance Period|Withdrawal by Subject|4|||
48537104|NCT00102687|156154947|FG001|Maintenance Period|Withdrawal by Subject|0|||
48537105|NCT00102687|156154948|FG002|Maintenance Period|Withdrawal by Subject|2|||
48537106|NCT00102687|156154949|FG003|Maintenance Period|Withdrawal by Subject|3|||
48537107|NCT00102687|156154950|FG004|Maintenance Period|Withdrawal by Subject|1|||
48537108|NCT00102687|156154946|FG000|Maintenance Period|Adverse Event|1|||
48537109|NCT00102687|156154947|FG001|Maintenance Period|Adverse Event|0|||
48537110|NCT00102687|156154948|FG002|Maintenance Period|Adverse Event|0|||
48537111|NCT00102687|156154949|FG003|Maintenance Period|Adverse Event|1|||
48537112|NCT00102687|156154950|FG004|Maintenance Period|Adverse Event|3|||
48537113|NCT00102687|156154946|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
48537114|NCT00102687|156154947|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
48537115|NCT00102687|156154948|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
48537116|NCT00102687|156154949|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
48537117|NCT00102687|156154950|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
48537118|NCT00102687|156154946|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
48537119|NCT00102687|156154947|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
48537120|NCT00102687|156154948|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
48537121|NCT00102687|156154949|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
48537122|NCT00102687|156154950|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
48537123|NCT00102687|156154946|FG000|Maintenance Period|Death|0|||
48537124|NCT00102687|156154947|FG001|Maintenance Period|Death|0|||
48537125|NCT00102687|156154948|FG002|Maintenance Period|Death|0|||
48537126|NCT00102687|156154949|FG003|Maintenance Period|Death|1|||
48537127|NCT00102687|156154950|FG004|Maintenance Period|Death|1|||
48537128|NCT00102687|156154946|FG000|Maintenance Period|Physician Decision|1|||
48537129|NCT00102687|156154947|FG001|Maintenance Period|Physician Decision|2|||
48537130|NCT00102687|156154948|FG002|Maintenance Period|Physician Decision|3|||
48537131|NCT00102687|156154949|FG003|Maintenance Period|Physician Decision|0|||
48605779|NCT01863771|156413594|FG002|Maintenance Phase|Withdrawal by Subject|2|||
48840543|NCT04037891|157256360|FG000|Open-label Period|Withdrawal by Subject|1|||
48840544|NCT04037891|157256361|FG001|Open-label Period|Withdrawal by Subject|0|||
48840545|NCT04037891|157256362|FG002|Open-label Period|Withdrawal by Subject|0|||
48840546|NCT04037891|157256360|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
48840547|NCT04037891|157256361|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
48840548|NCT04037891|157256362|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
48840549|NCT03875235|157256363|FG000|Overall Study|Ongoing study treatment|63|||
48840550|NCT03875235|157256364|FG001|Overall Study|Ongoing study treatment|20|||
48840551|NCT03875235|157256363|FG000|Overall Study|Off treatment|77|||
48840552|NCT03875235|157256364|FG001|Overall Study|Off treatment|91|||
48537132|NCT00102687|156154950|FG004|Maintenance Period|Physician Decision|4|||
48537133|NCT00355472|156154953|FG000|Overall Study|Physician Decision|1|||
48537134|NCT00865514|156154958|FG000|Overall Study|Infusion cost exceeded funding|2|||
48537135|NCT03649412|156154959|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
48537136|NCT03649412|156154960|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
48605780|NCT01863771|156413595|FG003|Maintenance Phase|Withdrawal by Subject|3|||
48537137|NCT03649412|156154959|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
48537138|NCT03649412|156154960|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
48537139|NCT03649412|156154959|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
48537140|NCT03649412|156154960|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48537141|NCT03649412|156154959|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
48537142|NCT03649412|156154960|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
48537143|NCT03649412|156154959|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
48537144|NCT03649412|156154960|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
48537145|NCT03649412|156154959|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
48537146|NCT03649412|156154960|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
48735635|NCT00961649|156883698|FG001|Overall Study|Patient has travel plans during holidays|0|||
48735636|NCT00961649|156883699|FG002|Overall Study|Patient has travel plans during holidays|1|||
48840553|NCT03875235|157256363|FG000|Overall Study|Withdrawal by Subject|3|||
48840554|NCT03875235|157256364|FG001|Overall Study|Withdrawal by Subject|10|||
48840555|NCT03875235|157256363|FG000|Overall Study|Death|198|||
48840556|NCT03875235|157256364|FG001|Overall Study|Death|223|||
48840557|NCT04211337|157256365|FG000|Overall Study|On Treatment|175|||
48840558|NCT04211337|157256366|FG001|Overall Study|On Treatment|40|||
48840559|NCT04211337|157256365|FG000|Overall Study|Withdrawal by Subject|0|||
48840560|NCT04211337|157256366|FG001|Overall Study|Withdrawal by Subject|2|||
48840561|NCT02101853|157256367|FG000|Block 1 Induction|Adverse Event|11|||
48840562|NCT02101853|157256368|FG001|Block 1 Induction|Adverse Event|0|||
48840563|NCT02101853|157256369|FG002|Block 1 Induction|Adverse Event|0|||
48840564|NCT02101853|157256370|FG003|Block 1 Induction|Adverse Event|0|||
48840565|NCT02101853|157256371|FG004|Block 1 Induction|Adverse Event|0|||
48840566|NCT02101853|157256372|FG005|Block 1 Induction|Adverse Event|0|||
48840567|NCT02101853|157256367|FG000|Block 1 Induction|Death|20|||
48840568|NCT02101853|157256368|FG001|Block 1 Induction|Death|0|||
48840569|NCT02101853|157256369|FG002|Block 1 Induction|Death|0|||
48840570|NCT02101853|157256370|FG003|Block 1 Induction|Death|0|||
48840571|NCT02101853|157256371|FG004|Block 1 Induction|Death|0|||
48840572|NCT02101853|157256372|FG005|Block 1 Induction|Death|0|||
48840573|NCT02101853|157256367|FG000|Block 1 Induction|Lack of Efficacy|6|||
48840574|NCT02101853|157256368|FG001|Block 1 Induction|Lack of Efficacy|0|||
48840575|NCT02101853|157256369|FG002|Block 1 Induction|Lack of Efficacy|0|||
48840576|NCT02101853|157256370|FG003|Block 1 Induction|Lack of Efficacy|0|||
48840577|NCT02101853|157256371|FG004|Block 1 Induction|Lack of Efficacy|0|||
48840578|NCT02101853|157256372|FG005|Block 1 Induction|Lack of Efficacy|0|||
48840579|NCT02101853|157256367|FG000|Block 1 Induction|Physician Decision|61|||
48840580|NCT02101853|157256368|FG001|Block 1 Induction|Physician Decision|0|||
48840581|NCT02101853|157256369|FG002|Block 1 Induction|Physician Decision|0|||
48840582|NCT02101853|157256370|FG003|Block 1 Induction|Physician Decision|0|||
48840583|NCT02101853|157256371|FG004|Block 1 Induction|Physician Decision|0|||
48840584|NCT02101853|157256372|FG005|Block 1 Induction|Physician Decision|0|||
48840585|NCT02101853|157256367|FG000|Block 1 Induction|Protocol Violation|2|||
48840586|NCT02101853|157256368|FG001|Block 1 Induction|Protocol Violation|0|||
48537147|NCT01157897|156154961|FG000|Overall Study|Lost to Follow-up|2|||
48537148|NCT01157897|156154962|FG001|Overall Study|Lost to Follow-up|0|||
48537149|NCT01157897|156154963|FG002|Overall Study|Lost to Follow-up|0|||
48537150|NCT01157897|156154964|FG003|Overall Study|Lost to Follow-up|1|||
48537151|NCT01157897|156154961|FG000|Overall Study|Relocated|0|||
48537152|NCT01157897|156154962|FG001|Overall Study|Relocated|2|||
48537153|NCT01157897|156154963|FG002|Overall Study|Relocated|0|||
48537154|NCT01157897|156154964|FG003|Overall Study|Relocated|0|||
48537155|NCT03096847|156154965|FG000|Overall Study|Other|2|||
48537156|NCT03096847|156154966|FG001|Overall Study|Other|1|||
48537157|NCT03096847|156154967|FG002|Overall Study|Other|2|||
48537158|NCT03096847|156154965|FG000|Overall Study|Lost to Follow-up|1|||
48537159|NCT03096847|156154966|FG001|Overall Study|Lost to Follow-up|0|||
48537160|NCT03096847|156154967|FG002|Overall Study|Lost to Follow-up|1|||
48537161|NCT03096847|156154965|FG000|Overall Study|Death|6|||
48537162|NCT03096847|156154966|FG001|Overall Study|Death|0|||
48537163|NCT03096847|156154967|FG002|Overall Study|Death|2|||
48537164|NCT03096847|156154965|FG000|Overall Study|Protocol Violation|3|||
48840587|NCT02101853|157256369|FG002|Block 1 Induction|Protocol Violation|0|||
48840588|NCT02101853|157256370|FG003|Block 1 Induction|Protocol Violation|0|||
48840589|NCT02101853|157256371|FG004|Block 1 Induction|Protocol Violation|0|||
48840590|NCT02101853|157256372|FG005|Block 1 Induction|Protocol Violation|0|||
48537165|NCT03096847|156154966|FG001|Overall Study|Protocol Violation|0|||
48537166|NCT03096847|156154967|FG002|Overall Study|Protocol Violation|6|||
48537167|NCT03096847|156154965|FG000|Overall Study|Physician Decision|12|||
48537168|NCT03096847|156154966|FG001|Overall Study|Physician Decision|2|||
48537169|NCT03096847|156154967|FG002|Overall Study|Physician Decision|8|||
48537170|NCT03096847|156154965|FG000|Overall Study|Withdrawal by Subject|24|||
48537171|NCT03096847|156154966|FG001|Overall Study|Withdrawal by Subject|1|||
48537172|NCT03096847|156154967|FG002|Overall Study|Withdrawal by Subject|12|||
48537173|NCT03096847|156154965|FG000|Overall Study|Adverse Event|72|||
48537174|NCT03096847|156154966|FG001|Overall Study|Adverse Event|6|||
48537175|NCT03096847|156154967|FG002|Overall Study|Adverse Event|28|||
48537176|NCT03096847|156154965|FG000|Overall Study|Progressive disease|97|||
48537177|NCT03096847|156154966|FG001|Overall Study|Progressive disease|10|||
48537178|NCT03096847|156154967|FG002|Overall Study|Progressive disease|78|||
48537179|NCT03096847|156154965|FG000|Overall Study|Non-compliance with study medication|1|||
48537180|NCT03096847|156154966|FG001|Overall Study|Non-compliance with study medication|0|||
48537181|NCT03096847|156154967|FG002|Overall Study|Non-compliance with study medication|0|||
48537182|NCT03096847|156154965|FG000|Overall Study|New therapy for study indication|1|||
48537183|NCT03096847|156154966|FG001|Overall Study|New therapy for study indication|0|||
48537184|NCT03096847|156154967|FG002|Overall Study|New therapy for study indication|1|||
48537185|NCT02749292|156154970|FG000|Overall Study|Physician Decision|1|||
48537186|NCT02749292|156154971|FG001|Overall Study|Physician Decision|0|||
48537187|NCT02749292|156154970|FG000|Overall Study|Withdrawal by Subject|5|||
48537188|NCT02749292|156154971|FG001|Overall Study|Withdrawal by Subject|7|||
48537189|NCT02749292|156154970|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
48537190|NCT02749292|156154971|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
48537191|NCT02749292|156154970|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
48537192|NCT02749292|156154971|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
48537193|NCT02749292|156154970|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
48537194|NCT02749292|156154971|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
48537195|NCT02749292|156154970|FG000|Overall Study|Adverse Event|4|||
48537196|NCT02749292|156154971|FG001|Overall Study|Adverse Event|1|||
48537197|NCT02749292|156154970|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
48537198|NCT02749292|156154971|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
48537199|NCT02749292|156154970|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
48537200|NCT02749292|156154971|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
48537201|NCT02749292|156154970|FG000|Overall Study|Requiring glucocorticoids|0|||
48537202|NCT02749292|156154971|FG001|Overall Study|Requiring glucocorticoids|3|||
48537203|NCT02749292|156154970|FG000|Overall Study|Cancer|1|||
48605781|NCT02337491|156413598|FG000|Overall Study|Death|1|||
48605782|NCT02337491|156413599|FG001|Overall Study|Death|1|||
48605783|NCT02337491|156413598|FG000|Overall Study|Adverse Event|0|||
48605784|NCT02337491|156413599|FG001|Overall Study|Adverse Event|1|||
48605785|NCT02337491|156413598|FG000|Overall Study|Withdrawal by Subject|3|||
48605786|NCT02337491|156413599|FG001|Overall Study|Withdrawal by Subject|0|||
48605787|NCT02337491|156413598|FG000|Overall Study|Progressive Disease|44|||
48605788|NCT02337491|156413599|FG001|Overall Study|Progressive Disease|28|||
48605789|NCT02337491|156413598|FG000|Overall Study|On Treatment|2|||
48537204|NCT02749292|156154971|FG001|Overall Study|Cancer|0|||
48537205|NCT01791153|156154976|FG000|Part 1: Blinded Period|Adverse Event|7|||
48537206|NCT01791153|156154977|FG001|Part 1: Blinded Period|Adverse Event|3|||
48537207|NCT01791153|156154978|FG002|Part 1: Blinded Period|Adverse Event|2|||
48537208|NCT01791153|156154979|FG003|Part 1: Blinded Period|Adverse Event|0|||
48537209|NCT01791153|156154980|FG004|Part 1: Blinded Period|Adverse Event|0|||
48537210|NCT01791153|156154981|FG005|Part 1: Blinded Period|Adverse Event|0|||
48537211|NCT01791153|156154982|FG006|Part 1: Blinded Period|Adverse Event|0|||
48605790|NCT02337491|156413599|FG001|Overall Study|On Treatment|0|||
48605791|NCT02771275|156413600|FG000|Overall Study|Reoperation|3|||
48537212|NCT01791153|156154983|FG007|Part 1: Blinded Period|Adverse Event|0|||
48537213|NCT01791153|156154976|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
48537214|NCT01791153|156154977|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
48537215|NCT01791153|156154978|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
48537216|NCT01791153|156154979|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
48537217|NCT01791153|156154980|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
48537218|NCT01791153|156154981|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
48537219|NCT01791153|156154982|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
48537220|NCT01791153|156154983|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
48537221|NCT01791153|156154976|FG000|Part 1: Blinded Period|Non-Compliance|1|||
48537222|NCT01791153|156154977|FG001|Part 1: Blinded Period|Non-Compliance|0|||
48537223|NCT01791153|156154978|FG002|Part 1: Blinded Period|Non-Compliance|0|||
48537224|NCT01791153|156154979|FG003|Part 1: Blinded Period|Non-Compliance|0|||
48537225|NCT01791153|156154980|FG004|Part 1: Blinded Period|Non-Compliance|0|||
48537226|NCT01791153|156154981|FG005|Part 1: Blinded Period|Non-Compliance|0|||
48537227|NCT01791153|156154982|FG006|Part 1: Blinded Period|Non-Compliance|0|||
48537228|NCT01791153|156154983|FG007|Part 1: Blinded Period|Non-Compliance|0|||
48537229|NCT01791153|156154976|FG000|Part 1: Blinded Period|Physician Decision|0|||
48537230|NCT01791153|156154977|FG001|Part 1: Blinded Period|Physician Decision|0|||
48537231|NCT01791153|156154978|FG002|Part 1: Blinded Period|Physician Decision|0|||
48537232|NCT01791153|156154979|FG003|Part 1: Blinded Period|Physician Decision|1|||
48537233|NCT01791153|156154980|FG004|Part 1: Blinded Period|Physician Decision|0|||
48537234|NCT01791153|156154981|FG005|Part 1: Blinded Period|Physician Decision|0|||
48537235|NCT01791153|156154982|FG006|Part 1: Blinded Period|Physician Decision|0|||
48537236|NCT01791153|156154983|FG007|Part 1: Blinded Period|Physician Decision|0|||
48537237|NCT01791153|156154976|FG000|Part 1: Blinded Period|Protocol Violation|0|||
48537238|NCT01791153|156154977|FG001|Part 1: Blinded Period|Protocol Violation|0|||
48537239|NCT01791153|156154978|FG002|Part 1: Blinded Period|Protocol Violation|0|||
48537240|NCT01791153|156154979|FG003|Part 1: Blinded Period|Protocol Violation|1|||
48537241|NCT01791153|156154980|FG004|Part 1: Blinded Period|Protocol Violation|0|||
48537242|NCT01791153|156154981|FG005|Part 1: Blinded Period|Protocol Violation|0|||
48537243|NCT01791153|156154982|FG006|Part 1: Blinded Period|Protocol Violation|0|||
48537244|NCT01791153|156154983|FG007|Part 1: Blinded Period|Protocol Violation|0|||
48537245|NCT01791153|156154976|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
48537246|NCT01791153|156154977|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
48537247|NCT01791153|156154978|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
48537248|NCT01791153|156154979|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
48537249|NCT01791153|156154980|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
48537250|NCT01791153|156154981|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
48537251|NCT01791153|156154982|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
48537252|NCT01791153|156154983|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
48537253|NCT01791153|156154976|FG000|Part 2: Open-label Period|Adverse Event|0|||
48537254|NCT01791153|156154977|FG001|Part 2: Open-label Period|Adverse Event|0|||
48537255|NCT01791153|156154978|FG002|Part 2: Open-label Period|Adverse Event|0|||
48537256|NCT01791153|156154979|FG003|Part 2: Open-label Period|Adverse Event|0|||
48537257|NCT01791153|156154980|FG004|Part 2: Open-label Period|Adverse Event|0|||
48537258|NCT01791153|156154981|FG005|Part 2: Open-label Period|Adverse Event|1|||
48537259|NCT01791153|156154982|FG006|Part 2: Open-label Period|Adverse Event|1|||
48537260|NCT01791153|156154983|FG007|Part 2: Open-label Period|Adverse Event|2|||
48537261|NCT01791153|156154976|FG000|Part 2: Open-label Period|Death|0|||
48537262|NCT01791153|156154977|FG001|Part 2: Open-label Period|Death|0|||
48537263|NCT01791153|156154978|FG002|Part 2: Open-label Period|Death|0|||
48537264|NCT01791153|156154979|FG003|Part 2: Open-label Period|Death|0|||
48537265|NCT01791153|156154980|FG004|Part 2: Open-label Period|Death|0|||
48537266|NCT01791153|156154981|FG005|Part 2: Open-label Period|Death|1|||
48537267|NCT01791153|156154982|FG006|Part 2: Open-label Period|Death|1|||
48537268|NCT01791153|156154983|FG007|Part 2: Open-label Period|Death|1|||
48537269|NCT01791153|156154976|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
48840591|NCT02101853|157256367|FG000|Block 1 Induction|Withdrawal by Subject|65|||
48537270|NCT01791153|156154977|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
48537271|NCT01791153|156154978|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
48840592|NCT02101853|157256368|FG001|Block 1 Induction|Withdrawal by Subject|0|||
48840593|NCT02101853|157256369|FG002|Block 1 Induction|Withdrawal by Subject|0|||
48840594|NCT02101853|157256370|FG003|Block 1 Induction|Withdrawal by Subject|0|||
48537272|NCT01791153|156154979|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
48537273|NCT01791153|156154980|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
48840595|NCT02101853|157256371|FG004|Block 1 Induction|Withdrawal by Subject|0|||
48537274|NCT01791153|156154981|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
48537275|NCT01791153|156154982|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
48537276|NCT01791153|156154983|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
48537277|NCT01791153|156154976|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
48537278|NCT01791153|156154977|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
48537279|NCT01791153|156154978|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
48537280|NCT01791153|156154979|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
48537281|NCT01791153|156154980|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
48537282|NCT01791153|156154981|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
48537283|NCT01791153|156154982|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
48537284|NCT01791153|156154983|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
48537285|NCT01791153|156154976|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
48537286|NCT01791153|156154977|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
48537287|NCT01791153|156154978|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
48537288|NCT01791153|156154979|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
48537289|NCT01791153|156154980|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
48537290|NCT01791153|156154981|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
48537291|NCT01791153|156154982|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
48537292|NCT01791153|156154983|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
48537293|NCT01791153|156154976|FG000|Part 2: Open-label Period|Physician Decision|0|||
48537294|NCT01791153|156154977|FG001|Part 2: Open-label Period|Physician Decision|0|||
48537295|NCT01791153|156154978|FG002|Part 2: Open-label Period|Physician Decision|0|||
48537296|NCT01791153|156154979|FG003|Part 2: Open-label Period|Physician Decision|0|||
48537297|NCT01791153|156154980|FG004|Part 2: Open-label Period|Physician Decision|1|||
48537298|NCT01791153|156154981|FG005|Part 2: Open-label Period|Physician Decision|1|||
48537299|NCT01791153|156154982|FG006|Part 2: Open-label Period|Physician Decision|0|||
48537300|NCT01791153|156154983|FG007|Part 2: Open-label Period|Physician Decision|0|||
48537301|NCT02562482|156154984|FG000|Overall Study|Enrolled, but did not receive product|4|||
48537302|NCT02562482|156154985|FG001|Overall Study|Enrolled, but did not receive product|0|||
48537303|NCT02562482|156154984|FG000|Overall Study|Lost to Follow-up|9|||
48537304|NCT02562482|156154985|FG001|Overall Study|Lost to Follow-up|6|||
48537305|NCT02562482|156154984|FG000|Overall Study|Moved from area|2|||
48537306|NCT02562482|156154985|FG001|Overall Study|Moved from area|3|||
48537307|NCT02562482|156154984|FG000|Overall Study|Withdrawal by Subject|5|||
48537308|NCT02562482|156154985|FG001|Overall Study|Withdrawal by Subject|3|||
48537309|NCT02562482|156154984|FG000|Overall Study|Physician Decision|1|||
48537310|NCT02562482|156154985|FG001|Overall Study|Physician Decision|3|||
48537311|NCT02562482|156154984|FG000|Overall Study|Illness/Injury unrelated to product|0|||
48537312|NCT02562482|156154985|FG001|Overall Study|Illness/Injury unrelated to product|1|||
48537313|NCT00430950|156154989|FG000|Overall Study|Adverse Event|7|||
48537314|NCT00430950|156154990|FG001|Overall Study|Adverse Event|6|||
48537315|NCT00430950|156154989|FG000|Overall Study|Withdrawal by Subject|1|||
48537316|NCT00430950|156154990|FG001|Overall Study|Withdrawal by Subject|0|||
48537317|NCT00430950|156154989|FG000|Overall Study|concomitant medication,etc.|5|||
48537318|NCT00430950|156154990|FG001|Overall Study|concomitant medication,etc.|7|||
48537319|NCT00613834|156154991|FG000|Overall Study|Withdrawal by Subject|0|||
48537320|NCT00613834|156154992|FG001|Overall Study|Withdrawal by Subject|3|||
48537321|NCT02357342|156154993|FG000|First 6 Months|Death|2|||
48537322|NCT02357342|156154994|FG001|First 6 Months|Death|0|||
48537323|NCT01189500|156154995|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
48537324|NCT01189500|156154995|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
48537325|NCT00062751|156154998|FG000|Overall Study|Disease progression|24|||
48537326|NCT00062751|156154999|FG001|Overall Study|Disease progression|17|||
48537327|NCT00062751|156155000|FG002|Overall Study|Disease progression|24|||
48537328|NCT00062751|156155001|FG003|Overall Study|Disease progression|2|||
48537329|NCT00062751|156155002|FG004|Overall Study|Disease progression|2|||
48537330|NCT00062751|156154998|FG000|Overall Study|Adverse Event|4|||
48537331|NCT00062751|156154999|FG001|Overall Study|Adverse Event|7|||
48537332|NCT00062751|156155000|FG002|Overall Study|Adverse Event|2|||
48692905|NCT03137992|156724650|FG004|Washout Period 1|Principal Investigator Discretion|0|||
48840596|NCT02101853|157256372|FG005|Block 1 Induction|Withdrawal by Subject|0|||
48840597|NCT02101853|157256367|FG000|Block 1 Induction|Ineligible|8|||
48840598|NCT02101853|157256368|FG001|Block 1 Induction|Ineligible|0|||
48840599|NCT02101853|157256369|FG002|Block 1 Induction|Ineligible|0|||
48840600|NCT02101853|157256370|FG003|Block 1 Induction|Ineligible|0|||
48840601|NCT02101853|157256371|FG004|Block 1 Induction|Ineligible|0|||
48840602|NCT02101853|157256372|FG005|Block 1 Induction|Ineligible|0|||
48840603|NCT02101853|157256367|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
48840604|NCT02101853|157256368|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
48840605|NCT02101853|157256369|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
48840606|NCT02101853|157256370|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
48840607|NCT02101853|157256371|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
48840608|NCT02101853|157256372|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
48840609|NCT02101853|157256367|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
48537333|NCT00062751|156155001|FG003|Overall Study|Adverse Event|2|||
48537334|NCT00062751|156155002|FG004|Overall Study|Adverse Event|2|||
48537335|NCT00062751|156154998|FG000|Overall Study|Other|2|||
48537336|NCT00062751|156154999|FG001|Overall Study|Other|3|||
48537337|NCT00062751|156155000|FG002|Overall Study|Other|1|||
48537338|NCT00062751|156155001|FG003|Overall Study|Other|0|||
48537339|NCT00062751|156155002|FG004|Overall Study|Other|1|||
48537340|NCT00062751|156154998|FG000|Overall Study|Withdrawal by Subject|1|||
48537341|NCT00062751|156154999|FG001|Overall Study|Withdrawal by Subject|2|||
48537342|NCT00062751|156155000|FG002|Overall Study|Withdrawal by Subject|2|||
48537343|NCT00062751|156155001|FG003|Overall Study|Withdrawal by Subject|1|||
48537344|NCT00062751|156155002|FG004|Overall Study|Withdrawal by Subject|0|||
48605792|NCT02771275|156413600|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
48840610|NCT02101853|157256368|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48537345|NCT00062751|156154998|FG000|Overall Study|Symptomatic deterioration|1|||
48537346|NCT00062751|156154999|FG001|Overall Study|Symptomatic deterioration|1|||
48537347|NCT00062751|156155000|FG002|Overall Study|Symptomatic deterioration|0|||
48537348|NCT00062751|156155001|FG003|Overall Study|Symptomatic deterioration|0|||
48537349|NCT00062751|156155002|FG004|Overall Study|Symptomatic deterioration|1|||
48537350|NCT00062751|156154998|FG000|Overall Study|Death|1|||
48537351|NCT00062751|156154999|FG001|Overall Study|Death|0|||
48537352|NCT00062751|156155000|FG002|Overall Study|Death|1|||
48537353|NCT00062751|156155001|FG003|Overall Study|Death|0|||
48537354|NCT00062751|156155002|FG004|Overall Study|Death|0|||
48537355|NCT03545191|156155005|FG000|Overall Study|Death|1|||
48537356|NCT03545191|156155006|FG001|Overall Study|Death|0|||
48537357|NCT03545191|156155007|FG002|Overall Study|Death|0|||
48537358|NCT03545191|156155005|FG000|Overall Study|Adverse Event|4|||
48537359|NCT03545191|156155006|FG001|Overall Study|Adverse Event|2|||
48537360|NCT03545191|156155007|FG002|Overall Study|Adverse Event|7|||
48537361|NCT03545191|156155005|FG000|Overall Study|Other reasons|3|||
48537362|NCT03545191|156155006|FG001|Overall Study|Other reasons|11|||
48537363|NCT03545191|156155007|FG002|Overall Study|Other reasons|8|||
48537364|NCT03545191|156155005|FG000|Overall Study|Withdrawal by Subject|13|||
48537365|NCT03545191|156155006|FG001|Overall Study|Withdrawal by Subject|10|||
48537366|NCT03545191|156155007|FG002|Overall Study|Withdrawal by Subject|12|||
48537367|NCT03545191|156155005|FG000|Overall Study|Lost to Follow-up|1|||
48537368|NCT03545191|156155006|FG001|Overall Study|Lost to Follow-up|2|||
48537369|NCT03545191|156155007|FG002|Overall Study|Lost to Follow-up|3|||
48537370|NCT01490866|156155014|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
48537371|NCT01490866|156155014|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
48537372|NCT01490866|156155014|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
48537373|NCT01490866|156155014|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
48537374|NCT01490866|156155014|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
48537375|NCT01490866|156155014|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
48537376|NCT01490866|156155014|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
48537377|NCT01490866|156155014|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
48537378|NCT01490866|156155014|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
48537379|NCT01490866|156155014|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
48537380|NCT01490866|156155014|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
48537381|NCT03923530|156155019|FG000|Overall Study|Withdrawal by Subject|1|||
48537382|NCT03923530|156155019|FG000|Overall Study|screen failure|3|||
48605793|NCT03006562|156413601|FG000|Overall Study|Lost to Follow-up|0|||
48840611|NCT02101853|157256369|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48840612|NCT02101853|157256370|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48840613|NCT02101853|157256371|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48605794|NCT03006562|156413602|FG001|Overall Study|Lost to Follow-up|1|||
48840614|NCT02101853|157256372|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48840615|NCT02101853|157256367|FG000|Post Induction Randomization|Adverse Event|0|||
48840616|NCT02101853|157256368|FG001|Post Induction Randomization|Adverse Event|3|||
48840617|NCT02101853|157256369|FG002|Post Induction Randomization|Adverse Event|8|||
48840618|NCT02101853|157256370|FG003|Post Induction Randomization|Adverse Event|4|||
48840619|NCT02101853|157256371|FG004|Post Induction Randomization|Adverse Event|4|||
48840620|NCT02101853|157256372|FG005|Post Induction Randomization|Adverse Event|0|||
48840621|NCT02101853|157256367|FG000|Post Induction Randomization|Death|0|||
48840622|NCT02101853|157256368|FG001|Post Induction Randomization|Death|9|||
48840623|NCT02101853|157256369|FG002|Post Induction Randomization|Death|2|||
48840624|NCT02101853|157256370|FG003|Post Induction Randomization|Death|2|||
48840625|NCT02101853|157256371|FG004|Post Induction Randomization|Death|0|||
48840626|NCT02101853|157256372|FG005|Post Induction Randomization|Death|0|||
48840627|NCT02101853|157256367|FG000|Post Induction Randomization|Lack of Efficacy|0|||
48840628|NCT02101853|157256368|FG001|Post Induction Randomization|Lack of Efficacy|14|||
48840629|NCT02101853|157256369|FG002|Post Induction Randomization|Lack of Efficacy|23|||
48537383|NCT01491035|156155026|FG000|Overall Study|Lost to Follow-up|0|||
48537384|NCT01491035|156155027|FG001|Overall Study|Lost to Follow-up|0|||
48537385|NCT01491035|156155028|FG002|Overall Study|Lost to Follow-up|0|||
48537386|NCT01491035|156155029|FG003|Overall Study|Lost to Follow-up|0|||
48537387|NCT01491035|156155030|FG004|Overall Study|Lost to Follow-up|1|||
48537388|NCT01491035|156155031|FG005|Overall Study|Lost to Follow-up|0|||
48537389|NCT01491035|156155032|FG006|Overall Study|Lost to Follow-up|0|||
48537390|NCT01491035|156155033|FG007|Overall Study|Lost to Follow-up|0|||
48537391|NCT00407758|156155034|FG000|Overall Study|ineligible -improper prior treatment|1|||
48537392|NCT00741936|156155044|FG000|Overall Study|Lost to Follow-up|1|||
48537393|NCT00741936|156155045|FG001|Overall Study|Lost to Follow-up|1|||
48537394|NCT00741936|156155044|FG000|Overall Study|Adverse Event|3|||
48537395|NCT00741936|156155045|FG001|Overall Study|Adverse Event|4|||
48537396|NCT00741936|156155044|FG000|Overall Study|Pregnancy|0|||
48537397|NCT00741936|156155045|FG001|Overall Study|Pregnancy|1|||
48537398|NCT00741936|156155044|FG000|Overall Study|Protocol Violation|2|||
48537399|NCT00741936|156155045|FG001|Overall Study|Protocol Violation|0|||
48537400|NCT00741936|156155044|FG000|Overall Study|Lack of Efficacy|0|||
48537401|NCT00741936|156155045|FG001|Overall Study|Lack of Efficacy|2|||
48537402|NCT00741936|156155044|FG000|Overall Study|Low compliance|3|||
48537403|NCT00741936|156155045|FG001|Overall Study|Low compliance|0|||
48537404|NCT03097588|156155046|FG000|Overall Study|Adverse Event|1|||
48537405|NCT01181271|156155047|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
48537406|NCT01181271|156155047|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
48537407|NCT01181271|156155047|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
48537408|NCT01181271|156155047|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
48537409|NCT01408628|156155048|FG000|Consented|Withdrawal by Subject|12|||
48537410|NCT01408628|156155048|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
48537411|NCT01408628|156155048|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
48537412|NCT01408628|156155048|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
48537413|NCT03123861|156155049|FG000|Overall Study|Protocol Violation|1|||
48537414|NCT03123861|156155050|FG001|Overall Study|Protocol Violation|1|||
48537415|NCT03123861|156155049|FG000|Overall Study|Withdrawal by Subject|2|||
48537416|NCT03123861|156155050|FG001|Overall Study|Withdrawal by Subject|2|||
48537417|NCT05069155|156155051|FG000|Overall Study|Withdrawal by Subject|1|||
48537418|NCT05069155|156155052|FG001|Overall Study|Withdrawal by Subject|3|||
48537419|NCT03165955|156155053|FG000|Treatment|Withdrawal by Subject|3|||
48537420|NCT03165955|156155053|FG000|Treatment|Death|1|||
48537421|NCT03165955|156155053|FG000|Treatment|Adverse Event|1|||
48537422|NCT03165955|156155053|FG000|Treatment|Progressive disease|3|||
48537423|NCT00507546|156155056|FG000|Overall Study|Withdrawal by Subject|1|||
48537424|NCT00507546|156155057|FG001|Overall Study|Withdrawal by Subject|0|||
48537425|NCT00507546|156155056|FG000|Overall Study|Protocol Violation|1|||
48537426|NCT00507546|156155057|FG001|Overall Study|Protocol Violation|0|||
48537427|NCT00507546|156155056|FG000|Overall Study|Physician Decision|0|||
48537428|NCT00507546|156155057|FG001|Overall Study|Physician Decision|1|||
48537429|NCT01673698|156155058|FG000|Overall Study|Lost to Follow-up|51|||
48537430|NCT01673698|156155059|FG001|Overall Study|Lost to Follow-up|13|||
48537431|NCT00444457|156155060|FG000|Infant Series|Other|0|||
48537432|NCT00444457|156155061|FG001|Infant Series|Other|1|||
48537433|NCT00444457|156155062|FG002|Infant Series|Other|0|||
48537434|NCT00444457|156155063|FG003|Infant Series|Other|0|||
48537435|NCT00444457|156155060|FG000|Infant Series|Parent or legal guardian request|18|||
48537436|NCT00444457|156155061|FG001|Infant Series|Parent or legal guardian request|29|||
48537437|NCT00444457|156155062|FG002|Infant Series|Parent or legal guardian request|34|||
48537438|NCT00444457|156155063|FG003|Infant Series|Parent or legal guardian request|14|||
48605795|NCT00126594|156413615|FG000|Overall Study|Ineligible|2|||
48605796|NCT00126594|156413616|FG001|Overall Study|Ineligible|0|||
48605797|NCT00126594|156413615|FG000|Overall Study|Withdrawal by Subject|0|||
48605798|NCT00126594|156413616|FG001|Overall Study|Withdrawal by Subject|4|||
48605799|NCT00126594|156413615|FG000|Overall Study|Physician Decision|1|||
48605800|NCT00126594|156413616|FG001|Overall Study|Physician Decision|3|||
48605801|NCT00126594|156413615|FG000|Overall Study|Adverse Event|7|||
48605802|NCT00126594|156413616|FG001|Overall Study|Adverse Event|5|||
48605803|NCT00126594|156413615|FG000|Overall Study|Non-compliance|0|||
48605804|NCT00126594|156413616|FG001|Overall Study|Non-compliance|1|||
48605805|NCT00126594|156413615|FG000|Overall Study|Disease Progression|29|||
48605806|NCT00126594|156413616|FG001|Overall Study|Disease Progression|24|||
48605807|NCT03238417|156413619|FG000|Overall|non-response|955|||
48605808|NCT03238417|156413620|FG001|Overall|non-response|1920|||
48605809|NCT03238417|156413619|FG000|Overall|partial completion|48|||
48605810|NCT03238417|156413620|FG001|Overall|partial completion|68|||
48605811|NCT03238417|156413619|FG000|Baseline|Partial completion|17|||
48605812|NCT03238417|156413620|FG001|Baseline|Partial completion|48|||
48605813|NCT03238417|156413619|FG000|Baseline|non-response|372|||
48605814|NCT03238417|156413620|FG001|Baseline|non-response|669|||
48605815|NCT03238417|156413619|FG000|12-month|non-response|296|||
48605816|NCT03238417|156413620|FG001|12-month|non-response|669|||
48605817|NCT03238417|156413619|FG000|12-month|partial completion|23|||
48605818|NCT03238417|156413620|FG001|12-month|partial completion|37|||
48605819|NCT03238417|156413619|FG000|24-month|non-response|287|||
48605820|NCT03238417|156413620|FG001|24-month|non-response|594|||
48840630|NCT02101853|157256370|FG003|Post Induction Randomization|Lack of Efficacy|18|||
48840631|NCT02101853|157256371|FG004|Post Induction Randomization|Lack of Efficacy|21|||
48840632|NCT02101853|157256372|FG005|Post Induction Randomization|Lack of Efficacy|0|||
48840633|NCT02101853|157256367|FG000|Post Induction Randomization|Physician Decision|0|||
48840634|NCT02101853|157256368|FG001|Post Induction Randomization|Physician Decision|43|||
48840635|NCT02101853|157256369|FG002|Post Induction Randomization|Physician Decision|23|||
48840636|NCT02101853|157256370|FG003|Post Induction Randomization|Physician Decision|14|||
48840637|NCT02101853|157256371|FG004|Post Induction Randomization|Physician Decision|14|||
48840638|NCT02101853|157256372|FG005|Post Induction Randomization|Physician Decision|0|||
48840639|NCT02101853|157256367|FG000|Post Induction Randomization|Protocol Violation|0|||
48840640|NCT02101853|157256368|FG001|Post Induction Randomization|Protocol Violation|3|||
48840641|NCT02101853|157256369|FG002|Post Induction Randomization|Protocol Violation|0|||
48840642|NCT02101853|157256370|FG003|Post Induction Randomization|Protocol Violation|0|||
48840643|NCT02101853|157256371|FG004|Post Induction Randomization|Protocol Violation|0|||
48840644|NCT02101853|157256372|FG005|Post Induction Randomization|Protocol Violation|0|||
48840645|NCT02101853|157256367|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
48840646|NCT02101853|157256368|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
48445968|NCT01576406|155820565|FG004|Overall Study|Death|7|||
48445969|NCT01576406|155820566|FG005|Overall Study|Death|9|||
48445970|NCT01576406|155820561|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
48445971|NCT01576406|155820562|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
48445972|NCT01576406|155820563|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
48445973|NCT01576406|155820564|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
48445974|NCT01576406|155820565|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
48445975|NCT01576406|155820566|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
48445976|NCT01576406|155820561|FG000|Overall Study|Withdrawal the consent|2|||
48445977|NCT01576406|155820562|FG001|Overall Study|Withdrawal the consent|2|||
48445978|NCT01576406|155820563|FG002|Overall Study|Withdrawal the consent|5|||
48445979|NCT01576406|155820564|FG003|Overall Study|Withdrawal the consent|1|||
48445980|NCT01576406|155820565|FG004|Overall Study|Withdrawal the consent|1|||
48445981|NCT01576406|155820566|FG005|Overall Study|Withdrawal the consent|3|||
48445982|NCT01576406|155820561|FG000|Overall Study|Other|0|||
48445983|NCT01576406|155820562|FG001|Overall Study|Other|0|||
48445984|NCT01576406|155820563|FG002|Overall Study|Other|2|||
48445985|NCT01576406|155820564|FG003|Overall Study|Other|2|||
48445986|NCT01576406|155820565|FG004|Overall Study|Other|0|||
48445987|NCT01576406|155820566|FG005|Overall Study|Other|0|||
48445988|NCT05567393|155820567|FG000|Overall Study|Voluntary Withdrawal|0|||
48445989|NCT05567393|155820568|FG001|Overall Study|Voluntary Withdrawal|0|||
48445990|NCT05567393|155820569|FG002|Overall Study|Voluntary Withdrawal|0|||
48445991|NCT05567393|155820570|FG003|Overall Study|Voluntary Withdrawal|0|||
48445992|NCT05567393|155820571|FG004|Overall Study|Voluntary Withdrawal|0|||
48445993|NCT05567393|155820572|FG005|Overall Study|Voluntary Withdrawal|0|||
48445994|NCT05567393|155820573|FG006|Overall Study|Voluntary Withdrawal|0|||
48445995|NCT05567393|155820574|FG007|Overall Study|Voluntary Withdrawal|0|||
48840647|NCT02101853|157256369|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
48840648|NCT02101853|157256370|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
48840649|NCT02101853|157256371|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
48840650|NCT02101853|157256372|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
48840651|NCT02101853|157256367|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48840652|NCT02101853|157256368|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48840653|NCT02101853|157256369|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48840654|NCT02101853|157256370|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
48840655|NCT02101853|157256371|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48840656|NCT02101853|157256372|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
48840657|NCT02101853|157256367|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
48840658|NCT02101853|157256368|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
48840659|NCT02101853|157256369|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
48840660|NCT02101853|157256370|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
48840661|NCT02101853|157256371|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
48840662|NCT02101853|157256372|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
48840663|NCT02101853|157256367|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
48840664|NCT02101853|157256368|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
48840665|NCT02101853|157256369|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
48840666|NCT02101853|157256370|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
48840667|NCT02101853|157256371|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
48840668|NCT02101853|157256372|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
48840669|NCT02101853|157256367|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
48840670|NCT02101853|157256368|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
48840671|NCT02101853|157256369|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
48840672|NCT02101853|157256370|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
48840673|NCT02101853|157256371|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
48840674|NCT02101853|157256372|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
48840675|NCT02101853|157256367|FG000|Blinatumomab Salvage Therapy|Death|0|||
48840676|NCT02101853|157256368|FG001|Blinatumomab Salvage Therapy|Death|0|||
48840677|NCT02101853|157256369|FG002|Blinatumomab Salvage Therapy|Death|0|||
48840678|NCT02101853|157256370|FG003|Blinatumomab Salvage Therapy|Death|0|||
48840679|NCT02101853|157256371|FG004|Blinatumomab Salvage Therapy|Death|0|||
48840680|NCT02101853|157256372|FG005|Blinatumomab Salvage Therapy|Death|2|||
48840681|NCT02101853|157256367|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
48840682|NCT02101853|157256368|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
48840683|NCT02101853|157256369|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
48840684|NCT02101853|157256370|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
48840685|NCT02101853|157256371|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
48840686|NCT02101853|157256372|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
48840687|NCT02101853|157256367|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
48840688|NCT02101853|157256368|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
48840689|NCT02101853|157256369|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
48840690|NCT02101853|157256370|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
48840691|NCT02101853|157256371|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
48840692|NCT02101853|157256372|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
48840693|NCT02101853|157256367|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
48840694|NCT02101853|157256368|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
48840695|NCT02101853|157256369|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
48840696|NCT02101853|157256370|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
48840697|NCT02101853|157256371|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
48840698|NCT02101853|157256372|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
48840699|NCT02112916|157256373|FG000|Overall Study|Adverse Event|6|||
48840700|NCT02112916|157256374|FG001|Overall Study|Adverse Event|9|||
48840701|NCT02112916|157256375|FG002|Overall Study|Adverse Event|3|||
48840702|NCT02112916|157256376|FG003|Overall Study|Adverse Event|2|||
48840703|NCT02112916|157256373|FG000|Overall Study|Death|9|||
48840704|NCT02112916|157256374|FG001|Overall Study|Death|9|||
48840705|NCT02112916|157256375|FG002|Overall Study|Death|3|||
48840706|NCT02112916|157256376|FG003|Overall Study|Death|4|||
48840707|NCT02112916|157256373|FG000|Overall Study|Lost to Follow-up|1|||
48840708|NCT02112916|157256374|FG001|Overall Study|Lost to Follow-up|0|||
48840709|NCT02112916|157256375|FG002|Overall Study|Lost to Follow-up|0|||
48840710|NCT02112916|157256376|FG003|Overall Study|Lost to Follow-up|0|||
48537439|NCT00444457|156155060|FG000|Infant Series|Lost to Follow-up|10|||
48840711|NCT02112916|157256373|FG000|Overall Study|Physician Decision|94|||
48840712|NCT02112916|157256374|FG001|Overall Study|Physician Decision|72|||
48840713|NCT02112916|157256375|FG002|Overall Study|Physician Decision|24|||
48840714|NCT02112916|157256376|FG003|Overall Study|Physician Decision|15|||
48840715|NCT02112916|157256373|FG000|Overall Study|Withdrawal by Subject|5|||
48840716|NCT02112916|157256374|FG001|Overall Study|Withdrawal by Subject|3|||
48840717|NCT02112916|157256375|FG002|Overall Study|Withdrawal by Subject|1|||
48840718|NCT02112916|157256376|FG003|Overall Study|Withdrawal by Subject|1|||
48840719|NCT02112916|157256373|FG000|Overall Study|Ineligible|4|||
48840720|NCT02112916|157256374|FG001|Overall Study|Ineligible|8|||
48840721|NCT02112916|157256375|FG002|Overall Study|Ineligible|3|||
48840722|NCT02112916|157256376|FG003|Overall Study|Ineligible|8|||
48840723|NCT02112916|157256373|FG000|Overall Study|Inevaluable|6|||
48840724|NCT02112916|157256374|FG001|Overall Study|Inevaluable|4|||
48840725|NCT02112916|157256375|FG002|Overall Study|Inevaluable|5|||
48840726|NCT02112916|157256376|FG003|Overall Study|Inevaluable|5|||
48840727|NCT02112916|157256373|FG000|Overall Study|Refusal of further protocol therapy|19|||
48840728|NCT02112916|157256374|FG001|Overall Study|Refusal of further protocol therapy|16|||
48840729|NCT02112916|157256375|FG002|Overall Study|Refusal of further protocol therapy|1|||
48840730|NCT02112916|157256376|FG003|Overall Study|Refusal of further protocol therapy|7|||
48840731|NCT02112916|157256373|FG000|Overall Study|Development of SMN|1|||
48840732|NCT02112916|157256374|FG001|Overall Study|Development of SMN|0|||
48840733|NCT02112916|157256375|FG002|Overall Study|Development of SMN|0|||
48840734|NCT02112916|157256376|FG003|Overall Study|Development of SMN|1|||
48840735|NCT02112916|157256373|FG000|Overall Study|Relapse/Progression|10|||
48840736|NCT02112916|157256374|FG001|Overall Study|Relapse/Progression|18|||
48840737|NCT02112916|157256375|FG002|Overall Study|Relapse/Progression|15|||
48840738|NCT02112916|157256376|FG003|Overall Study|Relapse/Progression|2|||
48840739|NCT02112916|157256373|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
48840740|NCT02112916|157256374|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
48840741|NCT02112916|157256375|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
48840742|NCT02112916|157256376|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
48840743|NCT02112916|157256373|FG000|Overall Study|Still on Therapy|44|||
48840744|NCT02112916|157256374|FG001|Overall Study|Still on Therapy|47|||
48840745|NCT02112916|157256375|FG002|Overall Study|Still on Therapy|3|||
48840746|NCT02112916|157256376|FG003|Overall Study|Still on Therapy|2|||
48840747|NCT02112916|157256373|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
48840748|NCT02112916|157256374|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
48840749|NCT02112916|157256375|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
48840750|NCT02112916|157256376|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
48840751|NCT02112916|157256373|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
48840752|NCT02112916|157256374|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
48840753|NCT02112916|157256375|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
48840754|NCT02112916|157256376|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
48840755|NCT04194944|157256377|FG000|Overall Study|Lost to Follow-up|3|||
48840756|NCT04194944|157256378|FG001|Overall Study|Lost to Follow-up|0|||
48840757|NCT04194944|157256377|FG000|Overall Study|Withdrawal by Subject|2|||
48840758|NCT04194944|157256378|FG001|Overall Study|Withdrawal by Subject|2|||
48840759|NCT04194944|157256377|FG000|Overall Study|On Treatment|93|||
48840760|NCT04194944|157256378|FG001|Overall Study|On Treatment|30|||
48840761|NCT02577354|157256381|FG000|Overall Study|Lack of Efficacy|4|||
48840762|NCT02577354|157256382|FG001|Overall Study|Lack of Efficacy|4|||
48840763|NCT02577354|157256381|FG000|Overall Study|Lost to Follow-up|3|||
48840764|NCT02577354|157256382|FG001|Overall Study|Lost to Follow-up|1|||
48840765|NCT02577354|157256381|FG000|Overall Study|Missed Visit|4|||
48840766|NCT02577354|157256382|FG001|Overall Study|Missed Visit|3|||
48840767|NCT02577354|157256381|FG000|Overall Study|Adverse Event|4|||
48840768|NCT02577354|157256382|FG001|Overall Study|Adverse Event|5|||
48840769|NCT04631016|157256393|FG000|Overall Study|Adverse Event|3|||
48840770|NCT04631016|157256394|FG001|Overall Study|Adverse Event|0|||
48840771|NCT04631016|157256393|FG000|Overall Study|Withdrawal by Subject|5|||
48840772|NCT04631016|157256394|FG001|Overall Study|Withdrawal by Subject|4|||
48840773|NCT04631016|157256393|FG000|Overall Study|Reason unspecified|1|||
48840774|NCT04631016|157256394|FG001|Overall Study|Reason unspecified|0|||
48840775|NCT04631016|157256393|FG000|Overall Study|Failure to meet randomization criteria|2|||
48840776|NCT04631016|157256394|FG001|Overall Study|Failure to meet randomization criteria|1|||
48840777|NCT02611037|157256395|FG000|Overall Study|Withdrawal prior to treatment|2|||
48840778|NCT02611037|157256396|FG001|Overall Study|Withdrawal prior to treatment|0|||
48840779|NCT04526665|157256397|FG000|Overall Study|Withdrawal by Subject|6|||
48537440|NCT00444457|156155061|FG001|Infant Series|Lost to Follow-up|11|||
48537441|NCT00444457|156155062|FG002|Infant Series|Lost to Follow-up|7|||
48537442|NCT00444457|156155063|FG003|Infant Series|Lost to Follow-up|6|||
48537443|NCT00444457|156155060|FG000|Infant Series|Protocol Violation|16|||
48537444|NCT00444457|156155061|FG001|Infant Series|Protocol Violation|8|||
48537445|NCT00444457|156155062|FG002|Infant Series|Protocol Violation|6|||
48537446|NCT00444457|156155063|FG003|Infant Series|Protocol Violation|3|||
48537447|NCT00444457|156155060|FG000|Infant Series|Failed to return|5|||
48537448|NCT00444457|156155061|FG001|Infant Series|Failed to return|4|||
48537449|NCT00444457|156155062|FG002|Infant Series|Failed to return|4|||
48537450|NCT00444457|156155063|FG003|Infant Series|Failed to return|2|||
48537451|NCT00444457|156155060|FG000|Infant Series|Investigator request|4|||
48537452|NCT00444457|156155061|FG001|Infant Series|Investigator request|3|||
48537453|NCT00444457|156155062|FG002|Infant Series|Investigator request|3|||
48605821|NCT03238417|156413619|FG000|24-month|partial completion|8|||
48605822|NCT03238417|156413620|FG001|24-month|partial completion|31|||
48605823|NCT00001566|156413621|FG000|Overall Study|patients' choice to discontinue protocol|3|||
48605824|NCT00001566|156413621|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
48605825|NCT00001566|156413621|FG000|Overall Study|Death|13|||
48605826|NCT00001566|156413621|FG000|Overall Study|Lost to Follow-up|1|||
48605827|NCT00001566|156413621|FG000|Overall Study|unable to complete initial apheresis|1|||
48605828|NCT00853762|156413622|FG000|Overall Study|Premature Termination|16|||
48605829|NCT00853762|156413623|FG001|Overall Study|Premature Termination|15|||
48605830|NCT00853762|156413624|FG002|Overall Study|Premature Termination|14|||
48605831|NCT00853762|156413625|FG003|Overall Study|Premature Termination|21|||
48605832|NCT00853762|156413622|FG000|Overall Study|Protocol Violation|0|||
48605833|NCT00853762|156413623|FG001|Overall Study|Protocol Violation|0|||
48605834|NCT00853762|156413624|FG002|Overall Study|Protocol Violation|0|||
48605835|NCT00853762|156413625|FG003|Overall Study|Protocol Violation|1|||
48605836|NCT00853762|156413622|FG000|Overall Study|Withdrawal by Subject|0|||
48605837|NCT00853762|156413623|FG001|Overall Study|Withdrawal by Subject|0|||
48605838|NCT00853762|156413624|FG002|Overall Study|Withdrawal by Subject|1|||
48605839|NCT00853762|156413625|FG003|Overall Study|Withdrawal by Subject|0|||
48605840|NCT00853762|156413622|FG000|Overall Study|Other|0|||
48605841|NCT00853762|156413623|FG001|Overall Study|Other|2|||
48605842|NCT00853762|156413624|FG002|Overall Study|Other|0|||
48605843|NCT00853762|156413625|FG003|Overall Study|Other|0|||
48605844|NCT00853762|156413622|FG000|Overall Study|Randomised but not Treated|0|||
48605845|NCT00853762|156413623|FG001|Overall Study|Randomised but not Treated|2|||
48605846|NCT00853762|156413624|FG002|Overall Study|Randomised but not Treated|2|||
48605847|NCT00853762|156413625|FG003|Overall Study|Randomised but not Treated|0|||
48605848|NCT00492297|156413626|FG000|Treatment|Death|2|||
48605849|NCT00492297|156413626|FG000|Treatment|Study terminated by sponsor|3|||
48605850|NCT00492297|156413626|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
48605851|NCT00492297|156413626|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
48605852|NCT00492297|156413626|FG000|Survival Only Follow-up|Death|46|||
48605853|NCT00492297|156413626|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
48605854|NCT00492297|156413626|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
48605855|NCT03885908|156413627|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
48605856|NCT03885908|156413628|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
48605857|NCT03885908|156413627|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
48605858|NCT03885908|156413628|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
48605859|NCT03885908|156413627|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
48537454|NCT00444457|156155063|FG003|Infant Series|Investigator request|2|||
48537455|NCT00444457|156155060|FG000|Infant Series|Other|0|||
48537456|NCT00444457|156155061|FG001|Infant Series|Other|2|||
48537457|NCT00444457|156155062|FG002|Infant Series|Other|4|||
48605860|NCT03885908|156413628|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
48605861|NCT03885908|156413627|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
48537458|NCT00444457|156155063|FG003|Infant Series|Other|0|||
48537459|NCT00444457|156155060|FG000|Infant Series|Adverse Event|1|||
48537460|NCT00444457|156155061|FG001|Infant Series|Adverse Event|2|||
48537461|NCT00444457|156155062|FG002|Infant Series|Adverse Event|2|||
48537462|NCT00444457|156155063|FG003|Infant Series|Adverse Event|0|||
48537463|NCT00444457|156155060|FG000|Infant Series|Death|0|||
48537464|NCT00444457|156155061|FG001|Infant Series|Death|1|||
48537465|NCT00444457|156155062|FG002|Infant Series|Death|1|||
48537466|NCT00444457|156155063|FG003|Infant Series|Death|1|||
48537467|NCT00444457|156155060|FG000|After Infant Series|Other|0|||
48537468|NCT00444457|156155061|FG001|After Infant Series|Other|1|||
48537469|NCT00444457|156155062|FG002|After Infant Series|Other|1|||
48537470|NCT00444457|156155063|FG003|After Infant Series|Other|1|||
48537471|NCT00444457|156155060|FG000|After Infant Series|Parent or legal guardian request|4|||
48537472|NCT00444457|156155061|FG001|After Infant Series|Parent or legal guardian request|11|||
48537473|NCT00444457|156155062|FG002|After Infant Series|Parent or legal guardian request|6|||
48537474|NCT00444457|156155063|FG003|After Infant Series|Parent or legal guardian request|3|||
48537475|NCT00444457|156155060|FG000|After Infant Series|Failed to return|7|||
48537476|NCT00444457|156155061|FG001|After Infant Series|Failed to return|6|||
48537477|NCT00444457|156155062|FG002|After Infant Series|Failed to return|5|||
48537478|NCT00444457|156155063|FG003|After Infant Series|Failed to return|1|||
48537479|NCT00444457|156155060|FG000|After Infant Series|Lost to Follow-up|5|||
48537480|NCT00444457|156155061|FG001|After Infant Series|Lost to Follow-up|5|||
48537481|NCT00444457|156155062|FG002|After Infant Series|Lost to Follow-up|5|||
48537482|NCT00444457|156155063|FG003|After Infant Series|Lost to Follow-up|2|||
48537483|NCT00444457|156155060|FG000|After Infant Series|Protocol Violation|2|||
48537484|NCT00444457|156155061|FG001|After Infant Series|Protocol Violation|4|||
48840780|NCT04526665|157256398|FG001|Overall Study|Withdrawal by Subject|3|||
48840781|NCT04526665|157256397|FG000|Overall Study|Adverse Event|4|||
48840782|NCT04526665|157256398|FG001|Overall Study|Adverse Event|1|||
48840783|NCT04526665|157256397|FG000|Overall Study|Physician Decision|2|||
48840784|NCT04526665|157256398|FG001|Overall Study|Physician Decision|2|||
48840785|NCT04526665|157256397|FG000|Overall Study|Death|2|||
48840786|NCT04526665|157256398|FG001|Overall Study|Death|0|||
48840787|NCT04526665|157256397|FG000|Overall Study|Other|0|||
48840788|NCT04526665|157256398|FG001|Overall Study|Other|1|||
48537485|NCT00444457|156155062|FG002|After Infant Series|Protocol Violation|2|||
48840789|NCT04283994|157256401|FG000|Overall Study|Death|11|||
48840790|NCT04283994|157256402|FG001|Overall Study|Death|20|||
48840791|NCT04283994|157256403|FG002|Overall Study|Death|11|||
48840792|NCT04283994|157256404|FG003|Overall Study|Death|0|||
48840793|NCT04283994|157256405|FG004|Overall Study|Death|0|||
48840794|NCT04283994|157256406|FG005|Overall Study|Death|0|||
48840795|NCT04283994|157256407|FG006|Overall Study|Death|0|||
48840796|NCT04283994|157256401|FG000|Overall Study|Withdrawal by Subject|16|||
48840797|NCT04283994|157256402|FG001|Overall Study|Withdrawal by Subject|4|||
48840798|NCT04283994|157256403|FG002|Overall Study|Withdrawal by Subject|6|||
48840799|NCT04283994|157256404|FG003|Overall Study|Withdrawal by Subject|1|||
48840800|NCT04283994|157256405|FG004|Overall Study|Withdrawal by Subject|0|||
48840801|NCT04283994|157256406|FG005|Overall Study|Withdrawal by Subject|1|||
48840802|NCT04283994|157256407|FG006|Overall Study|Withdrawal by Subject|0|||
48840803|NCT03744676|157256408|FG000|Pre-Treatment Phase|Disease related complications|2|||
48840804|NCT03744676|157256408|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
48840805|NCT03744676|157256408|FG000|Pre-Treatment Phase|Death|7|||
48840806|NCT03744676|157256408|FG000|Pre-Treatment Phase|Other Reasons|7|||
48840807|NCT03744676|157256408|FG000|Treatment Phase|Participant withdrew consent|8|||
48537486|NCT00444457|156155063|FG003|After Infant Series|Protocol Violation|2|||
48537487|NCT00444457|156155060|FG000|After Infant Series|Adverse Event|2|||
48537488|NCT00444457|156155061|FG001|After Infant Series|Adverse Event|2|||
48537489|NCT00444457|156155062|FG002|After Infant Series|Adverse Event|0|||
48537490|NCT00444457|156155063|FG003|After Infant Series|Adverse Event|0|||
48537491|NCT00444457|156155060|FG000|After Infant Series|Investigator request|0|||
48537492|NCT00444457|156155061|FG001|After Infant Series|Investigator request|0|||
48537493|NCT00444457|156155062|FG002|After Infant Series|Investigator request|0|||
48840808|NCT03744676|157256408|FG000|Treatment Phase|Death|33|||
48840809|NCT03744676|157256408|FG000|Treatment Phase|other reasons|6|||
48692906|NCT03137992|156724651|FG005|Washout Period 1|Principal Investigator Discretion|0|||
48840810|NCT02510235|157256409|FG000|Overall Study|Withdrawal by Subject|1|||
48840811|NCT02510235|157256410|FG001|Overall Study|Withdrawal by Subject|0|||
48840812|NCT04908930|157256411|FG000|Overall Study|Lost to Follow-up|1|||
48537494|NCT00444457|156155063|FG003|After Infant Series|Investigator request|1|||
48840813|NCT04908930|157256412|FG001|Overall Study|Lost to Follow-up|1|||
48840814|NCT04908930|157256413|FG002|Overall Study|Lost to Follow-up|0|||
48840815|NCT04908930|157256414|FG003|Overall Study|Lost to Follow-up|0|||
48840816|NCT04908930|157256415|FG004|Overall Study|Lost to Follow-up|0|||
48840817|NCT04908930|157256411|FG000|Overall Study|hardware in mouth|1|||
48840818|NCT04908930|157256412|FG001|Overall Study|hardware in mouth|1|||
48840819|NCT04908930|157256413|FG002|Overall Study|hardware in mouth|0|||
48840820|NCT04908930|157256414|FG003|Overall Study|hardware in mouth|0|||
48840821|NCT04908930|157256415|FG004|Overall Study|hardware in mouth|0|||
48840822|NCT04908930|157256411|FG000|Overall Study|wrong team|1|||
48840823|NCT04908930|157256412|FG001|Overall Study|wrong team|0|||
48840824|NCT04908930|157256413|FG002|Overall Study|wrong team|0|||
48840825|NCT04908930|157256414|FG003|Overall Study|wrong team|0|||
48840826|NCT04908930|157256415|FG004|Overall Study|wrong team|0|||
48840827|NCT04908930|157256411|FG000|Overall Study|quit team|2|||
48840828|NCT04908930|157256412|FG001|Overall Study|quit team|4|||
48840829|NCT04908930|157256413|FG002|Overall Study|quit team|0|||
48840830|NCT04908930|157256414|FG003|Overall Study|quit team|0|||
48840831|NCT04908930|157256415|FG004|Overall Study|quit team|0|||
48840832|NCT04908930|157256411|FG000|Overall Study|Withdrawal by Subject|1|||
48840833|NCT04908930|157256412|FG001|Overall Study|Withdrawal by Subject|2|||
48840834|NCT04908930|157256413|FG002|Overall Study|Withdrawal by Subject|0|||
48840835|NCT04908930|157256414|FG003|Overall Study|Withdrawal by Subject|0|||
48840836|NCT04908930|157256415|FG004|Overall Study|Withdrawal by Subject|0|||
48840837|NCT04908930|157256411|FG000|Overall Study|parent not liking program|0|||
48840838|NCT04908930|157256412|FG001|Overall Study|parent not liking program|1|||
48840839|NCT04908930|157256413|FG002|Overall Study|parent not liking program|0|||
48840840|NCT04908930|157256414|FG003|Overall Study|parent not liking program|0|||
48840841|NCT04908930|157256415|FG004|Overall Study|parent not liking program|0|||
48840842|NCT03807778|157256426|FG000|Overall Study|Adverse Event|0|||
48840843|NCT03807778|157256427|FG001|Overall Study|Adverse Event|0|||
48840844|NCT03807778|157256428|FG002|Overall Study|Adverse Event|3|||
48840845|NCT03807778|157256429|FG003|Overall Study|Adverse Event|5|||
48840846|NCT03807778|157256426|FG000|Overall Study|Progressive Disease|4|||
48840847|NCT03807778|157256427|FG001|Overall Study|Progressive Disease|2|||
48840848|NCT03807778|157256428|FG002|Overall Study|Progressive Disease|8|||
48840849|NCT03807778|157256429|FG003|Overall Study|Progressive Disease|15|||
48840850|NCT03807778|157256426|FG000|Overall Study|Symptomatic Deterioration|0|||
48840851|NCT03807778|157256427|FG001|Overall Study|Symptomatic Deterioration|1|||
48840852|NCT03807778|157256428|FG002|Overall Study|Symptomatic Deterioration|0|||
48840853|NCT03807778|157256429|FG003|Overall Study|Symptomatic Deterioration|1|||
48840854|NCT03807778|157256426|FG000|Overall Study|Withdrawal by Subject|0|||
48840855|NCT03807778|157256427|FG001|Overall Study|Withdrawal by Subject|1|||
48840856|NCT03807778|157256428|FG002|Overall Study|Withdrawal by Subject|0|||
48840857|NCT03807778|157256429|FG003|Overall Study|Withdrawal by Subject|1|||
48840858|NCT03807778|157256426|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
48840859|NCT03807778|157256427|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
48840860|NCT03807778|157256428|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
48840861|NCT03807778|157256429|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
48840862|NCT03250676|157256432|FG000|Overall Study|Adverse Event|0|||
48840863|NCT03250676|157256433|FG001|Overall Study|Adverse Event|0|||
48840864|NCT03250676|157256434|FG002|Overall Study|Adverse Event|0|||
48840865|NCT03250676|157256435|FG003|Overall Study|Adverse Event|1|||
48840866|NCT03250676|157256436|FG004|Overall Study|Adverse Event|2|||
48840867|NCT03250676|157256437|FG005|Overall Study|Adverse Event|9|||
48840868|NCT03250676|157256432|FG000|Overall Study|Withdrawal by Subject|1|||
48840869|NCT03250676|157256433|FG001|Overall Study|Withdrawal by Subject|0|||
48840870|NCT03250676|157256434|FG002|Overall Study|Withdrawal by Subject|0|||
48840871|NCT03250676|157256435|FG003|Overall Study|Withdrawal by Subject|1|||
48840872|NCT03250676|157256436|FG004|Overall Study|Withdrawal by Subject|1|||
48840873|NCT03250676|157256437|FG005|Overall Study|Withdrawal by Subject|2|||
48840874|NCT03250676|157256432|FG000|Overall Study|Physician Decision|0|||
48840875|NCT03250676|157256433|FG001|Overall Study|Physician Decision|0|||
48840876|NCT03250676|157256434|FG002|Overall Study|Physician Decision|0|||
48840877|NCT03250676|157256435|FG003|Overall Study|Physician Decision|2|||
48840878|NCT03250676|157256436|FG004|Overall Study|Physician Decision|0|||
48840879|NCT03250676|157256437|FG005|Overall Study|Physician Decision|3|||
48840880|NCT03250676|157256432|FG000|Overall Study|Withdrawal of consent|0|||
48537495|NCT00444457|156155060|FG000|After Infant Series|Other|0|||
48537496|NCT00444457|156155061|FG001|After Infant Series|Other|1|||
48840881|NCT03250676|157256433|FG001|Overall Study|Withdrawal of consent|0|||
48840882|NCT03250676|157256434|FG002|Overall Study|Withdrawal of consent|2|||
48840883|NCT03250676|157256435|FG003|Overall Study|Withdrawal of consent|0|||
48840884|NCT03250676|157256436|FG004|Overall Study|Withdrawal of consent|0|||
48840885|NCT03250676|157256437|FG005|Overall Study|Withdrawal of consent|2|||
48840886|NCT03250676|157256432|FG000|Overall Study|Other|1|||
48840887|NCT03250676|157256433|FG001|Overall Study|Other|0|||
48840888|NCT03250676|157256434|FG002|Overall Study|Other|0|||
48840889|NCT03250676|157256435|FG003|Overall Study|Other|0|||
48840890|NCT03250676|157256436|FG004|Overall Study|Other|0|||
48537497|NCT00444457|156155062|FG002|After Infant Series|Other|0|||
48840891|NCT03250676|157256437|FG005|Overall Study|Other|0|||
48840892|NCT03250676|157256432|FG000|Overall Study|Disease progression|4|||
48840893|NCT03250676|157256433|FG001|Overall Study|Disease progression|12|||
48840894|NCT03250676|157256434|FG002|Overall Study|Disease progression|9|||
48840895|NCT03250676|157256435|FG003|Overall Study|Disease progression|7|||
48840896|NCT03250676|157256436|FG004|Overall Study|Disease progression|4|||
48840897|NCT03250676|157256437|FG005|Overall Study|Disease progression|88|||
48840898|NCT01560416|157256438|FG000|Randomized Phase|Crossover Participants|7|||
48840899|NCT01560416|157256439|FG001|Randomized Phase|Crossover Participants|0|||
48840900|NCT01366092|157256440|FG000|Overall Study|Progressive cGVHD|2|||
48840901|NCT01366092|157256440|FG000|Overall Study|Physician Decision|1|||
48840902|NCT01366092|157256440|FG000|Overall Study|Withdrawal by Subject|1|||
48840903|NCT00977574|157256441|FG000|Overall Study|Never Treated|4|||
48840904|NCT00977574|157256442|FG001|Overall Study|Never Treated|2|||
48840905|NCT00977574|157256443|FG002|Overall Study|Never Treated|4|||
48840906|NCT03414684|157256444|FG000|First-course Treatment|Complete response|0|||
48840907|NCT03414684|157256445|FG001|First-course Treatment|Complete response|1|||
48840908|NCT03414684|157256444|FG000|First-course Treatment|Intercurrent illness|1|||
48840909|NCT03414684|157256445|FG001|First-course Treatment|Intercurrent illness|0|||
48840910|NCT03414684|157256444|FG000|First-course Treatment|Progressive Disease|31|||
48840911|NCT03414684|157256445|FG001|First-course Treatment|Progressive Disease|32|||
48840912|NCT03414684|157256444|FG000|First-course Treatment|Adverse Event|1|||
48840913|NCT03414684|157256445|FG001|First-course Treatment|Adverse Event|2|||
48840914|NCT03414684|157256444|FG000|First-course Treatment|Physician Decision|0|||
48840915|NCT03414684|157256445|FG001|First-course Treatment|Physician Decision|1|||
48840916|NCT03414684|157256444|FG000|First-course Treatment|Withdrawal by Subject|0|||
48840917|NCT03414684|157256445|FG001|First-course Treatment|Withdrawal by Subject|1|||
48840918|NCT03414684|157256444|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
48840919|NCT03414684|157256445|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
48840920|NCT03414684|157256444|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
48840921|NCT03414684|157256445|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
48840922|NCT03414684|157256444|FG000|First-course Treatment|Still on treatment|3|||
48840923|NCT03414684|157256445|FG001|First-course Treatment|Still on treatment|0|||
48840924|NCT03414684|157256444|FG000|First-course Treatment|Never started protocol therapy|2|||
48840925|NCT03414684|157256445|FG001|First-course Treatment|Never started protocol therapy|1|||
48840926|NCT03414684|157256444|FG000|Crossover Treatment|Progressive disease|0|||
48840927|NCT03414684|157256445|FG001|Crossover Treatment|Progressive disease|12|||
48840928|NCT03414684|157256444|FG000|Crossover Treatment|Adverse Event|0|||
48840929|NCT03414684|157256445|FG001|Crossover Treatment|Adverse Event|3|||
48840930|NCT03414684|157256444|FG000|Crossover Treatment|Physician Decision|0|||
48840931|NCT03414684|157256445|FG001|Crossover Treatment|Physician Decision|1|||
48840932|NCT03414684|157256444|FG000|Crossover Treatment|Still on treatment|0|||
48840933|NCT03414684|157256445|FG001|Crossover Treatment|Still on treatment|2|||
48840934|NCT04303780|157256446|FG000|Overall Study|Death|104|||
48840935|NCT04303780|157256447|FG001|Overall Study|Death|85|||
48840936|NCT04303780|157256446|FG000|Overall Study|Lost to Follow-up|5|||
48840937|NCT04303780|157256447|FG001|Overall Study|Lost to Follow-up|2|||
48840938|NCT04303780|157256446|FG000|Overall Study|Withdrawal by Subject|12|||
48840939|NCT04303780|157256447|FG001|Overall Study|Withdrawal by Subject|39|||
48840940|NCT04303780|157256446|FG000|Overall Study|Ongoing in study|50|||
48840941|NCT04303780|157256447|FG001|Overall Study|Ongoing in study|45|||
48840942|NCT04899674|157256452|FG000|Test|Adverse Event|1|||
48537498|NCT00444457|156155063|FG003|After Infant Series|Other|0|||
48537499|NCT00444457|156155060|FG000|Toddler Dose|Lost to Follow-up|4|||
48840943|NCT03789110|157257077|FG000|Overall Study|Adverse Event|2|||
48840944|NCT03789110|157257077|FG000|Overall Study|Physician Decision|1|||
48840945|NCT03789110|157257077|FG000|Overall Study|Withdrawal by Subject|2|||
48840946|NCT03789110|157257077|FG000|Overall Study|Lack of Efficacy|22|||
48840947|NCT03789110|157257077|FG000|Overall Study|still on treatment|3|||
48840948|NCT03343704|157257078|FG000|Overall Study|Refused to complete follow up|0|||
48840949|NCT03343704|157257079|FG001|Overall Study|Refused to complete follow up|1|||
48840950|NCT03343704|157257078|FG000|Overall Study|Death|0|||
48840951|NCT03343704|157257079|FG001|Overall Study|Death|1|||
48840952|NCT03343704|157257078|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
48840953|NCT03343704|157257079|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
48840954|NCT02761187|157257080|FG000|Overall Study|Too ill to Participate|13|||
48840955|NCT02761187|157257081|FG001|Overall Study|Too ill to Participate|8|||
48840956|NCT02761187|157257080|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
48840957|NCT02761187|157257081|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
48840958|NCT02761187|157257080|FG000|Overall Study|Patient withdrew consent|64|||
48840959|NCT02761187|157257081|FG001|Overall Study|Patient withdrew consent|58|||
48840960|NCT02761187|157257080|FG000|Overall Study|Physician discretion|4|||
48840961|NCT02761187|157257081|FG001|Overall Study|Physician discretion|8|||
48840962|NCT02761187|157257080|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
48840963|NCT02761187|157257081|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
48840964|NCT02761187|157257080|FG000|Overall Study|On Hospice|20|||
48840965|NCT02761187|157257081|FG001|Overall Study|On Hospice|26|||
48537500|NCT00444457|156155061|FG001|Toddler Dose|Lost to Follow-up|1|||
48537501|NCT00444457|156155062|FG002|Toddler Dose|Lost to Follow-up|1|||
48537502|NCT00444457|156155063|FG003|Toddler Dose|Lost to Follow-up|3|||
48537503|NCT00444457|156155060|FG000|Toddler Dose|Failed to return|2|||
48537504|NCT00444457|156155061|FG001|Toddler Dose|Failed to return|2|||
48537505|NCT00444457|156155062|FG002|Toddler Dose|Failed to return|1|||
48537506|NCT00444457|156155063|FG003|Toddler Dose|Failed to return|3|||
48537507|NCT00444457|156155060|FG000|Toddler Dose|Parent or legal guardian request|0|||
48537508|NCT00444457|156155061|FG001|Toddler Dose|Parent or legal guardian request|3|||
48537509|NCT00444457|156155062|FG002|Toddler Dose|Parent or legal guardian request|2|||
48537510|NCT00444457|156155063|FG003|Toddler Dose|Parent or legal guardian request|1|||
48537511|NCT00444457|156155060|FG000|Toddler Dose|Protocol Violation|1|||
48537512|NCT00444457|156155061|FG001|Toddler Dose|Protocol Violation|0|||
48537513|NCT00444457|156155062|FG002|Toddler Dose|Protocol Violation|0|||
48537514|NCT00444457|156155063|FG003|Toddler Dose|Protocol Violation|1|||
48537515|NCT03250299|156156678|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
48537516|NCT03250299|156156679|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
48537517|NCT03250299|156156680|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
48537518|NCT03250299|156156681|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
48537519|NCT03250299|156156682|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
48537520|NCT03250299|156156678|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
48537521|NCT03250299|156156679|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
48537522|NCT03250299|156156680|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
48537523|NCT03250299|156156681|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
48537524|NCT03250299|156156682|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
48537525|NCT03250299|156156678|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
48537526|NCT03250299|156156679|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
48537527|NCT03250299|156156680|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
48537528|NCT03250299|156156681|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
48537529|NCT03250299|156156682|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
48537530|NCT03250299|156156678|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
48537531|NCT03250299|156156679|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
48537532|NCT03250299|156156680|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
48537533|NCT03250299|156156681|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
48537534|NCT03250299|156156682|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
48537535|NCT02813421|156156687|FG000|Overall Study|Withdrawal by Subject|1|||
48537536|NCT02813421|156156688|FG001|Overall Study|Withdrawal by Subject|2|||
48537537|NCT02813421|156156687|FG000|Overall Study|Lost to Follow-up|1|||
48537538|NCT02813421|156156688|FG001|Overall Study|Lost to Follow-up|1|||
48537539|NCT05142566|156156691|FG000|Overall Study|Protocol Violation|1|||
48537540|NCT02221037|156156693|FG000|Overall Study|Physician Decision|0|||
48537541|NCT02221037|156156694|FG001|Overall Study|Physician Decision|0|||
48537542|NCT02221037|156156695|FG002|Overall Study|Physician Decision|1|||
48537543|NCT02221037|156156696|FG003|Overall Study|Physician Decision|0|||
48537544|NCT03188718|156156697|FG000|Overall Study|Participant noncompliance|4|||
48537545|NCT03188718|156156697|FG000|Overall Study|Withdrawal by Subject|1|||
48537546|NCT03188718|156156697|FG000|Overall Study|Device failure|3|||
48537547|NCT00871741|156156698|FG000|Overall Study|Premature study termination|9|||
48537548|NCT00871741|156156699|FG001|Overall Study|Premature study termination|7|||
48537549|NCT01117337|156156700|FG000|Overall Study|Lost to Follow-up|4|||
48537550|NCT01117337|156156701|FG001|Overall Study|Lost to Follow-up|0|||
48537551|NCT00059787|156156702|FG000|Overall Study|Adverse Event|13|||
48537552|NCT00059787|156156702|FG000|Overall Study|disease progression|2|||
48537553|NCT00059787|156156702|FG000|Overall Study|ineligible|1|||
48537554|NCT00059787|156156702|FG000|Overall Study|Other|4|||
48537555|NCT03575871|156156703|FG000|Overall Study|Adverse Event|5|||
48537556|NCT03575871|156156704|FG001|Overall Study|Adverse Event|5|||
48537557|NCT03575871|156156705|FG002|Overall Study|Adverse Event|8|||
48537558|NCT03575871|156156703|FG000|Overall Study|Death|1|||
48537559|NCT03575871|156156704|FG001|Overall Study|Death|0|||
48537560|NCT03575871|156156705|FG002|Overall Study|Death|0|||
48537561|NCT03575871|156156703|FG000|Overall Study|Lack of Efficacy|5|||
48537562|NCT03575871|156156704|FG001|Overall Study|Lack of Efficacy|4|||
48537563|NCT03575871|156156705|FG002|Overall Study|Lack of Efficacy|7|||
48537564|NCT03575871|156156703|FG000|Overall Study|Lost to Follow-up|1|||
48537565|NCT03575871|156156704|FG001|Overall Study|Lost to Follow-up|1|||
48537566|NCT03575871|156156705|FG002|Overall Study|Lost to Follow-up|1|||
48537567|NCT03575871|156156703|FG000|Overall Study|Protocol Deviation|1|||
48537568|NCT03575871|156156704|FG001|Overall Study|Protocol Deviation|1|||
48537569|NCT03575871|156156705|FG002|Overall Study|Protocol Deviation|1|||
48537570|NCT03575871|156156703|FG000|Overall Study|Withdrawal by Subject|6|||
48537571|NCT03575871|156156704|FG001|Overall Study|Withdrawal by Subject|1|||
48537572|NCT03575871|156156705|FG002|Overall Study|Withdrawal by Subject|9|||
48537573|NCT03575871|156156703|FG000|Overall Study|Other than specified|2|||
48537574|NCT03575871|156156704|FG001|Overall Study|Other than specified|2|||
48537575|NCT03575871|156156705|FG002|Overall Study|Other than specified|0|||
48537576|NCT00292188|156156706|FG000|Single-Blind|Adverse Event|14|||
48537577|NCT00292188|156156707|FG001|Single-Blind|Adverse Event|0|||
48537578|NCT00292188|156156708|FG002|Single-Blind|Adverse Event|0|||
48537579|NCT00292188|156156706|FG000|Single-Blind|Lack of Efficacy|2|||
48537580|NCT00292188|156156707|FG001|Single-Blind|Lack of Efficacy|0|||
48537581|NCT00292188|156156708|FG002|Single-Blind|Lack of Efficacy|0|||
48537582|NCT00292188|156156706|FG000|Single-Blind|Laboratory Abnormality|5|||
48537583|NCT00292188|156156707|FG001|Single-Blind|Laboratory Abnormality|0|||
48537584|NCT00292188|156156708|FG002|Single-Blind|Laboratory Abnormality|0|||
48537585|NCT00292188|156156706|FG000|Single-Blind|Lost to Follow-up|3|||
48537586|NCT00292188|156156707|FG001|Single-Blind|Lost to Follow-up|0|||
48537587|NCT00292188|156156708|FG002|Single-Blind|Lost to Follow-up|0|||
48537588|NCT00292188|156156706|FG000|Single-Blind|Other|77|||
48537589|NCT00292188|156156707|FG001|Single-Blind|Other|0|||
48537590|NCT00292188|156156708|FG002|Single-Blind|Other|0|||
48537591|NCT00292188|156156706|FG000|Single-Blind|Withdrawal by Subject|12|||
48537592|NCT00292188|156156707|FG001|Single-Blind|Withdrawal by Subject|0|||
48537593|NCT00292188|156156708|FG002|Single-Blind|Withdrawal by Subject|0|||
48537594|NCT00292188|156156706|FG000|Single-Blind|Did not receive treatment|1|||
48537595|NCT00292188|156156707|FG001|Single-Blind|Did not receive treatment|0|||
48840966|NCT02761187|157257080|FG000|Overall Study|Deceased|474|||
48840967|NCT02761187|157257081|FG001|Overall Study|Deceased|642|||
48840968|NCT02761187|157257080|FG000|Overall Study|Lost to Follow-up|73|||
48840969|NCT02761187|157257081|FG001|Overall Study|Lost to Follow-up|63|||
48840970|NCT02761187|157257080|FG000|Overall Study|Due to study discontinued at site|100|||
48840971|NCT02761187|157257081|FG001|Overall Study|Due to study discontinued at site|85|||
48840972|NCT02761187|157257080|FG000|Overall Study|Reason not Specified|1484|||
48840973|NCT02761187|157257081|FG001|Overall Study|Reason not Specified|937|||
48840974|NCT02609048|157257082|FG000|Overall Study|Adverse Event|3|||
48840975|NCT02609048|157257083|FG001|Overall Study|Adverse Event|0|||
48840976|NCT02609048|157257084|FG002|Overall Study|Adverse Event|0|||
48840977|NCT02609048|157257082|FG000|Overall Study|Randomized but never treated|1|||
48840978|NCT02609048|157257083|FG001|Overall Study|Randomized but never treated|1|||
48840979|NCT02609048|157257084|FG002|Overall Study|Randomized but never treated|1|||
48840980|NCT02609048|157257082|FG000|Overall Study|Withdrawal of informed consent|1|||
48537596|NCT00292188|156156708|FG002|Single-Blind|Did not receive treatment|0|||
48537597|NCT00292188|156156706|FG000|Double-Blind|Adverse Event|0|||
48537598|NCT00292188|156156707|FG001|Double-Blind|Adverse Event|25|||
48537599|NCT00292188|156156708|FG002|Double-Blind|Adverse Event|9|||
48537600|NCT00292188|156156706|FG000|Double-Blind|Lack of Efficacy|0|||
48537601|NCT00292188|156156707|FG001|Double-Blind|Lack of Efficacy|2|||
48537602|NCT00292188|156156708|FG002|Double-Blind|Lack of Efficacy|12|||
48537603|NCT00292188|156156706|FG000|Double-Blind|Lost to Follow-up|0|||
48537604|NCT00292188|156156707|FG001|Double-Blind|Lost to Follow-up|1|||
48537605|NCT00292188|156156708|FG002|Double-Blind|Lost to Follow-up|0|||
48537606|NCT00292188|156156706|FG000|Double-Blind|Other|0|||
48537607|NCT00292188|156156707|FG001|Double-Blind|Other|3|||
48537608|NCT00292188|156156708|FG002|Double-Blind|Other|4|||
48537609|NCT00292188|156156706|FG000|Double-Blind|Withdrawal by Subject|0|||
48537610|NCT00292188|156156707|FG001|Double-Blind|Withdrawal by Subject|0|||
48537611|NCT00292188|156156708|FG002|Double-Blind|Withdrawal by Subject|3|||
48537612|NCT00292188|156156706|FG000|Double-Blind|Laboratory Abnormality|0|||
48537613|NCT00292188|156156707|FG001|Double-Blind|Laboratory Abnormality|0|||
48537614|NCT00292188|156156708|FG002|Double-Blind|Laboratory Abnormality|1|||
48537615|NCT01045993|156156711|FG000|Overall Study|Treated-later found eligibility not met|0|||
48537616|NCT01045993|156156712|FG001|Overall Study|Treated-later found eligibility not met|1|||
48537617|NCT01045993|156156713|FG002|Overall Study|Treated-later found eligibility not met|0|||
48537618|NCT01045993|156156714|FG003|Overall Study|Treated-later found eligibility not met|0|||
48537619|NCT01659736|156156715|FG000|Treatment Period|Adverse Event|1|||
48537620|NCT01659736|156156716|FG001|Treatment Period|Adverse Event|1|||
48840981|NCT02609048|157257083|FG001|Overall Study|Withdrawal of informed consent|0|||
48840982|NCT02609048|157257084|FG002|Overall Study|Withdrawal of informed consent|0|||
48537621|NCT01659736|156156715|FG000|Treatment Period|Protocol Violation|3|||
48537622|NCT01659736|156156716|FG001|Treatment Period|Protocol Violation|1|||
48537623|NCT01659736|156156715|FG000|Treatment Period|Withdrawal by Subject|1|||
48840983|NCT02609048|157257082|FG000|Overall Study|Reason not specified|6|||
48840984|NCT02609048|157257083|FG001|Overall Study|Reason not specified|9|||
48840985|NCT02609048|157257084|FG002|Overall Study|Reason not specified|9|||
48840986|NCT02830204|157257085|FG000|Overall Study|Death|9|||
48840987|NCT02830204|157257085|FG000|Overall Study|Withdrawal by Subject|1|||
48840988|NCT01950390|157257090|FG000|Overall Study|Never started treatment|3|||
48840989|NCT01950390|157257091|FG001|Overall Study|Never started treatment|2|||
48840990|NCT01950390|157257090|FG000|Overall Study|Disease progression|45|||
48840991|NCT01950390|157257091|FG001|Overall Study|Disease progression|52|||
48840992|NCT01950390|157257090|FG000|Overall Study|Adverse Event|22|||
48840993|NCT01950390|157257091|FG001|Overall Study|Adverse Event|16|||
48840994|NCT01950390|157257090|FG000|Overall Study|Death|5|||
48840995|NCT01950390|157257091|FG001|Overall Study|Death|3|||
48840996|NCT01950390|157257090|FG000|Overall Study|Withdrawal by Subject|5|||
48840997|NCT01950390|157257091|FG001|Overall Study|Withdrawal by Subject|1|||
48537624|NCT01659736|156156716|FG001|Treatment Period|Withdrawal by Subject|0|||
48537625|NCT01659736|156156715|FG000|3-month Follow-up|Lost to Follow-up|0|||
48537626|NCT01659736|156156716|FG001|3-month Follow-up|Lost to Follow-up|1|||
48537627|NCT01300052|156156724|FG000|Overall Study|Adverse Event|3|||
48537628|NCT01300052|156156725|FG001|Overall Study|Adverse Event|0|||
48537629|NCT01300052|156156724|FG000|Overall Study|Withdrawal by Subject|2|||
48537630|NCT01300052|156156725|FG001|Overall Study|Withdrawal by Subject|2|||
48840998|NCT01950390|157257090|FG000|Overall Study|Alternative therapy|0|||
48840999|NCT01950390|157257091|FG001|Overall Study|Alternative therapy|3|||
48537631|NCT01300052|156156724|FG000|Overall Study|Protocol Violation|1|||
48537632|NCT01300052|156156725|FG001|Overall Study|Protocol Violation|1|||
48537633|NCT02138136|156156726|FG000|Overall Study|Protocol Violation|4|||
48537634|NCT02138136|156156726|FG000|Overall Study|Physician Decision|7|||
48537635|NCT02138136|156156726|FG000|Overall Study|Lack of Efficacy|35|||
48537636|NCT02138136|156156726|FG000|Overall Study|Pregnancy|2|||
48537637|NCT02138136|156156726|FG000|Overall Study|Adverse Event|18|||
48537638|NCT02138136|156156726|FG000|Overall Study|Withdrawal by Subject|36|||
48537639|NCT02138136|156156726|FG000|Overall Study|Lost to Follow-up|32|||
48537640|NCT02138136|156156726|FG000|Overall Study|Withdrawn by Sponsor|5|||
48537641|NCT01338987|156156727|FG000|Overall Study|enrolled on new protocol|0|||
48537642|NCT01338987|156156728|FG001|Overall Study|enrolled on new protocol|0|||
48537643|NCT01338987|156156729|FG002|Overall Study|enrolled on new protocol|1|||
48537644|NCT01338987|156156730|FG003|Overall Study|enrolled on new protocol|0|||
48537645|NCT01338987|156156731|FG004|Overall Study|enrolled on new protocol|0|||
48537646|NCT01338987|156156727|FG000|Overall Study|Disease progression on study|2|||
48537647|NCT01338987|156156728|FG001|Overall Study|Disease progression on study|1|||
48537648|NCT01338987|156156729|FG002|Overall Study|Disease progression on study|1|||
48537649|NCT01338987|156156730|FG003|Overall Study|Disease progression on study|0|||
48537650|NCT01338987|156156731|FG004|Overall Study|Disease progression on study|0|||
48537651|NCT02697773|156156737|FG000|Overall Study|Adverse Event|2|||
48537652|NCT02697773|156156738|FG001|Overall Study|Adverse Event|1|||
48537653|NCT02697773|156156739|FG002|Overall Study|Adverse Event|2|||
48537654|NCT02697773|156156737|FG000|Overall Study|Death|0|||
48537655|NCT02697773|156156738|FG001|Overall Study|Death|0|||
48537656|NCT02697773|156156739|FG002|Overall Study|Death|2|||
48537657|NCT02697773|156156737|FG000|Overall Study|Lack of Efficacy|4|||
48537658|NCT02697773|156156738|FG001|Overall Study|Lack of Efficacy|6|||
48537659|NCT02697773|156156739|FG002|Overall Study|Lack of Efficacy|6|||
48537660|NCT02697773|156156737|FG000|Overall Study|Lost to Follow-up|5|||
48537661|NCT02697773|156156738|FG001|Overall Study|Lost to Follow-up|5|||
48537662|NCT02697773|156156739|FG002|Overall Study|Lost to Follow-up|7|||
48537663|NCT02697773|156156737|FG000|Overall Study|Other|15|||
48537664|NCT02697773|156156738|FG001|Overall Study|Other|11|||
48537665|NCT02697773|156156739|FG002|Overall Study|Other|10|||
48537666|NCT02697773|156156737|FG000|Overall Study|Protocol Violation|1|||
48537667|NCT02697773|156156738|FG001|Overall Study|Protocol Violation|1|||
48537668|NCT02697773|156156739|FG002|Overall Study|Protocol Violation|0|||
48537669|NCT02697773|156156737|FG000|Overall Study|Withdrawal by Subject|10|||
48537670|NCT02697773|156156738|FG001|Overall Study|Withdrawal by Subject|13|||
48537671|NCT02697773|156156739|FG002|Overall Study|Withdrawal by Subject|13|||
48692907|NCT03137992|156724646|FG000|Washout Period 1|COPD Exacerbation|1|||
48537672|NCT02697773|156156737|FG000|Overall Study|Randomized but not treated|1|||
48537673|NCT02697773|156156738|FG001|Overall Study|Randomized but not treated|1|||
48537674|NCT02697773|156156739|FG002|Overall Study|Randomized but not treated|0|||
48537675|NCT01782482|156156743|FG000|Overall Study|Adverse Event|2|||
48537676|NCT01782482|156156744|FG001|Overall Study|Adverse Event|1|||
48537677|NCT01782482|156156743|FG000|Overall Study|Lost to Follow-up|2|||
48841000|NCT01950390|157257090|FG000|Overall Study|Complicating disease|1|||
48841001|NCT01950390|157257091|FG001|Overall Study|Complicating disease|0|||
48841002|NCT01950390|157257090|FG000|Overall Study|On treatment|1|||
48841003|NCT01950390|157257091|FG001|Overall Study|On treatment|0|||
48841004|NCT01950390|157257090|FG000|Overall Study|Symptomatic deterioration|2|||
48841005|NCT01950390|157257091|FG001|Overall Study|Symptomatic deterioration|1|||
48841006|NCT01950390|157257090|FG000|Overall Study|Physician Decision|0|||
48841007|NCT01950390|157257091|FG001|Overall Study|Physician Decision|4|||
48841008|NCT01950390|157257090|FG000|Overall Study|Lack of clinical benefit|0|||
48841009|NCT01950390|157257091|FG001|Overall Study|Lack of clinical benefit|1|||
48841010|NCT01950390|157257090|FG000|Overall Study|Maintained PR and moved to observation only|0|||
48841011|NCT01950390|157257091|FG001|Overall Study|Maintained PR and moved to observation only|1|||
48841012|NCT02180867|157257094|FG000|Overall Study|Adverse Event|3|||
48537678|NCT01782482|156156744|FG001|Overall Study|Lost to Follow-up|3|||
48537679|NCT01782482|156156743|FG000|Overall Study|Physician Decision|1|||
48537680|NCT01782482|156156744|FG001|Overall Study|Physician Decision|0|||
48537681|NCT01782482|156156743|FG000|Overall Study|Protocol Violation|1|||
48537682|NCT01782482|156156744|FG001|Overall Study|Protocol Violation|0|||
48537683|NCT01782482|156156743|FG000|Overall Study|Withdrawal by Subject|2|||
48537684|NCT01782482|156156744|FG001|Overall Study|Withdrawal by Subject|3|||
48537685|NCT01782482|156156743|FG000|Overall Study|Randomized in Error|2|||
48537686|NCT01782482|156156744|FG001|Overall Study|Randomized in Error|2|||
48537687|NCT01782482|156156743|FG000|Overall Study|Habitually wearing toric lens OS|0|||
48537688|NCT01782482|156156744|FG001|Overall Study|Habitually wearing toric lens OS|1|||
48537689|NCT02377063|156156747|FG000|Overall Study|Non-compliance|5|||
48537690|NCT01277718|156156749|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
48537691|NCT01277718|156156750|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
48537692|NCT01277718|156156749|FG000|Period 2 - Second Intervention|Physician Decision|0|||
48537693|NCT01277718|156156750|FG001|Period 2 - Second Intervention|Physician Decision|2|||
48537694|NCT01524913|156156751|FG000|Overall Study|Lost to Follow-up|4|||
48537695|NCT01524913|156156752|FG001|Overall Study|Lost to Follow-up|0|||
48537696|NCT01524913|156156753|FG002|Overall Study|Lost to Follow-up|0|||
48537697|NCT00702208|156156754|FG000|Overall Study|Lost to Follow-up|28|||
48537698|NCT00702208|156156754|FG000|Overall Study|Did not self-lavage|1|||
48537699|NCT00702208|156156754|FG000|Overall Study|Unsatisfactory colposcopy|2|||
48537700|NCT00321737|156156757|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
48537701|NCT00321737|156156758|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
48537702|NCT00321737|156156759|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
48537703|NCT00321737|156156757|FG000|Overall Study|Adverse Event|11|||
48537704|NCT00321737|156156758|FG001|Overall Study|Adverse Event|3|||
48537705|NCT00321737|156156759|FG002|Overall Study|Adverse Event|6|||
48841013|NCT02180867|157257095|FG001|Overall Study|Adverse Event|4|||
48841014|NCT02180867|157257096|FG002|Overall Study|Adverse Event|1|||
48841015|NCT02180867|157257097|FG003|Overall Study|Adverse Event|5|||
48841016|NCT02180867|157257098|FG004|Overall Study|Adverse Event|0|||
48841017|NCT02180867|157257099|FG005|Overall Study|Adverse Event|0|||
48841018|NCT02180867|157257100|FG006|Overall Study|Adverse Event|0|||
48841019|NCT02180867|157257094|FG000|Overall Study|Death|0|||
48841020|NCT02180867|157257095|FG001|Overall Study|Death|0|||
48841021|NCT02180867|157257096|FG002|Overall Study|Death|0|||
48841022|NCT02180867|157257097|FG003|Overall Study|Death|0|||
48841023|NCT02180867|157257098|FG004|Overall Study|Death|1|||
48841024|NCT02180867|157257099|FG005|Overall Study|Death|0|||
48841025|NCT02180867|157257100|FG006|Overall Study|Death|0|||
48841026|NCT02180867|157257094|FG000|Overall Study|Lack of Efficacy|0|||
48841027|NCT02180867|157257095|FG001|Overall Study|Lack of Efficacy|2|||
48841028|NCT02180867|157257096|FG002|Overall Study|Lack of Efficacy|0|||
48841029|NCT02180867|157257097|FG003|Overall Study|Lack of Efficacy|1|||
48841030|NCT02180867|157257098|FG004|Overall Study|Lack of Efficacy|6|||
48841031|NCT02180867|157257099|FG005|Overall Study|Lack of Efficacy|0|||
48841032|NCT02180867|157257100|FG006|Overall Study|Lack of Efficacy|1|||
48841033|NCT02180867|157257094|FG000|Overall Study|Physician Decision|1|||
48841034|NCT02180867|157257095|FG001|Overall Study|Physician Decision|3|||
48841035|NCT02180867|157257096|FG002|Overall Study|Physician Decision|1|||
48841036|NCT02180867|157257097|FG003|Overall Study|Physician Decision|10|||
48841037|NCT02180867|157257098|FG004|Overall Study|Physician Decision|9|||
48841038|NCT02180867|157257099|FG005|Overall Study|Physician Decision|3|||
48841039|NCT02180867|157257100|FG006|Overall Study|Physician Decision|4|||
48841040|NCT02180867|157257094|FG000|Overall Study|Withdrawal by Subject|0|||
48841041|NCT02180867|157257095|FG001|Overall Study|Withdrawal by Subject|0|||
48841042|NCT02180867|157257096|FG002|Overall Study|Withdrawal by Subject|0|||
48841043|NCT02180867|157257097|FG003|Overall Study|Withdrawal by Subject|1|||
48841044|NCT02180867|157257098|FG004|Overall Study|Withdrawal by Subject|1|||
48841045|NCT02180867|157257099|FG005|Overall Study|Withdrawal by Subject|0|||
48841046|NCT02180867|157257100|FG006|Overall Study|Withdrawal by Subject|0|||
48841047|NCT02180867|157257094|FG000|Overall Study|Ineligible|1|||
48841048|NCT02180867|157257095|FG001|Overall Study|Ineligible|2|||
48841049|NCT02180867|157257096|FG002|Overall Study|Ineligible|0|||
48841050|NCT02180867|157257097|FG003|Overall Study|Ineligible|3|||
48841051|NCT02180867|157257098|FG004|Overall Study|Ineligible|5|||
48841052|NCT02180867|157257099|FG005|Overall Study|Ineligible|0|||
48841053|NCT02180867|157257100|FG006|Overall Study|Ineligible|0|||
48841054|NCT02180867|157257094|FG000|Overall Study|Repeat Eligibility Studies|0|||
48841055|NCT02180867|157257095|FG001|Overall Study|Repeat Eligibility Studies|0|||
48841056|NCT02180867|157257096|FG002|Overall Study|Repeat Eligibility Studies|0|||
48841057|NCT02180867|157257097|FG003|Overall Study|Repeat Eligibility Studies|0|||
48841058|NCT02180867|157257098|FG004|Overall Study|Repeat Eligibility Studies|1|||
48841059|NCT02180867|157257099|FG005|Overall Study|Repeat Eligibility Studies|0|||
48841060|NCT02180867|157257100|FG006|Overall Study|Repeat Eligibility Studies|0|||
48841061|NCT02180867|157257094|FG000|Overall Study|Refusal of further protocol therapy|1|||
48841062|NCT02180867|157257095|FG001|Overall Study|Refusal of further protocol therapy|0|||
48841063|NCT02180867|157257096|FG002|Overall Study|Refusal of further protocol therapy|2|||
48841064|NCT02180867|157257097|FG003|Overall Study|Refusal of further protocol therapy|6|||
48841065|NCT02180867|157257098|FG004|Overall Study|Refusal of further protocol therapy|4|||
48446067|NCT00628758|155820615|FG000|Overall Study|Treatment Failure|0|||
48446068|NCT00628758|155820616|FG001|Overall Study|Treatment Failure|2|||
48446069|NCT04179786|155820619|FG000|Overall Study|Withdrawal by Subject|8|||
48446070|NCT02228564|155820620|FG000|Overall Study|Withdrawal by Subject|10|||
48446071|NCT02228564|155820620|FG000|Overall Study|Death|11|||
48446072|NCT02228564|155820620|FG000|Overall Study|Physician Decision|5|||
48446073|NCT02228564|155820620|FG000|Overall Study|Lost to Follow-up|17|||
48446074|NCT02228564|155820620|FG000|Overall Study|Other|6|||
48446075|NCT00065442|155820621|FG000|Overall Study|Lost to Follow-up|1|||
48446076|NCT00065442|155820622|FG001|Overall Study|Lost to Follow-up|1|||
48446077|NCT00065442|155820621|FG000|Overall Study|Death|121|||
48446078|NCT00065442|155820622|FG001|Overall Study|Death|210|||
48446079|NCT00065442|155820621|FG000|Overall Study|Withdrawal by Subject|3|||
48446080|NCT00065442|155820622|FG001|Overall Study|Withdrawal by Subject|9|||
48446081|NCT03287869|155822260|FG000|Overall Study|Adverse Event|14|||
48446082|NCT03287869|155822261|FG001|Overall Study|Adverse Event|12|||
48446083|NCT03287869|155822260|FG000|Overall Study|Lack of Efficacy|1|||
48446084|NCT03287869|155822261|FG001|Overall Study|Lack of Efficacy|0|||
48446085|NCT03287869|155822260|FG000|Overall Study|Lost to Follow-up|13|||
48446086|NCT03287869|155822261|FG001|Overall Study|Lost to Follow-up|19|||
48537706|NCT00321737|156156757|FG000|Overall Study|Lost to Follow-up|5|||
48537707|NCT00321737|156156758|FG001|Overall Study|Lost to Follow-up|5|||
48537708|NCT00321737|156156759|FG002|Overall Study|Lost to Follow-up|6|||
48537709|NCT00321737|156156757|FG000|Overall Study|Withdrawal by Subject|19|||
48537710|NCT00321737|156156758|FG001|Overall Study|Withdrawal by Subject|12|||
48537711|NCT00321737|156156759|FG002|Overall Study|Withdrawal by Subject|17|||
48841066|NCT02180867|157257099|FG005|Overall Study|Refusal of further protocol therapy|0|||
48841067|NCT02180867|157257100|FG006|Overall Study|Refusal of further protocol therapy|0|||
48841068|NCT04218357|157257103|FG000|1st Allocation|Withdrawal by Subject|1|||
48841069|NCT04218357|157257104|FG001|1st Allocation|Withdrawal by Subject|0|||
48841070|NCT03581292|157257105|FG000|Overall Study|Physician Decision|9|||
48841071|NCT03581292|157257106|FG001|Overall Study|Physician Decision|5|||
48841072|NCT03581292|157257105|FG000|Overall Study|Withdrawal by Subject|3|||
48841073|NCT03581292|157257106|FG001|Overall Study|Withdrawal by Subject|0|||
48841074|NCT03581292|157257105|FG000|Overall Study|Withdrawal before Therapy Start|1|||
48841075|NCT03581292|157257106|FG001|Overall Study|Withdrawal before Therapy Start|0|||
48841076|NCT05529992|157257107|FG000|Overall Study|Withdrawal by Subject|1|||
48841077|NCT05293717|157257108|FG000|Overall Study|Physician Decision|1|||
48841078|NCT03659136|157257112|FG000|Overall Study|Not treated|2|||
48841079|NCT03659136|157257113|FG001|Overall Study|Not treated|0|||
48841080|NCT03659136|157257112|FG000|Overall Study|Covid-19 related|1|||
48841081|NCT03659136|157257113|FG001|Overall Study|Covid-19 related|1|||
48841082|NCT03659136|157257112|FG000|Overall Study|Withdrawal by Subject|1|||
48841083|NCT03659136|157257113|FG001|Overall Study|Withdrawal by Subject|6|||
48841084|NCT03659136|157257112|FG000|Overall Study|Adverse Event|4|||
48841085|NCT03659136|157257113|FG001|Overall Study|Adverse Event|6|||
48841086|NCT03659136|157257112|FG000|Overall Study|Progressive disease|37|||
48841087|NCT03659136|157257113|FG001|Overall Study|Progressive disease|31|||
48841088|NCT03659136|157257112|FG000|Overall Study|Study closure|2|||
48841089|NCT03659136|157257113|FG001|Overall Study|Study closure|2|||
48841090|NCT03659136|157257112|FG000|Overall Study|Sponsor decision/recommendation|3|||
48841091|NCT03659136|157257113|FG001|Overall Study|Sponsor decision/recommendation|2|||
48841092|NCT03659136|157257112|FG000|Overall Study|Switched to other drug/therapy|2|||
48841093|NCT03659136|157257113|FG001|Overall Study|Switched to other drug/therapy|2|||
48841094|NCT03659136|157257112|FG000|Overall Study|Lack of clinical benefit|0|||
48841095|NCT03659136|157257113|FG001|Overall Study|Lack of clinical benefit|1|||
48446165|NCT01807949|155822296|FG002|Overall Study|Non-Compliance|1|||
48446166|NCT01807949|155822294|FG000|Overall Study|Undefined|0|||
48446167|NCT01807949|155822295|FG001|Overall Study|Undefined|1|||
48446168|NCT01807949|155822296|FG002|Overall Study|Undefined|2|||
48446169|NCT01807949|155822294|FG000|Overall Study|Randomized But Not Treated|0|||
48446170|NCT01807949|155822295|FG001|Overall Study|Randomized But Not Treated|2|||
48446171|NCT01807949|155822296|FG002|Overall Study|Randomized But Not Treated|2|||
48446172|NCT00407550|155822297|FG000|Overall Study|Adverse Event|0|||
48446173|NCT00407550|155822298|FG001|Overall Study|Adverse Event|1|||
48446174|NCT00407550|155822297|FG000|Overall Study|Withdrawal by Subject|0|||
48446175|NCT00407550|155822298|FG001|Overall Study|Withdrawal by Subject|2|||
48446176|NCT00407550|155822297|FG000|Overall Study|Death|1|||
48446177|NCT00407550|155822298|FG001|Overall Study|Death|0|||
48446178|NCT00407550|155822297|FG000|Overall Study|Insurance or Other medical condition|2|||
48537712|NCT00321737|156156757|FG000|Overall Study|Protocol Violation|0|||
48537713|NCT00321737|156156758|FG001|Overall Study|Protocol Violation|0|||
48537714|NCT00321737|156156759|FG002|Overall Study|Protocol Violation|1|||
48537715|NCT00321737|156156757|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
48537716|NCT00321737|156156758|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
48537717|NCT00321737|156156759|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
48537718|NCT00321737|156156757|FG000|Overall Study|Possible Barrett's Esophagus|2|||
48537719|NCT00321737|156156758|FG001|Overall Study|Possible Barrett's Esophagus|1|||
48537720|NCT00321737|156156759|FG002|Overall Study|Possible Barrett's Esophagus|1|||
48605862|NCT03885908|156413628|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
48605863|NCT02662569|156413632|FG000|Overall Study|Withdrawal by Subject|6|||
48605864|NCT02662569|156413633|FG001|Overall Study|Withdrawal by Subject|1|||
48605865|NCT02662569|156413634|FG002|Overall Study|Withdrawal by Subject|6|||
48537721|NCT00321737|156156757|FG000|Overall Study|Therapeutic Failure|6|||
48537722|NCT00321737|156156758|FG001|Overall Study|Therapeutic Failure|0|||
48605866|NCT02662569|156413635|FG003|Overall Study|Withdrawal by Subject|4|||
48605867|NCT02662569|156413632|FG000|Overall Study|Lost to Follow-up|1|||
48537723|NCT00321737|156156759|FG002|Overall Study|Therapeutic Failure|2|||
48537724|NCT00321737|156156757|FG000|Overall Study|Pregnancy|0|||
48537725|NCT00321737|156156758|FG001|Overall Study|Pregnancy|2|||
48537726|NCT00321737|156156759|FG002|Overall Study|Pregnancy|0|||
48537727|NCT00321737|156156757|FG000|Overall Study|Noncompliance|2|||
48537728|NCT00321737|156156758|FG001|Overall Study|Noncompliance|0|||
48537729|NCT00321737|156156759|FG002|Overall Study|Noncompliance|0|||
48537730|NCT00321737|156156757|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
48537731|NCT00321737|156156758|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
48537732|NCT00321737|156156759|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
48537733|NCT02989168|156156762|FG000|Overall Study|Withdrawal by Subject|2|||
48537734|NCT02989168|156156763|FG001|Overall Study|Withdrawal by Subject|0|||
48537735|NCT02989168|156156762|FG000|Overall Study|Physician Decision|0|||
48537736|NCT02989168|156156763|FG001|Overall Study|Physician Decision|1|||
48537737|NCT02989168|156156762|FG000|Overall Study|Adverse Event|1|||
48537738|NCT02989168|156156763|FG001|Overall Study|Adverse Event|2|||
48537739|NCT02989168|156156762|FG000|Overall Study|Sponsor stopped study.|1|||
48537740|NCT02989168|156156763|FG001|Overall Study|Sponsor stopped study.|0|||
48537741|NCT00456495|156156766|FG000|Overall Study|Physician Decision|2|||
48537742|NCT01300923|156156767|FG000|Overall Study|Physician Decision|0|||
48537743|NCT01300923|156156768|FG001|Overall Study|Physician Decision|2|||
48537744|NCT00995085|156156771|FG000|Overall Study|Withdrawal by Subject|5|||
48537745|NCT03864042|156156772|FG000|DDI Phase|Adverse Event|2|||
48537746|NCT03864042|156156773|FG001|DDI Phase|Adverse Event|0|||
48537747|NCT03864042|156156774|FG002|DDI Phase|Adverse Event|0|||
48537748|NCT03864042|156156772|FG000|DDI Phase|Physician Decision|1|||
48537749|NCT03864042|156156773|FG001|DDI Phase|Physician Decision|0|||
48537750|NCT03864042|156156774|FG002|DDI Phase|Physician Decision|0|||
48537751|NCT03864042|156156772|FG000|DDI Phase|Progressive Disease|1|||
48537752|NCT03864042|156156773|FG001|DDI Phase|Progressive Disease|0|||
48537753|NCT03864042|156156774|FG002|DDI Phase|Progressive Disease|0|||
48537754|NCT03864042|156156772|FG000|Post-DDI Phase|Adverse Event|5|||
48537755|NCT03864042|156156773|FG001|Post-DDI Phase|Adverse Event|3|||
48537756|NCT03864042|156156774|FG002|Post-DDI Phase|Adverse Event|2|||
48537757|NCT03864042|156156772|FG000|Post-DDI Phase|Progressive Disease|11|||
48537758|NCT03864042|156156773|FG001|Post-DDI Phase|Progressive Disease|6|||
48537759|NCT03864042|156156774|FG002|Post-DDI Phase|Progressive Disease|13|||
48605868|NCT02662569|156413633|FG001|Overall Study|Lost to Follow-up|0|||
48605869|NCT02662569|156413634|FG002|Overall Study|Lost to Follow-up|0|||
48537760|NCT03864042|156156772|FG000|Post-DDI Phase|Discretion of investigator|1|||
48537761|NCT03864042|156156773|FG001|Post-DDI Phase|Discretion of investigator|1|||
48537762|NCT03864042|156156774|FG002|Post-DDI Phase|Discretion of investigator|0|||
48537763|NCT03864042|156156772|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
48537764|NCT03864042|156156773|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
48537765|NCT03864042|156156774|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
48537766|NCT03864042|156156772|FG000|Post-DDI Phase|Withdrawal of consent|1|||
48537767|NCT03864042|156156773|FG001|Post-DDI Phase|Withdrawal of consent|2|||
48537768|NCT03864042|156156774|FG002|Post-DDI Phase|Withdrawal of consent|0|||
48537769|NCT01698775|156156775|FG000|Phase A|Adverse Event|2|||
48537770|NCT01698775|156156776|FG001|Phase A|Adverse Event|1|||
48537771|NCT01698775|156156775|FG000|Phase A|Death|1|||
48537772|NCT01698775|156156776|FG001|Phase A|Death|1|||
48537773|NCT01698775|156156775|FG000|Phase A|Lack of Efficacy|1|||
48537774|NCT01698775|156156776|FG001|Phase A|Lack of Efficacy|0|||
48537775|NCT01698775|156156775|FG000|Phase A|Lost to Follow-up|1|||
48537776|NCT01698775|156156776|FG001|Phase A|Lost to Follow-up|2|||
48537777|NCT01698775|156156775|FG000|Phase A|Protocol Violation|1|||
48537778|NCT01698775|156156776|FG001|Phase A|Protocol Violation|0|||
48537779|NCT01698775|156156775|FG000|Phase A|Withdrawal by Subject|3|||
48537780|NCT01698775|156156776|FG001|Phase A|Withdrawal by Subject|4|||
48537781|NCT01698775|156156775|FG000|Phase A|Kidney [transplant]|0|||
48537782|NCT01698775|156156776|FG001|Phase A|Kidney [transplant]|1|||
48537783|NCT01698775|156156775|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
48537784|NCT01698775|156156776|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
48605870|NCT02662569|156413635|FG003|Overall Study|Lost to Follow-up|0|||
48605871|NCT01159574|156413636|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
48605872|NCT01159574|156413636|FG000|Treatment Phase|Adverse Event|3|||
48537785|NCT01698775|156156775|FG000|Phase B|Adverse Event|6|||
48537786|NCT01698775|156156776|FG001|Phase B|Adverse Event|3|||
48537787|NCT01698775|156156775|FG000|Phase B|Death|0|||
48605873|NCT01159574|156413636|FG000|Treatment Phase|Death|6|||
48605874|NCT01159574|156413636|FG000|Treatment Phase|Physician Decision|2|||
48537788|NCT01698775|156156776|FG001|Phase B|Death|1|||
48537789|NCT01698775|156156775|FG000|Phase B|Lack of Efficacy|0|||
48537790|NCT01698775|156156776|FG001|Phase B|Lack of Efficacy|1|||
48537791|NCT01698775|156156775|FG000|Phase B|Lost to Follow-up|0|||
48537792|NCT01698775|156156776|FG001|Phase B|Lost to Follow-up|1|||
48537793|NCT01698775|156156775|FG000|Phase B|Physician Decision|1|||
48537794|NCT01698775|156156776|FG001|Phase B|Physician Decision|1|||
48537795|NCT01698775|156156775|FG000|Phase B|Protocol Violation|1|||
48537796|NCT01698775|156156776|FG001|Phase B|Protocol Violation|1|||
48537797|NCT01698775|156156775|FG000|Phase B|Withdrawal by Subject|6|||
48537798|NCT01698775|156156776|FG001|Phase B|Withdrawal by Subject|2|||
48537799|NCT02707861|156156779|FG000|Overall Study|Went onto commercial drug|30|||
48537800|NCT02707861|156156780|FG001|Overall Study|Went onto commercial drug|23|||
48537801|NCT02707861|156156779|FG000|Overall Study|Adverse Event|2|||
48537802|NCT02707861|156156780|FG001|Overall Study|Adverse Event|3|||
48537803|NCT02707861|156156779|FG000|Overall Study|Death|5|||
48537804|NCT02707861|156156780|FG001|Overall Study|Death|2|||
48537805|NCT02707861|156156779|FG000|Overall Study|Lack of Efficacy|0|||
48537806|NCT02707861|156156780|FG001|Overall Study|Lack of Efficacy|2|||
48537807|NCT02707861|156156779|FG000|Overall Study|Physician Decision|1|||
48537808|NCT02707861|156156780|FG001|Overall Study|Physician Decision|4|||
48537809|NCT02707861|156156779|FG000|Overall Study|Withdrawal by Subject|2|||
48537810|NCT02707861|156156780|FG001|Overall Study|Withdrawal by Subject|1|||
48537811|NCT02707861|156156779|FG000|Overall Study|Lost to Follow-up|1|||
48537812|NCT02707861|156156780|FG001|Overall Study|Lost to Follow-up|3|||
48537813|NCT02143583|156156781|FG000|Overall Study|Withdrawal by Subject|1|||
48537814|NCT02143583|156156782|FG001|Overall Study|Withdrawal by Subject|0|||
48537815|NCT02143583|156156783|FG002|Overall Study|Withdrawal by Subject|1|||
48537816|NCT02143583|156156781|FG000|Overall Study|husband illness|0|||
48537817|NCT02143583|156156782|FG001|Overall Study|husband illness|0|||
48537818|NCT02143583|156156783|FG002|Overall Study|husband illness|1|||
48537819|NCT01244061|156156786|FG000|Overall Study|Death|1|||
48537820|NCT01244061|156156787|FG001|Overall Study|Death|0|||
48537821|NCT01244061|156156786|FG000|Overall Study|Did not meet entrance criteria|1|||
48537822|NCT01244061|156156787|FG001|Overall Study|Did not meet entrance criteria|0|||
48537823|NCT01244061|156156786|FG000|Overall Study|Lack of Efficacy|1|||
48537824|NCT01244061|156156787|FG001|Overall Study|Lack of Efficacy|3|||
48537825|NCT01244061|156156786|FG000|Overall Study|Lost to Follow-up|34|||
48537826|NCT01244061|156156787|FG001|Overall Study|Lost to Follow-up|30|||
48537827|NCT01244061|156156786|FG000|Overall Study|Withdrawal by Subject|29|||
48537828|NCT01244061|156156787|FG001|Overall Study|Withdrawal by Subject|46|||
48537829|NCT01244061|156156786|FG000|Overall Study|Other|8|||
48537830|NCT01244061|156156787|FG001|Overall Study|Other|19|||
48537831|NCT01244061|156156786|FG000|Overall Study|Protocol Violation|1|||
48537832|NCT01244061|156156787|FG001|Overall Study|Protocol Violation|1|||
48537833|NCT01244061|156156786|FG000|Overall Study|Adverse Event|5|||
48537834|NCT01244061|156156787|FG001|Overall Study|Adverse Event|2|||
48537835|NCT01244061|156156786|FG000|Overall Study|Randomized but not treated|2|||
48537836|NCT01244061|156156787|FG001|Overall Study|Randomized but not treated|2|||
48537837|NCT01641133|156156788|FG000|Overall Study|Protocol Violation|0|||
48537838|NCT01641133|156156789|FG001|Overall Study|Protocol Violation|1|||
48537839|NCT01641133|156156790|FG002|Overall Study|Protocol Violation|1|||
48537840|NCT01641133|156156788|FG000|Overall Study|Migrated/moved from study area|5|||
48537841|NCT01641133|156156789|FG001|Overall Study|Migrated/moved from study area|3|||
48537842|NCT01641133|156156790|FG002|Overall Study|Migrated/moved from study area|1|||
48537843|NCT01641133|156156788|FG000|Overall Study|Adverse Event|0|||
48537844|NCT01641133|156156789|FG001|Overall Study|Adverse Event|0|||
48537845|NCT01641133|156156790|FG002|Overall Study|Adverse Event|1|||
48537846|NCT01641133|156156788|FG000|Overall Study|Withdrawal by Subject|5|||
48537847|NCT01641133|156156789|FG001|Overall Study|Withdrawal by Subject|3|||
48537848|NCT01641133|156156790|FG002|Overall Study|Withdrawal by Subject|3|||
48537849|NCT01641133|156156788|FG000|Overall Study|Lost to Follow-up|0|||
48537850|NCT01641133|156156789|FG001|Overall Study|Lost to Follow-up|2|||
48537851|NCT01641133|156156790|FG002|Overall Study|Lost to Follow-up|2|||
48537852|NCT02980874|156156791|FG000|Overall Study|Adverse Event|2|||
48537853|NCT02980874|156156792|FG001|Overall Study|Adverse Event|7|||
48537854|NCT02980874|156156791|FG000|Overall Study|Withdrawal by Subject|7|||
48537855|NCT02980874|156156792|FG001|Overall Study|Withdrawal by Subject|2|||
48537856|NCT02980874|156156791|FG000|Overall Study|Lost to Follow-up|5|||
48537857|NCT02980874|156156792|FG001|Overall Study|Lost to Follow-up|5|||
48537858|NCT02980874|156156791|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
48537859|NCT02980874|156156792|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
48537860|NCT02980874|156156791|FG000|Overall Study|Unknown study completion status|1|||
48537861|NCT02980874|156156792|FG001|Overall Study|Unknown study completion status|0|||
48537862|NCT01346774|156156793|FG000|Overall Study|Did not take a single dose|6|||
48537863|NCT01346774|156156794|FG001|Overall Study|Did not take a single dose|4|||
48537864|NCT01346774|156156793|FG000|Overall Study|Lost to Follow-up|3|||
48537865|NCT01346774|156156794|FG001|Overall Study|Lost to Follow-up|4|||
48537866|NCT01346774|156156793|FG000|Overall Study|Withdrawal by Subject|1|||
48537867|NCT01346774|156156794|FG001|Overall Study|Withdrawal by Subject|4|||
48537868|NCT01346774|156156793|FG000|Overall Study|Protocol Violation|2|||
48537869|NCT01346774|156156794|FG001|Overall Study|Protocol Violation|3|||
48537870|NCT01346774|156156793|FG000|Overall Study|Adverse Event|1|||
48537871|NCT01346774|156156794|FG001|Overall Study|Adverse Event|2|||
48537872|NCT04135196|156156795|FG000|Overall Study|Lost to Follow-up|8|||
48537873|NCT04135196|156156796|FG001|Overall Study|Lost to Follow-up|7|||
48537874|NCT04135196|156156797|FG002|Overall Study|Lost to Follow-up|8|||
48537875|NCT04135196|156156798|FG003|Overall Study|Lost to Follow-up|9|||
48537876|NCT04135196|156156799|FG004|Overall Study|Lost to Follow-up|1|||
48537877|NCT04135196|156156795|FG000|Overall Study|Pregnancy|0|||
48537878|NCT04135196|156156796|FG001|Overall Study|Pregnancy|0|||
48537879|NCT04135196|156156797|FG002|Overall Study|Pregnancy|1|||
48537880|NCT04135196|156156798|FG003|Overall Study|Pregnancy|0|||
48537881|NCT04135196|156156799|FG004|Overall Study|Pregnancy|0|||
48537882|NCT04135196|156156795|FG000|Overall Study|Withdrawal by Subject|0|||
48537883|NCT04135196|156156796|FG001|Overall Study|Withdrawal by Subject|0|||
48537884|NCT04135196|156156797|FG002|Overall Study|Withdrawal by Subject|0|||
48537885|NCT04135196|156156798|FG003|Overall Study|Withdrawal by Subject|0|||
48537886|NCT04135196|156156799|FG004|Overall Study|Withdrawal by Subject|1|||
48537887|NCT03212521|156156802|FG000|Overall Study|Adverse Event|1|||
48537888|NCT03212521|156156802|FG000|Overall Study|Lost to Follow-up|4|||
48537889|NCT03212521|156156802|FG000|Overall Study|Withdrawal by Subject|1|||
48537890|NCT03212521|156156802|FG000|Overall Study|Other|1|||
48537891|NCT02435836|156156807|FG000|Overall Study|Lost to Follow-up|21|||
48537892|NCT02435836|156156807|FG000|Overall Study|Lack of Efficacy|1|||
48537893|NCT02435836|156156807|FG000|Overall Study|Withdrawal by Subject|236|||
48537894|NCT02435836|156156807|FG000|Overall Study|Insufficient Clinical Response|26|||
48537895|NCT02435836|156156807|FG000|Overall Study|Adverse Event|44|||
48537896|NCT02435836|156156807|FG000|Overall Study|Sponsor discontinued trial|167|||
48537897|NCT02435836|156156807|FG000|Overall Study|Noncompliance|27|||
48537898|NCT02435836|156156807|FG000|Overall Study|Protocol Violation|6|||
48537899|NCT02435836|156156807|FG000|Overall Study|Met Withdrawal Criteria|7|||
48537900|NCT02435836|156156807|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
48537901|NCT03512262|156156810|FG000|Overall Study|Adverse Event|8|||
48537902|NCT03512262|156156811|FG001|Overall Study|Adverse Event|3|||
48537903|NCT03512262|156156810|FG000|Overall Study|Death (non-treatment emergent)|1|||
48537904|NCT03512262|156156811|FG001|Overall Study|Death (non-treatment emergent)|0|||
48537905|NCT03512262|156156810|FG000|Overall Study|Withdrawal by Subject|17|||
48537906|NCT03512262|156156811|FG001|Overall Study|Withdrawal by Subject|9|||
48537907|NCT03512262|156156810|FG000|Overall Study|Lost to Follow-up|7|||
48537908|NCT03512262|156156811|FG001|Overall Study|Lost to Follow-up|1|||
48537909|NCT03512262|156156810|FG000|Overall Study|Other than Specified|2|||
48537910|NCT03512262|156156811|FG001|Overall Study|Other than Specified|2|||
48584972|NCT01179737|156333738|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
48537911|NCT02522403|156159259|FG000|Overall Study|Lost to Follow-up|2|||
48537912|NCT02522403|156159260|FG001|Overall Study|Lost to Follow-up|2|||
48537913|NCT02522403|156159259|FG000|Overall Study|Withdrawal by Subject|2|||
48537914|NCT02522403|156159260|FG001|Overall Study|Withdrawal by Subject|4|||
48537915|NCT01045421|156159261|FG000|Phase 1|Progressive Disease|0|||
48537916|NCT01045421|156159262|FG001|Phase 1|Progressive Disease|0|||
48537917|NCT01045421|156159263|FG002|Phase 1|Progressive Disease|0|||
48537918|NCT01045421|156159264|FG003|Phase 1|Progressive Disease|0|||
48537919|NCT01045421|156159265|FG004|Phase 1|Progressive Disease|1|||
48537920|NCT01045421|156159266|FG005|Phase 1|Progressive Disease|0|||
48537921|NCT01045421|156159267|FG006|Phase 1|Progressive Disease|0|||
48537922|NCT01045421|156159268|FG007|Phase 1|Progressive Disease|0|||
48537923|NCT01045421|156159269|FG008|Phase 1|Progressive Disease|0|||
48537924|NCT01045421|156159270|FG009|Phase 1|Progressive Disease|0|||
48537925|NCT01045421|156159271|FG010|Phase 1|Progressive Disease|0|||
48537926|NCT01045421|156159261|FG000|Phase 1|Withdrawal by Subject|0|||
48537927|NCT01045421|156159262|FG001|Phase 1|Withdrawal by Subject|0|||
48537928|NCT01045421|156159263|FG002|Phase 1|Withdrawal by Subject|0|||
48537929|NCT01045421|156159264|FG003|Phase 1|Withdrawal by Subject|1|||
48537930|NCT01045421|156159265|FG004|Phase 1|Withdrawal by Subject|0|||
48537931|NCT01045421|156159266|FG005|Phase 1|Withdrawal by Subject|0|||
48537932|NCT01045421|156159267|FG006|Phase 1|Withdrawal by Subject|0|||
48537933|NCT01045421|156159268|FG007|Phase 1|Withdrawal by Subject|0|||
48537934|NCT01045421|156159269|FG008|Phase 1|Withdrawal by Subject|0|||
48537935|NCT01045421|156159270|FG009|Phase 1|Withdrawal by Subject|0|||
48537936|NCT01045421|156159271|FG010|Phase 1|Withdrawal by Subject|0|||
48537937|NCT01045421|156159261|FG000|Phase 2|Progressive Disease|0|||
48537938|NCT01045421|156159262|FG001|Phase 2|Progressive Disease|0|||
48537939|NCT01045421|156159263|FG002|Phase 2|Progressive Disease|0|||
48537940|NCT01045421|156159264|FG003|Phase 2|Progressive Disease|0|||
48537941|NCT01045421|156159265|FG004|Phase 2|Progressive Disease|0|||
48537942|NCT01045421|156159266|FG005|Phase 2|Progressive Disease|0|||
48537943|NCT01045421|156159267|FG006|Phase 2|Progressive Disease|0|||
48537944|NCT01045421|156159268|FG007|Phase 2|Progressive Disease|1|||
48537945|NCT01045421|156159269|FG008|Phase 2|Progressive Disease|1|||
48537946|NCT01045421|156159270|FG009|Phase 2|Progressive Disease|1|||
48537947|NCT01045421|156159271|FG010|Phase 2|Progressive Disease|1|||
48537948|NCT01045421|156159261|FG000|Phase 2|Death|0|||
48537949|NCT01045421|156159262|FG001|Phase 2|Death|0|||
48537950|NCT01045421|156159263|FG002|Phase 2|Death|0|||
48537951|NCT01045421|156159264|FG003|Phase 2|Death|0|||
48537952|NCT01045421|156159265|FG004|Phase 2|Death|0|||
48537953|NCT01045421|156159266|FG005|Phase 2|Death|0|||
48537954|NCT01045421|156159267|FG006|Phase 2|Death|0|||
48537955|NCT01045421|156159268|FG007|Phase 2|Death|1|||
48537956|NCT01045421|156159269|FG008|Phase 2|Death|1|||
48537957|NCT01045421|156159270|FG009|Phase 2|Death|2|||
48537958|NCT01045421|156159271|FG010|Phase 2|Death|0|||
48537959|NCT01045421|156159261|FG000|Phase 2|Other|0|||
48537960|NCT01045421|156159262|FG001|Phase 2|Other|0|||
48537961|NCT01045421|156159263|FG002|Phase 2|Other|0|||
48537962|NCT01045421|156159264|FG003|Phase 2|Other|0|||
48537963|NCT01045421|156159265|FG004|Phase 2|Other|0|||
48537964|NCT01045421|156159266|FG005|Phase 2|Other|0|||
48537965|NCT01045421|156159267|FG006|Phase 2|Other|0|||
48537966|NCT01045421|156159268|FG007|Phase 2|Other|3|||
48537967|NCT01045421|156159269|FG008|Phase 2|Other|0|||
48537968|NCT01045421|156159270|FG009|Phase 2|Other|0|||
48537969|NCT01045421|156159271|FG010|Phase 2|Other|1|||
48537970|NCT03340064|156159272|FG000|First Period|Adverse Event, non-fatal|2|||
48537971|NCT03340064|156159273|FG001|First Period|Adverse Event, non-fatal|0|||
48537972|NCT03340064|156159272|FG000|First Period|Lack of Efficacy|3|||
48537973|NCT03340064|156159273|FG001|First Period|Lack of Efficacy|0|||
48537974|NCT03340064|156159272|FG000|Second Period|Adverse Event, non-fatal|1|||
48537975|NCT03340064|156159273|FG001|Second Period|Adverse Event, non-fatal|1|||
48537976|NCT03340064|156159272|FG000|Second Period|Lack of Efficacy|11|||
48537977|NCT03340064|156159273|FG001|Second Period|Lack of Efficacy|0|||
48605875|NCT01159574|156413636|FG000|Treatment Phase|Withdrawal by Subject|7|||
48537978|NCT03340064|156159272|FG000|Second Period|Physician Decision|3|||
48537979|NCT03340064|156159273|FG001|Second Period|Physician Decision|0|||
48537980|NCT03340064|156159272|FG000|Second Period|Withdrawal by Subject|2|||
48537981|NCT03340064|156159273|FG001|Second Period|Withdrawal by Subject|1|||
48537982|NCT03340064|156159272|FG000|Second Period|Approved Drug Available For Indication|1|||
48537983|NCT03340064|156159273|FG001|Second Period|Approved Drug Available For Indication|0|||
48537984|NCT03340064|156159272|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
48537985|NCT03340064|156159273|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
48537986|NCT01475253|156159274|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
48537987|NCT01475253|156159275|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
48537988|NCT01475253|156159276|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
48537989|NCT01475253|156159277|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
48537990|NCT01475253|156159274|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
48537991|NCT01475253|156159275|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
48537992|NCT01475253|156159276|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
48537993|NCT01475253|156159277|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
48537994|NCT01460901|156159289|FG000|Overall Study|Withdrawal by Subject|2|||
48537995|NCT05506358|156159290|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
48537996|NCT05506358|156159291|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
48537997|NCT05506358|156159292|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
48537998|NCT05506358|156159293|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
48537999|NCT05506358|156159294|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
48538000|NCT05506358|156159290|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
48538001|NCT05506358|156159291|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
48538002|NCT05506358|156159292|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
48538003|NCT05506358|156159293|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
48538004|NCT05506358|156159294|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
48538005|NCT05506358|156159290|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
48538006|NCT05506358|156159291|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
48538007|NCT05506358|156159292|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
48538008|NCT05506358|156159293|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
48538009|NCT05506358|156159294|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
48538010|NCT05506358|156159290|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
48538011|NCT05506358|156159291|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
48538012|NCT05506358|156159292|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
48538013|NCT05506358|156159293|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
48538014|NCT05506358|156159294|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
48538015|NCT05506358|156159290|FG000|Overall Study|HbE trait|0|||
48538016|NCT05506358|156159291|FG001|Overall Study|HbE trait|0|||
48538017|NCT05506358|156159292|FG002|Overall Study|HbE trait|0|||
48538018|NCT05506358|156159293|FG003|Overall Study|HbE trait|1|||
48538019|NCT05506358|156159294|FG004|Overall Study|HbE trait|0|||
48538020|NCT00804141|156159295|FG000|Overall Study|Adverse Event|157|||
48538021|NCT00804141|156159295|FG000|Overall Study|Death|4|||
48538022|NCT00804141|156159295|FG000|Overall Study|Failed to return|96|||
48538023|NCT00804141|156159295|FG000|Overall Study|Investigator request|8|||
48538024|NCT00804141|156159295|FG000|Overall Study|Protocol Violation|85|||
48538025|NCT00804141|156159295|FG000|Overall Study|Withdrawal by Subject|131|||
48538026|NCT00804141|156159295|FG000|Overall Study|Lack of Efficacy|46|||
48538027|NCT00804141|156159295|FG000|Overall Study|Other than specified|30|||
48538028|NCT00804141|156159295|FG000|Overall Study|Enrolled but not treated|6|||
48538029|NCT02581163|156159299|FG000|Overall Study|Failure to return|15|||
48538030|NCT02581163|156159299|FG000|Overall Study|Insufficient virological response|3|||
48538031|NCT02581163|156159299|FG000|Overall Study|Withdrew consent|1|||
48538032|NCT02581163|156159299|FG000|Overall Study|Death|1|||
48538033|NCT02581163|156159299|FG000|Overall Study|Other, not specified|9|||
48538034|NCT02072824|156159300|FG000|Overall Study|Insufficient clinical response|1|||
48538035|NCT02072824|156159301|FG001|Overall Study|Insufficient clinical response|0|||
48538036|NCT02072824|156159302|FG002|Overall Study|Insufficient clinical response|1|||
48538037|NCT02072824|156159300|FG000|Overall Study|No longer willing to participate|1|||
48538038|NCT02072824|156159301|FG001|Overall Study|No longer willing to participate|0|||
48538039|NCT02072824|156159302|FG002|Overall Study|No longer willing to participate|1|||
48538040|NCT02072824|156159300|FG000|Overall Study|Medication error|0|||
48538041|NCT02072824|156159301|FG001|Overall Study|Medication error|1|||
48538042|NCT02072824|156159302|FG002|Overall Study|Medication error|0|||
48538043|NCT02072824|156159300|FG000|Overall Study|Adverse Event|0|||
48538044|NCT02072824|156159301|FG001|Overall Study|Adverse Event|0|||
48538045|NCT02072824|156159302|FG002|Overall Study|Adverse Event|1|||
48538046|NCT00608517|156159303|FG000|Overall Study|Death|1|||
48538047|NCT00608517|156159304|FG001|Overall Study|Death|0|||
48538048|NCT00608517|156159305|FG002|Overall Study|Death|0|||
48538049|NCT03095118|156159306|FG000|Overall Study|Adverse Event|1|||
48538050|NCT03095118|156159306|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
48538051|NCT02865395|156159311|FG000|Overall Study|Physician Decision|6|||
48538052|NCT02865395|156159312|FG001|Overall Study|Physician Decision|10|||
48538053|NCT02865395|156159313|FG002|Overall Study|Physician Decision|7|||
48538054|NCT02025751|156159318|FG000|Overall Study|Lost to Follow-up|1|||
48538055|NCT02025751|156159319|FG001|Overall Study|Lost to Follow-up|0|||
48538056|NCT02025751|156159318|FG000|Overall Study|Adverse Event|0|||
48538057|NCT02025751|156159319|FG001|Overall Study|Adverse Event|1|||
48538058|NCT02025751|156159318|FG000|Overall Study|Physician Decision|0|||
48538059|NCT02025751|156159319|FG001|Overall Study|Physician Decision|1|||
48538060|NCT02025751|156159318|FG000|Overall Study|Withdrawal by Subject|0|||
48538061|NCT02025751|156159319|FG001|Overall Study|Withdrawal by Subject|1|||
48538062|NCT03456960|156159320|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48538063|NCT03456960|156159321|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48538064|NCT03456960|156159322|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
48538065|NCT03456960|156159323|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
48538066|NCT03456960|156159324|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48538067|NCT03456960|156159325|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48538068|NCT03456960|156159320|FG000|Period 2 (1 Day)|Adverse Event|1|||
48538069|NCT03456960|156159321|FG001|Period 2 (1 Day)|Adverse Event|0|||
48538070|NCT03456960|156159322|FG002|Period 2 (1 Day)|Adverse Event|0|||
48538071|NCT03456960|156159323|FG003|Period 2 (1 Day)|Adverse Event|1|||
48538072|NCT03456960|156159324|FG004|Period 2 (1 Day)|Adverse Event|0|||
48538073|NCT03456960|156159325|FG005|Period 2 (1 Day)|Adverse Event|0|||
48538074|NCT01138826|156159326|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
48538075|NCT01138826|156159327|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
48538076|NCT01138826|156159328|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
48538077|NCT01138826|156159329|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
48538078|NCT01138826|156159330|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
48538079|NCT01138826|156159331|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
48538080|NCT00653991|156159332|FG000|3 Month Follow-up|Participant would not respond|150|||
48538081|NCT00653991|156159333|FG001|3 Month Follow-up|Participant would not respond|157|||
48538082|NCT00653991|156159332|FG000|6 Month Follow-up|Participant would not respond|133|||
48538083|NCT00653991|156159333|FG001|6 Month Follow-up|Participant would not respond|141|||
48538084|NCT00629265|156159334|FG000|Overall Study|Lost to Follow-up|4|||
48538085|NCT00629265|156159335|FG001|Overall Study|Lost to Follow-up|5|||
48538086|NCT00629265|156159334|FG000|Overall Study|Withdrawal by Subject|11|||
48446258|NCT03228394|155822339|FG000|Overall Study|Physician Decision|0|||
48446259|NCT03228394|155822340|FG001|Overall Study|Physician Decision|0|||
48446260|NCT03228394|155822341|FG002|Overall Study|Physician Decision|0|||
48446261|NCT03228394|155822342|FG003|Overall Study|Physician Decision|0|||
48446262|NCT03228394|155822343|FG004|Overall Study|Physician Decision|0|||
48446263|NCT03228394|155822344|FG005|Overall Study|Physician Decision|0|||
48446264|NCT03228394|155822345|FG006|Overall Study|Physician Decision|1|||
48446265|NCT03228394|155822346|FG007|Overall Study|Physician Decision|0|||
48446266|NCT03228394|155822339|FG000|Overall Study|Noncompliance|0|||
48446267|NCT03228394|155822340|FG001|Overall Study|Noncompliance|0|||
48446268|NCT03228394|155822341|FG002|Overall Study|Noncompliance|0|||
48446269|NCT03228394|155822342|FG003|Overall Study|Noncompliance|0|||
48446270|NCT03228394|155822343|FG004|Overall Study|Noncompliance|0|||
48446271|NCT03228394|155822344|FG005|Overall Study|Noncompliance|0|||
48446272|NCT03228394|155822345|FG006|Overall Study|Noncompliance|1|||
48446273|NCT03228394|155822346|FG007|Overall Study|Noncompliance|0|||
48446274|NCT00879437|155822348|FG000|Overall Study|Protocol Violation|0|||
48446275|NCT00879437|155822349|FG001|Overall Study|Protocol Violation|1|||
48446276|NCT00879437|155822348|FG000|Overall Study|Death|1|||
48446277|NCT00879437|155822349|FG001|Overall Study|Death|0|||
48446278|NCT04581863|155822350|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
48446279|NCT04581863|155822351|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
48446280|NCT00268463|155822352|FG000|Overall Study|study terminated due to low accrual|10|||
48446281|NCT00268463|155822353|FG001|Overall Study|study terminated due to low accrual|12|||
48538087|NCT00629265|156159335|FG001|Overall Study|Withdrawal by Subject|8|||
48538088|NCT00629265|156159334|FG000|Overall Study|Death|1|||
48538089|NCT00629265|156159335|FG001|Overall Study|Death|0|||
48538090|NCT00629265|156159334|FG000|Overall Study|Adverse Event|2|||
48538091|NCT00629265|156159335|FG001|Overall Study|Adverse Event|0|||
48538092|NCT00629265|156159334|FG000|Overall Study|HNC Recurrence|4|||
48538093|NCT00629265|156159335|FG001|Overall Study|HNC Recurrence|0|||
48538094|NCT00629265|156159334|FG000|Overall Study|Other CA Requiring Treatment|1|||
48538095|NCT00629265|156159335|FG001|Overall Study|Other CA Requiring Treatment|3|||
48538096|NCT00629265|156159334|FG000|Overall Study|Needed Esophageal Dilation|4|||
48538097|NCT00629265|156159335|FG001|Overall Study|Needed Esophageal Dilation|1|||
48538098|NCT00629265|156159334|FG000|Overall Study|Unrelated Medical Complications|3|||
48538099|NCT00629265|156159335|FG001|Overall Study|Unrelated Medical Complications|1|||
48538100|NCT00629265|156159334|FG000|Overall Study|Unknown Reason|2|||
48538101|NCT00629265|156159335|FG001|Overall Study|Unknown Reason|2|||
48538102|NCT01846273|156159340|FG000|Overall Study|Adverse Event|9|||
48538103|NCT01846273|156159341|FG001|Overall Study|Adverse Event|7|||
48538104|NCT01846273|156159342|FG002|Overall Study|Adverse Event|0|||
48538105|NCT01846273|156159340|FG000|Overall Study|Subject withdrew consent|5|||
48538106|NCT01846273|156159341|FG001|Overall Study|Subject withdrew consent|8|||
48538107|NCT01846273|156159342|FG002|Overall Study|Subject withdrew consent|0|||
48538108|NCT01846273|156159340|FG000|Overall Study|Lost to Follow-up|2|||
48538109|NCT01846273|156159341|FG001|Overall Study|Lost to Follow-up|1|||
48538110|NCT01846273|156159342|FG002|Overall Study|Lost to Follow-up|0|||
48538111|NCT01846273|156159340|FG000|Overall Study|Administrative problems|1|||
48538112|NCT01846273|156159341|FG001|Overall Study|Administrative problems|0|||
48538113|NCT01846273|156159342|FG002|Overall Study|Administrative problems|0|||
48538114|NCT01846273|156159340|FG000|Overall Study|Death|2|||
48538115|NCT01846273|156159341|FG001|Overall Study|Death|1|||
48538116|NCT01846273|156159342|FG002|Overall Study|Death|0|||
48538117|NCT01846273|156159340|FG000|Overall Study|Disease Progression|0|||
48538118|NCT01846273|156159341|FG001|Overall Study|Disease Progression|4|||
48538119|NCT01846273|156159342|FG002|Overall Study|Disease Progression|0|||
48538120|NCT01846273|156159340|FG000|Overall Study|Protocol Deviation|2|||
48538121|NCT01846273|156159341|FG001|Overall Study|Protocol Deviation|3|||
48538122|NCT01846273|156159342|FG002|Overall Study|Protocol Deviation|0|||
48538123|NCT01846273|156159340|FG000|Overall Study|Physician Decision|1|||
48538124|NCT01846273|156159341|FG001|Overall Study|Physician Decision|2|||
48538125|NCT01846273|156159342|FG002|Overall Study|Physician Decision|0|||
48538126|NCT01941940|156159343|FG000|Overall Study|Adverse Event|11|||
48538127|NCT01941940|156159343|FG000|Overall Study|Lost to Follow-up|2|||
48605876|NCT01159574|156413636|FG000|Treatment Phase|still on treatment|2|||
48605877|NCT01159574|156413636|FG000|Follow Up Phase|Lost to Follow-up|2|||
48605878|NCT01159574|156413636|FG000|Follow Up Phase|still being followed for overall surviva|18|||
48605879|NCT02666222|156413639|FG000|Overall Study|Death|2|||
48605880|NCT01692119|156413644|FG000|Overall Study|Protocol Violation|3|||
48605881|NCT01692119|156413645|FG001|Overall Study|Protocol Violation|1|||
48605882|NCT01692119|156413644|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
48605883|NCT01692119|156413645|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
48605884|NCT03307174|156413647|FG000|Overall Study|Unplanned ICU Administrion|5|||
48605885|NCT03307174|156413648|FG001|Overall Study|Unplanned ICU Administrion|3|||
48605886|NCT03307174|156413647|FG000|Overall Study|Aborted Surgery|1|||
48605887|NCT03307174|156413648|FG001|Overall Study|Aborted Surgery|2|||
48605888|NCT03307174|156413647|FG000|Overall Study|Hypotension|6|||
48605889|NCT03307174|156413648|FG001|Overall Study|Hypotension|0|||
48605890|NCT03307174|156413647|FG000|Overall Study|Nonfunctional epidural|1|||
48605891|NCT03307174|156413648|FG001|Overall Study|Nonfunctional epidural|1|||
48605892|NCT03307174|156413647|FG000|Overall Study|Planned epidural removal|1|||
48605893|NCT03307174|156413648|FG001|Overall Study|Planned epidural removal|0|||
48605894|NCT03307174|156413647|FG000|Overall Study|Intrathecal catheter placement|0|||
48605895|NCT03307174|156413648|FG001|Overall Study|Intrathecal catheter placement|1|||
48605896|NCT00863707|156413649|FG000|Overall Study|Randomized, but drug not received|4|||
48605897|NCT00863707|156413650|FG001|Overall Study|Randomized, but drug not received|3|||
48605898|NCT01664091|156413651|FG000|Overall Study|Death|1|||
48538128|NCT01941940|156159343|FG000|Overall Study|Physician Decision|2|||
48538129|NCT01941940|156159343|FG000|Overall Study|Withdrawal by Subject|15|||
48538130|NCT01941940|156159343|FG000|Overall Study|Death|1|||
48538131|NCT01941940|156159343|FG000|Overall Study|Other|1|||
48538132|NCT01941940|156159343|FG000|Overall Study|Other|1|||
48538133|NCT03828448|156159344|FG000|Overall Study|Sponsor's Discretion|34|||
48538134|NCT02037165|156159345|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
48538135|NCT02037165|156159346|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
48538136|NCT02037165|156159347|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
48538137|NCT02037165|156159348|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
48538138|NCT02037165|156159349|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
48538139|NCT00532935|156159352|FG000|Overall Study|Adverse Event|11|||
48538140|NCT00532935|156159353|FG001|Overall Study|Adverse Event|12|||
48538141|NCT00532935|156159352|FG000|Overall Study|Lack of Efficacy|0|||
48538142|NCT00532935|156159353|FG001|Overall Study|Lack of Efficacy|3|||
48538143|NCT00532935|156159352|FG000|Overall Study|Lost to Follow-up|10|||
48538144|NCT00532935|156159353|FG001|Overall Study|Lost to Follow-up|6|||
48538145|NCT00532935|156159352|FG000|Overall Study|Physician Decision|4|||
48538146|NCT00532935|156159353|FG001|Overall Study|Physician Decision|5|||
48538147|NCT00532935|156159352|FG000|Overall Study|Pregnancy|1|||
48538148|NCT00532935|156159353|FG001|Overall Study|Pregnancy|0|||
48538149|NCT00532935|156159352|FG000|Overall Study|Protocol Violation|4|||
48538150|NCT00532935|156159353|FG001|Overall Study|Protocol Violation|2|||
48538151|NCT00532935|156159352|FG000|Overall Study|Withdrawal by Subject|10|||
48538152|NCT00532935|156159353|FG001|Overall Study|Withdrawal by Subject|9|||
48538153|NCT00532935|156159352|FG000|Overall Study|Protocol Specific Criteria|11|||
48605899|NCT01664091|156413651|FG000|Overall Study|Disease Progression|2|||
48605900|NCT01664091|156413651|FG000|Overall Study|Lost to Follow-up|2|||
48605901|NCT01664091|156413651|FG000|Overall Study|Withdrawal by Subject|1|||
48605902|NCT01867008|156413652|FG000|Overall Study|Withdrawal by Subject|1|||
48605903|NCT02391337|156413659|FG000|6 Months Follow-up|Death|5|||
48605904|NCT02391337|156413660|FG001|6 Months Follow-up|Death|4|||
48605905|NCT02391337|156413659|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
48605906|NCT02391337|156413660|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
48605907|NCT02391337|156413659|FG000|12 Months Follow-up|Death|2|||
48605908|NCT02391337|156413660|FG001|12 Months Follow-up|Death|0|||
48605909|NCT02391337|156413659|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
48605910|NCT02391337|156413660|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
48605911|NCT02391337|156413659|FG000|12 Months Follow-up|Lost to Follow-up|0|||
48605912|NCT02391337|156413660|FG001|12 Months Follow-up|Lost to Follow-up|2|||
48605913|NCT00289276|156413661|FG000|Second Part of FAST Study (Expansion)|Death|0|||
48605914|NCT00289276|156413662|FG001|Second Part of FAST Study (Expansion)|Death|2|||
48605915|NCT00289276|156413661|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
48605916|NCT00289276|156413662|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
48538154|NCT00532935|156159353|FG001|Overall Study|Protocol Specific Criteria|15|||
48538155|NCT02939014|156159357|FG000|Overall Study|Lost to Follow-up|1|||
48605917|NCT00746551|156413663|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
48605918|NCT00746551|156413664|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
48605919|NCT00746551|156413663|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
48538156|NCT02939014|156159358|FG001|Overall Study|Lost to Follow-up|0|||
48538157|NCT02939014|156159357|FG000|Overall Study|Death|4|||
48538158|NCT02939014|156159358|FG001|Overall Study|Death|3|||
48538159|NCT03433755|156159359|FG000|Overall Study|Lost to Follow-up|1|||
48538160|NCT03433755|156159360|FG001|Overall Study|Lost to Follow-up|0|||
48538161|NCT03433755|156159361|FG002|Overall Study|Lost to Follow-up|0|||
48538162|NCT03433755|156159362|FG003|Overall Study|Lost to Follow-up|0|||
48538163|NCT03433755|156159359|FG000|Overall Study|Decision by Sponsor|1|||
48538164|NCT03433755|156159360|FG001|Overall Study|Decision by Sponsor|0|||
48538165|NCT03433755|156159361|FG002|Overall Study|Decision by Sponsor|0|||
48538166|NCT03433755|156159362|FG003|Overall Study|Decision by Sponsor|0|||
48538167|NCT00594646|156159363|FG000|Overall Study|Withdrawal by Subject|1|||
48538168|NCT00594646|156159363|FG000|Overall Study|Lost to Follow-up|15|||
48538169|NCT02192164|156159364|FG000|Overall Study|Other|8|||
48538170|NCT02192164|156159364|FG000|Overall Study|Withdrawal by Subject|1|||
48538171|NCT02192164|156159364|FG000|Overall Study|Physician Decision|4|||
48538172|NCT02192164|156159364|FG000|Overall Study|Did not meet the exclusion criteria|1|||
48538173|NCT01301508|156159365|FG000|Overall Study|Withdrawal by Subject|1|||
48538174|NCT01301508|156159366|FG001|Overall Study|Withdrawal by Subject|2|||
48538175|NCT01301508|156159365|FG000|Overall Study|Lost to Follow-up|0|||
48538176|NCT01301508|156159366|FG001|Overall Study|Lost to Follow-up|1|||
48538177|NCT00750308|156159367|FG000|First Treatment|Adverse Event|0|||
48538178|NCT00750308|156159368|FG001|First Treatment|Adverse Event|1|||
48538179|NCT00750308|156159369|FG002|First Treatment|Adverse Event|0|||
48538180|NCT00750308|156159370|FG003|First Treatment|Adverse Event|0|||
48538181|NCT00750308|156159371|FG004|First Treatment|Adverse Event|0|||
48538182|NCT00750308|156159372|FG005|First Treatment|Adverse Event|0|||
48538183|NCT00750308|156159373|FG006|First Treatment|Adverse Event|0|||
48538184|NCT00750308|156159374|FG007|First Treatment|Adverse Event|0|||
48538185|NCT00750308|156159375|FG008|First Treatment|Adverse Event|0|||
48538186|NCT00750308|156159376|FG009|First Treatment|Adverse Event|0|||
48538187|NCT00750308|156159377|FG010|First Treatment|Adverse Event|1|||
48538188|NCT00750308|156159378|FG011|First Treatment|Adverse Event|1|||
48538189|NCT00750308|156159367|FG000|First Treatment|Withdrawal by Subject|0|||
48538190|NCT00750308|156159368|FG001|First Treatment|Withdrawal by Subject|0|||
48538191|NCT00750308|156159369|FG002|First Treatment|Withdrawal by Subject|0|||
48538192|NCT00750308|156159370|FG003|First Treatment|Withdrawal by Subject|1|||
48538193|NCT00750308|156159371|FG004|First Treatment|Withdrawal by Subject|0|||
48538194|NCT00750308|156159372|FG005|First Treatment|Withdrawal by Subject|0|||
48538195|NCT00750308|156159373|FG006|First Treatment|Withdrawal by Subject|0|||
48538196|NCT00750308|156159374|FG007|First Treatment|Withdrawal by Subject|1|||
48538197|NCT00750308|156159375|FG008|First Treatment|Withdrawal by Subject|0|||
48538198|NCT00750308|156159376|FG009|First Treatment|Withdrawal by Subject|0|||
48538199|NCT00750308|156159377|FG010|First Treatment|Withdrawal by Subject|0|||
48538200|NCT00750308|156159378|FG011|First Treatment|Withdrawal by Subject|0|||
48538201|NCT00750308|156159367|FG000|Second Treatment|Adverse Event|0|||
48538202|NCT00750308|156159368|FG001|Second Treatment|Adverse Event|0|||
48538203|NCT00750308|156159369|FG002|Second Treatment|Adverse Event|0|||
48538204|NCT00750308|156159370|FG003|Second Treatment|Adverse Event|0|||
48538205|NCT00750308|156159371|FG004|Second Treatment|Adverse Event|0|||
48538206|NCT00750308|156159372|FG005|Second Treatment|Adverse Event|1|||
48538207|NCT00750308|156159373|FG006|Second Treatment|Adverse Event|0|||
48538208|NCT00750308|156159374|FG007|Second Treatment|Adverse Event|0|||
48538209|NCT00750308|156159375|FG008|Second Treatment|Adverse Event|1|||
48538210|NCT00750308|156159376|FG009|Second Treatment|Adverse Event|0|||
48538211|NCT00750308|156159377|FG010|Second Treatment|Adverse Event|0|||
48538212|NCT00750308|156159378|FG011|Second Treatment|Adverse Event|0|||
48538213|NCT00750308|156159367|FG000|Second Treatment|Withdrawal by Subject|0|||
48538214|NCT00750308|156159368|FG001|Second Treatment|Withdrawal by Subject|0|||
48538215|NCT00750308|156159369|FG002|Second Treatment|Withdrawal by Subject|0|||
48538216|NCT00750308|156159370|FG003|Second Treatment|Withdrawal by Subject|0|||
48538217|NCT00750308|156159371|FG004|Second Treatment|Withdrawal by Subject|1|||
48538218|NCT00750308|156159372|FG005|Second Treatment|Withdrawal by Subject|0|||
48538219|NCT00750308|156159373|FG006|Second Treatment|Withdrawal by Subject|0|||
48538220|NCT00750308|156159374|FG007|Second Treatment|Withdrawal by Subject|0|||
48538221|NCT00750308|156159375|FG008|Second Treatment|Withdrawal by Subject|0|||
48538222|NCT00750308|156159376|FG009|Second Treatment|Withdrawal by Subject|0|||
48538223|NCT00750308|156159377|FG010|Second Treatment|Withdrawal by Subject|0|||
48538224|NCT00750308|156159378|FG011|Second Treatment|Withdrawal by Subject|0|||
48538225|NCT00750308|156159367|FG000|Third Treatment|Withdrawal by Subject|0|||
48538226|NCT00750308|156159368|FG001|Third Treatment|Withdrawal by Subject|1|||
48538227|NCT00750308|156159369|FG002|Third Treatment|Withdrawal by Subject|0|||
48538228|NCT00750308|156159370|FG003|Third Treatment|Withdrawal by Subject|0|||
48538229|NCT00750308|156159371|FG004|Third Treatment|Withdrawal by Subject|0|||
48538230|NCT00750308|156159372|FG005|Third Treatment|Withdrawal by Subject|0|||
48446282|NCT01170221|155822354|FG000|Overall Study|Lost to Follow-up|22|||
48538231|NCT00750308|156159373|FG006|Third Treatment|Withdrawal by Subject|0|||
48538232|NCT00750308|156159374|FG007|Third Treatment|Withdrawal by Subject|0|||
48538233|NCT00750308|156159375|FG008|Third Treatment|Withdrawal by Subject|0|||
48538234|NCT00750308|156159376|FG009|Third Treatment|Withdrawal by Subject|0|||
48538235|NCT00750308|156159377|FG010|Third Treatment|Withdrawal by Subject|0|||
48538236|NCT00750308|156159378|FG011|Third Treatment|Withdrawal by Subject|0|||
48538237|NCT02149121|156159379|FG000|Main Study Period|Lack of Efficacy|2|||
48538238|NCT02149121|156159380|FG001|Main Study Period|Lack of Efficacy|2|||
48538239|NCT02149121|156159381|FG002|Main Study Period|Lack of Efficacy|1|||
48538240|NCT02149121|156159382|FG003|Main Study Period|Lack of Efficacy|0|||
48538241|NCT02149121|156159383|FG004|Main Study Period|Lack of Efficacy|0|||
48538242|NCT02149121|156159384|FG005|Main Study Period|Lack of Efficacy|0|||
48538243|NCT02149121|156159385|FG006|Main Study Period|Lack of Efficacy|0|||
48538244|NCT02149121|156159379|FG000|Main Study Period|Withdrawal by Subject|9|||
48538245|NCT02149121|156159380|FG001|Main Study Period|Withdrawal by Subject|5|||
48538246|NCT02149121|156159381|FG002|Main Study Period|Withdrawal by Subject|1|||
48538247|NCT02149121|156159382|FG003|Main Study Period|Withdrawal by Subject|0|||
48538248|NCT02149121|156159383|FG004|Main Study Period|Withdrawal by Subject|0|||
48538249|NCT02149121|156159384|FG005|Main Study Period|Withdrawal by Subject|0|||
48538250|NCT02149121|156159385|FG006|Main Study Period|Withdrawal by Subject|0|||
48538251|NCT02149121|156159379|FG000|Main Study Period|Adverse Event|2|||
48538252|NCT02149121|156159380|FG001|Main Study Period|Adverse Event|5|||
48538253|NCT02149121|156159381|FG002|Main Study Period|Adverse Event|1|||
48538254|NCT02149121|156159382|FG003|Main Study Period|Adverse Event|0|||
48538255|NCT02149121|156159383|FG004|Main Study Period|Adverse Event|0|||
48538256|NCT02149121|156159384|FG005|Main Study Period|Adverse Event|0|||
48538257|NCT02149121|156159385|FG006|Main Study Period|Adverse Event|0|||
48538258|NCT02149121|156159379|FG000|Main Study Period|Protocol Violation|2|||
48446283|NCT01170221|155822355|FG001|Overall Study|Lost to Follow-up|21|||
48446284|NCT01170221|155822354|FG000|Overall Study|Withdrawal by Subject|9|||
48446285|NCT01170221|155822355|FG001|Overall Study|Withdrawal by Subject|7|||
48446286|NCT01170221|155822354|FG000|Overall Study|Subject completed only screening and LFU|1|||
48446287|NCT01170221|155822355|FG001|Overall Study|Subject completed only screening and LFU|0|||
48446288|NCT01170221|155822354|FG000|Overall Study|Randomized but not treated|1|||
48446289|NCT01170221|155822355|FG001|Overall Study|Randomized but not treated|0|||
48446290|NCT03970824|155822356|FG000|Overall Study|Withdrawal by Subject|1|||
48446291|NCT03970824|155822357|FG001|Overall Study|Withdrawal by Subject|1|||
48446292|NCT03970824|155822358|FG002|Overall Study|Withdrawal by Subject|3|||
48446293|NCT03970824|155822356|FG000|Overall Study|Lost to Follow-up|0|||
48446294|NCT03970824|155822357|FG001|Overall Study|Lost to Follow-up|2|||
48538259|NCT02149121|156159380|FG001|Main Study Period|Protocol Violation|0|||
48538260|NCT02149121|156159381|FG002|Main Study Period|Protocol Violation|0|||
48538261|NCT02149121|156159382|FG003|Main Study Period|Protocol Violation|0|||
48538262|NCT02149121|156159383|FG004|Main Study Period|Protocol Violation|0|||
48538263|NCT02149121|156159384|FG005|Main Study Period|Protocol Violation|0|||
48538264|NCT02149121|156159385|FG006|Main Study Period|Protocol Violation|0|||
48538265|NCT02149121|156159379|FG000|Main Study Period|Lost to Follow-up|2|||
48538266|NCT02149121|156159380|FG001|Main Study Period|Lost to Follow-up|1|||
48538267|NCT02149121|156159381|FG002|Main Study Period|Lost to Follow-up|0|||
48538268|NCT02149121|156159382|FG003|Main Study Period|Lost to Follow-up|0|||
48538269|NCT02149121|156159383|FG004|Main Study Period|Lost to Follow-up|0|||
48538270|NCT02149121|156159384|FG005|Main Study Period|Lost to Follow-up|0|||
48538271|NCT02149121|156159385|FG006|Main Study Period|Lost to Follow-up|0|||
48538272|NCT02149121|156159379|FG000|Main Study Period|Death|1|||
48538273|NCT02149121|156159380|FG001|Main Study Period|Death|0|||
48538274|NCT02149121|156159381|FG002|Main Study Period|Death|0|||
48538275|NCT02149121|156159382|FG003|Main Study Period|Death|0|||
48538276|NCT02149121|156159383|FG004|Main Study Period|Death|0|||
48538277|NCT02149121|156159384|FG005|Main Study Period|Death|0|||
48538278|NCT02149121|156159385|FG006|Main Study Period|Death|0|||
48538279|NCT02149121|156159379|FG000|Main Study Period|Physician Decision|1|||
48538280|NCT02149121|156159380|FG001|Main Study Period|Physician Decision|0|||
48538281|NCT02149121|156159381|FG002|Main Study Period|Physician Decision|0|||
48538282|NCT02149121|156159382|FG003|Main Study Period|Physician Decision|0|||
48538283|NCT02149121|156159383|FG004|Main Study Period|Physician Decision|0|||
48538284|NCT02149121|156159384|FG005|Main Study Period|Physician Decision|0|||
48538285|NCT02149121|156159385|FG006|Main Study Period|Physician Decision|0|||
48538286|NCT02149121|156159379|FG000|Main Study Period|Developed any malignancy|0|||
48538287|NCT02149121|156159380|FG001|Main Study Period|Developed any malignancy|1|||
48538288|NCT02149121|156159381|FG002|Main Study Period|Developed any malignancy|1|||
48538289|NCT02149121|156159382|FG003|Main Study Period|Developed any malignancy|0|||
48538290|NCT02149121|156159383|FG004|Main Study Period|Developed any malignancy|0|||
48538291|NCT02149121|156159384|FG005|Main Study Period|Developed any malignancy|0|||
48538292|NCT02149121|156159385|FG006|Main Study Period|Developed any malignancy|0|||
48538293|NCT02149121|156159379|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
48538294|NCT02149121|156159380|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
48538295|NCT02149121|156159381|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
48538296|NCT02149121|156159382|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
48538297|NCT02149121|156159383|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
48538298|NCT02149121|156159384|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
48538299|NCT02149121|156159385|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
48538300|NCT02149121|156159379|FG000|Main Study Period|Disease progression|0|||
48538301|NCT02149121|156159380|FG001|Main Study Period|Disease progression|1|||
48538302|NCT02149121|156159381|FG002|Main Study Period|Disease progression|0|||
48605920|NCT00746551|156413664|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
48538303|NCT02149121|156159382|FG003|Main Study Period|Disease progression|0|||
48538304|NCT02149121|156159383|FG004|Main Study Period|Disease progression|0|||
48538305|NCT02149121|156159384|FG005|Main Study Period|Disease progression|0|||
48538306|NCT02149121|156159385|FG006|Main Study Period|Disease progression|0|||
48538307|NCT02149121|156159379|FG000|Extension Study Period|Withdrawal by Subject|0|||
48538308|NCT02149121|156159380|FG001|Extension Study Period|Withdrawal by Subject|0|||
48538309|NCT02149121|156159381|FG002|Extension Study Period|Withdrawal by Subject|0|||
48538310|NCT02149121|156159382|FG003|Extension Study Period|Withdrawal by Subject|1|||
48538311|NCT02149121|156159383|FG004|Extension Study Period|Withdrawal by Subject|0|||
48538312|NCT02149121|156159384|FG005|Extension Study Period|Withdrawal by Subject|2|||
48538313|NCT02149121|156159385|FG006|Extension Study Period|Withdrawal by Subject|0|||
48538314|NCT01568866|156159388|FG000|Overall Study|Disease Progression|208|||
48538315|NCT01568866|156159389|FG001|Overall Study|Disease Progression|183|||
48538316|NCT01568866|156159388|FG000|Overall Study|Adverse Event|94|||
48538317|NCT01568866|156159389|FG001|Overall Study|Adverse Event|96|||
48538318|NCT01568866|156159388|FG000|Overall Study|Patient Request|55|||
48538319|NCT01568866|156159389|FG001|Overall Study|Patient Request|71|||
48538320|NCT01568866|156159388|FG000|Overall Study|Physician Decision|40|||
48538321|NCT01568866|156159389|FG001|Overall Study|Physician Decision|32|||
48538322|NCT01568866|156159388|FG000|Overall Study|Withdrawal by Subject|19|||
48538323|NCT01568866|156159389|FG001|Overall Study|Withdrawal by Subject|11|||
48538324|NCT01568866|156159388|FG000|Overall Study|Death|10|||
48538325|NCT01568866|156159389|FG001|Overall Study|Death|18|||
48538326|NCT01568866|156159388|FG000|Overall Study|Protocol Non-compliance|2|||
48538327|NCT01568866|156159389|FG001|Overall Study|Protocol Non-compliance|4|||
48538328|NCT01568866|156159388|FG000|Overall Study|Lost to Follow-up|1|||
48538329|NCT01568866|156159389|FG001|Overall Study|Lost to Follow-up|0|||
48538330|NCT01568866|156159388|FG000|Overall Study|Randomized but Not Dosed|9|||
48538331|NCT01568866|156159389|FG001|Overall Study|Randomized but Not Dosed|1|||
48538332|NCT00851643|156159390|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
48538333|NCT00851643|156159391|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
48538334|NCT00851643|156159392|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
48538335|NCT00851643|156159393|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
48538336|NCT00851643|156159394|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
48538337|NCT00851643|156159395|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
48538338|NCT00851643|156159390|FG000|Base Study (Up to 12 Months)|Other|0|||
48605921|NCT00746551|156413663|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
48605922|NCT00746551|156413664|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
48605923|NCT01035138|156413666|FG000|Overall Study|Adverse Event|4|||
48605924|NCT01035138|156413667|FG001|Overall Study|Adverse Event|0|||
48538339|NCT00851643|156159391|FG001|Base Study (Up to 12 Months)|Other|0|||
48538340|NCT00851643|156159392|FG002|Base Study (Up to 12 Months)|Other|0|||
48538341|NCT00851643|156159393|FG003|Base Study (Up to 12 Months)|Other|0|||
48538342|NCT00851643|156159394|FG004|Base Study (Up to 12 Months)|Other|0|||
48538343|NCT00851643|156159395|FG005|Base Study (Up to 12 Months)|Other|1|||
48538344|NCT00851643|156159390|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
48538345|NCT00851643|156159391|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
48538346|NCT00851643|156159392|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
48538347|NCT00851643|156159393|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
48538348|NCT00851643|156159394|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
48538349|NCT00851643|156159395|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
48538350|NCT00851643|156159390|FG000|Extension Study (Up to 36 Months)|Moved|0|||
48538351|NCT00851643|156159391|FG001|Extension Study (Up to 36 Months)|Moved|2|||
48538352|NCT00851643|156159392|FG002|Extension Study (Up to 36 Months)|Moved|1|||
48538353|NCT00851643|156159393|FG003|Extension Study (Up to 36 Months)|Moved|1|||
48538354|NCT00851643|156159394|FG004|Extension Study (Up to 36 Months)|Moved|0|||
48538355|NCT00851643|156159395|FG005|Extension Study (Up to 36 Months)|Moved|1|||
48605925|NCT01035138|156413668|FG002|Overall Study|Adverse Event|2|||
48538356|NCT00359788|156159398|FG000|Overall Study|Adverse Event|11|||
48538357|NCT00359788|156159399|FG001|Overall Study|Adverse Event|10|||
48538358|NCT00359788|156159398|FG000|Overall Study|Lack of Efficacy|1|||
48538359|NCT00359788|156159399|FG001|Overall Study|Lack of Efficacy|2|||
48538360|NCT00359788|156159398|FG000|Overall Study|Lost to Follow-up|3|||
48538361|NCT00359788|156159399|FG001|Overall Study|Lost to Follow-up|2|||
48538362|NCT00359788|156159398|FG000|Overall Study|Withdrawal by Subject|4|||
48538363|NCT00359788|156159399|FG001|Overall Study|Withdrawal by Subject|1|||
48538364|NCT00359788|156159398|FG000|Overall Study|Protocol Violation|4|||
48538365|NCT00359788|156159399|FG001|Overall Study|Protocol Violation|2|||
48538366|NCT00673933|156159400|FG000|Overall Study|Withdrawal by Subject|2|||
48538367|NCT00673933|156159400|FG000|Overall Study|Lost to Follow-up|1|||
48538368|NCT04156620|156159401|FG000|Overall Study|Adverse event - TP 1|5|||
48538369|NCT04156620|156159402|FG001|Overall Study|Adverse event - TP 1|2|||
48538370|NCT04156620|156159401|FG000|Overall Study|Lost to follow-up TP 1|1|||
48538371|NCT04156620|156159402|FG001|Overall Study|Lost to follow-up TP 1|1|||
48538372|NCT04156620|156159401|FG000|Overall Study|Progressive disease - TP 1|0|||
48538373|NCT04156620|156159402|FG001|Overall Study|Progressive disease - TP 1|1|||
48538374|NCT04156620|156159401|FG000|Overall Study|Subject decision - TP 1|3|||
48538375|NCT04156620|156159402|FG001|Overall Study|Subject decision - TP 1|5|||
48538376|NCT04156620|156159401|FG000|Overall Study|Adverse event - TP 2|5|||
48538377|NCT04156620|156159402|FG001|Overall Study|Adverse event - TP 2|6|||
48538378|NCT04156620|156159401|FG000|Overall Study|Death - TP 2|1|||
48605926|NCT01035138|156413666|FG000|Overall Study|Caregiver Decision|2|||
48605927|NCT01035138|156413667|FG001|Overall Study|Caregiver Decision|0|||
48605928|NCT01035138|156413668|FG002|Overall Study|Caregiver Decision|1|||
48605929|NCT01035138|156413666|FG000|Overall Study|Withdrawal by Subject|1|||
48605930|NCT01035138|156413667|FG001|Overall Study|Withdrawal by Subject|0|||
48605931|NCT01035138|156413668|FG002|Overall Study|Withdrawal by Subject|0|||
48605932|NCT01035138|156413666|FG000|Overall Study|Physician Decision|0|||
48605933|NCT01035138|156413667|FG001|Overall Study|Physician Decision|0|||
48605934|NCT01035138|156413668|FG002|Overall Study|Physician Decision|1|||
48538379|NCT04156620|156159402|FG001|Overall Study|Death - TP 2|0|||
48538380|NCT04156620|156159401|FG000|Overall Study|Lost to follow-up - TP 2|5|||
48538381|NCT04156620|156159402|FG001|Overall Study|Lost to follow-up - TP 2|2|||
48538382|NCT04156620|156159401|FG000|Overall Study|Physician decision - TP 2|4|||
48538383|NCT04156620|156159402|FG001|Overall Study|Physician decision - TP 2|2|||
48538384|NCT04156620|156159401|FG000|Overall Study|Pregnancy - TP 2|1|||
48538385|NCT04156620|156159402|FG001|Overall Study|Pregnancy - TP 2|1|||
48538386|NCT04156620|156159401|FG000|Overall Study|Subject decision - TP 2|11|||
48538387|NCT04156620|156159402|FG001|Overall Study|Subject decision - TP 2|9|||
48538388|NCT04156620|156159401|FG000|Overall Study|New therapy for study indication - TP 2|1|||
48538389|NCT04156620|156159402|FG001|Overall Study|New therapy for study indication - TP 2|0|||
48538390|NCT00389831|156159405|FG000|Overall Study|Lack of Efficacy|0|||
48538391|NCT00389831|156159406|FG001|Overall Study|Lack of Efficacy|2|||
48538392|NCT00389831|156159405|FG000|Overall Study|Did not receive treatment.|0|||
48538393|NCT00389831|156159406|FG001|Overall Study|Did not receive treatment.|2|||
48538394|NCT00389831|156159405|FG000|Overall Study|Other reasons|0|||
48538395|NCT00389831|156159406|FG001|Overall Study|Other reasons|2|||
48538396|NCT00389831|156159405|FG000|Overall Study|Lost to Follow-up|0|||
48538397|NCT00389831|156159406|FG001|Overall Study|Lost to Follow-up|1|||
48538398|NCT01929031|156159407|FG000|Overall Study|Adverse Event|3|||
48538399|NCT01929031|156159408|FG001|Overall Study|Adverse Event|1|||
48538400|NCT01929031|156159409|FG002|Overall Study|Adverse Event|1|||
48538401|NCT01929031|156159410|FG003|Overall Study|Adverse Event|0|||
48538402|NCT01929031|156159411|FG004|Overall Study|Adverse Event|0|||
48538403|NCT01929031|156159412|FG005|Overall Study|Adverse Event|0|||
48538404|NCT01929031|156159407|FG000|Overall Study|Protocol Violation|1|||
48538405|NCT01929031|156159408|FG001|Overall Study|Protocol Violation|0|||
48538406|NCT01929031|156159409|FG002|Overall Study|Protocol Violation|0|||
48538407|NCT01929031|156159410|FG003|Overall Study|Protocol Violation|0|||
48538408|NCT01929031|156159411|FG004|Overall Study|Protocol Violation|0|||
48538409|NCT01929031|156159412|FG005|Overall Study|Protocol Violation|1|||
48538410|NCT01929031|156159407|FG000|Overall Study|Reason other than specified above|0|||
48538411|NCT01929031|156159408|FG001|Overall Study|Reason other than specified above|1|||
48538412|NCT01929031|156159409|FG002|Overall Study|Reason other than specified above|0|||
48538413|NCT01929031|156159410|FG003|Overall Study|Reason other than specified above|0|||
48538414|NCT01929031|156159411|FG004|Overall Study|Reason other than specified above|1|||
48605935|NCT01035138|156413666|FG000|Overall Study|Sponsor Decision|66|||
48538415|NCT01929031|156159412|FG005|Overall Study|Reason other than specified above|0|||
48538416|NCT01970865|156159413|FG000|Overall Study|Death|3|||
48538417|NCT01970865|156159414|FG001|Overall Study|Death|2|||
48538418|NCT01970865|156159415|FG002|Overall Study|Death|3|||
48538419|NCT01970865|156159416|FG003|Overall Study|Death|6|||
48538420|NCT01970865|156159417|FG004|Overall Study|Death|9|||
48538421|NCT01970865|156159418|FG005|Overall Study|Death|3|||
48605936|NCT01035138|156413667|FG001|Overall Study|Sponsor Decision|60|||
48538422|NCT01970865|156159419|FG006|Overall Study|Death|2|||
48538423|NCT01970865|156159420|FG007|Overall Study|Death|3|||
48538424|NCT01970865|156159421|FG008|Overall Study|Death|2|||
48538425|NCT01970865|156159422|FG009|Overall Study|Death|2|||
48538426|NCT01970865|156159423|FG010|Overall Study|Death|8|||
48538427|NCT01970865|156159424|FG011|Overall Study|Death|13|||
48538428|NCT01970865|156159425|FG012|Overall Study|Death|25|||
48538429|NCT01970865|156159426|FG013|Overall Study|Death|46|||
48538430|NCT01970865|156159427|FG014|Overall Study|Death|37|||
48538431|NCT01970865|156159428|FG015|Overall Study|Death|22|||
48538432|NCT01970865|156159429|FG016|Overall Study|Death|1|||
48538433|NCT01970865|156159430|FG017|Overall Study|Death|17|||
48538434|NCT01970865|156159413|FG000|Overall Study|Lost to Follow-up|0|||
48538435|NCT01970865|156159414|FG001|Overall Study|Lost to Follow-up|0|||
48538436|NCT01970865|156159415|FG002|Overall Study|Lost to Follow-up|0|||
48538437|NCT01970865|156159416|FG003|Overall Study|Lost to Follow-up|1|||
48538438|NCT01970865|156159417|FG004|Overall Study|Lost to Follow-up|1|||
48538439|NCT01970865|156159418|FG005|Overall Study|Lost to Follow-up|0|||
48538440|NCT01970865|156159419|FG006|Overall Study|Lost to Follow-up|0|||
48538441|NCT01970865|156159420|FG007|Overall Study|Lost to Follow-up|0|||
48538442|NCT01970865|156159421|FG008|Overall Study|Lost to Follow-up|0|||
48538443|NCT01970865|156159422|FG009|Overall Study|Lost to Follow-up|0|||
48538444|NCT01970865|156159423|FG010|Overall Study|Lost to Follow-up|1|||
48538445|NCT01970865|156159424|FG011|Overall Study|Lost to Follow-up|0|||
48538446|NCT01970865|156159425|FG012|Overall Study|Lost to Follow-up|2|||
48538447|NCT01970865|156159426|FG013|Overall Study|Lost to Follow-up|0|||
48538448|NCT01970865|156159427|FG014|Overall Study|Lost to Follow-up|1|||
48538449|NCT01970865|156159428|FG015|Overall Study|Lost to Follow-up|4|||
48538450|NCT01970865|156159429|FG016|Overall Study|Lost to Follow-up|0|||
48538451|NCT01970865|156159430|FG017|Overall Study|Lost to Follow-up|1|||
48538452|NCT01970865|156159413|FG000|Overall Study|Other|0|||
48538453|NCT01970865|156159414|FG001|Overall Study|Other|1|||
48538454|NCT01970865|156159415|FG002|Overall Study|Other|0|||
48538455|NCT01970865|156159416|FG003|Overall Study|Other|1|||
48538456|NCT01970865|156159417|FG004|Overall Study|Other|1|||
48538457|NCT01970865|156159418|FG005|Overall Study|Other|0|||
48538458|NCT01970865|156159419|FG006|Overall Study|Other|1|||
48538459|NCT01970865|156159420|FG007|Overall Study|Other|0|||
48538460|NCT01970865|156159421|FG008|Overall Study|Other|0|||
48538461|NCT01970865|156159422|FG009|Overall Study|Other|0|||
48538462|NCT01970865|156159423|FG010|Overall Study|Other|2|||
48538463|NCT01970865|156159424|FG011|Overall Study|Other|3|||
48538464|NCT01970865|156159425|FG012|Overall Study|Other|8|||
48538465|NCT01970865|156159426|FG013|Overall Study|Other|3|||
48538466|NCT01970865|156159427|FG014|Overall Study|Other|2|||
48538467|NCT01970865|156159428|FG015|Overall Study|Other|3|||
48538468|NCT01970865|156159429|FG016|Overall Study|Other|0|||
48538469|NCT01970865|156159430|FG017|Overall Study|Other|2|||
48538470|NCT01970865|156159413|FG000|Overall Study|Participant refused further follow-up|0|||
48538471|NCT01970865|156159414|FG001|Overall Study|Participant refused further follow-up|0|||
48538472|NCT01970865|156159415|FG002|Overall Study|Participant refused further follow-up|0|||
48538473|NCT01970865|156159416|FG003|Overall Study|Participant refused further follow-up|2|||
48538474|NCT01970865|156159417|FG004|Overall Study|Participant refused further follow-up|3|||
48538475|NCT01970865|156159418|FG005|Overall Study|Participant refused further follow-up|0|||
48538476|NCT01970865|156159419|FG006|Overall Study|Participant refused further follow-up|0|||
48538477|NCT01970865|156159420|FG007|Overall Study|Participant refused further follow-up|0|||
48538478|NCT01970865|156159421|FG008|Overall Study|Participant refused further follow-up|0|||
48538479|NCT01970865|156159422|FG009|Overall Study|Participant refused further follow-up|0|||
48538480|NCT01970865|156159423|FG010|Overall Study|Participant refused further follow-up|1|||
48538481|NCT01970865|156159424|FG011|Overall Study|Participant refused further follow-up|4|||
48538482|NCT01970865|156159425|FG012|Overall Study|Participant refused further follow-up|7|||
48538483|NCT01970865|156159426|FG013|Overall Study|Participant refused further follow-up|8|||
48538484|NCT01970865|156159427|FG014|Overall Study|Participant refused further follow-up|3|||
48538485|NCT01970865|156159428|FG015|Overall Study|Participant refused further follow-up|11|||
48538486|NCT01970865|156159429|FG016|Overall Study|Participant refused further follow-up|0|||
48538487|NCT01970865|156159430|FG017|Overall Study|Participant refused further follow-up|6|||
48538488|NCT01111019|156159431|FG000|Overall Study|Withdrew Prematurely|2|||
48538489|NCT01111019|156159431|FG000|Overall Study|Other|1|||
48538490|NCT01583218|156159432|FG000|Overall Study|Withdrawal by Subject|43|||
48538491|NCT01583218|156159433|FG001|Overall Study|Withdrawal by Subject|29|||
48538492|NCT01583218|156159432|FG000|Overall Study|Death|206|||
48605937|NCT01035138|156413668|FG002|Overall Study|Sponsor Decision|42|||
48605938|NCT01035138|156413666|FG000|Overall Study|Lost to Follow-up|0|||
48605939|NCT01035138|156413667|FG001|Overall Study|Lost to Follow-up|0|||
48605940|NCT01035138|156413668|FG002|Overall Study|Lost to Follow-up|1|||
48605941|NCT00885118|156413669|FG000|Overall Study|Adverse Event|1|||
48605942|NCT00885118|156413670|FG001|Overall Study|Adverse Event|0|||
48538493|NCT01583218|156159433|FG001|Overall Study|Death|211|||
48538494|NCT01583218|156159432|FG000|Overall Study|Lost to Follow-up|11|||
48538495|NCT01583218|156159433|FG001|Overall Study|Lost to Follow-up|17|||
48538496|NCT01583218|156159432|FG000|Overall Study|Adverse event or serious adverse event|3|||
48538497|NCT01583218|156159433|FG001|Overall Study|Adverse event or serious adverse event|3|||
48538498|NCT01583218|156159432|FG000|Overall Study|Patient /Family decision|3|||
48538499|NCT01583218|156159433|FG001|Overall Study|Patient /Family decision|0|||
48538500|NCT01583218|156159432|FG000|Overall Study|Cannot contact patient directly|1|||
48538501|NCT01583218|156159433|FG001|Overall Study|Cannot contact patient directly|2|||
48538502|NCT01583218|156159432|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
48538503|NCT01583218|156159433|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
48538504|NCT01583218|156159432|FG000|Overall Study|Patient did not wish to attend visits|0|||
48538505|NCT01583218|156159433|FG001|Overall Study|Patient did not wish to attend visits|1|||
48538506|NCT01583218|156159432|FG000|Overall Study|Patient randomized but not dosed|17|||
48538507|NCT01583218|156159433|FG001|Overall Study|Patient randomized but not dosed|16|||
48538508|NCT01583218|156159432|FG000|Overall Study|Patient was assessed via phone in person|1|||
48538509|NCT01583218|156159433|FG001|Overall Study|Patient was assessed via phone in person|0|||
48538510|NCT01583218|156159432|FG000|Overall Study|Patient deemed ineligible after random|2|||
48538511|NCT01583218|156159433|FG001|Overall Study|Patient deemed ineligible after random|0|||
48538512|NCT01583218|156159432|FG000|Overall Study|Patient was early terminated from study|0|||
48538513|NCT01583218|156159433|FG001|Overall Study|Patient was early terminated from study|1|||
48538514|NCT01583218|156159432|FG000|Overall Study|Patient was randomized due to mistake|1|||
48538515|NCT01583218|156159433|FG001|Overall Study|Patient was randomized due to mistake|0|||
48538516|NCT01583218|156159432|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
48538517|NCT01583218|156159433|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
48538518|NCT01583218|156159432|FG000|Overall Study|Withdraw of consent on day of random|1|||
48538519|NCT01583218|156159433|FG001|Overall Study|Withdraw of consent on day of random|0|||
48538520|NCT01661179|156159434|FG000|Overall Study|Death|1|||
48538521|NCT01661179|156159434|FG000|Overall Study|Withdrawal by Subject|1|||
48538522|NCT01661179|156159434|FG000|Overall Study|Other Eligibility criteria|4|||
48605943|NCT00885118|156413671|FG002|Overall Study|Adverse Event|0|||
48605944|NCT00885118|156413672|FG003|Overall Study|Adverse Event|0|||
48605945|NCT00885118|156413673|FG004|Overall Study|Adverse Event|0|||
48538523|NCT00914459|156159435|FG000|Overall Study|Protocol Violation|0|||
48538524|NCT00914459|156159436|FG001|Overall Study|Protocol Violation|1|||
48538525|NCT00914459|156159435|FG000|Overall Study|Parent/Legal guardian request|1|||
48538526|NCT00914459|156159436|FG001|Overall Study|Parent/Legal guardian request|0|||
48538527|NCT00809159|156159437|FG000|Part 1|Adverse Event|1|||
48538528|NCT00809159|156159438|FG001|Part 1|Adverse Event|1|||
48605946|NCT00885118|156413669|FG000|Overall Study|Withdrawal by Subject|0|||
48605947|NCT00885118|156413670|FG001|Overall Study|Withdrawal by Subject|0|||
48605948|NCT00885118|156413671|FG002|Overall Study|Withdrawal by Subject|0|||
48605949|NCT00885118|156413672|FG003|Overall Study|Withdrawal by Subject|0|||
48605950|NCT00885118|156413673|FG004|Overall Study|Withdrawal by Subject|1|||
48605951|NCT00885118|156413669|FG000|Overall Study|Other reason not defined above|0|||
48605952|NCT00885118|156413670|FG001|Overall Study|Other reason not defined above|0|||
48605953|NCT00885118|156413671|FG002|Overall Study|Other reason not defined above|1|||
48605954|NCT00885118|156413672|FG003|Overall Study|Other reason not defined above|0|||
48605955|NCT00885118|156413673|FG004|Overall Study|Other reason not defined above|0|||
48538529|NCT00809159|156159439|FG002|Part 1|Adverse Event|0|||
48538530|NCT00809159|156159440|FG003|Part 1|Adverse Event|0|||
48538531|NCT00809159|156159441|FG004|Part 1|Adverse Event|0|||
48538532|NCT00809159|156159442|FG005|Part 1|Adverse Event|0|||
48538533|NCT00809159|156159437|FG000|Part 1|Lost to Follow-up|1|||
48605956|NCT00794664|156413677|FG000|Treatment Period|Withdrawal by Subject|0|||
48605957|NCT00794664|156413678|FG001|Treatment Period|Withdrawal by Subject|2|||
48605958|NCT00794664|156413677|FG000|Treatment Period|Protocol non-compliance|0|||
48605959|NCT00794664|156413678|FG001|Treatment Period|Protocol non-compliance|1|||
48605960|NCT00794664|156413677|FG000|Treatment Period|Other|0|||
48605961|NCT00794664|156413678|FG001|Treatment Period|Other|1|||
48605962|NCT00794664|156413677|FG000|Treatment Period|Adverse Event|1|||
48605963|NCT00794664|156413678|FG001|Treatment Period|Adverse Event|8|||
48605964|NCT00794664|156413677|FG000|Follow-up Period|Other|1|||
48605965|NCT00794664|156413678|FG001|Follow-up Period|Other|2|||
48605966|NCT00794664|156413677|FG000|Follow-up Period|Withdrawal by Subject|0|||
48605967|NCT00794664|156413678|FG001|Follow-up Period|Withdrawal by Subject|2|||
48605968|NCT00794664|156413677|FG000|Follow-up Period|Protocol non-compliance|0|||
48605969|NCT00794664|156413678|FG001|Follow-up Period|Protocol non-compliance|1|||
48605970|NCT01200329|156413681|FG000|Overall Study|Lack of financial coverage|2|||
48605971|NCT01200329|156413681|FG000|Overall Study|Progressive disease|1|||
48605972|NCT01850641|156413682|FG000|Overall Study|Physician Decision|1|||
48605973|NCT01850641|156413682|FG000|Overall Study|Decrease in serum phosphorus|1|||
48605974|NCT01850641|156413682|FG000|Overall Study|Decrease in serum calcium|2|||
48605975|NCT01850641|156413682|FG000|Overall Study|Increase in serum ferritin|1|||
48605976|NCT01420536|156413685|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
48605977|NCT01420536|156413686|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
48605978|NCT01157845|156413688|FG000|Overall Study|Lost to Follow-up|5|||
48605979|NCT01157845|156413688|FG000|Overall Study|Withdrawal by Subject|12|||
48605980|NCT01157845|156413688|FG000|Overall Study|Physician Decision|3|||
48605981|NCT01157845|156413688|FG000|Overall Study|Protocol Violation|13|||
48538534|NCT00809159|156159438|FG001|Part 1|Lost to Follow-up|0|||
48538535|NCT00809159|156159439|FG002|Part 1|Lost to Follow-up|0|||
48538536|NCT00809159|156159440|FG003|Part 1|Lost to Follow-up|0|||
48538537|NCT00809159|156159441|FG004|Part 1|Lost to Follow-up|0|||
48538538|NCT00809159|156159442|FG005|Part 1|Lost to Follow-up|0|||
48538539|NCT00809159|156159437|FG000|Part 1|Withdrawal by Subject|3|||
48538540|NCT00809159|156159438|FG001|Part 1|Withdrawal by Subject|1|||
48538541|NCT00809159|156159439|FG002|Part 1|Withdrawal by Subject|0|||
48538542|NCT00809159|156159440|FG003|Part 1|Withdrawal by Subject|0|||
48605982|NCT01157845|156413688|FG000|Overall Study|Study was ended|1|||
48605983|NCT01157845|156413688|FG000|Overall Study|Device malfunction|1|||
48605984|NCT02781324|156413691|FG000|Overall Study|Withdrawal by Subject|1|||
48605985|NCT02781324|156413692|FG001|Overall Study|Withdrawal by Subject|0|||
48605986|NCT02781324|156413691|FG000|Overall Study|Physician Decision|1|||
48605987|NCT02781324|156413692|FG001|Overall Study|Physician Decision|2|||
48605988|NCT03499795|156415446|FG000|Overall Study|Adverse Event|1|||
48605989|NCT03499795|156415446|FG000|Overall Study|Lost to Follow-up|1|||
48538543|NCT00809159|156159441|FG004|Part 1|Withdrawal by Subject|0|||
48538544|NCT00809159|156159442|FG005|Part 1|Withdrawal by Subject|0|||
48538545|NCT00809159|156159437|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
48538546|NCT00809159|156159438|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
48605990|NCT01774981|156415447|FG000|Overall Study|Adverse Event|0|||
48605991|NCT01774981|156415448|FG001|Overall Study|Adverse Event|0|||
48605992|NCT01774981|156415449|FG002|Overall Study|Adverse Event|0|||
48605993|NCT01774981|156415450|FG003|Overall Study|Adverse Event|0|||
48605994|NCT01774981|156415451|FG004|Overall Study|Adverse Event|0|||
48605995|NCT01774981|156415452|FG005|Overall Study|Adverse Event|1|||
48538547|NCT00809159|156159439|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
48538548|NCT00809159|156159440|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
48538549|NCT00809159|156159441|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
48538550|NCT00809159|156159442|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
48538551|NCT00809159|156159437|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
48538552|NCT00809159|156159438|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
48538553|NCT00809159|156159439|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
48538554|NCT00809159|156159440|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
48538555|NCT00809159|156159441|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
48538556|NCT00809159|156159442|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
48538557|NCT00809159|156159437|FG000|Part 1 and 2|Administrative problems|0|||
48538558|NCT00809159|156159438|FG001|Part 1 and 2|Administrative problems|0|||
48538559|NCT00809159|156159439|FG002|Part 1 and 2|Administrative problems|0|||
48538560|NCT00809159|156159440|FG003|Part 1 and 2|Administrative problems|1|||
48538561|NCT00809159|156159441|FG004|Part 1 and 2|Administrative problems|0|||
48538562|NCT00809159|156159442|FG005|Part 1 and 2|Administrative problems|0|||
48538563|NCT00809159|156159437|FG000|Part 1 and 2|Adverse Event|0|||
48538564|NCT00809159|156159438|FG001|Part 1 and 2|Adverse Event|0|||
48538565|NCT00809159|156159439|FG002|Part 1 and 2|Adverse Event|1|||
48538566|NCT00809159|156159440|FG003|Part 1 and 2|Adverse Event|0|||
48538567|NCT00809159|156159441|FG004|Part 1 and 2|Adverse Event|1|||
48538568|NCT00809159|156159442|FG005|Part 1 and 2|Adverse Event|1|||
48538569|NCT00809159|156159437|FG000|Part 1 and 2|Lost to Follow-up|0|||
48538570|NCT00809159|156159438|FG001|Part 1 and 2|Lost to Follow-up|0|||
48538571|NCT00809159|156159439|FG002|Part 1 and 2|Lost to Follow-up|1|||
48538572|NCT00809159|156159440|FG003|Part 1 and 2|Lost to Follow-up|1|||
48538573|NCT00809159|156159441|FG004|Part 1 and 2|Lost to Follow-up|0|||
48538574|NCT00809159|156159442|FG005|Part 1 and 2|Lost to Follow-up|0|||
48538575|NCT00809159|156159437|FG000|Part 1 and 2|Withdrawal by Subject|0|||
48538576|NCT00809159|156159438|FG001|Part 1 and 2|Withdrawal by Subject|0|||
48538577|NCT00809159|156159439|FG002|Part 1 and 2|Withdrawal by Subject|4|||
48538578|NCT00809159|156159440|FG003|Part 1 and 2|Withdrawal by Subject|0|||
48538579|NCT00809159|156159441|FG004|Part 1 and 2|Withdrawal by Subject|0|||
48538580|NCT00809159|156159442|FG005|Part 1 and 2|Withdrawal by Subject|1|||
48538581|NCT03176459|156159446|FG000|Overall Study|Lost to Follow-up|5|||
48605996|NCT01774981|156415453|FG006|Overall Study|Adverse Event|0|||
48605997|NCT01774981|156415454|FG007|Overall Study|Adverse Event|0|||
48605998|NCT01774981|156415447|FG000|Overall Study|Withdrawal by Subject|0|||
48605999|NCT01774981|156415448|FG001|Overall Study|Withdrawal by Subject|0|||
48606000|NCT01774981|156415449|FG002|Overall Study|Withdrawal by Subject|0|||
48606001|NCT01774981|156415450|FG003|Overall Study|Withdrawal by Subject|0|||
48538582|NCT03176459|156159447|FG001|Overall Study|Lost to Follow-up|7|||
48538583|NCT00712985|156159450|FG000|Overall Study|1 withdrew prior to start of drug|1|||
48538584|NCT00712985|156159450|FG000|Overall Study|1 patient moved out of state|1|||
48538585|NCT00712985|156159450|FG000|Overall Study|Lack of Efficacy|3|||
48538586|NCT02674061|156159453|FG000|Overall Study|Death|229|||
48538587|NCT02674061|156159454|FG001|Overall Study|Death|77|||
48538588|NCT02674061|156159453|FG000|Overall Study|Lost to Follow-up|3|||
48538589|NCT02674061|156159454|FG001|Overall Study|Lost to Follow-up|3|||
48538590|NCT02674061|156159453|FG000|Overall Study|Withdrawal by Subject|9|||
48538591|NCT02674061|156159454|FG001|Overall Study|Withdrawal by Subject|1|||
48538592|NCT02674061|156159453|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
48538593|NCT02674061|156159454|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
48538594|NCT03201211|156159455|FG000|Overall Study|Adverse Event|1|||
48538595|NCT03201211|156159456|FG001|Overall Study|Adverse Event|0|||
48538596|NCT03201211|156159457|FG002|Overall Study|Adverse Event|0|||
48538597|NCT03201211|156159455|FG000|Overall Study|Protocol Violation|1|||
48538598|NCT03201211|156159456|FG001|Overall Study|Protocol Violation|0|||
48538599|NCT03201211|156159457|FG002|Overall Study|Protocol Violation|0|||
48538600|NCT03201211|156159455|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48538601|NCT03201211|156159456|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48538602|NCT03201211|156159457|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
48538603|NCT03201211|156159455|FG000|Overall Study|OTHER unknown reasons|0|||
48538604|NCT03201211|156159456|FG001|Overall Study|OTHER unknown reasons|1|||
48538605|NCT03201211|156159457|FG002|Overall Study|OTHER unknown reasons|0|||
48538606|NCT01299805|156159460|FG000|Overall Study|Adverse Event|2|||
48538607|NCT01299805|156159461|FG001|Overall Study|Adverse Event|0|||
48538608|NCT01629966|156159464|FG000|Overall Study|Pregnancy|0|||
48538609|NCT01629966|156159465|FG001|Overall Study|Pregnancy|1|||
48538610|NCT01629966|156159466|FG002|Overall Study|Pregnancy|0|||
48538611|NCT01629966|156159464|FG000|Overall Study|Lost to Follow-up|10|||
48538612|NCT01629966|156159465|FG001|Overall Study|Lost to Follow-up|13|||
48538613|NCT01629966|156159466|FG002|Overall Study|Lost to Follow-up|9|||
48538614|NCT01629966|156159464|FG000|Overall Study|Withdrawal by Subject|8|||
48538615|NCT01629966|156159465|FG001|Overall Study|Withdrawal by Subject|9|||
48538616|NCT01629966|156159466|FG002|Overall Study|Withdrawal by Subject|16|||
48538617|NCT01629966|156159464|FG000|Overall Study|Protocol Violation|7|||
48538618|NCT01629966|156159465|FG001|Overall Study|Protocol Violation|9|||
48538619|NCT01629966|156159466|FG002|Overall Study|Protocol Violation|7|||
48538620|NCT01629966|156159464|FG000|Overall Study|Lack of Efficacy|5|||
48538621|NCT01629966|156159465|FG001|Overall Study|Lack of Efficacy|2|||
48538622|NCT01629966|156159466|FG002|Overall Study|Lack of Efficacy|4|||
48538623|NCT01629966|156159464|FG000|Overall Study|Adverse Event|11|||
48538624|NCT01629966|156159465|FG001|Overall Study|Adverse Event|18|||
48538625|NCT01629966|156159466|FG002|Overall Study|Adverse Event|30|||
48538626|NCT01602965|156159467|FG000|Overall Study|Lost to Follow-up|4|||
48538627|NCT01602965|156159468|FG001|Overall Study|Lost to Follow-up|2|||
48538628|NCT04146363|156160894|FG000|Induction Period|Adverse Event|1|||
48538629|NCT04146363|156160895|FG001|Induction Period|Adverse Event|2|||
48538630|NCT04146363|156160896|FG002|Induction Period|Adverse Event|0|||
48538631|NCT04146363|156160897|FG003|Induction Period|Adverse Event|0|||
48538632|NCT04146363|156160898|FG004|Induction Period|Adverse Event|0|||
48538633|NCT04146363|156160899|FG005|Induction Period|Adverse Event|0|||
48538634|NCT04146363|156160900|FG006|Induction Period|Adverse Event|0|||
48446295|NCT03970824|155822358|FG002|Overall Study|Lost to Follow-up|1|||
48446296|NCT03970824|155822356|FG000|Overall Study|Adverse Event|1|||
48538635|NCT04146363|156160901|FG007|Induction Period|Adverse Event|0|||
48538636|NCT04146363|156160902|FG008|Induction Period|Adverse Event|0|||
48538637|NCT04146363|156160903|FG009|Induction Period|Adverse Event|0|||
48538638|NCT04146363|156160904|FG010|Induction Period|Adverse Event|0|||
48538639|NCT04146363|156160894|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
48538640|NCT04146363|156160895|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
48538641|NCT04146363|156160896|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
48446297|NCT03970824|155822357|FG001|Overall Study|Adverse Event|0|||
48446298|NCT03970824|155822358|FG002|Overall Study|Adverse Event|0|||
48446299|NCT02693691|155822359|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
48446300|NCT02693691|155822359|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
48446301|NCT02693691|155822359|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
48446302|NCT02693691|155822359|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
48446303|NCT02693691|155822359|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
48446304|NCT02693691|155822359|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
48446305|NCT02693691|155822359|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
48446306|NCT01153893|155822360|FG000|Overall Study|Adverse Event|1|||
48446307|NCT01153893|155822361|FG001|Overall Study|Adverse Event|0|||
48446308|NCT04362813|155822362|FG000|Overall Study|Death|12|||
48446309|NCT04362813|155822363|FG001|Overall Study|Death|16|||
48446310|NCT04362813|155822362|FG000|Overall Study|Withdrawal by Subject|3|||
48446311|NCT04362813|155822363|FG001|Overall Study|Withdrawal by Subject|1|||
48446312|NCT04362813|155822362|FG000|Overall Study|Protocol Violation|0|||
48446313|NCT04362813|155822363|FG001|Overall Study|Protocol Violation|3|||
48446314|NCT04362813|155822362|FG000|Overall Study|Lost to Follow-up|1|||
48446315|NCT04362813|155822363|FG001|Overall Study|Lost to Follow-up|1|||
48446316|NCT04362813|155822362|FG000|Overall Study|Enrolled but did not receive treatment|2|||
48446317|NCT04362813|155822363|FG001|Overall Study|Enrolled but did not receive treatment|4|||
48446318|NCT00389441|155822364|FG000|Overall Study|Adverse Event|7|||
48446319|NCT00389441|155822364|FG000|Overall Study|Death|4|||
48446320|NCT00389441|155822364|FG000|Overall Study|Lost to Follow-up|2|||
48446321|NCT00389441|155822364|FG000|Overall Study|Withdrawal by Subject|4|||
48446322|NCT00389441|155822364|FG000|Overall Study|Physician Decision|1|||
48446323|NCT00389441|155822364|FG000|Overall Study|Protocol Violation|1|||
48446324|NCT00389441|155822364|FG000|Overall Study|Global deterioration of health status|4|||
48446325|NCT00389441|155822364|FG000|Overall Study|Objective progression or relapse|26|||
48538642|NCT04146363|156160897|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
48538643|NCT04146363|156160898|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
48538644|NCT04146363|156160899|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
48538645|NCT04146363|156160900|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
48538646|NCT04146363|156160901|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
48538647|NCT04146363|156160902|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
48538648|NCT04146363|156160903|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
48538649|NCT04146363|156160904|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
48538650|NCT04146363|156160894|FG000|Induction Period|Lack of Efficacy|7|||
48538651|NCT04146363|156160895|FG001|Induction Period|Lack of Efficacy|2|||
48538652|NCT04146363|156160896|FG002|Induction Period|Lack of Efficacy|0|||
48538653|NCT04146363|156160897|FG003|Induction Period|Lack of Efficacy|0|||
48538654|NCT04146363|156160898|FG004|Induction Period|Lack of Efficacy|0|||
48538655|NCT04146363|156160899|FG005|Induction Period|Lack of Efficacy|0|||
48538656|NCT04146363|156160900|FG006|Induction Period|Lack of Efficacy|0|||
48538657|NCT04146363|156160901|FG007|Induction Period|Lack of Efficacy|0|||
48538658|NCT04146363|156160902|FG008|Induction Period|Lack of Efficacy|0|||
48606002|NCT01774981|156415451|FG004|Overall Study|Withdrawal by Subject|0|||
48606003|NCT01774981|156415452|FG005|Overall Study|Withdrawal by Subject|0|||
48606004|NCT01774981|156415453|FG006|Overall Study|Withdrawal by Subject|0|||
48606005|NCT01774981|156415454|FG007|Overall Study|Withdrawal by Subject|1|||
48606006|NCT01774981|156415447|FG000|Overall Study|Death|0|||
48606007|NCT01774981|156415448|FG001|Overall Study|Death|0|||
48606008|NCT01774981|156415449|FG002|Overall Study|Death|0|||
48606009|NCT01774981|156415450|FG003|Overall Study|Death|0|||
48606010|NCT01774981|156415451|FG004|Overall Study|Death|1|||
48606011|NCT01774981|156415452|FG005|Overall Study|Death|0|||
48606012|NCT01774981|156415453|FG006|Overall Study|Death|0|||
48606013|NCT01774981|156415454|FG007|Overall Study|Death|0|||
48606014|NCT01324102|156415457|FG000|Overall Study|illness|1|||
48606015|NCT01324102|156415458|FG001|Overall Study|illness|6|||
48606016|NCT02914834|156415461|FG000|Overall Study|Study halted due to COVID|1|||
48606017|NCT02914834|156415462|FG001|Overall Study|Study halted due to COVID|1|||
48606018|NCT02914834|156415461|FG000|Overall Study|1 subject withdrew|0|||
48606019|NCT02914834|156415462|FG001|Overall Study|1 subject withdrew|1|||
48606020|NCT00473655|156415463|FG000|Overall Study|Lost to Follow-up|9|||
48446405|NCT02633046|155822399|FG000|Overall Study|Physician Decision|7|||
48606021|NCT00473655|156415464|FG001|Overall Study|Lost to Follow-up|5|||
48606022|NCT00473655|156415465|FG002|Overall Study|Lost to Follow-up|8|||
48446406|NCT02633046|155822399|FG000|Overall Study|Withdrawal by Subject|8|||
48446407|NCT02633046|155822399|FG000|Overall Study|Increased proteinuria|2|||
48446408|NCT02633046|155822399|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
48446409|NCT02633046|155822399|FG000|Overall Study|Mutual decision patient and physician|1|||
48446410|NCT02142504|155822403|FG000|Overall Study|Protocol Violation|2|||
48446411|NCT02142504|155822404|FG001|Overall Study|Protocol Violation|1|||
48446412|NCT02142504|155822405|FG002|Overall Study|Protocol Violation|2|||
48446413|NCT02142504|155822403|FG000|Overall Study|Adverse Event|2|||
48446414|NCT02142504|155822404|FG001|Overall Study|Adverse Event|3|||
48446415|NCT02142504|155822405|FG002|Overall Study|Adverse Event|4|||
48446416|NCT02142504|155822403|FG000|Overall Study|Lost to Follow-up|12|||
48446417|NCT02142504|155822404|FG001|Overall Study|Lost to Follow-up|19|||
48446418|NCT02142504|155822405|FG002|Overall Study|Lost to Follow-up|17|||
48446419|NCT02142504|155822403|FG000|Overall Study|Withdrawal by Subject|7|||
48446420|NCT02142504|155822404|FG001|Overall Study|Withdrawal by Subject|9|||
48446421|NCT02142504|155822405|FG002|Overall Study|Withdrawal by Subject|11|||
48446422|NCT02142504|155822403|FG000|Overall Study|Pregnancy|4|||
48446423|NCT02142504|155822404|FG001|Overall Study|Pregnancy|4|||
48446424|NCT02142504|155822405|FG002|Overall Study|Pregnancy|2|||
48446425|NCT02142504|155822403|FG000|Overall Study|Physician Decision|0|||
48446426|NCT02142504|155822404|FG001|Overall Study|Physician Decision|1|||
48446427|NCT02142504|155822405|FG002|Overall Study|Physician Decision|3|||
48446428|NCT02142504|155822403|FG000|Overall Study|Reason Not Specified|4|||
48446429|NCT02142504|155822404|FG001|Overall Study|Reason Not Specified|5|||
48446430|NCT02142504|155822405|FG002|Overall Study|Reason Not Specified|4|||
48446431|NCT02427100|155822407|FG000|Overall Study|Lost to Follow-up|0|||
48446432|NCT02427100|155822408|FG001|Overall Study|Lost to Follow-up|2|||
48446433|NCT05263921|155824342|FG000|Overall Study|Other: family emergency.|0|||
48446434|NCT05263921|155824343|FG001|Overall Study|Other: family emergency.|0|||
48446435|NCT05263921|155824344|FG002|Overall Study|Other: family emergency.|1|||
48446436|NCT05263921|155824345|FG003|Overall Study|Other: family emergency.|0|||
48446437|NCT02499575|155824346|FG000|Overall Study|Protocol Violation|0|||
48446438|NCT02499575|155824347|FG001|Overall Study|Protocol Violation|1|||
48446439|NCT02670928|155824348|FG000|Overall Study|Adverse Event|3|||
48446440|NCT02670928|155824349|FG001|Overall Study|Adverse Event|1|||
48446441|NCT02670928|155824348|FG000|Overall Study|Withdrawal by Subject|4|||
48538659|NCT04146363|156160903|FG009|Induction Period|Lack of Efficacy|0|||
48538660|NCT04146363|156160904|FG010|Induction Period|Lack of Efficacy|0|||
48538661|NCT04146363|156160894|FG000|Induction Period|Lost to Follow-up|1|||
48538662|NCT04146363|156160895|FG001|Induction Period|Lost to Follow-up|4|||
48538663|NCT04146363|156160896|FG002|Induction Period|Lost to Follow-up|0|||
48538664|NCT04146363|156160897|FG003|Induction Period|Lost to Follow-up|0|||
48538665|NCT04146363|156160898|FG004|Induction Period|Lost to Follow-up|0|||
48538666|NCT04146363|156160899|FG005|Induction Period|Lost to Follow-up|0|||
48538667|NCT04146363|156160900|FG006|Induction Period|Lost to Follow-up|0|||
48538668|NCT04146363|156160901|FG007|Induction Period|Lost to Follow-up|0|||
48538669|NCT04146363|156160902|FG008|Induction Period|Lost to Follow-up|0|||
48538670|NCT04146363|156160903|FG009|Induction Period|Lost to Follow-up|0|||
48538671|NCT04146363|156160904|FG010|Induction Period|Lost to Follow-up|0|||
48538672|NCT04146363|156160894|FG000|Induction Period|Positive quantiferon test|0|||
48538673|NCT04146363|156160895|FG001|Induction Period|Positive quantiferon test|1|||
48538674|NCT04146363|156160896|FG002|Induction Period|Positive quantiferon test|0|||
48538675|NCT04146363|156160897|FG003|Induction Period|Positive quantiferon test|0|||
48538676|NCT04146363|156160898|FG004|Induction Period|Positive quantiferon test|0|||
48538677|NCT04146363|156160899|FG005|Induction Period|Positive quantiferon test|0|||
48538678|NCT04146363|156160900|FG006|Induction Period|Positive quantiferon test|0|||
48538679|NCT04146363|156160901|FG007|Induction Period|Positive quantiferon test|0|||
48538680|NCT04146363|156160902|FG008|Induction Period|Positive quantiferon test|0|||
48538681|NCT04146363|156160903|FG009|Induction Period|Positive quantiferon test|0|||
48538682|NCT04146363|156160904|FG010|Induction Period|Positive quantiferon test|0|||
48538683|NCT04146363|156160894|FG000|Induction Period|Protocol Deviation|5|||
48538684|NCT04146363|156160895|FG001|Induction Period|Protocol Deviation|6|||
48538685|NCT04146363|156160896|FG002|Induction Period|Protocol Deviation|0|||
48538686|NCT04146363|156160897|FG003|Induction Period|Protocol Deviation|0|||
48538687|NCT04146363|156160898|FG004|Induction Period|Protocol Deviation|0|||
48606023|NCT02631941|156415474|FG000|Overall Study|Physician Decision|0|||
48606024|NCT02631941|156415475|FG001|Overall Study|Physician Decision|1|||
48606025|NCT02631941|156415476|FG002|Overall Study|Physician Decision|0|||
48606026|NCT02631941|156415477|FG003|Overall Study|Physician Decision|0|||
48606027|NCT02631941|156415478|FG004|Overall Study|Physician Decision|0|||
48606028|NCT02631941|156415479|FG005|Overall Study|Physician Decision|0|||
48606029|NCT02631941|156415480|FG006|Overall Study|Physician Decision|0|||
48606030|NCT02631941|156415481|FG007|Overall Study|Physician Decision|0|||
48606031|NCT02631941|156415482|FG008|Overall Study|Physician Decision|0|||
48606032|NCT02631941|156415483|FG009|Overall Study|Physician Decision|0|||
48606033|NCT02631941|156415474|FG000|Overall Study|Adverse Event|0|||
48606034|NCT02631941|156415475|FG001|Overall Study|Adverse Event|1|||
48606035|NCT02631941|156415476|FG002|Overall Study|Adverse Event|0|||
48606036|NCT02631941|156415477|FG003|Overall Study|Adverse Event|0|||
48606037|NCT02631941|156415478|FG004|Overall Study|Adverse Event|0|||
48446516|NCT02591238|155824371|FG003|Overall Study|influenza|1|||
48446517|NCT02591238|155824368|FG000|Overall Study|personal circumstances|0|||
48446518|NCT02591238|155824369|FG001|Overall Study|personal circumstances|0|||
48446519|NCT02591238|155824370|FG002|Overall Study|personal circumstances|0|||
48446520|NCT02591238|155824371|FG003|Overall Study|personal circumstances|1|||
48446521|NCT02591238|155824368|FG000|Overall Study|personal circumstances|0|||
48446522|NCT02591238|155824369|FG001|Overall Study|personal circumstances|1|||
48446523|NCT02591238|155824370|FG002|Overall Study|personal circumstances|0|||
48446524|NCT02591238|155824371|FG003|Overall Study|personal circumstances|0|||
48446525|NCT00656084|155824372|FG000|Overall Study|Adverse Event|4|||
48446526|NCT00656084|155824372|FG000|Overall Study|Withdrawal by Subject|1|||
48446527|NCT00656084|155824372|FG000|Overall Study|Patient Request|1|||
48446528|NCT00656084|155824372|FG000|Overall Study|Investigator Request|1|||
48446529|NCT02528253|155824375|FG000|Overall Study|Adverse Event|3|||
48446530|NCT02528253|155824376|FG001|Overall Study|Adverse Event|4|||
48446531|NCT02528253|155824377|FG002|Overall Study|Adverse Event|4|||
48446532|NCT02528253|155824378|FG003|Overall Study|Adverse Event|8|||
48446533|NCT02528253|155824379|FG004|Overall Study|Adverse Event|18|||
48446534|NCT02528253|155824375|FG000|Overall Study|Death|2|||
48446535|NCT02528253|155824376|FG001|Overall Study|Death|2|||
48446536|NCT02528253|155824377|FG002|Overall Study|Death|1|||
48446537|NCT02528253|155824378|FG003|Overall Study|Death|0|||
48446538|NCT02528253|155824379|FG004|Overall Study|Death|1|||
48446539|NCT02528253|155824375|FG000|Overall Study|Insufficient clinical response|7|||
48446540|NCT02528253|155824376|FG001|Overall Study|Insufficient clinical response|10|||
48446541|NCT02528253|155824377|FG002|Overall Study|Insufficient clinical response|13|||
48446542|NCT02528253|155824378|FG003|Overall Study|Insufficient clinical response|12|||
48446543|NCT02528253|155824379|FG004|Overall Study|Insufficient clinical response|16|||
48446544|NCT02528253|155824375|FG000|Overall Study|Lost to Follow-up|16|||
48446545|NCT02528253|155824376|FG001|Overall Study|Lost to Follow-up|9|||
48446546|NCT02528253|155824377|FG002|Overall Study|Lost to Follow-up|31|||
48446547|NCT02528253|155824378|FG003|Overall Study|Lost to Follow-up|16|||
48606038|NCT02631941|156415479|FG005|Overall Study|Adverse Event|0|||
48606039|NCT02631941|156415480|FG006|Overall Study|Adverse Event|0|||
48606040|NCT02631941|156415481|FG007|Overall Study|Adverse Event|0|||
48606041|NCT02631941|156415482|FG008|Overall Study|Adverse Event|0|||
48606042|NCT02631941|156415483|FG009|Overall Study|Adverse Event|0|||
48606043|NCT02631941|156415474|FG000|Overall Study|Withdrawal by Subject|0|||
48606044|NCT02631941|156415475|FG001|Overall Study|Withdrawal by Subject|0|||
48606045|NCT02631941|156415476|FG002|Overall Study|Withdrawal by Subject|0|||
48606046|NCT02631941|156415477|FG003|Overall Study|Withdrawal by Subject|0|||
48606047|NCT02631941|156415478|FG004|Overall Study|Withdrawal by Subject|1|||
48606048|NCT02631941|156415479|FG005|Overall Study|Withdrawal by Subject|0|||
48606049|NCT02631941|156415480|FG006|Overall Study|Withdrawal by Subject|0|||
48606050|NCT02631941|156415481|FG007|Overall Study|Withdrawal by Subject|1|||
48606051|NCT02631941|156415482|FG008|Overall Study|Withdrawal by Subject|0|||
48606052|NCT02631941|156415483|FG009|Overall Study|Withdrawal by Subject|0|||
48606053|NCT02631941|156415474|FG000|Overall Study|Lost to Follow-up|0|||
48606054|NCT02631941|156415475|FG001|Overall Study|Lost to Follow-up|0|||
48606055|NCT02631941|156415476|FG002|Overall Study|Lost to Follow-up|0|||
48606056|NCT02631941|156415477|FG003|Overall Study|Lost to Follow-up|0|||
48606057|NCT02631941|156415478|FG004|Overall Study|Lost to Follow-up|0|||
48606058|NCT02631941|156415479|FG005|Overall Study|Lost to Follow-up|0|||
48606059|NCT02631941|156415480|FG006|Overall Study|Lost to Follow-up|0|||
48606060|NCT02631941|156415481|FG007|Overall Study|Lost to Follow-up|0|||
48606061|NCT02631941|156415482|FG008|Overall Study|Lost to Follow-up|1|||
48606062|NCT02631941|156415483|FG009|Overall Study|Lost to Follow-up|0|||
48606063|NCT01225549|156415484|FG000|Period 4 - Washout|Disallowed medication|0|||
48606064|NCT01225549|156415485|FG001|Period 4 - Washout|Disallowed medication|1|||
48606065|NCT01225549|156415486|FG002|Period 4 - Washout|Disallowed medication|0|||
48606066|NCT01225549|156415487|FG003|Period 4 - Washout|Disallowed medication|0|||
48606067|NCT01225549|156415488|FG004|Period 4 - Washout|Disallowed medication|0|||
48606068|NCT01225549|156415489|FG005|Period 4 - Washout|Disallowed medication|0|||
48606069|NCT01225549|156415490|FG006|Period 4 - Washout|Disallowed medication|0|||
48606070|NCT01225549|156415491|FG007|Period 4 - Washout|Disallowed medication|0|||
48606071|NCT01225549|156415492|FG008|Period 4 - Washout|Disallowed medication|0|||
48606072|NCT01225549|156415493|FG009|Period 4 - Washout|Disallowed medication|0|||
48606073|NCT01225549|156415484|FG000|Period 6 - Washout|Disallowed medication|0|||
48606074|NCT01225549|156415485|FG001|Period 6 - Washout|Disallowed medication|0|||
48606075|NCT01225549|156415486|FG002|Period 6 - Washout|Disallowed medication|0|||
48606076|NCT01225549|156415487|FG003|Period 6 - Washout|Disallowed medication|1|||
48606077|NCT01225549|156415488|FG004|Period 6 - Washout|Disallowed medication|0|||
48606078|NCT01225549|156415489|FG005|Period 6 - Washout|Disallowed medication|0|||
48606079|NCT01225549|156415490|FG006|Period 6 - Washout|Disallowed medication|0|||
48606080|NCT01225549|156415491|FG007|Period 6 - Washout|Disallowed medication|0|||
48606081|NCT01225549|156415492|FG008|Period 6 - Washout|Disallowed medication|0|||
48606082|NCT01225549|156415493|FG009|Period 6 - Washout|Disallowed medication|0|||
48606083|NCT02732639|156415496|FG000|Overall Study|Lost to Follow-up|1|||
48606084|NCT00473083|156415497|FG000|Overall Study|Adverse Event|1|||
48606085|NCT00473083|156415498|FG001|Overall Study|Adverse Event|0|||
48606086|NCT00473083|156415499|FG002|Overall Study|Adverse Event|0|||
48606087|NCT02513550|156415500|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
48606088|NCT02513550|156415501|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
48606089|NCT02513550|156415502|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
48606090|NCT02513550|156415503|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
48606091|NCT02513550|156415504|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
48606092|NCT02513550|156415505|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
48606093|NCT02513550|156415500|FG000|Double Blind Treatment Period|Adverse Event|5|||
48606094|NCT02513550|156415501|FG001|Double Blind Treatment Period|Adverse Event|13|||
48606095|NCT02513550|156415502|FG002|Double Blind Treatment Period|Adverse Event|17|||
48606096|NCT02513550|156415503|FG003|Double Blind Treatment Period|Adverse Event|0|||
48606097|NCT02513550|156415504|FG004|Double Blind Treatment Period|Adverse Event|1|||
48446548|NCT02528253|155824379|FG004|Overall Study|Lost to Follow-up|34|||
48446549|NCT02528253|155824375|FG000|Overall Study|Other|21|||
48446550|NCT02528253|155824376|FG001|Overall Study|Other|22|||
48446551|NCT02528253|155824377|FG002|Overall Study|Other|58|||
48446552|NCT02528253|155824378|FG003|Overall Study|Other|52|||
48446553|NCT02528253|155824379|FG004|Overall Study|Other|76|||
48446554|NCT02528253|155824375|FG000|Overall Study|Withdrawal by Subject|25|||
48446555|NCT02528253|155824376|FG001|Overall Study|Withdrawal by Subject|20|||
48446556|NCT02528253|155824377|FG002|Overall Study|Withdrawal by Subject|29|||
48446557|NCT02528253|155824378|FG003|Overall Study|Withdrawal by Subject|48|||
48446558|NCT02528253|155824379|FG004|Overall Study|Withdrawal by Subject|73|||
48446559|NCT02528253|155824375|FG000|Overall Study|Protocol Violation|1|||
48446560|NCT02528253|155824376|FG001|Overall Study|Protocol Violation|2|||
48446561|NCT02528253|155824377|FG002|Overall Study|Protocol Violation|4|||
48446562|NCT02528253|155824378|FG003|Overall Study|Protocol Violation|0|||
48446563|NCT02528253|155824379|FG004|Overall Study|Protocol Violation|4|||
48538688|NCT04146363|156160899|FG005|Induction Period|Protocol Deviation|0|||
48538689|NCT04146363|156160900|FG006|Induction Period|Protocol Deviation|0|||
48538690|NCT04146363|156160901|FG007|Induction Period|Protocol Deviation|0|||
48538691|NCT04146363|156160902|FG008|Induction Period|Protocol Deviation|0|||
48538692|NCT04146363|156160903|FG009|Induction Period|Protocol Deviation|0|||
48538693|NCT04146363|156160904|FG010|Induction Period|Protocol Deviation|0|||
48538694|NCT04146363|156160894|FG000|Induction Period|Withdrawal by Subject|6|||
48538695|NCT04146363|156160895|FG001|Induction Period|Withdrawal by Subject|3|||
48538696|NCT04146363|156160896|FG002|Induction Period|Withdrawal by Subject|0|||
48538697|NCT04146363|156160897|FG003|Induction Period|Withdrawal by Subject|0|||
48538698|NCT04146363|156160898|FG004|Induction Period|Withdrawal by Subject|0|||
48538699|NCT04146363|156160899|FG005|Induction Period|Withdrawal by Subject|0|||
48538700|NCT04146363|156160900|FG006|Induction Period|Withdrawal by Subject|0|||
48538701|NCT04146363|156160901|FG007|Induction Period|Withdrawal by Subject|0|||
48538702|NCT04146363|156160902|FG008|Induction Period|Withdrawal by Subject|0|||
48538703|NCT04146363|156160903|FG009|Induction Period|Withdrawal by Subject|0|||
48538704|NCT04146363|156160904|FG010|Induction Period|Withdrawal by Subject|0|||
48538705|NCT04146363|156160894|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538706|NCT04146363|156160895|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538707|NCT04146363|156160896|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538708|NCT04146363|156160897|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538709|NCT04146363|156160898|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538710|NCT04146363|156160899|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538711|NCT04146363|156160900|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
48538712|NCT04146363|156160901|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
48538713|NCT04146363|156160902|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538714|NCT04146363|156160903|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538715|NCT04146363|156160904|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
48538716|NCT04146363|156160894|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538717|NCT04146363|156160895|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538718|NCT04146363|156160896|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538719|NCT04146363|156160897|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538720|NCT04146363|156160898|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538721|NCT04146363|156160899|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538722|NCT04146363|156160900|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538723|NCT04146363|156160901|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
48538724|NCT04146363|156160902|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538725|NCT04146363|156160903|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538726|NCT04146363|156160904|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
48538727|NCT04146363|156160894|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538728|NCT04146363|156160895|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538729|NCT04146363|156160896|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538730|NCT04146363|156160897|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538731|NCT04146363|156160898|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538732|NCT04146363|156160899|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538733|NCT04146363|156160900|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
48538734|NCT04146363|156160901|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
48538735|NCT04146363|156160902|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538736|NCT04146363|156160903|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538737|NCT04146363|156160904|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
48538738|NCT04146363|156160894|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538739|NCT04146363|156160895|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538740|NCT04146363|156160896|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
48538741|NCT04146363|156160897|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538742|NCT04146363|156160898|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538743|NCT04146363|156160899|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
48538744|NCT04146363|156160900|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538745|NCT04146363|156160901|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538746|NCT04146363|156160902|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538747|NCT04146363|156160903|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538748|NCT04146363|156160904|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
48538749|NCT04146363|156160894|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48538750|NCT04146363|156160895|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48538751|NCT04146363|156160896|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48538752|NCT04146363|156160897|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48538753|NCT04146363|156160898|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
48538754|NCT04146363|156160899|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
48538755|NCT04146363|156160900|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
48538756|NCT04146363|156160901|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
48538757|NCT04146363|156160902|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48538758|NCT04146363|156160903|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48538759|NCT04146363|156160904|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
48538760|NCT04146363|156160894|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48538761|NCT04146363|156160895|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48538762|NCT04146363|156160896|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
48538763|NCT04146363|156160897|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48538764|NCT04146363|156160898|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48538765|NCT04146363|156160899|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
48538766|NCT04146363|156160900|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
48538767|NCT04146363|156160901|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
48538768|NCT04146363|156160902|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48538769|NCT04146363|156160903|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48538770|NCT04146363|156160904|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
48538771|NCT04146363|156160894|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538772|NCT04146363|156160895|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538773|NCT04146363|156160896|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538774|NCT04146363|156160897|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538775|NCT04146363|156160898|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538776|NCT04146363|156160899|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538777|NCT04146363|156160900|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538778|NCT04146363|156160901|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538779|NCT04146363|156160902|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
48538780|NCT04146363|156160903|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
48538781|NCT04146363|156160904|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
48538782|NCT04146363|156160894|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48538783|NCT04146363|156160895|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48538784|NCT04146363|156160896|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48538785|NCT04146363|156160897|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48538786|NCT04146363|156160898|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48538787|NCT04146363|156160899|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48538788|NCT04146363|156160900|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48606098|NCT02513550|156415505|FG005|Double Blind Treatment Period|Adverse Event|0|||
48538789|NCT04146363|156160901|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48538790|NCT04146363|156160902|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
48538791|NCT04146363|156160903|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
48538792|NCT04146363|156160904|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
48538793|NCT04146363|156160894|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48538794|NCT04146363|156160895|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48538795|NCT04146363|156160896|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48606099|NCT02513550|156415500|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
48606100|NCT02513550|156415501|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
48538796|NCT04146363|156160897|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48538797|NCT04146363|156160898|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48538798|NCT04146363|156160899|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48538799|NCT04146363|156160900|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48538800|NCT04146363|156160901|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48538801|NCT04146363|156160902|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
48538802|NCT04146363|156160903|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
48538803|NCT04146363|156160904|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48538804|NCT04146363|156160894|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538805|NCT04146363|156160895|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538806|NCT04146363|156160896|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538807|NCT04146363|156160897|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538808|NCT04146363|156160898|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538809|NCT04146363|156160899|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538810|NCT04146363|156160900|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538811|NCT04146363|156160901|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538812|NCT04146363|156160902|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
48538813|NCT04146363|156160903|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
48538814|NCT04146363|156160904|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
48538815|NCT04146363|156160894|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48538816|NCT04146363|156160895|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48538817|NCT04146363|156160896|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48538818|NCT04146363|156160897|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48538819|NCT04146363|156160898|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48538820|NCT04146363|156160899|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48538821|NCT04146363|156160900|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48538822|NCT04146363|156160901|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48538823|NCT04146363|156160902|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
48538824|NCT04146363|156160903|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
48538825|NCT04146363|156160904|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
48538826|NCT04146363|156160894|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538827|NCT04146363|156160895|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538828|NCT04146363|156160896|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538829|NCT04146363|156160897|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538830|NCT04146363|156160898|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538831|NCT04146363|156160899|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538832|NCT04146363|156160900|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538833|NCT04146363|156160901|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
48606101|NCT02513550|156415502|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
48538834|NCT04146363|156160902|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538835|NCT04146363|156160903|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
48538836|NCT04146363|156160904|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
48538837|NCT04146363|156160894|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538838|NCT04146363|156160895|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538839|NCT04146363|156160896|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538840|NCT04146363|156160897|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538841|NCT04146363|156160898|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538842|NCT04146363|156160899|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538843|NCT04146363|156160900|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538844|NCT04146363|156160901|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538845|NCT04146363|156160902|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538846|NCT04146363|156160903|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
48538847|NCT04146363|156160904|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
48538848|NCT02914236|156160908|FG000|Overall Study|Lost to Follow-up|1|||
48538849|NCT00856973|156160913|FG000|Overall Study|Adverse Event|5|||
48538850|NCT00856973|156160914|FG001|Overall Study|Adverse Event|5|||
48538851|NCT00856973|156160915|FG002|Overall Study|Adverse Event|3|||
48538852|NCT00856973|156160913|FG000|Overall Study|Lost to Follow-up|6|||
48538853|NCT00856973|156160914|FG001|Overall Study|Lost to Follow-up|3|||
48538854|NCT00856973|156160915|FG002|Overall Study|Lost to Follow-up|5|||
48538855|NCT00856973|156160913|FG000|Overall Study|Physician Decision|0|||
48538856|NCT00856973|156160914|FG001|Overall Study|Physician Decision|3|||
48538857|NCT00856973|156160915|FG002|Overall Study|Physician Decision|1|||
48538858|NCT00856973|156160913|FG000|Overall Study|Protocol Violation|1|||
48538859|NCT00856973|156160914|FG001|Overall Study|Protocol Violation|2|||
48538860|NCT00856973|156160915|FG002|Overall Study|Protocol Violation|1|||
48538861|NCT00856973|156160913|FG000|Overall Study|Withdrawal by Subject|13|||
48538862|NCT00856973|156160914|FG001|Overall Study|Withdrawal by Subject|16|||
48538863|NCT00856973|156160915|FG002|Overall Study|Withdrawal by Subject|15|||
48538864|NCT00856973|156160913|FG000|Overall Study|Other|11|||
48538865|NCT00856973|156160914|FG001|Overall Study|Other|12|||
48538866|NCT00856973|156160915|FG002|Overall Study|Other|13|||
48538867|NCT02551666|156160916|FG000|Overall Study|Withdrawal by Subject|1|||
48538868|NCT02551666|156160917|FG001|Overall Study|Withdrawal by Subject|3|||
48538869|NCT04718194|156160918|FG000|Overall Study|Withdrawal by Subject|3|||
48538870|NCT04718194|156160919|FG001|Overall Study|Withdrawal by Subject|0|||
48538871|NCT04718194|156160918|FG000|Overall Study|Lost to Follow-up|3|||
48538872|NCT04718194|156160919|FG001|Overall Study|Lost to Follow-up|0|||
48538873|NCT00931268|156160923|FG000|Overall Study|Lost to Follow-up|6|||
48538874|NCT02566993|156160933|FG000|Overall Study|Randomized but not treated|5|||
48538875|NCT02566993|156160934|FG001|Overall Study|Randomized but not treated|16|||
48538876|NCT02566993|156160933|FG000|Overall Study|Progressive disease|213|||
48538877|NCT02566993|156160934|FG001|Overall Study|Progressive disease|152|||
48538878|NCT02566993|156160933|FG000|Overall Study|Withdrawal by Subject|12|||
48538879|NCT02566993|156160934|FG001|Overall Study|Withdrawal by Subject|28|||
48538880|NCT02566993|156160933|FG000|Overall Study|Death|17|||
48538881|NCT02566993|156160934|FG001|Overall Study|Death|23|||
48538882|NCT02566993|156160933|FG000|Overall Study|Physician Decision|10|||
48538883|NCT02566993|156160934|FG001|Overall Study|Physician Decision|17|||
48538884|NCT02566993|156160933|FG000|Overall Study|Study drug-related adverse event|20|||
48538885|NCT02566993|156160934|FG001|Overall Study|Study drug-related adverse event|41|||
48538886|NCT02566993|156160933|FG000|Overall Study|Non study drug-related adverse event|9|||
48538887|NCT02566993|156160934|FG001|Overall Study|Non study drug-related adverse event|9|||
48538888|NCT02566993|156160933|FG000|Overall Study|Symptomatic deterioration|9|||
48538889|NCT02566993|156160934|FG001|Overall Study|Symptomatic deterioration|16|||
48538890|NCT02566993|156160933|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
48538891|NCT02566993|156160934|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
48538892|NCT02566993|156160933|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
48538893|NCT02566993|156160934|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
48538894|NCT02566993|156160933|FG000|Overall Study|Screening failure|2|||
48538895|NCT02566993|156160934|FG001|Overall Study|Screening failure|0|||
48538896|NCT02566993|156160933|FG000|Overall Study|Lost to Follow-up|0|||
48538897|NCT02566993|156160934|FG001|Overall Study|Lost to Follow-up|1|||
48584973|NCT01179737|156333739|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
48584974|NCT01179737|156333740|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
48538898|NCT02566993|156160933|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
48538899|NCT02566993|156160934|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
48538900|NCT00669071|156160935|FG000|Overall Study|Lost to Follow-up|3|||
48606102|NCT02513550|156415503|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
48606103|NCT02513550|156415504|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
48606104|NCT02513550|156415505|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
48606105|NCT02513550|156415500|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
48538901|NCT00669071|156160935|FG000|Overall Study|Final visit 40 days out of window|1|||
48538902|NCT01616953|156160938|FG000|Overall Study|Lost to Follow-up|1|||
48606106|NCT02513550|156415501|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
48606107|NCT02513550|156415502|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
48606108|NCT02513550|156415503|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
48606109|NCT02513550|156415504|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
48606110|NCT02513550|156415505|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
48606111|NCT02513550|156415500|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48606112|NCT02513550|156415501|FG001|Double Blind Treatment Period|Protocol Violation|1|||
48606113|NCT02513550|156415502|FG002|Double Blind Treatment Period|Protocol Violation|4|||
48606114|NCT02513550|156415503|FG003|Double Blind Treatment Period|Protocol Violation|0|||
48538903|NCT01616953|156160939|FG001|Overall Study|Lost to Follow-up|0|||
48538904|NCT01616953|156160938|FG000|Overall Study|lack of bone and soft tissue|1|||
48538905|NCT01616953|156160939|FG001|Overall Study|lack of bone and soft tissue|0|||
48538906|NCT01940497|156160944|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
48538907|NCT01940497|156160945|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
48538908|NCT01940497|156160944|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
48538909|NCT01940497|156160945|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
48538910|NCT01940497|156160944|FG000|Overall Study|Violation of Entry Criteria|1|||
48538911|NCT01940497|156160945|FG001|Overall Study|Violation of Entry Criteria|1|||
48538912|NCT01940497|156160944|FG000|Overall Study|Refused Treatment|1|||
48538913|NCT01940497|156160945|FG001|Overall Study|Refused Treatment|3|||
48538914|NCT01940497|156160944|FG000|Overall Study|Withdrew Consent|6|||
48538915|NCT01940497|156160945|FG001|Overall Study|Withdrew Consent|2|||
48538916|NCT01940497|156160944|FG000|Overall Study|Administrative/Other|1|||
48538917|NCT01940497|156160945|FG001|Overall Study|Administrative/Other|1|||
48538918|NCT02206620|156160948|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
48538919|NCT02206620|156160949|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
48538920|NCT02206620|156160948|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
48538921|NCT02206620|156160949|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
48538922|NCT00513682|156160950|FG000|Washout Phase|Adverse Event|2|||
48538923|NCT00369382|156160951|FG000|Overall Study|Death|0|||
48538924|NCT00369382|156160952|FG001|Overall Study|Death|2|||
48606115|NCT02513550|156415504|FG004|Double Blind Treatment Period|Protocol Violation|0|||
48606116|NCT02513550|156415505|FG005|Double Blind Treatment Period|Protocol Violation|0|||
48606117|NCT02513550|156415500|FG000|Double Blind Treatment Period|Physician Decision|2|||
48606118|NCT02513550|156415501|FG001|Double Blind Treatment Period|Physician Decision|0|||
48606119|NCT02513550|156415502|FG002|Double Blind Treatment Period|Physician Decision|4|||
48606120|NCT02513550|156415503|FG003|Double Blind Treatment Period|Physician Decision|0|||
48606121|NCT02513550|156415504|FG004|Double Blind Treatment Period|Physician Decision|0|||
48606122|NCT02513550|156415505|FG005|Double Blind Treatment Period|Physician Decision|0|||
48606123|NCT02513550|156415500|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
48538925|NCT00369382|156160951|FG000|Overall Study|Physician Decision|2|||
48538926|NCT00369382|156160952|FG001|Overall Study|Physician Decision|1|||
48538927|NCT00369382|156160951|FG000|Overall Study|Withdrawal by Subject|5|||
48538928|NCT00369382|156160952|FG001|Overall Study|Withdrawal by Subject|0|||
48538929|NCT00369382|156160951|FG000|Overall Study|Randomized, not treated|2|||
48538930|NCT00369382|156160952|FG001|Overall Study|Randomized, not treated|0|||
48538931|NCT00369382|156160951|FG000|Overall Study|Other|1|||
48538932|NCT00369382|156160952|FG001|Overall Study|Other|0|||
48538933|NCT03487848|156160953|FG000|Overall Study|Lost to Follow-up|1|||
48538934|NCT04465630|156160954|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
48538935|NCT04465630|156160954|FG000|Overall Study|Screen failure|8|||
48538936|NCT04465630|156160954|FG000|Overall Study|Baseline failure|16|||
48538937|NCT02722148|156160955|FG000|Overall Study|Lost to Follow-up|2|||
48538938|NCT02722148|156160955|FG000|Overall Study|Non compliant with treatment regimen|3|||
48538939|NCT02394730|156160956|FG000|Overall Study|Lost to Follow-up|1|||
48538940|NCT02394730|156160957|FG001|Overall Study|Lost to Follow-up|0|||
48538941|NCT02394730|156160956|FG000|Overall Study|Withdrawal by Subject|0|||
48538942|NCT02394730|156160957|FG001|Overall Study|Withdrawal by Subject|1|||
48538943|NCT00588640|156160959|FG000|Overall Study|Physician Decision|1|||
48538944|NCT00588640|156160959|FG000|Overall Study|Ineligible Patient|1|||
48538945|NCT02384850|156160960|FG000|Overall Study|Withdrawal by Subject|2|||
48538946|NCT02384850|156160961|FG001|Overall Study|Withdrawal by Subject|2|||
48538947|NCT01458106|156160962|FG000|Overall Study|Withdrawal by Subject|2|||
48538948|NCT01458106|156160963|FG001|Overall Study|Withdrawal by Subject|0|||
48538949|NCT01458106|156160962|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
48538950|NCT01458106|156160963|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
48538951|NCT01458106|156160962|FG000|Overall Study|Withdrawn Per Protocol|0|||
48538952|NCT01458106|156160963|FG001|Overall Study|Withdrawn Per Protocol|1|||
48538953|NCT00073021|156160964|FG000|Overall Study|Protocol Violation|2|||
48538954|NCT00073021|156160965|FG001|Overall Study|Protocol Violation|1|||
48538955|NCT00073021|156160964|FG000|Overall Study|Adverse Event|4|||
48538956|NCT00073021|156160965|FG001|Overall Study|Adverse Event|4|||
48538957|NCT00073021|156160964|FG000|Overall Study|Withdrawal by Subject|6|||
48538958|NCT00073021|156160965|FG001|Overall Study|Withdrawal by Subject|5|||
48538959|NCT00073021|156160964|FG000|Overall Study|Physician Decision|3|||
48538960|NCT00073021|156160965|FG001|Overall Study|Physician Decision|1|||
48538961|NCT00073021|156160964|FG000|Overall Study|Lack of Efficacy|11|||
48538962|NCT00073021|156160965|FG001|Overall Study|Lack of Efficacy|5|||
48538963|NCT01753336|156160968|FG000|Overall Study|Patient decision|12|||
48538964|NCT01753336|156160968|FG000|Overall Study|Lost to Follow-up|3|||
48538965|NCT01753336|156160968|FG000|Overall Study|Physician Decision|2|||
48538966|NCT01753336|156160968|FG000|Overall Study|Sponsor's decision|2|||
48538967|NCT01753336|156160968|FG000|Overall Study|Withdrawal by Subject|1|||
48538968|NCT00448136|156160969|FG000|Overall Study|Death|3|||
48538969|NCT00448136|156160970|FG001|Overall Study|Death|8|||
48538970|NCT00448136|156160969|FG000|Overall Study|Investigator's decision (progression)|1|||
48606124|NCT02513550|156415501|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
48538971|NCT00448136|156160970|FG001|Overall Study|Investigator's decision (progression)|0|||
48538972|NCT00609466|156160971|FG000|Overall Study|Withdrawal by Subject|0|||
48538973|NCT00609466|156160972|FG001|Overall Study|Withdrawal by Subject|1|||
48538974|NCT00609466|156160973|FG002|Overall Study|Withdrawal by Subject|1|||
48538975|NCT00609466|156160971|FG000|Overall Study|Adverse Event|2|||
48538976|NCT00609466|156160972|FG001|Overall Study|Adverse Event|3|||
48538977|NCT00609466|156160973|FG002|Overall Study|Adverse Event|1|||
48538978|NCT00609466|156160971|FG000|Overall Study|Lack of Efficacy|0|||
48538979|NCT00609466|156160972|FG001|Overall Study|Lack of Efficacy|2|||
48538980|NCT00609466|156160973|FG002|Overall Study|Lack of Efficacy|2|||
48538981|NCT01121666|156160974|FG000|Overall Study|Protocol Violation|29|||
48538982|NCT01121666|156160975|FG001|Overall Study|Protocol Violation|10|||
48538983|NCT01144364|156160976|FG000|Induction Phase|Disease progression|14|||
48538984|NCT01144364|156160977|FG001|Induction Phase|Disease progression|0|||
48538985|NCT01144364|156160978|FG002|Induction Phase|Disease progression|0|||
48538986|NCT01144364|156160976|FG000|Induction Phase|Adverse Event|9|||
48538987|NCT01144364|156160977|FG001|Induction Phase|Adverse Event|0|||
48538988|NCT01144364|156160978|FG002|Induction Phase|Adverse Event|0|||
48538989|NCT01144364|156160976|FG000|Induction Phase|Death|1|||
48538990|NCT01144364|156160977|FG001|Induction Phase|Death|0|||
48538991|NCT01144364|156160978|FG002|Induction Phase|Death|0|||
48538992|NCT01144364|156160976|FG000|Induction Phase|Withdrawal by Subject|1|||
48538993|NCT01144364|156160977|FG001|Induction Phase|Withdrawal by Subject|0|||
48538994|NCT01144364|156160978|FG002|Induction Phase|Withdrawal by Subject|0|||
48538995|NCT01144364|156160976|FG000|Induction Phase|Lost to Follow-up|2|||
48538996|NCT01144364|156160977|FG001|Induction Phase|Lost to Follow-up|0|||
48538997|NCT01144364|156160978|FG002|Induction Phase|Lost to Follow-up|0|||
48538998|NCT01144364|156160976|FG000|Induction Phase|Physician Decision|1|||
48538999|NCT01144364|156160977|FG001|Induction Phase|Physician Decision|0|||
48539000|NCT01144364|156160978|FG002|Induction Phase|Physician Decision|0|||
48539001|NCT01144364|156160976|FG000|Induction Phase|Stable disease|2|||
48539002|NCT01144364|156160977|FG001|Induction Phase|Stable disease|0|||
48539003|NCT01144364|156160978|FG002|Induction Phase|Stable disease|0|||
48539004|NCT01144364|156160976|FG000|Induction Phase|Secondary neoplasia|1|||
48539005|NCT01144364|156160977|FG001|Induction Phase|Secondary neoplasia|0|||
48539006|NCT01144364|156160978|FG002|Induction Phase|Secondary neoplasia|0|||
48539007|NCT01144364|156160976|FG000|Induction Phase|Protocol Violation|1|||
48539008|NCT01144364|156160977|FG001|Induction Phase|Protocol Violation|0|||
48539009|NCT01144364|156160978|FG002|Induction Phase|Protocol Violation|0|||
48539010|NCT01144364|156160976|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
48539011|NCT01144364|156160977|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
48539012|NCT01144364|156160978|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
48539013|NCT01144364|156160976|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
48539014|NCT01144364|156160977|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
48539015|NCT01144364|156160978|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
48539016|NCT01144364|156160976|FG000|Follow-Up/Maintenance Phase|Death|0|||
48539017|NCT01144364|156160977|FG001|Follow-Up/Maintenance Phase|Death|2|||
48539018|NCT01144364|156160978|FG002|Follow-Up/Maintenance Phase|Death|0|||
48539019|NCT01144364|156160976|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
48539020|NCT01144364|156160977|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
48606125|NCT02513550|156415502|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
48606126|NCT02513550|156415503|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
48606127|NCT02513550|156415504|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
48606128|NCT02513550|156415505|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
48606129|NCT02513550|156415500|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
48606130|NCT02513550|156415501|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
48606131|NCT02513550|156415502|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
48606132|NCT02513550|156415503|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
48606133|NCT02513550|156415504|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
48539021|NCT01144364|156160978|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
48539022|NCT01144364|156160976|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
48539023|NCT01144364|156160977|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
48539024|NCT01144364|156160978|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
48539025|NCT01144364|156160976|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
48539026|NCT01144364|156160977|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
48539027|NCT01144364|156160978|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
48539028|NCT01144364|156160976|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
48606134|NCT02513550|156415505|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
48539029|NCT01144364|156160977|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
48539030|NCT01144364|156160978|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
48539031|NCT00855803|156160979|FG000|Overall Study|Death|2|||
48539032|NCT00855803|156160979|FG000|Overall Study|Lost to Follow-up|2|||
48539033|NCT00855803|156160979|FG000|Overall Study|Technical inability to undergo procedure|2|||
48539034|NCT00855803|156160979|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
48606135|NCT02513550|156415500|FG000|Double Blind Treatment Period|Due to personal business|2|||
48606136|NCT02513550|156415501|FG001|Double Blind Treatment Period|Due to personal business|0|||
48606137|NCT02513550|156415502|FG002|Double Blind Treatment Period|Due to personal business|1|||
48606138|NCT02513550|156415503|FG003|Double Blind Treatment Period|Due to personal business|0|||
48606139|NCT02513550|156415504|FG004|Double Blind Treatment Period|Due to personal business|0|||
48606140|NCT02513550|156415505|FG005|Double Blind Treatment Period|Due to personal business|0|||
48606141|NCT02513550|156415500|FG000|Double Blind Treatment Period|Death|1|||
48606142|NCT02513550|156415501|FG001|Double Blind Treatment Period|Death|0|||
48606143|NCT02513550|156415502|FG002|Double Blind Treatment Period|Death|2|||
48606144|NCT02513550|156415503|FG003|Double Blind Treatment Period|Death|0|||
48606145|NCT02513550|156415504|FG004|Double Blind Treatment Period|Death|0|||
48606146|NCT02513550|156415505|FG005|Double Blind Treatment Period|Death|0|||
48606147|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
48606148|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
48606149|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
48606150|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48606151|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48606152|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48606153|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
48606154|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
48606155|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
48606156|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
48606157|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
48606158|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
48606159|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
48606160|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
48606161|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
48606162|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48606163|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48606164|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48606165|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
48606166|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
48606167|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
48606168|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
48606169|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
48606170|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
48606171|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
48606172|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
48606173|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
48606174|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
48606175|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
48606176|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
48539035|NCT00855803|156160979|FG000|Overall Study|Withdrawal by Subject|3|||
48539036|NCT00855803|156160979|FG000|Overall Study|Physician Decision|3|||
48539037|NCT02013375|156160982|FG000|Overall Study|Did not engraft|1|||
48539038|NCT02013375|156160982|FG000|Overall Study|Did not engraft|1|||
48539039|NCT02478320|156160986|FG000|Overall Study|Adverse Event|2|||
48539040|NCT02478320|156160987|FG001|Overall Study|Adverse Event|0|||
48539041|NCT02478320|156160986|FG000|Overall Study|Death|1|||
48539042|NCT02478320|156160987|FG001|Overall Study|Death|0|||
48539043|NCT02478320|156160986|FG000|Overall Study|Lack of Efficacy|4|||
48539044|NCT02478320|156160987|FG001|Overall Study|Lack of Efficacy|0|||
48539045|NCT02478320|156160986|FG000|Overall Study|Withdrawal by Subject|2|||
48606177|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Death|0|||
48606178|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Death|0|||
48606179|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Death|1|||
48606180|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Death|0|||
48606181|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Death|0|||
48606182|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Death|0|||
48606183|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
48606184|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
48606185|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
48606186|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
48606187|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
48539046|NCT02478320|156160987|FG001|Overall Study|Withdrawal by Subject|0|||
48539047|NCT02478320|156160986|FG000|Overall Study|Screen Failure|3|||
48539048|NCT02478320|156160987|FG001|Overall Study|Screen Failure|0|||
48539049|NCT01946191|156160988|FG000|Allocation|Did not complete orientation|1|||
48539050|NCT01946191|156160989|FG001|Allocation|Did not complete orientation|1|||
48539051|NCT01946191|156160988|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
48539052|NCT01946191|156160989|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
48539053|NCT01946191|156160988|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
48539054|NCT01946191|156160989|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
48539055|NCT01946191|156160988|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
48539056|NCT01946191|156160989|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
48539057|NCT02041091|156160991|FG000|Treatment|Adverse Event|3|||
48539058|NCT02041091|156160992|FG001|Treatment|Adverse Event|3|||
48539059|NCT02041091|156160991|FG000|Treatment|Withdrawal by Subject|2|||
48539060|NCT02041091|156160992|FG001|Treatment|Withdrawal by Subject|4|||
48539061|NCT02041091|156160991|FG000|Treatment|Physician Decision|1|||
48539062|NCT02041091|156160992|FG001|Treatment|Physician Decision|0|||
48539063|NCT02041091|156160991|FG000|Treatment|Sponsor Decision|15|||
48539064|NCT02041091|156160992|FG001|Treatment|Sponsor Decision|16|||
48539065|NCT02041091|156160991|FG000|Treatment|Lost to Follow-up|1|||
48539066|NCT02041091|156160992|FG001|Treatment|Lost to Follow-up|0|||
48539067|NCT02041091|156160991|FG000|Optional Safety Extension Period|Adverse Event|4|||
48539068|NCT02041091|156160992|FG001|Optional Safety Extension Period|Adverse Event|2|||
48539069|NCT02041091|156160991|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
48539070|NCT02041091|156160992|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
48539071|NCT02041091|156160991|FG000|Optional Safety Extension Period|Protocol Violation|2|||
48539072|NCT02041091|156160992|FG001|Optional Safety Extension Period|Protocol Violation|0|||
48539073|NCT02041091|156160991|FG000|Optional Safety Extension Period|Physician Decision|2|||
48539074|NCT02041091|156160992|FG001|Optional Safety Extension Period|Physician Decision|1|||
48539075|NCT02041091|156160991|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
48539076|NCT02041091|156160992|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
48539077|NCT02041091|156160991|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
48539078|NCT02041091|156160992|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
48539079|NCT01855074|156160993|FG000|Overall Study|Adverse Event|1|||
48539080|NCT01855074|156160993|FG000|Overall Study|Lost to Follow-up|4|||
48539081|NCT01855074|156160993|FG000|Overall Study|Withdrawal by Subject|8|||
48539082|NCT01855074|156160993|FG000|Overall Study|Started but not treated|1|||
48539083|NCT02991430|156160996|FG000|Treatment Period 1|Adverse Event|1|||
48539084|NCT02991430|156160997|FG001|Treatment Period 1|Adverse Event|0|||
48539085|NCT02991430|156160998|FG002|Treatment Period 1|Adverse Event|2|||
48539086|NCT02991430|156160996|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48539087|NCT02991430|156160997|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48539088|NCT02991430|156160998|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48539089|NCT02991430|156160996|FG000|Treatment Period 2|Study Termination|6|||
48539090|NCT02991430|156160997|FG001|Treatment Period 2|Study Termination|3|||
48539091|NCT02991430|156160998|FG002|Treatment Period 2|Study Termination|3|||
48539092|NCT02991430|156160996|FG000|Treatment Period 2|Lost to Follow-up|0|||
48539093|NCT02991430|156160997|FG001|Treatment Period 2|Lost to Follow-up|0|||
48539094|NCT02991430|156160998|FG002|Treatment Period 2|Lost to Follow-up|1|||
48539095|NCT02991430|156160996|FG000|Post-treatment Observation Period|Study Termination|3|||
48539096|NCT02991430|156160997|FG001|Post-treatment Observation Period|Study Termination|6|||
48539097|NCT02991430|156160998|FG002|Post-treatment Observation Period|Study Termination|5|||
48539098|NCT03407430|156161000|FG000|Washout|Protocol Violation|1|||
48539099|NCT03407430|156161001|FG001|Washout|Protocol Violation|0|||
48539100|NCT00891839|156161002|FG000|Overall Study|Adverse Event|2|||
48539101|NCT00891839|156161002|FG000|Overall Study|Withdrawal by Subject|2|||
48539102|NCT00891839|156161002|FG000|Overall Study|Disease progression|3|||
48539103|NCT01150890|156161005|FG000|Overall Study|Other|0|||
48539104|NCT01150890|156161006|FG001|Overall Study|Other|1|||
48539105|NCT01150890|156161007|FG002|Overall Study|Other|0|||
48539106|NCT01150890|156161008|FG003|Overall Study|Other|2|||
48539107|NCT01150890|156161005|FG000|Overall Study|Pregnancy|0|||
48539108|NCT01150890|156161006|FG001|Overall Study|Pregnancy|0|||
48539109|NCT01150890|156161007|FG002|Overall Study|Pregnancy|0|||
48539110|NCT01150890|156161008|FG003|Overall Study|Pregnancy|1|||
48539111|NCT01150890|156161005|FG000|Overall Study|Administrative Decision|4|||
48606188|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
48539112|NCT01150890|156161006|FG001|Overall Study|Administrative Decision|4|||
48539113|NCT01150890|156161007|FG002|Overall Study|Administrative Decision|5|||
48539114|NCT01150890|156161008|FG003|Overall Study|Administrative Decision|6|||
48539115|NCT01150890|156161005|FG000|Overall Study|Ineligibility determined|0|||
48539116|NCT01150890|156161006|FG001|Overall Study|Ineligibility determined|1|||
48539117|NCT01150890|156161007|FG002|Overall Study|Ineligibility determined|0|||
48539118|NCT01150890|156161008|FG003|Overall Study|Ineligibility determined|0|||
48539119|NCT01150890|156161005|FG000|Overall Study|Adverse Event|0|||
48539120|NCT01150890|156161006|FG001|Overall Study|Adverse Event|0|||
48539121|NCT01150890|156161007|FG002|Overall Study|Adverse Event|2|||
48539122|NCT01150890|156161008|FG003|Overall Study|Adverse Event|0|||
48539123|NCT01150890|156161005|FG000|Overall Study|Withdrawal by Subject|0|||
48539124|NCT01150890|156161006|FG001|Overall Study|Withdrawal by Subject|0|||
48539125|NCT01150890|156161007|FG002|Overall Study|Withdrawal by Subject|2|||
48539126|NCT01150890|156161008|FG003|Overall Study|Withdrawal by Subject|1|||
48539127|NCT01150890|156161005|FG000|Overall Study|Disease progression|0|||
48539128|NCT01150890|156161006|FG001|Overall Study|Disease progression|7|||
48539129|NCT01150890|156161007|FG002|Overall Study|Disease progression|3|||
48539130|NCT01150890|156161008|FG003|Overall Study|Disease progression|7|||
48539131|NCT00123955|156161011|FG000|Overall Study|Adverse Event|1|||
48539132|NCT00123955|156161012|FG001|Overall Study|Adverse Event|0|||
48539133|NCT00123955|156161011|FG000|Overall Study|Withdrawal by Subject|4|||
48539134|NCT00123955|156161012|FG001|Overall Study|Withdrawal by Subject|3|||
48539135|NCT00123955|156161011|FG000|Overall Study|Death|0|||
48539136|NCT00123955|156161012|FG001|Overall Study|Death|1|||
48539137|NCT01172821|156161013|FG000|Overall Study|Adverse Event|5|||
48539138|NCT01172821|156161014|FG001|Overall Study|Adverse Event|2|||
48539139|NCT01172821|156161015|FG002|Overall Study|Adverse Event|2|||
48539140|NCT01172821|156161016|FG003|Overall Study|Adverse Event|7|||
48539141|NCT01172821|156161013|FG000|Overall Study|Protocol Violation|0|||
48539142|NCT01172821|156161014|FG001|Overall Study|Protocol Violation|2|||
48539143|NCT01172821|156161015|FG002|Overall Study|Protocol Violation|1|||
48539144|NCT01172821|156161016|FG003|Overall Study|Protocol Violation|2|||
48539145|NCT01172821|156161013|FG000|Overall Study|Lost to Follow-up|4|||
48539146|NCT01172821|156161014|FG001|Overall Study|Lost to Follow-up|1|||
48539147|NCT01172821|156161015|FG002|Overall Study|Lost to Follow-up|2|||
48539148|NCT01172821|156161016|FG003|Overall Study|Lost to Follow-up|2|||
48539149|NCT01172821|156161013|FG000|Overall Study|Withdrawal by Subject|2|||
48539150|NCT01172821|156161014|FG001|Overall Study|Withdrawal by Subject|3|||
48539151|NCT01172821|156161015|FG002|Overall Study|Withdrawal by Subject|3|||
48539152|NCT01172821|156161016|FG003|Overall Study|Withdrawal by Subject|3|||
48539153|NCT01172821|156161013|FG000|Overall Study|Other|3|||
48539154|NCT01172821|156161014|FG001|Overall Study|Other|4|||
48539155|NCT01172821|156161015|FG002|Overall Study|Other|5|||
48539156|NCT01172821|156161016|FG003|Overall Study|Other|3|||
48539157|NCT04223778|156161019|FG000|Overall Study|Ongoing|322|||
48539158|NCT04223778|156161020|FG001|Overall Study|Ongoing|326|||
48539159|NCT04223778|156161019|FG000|Overall Study|Death|0|||
48539160|NCT04223778|156161020|FG001|Overall Study|Death|1|||
48539161|NCT04223778|156161019|FG000|Overall Study|Lost to Follow-up|1|||
48539162|NCT04223778|156161020|FG001|Overall Study|Lost to Follow-up|5|||
48539163|NCT04223778|156161019|FG000|Overall Study|Physician Decision|3|||
48539164|NCT04223778|156161020|FG001|Overall Study|Physician Decision|1|||
48539165|NCT04223778|156161019|FG000|Overall Study|Withdrawal by Subject|10|||
48539166|NCT04223778|156161020|FG001|Overall Study|Withdrawal by Subject|1|||
48539167|NCT04223778|156161019|FG000|Overall Study|Lack of Efficacy|0|||
48539168|NCT04223778|156161020|FG001|Overall Study|Lack of Efficacy|2|||
48539169|NCT02091141|156163799|FG000|Overall Study|Death|280|||
48539170|NCT02091141|156163800|FG001|Overall Study|Death|118|||
48539171|NCT02091141|156163801|FG002|Overall Study|Death|46|||
48539172|NCT02091141|156163802|FG003|Overall Study|Death|13|||
48539173|NCT02091141|156163803|FG004|Overall Study|Death|31|||
48539174|NCT02091141|156163804|FG005|Overall Study|Death|16|||
48539175|NCT02091141|156163805|FG006|Overall Study|Death|12|||
48539176|NCT02091141|156163799|FG000|Overall Study|Withdrawal by Subject|21|||
48539177|NCT02091141|156163800|FG001|Overall Study|Withdrawal by Subject|13|||
48539178|NCT02091141|156163801|FG002|Overall Study|Withdrawal by Subject|3|||
48539179|NCT02091141|156163802|FG003|Overall Study|Withdrawal by Subject|2|||
48539180|NCT02091141|156163803|FG004|Overall Study|Withdrawal by Subject|2|||
48539181|NCT02091141|156163804|FG005|Overall Study|Withdrawal by Subject|3|||
48539182|NCT02091141|156163805|FG006|Overall Study|Withdrawal by Subject|0|||
48539183|NCT02091141|156163799|FG000|Overall Study|Lost to Follow-up|21|||
48539184|NCT02091141|156163800|FG001|Overall Study|Lost to Follow-up|5|||
48539185|NCT02091141|156163801|FG002|Overall Study|Lost to Follow-up|1|||
48539186|NCT02091141|156163802|FG003|Overall Study|Lost to Follow-up|0|||
48539187|NCT02091141|156163803|FG004|Overall Study|Lost to Follow-up|1|||
48539188|NCT02091141|156163804|FG005|Overall Study|Lost to Follow-up|2|||
48539189|NCT02091141|156163805|FG006|Overall Study|Lost to Follow-up|0|||
48539190|NCT02091141|156163799|FG000|Overall Study|Reason Not Specified|6|||
48539191|NCT02091141|156163800|FG001|Overall Study|Reason Not Specified|5|||
48539192|NCT02091141|156163801|FG002|Overall Study|Reason Not Specified|2|||
48539193|NCT02091141|156163802|FG003|Overall Study|Reason Not Specified|0|||
48539194|NCT02091141|156163803|FG004|Overall Study|Reason Not Specified|0|||
48539195|NCT02091141|156163804|FG005|Overall Study|Reason Not Specified|0|||
48539196|NCT02091141|156163805|FG006|Overall Study|Reason Not Specified|1|||
48539197|NCT02091141|156163799|FG000|Overall Study|Study Ended by Sponsor|1|||
48539198|NCT02091141|156163800|FG001|Overall Study|Study Ended by Sponsor|9|||
48539199|NCT02091141|156163801|FG002|Overall Study|Study Ended by Sponsor|0|||
48539200|NCT02091141|156163802|FG003|Overall Study|Study Ended by Sponsor|0|||
48539201|NCT02091141|156163803|FG004|Overall Study|Study Ended by Sponsor|0|||
48539202|NCT02091141|156163804|FG005|Overall Study|Study Ended by Sponsor|0|||
48539203|NCT02091141|156163805|FG006|Overall Study|Study Ended by Sponsor|0|||
48539204|NCT02091141|156163799|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
48539205|NCT02091141|156163800|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
48539206|NCT02091141|156163801|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
48539207|NCT02091141|156163802|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
48539208|NCT02091141|156163803|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
48539209|NCT02091141|156163804|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
48539210|NCT02091141|156163805|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
48539211|NCT02246439|156163806|FG000|Overall Study|Adverse Event|3|||
48539212|NCT02246439|156163807|FG001|Overall Study|Adverse Event|0|||
48539213|NCT02246439|156163806|FG000|Overall Study|Lost to Follow-up|7|||
48539214|NCT02246439|156163807|FG001|Overall Study|Lost to Follow-up|5|||
48539215|NCT02246439|156163806|FG000|Overall Study|Protocol Violation|0|||
48539216|NCT02246439|156163807|FG001|Overall Study|Protocol Violation|2|||
48539217|NCT02246439|156163806|FG000|Overall Study|Physician Decision|0|||
48539218|NCT02246439|156163807|FG001|Overall Study|Physician Decision|1|||
48606189|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
48606190|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
48606191|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
48606192|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
48606193|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
48606194|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
48606195|NCT02513550|156415500|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
48606196|NCT02513550|156415501|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
48606197|NCT02513550|156415502|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
48606198|NCT02513550|156415503|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
48606199|NCT02513550|156415504|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
48606200|NCT02513550|156415505|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
48606201|NCT00888654|156415506|FG000|Overall Study|Problems swallowing oral meds.|1|||
48606202|NCT00888654|156415506|FG000|Overall Study|Not enough oral meds before surgery|3|||
48606203|NCT00888654|156415506|FG000|Overall Study|Surgery aborted|2|||
48606204|NCT00888654|156415506|FG000|Overall Study|Withdrawal by Subject|1|||
48606205|NCT00888654|156415506|FG000|Overall Study|Inelig. due to contraindication of med|1|||
48606206|NCT00888654|156415506|FG000|Overall Study|Change in surg date|1|||
48606207|NCT00888654|156415506|FG000|Overall Study|Stopped meds due to headaches|1|||
48606208|NCT02674516|156415508|FG000|Overall Study|Lost to Follow-up|3|||
48606209|NCT02674516|156415509|FG001|Overall Study|Lost to Follow-up|0|||
48606210|NCT02674516|156415508|FG000|Overall Study|Protocol Violation|0|||
48606211|NCT02674516|156415509|FG001|Overall Study|Protocol Violation|4|||
48606212|NCT02674516|156415508|FG000|Overall Study|Knowledge of study hypothesis|1|||
48606213|NCT02674516|156415509|FG001|Overall Study|Knowledge of study hypothesis|0|||
48606214|NCT04494646|156415510|FG000|Overall Study|Adverse Event|0|||
48606215|NCT04494646|156415511|FG001|Overall Study|Adverse Event|1|||
48606216|NCT04494646|156415510|FG000|Overall Study|Withdrawal by Subject|0|||
48606217|NCT04494646|156415511|FG001|Overall Study|Withdrawal by Subject|1|||
48606218|NCT03504917|156415512|FG000|Blinded Treatment Period|Protocol Violation|1|||
48606219|NCT03504917|156415513|FG001|Blinded Treatment Period|Protocol Violation|0|||
48606220|NCT03504917|156415512|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
48606221|NCT03504917|156415513|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
48606222|NCT03504917|156415512|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
48606223|NCT03504917|156415513|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
48606224|NCT03504917|156415512|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
48606225|NCT03504917|156415513|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
48606226|NCT03504917|156415512|FG000|Blinded Treatment Period|Adverse Event|4|||
48606227|NCT03504917|156415513|FG001|Blinded Treatment Period|Adverse Event|4|||
48606228|NCT03504917|156415512|FG000|Blinded Treatment Period|Physician Decision|1|||
48606229|NCT03504917|156415513|FG001|Blinded Treatment Period|Physician Decision|0|||
48539219|NCT02246439|156163806|FG000|Overall Study|Unkonwn|1|||
48539220|NCT02246439|156163807|FG001|Overall Study|Unkonwn|3|||
48539221|NCT02246439|156163806|FG000|Overall Study|Withdrawal by Subject|1|||
48539222|NCT02246439|156163807|FG001|Overall Study|Withdrawal by Subject|0|||
48539223|NCT03439852|156163810|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
48539224|NCT03439852|156163811|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
48539225|NCT03439852|156163810|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
48539226|NCT03439852|156163811|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
48539227|NCT03439852|156163810|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
48539228|NCT03439852|156163811|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
48539229|NCT04556552|156163812|FG000|Overall Study|Lost to Follow-up|1|||
48539230|NCT04556552|156163813|FG001|Overall Study|Lost to Follow-up|0|||
48539231|NCT04556552|156163812|FG000|Overall Study|Claustrophobia|0|||
48539232|NCT04556552|156163813|FG001|Overall Study|Claustrophobia|1|||
48539233|NCT04556552|156163812|FG000|Overall Study|Inability to continue|0|||
48539234|NCT04556552|156163813|FG001|Overall Study|Inability to continue|1|||
48539235|NCT04551911|156163814|FG000|Overall Study|Lost to Follow-up|2|||
48606230|NCT03504917|156415512|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
48606231|NCT03504917|156415513|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
48606232|NCT03504917|156415512|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
48606233|NCT03504917|156415513|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
48606234|NCT03504917|156415512|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
48606235|NCT03504917|156415513|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
48606236|NCT03504917|156415512|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
48606237|NCT03504917|156415513|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
48606238|NCT03504917|156415512|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
48606239|NCT03504917|156415513|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
48606240|NCT03504917|156415512|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
48606241|NCT03504917|156415513|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
48606242|NCT03504917|156415512|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
48606243|NCT03504917|156415513|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
48606244|NCT03504917|156415512|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
48606245|NCT03504917|156415513|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
48606246|NCT03504917|156415512|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
48606247|NCT03504917|156415513|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
48606248|NCT03504917|156415512|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
48606249|NCT03504917|156415513|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
48606250|NCT00321763|156415514|FG000|Overall Study|Adverse Event|1|||
48606251|NCT00321763|156415515|FG001|Overall Study|Adverse Event|1|||
48606252|NCT00321763|156415516|FG002|Overall Study|Adverse Event|0|||
48606253|NCT00321763|156415517|FG003|Overall Study|Adverse Event|1|||
48606254|NCT00321763|156415514|FG000|Overall Study|Withdrawal by Subject|2|||
48606255|NCT00321763|156415515|FG001|Overall Study|Withdrawal by Subject|0|||
48606256|NCT00321763|156415516|FG002|Overall Study|Withdrawal by Subject|1|||
48606257|NCT00321763|156415517|FG003|Overall Study|Withdrawal by Subject|0|||
48606258|NCT00321763|156415514|FG000|Overall Study|Lost to Follow-up|3|||
48606259|NCT00321763|156415515|FG001|Overall Study|Lost to Follow-up|1|||
48606260|NCT00321763|156415516|FG002|Overall Study|Lost to Follow-up|5|||
48606261|NCT00321763|156415517|FG003|Overall Study|Lost to Follow-up|4|||
48606262|NCT03863353|156415525|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
48606263|NCT03863353|156415526|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
48606264|NCT02495389|156415533|FG000|Overall Study|Withdrawal by Subject|40|||
48606265|NCT04079790|156415536|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
48606266|NCT04079790|156415537|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
48606267|NCT04079790|156415538|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
48606268|NCT04079790|156415539|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
48606269|NCT04079790|156415536|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
48606270|NCT04079790|156415537|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
48539236|NCT04551911|156163815|FG001|Overall Study|Lost to Follow-up|1|||
48539237|NCT04551911|156163814|FG000|Overall Study|Withdrawal by Subject|10|||
48539238|NCT04551911|156163815|FG001|Overall Study|Withdrawal by Subject|10|||
48539239|NCT04551911|156163814|FG000|Overall Study|Did not receive the study drug|3|||
48539240|NCT04551911|156163815|FG001|Overall Study|Did not receive the study drug|4|||
48606271|NCT04079790|156415538|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
48606272|NCT04079790|156415539|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
48606273|NCT04079790|156415536|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
48606274|NCT04079790|156415537|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
48539241|NCT01553279|156163816|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
48539242|NCT01553279|156163817|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
48539243|NCT01553279|156163816|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
48539244|NCT01553279|156163817|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
48606275|NCT04079790|156415538|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
48606276|NCT04079790|156415539|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
48606277|NCT01253161|156415540|FG000|Overall Study|Adverse Event|1|||
48606278|NCT01924533|156415541|FG000|Overall Study|Death|181|||
48606279|NCT01924533|156415542|FG001|Overall Study|Death|200|||
48606280|NCT01924533|156415541|FG000|Overall Study|Lost to Follow-up|0|||
48606281|NCT01924533|156415542|FG001|Overall Study|Lost to Follow-up|1|||
48606282|NCT01924533|156415541|FG000|Overall Study|Withdrawal by Subject|7|||
48606283|NCT01924533|156415542|FG001|Overall Study|Withdrawal by Subject|3|||
48606284|NCT01924533|156415541|FG000|Overall Study|Other Eligibility criteria|1|||
48606285|NCT01924533|156415542|FG001|Overall Study|Other Eligibility criteria|1|||
48606286|NCT05002972|156415546|FG000|Overall Study|Withdrawal by Subject|2|||
48606287|NCT00427908|156415547|FG000|Primary Phase|Lost to Follow-up|4|||
48606288|NCT00427908|156415548|FG001|Primary Phase|Lost to Follow-up|0|||
48606289|NCT00427908|156415549|FG002|Primary Phase|Lost to Follow-up|2|||
48606290|NCT00427908|156415550|FG003|Primary Phase|Lost to Follow-up|0|||
48606291|NCT00427908|156415547|FG000|Primary Phase|Withdrawal by Subject|1|||
48606292|NCT00427908|156415548|FG001|Primary Phase|Withdrawal by Subject|2|||
48606293|NCT00427908|156415549|FG002|Primary Phase|Withdrawal by Subject|1|||
48606294|NCT00427908|156415550|FG003|Primary Phase|Withdrawal by Subject|0|||
48606295|NCT00427908|156415547|FG000|Primary Phase|Adverse Event|0|||
48606296|NCT00427908|156415548|FG001|Primary Phase|Adverse Event|1|||
48606297|NCT00427908|156415549|FG002|Primary Phase|Adverse Event|0|||
48606298|NCT00427908|156415550|FG003|Primary Phase|Adverse Event|0|||
48606299|NCT03040726|156415553|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
48606300|NCT03040726|156415554|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
48606301|NCT03040726|156415553|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
48606302|NCT03040726|156415554|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
48606303|NCT03040726|156415553|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
48606304|NCT03040726|156415554|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
48606305|NCT03040726|156415553|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
48606306|NCT03040726|156415554|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
48606307|NCT03040726|156415553|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
48606308|NCT03040726|156415554|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
48606309|NCT03805841|156415555|FG000|Overall Study|Clinical Progression|2|||
48606310|NCT03805841|156415556|FG001|Overall Study|Clinical Progression|0|||
48606311|NCT03805841|156415557|FG002|Overall Study|Clinical Progression|0|||
48606312|NCT03805841|156415555|FG000|Overall Study|Death|0|||
48606313|NCT03805841|156415556|FG001|Overall Study|Death|3|||
48606314|NCT03805841|156415557|FG002|Overall Study|Death|1|||
48606315|NCT03805841|156415555|FG000|Overall Study|Lost to Follow-up|0|||
48606316|NCT03805841|156415556|FG001|Overall Study|Lost to Follow-up|0|||
48606317|NCT03805841|156415557|FG002|Overall Study|Lost to Follow-up|1|||
48606318|NCT03805841|156415555|FG000|Overall Study|Withdrawal by Subject|2|||
48606319|NCT03805841|156415556|FG001|Overall Study|Withdrawal by Subject|3|||
48606320|NCT03805841|156415557|FG002|Overall Study|Withdrawal by Subject|0|||
48606321|NCT03805841|156415555|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
48606322|NCT03805841|156415556|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
48606323|NCT03805841|156415557|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
48606324|NCT00171249|156415565|FG000|Overall Study|Withdrawal by Subject|2|||
48606325|NCT00171249|156415566|FG001|Overall Study|Withdrawal by Subject|0|||
48606326|NCT00171249|156415567|FG002|Overall Study|Withdrawal by Subject|0|||
48606327|NCT00171249|156415568|FG003|Overall Study|Withdrawal by Subject|6|||
48606328|NCT00171249|156415569|FG004|Overall Study|Withdrawal by Subject|0|||
48606329|NCT00171249|156415570|FG005|Overall Study|Withdrawal by Subject|0|||
48606330|NCT00171249|156415571|FG006|Overall Study|Withdrawal by Subject|0|||
48606331|NCT00171249|156415565|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
48606332|NCT00171249|156415566|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48539245|NCT01553279|156163816|FG000|Interim Period|Withdrawal by Subject|2|||
48539246|NCT01553279|156163817|FG001|Interim Period|Withdrawal by Subject|2|||
48539247|NCT01553279|156163816|FG000|Interim Period|Lost to Follow-up|1|||
48539248|NCT01553279|156163817|FG001|Interim Period|Lost to Follow-up|0|||
48606333|NCT00171249|156415567|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
48606334|NCT00171249|156415568|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
48606335|NCT00171249|156415569|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48606336|NCT00171249|156415570|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
48606337|NCT00171249|156415571|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
48539249|NCT01553279|156163816|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
48539250|NCT01553279|156163817|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
48539251|NCT01553279|156163816|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
48539252|NCT01553279|156163817|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
48539253|NCT01215513|156163818|FG000|Overall Study|Not completed CS42|9|||
48539254|NCT01215513|156163818|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
48539255|NCT01215513|156163818|FG000|Overall Study|Adverse event (CS42A)|2|||
48539256|NCT01215513|156163818|FG000|Overall Study|Physician decision (CS42A)|6|||
48539257|NCT01215513|156163818|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
48539258|NCT01215513|156163818|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
48539259|NCT00605865|156163826|FG000|Overall Study|Protocol Violation|115|||
48539260|NCT00380692|156163827|FG000|Study Period II - Double Blind|Adverse Event|1|||
48539261|NCT00380692|156163828|FG001|Study Period II - Double Blind|Adverse Event|0|||
48539262|NCT00380692|156163827|FG000|Study Period II - Double Blind|Protocol Violation|2|||
48539263|NCT00380692|156163828|FG001|Study Period II - Double Blind|Protocol Violation|2|||
48539264|NCT00380692|156163827|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
48539265|NCT00380692|156163828|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
48539266|NCT00380692|156163827|FG000|Study Period II - Double Blind|Physician Decision|0|||
48539267|NCT00380692|156163828|FG001|Study Period II - Double Blind|Physician Decision|1|||
48539268|NCT00380692|156163827|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
48539269|NCT00380692|156163828|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
48539270|NCT00380692|156163827|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
48539271|NCT00380692|156163828|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
48539272|NCT00380692|156163827|FG000|Study Period III - Open Label|Adverse Event|5|||
48539273|NCT00380692|156163828|FG001|Study Period III - Open Label|Adverse Event|3|||
48539274|NCT00380692|156163827|FG000|Study Period III - Open Label|Protocol Violation|0|||
48539275|NCT00380692|156163828|FG001|Study Period III - Open Label|Protocol Violation|0|||
48539276|NCT00380692|156163827|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
48539277|NCT00380692|156163828|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
48539278|NCT00380692|156163827|FG000|Study Period III - Open Label|Physician Decision|0|||
48539279|NCT00380692|156163828|FG001|Study Period III - Open Label|Physician Decision|3|||
48539280|NCT00380692|156163827|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
48539281|NCT00380692|156163828|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
48539282|NCT00380692|156163827|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
48539283|NCT00380692|156163828|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
48539284|NCT01195272|156163829|FG000|Overall Study|Adverse Event|1|||
48539285|NCT01195272|156163829|FG000|Overall Study|Lack of Efficacy|3|||
48539286|NCT01769339|156163830|FG000|Overall Study|Lost to Follow-up|42|||
48539287|NCT01769339|156163830|FG000|Overall Study|Adverse Event|1|||
48539288|NCT00704730|156163831|FG000|Overall Study|Adverse Event|35|||
48539289|NCT00704730|156163832|FG001|Overall Study|Adverse Event|9|||
48539290|NCT00704730|156163831|FG000|Overall Study|Death|11|||
48539291|NCT00704730|156163832|FG001|Overall Study|Death|5|||
48539292|NCT00704730|156163831|FG000|Overall Study|Physician Decision|2|||
48539293|NCT00704730|156163832|FG001|Overall Study|Physician Decision|0|||
48539294|NCT00704730|156163831|FG000|Overall Study|Did not receive drug|5|||
48539295|NCT00704730|156163832|FG001|Overall Study|Did not receive drug|2|||
48539296|NCT00704730|156163831|FG000|Overall Study|Disease progression per PI|58|||
48539297|NCT00704730|156163832|FG001|Overall Study|Disease progression per PI|67|||
48539298|NCT00704730|156163831|FG000|Overall Study|data unavailable|1|||
48539299|NCT00704730|156163832|FG001|Overall Study|data unavailable|0|||
48539300|NCT00704730|156163831|FG000|Overall Study|Withdrawal by Subject|9|||
48539301|NCT00704730|156163832|FG001|Overall Study|Withdrawal by Subject|13|||
48539302|NCT03955471|156163835|FG000|Overall Study|Death|22|||
48539303|NCT03955471|156163835|FG000|Overall Study|Lost to Follow-up|1|||
48539304|NCT03955471|156163835|FG000|Overall Study|Withdrawal by Subject|6|||
48539305|NCT03955471|156163835|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
48539306|NCT00706095|156163841|FG000|Overall Study|Progressive Disease|4|||
48539307|NCT00706095|156163842|FG001|Overall Study|Progressive Disease|5|||
48539308|NCT00706095|156163843|FG002|Overall Study|Progressive Disease|3|||
48539309|NCT00706095|156163841|FG000|Overall Study|Clinical Progression|1|||
48539310|NCT00706095|156163842|FG001|Overall Study|Clinical Progression|2|||
48539311|NCT00706095|156163843|FG002|Overall Study|Clinical Progression|2|||
48539312|NCT00706095|156163841|FG000|Overall Study|Withdrawal by Subject|1|||
48539313|NCT00706095|156163842|FG001|Overall Study|Withdrawal by Subject|0|||
48539314|NCT00706095|156163843|FG002|Overall Study|Withdrawal by Subject|0|||
48539315|NCT01700049|156163848|FG000|Overall Study|Withdrawal by Subject|1|||
48539316|NCT02791893|156163849|FG000|Blinded Phase|Lost to Follow-up|2|||
48539317|NCT02791893|156163850|FG001|Blinded Phase|Lost to Follow-up|2|||
48539318|NCT02791893|156163849|FG000|Blinded Phase|Withdrawal by Subject|1|||
48539319|NCT02791893|156163850|FG001|Blinded Phase|Withdrawal by Subject|2|||
48539320|NCT02791893|156163849|FG000|Open Label Phase|Lost to Follow-up|3|||
48539321|NCT02791893|156163850|FG001|Open Label Phase|Lost to Follow-up|0|||
48539322|NCT02791893|156163849|FG000|Open Label Phase|Withdrawal by Subject|0|||
48539323|NCT02791893|156163850|FG001|Open Label Phase|Withdrawal by Subject|2|||
48539324|NCT01859130|156163853|FG000|Overall Study|Death|4|||
48539325|NCT01859130|156163853|FG000|Overall Study|Lost to Follow-up|16|||
48539326|NCT01859130|156163853|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
48539327|NCT01859130|156163853|FG000|Overall Study|Physician Decision|6|||
48539328|NCT01859130|156163853|FG000|Overall Study|Withdrawal by Subject|17|||
48539329|NCT01859130|156163853|FG000|Overall Study|Adverse Event|11|||
48539330|NCT01388166|156163854|FG000|Overall Study|Adverse Event|16|||
48539331|NCT01388166|156163854|FG000|Overall Study|Lost to Follow-up|30|||
48539332|NCT01388166|156163854|FG000|Overall Study|Others than specified above|13|||
48539333|NCT03438396|156163855|FG000|Overall Study|Reason Not Specified|9|||
48539334|NCT03438396|156163855|FG000|Overall Study|Withdrawal by Subject|5|||
48606338|NCT00171249|156415565|FG000|Overall Study|Death|7|||
48606339|NCT00171249|156415566|FG001|Overall Study|Death|1|||
48606340|NCT00171249|156415567|FG002|Overall Study|Death|0|||
48606341|NCT00171249|156415568|FG003|Overall Study|Death|4|||
48539335|NCT03438396|156163855|FG000|Overall Study|Lost to Follow-up|2|||
48539336|NCT03438396|156163855|FG000|Overall Study|Death|85|||
48539337|NCT03438396|156163855|FG000|Overall Study|Not treated|1|||
48539338|NCT00136318|156163856|FG000|Overall Study|Adverse Event|5|||
48606342|NCT00171249|156415569|FG004|Overall Study|Death|0|||
48606343|NCT00171249|156415570|FG005|Overall Study|Death|3|||
48539339|NCT00136318|156163857|FG001|Overall Study|Adverse Event|5|||
48539340|NCT00136318|156163856|FG000|Overall Study|Withdrawal by Subject|2|||
48539341|NCT00136318|156163857|FG001|Overall Study|Withdrawal by Subject|2|||
48539342|NCT01744093|156163858|FG000|Overall Study|Withdrawal by Subject|6|||
48539343|NCT01744093|156163859|FG001|Overall Study|Withdrawal by Subject|1|||
48539344|NCT01570283|156163860|FG000|Cohort 1: Dose Level 1|Death|0|||
48539345|NCT01570283|156163861|FG001|Cohort 1: Dose Level 1|Death|1|||
48539346|NCT01570283|156163862|FG002|Cohort 1: Dose Level 1|Death|0|||
48539347|NCT01570283|156163863|FG003|Cohort 1: Dose Level 1|Death|0|||
48539348|NCT01570283|156163864|FG004|Cohort 1: Dose Level 1|Death|0|||
48539349|NCT01570283|156163865|FG005|Cohort 1: Dose Level 1|Death|0|||
48539350|NCT01570283|156163860|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
48539351|NCT01570283|156163861|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
48539352|NCT01570283|156163862|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
48539353|NCT01570283|156163863|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
48539354|NCT01570283|156163864|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
48539355|NCT01570283|156163865|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
48539356|NCT01570283|156163860|FG000|Cohort 2: Dose Level 2|Death|0|||
48539357|NCT01570283|156163861|FG001|Cohort 2: Dose Level 2|Death|0|||
48539358|NCT01570283|156163862|FG002|Cohort 2: Dose Level 2|Death|1|||
48539359|NCT01570283|156163863|FG003|Cohort 2: Dose Level 2|Death|0|||
48539360|NCT01570283|156163864|FG004|Cohort 2: Dose Level 2|Death|0|||
48539361|NCT01570283|156163865|FG005|Cohort 2: Dose Level 2|Death|0|||
48539362|NCT01570283|156163860|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
48539363|NCT01570283|156163861|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
48539364|NCT01570283|156163862|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
48539365|NCT01570283|156163863|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
48539366|NCT01570283|156163864|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
48539367|NCT01570283|156163865|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
48539368|NCT01570283|156163860|FG000|Cohort 3: Dose Level 3|Death|0|||
48539369|NCT01570283|156163861|FG001|Cohort 3: Dose Level 3|Death|0|||
48539370|NCT01570283|156163862|FG002|Cohort 3: Dose Level 3|Death|0|||
48539371|NCT01570283|156163863|FG003|Cohort 3: Dose Level 3|Death|0|||
48539372|NCT01570283|156163864|FG004|Cohort 3: Dose Level 3|Death|0|||
48539373|NCT01570283|156163865|FG005|Cohort 3: Dose Level 3|Death|1|||
48539374|NCT01570283|156163860|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
48539375|NCT01570283|156163861|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
48539376|NCT01570283|156163862|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
48539377|NCT01570283|156163863|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
48539378|NCT01570283|156163864|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
48539379|NCT01570283|156163865|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
48539380|NCT02006628|156163866|FG000|Overall Study|Adverse Event|1|||
48539381|NCT02006628|156163867|FG001|Overall Study|Adverse Event|1|||
48539382|NCT02006628|156163866|FG000|Overall Study|Withdrawal by Subject|2|||
48539383|NCT02006628|156163867|FG001|Overall Study|Withdrawal by Subject|1|||
48539384|NCT00841906|156163870|FG000|Overall Study|Withdrawal by Subject|2|||
48539385|NCT00841906|156163871|FG001|Overall Study|Withdrawal by Subject|0|||
48539386|NCT02072148|156163872|FG000|Overall Study|withdrew prior to surgery|23|||
48539387|NCT02072148|156163873|FG001|Overall Study|withdrew prior to surgery|0|||
48539388|NCT02072148|156163874|FG002|Overall Study|withdrew prior to surgery|0|||
48539389|NCT02072148|156163872|FG000|Overall Study|Death|0|||
48539390|NCT02072148|156163873|FG001|Overall Study|Death|0|||
48539391|NCT02072148|156163874|FG002|Overall Study|Death|1|||
48539392|NCT02072148|156163872|FG000|Overall Study|Withdrawal by Subject|0|||
48539393|NCT02072148|156163873|FG001|Overall Study|Withdrawal by Subject|13|||
48539394|NCT02072148|156163874|FG002|Overall Study|Withdrawal by Subject|12|||
48539395|NCT00430495|156163878|FG000|Overall Study|Adverse Event|2|||
48539396|NCT00430495|156163879|FG001|Overall Study|Adverse Event|3|||
48539397|NCT00430495|156163880|FG002|Overall Study|Adverse Event|2|||
48539398|NCT00430495|156163881|FG003|Overall Study|Adverse Event|0|||
48539399|NCT00430495|156163878|FG000|Overall Study|Death|0|||
48539400|NCT00430495|156163879|FG001|Overall Study|Death|0|||
48539401|NCT00430495|156163880|FG002|Overall Study|Death|1|||
48539402|NCT00430495|156163881|FG003|Overall Study|Death|0|||
48539403|NCT00430495|156163878|FG000|Overall Study|Lost to Follow-up|0|||
48539404|NCT00430495|156163879|FG001|Overall Study|Lost to Follow-up|1|||
48539405|NCT00430495|156163880|FG002|Overall Study|Lost to Follow-up|4|||
48539406|NCT00430495|156163881|FG003|Overall Study|Lost to Follow-up|0|||
48539407|NCT00430495|156163878|FG000|Overall Study|Protocol Violation|1|||
48539408|NCT00430495|156163879|FG001|Overall Study|Protocol Violation|0|||
48539409|NCT00430495|156163880|FG002|Overall Study|Protocol Violation|1|||
48539410|NCT00430495|156163881|FG003|Overall Study|Protocol Violation|0|||
48539411|NCT00430495|156163878|FG000|Overall Study|Disease Progression|1|||
48539412|NCT00430495|156163879|FG001|Overall Study|Disease Progression|1|||
48539413|NCT00430495|156163880|FG002|Overall Study|Disease Progression|0|||
48539414|NCT00430495|156163881|FG003|Overall Study|Disease Progression|0|||
48539415|NCT00430495|156163878|FG000|Overall Study|Other|8|||
48539416|NCT00430495|156163879|FG001|Overall Study|Other|2|||
48539417|NCT00430495|156163880|FG002|Overall Study|Other|5|||
48539418|NCT00430495|156163881|FG003|Overall Study|Other|4|||
48539419|NCT00430495|156163878|FG000|Overall Study|Randomized but not Treated|2|||
48539420|NCT00430495|156163879|FG001|Overall Study|Randomized but not Treated|0|||
48539421|NCT00430495|156163880|FG002|Overall Study|Randomized but not Treated|0|||
48539422|NCT00430495|156163881|FG003|Overall Study|Randomized but not Treated|0|||
48539423|NCT02751359|156163886|FG000|Overall Study|Lost to Follow-up|1|||
48539424|NCT04053465|156163892|FG000|Overall Study|Withdrawal by Subject|4|||
48539425|NCT04053465|156163893|FG001|Overall Study|Withdrawal by Subject|4|||
48539426|NCT02145026|156163897|FG000|Overall Study|Adverse Event|2|||
48539427|NCT02145026|156163897|FG000|Overall Study|Death|4|||
48539428|NCT02145026|156163897|FG000|Overall Study|Withdrawal by Subject|2|||
48539429|NCT02145026|156163897|FG000|Overall Study|Physician Decision|4|||
48539430|NCT00262041|156163900|FG000|Overall Study|Withdrawal by Subject|0|||
48539431|NCT00262041|156163901|FG001|Overall Study|Withdrawal by Subject|3|||
48539432|NCT00262041|156163902|FG002|Overall Study|Withdrawal by Subject|1|||
48539433|NCT00262041|156163900|FG000|Overall Study|Lost to Follow-up|1|||
48539434|NCT00262041|156163901|FG001|Overall Study|Lost to Follow-up|1|||
48539435|NCT00262041|156163902|FG002|Overall Study|Lost to Follow-up|5|||
48539436|NCT00262041|156163900|FG000|Overall Study|Unable to classify|1|||
48539437|NCT00262041|156163901|FG001|Overall Study|Unable to classify|0|||
48539438|NCT00262041|156163902|FG002|Overall Study|Unable to classify|0|||
48539439|NCT00127036|156163904|FG000|Overall Study|Insufficient Data for Analysis|6|||
48539440|NCT00127036|156163905|FG001|Overall Study|Insufficient Data for Analysis|11|||
48539441|NCT00127036|156163904|FG000|Overall Study|Screen Failure|2|||
48539442|NCT00127036|156163905|FG001|Overall Study|Screen Failure|0|||
48539443|NCT01462318|156163908|FG000|Main Study / TP-DI Study|Other|2|||
48539444|NCT01462318|156163909|FG001|Main Study / TP-DI Study|Other|0|||
48539445|NCT01462318|156163910|FG002|Main Study / TP-DI Study|Other|0|||
48539446|NCT01462318|156163908|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
48539447|NCT01462318|156163909|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
48539448|NCT01462318|156163910|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
48539449|NCT01462318|156163908|FG000|Main Study / TP-DI Study|Adverse Event|4|||
48539450|NCT01462318|156163909|FG001|Main Study / TP-DI Study|Adverse Event|0|||
48606344|NCT00171249|156415571|FG006|Overall Study|Death|1|||
48606345|NCT00171249|156415565|FG000|Overall Study|Other|10|||
48539451|NCT01462318|156163910|FG002|Main Study / TP-DI Study|Adverse Event|0|||
48539452|NCT01462318|156163908|FG000|Extension Phase|Lost to Follow-up|0|||
48539453|NCT01462318|156163909|FG001|Extension Phase|Lost to Follow-up|0|||
48539454|NCT01462318|156163910|FG002|Extension Phase|Lost to Follow-up|1|||
48539455|NCT01462318|156163908|FG000|Extension Phase|Other|0|||
48606346|NCT00171249|156415566|FG001|Overall Study|Other|0|||
48539456|NCT01462318|156163909|FG001|Extension Phase|Other|0|||
48539457|NCT01462318|156163910|FG002|Extension Phase|Other|1|||
48539458|NCT01462318|156163908|FG000|Extension Phase|Disease Progression|0|||
48539459|NCT01462318|156163909|FG001|Extension Phase|Disease Progression|0|||
48539460|NCT01462318|156163910|FG002|Extension Phase|Disease Progression|1|||
48539461|NCT01462318|156163908|FG000|Extension Phase|Withdrawal by Subject|0|||
48539462|NCT01462318|156163909|FG001|Extension Phase|Withdrawal by Subject|0|||
48539463|NCT01462318|156163910|FG002|Extension Phase|Withdrawal by Subject|15|||
48539464|NCT01462318|156163908|FG000|Extension Phase|Investigator Decision|0|||
48539465|NCT01462318|156163909|FG001|Extension Phase|Investigator Decision|0|||
48539466|NCT01462318|156163910|FG002|Extension Phase|Investigator Decision|5|||
48539467|NCT01462318|156163908|FG000|Extension Phase|Adverse Event|0|||
48539468|NCT01462318|156163909|FG001|Extension Phase|Adverse Event|0|||
48539469|NCT01462318|156163910|FG002|Extension Phase|Adverse Event|22|||
48539470|NCT01732484|156163911|FG000|Overall Study|Death|7|||
48539471|NCT01732484|156163911|FG000|Overall Study|Lost to Follow-up|14|||
48539472|NCT01732484|156163911|FG000|Overall Study|chronical illness|5|||
48539473|NCT03827564|156163912|FG000|Overall Study|Discontinued due to Study Termination|1|||
48539474|NCT03827564|156163913|FG001|Overall Study|Discontinued due to Study Termination|0|||
48539475|NCT00270257|156163914|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
48539476|NCT00270257|156163915|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
48539477|NCT01568320|156163922|FG000|Overall Study|Death|20|||
48539478|NCT01568320|156163922|FG000|Overall Study|Lost to Follow-up|9|||
48539479|NCT01568320|156163922|FG000|Overall Study|Withdrawal by Subject|10|||
48539480|NCT01568320|156163922|FG000|Overall Study|Conversion to open repair|1|||
48539481|NCT01568320|156163922|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
48539482|NCT01621191|156163925|FG000|Overall Study|Adverse Event|9|||
48539483|NCT01621191|156163925|FG000|Overall Study|Withdrawal by Subject|8|||
48539484|NCT01621191|156163925|FG000|Overall Study|Lack of Efficacy|6|||
48539485|NCT01621191|156163925|FG000|Overall Study|Lost to Follow-up|1|||
48539486|NCT01621191|156163925|FG000|Overall Study|Site Removed From Study|1|||
48539487|NCT01550744|156163926|FG000|Open-Label|Lost to Follow-up|7|||
48539488|NCT01550744|156163927|FG001|Open-Label|Lost to Follow-up|0|||
48539489|NCT01550744|156163928|FG002|Open-Label|Lost to Follow-up|0|||
48539490|NCT01550744|156163926|FG000|Open-Label|Withdrawal by Subject|13|||
48539491|NCT01550744|156163927|FG001|Open-Label|Withdrawal by Subject|0|||
48539492|NCT01550744|156163928|FG002|Open-Label|Withdrawal by Subject|0|||
48539493|NCT01550744|156163926|FG000|Open-Label|Adverse Event|11|||
48539494|NCT01550744|156163927|FG001|Open-Label|Adverse Event|0|||
48539495|NCT01550744|156163928|FG002|Open-Label|Adverse Event|0|||
48539496|NCT01550744|156163926|FG000|Open-Label|Lack of Efficacy|4|||
48539497|NCT01550744|156163927|FG001|Open-Label|Lack of Efficacy|0|||
48539498|NCT01550744|156163928|FG002|Open-Label|Lack of Efficacy|0|||
48539499|NCT01550744|156163926|FG000|Open-Label|Protocol Violation|4|||
48539500|NCT01550744|156163927|FG001|Open-Label|Protocol Violation|0|||
48539501|NCT01550744|156163928|FG002|Open-Label|Protocol Violation|0|||
48539502|NCT01550744|156163926|FG000|Open-Label|Not all 3 study drug injections received|2|||
48539503|NCT01550744|156163927|FG001|Open-Label|Not all 3 study drug injections received|0|||
48539504|NCT01550744|156163928|FG002|Open-Label|Not all 3 study drug injections received|0|||
48539505|NCT01550744|156163926|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
48539506|NCT01550744|156163927|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
48539507|NCT01550744|156163928|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
48539508|NCT01550744|156163926|FG000|Open-Label|Other|1|||
48606347|NCT00171249|156415567|FG002|Overall Study|Other|0|||
48606348|NCT00171249|156415568|FG003|Overall Study|Other|43|||
48539509|NCT01550744|156163927|FG001|Open-Label|Other|0|||
48539510|NCT01550744|156163928|FG002|Open-Label|Other|0|||
48539511|NCT01550744|156163926|FG000|Double-Blind|Lost to Follow-up|0|||
48539512|NCT01550744|156163927|FG001|Double-Blind|Lost to Follow-up|6|||
48539513|NCT01550744|156163928|FG002|Double-Blind|Lost to Follow-up|12|||
48539514|NCT01550744|156163926|FG000|Double-Blind|Withdrawal by Subject|0|||
48539515|NCT01550744|156163927|FG001|Double-Blind|Withdrawal by Subject|2|||
48539516|NCT01550744|156163928|FG002|Double-Blind|Withdrawal by Subject|15|||
48606349|NCT00171249|156415569|FG004|Overall Study|Other|0|||
48606350|NCT00171249|156415570|FG005|Overall Study|Other|2|||
48539517|NCT01550744|156163926|FG000|Double-Blind|Adverse Event|0|||
48539518|NCT01550744|156163927|FG001|Double-Blind|Adverse Event|4|||
48539519|NCT01550744|156163928|FG002|Double-Blind|Adverse Event|15|||
48539520|NCT01550744|156163926|FG000|Double-Blind|Death|0|||
48539521|NCT01550744|156163927|FG001|Double-Blind|Death|1|||
48539522|NCT01550744|156163928|FG002|Double-Blind|Death|0|||
48539523|NCT01550744|156163926|FG000|Double-Blind|Lack of Efficacy|0|||
48539524|NCT01550744|156163927|FG001|Double-Blind|Lack of Efficacy|2|||
48539525|NCT01550744|156163928|FG002|Double-Blind|Lack of Efficacy|8|||
48539526|NCT01550744|156163926|FG000|Double-Blind|Protocol Violation|0|||
48539527|NCT01550744|156163927|FG001|Double-Blind|Protocol Violation|0|||
48539528|NCT01550744|156163928|FG002|Double-Blind|Protocol Violation|4|||
48539529|NCT01550744|156163926|FG000|Double-Blind|Pregnancy|0|||
48539530|NCT01550744|156163927|FG001|Double-Blind|Pregnancy|0|||
48539531|NCT01550744|156163928|FG002|Double-Blind|Pregnancy|3|||
48539532|NCT01550744|156163926|FG000|Double-Blind|Other|0|||
48539533|NCT01550744|156163927|FG001|Double-Blind|Other|2|||
48539534|NCT01550744|156163928|FG002|Double-Blind|Other|10|||
48539535|NCT01359644|156163929|FG000|Treatment Period|Lack of Efficacy|0|||
48539536|NCT01359644|156163930|FG001|Treatment Period|Lack of Efficacy|1|||
48606351|NCT00171249|156415571|FG006|Overall Study|Other|0|||
48606352|NCT00171249|156415565|FG000|Overall Study|No Longer Requires Study Drug|4|||
48539537|NCT01359644|156163931|FG002|Treatment Period|Lack of Efficacy|0|||
48539538|NCT01359644|156163932|FG003|Treatment Period|Lack of Efficacy|0|||
48539539|NCT01359644|156163933|FG004|Treatment Period|Lack of Efficacy|0|||
48539540|NCT01359644|156163934|FG005|Treatment Period|Lack of Efficacy|0|||
48539541|NCT01359644|156163935|FG006|Treatment Period|Lack of Efficacy|0|||
48539542|NCT01359644|156163936|FG007|Treatment Period|Lack of Efficacy|0|||
48539543|NCT01359644|156163937|FG008|Treatment Period|Lack of Efficacy|0|||
48539544|NCT01359644|156163938|FG009|Treatment Period|Lack of Efficacy|0|||
48539545|NCT01359644|156163929|FG000|Treatment Period|Adverse Event|0|||
48539546|NCT01359644|156163930|FG001|Treatment Period|Adverse Event|0|||
48539547|NCT01359644|156163931|FG002|Treatment Period|Adverse Event|1|||
48539548|NCT01359644|156163932|FG003|Treatment Period|Adverse Event|0|||
48539549|NCT01359644|156163933|FG004|Treatment Period|Adverse Event|0|||
48539550|NCT01359644|156163934|FG005|Treatment Period|Adverse Event|1|||
48539551|NCT01359644|156163935|FG006|Treatment Period|Adverse Event|0|||
48539552|NCT01359644|156163936|FG007|Treatment Period|Adverse Event|0|||
48539553|NCT01359644|156163937|FG008|Treatment Period|Adverse Event|0|||
48539554|NCT01359644|156163938|FG009|Treatment Period|Adverse Event|0|||
48539555|NCT01359644|156163929|FG000|Treatment Period|Lost to Follow-up|0|||
48539556|NCT01359644|156163930|FG001|Treatment Period|Lost to Follow-up|0|||
48539557|NCT01359644|156163931|FG002|Treatment Period|Lost to Follow-up|0|||
48539558|NCT01359644|156163932|FG003|Treatment Period|Lost to Follow-up|0|||
48539559|NCT01359644|156163933|FG004|Treatment Period|Lost to Follow-up|0|||
48539560|NCT01359644|156163934|FG005|Treatment Period|Lost to Follow-up|1|||
48539561|NCT01359644|156163935|FG006|Treatment Period|Lost to Follow-up|0|||
48539562|NCT01359644|156163936|FG007|Treatment Period|Lost to Follow-up|0|||
48539563|NCT01359644|156163937|FG008|Treatment Period|Lost to Follow-up|0|||
48539564|NCT01359644|156163938|FG009|Treatment Period|Lost to Follow-up|0|||
48539565|NCT01359644|156163929|FG000|Follow-up Period|Withdrawal by Subject|0|||
48539566|NCT01359644|156163930|FG001|Follow-up Period|Withdrawal by Subject|0|||
48539567|NCT01359644|156163931|FG002|Follow-up Period|Withdrawal by Subject|0|||
48539568|NCT01359644|156163932|FG003|Follow-up Period|Withdrawal by Subject|0|||
48539569|NCT01359644|156163933|FG004|Follow-up Period|Withdrawal by Subject|0|||
48539570|NCT01359644|156163934|FG005|Follow-up Period|Withdrawal by Subject|1|||
48539571|NCT01359644|156163935|FG006|Follow-up Period|Withdrawal by Subject|0|||
48539572|NCT01359644|156163936|FG007|Follow-up Period|Withdrawal by Subject|0|||
48539573|NCT01359644|156163937|FG008|Follow-up Period|Withdrawal by Subject|0|||
48539574|NCT01359644|156163938|FG009|Follow-up Period|Withdrawal by Subject|0|||
48539575|NCT01359644|156163929|FG000|Follow-up Period|Lost to Follow-up|0|||
48539576|NCT01359644|156163930|FG001|Follow-up Period|Lost to Follow-up|0|||
48539577|NCT01359644|156163931|FG002|Follow-up Period|Lost to Follow-up|0|||
48539578|NCT01359644|156163932|FG003|Follow-up Period|Lost to Follow-up|0|||
48539579|NCT01359644|156163933|FG004|Follow-up Period|Lost to Follow-up|0|||
48539580|NCT01359644|156163934|FG005|Follow-up Period|Lost to Follow-up|0|||
48539581|NCT01359644|156163935|FG006|Follow-up Period|Lost to Follow-up|1|||
48539582|NCT01359644|156163936|FG007|Follow-up Period|Lost to Follow-up|2|||
48539583|NCT01359644|156163937|FG008|Follow-up Period|Lost to Follow-up|0|||
48539584|NCT01359644|156163938|FG009|Follow-up Period|Lost to Follow-up|0|||
48539585|NCT03734666|156163941|FG000|Overall Study|Other|7|||
48539586|NCT03734666|156163942|FG001|Overall Study|Other|4|||
48539587|NCT03734666|156163941|FG000|Overall Study|Lost to Follow-up|12|||
48539588|NCT03734666|156163942|FG001|Overall Study|Lost to Follow-up|12|||
48539589|NCT00757848|156163943|FG000|Overall Study|Voluntary discontinuation|1|||
48539590|NCT00757848|156163944|FG001|Overall Study|Voluntary discontinuation|0|||
48539591|NCT00757848|156163943|FG000|Overall Study|Adverse Event|1|||
48539592|NCT00757848|156163944|FG001|Overall Study|Adverse Event|2|||
48539593|NCT00757848|156163943|FG000|Overall Study|Incorrect enrolment|1|||
48539594|NCT00757848|156163944|FG001|Overall Study|Incorrect enrolment|0|||
48539595|NCT00922987|156163951|FG000|Overall Study|Insufficient clinical response|1|||
48539596|NCT00922987|156163951|FG000|Overall Study|Protocol Violation|2|||
48539597|NCT00922987|156163951|FG000|Overall Study|Adverse Event|1|||
48539598|NCT01672970|156163952|FG000|Overall Study|Lack of Efficacy|12|||
48539599|NCT01672970|156163952|FG000|Overall Study|Adverse Event|18|||
48539600|NCT01672970|156163952|FG000|Overall Study|Withdrawal by Subject|2|||
48539601|NCT01672970|156163952|FG000|Overall Study|Lost to Follow-up|5|||
48539602|NCT01672970|156163952|FG000|Overall Study|Other|9|||
48539603|NCT01672970|156163952|FG000|Overall Study|Enrolled but not treated|1|||
48539604|NCT03118570|156163953|FG000|Overall Study|Adverse Event|2|||
48539605|NCT03118570|156163954|FG001|Overall Study|Adverse Event|0|||
48539606|NCT03118570|156163955|FG002|Overall Study|Adverse Event|0|||
48539607|NCT03118570|156163956|FG003|Overall Study|Adverse Event|0|||
48539608|NCT03118570|156163957|FG004|Overall Study|Adverse Event|3|||
48539609|NCT03118570|156163953|FG000|Overall Study|Withdrawal by Subject|0|||
48539610|NCT03118570|156163954|FG001|Overall Study|Withdrawal by Subject|1|||
48539611|NCT03118570|156163955|FG002|Overall Study|Withdrawal by Subject|4|||
48539612|NCT03118570|156163956|FG003|Overall Study|Withdrawal by Subject|0|||
48539613|NCT03118570|156163957|FG004|Overall Study|Withdrawal by Subject|1|||
48539614|NCT03118570|156163953|FG000|Overall Study|Lost to Follow-up|2|||
48606353|NCT00171249|156415566|FG001|Overall Study|No Longer Requires Study Drug|0|||
48606354|NCT00171249|156415567|FG002|Overall Study|No Longer Requires Study Drug|0|||
48606355|NCT00171249|156415568|FG003|Overall Study|No Longer Requires Study Drug|3|||
48606356|NCT00171249|156415569|FG004|Overall Study|No Longer Requires Study Drug|0|||
48606357|NCT00171249|156415570|FG005|Overall Study|No Longer Requires Study Drug|5|||
48606358|NCT00171249|156415571|FG006|Overall Study|No Longer Requires Study Drug|0|||
48606359|NCT00171249|156415565|FG000|Overall Study|Administrative Problems|1|||
48606360|NCT00171249|156415566|FG001|Overall Study|Administrative Problems|0|||
48606361|NCT00171249|156415567|FG002|Overall Study|Administrative Problems|0|||
48606362|NCT00171249|156415568|FG003|Overall Study|Administrative Problems|2|||
48606363|NCT00171249|156415569|FG004|Overall Study|Administrative Problems|0|||
48606364|NCT00171249|156415570|FG005|Overall Study|Administrative Problems|0|||
48606365|NCT00171249|156415571|FG006|Overall Study|Administrative Problems|0|||
48606366|NCT00171249|156415565|FG000|Overall Study|Adverse Event|3|||
48606367|NCT00171249|156415566|FG001|Overall Study|Adverse Event|1|||
48606368|NCT00171249|156415567|FG002|Overall Study|Adverse Event|0|||
48606369|NCT00171249|156415568|FG003|Overall Study|Adverse Event|15|||
48606370|NCT00171249|156415569|FG004|Overall Study|Adverse Event|0|||
48606371|NCT00171249|156415570|FG005|Overall Study|Adverse Event|2|||
48606372|NCT00171249|156415571|FG006|Overall Study|Adverse Event|0|||
48606373|NCT00171249|156415565|FG000|Overall Study|Lost to Follow-up|5|||
48606374|NCT00171249|156415566|FG001|Overall Study|Lost to Follow-up|0|||
48606375|NCT00171249|156415567|FG002|Overall Study|Lost to Follow-up|0|||
48606376|NCT00171249|156415568|FG003|Overall Study|Lost to Follow-up|9|||
48606377|NCT00171249|156415569|FG004|Overall Study|Lost to Follow-up|0|||
48606378|NCT00171249|156415570|FG005|Overall Study|Lost to Follow-up|0|||
48606379|NCT00171249|156415571|FG006|Overall Study|Lost to Follow-up|0|||
48606380|NCT01776554|156415572|FG000|Overall Study|Adverse Event|1|||
48606381|NCT01776554|156415573|FG001|Overall Study|Adverse Event|0|||
48606382|NCT01776554|156415572|FG000|Overall Study|Withdrawal by Subject|3|||
48606383|NCT01776554|156415573|FG001|Overall Study|Withdrawal by Subject|8|||
48606384|NCT01776554|156415572|FG000|Overall Study|Lost to Follow-up|6|||
48606385|NCT01776554|156415573|FG001|Overall Study|Lost to Follow-up|9|||
48606386|NCT01776554|156415572|FG000|Overall Study|Administrative Reason|2|||
48606387|NCT01776554|156415573|FG001|Overall Study|Administrative Reason|5|||
48606388|NCT01776554|156415572|FG000|Overall Study|Protocol Violation|1|||
48606389|NCT01776554|156415573|FG001|Overall Study|Protocol Violation|0|||
48606390|NCT01776554|156415572|FG000|Overall Study|Unclassified|4|||
48606391|NCT01776554|156415573|FG001|Overall Study|Unclassified|1|||
48606392|NCT03608826|156415578|FG000|Overall Study|Death|3|||
48539615|NCT03118570|156163954|FG001|Overall Study|Lost to Follow-up|3|||
48539616|NCT03118570|156163955|FG002|Overall Study|Lost to Follow-up|1|||
48539617|NCT03118570|156163956|FG003|Overall Study|Lost to Follow-up|0|||
48539618|NCT03118570|156163957|FG004|Overall Study|Lost to Follow-up|1|||
48539619|NCT03118570|156163953|FG000|Overall Study|Other, Not Specified|1|||
48539620|NCT03118570|156163954|FG001|Overall Study|Other, Not Specified|3|||
48606393|NCT03608826|156415578|FG000|Overall Study|Heart Transplant|3|||
48606394|NCT03608826|156415578|FG000|Overall Study|Physician Decision|4|||
48606395|NCT02668640|156415583|FG000|Overall Study|Lost to Follow-up|13|||
48606396|NCT02668640|156415583|FG000|Overall Study|Other, not specified|1|||
48606397|NCT02008526|156415584|FG000|Overall Study|Death|0|||
48606398|NCT02008526|156415585|FG001|Overall Study|Death|2|||
48606399|NCT02008526|156415586|FG002|Overall Study|Death|1|||
48539621|NCT03118570|156163955|FG002|Overall Study|Other, Not Specified|0|||
48539622|NCT03118570|156163956|FG003|Overall Study|Other, Not Specified|0|||
48539623|NCT03118570|156163957|FG004|Overall Study|Other, Not Specified|0|||
48539624|NCT03918109|156163959|FG000|Overall Study|Withdrawal by Subject|0|||
48539625|NCT03918109|156163960|FG001|Overall Study|Withdrawal by Subject|0|||
48539626|NCT03918109|156163961|FG002|Overall Study|Withdrawal by Subject|2|||
48539627|NCT03918109|156163962|FG003|Overall Study|Withdrawal by Subject|1|||
48539628|NCT03918109|156163959|FG000|Overall Study|Lost to Follow-up|0|||
48539629|NCT03918109|156163960|FG001|Overall Study|Lost to Follow-up|0|||
48539630|NCT03918109|156163961|FG002|Overall Study|Lost to Follow-up|0|||
48539631|NCT03918109|156163962|FG003|Overall Study|Lost to Follow-up|1|||
48539632|NCT03970837|156163963|FG000|Overall Study|Adverse Event|23|||
48539633|NCT03970837|156163964|FG001|Overall Study|Adverse Event|20|||
48539634|NCT03970837|156163965|FG002|Overall Study|Adverse Event|16|||
48539635|NCT03970837|156163966|FG003|Overall Study|Adverse Event|6|||
48539636|NCT03970837|156163967|FG004|Overall Study|Adverse Event|4|||
48539637|NCT03970837|156163968|FG005|Overall Study|Adverse Event|5|||
48539638|NCT03970837|156163969|FG006|Overall Study|Adverse Event|1|||
48539639|NCT03970837|156163970|FG007|Overall Study|Adverse Event|5|||
48539640|NCT03970837|156163971|FG008|Overall Study|Adverse Event|0|||
48539641|NCT03970837|156163972|FG009|Overall Study|Adverse Event|0|||
48539642|NCT03970837|156163973|FG010|Overall Study|Adverse Event|1|||
48539643|NCT03970837|156163974|FG011|Overall Study|Adverse Event|1|||
48539644|NCT03970837|156163963|FG000|Overall Study|Lack of Efficacy|14|||
48539645|NCT03970837|156163964|FG001|Overall Study|Lack of Efficacy|12|||
48539646|NCT03970837|156163965|FG002|Overall Study|Lack of Efficacy|1|||
48539647|NCT03970837|156163966|FG003|Overall Study|Lack of Efficacy|2|||
48539648|NCT03970837|156163967|FG004|Overall Study|Lack of Efficacy|3|||
48539649|NCT03970837|156163968|FG005|Overall Study|Lack of Efficacy|4|||
48539650|NCT03970837|156163969|FG006|Overall Study|Lack of Efficacy|6|||
48539651|NCT03970837|156163970|FG007|Overall Study|Lack of Efficacy|1|||
48539652|NCT03970837|156163971|FG008|Overall Study|Lack of Efficacy|1|||
48539653|NCT03970837|156163972|FG009|Overall Study|Lack of Efficacy|0|||
48539654|NCT03970837|156163973|FG010|Overall Study|Lack of Efficacy|0|||
48539655|NCT03970837|156163974|FG011|Overall Study|Lack of Efficacy|0|||
48539656|NCT03970837|156163963|FG000|Overall Study|Lost to Follow-up|6|||
48539657|NCT03970837|156163964|FG001|Overall Study|Lost to Follow-up|5|||
48539658|NCT03970837|156163965|FG002|Overall Study|Lost to Follow-up|5|||
48539659|NCT03970837|156163966|FG003|Overall Study|Lost to Follow-up|1|||
48539660|NCT03970837|156163967|FG004|Overall Study|Lost to Follow-up|0|||
48539661|NCT03970837|156163968|FG005|Overall Study|Lost to Follow-up|2|||
48539662|NCT03970837|156163969|FG006|Overall Study|Lost to Follow-up|0|||
48539663|NCT03970837|156163970|FG007|Overall Study|Lost to Follow-up|0|||
48539664|NCT03970837|156163971|FG008|Overall Study|Lost to Follow-up|0|||
48539665|NCT03970837|156163972|FG009|Overall Study|Lost to Follow-up|0|||
48539666|NCT03970837|156163973|FG010|Overall Study|Lost to Follow-up|0|||
48539667|NCT03970837|156163974|FG011|Overall Study|Lost to Follow-up|0|||
48539668|NCT03970837|156163963|FG000|Overall Study|Protocol Violation|1|||
48539669|NCT03970837|156163964|FG001|Overall Study|Protocol Violation|0|||
48539670|NCT03970837|156163965|FG002|Overall Study|Protocol Violation|0|||
48539671|NCT03970837|156163966|FG003|Overall Study|Protocol Violation|0|||
48539672|NCT03970837|156163967|FG004|Overall Study|Protocol Violation|0|||
48539673|NCT03970837|156163968|FG005|Overall Study|Protocol Violation|0|||
48539674|NCT03970837|156163969|FG006|Overall Study|Protocol Violation|0|||
48539675|NCT03970837|156163970|FG007|Overall Study|Protocol Violation|0|||
48539676|NCT03970837|156163971|FG008|Overall Study|Protocol Violation|0|||
48539677|NCT03970837|156163972|FG009|Overall Study|Protocol Violation|0|||
48606400|NCT02008526|156415584|FG000|Overall Study|Withdrawal by Subject|3|||
48539678|NCT03970837|156163973|FG010|Overall Study|Protocol Violation|0|||
48539679|NCT03970837|156163974|FG011|Overall Study|Protocol Violation|0|||
48539680|NCT03970837|156163963|FG000|Overall Study|Physician Decision|5|||
48539681|NCT03970837|156163964|FG001|Overall Study|Physician Decision|8|||
48539682|NCT03970837|156163965|FG002|Overall Study|Physician Decision|4|||
48539683|NCT03970837|156163966|FG003|Overall Study|Physician Decision|1|||
48539684|NCT03970837|156163967|FG004|Overall Study|Physician Decision|5|||
48539685|NCT03970837|156163968|FG005|Overall Study|Physician Decision|2|||
48539686|NCT03970837|156163969|FG006|Overall Study|Physician Decision|4|||
48539687|NCT03970837|156163970|FG007|Overall Study|Physician Decision|5|||
48539688|NCT03970837|156163971|FG008|Overall Study|Physician Decision|0|||
48539689|NCT03970837|156163972|FG009|Overall Study|Physician Decision|1|||
48539690|NCT03970837|156163973|FG010|Overall Study|Physician Decision|0|||
48539691|NCT03970837|156163974|FG011|Overall Study|Physician Decision|0|||
48539692|NCT03970837|156163963|FG000|Overall Study|Withdrawal by Subject|32|||
48539693|NCT03970837|156163964|FG001|Overall Study|Withdrawal by Subject|35|||
48539694|NCT03970837|156163965|FG002|Overall Study|Withdrawal by Subject|12|||
48539695|NCT03970837|156163966|FG003|Overall Study|Withdrawal by Subject|8|||
48539696|NCT03970837|156163967|FG004|Overall Study|Withdrawal by Subject|6|||
48539697|NCT03970837|156163968|FG005|Overall Study|Withdrawal by Subject|8|||
48539698|NCT03970837|156163969|FG006|Overall Study|Withdrawal by Subject|2|||
48539699|NCT03970837|156163970|FG007|Overall Study|Withdrawal by Subject|3|||
48539700|NCT03970837|156163971|FG008|Overall Study|Withdrawal by Subject|0|||
48539701|NCT03970837|156163972|FG009|Overall Study|Withdrawal by Subject|0|||
48539702|NCT03970837|156163973|FG010|Overall Study|Withdrawal by Subject|0|||
48539703|NCT03970837|156163974|FG011|Overall Study|Withdrawal by Subject|1|||
48539704|NCT03970837|156163963|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
48539705|NCT03970837|156163964|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
48539706|NCT03970837|156163965|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
48539707|NCT03970837|156163966|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
48539708|NCT03970837|156163967|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
48539709|NCT03970837|156163968|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
48539710|NCT03970837|156163969|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
48539711|NCT03970837|156163970|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
48539712|NCT03970837|156163971|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
48539713|NCT03970837|156163972|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
48539714|NCT03970837|156163973|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
48539715|NCT03970837|156163974|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
48539716|NCT03970837|156163963|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
48539717|NCT03970837|156163964|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
48539718|NCT03970837|156163965|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
48539719|NCT03970837|156163966|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
48539720|NCT03970837|156163967|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
48539721|NCT03970837|156163968|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
48539722|NCT03970837|156163969|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
48539723|NCT03970837|156163970|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
48539724|NCT03970837|156163971|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
48539725|NCT03970837|156163972|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
48606401|NCT02008526|156415585|FG001|Overall Study|Withdrawal by Subject|3|||
48539726|NCT03970837|156163973|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
48539727|NCT03970837|156163974|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
48539728|NCT02132754|156163975|FG000|Overall Study|Adverse Event|0|||
48606402|NCT02008526|156415586|FG002|Overall Study|Withdrawal by Subject|2|||
48606403|NCT02008526|156415584|FG000|Overall Study|Lost to Follow-up|5|||
48539729|NCT02132754|156163976|FG001|Overall Study|Adverse Event|0|||
48539730|NCT02132754|156163977|FG002|Overall Study|Adverse Event|0|||
48539731|NCT02132754|156163978|FG003|Overall Study|Adverse Event|0|||
48539732|NCT02132754|156163979|FG004|Overall Study|Adverse Event|0|||
48539733|NCT02132754|156163980|FG005|Overall Study|Adverse Event|0|||
48539734|NCT02132754|156163981|FG006|Overall Study|Adverse Event|0|||
48539735|NCT02132754|156163982|FG007|Overall Study|Adverse Event|0|||
48539736|NCT02132754|156163983|FG008|Overall Study|Adverse Event|0|||
48539737|NCT02132754|156163984|FG009|Overall Study|Adverse Event|0|||
48606404|NCT02008526|156415585|FG001|Overall Study|Lost to Follow-up|9|||
48606405|NCT02008526|156415586|FG002|Overall Study|Lost to Follow-up|6|||
48539738|NCT02132754|156163985|FG010|Overall Study|Adverse Event|0|||
48539739|NCT02132754|156163986|FG011|Overall Study|Adverse Event|0|||
48539740|NCT02132754|156163987|FG012|Overall Study|Adverse Event|0|||
48539741|NCT02132754|156163988|FG013|Overall Study|Adverse Event|0|||
48539742|NCT02132754|156163989|FG014|Overall Study|Adverse Event|0|||
48539743|NCT02132754|156163990|FG015|Overall Study|Adverse Event|0|||
48539744|NCT02132754|156163991|FG016|Overall Study|Adverse Event|0|||
48539745|NCT02132754|156163992|FG017|Overall Study|Adverse Event|1|||
48539746|NCT02132754|156163993|FG018|Overall Study|Adverse Event|0|||
48539747|NCT02132754|156163994|FG019|Overall Study|Adverse Event|0|||
48539748|NCT02132754|156163995|FG020|Overall Study|Adverse Event|0|||
48539749|NCT02132754|156163996|FG021|Overall Study|Adverse Event|0|||
48539750|NCT02132754|156163997|FG022|Overall Study|Adverse Event|0|||
48539751|NCT02132754|156163998|FG023|Overall Study|Adverse Event|0|||
48539752|NCT02132754|156163999|FG024|Overall Study|Adverse Event|0|||
48539753|NCT02132754|156164000|FG025|Overall Study|Adverse Event|1|||
48539754|NCT02132754|156164001|FG026|Overall Study|Adverse Event|1|||
48539755|NCT02132754|156164002|FG027|Overall Study|Adverse Event|0|||
48539756|NCT02132754|156164003|FG028|Overall Study|Adverse Event|0|||
48539757|NCT02132754|156164004|FG029|Overall Study|Adverse Event|0|||
48539758|NCT02132754|156164005|FG030|Overall Study|Adverse Event|1|||
48539759|NCT02132754|156164006|FG031|Overall Study|Adverse Event|0|||
48539760|NCT02132754|156164007|FG032|Overall Study|Adverse Event|1|||
48539761|NCT02132754|156164008|FG033|Overall Study|Adverse Event|1|||
48539762|NCT02132754|156163975|FG000|Overall Study|Clinical Progression|0|||
48539763|NCT02132754|156163976|FG001|Overall Study|Clinical Progression|0|||
48539764|NCT02132754|156163977|FG002|Overall Study|Clinical Progression|0|||
48539765|NCT02132754|156163978|FG003|Overall Study|Clinical Progression|0|||
48539766|NCT02132754|156163979|FG004|Overall Study|Clinical Progression|0|||
48539767|NCT02132754|156163980|FG005|Overall Study|Clinical Progression|0|||
48539768|NCT02132754|156163981|FG006|Overall Study|Clinical Progression|0|||
48539769|NCT02132754|156163982|FG007|Overall Study|Clinical Progression|0|||
48539770|NCT02132754|156163983|FG008|Overall Study|Clinical Progression|0|||
48539771|NCT02132754|156163984|FG009|Overall Study|Clinical Progression|1|||
48539772|NCT02132754|156163985|FG010|Overall Study|Clinical Progression|0|||
48539773|NCT02132754|156163986|FG011|Overall Study|Clinical Progression|0|||
48539774|NCT02132754|156163987|FG012|Overall Study|Clinical Progression|0|||
48539775|NCT02132754|156163988|FG013|Overall Study|Clinical Progression|0|||
48539776|NCT02132754|156163989|FG014|Overall Study|Clinical Progression|0|||
48539777|NCT02132754|156163990|FG015|Overall Study|Clinical Progression|0|||
48539778|NCT02132754|156163991|FG016|Overall Study|Clinical Progression|1|||
48539779|NCT02132754|156163992|FG017|Overall Study|Clinical Progression|1|||
48539780|NCT02132754|156163993|FG018|Overall Study|Clinical Progression|0|||
48539781|NCT02132754|156163994|FG019|Overall Study|Clinical Progression|1|||
48539782|NCT02132754|156163995|FG020|Overall Study|Clinical Progression|0|||
48539783|NCT02132754|156163996|FG021|Overall Study|Clinical Progression|0|||
48539784|NCT02132754|156163997|FG022|Overall Study|Clinical Progression|1|||
48539785|NCT02132754|156163998|FG023|Overall Study|Clinical Progression|0|||
48539786|NCT02132754|156163999|FG024|Overall Study|Clinical Progression|1|||
48539787|NCT02132754|156164000|FG025|Overall Study|Clinical Progression|1|||
48539788|NCT02132754|156164001|FG026|Overall Study|Clinical Progression|0|||
48539789|NCT02132754|156164002|FG027|Overall Study|Clinical Progression|1|||
48539790|NCT02132754|156164003|FG028|Overall Study|Clinical Progression|1|||
48539791|NCT02132754|156164004|FG029|Overall Study|Clinical Progression|0|||
48539792|NCT02132754|156164005|FG030|Overall Study|Clinical Progression|1|||
48539793|NCT02132754|156164006|FG031|Overall Study|Clinical Progression|0|||
48539794|NCT02132754|156164007|FG032|Overall Study|Clinical Progression|0|||
48539795|NCT02132754|156164008|FG033|Overall Study|Clinical Progression|2|||
48539796|NCT02132754|156163975|FG000|Overall Study|Death|0|||
48539797|NCT02132754|156163976|FG001|Overall Study|Death|0|||
48539798|NCT02132754|156163977|FG002|Overall Study|Death|0|||
48539799|NCT02132754|156163978|FG003|Overall Study|Death|0|||
48539800|NCT02132754|156163979|FG004|Overall Study|Death|0|||
48539801|NCT02132754|156163980|FG005|Overall Study|Death|0|||
48539802|NCT02132754|156163981|FG006|Overall Study|Death|0|||
48539803|NCT02132754|156163982|FG007|Overall Study|Death|0|||
48539804|NCT02132754|156163983|FG008|Overall Study|Death|0|||
48539805|NCT02132754|156163984|FG009|Overall Study|Death|0|||
48539806|NCT02132754|156163985|FG010|Overall Study|Death|0|||
48539807|NCT02132754|156163986|FG011|Overall Study|Death|0|||
48539808|NCT02132754|156163987|FG012|Overall Study|Death|0|||
48539809|NCT02132754|156163988|FG013|Overall Study|Death|0|||
48539810|NCT02132754|156163989|FG014|Overall Study|Death|0|||
48539811|NCT02132754|156163990|FG015|Overall Study|Death|1|||
48539812|NCT02132754|156163991|FG016|Overall Study|Death|0|||
48539813|NCT02132754|156163992|FG017|Overall Study|Death|0|||
48539814|NCT02132754|156163993|FG018|Overall Study|Death|0|||
48539815|NCT02132754|156163994|FG019|Overall Study|Death|1|||
48539816|NCT02132754|156163995|FG020|Overall Study|Death|0|||
48539817|NCT02132754|156163996|FG021|Overall Study|Death|1|||
48539818|NCT02132754|156163997|FG022|Overall Study|Death|0|||
48539819|NCT02132754|156163998|FG023|Overall Study|Death|0|||
48539820|NCT02132754|156163999|FG024|Overall Study|Death|0|||
48539821|NCT02132754|156164000|FG025|Overall Study|Death|0|||
48539822|NCT02132754|156164001|FG026|Overall Study|Death|1|||
48539823|NCT02132754|156164002|FG027|Overall Study|Death|0|||
48539824|NCT02132754|156164003|FG028|Overall Study|Death|0|||
48539825|NCT02132754|156164004|FG029|Overall Study|Death|0|||
48539826|NCT02132754|156164005|FG030|Overall Study|Death|0|||
48539827|NCT02132754|156164006|FG031|Overall Study|Death|0|||
48539828|NCT02132754|156164007|FG032|Overall Study|Death|0|||
48539829|NCT02132754|156164008|FG033|Overall Study|Death|2|||
48539830|NCT02132754|156163975|FG000|Overall Study|Excluded Medication|0|||
48539831|NCT02132754|156163976|FG001|Overall Study|Excluded Medication|0|||
48539832|NCT02132754|156163977|FG002|Overall Study|Excluded Medication|0|||
48539833|NCT02132754|156163978|FG003|Overall Study|Excluded Medication|0|||
48539834|NCT02132754|156163979|FG004|Overall Study|Excluded Medication|0|||
48539835|NCT02132754|156163980|FG005|Overall Study|Excluded Medication|0|||
48539836|NCT02132754|156163981|FG006|Overall Study|Excluded Medication|0|||
48539837|NCT02132754|156163982|FG007|Overall Study|Excluded Medication|0|||
48539838|NCT02132754|156163983|FG008|Overall Study|Excluded Medication|0|||
48539839|NCT02132754|156163984|FG009|Overall Study|Excluded Medication|0|||
48539840|NCT02132754|156163985|FG010|Overall Study|Excluded Medication|0|||
48539841|NCT02132754|156163986|FG011|Overall Study|Excluded Medication|0|||
48539842|NCT02132754|156163987|FG012|Overall Study|Excluded Medication|0|||
48539843|NCT02132754|156163988|FG013|Overall Study|Excluded Medication|0|||
48539844|NCT02132754|156163989|FG014|Overall Study|Excluded Medication|0|||
48539845|NCT02132754|156163990|FG015|Overall Study|Excluded Medication|0|||
48539846|NCT02132754|156163991|FG016|Overall Study|Excluded Medication|0|||
48539847|NCT02132754|156163992|FG017|Overall Study|Excluded Medication|0|||
48539848|NCT02132754|156163993|FG018|Overall Study|Excluded Medication|0|||
48539849|NCT02132754|156163994|FG019|Overall Study|Excluded Medication|0|||
48539850|NCT02132754|156163995|FG020|Overall Study|Excluded Medication|1|||
48539851|NCT02132754|156163996|FG021|Overall Study|Excluded Medication|0|||
48539852|NCT02132754|156163997|FG022|Overall Study|Excluded Medication|0|||
48539853|NCT02132754|156163998|FG023|Overall Study|Excluded Medication|0|||
48539854|NCT02132754|156163999|FG024|Overall Study|Excluded Medication|0|||
48539855|NCT02132754|156164000|FG025|Overall Study|Excluded Medication|0|||
48539856|NCT02132754|156164001|FG026|Overall Study|Excluded Medication|0|||
48539857|NCT02132754|156164002|FG027|Overall Study|Excluded Medication|0|||
48606406|NCT02792504|156415587|FG000|Overall Study|Lost to Follow-up|24|||
48606407|NCT02792504|156415587|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
48606408|NCT01811238|156415588|FG000|Overall Study|Withdrawal by Subject|42|||
48606409|NCT01811238|156415588|FG000|Overall Study|Adverse Event|25|||
48606410|NCT01811238|156415588|FG000|Overall Study|Protocol Violation|4|||
48606411|NCT01811238|156415588|FG000|Overall Study|Lack of Efficacy|4|||
48606412|NCT01811238|156415588|FG000|Overall Study|subject refused study medication|6|||
48606413|NCT00848497|156415589|FG000|Overall Study|Screen failure|2|||
48606414|NCT00848497|156415590|FG001|Overall Study|Screen failure|0|||
48606415|NCT00848497|156415589|FG000|Overall Study|Withdrawal by Subject|0|||
48539858|NCT02132754|156164003|FG028|Overall Study|Excluded Medication|0|||
48606416|NCT00848497|156415590|FG001|Overall Study|Withdrawal by Subject|1|||
48539859|NCT02132754|156164004|FG029|Overall Study|Excluded Medication|0|||
48539860|NCT02132754|156164005|FG030|Overall Study|Excluded Medication|0|||
48539861|NCT02132754|156164006|FG031|Overall Study|Excluded Medication|0|||
48539862|NCT02132754|156164007|FG032|Overall Study|Excluded Medication|0|||
48539863|NCT02132754|156164008|FG033|Overall Study|Excluded Medication|1|||
48606417|NCT00141817|156415592|FG000|Overall Study|Protocol Violation|0|||
48606418|NCT00141817|156415593|FG001|Overall Study|Protocol Violation|0|||
48539864|NCT02132754|156163975|FG000|Overall Study|Physician Decision|0|||
48539865|NCT02132754|156163976|FG001|Overall Study|Physician Decision|0|||
48539866|NCT02132754|156163977|FG002|Overall Study|Physician Decision|0|||
48539867|NCT02132754|156163978|FG003|Overall Study|Physician Decision|0|||
48539868|NCT02132754|156163979|FG004|Overall Study|Physician Decision|0|||
48539869|NCT02132754|156163980|FG005|Overall Study|Physician Decision|0|||
48539870|NCT02132754|156163981|FG006|Overall Study|Physician Decision|0|||
48539871|NCT02132754|156163982|FG007|Overall Study|Physician Decision|0|||
48539872|NCT02132754|156163983|FG008|Overall Study|Physician Decision|0|||
48539873|NCT02132754|156163984|FG009|Overall Study|Physician Decision|1|||
48539874|NCT02132754|156163985|FG010|Overall Study|Physician Decision|0|||
48539875|NCT02132754|156163986|FG011|Overall Study|Physician Decision|1|||
48539876|NCT02132754|156163987|FG012|Overall Study|Physician Decision|1|||
48539877|NCT02132754|156163988|FG013|Overall Study|Physician Decision|0|||
48539878|NCT02132754|156163989|FG014|Overall Study|Physician Decision|0|||
48539879|NCT02132754|156163990|FG015|Overall Study|Physician Decision|1|||
48539880|NCT02132754|156163991|FG016|Overall Study|Physician Decision|0|||
48539881|NCT02132754|156163992|FG017|Overall Study|Physician Decision|0|||
48539882|NCT02132754|156163993|FG018|Overall Study|Physician Decision|0|||
48539883|NCT02132754|156163994|FG019|Overall Study|Physician Decision|0|||
48539884|NCT02132754|156163995|FG020|Overall Study|Physician Decision|0|||
48539885|NCT02132754|156163996|FG021|Overall Study|Physician Decision|0|||
48539886|NCT02132754|156163997|FG022|Overall Study|Physician Decision|0|||
48539887|NCT02132754|156163998|FG023|Overall Study|Physician Decision|0|||
48539888|NCT02132754|156163999|FG024|Overall Study|Physician Decision|1|||
48539889|NCT02132754|156164000|FG025|Overall Study|Physician Decision|0|||
48539890|NCT02132754|156164001|FG026|Overall Study|Physician Decision|0|||
48539891|NCT02132754|156164002|FG027|Overall Study|Physician Decision|0|||
48539892|NCT02132754|156164003|FG028|Overall Study|Physician Decision|0|||
48539893|NCT02132754|156164004|FG029|Overall Study|Physician Decision|0|||
48539894|NCT02132754|156164005|FG030|Overall Study|Physician Decision|0|||
48539895|NCT02132754|156164006|FG031|Overall Study|Physician Decision|1|||
48539896|NCT02132754|156164007|FG032|Overall Study|Physician Decision|0|||
48539897|NCT02132754|156164008|FG033|Overall Study|Physician Decision|3|||
48539898|NCT02132754|156163975|FG000|Overall Study|Progressive Disease|1|||
48539899|NCT02132754|156163976|FG001|Overall Study|Progressive Disease|1|||
48539900|NCT02132754|156163977|FG002|Overall Study|Progressive Disease|1|||
48539901|NCT02132754|156163978|FG003|Overall Study|Progressive Disease|1|||
48539902|NCT02132754|156163979|FG004|Overall Study|Progressive Disease|1|||
48539903|NCT02132754|156163980|FG005|Overall Study|Progressive Disease|1|||
48539904|NCT02132754|156163981|FG006|Overall Study|Progressive Disease|1|||
48539905|NCT02132754|156163982|FG007|Overall Study|Progressive Disease|1|||
48539906|NCT02132754|156163983|FG008|Overall Study|Progressive Disease|1|||
48539907|NCT02132754|156163984|FG009|Overall Study|Progressive Disease|3|||
48539908|NCT02132754|156163985|FG010|Overall Study|Progressive Disease|3|||
48539909|NCT02132754|156163986|FG011|Overall Study|Progressive Disease|2|||
48539910|NCT02132754|156163987|FG012|Overall Study|Progressive Disease|2|||
48539911|NCT02132754|156163988|FG013|Overall Study|Progressive Disease|3|||
48539912|NCT02132754|156163989|FG014|Overall Study|Progressive Disease|2|||
48539913|NCT02132754|156163990|FG015|Overall Study|Progressive Disease|1|||
48539914|NCT02132754|156163991|FG016|Overall Study|Progressive Disease|2|||
48539915|NCT02132754|156163992|FG017|Overall Study|Progressive Disease|1|||
48539916|NCT02132754|156163993|FG018|Overall Study|Progressive Disease|3|||
48539917|NCT02132754|156163994|FG019|Overall Study|Progressive Disease|1|||
48539918|NCT02132754|156163995|FG020|Overall Study|Progressive Disease|1|||
48539919|NCT02132754|156163996|FG021|Overall Study|Progressive Disease|3|||
48539920|NCT02132754|156163997|FG022|Overall Study|Progressive Disease|2|||
48539921|NCT02132754|156163998|FG023|Overall Study|Progressive Disease|3|||
48539922|NCT02132754|156163999|FG024|Overall Study|Progressive Disease|0|||
48539923|NCT02132754|156164000|FG025|Overall Study|Progressive Disease|1|||
48606419|NCT00141817|156415594|FG002|Overall Study|Protocol Violation|1|||
48539924|NCT02132754|156164001|FG026|Overall Study|Progressive Disease|2|||
48539925|NCT02132754|156164002|FG027|Overall Study|Progressive Disease|1|||
48539926|NCT02132754|156164003|FG028|Overall Study|Progressive Disease|2|||
48539927|NCT02132754|156164004|FG029|Overall Study|Progressive Disease|3|||
48539928|NCT02132754|156164005|FG030|Overall Study|Progressive Disease|1|||
48539929|NCT02132754|156164006|FG031|Overall Study|Progressive Disease|1|||
48539930|NCT02132754|156164007|FG032|Overall Study|Progressive Disease|3|||
48539931|NCT02132754|156164008|FG033|Overall Study|Progressive Disease|6|||
48539932|NCT02132754|156163975|FG000|Overall Study|Screen Failure|0|||
48539933|NCT02132754|156163976|FG001|Overall Study|Screen Failure|0|||
48539934|NCT02132754|156163977|FG002|Overall Study|Screen Failure|0|||
48539935|NCT02132754|156163978|FG003|Overall Study|Screen Failure|0|||
48539936|NCT02132754|156163979|FG004|Overall Study|Screen Failure|0|||
48539937|NCT02132754|156163980|FG005|Overall Study|Screen Failure|0|||
48539938|NCT02132754|156163981|FG006|Overall Study|Screen Failure|0|||
48539939|NCT02132754|156163982|FG007|Overall Study|Screen Failure|0|||
48539940|NCT02132754|156163983|FG008|Overall Study|Screen Failure|0|||
48539941|NCT02132754|156163984|FG009|Overall Study|Screen Failure|0|||
48539942|NCT02132754|156163985|FG010|Overall Study|Screen Failure|0|||
48539943|NCT02132754|156163986|FG011|Overall Study|Screen Failure|0|||
48539944|NCT02132754|156163987|FG012|Overall Study|Screen Failure|0|||
48539945|NCT02132754|156163988|FG013|Overall Study|Screen Failure|0|||
48539946|NCT02132754|156163989|FG014|Overall Study|Screen Failure|0|||
48606420|NCT00141817|156415595|FG003|Overall Study|Protocol Violation|0|||
48539947|NCT02132754|156163990|FG015|Overall Study|Screen Failure|0|||
48606421|NCT00141817|156415592|FG000|Overall Study|Parent request|1|||
48606422|NCT00141817|156415593|FG001|Overall Study|Parent request|0|||
48606423|NCT00141817|156415594|FG002|Overall Study|Parent request|0|||
48606424|NCT00141817|156415595|FG003|Overall Study|Parent request|0|||
48606425|NCT01981616|156415596|FG000|Overall Study|Adverse Event|0|||
48606426|NCT01981616|156415597|FG001|Overall Study|Adverse Event|1|||
48606427|NCT01981616|156415596|FG000|Overall Study|Protocol Violation|1|||
48606428|NCT01981616|156415597|FG001|Overall Study|Protocol Violation|0|||
48606429|NCT03642990|156415600|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
48606430|NCT03642990|156415600|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
48606431|NCT00094445|156415601|FG000|Overall Study|Withdrawal by Subject|3|||
48606432|NCT00094445|156415601|FG000|Overall Study|Lost to Follow-up|1|||
48539948|NCT02132754|156163991|FG016|Overall Study|Screen Failure|0|||
48539949|NCT02132754|156163992|FG017|Overall Study|Screen Failure|0|||
48539950|NCT02132754|156163993|FG018|Overall Study|Screen Failure|0|||
48539951|NCT02132754|156163994|FG019|Overall Study|Screen Failure|1|||
48539952|NCT02132754|156163995|FG020|Overall Study|Screen Failure|0|||
48539953|NCT02132754|156163996|FG021|Overall Study|Screen Failure|1|||
48606433|NCT00094445|156415601|FG000|Overall Study|Progressive Disease|2|||
48539954|NCT02132754|156163997|FG022|Overall Study|Screen Failure|0|||
48539955|NCT02132754|156163998|FG023|Overall Study|Screen Failure|0|||
48539956|NCT02132754|156163999|FG024|Overall Study|Screen Failure|0|||
48539957|NCT02132754|156164000|FG025|Overall Study|Screen Failure|0|||
48539958|NCT02132754|156164001|FG026|Overall Study|Screen Failure|0|||
48539959|NCT02132754|156164002|FG027|Overall Study|Screen Failure|0|||
48539960|NCT02132754|156164003|FG028|Overall Study|Screen Failure|0|||
48539961|NCT02132754|156164004|FG029|Overall Study|Screen Failure|0|||
48539962|NCT02132754|156164005|FG030|Overall Study|Screen Failure|0|||
48539963|NCT02132754|156164006|FG031|Overall Study|Screen Failure|0|||
48539964|NCT02132754|156164007|FG032|Overall Study|Screen Failure|0|||
48539965|NCT02132754|156164008|FG033|Overall Study|Screen Failure|0|||
48539966|NCT02132754|156163975|FG000|Overall Study|Transferred to Extension Study|0|||
48539967|NCT02132754|156163976|FG001|Overall Study|Transferred to Extension Study|0|||
48539968|NCT02132754|156163977|FG002|Overall Study|Transferred to Extension Study|0|||
48539969|NCT02132754|156163978|FG003|Overall Study|Transferred to Extension Study|0|||
48539970|NCT02132754|156163979|FG004|Overall Study|Transferred to Extension Study|0|||
48539971|NCT02132754|156163980|FG005|Overall Study|Transferred to Extension Study|0|||
48539972|NCT02132754|156163981|FG006|Overall Study|Transferred to Extension Study|0|||
48539973|NCT02132754|156163982|FG007|Overall Study|Transferred to Extension Study|0|||
48539974|NCT02132754|156163983|FG008|Overall Study|Transferred to Extension Study|0|||
48539975|NCT02132754|156163984|FG009|Overall Study|Transferred to Extension Study|0|||
48539976|NCT02132754|156163985|FG010|Overall Study|Transferred to Extension Study|0|||
48539977|NCT02132754|156163986|FG011|Overall Study|Transferred to Extension Study|0|||
48539978|NCT02132754|156163987|FG012|Overall Study|Transferred to Extension Study|0|||
48539979|NCT02132754|156163988|FG013|Overall Study|Transferred to Extension Study|0|||
48539980|NCT02132754|156163989|FG014|Overall Study|Transferred to Extension Study|0|||
48539981|NCT02132754|156163990|FG015|Overall Study|Transferred to Extension Study|0|||
48539982|NCT02132754|156163991|FG016|Overall Study|Transferred to Extension Study|0|||
48539983|NCT02132754|156163992|FG017|Overall Study|Transferred to Extension Study|0|||
48539984|NCT02132754|156163993|FG018|Overall Study|Transferred to Extension Study|0|||
48539985|NCT02132754|156163994|FG019|Overall Study|Transferred to Extension Study|0|||
48539986|NCT02132754|156163995|FG020|Overall Study|Transferred to Extension Study|0|||
48539987|NCT02132754|156163996|FG021|Overall Study|Transferred to Extension Study|0|||
48539988|NCT02132754|156163997|FG022|Overall Study|Transferred to Extension Study|0|||
48539989|NCT02132754|156163998|FG023|Overall Study|Transferred to Extension Study|0|||
48539990|NCT02132754|156163999|FG024|Overall Study|Transferred to Extension Study|0|||
48539991|NCT02132754|156164000|FG025|Overall Study|Transferred to Extension Study|0|||
48539992|NCT02132754|156164001|FG026|Overall Study|Transferred to Extension Study|0|||
48539993|NCT02132754|156164002|FG027|Overall Study|Transferred to Extension Study|0|||
48539994|NCT02132754|156164003|FG028|Overall Study|Transferred to Extension Study|0|||
48539995|NCT02132754|156164004|FG029|Overall Study|Transferred to Extension Study|0|||
48539996|NCT02132754|156164005|FG030|Overall Study|Transferred to Extension Study|0|||
48539997|NCT02132754|156164006|FG031|Overall Study|Transferred to Extension Study|0|||
48539998|NCT02132754|156164007|FG032|Overall Study|Transferred to Extension Study|0|||
48539999|NCT02132754|156164008|FG033|Overall Study|Transferred to Extension Study|6|||
48540000|NCT02132754|156163975|FG000|Overall Study|Withdrawal by Subject|0|||
48540001|NCT02132754|156163976|FG001|Overall Study|Withdrawal by Subject|0|||
48540002|NCT02132754|156163977|FG002|Overall Study|Withdrawal by Subject|0|||
48540003|NCT02132754|156163978|FG003|Overall Study|Withdrawal by Subject|0|||
48540004|NCT02132754|156163979|FG004|Overall Study|Withdrawal by Subject|0|||
48540005|NCT02132754|156163980|FG005|Overall Study|Withdrawal by Subject|0|||
48540006|NCT02132754|156163981|FG006|Overall Study|Withdrawal by Subject|0|||
48540007|NCT02132754|156163982|FG007|Overall Study|Withdrawal by Subject|0|||
48540008|NCT02132754|156163983|FG008|Overall Study|Withdrawal by Subject|0|||
48540009|NCT02132754|156163984|FG009|Overall Study|Withdrawal by Subject|1|||
48540010|NCT02132754|156163985|FG010|Overall Study|Withdrawal by Subject|0|||
48540011|NCT02132754|156163986|FG011|Overall Study|Withdrawal by Subject|0|||
48540012|NCT02132754|156163987|FG012|Overall Study|Withdrawal by Subject|1|||
48540013|NCT02132754|156163988|FG013|Overall Study|Withdrawal by Subject|0|||
48540014|NCT02132754|156163989|FG014|Overall Study|Withdrawal by Subject|1|||
48540015|NCT02132754|156163990|FG015|Overall Study|Withdrawal by Subject|2|||
48540016|NCT02132754|156163991|FG016|Overall Study|Withdrawal by Subject|1|||
48540017|NCT02132754|156163992|FG017|Overall Study|Withdrawal by Subject|0|||
48540018|NCT02132754|156163993|FG018|Overall Study|Withdrawal by Subject|0|||
48540019|NCT02132754|156163994|FG019|Overall Study|Withdrawal by Subject|0|||
48540020|NCT02132754|156163995|FG020|Overall Study|Withdrawal by Subject|1|||
48540021|NCT02132754|156163996|FG021|Overall Study|Withdrawal by Subject|0|||
48540022|NCT02132754|156163997|FG022|Overall Study|Withdrawal by Subject|0|||
48540023|NCT02132754|156163998|FG023|Overall Study|Withdrawal by Subject|0|||
48540024|NCT02132754|156163999|FG024|Overall Study|Withdrawal by Subject|1|||
48540025|NCT02132754|156164000|FG025|Overall Study|Withdrawal by Subject|0|||
48540026|NCT02132754|156164001|FG026|Overall Study|Withdrawal by Subject|0|||
48540027|NCT02132754|156164002|FG027|Overall Study|Withdrawal by Subject|1|||
48540028|NCT02132754|156164003|FG028|Overall Study|Withdrawal by Subject|0|||
48540029|NCT02132754|156164004|FG029|Overall Study|Withdrawal by Subject|0|||
48540030|NCT02132754|156164005|FG030|Overall Study|Withdrawal by Subject|0|||
48540031|NCT02132754|156164006|FG031|Overall Study|Withdrawal by Subject|1|||
48540032|NCT02132754|156164007|FG032|Overall Study|Withdrawal by Subject|0|||
48540033|NCT02132754|156164008|FG033|Overall Study|Withdrawal by Subject|2|||
48540034|NCT01833533|156165841|FG000|Overall Study|Adverse Event|0|||
48540035|NCT01833533|156165842|FG001|Overall Study|Adverse Event|1|||
48540036|NCT01833533|156165841|FG000|Overall Study|Lost to Follow-up|4|||
48540037|NCT01833533|156165842|FG001|Overall Study|Lost to Follow-up|9|||
48606434|NCT03087058|156415602|FG000|Overall Study|Withdrawal by Subject|2|||
48606435|NCT03087058|156415603|FG001|Overall Study|Withdrawal by Subject|0|||
48606436|NCT03087058|156415604|FG002|Overall Study|Withdrawal by Subject|0|||
48606437|NCT00855218|156415607|FG000|Overall Study|Adverse Event|43|||
48606438|NCT00855218|156415608|FG001|Overall Study|Adverse Event|27|||
48606439|NCT00855218|156415607|FG000|Overall Study|Withdrawal by Subject|10|||
48606440|NCT00855218|156415608|FG001|Overall Study|Withdrawal by Subject|6|||
48540038|NCT01833533|156165841|FG000|Overall Study|To Enter an Extension Study|0|||
48540039|NCT01833533|156165842|FG001|Overall Study|To Enter an Extension Study|4|||
48540040|NCT01833533|156165841|FG000|Overall Study|Other|2|||
48540041|NCT01833533|156165842|FG001|Overall Study|Other|7|||
48540042|NCT01196078|156165843|FG000|Overall Study|Withdrawal by Subject|3|||
48606441|NCT00855218|156415607|FG000|Overall Study|Physician Decision|18|||
48606442|NCT00855218|156415608|FG001|Overall Study|Physician Decision|11|||
48606443|NCT00855218|156415607|FG000|Overall Study|Lost to Follow-up|0|||
48606444|NCT00855218|156415608|FG001|Overall Study|Lost to Follow-up|1|||
48606445|NCT00855218|156415607|FG000|Overall Study|Protocol Violation|5|||
48606446|NCT00855218|156415608|FG001|Overall Study|Protocol Violation|9|||
48606447|NCT00855218|156415607|FG000|Overall Study|non-compliant with study drug|3|||
48606448|NCT00855218|156415608|FG001|Overall Study|non-compliant with study drug|1|||
48606449|NCT00855218|156415607|FG000|Overall Study|patient convenience|2|||
48606450|NCT00855218|156415608|FG001|Overall Study|patient convenience|0|||
48606451|NCT00855218|156415607|FG000|Overall Study|technical problems|2|||
48606452|NCT00855218|156415608|FG001|Overall Study|technical problems|1|||
48606453|NCT00855218|156415607|FG000|Overall Study|Still treated with study medication|0|||
48606454|NCT00855218|156415608|FG001|Overall Study|Still treated with study medication|1|||
48606455|NCT00855218|156415607|FG000|Overall Study|Untreatable disease progression|54|||
48606456|NCT00855218|156415608|FG001|Overall Study|Untreatable disease progression|67|||
48606457|NCT00855218|156415607|FG000|Overall Study|Second malignancy|0|||
48606458|NCT00855218|156415608|FG001|Overall Study|Second malignancy|1|||
48606459|NCT00855218|156415607|FG000|Overall Study|Progression measurement proven|7|||
48606460|NCT00855218|156415608|FG001|Overall Study|Progression measurement proven|15|||
48606461|NCT00855218|156415607|FG000|Overall Study|Clinical endpoint reached|10|||
48606462|NCT00855218|156415608|FG001|Overall Study|Clinical endpoint reached|13|||
48606463|NCT01652690|156415612|FG000|Overall Study|Withdrawal by Subject|16|||
48606464|NCT01652690|156415613|FG001|Overall Study|Withdrawal by Subject|4|||
48606465|NCT01652690|156415612|FG000|Overall Study|Other|8|||
48606466|NCT01652690|156415613|FG001|Overall Study|Other|9|||
48606467|NCT01652690|156415612|FG000|Overall Study|Lost to Follow-up|6|||
48606468|NCT01652690|156415613|FG001|Overall Study|Lost to Follow-up|6|||
48606469|NCT01652690|156415612|FG000|Overall Study|Death|5|||
48606470|NCT01652690|156415613|FG001|Overall Study|Death|2|||
48606471|NCT02273167|156415618|FG000|Overall Study|Adverse Event|1|||
48606472|NCT02273167|156415619|FG001|Overall Study|Adverse Event|0|||
48540043|NCT01196078|156165844|FG001|Overall Study|Withdrawal by Subject|5|||
48606473|NCT02273167|156415620|FG002|Overall Study|Adverse Event|0|||
48606474|NCT02273167|156415618|FG000|Overall Study|Protocol Violation|3|||
48540044|NCT01196078|156165843|FG000|Overall Study|Adverse Event|4|||
48540045|NCT01196078|156165844|FG001|Overall Study|Adverse Event|4|||
48540046|NCT01196078|156165843|FG000|Overall Study|Protocol Violation|2|||
48540047|NCT01196078|156165844|FG001|Overall Study|Protocol Violation|1|||
48540048|NCT01196078|156165843|FG000|Overall Study|Lack of Efficacy|17|||
48540049|NCT01196078|156165844|FG001|Overall Study|Lack of Efficacy|23|||
48540050|NCT01196078|156165843|FG000|Overall Study|Lost to Follow-up|1|||
48540051|NCT01196078|156165844|FG001|Overall Study|Lost to Follow-up|0|||
48540052|NCT01196078|156165843|FG000|Overall Study|Death|6|||
48540053|NCT01196078|156165844|FG001|Overall Study|Death|4|||
48540054|NCT02667288|156165845|FG000|Overall Study|Protocol Violation|5|||
48540055|NCT02667288|156165845|FG000|Overall Study|Lost to Follow-up|3|||
48540056|NCT02667288|156165845|FG000|Overall Study|Withdrawal by Subject|5|||
48540057|NCT00912093|156165846|FG000|The Controlled Phase|Death|0|||
48540058|NCT00912093|156165847|FG001|The Controlled Phase|Death|1|||
48540059|NCT00912093|156165848|FG002|The Controlled Phase|Death|0|||
48540060|NCT00912093|156165849|FG003|The Controlled Phase|Death|0|||
48540061|NCT00912093|156165850|FG004|The Controlled Phase|Death|0|||
48540062|NCT00912093|156165846|FG000|The Controlled Phase|Medical Condition|0|||
48540063|NCT00912093|156165847|FG001|The Controlled Phase|Medical Condition|1|||
48540064|NCT00912093|156165848|FG002|The Controlled Phase|Medical Condition|0|||
48540065|NCT00912093|156165849|FG003|The Controlled Phase|Medical Condition|0|||
48540066|NCT00912093|156165850|FG004|The Controlled Phase|Medical Condition|0|||
48540067|NCT00912093|156165846|FG000|The Controlled Phase|Lost to Follow-up|0|||
48540068|NCT00912093|156165847|FG001|The Controlled Phase|Lost to Follow-up|0|||
48540069|NCT00912093|156165848|FG002|The Controlled Phase|Lost to Follow-up|0|||
48540070|NCT00912093|156165849|FG003|The Controlled Phase|Lost to Follow-up|0|||
48540071|NCT00912093|156165850|FG004|The Controlled Phase|Lost to Follow-up|1|||
48606475|NCT02273167|156415619|FG001|Overall Study|Protocol Violation|1|||
48606476|NCT02273167|156415620|FG002|Overall Study|Protocol Violation|1|||
48606477|NCT02273167|156415618|FG000|Overall Study|Lost to Follow-up|0|||
48606478|NCT02273167|156415619|FG001|Overall Study|Lost to Follow-up|1|||
48606479|NCT02273167|156415620|FG002|Overall Study|Lost to Follow-up|1|||
48606480|NCT02273167|156415618|FG000|Overall Study|Withdrawal by Subject|10|||
48606481|NCT02273167|156415619|FG001|Overall Study|Withdrawal by Subject|12|||
48606482|NCT02273167|156415620|FG002|Overall Study|Withdrawal by Subject|11|||
48606483|NCT02273167|156415618|FG000|Overall Study|Various|10|||
48606484|NCT02273167|156415619|FG001|Overall Study|Various|9|||
48606485|NCT02273167|156415620|FG002|Overall Study|Various|8|||
48606486|NCT03311555|156415626|FG000|Overall Study|Adverse Event|1|||
48606487|NCT02160626|156415629|FG000|Overall Study|Adverse Event|1|||
48606488|NCT02160626|156415630|FG001|Overall Study|Adverse Event|0|||
48606489|NCT02160626|156415631|FG002|Overall Study|Adverse Event|0|||
48606490|NCT02160626|156415629|FG000|Overall Study|Schedule not conducive to study visits|0|||
48606491|NCT02160626|156415630|FG001|Overall Study|Schedule not conducive to study visits|0|||
48606492|NCT02160626|156415631|FG002|Overall Study|Schedule not conducive to study visits|1|||
48606493|NCT02160626|156415629|FG000|Overall Study|Withdrawal by Subject|0|||
48606494|NCT02160626|156415630|FG001|Overall Study|Withdrawal by Subject|1|||
48606495|NCT02160626|156415631|FG002|Overall Study|Withdrawal by Subject|0|||
48606496|NCT03074500|156415632|FG000|Overall Study|Lost to Follow-up|1|||
48606497|NCT03074500|156415633|FG001|Overall Study|Lost to Follow-up|0|||
48606498|NCT03074500|156415634|FG002|Overall Study|Lost to Follow-up|0|||
48606499|NCT03074500|156415632|FG000|Overall Study|Lack of Efficacy|0|||
48606500|NCT03074500|156415633|FG001|Overall Study|Lack of Efficacy|1|||
48606501|NCT03074500|156415634|FG002|Overall Study|Lack of Efficacy|0|||
48606502|NCT03074500|156415632|FG000|Overall Study|Adverse Event|0|||
48606503|NCT03074500|156415633|FG001|Overall Study|Adverse Event|0|||
48606504|NCT03074500|156415634|FG002|Overall Study|Adverse Event|1|||
48540072|NCT00103311|156165851|FG000|Overall Study|Lost to Follow-up|1|||
48540073|NCT00103311|156165852|FG001|Overall Study|Lost to Follow-up|0|||
48606505|NCT01248455|156416998|FG000|Overall Study|switched to alternate treatment|1|||
48540074|NCT00103311|156165851|FG000|Overall Study|Withdrawal by Subject|2|||
48540075|NCT00103311|156165852|FG001|Overall Study|Withdrawal by Subject|1|||
48540076|NCT00103311|156165851|FG000|Overall Study|Adverse Event|1|||
48540077|NCT00103311|156165852|FG001|Overall Study|Adverse Event|0|||
48540078|NCT02400671|156165853|FG000|Overall Study|Death|5|||
48540079|NCT02400671|156165854|FG001|Overall Study|Death|3|||
48606506|NCT00386334|156417001|FG000|Double Blind Period|Adverse Event|9|||
48606507|NCT00386334|156417002|FG001|Double Blind Period|Adverse Event|14|||
48606508|NCT00386334|156417001|FG000|Double Blind Period|Protocol Violation|1|||
48606509|NCT00386334|156417002|FG001|Double Blind Period|Protocol Violation|1|||
48606510|NCT00386334|156417001|FG000|Double Blind Period|Withdrawal by Subject|9|||
48606511|NCT00386334|156417002|FG001|Double Blind Period|Withdrawal by Subject|13|||
48540080|NCT02400671|156165855|FG002|Overall Study|Death|4|||
48540081|NCT02400671|156165853|FG000|Overall Study|Lost to Follow-up|20|||
48540082|NCT02400671|156165854|FG001|Overall Study|Lost to Follow-up|27|||
48606512|NCT00386334|156417001|FG000|Double Blind Period|Lack of Efficacy|20|||
48540083|NCT02400671|156165855|FG002|Overall Study|Lost to Follow-up|24|||
48540084|NCT02400671|156165853|FG000|Overall Study|Withdrawal by Subject|2|||
48540085|NCT02400671|156165854|FG001|Overall Study|Withdrawal by Subject|2|||
48540086|NCT02400671|156165855|FG002|Overall Study|Withdrawal by Subject|0|||
48540087|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
48540088|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
48540089|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
48540090|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
48540091|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
48540092|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
48540093|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
48540094|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
48540095|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
48540096|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
48540097|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
48540098|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
48540099|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
48540100|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
48540101|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
48540102|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
48540103|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
48540104|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
48540105|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
48540106|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
48540107|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
48540108|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
48540109|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
48540110|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
48540111|NCT01421342|156165856|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
48540112|NCT01421342|156165857|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
48540113|NCT01421342|156165858|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
48540114|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
48540115|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
48540116|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
48540117|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
48540118|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
48540119|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
48540120|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
48540121|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
48540122|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
48540123|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
48540124|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
48540125|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
48540126|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
48540127|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
48540128|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
48540129|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
48540130|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
48540131|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
48540132|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
48540133|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
48540134|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
48540135|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
48540136|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
48540137|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
48540138|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
48540139|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
48540140|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
48540141|NCT01421342|156165856|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
48540142|NCT01421342|156165857|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
48540143|NCT01421342|156165858|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
48540144|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
48540145|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
48540146|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
48540147|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
48606513|NCT00386334|156417002|FG001|Double Blind Period|Lack of Efficacy|11|||
48606514|NCT00386334|156417001|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
48606515|NCT00386334|156417002|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
48606516|NCT00386334|156417001|FG000|Double Blind Period|Other|3|||
48606517|NCT00386334|156417002|FG001|Double Blind Period|Other|3|||
48606518|NCT00386334|156417001|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
48606519|NCT00386334|156417002|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
48606520|NCT01079780|156417003|FG000|Overall Study|Disease progression|43|||
48606521|NCT01079780|156417004|FG001|Overall Study|Disease progression|7|||
48606522|NCT01079780|156417005|FG002|Overall Study|Disease progression|31|||
48606523|NCT01079780|156417003|FG000|Overall Study|Adverse Event|13|||
48606524|NCT01079780|156417004|FG001|Overall Study|Adverse Event|5|||
48606525|NCT01079780|156417005|FG002|Overall Study|Adverse Event|7|||
48606526|NCT01079780|156417003|FG000|Overall Study|Death|2|||
48606527|NCT01079780|156417004|FG001|Overall Study|Death|0|||
48606528|NCT01079780|156417005|FG002|Overall Study|Death|2|||
48606529|NCT01079780|156417003|FG000|Overall Study|Withdrawal by Subject|6|||
48606530|NCT01079780|156417004|FG001|Overall Study|Withdrawal by Subject|4|||
48606531|NCT01079780|156417005|FG002|Overall Study|Withdrawal by Subject|4|||
48606532|NCT01079780|156417003|FG000|Overall Study|Alternative therapy|2|||
48606533|NCT01079780|156417004|FG001|Overall Study|Alternative therapy|0|||
48606534|NCT01079780|156417005|FG002|Overall Study|Alternative therapy|2|||
48606535|NCT01079780|156417003|FG000|Overall Study|Physician Decision|1|||
48606536|NCT01079780|156417004|FG001|Overall Study|Physician Decision|0|||
48606537|NCT01079780|156417005|FG002|Overall Study|Physician Decision|1|||
48606538|NCT01079780|156417003|FG000|Overall Study|Error made in lesion measurement|1|||
48606539|NCT01079780|156417004|FG001|Overall Study|Error made in lesion measurement|0|||
48606540|NCT01079780|156417005|FG002|Overall Study|Error made in lesion measurement|0|||
48606541|NCT01079780|156417003|FG000|Overall Study|Patient had surgery|1|||
48606542|NCT01079780|156417004|FG001|Overall Study|Patient had surgery|0|||
48606543|NCT01079780|156417005|FG002|Overall Study|Patient had surgery|0|||
48606544|NCT01079780|156417003|FG000|Overall Study|Treatment cycle delay|0|||
48606545|NCT01079780|156417004|FG001|Overall Study|Treatment cycle delay|0|||
48606546|NCT01079780|156417005|FG002|Overall Study|Treatment cycle delay|1|||
48606547|NCT01079780|156417003|FG000|Overall Study|Never started treatment|1|||
48606548|NCT01079780|156417004|FG001|Overall Study|Never started treatment|0|||
48606549|NCT01079780|156417005|FG002|Overall Study|Never started treatment|2|||
48606550|NCT01178294|156417011|FG000|Overall Study|Adverse Event|4|||
48606551|NCT01178294|156417011|FG000|Overall Study|Lost to Follow-up|2|||
48606552|NCT01178294|156417011|FG000|Overall Study|Lack of Efficacy|1|||
48606553|NCT01178294|156417011|FG000|Overall Study|Death|1|||
48606554|NCT01178294|156417011|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
48606555|NCT01178294|156417011|FG000|Overall Study|Subject status is terminal|1|||
48606556|NCT01178294|156417011|FG000|Overall Study|Completion status could not be verified|1|||
48606557|NCT03435055|156417012|FG000|Screening|Physician Decision|2|||
48606558|NCT03435055|156417012|FG000|Received Intervention|Did not complete nitrous administration|3|||
48606559|NCT01239797|156417013|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
48606560|NCT01239797|156417014|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
48606561|NCT01239797|156417013|FG000|Randomized Participants|Participant withdrew consent|1|||
48606562|NCT01239797|156417014|FG001|Randomized Participants|Participant withdrew consent|7|||
48606563|NCT01239797|156417013|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
48606564|NCT01239797|156417014|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
48540148|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
48540149|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
48540150|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
48540151|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
48540152|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
48540153|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
48540154|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
48540155|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
48540156|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
48540157|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
48540158|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
48540159|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
48606565|NCT01239797|156417013|FG000|Treated Participants|Disease progression|185|||
48606566|NCT01239797|156417014|FG001|Treated Participants|Disease progression|185|||
48606567|NCT01239797|156417013|FG000|Treated Participants|Study drug toxicity|39|||
48606568|NCT01239797|156417014|FG001|Treated Participants|Study drug toxicity|45|||
48606569|NCT01239797|156417013|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
48606570|NCT01239797|156417014|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
48606571|NCT01239797|156417013|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
48606572|NCT01239797|156417014|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
48606573|NCT01239797|156417013|FG000|Treated Participants|Administrative reason by sponsor|13|||
48606574|NCT01239797|156417014|FG001|Treated Participants|Administrative reason by sponsor|4|||
48606575|NCT01239797|156417013|FG000|Treated Participants|Other reasons|14|||
48540160|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
48606576|NCT01239797|156417014|FG001|Treated Participants|Other reasons|14|||
48606577|NCT01239797|156417013|FG000|Treated Participants|Participant withdrew consent|6|||
48606578|NCT01239797|156417014|FG001|Treated Participants|Participant withdrew consent|11|||
48606579|NCT01239797|156417013|FG000|Treated Participants|Death|1|||
48540161|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
48540162|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
48540163|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
48540164|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
48540165|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
48540166|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
48540167|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
48540168|NCT01421342|156165856|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
48540169|NCT01421342|156165857|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
48540170|NCT01421342|156165858|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
48540171|NCT03578237|156165859|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
48540172|NCT03578237|156165860|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
48540173|NCT04397445|156165863|FG000|Overall Study|Withdrawal by Subject|1|||
48540174|NCT04397445|156165864|FG001|Overall Study|Withdrawal by Subject|0|||
48540175|NCT04397445|156165865|FG002|Overall Study|Withdrawal by Subject|0|||
48540176|NCT04397445|156165866|FG003|Overall Study|Withdrawal by Subject|0|||
48540177|NCT02310646|156165868|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
48540178|NCT02310646|156165869|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
48540179|NCT02310646|156165868|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
48540180|NCT02310646|156165869|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
48540181|NCT00857792|156165874|FG000|Overall Study|inadequate image quality for analysis|12|||
48540182|NCT00584844|156165875|FG000|Overall Study|Withdrawal by Subject|59|||
48540183|NCT00584844|156165875|FG000|Overall Study|Screen Failure|20|||
48540184|NCT02238626|156165880|FG000|Overall Study|Adverse Event|3|||
48540185|NCT02238626|156165881|FG001|Overall Study|Adverse Event|5|||
48540186|NCT02238626|156165882|FG002|Overall Study|Adverse Event|0|||
48540187|NCT02238626|156165883|FG003|Overall Study|Adverse Event|3|||
48540188|NCT02238626|156165880|FG000|Overall Study|Lost to Follow-up|2|||
48540189|NCT02238626|156165881|FG001|Overall Study|Lost to Follow-up|4|||
48540190|NCT02238626|156165882|FG002|Overall Study|Lost to Follow-up|2|||
48540191|NCT02238626|156165883|FG003|Overall Study|Lost to Follow-up|2|||
48540192|NCT02238626|156165880|FG000|Overall Study|Withdrawal by Subject|0|||
48540193|NCT02238626|156165881|FG001|Overall Study|Withdrawal by Subject|3|||
48540194|NCT02238626|156165882|FG002|Overall Study|Withdrawal by Subject|0|||
48540195|NCT02238626|156165883|FG003|Overall Study|Withdrawal by Subject|1|||
48540196|NCT02238626|156165880|FG000|Overall Study|Death|0|||
48540197|NCT02238626|156165881|FG001|Overall Study|Death|0|||
48606580|NCT01239797|156417014|FG001|Treated Participants|Death|1|||
48606581|NCT01239797|156417013|FG000|Treated Participants|Participant no longer meets study criteria|1|||
48606582|NCT01239797|156417014|FG001|Treated Participants|Participant no longer meets study criteria|1|||
48540198|NCT02238626|156165882|FG002|Overall Study|Death|1|||
48540199|NCT02238626|156165883|FG003|Overall Study|Death|1|||
48540200|NCT02238626|156165880|FG000|Overall Study|Other|0|||
48540201|NCT02238626|156165881|FG001|Overall Study|Other|2|||
48540202|NCT02238626|156165882|FG002|Overall Study|Other|0|||
48540203|NCT02238626|156165883|FG003|Overall Study|Other|0|||
48540204|NCT01797835|156165887|FG000|Overall Study|Lost to Follow-up|31|||
48540205|NCT01797835|156165888|FG001|Overall Study|Lost to Follow-up|27|||
48540206|NCT03001219|156165889|FG000|Proof of Concept|Study Termination by Sponsor|0|||
48540207|NCT03001219|156165890|FG001|Proof of Concept|Study Termination by Sponsor|1|||
48540208|NCT03001219|156165889|FG000|Proof of Concept|Withdrawal by Subject|0|||
48540209|NCT03001219|156165890|FG001|Proof of Concept|Withdrawal by Subject|4|||
48540210|NCT03001219|156165889|FG000|Proof of Concept|Protocol Deviation|0|||
48540211|NCT03001219|156165890|FG001|Proof of Concept|Protocol Deviation|1|||
48540212|NCT03001219|156165889|FG000|Proof of Concept|Adverse Event|1|||
48540213|NCT03001219|156165890|FG001|Proof of Concept|Adverse Event|1|||
48606583|NCT01239797|156417013|FG000|Treated Participants|Poor/non-compliance|0|||
48606584|NCT01239797|156417014|FG001|Treated Participants|Poor/non-compliance|1|||
48606585|NCT03712280|156417015|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
48540214|NCT03001219|156165889|FG000|Proof of Concept|Physician Decision|1|||
48540215|NCT03001219|156165890|FG001|Proof of Concept|Physician Decision|0|||
48540216|NCT03001219|156165889|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
48540217|NCT03001219|156165890|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
48540218|NCT03001219|156165889|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
48540219|NCT03001219|156165890|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
48540220|NCT03001219|156165889|FG000|Extension Period Analysis|Physician Decision|0|||
48540221|NCT03001219|156165890|FG001|Extension Period Analysis|Physician Decision|1|||
48540222|NCT03001219|156165889|FG000|Extension Period Analysis|Adverse Event|1|||
48540223|NCT03001219|156165890|FG001|Extension Period Analysis|Adverse Event|1|||
48540224|NCT03001219|156165889|FG000|Extension Period Analysis|Protocol Deviation|0|||
48540225|NCT03001219|156165890|FG001|Extension Period Analysis|Protocol Deviation|1|||
48540226|NCT03001219|156165889|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
48540227|NCT03001219|156165890|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
48540228|NCT01403064|156165893|FG000|Overall Study|Death|0|||
48540229|NCT01403064|156165894|FG001|Overall Study|Death|0|||
48540230|NCT01403064|156165895|FG002|Overall Study|Death|1|||
48540231|NCT01403064|156165896|FG003|Overall Study|Death|1|||
48540232|NCT01403064|156165893|FG000|Overall Study|Withdrawal by Subject|0|||
48540233|NCT01403064|156165894|FG001|Overall Study|Withdrawal by Subject|0|||
48540234|NCT01403064|156165895|FG002|Overall Study|Withdrawal by Subject|1|||
48540235|NCT01403064|156165896|FG003|Overall Study|Withdrawal by Subject|1|||
48540236|NCT01403064|156165893|FG000|Overall Study|Other|1|||
48606586|NCT03712280|156417016|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
48606587|NCT03712280|156417017|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
48606588|NCT03712280|156417018|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
48606589|NCT03712280|156417015|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
48606590|NCT03712280|156417016|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
48606591|NCT03712280|156417017|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
48606592|NCT03712280|156417018|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
48606593|NCT03712280|156417015|FG000|Overall Study|Adverse Event|0|||
48606594|NCT03712280|156417016|FG001|Overall Study|Adverse Event|0|||
48606595|NCT03712280|156417017|FG002|Overall Study|Adverse Event|1|||
48606596|NCT03712280|156417018|FG003|Overall Study|Adverse Event|0|||
48606597|NCT02133508|156417026|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
48606598|NCT02133508|156417026|FG000|Overall Study|Death|12|||
48606599|NCT02133508|156417026|FG000|Overall Study|Lost to Follow-up|2|||
48606600|NCT02643693|156417027|FG000|Overall Study|Physician Decision|0|||
48606601|NCT02643693|156417028|FG001|Overall Study|Physician Decision|1|||
48606602|NCT02643693|156417029|FG002|Overall Study|Physician Decision|0|||
48606603|NCT02643693|156417030|FG003|Overall Study|Physician Decision|0|||
48606604|NCT02643693|156417031|FG004|Overall Study|Physician Decision|0|||
48606605|NCT02643693|156417032|FG005|Overall Study|Physician Decision|0|||
48606606|NCT02643693|156417027|FG000|Overall Study|Withdrawal by Subject|0|||
48606607|NCT02643693|156417028|FG001|Overall Study|Withdrawal by Subject|1|||
48606608|NCT02643693|156417029|FG002|Overall Study|Withdrawal by Subject|0|||
48606609|NCT02643693|156417030|FG003|Overall Study|Withdrawal by Subject|0|||
48606610|NCT02643693|156417031|FG004|Overall Study|Withdrawal by Subject|0|||
48606611|NCT02643693|156417032|FG005|Overall Study|Withdrawal by Subject|0|||
48606612|NCT02643693|156417027|FG000|Overall Study|Protocol Adherence Issues|2|||
48606613|NCT02643693|156417028|FG001|Overall Study|Protocol Adherence Issues|0|||
48606614|NCT02643693|156417029|FG002|Overall Study|Protocol Adherence Issues|1|||
48540237|NCT01403064|156165894|FG001|Overall Study|Other|0|||
48540238|NCT01403064|156165895|FG002|Overall Study|Other|2|||
48540239|NCT01403064|156165896|FG003|Overall Study|Other|1|||
48540240|NCT01660334|156165899|FG000|Overall Study|Lost to Follow-up|1|||
48540241|NCT00816361|156165900|FG000|Overall Study|Withdrawal by Subject|0|||
48540242|NCT00816361|156165901|FG001|Overall Study|Withdrawal by Subject|0|||
48540243|NCT00816361|156165902|FG002|Overall Study|Withdrawal by Subject|0|||
48540244|NCT00816361|156165903|FG003|Overall Study|Withdrawal by Subject|0|||
48540245|NCT00816361|156165904|FG004|Overall Study|Withdrawal by Subject|1|||
48540246|NCT00816361|156165905|FG005|Overall Study|Withdrawal by Subject|2|||
48540247|NCT00816361|156165906|FG006|Overall Study|Withdrawal by Subject|0|||
48540248|NCT00816361|156165907|FG007|Overall Study|Withdrawal by Subject|2|||
48540249|NCT00816361|156165908|FG008|Overall Study|Withdrawal by Subject|1|||
48540250|NCT00816361|156165900|FG000|Overall Study|Death|4|||
48540251|NCT00816361|156165901|FG001|Overall Study|Death|3|||
48540252|NCT00816361|156165902|FG002|Overall Study|Death|3|||
48606615|NCT02643693|156417030|FG003|Overall Study|Protocol Adherence Issues|0|||
48540253|NCT00816361|156165903|FG003|Overall Study|Death|3|||
48540254|NCT00816361|156165904|FG004|Overall Study|Death|1|||
48540255|NCT00816361|156165905|FG005|Overall Study|Death|1|||
48540256|NCT00816361|156165906|FG006|Overall Study|Death|3|||
48606616|NCT02643693|156417031|FG004|Overall Study|Protocol Adherence Issues|0|||
48606617|NCT02643693|156417032|FG005|Overall Study|Protocol Adherence Issues|1|||
48606618|NCT01670292|156417034|FG000|Overall Study|Lost to Follow-up|14|||
48606619|NCT03903172|156417035|FG000|Overall Study|screen fail|4|||
48606620|NCT03903172|156417036|FG001|Overall Study|screen fail|1|||
48606621|NCT01701245|156417037|FG000|Overall Study|Protocol Violation|1|||
48606622|NCT01701245|156417038|FG001|Overall Study|Protocol Violation|3|||
48606623|NCT01701245|156417037|FG000|Overall Study|Did not complete the open label period|11|||
48606624|NCT01701245|156417038|FG001|Overall Study|Did not complete the open label period|12|||
48540257|NCT00816361|156165907|FG007|Overall Study|Death|7|||
48540258|NCT00816361|156165908|FG008|Overall Study|Death|8|||
48540259|NCT00816361|156165900|FG000|Overall Study|Other|0|||
48540260|NCT00816361|156165901|FG001|Overall Study|Other|0|||
48540261|NCT00816361|156165902|FG002|Overall Study|Other|0|||
48540262|NCT00816361|156165903|FG003|Overall Study|Other|0|||
48540263|NCT00816361|156165904|FG004|Overall Study|Other|0|||
48540264|NCT00816361|156165905|FG005|Overall Study|Other|0|||
48540265|NCT00816361|156165906|FG006|Overall Study|Other|0|||
48540266|NCT00816361|156165907|FG007|Overall Study|Other|0|||
48540267|NCT00816361|156165908|FG008|Overall Study|Other|1|||
48540268|NCT00311311|156165909|FG000|Overall Study|Adverse Event|3|||
48540269|NCT00311311|156165910|FG001|Overall Study|Adverse Event|2|||
48606625|NCT01787552|156417042|FG000|Overall Study|Withdrawal by Subject|2|||
48540270|NCT00311311|156165909|FG000|Overall Study|Withdrawal by Subject|1|||
48540271|NCT00311311|156165910|FG001|Overall Study|Withdrawal by Subject|1|||
48540272|NCT00311311|156165909|FG000|Overall Study|Noncompliance|0|||
48540273|NCT00311311|156165910|FG001|Overall Study|Noncompliance|1|||
48540274|NCT00311311|156165909|FG000|Overall Study|Study Termination by Sponsor|3|||
48540275|NCT00311311|156165910|FG001|Overall Study|Study Termination by Sponsor|4|||
48606626|NCT01787552|156417043|FG001|Overall Study|Withdrawal by Subject|0|||
48606627|NCT01787552|156417044|FG002|Overall Study|Withdrawal by Subject|0|||
48606628|NCT01787552|156417045|FG003|Overall Study|Withdrawal by Subject|4|||
48606629|NCT01787552|156417042|FG000|Overall Study|Physician Decision|2|||
48606630|NCT01787552|156417043|FG001|Overall Study|Physician Decision|2|||
48540276|NCT00311311|156165909|FG000|Overall Study|Death|1|||
48540277|NCT00311311|156165910|FG001|Overall Study|Death|0|||
48540278|NCT00311311|156165909|FG000|Overall Study|Lack of ancillary assistance|0|||
48540279|NCT00311311|156165910|FG001|Overall Study|Lack of ancillary assistance|1|||
48540280|NCT00546572|156165912|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
48606631|NCT01787552|156417044|FG002|Overall Study|Physician Decision|1|||
48606632|NCT01787552|156417045|FG003|Overall Study|Physician Decision|2|||
48606633|NCT01787552|156417042|FG000|Overall Study|Death|0|||
48606634|NCT01787552|156417043|FG001|Overall Study|Death|0|||
48540281|NCT00546572|156165913|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
48540282|NCT00546572|156165912|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
48540283|NCT00546572|156165913|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
48540284|NCT00546572|156165912|FG000|Vax 1 / Year 0|Protocol Violation|3|||
48540285|NCT00546572|156165913|FG001|Vax 1 / Year 0|Protocol Violation|4|||
48540286|NCT00546572|156165912|FG000|Vax 1 / Year 0|Death|2|||
48540287|NCT00546572|156165913|FG001|Vax 1 / Year 0|Death|2|||
48540288|NCT00546572|156165912|FG000|Vax 1 / Year 0|Adverse Event|0|||
48540289|NCT00546572|156165913|FG001|Vax 1 / Year 0|Adverse Event|1|||
48540290|NCT00546572|156165912|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
48540291|NCT00546572|156165913|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
48540292|NCT00546572|156165912|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
48540293|NCT00546572|156165913|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
48540294|NCT00546572|156165912|FG000|Vax 2 / Year 1|Other|1|||
48540295|NCT00546572|156165913|FG001|Vax 2 / Year 1|Other|1|||
48540296|NCT00546572|156165912|FG000|Vax 2 / Year 1|Adverse Event|1|||
48540297|NCT00546572|156165913|FG001|Vax 2 / Year 1|Adverse Event|0|||
48540298|NCT00546572|156165912|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
48540299|NCT00546572|156165913|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
48540300|NCT01986010|156165916|FG000|Overall Study|Adverse Event|0|||
48540301|NCT01986010|156165917|FG001|Overall Study|Adverse Event|1|||
48540302|NCT01986010|156165918|FG002|Overall Study|Adverse Event|0|||
48540303|NCT01986010|156165919|FG003|Overall Study|Adverse Event|0|||
48540304|NCT01986010|156165920|FG004|Overall Study|Adverse Event|0|||
48540305|NCT01986010|156165921|FG005|Overall Study|Adverse Event|0|||
48540306|NCT01986010|156165922|FG006|Overall Study|Adverse Event|0|||
48540307|NCT01986010|156165923|FG007|Overall Study|Adverse Event|0|||
48540308|NCT01986010|156165924|FG008|Overall Study|Adverse Event|0|||
48540309|NCT01986010|156165925|FG009|Overall Study|Adverse Event|0|||
48540310|NCT01986010|156165926|FG010|Overall Study|Adverse Event|0|||
48540311|NCT01986010|156165927|FG011|Overall Study|Adverse Event|0|||
48540312|NCT01986010|156165928|FG012|Overall Study|Adverse Event|0|||
48540313|NCT01986010|156165929|FG013|Overall Study|Adverse Event|0|||
48540314|NCT01986010|156165930|FG014|Overall Study|Adverse Event|0|||
48540315|NCT01986010|156165931|FG015|Overall Study|Adverse Event|1|||
48540316|NCT01986010|156165932|FG016|Overall Study|Adverse Event|0|||
48540317|NCT01986010|156165916|FG000|Overall Study|Lost to Follow-up|2|||
48540318|NCT01986010|156165917|FG001|Overall Study|Lost to Follow-up|1|||
48540319|NCT01986010|156165918|FG002|Overall Study|Lost to Follow-up|2|||
48540320|NCT01986010|156165919|FG003|Overall Study|Lost to Follow-up|2|||
48540321|NCT01986010|156165920|FG004|Overall Study|Lost to Follow-up|2|||
48540322|NCT01986010|156165921|FG005|Overall Study|Lost to Follow-up|2|||
48540323|NCT01986010|156165922|FG006|Overall Study|Lost to Follow-up|0|||
48540324|NCT01986010|156165923|FG007|Overall Study|Lost to Follow-up|0|||
48540325|NCT01986010|156165924|FG008|Overall Study|Lost to Follow-up|4|||
48540326|NCT01986010|156165925|FG009|Overall Study|Lost to Follow-up|2|||
48540327|NCT01986010|156165926|FG010|Overall Study|Lost to Follow-up|0|||
48540328|NCT01986010|156165927|FG011|Overall Study|Lost to Follow-up|1|||
48540329|NCT01986010|156165928|FG012|Overall Study|Lost to Follow-up|1|||
48540330|NCT01986010|156165929|FG013|Overall Study|Lost to Follow-up|1|||
48540331|NCT01986010|156165930|FG014|Overall Study|Lost to Follow-up|2|||
48540332|NCT01986010|156165931|FG015|Overall Study|Lost to Follow-up|0|||
48540333|NCT01986010|156165932|FG016|Overall Study|Lost to Follow-up|0|||
48540334|NCT01986010|156165916|FG000|Overall Study|Physician Decision|0|||
48540335|NCT01986010|156165917|FG001|Overall Study|Physician Decision|0|||
48540336|NCT01986010|156165918|FG002|Overall Study|Physician Decision|0|||
48540337|NCT01986010|156165919|FG003|Overall Study|Physician Decision|0|||
48540338|NCT01986010|156165920|FG004|Overall Study|Physician Decision|0|||
48540339|NCT01986010|156165921|FG005|Overall Study|Physician Decision|0|||
48540340|NCT01986010|156165922|FG006|Overall Study|Physician Decision|0|||
48540341|NCT01986010|156165923|FG007|Overall Study|Physician Decision|0|||
48540342|NCT01986010|156165924|FG008|Overall Study|Physician Decision|0|||
48540343|NCT01986010|156165925|FG009|Overall Study|Physician Decision|0|||
48540344|NCT01986010|156165926|FG010|Overall Study|Physician Decision|0|||
48540345|NCT01986010|156165927|FG011|Overall Study|Physician Decision|0|||
48540346|NCT01986010|156165928|FG012|Overall Study|Physician Decision|0|||
48540347|NCT01986010|156165929|FG013|Overall Study|Physician Decision|0|||
48540348|NCT01986010|156165930|FG014|Overall Study|Physician Decision|1|||
48540349|NCT01986010|156165931|FG015|Overall Study|Physician Decision|0|||
48606635|NCT01787552|156417044|FG002|Overall Study|Death|0|||
48540350|NCT01986010|156165932|FG016|Overall Study|Physician Decision|0|||
48540351|NCT01986010|156165916|FG000|Overall Study|Withdrawal by Subject|2|||
48540352|NCT01986010|156165917|FG001|Overall Study|Withdrawal by Subject|2|||
48540353|NCT01986010|156165918|FG002|Overall Study|Withdrawal by Subject|3|||
48540354|NCT01986010|156165919|FG003|Overall Study|Withdrawal by Subject|0|||
48540355|NCT01986010|156165920|FG004|Overall Study|Withdrawal by Subject|2|||
48540356|NCT01986010|156165921|FG005|Overall Study|Withdrawal by Subject|4|||
48540357|NCT01986010|156165922|FG006|Overall Study|Withdrawal by Subject|0|||
48540358|NCT01986010|156165923|FG007|Overall Study|Withdrawal by Subject|0|||
48606636|NCT01787552|156417045|FG003|Overall Study|Death|1|||
48606637|NCT01787552|156417042|FG000|Overall Study|Adverse Event|2|||
48606638|NCT01787552|156417043|FG001|Overall Study|Adverse Event|5|||
48606639|NCT01787552|156417044|FG002|Overall Study|Adverse Event|2|||
48606640|NCT01787552|156417045|FG003|Overall Study|Adverse Event|16|||
48606641|NCT01787552|156417042|FG000|Overall Study|Study terminated by Sponsor|0|||
48606642|NCT01787552|156417043|FG001|Overall Study|Study terminated by Sponsor|0|||
48606643|NCT01787552|156417044|FG002|Overall Study|Study terminated by Sponsor|1|||
48606644|NCT01787552|156417045|FG003|Overall Study|Study terminated by Sponsor|3|||
48606645|NCT01787552|156417042|FG000|Overall Study|Progressive Disease|2|||
48606646|NCT01787552|156417043|FG001|Overall Study|Progressive Disease|2|||
48606647|NCT01787552|156417044|FG002|Overall Study|Progressive Disease|1|||
48606648|NCT01787552|156417045|FG003|Overall Study|Progressive Disease|1|||
48606649|NCT00207740|156417048|FG000|Overall Study|Adverse Event|4|||
48606650|NCT00207740|156417049|FG001|Overall Study|Adverse Event|14|||
48606651|NCT00207740|156417050|FG002|Overall Study|Adverse Event|14|||
48606652|NCT00207740|156417051|FG003|Overall Study|Adverse Event|11|||
48606653|NCT00207740|156417048|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48606654|NCT00207740|156417049|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48606655|NCT00207740|156417050|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48606656|NCT00207740|156417051|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
48606657|NCT00207740|156417048|FG000|Overall Study|Lost to Follow-up|0|||
48606658|NCT00207740|156417049|FG001|Overall Study|Lost to Follow-up|2|||
48606659|NCT00207740|156417050|FG002|Overall Study|Lost to Follow-up|1|||
48606660|NCT00207740|156417051|FG003|Overall Study|Lost to Follow-up|1|||
48606661|NCT00207740|156417048|FG000|Overall Study|Death|0|||
48606662|NCT00207740|156417049|FG001|Overall Study|Death|0|||
48606663|NCT00207740|156417050|FG002|Overall Study|Death|0|||
48606664|NCT00207740|156417051|FG003|Overall Study|Death|1|||
48606665|NCT00207740|156417048|FG000|Overall Study|Sponsor Directive|22|||
48606666|NCT00207740|156417049|FG001|Overall Study|Sponsor Directive|15|||
48606667|NCT00207740|156417050|FG002|Overall Study|Sponsor Directive|16|||
48606668|NCT00207740|156417051|FG003|Overall Study|Sponsor Directive|21|||
48606669|NCT00207740|156417048|FG000|Overall Study|Other|2|||
48540359|NCT01986010|156165924|FG008|Overall Study|Withdrawal by Subject|0|||
48540360|NCT01986010|156165925|FG009|Overall Study|Withdrawal by Subject|0|||
48540361|NCT01986010|156165926|FG010|Overall Study|Withdrawal by Subject|0|||
48540362|NCT01986010|156165927|FG011|Overall Study|Withdrawal by Subject|2|||
48540363|NCT01986010|156165928|FG012|Overall Study|Withdrawal by Subject|0|||
48540364|NCT01986010|156165929|FG013|Overall Study|Withdrawal by Subject|1|||
48540365|NCT01986010|156165930|FG014|Overall Study|Withdrawal by Subject|2|||
48540366|NCT01986010|156165931|FG015|Overall Study|Withdrawal by Subject|0|||
48540367|NCT01986010|156165932|FG016|Overall Study|Withdrawal by Subject|0|||
48540368|NCT01986010|156165916|FG000|Overall Study|Status Not Recorded|2|||
48540369|NCT01986010|156165917|FG001|Overall Study|Status Not Recorded|4|||
48540370|NCT01986010|156165918|FG002|Overall Study|Status Not Recorded|2|||
48540371|NCT01986010|156165919|FG003|Overall Study|Status Not Recorded|0|||
48540372|NCT01986010|156165920|FG004|Overall Study|Status Not Recorded|1|||
48540373|NCT01986010|156165921|FG005|Overall Study|Status Not Recorded|2|||
48540374|NCT01986010|156165922|FG006|Overall Study|Status Not Recorded|0|||
48540375|NCT01986010|156165923|FG007|Overall Study|Status Not Recorded|0|||
48540376|NCT01986010|156165924|FG008|Overall Study|Status Not Recorded|2|||
48540377|NCT01986010|156165925|FG009|Overall Study|Status Not Recorded|1|||
48540378|NCT01986010|156165926|FG010|Overall Study|Status Not Recorded|7|||
48540379|NCT01986010|156165927|FG011|Overall Study|Status Not Recorded|7|||
48540380|NCT01986010|156165928|FG012|Overall Study|Status Not Recorded|9|||
48540381|NCT01986010|156165929|FG013|Overall Study|Status Not Recorded|9|||
48540382|NCT01986010|156165930|FG014|Overall Study|Status Not Recorded|5|||
48540383|NCT01986010|156165931|FG015|Overall Study|Status Not Recorded|10|||
48540384|NCT01986010|156165932|FG016|Overall Study|Status Not Recorded|4|||
48540385|NCT01394952|156165935|FG000|Overall Study|Lost to Follow-up|0|||
48540386|NCT01394952|156165936|FG001|Overall Study|Lost to Follow-up|5|||
48540387|NCT01394952|156165935|FG000|Overall Study|Withdrawal by Subject|10|||
48540388|NCT01394952|156165936|FG001|Overall Study|Withdrawal by Subject|5|||
48540389|NCT01394952|156165935|FG000|Overall Study|Physician Decision|2|||
48540390|NCT01394952|156165936|FG001|Overall Study|Physician Decision|0|||
48540391|NCT01394952|156165935|FG000|Overall Study|Sponsor Decision|5|||
48540392|NCT01394952|156165936|FG001|Overall Study|Sponsor Decision|7|||
48540393|NCT01481324|156165939|FG000|Overall Study|Missing Data|0|||
48540394|NCT01481324|156165940|FG001|Overall Study|Missing Data|2|||
48540395|NCT01481324|156165941|FG002|Overall Study|Missing Data|2|||
48540396|NCT03334721|156165943|FG000|Overall Study|Withdrawal by Subject|1|||
48540397|NCT03334721|156165944|FG001|Overall Study|Withdrawal by Subject|0|||
48540398|NCT03334721|156165943|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
48540399|NCT03334721|156165944|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
48540400|NCT00289874|156165945|FG000|Overall Study|Adverse Event|1|||
48540401|NCT00289874|156165946|FG001|Overall Study|Adverse Event|5|||
48540402|NCT00289874|156165945|FG000|Overall Study|Lost to Follow-up|1|||
48540403|NCT00289874|156165946|FG001|Overall Study|Lost to Follow-up|1|||
48540404|NCT00289874|156165945|FG000|Overall Study|Protocol Violation|3|||
48540405|NCT00289874|156165946|FG001|Overall Study|Protocol Violation|2|||
48540406|NCT00289874|156165945|FG000|Overall Study|Did not meet eligibility|1|||
48540407|NCT00289874|156165946|FG001|Overall Study|Did not meet eligibility|0|||
48540408|NCT03510182|156165949|FG000|Overall Study|Withdrawal by Subject|2|||
48606670|NCT00207740|156417049|FG001|Overall Study|Other|10|||
48606671|NCT00207740|156417050|FG002|Overall Study|Other|7|||
48606672|NCT00207740|156417051|FG003|Overall Study|Other|5|||
48606673|NCT00323063|156417052|FG000|Overall Study|Adverse Event|1|||
48606674|NCT00323063|156417053|FG001|Overall Study|Adverse Event|0|||
48606675|NCT00323063|156417052|FG000|Overall Study|brain mets discovered prior to treatment|1|||
48606676|NCT00323063|156417053|FG001|Overall Study|brain mets discovered prior to treatment|0|||
48606677|NCT03055936|156417054|FG000|Overall Study|Adverse Event|0|||
48540409|NCT03185013|156165960|FG000|Overall Study|Withdrawal by Subject|5|||
48540410|NCT03185013|156165961|FG001|Overall Study|Withdrawal by Subject|3|||
48540411|NCT03185013|156165960|FG000|Overall Study|Adverse Event|1|||
48540412|NCT03185013|156165961|FG001|Overall Study|Adverse Event|0|||
48540413|NCT03185013|156165960|FG000|Overall Study|Progressive Disease|1|||
48540414|NCT03185013|156165961|FG001|Overall Study|Progressive Disease|0|||
48540415|NCT03185013|156165960|FG000|Overall Study|Lost to Follow-up|8|||
48606678|NCT03055936|156417055|FG001|Overall Study|Adverse Event|1|||
48606679|NCT03055936|156417056|FG002|Overall Study|Adverse Event|1|||
48606680|NCT03055936|156417057|FG003|Overall Study|Adverse Event|1|||
48540416|NCT03185013|156165961|FG001|Overall Study|Lost to Follow-up|2|||
48540417|NCT03185013|156165960|FG000|Overall Study|Physician Decision|1|||
48606681|NCT03055936|156417054|FG000|Overall Study|Personal reason|2|||
48540418|NCT03185013|156165961|FG001|Overall Study|Physician Decision|0|||
48540419|NCT03185013|156165960|FG000|Overall Study|Protocol Deviation|2|||
48540420|NCT03185013|156165961|FG001|Overall Study|Protocol Deviation|0|||
48606682|NCT03055936|156417055|FG001|Overall Study|Personal reason|0|||
48606683|NCT03055936|156417056|FG002|Overall Study|Personal reason|1|||
48606684|NCT03055936|156417057|FG003|Overall Study|Personal reason|0|||
48606685|NCT00983372|156417064|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
48606686|NCT00983372|156417064|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
48606687|NCT00983372|156417064|FG000|Diltiazem ER Alone|Adverse Event|1|||
48606688|NCT00111761|156417074|FG000|Part 1|Physician Decision|0|||
48606689|NCT00111761|156417075|FG001|Part 1|Physician Decision|1|||
48606690|NCT00111761|156417074|FG000|Part 1|Death|0|||
48606691|NCT00111761|156417075|FG001|Part 1|Death|2|||
48606692|NCT00111761|156417074|FG000|Part 1|Other|0|||
48606693|NCT00111761|156417075|FG001|Part 1|Other|1|||
48606694|NCT00111761|156417074|FG000|Part 1|Withdrawal by Subject|0|||
48606695|NCT00111761|156417075|FG001|Part 1|Withdrawal by Subject|1|||
48606696|NCT00111761|156417074|FG000|Part 2|Adverse Event|1|||
48606697|NCT00111761|156417075|FG001|Part 2|Adverse Event|0|||
48606698|NCT00111761|156417074|FG000|Part 2|Physician Decision|1|||
48606699|NCT00111761|156417075|FG001|Part 2|Physician Decision|0|||
48606700|NCT00111761|156417074|FG000|Part 2|Death|1|||
48606701|NCT00111761|156417075|FG001|Part 2|Death|0|||
48606702|NCT00111761|156417074|FG000|Part 2|Disease progression|3|||
48606703|NCT00111761|156417075|FG001|Part 2|Disease progression|0|||
48606704|NCT00111761|156417074|FG000|Part 2|Protocol-specified criteria|1|||
48606705|NCT00111761|156417075|FG001|Part 2|Protocol-specified criteria|0|||
48606706|NCT00111761|156417074|FG000|Part 2|Other|1|||
48606707|NCT00111761|156417075|FG001|Part 2|Other|0|||
48606708|NCT00726609|156417076|FG000|Overall Study|Adverse Event|10|||
48606709|NCT00726609|156417076|FG000|Overall Study|Withdrawal by Subject|2|||
48606710|NCT00726609|156417076|FG000|Overall Study|Lack of Efficacy|25|||
48606711|NCT00726609|156417076|FG000|Overall Study|Other|16|||
48606712|NCT00726609|156417076|FG000|Overall Study|Missing|42|||
48606713|NCT00726609|156417076|FG000|Overall Study|Other|3|||
48606714|NCT01764841|156417079|FG000|Overall Study|Logistical Difficulties|0|||
48606715|NCT01764841|156417080|FG001|Overall Study|Logistical Difficulties|1|||
48606716|NCT01764841|156417081|FG002|Overall Study|Logistical Difficulties|0|||
48606717|NCT01764841|156417082|FG003|Overall Study|Logistical Difficulties|0|||
48606718|NCT01764841|156417079|FG000|Overall Study|Death|3|||
48606719|NCT01764841|156417080|FG001|Overall Study|Death|0|||
48606720|NCT01764841|156417081|FG002|Overall Study|Death|1|||
48606721|NCT01764841|156417082|FG003|Overall Study|Death|4|||
48606722|NCT01764841|156417079|FG000|Overall Study|No Follow Up|1|||
48606723|NCT01764841|156417080|FG001|Overall Study|No Follow Up|0|||
48606724|NCT01764841|156417081|FG002|Overall Study|No Follow Up|1|||
48606725|NCT01764841|156417082|FG003|Overall Study|No Follow Up|0|||
48606726|NCT01764841|156417079|FG000|Overall Study|Protocol Violation|0|||
48606727|NCT01764841|156417080|FG001|Overall Study|Protocol Violation|1|||
48606728|NCT01764841|156417081|FG002|Overall Study|Protocol Violation|0|||
48606729|NCT01764841|156417082|FG003|Overall Study|Protocol Violation|0|||
48606730|NCT01764841|156417079|FG000|Overall Study|Withdrawal by Subject|16|||
48606731|NCT01764841|156417080|FG001|Overall Study|Withdrawal by Subject|24|||
48606732|NCT01764841|156417081|FG002|Overall Study|Withdrawal by Subject|11|||
48606733|NCT01764841|156417082|FG003|Overall Study|Withdrawal by Subject|15|||
48540421|NCT03185013|156165960|FG000|Overall Study|Reason not Specified|3|||
48606734|NCT01764841|156417079|FG000|Overall Study|Lost to Follow-up|3|||
48606735|NCT01764841|156417080|FG001|Overall Study|Lost to Follow-up|0|||
48606736|NCT01764841|156417081|FG002|Overall Study|Lost to Follow-up|1|||
48606737|NCT01764841|156417082|FG003|Overall Study|Lost to Follow-up|0|||
48606738|NCT02144701|156417089|FG000|Overall Study|development of relapse, GVHD or death|9|||
48606739|NCT02144701|156417090|FG001|Overall Study|development of relapse, GVHD or death|3|||
48540422|NCT03185013|156165961|FG001|Overall Study|Reason not Specified|2|||
48540423|NCT03185013|156165960|FG000|Overall Study|Death|1|||
48540424|NCT03185013|156165961|FG001|Overall Study|Death|0|||
48540425|NCT00477295|156165962|FG000|Overall Study|Adverse Event|31|||
48540426|NCT00477295|156165963|FG001|Overall Study|Adverse Event|35|||
48540427|NCT00477295|156165962|FG000|Overall Study|Withdrawal by Subject|35|||
48540428|NCT00477295|156165963|FG001|Overall Study|Withdrawal by Subject|24|||
48540429|NCT00477295|156165962|FG000|Overall Study|Lack of Efficacy|23|||
48540430|NCT00477295|156165963|FG001|Overall Study|Lack of Efficacy|23|||
48540431|NCT00477295|156165962|FG000|Overall Study|Protocol Violation|3|||
48540432|NCT00477295|156165963|FG001|Overall Study|Protocol Violation|8|||
48540433|NCT00477295|156165962|FG000|Overall Study|Physician Decision|4|||
48540434|NCT00477295|156165963|FG001|Overall Study|Physician Decision|5|||
48540435|NCT00477295|156165962|FG000|Overall Study|Lost to Follow-up|21|||
48540436|NCT00477295|156165963|FG001|Overall Study|Lost to Follow-up|11|||
48606740|NCT01041859|156417093|FG000|Open-Label Titration|Adverse Event|69|||
48606741|NCT01041859|156417094|FG001|Open-Label Titration|Adverse Event|0|||
48606742|NCT01041859|156417095|FG002|Open-Label Titration|Adverse Event|0|||
48606743|NCT01041859|156417093|FG000|Open-Label Titration|Lack of Efficacy|3|||
48606744|NCT01041859|156417094|FG001|Open-Label Titration|Lack of Efficacy|0|||
48606745|NCT01041859|156417095|FG002|Open-Label Titration|Lack of Efficacy|0|||
48606746|NCT01041859|156417093|FG000|Open-Label Titration|Lost to Follow-up|1|||
48606747|NCT01041859|156417094|FG001|Open-Label Titration|Lost to Follow-up|0|||
48606748|NCT01041859|156417095|FG002|Open-Label Titration|Lost to Follow-up|0|||
48606749|NCT01041859|156417093|FG000|Open-Label Titration|Physician Decision|1|||
48606750|NCT01041859|156417094|FG001|Open-Label Titration|Physician Decision|0|||
48606751|NCT01041859|156417095|FG002|Open-Label Titration|Physician Decision|0|||
48606752|NCT01041859|156417093|FG000|Open-Label Titration|Protocol Violation|1|||
48606753|NCT01041859|156417094|FG001|Open-Label Titration|Protocol Violation|0|||
48606754|NCT01041859|156417095|FG002|Open-Label Titration|Protocol Violation|0|||
48606755|NCT01041859|156417093|FG000|Open-Label Titration|Other|7|||
48606756|NCT01041859|156417094|FG001|Open-Label Titration|Other|0|||
48606757|NCT01041859|156417095|FG002|Open-Label Titration|Other|0|||
48606758|NCT01041859|156417093|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
48606759|NCT01041859|156417094|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
48606760|NCT01041859|156417095|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
48606761|NCT01041859|156417093|FG000|Open-Label Titration|Withdrawal by Subject|11|||
48606762|NCT01041859|156417094|FG001|Open-Label Titration|Withdrawal by Subject|0|||
48606763|NCT01041859|156417095|FG002|Open-Label Titration|Withdrawal by Subject|0|||
48606764|NCT01041859|156417093|FG000|Double-Blind Maintenance|Adverse Event|0|||
48606765|NCT01041859|156417094|FG001|Double-Blind Maintenance|Adverse Event|23|||
48606766|NCT01041859|156417095|FG002|Double-Blind Maintenance|Adverse Event|13|||
48606767|NCT01041859|156417093|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
48606768|NCT01041859|156417094|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
48606769|NCT01041859|156417095|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
48606770|NCT01041859|156417093|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
48606771|NCT01041859|156417094|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
48606772|NCT01041859|156417095|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
48606773|NCT01041859|156417093|FG000|Double-Blind Maintenance|Physician Decision|0|||
48606774|NCT01041859|156417094|FG001|Double-Blind Maintenance|Physician Decision|2|||
48606775|NCT01041859|156417095|FG002|Double-Blind Maintenance|Physician Decision|1|||
48606776|NCT01041859|156417093|FG000|Double-Blind Maintenance|Protocol Violation|0|||
48606777|NCT01041859|156417094|FG001|Double-Blind Maintenance|Protocol Violation|1|||
48447061|NCT01072448|155824498|FG000|Overall Study|Adverse Event|9|||
48447062|NCT01072448|155824499|FG001|Overall Study|Adverse Event|10|||
48447063|NCT01072448|155824498|FG000|Overall Study|Subject withdrew consent|4|||
48447064|NCT01072448|155824499|FG001|Overall Study|Subject withdrew consent|9|||
48447065|NCT01072448|155824498|FG000|Overall Study|Protocol deviation|3|||
48447066|NCT01072448|155824499|FG001|Overall Study|Protocol deviation|4|||
48447067|NCT01072448|155824498|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48447068|NCT01072448|155824499|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48447069|NCT01072448|155824498|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48447070|NCT01072448|155824499|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48606778|NCT01041859|156417095|FG002|Double-Blind Maintenance|Protocol Violation|3|||
48606779|NCT01041859|156417093|FG000|Double-Blind Maintenance|Other|0|||
48606780|NCT01041859|156417094|FG001|Double-Blind Maintenance|Other|6|||
48606781|NCT01041859|156417095|FG002|Double-Blind Maintenance|Other|2|||
48606782|NCT01041859|156417093|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
48606783|NCT01041859|156417094|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
48606784|NCT01041859|156417095|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
48606785|NCT01041859|156417093|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
48606786|NCT01041859|156417094|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
48606787|NCT01041859|156417095|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
48606788|NCT02475369|156417096|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
48606789|NCT02475369|156417097|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
48606790|NCT02121210|156417100|FG000|Overall Study|Adverse Event|5|||
48606791|NCT02121210|156417101|FG001|Overall Study|Adverse Event|7|||
48606792|NCT02121210|156417100|FG000|Overall Study|Lack of Efficacy|2|||
48606793|NCT02121210|156417101|FG001|Overall Study|Lack of Efficacy|0|||
48606794|NCT02121210|156417100|FG000|Overall Study|Other than specified above|0|||
48606795|NCT02121210|156417101|FG001|Overall Study|Other than specified above|2|||
48606796|NCT04609514|156417106|FG000|Overall Study|Lost to Follow-up|5|||
48606797|NCT04609514|156417107|FG001|Overall Study|Lost to Follow-up|4|||
48606798|NCT04609514|156417106|FG000|Overall Study|Withdrawal by PI|0|||
48606799|NCT04609514|156417107|FG001|Overall Study|Withdrawal by PI|2|||
48606800|NCT03122171|156417108|FG000|Overall Study|Withdrawal by Subject|1|||
48606801|NCT00671788|156417109|FG000|Overall Study|Adverse Event|8|||
48606802|NCT00671788|156417109|FG000|Overall Study|Refused further treatment|3|||
48606803|NCT00671788|156417109|FG000|Overall Study|Ineligible|1|||
48606804|NCT00671788|156417109|FG000|Overall Study|MD Decision|1|||
48606805|NCT00671788|156417109|FG000|Overall Study|Other|1|||
48606806|NCT02460289|156417116|FG000|Overall Study|Adverse Event|1|||
48540437|NCT00477295|156165962|FG000|Overall Study|Other|4|||
48540438|NCT00477295|156165963|FG001|Overall Study|Other|3|||
48540439|NCT01425723|156165964|FG000|Overall Study|Lack of Efficacy|0|||
48540440|NCT01425723|156165965|FG001|Overall Study|Lack of Efficacy|1|||
48606807|NCT02460289|156417116|FG000|Overall Study|Withdrawal by Subject|8|||
48606808|NCT02460289|156417116|FG000|Overall Study|Lost to Follow-up|1|||
48606809|NCT00720499|156417117|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
48540441|NCT01425723|156165964|FG000|Overall Study|Withdrawal by Subject|1|||
48540442|NCT01425723|156165965|FG001|Overall Study|Withdrawal by Subject|4|||
48540443|NCT01425723|156165964|FG000|Overall Study|Lost to Follow-up|0|||
48540444|NCT01425723|156165965|FG001|Overall Study|Lost to Follow-up|3|||
48540445|NCT01425723|156165964|FG000|Overall Study|Physician Decision|2|||
48540446|NCT01425723|156165965|FG001|Overall Study|Physician Decision|0|||
48540447|NCT01425723|156165964|FG000|Overall Study|Other|1|||
48540448|NCT01425723|156165965|FG001|Overall Study|Other|10|||
48540449|NCT01565850|156165966|FG000|Overall Study|Adverse Event|0|||
48606810|NCT00720499|156417118|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
48606811|NCT00720499|156417117|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
48606812|NCT00720499|156417118|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
48606813|NCT00720499|156417117|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
48606814|NCT00720499|156417118|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
48606815|NCT00296517|156417119|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
48606816|NCT00296517|156417120|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
48606817|NCT00296517|156417119|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
48606818|NCT00296517|156417120|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
48606819|NCT00296517|156417119|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
48606820|NCT00296517|156417120|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
48606821|NCT00296517|156417119|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
48606822|NCT00296517|156417120|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
48606823|NCT00296517|156417119|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
48540450|NCT01565850|156165967|FG001|Overall Study|Adverse Event|1|||
48540451|NCT01565850|156165966|FG000|Overall Study|Lost to Follow-up|12|||
48606824|NCT00296517|156417120|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
48606825|NCT00296517|156417119|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
48606826|NCT00296517|156417120|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
48606827|NCT00296517|156417119|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
48606828|NCT00296517|156417120|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
48540452|NCT01565850|156165967|FG001|Overall Study|Lost to Follow-up|4|||
48540453|NCT01565850|156165966|FG000|Overall Study|Investigator's Discretion|2|||
48540454|NCT01565850|156165967|FG001|Overall Study|Investigator's Discretion|1|||
48540455|NCT01565850|156165966|FG000|Overall Study|Participant noncompliance|2|||
48540456|NCT01565850|156165967|FG001|Overall Study|Participant noncompliance|0|||
48540457|NCT01565850|156165966|FG000|Overall Study|Withdrew Consent|4|||
48606829|NCT00296517|156417119|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
48606830|NCT00296517|156417120|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
48606831|NCT00296517|156417119|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
48606832|NCT00296517|156417120|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
48606833|NCT02814526|156417121|FG000|Overall Study|Adverse Event|4|||
48606834|NCT02814526|156417122|FG001|Overall Study|Adverse Event|3|||
48606835|NCT02814526|156417121|FG000|Overall Study|Death|1|||
48606836|NCT02814526|156417122|FG001|Overall Study|Death|1|||
48606837|NCT02814526|156417121|FG000|Overall Study|Lost to Follow-up|3|||
48606838|NCT02814526|156417122|FG001|Overall Study|Lost to Follow-up|4|||
48606839|NCT02814526|156417121|FG000|Overall Study|non site physician decision|1|||
48606840|NCT02814526|156417122|FG001|Overall Study|non site physician decision|0|||
48606841|NCT02814526|156417121|FG000|Overall Study|participant noncompliance|1|||
48606842|NCT02814526|156417122|FG001|Overall Study|participant noncompliance|1|||
48606843|NCT02814526|156417121|FG000|Overall Study|Withdrawal by Subject|20|||
48606844|NCT02814526|156417122|FG001|Overall Study|Withdrawal by Subject|14|||
48606845|NCT02814526|156417121|FG000|Overall Study|safety risk|2|||
48606846|NCT02814526|156417122|FG001|Overall Study|safety risk|1|||
48606847|NCT02814526|156417121|FG000|Overall Study|early termination-study terminated|1|||
48606848|NCT02814526|156417122|FG001|Overall Study|early termination-study terminated|2|||
48606849|NCT02814526|156417121|FG000|Overall Study|Other|0|||
48606850|NCT02814526|156417122|FG001|Overall Study|Other|4|||
48606851|NCT00161213|156418455|FG000|Overall Study|Withdrawal by Subject|1|||
48540458|NCT01565850|156165967|FG001|Overall Study|Withdrew Consent|2|||
48540459|NCT03835221|156165968|FG000|Methafilcon A|Withdrawal by Subject|1|||
48540460|NCT00186043|156165969|FG000|Overall Study|Lack of Efficacy|1|||
48540461|NCT00186043|156165970|FG001|Overall Study|Lack of Efficacy|3|||
48540462|NCT00186043|156165969|FG000|Overall Study|Lost to Follow-up|4|||
48540463|NCT00186043|156165970|FG001|Overall Study|Lost to Follow-up|6|||
48540464|NCT00186043|156165969|FG000|Overall Study|Withdrawal by Subject|1|||
48540465|NCT00186043|156165970|FG001|Overall Study|Withdrawal by Subject|0|||
48540466|NCT00186043|156165969|FG000|Overall Study|Adverse Event|7|||
48540467|NCT00186043|156165970|FG001|Overall Study|Adverse Event|3|||
48540468|NCT00186043|156165969|FG000|Overall Study|Protocol Violation|2|||
48540469|NCT00186043|156165970|FG001|Overall Study|Protocol Violation|1|||
48540470|NCT04874636|156165971|FG000|Overall Study|Adverse Event|17|||
48540471|NCT04874636|156165972|FG001|Overall Study|Adverse Event|7|||
48540472|NCT04874636|156165971|FG000|Overall Study|Lost to Follow-up|1|||
48540473|NCT04874636|156165972|FG001|Overall Study|Lost to Follow-up|0|||
48540474|NCT04874636|156165971|FG000|Overall Study|Non-Compliance with Study Drug|2|||
48540475|NCT04874636|156165972|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48540476|NCT04874636|156165971|FG000|Overall Study|Physician Decision|1|||
48540477|NCT04874636|156165972|FG001|Overall Study|Physician Decision|0|||
48540478|NCT04874636|156165971|FG000|Overall Study|Withdrawal by Subject|6|||
48540479|NCT04874636|156165972|FG001|Overall Study|Withdrawal by Subject|5|||
48540480|NCT00446199|156165974|FG000|Overall Study|Adverse Event|7|||
48540481|NCT00446199|156165975|FG001|Overall Study|Adverse Event|4|||
48540482|NCT00446199|156165976|FG002|Overall Study|Adverse Event|6|||
48540483|NCT00446199|156165977|FG003|Overall Study|Adverse Event|4|||
48540484|NCT00446199|156165974|FG000|Overall Study|Lost to Follow-up|4|||
48540485|NCT00446199|156165975|FG001|Overall Study|Lost to Follow-up|5|||
48540486|NCT00446199|156165976|FG002|Overall Study|Lost to Follow-up|2|||
48540487|NCT00446199|156165977|FG003|Overall Study|Lost to Follow-up|6|||
48540488|NCT00446199|156165974|FG000|Overall Study|Protocol Violation|1|||
48540489|NCT00446199|156165975|FG001|Overall Study|Protocol Violation|2|||
48540490|NCT00446199|156165976|FG002|Overall Study|Protocol Violation|1|||
48606852|NCT00161213|156418455|FG000|Overall Study|Evaluable for toxicity but not response|1|||
48606853|NCT03964207|156418458|FG000|First Treatment|Withdrawal by Subject|1|||
48606854|NCT03964207|156418459|FG001|First Treatment|Withdrawal by Subject|2|||
48606855|NCT03964207|156418458|FG000|First Treatment|Protocol Violation|1|||
48606856|NCT03964207|156418459|FG001|First Treatment|Protocol Violation|0|||
48606857|NCT03964207|156418458|FG000|First Treatment|Lost to Follow-up|1|||
48606858|NCT03964207|156418459|FG001|First Treatment|Lost to Follow-up|0|||
48540491|NCT00446199|156165977|FG003|Overall Study|Protocol Violation|3|||
48540492|NCT00446199|156165974|FG000|Overall Study|Withdrawal by Subject|2|||
48540493|NCT00446199|156165975|FG001|Overall Study|Withdrawal by Subject|5|||
48540494|NCT00446199|156165976|FG002|Overall Study|Withdrawal by Subject|9|||
48606859|NCT03964207|156418458|FG000|Second Treatment|Lost to Follow-up|0|||
48540495|NCT00446199|156165977|FG003|Overall Study|Withdrawal by Subject|10|||
48540496|NCT00446199|156165974|FG000|Overall Study|Site termination|2|||
48540497|NCT00446199|156165975|FG001|Overall Study|Site termination|0|||
48540498|NCT00446199|156165976|FG002|Overall Study|Site termination|0|||
48540499|NCT00446199|156165977|FG003|Overall Study|Site termination|1|||
48540500|NCT00446199|156165974|FG000|Overall Study|Randomization in Error|2|||
48540501|NCT00446199|156165975|FG001|Overall Study|Randomization in Error|0|||
48540502|NCT00446199|156165976|FG002|Overall Study|Randomization in Error|1|||
48540503|NCT00446199|156165977|FG003|Overall Study|Randomization in Error|1|||
48540504|NCT00446199|156165974|FG000|Overall Study|Lack of Efficacy|1|||
48540505|NCT00446199|156165975|FG001|Overall Study|Lack of Efficacy|0|||
48540506|NCT00446199|156165976|FG002|Overall Study|Lack of Efficacy|0|||
48540507|NCT00446199|156165977|FG003|Overall Study|Lack of Efficacy|1|||
48540508|NCT00446199|156165974|FG000|Overall Study|Non-compliant with study drug|1|||
48540509|NCT00446199|156165975|FG001|Overall Study|Non-compliant with study drug|0|||
48540510|NCT00446199|156165976|FG002|Overall Study|Non-compliant with study drug|5|||
48540511|NCT00446199|156165977|FG003|Overall Study|Non-compliant with study drug|0|||
48540512|NCT00446199|156165974|FG000|Overall Study|Non-compliant with visit schedule|1|||
48540513|NCT00446199|156165975|FG001|Overall Study|Non-compliant with visit schedule|1|||
48540514|NCT00446199|156165976|FG002|Overall Study|Non-compliant with visit schedule|1|||
48540515|NCT00446199|156165977|FG003|Overall Study|Non-compliant with visit schedule|2|||
48540516|NCT00446199|156165974|FG000|Overall Study|Hormone fear|0|||
48540517|NCT00446199|156165975|FG001|Overall Study|Hormone fear|0|||
48540518|NCT00446199|156165976|FG002|Overall Study|Hormone fear|0|||
48540519|NCT00446199|156165977|FG003|Overall Study|Hormone fear|1|||
48540520|NCT00446199|156165974|FG000|Overall Study|Lost interest in study participation|0|||
48540521|NCT00446199|156165975|FG001|Overall Study|Lost interest in study participation|1|||
48540522|NCT00446199|156165976|FG002|Overall Study|Lost interest in study participation|0|||
48540523|NCT00446199|156165977|FG003|Overall Study|Lost interest in study participation|0|||
48540524|NCT00446199|156165974|FG000|Overall Study|In-/Exclusion criterion violated|2|||
48540525|NCT00446199|156165975|FG001|Overall Study|In-/Exclusion criterion violated|1|||
48540526|NCT00446199|156165976|FG002|Overall Study|In-/Exclusion criterion violated|2|||
48540527|NCT00446199|156165977|FG003|Overall Study|In-/Exclusion criterion violated|1|||
48540528|NCT00446199|156165974|FG000|Overall Study|Move|0|||
48540529|NCT00446199|156165975|FG001|Overall Study|Move|1|||
48540530|NCT00446199|156165976|FG002|Overall Study|Move|0|||
48540531|NCT00446199|156165977|FG003|Overall Study|Move|0|||
48540532|NCT01169532|156165981|FG000|Overall Study|Withdrawal by Subject|1|||
48540533|NCT02823652|156165982|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
48540534|NCT02823652|156165983|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
48540535|NCT02823652|156165984|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
48540536|NCT02823652|156165982|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
48540537|NCT02823652|156165983|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
48540538|NCT02823652|156165984|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
48540539|NCT02823652|156165982|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
48540540|NCT02823652|156165983|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
48540541|NCT02823652|156165984|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
48540542|NCT02823652|156165982|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
48540543|NCT02823652|156165983|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
48540544|NCT02823652|156165984|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
48540545|NCT00960115|156165995|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
48540546|NCT00960115|156165996|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
48540547|NCT03258853|156165997|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
48540548|NCT03258853|156165998|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
48540549|NCT01030341|156167527|FG000|Overall Study|Withdrawal by Subject|1|||
48540550|NCT01030341|156167527|FG000|Overall Study|Lost to Follow-up|2|||
48540551|NCT01685073|156167528|FG000|Overall Study|Lost to Follow-up|6|||
48540552|NCT01685073|156167529|FG001|Overall Study|Lost to Follow-up|8|||
48540553|NCT01685073|156167528|FG000|Overall Study|Withdrawal by Subject|24|||
48540554|NCT01685073|156167529|FG001|Overall Study|Withdrawal by Subject|24|||
48540555|NCT00821873|156167532|FG000|Overall Study|Lost to Follow-up|4|||
48540556|NCT00759902|156167533|FG000|Overall Study|Adverse Event|0|||
48540557|NCT00759902|156167534|FG001|Overall Study|Adverse Event|1|||
48540558|NCT00158756|156167541|FG000|Overall Study|Withdrawal by Subject|5|||
48540559|NCT00158756|156167542|FG001|Overall Study|Withdrawal by Subject|0|||
48540560|NCT00158756|156167543|FG002|Overall Study|Withdrawal by Subject|6|||
48540561|NCT00158756|156167544|FG003|Overall Study|Withdrawal by Subject|1|||
48540562|NCT00158756|156167545|FG004|Overall Study|Withdrawal by Subject|3|||
48540563|NCT00158756|156167541|FG000|Overall Study|Adverse Event|0|||
48540564|NCT00158756|156167542|FG001|Overall Study|Adverse Event|0|||
48540565|NCT00158756|156167543|FG002|Overall Study|Adverse Event|1|||
48540566|NCT00158756|156167544|FG003|Overall Study|Adverse Event|0|||
48540567|NCT00158756|156167545|FG004|Overall Study|Adverse Event|0|||
48540568|NCT00158756|156167541|FG000|Overall Study|Serious adverse event|0|||
48540569|NCT00158756|156167542|FG001|Overall Study|Serious adverse event|0|||
48540570|NCT00158756|156167543|FG002|Overall Study|Serious adverse event|1|||
48540571|NCT00158756|156167544|FG003|Overall Study|Serious adverse event|0|||
48540572|NCT00158756|156167545|FG004|Overall Study|Serious adverse event|0|||
48540573|NCT01173471|156167548|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48540574|NCT01173471|156167549|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48540575|NCT01173471|156167550|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
48540576|NCT01173471|156167551|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48540577|NCT01173471|156167548|FG000|Overall Study|Condition under investigation worsened|2|||
48540578|NCT01173471|156167549|FG001|Overall Study|Condition under investigation worsened|0|||
48540579|NCT01173471|156167550|FG002|Overall Study|Condition under investigation worsened|0|||
48540580|NCT01173471|156167551|FG003|Overall Study|Condition under investigation worsened|0|||
48540581|NCT01173471|156167548|FG000|Overall Study|Lost to Follow-up|0|||
48540582|NCT01173471|156167549|FG001|Overall Study|Lost to Follow-up|0|||
48540583|NCT01173471|156167550|FG002|Overall Study|Lost to Follow-up|1|||
48540584|NCT01173471|156167551|FG003|Overall Study|Lost to Follow-up|0|||
48540585|NCT01173471|156167548|FG000|Overall Study|Reason given as Other|0|||
48540586|NCT01173471|156167549|FG001|Overall Study|Reason given as Other|0|||
48540587|NCT01173471|156167550|FG002|Overall Study|Reason given as Other|1|||
48540588|NCT01173471|156167551|FG003|Overall Study|Reason given as Other|0|||
48540589|NCT01429051|156167552|FG000|Titration Phase|Death|1|||
48540590|NCT01429051|156167552|FG000|Titration Phase|Withdrawal by Subject|7|||
48540591|NCT01429051|156167552|FG000|Titration Phase|Physician Decision|1|||
48540592|NCT01429051|156167552|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
48540593|NCT01429051|156167552|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
48540594|NCT01429051|156167552|FG000|Efficacy Phase|Adverse Event|1|||
48540595|NCT01429051|156167552|FG000|Efficacy Phase|Death|1|||
48540596|NCT01429051|156167552|FG000|Tolerability Phase|Death|5|||
48540597|NCT01429051|156167552|FG000|Tolerability Phase|Adverse Event|2|||
48540598|NCT01429051|156167552|FG000|Tolerability Phase|Withdrawal by Subject|5|||
48540599|NCT01429051|156167552|FG000|Tolerability Phase|Physician Decision|1|||
48540600|NCT01429051|156167552|FG000|Tolerability Phase|Other|2|||
48540601|NCT03921151|156167553|FG000|Overall Study|Withdrawal by Subject|11|||
48540602|NCT03921151|156167554|FG001|Overall Study|Withdrawal by Subject|16|||
48540603|NCT04132336|156167557|FG000|Overall Study|Investigator Decision|0|||
48540604|NCT04132336|156167558|FG001|Overall Study|Investigator Decision|1|||
48540605|NCT04132336|156167559|FG002|Overall Study|Investigator Decision|0|||
48540606|NCT04132336|156167560|FG003|Overall Study|Investigator Decision|0|||
48540607|NCT04132336|156167561|FG004|Overall Study|Investigator Decision|0|||
48540608|NCT04132336|156167562|FG005|Overall Study|Investigator Decision|0|||
48540609|NCT04132336|156167563|FG006|Overall Study|Investigator Decision|0|||
48540610|NCT00891371|156167566|FG000|Pre-assignment|Inclusion/exclusion|5|||
48540611|NCT00891371|156167566|FG000|Pre-assignment|Consent withdrawal|1|||
48540612|NCT00891371|156167566|FG000|Treatment|Lack of Efficacy|5|||
48540613|NCT00891371|156167566|FG000|Treatment|Adverse Event|2|||
48540614|NCT00891371|156167566|FG000|Treatment|Death|1|||
48540615|NCT00891371|156167566|FG000|Treatment|Lost to Follow-up|1|||
48540616|NCT02017860|156167567|FG000|Overall Study|Adverse Event|1|||
48540617|NCT02017860|156167567|FG000|Overall Study|Withdrawal by Subject|1|||
48540618|NCT03656874|156167568|FG000|Overall Study|Lost to Follow-up|3|||
48540619|NCT03656874|156167569|FG001|Overall Study|Lost to Follow-up|17|||
48540620|NCT02488330|156167570|FG000|Overall Study|Adverse Event|1|||
48540621|NCT02488330|156167570|FG000|Overall Study|Physician Decision|2|||
48540622|NCT02488330|156167570|FG000|Overall Study|Death|2|||
48540623|NCT02488330|156167570|FG000|Overall Study|Disease Progression|3|||
48540624|NCT02488330|156167570|FG000|Overall Study|Study Termination by Sponsor|4|||
48540625|NCT01206816|156167571|FG000|Overall Study|Protocol Violation|0|||
48540626|NCT01206816|156167572|FG001|Overall Study|Protocol Violation|0|||
48540627|NCT01206816|156167573|FG002|Overall Study|Protocol Violation|1|||
48540628|NCT01206816|156167574|FG003|Overall Study|Protocol Violation|0|||
48540629|NCT01206816|156167575|FG004|Overall Study|Protocol Violation|0|||
48540630|NCT01206816|156167576|FG005|Overall Study|Protocol Violation|0|||
48540631|NCT01206816|156167577|FG006|Overall Study|Protocol Violation|0|||
48540632|NCT01206816|156167571|FG000|Overall Study|Withdrawal by Subject|0|||
48540633|NCT01206816|156167572|FG001|Overall Study|Withdrawal by Subject|0|||
48540634|NCT01206816|156167573|FG002|Overall Study|Withdrawal by Subject|1|||
48540635|NCT01206816|156167574|FG003|Overall Study|Withdrawal by Subject|0|||
48540636|NCT01206816|156167575|FG004|Overall Study|Withdrawal by Subject|0|||
48540637|NCT01206816|156167576|FG005|Overall Study|Withdrawal by Subject|0|||
48540638|NCT01206816|156167577|FG006|Overall Study|Withdrawal by Subject|0|||
48540639|NCT01206816|156167571|FG000|Overall Study|Progressive disease|3|||
48540640|NCT01206816|156167572|FG001|Overall Study|Progressive disease|3|||
48540641|NCT01206816|156167573|FG002|Overall Study|Progressive disease|13|||
48540642|NCT01206816|156167574|FG003|Overall Study|Progressive disease|3|||
48540643|NCT01206816|156167575|FG004|Overall Study|Progressive disease|3|||
48606860|NCT03964207|156418459|FG001|Second Treatment|Lost to Follow-up|1|||
48606861|NCT03964207|156418458|FG000|Second Treatment|Adverse Event|1|||
48606862|NCT03964207|156418459|FG001|Second Treatment|Adverse Event|2|||
48606863|NCT02579629|156418461|FG000|Overall Study|Withdrawal by Subject|0|||
48606864|NCT02579629|156418462|FG001|Overall Study|Withdrawal by Subject|1|||
48606865|NCT02579629|156418463|FG002|Overall Study|Withdrawal by Subject|0|||
48606866|NCT02579629|156418461|FG000|Overall Study|Screen Failure|2|||
48606867|NCT02579629|156418462|FG001|Overall Study|Screen Failure|0|||
48606868|NCT02579629|156418463|FG002|Overall Study|Screen Failure|2|||
48606869|NCT00183430|156418466|FG000|Overall Study|Adverse Event|1|||
48606870|NCT00183430|156418467|FG001|Overall Study|Adverse Event|0|||
48606871|NCT00183430|156418466|FG000|Overall Study|Lost to Follow-up|3|||
48606872|NCT00183430|156418467|FG001|Overall Study|Lost to Follow-up|0|||
48606873|NCT00183430|156418466|FG000|Overall Study|did not meet inclusion criteria|1|||
48606874|NCT00183430|156418467|FG001|Overall Study|did not meet inclusion criteria|0|||
48606875|NCT00183430|156418466|FG000|Overall Study|Withdrawal by Subject|1|||
48540644|NCT01206816|156167576|FG005|Overall Study|Progressive disease|16|||
48540645|NCT01206816|156167577|FG006|Overall Study|Progressive disease|3|||
48540646|NCT01206816|156167571|FG000|Overall Study|Other AE|0|||
48540647|NCT01206816|156167572|FG001|Overall Study|Other AE|0|||
48540648|NCT01206816|156167573|FG002|Overall Study|Other AE|4|||
48540649|NCT01206816|156167574|FG003|Overall Study|Other AE|0|||
48540650|NCT01206816|156167575|FG004|Overall Study|Other AE|0|||
48540651|NCT01206816|156167576|FG005|Overall Study|Other AE|3|||
48540652|NCT01206816|156167577|FG006|Overall Study|Other AE|2|||
48540653|NCT01206816|156167571|FG000|Overall Study|other than stated above|0|||
48540654|NCT01206816|156167572|FG001|Overall Study|other than stated above|0|||
48540655|NCT01206816|156167573|FG002|Overall Study|other than stated above|1|||
48606876|NCT00183430|156418467|FG001|Overall Study|Withdrawal by Subject|0|||
48606877|NCT02466399|156418468|FG000|Overall Study|Adverse Event|1|||
48606878|NCT02466399|156418469|FG001|Overall Study|Adverse Event|0|||
48606879|NCT02466399|156418468|FG000|Overall Study|Early exit due to family emergency|1|||
48540656|NCT01206816|156167574|FG003|Overall Study|other than stated above|0|||
48540657|NCT01206816|156167575|FG004|Overall Study|other than stated above|0|||
48540658|NCT01206816|156167576|FG005|Overall Study|other than stated above|0|||
48540659|NCT01206816|156167577|FG006|Overall Study|other than stated above|1|||
48540660|NCT02622113|156167578|FG000|Overall Study|Adverse Event|4|||
48540661|NCT02622113|156167579|FG001|Overall Study|Adverse Event|4|||
48540662|NCT02622113|156167578|FG000|Overall Study|Physician Decision|0|||
48540663|NCT02622113|156167579|FG001|Overall Study|Physician Decision|1|||
48540664|NCT02622113|156167578|FG000|Overall Study|Withdrawal by Subject|0|||
48540665|NCT02622113|156167579|FG001|Overall Study|Withdrawal by Subject|2|||
48540666|NCT02622113|156167578|FG000|Overall Study|Stopping Criteria|1|||
48540667|NCT02622113|156167579|FG001|Overall Study|Stopping Criteria|3|||
48606880|NCT02466399|156418469|FG001|Overall Study|Early exit due to family emergency|0|||
48540668|NCT01195103|156167580|FG000|Overall Study|Withdrawal by Subject|1|||
48540669|NCT01195103|156167581|FG001|Overall Study|Withdrawal by Subject|0|||
48540670|NCT01195103|156167582|FG002|Overall Study|Withdrawal by Subject|0|||
48540671|NCT00302081|156167583|FG000|Overall Study|Adverse Event|6|||
48540672|NCT00302081|156167584|FG001|Overall Study|Adverse Event|5|||
48606881|NCT01799941|156418470|FG000|Overall Study|Adverse Event|34|||
48606882|NCT01799941|156418470|FG000|Overall Study|Withdrawal by Subject|21|||
48606883|NCT01799941|156418470|FG000|Overall Study|Death|2|||
48540673|NCT00302081|156167585|FG002|Overall Study|Adverse Event|4|||
48540674|NCT00302081|156167583|FG000|Overall Study|Lost to Follow-up|21|||
48540675|NCT00302081|156167584|FG001|Overall Study|Lost to Follow-up|18|||
48540676|NCT00302081|156167585|FG002|Overall Study|Lost to Follow-up|28|||
48540677|NCT00302081|156167583|FG000|Overall Study|Withdrawal by Subject|8|||
48606884|NCT01799941|156418470|FG000|Overall Study|Investigator Decision|4|||
48606885|NCT01799941|156418470|FG000|Overall Study|Lack of Efficacy|3|||
48540678|NCT00302081|156167584|FG001|Overall Study|Withdrawal by Subject|12|||
48540679|NCT00302081|156167585|FG002|Overall Study|Withdrawal by Subject|8|||
48540680|NCT00302081|156167583|FG000|Overall Study|Protocol Violation|5|||
48540681|NCT00302081|156167584|FG001|Overall Study|Protocol Violation|1|||
48540682|NCT00302081|156167585|FG002|Overall Study|Protocol Violation|2|||
48540683|NCT00302081|156167583|FG000|Overall Study|Lack of Efficacy|1|||
48540684|NCT00302081|156167584|FG001|Overall Study|Lack of Efficacy|0|||
48540685|NCT00302081|156167585|FG002|Overall Study|Lack of Efficacy|5|||
48540686|NCT00302081|156167583|FG000|Overall Study|Death|2|||
48540687|NCT00302081|156167584|FG001|Overall Study|Death|1|||
48540688|NCT00302081|156167585|FG002|Overall Study|Death|0|||
48540689|NCT00302081|156167583|FG000|Overall Study|Other|13|||
48540690|NCT00302081|156167584|FG001|Overall Study|Other|6|||
48540691|NCT00302081|156167585|FG002|Overall Study|Other|5|||
48540692|NCT02528123|156167586|FG000|Overall Study|Lost to Follow-up|1|||
48540693|NCT03733210|156167587|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
48540694|NCT03733210|156167588|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
48540695|NCT03760250|156167590|FG000|Overall Study|Withdrawal by Subject|1|||
48540696|NCT03760250|156167590|FG000|Overall Study|Physician Decision|1|||
48540697|NCT00307034|156167597|FG000|Overall Study|Adverse Event|1|||
48540698|NCT00307034|156167598|FG001|Overall Study|Adverse Event|2|||
48540699|NCT00307034|156167597|FG000|Overall Study|Withdrawal by Subject|1|||
48540700|NCT00307034|156167598|FG001|Overall Study|Withdrawal by Subject|2|||
48540701|NCT00307034|156167597|FG000|Overall Study|Lost to Follow-up|0|||
48540702|NCT00307034|156167598|FG001|Overall Study|Lost to Follow-up|3|||
48540703|NCT02621034|156167599|FG000|Overall Study|Lost to Follow-up|3|||
48540704|NCT02621034|156167600|FG001|Overall Study|Lost to Follow-up|2|||
48540705|NCT02621034|156167601|FG002|Overall Study|Lost to Follow-up|5|||
48540706|NCT01939496|156167603|FG000|Overall Study|Adverse Event|2|||
48540707|NCT01939496|156167604|FG001|Overall Study|Adverse Event|0|||
48540708|NCT01939496|156167605|FG002|Overall Study|Adverse Event|0|||
48540709|NCT01939496|156167603|FG000|Overall Study|Lost to Follow-up|1|||
48540710|NCT01939496|156167604|FG001|Overall Study|Lost to Follow-up|1|||
48540711|NCT01939496|156167605|FG002|Overall Study|Lost to Follow-up|0|||
48540712|NCT01939496|156167603|FG000|Overall Study|Physician Decision|1|||
48606886|NCT01799941|156418470|FG000|Overall Study|Lost to Follow-up|17|||
48606887|NCT01799941|156418470|FG000|Overall Study|Other|15|||
48606888|NCT04889040|156418471|FG000|Overall Study|Withdrawal by Subject|3|||
48606889|NCT04889040|156418472|FG001|Overall Study|Withdrawal by Subject|3|||
48606890|NCT04889040|156418471|FG000|Overall Study|Lost to Follow-up|0|||
48606891|NCT04889040|156418472|FG001|Overall Study|Lost to Follow-up|1|||
48606892|NCT04889040|156418471|FG000|Overall Study|Adverse Event|2|||
48606893|NCT04889040|156418472|FG001|Overall Study|Adverse Event|1|||
48540713|NCT01939496|156167604|FG001|Overall Study|Physician Decision|0|||
48540714|NCT01939496|156167605|FG002|Overall Study|Physician Decision|0|||
48540715|NCT01939496|156167603|FG000|Overall Study|Protocol Violation|3|||
48540716|NCT01939496|156167604|FG001|Overall Study|Protocol Violation|0|||
48540717|NCT01939496|156167605|FG002|Overall Study|Protocol Violation|0|||
48540718|NCT01939496|156167603|FG000|Overall Study|Withdrawal by Subject|0|||
48540719|NCT01939496|156167604|FG001|Overall Study|Withdrawal by Subject|1|||
48540720|NCT01939496|156167605|FG002|Overall Study|Withdrawal by Subject|1|||
48540721|NCT01939496|156167603|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
48540722|NCT01939496|156167604|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
48540723|NCT01939496|156167605|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
48540724|NCT01939496|156167603|FG000|Overall Study|Other|2|||
48540725|NCT01939496|156167604|FG001|Overall Study|Other|0|||
48540726|NCT01939496|156167605|FG002|Overall Study|Other|1|||
48540727|NCT04421586|156167613|FG000|Overall Study|Death|0|||
48540728|NCT04421586|156167614|FG001|Overall Study|Death|1|||
48540729|NCT04421586|156167613|FG000|Overall Study|Lost to Follow-up|2|||
48540730|NCT04421586|156167614|FG001|Overall Study|Lost to Follow-up|2|||
48540731|NCT04421586|156167613|FG000|Overall Study|Withdrawn by PI|1|||
48540732|NCT04421586|156167614|FG001|Overall Study|Withdrawn by PI|0|||
48540733|NCT04421586|156167613|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
48606894|NCT04040439|156418475|FG000|Overall Study|Invalid registration|11|||
48540734|NCT04421586|156167614|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
48540735|NCT03052322|156167615|FG000|Overall Study|Other un-specified|1|||
48540736|NCT03052322|156167616|FG001|Overall Study|Other un-specified|2|||
48540737|NCT03052322|156167615|FG000|Overall Study|Withdrawal by Subject|10|||
48540738|NCT03052322|156167616|FG001|Overall Study|Withdrawal by Subject|9|||
48540739|NCT03052322|156167615|FG000|Overall Study|Death|0|||
48540740|NCT03052322|156167616|FG001|Overall Study|Death|2|||
48606895|NCT04040439|156418475|FG000|Overall Study|No IC* on publication of study results|2|||
48540741|NCT03052322|156167615|FG000|Overall Study|Lack of Efficacy|1|||
48540742|NCT03052322|156167616|FG001|Overall Study|Lack of Efficacy|2|||
48540743|NCT03052322|156167615|FG000|Overall Study|Protocol Violation|1|||
48540744|NCT03052322|156167616|FG001|Overall Study|Protocol Violation|0|||
48540745|NCT03052322|156167615|FG000|Overall Study|Lost to Follow-up|2|||
48540746|NCT03052322|156167616|FG001|Overall Study|Lost to Follow-up|4|||
48606896|NCT00547339|156418476|FG000|Overall Study|Physician Decision|0|||
48606897|NCT00547339|156418477|FG001|Overall Study|Physician Decision|0|||
48606898|NCT00547339|156418478|FG002|Overall Study|Physician Decision|1|||
48606899|NCT00547339|156418479|FG003|Overall Study|Physician Decision|0|||
48606900|NCT01674725|156418483|FG000|Overall Study|Adverse Event|1|||
48606901|NCT01674725|156418484|FG001|Overall Study|Adverse Event|0|||
48606902|NCT01674725|156418483|FG000|Overall Study|Did not receive study drug|1|||
48540747|NCT03052322|156167615|FG000|Overall Study|Adverse Event|6|||
48540748|NCT03052322|156167616|FG001|Overall Study|Adverse Event|13|||
48540749|NCT00973765|156167617|FG000|Overall Study|Lost to Follow-up|8|||
48540750|NCT00973765|156167618|FG001|Overall Study|Lost to Follow-up|14|||
48540751|NCT02384941|156167619|FG000|Overall Study|Adverse Event|11|||
48540752|NCT02384941|156167620|FG001|Overall Study|Adverse Event|13|||
48540753|NCT02384941|156167621|FG002|Overall Study|Adverse Event|17|||
48540754|NCT02384941|156167619|FG000|Overall Study|Lost to Follow-up|3|||
48540755|NCT02384941|156167620|FG001|Overall Study|Lost to Follow-up|2|||
48540756|NCT02384941|156167621|FG002|Overall Study|Lost to Follow-up|1|||
48540757|NCT02384941|156167619|FG000|Overall Study|Non-Compliance With Study Drug|2|||
48540758|NCT02384941|156167620|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48540759|NCT02384941|156167621|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48540760|NCT02384941|156167619|FG000|Overall Study|Physician Decision|1|||
48540761|NCT02384941|156167620|FG001|Overall Study|Physician Decision|1|||
48540762|NCT02384941|156167621|FG002|Overall Study|Physician Decision|0|||
48540763|NCT02384941|156167619|FG000|Overall Study|Protocol Violation|3|||
48540764|NCT02384941|156167620|FG001|Overall Study|Protocol Violation|0|||
48540765|NCT02384941|156167621|FG002|Overall Study|Protocol Violation|0|||
48540766|NCT02384941|156167619|FG000|Overall Study|Withdrawal by Subject|26|||
48540767|NCT02384941|156167620|FG001|Overall Study|Withdrawal by Subject|19|||
48540768|NCT02384941|156167621|FG002|Overall Study|Withdrawal by Subject|20|||
48606903|NCT01674725|156418484|FG001|Overall Study|Did not receive study drug|0|||
48606904|NCT01674725|156418483|FG000|Overall Study|Withdrawal by Subject|1|||
48606905|NCT01674725|156418484|FG001|Overall Study|Withdrawal by Subject|0|||
48606906|NCT01674725|156418483|FG000|Overall Study|Lost to Follow-up|0|||
48606907|NCT01674725|156418484|FG001|Overall Study|Lost to Follow-up|1|||
48606908|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
48540769|NCT02384941|156167619|FG000|Overall Study|Pregnancy|0|||
48540770|NCT02384941|156167620|FG001|Overall Study|Pregnancy|0|||
48540771|NCT02384941|156167621|FG002|Overall Study|Pregnancy|1|||
48540772|NCT02384941|156167619|FG000|Overall Study|Other than specified above|4|||
48540773|NCT02384941|156167620|FG001|Overall Study|Other than specified above|0|||
48540774|NCT02384941|156167621|FG002|Overall Study|Other than specified above|1|||
48540775|NCT02011113|156167622|FG000|Overall Study|Adverse Event|4|||
48540776|NCT02011113|156167622|FG000|Overall Study|Disease Progression (DP)|16|||
48540777|NCT02011113|156167622|FG000|Overall Study|Death|1|||
48540778|NCT02011113|156167622|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
48540779|NCT02011113|156167622|FG000|Overall Study|Investigator's judgement- DP|3|||
48540780|NCT02011113|156167622|FG000|Overall Study|Study terminated by sponsor|11|||
48540781|NCT02034058|156167632|FG000|Overall Study|Death|3|||
48540782|NCT05304611|156167633|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
48540783|NCT05304611|156167634|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
48540784|NCT05304611|156167635|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
48540785|NCT05304611|156167636|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
48540786|NCT05304611|156167637|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
48540787|NCT05304611|156167638|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
48540788|NCT05304611|156167639|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
48540789|NCT05304611|156167640|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
48540790|NCT05304611|156167641|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
48540791|NCT05304611|156167633|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
48540792|NCT05304611|156167634|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
48540793|NCT05304611|156167635|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
48540794|NCT05304611|156167636|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
48540795|NCT05304611|156167637|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
48540796|NCT05304611|156167638|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
48606909|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
48540797|NCT05304611|156167639|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
48606910|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
48606911|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
48606912|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
48606913|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
48606914|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
48606915|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
48606916|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
48606917|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
48606918|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
48606919|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
48606920|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
48606921|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
48606922|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
48606923|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
48606924|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
48606925|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
48606926|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
48606927|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
48606928|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
48606929|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
48606930|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
48606931|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
48606932|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
48606933|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
48606934|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
48606935|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
48606936|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
48606937|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
48606938|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
48606939|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
48606940|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
48606941|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
48606942|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
48606943|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
48606944|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
48606945|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
48606946|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
48606947|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
48606948|NCT02709746|156418485|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
48606949|NCT02709746|156418486|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
48606950|NCT02709746|156418487|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
48606951|NCT02709746|156418488|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
48606952|NCT02709746|156418489|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
48606953|NCT02709746|156418485|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
48606954|NCT02709746|156418486|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
48606955|NCT02709746|156418487|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
48606956|NCT02709746|156418488|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
48606957|NCT02709746|156418489|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
48606958|NCT02709746|156418485|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
48540798|NCT05304611|156167640|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
48540799|NCT05304611|156167641|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
48540800|NCT01335997|156167643|FG000|Period I and II|Adverse Event|63|||
48540801|NCT01335997|156167644|FG001|Period I and II|Adverse Event|43|||
48540802|NCT01335997|156167643|FG000|Period I and II|Noncompliance with Study Drug|1|||
48540803|NCT01335997|156167644|FG001|Period I and II|Noncompliance with Study Drug|1|||
48540804|NCT01335997|156167643|FG000|Period I and II|Lost to Follow-up|3|||
48540805|NCT01335997|156167644|FG001|Period I and II|Lost to Follow-up|5|||
48540806|NCT01335997|156167643|FG000|Period I and II|Withdrawal by Subject|9|||
48540807|NCT01335997|156167644|FG001|Period I and II|Withdrawal by Subject|4|||
48540808|NCT01335997|156167643|FG000|Period I and II|Study Terminated by Sponsor|406|||
48540809|NCT01335997|156167644|FG001|Period I and II|Study Terminated by Sponsor|415|||
48540810|NCT01335997|156167643|FG000|Period I and II|Protocol Violation|9|||
48540811|NCT01335997|156167644|FG001|Period I and II|Protocol Violation|10|||
48540812|NCT01335997|156167643|FG000|Period I and II|Physician Decision|2|||
48540813|NCT01335997|156167644|FG001|Period I and II|Physician Decision|1|||
48540814|NCT01335997|156167643|FG000|Period III|Adverse Event|0|||
48540815|NCT01335997|156167644|FG001|Period III|Adverse Event|2|||
48540816|NCT01335997|156167643|FG000|Period III|Study Terminated by Sponsor|77|||
48540817|NCT01335997|156167644|FG001|Period III|Study Terminated by Sponsor|76|||
48540818|NCT01335997|156167643|FG000|Period III|Protocol Violation|0|||
48540819|NCT01335997|156167644|FG001|Period III|Protocol Violation|1|||
48540820|NCT01335997|156167643|FG000|Period III|Lost to Follow-up|1|||
48540821|NCT01335997|156167644|FG001|Period III|Lost to Follow-up|0|||
48540822|NCT03979820|156167647|FG000|Overall Study|Protocol Violation|1|||
48540823|NCT03979820|156167648|FG001|Overall Study|Protocol Violation|0|||
48540824|NCT03979820|156167649|FG002|Overall Study|Protocol Violation|0|||
48540825|NCT03979820|156167650|FG003|Overall Study|Protocol Violation|0|||
48540826|NCT03979820|156167647|FG000|Overall Study|Withdrawal by Subject|0|||
48540827|NCT03979820|156167648|FG001|Overall Study|Withdrawal by Subject|0|||
48540828|NCT03979820|156167649|FG002|Overall Study|Withdrawal by Subject|1|||
48540829|NCT03979820|156167650|FG003|Overall Study|Withdrawal by Subject|0|||
48540830|NCT03979820|156167647|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
48540831|NCT03979820|156167648|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
48540832|NCT03979820|156167649|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
48540833|NCT03979820|156167650|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
48540834|NCT00988065|156167651|FG000|Overall Study|Adverse Event|4|||
48540835|NCT00988065|156167652|FG001|Overall Study|Adverse Event|10|||
48540836|NCT00988065|156167653|FG002|Overall Study|Adverse Event|2|||
48540837|NCT00988065|156167651|FG000|Overall Study|Lost to Follow-up|1|||
48540838|NCT00988065|156167652|FG001|Overall Study|Lost to Follow-up|2|||
48540839|NCT00988065|156167653|FG002|Overall Study|Lost to Follow-up|2|||
48540840|NCT00988065|156167651|FG000|Overall Study|Subject withdrew consent|3|||
48540841|NCT00988065|156167652|FG001|Overall Study|Subject withdrew consent|5|||
48540842|NCT00988065|156167653|FG002|Overall Study|Subject withdrew consent|2|||
48540843|NCT00988065|156167651|FG000|Overall Study|Noncompliance with protocol|5|||
48540844|NCT00988065|156167652|FG001|Overall Study|Noncompliance with protocol|6|||
48540845|NCT00988065|156167653|FG002|Overall Study|Noncompliance with protocol|9|||
48540846|NCT01229735|156167654|FG000|Overall Study|Lack of Efficacy|8|||
48540847|NCT01229735|156167655|FG001|Overall Study|Lack of Efficacy|8|||
48540848|NCT01229735|156167654|FG000|Overall Study|Protocol Violation|13|||
48540849|NCT01229735|156167655|FG001|Overall Study|Protocol Violation|8|||
48540850|NCT01229735|156167654|FG000|Overall Study|Lost to Follow-up|0|||
48540851|NCT01229735|156167655|FG001|Overall Study|Lost to Follow-up|2|||
48540852|NCT01229735|156167654|FG000|Overall Study|Withdrawal by Subject|18|||
48540853|NCT01229735|156167655|FG001|Overall Study|Withdrawal by Subject|17|||
48540854|NCT01229735|156167654|FG000|Overall Study|Other Reason|13|||
48540855|NCT01229735|156167655|FG001|Overall Study|Other Reason|10|||
48540856|NCT01229735|156167654|FG000|Overall Study|SAE, non-fatal|0|||
48540857|NCT01229735|156167655|FG001|Overall Study|SAE, non-fatal|4|||
48540858|NCT01229735|156167654|FG000|Overall Study|AE, non-serious non-fatal|13|||
48540859|NCT01229735|156167655|FG001|Overall Study|AE, non-serious non-fatal|17|||
48540860|NCT01229735|156167654|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48540861|NCT01229735|156167655|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48540862|NCT02685202|156167657|FG000|Overall Study|Lost to Follow-up|9|||
48540863|NCT00706381|156167659|FG000|Overall Study|Lost to Follow-up|0|||
48540864|NCT00706381|156167660|FG001|Overall Study|Lost to Follow-up|1|||
48540865|NCT00706381|156167661|FG002|Overall Study|Lost to Follow-up|1|||
48540866|NCT00706381|156167662|FG003|Overall Study|Lost to Follow-up|0|||
48540867|NCT00085423|156167663|FG000|Overall Study|Withdrawal by Subject|1|||
48540868|NCT00085423|156167663|FG000|Overall Study|screen failure|1|||
48540869|NCT02130882|156167664|FG000|Overall Study|Withdrawal by Subject|0|||
48540870|NCT02130882|156167665|FG001|Overall Study|Withdrawal by Subject|1|||
48540871|NCT04740814|156167666|FG000|Overall Study|Adverse Event|3|||
48540872|NCT04740814|156167666|FG000|Overall Study|Protocol Violation|2|||
48540873|NCT04740814|156167666|FG000|Overall Study|Lost to Follow-up|2|||
48540874|NCT04740814|156167666|FG000|Overall Study|Withdrawal by Subject|3|||
48540875|NCT01321008|156167667|FG000|Overall Study|Early Study Termination|1|||
48540876|NCT03276780|156167676|FG000|Overall Study|Withdrawal by Subject|5|||
48540877|NCT03276780|156167677|FG001|Overall Study|Withdrawal by Subject|3|||
48540878|NCT03276780|156167676|FG000|Overall Study|Lost to Follow-up|3|||
48540879|NCT03276780|156167677|FG001|Overall Study|Lost to Follow-up|5|||
48540880|NCT03276780|156167676|FG000|Overall Study|Moved out of state|1|||
48540881|NCT03276780|156167677|FG001|Overall Study|Moved out of state|1|||
48540882|NCT03276780|156167676|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
48540883|NCT03276780|156167677|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
48540884|NCT03276780|156167676|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
48540885|NCT03276780|156167677|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
48540886|NCT03050060|156167680|FG000|Overall Study|Adverse Event|7|||
48540887|NCT03050060|156167680|FG000|Overall Study|Withdrawal by Subject|1|||
48540888|NCT03050060|156167680|FG000|Overall Study|Progression|7|||
48540889|NCT04568031|156167681|FG000|Overall Study|Lost to Follow-up|1|||
48540890|NCT04568031|156167682|FG001|Overall Study|Lost to Follow-up|0|||
48540891|NCT04568031|156167683|FG002|Overall Study|Lost to Follow-up|0|||
48540892|NCT04568031|156167684|FG003|Overall Study|Lost to Follow-up|0|||
48540893|NCT04568031|156167681|FG000|Overall Study|Physician Decision|1|||
48540894|NCT04568031|156167682|FG001|Overall Study|Physician Decision|0|||
48540895|NCT04568031|156167683|FG002|Overall Study|Physician Decision|1|||
48540896|NCT04568031|156167684|FG003|Overall Study|Physician Decision|0|||
48540897|NCT04568031|156167681|FG000|Overall Study|Withdrawal by Subject|1|||
48540898|NCT04568031|156167682|FG001|Overall Study|Withdrawal by Subject|0|||
48540899|NCT04568031|156167683|FG002|Overall Study|Withdrawal by Subject|4|||
48540900|NCT04568031|156167684|FG003|Overall Study|Withdrawal by Subject|1|||
48540901|NCT00510289|156167685|FG000|Overall Study|Withdrawal by Subject|7|||
48540902|NCT00510289|156167685|FG000|Overall Study|Refused bone marrow biopsy|2|||
48540903|NCT00510289|156167685|FG000|Overall Study|Lost to Follow-up|1|||
48540904|NCT00510289|156167685|FG000|Overall Study|Progressed prior to starting drug|2|||
48540905|NCT02283294|156167686|FG000|Overall Study|Lost to Follow-up|1|||
48540906|NCT02283294|156167687|FG001|Overall Study|Lost to Follow-up|1|||
48540907|NCT02283294|156167686|FG000|Overall Study|Withdrawal by Subject|1|||
48540908|NCT02283294|156167687|FG001|Overall Study|Withdrawal by Subject|6|||
48540909|NCT02283294|156167686|FG000|Overall Study|Protocol Violation|1|||
48540910|NCT02283294|156167687|FG001|Overall Study|Protocol Violation|0|||
48540911|NCT02283294|156167686|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
48540912|NCT02283294|156167687|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
48606959|NCT02709746|156418486|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
48606960|NCT02709746|156418487|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
48606961|NCT02709746|156418488|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
48606962|NCT02709746|156418489|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
48606963|NCT02709746|156418485|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
48606964|NCT02709746|156418486|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
48606965|NCT02709746|156418487|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
48606966|NCT02709746|156418488|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
48606967|NCT02709746|156418489|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
48606968|NCT02709746|156418485|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
48606969|NCT02709746|156418486|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
48606970|NCT02709746|156418487|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
48606971|NCT02709746|156418488|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
48606972|NCT02709746|156418489|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
48606973|NCT02709746|156418485|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
48606974|NCT02709746|156418486|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
48606975|NCT02709746|156418487|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
48606976|NCT02709746|156418488|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
48606977|NCT02709746|156418489|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
48540913|NCT00197496|156167688|FG000|Baseline to Discharge|not interested|1|||
48540914|NCT00197496|156167689|FG001|Baseline to Discharge|not interested|0|||
48540915|NCT00197496|156167688|FG000|Baseline to Discharge|MRSA|1|||
48540916|NCT00197496|156167689|FG001|Baseline to Discharge|MRSA|0|||
48540917|NCT00197496|156167688|FG000|Baseline to Discharge|Physician Decision|0|||
48540918|NCT00197496|156167689|FG001|Baseline to Discharge|Physician Decision|1|||
48540919|NCT00197496|156167688|FG000|Baseline to Discharge|Protocol Violation|0|||
48540920|NCT00197496|156167689|FG001|Baseline to Discharge|Protocol Violation|1|||
48540921|NCT00197496|156167688|FG000|Follow-up|Lost to Follow-up|2|||
48540922|NCT00197496|156167689|FG001|Follow-up|Lost to Follow-up|1|||
48540923|NCT02304458|156167690|FG000|Overall Study|Adverse Event|0|||
48540924|NCT02304458|156167691|FG001|Overall Study|Adverse Event|0|||
48540925|NCT02304458|156167692|FG002|Overall Study|Adverse Event|7|||
48540926|NCT02304458|156167693|FG003|Overall Study|Adverse Event|0|||
48540927|NCT02304458|156167694|FG004|Overall Study|Adverse Event|0|||
48540928|NCT02304458|156167695|FG005|Overall Study|Adverse Event|0|||
48540929|NCT02304458|156167696|FG006|Overall Study|Adverse Event|3|||
48540930|NCT02304458|156167697|FG007|Overall Study|Adverse Event|4|||
48540931|NCT02304458|156167690|FG000|Overall Study|Death|0|||
48540932|NCT02304458|156167691|FG001|Overall Study|Death|0|||
48540933|NCT02304458|156167692|FG002|Overall Study|Death|2|||
48540934|NCT02304458|156167693|FG003|Overall Study|Death|0|||
48540935|NCT02304458|156167694|FG004|Overall Study|Death|0|||
48540936|NCT02304458|156167695|FG005|Overall Study|Death|0|||
48540937|NCT02304458|156167696|FG006|Overall Study|Death|1|||
48540938|NCT02304458|156167697|FG007|Overall Study|Death|0|||
48540939|NCT02304458|156167690|FG000|Overall Study|Lack of Efficacy|4|||
48540940|NCT02304458|156167691|FG001|Overall Study|Lack of Efficacy|6|||
48540941|NCT02304458|156167692|FG002|Overall Study|Lack of Efficacy|38|||
48540942|NCT02304458|156167693|FG003|Overall Study|Lack of Efficacy|5|||
48540943|NCT02304458|156167694|FG004|Overall Study|Lack of Efficacy|6|||
48540944|NCT02304458|156167695|FG005|Overall Study|Lack of Efficacy|6|||
48540945|NCT02304458|156167696|FG006|Overall Study|Lack of Efficacy|21|||
48540946|NCT02304458|156167697|FG007|Overall Study|Lack of Efficacy|4|||
48540947|NCT02304458|156167690|FG000|Overall Study|Physician Decision|2|||
48540948|NCT02304458|156167691|FG001|Overall Study|Physician Decision|0|||
48540949|NCT02304458|156167692|FG002|Overall Study|Physician Decision|16|||
48540950|NCT02304458|156167693|FG003|Overall Study|Physician Decision|1|||
48540951|NCT02304458|156167694|FG004|Overall Study|Physician Decision|0|||
48540952|NCT02304458|156167695|FG005|Overall Study|Physician Decision|0|||
48540953|NCT02304458|156167696|FG006|Overall Study|Physician Decision|3|||
48540954|NCT02304458|156167697|FG007|Overall Study|Physician Decision|0|||
48540955|NCT02304458|156167690|FG000|Overall Study|Protocol Violation|0|||
48540956|NCT02304458|156167691|FG001|Overall Study|Protocol Violation|0|||
48540957|NCT02304458|156167692|FG002|Overall Study|Protocol Violation|1|||
48540958|NCT02304458|156167693|FG003|Overall Study|Protocol Violation|0|||
48540959|NCT02304458|156167694|FG004|Overall Study|Protocol Violation|0|||
48540960|NCT02304458|156167695|FG005|Overall Study|Protocol Violation|0|||
48540961|NCT02304458|156167696|FG006|Overall Study|Protocol Violation|0|||
48540962|NCT02304458|156167697|FG007|Overall Study|Protocol Violation|0|||
48540963|NCT02304458|156167690|FG000|Overall Study|Withdrawal by Subject|1|||
48540964|NCT02304458|156167691|FG001|Overall Study|Withdrawal by Subject|0|||
48540965|NCT02304458|156167692|FG002|Overall Study|Withdrawal by Subject|7|||
48540966|NCT02304458|156167693|FG003|Overall Study|Withdrawal by Subject|0|||
48540967|NCT02304458|156167694|FG004|Overall Study|Withdrawal by Subject|0|||
48540968|NCT02304458|156167695|FG005|Overall Study|Withdrawal by Subject|0|||
48540969|NCT02304458|156167696|FG006|Overall Study|Withdrawal by Subject|1|||
48540970|NCT02304458|156167697|FG007|Overall Study|Withdrawal by Subject|0|||
48540971|NCT00857584|156167703|FG000|Overall Study|Lack of Efficacy|1|||
48540972|NCT00857584|156167704|FG001|Overall Study|Lack of Efficacy|2|||
48540973|NCT00857584|156167703|FG000|Overall Study|Adverse Event|2|||
48540974|NCT00857584|156167704|FG001|Overall Study|Adverse Event|2|||
48540975|NCT00857584|156167703|FG000|Overall Study|Physician Decision|1|||
48540976|NCT00857584|156167704|FG001|Overall Study|Physician Decision|1|||
48540977|NCT00861198|156167707|FG000|Overall Study|SpyGlass Failed|5|||
48540978|NCT02128217|156170120|FG000|Overall Study|Lost to Follow-up|0|||
48540979|NCT02128217|156170121|FG001|Overall Study|Lost to Follow-up|1|||
48540980|NCT00541970|156170123|FG000|Month 7|Protocol Violation|9|||
48540981|NCT00541970|156170124|FG001|Month 7|Protocol Violation|13|||
48540982|NCT00541970|156170125|FG002|Month 7|Protocol Violation|11|||
48540983|NCT00541970|156170126|FG003|Month 7|Protocol Violation|5|||
48540984|NCT00541970|156170123|FG000|Month 12|Adverse Event|0|||
48540985|NCT00541970|156170124|FG001|Month 12|Adverse Event|1|||
48540986|NCT00541970|156170125|FG002|Month 12|Adverse Event|1|||
48540987|NCT00541970|156170126|FG003|Month 12|Adverse Event|1|||
48540988|NCT00541970|156170123|FG000|Month 12|Protocol Violation|12|||
48540989|NCT00541970|156170124|FG001|Month 12|Protocol Violation|21|||
48540990|NCT00541970|156170125|FG002|Month 12|Protocol Violation|20|||
48540991|NCT00541970|156170126|FG003|Month 12|Protocol Violation|15|||
48540992|NCT00541970|156170123|FG000|Month 18|Adverse Event|0|||
48540993|NCT00541970|156170124|FG001|Month 18|Adverse Event|1|||
48540994|NCT00541970|156170125|FG002|Month 18|Adverse Event|1|||
48540995|NCT00541970|156170126|FG003|Month 18|Adverse Event|1|||
48540996|NCT00541970|156170123|FG000|Month 18|Protocol Violation|14|||
48540997|NCT00541970|156170124|FG001|Month 18|Protocol Violation|23|||
48540998|NCT00541970|156170125|FG002|Month 18|Protocol Violation|24|||
48540999|NCT00541970|156170126|FG003|Month 18|Protocol Violation|16|||
48541000|NCT00541970|156170123|FG000|Month 24|Adverse Event|0|||
48541001|NCT00541970|156170124|FG001|Month 24|Adverse Event|1|||
48541002|NCT00541970|156170125|FG002|Month 24|Adverse Event|1|||
48541003|NCT00541970|156170126|FG003|Month 24|Adverse Event|1|||
48541004|NCT00541970|156170123|FG000|Month 24|Protocol Violation|29|||
48541005|NCT00541970|156170124|FG001|Month 24|Protocol Violation|31|||
48541006|NCT00541970|156170125|FG002|Month 24|Protocol Violation|31|||
48541007|NCT00541970|156170126|FG003|Month 24|Protocol Violation|21|||
48541008|NCT00541970|156170123|FG000|Month 36|Protocol Violation|61|||
48541009|NCT00541970|156170124|FG001|Month 36|Protocol Violation|66|||
48541010|NCT00541970|156170125|FG002|Month 36|Protocol Violation|66|||
48541011|NCT00541970|156170126|FG003|Month 36|Protocol Violation|60|||
48541012|NCT00541970|156170123|FG000|Month 48|Withdrawal by Subject|2|||
48541013|NCT00541970|156170124|FG001|Month 48|Withdrawal by Subject|4|||
48541014|NCT00541970|156170125|FG002|Month 48|Withdrawal by Subject|4|||
48541015|NCT00541970|156170126|FG003|Month 48|Withdrawal by Subject|2|||
48541016|NCT00541970|156170123|FG000|Month 48|Other|3|||
48541017|NCT00541970|156170124|FG001|Month 48|Other|1|||
48541018|NCT00541970|156170125|FG002|Month 48|Other|1|||
48541019|NCT00541970|156170126|FG003|Month 48|Other|0|||
48541020|NCT00541970|156170123|FG000|Month 48|Lost to Follow-up|66|||
48541021|NCT00541970|156170124|FG001|Month 48|Lost to Follow-up|68|||
48541022|NCT00541970|156170125|FG002|Month 48|Lost to Follow-up|68|||
48541023|NCT00541970|156170126|FG003|Month 48|Lost to Follow-up|73|||
48541024|NCT00541970|156170123|FG000|Month 60|Protocol Violation|78|||
48541025|NCT00541970|156170124|FG001|Month 60|Protocol Violation|77|||
48541026|NCT00541970|156170125|FG002|Month 60|Protocol Violation|82|||
48541027|NCT00541970|156170126|FG003|Month 60|Protocol Violation|72|||
48541028|NCT01884311|156170129|FG000|Overall Study|Withdrawal by Subject|3|||
48541029|NCT01884311|156170129|FG000|Overall Study|withdrew consent due to AEs|1|||
48541030|NCT01884311|156170129|FG000|Overall Study|Precautionary measure|1|||
48541031|NCT03107026|156170130|FG000|Overall Study|Adverse Event|2|||
48541032|NCT03107026|156170131|FG001|Overall Study|Adverse Event|14|||
48541033|NCT03107026|156170132|FG002|Overall Study|Adverse Event|23|||
48541034|NCT03107026|156170130|FG000|Overall Study|Lost to Follow-up|12|||
48541035|NCT03107026|156170131|FG001|Overall Study|Lost to Follow-up|12|||
48541036|NCT03107026|156170132|FG002|Overall Study|Lost to Follow-up|13|||
48541037|NCT03107026|156170130|FG000|Overall Study|Protocol Violation|1|||
48541038|NCT03107026|156170131|FG001|Overall Study|Protocol Violation|2|||
48541039|NCT03107026|156170132|FG002|Overall Study|Protocol Violation|0|||
48541040|NCT03107026|156170130|FG000|Overall Study|Pregnancy|1|||
48541041|NCT03107026|156170131|FG001|Overall Study|Pregnancy|0|||
48541042|NCT03107026|156170132|FG002|Overall Study|Pregnancy|0|||
48541043|NCT03107026|156170130|FG000|Overall Study|Withdrawal by Subject|13|||
48541044|NCT03107026|156170131|FG001|Overall Study|Withdrawal by Subject|5|||
48541045|NCT03107026|156170132|FG002|Overall Study|Withdrawal by Subject|17|||
48606978|NCT02709746|156418485|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
48606979|NCT02709746|156418486|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
48606980|NCT02709746|156418487|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
48606981|NCT02709746|156418488|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
48606982|NCT02709746|156418489|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
48606983|NCT02709746|156418485|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
48606984|NCT02709746|156418486|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
48606985|NCT02709746|156418487|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
48606986|NCT02709746|156418488|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
48606987|NCT02709746|156418489|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
48606988|NCT02709746|156418485|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
48606989|NCT02709746|156418486|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
48606990|NCT02709746|156418487|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
48606991|NCT02709746|156418488|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
48606992|NCT02709746|156418489|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
48541046|NCT03107026|156170130|FG000|Overall Study|non compliance with study visits|1|||
48541047|NCT03107026|156170131|FG001|Overall Study|non compliance with study visits|2|||
48541048|NCT03107026|156170132|FG002|Overall Study|non compliance with study visits|0|||
48541049|NCT03107026|156170130|FG000|Overall Study|non-compliance with study drug|2|||
48606993|NCT03191799|156418494|FG000|Overall Study|Withdrawal by Subject|4|||
48606994|NCT03191799|156418494|FG000|Overall Study|Physician Decision|2|||
48606995|NCT03191799|156418494|FG000|Overall Study|Lost to Follow-up|1|||
48606996|NCT03191799|156418494|FG000|Overall Study|Death|2|||
48606997|NCT04275336|156418495|FG000|Overall Study|First venipuncture failed|4|||
48541050|NCT03107026|156170131|FG001|Overall Study|non-compliance with study drug|2|||
48541051|NCT03107026|156170132|FG002|Overall Study|non-compliance with study drug|3|||
48541052|NCT03107026|156170130|FG000|Overall Study|Physician Decision|0|||
48606998|NCT04275336|156418496|FG001|Overall Study|First venipuncture failed|6|||
48606999|NCT04275336|156418497|FG002|Overall Study|First venipuncture failed|5|||
48607000|NCT04275336|156418495|FG000|Overall Study|Unscheduled venipuncture|9|||
48607001|NCT04275336|156418496|FG001|Overall Study|Unscheduled venipuncture|13|||
48541053|NCT03107026|156170131|FG001|Overall Study|Physician Decision|1|||
48541054|NCT03107026|156170132|FG002|Overall Study|Physician Decision|0|||
48541055|NCT00112866|156170133|FG000|Overall Study|Protocol Violation|1|||
48541056|NCT00112866|156170134|FG001|Overall Study|Protocol Violation|0|||
48607002|NCT04275336|156418497|FG002|Overall Study|Unscheduled venipuncture|7|||
48607003|NCT04275336|156418495|FG000|Overall Study|Failed specimen of saliva|4|||
48541057|NCT00112866|156170133|FG000|Overall Study|did not start treatment post-op|1|||
48541058|NCT00112866|156170134|FG001|Overall Study|did not start treatment post-op|2|||
48541059|NCT02307266|156170135|FG000|Overall Study|Adverse Event|3|||
48541060|NCT02307266|156170136|FG001|Overall Study|Adverse Event|1|||
48541061|NCT02307266|156170137|FG002|Overall Study|Adverse Event|5|||
48541062|NCT02307266|156170135|FG000|Overall Study|Withdrawal by Subject|2|||
48607004|NCT04275336|156418496|FG001|Overall Study|Failed specimen of saliva|3|||
48607005|NCT04275336|156418497|FG002|Overall Study|Failed specimen of saliva|4|||
48607006|NCT01483118|156418498|FG000|Overall Study|Lost to Follow-up|12|||
48607007|NCT01483118|156418499|FG001|Overall Study|Lost to Follow-up|16|||
48541063|NCT02307266|156170136|FG001|Overall Study|Withdrawal by Subject|0|||
48541064|NCT02307266|156170137|FG002|Overall Study|Withdrawal by Subject|1|||
48541065|NCT02307266|156170135|FG000|Overall Study|Lost to Follow-up|3|||
48541066|NCT02307266|156170136|FG001|Overall Study|Lost to Follow-up|0|||
48541067|NCT02307266|156170137|FG002|Overall Study|Lost to Follow-up|0|||
48541068|NCT00062010|156170138|FG000|Overall Study|Ineligible|3|||
48541069|NCT00773734|156170139|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
48541070|NCT00773734|156170140|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
48541071|NCT00773734|156170141|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
48541072|NCT00773734|156170142|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
48541073|NCT00773734|156170143|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
48541074|NCT00773734|156170144|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
48541075|NCT00773734|156170139|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
48541076|NCT00773734|156170140|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
48541077|NCT00773734|156170141|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
48541078|NCT00773734|156170142|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
48541079|NCT00773734|156170143|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
48541080|NCT00773734|156170144|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
48541081|NCT00773734|156170139|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
48541082|NCT00773734|156170140|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
48541083|NCT00773734|156170141|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
48541084|NCT00773734|156170142|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
48541085|NCT00773734|156170143|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
48541086|NCT00773734|156170144|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
48541087|NCT00773734|156170139|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
48541088|NCT00773734|156170140|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
48541089|NCT00773734|156170141|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
48541090|NCT00773734|156170142|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
48541091|NCT00773734|156170143|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
48541092|NCT00773734|156170144|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
48541093|NCT00773734|156170139|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
48541094|NCT00773734|156170140|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
48541095|NCT00773734|156170141|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
48541096|NCT00773734|156170142|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
48541097|NCT00773734|156170143|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
48541098|NCT00773734|156170144|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
48541099|NCT00773734|156170139|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
48541100|NCT00773734|156170140|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
48541101|NCT00773734|156170141|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
48541102|NCT00773734|156170142|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
48541103|NCT00773734|156170143|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
48541104|NCT00773734|156170144|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
48541105|NCT00773734|156170139|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
48541106|NCT00773734|156170140|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
48541107|NCT00773734|156170141|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
48541108|NCT00773734|156170142|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
48541109|NCT00773734|156170143|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
48541110|NCT00773734|156170144|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
48541111|NCT00773734|156170139|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
48541112|NCT00773734|156170140|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
48541113|NCT00773734|156170141|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
48541114|NCT00773734|156170142|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
48541115|NCT00773734|156170143|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
48541116|NCT00773734|156170144|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
48541117|NCT00773734|156170139|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
48541118|NCT00773734|156170140|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
48541119|NCT00773734|156170141|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
48541120|NCT00773734|156170142|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
48541121|NCT00773734|156170143|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
48541122|NCT00773734|156170144|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
48541123|NCT00773734|156170139|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
48541124|NCT00773734|156170140|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
48541125|NCT00773734|156170141|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
48541126|NCT00773734|156170142|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
48541127|NCT00773734|156170143|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
48607008|NCT02000921|156418502|FG000|Overall Study|Withdrawal by Subject|3|||
48541128|NCT00773734|156170144|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
48541129|NCT00773734|156170139|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
48541130|NCT00773734|156170140|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
48541131|NCT00773734|156170141|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
48541132|NCT00773734|156170142|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
48541133|NCT00773734|156170143|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
48541134|NCT00773734|156170144|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
48541135|NCT00773734|156170139|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
48541136|NCT00773734|156170140|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
48541137|NCT00773734|156170141|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
48541138|NCT00773734|156170142|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
48541139|NCT00773734|156170143|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
48541140|NCT00773734|156170144|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
48541141|NCT00773734|156170139|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
48541142|NCT00773734|156170140|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
48541143|NCT00773734|156170141|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
48541144|NCT00773734|156170142|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
48541145|NCT00773734|156170143|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
48541146|NCT00773734|156170144|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
48541147|NCT00773734|156170139|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
48541148|NCT00773734|156170140|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
48541149|NCT00773734|156170141|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
48541150|NCT00773734|156170142|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
48541151|NCT00773734|156170143|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
48541152|NCT00773734|156170144|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
48541153|NCT00773734|156170139|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
48541154|NCT00773734|156170140|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
48541155|NCT00773734|156170141|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
48541156|NCT00773734|156170142|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
48541157|NCT00773734|156170143|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
48541158|NCT00773734|156170144|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
48541159|NCT00773734|156170139|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
48541160|NCT00773734|156170140|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
48541161|NCT00773734|156170141|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
48541162|NCT00773734|156170142|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
48541163|NCT00773734|156170143|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
48541164|NCT00773734|156170144|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
48541165|NCT00773734|156170139|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
48541166|NCT00773734|156170140|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
48541167|NCT00773734|156170141|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
48541168|NCT00773734|156170142|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
48541169|NCT00773734|156170143|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
48541170|NCT00773734|156170144|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
48541171|NCT00773734|156170139|FG000|Extension: Active Treatment Week 24-52|Other|0|||
48541172|NCT00773734|156170140|FG001|Extension: Active Treatment Week 24-52|Other|0|||
48735637|NCT00961649|156883700|FG003|Overall Study|Patient has travel plans during holidays|0|||
48541173|NCT00773734|156170141|FG002|Extension: Active Treatment Week 24-52|Other|1|||
48541174|NCT00773734|156170142|FG003|Extension: Active Treatment Week 24-52|Other|2|||
48541175|NCT00773734|156170143|FG004|Extension: Active Treatment Week 24-52|Other|0|||
48541176|NCT00773734|156170144|FG005|Extension: Active Treatment Week 24-52|Other|1|||
48541177|NCT00773734|156170139|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
48541178|NCT00773734|156170140|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
48541179|NCT00773734|156170141|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
48541180|NCT00773734|156170142|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
48541181|NCT00773734|156170143|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
48541182|NCT00773734|156170144|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
48541183|NCT00773734|156170139|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
48541184|NCT00773734|156170140|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
48541185|NCT00773734|156170141|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
48541186|NCT00773734|156170142|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
48541187|NCT00773734|156170143|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
48541188|NCT00773734|156170144|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
48541189|NCT00773734|156170139|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
48541190|NCT00773734|156170140|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
48541191|NCT00773734|156170141|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
48541192|NCT00773734|156170142|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
48541193|NCT00773734|156170143|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
48541194|NCT00773734|156170144|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
48541195|NCT00773734|156170139|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
48541196|NCT00773734|156170140|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
48541197|NCT00773734|156170141|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
48541198|NCT00773734|156170142|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
48541199|NCT00773734|156170143|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
48541200|NCT00773734|156170144|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
48541201|NCT02177136|156170148|FG000|DB Phase|Withdrawal by Subject|2|||
48541202|NCT02177136|156170149|FG001|DB Phase|Withdrawal by Subject|0|||
48541203|NCT02177136|156170150|FG002|DB Phase|Withdrawal by Subject|0|||
48541204|NCT02177136|156170151|FG003|DB Phase|Withdrawal by Subject|0|||
48541205|NCT02177136|156170148|FG000|DB Phase|Discontinued Due to Pruritus|1|||
48541206|NCT02177136|156170149|FG001|DB Phase|Discontinued Due to Pruritus|3|||
48541207|NCT02177136|156170150|FG002|DB Phase|Discontinued Due to Pruritus|0|||
48607009|NCT02000921|156418503|FG001|Overall Study|Withdrawal by Subject|10|||
48607010|NCT02000921|156418504|FG002|Overall Study|Withdrawal by Subject|5|||
48607011|NCT02000921|156418502|FG000|Overall Study|Lost to Follow-up|2|||
48607012|NCT02000921|156418503|FG001|Overall Study|Lost to Follow-up|4|||
48607013|NCT02000921|156418504|FG002|Overall Study|Lost to Follow-up|5|||
48607014|NCT02000921|156418502|FG000|Overall Study|Physician Decision|0|||
48607015|NCT02000921|156418503|FG001|Overall Study|Physician Decision|2|||
48607016|NCT02000921|156418504|FG002|Overall Study|Physician Decision|0|||
48607017|NCT02051296|156418511|FG000|Overall Study|Lost to Follow-up|1|||
48607018|NCT02051296|156418512|FG001|Overall Study|Lost to Follow-up|2|||
48607019|NCT02051296|156418511|FG000|Overall Study|withdraw prior to treatment|7|||
48607020|NCT02051296|156418512|FG001|Overall Study|withdraw prior to treatment|7|||
48607021|NCT00975416|156418513|FG000|Overall Study|early discharge from tx|3|||
48607022|NCT00975416|156418514|FG001|Overall Study|early discharge from tx|5|||
48607023|NCT03439137|156418515|FG000|Overall Study|Adverse Event|16|||
48607024|NCT03439137|156418516|FG001|Overall Study|Adverse Event|12|||
48607025|NCT03439137|156418515|FG000|Overall Study|Physician Decision|0|||
48607026|NCT03439137|156418516|FG001|Overall Study|Physician Decision|5|||
48607027|NCT03439137|156418515|FG000|Overall Study|Withdrawal by Subject|14|||
48607028|NCT03439137|156418516|FG001|Overall Study|Withdrawal by Subject|4|||
48607029|NCT03439137|156418515|FG000|Overall Study|Conducting rescue therapy|2|||
48607030|NCT03439137|156418516|FG001|Overall Study|Conducting rescue therapy|1|||
48607031|NCT03439137|156418515|FG000|Overall Study|Difficult to control Hb|10|||
48607032|NCT03439137|156418516|FG001|Overall Study|Difficult to control Hb|2|||
48607033|NCT03439137|156418515|FG000|Overall Study|Initiation of a renal transplant|0|||
48607034|NCT03439137|156418516|FG001|Overall Study|Initiation of a renal transplant|2|||
48607035|NCT02251275|156418518|FG000|Overall Study|Adverse Event|23|||
48607036|NCT02251275|156418519|FG001|Overall Study|Adverse Event|60|||
48607037|NCT02251275|156418520|FG002|Overall Study|Adverse Event|28|||
48607038|NCT02251275|156418521|FG003|Overall Study|Adverse Event|0|||
48607039|NCT02251275|156418522|FG004|Overall Study|Adverse Event|0|||
48607040|NCT02251275|156418518|FG000|Overall Study|Lost to Follow-up|5|||
48607041|NCT02251275|156418519|FG001|Overall Study|Lost to Follow-up|6|||
48607042|NCT02251275|156418520|FG002|Overall Study|Lost to Follow-up|4|||
48541208|NCT02177136|156170151|FG003|DB Phase|Discontinued Due to Pruritus|0|||
48541209|NCT02177136|156170148|FG000|DB Phase|Adverse Event|3|||
48541210|NCT02177136|156170149|FG001|DB Phase|Adverse Event|2|||
48541211|NCT02177136|156170150|FG002|DB Phase|Adverse Event|3|||
48541212|NCT02177136|156170151|FG003|DB Phase|Adverse Event|0|||
48541213|NCT02177136|156170148|FG000|DB Phase|Protocol Violation|0|||
48541214|NCT02177136|156170149|FG001|DB Phase|Protocol Violation|0|||
48541215|NCT02177136|156170150|FG002|DB Phase|Protocol Violation|1|||
48541216|NCT02177136|156170151|FG003|DB Phase|Protocol Violation|0|||
48541217|NCT02177136|156170148|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
48541218|NCT02177136|156170149|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
48541219|NCT02177136|156170150|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
48541220|NCT02177136|156170151|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
48541221|NCT02177136|156170148|FG000|LTSE Phase|Withdrawal by Subject|0|||
48541222|NCT02177136|156170149|FG001|LTSE Phase|Withdrawal by Subject|0|||
48541223|NCT02177136|156170150|FG002|LTSE Phase|Withdrawal by Subject|0|||
48541224|NCT02177136|156170151|FG003|LTSE Phase|Withdrawal by Subject|6|||
48541225|NCT02177136|156170148|FG000|LTSE Phase|Adverse Event|0|||
48541226|NCT02177136|156170149|FG001|LTSE Phase|Adverse Event|0|||
48541227|NCT02177136|156170150|FG002|LTSE Phase|Adverse Event|0|||
48541228|NCT02177136|156170151|FG003|LTSE Phase|Adverse Event|10|||
48541229|NCT02177136|156170148|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
48541230|NCT02177136|156170149|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
48541231|NCT02177136|156170150|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
48541232|NCT02177136|156170151|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
48541233|NCT02177136|156170148|FG000|LTSE Phase|Physician Decision|0|||
48541234|NCT02177136|156170149|FG001|LTSE Phase|Physician Decision|0|||
48541235|NCT02177136|156170150|FG002|LTSE Phase|Physician Decision|0|||
48541236|NCT02177136|156170151|FG003|LTSE Phase|Physician Decision|2|||
48541237|NCT02177136|156170148|FG000|LTSE Phase|Lost to Follow-up|0|||
48541238|NCT02177136|156170149|FG001|LTSE Phase|Lost to Follow-up|0|||
48541239|NCT02177136|156170150|FG002|LTSE Phase|Lost to Follow-up|0|||
48541240|NCT02177136|156170151|FG003|LTSE Phase|Lost to Follow-up|1|||
48541241|NCT02177136|156170148|FG000|LTSE Phase|Participant Moved|0|||
48541242|NCT02177136|156170149|FG001|LTSE Phase|Participant Moved|0|||
48541243|NCT02177136|156170150|FG002|LTSE Phase|Participant Moved|0|||
48541244|NCT02177136|156170151|FG003|LTSE Phase|Participant Moved|1|||
48607043|NCT02251275|156418521|FG003|Overall Study|Lost to Follow-up|0|||
48607044|NCT02251275|156418522|FG004|Overall Study|Lost to Follow-up|0|||
48607045|NCT02251275|156418518|FG000|Overall Study|Physician Decision|19|||
48607046|NCT02251275|156418519|FG001|Overall Study|Physician Decision|30|||
48541245|NCT02963441|156170159|FG000|Overall Study|Protocol violation or withdrawn|8|||
48541246|NCT02963441|156170159|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
48541247|NCT02963441|156170159|FG000|Overall Study|IDx-DR insufficient quality|33|||
48541248|NCT04920916|156170160|FG000|Phase IIa 60 Day Study|Death|2|||
48541249|NCT04920916|156170161|FG001|Phase IIa 60 Day Study|Death|5|||
48541250|NCT04920916|156170160|FG000|1 Year Follow up (Phone Call)|Death|1|||
48541251|NCT04920916|156170161|FG001|1 Year Follow up (Phone Call)|Death|3|||
48541252|NCT04920916|156170160|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
48541253|NCT04920916|156170161|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
48607047|NCT02251275|156418520|FG002|Overall Study|Physician Decision|26|||
48607048|NCT02251275|156418521|FG003|Overall Study|Physician Decision|0|||
48541254|NCT02493777|156170162|FG000|Overall Study|Lost to Follow-up|0|||
48541255|NCT02493777|156170163|FG001|Overall Study|Lost to Follow-up|1|||
48541256|NCT04688931|156170164|FG000|Overall Study|Adverse Event|4|||
48541257|NCT04688931|156170165|FG001|Overall Study|Adverse Event|1|||
48541258|NCT04688931|156170164|FG000|Overall Study|Withdrawal by Subject|5|||
48541259|NCT04688931|156170165|FG001|Overall Study|Withdrawal by Subject|16|||
48607049|NCT02251275|156418522|FG004|Overall Study|Physician Decision|1|||
48607050|NCT02251275|156418518|FG000|Overall Study|Protocol Deviation|0|||
48607051|NCT02251275|156418519|FG001|Overall Study|Protocol Deviation|0|||
48607052|NCT02251275|156418520|FG002|Overall Study|Protocol Deviation|1|||
48607053|NCT02251275|156418521|FG003|Overall Study|Protocol Deviation|0|||
48607054|NCT02251275|156418522|FG004|Overall Study|Protocol Deviation|0|||
48607055|NCT02251275|156418518|FG000|Overall Study|Withdrawal by Subject|25|||
48607056|NCT02251275|156418519|FG001|Overall Study|Withdrawal by Subject|51|||
48607057|NCT02251275|156418520|FG002|Overall Study|Withdrawal by Subject|35|||
48607058|NCT02251275|156418521|FG003|Overall Study|Withdrawal by Subject|1|||
48607059|NCT02251275|156418522|FG004|Overall Study|Withdrawal by Subject|0|||
48607060|NCT04456686|156418526|FG000|Overall Study|Adverse Event|2|||
48607061|NCT04456686|156418527|FG001|Overall Study|Adverse Event|1|||
48607062|NCT04456686|156418526|FG000|Overall Study|Lack of Efficacy|3|||
48607063|NCT04456686|156418527|FG001|Overall Study|Lack of Efficacy|1|||
48607064|NCT04456686|156418526|FG000|Overall Study|Withdrew consent|3|||
48607065|NCT04456686|156418527|FG001|Overall Study|Withdrew consent|1|||
48607066|NCT04456686|156418526|FG000|Overall Study|Physician Decision|2|||
48607067|NCT04456686|156418527|FG001|Overall Study|Physician Decision|2|||
48607068|NCT04456686|156418526|FG000|Overall Study|Withdrawal by Subject|5|||
48607069|NCT04456686|156418527|FG001|Overall Study|Withdrawal by Subject|1|||
48607070|NCT04456686|156418526|FG000|Overall Study|Protocol Violation|0|||
48607071|NCT04456686|156418527|FG001|Overall Study|Protocol Violation|1|||
48607072|NCT03426345|156418533|FG000|Overall Study|Adverse Event|4|||
48607073|NCT03426345|156418534|FG001|Overall Study|Adverse Event|4|||
48607074|NCT03426345|156418533|FG000|Overall Study|Lack of Efficacy|1|||
48607075|NCT03426345|156418534|FG001|Overall Study|Lack of Efficacy|0|||
48607076|NCT03426345|156418533|FG000|Overall Study|Withdrawal by Subject|5|||
48607077|NCT03426345|156418534|FG001|Overall Study|Withdrawal by Subject|6|||
48607078|NCT03426345|156418533|FG000|Overall Study|Lost to Follow-up|3|||
48607079|NCT03426345|156418534|FG001|Overall Study|Lost to Follow-up|1|||
48607080|NCT03426345|156418533|FG000|Overall Study|Protocol Deviation|3|||
48607081|NCT03426345|156418534|FG001|Overall Study|Protocol Deviation|4|||
48607082|NCT03426345|156418533|FG000|Overall Study|Reason Not Specified|1|||
48607083|NCT03426345|156418534|FG001|Overall Study|Reason Not Specified|2|||
48607084|NCT03426345|156418533|FG000|Overall Study|Missing Completion Status|1|||
48607085|NCT03426345|156418534|FG001|Overall Study|Missing Completion Status|0|||
48607086|NCT00748241|156418535|FG000|Overall Study|Implant failure|1|||
48607087|NCT00748241|156418535|FG000|Overall Study|Lost to Follow-up|5|||
48607088|NCT00748241|156418535|FG000|Overall Study|Death|2|||
48607089|NCT01240382|156418536|FG000|Overall Study|Adverse Event|2|||
48607090|NCT01240382|156418537|FG001|Overall Study|Adverse Event|1|||
48607091|NCT01240382|156418536|FG000|Overall Study|Lack of Efficacy|0|||
48607092|NCT01240382|156418537|FG001|Overall Study|Lack of Efficacy|2|||
48447071|NCT01072448|155824498|FG000|Overall Study|Lost to Follow-up|1|||
48447072|NCT01072448|155824499|FG001|Overall Study|Lost to Follow-up|1|||
48447073|NCT01072448|155824498|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48447074|NCT01072448|155824499|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48447075|NCT01072448|155824498|FG000|Overall Study|Death|0|||
48447076|NCT01072448|155824499|FG001|Overall Study|Death|2|||
48447077|NCT00967226|155825762|FG000|Overall Study|Adverse Event|0|||
48447078|NCT00967226|155825763|FG001|Overall Study|Adverse Event|5|||
48447079|NCT00967226|155825762|FG000|Overall Study|Protocol Violation|2|||
48447080|NCT00967226|155825763|FG001|Overall Study|Protocol Violation|0|||
48447081|NCT00967226|155825762|FG000|Overall Study|Physician Decision|0|||
48447082|NCT00967226|155825763|FG001|Overall Study|Physician Decision|1|||
48447083|NCT03947255|155825764|FG000|Overall Study|Study Closure by Sponsor|2|||
48447084|NCT03947255|155825765|FG001|Overall Study|Study Closure by Sponsor|2|||
48447085|NCT03947255|155825764|FG000|Overall Study|Withdrawal by Subject|2|||
48447086|NCT03947255|155825765|FG001|Overall Study|Withdrawal by Subject|2|||
48447087|NCT03947255|155825764|FG000|Overall Study|Lost to Follow-up|2|||
48447088|NCT03947255|155825765|FG001|Overall Study|Lost to Follow-up|0|||
48447089|NCT03947255|155825764|FG000|Overall Study|Death|0|||
48447090|NCT03947255|155825765|FG001|Overall Study|Death|2|||
48447091|NCT03073213|155825766|FG000|Multiple Dose Period|Protocol Violation|0|||
48447092|NCT03073213|155825767|FG001|Multiple Dose Period|Protocol Violation|0|||
48447093|NCT03073213|155825768|FG002|Multiple Dose Period|Protocol Violation|1|||
48447094|NCT01253187|155825772|FG000|Period 2|Withdrawal by Subject|0|||
48607093|NCT01240382|156418536|FG000|Overall Study|Fear of adverse events|0|||
48607094|NCT01240382|156418537|FG001|Overall Study|Fear of adverse events|1|||
48607095|NCT02152007|156418538|FG000|Overall Study|Withdrawal by Subject|1|||
48607096|NCT01302899|156418543|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
48607097|NCT01302899|156418544|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
48607098|NCT01302899|156418543|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
48607099|NCT01302899|156418544|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
48607100|NCT02834975|156418545|FG000|Overall Study|Physician Decision|2|||
48541260|NCT04688931|156170164|FG000|Overall Study|Physician Decision|3|||
48541261|NCT04688931|156170165|FG001|Overall Study|Physician Decision|5|||
48541262|NCT04688931|156170164|FG000|Overall Study|Noncompliance|0|||
48541263|NCT04688931|156170165|FG001|Overall Study|Noncompliance|1|||
48541264|NCT04688931|156170164|FG000|Overall Study|Lost to Follow-up|1|||
48541265|NCT04688931|156170165|FG001|Overall Study|Lost to Follow-up|3|||
48541266|NCT04688931|156170164|FG000|Overall Study|Randomization Error|3|||
48541267|NCT04688931|156170165|FG001|Overall Study|Randomization Error|0|||
48541268|NCT04688931|156170164|FG000|Overall Study|Not Eligible|1|||
48607101|NCT02834975|156418545|FG000|Overall Study|Adverse Event|1|||
48607102|NCT02834975|156418545|FG000|Overall Study|Withdrawal by Subject|1|||
48541269|NCT04688931|156170165|FG001|Overall Study|Not Eligible|3|||
48541270|NCT04688931|156170164|FG000|Overall Study|Disease Progression|0|||
48541271|NCT04688931|156170165|FG001|Overall Study|Disease Progression|2|||
48607103|NCT02834975|156418545|FG000|Overall Study|Lack of Efficacy|1|||
48607104|NCT02497469|156418546|FG000|Overall Study|Randomized but not Treated|0|||
48607105|NCT02497469|156418547|FG001|Overall Study|Randomized but not Treated|2|||
48607106|NCT02497469|156418546|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
48607107|NCT02497469|156418547|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
48607108|NCT02497469|156418546|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
48607109|NCT02497469|156418547|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
48607110|NCT02497469|156418546|FG000|Overall Study|Significant Protocol Deviation|4|||
48607111|NCT02497469|156418547|FG001|Overall Study|Significant Protocol Deviation|5|||
48607112|NCT02497469|156418546|FG000|Overall Study|Lost to Follow-up|14|||
48607113|NCT02497469|156418547|FG001|Overall Study|Lost to Follow-up|4|||
48607114|NCT02497469|156418546|FG000|Overall Study|Voluntary Withdrawal|39|||
48607115|NCT02497469|156418547|FG001|Overall Study|Voluntary Withdrawal|41|||
48607116|NCT02497469|156418546|FG000|Overall Study|Pregnancy|1|||
48607117|NCT02497469|156418547|FG001|Overall Study|Pregnancy|1|||
48607118|NCT02497469|156418546|FG000|Overall Study|Lack of Efficacy|86|||
48541272|NCT04688931|156170164|FG000|Overall Study|Sponsor Requirement|1|||
48607119|NCT02497469|156418547|FG001|Overall Study|Lack of Efficacy|40|||
48541273|NCT04688931|156170165|FG001|Overall Study|Sponsor Requirement|1|||
48541274|NCT04688931|156170164|FG000|Overall Study|Other Reason|1|||
48541275|NCT04688931|156170165|FG001|Overall Study|Other Reason|2|||
48541276|NCT00667810|156170166|FG000|Overall Study|Adverse Event|13|||
48541277|NCT00667810|156170167|FG001|Overall Study|Adverse Event|14|||
48541278|NCT00667810|156170168|FG002|Overall Study|Adverse Event|19|||
48541279|NCT00667810|156170169|FG003|Overall Study|Adverse Event|1|||
48541280|NCT00667810|156170166|FG000|Overall Study|Death|1|||
48541281|NCT00667810|156170167|FG001|Overall Study|Death|1|||
48541282|NCT00667810|156170168|FG002|Overall Study|Death|3|||
48541283|NCT00667810|156170169|FG003|Overall Study|Death|0|||
48541284|NCT00667810|156170166|FG000|Overall Study|Lack of Efficacy|1|||
48541285|NCT00667810|156170167|FG001|Overall Study|Lack of Efficacy|0|||
48607120|NCT02497469|156418546|FG000|Overall Study|Reason not Specified|6|||
48607121|NCT02497469|156418547|FG001|Overall Study|Reason not Specified|6|||
48607122|NCT03363906|156418552|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
48607123|NCT03363906|156418553|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
48607124|NCT03363906|156418552|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
48607125|NCT03363906|156418553|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
48607126|NCT03363906|156418552|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
48607127|NCT03363906|156418553|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
48607128|NCT03363906|156418552|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
48607129|NCT03363906|156418553|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
48607130|NCT02059239|156418554|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
48607131|NCT02059239|156418555|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
48607132|NCT02059239|156418554|FG000|Overall Study|Physician Decision|1|||
48607133|NCT02059239|156418555|FG001|Overall Study|Physician Decision|0|||
48607134|NCT00472420|156418557|FG000|Induction Treatment Period|Physician Decision|9|||
48607135|NCT00472420|156418557|FG000|Induction Treatment Period|Adverse Event|3|||
48607136|NCT00472420|156418557|FG000|Induction Treatment Period|Non-compliance|1|||
48607137|NCT00472420|156418557|FG000|Induction Treatment Period|Death|3|||
48607138|NCT00472420|156418557|FG000|Follow-up Period|Death|5|||
48607139|NCT00472420|156418557|FG000|Follow-up Period|Physician Decision|9|||
48607140|NCT00472420|156418557|FG000|Follow-up Period|Lost to Follow-up|2|||
48607141|NCT00472420|156418557|FG000|Follow-up Period|Protocol Violation|1|||
48607142|NCT01268267|156418558|FG000|Overall Study|Protocol Violation|1|||
48607143|NCT00686972|156418559|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
48607144|NCT00113607|156418560|FG000|Overall Study|Adverse Event|40|||
48607145|NCT00113607|156418561|FG001|Overall Study|Adverse Event|71|||
48607146|NCT00113607|156418560|FG000|Overall Study|Death|8|||
48607147|NCT00113607|156418561|FG001|Overall Study|Death|8|||
48607148|NCT00113607|156418560|FG000|Overall Study|Withdrawal by Subject|50|||
48607149|NCT00113607|156418561|FG001|Overall Study|Withdrawal by Subject|58|||
48607150|NCT00113607|156418560|FG000|Overall Study|Lost to Follow-up|0|||
48607151|NCT00113607|156418561|FG001|Overall Study|Lost to Follow-up|2|||
48607152|NCT00113607|156418560|FG000|Overall Study|Disease Progression|180|||
48541286|NCT00667810|156170168|FG002|Overall Study|Lack of Efficacy|2|||
48607153|NCT00113607|156418561|FG001|Overall Study|Disease Progression|142|||
48607154|NCT00113607|156418560|FG000|Overall Study|Complete Response (Confirmed)|14|||
48607155|NCT00113607|156418561|FG001|Overall Study|Complete Response (Confirmed)|24|||
48607156|NCT00113607|156418560|FG000|Overall Study|Other|43|||
48607157|NCT00113607|156418561|FG001|Overall Study|Other|32|||
48541287|NCT00667810|156170169|FG003|Overall Study|Lack of Efficacy|0|||
48541288|NCT00667810|156170166|FG000|Overall Study|Lost to Follow-up|1|||
48541289|NCT00667810|156170167|FG001|Overall Study|Lost to Follow-up|4|||
48607158|NCT01901185|156418562|FG000|Overall Study|Withdrawal by Subject|2|||
48607159|NCT00909844|156418565|FG000|Overall Study|Adverse Event|1|||
48607160|NCT00909844|156418565|FG000|Overall Study|Withdrawal by Subject|1|||
48607161|NCT00909844|156418565|FG000|Overall Study|Lost to Follow-up|2|||
48607162|NCT04919317|156418566|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
48607163|NCT04919317|156418567|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
48607164|NCT04919317|156418566|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
48607165|NCT04919317|156418567|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
48607166|NCT02410629|156418568|FG000|Overall Study|Family cannot commit to the study|2|||
48607167|NCT02410629|156418569|FG001|Overall Study|Family cannot commit to the study|1|||
48607168|NCT02410629|156418568|FG000|Overall Study|Subject returned to work|1|||
48607169|NCT02410629|156418569|FG001|Overall Study|Subject returned to work|0|||
48607170|NCT02410629|156418568|FG000|Overall Study|Subject moved back to home country|0|||
48607171|NCT02410629|156418569|FG001|Overall Study|Subject moved back to home country|1|||
48607172|NCT02410629|156418568|FG000|Overall Study|Subject underwent heart surgery|0|||
48607173|NCT02410629|156418569|FG001|Overall Study|Subject underwent heart surgery|1|||
48607174|NCT03470922|156418572|FG000|Overall Study|Death|107|||
48607175|NCT03470922|156418573|FG001|Overall Study|Death|118|||
48607176|NCT03470922|156418572|FG000|Overall Study|Lost to Follow-up|5|||
48607177|NCT03470922|156418573|FG001|Overall Study|Lost to Follow-up|5|||
48607178|NCT03470922|156418572|FG000|Overall Study|Participant Withdrew Consent|4|||
48607179|NCT03470922|156418573|FG001|Overall Study|Participant Withdrew Consent|9|||
48607180|NCT03470922|156418572|FG000|Overall Study|Other reasons|1|||
48607181|NCT03470922|156418573|FG001|Overall Study|Other reasons|0|||
48541290|NCT00667810|156170168|FG002|Overall Study|Lost to Follow-up|2|||
48541291|NCT00667810|156170169|FG003|Overall Study|Lost to Follow-up|0|||
48541292|NCT00667810|156170166|FG000|Overall Study|Physician Decision|1|||
48541293|NCT00667810|156170167|FG001|Overall Study|Physician Decision|1|||
48541294|NCT00667810|156170168|FG002|Overall Study|Physician Decision|2|||
48541295|NCT00667810|156170169|FG003|Overall Study|Physician Decision|0|||
48541296|NCT00667810|156170166|FG000|Overall Study|Protocol Violation|0|||
48541297|NCT00667810|156170167|FG001|Overall Study|Protocol Violation|2|||
48541298|NCT00667810|156170168|FG002|Overall Study|Protocol Violation|0|||
48541299|NCT00667810|156170169|FG003|Overall Study|Protocol Violation|0|||
48541300|NCT00667810|156170166|FG000|Overall Study|Withdrawal by Subject|14|||
48541301|NCT00667810|156170167|FG001|Overall Study|Withdrawal by Subject|20|||
48541302|NCT00667810|156170168|FG002|Overall Study|Withdrawal by Subject|29|||
48541303|NCT00667810|156170169|FG003|Overall Study|Withdrawal by Subject|1|||
48541304|NCT00667810|156170166|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
48541305|NCT00667810|156170167|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
48541306|NCT00667810|156170168|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
48541307|NCT00667810|156170169|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
48541308|NCT00667810|156170166|FG000|Overall Study|Failed to Return|0|||
48541309|NCT00667810|156170167|FG001|Overall Study|Failed to Return|0|||
48541310|NCT00667810|156170168|FG002|Overall Study|Failed to Return|2|||
48541311|NCT00667810|156170169|FG003|Overall Study|Failed to Return|0|||
48541312|NCT00667810|156170166|FG000|Overall Study|Loss of Caregiver|0|||
48541313|NCT00667810|156170167|FG001|Overall Study|Loss of Caregiver|1|||
48541314|NCT00667810|156170168|FG002|Overall Study|Loss of Caregiver|3|||
48541315|NCT00667810|156170169|FG003|Overall Study|Loss of Caregiver|0|||
48541316|NCT00667810|156170166|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
48541317|NCT00667810|156170167|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
48541318|NCT00667810|156170168|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
48541319|NCT00667810|156170169|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
48541320|NCT00667810|156170166|FG000|Overall Study|Other|6|||
48541321|NCT00667810|156170167|FG001|Overall Study|Other|6|||
48541322|NCT00667810|156170168|FG002|Overall Study|Other|5|||
48541323|NCT00667810|156170169|FG003|Overall Study|Other|0|||
48541324|NCT00361335|156170172|FG000|IV Period: Baseline to E0|Adverse Event|9|||
48541325|NCT00361335|156170173|FG001|IV Period: Baseline to E0|Adverse Event|4|||
48541326|NCT00361335|156170174|FG002|IV Period: Baseline to E0|Adverse Event|5|||
48541327|NCT00361335|156170175|FG003|IV Period: Baseline to E0|Adverse Event|9|||
48541328|NCT00361335|156170176|FG004|IV Period: Baseline to E0|Adverse Event|8|||
48541329|NCT00361335|156170177|FG005|IV Period: Baseline to E0|Adverse Event|0|||
48541330|NCT00361335|156170178|FG006|IV Period: Baseline to E0|Adverse Event|0|||
48541331|NCT00361335|156170172|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
48541332|NCT00361335|156170173|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
48541333|NCT00361335|156170174|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
48541334|NCT00361335|156170175|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
48541335|NCT00361335|156170176|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
48541336|NCT00361335|156170177|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
48607182|NCT03470922|156418572|FG000|Overall Study|Not reported|1|||
48607183|NCT03470922|156418573|FG001|Overall Study|Not reported|0|||
48607184|NCT03093181|156418576|FG000|Overall Study|Withdrawal by Subject|2|||
48607185|NCT03093181|156418577|FG001|Overall Study|Withdrawal by Subject|1|||
48607186|NCT03093181|156418578|FG002|Overall Study|Withdrawal by Subject|2|||
48607187|NCT03093181|156418576|FG000|Overall Study|Other (Not specified)|1|||
48607188|NCT03093181|156418577|FG001|Overall Study|Other (Not specified)|0|||
48607189|NCT03093181|156418578|FG002|Overall Study|Other (Not specified)|0|||
48607190|NCT03093181|156418576|FG000|Overall Study|Adverse Event|0|||
48607191|NCT03093181|156418577|FG001|Overall Study|Adverse Event|1|||
48607192|NCT03093181|156418578|FG002|Overall Study|Adverse Event|0|||
48607193|NCT03093181|156418576|FG000|Overall Study|Other (Protocol violation)|0|||
48607194|NCT03093181|156418577|FG001|Overall Study|Other (Protocol violation)|0|||
48607195|NCT03093181|156418578|FG002|Overall Study|Other (Protocol violation)|1|||
48607196|NCT00087178|156418579|FG000|Overall Study|No follow up data|5|||
48607197|NCT00087178|156418580|FG001|Overall Study|No follow up data|15|||
48607198|NCT00087178|156418579|FG000|Overall Study|No clinical assessment|1|||
48607199|NCT00087178|156418580|FG001|Overall Study|No clinical assessment|2|||
48607200|NCT00087178|156418579|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
48607201|NCT00087178|156418580|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
48607202|NCT02378662|156418581|FG000|Overall Study|Early Discontinuation|2|||
48607203|NCT02378662|156418582|FG001|Overall Study|Early Discontinuation|0|||
48607204|NCT02357459|156420450|FG000|Overall Study|Adverse Event|0|||
48607205|NCT02357459|156420451|FG001|Overall Study|Adverse Event|1|||
48607206|NCT02357459|156420452|FG002|Overall Study|Adverse Event|1|||
48607207|NCT02357459|156420450|FG000|Overall Study|Withdrawal by Subject|5|||
48607208|NCT02357459|156420451|FG001|Overall Study|Withdrawal by Subject|3|||
48607209|NCT02357459|156420452|FG002|Overall Study|Withdrawal by Subject|3|||
48607210|NCT02357459|156420450|FG000|Overall Study|Physician Decision|0|||
48607211|NCT02357459|156420451|FG001|Overall Study|Physician Decision|2|||
48607212|NCT02357459|156420452|FG002|Overall Study|Physician Decision|0|||
48607213|NCT02357459|156420450|FG000|Overall Study|Protocol Violation|1|||
48607214|NCT02357459|156420451|FG001|Overall Study|Protocol Violation|1|||
48607215|NCT02357459|156420452|FG002|Overall Study|Protocol Violation|0|||
48607216|NCT02357459|156420450|FG000|Overall Study|Lost to Follow-up|1|||
48607217|NCT02357459|156420451|FG001|Overall Study|Lost to Follow-up|3|||
48607218|NCT02357459|156420452|FG002|Overall Study|Lost to Follow-up|0|||
48607219|NCT02357459|156420450|FG000|Overall Study|Lack of Efficacy|7|||
48607220|NCT02357459|156420451|FG001|Overall Study|Lack of Efficacy|4|||
48607221|NCT02357459|156420452|FG002|Overall Study|Lack of Efficacy|4|||
48607222|NCT02357459|156420450|FG000|Overall Study|Patient Relocated|2|||
48607223|NCT02357459|156420451|FG001|Overall Study|Patient Relocated|0|||
48607224|NCT02357459|156420452|FG002|Overall Study|Patient Relocated|0|||
48607225|NCT02357459|156420450|FG000|Overall Study|Instruction from PCP|1|||
48607226|NCT02357459|156420451|FG001|Overall Study|Instruction from PCP|0|||
48607227|NCT02357459|156420452|FG002|Overall Study|Instruction from PCP|0|||
48607228|NCT02357459|156420450|FG000|Overall Study|Incarceration|0|||
48541337|NCT00361335|156170178|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
48541338|NCT00361335|156170172|FG000|IV Period: Baseline to E0|Death|1|||
48541339|NCT00361335|156170173|FG001|IV Period: Baseline to E0|Death|1|||
48541340|NCT00361335|156170174|FG002|IV Period: Baseline to E0|Death|1|||
48541341|NCT00361335|156170175|FG003|IV Period: Baseline to E0|Death|1|||
48541342|NCT00361335|156170176|FG004|IV Period: Baseline to E0|Death|0|||
48541343|NCT00361335|156170177|FG005|IV Period: Baseline to E0|Death|0|||
48541344|NCT00361335|156170178|FG006|IV Period: Baseline to E0|Death|0|||
48541345|NCT00361335|156170172|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
48541346|NCT00361335|156170173|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
48541347|NCT00361335|156170174|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
48541348|NCT00361335|156170175|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
48541349|NCT00361335|156170176|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
48541350|NCT00361335|156170177|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
48541351|NCT00361335|156170178|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
48607229|NCT02357459|156420451|FG001|Overall Study|Incarceration|0|||
48607230|NCT02357459|156420452|FG002|Overall Study|Incarceration|1|||
48607231|NCT02357459|156420450|FG000|Overall Study|Pre-planned Knee surgery|0|||
48541352|NCT00361335|156170172|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
48607232|NCT02357459|156420451|FG001|Overall Study|Pre-planned Knee surgery|0|||
48607233|NCT02357459|156420452|FG002|Overall Study|Pre-planned Knee surgery|2|||
48607234|NCT02357459|156420450|FG000|Overall Study|Job Commitments|0|||
48607235|NCT02357459|156420451|FG001|Overall Study|Job Commitments|0|||
48607236|NCT02357459|156420452|FG002|Overall Study|Job Commitments|1|||
48607237|NCT01548599|156420453|FG000|Overall Study|Lost to Follow-up|0|||
48541353|NCT00361335|156170173|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
48607238|NCT01548599|156420454|FG001|Overall Study|Lost to Follow-up|1|||
48607239|NCT01548599|156420453|FG000|Overall Study|Withdrawal by Subject|4|||
48541354|NCT00361335|156170174|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
48541355|NCT00361335|156170175|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
48541356|NCT00361335|156170176|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
48541357|NCT00361335|156170177|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
48541358|NCT00361335|156170178|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
48541359|NCT00361335|156170172|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
48541360|NCT00361335|156170173|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
48541361|NCT00361335|156170174|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
48541362|NCT00361335|156170175|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
48541363|NCT00361335|156170176|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
48541364|NCT00361335|156170177|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
48541365|NCT00361335|156170178|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
48541366|NCT00361335|156170172|FG000|IV Period: Baseline to E0|Other|2|||
48541367|NCT00361335|156170173|FG001|IV Period: Baseline to E0|Other|9|||
48541368|NCT00361335|156170174|FG002|IV Period: Baseline to E0|Other|9|||
48541369|NCT00361335|156170175|FG003|IV Period: Baseline to E0|Other|3|||
48541370|NCT00361335|156170176|FG004|IV Period: Baseline to E0|Other|2|||
48541371|NCT00361335|156170177|FG005|IV Period: Baseline to E0|Other|0|||
48607240|NCT01548599|156420454|FG001|Overall Study|Withdrawal by Subject|0|||
48607241|NCT01548599|156420453|FG000|Overall Study|Death|2|||
48607242|NCT01548599|156420454|FG001|Overall Study|Death|1|||
48607243|NCT02873689|156420455|FG000|Overall Study|Lack of Efficacy|1|||
48607244|NCT02873689|156420456|FG001|Overall Study|Lack of Efficacy|0|||
48607245|NCT02873689|156420455|FG000|Overall Study|Withdrawal by Subject|2|||
48607246|NCT02873689|156420456|FG001|Overall Study|Withdrawal by Subject|2|||
48607247|NCT02873689|156420455|FG000|Overall Study|Protocol Violation|1|||
48607248|NCT02873689|156420456|FG001|Overall Study|Protocol Violation|0|||
48607249|NCT02873689|156420455|FG000|Overall Study|Adverse Event|2|||
48607250|NCT02873689|156420456|FG001|Overall Study|Adverse Event|2|||
48607251|NCT02873689|156420455|FG000|Overall Study|Randomized but not Treated|1|||
48607252|NCT02873689|156420456|FG001|Overall Study|Randomized but not Treated|1|||
48607253|NCT05630196|156420457|FG000|Overall Study|Adverse Event|2|||
48607254|NCT05630196|156420458|FG001|Overall Study|Adverse Event|1|||
48607255|NCT05630196|156420457|FG000|Overall Study|Lost to Follow-up|1|||
48607256|NCT05630196|156420458|FG001|Overall Study|Lost to Follow-up|1|||
48607257|NCT05630196|156420457|FG000|Overall Study|Protocol Violation|2|||
48607258|NCT05630196|156420458|FG001|Overall Study|Protocol Violation|3|||
48607259|NCT05630196|156420457|FG000|Overall Study|Physician Decision|1|||
48607260|NCT05630196|156420458|FG001|Overall Study|Physician Decision|0|||
48607261|NCT05630196|156420457|FG000|Overall Study|Withdrawal by Subject|3|||
48607262|NCT05630196|156420458|FG001|Overall Study|Withdrawal by Subject|4|||
48607263|NCT03250273|156420459|FG000|Overall Study|Disease Progression|2|||
48607264|NCT03250273|156420460|FG001|Overall Study|Disease Progression|11|||
48607265|NCT03250273|156420459|FG000|Overall Study|Death|0|||
48541372|NCT00361335|156170178|FG006|IV Period: Baseline to E0|Other|0|||
48541373|NCT00361335|156170172|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
48541374|NCT00361335|156170173|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
48541375|NCT00361335|156170174|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
48541376|NCT00361335|156170175|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
48541377|NCT00361335|156170176|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
48541378|NCT00361335|156170177|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
48541379|NCT00361335|156170178|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
48541380|NCT00361335|156170172|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
48541381|NCT00361335|156170173|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
48541382|NCT00361335|156170174|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
48541383|NCT00361335|156170175|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
48607266|NCT03250273|156420460|FG001|Overall Study|Death|1|||
48541384|NCT00361335|156170176|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
48541385|NCT00361335|156170177|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
48541386|NCT00361335|156170178|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
48541387|NCT00361335|156170172|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
48541388|NCT00361335|156170173|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
48541389|NCT00361335|156170174|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
48607267|NCT01317641|156420468|FG000|Overall Study|Not treated|0|||
48607268|NCT01317641|156420469|FG001|Overall Study|Not treated|0|||
48541390|NCT00361335|156170175|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
48541391|NCT00361335|156170176|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
48607269|NCT01317641|156420470|FG002|Overall Study|Not treated|0|||
48607270|NCT01317641|156420471|FG003|Overall Study|Not treated|0|||
48607271|NCT01317641|156420472|FG004|Overall Study|Not treated|0|||
48607272|NCT01317641|156420473|FG005|Overall Study|Not treated|0|||
48607273|NCT01317641|156420474|FG006|Overall Study|Not treated|0|||
48607274|NCT01317641|156420475|FG007|Overall Study|Not treated|1|||
48607275|NCT01317641|156420476|FG008|Overall Study|Not treated|1|||
48607276|NCT01317641|156420468|FG000|Overall Study|Adverse Event|0|||
48607277|NCT01317641|156420469|FG001|Overall Study|Adverse Event|1|||
48607278|NCT01317641|156420470|FG002|Overall Study|Adverse Event|0|||
48607279|NCT01317641|156420471|FG003|Overall Study|Adverse Event|1|||
48541392|NCT00361335|156170177|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
48541393|NCT00361335|156170178|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
48541394|NCT00361335|156170172|FG000|SC Period: Week E0 to Week E24|Death|0|||
48541395|NCT00361335|156170173|FG001|SC Period: Week E0 to Week E24|Death|0|||
48541396|NCT00361335|156170174|FG002|SC Period: Week E0 to Week E24|Death|0|||
48541397|NCT00361335|156170175|FG003|SC Period: Week E0 to Week E24|Death|0|||
48541398|NCT00361335|156170176|FG004|SC Period: Week E0 to Week E24|Death|0|||
48541399|NCT00361335|156170177|FG005|SC Period: Week E0 to Week E24|Death|0|||
48541400|NCT00361335|156170178|FG006|SC Period: Week E0 to Week E24|Death|1|||
48541401|NCT00361335|156170172|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
48541402|NCT00361335|156170173|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
48541403|NCT00361335|156170174|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
48541404|NCT00361335|156170175|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
48541405|NCT00361335|156170176|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
48541406|NCT00361335|156170177|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
48541407|NCT00361335|156170178|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
48541408|NCT00361335|156170172|FG000|SC Period: Week E0 to Week E24|Other|1|||
48541409|NCT00361335|156170173|FG001|SC Period: Week E0 to Week E24|Other|0|||
48541410|NCT00361335|156170174|FG002|SC Period: Week E0 to Week E24|Other|0|||
48541411|NCT00361335|156170175|FG003|SC Period: Week E0 to Week E24|Other|1|||
48607280|NCT01317641|156420472|FG004|Overall Study|Adverse Event|0|||
48607281|NCT01317641|156420473|FG005|Overall Study|Adverse Event|0|||
48607282|NCT01317641|156420474|FG006|Overall Study|Adverse Event|2|||
48607283|NCT01317641|156420475|FG007|Overall Study|Adverse Event|1|||
48607284|NCT01317641|156420476|FG008|Overall Study|Adverse Event|0|||
48541412|NCT00361335|156170176|FG004|SC Period: Week E0 to Week E24|Other|0|||
48541413|NCT00361335|156170177|FG005|SC Period: Week E0 to Week E24|Other|1|||
48541414|NCT00361335|156170178|FG006|SC Period: Week E0 to Week E24|Other|2|||
48541415|NCT00361335|156170172|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
48541416|NCT00361335|156170173|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
48541417|NCT00361335|156170174|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
48541418|NCT00361335|156170175|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
48607285|NCT01317641|156420468|FG000|Overall Study|Protocol Violation|1|||
48541419|NCT00361335|156170176|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
48607286|NCT01317641|156420469|FG001|Overall Study|Protocol Violation|0|||
48607287|NCT01317641|156420470|FG002|Overall Study|Protocol Violation|0|||
48607288|NCT01317641|156420471|FG003|Overall Study|Protocol Violation|0|||
48607289|NCT01317641|156420472|FG004|Overall Study|Protocol Violation|0|||
48607290|NCT01317641|156420473|FG005|Overall Study|Protocol Violation|0|||
48607291|NCT01317641|156420474|FG006|Overall Study|Protocol Violation|0|||
48607292|NCT01317641|156420475|FG007|Overall Study|Protocol Violation|0|||
48607293|NCT01317641|156420476|FG008|Overall Study|Protocol Violation|0|||
48541420|NCT00361335|156170177|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
48541421|NCT00361335|156170178|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
48541422|NCT01959035|156170179|FG000|Overall Study|Adverse Event|5|||
48541423|NCT01959035|156170179|FG000|Overall Study|Withdrawal by Subject|4|||
48541424|NCT01959035|156170179|FG000|Overall Study|Lost to Follow-up|1|||
48541425|NCT01959035|156170179|FG000|Overall Study|Other (no primary reason given)|1|||
48541426|NCT00450619|156170180|FG000|Overall Study|refused treatment after randomization|2|||
48541427|NCT00450619|156170181|FG001|Overall Study|refused treatment after randomization|0|||
48541428|NCT00450619|156170180|FG000|Overall Study|did not progress; refused further trmt|1|||
48541429|NCT00450619|156170181|FG001|Overall Study|did not progress; refused further trmt|1|||
48541430|NCT00450619|156170180|FG000|Overall Study|Adverse Event|1|||
48541431|NCT00450619|156170181|FG001|Overall Study|Adverse Event|0|||
48541432|NCT03254602|156170184|FG000|Overall Study|Lost to Follow-up|4|||
48541433|NCT01765582|156170187|FG000|Overall Study|Other|3|||
48541434|NCT01765582|156170188|FG001|Overall Study|Other|6|||
48541435|NCT01765582|156170189|FG002|Overall Study|Other|9|||
48541436|NCT01765582|156170187|FG000|Overall Study|Lost to Follow-up|2|||
48541437|NCT01765582|156170188|FG001|Overall Study|Lost to Follow-up|2|||
48541438|NCT01765582|156170189|FG002|Overall Study|Lost to Follow-up|1|||
48541439|NCT01765582|156170187|FG000|Overall Study|Death|31|||
48541440|NCT01765582|156170188|FG001|Overall Study|Death|36|||
48541441|NCT01765582|156170189|FG002|Overall Study|Death|33|||
48541442|NCT01765582|156170187|FG000|Overall Study|Sponsor Decision|46|||
48541443|NCT01765582|156170188|FG001|Overall Study|Sponsor Decision|42|||
48541444|NCT01765582|156170189|FG002|Overall Study|Sponsor Decision|42|||
48541445|NCT01765582|156170187|FG000|Overall Study|Withdrawal of Consent|11|||
48541446|NCT01765582|156170188|FG001|Overall Study|Withdrawal of Consent|6|||
48541447|NCT01765582|156170189|FG002|Overall Study|Withdrawal of Consent|10|||
48541448|NCT00986180|156170190|FG000|Overall Study|Adverse Event|21|||
48541449|NCT00986180|156170191|FG001|Overall Study|Adverse Event|23|||
48541450|NCT00986180|156170190|FG000|Overall Study|Lack of Efficacy|4|||
48541451|NCT00986180|156170191|FG001|Overall Study|Lack of Efficacy|3|||
48541452|NCT00986180|156170190|FG000|Overall Study|Lost to Follow-up|5|||
48541453|NCT00986180|156170191|FG001|Overall Study|Lost to Follow-up|7|||
48541454|NCT00986180|156170190|FG000|Overall Study|Physician Decision|1|||
48541455|NCT00986180|156170191|FG001|Overall Study|Physician Decision|3|||
48541456|NCT00986180|156170190|FG000|Overall Study|Protocol Violation|2|||
48541457|NCT00986180|156170191|FG001|Overall Study|Protocol Violation|0|||
48541458|NCT00986180|156170190|FG000|Overall Study|Withdrawal by Subject|1|||
48541459|NCT00986180|156170191|FG001|Overall Study|Withdrawal by Subject|9|||
48541460|NCT00986180|156170190|FG000|Overall Study|Miscellanies|10|||
48541461|NCT00986180|156170191|FG001|Overall Study|Miscellanies|11|||
48541462|NCT01691820|156170192|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
48541463|NCT01691820|156170193|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
48541464|NCT01691820|156170192|FG000|Overall Study|Migrated/moved from study area|7|||
48541465|NCT01691820|156170193|FG001|Overall Study|Migrated/moved from study area|4|||
48541466|NCT01691820|156170192|FG000|Overall Study|Lost to Follow-up|6|||
48541467|NCT01691820|156170193|FG001|Overall Study|Lost to Follow-up|17|||
48541468|NCT01691820|156170192|FG000|Overall Study|Other (unspecified)|4|||
48541469|NCT01691820|156170193|FG001|Overall Study|Other (unspecified)|1|||
48541470|NCT00616941|156170195|FG000|Overall Study|Progressive Disease|1|||
48541471|NCT00616941|156170196|FG001|Overall Study|Progressive Disease|2|||
48541472|NCT00616941|156170197|FG002|Overall Study|Progressive Disease|1|||
48541473|NCT00616941|156170195|FG000|Overall Study|Adverse Event|0|||
48607294|NCT01317641|156420468|FG000|Overall Study|Disease progression|0|||
48541474|NCT00616941|156170196|FG001|Overall Study|Adverse Event|1|||
48541475|NCT00616941|156170197|FG002|Overall Study|Adverse Event|1|||
48541476|NCT00616941|156170195|FG000|Overall Study|Subject Non-compliance|0|||
48541477|NCT00616941|156170196|FG001|Overall Study|Subject Non-compliance|0|||
48541478|NCT00616941|156170197|FG002|Overall Study|Subject Non-compliance|1|||
48541479|NCT00616941|156170195|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
48541480|NCT00616941|156170196|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
48541481|NCT00616941|156170197|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
48541482|NCT00616941|156170195|FG000|Overall Study|Vaccination Suspended|0|||
48541483|NCT00616941|156170196|FG001|Overall Study|Vaccination Suspended|0|||
48541484|NCT00616941|156170197|FG002|Overall Study|Vaccination Suspended|3|||
48607295|NCT01317641|156420469|FG001|Overall Study|Disease progression|0|||
48541485|NCT02771795|156170198|FG000|Overall Study|Withdrawal by Subject|47|||
48541486|NCT02771795|156170199|FG001|Overall Study|Withdrawal by Subject|37|||
48541487|NCT02771795|156170198|FG000|Overall Study|Termination by premature discontinuation of study|168|||
48541488|NCT02771795|156170199|FG001|Overall Study|Termination by premature discontinuation of study|185|||
48541489|NCT04442490|156170200|FG000|Overall Study|Withdrawal by Subject|18|||
48541490|NCT04442490|156170201|FG001|Overall Study|Withdrawal by Subject|10|||
48541491|NCT04442490|156170200|FG000|Overall Study|Lost to Follow-up|7|||
48541492|NCT04442490|156170201|FG001|Overall Study|Lost to Follow-up|7|||
48541493|NCT04442490|156170200|FG000|Overall Study|Adverse Event|2|||
48541494|NCT04442490|156170201|FG001|Overall Study|Adverse Event|6|||
48541495|NCT04442490|156170200|FG000|Overall Study|Noncompliance|3|||
48541496|NCT04442490|156170201|FG001|Overall Study|Noncompliance|1|||
48541497|NCT04442490|156170200|FG000|Overall Study|Physician Decision|2|||
48541498|NCT04442490|156170201|FG001|Overall Study|Physician Decision|1|||
48541499|NCT04442490|156170200|FG000|Overall Study|Reason not Specified|2|||
48541500|NCT04442490|156170201|FG001|Overall Study|Reason not Specified|1|||
48541501|NCT04442490|156170200|FG000|Overall Study|Randomized but not Treated|3|||
48541502|NCT04442490|156170201|FG001|Overall Study|Randomized but not Treated|3|||
48541503|NCT00076804|156170202|FG000|Overall Study|Death|9|||
48541504|NCT00076804|156170203|FG001|Overall Study|Death|20|||
48541505|NCT00076804|156170202|FG000|Overall Study|Lost to Follow-up|9|||
48541506|NCT00076804|156170203|FG001|Overall Study|Lost to Follow-up|9|||
48541507|NCT00076804|156170202|FG000|Overall Study|Withdrawal by Subject|10|||
48541508|NCT00076804|156170203|FG001|Overall Study|Withdrawal by Subject|8|||
48541509|NCT00076804|156170202|FG000|Overall Study|Early study Closure|32|||
48541510|NCT00076804|156170203|FG001|Overall Study|Early study Closure|32|||
48541511|NCT02836496|156170206|FG000|Overall Study|Adverse Event|2|||
48541512|NCT02836496|156170207|FG001|Overall Study|Adverse Event|1|||
48541513|NCT02836496|156170206|FG000|Overall Study|Withdrawal by Subject|0|||
48541514|NCT02836496|156170207|FG001|Overall Study|Withdrawal by Subject|1|||
48541515|NCT00354341|156170208|FG000|Overall Study|Adverse Event|1|||
48541516|NCT00354341|156170209|FG001|Overall Study|Adverse Event|0|||
48541517|NCT00354341|156170208|FG000|Overall Study|Death|0|||
48541518|NCT00354341|156170209|FG001|Overall Study|Death|2|||
48541519|NCT00354341|156170208|FG000|Overall Study|Refused treatment|1|||
48541520|NCT00354341|156170209|FG001|Overall Study|Refused treatment|2|||
48541521|NCT00354341|156170208|FG000|Overall Study|Failure to return|0|||
48541522|NCT00354341|156170209|FG001|Overall Study|Failure to return|1|||
48541523|NCT00354341|156170208|FG000|Overall Study|Other|1|||
48541524|NCT00354341|156170209|FG001|Overall Study|Other|2|||
48541525|NCT01642914|156170210|FG000|Overall Study|Adverse Event|11|||
48541526|NCT01642914|156170211|FG001|Overall Study|Adverse Event|7|||
48541527|NCT01642914|156170212|FG002|Overall Study|Adverse Event|15|||
48541528|NCT01642914|156170210|FG000|Overall Study|Lack of Efficacy|9|||
48541529|NCT01642914|156170211|FG001|Overall Study|Lack of Efficacy|4|||
48541530|NCT01642914|156170212|FG002|Overall Study|Lack of Efficacy|2|||
48541531|NCT01642914|156170210|FG000|Overall Study|Protocol Violation|15|||
48541532|NCT01642914|156170211|FG001|Overall Study|Protocol Violation|13|||
48541533|NCT01642914|156170212|FG002|Overall Study|Protocol Violation|6|||
48541534|NCT01642914|156170210|FG000|Overall Study|Withdrawal by Subject|5|||
48541535|NCT01642914|156170211|FG001|Overall Study|Withdrawal by Subject|5|||
48541536|NCT01642914|156170212|FG002|Overall Study|Withdrawal by Subject|10|||
48541537|NCT01642914|156170210|FG000|Overall Study|Lost to Follow-up|5|||
48541538|NCT01642914|156170211|FG001|Overall Study|Lost to Follow-up|3|||
48541539|NCT01642914|156170212|FG002|Overall Study|Lost to Follow-up|7|||
48541540|NCT01642914|156170210|FG000|Overall Study|Other Reason|1|||
48541541|NCT01642914|156170211|FG001|Overall Study|Other Reason|0|||
48541542|NCT01642914|156170212|FG002|Overall Study|Other Reason|0|||
48541543|NCT01400919|156170213|FG000|Overall Study|Withdrawal by Subject|4|||
48541544|NCT01400919|156170213|FG000|Overall Study|Lost to Follow-up|2|||
48541545|NCT01400919|156170213|FG000|Overall Study|Missed visit|2|||
48541546|NCT04112173|156170217|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
48541547|NCT01561430|156170218|FG000|Overall Study|Adverse Event|0|||
48541548|NCT01561430|156170219|FG001|Overall Study|Adverse Event|0|||
48541549|NCT01561430|156170220|FG002|Overall Study|Adverse Event|3|||
48541550|NCT01561430|156170221|FG003|Overall Study|Adverse Event|1|||
48541551|NCT01561430|156170218|FG000|Overall Study|Withdrawal by Subject|0|||
48541552|NCT01561430|156170219|FG001|Overall Study|Withdrawal by Subject|0|||
48541553|NCT01561430|156170220|FG002|Overall Study|Withdrawal by Subject|1|||
48541554|NCT01561430|156170221|FG003|Overall Study|Withdrawal by Subject|0|||
48541555|NCT01561430|156170218|FG000|Overall Study|Physician Decision|0|||
48541556|NCT01561430|156170219|FG001|Overall Study|Physician Decision|1|||
48541557|NCT01561430|156170220|FG002|Overall Study|Physician Decision|0|||
48541558|NCT01561430|156170221|FG003|Overall Study|Physician Decision|0|||
48541559|NCT01561430|156170218|FG000|Overall Study|Sponsor Decision|1|||
48541560|NCT01561430|156170219|FG001|Overall Study|Sponsor Decision|14|||
48541561|NCT01561430|156170220|FG002|Overall Study|Sponsor Decision|13|||
48541562|NCT01561430|156170221|FG003|Overall Study|Sponsor Decision|12|||
48541563|NCT03028740|156170222|FG000|Overall Study|Did not Receive Study Drug|4|||
48607296|NCT01317641|156420470|FG002|Overall Study|Disease progression|0|||
48607297|NCT01317641|156420471|FG003|Overall Study|Disease progression|0|||
48607298|NCT01317641|156420472|FG004|Overall Study|Disease progression|0|||
48607299|NCT01317641|156420473|FG005|Overall Study|Disease progression|0|||
48607300|NCT01317641|156420474|FG006|Overall Study|Disease progression|0|||
48607301|NCT01317641|156420475|FG007|Overall Study|Disease progression|3|||
48607302|NCT01317641|156420476|FG008|Overall Study|Disease progression|4|||
48607303|NCT01317641|156420468|FG000|Overall Study|Withdrawal by Subject|0|||
48607304|NCT01317641|156420469|FG001|Overall Study|Withdrawal by Subject|0|||
48607305|NCT01317641|156420470|FG002|Overall Study|Withdrawal by Subject|0|||
48607306|NCT01317641|156420471|FG003|Overall Study|Withdrawal by Subject|0|||
48607307|NCT01317641|156420472|FG004|Overall Study|Withdrawal by Subject|0|||
48607308|NCT01317641|156420473|FG005|Overall Study|Withdrawal by Subject|0|||
48607309|NCT01317641|156420474|FG006|Overall Study|Withdrawal by Subject|1|||
48607310|NCT01317641|156420475|FG007|Overall Study|Withdrawal by Subject|0|||
48607311|NCT01317641|156420476|FG008|Overall Study|Withdrawal by Subject|0|||
48607312|NCT04006145|156420477|FG000|Overall Study|Lost to Follow-up|0|||
48607313|NCT04006145|156420478|FG001|Overall Study|Lost to Follow-up|1|||
48607314|NCT04006145|156420477|FG000|Overall Study|Other|1|||
48607315|NCT04006145|156420478|FG001|Overall Study|Other|2|||
48607316|NCT00830219|156420479|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
48607317|NCT00830219|156420480|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
48541564|NCT03028740|156170223|FG001|Overall Study|Did not Receive Study Drug|5|||
48541565|NCT03028740|156170222|FG000|Overall Study|Adverse Event|8|||
48541566|NCT03028740|156170223|FG001|Overall Study|Adverse Event|26|||
48541567|NCT03028740|156170222|FG000|Overall Study|Lack of Efficacy|0|||
48541568|NCT03028740|156170223|FG001|Overall Study|Lack of Efficacy|1|||
48541569|NCT03028740|156170222|FG000|Overall Study|Withdrawal by Subject|48|||
48541570|NCT03028740|156170223|FG001|Overall Study|Withdrawal by Subject|101|||
48541571|NCT03028740|156170222|FG000|Overall Study|Lost to Follow-up|30|||
48541572|NCT03028740|156170223|FG001|Overall Study|Lost to Follow-up|54|||
48541573|NCT03028740|156170222|FG000|Overall Study|Physician Decision|4|||
48541574|NCT03028740|156170223|FG001|Overall Study|Physician Decision|11|||
48541575|NCT03028740|156170222|FG000|Overall Study|Protocol Violation|4|||
48541576|NCT03028740|156170223|FG001|Overall Study|Protocol Violation|8|||
48541577|NCT03028740|156170222|FG000|Overall Study|Non-compliance with Study Drug|0|||
48541578|NCT03028740|156170223|FG001|Overall Study|Non-compliance with Study Drug|2|||
48541579|NCT03028740|156170222|FG000|Overall Study|Study Terminated by Sponsor|467|||
48541580|NCT03028740|156170223|FG001|Overall Study|Study Terminated by Sponsor|917|||
48541581|NCT03028740|156170222|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
48541582|NCT03028740|156170223|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
48541583|NCT03028740|156170222|FG000|Overall Study|Reason not Specified|1|||
48541584|NCT03028740|156170223|FG001|Overall Study|Reason not Specified|5|||
48541585|NCT03347422|156170224|FG000|Part A (26 Weeks)|Adverse Event|3|||
48541586|NCT03347422|156170225|FG001|Part A (26 Weeks)|Adverse Event|0|||
48541587|NCT03347422|156170224|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
48541588|NCT03347422|156170225|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
48541589|NCT03347422|156170224|FG000|Part B (149 Weeks)|Adverse Event|0|||
48541590|NCT03347422|156170225|FG001|Part B (149 Weeks)|Adverse Event|1|||
48541591|NCT03347422|156170224|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
48541592|NCT03347422|156170225|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
48607318|NCT01145482|156420481|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
48607319|NCT01145482|156420482|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
48607320|NCT02351934|156420483|FG000|Allocation|POD weight<pre-op weight|3|||
48607321|NCT02351934|156420484|FG001|Allocation|POD weight<pre-op weight|0|||
48607322|NCT02351934|156420483|FG000|Allocation|Hypotension preventing administration|2|||
48607323|NCT02351934|156420484|FG001|Allocation|Hypotension preventing administration|0|||
48607324|NCT02351934|156420483|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
48607325|NCT02351934|156420484|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
48607326|NCT02351934|156420483|FG000|Follow-Up|POD weight<pre-op weight|3|||
48607327|NCT02351934|156420484|FG001|Follow-Up|POD weight<pre-op weight|0|||
48541593|NCT03347422|156170224|FG000|Part B (149 Weeks)|Other|1|||
48541594|NCT03347422|156170225|FG001|Part B (149 Weeks)|Other|0|||
48541595|NCT01059539|156170226|FG000|Overall Study|Adverse Event|66|||
48541596|NCT01059539|156170226|FG000|Overall Study|Insufficient Therapeutic Response|26|||
48607328|NCT02351934|156420483|FG000|Follow-Up|Acute Kidney Injury|1|||
48607329|NCT02351934|156420484|FG001|Follow-Up|Acute Kidney Injury|0|||
48607330|NCT02351934|156420483|FG000|Follow-Up|Early dismissal|3|||
48541597|NCT01059539|156170226|FG000|Overall Study|Protocol Violation|55|||
48541598|NCT01059539|156170226|FG000|Overall Study|Withdrawal of Consent|80|||
48541599|NCT01059539|156170226|FG000|Overall Study|Lost to Follow-up|42|||
48607331|NCT02351934|156420484|FG001|Follow-Up|Early dismissal|0|||
48607332|NCT02351934|156420483|FG000|Follow-Up|Hypotension|3|||
48607333|NCT02351934|156420484|FG001|Follow-Up|Hypotension|0|||
48607334|NCT02351934|156420483|FG000|Follow-Up|No documentation|2|||
48541600|NCT01059539|156170226|FG000|Overall Study|Reason Not Specified|2|||
48541601|NCT00536263|156170227|FG000|Overall Study|Adverse Event|5|||
48607335|NCT02351934|156420484|FG001|Follow-Up|No documentation|0|||
48607336|NCT02351934|156420483|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
48607337|NCT02351934|156420484|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
48607338|NCT02351934|156420483|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
48607339|NCT02351934|156420484|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
48607340|NCT01699750|156420485|FG000|Overall Study|Withdrew Consent|0|||
48607341|NCT01699750|156420486|FG001|Overall Study|Withdrew Consent|1|||
48607342|NCT01699750|156420485|FG000|Overall Study|Other|0|||
48607343|NCT01699750|156420486|FG001|Overall Study|Other|2|||
48607344|NCT04635839|156420487|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
48607345|NCT04635839|156420488|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
48607346|NCT02870868|156420489|FG000|Overall Study|Withdrawal by Subject|2|||
48607347|NCT02870868|156420490|FG001|Overall Study|Withdrawal by Subject|1|||
48607348|NCT00744939|156420491|FG000|Overall Study|Withdrawal by Subject|9|||
48607349|NCT00744939|156420491|FG000|Overall Study|Protocol Violation|13|||
48607350|NCT00744939|156420491|FG000|Overall Study|Death|24|||
48607351|NCT00744939|156420491|FG000|Overall Study|distance|4|||
48607352|NCT00744939|156420491|FG000|Overall Study|Lost to Follow-up|12|||
48607353|NCT00744939|156420491|FG000|Overall Study|Medical history exclusionary|1|||
48607354|NCT00744939|156420491|FG000|Overall Study|Did not receive Magnevist|7|||
48607355|NCT00744939|156420491|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
48607356|NCT00744939|156420491|FG000|Overall Study|coma|1|||
48607357|NCT00744939|156420491|FG000|Overall Study|incorrect race|1|||
48607358|NCT01649765|156420493|FG000|Overall Study|Adverse Event|5|||
48607359|NCT01649765|156420494|FG001|Overall Study|Adverse Event|3|||
48607360|NCT01649765|156420493|FG000|Overall Study|Lack of Efficacy|1|||
48607361|NCT01649765|156420494|FG001|Overall Study|Lack of Efficacy|1|||
48607362|NCT01649765|156420493|FG000|Overall Study|Physician Decision|0|||
48607363|NCT01649765|156420494|FG001|Overall Study|Physician Decision|3|||
48607364|NCT01649765|156420493|FG000|Overall Study|Protocol Violation|1|||
48607365|NCT01649765|156420494|FG001|Overall Study|Protocol Violation|0|||
48607366|NCT01649765|156420493|FG000|Overall Study|Withdrawal by Subject|2|||
48607367|NCT01649765|156420494|FG001|Overall Study|Withdrawal by Subject|1|||
48607368|NCT02452047|156420495|FG000|Overall Study|Adverse Event|0|||
48607369|NCT02452047|156420496|FG001|Overall Study|Adverse Event|1|||
48607370|NCT02452047|156420497|FG002|Overall Study|Adverse Event|1|||
48541602|NCT00536263|156170228|FG001|Overall Study|Adverse Event|5|||
48541603|NCT00536263|156170229|FG002|Overall Study|Adverse Event|7|||
48541604|NCT00536263|156170227|FG000|Overall Study|Lost to Follow-up|3|||
48541605|NCT00536263|156170228|FG001|Overall Study|Lost to Follow-up|4|||
48541606|NCT00536263|156170229|FG002|Overall Study|Lost to Follow-up|4|||
48541607|NCT00536263|156170227|FG000|Overall Study|Subject withdrew - not treatment related|2|||
48541608|NCT00536263|156170228|FG001|Overall Study|Subject withdrew - not treatment related|0|||
48541609|NCT00536263|156170229|FG002|Overall Study|Subject withdrew - not treatment related|5|||
48541610|NCT00536263|156170227|FG000|Overall Study|Subject withdrew - treatment related|0|||
48541611|NCT00536263|156170228|FG001|Overall Study|Subject withdrew - treatment related|3|||
48541612|NCT00536263|156170229|FG002|Overall Study|Subject withdrew - treatment related|2|||
48541613|NCT00536263|156170227|FG000|Overall Study|Noncompliance with protocol|0|||
48541614|NCT00536263|156170228|FG001|Overall Study|Noncompliance with protocol|0|||
48607371|NCT02452047|156420495|FG000|Overall Study|Death|1|||
48607372|NCT02452047|156420496|FG001|Overall Study|Death|3|||
48607373|NCT02452047|156420497|FG002|Overall Study|Death|1|||
48607374|NCT02452047|156420495|FG000|Overall Study|Physician Decision|1|||
48607375|NCT02452047|156420496|FG001|Overall Study|Physician Decision|0|||
48607376|NCT02452047|156420497|FG002|Overall Study|Physician Decision|0|||
48607377|NCT02452047|156420495|FG000|Overall Study|Lost to Follow-up|1|||
48607378|NCT02452047|156420496|FG001|Overall Study|Lost to Follow-up|1|||
48607379|NCT02452047|156420497|FG002|Overall Study|Lost to Follow-up|0|||
48607380|NCT02452047|156420495|FG000|Overall Study|Withdrawal by Subject|1|||
48607381|NCT02452047|156420496|FG001|Overall Study|Withdrawal by Subject|0|||
48607382|NCT02452047|156420497|FG002|Overall Study|Withdrawal by Subject|0|||
48607383|NCT00499122|156420498|FG000|Overall Study|Withdrawal by Subject|2|||
48607384|NCT01739335|156420499|FG000|Overall Study|Lost to Follow-up|7|||
48607385|NCT01739335|156420500|FG001|Overall Study|Lost to Follow-up|4|||
48607386|NCT01739335|156420499|FG000|Overall Study|Ineligible patient randomized|0|||
48607387|NCT01739335|156420500|FG001|Overall Study|Ineligible patient randomized|1|||
48607388|NCT01715831|156420505|FG000|Overall Study|Adverse Event|1|||
48607389|NCT04748718|156420506|FG000|Overall Study|Lost to Follow-up|50|||
48607390|NCT03074695|156420508|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
48607391|NCT03074695|156420509|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
48607392|NCT03074695|156420508|FG000|Overall Study|Research staff not available|1|||
48607393|NCT03074695|156420509|FG001|Overall Study|Research staff not available|2|||
48607394|NCT03074695|156420508|FG000|Overall Study|Did not receive neuraxial block|2|||
48607395|NCT03074695|156420509|FG001|Overall Study|Did not receive neuraxial block|2|||
48607396|NCT03248037|156420510|FG000|Overall Study|Withdrawal by Subject|6|||
48607397|NCT03248037|156420511|FG001|Overall Study|Withdrawal by Subject|9|||
48607398|NCT03248037|156420510|FG000|Overall Study|Adverse Event|15|||
48607399|NCT03248037|156420511|FG001|Overall Study|Adverse Event|0|||
48607400|NCT02897349|156420512|FG000|Overall Study|Lost to Follow-up|2|||
48607401|NCT02897349|156420513|FG001|Overall Study|Lost to Follow-up|2|||
48607402|NCT02897349|156420512|FG000|Overall Study|Adverse Event|3|||
48607403|NCT02897349|156420513|FG001|Overall Study|Adverse Event|3|||
48607404|NCT02897349|156420512|FG000|Overall Study|Other than listed above|0|||
48607405|NCT02897349|156420513|FG001|Overall Study|Other than listed above|1|||
48607406|NCT03409744|156420514|FG000|Overall Study|Death|2|||
48607407|NCT03409744|156420514|FG000|Overall Study|Physician Decision|5|||
48607408|NCT03409744|156420514|FG000|Overall Study|Pregnancy|1|||
48607409|NCT03409744|156420514|FG000|Overall Study|Lost to Follow-up|1|||
48607410|NCT03409744|156420514|FG000|Overall Study|Protocol Violation|1|||
48607411|NCT02783066|156420515|FG000|Overall Study|Withdrawal by Subject|13|||
48607412|NCT00106002|156420526|FG000|Overall Study|Did not take any study drug|1|||
48607413|NCT00106002|156420526|FG000|Overall Study|Ineligible after Registration|1|||
48607414|NCT01663623|156420527|FG000|Overall Study|Adverse Event|3|||
48607415|NCT01663623|156420528|FG001|Overall Study|Adverse Event|7|||
48607416|NCT01663623|156420527|FG000|Overall Study|Lack of Efficacy|5|||
48607417|NCT01663623|156420528|FG001|Overall Study|Lack of Efficacy|6|||
48607418|NCT01663623|156420527|FG000|Overall Study|Protocol Violation|0|||
48607419|NCT01663623|156420528|FG001|Overall Study|Protocol Violation|1|||
48541615|NCT00536263|156170229|FG002|Overall Study|Noncompliance with protocol|1|||
48541616|NCT00536263|156170227|FG000|Overall Study|Did not meet protocol eligibility|1|||
48541617|NCT00536263|156170228|FG001|Overall Study|Did not meet protocol eligibility|2|||
48541618|NCT00536263|156170229|FG002|Overall Study|Did not meet protocol eligibility|2|||
48541619|NCT04430855|156170231|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
48541620|NCT04430855|156170232|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
48541621|NCT04430855|156170231|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
48541622|NCT04430855|156170232|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
48541623|NCT04430855|156170231|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
48541624|NCT04430855|156170232|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
48541625|NCT04430855|156170231|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
48541626|NCT04430855|156170232|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
48541627|NCT04430855|156170231|FG000|Period 1 (Weeks 1-12)|Other|0|||
48541628|NCT04430855|156170232|FG001|Period 1 (Weeks 1-12)|Other|1|||
48541629|NCT04430855|156170231|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
48541630|NCT04430855|156170232|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
48541631|NCT04430855|156170231|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
48541632|NCT04430855|156170232|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
48541633|NCT04430855|156170231|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
48541634|NCT04430855|156170232|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
48541635|NCT03071094|156170238|FG000|Overall Study|Death|1|||
48607420|NCT01663623|156420527|FG000|Overall Study|Other-Study closed/terminated|1|||
48607421|NCT01663623|156420528|FG001|Overall Study|Other-Study closed/terminated|1|||
48607422|NCT01663623|156420527|FG000|Overall Study|Physician Decision|1|||
48607423|NCT01663623|156420528|FG001|Overall Study|Physician Decision|4|||
48607424|NCT01663623|156420527|FG000|Overall Study|Withdrawal by Subject|2|||
48607425|NCT01663623|156420528|FG001|Overall Study|Withdrawal by Subject|1|||
48607426|NCT01033136|156420532|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
48607427|NCT01033136|156420533|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
48607428|NCT00465179|156420541|FG000|Overall Study|Adverse Event|4|||
48607429|NCT00465179|156420541|FG000|Overall Study|Withdrawal by Subject|2|||
48607430|NCT00465179|156420541|FG000|Overall Study|Progression of Disease|47|||
48607431|NCT00402831|156420542|FG000|Overall Study|Lost to Follow-up|1|||
48607432|NCT00402831|156420543|FG001|Overall Study|Lost to Follow-up|2|||
48607433|NCT00402831|156420542|FG000|Overall Study|Non-compliance with protocol|0|||
48607434|NCT00402831|156420543|FG001|Overall Study|Non-compliance with protocol|1|||
48607435|NCT01114724|156420555|FG000|Overall Study|Death|8|||
48607436|NCT01114724|156420555|FG000|Overall Study|Lost to Follow-up|1|||
48607437|NCT01114724|156420555|FG000|Overall Study|Withdrawal by Subject|1|||
48607438|NCT02966834|156420556|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
48607439|NCT02966834|156420557|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
48607440|NCT02966834|156420558|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
48607441|NCT02966834|156420559|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
48607442|NCT02966834|156420560|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
48607443|NCT02966834|156420561|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
48607444|NCT02966834|156420556|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
48607445|NCT02966834|156420557|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48607446|NCT02966834|156420558|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48607447|NCT02966834|156420559|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48607448|NCT02966834|156420560|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48607449|NCT02966834|156420561|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48607450|NCT02966834|156420556|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
48607451|NCT02966834|156420557|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
48607452|NCT02966834|156420558|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
48607453|NCT02966834|156420559|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
48607454|NCT02966834|156420560|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
48607455|NCT02966834|156420561|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
48607456|NCT02966834|156420556|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
48607457|NCT02966834|156420557|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
48607458|NCT02966834|156420558|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
48607459|NCT02966834|156420559|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
48607460|NCT02966834|156420560|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
48607461|NCT02966834|156420561|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
48607462|NCT02966834|156420556|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48607463|NCT02966834|156420557|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48607464|NCT02966834|156420558|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48607465|NCT02966834|156420559|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
48607466|NCT02966834|156420560|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48607467|NCT02966834|156420561|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48607468|NCT02966834|156420556|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
48607469|NCT02966834|156420557|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
48607470|NCT02966834|156420558|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
48607471|NCT02966834|156420559|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
48607472|NCT02966834|156420560|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
48607473|NCT02966834|156420561|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
48607474|NCT01922934|156420562|FG000|Eligible Patients|Death|0|||
48607475|NCT01922934|156420563|FG001|Eligible Patients|Death|7|||
48607476|NCT01922934|156420562|FG000|Eligible Patients|Physician Decision|17|||
48607477|NCT01922934|156420563|FG001|Eligible Patients|Physician Decision|0|||
48607478|NCT01922934|156420562|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
48607479|NCT01922934|156420563|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
48607480|NCT01922934|156420562|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
48607481|NCT01922934|156420563|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
48607482|NCT01922934|156420562|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
48607483|NCT01922934|156420563|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
48607484|NCT01922934|156420562|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
48607485|NCT01922934|156420563|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
48607486|NCT01326871|156420564|FG000|Overall Study|Major surgery|0|||
48447095|NCT01253187|155825773|FG001|Period 2|Withdrawal by Subject|0|||
48447096|NCT01253187|155825774|FG002|Period 2|Withdrawal by Subject|0|||
48447097|NCT01253187|155825775|FG003|Period 2|Withdrawal by Subject|0|||
48447098|NCT01253187|155825776|FG004|Period 2|Withdrawal by Subject|1|||
48447099|NCT01253187|155825777|FG005|Period 2|Withdrawal by Subject|0|||
48447100|NCT01253187|155825772|FG000|Period 3|Pregnancy|1|||
48447101|NCT01253187|155825773|FG001|Period 3|Pregnancy|0|||
48447102|NCT01253187|155825774|FG002|Period 3|Pregnancy|0|||
48447103|NCT01253187|155825775|FG003|Period 3|Pregnancy|0|||
48447104|NCT01253187|155825776|FG004|Period 3|Pregnancy|0|||
48447105|NCT01253187|155825777|FG005|Period 3|Pregnancy|0|||
48447106|NCT01253187|155825772|FG000|Period 3|difficulty with blood sampling|0|||
48607487|NCT01326871|156420565|FG001|Overall Study|Major surgery|1|||
48607488|NCT01326871|156420566|FG002|Overall Study|Major surgery|0|||
48607489|NCT01326871|156420564|FG000|Overall Study|SAE and death|0|||
48607490|NCT01326871|156420565|FG001|Overall Study|SAE and death|2|||
48607491|NCT01326871|156420566|FG002|Overall Study|SAE and death|0|||
48607492|NCT01326871|156420564|FG000|Overall Study|Physician decision and decreased performance status|0|||
48541636|NCT03071094|156170239|FG001|Overall Study|Death|1|||
48541637|NCT03071094|156170238|FG000|Overall Study|Adverse Event|1|||
48541638|NCT03071094|156170239|FG001|Overall Study|Adverse Event|0|||
48541639|NCT04188301|156170244|FG000|Month 3|Lost to Follow-up|0|||
48541640|NCT04188301|156170245|FG001|Month 3|Lost to Follow-up|0|||
48541641|NCT04188301|156170246|FG002|Month 3|Lost to Follow-up|1|||
48541642|NCT04188301|156170244|FG000|Month 12|Lost to Follow-up|0|||
48541643|NCT04188301|156170245|FG001|Month 12|Lost to Follow-up|0|||
48541644|NCT04188301|156170246|FG002|Month 12|Lost to Follow-up|2|||
48541645|NCT04188301|156170244|FG000|Month 12|Death|1|||
48541646|NCT04188301|156170245|FG001|Month 12|Death|1|||
48541647|NCT04188301|156170246|FG002|Month 12|Death|0|||
48541648|NCT04188301|156170244|FG000|Month 18|Lost to Follow-up|6|||
48541649|NCT04188301|156170245|FG001|Month 18|Lost to Follow-up|0|||
48541650|NCT04188301|156170246|FG002|Month 18|Lost to Follow-up|0|||
48541651|NCT01770392|156170247|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
48541652|NCT02312063|156170248|FG000|Overall Study|Withdrawal by Subject|0|||
48541653|NCT02312063|156170249|FG001|Overall Study|Withdrawal by Subject|1|||
48541654|NCT01083810|156170253|FG000|Overall Study|Lost to Follow-up|23|||
48541655|NCT01083810|156170254|FG001|Overall Study|Lost to Follow-up|11|||
48541656|NCT01083810|156170255|FG002|Overall Study|Lost to Follow-up|4|||
48541657|NCT01083810|156170253|FG000|Overall Study|Adverse Event|15|||
48541658|NCT01083810|156170254|FG001|Overall Study|Adverse Event|11|||
48541659|NCT01083810|156170255|FG002|Overall Study|Adverse Event|4|||
48541660|NCT01083810|156170253|FG000|Overall Study|Withdrawal by Subject|7|||
48541661|NCT01083810|156170254|FG001|Overall Study|Withdrawal by Subject|2|||
48541662|NCT01083810|156170255|FG002|Overall Study|Withdrawal by Subject|4|||
48541663|NCT01083810|156170253|FG000|Overall Study|Reason not reported|6|||
48541664|NCT01083810|156170254|FG001|Overall Study|Reason not reported|1|||
48541665|NCT01083810|156170255|FG002|Overall Study|Reason not reported|1|||
48541666|NCT01083810|156170253|FG000|Overall Study|Non-compliance|4|||
48541667|NCT01083810|156170254|FG001|Overall Study|Non-compliance|7|||
48541668|NCT01083810|156170255|FG002|Overall Study|Non-compliance|2|||
48541669|NCT01083810|156170253|FG000|Overall Study|Simplification|4|||
48541670|NCT01083810|156170254|FG001|Overall Study|Simplification|1|||
48541671|NCT01083810|156170255|FG002|Overall Study|Simplification|0|||
48541672|NCT01083810|156170253|FG000|Overall Study|Death|2|||
48541673|NCT01083810|156170254|FG001|Overall Study|Death|2|||
48541674|NCT01083810|156170255|FG002|Overall Study|Death|3|||
48541675|NCT01083810|156170253|FG000|Overall Study|Co-morbidities|1|||
48541676|NCT01083810|156170254|FG001|Overall Study|Co-morbidities|0|||
48541677|NCT01083810|156170255|FG002|Overall Study|Co-morbidities|0|||
48541678|NCT01083810|156170253|FG000|Overall Study|Participation in study|1|||
48541679|NCT01083810|156170254|FG001|Overall Study|Participation in study|0|||
48541680|NCT01083810|156170255|FG002|Overall Study|Participation in study|0|||
48541681|NCT01083810|156170253|FG000|Overall Study|Therapy break|1|||
48541682|NCT01083810|156170254|FG001|Overall Study|Therapy break|2|||
48541683|NCT01083810|156170255|FG002|Overall Study|Therapy break|2|||
48541684|NCT01083810|156170253|FG000|Overall Study|Virologic failure|1|||
48541685|NCT01083810|156170254|FG001|Overall Study|Virologic failure|8|||
48541686|NCT01083810|156170255|FG002|Overall Study|Virologic failure|0|||
48541687|NCT04639713|156170256|FG000|Overall Study|Protocol Noncompliance|2|||
48541688|NCT04639713|156170256|FG000|Overall Study|Withdrawal by Subject|1|||
48541689|NCT00228423|156170257|FG000|Overall Study|Adverse Event|2|||
48541690|NCT00228423|156170258|FG001|Overall Study|Adverse Event|5|||
48541691|NCT00228423|156170257|FG000|Overall Study|Withdrawal by Subject|7|||
48541692|NCT00228423|156170258|FG001|Overall Study|Withdrawal by Subject|3|||
48541693|NCT00228423|156170257|FG000|Overall Study|Protocol Violation|1|||
48541694|NCT00228423|156170258|FG001|Overall Study|Protocol Violation|3|||
48541695|NCT00228423|156170257|FG000|Overall Study|Physician Decision|0|||
48541696|NCT00228423|156170258|FG001|Overall Study|Physician Decision|1|||
48541697|NCT00390221|156170261|FG000|Overall Study|Lost to Follow-up|0|||
48607493|NCT01326871|156420565|FG001|Overall Study|Physician decision and decreased performance status|1|||
48541698|NCT00390221|156170262|FG001|Overall Study|Lost to Follow-up|3|||
48541699|NCT00390221|156170263|FG002|Overall Study|Lost to Follow-up|0|||
48541700|NCT00390221|156170261|FG000|Overall Study|Adverse Event|1|||
48541701|NCT00390221|156170262|FG001|Overall Study|Adverse Event|4|||
48607494|NCT01326871|156420566|FG002|Overall Study|Physician decision and decreased performance status|0|||
48607495|NCT01326871|156420564|FG000|Overall Study|Disease progression|0|||
48607496|NCT01326871|156420565|FG001|Overall Study|Disease progression|11|||
48607497|NCT01326871|156420566|FG002|Overall Study|Disease progression|5|||
48607498|NCT01326871|156420564|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
48607499|NCT01326871|156420565|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
48607500|NCT01326871|156420566|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
48607501|NCT01326871|156420564|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
48607502|NCT01326871|156420565|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
48607503|NCT01326871|156420566|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
48607504|NCT01326871|156420564|FG000|Overall Study|Withdrawal by Subject|0|||
48607505|NCT01326871|156420565|FG001|Overall Study|Withdrawal by Subject|1|||
48607506|NCT01326871|156420566|FG002|Overall Study|Withdrawal by Subject|0|||
48607507|NCT01326871|156420564|FG000|Overall Study|DLT|0|||
48607508|NCT01326871|156420565|FG001|Overall Study|DLT|2|||
48607509|NCT01326871|156420566|FG002|Overall Study|DLT|0|||
48607510|NCT01326871|156420564|FG000|Overall Study|SAE, disease progression and subject decision|0|||
48607511|NCT01326871|156420565|FG001|Overall Study|SAE, disease progression and subject decision|1|||
48541702|NCT00390221|156170263|FG002|Overall Study|Adverse Event|3|||
48541703|NCT00390221|156170261|FG000|Overall Study|Investigator Decision|0|||
48541704|NCT00390221|156170262|FG001|Overall Study|Investigator Decision|0|||
48541705|NCT00390221|156170263|FG002|Overall Study|Investigator Decision|1|||
48541706|NCT00390221|156170261|FG000|Overall Study|Withdrawal by Subject|13|||
48541707|NCT00390221|156170262|FG001|Overall Study|Withdrawal by Subject|9|||
48541708|NCT00390221|156170263|FG002|Overall Study|Withdrawal by Subject|7|||
48541709|NCT00390221|156170261|FG000|Overall Study|Subject Non-compliance|1|||
48541710|NCT00390221|156170262|FG001|Overall Study|Subject Non-compliance|0|||
48541711|NCT00390221|156170263|FG002|Overall Study|Subject Non-compliance|2|||
48541712|NCT00390221|156170261|FG000|Overall Study|Other|3|||
48541713|NCT00390221|156170262|FG001|Overall Study|Other|4|||
48541714|NCT00390221|156170263|FG002|Overall Study|Other|2|||
48541715|NCT00003138|156170264|FG000|Step 1|Reasons off treatment not documented|60|||
48541716|NCT00003138|156170265|FG001|Step 1|Reasons off treatment not documented|57|||
48607512|NCT01326871|156420566|FG002|Overall Study|SAE, disease progression and subject decision|0|||
48607513|NCT01326871|156420564|FG000|Overall Study|Death|0|||
48607514|NCT01326871|156420565|FG001|Overall Study|Death|1|||
48607515|NCT01326871|156420566|FG002|Overall Study|Death|0|||
48607516|NCT01326871|156420564|FG000|Overall Study|Other|0|||
48607517|NCT01326871|156420565|FG001|Overall Study|Other|3|||
48607518|NCT01326871|156420566|FG002|Overall Study|Other|0|||
48607519|NCT01326871|156420564|FG000|Overall Study|SAE and disease progression|0|||
48607520|NCT01326871|156420565|FG001|Overall Study|SAE and disease progression|0|||
48607521|NCT01326871|156420566|FG002|Overall Study|SAE and disease progression|1|||
48607522|NCT01326871|156420564|FG000|Overall Study|SAE and physician decision|0|||
48607523|NCT01326871|156420565|FG001|Overall Study|SAE and physician decision|0|||
48607524|NCT01326871|156420566|FG002|Overall Study|SAE and physician decision|1|||
48607525|NCT01326871|156420564|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
48607526|NCT01326871|156420565|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
48607527|NCT01326871|156420566|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
48607528|NCT01326871|156420564|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
48607529|NCT01326871|156420565|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
48607530|NCT01326871|156420566|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
48607531|NCT01326871|156420564|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
48607532|NCT01326871|156420565|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
48607533|NCT01326871|156420566|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
48607534|NCT01326871|156420564|FG000|Overall Study|Physician Decision|0|||
48607535|NCT01326871|156420565|FG001|Overall Study|Physician Decision|0|||
48607536|NCT01326871|156420566|FG002|Overall Study|Physician Decision|1|||
48607537|NCT01326871|156420564|FG000|Overall Study|SAE|0|||
48607538|NCT01326871|156420565|FG001|Overall Study|SAE|0|||
48607539|NCT01326871|156420566|FG002|Overall Study|SAE|1|||
48607540|NCT01326871|156420564|FG000|Overall Study|Disease progression and death|0|||
48607541|NCT01326871|156420565|FG001|Overall Study|Disease progression and death|0|||
48607542|NCT01326871|156420566|FG002|Overall Study|Disease progression and death|1|||
48607543|NCT01326871|156420564|FG000|Overall Study|Subject decision|0|||
48607544|NCT01326871|156420565|FG001|Overall Study|Subject decision|0|||
48541717|NCT00003138|156170264|FG000|Step 1|Never started treatment|1|||
48607545|NCT01326871|156420566|FG002|Overall Study|Subject decision|1|||
48541718|NCT00003138|156170265|FG001|Step 1|Never started treatment|0|||
48541719|NCT00003138|156170264|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
48541720|NCT00003138|156170265|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
48607546|NCT00251758|156420567|FG000|Overall Study|Adverse Event|7|||
48607547|NCT00251758|156420568|FG001|Overall Study|Adverse Event|9|||
48607548|NCT00251758|156420569|FG002|Overall Study|Adverse Event|11|||
48607549|NCT00251758|156420567|FG000|Overall Study|Lost to Follow-up|4|||
48607550|NCT00251758|156420568|FG001|Overall Study|Lost to Follow-up|2|||
48607551|NCT00251758|156420569|FG002|Overall Study|Lost to Follow-up|5|||
48607552|NCT00251758|156420567|FG000|Overall Study|Withdrawal by Subject|13|||
48607553|NCT00251758|156420568|FG001|Overall Study|Withdrawal by Subject|7|||
48607554|NCT00251758|156420569|FG002|Overall Study|Withdrawal by Subject|3|||
48607555|NCT00251758|156420567|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
48607556|NCT00251758|156420568|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
48607557|NCT00251758|156420569|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
48607558|NCT00251758|156420567|FG000|Overall Study|Lack of Efficacy|3|||
48607559|NCT00251758|156420568|FG001|Overall Study|Lack of Efficacy|0|||
48607560|NCT00251758|156420569|FG002|Overall Study|Lack of Efficacy|0|||
48607561|NCT00251758|156420567|FG000|Overall Study|Noncompliant|0|||
48607562|NCT00251758|156420568|FG001|Overall Study|Noncompliant|2|||
48607563|NCT00251758|156420569|FG002|Overall Study|Noncompliant|2|||
48607564|NCT00251758|156420567|FG000|Overall Study|Pregnancy|0|||
48607565|NCT00251758|156420568|FG001|Overall Study|Pregnancy|1|||
48607566|NCT00251758|156420569|FG002|Overall Study|Pregnancy|0|||
48607567|NCT00251758|156420567|FG000|Overall Study|Per Subject Request|0|||
48541721|NCT00003138|156170264|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
48541722|NCT00003138|156170265|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
48541723|NCT00003138|156170264|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
48541724|NCT00003138|156170265|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
48541725|NCT00003138|156170264|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
48541726|NCT00003138|156170265|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
48541727|NCT01177059|156170268|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
48541728|NCT01177059|156170268|FG000|Overall Study|Withdrew consent|2|||
48541729|NCT01177059|156170268|FG000|Overall Study|Lost to Follow-up|18|||
48541730|NCT02533375|156170269|FG000|Overall Study|Lack of Efficacy|3|||
48541731|NCT02533375|156170269|FG000|Overall Study|Adverse Event|2|||
48541732|NCT00673387|156170270|FG000|Overall Study|Withdrawal by Subject|15|||
48541733|NCT00673387|156170271|FG001|Overall Study|Withdrawal by Subject|16|||
48541734|NCT00673387|156170272|FG002|Overall Study|Withdrawal by Subject|20|||
48541735|NCT00673387|156170273|FG003|Overall Study|Withdrawal by Subject|16|||
48541736|NCT00673387|156170274|FG004|Overall Study|Withdrawal by Subject|18|||
48541737|NCT00673387|156170275|FG005|Overall Study|Withdrawal by Subject|21|||
48541738|NCT00673387|156170276|FG006|Overall Study|Withdrawal by Subject|15|||
48541739|NCT00673387|156170277|FG007|Overall Study|Withdrawal by Subject|21|||
48541740|NCT00673387|156170270|FG000|Overall Study|Adverse Event|3|||
48541741|NCT00673387|156170271|FG001|Overall Study|Adverse Event|1|||
48541742|NCT00673387|156170272|FG002|Overall Study|Adverse Event|5|||
48541743|NCT00673387|156170273|FG003|Overall Study|Adverse Event|2|||
48541744|NCT00673387|156170274|FG004|Overall Study|Adverse Event|6|||
48541745|NCT00673387|156170275|FG005|Overall Study|Adverse Event|2|||
48541746|NCT00673387|156170276|FG006|Overall Study|Adverse Event|5|||
48541747|NCT00673387|156170277|FG007|Overall Study|Adverse Event|5|||
48541748|NCT00673387|156170270|FG000|Overall Study|Physician Decision|0|||
48541749|NCT00673387|156170271|FG001|Overall Study|Physician Decision|0|||
48541750|NCT00673387|156170272|FG002|Overall Study|Physician Decision|0|||
48541751|NCT00673387|156170273|FG003|Overall Study|Physician Decision|0|||
48541752|NCT00673387|156170274|FG004|Overall Study|Physician Decision|0|||
48541753|NCT00673387|156170275|FG005|Overall Study|Physician Decision|5|||
48607568|NCT00251758|156420568|FG001|Overall Study|Per Subject Request|0|||
48607569|NCT00251758|156420569|FG002|Overall Study|Per Subject Request|1|||
48541754|NCT00673387|156170276|FG006|Overall Study|Physician Decision|1|||
48541755|NCT00673387|156170277|FG007|Overall Study|Physician Decision|1|||
48541756|NCT00673387|156170270|FG000|Overall Study|Protocol Violation|3|||
48541757|NCT00673387|156170271|FG001|Overall Study|Protocol Violation|0|||
48541758|NCT00673387|156170272|FG002|Overall Study|Protocol Violation|1|||
48541759|NCT00673387|156170273|FG003|Overall Study|Protocol Violation|2|||
48541760|NCT00673387|156170274|FG004|Overall Study|Protocol Violation|0|||
48607570|NCT00251758|156420567|FG000|Overall Study|Per Investigator Request|1|||
48607571|NCT00251758|156420568|FG001|Overall Study|Per Investigator Request|0|||
48541761|NCT00673387|156170275|FG005|Overall Study|Protocol Violation|1|||
48541762|NCT00673387|156170276|FG006|Overall Study|Protocol Violation|1|||
48541763|NCT00673387|156170277|FG007|Overall Study|Protocol Violation|3|||
48541764|NCT00673387|156170270|FG000|Overall Study|Lost to Follow-up|8|||
48541765|NCT00673387|156170271|FG001|Overall Study|Lost to Follow-up|6|||
48607572|NCT00251758|156420569|FG002|Overall Study|Per Investigator Request|0|||
48541766|NCT00673387|156170272|FG002|Overall Study|Lost to Follow-up|5|||
48541767|NCT00673387|156170273|FG003|Overall Study|Lost to Follow-up|6|||
48607573|NCT01387269|156420573|FG000|Overall Study|Death|38|||
48607574|NCT01387269|156420574|FG001|Overall Study|Death|20|||
48607575|NCT01387269|156420573|FG000|Overall Study|Other|8|||
48607576|NCT01387269|156420574|FG001|Overall Study|Other|7|||
48607577|NCT01387269|156420573|FG000|Overall Study|Unrelated AE|12|||
48607578|NCT01387269|156420574|FG001|Overall Study|Unrelated AE|3|||
48607579|NCT01387269|156420573|FG000|Overall Study|Withdrawal by patient|32|||
48607580|NCT01387269|156420574|FG001|Overall Study|Withdrawal by patient|10|||
48607581|NCT01387269|156420573|FG000|Overall Study|Study drug-related AE|1|||
48607582|NCT01387269|156420574|FG001|Overall Study|Study drug-related AE|0|||
48607583|NCT01387269|156420573|FG000|Overall Study|Lost to Follow-up|1|||
48607584|NCT01387269|156420574|FG001|Overall Study|Lost to Follow-up|0|||
48607585|NCT02774889|156420579|FG000|Overall Study|Lost to Follow-up|2|||
48607586|NCT02774889|156420580|FG001|Overall Study|Lost to Follow-up|1|||
48607587|NCT01020123|156420582|FG000|Main Period|Withdrawal by Subject|6|||
48607588|NCT01020123|156420583|FG001|Main Period|Withdrawal by Subject|5|||
48607589|NCT01020123|156420584|FG002|Main Period|Withdrawal by Subject|3|||
48607590|NCT01020123|156420585|FG003|Main Period|Withdrawal by Subject|1|||
48607591|NCT01020123|156420586|FG004|Main Period|Withdrawal by Subject|6|||
48607592|NCT01020123|156420587|FG005|Main Period|Withdrawal by Subject|3|||
48607593|NCT01020123|156420588|FG006|Main Period|Withdrawal by Subject|2|||
48607594|NCT01020123|156420582|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
48607595|NCT01020123|156420583|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
48607596|NCT01020123|156420584|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
48607597|NCT01020123|156420585|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
48607598|NCT01020123|156420586|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
48607599|NCT01020123|156420587|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
48607600|NCT01020123|156420588|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
48607601|NCT01020123|156420582|FG000|Main Period|Adverse Event|5|||
48607602|NCT01020123|156420583|FG001|Main Period|Adverse Event|2|||
48607603|NCT01020123|156420584|FG002|Main Period|Adverse Event|2|||
48607604|NCT01020123|156420585|FG003|Main Period|Adverse Event|1|||
48607605|NCT01020123|156420586|FG004|Main Period|Adverse Event|1|||
48607606|NCT01020123|156420587|FG005|Main Period|Adverse Event|2|||
48607607|NCT01020123|156420588|FG006|Main Period|Adverse Event|1|||
48607608|NCT01020123|156420582|FG000|Main Period|Protocol Violation|4|||
48607609|NCT01020123|156420583|FG001|Main Period|Protocol Violation|4|||
48607610|NCT01020123|156420584|FG002|Main Period|Protocol Violation|2|||
48607611|NCT01020123|156420585|FG003|Main Period|Protocol Violation|5|||
48607612|NCT01020123|156420586|FG004|Main Period|Protocol Violation|2|||
48607613|NCT01020123|156420587|FG005|Main Period|Protocol Violation|3|||
48607614|NCT01020123|156420588|FG006|Main Period|Protocol Violation|2|||
48541768|NCT00673387|156170274|FG004|Overall Study|Lost to Follow-up|6|||
48541769|NCT00673387|156170275|FG005|Overall Study|Lost to Follow-up|5|||
48541770|NCT00673387|156170276|FG006|Overall Study|Lost to Follow-up|8|||
48541771|NCT00673387|156170277|FG007|Overall Study|Lost to Follow-up|5|||
48541772|NCT02005887|156170278|FG000|Overall Study|Protocol Violation|0|||
48541773|NCT02005887|156170279|FG001|Overall Study|Protocol Violation|2|||
48541774|NCT00321828|156172177|FG000|Overall Study|Ineligible|3|||
48541775|NCT00321828|156172177|FG000|Overall Study|No follow up data|1|||
48541776|NCT00440466|156172183|FG000|Overall Study|Death|3|||
48607615|NCT01020123|156420582|FG000|Main Period|Lost to Follow-up|0|||
48607616|NCT01020123|156420583|FG001|Main Period|Lost to Follow-up|2|||
48541777|NCT00440466|156172184|FG001|Overall Study|Death|2|||
48541778|NCT00440466|156172185|FG002|Overall Study|Death|9|||
48607617|NCT01020123|156420584|FG002|Main Period|Lost to Follow-up|0|||
48607618|NCT01020123|156420585|FG003|Main Period|Lost to Follow-up|0|||
48607619|NCT01020123|156420586|FG004|Main Period|Lost to Follow-up|0|||
48607620|NCT01020123|156420587|FG005|Main Period|Lost to Follow-up|0|||
48607621|NCT01020123|156420588|FG006|Main Period|Lost to Follow-up|0|||
48607622|NCT01020123|156420582|FG000|Main Period|Unclasified|2|||
48607623|NCT01020123|156420583|FG001|Main Period|Unclasified|0|||
48541779|NCT00440466|156172183|FG000|Overall Study|Adverse Event|3|||
48541780|NCT00440466|156172184|FG001|Overall Study|Adverse Event|4|||
48541781|NCT00440466|156172185|FG002|Overall Study|Adverse Event|11|||
48541782|NCT00440466|156172183|FG000|Overall Study|Lost to Follow-up|1|||
48541783|NCT00440466|156172184|FG001|Overall Study|Lost to Follow-up|0|||
48541784|NCT00440466|156172185|FG002|Overall Study|Lost to Follow-up|2|||
48541785|NCT00440466|156172183|FG000|Overall Study|Physician Decision|2|||
48607624|NCT01020123|156420584|FG002|Main Period|Unclasified|1|||
48607625|NCT01020123|156420585|FG003|Main Period|Unclasified|0|||
48607626|NCT01020123|156420586|FG004|Main Period|Unclasified|1|||
48607627|NCT01020123|156420587|FG005|Main Period|Unclasified|3|||
48607628|NCT01020123|156420588|FG006|Main Period|Unclasified|6|||
48607629|NCT01020123|156420582|FG000|Extention Period|Withdrawal by Subject|2|||
48607630|NCT01020123|156420583|FG001|Extention Period|Withdrawal by Subject|1|||
48607631|NCT01020123|156420584|FG002|Extention Period|Withdrawal by Subject|1|||
48541786|NCT00440466|156172184|FG001|Overall Study|Physician Decision|0|||
48541787|NCT00440466|156172185|FG002|Overall Study|Physician Decision|1|||
48607632|NCT01020123|156420585|FG003|Extention Period|Withdrawal by Subject|0|||
48541788|NCT00440466|156172183|FG000|Overall Study|Protocol Violation|2|||
48541789|NCT00440466|156172184|FG001|Overall Study|Protocol Violation|0|||
48541790|NCT00440466|156172185|FG002|Overall Study|Protocol Violation|4|||
48541791|NCT00440466|156172183|FG000|Overall Study|Withdrawal by Subject|2|||
48541792|NCT00440466|156172184|FG001|Overall Study|Withdrawal by Subject|5|||
48541793|NCT00440466|156172185|FG002|Overall Study|Withdrawal by Subject|9|||
48541794|NCT00440466|156172183|FG000|Overall Study|Began Dialysis|0|||
48541795|NCT00440466|156172184|FG001|Overall Study|Began Dialysis|0|||
48541796|NCT00440466|156172185|FG002|Overall Study|Began Dialysis|1|||
48541797|NCT00440466|156172183|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
48541798|NCT00440466|156172184|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
48541799|NCT00440466|156172185|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
48541800|NCT03861481|156172186|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
48541801|NCT03861481|156172187|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
48541802|NCT03861481|156172186|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
48541803|NCT03861481|156172187|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
48541804|NCT03861481|156172186|FG000|Overall Study|Relapse|1|||
48541805|NCT03861481|156172187|FG001|Overall Study|Relapse|0|||
48541806|NCT03861481|156172186|FG000|Overall Study|Withdrawal by Subject|0|||
48541807|NCT03861481|156172187|FG001|Overall Study|Withdrawal by Subject|1|||
48541808|NCT03861481|156172186|FG000|Overall Study|Lack of Efficacy|4|||
48541809|NCT03861481|156172187|FG001|Overall Study|Lack of Efficacy|5|||
48541810|NCT02856880|156172194|FG000|Overall Study|Withdrawal of consent|1|||
48541811|NCT02054130|156172195|FG000|Overall Study|Withdrawal by Subject|4|||
48541812|NCT02054130|156172196|FG001|Overall Study|Withdrawal by Subject|4|||
48541813|NCT02054130|156172197|FG002|Overall Study|Withdrawal by Subject|7|||
48541814|NCT02054130|156172198|FG003|Overall Study|Withdrawal by Subject|10|||
48541815|NCT02054130|156172195|FG000|Overall Study|Death|0|||
48541816|NCT02054130|156172196|FG001|Overall Study|Death|1|||
48541817|NCT02054130|156172197|FG002|Overall Study|Death|0|||
48541818|NCT02054130|156172198|FG003|Overall Study|Death|0|||
48541819|NCT02054130|156172195|FG000|Overall Study|Lost to Follow-up|0|||
48541820|NCT02054130|156172196|FG001|Overall Study|Lost to Follow-up|0|||
48541821|NCT02054130|156172197|FG002|Overall Study|Lost to Follow-up|1|||
48541822|NCT02054130|156172198|FG003|Overall Study|Lost to Follow-up|2|||
48541823|NCT02054130|156172195|FG000|Overall Study|Missed dose|4|||
48541824|NCT02054130|156172196|FG001|Overall Study|Missed dose|6|||
48541825|NCT02054130|156172197|FG002|Overall Study|Missed dose|7|||
48541826|NCT02054130|156172198|FG003|Overall Study|Missed dose|10|||
48541827|NCT00856830|156172199|FG000|Irinotecan & Bendamustine|Death|0|||
48541828|NCT00856830|156172200|FG001|Irinotecan & Bendamustine|Death|0|||
48541829|NCT00856830|156172201|FG002|Irinotecan & Bendamustine|Death|0|||
48541830|NCT00856830|156172202|FG003|Irinotecan & Bendamustine|Death|2|||
48541831|NCT00856830|156172199|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
48541832|NCT00856830|156172200|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
48541833|NCT00856830|156172201|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
48541834|NCT00856830|156172202|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
48541835|NCT00793780|156172205|FG000|Overall Study|Withdrawal by Subject|2|||
48541836|NCT00793780|156172206|FG001|Overall Study|Withdrawal by Subject|1|||
48541837|NCT02669940|156172207|FG000|Overall Study|Failure to return|0|||
48541838|NCT02669940|156172208|FG001|Overall Study|Failure to return|3|||
48541839|NCT02669940|156172207|FG000|Overall Study|Insufficient follow-up data|1|||
48541840|NCT02669940|156172208|FG001|Overall Study|Insufficient follow-up data|0|||
48541841|NCT00974974|156172212|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
48541842|NCT00974974|156172213|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
48541843|NCT00974974|156172212|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
48541844|NCT00974974|156172213|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
48541845|NCT00974974|156172212|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
48541846|NCT00974974|156172213|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
48541847|NCT00974974|156172212|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
48541848|NCT00974974|156172213|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
48541849|NCT00974974|156172212|FG000|IR CD-LD Dose Adjustment|Various|0|||
48541850|NCT00974974|156172213|FG001|IR CD-LD Dose Adjustment|Various|9|||
48541851|NCT00974974|156172212|FG000|IPX066 Dose Conversion|Adverse Event|23|||
48541852|NCT00974974|156172213|FG001|IPX066 Dose Conversion|Adverse Event|0|||
48541853|NCT00974974|156172212|FG000|IPX066 Dose Conversion|Death|2|||
48541854|NCT00974974|156172213|FG001|IPX066 Dose Conversion|Death|0|||
48541855|NCT00974974|156172212|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
48541856|NCT00974974|156172213|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
48607633|NCT01020123|156420586|FG004|Extention Period|Withdrawal by Subject|0|||
48541857|NCT00974974|156172212|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
48541858|NCT00974974|156172213|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
48541859|NCT00974974|156172212|FG000|IPX066 Dose Conversion|Various|3|||
48541860|NCT00974974|156172213|FG001|IPX066 Dose Conversion|Various|0|||
48541861|NCT00974974|156172212|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
48541862|NCT00974974|156172213|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
48541863|NCT00974974|156172212|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
48541864|NCT00974974|156172213|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
48541865|NCT00974974|156172212|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
48541866|NCT00974974|156172213|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
48541867|NCT00974974|156172212|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
48541868|NCT00974974|156172213|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
48541869|NCT00974974|156172212|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
48607634|NCT01020123|156420587|FG005|Extention Period|Withdrawal by Subject|0|||
48607635|NCT01020123|156420588|FG006|Extention Period|Withdrawal by Subject|0|||
48607636|NCT01020123|156420582|FG000|Extention Period|Adverse Event|0|||
48607637|NCT01020123|156420583|FG001|Extention Period|Adverse Event|0|||
48607638|NCT01020123|156420584|FG002|Extention Period|Adverse Event|0|||
48607639|NCT01020123|156420585|FG003|Extention Period|Adverse Event|1|||
48607640|NCT01020123|156420586|FG004|Extention Period|Adverse Event|0|||
48607641|NCT01020123|156420587|FG005|Extention Period|Adverse Event|0|||
48607642|NCT01020123|156420588|FG006|Extention Period|Adverse Event|0|||
48607643|NCT01020123|156420582|FG000|Extention Period|Protocol Violation|1|||
48607644|NCT01020123|156420583|FG001|Extention Period|Protocol Violation|1|||
48607645|NCT01020123|156420584|FG002|Extention Period|Protocol Violation|1|||
48541870|NCT00974974|156172213|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
48541871|NCT00974974|156172212|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
48541872|NCT00974974|156172213|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
48541873|NCT00974974|156172212|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
48541874|NCT00974974|156172213|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
48541875|NCT00974974|156172212|FG000|Maintenance - Double Blind Treatment|Various|4|||
48541876|NCT00974974|156172213|FG001|Maintenance - Double Blind Treatment|Various|0|||
48541877|NCT01892657|156172214|FG000|Overall Study|Withdrawal by Subject|6|||
48541878|NCT01892657|156172214|FG000|Overall Study|Protocol Violation|12|||
48541879|NCT05065983|156172215|FG000|Overall Study|Lost to Follow-up|2|||
48541880|NCT03251963|156172220|FG000|Overall Study|inappropriate Xa level timing|6|||
48541881|NCT03251963|156172221|FG001|Overall Study|inappropriate Xa level timing|3|||
48541882|NCT03251963|156172220|FG000|Overall Study|no peak Xa level drawn|2|||
48541883|NCT03251963|156172221|FG001|Overall Study|no peak Xa level drawn|0|||
48541884|NCT03251963|156172220|FG000|Overall Study|bled prior to Xa level|1|||
48541885|NCT03251963|156172221|FG001|Overall Study|bled prior to Xa level|2|||
48541886|NCT00714493|156172229|FG000|Overall Study|Adverse Event|11|||
48541887|NCT00714493|156172229|FG000|Overall Study|Death|3|||
48541888|NCT00714493|156172229|FG000|Overall Study|Lack of Efficacy|10|||
48541889|NCT00714493|156172229|FG000|Overall Study|Lost to Follow-up|3|||
48541890|NCT00714493|156172229|FG000|Overall Study|Protocol Violation|12|||
48541891|NCT00714493|156172229|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
48541892|NCT00714493|156172229|FG000|Overall Study|OTHER|2|||
48541893|NCT02372071|156172230|FG000|Overall Study|Protocol Violation|18|||
48541894|NCT04505293|156172231|FG000|Overall Study|Lost to Follow-up|2|||
48541895|NCT04505293|156172231|FG000|Overall Study|Withdrawal by Subject|6|||
48541896|NCT04505293|156172231|FG000|Overall Study|CT scan unreadable|277|||
48541897|NCT02227147|156172232|FG000|Controlled Treatment Period|Adverse Event|4|||
48541898|NCT02227147|156172233|FG001|Controlled Treatment Period|Adverse Event|3|||
48541899|NCT02227147|156172232|FG000|Controlled Treatment Period|Other|2|||
48541900|NCT02227147|156172233|FG001|Controlled Treatment Period|Other|0|||
48541901|NCT02227147|156172232|FG000|Follow-up Period|Other|3|||
48541902|NCT02227147|156172233|FG001|Follow-up Period|Other|5|||
48541903|NCT00506129|156172235|FG000|Overall Study|Disease Progression/Relapse|15|||
48541904|NCT00506129|156172235|FG000|Overall Study|Death|7|||
48607646|NCT01020123|156420585|FG003|Extention Period|Protocol Violation|0|||
48607647|NCT01020123|156420586|FG004|Extention Period|Protocol Violation|0|||
48541905|NCT01968694|156172238|FG000|Washout (1 Month)|Lost to Follow-up|0|||
48541906|NCT01968694|156172239|FG001|Washout (1 Month)|Lost to Follow-up|1|||
48541907|NCT03514641|156172241|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
48607648|NCT01020123|156420587|FG005|Extention Period|Protocol Violation|0|||
48607649|NCT01020123|156420588|FG006|Extention Period|Protocol Violation|1|||
48607650|NCT01020123|156420582|FG000|Extention Period|Lost to Follow-up|0|||
48607651|NCT01020123|156420583|FG001|Extention Period|Lost to Follow-up|0|||
48607652|NCT01020123|156420584|FG002|Extention Period|Lost to Follow-up|0|||
48607653|NCT01020123|156420585|FG003|Extention Period|Lost to Follow-up|0|||
48607654|NCT01020123|156420586|FG004|Extention Period|Lost to Follow-up|0|||
48607655|NCT01020123|156420587|FG005|Extention Period|Lost to Follow-up|2|||
48607656|NCT01020123|156420588|FG006|Extention Period|Lost to Follow-up|0|||
48607657|NCT00846365|156420589|FG000|Overall Study|Adverse Event|20|||
48607658|NCT00846365|156420590|FG001|Overall Study|Adverse Event|30|||
48541908|NCT03514641|156172242|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
48541909|NCT03514641|156172243|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
48541910|NCT03514641|156172244|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
48541911|NCT03514641|156172241|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
48541912|NCT03514641|156172242|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
48607659|NCT00846365|156420591|FG002|Overall Study|Adverse Event|11|||
48607660|NCT00846365|156420589|FG000|Overall Study|Protocol Violation|5|||
48607661|NCT00846365|156420590|FG001|Overall Study|Protocol Violation|4|||
48607662|NCT00846365|156420591|FG002|Overall Study|Protocol Violation|0|||
48607663|NCT00846365|156420589|FG000|Overall Study|Lost to Follow-up|8|||
48607664|NCT00846365|156420590|FG001|Overall Study|Lost to Follow-up|2|||
48607665|NCT00846365|156420591|FG002|Overall Study|Lost to Follow-up|5|||
48607666|NCT00846365|156420589|FG000|Overall Study|Withdrawal by Subject|11|||
48607667|NCT00846365|156420590|FG001|Overall Study|Withdrawal by Subject|11|||
48607668|NCT00846365|156420591|FG002|Overall Study|Withdrawal by Subject|9|||
48607669|NCT00846365|156420589|FG000|Overall Study|Pregnancy|1|||
48607670|NCT00846365|156420590|FG001|Overall Study|Pregnancy|0|||
48607671|NCT00846365|156420591|FG002|Overall Study|Pregnancy|0|||
48607672|NCT00846365|156420589|FG000|Overall Study|Lack of Efficacy|1|||
48541913|NCT03514641|156172243|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
48541914|NCT03514641|156172244|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
48541915|NCT03514641|156172241|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
48541916|NCT03514641|156172242|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
48541917|NCT03514641|156172243|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
48541918|NCT03514641|156172244|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
48541919|NCT03514641|156172241|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
48541920|NCT03514641|156172242|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
48541921|NCT03514641|156172243|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
48541922|NCT03514641|156172244|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
48541923|NCT03514641|156172241|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
48541924|NCT03514641|156172242|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
48541925|NCT03514641|156172243|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
48541926|NCT03514641|156172244|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
48541927|NCT03514641|156172241|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
48541928|NCT03514641|156172242|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
48541929|NCT03514641|156172243|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
48541930|NCT03514641|156172244|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
48541931|NCT03514641|156172241|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
48541932|NCT03514641|156172242|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
48541933|NCT03514641|156172243|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
48541934|NCT03514641|156172244|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
48541935|NCT03514641|156172241|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
48541936|NCT03514641|156172242|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
48541937|NCT03514641|156172243|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
48541938|NCT03514641|156172244|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
48541939|NCT03514641|156172241|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
48541940|NCT03514641|156172242|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
48541941|NCT03514641|156172243|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
48541942|NCT03514641|156172244|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
48541943|NCT03514641|156172241|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
48541944|NCT03514641|156172242|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
48541945|NCT03514641|156172243|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
48541946|NCT03514641|156172244|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
48541947|NCT03514641|156172241|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
48541948|NCT03514641|156172242|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
48541949|NCT03514641|156172243|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
48541950|NCT03514641|156172244|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
48541951|NCT03514641|156172241|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
48541952|NCT03514641|156172242|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
48541953|NCT03514641|156172243|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
48541954|NCT03514641|156172244|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
48541955|NCT04295135|156172245|FG000|Overall Study|Withdrawal by Subject|2|||
48541956|NCT04295135|156172246|FG001|Overall Study|Withdrawal by Subject|1|||
48607673|NCT00846365|156420590|FG001|Overall Study|Lack of Efficacy|1|||
48607674|NCT00846365|156420591|FG002|Overall Study|Lack of Efficacy|2|||
48607675|NCT00846365|156420589|FG000|Overall Study|Other|9|||
48607676|NCT00846365|156420590|FG001|Overall Study|Other|1|||
48607677|NCT00846365|156420591|FG002|Overall Study|Other|6|||
48607678|NCT02577029|156420592|FG000|Overall Study|Adverse Event|1|||
48607679|NCT02577029|156420593|FG001|Overall Study|Adverse Event|0|||
48607680|NCT02577029|156420594|FG002|Overall Study|Adverse Event|2|||
48607681|NCT02577029|156420595|FG003|Overall Study|Adverse Event|0|||
48607682|NCT02577029|156420596|FG004|Overall Study|Adverse Event|1|||
48607683|NCT02577029|156420597|FG005|Overall Study|Adverse Event|0|||
48541957|NCT04295135|156172245|FG000|Overall Study|Subject left organization|8|||
48541958|NCT04295135|156172246|FG001|Overall Study|Subject left organization|4|||
48541959|NCT01732874|156172250|FG000|Overall Study|Withdrawal by Subject|5|||
48541960|NCT01732874|156172251|FG001|Overall Study|Withdrawal by Subject|1|||
48541961|NCT01732874|156172250|FG000|Overall Study|Death of Infant|3|||
48541962|NCT01732874|156172251|FG001|Overall Study|Death of Infant|2|||
48541963|NCT02923674|156172252|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
48541964|NCT02923674|156172253|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
48541965|NCT02923674|156172254|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
48541966|NCT02923674|156172252|FG000|Overall Study|Lost to Follow-up|7|||
48541967|NCT02923674|156172253|FG001|Overall Study|Lost to Follow-up|12|||
48541968|NCT02923674|156172254|FG002|Overall Study|Lost to Follow-up|7|||
48541969|NCT02923674|156172252|FG000|Overall Study|Problem with intervention|2|||
48541970|NCT02923674|156172253|FG001|Overall Study|Problem with intervention|2|||
48541971|NCT02923674|156172254|FG002|Overall Study|Problem with intervention|1|||
48541972|NCT02923674|156172252|FG000|Overall Study|Adverse Event|3|||
48541973|NCT02923674|156172253|FG001|Overall Study|Adverse Event|1|||
48541974|NCT02923674|156172254|FG002|Overall Study|Adverse Event|1|||
48541975|NCT02923674|156172252|FG000|Overall Study|Withdrawal by Subject|2|||
48541976|NCT02923674|156172253|FG001|Overall Study|Withdrawal by Subject|2|||
48541977|NCT02923674|156172254|FG002|Overall Study|Withdrawal by Subject|2|||
48541978|NCT02906930|156172257|FG000|Overall Study|Withdrawal by Subject|0|||
48541979|NCT02906930|156172258|FG001|Overall Study|Withdrawal by Subject|5|||
48607684|NCT02577029|156420598|FG006|Overall Study|Adverse Event|0|||
48607685|NCT02577029|156420599|FG007|Overall Study|Adverse Event|0|||
48607686|NCT02577029|156420592|FG000|Overall Study|Withdrawal by Subject|0|||
48607687|NCT02577029|156420593|FG001|Overall Study|Withdrawal by Subject|0|||
48607688|NCT02577029|156420594|FG002|Overall Study|Withdrawal by Subject|0|||
48607689|NCT02577029|156420595|FG003|Overall Study|Withdrawal by Subject|0|||
48607690|NCT02577029|156420596|FG004|Overall Study|Withdrawal by Subject|0|||
48607691|NCT02577029|156420597|FG005|Overall Study|Withdrawal by Subject|1|||
48607692|NCT02577029|156420598|FG006|Overall Study|Withdrawal by Subject|0|||
48607693|NCT02577029|156420599|FG007|Overall Study|Withdrawal by Subject|0|||
48607694|NCT02577029|156420592|FG000|Overall Study|Sponsor Termination of the Study|9|||
48607695|NCT02577029|156420593|FG001|Overall Study|Sponsor Termination of the Study|2|||
48607696|NCT02577029|156420594|FG002|Overall Study|Sponsor Termination of the Study|5|||
48541980|NCT02906930|156172259|FG002|Overall Study|Withdrawal by Subject|5|||
48541981|NCT02906930|156172260|FG003|Overall Study|Withdrawal by Subject|4|||
48607697|NCT02577029|156420595|FG003|Overall Study|Sponsor Termination of the Study|12|||
48541982|NCT02906930|156172257|FG000|Overall Study|Lost to Follow-up|5|||
48541983|NCT02906930|156172258|FG001|Overall Study|Lost to Follow-up|7|||
48541984|NCT02906930|156172259|FG002|Overall Study|Lost to Follow-up|5|||
48541985|NCT02906930|156172260|FG003|Overall Study|Lost to Follow-up|2|||
48541986|NCT02906930|156172257|FG000|Overall Study|Death|0|||
48607698|NCT02577029|156420596|FG004|Overall Study|Sponsor Termination of the Study|10|||
48607699|NCT02577029|156420597|FG005|Overall Study|Sponsor Termination of the Study|12|||
48607700|NCT02577029|156420598|FG006|Overall Study|Sponsor Termination of the Study|12|||
48607701|NCT02577029|156420599|FG007|Overall Study|Sponsor Termination of the Study|12|||
48607702|NCT00721799|156420600|FG000|Overall Study|Withdrawal by Subject|7|||
48607703|NCT00721799|156420600|FG000|Overall Study|withdraw by subject after scan 1|1|||
48607704|NCT01047319|156420601|FG000|Overall Study|Teva requested participant withdrawal|3|||
48607705|NCT01047319|156420602|FG001|Overall Study|Teva requested participant withdrawal|0|||
48607706|NCT01047319|156420603|FG002|Overall Study|Teva requested participant withdrawal|1|||
48607707|NCT01047319|156420601|FG000|Overall Study|Protocol Violation|3|||
48607708|NCT01047319|156420602|FG001|Overall Study|Protocol Violation|2|||
48607709|NCT01047319|156420603|FG002|Overall Study|Protocol Violation|4|||
48607710|NCT01047319|156420601|FG000|Overall Study|Lack of Efficacy|4|||
48607711|NCT01047319|156420602|FG001|Overall Study|Lack of Efficacy|3|||
48607712|NCT01047319|156420603|FG002|Overall Study|Lack of Efficacy|3|||
48607713|NCT01047319|156420601|FG000|Overall Study|Death|5|||
48607714|NCT01047319|156420602|FG001|Overall Study|Death|1|||
48607715|NCT01047319|156420603|FG002|Overall Study|Death|5|||
48607716|NCT01047319|156420601|FG000|Overall Study|Pregnancy|13|||
48541987|NCT02906930|156172258|FG001|Overall Study|Death|0|||
48541988|NCT02906930|156172259|FG002|Overall Study|Death|1|||
48541989|NCT02906930|156172260|FG003|Overall Study|Death|0|||
48541990|NCT02906930|156172257|FG000|Overall Study|Other|1|||
48541991|NCT02906930|156172258|FG001|Overall Study|Other|2|||
48541992|NCT02906930|156172259|FG002|Overall Study|Other|1|||
48541993|NCT02906930|156172260|FG003|Overall Study|Other|2|||
48541994|NCT03709823|156172261|FG000|Overall Study|Adverse Event|0|||
48541995|NCT03709823|156172262|FG001|Overall Study|Adverse Event|0|||
48541996|NCT03709823|156172263|FG002|Overall Study|Adverse Event|1|||
48541997|NCT03709823|156172264|FG003|Overall Study|Adverse Event|0|||
48541998|NCT03709823|156172265|FG004|Overall Study|Adverse Event|0|||
48541999|NCT03709823|156172266|FG005|Overall Study|Adverse Event|0|||
48542000|NCT03709823|156172261|FG000|Overall Study|Lost to Follow-up|2|||
48542001|NCT03709823|156172262|FG001|Overall Study|Lost to Follow-up|2|||
48542002|NCT03709823|156172263|FG002|Overall Study|Lost to Follow-up|2|||
48542003|NCT03709823|156172264|FG003|Overall Study|Lost to Follow-up|1|||
48542004|NCT03709823|156172265|FG004|Overall Study|Lost to Follow-up|1|||
48542005|NCT03709823|156172266|FG005|Overall Study|Lost to Follow-up|0|||
48542006|NCT03709823|156172261|FG000|Overall Study|Withdrawal by Subject|1|||
48542007|NCT03709823|156172262|FG001|Overall Study|Withdrawal by Subject|3|||
48542008|NCT03709823|156172263|FG002|Overall Study|Withdrawal by Subject|0|||
48542009|NCT03709823|156172264|FG003|Overall Study|Withdrawal by Subject|0|||
48542010|NCT03709823|156172265|FG004|Overall Study|Withdrawal by Subject|0|||
48542011|NCT03709823|156172266|FG005|Overall Study|Withdrawal by Subject|0|||
48542012|NCT03709823|156172261|FG000|Overall Study|Other, Not Specified|0|||
48542013|NCT03709823|156172262|FG001|Overall Study|Other, Not Specified|0|||
48542014|NCT03709823|156172263|FG002|Overall Study|Other, Not Specified|0|||
48542015|NCT03709823|156172264|FG003|Overall Study|Other, Not Specified|1|||
48607717|NCT01047319|156420602|FG001|Overall Study|Pregnancy|8|||
48607718|NCT01047319|156420603|FG002|Overall Study|Pregnancy|8|||
48607719|NCT01047319|156420601|FG000|Overall Study|Physician Decision|12|||
48607720|NCT01047319|156420602|FG001|Overall Study|Physician Decision|9|||
48607721|NCT01047319|156420603|FG002|Overall Study|Physician Decision|10|||
48607722|NCT01047319|156420601|FG000|Overall Study|Lost to Follow-up|14|||
48607723|NCT01047319|156420602|FG001|Overall Study|Lost to Follow-up|10|||
48607724|NCT01047319|156420603|FG002|Overall Study|Lost to Follow-up|10|||
48607725|NCT01047319|156420601|FG000|Overall Study|Adverse Event|16|||
48607726|NCT01047319|156420602|FG001|Overall Study|Adverse Event|27|||
48542016|NCT03709823|156172265|FG004|Overall Study|Other, Not Specified|0|||
48542017|NCT03709823|156172266|FG005|Overall Study|Other, Not Specified|0|||
48542018|NCT00688376|156172274|FG000|Double-Blind Phase|Adverse Event|4|||
48542019|NCT00688376|156172275|FG001|Double-Blind Phase|Adverse Event|4|||
48542020|NCT00688376|156172274|FG000|Double-Blind Phase|Protocol Violation|1|||
48542021|NCT00688376|156172275|FG001|Double-Blind Phase|Protocol Violation|2|||
48542022|NCT00688376|156172274|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
48607727|NCT01047319|156420603|FG002|Overall Study|Adverse Event|21|||
48607728|NCT01047319|156420601|FG000|Overall Study|Withdrawal by Subject|77|||
48607729|NCT01047319|156420602|FG001|Overall Study|Withdrawal by Subject|75|||
48607730|NCT01047319|156420603|FG002|Overall Study|Withdrawal by Subject|87|||
48607731|NCT01047319|156420601|FG000|Overall Study|Study terminated by Sponsor|198|||
48607732|NCT01047319|156420602|FG001|Overall Study|Study terminated by Sponsor|215|||
48607733|NCT01047319|156420603|FG002|Overall Study|Study terminated by Sponsor|203|||
48607734|NCT03573297|156420609|FG000|Open Label Treatment Period|Adverse Event|67|||
48607735|NCT03573297|156420610|FG001|Open Label Treatment Period|Adverse Event|0|||
48607736|NCT03573297|156420611|FG002|Open Label Treatment Period|Adverse Event|0|||
48607737|NCT03573297|156420612|FG003|Open Label Treatment Period|Adverse Event|0|||
48607738|NCT03573297|156420609|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
48607739|NCT03573297|156420610|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
48607740|NCT03573297|156420611|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
48607741|NCT03573297|156420612|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
48607742|NCT03573297|156420609|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
48607743|NCT03573297|156420610|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
48607744|NCT03573297|156420611|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
48607745|NCT03573297|156420612|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
48607746|NCT03573297|156420609|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
48735638|NCT00961649|156883697|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
48447185|NCT03485222|155825824|FG000|Overall Study|Death|0|||
48447186|NCT03485222|155825825|FG001|Overall Study|Death|1|||
48447187|NCT03485222|155825824|FG000|Overall Study|Lost to Follow-up|2|||
48447188|NCT03485222|155825825|FG001|Overall Study|Lost to Follow-up|1|||
48447189|NCT03276572|155825828|FG000|Overall Study|In follow-up|0|||
48447190|NCT03276572|155825829|FG001|Overall Study|In follow-up|0|||
48447191|NCT03276572|155825830|FG002|Overall Study|In follow-up|0|||
48447192|NCT03276572|155825831|FG003|Overall Study|In follow-up|0|||
48447193|NCT03276572|155825832|FG004|Overall Study|In follow-up|0|||
48447194|NCT03276572|155825833|FG005|Overall Study|In follow-up|1|||
48447195|NCT03276572|155825834|FG006|Overall Study|In follow-up|1|||
48447196|NCT03276572|155825828|FG000|Overall Study|Lost to Follow-up|0|||
48447197|NCT03276572|155825829|FG001|Overall Study|Lost to Follow-up|0|||
48447198|NCT03276572|155825830|FG002|Overall Study|Lost to Follow-up|0|||
48447199|NCT03276572|155825831|FG003|Overall Study|Lost to Follow-up|0|||
48447200|NCT03276572|155825832|FG004|Overall Study|Lost to Follow-up|0|||
48447201|NCT03276572|155825833|FG005|Overall Study|Lost to Follow-up|0|||
48447202|NCT03276572|155825834|FG006|Overall Study|Lost to Follow-up|1|||
48447203|NCT03657810|155825835|FG000|Overall Study|Adverse Event|0|||
48447204|NCT03657810|155825836|FG001|Overall Study|Adverse Event|1|||
48447205|NCT03657810|155825837|FG002|Overall Study|Adverse Event|0|||
48447206|NCT03657810|155825835|FG000|Overall Study|Lack of Efficacy|4|||
48447207|NCT03657810|155825836|FG001|Overall Study|Lack of Efficacy|1|||
48447208|NCT03657810|155825837|FG002|Overall Study|Lack of Efficacy|3|||
48447209|NCT03657810|155825835|FG000|Overall Study|Protocol Violation|1|||
48607747|NCT03573297|156420610|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
48607748|NCT03573297|156420611|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
48607749|NCT03573297|156420612|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
48607750|NCT03573297|156420609|FG000|Open Label Treatment Period|Pregnancy|1|||
48607751|NCT03573297|156420610|FG001|Open Label Treatment Period|Pregnancy|0|||
48607752|NCT03573297|156420611|FG002|Open Label Treatment Period|Pregnancy|0|||
48542023|NCT00688376|156172275|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
48542024|NCT00688376|156172274|FG000|Double-Blind Phase|Not treated|0|||
48542025|NCT00688376|156172275|FG001|Double-Blind Phase|Not treated|1|||
48542026|NCT00688376|156172274|FG000|Blinded Extension Phase|Adverse Event|3|||
48542027|NCT00688376|156172275|FG001|Blinded Extension Phase|Adverse Event|4|||
48542028|NCT00688376|156172274|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
48542029|NCT00688376|156172275|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
48542030|NCT00688376|156172274|FG000|Blinded Extension Phase|Physician Decision|1|||
48542031|NCT00688376|156172275|FG001|Blinded Extension Phase|Physician Decision|0|||
48542032|NCT00688376|156172274|FG000|Blinded Extension Phase|Other|1|||
48542033|NCT00688376|156172275|FG001|Blinded Extension Phase|Other|0|||
48542034|NCT00557076|156172276|FG000|Overall Study|Unblinding|0|||
48542035|NCT00557076|156172277|FG001|Overall Study|Unblinding|1|||
48542036|NCT02564211|156172278|FG000|Overall Study|Adverse Event|4|||
48542037|NCT02558231|156172280|FG000|Overall Study|Death|4|||
48542038|NCT02558231|156172281|FG001|Overall Study|Death|12|||
48542039|NCT02558231|156172280|FG000|Overall Study|Lost to Follow-up|7|||
48542040|NCT02558231|156172281|FG001|Overall Study|Lost to Follow-up|4|||
48542041|NCT02558231|156172280|FG000|Overall Study|Withdrawal by Subject|7|||
48542042|NCT02558231|156172281|FG001|Overall Study|Withdrawal by Subject|4|||
48542043|NCT02558231|156172280|FG000|Overall Study|Physician Decision|7|||
48542044|NCT02558231|156172281|FG001|Overall Study|Physician Decision|5|||
48542045|NCT02558231|156172280|FG000|Overall Study|Sponsor Decision|0|||
48607753|NCT03573297|156420612|FG003|Open Label Treatment Period|Pregnancy|0|||
48607754|NCT03573297|156420609|FG000|Open Label Treatment Period|Protocol Violation|17|||
48607755|NCT03573297|156420610|FG001|Open Label Treatment Period|Protocol Violation|0|||
48542046|NCT02558231|156172281|FG001|Overall Study|Sponsor Decision|1|||
48542047|NCT00910091|156172282|FG000|Pre-assignment|Withdrawal by Subject|0|||
48542048|NCT00910091|156172283|FG001|Pre-assignment|Withdrawal by Subject|2|||
48542049|NCT00910091|156172282|FG000|Treatment and Survival|Withdrawal by Subject|3|||
48542050|NCT00910091|156172283|FG001|Treatment and Survival|Withdrawal by Subject|4|||
48542051|NCT00910091|156172282|FG000|Treatment and Survival|Adverse Event|1|||
48542052|NCT00910091|156172283|FG001|Treatment and Survival|Adverse Event|0|||
48542053|NCT04492020|156172288|FG000|Overall Study|Adverse Event|1|||
48542054|NCT04492020|156172289|FG001|Overall Study|Adverse Event|3|||
48542055|NCT04492020|156172288|FG000|Overall Study|Withdrawal by Subject|4|||
48607756|NCT03573297|156420611|FG002|Open Label Treatment Period|Protocol Violation|0|||
48607757|NCT03573297|156420612|FG003|Open Label Treatment Period|Protocol Violation|0|||
48607758|NCT03573297|156420609|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
48607759|NCT03573297|156420610|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
48607760|NCT03573297|156420611|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
48607761|NCT03573297|156420612|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
48607762|NCT03573297|156420609|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
48607763|NCT03573297|156420610|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
48607764|NCT03573297|156420611|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
48607765|NCT03573297|156420612|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
48607766|NCT03573297|156420609|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
48607767|NCT03573297|156420610|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
48607768|NCT03573297|156420611|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
48607769|NCT03573297|156420612|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
48607770|NCT03573297|156420609|FG000|Open Label Treatment Period|Other, Not Specified|7|||
48542056|NCT04492020|156172289|FG001|Overall Study|Withdrawal by Subject|3|||
48542057|NCT04492020|156172288|FG000|Overall Study|Lost to Follow-up|4|||
48542058|NCT04492020|156172289|FG001|Overall Study|Lost to Follow-up|3|||
48542059|NCT04492020|156172288|FG000|Overall Study|Protocol Violation|5|||
48542060|NCT04492020|156172289|FG001|Overall Study|Protocol Violation|2|||
48542061|NCT04492020|156172288|FG000|Overall Study|Lack of Qualifying Event|25|||
48542062|NCT04492020|156172289|FG001|Overall Study|Lack of Qualifying Event|27|||
48542063|NCT04492020|156172288|FG000|Overall Study|Non-compliance with Study Drug|2|||
48542064|NCT04492020|156172289|FG001|Overall Study|Non-compliance with Study Drug|1|||
48607771|NCT03573297|156420610|FG001|Open Label Treatment Period|Other, Not Specified|0|||
48607772|NCT03573297|156420611|FG002|Open Label Treatment Period|Other, Not Specified|0|||
48542065|NCT03127644|156172290|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48542066|NCT03127644|156172291|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48607773|NCT03573297|156420612|FG003|Open Label Treatment Period|Other, Not Specified|0|||
48542067|NCT03127644|156172292|FG002|Overall Study|Study-specific withdrawal criteria|2|||
48542068|NCT00171301|156172293|FG000|Overall Study|Death|1|||
48607774|NCT03573297|156420609|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
48607775|NCT03573297|156420610|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
48607776|NCT03573297|156420611|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
48607777|NCT03573297|156420612|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
48607778|NCT03573297|156420609|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48607779|NCT03573297|156420610|FG001|Double-Blind Treatment Period|Adverse Event|1|||
48607780|NCT03573297|156420611|FG002|Double-Blind Treatment Period|Adverse Event|5|||
48607781|NCT03573297|156420612|FG003|Double-Blind Treatment Period|Adverse Event|1|||
48607782|NCT03573297|156420609|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
48607783|NCT03573297|156420610|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
48607784|NCT03573297|156420611|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
48607785|NCT03573297|156420612|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
48607786|NCT03573297|156420609|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48607787|NCT03573297|156420610|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
48607788|NCT03573297|156420611|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
48607789|NCT03573297|156420612|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
48607790|NCT03573297|156420609|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48607791|NCT03573297|156420610|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
48607792|NCT03573297|156420611|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
48607793|NCT03573297|156420612|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
48607794|NCT03573297|156420609|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48607795|NCT03573297|156420610|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
48607796|NCT03573297|156420611|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
48607797|NCT03573297|156420612|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
48607798|NCT03573297|156420609|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
48607799|NCT03573297|156420610|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
48607800|NCT03573297|156420611|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
48607801|NCT03573297|156420612|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
48607802|NCT03573297|156420609|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
48607803|NCT03573297|156420610|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
48607804|NCT03573297|156420611|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
48607805|NCT03573297|156420612|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
48607806|NCT01094288|156423079|FG000|Overall Study|Adverse Event|0|||
48607807|NCT01094288|156423080|FG001|Overall Study|Adverse Event|3|||
48607808|NCT01094288|156423081|FG002|Overall Study|Adverse Event|1|||
48607809|NCT01094288|156423082|FG003|Overall Study|Adverse Event|1|||
48607810|NCT01094288|156423083|FG004|Overall Study|Adverse Event|0|||
48607811|NCT01094288|156423084|FG005|Overall Study|Adverse Event|0|||
48607812|NCT01094288|156423085|FG006|Overall Study|Adverse Event|0|||
48607813|NCT01094288|156423086|FG007|Overall Study|Adverse Event|0|||
48607814|NCT01094288|156423079|FG000|Overall Study|Withdrawal by Subject|0|||
48607815|NCT01094288|156423080|FG001|Overall Study|Withdrawal by Subject|1|||
48607816|NCT01094288|156423081|FG002|Overall Study|Withdrawal by Subject|2|||
48607817|NCT01094288|156423082|FG003|Overall Study|Withdrawal by Subject|0|||
48607818|NCT01094288|156423083|FG004|Overall Study|Withdrawal by Subject|0|||
48607819|NCT01094288|156423084|FG005|Overall Study|Withdrawal by Subject|0|||
48607820|NCT01094288|156423085|FG006|Overall Study|Withdrawal by Subject|0|||
48607821|NCT01094288|156423086|FG007|Overall Study|Withdrawal by Subject|2|||
48607822|NCT01094288|156423079|FG000|Overall Study|Initiation of Alternative Therapy|0|||
48607823|NCT01094288|156423080|FG001|Overall Study|Initiation of Alternative Therapy|0|||
48607824|NCT01094288|156423081|FG002|Overall Study|Initiation of Alternative Therapy|1|||
48607825|NCT01094288|156423082|FG003|Overall Study|Initiation of Alternative Therapy|0|||
48542069|NCT00171301|156172294|FG001|Overall Study|Death|2|||
48542070|NCT00171301|156172293|FG000|Overall Study|Adverse Event|1|||
48542071|NCT00171301|156172294|FG001|Overall Study|Adverse Event|2|||
48542072|NCT00171301|156172293|FG000|Overall Study|Lost to Follow-up|6|||
48542073|NCT00171301|156172294|FG001|Overall Study|Lost to Follow-up|2|||
48542074|NCT00171301|156172293|FG000|Overall Study|Protocol Violation|0|||
48542075|NCT00171301|156172294|FG001|Overall Study|Protocol Violation|2|||
48542076|NCT00171301|156172293|FG000|Overall Study|Withdrawal by Subject|0|||
48542077|NCT00171301|156172294|FG001|Overall Study|Withdrawal by Subject|1|||
48542078|NCT04594707|156172295|FG000|Overall Study|Adverse Event|0|||
48542079|NCT04594707|156172296|FG001|Overall Study|Adverse Event|0|||
48542080|NCT04594707|156172297|FG002|Overall Study|Adverse Event|1|||
48542081|NCT04594707|156172295|FG000|Overall Study|Death|0|||
48542082|NCT04594707|156172296|FG001|Overall Study|Death|2|||
48542083|NCT04594707|156172297|FG002|Overall Study|Death|2|||
48542084|NCT04594707|156172295|FG000|Overall Study|Lung Transplant|0|||
48542085|NCT04594707|156172296|FG001|Overall Study|Lung Transplant|0|||
48542086|NCT04594707|156172297|FG002|Overall Study|Lung Transplant|1|||
48542087|NCT04594707|156172295|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
48542088|NCT04594707|156172296|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
48607826|NCT01094288|156423083|FG004|Overall Study|Initiation of Alternative Therapy|0|||
48607827|NCT01094288|156423084|FG005|Overall Study|Initiation of Alternative Therapy|0|||
48607828|NCT01094288|156423085|FG006|Overall Study|Initiation of Alternative Therapy|0|||
48542089|NCT04594707|156172297|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
48542090|NCT04594707|156172295|FG000|Overall Study|Study Terminated By Sponsor|19|||
48542091|NCT04594707|156172296|FG001|Overall Study|Study Terminated By Sponsor|47|||
48542092|NCT04594707|156172297|FG002|Overall Study|Study Terminated By Sponsor|41|||
48542093|NCT04594707|156172295|FG000|Overall Study|Withdrawal by Subject|1|||
48542094|NCT04594707|156172296|FG001|Overall Study|Withdrawal by Subject|0|||
48542095|NCT04594707|156172297|FG002|Overall Study|Withdrawal by Subject|2|||
48542096|NCT02500641|156172303|FG000|Overall Study|Adverse Event|0|||
48542097|NCT02500641|156172304|FG001|Overall Study|Adverse Event|2|||
48542098|NCT02500641|156172303|FG000|Overall Study|Withdrawal by Subject|4|||
48542099|NCT02500641|156172304|FG001|Overall Study|Withdrawal by Subject|5|||
48542100|NCT02500641|156172303|FG000|Overall Study|Unable to follow study procedures|3|||
48542101|NCT02500641|156172304|FG001|Overall Study|Unable to follow study procedures|2|||
48542102|NCT02500641|156172303|FG000|Overall Study|Protocol Violation|1|||
48607829|NCT01094288|156423086|FG007|Overall Study|Initiation of Alternative Therapy|0|||
48607830|NCT01094288|156423079|FG000|Overall Study|Reason not Specified|2|||
48607831|NCT01094288|156423080|FG001|Overall Study|Reason not Specified|3|||
48607832|NCT01094288|156423081|FG002|Overall Study|Reason not Specified|0|||
48607833|NCT01094288|156423082|FG003|Overall Study|Reason not Specified|1|||
48607834|NCT01094288|156423083|FG004|Overall Study|Reason not Specified|0|||
48607835|NCT01094288|156423084|FG005|Overall Study|Reason not Specified|0|||
48607836|NCT01094288|156423085|FG006|Overall Study|Reason not Specified|0|||
48607837|NCT01094288|156423086|FG007|Overall Study|Reason not Specified|0|||
48542103|NCT02500641|156172304|FG001|Overall Study|Protocol Violation|2|||
48542104|NCT02500641|156172303|FG000|Overall Study|Lost to Follow-up|1|||
48542105|NCT02500641|156172304|FG001|Overall Study|Lost to Follow-up|0|||
48542106|NCT02500641|156172303|FG000|Overall Study|Sponsor decision|1|||
48542107|NCT02500641|156172304|FG001|Overall Study|Sponsor decision|0|||
48542108|NCT02500641|156172303|FG000|Overall Study|Non compliance to study drug|0|||
48542109|NCT02500641|156172304|FG001|Overall Study|Non compliance to study drug|1|||
48542110|NCT02440568|156172307|FG000|Overall Study|Death|1|||
48542111|NCT02440568|156172308|FG001|Overall Study|Death|3|||
48542112|NCT02440568|156172309|FG002|Overall Study|Death|4|||
48542113|NCT02440568|156172310|FG003|Overall Study|Death|2|||
48542114|NCT02440568|156172307|FG000|Overall Study|Lack of Efficacy|2|||
48542115|NCT02440568|156172308|FG001|Overall Study|Lack of Efficacy|0|||
48542116|NCT02440568|156172309|FG002|Overall Study|Lack of Efficacy|1|||
48542117|NCT02440568|156172310|FG003|Overall Study|Lack of Efficacy|0|||
48542118|NCT02440568|156172307|FG000|Overall Study|Lost to Follow-up|1|||
48542119|NCT02440568|156172308|FG001|Overall Study|Lost to Follow-up|0|||
48542120|NCT02440568|156172309|FG002|Overall Study|Lost to Follow-up|0|||
48542121|NCT02440568|156172310|FG003|Overall Study|Lost to Follow-up|0|||
48542122|NCT04355663|156172316|FG000|Overall Study|Physician Decision|2|||
48542123|NCT04355663|156172317|FG001|Overall Study|Physician Decision|7|||
48542124|NCT04355663|156172318|FG002|Overall Study|Physician Decision|0|||
48542125|NCT04355663|156172316|FG000|Overall Study|Adverse Event|0|||
48542126|NCT04355663|156172317|FG001|Overall Study|Adverse Event|0|||
48542127|NCT04355663|156172318|FG002|Overall Study|Adverse Event|1|||
48542128|NCT04355663|156172316|FG000|Overall Study|Withdrawal by Subject|0|||
48607838|NCT01094288|156423079|FG000|Overall Study|Ongoing Participants|0|||
48607839|NCT01094288|156423080|FG001|Overall Study|Ongoing Participants|3|||
48607840|NCT01094288|156423081|FG002|Overall Study|Ongoing Participants|0|||
48607841|NCT01094288|156423082|FG003|Overall Study|Ongoing Participants|0|||
48542129|NCT04355663|156172317|FG001|Overall Study|Withdrawal by Subject|8|||
48542130|NCT04355663|156172318|FG002|Overall Study|Withdrawal by Subject|3|||
48542131|NCT00826449|156172321|FG000|Overall Study|Disease Progression|4|||
48542132|NCT00826449|156172321|FG000|Overall Study|Withdrawal by Subject|1|||
48607842|NCT01094288|156423083|FG004|Overall Study|Ongoing Participants|0|||
48607843|NCT01094288|156423084|FG005|Overall Study|Ongoing Participants|0|||
48607844|NCT01094288|156423085|FG006|Overall Study|Ongoing Participants|0|||
48607845|NCT01094288|156423086|FG007|Overall Study|Ongoing Participants|0|||
48542133|NCT02994940|156172324|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
48542134|NCT02994940|156172325|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
48542135|NCT02994940|156172324|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
48542136|NCT02994940|156172325|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
48542137|NCT02994940|156172324|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
48542138|NCT02994940|156172325|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
48542139|NCT01103466|156172326|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
48542140|NCT01103466|156172327|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
48542141|NCT01103466|156172328|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
48542142|NCT01103466|156172326|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
48542143|NCT01103466|156172327|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
48542144|NCT01103466|156172328|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
48542145|NCT01103466|156172326|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
48542146|NCT01103466|156172327|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
48542147|NCT01103466|156172328|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
48542148|NCT01103466|156172326|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
48542149|NCT01103466|156172327|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
48542150|NCT01103466|156172328|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
48607846|NCT01389232|156423087|FG000|Overall Study|Had scaffold removed|15|||
48607847|NCT01389232|156423087|FG000|Overall Study|Personal reasons|2|||
48607848|NCT01389232|156423087|FG000|Overall Study|Adverse Event|1|||
48542151|NCT01103466|156172326|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
48607849|NCT01389232|156423087|FG000|Overall Study|Death|1|||
48607850|NCT00945243|156423088|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
48607851|NCT03255187|156423089|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
48607852|NCT03255187|156423090|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
48607853|NCT03255187|156423089|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
48607854|NCT03255187|156423090|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
48542152|NCT01103466|156172327|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
48542153|NCT01103466|156172328|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
48542154|NCT01103466|156172326|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
48542155|NCT01103466|156172327|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
48542156|NCT01103466|156172328|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
48542157|NCT03233230|156172329|FG000|Overall Study|Adverse Event|6|||
48542158|NCT03233230|156172330|FG001|Overall Study|Adverse Event|3|||
48542159|NCT03233230|156172331|FG002|Overall Study|Adverse Event|6|||
48542160|NCT03233230|156172332|FG003|Overall Study|Adverse Event|3|||
48542161|NCT03233230|156172329|FG000|Overall Study|Protocol Violation|1|||
48542162|NCT03233230|156172330|FG001|Overall Study|Protocol Violation|2|||
48542163|NCT03233230|156172331|FG002|Overall Study|Protocol Violation|1|||
48542164|NCT03233230|156172332|FG003|Overall Study|Protocol Violation|1|||
48542165|NCT03233230|156172329|FG000|Overall Study|Lack of Efficacy|1|||
48542166|NCT03233230|156172330|FG001|Overall Study|Lack of Efficacy|0|||
48542167|NCT03233230|156172331|FG002|Overall Study|Lack of Efficacy|0|||
48542168|NCT03233230|156172332|FG003|Overall Study|Lack of Efficacy|0|||
48542169|NCT03233230|156172329|FG000|Overall Study|Other|5|||
48542170|NCT03233230|156172330|FG001|Overall Study|Other|5|||
48542171|NCT03233230|156172331|FG002|Overall Study|Other|5|||
48542172|NCT03233230|156172332|FG003|Overall Study|Other|3|||
48542173|NCT03233230|156172329|FG000|Overall Study|Withdrawal by Subject|2|||
48542174|NCT03233230|156172330|FG001|Overall Study|Withdrawal by Subject|2|||
48607855|NCT03256578|156423091|FG000|Overall Study|Excluded Post Randomization|66|||
48607856|NCT03256578|156423092|FG001|Overall Study|Excluded Post Randomization|56|||
48607857|NCT04969289|156423093|FG000|Overall Study|Lost to Follow-up|13|||
48607858|NCT04969289|156423094|FG001|Overall Study|Lost to Follow-up|9|||
48607859|NCT02787304|156423095|FG000|Overall Study|Adverse Event|9|||
48607860|NCT02787304|156423096|FG001|Overall Study|Adverse Event|3|||
48607861|NCT02787304|156423097|FG002|Overall Study|Adverse Event|8|||
48607862|NCT02787304|156423098|FG003|Overall Study|Adverse Event|1|||
48607863|NCT02787304|156423095|FG000|Overall Study|Withdrawal by Subject|1|||
48607864|NCT02787304|156423096|FG001|Overall Study|Withdrawal by Subject|4|||
48607865|NCT02787304|156423097|FG002|Overall Study|Withdrawal by Subject|0|||
48607866|NCT02787304|156423098|FG003|Overall Study|Withdrawal by Subject|0|||
48607867|NCT02787304|156423095|FG000|Overall Study|Lost to Follow-up|1|||
48607868|NCT02787304|156423096|FG001|Overall Study|Lost to Follow-up|0|||
48607869|NCT02787304|156423097|FG002|Overall Study|Lost to Follow-up|0|||
48607870|NCT02787304|156423098|FG003|Overall Study|Lost to Follow-up|1|||
48607871|NCT02787304|156423095|FG000|Overall Study|Noncompliance with study drug|0|||
48607872|NCT02787304|156423096|FG001|Overall Study|Noncompliance with study drug|0|||
48607873|NCT02787304|156423097|FG002|Overall Study|Noncompliance with study drug|1|||
48542175|NCT03233230|156172331|FG002|Overall Study|Withdrawal by Subject|0|||
48542176|NCT03233230|156172332|FG003|Overall Study|Withdrawal by Subject|1|||
48542177|NCT03233230|156172329|FG000|Overall Study|Lost to Follow-up|0|||
48542178|NCT03233230|156172330|FG001|Overall Study|Lost to Follow-up|3|||
48542179|NCT03233230|156172331|FG002|Overall Study|Lost to Follow-up|0|||
48607874|NCT02787304|156423098|FG003|Overall Study|Noncompliance with study drug|0|||
48607875|NCT02787304|156423095|FG000|Overall Study|Physician Decision|0|||
48607876|NCT02787304|156423096|FG001|Overall Study|Physician Decision|0|||
48542180|NCT03233230|156172332|FG003|Overall Study|Lost to Follow-up|0|||
48607877|NCT02787304|156423097|FG002|Overall Study|Physician Decision|1|||
48607878|NCT02787304|156423098|FG003|Overall Study|Physician Decision|0|||
48542181|NCT02331368|156172333|FG000|Overall Study|Withdrawal by Subject|3|||
48542182|NCT00468650|156172338|FG000|Overall Study|Lost to Follow-up|4|||
48542183|NCT00468650|156172338|FG000|Overall Study|Withdrawal by Subject|2|||
48542184|NCT00468650|156172338|FG000|Overall Study|Protocol Violation|1|||
48542185|NCT04209205|156172342|FG000|Overall Study|Adverse Event|2|||
48542186|NCT04209205|156172343|FG001|Overall Study|Adverse Event|3|||
48542187|NCT04209205|156172342|FG000|Overall Study|Lost to Follow-up|3|||
48542188|NCT04209205|156172343|FG001|Overall Study|Lost to Follow-up|1|||
48542189|NCT04209205|156172342|FG000|Overall Study|Physician Decision|1|||
48542190|NCT04209205|156172343|FG001|Overall Study|Physician Decision|1|||
48542191|NCT04209205|156172342|FG000|Overall Study|Subject decision|10|||
48542192|NCT04209205|156172343|FG001|Overall Study|Subject decision|10|||
48542193|NCT04209205|156172342|FG000|Overall Study|Progressive disease|1|||
48542194|NCT04209205|156172343|FG001|Overall Study|Progressive disease|0|||
48542195|NCT04209205|156172342|FG000|Overall Study|Protocol deviation|0|||
48542196|NCT04209205|156172343|FG001|Overall Study|Protocol deviation|1|||
48542197|NCT04209205|156172342|FG000|Overall Study|New therapy for study indication|1|||
48542198|NCT04209205|156172343|FG001|Overall Study|New therapy for study indication|0|||
48542199|NCT04209205|156172342|FG000|Overall Study|Adverse event - placebo not switched|0|||
48542200|NCT04209205|156172343|FG001|Overall Study|Adverse event - placebo not switched|1|||
48542201|NCT04209205|156172342|FG000|Overall Study|Subject decision - placebo not switched|0|||
48542202|NCT04209205|156172343|FG001|Overall Study|Subject decision - placebo not switched|5|||
48542203|NCT04209205|156172342|FG000|Overall Study|Death - placebo not switched|0|||
48542204|NCT04209205|156172343|FG001|Overall Study|Death - placebo not switched|1|||
48542205|NCT03401450|156172349|FG000|Overall Study|Lost to Follow-up|4|||
48542206|NCT03401450|156172350|FG001|Overall Study|Lost to Follow-up|6|||
48542207|NCT03401450|156172349|FG000|Overall Study|Anesthesia plan changed|2|||
48542208|NCT03401450|156172350|FG001|Overall Study|Anesthesia plan changed|2|||
48542209|NCT03401450|156172349|FG000|Overall Study|Did not complete medication diary|4|||
48542210|NCT03401450|156172350|FG001|Overall Study|Did not complete medication diary|2|||
48542211|NCT03401450|156172349|FG000|Overall Study|post surgery medication change|2|||
48542212|NCT03401450|156172350|FG001|Overall Study|post surgery medication change|1|||
48542213|NCT03401450|156172349|FG000|Overall Study|Cancelled surgery|0|||
48542214|NCT03401450|156172350|FG001|Overall Study|Cancelled surgery|2|||
48542215|NCT03768726|156174668|FG000|Treatment Phase|Adverse Event|2|||
48542216|NCT03768726|156174669|FG001|Treatment Phase|Adverse Event|2|||
48542217|NCT03768726|156174668|FG000|Treatment Phase|Lost to Follow-up|1|||
48542218|NCT03768726|156174669|FG001|Treatment Phase|Lost to Follow-up|0|||
48542219|NCT03768726|156174668|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
48542220|NCT03768726|156174669|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
48542221|NCT03768726|156174668|FG000|Treatment Phase|Withdrawal by Subject|3|||
48542222|NCT03768726|156174669|FG001|Treatment Phase|Withdrawal by Subject|1|||
48542223|NCT03768726|156174668|FG000|Follow-Up|Adverse Event|2|||
48542224|NCT03768726|156174669|FG001|Follow-Up|Adverse Event|2|||
48542225|NCT03768726|156174668|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
48607879|NCT02787304|156423095|FG000|Overall Study|Study terminated by sponsor|25|||
48607880|NCT02787304|156423096|FG001|Overall Study|Study terminated by sponsor|31|||
48607881|NCT02787304|156423097|FG002|Overall Study|Study terminated by sponsor|31|||
48607882|NCT02787304|156423098|FG003|Overall Study|Study terminated by sponsor|32|||
48607883|NCT01075048|156423104|FG000|Overall Study|Death|4|||
48607884|NCT01075048|156423105|FG001|Overall Study|Death|17|||
48607885|NCT01075048|156423106|FG002|Overall Study|Death|12|||
48607886|NCT01075048|156423104|FG000|Overall Study|Start of other or new therapy|4|||
48607887|NCT01075048|156423105|FG001|Overall Study|Start of other or new therapy|36|||
48607888|NCT01075048|156423106|FG002|Overall Study|Start of other or new therapy|46|||
48607889|NCT01075048|156423104|FG000|Overall Study|Withdrawal by Subject|1|||
48607890|NCT01075048|156423105|FG001|Overall Study|Withdrawal by Subject|6|||
48542226|NCT03768726|156174669|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
48542227|NCT03768726|156174668|FG000|Follow-Up|Withdrawal by Subject|2|||
48542228|NCT03768726|156174669|FG001|Follow-Up|Withdrawal by Subject|0|||
48542229|NCT03768726|156174668|FG000|Follow-Up|Other|1|||
48542230|NCT03768726|156174669|FG001|Follow-Up|Other|0|||
48542231|NCT02858492|156174670|FG000|Overall Study|Withdrawal by Subject|0|||
48542232|NCT02858492|156174671|FG001|Overall Study|Withdrawal by Subject|1|||
48542233|NCT02858492|156174672|FG002|Overall Study|Withdrawal by Subject|0|||
48542234|NCT02858492|156174673|FG003|Overall Study|Withdrawal by Subject|1|||
48542235|NCT02858492|156174670|FG000|Overall Study|Adverse Event|0|||
48542236|NCT02858492|156174671|FG001|Overall Study|Adverse Event|0|||
48542237|NCT02858492|156174672|FG002|Overall Study|Adverse Event|0|||
48542238|NCT02858492|156174673|FG003|Overall Study|Adverse Event|3|||
48542239|NCT02858492|156174670|FG000|Overall Study|Lack of Efficacy|0|||
48542240|NCT02858492|156174671|FG001|Overall Study|Lack of Efficacy|0|||
48542241|NCT02858492|156174672|FG002|Overall Study|Lack of Efficacy|0|||
48542242|NCT02858492|156174673|FG003|Overall Study|Lack of Efficacy|1|||
48542243|NCT02858492|156174670|FG000|Overall Study|Protocol defined stopping criteria|0|||
48542244|NCT02858492|156174671|FG001|Overall Study|Protocol defined stopping criteria|0|||
48542245|NCT02858492|156174672|FG002|Overall Study|Protocol defined stopping criteria|0|||
48542246|NCT02858492|156174673|FG003|Overall Study|Protocol defined stopping criteria|1|||
48542247|NCT00573157|156174674|FG000|Overall Study|Adverse Event|3|||
48542248|NCT00573157|156174675|FG001|Overall Study|Adverse Event|1|||
48542249|NCT00573157|156174674|FG000|Overall Study|Other|1|||
48542250|NCT00573157|156174675|FG001|Overall Study|Other|1|||
48542251|NCT01386684|156174676|FG000|Overall Study|Lost to Follow-up|51|||
48542252|NCT01386684|156174676|FG000|Overall Study|Other|51|||
48607891|NCT01075048|156423106|FG002|Overall Study|Withdrawal by Subject|3|||
48607892|NCT01075048|156423104|FG000|Overall Study|Lost to Follow-up|0|||
48607893|NCT01075048|156423105|FG001|Overall Study|Lost to Follow-up|1|||
48542253|NCT01386684|156174676|FG000|Overall Study|Death|47|||
48542254|NCT01386684|156174676|FG000|Overall Study|Withdrawal of Consent|44|||
48542255|NCT01386684|156174676|FG000|Overall Study|Alternative Therapy Required|37|||
48607894|NCT01075048|156423106|FG002|Overall Study|Lost to Follow-up|1|||
48607895|NCT01433159|156423107|FG000|Overall Study|Adverse Event|1|||
48607896|NCT01433159|156423108|FG001|Overall Study|Adverse Event|0|||
48607897|NCT01433159|156423107|FG000|Overall Study|Physician Decision|1|||
48607898|NCT01433159|156423108|FG001|Overall Study|Physician Decision|0|||
48607899|NCT01433159|156423107|FG000|Overall Study|Protocol Violation|0|||
48607900|NCT01433159|156423108|FG001|Overall Study|Protocol Violation|1|||
48607901|NCT04161391|156423109|FG000|Overall Study|Adverse Event|0|||
48607902|NCT04161391|156423110|FG001|Overall Study|Adverse Event|1|||
48542256|NCT01386684|156174676|FG000|Overall Study|Disease Progression|28|||
48607903|NCT04161391|156423111|FG002|Overall Study|Adverse Event|0|||
48607904|NCT04161391|156423112|FG003|Overall Study|Adverse Event|1|||
48607905|NCT04161391|156423113|FG004|Overall Study|Adverse Event|0|||
48607906|NCT04161391|156423114|FG005|Overall Study|Adverse Event|0|||
48607907|NCT04161391|156423115|FG006|Overall Study|Adverse Event|0|||
48542257|NCT01386684|156174676|FG000|Overall Study|Adverse Event|20|||
48607908|NCT04161391|156423116|FG007|Overall Study|Adverse Event|3|||
48607909|NCT04161391|156423117|FG008|Overall Study|Adverse Event|0|||
48542258|NCT01386684|156174676|FG000|Overall Study|Noncompliance|8|||
48542259|NCT01386684|156174676|FG000|Overall Study|Protocol Violation|4|||
48542260|NCT01386684|156174676|FG000|Overall Study|Missing|3|||
48542261|NCT02944383|156174679|FG000|Overall Study|Lost to Follow-up|0|||
48542262|NCT02944383|156174680|FG001|Overall Study|Lost to Follow-up|0|||
48542263|NCT02944383|156174681|FG002|Overall Study|Lost to Follow-up|1|||
48542264|NCT02944383|156174679|FG000|Overall Study|Withdrawal by Subject|1|||
48542265|NCT02944383|156174680|FG001|Overall Study|Withdrawal by Subject|0|||
48542266|NCT02944383|156174681|FG002|Overall Study|Withdrawal by Subject|0|||
48542267|NCT01032018|156174684|FG000|Overall Study|Lost to Follow-up|6|||
48542268|NCT01032018|156174685|FG001|Overall Study|Lost to Follow-up|5|||
48542269|NCT01032018|156174684|FG000|Overall Study|Death|0|||
48542270|NCT01032018|156174685|FG001|Overall Study|Death|1|||
48542271|NCT00468728|156174692|FG000|Treatment|criteria for mITT population|4|||
48542272|NCT00468728|156174693|FG001|Treatment|criteria for mITT population|11|||
48542273|NCT00468728|156174692|FG000|Follow-up|mITT failure|34|||
48542274|NCT00468728|156174693|FG001|Follow-up|mITT failure|31|||
48542275|NCT02963311|156174694|FG000|Overall Study|Withdrawal by Subject|1|||
48542276|NCT02963311|156174694|FG000|Overall Study|Screen Failure|4|||
48542277|NCT00251719|156174712|FG000|Overall Study|Adverse Event|14|||
48542278|NCT00251719|156174713|FG001|Overall Study|Adverse Event|8|||
48542279|NCT00251719|156174714|FG002|Overall Study|Adverse Event|7|||
48542280|NCT00251719|156174712|FG000|Overall Study|Protocol Violation|1|||
48542281|NCT00251719|156174713|FG001|Overall Study|Protocol Violation|1|||
48542282|NCT00251719|156174714|FG002|Overall Study|Protocol Violation|1|||
48542283|NCT00251719|156174712|FG000|Overall Study|Lost to Follow-up|5|||
48542284|NCT00251719|156174713|FG001|Overall Study|Lost to Follow-up|11|||
48542285|NCT00251719|156174714|FG002|Overall Study|Lost to Follow-up|8|||
48542286|NCT00251719|156174712|FG000|Overall Study|Withdrawal by Subject|14|||
48542287|NCT00251719|156174713|FG001|Overall Study|Withdrawal by Subject|12|||
48542288|NCT00251719|156174714|FG002|Overall Study|Withdrawal by Subject|11|||
48542289|NCT00251719|156174712|FG000|Overall Study|Lack of Efficacy|2|||
48542290|NCT00251719|156174713|FG001|Overall Study|Lack of Efficacy|1|||
48542291|NCT00251719|156174714|FG002|Overall Study|Lack of Efficacy|0|||
48542292|NCT00251719|156174712|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
48542293|NCT00251719|156174713|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
48542294|NCT00251719|156174714|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
48542295|NCT00251719|156174712|FG000|Overall Study|Investigator decision|1|||
48542296|NCT00251719|156174713|FG001|Overall Study|Investigator decision|1|||
48542297|NCT00251719|156174714|FG002|Overall Study|Investigator decision|0|||
48542298|NCT00251719|156174712|FG000|Overall Study|Noncompliance|2|||
48542299|NCT00251719|156174713|FG001|Overall Study|Noncompliance|3|||
48542300|NCT00251719|156174714|FG002|Overall Study|Noncompliance|1|||
48542301|NCT00251719|156174712|FG000|Overall Study|Barrett's esophagus|2|||
48542302|NCT00251719|156174713|FG001|Overall Study|Barrett's esophagus|2|||
48542303|NCT00251719|156174714|FG002|Overall Study|Barrett's esophagus|0|||
48542304|NCT01449279|156174715|FG000|Overall Study|Lack of Efficacy|5|||
48542305|NCT01449279|156174715|FG000|Overall Study|Toxicity|2|||
48542306|NCT02032706|156174716|FG000|Overall Study|Did not qualify|5|||
48542307|NCT02032706|156174716|FG000|Overall Study|Protocol Violation|1|||
48542308|NCT00505375|156174721|FG000|Overall Study|Death|1|||
48542309|NCT00505375|156174722|FG001|Overall Study|Death|0|||
48542310|NCT00505375|156174721|FG000|Overall Study|Withdrawal by Subject|2|||
48542311|NCT00505375|156174722|FG001|Overall Study|Withdrawal by Subject|2|||
48542312|NCT00505375|156174721|FG000|Overall Study|Lost to Follow-up|0|||
48542313|NCT00505375|156174722|FG001|Overall Study|Lost to Follow-up|2|||
48542314|NCT00505375|156174721|FG000|Overall Study|Pregnancy|1|||
48542315|NCT00505375|156174722|FG001|Overall Study|Pregnancy|0|||
48542316|NCT00505375|156174721|FG000|Overall Study|Travel issues|0|||
48542317|NCT00505375|156174722|FG001|Overall Study|Travel issues|1|||
48542318|NCT01345175|156174723|FG000|Overall Study|Physician Decision|0|||
48542319|NCT01345175|156174724|FG001|Overall Study|Physician Decision|1|||
48542320|NCT01345175|156174723|FG000|Overall Study|Withdrawal by Subject|1|||
48542321|NCT01345175|156174724|FG001|Overall Study|Withdrawal by Subject|1|||
48542322|NCT01345175|156174723|FG000|Overall Study|Failed to complete BFI|3|||
48542323|NCT01345175|156174724|FG001|Overall Study|Failed to complete BFI|2|||
48542324|NCT01345175|156174723|FG000|Overall Study|Stopped taking medication|2|||
48542325|NCT01345175|156174724|FG001|Overall Study|Stopped taking medication|2|||
48542326|NCT03822832|156174725|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
48542327|NCT03822832|156174726|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
48542328|NCT03822832|156174725|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
48542329|NCT03822832|156174726|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
48542330|NCT03822832|156174725|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
48542331|NCT03822832|156174726|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
48542332|NCT03822832|156174725|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
48542333|NCT03822832|156174726|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
48542334|NCT03822832|156174725|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
48607910|NCT04161391|156423109|FG000|Overall Study|Death|0|||
48607911|NCT04161391|156423110|FG001|Overall Study|Death|0|||
48607912|NCT04161391|156423111|FG002|Overall Study|Death|0|||
48607913|NCT04161391|156423112|FG003|Overall Study|Death|0|||
48607914|NCT04161391|156423113|FG004|Overall Study|Death|0|||
48542335|NCT03822832|156174726|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
48542336|NCT03822832|156174725|FG000|Re-allocation|Not re-allocated to open label period|2|||
48542337|NCT03822832|156174726|FG001|Re-allocation|Not re-allocated to open label period|6|||
48542338|NCT03822832|156174725|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
48542339|NCT03822832|156174726|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
48542340|NCT03822832|156174725|FG000|Period 2 - Open Label Period|Adverse Event|0|||
48542341|NCT03822832|156174726|FG001|Period 2 - Open Label Period|Adverse Event|3|||
48542342|NCT01705236|156174727|FG000|Overall Study|Lost to Follow-up|1|||
48607915|NCT04161391|156423114|FG005|Overall Study|Death|0|||
48607916|NCT04161391|156423115|FG006|Overall Study|Death|0|||
48607917|NCT04161391|156423116|FG007|Overall Study|Death|1|||
48607918|NCT04161391|156423117|FG008|Overall Study|Death|0|||
48607919|NCT04161391|156423109|FG000|Overall Study|Physician Decision|0|||
48607920|NCT04161391|156423110|FG001|Overall Study|Physician Decision|0|||
48607921|NCT04161391|156423111|FG002|Overall Study|Physician Decision|1|||
48607922|NCT04161391|156423112|FG003|Overall Study|Physician Decision|2|||
48607923|NCT04161391|156423113|FG004|Overall Study|Physician Decision|0|||
48607924|NCT04161391|156423114|FG005|Overall Study|Physician Decision|0|||
48607925|NCT04161391|156423115|FG006|Overall Study|Physician Decision|2|||
48607926|NCT04161391|156423116|FG007|Overall Study|Physician Decision|0|||
48607927|NCT04161391|156423117|FG008|Overall Study|Physician Decision|0|||
48607928|NCT04161391|156423109|FG000|Overall Study|Progressive Disease|4|||
48607929|NCT04161391|156423110|FG001|Overall Study|Progressive Disease|3|||
48607930|NCT04161391|156423111|FG002|Overall Study|Progressive Disease|3|||
48607931|NCT04161391|156423112|FG003|Overall Study|Progressive Disease|5|||
48607932|NCT04161391|156423113|FG004|Overall Study|Progressive Disease|3|||
48607933|NCT04161391|156423114|FG005|Overall Study|Progressive Disease|3|||
48607934|NCT04161391|156423115|FG006|Overall Study|Progressive Disease|5|||
48607935|NCT04161391|156423116|FG007|Overall Study|Progressive Disease|2|||
48607936|NCT04161391|156423117|FG008|Overall Study|Progressive Disease|2|||
48607937|NCT03630393|156423118|FG000|Overall Study|Death|1|||
48607938|NCT03630393|156423119|FG001|Overall Study|Death|0|||
48607939|NCT01586195|156423120|FG000|Overall Study|Death|11|||
48607940|NCT01586195|156423120|FG000|Overall Study|Withdrawal of Consent|5|||
48607941|NCT01586195|156423120|FG000|Overall Study|Started new anti-melanoma therapy|1|||
48607942|NCT01586195|156423120|FG000|Overall Study|Reason not specified|9|||
48607943|NCT00266708|156423122|FG000|Overall Study|No renal function|1|||
48607944|NCT00266708|156423123|FG001|Overall Study|No renal function|1|||
48607945|NCT00266708|156423122|FG000|Overall Study|Refused biopsy|3|||
48607946|NCT00266708|156423123|FG001|Overall Study|Refused biopsy|6|||
48607947|NCT00266708|156423122|FG000|Overall Study|Asthma|0|||
48607948|NCT00266708|156423123|FG001|Overall Study|Asthma|2|||
48607949|NCT01548404|156423124|FG000|Overall Study|Adverse Event|3|||
48607950|NCT01548404|156423125|FG001|Overall Study|Adverse Event|1|||
48607951|NCT01548404|156423124|FG000|Overall Study|Physician Decision|2|||
48607952|NCT01548404|156423125|FG001|Overall Study|Physician Decision|1|||
48607953|NCT01548404|156423124|FG000|Overall Study|Inadequate response to study treatment|23|||
48607954|NCT01548404|156423125|FG001|Overall Study|Inadequate response to study treatment|7|||
48607955|NCT01548404|156423124|FG000|Overall Study|Lost to Follow-up|2|||
48607956|NCT01548404|156423125|FG001|Overall Study|Lost to Follow-up|0|||
48607957|NCT01548404|156423124|FG000|Overall Study|Withdrawal by Subject|0|||
48607958|NCT01548404|156423125|FG001|Overall Study|Withdrawal by Subject|3|||
48607959|NCT01548404|156423124|FG000|Overall Study|Other than specified above|0|||
48607960|NCT01548404|156423125|FG001|Overall Study|Other than specified above|2|||
48607961|NCT00427934|156423128|FG000|Overall Study|Adverse Event|1|||
48607962|NCT00427934|156423129|FG001|Overall Study|Adverse Event|0|||
48607963|NCT00427934|156423130|FG002|Overall Study|Adverse Event|5|||
48607964|NCT00427934|156423131|FG003|Overall Study|Adverse Event|4|||
48607965|NCT00427934|156423128|FG000|Overall Study|Lack of Efficacy|0|||
48607966|NCT00427934|156423129|FG001|Overall Study|Lack of Efficacy|0|||
48607967|NCT00427934|156423130|FG002|Overall Study|Lack of Efficacy|5|||
48607968|NCT00427934|156423131|FG003|Overall Study|Lack of Efficacy|2|||
48607969|NCT00427934|156423128|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
48607970|NCT00427934|156423129|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
48607971|NCT00427934|156423130|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
48607972|NCT00427934|156423131|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
48542343|NCT01705236|156174727|FG000|Overall Study|Administrative problems|2|||
48542344|NCT01705236|156174727|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
48542345|NCT01705236|156174727|FG000|Overall Study|Protocol Violation|3|||
48542346|NCT01705236|156174727|FG000|Overall Study|Abnormal test procedure result(s)|4|||
48542347|NCT01705236|156174727|FG000|Overall Study|Abnormal laboratory value(s)|4|||
48542348|NCT01705236|156174727|FG000|Overall Study|Withdrawal by Subject|5|||
48542349|NCT01705236|156174727|FG000|Overall Study|Adverse Event|5|||
48542350|NCT04234984|156174728|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
48542351|NCT04234984|156174728|FG000|Follow-up at the Second Time Point|Death|1|||
48542352|NCT04234984|156174728|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
48542353|NCT01055132|156174733|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
48542354|NCT01055132|156174734|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
48542355|NCT01055132|156174733|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
48542356|NCT01055132|156174734|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
48542357|NCT00158600|156174735|FG000|Overall Study|unable to commit time to study|0|||
48542358|NCT00158600|156174736|FG001|Overall Study|unable to commit time to study|1|||
48542359|NCT00158600|156174735|FG000|Overall Study|Adverse Event|2|||
48542360|NCT00158600|156174736|FG001|Overall Study|Adverse Event|1|||
48542361|NCT00158600|156174735|FG000|Overall Study|Death|1|||
48542362|NCT00158600|156174736|FG001|Overall Study|Death|0|||
48542363|NCT00158600|156174735|FG000|Overall Study|Withdrawal by Subject|2|||
48542364|NCT00158600|156174736|FG001|Overall Study|Withdrawal by Subject|2|||
48542365|NCT00324649|156174737|FG000|Overall Study|Adverse Event|1|||
48542366|NCT00324649|156174738|FG001|Overall Study|Adverse Event|4|||
48542367|NCT00324649|156174737|FG000|Overall Study|Withdrawal by Subject|0|||
48542368|NCT00324649|156174738|FG001|Overall Study|Withdrawal by Subject|1|||
48542369|NCT00324649|156174737|FG000|Overall Study|Noncompliance|1|||
48542370|NCT00324649|156174738|FG001|Overall Study|Noncompliance|0|||
48542371|NCT02570113|156174739|FG000|Overall Study|Withdrawal by Subject|3|||
48542372|NCT02038907|156174740|FG000|Overall Study|Protocol Violation|0|||
48542373|NCT02038907|156174741|FG001|Overall Study|Protocol Violation|0|||
48542374|NCT02038907|156174742|FG002|Overall Study|Protocol Violation|0|||
48542375|NCT02038907|156174743|FG003|Overall Study|Protocol Violation|0|||
48542376|NCT02038907|156174744|FG004|Overall Study|Protocol Violation|0|||
48542377|NCT02038907|156174745|FG005|Overall Study|Protocol Violation|0|||
48542378|NCT02038907|156174746|FG006|Overall Study|Protocol Violation|0|||
48542379|NCT02038907|156174747|FG007|Overall Study|Protocol Violation|0|||
48542380|NCT02038907|156174748|FG008|Overall Study|Protocol Violation|0|||
48542381|NCT02038907|156174749|FG009|Overall Study|Protocol Violation|0|||
48542382|NCT02038907|156174750|FG010|Overall Study|Protocol Violation|1|||
48542383|NCT02038907|156174751|FG011|Overall Study|Protocol Violation|0|||
48542384|NCT02038907|156174752|FG012|Overall Study|Protocol Violation|0|||
48542385|NCT02038907|156174753|FG013|Overall Study|Protocol Violation|0|||
48542386|NCT02038907|156174740|FG000|Overall Study|Withdrawal by Subject|0|||
48542387|NCT02038907|156174741|FG001|Overall Study|Withdrawal by Subject|0|||
48542388|NCT02038907|156174742|FG002|Overall Study|Withdrawal by Subject|0|||
48542389|NCT02038907|156174743|FG003|Overall Study|Withdrawal by Subject|0|||
48542390|NCT02038907|156174744|FG004|Overall Study|Withdrawal by Subject|0|||
48735639|NCT00961649|156883698|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
48542391|NCT02038907|156174745|FG005|Overall Study|Withdrawal by Subject|0|||
48542392|NCT02038907|156174746|FG006|Overall Study|Withdrawal by Subject|0|||
48607973|NCT00427934|156423128|FG000|Overall Study|Other|0|||
48607974|NCT00427934|156423129|FG001|Overall Study|Other|0|||
48607975|NCT00427934|156423130|FG002|Overall Study|Other|11|||
48607976|NCT00427934|156423131|FG003|Overall Study|Other|5|||
48542393|NCT02038907|156174747|FG007|Overall Study|Withdrawal by Subject|0|||
48542394|NCT02038907|156174748|FG008|Overall Study|Withdrawal by Subject|0|||
48542395|NCT02038907|156174749|FG009|Overall Study|Withdrawal by Subject|0|||
48542396|NCT02038907|156174750|FG010|Overall Study|Withdrawal by Subject|1|||
48542397|NCT02038907|156174751|FG011|Overall Study|Withdrawal by Subject|0|||
48542398|NCT02038907|156174752|FG012|Overall Study|Withdrawal by Subject|0|||
48542399|NCT02038907|156174753|FG013|Overall Study|Withdrawal by Subject|0|||
48542400|NCT00540293|156174754|FG000|Overall Study|Adverse event related to study drug|10|||
48542401|NCT00540293|156174754|FG000|Overall Study|Adverse event not related to study drug|7|||
48542402|NCT00540293|156174754|FG000|Overall Study|Withdrawal by Subject|6|||
48542403|NCT00540293|156174754|FG000|Overall Study|Protocol violation, & subject schedule|12|||
48542404|NCT02746471|156174755|FG000|Overall Study|Death|43|||
48542405|NCT02746471|156174755|FG000|Overall Study|Exited before 36 months|1119|||
48542406|NCT01246011|156174760|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
48542407|NCT01246011|156174761|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
48542408|NCT01246011|156174762|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
48542409|NCT01246011|156174760|FG000|Overall Study|Withdrawal by Subject|0|||
48542410|NCT01246011|156174761|FG001|Overall Study|Withdrawal by Subject|0|||
48542411|NCT01246011|156174762|FG002|Overall Study|Withdrawal by Subject|1|||
48542412|NCT01007942|156174763|FG000|Overall Study|Adverse Event|29|||
48542413|NCT01007942|156174764|FG001|Overall Study|Adverse Event|14|||
48542414|NCT01007942|156174763|FG000|Overall Study|Abnormal test procedure|0|||
48542415|NCT01007942|156174764|FG001|Overall Study|Abnormal test procedure|1|||
48542416|NCT01007942|156174763|FG000|Overall Study|Disease progression|217|||
48542417|NCT01007942|156174764|FG001|Overall Study|Disease progression|242|||
48542418|NCT01007942|156174763|FG000|Overall Study|New cancer therapy|5|||
48542419|NCT01007942|156174764|FG001|Overall Study|New cancer therapy|1|||
48542420|NCT01007942|156174763|FG000|Overall Study|Protocol Violation|1|||
48542421|NCT01007942|156174764|FG001|Overall Study|Protocol Violation|1|||
48542422|NCT01007942|156174763|FG000|Overall Study|Withdrawal by Subject|19|||
48542423|NCT01007942|156174764|FG001|Overall Study|Withdrawal by Subject|14|||
48542424|NCT01007942|156174763|FG000|Overall Study|Lost to Follow-up|1|||
48542425|NCT01007942|156174764|FG001|Overall Study|Lost to Follow-up|0|||
48542426|NCT01007942|156174763|FG000|Overall Study|Administrative problems|2|||
48542427|NCT01007942|156174764|FG001|Overall Study|Administrative problems|0|||
48542428|NCT01007942|156174763|FG000|Overall Study|Death|3|||
48542429|NCT01007942|156174764|FG001|Overall Study|Death|2|||
48542430|NCT01007942|156174763|FG000|Overall Study|Patients untreated|4|||
48542431|NCT01007942|156174764|FG001|Overall Study|Patients untreated|3|||
48542432|NCT00325195|156174765|FG000|Randomized|Not dosed|5|||
48542433|NCT00325195|156174766|FG001|Randomized|Not dosed|5|||
48542434|NCT00325195|156174767|FG002|Randomized|Not dosed|3|||
48542435|NCT00325195|156174765|FG000|Received Intervention: ITT Population|Adverse Event|15|||
48607977|NCT00427934|156423128|FG000|Overall Study|Withdrawal by Subject|0|||
48607978|NCT00427934|156423129|FG001|Overall Study|Withdrawal by Subject|0|||
48607979|NCT00427934|156423130|FG002|Overall Study|Withdrawal by Subject|1|||
48607980|NCT00427934|156423131|FG003|Overall Study|Withdrawal by Subject|3|||
48607981|NCT00288912|156423132|FG000|Overall Study|Developed exclusion criterion|4|||
48607982|NCT00288912|156423133|FG001|Overall Study|Developed exclusion criterion|6|||
48607983|NCT00288912|156423134|FG002|Overall Study|Developed exclusion criterion|7|||
48607984|NCT00288912|156423132|FG000|Overall Study|Lost to Follow-up|9|||
48607985|NCT00288912|156423133|FG001|Overall Study|Lost to Follow-up|6|||
48607986|NCT00288912|156423134|FG002|Overall Study|Lost to Follow-up|9|||
48607987|NCT00288912|156423132|FG000|Overall Study|Withdrawal by Subject|4|||
48607988|NCT00288912|156423133|FG001|Overall Study|Withdrawal by Subject|5|||
48607989|NCT00288912|156423134|FG002|Overall Study|Withdrawal by Subject|12|||
48607990|NCT03312738|156423135|FG000|Overall Study|Progressive disease|58|||
48607991|NCT03312738|156423136|FG001|Overall Study|Progressive disease|67|||
48607992|NCT03312738|156423135|FG000|Overall Study|Patient/guardian decision|13|||
48607993|NCT03312738|156423136|FG001|Overall Study|Patient/guardian decision|5|||
48607994|NCT03312738|156423135|FG000|Overall Study|Adverse Event|5|||
48607995|NCT03312738|156423136|FG001|Overall Study|Adverse Event|3|||
48607996|NCT03312738|156423135|FG000|Overall Study|Protocol deviation|2|||
48607997|NCT03312738|156423136|FG001|Overall Study|Protocol deviation|0|||
48607998|NCT03312738|156423135|FG000|Overall Study|Technical problems|0|||
48607999|NCT03312738|156423136|FG001|Overall Study|Technical problems|1|||
48608000|NCT03312738|156423135|FG000|Overall Study|Physician Decision|2|||
48608001|NCT03312738|156423136|FG001|Overall Study|Physician Decision|3|||
48608002|NCT01316614|156423140|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
48608003|NCT01316614|156423140|FG000|Overall Study|Cytology slides not available for review|4|||
48608004|NCT01316614|156423140|FG000|Overall Study|Cystic lesion|5|||
48608005|NCT01316614|156423140|FG000|Overall Study|Inadequate number of passes|2|||
48608006|NCT01316614|156423140|FG000|Overall Study|Medically unstable|1|||
48608007|NCT00076570|156423141|FG000|Overall Study|Drug intolerance|8|||
48608008|NCT00076570|156423142|FG001|Overall Study|Drug intolerance|8|||
48608009|NCT03427411|156423143|FG000|Overall Study|Screen failure - platelets too low|0|||
48608010|NCT03427411|156423144|FG001|Overall Study|Screen failure - platelets too low|1|||
48608011|NCT04539275|156423148|FG000|Overall Study|Death|2|||
48542436|NCT00325195|156174766|FG001|Received Intervention: ITT Population|Adverse Event|17|||
48542437|NCT00325195|156174767|FG002|Received Intervention: ITT Population|Adverse Event|1|||
48542438|NCT00325195|156174765|FG000|Received Intervention: ITT Population|Death|3|||
48542439|NCT00325195|156174766|FG001|Received Intervention: ITT Population|Death|1|||
48542440|NCT00325195|156174767|FG002|Received Intervention: ITT Population|Death|0|||
48542441|NCT00325195|156174765|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
48542442|NCT00325195|156174766|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
48542443|NCT00325195|156174767|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
48542444|NCT00325195|156174765|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
48542445|NCT00325195|156174766|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
48542446|NCT00325195|156174767|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
48542447|NCT00325195|156174765|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
48542448|NCT00325195|156174766|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
48542449|NCT00325195|156174767|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
48542450|NCT02792959|156174776|FG000|Overall Study|Protocol Violation|1|||
48542451|NCT04319159|156174777|FG000|Overall Study|Screening failure|13|||
48542452|NCT04319159|156174777|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
48542453|NCT04319159|156174777|FG000|Overall Study|Withdrawal by Subject|1|||
48542454|NCT02288182|156174791|FG000|Overall Study|Adverse Event|0|||
48542455|NCT02288182|156174792|FG001|Overall Study|Adverse Event|1|||
48542456|NCT02288182|156174791|FG000|Overall Study|Lost to Follow-up|0|||
48542457|NCT02288182|156174792|FG001|Overall Study|Lost to Follow-up|1|||
48542458|NCT01104792|156174805|FG000|Overall Study|Adverse Event|77|||
48542459|NCT01104792|156174805|FG000|Overall Study|Insufficient Therapeutic Response|22|||
48542460|NCT01104792|156174805|FG000|Overall Study|Protocol Violation|45|||
48542461|NCT01104792|156174805|FG000|Overall Study|Withdrawal of Consent|179|||
48542462|NCT01104792|156174805|FG000|Overall Study|Lost to Follow-up|43|||
48542463|NCT01104792|156174805|FG000|Overall Study|Reasons Not Specified|27|||
48542464|NCT01104792|156174805|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
48542465|NCT03567382|156174811|FG000|Overall Study|Lost to Follow-up|1|||
48542466|NCT03567382|156174812|FG001|Overall Study|Lost to Follow-up|21|||
48542467|NCT03567382|156174813|FG002|Overall Study|Lost to Follow-up|1|||
48542468|NCT03567382|156174814|FG003|Overall Study|Lost to Follow-up|21|||
48542469|NCT03567382|156174811|FG000|Overall Study|Withdrawal by Subject|2|||
48542470|NCT03567382|156174812|FG001|Overall Study|Withdrawal by Subject|14|||
48542471|NCT03567382|156174813|FG002|Overall Study|Withdrawal by Subject|1|||
48542472|NCT03567382|156174814|FG003|Overall Study|Withdrawal by Subject|12|||
48608012|NCT04539275|156423149|FG001|Overall Study|Death|4|||
48608013|NCT04539275|156423148|FG000|Overall Study|Lost to Follow-up|1|||
48608014|NCT04539275|156423149|FG001|Overall Study|Lost to Follow-up|1|||
48608015|NCT04539275|156423148|FG000|Overall Study|Withdrawal by Subject|3|||
48608016|NCT04539275|156423149|FG001|Overall Study|Withdrawal by Subject|0|||
48608017|NCT02669849|156423150|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
48608018|NCT02669849|156423151|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
48608019|NCT02669849|156423152|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
48608020|NCT02669849|156423150|FG000|Overall Study|Lost to Follow-up|1|||
48608021|NCT02669849|156423151|FG001|Overall Study|Lost to Follow-up|0|||
48608022|NCT02669849|156423152|FG002|Overall Study|Lost to Follow-up|3|||
48608023|NCT02669849|156423150|FG000|Overall Study|Death|1|||
48608024|NCT02669849|156423151|FG001|Overall Study|Death|1|||
48608025|NCT02669849|156423152|FG002|Overall Study|Death|2|||
48608026|NCT02669849|156423150|FG000|Overall Study|Study terminated by sponsor|16|||
48608027|NCT02669849|156423151|FG001|Overall Study|Study terminated by sponsor|1|||
48608028|NCT02669849|156423152|FG002|Overall Study|Study terminated by sponsor|14|||
48608029|NCT02669849|156423150|FG000|Overall Study|Other|0|||
48608030|NCT02669849|156423151|FG001|Overall Study|Other|0|||
48608031|NCT02669849|156423152|FG002|Overall Study|Other|2|||
48608032|NCT03257267|156423153|FG000|Overall Study|Adverse Event|17|||
48608033|NCT03257267|156423154|FG001|Overall Study|Adverse Event|7|||
48608034|NCT03257267|156423153|FG000|Overall Study|Death|96|||
48608035|NCT03257267|156423154|FG001|Overall Study|Death|98|||
48608036|NCT03257267|156423153|FG000|Overall Study|Lost to Follow-up|2|||
48608037|NCT03257267|156423154|FG001|Overall Study|Lost to Follow-up|2|||
48608038|NCT03257267|156423153|FG000|Overall Study|Non-compliance with Study Drug|0|||
48608039|NCT03257267|156423154|FG001|Overall Study|Non-compliance with Study Drug|2|||
48608040|NCT03257267|156423153|FG000|Overall Study|Participant Decision|35|||
48608041|NCT03257267|156423154|FG001|Overall Study|Participant Decision|43|||
48608042|NCT03257267|156423153|FG000|Overall Study|Sponsor Decision|1|||
48608043|NCT03257267|156423154|FG001|Overall Study|Sponsor Decision|0|||
48608044|NCT03257267|156423153|FG000|Overall Study|Physician Decision|1|||
48608045|NCT03257267|156423154|FG001|Overall Study|Physician Decision|3|||
48608046|NCT03257267|156423153|FG000|Overall Study|Disease Progression|109|||
48608047|NCT03257267|156423154|FG001|Overall Study|Disease Progression|121|||
48608048|NCT03257267|156423153|FG000|Overall Study|Withdrawal by Subject|8|||
48608049|NCT03257267|156423154|FG001|Overall Study|Withdrawal by Subject|26|||
48608050|NCT03257267|156423153|FG000|Overall Study|Other|0|||
48608051|NCT03257267|156423154|FG001|Overall Study|Other|2|||
48608052|NCT00606008|156423162|FG000|Overall Study|Adverse Event|1|||
48608053|NCT00606008|156423162|FG000|Overall Study|Withdrawal by Subject|4|||
48608054|NCT03183908|156423169|FG000|Overall Study|Missing Symptom Diary Data|0|||
48608055|NCT03183908|156423170|FG001|Overall Study|Missing Symptom Diary Data|2|||
48608056|NCT02014272|156423171|FG000|Intervention Period 1|Withdrawal by Subject|1|||
48608057|NCT02014272|156423172|FG001|Intervention Period 1|Withdrawal by Subject|0|||
48608058|NCT02014272|156423171|FG000|Intervention Period 1|Adverse Event|0|||
48608059|NCT02014272|156423172|FG001|Intervention Period 1|Adverse Event|1|||
48608060|NCT01240746|156423173|FG000|Overall Study|Adverse Event|2|||
48608061|NCT01240746|156423174|FG001|Overall Study|Adverse Event|0|||
48608062|NCT01240746|156423175|FG002|Overall Study|Adverse Event|10|||
48608063|NCT01240746|156423173|FG000|Overall Study|Lost to Follow-up|23|||
48608064|NCT01240746|156423174|FG001|Overall Study|Lost to Follow-up|20|||
48608065|NCT01240746|156423175|FG002|Overall Study|Lost to Follow-up|102|||
48608066|NCT01240746|156423173|FG000|Overall Study|Protocol Violation|24|||
48608067|NCT01240746|156423174|FG001|Overall Study|Protocol Violation|15|||
48608068|NCT01240746|156423175|FG002|Overall Study|Protocol Violation|72|||
48608069|NCT01240746|156423173|FG000|Overall Study|Withdrawal by Subject|10|||
48608070|NCT01240746|156423174|FG001|Overall Study|Withdrawal by Subject|13|||
48608071|NCT01240746|156423175|FG002|Overall Study|Withdrawal by Subject|59|||
48608072|NCT03636256|156423176|FG000|Overall Study|Lost to Follow-up|3|||
48608073|NCT03636256|156423177|FG001|Overall Study|Lost to Follow-up|0|||
48608074|NCT03636256|156423178|FG002|Overall Study|Lost to Follow-up|2|||
48608075|NCT03636256|156423179|FG003|Overall Study|Lost to Follow-up|1|||
48608076|NCT03636256|156423180|FG004|Overall Study|Lost to Follow-up|0|||
48608077|NCT03636256|156423181|FG005|Overall Study|Lost to Follow-up|4|||
48608078|NCT03636256|156423182|FG006|Overall Study|Lost to Follow-up|2|||
48608079|NCT03636256|156423183|FG007|Overall Study|Lost to Follow-up|0|||
48608080|NCT03636256|156423184|FG008|Overall Study|Lost to Follow-up|4|||
48608081|NCT03636256|156423176|FG000|Overall Study|Withdrawal by Subject|0|||
48608082|NCT03636256|156423177|FG001|Overall Study|Withdrawal by Subject|0|||
48608083|NCT03636256|156423178|FG002|Overall Study|Withdrawal by Subject|0|||
48608084|NCT03636256|156423179|FG003|Overall Study|Withdrawal by Subject|0|||
48608085|NCT03636256|156423180|FG004|Overall Study|Withdrawal by Subject|0|||
48608086|NCT03636256|156423181|FG005|Overall Study|Withdrawal by Subject|0|||
48608087|NCT03636256|156423182|FG006|Overall Study|Withdrawal by Subject|0|||
48608088|NCT03636256|156423183|FG007|Overall Study|Withdrawal by Subject|0|||
48608089|NCT03636256|156423184|FG008|Overall Study|Withdrawal by Subject|1|||
48608090|NCT05379920|156423185|FG000|Overall Study|Lost to Follow-up|0|||
48608091|NCT05379920|156423186|FG001|Overall Study|Lost to Follow-up|5|||
48608092|NCT05379920|156423187|FG002|Overall Study|Lost to Follow-up|0|||
48608093|NCT05379920|156423188|FG003|Overall Study|Lost to Follow-up|0|||
48608094|NCT03176771|156423189|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
48608095|NCT03176771|156423190|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
48608096|NCT03176771|156423191|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
48608097|NCT03176771|156423192|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
48608098|NCT03176771|156423193|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
48608099|NCT03176771|156423189|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
48608100|NCT03176771|156423190|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
48608101|NCT03176771|156423191|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
48608102|NCT03176771|156423192|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
48608103|NCT03176771|156423193|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
48608104|NCT03176771|156423189|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
48608105|NCT03176771|156423190|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
48608106|NCT03176771|156423191|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
48608107|NCT03176771|156423192|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
48608108|NCT03176771|156423193|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
48608109|NCT03176771|156423189|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
48608110|NCT03176771|156423190|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
48608111|NCT03176771|156423191|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
48608112|NCT03176771|156423192|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
48608113|NCT03176771|156423193|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
48608114|NCT03176771|156423189|FG000|Double-Blind Extension Period|Adverse Event|0|||
48608115|NCT03176771|156423190|FG001|Double-Blind Extension Period|Adverse Event|0|||
48608116|NCT03176771|156423191|FG002|Double-Blind Extension Period|Adverse Event|0|||
48608117|NCT03176771|156423192|FG003|Double-Blind Extension Period|Adverse Event|15|||
48608118|NCT03176771|156423193|FG004|Double-Blind Extension Period|Adverse Event|18|||
48608119|NCT03176771|156423189|FG000|Double-Blind Extension Period|Death|0|||
48608120|NCT03176771|156423190|FG001|Double-Blind Extension Period|Death|0|||
48608121|NCT03176771|156423191|FG002|Double-Blind Extension Period|Death|0|||
48608122|NCT03176771|156423192|FG003|Double-Blind Extension Period|Death|3|||
48608123|NCT03176771|156423193|FG004|Double-Blind Extension Period|Death|4|||
48608124|NCT03176771|156423189|FG000|Double-Blind Extension Period|Physician Decision|0|||
48608125|NCT03176771|156423190|FG001|Double-Blind Extension Period|Physician Decision|0|||
48608126|NCT03176771|156423191|FG002|Double-Blind Extension Period|Physician Decision|0|||
48608127|NCT03176771|156423192|FG003|Double-Blind Extension Period|Physician Decision|3|||
48608128|NCT03176771|156423193|FG004|Double-Blind Extension Period|Physician Decision|1|||
48608129|NCT03176771|156423189|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
48608130|NCT03176771|156423190|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
48608131|NCT03176771|156423191|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
48608132|NCT03176771|156423192|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
48608133|NCT03176771|156423193|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
48608134|NCT02915835|156423209|FG000|Overall Study|Physician Decision|1|||
48608135|NCT02915835|156423210|FG001|Overall Study|Physician Decision|0|||
48608136|NCT02915835|156423209|FG000|Overall Study|Withdrawal by Subject|0|||
48608137|NCT02915835|156423210|FG001|Overall Study|Withdrawal by Subject|1|||
48608138|NCT01569022|156423211|FG000|First Intervention|Lost to Follow-up|2|||
48608139|NCT01569022|156423212|FG001|First Intervention|Lost to Follow-up|1|||
48608140|NCT01569022|156423211|FG000|Second Intervention|Lost to Follow-up|2|||
48608141|NCT01569022|156423212|FG001|Second Intervention|Lost to Follow-up|2|||
48608142|NCT00572832|156423213|FG000|Overall Study|Lost to Follow-up|0|||
48608143|NCT00572832|156423214|FG001|Overall Study|Lost to Follow-up|11|||
48608144|NCT00572832|156423213|FG000|Overall Study|Pregnancy|0|||
48735640|NCT00961649|156883699|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
48542473|NCT04619992|156174817|FG000|Overall Study|Withdrawal by Subject|1|||
48542474|NCT04619992|156174818|FG001|Overall Study|Withdrawal by Subject|0|||
48542475|NCT01197755|156174819|FG000|Overall Study|Adverse Event|8|||
48542476|NCT01197755|156174820|FG001|Overall Study|Adverse Event|10|||
48542477|NCT01197755|156174821|FG002|Overall Study|Adverse Event|10|||
48542478|NCT01197755|156174819|FG000|Overall Study|Study-specific discontinuation criteria|2|||
48542479|NCT01197755|156174820|FG001|Overall Study|Study-specific discontinuation criteria|1|||
48542480|NCT01197755|156174821|FG002|Overall Study|Study-specific discontinuation criteria|0|||
48542481|NCT01197755|156174819|FG000|Overall Study|Entered the long-term extension study|18|||
48542482|NCT01197755|156174820|FG001|Overall Study|Entered the long-term extension study|21|||
48542483|NCT01197755|156174821|FG002|Overall Study|Entered the long-term extension study|35|||
48542484|NCT01197755|156174819|FG000|Overall Study|Lack of therapeutic response|0|||
48542485|NCT01197755|156174820|FG001|Overall Study|Lack of therapeutic response|7|||
48542486|NCT01197755|156174821|FG002|Overall Study|Lack of therapeutic response|4|||
48542487|NCT01197755|156174819|FG000|Overall Study|Severe non-compliance to the protocol|2|||
48542488|NCT01197755|156174820|FG001|Overall Study|Severe non-compliance to the protocol|1|||
48542489|NCT01197755|156174821|FG002|Overall Study|Severe non-compliance to the protocol|2|||
48542490|NCT01197755|156174819|FG000|Overall Study|Withdrawal by Subject|1|||
48542491|NCT01197755|156174820|FG001|Overall Study|Withdrawal by Subject|0|||
48542492|NCT01197755|156174821|FG002|Overall Study|Withdrawal by Subject|0|||
48542493|NCT01197755|156174819|FG000|Overall Study|Lost to Follow-up|0|||
48542494|NCT01197755|156174820|FG001|Overall Study|Lost to Follow-up|0|||
48542495|NCT01197755|156174821|FG002|Overall Study|Lost to Follow-up|1|||
48542496|NCT01197755|156174819|FG000|Overall Study|eg, change in circumstances|7|||
48542497|NCT01197755|156174820|FG001|Overall Study|eg, change in circumstances|3|||
48542498|NCT01197755|156174821|FG002|Overall Study|eg, change in circumstances|2|||
48542499|NCT03255655|156174822|FG000|Overall Study|Lost to Follow-up|7|||
48542500|NCT03255655|156174823|FG001|Overall Study|Lost to Follow-up|4|||
48542501|NCT01709838|156174826|FG000|Overall Study|Withdrawal by Subject|21|||
48542502|NCT01709838|156174826|FG000|Overall Study|Lost to Follow-up|16|||
48542503|NCT01709838|156174826|FG000|Overall Study|Pregnancy|10|||
48542504|NCT01709838|156174826|FG000|Overall Study|Subject/guardian decision|8|||
48542505|NCT01709838|156174826|FG000|Overall Study|Adverse Event|4|||
48542506|NCT01709838|156174826|FG000|Overall Study|Physician Decision|4|||
48542507|NCT01709838|156174826|FG000|Overall Study|Death|3|||
48542508|NCT01709838|156174826|FG000|Overall Study|Protocol Violation|1|||
48542509|NCT00620659|156174827|FG000|Treatment Period 1|Adverse Event|1|||
48542510|NCT00620659|156174828|FG001|Treatment Period 1|Adverse Event|0|||
48542511|NCT00620659|156174829|FG002|Treatment Period 1|Adverse Event|0|||
48542512|NCT00620659|156174830|FG003|Treatment Period 1|Adverse Event|3|||
48542513|NCT00620659|156174831|FG004|Treatment Period 1|Adverse Event|0|||
48542514|NCT00620659|156174832|FG005|Treatment Period 1|Adverse Event|0|||
48542515|NCT00620659|156174827|FG000|Treatment Period 1|Protocol Violation|1|||
48542516|NCT00620659|156174828|FG001|Treatment Period 1|Protocol Violation|0|||
48542517|NCT00620659|156174829|FG002|Treatment Period 1|Protocol Violation|0|||
48542518|NCT00620659|156174830|FG003|Treatment Period 1|Protocol Violation|0|||
48542519|NCT00620659|156174831|FG004|Treatment Period 1|Protocol Violation|0|||
48542520|NCT00620659|156174832|FG005|Treatment Period 1|Protocol Violation|0|||
48542521|NCT00620659|156174827|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48542522|NCT00620659|156174828|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48542523|NCT00620659|156174829|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48542524|NCT00620659|156174830|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48542525|NCT00620659|156174831|FG004|Treatment Period 1|Withdrawal by Subject|1|||
48542526|NCT00620659|156174832|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48542527|NCT00620659|156174827|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
48542528|NCT00620659|156174828|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
48542529|NCT00620659|156174829|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
48542530|NCT00620659|156174830|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
48542531|NCT00620659|156174831|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
48542532|NCT00620659|156174832|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
48542533|NCT00620659|156174827|FG000|Treatment Period 2|Adverse Event|0|||
48542534|NCT00620659|156174828|FG001|Treatment Period 2|Adverse Event|3|||
48542535|NCT00620659|156174829|FG002|Treatment Period 2|Adverse Event|0|||
48542536|NCT00620659|156174830|FG003|Treatment Period 2|Adverse Event|0|||
48542537|NCT00620659|156174831|FG004|Treatment Period 2|Adverse Event|2|||
48542538|NCT00620659|156174832|FG005|Treatment Period 2|Adverse Event|0|||
48542539|NCT00620659|156174827|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48542540|NCT00620659|156174828|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48542541|NCT00620659|156174829|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48542542|NCT00620659|156174830|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48608145|NCT00572832|156423214|FG001|Overall Study|Pregnancy|1|||
48608146|NCT00284856|156423215|FG000|Overall Study|Adverse Event|3|||
48608147|NCT00284856|156423216|FG001|Overall Study|Adverse Event|3|||
48608148|NCT00284856|156423217|FG002|Overall Study|Adverse Event|3|||
48608149|NCT00284856|156423215|FG000|Overall Study|Lack of Efficacy|2|||
48608150|NCT00284856|156423216|FG001|Overall Study|Lack of Efficacy|1|||
48608151|NCT00284856|156423217|FG002|Overall Study|Lack of Efficacy|8|||
48608152|NCT00284856|156423215|FG000|Overall Study|Lost to Follow-up|25|||
48542543|NCT00620659|156174831|FG004|Treatment Period 2|Withdrawal by Subject|3|||
48542544|NCT00620659|156174832|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48542545|NCT00620659|156174827|FG000|Placebo Washout Period 2|Adverse Event|2|||
48542546|NCT00620659|156174828|FG001|Placebo Washout Period 2|Adverse Event|0|||
48542547|NCT00620659|156174829|FG002|Placebo Washout Period 2|Adverse Event|0|||
48542548|NCT00620659|156174830|FG003|Placebo Washout Period 2|Adverse Event|0|||
48542549|NCT00620659|156174831|FG004|Placebo Washout Period 2|Adverse Event|0|||
48542550|NCT00620659|156174832|FG005|Placebo Washout Period 2|Adverse Event|0|||
48542551|NCT00620659|156174827|FG000|Treatment Period 3|Adverse Event|0|||
48542552|NCT00620659|156174828|FG001|Treatment Period 3|Adverse Event|2|||
48542553|NCT00620659|156174829|FG002|Treatment Period 3|Adverse Event|0|||
48542554|NCT00620659|156174830|FG003|Treatment Period 3|Adverse Event|0|||
48542555|NCT00620659|156174831|FG004|Treatment Period 3|Adverse Event|0|||
48542556|NCT00620659|156174832|FG005|Treatment Period 3|Adverse Event|0|||
48542557|NCT00620659|156174827|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48542558|NCT00620659|156174828|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48542559|NCT00620659|156174829|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48542560|NCT00620659|156174830|FG003|Treatment Period 3|Withdrawal by Subject|1|||
48542561|NCT00620659|156174831|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48542562|NCT00620659|156174832|FG005|Treatment Period 3|Withdrawal by Subject|0|||
48542563|NCT04428333|156174833|FG000|Overall Study|Physician Decision|5|||
48542564|NCT04428333|156174834|FG001|Overall Study|Physician Decision|6|||
48542565|NCT04428333|156174833|FG000|Overall Study|Withdrawal by Subject|1|||
48542566|NCT04428333|156174834|FG001|Overall Study|Withdrawal by Subject|3|||
48542567|NCT04428333|156174833|FG000|Overall Study|Study Terminated By Sponsor|14|||
48542568|NCT04428333|156174834|FG001|Overall Study|Study Terminated By Sponsor|16|||
48542569|NCT02269163|156174835|FG000|Overall Study|Lost to Follow-up|1|||
48542570|NCT02269163|156174836|FG001|Overall Study|Lost to Follow-up|0|||
48542571|NCT02269163|156174835|FG000|Overall Study|Major protocol violation|0|||
48542572|NCT02269163|156174836|FG001|Overall Study|Major protocol violation|1|||
48542573|NCT02269163|156174835|FG000|Overall Study|Other|2|||
48542574|NCT02269163|156174836|FG001|Overall Study|Other|2|||
48542575|NCT02269163|156174835|FG000|Overall Study|Withdrawal by Subject|0|||
48542576|NCT02269163|156174836|FG001|Overall Study|Withdrawal by Subject|3|||
48542577|NCT02269163|156174835|FG000|Overall Study|Physician Decision|0|||
48608153|NCT00284856|156423216|FG001|Overall Study|Lost to Follow-up|21|||
48608154|NCT00284856|156423217|FG002|Overall Study|Lost to Follow-up|22|||
48608155|NCT00284856|156423215|FG000|Overall Study|Protocol Violation|5|||
48608156|NCT00284856|156423216|FG001|Overall Study|Protocol Violation|4|||
48608157|NCT00284856|156423217|FG002|Overall Study|Protocol Violation|5|||
48542578|NCT02269163|156174836|FG001|Overall Study|Physician Decision|1|||
48542579|NCT02352779|156174843|FG000|Overall Study|Personal Issues|1|||
48542580|NCT02352779|156174844|FG001|Overall Study|Personal Issues|1|||
48542581|NCT02352779|156174845|FG002|Overall Study|Personal Issues|0|||
48542582|NCT02352779|156174843|FG000|Overall Study|Too Many Forms|2|||
48542583|NCT02352779|156174844|FG001|Overall Study|Too Many Forms|0|||
48542584|NCT02352779|156174845|FG002|Overall Study|Too Many Forms|0|||
48608158|NCT00284856|156423215|FG000|Overall Study|Withdrawal by Subject|12|||
48608159|NCT00284856|156423216|FG001|Overall Study|Withdrawal by Subject|16|||
48542585|NCT02352779|156174843|FG000|Overall Study|Feeling Overwhelmed|1|||
48542586|NCT02352779|156174844|FG001|Overall Study|Feeling Overwhelmed|0|||
48542587|NCT02352779|156174845|FG002|Overall Study|Feeling Overwhelmed|0|||
48542588|NCT02352779|156174843|FG000|Overall Study|Disliked Intervention|1|||
48542589|NCT02352779|156174844|FG001|Overall Study|Disliked Intervention|0|||
48542590|NCT02352779|156174845|FG002|Overall Study|Disliked Intervention|0|||
48542591|NCT02352779|156174843|FG000|Overall Study|Changed Mind|1|||
48542592|NCT02352779|156174844|FG001|Overall Study|Changed Mind|0|||
48542593|NCT02352779|156174845|FG002|Overall Study|Changed Mind|0|||
48542594|NCT02352779|156174843|FG000|Overall Study|Study Related Symptoms|1|||
48542595|NCT02352779|156174844|FG001|Overall Study|Study Related Symptoms|0|||
48542596|NCT02352779|156174845|FG002|Overall Study|Study Related Symptoms|0|||
48542597|NCT02352779|156174843|FG000|Overall Study|Absence of Symptoms|1|||
48542598|NCT02352779|156174844|FG001|Overall Study|Absence of Symptoms|0|||
48542599|NCT02352779|156174845|FG002|Overall Study|Absence of Symptoms|0|||
48542600|NCT02352779|156174843|FG000|Overall Study|Other Medical Reason|0|||
48542601|NCT02352779|156174844|FG001|Overall Study|Other Medical Reason|0|||
48542602|NCT02352779|156174845|FG002|Overall Study|Other Medical Reason|1|||
48542603|NCT02352779|156174843|FG000|Overall Study|No Reason|0|||
48542604|NCT02352779|156174844|FG001|Overall Study|No Reason|0|||
48542605|NCT02352779|156174845|FG002|Overall Study|No Reason|1|||
48542606|NCT04319718|156174849|FG000|Overall Study|Adverse Event|0|||
48542607|NCT04319718|156174850|FG001|Overall Study|Adverse Event|2|||
48542608|NCT04319718|156174849|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
48542609|NCT04319718|156174850|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
48542610|NCT01214915|156174852|FG000|Overall Study|Adverse Event|8|||
48542611|NCT01214915|156174852|FG000|Overall Study|Lack of Efficacy|3|||
48542612|NCT00416884|156174853|FG000|Overall Study|Study terminated due to low accrual|1|||
48542613|NCT01183221|156176211|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
48542614|NCT01183221|156176212|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
48542615|NCT01220297|156176213|FG000|Overall Study|Death|2|||
48542616|NCT01220297|156176213|FG000|Overall Study|Lost to Follow-up|1|||
48542617|NCT00858143|156176216|FG000|Overall Study|Adverse Event|16|||
48542618|NCT00858143|156176216|FG000|Overall Study|Lack of Efficacy|4|||
48542619|NCT00858143|156176216|FG000|Overall Study|Death|7|||
48542620|NCT00858143|156176216|FG000|Overall Study|Other|23|||
48542621|NCT00622466|156176227|FG000|Overall Study|Death|1|||
48542622|NCT00622466|156176227|FG000|Overall Study|Adverse Event|1|||
48542623|NCT00622466|156176227|FG000|Overall Study|Withdrawal by Subject|2|||
48542624|NCT01908816|156176228|FG000|Overall Study|Subject's no longer requires study drug|0|||
48542625|NCT01908816|156176229|FG001|Overall Study|Subject's no longer requires study drug|0|||
48542626|NCT01908816|156176230|FG002|Overall Study|Subject's no longer requires study drug|0|||
48542627|NCT01908816|156176231|FG003|Overall Study|Subject's no longer requires study drug|1|||
48542628|NCT01908816|156176228|FG000|Overall Study|Protocol deviation|1|||
48542629|NCT01908816|156176229|FG001|Overall Study|Protocol deviation|2|||
48542630|NCT01908816|156176230|FG002|Overall Study|Protocol deviation|1|||
48542631|NCT01908816|156176231|FG003|Overall Study|Protocol deviation|1|||
48542632|NCT01908816|156176228|FG000|Overall Study|Withdrawal by Subject|0|||
48542633|NCT01908816|156176229|FG001|Overall Study|Withdrawal by Subject|4|||
48542634|NCT01908816|156176230|FG002|Overall Study|Withdrawal by Subject|2|||
48542635|NCT01908816|156176231|FG003|Overall Study|Withdrawal by Subject|2|||
48542636|NCT01908816|156176228|FG000|Overall Study|Lost to Follow-up|3|||
48542637|NCT01908816|156176229|FG001|Overall Study|Lost to Follow-up|5|||
48542638|NCT01908816|156176230|FG002|Overall Study|Lost to Follow-up|4|||
48542639|NCT01908816|156176231|FG003|Overall Study|Lost to Follow-up|2|||
48542640|NCT01908816|156176228|FG000|Overall Study|Death|1|||
48542641|NCT01908816|156176229|FG001|Overall Study|Death|0|||
48542642|NCT01908816|156176230|FG002|Overall Study|Death|7|||
48542643|NCT01908816|156176231|FG003|Overall Study|Death|1|||
48608160|NCT00284856|156423217|FG002|Overall Study|Withdrawal by Subject|18|||
48608161|NCT00284856|156423215|FG000|Overall Study|Other|4|||
48608162|NCT00284856|156423216|FG001|Overall Study|Other|5|||
48608163|NCT00284856|156423217|FG002|Overall Study|Other|4|||
48542644|NCT01908816|156176228|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48542645|NCT01908816|156176229|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
48542646|NCT01908816|156176230|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
48542647|NCT01908816|156176231|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48542648|NCT01908816|156176228|FG000|Overall Study|Early termination|87|||
48542649|NCT01908816|156176229|FG001|Overall Study|Early termination|60|||
48542650|NCT01908816|156176230|FG002|Overall Study|Early termination|43|||
48542651|NCT01908816|156176231|FG003|Overall Study|Early termination|28|||
48542652|NCT00846521|156176234|FG000|Overall Study|Withdrawal by Subject|5|||
48542653|NCT00846521|156176234|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
48542654|NCT00846521|156176234|FG000|Overall Study|Protocol Violation|1|||
48542655|NCT04771403|156176235|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
48542656|NCT04771403|156176236|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
48608164|NCT00423046|156423218|FG000|Overall Study|Other|340|||
48608165|NCT00423046|156423219|FG001|Overall Study|Other|345|||
48608166|NCT03704064|156423220|FG000|Overall Study|Lost to Follow-up|8|||
48608167|NCT03704064|156423221|FG001|Overall Study|Lost to Follow-up|4|||
48608168|NCT03704064|156423220|FG000|Overall Study|Withdrawal by Subject|1|||
48608169|NCT03704064|156423221|FG001|Overall Study|Withdrawal by Subject|1|||
48608170|NCT03704064|156423220|FG000|Overall Study|No longer available for study visits|0|||
48608171|NCT03704064|156423221|FG001|Overall Study|No longer available for study visits|1|||
48608172|NCT03704064|156423220|FG000|Overall Study|Censoring event|1|||
48608173|NCT03704064|156423221|FG001|Overall Study|Censoring event|0|||
48608174|NCT01286129|156423222|FG000|Overall Study|Withdrawal by Subject|4|||
48608175|NCT01286129|156423223|FG001|Overall Study|Withdrawal by Subject|1|||
48608176|NCT01286129|156423222|FG000|Overall Study|Could not comply with study requirements|4|||
48608177|NCT01286129|156423223|FG001|Overall Study|Could not comply with study requirements|4|||
48608178|NCT01604785|156423224|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
48608179|NCT01604785|156423225|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
48608180|NCT01285518|156423226|FG000|Overall Study|Lost to Follow-up|0|||
48608181|NCT01285518|156423227|FG001|Overall Study|Lost to Follow-up|0|||
48608182|NCT01285518|156423228|FG002|Overall Study|Lost to Follow-up|0|||
48542657|NCT04771403|156176235|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
48608183|NCT01285518|156423229|FG003|Overall Study|Lost to Follow-up|0|||
48608184|NCT01285518|156423230|FG004|Overall Study|Lost to Follow-up|0|||
48608185|NCT01285518|156423231|FG005|Overall Study|Lost to Follow-up|1|||
48608186|NCT01285518|156423232|FG006|Overall Study|Lost to Follow-up|0|||
48608187|NCT01285518|156423233|FG007|Overall Study|Lost to Follow-up|0|||
48542658|NCT04771403|156176236|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
48608188|NCT00879658|156423234|FG000|Overall Study|Abnormal laboratory value(s)|3|||
48542659|NCT04771403|156176235|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
48542660|NCT04771403|156176236|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
48542661|NCT04771403|156176235|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
48542662|NCT04771403|156176236|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
48542663|NCT04771403|156176235|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
48542664|NCT04771403|156176236|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
48542665|NCT04771403|156176235|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
48542666|NCT04771403|156176236|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
48542667|NCT04771403|156176235|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
48542668|NCT04771403|156176236|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
48542669|NCT04771403|156176235|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
48542670|NCT04771403|156176236|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
48542671|NCT02618408|156176237|FG000|Overall Study|Withdrawal by Subject|1|||
48542672|NCT02618408|156176238|FG001|Overall Study|Withdrawal by Subject|0|||
48542673|NCT02618408|156176239|FG002|Overall Study|Withdrawal by Subject|4|||
48542674|NCT02618408|156176237|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
48542675|NCT02618408|156176238|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
48542676|NCT02618408|156176239|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
48542677|NCT02618408|156176237|FG000|Overall Study|Lost to Follow-up|4|||
48542678|NCT02618408|156176238|FG001|Overall Study|Lost to Follow-up|2|||
48542679|NCT02618408|156176239|FG002|Overall Study|Lost to Follow-up|6|||
48542680|NCT02618408|156176237|FG000|Overall Study|Adverse Event|4|||
48542681|NCT02618408|156176238|FG001|Overall Study|Adverse Event|0|||
48542682|NCT02618408|156176239|FG002|Overall Study|Adverse Event|10|||
48542683|NCT02618408|156176237|FG000|Overall Study|Physician Decision|1|||
48542684|NCT02618408|156176238|FG001|Overall Study|Physician Decision|1|||
48542685|NCT02618408|156176239|FG002|Overall Study|Physician Decision|2|||
48542686|NCT02618408|156176237|FG000|Overall Study|Protocol Violation|1|||
48542687|NCT02618408|156176238|FG001|Overall Study|Protocol Violation|1|||
48542688|NCT02618408|156176239|FG002|Overall Study|Protocol Violation|2|||
48542689|NCT02618408|156176237|FG000|Overall Study|Other, Multiple Categories|0|||
48542690|NCT02618408|156176238|FG001|Overall Study|Other, Multiple Categories|0|||
48542691|NCT02618408|156176239|FG002|Overall Study|Other, Multiple Categories|4|||
48542692|NCT04392583|156176240|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
48542693|NCT03914950|156176242|FG000|Overall Study|Physician Decision|54|||
48542694|NCT01155024|156176243|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
48542695|NCT01155024|156176244|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
48542696|NCT01155024|156176243|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
48542697|NCT01155024|156176244|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
48542698|NCT01155024|156176243|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
48542699|NCT01155024|156176244|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
48542700|NCT01822275|156176245|FG000|Overall Study|Withdrawal by Subject|3|||
48542701|NCT01822275|156176245|FG000|Overall Study|Adverse Event|3|||
48542702|NCT01822275|156176245|FG000|Overall Study|Progression|14|||
48608189|NCT00879658|156423235|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48608190|NCT00879658|156423236|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48608191|NCT00879658|156423237|FG003|Overall Study|Abnormal laboratory value(s)|1|||
48608192|NCT00879658|156423238|FG004|Overall Study|Abnormal laboratory value(s)|0|||
48608193|NCT00879658|156423239|FG005|Overall Study|Abnormal laboratory value(s)|0|||
48608194|NCT00879658|156423240|FG006|Overall Study|Abnormal laboratory value(s)|0|||
48608195|NCT00879658|156423234|FG000|Overall Study|Administrative problems|2|||
48608196|NCT00879658|156423235|FG001|Overall Study|Administrative problems|1|||
48608197|NCT00879658|156423236|FG002|Overall Study|Administrative problems|0|||
48608198|NCT00879658|156423237|FG003|Overall Study|Administrative problems|1|||
48608199|NCT00879658|156423238|FG004|Overall Study|Administrative problems|0|||
48608200|NCT00879658|156423239|FG005|Overall Study|Administrative problems|0|||
48608201|NCT00879658|156423240|FG006|Overall Study|Administrative problems|0|||
48608202|NCT00879658|156423234|FG000|Overall Study|Adverse Event|6|||
48608203|NCT00879658|156423235|FG001|Overall Study|Adverse Event|4|||
48608204|NCT00879658|156423236|FG002|Overall Study|Adverse Event|3|||
48608205|NCT00879658|156423237|FG003|Overall Study|Adverse Event|1|||
48608206|NCT00879658|156423238|FG004|Overall Study|Adverse Event|2|||
48608207|NCT00879658|156423239|FG005|Overall Study|Adverse Event|0|||
48608208|NCT00879658|156423240|FG006|Overall Study|Adverse Event|0|||
48608209|NCT00879658|156423234|FG000|Overall Study|Protocol Violation|1|||
48608210|NCT00879658|156423235|FG001|Overall Study|Protocol Violation|0|||
48542703|NCT01822275|156176245|FG000|Overall Study|Physician Decision|2|||
48542704|NCT01593696|156176246|FG000|Dose Escalation|Progressive Disease|2|||
48542705|NCT01593696|156176247|FG001|Dose Escalation|Progressive Disease|0|||
48542706|NCT01593696|156176248|FG002|Dose Escalation|Progressive Disease|0|||
48608211|NCT00879658|156423236|FG002|Overall Study|Protocol Violation|0|||
48608212|NCT00879658|156423237|FG003|Overall Study|Protocol Violation|0|||
48608213|NCT00879658|156423238|FG004|Overall Study|Protocol Violation|0|||
48608214|NCT00879658|156423239|FG005|Overall Study|Protocol Violation|0|||
48608215|NCT00879658|156423240|FG006|Overall Study|Protocol Violation|0|||
48608216|NCT00879658|156423234|FG000|Overall Study|Withdrawal by Subject|3|||
48608217|NCT00879658|156423235|FG001|Overall Study|Withdrawal by Subject|0|||
48608218|NCT00879658|156423236|FG002|Overall Study|Withdrawal by Subject|2|||
48608219|NCT00879658|156423237|FG003|Overall Study|Withdrawal by Subject|0|||
48608220|NCT00879658|156423238|FG004|Overall Study|Withdrawal by Subject|0|||
48608221|NCT00879658|156423239|FG005|Overall Study|Withdrawal by Subject|1|||
48608222|NCT00879658|156423240|FG006|Overall Study|Withdrawal by Subject|0|||
48608223|NCT00879658|156423234|FG000|Overall Study|Lack of Efficacy|0|||
48608224|NCT00879658|156423235|FG001|Overall Study|Lack of Efficacy|0|||
48542707|NCT01593696|156176249|FG003|Dose Escalation|Progressive Disease|0|||
48542708|NCT01593696|156176246|FG000|Dose Expansion|Fungal infection|0|||
48542709|NCT01593696|156176247|FG001|Dose Expansion|Fungal infection|0|||
48542710|NCT01593696|156176248|FG002|Dose Expansion|Fungal infection|1|||
48608225|NCT00879658|156423236|FG002|Overall Study|Lack of Efficacy|2|||
48608226|NCT00879658|156423237|FG003|Overall Study|Lack of Efficacy|0|||
48608227|NCT00879658|156423238|FG004|Overall Study|Lack of Efficacy|0|||
48608228|NCT00879658|156423239|FG005|Overall Study|Lack of Efficacy|0|||
48608229|NCT00879658|156423240|FG006|Overall Study|Lack of Efficacy|0|||
48608230|NCT00879658|156423234|FG000|Overall Study|misrandomized (never received study med)|0|||
48608231|NCT00879658|156423235|FG001|Overall Study|misrandomized (never received study med)|0|||
48608232|NCT00879658|156423236|FG002|Overall Study|misrandomized (never received study med)|0|||
48608233|NCT00879658|156423237|FG003|Overall Study|misrandomized (never received study med)|1|||
48608234|NCT00879658|156423238|FG004|Overall Study|misrandomized (never received study med)|0|||
48608235|NCT00879658|156423239|FG005|Overall Study|misrandomized (never received study med)|0|||
48608236|NCT00879658|156423240|FG006|Overall Study|misrandomized (never received study med)|0|||
48608237|NCT00833755|156423243|FG000|Overall Study|Physician Decision|4|||
48608238|NCT00833755|156423244|FG001|Overall Study|Physician Decision|4|||
48608239|NCT00833755|156423245|FG002|Overall Study|Physician Decision|2|||
48608240|NCT00833755|156423246|FG003|Overall Study|Physician Decision|6|||
48608241|NCT00833755|156423243|FG000|Overall Study|Subject had scheduling issues|0|||
48608242|NCT00833755|156423244|FG001|Overall Study|Subject had scheduling issues|1|||
48608243|NCT00833755|156423245|FG002|Overall Study|Subject had scheduling issues|0|||
48608244|NCT00833755|156423246|FG003|Overall Study|Subject had scheduling issues|0|||
48608245|NCT00471497|156423247|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
48608246|NCT00471497|156423248|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
48608247|NCT00471497|156423249|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
48608248|NCT00471497|156423247|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
48608249|NCT00471497|156423248|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
48608250|NCT00471497|156423249|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
48608251|NCT00471497|156423247|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
48608252|NCT00471497|156423248|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
48608253|NCT00471497|156423249|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
48608254|NCT00471497|156423247|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
48608255|NCT00471497|156423248|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
48608256|NCT00471497|156423249|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
48608257|NCT00471497|156423247|FG000|Core Treatment Phase|Lost to Follow-up|6|||
48608258|NCT00471497|156423248|FG001|Core Treatment Phase|Lost to Follow-up|6|||
48542711|NCT01593696|156176249|FG003|Dose Expansion|Fungal infection|0|||
48542712|NCT01936623|156176263|FG000|Overall Study|Lost to Follow-up|0|||
48542713|NCT01936623|156176264|FG001|Overall Study|Lost to Follow-up|5|||
48608259|NCT00471497|156423249|FG002|Core Treatment Phase|Lost to Follow-up|3|||
48608260|NCT00471497|156423247|FG000|Core Treatment Phase|Death|3|||
48608261|NCT00471497|156423248|FG001|Core Treatment Phase|Death|9|||
48542714|NCT03201250|156176265|FG000|Overall Study|screen failures|3|||
48608262|NCT00471497|156423249|FG002|Core Treatment Phase|Death|3|||
48608263|NCT00471497|156423247|FG000|Core Treatment Phase|Disease Progression|10|||
48608264|NCT00471497|156423248|FG001|Core Treatment Phase|Disease Progression|2|||
48608265|NCT00471497|156423249|FG002|Core Treatment Phase|Disease Progression|4|||
48608266|NCT00471497|156423247|FG000|Core Treatment Phase|Protocol Violation|6|||
48608267|NCT00471497|156423248|FG001|Core Treatment Phase|Protocol Violation|15|||
48608268|NCT00471497|156423249|FG002|Core Treatment Phase|Protocol Violation|11|||
48542715|NCT03201250|156176266|FG001|Overall Study|screen failures|0|||
48542716|NCT03201250|156176267|FG002|Overall Study|screen failures|0|||
48608269|NCT00471497|156423247|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
48542717|NCT01383135|156176270|FG000|Overall Study|Not Scanned / Imaged|1|||
48542718|NCT01383135|156176271|FG001|Overall Study|Not Scanned / Imaged|0|||
48608270|NCT00471497|156423248|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
48608271|NCT00471497|156423249|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
48608272|NCT00471497|156423247|FG000|Core Treatment Phase|Administrative problems|14|||
48608273|NCT00471497|156423248|FG001|Core Treatment Phase|Administrative problems|14|||
48608274|NCT00471497|156423249|FG002|Core Treatment Phase|Administrative problems|12|||
48608275|NCT00471497|156423247|FG000|Core Treatment Phase|Adverse Event|43|||
48608276|NCT00471497|156423248|FG001|Core Treatment Phase|Adverse Event|53|||
48608277|NCT00471497|156423249|FG002|Core Treatment Phase|Adverse Event|89|||
48608278|NCT00471497|156423247|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
48608279|NCT00471497|156423248|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
48608280|NCT00471497|156423249|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
48608281|NCT00471497|156423247|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
48542719|NCT01383135|156176272|FG002|Overall Study|Not Scanned / Imaged|1|||
48608282|NCT00471497|156423248|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
48608283|NCT00471497|156423249|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
48608284|NCT00471497|156423247|FG000|Extension Phase|Adverse Event|9|||
48608285|NCT00471497|156423248|FG001|Extension Phase|Adverse Event|5|||
48608286|NCT00471497|156423249|FG002|Extension Phase|Adverse Event|1|||
48608287|NCT00471497|156423247|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
48608288|NCT00471497|156423248|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
48608289|NCT00471497|156423249|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
48608290|NCT00471497|156423247|FG000|Extension Phase|Withdrawal by Subject|3|||
48608291|NCT00471497|156423248|FG001|Extension Phase|Withdrawal by Subject|1|||
48608292|NCT00471497|156423249|FG002|Extension Phase|Withdrawal by Subject|0|||
48608293|NCT00471497|156423247|FG000|Extension Phase|Lost to Follow-up|2|||
48608294|NCT00471497|156423248|FG001|Extension Phase|Lost to Follow-up|0|||
48608295|NCT00471497|156423249|FG002|Extension Phase|Lost to Follow-up|0|||
48608296|NCT00471497|156423247|FG000|Extension Phase|Death|1|||
48608297|NCT00471497|156423248|FG001|Extension Phase|Death|0|||
48608298|NCT00471497|156423249|FG002|Extension Phase|Death|0|||
48608299|NCT00471497|156423247|FG000|Extension Phase|Disease progression|2|||
48608300|NCT00471497|156423248|FG001|Extension Phase|Disease progression|0|||
48608301|NCT00471497|156423249|FG002|Extension Phase|Disease progression|0|||
48608302|NCT00471497|156423247|FG000|Extension Phase|Protocol Violation|2|||
48608303|NCT00471497|156423248|FG001|Extension Phase|Protocol Violation|2|||
48608304|NCT00471497|156423249|FG002|Extension Phase|Protocol Violation|0|||
48608305|NCT03506477|156423250|FG000|Overall Study|Withdrawal by Subject|1|||
48608306|NCT03506477|156423251|FG001|Overall Study|Withdrawal by Subject|0|||
48608307|NCT01654276|156423252|FG000|Overall Study|Lack of Efficacy|1|||
48608308|NCT01654276|156423252|FG000|Overall Study|Lost to Follow-up|4|||
48608309|NCT01654276|156423252|FG000|Overall Study|Withdrawal by Subject|1|||
48608310|NCT00909870|156423261|FG000|Overall Study|Adverse Event|13|||
48608311|NCT00909870|156423262|FG001|Overall Study|Adverse Event|7|||
48608312|NCT00909870|156423261|FG000|Overall Study|Protocol Violation|1|||
48608313|NCT00909870|156423262|FG001|Overall Study|Protocol Violation|2|||
48608314|NCT00909870|156423261|FG000|Overall Study|Withdrawal by Subject|5|||
48608315|NCT00909870|156423262|FG001|Overall Study|Withdrawal by Subject|8|||
48608316|NCT00909870|156423261|FG000|Overall Study|Lost to Follow-up|3|||
48608317|NCT00909870|156423262|FG001|Overall Study|Lost to Follow-up|3|||
48608318|NCT00909870|156423261|FG000|Overall Study|Physician Decision|0|||
48608319|NCT00909870|156423262|FG001|Overall Study|Physician Decision|2|||
48542720|NCT01383135|156176273|FG003|Overall Study|Not Scanned / Imaged|0|||
48542721|NCT03167723|156176277|FG000|Overall Study|Protocol Violation|4|||
48542722|NCT03167723|156176278|FG001|Overall Study|Protocol Violation|6|||
48542723|NCT01175811|156176280|FG000|Overall Study|Adverse Event|1|||
48542724|NCT01175811|156176281|FG001|Overall Study|Adverse Event|1|||
48608320|NCT00909870|156423261|FG000|Overall Study|Other|1|||
48608321|NCT00909870|156423262|FG001|Overall Study|Other|5|||
48608322|NCT02078817|156423276|FG000|Overall Study|Withdrawal by Subject|1|||
48608323|NCT03415178|156423281|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
48608324|NCT03415178|156423282|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
48608325|NCT03415178|156423281|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
48608326|NCT03415178|156423282|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
48608327|NCT00666237|156423285|FG000|Overall Study|Death|5|||
48608328|NCT00666237|156423286|FG001|Overall Study|Death|5|||
48608329|NCT00666237|156423285|FG000|Overall Study|Lost to Follow-up|29|||
48542725|NCT01175811|156176280|FG000|Overall Study|Entry criteria not met|3|||
48608330|NCT00666237|156423286|FG001|Overall Study|Lost to Follow-up|25|||
48608331|NCT03736967|156425025|FG000|Overall Study|Withdrawal by Subject|26|||
48608332|NCT03736967|156425026|FG001|Overall Study|Withdrawal by Subject|25|||
48608333|NCT03736967|156425027|FG002|Overall Study|Withdrawal by Subject|23|||
48542726|NCT01175811|156176281|FG001|Overall Study|Entry criteria not met|1|||
48608334|NCT03736967|156425028|FG003|Overall Study|Withdrawal by Subject|26|||
48542727|NCT01175811|156176280|FG000|Overall Study|Lack of Efficacy|1|||
48542728|NCT01175811|156176281|FG001|Overall Study|Lack of Efficacy|0|||
48542729|NCT01175811|156176280|FG000|Overall Study|Lost to Follow-up|3|||
48542730|NCT01175811|156176281|FG001|Overall Study|Lost to Follow-up|2|||
48542731|NCT01175811|156176280|FG000|Overall Study|Physician Decision|1|||
48542732|NCT01175811|156176281|FG001|Overall Study|Physician Decision|1|||
48542733|NCT01175811|156176280|FG000|Overall Study|Protocol Violation|1|||
48542734|NCT01175811|156176281|FG001|Overall Study|Protocol Violation|2|||
48608335|NCT03736967|156425025|FG000|Overall Study|Lost to Follow-up|3|||
48608336|NCT03736967|156425026|FG001|Overall Study|Lost to Follow-up|2|||
48608337|NCT03736967|156425027|FG002|Overall Study|Lost to Follow-up|1|||
48608338|NCT03736967|156425028|FG003|Overall Study|Lost to Follow-up|1|||
48608339|NCT03736967|156425025|FG000|Overall Study|Physician Decision|1|||
48608340|NCT03736967|156425026|FG001|Overall Study|Physician Decision|0|||
48608341|NCT03736967|156425027|FG002|Overall Study|Physician Decision|0|||
48608342|NCT03736967|156425028|FG003|Overall Study|Physician Decision|1|||
48608343|NCT03736967|156425025|FG000|Overall Study|Adverse Event|0|||
48608344|NCT03736967|156425026|FG001|Overall Study|Adverse Event|1|||
48608345|NCT03736967|156425027|FG002|Overall Study|Adverse Event|0|||
48608346|NCT03736967|156425028|FG003|Overall Study|Adverse Event|1|||
48608347|NCT03736967|156425025|FG000|Overall Study|Death|0|||
48608348|NCT03736967|156425026|FG001|Overall Study|Death|0|||
48608349|NCT03736967|156425027|FG002|Overall Study|Death|0|||
48608350|NCT03736967|156425028|FG003|Overall Study|Death|1|||
48608351|NCT03736967|156425025|FG000|Overall Study|Randomized but never treated|1|||
48608352|NCT03736967|156425026|FG001|Overall Study|Randomized but never treated|0|||
48608353|NCT03736967|156425027|FG002|Overall Study|Randomized but never treated|0|||
48608354|NCT03736967|156425028|FG003|Overall Study|Randomized but never treated|0|||
48608355|NCT02369653|156425029|FG000|Overall Study|Lost to Follow-up|0|||
48608356|NCT02369653|156425030|FG001|Overall Study|Lost to Follow-up|1|||
48608357|NCT02369653|156425029|FG000|Overall Study|Administrative reason by sponsor|0|||
48608358|NCT02369653|156425030|FG001|Overall Study|Administrative reason by sponsor|1|||
48608359|NCT02369653|156425029|FG000|Overall Study|Death|1|||
48608360|NCT02369653|156425030|FG001|Overall Study|Death|2|||
48608361|NCT02369653|156425029|FG000|Overall Study|Participant withdrew consent|13|||
48608362|NCT02369653|156425030|FG001|Overall Study|Participant withdrew consent|3|||
48608363|NCT03587636|156425035|FG000|Overall Study|Lost to Follow-up|2|||
48608364|NCT03587636|156425036|FG001|Overall Study|Lost to Follow-up|5|||
48608365|NCT01458587|156425037|FG000|Overall Study|Withdrawal by Subject|1|||
48608366|NCT01458587|156425038|FG001|Overall Study|Withdrawal by Subject|0|||
48542735|NCT01175811|156176280|FG000|Overall Study|Withdrawal by Subject|6|||
48542736|NCT01175811|156176281|FG001|Overall Study|Withdrawal by Subject|7|||
48542737|NCT02575911|156176282|FG000|Overall Study|Lost to Follow-up|1|||
48542738|NCT03052959|156176283|FG000|Overall Study|Lost to Follow-up|4|||
48542739|NCT03052959|156176284|FG001|Overall Study|Lost to Follow-up|5|||
48542740|NCT00423319|156176287|FG000|Overall Study|Death|2|||
48542741|NCT00423319|156176288|FG001|Overall Study|Death|0|||
48542742|NCT00423319|156176287|FG000|Overall Study|Adverse Event|93|||
48542743|NCT00423319|156176288|FG001|Overall Study|Adverse Event|112|||
48542744|NCT00423319|156176287|FG000|Overall Study|Withdrawal by Subject|86|||
48542745|NCT00423319|156176288|FG001|Overall Study|Withdrawal by Subject|99|||
48542746|NCT00423319|156176287|FG000|Overall Study|Lost to Follow-up|4|||
48542747|NCT00423319|156176288|FG001|Overall Study|Lost to Follow-up|3|||
48608367|NCT00726453|156425039|FG000|Primary Enrollment Group|Death|18|||
48608368|NCT00726453|156425040|FG001|Primary Enrollment Group|Death|0|||
48542748|NCT00423319|156176287|FG000|Overall Study|Poor compliance or noncompliance|1|||
48542749|NCT00423319|156176288|FG001|Overall Study|Poor compliance or noncompliance|1|||
48542750|NCT00423319|156176287|FG000|Overall Study|No longer meets study criteria|15|||
48608369|NCT00726453|156425039|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
48608370|NCT00726453|156425040|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
48542751|NCT00423319|156176288|FG001|Overall Study|No longer meets study criteria|15|||
48608371|NCT00726453|156425039|FG000|38 mm Length Group|Death|0|||
48608372|NCT00726453|156425040|FG001|38 mm Length Group|Death|3|||
48608373|NCT00977197|156425041|FG000|Overall Study|Withdrawal by Subject|3|||
48608374|NCT00977197|156425042|FG001|Overall Study|Withdrawal by Subject|4|||
48542752|NCT00423319|156176287|FG000|Overall Study|Other|23|||
48542753|NCT00423319|156176288|FG001|Overall Study|Other|22|||
48542754|NCT01763684|156176289|FG000|Overall Study|Study terminated early due to low enrollment|126|||
48542755|NCT01763684|156176290|FG001|Overall Study|Study terminated early due to low enrollment|127|||
48608375|NCT00977197|156425041|FG000|Overall Study|Adverse Event|3|||
48608376|NCT00977197|156425042|FG001|Overall Study|Adverse Event|1|||
48608377|NCT00977197|156425041|FG000|Overall Study|Lack of Efficacy|1|||
48608378|NCT00977197|156425042|FG001|Overall Study|Lack of Efficacy|0|||
48608379|NCT00977197|156425041|FG000|Overall Study|Lost to Follow-up|1|||
48608380|NCT00977197|156425042|FG001|Overall Study|Lost to Follow-up|3|||
48542756|NCT01763684|156176289|FG000|Overall Study|Study surgery not performed|7|||
48608381|NCT00977197|156425041|FG000|Overall Study|Nonadherence|1|||
48608382|NCT00977197|156425042|FG001|Overall Study|Nonadherence|1|||
48608383|NCT00551369|156425043|FG000|Overall Study|Protocol Violation|5|||
48608384|NCT00551369|156425043|FG000|Overall Study|Withdrawal by Subject|1|||
48608385|NCT00551369|156425043|FG000|Overall Study|Not treated per protocol and re|1|||
48608386|NCT02349386|156425047|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
48608387|NCT02349386|156425048|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
48608388|NCT02349386|156425049|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
48608389|NCT02349386|156425050|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
48608390|NCT02349386|156425047|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
48608391|NCT02349386|156425048|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
48608392|NCT02349386|156425049|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
48608393|NCT02349386|156425050|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
48608394|NCT02349386|156425047|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
48608395|NCT02349386|156425048|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
48542757|NCT01763684|156176290|FG001|Overall Study|Study surgery not performed|6|||
48542758|NCT01584843|156176291|FG000|First Treatment Period|Adverse Event|0|||
48542759|NCT01584843|156176292|FG001|First Treatment Period|Adverse Event|0|||
48542760|NCT01584843|156176293|FG002|First Treatment Period|Adverse Event|1|||
48542761|NCT01584843|156176294|FG003|First Treatment Period|Adverse Event|0|||
48542762|NCT01584843|156176295|FG004|First Treatment Period|Adverse Event|0|||
48542763|NCT01584843|156176296|FG005|First Treatment Period|Adverse Event|0|||
48608396|NCT02349386|156425049|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
48608397|NCT02349386|156425050|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
48608398|NCT02349386|156425047|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
48608399|NCT02349386|156425048|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
48608400|NCT02349386|156425049|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
48608401|NCT02349386|156425050|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
48608402|NCT02349386|156425047|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
48608403|NCT02349386|156425048|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
48608404|NCT02349386|156425049|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
48608405|NCT02349386|156425050|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
48608406|NCT02349386|156425047|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
48608407|NCT02349386|156425048|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
48608408|NCT02349386|156425049|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
48608409|NCT02349386|156425050|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
48608410|NCT01496456|156425051|FG000|Overall Study|Protocol Violation|1|||
48542764|NCT01584843|156176291|FG000|First Treatment Period|Protocol Violation|0|||
48542765|NCT01584843|156176292|FG001|First Treatment Period|Protocol Violation|0|||
48542766|NCT01584843|156176293|FG002|First Treatment Period|Protocol Violation|0|||
48542767|NCT01584843|156176294|FG003|First Treatment Period|Protocol Violation|0|||
48542768|NCT01584843|156176295|FG004|First Treatment Period|Protocol Violation|0|||
48542769|NCT01584843|156176296|FG005|First Treatment Period|Protocol Violation|1|||
48542770|NCT01584843|156176291|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
48542771|NCT01584843|156176292|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
48542772|NCT01584843|156176293|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
48542773|NCT01584843|156176294|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
48542774|NCT01584843|156176295|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
48542775|NCT01584843|156176296|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
48542776|NCT01584843|156176291|FG000|Second Treatment Period|Withdrawal by Subject|0|||
48542777|NCT01584843|156176292|FG001|Second Treatment Period|Withdrawal by Subject|0|||
48542778|NCT01584843|156176293|FG002|Second Treatment Period|Withdrawal by Subject|0|||
48542779|NCT01584843|156176294|FG003|Second Treatment Period|Withdrawal by Subject|0|||
48542780|NCT01584843|156176295|FG004|Second Treatment Period|Withdrawal by Subject|0|||
48542781|NCT01584843|156176296|FG005|Second Treatment Period|Withdrawal by Subject|1|||
48542782|NCT02987959|156176299|FG000|Overall Study|Grantor stopped supply of drugs|6|||
48542783|NCT02639052|156176300|FG000|Overall Study|Lost to Follow-up|1|||
48542784|NCT04126213|156176308|FG000|Overall Study|Lost to Follow-up|9|||
48542785|NCT04126213|156176309|FG001|Overall Study|Lost to Follow-up|1|||
48542786|NCT04126213|156176310|FG002|Overall Study|Lost to Follow-up|5|||
48542787|NCT04126213|156176311|FG003|Overall Study|Lost to Follow-up|10|||
48608411|NCT01496456|156425051|FG000|Overall Study|Lost to Follow-up|7|||
48608412|NCT03451071|156425058|FG000|First Vaccine|Withdrawal by Subject|1|||
48608413|NCT03451071|156425058|FG000|Second Vaccine|Lost to Follow-up|19|||
48608414|NCT03451071|156425058|FG000|Third Vaccine|Lost to Follow-up|22|||
48608415|NCT03451071|156425058|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
48542788|NCT04126213|156176312|FG004|Overall Study|Lost to Follow-up|4|||
48542789|NCT04126213|156176313|FG005|Overall Study|Lost to Follow-up|7|||
48608416|NCT00297167|156425059|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
48608417|NCT00297167|156425060|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
48608418|NCT00297167|156425061|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
48608419|NCT00297167|156425059|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
48608420|NCT00297167|156425060|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
48608421|NCT00297167|156425061|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
48608422|NCT03834350|156425062|FG000|Overall Study|Withdrawal by Subject|1|||
48608423|NCT01603277|156425063|FG000|Overall Study|Adverse Event|1|||
48608424|NCT01603277|156425064|FG001|Overall Study|Adverse Event|2|||
48608425|NCT01603277|156425063|FG000|Overall Study|Physician Decision|0|||
48608426|NCT01603277|156425064|FG001|Overall Study|Physician Decision|1|||
48608427|NCT01603277|156425063|FG000|Overall Study|Protocol Violation|6|||
48608428|NCT01603277|156425064|FG001|Overall Study|Protocol Violation|10|||
48608429|NCT01603277|156425063|FG000|Overall Study|Withdrawal by Subject|5|||
48608430|NCT01603277|156425064|FG001|Overall Study|Withdrawal by Subject|4|||
48608431|NCT01603277|156425063|FG000|Overall Study|Non-Compliance|2|||
48608432|NCT01603277|156425064|FG001|Overall Study|Non-Compliance|1|||
48608433|NCT01186770|156425065|FG000|Overall Study|Ineligibility|0|||
48608434|NCT01186770|156425066|FG001|Overall Study|Ineligibility|0|||
48608435|NCT01186770|156425067|FG002|Overall Study|Ineligibility|2|||
48608436|NCT01186770|156425068|FG003|Overall Study|Ineligibility|0|||
48608437|NCT01186770|156425065|FG000|Overall Study|Protocol Violation|7|||
48608438|NCT01186770|156425066|FG001|Overall Study|Protocol Violation|9|||
48608439|NCT01186770|156425067|FG002|Overall Study|Protocol Violation|12|||
48608440|NCT01186770|156425068|FG003|Overall Study|Protocol Violation|14|||
48542790|NCT04126213|156176308|FG000|Overall Study|Withdrawal by Subject|3|||
48542791|NCT04126213|156176309|FG001|Overall Study|Withdrawal by Subject|2|||
48542792|NCT04126213|156176310|FG002|Overall Study|Withdrawal by Subject|1|||
48542793|NCT04126213|156176311|FG003|Overall Study|Withdrawal by Subject|1|||
48542794|NCT04126213|156176312|FG004|Overall Study|Withdrawal by Subject|1|||
48542795|NCT04126213|156176313|FG005|Overall Study|Withdrawal by Subject|1|||
48542796|NCT04126213|156176308|FG000|Overall Study|Other|0|||
48542797|NCT04126213|156176309|FG001|Overall Study|Other|0|||
48542798|NCT04126213|156176310|FG002|Overall Study|Other|2|||
48542799|NCT04126213|156176311|FG003|Overall Study|Other|2|||
48542800|NCT04126213|156176312|FG004|Overall Study|Other|0|||
48542801|NCT04126213|156176313|FG005|Overall Study|Other|1|||
48608441|NCT01186770|156425065|FG000|Overall Study|Adverse Event|2|||
48608442|NCT01186770|156425066|FG001|Overall Study|Adverse Event|9|||
48542802|NCT04126213|156176308|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48542803|NCT04126213|156176309|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
48542804|NCT04126213|156176310|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48542805|NCT04126213|156176311|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48542806|NCT04126213|156176312|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48542807|NCT04126213|156176313|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
48542808|NCT02302859|156176317|FG000|Overall Study|Lost Phone|1|||
48542809|NCT02302859|156176318|FG001|Overall Study|Lost Phone|1|||
48542810|NCT02302859|156176317|FG000|Overall Study|Withdrawal by Subject|0|||
48542811|NCT02302859|156176318|FG001|Overall Study|Withdrawal by Subject|1|||
48542812|NCT02853370|156176319|FG000|Overall Study|Physician Decision|1|||
48542813|NCT02853370|156176319|FG000|Overall Study|Lack of Efficacy|2|||
48542814|NCT02853370|156176319|FG000|Overall Study|Death|1|||
48542815|NCT02853370|156176319|FG000|Overall Study|Adverse Event|4|||
48608443|NCT01186770|156425067|FG002|Overall Study|Adverse Event|7|||
48608444|NCT01186770|156425068|FG003|Overall Study|Adverse Event|9|||
48608445|NCT01186770|156425065|FG000|Overall Study|Withdrawal by Subject|15|||
48608446|NCT01186770|156425066|FG001|Overall Study|Withdrawal by Subject|13|||
48608447|NCT01186770|156425067|FG002|Overall Study|Withdrawal by Subject|11|||
48608448|NCT01186770|156425068|FG003|Overall Study|Withdrawal by Subject|17|||
48608449|NCT01186770|156425065|FG000|Overall Study|Lost to Follow-up|10|||
48608450|NCT01186770|156425066|FG001|Overall Study|Lost to Follow-up|6|||
48608451|NCT01186770|156425067|FG002|Overall Study|Lost to Follow-up|14|||
48608452|NCT01186770|156425068|FG003|Overall Study|Lost to Follow-up|9|||
48608453|NCT01186770|156425065|FG000|Overall Study|Insufficient response to treatment|7|||
48608454|NCT01186770|156425066|FG001|Overall Study|Insufficient response to treatment|8|||
48608455|NCT01186770|156425067|FG002|Overall Study|Insufficient response to treatment|5|||
48608456|NCT01186770|156425068|FG003|Overall Study|Insufficient response to treatment|7|||
48608457|NCT01186770|156425065|FG000|Overall Study|Other than specified|0|||
48608458|NCT01186770|156425066|FG001|Overall Study|Other than specified|1|||
48608459|NCT01186770|156425067|FG002|Overall Study|Other than specified|1|||
48608460|NCT01186770|156425068|FG003|Overall Study|Other than specified|2|||
48608461|NCT01900444|156425072|FG000|Overall Study|Protocol Violation|2|||
48608462|NCT01900444|156425072|FG000|Overall Study|Lost to Follow-up|1|||
48608463|NCT00630916|156425073|FG000|Overall Study|Death|110|||
48542816|NCT02853370|156176319|FG000|Overall Study|Withdrawal by Subject|3|||
48542817|NCT03276221|156176320|FG000|Overall Study|Lost to Follow-up|6|||
48542818|NCT03276221|156176321|FG001|Overall Study|Lost to Follow-up|2|||
48608464|NCT00630916|156425073|FG000|Overall Study|Explant|8|||
48608465|NCT00630916|156425073|FG000|Overall Study|Lost to Follow-up|5|||
48542819|NCT03276221|156176322|FG002|Overall Study|Lost to Follow-up|0|||
48542820|NCT03276221|156176320|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
48608466|NCT00630916|156425073|FG000|Overall Study|Withdrawal by Subject|30|||
48608467|NCT00630916|156425073|FG000|Overall Study|Protocol Violation|7|||
48608468|NCT00630916|156425073|FG000|Overall Study|Physician Decision|47|||
48608469|NCT00630916|156425073|FG000|Overall Study|Lack of Efficacy|3|||
48542821|NCT03276221|156176321|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
48542822|NCT03276221|156176322|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
48542823|NCT01102374|156176323|FG000|Overall Study|Death|9|||
48542824|NCT01102374|156176324|FG001|Overall Study|Death|13|||
48542825|NCT01102374|156176323|FG000|Overall Study|Lost to Follow-up|7|||
48542826|NCT01102374|156176324|FG001|Overall Study|Lost to Follow-up|6|||
48542827|NCT00418821|156176326|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
48542828|NCT02582866|156176328|FG000|Overall Study|Death|1|||
48542829|NCT02582866|156176328|FG000|Overall Study|Lack of Efficacy|2|||
48542830|NCT02582866|156176328|FG000|Overall Study|Lost to Follow-up|2|||
48542831|NCT02582866|156176328|FG000|Overall Study|Withdrawal by Subject|7|||
48542832|NCT02582866|156176328|FG000|Overall Study|Investigator decision|5|||
48542833|NCT02582866|156176328|FG000|Overall Study|Participant wants to get pregnant|1|||
48542834|NCT02582866|156176328|FG000|Overall Study|Pregnancy|2|||
48542835|NCT02582866|156176328|FG000|Overall Study|Sponsor decision|1|||
48542836|NCT02582866|156176328|FG000|Overall Study|Withdrawal due to personal reasons|1|||
48542837|NCT02071849|156176329|FG000|6-month Primary Endpoint|Did not receive device|4|||
48542838|NCT02071849|156176329|FG000|6-month Primary Endpoint|Adverse Event|1|||
48542839|NCT02071849|156176329|FG000|2-year Extended Follow-up|Adverse Event|1|||
48542840|NCT00985712|156176339|FG000|Overall Study|Adverse Event|0|||
48542841|NCT00985712|156176340|FG001|Overall Study|Adverse Event|1|||
48542842|NCT00985712|156176339|FG000|Overall Study|Lost to Follow-up|2|||
48542843|NCT00985712|156176340|FG001|Overall Study|Lost to Follow-up|2|||
48542844|NCT00985712|156176339|FG000|Overall Study|Protocol Violation|0|||
48542845|NCT00985712|156176340|FG001|Overall Study|Protocol Violation|1|||
48542846|NCT00985712|156176339|FG000|Overall Study|Withdrawal by Subject|4|||
48542847|NCT00985712|156176340|FG001|Overall Study|Withdrawal by Subject|1|||
48542848|NCT00985712|156176339|FG000|Overall Study|Sponsor decision|0|||
48542849|NCT00985712|156176340|FG001|Overall Study|Sponsor decision|2|||
48542850|NCT00719849|156176341|FG000|Overall Study|Death|0|||
48542851|NCT00719849|156176342|FG001|Overall Study|Death|1|||
48542852|NCT04495283|156176343|FG000|Overall Study|Physician Decision|0|||
48542853|NCT04495283|156176344|FG001|Overall Study|Physician Decision|0|||
48542854|NCT04495283|156176345|FG002|Overall Study|Physician Decision|1|||
48542855|NCT04495283|156176343|FG000|Overall Study|Withdrawal by Subject|0|||
48542856|NCT04495283|156176344|FG001|Overall Study|Withdrawal by Subject|1|||
48542857|NCT04495283|156176345|FG002|Overall Study|Withdrawal by Subject|1|||
48542858|NCT04495283|156176343|FG000|Overall Study|Other|1|||
48542859|NCT04495283|156176344|FG001|Overall Study|Other|0|||
48542860|NCT04495283|156176345|FG002|Overall Study|Other|1|||
48542861|NCT01287039|156177610|FG000|Overall Study|Noncompliance with study procedures|0|||
48542862|NCT01287039|156177611|FG001|Overall Study|Noncompliance with study procedures|1|||
48542863|NCT01287039|156177610|FG000|Overall Study|Change of location/residence|0|||
48542864|NCT01287039|156177611|FG001|Overall Study|Change of location/residence|3|||
48542865|NCT01287039|156177610|FG000|Overall Study|Elective surgery|0|||
48542866|NCT01287039|156177611|FG001|Overall Study|Elective surgery|1|||
48608470|NCT02147626|156425077|FG000|Overall Study|Lost to Follow-up|4|||
48608471|NCT02147626|156425078|FG001|Overall Study|Lost to Follow-up|4|||
48608472|NCT02147626|156425077|FG000|Overall Study|Pregnancy|1|||
48608473|NCT02147626|156425078|FG001|Overall Study|Pregnancy|2|||
48608474|NCT02147626|156425077|FG000|Overall Study|Withdrawal by Subject|0|||
48608475|NCT02147626|156425078|FG001|Overall Study|Withdrawal by Subject|1|||
48608476|NCT04009837|156425081|FG000|Overall Study|Withdrawal by Subject|5|||
48608477|NCT04009837|156425082|FG001|Overall Study|Withdrawal by Subject|4|||
48608478|NCT04009837|156425081|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
48608479|NCT04009837|156425082|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
48608480|NCT01838876|156425085|FG000|Overall Study|Adverse Event|49|||
48608481|NCT01838876|156425085|FG000|Overall Study|Insufficient Therapeutic Response|10|||
48608482|NCT01838876|156425085|FG000|Overall Study|Protocol Violation|34|||
48608483|NCT01838876|156425085|FG000|Overall Study|Withdrawal of Consent|33|||
48608484|NCT01838876|156425085|FG000|Overall Study|Lost to Follow-up|21|||
48608485|NCT01838876|156425085|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
48608486|NCT01838876|156425085|FG000|Overall Study|Reason not Specified|7|||
48608487|NCT01838876|156425085|FG000|Overall Study|Did not meet eligibility criteria|78|||
48608488|NCT03101020|156425088|FG000|Overall Study|Lack of time to participate|1|||
48608489|NCT03101020|156425089|FG001|Overall Study|Lack of time to participate|0|||
48608490|NCT03101020|156425088|FG000|Overall Study|Ran over by a car|0|||
48608491|NCT03101020|156425089|FG001|Overall Study|Ran over by a car|1|||
48608492|NCT03101020|156425088|FG000|Overall Study|Withdrawal by Subject|0|||
48608493|NCT03101020|156425089|FG001|Overall Study|Withdrawal by Subject|2|||
48608494|NCT05412134|156425091|FG000|Overall Study|Lost to Follow-up|2|||
48608495|NCT05412134|156425092|FG001|Overall Study|Lost to Follow-up|0|||
48608496|NCT01192815|156425097|FG000|Overall Study|Withdrawal by Subject|1|||
48608497|NCT01192815|156425097|FG000|Overall Study|Lack of Efficacy|1|||
48608498|NCT03444584|156425101|FG000|Overall Study|Withdrawal by Subject|0|||
48608499|NCT03444584|156425102|FG001|Overall Study|Withdrawal by Subject|1|||
48608500|NCT03444584|156425101|FG000|Overall Study|Other|0|||
48608501|NCT03444584|156425102|FG001|Overall Study|Other|1|||
48608502|NCT02592824|156425108|FG000|Overall Study|Protocol Violation|5|||
48608503|NCT02592824|156425109|FG001|Overall Study|Protocol Violation|3|||
48608504|NCT02592824|156425108|FG000|Overall Study|Lost to Follow-up|2|||
48608505|NCT02592824|156425109|FG001|Overall Study|Lost to Follow-up|1|||
48608506|NCT01142336|156425110|FG000|Overall Study|Adverse Event|1|||
48608507|NCT01142336|156425111|FG001|Overall Study|Adverse Event|1|||
48608508|NCT01142336|156425110|FG000|Overall Study|Lost to Follow-up|0|||
48608509|NCT01142336|156425111|FG001|Overall Study|Lost to Follow-up|1|||
48608510|NCT01704261|156425112|FG000|Overall Study|Withdrawal by Subject|12|||
48608511|NCT01704261|156425113|FG001|Overall Study|Withdrawal by Subject|15|||
48608512|NCT01704261|156425112|FG000|Overall Study|Lost to Follow-up|1|||
48608513|NCT01704261|156425113|FG001|Overall Study|Lost to Follow-up|0|||
48608514|NCT00869960|156425114|FG000|Overall Study|Lost to Follow-up|2|||
48608515|NCT02153918|156425119|FG000|Overall Study|Refused further treatment|1|||
48608516|NCT02783911|156425122|FG000|Overall Study|Lost to Follow-up|3|||
48608517|NCT02783911|156425123|FG001|Overall Study|Lost to Follow-up|32|||
48608518|NCT01218802|156425127|FG000|Overall Study|Lost to Follow-up|5|||
48608519|NCT01218802|156425128|FG001|Overall Study|Lost to Follow-up|6|||
48608520|NCT01218802|156425127|FG000|Overall Study|Withdrawal by Subject|3|||
48608521|NCT01218802|156425128|FG001|Overall Study|Withdrawal by Subject|10|||
48608522|NCT01218802|156425127|FG000|Overall Study|Adverse Event|0|||
48608523|NCT01218802|156425128|FG001|Overall Study|Adverse Event|2|||
48608524|NCT01218802|156425127|FG000|Overall Study|Incarcerated|2|||
48608525|NCT01218802|156425128|FG001|Overall Study|Incarcerated|0|||
48608526|NCT01123655|156425129|FG000|Overall Study|Medication for RA had to be changed|1|||
48542867|NCT01287039|156177610|FG000|Overall Study|Protocol Violation|2|||
48542868|NCT01287039|156177611|FG001|Overall Study|Protocol Violation|3|||
48542869|NCT01287039|156177610|FG000|Overall Study|Excluded medication taken|1|||
48542870|NCT01287039|156177611|FG001|Overall Study|Excluded medication taken|0|||
48542871|NCT01287039|156177610|FG000|Overall Study|Noncompliance with study medication|0|||
48542872|NCT01287039|156177611|FG001|Overall Study|Noncompliance with study medication|1|||
48542873|NCT01287039|156177610|FG000|Overall Study|Problem with travel|0|||
48542874|NCT01287039|156177611|FG001|Overall Study|Problem with travel|1|||
48542875|NCT01287039|156177610|FG000|Overall Study|Death|1|||
48542876|NCT01287039|156177611|FG001|Overall Study|Death|0|||
48542877|NCT01287039|156177610|FG000|Overall Study|Change of residence|1|||
48542878|NCT01287039|156177611|FG001|Overall Study|Change of residence|0|||
48542879|NCT01287039|156177610|FG000|Overall Study|Adverse Event|7|||
48542880|NCT01287039|156177611|FG001|Overall Study|Adverse Event|4|||
48608527|NCT01123655|156425130|FG001|Overall Study|Medication for RA had to be changed|0|||
48608528|NCT01123655|156425131|FG002|Overall Study|Medication for RA had to be changed|0|||
48608529|NCT01123655|156425129|FG000|Overall Study|new illness|0|||
48608530|NCT01123655|156425130|FG001|Overall Study|new illness|1|||
48608531|NCT01123655|156425131|FG002|Overall Study|new illness|0|||
48608532|NCT01123655|156425129|FG000|Overall Study|began prohibitive drug|0|||
48608533|NCT01123655|156425130|FG001|Overall Study|began prohibitive drug|0|||
48542881|NCT01287039|156177610|FG000|Overall Study|Withdrawal by Subject|14|||
48542882|NCT01287039|156177611|FG001|Overall Study|Withdrawal by Subject|11|||
48542883|NCT01287039|156177610|FG000|Overall Study|Lost to Follow-up|3|||
48542884|NCT01287039|156177611|FG001|Overall Study|Lost to Follow-up|2|||
48542885|NCT03853148|156177618|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
48542886|NCT03853148|156177619|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
48542887|NCT03853148|156177620|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
48608534|NCT01123655|156425131|FG002|Overall Study|began prohibitive drug|1|||
48608535|NCT00062166|156425132|FG000|Overall Study|Withdrawal by Subject|6|||
48608536|NCT00262119|156425134|FG000|Overall Study|Lost to Follow-up|38|||
48608537|NCT00262119|156425135|FG001|Overall Study|Lost to Follow-up|51|||
48608538|NCT00262119|156425136|FG002|Overall Study|Lost to Follow-up|42|||
48608539|NCT00262119|156425134|FG000|Overall Study|Death|20|||
48608540|NCT00262119|156425135|FG001|Overall Study|Death|19|||
48608541|NCT00262119|156425136|FG002|Overall Study|Death|16|||
48608542|NCT04682301|156425137|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
48542888|NCT03853148|156177621|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
48542889|NCT02119286|156177622|FG000|Overall Study|Adverse Event|9|||
48542890|NCT02119286|156177623|FG001|Overall Study|Adverse Event|7|||
48542891|NCT02119286|156177624|FG002|Overall Study|Adverse Event|2|||
48542892|NCT02119286|156177622|FG000|Overall Study|Lack of Efficacy|11|||
48542893|NCT02119286|156177623|FG001|Overall Study|Lack of Efficacy|3|||
48542894|NCT02119286|156177624|FG002|Overall Study|Lack of Efficacy|4|||
48542895|NCT02119286|156177622|FG000|Overall Study|Lost to Follow-up|2|||
48542896|NCT02119286|156177623|FG001|Overall Study|Lost to Follow-up|0|||
48542897|NCT02119286|156177624|FG002|Overall Study|Lost to Follow-up|1|||
48542898|NCT02119286|156177622|FG000|Overall Study|Withdrawal by Subject|4|||
48542899|NCT02119286|156177623|FG001|Overall Study|Withdrawal by Subject|1|||
48542900|NCT02119286|156177624|FG002|Overall Study|Withdrawal by Subject|0|||
48542901|NCT00658658|156177625|FG000|Overall Study|Withdrawal by Subject|0|||
48542902|NCT00658658|156177626|FG001|Overall Study|Withdrawal by Subject|1|||
48542903|NCT00658658|156177627|FG002|Overall Study|Withdrawal by Subject|0|||
48542904|NCT00658658|156177628|FG003|Overall Study|Withdrawal by Subject|0|||
48542905|NCT00658658|156177629|FG004|Overall Study|Withdrawal by Subject|0|||
48542906|NCT00658658|156177625|FG000|Overall Study|Death|4|||
48542907|NCT00658658|156177626|FG001|Overall Study|Death|0|||
48542908|NCT00658658|156177627|FG002|Overall Study|Death|0|||
48542909|NCT00658658|156177628|FG003|Overall Study|Death|1|||
48542910|NCT00658658|156177629|FG004|Overall Study|Death|1|||
48542911|NCT00658658|156177625|FG000|Overall Study|Disease Progression|0|||
48542912|NCT00658658|156177626|FG001|Overall Study|Disease Progression|1|||
48542913|NCT00658658|156177627|FG002|Overall Study|Disease Progression|0|||
48542914|NCT00658658|156177628|FG003|Overall Study|Disease Progression|1|||
48542915|NCT00658658|156177629|FG004|Overall Study|Disease Progression|3|||
48542916|NCT00658658|156177625|FG000|Overall Study|Protocol-specified Criteria|1|||
48542917|NCT00658658|156177626|FG001|Overall Study|Protocol-specified Criteria|0|||
48542918|NCT00658658|156177627|FG002|Overall Study|Protocol-specified Criteria|0|||
48542919|NCT00658658|156177628|FG003|Overall Study|Protocol-specified Criteria|0|||
48542920|NCT00658658|156177629|FG004|Overall Study|Protocol-specified Criteria|0|||
48542921|NCT00658658|156177625|FG000|Overall Study|Other|0|||
48542922|NCT00658658|156177626|FG001|Overall Study|Other|0|||
48542923|NCT00658658|156177627|FG002|Overall Study|Other|0|||
48542924|NCT00658658|156177628|FG003|Overall Study|Other|0|||
48542925|NCT00658658|156177629|FG004|Overall Study|Other|1|||
48608543|NCT04682301|156425137|FG000|Overall Study|Death|2|||
48542926|NCT03247517|156177635|FG000|Overall Study|Adverse Event|0|||
48542927|NCT03247517|156177636|FG001|Overall Study|Adverse Event|4|||
48542928|NCT03247517|156177637|FG002|Overall Study|Adverse Event|2|||
48542929|NCT03247517|156177635|FG000|Overall Study|Lost to Follow-up|2|||
48542930|NCT03247517|156177636|FG001|Overall Study|Lost to Follow-up|6|||
48608544|NCT00392223|156425138|FG000|Overall Study|Adverse Event|5|||
48608545|NCT00392223|156425139|FG001|Overall Study|Adverse Event|4|||
48608546|NCT00392223|156425138|FG000|Overall Study|Lost to Follow-up|1|||
48608547|NCT00392223|156425139|FG001|Overall Study|Lost to Follow-up|4|||
48608548|NCT00392223|156425138|FG000|Overall Study|Protocol Violation|0|||
48608549|NCT00392223|156425139|FG001|Overall Study|Protocol Violation|3|||
48608550|NCT00392223|156425138|FG000|Overall Study|Withdrawal by Subject|3|||
48608551|NCT00392223|156425139|FG001|Overall Study|Withdrawal by Subject|2|||
48608552|NCT03462680|156425140|FG000|Overall Study|Withdrawal by Subject|3|||
48608553|NCT03462680|156425141|FG001|Overall Study|Withdrawal by Subject|5|||
48608554|NCT01832766|156425144|FG000|Washout|Lost to Follow-up|0|||
48608555|NCT01832766|156425145|FG001|Washout|Lost to Follow-up|1|||
48608556|NCT01192178|156425146|FG000|Overall Study|Withdrawal by Subject|6|||
48608557|NCT01192178|156425147|FG001|Overall Study|Withdrawal by Subject|10|||
48608558|NCT01192178|156425146|FG000|Overall Study|Protocol Violation|10|||
48608559|NCT01192178|156425147|FG001|Overall Study|Protocol Violation|3|||
48608560|NCT01192178|156425146|FG000|Overall Study|Physician Decision|2|||
48608561|NCT01192178|156425147|FG001|Overall Study|Physician Decision|4|||
48608562|NCT01192178|156425146|FG000|Overall Study|Lost to Follow-up|3|||
48608563|NCT01192178|156425147|FG001|Overall Study|Lost to Follow-up|3|||
48608564|NCT01192178|156425146|FG000|Overall Study|Adverse Event|2|||
48608565|NCT01192178|156425147|FG001|Overall Study|Adverse Event|1|||
48608566|NCT01192178|156425146|FG000|Overall Study|Lack of Efficacy|1|||
48608567|NCT01192178|156425147|FG001|Overall Study|Lack of Efficacy|2|||
48608568|NCT01155570|156425148|FG000|Overall Study|Adverse Event|39|||
48608569|NCT01155570|156425148|FG000|Overall Study|Lack of Efficacy|46|||
48608570|NCT01155570|156425148|FG000|Overall Study|Participant's Economic Reasons|17|||
48608571|NCT01155570|156425148|FG000|Overall Study|No Hospital Visits|7|||
48608572|NCT01155570|156425148|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
48608573|NCT01155570|156425148|FG000|Overall Study|Adverse Event + Other Reasons|7|||
48608574|NCT01155570|156425148|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
48608575|NCT01155570|156425148|FG000|Overall Study|Other Reasons|23|||
48608576|NCT02324153|156425149|FG000|Overall Study|Withdrawal by Subject|4|||
48608577|NCT02324153|156425150|FG001|Overall Study|Withdrawal by Subject|1|||
48608578|NCT02324153|156425149|FG000|Overall Study|Surgery postponed after randomization|3|||
48608579|NCT02324153|156425150|FG001|Overall Study|Surgery postponed after randomization|0|||
48608580|NCT02324153|156425149|FG000|Overall Study|Developed delirium preoperatively|1|||
48608581|NCT02324153|156425150|FG001|Overall Study|Developed delirium preoperatively|0|||
48608582|NCT00700635|156425153|FG000|Overall Study|Adverse Event|1|||
48608583|NCT00700635|156425154|FG001|Overall Study|Adverse Event|0|||
48608584|NCT00700635|156425155|FG002|Overall Study|Adverse Event|0|||
48608585|NCT00700635|156425153|FG000|Overall Study|Lost to Follow-up|1|||
48608586|NCT00700635|156425154|FG001|Overall Study|Lost to Follow-up|3|||
48608587|NCT00700635|156425155|FG002|Overall Study|Lost to Follow-up|0|||
48608588|NCT00700635|156425153|FG000|Overall Study|Protocol Violation|2|||
48608589|NCT00700635|156425154|FG001|Overall Study|Protocol Violation|2|||
48608590|NCT00700635|156425155|FG002|Overall Study|Protocol Violation|0|||
48608591|NCT00700635|156425153|FG000|Overall Study|Withdrawal by Subject|7|||
48608592|NCT00700635|156425154|FG001|Overall Study|Withdrawal by Subject|3|||
48608593|NCT00700635|156425155|FG002|Overall Study|Withdrawal by Subject|1|||
48608594|NCT02394756|156425156|FG000|Period 1|Lens Discomfort|0|||
48608595|NCT02394756|156425157|FG001|Period 1|Lens Discomfort|0|||
48608596|NCT02394756|156425158|FG002|Period 1|Lens Discomfort|0|||
48608597|NCT02394756|156425159|FG003|Period 1|Lens Discomfort|0|||
48608598|NCT02394756|156425160|FG004|Period 1|Lens Discomfort|0|||
48608599|NCT02394756|156425161|FG005|Period 1|Lens Discomfort|1|||
48608600|NCT02394756|156425156|FG000|Period 1|Withdrawal by Subject|0|||
48608601|NCT02394756|156425157|FG001|Period 1|Withdrawal by Subject|1|||
48608602|NCT02394756|156425158|FG002|Period 1|Withdrawal by Subject|1|||
48608603|NCT02394756|156425159|FG003|Period 1|Withdrawal by Subject|1|||
48608604|NCT02394756|156425160|FG004|Period 1|Withdrawal by Subject|0|||
48608605|NCT02394756|156425161|FG005|Period 1|Withdrawal by Subject|0|||
48608606|NCT02394756|156425156|FG000|Period 2|Unsatisfactory Visual Response|0|||
48608607|NCT02394756|156425157|FG001|Period 2|Unsatisfactory Visual Response|0|||
48608608|NCT02394756|156425158|FG002|Period 2|Unsatisfactory Visual Response|0|||
48608609|NCT02394756|156425159|FG003|Period 2|Unsatisfactory Visual Response|0|||
48608610|NCT02394756|156425160|FG004|Period 2|Unsatisfactory Visual Response|1|||
48608611|NCT02394756|156425161|FG005|Period 2|Unsatisfactory Visual Response|0|||
48608612|NCT01525589|156425162|FG000|Overall Study|Non-treatment-related AE|1|||
48608613|NCT01525589|156425163|FG001|Overall Study|Non-treatment-related AE|0|||
48608614|NCT01525589|156425164|FG002|Overall Study|Non-treatment-related AE|0|||
48608615|NCT01525589|156425162|FG000|Overall Study|Progressive disease|48|||
48608616|NCT01525589|156425163|FG001|Overall Study|Progressive disease|15|||
48608617|NCT01525589|156425164|FG002|Overall Study|Progressive disease|29|||
48608618|NCT01525589|156425162|FG000|Overall Study|Never treated|2|||
48608619|NCT01525589|156425163|FG001|Overall Study|Never treated|0|||
48608620|NCT01525589|156425164|FG002|Overall Study|Never treated|0|||
48608621|NCT01525589|156425162|FG000|Overall Study|Physician Decision|4|||
48608622|NCT01525589|156425163|FG001|Overall Study|Physician Decision|2|||
48608623|NCT01525589|156425164|FG002|Overall Study|Physician Decision|2|||
48608624|NCT01525589|156425162|FG000|Overall Study|Death|0|||
48608625|NCT01525589|156425163|FG001|Overall Study|Death|0|||
48608626|NCT01525589|156425164|FG002|Overall Study|Death|2|||
48608627|NCT01525589|156425162|FG000|Overall Study|Treatment-related AE|1|||
48608628|NCT01525589|156425163|FG001|Overall Study|Treatment-related AE|1|||
48608629|NCT01525589|156425164|FG002|Overall Study|Treatment-related AE|2|||
48608630|NCT01525589|156425162|FG000|Overall Study|Other reasons|0|||
48608631|NCT01525589|156425163|FG001|Overall Study|Other reasons|1|||
48608632|NCT01525589|156425164|FG002|Overall Study|Other reasons|0|||
48608633|NCT01525589|156425162|FG000|Overall Study|Withdrawal by Subject|0|||
48608634|NCT01525589|156425163|FG001|Overall Study|Withdrawal by Subject|1|||
48608635|NCT01525589|156425164|FG002|Overall Study|Withdrawal by Subject|0|||
48608636|NCT04584788|156425167|FG000|Overall Study|Physician Decision|8|||
48608637|NCT04584788|156425167|FG000|Overall Study|Withdrawal by Subject|1|||
48608638|NCT04584788|156425167|FG000|Overall Study|Adverse Event|3|||
48608639|NCT00834041|156425168|FG000|Overall Study|Withdrawal by Subject|1|||
48608640|NCT00834041|156425169|FG001|Overall Study|Withdrawal by Subject|0|||
48608641|NCT00834041|156425168|FG000|Overall Study|Lost to Follow-up|0|||
48608642|NCT00834041|156425169|FG001|Overall Study|Lost to Follow-up|1|||
48608643|NCT03353220|156425170|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
48608644|NCT03353220|156425171|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
48608645|NCT02188160|156426799|FG000|Overall Study|Adverse Event|1|||
48608646|NCT02188160|156426800|FG001|Overall Study|Adverse Event|0|||
48608647|NCT02188160|156426799|FG000|Overall Study|Use of an excluded medication|0|||
48608648|NCT02188160|156426800|FG001|Overall Study|Use of an excluded medication|1|||
48608649|NCT03440320|156426801|FG000|Overall Study|Withdrawal by Subject|0|||
48608650|NCT03440320|156426802|FG001|Overall Study|Withdrawal by Subject|1|||
48608651|NCT04113694|156426803|FG000|Overall Study|Adverse Event|2|||
48608652|NCT04113694|156426803|FG000|Overall Study|Lost to Follow-up|2|||
48608653|NCT04113694|156426803|FG000|Overall Study|Withdrawal by Subject|6|||
48608654|NCT04113694|156426803|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
48608655|NCT00352118|156426808|FG000|Overall Study|Physician Decision|4|||
48608656|NCT03427892|156426811|FG000|Overall Study|Lost to Follow-up|2|||
48608657|NCT01673386|156426817|FG000|Overall Study|Study terminated by sponsor|16|||
48608658|NCT01673386|156426818|FG001|Overall Study|Study terminated by sponsor|22|||
48608659|NCT01673386|156426817|FG000|Overall Study|Adverse Event|5|||
48608660|NCT01673386|156426818|FG001|Overall Study|Adverse Event|2|||
48608661|NCT01673386|156426817|FG000|Overall Study|Progressive disease|4|||
48608662|NCT01673386|156426818|FG001|Overall Study|Progressive disease|1|||
48608663|NCT01673386|156426817|FG000|Overall Study|Withdrawal by Subject|0|||
48608664|NCT01673386|156426818|FG001|Overall Study|Withdrawal by Subject|2|||
48608665|NCT00329108|156426819|FG000|Overall Study|Adverse Event|2|||
48608666|NCT00329108|156426820|FG001|Overall Study|Adverse Event|2|||
48608667|NCT00329108|156426819|FG000|Overall Study|Lack of Efficacy|3|||
48608668|NCT00329108|156426820|FG001|Overall Study|Lack of Efficacy|3|||
48608669|NCT00329108|156426819|FG000|Overall Study|Withdrawal by Subject|0|||
48608670|NCT00329108|156426820|FG001|Overall Study|Withdrawal by Subject|2|||
48608671|NCT00329108|156426819|FG000|Overall Study|symptomatic deterioration|1|||
48608672|NCT00329108|156426820|FG001|Overall Study|symptomatic deterioration|1|||
48542931|NCT03247517|156177637|FG002|Overall Study|Lost to Follow-up|4|||
48542932|NCT03247517|156177635|FG000|Overall Study|Consent withdrawn by caregiver|1|||
48542933|NCT03247517|156177636|FG001|Overall Study|Consent withdrawn by caregiver|4|||
48542934|NCT03247517|156177637|FG002|Overall Study|Consent withdrawn by caregiver|7|||
48542935|NCT03247517|156177635|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
48542936|NCT03247517|156177636|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
48542937|NCT03247517|156177637|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
48542938|NCT03247517|156177635|FG000|Overall Study|Protocol Violation|0|||
48542939|NCT03247517|156177636|FG001|Overall Study|Protocol Violation|2|||
48542940|NCT03247517|156177637|FG002|Overall Study|Protocol Violation|0|||
48542941|NCT03247517|156177635|FG000|Overall Study|Multiple reasons|3|||
48542942|NCT03247517|156177636|FG001|Overall Study|Multiple reasons|1|||
48608673|NCT00329108|156426819|FG000|Overall Study|Subject no longer willing to participate|2|||
48608674|NCT00329108|156426820|FG001|Overall Study|Subject no longer willing to participate|2|||
48542943|NCT03247517|156177637|FG002|Overall Study|Multiple reasons|0|||
48542944|NCT00678041|156177638|FG000|Overall Study|Physician Decision|5|||
48542945|NCT00678041|156177639|FG001|Overall Study|Physician Decision|5|||
48608675|NCT00329108|156426819|FG000|Overall Study|study terminated by sponsor|1|||
48608676|NCT00329108|156426820|FG001|Overall Study|study terminated by sponsor|0|||
48608677|NCT00329108|156426819|FG000|Overall Study|withdrew patient after SAE resolved|1|||
48608678|NCT00329108|156426820|FG001|Overall Study|withdrew patient after SAE resolved|0|||
48608679|NCT00329108|156426819|FG000|Overall Study|Protocol Violation|0|||
48608680|NCT00329108|156426820|FG001|Overall Study|Protocol Violation|2|||
48608681|NCT01799889|156426826|FG000|Overall Study|Adverse Event|4|||
48608682|NCT01799889|156426827|FG001|Overall Study|Adverse Event|4|||
48608683|NCT01799889|156426828|FG002|Overall Study|Adverse Event|5|||
48608684|NCT01799889|156426829|FG003|Overall Study|Adverse Event|1|||
48542946|NCT02358343|156177640|FG000|Screening Intervention|Death|0|||
48542947|NCT02358343|156177641|FG001|Screening Intervention|Death|2|||
48542948|NCT02358343|156177642|FG002|Screening Intervention|Death|0|||
48542949|NCT02358343|156177643|FG003|Screening Intervention|Death|0|||
48542950|NCT02358343|156177644|FG004|Screening Intervention|Death|0|||
48542951|NCT02358343|156177640|FG000|Screening Intervention|Withdrawal by Subject|1|||
48542952|NCT02358343|156177641|FG001|Screening Intervention|Withdrawal by Subject|0|||
48542953|NCT02358343|156177642|FG002|Screening Intervention|Withdrawal by Subject|0|||
48542954|NCT02358343|156177643|FG003|Screening Intervention|Withdrawal by Subject|0|||
48542955|NCT02358343|156177644|FG004|Screening Intervention|Withdrawal by Subject|0|||
48542956|NCT02358343|156177640|FG000|Screening Intervention|Determined Ineligible|5|||
48542957|NCT02358343|156177641|FG001|Screening Intervention|Determined Ineligible|6|||
48542958|NCT02358343|156177642|FG002|Screening Intervention|Determined Ineligible|0|||
48542959|NCT02358343|156177643|FG003|Screening Intervention|Determined Ineligible|0|||
48542960|NCT02358343|156177644|FG004|Screening Intervention|Determined Ineligible|0|||
48542961|NCT02358343|156177640|FG000|Comparative Efficacy Trial / Observation|Death|0|||
48542962|NCT02358343|156177641|FG001|Comparative Efficacy Trial / Observation|Death|0|||
48542963|NCT02358343|156177642|FG002|Comparative Efficacy Trial / Observation|Death|2|||
48542964|NCT02358343|156177643|FG003|Comparative Efficacy Trial / Observation|Death|0|||
48542965|NCT02358343|156177644|FG004|Comparative Efficacy Trial / Observation|Death|0|||
48542966|NCT02358343|156177640|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
48542967|NCT02358343|156177641|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
48542968|NCT02358343|156177642|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
48542969|NCT02358343|156177643|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
48542970|NCT02358343|156177644|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
48542971|NCT02358343|156177640|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
48542972|NCT02358343|156177641|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
48542973|NCT02358343|156177642|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
48542974|NCT02358343|156177643|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
48542975|NCT02358343|156177644|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
48542976|NCT03596151|156177647|FG000|Overall Study|Withdrawal by Subject|1|||
48542977|NCT02387983|156177648|FG000|Overall Study|Adverse Event|4|||
48542978|NCT02387983|156177648|FG000|Overall Study|Protocol Violation|1|||
48542979|NCT02387983|156177648|FG000|Overall Study|Withdrawal by Subject|2|||
48542980|NCT03579966|156177649|FG000|Overall Study|Adverse Event|6|||
48542981|NCT03579966|156177649|FG000|Overall Study|Lost to Follow-up|4|||
48542982|NCT03579966|156177649|FG000|Overall Study|Physician Decision|10|||
48542983|NCT03579966|156177649|FG000|Overall Study|Pregnancy|1|||
48542984|NCT03579966|156177649|FG000|Overall Study|Withdrawal by Subject|16|||
48542985|NCT03579966|156177649|FG000|Overall Study|Study terminated by Sponsor|22|||
48542986|NCT03579966|156177649|FG000|Overall Study|Protocol Violation|1|||
48542987|NCT01249365|156177650|FG000|Overall Study|Lost to Follow-up|1|||
48542988|NCT03484117|156177651|FG000|Overall Study|Lost to Follow-up|1|||
48542989|NCT03484117|156177652|FG001|Overall Study|Lost to Follow-up|3|||
48542990|NCT03484117|156177651|FG000|Overall Study|Declined participation in exit assess|1|||
48542991|NCT03484117|156177652|FG001|Overall Study|Declined participation in exit assess|1|||
48542992|NCT00415194|156177656|FG000|Overall Study|Adverse Event|37|||
48542993|NCT00415194|156177657|FG001|Overall Study|Adverse Event|32|||
48542994|NCT00415194|156177656|FG000|Overall Study|Entry Criteria Not Met|4|||
48542995|NCT00415194|156177657|FG001|Overall Study|Entry Criteria Not Met|8|||
48542996|NCT00415194|156177656|FG000|Overall Study|Lost to Follow-up|1|||
48542997|NCT00415194|156177657|FG001|Overall Study|Lost to Follow-up|0|||
48542998|NCT00415194|156177656|FG000|Overall Study|Physician Decision|10|||
48542999|NCT00415194|156177657|FG001|Overall Study|Physician Decision|16|||
48543000|NCT00415194|156177656|FG000|Overall Study|Progressive Disease|180|||
48543001|NCT00415194|156177657|FG001|Overall Study|Progressive Disease|217|||
48543002|NCT00415194|156177656|FG000|Overall Study|Protocol Violation|4|||
48543003|NCT00415194|156177657|FG001|Overall Study|Protocol Violation|2|||
48543004|NCT00415194|156177656|FG000|Overall Study|Withdrawal by Subject|28|||
48543005|NCT00415194|156177657|FG001|Overall Study|Withdrawal by Subject|21|||
48543006|NCT00415194|156177656|FG000|Overall Study|Death Due to Study Disease|26|||
48608685|NCT01799889|156426830|FG004|Overall Study|Adverse Event|11|||
48543007|NCT00415194|156177657|FG001|Overall Study|Death Due to Study Disease|29|||
48543008|NCT00415194|156177656|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
48543009|NCT00415194|156177657|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
48543010|NCT00415194|156177656|FG000|Overall Study|Death Due to Procedural Related AE|0|||
48543011|NCT00415194|156177657|FG001|Overall Study|Death Due to Procedural Related AE|1|||
48543012|NCT00415194|156177656|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
48543013|NCT00415194|156177657|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
48543014|NCT00114166|156177658|FG000|Overall Study|Wrong primary|0|||
48543015|NCT00114166|156177659|FG001|Overall Study|Wrong primary|1|||
48543016|NCT01297465|156177660|FG000|Overall Study|Lack of Ovarian Response|1|||
48543017|NCT01297465|156177661|FG001|Overall Study|Lack of Ovarian Response|1|||
48543018|NCT01297465|156177660|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
48543019|NCT01297465|156177661|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48543020|NCT01297465|156177660|FG000|Overall Study|No Oocytes Retrieved|1|||
48543021|NCT01297465|156177661|FG001|Overall Study|No Oocytes Retrieved|1|||
48543022|NCT01297465|156177660|FG000|Overall Study|Poor oocyte quality|0|||
48543023|NCT01297465|156177661|FG001|Overall Study|Poor oocyte quality|1|||
48543024|NCT01297465|156177660|FG000|Overall Study|No Fertilization|6|||
48608686|NCT01799889|156426831|FG005|Overall Study|Adverse Event|1|||
48543025|NCT01297465|156177661|FG001|Overall Study|No Fertilization|4|||
48543026|NCT01297465|156177660|FG000|Overall Study|All Embryos Discarded|0|||
48543027|NCT01297465|156177661|FG001|Overall Study|All Embryos Discarded|1|||
48543028|NCT01297465|156177660|FG000|Overall Study|Intention to Freeze all Embryos|0|||
48543029|NCT01297465|156177661|FG001|Overall Study|Intention to Freeze all Embryos|1|||
48543030|NCT02397408|156177664|FG000|Overall Study|Physician Decision|4|||
48543031|NCT02397408|156177664|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
48543032|NCT05256134|156177665|FG000|Overall Study|Study Terminated by Sponsor|11|||
48543033|NCT05256134|156177666|FG001|Overall Study|Study Terminated by Sponsor|10|||
48543034|NCT05256134|156177665|FG000|Overall Study|Withdrawal by Subject|1|||
48543035|NCT05256134|156177666|FG001|Overall Study|Withdrawal by Subject|3|||
48543036|NCT01683838|156177667|FG000|Overall Study|Adverse Event|12|||
48543037|NCT01683838|156177668|FG001|Overall Study|Adverse Event|2|||
48543038|NCT01683838|156177667|FG000|Overall Study|Protocol Violation|3|||
48543039|NCT01683838|156177668|FG001|Overall Study|Protocol Violation|1|||
48543040|NCT01683838|156177667|FG000|Overall Study|Withdrawal by Subject|6|||
48608687|NCT01799889|156426832|FG006|Overall Study|Adverse Event|5|||
48608688|NCT01799889|156426833|FG007|Overall Study|Adverse Event|2|||
48608689|NCT01799889|156426834|FG008|Overall Study|Adverse Event|3|||
48608690|NCT01799889|156426835|FG009|Overall Study|Adverse Event|1|||
48608691|NCT01799889|156426836|FG010|Overall Study|Adverse Event|1|||
48608692|NCT01799889|156426837|FG011|Overall Study|Adverse Event|0|||
48608693|NCT01799889|156426826|FG000|Overall Study|Death|1|||
48608694|NCT01799889|156426827|FG001|Overall Study|Death|0|||
48608695|NCT01799889|156426828|FG002|Overall Study|Death|5|||
48608696|NCT01799889|156426829|FG003|Overall Study|Death|3|||
48608697|NCT01799889|156426830|FG004|Overall Study|Death|1|||
48608698|NCT01799889|156426831|FG005|Overall Study|Death|0|||
48608699|NCT01799889|156426832|FG006|Overall Study|Death|0|||
48608700|NCT01799889|156426833|FG007|Overall Study|Death|0|||
48608701|NCT01799889|156426834|FG008|Overall Study|Death|1|||
48608702|NCT01799889|156426835|FG009|Overall Study|Death|0|||
48608703|NCT01799889|156426836|FG010|Overall Study|Death|1|||
48608704|NCT01799889|156426837|FG011|Overall Study|Death|0|||
48608705|NCT01799889|156426826|FG000|Overall Study|Lack of Efficacy|1|||
48608706|NCT01799889|156426827|FG001|Overall Study|Lack of Efficacy|1|||
48608707|NCT01799889|156426828|FG002|Overall Study|Lack of Efficacy|0|||
48608708|NCT01799889|156426829|FG003|Overall Study|Lack of Efficacy|1|||
48608709|NCT01799889|156426830|FG004|Overall Study|Lack of Efficacy|2|||
48608710|NCT01799889|156426831|FG005|Overall Study|Lack of Efficacy|2|||
48608711|NCT01799889|156426832|FG006|Overall Study|Lack of Efficacy|0|||
48543041|NCT01683838|156177668|FG001|Overall Study|Withdrawal by Subject|5|||
48543042|NCT01683838|156177667|FG000|Overall Study|Lost to Follow-up|1|||
48608712|NCT01799889|156426833|FG007|Overall Study|Lack of Efficacy|0|||
48608713|NCT01799889|156426834|FG008|Overall Study|Lack of Efficacy|2|||
48608714|NCT01799889|156426835|FG009|Overall Study|Lack of Efficacy|0|||
48543043|NCT01683838|156177668|FG001|Overall Study|Lost to Follow-up|1|||
48543044|NCT01683838|156177667|FG000|Overall Study|Other|4|||
48608715|NCT01799889|156426836|FG010|Overall Study|Lack of Efficacy|1|||
48608716|NCT01799889|156426837|FG011|Overall Study|Lack of Efficacy|0|||
48608717|NCT01799889|156426826|FG000|Overall Study|Lost to Follow-up|0|||
48608718|NCT01799889|156426827|FG001|Overall Study|Lost to Follow-up|1|||
48608719|NCT01799889|156426828|FG002|Overall Study|Lost to Follow-up|0|||
48608720|NCT01799889|156426829|FG003|Overall Study|Lost to Follow-up|0|||
48608721|NCT01799889|156426830|FG004|Overall Study|Lost to Follow-up|0|||
48543045|NCT01683838|156177668|FG001|Overall Study|Other|3|||
48543046|NCT01646138|156177669|FG000|Overall Study|Lost to Follow-up|0|||
48543047|NCT01646138|156177670|FG001|Overall Study|Lost to Follow-up|0|||
48543048|NCT01646138|156177671|FG002|Overall Study|Lost to Follow-up|0|||
48543049|NCT01646138|156177672|FG003|Overall Study|Lost to Follow-up|0|||
48543050|NCT01646138|156177673|FG004|Overall Study|Lost to Follow-up|2|||
48543051|NCT04049617|156177674|FG000|Overall Study|Adverse Event|0|||
48543052|NCT04049617|156177675|FG001|Overall Study|Adverse Event|0|||
48543053|NCT04049617|156177676|FG002|Overall Study|Adverse Event|0|||
48543054|NCT04049617|156177677|FG003|Overall Study|Adverse Event|1|||
48543055|NCT04049617|156177678|FG004|Overall Study|Adverse Event|0|||
48543056|NCT04049617|156177679|FG005|Overall Study|Adverse Event|0|||
48543057|NCT04049617|156177674|FG000|Overall Study|Death|0|||
48543058|NCT04049617|156177675|FG001|Overall Study|Death|0|||
48543059|NCT04049617|156177676|FG002|Overall Study|Death|0|||
48543060|NCT04049617|156177677|FG003|Overall Study|Death|0|||
48543061|NCT04049617|156177678|FG004|Overall Study|Death|0|||
48543062|NCT04049617|156177679|FG005|Overall Study|Death|1|||
48543063|NCT04049617|156177674|FG000|Overall Study|Lost to Follow-up|0|||
48543064|NCT04049617|156177675|FG001|Overall Study|Lost to Follow-up|0|||
48543065|NCT04049617|156177676|FG002|Overall Study|Lost to Follow-up|0|||
48543066|NCT04049617|156177677|FG003|Overall Study|Lost to Follow-up|1|||
48543067|NCT04049617|156177678|FG004|Overall Study|Lost to Follow-up|0|||
48543068|NCT04049617|156177679|FG005|Overall Study|Lost to Follow-up|0|||
48543069|NCT04049617|156177674|FG000|Overall Study|Withdrew consent|0|||
48543070|NCT04049617|156177675|FG001|Overall Study|Withdrew consent|0|||
48543071|NCT04049617|156177676|FG002|Overall Study|Withdrew consent|1|||
48543072|NCT04049617|156177677|FG003|Overall Study|Withdrew consent|0|||
48543073|NCT04049617|156177678|FG004|Overall Study|Withdrew consent|0|||
48543074|NCT04049617|156177679|FG005|Overall Study|Withdrew consent|0|||
48608722|NCT01799889|156426831|FG005|Overall Study|Lost to Follow-up|0|||
48608723|NCT01799889|156426832|FG006|Overall Study|Lost to Follow-up|0|||
48608724|NCT01799889|156426833|FG007|Overall Study|Lost to Follow-up|0|||
48608725|NCT01799889|156426834|FG008|Overall Study|Lost to Follow-up|0|||
48608726|NCT01799889|156426835|FG009|Overall Study|Lost to Follow-up|0|||
48608727|NCT01799889|156426836|FG010|Overall Study|Lost to Follow-up|0|||
48608728|NCT01799889|156426837|FG011|Overall Study|Lost to Follow-up|0|||
48608729|NCT01799889|156426826|FG000|Overall Study|Physician Decision|3|||
48608730|NCT01799889|156426827|FG001|Overall Study|Physician Decision|2|||
48608731|NCT01799889|156426828|FG002|Overall Study|Physician Decision|4|||
48608732|NCT01799889|156426829|FG003|Overall Study|Physician Decision|4|||
48608733|NCT01799889|156426830|FG004|Overall Study|Physician Decision|5|||
48608734|NCT01799889|156426831|FG005|Overall Study|Physician Decision|5|||
48608735|NCT01799889|156426832|FG006|Overall Study|Physician Decision|5|||
48608736|NCT01799889|156426833|FG007|Overall Study|Physician Decision|2|||
48608737|NCT01799889|156426834|FG008|Overall Study|Physician Decision|6|||
48608738|NCT01799889|156426835|FG009|Overall Study|Physician Decision|0|||
48608739|NCT01799889|156426836|FG010|Overall Study|Physician Decision|0|||
48608740|NCT01799889|156426837|FG011|Overall Study|Physician Decision|1|||
48608741|NCT01799889|156426826|FG000|Overall Study|Progressive Disease|30|||
48608742|NCT01799889|156426827|FG001|Overall Study|Progressive Disease|26|||
48608743|NCT01799889|156426828|FG002|Overall Study|Progressive Disease|25|||
48608744|NCT01799889|156426829|FG003|Overall Study|Progressive Disease|30|||
48608745|NCT01799889|156426830|FG004|Overall Study|Progressive Disease|23|||
48608746|NCT01799889|156426831|FG005|Overall Study|Progressive Disease|9|||
48608747|NCT01799889|156426832|FG006|Overall Study|Progressive Disease|8|||
48608748|NCT01799889|156426833|FG007|Overall Study|Progressive Disease|13|||
48608749|NCT01799889|156426834|FG008|Overall Study|Progressive Disease|18|||
48608750|NCT01799889|156426835|FG009|Overall Study|Progressive Disease|5|||
48543075|NCT03551496|156177680|FG000|Overall Study|Death|11|||
48543076|NCT03551496|156177681|FG001|Overall Study|Death|7|||
48543077|NCT03551496|156177680|FG000|Overall Study|Withdrawal by Subject|4|||
48543078|NCT03551496|156177681|FG001|Overall Study|Withdrawal by Subject|3|||
48543079|NCT03551496|156177680|FG000|Overall Study|Other Reasons|1|||
48543080|NCT03551496|156177681|FG001|Overall Study|Other Reasons|0|||
48543081|NCT01524679|156177682|FG000|Overall Study|Lost to Follow-up|1|||
48543082|NCT01524679|156177683|FG001|Overall Study|Lost to Follow-up|4|||
48543083|NCT01524679|156177682|FG000|Overall Study|Withdrawal by Subject|4|||
48608751|NCT01799889|156426836|FG010|Overall Study|Progressive Disease|3|||
48608752|NCT01799889|156426837|FG011|Overall Study|Progressive Disease|1|||
48608753|NCT01799889|156426826|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
48608754|NCT01799889|156426827|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
48608755|NCT01799889|156426828|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
48543084|NCT01524679|156177683|FG001|Overall Study|Withdrawal by Subject|4|||
48543085|NCT01524679|156177682|FG000|Overall Study|Adverse Event|9|||
48543086|NCT01524679|156177683|FG001|Overall Study|Adverse Event|0|||
48543087|NCT01524679|156177682|FG000|Overall Study|Protocol Violation|1|||
48543088|NCT01524679|156177683|FG001|Overall Study|Protocol Violation|0|||
48608756|NCT01799889|156426829|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
48608757|NCT01799889|156426830|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
48608758|NCT01799889|156426831|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
48608759|NCT01799889|156426832|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
48608760|NCT01799889|156426833|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
48608761|NCT01799889|156426834|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
48608762|NCT01799889|156426835|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
48608763|NCT01799889|156426836|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
48608764|NCT01799889|156426837|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
48608765|NCT01799889|156426826|FG000|Overall Study|Study Terminated By Sponsor|1|||
48608766|NCT01799889|156426827|FG001|Overall Study|Study Terminated By Sponsor|0|||
48608767|NCT01799889|156426828|FG002|Overall Study|Study Terminated By Sponsor|0|||
48608768|NCT01799889|156426829|FG003|Overall Study|Study Terminated By Sponsor|0|||
48608769|NCT01799889|156426830|FG004|Overall Study|Study Terminated By Sponsor|2|||
48608770|NCT01799889|156426831|FG005|Overall Study|Study Terminated By Sponsor|1|||
48608771|NCT01799889|156426832|FG006|Overall Study|Study Terminated By Sponsor|0|||
48608772|NCT01799889|156426833|FG007|Overall Study|Study Terminated By Sponsor|2|||
48608773|NCT01799889|156426834|FG008|Overall Study|Study Terminated By Sponsor|1|||
48608774|NCT01799889|156426835|FG009|Overall Study|Study Terminated By Sponsor|1|||
48608775|NCT01799889|156426836|FG010|Overall Study|Study Terminated By Sponsor|0|||
48608776|NCT01799889|156426837|FG011|Overall Study|Study Terminated By Sponsor|0|||
48608777|NCT01799889|156426826|FG000|Overall Study|Withdrawal by Subject|1|||
48608778|NCT01799889|156426827|FG001|Overall Study|Withdrawal by Subject|6|||
48608779|NCT01799889|156426828|FG002|Overall Study|Withdrawal by Subject|4|||
48608780|NCT01799889|156426829|FG003|Overall Study|Withdrawal by Subject|0|||
48608781|NCT01799889|156426830|FG004|Overall Study|Withdrawal by Subject|5|||
48608782|NCT01799889|156426831|FG005|Overall Study|Withdrawal by Subject|1|||
48608783|NCT01799889|156426832|FG006|Overall Study|Withdrawal by Subject|3|||
48608784|NCT01799889|156426833|FG007|Overall Study|Withdrawal by Subject|1|||
48608785|NCT01799889|156426834|FG008|Overall Study|Withdrawal by Subject|2|||
48608786|NCT01799889|156426835|FG009|Overall Study|Withdrawal by Subject|1|||
48608787|NCT01799889|156426836|FG010|Overall Study|Withdrawal by Subject|1|||
48608788|NCT01799889|156426837|FG011|Overall Study|Withdrawal by Subject|1|||
48608789|NCT01799889|156426826|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48608790|NCT01799889|156426827|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48608791|NCT01799889|156426828|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48608792|NCT01799889|156426829|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48608793|NCT01799889|156426830|FG004|Overall Study|Non-Compliance With Study Drug|0|||
48608794|NCT01799889|156426831|FG005|Overall Study|Non-Compliance With Study Drug|1|||
48543089|NCT01524679|156177682|FG000|Overall Study|Lack of Efficacy|2|||
48543090|NCT01524679|156177683|FG001|Overall Study|Lack of Efficacy|0|||
48543091|NCT01524679|156177682|FG000|Overall Study|e.g.wish for children, relocation|6|||
48543092|NCT01524679|156177683|FG001|Overall Study|e.g.wish for children, relocation|1|||
48543093|NCT01154816|156177684|FG000|Overall Study|Withdrawal by Subject|1|||
48543094|NCT01154816|156177685|FG001|Overall Study|Withdrawal by Subject|0|||
48543095|NCT01154816|156177686|FG002|Overall Study|Withdrawal by Subject|0|||
48543096|NCT01154816|156177687|FG003|Overall Study|Withdrawal by Subject|1|||
48543097|NCT01154816|156177688|FG004|Overall Study|Withdrawal by Subject|0|||
48543098|NCT01154816|156177689|FG005|Overall Study|Withdrawal by Subject|0|||
48543099|NCT01154816|156177690|FG006|Overall Study|Withdrawal by Subject|0|||
48543100|NCT01154816|156177691|FG007|Overall Study|Withdrawal by Subject|0|||
48543101|NCT01154816|156177692|FG008|Overall Study|Withdrawal by Subject|1|||
48543102|NCT01154816|156177693|FG009|Overall Study|Withdrawal by Subject|3|||
48543103|NCT01154816|156177694|FG010|Overall Study|Withdrawal by Subject|0|||
48543104|NCT01154816|156177695|FG011|Overall Study|Withdrawal by Subject|0|||
48543105|NCT01154816|156177684|FG000|Overall Study|Progressive Disease|13|||
48543106|NCT01154816|156177685|FG001|Overall Study|Progressive Disease|8|||
48543107|NCT01154816|156177686|FG002|Overall Study|Progressive Disease|9|||
48543108|NCT01154816|156177687|FG003|Overall Study|Progressive Disease|9|||
48608795|NCT01799889|156426832|FG006|Overall Study|Non-Compliance With Study Drug|0|||
48608796|NCT01799889|156426833|FG007|Overall Study|Non-Compliance With Study Drug|0|||
48543109|NCT01154816|156177688|FG004|Overall Study|Progressive Disease|8|||
48543110|NCT01154816|156177689|FG005|Overall Study|Progressive Disease|8|||
48543111|NCT01154816|156177690|FG006|Overall Study|Progressive Disease|5|||
48608797|NCT01799889|156426834|FG008|Overall Study|Non-Compliance With Study Drug|0|||
48608798|NCT01799889|156426835|FG009|Overall Study|Non-Compliance With Study Drug|0|||
48608799|NCT01799889|156426836|FG010|Overall Study|Non-Compliance With Study Drug|0|||
48608800|NCT01799889|156426837|FG011|Overall Study|Non-Compliance With Study Drug|0|||
48608801|NCT02308046|156426838|FG000|Overall Study|Negative yeast culture at Baseline|32|||
48608802|NCT02308046|156426839|FG001|Overall Study|Negative yeast culture at Baseline|33|||
48608803|NCT02308046|156426838|FG000|Overall Study|Positive for STD at Baseline|1|||
48608804|NCT02308046|156426839|FG001|Overall Study|Positive for STD at Baseline|2|||
48608805|NCT02308046|156426838|FG000|Overall Study|Lost to Follow-up|1|||
48608806|NCT02308046|156426839|FG001|Overall Study|Lost to Follow-up|3|||
48608807|NCT01181167|156426840|FG000|Overall Study|Adverse Event|11|||
48608808|NCT01181167|156426841|FG001|Overall Study|Adverse Event|21|||
48608809|NCT01181167|156426840|FG000|Overall Study|Lost to Follow-up|1|||
48608810|NCT01181167|156426841|FG001|Overall Study|Lost to Follow-up|0|||
48608811|NCT01181167|156426840|FG000|Overall Study|Physician Decision|2|||
48608812|NCT01181167|156426841|FG001|Overall Study|Physician Decision|3|||
48608813|NCT01181167|156426840|FG000|Overall Study|Protocol Violation|3|||
48608814|NCT01181167|156426841|FG001|Overall Study|Protocol Violation|0|||
48608815|NCT01181167|156426840|FG000|Overall Study|Withdrawal by Subject|6|||
48608816|NCT01181167|156426841|FG001|Overall Study|Withdrawal by Subject|8|||
48608817|NCT01147822|156426842|FG000|Overall Study|Death|66|||
48608818|NCT01147822|156426843|FG001|Overall Study|Death|59|||
48608819|NCT01147822|156426842|FG000|Overall Study|Protocol Violation|0|||
48608820|NCT01147822|156426843|FG001|Overall Study|Protocol Violation|1|||
48608821|NCT01147822|156426842|FG000|Overall Study|Lost to Follow-up|3|||
48608822|NCT01147822|156426843|FG001|Overall Study|Lost to Follow-up|2|||
48608823|NCT01147822|156426842|FG000|Overall Study|Physician Decision|0|||
48543112|NCT01154816|156177691|FG007|Overall Study|Progressive Disease|6|||
48608824|NCT01147822|156426843|FG001|Overall Study|Physician Decision|2|||
48608825|NCT01147822|156426842|FG000|Overall Study|Withdrawal by Subject|8|||
48608826|NCT01147822|156426843|FG001|Overall Study|Withdrawal by Subject|13|||
48608827|NCT01147822|156426842|FG000|Overall Study|Not Completed/Ongoing|111|||
48608828|NCT01147822|156426843|FG001|Overall Study|Not Completed/Ongoing|102|||
48608829|NCT03103503|156426844|FG000|Overall Study|Death|64|||
48608830|NCT03103503|156426844|FG000|Overall Study|Physician Decision|57|||
48543113|NCT01154816|156177692|FG008|Overall Study|Progressive Disease|8|||
48543114|NCT01154816|156177693|FG009|Overall Study|Progressive Disease|6|||
48543115|NCT01154816|156177694|FG010|Overall Study|Progressive Disease|10|||
48543116|NCT01154816|156177695|FG011|Overall Study|Progressive Disease|3|||
48543117|NCT01154816|156177684|FG000|Overall Study|Physician Decision|1|||
48543118|NCT01154816|156177685|FG001|Overall Study|Physician Decision|0|||
48543119|NCT01154816|156177686|FG002|Overall Study|Physician Decision|1|||
48543120|NCT01154816|156177687|FG003|Overall Study|Physician Decision|0|||
48543121|NCT01154816|156177688|FG004|Overall Study|Physician Decision|2|||
48543122|NCT01154816|156177689|FG005|Overall Study|Physician Decision|0|||
48543123|NCT01154816|156177690|FG006|Overall Study|Physician Decision|0|||
48543124|NCT01154816|156177691|FG007|Overall Study|Physician Decision|0|||
48543125|NCT01154816|156177692|FG008|Overall Study|Physician Decision|0|||
48543126|NCT01154816|156177693|FG009|Overall Study|Physician Decision|1|||
48543127|NCT01154816|156177694|FG010|Overall Study|Physician Decision|1|||
48543128|NCT01154816|156177695|FG011|Overall Study|Physician Decision|1|||
48543129|NCT01154816|156177684|FG000|Overall Study|Adverse Event|5|||
48543130|NCT01154816|156177685|FG001|Overall Study|Adverse Event|2|||
48543131|NCT01154816|156177686|FG002|Overall Study|Adverse Event|0|||
48543132|NCT01154816|156177687|FG003|Overall Study|Adverse Event|0|||
48543133|NCT01154816|156177688|FG004|Overall Study|Adverse Event|0|||
48543134|NCT01154816|156177689|FG005|Overall Study|Adverse Event|0|||
48543135|NCT01154816|156177690|FG006|Overall Study|Adverse Event|1|||
48543136|NCT01154816|156177691|FG007|Overall Study|Adverse Event|1|||
48543137|NCT01154816|156177692|FG008|Overall Study|Adverse Event|0|||
48543138|NCT01154816|156177693|FG009|Overall Study|Adverse Event|0|||
48608831|NCT03103503|156426844|FG000|Overall Study|Withdrawal by Subject|10|||
48608832|NCT03103503|156426844|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
48608833|NCT03103503|156426844|FG000|Overall Study|Lost to Follow-up|3|||
48608834|NCT03103503|156426844|FG000|Overall Study|Study Closure|757|||
48608835|NCT01162343|156426848|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
48543139|NCT01154816|156177694|FG010|Overall Study|Adverse Event|0|||
48608836|NCT01162343|156426848|FG000|Overall Study|Refused psychiatrist assessment|12|||
48608837|NCT00408499|156426849|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
48543140|NCT01154816|156177695|FG011|Overall Study|Adverse Event|0|||
48543141|NCT00801099|156177696|FG000|Overall Study|Lost to Follow-up|101|||
48543142|NCT01780987|156177700|FG000|Overall Study|Adverse Event|0|||
48543143|NCT01780987|156177701|FG001|Overall Study|Adverse Event|4|||
48543144|NCT01780987|156177700|FG000|Overall Study|Withdrawal by Subject|2|||
48543145|NCT01780987|156177701|FG001|Overall Study|Withdrawal by Subject|0|||
48608838|NCT00408499|156426850|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
48608839|NCT00408499|156426851|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
48608840|NCT00408499|156426852|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
48608841|NCT00408499|156426853|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
48608842|NCT00408499|156426849|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
48608843|NCT00408499|156426850|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
48608844|NCT00408499|156426851|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
48608845|NCT00408499|156426852|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
48608846|NCT00408499|156426853|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
48608847|NCT00408499|156426849|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
48608848|NCT00408499|156426850|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
48608849|NCT00408499|156426851|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
48608850|NCT00408499|156426852|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
48608851|NCT00408499|156426853|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
48608852|NCT00408499|156426849|FG000|Phase II- MTD Expansion|Adverse Event|0|||
48608853|NCT00408499|156426850|FG001|Phase II- MTD Expansion|Adverse Event|0|||
48608854|NCT00408499|156426851|FG002|Phase II- MTD Expansion|Adverse Event|0|||
48608855|NCT00408499|156426852|FG003|Phase II- MTD Expansion|Adverse Event|0|||
48608856|NCT00408499|156426853|FG004|Phase II- MTD Expansion|Adverse Event|9|||
48608857|NCT00408499|156426849|FG000|Phase II- MTD Expansion|Death|0|||
48608858|NCT00408499|156426850|FG001|Phase II- MTD Expansion|Death|0|||
48608859|NCT00408499|156426851|FG002|Phase II- MTD Expansion|Death|0|||
48608860|NCT00408499|156426852|FG003|Phase II- MTD Expansion|Death|0|||
48608861|NCT00408499|156426853|FG004|Phase II- MTD Expansion|Death|2|||
48608862|NCT00408499|156426849|FG000|Phase II- MTD Expansion|Physician Decision|0|||
48608863|NCT00408499|156426850|FG001|Phase II- MTD Expansion|Physician Decision|0|||
48608864|NCT00408499|156426851|FG002|Phase II- MTD Expansion|Physician Decision|0|||
48608865|NCT00408499|156426852|FG003|Phase II- MTD Expansion|Physician Decision|0|||
48608866|NCT00408499|156426853|FG004|Phase II- MTD Expansion|Physician Decision|1|||
48608867|NCT00408499|156426849|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
48608868|NCT00408499|156426850|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
48608869|NCT00408499|156426851|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
48608870|NCT00408499|156426852|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
48608871|NCT00408499|156426853|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
48543146|NCT01780987|156177700|FG000|Overall Study|Request of Changing Hospital|0|||
48543147|NCT01780987|156177701|FG001|Overall Study|Request of Changing Hospital|1|||
48543148|NCT01780987|156177700|FG000|Overall Study|Changing Residence|1|||
48543149|NCT01780987|156177701|FG001|Overall Study|Changing Residence|0|||
48543150|NCT01780987|156177700|FG000|Overall Study|Not Receiving any Study Medication|0|||
48543151|NCT01780987|156177701|FG001|Overall Study|Not Receiving any Study Medication|1|||
48543152|NCT02303041|156177702|FG000|Overall Study|Adverse Event|1|||
48543153|NCT02303041|156177703|FG001|Overall Study|Adverse Event|2|||
48543154|NCT02196701|156177704|FG000|Overall Study|Adverse Event|1|||
48543155|NCT02196701|156177704|FG000|Overall Study|Lost to Follow-up|1|||
48543156|NCT02196701|156177704|FG000|Overall Study|Non-adherence to Protocol|1|||
48543157|NCT00643565|156177708|FG000|Overall Study|Death|12|||
48543158|NCT00643565|156177709|FG001|Overall Study|Death|11|||
48543159|NCT00643565|156177708|FG000|Overall Study|Withdrawal by Subject|4|||
48543160|NCT00643565|156177709|FG001|Overall Study|Withdrawal by Subject|1|||
48543161|NCT00643565|156177708|FG000|Overall Study|Lost to Follow-up|0|||
48543162|NCT00643565|156177709|FG001|Overall Study|Lost to Follow-up|6|||
48543163|NCT00643565|156177708|FG000|Overall Study|Other|7|||
48543164|NCT00643565|156177709|FG001|Overall Study|Other|8|||
48543165|NCT00643565|156177708|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
48543166|NCT00643565|156177709|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
48543167|NCT00643565|156177708|FG000|Overall Study|Recurrence of Disease|2|||
48543168|NCT00643565|156177709|FG001|Overall Study|Recurrence of Disease|1|||
48543169|NCT00643565|156177708|FG000|Overall Study|Progression of Disease|18|||
48543170|NCT00643565|156177709|FG001|Overall Study|Progression of Disease|14|||
48543171|NCT00643565|156177708|FG000|Overall Study|Protocol Violation|3|||
48543172|NCT00643565|156177709|FG001|Overall Study|Protocol Violation|0|||
48543173|NCT00643565|156177708|FG000|Overall Study|Did Not Cooperate|0|||
48543174|NCT00643565|156177709|FG001|Overall Study|Did Not Cooperate|1|||
48608872|NCT00408499|156426849|FG000|Phase II- MTD Expansion|treatment delay|0|||
48608873|NCT00408499|156426850|FG001|Phase II- MTD Expansion|treatment delay|0|||
48608874|NCT00408499|156426851|FG002|Phase II- MTD Expansion|treatment delay|0|||
48608875|NCT00408499|156426852|FG003|Phase II- MTD Expansion|treatment delay|0|||
48608876|NCT00408499|156426853|FG004|Phase II- MTD Expansion|treatment delay|3|||
48608877|NCT00997334|156426854|FG000|Overall Study|still on therapy|12|||
48543175|NCT00643565|156177708|FG000|Overall Study|Administrative|22|||
48543176|NCT00643565|156177709|FG001|Overall Study|Administrative|16|||
48543177|NCT00643565|156177708|FG000|Overall Study|Adverse Event|5|||
48543178|NCT00643565|156177709|FG001|Overall Study|Adverse Event|8|||
48543179|NCT01910389|156177711|FG000|Overall Study|Withdrawal by Subject|2|||
48543180|NCT01910389|156177712|FG001|Overall Study|Withdrawal by Subject|0|||
48543181|NCT01910389|156177711|FG000|Overall Study|Study Closed|13|||
48543182|NCT01910389|156177712|FG001|Overall Study|Study Closed|8|||
48608878|NCT00997334|156426854|FG000|Overall Study|Adverse Event|3|||
48608879|NCT00997334|156426854|FG000|Overall Study|Patient non-compliance|1|||
48608880|NCT00997334|156426854|FG000|Overall Study|Withdrawal by Subject|3|||
48608881|NCT00997334|156426854|FG000|Overall Study|Death|2|||
48608882|NCT00997334|156426854|FG000|Overall Study|Urgent Palliative Care|2|||
48608883|NCT00997334|156426854|FG000|Overall Study|No lesion amenable|1|||
48608884|NCT00997334|156426854|FG000|Overall Study|Ineligible|1|||
48608885|NCT01287936|156426855|FG000|Overall Study|Lost to Follow-up|0|||
48608886|NCT01287936|156426856|FG001|Overall Study|Lost to Follow-up|1|||
48608887|NCT01287936|156426857|FG002|Overall Study|Lost to Follow-up|1|||
48608888|NCT00296244|156426858|FG000|Overall Study|Underwent retransplant|0|||
48608889|NCT00296244|156426859|FG001|Overall Study|Underwent retransplant|1|||
48608890|NCT01140906|156426860|FG000|Overall Study|Adverse Event|7|||
48608891|NCT01140906|156426861|FG001|Overall Study|Adverse Event|10|||
48608892|NCT01140906|156426862|FG002|Overall Study|Adverse Event|17|||
48608893|NCT01140906|156426863|FG003|Overall Study|Adverse Event|7|||
48608894|NCT01140906|156426860|FG000|Overall Study|Lack of Efficacy|6|||
48608895|NCT01140906|156426861|FG001|Overall Study|Lack of Efficacy|8|||
48608896|NCT01140906|156426862|FG002|Overall Study|Lack of Efficacy|2|||
48608897|NCT01140906|156426863|FG003|Overall Study|Lack of Efficacy|1|||
48608898|NCT01140906|156426860|FG000|Overall Study|Non-compliance|0|||
48608899|NCT01140906|156426861|FG001|Overall Study|Non-compliance|1|||
48608900|NCT01140906|156426862|FG002|Overall Study|Non-compliance|0|||
48608901|NCT01140906|156426863|FG003|Overall Study|Non-compliance|1|||
48608902|NCT01140906|156426860|FG000|Overall Study|Protocol Violation|5|||
48608903|NCT01140906|156426861|FG001|Overall Study|Protocol Violation|3|||
48608904|NCT01140906|156426862|FG002|Overall Study|Protocol Violation|2|||
48608905|NCT01140906|156426863|FG003|Overall Study|Protocol Violation|1|||
48608906|NCT01140906|156426860|FG000|Overall Study|Withdrawal of consent|6|||
48608907|NCT01140906|156426861|FG001|Overall Study|Withdrawal of consent|6|||
48608908|NCT01140906|156426862|FG002|Overall Study|Withdrawal of consent|2|||
48608909|NCT01140906|156426863|FG003|Overall Study|Withdrawal of consent|2|||
48608910|NCT01140906|156426860|FG000|Overall Study|Lost to Follow-up|1|||
48608911|NCT01140906|156426861|FG001|Overall Study|Lost to Follow-up|1|||
48608912|NCT01140906|156426862|FG002|Overall Study|Lost to Follow-up|0|||
48608913|NCT01140906|156426863|FG003|Overall Study|Lost to Follow-up|2|||
48608914|NCT01140906|156426860|FG000|Overall Study|Administrative or other reason|0|||
48608915|NCT01140906|156426861|FG001|Overall Study|Administrative or other reason|5|||
48608916|NCT01140906|156426862|FG002|Overall Study|Administrative or other reason|3|||
48608917|NCT01140906|156426863|FG003|Overall Study|Administrative or other reason|2|||
48608918|NCT01130272|156426864|FG000|Overall Study|Adverse Event|2|||
48608919|NCT01130272|156426865|FG001|Overall Study|Adverse Event|5|||
48608920|NCT01130272|156426866|FG002|Overall Study|Adverse Event|6|||
48608921|NCT01130272|156426867|FG003|Overall Study|Adverse Event|22|||
48608922|NCT01130272|156426868|FG004|Overall Study|Adverse Event|7|||
48608923|NCT01130272|156426864|FG000|Overall Study|IVRS-confirmed constipation|0|||
48608924|NCT01130272|156426865|FG001|Overall Study|IVRS-confirmed constipation|1|||
48608925|NCT01130272|156426866|FG002|Overall Study|IVRS-confirmed constipation|1|||
48608926|NCT01130272|156426867|FG003|Overall Study|IVRS-confirmed constipation|2|||
48608927|NCT01130272|156426868|FG004|Overall Study|IVRS-confirmed constipation|0|||
48608928|NCT01130272|156426864|FG000|Overall Study|Rescue medications due to diarrhea|3|||
48608929|NCT01130272|156426865|FG001|Overall Study|Rescue medications due to diarrhea|5|||
48543183|NCT04853992|156177713|FG000|Treatment Period A|Adverse Event|0|||
48543184|NCT04853992|156177714|FG001|Treatment Period A|Adverse Event|1|||
48543185|NCT04853992|156177713|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
48543186|NCT04853992|156177714|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
48543187|NCT00499174|156177715|FG000|Overall Study|Physician Decision|78|||
48543188|NCT00499174|156177716|FG001|Overall Study|Physician Decision|9|||
48543189|NCT03582826|156177720|FG000|Overall Study|Lost to Follow-up|39|||
48543190|NCT03582826|156177721|FG001|Overall Study|Lost to Follow-up|0|||
48543191|NCT03582826|156177720|FG000|Overall Study|Withdrawal by Subject|2|||
48543192|NCT03582826|156177721|FG001|Overall Study|Withdrawal by Subject|0|||
48543193|NCT01372774|156177725|FG000|Overall Study|Withdrawal prior to treatment|4|||
48608930|NCT01130272|156426866|FG002|Overall Study|Rescue medications due to diarrhea|8|||
48608931|NCT01130272|156426867|FG003|Overall Study|Rescue medications due to diarrhea|8|||
48608932|NCT01130272|156426868|FG004|Overall Study|Rescue medications due to diarrhea|6|||
48608933|NCT01130272|156426864|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
48608934|NCT01130272|156426865|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
48608935|NCT01130272|156426866|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
48608936|NCT01130272|156426867|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
48543194|NCT01372774|156177726|FG001|Overall Study|Withdrawal prior to treatment|5|||
48543195|NCT04669691|156177728|FG000|Overall Study|Death|0|||
48543196|NCT04669691|156177729|FG001|Overall Study|Death|1|||
48543197|NCT04669691|156177730|FG002|Overall Study|Death|0|||
48608937|NCT01130272|156426868|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
48608938|NCT01130272|156426864|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
48608939|NCT01130272|156426865|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
48608940|NCT01130272|156426866|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
48608941|NCT01130272|156426867|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
48608942|NCT01130272|156426868|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
48608943|NCT01130272|156426864|FG000|Overall Study|Protocol Violation|0|||
48608944|NCT01130272|156426865|FG001|Overall Study|Protocol Violation|0|||
48608945|NCT01130272|156426866|FG002|Overall Study|Protocol Violation|3|||
48608946|NCT01130272|156426867|FG003|Overall Study|Protocol Violation|5|||
48608947|NCT01130272|156426868|FG004|Overall Study|Protocol Violation|5|||
48608948|NCT01130272|156426864|FG000|Overall Study|Lost to Follow-up|4|||
48608949|NCT01130272|156426865|FG001|Overall Study|Lost to Follow-up|3|||
48608950|NCT01130272|156426866|FG002|Overall Study|Lost to Follow-up|4|||
48608951|NCT01130272|156426867|FG003|Overall Study|Lost to Follow-up|7|||
48608952|NCT01130272|156426868|FG004|Overall Study|Lost to Follow-up|6|||
48608953|NCT01130272|156426864|FG000|Overall Study|Withdrawal by Subject|4|||
48608954|NCT01130272|156426865|FG001|Overall Study|Withdrawal by Subject|11|||
48608955|NCT01130272|156426866|FG002|Overall Study|Withdrawal by Subject|10|||
48608956|NCT01130272|156426867|FG003|Overall Study|Withdrawal by Subject|9|||
48608957|NCT01130272|156426868|FG004|Overall Study|Withdrawal by Subject|8|||
48608958|NCT01130272|156426864|FG000|Overall Study|Physician Decision|1|||
48608959|NCT01130272|156426865|FG001|Overall Study|Physician Decision|1|||
48608960|NCT01130272|156426866|FG002|Overall Study|Physician Decision|0|||
48608961|NCT01130272|156426867|FG003|Overall Study|Physician Decision|1|||
48608962|NCT01130272|156426868|FG004|Overall Study|Physician Decision|2|||
48608963|NCT01130272|156426864|FG000|Overall Study|Sponsor decision|6|||
48608964|NCT01130272|156426865|FG001|Overall Study|Sponsor decision|15|||
48608965|NCT01130272|156426866|FG002|Overall Study|Sponsor decision|16|||
48608966|NCT01130272|156426867|FG003|Overall Study|Sponsor decision|13|||
48608967|NCT01130272|156426868|FG004|Overall Study|Sponsor decision|16|||
48608968|NCT01130272|156426864|FG000|Overall Study|Study arm discontinued|38|||
48608969|NCT01130272|156426865|FG001|Overall Study|Study arm discontinued|0|||
48543198|NCT04669691|156177731|FG003|Overall Study|Death|0|||
48543199|NCT04669691|156177732|FG004|Overall Study|Death|0|||
48543200|NCT04669691|156177733|FG005|Overall Study|Death|0|||
48543201|NCT04007991|156177734|FG000|Overall Study|Withdrawal by Subject|1|||
48543202|NCT04007991|156177735|FG001|Overall Study|Withdrawal by Subject|1|||
48543203|NCT04007991|156177734|FG000|Overall Study|Physician Decision|1|||
48543204|NCT04007991|156177735|FG001|Overall Study|Physician Decision|1|||
48543205|NCT04007991|156177734|FG000|Overall Study|Non-compliance with Study Drug|0|||
48543206|NCT04007991|156177735|FG001|Overall Study|Non-compliance with Study Drug|1|||
48543207|NCT04007991|156177734|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
48543208|NCT04007991|156177735|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
48543209|NCT04007991|156177734|FG000|Overall Study|Adverse event, non-fatal|5|||
48543210|NCT04007991|156177735|FG001|Overall Study|Adverse event, non-fatal|0|||
48543211|NCT04007991|156177734|FG000|Overall Study|Lost to Follow-up|2|||
48543212|NCT04007991|156177735|FG001|Overall Study|Lost to Follow-up|1|||
48543213|NCT04555720|156177738|FG000|Overall Study|Lost to Follow-up|2|||
48543214|NCT04555720|156177739|FG001|Overall Study|Lost to Follow-up|0|||
48543215|NCT04555720|156177740|FG002|Overall Study|Lost to Follow-up|0|||
48543216|NCT04555720|156177741|FG003|Overall Study|Lost to Follow-up|0|||
48543217|NCT04555720|156177738|FG000|Overall Study|Withdrawal by Subject|4|||
48543218|NCT04555720|156177739|FG001|Overall Study|Withdrawal by Subject|6|||
48543219|NCT04555720|156177740|FG002|Overall Study|Withdrawal by Subject|0|||
48543220|NCT04555720|156177741|FG003|Overall Study|Withdrawal by Subject|0|||
48543221|NCT00278889|156177742|FG000|Overall Study|Withdrawal by Subject|0|||
48543222|NCT00278889|156177743|FG001|Overall Study|Withdrawal by Subject|5|||
48543223|NCT00278889|156177744|FG002|Overall Study|Withdrawal by Subject|3|||
48543224|NCT00278889|156177742|FG000|Overall Study|Lost to Follow-up|1|||
48543225|NCT00278889|156177743|FG001|Overall Study|Lost to Follow-up|1|||
48543226|NCT00278889|156177744|FG002|Overall Study|Lost to Follow-up|0|||
48543227|NCT00278889|156177742|FG000|Overall Study|Death|24|||
48543228|NCT00278889|156177743|FG001|Overall Study|Death|21|||
48543229|NCT00278889|156177744|FG002|Overall Study|Death|17|||
48608970|NCT01130272|156426866|FG002|Overall Study|Study arm discontinued|0|||
48608971|NCT01130272|156426867|FG003|Overall Study|Study arm discontinued|0|||
48608972|NCT01130272|156426868|FG004|Overall Study|Study arm discontinued|0|||
48608973|NCT01294423|156426869|FG000|Overall Study|Adverse Event|1|||
48608974|NCT01294423|156426870|FG001|Overall Study|Adverse Event|2|||
48608975|NCT01294423|156426871|FG002|Overall Study|Adverse Event|3|||
48543230|NCT01995266|156179365|FG000|Overall Study|Death|1|||
48543231|NCT01995266|156179365|FG000|Overall Study|Lack of Efficacy|6|||
48543232|NCT01995266|156179365|FG000|Overall Study|Adverse Event|2|||
48543233|NCT00852969|156179366|FG000|Overall Study|Adverse Event|0|||
48543234|NCT00852969|156179367|FG001|Overall Study|Adverse Event|1|||
48543235|NCT00852969|156179366|FG000|Overall Study|Lost to Follow-up|0|||
48543236|NCT00852969|156179367|FG001|Overall Study|Lost to Follow-up|1|||
48543237|NCT03310411|156179368|FG000|Period 1|Adverse Event|0|||
48543238|NCT03310411|156179369|FG001|Period 1|Adverse Event|0|||
48543239|NCT03310411|156179370|FG002|Period 1|Adverse Event|0|||
48543240|NCT03310411|156179371|FG003|Period 1|Adverse Event|1|||
48608976|NCT01294423|156426869|FG000|Overall Study|Withdrawal by Subject|1|||
48608977|NCT01294423|156426870|FG001|Overall Study|Withdrawal by Subject|2|||
48608978|NCT01294423|156426871|FG002|Overall Study|Withdrawal by Subject|2|||
48608979|NCT01294423|156426869|FG000|Overall Study|subject no longer meets study criteria|2|||
48608980|NCT01294423|156426870|FG001|Overall Study|subject no longer meets study criteria|5|||
48608981|NCT01294423|156426871|FG002|Overall Study|subject no longer meets study criteria|2|||
48608982|NCT01294423|156426869|FG000|Overall Study|poor/non-compliance|1|||
48608983|NCT01294423|156426870|FG001|Overall Study|poor/non-compliance|0|||
48608984|NCT01294423|156426871|FG002|Overall Study|poor/non-compliance|1|||
48608985|NCT00641056|156426872|FG000|Overall Study|Adverse Event|12|||
48608986|NCT00641056|156426873|FG001|Overall Study|Adverse Event|2|||
48608987|NCT00641056|156426872|FG000|Overall Study|Lost to Follow-up|2|||
48608988|NCT00641056|156426873|FG001|Overall Study|Lost to Follow-up|1|||
48608989|NCT00641056|156426872|FG000|Overall Study|Physician Decision|3|||
48543241|NCT00619112|156179372|FG000|Overall Study|Adverse Event|1|||
48543242|NCT00619112|156179373|FG001|Overall Study|Adverse Event|2|||
48543243|NCT00090610|156179374|FG000|Overall Study|Withdrawal by Subject|1|||
48543244|NCT00090610|156179375|FG001|Overall Study|Withdrawal by Subject|1|||
48608990|NCT00641056|156426873|FG001|Overall Study|Physician Decision|1|||
48608991|NCT00641056|156426872|FG000|Overall Study|Protocol Violation|2|||
48608992|NCT00641056|156426873|FG001|Overall Study|Protocol Violation|0|||
48608993|NCT00641056|156426872|FG000|Overall Study|Entry Criteria Not Met|3|||
48608994|NCT00641056|156426873|FG001|Overall Study|Entry Criteria Not Met|0|||
48608995|NCT00641056|156426872|FG000|Overall Study|Subject Decision|6|||
48608996|NCT00641056|156426873|FG001|Overall Study|Subject Decision|19|||
48608997|NCT00641056|156426872|FG000|Overall Study|Sponsor Decision|1|||
48608998|NCT00641056|156426873|FG001|Overall Study|Sponsor Decision|2|||
48608999|NCT01721798|156426876|FG000|Overall Study|Death|0|||
48543245|NCT00807248|156179377|FG000|Overall Study|Adverse Event|1|||
48543246|NCT00807248|156179378|FG001|Overall Study|Adverse Event|2|||
48543247|NCT00807248|156179379|FG002|Overall Study|Adverse Event|2|||
48543248|NCT00807248|156179380|FG003|Overall Study|Adverse Event|6|||
48543249|NCT00807248|156179377|FG000|Overall Study|Lack of Efficacy|14|||
48543250|NCT00807248|156179378|FG001|Overall Study|Lack of Efficacy|4|||
48609000|NCT01721798|156426877|FG001|Overall Study|Death|0|||
48609001|NCT01721798|156426878|FG002|Overall Study|Death|1|||
48543251|NCT00807248|156179379|FG002|Overall Study|Lack of Efficacy|8|||
48543252|NCT00807248|156179380|FG003|Overall Study|Lack of Efficacy|3|||
48543253|NCT00807248|156179377|FG000|Overall Study|Protocol Violation|0|||
48543254|NCT00807248|156179378|FG001|Overall Study|Protocol Violation|1|||
48543255|NCT00807248|156179379|FG002|Overall Study|Protocol Violation|1|||
48543256|NCT00807248|156179380|FG003|Overall Study|Protocol Violation|0|||
48543257|NCT00807248|156179377|FG000|Overall Study|Withdrawal of Consent|5|||
48543258|NCT00807248|156179378|FG001|Overall Study|Withdrawal of Consent|5|||
48543259|NCT00807248|156179379|FG002|Overall Study|Withdrawal of Consent|5|||
48543260|NCT00807248|156179380|FG003|Overall Study|Withdrawal of Consent|5|||
48543261|NCT00807248|156179377|FG000|Overall Study|Lost to Follow-up|1|||
48543262|NCT00807248|156179378|FG001|Overall Study|Lost to Follow-up|0|||
48543263|NCT00807248|156179379|FG002|Overall Study|Lost to Follow-up|0|||
48543264|NCT00807248|156179380|FG003|Overall Study|Lost to Follow-up|0|||
48543265|NCT00807248|156179377|FG000|Overall Study|Other Reason|0|||
48543266|NCT00807248|156179378|FG001|Overall Study|Other Reason|0|||
48543267|NCT00807248|156179379|FG002|Overall Study|Other Reason|2|||
48543268|NCT00807248|156179380|FG003|Overall Study|Other Reason|0|||
48543269|NCT02444793|156179381|FG000|Overall Study|Lost to Follow-up|2|||
48543270|NCT02444793|156179382|FG001|Overall Study|Lost to Follow-up|2|||
48543271|NCT02444793|156179383|FG002|Overall Study|Lost to Follow-up|0|||
48543272|NCT02444793|156179384|FG003|Overall Study|Lost to Follow-up|0|||
48543273|NCT02444793|156179381|FG000|Overall Study|Death|0|||
48609002|NCT01721798|156426879|FG003|Overall Study|Death|1|||
48609003|NCT01721798|156426876|FG000|Overall Study|Lost to Follow-up|2|||
48609004|NCT01721798|156426877|FG001|Overall Study|Lost to Follow-up|2|||
48609005|NCT01721798|156426878|FG002|Overall Study|Lost to Follow-up|9|||
48543274|NCT02444793|156179382|FG001|Overall Study|Death|3|||
48543275|NCT02444793|156179383|FG002|Overall Study|Death|0|||
48543276|NCT02444793|156179384|FG003|Overall Study|Death|0|||
48543277|NCT02444793|156179381|FG000|Overall Study|Other|0|||
48543278|NCT02444793|156179382|FG001|Overall Study|Other|0|||
48543279|NCT02444793|156179383|FG002|Overall Study|Other|2|||
48543280|NCT02444793|156179384|FG003|Overall Study|Other|0|||
48543281|NCT02444793|156179381|FG000|Overall Study|Objective progression or relapse|9|||
48543282|NCT02444793|156179382|FG001|Overall Study|Objective progression or relapse|1|||
48543283|NCT02444793|156179383|FG002|Overall Study|Objective progression or relapse|2|||
48543284|NCT02444793|156179384|FG003|Overall Study|Objective progression or relapse|3|||
48543285|NCT00729248|156179389|FG000|Overall Study|Physician Decision|2|||
48543286|NCT01340768|156179390|FG000|Overall Study|Lost to Follow-up|10|||
48543287|NCT01340768|156179391|FG001|Overall Study|Lost to Follow-up|4|||
48609006|NCT01721798|156426879|FG003|Overall Study|Lost to Follow-up|9|||
48609007|NCT01721798|156426876|FG000|Overall Study|Pregnancy|0|||
48609008|NCT01721798|156426877|FG001|Overall Study|Pregnancy|0|||
48609009|NCT01721798|156426878|FG002|Overall Study|Pregnancy|1|||
48543288|NCT01340768|156179390|FG000|Overall Study|Withdrawal by Subject|5|||
48609010|NCT01721798|156426879|FG003|Overall Study|Pregnancy|1|||
48609011|NCT01721798|156426876|FG000|Overall Study|Withdrawal by Subject|1|||
48609012|NCT01721798|156426877|FG001|Overall Study|Withdrawal by Subject|0|||
48609013|NCT01721798|156426878|FG002|Overall Study|Withdrawal by Subject|2|||
48609014|NCT01721798|156426879|FG003|Overall Study|Withdrawal by Subject|1|||
48609015|NCT01721798|156426876|FG000|Overall Study|Not eligible for 24 month visit|1|||
48609016|NCT01721798|156426877|FG001|Overall Study|Not eligible for 24 month visit|0|||
48543289|NCT01340768|156179391|FG001|Overall Study|Withdrawal by Subject|1|||
48543290|NCT01340768|156179390|FG000|Overall Study|Other|2|||
48543291|NCT01340768|156179391|FG001|Overall Study|Other|0|||
48543292|NCT02408068|156179392|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
48543293|NCT02408068|156179393|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
48543294|NCT02408068|156179394|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
48543295|NCT02408068|156179395|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
48543296|NCT02408068|156179396|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
48543297|NCT02408068|156179397|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
48543298|NCT02712333|156179402|FG000|First Period|Withdrawal by Subject|3|||
48543299|NCT02712333|156179403|FG001|First Period|Withdrawal by Subject|2|||
48543300|NCT00003875|156179404|FG000|Overall Study|Screen Failed|1|||
48543301|NCT00969540|156179405|FG000|Overall Study|Lost to Follow-up|1|||
48543302|NCT00969540|156179406|FG001|Overall Study|Lost to Follow-up|1|||
48543303|NCT00369655|156179407|FG000|Overall Study|Refusal of further treatment|2|||
48543304|NCT03397771|156179408|FG000|Overall Study|2 erroneously randomized, never treated|3|||
48543305|NCT03397771|156179409|FG001|Overall Study|2 erroneously randomized, never treated|1|||
48543306|NCT03397771|156179408|FG000|Overall Study|Withdrawal by Subject|1|||
48543307|NCT03397771|156179409|FG001|Overall Study|Withdrawal by Subject|3|||
48543308|NCT03397771|156179408|FG000|Overall Study|Protocol Violation|2|||
48543309|NCT03397771|156179409|FG001|Overall Study|Protocol Violation|2|||
48543310|NCT03397771|156179408|FG000|Overall Study|Adverse Event|2|||
48543311|NCT03397771|156179409|FG001|Overall Study|Adverse Event|1|||
48543312|NCT03321630|156179412|FG000|Overall Study|Adverse Event|1|||
48543313|NCT03321630|156179412|FG000|Overall Study|Investigator Discretion|2|||
48543314|NCT03321630|156179412|FG000|Overall Study|Withdrawal by Subject|1|||
48609017|NCT01721798|156426878|FG002|Overall Study|Not eligible for 24 month visit|8|||
48609018|NCT01721798|156426879|FG003|Overall Study|Not eligible for 24 month visit|7|||
48609019|NCT00301834|156426880|FG000|Overall Study|Death|1|||
48609020|NCT00336544|156426883|FG000|Overall Study|Lack of Efficacy|8|||
48609021|NCT00336544|156426884|FG001|Overall Study|Lack of Efficacy|5|||
48609022|NCT00336544|156426883|FG000|Overall Study|Adverse Event|4|||
48609023|NCT00336544|156426884|FG001|Overall Study|Adverse Event|9|||
48609024|NCT00336544|156426883|FG000|Overall Study|Withdrawal by Subject|4|||
48609025|NCT00336544|156426884|FG001|Overall Study|Withdrawal by Subject|3|||
48543315|NCT00140426|156179413|FG000|Overall Study|Withdrawal by Subject|0|||
48543316|NCT00140426|156179414|FG001|Overall Study|Withdrawal by Subject|3|||
48543317|NCT02669758|156179415|FG000|Overall Study|Withdrawal by Subject|43|||
48543318|NCT02669758|156179415|FG000|Overall Study|Lost to Follow-up|19|||
48543319|NCT02669758|156179415|FG000|Overall Study|Adverse Event|16|||
48609026|NCT00336544|156426883|FG000|Overall Study|Other|3|||
48609027|NCT00336544|156426884|FG001|Overall Study|Other|5|||
48609028|NCT02119299|156426885|FG000|Overall Study|Withdrawal by Subject|7|||
48543320|NCT02669758|156179415|FG000|Overall Study|Non-Compliance with Study Drug|8|||
48609029|NCT02119299|156426885|FG000|Overall Study|Lack of Efficacy|1|||
48543321|NCT02669758|156179415|FG000|Overall Study|Lack of Efficacy|5|||
48543322|NCT02669758|156179415|FG000|Overall Study|Pregnancy|1|||
48543323|NCT02669758|156179415|FG000|Overall Study|Study noncompliance|1|||
48543324|NCT02669758|156179415|FG000|Overall Study|Protocol Violation|1|||
48543325|NCT02149108|156179416|FG000|Overall Study|Not treated|1|||
48543326|NCT02149108|156179417|FG001|Overall Study|Not treated|2|||
48543327|NCT02149108|156179416|FG000|Overall Study|Progressive Disease (PD)|324|||
48543328|NCT02149108|156179417|FG001|Overall Study|Progressive Disease (PD)|318|||
48543329|NCT02149108|156179416|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
48543330|NCT02149108|156179417|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
48543331|NCT02149108|156179416|FG000|Overall Study|Other Adverse Event (AE)|8|||
48543332|NCT02149108|156179417|FG001|Overall Study|Other Adverse Event (AE)|18|||
48543333|NCT02149108|156179416|FG000|Overall Study|Other not defined above|0|||
48543334|NCT02149108|156179417|FG001|Overall Study|Other not defined above|2|||
48543335|NCT02149108|156179416|FG000|Overall Study|Refusal to continue trial medication|15|||
48543336|NCT02149108|156179417|FG001|Overall Study|Refusal to continue trial medication|11|||
48543337|NCT02149108|156179416|FG000|Overall Study|Lost to Follow-up|1|||
48543338|NCT02149108|156179417|FG001|Overall Study|Lost to Follow-up|0|||
48543339|NCT00950963|156179422|FG000|Overall Study|Lost to Follow-up|29|||
48543340|NCT00950963|156179423|FG001|Overall Study|Lost to Follow-up|24|||
48543341|NCT02455050|156179426|FG000|Treatment Period 1|Lost to Follow-up|1|||
48543342|NCT02455050|156179427|FG001|Treatment Period 1|Lost to Follow-up|1|||
48543343|NCT02455050|156179428|FG002|Treatment Period 1|Lost to Follow-up|1|||
48543344|NCT02455050|156179429|FG003|Treatment Period 1|Lost to Follow-up|2|||
48543345|NCT02455050|156179426|FG000|Treatment Period 2|Lost to Follow-up|1|||
48543346|NCT02455050|156179427|FG001|Treatment Period 2|Lost to Follow-up|0|||
48543347|NCT02455050|156179428|FG002|Treatment Period 2|Lost to Follow-up|2|||
48543348|NCT02455050|156179429|FG003|Treatment Period 2|Lost to Follow-up|1|||
48543349|NCT03402750|156179430|FG000|Overall Study|Lost to Follow-up|2|||
48543350|NCT03402750|156179431|FG001|Overall Study|Lost to Follow-up|1|||
48543351|NCT04168190|156179432|FG000|Overall Study|Lost to Follow-up|0|||
48543352|NCT04168190|156179433|FG001|Overall Study|Lost to Follow-up|1|||
48543353|NCT04168190|156179434|FG002|Overall Study|Lost to Follow-up|0|||
48543354|NCT04168190|156179435|FG003|Overall Study|Lost to Follow-up|7|||
48609030|NCT02119299|156426885|FG000|Overall Study|Pregnancy|1|||
48609031|NCT00486044|156426894|FG000|Overall Study|Withdrawal by Subject|2|||
48609032|NCT00486044|156426895|FG001|Overall Study|Withdrawal by Subject|1|||
48609033|NCT00486044|156426894|FG000|Overall Study|Adverse Event|0|||
48609034|NCT00486044|156426895|FG001|Overall Study|Adverse Event|1|||
48609035|NCT00486044|156426894|FG000|Overall Study|Lost to Follow-up|0|||
48609036|NCT00486044|156426895|FG001|Overall Study|Lost to Follow-up|1|||
48609037|NCT02737722|156426896|FG000|Overall Study|Physician Decision|0|||
48609038|NCT02737722|156426897|FG001|Overall Study|Physician Decision|0|||
48609039|NCT02737722|156426898|FG002|Overall Study|Physician Decision|1|||
48609040|NCT02737722|156426899|FG003|Overall Study|Physician Decision|0|||
48609041|NCT01026493|156426900|FG000|Overall Study|Protocol Violation|0|||
48609042|NCT01026493|156426901|FG001|Overall Study|Protocol Violation|1|||
48609043|NCT01026493|156426902|FG002|Overall Study|Protocol Violation|0|||
48609044|NCT01026493|156426903|FG003|Overall Study|Protocol Violation|0|||
48609045|NCT01026493|156426904|FG004|Overall Study|Protocol Violation|2|||
48609046|NCT01026493|156426905|FG005|Overall Study|Protocol Violation|3|||
48609047|NCT01026493|156426906|FG006|Overall Study|Protocol Violation|4|||
48609048|NCT01026493|156426907|FG007|Overall Study|Protocol Violation|1|||
48609049|NCT01206764|156426908|FG000|Overall Study|Adverse Event|20|||
48609050|NCT01206764|156426908|FG000|Overall Study|Abnormal laboratory value|2|||
48609051|NCT01206764|156426908|FG000|Overall Study|Abnormal test procedure result|1|||
48609052|NCT01206764|156426908|FG000|Overall Study|Patient withdrew consent|5|||
48609053|NCT01206764|156426908|FG000|Overall Study|Lost to Follow-up|6|||
48543355|NCT04168190|156179436|FG004|Overall Study|Lost to Follow-up|5|||
48543356|NCT04168190|156179432|FG000|Overall Study|Withdrawal by Subject|1|||
48543357|NCT04168190|156179433|FG001|Overall Study|Withdrawal by Subject|0|||
48609054|NCT01206764|156426908|FG000|Overall Study|Death|11|||
48609055|NCT01206764|156426908|FG000|Overall Study|New cancer therapy|2|||
48609056|NCT01206764|156426908|FG000|Overall Study|Disease progression|88|||
48609057|NCT01206764|156426908|FG000|Overall Study|Protocol deviation|3|||
48609058|NCT00314145|156426909|FG000|Overall Study|Withdrawal by Subject|8|||
48609059|NCT00314145|156426910|FG001|Overall Study|Withdrawal by Subject|10|||
48609060|NCT00314145|156426909|FG000|Overall Study|Lost to Follow-up|5|||
48609061|NCT00314145|156426910|FG001|Overall Study|Lost to Follow-up|12|||
48609062|NCT00314145|156426909|FG000|Overall Study|Physician Decision|3|||
48609063|NCT00314145|156426910|FG001|Overall Study|Physician Decision|4|||
48609064|NCT00314145|156426909|FG000|Overall Study|Adverse Event|0|||
48609065|NCT00314145|156426910|FG001|Overall Study|Adverse Event|3|||
48609066|NCT00314145|156426909|FG000|Overall Study|Protocol Violation|3|||
48609067|NCT00314145|156426910|FG001|Overall Study|Protocol Violation|0|||
48609068|NCT00314145|156426909|FG000|Overall Study|Sponsor Decision|2|||
48609069|NCT00314145|156426910|FG001|Overall Study|Sponsor Decision|0|||
48609070|NCT02029417|156426911|FG000|Overall Study|Death|1|||
48609071|NCT02029417|156426911|FG000|Overall Study|Adverse Event|1|||
48609072|NCT05259917|156426912|FG000|Overall Study|Protocol Violation|0|||
48609073|NCT05259917|156426913|FG001|Overall Study|Protocol Violation|0|||
48609074|NCT05259917|156426914|FG002|Overall Study|Protocol Violation|1|||
48609075|NCT05259917|156426915|FG003|Overall Study|Protocol Violation|0|||
48609076|NCT05259917|156426916|FG004|Overall Study|Protocol Violation|0|||
48609077|NCT05259917|156426917|FG005|Overall Study|Protocol Violation|0|||
48609078|NCT05259917|156426912|FG000|Overall Study|Lost to Follow-up|0|||
48609079|NCT05259917|156426913|FG001|Overall Study|Lost to Follow-up|0|||
48543358|NCT04168190|156179434|FG002|Overall Study|Withdrawal by Subject|0|||
48543359|NCT04168190|156179435|FG003|Overall Study|Withdrawal by Subject|2|||
48543360|NCT04168190|156179436|FG004|Overall Study|Withdrawal by Subject|4|||
48543361|NCT04168190|156179432|FG000|Overall Study|Death|0|||
48543362|NCT04168190|156179433|FG001|Overall Study|Death|0|||
48543363|NCT04168190|156179434|FG002|Overall Study|Death|0|||
48543364|NCT04168190|156179435|FG003|Overall Study|Death|1|||
48543365|NCT04168190|156179436|FG004|Overall Study|Death|0|||
48543366|NCT03469336|156179437|FG000|Overall Study|Adverse Event|1|||
48543367|NCT00886288|156179439|FG000|Overall Study|no respect of the 12 weeks period|657|||
48543368|NCT00886288|156179440|FG001|Overall Study|no respect of the 12 weeks period|227|||
48543369|NCT00886288|156179439|FG000|Overall Study|Lost to Follow-up|86|||
48543370|NCT00886288|156179440|FG001|Overall Study|Lost to Follow-up|0|||
48543371|NCT01259115|156179441|FG000|Period 1|Adverse Event|1|||
48543372|NCT01259115|156179442|FG001|Period 1|Adverse Event|0|||
48609080|NCT05259917|156426914|FG002|Overall Study|Lost to Follow-up|1|||
48609081|NCT05259917|156426915|FG003|Overall Study|Lost to Follow-up|0|||
48543373|NCT01259115|156179441|FG000|Period 1|Protocol Violation|2|||
48543374|NCT01259115|156179442|FG001|Period 1|Protocol Violation|0|||
48543375|NCT01259115|156179441|FG000|Period 1|Lost to Follow-up|0|||
48609082|NCT05259917|156426916|FG004|Overall Study|Lost to Follow-up|0|||
48609083|NCT05259917|156426917|FG005|Overall Study|Lost to Follow-up|1|||
48609084|NCT05259917|156426912|FG000|Overall Study|Physician Decision|0|||
48609085|NCT05259917|156426913|FG001|Overall Study|Physician Decision|1|||
48609086|NCT05259917|156426914|FG002|Overall Study|Physician Decision|0|||
48543376|NCT01259115|156179442|FG001|Period 1|Lost to Follow-up|1|||
48543377|NCT01259115|156179441|FG000|Period 2|Adverse Event|1|||
48543378|NCT01259115|156179442|FG001|Period 2|Adverse Event|0|||
48543379|NCT01675661|156179443|FG000|Overall Study|Lost to Follow-up|22|||
48543380|NCT01675661|156179444|FG001|Overall Study|Lost to Follow-up|23|||
48543381|NCT01675661|156179443|FG000|Overall Study|Practical problems|9|||
48543382|NCT01675661|156179444|FG001|Overall Study|Practical problems|5|||
48543383|NCT01675661|156179443|FG000|Overall Study|Moved away|5|||
48543384|NCT01675661|156179444|FG001|Overall Study|Moved away|6|||
48543385|NCT01675661|156179443|FG000|Overall Study|Withdrawal by Subject|3|||
48543386|NCT01675661|156179444|FG001|Overall Study|Withdrawal by Subject|7|||
48543387|NCT01675661|156179443|FG000|Overall Study|Physician Decision|0|||
48543388|NCT01675661|156179444|FG001|Overall Study|Physician Decision|2|||
48543389|NCT01675661|156179443|FG000|Overall Study|Death|0|||
48543390|NCT01675661|156179444|FG001|Overall Study|Death|1|||
48543391|NCT01675661|156179443|FG000|Overall Study|Other reason|1|||
48543392|NCT01675661|156179444|FG001|Overall Study|Other reason|2|||
48543393|NCT00742924|156179446|FG000|Overall Study|Adverse Event|0|||
48543394|NCT00742924|156179447|FG001|Overall Study|Adverse Event|0|||
48543395|NCT00742924|156179448|FG002|Overall Study|Adverse Event|1|||
48543396|NCT00742924|156179449|FG003|Overall Study|Adverse Event|1|||
48543397|NCT00742924|156179446|FG000|Overall Study|Lack of Efficacy|5|||
48543398|NCT00742924|156179447|FG001|Overall Study|Lack of Efficacy|1|||
48543399|NCT00742924|156179448|FG002|Overall Study|Lack of Efficacy|2|||
48543400|NCT00742924|156179449|FG003|Overall Study|Lack of Efficacy|4|||
48543401|NCT00742924|156179446|FG000|Overall Study|Physician Decision|0|||
48543402|NCT00742924|156179447|FG001|Overall Study|Physician Decision|0|||
48543403|NCT00742924|156179448|FG002|Overall Study|Physician Decision|0|||
48543404|NCT00742924|156179449|FG003|Overall Study|Physician Decision|1|||
48543405|NCT00742924|156179446|FG000|Overall Study|Withdrawal by Subject|0|||
48543406|NCT00742924|156179447|FG001|Overall Study|Withdrawal by Subject|1|||
48543407|NCT00742924|156179448|FG002|Overall Study|Withdrawal by Subject|1|||
48543408|NCT00742924|156179449|FG003|Overall Study|Withdrawal by Subject|0|||
48543409|NCT00080938|156179450|FG000|Overall Study|Adverse Event|3|||
48543410|NCT00080938|156179450|FG000|Overall Study|Withdrawal by Subject|6|||
48543411|NCT00080938|156179450|FG000|Overall Study|Death|2|||
48543412|NCT00080938|156179450|FG000|Overall Study|Lack of Efficacy|7|||
48543413|NCT00080938|156179450|FG000|Overall Study|other disease|1|||
48543414|NCT00080938|156179450|FG000|Overall Study|Not started protocol therapy|1|||
48543415|NCT00080938|156179450|FG000|Overall Study|Ineligible|4|||
48543416|NCT02317614|156179453|FG000|Overall Study|Lost to Follow-up|1|||
48543417|NCT02317614|156179454|FG001|Overall Study|Lost to Follow-up|1|||
48543418|NCT02317614|156179453|FG000|Overall Study|Withdrawal by Subject|1|||
48543419|NCT02317614|156179454|FG001|Overall Study|Withdrawal by Subject|0|||
48543420|NCT02317614|156179453|FG000|Overall Study|Death|1|||
48543421|NCT02317614|156179454|FG001|Overall Study|Death|1|||
48543422|NCT00160641|156179456|FG000|Overall Study|Adverse Event|102|||
48543423|NCT00160641|156179456|FG000|Overall Study|Withdrawal by Subject|87|||
48543424|NCT00160641|156179456|FG000|Overall Study|Lost to Follow-up|8|||
48543425|NCT00160641|156179456|FG000|Overall Study|Lack of Efficacy|12|||
48543426|NCT00160641|156179456|FG000|Overall Study|Protocol Violation|3|||
48543427|NCT00160641|156179456|FG000|Overall Study|Other|9|||
48543428|NCT00369317|156179461|FG000|Overall Study|Adverse Event|3|||
48543429|NCT00369317|156179461|FG000|Overall Study|Death|1|||
48543430|NCT00369317|156179461|FG000|Overall Study|Lack of Efficacy|5|||
48543431|NCT00369317|156179461|FG000|Overall Study|Physician Decision|2|||
48543432|NCT00369317|156179461|FG000|Overall Study|Withdrawal by Subject|8|||
48543433|NCT00369317|156179461|FG000|Overall Study|Ineligible|1|||
48543434|NCT02365558|156179462|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
48609087|NCT05259917|156426915|FG003|Overall Study|Physician Decision|0|||
48609088|NCT05259917|156426916|FG004|Overall Study|Physician Decision|0|||
48609089|NCT05259917|156426917|FG005|Overall Study|Physician Decision|0|||
48609090|NCT05259917|156426912|FG000|Overall Study|Withdrawal by Subject|0|||
48609091|NCT05259917|156426913|FG001|Overall Study|Withdrawal by Subject|1|||
48609092|NCT05259917|156426914|FG002|Overall Study|Withdrawal by Subject|0|||
48609093|NCT05259917|156426915|FG003|Overall Study|Withdrawal by Subject|0|||
48609094|NCT05259917|156426916|FG004|Overall Study|Withdrawal by Subject|1|||
48609095|NCT05259917|156426917|FG005|Overall Study|Withdrawal by Subject|1|||
48609096|NCT05259917|156426912|FG000|Overall Study|Trial Termination by Sponsor|7|||
48609097|NCT05259917|156426913|FG001|Overall Study|Trial Termination by Sponsor|2|||
48609098|NCT05259917|156426914|FG002|Overall Study|Trial Termination by Sponsor|3|||
48609099|NCT05259917|156426915|FG003|Overall Study|Trial Termination by Sponsor|5|||
48609100|NCT05259917|156426916|FG004|Overall Study|Trial Termination by Sponsor|11|||
48609101|NCT05259917|156426917|FG005|Overall Study|Trial Termination by Sponsor|4|||
48609102|NCT05259917|156426912|FG000|Overall Study|Other|1|||
48609103|NCT05259917|156426913|FG001|Overall Study|Other|0|||
48609104|NCT05259917|156426914|FG002|Overall Study|Other|2|||
48543435|NCT02365558|156179463|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
48543436|NCT02365558|156179462|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
48543437|NCT02365558|156179463|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
48543438|NCT02011386|156179464|FG000|Overall Study|Non-compliance|2|||
48543439|NCT02011386|156179464|FG000|Overall Study|Lack of Efficacy|3|||
48543440|NCT03365011|156179465|FG000|Overall Study|Withdrawal by Subject|1|||
48543441|NCT03365011|156179466|FG001|Overall Study|Withdrawal by Subject|2|||
48609105|NCT05259917|156426915|FG003|Overall Study|Other|0|||
48609106|NCT05259917|156426916|FG004|Overall Study|Other|0|||
48609107|NCT05259917|156426917|FG005|Overall Study|Other|0|||
48609108|NCT01933594|156426919|FG000|Overall Study|Lost to Follow-up|1|||
48609109|NCT01933594|156426920|FG001|Overall Study|Lost to Follow-up|0|||
48609110|NCT01933594|156426921|FG002|Overall Study|Lost to Follow-up|0|||
48609111|NCT01933594|156426922|FG003|Overall Study|Lost to Follow-up|0|||
48609112|NCT01933594|156426923|FG004|Overall Study|Lost to Follow-up|1|||
48609113|NCT01933594|156426924|FG005|Overall Study|Lost to Follow-up|0|||
48609114|NCT01933594|156426919|FG000|Overall Study|Ineligible for subsequent study step|0|||
48609115|NCT01933594|156426920|FG001|Overall Study|Ineligible for subsequent study step|0|||
48609116|NCT01933594|156426921|FG002|Overall Study|Ineligible for subsequent study step|0|||
48609117|NCT01933594|156426922|FG003|Overall Study|Ineligible for subsequent study step|0|||
48609118|NCT01933594|156426923|FG004|Overall Study|Ineligible for subsequent study step|1|||
48609119|NCT01933594|156426924|FG005|Overall Study|Ineligible for subsequent study step|0|||
48543442|NCT01193127|156179467|FG000|Randomized|Surgery Cancelled|0|||
48543443|NCT01193127|156179468|FG001|Randomized|Surgery Cancelled|0|||
48543444|NCT01193127|156179469|FG002|Randomized|Surgery Cancelled|0|||
48543445|NCT01193127|156179470|FG003|Randomized|Surgery Cancelled|1|||
48543446|NCT01193127|156179467|FG000|Treated|Withdrawal by Subject|0|||
48543447|NCT01193127|156179468|FG001|Treated|Withdrawal by Subject|0|||
48543448|NCT01193127|156179469|FG002|Treated|Withdrawal by Subject|0|||
48543449|NCT01193127|156179470|FG003|Treated|Withdrawal by Subject|1|||
48543450|NCT03246646|156179475|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
48543451|NCT03246646|156179476|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
48543452|NCT03246646|156179475|FG000|Overall Study|Withdrawal by Subject|3|||
48543453|NCT03246646|156179476|FG001|Overall Study|Withdrawal by Subject|0|||
48543454|NCT03246646|156179475|FG000|Overall Study|Lost to Follow-up|7|||
48543455|NCT03246646|156179476|FG001|Overall Study|Lost to Follow-up|0|||
48543456|NCT00319982|156179479|FG000|Overall Study|Withdrawal by Subject|1|||
48543457|NCT00319982|156179480|FG001|Overall Study|Withdrawal by Subject|0|||
48543458|NCT00761865|156179481|FG000|Overall Study|Lost to Follow-up|8|||
48543459|NCT00761865|156179482|FG001|Overall Study|Lost to Follow-up|7|||
48543460|NCT02351960|156179483|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
48609120|NCT03329885|156426930|FG000|Overall Study|Sponsor discontinued the study early|0|||
48543461|NCT02351960|156179484|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
48543462|NCT02351960|156179483|FG000|Overall Study|Voluntary Withdrawal|5|||
48543463|NCT02351960|156179484|FG001|Overall Study|Voluntary Withdrawal|4|||
48543464|NCT02351960|156179483|FG000|Overall Study|Significant Protocol Deviation|0|||
48609121|NCT03329885|156426931|FG001|Overall Study|Sponsor discontinued the study early|0|||
48543465|NCT02351960|156179484|FG001|Overall Study|Significant Protocol Deviation|5|||
48543466|NCT00259272|156179485|FG000|Overall Study|Adverse Event|2|||
48543467|NCT00259272|156179486|FG001|Overall Study|Adverse Event|1|||
48543468|NCT00259272|156179487|FG002|Overall Study|Adverse Event|0|||
48543469|NCT00259272|156179488|FG003|Overall Study|Adverse Event|3|||
48543470|NCT00259272|156179485|FG000|Overall Study|Lack of Efficacy|5|||
48543471|NCT00259272|156179486|FG001|Overall Study|Lack of Efficacy|1|||
48543472|NCT00259272|156179487|FG002|Overall Study|Lack of Efficacy|2|||
48543473|NCT00259272|156179488|FG003|Overall Study|Lack of Efficacy|6|||
48543474|NCT00259272|156179485|FG000|Overall Study|Physician Decision|1|||
48543475|NCT00259272|156179486|FG001|Overall Study|Physician Decision|2|||
48543476|NCT00259272|156179487|FG002|Overall Study|Physician Decision|1|||
48543477|NCT00259272|156179488|FG003|Overall Study|Physician Decision|3|||
48543478|NCT00259272|156179485|FG000|Overall Study|Protocol Violation|2|||
48543479|NCT00259272|156179486|FG001|Overall Study|Protocol Violation|0|||
48543480|NCT00259272|156179487|FG002|Overall Study|Protocol Violation|0|||
48543481|NCT00259272|156179488|FG003|Overall Study|Protocol Violation|1|||
48543482|NCT00259272|156179485|FG000|Overall Study|Sponsor Decision|0|||
48543483|NCT00259272|156179486|FG001|Overall Study|Sponsor Decision|1|||
48543484|NCT00259272|156179487|FG002|Overall Study|Sponsor Decision|0|||
48543485|NCT00259272|156179488|FG003|Overall Study|Sponsor Decision|0|||
48543486|NCT00259272|156179485|FG000|Overall Study|Withdrawal by Subject|4|||
48543487|NCT00259272|156179486|FG001|Overall Study|Withdrawal by Subject|2|||
48543488|NCT00259272|156179487|FG002|Overall Study|Withdrawal by Subject|2|||
48543489|NCT00259272|156179488|FG003|Overall Study|Withdrawal by Subject|7|||
48543490|NCT00259272|156179485|FG000|Overall Study|Lost to Follow-up|1|||
48543491|NCT00259272|156179486|FG001|Overall Study|Lost to Follow-up|0|||
48543492|NCT00259272|156179487|FG002|Overall Study|Lost to Follow-up|0|||
48543493|NCT00259272|156179488|FG003|Overall Study|Lost to Follow-up|1|||
48543494|NCT00574912|156179489|FG000|Overall Study|Could not place IV lines.|3|||
48543495|NCT00574912|156179489|FG000|Overall Study|scheduling conflicts|3|||
48543496|NCT00574912|156179489|FG000|Overall Study|Physician Decision|2|||
48543497|NCT00103610|156179492|FG000|Overall Study|Entered Rescue Procedure|10|||
48543498|NCT00103610|156179493|FG001|Overall Study|Entered Rescue Procedure|52|||
48543499|NCT00103610|156179492|FG000|Overall Study|Death|16|||
48543500|NCT00103610|156179493|FG001|Overall Study|Death|12|||
48543501|NCT00103610|156179492|FG000|Overall Study|Elective Withdrawal|4|||
48543502|NCT00103610|156179493|FG001|Overall Study|Elective Withdrawal|0|||
48543503|NCT00103610|156179492|FG000|Overall Study|Lost to Follow-up|3|||
48543504|NCT00103610|156179493|FG001|Overall Study|Lost to Follow-up|1|||
48543505|NCT00103610|156179492|FG000|Overall Study|Adverse Event|2|||
48543506|NCT00103610|156179493|FG001|Overall Study|Adverse Event|2|||
48543507|NCT00103610|156179492|FG000|Overall Study|Other|2|||
48543508|NCT00103610|156179493|FG001|Overall Study|Other|7|||
48543509|NCT00103610|156179492|FG000|Overall Study|Failed mobilization|1|||
48543510|NCT00103610|156179493|FG001|Overall Study|Failed mobilization|5|||
48543511|NCT00103610|156179492|FG000|Overall Study|Noncompliance|0|||
48543512|NCT00103610|156179493|FG001|Overall Study|Noncompliance|1|||
48543513|NCT03301623|156179494|FG000|Overall Study|Death|3|||
48543514|NCT03301623|156179495|FG001|Overall Study|Death|1|||
48543515|NCT03301623|156179494|FG000|Overall Study|Withdrawal by Subject|11|||
48543516|NCT03301623|156179495|FG001|Overall Study|Withdrawal by Subject|13|||
48543517|NCT03301623|156179494|FG000|Overall Study|Lost to Follow-up|3|||
48543518|NCT03301623|156179495|FG001|Overall Study|Lost to Follow-up|1|||
48543519|NCT03866902|156179497|FG000|Overall Study|Lost to Follow-up|98|||
48609122|NCT03329885|156426932|FG002|Overall Study|Sponsor discontinued the study early|0|||
48609123|NCT03329885|156426933|FG003|Overall Study|Sponsor discontinued the study early|0|||
48609124|NCT03329885|156426934|FG004|Overall Study|Sponsor discontinued the study early|0|||
48609125|NCT03329885|156426935|FG005|Overall Study|Sponsor discontinued the study early|0|||
48609126|NCT03329885|156426936|FG006|Overall Study|Sponsor discontinued the study early|1|||
48609127|NCT03329885|156426937|FG007|Overall Study|Sponsor discontinued the study early|1|||
48609128|NCT03329885|156426938|FG008|Overall Study|Sponsor discontinued the study early|0|||
48609129|NCT02908347|156426939|FG000|Overall Study|Adverse Event|0|||
48609130|NCT02908347|156426940|FG001|Overall Study|Adverse Event|1|||
48609131|NCT02908347|156426939|FG000|Overall Study|Lost to Follow-up|1|||
48609132|NCT02908347|156426940|FG001|Overall Study|Lost to Follow-up|0|||
48609133|NCT03886272|156426941|FG000|Period 1|Withdrawal by Subject|0|||
48609134|NCT03886272|156426942|FG001|Period 1|Withdrawal by Subject|0|||
48609135|NCT03886272|156426943|FG002|Period 1|Withdrawal by Subject|0|||
48609136|NCT03886272|156426944|FG003|Period 1|Withdrawal by Subject|0|||
48543520|NCT03866902|156179498|FG001|Overall Study|Lost to Follow-up|82|||
48543521|NCT03866902|156179497|FG000|Overall Study|Pregnancy|18|||
48543522|NCT03866902|156179498|FG001|Overall Study|Pregnancy|24|||
48543523|NCT01806506|156179502|FG000|Overall Study|Lost to Follow-up|2|||
48543524|NCT01806506|156179503|FG001|Overall Study|Lost to Follow-up|1|||
48543525|NCT01288053|156182747|FG000|Overall Study|Death|1|||
48543526|NCT03623386|156182748|FG000|Overall Study|Protocol Violation|3|||
48543527|NCT03623386|156182749|FG001|Overall Study|Protocol Violation|2|||
48543528|NCT03623386|156182750|FG002|Overall Study|Protocol Violation|0|||
48543529|NCT03623386|156182748|FG000|Overall Study|Physician Decision|1|||
48543530|NCT03623386|156182749|FG001|Overall Study|Physician Decision|1|||
48543531|NCT03623386|156182750|FG002|Overall Study|Physician Decision|0|||
48543532|NCT03623386|156182748|FG000|Overall Study|Lost to Follow-up|0|||
48543533|NCT03623386|156182749|FG001|Overall Study|Lost to Follow-up|2|||
48543534|NCT03623386|156182750|FG002|Overall Study|Lost to Follow-up|0|||
48543535|NCT03623386|156182748|FG000|Overall Study|COVID-19|0|||
48543536|NCT03623386|156182749|FG001|Overall Study|COVID-19|1|||
48543537|NCT03623386|156182750|FG002|Overall Study|COVID-19|0|||
48543538|NCT03188666|156182751|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
48543539|NCT03188666|156182752|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
48543540|NCT03188666|156182753|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
48543541|NCT03188666|156182754|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
48543542|NCT03188666|156182751|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
48543543|NCT03188666|156182752|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
48543544|NCT03188666|156182753|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
48543545|NCT03188666|156182754|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
48543546|NCT03188666|156182751|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
48543547|NCT03188666|156182752|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
48543548|NCT03188666|156182753|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
48543549|NCT03188666|156182754|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
48543550|NCT03188666|156182751|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
48543551|NCT03188666|156182752|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
48543552|NCT03188666|156182753|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
48543553|NCT03188666|156182754|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
48543554|NCT02504671|156182763|FG000|Overall Study|Withdrawal by Subject|1|||
48543555|NCT02504671|156182764|FG001|Overall Study|Withdrawal by Subject|5|||
48543556|NCT02504671|156182765|FG002|Overall Study|Withdrawal by Subject|4|||
48543557|NCT02504671|156182766|FG003|Overall Study|Withdrawal by Subject|4|||
48543558|NCT02504671|156182767|FG004|Overall Study|Withdrawal by Subject|5|||
48543559|NCT02504671|156182768|FG005|Overall Study|Withdrawal by Subject|3|||
48543560|NCT02504671|156182763|FG000|Overall Study|Lack of Efficacy|1|||
48543561|NCT02504671|156182764|FG001|Overall Study|Lack of Efficacy|3|||
48609137|NCT03886272|156426945|FG004|Period 1|Withdrawal by Subject|0|||
48543562|NCT02504671|156182765|FG002|Overall Study|Lack of Efficacy|1|||
48543563|NCT02504671|156182766|FG003|Overall Study|Lack of Efficacy|0|||
48543564|NCT02504671|156182767|FG004|Overall Study|Lack of Efficacy|4|||
48609138|NCT03886272|156426946|FG005|Period 1|Withdrawal by Subject|1|||
48609139|NCT03886272|156426947|FG006|Period 1|Withdrawal by Subject|0|||
48609140|NCT00325416|156426948|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
48609141|NCT00325416|156426949|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
48543565|NCT02504671|156182768|FG005|Overall Study|Lack of Efficacy|4|||
48543566|NCT02504671|156182763|FG000|Overall Study|Adverse Event|1|||
48543567|NCT02504671|156182764|FG001|Overall Study|Adverse Event|1|||
48543568|NCT02504671|156182765|FG002|Overall Study|Adverse Event|0|||
48543569|NCT02504671|156182766|FG003|Overall Study|Adverse Event|1|||
48543570|NCT02504671|156182767|FG004|Overall Study|Adverse Event|0|||
48543571|NCT02504671|156182768|FG005|Overall Study|Adverse Event|2|||
48543572|NCT02504671|156182763|FG000|Overall Study|Protocol Violation|2|||
48543573|NCT02504671|156182764|FG001|Overall Study|Protocol Violation|1|||
48609142|NCT00325416|156426948|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
48543574|NCT02504671|156182765|FG002|Overall Study|Protocol Violation|0|||
48543575|NCT02504671|156182766|FG003|Overall Study|Protocol Violation|0|||
48543576|NCT02504671|156182767|FG004|Overall Study|Protocol Violation|0|||
48543577|NCT02504671|156182768|FG005|Overall Study|Protocol Violation|1|||
48543578|NCT02504671|156182763|FG000|Overall Study|Lost to Follow-up|0|||
48543579|NCT02504671|156182764|FG001|Overall Study|Lost to Follow-up|0|||
48543580|NCT02504671|156182765|FG002|Overall Study|Lost to Follow-up|2|||
48543581|NCT02504671|156182766|FG003|Overall Study|Lost to Follow-up|0|||
48543582|NCT02504671|156182767|FG004|Overall Study|Lost to Follow-up|0|||
48543583|NCT02504671|156182768|FG005|Overall Study|Lost to Follow-up|1|||
48543584|NCT02504671|156182763|FG000|Overall Study|Protocol defined stopping criteria|7|||
48609143|NCT00325416|156426949|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
48609144|NCT00325416|156426948|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
48609145|NCT00325416|156426949|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
48609146|NCT00325416|156426948|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
48609147|NCT00325416|156426949|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
48609148|NCT00325416|156426948|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
48609149|NCT00325416|156426949|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
48609150|NCT00325416|156426948|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
48609151|NCT00325416|156426949|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
48609152|NCT01299909|156426950|FG000|Overall Study|Lost to Follow-up|22|||
48609153|NCT01299909|156426951|FG001|Overall Study|Lost to Follow-up|18|||
48609154|NCT01299909|156426952|FG002|Overall Study|Lost to Follow-up|17|||
48609155|NCT02340949|156426953|FG000|Overall Study|Adverse Event|4|||
48609156|NCT02340949|156426954|FG001|Overall Study|Adverse Event|2|||
48609157|NCT02340949|156426953|FG000|Overall Study|Withdrawal by Subject|2|||
48609158|NCT02340949|156426954|FG001|Overall Study|Withdrawal by Subject|0|||
48609159|NCT02340949|156426953|FG000|Overall Study|Progression disease|6|||
48609160|NCT02340949|156426954|FG001|Overall Study|Progression disease|2|||
48609161|NCT02340949|156426953|FG000|Overall Study|Death|3|||
48609162|NCT02340949|156426954|FG001|Overall Study|Death|0|||
48609163|NCT02340949|156426953|FG000|Overall Study|Physician Decision|1|||
48609164|NCT02340949|156426954|FG001|Overall Study|Physician Decision|0|||
48609165|NCT01277861|156426957|FG000|Overall Study|Physician Decision|2|||
48609166|NCT01277861|156426958|FG001|Overall Study|Physician Decision|2|||
48609167|NCT01349595|156426970|FG000|Overall Study|Lack of funding|2|||
48609168|NCT01349595|156426971|FG001|Overall Study|Lack of funding|2|||
48609169|NCT01937299|156426972|FG000|Overall Study|Adverse Event|13|||
48609170|NCT01937299|156426973|FG001|Overall Study|Adverse Event|0|||
48543585|NCT02504671|156182764|FG001|Overall Study|Protocol defined stopping criteria|4|||
48609171|NCT01937299|156426972|FG000|Overall Study|Lack of Efficacy|0|||
48609172|NCT01937299|156426973|FG001|Overall Study|Lack of Efficacy|4|||
48609173|NCT01937299|156426972|FG000|Overall Study|Withdrawal by Subject|1|||
48609174|NCT01937299|156426973|FG001|Overall Study|Withdrawal by Subject|0|||
48609175|NCT00385840|156426974|FG000|Overall Study|Adverse Event|1|||
48609176|NCT00385840|156426975|FG001|Overall Study|Adverse Event|1|||
48609177|NCT00385840|156426974|FG000|Overall Study|Lost to Follow-up|3|||
48609178|NCT00385840|156426975|FG001|Overall Study|Lost to Follow-up|13|||
48543586|NCT02504671|156182765|FG002|Overall Study|Protocol defined stopping criteria|3|||
48543587|NCT02504671|156182766|FG003|Overall Study|Protocol defined stopping criteria|5|||
48543588|NCT02504671|156182767|FG004|Overall Study|Protocol defined stopping criteria|3|||
48543589|NCT02504671|156182768|FG005|Overall Study|Protocol defined stopping criteria|3|||
48609179|NCT00921024|156426977|FG000|Overall Study|Lost to Follow-up|2|||
48609180|NCT00921024|156426978|FG001|Overall Study|Lost to Follow-up|0|||
48609181|NCT00921024|156426977|FG000|Overall Study|Received concomittant therapy|2|||
48609182|NCT00921024|156426978|FG001|Overall Study|Received concomittant therapy|0|||
48609183|NCT00921024|156426977|FG000|Overall Study|Withdrawal by Subject|0|||
48609184|NCT00921024|156426978|FG001|Overall Study|Withdrawal by Subject|3|||
48609185|NCT02074514|156426981|FG000|Overall Study|Lack of Efficacy|3|||
48609186|NCT02074514|156426982|FG001|Overall Study|Lack of Efficacy|2|||
48609187|NCT02074514|156426981|FG000|Overall Study|Lost to Follow-up|0|||
48609188|NCT02074514|156426982|FG001|Overall Study|Lost to Follow-up|1|||
48609189|NCT02074514|156426981|FG000|Overall Study|Withdrew Consent|0|||
48609190|NCT02074514|156426982|FG001|Overall Study|Withdrew Consent|1|||
48543590|NCT01996332|156182769|FG000|Overall Study|Adverse Event|117|||
48609191|NCT03069989|156426984|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
48692908|NCT03137992|156724647|FG001|Washout Period 1|COPD Exacerbation|1|||
48543591|NCT01996332|156182769|FG000|Overall Study|Lack of Efficacy|1245|||
48543592|NCT01996332|156182769|FG000|Overall Study|Death|264|||
48543593|NCT01996332|156182769|FG000|Overall Study|Protocol Violation|9|||
48543594|NCT01996332|156182769|FG000|Overall Study|Withdrawal by Subject|71|||
48543595|NCT01996332|156182769|FG000|Overall Study|Other|20|||
48543596|NCT01996332|156182769|FG000|Overall Study|Clinical Deterioration|28|||
48543597|NCT01996332|156182769|FG000|Overall Study|Physician Decision|17|||
48543598|NCT01996332|156182769|FG000|Overall Study|Lost to Follow-up|34|||
48543599|NCT00210249|156182770|FG000|Overall Study|Lost to Follow-up|5|||
48543600|NCT00210249|156182770|FG000|Overall Study|Protocol Violation|11|||
48543601|NCT02113189|156182771|FG000|Overall Study|Lost to follow up|2|||
48543602|NCT02113189|156182772|FG001|Overall Study|Lost to follow up|1|||
48543603|NCT02113189|156182773|FG002|Overall Study|Lost to follow up|3|||
48543604|NCT03222583|156182776|FG000|Overall Study|Withdrawal by Subject|3|||
48543605|NCT03222583|156182777|FG001|Overall Study|Withdrawal by Subject|3|||
48543606|NCT03222583|156182776|FG000|Overall Study|Lost to Follow-up|1|||
48543607|NCT03222583|156182777|FG001|Overall Study|Lost to Follow-up|0|||
48543608|NCT03222583|156182776|FG000|Overall Study|Other|1|||
48543609|NCT03222583|156182777|FG001|Overall Study|Other|3|||
48543610|NCT03573505|156182778|FG000|Overall Study|Adverse Event|1|||
48543611|NCT03573505|156182779|FG001|Overall Study|Adverse Event|1|||
48543612|NCT03573505|156182778|FG000|Overall Study|Consent withdrawn|0|||
48543613|NCT03573505|156182779|FG001|Overall Study|Consent withdrawn|1|||
48543614|NCT03573505|156182778|FG000|Overall Study|Disease progression|0|||
48543615|NCT03573505|156182779|FG001|Overall Study|Disease progression|1|||
48543616|NCT03573505|156182778|FG000|Overall Study|Site Terminated by Sponsor|1|||
48543617|NCT03573505|156182779|FG001|Overall Study|Site Terminated by Sponsor|1|||
48543618|NCT03573505|156182778|FG000|Overall Study|Study terminated by sponsor|50|||
48543619|NCT03573505|156182779|FG001|Overall Study|Study terminated by sponsor|45|||
48543620|NCT03573505|156182778|FG000|Overall Study|Reason not specified|0|||
48543621|NCT03573505|156182779|FG001|Overall Study|Reason not specified|1|||
48543622|NCT03573505|156182778|FG000|Overall Study|Death|0|||
48543623|NCT03573505|156182779|FG001|Overall Study|Death|4|||
48543624|NCT04280705|156182780|FG000|Overall Study|Enrolled but not treated|4|||
48543625|NCT04280705|156182781|FG001|Overall Study|Enrolled but not treated|10|||
48543626|NCT04280705|156182780|FG000|Overall Study|Physician Decision|1|||
48543627|NCT04280705|156182781|FG001|Overall Study|Physician Decision|0|||
48543628|NCT04280705|156182780|FG000|Overall Study|Withdrawal by Subject|7|||
48543629|NCT04280705|156182781|FG001|Overall Study|Withdrawal by Subject|9|||
48543630|NCT04280705|156182780|FG000|Overall Study|Adverse Event|0|||
48543631|NCT04280705|156182781|FG001|Overall Study|Adverse Event|4|||
48543632|NCT04280705|156182780|FG000|Overall Study|Transferred to another hospital|1|||
48543633|NCT04280705|156182781|FG001|Overall Study|Transferred to another hospital|1|||
48543634|NCT04078126|156182784|FG000|Washout|Study put on hold due to COVID-19|0|||
48543635|NCT04078126|156182785|FG001|Washout|Study put on hold due to COVID-19|2|||
48543636|NCT04078126|156182784|FG000|Period 2|Study put on hold due to COVID-19|1|||
48543637|NCT04078126|156182785|FG001|Period 2|Study put on hold due to COVID-19|1|||
48543638|NCT00806286|156182786|FG000|Overall Study|Adverse Event|5|||
48543639|NCT00806286|156182787|FG001|Overall Study|Adverse Event|2|||
48609192|NCT03069989|156426985|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
48609193|NCT01416571|156426986|FG000|Overall Study|Lost to Follow-up|2|||
48609194|NCT02371616|156428773|FG000|Overall Study|Protocol Violation|2|||
48609195|NCT02371616|156428774|FG001|Overall Study|Protocol Violation|1|||
48609196|NCT02371616|156428773|FG000|Overall Study|Adverse Event|0|||
48609197|NCT02371616|156428774|FG001|Overall Study|Adverse Event|1|||
48609198|NCT02371616|156428773|FG000|Overall Study|Withdrawal of Consent|1|||
48609199|NCT02371616|156428774|FG001|Overall Study|Withdrawal of Consent|0|||
48609200|NCT02371616|156428773|FG000|Overall Study|Other (Not specified)|1|||
48609201|NCT02371616|156428774|FG001|Overall Study|Other (Not specified)|5|||
48609202|NCT00593814|156428793|FG000|Overall Study|Death|7|||
48609203|NCT00593814|156428794|FG001|Overall Study|Death|0|||
48609204|NCT00593814|156428793|FG000|Overall Study|Withdrawal by Subject|7|||
48609205|NCT00593814|156428794|FG001|Overall Study|Withdrawal by Subject|0|||
48609206|NCT00593814|156428793|FG000|Overall Study|Lost to Follow-up|7|||
48609207|NCT00593814|156428794|FG001|Overall Study|Lost to Follow-up|0|||
48609208|NCT00593814|156428793|FG000|Overall Study|Physician Decision|3|||
48609209|NCT00593814|156428794|FG001|Overall Study|Physician Decision|0|||
48609210|NCT00557466|156428795|FG000|Overall Study|Adverse Event|3|||
48609211|NCT00557466|156428796|FG001|Overall Study|Adverse Event|1|||
48609212|NCT00557466|156428797|FG002|Overall Study|Adverse Event|4|||
48609213|NCT00557466|156428798|FG003|Overall Study|Adverse Event|1|||
48609214|NCT00557466|156428799|FG004|Overall Study|Adverse Event|2|||
48609215|NCT00557466|156428800|FG005|Overall Study|Adverse Event|4|||
48609216|NCT00557466|156428795|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48609217|NCT00557466|156428796|FG001|Overall Study|Abnormal laboratory value(s)|2|||
48609218|NCT00557466|156428797|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48609219|NCT00557466|156428798|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48609220|NCT00557466|156428799|FG004|Overall Study|Abnormal laboratory value(s)|0|||
48609221|NCT00557466|156428800|FG005|Overall Study|Abnormal laboratory value(s)|0|||
48609222|NCT00557466|156428795|FG000|Overall Study|Protocol deviation|0|||
48609223|NCT00557466|156428796|FG001|Overall Study|Protocol deviation|1|||
48609224|NCT00557466|156428797|FG002|Overall Study|Protocol deviation|0|||
48609225|NCT00557466|156428798|FG003|Overall Study|Protocol deviation|2|||
48609226|NCT00557466|156428799|FG004|Overall Study|Protocol deviation|0|||
48609227|NCT00557466|156428800|FG005|Overall Study|Protocol deviation|0|||
48609228|NCT00557466|156428795|FG000|Overall Study|Subject withdrew consent|0|||
48609229|NCT00557466|156428796|FG001|Overall Study|Subject withdrew consent|0|||
48609230|NCT00557466|156428797|FG002|Overall Study|Subject withdrew consent|0|||
48609231|NCT00557466|156428798|FG003|Overall Study|Subject withdrew consent|0|||
48609232|NCT00557466|156428799|FG004|Overall Study|Subject withdrew consent|1|||
48609233|NCT00557466|156428800|FG005|Overall Study|Subject withdrew consent|2|||
48609234|NCT00557466|156428795|FG000|Overall Study|Administrative problems|0|||
48609235|NCT00557466|156428796|FG001|Overall Study|Administrative problems|1|||
48609236|NCT00557466|156428797|FG002|Overall Study|Administrative problems|1|||
48609237|NCT00557466|156428798|FG003|Overall Study|Administrative problems|0|||
48609238|NCT00557466|156428799|FG004|Overall Study|Administrative problems|0|||
48609239|NCT00557466|156428800|FG005|Overall Study|Administrative problems|0|||
48609240|NCT00557466|156428795|FG000|Overall Study|Abnormal test procedure results|0|||
48609241|NCT00557466|156428796|FG001|Overall Study|Abnormal test procedure results|0|||
48609242|NCT00557466|156428797|FG002|Overall Study|Abnormal test procedure results|1|||
48609243|NCT00557466|156428798|FG003|Overall Study|Abnormal test procedure results|0|||
48609244|NCT00557466|156428799|FG004|Overall Study|Abnormal test procedure results|0|||
48609245|NCT00557466|156428800|FG005|Overall Study|Abnormal test procedure results|0|||
48609246|NCT00557466|156428795|FG000|Overall Study|Lost to Follow-up|0|||
48609247|NCT00557466|156428796|FG001|Overall Study|Lost to Follow-up|0|||
48609248|NCT00557466|156428797|FG002|Overall Study|Lost to Follow-up|0|||
48609249|NCT00557466|156428798|FG003|Overall Study|Lost to Follow-up|1|||
48609250|NCT00557466|156428799|FG004|Overall Study|Lost to Follow-up|0|||
48609251|NCT00557466|156428800|FG005|Overall Study|Lost to Follow-up|0|||
48609252|NCT00947544|156428813|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
48609253|NCT00947544|156428814|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
48609254|NCT03408899|156428815|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
48609255|NCT04745351|156428816|FG000|Overall Study|Death|51|||
48609256|NCT04745351|156428817|FG001|Overall Study|Death|25|||
48609257|NCT04745351|156428816|FG000|Overall Study|Lost to Follow-up|9|||
48609258|NCT04745351|156428817|FG001|Overall Study|Lost to Follow-up|3|||
48609259|NCT04745351|156428816|FG000|Overall Study|Randomized but Never Treated|3|||
48609260|NCT04745351|156428817|FG001|Overall Study|Randomized but Never Treated|3|||
48609261|NCT04745351|156428816|FG000|Overall Study|Adverse Event|4|||
48609262|NCT04745351|156428817|FG001|Overall Study|Adverse Event|0|||
48609263|NCT04745351|156428816|FG000|Overall Study|Withdrew Consent|1|||
48609264|NCT04745351|156428817|FG001|Overall Study|Withdrew Consent|2|||
48609265|NCT04745351|156428816|FG000|Overall Study|Investigator's Discretion|2|||
48609266|NCT04745351|156428817|FG001|Overall Study|Investigator's Discretion|0|||
48609267|NCT04745351|156428816|FG000|Overall Study|Protocol Violation|1|||
48609268|NCT04745351|156428817|FG001|Overall Study|Protocol Violation|0|||
48609269|NCT00900562|156428818|FG000|Overall Study|Progressive disease|9|||
48609270|NCT00900562|156428819|FG001|Overall Study|Progressive disease|5|||
48609271|NCT00900562|156428818|FG000|Overall Study|Toxicity|1|||
48609272|NCT00900562|156428819|FG001|Overall Study|Toxicity|0|||
48609273|NCT00900562|156428818|FG000|Overall Study|Death|1|||
48609274|NCT00900562|156428819|FG001|Overall Study|Death|1|||
48609275|NCT00900562|156428818|FG000|Overall Study|Withdrawal by Subject|0|||
48609276|NCT00900562|156428819|FG001|Overall Study|Withdrawal by Subject|1|||
48609277|NCT00900562|156428818|FG000|Overall Study|Unrelated adverse event|1|||
48609278|NCT00900562|156428819|FG001|Overall Study|Unrelated adverse event|0|||
48609279|NCT02426684|156428820|FG000|Overall Study|Physician Decision|1|||
48609280|NCT01715298|156428821|FG000|Overall Study|Lost to Follow-up|0|||
48609281|NCT01715298|156428822|FG001|Overall Study|Lost to Follow-up|2|||
48609282|NCT01715298|156428821|FG000|Overall Study|Patient/guardian decision|7|||
48609283|NCT01715298|156428822|FG001|Overall Study|Patient/guardian decision|9|||
48609284|NCT01126424|156428823|FG000|Overall Study|Adverse Event|0|||
48609285|NCT01126424|156428824|FG001|Overall Study|Adverse Event|0|||
48609286|NCT01126424|156428825|FG002|Overall Study|Adverse Event|0|||
48609287|NCT01126424|156428826|FG003|Overall Study|Adverse Event|0|||
48609288|NCT01126424|156428827|FG004|Overall Study|Adverse Event|1|||
48609289|NCT01126424|156428828|FG005|Overall Study|Adverse Event|0|||
48609290|NCT01126424|156428823|FG000|Overall Study|Withdrawal by Subject|0|||
48609291|NCT01126424|156428824|FG001|Overall Study|Withdrawal by Subject|0|||
48609292|NCT01126424|156428825|FG002|Overall Study|Withdrawal by Subject|1|||
48609293|NCT01126424|156428826|FG003|Overall Study|Withdrawal by Subject|3|||
48609294|NCT01126424|156428827|FG004|Overall Study|Withdrawal by Subject|1|||
48609295|NCT01126424|156428828|FG005|Overall Study|Withdrawal by Subject|0|||
48609296|NCT00426270|156428829|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
48543640|NCT00806286|156182788|FG002|Overall Study|Adverse Event|0|||
48543641|NCT00806286|156182786|FG000|Overall Study|Disease progression|31|||
48543642|NCT00806286|156182787|FG001|Overall Study|Disease progression|38|||
48543643|NCT00806286|156182788|FG002|Overall Study|Disease progression|1|||
48543644|NCT00806286|156182786|FG000|Overall Study|Death|1|||
48543645|NCT00806286|156182787|FG001|Overall Study|Death|6|||
48543646|NCT00806286|156182788|FG002|Overall Study|Death|0|||
48543647|NCT00806286|156182786|FG000|Overall Study|Lost to Follow-up|0|||
48543648|NCT00806286|156182787|FG001|Overall Study|Lost to Follow-up|1|||
48543649|NCT00806286|156182788|FG002|Overall Study|Lost to Follow-up|0|||
48543650|NCT00806286|156182786|FG000|Overall Study|Withdrawal by Subject|8|||
48543651|NCT00806286|156182787|FG001|Overall Study|Withdrawal by Subject|3|||
48543652|NCT00806286|156182788|FG002|Overall Study|Withdrawal by Subject|1|||
48543653|NCT00806286|156182786|FG000|Overall Study|Physician Decision|2|||
48543654|NCT00806286|156182787|FG001|Overall Study|Physician Decision|2|||
48543655|NCT00806286|156182788|FG002|Overall Study|Physician Decision|0|||
48543656|NCT00806286|156182786|FG000|Overall Study|Due to a variety of reasons|7|||
48543657|NCT00806286|156182787|FG001|Overall Study|Due to a variety of reasons|2|||
48543658|NCT00806286|156182788|FG002|Overall Study|Due to a variety of reasons|1|||
48609297|NCT00426270|156428829|FG000|Overall Study|Adverse Event|5|||
48609298|NCT01603602|156428830|FG000|Overall Study|Adverse Event|1|||
48609299|NCT01603602|156428831|FG001|Overall Study|Adverse Event|0|||
48609300|NCT01603602|156428832|FG002|Overall Study|Adverse Event|0|||
48609301|NCT01603602|156428830|FG000|Overall Study|Personal Reasons|1|||
48609302|NCT01603602|156428831|FG001|Overall Study|Personal Reasons|0|||
48609303|NCT01603602|156428832|FG002|Overall Study|Personal Reasons|1|||
48609304|NCT01117870|156428834|FG000|Overall Study|Inability to place needle|1|||
48609305|NCT01117870|156428835|FG001|Overall Study|Inability to place needle|0|||
48543659|NCT02628743|156182790|FG000|Overall Study|Other|3|||
48609306|NCT00083915|156428838|FG000|Overall Study|Death|6|||
48609307|NCT00083915|156428839|FG001|Overall Study|Death|3|||
48543660|NCT02628743|156182790|FG000|Overall Study|Withdrawal by Subject|50|||
48543661|NCT02628743|156182790|FG000|Overall Study|Study Terminated by Sponsor|76|||
48543662|NCT02628743|156182790|FG000|Overall Study|Physician Decision|2|||
48543663|NCT02981303|156182791|FG000|Overall Study|Progressive Disease|17|||
48609308|NCT00083915|156428838|FG000|Overall Study|Physician Decision|11|||
48609309|NCT00083915|156428839|FG001|Overall Study|Physician Decision|6|||
48609310|NCT00083915|156428838|FG000|Overall Study|Withdrawal by Subject|8|||
48609311|NCT00083915|156428839|FG001|Overall Study|Withdrawal by Subject|3|||
48609312|NCT00083915|156428838|FG000|Overall Study|disease progression|18|||
48609313|NCT00083915|156428839|FG001|Overall Study|disease progression|23|||
48609314|NCT00083915|156428838|FG000|Overall Study|Failure to collect|3|||
48609315|NCT00083915|156428839|FG001|Overall Study|Failure to collect|0|||
48543664|NCT02981303|156182792|FG001|Overall Study|Progressive Disease|37|||
48543665|NCT02981303|156182791|FG000|Overall Study|Adverse Event|1|||
48543666|NCT02981303|156182792|FG001|Overall Study|Adverse Event|4|||
48543667|NCT02981303|156182791|FG000|Overall Study|Withdrawal by Subject|0|||
48609316|NCT00083915|156428838|FG000|Overall Study|No response|3|||
48609317|NCT00083915|156428839|FG001|Overall Study|No response|1|||
48609318|NCT00083915|156428838|FG000|Overall Study|Insurance issues|1|||
48609319|NCT00083915|156428839|FG001|Overall Study|Insurance issues|1|||
48609320|NCT02089347|156428840|FG000|Overall Study|Protocol Violation|1|||
48609321|NCT02089347|156428841|FG001|Overall Study|Protocol Violation|0|||
48609322|NCT03530293|156428842|FG000|Pre-randomization|Adverse Event|12|||
48609323|NCT03530293|156428843|FG001|Pre-randomization|Adverse Event|0|||
48609324|NCT03530293|156428844|FG002|Pre-randomization|Adverse Event|0|||
48543668|NCT02981303|156182792|FG001|Overall Study|Withdrawal by Subject|1|||
48543669|NCT00686075|156182793|FG000|Overall Study|Withdrawal by Subject|4|||
48543670|NCT00686075|156182794|FG001|Overall Study|Withdrawal by Subject|3|||
48543671|NCT00686075|156182795|FG002|Overall Study|Withdrawal by Subject|3|||
48543672|NCT00686075|156182796|FG003|Overall Study|Withdrawal by Subject|7|||
48543673|NCT00686075|156182797|FG004|Overall Study|Withdrawal by Subject|1|||
48543674|NCT00686075|156182798|FG005|Overall Study|Withdrawal by Subject|0|||
48543675|NCT00686075|156182799|FG006|Overall Study|Withdrawal by Subject|0|||
48543676|NCT00686075|156182800|FG007|Overall Study|Withdrawal by Subject|2|||
48543677|NCT00686075|156182801|FG008|Overall Study|Withdrawal by Subject|4|||
48543678|NCT00686075|156182802|FG009|Overall Study|Withdrawal by Subject|6|||
48543679|NCT00686075|156182793|FG000|Overall Study|Lost to Follow-up|3|||
48543680|NCT00686075|156182794|FG001|Overall Study|Lost to Follow-up|6|||
48543681|NCT00686075|156182795|FG002|Overall Study|Lost to Follow-up|3|||
48543682|NCT00686075|156182796|FG003|Overall Study|Lost to Follow-up|2|||
48543683|NCT00686075|156182797|FG004|Overall Study|Lost to Follow-up|3|||
48543684|NCT00686075|156182798|FG005|Overall Study|Lost to Follow-up|3|||
48543685|NCT00686075|156182799|FG006|Overall Study|Lost to Follow-up|0|||
48543686|NCT00686075|156182800|FG007|Overall Study|Lost to Follow-up|0|||
48543687|NCT00686075|156182801|FG008|Overall Study|Lost to Follow-up|2|||
48543688|NCT00686075|156182802|FG009|Overall Study|Lost to Follow-up|3|||
48543689|NCT00686075|156182793|FG000|Overall Study|Other|1|||
48543690|NCT00686075|156182794|FG001|Overall Study|Other|1|||
48543691|NCT00686075|156182795|FG002|Overall Study|Other|0|||
48543692|NCT00686075|156182796|FG003|Overall Study|Other|0|||
48543693|NCT00686075|156182797|FG004|Overall Study|Other|0|||
48543694|NCT00686075|156182798|FG005|Overall Study|Other|0|||
48543695|NCT00686075|156182799|FG006|Overall Study|Other|0|||
48543696|NCT00686075|156182800|FG007|Overall Study|Other|0|||
48543697|NCT00686075|156182801|FG008|Overall Study|Other|0|||
48543698|NCT00686075|156182802|FG009|Overall Study|Other|1|||
48543699|NCT02932306|156182803|FG000|Overall Study|Withdrawal by Subject|16|||
48543700|NCT02932306|156182804|FG001|Overall Study|Withdrawal by Subject|25|||
48543701|NCT02932306|156182803|FG000|Overall Study|Adverse Event|3|||
48543702|NCT02932306|156182804|FG001|Overall Study|Adverse Event|0|||
48543703|NCT02932306|156182803|FG000|Overall Study|Pregnancy|2|||
48543704|NCT02932306|156182804|FG001|Overall Study|Pregnancy|0|||
48543705|NCT02932306|156182803|FG000|Overall Study|Protocol Violation|1|||
48543706|NCT02932306|156182804|FG001|Overall Study|Protocol Violation|1|||
48543707|NCT02932306|156182803|FG000|Overall Study|Noncompliance with Study Drug|1|||
48543708|NCT02932306|156182804|FG001|Overall Study|Noncompliance with Study Drug|1|||
48543709|NCT02932306|156182803|FG000|Overall Study|Lost to Follow-up|36|||
48543710|NCT02932306|156182804|FG001|Overall Study|Lost to Follow-up|40|||
48543711|NCT02932306|156182803|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
48543712|NCT02932306|156182804|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
48543713|NCT02932306|156182803|FG000|Overall Study|Lack of Efficacy|0|||
48543714|NCT02932306|156182804|FG001|Overall Study|Lack of Efficacy|2|||
48543715|NCT02932306|156182803|FG000|Overall Study|Worsening condition|2|||
48543716|NCT02932306|156182804|FG001|Overall Study|Worsening condition|0|||
48543717|NCT02932306|156182803|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
48609325|NCT03530293|156428842|FG000|Pre-randomization|Protocol Violation|2|||
48609326|NCT03530293|156428843|FG001|Pre-randomization|Protocol Violation|0|||
48609327|NCT03530293|156428844|FG002|Pre-randomization|Protocol Violation|0|||
48609328|NCT03530293|156428842|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
48609329|NCT03530293|156428843|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
48609330|NCT03530293|156428844|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
48609331|NCT03530293|156428842|FG000|Pre-randomization|Withdrawal by Subject|5|||
48609332|NCT03530293|156428843|FG001|Pre-randomization|Withdrawal by Subject|0|||
48609333|NCT03530293|156428844|FG002|Pre-randomization|Withdrawal by Subject|0|||
48543718|NCT02932306|156182804|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
48543719|NCT02325518|156182805|FG000|Overall Study|Adverse Event|4|||
48543720|NCT02325518|156182806|FG001|Overall Study|Adverse Event|1|||
48543721|NCT02325518|156182805|FG000|Overall Study|Physician Decision|0|||
48543722|NCT02325518|156182806|FG001|Overall Study|Physician Decision|1|||
48543723|NCT02325518|156182805|FG000|Overall Study|Withdrawal by Subject|0|||
48543724|NCT02325518|156182806|FG001|Overall Study|Withdrawal by Subject|1|||
48543725|NCT04715932|156182807|FG000|Overall Study|Lost to Follow-up|1|||
48543726|NCT04715932|156182808|FG001|Overall Study|Lost to Follow-up|0|||
48543727|NCT02740699|156182821|FG000|Overall Study|Lost to Follow-up|5|||
48543728|NCT02740699|156182821|FG000|Overall Study|Withdrawal by Subject|14|||
48543729|NCT02740699|156182821|FG000|Overall Study|Physician Decision|5|||
48543730|NCT03393806|156182823|FG000|Overall Study|Physician Decision|1|||
48543731|NCT03393806|156182824|FG001|Overall Study|Physician Decision|0|||
48543732|NCT02534844|156182825|FG000|Part B|Withdrawal by Subject|0|||
48543733|NCT02534844|156182826|FG001|Part B|Withdrawal by Subject|0|||
48543734|NCT02534844|156182827|FG002|Part B|Withdrawal by Subject|0|||
48543735|NCT02534844|156182828|FG003|Part B|Withdrawal by Subject|0|||
48543736|NCT02534844|156182829|FG004|Part B|Withdrawal by Subject|2|||
48543737|NCT02534844|156182830|FG005|Part B|Withdrawal by Subject|1|||
48543738|NCT02731326|156182831|FG000|Overall Study|Withdrawal by Subject|4|||
48543739|NCT02731326|156182832|FG001|Overall Study|Withdrawal by Subject|1|||
48543740|NCT02731326|156182831|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
48543741|NCT02731326|156182832|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
48543742|NCT02731326|156182831|FG000|Overall Study|Discharged without AliveCor|10|||
48543743|NCT02731326|156182832|FG001|Overall Study|Discharged without AliveCor|0|||
48543744|NCT02731326|156182831|FG000|Overall Study|Duplicate Participant|1|||
48543745|NCT02731326|156182832|FG001|Overall Study|Duplicate Participant|1|||
48543746|NCT02393248|156182833|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543747|NCT02393248|156182834|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
48543748|NCT02393248|156182835|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543749|NCT02393248|156182836|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543750|NCT02393248|156182837|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543751|NCT02393248|156182838|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
48543752|NCT02393248|156182839|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
48543753|NCT02393248|156182840|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543754|NCT02393248|156182841|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48609334|NCT03530293|156428842|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
48609335|NCT03530293|156428843|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
48609336|NCT03530293|156428844|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
48609337|NCT03530293|156428842|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
48609338|NCT03530293|156428843|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
48609339|NCT03530293|156428844|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
48609340|NCT03530293|156428842|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
48609341|NCT03530293|156428843|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
48609342|NCT03530293|156428844|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
48609343|NCT03530293|156428842|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
48609344|NCT03530293|156428843|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
48609345|NCT03530293|156428844|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
48609346|NCT03530293|156428842|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
48609347|NCT03530293|156428843|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
48609348|NCT03530293|156428844|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
48543755|NCT02393248|156182842|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543756|NCT02393248|156182843|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543757|NCT02393248|156182844|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48609349|NCT00719901|156428845|FG000|Overall Study|Adverse Event|5|||
48543758|NCT02393248|156182845|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543759|NCT02393248|156182846|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543760|NCT02393248|156182847|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543761|NCT02393248|156182848|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543762|NCT02393248|156182849|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543763|NCT02393248|156182850|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543764|NCT02393248|156182851|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543765|NCT02393248|156182852|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543766|NCT02393248|156182853|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543767|NCT02393248|156182854|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543768|NCT02393248|156182855|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543769|NCT02393248|156182856|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543770|NCT02393248|156182857|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
48543771|NCT02393248|156182833|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543772|NCT02393248|156182834|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
48543773|NCT02393248|156182835|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543774|NCT02393248|156182836|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543775|NCT02393248|156182837|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543776|NCT02393248|156182838|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543777|NCT02393248|156182839|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543778|NCT02393248|156182840|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543779|NCT02393248|156182841|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543780|NCT02393248|156182842|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543781|NCT02393248|156182843|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543782|NCT02393248|156182844|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543783|NCT02393248|156182845|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543784|NCT02393248|156182846|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543785|NCT02393248|156182847|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543786|NCT02393248|156182848|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543787|NCT02393248|156182849|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543788|NCT02393248|156182850|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543789|NCT02393248|156182851|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543790|NCT02393248|156182852|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543791|NCT02393248|156182853|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543792|NCT02393248|156182854|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543793|NCT02393248|156182855|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543794|NCT02393248|156182856|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543795|NCT02393248|156182857|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
48543796|NCT02393248|156182833|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
48543797|NCT02393248|156182834|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
48543798|NCT02393248|156182835|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
48543799|NCT02393248|156182836|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
48543800|NCT02393248|156182837|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
48543801|NCT02393248|156182838|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
48543802|NCT02393248|156182839|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
48543803|NCT02393248|156182840|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
48543804|NCT02393248|156182841|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
48543805|NCT02393248|156182842|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
48543806|NCT02393248|156182843|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
48543807|NCT02393248|156182844|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
48543808|NCT02393248|156182845|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
48543809|NCT02393248|156182846|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
48543810|NCT02393248|156182847|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
48543811|NCT02393248|156182848|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
48543812|NCT02393248|156182849|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
48543813|NCT02393248|156182850|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
48543814|NCT02393248|156182851|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
48543815|NCT02393248|156182852|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
48543816|NCT02393248|156182853|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
48543817|NCT02393248|156182854|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
48543818|NCT02393248|156182855|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
48543819|NCT02393248|156182856|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
48543820|NCT02393248|156182857|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
48543821|NCT02393248|156182833|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
48543822|NCT02393248|156182834|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543823|NCT02393248|156182835|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543824|NCT02393248|156182836|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543825|NCT02393248|156182837|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543826|NCT02393248|156182838|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543827|NCT02393248|156182839|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543828|NCT02393248|156182840|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543829|NCT02393248|156182841|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543830|NCT02393248|156182842|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543831|NCT02393248|156182843|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543832|NCT02393248|156182844|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543833|NCT02393248|156182845|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543834|NCT02393248|156182846|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543835|NCT02393248|156182847|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543836|NCT02393248|156182848|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543837|NCT02393248|156182849|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543838|NCT02393248|156182850|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543839|NCT02393248|156182851|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543840|NCT02393248|156182852|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543841|NCT02393248|156182853|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543842|NCT02393248|156182854|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543843|NCT02393248|156182855|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543844|NCT02393248|156182856|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543845|NCT02393248|156182857|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
48543846|NCT02393248|156182833|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543847|NCT02393248|156182834|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543848|NCT02393248|156182835|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543849|NCT02393248|156182836|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543850|NCT02393248|156182837|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543851|NCT02393248|156182838|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
48543852|NCT02393248|156182839|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
48543853|NCT02393248|156182840|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543854|NCT02393248|156182841|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543855|NCT02393248|156182842|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
48543856|NCT02393248|156182843|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543857|NCT02393248|156182844|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543858|NCT02393248|156182845|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543859|NCT02393248|156182846|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543860|NCT02393248|156182847|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543861|NCT02393248|156182848|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543862|NCT02393248|156182849|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543863|NCT02393248|156182850|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543864|NCT02393248|156182851|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543865|NCT02393248|156182852|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543866|NCT02393248|156182853|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543867|NCT02393248|156182854|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543868|NCT02393248|156182855|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543869|NCT02393248|156182856|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543870|NCT02393248|156182857|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
48543871|NCT02393248|156182833|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543872|NCT02393248|156182834|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543873|NCT02393248|156182835|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543874|NCT02393248|156182836|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543875|NCT02393248|156182837|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543876|NCT02393248|156182838|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543877|NCT02393248|156182839|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
48543878|NCT02393248|156182840|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543879|NCT02393248|156182841|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543880|NCT02393248|156182842|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543881|NCT02393248|156182843|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543882|NCT02393248|156182844|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543883|NCT02393248|156182845|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543884|NCT02393248|156182846|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543885|NCT02393248|156182847|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543886|NCT02393248|156182848|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543887|NCT02393248|156182849|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543888|NCT02393248|156182850|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543889|NCT02393248|156182851|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543890|NCT02393248|156182852|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543891|NCT02393248|156182853|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543892|NCT02393248|156182854|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543893|NCT02393248|156182855|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543894|NCT02393248|156182856|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543895|NCT02393248|156182857|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
48543896|NCT02393248|156182833|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543897|NCT02393248|156182834|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543898|NCT02393248|156182835|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543899|NCT02393248|156182836|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543900|NCT02393248|156182837|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543901|NCT02393248|156182838|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543902|NCT02393248|156182839|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543903|NCT02393248|156182840|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543904|NCT02393248|156182841|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543905|NCT02393248|156182842|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543906|NCT02393248|156182843|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48609350|NCT00719901|156428845|FG000|Overall Study|Withdrawal by Subject|1|||
48543907|NCT02393248|156182844|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
48543908|NCT02393248|156182845|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
48543909|NCT02393248|156182846|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
48543910|NCT02393248|156182847|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
48543911|NCT02393248|156182848|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48609351|NCT00719901|156428845|FG000|Overall Study|Alternate Treatment|1|||
48609352|NCT00719901|156428845|FG000|Overall Study|Disease Progression|3|||
48609353|NCT00719901|156428845|FG000|Overall Study|Availability of Study Drug|1|||
48609354|NCT02765035|156428846|FG000|First Intervention (90 Days)|Adverse Event|1|||
48609355|NCT02765035|156428847|FG001|First Intervention (90 Days)|Adverse Event|1|||
48609356|NCT02765035|156428846|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
48609357|NCT02765035|156428847|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
48609358|NCT00891813|156428849|FG000|Overall Study|Adverse Event|3|||
48609359|NCT00891813|156428849|FG000|Overall Study|Withdrawal by Subject|1|||
48609360|NCT00891813|156428849|FG000|Overall Study|Patient Noncompliance|6|||
48609361|NCT00891813|156428849|FG000|Overall Study|Protocol Violation|2|||
48609362|NCT01712178|156428850|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
48609363|NCT01712178|156428851|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
48609364|NCT01712178|156428850|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
48609365|NCT01712178|156428851|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
48609366|NCT01712178|156428850|FG000|Overall Study|Lost to Follow-up|0|||
48609367|NCT01712178|156428851|FG001|Overall Study|Lost to Follow-up|1|||
48609368|NCT01122173|156428852|FG000|Overall Study|Lost to Follow-up|3|||
48609369|NCT01122173|156428852|FG000|Overall Study|Withdrawal by Subject|3|||
48609370|NCT01122173|156428852|FG000|Overall Study|Left study for other reasons|3|||
48609371|NCT00856180|156428855|FG000|Overall Study|Adverse Event|4|||
48609372|NCT00856180|156428855|FG000|Overall Study|Progressive Disease|16|||
48609373|NCT02265510|156428856|FG000|Overall Study|Withdrawal by Subject|1|||
48609374|NCT02265510|156428857|FG001|Overall Study|Withdrawal by Subject|1|||
48609375|NCT02265510|156428858|FG002|Overall Study|Withdrawal by Subject|2|||
48609376|NCT02265510|156428859|FG003|Overall Study|Withdrawal by Subject|1|||
48609377|NCT02265510|156428860|FG004|Overall Study|Withdrawal by Subject|0|||
48609378|NCT02265510|156428861|FG005|Overall Study|Withdrawal by Subject|2|||
48609379|NCT02265510|156428862|FG006|Overall Study|Withdrawal by Subject|0|||
48609380|NCT02265510|156428863|FG007|Overall Study|Withdrawal by Subject|2|||
48609381|NCT02265510|156428864|FG008|Overall Study|Withdrawal by Subject|0|||
48609382|NCT02265510|156428865|FG009|Overall Study|Withdrawal by Subject|0|||
48609383|NCT02265510|156428866|FG010|Overall Study|Withdrawal by Subject|0|||
48609384|NCT02265510|156428867|FG011|Overall Study|Withdrawal by Subject|0|||
48609385|NCT02265510|156428868|FG012|Overall Study|Withdrawal by Subject|1|||
48609386|NCT02265510|156428869|FG013|Overall Study|Withdrawal by Subject|0|||
48609387|NCT02265510|156428856|FG000|Overall Study|Disease Progression|0|||
48609388|NCT02265510|156428857|FG001|Overall Study|Disease Progression|1|||
48609389|NCT02265510|156428858|FG002|Overall Study|Disease Progression|2|||
48609390|NCT02265510|156428859|FG003|Overall Study|Disease Progression|1|||
48609391|NCT02265510|156428860|FG004|Overall Study|Disease Progression|1|||
48609392|NCT02265510|156428861|FG005|Overall Study|Disease Progression|0|||
48609393|NCT02265510|156428862|FG006|Overall Study|Disease Progression|0|||
48609394|NCT02265510|156428863|FG007|Overall Study|Disease Progression|0|||
48609395|NCT02265510|156428864|FG008|Overall Study|Disease Progression|0|||
48609396|NCT02265510|156428865|FG009|Overall Study|Disease Progression|0|||
48609397|NCT02265510|156428866|FG010|Overall Study|Disease Progression|0|||
48609398|NCT02265510|156428867|FG011|Overall Study|Disease Progression|0|||
48609399|NCT02265510|156428868|FG012|Overall Study|Disease Progression|0|||
48609400|NCT02265510|156428869|FG013|Overall Study|Disease Progression|0|||
48609401|NCT02265510|156428856|FG000|Overall Study|Death|2|||
48609402|NCT02265510|156428857|FG001|Overall Study|Death|0|||
48609403|NCT02265510|156428858|FG002|Overall Study|Death|2|||
48609404|NCT02265510|156428859|FG003|Overall Study|Death|2|||
48609405|NCT02265510|156428860|FG004|Overall Study|Death|1|||
48609406|NCT02265510|156428861|FG005|Overall Study|Death|3|||
48609407|NCT02265510|156428862|FG006|Overall Study|Death|2|||
48609408|NCT02265510|156428863|FG007|Overall Study|Death|1|||
48609409|NCT02265510|156428864|FG008|Overall Study|Death|3|||
48609410|NCT02265510|156428865|FG009|Overall Study|Death|3|||
48609411|NCT02265510|156428866|FG010|Overall Study|Death|4|||
48609412|NCT02265510|156428867|FG011|Overall Study|Death|12|||
48609413|NCT02265510|156428868|FG012|Overall Study|Death|7|||
48609414|NCT02265510|156428869|FG013|Overall Study|Death|6|||
48609415|NCT02265510|156428856|FG000|Overall Study|Lost to Follow-up|0|||
48609416|NCT02265510|156428857|FG001|Overall Study|Lost to Follow-up|0|||
48609417|NCT02265510|156428858|FG002|Overall Study|Lost to Follow-up|0|||
48609418|NCT02265510|156428859|FG003|Overall Study|Lost to Follow-up|0|||
48609419|NCT02265510|156428860|FG004|Overall Study|Lost to Follow-up|1|||
48609420|NCT02265510|156428861|FG005|Overall Study|Lost to Follow-up|0|||
48609421|NCT02265510|156428862|FG006|Overall Study|Lost to Follow-up|0|||
48609422|NCT02265510|156428863|FG007|Overall Study|Lost to Follow-up|0|||
48609423|NCT02265510|156428864|FG008|Overall Study|Lost to Follow-up|0|||
48609424|NCT02265510|156428865|FG009|Overall Study|Lost to Follow-up|2|||
48609425|NCT02265510|156428866|FG010|Overall Study|Lost to Follow-up|0|||
48609426|NCT02265510|156428867|FG011|Overall Study|Lost to Follow-up|0|||
48543912|NCT02393248|156182849|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543913|NCT02393248|156182850|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543914|NCT02393248|156182851|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543915|NCT02393248|156182852|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543916|NCT02393248|156182853|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543917|NCT02393248|156182854|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543918|NCT02393248|156182855|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543919|NCT02393248|156182856|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543920|NCT02393248|156182857|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
48543921|NCT02393248|156182833|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543922|NCT02393248|156182834|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543923|NCT02393248|156182835|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48609427|NCT02265510|156428868|FG012|Overall Study|Lost to Follow-up|0|||
48609428|NCT02265510|156428869|FG013|Overall Study|Lost to Follow-up|2|||
48609429|NCT02265510|156428856|FG000|Overall Study|Other|0|||
48609430|NCT02265510|156428857|FG001|Overall Study|Other|1|||
48609431|NCT02265510|156428858|FG002|Overall Study|Other|0|||
48609432|NCT02265510|156428859|FG003|Overall Study|Other|0|||
48609433|NCT02265510|156428860|FG004|Overall Study|Other|0|||
48609434|NCT02265510|156428861|FG005|Overall Study|Other|0|||
48609435|NCT02265510|156428862|FG006|Overall Study|Other|0|||
48609436|NCT02265510|156428863|FG007|Overall Study|Other|0|||
48609437|NCT02265510|156428864|FG008|Overall Study|Other|0|||
48609438|NCT02265510|156428865|FG009|Overall Study|Other|0|||
48609439|NCT02265510|156428866|FG010|Overall Study|Other|0|||
48609440|NCT02265510|156428867|FG011|Overall Study|Other|0|||
48609441|NCT02265510|156428868|FG012|Overall Study|Other|0|||
48609442|NCT02265510|156428869|FG013|Overall Study|Other|0|||
48609443|NCT02265510|156428856|FG000|Overall Study|Study Terminated by Sponsor|0|||
48609444|NCT02265510|156428857|FG001|Overall Study|Study Terminated by Sponsor|0|||
48609445|NCT02265510|156428858|FG002|Overall Study|Study Terminated by Sponsor|0|||
48609446|NCT02265510|156428859|FG003|Overall Study|Study Terminated by Sponsor|0|||
48609447|NCT02265510|156428860|FG004|Overall Study|Study Terminated by Sponsor|0|||
48609448|NCT02265510|156428861|FG005|Overall Study|Study Terminated by Sponsor|1|||
48609449|NCT02265510|156428862|FG006|Overall Study|Study Terminated by Sponsor|1|||
48609450|NCT02265510|156428863|FG007|Overall Study|Study Terminated by Sponsor|1|||
48609451|NCT02265510|156428864|FG008|Overall Study|Study Terminated by Sponsor|1|||
48609452|NCT02265510|156428865|FG009|Overall Study|Study Terminated by Sponsor|2|||
48609453|NCT02265510|156428866|FG010|Overall Study|Study Terminated by Sponsor|1|||
48609454|NCT02265510|156428867|FG011|Overall Study|Study Terminated by Sponsor|4|||
48609455|NCT02265510|156428868|FG012|Overall Study|Study Terminated by Sponsor|1|||
48609456|NCT02265510|156428869|FG013|Overall Study|Study Terminated by Sponsor|2|||
48609457|NCT01668797|156428870|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
48609458|NCT01668797|156428871|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
48609459|NCT01668797|156428872|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
48609460|NCT01668797|156428873|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
48609461|NCT01668797|156428870|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
48609462|NCT01668797|156428871|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
48609463|NCT01668797|156428872|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
48609464|NCT01668797|156428873|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
48609465|NCT01668797|156428870|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
48609466|NCT01668797|156428871|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
48609467|NCT01668797|156428872|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
48609468|NCT01668797|156428873|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
48609469|NCT01668797|156428870|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
48609470|NCT01668797|156428871|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
48543924|NCT02393248|156182836|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543925|NCT02393248|156182837|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48609471|NCT01668797|156428872|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
48609472|NCT01668797|156428873|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
48609473|NCT01668797|156428870|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
48609474|NCT01668797|156428871|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
48609475|NCT01668797|156428872|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
48609476|NCT01668797|156428873|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
48609477|NCT01668797|156428870|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
48609478|NCT01668797|156428871|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
48609479|NCT01668797|156428872|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
48609480|NCT01668797|156428873|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
48609481|NCT01668797|156428870|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
48609482|NCT01668797|156428871|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
48609483|NCT01668797|156428872|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
48609484|NCT01668797|156428873|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
48609485|NCT01668797|156428870|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
48609486|NCT01668797|156428871|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
48609487|NCT01668797|156428872|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
48609488|NCT01668797|156428873|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
48609489|NCT01668797|156428870|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
48609490|NCT01668797|156428871|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
48609491|NCT01668797|156428872|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
48609492|NCT01668797|156428873|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
48609493|NCT01668797|156428870|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
48609494|NCT01668797|156428871|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
48609495|NCT01668797|156428872|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
48609496|NCT01668797|156428873|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
48609497|NCT01668797|156428870|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
48609498|NCT01668797|156428871|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
48609499|NCT01668797|156428872|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
48609500|NCT01668797|156428873|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
48609501|NCT01668797|156428870|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
48609502|NCT01668797|156428871|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
48609503|NCT01668797|156428872|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
48609504|NCT01668797|156428873|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
48609505|NCT01668797|156428870|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
48609506|NCT01668797|156428871|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
48609507|NCT01668797|156428872|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
48609508|NCT01668797|156428873|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
48609509|NCT01668797|156428870|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
48609510|NCT01668797|156428871|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
48609511|NCT01668797|156428872|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
48609512|NCT01668797|156428873|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
48609513|NCT01668797|156428870|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
48609514|NCT01668797|156428871|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
48609515|NCT01668797|156428872|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
48609516|NCT01668797|156428873|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
48609517|NCT01668797|156428870|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
48609518|NCT01668797|156428871|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
48609519|NCT01668797|156428872|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
48609520|NCT01668797|156428873|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
48609521|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
48609522|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
48609523|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
48609524|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
48609525|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
48609526|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
48609527|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
48609528|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
48609529|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
48609530|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
48543926|NCT02393248|156182838|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543927|NCT02393248|156182839|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543928|NCT02393248|156182840|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543929|NCT02393248|156182841|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543930|NCT02393248|156182842|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543931|NCT02393248|156182843|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
48543932|NCT02393248|156182844|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
48543933|NCT02393248|156182845|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543934|NCT02393248|156182846|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543935|NCT02393248|156182847|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543936|NCT02393248|156182848|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543937|NCT02393248|156182849|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543938|NCT02393248|156182850|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543939|NCT02393248|156182851|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543940|NCT02393248|156182852|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543941|NCT02393248|156182853|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543942|NCT02393248|156182854|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543943|NCT02393248|156182855|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543944|NCT02393248|156182856|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543945|NCT02393248|156182857|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
48543946|NCT02393248|156182833|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
48543947|NCT02393248|156182834|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
48543948|NCT02393248|156182835|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
48543949|NCT02393248|156182836|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
48543950|NCT02393248|156182837|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
48543951|NCT02393248|156182838|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
48543952|NCT02393248|156182839|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
48543953|NCT02393248|156182840|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
48543954|NCT02393248|156182841|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
48543955|NCT02393248|156182842|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
48543956|NCT02393248|156182843|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
48543957|NCT02393248|156182844|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
48543958|NCT02393248|156182845|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
48543959|NCT02393248|156182846|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
48543960|NCT02393248|156182847|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
48609531|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
48609532|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
48609533|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
48609534|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
48609535|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
48609536|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
48609537|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
48609538|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
48609539|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
48609540|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
48609541|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
48609542|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
48609543|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
48609544|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
48609545|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
48609546|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
48543961|NCT02393248|156182848|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
48543962|NCT02393248|156182849|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
48543963|NCT02393248|156182850|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
48543964|NCT02393248|156182851|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
48543965|NCT02393248|156182852|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
48543966|NCT02393248|156182853|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
48543967|NCT02393248|156182854|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
48543968|NCT02393248|156182855|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
48609547|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
48609548|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
48609549|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
48609550|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
48609551|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
48609552|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
48609553|NCT01668797|156428870|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
48543969|NCT02393248|156182856|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
48543970|NCT02393248|156182857|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
48543971|NCT02393248|156182833|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543972|NCT02393248|156182834|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543973|NCT02393248|156182835|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543974|NCT02393248|156182836|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543975|NCT02393248|156182837|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543976|NCT02393248|156182838|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543977|NCT02393248|156182839|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543978|NCT02393248|156182840|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48609554|NCT01668797|156428871|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
48609555|NCT01668797|156428872|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
48609556|NCT01668797|156428873|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
48609557|NCT01004614|156428874|FG000|Washout|Withdrawal by Subject|0|||
48609558|NCT01004614|156428875|FG001|Washout|Withdrawal by Subject|1|||
48609559|NCT01004614|156428876|FG002|Washout|Withdrawal by Subject|0|||
48609560|NCT01004614|156428877|FG003|Washout|Withdrawal by Subject|0|||
48609561|NCT02530385|156428878|FG000|Overall Study|Withdrawal by Subject|0|||
48609562|NCT02530385|156428879|FG001|Overall Study|Withdrawal by Subject|1|||
48609563|NCT00626639|156428884|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
48609564|NCT00626639|156428885|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
48609565|NCT00827567|156428886|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
48609566|NCT00644059|156428887|FG000|Overall Study|Lost to Follow-up|37|||
48609567|NCT00644059|156428888|FG001|Overall Study|Lost to Follow-up|34|||
48609568|NCT00644059|156428889|FG002|Overall Study|Lost to Follow-up|16|||
48609569|NCT00644059|156428887|FG000|Overall Study|Withdrawal by Subject|52|||
48609570|NCT00644059|156428888|FG001|Overall Study|Withdrawal by Subject|60|||
48609571|NCT00644059|156428889|FG002|Overall Study|Withdrawal by Subject|30|||
48609572|NCT00644059|156428887|FG000|Overall Study|Adverse Event|8|||
48609573|NCT00644059|156428888|FG001|Overall Study|Adverse Event|5|||
48609574|NCT00644059|156428889|FG002|Overall Study|Adverse Event|1|||
48609575|NCT00644059|156428887|FG000|Overall Study|Inappropriate Enrollment|1|||
48609576|NCT00644059|156428888|FG001|Overall Study|Inappropriate Enrollment|3|||
48609577|NCT00644059|156428889|FG002|Overall Study|Inappropriate Enrollment|0|||
48609578|NCT00644059|156428887|FG000|Overall Study|Protocol Deviation/violation|20|||
48609579|NCT00644059|156428888|FG001|Overall Study|Protocol Deviation/violation|19|||
48609580|NCT00644059|156428889|FG002|Overall Study|Protocol Deviation/violation|15|||
48609581|NCT00644059|156428887|FG000|Overall Study|Unable to classify|6|||
48609582|NCT00644059|156428888|FG001|Overall Study|Unable to classify|2|||
48609583|NCT00644059|156428889|FG002|Overall Study|Unable to classify|3|||
48609584|NCT02020941|156428890|FG000|Overall Study|Adverse Event|1|||
48609585|NCT02020941|156428890|FG000|Overall Study|Physician Decision|2|||
48609586|NCT02020941|156428890|FG000|Overall Study|Withdrawal by Subject|1|||
48609587|NCT02020941|156428890|FG000|Overall Study|Disease Progression|4|||
48609588|NCT02736617|156428893|FG000|Treatment|Adverse Event|1|||
48609589|NCT02736617|156428893|FG000|Treatment|Lack of Efficacy|1|||
48609590|NCT02736617|156428893|FG000|Treatment|Withdrawal by Subject|1|||
48609591|NCT02736617|156428893|FG000|Maintenance|Lack of Efficacy|4|||
48609592|NCT02736617|156428893|FG000|Maintenance|Physician Decision|1|||
48609593|NCT00819039|156428894|FG000|Overall Study|Physician Decision|1|||
48609594|NCT00819039|156428895|FG001|Overall Study|Physician Decision|0|||
48609595|NCT00819039|156428896|FG002|Overall Study|Physician Decision|1|||
48609596|NCT00819039|156428894|FG000|Overall Study|Protocol Violation|1|||
48609597|NCT00819039|156428895|FG001|Overall Study|Protocol Violation|0|||
48609598|NCT00819039|156428896|FG002|Overall Study|Protocol Violation|0|||
48609599|NCT03502798|156428901|FG000|Overall Study|equipment failure|0|||
48609600|NCT03502798|156428902|FG001|Overall Study|equipment failure|7|||
48609601|NCT04076917|156428903|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
48609602|NCT04076917|156428903|FG000|Overall Study|Study closure|13|||
48609603|NCT04076917|156428903|FG000|Overall Study|Physician Decision|3|||
48609604|NCT04076917|156428903|FG000|Overall Study|Death|1|||
48609605|NCT04076917|156428903|FG000|Overall Study|Lost to Follow-up|1|||
48609606|NCT04076917|156428903|FG000|Overall Study|Withdrawal by Subject|1|||
48609607|NCT04076917|156428903|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
48609608|NCT00505921|156428904|FG000|Overall Study|Ineligible|1|||
48609609|NCT00505921|156428904|FG000|Overall Study|Failed to Mobilize|8|||
48609610|NCT04219189|156428905|FG000|Overall Study|Withdrawal by Subject|1|||
48609611|NCT04219189|156428906|FG001|Overall Study|Withdrawal by Subject|2|||
48609612|NCT04219189|156428905|FG000|Overall Study|Protocol Violation|0|||
48609613|NCT04219189|156428906|FG001|Overall Study|Protocol Violation|1|||
48609614|NCT04219189|156428905|FG000|Overall Study|Lost to Follow-up|0|||
48609615|NCT04219189|156428906|FG001|Overall Study|Lost to Follow-up|1|||
48543979|NCT02393248|156182841|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543980|NCT02393248|156182842|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543981|NCT02393248|156182843|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543982|NCT02393248|156182844|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
48543983|NCT02393248|156182845|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543984|NCT02393248|156182846|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
48543985|NCT02393248|156182847|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48609616|NCT04219189|156428905|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
48609617|NCT04219189|156428906|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
48609618|NCT00487188|156428907|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
48609619|NCT00487188|156428908|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
48609620|NCT00487188|156428909|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
48609621|NCT00487188|156428907|FG000|Induction Phase|Adverse Event|5|||
48609622|NCT00487188|156428908|FG001|Induction Phase|Adverse Event|0|||
48543986|NCT02393248|156182848|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543987|NCT02393248|156182849|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543988|NCT02393248|156182850|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543989|NCT02393248|156182851|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543990|NCT02393248|156182852|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543991|NCT02393248|156182853|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543992|NCT02393248|156182854|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543993|NCT02393248|156182855|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543994|NCT02393248|156182856|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543995|NCT02393248|156182857|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
48543996|NCT02393248|156182833|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48543997|NCT02393248|156182834|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48543998|NCT02393248|156182835|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48543999|NCT02393248|156182836|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544000|NCT02393248|156182837|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544001|NCT02393248|156182838|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544002|NCT02393248|156182839|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544003|NCT02393248|156182840|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544004|NCT02393248|156182841|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544005|NCT02393248|156182842|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544006|NCT02393248|156182843|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544007|NCT02393248|156182844|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544008|NCT02393248|156182845|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544009|NCT02393248|156182846|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544010|NCT02393248|156182847|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544011|NCT02393248|156182848|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544012|NCT02393248|156182849|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48609623|NCT00487188|156428909|FG002|Induction Phase|Adverse Event|0|||
48544013|NCT02393248|156182850|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544014|NCT02393248|156182851|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
48544015|NCT02393248|156182852|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48609624|NCT00487188|156428907|FG000|Induction Phase|Lack of Efficacy|0|||
48609625|NCT00487188|156428908|FG001|Induction Phase|Lack of Efficacy|1|||
48544016|NCT02393248|156182853|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
48544017|NCT02393248|156182854|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
48544018|NCT02393248|156182855|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544019|NCT02393248|156182856|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
48544020|NCT02393248|156182857|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
48544021|NCT02393248|156182833|FG000|Part 3: Combination Therapy|Death|0|||
48544022|NCT02393248|156182834|FG001|Part 3: Combination Therapy|Death|0|||
48544023|NCT02393248|156182835|FG002|Part 3: Combination Therapy|Death|0|||
48544024|NCT02393248|156182836|FG003|Part 3: Combination Therapy|Death|0|||
48544025|NCT02393248|156182837|FG004|Part 3: Combination Therapy|Death|0|||
48544026|NCT02393248|156182838|FG005|Part 3: Combination Therapy|Death|0|||
48544027|NCT02393248|156182839|FG006|Part 3: Combination Therapy|Death|0|||
48544028|NCT02393248|156182840|FG007|Part 3: Combination Therapy|Death|0|||
48544029|NCT02393248|156182841|FG008|Part 3: Combination Therapy|Death|0|||
48544030|NCT02393248|156182842|FG009|Part 3: Combination Therapy|Death|0|||
48544031|NCT02393248|156182843|FG010|Part 3: Combination Therapy|Death|0|||
48544032|NCT02393248|156182844|FG011|Part 3: Combination Therapy|Death|0|||
48544033|NCT02393248|156182845|FG012|Part 3: Combination Therapy|Death|0|||
48544034|NCT02393248|156182846|FG013|Part 3: Combination Therapy|Death|0|||
48544035|NCT02393248|156182847|FG014|Part 3: Combination Therapy|Death|0|||
48544036|NCT02393248|156182848|FG015|Part 3: Combination Therapy|Death|1|||
48544037|NCT02393248|156182849|FG016|Part 3: Combination Therapy|Death|7|||
48544038|NCT02393248|156182850|FG017|Part 3: Combination Therapy|Death|5|||
48544039|NCT02393248|156182851|FG018|Part 3: Combination Therapy|Death|5|||
48544040|NCT02393248|156182852|FG019|Part 3: Combination Therapy|Death|3|||
48544041|NCT02393248|156182853|FG020|Part 3: Combination Therapy|Death|7|||
48544042|NCT02393248|156182854|FG021|Part 3: Combination Therapy|Death|5|||
48544043|NCT02393248|156182855|FG022|Part 3: Combination Therapy|Death|6|||
48544044|NCT02393248|156182856|FG023|Part 3: Combination Therapy|Death|3|||
48544045|NCT02393248|156182857|FG024|Part 3: Combination Therapy|Death|0|||
48544046|NCT02393248|156182833|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544047|NCT02393248|156182834|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544048|NCT02393248|156182835|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544049|NCT02393248|156182836|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544050|NCT02393248|156182837|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544051|NCT02393248|156182838|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544052|NCT02393248|156182839|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544053|NCT02393248|156182840|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544054|NCT02393248|156182841|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544055|NCT02393248|156182842|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544056|NCT02393248|156182843|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544057|NCT02393248|156182844|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544058|NCT02393248|156182845|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544059|NCT02393248|156182846|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544060|NCT02393248|156182847|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544061|NCT02393248|156182848|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544062|NCT02393248|156182849|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544063|NCT02393248|156182850|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
48544064|NCT02393248|156182851|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
48544065|NCT02393248|156182852|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
48544066|NCT02393248|156182853|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
48544067|NCT02393248|156182854|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
48544068|NCT02393248|156182855|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
48544069|NCT02393248|156182856|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
48544070|NCT02393248|156182857|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
48544071|NCT02393248|156182833|FG000|Part 3: Combination Therapy|Disease Progression|0|||
48544072|NCT02393248|156182834|FG001|Part 3: Combination Therapy|Disease Progression|0|||
48544073|NCT02393248|156182835|FG002|Part 3: Combination Therapy|Disease Progression|0|||
48544074|NCT02393248|156182836|FG003|Part 3: Combination Therapy|Disease Progression|0|||
48544075|NCT02393248|156182837|FG004|Part 3: Combination Therapy|Disease Progression|0|||
48544076|NCT02393248|156182838|FG005|Part 3: Combination Therapy|Disease Progression|0|||
48544077|NCT02393248|156182839|FG006|Part 3: Combination Therapy|Disease Progression|0|||
48544078|NCT02393248|156182840|FG007|Part 3: Combination Therapy|Disease Progression|0|||
48544079|NCT02393248|156182841|FG008|Part 3: Combination Therapy|Disease Progression|0|||
48544080|NCT02393248|156182842|FG009|Part 3: Combination Therapy|Disease Progression|0|||
48544081|NCT02393248|156182843|FG010|Part 3: Combination Therapy|Disease Progression|0|||
48544082|NCT02393248|156182844|FG011|Part 3: Combination Therapy|Disease Progression|0|||
48544083|NCT02393248|156182845|FG012|Part 3: Combination Therapy|Disease Progression|0|||
48544084|NCT02393248|156182846|FG013|Part 3: Combination Therapy|Disease Progression|0|||
48544085|NCT02393248|156182847|FG014|Part 3: Combination Therapy|Disease Progression|0|||
48544086|NCT02393248|156182848|FG015|Part 3: Combination Therapy|Disease Progression|0|||
48544087|NCT02393248|156182849|FG016|Part 3: Combination Therapy|Disease Progression|0|||
48544088|NCT02393248|156182850|FG017|Part 3: Combination Therapy|Disease Progression|0|||
48609626|NCT00487188|156428909|FG002|Induction Phase|Lack of Efficacy|0|||
48609627|NCT00487188|156428907|FG000|Induction Phase|Protocol Violation|1|||
48609628|NCT00487188|156428908|FG001|Induction Phase|Protocol Violation|0|||
48544089|NCT02393248|156182851|FG018|Part 3: Combination Therapy|Disease Progression|0|||
48544090|NCT02393248|156182852|FG019|Part 3: Combination Therapy|Disease Progression|0|||
48544091|NCT02393248|156182853|FG020|Part 3: Combination Therapy|Disease Progression|2|||
48544092|NCT02393248|156182854|FG021|Part 3: Combination Therapy|Disease Progression|1|||
48544093|NCT02393248|156182855|FG022|Part 3: Combination Therapy|Disease Progression|0|||
48544094|NCT02393248|156182856|FG023|Part 3: Combination Therapy|Disease Progression|0|||
48544095|NCT02393248|156182857|FG024|Part 3: Combination Therapy|Disease Progression|0|||
48544096|NCT02393248|156182833|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
48609629|NCT00487188|156428909|FG002|Induction Phase|Protocol Violation|0|||
48609630|NCT00487188|156428907|FG000|Induction Phase|Refused Treatment|1|||
48609631|NCT00487188|156428908|FG001|Induction Phase|Refused Treatment|2|||
48609632|NCT00487188|156428909|FG002|Induction Phase|Refused Treatment|0|||
48609633|NCT00487188|156428907|FG000|Induction Phase|Lost to Follow-up|2|||
48609634|NCT00487188|156428908|FG001|Induction Phase|Lost to Follow-up|2|||
48609635|NCT00487188|156428909|FG002|Induction Phase|Lost to Follow-up|0|||
48609636|NCT00487188|156428907|FG000|Induction Phase|Administrative|0|||
48609637|NCT00487188|156428908|FG001|Induction Phase|Administrative|1|||
48609638|NCT00487188|156428909|FG002|Induction Phase|Administrative|0|||
48609639|NCT00487188|156428907|FG000|Maintenance Phase|Adverse Event|1|||
48609640|NCT00487188|156428908|FG001|Maintenance Phase|Adverse Event|0|||
48609641|NCT00487188|156428909|FG002|Maintenance Phase|Adverse Event|0|||
48609642|NCT00487188|156428907|FG000|Maintenance Phase|Death|1|||
48609643|NCT00487188|156428908|FG001|Maintenance Phase|Death|0|||
48609644|NCT00487188|156428909|FG002|Maintenance Phase|Death|0|||
48609645|NCT00487188|156428907|FG000|Maintenance Phase|Lost to Follow-up|1|||
48609646|NCT00487188|156428908|FG001|Maintenance Phase|Lost to Follow-up|0|||
48609647|NCT00487188|156428909|FG002|Maintenance Phase|Lost to Follow-up|0|||
48609648|NCT00487188|156428907|FG000|Maintenance Phase|Administrative|0|||
48609649|NCT00487188|156428908|FG001|Maintenance Phase|Administrative|0|||
48609650|NCT00487188|156428909|FG002|Maintenance Phase|Administrative|1|||
48609651|NCT03530696|156428910|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
48609652|NCT03530696|156428911|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
48609653|NCT01299584|156428912|FG000|Overall Study|Protocol Violation|9|||
48609654|NCT03188822|156428916|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
48609655|NCT03188822|156428916|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
48609656|NCT00924898|156428917|FG000|Overall Study|Withdrawal by Subject|2|||
48609657|NCT01977846|156428923|FG000|Total Study - Prospective|Death|0|||
48609658|NCT01977846|156428924|FG001|Total Study - Prospective|Death|1|||
48609659|NCT01977846|156428923|FG000|Total Study - Prospective|Lost to Follow-up|0|||
48609660|NCT01977846|156428924|FG001|Total Study - Prospective|Lost to Follow-up|8|||
48609661|NCT01977846|156428923|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
48609662|NCT01977846|156428924|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
48609663|NCT01977846|156428923|FG000|Total Study - Prospective|Not available at time of visit|0|||
48609664|NCT01977846|156428924|FG001|Total Study - Prospective|Not available at time of visit|5|||
48609665|NCT01977846|156428923|FG000|Total Study - Prospective|No show|0|||
48609666|NCT01977846|156428924|FG001|Total Study - Prospective|No show|1|||
48609667|NCT01977846|156428923|FG000|Total Study - Prospective|Protocol Violation|0|||
48609668|NCT01977846|156428924|FG001|Total Study - Prospective|Protocol Violation|1|||
48609669|NCT02164916|156428925|FG000|Overall Study|Adverse Event|3|||
48609670|NCT02164916|156428926|FG001|Overall Study|Adverse Event|8|||
48609671|NCT02164916|156428925|FG000|Overall Study|Death|1|||
48609672|NCT02164916|156428926|FG001|Overall Study|Death|1|||
48609673|NCT02164916|156428925|FG000|Overall Study|Refusal unrelated to adverse event|3|||
48609674|NCT02164916|156428926|FG001|Overall Study|Refusal unrelated to adverse event|7|||
48609675|NCT02164916|156428925|FG000|Overall Study|Progression|37|||
48609676|NCT02164916|156428926|FG001|Overall Study|Progression|26|||
48609677|NCT02164916|156428925|FG000|Overall Study|Not protocol specified|5|||
48609678|NCT02164916|156428926|FG001|Overall Study|Not protocol specified|1|||
48609679|NCT02164916|156428925|FG000|Overall Study|Reason under review|1|||
48609680|NCT02164916|156428926|FG001|Overall Study|Reason under review|6|||
48609681|NCT02164916|156428925|FG000|Overall Study|Not eligible|2|||
48609682|NCT02164916|156428926|FG001|Overall Study|Not eligible|5|||
48609683|NCT02988661|156428927|FG000|Overall Study|Death|2|||
48609684|NCT02988661|156428928|FG001|Overall Study|Death|18|||
48609685|NCT02988661|156428927|FG000|Overall Study|Lost to Follow-up|0|||
48609686|NCT02988661|156428928|FG001|Overall Study|Lost to Follow-up|33|||
48609687|NCT02988661|156428927|FG000|Overall Study|Withdrawal by Subject|0|||
48609688|NCT02988661|156428928|FG001|Overall Study|Withdrawal by Subject|6|||
48609689|NCT02988661|156428927|FG000|Overall Study|Unable to complete the 18-month survey|1|||
48609690|NCT02988661|156428928|FG001|Overall Study|Unable to complete the 18-month survey|27|||
48609691|NCT03883386|156428931|FG000|First Assignment|Lost to Follow-up|1|||
48609692|NCT03883386|156428932|FG001|First Assignment|Lost to Follow-up|0|||
48609693|NCT03883386|156428931|FG000|First Assignment|Withdrawal by Subject|1|||
48609694|NCT03883386|156428932|FG001|First Assignment|Withdrawal by Subject|1|||
48609695|NCT00964782|156428933|FG000|Overall Study|Lost to Follow-up|1|||
48609696|NCT00964782|156428934|FG001|Overall Study|Lost to Follow-up|0|||
48609697|NCT03479905|156428943|FG000|Overall Study|Other airway method used|4|||
48609698|NCT03479905|156428944|FG001|Overall Study|Other airway method used|5|||
48609699|NCT03479905|156428945|FG002|Overall Study|Other airway method used|5|||
48609700|NCT05172570|156428946|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
48609701|NCT05172570|156428947|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
48609702|NCT05172570|156428948|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
48609703|NCT05172570|156428946|FG000|Overall Study|PI Decision due to equipment shortages|0|||
48609704|NCT05172570|156428947|FG001|Overall Study|PI Decision due to equipment shortages|0|||
48609705|NCT05172570|156428948|FG002|Overall Study|PI Decision due to equipment shortages|1|||
48609706|NCT00769561|156428949|FG000|Overall Study|Withdrawal by Subject|2|||
48609707|NCT00769561|156428950|FG001|Overall Study|Withdrawal by Subject|2|||
48609708|NCT00769561|156428949|FG000|Overall Study|Lost to Follow-up|1|||
48609709|NCT00769561|156428950|FG001|Overall Study|Lost to Follow-up|3|||
48609710|NCT01706328|156428958|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
48609711|NCT01706328|156428959|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48609712|NCT01706328|156428960|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48609713|NCT01706328|156428958|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
48609714|NCT01706328|156428959|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48609715|NCT01706328|156428960|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48609716|NCT01706328|156428958|FG000|2-week Run-in Period|Physician Decision|4|||
48609717|NCT01706328|156428959|FG001|2-week Run-in Period|Physician Decision|0|||
48609718|NCT01706328|156428960|FG002|2-week Run-in Period|Physician Decision|0|||
48544097|NCT02393248|156182834|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544098|NCT02393248|156182835|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544099|NCT02393248|156182836|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544100|NCT02393248|156182837|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544101|NCT02393248|156182838|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544102|NCT02393248|156182839|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544103|NCT02393248|156182840|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
48609719|NCT01706328|156428958|FG000|2-week Run-in Period|Adverse Event|4|||
48609720|NCT01706328|156428959|FG001|2-week Run-in Period|Adverse Event|0|||
48609721|NCT01706328|156428960|FG002|2-week Run-in Period|Adverse Event|0|||
48609722|NCT01706328|156428958|FG000|2-week Run-in Period|Lost to Follow-up|2|||
48609723|NCT01706328|156428959|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48609724|NCT01706328|156428960|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48609725|NCT01706328|156428958|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
48609726|NCT01706328|156428959|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
48544104|NCT02393248|156182841|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
48609727|NCT01706328|156428960|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
48609728|NCT01706328|156428958|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
48544105|NCT02393248|156182842|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544106|NCT02393248|156182843|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544107|NCT02393248|156182844|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544108|NCT02393248|156182845|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544109|NCT02393248|156182846|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544110|NCT02393248|156182847|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544111|NCT02393248|156182848|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544112|NCT02393248|156182849|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544113|NCT02393248|156182850|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544114|NCT02393248|156182851|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544115|NCT02393248|156182852|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544116|NCT02393248|156182853|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
48544117|NCT02393248|156182854|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
48544118|NCT02393248|156182855|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544119|NCT02393248|156182856|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544120|NCT02393248|156182857|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
48544121|NCT02393248|156182833|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544122|NCT02393248|156182834|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544123|NCT02393248|156182835|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544124|NCT02393248|156182836|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544125|NCT02393248|156182837|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544126|NCT02393248|156182838|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544127|NCT02393248|156182839|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544128|NCT02393248|156182840|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544129|NCT02393248|156182841|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544130|NCT02393248|156182842|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544131|NCT02393248|156182843|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48584975|NCT01179737|156333741|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
48584976|NCT01179737|156333738|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
48584977|NCT01179737|156333739|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
48584978|NCT01179737|156333740|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
48584979|NCT01179737|156333741|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
48584980|NCT01179737|156333738|FG000|Cohort 1 & Cohort 2|Death|0|||
48584981|NCT01179737|156333739|FG001|Cohort 1 & Cohort 2|Death|0|||
48584982|NCT01179737|156333740|FG002|Cohort 1 & Cohort 2|Death|1|||
48584983|NCT01179737|156333741|FG003|Cohort 1 & Cohort 2|Death|0|||
48584984|NCT01179737|156333738|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
48584985|NCT01179737|156333739|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
48584986|NCT01179737|156333740|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
48584987|NCT01179737|156333741|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
48584988|NCT01179737|156333738|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
48584989|NCT01179737|156333739|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
48584990|NCT01179737|156333740|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
48584991|NCT01179737|156333741|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
48584992|NCT01179737|156333738|FG000|Extension|The study was terminated|3|||
48584993|NCT01179737|156333739|FG001|Extension|The study was terminated|0|||
48584994|NCT01179737|156333740|FG002|Extension|The study was terminated|0|||
48584995|NCT01179737|156333741|FG003|Extension|The study was terminated|0|||
48584996|NCT00115037|156333742|FG000|Phase1|Lost to Follow-up|16|||
48584997|NCT00115037|156333743|FG001|Phase1|Lost to Follow-up|23|||
48584998|NCT00115037|156333744|FG002|Phase1|Lost to Follow-up|0|||
48584999|NCT00115037|156333745|FG003|Phase1|Lost to Follow-up|0|||
48585000|NCT00115037|156333746|FG004|Phase1|Lost to Follow-up|0|||
48585001|NCT00115037|156333747|FG005|Phase1|Lost to Follow-up|0|||
48585002|NCT00115037|156333742|FG000|Phase1|Withdrawal by Subject|9|||
48585003|NCT00115037|156333743|FG001|Phase1|Withdrawal by Subject|4|||
48585004|NCT00115037|156333744|FG002|Phase1|Withdrawal by Subject|0|||
48585005|NCT00115037|156333745|FG003|Phase1|Withdrawal by Subject|0|||
48609729|NCT01706328|156428959|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
48609730|NCT01706328|156428960|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
48609731|NCT01706328|156428958|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
48609732|NCT01706328|156428959|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
48609733|NCT01706328|156428960|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
48544132|NCT02393248|156182844|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544133|NCT02393248|156182845|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544134|NCT02393248|156182846|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544135|NCT02393248|156182847|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544136|NCT02393248|156182848|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544137|NCT02393248|156182849|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544138|NCT02393248|156182850|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544139|NCT02393248|156182851|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544140|NCT02393248|156182852|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544141|NCT02393248|156182853|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
48544142|NCT02393248|156182854|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544143|NCT02393248|156182855|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544144|NCT02393248|156182856|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544145|NCT02393248|156182857|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
48544146|NCT02393248|156182833|FG000|Part 3: Combination Therapy|Adverse Event|0|||
48544147|NCT02393248|156182834|FG001|Part 3: Combination Therapy|Adverse Event|0|||
48544148|NCT02393248|156182835|FG002|Part 3: Combination Therapy|Adverse Event|0|||
48544149|NCT02393248|156182836|FG003|Part 3: Combination Therapy|Adverse Event|0|||
48544150|NCT02393248|156182837|FG004|Part 3: Combination Therapy|Adverse Event|0|||
48544151|NCT02393248|156182838|FG005|Part 3: Combination Therapy|Adverse Event|0|||
48544152|NCT02393248|156182839|FG006|Part 3: Combination Therapy|Adverse Event|0|||
48544153|NCT02393248|156182840|FG007|Part 3: Combination Therapy|Adverse Event|0|||
48544154|NCT02393248|156182841|FG008|Part 3: Combination Therapy|Adverse Event|0|||
48544155|NCT02393248|156182842|FG009|Part 3: Combination Therapy|Adverse Event|0|||
48544156|NCT02393248|156182843|FG010|Part 3: Combination Therapy|Adverse Event|0|||
48544157|NCT02393248|156182844|FG011|Part 3: Combination Therapy|Adverse Event|0|||
48544158|NCT02393248|156182845|FG012|Part 3: Combination Therapy|Adverse Event|0|||
48544159|NCT02393248|156182846|FG013|Part 3: Combination Therapy|Adverse Event|0|||
48544160|NCT02393248|156182847|FG014|Part 3: Combination Therapy|Adverse Event|0|||
48544161|NCT02393248|156182848|FG015|Part 3: Combination Therapy|Adverse Event|0|||
48544162|NCT02393248|156182849|FG016|Part 3: Combination Therapy|Adverse Event|0|||
48544163|NCT02393248|156182850|FG017|Part 3: Combination Therapy|Adverse Event|0|||
48544164|NCT02393248|156182851|FG018|Part 3: Combination Therapy|Adverse Event|0|||
48544165|NCT02393248|156182852|FG019|Part 3: Combination Therapy|Adverse Event|0|||
48544166|NCT02393248|156182853|FG020|Part 3: Combination Therapy|Adverse Event|0|||
48544167|NCT02393248|156182854|FG021|Part 3: Combination Therapy|Adverse Event|0|||
48544168|NCT02393248|156182855|FG022|Part 3: Combination Therapy|Adverse Event|0|||
48544169|NCT02393248|156182856|FG023|Part 3: Combination Therapy|Adverse Event|1|||
48544170|NCT02393248|156182857|FG024|Part 3: Combination Therapy|Adverse Event|0|||
48544171|NCT02393248|156182833|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544172|NCT02393248|156182834|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544173|NCT02393248|156182835|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544174|NCT02393248|156182836|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544175|NCT02393248|156182837|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544176|NCT02393248|156182838|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544177|NCT02393248|156182839|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544178|NCT02393248|156182840|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544179|NCT02393248|156182841|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48692909|NCT03137992|156724648|FG002|Washout Period 1|COPD Exacerbation|1|||
48609734|NCT01706328|156428958|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
48609735|NCT01706328|156428959|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
48609736|NCT01706328|156428960|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
48544180|NCT02393248|156182842|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544181|NCT02393248|156182843|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48609737|NCT01706328|156428958|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
48609738|NCT01706328|156428959|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
48609739|NCT01706328|156428960|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
48609740|NCT01706328|156428958|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
48609741|NCT01706328|156428959|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
48609742|NCT01706328|156428960|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
48609743|NCT01706328|156428958|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48609744|NCT01706328|156428959|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
48609745|NCT01706328|156428960|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
48735641|NCT00961649|156883700|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
48544182|NCT02393248|156182844|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544183|NCT02393248|156182845|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544184|NCT02393248|156182846|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544185|NCT02393248|156182847|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544186|NCT02393248|156182848|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544187|NCT02393248|156182849|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544188|NCT02393248|156182850|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544189|NCT02393248|156182851|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544190|NCT02393248|156182852|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544191|NCT02393248|156182853|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544192|NCT02393248|156182854|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544193|NCT02393248|156182855|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544194|NCT02393248|156182856|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
48544195|NCT02393248|156182857|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
48544196|NCT03560986|156182858|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
48544197|NCT03560986|156182859|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
48544198|NCT03560986|156182858|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
48544199|NCT03560986|156182859|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
48544200|NCT03560986|156182858|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
48544201|NCT03560986|156182859|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
48544202|NCT03560986|156182858|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
48544203|NCT03560986|156182859|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
48544204|NCT03560986|156182858|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
48544205|NCT03560986|156182859|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
48544206|NCT03560986|156182858|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
48544207|NCT03560986|156182859|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
48544208|NCT03560986|156182858|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
48544209|NCT03560986|156182859|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
48544210|NCT02585934|156182861|FG000|Overall Study|Lost to Follow-up|2|||
48544211|NCT02585934|156182862|FG001|Overall Study|Lost to Follow-up|2|||
48544212|NCT02585934|156182861|FG000|Overall Study|Protocol Violation|14|||
48544213|NCT02585934|156182862|FG001|Overall Study|Protocol Violation|11|||
48544214|NCT02585934|156182861|FG000|Overall Study|Adverse Event|21|||
48544215|NCT02585934|156182862|FG001|Overall Study|Adverse Event|22|||
48544216|NCT02585934|156182861|FG000|Overall Study|Physician Decision|3|||
48544217|NCT02585934|156182862|FG001|Overall Study|Physician Decision|2|||
48544218|NCT02585934|156182861|FG000|Overall Study|Withdrawal by Subject|7|||
48544219|NCT02585934|156182862|FG001|Overall Study|Withdrawal by Subject|21|||
48544220|NCT02585934|156182861|FG000|Overall Study|Lack of Efficacy|2|||
48544221|NCT02585934|156182862|FG001|Overall Study|Lack of Efficacy|1|||
48544222|NCT02585934|156182861|FG000|Overall Study|Death|2|||
48544223|NCT02585934|156182862|FG001|Overall Study|Death|0|||
48544224|NCT02585934|156182861|FG000|Overall Study|Caregiver Withdrew Consent|7|||
48544225|NCT02585934|156182862|FG001|Overall Study|Caregiver Withdrew Consent|7|||
48544226|NCT02585934|156182861|FG000|Overall Study|Sponsor Termination|1|||
48544227|NCT02585934|156182862|FG001|Overall Study|Sponsor Termination|2|||
48544228|NCT02585934|156182861|FG000|Overall Study|Another Reason|10|||
48544229|NCT02585934|156182862|FG001|Overall Study|Another Reason|5|||
48544230|NCT04620135|156182863|FG000|Study Completion|Adverse Event|2|||
48544231|NCT04620135|156182864|FG001|Study Completion|Adverse Event|3|||
48544232|NCT04620135|156182863|FG000|Study Completion|Withdrawal by Subject|2|||
48544233|NCT04620135|156182864|FG001|Study Completion|Withdrawal by Subject|0|||
48544234|NCT01971970|156182865|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
48544235|NCT01971970|156182866|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
48544236|NCT01971970|156182865|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
48544237|NCT01971970|156182866|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
48544238|NCT01971970|156182865|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
48544239|NCT01971970|156182866|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
48544240|NCT01971970|156182865|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
48544241|NCT01971970|156182866|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
48609746|NCT01928771|156428961|FG000|Overall Study|Adverse Event|6|||
48544242|NCT01971970|156182865|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
48544243|NCT01971970|156182866|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
48544244|NCT01971970|156182865|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
48544245|NCT01971970|156182866|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
48544246|NCT01971970|156182865|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
48544247|NCT01971970|156182866|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
48544248|NCT00848107|156182867|FG000|Overall Study|Lost to Follow-up|2|||
48544249|NCT00848107|156182867|FG000|Overall Study|Withdrawal by Subject|8|||
48544250|NCT00848107|156182867|FG000|Overall Study|Adverse Event|9|||
48544251|NCT00848107|156182867|FG000|Overall Study|Death|1|||
48544252|NCT00848107|156182867|FG000|Overall Study|Pregnancy|1|||
48609747|NCT01928771|156428962|FG001|Overall Study|Adverse Event|5|||
48609748|NCT01928771|156428963|FG002|Overall Study|Adverse Event|1|||
48609749|NCT01928771|156428961|FG000|Overall Study|Death|2|||
48609750|NCT01928771|156428962|FG001|Overall Study|Death|2|||
48609751|NCT01928771|156428963|FG002|Overall Study|Death|2|||
48609752|NCT01928771|156428961|FG000|Overall Study|Lost to Follow-up|5|||
48609753|NCT01928771|156428962|FG001|Overall Study|Lost to Follow-up|6|||
48609754|NCT01928771|156428963|FG002|Overall Study|Lost to Follow-up|3|||
48609755|NCT01928771|156428961|FG000|Overall Study|Withdrawal by Subject|20|||
48609756|NCT01928771|156428962|FG001|Overall Study|Withdrawal by Subject|15|||
48609757|NCT01928771|156428963|FG002|Overall Study|Withdrawal by Subject|17|||
48609758|NCT01928771|156428961|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
48609759|NCT01928771|156428962|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
48609760|NCT01928771|156428963|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
48609761|NCT01928771|156428961|FG000|Overall Study|Other Reasons|9|||
48609762|NCT01928771|156428962|FG001|Overall Study|Other Reasons|9|||
48609763|NCT01928771|156428963|FG002|Overall Study|Other Reasons|14|||
48609764|NCT01928771|156428961|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
48609765|NCT01928771|156428962|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
48609766|NCT01928771|156428963|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
48609767|NCT04239924|156428966|FG000|Overall Study|Lost to Follow-up|2|||
48609768|NCT00350545|156430173|FG000|Overall Study|Withdrawal by Subject|2|||
48609769|NCT00916578|156430174|FG000|Overall Study|Physician Decision|2|||
48609770|NCT00916578|156430174|FG000|Overall Study|Withdrawal by Subject|3|||
48609771|NCT00916578|156430174|FG000|Overall Study|Insurance Denial|2|||
48609772|NCT00375752|156430176|FG000|Overall Study|Lack of Efficacy|4|||
48609773|NCT00375752|156430177|FG001|Overall Study|Lack of Efficacy|4|||
48609774|NCT00375752|156430176|FG000|Overall Study|Adverse Event|1|||
48609775|NCT00375752|156430177|FG001|Overall Study|Adverse Event|6|||
48609776|NCT00375752|156430176|FG000|Overall Study|Withdrawal by Subject|6|||
48609777|NCT00375752|156430177|FG001|Overall Study|Withdrawal by Subject|1|||
48609778|NCT00375752|156430176|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
48609779|NCT00375752|156430177|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
48609780|NCT00375752|156430176|FG000|Overall Study|Protocol Violation|0|||
48609781|NCT00375752|156430177|FG001|Overall Study|Protocol Violation|2|||
48609782|NCT00375752|156430176|FG000|Overall Study|Administrative Problems|0|||
48609783|NCT00375752|156430177|FG001|Overall Study|Administrative Problems|1|||
48609784|NCT00754741|156430178|FG000|Overall Study|Died or disenrolled|57|||
48609785|NCT00754741|156430179|FG001|Overall Study|Died or disenrolled|69|||
48609786|NCT00754741|156430180|FG002|Overall Study|Died or disenrolled|54|||
48609787|NCT01384877|156430181|FG000|Treatment 2|Lost to Follow-up|2|||
48609788|NCT01384877|156430182|FG001|Treatment 2|Lost to Follow-up|2|||
48609789|NCT00961064|156430183|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
48609790|NCT00961064|156430183|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
48609791|NCT00961064|156430183|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
48609792|NCT00961064|156430183|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
48609793|NCT00961064|156430183|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
48609794|NCT00961064|156430183|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
48609795|NCT00961064|156430183|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
48609796|NCT00961064|156430183|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
48609797|NCT00607893|156430186|FG000|Overall Study|Lost to Follow-up|4|||
48609798|NCT00607893|156430187|FG001|Overall Study|Lost to Follow-up|0|||
48609799|NCT00607893|156430186|FG000|Overall Study|withdrew due to loss of interest|0|||
48609800|NCT00607893|156430187|FG001|Overall Study|withdrew due to loss of interest|1|||
48609801|NCT00607893|156430186|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
48609802|NCT00607893|156430187|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
48609803|NCT00607893|156430186|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
48609804|NCT00607893|156430187|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
48544253|NCT00186888|156182868|FG000|Overall Study|Toxicity|0|||
48544254|NCT00186888|156182869|FG001|Overall Study|Toxicity|1|||
48544255|NCT00186888|156182870|FG002|Overall Study|Toxicity|0|||
48544256|NCT00186888|156182868|FG000|Overall Study|Relapse or progression of disease|4|||
48544257|NCT00186888|156182869|FG001|Overall Study|Relapse or progression of disease|2|||
48544258|NCT00186888|156182870|FG002|Overall Study|Relapse or progression of disease|0|||
48544259|NCT02335983|156182871|FG000|Overall Study|Sponsor Decision|0|||
48544260|NCT02335983|156182872|FG001|Overall Study|Sponsor Decision|0|||
48544261|NCT02335983|156182873|FG002|Overall Study|Sponsor Decision|1|||
48544262|NCT02335983|156182874|FG003|Overall Study|Sponsor Decision|1|||
48544263|NCT02335983|156182875|FG004|Overall Study|Sponsor Decision|0|||
48544264|NCT02335983|156182876|FG005|Overall Study|Sponsor Decision|1|||
48544265|NCT02335983|156182871|FG000|Overall Study|Withdrawal by Subject|3|||
48544266|NCT02335983|156182872|FG001|Overall Study|Withdrawal by Subject|2|||
48544267|NCT02335983|156182873|FG002|Overall Study|Withdrawal by Subject|2|||
48544268|NCT02335983|156182874|FG003|Overall Study|Withdrawal by Subject|1|||
48544269|NCT02335983|156182875|FG004|Overall Study|Withdrawal by Subject|3|||
48544270|NCT02335983|156182876|FG005|Overall Study|Withdrawal by Subject|9|||
48544271|NCT02335983|156182871|FG000|Overall Study|Death|0|||
48544272|NCT02335983|156182872|FG001|Overall Study|Death|0|||
48544273|NCT02335983|156182873|FG002|Overall Study|Death|2|||
48544274|NCT02335983|156182874|FG003|Overall Study|Death|0|||
48544275|NCT02335983|156182875|FG004|Overall Study|Death|0|||
48544276|NCT02335983|156182876|FG005|Overall Study|Death|0|||
48544277|NCT02335983|156182871|FG000|Overall Study|Lost to Follow-up|0|||
48544278|NCT02335983|156182872|FG001|Overall Study|Lost to Follow-up|0|||
48544279|NCT02335983|156182873|FG002|Overall Study|Lost to Follow-up|0|||
48544280|NCT02335983|156182874|FG003|Overall Study|Lost to Follow-up|0|||
48544281|NCT02335983|156182875|FG004|Overall Study|Lost to Follow-up|0|||
48544282|NCT02335983|156182876|FG005|Overall Study|Lost to Follow-up|1|||
48544283|NCT02335983|156182871|FG000|Overall Study|Protocol Specified Criteria|5|||
48544284|NCT02335983|156182872|FG001|Overall Study|Protocol Specified Criteria|7|||
48544285|NCT02335983|156182873|FG002|Overall Study|Protocol Specified Criteria|27|||
48544286|NCT02335983|156182874|FG003|Overall Study|Protocol Specified Criteria|7|||
48544287|NCT02335983|156182875|FG004|Overall Study|Protocol Specified Criteria|5|||
48544288|NCT02335983|156182876|FG005|Overall Study|Protocol Specified Criteria|21|||
48544289|NCT04713553|156182877|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
48544290|NCT04713553|156182878|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
48544291|NCT04713553|156182879|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
48544292|NCT04713553|156182880|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
48544293|NCT04713553|156182881|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
48544294|NCT04713553|156182882|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
48585006|NCT00115037|156333746|FG004|Phase1|Withdrawal by Subject|0|||
48544295|NCT04713553|156182883|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
48544296|NCT04713553|156182877|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
48544297|NCT04713553|156182878|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
48544298|NCT04713553|156182879|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
48544299|NCT04713553|156182880|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
48544300|NCT04713553|156182881|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
48544301|NCT04713553|156182882|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
48544302|NCT04713553|156182883|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
48544303|NCT04713553|156182877|FG000|Primary Study (2 Months)|Other|1|||
48544304|NCT04713553|156182878|FG001|Primary Study (2 Months)|Other|2|||
48544305|NCT04713553|156182879|FG002|Primary Study (2 Months)|Other|0|||
48544306|NCT04713553|156182880|FG003|Primary Study (2 Months)|Other|0|||
48544307|NCT04713553|156182881|FG004|Primary Study (2 Months)|Other|1|||
48544308|NCT04713553|156182882|FG005|Primary Study (2 Months)|Other|0|||
48544309|NCT04713553|156182883|FG006|Primary Study (2 Months)|Other|0|||
48544310|NCT04713553|156182877|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
48544311|NCT04713553|156182878|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
48544312|NCT04713553|156182879|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
48544313|NCT04713553|156182880|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
48544314|NCT04713553|156182881|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
48544315|NCT04713553|156182882|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
48544316|NCT04713553|156182883|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
48544317|NCT04713553|156182877|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
48544318|NCT04713553|156182878|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
48544319|NCT04713553|156182879|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
48544320|NCT04713553|156182880|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
48544321|NCT04713553|156182881|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
48544322|NCT04713553|156182882|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
48544323|NCT04713553|156182883|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
48544324|NCT00987389|156182895|FG000|Overall Study|Ineligible|0|||
48544325|NCT00987389|156182896|FG001|Overall Study|Ineligible|3|||
48544326|NCT00987389|156182897|FG002|Overall Study|Ineligible|0|||
48544327|NCT00987389|156182898|FG003|Overall Study|Ineligible|0|||
48544328|NCT00987389|156182895|FG000|Overall Study|Lost to Follow-up|4|||
48544329|NCT00987389|156182896|FG001|Overall Study|Lost to Follow-up|1|||
48544330|NCT00987389|156182897|FG002|Overall Study|Lost to Follow-up|3|||
48544331|NCT00987389|156182898|FG003|Overall Study|Lost to Follow-up|1|||
48544332|NCT00987389|156182895|FG000|Overall Study|Withdrawal by Subject|4|||
48544333|NCT00987389|156182896|FG001|Overall Study|Withdrawal by Subject|3|||
48544334|NCT00987389|156182897|FG002|Overall Study|Withdrawal by Subject|2|||
48544335|NCT00987389|156182898|FG003|Overall Study|Withdrawal by Subject|1|||
48544336|NCT00987389|156182895|FG000|Overall Study|Withdrawn from Treatment|0|||
48544337|NCT00987389|156182896|FG001|Overall Study|Withdrawn from Treatment|1|||
48544338|NCT00987389|156182897|FG002|Overall Study|Withdrawn from Treatment|0|||
48544339|NCT00987389|156182898|FG003|Overall Study|Withdrawn from Treatment|0|||
48544340|NCT00987389|156182895|FG000|Overall Study|Multiple different reasons|1|||
48544341|NCT00987389|156182896|FG001|Overall Study|Multiple different reasons|0|||
48544342|NCT00987389|156182897|FG002|Overall Study|Multiple different reasons|3|||
48544343|NCT00987389|156182898|FG003|Overall Study|Multiple different reasons|1|||
48544344|NCT01831765|156182901|FG000|Overall Study|Lack of Efficacy|1|||
48544345|NCT01831765|156182902|FG001|Overall Study|Lack of Efficacy|0|||
48544346|NCT01831765|156182903|FG002|Overall Study|Lack of Efficacy|0|||
48544347|NCT01831765|156182901|FG000|Overall Study|Other, sponsor withdrew subject|0|||
48544348|NCT01831765|156182902|FG001|Overall Study|Other, sponsor withdrew subject|1|||
48544349|NCT01831765|156182903|FG002|Overall Study|Other, sponsor withdrew subject|0|||
48544350|NCT01831765|156182901|FG000|Overall Study|Pregnancy|1|||
48544351|NCT01831765|156182902|FG001|Overall Study|Pregnancy|1|||
48544352|NCT01831765|156182903|FG002|Overall Study|Pregnancy|2|||
48609805|NCT00607893|156430186|FG000|Overall Study|Declined to be treated|1|||
48609806|NCT00607893|156430187|FG001|Overall Study|Declined to be treated|0|||
48609807|NCT00607893|156430186|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
48609808|NCT00607893|156430187|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
48609809|NCT00089648|156430192|FG000|Overall Study|Adverse Event|7|||
48609810|NCT00089648|156430192|FG000|Overall Study|Withdrawal by Subject|1|||
48609811|NCT00089648|156430192|FG000|Overall Study|Lack of Efficacy|33|||
48609812|NCT03979313|156430193|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
48609813|NCT03979313|156430194|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
48609814|NCT03979313|156430193|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
48609815|NCT03979313|156430194|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
48609816|NCT03979313|156430193|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
48609817|NCT03979313|156430194|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
48609818|NCT03979313|156430193|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
48609819|NCT03979313|156430194|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
48609820|NCT03979313|156430193|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
48609821|NCT03979313|156430194|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
48609822|NCT03979313|156430193|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
48609823|NCT03979313|156430194|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
48609824|NCT03979313|156430193|FG000|All Subjects|Any Other Reason|16|||
48609825|NCT03979313|156430194|FG001|All Subjects|Any Other Reason|23|||
48609826|NCT03979313|156430193|FG000|All Subjects|Covid-19|1|||
48609827|NCT03979313|156430194|FG001|All Subjects|Covid-19|3|||
48609828|NCT03979313|156430193|FG000|All Subjects|Withdrawal by Subject|35|||
48609829|NCT03979313|156430194|FG001|All Subjects|Withdrawal by Subject|44|||
48609830|NCT03979313|156430193|FG000|All Subjects|Death|0|||
48609831|NCT03979313|156430194|FG001|All Subjects|Death|5|||
48609832|NCT03979313|156430193|FG000|All Subjects|Lost to Follow-up|28|||
48609833|NCT03979313|156430194|FG001|All Subjects|Lost to Follow-up|61|||
48609834|NCT00300053|156430195|FG000|Overall Study|Patient/Caregiver Preference|2|||
48609835|NCT00300053|156430196|FG001|Overall Study|Patient/Caregiver Preference|2|||
48609836|NCT00300053|156430197|FG002|Overall Study|Patient/Caregiver Preference|3|||
48609837|NCT00300053|156430195|FG000|Overall Study|Death|0|||
48609838|NCT00300053|156430196|FG001|Overall Study|Death|0|||
48609839|NCT00300053|156430197|FG002|Overall Study|Death|3|||
48609840|NCT00300053|156430195|FG000|Overall Study|Lost to Follow-up|0|||
48609841|NCT00300053|156430196|FG001|Overall Study|Lost to Follow-up|1|||
48609842|NCT00300053|156430197|FG002|Overall Study|Lost to Follow-up|0|||
48609843|NCT01125930|156430198|FG000|Overall Study|Adverse Event|0|||
48609844|NCT01125930|156430199|FG001|Overall Study|Adverse Event|1|||
48609845|NCT01125930|156430198|FG000|Overall Study|Withdrawal by Subject|1|||
48609846|NCT01125930|156430199|FG001|Overall Study|Withdrawal by Subject|6|||
48609847|NCT01125930|156430198|FG000|Overall Study|Protocol Violation|0|||
48609848|NCT01125930|156430199|FG001|Overall Study|Protocol Violation|1|||
48609849|NCT01125930|156430198|FG000|Overall Study|Lost to Follow-up|0|||
48609850|NCT01125930|156430199|FG001|Overall Study|Lost to Follow-up|2|||
48609851|NCT04400318|156430200|FG000|Overall Study|Adverse Event|1|||
48609852|NCT04400318|156430201|FG001|Overall Study|Adverse Event|0|||
48609853|NCT04400318|156430200|FG000|Overall Study|Withdrawal by Subject|1|||
48609854|NCT04400318|156430201|FG001|Overall Study|Withdrawal by Subject|1|||
48609855|NCT04400318|156430200|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
48609856|NCT04400318|156430201|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
48609857|NCT02026141|156430202|FG000|Overall Study|Protocol Violation|0|||
48609858|NCT02026141|156430203|FG001|Overall Study|Protocol Violation|1|||
48609859|NCT01991314|156430204|FG000|Overall Study|Adverse Event|5|||
48609860|NCT01991314|156430205|FG001|Overall Study|Adverse Event|1|||
48609861|NCT01991314|156430204|FG000|Overall Study|Lost to Follow-up|6|||
48609862|NCT01991314|156430205|FG001|Overall Study|Lost to Follow-up|10|||
48609863|NCT00883181|156430206|FG000|Overall Study|Hematological Adverse Event|26|||
48609864|NCT00883181|156430206|FG000|Overall Study|Non-hematological Adverse Event|55|||
48609865|NCT00883181|156430206|FG000|Overall Study|Disease Progression|94|||
48609866|NCT00883181|156430206|FG000|Overall Study|Administrative Reason|24|||
48609867|NCT00883181|156430206|FG000|Overall Study|Withdrawal by Subject|4|||
48609868|NCT00883181|156430206|FG000|Overall Study|Death|31|||
48609869|NCT00883181|156430206|FG000|Overall Study|Other|38|||
48609870|NCT00883181|156430206|FG000|Overall Study|Protocol Deviation|3|||
48609871|NCT00883181|156430206|FG000|Overall Study|Noncompliance|3|||
48609872|NCT02472405|156430207|FG000|Overall Study|Lost to Follow-up|9|||
48544353|NCT01831765|156182901|FG000|Overall Study|Death|0|||
48544354|NCT01831765|156182902|FG001|Overall Study|Death|1|||
48544355|NCT01831765|156182903|FG002|Overall Study|Death|1|||
48544356|NCT01831765|156182901|FG000|Overall Study|Other, site closed|1|||
48544357|NCT01831765|156182902|FG001|Overall Study|Other, site closed|1|||
48544358|NCT01831765|156182903|FG002|Overall Study|Other, site closed|0|||
48544359|NCT01831765|156182901|FG000|Overall Study|Adverse Event|5|||
48544360|NCT01831765|156182902|FG001|Overall Study|Adverse Event|3|||
48544361|NCT01831765|156182903|FG002|Overall Study|Adverse Event|3|||
48544362|NCT01831765|156182901|FG000|Overall Study|Withdrawal by Subject|22|||
48544363|NCT01831765|156182902|FG001|Overall Study|Withdrawal by Subject|7|||
48544364|NCT01831765|156182903|FG002|Overall Study|Withdrawal by Subject|17|||
48544365|NCT01831765|156182901|FG000|Overall Study|Withdrawal criteria|12|||
48544366|NCT01831765|156182902|FG001|Overall Study|Withdrawal criteria|10|||
48544367|NCT01831765|156182903|FG002|Overall Study|Withdrawal criteria|16|||
48544368|NCT01831765|156182901|FG000|Overall Study|Lost to Follow-up|2|||
48544369|NCT01831765|156182902|FG001|Overall Study|Lost to Follow-up|3|||
48544370|NCT01831765|156182903|FG002|Overall Study|Lost to Follow-up|3|||
48544371|NCT00655876|156182904|FG000|Overall Study|Protocol Violation|9|||
48544372|NCT00655876|156182905|FG001|Overall Study|Protocol Violation|7|||
48544373|NCT00326963|156182906|FG000|Overall Study|Adverse Event|2|||
48544374|NCT00326963|156182906|FG000|Overall Study|Injection site reaction|1|||
48544375|NCT00326963|156182906|FG000|Overall Study|Death|1|||
48544376|NCT00326963|156182906|FG000|Overall Study|Failure to return|10|||
48544377|NCT00326963|156182906|FG000|Overall Study|Withdrawal by Subject|10|||
48544378|NCT00326963|156182906|FG000|Overall Study|Refused treatment / did not cooperate|5|||
48544379|NCT00326963|156182906|FG000|Overall Study|Violation of selection criteria at entry|2|||
48544380|NCT00326963|156182906|FG000|Overall Study|Other protocol violation|1|||
48544381|NCT00326963|156182906|FG000|Overall Study|Administrative / other|1|||
48544382|NCT00507130|156182907|FG000|Overall Study|Lost to Follow-up|0|||
48544383|NCT00507130|156182908|FG001|Overall Study|Lost to Follow-up|0|||
48544384|NCT00507130|156182909|FG002|Overall Study|Lost to Follow-up|1|||
48544385|NCT00507130|156182910|FG003|Overall Study|Lost to Follow-up|1|||
48544386|NCT00507130|156182907|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
48544387|NCT00507130|156182908|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
48544388|NCT00507130|156182909|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
48544389|NCT00507130|156182910|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
48544390|NCT02524730|156182911|FG000|Overall Study|Lost to Follow-up|5|||
48544391|NCT02524730|156182911|FG000|Overall Study|Withdrawal by Subject|18|||
48544392|NCT02524730|156182911|FG000|Overall Study|Death|10|||
48544393|NCT02524730|156182911|FG000|Overall Study|Adverse Event|8|||
48544394|NCT02524730|156182911|FG000|Overall Study|Protocol Violation|1|||
48544395|NCT02524730|156182911|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
48544396|NCT00859586|156182912|FG000|Overall Study|Donors|4|||
48544397|NCT03783039|156182913|FG000|Overall Study|Death|2|||
48544398|NCT03783039|156182914|FG001|Overall Study|Death|1|||
48544399|NCT01682863|156182915|FG000|Overall Study|Subject/guardian decision|19|||
48544400|NCT01682863|156182916|FG001|Overall Study|Subject/guardian decision|12|||
48544401|NCT01682863|156182917|FG002|Overall Study|Subject/guardian decision|10|||
48544402|NCT01682863|156182915|FG000|Overall Study|Lost to Follow-up|5|||
48544403|NCT01682863|156182916|FG001|Overall Study|Lost to Follow-up|1|||
48544404|NCT01682863|156182917|FG002|Overall Study|Lost to Follow-up|6|||
48544405|NCT01682863|156182915|FG000|Overall Study|Death|1|||
48544406|NCT01682863|156182916|FG001|Overall Study|Death|3|||
48544407|NCT01682863|156182917|FG002|Overall Study|Death|4|||
48544408|NCT01682863|156182915|FG000|Overall Study|Protocol deviation|1|||
48544409|NCT01682863|156182916|FG001|Overall Study|Protocol deviation|0|||
48544410|NCT01682863|156182917|FG002|Overall Study|Protocol deviation|1|||
48544411|NCT01682863|156182915|FG000|Overall Study|Technical problems|1|||
48544412|NCT01682863|156182916|FG001|Overall Study|Technical problems|0|||
48544413|NCT01682863|156182917|FG002|Overall Study|Technical problems|0|||
48544414|NCT01682863|156182915|FG000|Overall Study|Adverse Event|0|||
48544415|NCT01682863|156182916|FG001|Overall Study|Adverse Event|1|||
48544416|NCT01682863|156182917|FG002|Overall Study|Adverse Event|2|||
48544417|NCT01682863|156182915|FG000|Overall Study|Physician Decision|0|||
48544418|NCT01682863|156182916|FG001|Overall Study|Physician Decision|0|||
48544419|NCT01682863|156182917|FG002|Overall Study|Physician Decision|1|||
48544420|NCT02272634|156182922|FG000|Overall Study|Adverse Event|1|||
48544421|NCT02272634|156182923|FG001|Overall Study|Adverse Event|0|||
48544422|NCT02272634|156182924|FG002|Overall Study|Adverse Event|0|||
48544423|NCT02272634|156182922|FG000|Overall Study|Protocol Violation|0|||
48544424|NCT02272634|156182923|FG001|Overall Study|Protocol Violation|0|||
48544425|NCT02272634|156182924|FG002|Overall Study|Protocol Violation|1|||
48544426|NCT02272634|156182922|FG000|Overall Study|Withdrawal by Subject|0|||
48544427|NCT02272634|156182923|FG001|Overall Study|Withdrawal by Subject|1|||
48544428|NCT02272634|156182924|FG002|Overall Study|Withdrawal by Subject|0|||
48544429|NCT02116608|156182930|FG000|Overall Study|Lost to Follow-up|0|||
48544430|NCT02116608|156182931|FG001|Overall Study|Lost to Follow-up|0|||
48609873|NCT02472405|156430207|FG000|Overall Study|Adverse Event|1|||
48609874|NCT03617588|156430208|FG000|Overall Study|Withdrawal by Subject|1|||
48609875|NCT03617588|156430209|FG001|Overall Study|Withdrawal by Subject|0|||
48609876|NCT01118299|156430210|FG000|Overall Study|Death|7|||
48609877|NCT01118299|156430211|FG001|Overall Study|Death|5|||
48609878|NCT01118299|156430210|FG000|Overall Study|Withdrawal by Subject|8|||
48609879|NCT01118299|156430211|FG001|Overall Study|Withdrawal by Subject|8|||
48609880|NCT01118299|156430210|FG000|Overall Study|Lost to Follow-up|2|||
48544431|NCT02116608|156182932|FG002|Overall Study|Lost to Follow-up|1|||
48544432|NCT02116608|156182930|FG000|Overall Study|Physician Decision|0|||
48544433|NCT02116608|156182931|FG001|Overall Study|Physician Decision|1|||
48544434|NCT02116608|156182932|FG002|Overall Study|Physician Decision|0|||
48544435|NCT02116608|156182930|FG000|Overall Study|Death|0|||
48544436|NCT02116608|156182931|FG001|Overall Study|Death|1|||
48544437|NCT02116608|156182932|FG002|Overall Study|Death|0|||
48544438|NCT00827632|156182935|FG000|Overall Study|Lost to Follow-up|8|||
48544439|NCT00827632|156182936|FG001|Overall Study|Lost to Follow-up|12|||
48544440|NCT00827632|156182935|FG000|Overall Study|Early withdrawal|14|||
48544441|NCT00827632|156182936|FG001|Overall Study|Early withdrawal|11|||
48544442|NCT00128830|156182938|FG000|Overall Study|Adverse Event|10|||
48544443|NCT00128830|156182938|FG000|Overall Study|Withdrawal by Subject|14|||
48544444|NCT00128830|156182938|FG000|Overall Study|Lost to Follow-up|4|||
48544445|NCT00128830|156182938|FG000|Overall Study|Reached a virologic endpoint|29|||
48544446|NCT00128830|156182938|FG000|Overall Study|Non-compliant|4|||
48544447|NCT00128830|156182938|FG000|Overall Study|Discontinued or ineligible for study|2|||
48544448|NCT00128830|156182938|FG000|Overall Study|Other|9|||
48544449|NCT02730351|156182939|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
48544450|NCT02730351|156182940|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
48544451|NCT02730351|156182939|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
48544452|NCT02730351|156182940|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
48544453|NCT02730351|156182939|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
48544454|NCT02730351|156182940|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
48544455|NCT02730351|156182939|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
48544456|NCT02730351|156182940|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
48544457|NCT02730351|156182939|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
48544458|NCT02730351|156182940|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
48544459|NCT00838435|156182943|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
48544460|NCT00838435|156182943|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
48544461|NCT00838435|156182943|FG000|Part 2 (7 Years)|Adverse Event|2|||
48544462|NCT00838435|156182943|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
48544463|NCT00838435|156182943|FG000|Part 2 (7 Years)|Physician Decision|1|||
48544464|NCT00838435|156182943|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
48544465|NCT00838435|156182943|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
48544466|NCT03837743|156182944|FG000|Overall Study|Adverse Event|1|||
48544467|NCT03837743|156182944|FG000|Overall Study|Withdrawal by Subject|2|||
48544468|NCT02640053|156182950|FG000|Overall Study|Withdrawal by Subject|2|||
48544469|NCT02640053|156182951|FG001|Overall Study|Withdrawal by Subject|1|||
48544470|NCT02640053|156182950|FG000|Overall Study|Adverse Event|1|||
48609881|NCT01118299|156430211|FG001|Overall Study|Lost to Follow-up|1|||
48544471|NCT02640053|156182951|FG001|Overall Study|Adverse Event|1|||
48544472|NCT02640053|156182950|FG000|Overall Study|Alternative Therapy|1|||
48544473|NCT02640053|156182951|FG001|Overall Study|Alternative Therapy|1|||
48544474|NCT02640053|156182950|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
48544475|NCT02640053|156182951|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
48544476|NCT00424775|156182954|FG000|Overall Study|Adverse Event|2|||
48544477|NCT00424775|156182955|FG001|Overall Study|Adverse Event|0|||
48544478|NCT00424775|156182954|FG000|Overall Study|Lack of Efficacy|1|||
48544479|NCT00424775|156182955|FG001|Overall Study|Lack of Efficacy|0|||
48544480|NCT00681590|156182956|FG000|Overall Study|Withdrawal by Subject|2|||
48544481|NCT00681590|156182957|FG001|Overall Study|Withdrawal by Subject|12|||
48544482|NCT02912650|156182960|FG000|Overall Study|Withdrawal by Subject|1|||
48544483|NCT02912650|156182961|FG001|Overall Study|Withdrawal by Subject|0|||
48544484|NCT02912650|156182962|FG002|Overall Study|Withdrawal by Subject|1|||
48544485|NCT02912650|156182963|FG003|Overall Study|Withdrawal by Subject|5|||
48544486|NCT02912650|156182960|FG000|Overall Study|Adverse Event|0|||
48544487|NCT02912650|156182961|FG001|Overall Study|Adverse Event|0|||
48544488|NCT02912650|156182962|FG002|Overall Study|Adverse Event|1|||
48544489|NCT02912650|156182963|FG003|Overall Study|Adverse Event|0|||
48544490|NCT00758680|156182964|FG000|Overall Study|Adverse Event|0|||
48544491|NCT00758680|156182965|FG001|Overall Study|Adverse Event|0|||
48544492|NCT00758680|156182966|FG002|Overall Study|Adverse Event|0|||
48544493|NCT00758680|156182967|FG003|Overall Study|Adverse Event|0|||
48544494|NCT00758680|156182968|FG004|Overall Study|Adverse Event|0|||
48544495|NCT00758680|156182969|FG005|Overall Study|Adverse Event|0|||
48544496|NCT00758680|156182970|FG006|Overall Study|Adverse Event|0|||
48544497|NCT00758680|156182971|FG007|Overall Study|Adverse Event|1|||
48544498|NCT00758680|156182972|FG008|Overall Study|Adverse Event|0|||
48544499|NCT00758680|156182973|FG009|Overall Study|Adverse Event|1|||
48544500|NCT00758680|156182964|FG000|Overall Study|Laboratory Adverse Event|0|||
48544501|NCT00758680|156182965|FG001|Overall Study|Laboratory Adverse Event|0|||
48544502|NCT00758680|156182966|FG002|Overall Study|Laboratory Adverse Event|0|||
48544503|NCT00758680|156182967|FG003|Overall Study|Laboratory Adverse Event|0|||
48544504|NCT00758680|156182968|FG004|Overall Study|Laboratory Adverse Event|0|||
48544505|NCT00758680|156182969|FG005|Overall Study|Laboratory Adverse Event|0|||
48544506|NCT00758680|156182970|FG006|Overall Study|Laboratory Adverse Event|0|||
48544507|NCT00758680|156182971|FG007|Overall Study|Laboratory Adverse Event|0|||
48544508|NCT00758680|156182972|FG008|Overall Study|Laboratory Adverse Event|1|||
48544509|NCT00758680|156182973|FG009|Overall Study|Laboratory Adverse Event|0|||
48544510|NCT00758680|156182964|FG000|Overall Study|Withdrawal by Subject|0|||
48544511|NCT00758680|156182965|FG001|Overall Study|Withdrawal by Subject|0|||
48544512|NCT00758680|156182966|FG002|Overall Study|Withdrawal by Subject|0|||
48544513|NCT00758680|156182967|FG003|Overall Study|Withdrawal by Subject|0|||
48544514|NCT00758680|156182968|FG004|Overall Study|Withdrawal by Subject|0|||
48544515|NCT00758680|156182969|FG005|Overall Study|Withdrawal by Subject|0|||
48544516|NCT00758680|156182970|FG006|Overall Study|Withdrawal by Subject|1|||
48544517|NCT00758680|156182971|FG007|Overall Study|Withdrawal by Subject|0|||
48544518|NCT00758680|156182972|FG008|Overall Study|Withdrawal by Subject|1|||
48544519|NCT00758680|156182973|FG009|Overall Study|Withdrawal by Subject|0|||
48544520|NCT02056392|156182976|FG000|Overall Study|Lost to Follow-up|0|||
48544521|NCT02056392|156182977|FG001|Overall Study|Lost to Follow-up|1|||
48544522|NCT02056392|156182978|FG002|Overall Study|Lost to Follow-up|2|||
48544523|NCT02056392|156182979|FG003|Overall Study|Lost to Follow-up|0|||
48544524|NCT02056392|156182980|FG004|Overall Study|Lost to Follow-up|0|||
48544525|NCT02056392|156182981|FG005|Overall Study|Lost to Follow-up|0|||
48544526|NCT02056392|156182976|FG000|Overall Study|Protocol Violation|1|||
48544527|NCT02056392|156182977|FG001|Overall Study|Protocol Violation|0|||
48544528|NCT02056392|156182978|FG002|Overall Study|Protocol Violation|1|||
48544529|NCT02056392|156182979|FG003|Overall Study|Protocol Violation|0|||
48544530|NCT02056392|156182980|FG004|Overall Study|Protocol Violation|0|||
48544531|NCT02056392|156182981|FG005|Overall Study|Protocol Violation|0|||
48544532|NCT02056392|156182976|FG000|Overall Study|Withdrawal by Subject|1|||
48544533|NCT02056392|156182977|FG001|Overall Study|Withdrawal by Subject|0|||
48544534|NCT02056392|156182978|FG002|Overall Study|Withdrawal by Subject|0|||
48544535|NCT02056392|156182979|FG003|Overall Study|Withdrawal by Subject|0|||
48544536|NCT02056392|156182980|FG004|Overall Study|Withdrawal by Subject|1|||
48544537|NCT02056392|156182981|FG005|Overall Study|Withdrawal by Subject|0|||
48544538|NCT03480386|156182982|FG000|Overall Study|Did not complete measures at 3-months|17|||
48544539|NCT03480386|156182983|FG001|Overall Study|Did not complete measures at 3-months|14|||
48544540|NCT03480386|156182982|FG000|Overall Study|No baseline measures|11|||
48544541|NCT03480386|156182983|FG001|Overall Study|No baseline measures|14|||
48544542|NCT03480386|156182982|FG000|Overall Study|Death|0|||
48544543|NCT03480386|156182983|FG001|Overall Study|Death|5|||
48544544|NCT03480386|156182982|FG000|Overall Study|Withdrawal by Subject|12|||
48544545|NCT03480386|156182983|FG001|Overall Study|Withdrawal by Subject|8|||
48544546|NCT03480386|156182982|FG000|Overall Study|Lost to Follow-up|2|||
48544547|NCT03480386|156182983|FG001|Overall Study|Lost to Follow-up|1|||
48609882|NCT01118299|156430210|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
48544548|NCT03480386|156182982|FG000|Overall Study|Complicating disease|0|||
48544549|NCT03480386|156182983|FG001|Overall Study|Complicating disease|1|||
48544550|NCT03480386|156182982|FG000|Overall Study|Disease progression|3|||
48544551|NCT03480386|156182983|FG001|Overall Study|Disease progression|0|||
48544552|NCT03480386|156182982|FG000|Overall Study|Became ineligible|0|||
48544553|NCT03480386|156182983|FG001|Overall Study|Became ineligible|2|||
48544554|NCT01094886|156182984|FG000|Overall Study|Adverse Event|2|||
48544555|NCT01094886|156182984|FG000|Overall Study|Withdrawal by Subject|5|||
48544556|NCT00658021|156182985|FG000|28-Week Treatment Period|Adverse Event|3|||
48544557|NCT00658021|156182986|FG001|28-Week Treatment Period|Adverse Event|1|||
48544558|NCT00658021|156182987|FG002|28-Week Treatment Period|Adverse Event|0|||
48544559|NCT00658021|156182985|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
48544560|NCT00658021|156182986|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
48544561|NCT00658021|156182987|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
48544562|NCT00658021|156182985|FG000|28-Week Treatment Period|Protocol Violation|0|||
48544563|NCT00658021|156182986|FG001|28-Week Treatment Period|Protocol Violation|2|||
48544564|NCT00658021|156182987|FG002|28-Week Treatment Period|Protocol Violation|1|||
48544565|NCT00658021|156182985|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
48544566|NCT00658021|156182986|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
48544567|NCT00658021|156182987|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
48544568|NCT00658021|156182985|FG000|28-Week Treatment Period|Physician Decision|1|||
48544569|NCT00658021|156182986|FG001|28-Week Treatment Period|Physician Decision|2|||
48544570|NCT00658021|156182987|FG002|28-Week Treatment Period|Physician Decision|1|||
48544571|NCT00658021|156182985|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
48544572|NCT00658021|156182986|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
48544573|NCT00658021|156182987|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
48544574|NCT00658021|156182985|FG000|28-Week Treatment Period|Loss of glucose control|1|||
48544575|NCT00658021|156182986|FG001|28-Week Treatment Period|Loss of glucose control|1|||
48544576|NCT00658021|156182987|FG002|28-Week Treatment Period|Loss of glucose control|10|||
48544577|NCT00658021|156182985|FG000|28-Week Treatment Period|Other|2|||
48544578|NCT00658021|156182986|FG001|28-Week Treatment Period|Other|3|||
48544579|NCT00658021|156182987|FG002|28-Week Treatment Period|Other|1|||
48544580|NCT00658021|156182985|FG000|28-Week Treatment Period|Did not receive treatment|2|||
48544581|NCT00658021|156182986|FG001|28-Week Treatment Period|Did not receive treatment|0|||
48544582|NCT00658021|156182987|FG002|28-Week Treatment Period|Did not receive treatment|0|||
48544583|NCT00658021|156182985|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
48544584|NCT00658021|156182986|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
48544585|NCT00658021|156182987|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
48544586|NCT00658021|156182985|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
48544587|NCT00658021|156182986|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
48544588|NCT00658021|156182987|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
48544589|NCT00548093|156182988|FG000|Overall Study|Death|33|||
48544590|NCT00548093|156182989|FG001|Overall Study|Death|13|||
48544591|NCT00548093|156182988|FG000|Overall Study|Lost to Follow-up|3|||
48544592|NCT00548093|156182989|FG001|Overall Study|Lost to Follow-up|1|||
48544593|NCT00548093|156182988|FG000|Overall Study|Objective progression or relapse|1|||
48544594|NCT00548093|156182989|FG001|Overall Study|Objective progression or relapse|1|||
48544595|NCT00548093|156182988|FG000|Overall Study|Other|11|||
48544596|NCT00548093|156182989|FG001|Overall Study|Other|1|||
48544597|NCT00548093|156182988|FG000|Overall Study|Withdrawal by Subject|1|||
48544598|NCT00548093|156182989|FG001|Overall Study|Withdrawal by Subject|0|||
48544599|NCT00548093|156182988|FG000|Overall Study|Completed post-treatment follow-up|1|||
48544600|NCT00548093|156182989|FG001|Overall Study|Completed post-treatment follow-up|0|||
48544601|NCT00968799|156182990|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
48544602|NCT02516553|156182993|FG000|Overall Study|Progressive disease|2|||
48544603|NCT02516553|156182994|FG001|Overall Study|Progressive disease|2|||
48544604|NCT02516553|156182995|FG002|Overall Study|Progressive disease|3|||
48609883|NCT01118299|156430211|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
48544605|NCT02516553|156182996|FG003|Overall Study|Progressive disease|5|||
48544606|NCT02516553|156182997|FG004|Overall Study|Progressive disease|3|||
48544607|NCT02516553|156182998|FG005|Overall Study|Progressive disease|0|||
48544608|NCT02516553|156182999|FG006|Overall Study|Progressive disease|5|||
48544609|NCT02516553|156183000|FG007|Overall Study|Progressive disease|5|||
48544610|NCT02516553|156183001|FG008|Overall Study|Progressive disease|11|||
48544611|NCT02516553|156183002|FG009|Overall Study|Progressive disease|3|||
48544612|NCT02516553|156183003|FG010|Overall Study|Progressive disease|10|||
48544613|NCT02516553|156183004|FG011|Overall Study|Progressive disease|8|||
48544614|NCT02516553|156183005|FG012|Overall Study|Progressive disease|8|||
48544615|NCT02516553|156183006|FG013|Overall Study|Progressive disease|2|||
48609884|NCT04459338|156430212|FG000|Overall Study|Loss of IV during study|1|||
48544616|NCT02516553|156183007|FG014|Overall Study|Progressive disease|2|||
48544617|NCT02516553|156183008|FG015|Overall Study|Progressive disease|2|||
48609885|NCT04459338|156430213|FG001|Overall Study|Loss of IV during study|0|||
48609886|NCT02690727|156430214|FG000|Overall Study|Adverse Event|2|||
48609887|NCT02690727|156430215|FG001|Overall Study|Adverse Event|2|||
48544618|NCT02516553|156183009|FG016|Overall Study|Progressive disease|1|||
48544619|NCT02516553|156183010|FG017|Overall Study|Progressive disease|9|||
48544620|NCT02516553|156183011|FG018|Overall Study|Progressive disease|12|||
48544621|NCT02516553|156183012|FG019|Overall Study|Progressive disease|7|||
48544622|NCT02516553|156183013|FG020|Overall Study|Progressive disease|16|||
48609888|NCT03157089|156430216|FG000|Overall Study|Treated only with pembrolizumab|1|||
48609889|NCT03157089|156430217|FG001|Overall Study|Treated only with pembrolizumab|0|||
48609890|NCT03157089|156430216|FG000|Overall Study|Adverse Event|5|||
48609891|NCT03157089|156430217|FG001|Overall Study|Adverse Event|4|||
48609892|NCT03157089|156430216|FG000|Overall Study|Progressive disease|6|||
48609893|NCT03157089|156430217|FG001|Overall Study|Progressive disease|8|||
48609894|NCT04018066|156430220|FG000|Overall Study|participants started taking medications during the study period|3|||
48609895|NCT04018066|156430220|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
48609896|NCT03817528|156430221|FG000|Overall Study|Withdrawal by Subject|1|||
48609897|NCT03817528|156430221|FG000|Overall Study|Adverse Event|2|||
48609898|NCT00091819|156430225|FG000|Overall Study|Adverse Event|1|||
48609899|NCT00091819|156430226|FG001|Overall Study|Adverse Event|1|||
48609900|NCT00091819|156430225|FG000|Overall Study|Death|4|||
48609901|NCT00091819|156430226|FG001|Overall Study|Death|5|||
48609902|NCT00091819|156430225|FG000|Overall Study|Lost to Follow-up|26|||
48609903|NCT00091819|156430226|FG001|Overall Study|Lost to Follow-up|23|||
48609904|NCT00091819|156430225|FG000|Overall Study|Withdrawal by Subject|5|||
48609905|NCT00091819|156430226|FG001|Overall Study|Withdrawal by Subject|8|||
48609906|NCT00091819|156430225|FG000|Overall Study|Protocol Violation|1|||
48609907|NCT00091819|156430226|FG001|Overall Study|Protocol Violation|2|||
48609908|NCT00091819|156430225|FG000|Overall Study|Other|2|||
48609909|NCT00091819|156430226|FG001|Overall Study|Other|3|||
48609910|NCT00091819|156430225|FG000|Overall Study|Never received study treatment|3|||
48609911|NCT00091819|156430226|FG001|Overall Study|Never received study treatment|4|||
48609912|NCT00116142|156430228|FG000|Overall Study|Adverse Event|8|||
48609913|NCT00116142|156430229|FG001|Overall Study|Adverse Event|7|||
48609914|NCT00116142|156430228|FG000|Overall Study|Protocol Violation|2|||
48609915|NCT00116142|156430229|FG001|Overall Study|Protocol Violation|1|||
48609916|NCT00116142|156430228|FG000|Overall Study|Withdrawal by Subject|5|||
48609917|NCT00116142|156430229|FG001|Overall Study|Withdrawal by Subject|5|||
48609918|NCT00116142|156430228|FG000|Overall Study|Physician Decision|3|||
48609919|NCT00116142|156430229|FG001|Overall Study|Physician Decision|1|||
48609920|NCT00116142|156430228|FG000|Overall Study|Delayed Radiation Therapy|1|||
48609921|NCT00116142|156430229|FG001|Overall Study|Delayed Radiation Therapy|0|||
48609922|NCT00116142|156430228|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
48609923|NCT00116142|156430229|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
48609924|NCT00116142|156430228|FG000|Overall Study|Patient stopped due to depression|0|||
48609925|NCT00116142|156430229|FG001|Overall Study|Patient stopped due to depression|1|||
48544623|NCT02516553|156183014|FG021|Overall Study|Progressive disease|18|||
48544624|NCT02516553|156182993|FG000|Overall Study|Dose limiting toxicity|0|||
48544625|NCT02516553|156182994|FG001|Overall Study|Dose limiting toxicity|0|||
48544626|NCT02516553|156182995|FG002|Overall Study|Dose limiting toxicity|0|||
48544627|NCT02516553|156182996|FG003|Overall Study|Dose limiting toxicity|0|||
48544628|NCT02516553|156182997|FG004|Overall Study|Dose limiting toxicity|3|||
48544629|NCT02516553|156182998|FG005|Overall Study|Dose limiting toxicity|1|||
48544630|NCT02516553|156182999|FG006|Overall Study|Dose limiting toxicity|1|||
48544631|NCT02516553|156183000|FG007|Overall Study|Dose limiting toxicity|0|||
48609926|NCT00116142|156430228|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
48609927|NCT00116142|156430229|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
48609928|NCT00116142|156430228|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
48609929|NCT00116142|156430229|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
48609930|NCT00116142|156430228|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
48609931|NCT00116142|156430229|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
48609932|NCT00433836|156430230|FG000|Overall Study|Adverse Event|7|||
48735642|NCT00961649|156883697|FG000|Overall Study|Study terminated by sponsor|4|||
48735643|NCT00961649|156883698|FG001|Overall Study|Study terminated by sponsor|4|||
48735644|NCT00961649|156883699|FG002|Overall Study|Study terminated by sponsor|4|||
48735645|NCT00961649|156883700|FG003|Overall Study|Study terminated by sponsor|1|||
48735646|NCT02215096|156883705|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
48544632|NCT02516553|156183001|FG008|Overall Study|Dose limiting toxicity|1|||
48544633|NCT02516553|156183002|FG009|Overall Study|Dose limiting toxicity|0|||
48544634|NCT02516553|156183003|FG010|Overall Study|Dose limiting toxicity|0|||
48544635|NCT02516553|156183004|FG011|Overall Study|Dose limiting toxicity|1|||
48544636|NCT02516553|156183005|FG012|Overall Study|Dose limiting toxicity|0|||
48544637|NCT02516553|156183006|FG013|Overall Study|Dose limiting toxicity|1|||
48609933|NCT00433836|156430231|FG001|Overall Study|Adverse Event|0|||
48609934|NCT00433836|156430230|FG000|Overall Study|Lost to Follow-up|3|||
48609935|NCT00433836|156430231|FG001|Overall Study|Lost to Follow-up|0|||
48544638|NCT02516553|156183007|FG014|Overall Study|Dose limiting toxicity|0|||
48544639|NCT02516553|156183008|FG015|Overall Study|Dose limiting toxicity|0|||
48544640|NCT02516553|156183009|FG016|Overall Study|Dose limiting toxicity|1|||
48609936|NCT00433836|156430230|FG000|Overall Study|Withdrawal by Subject|2|||
48609937|NCT00433836|156430231|FG001|Overall Study|Withdrawal by Subject|1|||
48609938|NCT00433836|156430230|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48609939|NCT00433836|156430231|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48609940|NCT00433836|156430230|FG000|Overall Study|Protocol Violation|0|||
48609941|NCT00433836|156430231|FG001|Overall Study|Protocol Violation|2|||
48609942|NCT00433836|156430230|FG000|Overall Study|Condition no longer requires study drug|0|||
48609943|NCT00433836|156430231|FG001|Overall Study|Condition no longer requires study drug|1|||
48609944|NCT00433836|156430230|FG000|Overall Study|Abnormal laboratory values|0|||
48609945|NCT00433836|156430231|FG001|Overall Study|Abnormal laboratory values|1|||
48609946|NCT00851591|156430234|FG000|Overall Study|Withdrawal by Subject|2|||
48609947|NCT00851591|156430235|FG001|Overall Study|Withdrawal by Subject|0|||
48609948|NCT03558516|156430236|FG000|Overall Study|Protocol Violation|2|||
48609949|NCT03558516|156430237|FG001|Overall Study|Protocol Violation|2|||
48609950|NCT02469857|156430238|FG000|Overall Study|Death|24|||
48609951|NCT02469857|156430239|FG001|Overall Study|Death|29|||
48609952|NCT02469857|156430238|FG000|Overall Study|Discontinuation|1|||
48609953|NCT02469857|156430239|FG001|Overall Study|Discontinuation|3|||
48609954|NCT00142415|156430240|FG000|Overall Study|Physician Decision|0|||
48609955|NCT00142415|156430241|FG001|Overall Study|Physician Decision|0|||
48609956|NCT00142415|156430242|FG002|Overall Study|Physician Decision|0|||
48609957|NCT00142415|156430243|FG003|Overall Study|Physician Decision|0|||
48609958|NCT00142415|156430244|FG004|Overall Study|Physician Decision|1|||
48609959|NCT00142415|156430245|FG005|Overall Study|Physician Decision|2|||
48609960|NCT01553851|156430249|FG000|Overall Study|Adverse Event|2|||
48609961|NCT01553851|156430249|FG000|Overall Study|constipation|1|||
48609962|NCT02472353|156430251|FG000|Overall Study|Lost to Follow-up|1|||
48609963|NCT02472353|156430252|FG001|Overall Study|Lost to Follow-up|1|||
48609964|NCT02472353|156430251|FG000|Overall Study|Withdrawal by Subject|2|||
48609965|NCT02472353|156430252|FG001|Overall Study|Withdrawal by Subject|1|||
48609966|NCT02472353|156430251|FG000|Overall Study|Study Termination|1|||
48609967|NCT02472353|156430252|FG001|Overall Study|Study Termination|4|||
48609968|NCT00797563|156430253|FG000|Overall Study|Adverse Event|1|||
48609969|NCT00701363|156430254|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
48609970|NCT00701363|156430255|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
48609971|NCT00701363|156430256|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
48609972|NCT00701363|156430257|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
48609973|NCT00701363|156430254|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
48609974|NCT00701363|156430255|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
48609975|NCT00701363|156430256|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
48609976|NCT00701363|156430257|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
48609977|NCT00701363|156430254|FG000|Treatment Phase 1|Adverse Event|7|||
48609978|NCT00701363|156430255|FG001|Treatment Phase 1|Adverse Event|0|||
48609979|NCT00701363|156430256|FG002|Treatment Phase 1|Adverse Event|0|||
48609980|NCT00701363|156430257|FG003|Treatment Phase 1|Adverse Event|0|||
48609981|NCT00701363|156430254|FG000|Treatment Phase 1|Protocol Violation|1|||
48609982|NCT00701363|156430255|FG001|Treatment Phase 1|Protocol Violation|0|||
48609983|NCT00701363|156430256|FG002|Treatment Phase 1|Protocol Violation|0|||
48609984|NCT00701363|156430257|FG003|Treatment Phase 1|Protocol Violation|0|||
48609985|NCT00701363|156430254|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
48609986|NCT00701363|156430255|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
48609987|NCT00701363|156430256|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
48609988|NCT00701363|156430257|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
48609989|NCT00701363|156430254|FG000|Treatment Phase 1|Lack of Efficacy|1|||
48609990|NCT00701363|156430255|FG001|Treatment Phase 1|Lack of Efficacy|0|||
48609991|NCT00701363|156430256|FG002|Treatment Phase 1|Lack of Efficacy|0|||
48609992|NCT00701363|156430257|FG003|Treatment Phase 1|Lack of Efficacy|0|||
48609993|NCT00701363|156430254|FG000|Treatment Phase 2|Adverse Event|0|||
48609994|NCT00701363|156430255|FG001|Treatment Phase 2|Adverse Event|0|||
48609995|NCT00701363|156430256|FG002|Treatment Phase 2|Adverse Event|1|||
48609996|NCT00701363|156430257|FG003|Treatment Phase 2|Adverse Event|0|||
48609997|NCT00701363|156430254|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
48609998|NCT00701363|156430255|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
48609999|NCT00701363|156430256|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
48610000|NCT00701363|156430257|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
48610001|NCT02722967|156430261|FG000|Overall Study|Adverse Event|1|||
48610002|NCT02722967|156430262|FG001|Overall Study|Adverse Event|0|||
48610003|NCT02722967|156430263|FG002|Overall Study|Adverse Event|0|||
48447210|NCT03657810|155825836|FG001|Overall Study|Protocol Violation|0|||
48544641|NCT02516553|156183010|FG017|Overall Study|Dose limiting toxicity|1|||
48544642|NCT02516553|156183011|FG018|Overall Study|Dose limiting toxicity|0|||
48544643|NCT02516553|156183012|FG019|Overall Study|Dose limiting toxicity|2|||
48544644|NCT02516553|156183013|FG020|Overall Study|Dose limiting toxicity|0|||
48544645|NCT02516553|156183014|FG021|Overall Study|Dose limiting toxicity|0|||
48544646|NCT02516553|156182993|FG000|Overall Study|Other Adverse Events|0|||
48544647|NCT02516553|156182994|FG001|Overall Study|Other Adverse Events|0|||
48544648|NCT02516553|156182995|FG002|Overall Study|Other Adverse Events|0|||
48544649|NCT02516553|156182996|FG003|Overall Study|Other Adverse Events|1|||
48544650|NCT02516553|156182997|FG004|Overall Study|Other Adverse Events|0|||
48544651|NCT02516553|156182998|FG005|Overall Study|Other Adverse Events|1|||
48544652|NCT02516553|156182999|FG006|Overall Study|Other Adverse Events|0|||
48544653|NCT02516553|156183000|FG007|Overall Study|Other Adverse Events|0|||
48544654|NCT02516553|156183001|FG008|Overall Study|Other Adverse Events|0|||
48544655|NCT02516553|156183002|FG009|Overall Study|Other Adverse Events|1|||
48544656|NCT02516553|156183003|FG010|Overall Study|Other Adverse Events|3|||
48544657|NCT02516553|156183004|FG011|Overall Study|Other Adverse Events|2|||
48544658|NCT02516553|156183005|FG012|Overall Study|Other Adverse Events|0|||
48544659|NCT02516553|156183006|FG013|Overall Study|Other Adverse Events|1|||
48544660|NCT02516553|156183007|FG014|Overall Study|Other Adverse Events|0|||
48610004|NCT02722967|156430261|FG000|Overall Study|Lost to Follow-up|0|||
48610005|NCT02722967|156430262|FG001|Overall Study|Lost to Follow-up|1|||
48544661|NCT02516553|156183008|FG015|Overall Study|Other Adverse Events|0|||
48544662|NCT02516553|156183009|FG016|Overall Study|Other Adverse Events|0|||
48544663|NCT02516553|156183010|FG017|Overall Study|Other Adverse Events|2|||
48544664|NCT02516553|156183011|FG018|Overall Study|Other Adverse Events|1|||
48544665|NCT02516553|156183012|FG019|Overall Study|Other Adverse Events|2|||
48544666|NCT02516553|156183013|FG020|Overall Study|Other Adverse Events|2|||
48610006|NCT02722967|156430263|FG002|Overall Study|Lost to Follow-up|0|||
48610007|NCT02722967|156430261|FG000|Overall Study|Non-compliance with patch wearing|2|||
48610008|NCT02722967|156430262|FG001|Overall Study|Non-compliance with patch wearing|1|||
48610009|NCT02722967|156430263|FG002|Overall Study|Non-compliance with patch wearing|1|||
48610010|NCT02722967|156430261|FG000|Overall Study|Withdrawal by Subject|1|||
48610011|NCT02722967|156430262|FG001|Overall Study|Withdrawal by Subject|0|||
48610012|NCT02722967|156430263|FG002|Overall Study|Withdrawal by Subject|1|||
48610013|NCT02722967|156430261|FG000|Overall Study|Physician Decision|1|||
48610014|NCT02722967|156430262|FG001|Overall Study|Physician Decision|0|||
48610015|NCT02722967|156430263|FG002|Overall Study|Physician Decision|0|||
48610016|NCT02722967|156430261|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
48610017|NCT02722967|156430262|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
48610018|NCT02722967|156430263|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
48610019|NCT00695019|156430264|FG000|Overall Study|Withdrawal by Subject|8|||
48610020|NCT00695019|156430265|FG001|Overall Study|Withdrawal by Subject|6|||
48610021|NCT00695019|156430266|FG002|Overall Study|Withdrawal by Subject|4|||
48610022|NCT00695019|156430264|FG000|Overall Study|Protocol Violation|1|||
48610023|NCT00695019|156430265|FG001|Overall Study|Protocol Violation|3|||
48610024|NCT00695019|156430266|FG002|Overall Study|Protocol Violation|1|||
48610025|NCT00695019|156430264|FG000|Overall Study|Lack of Efficacy|0|||
48610026|NCT00695019|156430265|FG001|Overall Study|Lack of Efficacy|0|||
48610027|NCT00695019|156430266|FG002|Overall Study|Lack of Efficacy|1|||
48610028|NCT00695019|156430264|FG000|Overall Study|Various|4|||
48610029|NCT00695019|156430265|FG001|Overall Study|Various|5|||
48610030|NCT00695019|156430266|FG002|Overall Study|Various|4|||
48610031|NCT00639509|156430267|FG000|Overall Study|Death|1|||
48610032|NCT03122106|156430268|FG000|Overall Study|Not enough tissue|1|||
48610033|NCT03122106|156430268|FG000|Overall Study|Disease progression during screening|2|||
48610034|NCT03122106|156430268|FG000|Overall Study|Poor RNA quality for vaccine|1|||
48610035|NCT01143324|156430269|FG000|Overall Study|Lost to Follow-up|11|||
48610036|NCT01143324|156430269|FG000|Overall Study|Withdrawal by Subject|4|||
48610037|NCT01143324|156430269|FG000|Overall Study|Explant of the device|4|||
48610038|NCT00434252|156431675|FG000|Overall Study|Lack of Efficacy|50|||
48610039|NCT00434252|156431676|FG001|Overall Study|Lack of Efficacy|100|||
48610040|NCT00434252|156431675|FG000|Overall Study|Adverse Event|6|||
48544667|NCT02516553|156183014|FG021|Overall Study|Other Adverse Events|1|||
48544668|NCT02516553|156182993|FG000|Overall Study|Refused to continue trial medication|0|||
48544669|NCT02516553|156182994|FG001|Overall Study|Refused to continue trial medication|0|||
48544670|NCT02516553|156182995|FG002|Overall Study|Refused to continue trial medication|0|||
48544671|NCT02516553|156182996|FG003|Overall Study|Refused to continue trial medication|0|||
48544672|NCT02516553|156182997|FG004|Overall Study|Refused to continue trial medication|0|||
48544673|NCT02516553|156182998|FG005|Overall Study|Refused to continue trial medication|0|||
48544674|NCT02516553|156182999|FG006|Overall Study|Refused to continue trial medication|0|||
48544675|NCT02516553|156183000|FG007|Overall Study|Refused to continue trial medication|0|||
48544676|NCT02516553|156183001|FG008|Overall Study|Refused to continue trial medication|0|||
48544677|NCT02516553|156183002|FG009|Overall Study|Refused to continue trial medication|0|||
48544678|NCT02516553|156183003|FG010|Overall Study|Refused to continue trial medication|1|||
48544679|NCT02516553|156183004|FG011|Overall Study|Refused to continue trial medication|0|||
48544680|NCT02516553|156183005|FG012|Overall Study|Refused to continue trial medication|0|||
48544681|NCT02516553|156183006|FG013|Overall Study|Refused to continue trial medication|0|||
48544682|NCT02516553|156183007|FG014|Overall Study|Refused to continue trial medication|0|||
48544683|NCT02516553|156183008|FG015|Overall Study|Refused to continue trial medication|0|||
48544684|NCT02516553|156183009|FG016|Overall Study|Refused to continue trial medication|0|||
48544685|NCT02516553|156183010|FG017|Overall Study|Refused to continue trial medication|0|||
48544686|NCT02516553|156183011|FG018|Overall Study|Refused to continue trial medication|1|||
48544687|NCT02516553|156183012|FG019|Overall Study|Refused to continue trial medication|0|||
48544688|NCT02516553|156183013|FG020|Overall Study|Refused to continue trial medication|0|||
48544689|NCT02516553|156183014|FG021|Overall Study|Refused to continue trial medication|1|||
48544690|NCT02516553|156182993|FG000|Overall Study|other reasons than listed|0|||
48544691|NCT02516553|156182994|FG001|Overall Study|other reasons than listed|0|||
48544692|NCT02516553|156182995|FG002|Overall Study|other reasons than listed|0|||
48544693|NCT02516553|156182996|FG003|Overall Study|other reasons than listed|0|||
48544694|NCT02516553|156182997|FG004|Overall Study|other reasons than listed|0|||
48544695|NCT02516553|156182998|FG005|Overall Study|other reasons than listed|0|||
48544696|NCT02516553|156182999|FG006|Overall Study|other reasons than listed|0|||
48544697|NCT02516553|156183000|FG007|Overall Study|other reasons than listed|1|||
48544698|NCT02516553|156183001|FG008|Overall Study|other reasons than listed|1|||
48544699|NCT02516553|156183002|FG009|Overall Study|other reasons than listed|0|||
48544700|NCT02516553|156183003|FG010|Overall Study|other reasons than listed|1|||
48544701|NCT02516553|156183004|FG011|Overall Study|other reasons than listed|1|||
48544702|NCT02516553|156183005|FG012|Overall Study|other reasons than listed|0|||
48544703|NCT02516553|156183006|FG013|Overall Study|other reasons than listed|0|||
48544704|NCT02516553|156183007|FG014|Overall Study|other reasons than listed|0|||
48544705|NCT02516553|156183008|FG015|Overall Study|other reasons than listed|0|||
48544706|NCT02516553|156183009|FG016|Overall Study|other reasons than listed|0|||
48544707|NCT02516553|156183010|FG017|Overall Study|other reasons than listed|0|||
48544708|NCT02516553|156183011|FG018|Overall Study|other reasons than listed|0|||
48544709|NCT02516553|156183012|FG019|Overall Study|other reasons than listed|0|||
48544710|NCT02516553|156183013|FG020|Overall Study|other reasons than listed|2|||
48544711|NCT02516553|156183014|FG021|Overall Study|other reasons than listed|2|||
48544712|NCT02447744|156183017|FG000|Overall Study|Withdrawal by Subject|3|||
48544713|NCT02447744|156183018|FG001|Overall Study|Withdrawal by Subject|1|||
48544714|NCT02447744|156183017|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
48544715|NCT02447744|156183018|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
48544716|NCT04730349|156183021|FG000|Overall Study|Participant withdrew consent|1|||
48544717|NCT04730349|156183022|FG001|Overall Study|Participant withdrew consent|0|||
48544718|NCT04730349|156183021|FG000|Overall Study|Disease progression|6|||
48544719|NCT04730349|156183022|FG001|Overall Study|Disease progression|4|||
48544720|NCT04730349|156183021|FG000|Overall Study|Study drug toxicity|0|||
48544721|NCT04730349|156183022|FG001|Overall Study|Study drug toxicity|1|||
48544722|NCT04271735|156184985|FG000|Overall Study|Physician Decision|2|||
48544723|NCT04271735|156184986|FG001|Overall Study|Physician Decision|0|||
48544724|NCT00515541|156184987|FG000|Overall Study|Physician Decision|0|||
48544725|NCT00515541|156184988|FG001|Overall Study|Physician Decision|2|||
48544726|NCT00515541|156184989|FG002|Overall Study|Physician Decision|0|||
48544727|NCT00515541|156184990|FG003|Overall Study|Physician Decision|1|||
48544728|NCT00515541|156184987|FG000|Overall Study|No show for appointments|0|||
48544729|NCT00515541|156184988|FG001|Overall Study|No show for appointments|1|||
48544730|NCT00515541|156184989|FG002|Overall Study|No show for appointments|0|||
48544731|NCT00515541|156184990|FG003|Overall Study|No show for appointments|2|||
48544732|NCT00515541|156184987|FG000|Overall Study|Withdrawal by Subject|0|||
48544733|NCT00515541|156184988|FG001|Overall Study|Withdrawal by Subject|2|||
48544734|NCT00515541|156184989|FG002|Overall Study|Withdrawal by Subject|0|||
48544735|NCT00515541|156184990|FG003|Overall Study|Withdrawal by Subject|2|||
48544736|NCT04268316|156184991|FG000|Overall Study|Withdrawal by Subject|2|||
48544737|NCT04268316|156184992|FG001|Overall Study|Withdrawal by Subject|1|||
48544738|NCT04268316|156184993|FG002|Overall Study|Withdrawal by Subject|0|||
48544739|NCT02518919|156184995|FG000|Overall Study|Protocol Violation|1|||
48544740|NCT02518919|156184996|FG001|Overall Study|Protocol Violation|1|||
48544741|NCT02518919|156184997|FG002|Overall Study|Protocol Violation|2|||
48544742|NCT00599521|156184998|FG000|Overall Study|Lack of Efficacy|4|||
48544743|NCT00599521|156184999|FG001|Overall Study|Lack of Efficacy|8|||
48544744|NCT00599521|156184998|FG000|Overall Study|Adverse Event|4|||
48544745|NCT00599521|156184999|FG001|Overall Study|Adverse Event|1|||
48544746|NCT00599521|156184998|FG000|Overall Study|Withdrawal by Subject|28|||
48544747|NCT00599521|156184999|FG001|Overall Study|Withdrawal by Subject|34|||
48544748|NCT00599521|156184998|FG000|Overall Study|Protocol Violation|1|||
48544749|NCT00599521|156184999|FG001|Overall Study|Protocol Violation|1|||
48544750|NCT00599521|156184998|FG000|Overall Study|Lost to Follow-up|23|||
48544751|NCT00599521|156184999|FG001|Overall Study|Lost to Follow-up|23|||
48544752|NCT00599521|156184998|FG000|Overall Study|Pregnancy|0|||
48544753|NCT00599521|156184999|FG001|Overall Study|Pregnancy|2|||
48544754|NCT02040779|156185000|FG000|Overall Study|Adverse Event|1|||
48544755|NCT02040779|156185001|FG001|Overall Study|Adverse Event|0|||
48544756|NCT02040779|156185002|FG002|Overall Study|Adverse Event|0|||
48544757|NCT02040779|156185000|FG000|Overall Study|Withdrawal by Subject|4|||
48544758|NCT02040779|156185001|FG001|Overall Study|Withdrawal by Subject|1|||
48544759|NCT02040779|156185002|FG002|Overall Study|Withdrawal by Subject|3|||
48544760|NCT02040779|156185000|FG000|Overall Study|Non-compliance|0|||
48544761|NCT02040779|156185001|FG001|Overall Study|Non-compliance|1|||
48544762|NCT02040779|156185002|FG002|Overall Study|Non-compliance|0|||
48544763|NCT02040779|156185000|FG000|Overall Study|Protocol Violation|2|||
48544764|NCT02040779|156185001|FG001|Overall Study|Protocol Violation|1|||
48544765|NCT02040779|156185002|FG002|Overall Study|Protocol Violation|0|||
48544766|NCT02040779|156185000|FG000|Overall Study|Lost to Follow-up|1|||
48544767|NCT02040779|156185001|FG001|Overall Study|Lost to Follow-up|2|||
48544768|NCT02040779|156185002|FG002|Overall Study|Lost to Follow-up|1|||
48544769|NCT02040779|156185000|FG000|Overall Study|Lack of Efficacy|4|||
48544770|NCT02040779|156185001|FG001|Overall Study|Lack of Efficacy|2|||
48544771|NCT02040779|156185002|FG002|Overall Study|Lack of Efficacy|0|||
48544772|NCT04498403|156185003|FG000|Overall Study|Adverse Event|1|||
48544773|NCT04498403|156185004|FG001|Overall Study|Adverse Event|0|||
48544774|NCT04498403|156185003|FG000|Overall Study|Study Terminated By Sponsor|29|||
48544775|NCT04498403|156185004|FG001|Overall Study|Study Terminated By Sponsor|10|||
48544776|NCT02968849|156185006|FG000|Overall Study|Death|8|||
48544777|NCT02968849|156185007|FG001|Overall Study|Death|10|||
48544778|NCT02968849|156185006|FG000|Overall Study|Lost to Follow-up|31|||
48544779|NCT02968849|156185007|FG001|Overall Study|Lost to Follow-up|29|||
48544780|NCT02968849|156185006|FG000|Overall Study|Withdrawal by Subject|73|||
48544781|NCT02968849|156185007|FG001|Overall Study|Withdrawal by Subject|64|||
48544782|NCT02968849|156185006|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
48544783|NCT02968849|156185007|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
48544784|NCT02968849|156185006|FG000|Overall Study|Physician Decision|6|||
48544785|NCT02968849|156185007|FG001|Overall Study|Physician Decision|9|||
48544786|NCT02968849|156185006|FG000|Overall Study|Other|16|||
48544787|NCT02968849|156185007|FG001|Overall Study|Other|10|||
48544788|NCT01951885|156185008|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
48544789|NCT01951885|156185009|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
48544790|NCT01951885|156185008|FG000|Overall Study|Adverse Event|1|||
48544791|NCT01951885|156185009|FG001|Overall Study|Adverse Event|0|||
48544792|NCT01951885|156185008|FG000|Overall Study|Withdrawal by Subject|0|||
48544793|NCT01951885|156185009|FG001|Overall Study|Withdrawal by Subject|1|||
48544794|NCT01951885|156185008|FG000|Overall Study|ineligible due to a change in donor|0|||
48544795|NCT01951885|156185009|FG001|Overall Study|ineligible due to a change in donor|1|||
48544796|NCT01951885|156185008|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
48544797|NCT01951885|156185009|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
48544798|NCT00977379|156185012|FG000|Overall Study|Withdrawal by Subject|1|||
48544799|NCT00977379|156185013|FG001|Overall Study|Withdrawal by Subject|1|||
48544800|NCT00977379|156185012|FG000|Overall Study|Death|7|||
48544801|NCT00977379|156185013|FG001|Overall Study|Death|9|||
48544802|NCT00977379|156185012|FG000|Overall Study|Premature Study Termination|4|||
48544803|NCT00977379|156185013|FG001|Overall Study|Premature Study Termination|0|||
48544804|NCT00977379|156185012|FG000|Overall Study|Participant Moving House|0|||
48544805|NCT00977379|156185013|FG001|Overall Study|Participant Moving House|1|||
48544806|NCT00977379|156185012|FG000|Overall Study|Randomization Error|0|||
48544807|NCT00977379|156185013|FG001|Overall Study|Randomization Error|1|||
48610041|NCT00434252|156431676|FG001|Overall Study|Adverse Event|13|||
48610042|NCT00434252|156431675|FG000|Overall Study|Death|1|||
48544808|NCT00918138|156185014|FG000|Overall Study|Subject withdrew consent|1|||
48544809|NCT00918138|156185015|FG001|Overall Study|Subject withdrew consent|1|||
48544810|NCT00918138|156185014|FG000|Overall Study|Death|1|||
48544811|NCT00918138|156185015|FG001|Overall Study|Death|0|||
48544812|NCT02448706|156185016|FG000|Overall Study|Withdrawal by Subject|4|||
48544813|NCT02448706|156185017|FG001|Overall Study|Withdrawal by Subject|3|||
48544814|NCT02448706|156185016|FG000|Overall Study|Protocol Violation|1|||
48544815|NCT02448706|156185017|FG001|Overall Study|Protocol Violation|1|||
48544816|NCT00706511|156185020|FG000|Overall Study|Withdrawal by Subject|1|||
48544817|NCT00706511|156185021|FG001|Overall Study|Withdrawal by Subject|0|||
48544818|NCT00706511|156185022|FG002|Overall Study|Withdrawal by Subject|0|||
48544819|NCT00706511|156185023|FG003|Overall Study|Withdrawal by Subject|0|||
48544820|NCT02605993|156185025|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
48544821|NCT02605993|156185026|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
48544822|NCT02605993|156185027|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
48544823|NCT02605993|156185028|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
48544824|NCT02603393|156185029|FG000|Overall Study|Patient/guardian decision|32|||
48544825|NCT02603393|156185030|FG001|Overall Study|Patient/guardian decision|18|||
48544826|NCT02603393|156185029|FG000|Overall Study|Adverse Event|17|||
48544827|NCT02603393|156185030|FG001|Overall Study|Adverse Event|15|||
48544828|NCT02603393|156185029|FG000|Overall Study|Technical problems|4|||
48544829|NCT02603393|156185030|FG001|Overall Study|Technical problems|7|||
48544830|NCT02603393|156185029|FG000|Overall Study|Lack of Efficacy|7|||
48544831|NCT02603393|156185030|FG001|Overall Study|Lack of Efficacy|2|||
48610043|NCT00434252|156431676|FG001|Overall Study|Death|2|||
48544832|NCT02603393|156185029|FG000|Overall Study|Death|3|||
48544833|NCT02603393|156185030|FG001|Overall Study|Death|4|||
48544834|NCT02603393|156185029|FG000|Overall Study|Physician Decision|3|||
48544835|NCT02603393|156185030|FG001|Overall Study|Physician Decision|3|||
48544836|NCT02603393|156185029|FG000|Overall Study|Protocol deviation|2|||
48544837|NCT02603393|156185030|FG001|Overall Study|Protocol deviation|3|||
48544838|NCT02603393|156185029|FG000|Overall Study|Lost to Follow-up|1|||
48544839|NCT02603393|156185030|FG001|Overall Study|Lost to Follow-up|2|||
48544840|NCT02603393|156185029|FG000|Overall Study|Non-compliance with study treatment|1|||
48544841|NCT02603393|156185030|FG001|Overall Study|Non-compliance with study treatment|0|||
48544842|NCT02603393|156185029|FG000|Overall Study|Sponsor decision|1|||
48544843|NCT02603393|156185030|FG001|Overall Study|Sponsor decision|0|||
48544844|NCT02425904|156185031|FG000|Overall Study|Lost to Follow-up|1|||
48544845|NCT02425904|156185032|FG001|Overall Study|Lost to Follow-up|0|||
48544846|NCT02425904|156185031|FG000|Overall Study|Withdrawal by Subject|2|||
48544847|NCT02425904|156185032|FG001|Overall Study|Withdrawal by Subject|0|||
48544848|NCT02425904|156185031|FG000|Overall Study|Death|0|||
48544849|NCT02425904|156185032|FG001|Overall Study|Death|3|||
48544850|NCT01359969|156185036|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
48544851|NCT00593736|156185040|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
48544852|NCT00593736|156185041|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
48544853|NCT00593736|156185042|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
48544854|NCT00593736|156185043|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
48544855|NCT00593736|156185040|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
48544856|NCT00593736|156185041|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
48544857|NCT00593736|156185042|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
48544858|NCT00593736|156185043|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
48544859|NCT00593736|156185040|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
48544860|NCT00593736|156185041|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
48544861|NCT00593736|156185042|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
48544862|NCT00593736|156185043|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
48544863|NCT00593736|156185040|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
48544864|NCT00593736|156185041|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
48544865|NCT00593736|156185042|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
48544866|NCT00593736|156185043|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
48544867|NCT00593736|156185040|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
48544868|NCT00593736|156185041|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
48544869|NCT00593736|156185042|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
48544870|NCT00593736|156185043|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
48544871|NCT00593736|156185040|FG000|Screening Period and Placebo Run-in|Various|0|||
48544872|NCT00593736|156185041|FG001|Screening Period and Placebo Run-in|Various|0|||
48544873|NCT00593736|156185042|FG002|Screening Period and Placebo Run-in|Various|0|||
48544874|NCT00593736|156185043|FG003|Screening Period and Placebo Run-in|Various|25|||
48544875|NCT00593736|156185040|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
48544876|NCT00593736|156185041|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
48544877|NCT00593736|156185042|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
48544878|NCT00593736|156185043|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
48544879|NCT00593736|156185040|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
48544880|NCT00593736|156185041|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
48544881|NCT00593736|156185042|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
48544882|NCT00593736|156185043|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
48610044|NCT00434252|156431675|FG000|Overall Study|Lost to Follow-up|0|||
48610045|NCT00434252|156431676|FG001|Overall Study|Lost to Follow-up|1|||
48610046|NCT00434252|156431675|FG000|Overall Study|Physician Decision|4|||
48610047|NCT00434252|156431676|FG001|Overall Study|Physician Decision|8|||
48610048|NCT00434252|156431675|FG000|Overall Study|Withdrawal by Subject|3|||
48610049|NCT00434252|156431676|FG001|Overall Study|Withdrawal by Subject|7|||
48610050|NCT01655901|156431677|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
48610051|NCT01655901|156431678|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
48610052|NCT01655901|156431679|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
48610053|NCT01655901|156431680|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
48610054|NCT01655901|156431681|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
48610055|NCT01655901|156431682|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
48610056|NCT03861039|156431685|FG000|Overall Study|Adverse Event|2|||
48610057|NCT03861039|156431686|FG001|Overall Study|Adverse Event|5|||
48610058|NCT03861039|156431687|FG002|Overall Study|Adverse Event|11|||
48610059|NCT03861039|156431685|FG000|Overall Study|Withdrawal by Subject|1|||
48610060|NCT03861039|156431686|FG001|Overall Study|Withdrawal by Subject|3|||
48610061|NCT03861039|156431687|FG002|Overall Study|Withdrawal by Subject|4|||
48610062|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
48610063|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
48610064|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
48610065|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
48610066|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
48610067|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
48610068|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
48610069|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
48610070|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
48610071|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
48610072|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
48610073|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
48610074|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
48610075|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
48610076|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
48610077|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
48610078|NCT00849056|156431688|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
48610079|NCT00849056|156431689|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
48610080|NCT00849056|156431688|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
48610081|NCT00849056|156431689|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
48610082|NCT00849056|156431688|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
48610083|NCT00849056|156431689|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
48610084|NCT00849056|156431688|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
48610085|NCT00849056|156431689|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
48610086|NCT00849056|156431688|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
48610087|NCT00849056|156431689|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
48610088|NCT00849056|156431688|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
48610089|NCT00849056|156431689|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
48610090|NCT00849056|156431688|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
48610091|NCT00849056|156431689|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
48610092|NCT00849056|156431688|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
48610093|NCT00849056|156431689|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
48610094|NCT00548327|156431692|FG000|Overall Study|Adverse Event|0|||
48610095|NCT00548327|156431693|FG001|Overall Study|Adverse Event|1|||
48610096|NCT02997163|156431698|FG000|Overall Study|Adverse Event|1|||
48544883|NCT00593736|156185040|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
48544884|NCT00593736|156185041|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
48544885|NCT00593736|156185042|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
48544886|NCT00593736|156185043|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
48544887|NCT00593736|156185040|FG000|Treatment Period and Placebo Run-out|Various|1|||
48544888|NCT00593736|156185041|FG001|Treatment Period and Placebo Run-out|Various|1|||
48544889|NCT00593736|156185042|FG002|Treatment Period and Placebo Run-out|Various|1|||
48544890|NCT00593736|156185043|FG003|Treatment Period and Placebo Run-out|Various|0|||
48544891|NCT01437943|156185044|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
48610097|NCT02997163|156431699|FG001|Overall Study|Adverse Event|0|||
48610098|NCT02997163|156431700|FG002|Overall Study|Adverse Event|0|||
48610099|NCT02997163|156431701|FG003|Overall Study|Adverse Event|1|||
48610100|NCT00903201|156431702|FG000|Overall Study|Adverse Event|1|||
48610101|NCT00903201|156431703|FG001|Overall Study|Adverse Event|4|||
48610102|NCT00903201|156431704|FG002|Overall Study|Adverse Event|0|||
48610103|NCT00903201|156431702|FG000|Overall Study|Protocol Violation|2|||
48610104|NCT00903201|156431703|FG001|Overall Study|Protocol Violation|1|||
48610105|NCT00903201|156431704|FG002|Overall Study|Protocol Violation|0|||
48610106|NCT00903201|156431702|FG000|Overall Study|Lost to Follow-up|0|||
48610107|NCT00903201|156431703|FG001|Overall Study|Lost to Follow-up|1|||
48610108|NCT00903201|156431704|FG002|Overall Study|Lost to Follow-up|0|||
48610109|NCT00903201|156431702|FG000|Overall Study|Physician Decision|1|||
48610110|NCT00903201|156431703|FG001|Overall Study|Physician Decision|0|||
48610111|NCT00903201|156431704|FG002|Overall Study|Physician Decision|1|||
48610112|NCT00903201|156431702|FG000|Overall Study|Withdrawal by Subject|1|||
48610113|NCT00903201|156431703|FG001|Overall Study|Withdrawal by Subject|0|||
48544892|NCT01437943|156185045|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
48544893|NCT01437943|156185044|FG000|Overall Study|Subject expressed pregnancy plans|1|||
48544894|NCT01437943|156185045|FG001|Overall Study|Subject expressed pregnancy plans|0|||
48544895|NCT01437943|156185044|FG000|Overall Study|Adverse Event|2|||
48544896|NCT01437943|156185045|FG001|Overall Study|Adverse Event|0|||
48544897|NCT01868893|156185046|FG000|Overall Study|Adverse Event|2|||
48544898|NCT01868893|156185046|FG000|Overall Study|Commercial availability of study drug|17|||
48544899|NCT01868893|156185046|FG000|Overall Study|Neutropenia|1|||
48544900|NCT01857271|156185047|FG000|Overall Study|Lost to Follow-up|1|||
48544901|NCT01070771|156185048|FG000|Overall Study|Adverse Event|2|||
48544902|NCT01070771|156185048|FG000|Overall Study|Protocol Violation|1|||
48544903|NCT01199471|156185049|FG000|Overall Study|Protocol Violation|4|||
48544904|NCT01199471|156185049|FG000|Overall Study|Withdrawal by Subject|1|||
48544905|NCT01199471|156185049|FG000|Overall Study|Physician Decision|1|||
48544906|NCT01777620|156185053|FG000|Overall Study|Subject Withdrawal|1|||
48544907|NCT01777620|156185054|FG001|Overall Study|Subject Withdrawal|0|||
48544908|NCT04645966|156185055|FG000|Vaccination Phase|Adverse Event|1|||
48544909|NCT04645966|156185056|FG001|Vaccination Phase|Adverse Event|0|||
48544910|NCT04645966|156185057|FG002|Vaccination Phase|Adverse Event|0|||
48544911|NCT04645966|156185058|FG003|Vaccination Phase|Adverse Event|0|||
48544912|NCT04645966|156185059|FG004|Vaccination Phase|Adverse Event|0|||
48544913|NCT04645966|156185060|FG005|Vaccination Phase|Adverse Event|0|||
48544914|NCT04645966|156185061|FG006|Vaccination Phase|Adverse Event|1|||
48544915|NCT04645966|156185062|FG007|Vaccination Phase|Adverse Event|0|||
48544916|NCT04645966|156185063|FG008|Vaccination Phase|Adverse Event|0|||
48544917|NCT04645966|156185055|FG000|Vaccination Phase|Death|0|||
48544918|NCT04645966|156185056|FG001|Vaccination Phase|Death|0|||
48544919|NCT04645966|156185057|FG002|Vaccination Phase|Death|0|||
48544920|NCT04645966|156185058|FG003|Vaccination Phase|Death|0|||
48544921|NCT04645966|156185059|FG004|Vaccination Phase|Death|0|||
48544922|NCT04645966|156185060|FG005|Vaccination Phase|Death|1|||
48544923|NCT04645966|156185061|FG006|Vaccination Phase|Death|0|||
48544924|NCT04645966|156185062|FG007|Vaccination Phase|Death|0|||
48544925|NCT04645966|156185063|FG008|Vaccination Phase|Death|0|||
48544926|NCT04645966|156185055|FG000|Vaccination Phase|Protocol Violation|0|||
48610114|NCT00903201|156431704|FG002|Overall Study|Withdrawal by Subject|1|||
48544927|NCT04645966|156185056|FG001|Vaccination Phase|Protocol Violation|0|||
48610115|NCT02337764|156431705|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
48610116|NCT02337764|156431705|FG000|Overall Study|Voluntary Withdrawal|12|||
48610117|NCT02337764|156431705|FG000|Overall Study|Lack of Efficacy|2|||
48610118|NCT01787838|156431706|FG000|Overall Study|refused|1413|||
48610119|NCT01516216|156431707|FG000|Overall Study|Adverse Event|2|||
48610120|NCT01516216|156431708|FG001|Overall Study|Adverse Event|4|||
48544928|NCT04645966|156185057|FG002|Vaccination Phase|Protocol Violation|0|||
48544929|NCT04645966|156185058|FG003|Vaccination Phase|Protocol Violation|0|||
48544930|NCT04645966|156185059|FG004|Vaccination Phase|Protocol Violation|1|||
48544931|NCT04645966|156185060|FG005|Vaccination Phase|Protocol Violation|0|||
48544932|NCT04645966|156185061|FG006|Vaccination Phase|Protocol Violation|0|||
48544933|NCT04645966|156185062|FG007|Vaccination Phase|Protocol Violation|0|||
48544934|NCT04645966|156185063|FG008|Vaccination Phase|Protocol Violation|0|||
48544935|NCT04645966|156185055|FG000|Vaccination Phase|Study terminated by sponsor|0|||
48544936|NCT04645966|156185056|FG001|Vaccination Phase|Study terminated by sponsor|0|||
48544937|NCT04645966|156185057|FG002|Vaccination Phase|Study terminated by sponsor|14|||
48544938|NCT04645966|156185058|FG003|Vaccination Phase|Study terminated by sponsor|15|||
48544939|NCT04645966|156185059|FG004|Vaccination Phase|Study terminated by sponsor|47|||
48544940|NCT04645966|156185060|FG005|Vaccination Phase|Study terminated by sponsor|43|||
48544941|NCT04645966|156185061|FG006|Vaccination Phase|Study terminated by sponsor|29|||
48610121|NCT01516216|156431707|FG000|Overall Study|Disease Progression|38|||
48544942|NCT04645966|156185062|FG007|Vaccination Phase|Study terminated by sponsor|29|||
48544943|NCT04645966|156185063|FG008|Vaccination Phase|Study terminated by sponsor|12|||
48544944|NCT04645966|156185055|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
48544945|NCT04645966|156185056|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
48544946|NCT04645966|156185057|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
48544947|NCT04645966|156185058|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
48544948|NCT04645966|156185059|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
48544949|NCT04645966|156185060|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
48544950|NCT04645966|156185061|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
48610122|NCT01516216|156431708|FG001|Overall Study|Disease Progression|34|||
48610123|NCT01516216|156431707|FG000|Overall Study|Withdrawal by Subject|9|||
48610124|NCT01516216|156431708|FG001|Overall Study|Withdrawal by Subject|11|||
48610125|NCT01516216|156431707|FG000|Overall Study|Potentially Curative Resection|6|||
48610126|NCT01516216|156431708|FG001|Overall Study|Potentially Curative Resection|12|||
48610127|NCT01516216|156431707|FG000|Overall Study|Nonadherence|2|||
48610128|NCT01516216|156431708|FG001|Overall Study|Nonadherence|3|||
48610129|NCT01516216|156431707|FG000|Overall Study|Physician Decision|6|||
48610130|NCT01516216|156431708|FG001|Overall Study|Physician Decision|3|||
48610131|NCT01516216|156431707|FG000|Overall Study|Prolonged Treatment Delay|5|||
48610132|NCT01516216|156431708|FG001|Overall Study|Prolonged Treatment Delay|1|||
48544951|NCT04645966|156185062|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
48544952|NCT04645966|156185063|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
48544953|NCT04645966|156185055|FG000|Vaccination Phase|Other|0|||
48544954|NCT04645966|156185056|FG001|Vaccination Phase|Other|0|||
48544955|NCT04645966|156185057|FG002|Vaccination Phase|Other|0|||
48544956|NCT04645966|156185058|FG003|Vaccination Phase|Other|0|||
48610133|NCT01516216|156431707|FG000|Overall Study|Intercurrent Illness|1|||
48610134|NCT01516216|156431708|FG001|Overall Study|Intercurrent Illness|0|||
48610135|NCT01516216|156431707|FG000|Overall Study|Death|1|||
48610136|NCT01516216|156431708|FG001|Overall Study|Death|1|||
48610137|NCT03098979|156431709|FG000|Overall Study|Adverse Event|1|||
48610138|NCT03098979|156431710|FG001|Overall Study|Adverse Event|0|||
48610139|NCT03098979|156431711|FG002|Overall Study|Adverse Event|1|||
48610140|NCT03098979|156431712|FG003|Overall Study|Adverse Event|4|||
48610141|NCT03098979|156431713|FG004|Overall Study|Adverse Event|6|||
48610142|NCT03098979|156431714|FG005|Overall Study|Adverse Event|1|||
48610143|NCT03098979|156431709|FG000|Overall Study|Withdrawal by Subject|2|||
48610144|NCT03098979|156431710|FG001|Overall Study|Withdrawal by Subject|1|||
48544957|NCT04645966|156185059|FG004|Vaccination Phase|Other|0|||
48544958|NCT04645966|156185060|FG005|Vaccination Phase|Other|2|||
48610145|NCT03098979|156431711|FG002|Overall Study|Withdrawal by Subject|1|||
48610146|NCT03098979|156431712|FG003|Overall Study|Withdrawal by Subject|1|||
48610147|NCT03098979|156431713|FG004|Overall Study|Withdrawal by Subject|2|||
48610148|NCT03098979|156431714|FG005|Overall Study|Withdrawal by Subject|1|||
48610149|NCT03098979|156431709|FG000|Overall Study|Death|1|||
48610150|NCT03098979|156431710|FG001|Overall Study|Death|0|||
48610151|NCT03098979|156431711|FG002|Overall Study|Death|2|||
48610152|NCT03098979|156431712|FG003|Overall Study|Death|0|||
48610153|NCT03098979|156431713|FG004|Overall Study|Death|1|||
48544959|NCT04645966|156185061|FG006|Vaccination Phase|Other|0|||
48610154|NCT03098979|156431714|FG005|Overall Study|Death|0|||
48610155|NCT03098979|156431709|FG000|Overall Study|Physician Decision|2|||
48544960|NCT04645966|156185062|FG007|Vaccination Phase|Other|0|||
48544961|NCT04645966|156185063|FG008|Vaccination Phase|Other|0|||
48610156|NCT03098979|156431710|FG001|Overall Study|Physician Decision|1|||
48610157|NCT03098979|156431711|FG002|Overall Study|Physician Decision|0|||
48544962|NCT04645966|156185055|FG000|Vaccination Phase|Lost to Follow-up|0|||
48544963|NCT04645966|156185056|FG001|Vaccination Phase|Lost to Follow-up|0|||
48544964|NCT04645966|156185057|FG002|Vaccination Phase|Lost to Follow-up|0|||
48544965|NCT04645966|156185058|FG003|Vaccination Phase|Lost to Follow-up|0|||
48544966|NCT04645966|156185059|FG004|Vaccination Phase|Lost to Follow-up|0|||
48544967|NCT04645966|156185060|FG005|Vaccination Phase|Lost to Follow-up|0|||
48544968|NCT04645966|156185061|FG006|Vaccination Phase|Lost to Follow-up|0|||
48544969|NCT04645966|156185062|FG007|Vaccination Phase|Lost to Follow-up|1|||
48544970|NCT04645966|156185063|FG008|Vaccination Phase|Lost to Follow-up|0|||
48544971|NCT04645966|156185055|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
48544972|NCT04645966|156185056|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
48544973|NCT04645966|156185057|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
48544974|NCT04645966|156185058|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
48544975|NCT04645966|156185059|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
48544976|NCT04645966|156185060|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
48544977|NCT04645966|156185061|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
48544978|NCT04645966|156185062|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
48544979|NCT04645966|156185063|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
48544980|NCT04645966|156185055|FG000|Follow-up Phase|Lost to Follow-up|0|||
48544981|NCT04645966|156185056|FG001|Follow-up Phase|Lost to Follow-up|0|||
48544982|NCT04645966|156185057|FG002|Follow-up Phase|Lost to Follow-up|0|||
48544983|NCT04645966|156185058|FG003|Follow-up Phase|Lost to Follow-up|0|||
48544984|NCT04645966|156185059|FG004|Follow-up Phase|Lost to Follow-up|0|||
48544985|NCT04645966|156185060|FG005|Follow-up Phase|Lost to Follow-up|0|||
48544986|NCT04645966|156185061|FG006|Follow-up Phase|Lost to Follow-up|0|||
48544987|NCT04645966|156185062|FG007|Follow-up Phase|Lost to Follow-up|1|||
48544988|NCT04645966|156185063|FG008|Follow-up Phase|Lost to Follow-up|0|||
48544989|NCT03825341|156185066|FG000|Overall Study|Withdrawal by Subject|0|||
48544990|NCT03825341|156185067|FG001|Overall Study|Withdrawal by Subject|1|||
48544991|NCT02992418|156185068|FG000|Overall Study|Withdrawal by Subject|11|||
48544992|NCT02992418|156185069|FG001|Overall Study|Withdrawal by Subject|12|||
48544993|NCT02992418|156185068|FG000|Overall Study|Non-compliance with the protocol|308|||
48544994|NCT02992418|156185069|FG001|Overall Study|Non-compliance with the protocol|308|||
48544995|NCT02992418|156185068|FG000|Overall Study|Lost to Follow-up|27|||
48544996|NCT02992418|156185069|FG001|Overall Study|Lost to Follow-up|22|||
48544997|NCT00777036|156185070|FG000|On Treatment|Reason Not Specified|4|||
48544998|NCT00777036|156185071|FG001|On Treatment|Reason Not Specified|7|||
48544999|NCT00777036|156185072|FG002|On Treatment|Reason Not Specified|12|||
48545000|NCT00777036|156185070|FG000|On Treatment|Failure to Meet Study Criteria|0|||
48545001|NCT00777036|156185071|FG001|On Treatment|Failure to Meet Study Criteria|1|||
48585007|NCT00115037|156333747|FG005|Phase1|Withdrawal by Subject|0|||
48585008|NCT00115037|156333742|FG000|Phase2|Death|0|||
48585009|NCT00115037|156333743|FG001|Phase2|Death|0|||
48585010|NCT00115037|156333744|FG002|Phase2|Death|1|||
48585011|NCT00115037|156333745|FG003|Phase2|Death|0|||
48585012|NCT00115037|156333746|FG004|Phase2|Death|0|||
48585013|NCT00115037|156333747|FG005|Phase2|Death|1|||
48585014|NCT00115037|156333742|FG000|Phase2|Withdrawal by Subject|0|||
48585015|NCT00115037|156333743|FG001|Phase2|Withdrawal by Subject|0|||
48585016|NCT00115037|156333744|FG002|Phase2|Withdrawal by Subject|2|||
48585017|NCT00115037|156333745|FG003|Phase2|Withdrawal by Subject|1|||
48585018|NCT00115037|156333746|FG004|Phase2|Withdrawal by Subject|2|||
48585019|NCT00115037|156333747|FG005|Phase2|Withdrawal by Subject|1|||
48585020|NCT00115037|156333742|FG000|Phase2|Lost to Follow-up|0|||
48585021|NCT00115037|156333743|FG001|Phase2|Lost to Follow-up|0|||
48585022|NCT00115037|156333744|FG002|Phase2|Lost to Follow-up|12|||
48585023|NCT00115037|156333745|FG003|Phase2|Lost to Follow-up|14|||
48585024|NCT00115037|156333746|FG004|Phase2|Lost to Follow-up|4|||
48585025|NCT00115037|156333747|FG005|Phase2|Lost to Follow-up|10|||
48585026|NCT01546038|156333752|FG000|Overall Study|Death|15|||
48585027|NCT01546038|156333753|FG001|Overall Study|Death|6|||
48585028|NCT01546038|156333754|FG002|Overall Study|Death|4|||
48545002|NCT00777036|156185072|FG002|On Treatment|Failure to Meet Study Criteria|0|||
48545003|NCT00777036|156185070|FG000|On Treatment|Non-compliance with Study Drug|1|||
48545004|NCT00777036|156185071|FG001|On Treatment|Non-compliance with Study Drug|0|||
48545005|NCT00777036|156185072|FG002|On Treatment|Non-compliance with Study Drug|0|||
48545006|NCT00777036|156185070|FG000|On Treatment|Maximum Clinical Benefit|2|||
48545007|NCT00777036|156185071|FG001|On Treatment|Maximum Clinical Benefit|0|||
48545008|NCT00777036|156185072|FG002|On Treatment|Maximum Clinical Benefit|1|||
48545009|NCT00777036|156185070|FG000|On Treatment|Withdrawal by Subject|3|||
48545010|NCT00777036|156185071|FG001|On Treatment|Withdrawal by Subject|2|||
48545011|NCT00777036|156185072|FG002|On Treatment|Withdrawal by Subject|3|||
48545012|NCT00777036|156185070|FG000|On Treatment|Death|0|||
48545013|NCT00777036|156185071|FG001|On Treatment|Death|2|||
48545014|NCT00777036|156185072|FG002|On Treatment|Death|0|||
48545015|NCT00777036|156185070|FG000|On Treatment|Study Drug Toxicity|0|||
48545016|NCT00777036|156185071|FG001|On Treatment|Study Drug Toxicity|0|||
48545017|NCT00777036|156185072|FG002|On Treatment|Study Drug Toxicity|1|||
48545018|NCT00777036|156185070|FG000|On Treatment|Progressive Disease|5|||
48545019|NCT00777036|156185071|FG001|On Treatment|Progressive Disease|4|||
48545020|NCT00777036|156185072|FG002|On Treatment|Progressive Disease|6|||
48545021|NCT00777036|156185070|FG000|Follow-Up|Lost to Follow-up|1|||
48545022|NCT00777036|156185071|FG001|Follow-Up|Lost to Follow-up|0|||
48545023|NCT00777036|156185072|FG002|Follow-Up|Lost to Follow-up|0|||
48545024|NCT00777036|156185070|FG000|Follow-Up|Reason Not Specified|2|||
48545025|NCT00777036|156185071|FG001|Follow-Up|Reason Not Specified|0|||
48545026|NCT00777036|156185072|FG002|Follow-Up|Reason Not Specified|0|||
48545027|NCT00777036|156185070|FG000|Follow-Up|Withdrawal by Subject|1|||
48545028|NCT00777036|156185071|FG001|Follow-Up|Withdrawal by Subject|0|||
48545029|NCT00777036|156185072|FG002|Follow-Up|Withdrawal by Subject|4|||
48545030|NCT00777036|156185070|FG000|Follow-Up|Death|1|||
48545031|NCT00777036|156185071|FG001|Follow-Up|Death|8|||
48545032|NCT00777036|156185072|FG002|Follow-Up|Death|0|||
48545033|NCT00289536|156185075|FG000|Period 3|Lost to Follow-up|0|||
48545034|NCT00289536|156185076|FG001|Period 3|Lost to Follow-up|0|||
48545035|NCT00289536|156185077|FG002|Period 3|Lost to Follow-up|1|||
48545036|NCT02065700|156185080|FG000|Overall Study|Adverse Event|165|||
48545037|NCT02065700|156185081|FG001|Overall Study|Adverse Event|101|||
48545038|NCT02065700|156185080|FG000|Overall Study|Withdrawal by Subject|90|||
48545039|NCT02065700|156185081|FG001|Overall Study|Withdrawal by Subject|29|||
48545040|NCT02065700|156185080|FG000|Overall Study|Lost to Follow-up|12|||
48545041|NCT02065700|156185081|FG001|Overall Study|Lost to Follow-up|9|||
48545042|NCT02065700|156185080|FG000|Overall Study|Physician Decision|2|||
48545043|NCT02065700|156185081|FG001|Overall Study|Physician Decision|0|||
48545044|NCT02065700|156185080|FG000|Overall Study|Sponsor Request|38|||
48545045|NCT02065700|156185081|FG001|Overall Study|Sponsor Request|15|||
48545046|NCT02065700|156185080|FG000|Overall Study|Treatment Failure|3|||
48545047|NCT02065700|156185081|FG001|Overall Study|Treatment Failure|2|||
48545048|NCT02065700|156185080|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
48545049|NCT02065700|156185081|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
48545050|NCT02065700|156185080|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
48545051|NCT02065700|156185081|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
48545052|NCT02065700|156185080|FG000|Overall Study|Non-compliance with Study Procedures|2|||
48545053|NCT02065700|156185081|FG001|Overall Study|Non-compliance with Study Procedures|0|||
48545054|NCT02065700|156185080|FG000|Overall Study|Not Defined|21|||
48545055|NCT02065700|156185081|FG001|Overall Study|Not Defined|3|||
48545056|NCT04283500|156185083|FG000|Overall Study|Lost to Follow-up|8|||
48545057|NCT04283500|156185083|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
48545058|NCT00988442|156185084|FG000|Overall Study|Death|1|||
48545059|NCT00988442|156185085|FG001|Overall Study|Death|2|||
48545060|NCT00988442|156185084|FG000|Overall Study|Lost to Follow-up|0|||
48545061|NCT00988442|156185085|FG001|Overall Study|Lost to Follow-up|1|||
48545062|NCT00988442|156185084|FG000|Overall Study|Early Study Closure|29|||
48545063|NCT00988442|156185085|FG001|Overall Study|Early Study Closure|25|||
48545064|NCT01635218|156185096|FG000|Overall Study|Lost to Follow-up|3|||
48545065|NCT01635218|156185097|FG001|Overall Study|Lost to Follow-up|7|||
48545066|NCT01635218|156185098|FG002|Overall Study|Lost to Follow-up|6|||
48545067|NCT01006135|156185099|FG000|Overall Study|Adverse Event|22|||
48545068|NCT01006135|156185099|FG000|Overall Study|Protocol Violation|14|||
48545069|NCT01006135|156185099|FG000|Overall Study|Lost to Follow-up|32|||
48545070|NCT01006135|156185099|FG000|Overall Study|Other|72|||
48545071|NCT05297578|156185105|FG000|Overall Study|Lost to Follow-up|1|||
48545072|NCT05297578|156185106|FG001|Overall Study|Lost to Follow-up|1|||
48610158|NCT03098979|156431712|FG003|Overall Study|Physician Decision|0|||
48610159|NCT03098979|156431713|FG004|Overall Study|Physician Decision|0|||
48545073|NCT05297578|156185107|FG002|Overall Study|Lost to Follow-up|2|||
48545074|NCT05297578|156185108|FG003|Overall Study|Lost to Follow-up|1|||
48545075|NCT05297578|156185105|FG000|Overall Study|Death|0|||
48545076|NCT05297578|156185106|FG001|Overall Study|Death|1|||
48545077|NCT05297578|156185107|FG002|Overall Study|Death|0|||
48545078|NCT05297578|156185108|FG003|Overall Study|Death|0|||
48545079|NCT05297578|156185105|FG000|Overall Study|Withdrawal by Subject|0|||
48610160|NCT03098979|156431714|FG005|Overall Study|Physician Decision|0|||
48545080|NCT05297578|156185106|FG001|Overall Study|Withdrawal by Subject|0|||
48545081|NCT05297578|156185107|FG002|Overall Study|Withdrawal by Subject|1|||
48545082|NCT05297578|156185108|FG003|Overall Study|Withdrawal by Subject|0|||
48610161|NCT03098979|156431709|FG000|Overall Study|Non-compliance|0|||
48545083|NCT02655666|156185110|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
48545084|NCT01267994|156185111|FG000|Overall Study|Adverse Event|2|||
48610162|NCT03098979|156431710|FG001|Overall Study|Non-compliance|0|||
48545085|NCT00311402|156185112|FG000|Overall Study|Adverse Event|118|||
48545086|NCT00311402|156185113|FG001|Overall Study|Adverse Event|105|||
48545087|NCT00311402|156185112|FG000|Overall Study|Lost to Follow-up|0|||
48545088|NCT00311402|156185113|FG001|Overall Study|Lost to Follow-up|3|||
48545089|NCT00311402|156185112|FG000|Overall Study|Withdrawal by Subject|17|||
48545090|NCT00311402|156185113|FG001|Overall Study|Withdrawal by Subject|18|||
48545091|NCT00311402|156185112|FG000|Overall Study|Lack of Efficacy|58|||
48545092|NCT00311402|156185113|FG001|Overall Study|Lack of Efficacy|42|||
48545093|NCT00311402|156185112|FG000|Overall Study|Protocol Violation|7|||
48545094|NCT00311402|156185113|FG001|Overall Study|Protocol Violation|6|||
48545095|NCT00311402|156185112|FG000|Overall Study|IRB's rejection etc.|10|||
48545096|NCT00311402|156185113|FG001|Overall Study|IRB's rejection etc.|3|||
48545097|NCT02924727|156185122|FG000|Overall Study|Withdrawal by Subject|2|||
48545098|NCT02924727|156185123|FG001|Overall Study|Withdrawal by Subject|4|||
48545099|NCT02924727|156185122|FG000|Overall Study|Lost to Follow-up|2|||
48545100|NCT02924727|156185123|FG001|Overall Study|Lost to Follow-up|5|||
48545101|NCT02924727|156185122|FG000|Overall Study|Death|221|||
48545102|NCT02924727|156185123|FG001|Overall Study|Death|247|||
48545103|NCT02924727|156185122|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
48545104|NCT02924727|156185123|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
48545105|NCT03052127|156185124|FG000|Overall Study|Withdrawal by Subject|0|||
48545106|NCT03052127|156185125|FG001|Overall Study|Withdrawal by Subject|0|||
48545107|NCT03052127|156185126|FG002|Overall Study|Withdrawal by Subject|0|||
48545108|NCT03052127|156185127|FG003|Overall Study|Withdrawal by Subject|0|||
48545109|NCT03052127|156185128|FG004|Overall Study|Withdrawal by Subject|0|||
48545110|NCT03052127|156185129|FG005|Overall Study|Withdrawal by Subject|0|||
48545111|NCT03052127|156185130|FG006|Overall Study|Withdrawal by Subject|0|||
48545112|NCT03052127|156185131|FG007|Overall Study|Withdrawal by Subject|1|||
48545113|NCT03052127|156185132|FG008|Overall Study|Withdrawal by Subject|1|||
48545114|NCT03052127|156185133|FG009|Overall Study|Withdrawal by Subject|1|||
48545115|NCT03052127|156185134|FG010|Overall Study|Withdrawal by Subject|0|||
48545116|NCT03052127|156185135|FG011|Overall Study|Withdrawal by Subject|0|||
48545117|NCT03052127|156185124|FG000|Overall Study|Discontinuation by Sponsor|0|||
48545118|NCT03052127|156185125|FG001|Overall Study|Discontinuation by Sponsor|0|||
48545119|NCT03052127|156185126|FG002|Overall Study|Discontinuation by Sponsor|0|||
48545120|NCT03052127|156185127|FG003|Overall Study|Discontinuation by Sponsor|0|||
48545121|NCT03052127|156185128|FG004|Overall Study|Discontinuation by Sponsor|0|||
48545122|NCT03052127|156185129|FG005|Overall Study|Discontinuation by Sponsor|0|||
48545123|NCT03052127|156185130|FG006|Overall Study|Discontinuation by Sponsor|0|||
48545124|NCT03052127|156185131|FG007|Overall Study|Discontinuation by Sponsor|0|||
48545125|NCT03052127|156185132|FG008|Overall Study|Discontinuation by Sponsor|4|||
48545126|NCT03052127|156185133|FG009|Overall Study|Discontinuation by Sponsor|2|||
48545127|NCT03052127|156185134|FG010|Overall Study|Discontinuation by Sponsor|5|||
48545128|NCT03052127|156185135|FG011|Overall Study|Discontinuation by Sponsor|13|||
48610163|NCT03098979|156431711|FG002|Overall Study|Non-compliance|0|||
48610164|NCT03098979|156431712|FG003|Overall Study|Non-compliance|0|||
48610165|NCT03098979|156431713|FG004|Overall Study|Non-compliance|0|||
48610166|NCT03098979|156431714|FG005|Overall Study|Non-compliance|1|||
48610167|NCT03098979|156431709|FG000|Overall Study|Protocol Violation|0|||
48610168|NCT03098979|156431710|FG001|Overall Study|Protocol Violation|0|||
48610169|NCT03098979|156431711|FG002|Overall Study|Protocol Violation|0|||
48610170|NCT03098979|156431712|FG003|Overall Study|Protocol Violation|0|||
48610171|NCT03098979|156431713|FG004|Overall Study|Protocol Violation|0|||
48610172|NCT03098979|156431714|FG005|Overall Study|Protocol Violation|1|||
48610173|NCT00941928|156431719|FG000|Overall Study|Withdrawal by Subject|1|||
48610174|NCT00941928|156431719|FG000|Overall Study|Disease Progression|1|||
48610175|NCT01829347|156431722|FG000|VTI-210|Death|5|||
48610176|NCT01829347|156431723|FG001|VTI-210|Death|3|||
48610177|NCT01829347|156431722|FG000|VTI-210|Withdrawal by Subject|1|||
48610178|NCT01829347|156431723|FG001|VTI-210|Withdrawal by Subject|0|||
48610179|NCT01829347|156431722|FG000|VTI-210E|Death|2|||
48610180|NCT01829347|156431723|FG001|VTI-210E|Death|1|||
48610181|NCT01829347|156431722|FG000|VTI-210E|Study terminated prematurely|1|||
48610182|NCT01829347|156431723|FG001|VTI-210E|Study terminated prematurely|5|||
48610183|NCT02471339|156431728|FG000|Overall Study|Did not provide follow-up data|2|||
48610184|NCT02471339|156431729|FG001|Overall Study|Did not provide follow-up data|0|||
48610185|NCT00984867|156431730|FG000|Overall Study|Adverse Event|3|||
48610186|NCT00984867|156431731|FG001|Overall Study|Adverse Event|7|||
48610187|NCT00984867|156431730|FG000|Overall Study|Death|1|||
48610188|NCT00984867|156431731|FG001|Overall Study|Death|0|||
48610189|NCT00984867|156431730|FG000|Overall Study|Withdrawal by Subject|13|||
48610190|NCT00984867|156431731|FG001|Overall Study|Withdrawal by Subject|4|||
48610191|NCT00984867|156431730|FG000|Overall Study|Lost to Follow-up|3|||
48610192|NCT00984867|156431731|FG001|Overall Study|Lost to Follow-up|4|||
48610193|NCT00984867|156431730|FG000|Overall Study|Poor/non-compliance|0|||
48610194|NCT00984867|156431731|FG001|Overall Study|Poor/non-compliance|1|||
48610195|NCT00984867|156431730|FG000|Overall Study|Subject no longer meets study criteria|1|||
48610196|NCT00984867|156431731|FG001|Overall Study|Subject no longer meets study criteria|1|||
48610197|NCT00984867|156431730|FG000|Overall Study|site closing|1|||
48610198|NCT00984867|156431731|FG001|Overall Study|site closing|0|||
48610199|NCT00984867|156431730|FG000|Overall Study|lack of efficacy and subject compliance|1|||
48610200|NCT00984867|156431731|FG001|Overall Study|lack of efficacy and subject compliance|0|||
48610201|NCT00407511|156431732|FG000|Overall Study|Adverse Event|9|||
48610202|NCT00407511|156431732|FG000|Overall Study|Lost to Follow-up|4|||
48610203|NCT00407511|156431732|FG000|Overall Study|Other|5|||
48610204|NCT00407511|156431732|FG000|Overall Study|Withdrawal by Subject|4|||
48610205|NCT01184872|156431733|FG000|Overall Study|Adverse Event|3|||
48610206|NCT01184872|156431734|FG001|Overall Study|Adverse Event|4|||
48610207|NCT01184872|156431733|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
48610208|NCT01184872|156431734|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48610209|NCT01184872|156431733|FG000|Overall Study|Withdrawal by Subject|2|||
48610210|NCT01184872|156431734|FG001|Overall Study|Withdrawal by Subject|0|||
48610211|NCT01184872|156431733|FG000|Overall Study|Lost to Follow-up|0|||
48610212|NCT01184872|156431734|FG001|Overall Study|Lost to Follow-up|1|||
48610213|NCT01184872|156431733|FG000|Overall Study|Administrative problems|1|||
48545129|NCT03052127|156185124|FG000|Overall Study|Inability to comply with trial requirements|0|||
48545130|NCT03052127|156185125|FG001|Overall Study|Inability to comply with trial requirements|0|||
48545131|NCT03052127|156185126|FG002|Overall Study|Inability to comply with trial requirements|1|||
48545132|NCT03052127|156185127|FG003|Overall Study|Inability to comply with trial requirements|0|||
48545133|NCT03052127|156185128|FG004|Overall Study|Inability to comply with trial requirements|0|||
48545134|NCT03052127|156185129|FG005|Overall Study|Inability to comply with trial requirements|0|||
48545135|NCT03052127|156185130|FG006|Overall Study|Inability to comply with trial requirements|0|||
48545136|NCT03052127|156185131|FG007|Overall Study|Inability to comply with trial requirements|0|||
48545137|NCT03052127|156185132|FG008|Overall Study|Inability to comply with trial requirements|0|||
48545138|NCT03052127|156185133|FG009|Overall Study|Inability to comply with trial requirements|0|||
48545139|NCT03052127|156185134|FG010|Overall Study|Inability to comply with trial requirements|0|||
48545140|NCT03052127|156185135|FG011|Overall Study|Inability to comply with trial requirements|0|||
48545141|NCT03052127|156185124|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
48545142|NCT03052127|156185125|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
48545143|NCT03052127|156185126|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
48545144|NCT03052127|156185127|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
48545145|NCT03052127|156185128|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
48545146|NCT03052127|156185129|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
48545147|NCT03052127|156185130|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
48545148|NCT03052127|156185131|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
48545149|NCT03052127|156185132|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
48545150|NCT03052127|156185133|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
48545151|NCT03052127|156185134|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
48545152|NCT03052127|156185135|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
48545153|NCT03694327|156185139|FG000|Overall Study|Lost to Follow-up|13|||
48545154|NCT03694327|156185140|FG001|Overall Study|Lost to Follow-up|23|||
48545155|NCT00315731|156185141|FG000|Overall Study|Lost to Follow-up|1|||
48545156|NCT00315731|156185141|FG000|Overall Study|Death|5|||
48545157|NCT02132637|156186353|FG000|Study Period 1|Withdrawal by Subject|0|||
48545158|NCT02132637|156186354|FG001|Study Period 1|Withdrawal by Subject|4|||
48545159|NCT02132637|156186353|FG000|Study Period 1|Physician Decision|1|||
48545160|NCT02132637|156186354|FG001|Study Period 1|Physician Decision|0|||
48545161|NCT02132637|156186353|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
48545162|NCT02132637|156186354|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
48545163|NCT02132637|156186353|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
48545164|NCT02132637|156186354|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
48545165|NCT03265288|156186355|FG000|Overall Study|Adverse Event|0|||
48545166|NCT03265288|156186356|FG001|Overall Study|Adverse Event|1|||
48545167|NCT03265288|156186355|FG000|Overall Study|Withdrawal by Subject|13|||
48545168|NCT03265288|156186356|FG001|Overall Study|Withdrawal by Subject|5|||
48545169|NCT03265288|156186355|FG000|Overall Study|Drug Withdrawn|3|||
48545170|NCT03265288|156186356|FG001|Overall Study|Drug Withdrawn|3|||
48545171|NCT03265288|156186355|FG000|Overall Study|Any Other Reason|7|||
48545172|NCT03265288|156186356|FG001|Overall Study|Any Other Reason|3|||
48545173|NCT00922272|156186357|FG000|Open-label Phase|Adverse Event|5|||
48545174|NCT00922272|156186358|FG001|Open-label Phase|Adverse Event|0|||
48545175|NCT00922272|156186357|FG000|Open-label Phase|Protocol Violation|1|||
48545176|NCT00922272|156186358|FG001|Open-label Phase|Protocol Violation|0|||
48545177|NCT00922272|156186357|FG000|Open-label Phase|Withdrawal by Subject|11|||
48545178|NCT00922272|156186358|FG001|Open-label Phase|Withdrawal by Subject|0|||
48545179|NCT00922272|156186357|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
48545180|NCT00922272|156186358|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
48545181|NCT00922272|156186357|FG000|Open-label Phase|Withdrawal criteria met|5|||
48545182|NCT00922272|156186358|FG001|Open-label Phase|Withdrawal criteria met|0|||
48545183|NCT00922272|156186357|FG000|Double-blind Phase|Adverse Event|1|||
48545184|NCT00922272|156186358|FG001|Double-blind Phase|Adverse Event|1|||
48545185|NCT00922272|156186357|FG000|Double-blind Phase|Withdrawal by Subject|1|||
48545186|NCT00922272|156186358|FG001|Double-blind Phase|Withdrawal by Subject|1|||
48545187|NCT00922272|156186357|FG000|Double-blind Phase|Lost to Follow-up|2|||
48545188|NCT00922272|156186358|FG001|Double-blind Phase|Lost to Follow-up|1|||
48545189|NCT00922272|156186357|FG000|Double-blind Phase|Withdrawal criteria met|1|||
48545190|NCT00922272|156186358|FG001|Double-blind Phase|Withdrawal criteria met|1|||
48545191|NCT00922272|156186357|FG000|Double-blind Phase|Noncompliance|1|||
48545192|NCT00922272|156186358|FG001|Double-blind Phase|Noncompliance|1|||
48545193|NCT00922272|156186357|FG000|Double-blind Phase|Positive urine drug screen|1|||
48545194|NCT00922272|156186358|FG001|Double-blind Phase|Positive urine drug screen|1|||
48545195|NCT01293539|156186359|FG000|Overall Study|Physician Decision|1|||
48545196|NCT00866658|156186366|FG000|Overall Study|Adverse Event|5|||
48545197|NCT00866658|156186367|FG001|Overall Study|Adverse Event|14|||
48545198|NCT00866658|156186366|FG000|Overall Study|Lack of Efficacy|2|||
48545199|NCT00866658|156186367|FG001|Overall Study|Lack of Efficacy|1|||
48545200|NCT00866658|156186366|FG000|Overall Study|Withdrawal by Subject|1|||
48545201|NCT00866658|156186367|FG001|Overall Study|Withdrawal by Subject|0|||
48545202|NCT00866658|156186366|FG000|Overall Study|Protocol Violation|1|||
48545203|NCT00866658|156186367|FG001|Overall Study|Protocol Violation|1|||
48545204|NCT00866658|156186366|FG000|Overall Study|Familial and Personal Reasons|4|||
48545205|NCT00866658|156186367|FG001|Overall Study|Familial and Personal Reasons|5|||
48545206|NCT04647721|156186368|FG000|Overall Study|Withdrawal by Subject|0|||
48545207|NCT04647721|156186369|FG001|Overall Study|Withdrawal by Subject|2|||
48545208|NCT04647721|156186368|FG000|Overall Study|Lost to Follow-up|2|||
48545209|NCT04647721|156186369|FG001|Overall Study|Lost to Follow-up|0|||
48545210|NCT01167257|156186371|FG000|Overall Study|Lost to Follow-up|2|||
48545211|NCT01167257|156186372|FG001|Overall Study|Lost to Follow-up|2|||
48545212|NCT01167257|156186371|FG000|Overall Study|Withdrew consent|1|||
48545213|NCT01167257|156186372|FG001|Overall Study|Withdrew consent|1|||
48545214|NCT00699374|156186374|FG000|Overall Study|Death|93|||
48545215|NCT00699374|156186375|FG001|Overall Study|Death|83|||
48545216|NCT00699374|156186374|FG000|Overall Study|Adverse Event|70|||
48545217|NCT00699374|156186375|FG001|Overall Study|Adverse Event|67|||
48545218|NCT00699374|156186374|FG000|Overall Study|Global deterioration of health status|7|||
48545219|NCT00699374|156186375|FG001|Overall Study|Global deterioration of health status|8|||
48545220|NCT00699374|156186374|FG000|Overall Study|Lost to Follow-up|3|||
48545221|NCT00699374|156186375|FG001|Overall Study|Lost to Follow-up|5|||
48545222|NCT00699374|156186374|FG000|Overall Study|Withdrawal by Subject|34|||
48545223|NCT00699374|156186375|FG001|Overall Study|Withdrawal by Subject|44|||
48545224|NCT00699374|156186374|FG000|Overall Study|Objective progression or relapse|281|||
48545225|NCT00699374|156186375|FG001|Overall Study|Objective progression or relapse|277|||
48545226|NCT00699374|156186374|FG000|Overall Study|Other|18|||
48545227|NCT00699374|156186375|FG001|Overall Study|Other|15|||
48545228|NCT00699374|156186374|FG000|Overall Study|Protocol Violation|2|||
48545229|NCT00699374|156186375|FG001|Overall Study|Protocol Violation|6|||
48545230|NCT00699374|156186374|FG000|Overall Study|Study terminated by sponsor|13|||
48545231|NCT00699374|156186375|FG001|Overall Study|Study terminated by sponsor|28|||
48545232|NCT00699374|156186374|FG000|Overall Study|Randomized but not treated|4|||
48545233|NCT00699374|156186375|FG001|Overall Study|Randomized but not treated|2|||
48545234|NCT00699374|156186374|FG000|Overall Study|Died 28 days after last dose|5|||
48545235|NCT00699374|156186375|FG001|Overall Study|Died 28 days after last dose|9|||
48610214|NCT01184872|156431734|FG001|Overall Study|Administrative problems|1|||
48610215|NCT01184872|156431733|FG000|Overall Study|Protocol deviation|1|||
48610216|NCT01184872|156431734|FG001|Overall Study|Protocol deviation|0|||
48610217|NCT03722576|156431735|FG000|Overall Study|Withdrawal by Subject|3|||
48610218|NCT03722576|156431735|FG000|Overall Study|Adverse Event|2|||
48610219|NCT03722576|156431735|FG000|Overall Study|Physician Decision|1|||
48610220|NCT03722576|156431735|FG000|Overall Study|Lost to Follow-up|1|||
48610221|NCT03329989|156431740|FG000|Overall Study|Withdrawal by Subject|9|||
48610222|NCT03329989|156431740|FG000|Overall Study|Lost to Follow-up|8|||
48610223|NCT03329989|156431740|FG000|Overall Study|Adverse Event|5|||
48610224|NCT03329989|156431740|FG000|Overall Study|Protocol Violation|1|||
48610225|NCT00706797|156431743|FG000|Overall Study|Lack of Efficacy|3|||
48610226|NCT00706797|156431744|FG001|Overall Study|Lack of Efficacy|0|||
48610227|NCT00706797|156431743|FG000|Overall Study|Adverse Event|0|||
48610228|NCT00706797|156431744|FG001|Overall Study|Adverse Event|3|||
48610229|NCT00706797|156431743|FG000|Overall Study|Withdrawal by Subject|8|||
48610230|NCT00706797|156431744|FG001|Overall Study|Withdrawal by Subject|1|||
48610231|NCT00706797|156431743|FG000|Overall Study|Death|1|||
48610232|NCT00706797|156431744|FG001|Overall Study|Death|0|||
48545236|NCT02006693|156186377|FG000|Overall Study|No Reason Specified|6|||
48545237|NCT02006693|156186378|FG001|Overall Study|No Reason Specified|8|||
48545238|NCT02006693|156186377|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
48545239|NCT02006693|156186378|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
48545240|NCT02006693|156186377|FG000|Overall Study|XEN Implant Explantation|0|||
48545241|NCT02006693|156186378|FG001|Overall Study|XEN Implant Explantation|1|||
48610233|NCT00706797|156431743|FG000|Overall Study|Discontinuation of study by sponsor|52|||
48545242|NCT02006693|156186377|FG000|Overall Study|Death|2|||
48545243|NCT02006693|156186378|FG001|Overall Study|Death|2|||
48545244|NCT02006693|156186377|FG000|Overall Study|Lost to Follow-up|4|||
48545245|NCT02006693|156186378|FG001|Overall Study|Lost to Follow-up|1|||
48545246|NCT02006693|156186377|FG000|Overall Study|Patient Decision|4|||
48610234|NCT00706797|156431744|FG001|Overall Study|Discontinuation of study by sponsor|63|||
48610235|NCT00706797|156431743|FG000|Overall Study|Protocol Violation|3|||
48610236|NCT00706797|156431744|FG001|Overall Study|Protocol Violation|2|||
48610237|NCT00706797|156431743|FG000|Overall Study|Lost to Follow-up|1|||
48610238|NCT00706797|156431744|FG001|Overall Study|Lost to Follow-up|2|||
48610239|NCT00706797|156431743|FG000|Overall Study|Other|1|||
48610240|NCT00706797|156431744|FG001|Overall Study|Other|0|||
48610241|NCT00537277|156431752|FG000|Overall Study|Adverse Event|1|||
48610242|NCT00537277|156431752|FG000|Overall Study|Lack of Efficacy|2|||
48610243|NCT00537277|156431752|FG000|Overall Study|Lost to Follow-up|12|||
48610244|NCT00537277|156431752|FG000|Overall Study|Protocol Violation|11|||
48610245|NCT00537277|156431752|FG000|Overall Study|Unclassified|4|||
48610246|NCT00537277|156431752|FG000|Overall Study|Inability to tolerate trial medication|4|||
48610247|NCT00537277|156431752|FG000|Overall Study|Non-compliance with trial procedures|15|||
48610248|NCT00997893|156431755|FG000|Overall Study|Adverse Event|1|||
48610249|NCT00997893|156431756|FG001|Overall Study|Adverse Event|0|||
48610250|NCT00997893|156431757|FG002|Overall Study|Adverse Event|0|||
48610251|NCT00997893|156431755|FG000|Overall Study|Unable to meet study timelines|1|||
48545247|NCT02006693|156186378|FG001|Overall Study|Patient Decision|0|||
48545248|NCT00552578|156186381|FG000|Overall Study|Lost to Follow-up|1|||
48545249|NCT00552578|156186382|FG001|Overall Study|Lost to Follow-up|1|||
48545250|NCT00837473|156186383|FG000|Overall Study|Lost to Follow-up|1|||
48545251|NCT00837473|156186383|FG000|Overall Study|Withdrawal by Subject|2|||
48545252|NCT00470067|156186384|FG000|Overall Study|Death|1|||
48545253|NCT00470067|156186384|FG000|Overall Study|Disease Progression|6|||
48545254|NCT03400943|156186387|FG000|Treatment Period 1|Adverse Event|0|||
48545255|NCT03400943|156186388|FG001|Treatment Period 1|Adverse Event|0|||
48610252|NCT00997893|156431756|FG001|Overall Study|Unable to meet study timelines|0|||
48610253|NCT00997893|156431757|FG002|Overall Study|Unable to meet study timelines|0|||
48610254|NCT00997893|156431755|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
48610255|NCT00997893|156431756|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
48610256|NCT00997893|156431757|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
48610257|NCT03620162|156431758|FG000|Overall Study|Physician Decision|4|||
48610258|NCT03620162|156431759|FG001|Overall Study|Physician Decision|0|||
48545256|NCT03400943|156186389|FG002|Treatment Period 1|Adverse Event|0|||
48545257|NCT03400943|156186390|FG003|Treatment Period 1|Adverse Event|1|||
48545258|NCT03400943|156186387|FG000|Treatment Period 1|Lost to Follow-up|1|||
48545259|NCT03400943|156186388|FG001|Treatment Period 1|Lost to Follow-up|0|||
48545260|NCT03400943|156186389|FG002|Treatment Period 1|Lost to Follow-up|0|||
48545261|NCT03400943|156186390|FG003|Treatment Period 1|Lost to Follow-up|0|||
48545262|NCT03400943|156186387|FG000|Treatment Period 1|Protocol Violation|0|||
48545263|NCT03400943|156186388|FG001|Treatment Period 1|Protocol Violation|1|||
48610259|NCT03620162|156431760|FG002|Overall Study|Physician Decision|1|||
48610260|NCT03620162|156431761|FG003|Overall Study|Physician Decision|0|||
48610261|NCT03620162|156431762|FG004|Overall Study|Physician Decision|2|||
48610262|NCT03620162|156431758|FG000|Overall Study|Lost to Follow-up|2|||
48545264|NCT03400943|156186389|FG002|Treatment Period 1|Protocol Violation|1|||
48545265|NCT03400943|156186390|FG003|Treatment Period 1|Protocol Violation|0|||
48610263|NCT03620162|156431759|FG001|Overall Study|Lost to Follow-up|6|||
48545266|NCT03400943|156186387|FG000|Treatment Period 1|Study terminated by sponsor|2|||
48545267|NCT03400943|156186388|FG001|Treatment Period 1|Study terminated by sponsor|0|||
48610264|NCT03620162|156431760|FG002|Overall Study|Lost to Follow-up|7|||
48610265|NCT03620162|156431761|FG003|Overall Study|Lost to Follow-up|3|||
48610266|NCT03620162|156431762|FG004|Overall Study|Lost to Follow-up|2|||
48610267|NCT03620162|156431758|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
48610268|NCT03620162|156431759|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
48610269|NCT03620162|156431760|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
48610270|NCT03620162|156431761|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
48610271|NCT03620162|156431762|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
48610272|NCT00717886|156431764|FG000|Overall Study|Withdrawal by Subject|3|||
48610273|NCT00717886|156431764|FG000|Overall Study|Treatment Failure|1|||
48610274|NCT00390689|156431765|FG000|Overall Study|Adverse Event|2|||
48610275|NCT00390689|156431766|FG001|Overall Study|Adverse Event|5|||
48610276|NCT00390689|156431767|FG002|Overall Study|Adverse Event|2|||
48610277|NCT00390689|156431765|FG000|Overall Study|Lack of Efficacy|0|||
48545268|NCT03400943|156186389|FG002|Treatment Period 1|Study terminated by sponsor|0|||
48545269|NCT03400943|156186390|FG003|Treatment Period 1|Study terminated by sponsor|1|||
48545270|NCT03400943|156186387|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48545271|NCT03400943|156186388|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48545272|NCT03400943|156186389|FG002|Treatment Period 1|Withdrawal by Subject|3|||
48545273|NCT03400943|156186390|FG003|Treatment Period 1|Withdrawal by Subject|1|||
48545274|NCT03400943|156186387|FG000|Treatment Period 1|Other|2|||
48545275|NCT03400943|156186388|FG001|Treatment Period 1|Other|1|||
48545276|NCT03400943|156186389|FG002|Treatment Period 1|Other|2|||
48545277|NCT03400943|156186390|FG003|Treatment Period 1|Other|2|||
48545278|NCT03400943|156186387|FG000|Post-treatment Period 1|Adverse Event|2|||
48545279|NCT03400943|156186388|FG001|Post-treatment Period 1|Adverse Event|0|||
48545280|NCT03400943|156186389|FG002|Post-treatment Period 1|Adverse Event|0|||
48545281|NCT03400943|156186390|FG003|Post-treatment Period 1|Adverse Event|0|||
48545282|NCT03400943|156186387|FG000|Post-treatment Period 1|Protocol Violation|1|||
48545283|NCT03400943|156186388|FG001|Post-treatment Period 1|Protocol Violation|0|||
48545284|NCT03400943|156186389|FG002|Post-treatment Period 1|Protocol Violation|0|||
48545285|NCT03400943|156186390|FG003|Post-treatment Period 1|Protocol Violation|0|||
48545286|NCT03400943|156186387|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
48545287|NCT03400943|156186388|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
48545288|NCT03400943|156186389|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
48545289|NCT03400943|156186390|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
48545290|NCT03400943|156186387|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
48545291|NCT03400943|156186388|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
48545292|NCT03400943|156186389|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
48610278|NCT00390689|156431766|FG001|Overall Study|Lack of Efficacy|0|||
48610279|NCT00390689|156431767|FG002|Overall Study|Lack of Efficacy|1|||
48610280|NCT00390689|156431765|FG000|Overall Study|Protocol Violation|1|||
48610281|NCT00390689|156431766|FG001|Overall Study|Protocol Violation|0|||
48610282|NCT00390689|156431767|FG002|Overall Study|Protocol Violation|0|||
48610283|NCT00390689|156431765|FG000|Overall Study|Investigator's judgement|2|||
48610284|NCT00390689|156431766|FG001|Overall Study|Investigator's judgement|0|||
48610285|NCT00390689|156431767|FG002|Overall Study|Investigator's judgement|0|||
48610286|NCT02747927|156431768|FG000|Overall Study|Adverse Event|5|||
48610287|NCT02747927|156431769|FG001|Overall Study|Adverse Event|14|||
48610288|NCT02747927|156431768|FG000|Overall Study|Lost to Follow-up|22|||
48610289|NCT02747927|156431769|FG001|Overall Study|Lost to Follow-up|43|||
48610290|NCT02747927|156431768|FG000|Overall Study|Pregnancy|34|||
48610291|NCT02747927|156431769|FG001|Overall Study|Pregnancy|66|||
48610292|NCT02747927|156431768|FG000|Overall Study|Protocol Violation|2|||
48610293|NCT02747927|156431769|FG001|Overall Study|Protocol Violation|4|||
48610294|NCT02747927|156431768|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
48610295|NCT02747927|156431769|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
48610296|NCT02747927|156431768|FG000|Overall Study|Reason not Specified|11|||
48610297|NCT02747927|156431769|FG001|Overall Study|Reason not Specified|27|||
48610298|NCT03451045|156431770|FG000|Overall Study|Lack of Efficacy|3|||
48610299|NCT03451045|156431771|FG001|Overall Study|Lack of Efficacy|2|||
48610300|NCT03451045|156431772|FG002|Overall Study|Lack of Efficacy|2|||
48610301|NCT03451045|156431770|FG000|Overall Study|Physician Decision|1|||
48610302|NCT03451045|156431771|FG001|Overall Study|Physician Decision|1|||
48610303|NCT03451045|156431772|FG002|Overall Study|Physician Decision|1|||
48610304|NCT03451045|156431770|FG000|Overall Study|Withdrawal by Subject|4|||
48610305|NCT03451045|156431771|FG001|Overall Study|Withdrawal by Subject|0|||
48610306|NCT03451045|156431772|FG002|Overall Study|Withdrawal by Subject|5|||
48610307|NCT03451045|156431770|FG000|Overall Study|Pregnancy|0|||
48610308|NCT03451045|156431771|FG001|Overall Study|Pregnancy|0|||
48610309|NCT03451045|156431772|FG002|Overall Study|Pregnancy|2|||
48610310|NCT03451045|156431770|FG000|Overall Study|Adverse Event|7|||
48610311|NCT03451045|156431771|FG001|Overall Study|Adverse Event|1|||
48610312|NCT03451045|156431772|FG002|Overall Study|Adverse Event|3|||
48610313|NCT03451045|156431770|FG000|Overall Study|Non-compliance with study|2|||
48610314|NCT03451045|156431771|FG001|Overall Study|Non-compliance with study|0|||
48610315|NCT03451045|156431772|FG002|Overall Study|Non-compliance with study|1|||
48610316|NCT03451045|156431770|FG000|Overall Study|any other reason|10|||
48610317|NCT03451045|156431771|FG001|Overall Study|any other reason|2|||
48610318|NCT03451045|156431772|FG002|Overall Study|any other reason|13|||
48610319|NCT02550795|156431777|FG000|Overall Study|Physician Decision|0|||
48447211|NCT03657810|155825837|FG002|Overall Study|Protocol Violation|0|||
48545293|NCT03400943|156186390|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
48610320|NCT02550795|156431778|FG001|Overall Study|Physician Decision|1|||
48610321|NCT02550795|156431779|FG002|Overall Study|Physician Decision|0|||
48610322|NCT03197129|156431782|FG000|Overall Study|did not answer the VPT: shyness|4|||
48610323|NCT03197129|156431783|FG001|Overall Study|did not answer the VPT: shyness|5|||
48610324|NCT00071981|156431784|FG000|Overall Study|Lack of Efficacy|37|||
48610325|NCT00071981|156431785|FG001|Overall Study|Lack of Efficacy|29|||
48610326|NCT00071981|156431786|FG002|Overall Study|Lack of Efficacy|30|||
48545294|NCT03400943|156186387|FG000|Post-treatment Period 1|Other|2|||
48545295|NCT03400943|156186388|FG001|Post-treatment Period 1|Other|0|||
48545296|NCT03400943|156186389|FG002|Post-treatment Period 1|Other|4|||
48545297|NCT03400943|156186390|FG003|Post-treatment Period 1|Other|5|||
48545298|NCT03400943|156186387|FG000|Treatment Period 2|Study terminated by sponsor|0|||
48545299|NCT03400943|156186388|FG001|Treatment Period 2|Study terminated by sponsor|1|||
48545300|NCT03400943|156186389|FG002|Treatment Period 2|Study terminated by sponsor|0|||
48545301|NCT03400943|156186390|FG003|Treatment Period 2|Study terminated by sponsor|0|||
48545302|NCT03400943|156186387|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48545303|NCT03400943|156186388|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48545304|NCT03400943|156186389|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48545305|NCT03400943|156186390|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48545306|NCT03400943|156186387|FG000|Treatment Period 2|Other|1|||
48545307|NCT03400943|156186388|FG001|Treatment Period 2|Other|6|||
48545308|NCT03400943|156186389|FG002|Treatment Period 2|Other|0|||
48545309|NCT03400943|156186390|FG003|Treatment Period 2|Other|0|||
48545310|NCT03400943|156186387|FG000|Follow-up Period|Withdrawal by Subject|1|||
48610327|NCT00071981|156431787|FG003|Overall Study|Lack of Efficacy|43|||
48610328|NCT00071981|156431784|FG000|Overall Study|Adverse Event|4|||
48610329|NCT00071981|156431785|FG001|Overall Study|Adverse Event|4|||
48610330|NCT00071981|156431786|FG002|Overall Study|Adverse Event|3|||
48610331|NCT00071981|156431787|FG003|Overall Study|Adverse Event|1|||
48610332|NCT00071981|156431784|FG000|Overall Study|Death|0|||
48610333|NCT00071981|156431785|FG001|Overall Study|Death|0|||
48610334|NCT00071981|156431786|FG002|Overall Study|Death|1|||
48610335|NCT00071981|156431787|FG003|Overall Study|Death|1|||
48610336|NCT00071981|156431784|FG000|Overall Study|Withdrawal by Subject|3|||
48610337|NCT00071981|156431785|FG001|Overall Study|Withdrawal by Subject|1|||
48610338|NCT00071981|156431786|FG002|Overall Study|Withdrawal by Subject|0|||
48610339|NCT00071981|156431787|FG003|Overall Study|Withdrawal by Subject|0|||
48610340|NCT00071981|156431784|FG000|Overall Study|No protocol therapy|2|||
48610341|NCT00071981|156431785|FG001|Overall Study|No protocol therapy|5|||
48610342|NCT00071981|156431786|FG002|Overall Study|No protocol therapy|1|||
48610343|NCT00071981|156431787|FG003|Overall Study|No protocol therapy|0|||
48610344|NCT00071981|156431784|FG000|Overall Study|others (not specified in the study)|0|||
48545311|NCT03400943|156186388|FG001|Follow-up Period|Withdrawal by Subject|0|||
48545312|NCT03400943|156186389|FG002|Follow-up Period|Withdrawal by Subject|0|||
48545313|NCT03400943|156186390|FG003|Follow-up Period|Withdrawal by Subject|0|||
48545314|NCT04729309|156186391|FG000|Period 1|Subject unable to return for Period 2|3|||
48545315|NCT04729309|156186392|FG001|Period 1|Subject unable to return for Period 2|0|||
48545316|NCT04729309|156186391|FG000|Period 1|Lost to Follow-up|1|||
48610345|NCT00071981|156431785|FG001|Overall Study|others (not specified in the study)|2|||
48610346|NCT00071981|156431786|FG002|Overall Study|others (not specified in the study)|2|||
48610347|NCT00071981|156431787|FG003|Overall Study|others (not specified in the study)|0|||
48545317|NCT04729309|156186392|FG001|Period 1|Lost to Follow-up|0|||
48545318|NCT01212588|156186397|FG000|Overall Study|Physician Decision|0|||
48545319|NCT01212588|156186398|FG001|Overall Study|Physician Decision|1|||
48545320|NCT01212588|156186397|FG000|Overall Study|Protocol Violation|1|||
48545321|NCT01212588|156186398|FG001|Overall Study|Protocol Violation|1|||
48545322|NCT02338193|156186399|FG000|Overall Study|Withdrawal by Subject|0|||
48610348|NCT00317369|156431790|FG000|Overall Study|Adverse Event|2|||
48610349|NCT00317369|156431791|FG001|Overall Study|Adverse Event|1|||
48610350|NCT00317369|156431792|FG002|Overall Study|Adverse Event|0|||
48610351|NCT00317369|156431790|FG000|Overall Study|Lack of Efficacy|0|||
48610352|NCT00317369|156431791|FG001|Overall Study|Lack of Efficacy|1|||
48610353|NCT00317369|156431792|FG002|Overall Study|Lack of Efficacy|1|||
48545323|NCT02338193|156186400|FG001|Overall Study|Withdrawal by Subject|0|||
48545324|NCT02338193|156186401|FG002|Overall Study|Withdrawal by Subject|2|||
48545325|NCT02338193|156186399|FG000|Overall Study|Pregnancy|0|||
48545326|NCT02338193|156186400|FG001|Overall Study|Pregnancy|1|||
48545327|NCT02338193|156186401|FG002|Overall Study|Pregnancy|1|||
48610354|NCT00317369|156431790|FG000|Overall Study|Withdrawal by Subject|0|||
48610355|NCT00317369|156431791|FG001|Overall Study|Withdrawal by Subject|0|||
48610356|NCT00317369|156431792|FG002|Overall Study|Withdrawal by Subject|1|||
48610357|NCT00157755|156431793|FG000|Overall Study|Death|2|||
48610358|NCT00157755|156431794|FG001|Overall Study|Death|3|||
48610359|NCT00157755|156431795|FG002|Overall Study|Death|3|||
48610360|NCT00157755|156431796|FG003|Overall Study|Death|2|||
48610361|NCT00157755|156431797|FG004|Overall Study|Death|0|||
48610362|NCT00157755|156431798|FG005|Overall Study|Death|0|||
48610363|NCT00157755|156431793|FG000|Overall Study|Lost to Follow-up|0|||
48610364|NCT00157755|156431794|FG001|Overall Study|Lost to Follow-up|0|||
48610365|NCT00157755|156431795|FG002|Overall Study|Lost to Follow-up|1|||
48610366|NCT00157755|156431796|FG003|Overall Study|Lost to Follow-up|0|||
48610367|NCT00157755|156431797|FG004|Overall Study|Lost to Follow-up|0|||
48610368|NCT00157755|156431798|FG005|Overall Study|Lost to Follow-up|0|||
48545328|NCT02338193|156186399|FG000|Overall Study|Noncompliant with visits|2|||
48545329|NCT02338193|156186400|FG001|Overall Study|Noncompliant with visits|2|||
48545330|NCT02338193|156186401|FG002|Overall Study|Noncompliant with visits|7|||
48610369|NCT00157755|156431793|FG000|Overall Study|Withdrawal by Subject|0|||
48610370|NCT00157755|156431794|FG001|Overall Study|Withdrawal by Subject|0|||
48610371|NCT00157755|156431795|FG002|Overall Study|Withdrawal by Subject|1|||
48610372|NCT00157755|156431796|FG003|Overall Study|Withdrawal by Subject|1|||
48610373|NCT00157755|156431797|FG004|Overall Study|Withdrawal by Subject|1|||
48610374|NCT00157755|156431798|FG005|Overall Study|Withdrawal by Subject|2|||
48610375|NCT00157755|156431793|FG000|Overall Study|Explant due to infection|0|||
48610376|NCT00157755|156431794|FG001|Overall Study|Explant due to infection|0|||
48610377|NCT00157755|156431795|FG002|Overall Study|Explant due to infection|1|||
48610378|NCT00157755|156431796|FG003|Overall Study|Explant due to infection|0|||
48610379|NCT00157755|156431797|FG004|Overall Study|Explant due to infection|0|||
48610380|NCT00157755|156431798|FG005|Overall Study|Explant due to infection|0|||
48610381|NCT00157755|156431793|FG000|Overall Study|Medical reason|0|||
48610382|NCT00157755|156431794|FG001|Overall Study|Medical reason|0|||
48610383|NCT00157755|156431795|FG002|Overall Study|Medical reason|1|||
48610384|NCT00157755|156431796|FG003|Overall Study|Medical reason|1|||
48610385|NCT00157755|156431797|FG004|Overall Study|Medical reason|0|||
48610386|NCT00157755|156431798|FG005|Overall Study|Medical reason|0|||
48610387|NCT00157755|156431793|FG000|Overall Study|Study site closure|0|||
48610388|NCT00157755|156431794|FG001|Overall Study|Study site closure|1|||
48610389|NCT00157755|156431795|FG002|Overall Study|Study site closure|0|||
48610390|NCT00157755|156431796|FG003|Overall Study|Study site closure|0|||
48610391|NCT00157755|156431797|FG004|Overall Study|Study site closure|0|||
48610392|NCT00157755|156431798|FG005|Overall Study|Study site closure|0|||
48610393|NCT00157755|156431793|FG000|Overall Study|Subject non-compliance|0|||
48610394|NCT00157755|156431794|FG001|Overall Study|Subject non-compliance|0|||
48610395|NCT00157755|156431795|FG002|Overall Study|Subject non-compliance|0|||
48610396|NCT00157755|156431796|FG003|Overall Study|Subject non-compliance|0|||
48610397|NCT00157755|156431797|FG004|Overall Study|Subject non-compliance|0|||
48610398|NCT00157755|156431798|FG005|Overall Study|Subject non-compliance|1|||
48610399|NCT00157755|156431793|FG000|Overall Study|Study completion|0|||
48610400|NCT00157755|156431794|FG001|Overall Study|Study completion|0|||
48610401|NCT00157755|156431795|FG002|Overall Study|Study completion|0|||
48610402|NCT00157755|156431796|FG003|Overall Study|Study completion|0|||
48610403|NCT00157755|156431797|FG004|Overall Study|Study completion|1|||
48610404|NCT00157755|156431798|FG005|Overall Study|Study completion|2|||
48610405|NCT02696798|156431803|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
48610406|NCT02696798|156431804|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
48610407|NCT02696798|156431805|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
48545331|NCT02338193|156186399|FG000|Overall Study|moved out of state|0|||
48545332|NCT02338193|156186400|FG001|Overall Study|moved out of state|1|||
48545333|NCT02338193|156186401|FG002|Overall Study|moved out of state|0|||
48545334|NCT02338193|156186399|FG000|Overall Study|intolerant of side effects|1|||
48545335|NCT02338193|156186400|FG001|Overall Study|intolerant of side effects|0|||
48610408|NCT02696798|156431803|FG000|Blinded Treatment Dosing Period|Death|0|||
48610409|NCT02696798|156431804|FG001|Blinded Treatment Dosing Period|Death|0|||
48545336|NCT02338193|156186401|FG002|Overall Study|intolerant of side effects|0|||
48610410|NCT02696798|156431805|FG002|Blinded Treatment Dosing Period|Death|1|||
48610411|NCT02696798|156431803|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
48610412|NCT02696798|156431804|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
48610413|NCT02696798|156431805|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
48610414|NCT02696798|156431803|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
48610415|NCT02696798|156431804|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
48610416|NCT02696798|156431805|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
48545337|NCT02140411|156186402|FG000|Overall Study|Adverse Event|1|||
48610417|NCT02696798|156431803|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
48610418|NCT02696798|156431804|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
48545338|NCT03981419|156186408|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
48545339|NCT03981419|156186409|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
48545340|NCT03839823|156186410|FG000|Overall Study|Adverse Event|8|||
48545341|NCT03839823|156186411|FG001|Overall Study|Adverse Event|4|||
48545342|NCT03839823|156186410|FG000|Overall Study|Death|1|||
48545343|NCT03839823|156186411|FG001|Overall Study|Death|0|||
48545344|NCT03839823|156186410|FG000|Overall Study|Physician Decision|1|||
48545345|NCT03839823|156186411|FG001|Overall Study|Physician Decision|5|||
48545346|NCT03839823|156186410|FG000|Overall Study|Progressive Disease (PD)|65|||
48545347|NCT03839823|156186411|FG001|Overall Study|Progressive Disease (PD)|65|||
48545348|NCT03839823|156186410|FG000|Overall Study|Subject Decision|2|||
48545349|NCT03839823|156186411|FG001|Overall Study|Subject Decision|9|||
48545350|NCT03839823|156186410|FG000|Overall Study|Not Treated|0|||
48545351|NCT03839823|156186411|FG001|Overall Study|Not Treated|10|||
48545352|NCT03285308|156186412|FG000|Overall Study|Adverse Event|3|||
48545353|NCT03285308|156186413|FG001|Overall Study|Adverse Event|7|||
48545354|NCT03285308|156186412|FG000|Overall Study|Withdrawal by Subject|8|||
48545355|NCT03285308|156186413|FG001|Overall Study|Withdrawal by Subject|9|||
48545356|NCT03285308|156186412|FG000|Overall Study|Lost to Follow-up|3|||
48545357|NCT03285308|156186413|FG001|Overall Study|Lost to Follow-up|1|||
48545358|NCT03285308|156186412|FG000|Overall Study|Protocol Deviation|6|||
48545359|NCT03285308|156186413|FG001|Overall Study|Protocol Deviation|5|||
48545360|NCT03285308|156186412|FG000|Overall Study|Reason not Specified|0|||
48545361|NCT03285308|156186413|FG001|Overall Study|Reason not Specified|1|||
48545362|NCT02283983|156186414|FG000|Overall Study|Inclusion criteria not met|0|||
48545363|NCT02283983|156186415|FG001|Overall Study|Inclusion criteria not met|1|||
48545364|NCT02283983|156186414|FG000|Overall Study|Withdrawal by Subject|4|||
48545365|NCT02283983|156186415|FG001|Overall Study|Withdrawal by Subject|2|||
48545366|NCT02283983|156186414|FG000|Overall Study|Protocol Violation|0|||
48545367|NCT02283983|156186415|FG001|Overall Study|Protocol Violation|4|||
48545368|NCT02283983|156186414|FG000|Overall Study|Physician Decision|2|||
48545369|NCT02283983|156186415|FG001|Overall Study|Physician Decision|4|||
48545370|NCT02283983|156186414|FG000|Overall Study|Death|1|||
48545371|NCT02283983|156186415|FG001|Overall Study|Death|0|||
48545372|NCT02283983|156186414|FG000|Overall Study|Adverse Event|1|||
48545373|NCT02283983|156186415|FG001|Overall Study|Adverse Event|0|||
48545374|NCT02283983|156186414|FG000|Overall Study|Lost to Follow-up|9|||
48545375|NCT02283983|156186415|FG001|Overall Study|Lost to Follow-up|8|||
48545376|NCT02283983|156186414|FG000|Overall Study|Relapse|1|||
48545377|NCT02283983|156186415|FG001|Overall Study|Relapse|0|||
48545378|NCT03283761|156186416|FG000|Study Treatment|Patient Non-Compliance|1|||
48545379|NCT03283761|156186416|FG000|Study Treatment|Alternative Cancer Therapy|7|||
48545380|NCT03283761|156186416|FG000|Study Treatment|Disease progression|21|||
48545381|NCT03283761|156186416|FG000|Study Treatment|Adverse Event|3|||
48545382|NCT03283761|156186416|FG000|Study Treatment|Withdrawal by Subject|4|||
48545383|NCT03283761|156186416|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
48545384|NCT03283761|156186416|FG000|Study Treatment|Symptomatic Deterioration|1|||
48545385|NCT03283761|156186416|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
48545386|NCT03283761|156186416|FG000|Follow up|Lost to Follow-up|1|||
48545387|NCT03283761|156186416|FG000|Follow up|Symptomatic Deterioration|1|||
48545388|NCT03283761|156186416|FG000|Follow up|Death|29|||
48545389|NCT03283761|156186416|FG000|Follow up|study terminated|4|||
48545390|NCT03283761|156186416|FG000|Follow up|Primary Investigator Withdrawal|1|||
48545391|NCT03283761|156186416|FG000|Follow up|Switched to alternative therapy|1|||
48545392|NCT03283761|156186416|FG000|Follow up|Subject is now in Hospice|1|||
48545393|NCT04159935|156186417|FG000|Overall Study|Study terminated due to COVID-19|1|||
48545394|NCT04159935|156186418|FG001|Overall Study|Study terminated due to COVID-19|3|||
48545395|NCT03275064|156186419|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
48545396|NCT03275064|156186420|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
48545397|NCT03275064|156186421|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
48545398|NCT03275064|156186422|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
48545399|NCT03275064|156186423|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
48545400|NCT03275064|156186419|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
48545401|NCT03275064|156186420|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
48545402|NCT03275064|156186421|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
48585029|NCT01546038|156333755|FG003|Overall Study|Death|2|||
48585030|NCT01546038|156333756|FG004|Overall Study|Death|9|||
48585031|NCT01546038|156333757|FG005|Overall Study|Death|3|||
48585032|NCT01546038|156333758|FG006|Overall Study|Death|46|||
48585033|NCT01546038|156333759|FG007|Overall Study|Death|76|||
48585034|NCT01546038|156333760|FG008|Overall Study|Death|39|||
48585035|NCT01546038|156333752|FG000|Overall Study|Lost to Follow-up|0|||
48585036|NCT01546038|156333753|FG001|Overall Study|Lost to Follow-up|0|||
48610419|NCT02696798|156431805|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
48610420|NCT02696798|156431803|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
48610421|NCT02696798|156431804|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
48610422|NCT02696798|156431805|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
48610423|NCT02696798|156431803|FG000|Extended Treatment Period|Adverse Event|1|||
48610424|NCT02696798|156431804|FG001|Extended Treatment Period|Adverse Event|4|||
48545403|NCT03275064|156186422|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
48545404|NCT03275064|156186423|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
48545405|NCT03275064|156186419|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
48545406|NCT03275064|156186420|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
48545407|NCT03275064|156186421|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
48545408|NCT03275064|156186422|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
48545409|NCT03275064|156186423|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
48545410|NCT03275064|156186419|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
48545411|NCT03275064|156186420|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
48545412|NCT03275064|156186421|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
48545413|NCT03275064|156186422|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
48545414|NCT03275064|156186423|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
48545415|NCT03275064|156186419|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
48545416|NCT03275064|156186420|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
48545417|NCT03275064|156186421|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
48545418|NCT03275064|156186422|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
48545419|NCT03275064|156186423|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
48545420|NCT01898650|156186424|FG000|Overall Study|the subject would not lie still for imaging|1|||
48545421|NCT00426361|156186425|FG000|Overall Study|Lost to Follow-up|3|||
48545422|NCT00426361|156186426|FG001|Overall Study|Lost to Follow-up|2|||
48545423|NCT00426361|156186427|FG002|Overall Study|Lost to Follow-up|5|||
48545424|NCT00426361|156186425|FG000|Overall Study|Withdrawal by Subject|1|||
48545425|NCT00426361|156186426|FG001|Overall Study|Withdrawal by Subject|3|||
48545426|NCT00426361|156186427|FG002|Overall Study|Withdrawal by Subject|0|||
48545427|NCT00638027|156186429|FG000|Overall Study|Adverse Event|0|||
48545428|NCT00638027|156186430|FG001|Overall Study|Adverse Event|2|||
48545429|NCT01957176|156186435|FG000|Overall Study|Adverse Event|2|||
48545430|NCT01957176|156186436|FG001|Overall Study|Adverse Event|0|||
48545431|NCT01957176|156186435|FG000|Overall Study|Physician Decision|2|||
48545432|NCT01957176|156186436|FG001|Overall Study|Physician Decision|1|||
48545433|NCT01957176|156186435|FG000|Overall Study|Withdrawal by Subject|1|||
48610425|NCT02696798|156431805|FG002|Extended Treatment Period|Adverse Event|5|||
48610426|NCT02696798|156431803|FG000|Extended Treatment Period|Lack of Efficacy|7|||
48545434|NCT01957176|156186436|FG001|Overall Study|Withdrawal by Subject|0|||
48545435|NCT02092467|156186441|FG000|Overall Study|Death|49|||
48545436|NCT02092467|156186442|FG001|Overall Study|Death|66|||
48545437|NCT02092467|156186443|FG002|Overall Study|Death|38|||
48545438|NCT02092467|156186441|FG000|Overall Study|Lost to Follow-up|38|||
48545439|NCT02092467|156186442|FG001|Overall Study|Lost to Follow-up|35|||
48545440|NCT02092467|156186443|FG002|Overall Study|Lost to Follow-up|40|||
48545441|NCT02092467|156186441|FG000|Overall Study|Global Deterioration of Health Status|1|||
48545442|NCT02092467|156186442|FG001|Overall Study|Global Deterioration of Health Status|0|||
48545443|NCT02092467|156186443|FG002|Overall Study|Global Deterioration of Health Status|0|||
48610427|NCT02696798|156431804|FG001|Extended Treatment Period|Lack of Efficacy|2|||
48610428|NCT02696798|156431805|FG002|Extended Treatment Period|Lack of Efficacy|2|||
48610429|NCT02696798|156431803|FG000|Extended Treatment Period|Lost to Follow-up|1|||
48545444|NCT02092467|156186441|FG000|Overall Study|Other|32|||
48610430|NCT02696798|156431804|FG001|Extended Treatment Period|Lost to Follow-up|0|||
48610431|NCT02696798|156431805|FG002|Extended Treatment Period|Lost to Follow-up|0|||
48610432|NCT02696798|156431803|FG000|Extended Treatment Period|Physician Decision|0|||
48610433|NCT02696798|156431804|FG001|Extended Treatment Period|Physician Decision|1|||
48610434|NCT02696798|156431805|FG002|Extended Treatment Period|Physician Decision|0|||
48610435|NCT02696798|156431803|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
48610436|NCT02696798|156431804|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
48610437|NCT02696798|156431805|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
48610438|NCT02696798|156431803|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
48610439|NCT02696798|156431804|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
48545445|NCT02092467|156186442|FG001|Overall Study|Other|30|||
48545446|NCT02092467|156186443|FG002|Overall Study|Other|24|||
48545447|NCT02092467|156186441|FG000|Overall Study|Withdrawal by Subject|282|||
48545448|NCT02092467|156186442|FG001|Overall Study|Withdrawal by Subject|327|||
48610440|NCT02696798|156431805|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
48610441|NCT02696798|156431803|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
48610442|NCT02696798|156431804|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
48610443|NCT02696798|156431805|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
48610444|NCT02696798|156431803|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
48610445|NCT02696798|156431804|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
48610446|NCT02696798|156431805|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
48610447|NCT02696798|156431803|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
48610448|NCT02696798|156431804|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
48610449|NCT02696798|156431805|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
48610450|NCT02696798|156431803|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
48610451|NCT02696798|156431804|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
48610452|NCT02696798|156431805|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
48610453|NCT02696798|156431803|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
48610454|NCT02696798|156431804|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
48610455|NCT02696798|156431805|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
48610456|NCT01101178|156431807|FG000|Period 1|Withdrawal by Subject|1|||
48610457|NCT01101178|156431808|FG001|Period 1|Withdrawal by Subject|2|||
48610458|NCT01101178|156431807|FG000|Period 1|Positive drug screen|1|||
48610459|NCT01101178|156431808|FG001|Period 1|Positive drug screen|1|||
48610460|NCT01101178|156431807|FG000|Period 1|Adverse Event|2|||
48610461|NCT01101178|156431808|FG001|Period 1|Adverse Event|1|||
48610462|NCT01101178|156431807|FG000|Period 2|Withdrawal by Subject|0|||
48610463|NCT01101178|156431808|FG001|Period 2|Withdrawal by Subject|1|||
48610464|NCT00655889|156431809|FG000|Overall Study|Inadequate cell growth|1|||
48610465|NCT00655889|156431809|FG000|Overall Study|Protocol Violation|1|||
48610466|NCT00862992|156431814|FG000|Overall Study|Adverse Event|2|||
48610467|NCT00862992|156431815|FG001|Overall Study|Adverse Event|1|||
48610468|NCT00862992|156431816|FG002|Overall Study|Adverse Event|1|||
48610469|NCT00862992|156431814|FG000|Overall Study|Physician Decision|1|||
48610470|NCT00862992|156431815|FG001|Overall Study|Physician Decision|0|||
48610471|NCT00862992|156431816|FG002|Overall Study|Physician Decision|0|||
48610472|NCT00862992|156431814|FG000|Overall Study|Withdrawal by Subject|0|||
48610473|NCT00862992|156431815|FG001|Overall Study|Withdrawal by Subject|0|||
48610474|NCT00862992|156431816|FG002|Overall Study|Withdrawal by Subject|2|||
48610475|NCT01147458|156431817|FG000|First Intervention|Study terminated by sponsor|8|||
48610476|NCT01147458|156431818|FG001|First Intervention|Study terminated by sponsor|8|||
48610477|NCT01147458|156431819|FG002|First Intervention|Study terminated by sponsor|7|||
48610478|NCT01147458|156431820|FG003|First Intervention|Study terminated by sponsor|8|||
48610479|NCT01147458|156431817|FG000|First Intervention|Protocol Violation|2|||
48610480|NCT01147458|156431818|FG001|First Intervention|Protocol Violation|3|||
48610481|NCT01147458|156431819|FG002|First Intervention|Protocol Violation|2|||
48610482|NCT01147458|156431820|FG003|First Intervention|Protocol Violation|3|||
48610483|NCT01147458|156431817|FG000|First Intervention|Withdrawal by Subject|3|||
48610484|NCT01147458|156431818|FG001|First Intervention|Withdrawal by Subject|0|||
48610485|NCT01147458|156431819|FG002|First Intervention|Withdrawal by Subject|1|||
48610486|NCT01147458|156431820|FG003|First Intervention|Withdrawal by Subject|0|||
48610487|NCT01147458|156431817|FG000|First Intervention|Adverse Event|0|||
48610488|NCT01147458|156431818|FG001|First Intervention|Adverse Event|3|||
48610489|NCT01147458|156431819|FG002|First Intervention|Adverse Event|2|||
48610490|NCT01147458|156431820|FG003|First Intervention|Adverse Event|3|||
48610491|NCT01147458|156431817|FG000|First Intervention|Other|1|||
48610492|NCT01147458|156431818|FG001|First Intervention|Other|2|||
48610493|NCT01147458|156431819|FG002|First Intervention|Other|0|||
48610494|NCT01147458|156431820|FG003|First Intervention|Other|0|||
48610495|NCT01147458|156431817|FG000|Second Intervention|Study terminated by sponsor|7|||
48610496|NCT01147458|156431818|FG001|Second Intervention|Study terminated by sponsor|5|||
48610497|NCT01147458|156431819|FG002|Second Intervention|Study terminated by sponsor|5|||
48610498|NCT01147458|156431820|FG003|Second Intervention|Study terminated by sponsor|3|||
48447212|NCT03657810|155825835|FG000|Overall Study|Lost to Follow-up|0|||
48447213|NCT03657810|155825836|FG001|Overall Study|Lost to Follow-up|1|||
48447214|NCT03657810|155825837|FG002|Overall Study|Lost to Follow-up|0|||
48447215|NCT03657810|155825835|FG000|Overall Study|Not provided|0|||
48447216|NCT03657810|155825836|FG001|Overall Study|Not provided|1|||
48447217|NCT03657810|155825837|FG002|Overall Study|Not provided|0|||
48447218|NCT03911869|155825838|FG000|Safety Lead-in Phase|Death|7|||
48447219|NCT03911869|155825839|FG001|Safety Lead-in Phase|Death|0|||
48447220|NCT03911869|155825840|FG002|Safety Lead-in Phase|Death|0|||
48447221|NCT03911869|155825838|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
48447222|NCT03911869|155825839|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
48447223|NCT03911869|155825840|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
48447224|NCT03911869|155825838|FG000|Safety Lead-in Phase|Other|1|||
48447225|NCT03911869|155825839|FG001|Safety Lead-in Phase|Other|0|||
48447226|NCT03911869|155825840|FG002|Safety Lead-in Phase|Other|0|||
48447227|NCT03911869|155825838|FG000|Phase 2|Death|0|||
48447228|NCT03911869|155825839|FG001|Phase 2|Death|3|||
48610499|NCT01147458|156431817|FG000|Second Intervention|Protocol Violation|0|||
48610500|NCT01147458|156431818|FG001|Second Intervention|Protocol Violation|1|||
48610501|NCT01147458|156431819|FG002|Second Intervention|Protocol Violation|1|||
48610502|NCT01147458|156431820|FG003|Second Intervention|Protocol Violation|0|||
48610503|NCT01147458|156431817|FG000|Second Intervention|Withdrawal by Subject|0|||
48610504|NCT01147458|156431818|FG001|Second Intervention|Withdrawal by Subject|1|||
48610505|NCT01147458|156431819|FG002|Second Intervention|Withdrawal by Subject|0|||
48610506|NCT01147458|156431820|FG003|Second Intervention|Withdrawal by Subject|0|||
48610507|NCT01147458|156431817|FG000|Second Intervention|Adverse Event|2|||
48610508|NCT01147458|156431818|FG001|Second Intervention|Adverse Event|0|||
48610509|NCT01147458|156431819|FG002|Second Intervention|Adverse Event|1|||
48610510|NCT01147458|156431820|FG003|Second Intervention|Adverse Event|1|||
48610511|NCT01147458|156431817|FG000|Second Intervention|Other|0|||
48610512|NCT01147458|156431818|FG001|Second Intervention|Other|0|||
48610513|NCT01147458|156431819|FG002|Second Intervention|Other|1|||
48610514|NCT01147458|156431820|FG003|Second Intervention|Other|0|||
48610518|NCT00720759|156431824|FG000|Overall Study|Lost to Follow-up|0|||
48610519|NCT00720759|156431825|FG001|Overall Study|Lost to Follow-up|1|||
48610520|NCT00720759|156431826|FG002|Overall Study|Lost to Follow-up|1|||
48610521|NCT00720759|156431827|FG003|Overall Study|Lost to Follow-up|0|||
48610522|NCT00640289|156431834|FG000|Overall Study|Death|3|||
48610523|NCT00640289|156431834|FG000|Overall Study|Withdrawal by Subject|1|||
48610524|NCT00640289|156431834|FG000|Overall Study|Lost to Follow-up|1|||
48610525|NCT00640289|156431834|FG000|Overall Study|Data collected under different amendment|2|||
48610526|NCT00640289|156431834|FG000|Overall Study|Transferred to another center|1|||
48610527|NCT00640289|156431834|FG000|Overall Study|Missing status|5|||
48610528|NCT01288430|156433479|FG000|Part 1|Progressive disease|2|||
48610529|NCT01288430|156433480|FG001|Part 1|Progressive disease|1|||
48610530|NCT01288430|156433481|FG002|Part 1|Progressive disease|1|||
48610531|NCT01288430|156433482|FG003|Part 1|Progressive disease|6|||
48610532|NCT01288430|156433483|FG004|Part 1|Progressive disease|2|||
48610533|NCT01288430|156433484|FG005|Part 1|Progressive disease|4|||
48610534|NCT01288430|156433485|FG006|Part 1|Progressive disease|2|||
48610535|NCT01288430|156433486|FG007|Part 1|Progressive disease|0|||
48610536|NCT01288430|156433487|FG008|Part 1|Progressive disease|0|||
48610537|NCT01288430|156433488|FG009|Part 1|Progressive disease|0|||
48610538|NCT01288430|156433479|FG000|Part 1|Clinical disease progression|0|||
48610539|NCT01288430|156433480|FG001|Part 1|Clinical disease progression|0|||
48610540|NCT01288430|156433481|FG002|Part 1|Clinical disease progression|1|||
48610541|NCT01288430|156433482|FG003|Part 1|Clinical disease progression|0|||
48610542|NCT01288430|156433483|FG004|Part 1|Clinical disease progression|0|||
48610543|NCT01288430|156433484|FG005|Part 1|Clinical disease progression|2|||
48610544|NCT01288430|156433485|FG006|Part 1|Clinical disease progression|2|||
48610545|NCT01288430|156433486|FG007|Part 1|Clinical disease progression|0|||
48610546|NCT01288430|156433487|FG008|Part 1|Clinical disease progression|0|||
48610547|NCT01288430|156433488|FG009|Part 1|Clinical disease progression|0|||
48610548|NCT01288430|156433479|FG000|Part 1|Death due to disease progression|0|||
48610549|NCT01288430|156433480|FG001|Part 1|Death due to disease progression|0|||
48610550|NCT01288430|156433481|FG002|Part 1|Death due to disease progression|0|||
48610551|NCT01288430|156433482|FG003|Part 1|Death due to disease progression|0|||
48610552|NCT01288430|156433483|FG004|Part 1|Death due to disease progression|1|||
48610553|NCT01288430|156433484|FG005|Part 1|Death due to disease progression|0|||
48610554|NCT01288430|156433485|FG006|Part 1|Death due to disease progression|0|||
48545449|NCT02092467|156186443|FG002|Overall Study|Withdrawal by Subject|289|||
48545450|NCT02092467|156186441|FG000|Overall Study|Randomized but not treated|2|||
48545451|NCT02092467|156186442|FG001|Overall Study|Randomized but not treated|1|||
48610555|NCT01288430|156433486|FG007|Part 1|Death due to disease progression|0|||
48610556|NCT01288430|156433487|FG008|Part 1|Death due to disease progression|0|||
48610557|NCT01288430|156433488|FG009|Part 1|Death due to disease progression|0|||
48610558|NCT01288430|156433479|FG000|Part 1|Adverse Event|0|||
48610559|NCT01288430|156433480|FG001|Part 1|Adverse Event|0|||
48610560|NCT01288430|156433481|FG002|Part 1|Adverse Event|3|||
48610561|NCT01288430|156433482|FG003|Part 1|Adverse Event|1|||
48610562|NCT01288430|156433483|FG004|Part 1|Adverse Event|0|||
48610563|NCT01288430|156433484|FG005|Part 1|Adverse Event|0|||
48610564|NCT01288430|156433485|FG006|Part 1|Adverse Event|2|||
48610565|NCT01288430|156433486|FG007|Part 1|Adverse Event|0|||
48610566|NCT01288430|156433487|FG008|Part 1|Adverse Event|0|||
48610567|NCT01288430|156433488|FG009|Part 1|Adverse Event|0|||
48610568|NCT01288430|156433479|FG000|Part 1|Other|0|||
48610569|NCT01288430|156433480|FG001|Part 1|Other|2|||
48610570|NCT01288430|156433481|FG002|Part 1|Other|0|||
48610571|NCT01288430|156433482|FG003|Part 1|Other|0|||
48610572|NCT01288430|156433483|FG004|Part 1|Other|0|||
48610573|NCT01288430|156433484|FG005|Part 1|Other|0|||
48610574|NCT01288430|156433485|FG006|Part 1|Other|1|||
48610575|NCT01288430|156433486|FG007|Part 1|Other|0|||
48610576|NCT01288430|156433487|FG008|Part 1|Other|0|||
48610577|NCT01288430|156433488|FG009|Part 1|Other|0|||
48610578|NCT01288430|156433479|FG000|Part 2|Progressive disease|0|||
48545452|NCT02092467|156186443|FG002|Overall Study|Randomized but not treated|7|||
48545453|NCT04614246|156186444|FG000|Overall Study|Adverse Event|0|||
48610579|NCT01288430|156433480|FG001|Part 2|Progressive disease|0|||
48610580|NCT01288430|156433481|FG002|Part 2|Progressive disease|0|||
48610581|NCT01288430|156433482|FG003|Part 2|Progressive disease|0|||
48610582|NCT01288430|156433483|FG004|Part 2|Progressive disease|0|||
48610583|NCT01288430|156433484|FG005|Part 2|Progressive disease|0|||
48610584|NCT01288430|156433485|FG006|Part 2|Progressive disease|0|||
48610585|NCT01288430|156433486|FG007|Part 2|Progressive disease|8|||
48610586|NCT01288430|156433487|FG008|Part 2|Progressive disease|7|||
48610587|NCT01288430|156433488|FG009|Part 2|Progressive disease|2|||
48610588|NCT01288430|156433479|FG000|Part 2|Clinical disease progression|0|||
48610589|NCT01288430|156433480|FG001|Part 2|Clinical disease progression|0|||
48610590|NCT01288430|156433481|FG002|Part 2|Clinical disease progression|0|||
48610591|NCT01288430|156433482|FG003|Part 2|Clinical disease progression|0|||
48610592|NCT01288430|156433483|FG004|Part 2|Clinical disease progression|0|||
48610593|NCT01288430|156433484|FG005|Part 2|Clinical disease progression|0|||
48610594|NCT01288430|156433485|FG006|Part 2|Clinical disease progression|0|||
48610595|NCT01288430|156433486|FG007|Part 2|Clinical disease progression|2|||
48610596|NCT01288430|156433487|FG008|Part 2|Clinical disease progression|0|||
48610597|NCT01288430|156433488|FG009|Part 2|Clinical disease progression|0|||
48545454|NCT04614246|156186445|FG001|Overall Study|Adverse Event|1|||
48545455|NCT04614246|156186446|FG002|Overall Study|Adverse Event|1|||
48545456|NCT04614246|156186447|FG003|Overall Study|Adverse Event|2|||
48545457|NCT04614246|156186448|FG004|Overall Study|Adverse Event|1|||
48545458|NCT04614246|156186444|FG000|Overall Study|Lost to Follow-up|0|||
48545459|NCT04614246|156186445|FG001|Overall Study|Lost to Follow-up|1|||
48545460|NCT04614246|156186446|FG002|Overall Study|Lost to Follow-up|0|||
48545461|NCT04614246|156186447|FG003|Overall Study|Lost to Follow-up|1|||
48545462|NCT04614246|156186448|FG004|Overall Study|Lost to Follow-up|3|||
48545463|NCT04614246|156186444|FG000|Overall Study|Other reason|0|||
48545464|NCT04614246|156186445|FG001|Overall Study|Other reason|1|||
48545465|NCT04614246|156186446|FG002|Overall Study|Other reason|2|||
48545466|NCT04614246|156186447|FG003|Overall Study|Other reason|0|||
48610598|NCT01288430|156433479|FG000|Part 2|Withdrawal by Subject|0|||
48610599|NCT01288430|156433480|FG001|Part 2|Withdrawal by Subject|0|||
48610600|NCT01288430|156433481|FG002|Part 2|Withdrawal by Subject|0|||
48610601|NCT01288430|156433482|FG003|Part 2|Withdrawal by Subject|0|||
48610602|NCT01288430|156433483|FG004|Part 2|Withdrawal by Subject|0|||
48610603|NCT01288430|156433484|FG005|Part 2|Withdrawal by Subject|0|||
48610604|NCT01288430|156433485|FG006|Part 2|Withdrawal by Subject|0|||
48610605|NCT01288430|156433486|FG007|Part 2|Withdrawal by Subject|1|||
48610606|NCT01288430|156433487|FG008|Part 2|Withdrawal by Subject|4|||
48610607|NCT01288430|156433488|FG009|Part 2|Withdrawal by Subject|0|||
48610608|NCT01288430|156433479|FG000|Part 2|Adverse Event|0|||
48610609|NCT01288430|156433480|FG001|Part 2|Adverse Event|0|||
48610610|NCT01288430|156433481|FG002|Part 2|Adverse Event|0|||
48610611|NCT01288430|156433482|FG003|Part 2|Adverse Event|0|||
48545467|NCT04614246|156186448|FG004|Overall Study|Other reason|0|||
48545468|NCT04614246|156186444|FG000|Overall Study|Withdrawal by Subject|4|||
48545469|NCT04614246|156186445|FG001|Overall Study|Withdrawal by Subject|2|||
48545470|NCT04614246|156186446|FG002|Overall Study|Withdrawal by Subject|4|||
48610612|NCT01288430|156433483|FG004|Part 2|Adverse Event|0|||
48610613|NCT01288430|156433484|FG005|Part 2|Adverse Event|0|||
48610614|NCT01288430|156433485|FG006|Part 2|Adverse Event|0|||
48610615|NCT01288430|156433486|FG007|Part 2|Adverse Event|1|||
48610616|NCT01288430|156433487|FG008|Part 2|Adverse Event|1|||
48610617|NCT01288430|156433488|FG009|Part 2|Adverse Event|0|||
48610618|NCT01288430|156433479|FG000|Part 2|Other|0|||
48610619|NCT01288430|156433480|FG001|Part 2|Other|0|||
48610620|NCT01288430|156433481|FG002|Part 2|Other|0|||
48610621|NCT01288430|156433482|FG003|Part 2|Other|0|||
48610622|NCT01288430|156433483|FG004|Part 2|Other|0|||
48610623|NCT01288430|156433484|FG005|Part 2|Other|0|||
48610624|NCT01288430|156433485|FG006|Part 2|Other|0|||
48610625|NCT01288430|156433486|FG007|Part 2|Other|0|||
48610626|NCT01288430|156433487|FG008|Part 2|Other|0|||
48610627|NCT01288430|156433488|FG009|Part 2|Other|1|||
48610628|NCT00549055|156433489|FG000|Overall Study|Adverse Event|4|||
48610629|NCT00549055|156433489|FG000|Overall Study|Lack of Efficacy|18|||
48610630|NCT00549055|156433489|FG000|Overall Study|Stabilization|5|||
48610631|NCT00549055|156433489|FG000|Overall Study|Progression to fibrosis|2|||
48610632|NCT00549055|156433489|FG000|Overall Study|Decrease of size|1|||
48610633|NCT00549055|156433489|FG000|Overall Study|Active choroidal neovascula increased|1|||
48610634|NCT00549055|156433489|FG000|Overall Study|Vitreous hemorrhage|1|||
48610635|NCT00549055|156433489|FG000|Overall Study|Growth choroidal neovascularisation|1|||
48610636|NCT00549055|156433489|FG000|Overall Study|Choroidal neovascularization|1|||
48610637|NCT00549055|156433489|FG000|Overall Study|Very low visual acuity (VA)|1|||
48610638|NCT02807259|156433499|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
48610639|NCT02807259|156433500|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
48610640|NCT02807259|156433499|FG000|Midline (3 Months)|migration, refusal, not available|30|||
48610641|NCT02807259|156433500|FG001|Midline (3 Months)|migration, refusal, not available|34|||
48610642|NCT02807259|156433499|FG000|Endline (3 Months)|migration, refusal, not available|35|||
48610643|NCT02807259|156433500|FG001|Endline (3 Months)|migration, refusal, not available|87|||
48610644|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
48610645|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
48610646|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Death|1|||
48610647|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Death|3|||
48610648|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
48610649|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
48610650|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
48610651|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
48610652|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
48545471|NCT04614246|156186447|FG003|Overall Study|Withdrawal by Subject|3|||
48545472|NCT04614246|156186448|FG004|Overall Study|Withdrawal by Subject|4|||
48610653|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
48610654|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
48610655|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
48610656|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
48610657|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
48610658|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
48610659|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
48610660|NCT00362232|156433501|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
48610661|NCT00362232|156433502|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
48610662|NCT00362232|156433501|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
48610663|NCT00362232|156433502|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
48545473|NCT04614246|156186444|FG000|Overall Study|Physician Decision|0|||
48545474|NCT04614246|156186445|FG001|Overall Study|Physician Decision|2|||
48545475|NCT04614246|156186446|FG002|Overall Study|Physician Decision|1|||
48545476|NCT04614246|156186447|FG003|Overall Study|Physician Decision|0|||
48545477|NCT04614246|156186448|FG004|Overall Study|Physician Decision|0|||
48545478|NCT04614246|156186444|FG000|Overall Study|Study terminated by sponsor|10|||
48545479|NCT04614246|156186445|FG001|Overall Study|Study terminated by sponsor|15|||
48545480|NCT04614246|156186446|FG002|Overall Study|Study terminated by sponsor|12|||
48545481|NCT04614246|156186447|FG003|Overall Study|Study terminated by sponsor|13|||
48545482|NCT04614246|156186448|FG004|Overall Study|Study terminated by sponsor|9|||
48545483|NCT04614246|156186444|FG000|Overall Study|Pregnancy|2|||
48545484|NCT04614246|156186445|FG001|Overall Study|Pregnancy|0|||
48545485|NCT04614246|156186446|FG002|Overall Study|Pregnancy|1|||
48610664|NCT00362232|156433501|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
48610665|NCT00362232|156433502|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
48610666|NCT00362232|156433501|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
48610667|NCT00362232|156433502|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
48545486|NCT04614246|156186447|FG003|Overall Study|Pregnancy|0|||
48610668|NCT00362232|156433501|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
48610669|NCT00362232|156433502|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
48610670|NCT00109343|156433506|FG000|Overall Study|Adverse Event|1|||
48545487|NCT04614246|156186448|FG004|Overall Study|Pregnancy|0|||
48545488|NCT00725205|156186452|FG000|Overall Study|Adverse Event|22|||
48545489|NCT00725205|156186452|FG000|Overall Study|Investigator Discontinued|1|||
48545490|NCT00725205|156186452|FG000|Overall Study|Non-compliance With Protocol|14|||
48545491|NCT00725205|156186452|FG000|Overall Study|Other|8|||
48610671|NCT00109343|156433507|FG001|Overall Study|Adverse Event|0|||
48610672|NCT00109343|156433508|FG002|Overall Study|Adverse Event|2|||
48610673|NCT00109343|156433506|FG000|Overall Study|Lack of Efficacy|1|||
48610674|NCT00109343|156433507|FG001|Overall Study|Lack of Efficacy|0|||
48610675|NCT00109343|156433508|FG002|Overall Study|Lack of Efficacy|0|||
48610676|NCT00109343|156433506|FG000|Overall Study|Lost to Follow-up|35|||
48610677|NCT00109343|156433507|FG001|Overall Study|Lost to Follow-up|20|||
48610678|NCT00109343|156433508|FG002|Overall Study|Lost to Follow-up|14|||
48610679|NCT00109343|156433506|FG000|Overall Study|Protocol Violation|1|||
48610680|NCT00109343|156433507|FG001|Overall Study|Protocol Violation|2|||
48610681|NCT00109343|156433508|FG002|Overall Study|Protocol Violation|2|||
48610682|NCT00109343|156433506|FG000|Overall Study|Withdrawal by Subject|15|||
48610683|NCT00109343|156433507|FG001|Overall Study|Withdrawal by Subject|11|||
48610684|NCT00109343|156433508|FG002|Overall Study|Withdrawal by Subject|10|||
48610685|NCT00109343|156433506|FG000|Overall Study|Subject Moved|6|||
48610686|NCT00109343|156433507|FG001|Overall Study|Subject Moved|2|||
48610687|NCT00109343|156433508|FG002|Overall Study|Subject Moved|1|||
48610688|NCT00109343|156433506|FG000|Overall Study|Other|5|||
48610689|NCT00109343|156433507|FG001|Overall Study|Other|2|||
48610690|NCT00109343|156433508|FG002|Overall Study|Other|1|||
48610691|NCT00750269|156433509|FG000|Overall Study|Protocol Violation|0|||
48610692|NCT00750269|156433510|FG001|Overall Study|Protocol Violation|1|||
48610693|NCT00750269|156433511|FG002|Overall Study|Protocol Violation|1|||
48610694|NCT00750269|156433512|FG003|Overall Study|Protocol Violation|2|||
48610695|NCT00750269|156433513|FG004|Overall Study|Protocol Violation|4|||
48610696|NCT00750269|156433509|FG000|Overall Study|Withdrawal by Subject|0|||
48610697|NCT00750269|156433510|FG001|Overall Study|Withdrawal by Subject|0|||
48610698|NCT00750269|156433511|FG002|Overall Study|Withdrawal by Subject|2|||
48610699|NCT00750269|156433512|FG003|Overall Study|Withdrawal by Subject|2|||
48610700|NCT00750269|156433513|FG004|Overall Study|Withdrawal by Subject|2|||
48610701|NCT00750269|156433509|FG000|Overall Study|Physician Decision|0|||
48610702|NCT00750269|156433510|FG001|Overall Study|Physician Decision|0|||
48610703|NCT00750269|156433511|FG002|Overall Study|Physician Decision|0|||
48610704|NCT00750269|156433512|FG003|Overall Study|Physician Decision|0|||
48610705|NCT00750269|156433513|FG004|Overall Study|Physician Decision|2|||
48610706|NCT00750269|156433509|FG000|Overall Study|Patient too large for positioning|0|||
48610707|NCT00750269|156433510|FG001|Overall Study|Patient too large for positioning|0|||
48545492|NCT00725205|156186452|FG000|Overall Study|Protocol Defined Clinical Event|1|||
48545493|NCT00725205|156186452|FG000|Overall Study|Treatment Failure|41|||
48545494|NCT01680497|156186455|FG000|Overall Study|Lost to Follow-up|2|||
48545495|NCT00371397|156186456|FG000|Session 1|Withdrawal by Subject|1|||
48545496|NCT00371397|156186457|FG001|Session 1|Withdrawal by Subject|0|||
48545497|NCT00371397|156186458|FG002|Session 1|Withdrawal by Subject|0|||
48545498|NCT00371397|156186459|FG003|Session 1|Withdrawal by Subject|0|||
48545499|NCT00371397|156186460|FG004|Session 1|Withdrawal by Subject|0|||
48545500|NCT00371397|156186461|FG005|Session 1|Withdrawal by Subject|0|||
48545501|NCT00371397|156186462|FG006|Session 1|Withdrawal by Subject|0|||
48545502|NCT00371397|156186463|FG007|Session 1|Withdrawal by Subject|1|||
48610708|NCT00750269|156433511|FG002|Overall Study|Patient too large for positioning|1|||
48610709|NCT00750269|156433512|FG003|Overall Study|Patient too large for positioning|0|||
48610710|NCT00750269|156433513|FG004|Overall Study|Patient too large for positioning|0|||
48610711|NCT00750269|156433509|FG000|Overall Study|Site error|0|||
48610712|NCT00750269|156433510|FG001|Overall Study|Site error|0|||
48610713|NCT00750269|156433511|FG002|Overall Study|Site error|0|||
48610714|NCT00750269|156433512|FG003|Overall Study|Site error|1|||
48610715|NCT00750269|156433513|FG004|Overall Study|Site error|0|||
48545503|NCT00371397|156186464|FG008|Session 1|Withdrawal by Subject|0|||
48545504|NCT00371397|156186465|FG009|Session 1|Withdrawal by Subject|0|||
48545505|NCT00371397|156186466|FG010|Session 1|Withdrawal by Subject|0|||
48545506|NCT00371397|156186467|FG011|Session 1|Withdrawal by Subject|0|||
48610716|NCT00750269|156433509|FG000|Overall Study|SBRT plan could not be drawn|0|||
48610717|NCT00750269|156433510|FG001|Overall Study|SBRT plan could not be drawn|0|||
48610718|NCT00750269|156433511|FG002|Overall Study|SBRT plan could not be drawn|0|||
48545507|NCT03014180|156186468|FG000|Overall Study|Protocol Violation|2|||
48545508|NCT03654599|156186470|FG000|Overall Study|Lost to Follow-up|14|||
48545509|NCT03654599|156186471|FG001|Overall Study|Lost to Follow-up|12|||
48545510|NCT03654599|156186470|FG000|Overall Study|Death|8|||
48545511|NCT03654599|156186471|FG001|Overall Study|Death|6|||
48545512|NCT03654599|156186470|FG000|Overall Study|Withdrawal by Subject|6|||
48545513|NCT03654599|156186471|FG001|Overall Study|Withdrawal by Subject|4|||
48545514|NCT05422625|156186472|FG000|Overall Study|Withdrawal by Subject|1|||
48545515|NCT05422625|156186473|FG001|Overall Study|Withdrawal by Subject|0|||
48545516|NCT02588950|156188305|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
48545517|NCT02588950|156188306|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
48545518|NCT02588950|156188307|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
48545519|NCT02588950|156188308|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
48545520|NCT02588950|156188305|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
48545521|NCT02588950|156188306|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
48545522|NCT02588950|156188307|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
48545523|NCT02588950|156188308|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
48545524|NCT02031458|156188309|FG000|May 8, 2015 to January 11, 2019|Death|89|||
48545525|NCT02031458|156188310|FG001|May 8, 2015 to January 11, 2019|Death|193|||
48545526|NCT02031458|156188311|FG002|May 8, 2015 to January 11, 2019|Death|198|||
48545527|NCT02031458|156188309|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
48545528|NCT02031458|156188310|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
48545529|NCT02031458|156188311|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
48545530|NCT02031458|156188309|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
48545531|NCT02031458|156188310|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
48545532|NCT02031458|156188311|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
48545533|NCT02031458|156188309|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
48545534|NCT02031458|156188310|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
48585037|NCT01546038|156333754|FG002|Overall Study|Lost to Follow-up|0|||
48585038|NCT01546038|156333755|FG003|Overall Study|Lost to Follow-up|0|||
48585039|NCT01546038|156333756|FG004|Overall Study|Lost to Follow-up|1|||
48585040|NCT01546038|156333757|FG005|Overall Study|Lost to Follow-up|0|||
48585041|NCT01546038|156333758|FG006|Overall Study|Lost to Follow-up|2|||
48585042|NCT01546038|156333759|FG007|Overall Study|Lost to Follow-up|1|||
48585043|NCT01546038|156333760|FG008|Overall Study|Lost to Follow-up|0|||
48585044|NCT01546038|156333752|FG000|Overall Study|Withdrawal by Subject|1|||
48585045|NCT01546038|156333753|FG001|Overall Study|Withdrawal by Subject|0|||
48585046|NCT01546038|156333754|FG002|Overall Study|Withdrawal by Subject|0|||
48585047|NCT01546038|156333755|FG003|Overall Study|Withdrawal by Subject|1|||
48585048|NCT01546038|156333756|FG004|Overall Study|Withdrawal by Subject|0|||
48585049|NCT01546038|156333757|FG005|Overall Study|Withdrawal by Subject|1|||
48585050|NCT01546038|156333758|FG006|Overall Study|Withdrawal by Subject|3|||
48585051|NCT01546038|156333759|FG007|Overall Study|Withdrawal by Subject|3|||
48585052|NCT01546038|156333760|FG008|Overall Study|Withdrawal by Subject|1|||
48610719|NCT00750269|156433512|FG003|Overall Study|SBRT plan could not be drawn|0|||
48610720|NCT00750269|156433513|FG004|Overall Study|SBRT plan could not be drawn|1|||
48610721|NCT00750269|156433509|FG000|Overall Study|Fiducials could not be placed|0|||
48610722|NCT00750269|156433510|FG001|Overall Study|Fiducials could not be placed|0|||
48610723|NCT00750269|156433511|FG002|Overall Study|Fiducials could not be placed|0|||
48610724|NCT00750269|156433512|FG003|Overall Study|Fiducials could not be placed|0|||
48610725|NCT00750269|156433513|FG004|Overall Study|Fiducials could not be placed|1|||
48610726|NCT02934178|156433516|FG000|Received Vaccination 2|Death|0|||
48610727|NCT02934178|156433517|FG001|Received Vaccination 2|Death|1|||
48610728|NCT02934178|156433516|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
48610729|NCT02934178|156433517|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
48610730|NCT00870727|156433520|FG000|Overall Study|Lost to Follow-up|0|||
48610731|NCT00870727|156433521|FG001|Overall Study|Lost to Follow-up|1|||
48610732|NCT00870727|156433520|FG000|Overall Study|Lack of Efficacy|1|||
48610733|NCT00870727|156433521|FG001|Overall Study|Lack of Efficacy|3|||
48610734|NCT00870727|156433520|FG000|Overall Study|Adverse Event|0|||
48610735|NCT00870727|156433521|FG001|Overall Study|Adverse Event|1|||
48610736|NCT00720278|156433522|FG000|Overall Study|Adverse Event|5|||
48610737|NCT00720278|156433523|FG001|Overall Study|Adverse Event|3|||
48610738|NCT00720278|156433524|FG002|Overall Study|Adverse Event|4|||
48610739|NCT00720278|156433522|FG000|Overall Study|Withdrawal by Subject|0|||
48610740|NCT00720278|156433523|FG001|Overall Study|Withdrawal by Subject|1|||
48610741|NCT00720278|156433524|FG002|Overall Study|Withdrawal by Subject|0|||
48610742|NCT00720278|156433522|FG000|Overall Study|Lost to Follow-up|0|||
48610743|NCT00720278|156433523|FG001|Overall Study|Lost to Follow-up|0|||
48610744|NCT00720278|156433524|FG002|Overall Study|Lost to Follow-up|1|||
48610745|NCT00720278|156433522|FG000|Overall Study|Non-compliance|1|||
48610746|NCT00720278|156433523|FG001|Overall Study|Non-compliance|0|||
48610747|NCT00720278|156433524|FG002|Overall Study|Non-compliance|0|||
48610748|NCT00720278|156433522|FG000|Overall Study|eligibility criteria violation|1|||
48610749|NCT00720278|156433523|FG001|Overall Study|eligibility criteria violation|0|||
48610750|NCT00720278|156433524|FG002|Overall Study|eligibility criteria violation|1|||
48610751|NCT00737048|156433527|FG000|Overall Study|Physician Decision|0|||
48610752|NCT00737048|156433528|FG001|Overall Study|Physician Decision|0|||
48610753|NCT00737048|156433529|FG002|Overall Study|Physician Decision|1|||
48610754|NCT00737048|156433527|FG000|Overall Study|Adverse Event|0|||
48610755|NCT00737048|156433528|FG001|Overall Study|Adverse Event|1|||
48610756|NCT00737048|156433529|FG002|Overall Study|Adverse Event|0|||
48610757|NCT00737048|156433527|FG000|Overall Study|Worsening of the symptoms|3|||
48610758|NCT00737048|156433528|FG001|Overall Study|Worsening of the symptoms|5|||
48610759|NCT00737048|156433529|FG002|Overall Study|Worsening of the symptoms|3|||
48610760|NCT01294046|156433530|FG000|Overall Study|Infection and surgical explant|1|||
48610761|NCT01294046|156433530|FG000|Overall Study|Eligibility criteria expanded|1|||
48610762|NCT01294046|156433530|FG000|Overall Study|Stimulation response inadqequate|1|||
48610763|NCT01373164|156433535|FG000|Overall Study|Lost to Follow-up|0|||
48610764|NCT01373164|156433536|FG001|Overall Study|Lost to Follow-up|0|||
48610765|NCT01373164|156433537|FG002|Overall Study|Lost to Follow-up|1|||
48610766|NCT01373164|156433538|FG003|Overall Study|Lost to Follow-up|2|||
48610767|NCT01373164|156433539|FG004|Overall Study|Lost to Follow-up|0|||
48610768|NCT01373164|156433535|FG000|Overall Study|Withdrawal by Subject|0|||
48610769|NCT01373164|156433536|FG001|Overall Study|Withdrawal by Subject|1|||
48610770|NCT01373164|156433537|FG002|Overall Study|Withdrawal by Subject|0|||
48610771|NCT01373164|156433538|FG003|Overall Study|Withdrawal by Subject|10|||
48610772|NCT01373164|156433539|FG004|Overall Study|Withdrawal by Subject|2|||
48610773|NCT00420745|156433540|FG000|Overall Study|Adverse Event|2|||
48610774|NCT00420745|156433541|FG001|Overall Study|Adverse Event|2|||
48610775|NCT00420745|156433540|FG000|Overall Study|Lost to Follow-up|10|||
48610776|NCT00420745|156433541|FG001|Overall Study|Lost to Follow-up|2|||
48610777|NCT00420745|156433540|FG000|Overall Study|Protocol Violation|1|||
48610778|NCT00420745|156433541|FG001|Overall Study|Protocol Violation|0|||
48610779|NCT00420745|156433540|FG000|Overall Study|Physician Decision|1|||
48610780|NCT00420745|156433541|FG001|Overall Study|Physician Decision|1|||
48610781|NCT00420745|156433540|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
48545535|NCT02031458|156188311|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
48610782|NCT00420745|156433541|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
48610783|NCT00420745|156433540|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
48610784|NCT00420745|156433541|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
48610785|NCT01963611|156433542|FG000|Overall Study|Adverse Event|1|||
48610786|NCT01963611|156433543|FG001|Overall Study|Adverse Event|1|||
48610787|NCT01963611|156433544|FG002|Overall Study|Adverse Event|3|||
48610788|NCT01963611|156433545|FG003|Overall Study|Adverse Event|4|||
48610789|NCT01963611|156433546|FG004|Overall Study|Adverse Event|3|||
48610790|NCT01963611|156433542|FG000|Overall Study|Protocol Violation|0|||
48610791|NCT01963611|156433543|FG001|Overall Study|Protocol Violation|0|||
48610792|NCT01963611|156433544|FG002|Overall Study|Protocol Violation|0|||
48545536|NCT02031458|156188309|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
48545537|NCT02031458|156188310|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
48545538|NCT02031458|156188311|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
48545539|NCT02031458|156188309|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
48545540|NCT02031458|156188310|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
48545541|NCT02031458|156188311|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
48545542|NCT02031458|156188309|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
48545543|NCT02031458|156188310|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
48545544|NCT02031458|156188311|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
48545545|NCT02031458|156188309|FG000|Baseline to May 8, 2015|Death|36|||
48545546|NCT02031458|156188310|FG001|Baseline to May 8, 2015|Death|87|||
48545547|NCT02031458|156188311|FG002|Baseline to May 8, 2015|Death|100|||
48545548|NCT02031458|156188309|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
48545549|NCT02031458|156188310|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
48545550|NCT02031458|156188311|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
48545551|NCT02031458|156188309|FG000|Baseline to May 8, 2015|Physician Decision|0|||
48545552|NCT02031458|156188310|FG001|Baseline to May 8, 2015|Physician Decision|1|||
48545553|NCT02031458|156188311|FG002|Baseline to May 8, 2015|Physician Decision|0|||
48545554|NCT02031458|156188309|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
48545555|NCT02031458|156188310|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
48545556|NCT02031458|156188311|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
48610793|NCT01963611|156433545|FG003|Overall Study|Protocol Violation|1|||
48610794|NCT01963611|156433546|FG004|Overall Study|Protocol Violation|0|||
48610795|NCT01963611|156433542|FG000|Overall Study|Lack of Efficacy|0|||
48610796|NCT01963611|156433543|FG001|Overall Study|Lack of Efficacy|0|||
48545557|NCT02031458|156188309|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
48610797|NCT01963611|156433544|FG002|Overall Study|Lack of Efficacy|0|||
48610798|NCT01963611|156433545|FG003|Overall Study|Lack of Efficacy|1|||
48610799|NCT01963611|156433546|FG004|Overall Study|Lack of Efficacy|0|||
48610800|NCT01963611|156433542|FG000|Overall Study|Withdrawal by Subject|3|||
48610801|NCT01963611|156433543|FG001|Overall Study|Withdrawal by Subject|2|||
48610802|NCT01963611|156433544|FG002|Overall Study|Withdrawal by Subject|1|||
48610803|NCT01963611|156433545|FG003|Overall Study|Withdrawal by Subject|1|||
48610804|NCT01963611|156433546|FG004|Overall Study|Withdrawal by Subject|3|||
48610805|NCT01963611|156433542|FG000|Overall Study|Other|47|||
48610806|NCT01963611|156433543|FG001|Overall Study|Other|46|||
48610807|NCT01963611|156433544|FG002|Overall Study|Other|48|||
48610808|NCT01963611|156433545|FG003|Overall Study|Other|45|||
48610809|NCT01963611|156433546|FG004|Overall Study|Other|45|||
48610810|NCT02058095|156433547|FG000|Overall Study|Adverse Event|1|||
48610811|NCT02058095|156433548|FG001|Overall Study|Adverse Event|0|||
48610812|NCT00958074|156433554|FG000|Overall Study|Withdrawal by Subject|0|||
48610813|NCT00958074|156433555|FG001|Overall Study|Withdrawal by Subject|1|||
48610814|NCT02842866|156433558|FG000|Overall Study|Serious Adverse Event|0|||
48610815|NCT02842866|156433559|FG001|Overall Study|Serious Adverse Event|1|||
48610816|NCT02842866|156433558|FG000|Overall Study|Protocol Violation|4|||
48610817|NCT02842866|156433559|FG001|Overall Study|Protocol Violation|2|||
48610818|NCT02842866|156433558|FG000|Overall Study|Lost to Follow-up|2|||
48610819|NCT02842866|156433559|FG001|Overall Study|Lost to Follow-up|0|||
48610820|NCT02842866|156433558|FG000|Overall Study|Withdrawal by Subject|1|||
48610821|NCT02842866|156433559|FG001|Overall Study|Withdrawal by Subject|0|||
48610822|NCT02300610|156433560|FG000|Overall Study|Withdrawal by Subject|1|||
48610823|NCT02300610|156433561|FG001|Overall Study|Withdrawal by Subject|0|||
48610824|NCT02300610|156433562|FG002|Overall Study|Withdrawal by Subject|1|||
48610825|NCT00577408|156433563|FG000|Overall Study|Stopped attending study visits|9|||
48610826|NCT00577408|156433564|FG001|Overall Study|Stopped attending study visits|11|||
48610827|NCT00577408|156433563|FG000|Overall Study|Continued opioid use|3|||
48610828|NCT00577408|156433564|FG001|Overall Study|Continued opioid use|2|||
48610829|NCT00577408|156433563|FG000|Overall Study|Non-compliance with study meds|0|||
48610830|NCT00577408|156433564|FG001|Overall Study|Non-compliance with study meds|3|||
48610831|NCT00577408|156433563|FG000|Overall Study|Refused Oral Naltrexone|0|||
48610832|NCT00577408|156433564|FG001|Overall Study|Refused Oral Naltrexone|1|||
48610833|NCT00577408|156433563|FG000|Overall Study|Moved out of state|0|||
48610834|NCT00577408|156433564|FG001|Overall Study|Moved out of state|1|||
48610835|NCT00577408|156433563|FG000|Overall Study|Scheduling Issues|0|||
48610836|NCT00577408|156433564|FG001|Overall Study|Scheduling Issues|3|||
48610837|NCT00577408|156433563|FG000|Overall Study|Death|0|||
48610838|NCT00577408|156433564|FG001|Overall Study|Death|1|||
48610839|NCT00577408|156433563|FG000|Overall Study|Psychiatric hospitalization|0|||
48610840|NCT00577408|156433564|FG001|Overall Study|Psychiatric hospitalization|1|||
48610841|NCT03743194|156433565|FG000|Overall Study|Protocol Violation|7|||
48610842|NCT03743194|156433566|FG001|Overall Study|Protocol Violation|7|||
48610843|NCT03743194|156433565|FG000|Overall Study|Physician Decision|0|||
48610844|NCT03743194|156433566|FG001|Overall Study|Physician Decision|2|||
48610845|NCT02030600|156433568|FG000|Treatment Period 1|Adverse Event|5|||
48610846|NCT02030600|156433569|FG001|Treatment Period 1|Adverse Event|7|||
48610847|NCT02030600|156433568|FG000|Treatment Period 1|Lack of Efficacy|0|||
48610848|NCT02030600|156433569|FG001|Treatment Period 1|Lack of Efficacy|1|||
48610849|NCT02030600|156433568|FG000|Treatment Period 1|Lost to Follow-up|11|||
48610850|NCT02030600|156433569|FG001|Treatment Period 1|Lost to Follow-up|3|||
48610851|NCT02030600|156433568|FG000|Treatment Period 1|Protocol Violation|22|||
48610852|NCT02030600|156433569|FG001|Treatment Period 1|Protocol Violation|17|||
48610853|NCT02030600|156433568|FG000|Treatment Period 1|Withdrawal by Subject|13|||
48610854|NCT02030600|156433569|FG001|Treatment Period 1|Withdrawal by Subject|17|||
48610855|NCT02030600|156433568|FG000|Treatment Period 1|Casebook Unsigned|1|||
48545558|NCT02031458|156188310|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
48610856|NCT02030600|156433569|FG001|Treatment Period 1|Casebook Unsigned|0|||
48545559|NCT02031458|156188311|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
48545560|NCT02031458|156188309|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
48545561|NCT02031458|156188310|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
48545562|NCT02031458|156188311|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
48545563|NCT02031458|156188309|FG000|Baseline to May 8, 2015|On Treatment|43|||
48545564|NCT02031458|156188310|FG001|Baseline to May 8, 2015|On Treatment|81|||
48545565|NCT02031458|156188311|FG002|Baseline to May 8, 2015|On Treatment|73|||
48545566|NCT02031458|156188309|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
48545567|NCT02031458|156188310|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
48545568|NCT02031458|156188311|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
48545569|NCT04305587|156188314|FG000|Overall Study|Withdrawal by Subject|0|||
48610857|NCT02030600|156433568|FG000|Treatment Period 1|Unclassified|1|||
48610858|NCT02030600|156433569|FG001|Treatment Period 1|Unclassified|0|||
48610859|NCT02030600|156433568|FG000|Treatment Period 2|Adverse Event|4|||
48610860|NCT02030600|156433569|FG001|Treatment Period 2|Adverse Event|4|||
48545570|NCT04305587|156188315|FG001|Overall Study|Withdrawal by Subject|0|||
48545571|NCT04305587|156188316|FG002|Overall Study|Withdrawal by Subject|0|||
48610861|NCT02030600|156433568|FG000|Treatment Period 2|Lack of Efficacy|2|||
48610862|NCT02030600|156433569|FG001|Treatment Period 2|Lack of Efficacy|1|||
48610863|NCT02030600|156433568|FG000|Treatment Period 2|Lost to Follow-up|4|||
48610864|NCT02030600|156433569|FG001|Treatment Period 2|Lost to Follow-up|2|||
48610865|NCT02030600|156433568|FG000|Treatment Period 2|Protocol Violation|1|||
48610866|NCT02030600|156433569|FG001|Treatment Period 2|Protocol Violation|2|||
48610867|NCT02030600|156433568|FG000|Treatment Period 2|Withdrawal by Subject|13|||
48610868|NCT02030600|156433569|FG001|Treatment Period 2|Withdrawal by Subject|9|||
48610869|NCT02030600|156433568|FG000|Treatment Period 2|Unclassified|1|||
48610870|NCT02030600|156433569|FG001|Treatment Period 2|Unclassified|0|||
48610871|NCT01541748|156433571|FG000|Overall Study|Lost to Follow-up|17|||
48610872|NCT01541748|156433571|FG000|Overall Study|Moved out of state|1|||
48610873|NCT01541748|156433571|FG000|Overall Study|Withdrawal by Subject|7|||
48610874|NCT01541748|156433571|FG000|Overall Study|Screen failure|5|||
48610875|NCT01541748|156433571|FG000|Overall Study|Did not receive study device|1|||
48545572|NCT04305587|156188317|FG003|Overall Study|Withdrawal by Subject|1|||
48545573|NCT04305587|156188318|FG004|Overall Study|Withdrawal by Subject|0|||
48545574|NCT04305587|156188319|FG005|Overall Study|Withdrawal by Subject|0|||
48545575|NCT04305587|156188320|FG006|Overall Study|Withdrawal by Subject|0|||
48545576|NCT04305587|156188321|FG007|Overall Study|Withdrawal by Subject|0|||
48545577|NCT04305587|156188322|FG008|Overall Study|Withdrawal by Subject|0|||
48545578|NCT01523457|156188324|FG000|Overall Study|Withdrawal by Subject|7|||
48545579|NCT01523457|156188325|FG001|Overall Study|Withdrawal by Subject|2|||
48545580|NCT01367665|156188326|FG000|Overall Study|Death|102|||
48545581|NCT01367665|156188327|FG001|Overall Study|Death|19|||
48545582|NCT01367665|156188326|FG000|Overall Study|Lost to Follow-up|222|||
48545583|NCT01367665|156188327|FG001|Overall Study|Lost to Follow-up|22|||
48545584|NCT01367665|156188326|FG000|Overall Study|Not Done|118|||
48545585|NCT01367665|156188327|FG001|Overall Study|Not Done|14|||
48545586|NCT02752906|156188328|FG000|Overall Study|Protocol Violation|2|||
48545587|NCT02752906|156188329|FG001|Overall Study|Protocol Violation|1|||
48545588|NCT02752906|156188328|FG000|Overall Study|Withdrawal by Subject|2|||
48545589|NCT02752906|156188329|FG001|Overall Study|Withdrawal by Subject|2|||
48545590|NCT02752906|156188328|FG000|Overall Study|Lost to Follow-up|3|||
48545591|NCT02752906|156188329|FG001|Overall Study|Lost to Follow-up|2|||
48545592|NCT00609518|156188330|FG000|Overall Study|Death from Study Disease|32|||
48545593|NCT00609518|156188331|FG001|Overall Study|Death from Study Disease|32|||
48545594|NCT00609518|156188330|FG000|Overall Study|Withdrawal by Subject|5|||
48545595|NCT00609518|156188331|FG001|Overall Study|Withdrawal by Subject|3|||
48545596|NCT00609518|156188330|FG000|Overall Study|Lost to Follow-up|3|||
48545597|NCT00609518|156188331|FG001|Overall Study|Lost to Follow-up|0|||
48545598|NCT00609518|156188330|FG000|Overall Study|Physician Decision|1|||
48545599|NCT00609518|156188331|FG001|Overall Study|Physician Decision|3|||
48545600|NCT00609518|156188330|FG000|Overall Study|Death from Adverse Event|2|||
48545601|NCT00609518|156188331|FG001|Overall Study|Death from Adverse Event|2|||
48545602|NCT01687478|156188332|FG000|Overall Study|Adverse Event|3|||
48545603|NCT01687478|156188333|FG001|Overall Study|Adverse Event|10|||
48545604|NCT01687478|156188332|FG000|Overall Study|Lost to Follow-up|1|||
48545605|NCT01687478|156188333|FG001|Overall Study|Lost to Follow-up|3|||
48545606|NCT01687478|156188332|FG000|Overall Study|Protocol Violation|0|||
48545607|NCT01687478|156188333|FG001|Overall Study|Protocol Violation|2|||
48545608|NCT01687478|156188332|FG000|Overall Study|Withdrawal by Subject|21|||
48610876|NCT02111083|156433573|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
48610877|NCT02111083|156433574|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
48610878|NCT01259245|156433575|FG000|Overall Study|Withdrawal by Subject|27|||
48610879|NCT01259245|156433576|FG001|Overall Study|Withdrawal by Subject|24|||
48610880|NCT01259245|156433575|FG000|Overall Study|Death|1|||
48610881|NCT01259245|156433576|FG001|Overall Study|Death|2|||
48610882|NCT02832037|156433577|FG000|Overall Study|Administrative reasons|0|||
48610883|NCT02832037|156433578|FG001|Overall Study|Administrative reasons|0|||
48610884|NCT02832037|156433579|FG002|Overall Study|Administrative reasons|1|||
48610885|NCT02832037|156433580|FG003|Overall Study|Administrative reasons|0|||
48610886|NCT02832037|156433581|FG004|Overall Study|Administrative reasons|0|||
48610887|NCT02832037|156433577|FG000|Overall Study|Protocol Violation|3|||
48610888|NCT02832037|156433578|FG001|Overall Study|Protocol Violation|0|||
48610889|NCT02832037|156433579|FG002|Overall Study|Protocol Violation|4|||
48610890|NCT02832037|156433580|FG003|Overall Study|Protocol Violation|1|||
48610891|NCT02832037|156433581|FG004|Overall Study|Protocol Violation|2|||
48610892|NCT02832037|156433577|FG000|Overall Study|Lost to Follow-up|2|||
48610893|NCT02832037|156433578|FG001|Overall Study|Lost to Follow-up|0|||
48610894|NCT02832037|156433579|FG002|Overall Study|Lost to Follow-up|3|||
48610895|NCT02832037|156433580|FG003|Overall Study|Lost to Follow-up|0|||
48610896|NCT02832037|156433581|FG004|Overall Study|Lost to Follow-up|5|||
48610897|NCT02832037|156433577|FG000|Overall Study|Withdrawal by Subject|9|||
48610898|NCT02832037|156433578|FG001|Overall Study|Withdrawal by Subject|8|||
48610899|NCT02832037|156433579|FG002|Overall Study|Withdrawal by Subject|0|||
48610900|NCT02832037|156433580|FG003|Overall Study|Withdrawal by Subject|4|||
48610901|NCT02832037|156433581|FG004|Overall Study|Withdrawal by Subject|8|||
48610902|NCT02832037|156433577|FG000|Overall Study|Adverse Event|5|||
48610903|NCT02832037|156433578|FG001|Overall Study|Adverse Event|4|||
48610904|NCT02832037|156433579|FG002|Overall Study|Adverse Event|0|||
48610905|NCT02832037|156433580|FG003|Overall Study|Adverse Event|2|||
48610906|NCT02832037|156433581|FG004|Overall Study|Adverse Event|4|||
48610907|NCT01369433|156433582|FG000|Overall Study|Adverse Event|31|||
48610908|NCT01369433|156433583|FG001|Overall Study|Adverse Event|1|||
48610909|NCT01369433|156433582|FG000|Overall Study|Required significant surgical procedure|1|||
48610910|NCT01369433|156433583|FG001|Overall Study|Required significant surgical procedure|0|||
48610911|NCT01369433|156433582|FG000|Overall Study|Non-compliance|1|||
48610912|NCT01369433|156433583|FG001|Overall Study|Non-compliance|0|||
48610913|NCT01369433|156433582|FG000|Overall Study|Withdrawal by Subject|5|||
48610914|NCT01369433|156433583|FG001|Overall Study|Withdrawal by Subject|2|||
48610915|NCT01369433|156433582|FG000|Overall Study|Study terminated by Sponsor|67|||
48610916|NCT01369433|156433583|FG001|Overall Study|Study terminated by Sponsor|0|||
48545609|NCT01687478|156188333|FG001|Overall Study|Withdrawal by Subject|19|||
48545610|NCT01687478|156188332|FG000|Overall Study|Physician Decision|1|||
48545611|NCT01687478|156188333|FG001|Overall Study|Physician Decision|3|||
48545612|NCT01687478|156188332|FG000|Overall Study|Entry Criteria Not Met|6|||
48545613|NCT01687478|156188333|FG001|Overall Study|Entry Criteria Not Met|2|||
48545614|NCT02049450|156188336|FG000|Overall Study|Adverse Event|2|||
48545615|NCT02049450|156188336|FG000|Overall Study|Withdrawal by Subject|1|||
48545616|NCT02049450|156188336|FG000|Overall Study|Patients/guardian decision|1|||
48545617|NCT01783548|156188337|FG000|Overall Study|Adverse Event|8|||
48545618|NCT01783548|156188338|FG001|Overall Study|Adverse Event|4|||
48545619|NCT01783548|156188337|FG000|Overall Study|Withdrawal by Subject|11|||
48545620|NCT01783548|156188338|FG001|Overall Study|Withdrawal by Subject|8|||
48545621|NCT01783548|156188337|FG000|Overall Study|Non-compliance|4|||
48545622|NCT01783548|156188338|FG001|Overall Study|Non-compliance|0|||
48610917|NCT01369433|156433582|FG000|Overall Study|Lost to Follow-up|1|||
48610918|NCT01369433|156433583|FG001|Overall Study|Lost to Follow-up|0|||
48610919|NCT01369433|156433582|FG000|Overall Study|Death|5|||
48610920|NCT01369433|156433583|FG001|Overall Study|Death|0|||
48610921|NCT01369433|156433582|FG000|Overall Study|Investigator discretion|6|||
48610922|NCT01369433|156433583|FG001|Overall Study|Investigator discretion|1|||
48610923|NCT01369433|156433582|FG000|Overall Study|Progressive Disease|92|||
48610924|NCT01369433|156433583|FG001|Overall Study|Progressive Disease|12|||
48610925|NCT00963235|156433584|FG000|Overall Study|Withdrawal by Subject|22|||
48610926|NCT00963235|156433584|FG000|Overall Study|Lost to Follow-up|14|||
48610927|NCT00963235|156433584|FG000|Overall Study|Failed to return|9|||
48610928|NCT00963235|156433584|FG000|Overall Study|Protocol Violation|7|||
48610929|NCT00963235|156433584|FG000|Overall Study|Adverse Event|5|||
48610930|NCT00963235|156433584|FG000|Overall Study|Physician Decision|2|||
48610931|NCT00963235|156433584|FG000|Overall Study|Other|1|||
48610932|NCT01697579|156433585|FG000|Base Study-Cycle 1|Adverse Event|1|||
48610933|NCT01697579|156433586|FG001|Base Study-Cycle 1|Adverse Event|0|||
48610934|NCT01697579|156433587|FG002|Base Study-Cycle 1|Adverse Event|0|||
48610935|NCT01697579|156433588|FG003|Base Study-Cycle 1|Adverse Event|0|||
48610936|NCT01697579|156433589|FG004|Base Study-Cycle 1|Adverse Event|0|||
48610937|NCT01697579|156433590|FG005|Base Study-Cycle 1|Adverse Event|0|||
48610938|NCT01697579|156433591|FG006|Base Study-Cycle 1|Adverse Event|0|||
48610939|NCT01697579|156433585|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
48610940|NCT01697579|156433586|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
48610941|NCT01697579|156433587|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
48610942|NCT01697579|156433588|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
48610943|NCT01697579|156433589|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
48610944|NCT01697579|156433590|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
48610945|NCT01697579|156433591|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
48610946|NCT01697579|156433585|FG000|Base Study-Cycle 1|Protocol Violation|0|||
48610947|NCT01697579|156433586|FG001|Base Study-Cycle 1|Protocol Violation|0|||
48610948|NCT01697579|156433587|FG002|Base Study-Cycle 1|Protocol Violation|0|||
48610949|NCT01697579|156433588|FG003|Base Study-Cycle 1|Protocol Violation|0|||
48610950|NCT01697579|156433589|FG004|Base Study-Cycle 1|Protocol Violation|3|||
48610951|NCT01697579|156433590|FG005|Base Study-Cycle 1|Protocol Violation|0|||
48610952|NCT01697579|156433591|FG006|Base Study-Cycle 1|Protocol Violation|0|||
48610953|NCT01697579|156433585|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
48610954|NCT01697579|156433586|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
48610955|NCT01697579|156433587|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
48610956|NCT01697579|156433588|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
48610957|NCT01697579|156433589|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
48610958|NCT01697579|156433590|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
48610959|NCT01697579|156433591|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
48610960|NCT01697579|156433585|FG000|Base Study-Cycle 1|Technical Problems|0|||
48610961|NCT01697579|156433586|FG001|Base Study-Cycle 1|Technical Problems|0|||
48610962|NCT01697579|156433587|FG002|Base Study-Cycle 1|Technical Problems|1|||
48610963|NCT01697579|156433588|FG003|Base Study-Cycle 1|Technical Problems|1|||
48610964|NCT01697579|156433589|FG004|Base Study-Cycle 1|Technical Problems|0|||
48610965|NCT01697579|156433590|FG005|Base Study-Cycle 1|Technical Problems|0|||
48545623|NCT01783548|156188337|FG000|Overall Study|Protocol Violation|2|||
48545624|NCT01783548|156188338|FG001|Overall Study|Protocol Violation|2|||
48545625|NCT01783548|156188337|FG000|Overall Study|Lost to Follow-up|8|||
48545626|NCT01783548|156188338|FG001|Overall Study|Lost to Follow-up|3|||
48545627|NCT01783548|156188337|FG000|Overall Study|Lack of Efficacy|1|||
48545628|NCT01783548|156188338|FG001|Overall Study|Lack of Efficacy|1|||
48545629|NCT03493386|156188341|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48545630|NCT03493386|156188342|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
48545631|NCT03493386|156188343|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48545632|NCT03493386|156188344|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48545633|NCT03246126|156188345|FG000|Overall Study|Withdrawal by Subject|0|||
48545634|NCT03246126|156188346|FG001|Overall Study|Withdrawal by Subject|1|||
48545635|NCT01119508|156188349|FG000|Overall Study|Adverse Event|56|||
48545636|NCT01119508|156188349|FG000|Overall Study|Withdrawal by Subject|2|||
48545637|NCT01119508|156188349|FG000|Overall Study|Died before tumor response evaluation|1|||
48545638|NCT03151408|156188350|FG000|Overall Study|Adverse Event|24|||
48545639|NCT03151408|156188351|FG001|Overall Study|Adverse Event|23|||
48545640|NCT03151408|156188350|FG000|Overall Study|Death|46|||
48545641|NCT03151408|156188351|FG001|Overall Study|Death|26|||
48545642|NCT03151408|156188350|FG000|Overall Study|Physician Decision|13|||
48545643|NCT03151408|156188351|FG001|Overall Study|Physician Decision|19|||
48545644|NCT03151408|156188350|FG000|Overall Study|Withdrawal by Subject|16|||
48545645|NCT03151408|156188351|FG001|Overall Study|Withdrawal by Subject|20|||
48545646|NCT03151408|156188350|FG000|Overall Study|Progressive disease|45|||
48610966|NCT01697579|156433591|FG006|Base Study-Cycle 1|Technical Problems|0|||
48610967|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Death|0|||
48610968|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Death|0|||
48610969|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Death|0|||
48610970|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Death|0|||
48610971|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Death|0|||
48610972|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Death|0|||
48610973|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Death|2|||
48610974|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48610975|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48610976|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48610977|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48610978|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48610979|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
48610980|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
48610981|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
48610982|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
48610983|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
48610984|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
48610985|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
48610986|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
48610987|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
48610988|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
48610989|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
48610990|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
48610991|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
48610992|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
48610993|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
48545647|NCT03151408|156188351|FG001|Overall Study|Progressive disease|61|||
48545648|NCT03151408|156188350|FG000|Overall Study|non-compliance by patient|1|||
48610994|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
48610995|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
48610996|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
48610997|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
48610998|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
48610999|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
48611000|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
48611001|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
48611002|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
48611003|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
48611004|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
48611005|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
48611006|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
48611007|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
48611008|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
48611009|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
48545649|NCT03151408|156188351|FG001|Overall Study|non-compliance by patient|0|||
48545650|NCT03151408|156188350|FG000|Overall Study|other reasons|56|||
48545651|NCT03151408|156188351|FG001|Overall Study|other reasons|52|||
48545652|NCT03151408|156188350|FG000|Overall Study|randomized and not treated|2|||
48545653|NCT03151408|156188351|FG001|Overall Study|randomized and not treated|2|||
48545654|NCT00265395|156188352|FG000|Overall Study|Adverse Event|3|||
48545655|NCT00265395|156188353|FG001|Overall Study|Adverse Event|6|||
48545656|NCT00265395|156188352|FG000|Overall Study|Lost to Follow-up|2|||
48545657|NCT00265395|156188353|FG001|Overall Study|Lost to Follow-up|1|||
48611010|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
48611011|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
48611012|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
48611013|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
48611014|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
48611015|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
48611016|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
48611017|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
48611018|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
48611019|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
48611020|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
48611021|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
48545658|NCT00265395|156188352|FG000|Overall Study|Withdrawal by Subject|1|||
48545659|NCT00265395|156188353|FG001|Overall Study|Withdrawal by Subject|6|||
48545660|NCT00265395|156188352|FG000|Overall Study|Protocol Violation|2|||
48545661|NCT00265395|156188353|FG001|Overall Study|Protocol Violation|2|||
48545662|NCT00265395|156188352|FG000|Overall Study|Lack of Efficacy|0|||
48545663|NCT00265395|156188353|FG001|Overall Study|Lack of Efficacy|1|||
48545664|NCT00265395|156188352|FG000|Overall Study|Administrative|0|||
48545665|NCT00265395|156188353|FG001|Overall Study|Administrative|1|||
48545666|NCT02315196|156188358|FG000|Overall Study|Withdrew consent|9|||
48545667|NCT00117325|156188368|FG000|Overall Study|Adverse Event|3|||
48545668|NCT00117325|156188369|FG001|Overall Study|Adverse Event|3|||
48545669|NCT00117325|156188368|FG000|Overall Study|Lost to Follow-up|1|||
48545670|NCT00117325|156188369|FG001|Overall Study|Lost to Follow-up|1|||
48611022|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
48611023|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
48611024|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
48611025|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
48611026|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
48611027|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
48611028|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
48611029|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
48611030|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
48611031|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
48611032|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
48611033|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
48611034|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
48545671|NCT00117325|156188368|FG000|Overall Study|Protocol Violation|2|||
48545672|NCT00117325|156188369|FG001|Overall Study|Protocol Violation|3|||
48545673|NCT00117325|156188368|FG000|Overall Study|Withdrawal by Subject|3|||
48545674|NCT00117325|156188369|FG001|Overall Study|Withdrawal by Subject|2|||
48545675|NCT00117325|156188368|FG000|Overall Study|Lack of Efficacy|1|||
48545676|NCT00117325|156188369|FG001|Overall Study|Lack of Efficacy|0|||
48545677|NCT00117325|156188368|FG000|Overall Study|Use of prohibited medicine|1|||
48545678|NCT00117325|156188369|FG001|Overall Study|Use of prohibited medicine|2|||
48545679|NCT00117325|156188368|FG000|Overall Study|Early termination|1|||
48545680|NCT00117325|156188369|FG001|Overall Study|Early termination|1|||
48545681|NCT00117325|156188368|FG000|Overall Study|Admisnitrative|1|||
48545682|NCT00117325|156188369|FG001|Overall Study|Admisnitrative|0|||
48545683|NCT03262038|156188370|FG000|Overall Study|Withdrawal by Subject|0|||
48545684|NCT03262038|156188371|FG001|Overall Study|Withdrawal by Subject|1|||
48545685|NCT02085135|156188372|FG000|Overall Study|Adverse Event|4|||
48545686|NCT02085135|156188373|FG001|Overall Study|Adverse Event|7|||
48545687|NCT02085135|156188372|FG000|Overall Study|Lost to Follow-up|2|||
48545688|NCT02085135|156188373|FG001|Overall Study|Lost to Follow-up|2|||
48545689|NCT02085135|156188372|FG000|Overall Study|Withdrawal by Subject|3|||
48545690|NCT02085135|156188373|FG001|Overall Study|Withdrawal by Subject|0|||
48545691|NCT02085135|156188372|FG000|Overall Study|Lack of Efficacy|2|||
48545692|NCT02085135|156188373|FG001|Overall Study|Lack of Efficacy|0|||
48545693|NCT01468818|156188377|FG000|Overall Study|Death during treatment|2|||
48545694|NCT01156142|156188378|FG000|Overall Study|Withdrawal by Subject|8|||
48545695|NCT01156142|156188379|FG001|Overall Study|Withdrawal by Subject|6|||
48611035|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
48545696|NCT01156142|156188378|FG000|Overall Study|Ineligible|0|||
48545697|NCT01156142|156188379|FG001|Overall Study|Ineligible|1|||
48545698|NCT01330459|156188383|FG000|Overall Study|Physician Decision|0|||
48611036|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
48611037|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
48611038|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
48611039|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
48611040|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
48611041|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
48611042|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
48611043|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
48545699|NCT01330459|156188384|FG001|Overall Study|Physician Decision|2|||
48545700|NCT04091659|156188385|FG000|Overall Study|Protocol Violation|3|||
48545701|NCT04091659|156188386|FG001|Overall Study|Protocol Violation|0|||
48611044|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
48611045|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
48611046|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
48545702|NCT04091659|156188385|FG000|Overall Study|Lost to Follow-up|0|||
48545703|NCT04091659|156188386|FG001|Overall Study|Lost to Follow-up|1|||
48545704|NCT02787408|156188392|FG000|Overall Study|Death|16|||
48545705|NCT02787408|156188392|FG000|Overall Study|Withdrawal by Subject|1|||
48545706|NCT02787408|156188392|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
48545707|NCT01341782|156188393|FG000|Overall Study|Adverse Event|1|||
48545708|NCT01341782|156188394|FG001|Overall Study|Adverse Event|1|||
48545709|NCT01341782|156188393|FG000|Overall Study|Withdrawal by Subject|6|||
48545710|NCT01341782|156188394|FG001|Overall Study|Withdrawal by Subject|5|||
48545711|NCT01341782|156188393|FG000|Overall Study|Missed 3 consecutive doses|0|||
48545712|NCT01341782|156188394|FG001|Overall Study|Missed 3 consecutive doses|4|||
48545713|NCT01341782|156188393|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
48545714|NCT01341782|156188394|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
48545715|NCT01341782|156188393|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
48545716|NCT01341782|156188394|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
48545717|NCT01341782|156188393|FG000|Overall Study|Other|5|||
48545718|NCT01341782|156188394|FG001|Overall Study|Other|0|||
48545719|NCT00895414|156188402|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
48545720|NCT00895414|156188403|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
48545721|NCT00895414|156188402|FG000|First Intervention (14 Days)|Physician Decision|0|||
48545722|NCT00895414|156188403|FG001|First Intervention (14 Days)|Physician Decision|1|||
48545723|NCT02348723|156188404|FG000|Overall Study|No ablation|21|||
48545724|NCT02348723|156188405|FG001|Overall Study|No ablation|20|||
48545725|NCT02348723|156188404|FG000|Overall Study|Non-compliant with Protocol|1|||
48545726|NCT02348723|156188405|FG001|Overall Study|Non-compliant with Protocol|0|||
48545727|NCT02348723|156188404|FG000|Overall Study|Lost to Follow-up|1|||
48545728|NCT02348723|156188405|FG001|Overall Study|Lost to Follow-up|1|||
48545729|NCT02348723|156188404|FG000|Overall Study|Consent withdrawn|1|||
48545730|NCT02348723|156188405|FG001|Overall Study|Consent withdrawn|3|||
48545731|NCT02348723|156188404|FG000|Overall Study|Reason other than specified|1|||
48545732|NCT02348723|156188405|FG001|Overall Study|Reason other than specified|1|||
48545733|NCT02348723|156188404|FG000|Overall Study|Adverse Event|3|||
48545734|NCT02348723|156188405|FG001|Overall Study|Adverse Event|1|||
48545735|NCT00620555|156188406|FG000|Overall Study|Adverse Event|4|||
48545736|NCT00620555|156188406|FG000|Overall Study|Protocol Violation|2|||
48545737|NCT00620555|156188406|FG000|Overall Study|Lack of Efficacy|12|||
48545738|NCT00620555|156188406|FG000|Overall Study|Withdrawal by Subject|1|||
48545739|NCT00620555|156188406|FG000|Overall Study|Choice of other treatment|1|||
48545740|NCT00620555|156188406|FG000|Overall Study|Visit failure against planned|1|||
48545741|NCT02036775|156188407|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
48545742|NCT02036775|156188408|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
48545743|NCT02036775|156188409|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
48545744|NCT02036775|156188410|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
48545745|NCT02036775|156188411|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
48545746|NCT02036775|156188412|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
48545747|NCT01268501|156188413|FG000|Overall Study|Lost to Follow-up|1|||
48545748|NCT01268501|156188413|FG000|Overall Study|Withdrawal by Subject|3|||
48545749|NCT01268501|156188413|FG000|Overall Study|Unacceptable Subjective Vision|3|||
48545750|NCT01268501|156188413|FG000|Overall Study|Handling Difficulties|2|||
48545751|NCT01140503|156188414|FG000|Overall Study|Withdrawal by Subject|1|||
48545752|NCT00724048|156188421|FG000|Overall Study|Adverse Event|1|||
48545753|NCT00724048|156188422|FG001|Overall Study|Adverse Event|1|||
48545754|NCT00724048|156188423|FG002|Overall Study|Adverse Event|1|||
48545755|NCT00724048|156188424|FG003|Overall Study|Adverse Event|0|||
48545756|NCT00724048|156188421|FG000|Overall Study|Lost to Follow-up|0|||
48545757|NCT00724048|156188422|FG001|Overall Study|Lost to Follow-up|1|||
48545758|NCT00724048|156188423|FG002|Overall Study|Lost to Follow-up|0|||
48545759|NCT00724048|156188424|FG003|Overall Study|Lost to Follow-up|0|||
48545760|NCT00724048|156188421|FG000|Overall Study|Withdrawal by Subject|1|||
48545761|NCT00724048|156188422|FG001|Overall Study|Withdrawal by Subject|2|||
48545762|NCT00724048|156188423|FG002|Overall Study|Withdrawal by Subject|1|||
48545763|NCT00724048|156188424|FG003|Overall Study|Withdrawal by Subject|2|||
48545764|NCT00724048|156188421|FG000|Overall Study|Investigator decision|0|||
48545765|NCT00724048|156188422|FG001|Overall Study|Investigator decision|0|||
48545766|NCT00724048|156188423|FG002|Overall Study|Investigator decision|1|||
48545767|NCT00724048|156188424|FG003|Overall Study|Investigator decision|0|||
48545768|NCT00724048|156188421|FG000|Overall Study|Did not tolerate study drug|0|||
48545769|NCT00724048|156188422|FG001|Overall Study|Did not tolerate study drug|0|||
48545770|NCT00724048|156188423|FG002|Overall Study|Did not tolerate study drug|0|||
48545771|NCT00724048|156188424|FG003|Overall Study|Did not tolerate study drug|1|||
48545772|NCT00724048|156188421|FG000|Overall Study|Other than specified|1|||
48545773|NCT00724048|156188422|FG001|Overall Study|Other than specified|1|||
48545774|NCT00724048|156188423|FG002|Overall Study|Other than specified|0|||
48545775|NCT00724048|156188424|FG003|Overall Study|Other than specified|0|||
48545776|NCT02087189|156188425|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
48545777|NCT02257385|156188426|FG000|Overall Study|Adverse Event|12|||
48545778|NCT02257385|156188427|FG001|Overall Study|Adverse Event|8|||
48545779|NCT02257385|156188426|FG000|Overall Study|Lack of Efficacy|1|||
48611047|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
48611048|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
48545780|NCT02257385|156188427|FG001|Overall Study|Lack of Efficacy|2|||
48611049|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
48611050|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
48611051|NCT01697579|156433585|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
48611052|NCT01697579|156433586|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
48611053|NCT01697579|156433587|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
48611054|NCT01697579|156433588|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
48611055|NCT01697579|156433589|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
48611056|NCT01697579|156433590|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
48611057|NCT01697579|156433591|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
48611058|NCT03034967|156433592|FG000|Overall Study|Withdrawal by Subject|9|||
48611059|NCT03034967|156433593|FG001|Overall Study|Withdrawal by Subject|2|||
48611060|NCT03034967|156433594|FG002|Overall Study|Withdrawal by Subject|6|||
48611061|NCT03034967|156433595|FG003|Overall Study|Withdrawal by Subject|6|||
48611062|NCT03034967|156433596|FG004|Overall Study|Withdrawal by Subject|9|||
48611063|NCT03034967|156433597|FG005|Overall Study|Withdrawal by Subject|2|||
48611064|NCT03034967|156433592|FG000|Overall Study|Physician Decision|1|||
48611065|NCT03034967|156433593|FG001|Overall Study|Physician Decision|0|||
48611066|NCT03034967|156433594|FG002|Overall Study|Physician Decision|1|||
48611067|NCT03034967|156433595|FG003|Overall Study|Physician Decision|1|||
48611068|NCT03034967|156433596|FG004|Overall Study|Physician Decision|1|||
48611069|NCT03034967|156433597|FG005|Overall Study|Physician Decision|0|||
48611070|NCT03034967|156433592|FG000|Overall Study|Lost to Follow-up|0|||
48611071|NCT03034967|156433593|FG001|Overall Study|Lost to Follow-up|0|||
48611072|NCT03034967|156433594|FG002|Overall Study|Lost to Follow-up|0|||
48611073|NCT03034967|156433595|FG003|Overall Study|Lost to Follow-up|1|||
48611074|NCT03034967|156433596|FG004|Overall Study|Lost to Follow-up|0|||
48611075|NCT03034967|156433597|FG005|Overall Study|Lost to Follow-up|2|||
48611076|NCT03034967|156433592|FG000|Overall Study|Liver function test abnormality|0|||
48545781|NCT02257385|156188426|FG000|Overall Study|Protocol Violation|5|||
48545782|NCT02257385|156188427|FG001|Overall Study|Protocol Violation|7|||
48545783|NCT02257385|156188426|FG000|Overall Study|Lost to Follow-up|0|||
48611077|NCT03034967|156433593|FG001|Overall Study|Liver function test abnormality|0|||
48611078|NCT03034967|156433594|FG002|Overall Study|Liver function test abnormality|1|||
48611079|NCT03034967|156433595|FG003|Overall Study|Liver function test abnormality|0|||
48611080|NCT03034967|156433596|FG004|Overall Study|Liver function test abnormality|0|||
48611081|NCT03034967|156433597|FG005|Overall Study|Liver function test abnormality|0|||
48611082|NCT03034967|156433592|FG000|Overall Study|Protocol Violation|1|||
48545784|NCT02257385|156188427|FG001|Overall Study|Lost to Follow-up|1|||
48545785|NCT02257385|156188426|FG000|Overall Study|Withdrawal by Subject|4|||
48545786|NCT02257385|156188427|FG001|Overall Study|Withdrawal by Subject|4|||
48545787|NCT00077857|156188431|FG000|Overall Study|Adverse Event|30|||
48545788|NCT00077857|156188432|FG001|Overall Study|Adverse Event|32|||
48545789|NCT00077857|156188431|FG000|Overall Study|Death|7|||
48545790|NCT00077857|156188432|FG001|Overall Study|Death|3|||
48545791|NCT00077857|156188431|FG000|Overall Study|Insufficient therapeutic response|112|||
48545792|NCT00077857|156188432|FG001|Overall Study|Insufficient therapeutic response|128|||
48545793|NCT00077857|156188431|FG000|Overall Study|Violation of selection criteria at entry|3|||
48545794|NCT00077857|156188432|FG001|Overall Study|Violation of selection criteria at entry|1|||
48545795|NCT00077857|156188431|FG000|Overall Study|Other protocol violation|0|||
48545796|NCT00077857|156188432|FG001|Overall Study|Other protocol violation|1|||
48545797|NCT00077857|156188431|FG000|Overall Study|Refused treatment|29|||
48545798|NCT00077857|156188432|FG001|Overall Study|Refused treatment|21|||
48545799|NCT00077857|156188431|FG000|Overall Study|Failure to return|5|||
48545800|NCT00077857|156188432|FG001|Overall Study|Failure to return|5|||
48545801|NCT00077857|156188431|FG000|Overall Study|Other|15|||
48545802|NCT00077857|156188432|FG001|Overall Study|Other|13|||
48545803|NCT00896480|156188433|FG000|Overall Study|Disease progression/recurrence|21|||
48545804|NCT03753763|156188435|FG000|Overall Study|Adverse Event|2|||
48545805|NCT03753763|156188436|FG001|Overall Study|Adverse Event|0|||
48545806|NCT03753763|156188435|FG000|Overall Study|Withdrawal by Subject|3|||
48545807|NCT03753763|156188436|FG001|Overall Study|Withdrawal by Subject|1|||
48545808|NCT03753763|156188435|FG000|Overall Study|clinical deterioration|1|||
48545809|NCT03753763|156188436|FG001|Overall Study|clinical deterioration|0|||
48545810|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
48545811|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
48545812|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
48611083|NCT03034967|156433593|FG001|Overall Study|Protocol Violation|0|||
48545813|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
48545814|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
48545815|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
48545816|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
48611084|NCT03034967|156433594|FG002|Overall Study|Protocol Violation|0|||
48611085|NCT03034967|156433595|FG003|Overall Study|Protocol Violation|0|||
48611086|NCT03034967|156433596|FG004|Overall Study|Protocol Violation|0|||
48611087|NCT03034967|156433597|FG005|Overall Study|Protocol Violation|2|||
48611088|NCT03034967|156433592|FG000|Overall Study|Lack of Efficacy|0|||
48611089|NCT03034967|156433593|FG001|Overall Study|Lack of Efficacy|1|||
48611090|NCT03034967|156433594|FG002|Overall Study|Lack of Efficacy|2|||
48611091|NCT03034967|156433595|FG003|Overall Study|Lack of Efficacy|1|||
48611092|NCT03034967|156433596|FG004|Overall Study|Lack of Efficacy|1|||
48611093|NCT03034967|156433597|FG005|Overall Study|Lack of Efficacy|0|||
48611094|NCT03034967|156433592|FG000|Overall Study|Adverse Event, non-fatal|3|||
48611095|NCT03034967|156433593|FG001|Overall Study|Adverse Event, non-fatal|1|||
48611096|NCT03034967|156433594|FG002|Overall Study|Adverse Event, non-fatal|2|||
48611097|NCT03034967|156433595|FG003|Overall Study|Adverse Event, non-fatal|0|||
48611098|NCT03034967|156433596|FG004|Overall Study|Adverse Event, non-fatal|2|||
48611099|NCT03034967|156433597|FG005|Overall Study|Adverse Event, non-fatal|8|||
48611100|NCT03034967|156433592|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
48611101|NCT03034967|156433593|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
48611102|NCT03034967|156433594|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
48611103|NCT03034967|156433595|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
48611104|NCT03034967|156433596|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
48611105|NCT03034967|156433597|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
48611106|NCT01991795|156433599|FG000|Overall Study|Lost to Follow-up|6|||
48611107|NCT01991795|156433600|FG001|Overall Study|Lost to Follow-up|4|||
48611108|NCT01991795|156433599|FG000|Overall Study|Withdrawal by Subject|117|||
48611109|NCT01991795|156433600|FG001|Overall Study|Withdrawal by Subject|94|||
48611110|NCT01991795|156433599|FG000|Overall Study|Site prematurely closed by sponsor|26|||
48611111|NCT01991795|156433600|FG001|Overall Study|Site prematurely closed by sponsor|25|||
48611112|NCT02246777|156433601|FG000|Overall Study|Adverse Event|2|||
48611113|NCT02246777|156433601|FG000|Overall Study|Change of residence|1|||
48611114|NCT03980223|156433602|FG000|Overall Study|Lost to Follow-up|3|||
48611115|NCT03980223|156433603|FG001|Overall Study|Lost to Follow-up|7|||
48611116|NCT03980223|156433604|FG002|Overall Study|Lost to Follow-up|10|||
48611117|NCT03980223|156433605|FG003|Overall Study|Lost to Follow-up|8|||
48611118|NCT03980223|156433602|FG000|Overall Study|Withdrawal by Subject|0|||
48611119|NCT03980223|156433603|FG001|Overall Study|Withdrawal by Subject|0|||
48611120|NCT03980223|156433604|FG002|Overall Study|Withdrawal by Subject|1|||
48611121|NCT03980223|156433605|FG003|Overall Study|Withdrawal by Subject|2|||
48611122|NCT03980223|156433602|FG000|Overall Study|Physician Decision|0|||
48545817|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
48545818|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
48545819|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
48545820|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
48545821|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
48545822|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
48611123|NCT03980223|156433603|FG001|Overall Study|Physician Decision|0|||
48611124|NCT03980223|156433604|FG002|Overall Study|Physician Decision|1|||
48611125|NCT03980223|156433605|FG003|Overall Study|Physician Decision|0|||
48611126|NCT03980223|156433602|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
48611127|NCT03980223|156433603|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
48611128|NCT03980223|156433604|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
48611129|NCT03980223|156433605|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
48611130|NCT03091439|156433606|FG000|Overall Study|Study Terminated by the Sponsor|1|||
48611131|NCT03091439|156433607|FG001|Overall Study|Study Terminated by the Sponsor|0|||
48611132|NCT00596635|156433612|FG000|Overall Study|Lost to Follow-up|0|||
48611133|NCT00596635|156433613|FG001|Overall Study|Lost to Follow-up|2|||
48611134|NCT00596635|156433614|FG002|Overall Study|Lost to Follow-up|0|||
48611135|NCT00596635|156433612|FG000|Overall Study|Treatment for symptomatic UTI|4|||
48611136|NCT00596635|156433613|FG001|Overall Study|Treatment for symptomatic UTI|6|||
48611137|NCT00596635|156433614|FG002|Overall Study|Treatment for symptomatic UTI|3|||
48611138|NCT00596635|156433612|FG000|Overall Study|Hip fracture|2|||
48611139|NCT00596635|156433613|FG001|Overall Study|Hip fracture|3|||
48611140|NCT00596635|156433614|FG002|Overall Study|Hip fracture|3|||
48545823|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
48545824|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
48611141|NCT00596635|156433612|FG000|Overall Study|Could not provide urine specimen|1|||
48611142|NCT00596635|156433613|FG001|Overall Study|Could not provide urine specimen|2|||
48611143|NCT00596635|156433614|FG002|Overall Study|Could not provide urine specimen|2|||
48611144|NCT01860989|156433615|FG000|Overall Study|Unsatisfactory therapeutic|5|||
48611145|NCT02916927|156433618|FG000|Overall Study|Discharged prior to study drug receipt|0|||
48611146|NCT02916927|156433619|FG001|Overall Study|Discharged prior to study drug receipt|2|||
48611147|NCT02916927|156433618|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
48611148|NCT02916927|156433619|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
48611149|NCT02916927|156433618|FG000|Overall Study|Withdrawal before first time point|1|||
48611150|NCT02916927|156433619|FG001|Overall Study|Withdrawal before first time point|0|||
48611151|NCT00858988|156433620|FG000|Analysis|Lactulose unable to be detected in urine|2|||
48611152|NCT00858988|156433621|FG001|Analysis|Lactulose unable to be detected in urine|1|||
48611153|NCT02145390|156433622|FG000|Overall Study|Withdrawal by Subject|1|||
48611154|NCT01260948|156433623|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
48611155|NCT01260948|156433624|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
48611156|NCT01260948|156433623|FG000|Second Intervention|Emesis|0|||
48611157|NCT01260948|156433624|FG001|Second Intervention|Emesis|1|||
48611158|NCT02318940|156433625|FG000|Overall Study|lost the record|1|||
48611159|NCT02318940|156433626|FG001|Overall Study|lost the record|0|||
48611160|NCT01163617|156433627|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
48611161|NCT01163617|156433628|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
48611162|NCT01163617|156433629|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
48611163|NCT01163617|156433630|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
48611164|NCT01163617|156433631|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
48611165|NCT01163617|156433632|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
48611166|NCT01163617|156433633|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
48611167|NCT01163617|156433634|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
48611168|NCT01163617|156433627|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
48611169|NCT01163617|156433628|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
48611170|NCT01163617|156433629|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
48611171|NCT01163617|156433630|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
48611172|NCT01163617|156433631|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
48611173|NCT01163617|156433632|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
48611174|NCT01163617|156433633|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
48545825|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
48545826|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
48545827|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
48545828|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
48545829|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
48545830|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
48545831|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
48545832|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
48545833|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
48545834|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
48545835|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
48611175|NCT01163617|156433634|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
48611176|NCT01163617|156433627|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
48611177|NCT01163617|156433628|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
48611178|NCT01163617|156433629|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
48611179|NCT01163617|156433630|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
48611180|NCT01163617|156433631|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
48611181|NCT01163617|156433632|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
48447229|NCT03911869|155825840|FG002|Phase 2|Death|0|||
48447230|NCT00688545|155825841|FG000|Overall Study|Lost to Follow-up|1|||
48611182|NCT01163617|156433633|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
48611183|NCT01163617|156433634|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
48611184|NCT04711005|156433635|FG000|Overall Study|Withdrawal by Subject|0|||
48611185|NCT04711005|156433636|FG001|Overall Study|Withdrawal by Subject|0|||
48611186|NCT04711005|156433637|FG002|Overall Study|Withdrawal by Subject|0|||
48611187|NCT04711005|156433638|FG003|Overall Study|Withdrawal by Subject|0|||
48611188|NCT04711005|156433639|FG004|Overall Study|Withdrawal by Subject|0|||
48611189|NCT04711005|156433640|FG005|Overall Study|Withdrawal by Subject|0|||
48611190|NCT04711005|156433641|FG006|Overall Study|Withdrawal by Subject|0|||
48611191|NCT04711005|156433642|FG007|Overall Study|Withdrawal by Subject|1|||
48611192|NCT04711005|156433643|FG008|Overall Study|Withdrawal by Subject|0|||
48611193|NCT04711005|156433644|FG009|Overall Study|Withdrawal by Subject|0|||
48611194|NCT04711005|156433635|FG000|Overall Study|Physician Decision|0|||
48611195|NCT04711005|156433636|FG001|Overall Study|Physician Decision|0|||
48611196|NCT04711005|156433637|FG002|Overall Study|Physician Decision|0|||
48611197|NCT04711005|156433638|FG003|Overall Study|Physician Decision|0|||
48611198|NCT04711005|156433639|FG004|Overall Study|Physician Decision|0|||
48611199|NCT04711005|156433640|FG005|Overall Study|Physician Decision|0|||
48611200|NCT04711005|156433641|FG006|Overall Study|Physician Decision|0|||
48611201|NCT04711005|156433642|FG007|Overall Study|Physician Decision|2|||
48611202|NCT04711005|156433643|FG008|Overall Study|Physician Decision|1|||
48611203|NCT04711005|156433644|FG009|Overall Study|Physician Decision|0|||
48611204|NCT02034006|156435190|FG000|Overall Study|Withdrawal by Subject|7|||
48611205|NCT02034006|156435190|FG000|Overall Study|Lost to Follow-up|5|||
48611206|NCT02034006|156435190|FG000|Overall Study|Death|1|||
48611207|NCT02034006|156435190|FG000|Overall Study|Pregnancy|1|||
48611208|NCT00587457|156435191|FG000|Overall Study|Adverse Event|1|||
48611209|NCT00587457|156435192|FG001|Overall Study|Adverse Event|2|||
48611210|NCT00587457|156435193|FG002|Overall Study|Adverse Event|1|||
48611211|NCT00587457|156435191|FG000|Overall Study|Disease progression|2|||
48611212|NCT00587457|156435192|FG001|Overall Study|Disease progression|0|||
48447231|NCT00688545|155825842|FG001|Overall Study|Lost to Follow-up|4|||
48447232|NCT00688545|155825841|FG000|Overall Study|Insurance/cost of drug|0|||
48447233|NCT00688545|155825842|FG001|Overall Study|Insurance/cost of drug|1|||
48447234|NCT00688545|155825841|FG000|Overall Study|Withdrawal by Subject|2|||
48447235|NCT00688545|155825842|FG001|Overall Study|Withdrawal by Subject|3|||
48447236|NCT00688545|155825841|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
48447237|NCT00688545|155825842|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
48447238|NCT00469209|155825845|FG000|Overall Study|Adverse Event|1|||
48447239|NCT00469209|155825846|FG001|Overall Study|Adverse Event|0|||
48447240|NCT00469209|155825847|FG002|Overall Study|Adverse Event|1|||
48447241|NCT01192204|155825853|FG000|Overall Study|could not keep recall appointments|1|||
48447242|NCT01192204|155825854|FG001|Overall Study|could not keep recall appointments|0|||
48447243|NCT01998399|155825856|FG000|Overall Study|Lost to Follow-up|1|||
48447244|NCT01998399|155825857|FG001|Overall Study|Lost to Follow-up|3|||
48447245|NCT01998399|155825856|FG000|Overall Study|Death|4|||
48447246|NCT01998399|155825857|FG001|Overall Study|Death|2|||
48447247|NCT01998399|155825856|FG000|Overall Study|Study stopped before dosing completed|3|||
48447248|NCT01998399|155825857|FG001|Overall Study|Study stopped before dosing completed|3|||
48447249|NCT01998399|155825856|FG000|Overall Study|Withdrawal by Subject|0|||
48447250|NCT01998399|155825857|FG001|Overall Study|Withdrawal by Subject|1|||
48447251|NCT00842361|155825860|FG000|Overall Study|Protocol Violation|1|||
48447252|NCT00842361|155825861|FG001|Overall Study|Protocol Violation|0|||
48447253|NCT00842361|155825860|FG000|Overall Study|Unclassified|0|||
48447254|NCT00842361|155825861|FG001|Overall Study|Unclassified|2|||
48447255|NCT01496274|155825862|FG000|Overall Study|Protocol Violation|0|||
48447256|NCT01496274|155825863|FG001|Overall Study|Protocol Violation|1|||
48447257|NCT01496274|155825862|FG000|Overall Study|Adverse Event|1|||
48447258|NCT01496274|155825863|FG001|Overall Study|Adverse Event|1|||
48447259|NCT01496274|155825862|FG000|Overall Study|Withdrawal by Subject|2|||
48447260|NCT01496274|155825863|FG001|Overall Study|Withdrawal by Subject|0|||
48447261|NCT01496274|155825862|FG000|Overall Study|Lost to Follow-up|0|||
48447262|NCT01496274|155825863|FG001|Overall Study|Lost to Follow-up|3|||
48545836|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
48611213|NCT00587457|156435193|FG002|Overall Study|Disease progression|2|||
48611214|NCT00587457|156435191|FG000|Overall Study|Initiation of alternative therapy|0|||
48611215|NCT00587457|156435192|FG001|Overall Study|Initiation of alternative therapy|1|||
48545837|NCT02552212|156188438|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
48611216|NCT00587457|156435193|FG002|Overall Study|Initiation of alternative therapy|0|||
48611217|NCT00587457|156435191|FG000|Overall Study|Undefined|0|||
48611218|NCT00587457|156435192|FG001|Overall Study|Undefined|0|||
48611219|NCT00587457|156435193|FG002|Overall Study|Undefined|1|||
48611220|NCT00587457|156435191|FG000|Overall Study|Development of neutralizing Abs|0|||
48611221|NCT00587457|156435192|FG001|Overall Study|Development of neutralizing Abs|0|||
48611222|NCT00587457|156435193|FG002|Overall Study|Development of neutralizing Abs|1|||
48611223|NCT01712516|156435194|FG000|Overall Study|Technical problems|0|||
48611224|NCT01712516|156435195|FG001|Overall Study|Technical problems|0|||
48611225|NCT01712516|156435196|FG002|Overall Study|Technical problems|0|||
48611226|NCT01712516|156435197|FG003|Overall Study|Technical problems|2|||
48611227|NCT01712516|156435194|FG000|Overall Study|Lost to Follow-up|0|||
48611228|NCT01712516|156435195|FG001|Overall Study|Lost to Follow-up|0|||
48611229|NCT01712516|156435196|FG002|Overall Study|Lost to Follow-up|2|||
48611230|NCT01712516|156435197|FG003|Overall Study|Lost to Follow-up|1|||
48611231|NCT01712516|156435194|FG000|Overall Study|Death|0|||
48611232|NCT01712516|156435195|FG001|Overall Study|Death|1|||
48611233|NCT01712516|156435196|FG002|Overall Study|Death|0|||
48545838|NCT02552212|156188439|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
48545839|NCT02552212|156188440|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
48545840|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
48545841|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
48545842|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
48545843|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
48545844|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
48545845|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
48545846|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
48545847|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
48545848|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
48545849|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
48545850|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
48545851|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
48545852|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
48545853|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
48545854|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
48545855|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
48545856|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
48545857|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
48545858|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
48545859|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
48545860|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
48545861|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
48545862|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
48545863|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
48545864|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
48545865|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
48545866|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
48545867|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
48545868|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
48545869|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
48545870|NCT02552212|156188438|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
48545871|NCT02552212|156188439|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
48545872|NCT02552212|156188440|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
48545873|NCT01104779|156188443|FG000|Overall Study|Protocol Violation|1|||
48611234|NCT01712516|156435197|FG003|Overall Study|Death|0|||
48611235|NCT01712516|156435194|FG000|Overall Study|Protocol deviation|1|||
48611236|NCT01712516|156435195|FG001|Overall Study|Protocol deviation|0|||
48611237|NCT01712516|156435196|FG002|Overall Study|Protocol deviation|1|||
48611238|NCT01712516|156435197|FG003|Overall Study|Protocol deviation|0|||
48611239|NCT01712516|156435194|FG000|Overall Study|Physician Decision|2|||
48611240|NCT01712516|156435195|FG001|Overall Study|Physician Decision|0|||
48611241|NCT01712516|156435196|FG002|Overall Study|Physician Decision|0|||
48611242|NCT01712516|156435197|FG003|Overall Study|Physician Decision|1|||
48611243|NCT01712516|156435194|FG000|Overall Study|Withdrawal by Subject|3|||
48611244|NCT01712516|156435195|FG001|Overall Study|Withdrawal by Subject|9|||
48611245|NCT01712516|156435196|FG002|Overall Study|Withdrawal by Subject|3|||
48611246|NCT01712516|156435197|FG003|Overall Study|Withdrawal by Subject|9|||
48611247|NCT00715208|156435200|FG000|Overall Study|Withdrawal by Subject|1|||
48611248|NCT00715208|156435201|FG001|Overall Study|Withdrawal by Subject|1|||
48611249|NCT00715208|156435200|FG000|Overall Study|Adverse Event|0|||
48611250|NCT00715208|156435201|FG001|Overall Study|Adverse Event|6|||
48611251|NCT00715208|156435200|FG000|Overall Study|Lack of Efficacy|0|||
48611252|NCT00715208|156435201|FG001|Overall Study|Lack of Efficacy|2|||
48611253|NCT01648764|156435202|FG000|Overall Study|Progressive Disease|0|||
48611254|NCT01648764|156435203|FG001|Overall Study|Progressive Disease|1|||
48611255|NCT01648764|156435204|FG002|Overall Study|Progressive Disease|0|||
48611256|NCT01648764|156435205|FG003|Overall Study|Progressive Disease|0|||
48611257|NCT01648764|156435206|FG004|Overall Study|Progressive Disease|0|||
48611258|NCT01648764|156435207|FG005|Overall Study|Progressive Disease|1|||
48611259|NCT01648764|156435208|FG006|Overall Study|Progressive Disease|1|||
48611260|NCT01648764|156435209|FG007|Overall Study|Progressive Disease|0|||
48611261|NCT01648764|156435210|FG008|Overall Study|Progressive Disease|0|||
48611262|NCT01648764|156435211|FG009|Overall Study|Progressive Disease|2|||
48611263|NCT01648764|156435212|FG010|Overall Study|Progressive Disease|0|||
48611264|NCT01648764|156435213|FG011|Overall Study|Progressive Disease|1|||
48611265|NCT01648764|156435214|FG012|Overall Study|Progressive Disease|2|||
48611266|NCT01648764|156435215|FG013|Overall Study|Progressive Disease|1|||
48611267|NCT01648764|156435202|FG000|Overall Study|Adverse Event|0|||
48611268|NCT01648764|156435203|FG001|Overall Study|Adverse Event|0|||
48611269|NCT01648764|156435204|FG002|Overall Study|Adverse Event|0|||
48611270|NCT01648764|156435205|FG003|Overall Study|Adverse Event|0|||
48611271|NCT01648764|156435206|FG004|Overall Study|Adverse Event|0|||
48611272|NCT01648764|156435207|FG005|Overall Study|Adverse Event|1|||
48611273|NCT01648764|156435208|FG006|Overall Study|Adverse Event|0|||
48611274|NCT01648764|156435209|FG007|Overall Study|Adverse Event|0|||
48611275|NCT01648764|156435210|FG008|Overall Study|Adverse Event|0|||
48611276|NCT01648764|156435211|FG009|Overall Study|Adverse Event|1|||
48611277|NCT01648764|156435212|FG010|Overall Study|Adverse Event|0|||
48611278|NCT01648764|156435213|FG011|Overall Study|Adverse Event|3|||
48611279|NCT01648764|156435214|FG012|Overall Study|Adverse Event|1|||
48611280|NCT01648764|156435215|FG013|Overall Study|Adverse Event|1|||
48611281|NCT01648764|156435202|FG000|Overall Study|Death|0|||
48611282|NCT01648764|156435203|FG001|Overall Study|Death|0|||
48611283|NCT01648764|156435204|FG002|Overall Study|Death|0|||
48611284|NCT01648764|156435205|FG003|Overall Study|Death|0|||
48611285|NCT01648764|156435206|FG004|Overall Study|Death|0|||
48611286|NCT01648764|156435207|FG005|Overall Study|Death|0|||
48611287|NCT01648764|156435208|FG006|Overall Study|Death|1|||
48611288|NCT01648764|156435209|FG007|Overall Study|Death|0|||
48611289|NCT01648764|156435210|FG008|Overall Study|Death|0|||
48611290|NCT01648764|156435211|FG009|Overall Study|Death|0|||
48611291|NCT01648764|156435212|FG010|Overall Study|Death|0|||
48611292|NCT01648764|156435213|FG011|Overall Study|Death|0|||
48611293|NCT01648764|156435214|FG012|Overall Study|Death|0|||
48611294|NCT01648764|156435215|FG013|Overall Study|Death|1|||
48611295|NCT01648764|156435202|FG000|Overall Study|Withdrawal by Subject|0|||
48611296|NCT01648764|156435203|FG001|Overall Study|Withdrawal by Subject|0|||
48611297|NCT01648764|156435204|FG002|Overall Study|Withdrawal by Subject|0|||
48611298|NCT01648764|156435205|FG003|Overall Study|Withdrawal by Subject|0|||
48611299|NCT01648764|156435206|FG004|Overall Study|Withdrawal by Subject|0|||
48611300|NCT01648764|156435207|FG005|Overall Study|Withdrawal by Subject|0|||
48611301|NCT01648764|156435208|FG006|Overall Study|Withdrawal by Subject|2|||
48611302|NCT01648764|156435209|FG007|Overall Study|Withdrawal by Subject|0|||
48611303|NCT01648764|156435210|FG008|Overall Study|Withdrawal by Subject|0|||
48611304|NCT01648764|156435211|FG009|Overall Study|Withdrawal by Subject|0|||
48545874|NCT01104779|156188444|FG001|Overall Study|Protocol Violation|2|||
48545875|NCT01104779|156188445|FG002|Overall Study|Protocol Violation|2|||
48545876|NCT01104779|156188443|FG000|Overall Study|Lack of Efficacy|26|||
48545877|NCT01104779|156188444|FG001|Overall Study|Lack of Efficacy|12|||
48545878|NCT01104779|156188445|FG002|Overall Study|Lack of Efficacy|13|||
48545879|NCT01104779|156188443|FG000|Overall Study|Adverse Event|13|||
48545880|NCT01104779|156188444|FG001|Overall Study|Adverse Event|14|||
48545881|NCT01104779|156188445|FG002|Overall Study|Adverse Event|13|||
48545882|NCT01104779|156188443|FG000|Overall Study|Did not meet inc/exc criteria|1|||
48545883|NCT01104779|156188444|FG001|Overall Study|Did not meet inc/exc criteria|1|||
48545884|NCT01104779|156188445|FG002|Overall Study|Did not meet inc/exc criteria|1|||
48545885|NCT01104779|156188443|FG000|Overall Study|Other reasons|0|||
48545886|NCT01104779|156188444|FG001|Overall Study|Other reasons|1|||
48545887|NCT01104779|156188445|FG002|Overall Study|Other reasons|0|||
48545888|NCT01104779|156188443|FG000|Overall Study|Lost to Follow-up|2|||
48545889|NCT01104779|156188444|FG001|Overall Study|Lost to Follow-up|0|||
48545890|NCT01104779|156188445|FG002|Overall Study|Lost to Follow-up|1|||
48545891|NCT01104779|156188443|FG000|Overall Study|Withdrawal by Subject|16|||
48545892|NCT01104779|156188444|FG001|Overall Study|Withdrawal by Subject|25|||
48545893|NCT01104779|156188445|FG002|Overall Study|Withdrawal by Subject|32|||
48545894|NCT01284621|156188446|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
48545895|NCT01284621|156188447|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
48545896|NCT01284621|156188448|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
48545897|NCT01284621|156188449|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
48545898|NCT01284621|156188450|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
48545899|NCT01284621|156188451|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
48545900|NCT05819203|156188454|FG000|Overall Study|Protocol Violation|1|||
48545901|NCT05819203|156188455|FG001|Overall Study|Protocol Violation|2|||
48545902|NCT05819203|156188454|FG000|Overall Study|Withdrawal by Subject|1|||
48545903|NCT05819203|156188455|FG001|Overall Study|Withdrawal by Subject|0|||
48545904|NCT00307437|156188456|FG000|Controlled Period|Adverse Event|7|||
48545905|NCT00307437|156188457|FG001|Controlled Period|Adverse Event|2|||
48545906|NCT00307437|156188458|FG002|Controlled Period|Adverse Event|5|||
48545907|NCT00307437|156188459|FG003|Controlled Period|Adverse Event|0|||
48545908|NCT00307437|156188460|FG004|Controlled Period|Adverse Event|0|||
48545909|NCT00307437|156188461|FG005|Controlled Period|Adverse Event|0|||
48545910|NCT00307437|156188462|FG006|Controlled Period|Adverse Event|0|||
48545911|NCT00307437|156188456|FG000|Controlled Period|Death|0|||
48545912|NCT00307437|156188457|FG001|Controlled Period|Death|0|||
48545913|NCT00307437|156188458|FG002|Controlled Period|Death|1|||
48545914|NCT00307437|156188459|FG003|Controlled Period|Death|0|||
48545915|NCT00307437|156188460|FG004|Controlled Period|Death|0|||
48545916|NCT00307437|156188461|FG005|Controlled Period|Death|0|||
48545917|NCT00307437|156188462|FG006|Controlled Period|Death|0|||
48545918|NCT00307437|156188456|FG000|Controlled Period|Lack of Efficacy|2|||
48545919|NCT00307437|156188457|FG001|Controlled Period|Lack of Efficacy|0|||
48545920|NCT00307437|156188458|FG002|Controlled Period|Lack of Efficacy|0|||
48545921|NCT00307437|156188459|FG003|Controlled Period|Lack of Efficacy|0|||
48545922|NCT00307437|156188460|FG004|Controlled Period|Lack of Efficacy|0|||
48545923|NCT00307437|156188461|FG005|Controlled Period|Lack of Efficacy|0|||
48545924|NCT00307437|156188462|FG006|Controlled Period|Lack of Efficacy|0|||
48545925|NCT00307437|156188456|FG000|Controlled Period|Lost to Follow-up|2|||
48545926|NCT00307437|156188457|FG001|Controlled Period|Lost to Follow-up|3|||
48545927|NCT00307437|156188458|FG002|Controlled Period|Lost to Follow-up|0|||
48545928|NCT00307437|156188459|FG003|Controlled Period|Lost to Follow-up|0|||
48545929|NCT00307437|156188460|FG004|Controlled Period|Lost to Follow-up|0|||
48545930|NCT00307437|156188461|FG005|Controlled Period|Lost to Follow-up|0|||
48545931|NCT00307437|156188462|FG006|Controlled Period|Lost to Follow-up|0|||
48545932|NCT00307437|156188456|FG000|Controlled Period|Other|5|||
48545933|NCT00307437|156188457|FG001|Controlled Period|Other|1|||
48545934|NCT00307437|156188458|FG002|Controlled Period|Other|3|||
48545935|NCT00307437|156188459|FG003|Controlled Period|Other|0|||
48545936|NCT00307437|156188460|FG004|Controlled Period|Other|0|||
48545937|NCT00307437|156188461|FG005|Controlled Period|Other|0|||
48545938|NCT00307437|156188462|FG006|Controlled Period|Other|0|||
48545939|NCT00307437|156188456|FG000|After Controlled Period|Adverse Event|0|||
48545940|NCT00307437|156188457|FG001|After Controlled Period|Adverse Event|0|||
48545941|NCT00307437|156188458|FG002|After Controlled Period|Adverse Event|0|||
48545942|NCT00307437|156188459|FG003|After Controlled Period|Adverse Event|18|||
48545943|NCT00307437|156188460|FG004|After Controlled Period|Adverse Event|16|||
48545944|NCT00307437|156188461|FG005|After Controlled Period|Adverse Event|31|||
48545945|NCT00307437|156188462|FG006|After Controlled Period|Adverse Event|40|||
48545946|NCT00307437|156188456|FG000|After Controlled Period|Death|0|||
48545947|NCT00307437|156188457|FG001|After Controlled Period|Death|0|||
48545948|NCT00307437|156188458|FG002|After Controlled Period|Death|0|||
48545949|NCT00307437|156188459|FG003|After Controlled Period|Death|3|||
48545950|NCT00307437|156188460|FG004|After Controlled Period|Death|1|||
48545951|NCT00307437|156188461|FG005|After Controlled Period|Death|1|||
48611305|NCT01648764|156435212|FG010|Overall Study|Withdrawal by Subject|0|||
48611306|NCT01648764|156435213|FG011|Overall Study|Withdrawal by Subject|0|||
48611307|NCT01648764|156435214|FG012|Overall Study|Withdrawal by Subject|1|||
48611308|NCT01648764|156435215|FG013|Overall Study|Withdrawal by Subject|0|||
48545952|NCT00307437|156188462|FG006|After Controlled Period|Death|3|||
48545953|NCT00307437|156188456|FG000|After Controlled Period|Lack of Efficacy|0|||
48545954|NCT00307437|156188457|FG001|After Controlled Period|Lack of Efficacy|0|||
48545955|NCT00307437|156188458|FG002|After Controlled Period|Lack of Efficacy|0|||
48545956|NCT00307437|156188459|FG003|After Controlled Period|Lack of Efficacy|15|||
48545957|NCT00307437|156188460|FG004|After Controlled Period|Lack of Efficacy|17|||
48545958|NCT00307437|156188461|FG005|After Controlled Period|Lack of Efficacy|37|||
48545959|NCT00307437|156188462|FG006|After Controlled Period|Lack of Efficacy|24|||
48611309|NCT01648764|156435202|FG000|Overall Study|Investigator Decision|0|||
48611310|NCT01648764|156435203|FG001|Overall Study|Investigator Decision|0|||
48611311|NCT01648764|156435204|FG002|Overall Study|Investigator Decision|0|||
48611312|NCT01648764|156435205|FG003|Overall Study|Investigator Decision|0|||
48611313|NCT01648764|156435206|FG004|Overall Study|Investigator Decision|0|||
48611314|NCT01648764|156435207|FG005|Overall Study|Investigator Decision|0|||
48611315|NCT01648764|156435208|FG006|Overall Study|Investigator Decision|1|||
48611316|NCT01648764|156435209|FG007|Overall Study|Investigator Decision|0|||
48611317|NCT01648764|156435210|FG008|Overall Study|Investigator Decision|0|||
48611318|NCT01648764|156435211|FG009|Overall Study|Investigator Decision|0|||
48611319|NCT01648764|156435212|FG010|Overall Study|Investigator Decision|0|||
48611320|NCT01648764|156435213|FG011|Overall Study|Investigator Decision|1|||
48611321|NCT01648764|156435214|FG012|Overall Study|Investigator Decision|0|||
48611322|NCT01648764|156435215|FG013|Overall Study|Investigator Decision|0|||
48611323|NCT00656617|156435219|FG000|Overall Study|Adverse Event|1|||
48611324|NCT00656617|156435219|FG000|Overall Study|Death|2|||
48611325|NCT00656617|156435219|FG000|Overall Study|Insurance Issues|2|||
48611326|NCT00656617|156435219|FG000|Overall Study|Move to different clinical trial|2|||
48611327|NCT00634504|156435223|FG000|Overall Study|Protocol Violation|1|||
48611328|NCT00634504|156435224|FG001|Overall Study|Protocol Violation|0|||
48611329|NCT03482024|156435225|FG000|Overall Study|Physician Decision|1|||
48611330|NCT03482024|156435226|FG001|Overall Study|Physician Decision|0|||
48611331|NCT03482024|156435227|FG002|Overall Study|Physician Decision|0|||
48611332|NCT03482024|156435228|FG003|Overall Study|Physician Decision|0|||
48611333|NCT03482024|156435229|FG004|Overall Study|Physician Decision|0|||
48611334|NCT02453048|156435236|FG000|Overall Study|Only part of initial 6 mo. study|0|||
48611335|NCT02453048|156435237|FG001|Overall Study|Only part of initial 6 mo. study|0|||
48611336|NCT02453048|156435238|FG002|Overall Study|Only part of initial 6 mo. study|0|||
48611337|NCT02453048|156435239|FG003|Overall Study|Only part of initial 6 mo. study|0|||
48611338|NCT02453048|156435240|FG004|Overall Study|Only part of initial 6 mo. study|6|||
48611339|NCT02453048|156435236|FG000|Overall Study|Lost to Follow-up|0|||
48611340|NCT02453048|156435237|FG001|Overall Study|Lost to Follow-up|1|||
48611341|NCT02453048|156435238|FG002|Overall Study|Lost to Follow-up|2|||
48611342|NCT02453048|156435239|FG003|Overall Study|Lost to Follow-up|0|||
48611343|NCT02453048|156435240|FG004|Overall Study|Lost to Follow-up|0|||
48611344|NCT00676143|156435241|FG000|Overall Study|Adverse Event|34|||
48611345|NCT00676143|156435242|FG001|Overall Study|Adverse Event|60|||
48611346|NCT00676143|156435241|FG000|Overall Study|Death|4|||
48611347|NCT00676143|156435242|FG001|Overall Study|Death|4|||
48611348|NCT00676143|156435241|FG000|Overall Study|Lack of Efficacy|0|||
48611349|NCT00676143|156435242|FG001|Overall Study|Lack of Efficacy|6|||
48611350|NCT00676143|156435241|FG000|Overall Study|Lost to Follow-up|0|||
48611351|NCT00676143|156435242|FG001|Overall Study|Lost to Follow-up|13|||
48611352|NCT00676143|156435241|FG000|Overall Study|Physician Decision|5|||
48611353|NCT00676143|156435242|FG001|Overall Study|Physician Decision|8|||
48611354|NCT00676143|156435241|FG000|Overall Study|Protocol Violation|4|||
48545960|NCT00307437|156188456|FG000|After Controlled Period|Lost to Follow-up|0|||
48545961|NCT00307437|156188457|FG001|After Controlled Period|Lost to Follow-up|0|||
48611355|NCT00676143|156435242|FG001|Overall Study|Protocol Violation|8|||
48611356|NCT00676143|156435241|FG000|Overall Study|Withdrawal by Subject|24|||
48611357|NCT00676143|156435242|FG001|Overall Study|Withdrawal by Subject|42|||
48611358|NCT00676143|156435241|FG000|Overall Study|Discontinuation of study by sponsor|65|||
48611359|NCT00676143|156435242|FG001|Overall Study|Discontinuation of study by sponsor|88|||
48611360|NCT00676143|156435241|FG000|Overall Study|Failed to return|2|||
48611361|NCT00676143|156435242|FG001|Overall Study|Failed to return|1|||
48611362|NCT00676143|156435241|FG000|Overall Study|Loss of caregiver|5|||
48611363|NCT00676143|156435242|FG001|Overall Study|Loss of caregiver|3|||
48611364|NCT00676143|156435241|FG000|Overall Study|Other|11|||
48611365|NCT00676143|156435242|FG001|Overall Study|Other|20|||
48545962|NCT00307437|156188458|FG002|After Controlled Period|Lost to Follow-up|0|||
48611366|NCT00676143|156435241|FG000|Overall Study|Participant participation unknown|1|||
48611367|NCT00676143|156435242|FG001|Overall Study|Participant participation unknown|4|||
48611368|NCT00676143|156435241|FG000|Overall Study|Vasogenic edema recurrence|1|||
48611369|NCT00676143|156435242|FG001|Overall Study|Vasogenic edema recurrence|3|||
48611370|NCT02696616|156435243|FG000|Overall Study|Adverse Event|0|||
48545963|NCT00307437|156188459|FG003|After Controlled Period|Lost to Follow-up|7|||
48545964|NCT00307437|156188460|FG004|After Controlled Period|Lost to Follow-up|12|||
48545965|NCT00307437|156188461|FG005|After Controlled Period|Lost to Follow-up|13|||
48545966|NCT00307437|156188462|FG006|After Controlled Period|Lost to Follow-up|18|||
48545967|NCT00307437|156188456|FG000|After Controlled Period|Other|0|||
48545968|NCT00307437|156188457|FG001|After Controlled Period|Other|0|||
48545969|NCT00307437|156188458|FG002|After Controlled Period|Other|0|||
48545970|NCT00307437|156188459|FG003|After Controlled Period|Other|15|||
48545971|NCT00307437|156188460|FG004|After Controlled Period|Other|9|||
48545972|NCT00307437|156188461|FG005|After Controlled Period|Other|40|||
48545973|NCT00307437|156188462|FG006|After Controlled Period|Other|28|||
48545974|NCT04597632|156188463|FG000|Overall Study|Withdrawal by Subject|10|||
48545975|NCT04597632|156188463|FG000|Overall Study|Lost to Follow-up|1|||
48545976|NCT04597632|156188463|FG000|Overall Study|Death|1|||
48545977|NCT04597632|156188463|FG000|Overall Study|Adverse Event|5|||
48545978|NCT02952898|156188466|FG000|Overall Study|Withdrawal by Subject|10|||
48545979|NCT02952898|156188467|FG001|Overall Study|Withdrawal by Subject|8|||
48611371|NCT02696616|156435244|FG001|Overall Study|Adverse Event|1|||
48545980|NCT02952898|156188468|FG002|Overall Study|Withdrawal by Subject|8|||
48545981|NCT02952898|156188466|FG000|Overall Study|Adverse Event|8|||
48545982|NCT02952898|156188467|FG001|Overall Study|Adverse Event|8|||
48545983|NCT02952898|156188468|FG002|Overall Study|Adverse Event|3|||
48545984|NCT02952898|156188466|FG000|Overall Study|Lost to Follow-up|3|||
48545985|NCT02952898|156188467|FG001|Overall Study|Lost to Follow-up|2|||
48545986|NCT02952898|156188468|FG002|Overall Study|Lost to Follow-up|2|||
48545987|NCT02952898|156188466|FG000|Overall Study|Non-compliance with study drug|1|||
48545988|NCT02952898|156188467|FG001|Overall Study|Non-compliance with study drug|1|||
48545989|NCT02952898|156188468|FG002|Overall Study|Non-compliance with study drug|2|||
48545990|NCT04844762|156188473|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48545991|NCT04844762|156188474|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48545992|NCT04844762|156188475|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
48545993|NCT04844762|156188476|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48545994|NCT04844762|156188477|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48545995|NCT04844762|156188478|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48545996|NCT04844762|156188473|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
48545997|NCT04844762|156188474|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
48545998|NCT04844762|156188475|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
48545999|NCT04844762|156188476|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
48546000|NCT04844762|156188477|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
48546001|NCT04844762|156188478|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
48546002|NCT04844762|156188473|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546003|NCT04844762|156188474|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546004|NCT04844762|156188475|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
48546005|NCT04844762|156188476|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
48546006|NCT04844762|156188477|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546007|NCT04844762|156188478|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
48546008|NCT04844762|156188473|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48546009|NCT04844762|156188474|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48546010|NCT04844762|156188475|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
48546011|NCT04844762|156188476|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
48546012|NCT04844762|156188477|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
48546013|NCT04844762|156188478|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48611372|NCT02696616|156435245|FG002|Overall Study|Adverse Event|0|||
48611373|NCT02696616|156435246|FG003|Overall Study|Adverse Event|0|||
48611374|NCT02696616|156435247|FG004|Overall Study|Adverse Event|0|||
48611375|NCT02696616|156435248|FG005|Overall Study|Adverse Event|0|||
48611376|NCT02696616|156435249|FG006|Overall Study|Adverse Event|0|||
48611377|NCT03937778|156435252|FG000|Overall Study|Withdrawal by Subject|1|||
48546014|NCT04844762|156188473|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
48546015|NCT04844762|156188474|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
48546016|NCT04844762|156188475|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48611378|NCT03937778|156435252|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
48546017|NCT04844762|156188476|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48546018|NCT04844762|156188477|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48546019|NCT04844762|156188478|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48546020|NCT04844762|156188473|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
48546021|NCT04844762|156188474|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546022|NCT04844762|156188475|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546023|NCT04844762|156188476|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546024|NCT04844762|156188477|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546025|NCT04844762|156188478|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546026|NCT04844762|156188473|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48546027|NCT04844762|156188474|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48546028|NCT04844762|156188475|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48546029|NCT04844762|156188476|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48546030|NCT04844762|156188477|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
48546031|NCT04844762|156188478|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
48546032|NCT04844762|156188473|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
48546033|NCT04844762|156188474|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48546034|NCT04844762|156188475|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48546035|NCT04844762|156188476|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48546036|NCT04844762|156188477|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48546037|NCT04844762|156188478|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
48546038|NCT04844762|156188473|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
48546039|NCT04844762|156188474|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546040|NCT04844762|156188475|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546041|NCT04844762|156188476|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546042|NCT04844762|156188477|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
48546043|NCT04844762|156188478|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
48546044|NCT04844762|156188473|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
48546045|NCT04844762|156188474|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
48546046|NCT04844762|156188475|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
48546047|NCT04844762|156188476|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
48546048|NCT04844762|156188477|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
48546049|NCT04844762|156188478|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
48546050|NCT04844762|156188473|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
48546051|NCT04844762|156188474|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
48546052|NCT04844762|156188475|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
48546053|NCT04844762|156188476|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
48546054|NCT04844762|156188477|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
48546055|NCT04844762|156188478|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
48546056|NCT02099682|156188479|FG000|Overall Study|Data Not Available|51|||
48546057|NCT02099682|156188479|FG000|Overall Study|Lost to Follow-up|31|||
48546058|NCT02099682|156188479|FG000|Overall Study|Other|29|||
48546059|NCT02185053|156188480|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
48546060|NCT02185053|156188481|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
48546061|NCT02185053|156188482|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
48546062|NCT02185053|156188480|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
48546063|NCT02185053|156188481|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
48546064|NCT02185053|156188482|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
48546065|NCT02185053|156188480|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
48546066|NCT02185053|156188481|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
48546067|NCT02185053|156188482|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
48546068|NCT02185053|156188480|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
48546069|NCT02185053|156188481|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
48546070|NCT02185053|156188482|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
48546071|NCT02185053|156188480|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
48546072|NCT02185053|156188481|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
48546073|NCT02185053|156188482|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
48611379|NCT04796415|156435253|FG000|Overall Study|not interested|12|||
48611380|NCT04796415|156435253|FG000|Overall Study|health issue|8|||
48611381|NCT04796415|156435253|FG000|Overall Study|Other|4|||
48611382|NCT04796415|156435253|FG000|Overall Study|discharged from home health service|3|||
48611383|NCT04796415|156435253|FG000|Overall Study|re-hospitalization|2|||
48611384|NCT04796415|156435253|FG000|Overall Study|moving to nursing home|1|||
48611385|NCT04796415|156435253|FG000|Overall Study|lost contact|1|||
48611386|NCT02065557|156435256|FG000|Induction Period|Withdrawal by Subject|2|||
48611387|NCT02065557|156435257|FG001|Induction Period|Withdrawal by Subject|1|||
48611388|NCT02065557|156435258|FG002|Induction Period|Withdrawal by Subject|0|||
48611389|NCT02065557|156435259|FG003|Induction Period|Withdrawal by Subject|0|||
48611390|NCT02065557|156435260|FG004|Induction Period|Withdrawal by Subject|0|||
48611391|NCT02065557|156435261|FG005|Induction Period|Withdrawal by Subject|0|||
48611392|NCT02065557|156435256|FG000|Induction Period|Lack of Efficacy|2|||
48611393|NCT02065557|156435257|FG001|Induction Period|Lack of Efficacy|1|||
48611394|NCT02065557|156435258|FG002|Induction Period|Lack of Efficacy|1|||
48611395|NCT02065557|156435259|FG003|Induction Period|Lack of Efficacy|0|||
48611396|NCT02065557|156435260|FG004|Induction Period|Lack of Efficacy|0|||
48611397|NCT02065557|156435261|FG005|Induction Period|Lack of Efficacy|0|||
48611398|NCT02065557|156435256|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
48546074|NCT02185053|156188480|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
48546075|NCT02185053|156188481|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
48546076|NCT02185053|156188482|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
48546077|NCT02185053|156188480|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
48546078|NCT02185053|156188481|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
48546079|NCT02185053|156188482|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
48546080|NCT02185053|156188480|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
48546081|NCT02185053|156188481|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
48546082|NCT02185053|156188482|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
48546083|NCT00839254|156188483|FG000|Overall Study|Protocol Violation|0|||
48546084|NCT00839254|156188484|FG001|Overall Study|Protocol Violation|1|||
48546085|NCT00839254|156188485|FG002|Overall Study|Protocol Violation|1|||
48546086|NCT00839254|156188486|FG003|Overall Study|Protocol Violation|1|||
48546087|NCT00839254|156188487|FG004|Overall Study|Protocol Violation|0|||
48546088|NCT00839254|156188488|FG005|Overall Study|Protocol Violation|0|||
48546089|NCT00839254|156188489|FG006|Overall Study|Protocol Violation|1|||
48546090|NCT00839254|156188490|FG007|Overall Study|Protocol Violation|2|||
48546091|NCT00839254|156188483|FG000|Overall Study|Physician Decision|0|||
48546092|NCT00839254|156188484|FG001|Overall Study|Physician Decision|1|||
48546093|NCT00839254|156188485|FG002|Overall Study|Physician Decision|0|||
48546094|NCT00839254|156188486|FG003|Overall Study|Physician Decision|0|||
48546095|NCT00839254|156188487|FG004|Overall Study|Physician Decision|0|||
48546096|NCT00839254|156188488|FG005|Overall Study|Physician Decision|0|||
48546097|NCT00839254|156188489|FG006|Overall Study|Physician Decision|0|||
48546098|NCT00839254|156188490|FG007|Overall Study|Physician Decision|1|||
48546099|NCT00839254|156188483|FG000|Overall Study|Wrong treatment number allocation|0|||
48546100|NCT00839254|156188484|FG001|Overall Study|Wrong treatment number allocation|1|||
48546101|NCT00839254|156188485|FG002|Overall Study|Wrong treatment number allocation|0|||
48546102|NCT00839254|156188486|FG003|Overall Study|Wrong treatment number allocation|0|||
48546103|NCT00839254|156188487|FG004|Overall Study|Wrong treatment number allocation|0|||
48546104|NCT00839254|156188488|FG005|Overall Study|Wrong treatment number allocation|1|||
48546105|NCT00839254|156188489|FG006|Overall Study|Wrong treatment number allocation|0|||
48546106|NCT00839254|156188490|FG007|Overall Study|Wrong treatment number allocation|0|||
48546107|NCT00839254|156188483|FG000|Overall Study|Adverse Event|12|||
48546108|NCT00839254|156188484|FG001|Overall Study|Adverse Event|6|||
48546109|NCT00839254|156188485|FG002|Overall Study|Adverse Event|3|||
48546110|NCT00839254|156188486|FG003|Overall Study|Adverse Event|5|||
48546111|NCT00839254|156188487|FG004|Overall Study|Adverse Event|2|||
48546112|NCT00839254|156188488|FG005|Overall Study|Adverse Event|1|||
48546113|NCT00839254|156188489|FG006|Overall Study|Adverse Event|0|||
48546114|NCT00839254|156188490|FG007|Overall Study|Adverse Event|1|||
48546115|NCT00839254|156188483|FG000|Overall Study|Withdrawal by Subject|87|||
48546116|NCT00839254|156188484|FG001|Overall Study|Withdrawal by Subject|53|||
48546117|NCT00839254|156188485|FG002|Overall Study|Withdrawal by Subject|54|||
48546118|NCT00839254|156188486|FG003|Overall Study|Withdrawal by Subject|32|||
48546119|NCT00839254|156188487|FG004|Overall Study|Withdrawal by Subject|27|||
48546120|NCT00839254|156188488|FG005|Overall Study|Withdrawal by Subject|15|||
48546121|NCT00839254|156188489|FG006|Overall Study|Withdrawal by Subject|22|||
48546122|NCT00839254|156188490|FG007|Overall Study|Withdrawal by Subject|9|||
48546123|NCT00839254|156188483|FG000|Overall Study|Wrong group allocation|0|||
48546124|NCT00839254|156188484|FG001|Overall Study|Wrong group allocation|0|||
48546125|NCT00839254|156188485|FG002|Overall Study|Wrong group allocation|0|||
48611399|NCT02065557|156435257|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
48611400|NCT02065557|156435258|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
48611401|NCT02065557|156435259|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
48546126|NCT00839254|156188486|FG003|Overall Study|Wrong group allocation|0|||
48546127|NCT00839254|156188487|FG004|Overall Study|Wrong group allocation|0|||
48546128|NCT00839254|156188488|FG005|Overall Study|Wrong group allocation|0|||
48546129|NCT00839254|156188489|FG006|Overall Study|Wrong group allocation|1|||
48546130|NCT00839254|156188490|FG007|Overall Study|Wrong group allocation|0|||
48611402|NCT02065557|156435260|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
48611403|NCT02065557|156435261|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
48611404|NCT02065557|156435256|FG000|Induction Period|Non-Responder at Week 8|4|||
48611405|NCT02065557|156435257|FG001|Induction Period|Non-Responder at Week 8|4|||
48611406|NCT02065557|156435258|FG002|Induction Period|Non-Responder at Week 8|0|||
48611407|NCT02065557|156435259|FG003|Induction Period|Non-Responder at Week 8|0|||
48611408|NCT02065557|156435260|FG004|Induction Period|Non-Responder at Week 8|0|||
48611409|NCT02065557|156435261|FG005|Induction Period|Non-Responder at Week 8|0|||
48611410|NCT02065557|156435256|FG000|Induction Period|Adverse Event|1|||
48611411|NCT02065557|156435257|FG001|Induction Period|Adverse Event|1|||
48611412|NCT02065557|156435258|FG002|Induction Period|Adverse Event|0|||
48611413|NCT02065557|156435259|FG003|Induction Period|Adverse Event|0|||
48611414|NCT02065557|156435260|FG004|Induction Period|Adverse Event|0|||
48611415|NCT02065557|156435261|FG005|Induction Period|Adverse Event|0|||
48546131|NCT00839254|156188483|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
48546132|NCT00839254|156188484|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
48546133|NCT00839254|156188485|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
48546134|NCT00839254|156188486|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
48546135|NCT00839254|156188487|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
48546136|NCT00839254|156188488|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
48546137|NCT00839254|156188489|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
48546138|NCT00839254|156188490|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
48546139|NCT00839254|156188483|FG000|Overall Study|Withdrawn due to non-compliance|2|||
48546140|NCT00839254|156188484|FG001|Overall Study|Withdrawn due to non-compliance|0|||
48546141|NCT00839254|156188485|FG002|Overall Study|Withdrawn due to non-compliance|0|||
48546142|NCT00839254|156188486|FG003|Overall Study|Withdrawn due to non-compliance|0|||
48546143|NCT00839254|156188487|FG004|Overall Study|Withdrawn due to non-compliance|0|||
48546144|NCT00839254|156188488|FG005|Overall Study|Withdrawn due to non-compliance|0|||
48546145|NCT00839254|156188489|FG006|Overall Study|Withdrawn due to non-compliance|0|||
48546146|NCT00839254|156188490|FG007|Overall Study|Withdrawn due to non-compliance|0|||
48546147|NCT00839254|156188483|FG000|Overall Study|Lost to Follow-up|51|||
48546148|NCT00839254|156188484|FG001|Overall Study|Lost to Follow-up|30|||
48546149|NCT00839254|156188485|FG002|Overall Study|Lost to Follow-up|32|||
48546150|NCT00839254|156188486|FG003|Overall Study|Lost to Follow-up|24|||
48546151|NCT00839254|156188487|FG004|Overall Study|Lost to Follow-up|8|||
48546152|NCT00839254|156188488|FG005|Overall Study|Lost to Follow-up|8|||
48546153|NCT00839254|156188489|FG006|Overall Study|Lost to Follow-up|4|||
48546154|NCT00839254|156188490|FG007|Overall Study|Lost to Follow-up|2|||
48546155|NCT03283319|156189982|FG000|Overall Study|Lost to Follow-up|5|||
48546156|NCT03283319|156189983|FG001|Overall Study|Lost to Follow-up|4|||
48546157|NCT03283319|156189984|FG002|Overall Study|Lost to Follow-up|5|||
48546158|NCT03283319|156189985|FG003|Overall Study|Lost to Follow-up|5|||
48546159|NCT03283319|156189986|FG004|Overall Study|Lost to Follow-up|4|||
48546160|NCT03283319|156189987|FG005|Overall Study|Lost to Follow-up|3|||
48546161|NCT03283319|156189982|FG000|Overall Study|Withdrawal by Subject|2|||
48546162|NCT03283319|156189983|FG001|Overall Study|Withdrawal by Subject|2|||
48546163|NCT03283319|156189984|FG002|Overall Study|Withdrawal by Subject|2|||
48546164|NCT03283319|156189985|FG003|Overall Study|Withdrawal by Subject|1|||
48546165|NCT03283319|156189986|FG004|Overall Study|Withdrawal by Subject|0|||
48546166|NCT03283319|156189987|FG005|Overall Study|Withdrawal by Subject|1|||
48546167|NCT03283319|156189982|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
48546168|NCT03283319|156189983|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
48546169|NCT03283319|156189984|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
48546170|NCT03283319|156189985|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
48546171|NCT03283319|156189986|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
48546172|NCT03283319|156189987|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
48546173|NCT03559400|156189991|FG000|Overall Study|Lost to Follow-up|9|||
48546174|NCT03559400|156189992|FG001|Overall Study|Lost to Follow-up|7|||
48546175|NCT03559400|156189991|FG000|Overall Study|Death|0|||
48546176|NCT03559400|156189992|FG001|Overall Study|Death|2|||
48546177|NCT02563106|156189993|FG000|Overall Study|Withdrawal by Subject|7|||
48546178|NCT02563106|156189994|FG001|Overall Study|Withdrawal by Subject|8|||
48546179|NCT02563106|156189993|FG000|Overall Study|Adverse Event|17|||
48546180|NCT02563106|156189994|FG001|Overall Study|Adverse Event|15|||
48611416|NCT02065557|156435256|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
48611417|NCT02065557|156435257|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
48611418|NCT02065557|156435258|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
48611419|NCT02065557|156435259|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
48611420|NCT02065557|156435260|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
48611421|NCT02065557|156435261|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
48611422|NCT02065557|156435256|FG000|Maintenance Period|Withdrawal by Subject|0|||
48611423|NCT02065557|156435257|FG001|Maintenance Period|Withdrawal by Subject|0|||
48611424|NCT02065557|156435258|FG002|Maintenance Period|Withdrawal by Subject|0|||
48611425|NCT02065557|156435259|FG003|Maintenance Period|Withdrawal by Subject|0|||
48611426|NCT02065557|156435260|FG004|Maintenance Period|Withdrawal by Subject|2|||
48611427|NCT02065557|156435261|FG005|Maintenance Period|Withdrawal by Subject|1|||
48611428|NCT02065557|156435256|FG000|Maintenance Period|Lack of Efficacy|0|||
48611429|NCT02065557|156435257|FG001|Maintenance Period|Lack of Efficacy|0|||
48611430|NCT02065557|156435258|FG002|Maintenance Period|Lack of Efficacy|0|||
48611431|NCT02065557|156435259|FG003|Maintenance Period|Lack of Efficacy|0|||
48611432|NCT02065557|156435260|FG004|Maintenance Period|Lack of Efficacy|5|||
48611433|NCT02065557|156435261|FG005|Maintenance Period|Lack of Efficacy|2|||
48611434|NCT02065557|156435256|FG000|Maintenance Period|Subject Non-Compliance|0|||
48611435|NCT02065557|156435257|FG001|Maintenance Period|Subject Non-Compliance|0|||
48611436|NCT02065557|156435258|FG002|Maintenance Period|Subject Non-Compliance|0|||
48611437|NCT02065557|156435259|FG003|Maintenance Period|Subject Non-Compliance|0|||
48611438|NCT02065557|156435260|FG004|Maintenance Period|Subject Non-Compliance|0|||
48611439|NCT02065557|156435261|FG005|Maintenance Period|Subject Non-Compliance|1|||
48611440|NCT00250588|156435264|FG000|Overall Study|Withdrawal by Subject|3|||
48611441|NCT00250588|156435265|FG001|Overall Study|Withdrawal by Subject|6|||
48611442|NCT00250588|156435266|FG002|Overall Study|Withdrawal by Subject|0|||
48611443|NCT00250588|156435264|FG000|Overall Study|Lost to Follow-up|6|||
48611444|NCT00250588|156435265|FG001|Overall Study|Lost to Follow-up|13|||
48611445|NCT00250588|156435266|FG002|Overall Study|Lost to Follow-up|13|||
48611446|NCT04810962|156435268|FG000|Overall Study|Adverse Event|0|||
48611447|NCT04810962|156435269|FG001|Overall Study|Adverse Event|1|||
48611448|NCT04810962|156435268|FG000|Overall Study|Lost to Follow-up|2|||
48611449|NCT04810962|156435269|FG001|Overall Study|Lost to Follow-up|1|||
48611450|NCT04810962|156435268|FG000|Overall Study|Physician Decision|1|||
48611451|NCT04810962|156435269|FG001|Overall Study|Physician Decision|0|||
48611452|NCT04810962|156435268|FG000|Overall Study|Withdrawal by Subject|1|||
48611453|NCT04810962|156435269|FG001|Overall Study|Withdrawal by Subject|3|||
48611454|NCT04810962|156435268|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
48611455|NCT04810962|156435269|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
48611456|NCT02378181|156435273|FG000|Overall Study|Lost to Follow-up|2|||
48611457|NCT02378181|156435274|FG001|Overall Study|Lost to Follow-up|5|||
48611458|NCT02378181|156435273|FG000|Overall Study|Withdrawal by Subject|1|||
48611459|NCT02378181|156435274|FG001|Overall Study|Withdrawal by Subject|1|||
48611460|NCT02378181|156435273|FG000|Overall Study|Incarcerated|0|||
48611461|NCT02378181|156435274|FG001|Overall Study|Incarcerated|1|||
48611462|NCT01462942|156435275|FG000|Overall Study|Adverse Event|7|||
48611463|NCT01462942|156435276|FG001|Overall Study|Adverse Event|12|||
48611464|NCT01462942|156435277|FG002|Overall Study|Adverse Event|10|||
48611465|NCT01462942|156435278|FG003|Overall Study|Adverse Event|11|||
48611466|NCT01462942|156435279|FG004|Overall Study|Adverse Event|11|||
48611467|NCT01462942|156435275|FG000|Overall Study|Other, including COPD exacerbation|3|||
48611468|NCT01462942|156435276|FG001|Overall Study|Other, including COPD exacerbation|5|||
48611469|NCT01462942|156435277|FG002|Overall Study|Other, including COPD exacerbation|2|||
48611470|NCT01462942|156435278|FG003|Overall Study|Other, including COPD exacerbation|8|||
48611471|NCT01462942|156435279|FG004|Overall Study|Other, including COPD exacerbation|5|||
48611472|NCT01462942|156435275|FG000|Overall Study|Withdrawal by Subject|14|||
48611473|NCT01462942|156435276|FG001|Overall Study|Withdrawal by Subject|10|||
48611474|NCT01462942|156435277|FG002|Overall Study|Withdrawal by Subject|14|||
48611475|NCT01462942|156435278|FG003|Overall Study|Withdrawal by Subject|16|||
48611476|NCT01462942|156435279|FG004|Overall Study|Withdrawal by Subject|19|||
48611477|NCT01462942|156435275|FG000|Overall Study|Lack of Efficacy|6|||
48611478|NCT01462942|156435276|FG001|Overall Study|Lack of Efficacy|0|||
48611479|NCT01462942|156435277|FG002|Overall Study|Lack of Efficacy|4|||
48611480|NCT01462942|156435278|FG003|Overall Study|Lack of Efficacy|5|||
48611481|NCT01462942|156435279|FG004|Overall Study|Lack of Efficacy|3|||
48611482|NCT01462942|156435275|FG000|Overall Study|Lost to Follow-up|0|||
48611483|NCT01462942|156435276|FG001|Overall Study|Lost to Follow-up|1|||
48611484|NCT01462942|156435277|FG002|Overall Study|Lost to Follow-up|1|||
48611485|NCT01462942|156435278|FG003|Overall Study|Lost to Follow-up|1|||
48611486|NCT01462942|156435279|FG004|Overall Study|Lost to Follow-up|1|||
48611487|NCT01462942|156435275|FG000|Overall Study|Protocol Violation|4|||
48611488|NCT01462942|156435276|FG001|Overall Study|Protocol Violation|6|||
48611489|NCT01462942|156435277|FG002|Overall Study|Protocol Violation|9|||
48546181|NCT02563106|156189993|FG000|Overall Study|Protocol Violation|1|||
48546182|NCT02563106|156189994|FG001|Overall Study|Protocol Violation|0|||
48546183|NCT02563106|156189993|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
48546184|NCT02563106|156189994|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
48546185|NCT02563106|156189993|FG000|Overall Study|Lost to Follow-up|3|||
48546186|NCT02563106|156189994|FG001|Overall Study|Lost to Follow-up|2|||
48546187|NCT02563106|156189993|FG000|Overall Study|Physician Decision|3|||
48546188|NCT02563106|156189994|FG001|Overall Study|Physician Decision|1|||
48546189|NCT02563106|156189993|FG000|Overall Study|Other reason - not specified|2|||
48611490|NCT01462942|156435278|FG003|Overall Study|Protocol Violation|9|||
48611491|NCT01462942|156435279|FG004|Overall Study|Protocol Violation|6|||
48611492|NCT00296335|156435280|FG000|Overall Study|Recurrence|3|||
48611493|NCT00296335|156435281|FG001|Overall Study|Recurrence|51|||
48611494|NCT00296335|156435280|FG000|Overall Study|Adverse Event|17|||
48611495|NCT00296335|156435281|FG001|Overall Study|Adverse Event|27|||
48611496|NCT00296335|156435280|FG000|Overall Study|Lost to Follow-up|7|||
48611497|NCT00296335|156435281|FG001|Overall Study|Lost to Follow-up|33|||
48611498|NCT00296335|156435280|FG000|Overall Study|Physician Decision|3|||
48546190|NCT02563106|156189994|FG001|Overall Study|Other reason - not specified|1|||
48546191|NCT01087489|156189995|FG000|Overall Study|enrolled in another VA study|0|||
48546192|NCT01087489|156189996|FG001|Overall Study|enrolled in another VA study|1|||
48611499|NCT00296335|156435281|FG001|Overall Study|Physician Decision|11|||
48611500|NCT01027845|156435283|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
48611501|NCT01027845|156435284|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
48611502|NCT01027845|156435285|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
48546193|NCT01087489|156189995|FG000|Overall Study|Death|0|||
48546194|NCT01087489|156189996|FG001|Overall Study|Death|1|||
48546195|NCT01087489|156189995|FG000|Overall Study|unable to survey by telephone|0|||
48546196|NCT01087489|156189996|FG001|Overall Study|unable to survey by telephone|1|||
48611503|NCT01027845|156435286|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
48611504|NCT01027845|156435283|FG000|Primary Vaccination Phase|Adverse Event|1|||
48611505|NCT01027845|156435284|FG001|Primary Vaccination Phase|Adverse Event|0|||
48611506|NCT01027845|156435285|FG002|Primary Vaccination Phase|Adverse Event|0|||
48611507|NCT01027845|156435286|FG003|Primary Vaccination Phase|Adverse Event|0|||
48611508|NCT01027845|156435283|FG000|Primary Vaccination Phase|Protocol Violation|1|||
48546197|NCT00537303|156189997|FG000|Overall Study|Adverse Event|1|||
48546198|NCT00537303|156189998|FG001|Overall Study|Adverse Event|4|||
48546199|NCT00537303|156189997|FG000|Overall Study|Lack of Efficacy|6|||
48546200|NCT00537303|156189998|FG001|Overall Study|Lack of Efficacy|7|||
48546201|NCT00537303|156189997|FG000|Overall Study|Protocol Violation|8|||
48546202|NCT00537303|156189998|FG001|Overall Study|Protocol Violation|4|||
48546203|NCT00537303|156189997|FG000|Overall Study|Withdrawal criteria|3|||
48546204|NCT00537303|156189998|FG001|Overall Study|Withdrawal criteria|3|||
48546205|NCT00537303|156189997|FG000|Overall Study|Unclassified|8|||
48546206|NCT00537303|156189998|FG001|Overall Study|Unclassified|7|||
48546207|NCT00893737|156190003|FG000|Overall Study|Adverse Event|4|||
48546208|NCT00893737|156190003|FG000|Overall Study|Withdrawal by Subject|2|||
48611509|NCT01027845|156435284|FG001|Primary Vaccination Phase|Protocol Violation|0|||
48611510|NCT01027845|156435285|FG002|Primary Vaccination Phase|Protocol Violation|0|||
48611511|NCT01027845|156435286|FG003|Primary Vaccination Phase|Protocol Violation|0|||
48611512|NCT01027845|156435283|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
48546209|NCT00893737|156190003|FG000|Overall Study|Lost to Follow-up|6|||
48546210|NCT00928707|156190004|FG000|Overall Study|Protocol Violation|1|||
48546211|NCT00928707|156190005|FG001|Overall Study|Protocol Violation|0|||
48546212|NCT00132028|156190006|FG000|Overall Study|Adverse Event|7|||
48546213|NCT00132028|156190006|FG000|Overall Study|Death|2|||
48546214|NCT00132028|156190006|FG000|Overall Study|Lack of Efficacy|11|||
48546215|NCT00132028|156190006|FG000|Overall Study|Withdrawal by Subject|2|||
48546216|NCT00132028|156190006|FG000|Overall Study|not eligible|2|||
48546217|NCT00132028|156190006|FG000|Overall Study|Physician Decision|3|||
48546218|NCT01136967|156190007|FG000|Overall Study|Adverse Event|9|||
48546219|NCT01136967|156190008|FG001|Overall Study|Adverse Event|12|||
48546220|NCT01136967|156190007|FG000|Overall Study|Participant Choice|8|||
48546221|NCT01136967|156190008|FG001|Overall Study|Participant Choice|3|||
48546222|NCT01136967|156190007|FG000|Overall Study|Lost to Follow-up|0|||
48546223|NCT01136967|156190008|FG001|Overall Study|Lost to Follow-up|1|||
48546224|NCT01136967|156190007|FG000|Overall Study|Withdrawal by Subject|1|||
48546225|NCT01136967|156190008|FG001|Overall Study|Withdrawal by Subject|2|||
48546226|NCT01136967|156190007|FG000|Overall Study|Clinical Progression|3|||
48611513|NCT01027845|156435284|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
48611514|NCT01027845|156435285|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
48611515|NCT01027845|156435286|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
48611516|NCT01027845|156435283|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
48611517|NCT01027845|156435284|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
48611518|NCT01027845|156435285|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
48611519|NCT01027845|156435286|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
48611520|NCT01027845|156435283|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
48611521|NCT01027845|156435284|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
48611522|NCT01027845|156435285|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
48611523|NCT01027845|156435286|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
48611524|NCT02701634|156435287|FG000|Overall Study|Adverse Event|2|||
48611525|NCT02701634|156435288|FG001|Overall Study|Adverse Event|3|||
48611526|NCT02701634|156435287|FG000|Overall Study|Death|1|||
48611527|NCT02701634|156435288|FG001|Overall Study|Death|0|||
48611528|NCT02701634|156435287|FG000|Overall Study|Investigator's Discretion|7|||
48611529|NCT02701634|156435288|FG001|Overall Study|Investigator's Discretion|4|||
48611530|NCT02701634|156435287|FG000|Overall Study|Study terminated by Sponsor|15|||
48611531|NCT02701634|156435288|FG001|Overall Study|Study terminated by Sponsor|17|||
48611532|NCT02701634|156435287|FG000|Overall Study|Withdrew Consent|6|||
48611533|NCT02701634|156435288|FG001|Overall Study|Withdrew Consent|7|||
48611534|NCT02701634|156435287|FG000|Overall Study|Randomized but not treated|1|||
48611535|NCT02701634|156435288|FG001|Overall Study|Randomized but not treated|0|||
48611536|NCT02765165|156435289|FG000|Treatment Period|Progressive disease|3|||
48611537|NCT02765165|156435290|FG001|Treatment Period|Progressive disease|2|||
48546227|NCT01136967|156190008|FG001|Overall Study|Clinical Progression|5|||
48546228|NCT01136967|156190007|FG000|Overall Study|Radiation|1|||
48546229|NCT01136967|156190008|FG001|Overall Study|Radiation|0|||
48611538|NCT02765165|156435291|FG002|Treatment Period|Progressive disease|3|||
48611539|NCT02765165|156435292|FG003|Treatment Period|Progressive disease|3|||
48611540|NCT02765165|156435293|FG004|Treatment Period|Progressive disease|4|||
48611541|NCT02765165|156435294|FG005|Treatment Period|Progressive disease|2|||
48611542|NCT02765165|156435295|FG006|Treatment Period|Progressive disease|2|||
48611543|NCT02765165|156435289|FG000|Treatment Period|Physician Decision|0|||
48611544|NCT02765165|156435290|FG001|Treatment Period|Physician Decision|1|||
48611545|NCT02765165|156435291|FG002|Treatment Period|Physician Decision|0|||
48611546|NCT02765165|156435292|FG003|Treatment Period|Physician Decision|0|||
48611547|NCT02765165|156435293|FG004|Treatment Period|Physician Decision|0|||
48611548|NCT02765165|156435294|FG005|Treatment Period|Physician Decision|0|||
48546230|NCT01136967|156190007|FG000|Overall Study|Non-compliance|1|||
48546231|NCT01136967|156190008|FG001|Overall Study|Non-compliance|0|||
48546232|NCT01136967|156190007|FG000|Overall Study|Investigator's Choice|1|||
48546233|NCT01136967|156190008|FG001|Overall Study|Investigator's Choice|1|||
48546234|NCT01136967|156190007|FG000|Overall Study|Increase in Lesion Size|0|||
48546235|NCT01136967|156190008|FG001|Overall Study|Increase in Lesion Size|2|||
48546236|NCT01136967|156190007|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
48546237|NCT01136967|156190008|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
48546238|NCT04933968|156190009|FG000|Overall Study|Adverse Event|0|||
48546239|NCT04933968|156190010|FG001|Overall Study|Adverse Event|0|||
48611549|NCT02765165|156435295|FG006|Treatment Period|Physician Decision|0|||
48611550|NCT02765165|156435289|FG000|Treatment Period|Adverse Event|0|||
48611551|NCT02765165|156435290|FG001|Treatment Period|Adverse Event|1|||
48611552|NCT02765165|156435291|FG002|Treatment Period|Adverse Event|0|||
48611553|NCT02765165|156435292|FG003|Treatment Period|Adverse Event|0|||
48611554|NCT02765165|156435293|FG004|Treatment Period|Adverse Event|0|||
48611555|NCT02765165|156435294|FG005|Treatment Period|Adverse Event|0|||
48546240|NCT04933968|156190011|FG002|Overall Study|Adverse Event|1|||
48546241|NCT04933968|156190012|FG003|Overall Study|Adverse Event|1|||
48546242|NCT04933968|156190013|FG004|Overall Study|Adverse Event|0|||
48546243|NCT04933968|156190014|FG005|Overall Study|Adverse Event|0|||
48611556|NCT02765165|156435295|FG006|Treatment Period|Adverse Event|0|||
48611557|NCT02765165|156435289|FG000|Treatment Period|Withdrawal by Subject|0|||
48611558|NCT02765165|156435290|FG001|Treatment Period|Withdrawal by Subject|0|||
48611559|NCT02765165|156435291|FG002|Treatment Period|Withdrawal by Subject|0|||
48611560|NCT02765165|156435292|FG003|Treatment Period|Withdrawal by Subject|0|||
48611561|NCT02765165|156435293|FG004|Treatment Period|Withdrawal by Subject|2|||
48611562|NCT02765165|156435294|FG005|Treatment Period|Withdrawal by Subject|0|||
48611563|NCT02765165|156435295|FG006|Treatment Period|Withdrawal by Subject|0|||
48611564|NCT02765165|156435289|FG000|Treatment Period|Study terminated|0|||
48611565|NCT02765165|156435290|FG001|Treatment Period|Study terminated|0|||
48611566|NCT02765165|156435291|FG002|Treatment Period|Study terminated|0|||
48611567|NCT02765165|156435292|FG003|Treatment Period|Study terminated|0|||
48611568|NCT02765165|156435293|FG004|Treatment Period|Study terminated|0|||
48611569|NCT02765165|156435294|FG005|Treatment Period|Study terminated|1|||
48611570|NCT02765165|156435295|FG006|Treatment Period|Study terminated|2|||
48611571|NCT02765165|156435289|FG000|Post-treatment Follow-up|Death|1|||
48611572|NCT02765165|156435290|FG001|Post-treatment Follow-up|Death|2|||
48611573|NCT02765165|156435291|FG002|Post-treatment Follow-up|Death|1|||
48611574|NCT02765165|156435292|FG003|Post-treatment Follow-up|Death|1|||
48611575|NCT02765165|156435293|FG004|Post-treatment Follow-up|Death|1|||
48611576|NCT02765165|156435294|FG005|Post-treatment Follow-up|Death|1|||
48611577|NCT02765165|156435295|FG006|Post-treatment Follow-up|Death|0|||
48611578|NCT02765165|156435289|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
48611579|NCT02765165|156435290|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
48611580|NCT02765165|156435291|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
48611581|NCT02765165|156435292|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
48611582|NCT02765165|156435293|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
48611583|NCT02765165|156435294|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
48611584|NCT02765165|156435295|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
48611585|NCT02765165|156435289|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
48611586|NCT02765165|156435290|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
48611587|NCT02765165|156435291|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
48611588|NCT02765165|156435292|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
48611589|NCT02765165|156435293|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
48611590|NCT02765165|156435294|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
48611591|NCT02765165|156435295|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
48611592|NCT02765165|156435289|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
48611593|NCT02765165|156435290|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
48611594|NCT02765165|156435291|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
48611595|NCT02765165|156435292|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
48611596|NCT02765165|156435293|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
48611597|NCT02765165|156435294|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
48611598|NCT02765165|156435295|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
48611599|NCT02765165|156435289|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
48611600|NCT02765165|156435290|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
48611601|NCT02765165|156435291|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
48611602|NCT02765165|156435292|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
48611603|NCT02765165|156435293|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
48611604|NCT02765165|156435294|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
48611605|NCT02765165|156435295|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
48611606|NCT02765165|156435289|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
48611607|NCT02765165|156435290|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
48611608|NCT02765165|156435291|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
48611609|NCT02765165|156435292|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
48611610|NCT02765165|156435293|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
48611611|NCT02765165|156435294|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
48611612|NCT02765165|156435295|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
48611613|NCT04465422|156435298|FG000|Overall Study|Lost to Follow-up|0|||
48611614|NCT04465422|156435299|FG001|Overall Study|Lost to Follow-up|2|||
48611615|NCT00630292|156435300|FG000|Overall Study|Withdrawal by Subject|1|||
48611616|NCT01189266|156435303|FG000|Overall Study|Adverse Event|1|||
48611617|NCT01189266|156435304|FG001|Overall Study|Adverse Event|0|||
48611618|NCT01189266|156435305|FG002|Overall Study|Adverse Event|5|||
48611619|NCT01189266|156435303|FG000|Overall Study|Death|0|||
48611620|NCT01189266|156435304|FG001|Overall Study|Death|0|||
48611621|NCT01189266|156435305|FG002|Overall Study|Death|5|||
48611622|NCT01189266|156435303|FG000|Overall Study|Lack of Efficacy|4|||
48611623|NCT01189266|156435304|FG001|Overall Study|Lack of Efficacy|5|||
48611624|NCT01189266|156435305|FG002|Overall Study|Lack of Efficacy|44|||
48611625|NCT01189266|156435303|FG000|Overall Study|Physician Decision|0|||
48611626|NCT01189266|156435304|FG001|Overall Study|Physician Decision|0|||
48611627|NCT01189266|156435305|FG002|Overall Study|Physician Decision|1|||
48611628|NCT01189266|156435303|FG000|Overall Study|Protocol Violation|0|||
48611629|NCT01189266|156435304|FG001|Overall Study|Protocol Violation|1|||
48611630|NCT01189266|156435305|FG002|Overall Study|Protocol Violation|1|||
48611631|NCT01189266|156435303|FG000|Overall Study|Withdrawal by Subject|0|||
48611632|NCT01189266|156435304|FG001|Overall Study|Withdrawal by Subject|0|||
48611633|NCT01189266|156435305|FG002|Overall Study|Withdrawal by Subject|1|||
48611634|NCT01189266|156435303|FG000|Overall Study|Patient refuses further therapy|1|||
48611635|NCT01189266|156435304|FG001|Overall Study|Patient refuses further therapy|0|||
48611636|NCT01189266|156435305|FG002|Overall Study|Patient refuses further therapy|7|||
48611637|NCT01189266|156435303|FG000|Overall Study|No treatment|0|||
48611638|NCT01189266|156435304|FG001|Overall Study|No treatment|0|||
48611639|NCT01189266|156435305|FG002|Overall Study|No treatment|1|||
48611640|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
48611641|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
48611642|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
48611643|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
48611644|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
48611645|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
48611646|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
48611647|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
48611648|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
48611649|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
48546244|NCT04933968|156190009|FG000|Overall Study|Lost to Follow-up|1|||
48546245|NCT04933968|156190010|FG001|Overall Study|Lost to Follow-up|0|||
48546246|NCT04933968|156190011|FG002|Overall Study|Lost to Follow-up|1|||
48546247|NCT04933968|156190012|FG003|Overall Study|Lost to Follow-up|0|||
48546248|NCT04933968|156190013|FG004|Overall Study|Lost to Follow-up|0|||
48546249|NCT04933968|156190014|FG005|Overall Study|Lost to Follow-up|0|||
48546250|NCT04933968|156190009|FG000|Overall Study|Randomized not treated|1|||
48546251|NCT04933968|156190010|FG001|Overall Study|Randomized not treated|0|||
48546252|NCT04933968|156190011|FG002|Overall Study|Randomized not treated|0|||
48611650|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
48611651|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
48611652|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
48611653|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
48611654|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
48611655|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
48611656|NCT00410163|156435306|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
48611657|NCT00410163|156435307|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
48611658|NCT00410163|156435306|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
48611659|NCT00410163|156435307|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
48611660|NCT00410163|156435306|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
48611661|NCT00410163|156435307|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
48611662|NCT00410163|156435306|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
48611663|NCT00410163|156435307|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
48611664|NCT00410163|156435306|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
48546253|NCT04933968|156190012|FG003|Overall Study|Randomized not treated|0|||
48546254|NCT04933968|156190013|FG004|Overall Study|Randomized not treated|0|||
48546255|NCT04933968|156190014|FG005|Overall Study|Randomized not treated|0|||
48546256|NCT04933968|156190009|FG000|Overall Study|Sponsor terminated study|0|||
48546257|NCT04933968|156190010|FG001|Overall Study|Sponsor terminated study|0|||
48546258|NCT04933968|156190011|FG002|Overall Study|Sponsor terminated study|0|||
48546259|NCT04933968|156190012|FG003|Overall Study|Sponsor terminated study|1|||
48546260|NCT04933968|156190013|FG004|Overall Study|Sponsor terminated study|2|||
48546261|NCT04933968|156190014|FG005|Overall Study|Sponsor terminated study|0|||
48546262|NCT04933968|156190009|FG000|Overall Study|Other|0|||
48546263|NCT04933968|156190010|FG001|Overall Study|Other|0|||
48546264|NCT04933968|156190011|FG002|Overall Study|Other|0|||
48546265|NCT04933968|156190012|FG003|Overall Study|Other|1|||
48546266|NCT04933968|156190013|FG004|Overall Study|Other|0|||
48546267|NCT04933968|156190014|FG005|Overall Study|Other|0|||
48546268|NCT04933968|156190009|FG000|Overall Study|Missing|1|||
48546269|NCT04933968|156190010|FG001|Overall Study|Missing|3|||
48546270|NCT04933968|156190011|FG002|Overall Study|Missing|2|||
48546271|NCT04933968|156190012|FG003|Overall Study|Missing|1|||
48546272|NCT04933968|156190013|FG004|Overall Study|Missing|1|||
48546273|NCT04933968|156190014|FG005|Overall Study|Missing|0|||
48546274|NCT05386030|156190015|FG000|Overall Study|Death|1|||
48546275|NCT05386030|156190016|FG001|Overall Study|Death|0|||
48546276|NCT05386030|156190015|FG000|Overall Study|Physician Decision|2|||
48546277|NCT05386030|156190016|FG001|Overall Study|Physician Decision|1|||
48546278|NCT05386030|156190015|FG000|Overall Study|Lost to Follow-up|19|||
48546279|NCT05386030|156190016|FG001|Overall Study|Lost to Follow-up|7|||
48546280|NCT05386030|156190015|FG000|Overall Study|Withdrawal by Subject|20|||
48546281|NCT05386030|156190016|FG001|Overall Study|Withdrawal by Subject|10|||
48546282|NCT05386030|156190015|FG000|Overall Study|Eligibility criteria violation|1|||
48611665|NCT00410163|156435307|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
48546283|NCT05386030|156190016|FG001|Overall Study|Eligibility criteria violation|1|||
48546284|NCT05386030|156190015|FG000|Overall Study|Personal Reasons|1|||
48546285|NCT05386030|156190016|FG001|Overall Study|Personal Reasons|0|||
48546286|NCT02885181|156190017|FG000|Overall Study|Investigator's Discretion|0|||
48546287|NCT02885181|156190018|FG001|Overall Study|Investigator's Discretion|1|||
48611666|NCT00410163|156435306|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
48611667|NCT00410163|156435307|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
48611668|NCT00324155|156435310|FG000|Enrolled and Randomized|No longer met study criteria|3|||
48546288|NCT02885181|156190019|FG002|Overall Study|Investigator's Discretion|0|||
48546289|NCT02885181|156190020|FG003|Overall Study|Investigator's Discretion|1|||
48546290|NCT02885181|156190017|FG000|Overall Study|Adverse Event|0|||
48546291|NCT02885181|156190018|FG001|Overall Study|Adverse Event|0|||
48546292|NCT02885181|156190019|FG002|Overall Study|Adverse Event|0|||
48546293|NCT02885181|156190020|FG003|Overall Study|Adverse Event|1|||
48546294|NCT02885181|156190017|FG000|Overall Study|Withdrawal by Subject|0|||
48546295|NCT02885181|156190018|FG001|Overall Study|Withdrawal by Subject|0|||
48546296|NCT02885181|156190019|FG002|Overall Study|Withdrawal by Subject|0|||
48546297|NCT02885181|156190020|FG003|Overall Study|Withdrawal by Subject|1|||
48546298|NCT01735955|156190021|FG000|Overall Study|Administrative problems|1|||
48546299|NCT01735955|156190021|FG000|Overall Study|Patient/guardian decision|1|||
48546300|NCT01735955|156190021|FG000|Overall Study|Patient withdrew consent|2|||
48546301|NCT01735955|156190021|FG000|Overall Study|Physician Decision|4|||
48546302|NCT01735955|156190021|FG000|Overall Study|Disease progression|24|||
48546303|NCT01735955|156190021|FG000|Overall Study|Adverse Event|5|||
48546304|NCT03317834|156190026|FG000|Overall Study|Death|2|||
48546305|NCT03317834|156190026|FG000|Overall Study|Device Revision|5|||
48546306|NCT03317834|156190026|FG000|Overall Study|Withdrawal by Subject|13|||
48546307|NCT03317834|156190026|FG000|Overall Study|Lost to Follow-up|13|||
48546308|NCT01716715|156190027|FG000|Overall Study|Never Treated|2|||
48546309|NCT01716715|156190028|FG001|Overall Study|Never Treated|4|||
48546310|NCT00895947|156190029|FG000|Overall Study|Adverse Event|3|||
48546311|NCT00895947|156190030|FG001|Overall Study|Adverse Event|4|||
48546312|NCT00895947|156190029|FG000|Overall Study|Lost to Follow-up|3|||
48546313|NCT00895947|156190030|FG001|Overall Study|Lost to Follow-up|4|||
48546314|NCT00895947|156190029|FG000|Overall Study|Protocol Violation|4|||
48546315|NCT00895947|156190030|FG001|Overall Study|Protocol Violation|2|||
48546316|NCT00895947|156190029|FG000|Overall Study|Withdrawal by Subject|2|||
48546317|NCT00895947|156190030|FG001|Overall Study|Withdrawal by Subject|0|||
48546318|NCT00626392|156190031|FG000|Run-in Period|Adverse Event|0|||
48546319|NCT00626392|156190032|FG001|Run-in Period|Adverse Event|0|||
48546320|NCT00626392|156190033|FG002|Run-in Period|Adverse Event|1|||
48546321|NCT00626392|156190034|FG003|Run-in Period|Adverse Event|0|||
48546322|NCT00626392|156190035|FG004|Run-in Period|Adverse Event|1|||
48546323|NCT00626392|156190036|FG005|Run-in Period|Adverse Event|0|||
48546324|NCT00626392|156190031|FG000|Run-in Period|Withdrawal by Subject|0|||
48546325|NCT00626392|156190032|FG001|Run-in Period|Withdrawal by Subject|1|||
48546326|NCT00626392|156190033|FG002|Run-in Period|Withdrawal by Subject|1|||
48546327|NCT00626392|156190034|FG003|Run-in Period|Withdrawal by Subject|1|||
48546328|NCT00626392|156190035|FG004|Run-in Period|Withdrawal by Subject|3|||
48546329|NCT00626392|156190036|FG005|Run-in Period|Withdrawal by Subject|1|||
48546330|NCT00626392|156190031|FG000|Run-in Period|Noncompliance|1|||
48546331|NCT00626392|156190032|FG001|Run-in Period|Noncompliance|0|||
48546332|NCT00626392|156190033|FG002|Run-in Period|Noncompliance|1|||
48546333|NCT00626392|156190034|FG003|Run-in Period|Noncompliance|0|||
48546334|NCT00626392|156190035|FG004|Run-in Period|Noncompliance|0|||
48546335|NCT00626392|156190036|FG005|Run-in Period|Noncompliance|0|||
48546336|NCT00626392|156190031|FG000|Coadministration Period|Adverse Event|3|||
48546337|NCT00626392|156190032|FG001|Coadministration Period|Adverse Event|1|||
48546338|NCT00626392|156190033|FG002|Coadministration Period|Adverse Event|7|||
48546339|NCT00626392|156190034|FG003|Coadministration Period|Adverse Event|4|||
48546340|NCT00626392|156190035|FG004|Coadministration Period|Adverse Event|3|||
48546341|NCT00626392|156190036|FG005|Coadministration Period|Adverse Event|4|||
48546342|NCT00626392|156190031|FG000|Coadministration Period|Withdrawal by Subject|1|||
48546343|NCT00626392|156190032|FG001|Coadministration Period|Withdrawal by Subject|1|||
48546344|NCT00626392|156190033|FG002|Coadministration Period|Withdrawal by Subject|0|||
48546345|NCT00626392|156190034|FG003|Coadministration Period|Withdrawal by Subject|1|||
48546346|NCT00626392|156190035|FG004|Coadministration Period|Withdrawal by Subject|0|||
48546347|NCT00626392|156190036|FG005|Coadministration Period|Withdrawal by Subject|1|||
48546348|NCT00626392|156190031|FG000|Coadministration Period|Protocol Violation|0|||
48546349|NCT00626392|156190032|FG001|Coadministration Period|Protocol Violation|1|||
48546350|NCT00626392|156190033|FG002|Coadministration Period|Protocol Violation|0|||
48546351|NCT00626392|156190034|FG003|Coadministration Period|Protocol Violation|1|||
48546352|NCT00626392|156190035|FG004|Coadministration Period|Protocol Violation|1|||
48546353|NCT00626392|156190036|FG005|Coadministration Period|Protocol Violation|0|||
48546354|NCT00626392|156190031|FG000|Coadministration Period|Other|0|||
48546355|NCT00626392|156190032|FG001|Coadministration Period|Other|2|||
48546356|NCT00626392|156190033|FG002|Coadministration Period|Other|3|||
48546357|NCT00626392|156190034|FG003|Coadministration Period|Other|1|||
48546358|NCT00626392|156190035|FG004|Coadministration Period|Other|1|||
48546359|NCT00626392|156190036|FG005|Coadministration Period|Other|1|||
48546360|NCT03327792|156190037|FG000|Overall Study|Adverse Event|4|||
48546361|NCT03327792|156190038|FG001|Overall Study|Adverse Event|0|||
48546362|NCT03327792|156190037|FG000|Overall Study|Family/Personal issues|3|||
48546363|NCT03327792|156190038|FG001|Overall Study|Family/Personal issues|2|||
48546364|NCT03327792|156190037|FG000|Overall Study|Lost to Follow-up|0|||
48546365|NCT03327792|156190038|FG001|Overall Study|Lost to Follow-up|1|||
48546366|NCT04576923|156190039|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
48546367|NCT00338455|156190042|FG000|Overall Study|Death|2|||
48546368|NCT00338455|156190043|FG001|Overall Study|Death|1|||
48546369|NCT00338455|156190042|FG000|Overall Study|Physician Decision|1|||
48546370|NCT00338455|156190043|FG001|Overall Study|Physician Decision|0|||
48546371|NCT02266134|156190044|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
48546372|NCT02266134|156190045|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
48546373|NCT02266134|156190046|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
48546374|NCT02266134|156190047|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
48546375|NCT02266134|156190044|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
48546376|NCT02266134|156190045|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
48546377|NCT02266134|156190046|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
48546378|NCT02266134|156190047|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
48546379|NCT02266134|156190044|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
48546380|NCT02266134|156190045|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
48546381|NCT02266134|156190046|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
48546382|NCT02266134|156190047|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
48546383|NCT02266134|156190044|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
48546384|NCT02266134|156190045|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
48546385|NCT02266134|156190046|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
48546386|NCT02266134|156190047|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
48611669|NCT00324155|156435311|FG001|Enrolled and Randomized|No longer met study criteria|0|||
48611670|NCT00324155|156435310|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
48611671|NCT00324155|156435311|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
48611672|NCT00324155|156435310|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
48611673|NCT00324155|156435311|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
48611674|NCT00324155|156435310|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
48611675|NCT00324155|156435311|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
48611676|NCT00324155|156435310|FG000|Received Treatment in Induction Phase|Death|8|||
48546387|NCT02266134|156190044|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
48546388|NCT02266134|156190045|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
48546389|NCT02266134|156190046|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
48546390|NCT02266134|156190047|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
48546391|NCT02266134|156190044|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
48546392|NCT02266134|156190045|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
48546393|NCT02266134|156190046|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
48546394|NCT02266134|156190047|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
48546395|NCT03151811|156190053|FG000|Overall Study|Randomized But Not Treated|18|||
48546396|NCT03151811|156190054|FG001|Overall Study|Randomized But Not Treated|3|||
48546397|NCT03151811|156190053|FG000|Overall Study|Progressive Disease|130|||
48546398|NCT03151811|156190054|FG001|Overall Study|Progressive Disease|170|||
48546399|NCT03151811|156190053|FG000|Overall Study|Adverse Event|49|||
48546400|NCT03151811|156190054|FG001|Overall Study|Adverse Event|40|||
48546401|NCT03151811|156190053|FG000|Overall Study|Lack of Efficacy|6|||
48546402|NCT03151811|156190054|FG001|Overall Study|Lack of Efficacy|8|||
48546403|NCT03151811|156190053|FG000|Overall Study|Physician Decision|21|||
48546404|NCT03151811|156190054|FG001|Overall Study|Physician Decision|9|||
48546405|NCT03151811|156190053|FG000|Overall Study|Withdrawal by Subject|17|||
48546406|NCT03151811|156190054|FG001|Overall Study|Withdrawal by Subject|7|||
48546407|NCT03151811|156190053|FG000|Overall Study|Lost to Follow-up|0|||
48546408|NCT03151811|156190054|FG001|Overall Study|Lost to Follow-up|1|||
48546409|NCT03151811|156190053|FG000|Overall Study|Study Terminated by Sponsor|5|||
48546410|NCT03151811|156190054|FG001|Overall Study|Study Terminated by Sponsor|11|||
48546411|NCT01517373|156190055|FG000|Run-in Period|Death|1|||
48546412|NCT01517373|156190056|FG001|Run-in Period|Death|0|||
48546413|NCT01517373|156190057|FG002|Run-in Period|Death|0|||
48546414|NCT01517373|156190058|FG003|Run-in Period|Death|0|||
48546415|NCT01517373|156190059|FG004|Run-in Period|Death|0|||
48546416|NCT01517373|156190060|FG005|Run-in Period|Death|0|||
48546417|NCT01517373|156190055|FG000|Run-in Period|Adverse Event|5|||
48546418|NCT01517373|156190056|FG001|Run-in Period|Adverse Event|0|||
48546419|NCT01517373|156190057|FG002|Run-in Period|Adverse Event|0|||
48611677|NCT00324155|156435311|FG001|Received Treatment in Induction Phase|Death|15|||
48611678|NCT00324155|156435310|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
48611679|NCT00324155|156435311|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
48611680|NCT00324155|156435310|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
48546420|NCT01517373|156190058|FG003|Run-in Period|Adverse Event|0|||
48546421|NCT01517373|156190059|FG004|Run-in Period|Adverse Event|0|||
48546422|NCT01517373|156190060|FG005|Run-in Period|Adverse Event|0|||
48611681|NCT00324155|156435311|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
48611682|NCT00324155|156435310|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
48611683|NCT00324155|156435311|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
48611684|NCT00324155|156435310|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
48611685|NCT00324155|156435311|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
48611686|NCT00324155|156435310|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
48546423|NCT01517373|156190055|FG000|Run-in Period|Did not meet eligibility criteria|34|||
48546424|NCT01517373|156190056|FG001|Run-in Period|Did not meet eligibility criteria|0|||
48546425|NCT01517373|156190057|FG002|Run-in Period|Did not meet eligibility criteria|0|||
48546426|NCT01517373|156190058|FG003|Run-in Period|Did not meet eligibility criteria|0|||
48546427|NCT01517373|156190059|FG004|Run-in Period|Did not meet eligibility criteria|0|||
48546428|NCT01517373|156190060|FG005|Run-in Period|Did not meet eligibility criteria|0|||
48546429|NCT01517373|156190055|FG000|Run-in Period|Lost to Follow-up|1|||
48546430|NCT01517373|156190056|FG001|Run-in Period|Lost to Follow-up|0|||
48546431|NCT01517373|156190057|FG002|Run-in Period|Lost to Follow-up|0|||
48546432|NCT01517373|156190058|FG003|Run-in Period|Lost to Follow-up|0|||
48546433|NCT01517373|156190059|FG004|Run-in Period|Lost to Follow-up|0|||
48546434|NCT01517373|156190060|FG005|Run-in Period|Lost to Follow-up|0|||
48546435|NCT01517373|156190055|FG000|Run-in Period|Withdrawal by Subject|12|||
48546436|NCT01517373|156190056|FG001|Run-in Period|Withdrawal by Subject|0|||
48546437|NCT01517373|156190057|FG002|Run-in Period|Withdrawal by Subject|0|||
48546438|NCT01517373|156190058|FG003|Run-in Period|Withdrawal by Subject|0|||
48546439|NCT01517373|156190059|FG004|Run-in Period|Withdrawal by Subject|0|||
48546440|NCT01517373|156190060|FG005|Run-in Period|Withdrawal by Subject|0|||
48546441|NCT01517373|156190055|FG000|Run-in Period|Sponsor Decision|3|||
48546442|NCT01517373|156190056|FG001|Run-in Period|Sponsor Decision|0|||
48546443|NCT01517373|156190057|FG002|Run-in Period|Sponsor Decision|0|||
48546444|NCT01517373|156190058|FG003|Run-in Period|Sponsor Decision|0|||
48546445|NCT01517373|156190059|FG004|Run-in Period|Sponsor Decision|0|||
48546446|NCT01517373|156190060|FG005|Run-in Period|Sponsor Decision|0|||
48546447|NCT01517373|156190055|FG000|Run-in Period|Other|1|||
48546448|NCT01517373|156190056|FG001|Run-in Period|Other|0|||
48546449|NCT01517373|156190057|FG002|Run-in Period|Other|0|||
48546450|NCT01517373|156190058|FG003|Run-in Period|Other|0|||
48546451|NCT01517373|156190059|FG004|Run-in Period|Other|0|||
48546452|NCT01517373|156190060|FG005|Run-in Period|Other|0|||
48546453|NCT01517373|156190055|FG000|Treatment Period|Adverse Event|0|||
48546454|NCT01517373|156190056|FG001|Treatment Period|Adverse Event|0|||
48546455|NCT01517373|156190057|FG002|Treatment Period|Adverse Event|0|||
48611687|NCT00324155|156435311|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
48611688|NCT00324155|156435310|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
48611689|NCT00324155|156435311|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
48611690|NCT00324155|156435310|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
48611691|NCT00324155|156435311|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
48611692|NCT00324155|156435310|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
48611693|NCT00324155|156435311|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
48611694|NCT00324155|156435310|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
48611695|NCT00324155|156435311|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
48611696|NCT00324155|156435310|FG000|Follow-up Phase|On-going participants still on drug|11|||
48611697|NCT00324155|156435311|FG001|Follow-up Phase|On-going participants still on drug|6|||
48611698|NCT02309359|156435314|FG000|Overall Study|Adverse Event|4|||
48611699|NCT02309359|156435315|FG001|Overall Study|Adverse Event|5|||
48611700|NCT02309359|156435316|FG002|Overall Study|Adverse Event|5|||
48611701|NCT02309359|156435317|FG003|Overall Study|Adverse Event|4|||
48611702|NCT02309359|156435318|FG004|Overall Study|Adverse Event|4|||
48611703|NCT02309359|156435314|FG000|Overall Study|Death|1|||
48611704|NCT02309359|156435315|FG001|Overall Study|Death|0|||
48611705|NCT02309359|156435316|FG002|Overall Study|Death|0|||
48611706|NCT02309359|156435317|FG003|Overall Study|Death|0|||
48611707|NCT02309359|156435318|FG004|Overall Study|Death|0|||
48611708|NCT02309359|156435314|FG000|Overall Study|Withdrawal by Subject|2|||
48611709|NCT02309359|156435315|FG001|Overall Study|Withdrawal by Subject|2|||
48611710|NCT02309359|156435316|FG002|Overall Study|Withdrawal by Subject|4|||
48611711|NCT02309359|156435317|FG003|Overall Study|Withdrawal by Subject|4|||
48611712|NCT02309359|156435318|FG004|Overall Study|Withdrawal by Subject|0|||
48611713|NCT02309359|156435314|FG000|Overall Study|Lack of Efficacy|3|||
48611714|NCT02309359|156435315|FG001|Overall Study|Lack of Efficacy|1|||
48611715|NCT02309359|156435316|FG002|Overall Study|Lack of Efficacy|0|||
48611716|NCT02309359|156435317|FG003|Overall Study|Lack of Efficacy|0|||
48611717|NCT02309359|156435318|FG004|Overall Study|Lack of Efficacy|3|||
48546456|NCT01517373|156190058|FG003|Treatment Period|Adverse Event|0|||
48546457|NCT01517373|156190059|FG004|Treatment Period|Adverse Event|0|||
48546458|NCT01517373|156190060|FG005|Treatment Period|Adverse Event|2|||
48546459|NCT01517373|156190055|FG000|Treatment Period|Lost to Follow-up|0|||
48546460|NCT01517373|156190056|FG001|Treatment Period|Lost to Follow-up|0|||
48546461|NCT01517373|156190057|FG002|Treatment Period|Lost to Follow-up|1|||
48546462|NCT01517373|156190058|FG003|Treatment Period|Lost to Follow-up|1|||
48546463|NCT01517373|156190059|FG004|Treatment Period|Lost to Follow-up|0|||
48546464|NCT01517373|156190060|FG005|Treatment Period|Lost to Follow-up|0|||
48546465|NCT01517373|156190055|FG000|Treatment Period|Withdrawal by Subject|0|||
48546466|NCT01517373|156190056|FG001|Treatment Period|Withdrawal by Subject|3|||
48546467|NCT01517373|156190057|FG002|Treatment Period|Withdrawal by Subject|2|||
48546468|NCT01517373|156190058|FG003|Treatment Period|Withdrawal by Subject|2|||
48611718|NCT02309359|156435314|FG000|Overall Study|Lost to Follow-up|0|||
48611719|NCT02309359|156435315|FG001|Overall Study|Lost to Follow-up|0|||
48546469|NCT01517373|156190059|FG004|Treatment Period|Withdrawal by Subject|2|||
48611720|NCT02309359|156435316|FG002|Overall Study|Lost to Follow-up|0|||
48546470|NCT01517373|156190060|FG005|Treatment Period|Withdrawal by Subject|3|||
48546471|NCT01517373|156190055|FG000|Treatment Period|Other|0|||
48611721|NCT02309359|156435317|FG003|Overall Study|Lost to Follow-up|1|||
48611722|NCT02309359|156435318|FG004|Overall Study|Lost to Follow-up|0|||
48611723|NCT02309359|156435314|FG000|Overall Study|Other|2|||
48611724|NCT02309359|156435315|FG001|Overall Study|Other|0|||
48611725|NCT02309359|156435316|FG002|Overall Study|Other|2|||
48611726|NCT02309359|156435317|FG003|Overall Study|Other|3|||
48611727|NCT02309359|156435318|FG004|Overall Study|Other|2|||
48546472|NCT01517373|156190056|FG001|Treatment Period|Other|0|||
48546473|NCT01517373|156190057|FG002|Treatment Period|Other|0|||
48546474|NCT01517373|156190058|FG003|Treatment Period|Other|0|||
48546475|NCT01517373|156190059|FG004|Treatment Period|Other|1|||
48546476|NCT01517373|156190060|FG005|Treatment Period|Other|0|||
48546477|NCT01517373|156190055|FG000|Treatment Period|Protocol Violation|0|||
48546478|NCT01517373|156190056|FG001|Treatment Period|Protocol Violation|0|||
48546479|NCT01517373|156190057|FG002|Treatment Period|Protocol Violation|0|||
48546480|NCT01517373|156190058|FG003|Treatment Period|Protocol Violation|0|||
48546481|NCT01517373|156190059|FG004|Treatment Period|Protocol Violation|1|||
48546482|NCT01517373|156190060|FG005|Treatment Period|Protocol Violation|0|||
48546483|NCT01517373|156190055|FG000|Treatment Period|Lack of Efficacy|0|||
48546484|NCT01517373|156190056|FG001|Treatment Period|Lack of Efficacy|1|||
48546485|NCT01517373|156190057|FG002|Treatment Period|Lack of Efficacy|1|||
48546486|NCT01517373|156190058|FG003|Treatment Period|Lack of Efficacy|3|||
48546487|NCT01517373|156190059|FG004|Treatment Period|Lack of Efficacy|2|||
48546488|NCT01517373|156190060|FG005|Treatment Period|Lack of Efficacy|0|||
48546489|NCT01517373|156190055|FG000|Treatment Period|Medication error without AEs|0|||
48546490|NCT01517373|156190056|FG001|Treatment Period|Medication error without AEs|0|||
48546491|NCT01517373|156190057|FG002|Treatment Period|Medication error without AEs|2|||
48447417|NCT03175562|155827481|FG000|Overall Study|Adverse Event|1|||
48447418|NCT03175562|155827481|FG000|Overall Study|Lost to Follow-up|3|||
48447419|NCT03175562|155827481|FG000|Overall Study|Withdrawal by Subject|7|||
48447420|NCT03175562|155827481|FG000|Overall Study|Other (Not Specified)|5|||
48447421|NCT01878097|155827482|FG000|Baseline|Surveys not fully completed|2497|||
48447422|NCT01878097|155827483|FG001|Baseline|Surveys not fully completed|1800|||
48447423|NCT01878097|155827482|FG000|Implementation Year 1|Surveys not fully completed|3202|||
48447424|NCT01878097|155827483|FG001|Implementation Year 1|Surveys not fully completed|2549|||
48447425|NCT01878097|155827482|FG000|Implementation Year 2|Surveys not fully completed|3281|||
48447426|NCT01878097|155827483|FG001|Implementation Year 2|Surveys not fully completed|2841|||
48447427|NCT01878097|155827482|FG000|Implementation Year 3|Surveys not fully completed|3494|||
48447428|NCT01878097|155827483|FG001|Implementation Year 3|Surveys not fully completed|2980|||
48447429|NCT01878097|155827482|FG000|Implementation Year 4|Surveys not fully completed|3604|||
48447430|NCT01878097|155827483|FG001|Implementation Year 4|Surveys not fully completed|3007|||
48447431|NCT00510484|155827486|FG000|Wash-out Period|Adverse Event|0|||
48447432|NCT00510484|155827487|FG001|Wash-out Period|Adverse Event|1|||
48447433|NCT01590212|155827488|FG000|Overall Study|Withdrawal by Subject|2|||
48447434|NCT01590212|155827489|FG001|Overall Study|Withdrawal by Subject|2|||
48447435|NCT01590212|155827490|FG002|Overall Study|Withdrawal by Subject|2|||
48447436|NCT01590212|155827488|FG000|Overall Study|Lost to Follow-up|1|||
48447437|NCT01590212|155827489|FG001|Overall Study|Lost to Follow-up|2|||
48447438|NCT01590212|155827490|FG002|Overall Study|Lost to Follow-up|3|||
48447439|NCT00150345|155827496|FG000|Overall Study|Death|5|||
48447440|NCT00150345|155827497|FG001|Overall Study|Death|2|||
48447441|NCT00150345|155827496|FG000|Overall Study|Adverse Event|8|||
48447442|NCT00150345|155827497|FG001|Overall Study|Adverse Event|6|||
48447443|NCT00150345|155827496|FG000|Overall Study|Lack of Efficacy|5|||
48447444|NCT00150345|155827497|FG001|Overall Study|Lack of Efficacy|4|||
48447445|NCT00150345|155827496|FG000|Overall Study|Withdrawal by Subject|3|||
48447446|NCT00150345|155827497|FG001|Overall Study|Withdrawal by Subject|4|||
48447447|NCT00150345|155827496|FG000|Overall Study|Laboratory abnormality|1|||
48447448|NCT00150345|155827497|FG001|Overall Study|Laboratory abnormality|2|||
48447449|NCT00150345|155827496|FG000|Overall Study|Other|12|||
48447450|NCT00150345|155827497|FG001|Overall Study|Other|14|||
48447451|NCT01392742|155827498|FG000|Overall Study|Premature study termination|42|||
48447452|NCT01392742|155827498|FG000|Overall Study|Failure to return|35|||
48447453|NCT01392742|155827498|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
48447454|NCT01392742|155827498|FG000|Overall Study|Lost to Follow-up|34|||
48447455|NCT01392742|155827498|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
48447456|NCT01392742|155827498|FG000|Overall Study|ITR and Protocol deviation|1|||
48447457|NCT01392742|155827498|FG000|Overall Study|Adverse event/intercurrent illness|17|||
48447458|NCT01392742|155827498|FG000|Overall Study|Protocol Violation|14|||
48447459|NCT01392742|155827498|FG000|Overall Study|Other|3|||
48447460|NCT01392742|155827498|FG000|Overall Study|Missing information|13|||
48447461|NCT00712933|155827499|FG000|Overall Study|Adverse Event|69|||
48447462|NCT00712933|155827499|FG000|Overall Study|Lack of Efficacy|6|||
48447463|NCT00712933|155827499|FG000|Overall Study|Lost to Follow-up|22|||
48447464|NCT00712933|155827499|FG000|Overall Study|Non-compliance with study drug|13|||
48447465|NCT00712933|155827499|FG000|Overall Study|Other Pregnancy|37|||
48447466|NCT00712933|155827499|FG000|Overall Study|Sponsor decision|14|||
48447467|NCT00712933|155827499|FG000|Overall Study|Withdrew consent|4|||
48447468|NCT00712933|155827499|FG000|Overall Study|Hip replacement surgery|1|||
48447469|NCT00712933|155827499|FG000|Overall Study|Involved in Clinical research|3|||
48447470|NCT00712933|155827499|FG000|Overall Study|Participant hospitalized|1|||
48447471|NCT00712933|155827499|FG000|Overall Study|Participant travelled overseas|2|||
48447472|NCT00712933|155827499|FG000|Overall Study|Death of patient|1|||
48447473|NCT00712933|155827499|FG000|Overall Study|Other Physician decision|1|||
48447474|NCT00712933|155827499|FG000|Overall Study|Not committed to contraception|1|||
48611728|NCT02836769|156435320|FG000|Overall Study|Lost to Follow-up|10|||
48611729|NCT02836769|156435320|FG000|Overall Study|Medical withdrawal|2|||
48611730|NCT02836769|156435320|FG000|Overall Study|Withdrawal by Subject|3|||
48611731|NCT02452190|156435325|FG000|Overall Study|Withdrawal by Sponsor|1|||
48611732|NCT02452190|156435326|FG001|Overall Study|Withdrawal by Sponsor|3|||
48546492|NCT01517373|156190058|FG003|Treatment Period|Medication error without AEs|1|||
48546493|NCT01517373|156190059|FG004|Treatment Period|Medication error without AEs|0|||
48546494|NCT01517373|156190060|FG005|Treatment Period|Medication error without AEs|2|||
48546495|NCT01664130|156190066|FG000|Overall Study|competing secondary disease|2|||
48546496|NCT02728843|156190075|FG000|Overall Study|Adverse Event|0|||
48546497|NCT02728843|156190076|FG001|Overall Study|Adverse Event|2|||
48546498|NCT02728843|156190077|FG002|Overall Study|Adverse Event|3|||
48546499|NCT02728843|156190078|FG003|Overall Study|Adverse Event|1|||
48611733|NCT02452190|156435325|FG000|Overall Study|Pregnancy|1|||
48611734|NCT02452190|156435326|FG001|Overall Study|Pregnancy|0|||
48611735|NCT02452190|156435325|FG000|Overall Study|Investigator's Decision|2|||
48611736|NCT02452190|156435326|FG001|Overall Study|Investigator's Decision|0|||
48611737|NCT02452190|156435325|FG000|Overall Study|Lack of Efficacy|3|||
48611738|NCT02452190|156435326|FG001|Overall Study|Lack of Efficacy|1|||
48611739|NCT02452190|156435325|FG000|Overall Study|Lost to Follow-up|4|||
48611740|NCT02452190|156435326|FG001|Overall Study|Lost to Follow-up|3|||
48611741|NCT02452190|156435325|FG000|Overall Study|Adverse Event|2|||
48611742|NCT02452190|156435326|FG001|Overall Study|Adverse Event|5|||
48611743|NCT02452190|156435325|FG000|Overall Study|Withdrawal by Subject|20|||
48611744|NCT02452190|156435326|FG001|Overall Study|Withdrawal by Subject|11|||
48611745|NCT02452190|156435325|FG000|Overall Study|Noncompliance with study drug|1|||
48611746|NCT02452190|156435326|FG001|Overall Study|Noncompliance with study drug|0|||
48611747|NCT02452190|156435325|FG000|Overall Study|Participant traveled abroad|1|||
48611748|NCT02452190|156435326|FG001|Overall Study|Participant traveled abroad|0|||
48611749|NCT02452190|156435325|FG000|Overall Study|Death|0|||
48611750|NCT02452190|156435326|FG001|Overall Study|Death|1|||
48546500|NCT02728843|156190079|FG004|Overall Study|Adverse Event|2|||
48546501|NCT02728843|156190075|FG000|Overall Study|Lack of Efficacy|0|||
48611751|NCT03839641|156435327|FG000|Overall Study|Withdrawal by Subject|1|||
48611752|NCT03839641|156435328|FG001|Overall Study|Withdrawal by Subject|1|||
48611753|NCT00390013|156435329|FG000|Phase 1|tired|0|||
48611754|NCT00390013|156435330|FG001|Phase 1|tired|0|||
48546502|NCT02728843|156190076|FG001|Overall Study|Lack of Efficacy|1|||
48611755|NCT00390013|156435331|FG002|Phase 1|tired|0|||
48611756|NCT00390013|156435332|FG003|Phase 1|tired|1|||
48611757|NCT00390013|156435329|FG000|Phase 2 First Treatment|tired|1|||
48611758|NCT00390013|156435330|FG001|Phase 2 First Treatment|tired|0|||
48611759|NCT00390013|156435331|FG002|Phase 2 First Treatment|tired|0|||
48611760|NCT00390013|156435332|FG003|Phase 2 First Treatment|tired|0|||
48611761|NCT00390013|156435329|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
48611762|NCT00390013|156435330|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
48611763|NCT00390013|156435331|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
48611764|NCT00390013|156435332|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
48611765|NCT00374868|156435333|FG000|Overall Study|Adverse Event|12|||
48611766|NCT00374868|156435333|FG000|Overall Study|Progressive Disease|7|||
48611767|NCT00374868|156435333|FG000|Overall Study|Physician Decision|13|||
48611768|NCT00374868|156435333|FG000|Overall Study|Lost to Follow-up|1|||
48611769|NCT00374868|156435333|FG000|Overall Study|Death|2|||
48611770|NCT00374868|156435333|FG000|Overall Study|Other - Not Specified|1|||
48611771|NCT04470427|156435334|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
48611772|NCT04470427|156435335|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
48611773|NCT04470427|156435336|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
48611774|NCT04470427|156435337|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
48611775|NCT04470427|156435338|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
48611776|NCT04470427|156435339|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
48611777|NCT04470427|156435334|FG000|Part B :Open-label|Other than specified|0|||
48611778|NCT04470427|156435335|FG001|Part B :Open-label|Other than specified|0|||
48546503|NCT02728843|156190077|FG002|Overall Study|Lack of Efficacy|1|||
48546504|NCT02728843|156190078|FG003|Overall Study|Lack of Efficacy|0|||
48546505|NCT02728843|156190079|FG004|Overall Study|Lack of Efficacy|0|||
48546506|NCT02728843|156190075|FG000|Overall Study|Protocol Violation|2|||
48546507|NCT02728843|156190076|FG001|Overall Study|Protocol Violation|0|||
48546508|NCT02728843|156190077|FG002|Overall Study|Protocol Violation|4|||
48546509|NCT02728843|156190078|FG003|Overall Study|Protocol Violation|2|||
48611779|NCT04470427|156435336|FG002|Part B :Open-label|Other than specified|788|||
48611780|NCT04470427|156435337|FG003|Part B :Open-label|Other than specified|0|||
48611781|NCT04470427|156435338|FG004|Part B :Open-label|Other than specified|523|||
48611782|NCT04470427|156435339|FG005|Part B :Open-label|Other than specified|0|||
48611783|NCT04470427|156435334|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
48611784|NCT04470427|156435335|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
48611785|NCT04470427|156435336|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
48611786|NCT04470427|156435337|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
48611787|NCT04470427|156435338|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
48611788|NCT04470427|156435339|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
48611789|NCT04470427|156435334|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
48611790|NCT04470427|156435335|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
48611791|NCT04470427|156435336|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
48611792|NCT04470427|156435337|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
48611793|NCT04470427|156435338|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
48611794|NCT04470427|156435339|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
48611795|NCT02802228|156435340|FG000|Overall Study|Withdrawal by Subject|2|||
48611796|NCT02802228|156435341|FG001|Overall Study|Withdrawal by Subject|0|||
48611797|NCT02802228|156435340|FG000|Overall Study|Lost to Follow-up|1|||
48611798|NCT02802228|156435341|FG001|Overall Study|Lost to Follow-up|0|||
48611799|NCT02802228|156435340|FG000|Overall Study|Adverse Event|1|||
48611800|NCT02802228|156435341|FG001|Overall Study|Adverse Event|0|||
48611801|NCT02802228|156435340|FG000|Overall Study|Physician Decision|1|||
48611802|NCT02802228|156435341|FG001|Overall Study|Physician Decision|0|||
48546510|NCT02728843|156190079|FG004|Overall Study|Protocol Violation|2|||
48546511|NCT02728843|156190075|FG000|Overall Study|Withdrawal by Subject|1|||
48611803|NCT00724945|156435343|FG000|Period 1|non-compliance|1|||
48611804|NCT00724945|156435344|FG001|Period 1|non-compliance|0|||
48611805|NCT00724945|156435343|FG000|Period 1|Adverse Event|1|||
48546512|NCT02728843|156190076|FG001|Overall Study|Withdrawal by Subject|0|||
48546513|NCT02728843|156190077|FG002|Overall Study|Withdrawal by Subject|0|||
48611806|NCT00724945|156435344|FG001|Period 1|Adverse Event|1|||
48611807|NCT00724945|156435343|FG000|Period 1|Lost to Follow-up|1|||
48611808|NCT00724945|156435344|FG001|Period 1|Lost to Follow-up|0|||
48611809|NCT00724945|156435343|FG000|Period 2|lens comfort issue|3|||
48611810|NCT00724945|156435344|FG001|Period 2|lens comfort issue|0|||
48611811|NCT00724945|156435343|FG000|Period 2|lens physiology issue|1|||
48611812|NCT00724945|156435344|FG001|Period 2|lens physiology issue|0|||
48611813|NCT02207608|156435346|FG000|Overall Study|Adverse Event|1|||
48611814|NCT02207608|156435347|FG001|Overall Study|Adverse Event|0|||
48611815|NCT01030900|156435348|FG000|Overall Study|Not treated due to congestive heart failure|1|||
48611816|NCT01030900|156435348|FG000|Overall Study|Not treated due to rapid disease|1|||
48546514|NCT02728843|156190078|FG003|Overall Study|Withdrawal by Subject|1|||
48546515|NCT02728843|156190079|FG004|Overall Study|Withdrawal by Subject|0|||
48546516|NCT02728843|156190075|FG000|Overall Study|Use of rescue medication|0|||
48546517|NCT02728843|156190076|FG001|Overall Study|Use of rescue medication|2|||
48546518|NCT02728843|156190077|FG002|Overall Study|Use of rescue medication|0|||
48546519|NCT02728843|156190078|FG003|Overall Study|Use of rescue medication|2|||
48546520|NCT02728843|156190079|FG004|Overall Study|Use of rescue medication|1|||
48546521|NCT00205803|156190080|FG000|Infant Series|Lost to Follow-up|10|||
48546522|NCT00205803|156190081|FG001|Infant Series|Lost to Follow-up|4|||
48546523|NCT00205803|156190080|FG000|Infant Series|Withdrawal by Subject|2|||
48546524|NCT00205803|156190081|FG001|Infant Series|Withdrawal by Subject|5|||
48546525|NCT00205803|156190080|FG000|Infant Series|Physician Decision|3|||
48546526|NCT00205803|156190081|FG001|Infant Series|Physician Decision|1|||
48546527|NCT00205803|156190080|FG000|Infant Series|Protocol Violation|1|||
48546528|NCT00205803|156190081|FG001|Infant Series|Protocol Violation|0|||
48546529|NCT00205803|156190080|FG000|Infant Series|Lost Kaiser coverage|0|||
48546530|NCT00205803|156190081|FG001|Infant Series|Lost Kaiser coverage|1|||
48546531|NCT00205803|156190080|FG000|Infant Series|Non-compliant|1|||
48546532|NCT00205803|156190081|FG001|Infant Series|Non-compliant|0|||
48546533|NCT00205803|156190080|FG000|Infant Series|Sponsor request|1|||
48546534|NCT00205803|156190081|FG001|Infant Series|Sponsor request|0|||
48546535|NCT00205803|156190080|FG000|After Infant Series|Adverse Event|1|||
48546536|NCT00205803|156190081|FG001|After Infant Series|Adverse Event|1|||
48546537|NCT00205803|156190080|FG000|After Infant Series|Protocol Violation|1|||
48546538|NCT00205803|156190081|FG001|After Infant Series|Protocol Violation|1|||
48546539|NCT00205803|156190080|FG000|After Infant Series|Lost to Follow-up|2|||
48546540|NCT00205803|156190081|FG001|After Infant Series|Lost to Follow-up|1|||
48546541|NCT00205803|156190080|FG000|After Infant Series|Physician Decision|3|||
48546542|NCT00205803|156190081|FG001|After Infant Series|Physician Decision|2|||
48546543|NCT00205803|156190080|FG000|After Infant Series|Withdrawal by Subject|1|||
48546544|NCT00205803|156190081|FG001|After Infant Series|Withdrawal by Subject|4|||
48546545|NCT00205803|156190080|FG000|After Infant Series|Other|10|||
48546546|NCT00205803|156190081|FG001|After Infant Series|Other|4|||
48546547|NCT00205803|156190080|FG000|Toddler Dose|Lost to Follow-up|2|||
48546548|NCT00205803|156190081|FG001|Toddler Dose|Lost to Follow-up|3|||
48546549|NCT00554606|156190082|FG000|Overall Study|Adverse Event|3|||
48546550|NCT00554606|156190082|FG000|Overall Study|Abnormal laboratory values|1|||
48546551|NCT00554606|156190082|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
48546552|NCT00554606|156190082|FG000|Overall Study|Subject withdrew consent|2|||
48546553|NCT00554606|156190082|FG000|Overall Study|Lost to Follow-up|2|||
48546554|NCT00554606|156190082|FG000|Overall Study|Administrative problems|60|||
48546555|NCT00554606|156190082|FG000|Overall Study|Death|1|||
48546556|NCT00554606|156190082|FG000|Overall Study|Protocol deviation|2|||
48546557|NCT02648932|156190088|FG000|Overall Study|No transplant|3|||
48546558|NCT02648932|156190089|FG001|Overall Study|No transplant|1|||
48546559|NCT03323437|156190090|FG000|Overall Study|Withdrawal by Subject|0|||
48546560|NCT03323437|156190091|FG001|Overall Study|Withdrawal by Subject|4|||
48546561|NCT03678285|156190092|FG000|Overall Study|Adverse Event|2|||
48546562|NCT03678285|156190092|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
48546563|NCT03678285|156190092|FG000|Overall Study|Dehydrated prior to start of workout|1|||
48546564|NCT00123474|156190093|FG000|Randomized to Treatment|Randomized, never treated|1|||
48546565|NCT00123474|156190094|FG001|Randomized to Treatment|Randomized, never treated|4|||
48546566|NCT00123474|156190095|FG002|Randomized to Treatment|Randomized, never treated|2|||
48546567|NCT00123474|156190096|FG003|Randomized to Treatment|Randomized, never treated|1|||
48546568|NCT00123474|156190093|FG000|As Treated at Study Closure|not reported when site closed|1|||
48546569|NCT00123474|156190094|FG001|As Treated at Study Closure|not reported when site closed|0|||
48546570|NCT00123474|156190095|FG002|As Treated at Study Closure|not reported when site closed|1|||
48546571|NCT00123474|156190096|FG003|As Treated at Study Closure|not reported when site closed|0|||
48546572|NCT00123474|156190093|FG000|As Treated at Study Closure|Adverse Event|10|||
48546573|NCT00123474|156190094|FG001|As Treated at Study Closure|Adverse Event|4|||
48546574|NCT00123474|156190095|FG002|As Treated at Study Closure|Adverse Event|10|||
48546575|NCT00123474|156190096|FG003|As Treated at Study Closure|Adverse Event|8|||
48546576|NCT00123474|156190093|FG000|As Treated at Study Closure|Disease Progression|35|||
48546577|NCT00123474|156190094|FG001|As Treated at Study Closure|Disease Progression|42|||
48546578|NCT00123474|156190095|FG002|As Treated at Study Closure|Disease Progression|29|||
48546579|NCT00123474|156190096|FG003|As Treated at Study Closure|Disease Progression|27|||
48546580|NCT00123474|156190093|FG000|As Treated at Study Closure|Investigator Request|12|||
48546581|NCT00123474|156190094|FG001|As Treated at Study Closure|Investigator Request|6|||
48546582|NCT00123474|156190095|FG002|As Treated at Study Closure|Investigator Request|7|||
48546583|NCT00123474|156190096|FG003|As Treated at Study Closure|Investigator Request|5|||
48546584|NCT00123474|156190093|FG000|As Treated at Study Closure|non-specified|54|||
48546585|NCT00123474|156190094|FG001|As Treated at Study Closure|non-specified|47|||
48546586|NCT00123474|156190095|FG002|As Treated at Study Closure|non-specified|57|||
48546587|NCT00123474|156190096|FG003|As Treated at Study Closure|non-specified|60|||
48546588|NCT00123474|156190093|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
48546589|NCT00123474|156190094|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
48546590|NCT00123474|156190095|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
48611817|NCT03334175|156435349|FG000|Overall Study|Lost to Follow-up|0|||
48611818|NCT03334175|156435350|FG001|Overall Study|Lost to Follow-up|1|||
48611819|NCT00632359|156435351|FG000|Overall Study|Withdrawal by Subject|2|||
48611820|NCT01695772|156435354|FG000|Overall Study|Withdrawal by Subject|18|||
48611821|NCT01695772|156435354|FG000|Overall Study|Progressive Disease|8|||
48611822|NCT01695772|156435354|FG000|Overall Study|Investigator Decision|5|||
48611823|NCT01695772|156435354|FG000|Overall Study|Lost to Follow-up|4|||
48611824|NCT01695772|156435354|FG000|Overall Study|Protocol Violation|2|||
48611825|NCT01695772|156435354|FG000|Overall Study|Unspecified Reason|1|||
48611826|NCT00753519|156436773|FG000|Overall Study|Withdrawal by Subject|0|||
48611827|NCT00753519|156436774|FG001|Overall Study|Withdrawal by Subject|2|||
48611828|NCT04591015|156436777|FG000|Overall Study|Death|6|||
48611829|NCT04591015|156436778|FG001|Overall Study|Death|4|||
48611830|NCT04591015|156436777|FG000|Overall Study|Withdrawal by Subject|6|||
48611831|NCT04591015|156436778|FG001|Overall Study|Withdrawal by Subject|3|||
48546591|NCT00123474|156190096|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
48546592|NCT00123474|156190093|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
48546593|NCT00123474|156190094|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
48546594|NCT00123474|156190095|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
48546595|NCT00123474|156190096|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
48546596|NCT00616629|156190097|FG000|Overall Study|Protocol Violation|1|||
48546597|NCT00616629|156190098|FG001|Overall Study|Protocol Violation|2|||
48611832|NCT04591015|156436777|FG000|Overall Study|Lost to Follow-up|16|||
48611833|NCT04591015|156436778|FG001|Overall Study|Lost to Follow-up|11|||
48611834|NCT02194465|156436779|FG000|Overall Study|Adverse Event|6|||
48611835|NCT02194465|156436780|FG001|Overall Study|Adverse Event|1|||
48611836|NCT02194465|156436781|FG002|Overall Study|Adverse Event|4|||
48611837|NCT02194465|156436782|FG003|Overall Study|Adverse Event|4|||
48611838|NCT02194465|156436783|FG004|Overall Study|Adverse Event|4|||
48611839|NCT02194465|156436784|FG005|Overall Study|Adverse Event|2|||
48611840|NCT02194465|156436785|FG006|Overall Study|Adverse Event|0|||
48611841|NCT02194465|156436779|FG000|Overall Study|Lost to Follow-up|0|||
48611842|NCT02194465|156436780|FG001|Overall Study|Lost to Follow-up|0|||
48611843|NCT02194465|156436781|FG002|Overall Study|Lost to Follow-up|0|||
48611844|NCT02194465|156436782|FG003|Overall Study|Lost to Follow-up|1|||
48611845|NCT02194465|156436783|FG004|Overall Study|Lost to Follow-up|0|||
48611846|NCT02194465|156436784|FG005|Overall Study|Lost to Follow-up|1|||
48611847|NCT02194465|156436785|FG006|Overall Study|Lost to Follow-up|0|||
48611848|NCT02194465|156436779|FG000|Overall Study|Physician Decision|1|||
48611849|NCT02194465|156436780|FG001|Overall Study|Physician Decision|0|||
48611850|NCT02194465|156436781|FG002|Overall Study|Physician Decision|0|||
48611851|NCT02194465|156436782|FG003|Overall Study|Physician Decision|0|||
48611852|NCT02194465|156436783|FG004|Overall Study|Physician Decision|0|||
48611853|NCT02194465|156436784|FG005|Overall Study|Physician Decision|0|||
48611854|NCT02194465|156436785|FG006|Overall Study|Physician Decision|0|||
48611855|NCT02194465|156436779|FG000|Overall Study|Protocol Violation|1|||
48611856|NCT02194465|156436780|FG001|Overall Study|Protocol Violation|1|||
48611857|NCT02194465|156436781|FG002|Overall Study|Protocol Violation|2|||
48611858|NCT02194465|156436782|FG003|Overall Study|Protocol Violation|1|||
48611859|NCT02194465|156436783|FG004|Overall Study|Protocol Violation|1|||
48611860|NCT02194465|156436784|FG005|Overall Study|Protocol Violation|0|||
48611861|NCT02194465|156436785|FG006|Overall Study|Protocol Violation|0|||
48611862|NCT02194465|156436779|FG000|Overall Study|Withdrawal by Subject|1|||
48611863|NCT02194465|156436780|FG001|Overall Study|Withdrawal by Subject|3|||
48611864|NCT02194465|156436781|FG002|Overall Study|Withdrawal by Subject|1|||
48611865|NCT02194465|156436782|FG003|Overall Study|Withdrawal by Subject|2|||
48546598|NCT00616629|156190099|FG002|Overall Study|Protocol Violation|1|||
48546599|NCT00616629|156190100|FG003|Overall Study|Protocol Violation|0|||
48546600|NCT00616629|156190101|FG004|Overall Study|Protocol Violation|0|||
48611866|NCT02194465|156436783|FG004|Overall Study|Withdrawal by Subject|2|||
48546601|NCT00616629|156190097|FG000|Overall Study|AV-block|1|||
48611867|NCT02194465|156436784|FG005|Overall Study|Withdrawal by Subject|1|||
48611868|NCT02194465|156436785|FG006|Overall Study|Withdrawal by Subject|2|||
48611869|NCT02194465|156436779|FG000|Overall Study|Discontinued follow-up period|0|||
48611870|NCT02194465|156436780|FG001|Overall Study|Discontinued follow-up period|2|||
48611871|NCT02194465|156436781|FG002|Overall Study|Discontinued follow-up period|1|||
48611872|NCT02194465|156436782|FG003|Overall Study|Discontinued follow-up period|0|||
48546602|NCT00616629|156190098|FG001|Overall Study|AV-block|0|||
48611873|NCT02194465|156436783|FG004|Overall Study|Discontinued follow-up period|2|||
48611874|NCT02194465|156436784|FG005|Overall Study|Discontinued follow-up period|0|||
48611875|NCT02194465|156436785|FG006|Overall Study|Discontinued follow-up period|0|||
48611876|NCT00903968|156436786|FG000|Overall Study|Adverse Event|0|||
48611877|NCT00903968|156436787|FG001|Overall Study|Adverse Event|0|||
48611878|NCT00903968|156436788|FG002|Overall Study|Adverse Event|0|||
48611879|NCT00903968|156436789|FG003|Overall Study|Adverse Event|0|||
48611880|NCT00903968|156436790|FG004|Overall Study|Adverse Event|0|||
48611881|NCT00903968|156436791|FG005|Overall Study|Adverse Event|0|||
48611882|NCT00903968|156436792|FG006|Overall Study|Adverse Event|1|||
48611883|NCT00903968|156436793|FG007|Overall Study|Adverse Event|8|||
48611884|NCT00903968|156436786|FG000|Overall Study|DLT|0|||
48611885|NCT00903968|156436787|FG001|Overall Study|DLT|0|||
48611886|NCT00903968|156436788|FG002|Overall Study|DLT|0|||
48611887|NCT00903968|156436789|FG003|Overall Study|DLT|0|||
48611888|NCT00903968|156436790|FG004|Overall Study|DLT|0|||
48611889|NCT00903968|156436791|FG005|Overall Study|DLT|0|||
48611890|NCT00903968|156436792|FG006|Overall Study|DLT|2|||
48611891|NCT00903968|156436793|FG007|Overall Study|DLT|0|||
48611892|NCT00903968|156436786|FG000|Overall Study|Withdrawal by Subject|1|||
48611893|NCT00903968|156436787|FG001|Overall Study|Withdrawal by Subject|0|||
48611894|NCT00903968|156436788|FG002|Overall Study|Withdrawal by Subject|1|||
48611895|NCT00903968|156436789|FG003|Overall Study|Withdrawal by Subject|0|||
48611896|NCT00903968|156436790|FG004|Overall Study|Withdrawal by Subject|1|||
48611897|NCT00903968|156436791|FG005|Overall Study|Withdrawal by Subject|1|||
48611898|NCT00903968|156436792|FG006|Overall Study|Withdrawal by Subject|0|||
48611899|NCT00903968|156436793|FG007|Overall Study|Withdrawal by Subject|4|||
48611900|NCT00903968|156436786|FG000|Overall Study|Non-Compliance|0|||
48611901|NCT00903968|156436787|FG001|Overall Study|Non-Compliance|0|||
48611902|NCT00903968|156436788|FG002|Overall Study|Non-Compliance|0|||
48611903|NCT00903968|156436789|FG003|Overall Study|Non-Compliance|0|||
48611904|NCT00903968|156436790|FG004|Overall Study|Non-Compliance|0|||
48611905|NCT00903968|156436791|FG005|Overall Study|Non-Compliance|1|||
48611906|NCT00903968|156436792|FG006|Overall Study|Non-Compliance|0|||
48611907|NCT00903968|156436793|FG007|Overall Study|Non-Compliance|0|||
48611908|NCT00903968|156436786|FG000|Overall Study|Physician Decision|0|||
48611909|NCT00903968|156436787|FG001|Overall Study|Physician Decision|0|||
48611910|NCT00903968|156436788|FG002|Overall Study|Physician Decision|0|||
48611911|NCT00903968|156436789|FG003|Overall Study|Physician Decision|0|||
48611912|NCT00903968|156436790|FG004|Overall Study|Physician Decision|0|||
48611913|NCT00903968|156436791|FG005|Overall Study|Physician Decision|1|||
48611914|NCT00903968|156436792|FG006|Overall Study|Physician Decision|0|||
48611915|NCT00903968|156436793|FG007|Overall Study|Physician Decision|0|||
48611916|NCT00903968|156436786|FG000|Overall Study|Progressive Disease|2|||
48611917|NCT00903968|156436787|FG001|Overall Study|Progressive Disease|3|||
48611918|NCT00903968|156436788|FG002|Overall Study|Progressive Disease|2|||
48611919|NCT00903968|156436789|FG003|Overall Study|Progressive Disease|3|||
48611920|NCT00903968|156436790|FG004|Overall Study|Progressive Disease|3|||
48611921|NCT00903968|156436791|FG005|Overall Study|Progressive Disease|3|||
48611922|NCT00903968|156436792|FG006|Overall Study|Progressive Disease|0|||
48611923|NCT00903968|156436793|FG007|Overall Study|Progressive Disease|18|||
48611924|NCT00903968|156436786|FG000|Overall Study|Lack of Efficacy|0|||
48611925|NCT00903968|156436787|FG001|Overall Study|Lack of Efficacy|0|||
48611926|NCT00903968|156436788|FG002|Overall Study|Lack of Efficacy|0|||
48611927|NCT00903968|156436789|FG003|Overall Study|Lack of Efficacy|0|||
48611928|NCT00903968|156436790|FG004|Overall Study|Lack of Efficacy|0|||
48611929|NCT00903968|156436791|FG005|Overall Study|Lack of Efficacy|0|||
48611930|NCT00903968|156436792|FG006|Overall Study|Lack of Efficacy|0|||
48611931|NCT00903968|156436793|FG007|Overall Study|Lack of Efficacy|3|||
48611932|NCT03738696|156436794|FG000|Overall Study|Withdrawal by Subject|0|||
48611933|NCT03738696|156436795|FG001|Overall Study|Withdrawal by Subject|1|||
48611934|NCT03738696|156436794|FG000|Overall Study|Lost to Follow-up|8|||
48611935|NCT03738696|156436795|FG001|Overall Study|Lost to Follow-up|14|||
48611936|NCT01294514|156436798|FG000|Overall Study|Excluded due to Arrhythmia|1|||
48611937|NCT01572792|156436801|FG000|Lead-in Study|Lost to Follow-up|5|||
48611938|NCT01572792|156436802|FG001|Lead-in Study|Lost to Follow-up|9|||
48611939|NCT01572792|156436803|FG002|Lead-in Study|Lost to Follow-up|4|||
48611940|NCT01572792|156436804|FG003|Lead-in Study|Lost to Follow-up|2|||
48611941|NCT01572792|156436805|FG004|Lead-in Study|Lost to Follow-up|4|||
48611942|NCT01572792|156436801|FG000|Lead-in Study|Withdrawal by Subject|22|||
48611943|NCT01572792|156436802|FG001|Lead-in Study|Withdrawal by Subject|11|||
48611944|NCT01572792|156436803|FG002|Lead-in Study|Withdrawal by Subject|12|||
48611945|NCT01572792|156436804|FG003|Lead-in Study|Withdrawal by Subject|24|||
48546603|NCT00616629|156190099|FG002|Overall Study|AV-block|0|||
48546604|NCT00616629|156190100|FG003|Overall Study|AV-block|0|||
48546605|NCT00616629|156190101|FG004|Overall Study|AV-block|0|||
48546606|NCT01161407|156190102|FG000|Overall Study|Protocol Violation|3|||
48546607|NCT01161407|156190103|FG001|Overall Study|Protocol Violation|1|||
48546608|NCT03796039|156190104|FG000|Overall Study|Death|2|||
48546609|NCT03796039|156190105|FG001|Overall Study|Death|1|||
48546610|NCT03796039|156190104|FG000|Overall Study|Withdrawal by Subject|7|||
48546611|NCT03796039|156190105|FG001|Overall Study|Withdrawal by Subject|4|||
48546612|NCT00252239|156190106|FG000|Overall Study|Withdrawal by Subject|1|||
48611946|NCT01572792|156436805|FG004|Lead-in Study|Withdrawal by Subject|11|||
48611947|NCT01572792|156436801|FG000|Lead-in Study|Protocol Violation|19|||
48611948|NCT01572792|156436802|FG001|Lead-in Study|Protocol Violation|10|||
48611949|NCT01572792|156436803|FG002|Lead-in Study|Protocol Violation|12|||
48611950|NCT01572792|156436804|FG003|Lead-in Study|Protocol Violation|13|||
48611951|NCT01572792|156436805|FG004|Lead-in Study|Protocol Violation|21|||
48611952|NCT01572792|156436801|FG000|Lead-in Study|Lack of Efficacy|20|||
48611953|NCT01572792|156436802|FG001|Lead-in Study|Lack of Efficacy|5|||
48611954|NCT01572792|156436803|FG002|Lead-in Study|Lack of Efficacy|4|||
48611955|NCT01572792|156436804|FG003|Lead-in Study|Lack of Efficacy|8|||
48611956|NCT01572792|156436805|FG004|Lead-in Study|Lack of Efficacy|10|||
48611957|NCT01572792|156436801|FG000|Lead-in Study|Adverse Event|21|||
48611958|NCT01572792|156436802|FG001|Lead-in Study|Adverse Event|21|||
48546613|NCT00252239|156190107|FG001|Overall Study|Withdrawal by Subject|0|||
48611959|NCT01572792|156436803|FG002|Lead-in Study|Adverse Event|22|||
48611960|NCT01572792|156436804|FG003|Lead-in Study|Adverse Event|16|||
48611961|NCT01572792|156436805|FG004|Lead-in Study|Adverse Event|14|||
48611962|NCT01572792|156436801|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
48611963|NCT01572792|156436802|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
48546614|NCT00252239|156190108|FG002|Overall Study|Withdrawal by Subject|0|||
48546615|NCT00252239|156190109|FG003|Overall Study|Withdrawal by Subject|1|||
48546616|NCT00252239|156190106|FG000|Overall Study|Lost to Follow-up|0|||
48546617|NCT00252239|156190107|FG001|Overall Study|Lost to Follow-up|0|||
48546618|NCT00252239|156190108|FG002|Overall Study|Lost to Follow-up|2|||
48546619|NCT00252239|156190109|FG003|Overall Study|Lost to Follow-up|0|||
48546620|NCT02927366|156190110|FG000|Overall Study|Adverse Event|1|||
48546621|NCT02927366|156190111|FG001|Overall Study|Adverse Event|0|||
48546622|NCT02927366|156190110|FG000|Overall Study|Patient schedule|1|||
48546623|NCT02927366|156190111|FG001|Overall Study|Patient schedule|0|||
48546624|NCT02828241|156190112|FG000|Overall Study|Adverse Event|7|||
48546625|NCT02828241|156190113|FG001|Overall Study|Adverse Event|2|||
48546626|NCT02828241|156190112|FG000|Overall Study|Protocol Violation|1|||
48546627|NCT02828241|156190113|FG001|Overall Study|Protocol Violation|0|||
48546628|NCT02802631|156190116|FG000|Overall Study|Withdrawal by Subject|1|||
48546629|NCT02802631|156190117|FG001|Overall Study|Withdrawal by Subject|0|||
48546630|NCT02802631|156190118|FG002|Overall Study|Withdrawal by Subject|0|||
48546631|NCT02802631|156190119|FG003|Overall Study|Withdrawal by Subject|0|||
48546632|NCT02802631|156190120|FG004|Overall Study|Withdrawal by Subject|0|||
48546633|NCT02802631|156190121|FG005|Overall Study|Withdrawal by Subject|0|||
48546634|NCT02802631|156190122|FG006|Overall Study|Withdrawal by Subject|0|||
48546635|NCT02802631|156190123|FG007|Overall Study|Withdrawal by Subject|0|||
48546636|NCT02802631|156190116|FG000|Overall Study|Physician Decision|1|||
48546637|NCT02802631|156190117|FG001|Overall Study|Physician Decision|0|||
48546638|NCT02802631|156190118|FG002|Overall Study|Physician Decision|0|||
48546639|NCT02802631|156190119|FG003|Overall Study|Physician Decision|0|||
48611964|NCT01572792|156436803|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
48611965|NCT01572792|156436804|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
48611966|NCT01572792|156436805|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
48611967|NCT01572792|156436801|FG000|Extension Study|Lost to Follow-up|6|||
48611968|NCT01572792|156436802|FG001|Extension Study|Lost to Follow-up|2|||
48611969|NCT01572792|156436803|FG002|Extension Study|Lost to Follow-up|0|||
48611970|NCT01572792|156436804|FG003|Extension Study|Lost to Follow-up|3|||
48611971|NCT01572792|156436805|FG004|Extension Study|Lost to Follow-up|3|||
48611972|NCT01572792|156436801|FG000|Extension Study|Withdrawal by Subject|7|||
48546640|NCT02802631|156190120|FG004|Overall Study|Physician Decision|0|||
48546641|NCT02802631|156190121|FG005|Overall Study|Physician Decision|0|||
48546642|NCT02802631|156190122|FG006|Overall Study|Physician Decision|1|||
48611973|NCT01572792|156436802|FG001|Extension Study|Withdrawal by Subject|6|||
48546643|NCT02802631|156190123|FG007|Overall Study|Physician Decision|0|||
48546644|NCT02802631|156190116|FG000|Overall Study|Adverse Event|0|||
48546645|NCT02802631|156190117|FG001|Overall Study|Adverse Event|2|||
48611974|NCT01572792|156436803|FG002|Extension Study|Withdrawal by Subject|11|||
48611975|NCT01572792|156436804|FG003|Extension Study|Withdrawal by Subject|8|||
48611976|NCT01572792|156436805|FG004|Extension Study|Withdrawal by Subject|14|||
48546646|NCT02802631|156190118|FG002|Overall Study|Adverse Event|0|||
48546647|NCT02802631|156190119|FG003|Overall Study|Adverse Event|1|||
48611977|NCT01572792|156436801|FG000|Extension Study|Protocol Violation|0|||
48611978|NCT01572792|156436802|FG001|Extension Study|Protocol Violation|4|||
48611979|NCT01572792|156436803|FG002|Extension Study|Protocol Violation|3|||
48611980|NCT01572792|156436804|FG003|Extension Study|Protocol Violation|4|||
48611981|NCT01572792|156436805|FG004|Extension Study|Protocol Violation|3|||
48611982|NCT01572792|156436801|FG000|Extension Study|Lack of Efficacy|2|||
48611983|NCT01572792|156436802|FG001|Extension Study|Lack of Efficacy|3|||
48611984|NCT01572792|156436803|FG002|Extension Study|Lack of Efficacy|3|||
48611985|NCT01572792|156436804|FG003|Extension Study|Lack of Efficacy|2|||
48611986|NCT01572792|156436805|FG004|Extension Study|Lack of Efficacy|2|||
48611987|NCT01572792|156436801|FG000|Extension Study|Adverse Event|7|||
48611988|NCT01572792|156436802|FG001|Extension Study|Adverse Event|6|||
48611989|NCT01572792|156436803|FG002|Extension Study|Adverse Event|5|||
48611990|NCT01572792|156436804|FG003|Extension Study|Adverse Event|6|||
48611991|NCT01572792|156436805|FG004|Extension Study|Adverse Event|4|||
48611992|NCT01572792|156436801|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
48611993|NCT01572792|156436802|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
48611994|NCT01572792|156436803|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
48611995|NCT01572792|156436804|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
48611996|NCT01572792|156436805|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
48611997|NCT02101294|156436806|FG000|Overall Study|Withdrawal by Subject|5|||
48611998|NCT02101294|156436806|FG000|Overall Study|Lost to Follow-up|6|||
48611999|NCT03416179|156436807|FG000|Overall Study|Death|90|||
48612000|NCT03416179|156436808|FG001|Overall Study|Death|87|||
48612001|NCT03416179|156436809|FG002|Overall Study|Death|117|||
48612002|NCT03416179|156436810|FG003|Overall Study|Death|113|||
48612003|NCT03416179|156436807|FG000|Overall Study|Withdrawal by Subject|15|||
48612004|NCT03416179|156436808|FG001|Overall Study|Withdrawal by Subject|20|||
48612005|NCT03416179|156436809|FG002|Overall Study|Withdrawal by Subject|6|||
48612006|NCT03416179|156436810|FG003|Overall Study|Withdrawal by Subject|9|||
48612007|NCT03416179|156436807|FG000|Overall Study|Lost to Follow-up|1|||
48612008|NCT03416179|156436808|FG001|Overall Study|Lost to Follow-up|1|||
48612009|NCT03416179|156436809|FG002|Overall Study|Lost to Follow-up|0|||
48612010|NCT03416179|156436810|FG003|Overall Study|Lost to Follow-up|3|||
48447629|NCT02186561|155827578|FG000|Enrollment|Withdrawal by Subject|2|||
48447630|NCT02186561|155827578|FG000|Enrollment|Investigator Withdrew Consent|1|||
48447631|NCT02186561|155827578|FG000|30-Day Post Index Procedure Visit|Death|1|||
48447632|NCT02186561|155827578|FG000|1- Year Post Index Procedure Visit|Death|1|||
48447633|NCT02186561|155827578|FG000|1- Year Post Index Procedure Visit|Missed|1|||
48447634|NCT00587301|155827581|FG000|Overall Study|Screen Failure|9|||
48447635|NCT00587301|155827581|FG000|Overall Study|Lost to Follow-up|22|||
48447636|NCT00587301|155827581|FG000|Overall Study|Withdrawal by Subject|7|||
48447637|NCT00587301|155827581|FG000|Overall Study|Protocol Violation|7|||
48612011|NCT03416179|156436807|FG000|Overall Study|Study participation terminated by Sponsor|93|||
48612012|NCT03416179|156436808|FG001|Overall Study|Study participation terminated by Sponsor|91|||
48612013|NCT03416179|156436809|FG002|Overall Study|Study participation terminated by Sponsor|26|||
48612014|NCT03416179|156436810|FG003|Overall Study|Study participation terminated by Sponsor|31|||
48612015|NCT03416179|156436807|FG000|Overall Study|Other|2|||
48612016|NCT03416179|156436808|FG001|Overall Study|Other|3|||
48612017|NCT03416179|156436809|FG002|Overall Study|Other|1|||
48612018|NCT03416179|156436810|FG003|Overall Study|Other|0|||
48612019|NCT02311478|156436814|FG000|Overall Study|Withdrawal by Subject|1|||
48612020|NCT02311478|156436814|FG000|Overall Study|Lost to Follow-up|5|||
48612021|NCT02311478|156436814|FG000|Overall Study|Failed IUD Insertion|1|||
48612022|NCT02225587|156436817|FG000|Overall Study|Adverse Event|5|||
48612023|NCT02225587|156436818|FG001|Overall Study|Adverse Event|5|||
48612024|NCT02225587|156436817|FG000|Overall Study|Lost to Follow-up|5|||
48612025|NCT02225587|156436818|FG001|Overall Study|Lost to Follow-up|5|||
48612026|NCT02225587|156436817|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48612027|NCT02225587|156436818|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48612028|NCT02225587|156436817|FG000|Overall Study|Physician Decision|2|||
48612029|NCT02225587|156436818|FG001|Overall Study|Physician Decision|0|||
48612030|NCT02225587|156436817|FG000|Overall Study|Protocol Violation|1|||
48612031|NCT02225587|156436818|FG001|Overall Study|Protocol Violation|0|||
48612032|NCT02225587|156436817|FG000|Overall Study|Participant Moved|1|||
48612033|NCT02225587|156436818|FG001|Overall Study|Participant Moved|0|||
48612034|NCT02225587|156436817|FG000|Overall Study|Withdrawal by Subject|13|||
48612035|NCT02225587|156436818|FG001|Overall Study|Withdrawal by Subject|28|||
48612036|NCT01925794|156436821|FG000|180 Days|Death|2|||
48612037|NCT01925794|156436821|FG000|180 Days|Withdrawal by Subject|2|||
48612038|NCT01925794|156436821|FG000|270 Days|Death|2|||
48612039|NCT01925794|156436821|FG000|270 Days|Protocol Violation|3|||
48612040|NCT05073315|156436824|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
48612041|NCT05073315|156436825|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
48612042|NCT05073315|156436826|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
48612043|NCT05073315|156436824|FG000|Period 1 (Lead-in Period)|Death|1|||
48612044|NCT05073315|156436825|FG001|Period 1 (Lead-in Period)|Death|0|||
48612045|NCT05073315|156436826|FG002|Period 1 (Lead-in Period)|Death|0|||
48612046|NCT05073315|156436824|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
48612047|NCT05073315|156436825|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
48612048|NCT05073315|156436826|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
48612049|NCT05073315|156436824|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
48612050|NCT05073315|156436825|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
48612051|NCT05073315|156436826|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
48612052|NCT05073315|156436824|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
48612053|NCT05073315|156436825|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
48612054|NCT05073315|156436826|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
48612055|NCT05073315|156436824|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
48612056|NCT05073315|156436825|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
48612057|NCT05073315|156436826|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
48612058|NCT05073315|156436824|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
48612059|NCT05073315|156436825|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
48612060|NCT05073315|156436826|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
48612061|NCT05073315|156436824|FG000|Period 2|Adverse Event|0|||
48612062|NCT05073315|156436825|FG001|Period 2|Adverse Event|3|||
48612063|NCT05073315|156436826|FG002|Period 2|Adverse Event|6|||
48612064|NCT05073315|156436824|FG000|Period 2|Lost to Follow-up|0|||
48612065|NCT05073315|156436825|FG001|Period 2|Lost to Follow-up|5|||
48612066|NCT05073315|156436826|FG002|Period 2|Lost to Follow-up|5|||
48612067|NCT05073315|156436824|FG000|Period 2|Withdrawal by Subject|0|||
48612068|NCT05073315|156436825|FG001|Period 2|Withdrawal by Subject|4|||
48612069|NCT05073315|156436826|FG002|Period 2|Withdrawal by Subject|9|||
48612070|NCT05073315|156436824|FG000|Period 2|Protocol Violation|0|||
48612071|NCT05073315|156436825|FG001|Period 2|Protocol Violation|0|||
48612072|NCT05073315|156436826|FG002|Period 2|Protocol Violation|1|||
48612073|NCT00294658|156436827|FG000|Overall Study|Death|0|||
48612074|NCT00294658|156436828|FG001|Overall Study|Death|1|||
48612075|NCT00294658|156436827|FG000|Overall Study|Lost to Follow-up|4|||
48612076|NCT00294658|156436828|FG001|Overall Study|Lost to Follow-up|0|||
48612077|NCT00294658|156436827|FG000|Overall Study|Physician Decision|1|||
48612078|NCT00294658|156436828|FG001|Overall Study|Physician Decision|2|||
48546648|NCT02802631|156190120|FG004|Overall Study|Adverse Event|6|||
48546649|NCT02802631|156190121|FG005|Overall Study|Adverse Event|1|||
48546650|NCT02802631|156190122|FG006|Overall Study|Adverse Event|4|||
48546651|NCT02802631|156190123|FG007|Overall Study|Adverse Event|0|||
48546652|NCT02802631|156190116|FG000|Overall Study|Sponsor Decision|0|||
48546653|NCT02802631|156190117|FG001|Overall Study|Sponsor Decision|0|||
48546654|NCT02802631|156190118|FG002|Overall Study|Sponsor Decision|6|||
48546655|NCT02802631|156190119|FG003|Overall Study|Sponsor Decision|0|||
48546656|NCT02802631|156190120|FG004|Overall Study|Sponsor Decision|2|||
48546657|NCT02802631|156190121|FG005|Overall Study|Sponsor Decision|0|||
48546658|NCT02802631|156190122|FG006|Overall Study|Sponsor Decision|0|||
48546659|NCT02802631|156190123|FG007|Overall Study|Sponsor Decision|4|||
48546660|NCT01982812|156190124|FG000|Overall Study|Death|1|||
48546661|NCT01982812|156190125|FG001|Overall Study|Death|5|||
48546662|NCT01982812|156190124|FG000|Overall Study|Adverse Event|0|||
48546663|NCT01982812|156190125|FG001|Overall Study|Adverse Event|5|||
48546664|NCT04400682|156190126|FG000|Period 1|Withdrawal by Subject|1|||
48546665|NCT04400682|156190127|FG001|Period 1|Withdrawal by Subject|4|||
48546666|NCT02377427|156190128|FG000|Part A (Up to Week 20)|Physician Decision|1|||
48546667|NCT02377427|156190129|FG001|Part A (Up to Week 20)|Physician Decision|0|||
48546668|NCT02377427|156190130|FG002|Part A (Up to Week 20)|Physician Decision|0|||
48546669|NCT02377427|156190131|FG003|Part A (Up to Week 20)|Physician Decision|0|||
48546670|NCT02377427|156190132|FG004|Part A (Up to Week 20)|Physician Decision|0|||
48546671|NCT02377427|156190128|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
48546672|NCT02377427|156190129|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
48546673|NCT02377427|156190130|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
48546674|NCT02377427|156190131|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
48546675|NCT02377427|156190132|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
48546676|NCT02377427|156190128|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
48546677|NCT02377427|156190129|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
48546678|NCT02377427|156190130|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
48546679|NCT02377427|156190131|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
48546680|NCT02377427|156190132|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
48546681|NCT02377427|156190128|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
48546682|NCT02377427|156190129|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
48546683|NCT02377427|156190130|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
48546684|NCT02377427|156190131|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
48546685|NCT02377427|156190132|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
48546686|NCT02342639|156190139|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
48546687|NCT02342639|156190140|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
48546688|NCT02342639|156190139|FG000|Overall Study|Protocol Violation|0|||
48546689|NCT02342639|156190140|FG001|Overall Study|Protocol Violation|2|||
48546690|NCT02492880|156192257|FG000|Overall Study|Lost to Follow-up|1|||
48546691|NCT02492880|156192257|FG000|Overall Study|Protocol Violation|1|||
48546692|NCT03858634|156192258|FG000|Overall Study|Withdrawal by Subject|1|||
48612079|NCT00294658|156436827|FG000|Overall Study|Pregnancy|0|||
48546693|NCT03858634|156192259|FG001|Overall Study|Withdrawal by Subject|0|||
48612080|NCT00294658|156436828|FG001|Overall Study|Pregnancy|1|||
48612081|NCT00294658|156436827|FG000|Overall Study|Withdrawal by Subject|0|||
48612082|NCT00294658|156436828|FG001|Overall Study|Withdrawal by Subject|4|||
48612083|NCT00294658|156436827|FG000|Overall Study|Found to have invasive thymoma|1|||
48612084|NCT00294658|156436828|FG001|Overall Study|Found to have invasive thymoma|0|||
48612085|NCT00294658|156436827|FG000|Overall Study|Patient and family were not satisfied|0|||
48612086|NCT00294658|156436828|FG001|Overall Study|Patient and family were not satisfied|1|||
48612087|NCT00976027|156436830|FG000|Overall Study|Serious Adverse Event|36|||
48612088|NCT00976027|156436831|FG001|Overall Study|Serious Adverse Event|17|||
48612089|NCT00976027|156436830|FG000|Overall Study|Adverse Event|0|||
48612090|NCT00976027|156436831|FG001|Overall Study|Adverse Event|2|||
48612091|NCT00976027|156436830|FG000|Overall Study|Protocol Violation|60|||
48612092|NCT00976027|156436831|FG001|Overall Study|Protocol Violation|27|||
48612093|NCT00976027|156436830|FG000|Overall Study|Lost to Follow-up|208|||
48612094|NCT00976027|156436831|FG001|Overall Study|Lost to Follow-up|103|||
48612095|NCT00976027|156436830|FG000|Overall Study|Withdrawal by Subject|107|||
48612096|NCT00976027|156436831|FG001|Overall Study|Withdrawal by Subject|66|||
48612097|NCT02691572|156436844|FG000|Overall Study|Withdrawal by Subject|1|||
48612098|NCT02691572|156436845|FG001|Overall Study|Withdrawal by Subject|0|||
48612099|NCT02691572|156436844|FG000|Overall Study|Protocol Violation|0|||
48612100|NCT02691572|156436845|FG001|Overall Study|Protocol Violation|1|||
48546694|NCT03858634|156192258|FG000|Overall Study|Adverse Event|1|||
48546695|NCT03858634|156192259|FG001|Overall Study|Adverse Event|0|||
48546696|NCT03858634|156192258|FG000|Overall Study|Lost to Follow-up|0|||
48546697|NCT03858634|156192259|FG001|Overall Study|Lost to Follow-up|1|||
48546698|NCT03858634|156192258|FG000|Overall Study|Other, Not Specified|1|||
48546699|NCT03858634|156192259|FG001|Overall Study|Other, Not Specified|1|||
48546700|NCT00824616|156192260|FG000|Overall Study|Adverse Event|2|||
48546701|NCT00824616|156192261|FG001|Overall Study|Adverse Event|1|||
48546702|NCT00824616|156192260|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
48546703|NCT00824616|156192261|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
48546704|NCT00824616|156192260|FG000|Overall Study|Hyperglycemia|1|||
48612101|NCT00927472|156436846|FG000|Overall Study|Withdrawal by Subject|10|||
48612102|NCT00927472|156436847|FG001|Overall Study|Withdrawal by Subject|11|||
48612103|NCT00927472|156436846|FG000|Overall Study|Lost to Follow-up|1|||
48612104|NCT00927472|156436847|FG001|Overall Study|Lost to Follow-up|6|||
48612105|NCT00927472|156436846|FG000|Overall Study|Protocol Violation|0|||
48612106|NCT00927472|156436847|FG001|Overall Study|Protocol Violation|1|||
48612107|NCT00927472|156436846|FG000|Overall Study|Post treatment Assessment out of window|0|||
48612108|NCT00927472|156436847|FG001|Overall Study|Post treatment Assessment out of window|4|||
48612109|NCT02401230|156436849|FG000|Overall Study|Adverse Event|3|||
48612110|NCT02401230|156436850|FG001|Overall Study|Adverse Event|2|||
48612111|NCT02401230|156436851|FG002|Overall Study|Adverse Event|0|||
48612112|NCT02401230|156436849|FG000|Overall Study|Withdrawal by Subject|2|||
48612113|NCT02401230|156436850|FG001|Overall Study|Withdrawal by Subject|1|||
48612114|NCT02401230|156436851|FG002|Overall Study|Withdrawal by Subject|1|||
48612115|NCT02401230|156436849|FG000|Overall Study|Lost to Follow-up|1|||
48612116|NCT02401230|156436850|FG001|Overall Study|Lost to Follow-up|3|||
48612117|NCT02401230|156436851|FG002|Overall Study|Lost to Follow-up|3|||
48612118|NCT01925417|156436863|FG000|Overall Study|Withdrawal by Subject|2|||
48612119|NCT01925417|156436863|FG000|Overall Study|Death|1|||
48612120|NCT03550209|156436866|FG000|Overall Study|Lost to Follow-up|1|||
48612121|NCT03550209|156436867|FG001|Overall Study|Lost to Follow-up|0|||
48612122|NCT03550209|156436868|FG002|Overall Study|Lost to Follow-up|1|||
48546705|NCT00824616|156192261|FG001|Overall Study|Hyperglycemia|1|||
48546706|NCT00824616|156192260|FG000|Overall Study|Lack of Efficacy|2|||
48546707|NCT00824616|156192261|FG001|Overall Study|Lack of Efficacy|1|||
48546708|NCT00824616|156192260|FG000|Overall Study|Lost to Follow-up|0|||
48546709|NCT00824616|156192261|FG001|Overall Study|Lost to Follow-up|1|||
48546710|NCT00824616|156192260|FG000|Overall Study|Withdrawal by Subject|1|||
48546711|NCT00824616|156192261|FG001|Overall Study|Withdrawal by Subject|1|||
48546712|NCT00577395|156192262|FG000|Overall Study|Study was terminated early by Sponsor|7|||
48546713|NCT00577395|156192263|FG001|Overall Study|Study was terminated early by Sponsor|6|||
48546714|NCT01200992|156192264|FG000|Overall Study|Study terminated early|35|||
48546715|NCT01200992|156192265|FG001|Overall Study|Study terminated early|41|||
48546716|NCT01200992|156192264|FG000|Overall Study|Randomized but not treated|2|||
48546717|NCT01200992|156192265|FG001|Overall Study|Randomized but not treated|0|||
48546718|NCT03186781|156192268|FG000|Overall Study|Lost to Follow-up|0|||
48546719|NCT03186781|156192269|FG001|Overall Study|Lost to Follow-up|0|||
48612123|NCT03550209|156436869|FG003|Overall Study|Lost to Follow-up|0|||
48612124|NCT03550209|156436866|FG000|Overall Study|Withdrawal by Subject|0|||
48612125|NCT03550209|156436867|FG001|Overall Study|Withdrawal by Subject|3|||
48612126|NCT03550209|156436868|FG002|Overall Study|Withdrawal by Subject|1|||
48612127|NCT03550209|156436869|FG003|Overall Study|Withdrawal by Subject|2|||
48612128|NCT03550209|156436866|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
48612129|NCT03550209|156436867|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
48612130|NCT03550209|156436868|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
48612131|NCT03550209|156436869|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
48612132|NCT02555878|156436870|FG000|Overall Study|Lost to Follow-up|2|||
48612133|NCT02555878|156436871|FG001|Overall Study|Lost to Follow-up|3|||
48612134|NCT02555878|156436870|FG000|Overall Study|Withdrawal by Subject|48|||
48612135|NCT02555878|156436871|FG001|Overall Study|Withdrawal by Subject|48|||
48612136|NCT02555878|156436870|FG000|Overall Study|Adverse Event|12|||
48612137|NCT02555878|156436871|FG001|Overall Study|Adverse Event|8|||
48612138|NCT02555878|156436870|FG000|Overall Study|Death|74|||
48612139|NCT02555878|156436871|FG001|Overall Study|Death|59|||
48612140|NCT02555878|156436870|FG000|Overall Study|Protocol Violation|1|||
48612141|NCT02555878|156436871|FG001|Overall Study|Protocol Violation|2|||
48612142|NCT02555878|156436870|FG000|Overall Study|Physician Decision|12|||
48612143|NCT02555878|156436871|FG001|Overall Study|Physician Decision|13|||
48546720|NCT03186781|156192270|FG002|Overall Study|Lost to Follow-up|1|||
48546721|NCT03186781|156192271|FG003|Overall Study|Lost to Follow-up|0|||
48546722|NCT03186781|156192272|FG004|Overall Study|Lost to Follow-up|1|||
48546723|NCT03186781|156192273|FG005|Overall Study|Lost to Follow-up|0|||
48546724|NCT03186781|156192268|FG000|Overall Study|Moved from Area|0|||
48546725|NCT03186781|156192269|FG001|Overall Study|Moved from Area|0|||
48546726|NCT03186781|156192270|FG002|Overall Study|Moved from Area|0|||
48612144|NCT02555878|156436870|FG000|Overall Study|Other|17|||
48612145|NCT02555878|156436871|FG001|Overall Study|Other|17|||
48612146|NCT00765076|156436872|FG000|Overall Study|Adverse Event|1|||
48612147|NCT00765076|156436873|FG001|Overall Study|Adverse Event|0|||
48612148|NCT00765076|156436874|FG002|Overall Study|Adverse Event|0|||
48612149|NCT00765076|156436872|FG000|Overall Study|Withdrawal by Subject|0|||
48612150|NCT00765076|156436873|FG001|Overall Study|Withdrawal by Subject|0|||
48612151|NCT00765076|156436874|FG002|Overall Study|Withdrawal by Subject|1|||
48612152|NCT01164475|156436875|FG000|Overall Study|Lack of Efficacy|1|||
48612153|NCT01164475|156436876|FG001|Overall Study|Lack of Efficacy|0|||
48612154|NCT01164475|156436875|FG000|Overall Study|Other|0|||
48612155|NCT01164475|156436876|FG001|Overall Study|Other|1|||
48612156|NCT01164475|156436875|FG000|Overall Study|Progressive disease|0|||
48612157|NCT01164475|156436876|FG001|Overall Study|Progressive disease|1|||
48612158|NCT01164475|156436875|FG000|Overall Study|Protocol Violation|1|||
48612159|NCT01164475|156436876|FG001|Overall Study|Protocol Violation|0|||
48612160|NCT02335944|156436877|FG000|Treatment Phase|Progressive Disease|2|||
48612161|NCT02335944|156436878|FG001|Treatment Phase|Progressive Disease|5|||
48612162|NCT02335944|156436879|FG002|Treatment Phase|Progressive Disease|2|||
48612163|NCT02335944|156436880|FG003|Treatment Phase|Progressive Disease|11|||
48612164|NCT02335944|156436881|FG004|Treatment Phase|Progressive Disease|4|||
48612165|NCT02335944|156436882|FG005|Treatment Phase|Progressive Disease|25|||
48612166|NCT02335944|156436883|FG006|Treatment Phase|Progressive Disease|2|||
48612167|NCT02335944|156436884|FG007|Treatment Phase|Progressive Disease|30|||
48612168|NCT02335944|156436885|FG008|Treatment Phase|Progressive Disease|27|||
48612169|NCT02335944|156436886|FG009|Treatment Phase|Progressive Disease|0|||
48612170|NCT02335944|156436877|FG000|Treatment Phase|Adverse Event|2|||
48612171|NCT02335944|156436878|FG001|Treatment Phase|Adverse Event|0|||
48612172|NCT02335944|156436879|FG002|Treatment Phase|Adverse Event|0|||
48612173|NCT02335944|156436880|FG003|Treatment Phase|Adverse Event|2|||
48612174|NCT02335944|156436881|FG004|Treatment Phase|Adverse Event|1|||
48612175|NCT02335944|156436882|FG005|Treatment Phase|Adverse Event|15|||
48612176|NCT02335944|156436883|FG006|Treatment Phase|Adverse Event|0|||
48612177|NCT02335944|156436884|FG007|Treatment Phase|Adverse Event|5|||
48612178|NCT02335944|156436885|FG008|Treatment Phase|Adverse Event|7|||
48612179|NCT02335944|156436886|FG009|Treatment Phase|Adverse Event|0|||
48612180|NCT02335944|156436877|FG000|Treatment Phase|Physician Decision|0|||
48612181|NCT02335944|156436878|FG001|Treatment Phase|Physician Decision|0|||
48612182|NCT02335944|156436879|FG002|Treatment Phase|Physician Decision|0|||
48612183|NCT02335944|156436880|FG003|Treatment Phase|Physician Decision|1|||
48612184|NCT02335944|156436881|FG004|Treatment Phase|Physician Decision|0|||
48546727|NCT03186781|156192271|FG003|Overall Study|Moved from Area|0|||
48546728|NCT03186781|156192272|FG004|Overall Study|Moved from Area|1|||
48612185|NCT02335944|156436882|FG005|Treatment Phase|Physician Decision|6|||
48325477|NCT00371345|155389106|FG001|Overall Study|Participant Withdrew Consent|1|||
48612186|NCT02335944|156436883|FG006|Treatment Phase|Physician Decision|1|||
48612187|NCT02335944|156436884|FG007|Treatment Phase|Physician Decision|2|||
48612188|NCT02335944|156436885|FG008|Treatment Phase|Physician Decision|1|||
48612189|NCT02335944|156436886|FG009|Treatment Phase|Physician Decision|0|||
48612190|NCT02335944|156436877|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
48612191|NCT02335944|156436878|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
48612192|NCT02335944|156436879|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
48612193|NCT02335944|156436880|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
48546729|NCT03186781|156192273|FG005|Overall Study|Moved from Area|0|||
48546730|NCT03186781|156192268|FG000|Overall Study|Withdrawal by Subject|0|||
48612194|NCT02335944|156436881|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
48546731|NCT03186781|156192269|FG001|Overall Study|Withdrawal by Subject|0|||
48546732|NCT03186781|156192270|FG002|Overall Study|Withdrawal by Subject|0|||
48546733|NCT03186781|156192271|FG003|Overall Study|Withdrawal by Subject|0|||
48546734|NCT03186781|156192272|FG004|Overall Study|Withdrawal by Subject|1|||
48546735|NCT03186781|156192273|FG005|Overall Study|Withdrawal by Subject|0|||
48546736|NCT04663295|156192274|FG000|Run-in Period|Withdrawal by Subject|3|||
48546737|NCT04663295|156192274|FG000|Overall Study Period|Pregnancy|1|||
48546738|NCT04663295|156192274|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
48546739|NCT03665441|156192283|FG000|Overall Study|survival follow up ongoing|23|||
48546740|NCT03665441|156192284|FG001|Overall Study|survival follow up ongoing|0|||
48546741|NCT03665441|156192283|FG000|Overall Study|Patients ongoing on treatment|9|||
48546742|NCT03665441|156192284|FG001|Overall Study|Patients ongoing on treatment|6|||
48546743|NCT03665441|156192283|FG000|Overall Study|Randomized but not treated|7|||
48546744|NCT03665441|156192284|FG001|Overall Study|Randomized but not treated|11|||
48546745|NCT00554190|156192287|FG000|Overall Study|Termination forms not completed|10|||
48546746|NCT00121134|156192290|FG000|Overall Study|Progression of Disease|5|||
48546747|NCT00121134|156192291|FG001|Overall Study|Progression of Disease|3|||
48546748|NCT00121134|156192292|FG002|Overall Study|Progression of Disease|4|||
48546749|NCT00121134|156192293|FG003|Overall Study|Progression of Disease|2|||
48546750|NCT00121134|156192290|FG000|Overall Study|Toxicity|4|||
48546751|NCT00121134|156192291|FG001|Overall Study|Toxicity|7|||
48546752|NCT00121134|156192292|FG002|Overall Study|Toxicity|13|||
48546753|NCT00121134|156192293|FG003|Overall Study|Toxicity|5|||
48546754|NCT00121134|156192290|FG000|Overall Study|Physician Decision|6|||
48546755|NCT00121134|156192291|FG001|Overall Study|Physician Decision|4|||
48546756|NCT00121134|156192292|FG002|Overall Study|Physician Decision|4|||
48546757|NCT00121134|156192293|FG003|Overall Study|Physician Decision|1|||
48546758|NCT00121134|156192290|FG000|Overall Study|Treatment Delay|1|||
48546759|NCT00121134|156192291|FG001|Overall Study|Treatment Delay|0|||
48546760|NCT00121134|156192292|FG002|Overall Study|Treatment Delay|0|||
48546761|NCT00121134|156192293|FG003|Overall Study|Treatment Delay|0|||
48546762|NCT00121134|156192290|FG000|Overall Study|Intercurrent Illness|0|||
48546763|NCT00121134|156192291|FG001|Overall Study|Intercurrent Illness|0|||
48546764|NCT00121134|156192292|FG002|Overall Study|Intercurrent Illness|0|||
48546765|NCT00121134|156192293|FG003|Overall Study|Intercurrent Illness|1|||
48546766|NCT00121134|156192290|FG000|Overall Study|Patient Personal Reasons|0|||
48546767|NCT00121134|156192291|FG001|Overall Study|Patient Personal Reasons|1|||
48546768|NCT00121134|156192292|FG002|Overall Study|Patient Personal Reasons|0|||
48546769|NCT00121134|156192293|FG003|Overall Study|Patient Personal Reasons|0|||
48546770|NCT00565617|156192294|FG000|Overall Study|Withdrawal by Subject|1|||
48546771|NCT01085734|156192295|FG000|Overall Study|Adverse Event|0|||
48546772|NCT01085734|156192296|FG001|Overall Study|Adverse Event|2|||
48546773|NCT01085734|156192295|FG000|Overall Study|Death|1|||
48546774|NCT01085734|156192296|FG001|Overall Study|Death|0|||
48546775|NCT01085734|156192295|FG000|Overall Study|Lost to Follow-up|0|||
48546776|NCT01085734|156192296|FG001|Overall Study|Lost to Follow-up|1|||
48546777|NCT01085734|156192295|FG000|Overall Study|Withdrawal by Subject|0|||
48546778|NCT01085734|156192296|FG001|Overall Study|Withdrawal by Subject|1|||
48546779|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
48546780|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
48546781|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
48546782|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
48546783|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
48546784|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
48546785|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
48546786|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
48546787|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
48546788|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
48546789|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Death|1|||
48546790|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Death|0|||
48546791|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Death|0|||
48546792|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Death|0|||
48546793|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Death|0|||
48546794|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
48546795|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
48546796|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
48546797|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
48546798|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
48546799|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
48546800|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
48546801|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
48546802|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
48546803|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
48546804|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
48546805|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
48546806|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
48546807|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
48546808|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
48546809|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
48546810|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
48546811|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
48546812|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
48546813|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48546814|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
48546815|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48546816|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48546817|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48546818|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48546819|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Other|4|||
48546820|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Other|4|||
48546821|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Other|3|||
48546822|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Other|1|||
48546823|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Other|0|||
48546824|NCT01081834|156192299|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
48546825|NCT01081834|156192300|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
48546826|NCT01081834|156192301|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
48546827|NCT01081834|156192302|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
48546828|NCT01081834|156192303|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
48546829|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
48546830|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
48546831|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
48546832|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
48546833|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
48546834|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Death|1|||
48546835|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Death|0|||
48546836|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Death|0|||
48546837|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Death|0|||
48546838|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Death|0|||
48546839|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
48546840|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
48546841|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48546842|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48546843|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48546844|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48546845|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
48546846|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48546847|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48546848|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48546849|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48546850|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
48546851|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
48546852|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
48546853|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
48546854|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
48546855|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
48546856|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
48612195|NCT02335944|156436882|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
48612196|NCT02335944|156436883|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
48612197|NCT02335944|156436884|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
48612198|NCT02335944|156436885|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
48612199|NCT02335944|156436886|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
48612200|NCT02335944|156436877|FG000|Treatment Phase|Subject/Guardian Decision|0|||
48546857|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
48546858|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
48546859|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
48546860|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
48546861|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
48546862|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
48546863|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
48546864|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Other|4|||
48546865|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Other|5|||
48546866|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Other|4|||
48546867|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Other|0|||
48546868|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Other|0|||
48546869|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
48546870|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
48546871|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
48546872|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
48546873|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
48546874|NCT01081834|156192299|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48546875|NCT01081834|156192300|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
48546876|NCT01081834|156192301|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48546877|NCT01081834|156192302|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48546878|NCT01081834|156192303|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48546879|NCT02679235|156192304|FG000|Overall Study|Withdrawal by Subject|3|||
48546880|NCT02679235|156192304|FG000|Overall Study|Adverse Event|1|||
48546881|NCT01059344|156192305|FG000|Overall Study|Adverse Event|12|||
48546882|NCT01059344|156192306|FG001|Overall Study|Adverse Event|30|||
48546883|NCT01059344|156192305|FG000|Overall Study|Withdrawal by Subject|6|||
48546884|NCT01059344|156192306|FG001|Overall Study|Withdrawal by Subject|9|||
48546885|NCT01059344|156192305|FG000|Overall Study|Lost to Follow-up|1|||
48546886|NCT01059344|156192306|FG001|Overall Study|Lost to Follow-up|1|||
48546887|NCT01059344|156192305|FG000|Overall Study|Other|3|||
48546888|NCT01059344|156192306|FG001|Overall Study|Other|6|||
48546889|NCT00094861|156192311|FG000|Overall Study|Adverse Event|5|||
48546890|NCT00094861|156192312|FG001|Overall Study|Adverse Event|2|||
48546891|NCT00094861|156192311|FG000|Overall Study|Withdrawal by Subject|5|||
48546892|NCT00094861|156192312|FG001|Overall Study|Withdrawal by Subject|3|||
48546893|NCT00094861|156192311|FG000|Overall Study|Physician Decision|1|||
48546894|NCT00094861|156192312|FG001|Overall Study|Physician Decision|1|||
48546895|NCT00094861|156192311|FG000|Overall Study|Lost to Follow-up|0|||
48546896|NCT00094861|156192312|FG001|Overall Study|Lost to Follow-up|1|||
48546897|NCT00094861|156192311|FG000|Overall Study|Death|4|||
48546898|NCT00094861|156192312|FG001|Overall Study|Death|2|||
48546899|NCT00094861|156192311|FG000|Overall Study|Other|3|||
48546900|NCT00094861|156192312|FG001|Overall Study|Other|0|||
48546901|NCT02906358|156192315|FG000|Overall Study|Withdrawal by Subject|10|||
48546902|NCT02906358|156192316|FG001|Overall Study|Withdrawal by Subject|7|||
48546903|NCT02906358|156192315|FG000|Overall Study|Lost to Follow-up|12|||
48546904|NCT02906358|156192316|FG001|Overall Study|Lost to Follow-up|15|||
48546905|NCT01473524|156192317|FG000|DB Phase|Adverse Event|4|||
48546906|NCT01473524|156192318|FG001|DB Phase|Adverse Event|8|||
48546907|NCT01473524|156192319|FG002|DB Phase|Adverse Event|2|||
48546908|NCT01473524|156192320|FG003|DB Phase|Adverse Event|0|||
48546909|NCT01473524|156192321|FG004|DB Phase|Adverse Event|0|||
48546910|NCT01473524|156192322|FG005|DB Phase|Adverse Event|0|||
48546911|NCT01473524|156192317|FG000|DB Phase|Death|1|||
48546912|NCT01473524|156192318|FG001|DB Phase|Death|0|||
48546913|NCT01473524|156192319|FG002|DB Phase|Death|0|||
48546914|NCT01473524|156192320|FG003|DB Phase|Death|0|||
48546915|NCT01473524|156192321|FG004|DB Phase|Death|0|||
48546916|NCT01473524|156192322|FG005|DB Phase|Death|0|||
48546917|NCT01473524|156192317|FG000|DB Phase|Withdrawal by Subject|2|||
48546918|NCT01473524|156192318|FG001|DB Phase|Withdrawal by Subject|1|||
48546919|NCT01473524|156192319|FG002|DB Phase|Withdrawal by Subject|1|||
48546920|NCT01473524|156192320|FG003|DB Phase|Withdrawal by Subject|0|||
48546921|NCT01473524|156192321|FG004|DB Phase|Withdrawal by Subject|0|||
48546922|NCT01473524|156192322|FG005|DB Phase|Withdrawal by Subject|0|||
48546923|NCT01473524|156192317|FG000|LTSE Phase|Withdrawal by Subject|0|||
48546924|NCT01473524|156192318|FG001|LTSE Phase|Withdrawal by Subject|0|||
48546925|NCT01473524|156192319|FG002|LTSE Phase|Withdrawal by Subject|0|||
48546926|NCT01473524|156192320|FG003|LTSE Phase|Withdrawal by Subject|3|||
48546927|NCT01473524|156192321|FG004|LTSE Phase|Withdrawal by Subject|3|||
48546928|NCT01473524|156192322|FG005|LTSE Phase|Withdrawal by Subject|6|||
48546929|NCT01473524|156192317|FG000|LTSE Phase|Death|0|||
48546930|NCT01473524|156192318|FG001|LTSE Phase|Death|0|||
48546931|NCT01473524|156192319|FG002|LTSE Phase|Death|0|||
48612201|NCT02335944|156436878|FG001|Treatment Phase|Subject/Guardian Decision|0|||
48612202|NCT02335944|156436879|FG002|Treatment Phase|Subject/Guardian Decision|1|||
48612203|NCT02335944|156436880|FG003|Treatment Phase|Subject/Guardian Decision|0|||
48612204|NCT02335944|156436881|FG004|Treatment Phase|Subject/Guardian Decision|0|||
48612205|NCT02335944|156436882|FG005|Treatment Phase|Subject/Guardian Decision|1|||
48612206|NCT02335944|156436883|FG006|Treatment Phase|Subject/Guardian Decision|0|||
48612207|NCT02335944|156436884|FG007|Treatment Phase|Subject/Guardian Decision|4|||
48612208|NCT02335944|156436885|FG008|Treatment Phase|Subject/Guardian Decision|0|||
48612209|NCT02335944|156436886|FG009|Treatment Phase|Subject/Guardian Decision|0|||
48612210|NCT02335944|156436877|FG000|Post-treatment Follow-up|Progressive Disease|0|||
48612211|NCT02335944|156436878|FG001|Post-treatment Follow-up|Progressive Disease|0|||
48612212|NCT02335944|156436879|FG002|Post-treatment Follow-up|Progressive Disease|0|||
48612213|NCT02335944|156436880|FG003|Post-treatment Follow-up|Progressive Disease|1|||
48612214|NCT02335944|156436881|FG004|Post-treatment Follow-up|Progressive Disease|0|||
48612215|NCT02335944|156436882|FG005|Post-treatment Follow-up|Progressive Disease|9|||
48612216|NCT02335944|156436883|FG006|Post-treatment Follow-up|Progressive Disease|0|||
48612217|NCT02335944|156436884|FG007|Post-treatment Follow-up|Progressive Disease|2|||
48612218|NCT02335944|156436885|FG008|Post-treatment Follow-up|Progressive Disease|3|||
48612219|NCT02335944|156436886|FG009|Post-treatment Follow-up|Progressive Disease|0|||
48612220|NCT02335944|156436877|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48612221|NCT02335944|156436878|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48612222|NCT02335944|156436879|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48612223|NCT02335944|156436880|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48546932|NCT01473524|156192320|FG003|LTSE Phase|Death|0|||
48546933|NCT01473524|156192321|FG004|LTSE Phase|Death|1|||
48546934|NCT01473524|156192322|FG005|LTSE Phase|Death|0|||
48546935|NCT01473524|156192317|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
48546936|NCT01473524|156192318|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
48546937|NCT01473524|156192319|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
48546938|NCT01473524|156192320|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
48546939|NCT01473524|156192321|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
48546940|NCT01473524|156192322|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
48546941|NCT01473524|156192317|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
48546942|NCT01473524|156192318|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
48546943|NCT01473524|156192319|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
48546944|NCT01473524|156192320|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
48546945|NCT01473524|156192321|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
48546946|NCT01473524|156192322|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
48546947|NCT01473524|156192317|FG000|LTSE Phase|Lost to Follow-up|0|||
48546948|NCT01473524|156192318|FG001|LTSE Phase|Lost to Follow-up|0|||
48546949|NCT01473524|156192319|FG002|LTSE Phase|Lost to Follow-up|0|||
48546950|NCT01473524|156192320|FG003|LTSE Phase|Lost to Follow-up|1|||
48546951|NCT01473524|156192321|FG004|LTSE Phase|Lost to Follow-up|3|||
48546952|NCT01473524|156192322|FG005|LTSE Phase|Lost to Follow-up|2|||
48546953|NCT01473524|156192317|FG000|LTSE Phase|Principal Investigator Decision|0|||
48546954|NCT01473524|156192318|FG001|LTSE Phase|Principal Investigator Decision|0|||
48546955|NCT01473524|156192319|FG002|LTSE Phase|Principal Investigator Decision|0|||
48546956|NCT01473524|156192320|FG003|LTSE Phase|Principal Investigator Decision|1|||
48546957|NCT01473524|156192321|FG004|LTSE Phase|Principal Investigator Decision|1|||
48546958|NCT01473524|156192322|FG005|LTSE Phase|Principal Investigator Decision|3|||
48546959|NCT01473524|156192317|FG000|LTSE Phase|Liver Transplantation|0|||
48546960|NCT01473524|156192318|FG001|LTSE Phase|Liver Transplantation|0|||
48546961|NCT01473524|156192319|FG002|LTSE Phase|Liver Transplantation|0|||
48546962|NCT01473524|156192320|FG003|LTSE Phase|Liver Transplantation|0|||
48546963|NCT01473524|156192321|FG004|LTSE Phase|Liver Transplantation|0|||
48546964|NCT01473524|156192322|FG005|LTSE Phase|Liver Transplantation|1|||
48546965|NCT01473524|156192317|FG000|LTSE Phase|Pregnancy|0|||
48612224|NCT02335944|156436881|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48612225|NCT02335944|156436882|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
48546966|NCT01473524|156192318|FG001|LTSE Phase|Pregnancy|0|||
48546967|NCT01473524|156192319|FG002|LTSE Phase|Pregnancy|0|||
48546968|NCT01473524|156192320|FG003|LTSE Phase|Pregnancy|1|||
48546969|NCT01473524|156192321|FG004|LTSE Phase|Pregnancy|0|||
48546970|NCT01473524|156192322|FG005|LTSE Phase|Pregnancy|0|||
48546971|NCT01473524|156192317|FG000|LTSE Phase|Protocol Violation|0|||
48546972|NCT01473524|156192318|FG001|LTSE Phase|Protocol Violation|0|||
48546973|NCT01473524|156192319|FG002|LTSE Phase|Protocol Violation|0|||
48546974|NCT01473524|156192320|FG003|LTSE Phase|Protocol Violation|0|||
48546975|NCT01473524|156192321|FG004|LTSE Phase|Protocol Violation|0|||
48546976|NCT01473524|156192322|FG005|LTSE Phase|Protocol Violation|1|||
48546977|NCT01315132|156192323|FG000|Overall Study|not treated due to disease progression|1|||
48612226|NCT02335944|156436883|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48612227|NCT02335944|156436884|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48612228|NCT02335944|156436885|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48612229|NCT02335944|156436886|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
48612230|NCT02335944|156436877|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612231|NCT02335944|156436878|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612232|NCT02335944|156436879|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612233|NCT02335944|156436880|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612234|NCT02335944|156436881|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612235|NCT02335944|156436882|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612236|NCT02335944|156436883|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612237|NCT02335944|156436884|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
48612238|NCT02335944|156436885|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612239|NCT02335944|156436886|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
48612240|NCT02335944|156436877|FG000|Post-treatment Follow-up|Adverse Event|0|||
48612241|NCT02335944|156436878|FG001|Post-treatment Follow-up|Adverse Event|0|||
48612242|NCT02335944|156436879|FG002|Post-treatment Follow-up|Adverse Event|0|||
48612243|NCT02335944|156436880|FG003|Post-treatment Follow-up|Adverse Event|0|||
48612244|NCT02335944|156436881|FG004|Post-treatment Follow-up|Adverse Event|0|||
48612245|NCT02335944|156436882|FG005|Post-treatment Follow-up|Adverse Event|1|||
48612246|NCT02335944|156436883|FG006|Post-treatment Follow-up|Adverse Event|0|||
48612247|NCT02335944|156436884|FG007|Post-treatment Follow-up|Adverse Event|0|||
48612248|NCT02335944|156436885|FG008|Post-treatment Follow-up|Adverse Event|0|||
48612249|NCT02335944|156436886|FG009|Post-treatment Follow-up|Adverse Event|0|||
48612250|NCT02335944|156436877|FG000|Post-treatment Follow-up|Death|0|||
48612251|NCT02335944|156436878|FG001|Post-treatment Follow-up|Death|0|||
48612252|NCT02335944|156436879|FG002|Post-treatment Follow-up|Death|0|||
48612253|NCT02335944|156436880|FG003|Post-treatment Follow-up|Death|1|||
48612254|NCT02335944|156436881|FG004|Post-treatment Follow-up|Death|0|||
48612255|NCT02335944|156436882|FG005|Post-treatment Follow-up|Death|1|||
48612256|NCT02335944|156436883|FG006|Post-treatment Follow-up|Death|0|||
48612257|NCT02335944|156436884|FG007|Post-treatment Follow-up|Death|0|||
48612258|NCT02335944|156436885|FG008|Post-treatment Follow-up|Death|0|||
48546978|NCT03893565|156192328|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
48546979|NCT03893565|156192329|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
48546980|NCT03893565|156192330|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
48546981|NCT03893565|156192331|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
48546982|NCT03893565|156192332|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
48546983|NCT03893565|156192333|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
48546984|NCT03893565|156192334|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
48546985|NCT03893565|156192335|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
48546986|NCT03893565|156192336|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
48546987|NCT03893565|156192328|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
48546988|NCT03893565|156192329|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
48546989|NCT03893565|156192330|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
48546990|NCT03893565|156192331|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
48546991|NCT03893565|156192332|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
48546992|NCT03893565|156192333|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
48546993|NCT03893565|156192334|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
48546994|NCT03893565|156192335|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
48546995|NCT03893565|156192336|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
48546996|NCT03893565|156192328|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48546997|NCT03893565|156192329|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
48546998|NCT03893565|156192330|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48546999|NCT03893565|156192331|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
48612259|NCT02335944|156436886|FG009|Post-treatment Follow-up|Death|0|||
48612260|NCT02335944|156436877|FG000|Post-treatment Follow-up|Physician Decision|1|||
48612261|NCT02335944|156436878|FG001|Post-treatment Follow-up|Physician Decision|0|||
48612262|NCT02335944|156436879|FG002|Post-treatment Follow-up|Physician Decision|0|||
48612263|NCT02335944|156436880|FG003|Post-treatment Follow-up|Physician Decision|0|||
48612264|NCT02335944|156436881|FG004|Post-treatment Follow-up|Physician Decision|0|||
48612265|NCT02335944|156436882|FG005|Post-treatment Follow-up|Physician Decision|0|||
48612266|NCT02335944|156436883|FG006|Post-treatment Follow-up|Physician Decision|0|||
48612267|NCT02335944|156436884|FG007|Post-treatment Follow-up|Physician Decision|1|||
48612268|NCT02335944|156436885|FG008|Post-treatment Follow-up|Physician Decision|0|||
48612269|NCT02335944|156436886|FG009|Post-treatment Follow-up|Physician Decision|0|||
48612270|NCT01202591|156436887|FG000|Overall Study|Adverse Event|2|||
48547000|NCT03893565|156192332|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547001|NCT03893565|156192333|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547002|NCT03893565|156192334|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547003|NCT03893565|156192335|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547004|NCT03893565|156192336|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547005|NCT03893565|156192328|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
48547006|NCT03893565|156192329|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
48547007|NCT03893565|156192330|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
48612271|NCT01202591|156436888|FG001|Overall Study|Adverse Event|1|||
48612272|NCT01202591|156436889|FG002|Overall Study|Adverse Event|4|||
48612273|NCT01202591|156436890|FG003|Overall Study|Adverse Event|4|||
48612274|NCT01202591|156436891|FG004|Overall Study|Adverse Event|0|||
48612275|NCT01202591|156436892|FG005|Overall Study|Adverse Event|0|||
48612276|NCT01202591|156436887|FG000|Overall Study|Other reason as per investigator|3|||
48612277|NCT01202591|156436888|FG001|Overall Study|Other reason as per investigator|4|||
48612278|NCT01202591|156436889|FG002|Overall Study|Other reason as per investigator|7|||
48612279|NCT01202591|156436890|FG003|Overall Study|Other reason as per investigator|3|||
48612280|NCT01202591|156436891|FG004|Overall Study|Other reason as per investigator|1|||
48612281|NCT01202591|156436892|FG005|Overall Study|Other reason as per investigator|3|||
48612282|NCT01202591|156436887|FG000|Overall Study|Withdrawal by Subject|0|||
48612283|NCT01202591|156436888|FG001|Overall Study|Withdrawal by Subject|0|||
48547008|NCT03893565|156192331|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
48547009|NCT03893565|156192332|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
48547010|NCT03893565|156192333|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
48612284|NCT01202591|156436889|FG002|Overall Study|Withdrawal by Subject|0|||
48612285|NCT01202591|156436890|FG003|Overall Study|Withdrawal by Subject|0|||
48612286|NCT01202591|156436891|FG004|Overall Study|Withdrawal by Subject|2|||
48612287|NCT01202591|156436892|FG005|Overall Study|Withdrawal by Subject|1|||
48547011|NCT03893565|156192334|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
48547012|NCT03893565|156192335|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
48547013|NCT03893565|156192336|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
48547014|NCT03893565|156192328|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
48547015|NCT03893565|156192329|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
48547016|NCT03893565|156192330|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
48547017|NCT03893565|156192331|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547018|NCT03893565|156192332|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
48547019|NCT03893565|156192333|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547020|NCT03893565|156192334|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547021|NCT03893565|156192335|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547022|NCT03893565|156192336|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547023|NCT03893565|156192328|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
48547024|NCT03893565|156192329|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
48547025|NCT03893565|156192330|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
48547026|NCT03893565|156192331|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
48547027|NCT03893565|156192332|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
48547028|NCT03893565|156192333|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
48547029|NCT03893565|156192334|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
48547030|NCT03893565|156192335|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
48547031|NCT03893565|156192336|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
48547032|NCT03893565|156192328|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547033|NCT03893565|156192329|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547034|NCT03893565|156192330|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547035|NCT03893565|156192331|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
48547036|NCT03893565|156192332|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547037|NCT03893565|156192333|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547038|NCT03893565|156192334|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547039|NCT03893565|156192335|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547040|NCT03893565|156192336|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547041|NCT03893565|156192328|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
48547042|NCT03893565|156192329|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
48547043|NCT03893565|156192330|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
48547044|NCT03893565|156192331|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
48547045|NCT03893565|156192332|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
48547046|NCT03893565|156192333|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
48547047|NCT03893565|156192334|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
48547048|NCT03893565|156192335|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
48547049|NCT03893565|156192336|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
48547050|NCT03893565|156192328|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
48547051|NCT03893565|156192329|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
48547052|NCT03893565|156192330|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
48547053|NCT03893565|156192331|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
48547054|NCT03893565|156192332|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
48547055|NCT03893565|156192333|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
48547056|NCT03893565|156192334|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
48547057|NCT03893565|156192335|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
48547058|NCT03893565|156192336|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
48547059|NCT03893565|156192328|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
48547060|NCT03893565|156192329|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
48547061|NCT03893565|156192330|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
48547062|NCT03893565|156192331|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
48547063|NCT03893565|156192332|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
48547064|NCT03893565|156192333|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
48547065|NCT03893565|156192334|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
48547066|NCT03893565|156192335|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
48547067|NCT03893565|156192336|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
48547068|NCT03893565|156192328|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
48547069|NCT03893565|156192329|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
48547070|NCT03893565|156192330|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
48547071|NCT03893565|156192331|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
48547072|NCT03893565|156192332|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
48547073|NCT03893565|156192333|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
48547074|NCT03893565|156192334|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
48547075|NCT03893565|156192335|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
48547076|NCT03893565|156192336|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
48547077|NCT03893565|156192328|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
48547078|NCT03893565|156192329|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
48547079|NCT03893565|156192330|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
48547080|NCT03893565|156192331|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
48547081|NCT03893565|156192332|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
48547082|NCT03893565|156192333|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
48547083|NCT03893565|156192334|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
48547084|NCT03893565|156192335|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
48547085|NCT03893565|156192336|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
48547086|NCT03893565|156192328|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547087|NCT03893565|156192329|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547088|NCT03893565|156192330|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547089|NCT03893565|156192331|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547090|NCT03893565|156192332|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547091|NCT03893565|156192333|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547092|NCT03893565|156192334|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547093|NCT03893565|156192335|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
48547094|NCT03893565|156192336|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
48547095|NCT03893565|156192328|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547096|NCT03893565|156192329|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547097|NCT03893565|156192330|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547098|NCT03893565|156192331|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547099|NCT03893565|156192332|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547100|NCT03893565|156192333|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547101|NCT03893565|156192334|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547102|NCT03893565|156192335|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
48547103|NCT03893565|156192336|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
48547104|NCT03893565|156192328|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547105|NCT03893565|156192329|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547106|NCT03893565|156192330|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547107|NCT03893565|156192331|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547108|NCT03893565|156192332|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547109|NCT03893565|156192333|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48612288|NCT01202591|156436887|FG000|Overall Study|Objective Disease Progression|0|||
48612289|NCT01202591|156436888|FG001|Overall Study|Objective Disease Progression|0|||
48547110|NCT03893565|156192334|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547111|NCT03893565|156192335|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
48547112|NCT03893565|156192336|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
48547113|NCT03893565|156192328|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
48547114|NCT03893565|156192329|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
48547115|NCT03893565|156192330|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
48547116|NCT03893565|156192331|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
48547117|NCT03893565|156192332|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
48547118|NCT03893565|156192333|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
48547119|NCT03893565|156192334|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
48547120|NCT03893565|156192335|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
48612290|NCT01202591|156436889|FG002|Overall Study|Objective Disease Progression|0|||
48612291|NCT01202591|156436890|FG003|Overall Study|Objective Disease Progression|0|||
48612292|NCT01202591|156436891|FG004|Overall Study|Objective Disease Progression|2|||
48612293|NCT01202591|156436892|FG005|Overall Study|Objective Disease Progression|0|||
48547121|NCT03893565|156192336|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
48547122|NCT00912912|156192337|FG000|Overall Study|Withdrawal by Subject|1|||
48547123|NCT00912912|156192337|FG000|Overall Study|Disease Progression|3|||
48547124|NCT03207867|156192338|FG000|Overall Study|Adverse Event|1|||
48612294|NCT02406612|156436897|FG000|Overall Study|Screening Failure|3|||
48612295|NCT02406612|156436898|FG001|Overall Study|Screening Failure|0|||
48547125|NCT03207867|156192339|FG001|Overall Study|Adverse Event|0|||
48547126|NCT03207867|156192340|FG002|Overall Study|Adverse Event|1|||
48547127|NCT03207867|156192341|FG003|Overall Study|Adverse Event|0|||
48547128|NCT03207867|156192342|FG004|Overall Study|Adverse Event|0|||
48547129|NCT03207867|156192343|FG005|Overall Study|Adverse Event|2|||
48547130|NCT03207867|156192344|FG006|Overall Study|Adverse Event|1|||
48547131|NCT03207867|156192345|FG007|Overall Study|Adverse Event|1|||
48547132|NCT03207867|156192346|FG008|Overall Study|Adverse Event|2|||
48547133|NCT03207867|156192347|FG009|Overall Study|Adverse Event|2|||
48547134|NCT03207867|156192348|FG010|Overall Study|Adverse Event|0|||
48547135|NCT03207867|156192349|FG011|Overall Study|Adverse Event|0|||
48547136|NCT03207867|156192350|FG012|Overall Study|Adverse Event|0|||
48547137|NCT03207867|156192351|FG013|Overall Study|Adverse Event|0|||
48547138|NCT03207867|156192352|FG014|Overall Study|Adverse Event|0|||
48547139|NCT03207867|156192353|FG015|Overall Study|Adverse Event|0|||
48547140|NCT03207867|156192354|FG016|Overall Study|Adverse Event|3|||
48547141|NCT03207867|156192355|FG017|Overall Study|Adverse Event|1|||
48547142|NCT03207867|156192356|FG018|Overall Study|Adverse Event|2|||
48547143|NCT03207867|156192357|FG019|Overall Study|Adverse Event|1|||
48547144|NCT03207867|156192358|FG020|Overall Study|Adverse Event|0|||
48547145|NCT03207867|156192359|FG021|Overall Study|Adverse Event|0|||
48547146|NCT03207867|156192360|FG022|Overall Study|Adverse Event|0|||
48547147|NCT03207867|156192361|FG023|Overall Study|Adverse Event|0|||
48547148|NCT03207867|156192338|FG000|Overall Study|Death|0|||
48547149|NCT03207867|156192339|FG001|Overall Study|Death|0|||
48547150|NCT03207867|156192340|FG002|Overall Study|Death|0|||
48547151|NCT03207867|156192341|FG003|Overall Study|Death|0|||
48547152|NCT03207867|156192342|FG004|Overall Study|Death|0|||
48547153|NCT03207867|156192343|FG005|Overall Study|Death|1|||
48547154|NCT03207867|156192344|FG006|Overall Study|Death|0|||
48547155|NCT03207867|156192345|FG007|Overall Study|Death|3|||
48547156|NCT03207867|156192346|FG008|Overall Study|Death|1|||
48547157|NCT03207867|156192347|FG009|Overall Study|Death|2|||
48547158|NCT03207867|156192348|FG010|Overall Study|Death|0|||
48547159|NCT03207867|156192349|FG011|Overall Study|Death|1|||
48547160|NCT03207867|156192350|FG012|Overall Study|Death|0|||
48547161|NCT03207867|156192351|FG013|Overall Study|Death|1|||
48547162|NCT03207867|156192352|FG014|Overall Study|Death|0|||
48547163|NCT03207867|156192353|FG015|Overall Study|Death|0|||
48547164|NCT03207867|156192354|FG016|Overall Study|Death|0|||
48547165|NCT03207867|156192355|FG017|Overall Study|Death|2|||
48547166|NCT03207867|156192356|FG018|Overall Study|Death|0|||
48547167|NCT03207867|156192357|FG019|Overall Study|Death|1|||
48547168|NCT03207867|156192358|FG020|Overall Study|Death|0|||
48547169|NCT03207867|156192359|FG021|Overall Study|Death|0|||
48547170|NCT03207867|156192360|FG022|Overall Study|Death|0|||
48547171|NCT03207867|156192361|FG023|Overall Study|Death|0|||
48612296|NCT02406612|156436897|FG000|Overall Study|Intra-procedural Exclusion|1|||
48612297|NCT02406612|156436898|FG001|Overall Study|Intra-procedural Exclusion|3|||
48612298|NCT02406612|156436897|FG000|Overall Study|Guidewire Failure|0|||
48612299|NCT02406612|156436898|FG001|Overall Study|Guidewire Failure|1|||
48612300|NCT00959751|156437937|FG000|Overall Study|Lost to Follow-up|2|||
48612301|NCT00959751|156437938|FG001|Overall Study|Lost to Follow-up|3|||
48612302|NCT00959751|156437937|FG000|Overall Study|Consent Withdrawn|0|||
48612303|NCT00959751|156437938|FG001|Overall Study|Consent Withdrawn|1|||
48612304|NCT00959751|156437937|FG000|Overall Study|Non-compliance to Study Procedures|0|||
48612305|NCT00959751|156437938|FG001|Overall Study|Non-compliance to Study Procedures|1|||
48612306|NCT00959751|156437937|FG000|Overall Study|No migraine headache without aura|7|||
48612307|NCT00959751|156437938|FG001|Overall Study|No migraine headache without aura|7|||
48612308|NCT03846479|156437939|FG000|Overall Study|Death|8|||
48612309|NCT03846479|156437939|FG000|Overall Study|Lost to Follow-up|1|||
48612310|NCT05177094|156437940|FG000|Overall Study|Adverse Event|5|||
48612311|NCT05177094|156437941|FG001|Overall Study|Adverse Event|5|||
48612312|NCT05177094|156437940|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
48612313|NCT05177094|156437941|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
48612314|NCT05177094|156437940|FG000|Overall Study|Protocol Deviation|3|||
48612315|NCT05177094|156437941|FG001|Overall Study|Protocol Deviation|0|||
48547172|NCT03207867|156192338|FG000|Overall Study|Physician Decision|3|||
48547173|NCT03207867|156192339|FG001|Overall Study|Physician Decision|5|||
48547174|NCT03207867|156192340|FG002|Overall Study|Physician Decision|0|||
48547175|NCT03207867|156192341|FG003|Overall Study|Physician Decision|3|||
48547176|NCT03207867|156192342|FG004|Overall Study|Physician Decision|2|||
48547177|NCT03207867|156192343|FG005|Overall Study|Physician Decision|0|||
48547178|NCT03207867|156192344|FG006|Overall Study|Physician Decision|0|||
48547179|NCT03207867|156192345|FG007|Overall Study|Physician Decision|0|||
48547180|NCT03207867|156192346|FG008|Overall Study|Physician Decision|4|||
48547181|NCT03207867|156192347|FG009|Overall Study|Physician Decision|2|||
48547182|NCT03207867|156192348|FG010|Overall Study|Physician Decision|0|||
48547183|NCT03207867|156192349|FG011|Overall Study|Physician Decision|4|||
48547184|NCT03207867|156192350|FG012|Overall Study|Physician Decision|0|||
48547185|NCT03207867|156192351|FG013|Overall Study|Physician Decision|0|||
48547186|NCT03207867|156192352|FG014|Overall Study|Physician Decision|2|||
48547187|NCT03207867|156192353|FG015|Overall Study|Physician Decision|1|||
48547188|NCT03207867|156192354|FG016|Overall Study|Physician Decision|1|||
48547189|NCT03207867|156192355|FG017|Overall Study|Physician Decision|2|||
48547190|NCT03207867|156192356|FG018|Overall Study|Physician Decision|1|||
48547191|NCT03207867|156192357|FG019|Overall Study|Physician Decision|3|||
48547192|NCT03207867|156192358|FG020|Overall Study|Physician Decision|0|||
48547193|NCT03207867|156192359|FG021|Overall Study|Physician Decision|0|||
48547194|NCT03207867|156192360|FG022|Overall Study|Physician Decision|0|||
48547195|NCT03207867|156192361|FG023|Overall Study|Physician Decision|0|||
48547196|NCT03207867|156192338|FG000|Overall Study|Progressive Disease|7|||
48547197|NCT03207867|156192339|FG001|Overall Study|Progressive Disease|7|||
48547198|NCT03207867|156192340|FG002|Overall Study|Progressive Disease|9|||
48547199|NCT03207867|156192341|FG003|Overall Study|Progressive Disease|10|||
48547200|NCT03207867|156192342|FG004|Overall Study|Progressive Disease|11|||
48547201|NCT03207867|156192343|FG005|Overall Study|Progressive Disease|10|||
48547202|NCT03207867|156192344|FG006|Overall Study|Progressive Disease|9|||
48547203|NCT03207867|156192345|FG007|Overall Study|Progressive Disease|8|||
48547204|NCT03207867|156192346|FG008|Overall Study|Progressive Disease|19|||
48547205|NCT03207867|156192347|FG009|Overall Study|Progressive Disease|23|||
48547206|NCT03207867|156192348|FG010|Overall Study|Progressive Disease|2|||
48547207|NCT03207867|156192349|FG011|Overall Study|Progressive Disease|24|||
48547208|NCT03207867|156192350|FG012|Overall Study|Progressive Disease|3|||
48547209|NCT03207867|156192351|FG013|Overall Study|Progressive Disease|11|||
48547210|NCT03207867|156192352|FG014|Overall Study|Progressive Disease|9|||
48547211|NCT03207867|156192353|FG015|Overall Study|Progressive Disease|5|||
48547212|NCT03207867|156192354|FG016|Overall Study|Progressive Disease|10|||
48547213|NCT03207867|156192355|FG017|Overall Study|Progressive Disease|14|||
48547214|NCT03207867|156192356|FG018|Overall Study|Progressive Disease|13|||
48547215|NCT03207867|156192357|FG019|Overall Study|Progressive Disease|14|||
48547216|NCT03207867|156192358|FG020|Overall Study|Progressive Disease|6|||
48547217|NCT03207867|156192359|FG021|Overall Study|Progressive Disease|3|||
48612316|NCT05177094|156437940|FG000|Overall Study|Withdrawal by Subject|6|||
48547218|NCT03207867|156192360|FG022|Overall Study|Progressive Disease|3|||
48547219|NCT03207867|156192361|FG023|Overall Study|Progressive Disease|3|||
48547220|NCT03207867|156192338|FG000|Overall Study|Patient/guardian Decision|0|||
48547221|NCT03207867|156192339|FG001|Overall Study|Patient/guardian Decision|0|||
48547222|NCT03207867|156192340|FG002|Overall Study|Patient/guardian Decision|1|||
48547223|NCT03207867|156192341|FG003|Overall Study|Patient/guardian Decision|1|||
48547224|NCT03207867|156192342|FG004|Overall Study|Patient/guardian Decision|1|||
48547225|NCT03207867|156192343|FG005|Overall Study|Patient/guardian Decision|2|||
48547226|NCT03207867|156192344|FG006|Overall Study|Patient/guardian Decision|1|||
48547227|NCT03207867|156192345|FG007|Overall Study|Patient/guardian Decision|0|||
48547228|NCT03207867|156192346|FG008|Overall Study|Patient/guardian Decision|1|||
48612317|NCT05177094|156437941|FG001|Overall Study|Withdrawal by Subject|3|||
48612318|NCT05177094|156437940|FG000|Overall Study|Participant could not tolerate long study visits|1|||
48612319|NCT05177094|156437941|FG001|Overall Study|Participant could not tolerate long study visits|0|||
48612320|NCT03600350|156437942|FG000|Overall Study|Death|1|||
48612321|NCT03600350|156437942|FG000|Overall Study|On Follow Up|18|||
48612322|NCT01006629|156437943|FG000|Overall Study|Adverse Event|1|||
48547229|NCT03207867|156192347|FG009|Overall Study|Patient/guardian Decision|0|||
48612323|NCT01006629|156437943|FG000|Overall Study|Parent refused to continue participation|1|||
48612324|NCT01006629|156437943|FG000|Overall Study|Parent unable to perform site visit|4|||
48612325|NCT00782067|156437948|FG000|Overall Study|Adverse Event|35|||
48325478|NCT02357966|155389112|FG000|Overall Study|Death|0|||
48547230|NCT03207867|156192348|FG010|Overall Study|Patient/guardian Decision|0|||
48547231|NCT03207867|156192349|FG011|Overall Study|Patient/guardian Decision|1|||
48547232|NCT03207867|156192350|FG012|Overall Study|Patient/guardian Decision|0|||
48547233|NCT03207867|156192351|FG013|Overall Study|Patient/guardian Decision|1|||
48547234|NCT03207867|156192352|FG014|Overall Study|Patient/guardian Decision|2|||
48547235|NCT03207867|156192353|FG015|Overall Study|Patient/guardian Decision|0|||
48547236|NCT03207867|156192354|FG016|Overall Study|Patient/guardian Decision|1|||
48612326|NCT00782067|156437948|FG000|Overall Study|Subject withdrew consent|11|||
48612327|NCT00782067|156437948|FG000|Overall Study|Lost to Follow-up|2|||
48612328|NCT00782067|156437948|FG000|Overall Study|Administrative problems|14|||
48612329|NCT00782067|156437948|FG000|Overall Study|Death|9|||
48612330|NCT00782067|156437948|FG000|Overall Study|Disease progression|43|||
48612331|NCT00782067|156437948|FG000|Overall Study|Protocol deviation|2|||
48612332|NCT01134042|156437949|FG000|Overall Study|Adverse Event|3|||
48612333|NCT01134042|156437950|FG001|Overall Study|Adverse Event|7|||
48612334|NCT01134042|156437951|FG002|Overall Study|Adverse Event|2|||
48612335|NCT01134042|156437949|FG000|Overall Study|Lack of Efficacy|21|||
48612336|NCT01134042|156437950|FG001|Overall Study|Lack of Efficacy|6|||
48612337|NCT01134042|156437951|FG002|Overall Study|Lack of Efficacy|18|||
48612338|NCT01134042|156437949|FG000|Overall Study|Protocol Violation|5|||
48612339|NCT01134042|156437950|FG001|Overall Study|Protocol Violation|3|||
48612340|NCT01134042|156437951|FG002|Overall Study|Protocol Violation|5|||
48612341|NCT01134042|156437949|FG000|Overall Study|Lost to Follow-up|2|||
48612342|NCT01134042|156437950|FG001|Overall Study|Lost to Follow-up|0|||
48612343|NCT01134042|156437951|FG002|Overall Study|Lost to Follow-up|1|||
48612344|NCT01134042|156437949|FG000|Overall Study|Physician Decision|4|||
48612345|NCT01134042|156437950|FG001|Overall Study|Physician Decision|8|||
48612346|NCT01134042|156437951|FG002|Overall Study|Physician Decision|1|||
48612347|NCT01134042|156437949|FG000|Overall Study|Withdrawal by Subject|13|||
48612348|NCT01134042|156437950|FG001|Overall Study|Withdrawal by Subject|4|||
48612349|NCT01134042|156437951|FG002|Overall Study|Withdrawal by Subject|7|||
48612350|NCT01454284|156437957|FG000|Overall Study|Adverse Event|20|||
48612351|NCT01454284|156437958|FG001|Overall Study|Adverse Event|7|||
48612352|NCT01454284|156437957|FG000|Overall Study|Death|0|||
48612353|NCT01454284|156437958|FG001|Overall Study|Death|3|||
48612354|NCT01454284|156437957|FG000|Overall Study|Lost to Follow-up|13|||
48612355|NCT01454284|156437958|FG001|Overall Study|Lost to Follow-up|8|||
48612356|NCT01454284|156437957|FG000|Overall Study|Protocol Violation|9|||
48612357|NCT01454284|156437958|FG001|Overall Study|Protocol Violation|6|||
48612358|NCT01454284|156437957|FG000|Overall Study|Withdrawal by Subject|58|||
48612359|NCT01454284|156437958|FG001|Overall Study|Withdrawal by Subject|36|||
48612360|NCT01454284|156437957|FG000|Overall Study|Physician Decision|16|||
48612361|NCT01454284|156437958|FG001|Overall Study|Physician Decision|11|||
48612362|NCT01454284|156437957|FG000|Overall Study|Sponsor Decision|0|||
48612363|NCT01454284|156437958|FG001|Overall Study|Sponsor Decision|2|||
48612364|NCT02665117|156437959|FG000|Overall Study|Physician Decision|1|||
48612365|NCT02665117|156437960|FG001|Overall Study|Physician Decision|0|||
48612366|NCT00764517|156437965|FG000|Overall Study|Adverse Event|9|||
48612367|NCT00764517|156437966|FG001|Overall Study|Adverse Event|3|||
48612368|NCT00764517|156437965|FG000|Overall Study|Death|3|||
48612369|NCT00764517|156437966|FG001|Overall Study|Death|11|||
48612370|NCT00764517|156437965|FG000|Overall Study|Physician Decision|3|||
48612371|NCT00764517|156437966|FG001|Overall Study|Physician Decision|0|||
48612372|NCT00141921|156437967|FG000|Overall Study|Remain on Study|28|||
48612373|NCT00141921|156437967|FG000|Overall Study|Withdrawal by Subject|42|||
48612374|NCT00141921|156437967|FG000|Overall Study|Lost to Follow-up|19|||
48612375|NCT00141921|156437967|FG000|Overall Study|Noncompliance|17|||
48612376|NCT00141921|156437967|FG000|Overall Study|Disease Progression|7|||
48612377|NCT00141921|156437967|FG000|Overall Study|Protocol Deviation|7|||
48612378|NCT00141921|156437967|FG000|Overall Study|Adverse Event|5|||
48612379|NCT00141921|156437967|FG000|Overall Study|Administrative Decision|2|||
48547237|NCT03207867|156192355|FG017|Overall Study|Patient/guardian Decision|3|||
48547238|NCT03207867|156192356|FG018|Overall Study|Patient/guardian Decision|4|||
48547239|NCT03207867|156192357|FG019|Overall Study|Patient/guardian Decision|1|||
48547240|NCT03207867|156192358|FG020|Overall Study|Patient/guardian Decision|0|||
48547241|NCT03207867|156192359|FG021|Overall Study|Patient/guardian Decision|0|||
48547242|NCT03207867|156192360|FG022|Overall Study|Patient/guardian Decision|0|||
48547243|NCT03207867|156192361|FG023|Overall Study|Patient/guardian Decision|0|||
48547244|NCT03511326|156192364|FG000|Overall Study|Withdrawal by Subject|1|||
48547245|NCT04497948|156192365|FG000|Overall Study|Death|2|||
48547246|NCT00492024|156192368|FG000|Treatment|Adverse Event|3|||
48547247|NCT00492024|156192369|FG001|Treatment|Adverse Event|1|||
48547248|NCT00492024|156192368|FG000|Treatment|Lack of Efficacy|21|||
48547249|NCT00492024|156192369|FG001|Treatment|Lack of Efficacy|20|||
48547250|NCT00492024|156192368|FG000|Treatment|Lost to Follow-up|3|||
48547251|NCT00492024|156192369|FG001|Treatment|Lost to Follow-up|1|||
48547252|NCT00492024|156192368|FG000|Treatment|Withdrawal by Subject|2|||
48547253|NCT00492024|156192369|FG001|Treatment|Withdrawal by Subject|0|||
48547254|NCT00492024|156192368|FG000|Follow up|Lack of Efficacy|0|||
48547255|NCT00492024|156192369|FG001|Follow up|Lack of Efficacy|1|||
48547256|NCT00492024|156192368|FG000|Follow up|Lost to Follow-up|1|||
48547257|NCT00492024|156192369|FG001|Follow up|Lost to Follow-up|1|||
48547258|NCT03247816|156192372|FG000|Overall Study|Adverse Event|12|||
48547259|NCT03247816|156192372|FG000|Overall Study|Physician Decision|3|||
48547260|NCT03247816|156192372|FG000|Overall Study|Lack of Efficacy|1|||
48547261|NCT03247816|156192372|FG000|Overall Study|Lost to Follow-up|10|||
48612380|NCT00141921|156437967|FG000|Overall Study|Pregnancy|4|||
48612381|NCT00141921|156437967|FG000|Overall Study|Ineligibility Determined|2|||
48547262|NCT03247816|156192372|FG000|Overall Study|Missing Feraccru stop date|3|||
48547263|NCT01439009|156192375|FG000|Overall Study|Physician Decision|5|||
48547264|NCT01439009|156192376|FG001|Overall Study|Physician Decision|3|||
48547265|NCT01439009|156192375|FG000|Overall Study|Protocol Violation|2|||
48547266|NCT01439009|156192376|FG001|Overall Study|Protocol Violation|0|||
48547267|NCT01439009|156192375|FG000|Overall Study|Deviation of exclusion criteria|1|||
48612382|NCT00141921|156437967|FG000|Overall Study|Other|8|||
48612383|NCT01091259|156437968|FG000|Overall Study|Adverse Event|3|||
48612384|NCT01091259|156437968|FG000|Overall Study|Lack of Efficacy|2|||
48612385|NCT04307394|156437970|FG000|Overall Study|Lost to Follow-up|3|||
48612386|NCT04307394|156437970|FG000|Overall Study|Withdrawal by Subject|2|||
48612387|NCT01027949|156437971|FG000|Overall Study|Death|174|||
48612388|NCT01027949|156437971|FG000|Overall Study|Progressive Disease|163|||
48547268|NCT01439009|156192376|FG001|Overall Study|Deviation of exclusion criteria|0|||
48547269|NCT00926783|156192377|FG000|Overall Study|Incomplete CFAE Procedures|3|||
48547270|NCT00926783|156192378|FG001|Overall Study|Incomplete CFAE Procedures|3|||
48612389|NCT01027949|156437971|FG000|Overall Study|Adverse Event|172|||
48547271|NCT00936897|156192379|FG000|Overall Study|Withdrawal by Subject|9|||
48547272|NCT00936897|156192380|FG001|Overall Study|Withdrawal by Subject|19|||
48612390|NCT01027949|156437971|FG000|Overall Study|Withdrawal by Subject|113|||
48612391|NCT01027949|156437971|FG000|Overall Study|Lost to Follow-up|17|||
48612392|NCT01027949|156437971|FG000|Overall Study|Protocol Violation|13|||
48612393|NCT01027949|156437971|FG000|Overall Study|PI Decision|8|||
48612394|NCT01027949|156437971|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
48612395|NCT01027949|156437971|FG000|Overall Study|Non-compliance with Study Procedures|7|||
48612396|NCT01027949|156437971|FG000|Overall Study|Lung Transplant|5|||
48612397|NCT01027949|156437971|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
48612398|NCT01027949|156437971|FG000|Overall Study|Use of Excluded Medication|2|||
48612399|NCT01027949|156437971|FG000|Overall Study|Patient Self-discontinuation|1|||
48547273|NCT00936897|156192379|FG000|Overall Study|Adverse Event|4|||
48547274|NCT00936897|156192380|FG001|Overall Study|Adverse Event|13|||
48612400|NCT01027949|156437971|FG000|Overall Study|Pregnancy|1|||
48612401|NCT01027949|156437971|FG000|Overall Study|Surgery|1|||
48547275|NCT00936897|156192379|FG000|Overall Study|Other|3|||
48612402|NCT00898807|156437982|FG000|Overall Study|Withdrawal by Subject|5|||
48612403|NCT00898807|156437983|FG001|Overall Study|Withdrawal by Subject|3|||
48612404|NCT00898807|156437982|FG000|Overall Study|Family pressure to discontinue|2|||
48612405|NCT00898807|156437983|FG001|Overall Study|Family pressure to discontinue|2|||
48612406|NCT00898807|156437982|FG000|Overall Study|Lost to Follow-up|1|||
48547276|NCT00936897|156192380|FG001|Overall Study|Other|9|||
48547277|NCT00936897|156192379|FG000|Overall Study|Lost to Follow-up|1|||
48547278|NCT00936897|156192380|FG001|Overall Study|Lost to Follow-up|10|||
48547279|NCT00936897|156192379|FG000|Overall Study|Administrative Decision|1|||
48547280|NCT00936897|156192380|FG001|Overall Study|Administrative Decision|2|||
48547281|NCT00936897|156192379|FG000|Overall Study|Protocol Violation|1|||
48547282|NCT00936897|156192380|FG001|Overall Study|Protocol Violation|1|||
48547283|NCT00936897|156192379|FG000|Overall Study|Ineligibility Determined|0|||
48547284|NCT00936897|156192380|FG001|Overall Study|Ineligibility Determined|3|||
48547285|NCT00936897|156192379|FG000|Overall Study|Noncompliance|0|||
48547286|NCT00936897|156192380|FG001|Overall Study|Noncompliance|2|||
48547287|NCT00936897|156192379|FG000|Overall Study|Death|0|||
48547288|NCT00936897|156192380|FG001|Overall Study|Death|1|||
48547289|NCT00478426|156192381|FG000|Overall Study|Withdrawal by Subject|1|||
48547290|NCT00789737|156192388|FG000|Overall Study|Withdrawal by Subject|13|||
48547291|NCT00789737|156192389|FG001|Overall Study|Withdrawal by Subject|22|||
48547292|NCT00789737|156192388|FG000|Overall Study|Lost to Follow-up|10|||
48547293|NCT00789737|156192389|FG001|Overall Study|Lost to Follow-up|14|||
48612407|NCT00898807|156437983|FG001|Overall Study|Lost to Follow-up|3|||
48612408|NCT00898807|156437982|FG000|Overall Study|Death|0|||
48612409|NCT00898807|156437983|FG001|Overall Study|Death|1|||
48612410|NCT00817063|156437984|FG000|Overall Study|Adverse Event|32|||
48612411|NCT00817063|156437985|FG001|Overall Study|Adverse Event|13|||
48612412|NCT00817063|156437984|FG000|Overall Study|Death|1|||
48612413|NCT00817063|156437985|FG001|Overall Study|Death|1|||
48612414|NCT00817063|156437984|FG000|Overall Study|Lack of Efficacy|33|||
48612415|NCT00817063|156437985|FG001|Overall Study|Lack of Efficacy|86|||
48612416|NCT00817063|156437984|FG000|Overall Study|Failure to Return|13|||
48612417|NCT00817063|156437985|FG001|Overall Study|Failure to Return|12|||
48612418|NCT00817063|156437984|FG000|Overall Study|Violation of Selection at Entry|7|||
48612419|NCT00817063|156437985|FG001|Overall Study|Violation of Selection at Entry|4|||
48612420|NCT00817063|156437984|FG000|Overall Study|Protocol Violation|3|||
48612421|NCT00817063|156437985|FG001|Overall Study|Protocol Violation|8|||
48612422|NCT00817063|156437984|FG000|Overall Study|Withdrawal by Subject|17|||
48612423|NCT00817063|156437985|FG001|Overall Study|Withdrawal by Subject|37|||
48612424|NCT00817063|156437984|FG000|Overall Study|Early Improvement|19|||
48612425|NCT00817063|156437985|FG001|Overall Study|Early Improvement|4|||
48612426|NCT00817063|156437984|FG000|Overall Study|Administrative|10|||
48612427|NCT00817063|156437985|FG001|Overall Study|Administrative|4|||
48612428|NCT00817063|156437984|FG000|Overall Study|Abnormality of Laboratory Test|2|||
48612429|NCT00817063|156437985|FG001|Overall Study|Abnormality of Laboratory Test|1|||
48612430|NCT00671060|156437986|FG000|Overall Study|Protocol Violation|1|||
48612431|NCT00671060|156437987|FG001|Overall Study|Protocol Violation|0|||
48612432|NCT00671060|156437986|FG000|Overall Study|Physician Decision|0|||
48612433|NCT00671060|156437987|FG001|Overall Study|Physician Decision|1|||
48612434|NCT00671749|156437988|FG000|Overall Study|Adverse Event|2|||
48612435|NCT00671749|156437988|FG000|Overall Study|Withdrawal by Subject|4|||
48612436|NCT00671749|156437988|FG000|Overall Study|Protocol Violation|1|||
48612437|NCT00671749|156437988|FG000|Overall Study|Lost to Follow-up|1|||
48612438|NCT00529035|156437989|FG000|Overall Study|Withdrawal by Subject|1|||
48612439|NCT02515227|156437990|FG000|Overall Study|Adverse Event|0|||
48612440|NCT02515227|156437991|FG001|Overall Study|Adverse Event|2|||
48612441|NCT02515227|156437990|FG000|Overall Study|Progressive disease|2|||
48612442|NCT02515227|156437991|FG001|Overall Study|Progressive disease|9|||
48612443|NCT01461551|156437992|FG000|Overall Study|Physician Decision|2|||
48612444|NCT01461551|156437993|FG001|Overall Study|Physician Decision|1|||
48612445|NCT01461551|156437994|FG002|Overall Study|Physician Decision|2|||
48612446|NCT00303186|156437995|FG000|Overall Study|Other|52|||
48612447|NCT00712920|156437996|FG000|Overall Study|Adverse Event|3|||
48612448|NCT00712920|156437997|FG001|Overall Study|Adverse Event|4|||
48612449|NCT00712920|156437998|FG002|Overall Study|Adverse Event|7|||
48612450|NCT00712920|156437996|FG000|Overall Study|Withdrawal by Subject|4|||
48612451|NCT00712920|156437997|FG001|Overall Study|Withdrawal by Subject|2|||
48612452|NCT00712920|156437998|FG002|Overall Study|Withdrawal by Subject|1|||
48547294|NCT00789737|156192388|FG000|Overall Study|Adverse Event|8|||
48547295|NCT00789737|156192389|FG001|Overall Study|Adverse Event|8|||
48612453|NCT00712920|156437996|FG000|Overall Study|Lost to Follow-up|1|||
48612454|NCT00712920|156437997|FG001|Overall Study|Lost to Follow-up|4|||
48612455|NCT00712920|156437998|FG002|Overall Study|Lost to Follow-up|0|||
48612456|NCT00712920|156437996|FG000|Overall Study|Lack of Efficacy|1|||
48612457|NCT00712920|156437997|FG001|Overall Study|Lack of Efficacy|0|||
48612458|NCT00712920|156437998|FG002|Overall Study|Lack of Efficacy|1|||
48612459|NCT00712920|156437996|FG000|Overall Study|Other|5|||
48612460|NCT00712920|156437997|FG001|Overall Study|Other|7|||
48612461|NCT00712920|156437998|FG002|Overall Study|Other|3|||
48612462|NCT00712920|156437996|FG000|Overall Study|Non-compliance|3|||
48612463|NCT00712920|156437997|FG001|Overall Study|Non-compliance|0|||
48612464|NCT00712920|156437998|FG002|Overall Study|Non-compliance|0|||
48612465|NCT02326883|156437999|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
48612466|NCT02326883|156438000|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
48612467|NCT02326883|156438001|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
48612468|NCT00481676|156438008|FG000|Overall Study|Adverse Event|0|||
48612469|NCT00481676|156438009|FG001|Overall Study|Adverse Event|1|||
48612470|NCT00481676|156438008|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48612471|NCT00481676|156438009|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48547296|NCT00789737|156192388|FG000|Overall Study|Protocol Violation|3|||
48612472|NCT00481676|156438008|FG000|Overall Study|Administrative problem|1|||
48612473|NCT00481676|156438009|FG001|Overall Study|Administrative problem|0|||
48612474|NCT01513590|156438010|FG000|Overall Study|Adverse Event|2|||
48612475|NCT01513590|156438011|FG001|Overall Study|Adverse Event|3|||
48612476|NCT01513590|156438010|FG000|Overall Study|Withdrawal Criteria|3|||
48612477|NCT01513590|156438011|FG001|Overall Study|Withdrawal Criteria|0|||
48612478|NCT01513590|156438010|FG000|Overall Study|Unclassified|5|||
48612479|NCT01513590|156438011|FG001|Overall Study|Unclassified|10|||
48612480|NCT00844519|156438020|FG000|Overall Study|Withdrawal by Subject|1|||
48612481|NCT00844519|156438021|FG001|Overall Study|Withdrawal by Subject|1|||
48612482|NCT00844519|156438020|FG000|Overall Study|Adverse Event|1|||
48612483|NCT00844519|156438021|FG001|Overall Study|Adverse Event|0|||
48612484|NCT02948400|156438024|FG000|Overall Study|Withdrawal by Subject|17|||
48612485|NCT02948400|156438025|FG001|Overall Study|Withdrawal by Subject|10|||
48612486|NCT02948400|156438024|FG000|Overall Study|failed to attend appointments|47|||
48612487|NCT02948400|156438025|FG001|Overall Study|failed to attend appointments|34|||
48612488|NCT02948400|156438024|FG000|Overall Study|COVID-related closure|6|||
48612489|NCT02948400|156438025|FG001|Overall Study|COVID-related closure|2|||
48612490|NCT02948400|156438024|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
48612491|NCT02948400|156438025|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
48612492|NCT02948400|156438024|FG000|Overall Study|motion sickness in virtual reality|2|||
48612493|NCT02948400|156438025|FG001|Overall Study|motion sickness in virtual reality|0|||
48612494|NCT03325439|156438026|FG000|Overall Study|Ineligibility|3|||
48612495|NCT03301714|156438027|FG000|Overall Study|Lost to Follow-up|10|||
48612496|NCT03301714|156438028|FG001|Overall Study|Lost to Follow-up|4|||
48612497|NCT03301714|156438029|FG002|Overall Study|Lost to Follow-up|4|||
48547297|NCT00789737|156192389|FG001|Overall Study|Protocol Violation|0|||
48547298|NCT00789737|156192388|FG000|Overall Study|Lack of Efficacy|3|||
48547299|NCT00789737|156192389|FG001|Overall Study|Lack of Efficacy|0|||
48547300|NCT00789737|156192388|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
48547301|NCT00789737|156192389|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
48547302|NCT00789737|156192388|FG000|Overall Study|Other|11|||
48547303|NCT00789737|156192389|FG001|Overall Study|Other|7|||
48612498|NCT03301714|156438027|FG000|Overall Study|Did not receive allocated intervention|0|||
48612499|NCT03301714|156438028|FG001|Overall Study|Did not receive allocated intervention|2|||
48612500|NCT03301714|156438029|FG002|Overall Study|Did not receive allocated intervention|3|||
48612501|NCT01179516|156438030|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
48547304|NCT00813800|156192392|FG000|Overall Study|Screen Failure after Consent|2|||
48547305|NCT00813800|156192392|FG000|Overall Study|Adverse Event|1|||
48547306|NCT00813800|156192392|FG000|Overall Study|Worsening of depression|2|||
48547307|NCT00813800|156192392|FG000|Overall Study|Physician Decision|1|||
48547308|NCT01189487|156192399|FG000|Overall Study|Lack of Efficacy|2|||
48547309|NCT01189487|156192399|FG000|Overall Study|Adverse Event|1|||
48547310|NCT04630158|156192400|FG000|Overall Study|Adverse Event|1|||
48547311|NCT04630158|156192401|FG001|Overall Study|Adverse Event|1|||
48547312|NCT04630158|156192402|FG002|Overall Study|Adverse Event|1|||
48547313|NCT04630158|156192400|FG000|Overall Study|Physician Decision|0|||
48547314|NCT04630158|156192401|FG001|Overall Study|Physician Decision|2|||
48547315|NCT04630158|156192402|FG002|Overall Study|Physician Decision|0|||
48547316|NCT04630158|156192400|FG000|Overall Study|Protocol Violation|1|||
48547317|NCT04630158|156192401|FG001|Overall Study|Protocol Violation|0|||
48547318|NCT04630158|156192402|FG002|Overall Study|Protocol Violation|1|||
48547319|NCT04630158|156192400|FG000|Overall Study|Withdrawal by Subject|2|||
48547320|NCT04630158|156192401|FG001|Overall Study|Withdrawal by Subject|1|||
48547321|NCT04630158|156192402|FG002|Overall Study|Withdrawal by Subject|2|||
48547322|NCT01822366|156192403|FG000|Overall Study|Lost to Follow-up|5|||
48547323|NCT01822366|156192404|FG001|Overall Study|Lost to Follow-up|1|||
48547324|NCT01822366|156192405|FG002|Overall Study|Lost to Follow-up|5|||
48547325|NCT01822366|156192406|FG003|Overall Study|Lost to Follow-up|1|||
48547326|NCT01822366|156192403|FG000|Overall Study|Withdrawal by Subject|0|||
48547327|NCT01822366|156192404|FG001|Overall Study|Withdrawal by Subject|6|||
48547328|NCT01822366|156192405|FG002|Overall Study|Withdrawal by Subject|0|||
48547329|NCT01822366|156192406|FG003|Overall Study|Withdrawal by Subject|6|||
48547330|NCT01822366|156192403|FG000|Overall Study|Partial Intervention Completion|0|||
48547331|NCT01822366|156192404|FG001|Overall Study|Partial Intervention Completion|15|||
48547332|NCT01822366|156192405|FG002|Overall Study|Partial Intervention Completion|0|||
48547333|NCT01822366|156192406|FG003|Overall Study|Partial Intervention Completion|15|||
48547334|NCT04874155|156192409|FG000|Overall Study|Lost to Follow-up|1|||
48547335|NCT04874155|156192410|FG001|Overall Study|Lost to Follow-up|1|||
48547336|NCT04874155|156192409|FG000|Overall Study|Withdrawal by Subject|2|||
48547337|NCT04874155|156192410|FG001|Overall Study|Withdrawal by Subject|2|||
48547338|NCT01004003|156192415|FG000|Overall Study|Progressive disease|2|||
48547339|NCT01004003|156192416|FG001|Overall Study|Progressive disease|1|||
48547340|NCT01004003|156192417|FG002|Overall Study|Progressive disease|1|||
48547341|NCT01004003|156192418|FG003|Overall Study|Progressive disease|0|||
48547342|NCT01004003|156192419|FG004|Overall Study|Progressive disease|2|||
48547343|NCT01004003|156192420|FG005|Overall Study|Progressive disease|1|||
48547344|NCT01004003|156192421|FG006|Overall Study|Progressive disease|1|||
48547345|NCT01004003|156192422|FG007|Overall Study|Progressive disease|39|||
48547346|NCT01004003|156192423|FG008|Overall Study|Progressive disease|22|||
48547347|NCT01004003|156192415|FG000|Overall Study|Adverse Event|4|||
48547348|NCT01004003|156192416|FG001|Overall Study|Adverse Event|2|||
48547349|NCT01004003|156192417|FG002|Overall Study|Adverse Event|3|||
48547350|NCT01004003|156192418|FG003|Overall Study|Adverse Event|3|||
48547351|NCT01004003|156192419|FG004|Overall Study|Adverse Event|2|||
48547352|NCT01004003|156192420|FG005|Overall Study|Adverse Event|2|||
48547353|NCT01004003|156192421|FG006|Overall Study|Adverse Event|7|||
48547354|NCT01004003|156192422|FG007|Overall Study|Adverse Event|21|||
48547355|NCT01004003|156192423|FG008|Overall Study|Adverse Event|6|||
48547356|NCT01004003|156192415|FG000|Overall Study|Refused to continue taking trial med.|0|||
48547357|NCT01004003|156192416|FG001|Overall Study|Refused to continue taking trial med.|0|||
48547358|NCT01004003|156192417|FG002|Overall Study|Refused to continue taking trial med.|0|||
48547359|NCT01004003|156192418|FG003|Overall Study|Refused to continue taking trial med.|0|||
48547360|NCT01004003|156192419|FG004|Overall Study|Refused to continue taking trial med.|0|||
48547361|NCT01004003|156192420|FG005|Overall Study|Refused to continue taking trial med.|0|||
48547362|NCT01004003|156192421|FG006|Overall Study|Refused to continue taking trial med.|0|||
48547363|NCT01004003|156192422|FG007|Overall Study|Refused to continue taking trial med.|0|||
48547364|NCT01004003|156192423|FG008|Overall Study|Refused to continue taking trial med.|2|||
48547365|NCT01004003|156192415|FG000|Overall Study|Other|0|||
48547366|NCT01004003|156192416|FG001|Overall Study|Other|0|||
48547367|NCT01004003|156192417|FG002|Overall Study|Other|0|||
48547368|NCT01004003|156192418|FG003|Overall Study|Other|0|||
48547369|NCT01004003|156192419|FG004|Overall Study|Other|0|||
48547370|NCT01004003|156192420|FG005|Overall Study|Other|1|||
48547371|NCT01004003|156192421|FG006|Overall Study|Other|0|||
48547372|NCT01004003|156192422|FG007|Overall Study|Other|0|||
48547373|NCT01004003|156192423|FG008|Overall Study|Other|0|||
48547374|NCT00642278|156192424|FG000|Overall Study|Adverse Event|2|||
48547375|NCT00642278|156192425|FG001|Overall Study|Adverse Event|1|||
48547376|NCT00642278|156192426|FG002|Overall Study|Adverse Event|3|||
48547377|NCT00642278|156192427|FG003|Overall Study|Adverse Event|1|||
48547378|NCT00642278|156192428|FG004|Overall Study|Adverse Event|2|||
48547379|NCT00642278|156192429|FG005|Overall Study|Adverse Event|2|||
48547380|NCT00642278|156192430|FG006|Overall Study|Adverse Event|0|||
48547381|NCT00642278|156192424|FG000|Overall Study|Lack of Efficacy|0|||
48612502|NCT01179516|156438031|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
48612503|NCT01179516|156438032|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
48612504|NCT01179516|156438030|FG000|Overall Study|Lack of Efficacy|4|||
48612505|NCT01179516|156438031|FG001|Overall Study|Lack of Efficacy|2|||
48612506|NCT01179516|156438032|FG002|Overall Study|Lack of Efficacy|0|||
48612507|NCT01179516|156438030|FG000|Overall Study|Noncompliance with Study Drug|2|||
48612508|NCT01179516|156438031|FG001|Overall Study|Noncompliance with Study Drug|0|||
48612509|NCT01179516|156438032|FG002|Overall Study|Noncompliance with Study Drug|1|||
48612510|NCT01179516|156438030|FG000|Overall Study|Protocol Deviations|4|||
48612511|NCT01179516|156438031|FG001|Overall Study|Protocol Deviations|3|||
48612512|NCT01179516|156438032|FG002|Overall Study|Protocol Deviations|3|||
48612513|NCT01179516|156438030|FG000|Overall Study|Withdrawal of Consent|2|||
48612514|NCT01179516|156438031|FG001|Overall Study|Withdrawal of Consent|6|||
48612515|NCT01179516|156438032|FG002|Overall Study|Withdrawal of Consent|10|||
48612516|NCT01179516|156438030|FG000|Overall Study|Lost to Follow-up|7|||
48612517|NCT01179516|156438031|FG001|Overall Study|Lost to Follow-up|7|||
48612518|NCT01179516|156438032|FG002|Overall Study|Lost to Follow-up|3|||
48612519|NCT01179516|156438030|FG000|Overall Study|Other|2|||
48612520|NCT01179516|156438031|FG001|Overall Study|Other|0|||
48612521|NCT01179516|156438032|FG002|Overall Study|Other|2|||
48612522|NCT02572167|156438033|FG000|Overall Study|Withdrawal by Subject|0|||
48612523|NCT02572167|156438034|FG001|Overall Study|Withdrawal by Subject|3|||
48612524|NCT02572167|156438035|FG002|Overall Study|Withdrawal by Subject|0|||
48612525|NCT02572167|156438033|FG000|Overall Study|Lost to Follow-up|2|||
48612526|NCT02572167|156438034|FG001|Overall Study|Lost to Follow-up|5|||
48612527|NCT02572167|156438035|FG002|Overall Study|Lost to Follow-up|3|||
48612528|NCT02572167|156438033|FG000|Overall Study|Death|0|||
48612529|NCT02572167|156438034|FG001|Overall Study|Death|8|||
48612530|NCT02572167|156438035|FG002|Overall Study|Death|3|||
48612531|NCT02572167|156438033|FG000|Overall Study|Did not meet inclusion criteria|0|||
48612532|NCT02572167|156438034|FG001|Overall Study|Did not meet inclusion criteria|0|||
48612533|NCT02572167|156438035|FG002|Overall Study|Did not meet inclusion criteria|1|||
48612534|NCT02572167|156438033|FG000|Overall Study|Study closure by Sponsor|4|||
48612535|NCT02572167|156438034|FG001|Overall Study|Study closure by Sponsor|40|||
48612536|NCT02572167|156438035|FG002|Overall Study|Study closure by Sponsor|24|||
48612537|NCT01551173|156438036|FG000|Overall Study|Withdrawal by Subject|11|||
48612538|NCT01551173|156438037|FG001|Overall Study|Withdrawal by Subject|16|||
48612539|NCT01551173|156438036|FG000|Overall Study|Adverse Event|7|||
48612540|NCT01551173|156438037|FG001|Overall Study|Adverse Event|6|||
48612541|NCT01551173|156438036|FG000|Overall Study|Lost to Follow-up|5|||
48612542|NCT01551173|156438037|FG001|Overall Study|Lost to Follow-up|7|||
48612543|NCT01551173|156438036|FG000|Overall Study|Other|5|||
48612544|NCT01551173|156438037|FG001|Overall Study|Other|3|||
48612545|NCT02393755|156438038|FG000|Overall Study|Withdrawal by Subject|0|||
48612546|NCT02393755|156438039|FG001|Overall Study|Withdrawal by Subject|3|||
48612547|NCT02393755|156438038|FG000|Overall Study|Adverse Event|0|||
48612548|NCT02393755|156438039|FG001|Overall Study|Adverse Event|2|||
48612549|NCT02393755|156438038|FG000|Overall Study|Physician Decision|0|||
48612550|NCT02393755|156438039|FG001|Overall Study|Physician Decision|2|||
48612551|NCT00262925|156438040|FG000|Overall Study|Lack of Efficacy|3|||
48612552|NCT00262925|156438040|FG000|Overall Study|Adverse Event|4|||
48612553|NCT00262925|156438040|FG000|Overall Study|Death|2|||
48612554|NCT00262925|156438040|FG000|Overall Study|alternative therapy|1|||
48612555|NCT00262925|156438040|FG000|Overall Study|Other|1|||
48612556|NCT00544882|156438045|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
48612557|NCT00544882|156438046|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
48612558|NCT00544882|156438047|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
48612559|NCT00544882|156438045|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
48612560|NCT00544882|156438046|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
48612561|NCT00544882|156438047|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
48612562|NCT00544882|156438045|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
48612563|NCT00544882|156438046|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
48612564|NCT00544882|156438047|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
48612565|NCT00544882|156438045|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
48612566|NCT00544882|156438046|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
48612567|NCT00544882|156438047|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
48612568|NCT00544882|156438045|FG000|Cycle 3: Follow-up|Noncompliance|0|||
48612569|NCT00544882|156438046|FG001|Cycle 3: Follow-up|Noncompliance|1|||
48612570|NCT00544882|156438047|FG002|Cycle 3: Follow-up|Noncompliance|0|||
48612571|NCT00544882|156438045|FG000|Cycle 3: Follow-up|Pregnancy|0|||
48612572|NCT00544882|156438046|FG001|Cycle 3: Follow-up|Pregnancy|1|||
48612573|NCT00544882|156438047|FG002|Cycle 3: Follow-up|Pregnancy|0|||
48612574|NCT02583269|156438048|FG000|Overall Study|Patient hospitalized prior to start|1|||
48612575|NCT02583269|156438049|FG001|Overall Study|Patient hospitalized prior to start|0|||
48612576|NCT02583269|156438050|FG002|Overall Study|Patient hospitalized prior to start|0|||
48612577|NCT02583269|156438051|FG003|Overall Study|Patient hospitalized prior to start|0|||
48612578|NCT02583269|156438052|FG004|Overall Study|Patient hospitalized prior to start|0|||
48612579|NCT01171534|156439389|FG000|Overall Study|Lost to Follow-up|0|||
48612580|NCT01171534|156439390|FG001|Overall Study|Lost to Follow-up|2|||
48612581|NCT01171534|156439389|FG000|Overall Study|screen failure|0|||
48612582|NCT01171534|156439390|FG001|Overall Study|screen failure|1|||
48612583|NCT02332707|156439391|FG000|Overall Study|Adverse Event|0|||
48612584|NCT02332707|156439392|FG001|Overall Study|Adverse Event|0|||
48612585|NCT02332707|156439393|FG002|Overall Study|Adverse Event|0|||
48612586|NCT02332707|156439394|FG003|Overall Study|Adverse Event|0|||
48612587|NCT02332707|156439395|FG004|Overall Study|Adverse Event|0|||
48612588|NCT02332707|156439396|FG005|Overall Study|Adverse Event|0|||
48612589|NCT02332707|156439397|FG006|Overall Study|Adverse Event|0|||
48612590|NCT02332707|156439398|FG007|Overall Study|Adverse Event|0|||
48612591|NCT02332707|156439399|FG008|Overall Study|Adverse Event|0|||
48612592|NCT02332707|156439400|FG009|Overall Study|Adverse Event|0|||
48612593|NCT02332707|156439401|FG010|Overall Study|Adverse Event|0|||
48612594|NCT02332707|156439402|FG011|Overall Study|Adverse Event|0|||
48612595|NCT02332707|156439403|FG012|Overall Study|Adverse Event|1|||
48612596|NCT02332707|156439404|FG013|Overall Study|Adverse Event|0|||
48612597|NCT02332707|156439405|FG014|Overall Study|Adverse Event|0|||
48612598|NCT02332707|156439406|FG015|Overall Study|Adverse Event|0|||
48612599|NCT02332707|156439407|FG016|Overall Study|Adverse Event|0|||
48612600|NCT02332707|156439408|FG017|Overall Study|Adverse Event|0|||
48547382|NCT00642278|156192425|FG001|Overall Study|Lack of Efficacy|1|||
48547383|NCT00642278|156192426|FG002|Overall Study|Lack of Efficacy|0|||
48547384|NCT00642278|156192427|FG003|Overall Study|Lack of Efficacy|0|||
48547385|NCT00642278|156192428|FG004|Overall Study|Lack of Efficacy|0|||
48547386|NCT00642278|156192429|FG005|Overall Study|Lack of Efficacy|0|||
48547387|NCT00642278|156192430|FG006|Overall Study|Lack of Efficacy|0|||
48547388|NCT00642278|156192424|FG000|Overall Study|Lost to Follow-up|5|||
48547389|NCT00642278|156192425|FG001|Overall Study|Lost to Follow-up|1|||
48547390|NCT00642278|156192426|FG002|Overall Study|Lost to Follow-up|0|||
48547391|NCT00642278|156192427|FG003|Overall Study|Lost to Follow-up|1|||
48547392|NCT00642278|156192428|FG004|Overall Study|Lost to Follow-up|0|||
48547393|NCT00642278|156192429|FG005|Overall Study|Lost to Follow-up|1|||
48547394|NCT00642278|156192430|FG006|Overall Study|Lost to Follow-up|1|||
48547395|NCT00642278|156192424|FG000|Overall Study|Physician Decision|0|||
48547396|NCT00642278|156192425|FG001|Overall Study|Physician Decision|0|||
48547397|NCT00642278|156192426|FG002|Overall Study|Physician Decision|0|||
48547398|NCT00642278|156192427|FG003|Overall Study|Physician Decision|1|||
48547399|NCT00642278|156192428|FG004|Overall Study|Physician Decision|0|||
48612601|NCT02332707|156439391|FG000|Overall Study|Lost to Follow-up|0|||
48612602|NCT02332707|156439392|FG001|Overall Study|Lost to Follow-up|0|||
48612603|NCT02332707|156439393|FG002|Overall Study|Lost to Follow-up|0|||
48612604|NCT02332707|156439394|FG003|Overall Study|Lost to Follow-up|0|||
48612605|NCT02332707|156439395|FG004|Overall Study|Lost to Follow-up|0|||
48612606|NCT02332707|156439396|FG005|Overall Study|Lost to Follow-up|1|||
48547400|NCT00642278|156192429|FG005|Overall Study|Physician Decision|0|||
48547401|NCT00642278|156192430|FG006|Overall Study|Physician Decision|0|||
48547402|NCT00642278|156192424|FG000|Overall Study|Protocol Violation|0|||
48547403|NCT00642278|156192425|FG001|Overall Study|Protocol Violation|0|||
48547404|NCT00642278|156192426|FG002|Overall Study|Protocol Violation|1|||
48547405|NCT00642278|156192427|FG003|Overall Study|Protocol Violation|1|||
48547406|NCT00642278|156192428|FG004|Overall Study|Protocol Violation|0|||
48547407|NCT00642278|156192429|FG005|Overall Study|Protocol Violation|1|||
48547408|NCT00642278|156192430|FG006|Overall Study|Protocol Violation|2|||
48612607|NCT02332707|156439397|FG006|Overall Study|Lost to Follow-up|0|||
48612608|NCT02332707|156439398|FG007|Overall Study|Lost to Follow-up|0|||
48612609|NCT02332707|156439399|FG008|Overall Study|Lost to Follow-up|0|||
48612610|NCT02332707|156439400|FG009|Overall Study|Lost to Follow-up|0|||
48612611|NCT02332707|156439401|FG010|Overall Study|Lost to Follow-up|2|||
48612612|NCT02332707|156439402|FG011|Overall Study|Lost to Follow-up|0|||
48612613|NCT02332707|156439403|FG012|Overall Study|Lost to Follow-up|3|||
48612614|NCT02332707|156439404|FG013|Overall Study|Lost to Follow-up|0|||
48612615|NCT02332707|156439405|FG014|Overall Study|Lost to Follow-up|0|||
48612616|NCT02332707|156439406|FG015|Overall Study|Lost to Follow-up|0|||
48612617|NCT02332707|156439407|FG016|Overall Study|Lost to Follow-up|0|||
48612618|NCT02332707|156439408|FG017|Overall Study|Lost to Follow-up|0|||
48612619|NCT02332707|156439391|FG000|Overall Study|Physician Decision|0|||
48612620|NCT02332707|156439392|FG001|Overall Study|Physician Decision|0|||
48612621|NCT02332707|156439393|FG002|Overall Study|Physician Decision|0|||
48612622|NCT02332707|156439394|FG003|Overall Study|Physician Decision|1|||
48612623|NCT02332707|156439395|FG004|Overall Study|Physician Decision|0|||
48612624|NCT02332707|156439396|FG005|Overall Study|Physician Decision|0|||
48547409|NCT00642278|156192424|FG000|Overall Study|Withdrawal by Subject|1|||
48547410|NCT00642278|156192425|FG001|Overall Study|Withdrawal by Subject|1|||
48547411|NCT00642278|156192426|FG002|Overall Study|Withdrawal by Subject|1|||
48547412|NCT00642278|156192427|FG003|Overall Study|Withdrawal by Subject|3|||
48547413|NCT00642278|156192428|FG004|Overall Study|Withdrawal by Subject|6|||
48547414|NCT00642278|156192429|FG005|Overall Study|Withdrawal by Subject|2|||
48547415|NCT00642278|156192430|FG006|Overall Study|Withdrawal by Subject|2|||
48547416|NCT00642278|156192424|FG000|Overall Study|Noncompliance with study drug regimen|0|||
48547417|NCT00642278|156192425|FG001|Overall Study|Noncompliance with study drug regimen|0|||
48547418|NCT00642278|156192426|FG002|Overall Study|Noncompliance with study drug regimen|0|||
48547419|NCT00642278|156192427|FG003|Overall Study|Noncompliance with study drug regimen|1|||
48547420|NCT00642278|156192428|FG004|Overall Study|Noncompliance with study drug regimen|0|||
48547421|NCT00642278|156192429|FG005|Overall Study|Noncompliance with study drug regimen|0|||
48547422|NCT00642278|156192430|FG006|Overall Study|Noncompliance with study drug regimen|0|||
48547423|NCT00642278|156192424|FG000|Overall Study|Other|2|||
48547424|NCT00642278|156192425|FG001|Overall Study|Other|1|||
48547425|NCT00642278|156192426|FG002|Overall Study|Other|0|||
48547426|NCT00642278|156192427|FG003|Overall Study|Other|1|||
48547427|NCT00642278|156192428|FG004|Overall Study|Other|0|||
48547428|NCT00642278|156192429|FG005|Overall Study|Other|1|||
48547429|NCT00642278|156192430|FG006|Overall Study|Other|0|||
48547430|NCT01464931|156192431|FG000|Overall Study|Withdrawal by Subject|1|||
48547431|NCT01464931|156192432|FG001|Overall Study|Withdrawal by Subject|0|||
48547432|NCT02293863|156192434|FG000|Overall Study|Death|4|||
48547433|NCT02293863|156192435|FG001|Overall Study|Death|6|||
48547434|NCT02293863|156192436|FG002|Overall Study|Death|4|||
48547435|NCT02293863|156192434|FG000|Overall Study|Lost to Follow-up|2|||
48547436|NCT02293863|156192435|FG001|Overall Study|Lost to Follow-up|2|||
48547437|NCT02293863|156192436|FG002|Overall Study|Lost to Follow-up|2|||
48547438|NCT02293863|156192434|FG000|Overall Study|Withdrawal by Subject|3|||
48547439|NCT02293863|156192435|FG001|Overall Study|Withdrawal by Subject|3|||
48547440|NCT02293863|156192436|FG002|Overall Study|Withdrawal by Subject|1|||
48547441|NCT02293863|156192434|FG000|Overall Study|Reason Not Specified|0|||
48547442|NCT02293863|156192435|FG001|Overall Study|Reason Not Specified|2|||
48547443|NCT02293863|156192436|FG002|Overall Study|Reason Not Specified|2|||
48547444|NCT02212379|156192437|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
48547445|NCT02212379|156192437|FG000|From Baseline to Week 48|Adverse Event|7|||
48547446|NCT02212379|156192437|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
48547447|NCT02212379|156192437|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
48547448|NCT02212379|156192437|FG000|From Week 48 to Week 96|Adverse Event|1|||
48547449|NCT02212379|156192437|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
48547450|NCT04784533|156192438|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
48547451|NCT04784533|156192439|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
48547452|NCT04784533|156192440|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
48547453|NCT04784533|156192441|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
48547454|NCT04784533|156192442|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
48547455|NCT04784533|156192443|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
48612625|NCT02332707|156439397|FG006|Overall Study|Physician Decision|0|||
48612626|NCT02332707|156439398|FG007|Overall Study|Physician Decision|0|||
48612627|NCT02332707|156439399|FG008|Overall Study|Physician Decision|0|||
48547456|NCT04784533|156192444|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
48547457|NCT04784533|156192445|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
48547458|NCT04784533|156192446|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
48547459|NCT04784533|156192447|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
48547460|NCT04784533|156192438|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
48547461|NCT04784533|156192439|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
48547462|NCT04784533|156192440|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
48547463|NCT04784533|156192441|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
48547464|NCT04784533|156192442|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
48547465|NCT04784533|156192443|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
48547466|NCT04784533|156192444|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
48547467|NCT04784533|156192445|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
48547468|NCT04784533|156192446|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
48547469|NCT04784533|156192447|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
48547470|NCT04784533|156192438|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547471|NCT04784533|156192439|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
48547472|NCT04784533|156192440|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547473|NCT04784533|156192441|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547474|NCT04784533|156192442|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547475|NCT04784533|156192443|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547476|NCT04784533|156192444|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547477|NCT04784533|156192445|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547478|NCT04784533|156192446|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547479|NCT04784533|156192447|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
48547480|NCT04784533|156192438|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
48547481|NCT04784533|156192439|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48547482|NCT04784533|156192440|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48547483|NCT04784533|156192441|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48547484|NCT04784533|156192442|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48547485|NCT04784533|156192443|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48612628|NCT02332707|156439400|FG009|Overall Study|Physician Decision|0|||
48612629|NCT02332707|156439401|FG010|Overall Study|Physician Decision|0|||
48612630|NCT02332707|156439402|FG011|Overall Study|Physician Decision|0|||
48612631|NCT02332707|156439403|FG012|Overall Study|Physician Decision|1|||
48612632|NCT02332707|156439404|FG013|Overall Study|Physician Decision|0|||
48612633|NCT02332707|156439405|FG014|Overall Study|Physician Decision|0|||
48612634|NCT02332707|156439406|FG015|Overall Study|Physician Decision|0|||
48612635|NCT02332707|156439407|FG016|Overall Study|Physician Decision|0|||
48612636|NCT02332707|156439408|FG017|Overall Study|Physician Decision|0|||
48612637|NCT02332707|156439391|FG000|Overall Study|Withdrawal by Subject|0|||
48612638|NCT02332707|156439392|FG001|Overall Study|Withdrawal by Subject|0|||
48612639|NCT02332707|156439393|FG002|Overall Study|Withdrawal by Subject|1|||
48612640|NCT02332707|156439394|FG003|Overall Study|Withdrawal by Subject|0|||
48612641|NCT02332707|156439395|FG004|Overall Study|Withdrawal by Subject|0|||
48612642|NCT02332707|156439396|FG005|Overall Study|Withdrawal by Subject|0|||
48612643|NCT02332707|156439397|FG006|Overall Study|Withdrawal by Subject|0|||
48612644|NCT02332707|156439398|FG007|Overall Study|Withdrawal by Subject|0|||
48612645|NCT02332707|156439399|FG008|Overall Study|Withdrawal by Subject|0|||
48612646|NCT02332707|156439400|FG009|Overall Study|Withdrawal by Subject|3|||
48612647|NCT02332707|156439401|FG010|Overall Study|Withdrawal by Subject|0|||
48612648|NCT02332707|156439402|FG011|Overall Study|Withdrawal by Subject|0|||
48612649|NCT02332707|156439403|FG012|Overall Study|Withdrawal by Subject|0|||
48612650|NCT02332707|156439404|FG013|Overall Study|Withdrawal by Subject|0|||
48612651|NCT02332707|156439405|FG014|Overall Study|Withdrawal by Subject|0|||
48612652|NCT02332707|156439406|FG015|Overall Study|Withdrawal by Subject|0|||
48612653|NCT02332707|156439407|FG016|Overall Study|Withdrawal by Subject|0|||
48612654|NCT02332707|156439408|FG017|Overall Study|Withdrawal by Subject|0|||
48612655|NCT00274456|156439409|FG000|Overall Study|Still on treatment|2|||
48612656|NCT00274456|156439410|FG001|Overall Study|Still on treatment|3|||
48612657|NCT00274456|156439411|FG002|Overall Study|Still on treatment|5|||
48612658|NCT00274456|156439412|FG003|Overall Study|Still on treatment|1|||
48612659|NCT00274456|156439409|FG000|Overall Study|Unacceptable toxicity|10|||
48612660|NCT00274456|156439410|FG001|Overall Study|Unacceptable toxicity|5|||
48612661|NCT00274456|156439411|FG002|Overall Study|Unacceptable toxicity|12|||
48612662|NCT00274456|156439412|FG003|Overall Study|Unacceptable toxicity|16|||
48612663|NCT00274456|156439409|FG000|Overall Study|Adverse Event|0|||
48612664|NCT00274456|156439410|FG001|Overall Study|Adverse Event|1|||
48612665|NCT00274456|156439411|FG002|Overall Study|Adverse Event|2|||
48612666|NCT00274456|156439412|FG003|Overall Study|Adverse Event|2|||
48612667|NCT00274456|156439409|FG000|Overall Study|Physician Decision|7|||
48612668|NCT00274456|156439410|FG001|Overall Study|Physician Decision|5|||
48612669|NCT00274456|156439411|FG002|Overall Study|Physician Decision|6|||
48612670|NCT00274456|156439412|FG003|Overall Study|Physician Decision|13|||
48612671|NCT00274456|156439409|FG000|Overall Study|Lost to Follow-up|0|||
48612672|NCT00274456|156439410|FG001|Overall Study|Lost to Follow-up|0|||
48612673|NCT00274456|156439411|FG002|Overall Study|Lost to Follow-up|1|||
48612674|NCT00274456|156439412|FG003|Overall Study|Lost to Follow-up|0|||
48612675|NCT00274456|156439409|FG000|Overall Study|Withdrawal by Subject|18|||
48612676|NCT00274456|156439410|FG001|Overall Study|Withdrawal by Subject|13|||
48612677|NCT00274456|156439411|FG002|Overall Study|Withdrawal by Subject|9|||
48612678|NCT00274456|156439412|FG003|Overall Study|Withdrawal by Subject|13|||
48612679|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
48612680|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
48612681|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
48612682|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
48612683|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
48612684|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
48612685|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
48612686|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
48612687|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
48612688|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
48612689|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
48612690|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
48612691|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
48612692|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
48612693|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
48612694|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
48612695|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
48612696|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
48612697|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
48612698|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
48612699|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
48612700|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
48547486|NCT04784533|156192444|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48547487|NCT04784533|156192445|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48547488|NCT04784533|156192446|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48547489|NCT04784533|156192447|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
48547490|NCT04784533|156192438|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
48547491|NCT04784533|156192439|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
48547492|NCT04784533|156192440|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
48612701|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
48547493|NCT04784533|156192441|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
48547494|NCT04784533|156192442|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
48547495|NCT04784533|156192443|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
48547496|NCT04784533|156192444|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
48547497|NCT04784533|156192445|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
48547498|NCT04784533|156192446|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
48547499|NCT04784533|156192447|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
48547500|NCT04784533|156192438|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
48547501|NCT04784533|156192439|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
48547502|NCT04784533|156192440|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
48547503|NCT04784533|156192441|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
48547504|NCT04784533|156192442|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
48547505|NCT04784533|156192443|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
48547506|NCT04784533|156192444|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
48547507|NCT04784533|156192445|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
48547508|NCT04784533|156192446|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
48547509|NCT04784533|156192447|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
48547510|NCT04784533|156192438|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547511|NCT04784533|156192439|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547512|NCT04784533|156192440|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
48547513|NCT04784533|156192441|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547514|NCT04784533|156192442|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547515|NCT04784533|156192443|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547516|NCT04784533|156192444|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547517|NCT04784533|156192445|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547518|NCT04784533|156192446|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547519|NCT04784533|156192447|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
48547520|NCT04784533|156192438|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547521|NCT04784533|156192439|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547522|NCT04784533|156192440|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547523|NCT04784533|156192441|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547524|NCT04784533|156192442|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547525|NCT04784533|156192443|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547526|NCT04784533|156192444|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547527|NCT04784533|156192445|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547528|NCT04784533|156192446|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
48612702|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
48325479|NCT02357966|155389113|FG001|Overall Study|Death|0|||
48547529|NCT04784533|156192447|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
48547530|NCT04784533|156192438|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
48547531|NCT04784533|156192439|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
48547532|NCT04784533|156192440|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
48547533|NCT04784533|156192441|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
48547534|NCT04784533|156192442|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
48547535|NCT04784533|156192443|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
48547536|NCT04784533|156192444|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
48547537|NCT04784533|156192445|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
48547538|NCT04784533|156192446|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
48547539|NCT04784533|156192447|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
48547540|NCT00174954|156192448|FG000|Overall Study|Adverse Event|2|||
48547541|NCT00174954|156192448|FG000|Overall Study|No tophi found in MRI|1|||
48547542|NCT00174954|156192448|FG000|Overall Study|Physician Decision|1|||
48547543|NCT00721630|156194422|FG000|Overall Study|Participant found to be ineligible|1|||
48547544|NCT00792935|156194423|FG000|Overall Study|Adverse Event|2|||
48547545|NCT00792935|156194424|FG001|Overall Study|Adverse Event|1|||
48547546|NCT00792935|156194423|FG000|Overall Study|Lost to Follow-up|0|||
48547547|NCT00792935|156194424|FG001|Overall Study|Lost to Follow-up|1|||
48547548|NCT00792935|156194423|FG000|Overall Study|Protocol Violation|2|||
48547549|NCT00792935|156194424|FG001|Overall Study|Protocol Violation|0|||
48547550|NCT00792935|156194423|FG000|Overall Study|Withdrawal by Subject|0|||
48547551|NCT00792935|156194424|FG001|Overall Study|Withdrawal by Subject|1|||
48547552|NCT00090363|156194425|FG000|Overall Study|Lost to Follow-up|1|||
48547553|NCT00090363|156194426|FG001|Overall Study|Lost to Follow-up|2|||
48547554|NCT00090363|156194427|FG002|Overall Study|Lost to Follow-up|1|||
48612703|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
48612704|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
48612705|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
48612706|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
48612707|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
48612708|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
48547555|NCT00090363|156194425|FG000|Overall Study|Withdrawal by Subject|7|||
48547556|NCT00090363|156194426|FG001|Overall Study|Withdrawal by Subject|7|||
48547557|NCT00090363|156194427|FG002|Overall Study|Withdrawal by Subject|6|||
48547558|NCT00090363|156194425|FG000|Overall Study|Study-specific discontinuation criteria|75|||
48547559|NCT00090363|156194426|FG001|Overall Study|Study-specific discontinuation criteria|74|||
48547560|NCT00090363|156194427|FG002|Overall Study|Study-specific discontinuation criteria|62|||
48547561|NCT00090363|156194425|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48547562|NCT00090363|156194426|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48547563|NCT00090363|156194427|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
48547564|NCT00090363|156194425|FG000|Overall Study|Consent expired|7|||
48547565|NCT00090363|156194426|FG001|Overall Study|Consent expired|10|||
48547566|NCT00090363|156194427|FG002|Overall Study|Consent expired|9|||
48547567|NCT00090363|156194425|FG000|Overall Study|Reasons not specified|2|||
48547568|NCT00090363|156194426|FG001|Overall Study|Reasons not specified|1|||
48547569|NCT00090363|156194427|FG002|Overall Study|Reasons not specified|1|||
48547570|NCT00090363|156194425|FG000|Overall Study|Continuing on study off treatment|14|||
48547571|NCT00090363|156194426|FG001|Overall Study|Continuing on study off treatment|13|||
48547572|NCT00090363|156194427|FG002|Overall Study|Continuing on study off treatment|16|||
48547573|NCT00191113|156194428|FG000|Core Study|Withdrawal by Subject|25|||
48547574|NCT00191113|156194429|FG001|Core Study|Withdrawal by Subject|9|||
48547575|NCT00191113|156194428|FG000|Core Study|Protocol Violation|6|||
48547576|NCT00191113|156194429|FG001|Core Study|Protocol Violation|2|||
48547577|NCT00191113|156194428|FG000|Core Study|Lost to Follow-up|3|||
48547578|NCT00191113|156194429|FG001|Core Study|Lost to Follow-up|0|||
48547579|NCT00191113|156194428|FG000|Core Study|Adverse Event|0|||
48547580|NCT00191113|156194429|FG001|Core Study|Adverse Event|2|||
48547581|NCT00191113|156194428|FG000|Core Study|Lack of Efficacy|0|||
48547582|NCT00191113|156194429|FG001|Core Study|Lack of Efficacy|2|||
48547583|NCT00191113|156194428|FG000|Core Study|Death|1|||
48547584|NCT00191113|156194429|FG001|Core Study|Death|0|||
48547585|NCT03084367|156194430|FG000|Overall Study|Lost to Follow-up|32|||
48547586|NCT03084367|156194430|FG000|Overall Study|Withdrawal by Subject|4|||
48547587|NCT03084367|156194430|FG000|Overall Study|Other|1|||
48547588|NCT01206101|156194431|FG000|Overall Study|Adverse Event|1|||
48547589|NCT01206101|156194432|FG001|Overall Study|Adverse Event|0|||
48547590|NCT01206101|156194431|FG000|Overall Study|Physician Decision|0|||
48612709|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
48612710|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
48612711|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
48612712|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
48612713|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
48612714|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
48612715|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
48612716|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
48612717|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
48612718|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
48612719|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
48612720|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
48612721|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
48612722|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
48612723|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
48612724|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
48612725|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
48612726|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
48612727|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
48612728|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
48612729|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
48612730|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
48612731|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
48547591|NCT01206101|156194432|FG001|Overall Study|Physician Decision|1|||
48547592|NCT01206101|156194431|FG000|Overall Study|Unclassified|1|||
48547593|NCT01206101|156194432|FG001|Overall Study|Unclassified|0|||
48547594|NCT05307510|156194435|FG000|Overall Study|Lost to Follow-up|3|||
48547595|NCT05307510|156194436|FG001|Overall Study|Lost to Follow-up|6|||
48547596|NCT05307510|156194435|FG000|Overall Study|Withdrawal by Subject|0|||
48547597|NCT05307510|156194436|FG001|Overall Study|Withdrawal by Subject|1|||
48547598|NCT02213510|156194437|FG000|Overall Study|Death|0|||
48547599|NCT02213510|156194438|FG001|Overall Study|Death|1|||
48547600|NCT02213510|156194437|FG000|Overall Study|Lost to Follow-up|1|||
48547601|NCT02213510|156194438|FG001|Overall Study|Lost to Follow-up|0|||
48547602|NCT02383810|156194440|FG000|Overall Study|Physician Decision|1|||
48547603|NCT02383810|156194441|FG001|Overall Study|Physician Decision|1|||
48547604|NCT02383810|156194442|FG002|Overall Study|Physician Decision|0|||
48547605|NCT02383810|156194443|FG003|Overall Study|Physician Decision|0|||
48547606|NCT02383810|156194444|FG004|Overall Study|Physician Decision|0|||
48547607|NCT02383810|156194445|FG005|Overall Study|Physician Decision|0|||
48547608|NCT02383810|156194446|FG006|Overall Study|Physician Decision|0|||
48547609|NCT02383810|156194447|FG007|Overall Study|Physician Decision|0|||
48547610|NCT02383810|156194440|FG000|Overall Study|Withdrawal by Subject|2|||
48547611|NCT02383810|156194441|FG001|Overall Study|Withdrawal by Subject|3|||
48547612|NCT02383810|156194442|FG002|Overall Study|Withdrawal by Subject|3|||
48547613|NCT02383810|156194443|FG003|Overall Study|Withdrawal by Subject|3|||
48547614|NCT02383810|156194444|FG004|Overall Study|Withdrawal by Subject|0|||
48547615|NCT02383810|156194445|FG005|Overall Study|Withdrawal by Subject|0|||
48547616|NCT02383810|156194446|FG006|Overall Study|Withdrawal by Subject|0|||
48547617|NCT02383810|156194447|FG007|Overall Study|Withdrawal by Subject|0|||
48547618|NCT02383810|156194440|FG000|Overall Study|Adverse Event|0|||
48547619|NCT02383810|156194441|FG001|Overall Study|Adverse Event|2|||
48547620|NCT02383810|156194442|FG002|Overall Study|Adverse Event|4|||
48547621|NCT02383810|156194443|FG003|Overall Study|Adverse Event|5|||
48547622|NCT02383810|156194444|FG004|Overall Study|Adverse Event|0|||
48547623|NCT02383810|156194445|FG005|Overall Study|Adverse Event|1|||
48547624|NCT02383810|156194446|FG006|Overall Study|Adverse Event|1|||
48547625|NCT02383810|156194447|FG007|Overall Study|Adverse Event|0|||
48612732|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
48612733|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
48612734|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
48612735|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
48612736|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
48612737|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
48612738|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
48612739|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
48612740|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
48612741|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
48612742|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
48612743|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
48612744|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
48612745|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
48612746|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
48612747|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
48612748|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
48612749|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
48612750|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
48612751|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
48547626|NCT02383810|156194440|FG000|Overall Study|Lost to Follow-up|0|||
48547627|NCT02383810|156194441|FG001|Overall Study|Lost to Follow-up|1|||
48547628|NCT02383810|156194442|FG002|Overall Study|Lost to Follow-up|0|||
48547629|NCT02383810|156194443|FG003|Overall Study|Lost to Follow-up|1|||
48547630|NCT02383810|156194444|FG004|Overall Study|Lost to Follow-up|0|||
48547631|NCT02383810|156194445|FG005|Overall Study|Lost to Follow-up|0|||
48547632|NCT02383810|156194446|FG006|Overall Study|Lost to Follow-up|0|||
48547633|NCT02383810|156194447|FG007|Overall Study|Lost to Follow-up|0|||
48547634|NCT02383810|156194440|FG000|Overall Study|other|0|||
48547635|NCT02383810|156194441|FG001|Overall Study|other|0|||
48547636|NCT02383810|156194442|FG002|Overall Study|other|0|||
48547637|NCT02383810|156194443|FG003|Overall Study|other|2|||
48547638|NCT02383810|156194444|FG004|Overall Study|other|0|||
48547639|NCT02383810|156194445|FG005|Overall Study|other|0|||
48547640|NCT02383810|156194446|FG006|Overall Study|other|0|||
48547641|NCT02383810|156194447|FG007|Overall Study|other|0|||
48547642|NCT02383810|156194440|FG000|Overall Study|subject did not receive study treatment|0|||
48547643|NCT02383810|156194441|FG001|Overall Study|subject did not receive study treatment|1|||
48547644|NCT02383810|156194442|FG002|Overall Study|subject did not receive study treatment|0|||
48547645|NCT02383810|156194443|FG003|Overall Study|subject did not receive study treatment|0|||
48547646|NCT02383810|156194444|FG004|Overall Study|subject did not receive study treatment|0|||
48547647|NCT02383810|156194445|FG005|Overall Study|subject did not receive study treatment|0|||
48547648|NCT02383810|156194446|FG006|Overall Study|subject did not receive study treatment|0|||
48547649|NCT02383810|156194447|FG007|Overall Study|subject did not receive study treatment|0|||
48547650|NCT01248013|156194448|FG000|Overall Study|Withdrawal by Subject|14|||
48547651|NCT01724489|156194451|FG000|Overall Study|Adverse Event|8|||
48547652|NCT01724489|156194452|FG001|Overall Study|Adverse Event|3|||
48547653|NCT01724489|156194451|FG000|Overall Study|Surgery, medication|1|||
48547654|NCT01724489|156194452|FG001|Overall Study|Surgery, medication|1|||
48547655|NCT01724489|156194451|FG000|Overall Study|Lost to Follow-up|1|||
48547656|NCT01724489|156194452|FG001|Overall Study|Lost to Follow-up|2|||
48547657|NCT01724489|156194451|FG000|Overall Study|Withdrawal by Subject|6|||
48547658|NCT01724489|156194452|FG001|Overall Study|Withdrawal by Subject|6|||
48547659|NCT00923273|156194453|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
48547660|NCT00923273|156194454|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
48547661|NCT00923273|156194455|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
48547662|NCT00923273|156194456|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
48547663|NCT00923273|156194457|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
48547664|NCT00923273|156194453|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
48547665|NCT00923273|156194454|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
48547666|NCT00923273|156194455|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
48547667|NCT00923273|156194456|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
48547668|NCT00923273|156194457|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
48547669|NCT00605540|156194458|FG000|Overall Study|Death|15|||
48547670|NCT00605540|156194458|FG000|Overall Study|Lost to Follow-up|23|||
48547671|NCT01739348|156194459|FG000|Part I (Base Study)|Adverse Event|41|||
48547672|NCT01739348|156194460|FG001|Part I (Base Study)|Adverse Event|52|||
48547673|NCT01739348|156194461|FG002|Part I (Base Study)|Adverse Event|8|||
48547674|NCT01739348|156194462|FG003|Part I (Base Study)|Adverse Event|33|||
48547675|NCT01739348|156194459|FG000|Part I (Base Study)|Death|10|||
48547676|NCT01739348|156194460|FG001|Part I (Base Study)|Death|7|||
48547677|NCT01739348|156194461|FG002|Part I (Base Study)|Death|2|||
48547678|NCT01739348|156194462|FG003|Part I (Base Study)|Death|8|||
48547679|NCT01739348|156194459|FG000|Part I (Base Study)|Lack of Efficacy|3|||
48547680|NCT01739348|156194460|FG001|Part I (Base Study)|Lack of Efficacy|8|||
48547681|NCT01739348|156194461|FG002|Part I (Base Study)|Lack of Efficacy|0|||
48547682|NCT01739348|156194462|FG003|Part I (Base Study)|Lack of Efficacy|7|||
48547683|NCT01739348|156194459|FG000|Part I (Base Study)|Lost to Follow-up|4|||
48547684|NCT01739348|156194460|FG001|Part I (Base Study)|Lost to Follow-up|2|||
48547685|NCT01739348|156194461|FG002|Part I (Base Study)|Lost to Follow-up|4|||
48547686|NCT01739348|156194462|FG003|Part I (Base Study)|Lost to Follow-up|4|||
48547687|NCT01739348|156194459|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
48547688|NCT01739348|156194460|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
48547689|NCT01739348|156194461|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
48547690|NCT01739348|156194462|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
48547691|NCT01739348|156194459|FG000|Part I (Base Study)|Physician Decision|10|||
48547692|NCT01739348|156194460|FG001|Part I (Base Study)|Physician Decision|7|||
48547693|NCT01739348|156194461|FG002|Part I (Base Study)|Physician Decision|1|||
48547694|NCT01739348|156194462|FG003|Part I (Base Study)|Physician Decision|4|||
48547695|NCT01739348|156194459|FG000|Part I (Base Study)|Protocol Violation|2|||
48547696|NCT01739348|156194460|FG001|Part I (Base Study)|Protocol Violation|0|||
48547697|NCT01739348|156194461|FG002|Part I (Base Study)|Protocol Violation|1|||
48547698|NCT01739348|156194462|FG003|Part I (Base Study)|Protocol Violation|2|||
48547699|NCT01739348|156194459|FG000|Part I (Base Study)|Screen Failure|2|||
48612752|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
48612753|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
48612754|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
48612755|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
48612756|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
48612757|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
48547700|NCT01739348|156194460|FG001|Part I (Base Study)|Screen Failure|0|||
48547701|NCT01739348|156194461|FG002|Part I (Base Study)|Screen Failure|0|||
48547702|NCT01739348|156194462|FG003|Part I (Base Study)|Screen Failure|0|||
48547703|NCT01739348|156194459|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
48547704|NCT01739348|156194460|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
48547705|NCT01739348|156194461|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
48547706|NCT01739348|156194462|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
48547707|NCT01739348|156194459|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
48547708|NCT01739348|156194460|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
48547709|NCT01739348|156194461|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
48547710|NCT01739348|156194462|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
48547711|NCT01739348|156194459|FG000|Part I (Base Study)|Participant Moved|4|||
48547712|NCT01739348|156194460|FG001|Part I (Base Study)|Participant Moved|3|||
48547713|NCT01739348|156194461|FG002|Part I (Base Study)|Participant Moved|1|||
48547714|NCT01739348|156194462|FG003|Part I (Base Study)|Participant Moved|7|||
48547715|NCT01739348|156194459|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
48547716|NCT01739348|156194460|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
48547717|NCT01739348|156194461|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
48547718|NCT01739348|156194462|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
48547719|NCT01739348|156194459|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
48547720|NCT01739348|156194460|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
48547721|NCT01739348|156194461|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
48547722|NCT01739348|156194462|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
48547723|NCT01739348|156194459|FG000|Part II (Extension Study)|Adverse Event|10|||
48547724|NCT01739348|156194460|FG001|Part II (Extension Study)|Adverse Event|11|||
48547725|NCT01739348|156194461|FG002|Part II (Extension Study)|Adverse Event|7|||
48547726|NCT01739348|156194462|FG003|Part II (Extension Study)|Adverse Event|26|||
48547727|NCT01739348|156194459|FG000|Part II (Extension Study)|Death|3|||
48547728|NCT01739348|156194460|FG001|Part II (Extension Study)|Death|3|||
48547729|NCT01739348|156194461|FG002|Part II (Extension Study)|Death|2|||
48547730|NCT01739348|156194462|FG003|Part II (Extension Study)|Death|6|||
48547731|NCT01739348|156194459|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
48547732|NCT01739348|156194460|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
48547733|NCT01739348|156194461|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
48547734|NCT01739348|156194462|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
48547735|NCT01739348|156194459|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
48547736|NCT01739348|156194460|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
48547737|NCT01739348|156194461|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
48547738|NCT01739348|156194462|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
48547739|NCT01739348|156194459|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
48547740|NCT01739348|156194460|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
48547741|NCT01739348|156194461|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
48547742|NCT01739348|156194462|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
48547743|NCT01739348|156194459|FG000|Part II (Extension Study)|Physician Decision|7|||
48547744|NCT01739348|156194460|FG001|Part II (Extension Study)|Physician Decision|11|||
48547745|NCT01739348|156194461|FG002|Part II (Extension Study)|Physician Decision|6|||
48612758|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
48612759|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
48547746|NCT01739348|156194462|FG003|Part II (Extension Study)|Physician Decision|12|||
48547747|NCT01739348|156194459|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
48547748|NCT01739348|156194460|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
48547749|NCT01739348|156194461|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
48612760|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
48612761|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
48612762|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
48612763|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
48547750|NCT01739348|156194462|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
48547751|NCT01739348|156194459|FG000|Part II (Extension Study)|Participant Moved|3|||
48547752|NCT01739348|156194460|FG001|Part II (Extension Study)|Participant Moved|3|||
48547753|NCT01739348|156194461|FG002|Part II (Extension Study)|Participant Moved|0|||
48547754|NCT01739348|156194462|FG003|Part II (Extension Study)|Participant Moved|3|||
48547755|NCT01739348|156194459|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
48612764|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
48547756|NCT01739348|156194460|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
48547757|NCT01739348|156194461|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
48547758|NCT01739348|156194462|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
48547759|NCT01739348|156194459|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
48547760|NCT01739348|156194460|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
48547761|NCT01739348|156194461|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
48547762|NCT01739348|156194462|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
48547763|NCT00660400|156194466|FG000|Overall Study|Lack of insurance approval|1|||
48547764|NCT00660400|156194466|FG000|Overall Study|Suboptimal organ function|1|||
48547765|NCT00660400|156194466|FG000|Overall Study|Intracranial hemorrhage|1|||
48547766|NCT00660400|156194466|FG000|Overall Study|Withdrawal by Subject|1|||
48612765|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
48612766|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
48612767|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
48612768|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
48612769|NCT00090103|156439413|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
48612770|NCT00090103|156439414|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
48612771|NCT00090103|156439415|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
48612772|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
48612773|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
48612774|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
48547767|NCT01447420|156194467|FG000|Overall Study|Adverse Event|2|||
48547768|NCT01447420|156194468|FG001|Overall Study|Adverse Event|4|||
48547769|NCT01447420|156194469|FG002|Overall Study|Adverse Event|2|||
48547770|NCT01447420|156194467|FG000|Overall Study|Protocol Violation|3|||
48547771|NCT01447420|156194468|FG001|Overall Study|Protocol Violation|3|||
48547772|NCT01447420|156194469|FG002|Overall Study|Protocol Violation|0|||
48547773|NCT01447420|156194467|FG000|Overall Study|Withdrawal by Subject|4|||
48547774|NCT01447420|156194468|FG001|Overall Study|Withdrawal by Subject|1|||
48547775|NCT01447420|156194469|FG002|Overall Study|Withdrawal by Subject|0|||
48547776|NCT01447420|156194467|FG000|Overall Study|Lack of Efficacy|1|||
48547777|NCT01447420|156194468|FG001|Overall Study|Lack of Efficacy|19|||
48547778|NCT01447420|156194469|FG002|Overall Study|Lack of Efficacy|8|||
48547779|NCT04562155|156194472|FG000|Overall Study|COVID-19 pandemic|0|||
48547780|NCT04562155|156194473|FG001|Overall Study|COVID-19 pandemic|0|||
48547781|NCT04562155|156194474|FG002|Overall Study|COVID-19 pandemic|0|||
48547782|NCT04562155|156194475|FG003|Overall Study|COVID-19 pandemic|1|||
48547783|NCT04562155|156194472|FG000|Overall Study|Adverse Event|7|||
48547784|NCT04562155|156194473|FG001|Overall Study|Adverse Event|3|||
48547785|NCT04562155|156194474|FG002|Overall Study|Adverse Event|8|||
48547786|NCT04562155|156194475|FG003|Overall Study|Adverse Event|1|||
48547787|NCT04562155|156194472|FG000|Overall Study|Withdrawal by Subject|3|||
48547788|NCT04562155|156194473|FG001|Overall Study|Withdrawal by Subject|6|||
48547789|NCT04562155|156194474|FG002|Overall Study|Withdrawal by Subject|3|||
48547790|NCT04562155|156194475|FG003|Overall Study|Withdrawal by Subject|3|||
48547791|NCT04562155|156194472|FG000|Overall Study|Participant personal reason|1|||
48547792|NCT04562155|156194473|FG001|Overall Study|Participant personal reason|0|||
48547793|NCT04562155|156194474|FG002|Overall Study|Participant personal reason|2|||
48547794|NCT04562155|156194475|FG003|Overall Study|Participant personal reason|1|||
48547795|NCT00509366|156194476|FG000|Overall Study|Not Treated (Screen Failure)|1|||
48547796|NCT00509366|156194477|FG001|Overall Study|Not Treated (Screen Failure)|1|||
48547797|NCT00509366|156194478|FG002|Overall Study|Not Treated (Screen Failure)|1|||
48547798|NCT00509366|156194479|FG003|Overall Study|Not Treated (Screen Failure)|0|||
48547799|NCT00509366|156194480|FG004|Overall Study|Not Treated (Screen Failure)|0|||
48547800|NCT02119819|156194484|FG000|Overall Study|Adverse Event|3|||
48547801|NCT02119819|156194485|FG001|Overall Study|Adverse Event|1|||
48547802|NCT02119819|156194486|FG002|Overall Study|Adverse Event|2|||
48547803|NCT02119819|156194487|FG003|Overall Study|Adverse Event|3|||
48612775|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
48612776|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
48612777|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
48612778|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
48612779|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
48547804|NCT02119819|156194488|FG004|Overall Study|Adverse Event|0|||
48547805|NCT02119819|156194489|FG005|Overall Study|Adverse Event|1|||
48547806|NCT02119819|156194484|FG000|Overall Study|Lack of Efficacy|0|||
48547807|NCT02119819|156194485|FG001|Overall Study|Lack of Efficacy|0|||
48547808|NCT02119819|156194486|FG002|Overall Study|Lack of Efficacy|0|||
48547809|NCT02119819|156194487|FG003|Overall Study|Lack of Efficacy|0|||
48547810|NCT02119819|156194488|FG004|Overall Study|Lack of Efficacy|0|||
48547811|NCT02119819|156194489|FG005|Overall Study|Lack of Efficacy|1|||
48547812|NCT02119819|156194484|FG000|Overall Study|Lost to Follow-up|0|||
48547813|NCT02119819|156194485|FG001|Overall Study|Lost to Follow-up|0|||
48547814|NCT02119819|156194486|FG002|Overall Study|Lost to Follow-up|1|||
48547815|NCT02119819|156194487|FG003|Overall Study|Lost to Follow-up|2|||
48547816|NCT02119819|156194488|FG004|Overall Study|Lost to Follow-up|1|||
48547817|NCT02119819|156194489|FG005|Overall Study|Lost to Follow-up|2|||
48547818|NCT02119819|156194484|FG000|Overall Study|Physician Decision|1|||
48547819|NCT02119819|156194485|FG001|Overall Study|Physician Decision|1|||
48547820|NCT02119819|156194486|FG002|Overall Study|Physician Decision|0|||
48547821|NCT02119819|156194487|FG003|Overall Study|Physician Decision|0|||
48547822|NCT02119819|156194488|FG004|Overall Study|Physician Decision|0|||
48547823|NCT02119819|156194489|FG005|Overall Study|Physician Decision|1|||
48547824|NCT02119819|156194484|FG000|Overall Study|Withdrawal by Subject|5|||
48547825|NCT02119819|156194485|FG001|Overall Study|Withdrawal by Subject|3|||
48547826|NCT02119819|156194486|FG002|Overall Study|Withdrawal by Subject|0|||
48547827|NCT02119819|156194487|FG003|Overall Study|Withdrawal by Subject|0|||
48547828|NCT02119819|156194488|FG004|Overall Study|Withdrawal by Subject|6|||
48547829|NCT02119819|156194489|FG005|Overall Study|Withdrawal by Subject|10|||
48547830|NCT02119819|156194484|FG000|Overall Study|Jury Duty|0|||
48612780|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
48612781|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
48612782|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
48612783|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
48612784|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
48612785|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
48612786|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
48612787|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
48612788|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
48612789|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
48612790|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
48612791|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
48612792|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
48612793|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
48612794|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
48612795|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
48612796|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
48547831|NCT02119819|156194485|FG001|Overall Study|Jury Duty|0|||
48547832|NCT02119819|156194486|FG002|Overall Study|Jury Duty|1|||
48547833|NCT02119819|156194487|FG003|Overall Study|Jury Duty|0|||
48547834|NCT02119819|156194488|FG004|Overall Study|Jury Duty|0|||
48547835|NCT02119819|156194489|FG005|Overall Study|Jury Duty|0|||
48547836|NCT02119819|156194484|FG000|Overall Study|Protocol Violation|0|||
48547837|NCT02119819|156194485|FG001|Overall Study|Protocol Violation|0|||
48547838|NCT02119819|156194486|FG002|Overall Study|Protocol Violation|0|||
48547839|NCT02119819|156194487|FG003|Overall Study|Protocol Violation|1|||
48547840|NCT02119819|156194488|FG004|Overall Study|Protocol Violation|0|||
48547841|NCT02119819|156194489|FG005|Overall Study|Protocol Violation|0|||
48547842|NCT02119819|156194484|FG000|Overall Study|Left the city to get a job|0|||
48547843|NCT02119819|156194485|FG001|Overall Study|Left the city to get a job|0|||
48547844|NCT02119819|156194486|FG002|Overall Study|Left the city to get a job|0|||
48547845|NCT02119819|156194487|FG003|Overall Study|Left the city to get a job|1|||
48547846|NCT02119819|156194488|FG004|Overall Study|Left the city to get a job|0|||
48547847|NCT02119819|156194489|FG005|Overall Study|Left the city to get a job|0|||
48547848|NCT02699684|156194490|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
48547849|NCT02699684|156194491|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
48547850|NCT01544179|156194492|FG000|Overall Study|Death|50|||
48547851|NCT01544179|156194493|FG001|Overall Study|Death|37|||
48547852|NCT01544179|156194492|FG000|Overall Study|Lost to Follow-up|0|||
48547853|NCT01544179|156194493|FG001|Overall Study|Lost to Follow-up|1|||
48612797|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
48612798|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
48547854|NCT01544179|156194492|FG000|Overall Study|Adverse Event|0|||
48547855|NCT01544179|156194493|FG001|Overall Study|Adverse Event|1|||
48547856|NCT01544179|156194492|FG000|Overall Study|Withdrawal by Subject|12|||
48547857|NCT01544179|156194493|FG001|Overall Study|Withdrawal by Subject|7|||
48547858|NCT01544179|156194492|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
48547859|NCT01544179|156194493|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48547860|NCT01145508|156194494|FG000|Overall Study|Adverse Event|1|||
48547861|NCT01145508|156194495|FG001|Overall Study|Adverse Event|0|||
48547862|NCT01145508|156194494|FG000|Overall Study|Death|1|||
48547863|NCT01145508|156194495|FG001|Overall Study|Death|0|||
48547864|NCT01145508|156194494|FG000|Overall Study|Physician Decision|2|||
48547865|NCT01145508|156194495|FG001|Overall Study|Physician Decision|1|||
48547866|NCT01145508|156194494|FG000|Overall Study|Never started treatment|1|||
48547867|NCT01145508|156194495|FG001|Overall Study|Never started treatment|1|||
48547868|NCT01475097|156194499|FG000|Overall Study|Protocol Violation|1|||
48547869|NCT01475097|156194500|FG001|Overall Study|Protocol Violation|1|||
48547870|NCT02045147|156194501|FG000|Overall Study|Withdrawal by Subject|2|||
48547871|NCT02045147|156194502|FG001|Overall Study|Withdrawal by Subject|0|||
48547872|NCT02045147|156194503|FG002|Overall Study|Withdrawal by Subject|0|||
48547873|NCT02045147|156194504|FG003|Overall Study|Withdrawal by Subject|0|||
48547874|NCT02045147|156194505|FG004|Overall Study|Withdrawal by Subject|0|||
48547875|NCT02045147|156194506|FG005|Overall Study|Withdrawal by Subject|0|||
48547876|NCT02045147|156194507|FG006|Overall Study|Withdrawal by Subject|0|||
48547877|NCT02045147|156194508|FG007|Overall Study|Withdrawal by Subject|1|||
48547878|NCT02045147|156194501|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
48547879|NCT02045147|156194502|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
48547880|NCT02045147|156194503|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
48547881|NCT02045147|156194504|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
48547882|NCT02045147|156194505|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
48547883|NCT02045147|156194506|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
48547884|NCT02045147|156194507|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
48547885|NCT02045147|156194508|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
48547886|NCT01085201|156194509|FG000|Overall Study|Scheduling conflict|1|||
48547887|NCT01085201|156194510|FG001|Overall Study|Scheduling conflict|0|||
48547888|NCT01085201|156194511|FG002|Overall Study|Scheduling conflict|1|||
48547889|NCT01085201|156194512|FG003|Overall Study|Scheduling conflict|0|||
48547890|NCT01085201|156194513|FG004|Overall Study|Scheduling conflict|0|||
48547891|NCT01085201|156194509|FG000|Overall Study|Unknown- no study drug|2|||
48547892|NCT01085201|156194510|FG001|Overall Study|Unknown- no study drug|0|||
48547893|NCT01085201|156194511|FG002|Overall Study|Unknown- no study drug|0|||
48547894|NCT01085201|156194512|FG003|Overall Study|Unknown- no study drug|0|||
48547895|NCT01085201|156194513|FG004|Overall Study|Unknown- no study drug|0|||
48547896|NCT01085201|156194509|FG000|Overall Study|Fond ineligible after consent|0|||
48547897|NCT01085201|156194510|FG001|Overall Study|Fond ineligible after consent|1|||
48547898|NCT01085201|156194511|FG002|Overall Study|Fond ineligible after consent|1|||
48547899|NCT01085201|156194512|FG003|Overall Study|Fond ineligible after consent|0|||
48547900|NCT01085201|156194513|FG004|Overall Study|Fond ineligible after consent|0|||
48547901|NCT03146962|156194514|FG000|Overall Study|Lost to Follow-up|1|||
48547902|NCT03146962|156194515|FG001|Overall Study|Lost to Follow-up|1|||
48547903|NCT03146962|156194516|FG002|Overall Study|Lost to Follow-up|0|||
48547904|NCT03146962|156194517|FG003|Overall Study|Lost to Follow-up|0|||
48547905|NCT03146962|156194518|FG004|Overall Study|Lost to Follow-up|0|||
48547906|NCT03146962|156194519|FG005|Overall Study|Lost to Follow-up|0|||
48547907|NCT03146962|156194520|FG006|Overall Study|Lost to Follow-up|0|||
48547908|NCT03146962|156194521|FG007|Overall Study|Lost to Follow-up|0|||
48547909|NCT03146962|156194522|FG008|Overall Study|Lost to Follow-up|0|||
48547910|NCT03146962|156194523|FG009|Overall Study|Lost to Follow-up|0|||
48547911|NCT03146962|156194514|FG000|Overall Study|Adverse Event|0|||
48547912|NCT03146962|156194515|FG001|Overall Study|Adverse Event|3|||
48547913|NCT03146962|156194516|FG002|Overall Study|Adverse Event|0|||
48547914|NCT03146962|156194517|FG003|Overall Study|Adverse Event|0|||
48612799|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
48612800|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
48547915|NCT03146962|156194518|FG004|Overall Study|Adverse Event|0|||
48547916|NCT03146962|156194519|FG005|Overall Study|Adverse Event|0|||
48547917|NCT03146962|156194520|FG006|Overall Study|Adverse Event|0|||
48547918|NCT03146962|156194521|FG007|Overall Study|Adverse Event|1|||
48547919|NCT03146962|156194522|FG008|Overall Study|Adverse Event|0|||
48547920|NCT03146962|156194523|FG009|Overall Study|Adverse Event|0|||
48547921|NCT03146962|156194514|FG000|Overall Study|Withdrawal by Subject|0|||
48547922|NCT03146962|156194515|FG001|Overall Study|Withdrawal by Subject|0|||
48547923|NCT03146962|156194516|FG002|Overall Study|Withdrawal by Subject|0|||
48547924|NCT03146962|156194517|FG003|Overall Study|Withdrawal by Subject|0|||
48547925|NCT03146962|156194518|FG004|Overall Study|Withdrawal by Subject|1|||
48547926|NCT03146962|156194519|FG005|Overall Study|Withdrawal by Subject|0|||
48547927|NCT03146962|156194520|FG006|Overall Study|Withdrawal by Subject|0|||
48612801|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
48612802|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
48612803|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
48612804|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
48612805|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
48547928|NCT03146962|156194521|FG007|Overall Study|Withdrawal by Subject|0|||
48547929|NCT03146962|156194522|FG008|Overall Study|Withdrawal by Subject|0|||
48547930|NCT03146962|156194523|FG009|Overall Study|Withdrawal by Subject|0|||
48547931|NCT03146962|156194514|FG000|Overall Study|Death|0|||
48547932|NCT03146962|156194515|FG001|Overall Study|Death|1|||
48547933|NCT03146962|156194516|FG002|Overall Study|Death|0|||
48547934|NCT03146962|156194517|FG003|Overall Study|Death|0|||
48547935|NCT03146962|156194518|FG004|Overall Study|Death|0|||
48547936|NCT03146962|156194519|FG005|Overall Study|Death|0|||
48547937|NCT03146962|156194520|FG006|Overall Study|Death|0|||
48547938|NCT03146962|156194521|FG007|Overall Study|Death|0|||
48547939|NCT03146962|156194522|FG008|Overall Study|Death|0|||
48547940|NCT03146962|156194523|FG009|Overall Study|Death|0|||
48547941|NCT03146962|156194514|FG000|Overall Study|COVID Precautions|1|||
48547942|NCT03146962|156194515|FG001|Overall Study|COVID Precautions|0|||
48547943|NCT03146962|156194516|FG002|Overall Study|COVID Precautions|0|||
48547944|NCT03146962|156194517|FG003|Overall Study|COVID Precautions|0|||
48547945|NCT03146962|156194518|FG004|Overall Study|COVID Precautions|0|||
48547946|NCT03146962|156194519|FG005|Overall Study|COVID Precautions|0|||
48547947|NCT03146962|156194520|FG006|Overall Study|COVID Precautions|0|||
48547948|NCT03146962|156194521|FG007|Overall Study|COVID Precautions|0|||
48547949|NCT03146962|156194522|FG008|Overall Study|COVID Precautions|0|||
48547950|NCT03146962|156194523|FG009|Overall Study|COVID Precautions|0|||
48547951|NCT03146962|156194514|FG000|Overall Study|Physician Decision|0|||
48547952|NCT03146962|156194515|FG001|Overall Study|Physician Decision|0|||
48547953|NCT03146962|156194516|FG002|Overall Study|Physician Decision|0|||
48547954|NCT03146962|156194517|FG003|Overall Study|Physician Decision|0|||
48547955|NCT03146962|156194518|FG004|Overall Study|Physician Decision|0|||
48547956|NCT03146962|156194519|FG005|Overall Study|Physician Decision|0|||
48547957|NCT03146962|156194520|FG006|Overall Study|Physician Decision|0|||
48547958|NCT03146962|156194521|FG007|Overall Study|Physician Decision|0|||
48547959|NCT03146962|156194522|FG008|Overall Study|Physician Decision|0|||
48547960|NCT03146962|156194523|FG009|Overall Study|Physician Decision|1|||
48547961|NCT03146962|156194514|FG000|Overall Study|Started New Treatment|0|||
48547962|NCT03146962|156194515|FG001|Overall Study|Started New Treatment|1|||
48547963|NCT03146962|156194516|FG002|Overall Study|Started New Treatment|0|||
48547964|NCT03146962|156194517|FG003|Overall Study|Started New Treatment|0|||
48547965|NCT03146962|156194518|FG004|Overall Study|Started New Treatment|0|||
48547966|NCT03146962|156194519|FG005|Overall Study|Started New Treatment|0|||
48547967|NCT03146962|156194520|FG006|Overall Study|Started New Treatment|0|||
48547968|NCT03146962|156194521|FG007|Overall Study|Started New Treatment|0|||
48547969|NCT03146962|156194522|FG008|Overall Study|Started New Treatment|0|||
48547970|NCT03146962|156194523|FG009|Overall Study|Started New Treatment|0|||
48547971|NCT01438996|156194526|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
48547972|NCT01438996|156194527|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
48547973|NCT01438996|156194528|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
48547974|NCT00528411|156194531|FG000|Overall Study|Adverse Event|4|||
48547975|NCT00528411|156194532|FG001|Overall Study|Adverse Event|0|||
48612806|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
48612807|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
48612808|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
48612809|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
48547976|NCT00528411|156194533|FG002|Overall Study|Adverse Event|1|||
48547977|NCT00528411|156194531|FG000|Overall Study|Incorrect Enrolment|1|||
48547978|NCT00528411|156194532|FG001|Overall Study|Incorrect Enrolment|1|||
48547979|NCT00528411|156194533|FG002|Overall Study|Incorrect Enrolment|0|||
48547980|NCT00528411|156194531|FG000|Overall Study|Severe non-compliance to protocol|0|||
48547981|NCT00528411|156194532|FG001|Overall Study|Severe non-compliance to protocol|1|||
48547982|NCT00528411|156194533|FG002|Overall Study|Severe non-compliance to protocol|0|||
48547983|NCT00528411|156194531|FG000|Overall Study|Prior commitment medication|0|||
48547984|NCT00528411|156194532|FG001|Overall Study|Prior commitment medication|1|||
48547985|NCT00528411|156194533|FG002|Overall Study|Prior commitment medication|0|||
48547986|NCT04480710|156194534|FG000|Overall Study|Adverse Event|0|||
48547987|NCT04480710|156194535|FG001|Overall Study|Adverse Event|2|||
48547988|NCT04480710|156194536|FG002|Overall Study|Adverse Event|0|||
48547989|NCT04480710|156194537|FG003|Overall Study|Adverse Event|0|||
48547990|NCT04480710|156194534|FG000|Overall Study|Withdrawal by Subject|0|||
48547991|NCT04480710|156194535|FG001|Overall Study|Withdrawal by Subject|1|||
48547992|NCT04480710|156194536|FG002|Overall Study|Withdrawal by Subject|0|||
48547993|NCT04480710|156194537|FG003|Overall Study|Withdrawal by Subject|0|||
48547994|NCT04480710|156194534|FG000|Overall Study|Physician Decision|0|||
48547995|NCT04480710|156194535|FG001|Overall Study|Physician Decision|0|||
48547996|NCT04480710|156194536|FG002|Overall Study|Physician Decision|1|||
48547997|NCT04480710|156194537|FG003|Overall Study|Physician Decision|0|||
48547998|NCT00587990|156194538|FG000|Overall Study|Death|0|||
48547999|NCT00587990|156194539|FG001|Overall Study|Death|0|||
48548000|NCT00587990|156194540|FG002|Overall Study|Death|1|||
48548001|NCT02754856|156194541|FG000|Overall Study|Withdrawal by Subject|1|||
48548002|NCT00530218|156194544|FG000|Overall Study|CMV Not Detected|13|||
48548003|NCT00530218|156194544|FG000|Overall Study|Death|12|||
48548004|NCT05199090|156194545|FG000|Overall Study|Adverse Event|1|||
48548005|NCT05199090|156194546|FG001|Overall Study|Adverse Event|4|||
48548006|NCT05199090|156194547|FG002|Overall Study|Adverse Event|0|||
48548007|NCT05199090|156194548|FG003|Overall Study|Adverse Event|0|||
48548008|NCT05199090|156194549|FG004|Overall Study|Adverse Event|0|||
48548009|NCT05199090|156194550|FG005|Overall Study|Adverse Event|0|||
48548010|NCT05199090|156194545|FG000|Overall Study|Lost to Follow-up|1|||
48548011|NCT05199090|156194546|FG001|Overall Study|Lost to Follow-up|0|||
48548012|NCT05199090|156194547|FG002|Overall Study|Lost to Follow-up|1|||
48548013|NCT05199090|156194548|FG003|Overall Study|Lost to Follow-up|4|||
48548014|NCT05199090|156194549|FG004|Overall Study|Lost to Follow-up|0|||
48548015|NCT05199090|156194550|FG005|Overall Study|Lost to Follow-up|5|||
48548016|NCT05199090|156194545|FG000|Overall Study|Physician Decision|0|||
48548017|NCT05199090|156194546|FG001|Overall Study|Physician Decision|0|||
48548018|NCT05199090|156194547|FG002|Overall Study|Physician Decision|0|||
48548019|NCT05199090|156194548|FG003|Overall Study|Physician Decision|0|||
48548020|NCT05199090|156194549|FG004|Overall Study|Physician Decision|0|||
48548021|NCT05199090|156194550|FG005|Overall Study|Physician Decision|1|||
48548022|NCT05199090|156194545|FG000|Overall Study|Study terminated by sponsor|0|||
48548023|NCT05199090|156194546|FG001|Overall Study|Study terminated by sponsor|6|||
48548024|NCT05199090|156194547|FG002|Overall Study|Study terminated by sponsor|0|||
48548025|NCT05199090|156194548|FG003|Overall Study|Study terminated by sponsor|0|||
48548026|NCT05199090|156194549|FG004|Overall Study|Study terminated by sponsor|0|||
48548027|NCT05199090|156194550|FG005|Overall Study|Study terminated by sponsor|5|||
48548028|NCT05199090|156194545|FG000|Overall Study|Subject decision|0|||
48548029|NCT05199090|156194546|FG001|Overall Study|Subject decision|4|||
48548030|NCT05199090|156194547|FG002|Overall Study|Subject decision|0|||
48548031|NCT05199090|156194548|FG003|Overall Study|Subject decision|2|||
48548032|NCT05199090|156194549|FG004|Overall Study|Subject decision|5|||
48548033|NCT05199090|156194550|FG005|Overall Study|Subject decision|2|||
48548034|NCT03485365|156194551|FG000|Overall Study|Protocol Violation|0|||
48548035|NCT03485365|156194552|FG001|Overall Study|Protocol Violation|0|||
48548036|NCT03485365|156194553|FG002|Overall Study|Protocol Violation|0|||
48548037|NCT03485365|156194554|FG003|Overall Study|Protocol Violation|1|||
48548038|NCT03485365|156194555|FG004|Overall Study|Protocol Violation|0|||
48548039|NCT03485365|156194556|FG005|Overall Study|Protocol Violation|0|||
48548040|NCT03485365|156194557|FG006|Overall Study|Protocol Violation|1|||
48548041|NCT03485365|156194558|FG007|Overall Study|Protocol Violation|0|||
48548042|NCT03485365|156194559|FG008|Overall Study|Protocol Violation|0|||
48548043|NCT03136965|156194561|FG000|Overall Study|Lost to Follow-up|0|||
48548044|NCT03136965|156194562|FG001|Overall Study|Lost to Follow-up|1|||
48548045|NCT03136965|156194563|FG002|Overall Study|Lost to Follow-up|0|||
48548046|NCT03489109|156194564|FG000|Overall Study|Lost to Follow-up|1|||
48548047|NCT03489109|156194565|FG001|Overall Study|Lost to Follow-up|2|||
48548048|NCT04868968|156194568|FG000|Overall Study|Lost to Follow-up|1|||
48548049|NCT00384930|156194571|FG000|Overall Study|Adverse Event|5|||
48548050|NCT00384930|156194572|FG001|Overall Study|Adverse Event|4|||
48548051|NCT00384930|156194573|FG002|Overall Study|Adverse Event|12|||
48548052|NCT00384930|156194574|FG003|Overall Study|Adverse Event|11|||
48548053|NCT00384930|156194575|FG004|Overall Study|Adverse Event|14|||
48548054|NCT00384930|156194571|FG000|Overall Study|Entry Criteria Not Met|2|||
48548055|NCT00384930|156194572|FG001|Overall Study|Entry Criteria Not Met|6|||
48548056|NCT00384930|156194573|FG002|Overall Study|Entry Criteria Not Met|7|||
48548057|NCT00384930|156194574|FG003|Overall Study|Entry Criteria Not Met|8|||
48548058|NCT00384930|156194575|FG004|Overall Study|Entry Criteria Not Met|4|||
48548059|NCT00384930|156194571|FG000|Overall Study|Lack of Efficacy|1|||
48548060|NCT00384930|156194572|FG001|Overall Study|Lack of Efficacy|1|||
48548061|NCT00384930|156194573|FG002|Overall Study|Lack of Efficacy|2|||
48548062|NCT00384930|156194574|FG003|Overall Study|Lack of Efficacy|1|||
48548063|NCT00384930|156194575|FG004|Overall Study|Lack of Efficacy|2|||
48548064|NCT00384930|156194571|FG000|Overall Study|Lost to Follow-up|5|||
48548065|NCT00384930|156194572|FG001|Overall Study|Lost to Follow-up|3|||
48548066|NCT00384930|156194573|FG002|Overall Study|Lost to Follow-up|0|||
48548067|NCT00384930|156194574|FG003|Overall Study|Lost to Follow-up|4|||
48548068|NCT00384930|156194575|FG004|Overall Study|Lost to Follow-up|6|||
48548069|NCT00384930|156194571|FG000|Overall Study|Physician Decision|0|||
48548070|NCT00384930|156194572|FG001|Overall Study|Physician Decision|1|||
48548071|NCT00384930|156194573|FG002|Overall Study|Physician Decision|1|||
48548072|NCT00384930|156194574|FG003|Overall Study|Physician Decision|0|||
48548073|NCT00384930|156194575|FG004|Overall Study|Physician Decision|1|||
48548074|NCT00384930|156194571|FG000|Overall Study|Protocol Violation|1|||
48548075|NCT00384930|156194572|FG001|Overall Study|Protocol Violation|0|||
48548076|NCT00384930|156194573|FG002|Overall Study|Protocol Violation|1|||
48548077|NCT00384930|156194574|FG003|Overall Study|Protocol Violation|6|||
48548078|NCT00384930|156194575|FG004|Overall Study|Protocol Violation|4|||
48548079|NCT00384930|156194571|FG000|Overall Study|Sponsor Decision|3|||
48548080|NCT00384930|156194572|FG001|Overall Study|Sponsor Decision|4|||
48548081|NCT00384930|156194573|FG002|Overall Study|Sponsor Decision|0|||
48548082|NCT00384930|156194574|FG003|Overall Study|Sponsor Decision|5|||
48548083|NCT00384930|156194575|FG004|Overall Study|Sponsor Decision|0|||
48548084|NCT00384930|156194571|FG000|Overall Study|Withdrawal by Subject|9|||
48548085|NCT00384930|156194572|FG001|Overall Study|Withdrawal by Subject|7|||
48548086|NCT00384930|156194573|FG002|Overall Study|Withdrawal by Subject|7|||
48548087|NCT00384930|156194574|FG003|Overall Study|Withdrawal by Subject|6|||
48548088|NCT00384930|156194575|FG004|Overall Study|Withdrawal by Subject|16|||
48548089|NCT00384930|156194571|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
48548090|NCT00384930|156194572|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
48548091|NCT00384930|156194573|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
48548092|NCT00384930|156194574|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
48548093|NCT00384930|156194575|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
48548094|NCT00678886|156194576|FG000|Overall Study|Withdrawal by Subject|0|||
48548095|NCT00678886|156194577|FG001|Overall Study|Withdrawal by Subject|0|||
48548096|NCT00678886|156194578|FG002|Overall Study|Withdrawal by Subject|4|||
48548097|NCT00678886|156194579|FG003|Overall Study|Withdrawal by Subject|6|||
48548098|NCT00678886|156194576|FG000|Overall Study|Physician Decision|0|||
48548099|NCT00678886|156194577|FG001|Overall Study|Physician Decision|0|||
48548100|NCT00678886|156194578|FG002|Overall Study|Physician Decision|1|||
48548101|NCT00678886|156194579|FG003|Overall Study|Physician Decision|1|||
48548102|NCT00678886|156194576|FG000|Overall Study|Lost to Follow-up|0|||
48548103|NCT00678886|156194577|FG001|Overall Study|Lost to Follow-up|0|||
48548104|NCT00678886|156194578|FG002|Overall Study|Lost to Follow-up|3|||
48548105|NCT00678886|156194579|FG003|Overall Study|Lost to Follow-up|2|||
48548106|NCT00678886|156194576|FG000|Overall Study|Other|0|||
48548107|NCT00678886|156194577|FG001|Overall Study|Other|0|||
48548108|NCT00678886|156194578|FG002|Overall Study|Other|1|||
48548109|NCT00678886|156194579|FG003|Overall Study|Other|0|||
48548110|NCT00951496|156194580|FG000|Overall Study|Did not initiate study treatment|10|||
48548111|NCT00951496|156194581|FG001|Overall Study|Did not initiate study treatment|8|||
48548112|NCT00951496|156194582|FG002|Overall Study|Did not initiate study treatment|13|||
48548113|NCT01671332|156194587|FG000|Overall Study|Withdrawal by Subject|1|||
48548114|NCT01671332|156194588|FG001|Overall Study|Withdrawal by Subject|1|||
48548115|NCT03713619|156194589|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
48548116|NCT03713619|156194590|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
48548117|NCT03713619|156194591|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
48548118|NCT03713619|156194592|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
48548119|NCT03713619|156194593|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
48548120|NCT03713619|156194589|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
48548121|NCT03713619|156194590|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
48548122|NCT03713619|156194591|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
48548123|NCT03713619|156194592|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
48548124|NCT03713619|156194593|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
48548125|NCT03713619|156194589|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
48548126|NCT03713619|156194590|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
48548127|NCT03713619|156194591|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
48548128|NCT03713619|156194592|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
48548129|NCT03713619|156194593|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
48548130|NCT03713619|156194589|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
48548131|NCT03713619|156194590|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
48548132|NCT03713619|156194591|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
48548133|NCT03713619|156194592|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
48548134|NCT03713619|156194593|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
48548135|NCT03713619|156194589|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
48548136|NCT03713619|156194590|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
48548137|NCT03713619|156194591|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
48548138|NCT03713619|156194592|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
48548139|NCT03713619|156194593|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
48612810|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
48612811|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
48612812|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
48612813|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
48612814|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
48612815|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
48612816|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
48612817|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
48612818|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
48612819|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
48612820|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Death|1|||
48612821|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Death|0|||
48612822|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Death|1|||
48612823|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
48612824|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
48612825|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
48612826|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
48612827|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
48612828|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
48612829|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
48612830|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
48612831|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
48612832|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
48612833|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
48612834|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
48612835|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
48612836|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
48612837|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
48612838|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
48612839|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
48612840|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
48612841|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
48612842|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
48612843|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
48612844|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Depression|0|||
48612845|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Depression|1|||
48612846|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Depression|0|||
48612847|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
48612848|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
48612849|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
48612850|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Jailed|0|||
48612851|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Jailed|1|||
48612852|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Jailed|0|||
48612853|NCT00090103|156439413|FG000|16-Week Safety Follow-up Period|Other|0|||
48612854|NCT00090103|156439414|FG001|16-Week Safety Follow-up Period|Other|1|||
48612855|NCT00090103|156439415|FG002|16-Week Safety Follow-up Period|Other|0|||
48612856|NCT04766333|156439416|FG000|Overall Study|Lost to Follow-up|40|||
48612857|NCT04766333|156439417|FG001|Overall Study|Lost to Follow-up|826|||
48612858|NCT01898078|156439418|FG000|Overall Study|Progressive Disease|1|||
48612859|NCT01898078|156439419|FG001|Overall Study|Progressive Disease|5|||
48612860|NCT01898078|156439418|FG000|Overall Study|Adverse Event|2|||
48612861|NCT01898078|156439419|FG001|Overall Study|Adverse Event|1|||
48612862|NCT01898078|156439418|FG000|Overall Study|Withdrawal by Subject|1|||
48612863|NCT01898078|156439419|FG001|Overall Study|Withdrawal by Subject|1|||
48612864|NCT01898078|156439418|FG000|Overall Study|Symptomatic Deterioration|2|||
48612865|NCT01898078|156439419|FG001|Overall Study|Symptomatic Deterioration|0|||
48612866|NCT01898078|156439418|FG000|Overall Study|Reason not Specified|0|||
48612867|NCT01898078|156439419|FG001|Overall Study|Reason not Specified|1|||
48612868|NCT00541229|156439420|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
48612869|NCT00541229|156439421|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
48612870|NCT00541229|156439422|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
48612871|NCT00541229|156439423|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
48612872|NCT00541229|156439424|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
48612873|NCT00541229|156439425|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
48612874|NCT00541229|156439420|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
48612875|NCT00541229|156439421|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
48612876|NCT00541229|156439422|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
48612877|NCT00541229|156439423|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
48612878|NCT00541229|156439424|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
48612879|NCT00541229|156439425|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
48612880|NCT00541229|156439420|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
48612881|NCT00541229|156439421|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
48612882|NCT00541229|156439422|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
48612883|NCT00541229|156439423|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
48612884|NCT00541229|156439424|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
48612885|NCT00541229|156439425|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
48612886|NCT00541229|156439420|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
48612887|NCT00541229|156439421|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
48612888|NCT00541229|156439422|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
48612889|NCT00541229|156439423|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
48612890|NCT00541229|156439424|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
48612891|NCT00541229|156439425|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
48612892|NCT00541229|156439420|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
48612893|NCT00541229|156439421|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
48612894|NCT00541229|156439422|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
48612895|NCT00541229|156439423|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
48612896|NCT00541229|156439424|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
48612897|NCT00541229|156439425|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
48612898|NCT00541229|156439420|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
48612899|NCT00541229|156439421|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
48548140|NCT03713619|156194589|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
48548141|NCT03713619|156194590|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
48548142|NCT03713619|156194591|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
48548143|NCT03713619|156194592|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
48548144|NCT03713619|156194593|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
48548145|NCT03713619|156194589|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
48548146|NCT03713619|156194590|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
48548147|NCT03713619|156194591|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
48548148|NCT03713619|156194592|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
48548149|NCT03713619|156194593|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
48548150|NCT03713619|156194589|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
48548151|NCT03713619|156194590|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
48548152|NCT03713619|156194591|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
48548153|NCT03713619|156194592|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
48548154|NCT03713619|156194593|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
48548155|NCT03713619|156194589|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
48548156|NCT03713619|156194590|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
48548157|NCT03713619|156194591|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
48548158|NCT03713619|156194592|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
48548159|NCT03713619|156194593|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
48548160|NCT03713619|156194589|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
48548161|NCT03713619|156194590|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
48548162|NCT03713619|156194591|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
48548163|NCT03713619|156194592|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
48548164|NCT03713619|156194593|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
48548165|NCT03713619|156194589|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
48548166|NCT03713619|156194590|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
48548167|NCT03713619|156194591|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
48548168|NCT03713619|156194592|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
48548169|NCT03713619|156194593|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
48548170|NCT03713619|156194589|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
48612900|NCT00541229|156439422|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
48548171|NCT03713619|156194590|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
48612901|NCT00541229|156439423|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
48612902|NCT00541229|156439424|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
48548172|NCT03713619|156194591|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
48612903|NCT00541229|156439425|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
48612904|NCT00541229|156439420|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
48612905|NCT00541229|156439421|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
48548173|NCT03713619|156194592|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
48548174|NCT03713619|156194593|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
48612906|NCT00541229|156439422|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
48548175|NCT03713619|156194589|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
48548176|NCT03713619|156194590|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
48548177|NCT03713619|156194591|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
48548178|NCT03713619|156194592|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
48548179|NCT03713619|156194593|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
48548180|NCT03371459|156194594|FG000|Washout|Lost to Follow-up|0|||
48548181|NCT03371459|156194595|FG001|Washout|Lost to Follow-up|1|||
48548182|NCT02105974|156194598|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
48548183|NCT02105974|156194599|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
48548184|NCT02105974|156194600|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
48548185|NCT02105974|156194598|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
48548186|NCT02105974|156194599|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
48548187|NCT02105974|156194600|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
48548188|NCT02105974|156194598|FG000|2 Week Run-in Period|Adverse Event|6|||
48548189|NCT02105974|156194599|FG001|2 Week Run-in Period|Adverse Event|0|||
48548190|NCT02105974|156194600|FG002|2 Week Run-in Period|Adverse Event|0|||
48548191|NCT02105974|156194598|FG000|2 Week Run-in Period|Study closed/terminated|1|||
48548192|NCT02105974|156194599|FG001|2 Week Run-in Period|Study closed/terminated|0|||
48548193|NCT02105974|156194600|FG002|2 Week Run-in Period|Study closed/terminated|0|||
48548194|NCT02105974|156194598|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
48548195|NCT02105974|156194599|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
48548196|NCT02105974|156194600|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
48548197|NCT02105974|156194598|FG000|2 Week Run-in Period|Withdrew consent|23|||
48548198|NCT02105974|156194599|FG001|2 Week Run-in Period|Withdrew consent|0|||
48548199|NCT02105974|156194600|FG002|2 Week Run-in Period|Withdrew consent|0|||
48548200|NCT02105974|156194598|FG000|2 Week Run-in Period|Investigator discretion|8|||
48548201|NCT02105974|156194599|FG001|2 Week Run-in Period|Investigator discretion|0|||
48548202|NCT02105974|156194600|FG002|2 Week Run-in Period|Investigator discretion|0|||
48548203|NCT02105974|156194598|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
48548204|NCT02105974|156194599|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
48548205|NCT02105974|156194600|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
48548206|NCT02105974|156194598|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
48548207|NCT02105974|156194599|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
48548208|NCT02105974|156194600|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
48548209|NCT02105974|156194598|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
48548210|NCT02105974|156194599|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
48548211|NCT02105974|156194600|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
48548212|NCT02105974|156194598|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
48548213|NCT02105974|156194599|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
48548214|NCT02105974|156194600|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
48548215|NCT02105974|156194598|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
48548216|NCT02105974|156194599|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
48548217|NCT02105974|156194600|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
48548218|NCT02105974|156194598|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
48548219|NCT02105974|156194599|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
48548220|NCT02105974|156194600|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
48548221|NCT02105974|156194598|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
48612907|NCT00541229|156439423|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
48612908|NCT00541229|156439424|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
48612909|NCT00541229|156439425|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
48612910|NCT00541229|156439420|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
48612911|NCT00541229|156439421|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
48612912|NCT00541229|156439422|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
48612913|NCT00541229|156439423|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
48612914|NCT00541229|156439424|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
48612915|NCT00541229|156439425|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
48612916|NCT00541229|156439420|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
48612917|NCT00541229|156439421|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
48612918|NCT00541229|156439422|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
48612919|NCT00541229|156439423|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
48612920|NCT00541229|156439424|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
48612921|NCT00541229|156439425|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
48612922|NCT00541229|156439420|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
48612923|NCT00541229|156439421|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
48612924|NCT00541229|156439422|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
48612925|NCT00541229|156439423|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
48612926|NCT00541229|156439424|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
48612927|NCT00541229|156439425|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
48612928|NCT00541229|156439420|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
48612929|NCT00541229|156439421|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
48612930|NCT00541229|156439422|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
48612931|NCT00541229|156439423|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
48612932|NCT00541229|156439424|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
48612933|NCT00541229|156439425|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
48612934|NCT00541229|156439420|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
48612935|NCT00541229|156439421|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
48612936|NCT00541229|156439422|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
48612937|NCT00541229|156439423|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
48612938|NCT00541229|156439424|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
48612939|NCT00541229|156439425|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
48612940|NCT00541229|156439420|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
48612941|NCT00541229|156439421|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
48612942|NCT00541229|156439422|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
48612943|NCT00541229|156439423|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
48612944|NCT00541229|156439424|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
48612945|NCT00541229|156439425|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
48612946|NCT00541229|156439420|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
48612947|NCT00541229|156439421|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
48612948|NCT00541229|156439422|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
48612949|NCT00541229|156439423|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
48612950|NCT00541229|156439424|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
48612951|NCT00541229|156439425|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
48612952|NCT00541229|156439420|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
48612953|NCT00541229|156439421|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
48612954|NCT00541229|156439422|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
48612955|NCT00541229|156439423|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
48612956|NCT00541229|156439424|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
48612957|NCT00541229|156439425|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
48612958|NCT00541229|156439420|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
48612959|NCT00541229|156439421|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
48612960|NCT00541229|156439422|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
48612961|NCT00541229|156439423|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
48612962|NCT00541229|156439424|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
48612963|NCT00541229|156439425|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
48612964|NCT02017717|156439428|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
48612965|NCT02017717|156439429|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
48612966|NCT02017717|156439430|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
48612967|NCT02017717|156439431|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
48612968|NCT02017717|156439432|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
48612969|NCT02017717|156439433|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
48612970|NCT02017717|156439434|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
48612971|NCT02017717|156439435|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
48612972|NCT02017717|156439436|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
48612973|NCT02017717|156439428|FG000|Before Treatment Period|Participant request to stop therapy|0|||
48612974|NCT02017717|156439429|FG001|Before Treatment Period|Participant request to stop therapy|0|||
48612975|NCT02017717|156439430|FG002|Before Treatment Period|Participant request to stop therapy|0|||
48612976|NCT02017717|156439431|FG003|Before Treatment Period|Participant request to stop therapy|0|||
48612977|NCT02017717|156439432|FG004|Before Treatment Period|Participant request to stop therapy|5|||
48612978|NCT02017717|156439433|FG005|Before Treatment Period|Participant request to stop therapy|0|||
48612979|NCT02017717|156439434|FG006|Before Treatment Period|Participant request to stop therapy|0|||
48612980|NCT02017717|156439435|FG007|Before Treatment Period|Participant request to stop therapy|0|||
48612981|NCT02017717|156439436|FG008|Before Treatment Period|Participant request to stop therapy|0|||
48612982|NCT02017717|156439428|FG000|Before Treatment Period|Participant withdrew consent|0|||
48612983|NCT02017717|156439429|FG001|Before Treatment Period|Participant withdrew consent|0|||
48612984|NCT02017717|156439430|FG002|Before Treatment Period|Participant withdrew consent|0|||
48612985|NCT02017717|156439431|FG003|Before Treatment Period|Participant withdrew consent|0|||
48612986|NCT02017717|156439432|FG004|Before Treatment Period|Participant withdrew consent|11|||
48612987|NCT02017717|156439433|FG005|Before Treatment Period|Participant withdrew consent|0|||
48612988|NCT02017717|156439434|FG006|Before Treatment Period|Participant withdrew consent|0|||
48612989|NCT02017717|156439435|FG007|Before Treatment Period|Participant withdrew consent|0|||
48612990|NCT02017717|156439436|FG008|Before Treatment Period|Participant withdrew consent|2|||
48612991|NCT02017717|156439428|FG000|Before Treatment Period|Lost to Follow-up|0|||
48612992|NCT02017717|156439429|FG001|Before Treatment Period|Lost to Follow-up|0|||
48548222|NCT02105974|156194599|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
48548223|NCT02105974|156194600|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
48548224|NCT00477633|156194601|FG000|Overall Study|Did not receive treatment|23|||
48548225|NCT00477633|156194601|FG000|Overall Study|Adverse Event|143|||
48548226|NCT00477633|156194601|FG000|Overall Study|Pregnancy|23|||
48548227|NCT00477633|156194601|FG000|Overall Study|Lost to Follow-up|271|||
48548228|NCT00477633|156194601|FG000|Overall Study|Withdrawal by Subject|149|||
48548229|NCT00477633|156194601|FG000|Overall Study|Protocol Violation|25|||
48548230|NCT00477633|156194601|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
48612993|NCT02017717|156439430|FG002|Before Treatment Period|Lost to Follow-up|0|||
48612994|NCT02017717|156439431|FG003|Before Treatment Period|Lost to Follow-up|0|||
48612995|NCT02017717|156439432|FG004|Before Treatment Period|Lost to Follow-up|1|||
48612996|NCT02017717|156439433|FG005|Before Treatment Period|Lost to Follow-up|0|||
48612997|NCT02017717|156439434|FG006|Before Treatment Period|Lost to Follow-up|0|||
48612998|NCT02017717|156439435|FG007|Before Treatment Period|Lost to Follow-up|0|||
48612999|NCT02017717|156439436|FG008|Before Treatment Period|Lost to Follow-up|0|||
48613000|NCT02017717|156439428|FG000|Before Treatment Period|Participant no longer met criteria|0|||
48613001|NCT02017717|156439429|FG001|Before Treatment Period|Participant no longer met criteria|0|||
48613002|NCT02017717|156439430|FG002|Before Treatment Period|Participant no longer met criteria|0|||
48613003|NCT02017717|156439431|FG003|Before Treatment Period|Participant no longer met criteria|1|||
48613004|NCT02017717|156439432|FG004|Before Treatment Period|Participant no longer met criteria|2|||
48613005|NCT02017717|156439433|FG005|Before Treatment Period|Participant no longer met criteria|0|||
48613006|NCT02017717|156439434|FG006|Before Treatment Period|Participant no longer met criteria|0|||
48613007|NCT02017717|156439435|FG007|Before Treatment Period|Participant no longer met criteria|1|||
48613008|NCT02017717|156439436|FG008|Before Treatment Period|Participant no longer met criteria|0|||
48613009|NCT02017717|156439428|FG000|Before Treatment Period|other reason|0|||
48613010|NCT02017717|156439429|FG001|Before Treatment Period|other reason|0|||
48613011|NCT02017717|156439430|FG002|Before Treatment Period|other reason|0|||
48613012|NCT02017717|156439431|FG003|Before Treatment Period|other reason|0|||
48613013|NCT02017717|156439432|FG004|Before Treatment Period|other reason|1|||
48613014|NCT02017717|156439433|FG005|Before Treatment Period|other reason|0|||
48613015|NCT02017717|156439434|FG006|Before Treatment Period|other reason|0|||
48613016|NCT02017717|156439435|FG007|Before Treatment Period|other reason|0|||
48613017|NCT02017717|156439436|FG008|Before Treatment Period|other reason|0|||
48613018|NCT02017717|156439428|FG000|Treatment Period|Disease progression|7|||
48613019|NCT02017717|156439429|FG001|Treatment Period|Disease progression|9|||
48613020|NCT02017717|156439430|FG002|Treatment Period|Disease progression|12|||
48613021|NCT02017717|156439431|FG003|Treatment Period|Disease progression|165|||
48613022|NCT02017717|156439432|FG004|Treatment Period|Disease progression|134|||
48613023|NCT02017717|156439433|FG005|Treatment Period|Disease progression|20|||
48613024|NCT02017717|156439434|FG006|Treatment Period|Disease progression|26|||
48548231|NCT03155945|156194602|FG000|Overall Study|Lost to Follow-up|0|||
48548232|NCT03155945|156194603|FG001|Overall Study|Lost to Follow-up|1|||
48548233|NCT03155945|156194602|FG000|Overall Study|Withdrawal by Subject|0|||
48613025|NCT02017717|156439435|FG007|Treatment Period|Disease progression|17|||
48613026|NCT02017717|156439436|FG008|Treatment Period|Disease progression|22|||
48613027|NCT02017717|156439428|FG000|Treatment Period|Study drug toxicity|3|||
48613028|NCT02017717|156439429|FG001|Treatment Period|Study drug toxicity|0|||
48613029|NCT02017717|156439430|FG002|Treatment Period|Study drug toxicity|1|||
48613030|NCT02017717|156439431|FG003|Treatment Period|Study drug toxicity|7|||
48613031|NCT02017717|156439432|FG004|Treatment Period|Study drug toxicity|11|||
48613032|NCT02017717|156439433|FG005|Treatment Period|Study drug toxicity|4|||
48613033|NCT02017717|156439434|FG006|Treatment Period|Study drug toxicity|4|||
48613034|NCT02017717|156439435|FG007|Treatment Period|Study drug toxicity|5|||
48613035|NCT02017717|156439436|FG008|Treatment Period|Study drug toxicity|3|||
48613036|NCT02017717|156439428|FG000|Treatment Period|Death|0|||
48613037|NCT02017717|156439429|FG001|Treatment Period|Death|0|||
48613038|NCT02017717|156439430|FG002|Treatment Period|Death|1|||
48613039|NCT02017717|156439431|FG003|Treatment Period|Death|0|||
48613040|NCT02017717|156439432|FG004|Treatment Period|Death|0|||
48613041|NCT02017717|156439433|FG005|Treatment Period|Death|0|||
48613042|NCT02017717|156439434|FG006|Treatment Period|Death|0|||
48613043|NCT02017717|156439435|FG007|Treatment Period|Death|1|||
48613044|NCT02017717|156439436|FG008|Treatment Period|Death|0|||
48613045|NCT02017717|156439428|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
48613046|NCT02017717|156439429|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
48613047|NCT02017717|156439430|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
48613048|NCT02017717|156439431|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
48613049|NCT02017717|156439432|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
48613050|NCT02017717|156439433|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
48613051|NCT02017717|156439434|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
48613052|NCT02017717|156439435|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
48613053|NCT02017717|156439436|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
48613054|NCT02017717|156439428|FG000|Treatment Period|Participant request to stop therapy|0|||
48613055|NCT02017717|156439429|FG001|Treatment Period|Participant request to stop therapy|0|||
48548234|NCT03155945|156194603|FG001|Overall Study|Withdrawal by Subject|1|||
48613056|NCT02017717|156439430|FG002|Treatment Period|Participant request to stop therapy|3|||
48613057|NCT02017717|156439431|FG003|Treatment Period|Participant request to stop therapy|4|||
48613058|NCT02017717|156439432|FG004|Treatment Period|Participant request to stop therapy|7|||
48613059|NCT02017717|156439433|FG005|Treatment Period|Participant request to stop therapy|5|||
48613060|NCT02017717|156439434|FG006|Treatment Period|Participant request to stop therapy|0|||
48613061|NCT02017717|156439435|FG007|Treatment Period|Participant request to stop therapy|2|||
48613062|NCT02017717|156439436|FG008|Treatment Period|Participant request to stop therapy|1|||
48613063|NCT02017717|156439428|FG000|Treatment Period|Participant withdrew consent|0|||
48613064|NCT02017717|156439429|FG001|Treatment Period|Participant withdrew consent|0|||
48325480|NCT02357966|155389114|FG002|Overall Study|Death|1|||
48548235|NCT03155945|156194602|FG000|Overall Study|Other Reason|0|||
48548236|NCT03155945|156194603|FG001|Overall Study|Other Reason|1|||
48548237|NCT02013674|156194604|FG000|Overall Study|Death|0|||
48548238|NCT02013674|156194605|FG001|Overall Study|Death|1|||
48548239|NCT02013674|156194604|FG000|Overall Study|Lost to Follow-up|1|||
48548240|NCT02013674|156194605|FG001|Overall Study|Lost to Follow-up|0|||
48548241|NCT02359994|156194610|FG000|Overall Population Study|Adverse Event|1|||
48548242|NCT02359994|156194611|FG001|Overall Population Study|Adverse Event|1|||
48548243|NCT02359994|156194610|FG000|Overall Population Study|Death|1|||
48548244|NCT02359994|156194611|FG001|Overall Population Study|Death|5|||
48548245|NCT02359994|156194610|FG000|Overall Population Study|Lost to Follow-up|1|||
48548246|NCT02359994|156194611|FG001|Overall Population Study|Lost to Follow-up|1|||
48548247|NCT02359994|156194610|FG000|Overall Population Study|Withdrawal by Subject|1|||
48548248|NCT02359994|156194611|FG001|Overall Population Study|Withdrawal by Subject|0|||
48548249|NCT02359994|156194610|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
48548250|NCT02359994|156194611|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
48548251|NCT02359994|156194610|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
48548252|NCT02359994|156194611|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
48548253|NCT02359994|156194610|FG000|Extended Oncology 24-Month Survival|Death|19|||
48548254|NCT02359994|156194611|FG001|Extended Oncology 24-Month Survival|Death|21|||
48548255|NCT02359994|156194610|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
48548256|NCT02359994|156194611|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
48548257|NCT01823835|156194612|FG000|Overall Study|Adverse Event|0|||
48548258|NCT01823835|156194613|FG001|Overall Study|Adverse Event|0|||
48548259|NCT01823835|156194614|FG002|Overall Study|Adverse Event|0|||
48548260|NCT01823835|156194615|FG003|Overall Study|Adverse Event|0|||
48548261|NCT01823835|156194616|FG004|Overall Study|Adverse Event|1|||
48548262|NCT01823835|156194617|FG005|Overall Study|Adverse Event|0|||
48548263|NCT01823835|156194618|FG006|Overall Study|Adverse Event|1|||
48613065|NCT02017717|156439430|FG002|Treatment Period|Participant withdrew consent|1|||
48613066|NCT02017717|156439431|FG003|Treatment Period|Participant withdrew consent|1|||
48613067|NCT02017717|156439432|FG004|Treatment Period|Participant withdrew consent|4|||
48613068|NCT02017717|156439433|FG005|Treatment Period|Participant withdrew consent|0|||
48613069|NCT02017717|156439434|FG006|Treatment Period|Participant withdrew consent|0|||
48613070|NCT02017717|156439435|FG007|Treatment Period|Participant withdrew consent|2|||
48548264|NCT01823835|156194619|FG007|Overall Study|Adverse Event|0|||
48548265|NCT01823835|156194620|FG008|Overall Study|Adverse Event|0|||
48548266|NCT01823835|156194621|FG009|Overall Study|Adverse Event|0|||
48548267|NCT01823835|156194622|FG010|Overall Study|Adverse Event|1|||
48548268|NCT01823835|156194623|FG011|Overall Study|Adverse Event|2|||
48548269|NCT01823835|156194624|FG012|Overall Study|Adverse Event|0|||
48548270|NCT01823835|156194625|FG013|Overall Study|Adverse Event|0|||
48548271|NCT01823835|156194626|FG014|Overall Study|Adverse Event|0|||
48548272|NCT01823835|156194612|FG000|Overall Study|Physician Decision|0|||
48548273|NCT01823835|156194613|FG001|Overall Study|Physician Decision|0|||
48548274|NCT01823835|156194614|FG002|Overall Study|Physician Decision|0|||
48548275|NCT01823835|156194615|FG003|Overall Study|Physician Decision|0|||
48548276|NCT01823835|156194616|FG004|Overall Study|Physician Decision|0|||
48548277|NCT01823835|156194617|FG005|Overall Study|Physician Decision|0|||
48548278|NCT01823835|156194618|FG006|Overall Study|Physician Decision|0|||
48548279|NCT01823835|156194619|FG007|Overall Study|Physician Decision|0|||
48548280|NCT01823835|156194620|FG008|Overall Study|Physician Decision|0|||
48548281|NCT01823835|156194621|FG009|Overall Study|Physician Decision|0|||
48548282|NCT01823835|156194622|FG010|Overall Study|Physician Decision|0|||
48548283|NCT01823835|156194623|FG011|Overall Study|Physician Decision|2|||
48548284|NCT01823835|156194624|FG012|Overall Study|Physician Decision|0|||
48548285|NCT01823835|156194625|FG013|Overall Study|Physician Decision|0|||
48548286|NCT01823835|156194626|FG014|Overall Study|Physician Decision|0|||
48548287|NCT01823835|156194612|FG000|Overall Study|Progressive Disease|3|||
48548288|NCT01823835|156194613|FG001|Overall Study|Progressive Disease|4|||
48548289|NCT01823835|156194614|FG002|Overall Study|Progressive Disease|3|||
48548290|NCT01823835|156194615|FG003|Overall Study|Progressive Disease|6|||
48548291|NCT01823835|156194616|FG004|Overall Study|Progressive Disease|4|||
48548292|NCT01823835|156194617|FG005|Overall Study|Progressive Disease|6|||
48548293|NCT01823835|156194618|FG006|Overall Study|Progressive Disease|5|||
48548294|NCT01823835|156194619|FG007|Overall Study|Progressive Disease|3|||
48548295|NCT01823835|156194620|FG008|Overall Study|Progressive Disease|3|||
48548296|NCT01823835|156194621|FG009|Overall Study|Progressive Disease|18|||
48548297|NCT01823835|156194622|FG010|Overall Study|Progressive Disease|8|||
48548298|NCT01823835|156194623|FG011|Overall Study|Progressive Disease|46|||
48548299|NCT01823835|156194624|FG012|Overall Study|Progressive Disease|18|||
48548300|NCT01823835|156194625|FG013|Overall Study|Progressive Disease|4|||
48548301|NCT01823835|156194626|FG014|Overall Study|Progressive Disease|6|||
48548302|NCT01823835|156194612|FG000|Overall Study|Study Termination|0|||
48548303|NCT01823835|156194613|FG001|Overall Study|Study Termination|0|||
48548304|NCT01823835|156194614|FG002|Overall Study|Study Termination|0|||
48548305|NCT01823835|156194615|FG003|Overall Study|Study Termination|0|||
48548306|NCT01823835|156194616|FG004|Overall Study|Study Termination|1|||
48548307|NCT01823835|156194617|FG005|Overall Study|Study Termination|0|||
48548308|NCT01823835|156194618|FG006|Overall Study|Study Termination|0|||
48548309|NCT01823835|156194619|FG007|Overall Study|Study Termination|0|||
48548310|NCT01823835|156194620|FG008|Overall Study|Study Termination|0|||
48548311|NCT01823835|156194621|FG009|Overall Study|Study Termination|0|||
48548312|NCT01823835|156194622|FG010|Overall Study|Study Termination|0|||
48548313|NCT01823835|156194623|FG011|Overall Study|Study Termination|1|||
48548314|NCT01823835|156194624|FG012|Overall Study|Study Termination|0|||
48548315|NCT01823835|156194625|FG013|Overall Study|Study Termination|0|||
48548316|NCT01823835|156194626|FG014|Overall Study|Study Termination|0|||
48548317|NCT01823835|156194612|FG000|Overall Study|Withdrawal by Subject|0|||
48548318|NCT01823835|156194613|FG001|Overall Study|Withdrawal by Subject|0|||
48548319|NCT01823835|156194614|FG002|Overall Study|Withdrawal by Subject|1|||
48548320|NCT01823835|156194615|FG003|Overall Study|Withdrawal by Subject|0|||
48548321|NCT01823835|156194616|FG004|Overall Study|Withdrawal by Subject|0|||
48548322|NCT01823835|156194617|FG005|Overall Study|Withdrawal by Subject|0|||
48548323|NCT01823835|156194618|FG006|Overall Study|Withdrawal by Subject|0|||
48548324|NCT01823835|156194619|FG007|Overall Study|Withdrawal by Subject|0|||
48548325|NCT01823835|156194620|FG008|Overall Study|Withdrawal by Subject|0|||
48548326|NCT01823835|156194621|FG009|Overall Study|Withdrawal by Subject|1|||
48548327|NCT01823835|156194622|FG010|Overall Study|Withdrawal by Subject|1|||
48548328|NCT01823835|156194623|FG011|Overall Study|Withdrawal by Subject|2|||
48613071|NCT02017717|156439436|FG008|Treatment Period|Participant withdrew consent|0|||
48613072|NCT02017717|156439428|FG000|Treatment Period|Participant no longer met criteria|0|||
48613073|NCT02017717|156439429|FG001|Treatment Period|Participant no longer met criteria|0|||
48613074|NCT02017717|156439430|FG002|Treatment Period|Participant no longer met criteria|0|||
48613075|NCT02017717|156439431|FG003|Treatment Period|Participant no longer met criteria|0|||
48613076|NCT02017717|156439432|FG004|Treatment Period|Participant no longer met criteria|1|||
48613077|NCT02017717|156439433|FG005|Treatment Period|Participant no longer met criteria|0|||
48613078|NCT02017717|156439434|FG006|Treatment Period|Participant no longer met criteria|0|||
48613079|NCT02017717|156439435|FG007|Treatment Period|Participant no longer met criteria|0|||
48613080|NCT02017717|156439436|FG008|Treatment Period|Participant no longer met criteria|0|||
48613081|NCT02017717|156439428|FG000|Treatment Period|other reasons|0|||
48613082|NCT02017717|156439429|FG001|Treatment Period|other reasons|0|||
48613083|NCT02017717|156439430|FG002|Treatment Period|other reasons|0|||
48613084|NCT02017717|156439431|FG003|Treatment Period|other reasons|0|||
48613085|NCT02017717|156439432|FG004|Treatment Period|other reasons|1|||
48613086|NCT02017717|156439433|FG005|Treatment Period|other reasons|0|||
48613087|NCT02017717|156439434|FG006|Treatment Period|other reasons|0|||
48613088|NCT02017717|156439435|FG007|Treatment Period|other reasons|1|||
48613089|NCT02017717|156439436|FG008|Treatment Period|other reasons|1|||
48613090|NCT02017717|156439428|FG000|Treatment Period|Maximum clinical benefit|0|||
48613091|NCT02017717|156439429|FG001|Treatment Period|Maximum clinical benefit|0|||
48613092|NCT02017717|156439430|FG002|Treatment Period|Maximum clinical benefit|0|||
48613093|NCT02017717|156439431|FG003|Treatment Period|Maximum clinical benefit|0|||
48613094|NCT02017717|156439432|FG004|Treatment Period|Maximum clinical benefit|1|||
48613095|NCT02017717|156439433|FG005|Treatment Period|Maximum clinical benefit|0|||
48613096|NCT02017717|156439434|FG006|Treatment Period|Maximum clinical benefit|0|||
48613097|NCT02017717|156439435|FG007|Treatment Period|Maximum clinical benefit|0|||
48613098|NCT02017717|156439436|FG008|Treatment Period|Maximum clinical benefit|0|||
48613099|NCT00703534|156439437|FG000|Overall Study|Adverse Event|14|||
48613100|NCT00703534|156439438|FG001|Overall Study|Adverse Event|3|||
48613101|NCT00703534|156439437|FG000|Overall Study|Withdrawal by Subject|8|||
48613102|NCT00703534|156439438|FG001|Overall Study|Withdrawal by Subject|7|||
48613103|NCT00703534|156439437|FG000|Overall Study|Incorrect Enrollment|6|||
48613104|NCT00703534|156439438|FG001|Overall Study|Incorrect Enrollment|6|||
48613105|NCT00703534|156439437|FG000|Overall Study|Lost to Follow-up|1|||
48613106|NCT00703534|156439438|FG001|Overall Study|Lost to Follow-up|4|||
48613107|NCT00703534|156439437|FG000|Overall Study|Severe Non Compliance|1|||
48613108|NCT00703534|156439438|FG001|Overall Study|Severe Non Compliance|5|||
48548329|NCT01823835|156194624|FG012|Overall Study|Withdrawal by Subject|1|||
48548330|NCT01823835|156194625|FG013|Overall Study|Withdrawal by Subject|0|||
48548331|NCT01823835|156194626|FG014|Overall Study|Withdrawal by Subject|0|||
48548332|NCT01987479|156194632|FG000|Overall Study|Protocol Violation|1|||
48548333|NCT01987479|156194632|FG000|Overall Study|Physician Decision|2|||
48548334|NCT01987479|156194632|FG000|Overall Study|Participant/legal guardian decision|1|||
48613109|NCT00761319|156439439|FG000|Overall Study|Protocol Violation|21|||
48613110|NCT00761319|156439440|FG001|Overall Study|Protocol Violation|14|||
48613111|NCT00761319|156439439|FG000|Overall Study|Adverse Event|11|||
48613112|NCT00761319|156439440|FG001|Overall Study|Adverse Event|7|||
48613113|NCT00761319|156439439|FG000|Overall Study|Withdrawal by Subject|8|||
48613114|NCT00761319|156439440|FG001|Overall Study|Withdrawal by Subject|7|||
48548335|NCT01987479|156194632|FG000|Overall Study|Other|5|||
48548336|NCT01987479|156194632|FG000|Overall Study|Lost to Follow-up|1|||
48548337|NCT01987479|156194632|FG000|Overall Study|Adverse Event|7|||
48548338|NCT00351533|156194635|FG000|Overall Study|Extubated before first BAL|1|||
48548339|NCT00351533|156194636|FG001|Overall Study|Extubated before first BAL|0|||
48548340|NCT00351533|156194635|FG000|Overall Study|Lost to Follow-up|1|||
48548341|NCT00351533|156194636|FG001|Overall Study|Lost to Follow-up|3|||
48548342|NCT00351533|156194635|FG000|Overall Study|Physician Decision|0|||
48548343|NCT00351533|156194636|FG001|Overall Study|Physician Decision|1|||
48548344|NCT00351533|156194635|FG000|Overall Study|Withdrawal by Subject|0|||
48548345|NCT00351533|156194636|FG001|Overall Study|Withdrawal by Subject|1|||
48548346|NCT04123561|156194639|FG000|Overall Study|Lost to Follow-up|20|||
48548347|NCT04123561|156194640|FG001|Overall Study|Lost to Follow-up|12|||
48548348|NCT04123561|156194641|FG002|Overall Study|Lost to Follow-up|5|||
48548349|NCT04123561|156194639|FG000|Overall Study|Withdrawal by Subject|9|||
48548350|NCT04123561|156194640|FG001|Overall Study|Withdrawal by Subject|7|||
48548351|NCT04123561|156194641|FG002|Overall Study|Withdrawal by Subject|9|||
48548352|NCT04123561|156194639|FG000|Overall Study|Lack of Efficacy|7|||
48548353|NCT04123561|156194640|FG001|Overall Study|Lack of Efficacy|8|||
48613115|NCT00761319|156439439|FG000|Overall Study|Noncompliance|4|||
48613116|NCT00761319|156439440|FG001|Overall Study|Noncompliance|3|||
48613117|NCT00761319|156439439|FG000|Overall Study|Lost to Follow-up|1|||
48613118|NCT00761319|156439440|FG001|Overall Study|Lost to Follow-up|1|||
48613119|NCT00761319|156439439|FG000|Overall Study|Nonspecified|2|||
48613120|NCT00761319|156439440|FG001|Overall Study|Nonspecified|2|||
48613121|NCT00761319|156439439|FG000|Overall Study|Missing|1|||
48613122|NCT00761319|156439440|FG001|Overall Study|Missing|0|||
48548354|NCT04123561|156194641|FG002|Overall Study|Lack of Efficacy|6|||
48548355|NCT04123561|156194639|FG000|Overall Study|Adverse Event|5|||
48548356|NCT04123561|156194640|FG001|Overall Study|Adverse Event|2|||
48548357|NCT04123561|156194641|FG002|Overall Study|Adverse Event|3|||
48548358|NCT04123561|156194639|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
48548359|NCT04123561|156194640|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
48548360|NCT04123561|156194641|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
48548361|NCT04123561|156194639|FG000|Overall Study|Death|0|||
48548362|NCT04123561|156194640|FG001|Overall Study|Death|0|||
48548363|NCT04123561|156194641|FG002|Overall Study|Death|1|||
48548364|NCT04123561|156194639|FG000|Overall Study|Protocol Violation|0|||
48548365|NCT04123561|156194640|FG001|Overall Study|Protocol Violation|1|||
48548366|NCT04123561|156194641|FG002|Overall Study|Protocol Violation|0|||
48548367|NCT00509795|156194642|FG000|Overall Study|Adverse Event|4|||
48548368|NCT00509795|156194643|FG001|Overall Study|Adverse Event|3|||
48548369|NCT00509795|156194644|FG002|Overall Study|Adverse Event|5|||
48548370|NCT00509795|156194645|FG003|Overall Study|Adverse Event|4|||
48548371|NCT00509795|156194642|FG000|Overall Study|Death|3|||
48548372|NCT00509795|156194643|FG001|Overall Study|Death|1|||
48548373|NCT00509795|156194644|FG002|Overall Study|Death|2|||
48548374|NCT00509795|156194645|FG003|Overall Study|Death|7|||
48548375|NCT00509795|156194642|FG000|Overall Study|Lack of Efficacy|0|||
48548376|NCT00509795|156194643|FG001|Overall Study|Lack of Efficacy|0|||
48548377|NCT00509795|156194644|FG002|Overall Study|Lack of Efficacy|2|||
48548378|NCT00509795|156194645|FG003|Overall Study|Lack of Efficacy|2|||
48548379|NCT00509795|156194642|FG000|Overall Study|Lost to Follow-up|1|||
48548380|NCT00509795|156194643|FG001|Overall Study|Lost to Follow-up|2|||
48548381|NCT00509795|156194644|FG002|Overall Study|Lost to Follow-up|4|||
48548382|NCT00509795|156194645|FG003|Overall Study|Lost to Follow-up|4|||
48548383|NCT00509795|156194642|FG000|Overall Study|OTHER|1|||
48548384|NCT00509795|156194643|FG001|Overall Study|OTHER|0|||
48548385|NCT00509795|156194644|FG002|Overall Study|OTHER|4|||
48548386|NCT00509795|156194645|FG003|Overall Study|OTHER|1|||
48548387|NCT00509795|156194642|FG000|Overall Study|Protocol Violation|3|||
48548388|NCT00509795|156194643|FG001|Overall Study|Protocol Violation|0|||
48548389|NCT00509795|156194644|FG002|Overall Study|Protocol Violation|3|||
48548390|NCT00509795|156194645|FG003|Overall Study|Protocol Violation|1|||
48548391|NCT00509795|156194642|FG000|Overall Study|Withdrawal by Subject|10|||
48548392|NCT00509795|156194643|FG001|Overall Study|Withdrawal by Subject|5|||
48548393|NCT00509795|156194644|FG002|Overall Study|Withdrawal by Subject|7|||
48548394|NCT00509795|156194645|FG003|Overall Study|Withdrawal by Subject|8|||
48548395|NCT02521376|156194650|FG000|Overall Study|Enrolled, But Not Treated|1|||
48548396|NCT02521376|156194651|FG001|Overall Study|Enrolled, But Not Treated|0|||
48548397|NCT02521376|156194652|FG002|Overall Study|Enrolled, But Not Treated|0|||
48548398|NCT02521376|156194653|FG003|Overall Study|Enrolled, But Not Treated|0|||
48548399|NCT00144781|156196226|FG000|Overall Study|Adverse Event|0|||
48548400|NCT00144781|156196227|FG001|Overall Study|Adverse Event|1|||
48548401|NCT00144781|156196228|FG002|Overall Study|Adverse Event|0|||
48548402|NCT00144781|156196229|FG003|Overall Study|Adverse Event|0|||
48548403|NCT00144781|156196226|FG000|Overall Study|Non-compliant|0|||
48548404|NCT00144781|156196227|FG001|Overall Study|Non-compliant|1|||
48548405|NCT00144781|156196228|FG002|Overall Study|Non-compliant|0|||
48548406|NCT00144781|156196229|FG003|Overall Study|Non-compliant|0|||
48548407|NCT04709835|156196230|FG000|Overall Study|Withdrawal by Subject|0|||
48548408|NCT04709835|156196231|FG001|Overall Study|Withdrawal by Subject|1|||
48548409|NCT04709835|156196232|FG002|Overall Study|Withdrawal by Subject|0|||
48548410|NCT03954834|156196233|FG000|Overall Study|Adverse Event|1|||
48548411|NCT03954834|156196234|FG001|Overall Study|Adverse Event|3|||
48548412|NCT03954834|156196235|FG002|Overall Study|Adverse Event|1|||
48548413|NCT03954834|156196236|FG003|Overall Study|Adverse Event|1|||
48548414|NCT03954834|156196233|FG000|Overall Study|Death|0|||
48548415|NCT03954834|156196234|FG001|Overall Study|Death|0|||
48548416|NCT03954834|156196235|FG002|Overall Study|Death|0|||
48325481|NCT02357966|155389115|FG003|Overall Study|Death|0|||
48548417|NCT03954834|156196236|FG003|Overall Study|Death|1|||
48548418|NCT03954834|156196233|FG000|Overall Study|Physician Decision|0|||
48548419|NCT03954834|156196234|FG001|Overall Study|Physician Decision|1|||
48548420|NCT03954834|156196235|FG002|Overall Study|Physician Decision|0|||
48548421|NCT03954834|156196236|FG003|Overall Study|Physician Decision|2|||
48548422|NCT03954834|156196233|FG000|Overall Study|Protocol Violation|1|||
48548423|NCT03954834|156196234|FG001|Overall Study|Protocol Violation|0|||
48548424|NCT03954834|156196235|FG002|Overall Study|Protocol Violation|0|||
48548425|NCT03954834|156196236|FG003|Overall Study|Protocol Violation|1|||
48548426|NCT03954834|156196233|FG000|Overall Study|Withdrawal by Subject|2|||
48548427|NCT03954834|156196234|FG001|Overall Study|Withdrawal by Subject|3|||
48548428|NCT03954834|156196235|FG002|Overall Study|Withdrawal by Subject|13|||
48548429|NCT03954834|156196236|FG003|Overall Study|Withdrawal by Subject|6|||
48548430|NCT03954834|156196233|FG000|Overall Study|Participant left the country|0|||
48548431|NCT03954834|156196234|FG001|Overall Study|Participant left the country|0|||
48548432|NCT03954834|156196235|FG002|Overall Study|Participant left the country|1|||
48548433|NCT03954834|156196236|FG003|Overall Study|Participant left the country|0|||
48548434|NCT03954834|156196233|FG000|Overall Study|Lost to Follow-up|3|||
48548435|NCT03954834|156196234|FG001|Overall Study|Lost to Follow-up|2|||
48548436|NCT03954834|156196235|FG002|Overall Study|Lost to Follow-up|3|||
48548437|NCT03954834|156196236|FG003|Overall Study|Lost to Follow-up|5|||
48548438|NCT01502410|156196240|FG000|Overall Study|Adverse Event|1|||
48548439|NCT01502410|156196241|FG001|Overall Study|Adverse Event|2|||
48548440|NCT01502410|156196242|FG002|Overall Study|Adverse Event|0|||
48548441|NCT01502410|156196243|FG003|Overall Study|Adverse Event|0|||
48548442|NCT01502410|156196240|FG000|Overall Study|Lack of Efficacy|7|||
48548443|NCT01502410|156196241|FG001|Overall Study|Lack of Efficacy|7|||
48548444|NCT01502410|156196242|FG002|Overall Study|Lack of Efficacy|0|||
48548445|NCT01502410|156196243|FG003|Overall Study|Lack of Efficacy|0|||
48548446|NCT01502410|156196240|FG000|Overall Study|Physician Decision|0|||
48548447|NCT01502410|156196241|FG001|Overall Study|Physician Decision|1|||
48548448|NCT01502410|156196242|FG002|Overall Study|Physician Decision|0|||
48548449|NCT01502410|156196243|FG003|Overall Study|Physician Decision|0|||
48548450|NCT01502410|156196240|FG000|Overall Study|Withdrawal by Subject|2|||
48548451|NCT01502410|156196241|FG001|Overall Study|Withdrawal by Subject|0|||
48548452|NCT01502410|156196242|FG002|Overall Study|Withdrawal by Subject|0|||
48548453|NCT01502410|156196243|FG003|Overall Study|Withdrawal by Subject|0|||
48548454|NCT02903030|156196244|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
48548455|NCT02903030|156196245|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48548456|NCT04345601|156196246|FG000|Overall Study|Death|0|||
48548457|NCT04345601|156196247|FG001|Overall Study|Death|3|||
48548458|NCT04345601|156196248|FG002|Overall Study|Death|2|||
48548459|NCT04345601|156196246|FG000|Overall Study|Lost to Follow-up|0|||
48548460|NCT04345601|156196247|FG001|Overall Study|Lost to Follow-up|0|||
48548461|NCT04345601|156196248|FG002|Overall Study|Lost to Follow-up|2|||
48548462|NCT04325204|156196249|FG000|Overall Study|Death|0|||
48613123|NCT00423605|156439446|FG000|Overall Study|Adverse Event|129|||
48613124|NCT00423605|156439446|FG000|Overall Study|Withdrawal by Subject|36|||
48613125|NCT00423605|156439446|FG000|Overall Study|Lost to Follow-up|15|||
48613126|NCT00423605|156439446|FG000|Overall Study|Lack of Efficacy|38|||
48613127|NCT00423605|156439446|FG000|Overall Study|Sponsor Decision|3|||
48613128|NCT00423605|156439446|FG000|Overall Study|Physician Decision|8|||
48613129|NCT00423605|156439446|FG000|Overall Study|Protocol Violation|7|||
48548463|NCT04325204|156196250|FG001|Overall Study|Death|1|||
48548464|NCT04325204|156196249|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
48548465|NCT04325204|156196250|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
48548466|NCT04325204|156196249|FG000|Overall Study|Lost to Follow-up|8|||
48548467|NCT04325204|156196250|FG001|Overall Study|Lost to Follow-up|8|||
48548468|NCT04325204|156196249|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
48548469|NCT04325204|156196250|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
48548470|NCT03610516|156196254|FG000|Treatment Epoch|Adverse Event|3|||
48548471|NCT03610516|156196255|FG001|Treatment Epoch|Adverse Event|1|||
48548472|NCT03610516|156196254|FG000|Treatment Epoch|Death|1|||
48548473|NCT03610516|156196255|FG001|Treatment Epoch|Death|0|||
48548474|NCT03610516|156196254|FG000|Treatment Epoch|Lack of Efficacy|0|||
48548475|NCT03610516|156196255|FG001|Treatment Epoch|Lack of Efficacy|1|||
48548476|NCT03610516|156196254|FG000|Treatment Epoch|No longer requires treatment|1|||
48548477|NCT03610516|156196255|FG001|Treatment Epoch|No longer requires treatment|0|||
48548478|NCT03610516|156196254|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
48613130|NCT00423605|156439446|FG000|Overall Study|Not one of the pre-specified options|5|||
48325482|NCT02357966|155389116|FG004|Overall Study|Death|2|||
48613131|NCT02566005|156439451|FG000|Overall Study|vaginal bleeding|0|||
48548479|NCT03610516|156196255|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
48548480|NCT03610516|156196254|FG000|Treatment Epoch|Physician Decision|8|||
48548481|NCT03610516|156196255|FG001|Treatment Epoch|Physician Decision|5|||
48548482|NCT03610516|156196254|FG000|Treatment Epoch|Protocol Deviation|1|||
48548483|NCT03610516|156196255|FG001|Treatment Epoch|Protocol Deviation|0|||
48548484|NCT03610516|156196254|FG000|Treatment Epoch|Withdrawal by Subject|3|||
48548485|NCT03610516|156196255|FG001|Treatment Epoch|Withdrawal by Subject|1|||
48548486|NCT03610516|156196254|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
48548487|NCT03610516|156196255|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
48548488|NCT03610516|156196254|FG000|Post-Treatment Follow-up|Death|1|||
48548489|NCT03610516|156196255|FG001|Post-Treatment Follow-up|Death|0|||
48548490|NCT04839692|156196265|FG000|Overall Study|Withdrawal by Subject|0|||
48548491|NCT04839692|156196266|FG001|Overall Study|Withdrawal by Subject|3|||
48548492|NCT04839692|156196265|FG000|Overall Study|Physician Decision|1|||
48548493|NCT04839692|156196266|FG001|Overall Study|Physician Decision|0|||
48548494|NCT00049530|156196269|FG000|Overall Study|Lack of Efficacy|25|||
48548495|NCT00049530|156196269|FG000|Overall Study|Adverse Event|2|||
48613132|NCT02566005|156439452|FG001|Overall Study|vaginal bleeding|1|||
48548496|NCT00049530|156196269|FG000|Overall Study|Death|1|||
48548497|NCT00049530|156196269|FG000|Overall Study|symptomatic deterioration|1|||
48548498|NCT00049530|156196269|FG000|Overall Study|ineligible|3|||
48613133|NCT02566005|156439451|FG000|Overall Study|received foley|8|||
48548499|NCT01433549|156196272|FG000|Phase 2: Second Study Product|Adverse Event|0|||
48548500|NCT01433549|156196273|FG001|Phase 2: Second Study Product|Adverse Event|1|||
48548501|NCT01860677|156196276|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
48548502|NCT01860677|156196277|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
48548503|NCT03456453|156196278|FG000|Overall Study|Withdrawal by Subject|2|||
48548504|NCT03456453|156196279|FG001|Overall Study|Withdrawal by Subject|0|||
48548505|NCT03456453|156196278|FG000|Overall Study|Not released to community|1|||
48548506|NCT03456453|156196279|FG001|Overall Study|Not released to community|5|||
48548507|NCT03456453|156196278|FG000|Overall Study|Lost to Follow-up|0|||
48548508|NCT03456453|156196279|FG001|Overall Study|Lost to Follow-up|2|||
48548509|NCT04762277|156196280|FG000|Overall Study|Withdrawal by Subject|0|||
48548510|NCT04762277|156196281|FG001|Overall Study|Withdrawal by Subject|2|||
48548511|NCT04762277|156196280|FG000|Overall Study|Protocol Violation|0|||
48548512|NCT04762277|156196281|FG001|Overall Study|Protocol Violation|1|||
48548513|NCT04762277|156196280|FG000|Overall Study|Adverse Event|1|||
48548514|NCT04762277|156196281|FG001|Overall Study|Adverse Event|0|||
48548515|NCT02542293|156196282|FG000|Overall Study|Death|367|||
48548516|NCT02542293|156196283|FG001|Overall Study|Death|377|||
48548517|NCT02542293|156196282|FG000|Overall Study|Withdrawal by Subject|8|||
48548518|NCT02542293|156196283|FG001|Overall Study|Withdrawal by Subject|19|||
48548519|NCT00849186|156196289|FG000|Overall Study|Adverse Event|2|||
48548520|NCT00849186|156196289|FG000|Overall Study|Withdrawal by Subject|1|||
48548521|NCT00849186|156196289|FG000|Overall Study|not treated|6|||
48548522|NCT00849186|156196289|FG000|Overall Study|Other|1|||
48548523|NCT00447993|156196290|FG000|Overall Study|Lost to Follow-up|0|||
48548524|NCT00447993|156196291|FG001|Overall Study|Lost to Follow-up|0|||
48548525|NCT00447993|156196292|FG002|Overall Study|Lost to Follow-up|2|||
48548526|NCT00447993|156196293|FG003|Overall Study|Lost to Follow-up|2|||
48548527|NCT00447993|156196290|FG000|Overall Study|Withdrawal by Subject|0|||
48548528|NCT00447993|156196291|FG001|Overall Study|Withdrawal by Subject|0|||
48548529|NCT00447993|156196292|FG002|Overall Study|Withdrawal by Subject|2|||
48548530|NCT00447993|156196293|FG003|Overall Study|Withdrawal by Subject|2|||
48548531|NCT04058067|156196328|FG000|Overall Study|Adverse Event|2|||
48548532|NCT04058067|156196329|FG001|Overall Study|Adverse Event|0|||
48548533|NCT04058067|156196328|FG000|Overall Study|Death|0|||
48548534|NCT04058067|156196329|FG001|Overall Study|Death|1|||
48548535|NCT04058067|156196328|FG000|Overall Study|Physician Decision|3|||
48548536|NCT04058067|156196329|FG001|Overall Study|Physician Decision|1|||
48548537|NCT04058067|156196328|FG000|Overall Study|Protocol Violation|0|||
48548538|NCT04058067|156196329|FG001|Overall Study|Protocol Violation|1|||
48548539|NCT04058067|156196328|FG000|Overall Study|Withdrawal by Subject|7|||
48548540|NCT04058067|156196329|FG001|Overall Study|Withdrawal by Subject|8|||
48548541|NCT01283035|156196331|FG000|Overall Study|Subject later found ineligible|1|||
48548542|NCT00927394|156196335|FG000|Overall Study|Adverse Event|14|||
48548543|NCT00927394|156196336|FG001|Overall Study|Adverse Event|9|||
48548544|NCT00927394|156196335|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
48548545|NCT00927394|156196336|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
48548546|NCT00927394|156196335|FG000|Overall Study|Withdrawal by Subject|20|||
48548547|NCT00927394|156196336|FG001|Overall Study|Withdrawal by Subject|24|||
48548548|NCT00927394|156196335|FG000|Overall Study|Lost to Follow-up|8|||
48548549|NCT00927394|156196336|FG001|Overall Study|Lost to Follow-up|14|||
48548550|NCT00927394|156196335|FG000|Overall Study|Administrative Problem|1|||
48548551|NCT00927394|156196336|FG001|Overall Study|Administrative Problem|0|||
48548552|NCT00927394|156196335|FG000|Overall Study|Death|1|||
48548553|NCT00927394|156196336|FG001|Overall Study|Death|1|||
48548554|NCT00927394|156196335|FG000|Overall Study|Protocol deviation|16|||
48548555|NCT00927394|156196336|FG001|Overall Study|Protocol deviation|13|||
48548556|NCT00927394|156196335|FG000|Overall Study|Randomized in error|0|||
48548557|NCT00927394|156196336|FG001|Overall Study|Randomized in error|1|||
48548558|NCT03257865|156196338|FG000|Overall Study|Adverse Event|4|||
48548559|NCT03257865|156196339|FG001|Overall Study|Adverse Event|8|||
48548560|NCT03257865|156196338|FG000|Overall Study|Lack of Efficacy|1|||
48548561|NCT03257865|156196339|FG001|Overall Study|Lack of Efficacy|2|||
48548562|NCT03257865|156196338|FG000|Overall Study|Non-compliance with Study Drug|0|||
48548563|NCT03257865|156196339|FG001|Overall Study|Non-compliance with Study Drug|2|||
48548564|NCT03257865|156196338|FG000|Overall Study|Withdrawal by Subject|23|||
48548565|NCT03257865|156196339|FG001|Overall Study|Withdrawal by Subject|17|||
48548566|NCT03257865|156196338|FG000|Overall Study|Physician Decision|3|||
48548567|NCT03257865|156196339|FG001|Overall Study|Physician Decision|1|||
48548568|NCT03257865|156196338|FG000|Overall Study|Other|0|||
48548569|NCT03257865|156196339|FG001|Overall Study|Other|1|||
48548570|NCT03257865|156196338|FG000|Overall Study|Lost to Follow-up|4|||
48548571|NCT03257865|156196339|FG001|Overall Study|Lost to Follow-up|4|||
48548572|NCT01221363|156196340|FG000|Overall Study|Pregnancy|1|||
48548573|NCT01221363|156196341|FG001|Overall Study|Pregnancy|0|||
48548574|NCT01221363|156196340|FG000|Overall Study|Withdrawal by Subject|11|||
48548575|NCT01221363|156196341|FG001|Overall Study|Withdrawal by Subject|5|||
48548648|NCT01934335|156196354|FG000|Overall Study|Withdrawal by Subject|1|||
48548649|NCT01934335|156196355|FG001|Overall Study|Withdrawal by Subject|1|||
48548650|NCT04480021|156196356|FG000|Overall Study|Lost to Follow-up|3|||
48548651|NCT04480021|156196357|FG001|Overall Study|Lost to Follow-up|4|||
48548652|NCT02242045|156196358|FG000|Overall Study|Investigator's Discretion|1|||
48548653|NCT02242045|156196358|FG000|Overall Study|Progressive Disease|2|||
48548654|NCT02242045|156196358|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
48548655|NCT02242045|156196358|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
48548656|NCT03279692|156196359|FG000|Overall Study|Withdrawal by Subject|1|||
48548657|NCT01210612|156196362|FG000|Overall Study|Withdrawal by Subject|0|||
48548658|NCT01210612|156196363|FG001|Overall Study|Withdrawal by Subject|2|||
48548659|NCT00952731|156196364|FG000|Overall Study|Drug supply expired|1|||
48548660|NCT00952731|156196365|FG001|Overall Study|Drug supply expired|0|||
48548661|NCT03249792|156196366|FG000|Arms 1, 2, and 4|Death|1|||
48548662|NCT03249792|156196367|FG001|Arms 1, 2, and 4|Death|1|||
48548663|NCT03249792|156196368|FG002|Arms 1, 2, and 4|Death|0|||
48548664|NCT03249792|156196369|FG003|Arms 1, 2, and 4|Death|2|||
48548665|NCT03249792|156196370|FG004|Arms 1, 2, and 4|Death|3|||
48548666|NCT03249792|156196371|FG005|Arms 1, 2, and 4|Death|2|||
48548667|NCT03249792|156196372|FG006|Arms 1, 2, and 4|Death|2|||
48548668|NCT03249792|156196373|FG007|Arms 1, 2, and 4|Death|4|||
48548669|NCT03249792|156196374|FG008|Arms 1, 2, and 4|Death|2|||
48548670|NCT03249792|156196375|FG009|Arms 1, 2, and 4|Death|1|||
48548671|NCT03249792|156196376|FG010|Arms 1, 2, and 4|Death|7|||
48548672|NCT03249792|156196377|FG011|Arms 1, 2, and 4|Death|7|||
48548673|NCT03249792|156196378|FG012|Arms 1, 2, and 4|Death|12|||
48548674|NCT03249792|156196379|FG013|Arms 1, 2, and 4|Death|7|||
48548675|NCT03249792|156196380|FG014|Arms 1, 2, and 4|Death|0|||
48548676|NCT03249792|156196381|FG015|Arms 1, 2, and 4|Death|4|||
48548677|NCT03249792|156196382|FG016|Arms 1, 2, and 4|Death|4|||
48548678|NCT03249792|156196383|FG017|Arms 1, 2, and 4|Death|12|||
48548679|NCT03249792|156196384|FG018|Arms 1, 2, and 4|Death|6|||
48548680|NCT03249792|156196385|FG019|Arms 1, 2, and 4|Death|4|||
48548681|NCT03249792|156196386|FG020|Arms 1, 2, and 4|Death|2|||
48548682|NCT03249792|156196387|FG021|Arms 1, 2, and 4|Death|3|||
48548683|NCT03249792|156196388|FG022|Arms 1, 2, and 4|Death|1|||
48548684|NCT03249792|156196389|FG023|Arms 1, 2, and 4|Death|1|||
48548685|NCT03249792|156196390|FG024|Arms 1, 2, and 4|Death|4|||
48548686|NCT03249792|156196391|FG025|Arms 1, 2, and 4|Death|0|||
48548687|NCT03249792|156196392|FG026|Arms 1, 2, and 4|Death|0|||
48548688|NCT03249792|156196393|FG027|Arms 1, 2, and 4|Death|0|||
48548689|NCT03249792|156196394|FG028|Arms 1, 2, and 4|Death|0|||
48548690|NCT03249792|156196395|FG029|Arms 1, 2, and 4|Death|0|||
48548691|NCT03249792|156196396|FG030|Arms 1, 2, and 4|Death|0|||
48548692|NCT03249792|156196397|FG031|Arms 1, 2, and 4|Death|0|||
48548693|NCT03249792|156196398|FG032|Arms 1, 2, and 4|Death|0|||
48548694|NCT03249792|156196366|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548695|NCT03249792|156196367|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548696|NCT03249792|156196368|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
48548697|NCT03249792|156196369|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548698|NCT03249792|156196370|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548699|NCT03249792|156196371|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
48548700|NCT03249792|156196372|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
48548701|NCT03249792|156196373|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548702|NCT03249792|156196374|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
48548703|NCT03249792|156196375|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
48548704|NCT03249792|156196376|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
48548705|NCT03249792|156196377|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
48548706|NCT03249792|156196378|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
48548707|NCT03249792|156196379|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
48548708|NCT03249792|156196380|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548709|NCT03249792|156196381|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548710|NCT03249792|156196382|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
48548711|NCT03249792|156196383|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548712|NCT03249792|156196384|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
48548713|NCT03249792|156196385|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548714|NCT03249792|156196386|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548715|NCT03249792|156196387|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548716|NCT03249792|156196388|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
48548717|NCT03249792|156196389|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
48548718|NCT03249792|156196390|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548719|NCT03249792|156196391|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548720|NCT03249792|156196392|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548721|NCT03249792|156196393|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548722|NCT03249792|156196394|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548723|NCT03249792|156196395|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548724|NCT03249792|156196396|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548725|NCT03249792|156196397|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548726|NCT03249792|156196398|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
48548727|NCT03249792|156196366|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
48548728|NCT03249792|156196367|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
48548729|NCT03249792|156196368|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
48548730|NCT03249792|156196369|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
48548731|NCT03249792|156196370|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
48548732|NCT03249792|156196371|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
48548733|NCT03249792|156196372|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
48548734|NCT03249792|156196373|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
48548735|NCT03249792|156196374|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
48548736|NCT03249792|156196375|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
48548737|NCT03249792|156196376|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
48548738|NCT03249792|156196377|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
48548739|NCT03249792|156196378|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
48548740|NCT03249792|156196379|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
48548741|NCT03249792|156196380|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
48548742|NCT03249792|156196381|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
48548743|NCT03249792|156196382|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
48548744|NCT03249792|156196383|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
48548745|NCT03249792|156196384|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
48548746|NCT03249792|156196385|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
48548747|NCT03249792|156196386|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
48548748|NCT03249792|156196387|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
48548749|NCT03249792|156196388|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
48548750|NCT03249792|156196389|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
48548751|NCT03249792|156196390|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
48548752|NCT03249792|156196391|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
48548753|NCT03249792|156196392|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
48548754|NCT03249792|156196393|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
48548755|NCT03249792|156196394|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
48548756|NCT03249792|156196395|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
48548757|NCT03249792|156196396|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
48548758|NCT03249792|156196397|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
48548759|NCT03249792|156196398|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
48548760|NCT03249792|156196366|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548761|NCT03249792|156196367|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548762|NCT03249792|156196368|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548763|NCT03249792|156196369|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548764|NCT03249792|156196370|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548765|NCT03249792|156196371|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548766|NCT03249792|156196372|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548767|NCT03249792|156196373|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548768|NCT03249792|156196374|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
48548769|NCT03249792|156196375|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548770|NCT03249792|156196376|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548771|NCT03249792|156196377|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548772|NCT03249792|156196378|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548773|NCT03249792|156196379|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548774|NCT03249792|156196380|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548775|NCT03249792|156196381|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548776|NCT03249792|156196382|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
48548777|NCT03249792|156196383|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
48548778|NCT03249792|156196384|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548779|NCT03249792|156196385|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
48548780|NCT03249792|156196386|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548781|NCT03249792|156196387|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548782|NCT03249792|156196388|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548783|NCT03249792|156196389|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548784|NCT03249792|156196390|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548785|NCT03249792|156196391|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548786|NCT03249792|156196392|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548787|NCT03249792|156196393|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548788|NCT03249792|156196394|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548789|NCT03249792|156196395|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548790|NCT03249792|156196396|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548791|NCT03249792|156196397|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548792|NCT03249792|156196398|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
48548793|NCT03249792|156196366|FG000|Switch Over Period|Withdrawal by Subject|0|||
48548794|NCT03249792|156196367|FG001|Switch Over Period|Withdrawal by Subject|0|||
48548795|NCT03249792|156196368|FG002|Switch Over Period|Withdrawal by Subject|0|||
48548796|NCT03249792|156196369|FG003|Switch Over Period|Withdrawal by Subject|0|||
48548797|NCT03249792|156196370|FG004|Switch Over Period|Withdrawal by Subject|0|||
48548798|NCT03249792|156196371|FG005|Switch Over Period|Withdrawal by Subject|0|||
48548799|NCT03249792|156196372|FG006|Switch Over Period|Withdrawal by Subject|0|||
48548800|NCT03249792|156196373|FG007|Switch Over Period|Withdrawal by Subject|0|||
48548801|NCT03249792|156196374|FG008|Switch Over Period|Withdrawal by Subject|0|||
48548802|NCT03249792|156196375|FG009|Switch Over Period|Withdrawal by Subject|0|||
48548803|NCT03249792|156196376|FG010|Switch Over Period|Withdrawal by Subject|0|||
48548804|NCT03249792|156196377|FG011|Switch Over Period|Withdrawal by Subject|0|||
48548805|NCT03249792|156196378|FG012|Switch Over Period|Withdrawal by Subject|0|||
48548806|NCT03249792|156196379|FG013|Switch Over Period|Withdrawal by Subject|0|||
48548807|NCT03249792|156196380|FG014|Switch Over Period|Withdrawal by Subject|0|||
48548808|NCT03249792|156196381|FG015|Switch Over Period|Withdrawal by Subject|0|||
48548809|NCT03249792|156196382|FG016|Switch Over Period|Withdrawal by Subject|0|||
48548810|NCT03249792|156196383|FG017|Switch Over Period|Withdrawal by Subject|0|||
48548811|NCT03249792|156196384|FG018|Switch Over Period|Withdrawal by Subject|0|||
48548812|NCT03249792|156196385|FG019|Switch Over Period|Withdrawal by Subject|0|||
48548813|NCT03249792|156196386|FG020|Switch Over Period|Withdrawal by Subject|0|||
48548814|NCT03249792|156196387|FG021|Switch Over Period|Withdrawal by Subject|0|||
48548815|NCT03249792|156196388|FG022|Switch Over Period|Withdrawal by Subject|0|||
48548816|NCT03249792|156196389|FG023|Switch Over Period|Withdrawal by Subject|0|||
48548817|NCT03249792|156196390|FG024|Switch Over Period|Withdrawal by Subject|0|||
48548818|NCT03249792|156196391|FG025|Switch Over Period|Withdrawal by Subject|0|||
48548819|NCT03249792|156196392|FG026|Switch Over Period|Withdrawal by Subject|0|||
48548820|NCT03249792|156196393|FG027|Switch Over Period|Withdrawal by Subject|0|||
48548821|NCT03249792|156196394|FG028|Switch Over Period|Withdrawal by Subject|0|||
48548822|NCT03249792|156196395|FG029|Switch Over Period|Withdrawal by Subject|0|||
48548823|NCT03249792|156196396|FG030|Switch Over Period|Withdrawal by Subject|0|||
48548824|NCT03249792|156196397|FG031|Switch Over Period|Withdrawal by Subject|1|||
48548825|NCT03249792|156196398|FG032|Switch Over Period|Withdrawal by Subject|0|||
48548826|NCT03249792|156196366|FG000|Switch Over Period|Progressive Disease|0|||
48548827|NCT03249792|156196367|FG001|Switch Over Period|Progressive Disease|0|||
48548828|NCT03249792|156196368|FG002|Switch Over Period|Progressive Disease|0|||
48548829|NCT03249792|156196369|FG003|Switch Over Period|Progressive Disease|0|||
48548830|NCT03249792|156196370|FG004|Switch Over Period|Progressive Disease|0|||
48548831|NCT03249792|156196371|FG005|Switch Over Period|Progressive Disease|0|||
48548832|NCT03249792|156196372|FG006|Switch Over Period|Progressive Disease|0|||
48548833|NCT03249792|156196373|FG007|Switch Over Period|Progressive Disease|0|||
48548834|NCT03249792|156196374|FG008|Switch Over Period|Progressive Disease|0|||
48548835|NCT03249792|156196375|FG009|Switch Over Period|Progressive Disease|0|||
48548836|NCT03249792|156196376|FG010|Switch Over Period|Progressive Disease|0|||
48548837|NCT03249792|156196377|FG011|Switch Over Period|Progressive Disease|0|||
48548838|NCT03249792|156196378|FG012|Switch Over Period|Progressive Disease|0|||
48548839|NCT03249792|156196379|FG013|Switch Over Period|Progressive Disease|0|||
48548840|NCT03249792|156196380|FG014|Switch Over Period|Progressive Disease|0|||
48548841|NCT03249792|156196381|FG015|Switch Over Period|Progressive Disease|0|||
48548842|NCT03249792|156196382|FG016|Switch Over Period|Progressive Disease|0|||
48548843|NCT03249792|156196383|FG017|Switch Over Period|Progressive Disease|0|||
48548844|NCT03249792|156196384|FG018|Switch Over Period|Progressive Disease|0|||
48548845|NCT03249792|156196385|FG019|Switch Over Period|Progressive Disease|0|||
48548846|NCT03249792|156196386|FG020|Switch Over Period|Progressive Disease|0|||
48548847|NCT03249792|156196387|FG021|Switch Over Period|Progressive Disease|0|||
48548848|NCT03249792|156196388|FG022|Switch Over Period|Progressive Disease|0|||
48548849|NCT03249792|156196389|FG023|Switch Over Period|Progressive Disease|0|||
48548850|NCT03249792|156196390|FG024|Switch Over Period|Progressive Disease|0|||
48548851|NCT03249792|156196391|FG025|Switch Over Period|Progressive Disease|0|||
48548852|NCT03249792|156196392|FG026|Switch Over Period|Progressive Disease|1|||
48548853|NCT03249792|156196393|FG027|Switch Over Period|Progressive Disease|0|||
48548854|NCT03249792|156196394|FG028|Switch Over Period|Progressive Disease|1|||
48548855|NCT03249792|156196395|FG029|Switch Over Period|Progressive Disease|2|||
48548856|NCT03249792|156196396|FG030|Switch Over Period|Progressive Disease|1|||
48548857|NCT03249792|156196397|FG031|Switch Over Period|Progressive Disease|0|||
48548858|NCT03249792|156196398|FG032|Switch Over Period|Progressive Disease|1|||
48548859|NCT03249792|156196366|FG000|Switch Over Period|Adverse Event|0|||
48548860|NCT03249792|156196367|FG001|Switch Over Period|Adverse Event|0|||
48548861|NCT03249792|156196368|FG002|Switch Over Period|Adverse Event|0|||
48548862|NCT03249792|156196369|FG003|Switch Over Period|Adverse Event|0|||
48548863|NCT03249792|156196370|FG004|Switch Over Period|Adverse Event|0|||
48548864|NCT03249792|156196371|FG005|Switch Over Period|Adverse Event|0|||
48548865|NCT03249792|156196372|FG006|Switch Over Period|Adverse Event|0|||
48548866|NCT03249792|156196373|FG007|Switch Over Period|Adverse Event|0|||
48548867|NCT03249792|156196374|FG008|Switch Over Period|Adverse Event|0|||
48548868|NCT03249792|156196375|FG009|Switch Over Period|Adverse Event|0|||
48548869|NCT03249792|156196376|FG010|Switch Over Period|Adverse Event|0|||
48548870|NCT03249792|156196377|FG011|Switch Over Period|Adverse Event|0|||
48548871|NCT03249792|156196378|FG012|Switch Over Period|Adverse Event|0|||
48548872|NCT03249792|156196379|FG013|Switch Over Period|Adverse Event|0|||
48613134|NCT02566005|156439452|FG001|Overall Study|received foley|0|||
48548873|NCT03249792|156196380|FG014|Switch Over Period|Adverse Event|0|||
48548874|NCT03249792|156196381|FG015|Switch Over Period|Adverse Event|0|||
48548875|NCT03249792|156196382|FG016|Switch Over Period|Adverse Event|0|||
48548876|NCT03249792|156196383|FG017|Switch Over Period|Adverse Event|0|||
48548877|NCT03249792|156196384|FG018|Switch Over Period|Adverse Event|0|||
48548878|NCT03249792|156196385|FG019|Switch Over Period|Adverse Event|0|||
48548879|NCT03249792|156196386|FG020|Switch Over Period|Adverse Event|0|||
48548880|NCT03249792|156196387|FG021|Switch Over Period|Adverse Event|0|||
48548881|NCT03249792|156196388|FG022|Switch Over Period|Adverse Event|0|||
48548882|NCT03249792|156196389|FG023|Switch Over Period|Adverse Event|0|||
48548883|NCT03249792|156196390|FG024|Switch Over Period|Adverse Event|0|||
48548884|NCT03249792|156196391|FG025|Switch Over Period|Adverse Event|1|||
48548885|NCT03249792|156196392|FG026|Switch Over Period|Adverse Event|0|||
48548886|NCT03249792|156196393|FG027|Switch Over Period|Adverse Event|1|||
48548887|NCT03249792|156196394|FG028|Switch Over Period|Adverse Event|0|||
48548888|NCT03249792|156196395|FG029|Switch Over Period|Adverse Event|0|||
48548889|NCT03249792|156196396|FG030|Switch Over Period|Adverse Event|0|||
48548890|NCT03249792|156196397|FG031|Switch Over Period|Adverse Event|0|||
48548891|NCT03249792|156196398|FG032|Switch Over Period|Adverse Event|0|||
48548892|NCT02203331|156196403|FG000|Overall Study|Pregnancy|1|||
48548893|NCT02203331|156196404|FG001|Overall Study|Pregnancy|0|||
48548894|NCT02203331|156196405|FG002|Overall Study|Pregnancy|0|||
48548895|NCT02203331|156196406|FG003|Overall Study|Pregnancy|0|||
48548896|NCT02203331|156196407|FG004|Overall Study|Pregnancy|2|||
48548897|NCT02203331|156196408|FG005|Overall Study|Pregnancy|0|||
48548898|NCT02203331|156196403|FG000|Overall Study|Withdrawal by Subject|1|||
48548899|NCT02203331|156196404|FG001|Overall Study|Withdrawal by Subject|0|||
48548900|NCT02203331|156196405|FG002|Overall Study|Withdrawal by Subject|1|||
48548901|NCT02203331|156196406|FG003|Overall Study|Withdrawal by Subject|0|||
48548902|NCT02203331|156196407|FG004|Overall Study|Withdrawal by Subject|0|||
48548903|NCT02203331|156196408|FG005|Overall Study|Withdrawal by Subject|3|||
48548904|NCT02203331|156196403|FG000|Overall Study|Adverse Event|4|||
48548905|NCT02203331|156196404|FG001|Overall Study|Adverse Event|8|||
48548906|NCT02203331|156196405|FG002|Overall Study|Adverse Event|3|||
48548907|NCT02203331|156196406|FG003|Overall Study|Adverse Event|4|||
48548908|NCT02203331|156196407|FG004|Overall Study|Adverse Event|3|||
48548909|NCT02203331|156196408|FG005|Overall Study|Adverse Event|3|||
48548910|NCT02203331|156196403|FG000|Overall Study|Other Reasons|1|||
48548911|NCT02203331|156196404|FG001|Overall Study|Other Reasons|2|||
48548912|NCT02203331|156196405|FG002|Overall Study|Other Reasons|0|||
48548913|NCT02203331|156196406|FG003|Overall Study|Other Reasons|2|||
48548914|NCT02203331|156196407|FG004|Overall Study|Other Reasons|0|||
48548915|NCT02203331|156196408|FG005|Overall Study|Other Reasons|0|||
48613135|NCT02566005|156439451|FG000|Overall Study|did not receive foley|0|||
48613136|NCT02566005|156439452|FG001|Overall Study|did not receive foley|1|||
48613137|NCT02566005|156439451|FG000|Overall Study|labor after randomization|0|||
48613138|NCT02566005|156439452|FG001|Overall Study|labor after randomization|4|||
48613139|NCT03095287|156439453|FG000|Overall Study|Treatment Failure|1|||
48613140|NCT03095287|156439453|FG000|Overall Study|Adverse Event|1|||
48613141|NCT02107898|156439454|FG000|Overall Study|Adverse Event|4|||
48613142|NCT02107898|156439455|FG001|Overall Study|Adverse Event|7|||
48613143|NCT02107898|156439454|FG000|Overall Study|Poor compliance to protocol|0|||
48613144|NCT02107898|156439455|FG001|Overall Study|Poor compliance to protocol|1|||
48613145|NCT02107898|156439454|FG000|Overall Study|Participant moved|0|||
48613146|NCT02107898|156439455|FG001|Overall Study|Participant moved|2|||
48613147|NCT02107898|156439454|FG000|Overall Study|Consent withdrawn by participant|2|||
48613148|NCT02107898|156439455|FG001|Overall Study|Consent withdrawn by participant|1|||
48613149|NCT02107898|156439454|FG000|Overall Study|Randomized but not treated|0|||
48613150|NCT02107898|156439455|FG001|Overall Study|Randomized but not treated|1|||
48613151|NCT05001620|156439456|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
48613152|NCT05001620|156439457|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
48613153|NCT02115386|156439458|FG000|Overall Study|Protocol Violation|1|||
48613154|NCT02115386|156439458|FG000|Overall Study|Administrative - trial was terminated|6|||
48613155|NCT01240694|156439459|FG000|Overall Study|Adverse Event|9|||
48613156|NCT01240694|156439459|FG000|Overall Study|Lack of Efficacy|6|||
48613157|NCT01240694|156439459|FG000|Overall Study|Withdrawal by Subject|6|||
48613158|NCT01240694|156439459|FG000|Overall Study|Protocol Violation|2|||
48613159|NCT01240694|156439459|FG000|Overall Study|Lost to Follow-up|2|||
48613160|NCT01240694|156439459|FG000|Overall Study|Other than specified|3|||
48613161|NCT01240694|156439459|FG000|Overall Study|Withdrawn due to early study termination|107|||
48613162|NCT02714153|156439460|FG000|Overall Study|Death|1|||
48613163|NCT01137786|156439462|FG000|Overall Study|Lost to Follow-up|0|||
48613164|NCT01137786|156439463|FG001|Overall Study|Lost to Follow-up|2|||
48613165|NCT01137786|156439462|FG000|Overall Study|Withdrawal by Subject|1|||
48613166|NCT01137786|156439463|FG001|Overall Study|Withdrawal by Subject|1|||
48613167|NCT00147238|156439464|FG000|Overall Study|Inevaluable|8|||
48548916|NCT02203331|156196403|FG000|Overall Study|Lack of Efficacy|0|||
48548917|NCT02203331|156196404|FG001|Overall Study|Lack of Efficacy|2|||
48548918|NCT02203331|156196405|FG002|Overall Study|Lack of Efficacy|1|||
48548919|NCT02203331|156196406|FG003|Overall Study|Lack of Efficacy|0|||
48548920|NCT02203331|156196407|FG004|Overall Study|Lack of Efficacy|0|||
48548921|NCT02203331|156196408|FG005|Overall Study|Lack of Efficacy|1|||
48548922|NCT02203331|156196403|FG000|Overall Study|Protocol Violation|0|||
48548923|NCT02203331|156196404|FG001|Overall Study|Protocol Violation|2|||
48548924|NCT02203331|156196405|FG002|Overall Study|Protocol Violation|0|||
48548925|NCT02203331|156196406|FG003|Overall Study|Protocol Violation|1|||
48548926|NCT02203331|156196407|FG004|Overall Study|Protocol Violation|1|||
48548927|NCT02203331|156196408|FG005|Overall Study|Protocol Violation|0|||
48548928|NCT02203331|156196403|FG000|Overall Study|Lost to Follow-up|0|||
48548929|NCT02203331|156196404|FG001|Overall Study|Lost to Follow-up|0|||
48548930|NCT02203331|156196405|FG002|Overall Study|Lost to Follow-up|0|||
48548931|NCT02203331|156196406|FG003|Overall Study|Lost to Follow-up|0|||
48548932|NCT02203331|156196407|FG004|Overall Study|Lost to Follow-up|1|||
48548933|NCT02203331|156196408|FG005|Overall Study|Lost to Follow-up|0|||
48548934|NCT03017612|156196410|FG000|Overall Study|Adverse Event|2|||
48548935|NCT00338728|156196415|FG000|Overall Study|Screen Failure|14|||
48548936|NCT02831049|156196416|FG000|Overall Study|Lost to Follow-up|0|||
48548937|NCT02831049|156196417|FG001|Overall Study|Lost to Follow-up|0|||
48548938|NCT02831049|156196418|FG002|Overall Study|Lost to Follow-up|1|||
48548939|NCT02831049|156196416|FG000|Overall Study|Withdrawal by Subject|0|||
48548940|NCT02831049|156196417|FG001|Overall Study|Withdrawal by Subject|1|||
48548941|NCT02831049|156196418|FG002|Overall Study|Withdrawal by Subject|1|||
48548942|NCT02831049|156196416|FG000|Overall Study|Pandemic shutdown|1|||
48548943|NCT02831049|156196417|FG001|Overall Study|Pandemic shutdown|0|||
48548944|NCT02831049|156196418|FG002|Overall Study|Pandemic shutdown|0|||
48548945|NCT04710979|156197866|FG000|Overall Study|Lost to Follow-up|2|||
48548946|NCT04710979|156197867|FG001|Overall Study|Lost to Follow-up|4|||
48548947|NCT04710979|156197866|FG000|Overall Study|Withdrawal by Subject|1|||
48548948|NCT04710979|156197867|FG001|Overall Study|Withdrawal by Subject|0|||
48548949|NCT05005312|156197871|FG000|Overall Study|Enrolled, but not treated|0|||
48548950|NCT05005312|156197872|FG001|Overall Study|Enrolled, but not treated|1|||
48548951|NCT00867503|156197874|FG000|Overall Study|Withdrawal by Subject|1|||
48548952|NCT02704403|156197875|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
48548953|NCT02704403|156197876|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
48548954|NCT02704403|156197875|FG000|Overall Study|Administrative reasons by sponsor|1251|||
48548955|NCT02704403|156197876|FG001|Overall Study|Administrative reasons by sponsor|616|||
48548956|NCT02704403|156197875|FG000|Overall Study|Death|4|||
48548957|NCT02704403|156197876|FG001|Overall Study|Death|3|||
48548958|NCT02704403|156197875|FG000|Overall Study|Endpoint event|52|||
48548959|NCT02704403|156197876|FG001|Overall Study|Endpoint event|24|||
48548960|NCT02704403|156197875|FG000|Overall Study|Lost to Follow-up|22|||
48548961|NCT02704403|156197876|FG001|Overall Study|Lost to Follow-up|11|||
48548962|NCT02704403|156197875|FG000|Overall Study|Protocol Violation|15|||
48548963|NCT02704403|156197876|FG001|Overall Study|Protocol Violation|15|||
48548964|NCT02704403|156197875|FG000|Overall Study|Adverse Event|2|||
48548965|NCT02704403|156197876|FG001|Overall Study|Adverse Event|0|||
48548966|NCT02704403|156197875|FG000|Overall Study|Withdrawal by Subject|85|||
48548967|NCT02704403|156197876|FG001|Overall Study|Withdrawal by Subject|45|||
48548968|NCT02704403|156197875|FG000|Overall Study|Investigator decision|1|||
48548969|NCT02704403|156197876|FG001|Overall Study|Investigator decision|1|||
48548970|NCT02704403|156197875|FG000|Overall Study|Follow-up not possible|1|||
48548971|NCT02704403|156197876|FG001|Overall Study|Follow-up not possible|2|||
48548972|NCT00851318|156197877|FG000|Overall Study|Withdrawal by Subject|7|||
48548973|NCT00851318|156197878|FG001|Overall Study|Withdrawal by Subject|1|||
48548974|NCT00851318|156197879|FG002|Overall Study|Withdrawal by Subject|5|||
48548975|NCT00851318|156197880|FG003|Overall Study|Withdrawal by Subject|3|||
48548976|NCT00851318|156197877|FG000|Overall Study|Adverse Event|13|||
48548977|NCT00851318|156197878|FG001|Overall Study|Adverse Event|2|||
48548978|NCT00851318|156197879|FG002|Overall Study|Adverse Event|9|||
48548979|NCT00851318|156197880|FG003|Overall Study|Adverse Event|12|||
48548980|NCT00851318|156197877|FG000|Overall Study|Pregnancy|0|||
48548981|NCT00851318|156197878|FG001|Overall Study|Pregnancy|0|||
48548982|NCT00851318|156197879|FG002|Overall Study|Pregnancy|1|||
48548983|NCT00851318|156197880|FG003|Overall Study|Pregnancy|1|||
48548984|NCT00851318|156197877|FG000|Overall Study|Lack of Efficacy|8|||
48548985|NCT00851318|156197878|FG001|Overall Study|Lack of Efficacy|2|||
48548986|NCT00851318|156197879|FG002|Overall Study|Lack of Efficacy|4|||
48548987|NCT00851318|156197880|FG003|Overall Study|Lack of Efficacy|2|||
48548988|NCT00851318|156197877|FG000|Overall Study|Non-compliance with Study Procedures|2|||
48548989|NCT00851318|156197878|FG001|Overall Study|Non-compliance with Study Procedures|0|||
48548990|NCT00851318|156197879|FG002|Overall Study|Non-compliance with Study Procedures|1|||
48548991|NCT00851318|156197880|FG003|Overall Study|Non-compliance with Study Procedures|0|||
48548992|NCT00851318|156197877|FG000|Overall Study|Physician Decision|0|||
48548993|NCT00851318|156197878|FG001|Overall Study|Physician Decision|0|||
48548994|NCT00851318|156197879|FG002|Overall Study|Physician Decision|1|||
48548995|NCT00851318|156197880|FG003|Overall Study|Physician Decision|1|||
48548996|NCT01844856|156197893|FG000|Overall Study|Lost to Follow-up|15|||
48548997|NCT01844856|156197894|FG001|Overall Study|Lost to Follow-up|3|||
48548998|NCT01844856|156197893|FG000|Overall Study|Adverse Event|3|||
48548999|NCT01844856|156197894|FG001|Overall Study|Adverse Event|6|||
48549000|NCT01844856|156197893|FG000|Overall Study|Withdrawal by Subject|3|||
48549001|NCT01844856|156197894|FG001|Overall Study|Withdrawal by Subject|2|||
48549002|NCT01844856|156197893|FG000|Overall Study|Noncompliance|2|||
48549003|NCT01844856|156197894|FG001|Overall Study|Noncompliance|3|||
48549004|NCT01844856|156197893|FG000|Overall Study|Enterococcus Resistant|0|||
48549005|NCT01844856|156197894|FG001|Overall Study|Enterococcus Resistant|1|||
48549006|NCT01844856|156197893|FG000|Overall Study|Inadvertently Not Scheduled|1|||
48549007|NCT01844856|156197894|FG001|Overall Study|Inadvertently Not Scheduled|0|||
48549008|NCT01844856|156197893|FG000|Overall Study|Randomized but was a Screen Failure|0|||
48549009|NCT01844856|156197894|FG001|Overall Study|Randomized but was a Screen Failure|1|||
48549010|NCT01001988|156197895|FG000|Overall Study|Protocol Violation|84|||
48549011|NCT01001988|156197895|FG000|Overall Study|Withdrawal by Subject|18|||
48549012|NCT01001988|156197895|FG000|Overall Study|Lost to Follow-up|15|||
48549013|NCT01442688|156197896|FG000|First Intervention|Withdrawal by Subject|1|||
48549014|NCT01442688|156197897|FG001|First Intervention|Withdrawal by Subject|0|||
48549015|NCT01442688|156197896|FG000|First Intervention|subject incarcerated|1|||
48549016|NCT01442688|156197897|FG001|First Intervention|subject incarcerated|0|||
48549017|NCT01442688|156197896|FG000|Second Intervention|Adverse Event|1|||
48549018|NCT01442688|156197897|FG001|Second Intervention|Adverse Event|0|||
48549019|NCT02677714|156197898|FG000|Overall Study|Withdrawal by Subject|2|||
48549020|NCT02677714|156197899|FG001|Overall Study|Withdrawal by Subject|0|||
48549021|NCT04628793|156197902|FG000|Overall Study|Study terminated by sponsor|0|||
48549022|NCT04628793|156197903|FG001|Overall Study|Study terminated by sponsor|0|||
48549023|NCT04628793|156197904|FG002|Overall Study|Study terminated by sponsor|8|||
48549024|NCT04628793|156197902|FG000|Overall Study|Withdrawal by Subject|2|||
48549025|NCT04628793|156197903|FG001|Overall Study|Withdrawal by Subject|3|||
48549026|NCT04628793|156197904|FG002|Overall Study|Withdrawal by Subject|0|||
48549027|NCT04628793|156197902|FG000|Overall Study|Lost to Follow-up|0|||
48549028|NCT04628793|156197903|FG001|Overall Study|Lost to Follow-up|1|||
48549029|NCT04628793|156197904|FG002|Overall Study|Lost to Follow-up|0|||
48549030|NCT01421511|156197905|FG000|Overall Study|Lost to Follow-up|11|||
48549031|NCT01421511|156197906|FG001|Overall Study|Lost to Follow-up|14|||
48549032|NCT01421511|156197905|FG000|Overall Study|Randomized but didn't receive study drug|1|||
48549033|NCT01421511|156197906|FG001|Overall Study|Randomized but didn't receive study drug|7|||
48549034|NCT01421511|156197905|FG000|Overall Study|Physician Decision|0|||
48549035|NCT01421511|156197906|FG001|Overall Study|Physician Decision|1|||
48549036|NCT01421511|156197905|FG000|Overall Study|Withdrawal by Subject|6|||
48613168|NCT01348269|156439467|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
48613169|NCT01348269|156439468|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
48613170|NCT01348269|156439467|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
48613171|NCT01348269|156439468|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
48613172|NCT01348269|156439467|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
48613173|NCT01348269|156439468|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
48613174|NCT00800540|156439469|FG000|Period One: 6 Weeks|Noncompliance|1|||
48613175|NCT00800540|156439470|FG001|Period One: 6 Weeks|Noncompliance|0|||
48613176|NCT00800540|156439469|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
48613177|NCT00800540|156439470|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
48613178|NCT00800540|156439469|FG000|Period 2: 6 Weeks|Adverse Event|0|||
48613179|NCT00800540|156439470|FG001|Period 2: 6 Weeks|Adverse Event|1|||
48613180|NCT00805532|156439474|FG000|Overall Study|invalid data|0|||
48613181|NCT00805532|156439475|FG001|Overall Study|invalid data|1|||
48549037|NCT01421511|156197906|FG001|Overall Study|Withdrawal by Subject|5|||
48549038|NCT01421511|156197905|FG000|Overall Study|Death|1|||
48549039|NCT01421511|156197906|FG001|Overall Study|Death|1|||
48549040|NCT00106964|156197907|FG000|Overall Study|Lost to Follow-up|8|||
48549041|NCT00106964|156197908|FG001|Overall Study|Lost to Follow-up|6|||
48549042|NCT00106964|156197909|FG002|Overall Study|Lost to Follow-up|2|||
48549043|NCT00106964|156197907|FG000|Overall Study|Pregnancy|2|||
48549044|NCT00106964|156197908|FG001|Overall Study|Pregnancy|3|||
48549045|NCT00106964|156197909|FG002|Overall Study|Pregnancy|2|||
48549046|NCT00106964|156197907|FG000|Overall Study|Death|1|||
48549047|NCT00106964|156197908|FG001|Overall Study|Death|1|||
48549048|NCT00106964|156197909|FG002|Overall Study|Death|0|||
48549049|NCT00106964|156197907|FG000|Overall Study|Incarceration|0|||
48549050|NCT00106964|156197908|FG001|Overall Study|Incarceration|1|||
48549051|NCT00106964|156197909|FG002|Overall Study|Incarceration|0|||
48549052|NCT00106964|156197907|FG000|Overall Study|Site Funding Terminated|0|||
48549053|NCT00106964|156197908|FG001|Overall Study|Site Funding Terminated|1|||
48549054|NCT00106964|156197909|FG002|Overall Study|Site Funding Terminated|1|||
48613182|NCT00460798|156439478|FG000|Overall Study|Death|59|||
48613183|NCT00460798|156439478|FG000|Overall Study|Adverse Event|27|||
48613184|NCT00460798|156439478|FG000|Overall Study|Lost to Follow-up|19|||
48613185|NCT00460798|156439478|FG000|Overall Study|Progressive Disease|99|||
48613186|NCT00460798|156439478|FG000|Overall Study|Other|27|||
48613187|NCT00460798|156439478|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
48613188|NCT00460798|156439478|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
48613189|NCT00920816|156439479|FG000|Overall Study|Death|116|||
48613190|NCT00920816|156439480|FG001|Overall Study|Death|63|||
48613191|NCT00920816|156439481|FG002|Overall Study|Death|8|||
48613192|NCT00920816|156439482|FG003|Overall Study|Death|3|||
48613193|NCT00920816|156439479|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
48613194|NCT00920816|156439480|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
48613195|NCT00920816|156439481|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
48613196|NCT00920816|156439482|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
48613197|NCT00920816|156439479|FG000|Overall Study|Global deterioration of health status|2|||
48613198|NCT00920816|156439480|FG001|Overall Study|Global deterioration of health status|0|||
48613199|NCT00920816|156439481|FG002|Overall Study|Global deterioration of health status|0|||
48549055|NCT00106964|156197907|FG000|Overall Study|Failure to adhere|2|||
48549056|NCT00106964|156197908|FG001|Overall Study|Failure to adhere|0|||
48549057|NCT00106964|156197909|FG002|Overall Study|Failure to adhere|0|||
48549058|NCT00106964|156197907|FG000|Overall Study|Did not meet eligibility criteria|0|||
48613200|NCT00920816|156439482|FG003|Overall Study|Global deterioration of health status|0|||
48613201|NCT00920816|156439479|FG000|Overall Study|Objective progression or relapse|6|||
48549059|NCT00106964|156197908|FG001|Overall Study|Did not meet eligibility criteria|2|||
48549060|NCT00106964|156197909|FG002|Overall Study|Did not meet eligibility criteria|2|||
48613202|NCT00920816|156439480|FG001|Overall Study|Objective progression or relapse|2|||
48549061|NCT00106964|156197907|FG000|Overall Study|Required disallowed medication|0|||
48613203|NCT00920816|156439481|FG002|Overall Study|Objective progression or relapse|0|||
48613204|NCT00920816|156439482|FG003|Overall Study|Objective progression or relapse|0|||
48613205|NCT00920816|156439479|FG000|Overall Study|Other|26|||
48613206|NCT00920816|156439480|FG001|Overall Study|Other|15|||
48613207|NCT00920816|156439481|FG002|Overall Study|Other|1|||
48613208|NCT00920816|156439482|FG003|Overall Study|Other|2|||
48613209|NCT00920816|156439479|FG000|Overall Study|Lost to Follow-up|11|||
48613210|NCT00920816|156439480|FG001|Overall Study|Lost to Follow-up|2|||
48613211|NCT00920816|156439481|FG002|Overall Study|Lost to Follow-up|0|||
48613212|NCT00920816|156439482|FG003|Overall Study|Lost to Follow-up|0|||
48613213|NCT00920816|156439479|FG000|Overall Study|Adverse Event|1|||
48613214|NCT00920816|156439480|FG001|Overall Study|Adverse Event|1|||
48613215|NCT00920816|156439481|FG002|Overall Study|Adverse Event|1|||
48613216|NCT00920816|156439482|FG003|Overall Study|Adverse Event|0|||
48613217|NCT00920816|156439479|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
48613218|NCT00920816|156439480|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
48613219|NCT00920816|156439481|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
48613220|NCT00920816|156439482|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
48549062|NCT00106964|156197908|FG001|Overall Study|Required disallowed medication|1|||
48549063|NCT00106964|156197909|FG002|Overall Study|Required disallowed medication|0|||
48613221|NCT00920816|156439479|FG000|Overall Study|Randomized but not treated|3|||
48613222|NCT00920816|156439480|FG001|Overall Study|Randomized but not treated|0|||
48613223|NCT00920816|156439481|FG002|Overall Study|Randomized but not treated|0|||
48613224|NCT00920816|156439482|FG003|Overall Study|Randomized but not treated|0|||
48613225|NCT04115059|156439483|FG000|Overall Study|Withdrawal by Subject|1|||
48613226|NCT04115059|156439483|FG000|Overall Study|Lack of Efficacy|2|||
48613227|NCT00368550|156439484|FG000|Overall Study|Adverse Event|7|||
48613228|NCT00368550|156439485|FG001|Overall Study|Adverse Event|4|||
48549064|NCT01756079|156197910|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
48549065|NCT01756079|156197910|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
48549066|NCT01756079|156197910|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
48549067|NCT01756079|156197910|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
48549068|NCT01756079|156197910|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
48549069|NCT02181790|156197911|FG000|Overall Study|study terminated|2|||
48549070|NCT02181790|156197912|FG001|Overall Study|study terminated|0|||
48549071|NCT03276078|156197914|FG000|Overall Study|Adverse Event|1|||
48549072|NCT00206323|156197915|FG000|Overall Study|Lack of Efficacy|4|||
48549073|NCT00206323|156197916|FG001|Overall Study|Lack of Efficacy|1|||
48549074|NCT00206323|156197915|FG000|Overall Study|Adverse Event|1|||
48549075|NCT00206323|156197916|FG001|Overall Study|Adverse Event|1|||
48549076|NCT00206323|156197915|FG000|Overall Study|Lost to Follow-up|1|||
48549077|NCT00206323|156197916|FG001|Overall Study|Lost to Follow-up|1|||
48549078|NCT03477903|156197917|FG000|Overall Study|Study Terminated by Sponsor|1|||
48549079|NCT02552732|156197918|FG000|Overall Study|Lost to Follow-up|2|||
48549080|NCT02552732|156197918|FG000|Overall Study|Physician Decision|1|||
48549081|NCT02552732|156197918|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
48549082|NCT02552732|156197918|FG000|Overall Study|Withdrawal by Subject|6|||
48549083|NCT01147107|156197919|FG000|Overall Study|Lack of Efficacy|5|||
48549084|NCT01147107|156197920|FG001|Overall Study|Lack of Efficacy|0|||
48549085|NCT01147107|156197919|FG000|Overall Study|Withdrawal by Subject|1|||
48549086|NCT01147107|156197920|FG001|Overall Study|Withdrawal by Subject|1|||
48549087|NCT02458287|156197922|FG000|Overall Study|Adverse Event|0|||
48549088|NCT02458287|156197923|FG001|Overall Study|Adverse Event|0|||
48549089|NCT02458287|156197924|FG002|Overall Study|Adverse Event|0|||
48549090|NCT02458287|156197925|FG003|Overall Study|Adverse Event|1|||
48549091|NCT02458287|156197922|FG000|Overall Study|Lost to Follow-up|0|||
48549092|NCT02458287|156197923|FG001|Overall Study|Lost to Follow-up|1|||
48549093|NCT02458287|156197924|FG002|Overall Study|Lost to Follow-up|1|||
48549094|NCT02458287|156197925|FG003|Overall Study|Lost to Follow-up|0|||
48549095|NCT02458287|156197922|FG000|Overall Study|Protocol Violation|0|||
48549096|NCT02458287|156197923|FG001|Overall Study|Protocol Violation|1|||
48549097|NCT02458287|156197924|FG002|Overall Study|Protocol Violation|0|||
48549098|NCT02458287|156197925|FG003|Overall Study|Protocol Violation|0|||
48549099|NCT02458287|156197922|FG000|Overall Study|Withdrawal by Subject|0|||
48549100|NCT02458287|156197923|FG001|Overall Study|Withdrawal by Subject|2|||
48549101|NCT02458287|156197924|FG002|Overall Study|Withdrawal by Subject|2|||
48549102|NCT02458287|156197925|FG003|Overall Study|Withdrawal by Subject|1|||
48549103|NCT02458287|156197922|FG000|Overall Study|Relocated Out of State|0|||
48549104|NCT02458287|156197923|FG001|Overall Study|Relocated Out of State|0|||
48549105|NCT02458287|156197924|FG002|Overall Study|Relocated Out of State|0|||
48613229|NCT00368550|156439484|FG000|Overall Study|Lack of Efficacy|4|||
48613230|NCT00368550|156439485|FG001|Overall Study|Lack of Efficacy|9|||
48613231|NCT00368550|156439484|FG000|Overall Study|Withdrawal by Subject|17|||
48325483|NCT02357966|155389117|FG005|Overall Study|Death|0|||
48549106|NCT02458287|156197925|FG003|Overall Study|Relocated Out of State|1|||
48549107|NCT02613182|156197926|FG000|Overall Study|Death|6|||
48613232|NCT00368550|156439485|FG001|Overall Study|Withdrawal by Subject|10|||
48549108|NCT02613182|156197926|FG000|Overall Study|Physician Decision|1|||
48549109|NCT02613182|156197926|FG000|Overall Study|Study Terminated by Sponsor|21|||
48549110|NCT02613182|156197926|FG000|Overall Study|Withdrawal by Subject|6|||
48549111|NCT01659151|156197930|FG000|Overall Study|Inadequate TIL growth|1|||
48549112|NCT01499368|156197935|FG000|Overall Study|Did not meet I/E criteria|8|||
48549113|NCT01499368|156197936|FG001|Overall Study|Did not meet I/E criteria|4|||
48549114|NCT01499368|156197937|FG002|Overall Study|Did not meet I/E criteria|4|||
48549115|NCT01499368|156197935|FG000|Overall Study|Prohibited Concomitant medication|1|||
48549116|NCT01499368|156197936|FG001|Overall Study|Prohibited Concomitant medication|1|||
48549117|NCT01499368|156197937|FG002|Overall Study|Prohibited Concomitant medication|0|||
48549118|NCT01499368|156197935|FG000|Overall Study|Withdrawal by Subject|11|||
48549119|NCT01499368|156197936|FG001|Overall Study|Withdrawal by Subject|10|||
48549120|NCT01499368|156197937|FG002|Overall Study|Withdrawal by Subject|8|||
48549121|NCT01499368|156197935|FG000|Overall Study|Lost to Follow-up|3|||
48549122|NCT01499368|156197936|FG001|Overall Study|Lost to Follow-up|2|||
48549123|NCT01499368|156197937|FG002|Overall Study|Lost to Follow-up|5|||
48549124|NCT01499368|156197935|FG000|Overall Study|Adverse Event|4|||
48549125|NCT01499368|156197936|FG001|Overall Study|Adverse Event|0|||
48549126|NCT01499368|156197937|FG002|Overall Study|Adverse Event|2|||
48549127|NCT01499368|156197935|FG000|Overall Study|Physician Decision|0|||
48549128|NCT01499368|156197936|FG001|Overall Study|Physician Decision|1|||
48549129|NCT01499368|156197937|FG002|Overall Study|Physician Decision|0|||
48549130|NCT01499368|156197935|FG000|Overall Study|Deviation from visit window|0|||
48549131|NCT01499368|156197936|FG001|Overall Study|Deviation from visit window|0|||
48549132|NCT01499368|156197937|FG002|Overall Study|Deviation from visit window|1|||
48549133|NCT01499368|156197935|FG000|Overall Study|Error of Prescriptions|0|||
48549134|NCT01499368|156197936|FG001|Overall Study|Error of Prescriptions|0|||
48549135|NCT01499368|156197937|FG002|Overall Study|Error of Prescriptions|1|||
48549136|NCT01320150|156197938|FG000|Overall Study|Protocol Violation|15|||
48549137|NCT01320150|156197938|FG000|Overall Study|Withdrawal by Subject|5|||
48549138|NCT01320150|156197938|FG000|Overall Study|Death|2|||
48549139|NCT01320150|156197938|FG000|Overall Study|Lost to Follow-up|44|||
48549140|NCT03597464|156197941|FG000|Overall Study|Withdrawal by Subject|4|||
48549141|NCT03597464|156197942|FG001|Overall Study|Withdrawal by Subject|5|||
48549142|NCT03597464|156197941|FG000|Overall Study|Lost to Follow-up|3|||
48549143|NCT03597464|156197942|FG001|Overall Study|Lost to Follow-up|1|||
48549144|NCT03597464|156197941|FG000|Overall Study|Pregnancy|3|||
48549145|NCT03597464|156197942|FG001|Overall Study|Pregnancy|1|||
48549146|NCT03597464|156197941|FG000|Overall Study|Lack of Efficacy|2|||
48549147|NCT03597464|156197942|FG001|Overall Study|Lack of Efficacy|0|||
48549148|NCT03597464|156197941|FG000|Overall Study|Physician Decision|2|||
48549149|NCT03597464|156197942|FG001|Overall Study|Physician Decision|2|||
48549150|NCT03597464|156197941|FG000|Overall Study|Protocol Violation|1|||
48549151|NCT03597464|156197942|FG001|Overall Study|Protocol Violation|1|||
48549152|NCT03597464|156197941|FG000|Overall Study|Adverse Event|0|||
48549153|NCT03597464|156197942|FG001|Overall Study|Adverse Event|2|||
48549154|NCT03597464|156197941|FG000|Overall Study|Death|0|||
48549155|NCT03597464|156197942|FG001|Overall Study|Death|3|||
48549156|NCT03092674|156197947|FG000|Overall Study|Adverse Event or Side Effects|1|||
48549157|NCT03092674|156197948|FG001|Overall Study|Adverse Event or Side Effects|4|||
48549158|NCT03092674|156197949|FG002|Overall Study|Adverse Event or Side Effects|4|||
48549159|NCT03092674|156197947|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
48549160|NCT03092674|156197948|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
48549161|NCT03092674|156197949|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
48549162|NCT03092674|156197947|FG000|Overall Study|Progression/Relapse|5|||
48549163|NCT03092674|156197948|FG001|Overall Study|Progression/Relapse|4|||
48549164|NCT03092674|156197949|FG002|Overall Study|Progression/Relapse|8|||
48549165|NCT03092674|156197947|FG000|Overall Study|Death|4|||
48549166|NCT03092674|156197948|FG001|Overall Study|Death|8|||
48549167|NCT03092674|156197949|FG002|Overall Study|Death|2|||
48549168|NCT03092674|156197947|FG000|Overall Study|Other - Not Protocol Specified|11|||
48549169|NCT03092674|156197948|FG001|Overall Study|Other - Not Protocol Specified|8|||
48549170|NCT03092674|156197949|FG002|Overall Study|Other - Not Protocol Specified|8|||
48549171|NCT04895982|156197950|FG000|Overall Study|Withdrawal by Subject|0|||
48549172|NCT04895982|156197951|FG001|Overall Study|Withdrawal by Subject|0|||
48549173|NCT04895982|156197952|FG002|Overall Study|Withdrawal by Subject|0|||
48549174|NCT04895982|156197953|FG003|Overall Study|Withdrawal by Subject|0|||
48549175|NCT04895982|156197954|FG004|Overall Study|Withdrawal by Subject|0|||
48549176|NCT04895982|156197955|FG005|Overall Study|Withdrawal by Subject|1|||
48549177|NCT04895982|156197956|FG006|Overall Study|Withdrawal by Subject|1|||
48549178|NCT04895982|156197957|FG007|Overall Study|Withdrawal by Subject|0|||
48549179|NCT04895982|156197958|FG008|Overall Study|Withdrawal by Subject|0|||
48549180|NCT04895982|156197959|FG009|Overall Study|Withdrawal by Subject|1|||
48549181|NCT04895982|156197960|FG010|Overall Study|Withdrawal by Subject|0|||
48549182|NCT04895982|156197961|FG011|Overall Study|Withdrawal by Subject|1|||
48549183|NCT04895982|156197950|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48549184|NCT04895982|156197951|FG001|Overall Study|Withdrawal by parent/guardian|3|||
48549185|NCT04895982|156197952|FG002|Overall Study|Withdrawal by parent/guardian|3|||
48549186|NCT04895982|156197953|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48549187|NCT04895982|156197954|FG004|Overall Study|Withdrawal by parent/guardian|3|||
48549188|NCT04895982|156197955|FG005|Overall Study|Withdrawal by parent/guardian|2|||
48549189|NCT04895982|156197956|FG006|Overall Study|Withdrawal by parent/guardian|1|||
48549190|NCT04895982|156197957|FG007|Overall Study|Withdrawal by parent/guardian|0|||
48549191|NCT04895982|156197958|FG008|Overall Study|Withdrawal by parent/guardian|3|||
48549192|NCT04895982|156197959|FG009|Overall Study|Withdrawal by parent/guardian|0|||
48549193|NCT04895982|156197960|FG010|Overall Study|Withdrawal by parent/guardian|0|||
48549194|NCT04895982|156197961|FG011|Overall Study|Withdrawal by parent/guardian|0|||
48549195|NCT04895982|156197950|FG000|Overall Study|Other|0|||
48549196|NCT04895982|156197951|FG001|Overall Study|Other|0|||
48549197|NCT04895982|156197952|FG002|Overall Study|Other|1|||
48549198|NCT04895982|156197953|FG003|Overall Study|Other|1|||
48549199|NCT04895982|156197954|FG004|Overall Study|Other|0|||
48549200|NCT04895982|156197955|FG005|Overall Study|Other|0|||
48549201|NCT04895982|156197956|FG006|Overall Study|Other|0|||
48549202|NCT04895982|156197957|FG007|Overall Study|Other|0|||
48549203|NCT04895982|156197958|FG008|Overall Study|Other|0|||
48549204|NCT04895982|156197959|FG009|Overall Study|Other|1|||
48549205|NCT04895982|156197960|FG010|Overall Study|Other|0|||
48549206|NCT04895982|156197961|FG011|Overall Study|Other|0|||
48549207|NCT04895982|156197950|FG000|Overall Study|Protocol Violation|0|||
48549208|NCT04895982|156197951|FG001|Overall Study|Protocol Violation|0|||
48549209|NCT04895982|156197952|FG002|Overall Study|Protocol Violation|1|||
48549210|NCT04895982|156197953|FG003|Overall Study|Protocol Violation|1|||
48549211|NCT04895982|156197954|FG004|Overall Study|Protocol Violation|1|||
48549212|NCT04895982|156197955|FG005|Overall Study|Protocol Violation|0|||
48549213|NCT04895982|156197956|FG006|Overall Study|Protocol Violation|0|||
48549214|NCT04895982|156197957|FG007|Overall Study|Protocol Violation|1|||
48549215|NCT04895982|156197958|FG008|Overall Study|Protocol Violation|0|||
48549216|NCT04895982|156197959|FG009|Overall Study|Protocol Violation|0|||
48549217|NCT04895982|156197960|FG010|Overall Study|Protocol Violation|0|||
48549218|NCT04895982|156197961|FG011|Overall Study|Protocol Violation|0|||
48549219|NCT04895982|156197950|FG000|Overall Study|Lost to Follow-up|0|||
48549220|NCT04895982|156197951|FG001|Overall Study|Lost to Follow-up|0|||
48549221|NCT04895982|156197952|FG002|Overall Study|Lost to Follow-up|1|||
48549222|NCT04895982|156197953|FG003|Overall Study|Lost to Follow-up|0|||
48549223|NCT04895982|156197954|FG004|Overall Study|Lost to Follow-up|0|||
48549224|NCT04895982|156197955|FG005|Overall Study|Lost to Follow-up|1|||
48549225|NCT04895982|156197956|FG006|Overall Study|Lost to Follow-up|0|||
48549226|NCT04895982|156197957|FG007|Overall Study|Lost to Follow-up|0|||
48549227|NCT04895982|156197958|FG008|Overall Study|Lost to Follow-up|1|||
48549228|NCT04895982|156197959|FG009|Overall Study|Lost to Follow-up|0|||
48549229|NCT04895982|156197960|FG010|Overall Study|Lost to Follow-up|0|||
48549230|NCT04895982|156197961|FG011|Overall Study|Lost to Follow-up|0|||
48549231|NCT04895982|156197950|FG000|Overall Study|Refused further study procedures|0|||
48549232|NCT04895982|156197951|FG001|Overall Study|Refused further study procedures|0|||
48549233|NCT04895982|156197952|FG002|Overall Study|Refused further study procedures|1|||
48549234|NCT04895982|156197953|FG003|Overall Study|Refused further study procedures|0|||
48549235|NCT04895982|156197954|FG004|Overall Study|Refused further study procedures|0|||
48549236|NCT04895982|156197955|FG005|Overall Study|Refused further study procedures|0|||
48549237|NCT04895982|156197956|FG006|Overall Study|Refused further study procedures|0|||
48549238|NCT04895982|156197957|FG007|Overall Study|Refused further study procedures|0|||
48549239|NCT04895982|156197958|FG008|Overall Study|Refused further study procedures|0|||
48549240|NCT04895982|156197959|FG009|Overall Study|Refused further study procedures|0|||
48549241|NCT04895982|156197960|FG010|Overall Study|Refused further study procedures|0|||
48549242|NCT04895982|156197961|FG011|Overall Study|Refused further study procedures|0|||
48549243|NCT01329900|156197964|FG000|Overall Study|Elevated creatinine/renal function|1|||
48549244|NCT02542605|156197967|FG000|Part B: Challenge Phase|Sponsor decision|1|||
48549245|NCT02542605|156197968|FG001|Part B: Challenge Phase|Sponsor decision|0|||
48549246|NCT02542605|156197969|FG002|Part B: Challenge Phase|Sponsor decision|0|||
48549247|NCT02542605|156197967|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
48549248|NCT02542605|156197968|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
48549249|NCT02542605|156197969|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
48549250|NCT00919854|156197970|FG000|Overall Study|Adverse Event|1|||
48549251|NCT02682927|156197972|FG000|Overall Study|Adverse Event|0|||
48549252|NCT02682927|156197973|FG001|Overall Study|Adverse Event|0|||
48549253|NCT02682927|156197974|FG002|Overall Study|Adverse Event|5|||
48549254|NCT02682927|156197975|FG003|Overall Study|Adverse Event|1|||
48549255|NCT02682927|156197976|FG004|Overall Study|Adverse Event|0|||
48549256|NCT02682927|156197977|FG005|Overall Study|Adverse Event|2|||
48549257|NCT02682927|156197972|FG000|Overall Study|Death|0|||
48549258|NCT02682927|156197973|FG001|Overall Study|Death|0|||
48549259|NCT02682927|156197974|FG002|Overall Study|Death|0|||
48549260|NCT02682927|156197975|FG003|Overall Study|Death|1|||
48549261|NCT02682927|156197976|FG004|Overall Study|Death|0|||
48549262|NCT02682927|156197977|FG005|Overall Study|Death|0|||
48549263|NCT02682927|156197972|FG000|Overall Study|Lack of Efficacy|1|||
48549264|NCT02682927|156197973|FG001|Overall Study|Lack of Efficacy|0|||
48549265|NCT02682927|156197974|FG002|Overall Study|Lack of Efficacy|0|||
48549266|NCT02682927|156197975|FG003|Overall Study|Lack of Efficacy|1|||
48549267|NCT02682927|156197976|FG004|Overall Study|Lack of Efficacy|0|||
48549268|NCT02682927|156197977|FG005|Overall Study|Lack of Efficacy|0|||
48549269|NCT02682927|156197972|FG000|Overall Study|Other|0|||
48549270|NCT02682927|156197973|FG001|Overall Study|Other|0|||
48549271|NCT02682927|156197974|FG002|Overall Study|Other|0|||
48549272|NCT02682927|156197975|FG003|Overall Study|Other|2|||
48549273|NCT02682927|156197976|FG004|Overall Study|Other|0|||
48549274|NCT02682927|156197977|FG005|Overall Study|Other|0|||
48549275|NCT02682927|156197972|FG000|Overall Study|Withdrawal by Subject|2|||
48549276|NCT02682927|156197973|FG001|Overall Study|Withdrawal by Subject|0|||
48549277|NCT02682927|156197974|FG002|Overall Study|Withdrawal by Subject|1|||
48549278|NCT02682927|156197975|FG003|Overall Study|Withdrawal by Subject|0|||
48549279|NCT02682927|156197976|FG004|Overall Study|Withdrawal by Subject|1|||
48549280|NCT02682927|156197977|FG005|Overall Study|Withdrawal by Subject|1|||
48549281|NCT03587805|156197981|FG000|Overall Study|Adverse Event|72|||
48549282|NCT03587805|156197981|FG000|Overall Study|Death|1|||
48549283|NCT03587805|156197981|FG000|Overall Study|Lost to Follow-up|78|||
48549284|NCT03587805|156197981|FG000|Overall Study|Withdrawal by Subject|105|||
48549285|NCT03587805|156197981|FG000|Overall Study|Lack of Efficacy|119|||
48549286|NCT03587805|156197981|FG000|Overall Study|Reason unknown|26|||
48549287|NCT03587805|156197981|FG000|Overall Study|COVID_19 pandemic|4|||
48549288|NCT03587805|156197981|FG000|Overall Study|Various reasons|121|||
48549289|NCT03587805|156197981|FG000|Overall Study|Withdrawal by parent/guardian|3|||
48549290|NCT04711902|156199880|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
48549291|NCT04711902|156199881|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
48549292|NCT04711902|156199882|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
48549293|NCT04711902|156199883|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
48549294|NCT04711902|156199884|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
48549295|NCT04711902|156199885|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
48549296|NCT04171141|156199888|FG000|Overall Study|Adverse Event|0|||
48549297|NCT04171141|156199889|FG001|Overall Study|Adverse Event|0|||
48549298|NCT04171141|156199890|FG002|Overall Study|Adverse Event|2|||
48549299|NCT04171141|156199891|FG003|Overall Study|Adverse Event|0|||
48549300|NCT04171141|156199892|FG004|Overall Study|Adverse Event|0|||
48549301|NCT04171141|156199893|FG005|Overall Study|Adverse Event|0|||
48549302|NCT04171141|156199894|FG006|Overall Study|Adverse Event|0|||
48549303|NCT04171141|156199895|FG007|Overall Study|Adverse Event|0|||
48549304|NCT04171141|156199896|FG008|Overall Study|Adverse Event|0|||
48549305|NCT04171141|156199897|FG009|Overall Study|Adverse Event|0|||
48549306|NCT04171141|156199898|FG010|Overall Study|Adverse Event|0|||
48549307|NCT04171141|156199899|FG011|Overall Study|Adverse Event|0|||
48549308|NCT04171141|156199900|FG012|Overall Study|Adverse Event|0|||
48549309|NCT04171141|156199901|FG013|Overall Study|Adverse Event|2|||
48549310|NCT04171141|156199902|FG014|Overall Study|Adverse Event|0|||
48549311|NCT04171141|156199903|FG015|Overall Study|Adverse Event|0|||
48549312|NCT04171141|156199888|FG000|Overall Study|Physician Decision|0|||
48549313|NCT04171141|156199889|FG001|Overall Study|Physician Decision|0|||
48549314|NCT04171141|156199890|FG002|Overall Study|Physician Decision|0|||
48549315|NCT04171141|156199891|FG003|Overall Study|Physician Decision|0|||
48549316|NCT04171141|156199892|FG004|Overall Study|Physician Decision|1|||
48549317|NCT04171141|156199893|FG005|Overall Study|Physician Decision|0|||
48549318|NCT04171141|156199894|FG006|Overall Study|Physician Decision|0|||
48549319|NCT04171141|156199895|FG007|Overall Study|Physician Decision|0|||
48549320|NCT04171141|156199896|FG008|Overall Study|Physician Decision|0|||
48549321|NCT04171141|156199897|FG009|Overall Study|Physician Decision|0|||
48549322|NCT04171141|156199898|FG010|Overall Study|Physician Decision|0|||
48549323|NCT04171141|156199899|FG011|Overall Study|Physician Decision|0|||
48549324|NCT04171141|156199900|FG012|Overall Study|Physician Decision|0|||
48549325|NCT04171141|156199901|FG013|Overall Study|Physician Decision|0|||
48549326|NCT04171141|156199902|FG014|Overall Study|Physician Decision|0|||
48549327|NCT04171141|156199903|FG015|Overall Study|Physician Decision|1|||
48549328|NCT04171141|156199888|FG000|Overall Study|Progressive disease|2|||
48549329|NCT04171141|156199889|FG001|Overall Study|Progressive disease|3|||
48549330|NCT04171141|156199890|FG002|Overall Study|Progressive disease|4|||
48549331|NCT04171141|156199891|FG003|Overall Study|Progressive disease|7|||
48549332|NCT04171141|156199892|FG004|Overall Study|Progressive disease|1|||
48549333|NCT04171141|156199893|FG005|Overall Study|Progressive disease|8|||
48549334|NCT04171141|156199894|FG006|Overall Study|Progressive disease|4|||
48549335|NCT04171141|156199895|FG007|Overall Study|Progressive disease|6|||
48549336|NCT04171141|156199896|FG008|Overall Study|Progressive disease|7|||
48549337|NCT04171141|156199897|FG009|Overall Study|Progressive disease|3|||
48549338|NCT04171141|156199898|FG010|Overall Study|Progressive disease|4|||
48549339|NCT04171141|156199899|FG011|Overall Study|Progressive disease|3|||
48549340|NCT04171141|156199900|FG012|Overall Study|Progressive disease|4|||
48549341|NCT04171141|156199901|FG013|Overall Study|Progressive disease|2|||
48549342|NCT04171141|156199902|FG014|Overall Study|Progressive disease|4|||
48549343|NCT04171141|156199903|FG015|Overall Study|Progressive disease|1|||
48549344|NCT04171141|156199888|FG000|Overall Study|Withdrawal by Subject|0|||
48549345|NCT04171141|156199889|FG001|Overall Study|Withdrawal by Subject|0|||
48549346|NCT04171141|156199890|FG002|Overall Study|Withdrawal by Subject|0|||
48549347|NCT04171141|156199891|FG003|Overall Study|Withdrawal by Subject|1|||
48549348|NCT04171141|156199892|FG004|Overall Study|Withdrawal by Subject|0|||
48549349|NCT04171141|156199893|FG005|Overall Study|Withdrawal by Subject|0|||
48549350|NCT04171141|156199894|FG006|Overall Study|Withdrawal by Subject|1|||
48549351|NCT04171141|156199895|FG007|Overall Study|Withdrawal by Subject|0|||
48549352|NCT04171141|156199896|FG008|Overall Study|Withdrawal by Subject|0|||
48549353|NCT04171141|156199897|FG009|Overall Study|Withdrawal by Subject|1|||
48549354|NCT04171141|156199898|FG010|Overall Study|Withdrawal by Subject|0|||
48549355|NCT04171141|156199899|FG011|Overall Study|Withdrawal by Subject|0|||
48549356|NCT04171141|156199900|FG012|Overall Study|Withdrawal by Subject|0|||
48549357|NCT04171141|156199901|FG013|Overall Study|Withdrawal by Subject|0|||
48549358|NCT04171141|156199902|FG014|Overall Study|Withdrawal by Subject|0|||
48549359|NCT04171141|156199903|FG015|Overall Study|Withdrawal by Subject|0|||
48549360|NCT04171141|156199888|FG000|Overall Study|Global deterioration of health status|0|||
48549361|NCT04171141|156199889|FG001|Overall Study|Global deterioration of health status|0|||
48549362|NCT04171141|156199890|FG002|Overall Study|Global deterioration of health status|0|||
48549363|NCT04171141|156199891|FG003|Overall Study|Global deterioration of health status|1|||
48549364|NCT04171141|156199892|FG004|Overall Study|Global deterioration of health status|0|||
48549365|NCT04171141|156199893|FG005|Overall Study|Global deterioration of health status|2|||
48549366|NCT04171141|156199894|FG006|Overall Study|Global deterioration of health status|1|||
48549367|NCT04171141|156199895|FG007|Overall Study|Global deterioration of health status|0|||
48549368|NCT04171141|156199896|FG008|Overall Study|Global deterioration of health status|1|||
48549369|NCT04171141|156199897|FG009|Overall Study|Global deterioration of health status|0|||
48549370|NCT04171141|156199898|FG010|Overall Study|Global deterioration of health status|0|||
48549371|NCT04171141|156199899|FG011|Overall Study|Global deterioration of health status|0|||
48549372|NCT04171141|156199900|FG012|Overall Study|Global deterioration of health status|0|||
48549373|NCT04171141|156199901|FG013|Overall Study|Global deterioration of health status|0|||
48549374|NCT04171141|156199902|FG014|Overall Study|Global deterioration of health status|1|||
48549375|NCT04171141|156199903|FG015|Overall Study|Global deterioration of health status|1|||
48549376|NCT00213135|156199904|FG000|Overall Study|Adverse Event|9|||
48549377|NCT00213135|156199905|FG001|Overall Study|Adverse Event|5|||
48549378|NCT00213135|156199906|FG002|Overall Study|Adverse Event|5|||
48549379|NCT00213135|156199904|FG000|Overall Study|Lost to Follow-up|11|||
48549380|NCT00213135|156199905|FG001|Overall Study|Lost to Follow-up|8|||
48549381|NCT00213135|156199906|FG002|Overall Study|Lost to Follow-up|4|||
48549382|NCT00213135|156199904|FG000|Overall Study|Protocol Violation|4|||
48549383|NCT00213135|156199905|FG001|Overall Study|Protocol Violation|4|||
48549384|NCT00213135|156199906|FG002|Overall Study|Protocol Violation|10|||
48549385|NCT00213135|156199904|FG000|Overall Study|Death|1|||
48549386|NCT00213135|156199905|FG001|Overall Study|Death|1|||
48549387|NCT00213135|156199906|FG002|Overall Study|Death|2|||
48549388|NCT00213135|156199904|FG000|Overall Study|Disease progression|4|||
48549389|NCT00213135|156199905|FG001|Overall Study|Disease progression|5|||
48549390|NCT00213135|156199906|FG002|Overall Study|Disease progression|21|||
48549391|NCT00213135|156199904|FG000|Overall Study|Other|21|||
48549392|NCT00213135|156199905|FG001|Overall Study|Other|12|||
48549393|NCT00213135|156199906|FG002|Overall Study|Other|15|||
48549394|NCT03786718|156199910|FG000|Overall Study|Lost to Follow-up|3|||
48549395|NCT03786718|156199910|FG000|Overall Study|Withdrawal by Subject|1|||
48549396|NCT03786718|156199910|FG000|Overall Study|Did not use the intervention|2|||
48549397|NCT03786718|156199910|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
48549398|NCT00368979|156199911|FG000|Overall Study|Adverse Event|9|||
48549399|NCT00368979|156199912|FG001|Overall Study|Adverse Event|16|||
48549400|NCT00368979|156199911|FG000|Overall Study|Lack of Efficacy|5|||
48549401|NCT00368979|156199912|FG001|Overall Study|Lack of Efficacy|3|||
48549402|NCT00368979|156199911|FG000|Overall Study|Other|3|||
48549403|NCT00368979|156199912|FG001|Overall Study|Other|1|||
48549404|NCT00368979|156199911|FG000|Overall Study|Lost to Follow-up|1|||
48549405|NCT00368979|156199912|FG001|Overall Study|Lost to Follow-up|0|||
48549406|NCT00368979|156199911|FG000|Overall Study|Protocol Violation|2|||
48549407|NCT00368979|156199912|FG001|Overall Study|Protocol Violation|1|||
48549408|NCT00368979|156199911|FG000|Overall Study|Withdrawal by Subject|5|||
48549409|NCT00368979|156199912|FG001|Overall Study|Withdrawal by Subject|9|||
48549410|NCT05526430|156199923|FG000|Overall Study|Withdrawal by Subject|0|||
48549411|NCT05526430|156199924|FG001|Overall Study|Withdrawal by Subject|2|||
48549412|NCT05526430|156199925|FG002|Overall Study|Withdrawal by Subject|0|||
48549413|NCT05526430|156199926|FG003|Overall Study|Withdrawal by Subject|0|||
48549414|NCT01696058|156199927|FG000|Overall Study|Adverse Event|21|||
48549415|NCT01696058|156199928|FG001|Overall Study|Adverse Event|11|||
48549416|NCT01696058|156199927|FG000|Overall Study|Lack of Efficacy|2|||
48549417|NCT01696058|156199928|FG001|Overall Study|Lack of Efficacy|3|||
48549418|NCT01696058|156199927|FG000|Overall Study|Protocol Violation|9|||
48549419|NCT01696058|156199928|FG001|Overall Study|Protocol Violation|3|||
48549420|NCT01696058|156199927|FG000|Overall Study|Lost to Follow-up|2|||
48549421|NCT01696058|156199928|FG001|Overall Study|Lost to Follow-up|5|||
48549422|NCT01696058|156199927|FG000|Overall Study|Withdrawal by Subject|4|||
48549423|NCT01696058|156199928|FG001|Overall Study|Withdrawal by Subject|6|||
48549424|NCT01696058|156199927|FG000|Overall Study|Other reason prematurely discontinued|5|||
48549425|NCT01696058|156199928|FG001|Overall Study|Other reason prematurely discontinued|3|||
48549426|NCT02643355|156199929|FG000|Overall Study|Withdrawal by Subject|1|||
48549427|NCT02643355|156199930|FG001|Overall Study|Withdrawal by Subject|3|||
48549428|NCT02643355|156199929|FG000|Overall Study|Protocol Violation|0|||
48549429|NCT02643355|156199930|FG001|Overall Study|Protocol Violation|2|||
48549430|NCT01884337|156199936|FG000|Treatment|Adverse Event|2|||
48549431|NCT01884337|156199937|FG001|Treatment|Adverse Event|2|||
48549432|NCT01884337|156199936|FG000|Treatment|Subj. request to discont. treatment|2|||
48549433|NCT01884337|156199937|FG001|Treatment|Subj. request to discont. treatment|0|||
48549434|NCT01884337|156199936|FG000|Follow-up Period|Lost to Follow-up|1|||
48549435|NCT01884337|156199937|FG001|Follow-up Period|Lost to Follow-up|1|||
48549436|NCT02549027|156199942|FG000|Washout After Period 4|Withdrawal by Subject|0|||
48549437|NCT02549027|156199943|FG001|Washout After Period 4|Withdrawal by Subject|1|||
48549438|NCT02549027|156199944|FG002|Washout After Period 4|Withdrawal by Subject|1|||
48549439|NCT02549027|156199945|FG003|Washout After Period 4|Withdrawal by Subject|1|||
48549440|NCT02549027|156199946|FG004|Washout After Period 4|Withdrawal by Subject|0|||
48549441|NCT02549027|156199947|FG005|Washout After Period 4|Withdrawal by Subject|0|||
48549442|NCT02549027|156199942|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
48549443|NCT02549027|156199943|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
48549444|NCT02549027|156199944|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
48549445|NCT02549027|156199945|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
48549446|NCT02549027|156199946|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
48549447|NCT02549027|156199947|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
48549448|NCT01885195|156199951|FG000|Overall Study|Adverse Event|29|||
48549449|NCT01885195|156199951|FG000|Overall Study|Death|1|||
48549450|NCT01885195|156199951|FG000|Overall Study|Disease Progression|67|||
48549451|NCT01885195|156199951|FG000|Overall Study|Protocol Deviation|2|||
48549452|NCT01885195|156199951|FG000|Overall Study|Physician Decision|3|||
48549453|NCT01885195|156199951|FG000|Overall Study|Patient/guardian decision|8|||
48549454|NCT05314816|156199952|FG000|Overall Study|Lost to Follow-up|5|||
48549455|NCT05314816|156199953|FG001|Overall Study|Lost to Follow-up|0|||
48549456|NCT05314816|156199954|FG002|Overall Study|Lost to Follow-up|1|||
48549457|NCT05314816|156199952|FG000|Overall Study|Protocol Violation|13|||
48549458|NCT05314816|156199953|FG001|Overall Study|Protocol Violation|8|||
48549459|NCT05314816|156199954|FG002|Overall Study|Protocol Violation|0|||
48613233|NCT01582451|156439486|FG000|Overall Study|Adverse Event|1|||
48549460|NCT02278055|156199955|FG000|Overall Study|Adverse Event|1|||
48549461|NCT02278055|156199955|FG000|Overall Study|Lost to Follow-up|1|||
48549462|NCT02278055|156199955|FG000|Overall Study|Withdrawal by Subject|2|||
48549463|NCT02278055|156199955|FG000|Overall Study|Progressive Disease|4|||
48549464|NCT02186834|156199956|FG000|Dose Escalation|Death|0|||
48549465|NCT02186834|156199957|FG001|Dose Escalation|Death|0|||
48549466|NCT02186834|156199958|FG002|Dose Escalation|Death|0|||
48549467|NCT02186834|156199959|FG003|Dose Escalation|Death|1|||
48549468|NCT02186834|156199960|FG004|Dose Escalation|Death|0|||
48549469|NCT02186834|156199961|FG005|Dose Escalation|Death|0|||
48549470|NCT02186834|156199956|FG000|Treatment at RP2D|Died prior to treatment|0|||
48549471|NCT02186834|156199957|FG001|Treatment at RP2D|Died prior to treatment|0|||
48549472|NCT02186834|156199958|FG002|Treatment at RP2D|Died prior to treatment|0|||
48549473|NCT02186834|156199959|FG003|Treatment at RP2D|Died prior to treatment|0|||
48549474|NCT02186834|156199960|FG004|Treatment at RP2D|Died prior to treatment|0|||
48549475|NCT02186834|156199961|FG005|Treatment at RP2D|Died prior to treatment|1|||
48549476|NCT01329549|156199969|FG000|Overall Study|Withdrawal by Subject|1|||
48549477|NCT01329549|156199969|FG000|Overall Study|Adverse Event|1|||
48549478|NCT05384171|156199970|FG000|Overall Study|Lost to Follow-up|9|||
48549479|NCT05384171|156199971|FG001|Overall Study|Lost to Follow-up|9|||
48549480|NCT05384171|156199970|FG000|Overall Study|Withdrawal by Subject|3|||
48549481|NCT05384171|156199971|FG001|Overall Study|Withdrawal by Subject|0|||
48549482|NCT03760185|156199972|FG000|Overall Study|Lost to Follow-up|1|||
48549483|NCT03760185|156199973|FG001|Overall Study|Lost to Follow-up|1|||
48549484|NCT00749892|156199974|FG000|Overall Study|Withdrawal by Subject|3|||
48549485|NCT05940194|156199979|FG000|Overall Study|Adverse Event|0|||
48549486|NCT05940194|156199980|FG001|Overall Study|Adverse Event|1|||
48549487|NCT05940194|156199981|FG002|Overall Study|Adverse Event|0|||
48549488|NCT05940194|156199979|FG000|Overall Study|Migrated/Moved from the study area|2|||
48549489|NCT05940194|156199980|FG001|Overall Study|Migrated/Moved from the study area|2|||
48549490|NCT05940194|156199981|FG002|Overall Study|Migrated/Moved from the study area|4|||
48549491|NCT01111825|156199982|FG000|Overall Study|Withdrawal by Subject|0|||
48549492|NCT01111825|156199983|FG001|Overall Study|Withdrawal by Subject|0|||
48549493|NCT01111825|156199984|FG002|Overall Study|Withdrawal by Subject|1|||
48549494|NCT01111825|156199985|FG003|Overall Study|Withdrawal by Subject|0|||
48549495|NCT01111825|156199982|FG000|Overall Study|Lost to Follow-up|0|||
48549496|NCT01111825|156199983|FG001|Overall Study|Lost to Follow-up|0|||
48549497|NCT01111825|156199984|FG002|Overall Study|Lost to Follow-up|3|||
48549498|NCT01111825|156199985|FG003|Overall Study|Lost to Follow-up|1|||
48549499|NCT01111825|156199982|FG000|Overall Study|Adverse Event|2|||
48549500|NCT01111825|156199983|FG001|Overall Study|Adverse Event|1|||
48549501|NCT01111825|156199984|FG002|Overall Study|Adverse Event|4|||
48549502|NCT01111825|156199985|FG003|Overall Study|Adverse Event|0|||
48549503|NCT01111825|156199982|FG000|Overall Study|Disease Progression|1|||
48549504|NCT01111825|156199983|FG001|Overall Study|Disease Progression|0|||
48549505|NCT01111825|156199984|FG002|Overall Study|Disease Progression|0|||
48549506|NCT01111825|156199985|FG003|Overall Study|Disease Progression|0|||
48549507|NCT01111825|156199982|FG000|Overall Study|Discontinuation by Sponsor|0|||
48549508|NCT01111825|156199983|FG001|Overall Study|Discontinuation by Sponsor|0|||
48549509|NCT01111825|156199984|FG002|Overall Study|Discontinuation by Sponsor|0|||
48549510|NCT01111825|156199985|FG003|Overall Study|Discontinuation by Sponsor|20|||
48549511|NCT02111603|156199986|FG000|Overall Study|Withdrawal by Subject|1|||
48549512|NCT00976911|156199987|FG000|Overall Study|Withdrawal by Subject|4|||
48549513|NCT00976911|156199988|FG001|Overall Study|Withdrawal by Subject|6|||
48549514|NCT00976911|156199987|FG000|Overall Study|Death|138|||
48549515|NCT00976911|156199988|FG001|Overall Study|Death|126|||
48549516|NCT00976911|156199987|FG000|Overall Study|Adverse Event|0|||
48549517|NCT00976911|156199988|FG001|Overall Study|Adverse Event|1|||
48549518|NCT00976911|156199987|FG000|Overall Study|Protocol Violation|2|||
48549519|NCT00976911|156199988|FG001|Overall Study|Protocol Violation|0|||
48549520|NCT00976911|156199987|FG000|Overall Study|Other|8|||
48549521|NCT00976911|156199988|FG001|Overall Study|Other|9|||
48549522|NCT00976911|156199987|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
48549523|NCT00976911|156199988|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
48549524|NCT03240016|156199993|FG000|Overall Study|Adverse Event|9|||
48549525|NCT03240016|156199993|FG000|Overall Study|Withdrawal by Subject|7|||
48549526|NCT03240016|156199993|FG000|Overall Study|Death|1|||
48549527|NCT03240016|156199993|FG000|Overall Study|Physician Decision|2|||
48549528|NCT00603837|156199994|FG000|Overall Study|Physician Decision|3|||
48549529|NCT00603837|156199995|FG001|Overall Study|Physician Decision|0|||
48549530|NCT01275430|156200002|FG000|Overall Study|Adverse Event|1|||
48549531|NCT01275430|156200002|FG000|Overall Study|No Contrast Injection|6|||
48549532|NCT01275430|156200002|FG000|Overall Study|Device Malfunction|1|||
48549533|NCT01275430|156200002|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
48549534|NCT02910063|156200003|FG000|Phase 2|Withdrawal by Subject|3|||
48549535|NCT02910063|156200004|FG001|Phase 2|Withdrawal by Subject|0|||
48549536|NCT02910063|156200005|FG002|Phase 2|Withdrawal by Subject|0|||
48549537|NCT02910063|156200003|FG000|Phase 2|Lost to Follow-up|1|||
48549538|NCT02910063|156200004|FG001|Phase 2|Lost to Follow-up|0|||
48549539|NCT02910063|156200005|FG002|Phase 2|Lost to Follow-up|0|||
48549540|NCT02910063|156200003|FG000|Phase 2|Death|24|||
48549541|NCT02910063|156200004|FG001|Phase 2|Death|0|||
48549542|NCT02910063|156200005|FG002|Phase 2|Death|0|||
48549543|NCT04988087|156200007|FG000|Overall Study|Adverse Event|4|||
48549544|NCT04988087|156200008|FG001|Overall Study|Adverse Event|0|||
48549545|NCT04988087|156200009|FG002|Overall Study|Adverse Event|0|||
48549546|NCT04988087|156200010|FG003|Overall Study|Adverse Event|0|||
48549547|NCT04988087|156200007|FG000|Overall Study|Withdrawal by Subject|1|||
48549548|NCT04988087|156200008|FG001|Overall Study|Withdrawal by Subject|1|||
48549549|NCT04988087|156200009|FG002|Overall Study|Withdrawal by Subject|0|||
48549550|NCT04988087|156200010|FG003|Overall Study|Withdrawal by Subject|0|||
48549551|NCT04988087|156200007|FG000|Overall Study|Technical problems|7|||
48549552|NCT04988087|156200008|FG001|Overall Study|Technical problems|9|||
48549553|NCT04988087|156200009|FG002|Overall Study|Technical problems|1|||
48549554|NCT04988087|156200010|FG003|Overall Study|Technical problems|2|||
48549555|NCT00323856|156200011|FG000|Overall Study|Withdrawal by Subject|1|||
48549556|NCT00323856|156200011|FG000|Overall Study|Was uncooperative and noncompliant|1|||
48549557|NCT00323856|156200011|FG000|Overall Study|Reason not specified|1|||
48549558|NCT00323856|156200011|FG000|Overall Study|Missing|2|||
48549559|NCT02752087|156200012|FG000|Washout|Physician Decision|1|||
48549560|NCT02752087|156200013|FG001|Washout|Physician Decision|0|||
48549561|NCT00843635|156200014|FG000|Overall Study|Adverse Event|2|||
48549562|NCT00843635|156200015|FG001|Overall Study|Adverse Event|2|||
48549563|NCT00843635|156200016|FG002|Overall Study|Adverse Event|0|||
48549564|NCT03968978|156200017|FG000|Overall Study|Adverse Event|1|||
48549565|NCT03968978|156200018|FG001|Overall Study|Adverse Event|0|||
48549566|NCT03496610|156200019|FG000|Overall Study|Lost to Follow-up|3|||
48549567|NCT03496610|156200020|FG001|Overall Study|Lost to Follow-up|2|||
48549568|NCT03496610|156200019|FG000|Overall Study|Physician Decision|1|||
48549569|NCT03496610|156200020|FG001|Overall Study|Physician Decision|0|||
48549570|NCT03496610|156200019|FG000|Overall Study|Withdrawal by Subject|1|||
48549571|NCT03496610|156200020|FG001|Overall Study|Withdrawal by Subject|0|||
48549572|NCT01292226|156200021|FG000|Overall Study|Adverse Event|5|||
48549573|NCT01292226|156200021|FG000|Overall Study|Death|1|||
48549574|NCT01292226|156200021|FG000|Overall Study|Graft loss|1|||
48549575|NCT01292226|156200021|FG000|Overall Study|Protocol Violation|3|||
48549576|NCT01292226|156200021|FG000|Overall Study|Withdrawal by Subject|1|||
48549577|NCT01292226|156200021|FG000|Overall Study|Other|2|||
48549578|NCT00985491|156200022|FG000|Overall Study|Adverse Event|8|||
48549579|NCT00985491|156200022|FG000|Overall Study|device migration|7|||
48549580|NCT00985491|156200022|FG000|Overall Study|Withdrawal by Subject|1|||
48549581|NCT00985491|156200022|FG000|Overall Study|implant failure|3|||
48549582|NCT04102189|156200024|FG000|Overall Study|Withdrawal by Subject|1|||
48549583|NCT04102189|156200025|FG001|Overall Study|Withdrawal by Subject|2|||
48549584|NCT04102189|156200024|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48549585|NCT04102189|156200025|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48549586|NCT04102189|156200024|FG000|Overall Study|Lost to Follow-up|1|||
48549587|NCT04102189|156200025|FG001|Overall Study|Lost to Follow-up|0|||
48549588|NCT01449812|156200028|FG000|Overall Study|Migrated/moved from study area|1|||
48549589|NCT01449812|156200029|FG001|Overall Study|Migrated/moved from study area|0|||
48549590|NCT01449812|156200030|FG002|Overall Study|Migrated/moved from study area|0|||
48549591|NCT01449812|156200028|FG000|Overall Study|Withdrawal by Subject|0|||
48549592|NCT01449812|156200029|FG001|Overall Study|Withdrawal by Subject|0|||
48549593|NCT01449812|156200030|FG002|Overall Study|Withdrawal by Subject|1|||
48549594|NCT01449812|156200028|FG000|Overall Study|Lost to Follow-up|1|||
48549595|NCT01449812|156200029|FG001|Overall Study|Lost to Follow-up|0|||
48549596|NCT01449812|156200030|FG002|Overall Study|Lost to Follow-up|0|||
48549597|NCT01855828|156200033|FG000|Overall Study|Adverse Event|1|||
48549598|NCT01855828|156200033|FG000|Overall Study|Withdrawal by Subject|1|||
48549599|NCT03568461|156200035|FG000|Overall Study|Death|7|||
48549600|NCT03568461|156200035|FG000|Overall Study|Physician Decision|5|||
48549601|NCT03568461|156200035|FG000|Overall Study|Subject decision|5|||
48549602|NCT03568461|156200035|FG000|Overall Study|Lost to Follow-up|1|||
48549603|NCT01866098|156200036|FG000|Overall Study|Lost to Follow-up|11|||
48549604|NCT01866098|156200037|FG001|Overall Study|Lost to Follow-up|18|||
48549605|NCT01866098|156200038|FG002|Overall Study|Lost to Follow-up|13|||
48549606|NCT01866098|156200036|FG000|Overall Study|Physician Decision|0|||
48549607|NCT01866098|156200037|FG001|Overall Study|Physician Decision|1|||
48549608|NCT01866098|156200038|FG002|Overall Study|Physician Decision|2|||
48549609|NCT01866098|156200036|FG000|Overall Study|Adverse Event|1|||
48549610|NCT01866098|156200037|FG001|Overall Study|Adverse Event|5|||
48549611|NCT01866098|156200038|FG002|Overall Study|Adverse Event|4|||
48549612|NCT01866098|156200036|FG000|Overall Study|Protocol Violation|1|||
48549613|NCT01866098|156200037|FG001|Overall Study|Protocol Violation|0|||
48549614|NCT01866098|156200038|FG002|Overall Study|Protocol Violation|0|||
48549615|NCT01866098|156200036|FG000|Overall Study|Withdrawal by Subject|1|||
48549616|NCT01866098|156200037|FG001|Overall Study|Withdrawal by Subject|2|||
48549617|NCT01866098|156200038|FG002|Overall Study|Withdrawal by Subject|0|||
48549618|NCT01866098|156200036|FG000|Overall Study|Unrelated Hospitalization|2|||
48549619|NCT01866098|156200037|FG001|Overall Study|Unrelated Hospitalization|0|||
48549620|NCT01866098|156200038|FG002|Overall Study|Unrelated Hospitalization|1|||
48549621|NCT01866098|156200036|FG000|Overall Study|Non-compliance|1|||
48549622|NCT01866098|156200037|FG001|Overall Study|Non-compliance|0|||
48549623|NCT01866098|156200038|FG002|Overall Study|Non-compliance|1|||
48549624|NCT01866098|156200036|FG000|Overall Study|Pregnancy|2|||
48549625|NCT01866098|156200037|FG001|Overall Study|Pregnancy|0|||
48549626|NCT01866098|156200038|FG002|Overall Study|Pregnancy|0|||
48549627|NCT01866098|156200036|FG000|Overall Study|Death|0|||
48549628|NCT01866098|156200037|FG001|Overall Study|Death|1|||
48549629|NCT01866098|156200038|FG002|Overall Study|Death|0|||
48549630|NCT01374269|156200043|FG000|Overall Study|Withdrawal by Subject|4|||
48549631|NCT01374269|156200044|FG001|Overall Study|Withdrawal by Subject|0|||
48549632|NCT01374269|156200043|FG000|Overall Study|Lost to Follow-up|1|||
48549633|NCT01374269|156200044|FG001|Overall Study|Lost to Follow-up|3|||
48549634|NCT01374269|156200043|FG000|Overall Study|closed research|1|||
48549635|NCT01374269|156200044|FG001|Overall Study|closed research|2|||
48549636|NCT00143247|156200048|FG000|Overall Study|Death|8|||
48549637|NCT00143247|156200048|FG000|Overall Study|Adverse Event|19|||
48549638|NCT00143247|156200048|FG000|Overall Study|Lack of Efficacy|3|||
48549639|NCT00143247|156200048|FG000|Overall Study|Withdrawal by Subject|55|||
48549640|NCT00143247|156200048|FG000|Overall Study|Study terminated by sponsor|31|||
48549641|NCT00143247|156200048|FG000|Overall Study|Protocol Violation|15|||
48549642|NCT00143247|156200048|FG000|Overall Study|Lost to Follow-up|12|||
48549643|NCT00143247|156200048|FG000|Overall Study|following inaccurate lab adverse event|1|||
48549644|NCT00143247|156200048|FG000|Overall Study|Other|12|||
48549645|NCT04663737|156201756|FG000|Overall Study|Withdrawal by Subject|2|||
48549646|NCT04663737|156201757|FG001|Overall Study|Withdrawal by Subject|0|||
48549647|NCT04516759|156201758|FG000|Overall Study|Withdrawal by Subject|1|||
48549648|NCT04516759|156201759|FG001|Overall Study|Withdrawal by Subject|1|||
48549649|NCT04516759|156201758|FG000|Overall Study|Other|0|||
48549650|NCT04516759|156201759|FG001|Overall Study|Other|1|||
48549651|NCT03700385|156201760|FG000|Overall Study|Lost to Follow-up|1|||
48549652|NCT04241315|156201761|FG000|Overall Study|Withdrawal by Subject|0|||
48549653|NCT04241315|156201762|FG001|Overall Study|Withdrawal by Subject|1|||
48549654|NCT01555671|156201766|FG000|Overall Study|Physician Decision|20|||
48549655|NCT01555671|156201767|FG001|Overall Study|Physician Decision|25|||
48549656|NCT01635283|156201768|FG000|Overall Study|Tumor Progression|3|||
48549657|NCT01635283|156201768|FG000|Overall Study|Lost to Follow-up|1|||
48549658|NCT00372411|156201769|FG000|Overall Study|Withdrawal by Subject|3|||
48549659|NCT00372411|156201770|FG001|Overall Study|Withdrawal by Subject|4|||
48549660|NCT00372411|156201771|FG002|Overall Study|Withdrawal by Subject|1|||
48549661|NCT00372411|156201769|FG000|Overall Study|Death|0|||
48549662|NCT00372411|156201770|FG001|Overall Study|Death|2|||
48549663|NCT00372411|156201771|FG002|Overall Study|Death|1|||
48549664|NCT00372411|156201769|FG000|Overall Study|Lost to Follow-up|1|||
48549665|NCT00372411|156201770|FG001|Overall Study|Lost to Follow-up|1|||
48549666|NCT00372411|156201771|FG002|Overall Study|Lost to Follow-up|1|||
48549667|NCT00372411|156201769|FG000|Overall Study|Adverse Event|1|||
48549668|NCT00372411|156201770|FG001|Overall Study|Adverse Event|1|||
48549669|NCT00372411|156201771|FG002|Overall Study|Adverse Event|0|||
48549670|NCT00699283|156201772|FG000|Overall Study|Lack of Efficacy|15|||
48549671|NCT00699283|156201773|FG001|Overall Study|Lack of Efficacy|5|||
48549672|NCT00699283|156201772|FG000|Overall Study|Lost to Follow-up|2|||
48549673|NCT00699283|156201773|FG001|Overall Study|Lost to Follow-up|0|||
48549674|NCT00699283|156201772|FG000|Overall Study|Withdrawal by Subject|1|||
48549675|NCT00699283|156201773|FG001|Overall Study|Withdrawal by Subject|0|||
48549676|NCT00699283|156201772|FG000|Overall Study|Other Reason|5|||
48549677|NCT00699283|156201773|FG001|Overall Study|Other Reason|1|||
48549678|NCT00699283|156201772|FG000|Overall Study|SAE, non-fatal|1|||
48549679|NCT00699283|156201773|FG001|Overall Study|SAE, non-fatal|1|||
48549680|NCT00699283|156201772|FG000|Overall Study|AE, non-serious non-fatal|8|||
48549681|NCT00699283|156201773|FG001|Overall Study|AE, non-serious non-fatal|1|||
48549682|NCT00699283|156201772|FG000|Overall Study|AE of unknown type|1|||
48549683|NCT00699283|156201773|FG001|Overall Study|AE of unknown type|0|||
48549684|NCT04016662|156201774|FG000|Run-In Phase|Death|1|||
48549685|NCT04016662|156201774|FG000|Run-In Phase|Withdrawal by Subject|11|||
48549686|NCT04016662|156201774|FG000|Run-In Phase|Not meeting screening eligibility|9|||
48549687|NCT04016662|156201774|FG000|Run-In Phase|Physician Decision|3|||
48549688|NCT04016662|156201774|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
48549689|NCT04016662|156201774|FG000|PLGS (12 Weeks)|Death|1|||
48613234|NCT01582451|156439487|FG001|Overall Study|Adverse Event|3|||
48549690|NCT04016662|156201774|FG000|SAP (12 Weeks)|Death|1|||
48549691|NCT00394524|156201776|FG000|Overall Study|Protocol Violation|2|||
48549692|NCT00394524|156201777|FG001|Overall Study|Protocol Violation|3|||
48549693|NCT00394524|156201776|FG000|Overall Study|Death|1|||
48549694|NCT00394524|156201777|FG001|Overall Study|Death|0|||
48549695|NCT00394524|156201776|FG000|Overall Study|Withdrawal by Subject|0|||
48549696|NCT00394524|156201777|FG001|Overall Study|Withdrawal by Subject|1|||
48549697|NCT00282919|156201778|FG000|Overall Study|Lack of Efficacy|4|||
48549698|NCT00282919|156201778|FG000|Overall Study|Withdrawal by Subject|1|||
48549699|NCT00282919|156201778|FG000|Overall Study|Asymptomatic Parasitemia|2|||
48549700|NCT00339144|156201779|FG000|Overall Study|Disease progression|5|||
48549701|NCT00339144|156201780|FG001|Overall Study|Disease progression|2|||
48549702|NCT00339144|156201781|FG002|Overall Study|Disease progression|2|||
48549703|NCT00339144|156201779|FG000|Overall Study|Study drug toxicity|3|||
48549704|NCT00339144|156201780|FG001|Overall Study|Study drug toxicity|1|||
48549705|NCT00339144|156201781|FG002|Overall Study|Study drug toxicity|1|||
48549706|NCT00339144|156201779|FG000|Overall Study|Participant's request to discontinuation|1|||
48549707|NCT00339144|156201780|FG001|Overall Study|Participant's request to discontinuation|0|||
48549708|NCT00339144|156201781|FG002|Overall Study|Participant's request to discontinuation|1|||
48549709|NCT04581369|156201782|FG000|Overall Study|Death|7|||
48549710|NCT04581369|156201783|FG001|Overall Study|Death|6|||
48549711|NCT04581369|156201784|FG002|Overall Study|Death|0|||
48549712|NCT04581369|156201782|FG000|Overall Study|Lost to Follow-up|7|||
48549713|NCT04581369|156201783|FG001|Overall Study|Lost to Follow-up|3|||
48549714|NCT04581369|156201784|FG002|Overall Study|Lost to Follow-up|0|||
48549715|NCT04581369|156201782|FG000|Overall Study|liver transplant|2|||
48549716|NCT04581369|156201783|FG001|Overall Study|liver transplant|2|||
48549717|NCT04581369|156201784|FG002|Overall Study|liver transplant|0|||
48549718|NCT04581369|156201782|FG000|Overall Study|transitioned to hospice care|0|||
48549719|NCT04581369|156201783|FG001|Overall Study|transitioned to hospice care|5|||
48549720|NCT04581369|156201784|FG002|Overall Study|transitioned to hospice care|0|||
48549721|NCT00780910|156201785|FG000|Overall Study|Adverse Event|2|||
48549722|NCT02473523|156201786|FG000|Overall Study|Death|1|||
48549723|NCT02473523|156201786|FG000|Overall Study|Lost to Follow-up|1|||
48549724|NCT01191944|156201793|FG000|Overall Study|Adverse Event|11|||
48549725|NCT01191944|156201794|FG001|Overall Study|Adverse Event|12|||
48549726|NCT01191944|156201793|FG000|Overall Study|Protocol Violation|1|||
48549727|NCT01191944|156201794|FG001|Overall Study|Protocol Violation|2|||
48549728|NCT01191944|156201793|FG000|Overall Study|Withdrawal by Subject|4|||
48549729|NCT01191944|156201794|FG001|Overall Study|Withdrawal by Subject|2|||
48549730|NCT01191944|156201793|FG000|Overall Study|Other|1|||
48549731|NCT01191944|156201794|FG001|Overall Study|Other|3|||
48549732|NCT04914676|156201795|FG000|Overall Study|Study termination|3|||
48549733|NCT04914676|156201796|FG001|Overall Study|Study termination|0|||
48549734|NCT04040192|156201799|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
48549735|NCT04040192|156201800|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
48549736|NCT04040192|156201801|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
48549737|NCT04040192|156201799|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
48549738|NCT04040192|156201800|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
48549739|NCT04040192|156201801|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
48549740|NCT04040192|156201799|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
48549741|NCT04040192|156201800|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
48549742|NCT04040192|156201801|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
48549743|NCT04040192|156201799|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
48549744|NCT04040192|156201800|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
48549745|NCT04040192|156201801|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
48549746|NCT04040192|156201799|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
48549747|NCT04040192|156201800|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
48549748|NCT04040192|156201801|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
48549749|NCT04040192|156201799|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
48549750|NCT04040192|156201800|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
48549751|NCT04040192|156201801|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
48549752|NCT04040192|156201799|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
48549753|NCT04040192|156201800|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
48549754|NCT04040192|156201801|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
48549755|NCT04040192|156201799|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
48549756|NCT04040192|156201800|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
48549757|NCT04040192|156201801|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
48549758|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
48549759|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
48549760|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
48549761|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
48549762|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
48549763|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
48549764|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
48549765|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
48549766|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
48549767|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
48549768|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
48549769|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
48549770|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
48549771|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
48549772|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
48549773|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
48549774|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
48549775|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
48549776|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
48549777|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
48549778|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
48549779|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
48549780|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
48549781|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
48549782|NCT04040192|156201799|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
48549783|NCT04040192|156201800|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
48549784|NCT04040192|156201801|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
48549785|NCT03207243|156201804|FG000|Overall Study|Adverse Event|2|||
48549786|NCT03207243|156201805|FG001|Overall Study|Adverse Event|2|||
48549787|NCT03207243|156201804|FG000|Overall Study|Loss of Asthma Control|47|||
48613235|NCT01582451|156439486|FG000|Overall Study|Death|3|||
48613236|NCT01582451|156439487|FG001|Overall Study|Death|3|||
48613237|NCT01582451|156439486|FG000|Overall Study|Lost to Follow-up|0|||
48613238|NCT01582451|156439487|FG001|Overall Study|Lost to Follow-up|2|||
48613239|NCT01582451|156439486|FG000|Overall Study|Protocol Violation|11|||
48613240|NCT01582451|156439487|FG001|Overall Study|Protocol Violation|3|||
48613241|NCT01582451|156439486|FG000|Overall Study|Withdrawal by Subject|13|||
48613242|NCT01582451|156439487|FG001|Overall Study|Withdrawal by Subject|9|||
48613243|NCT01582451|156439486|FG000|Overall Study|Physician Decision|3|||
48613244|NCT01582451|156439487|FG001|Overall Study|Physician Decision|0|||
48613245|NCT01582451|156439486|FG000|Overall Study|Sponsor Decision|1|||
48613246|NCT01582451|156439487|FG001|Overall Study|Sponsor Decision|0|||
48613247|NCT02178956|156439497|FG000|Overall Study|Lost to Follow-up|4|||
48613248|NCT02178956|156439498|FG001|Overall Study|Lost to Follow-up|4|||
48613249|NCT02178956|156439497|FG000|Overall Study|Sponsor terminated study|49|||
48613250|NCT02178956|156439498|FG001|Overall Study|Sponsor terminated study|58|||
48613251|NCT02178956|156439497|FG000|Overall Study|Withdrawal by Subject|15|||
48613252|NCT02178956|156439498|FG001|Overall Study|Withdrawal by Subject|11|||
48613253|NCT02178956|156439497|FG000|Overall Study|Various Reasons|3|||
48613254|NCT02178956|156439498|FG001|Overall Study|Various Reasons|5|||
48613255|NCT02989389|156439501|FG000|Period 1|Lost to Follow-up|0|||
48549788|NCT03207243|156201805|FG001|Overall Study|Loss of Asthma Control|31|||
48549789|NCT03207243|156201804|FG000|Overall Study|Withdrawal by Subject|2|||
48549790|NCT03207243|156201805|FG001|Overall Study|Withdrawal by Subject|4|||
48549791|NCT03207243|156201804|FG000|Overall Study|Physician Decision|1|||
48549792|NCT03207243|156201805|FG001|Overall Study|Physician Decision|1|||
48549793|NCT03207243|156201804|FG000|Overall Study|Lost to Follow-up|0|||
48549794|NCT03207243|156201805|FG001|Overall Study|Lost to Follow-up|1|||
48549795|NCT03207243|156201804|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
48549796|NCT03207243|156201805|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
48549797|NCT03207243|156201804|FG000|Overall Study|Protocol Violation|0|||
48549798|NCT03207243|156201805|FG001|Overall Study|Protocol Violation|3|||
48549799|NCT04024813|156201815|FG000|Overall Study|Study terminated by Sponsor|1|||
48549800|NCT02552303|156201820|FG000|Allocation|Withdrawal by Subject|2|||
48549801|NCT02552303|156201821|FG001|Allocation|Withdrawal by Subject|1|||
48549802|NCT02552303|156201822|FG002|Allocation|Withdrawal by Subject|1|||
48549803|NCT02552303|156201823|FG003|Allocation|Withdrawal by Subject|1|||
48549804|NCT02552303|156201820|FG000|Allocation|ineligible|1|||
48549805|NCT02552303|156201821|FG001|Allocation|ineligible|1|||
48549806|NCT02552303|156201822|FG002|Allocation|ineligible|0|||
48549807|NCT02552303|156201823|FG003|Allocation|ineligible|0|||
48549808|NCT02552303|156201820|FG000|Follow-Up|Lost to Follow-up|0|||
48549809|NCT02552303|156201821|FG001|Follow-Up|Lost to Follow-up|0|||
48549810|NCT02552303|156201822|FG002|Follow-Up|Lost to Follow-up|1|||
48549811|NCT02552303|156201823|FG003|Follow-Up|Lost to Follow-up|0|||
48549812|NCT02552303|156201820|FG000|Follow-Up|ineligible|0|||
48613256|NCT02989389|156439502|FG001|Period 1|Lost to Follow-up|1|||
48613257|NCT02989389|156439503|FG002|Period 1|Lost to Follow-up|0|||
48613258|NCT02989389|156439504|FG003|Period 1|Lost to Follow-up|0|||
48613259|NCT02989389|156439505|FG004|Period 1|Lost to Follow-up|0|||
48613260|NCT02989389|156439506|FG005|Period 1|Lost to Follow-up|0|||
48549813|NCT02552303|156201821|FG001|Follow-Up|ineligible|2|||
48613261|NCT02989389|156439507|FG006|Period 1|Lost to Follow-up|0|||
48549814|NCT02552303|156201822|FG002|Follow-Up|ineligible|0|||
48549815|NCT02552303|156201823|FG003|Follow-Up|ineligible|0|||
48549816|NCT02695537|156201826|FG000|Overall Study|Adverse Event|3|||
48549817|NCT02695537|156201826|FG000|Overall Study|Lack of Efficacy|28|||
48549818|NCT02695537|156201826|FG000|Overall Study|Withdrawal by Subject|4|||
48549819|NCT02695537|156201826|FG000|Overall Study|Protocol Violation|3|||
48549820|NCT04602546|156201829|FG000|Overall Study|Training|2|||
48549821|NCT04602546|156201830|FG001|Overall Study|Training|2|||
48549822|NCT04602546|156201831|FG002|Overall Study|Training|1|||
48549823|NCT04602546|156201832|FG003|Overall Study|Training|2|||
48549824|NCT04602546|156201833|FG004|Overall Study|Training|0|||
48549825|NCT04602546|156201829|FG000|Overall Study|Randomized with disqualified data|2|||
48549826|NCT04602546|156201830|FG001|Overall Study|Randomized with disqualified data|0|||
48549827|NCT04602546|156201831|FG002|Overall Study|Randomized with disqualified data|2|||
48549828|NCT04602546|156201832|FG003|Overall Study|Randomized with disqualified data|5|||
48549829|NCT04602546|156201833|FG004|Overall Study|Randomized with disqualified data|3|||
48549830|NCT02794246|156201834|FG000|Overall Study|Withdrawal by Subject|2|||
48549831|NCT02794246|156201834|FG000|Overall Study|Physician Decision|4|||
48549832|NCT04501614|156201837|FG000|Overall Study|Study Terminated by Sponsor|6|||
48549833|NCT04501614|156201838|FG001|Overall Study|Study Terminated by Sponsor|3|||
48549834|NCT04501614|156201837|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
48549835|NCT04501614|156201838|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
48549836|NCT04015908|156201839|FG000|Overall Study|Lost to Follow-up|0|||
48549837|NCT04015908|156201840|FG001|Overall Study|Lost to Follow-up|1|||
48549838|NCT01547130|156201847|FG000|Overall Study|Lost to Follow-up|9|||
48549839|NCT01547130|156201848|FG001|Overall Study|Lost to Follow-up|5|||
48549840|NCT02714426|156201852|FG000|Overall Study|Withdrawal by Subject|2|||
48549841|NCT02714426|156201853|FG001|Overall Study|Withdrawal by Subject|2|||
48549842|NCT05524116|156201854|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
48549843|NCT05524116|156201855|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
48549844|NCT05524116|156201854|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
48549845|NCT05524116|156201855|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
48549846|NCT05524116|156201854|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
48549847|NCT05524116|156201855|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
48549848|NCT05524116|156201854|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
48549849|NCT05524116|156201855|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
48549850|NCT05524116|156201854|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
48613262|NCT02989389|156439508|FG007|Period 1|Lost to Follow-up|0|||
48613263|NCT02989389|156439509|FG008|Period 1|Lost to Follow-up|0|||
48549851|NCT05524116|156201855|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
48549852|NCT04435184|156201856|FG000|Overall Study|follow-up blood draws missing|3|||
48549853|NCT04435184|156201857|FG001|Overall Study|follow-up blood draws missing|5|||
48549854|NCT02068092|156201861|FG000|Overall Study|Physician Decision|2|||
48549855|NCT02068092|156201861|FG000|Overall Study|Adverse Event|2|||
48613264|NCT02989389|156439510|FG009|Period 1|Lost to Follow-up|0|||
48613265|NCT02989389|156439501|FG000|Period 1|Physician Decision|0|||
48613266|NCT02989389|156439502|FG001|Period 1|Physician Decision|0|||
48613267|NCT02989389|156439503|FG002|Period 1|Physician Decision|0|||
48613268|NCT02989389|156439504|FG003|Period 1|Physician Decision|0|||
48613269|NCT02989389|156439505|FG004|Period 1|Physician Decision|0|||
48613270|NCT02989389|156439506|FG005|Period 1|Physician Decision|0|||
48613271|NCT02989389|156439507|FG006|Period 1|Physician Decision|0|||
48613272|NCT02989389|156439508|FG007|Period 1|Physician Decision|0|||
48613273|NCT02989389|156439509|FG008|Period 1|Physician Decision|1|||
48613274|NCT02989389|156439510|FG009|Period 1|Physician Decision|0|||
48613275|NCT04615507|156439513|FG000|Period 1|Covid-19 exposure|2|||
48613276|NCT04615507|156439514|FG001|Period 1|Covid-19 exposure|1|||
48613277|NCT04615507|156439513|FG000|Period 2|Covid-19 exposure|0|||
48613278|NCT04615507|156439514|FG001|Period 2|Covid-19 exposure|1|||
48613279|NCT04615507|156439513|FG000|Period 2|Protocol Violation|1|||
48613280|NCT04615507|156439514|FG001|Period 2|Protocol Violation|0|||
48613281|NCT04615507|156439513|FG000|Period 2|Withdrawal by Subject|1|||
48613282|NCT04615507|156439514|FG001|Period 2|Withdrawal by Subject|0|||
48613283|NCT04615507|156439513|FG000|Period 2|Adverse Event|0|||
48613284|NCT04615507|156439514|FG001|Period 2|Adverse Event|1|||
48613285|NCT04615507|156439513|FG000|Period 3|Covid-19 exposure|0|||
48613286|NCT04615507|156439514|FG001|Period 3|Covid-19 exposure|1|||
48613287|NCT00699751|156439515|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
48613288|NCT00699751|156439516|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
48613289|NCT00699751|156439515|FG000|Period 1: Without/Before Drug Switch|Death|28|||
48549856|NCT02068092|156201861|FG000|Overall Study|Lost to Follow-up|4|||
48549857|NCT02068092|156201861|FG000|Overall Study|Withdrawal by Subject|2|||
48549858|NCT03548337|156201862|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
48613290|NCT00699751|156439516|FG001|Period 1: Without/Before Drug Switch|Death|29|||
48613291|NCT00699751|156439515|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
48613292|NCT00699751|156439516|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
48549859|NCT03548337|156201863|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
48549860|NCT03548337|156201862|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
48549861|NCT03548337|156201863|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
48549862|NCT03548337|156201862|FG000|Infant Series|Lost to Follow-up|2|||
48549863|NCT03548337|156201863|FG001|Infant Series|Lost to Follow-up|1|||
48549864|NCT03548337|156201862|FG000|Infant Series|Adverse Event|0|||
48549865|NCT03548337|156201863|FG001|Infant Series|Adverse Event|2|||
48549866|NCT03548337|156201862|FG000|Infant Series|Randomized but Not Vaccinated|1|||
48549867|NCT03548337|156201863|FG001|Infant Series|Randomized but Not Vaccinated|0|||
48549868|NCT03548337|156201862|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
48549869|NCT03548337|156201863|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
48549870|NCT01893346|156201864|FG000|Overall Study|Lost to Follow-up|0|||
48549871|NCT01893346|156201865|FG001|Overall Study|Lost to Follow-up|1|||
48549872|NCT01893346|156201866|FG002|Overall Study|Lost to Follow-up|0|||
48549873|NCT01893346|156201867|FG003|Overall Study|Lost to Follow-up|0|||
48549874|NCT01893346|156201864|FG000|Overall Study|Protocol Violation|1|||
48549875|NCT01893346|156201865|FG001|Overall Study|Protocol Violation|0|||
48549876|NCT01893346|156201866|FG002|Overall Study|Protocol Violation|0|||
48549877|NCT01893346|156201867|FG003|Overall Study|Protocol Violation|0|||
48549878|NCT01893346|156201864|FG000|Overall Study|Withdrawal by Subject|2|||
48549879|NCT01893346|156201865|FG001|Overall Study|Withdrawal by Subject|0|||
48549880|NCT01893346|156201866|FG002|Overall Study|Withdrawal by Subject|0|||
48549881|NCT01893346|156201867|FG003|Overall Study|Withdrawal by Subject|0|||
48549882|NCT04239027|156201875|FG000|Overall Study|Adverse Event|4|||
48549883|NCT04239027|156201875|FG000|Overall Study|Withdrawal by Subject|9|||
48549884|NCT04239027|156201875|FG000|Overall Study|Death|1|||
48549885|NCT04239027|156201875|FG000|Overall Study|Physician Decision|9|||
48549886|NCT04239027|156201875|FG000|Overall Study|Lost to Follow-up|2|||
48549887|NCT04239027|156201875|FG000|Overall Study|Lack of Efficacy|1|||
48549888|NCT02500576|156201876|FG000|Overall Study|Adverse Event|0|||
48549889|NCT02500576|156201877|FG001|Overall Study|Adverse Event|1|||
48549890|NCT02500576|156201876|FG000|Overall Study|Death|2|||
48549891|NCT02500576|156201877|FG001|Overall Study|Death|1|||
48613293|NCT00699751|156439515|FG000|Period 1: Without/Before Drug Switch|Other|30|||
48613294|NCT00699751|156439516|FG001|Period 1: Without/Before Drug Switch|Other|20|||
48549892|NCT02500576|156201876|FG000|Overall Study|Lack of Efficacy|5|||
48549893|NCT02500576|156201877|FG001|Overall Study|Lack of Efficacy|5|||
48549894|NCT02500576|156201876|FG000|Overall Study|Withdrawal by Subject|1|||
48549895|NCT02500576|156201877|FG001|Overall Study|Withdrawal by Subject|1|||
48549896|NCT02517463|156201878|FG000|Overall Study|Lost to Follow-up|5|||
48549897|NCT02517463|156201879|FG001|Overall Study|Lost to Follow-up|2|||
48549898|NCT03510598|156201888|FG000|Overall Study|Withdrawal by Subject|1|||
48549899|NCT02307682|156201889|FG000|Overall Study|Adverse Event|9|||
48549900|NCT02307682|156201890|FG001|Overall Study|Adverse Event|8|||
48549901|NCT02307682|156201891|FG002|Overall Study|Adverse Event|12|||
48549902|NCT02307682|156201889|FG000|Overall Study|Lack of Efficacy|1|||
48549903|NCT02307682|156201890|FG001|Overall Study|Lack of Efficacy|0|||
48549904|NCT02307682|156201891|FG002|Overall Study|Lack of Efficacy|1|||
48549905|NCT02307682|156201889|FG000|Overall Study|Physician Decision|2|||
48549906|NCT02307682|156201890|FG001|Overall Study|Physician Decision|2|||
48549907|NCT02307682|156201891|FG002|Overall Study|Physician Decision|8|||
48549908|NCT02307682|156201889|FG000|Overall Study|Progressive Disease|1|||
48549909|NCT02307682|156201890|FG001|Overall Study|Progressive Disease|0|||
48549910|NCT02307682|156201891|FG002|Overall Study|Progressive Disease|0|||
48549911|NCT02307682|156201889|FG000|Overall Study|Withdrawal by Subject|26|||
48549912|NCT02307682|156201890|FG001|Overall Study|Withdrawal by Subject|34|||
48549913|NCT02307682|156201891|FG002|Overall Study|Withdrawal by Subject|23|||
48613295|NCT00699751|156439515|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
48613296|NCT00699751|156439516|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
48549914|NCT02307682|156201889|FG000|Overall Study|Death|9|||
48549915|NCT02307682|156201890|FG001|Overall Study|Death|7|||
48549916|NCT02307682|156201891|FG002|Overall Study|Death|12|||
48549917|NCT02307682|156201889|FG000|Overall Study|Lost to Follow-up|1|||
48549918|NCT02307682|156201890|FG001|Overall Study|Lost to Follow-up|5|||
48549919|NCT02307682|156201891|FG002|Overall Study|Lost to Follow-up|6|||
48549920|NCT02307682|156201889|FG000|Overall Study|Protocol Deviation|0|||
48549921|NCT02307682|156201890|FG001|Overall Study|Protocol Deviation|0|||
48549922|NCT02307682|156201891|FG002|Overall Study|Protocol Deviation|2|||
48549923|NCT02307682|156201889|FG000|Overall Study|Other|1|||
48549924|NCT02307682|156201890|FG001|Overall Study|Other|1|||
48549925|NCT02307682|156201891|FG002|Overall Study|Other|0|||
48549926|NCT01184079|156201895|FG000|Overall Study|Lost to Follow-up|14|||
48549927|NCT01184079|156201896|FG001|Overall Study|Lost to Follow-up|2|||
48549928|NCT03999749|156201897|FG000|Overall Study|Toxicity|16|||
48549929|NCT03999749|156201897|FG000|Overall Study|Withdrawal by Subject|3|||
48549930|NCT03999749|156201897|FG000|Overall Study|Disease progression|26|||
48549931|NCT03999749|156201897|FG000|Overall Study|Physician Decision|4|||
48549932|NCT03999749|156201897|FG000|Overall Study|Death|5|||
48549933|NCT03999749|156201897|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
48549934|NCT00340678|156201898|FG000|Overall Study|Lost to Follow-up|1|||
48549935|NCT00340678|156201899|FG001|Overall Study|Lost to Follow-up|0|||
48549936|NCT00340678|156201900|FG002|Overall Study|Lost to Follow-up|0|||
48549937|NCT00340678|156201901|FG003|Overall Study|Lost to Follow-up|0|||
48549938|NCT02766283|156201903|FG000|Overall Study|Lost to Follow-up|27|||
48549939|NCT01590277|156201904|FG000|Overall Study|Withdrawal by Subject|3|||
48549940|NCT01590277|156201904|FG000|Overall Study|Withdrawal by Subject|2|||
48549941|NCT01590277|156201904|FG000|Overall Study|Withdrawal by Subject|1|||
48549942|NCT01590277|156201904|FG000|Overall Study|Withdrawal by Subject|1|||
48549943|NCT01377012|156201905|FG000|Core Study|Study terminated by Sponsor|47|||
48549944|NCT01377012|156201906|FG001|Core Study|Study terminated by Sponsor|54|||
48549945|NCT01377012|156201907|FG002|Core Study|Study terminated by Sponsor|46|||
48549946|NCT01377012|156201905|FG000|Core Study|Technical problems|1|||
48549947|NCT01377012|156201906|FG001|Core Study|Technical problems|0|||
48549948|NCT01377012|156201907|FG002|Core Study|Technical problems|0|||
48549949|NCT01377012|156201905|FG000|Core Study|Withdrawal by Subject|15|||
48549950|NCT01377012|156201906|FG001|Core Study|Withdrawal by Subject|23|||
48549951|NCT01377012|156201907|FG002|Core Study|Withdrawal by Subject|18|||
48549952|NCT01377012|156201905|FG000|Core Study|Protocol Violation|7|||
48549953|NCT01377012|156201906|FG001|Core Study|Protocol Violation|3|||
48549954|NCT01377012|156201907|FG002|Core Study|Protocol Violation|2|||
48549955|NCT01377012|156201905|FG000|Core Study|Pregnancy|0|||
48549956|NCT01377012|156201906|FG001|Core Study|Pregnancy|0|||
48549957|NCT01377012|156201907|FG002|Core Study|Pregnancy|1|||
48549958|NCT01377012|156201905|FG000|Core Study|Physician Decision|5|||
48549959|NCT01377012|156201906|FG001|Core Study|Physician Decision|4|||
48549960|NCT01377012|156201907|FG002|Core Study|Physician Decision|10|||
48549961|NCT01377012|156201905|FG000|Core Study|Non-Compliant with study treatment|0|||
48549962|NCT01377012|156201906|FG001|Core Study|Non-Compliant with study treatment|0|||
48549963|NCT01377012|156201907|FG002|Core Study|Non-Compliant with study treatment|1|||
48549964|NCT01377012|156201905|FG000|Core Study|No Longer require treatment|0|||
48549965|NCT01377012|156201906|FG001|Core Study|No Longer require treatment|0|||
48549966|NCT01377012|156201907|FG002|Core Study|No Longer require treatment|1|||
48549967|NCT01377012|156201905|FG000|Core Study|Lost to Follow-up|7|||
48549968|NCT01377012|156201906|FG001|Core Study|Lost to Follow-up|5|||
48549969|NCT01377012|156201907|FG002|Core Study|Lost to Follow-up|4|||
48549970|NCT01377012|156201905|FG000|Core Study|Lack of Efficacy|41|||
48549971|NCT01377012|156201906|FG001|Core Study|Lack of Efficacy|28|||
48549972|NCT01377012|156201907|FG002|Core Study|Lack of Efficacy|37|||
48549973|NCT01377012|156201905|FG000|Core Study|Death|1|||
48549974|NCT01377012|156201906|FG001|Core Study|Death|1|||
48549975|NCT01377012|156201907|FG002|Core Study|Death|1|||
48549976|NCT01377012|156201905|FG000|Core Study|Adverse Event|10|||
48549977|NCT01377012|156201906|FG001|Core Study|Adverse Event|14|||
48549978|NCT01377012|156201907|FG002|Core Study|Adverse Event|13|||
48549979|NCT01377012|156201905|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
48549980|NCT01377012|156201906|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
48549981|NCT01377012|156201907|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
48549982|NCT01377012|156201905|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
48549983|NCT01377012|156201906|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
48549984|NCT01377012|156201907|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
48549985|NCT01377012|156201905|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
48549986|NCT01377012|156201906|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
48549987|NCT01377012|156201907|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
48549988|NCT01377012|156201905|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
48549989|NCT01377012|156201906|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
48549990|NCT01377012|156201907|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
48549991|NCT01377012|156201905|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
48549992|NCT01377012|156201906|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
48549993|NCT01377012|156201907|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
48549994|NCT01377012|156201905|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
48549995|NCT01377012|156201906|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
48549996|NCT01377012|156201907|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
48549997|NCT01589497|156203294|FG000|Overall Study|Withdrawal by Subject|0|||
48549998|NCT01589497|156203295|FG001|Overall Study|Withdrawal by Subject|1|||
48549999|NCT01589497|156203296|FG002|Overall Study|Withdrawal by Subject|0|||
48550000|NCT01589497|156203297|FG003|Overall Study|Withdrawal by Subject|1|||
48550001|NCT01589497|156203294|FG000|Overall Study|Death|1|||
48550002|NCT01589497|156203295|FG001|Overall Study|Death|0|||
48550003|NCT01589497|156203296|FG002|Overall Study|Death|0|||
48550004|NCT01589497|156203297|FG003|Overall Study|Death|0|||
48550005|NCT01589497|156203294|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
48550006|NCT01589497|156203295|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
48550007|NCT01589497|156203296|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
48550008|NCT01589497|156203297|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
48550009|NCT03696953|156203298|FG000|Overall Study|Withdrawal by Subject|6|||
48550010|NCT03696953|156203299|FG001|Overall Study|Withdrawal by Subject|1|||
48550011|NCT03696953|156203298|FG000|Overall Study|missed GBS swabs|2|||
48550012|NCT03696953|156203299|FG001|Overall Study|missed GBS swabs|2|||
48550013|NCT03696953|156203298|FG000|Overall Study|lost study bottle containing capsules|2|||
48550014|NCT03696953|156203299|FG001|Overall Study|lost study bottle containing capsules|0|||
48550015|NCT03696953|156203298|FG000|Overall Study|Premature birth|1|||
48550016|NCT03696953|156203299|FG001|Overall Study|Premature birth|4|||
48550017|NCT03696953|156203298|FG000|Overall Study|Gestational hypertension|1|||
48550018|NCT03696953|156203299|FG001|Overall Study|Gestational hypertension|1|||
48550019|NCT03696953|156203298|FG000|Overall Study|Gestational diabetes|2|||
48550020|NCT03696953|156203299|FG001|Overall Study|Gestational diabetes|1|||
48550021|NCT03696953|156203298|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
48550022|NCT03696953|156203299|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
48550023|NCT03696953|156203298|FG000|Overall Study|Changed prenatal provider|1|||
48550024|NCT03696953|156203299|FG001|Overall Study|Changed prenatal provider|1|||
48550025|NCT03047330|156203303|FG000|Sleep Block 1|Withdrawal by Subject|3|||
48550026|NCT04590040|156203309|FG000|Treatment Period|Lost to Follow-up|2|||
48613297|NCT00699751|156439515|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
48613298|NCT00699751|156439516|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
48613299|NCT00699751|156439515|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
48613300|NCT00699751|156439516|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
48613301|NCT00699751|156439515|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
48613302|NCT00699751|156439516|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
48613303|NCT01947933|156439517|FG000|Overall Study|Withdrawal by Subject|0|||
48613304|NCT01947933|156439518|FG001|Overall Study|Withdrawal by Subject|0|||
48613305|NCT01947933|156439519|FG002|Overall Study|Withdrawal by Subject|1|||
48613306|NCT01947933|156439520|FG003|Overall Study|Withdrawal by Subject|0|||
48550027|NCT04590040|156203310|FG001|Treatment Period|Lost to Follow-up|5|||
48550028|NCT04590040|156203311|FG002|Treatment Period|Lost to Follow-up|0|||
48550029|NCT04590040|156203309|FG000|Treatment Period|Physician Decision|0|||
48550030|NCT04590040|156203310|FG001|Treatment Period|Physician Decision|0|||
48613307|NCT01947933|156439521|FG004|Overall Study|Withdrawal by Subject|0|||
48613308|NCT01947933|156439522|FG005|Overall Study|Withdrawal by Subject|0|||
48613309|NCT01947933|156439523|FG006|Overall Study|Withdrawal by Subject|0|||
48613310|NCT01947933|156439524|FG007|Overall Study|Withdrawal by Subject|0|||
48613311|NCT01947933|156439525|FG008|Overall Study|Withdrawal by Subject|0|||
48613312|NCT01947933|156439517|FG000|Overall Study|Lost to Follow-up|0|||
48613313|NCT01947933|156439518|FG001|Overall Study|Lost to Follow-up|0|||
48613314|NCT01947933|156439519|FG002|Overall Study|Lost to Follow-up|0|||
48613315|NCT01947933|156439520|FG003|Overall Study|Lost to Follow-up|0|||
48613316|NCT01947933|156439521|FG004|Overall Study|Lost to Follow-up|0|||
48613317|NCT01947933|156439522|FG005|Overall Study|Lost to Follow-up|0|||
48613318|NCT01947933|156439523|FG006|Overall Study|Lost to Follow-up|0|||
48613319|NCT01947933|156439524|FG007|Overall Study|Lost to Follow-up|0|||
48613320|NCT01947933|156439525|FG008|Overall Study|Lost to Follow-up|1|||
48613321|NCT00831844|156439526|FG000|Overall Study|Adverse Event|2|||
48613322|NCT00831844|156439527|FG001|Overall Study|Adverse Event|0|||
48613323|NCT00831844|156439528|FG002|Overall Study|Adverse Event|0|||
48613324|NCT00831844|156439529|FG003|Overall Study|Adverse Event|0|||
48613325|NCT00831844|156439530|FG004|Overall Study|Adverse Event|1|||
48613326|NCT00831844|156439531|FG005|Overall Study|Adverse Event|1|||
48613327|NCT00831844|156439532|FG006|Overall Study|Adverse Event|2|||
48550031|NCT04590040|156203311|FG002|Treatment Period|Physician Decision|2|||
48550032|NCT01398514|156203314|FG000|Overall Study|Adverse Event|1|||
48613328|NCT00831844|156439533|FG007|Overall Study|Adverse Event|0|||
48613329|NCT00831844|156439534|FG008|Overall Study|Adverse Event|0|||
48613330|NCT00831844|156439535|FG009|Overall Study|Adverse Event|0|||
48613331|NCT00831844|156439526|FG000|Overall Study|Death|0|||
48613332|NCT00831844|156439527|FG001|Overall Study|Death|0|||
48550033|NCT01398514|156203315|FG001|Overall Study|Adverse Event|0|||
48550034|NCT01398514|156203314|FG000|Overall Study|Non-compliance with study procedures|2|||
48550035|NCT01398514|156203315|FG001|Overall Study|Non-compliance with study procedures|0|||
48550036|NCT01398514|156203314|FG000|Overall Study|Physiologic non-responsiveness|1|||
48613333|NCT00831844|156439528|FG002|Overall Study|Death|0|||
48613334|NCT00831844|156439529|FG003|Overall Study|Death|1|||
48613335|NCT00831844|156439530|FG004|Overall Study|Death|0|||
48613336|NCT00831844|156439531|FG005|Overall Study|Death|0|||
48613337|NCT00831844|156439532|FG006|Overall Study|Death|0|||
48550037|NCT01398514|156203315|FG001|Overall Study|Physiologic non-responsiveness|3|||
48550038|NCT01398514|156203314|FG000|Overall Study|Failure to show a conditioned response|4|||
48550039|NCT01398514|156203315|FG001|Overall Study|Failure to show a conditioned response|3|||
48550040|NCT00000378|156203319|FG000|Overall Study|Lack of Efficacy|16|||
48550041|NCT00000378|156203320|FG001|Overall Study|Lack of Efficacy|14|||
48550042|NCT04746794|156203325|FG000|Overall Study|Did not complete any study assessment|50303|||
48550043|NCT04746794|156203326|FG001|Overall Study|Did not complete any study assessment|44997|||
48550044|NCT02954991|156203327|FG000|Overall Study|Death|92|||
48550045|NCT02954991|156203328|FG001|Overall Study|Death|11|||
48550046|NCT02954991|156203329|FG002|Overall Study|Death|2|||
48613338|NCT00831844|156439533|FG007|Overall Study|Death|0|||
48613339|NCT00831844|156439534|FG008|Overall Study|Death|0|||
48550047|NCT02954991|156203327|FG000|Overall Study|Lost to Follow-up|3|||
48550048|NCT02954991|156203328|FG001|Overall Study|Lost to Follow-up|2|||
48550049|NCT02954991|156203329|FG002|Overall Study|Lost to Follow-up|0|||
48550050|NCT02954991|156203327|FG000|Overall Study|Withdrawal by Subject|9|||
48550051|NCT02954991|156203328|FG001|Overall Study|Withdrawal by Subject|8|||
48550052|NCT02954991|156203329|FG002|Overall Study|Withdrawal by Subject|1|||
48550053|NCT02954991|156203327|FG000|Overall Study|Study Terminated by Sponsor|18|||
48550054|NCT02954991|156203328|FG001|Overall Study|Study Terminated by Sponsor|10|||
48550055|NCT02954991|156203329|FG002|Overall Study|Study Terminated by Sponsor|1|||
48550056|NCT02954991|156203327|FG000|Overall Study|Miscellaneous|2|||
48550057|NCT02954991|156203328|FG001|Overall Study|Miscellaneous|1|||
48550058|NCT02954991|156203329|FG002|Overall Study|Miscellaneous|1|||
48550059|NCT02838420|156203330|FG000|Overall Study|Ongoing in Study|113|||
48550060|NCT02838420|156203331|FG001|Overall Study|Ongoing in Study|45|||
48550061|NCT02838420|156203330|FG000|Overall Study|Lost to Follow-up|1|||
48550062|NCT02838420|156203331|FG001|Overall Study|Lost to Follow-up|0|||
48550063|NCT02838420|156203330|FG000|Overall Study|Withdrawal by Subject|3|||
48550064|NCT02838420|156203331|FG001|Overall Study|Withdrawal by Subject|4|||
48550065|NCT02838420|156203330|FG000|Overall Study|Death|8|||
48550066|NCT02838420|156203331|FG001|Overall Study|Death|13|||
48550067|NCT00576316|156203332|FG000|Overall Study|Adverse Event|9|||
48550068|NCT00576316|156203332|FG000|Overall Study|Withdrawal by Subject|2|||
48550069|NCT00576316|156203332|FG000|Overall Study|Protocol Violation|9|||
48550070|NCT01422187|156203333|FG000|Overall Study|Personal reason|1|||
48550071|NCT01422187|156203334|FG001|Overall Study|Personal reason|0|||
48550072|NCT01422187|156203335|FG002|Overall Study|Personal reason|0|||
48550073|NCT01422187|156203333|FG000|Overall Study|Lost to Follow-up|0|||
48550074|NCT01422187|156203334|FG001|Overall Study|Lost to Follow-up|1|||
48550075|NCT01422187|156203335|FG002|Overall Study|Lost to Follow-up|0|||
48550076|NCT01377987|156203336|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
48550077|NCT01377987|156203337|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
48550078|NCT00168818|156203338|FG000|Overall Study|Adverse Event|23|||
48550079|NCT00168818|156203339|FG001|Overall Study|Adverse Event|29|||
48550080|NCT00168818|156203340|FG002|Overall Study|Adverse Event|31|||
48550081|NCT00168818|156203338|FG000|Overall Study|Protocol Violation|16|||
48550082|NCT00168818|156203339|FG001|Overall Study|Protocol Violation|11|||
48550083|NCT00168818|156203340|FG002|Overall Study|Protocol Violation|11|||
48550084|NCT00168818|156203338|FG000|Overall Study|Lost to Follow-up|13|||
48550085|NCT00168818|156203339|FG001|Overall Study|Lost to Follow-up|4|||
48550086|NCT00168818|156203340|FG002|Overall Study|Lost to Follow-up|15|||
48550087|NCT00168818|156203338|FG000|Overall Study|Withdrawal by Subject|43|||
48550088|NCT00168818|156203339|FG001|Overall Study|Withdrawal by Subject|41|||
48550089|NCT00168818|156203340|FG002|Overall Study|Withdrawal by Subject|37|||
48550090|NCT00168818|156203338|FG000|Overall Study|Other|22|||
48550091|NCT00168818|156203339|FG001|Overall Study|Other|24|||
48550092|NCT00168818|156203340|FG002|Overall Study|Other|30|||
48550093|NCT00168818|156203338|FG000|Treatment|Adverse Event|77|||
48550094|NCT00168818|156203339|FG001|Treatment|Adverse Event|89|||
48550095|NCT00168818|156203340|FG002|Treatment|Adverse Event|68|||
48550096|NCT00168818|156203338|FG000|Treatment|Protocol Violation|8|||
48550097|NCT00168818|156203339|FG001|Treatment|Protocol Violation|11|||
48550098|NCT00168818|156203340|FG002|Treatment|Protocol Violation|11|||
48550099|NCT00168818|156203338|FG000|Treatment|Lost to Follow-up|0|||
48550100|NCT00168818|156203339|FG001|Treatment|Lost to Follow-up|2|||
48550101|NCT00168818|156203340|FG002|Treatment|Lost to Follow-up|1|||
48550102|NCT00168818|156203338|FG000|Treatment|Withdrawal by Subject|25|||
48550103|NCT00168818|156203339|FG001|Treatment|Withdrawal by Subject|20|||
48550104|NCT00168818|156203340|FG002|Treatment|Withdrawal by Subject|22|||
48550105|NCT00168818|156203338|FG000|Treatment|Other|23|||
48550106|NCT00168818|156203339|FG001|Treatment|Other|29|||
48550107|NCT00168818|156203340|FG002|Treatment|Other|31|||
48550108|NCT01959607|156203341|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
48550109|NCT01959607|156203342|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
48550110|NCT01959607|156203343|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
48550111|NCT01959607|156203344|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
48550112|NCT03597529|156203345|FG000|Overall Study|Lost to Follow-up|10|||
48550113|NCT03597529|156203346|FG001|Overall Study|Lost to Follow-up|12|||
48613340|NCT00831844|156439535|FG009|Overall Study|Death|0|||
48550114|NCT03597529|156203345|FG000|Overall Study|Physician Decision|3|||
48550115|NCT03597529|156203346|FG001|Overall Study|Physician Decision|1|||
48550116|NCT03597529|156203345|FG000|Overall Study|Withdrawal by Subject|6|||
48550117|NCT03597529|156203346|FG001|Overall Study|Withdrawal by Subject|3|||
48550118|NCT03597529|156203345|FG000|Overall Study|Non-compliant with study activities|1|||
48550119|NCT03597529|156203346|FG001|Overall Study|Non-compliant with study activities|2|||
48550120|NCT00469144|156203347|FG000|Overall Study|Death|0|||
48550121|NCT00469144|156203348|FG001|Overall Study|Death|1|||
48550122|NCT00469144|156203347|FG000|Overall Study|No Response|5|||
48550123|NCT00469144|156203348|FG001|Overall Study|No Response|5|||
48550124|NCT00469144|156203347|FG000|Overall Study|Progressive Disease|1|||
48550125|NCT00469144|156203348|FG001|Overall Study|Progressive Disease|0|||
48550126|NCT02792699|156203351|FG000|Overall Study|Adverse Event|1|||
48550127|NCT02792699|156203352|FG001|Overall Study|Adverse Event|2|||
48550128|NCT02792699|156203353|FG002|Overall Study|Adverse Event|4|||
48550129|NCT02792699|156203351|FG000|Overall Study|Withdrawal by Subject|4|||
48550130|NCT02792699|156203352|FG001|Overall Study|Withdrawal by Subject|4|||
48550131|NCT02792699|156203353|FG002|Overall Study|Withdrawal by Subject|3|||
48550132|NCT02792699|156203351|FG000|Overall Study|Lost to Follow-up|0|||
48550133|NCT02792699|156203352|FG001|Overall Study|Lost to Follow-up|1|||
48550134|NCT02792699|156203353|FG002|Overall Study|Lost to Follow-up|2|||
48550135|NCT02792699|156203351|FG000|Overall Study|Physician Decision|2|||
48550136|NCT02792699|156203352|FG001|Overall Study|Physician Decision|0|||
48550137|NCT02792699|156203353|FG002|Overall Study|Physician Decision|0|||
48550138|NCT02792699|156203351|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
48550139|NCT02792699|156203352|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
48550140|NCT02792699|156203353|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
48550141|NCT02792699|156203351|FG000|Overall Study|Other|1|||
48550142|NCT02792699|156203352|FG001|Overall Study|Other|0|||
48550143|NCT02792699|156203353|FG002|Overall Study|Other|0|||
48550144|NCT01582152|156203354|FG000|Overall Study|Disease Progression|4|||
48550145|NCT01582152|156203355|FG001|Overall Study|Disease Progression|5|||
48550146|NCT01582152|156203354|FG000|Overall Study|Adverse Event|2|||
48550147|NCT01582152|156203355|FG001|Overall Study|Adverse Event|1|||
48550148|NCT03390426|156203356|FG000|Overall Study|Protocol Violation|0|||
48550149|NCT03390426|156203357|FG001|Overall Study|Protocol Violation|1|||
48550150|NCT05566639|156203419|FG000|Overall Study|Adverse Event|1|||
48550151|NCT05566639|156203420|FG001|Overall Study|Adverse Event|1|||
48550152|NCT05566639|156203419|FG000|Overall Study|Serious Adverse Event|1|||
48550153|NCT05566639|156203420|FG001|Overall Study|Serious Adverse Event|3|||
48550154|NCT05566639|156203419|FG000|Overall Study|Death|44|||
48550155|NCT05566639|156203420|FG001|Overall Study|Death|45|||
48550156|NCT05566639|156203419|FG000|Overall Study|Lost to Follow-up|467|||
48550157|NCT05566639|156203420|FG001|Overall Study|Lost to Follow-up|461|||
48550158|NCT05566639|156203419|FG000|Overall Study|Physician Decision|45|||
48550159|NCT05566639|156203420|FG001|Overall Study|Physician Decision|44|||
48613341|NCT00831844|156439526|FG000|Overall Study|Lack of Efficacy|8|||
48613342|NCT00831844|156439527|FG001|Overall Study|Lack of Efficacy|10|||
48613343|NCT00831844|156439528|FG002|Overall Study|Lack of Efficacy|15|||
48613344|NCT00831844|156439529|FG003|Overall Study|Lack of Efficacy|8|||
48613345|NCT00831844|156439530|FG004|Overall Study|Lack of Efficacy|11|||
48613346|NCT00831844|156439531|FG005|Overall Study|Lack of Efficacy|17|||
48613347|NCT00831844|156439532|FG006|Overall Study|Lack of Efficacy|8|||
48613348|NCT00831844|156439533|FG007|Overall Study|Lack of Efficacy|9|||
48613349|NCT00831844|156439534|FG008|Overall Study|Lack of Efficacy|7|||
48613350|NCT00831844|156439535|FG009|Overall Study|Lack of Efficacy|0|||
48550160|NCT05566639|156203419|FG000|Overall Study|Protocol Deviation|4|||
48550161|NCT05566639|156203420|FG001|Overall Study|Protocol Deviation|4|||
48550162|NCT05566639|156203419|FG000|Overall Study|Withdrawal by Subject|277|||
48550163|NCT05566639|156203420|FG001|Overall Study|Withdrawal by Subject|271|||
48550164|NCT05566639|156203419|FG000|Overall Study|Other Than Specified|52|||
48613351|NCT00831844|156439526|FG000|Overall Study|Physician Decision|0|||
48613352|NCT00831844|156439527|FG001|Overall Study|Physician Decision|1|||
48550165|NCT05566639|156203420|FG001|Overall Study|Other Than Specified|64|||
48550166|NCT01890434|156203423|FG000|Overall Study|Adverse Event|8|||
48613353|NCT00831844|156439528|FG002|Overall Study|Physician Decision|3|||
48550167|NCT01890434|156203423|FG000|Overall Study|PCI at external hospital|1|||
48550168|NCT01890434|156203423|FG000|Overall Study|Assessment discrepancy|1|||
48613354|NCT00831844|156439529|FG003|Overall Study|Physician Decision|1|||
48550169|NCT01890434|156203423|FG000|Overall Study|CRC didn't contact participant for FU|1|||
48550170|NCT01890434|156203423|FG000|Overall Study|Could not get whole set of images|1|||
48550171|NCT01890434|156203423|FG000|Overall Study|Decline to return for GSPECT|1|||
48550172|NCT01890434|156203423|FG000|Overall Study|GSPECT at rest was not done|1|||
48550173|NCT01890434|156203423|FG000|Overall Study|Participant didn't complete MRI|1|||
48550174|NCT01890434|156203423|FG000|Overall Study|Uncontactable by phone|1|||
48613355|NCT00831844|156439530|FG004|Overall Study|Physician Decision|1|||
48613356|NCT00831844|156439531|FG005|Overall Study|Physician Decision|1|||
48613357|NCT00831844|156439532|FG006|Overall Study|Physician Decision|0|||
48613358|NCT00831844|156439533|FG007|Overall Study|Physician Decision|0|||
48613359|NCT00831844|156439534|FG008|Overall Study|Physician Decision|1|||
48613360|NCT00831844|156439535|FG009|Overall Study|Physician Decision|0|||
48613361|NCT00831844|156439526|FG000|Overall Study|Withdrawal by Subject|0|||
48613362|NCT00831844|156439527|FG001|Overall Study|Withdrawal by Subject|0|||
48613363|NCT00831844|156439528|FG002|Overall Study|Withdrawal by Subject|1|||
48613364|NCT00831844|156439529|FG003|Overall Study|Withdrawal by Subject|0|||
48613365|NCT00831844|156439530|FG004|Overall Study|Withdrawal by Subject|0|||
48613366|NCT00831844|156439531|FG005|Overall Study|Withdrawal by Subject|0|||
48613367|NCT00831844|156439532|FG006|Overall Study|Withdrawal by Subject|0|||
48613368|NCT00831844|156439533|FG007|Overall Study|Withdrawal by Subject|1|||
48613369|NCT00831844|156439534|FG008|Overall Study|Withdrawal by Subject|1|||
48613370|NCT00831844|156439535|FG009|Overall Study|Withdrawal by Subject|0|||
48613371|NCT00831844|156439526|FG000|Overall Study|Ineligible|0|||
48613372|NCT00831844|156439527|FG001|Overall Study|Ineligible|1|||
48550175|NCT01890434|156203423|FG000|Overall Study|Moved out of position|1|||
48550176|NCT01890434|156203423|FG000|Overall Study|Unable to contact|1|||
48550177|NCT01890434|156203423|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
48550178|NCT02227446|156203430|FG000|Overall Study|not eligible post randomization|18|||
48550179|NCT02227446|156203431|FG001|Overall Study|not eligible post randomization|29|||
48550180|NCT02227446|156203430|FG000|Overall Study|Withdrawal by Subject|4|||
48550181|NCT02227446|156203431|FG001|Overall Study|Withdrawal by Subject|5|||
48550182|NCT04623086|156203432|FG000|Overall Study|Withdrawal by Subject|0|||
48550183|NCT04623086|156203433|FG001|Overall Study|Withdrawal by Subject|0|||
48550184|NCT04623086|156203434|FG002|Overall Study|Withdrawal by Subject|10|||
48550185|NCT02538965|156203435|FG000|Treatment Period|Other = Death due to disease progression|1|||
48550186|NCT02538965|156203435|FG000|Treatment Period|Adverse Event|2|||
48550187|NCT02538965|156203435|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
48550188|NCT02538965|156203435|FG000|Treatment Period|Treatment Failure|9|||
48550189|NCT02538965|156203435|FG000|Treatment Period|Disease Progression|1|||
48550190|NCT02538965|156203435|FG000|Treatment Period|Physician Decision|2|||
48550191|NCT02538965|156203435|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
48550192|NCT02538965|156203435|FG000|Follow-Up Period|Withdrawal by Parent|4|||
48550193|NCT01715571|156203437|FG000|Overall Study|Lost to Follow-up|8|||
48613373|NCT00831844|156439528|FG002|Overall Study|Ineligible|1|||
48613374|NCT00831844|156439529|FG003|Overall Study|Ineligible|0|||
48613375|NCT00831844|156439530|FG004|Overall Study|Ineligible|1|||
48613376|NCT00831844|156439531|FG005|Overall Study|Ineligible|0|||
48550194|NCT00875797|156203438|FG000|Overall Study|Protocol Violation|6|||
48550195|NCT00875797|156203439|FG001|Overall Study|Protocol Violation|3|||
48613377|NCT00831844|156439532|FG006|Overall Study|Ineligible|0|||
48613378|NCT00831844|156439533|FG007|Overall Study|Ineligible|0|||
48613379|NCT00831844|156439534|FG008|Overall Study|Ineligible|0|||
48613380|NCT00831844|156439535|FG009|Overall Study|Ineligible|0|||
48613381|NCT00127803|156439538|FG000|Overall Study|Adverse Event|2|||
48613382|NCT00127803|156439539|FG001|Overall Study|Adverse Event|0|||
48613383|NCT00127803|156439540|FG002|Overall Study|Adverse Event|0|||
48613384|NCT00127803|156439541|FG003|Overall Study|Adverse Event|0|||
48613385|NCT00127803|156439538|FG000|Overall Study|Withdrawal by Subject|1|||
48613386|NCT00127803|156439539|FG001|Overall Study|Withdrawal by Subject|0|||
48613387|NCT00127803|156439540|FG002|Overall Study|Withdrawal by Subject|0|||
48613388|NCT00127803|156439541|FG003|Overall Study|Withdrawal by Subject|0|||
48550196|NCT04054193|156203440|FG000|Cycle 1|Physician Decision|1|||
48550197|NCT04054193|156203440|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
48550198|NCT04054193|156203440|FG000|Cycle 1|Allocated but not treated|3|||
48550199|NCT04054193|156203440|FG000|Cycles 2-3|Physician Decision|2|||
48550200|NCT04054193|156203440|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
48550201|NCT04054193|156203440|FG000|Cycles 2-3|Various reasons|17|||
48550202|NCT03464630|156203441|FG000|Overall Study|Lost to Follow-up|62|||
48550203|NCT03464630|156203442|FG001|Overall Study|Lost to Follow-up|52|||
48550204|NCT03464630|156203441|FG000|Overall Study|Withdrawal by Subject|16|||
48550205|NCT03464630|156203442|FG001|Overall Study|Withdrawal by Subject|10|||
48550206|NCT03464630|156203441|FG000|Overall Study|Passive Disengagement|8|||
48550207|NCT03464630|156203442|FG001|Overall Study|Passive Disengagement|4|||
48550208|NCT02364557|156203445|FG000|Overall Study|Protocol Violation|3|||
48550209|NCT02364557|156203446|FG001|Overall Study|Protocol Violation|1|||
48550210|NCT02121392|156203452|FG000|Prior to Intervention|Protocol Violation|40|||
48550211|NCT02121392|156203453|FG001|Prior to Intervention|Protocol Violation|35|||
48550212|NCT02121392|156203452|FG000|Prior to Intervention|Withdrawal by Subject|8|||
48613389|NCT00127803|156439538|FG000|Overall Study|Lost to Follow-up|0|||
48613390|NCT00127803|156439539|FG001|Overall Study|Lost to Follow-up|0|||
48613391|NCT00127803|156439540|FG002|Overall Study|Lost to Follow-up|0|||
48613392|NCT00127803|156439541|FG003|Overall Study|Lost to Follow-up|1|||
48613393|NCT05166876|156439544|FG000|Overall Study|Withdrawal by Subject|1|||
48613394|NCT05166876|156439545|FG001|Overall Study|Withdrawal by Subject|0|||
48613395|NCT05166876|156439546|FG002|Overall Study|Withdrawal by Subject|0|||
48613396|NCT00658528|156439547|FG000|Overall Study|Adverse Event|5|||
48613397|NCT00658528|156439548|FG001|Overall Study|Adverse Event|7|||
48550213|NCT02121392|156203453|FG001|Prior to Intervention|Withdrawal by Subject|6|||
48550214|NCT02121392|156203452|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
48550215|NCT02121392|156203453|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
48550216|NCT02121392|156203452|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
48550217|NCT02121392|156203453|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
48550218|NCT00741286|156203454|FG000|Overall Study|Lost to Follow-up|15|||
48550219|NCT00741286|156203455|FG001|Overall Study|Lost to Follow-up|10|||
48550220|NCT00741286|156203454|FG000|Overall Study|Adverse Event|1|||
48550221|NCT00741286|156203455|FG001|Overall Study|Adverse Event|6|||
48550222|NCT00741286|156203454|FG000|Overall Study|Protocol Violation|3|||
48550223|NCT00741286|156203455|FG001|Overall Study|Protocol Violation|2|||
48550224|NCT00741286|156203454|FG000|Overall Study|Primary Outcome|1|||
48550225|NCT00741286|156203455|FG001|Overall Study|Primary Outcome|1|||
48550226|NCT02455518|156203456|FG000|Overall Study|Protocol Violation|0|||
48550227|NCT02455518|156203457|FG001|Overall Study|Protocol Violation|1|||
48550228|NCT02455518|156203458|FG002|Overall Study|Protocol Violation|1|||
48550229|NCT02455518|156203459|FG003|Overall Study|Protocol Violation|3|||
48550230|NCT00025259|156203461|FG000|Overall Study|Death|1|||
48550231|NCT00025259|156203462|FG001|Overall Study|Death|3|||
48550232|NCT00025259|156203463|FG002|Overall Study|Death|0|||
48550233|NCT00025259|156203464|FG003|Overall Study|Death|3|||
48550234|NCT00025259|156203465|FG004|Overall Study|Death|0|||
48550235|NCT00025259|156203466|FG005|Overall Study|Death|1|||
48550236|NCT00025259|156203467|FG006|Overall Study|Death|2|||
48550237|NCT00025259|156203461|FG000|Overall Study|Lack of Efficacy|2|||
48550238|NCT00025259|156203462|FG001|Overall Study|Lack of Efficacy|46|||
48550239|NCT00025259|156203463|FG002|Overall Study|Lack of Efficacy|60|||
48550240|NCT00025259|156203464|FG003|Overall Study|Lack of Efficacy|78|||
48550241|NCT00025259|156203465|FG004|Overall Study|Lack of Efficacy|11|||
48550242|NCT00025259|156203466|FG005|Overall Study|Lack of Efficacy|30|||
48550243|NCT00025259|156203467|FG006|Overall Study|Lack of Efficacy|38|||
48550244|NCT00025259|156203461|FG000|Overall Study|Lost to Follow-up|2|||
48550245|NCT00025259|156203462|FG001|Overall Study|Lost to Follow-up|9|||
48550246|NCT00025259|156203463|FG002|Overall Study|Lost to Follow-up|13|||
48550247|NCT00025259|156203464|FG003|Overall Study|Lost to Follow-up|13|||
48550248|NCT00025259|156203465|FG004|Overall Study|Lost to Follow-up|1|||
48550249|NCT00025259|156203466|FG005|Overall Study|Lost to Follow-up|3|||
48550250|NCT00025259|156203467|FG006|Overall Study|Lost to Follow-up|1|||
48550251|NCT00025259|156203461|FG000|Overall Study|Physician Decision|12|||
48550252|NCT00025259|156203462|FG001|Overall Study|Physician Decision|1|||
48550253|NCT00025259|156203463|FG002|Overall Study|Physician Decision|0|||
48550254|NCT00025259|156203464|FG003|Overall Study|Physician Decision|5|||
48550255|NCT00025259|156203465|FG004|Overall Study|Physician Decision|4|||
48550256|NCT00025259|156203466|FG005|Overall Study|Physician Decision|2|||
48550257|NCT00025259|156203467|FG006|Overall Study|Physician Decision|1|||
48550258|NCT00025259|156203461|FG000|Overall Study|Protocol Violation|3|||
48550259|NCT00025259|156203462|FG001|Overall Study|Protocol Violation|2|||
48550260|NCT00025259|156203463|FG002|Overall Study|Protocol Violation|2|||
48550261|NCT00025259|156203464|FG003|Overall Study|Protocol Violation|1|||
48550262|NCT00025259|156203465|FG004|Overall Study|Protocol Violation|2|||
48550263|NCT00025259|156203466|FG005|Overall Study|Protocol Violation|1|||
48550264|NCT00025259|156203467|FG006|Overall Study|Protocol Violation|3|||
48550265|NCT00025259|156203461|FG000|Overall Study|Withdrawal by Subject|9|||
48550266|NCT00025259|156203462|FG001|Overall Study|Withdrawal by Subject|27|||
48550267|NCT00025259|156203463|FG002|Overall Study|Withdrawal by Subject|6|||
48550268|NCT00025259|156203464|FG003|Overall Study|Withdrawal by Subject|14|||
48550269|NCT00025259|156203465|FG004|Overall Study|Withdrawal by Subject|11|||
48550270|NCT00025259|156203466|FG005|Overall Study|Withdrawal by Subject|8|||
48550271|NCT00025259|156203467|FG006|Overall Study|Withdrawal by Subject|3|||
48550272|NCT00025259|156203461|FG000|Overall Study|Ineligible|14|||
48550273|NCT00025259|156203462|FG001|Overall Study|Ineligible|1|||
48550274|NCT00025259|156203463|FG002|Overall Study|Ineligible|0|||
48550275|NCT00025259|156203464|FG003|Overall Study|Ineligible|0|||
48550276|NCT00025259|156203465|FG004|Overall Study|Ineligible|6|||
48550277|NCT00025259|156203466|FG005|Overall Study|Ineligible|0|||
48550278|NCT00025259|156203467|FG006|Overall Study|Ineligible|1|||
48550279|NCT00025259|156203461|FG000|Overall Study|Randomization error|1|||
48550280|NCT00025259|156203462|FG001|Overall Study|Randomization error|0|||
48550281|NCT00025259|156203463|FG002|Overall Study|Randomization error|0|||
48550282|NCT00025259|156203464|FG003|Overall Study|Randomization error|0|||
48550283|NCT00025259|156203465|FG004|Overall Study|Randomization error|1|||
48550284|NCT00025259|156203466|FG005|Overall Study|Randomization error|7|||
48550285|NCT00025259|156203467|FG006|Overall Study|Randomization error|2|||
48550286|NCT00025259|156203461|FG000|Overall Study|Adverse Event|1|||
48550287|NCT00025259|156203462|FG001|Overall Study|Adverse Event|0|||
48550288|NCT00025259|156203463|FG002|Overall Study|Adverse Event|0|||
48550289|NCT00025259|156203464|FG003|Overall Study|Adverse Event|0|||
48550290|NCT00025259|156203465|FG004|Overall Study|Adverse Event|0|||
48550291|NCT00025259|156203466|FG005|Overall Study|Adverse Event|0|||
48550292|NCT00025259|156203467|FG006|Overall Study|Adverse Event|0|||
48550293|NCT04811716|156203468|FG000|Overall Study|Withdrawal by Subject|2|||
48550294|NCT04811716|156203469|FG001|Overall Study|Withdrawal by Subject|0|||
48550295|NCT04693416|156203470|FG000|Overall Study|Lost to Follow-up|13|||
48550296|NCT04693416|156203471|FG001|Overall Study|Lost to Follow-up|0|||
48550297|NCT01144715|156203472|FG000|Overall Study|Lost to Follow-up|2|||
48550298|NCT01144715|156203473|FG001|Overall Study|Lost to Follow-up|1|||
48550299|NCT01144715|156203472|FG000|Overall Study|Withdrawal by Subject|2|||
48550300|NCT01144715|156203473|FG001|Overall Study|Withdrawal by Subject|1|||
48550301|NCT01144715|156203472|FG000|Overall Study|Adverse Event|0|||
48550302|NCT01144715|156203473|FG001|Overall Study|Adverse Event|1|||
48550303|NCT02774642|156203475|FG000|Overall Study|Lost to Follow-up|9|||
48550304|NCT02774642|156203476|FG001|Overall Study|Lost to Follow-up|7|||
48550305|NCT01814553|156203477|FG000|Overall Study|PD per clinical progression|6|||
48550306|NCT01814553|156203478|FG001|Overall Study|PD per clinical progression|8|||
48550307|NCT01814553|156203477|FG000|Overall Study|Other Adverse Event|4|||
48550308|NCT01814553|156203478|FG001|Overall Study|Other Adverse Event|5|||
48550309|NCT01814553|156203477|FG000|Overall Study|Withdrawal by Subject|1|||
48550310|NCT01814553|156203478|FG001|Overall Study|Withdrawal by Subject|1|||
48550311|NCT01814553|156203477|FG000|Overall Study|Other than stated|7|||
48550312|NCT01814553|156203478|FG001|Overall Study|Other than stated|8|||
48550313|NCT00805961|156203490|FG000|Modality Therapy|Withdrawal by Subject|1|||
48550314|NCT00805961|156203490|FG000|Modality Therapy|Adverse Event|1|||
48550315|NCT00805961|156203490|FG000|Modality Therapy|Disease Progression|2|||
48550316|NCT00805961|156203490|FG000|Treatment-Free Interval|Adverse Event|3|||
48550317|NCT00805961|156203490|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
48550318|NCT00805961|156203490|FG000|Treatment-Free Interval|Physician Decision|1|||
48550319|NCT00805961|156203490|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
48550320|NCT00805961|156203490|FG000|Maintenance Treatment|Lack of Efficacy|13|||
48550321|NCT00805961|156203490|FG000|Maintenance Treatment|Intercurrent Illness|7|||
48550322|NCT00805961|156203490|FG000|Maintenance Treatment|Adverse Event|6|||
48550323|NCT00805961|156203490|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
48550324|NCT00805961|156203490|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
48550325|NCT00805961|156203490|FG000|Maintenance Treatment|Withdrawn Consent|1|||
48550326|NCT00660907|156205890|FG000|Overall Study|Incorrect Enrollment|1|||
48550327|NCT00660907|156205891|FG001|Overall Study|Incorrect Enrollment|1|||
48550328|NCT00660907|156205890|FG000|Overall Study|Adverse Event|33|||
48550329|NCT00660907|156205891|FG001|Overall Study|Adverse Event|19|||
48550330|NCT00660907|156205890|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
48550331|NCT00660907|156205891|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
48550332|NCT00660907|156205890|FG000|Overall Study|Withdrawal by Subject|23|||
48550333|NCT00660907|156205891|FG001|Overall Study|Withdrawal by Subject|32|||
48550334|NCT00660907|156205890|FG000|Overall Study|Lost to Follow-up|3|||
48550335|NCT00660907|156205891|FG001|Overall Study|Lost to Follow-up|3|||
48550336|NCT00660907|156205890|FG000|Overall Study|Poor/Non-Compliance|5|||
48550337|NCT00660907|156205891|FG001|Overall Study|Poor/Non-Compliance|1|||
48550338|NCT00660907|156205890|FG000|Overall Study|Safety|1|||
48550339|NCT00660907|156205891|FG001|Overall Study|Safety|0|||
48550340|NCT00660907|156205890|FG000|Overall Study|Death|1|||
48550341|NCT00660907|156205891|FG001|Overall Study|Death|3|||
48550342|NCT00660907|156205890|FG000|Overall Study|Various|11|||
48550343|NCT00660907|156205891|FG001|Overall Study|Various|8|||
48550344|NCT01908907|156205892|FG000|Overall Study|Physician Decision|1|||
48550345|NCT01908907|156205893|FG001|Overall Study|Physician Decision|0|||
48550346|NCT01908907|156205892|FG000|Overall Study|Protocol Violation|1|||
48550347|NCT01908907|156205893|FG001|Overall Study|Protocol Violation|0|||
48550348|NCT04975191|156205896|FG000|Overall Study|Protocol Violation|1|||
48550349|NCT04975191|156205897|FG001|Overall Study|Protocol Violation|2|||
48550350|NCT04975191|156205898|FG002|Overall Study|Protocol Violation|2|||
48550351|NCT04975191|156205899|FG003|Overall Study|Protocol Violation|2|||
48550352|NCT04975191|156205896|FG000|Overall Study|Lost to Follow-up|13|||
48550353|NCT04975191|156205897|FG001|Overall Study|Lost to Follow-up|3|||
48550354|NCT04975191|156205898|FG002|Overall Study|Lost to Follow-up|8|||
48550355|NCT04975191|156205899|FG003|Overall Study|Lost to Follow-up|8|||
48550356|NCT03976362|156205900|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
48550357|NCT03976362|156205901|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
48550358|NCT03976362|156205902|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
48550359|NCT03976362|156205900|FG000|Induction Phase|Death|62|||
48550360|NCT03976362|156205901|FG001|Induction Phase|Death|0|||
48550361|NCT03976362|156205902|FG002|Induction Phase|Death|0|||
48550362|NCT03976362|156205900|FG000|Maintenance Phase|Participants Ongoing|0|||
48550363|NCT03976362|156205901|FG001|Maintenance Phase|Participants Ongoing|106|||
48550364|NCT03976362|156205902|FG002|Maintenance Phase|Participants Ongoing|103|||
48550365|NCT03976362|156205900|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48550366|NCT03976362|156205901|FG001|Maintenance Phase|Withdrawal by Subject|4|||
48550367|NCT03976362|156205902|FG002|Maintenance Phase|Withdrawal by Subject|4|||
48550368|NCT03976362|156205900|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
48550369|NCT03976362|156205901|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
48550370|NCT03976362|156205902|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
48550371|NCT03976362|156205900|FG000|Maintenance Phase|Death|0|||
48550372|NCT03976362|156205901|FG001|Maintenance Phase|Death|186|||
48550373|NCT03976362|156205902|FG002|Maintenance Phase|Death|187|||
48550374|NCT03848065|156205903|FG000|Overall Study|Death|0|||
48550375|NCT03848065|156205904|FG001|Overall Study|Death|1|||
48550376|NCT03848065|156205905|FG002|Overall Study|Death|0|||
48550377|NCT03848065|156205903|FG000|Overall Study|Lost to Follow-up|0|||
48550378|NCT03848065|156205904|FG001|Overall Study|Lost to Follow-up|0|||
48550379|NCT03848065|156205905|FG002|Overall Study|Lost to Follow-up|1|||
48550380|NCT03848065|156205903|FG000|Overall Study|Physician Decision|0|||
48550381|NCT03848065|156205904|FG001|Overall Study|Physician Decision|0|||
48550382|NCT03848065|156205905|FG002|Overall Study|Physician Decision|1|||
48550383|NCT00631657|156205908|FG000|6-Month Treatment Period|Adverse Event|47|||
48550384|NCT00631657|156205909|FG001|6-Month Treatment Period|Adverse Event|0|||
48550385|NCT00631657|156205910|FG002|6-Month Treatment Period|Adverse Event|7|||
48550386|NCT00631657|156205908|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
48550387|NCT00631657|156205909|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
48550388|NCT00631657|156205910|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
48550389|NCT00631657|156205908|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
48550390|NCT00631657|156205909|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
48550391|NCT00631657|156205910|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
48550392|NCT00631657|156205908|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
48550393|NCT00631657|156205909|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
48550394|NCT00631657|156205910|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
48550395|NCT00631657|156205908|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
48550396|NCT00631657|156205909|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
48550397|NCT00631657|156205910|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
48550398|NCT00631657|156205908|FG000|6-Month Treatment Period|Other|16|||
48550399|NCT00631657|156205909|FG001|6-Month Treatment Period|Other|0|||
48550400|NCT00631657|156205910|FG002|6-Month Treatment Period|Other|4|||
48550401|NCT00631657|156205908|FG000|6-Month Treatment Period|Not Treated|2|||
48550402|NCT00631657|156205909|FG001|6-Month Treatment Period|Not Treated|0|||
48550403|NCT00631657|156205910|FG002|6-Month Treatment Period|Not Treated|1|||
48550404|NCT00631657|156205908|FG000|7-Day Discontinuation Period|Not Treated|1|||
48613398|NCT00658528|156439547|FG000|Overall Study|Lost to Follow-up|14|||
48613399|NCT00658528|156439548|FG001|Overall Study|Lost to Follow-up|22|||
48613400|NCT00658528|156439547|FG000|Overall Study|Withdrawal by Subject|8|||
48550405|NCT00631657|156205909|FG001|7-Day Discontinuation Period|Not Treated|1|||
48550406|NCT00631657|156205910|FG002|7-Day Discontinuation Period|Not Treated|1|||
48550407|NCT00631657|156205908|FG000|7-Day Discontinuation Period|Other|1|||
48550408|NCT00631657|156205909|FG001|7-Day Discontinuation Period|Other|0|||
48550409|NCT00631657|156205910|FG002|7-Day Discontinuation Period|Other|0|||
48550410|NCT01994291|156205911|FG000|Overall Study|Adverse Event|4|||
48550411|NCT01994291|156205912|FG001|Overall Study|Adverse Event|1|||
48550412|NCT01994291|156205913|FG002|Overall Study|Adverse Event|3|||
48550413|NCT01994291|156205911|FG000|Overall Study|Lost to Follow-up|1|||
48550414|NCT01994291|156205912|FG001|Overall Study|Lost to Follow-up|1|||
48550415|NCT01994291|156205913|FG002|Overall Study|Lost to Follow-up|0|||
48550416|NCT01994291|156205911|FG000|Overall Study|Does not meet entrance criteria|1|||
48550417|NCT01994291|156205912|FG001|Overall Study|Does not meet entrance criteria|0|||
48550418|NCT01994291|156205913|FG002|Overall Study|Does not meet entrance criteria|0|||
48550419|NCT01994291|156205911|FG000|Overall Study|Medication error without associated AE|1|||
48550420|NCT01994291|156205912|FG001|Overall Study|Medication error without associated AE|0|||
48550421|NCT01994291|156205913|FG002|Overall Study|Medication error without associated AE|1|||
48550422|NCT01994291|156205911|FG000|Overall Study|Protocol Violation|1|||
48550423|NCT01994291|156205912|FG001|Overall Study|Protocol Violation|0|||
48550424|NCT01994291|156205913|FG002|Overall Study|Protocol Violation|0|||
48550425|NCT01994291|156205911|FG000|Overall Study|Withdrawal by Subject|6|||
48550426|NCT01994291|156205912|FG001|Overall Study|Withdrawal by Subject|3|||
48550427|NCT01994291|156205913|FG002|Overall Study|Withdrawal by Subject|5|||
48550428|NCT01994291|156205911|FG000|Overall Study|Other|1|||
48550429|NCT01994291|156205912|FG001|Overall Study|Other|2|||
48550430|NCT01994291|156205913|FG002|Overall Study|Other|0|||
48550431|NCT04611529|156205914|FG000|2-day Follow up|Lost to Follow-up|5|||
48550432|NCT04611529|156205915|FG001|2-day Follow up|Lost to Follow-up|6|||
48550433|NCT04611529|156205916|FG002|2-day Follow up|Lost to Follow-up|3|||
48550434|NCT01775189|156205917|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48550435|NCT01775189|156205918|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
48550436|NCT01775189|156205919|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48550437|NCT01775189|156205920|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48550438|NCT01775189|156205921|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48550439|NCT01775189|156205922|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48550440|NCT01775189|156205923|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
48613401|NCT00658528|156439548|FG001|Overall Study|Withdrawal by Subject|6|||
48550441|NCT01775189|156205917|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48613402|NCT00658528|156439547|FG000|Overall Study|Withdrawal of consent|5|||
48550442|NCT01775189|156205918|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
48550443|NCT01775189|156205919|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48550444|NCT01775189|156205920|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48550445|NCT01775189|156205921|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48550446|NCT01775189|156205922|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48550447|NCT01775189|156205923|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
48550448|NCT01775189|156205917|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
48550449|NCT01775189|156205918|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
48550450|NCT01775189|156205919|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
48550451|NCT01775189|156205920|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
48550452|NCT01775189|156205921|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
48550453|NCT01775189|156205922|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
48550454|NCT01775189|156205923|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
48550455|NCT01775189|156205917|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
48550456|NCT01775189|156205918|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
48550457|NCT01775189|156205919|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
48550458|NCT01775189|156205920|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
48550459|NCT01775189|156205921|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
48550460|NCT01775189|156205922|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
48550461|NCT01775189|156205923|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
48550462|NCT01775189|156205917|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
48550463|NCT01775189|156205918|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
48550464|NCT01775189|156205919|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
48550465|NCT01775189|156205920|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
48550466|NCT01775189|156205921|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
48550467|NCT01775189|156205922|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
48550468|NCT01775189|156205923|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
48550469|NCT01775189|156205917|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
48550470|NCT01775189|156205918|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
48550471|NCT01775189|156205919|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
48550472|NCT01775189|156205920|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
48550473|NCT01775189|156205921|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
48550474|NCT01775189|156205922|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
48550475|NCT01775189|156205923|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
48550476|NCT00856375|156205925|FG000|Overall Study|Other|0|||
48550477|NCT00856375|156205926|FG001|Overall Study|Other|1|||
48550478|NCT00856375|156205925|FG000|Overall Study|Death|32|||
48550479|NCT00856375|156205926|FG001|Overall Study|Death|30|||
48550480|NCT00856375|156205925|FG000|Overall Study|Sponsor Terminated Study|7|||
48550481|NCT00856375|156205926|FG001|Overall Study|Sponsor Terminated Study|7|||
48550482|NCT00856375|156205925|FG000|Overall Study|Withdrawal by Subject|2|||
48550483|NCT00856375|156205926|FG001|Overall Study|Withdrawal by Subject|1|||
48550484|NCT00856375|156205925|FG000|Overall Study|Lost to Follow-up|1|||
48550485|NCT00856375|156205926|FG001|Overall Study|Lost to Follow-up|2|||
48550486|NCT00428116|156205927|FG000|Overall Study|Death|1|||
48550487|NCT00428116|156205928|FG001|Overall Study|Death|0|||
48550488|NCT00428116|156205927|FG000|Overall Study|Withdrawal by Subject|1|||
48550489|NCT00428116|156205928|FG001|Overall Study|Withdrawal by Subject|0|||
48550490|NCT00428116|156205927|FG000|Overall Study|Lost to Follow-up|1|||
48550491|NCT00428116|156205928|FG001|Overall Study|Lost to Follow-up|0|||
48550492|NCT00715624|156205929|FG000|Overall Study|Adverse Event|12|||
48550493|NCT00715624|156205930|FG001|Overall Study|Adverse Event|37|||
48550494|NCT00715624|156205929|FG000|Overall Study|Lack of Efficacy|11|||
48550495|NCT00715624|156205930|FG001|Overall Study|Lack of Efficacy|11|||
48550496|NCT00715624|156205929|FG000|Overall Study|Lost to Follow-up|1|||
48550497|NCT00715624|156205930|FG001|Overall Study|Lost to Follow-up|2|||
48550498|NCT00715624|156205929|FG000|Overall Study|Protocol Violation|1|||
48550499|NCT00715624|156205930|FG001|Overall Study|Protocol Violation|0|||
48550500|NCT00715624|156205929|FG000|Overall Study|Withdrawal by Subject|11|||
48550501|NCT00715624|156205930|FG001|Overall Study|Withdrawal by Subject|25|||
48550502|NCT00715624|156205929|FG000|Overall Study|Familial and personal reasons|10|||
48550503|NCT00715624|156205930|FG001|Overall Study|Familial and personal reasons|22|||
48550504|NCT00715624|156205929|FG000|Overall Study|Poor compliance|6|||
48550505|NCT00715624|156205930|FG001|Overall Study|Poor compliance|13|||
48550506|NCT00715624|156205929|FG000|Overall Study|Sponsor decision|0|||
48550507|NCT00715624|156205930|FG001|Overall Study|Sponsor decision|4|||
48325484|NCT02357966|155389112|FG000|Overall Study|Physician Decision|1|||
48550508|NCT00715624|156205929|FG000|Overall Study|Incorrect randomization (not treated)|0|||
48550509|NCT00715624|156205930|FG001|Overall Study|Incorrect randomization (not treated)|1|||
48550510|NCT00715624|156205929|FG000|Overall Study|Other|0|||
48550511|NCT00715624|156205930|FG001|Overall Study|Other|1|||
48550512|NCT03200912|156205931|FG000|Overall Study|Adverse Event|3|||
48550513|NCT03200912|156205932|FG001|Overall Study|Adverse Event|0|||
48550514|NCT03200912|156205933|FG002|Overall Study|Adverse Event|0|||
48550515|NCT03200912|156205931|FG000|Overall Study|Withdrawal by Subject|1|||
48550516|NCT03200912|156205932|FG001|Overall Study|Withdrawal by Subject|2|||
48550517|NCT03200912|156205933|FG002|Overall Study|Withdrawal by Subject|4|||
48550518|NCT03200912|156205931|FG000|Overall Study|Non-compliance with study drug|0|||
48550519|NCT03200912|156205932|FG001|Overall Study|Non-compliance with study drug|1|||
48550520|NCT03200912|156205933|FG002|Overall Study|Non-compliance with study drug|0|||
48550521|NCT01831258|156205935|FG000|Overall Study|Withdrawal by Subject|2|||
48550522|NCT01831258|156205936|FG001|Overall Study|Withdrawal by Subject|1|||
48550523|NCT01831258|156205935|FG000|Overall Study|Lost to Follow-up|3|||
48550524|NCT01831258|156205936|FG001|Overall Study|Lost to Follow-up|2|||
48550525|NCT03196635|156205937|FG000|Overall Study|Withdrawal by Subject|1|||
48550526|NCT00425373|156205945|FG000|Overall Study|Adverse Event|2|||
48550527|NCT00425373|156205946|FG001|Overall Study|Adverse Event|2|||
48550528|NCT00425373|156205947|FG002|Overall Study|Adverse Event|0|||
48550529|NCT00425373|156205948|FG003|Overall Study|Adverse Event|1|||
48550530|NCT00425373|156205949|FG004|Overall Study|Adverse Event|4|||
48550531|NCT00425373|156205950|FG005|Overall Study|Adverse Event|6|||
48550532|NCT00425373|156205951|FG006|Overall Study|Adverse Event|2|||
48550533|NCT00425373|156205952|FG007|Overall Study|Adverse Event|3|||
48550534|NCT00425373|156205953|FG008|Overall Study|Adverse Event|8|||
48550535|NCT00425373|156205945|FG000|Overall Study|Lost to Follow-up|0|||
48550536|NCT00425373|156205946|FG001|Overall Study|Lost to Follow-up|1|||
48550537|NCT00425373|156205947|FG002|Overall Study|Lost to Follow-up|0|||
48550538|NCT00425373|156205948|FG003|Overall Study|Lost to Follow-up|0|||
48550539|NCT00425373|156205949|FG004|Overall Study|Lost to Follow-up|1|||
48550540|NCT00425373|156205950|FG005|Overall Study|Lost to Follow-up|0|||
48550541|NCT00425373|156205951|FG006|Overall Study|Lost to Follow-up|0|||
48550542|NCT00425373|156205952|FG007|Overall Study|Lost to Follow-up|0|||
48550543|NCT00425373|156205953|FG008|Overall Study|Lost to Follow-up|0|||
48550544|NCT00425373|156205945|FG000|Overall Study|Protocol Violation|1|||
48550545|NCT00425373|156205946|FG001|Overall Study|Protocol Violation|0|||
48550546|NCT00425373|156205947|FG002|Overall Study|Protocol Violation|1|||
48550547|NCT00425373|156205948|FG003|Overall Study|Protocol Violation|0|||
48550548|NCT00425373|156205949|FG004|Overall Study|Protocol Violation|0|||
48550549|NCT00425373|156205950|FG005|Overall Study|Protocol Violation|0|||
48550550|NCT00425373|156205951|FG006|Overall Study|Protocol Violation|0|||
48550551|NCT00425373|156205952|FG007|Overall Study|Protocol Violation|5|||
48550552|NCT00425373|156205953|FG008|Overall Study|Protocol Violation|3|||
48550553|NCT00425373|156205945|FG000|Overall Study|Withdrawal by Subject|2|||
48550554|NCT00425373|156205946|FG001|Overall Study|Withdrawal by Subject|0|||
48550555|NCT00425373|156205947|FG002|Overall Study|Withdrawal by Subject|2|||
48550556|NCT00425373|156205948|FG003|Overall Study|Withdrawal by Subject|1|||
48550557|NCT00425373|156205949|FG004|Overall Study|Withdrawal by Subject|4|||
48550558|NCT00425373|156205950|FG005|Overall Study|Withdrawal by Subject|0|||
48550559|NCT00425373|156205951|FG006|Overall Study|Withdrawal by Subject|2|||
48550560|NCT00425373|156205952|FG007|Overall Study|Withdrawal by Subject|2|||
48550561|NCT00425373|156205953|FG008|Overall Study|Withdrawal by Subject|2|||
48550562|NCT00425373|156205945|FG000|Overall Study|Lack of Efficacy|0|||
48550563|NCT00425373|156205946|FG001|Overall Study|Lack of Efficacy|0|||
48550564|NCT00425373|156205947|FG002|Overall Study|Lack of Efficacy|0|||
48550565|NCT00425373|156205948|FG003|Overall Study|Lack of Efficacy|0|||
48550566|NCT00425373|156205949|FG004|Overall Study|Lack of Efficacy|1|||
48550567|NCT00425373|156205950|FG005|Overall Study|Lack of Efficacy|3|||
48550568|NCT00425373|156205951|FG006|Overall Study|Lack of Efficacy|3|||
48550569|NCT00425373|156205952|FG007|Overall Study|Lack of Efficacy|0|||
48550570|NCT00425373|156205953|FG008|Overall Study|Lack of Efficacy|5|||
48550571|NCT00253448|156205954|FG000|Overall Study|Withdrawal by Subject|1|||
48550572|NCT00229723|156205956|FG000|Concomitant Phase|Adverse Event|4|||
48550573|NCT00229723|156205957|FG001|Concomitant Phase|Adverse Event|2|||
48550574|NCT00229723|156205958|FG002|Concomitant Phase|Adverse Event|5|||
48550575|NCT00229723|156205959|FG003|Concomitant Phase|Adverse Event|2|||
48550576|NCT00229723|156205960|FG004|Concomitant Phase|Adverse Event|0|||
48550577|NCT00229723|156205961|FG005|Concomitant Phase|Adverse Event|1|||
48550578|NCT00229723|156205962|FG006|Concomitant Phase|Adverse Event|2|||
48550579|NCT00229723|156205956|FG000|Concomitant Phase|Objective disease progression|0|||
48550580|NCT00229723|156205957|FG001|Concomitant Phase|Objective disease progression|0|||
48550581|NCT00229723|156205958|FG002|Concomitant Phase|Objective disease progression|0|||
48550582|NCT00229723|156205959|FG003|Concomitant Phase|Objective disease progression|0|||
48550583|NCT00229723|156205960|FG004|Concomitant Phase|Objective disease progression|0|||
48550584|NCT00229723|156205961|FG005|Concomitant Phase|Objective disease progression|0|||
48550585|NCT00229723|156205962|FG006|Concomitant Phase|Objective disease progression|0|||
48550586|NCT00229723|156205956|FG000|Concomitant Phase|Clinical progression|0|||
48550587|NCT00229723|156205957|FG001|Concomitant Phase|Clinical progression|0|||
48550588|NCT00229723|156205958|FG002|Concomitant Phase|Clinical progression|0|||
48550589|NCT00229723|156205959|FG003|Concomitant Phase|Clinical progression|0|||
48550590|NCT00229723|156205960|FG004|Concomitant Phase|Clinical progression|0|||
48550591|NCT00229723|156205961|FG005|Concomitant Phase|Clinical progression|0|||
48550592|NCT00229723|156205962|FG006|Concomitant Phase|Clinical progression|1|||
48550593|NCT00229723|156205956|FG000|Concomitant Phase|Lost to Follow-up|0|||
48550594|NCT00229723|156205957|FG001|Concomitant Phase|Lost to Follow-up|0|||
48550595|NCT00229723|156205958|FG002|Concomitant Phase|Lost to Follow-up|0|||
48550596|NCT00229723|156205959|FG003|Concomitant Phase|Lost to Follow-up|0|||
48550597|NCT00229723|156205960|FG004|Concomitant Phase|Lost to Follow-up|1|||
48550598|NCT00229723|156205961|FG005|Concomitant Phase|Lost to Follow-up|0|||
48550599|NCT00229723|156205962|FG006|Concomitant Phase|Lost to Follow-up|0|||
48550600|NCT00229723|156205956|FG000|Concomitant Phase|Informed consent withdrawn|3|||
48550601|NCT00229723|156205957|FG001|Concomitant Phase|Informed consent withdrawn|2|||
48550602|NCT00229723|156205958|FG002|Concomitant Phase|Informed consent withdrawn|0|||
48550603|NCT00229723|156205959|FG003|Concomitant Phase|Informed consent withdrawn|2|||
48550604|NCT00229723|156205960|FG004|Concomitant Phase|Informed consent withdrawn|0|||
48550605|NCT00229723|156205961|FG005|Concomitant Phase|Informed consent withdrawn|0|||
48550606|NCT00229723|156205962|FG006|Concomitant Phase|Informed consent withdrawn|0|||
48550607|NCT00229723|156205956|FG000|Concomitant Phase|Severe non-compliance|0|||
48550608|NCT00229723|156205957|FG001|Concomitant Phase|Severe non-compliance|1|||
48550609|NCT00229723|156205958|FG002|Concomitant Phase|Severe non-compliance|0|||
48550610|NCT00229723|156205959|FG003|Concomitant Phase|Severe non-compliance|0|||
48550611|NCT00229723|156205960|FG004|Concomitant Phase|Severe non-compliance|1|||
48550612|NCT00229723|156205961|FG005|Concomitant Phase|Severe non-compliance|0|||
48550613|NCT00229723|156205962|FG006|Concomitant Phase|Severe non-compliance|0|||
48550614|NCT00229723|156205956|FG000|Concomitant Phase|Other|3|||
48550615|NCT00229723|156205957|FG001|Concomitant Phase|Other|0|||
48550616|NCT00229723|156205958|FG002|Concomitant Phase|Other|1|||
48550617|NCT00229723|156205959|FG003|Concomitant Phase|Other|1|||
48550618|NCT00229723|156205960|FG004|Concomitant Phase|Other|0|||
48550619|NCT00229723|156205961|FG005|Concomitant Phase|Other|2|||
48550620|NCT00229723|156205962|FG006|Concomitant Phase|Other|0|||
48550621|NCT00229723|156205956|FG000|Maintenance Phase|Adverse Event|7|||
48550622|NCT00229723|156205957|FG001|Maintenance Phase|Adverse Event|2|||
48550623|NCT00229723|156205958|FG002|Maintenance Phase|Adverse Event|1|||
48550624|NCT00229723|156205959|FG003|Maintenance Phase|Adverse Event|4|||
48550625|NCT00229723|156205960|FG004|Maintenance Phase|Adverse Event|7|||
48550626|NCT00229723|156205961|FG005|Maintenance Phase|Adverse Event|5|||
48550627|NCT00229723|156205962|FG006|Maintenance Phase|Adverse Event|2|||
48550628|NCT00229723|156205956|FG000|Maintenance Phase|Objective disease progression|5|||
48550629|NCT00229723|156205957|FG001|Maintenance Phase|Objective disease progression|5|||
48550630|NCT00229723|156205958|FG002|Maintenance Phase|Objective disease progression|3|||
48550631|NCT00229723|156205959|FG003|Maintenance Phase|Objective disease progression|6|||
48550632|NCT00229723|156205960|FG004|Maintenance Phase|Objective disease progression|2|||
48550633|NCT00229723|156205961|FG005|Maintenance Phase|Objective disease progression|9|||
48550634|NCT00229723|156205962|FG006|Maintenance Phase|Objective disease progression|5|||
48550635|NCT00229723|156205956|FG000|Maintenance Phase|Clinical progression|4|||
48550636|NCT00229723|156205957|FG001|Maintenance Phase|Clinical progression|1|||
48550637|NCT00229723|156205958|FG002|Maintenance Phase|Clinical progression|2|||
48550638|NCT00229723|156205959|FG003|Maintenance Phase|Clinical progression|2|||
48550639|NCT00229723|156205960|FG004|Maintenance Phase|Clinical progression|1|||
48550640|NCT00229723|156205961|FG005|Maintenance Phase|Clinical progression|1|||
48550641|NCT00229723|156205962|FG006|Maintenance Phase|Clinical progression|1|||
48550642|NCT00229723|156205956|FG000|Maintenance Phase|Lost to Follow-up|0|||
48550643|NCT00229723|156205957|FG001|Maintenance Phase|Lost to Follow-up|1|||
48550644|NCT00229723|156205958|FG002|Maintenance Phase|Lost to Follow-up|2|||
48550645|NCT00229723|156205959|FG003|Maintenance Phase|Lost to Follow-up|2|||
48550646|NCT00229723|156205960|FG004|Maintenance Phase|Lost to Follow-up|0|||
48550647|NCT00229723|156205961|FG005|Maintenance Phase|Lost to Follow-up|0|||
48550648|NCT00229723|156205962|FG006|Maintenance Phase|Lost to Follow-up|1|||
48550649|NCT00229723|156205956|FG000|Maintenance Phase|Informed consent withdrawn|1|||
48550650|NCT00229723|156205957|FG001|Maintenance Phase|Informed consent withdrawn|0|||
48550651|NCT00229723|156205958|FG002|Maintenance Phase|Informed consent withdrawn|0|||
48550652|NCT00229723|156205959|FG003|Maintenance Phase|Informed consent withdrawn|1|||
48550653|NCT00229723|156205960|FG004|Maintenance Phase|Informed consent withdrawn|1|||
48550654|NCT00229723|156205961|FG005|Maintenance Phase|Informed consent withdrawn|1|||
48550655|NCT00229723|156205962|FG006|Maintenance Phase|Informed consent withdrawn|0|||
48550656|NCT00229723|156205956|FG000|Maintenance Phase|Severe non-compliance|3|||
48550657|NCT00229723|156205957|FG001|Maintenance Phase|Severe non-compliance|1|||
48550658|NCT00229723|156205958|FG002|Maintenance Phase|Severe non-compliance|0|||
48550659|NCT00229723|156205959|FG003|Maintenance Phase|Severe non-compliance|0|||
48550660|NCT00229723|156205960|FG004|Maintenance Phase|Severe non-compliance|1|||
48550661|NCT00229723|156205961|FG005|Maintenance Phase|Severe non-compliance|0|||
48550662|NCT00229723|156205962|FG006|Maintenance Phase|Severe non-compliance|0|||
48550663|NCT00229723|156205956|FG000|Maintenance Phase|Other|5|||
48550664|NCT00229723|156205957|FG001|Maintenance Phase|Other|4|||
48550665|NCT00229723|156205958|FG002|Maintenance Phase|Other|1|||
48550666|NCT00229723|156205959|FG003|Maintenance Phase|Other|2|||
48550667|NCT00229723|156205960|FG004|Maintenance Phase|Other|3|||
48550668|NCT00229723|156205961|FG005|Maintenance Phase|Other|3|||
48550669|NCT00229723|156205962|FG006|Maintenance Phase|Other|1|||
48550670|NCT02309138|156205963|FG000|Overall Study|Withdrawal by Subject|44|||
48550671|NCT02309138|156205964|FG001|Overall Study|Withdrawal by Subject|15|||
48550672|NCT02309138|156205963|FG000|Overall Study|Protocol Violation|4|||
48550673|NCT02309138|156205964|FG001|Overall Study|Protocol Violation|2|||
48550674|NCT02309138|156205963|FG000|Overall Study|delivered before visit 2|0|||
48550675|NCT02309138|156205964|FG001|Overall Study|delivered before visit 2|1|||
48550676|NCT02564887|156205970|FG000|Overall Study|Lost to Follow-up|6|||
48550677|NCT02564887|156205971|FG001|Overall Study|Lost to Follow-up|0|||
48550678|NCT00998309|156205977|FG000|Overall Study|Protocol Violation|4|||
48550679|NCT02052011|156205984|FG000|Overall Study|Lost to Follow-up|3|||
48550680|NCT02052011|156205985|FG001|Overall Study|Lost to Follow-up|0|||
48550681|NCT02052011|156205984|FG000|Overall Study|Withdrawal by Subject|1|||
48550682|NCT02052011|156205985|FG001|Overall Study|Withdrawal by Subject|2|||
48550683|NCT02960490|156205990|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
48550684|NCT02960490|156205991|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
48550685|NCT02960490|156205992|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
48550686|NCT02960490|156205993|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
48550687|NCT02960490|156205994|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
48550688|NCT02960490|156205995|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
48550689|NCT02960490|156205996|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
48550690|NCT02960490|156205997|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
48550691|NCT02960490|156205998|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
48550692|NCT02960490|156205999|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
48550693|NCT02960490|156205990|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550694|NCT02960490|156205991|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
48550695|NCT02960490|156205992|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550696|NCT02960490|156205993|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550697|NCT02960490|156205994|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550698|NCT02960490|156205995|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550699|NCT02960490|156205996|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550700|NCT02960490|156205997|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550701|NCT02960490|156205998|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550702|NCT02960490|156205999|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
48550703|NCT02960490|156205990|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
48550704|NCT02960490|156205991|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
48550705|NCT02960490|156205992|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
48550706|NCT02960490|156205993|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
48550707|NCT02960490|156205994|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
48550708|NCT02960490|156205995|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
48550709|NCT02960490|156205996|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
48550710|NCT02960490|156205997|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
48550711|NCT02960490|156205998|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
48550712|NCT02960490|156205999|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
48550713|NCT02960490|156205990|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
48550714|NCT02960490|156205991|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
48550715|NCT02960490|156205992|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
48550716|NCT02960490|156205993|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
48550717|NCT02960490|156205994|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
48550718|NCT02960490|156205995|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
48550719|NCT02960490|156205996|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
48550720|NCT02960490|156205997|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
48550721|NCT02960490|156205998|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
48550722|NCT02960490|156205999|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
48550723|NCT02960490|156205990|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
48550724|NCT02960490|156205991|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
48550725|NCT02960490|156205992|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
48550726|NCT02960490|156205993|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
48550727|NCT02960490|156205994|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
48550728|NCT02960490|156205995|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
48550729|NCT02960490|156205996|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
48550730|NCT02960490|156205997|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
48550731|NCT02960490|156205998|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
48550732|NCT02960490|156205999|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
48550733|NCT02960490|156205990|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
48550734|NCT02960490|156205991|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
48550735|NCT02960490|156205992|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
48550736|NCT02960490|156205993|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
48550737|NCT02960490|156205994|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
48550738|NCT02960490|156205995|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
48550739|NCT02960490|156205996|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
48550740|NCT02960490|156205997|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
48550741|NCT02960490|156205998|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
48550742|NCT02960490|156205999|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
48550743|NCT02960490|156205990|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
48550744|NCT02960490|156205991|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
48550745|NCT02960490|156205992|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
48550746|NCT02960490|156205993|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
48550747|NCT02960490|156205994|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
48550748|NCT02960490|156205995|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
48550749|NCT02960490|156205996|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
48550750|NCT02960490|156205997|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
48550751|NCT02960490|156205998|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
48550752|NCT02960490|156205999|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
48550753|NCT02960490|156205990|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
48550754|NCT02960490|156205991|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
48550755|NCT02960490|156205992|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
48550756|NCT02960490|156205993|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
48550757|NCT02960490|156205994|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
48550758|NCT02960490|156205995|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
48550759|NCT02960490|156205996|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
48550760|NCT02960490|156205997|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
48550761|NCT02960490|156205998|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
48550762|NCT02960490|156205999|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
48550763|NCT02960490|156205990|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550764|NCT02960490|156205991|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550765|NCT02960490|156205992|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550766|NCT02960490|156205993|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550767|NCT02960490|156205994|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550768|NCT02960490|156205995|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550769|NCT02960490|156205996|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550770|NCT02960490|156205997|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
48550771|NCT02960490|156205998|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550772|NCT02960490|156205999|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
48550773|NCT02960490|156205990|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
48550774|NCT02960490|156205991|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
48550775|NCT02960490|156205992|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
48550776|NCT02960490|156205993|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
48550777|NCT02960490|156205994|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
48550778|NCT02960490|156205995|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
48550779|NCT02960490|156205996|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
48550780|NCT02960490|156205997|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
48550781|NCT02960490|156205998|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
48550782|NCT02960490|156205999|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
48550783|NCT02960490|156205990|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550784|NCT02960490|156205991|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550785|NCT02960490|156205992|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550786|NCT02960490|156205993|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550787|NCT02960490|156205994|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550788|NCT02960490|156205995|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550789|NCT02960490|156205996|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
48550790|NCT02960490|156205997|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550791|NCT02960490|156205998|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550792|NCT02960490|156205999|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
48550793|NCT02960490|156205990|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550794|NCT02960490|156205991|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550795|NCT02960490|156205992|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550796|NCT02960490|156205993|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550797|NCT02960490|156205994|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550798|NCT02960490|156205995|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550799|NCT02960490|156205996|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550800|NCT02960490|156205997|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
48550801|NCT02960490|156205998|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550802|NCT02960490|156205999|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
48550803|NCT01038297|156206000|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
48550804|NCT01038297|156206001|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
48550805|NCT01038297|156206002|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
48550806|NCT00474266|156206007|FG000|Overall Study|Withdrawal by Subject|7|||
48550807|NCT00474266|156206008|FG001|Overall Study|Withdrawal by Subject|20|||
48550808|NCT00474266|156206009|FG002|Overall Study|Withdrawal by Subject|4|||
48550809|NCT00474266|156206010|FG003|Overall Study|Withdrawal by Subject|7|||
48550810|NCT00863772|156206015|FG000|Overall Study|Adverse Event|1|||
48550811|NCT00863772|156206016|FG001|Overall Study|Adverse Event|4|||
48550812|NCT00863772|156206017|FG002|Overall Study|Adverse Event|0|||
48550813|NCT00863772|156206015|FG000|Overall Study|Lack of Efficacy|4|||
48550814|NCT00863772|156206016|FG001|Overall Study|Lack of Efficacy|2|||
48550815|NCT00863772|156206017|FG002|Overall Study|Lack of Efficacy|4|||
48550816|NCT00863772|156206015|FG000|Overall Study|Lost to Follow-up|5|||
48550817|NCT00863772|156206016|FG001|Overall Study|Lost to Follow-up|1|||
48550818|NCT00863772|156206017|FG002|Overall Study|Lost to Follow-up|1|||
48550819|NCT00863772|156206015|FG000|Overall Study|Protocol Violation|2|||
48550820|NCT00863772|156206016|FG001|Overall Study|Protocol Violation|0|||
48550821|NCT00863772|156206017|FG002|Overall Study|Protocol Violation|2|||
48550822|NCT00863772|156206015|FG000|Overall Study|Withdrawal by Subject|4|||
48550823|NCT00863772|156206016|FG001|Overall Study|Withdrawal by Subject|7|||
48550824|NCT00863772|156206017|FG002|Overall Study|Withdrawal by Subject|5|||
48550825|NCT00863772|156206015|FG000|Overall Study|Study terminated by sponsor|44|||
48550826|NCT00863772|156206016|FG001|Overall Study|Study terminated by sponsor|45|||
48550827|NCT00863772|156206017|FG002|Overall Study|Study terminated by sponsor|36|||
48550828|NCT00863772|156206015|FG000|Overall Study|Entered extension study|6|||
48550829|NCT00863772|156206016|FG001|Overall Study|Entered extension study|4|||
48550830|NCT00863772|156206017|FG002|Overall Study|Entered extension study|9|||
48550831|NCT00863772|156206015|FG000|Overall Study|Other|1|||
48550832|NCT00863772|156206016|FG001|Overall Study|Other|2|||
48550833|NCT00863772|156206017|FG002|Overall Study|Other|4|||
48550834|NCT00863772|156206015|FG000|Overall Study|Randomized but not Treated|1|||
48550835|NCT00863772|156206016|FG001|Overall Study|Randomized but not Treated|0|||
48550836|NCT00863772|156206017|FG002|Overall Study|Randomized but not Treated|0|||
48550837|NCT01449370|156206018|FG000|Overall Study|Disease Progression|5|||
48550838|NCT01449370|156206019|FG001|Overall Study|Disease Progression|4|||
48550839|NCT01449370|156206020|FG002|Overall Study|Disease Progression|8|||
48550840|NCT01449370|156206021|FG003|Overall Study|Disease Progression|3|||
48550841|NCT01449370|156206022|FG004|Overall Study|Disease Progression|3|||
48550842|NCT01449370|156206023|FG005|Overall Study|Disease Progression|3|||
48550843|NCT01449370|156206024|FG006|Overall Study|Disease Progression|3|||
48550844|NCT01449370|156206025|FG007|Overall Study|Disease Progression|2|||
48550845|NCT01449370|156206026|FG008|Overall Study|Disease Progression|9|||
48550846|NCT01449370|156206027|FG009|Overall Study|Disease Progression|1|||
48550847|NCT01449370|156206028|FG010|Overall Study|Disease Progression|3|||
48550848|NCT01449370|156206029|FG011|Overall Study|Disease Progression|3|||
48550849|NCT01449370|156206030|FG012|Overall Study|Disease Progression|2|||
48550850|NCT01449370|156206031|FG013|Overall Study|Disease Progression|8|||
48550851|NCT01449370|156206032|FG014|Overall Study|Disease Progression|3|||
48550852|NCT01449370|156206033|FG015|Overall Study|Disease Progression|1|||
48550853|NCT01449370|156206034|FG016|Overall Study|Disease Progression|4|||
48550854|NCT01449370|156206035|FG017|Overall Study|Disease Progression|3|||
48550855|NCT01449370|156206036|FG018|Overall Study|Disease Progression|1|||
48550856|NCT01449370|156206037|FG019|Overall Study|Disease Progression|2|||
48550857|NCT01449370|156206038|FG020|Overall Study|Disease Progression|5|||
48550858|NCT01449370|156206039|FG021|Overall Study|Disease Progression|2|||
48550859|NCT01449370|156206040|FG022|Overall Study|Disease Progression|3|||
48550860|NCT01449370|156206041|FG023|Overall Study|Disease Progression|7|||
48550861|NCT01449370|156206042|FG024|Overall Study|Disease Progression|3|||
48550862|NCT01449370|156206018|FG000|Overall Study|Adverse Event|1|||
48550863|NCT01449370|156206019|FG001|Overall Study|Adverse Event|2|||
48550864|NCT01449370|156206020|FG002|Overall Study|Adverse Event|0|||
48550865|NCT01449370|156206021|FG003|Overall Study|Adverse Event|1|||
48550866|NCT01449370|156206022|FG004|Overall Study|Adverse Event|0|||
48550867|NCT01449370|156206023|FG005|Overall Study|Adverse Event|0|||
48550868|NCT01449370|156206024|FG006|Overall Study|Adverse Event|0|||
48550869|NCT01449370|156206025|FG007|Overall Study|Adverse Event|0|||
48550870|NCT01449370|156206026|FG008|Overall Study|Adverse Event|1|||
48550871|NCT01449370|156206027|FG009|Overall Study|Adverse Event|1|||
48550872|NCT01449370|156206028|FG010|Overall Study|Adverse Event|0|||
48550873|NCT01449370|156206029|FG011|Overall Study|Adverse Event|0|||
48550874|NCT01449370|156206030|FG012|Overall Study|Adverse Event|0|||
48550875|NCT01449370|156206031|FG013|Overall Study|Adverse Event|2|||
48550876|NCT01449370|156206032|FG014|Overall Study|Adverse Event|0|||
48550877|NCT01449370|156206033|FG015|Overall Study|Adverse Event|1|||
48550878|NCT01449370|156206034|FG016|Overall Study|Adverse Event|0|||
48550879|NCT01449370|156206035|FG017|Overall Study|Adverse Event|0|||
48550880|NCT01449370|156206036|FG018|Overall Study|Adverse Event|1|||
48550881|NCT01449370|156206037|FG019|Overall Study|Adverse Event|1|||
48550882|NCT01449370|156206038|FG020|Overall Study|Adverse Event|0|||
48550883|NCT01449370|156206039|FG021|Overall Study|Adverse Event|1|||
48550884|NCT01449370|156206040|FG022|Overall Study|Adverse Event|0|||
48550885|NCT01449370|156206041|FG023|Overall Study|Adverse Event|1|||
48550886|NCT01449370|156206042|FG024|Overall Study|Adverse Event|3|||
48550887|NCT01449370|156206018|FG000|Overall Study|Participant Decision|0|||
48550888|NCT01449370|156206019|FG001|Overall Study|Participant Decision|0|||
48550889|NCT01449370|156206020|FG002|Overall Study|Participant Decision|0|||
48550890|NCT01449370|156206021|FG003|Overall Study|Participant Decision|0|||
48550891|NCT01449370|156206022|FG004|Overall Study|Participant Decision|0|||
48550892|NCT01449370|156206023|FG005|Overall Study|Participant Decision|0|||
48550893|NCT01449370|156206024|FG006|Overall Study|Participant Decision|0|||
48550894|NCT01449370|156206025|FG007|Overall Study|Participant Decision|1|||
48550895|NCT01449370|156206026|FG008|Overall Study|Participant Decision|1|||
48550896|NCT01449370|156206027|FG009|Overall Study|Participant Decision|0|||
48550897|NCT01449370|156206028|FG010|Overall Study|Participant Decision|0|||
48550898|NCT01449370|156206029|FG011|Overall Study|Participant Decision|0|||
48550899|NCT01449370|156206030|FG012|Overall Study|Participant Decision|1|||
48550900|NCT01449370|156206031|FG013|Overall Study|Participant Decision|1|||
48550901|NCT01449370|156206032|FG014|Overall Study|Participant Decision|0|||
48550902|NCT01449370|156206033|FG015|Overall Study|Participant Decision|1|||
48550903|NCT01449370|156206034|FG016|Overall Study|Participant Decision|3|||
48550904|NCT01449370|156206035|FG017|Overall Study|Participant Decision|0|||
48550905|NCT01449370|156206036|FG018|Overall Study|Participant Decision|1|||
48550906|NCT01449370|156206037|FG019|Overall Study|Participant Decision|0|||
48550907|NCT01449370|156206038|FG020|Overall Study|Participant Decision|0|||
48550908|NCT01449370|156206039|FG021|Overall Study|Participant Decision|1|||
48550909|NCT01449370|156206040|FG022|Overall Study|Participant Decision|0|||
48550910|NCT01449370|156206041|FG023|Overall Study|Participant Decision|0|||
48550911|NCT01449370|156206042|FG024|Overall Study|Participant Decision|1|||
48550912|NCT01449370|156206018|FG000|Overall Study|Lost to Follow-up|0|||
48550913|NCT01449370|156206019|FG001|Overall Study|Lost to Follow-up|0|||
48550914|NCT01449370|156206020|FG002|Overall Study|Lost to Follow-up|0|||
48550915|NCT01449370|156206021|FG003|Overall Study|Lost to Follow-up|0|||
48550916|NCT01449370|156206022|FG004|Overall Study|Lost to Follow-up|0|||
48550917|NCT01449370|156206023|FG005|Overall Study|Lost to Follow-up|0|||
48550918|NCT01449370|156206024|FG006|Overall Study|Lost to Follow-up|0|||
48550919|NCT01449370|156206025|FG007|Overall Study|Lost to Follow-up|0|||
48550920|NCT01449370|156206026|FG008|Overall Study|Lost to Follow-up|0|||
48550921|NCT01449370|156206027|FG009|Overall Study|Lost to Follow-up|0|||
48550922|NCT01449370|156206028|FG010|Overall Study|Lost to Follow-up|0|||
48550923|NCT01449370|156206029|FG011|Overall Study|Lost to Follow-up|0|||
48550924|NCT01449370|156206030|FG012|Overall Study|Lost to Follow-up|0|||
48550925|NCT01449370|156206031|FG013|Overall Study|Lost to Follow-up|0|||
48550926|NCT01449370|156206032|FG014|Overall Study|Lost to Follow-up|0|||
48550927|NCT01449370|156206033|FG015|Overall Study|Lost to Follow-up|0|||
48550928|NCT01449370|156206034|FG016|Overall Study|Lost to Follow-up|0|||
48550929|NCT01449370|156206035|FG017|Overall Study|Lost to Follow-up|0|||
48550930|NCT01449370|156206036|FG018|Overall Study|Lost to Follow-up|0|||
48550931|NCT01449370|156206037|FG019|Overall Study|Lost to Follow-up|0|||
48550932|NCT01449370|156206038|FG020|Overall Study|Lost to Follow-up|1|||
48550933|NCT01449370|156206039|FG021|Overall Study|Lost to Follow-up|0|||
48550934|NCT01449370|156206040|FG022|Overall Study|Lost to Follow-up|0|||
48550935|NCT01449370|156206041|FG023|Overall Study|Lost to Follow-up|0|||
48550936|NCT01449370|156206042|FG024|Overall Study|Lost to Follow-up|0|||
48550937|NCT01449370|156206018|FG000|Overall Study|Other|0|||
48550938|NCT01449370|156206019|FG001|Overall Study|Other|0|||
48550939|NCT01449370|156206020|FG002|Overall Study|Other|0|||
48550940|NCT01449370|156206021|FG003|Overall Study|Other|0|||
48550941|NCT01449370|156206022|FG004|Overall Study|Other|0|||
48550942|NCT01449370|156206023|FG005|Overall Study|Other|0|||
48550943|NCT01449370|156206024|FG006|Overall Study|Other|0|||
48550944|NCT01449370|156206025|FG007|Overall Study|Other|0|||
48550945|NCT01449370|156206026|FG008|Overall Study|Other|1|||
48550946|NCT01449370|156206027|FG009|Overall Study|Other|1|||
48550947|NCT01449370|156206028|FG010|Overall Study|Other|0|||
48550948|NCT01449370|156206029|FG011|Overall Study|Other|0|||
48550949|NCT01449370|156206030|FG012|Overall Study|Other|0|||
48550950|NCT01449370|156206031|FG013|Overall Study|Other|0|||
48550951|NCT01449370|156206032|FG014|Overall Study|Other|0|||
48550952|NCT01449370|156206033|FG015|Overall Study|Other|0|||
48550953|NCT01449370|156206034|FG016|Overall Study|Other|0|||
48550954|NCT01449370|156206035|FG017|Overall Study|Other|0|||
48550955|NCT01449370|156206036|FG018|Overall Study|Other|0|||
48550956|NCT01449370|156206037|FG019|Overall Study|Other|0|||
48550957|NCT01449370|156206038|FG020|Overall Study|Other|0|||
48550958|NCT01449370|156206039|FG021|Overall Study|Other|0|||
48550959|NCT01449370|156206040|FG022|Overall Study|Other|1|||
48550960|NCT01449370|156206041|FG023|Overall Study|Other|1|||
48550961|NCT01449370|156206042|FG024|Overall Study|Other|0|||
48550962|NCT01449370|156206018|FG000|Overall Study|Medication Prohibited by Protocol|0|||
48550963|NCT01449370|156206019|FG001|Overall Study|Medication Prohibited by Protocol|0|||
48550964|NCT01449370|156206020|FG002|Overall Study|Medication Prohibited by Protocol|0|||
48550965|NCT01449370|156206021|FG003|Overall Study|Medication Prohibited by Protocol|0|||
48550966|NCT01449370|156206022|FG004|Overall Study|Medication Prohibited by Protocol|0|||
48550967|NCT01449370|156206023|FG005|Overall Study|Medication Prohibited by Protocol|0|||
48550968|NCT01449370|156206024|FG006|Overall Study|Medication Prohibited by Protocol|0|||
48550969|NCT01449370|156206025|FG007|Overall Study|Medication Prohibited by Protocol|0|||
48550970|NCT01449370|156206026|FG008|Overall Study|Medication Prohibited by Protocol|0|||
48550971|NCT01449370|156206027|FG009|Overall Study|Medication Prohibited by Protocol|0|||
48550972|NCT01449370|156206028|FG010|Overall Study|Medication Prohibited by Protocol|0|||
48550973|NCT01449370|156206029|FG011|Overall Study|Medication Prohibited by Protocol|0|||
48613403|NCT00658528|156439548|FG001|Overall Study|Withdrawal of consent|6|||
48613404|NCT00658528|156439547|FG000|Overall Study|Other|8|||
48613405|NCT00658528|156439548|FG001|Overall Study|Other|4|||
48613406|NCT00832975|156439552|FG000|Overall Study|Lost to Follow-up|7|||
48550974|NCT01449370|156206030|FG012|Overall Study|Medication Prohibited by Protocol|0|||
48550975|NCT01449370|156206031|FG013|Overall Study|Medication Prohibited by Protocol|0|||
48550976|NCT01449370|156206032|FG014|Overall Study|Medication Prohibited by Protocol|0|||
48613407|NCT00832975|156439552|FG000|Overall Study|Protocol Violation|6|||
48613408|NCT00832975|156439552|FG000|Overall Study|Death|5|||
48613409|NCT00832975|156439552|FG000|Overall Study|Physician Decision|4|||
48613410|NCT00832975|156439552|FG000|Overall Study|Withdrawal by Subject|3|||
48613411|NCT00832975|156439552|FG000|Overall Study|Other reasons|14|||
48613412|NCT02811159|156439556|FG000|Treatment Course 1|Lost to Follow-up|1|||
48550977|NCT01449370|156206033|FG015|Overall Study|Medication Prohibited by Protocol|0|||
48550978|NCT01449370|156206034|FG016|Overall Study|Medication Prohibited by Protocol|0|||
48550979|NCT01449370|156206035|FG017|Overall Study|Medication Prohibited by Protocol|0|||
48613413|NCT00433290|156439563|FG000|Overall Study|Adverse Event|24|||
48613414|NCT00433290|156439564|FG001|Overall Study|Adverse Event|7|||
48613415|NCT00433290|156439563|FG000|Overall Study|Lack of Efficacy|1|||
48613416|NCT00433290|156439564|FG001|Overall Study|Lack of Efficacy|5|||
48613417|NCT00433290|156439563|FG000|Overall Study|Withdrawal by Subject|4|||
48613418|NCT00433290|156439564|FG001|Overall Study|Withdrawal by Subject|2|||
48613419|NCT00433290|156439563|FG000|Overall Study|Protocol Violation|3|||
48613420|NCT00433290|156439564|FG001|Overall Study|Protocol Violation|2|||
48613421|NCT00433290|156439563|FG000|Overall Study|Physician Decision|2|||
48613422|NCT00433290|156439564|FG001|Overall Study|Physician Decision|0|||
48613423|NCT00433290|156439563|FG000|Overall Study|Entry Criteria Not Met|0|||
48613424|NCT00433290|156439564|FG001|Overall Study|Entry Criteria Not Met|1|||
48550980|NCT01449370|156206036|FG018|Overall Study|Medication Prohibited by Protocol|0|||
48550981|NCT01449370|156206037|FG019|Overall Study|Medication Prohibited by Protocol|0|||
48550982|NCT01449370|156206038|FG020|Overall Study|Medication Prohibited by Protocol|0|||
48550983|NCT01449370|156206039|FG021|Overall Study|Medication Prohibited by Protocol|0|||
48550984|NCT01449370|156206040|FG022|Overall Study|Medication Prohibited by Protocol|0|||
48550985|NCT01449370|156206041|FG023|Overall Study|Medication Prohibited by Protocol|1|||
48550986|NCT01449370|156206042|FG024|Overall Study|Medication Prohibited by Protocol|0|||
48550987|NCT01449370|156206018|FG000|Overall Study|Death|0|||
48550988|NCT01449370|156206019|FG001|Overall Study|Death|0|||
48550989|NCT01449370|156206020|FG002|Overall Study|Death|0|||
48550990|NCT01449370|156206021|FG003|Overall Study|Death|0|||
48550991|NCT01449370|156206022|FG004|Overall Study|Death|0|||
48550992|NCT01449370|156206023|FG005|Overall Study|Death|0|||
48613425|NCT00433290|156439563|FG000|Overall Study|Lost to Follow-up|1|||
48613426|NCT00433290|156439564|FG001|Overall Study|Lost to Follow-up|0|||
48613427|NCT00857389|156439565|FG000|Overall Study|Did not proceed to transplant|2|||
48613428|NCT01113749|156441315|FG000|Overall Study|Lost to Follow-up|1|||
48613429|NCT01113749|156441316|FG001|Overall Study|Lost to Follow-up|2|||
48613430|NCT03439839|156441317|FG000|Overall Study|Death|3|||
48613431|NCT03439839|156441318|FG001|Overall Study|Death|0|||
48550993|NCT01449370|156206024|FG006|Overall Study|Death|0|||
48550994|NCT01449370|156206025|FG007|Overall Study|Death|0|||
48550995|NCT01449370|156206026|FG008|Overall Study|Death|0|||
48550996|NCT01449370|156206027|FG009|Overall Study|Death|0|||
48613432|NCT02100631|156441321|FG000|Overall Study|Withdrawal by Subject|1|||
48550997|NCT01449370|156206028|FG010|Overall Study|Death|0|||
48550998|NCT01449370|156206029|FG011|Overall Study|Death|0|||
48550999|NCT01449370|156206030|FG012|Overall Study|Death|0|||
48551000|NCT01449370|156206031|FG013|Overall Study|Death|0|||
48551001|NCT01449370|156206032|FG014|Overall Study|Death|0|||
48613433|NCT02100631|156441322|FG001|Overall Study|Withdrawal by Subject|0|||
48613434|NCT02100631|156441323|FG002|Overall Study|Withdrawal by Subject|0|||
48613435|NCT02100631|156441321|FG000|Overall Study|Lost to Follow-up|3|||
48613436|NCT02100631|156441322|FG001|Overall Study|Lost to Follow-up|4|||
48613437|NCT02100631|156441323|FG002|Overall Study|Lost to Follow-up|0|||
48613438|NCT02100631|156441321|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
48613439|NCT02100631|156441322|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
48613440|NCT02100631|156441323|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
48613441|NCT01847209|156441324|FG000|Overall Study|Withdrawal by Subject|1|||
48613442|NCT01847209|156441324|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
48613443|NCT01408641|156441325|FG000|Overall Study|Physician Decision|1|||
48613444|NCT01408641|156441326|FG001|Overall Study|Physician Decision|0|||
48613445|NCT00576758|156441327|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
48613446|NCT00576758|156441328|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
48613447|NCT00576758|156441327|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
48613448|NCT00576758|156441328|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
48613449|NCT00576758|156441327|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
48551002|NCT01449370|156206033|FG015|Overall Study|Death|0|||
48551003|NCT01449370|156206034|FG016|Overall Study|Death|0|||
48551004|NCT01449370|156206035|FG017|Overall Study|Death|0|||
48551005|NCT01449370|156206036|FG018|Overall Study|Death|0|||
48551006|NCT01449370|156206037|FG019|Overall Study|Death|0|||
48551007|NCT01449370|156206038|FG020|Overall Study|Death|0|||
48613450|NCT00576758|156441328|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
48613451|NCT00576758|156441327|FG000|Induction Treatment Period|Death|1|||
48613452|NCT00576758|156441328|FG001|Induction Treatment Period|Death|0|||
48613453|NCT00576758|156441327|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
48613454|NCT00576758|156441328|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
48613455|NCT00576758|156441327|FG000|Induction Treatment Period|Withdrew consent|1|||
48613456|NCT00576758|156441328|FG001|Induction Treatment Period|Withdrew consent|0|||
48613457|NCT00576758|156441327|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
48613458|NCT00576758|156441328|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
48613459|NCT00576758|156441327|FG000|Extension Treatment Period|Death|1|||
48613460|NCT00576758|156441328|FG001|Extension Treatment Period|Death|1|||
48613461|NCT00576758|156441327|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
48613462|NCT00576758|156441328|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
48613463|NCT00576758|156441327|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
48613464|NCT00576758|156441328|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
48613465|NCT00576758|156441327|FG000|Extension Treatment Period|Administrative/Other|3|||
48613466|NCT00576758|156441328|FG001|Extension Treatment Period|Administrative/Other|1|||
48613467|NCT00576758|156441327|FG000|Follow-up Period|Administrative/Other|6|||
48613468|NCT00576758|156441328|FG001|Follow-up Period|Administrative/Other|8|||
48613469|NCT00576758|156441327|FG000|Follow-up Period|Death|3|||
48613470|NCT00576758|156441328|FG001|Follow-up Period|Death|3|||
48613471|NCT00576758|156441327|FG000|Follow-up Period|Insufficient therapeutic response|16|||
48613472|NCT00576758|156441328|FG001|Follow-up Period|Insufficient therapeutic response|5|||
48613473|NCT00576758|156441327|FG000|Follow-up Period|Withdrew consent|2|||
48613474|NCT00576758|156441328|FG001|Follow-up Period|Withdrew consent|1|||
48613475|NCT01136954|156441347|FG000|Overall Study|Adverse Event|3|||
48613476|NCT01136954|156441348|FG001|Overall Study|Adverse Event|2|||
48551008|NCT01449370|156206039|FG021|Overall Study|Death|0|||
48551009|NCT01449370|156206040|FG022|Overall Study|Death|0|||
48551010|NCT01449370|156206041|FG023|Overall Study|Death|0|||
48551011|NCT01449370|156206042|FG024|Overall Study|Death|1|||
48613477|NCT01136954|156441347|FG000|Overall Study|Withdrawal by Subject|6|||
48613478|NCT01136954|156441348|FG001|Overall Study|Withdrawal by Subject|2|||
48613479|NCT01136954|156441347|FG000|Overall Study|Lack of Efficacy|14|||
48551012|NCT04580914|156206046|FG000|Overall Study|Withdrawal by Subject|6|||
48613480|NCT01136954|156441348|FG001|Overall Study|Lack of Efficacy|13|||
48613481|NCT01136954|156441347|FG000|Overall Study|Physician Decision|0|||
48613482|NCT01136954|156441348|FG001|Overall Study|Physician Decision|1|||
48613483|NCT01136954|156441347|FG000|Overall Study|Other|1|||
48613484|NCT01136954|156441348|FG001|Overall Study|Other|3|||
48613485|NCT03801252|156441351|FG000|Overall Study|Protocol Violation|1|||
48613486|NCT03801252|156441352|FG001|Overall Study|Protocol Violation|2|||
48613487|NCT02471183|156441357|FG000|Main Treatment Period|Adverse Event|1|||
48551013|NCT04580914|156206046|FG000|Overall Study|Lost to Follow-up|2|||
48551014|NCT01685840|156206047|FG000|Overall Study|Death|77|||
48551015|NCT01685840|156206048|FG001|Overall Study|Death|66|||
48551016|NCT01685840|156206047|FG000|Overall Study|Lost to Follow-up|27|||
48551017|NCT01685840|156206048|FG001|Overall Study|Lost to Follow-up|25|||
48551018|NCT01685840|156206047|FG000|Overall Study|Physician Decision|3|||
48551019|NCT01685840|156206048|FG001|Overall Study|Physician Decision|7|||
48551020|NCT01685840|156206047|FG000|Overall Study|Withdrawal by Subject|14|||
48551021|NCT01685840|156206048|FG001|Overall Study|Withdrawal by Subject|17|||
48613488|NCT02471183|156441357|FG000|Main Treatment Period|Withdrawal by Subject|1|||
48613489|NCT02471183|156441357|FG000|Extended Treatment Period|Lack of Efficacy|1|||
48613490|NCT02328105|156441361|FG000|Overall Study|Death|6|||
48613491|NCT02328105|156441361|FG000|Overall Study|Withdrawal by Subject|1|||
48613492|NCT02328105|156441361|FG000|Overall Study|Still On Study in Follow-Up|4|||
48613493|NCT01588509|156441364|FG000|Overall Study|Lost to Follow-up|1|||
48613494|NCT01588509|156441365|FG001|Overall Study|Lost to Follow-up|0|||
48613495|NCT03345004|156441366|FG000|Overall Study|Physician Decision|1|||
48613496|NCT03345004|156441367|FG001|Overall Study|Physician Decision|0|||
48613497|NCT03345004|156441366|FG000|Overall Study|Withdrawal by Subject|0|||
48613498|NCT03345004|156441367|FG001|Overall Study|Withdrawal by Subject|1|||
48551022|NCT01685840|156206047|FG000|Overall Study|Futility|197|||
48551023|NCT01685840|156206048|FG001|Overall Study|Futility|200|||
48551024|NCT01685840|156206047|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
48551025|NCT01685840|156206048|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
48551026|NCT00489827|156206050|FG000|Overall Study|Intraoperative exclusion criteria|1|||
48551027|NCT00489827|156206051|FG001|Overall Study|Intraoperative exclusion criteria|1|||
48551028|NCT00489827|156206050|FG000|Overall Study|Intraoperative exclusion criteria|1|||
48551029|NCT00489827|156206051|FG001|Overall Study|Intraoperative exclusion criteria|1|||
48551030|NCT02296931|156206055|FG000|Overall Study|Protocol Violation|0|||
48551031|NCT02296931|156206056|FG001|Overall Study|Protocol Violation|2|||
48551032|NCT05771467|156206059|FG000|Overall Study|Lost to Follow-up|6|||
48551033|NCT05771467|156206060|FG001|Overall Study|Lost to Follow-up|3|||
48551034|NCT02933255|156206063|FG000|Overall Study|Discontinued due to study closure.|1|||
48551035|NCT02933255|156206064|FG001|Overall Study|Discontinued due to study closure.|0|||
48551036|NCT04386616|156206073|FG000|Overall Study|Death|22|||
48551037|NCT04386616|156206074|FG001|Overall Study|Death|22|||
48551038|NCT04386616|156206075|FG002|Overall Study|Death|21|||
48551039|NCT04386616|156206073|FG000|Overall Study|Lost to Follow-up|5|||
48551040|NCT04386616|156206074|FG001|Overall Study|Lost to Follow-up|8|||
48551041|NCT04386616|156206075|FG002|Overall Study|Lost to Follow-up|6|||
48551042|NCT04386616|156206073|FG000|Overall Study|Withdrawal by Subject|2|||
48551043|NCT04386616|156206074|FG001|Overall Study|Withdrawal by Subject|4|||
48551044|NCT04386616|156206075|FG002|Overall Study|Withdrawal by Subject|1|||
48551045|NCT04386616|156206073|FG000|Overall Study|Adverse Event|1|||
48551046|NCT04386616|156206074|FG001|Overall Study|Adverse Event|1|||
48551047|NCT04386616|156206075|FG002|Overall Study|Adverse Event|0|||
48551048|NCT03449446|156206076|FG000|Overall Study|Randomized but Never Treated|0|||
48551049|NCT03449446|156206077|FG001|Overall Study|Randomized but Never Treated|0|||
48551050|NCT03449446|156206078|FG002|Overall Study|Randomized but Never Treated|1|||
48551051|NCT03449446|156206079|FG003|Overall Study|Randomized but Never Treated|1|||
48551052|NCT03449446|156206080|FG004|Overall Study|Randomized but Never Treated|1|||
48551053|NCT03449446|156206081|FG005|Overall Study|Randomized but Never Treated|0|||
48551054|NCT03449446|156206082|FG006|Overall Study|Randomized but Never Treated|0|||
48613499|NCT02932943|156441368|FG000|Overall Study|Lost to Follow-up|0|||
48613500|NCT02932943|156441369|FG001|Overall Study|Lost to Follow-up|2|||
48613501|NCT02932943|156441368|FG000|Overall Study|Adverse Event|2|||
48613502|NCT02932943|156441369|FG001|Overall Study|Adverse Event|2|||
48551055|NCT03449446|156206076|FG000|Overall Study|Unknown Reason|33|||
48551056|NCT03449446|156206077|FG001|Overall Study|Unknown Reason|1|||
48551057|NCT03449446|156206078|FG002|Overall Study|Unknown Reason|1|||
48551058|NCT03449446|156206079|FG003|Overall Study|Unknown Reason|1|||
48551059|NCT03449446|156206080|FG004|Overall Study|Unknown Reason|2|||
48551060|NCT03449446|156206081|FG005|Overall Study|Unknown Reason|2|||
48551061|NCT03449446|156206082|FG006|Overall Study|Unknown Reason|0|||
48551062|NCT03449446|156206076|FG000|Overall Study|Withdrew Consent|1|||
48551063|NCT03449446|156206077|FG001|Overall Study|Withdrew Consent|3|||
48551064|NCT03449446|156206078|FG002|Overall Study|Withdrew Consent|1|||
48551065|NCT03449446|156206079|FG003|Overall Study|Withdrew Consent|4|||
48551066|NCT03449446|156206080|FG004|Overall Study|Withdrew Consent|4|||
48551067|NCT03449446|156206081|FG005|Overall Study|Withdrew Consent|4|||
48551068|NCT03449446|156206082|FG006|Overall Study|Withdrew Consent|1|||
48551069|NCT03449446|156206076|FG000|Overall Study|Adverse Event|1|||
48551070|NCT03449446|156206077|FG001|Overall Study|Adverse Event|2|||
48551071|NCT03449446|156206078|FG002|Overall Study|Adverse Event|1|||
48551072|NCT03449446|156206079|FG003|Overall Study|Adverse Event|0|||
48551073|NCT03449446|156206080|FG004|Overall Study|Adverse Event|0|||
48551074|NCT03449446|156206081|FG005|Overall Study|Adverse Event|2|||
48551075|NCT03449446|156206082|FG006|Overall Study|Adverse Event|0|||
48551076|NCT03449446|156206076|FG000|Overall Study|Lost to Follow-up|0|||
48551077|NCT03449446|156206077|FG001|Overall Study|Lost to Follow-up|0|||
48551078|NCT03449446|156206078|FG002|Overall Study|Lost to Follow-up|2|||
48551079|NCT03449446|156206079|FG003|Overall Study|Lost to Follow-up|1|||
48551080|NCT03449446|156206080|FG004|Overall Study|Lost to Follow-up|3|||
48551081|NCT03449446|156206081|FG005|Overall Study|Lost to Follow-up|0|||
48613503|NCT02932943|156441368|FG000|Overall Study|Withdrawal by Subject|3|||
48613504|NCT02932943|156441369|FG001|Overall Study|Withdrawal by Subject|3|||
48613505|NCT01983930|156441370|FG000|Overall Study|Withdrawal by Subject|9|||
48613506|NCT01983930|156441371|FG001|Overall Study|Withdrawal by Subject|8|||
48613507|NCT01983930|156441370|FG000|Overall Study|Adverse Event|0|||
48613508|NCT01983930|156441371|FG001|Overall Study|Adverse Event|1|||
48613509|NCT03286504|156441378|FG000|Overall Study|Lost to Follow-up|19|||
48613510|NCT03286504|156441379|FG001|Overall Study|Lost to Follow-up|16|||
48613511|NCT01732692|156441391|FG000|Overall Study|Adverse Event|0|||
48613512|NCT01732692|156441392|FG001|Overall Study|Adverse Event|1|||
48613513|NCT00929669|156441395|FG000|Overall Study|elevated glucose levels|1|||
48613514|NCT01056276|156441396|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
48613515|NCT01056276|156441397|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
48613516|NCT01056276|156441396|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
48613517|NCT01056276|156441397|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
48613518|NCT01056276|156441396|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
48613519|NCT01056276|156441397|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
48613520|NCT01056276|156441396|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
48613521|NCT01056276|156441397|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
48613522|NCT01056276|156441396|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
48613523|NCT01056276|156441397|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
48613524|NCT01056276|156441396|FG000|Treatment Period-Cycles 1-8|Death|3|||
48613525|NCT01056276|156441397|FG001|Treatment Period-Cycles 1-8|Death|1|||
48613526|NCT01056276|156441396|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
48613527|NCT01056276|156441397|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
48613528|NCT01056276|156441396|FG000|Maintenance Therapy|Toxicity|0|||
48613529|NCT01056276|156441397|FG001|Maintenance Therapy|Toxicity|2|||
48613530|NCT01056276|156441396|FG000|Maintenance Therapy|Progressive Disease|0|||
48613531|NCT01056276|156441397|FG001|Maintenance Therapy|Progressive Disease|9|||
48613532|NCT01056276|156441396|FG000|Maintenance Therapy|Physician Decision|0|||
48613533|NCT01056276|156441397|FG001|Maintenance Therapy|Physician Decision|1|||
48613534|NCT01056276|156441396|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
48613535|NCT01056276|156441397|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
48613536|NCT01056276|156441396|FG000|Maintenance Therapy|Intercurrent Illness|0|||
48613537|NCT01056276|156441397|FG001|Maintenance Therapy|Intercurrent Illness|1|||
48551082|NCT03449446|156206082|FG006|Overall Study|Lost to Follow-up|0|||
48551083|NCT03449446|156206076|FG000|Overall Study|Investigator's Discretion|0|||
48551084|NCT03449446|156206077|FG001|Overall Study|Investigator's Discretion|1|||
48551085|NCT03449446|156206078|FG002|Overall Study|Investigator's Discretion|1|||
48551086|NCT03449446|156206079|FG003|Overall Study|Investigator's Discretion|2|||
48551087|NCT03449446|156206080|FG004|Overall Study|Investigator's Discretion|0|||
48613538|NCT01056276|156441396|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
48613539|NCT01056276|156441397|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
48613540|NCT01881425|156441398|FG000|Overall Study|Death|5|||
48551088|NCT03449446|156206081|FG005|Overall Study|Investigator's Discretion|0|||
48613541|NCT01881425|156441399|FG001|Overall Study|Death|1|||
48613542|NCT01881425|156441398|FG000|Overall Study|Withdrawal by Subject|8|||
48613543|NCT01881425|156441399|FG001|Overall Study|Withdrawal by Subject|3|||
48613544|NCT01881425|156441398|FG000|Overall Study|Physician Decision|2|||
48613545|NCT01881425|156441399|FG001|Overall Study|Physician Decision|1|||
48613546|NCT01881425|156441398|FG000|Overall Study|Adverse Event|3|||
48613547|NCT01881425|156441399|FG001|Overall Study|Adverse Event|0|||
48613548|NCT01881425|156441398|FG000|Overall Study|General Anesthesia panic attack|0|||
48613549|NCT01881425|156441399|FG001|Overall Study|General Anesthesia panic attack|1|||
48613550|NCT01881425|156441398|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
48613551|NCT01881425|156441399|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
48551089|NCT03449446|156206082|FG006|Overall Study|Investigator's Discretion|0|||
48551090|NCT03449446|156206076|FG000|Overall Study|Non Compliance with Study Drug|1|||
48551091|NCT03449446|156206077|FG001|Overall Study|Non Compliance with Study Drug|0|||
48551092|NCT03449446|156206078|FG002|Overall Study|Non Compliance with Study Drug|0|||
48551093|NCT03449446|156206079|FG003|Overall Study|Non Compliance with Study Drug|0|||
48551094|NCT03449446|156206080|FG004|Overall Study|Non Compliance with Study Drug|0|||
48551095|NCT03449446|156206081|FG005|Overall Study|Non Compliance with Study Drug|0|||
48551096|NCT03449446|156206082|FG006|Overall Study|Non Compliance with Study Drug|0|||
48551097|NCT03449446|156206076|FG000|Overall Study|Protocol Violation|0|||
48551098|NCT03449446|156206077|FG001|Overall Study|Protocol Violation|0|||
48551099|NCT03449446|156206078|FG002|Overall Study|Protocol Violation|0|||
48551100|NCT03449446|156206079|FG003|Overall Study|Protocol Violation|0|||
48551101|NCT03449446|156206080|FG004|Overall Study|Protocol Violation|1|||
48551102|NCT03449446|156206081|FG005|Overall Study|Protocol Violation|1|||
48551103|NCT03449446|156206082|FG006|Overall Study|Protocol Violation|0|||
48551104|NCT03449446|156206076|FG000|Overall Study|Death|0|||
48551105|NCT03449446|156206077|FG001|Overall Study|Death|0|||
48551106|NCT03449446|156206078|FG002|Overall Study|Death|0|||
48551107|NCT03449446|156206079|FG003|Overall Study|Death|0|||
48551108|NCT03449446|156206080|FG004|Overall Study|Death|1|||
48551109|NCT03449446|156206081|FG005|Overall Study|Death|0|||
48551110|NCT03449446|156206082|FG006|Overall Study|Death|0|||
48551111|NCT04873232|156206087|FG000|Overall Study|Lost to Follow-up|1|||
48551112|NCT04873232|156206088|FG001|Overall Study|Lost to Follow-up|4|||
48551113|NCT04873232|156206087|FG000|Overall Study|Withdrawal by Subject|1|||
48551114|NCT04873232|156206088|FG001|Overall Study|Withdrawal by Subject|0|||
48551115|NCT05325294|156206089|FG000|Overall Study|Adverse Event|3|||
48551116|NCT05325294|156206090|FG001|Overall Study|Adverse Event|3|||
48551117|NCT05325294|156206089|FG000|Overall Study|Physician Decision|0|||
48551118|NCT05325294|156206090|FG001|Overall Study|Physician Decision|1|||
48551119|NCT05325294|156206089|FG000|Overall Study|Withdrawal by Subject|0|||
48551120|NCT05325294|156206090|FG001|Overall Study|Withdrawal by Subject|3|||
48551121|NCT05325294|156206089|FG000|Overall Study|Lost to Follow-up|1|||
48551122|NCT05325294|156206090|FG001|Overall Study|Lost to Follow-up|0|||
48551123|NCT05325294|156206089|FG000|Overall Study|Sponsor Request|0|||
48551124|NCT05325294|156206090|FG001|Overall Study|Sponsor Request|2|||
48551125|NCT00761657|156207760|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
48551126|NCT00761657|156207761|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
48551127|NCT00761657|156207762|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
48551128|NCT00761657|156207763|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
48551129|NCT00761657|156207764|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
48551130|NCT00761657|156207765|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
48551131|NCT00761657|156207766|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
48551132|NCT00761657|156207767|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
48551133|NCT00761657|156207768|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
48551134|NCT00761657|156207760|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
48551135|NCT00761657|156207761|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
48551136|NCT00761657|156207762|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
48551137|NCT00761657|156207763|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
48551138|NCT00761657|156207764|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
48551139|NCT00761657|156207765|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
48551140|NCT00761657|156207766|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
48551141|NCT00761657|156207767|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
48551142|NCT00761657|156207768|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
48551143|NCT00761657|156207760|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
48551144|NCT00761657|156207761|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
48551145|NCT00761657|156207762|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
48551146|NCT00761657|156207763|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
48551147|NCT00761657|156207764|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
48551148|NCT00761657|156207765|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
48551149|NCT00761657|156207766|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
48551150|NCT00761657|156207767|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
48551151|NCT00761657|156207768|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
48551152|NCT00761657|156207760|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
48551153|NCT00761657|156207761|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
48613552|NCT01881425|156441398|FG000|Overall Study|Lost to Follow-up|7|||
48613553|NCT01881425|156441399|FG001|Overall Study|Lost to Follow-up|2|||
48613554|NCT04900272|156441400|FG000|Overall Study|Lost to Follow-up|2|||
48613555|NCT04900272|156441400|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
48613556|NCT04900272|156441400|FG000|Overall Study|Withdrawal by Subject|1|||
48613557|NCT00937950|156441401|FG000|Overall Study|Withdrawal by Subject|23|||
48613558|NCT00937950|156441401|FG000|Overall Study|Migrated/moved from study area|27|||
48613559|NCT00937950|156441401|FG000|Overall Study|Lost to Follow-up|144|||
48613560|NCT00937950|156441401|FG000|Overall Study|Missing confirmed|4|||
48613561|NCT00937950|156441401|FG000|Overall Study|Other|18|||
48613562|NCT00485303|156441402|FG000|Overall Study|Adverse Event|5|||
48613563|NCT00485303|156441402|FG000|Overall Study|Progressive Disease|44|||
48613564|NCT00485303|156441402|FG000|Overall Study|Other|3|||
48613565|NCT00485303|156441402|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
48613566|NCT00485303|156441402|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
48613567|NCT00741611|156441403|FG000|Overall Study|Death|0|||
48613568|NCT00741611|156441404|FG001|Overall Study|Death|0|||
48613569|NCT00741611|156441405|FG002|Overall Study|Death|1|||
48613570|NCT00741611|156441403|FG000|Overall Study|Withdrawal by Subject|0|||
48613571|NCT00741611|156441404|FG001|Overall Study|Withdrawal by Subject|2|||
48613572|NCT00741611|156441405|FG002|Overall Study|Withdrawal by Subject|2|||
48613573|NCT04424901|156441406|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
48613574|NCT04424901|156441407|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
48613575|NCT01970371|156441408|FG000|Overall Study|Death|8|||
48551154|NCT00761657|156207762|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
48551155|NCT00761657|156207763|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
48551156|NCT00761657|156207764|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
48551157|NCT00761657|156207765|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
48551158|NCT00761657|156207766|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
48613576|NCT01970371|156441409|FG001|Overall Study|Death|13|||
48613577|NCT01970371|156441410|FG002|Overall Study|Death|12|||
48551159|NCT00761657|156207767|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
48551160|NCT00761657|156207768|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
48551161|NCT02540850|156207774|FG000|Overall Study|Lost to Follow-up|69|||
48551162|NCT02540850|156207775|FG001|Overall Study|Lost to Follow-up|66|||
48613578|NCT01970371|156441408|FG000|Overall Study|Lost to Follow-up|0|||
48613579|NCT01970371|156441409|FG001|Overall Study|Lost to Follow-up|0|||
48613580|NCT01970371|156441410|FG002|Overall Study|Lost to Follow-up|1|||
48613581|NCT02239328|156441411|FG000|Overall Study|Benign disease noted at time of surgery|6|||
48613582|NCT02239328|156441411|FG000|Overall Study|Equipment or website malfunction|2|||
48613583|NCT00770367|156441412|FG000|First Intervention|Withdrawal by Subject|0|||
48613584|NCT00770367|156441413|FG001|First Intervention|Withdrawal by Subject|2|||
48613585|NCT00770367|156441412|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
48613586|NCT00770367|156441413|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
48613587|NCT00770367|156441412|FG000|Second Intervention|Lost to Follow-up|2|||
48551163|NCT02540850|156207776|FG002|Overall Study|Lost to Follow-up|34|||
48551164|NCT00478244|156207786|FG000|Overall Study|Did not receive transplant|1|||
48551165|NCT03190915|156207787|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
48551166|NCT03190915|156207787|FG000|Overall Study|Progressive Disease|3|||
48551167|NCT01755767|156207788|FG000|Overall Study|Progressive Disease|8|||
48551168|NCT01755767|156207789|FG001|Overall Study|Progressive Disease|7|||
48551169|NCT01755767|156207790|FG002|Overall Study|Progressive Disease|91|||
48551170|NCT01755767|156207791|FG003|Overall Study|Progressive Disease|43|||
48551171|NCT01755767|156207788|FG000|Overall Study|Clinical Disease Progression|4|||
48551172|NCT01755767|156207789|FG001|Overall Study|Clinical Disease Progression|2|||
48551173|NCT01755767|156207790|FG002|Overall Study|Clinical Disease Progression|29|||
48551174|NCT01755767|156207791|FG003|Overall Study|Clinical Disease Progression|20|||
48613588|NCT00770367|156441413|FG001|Second Intervention|Lost to Follow-up|0|||
48613589|NCT00435942|156441414|FG000|Overall Study|Death|17|||
48613590|NCT00435942|156441415|FG001|Overall Study|Death|10|||
48613591|NCT00435942|156441414|FG000|Overall Study|Withdrawal by Subject|2|||
48613592|NCT00435942|156441415|FG001|Overall Study|Withdrawal by Subject|0|||
48613593|NCT00435942|156441414|FG000|Overall Study|Lost to Follow-up|0|||
48613594|NCT00435942|156441415|FG001|Overall Study|Lost to Follow-up|16|||
48551175|NCT01755767|156207788|FG000|Overall Study|Radiographic Disease Progression|9|||
48613595|NCT00435942|156441414|FG000|Overall Study|Conversion to Open Repair|1|||
48551176|NCT01755767|156207789|FG001|Overall Study|Radiographic Disease Progression|4|||
48613596|NCT00435942|156441415|FG001|Overall Study|Conversion to Open Repair|0|||
48613597|NCT00435942|156441414|FG000|Overall Study|Technical Failure|3|||
48613598|NCT00435942|156441415|FG001|Overall Study|Technical Failure|0|||
48613599|NCT00435942|156441414|FG000|Overall Study|Other|0|||
48613600|NCT00435942|156441415|FG001|Overall Study|Other|1|||
48613601|NCT01875237|156441417|FG000|Overall Study|GVDH before DLI|1|||
48613602|NCT01875237|156441418|FG001|Overall Study|GVDH before DLI|0|||
48613603|NCT01875237|156441417|FG000|Overall Study|DLI cells could not be produced|1|||
48613604|NCT01875237|156441418|FG001|Overall Study|DLI cells could not be produced|0|||
48613605|NCT04871113|156441419|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613606|NCT04871113|156441420|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613607|NCT04871113|156441421|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613608|NCT04871113|156441422|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613609|NCT04871113|156441423|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613610|NCT04871113|156441424|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
48613611|NCT04871113|156441425|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613612|NCT04871113|156441426|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613613|NCT04871113|156441427|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613614|NCT04871113|156441428|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
48613615|NCT04871113|156441419|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
48613616|NCT04871113|156441420|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
48613617|NCT04871113|156441421|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
48613618|NCT04871113|156441422|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
48613619|NCT04871113|156441423|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
48613620|NCT04871113|156441424|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
48613621|NCT04871113|156441425|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
48613622|NCT04871113|156441426|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
48613623|NCT04871113|156441427|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
48613624|NCT04871113|156441428|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
48613625|NCT02412657|156441432|FG000|Overall Study|Lost to Follow-up|1|||
48613626|NCT02412657|156441433|FG001|Overall Study|Lost to Follow-up|0|||
48613627|NCT02412657|156441434|FG002|Overall Study|Lost to Follow-up|0|||
48613628|NCT02412657|156441432|FG000|Overall Study|Protocol Violation|0|||
48613629|NCT02412657|156441433|FG001|Overall Study|Protocol Violation|2|||
48551177|NCT01755767|156207790|FG002|Overall Study|Radiographic Disease Progression|44|||
48551178|NCT01755767|156207791|FG003|Overall Study|Radiographic Disease Progression|27|||
48551179|NCT01755767|156207788|FG000|Overall Study|Adverse Event|6|||
48551180|NCT01755767|156207789|FG001|Overall Study|Adverse Event|0|||
48551181|NCT01755767|156207790|FG002|Overall Study|Adverse Event|28|||
48551182|NCT01755767|156207791|FG003|Overall Study|Adverse Event|11|||
48551183|NCT01755767|156207788|FG000|Overall Study|Death|1|||
48551184|NCT01755767|156207789|FG001|Overall Study|Death|2|||
48551185|NCT01755767|156207790|FG002|Overall Study|Death|15|||
48551186|NCT01755767|156207791|FG003|Overall Study|Death|4|||
48551187|NCT01755767|156207788|FG000|Overall Study|Subject Decision|0|||
48551188|NCT01755767|156207789|FG001|Overall Study|Subject Decision|0|||
48613630|NCT02412657|156441434|FG002|Overall Study|Protocol Violation|3|||
48613631|NCT02382939|156441436|FG000|Overall Study|Adverse Event|1|||
48613632|NCT02382939|156441437|FG001|Overall Study|Adverse Event|1|||
48613633|NCT02382939|156441436|FG000|Overall Study|Withdrawal by Subject|2|||
48613634|NCT02382939|156441437|FG001|Overall Study|Withdrawal by Subject|2|||
48613635|NCT00689936|156441439|FG000|Active Treatment Phase|Adverse Event|68|||
48613636|NCT00689936|156441440|FG001|Active Treatment Phase|Adverse Event|71|||
48613637|NCT00689936|156441441|FG002|Active Treatment Phase|Adverse Event|76|||
48613638|NCT00689936|156441439|FG000|Active Treatment Phase|Disease Progression|273|||
48613639|NCT00689936|156441440|FG001|Active Treatment Phase|Disease Progression|362|||
48613640|NCT00689936|156441441|FG002|Active Treatment Phase|Disease Progression|339|||
48613641|NCT00689936|156441439|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
48551189|NCT01755767|156207790|FG002|Overall Study|Subject Decision|10|||
48613642|NCT00689936|156441440|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
48613643|NCT00689936|156441441|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
48613644|NCT00689936|156441439|FG000|Active Treatment Phase|Death|60|||
48551190|NCT01755767|156207791|FG003|Overall Study|Subject Decision|3|||
48551191|NCT01755767|156207788|FG000|Overall Study|Withdrawal by Subject|0|||
48551192|NCT01755767|156207789|FG001|Overall Study|Withdrawal by Subject|0|||
48551193|NCT01755767|156207790|FG002|Overall Study|Withdrawal by Subject|2|||
48551194|NCT01755767|156207791|FG003|Overall Study|Withdrawal by Subject|1|||
48551195|NCT01755767|156207788|FG000|Overall Study|Other|0|||
48551196|NCT01755767|156207789|FG001|Overall Study|Other|0|||
48551197|NCT01755767|156207790|FG002|Overall Study|Other|2|||
48613645|NCT00689936|156441440|FG001|Active Treatment Phase|Death|28|||
48613646|NCT00689936|156441441|FG002|Active Treatment Phase|Death|37|||
48613647|NCT00689936|156441439|FG000|Active Treatment Phase|Lost to Follow-up|0|||
48613648|NCT00689936|156441440|FG001|Active Treatment Phase|Lost to Follow-up|2|||
48613649|NCT00689936|156441441|FG002|Active Treatment Phase|Lost to Follow-up|2|||
48551198|NCT01755767|156207791|FG003|Overall Study|Other|3|||
48551199|NCT01755767|156207788|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
48551200|NCT01755767|156207789|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
48551201|NCT01755767|156207790|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
48551202|NCT01755767|156207791|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
48551203|NCT03459729|156207792|FG000|Overall Study|Physician Decision|2|||
48551204|NCT00191165|156207794|FG000|Overall Study|Adverse Event|2|||
48551205|NCT00191165|156207795|FG001|Overall Study|Adverse Event|0|||
48551206|NCT00191165|156207794|FG000|Overall Study|Protocol Violation|0|||
48551207|NCT00191165|156207795|FG001|Overall Study|Protocol Violation|1|||
48551208|NCT00191165|156207794|FG000|Overall Study|Participant Moved Away|0|||
48551209|NCT00191165|156207795|FG001|Overall Study|Participant Moved Away|1|||
48551210|NCT01352416|156207798|FG000|Overall Study|Physician Decision|1|||
48551211|NCT01352416|156207799|FG001|Overall Study|Physician Decision|2|||
48551212|NCT01352416|156207800|FG002|Overall Study|Physician Decision|2|||
48551213|NCT01352416|156207801|FG003|Overall Study|Physician Decision|1|||
48551214|NCT00735397|156207811|FG000|Overall Study|Adverse Event|194|||
48551215|NCT00735397|156207811|FG000|Overall Study|Lost to Follow-up|33|||
48551216|NCT00735397|156207811|FG000|Overall Study|Participant choice|252|||
48551217|NCT00735397|156207811|FG000|Overall Study|Inadequate therapeutic effect|202|||
48551218|NCT00735397|156207811|FG000|Overall Study|Administrative/Other|502|||
48551219|NCT03421730|156207812|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551220|NCT03421730|156207813|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
48551221|NCT03421730|156207814|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48613650|NCT00689936|156441439|FG000|Active Treatment Phase|Protocol Violation|2|||
48613651|NCT00689936|156441440|FG001|Active Treatment Phase|Protocol Violation|2|||
48551222|NCT03421730|156207815|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551223|NCT03421730|156207816|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551224|NCT03421730|156207817|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551225|NCT03421730|156207818|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48613652|NCT00689936|156441441|FG002|Active Treatment Phase|Protocol Violation|4|||
48613653|NCT00689936|156441439|FG000|Active Treatment Phase|Study Close Out|64|||
48613654|NCT00689936|156441440|FG001|Active Treatment Phase|Study Close Out|26|||
48613655|NCT00689936|156441441|FG002|Active Treatment Phase|Study Close Out|21|||
48613656|NCT00689936|156441439|FG000|Active Treatment Phase|Miscellaneous|52|||
48551226|NCT03421730|156207819|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551227|NCT03421730|156207820|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551228|NCT03421730|156207821|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551229|NCT03421730|156207822|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551230|NCT03421730|156207823|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
48551231|NCT03421730|156207812|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551232|NCT03421730|156207813|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551233|NCT03421730|156207814|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551234|NCT03421730|156207815|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551235|NCT03421730|156207816|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
48551236|NCT03421730|156207817|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551237|NCT03421730|156207818|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551238|NCT03421730|156207819|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551239|NCT03421730|156207820|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551240|NCT03421730|156207821|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551241|NCT03421730|156207822|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551242|NCT03421730|156207823|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
48551243|NCT01982448|156207824|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
48551244|NCT01982448|156207825|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
48551245|NCT01982448|156207824|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
48551246|NCT01982448|156207825|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
48551247|NCT01982448|156207824|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
48551248|NCT01982448|156207825|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
48551249|NCT01982448|156207824|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
48551250|NCT01982448|156207825|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
48325485|NCT02357966|155389113|FG001|Overall Study|Physician Decision|0|||
48551251|NCT01199016|156207826|FG000|Overall Study|No longer meets eligibility criteria|4|||
48551252|NCT01199016|156207826|FG000|Overall Study|Entrance criteria|5|||
48551253|NCT01199016|156207826|FG000|Overall Study|Protocol Violation|9|||
48551254|NCT01199016|156207826|FG000|Overall Study|Other|13|||
48551255|NCT01199016|156207826|FG000|Overall Study|Withdrawal by Subject|21|||
48551256|NCT01199016|156207826|FG000|Overall Study|Lost to Follow-up|25|||
48551257|NCT03016975|156207838|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
48551258|NCT03016975|156207839|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
48551259|NCT03016975|156207840|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
48551260|NCT03016975|156207838|FG000|At 6 Months Follow-up|Death|2|||
48551261|NCT03016975|156207839|FG001|At 6 Months Follow-up|Death|0|||
48551262|NCT03016975|156207840|FG002|At 6 Months Follow-up|Death|0|||
48551263|NCT03016975|156207838|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
48551264|NCT03016975|156207839|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
48551265|NCT03016975|156207840|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
48551266|NCT03016975|156207838|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
48551267|NCT03016975|156207839|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
48551268|NCT03016975|156207840|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
48551269|NCT03016975|156207838|FG000|At 6 Months Follow-up|Aborted implant|1|||
48551270|NCT03016975|156207839|FG001|At 6 Months Follow-up|Aborted implant|0|||
48551271|NCT03016975|156207840|FG002|At 6 Months Follow-up|Aborted implant|0|||
48551272|NCT03016975|156207838|FG000|At 2 Year Follow-up|Death|1|||
48551273|NCT03016975|156207839|FG001|At 2 Year Follow-up|Death|0|||
48551274|NCT03016975|156207840|FG002|At 2 Year Follow-up|Death|0|||
48551275|NCT03016975|156207838|FG000|At 3 Year Follow-up|Death|1|||
48551276|NCT03016975|156207839|FG001|At 3 Year Follow-up|Death|0|||
48551277|NCT03016975|156207840|FG002|At 3 Year Follow-up|Death|0|||
48551278|NCT03016975|156207838|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
48551279|NCT03016975|156207839|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
48551280|NCT03016975|156207840|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
48551281|NCT03016975|156207838|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
48551282|NCT03016975|156207839|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
48551283|NCT03016975|156207840|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
48551284|NCT04106661|156207841|FG000|Overall Study|Protocol Violation|3|||
48551285|NCT04106661|156207842|FG001|Overall Study|Protocol Violation|0|||
48551286|NCT04106661|156207841|FG000|Overall Study|Scheduling difficulties|1|||
48551287|NCT04106661|156207842|FG001|Overall Study|Scheduling difficulties|1|||
48551288|NCT02794870|156207849|FG000|Overall Study|Withdrawal by Subject|2|||
48551289|NCT02794870|156207850|FG001|Overall Study|Withdrawal by Subject|0|||
48551290|NCT01338870|156207853|FG000|Overall Study|Lost to Follow-up|0|||
48551291|NCT01338870|156207854|FG001|Overall Study|Lost to Follow-up|0|||
48551292|NCT01338870|156207855|FG002|Overall Study|Lost to Follow-up|1|||
48613657|NCT00689936|156441440|FG001|Active Treatment Phase|Miscellaneous|34|||
48613658|NCT00689936|156441441|FG002|Active Treatment Phase|Miscellaneous|47|||
48613659|NCT00689936|156441439|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
48613660|NCT00689936|156441440|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
48613661|NCT00689936|156441441|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
48613662|NCT01682031|156441442|FG000|Overall Study|Withdrawal by Subject|0|||
48613663|NCT01682031|156441443|FG001|Overall Study|Withdrawal by Subject|1|||
48613664|NCT01682031|156441442|FG000|Overall Study|Adverse Event|0|||
48613665|NCT01682031|156441443|FG001|Overall Study|Adverse Event|2|||
48613666|NCT01682031|156441442|FG000|Overall Study|MRI results indicate increased nodul|0|||
48613667|NCT01682031|156441443|FG001|Overall Study|MRI results indicate increased nodul|1|||
48613668|NCT01682031|156441442|FG000|Overall Study|Patient could not swallow tablets|1|||
48613669|NCT01682031|156441443|FG001|Overall Study|Patient could not swallow tablets|0|||
48613670|NCT01682031|156441442|FG000|Overall Study|Patient stopped selenium on his own|0|||
48613671|NCT01682031|156441443|FG001|Overall Study|Patient stopped selenium on his own|1|||
48613672|NCT03881371|156441445|FG000|Overall Study|Adverse Event|8|||
48613673|NCT03881371|156441446|FG001|Overall Study|Adverse Event|9|||
48613674|NCT03881371|156441445|FG000|Overall Study|Death|1|||
48613675|NCT03881371|156441446|FG001|Overall Study|Death|0|||
48613676|NCT03881371|156441445|FG000|Overall Study|Lost to Follow-up|1|||
48613677|NCT03881371|156441446|FG001|Overall Study|Lost to Follow-up|0|||
48551293|NCT01338870|156207856|FG003|Overall Study|Lost to Follow-up|0|||
48551294|NCT01338870|156207857|FG004|Overall Study|Lost to Follow-up|1|||
48551295|NCT01338870|156207858|FG005|Overall Study|Lost to Follow-up|0|||
48551296|NCT01338870|156207853|FG000|Overall Study|Withdrawal by Subject|2|||
48551297|NCT01338870|156207854|FG001|Overall Study|Withdrawal by Subject|3|||
48551298|NCT01338870|156207855|FG002|Overall Study|Withdrawal by Subject|4|||
48551299|NCT01338870|156207856|FG003|Overall Study|Withdrawal by Subject|0|||
48551300|NCT01338870|156207857|FG004|Overall Study|Withdrawal by Subject|0|||
48551301|NCT01338870|156207858|FG005|Overall Study|Withdrawal by Subject|2|||
48551302|NCT01338870|156207853|FG000|Overall Study|Other|3|||
48551303|NCT01338870|156207854|FG001|Overall Study|Other|3|||
48551304|NCT01338870|156207855|FG002|Overall Study|Other|3|||
48551305|NCT01338870|156207856|FG003|Overall Study|Other|2|||
48551306|NCT01338870|156207857|FG004|Overall Study|Other|0|||
48551307|NCT01338870|156207858|FG005|Overall Study|Other|2|||
48551308|NCT01338870|156207853|FG000|Overall Study|Protocol Violation|0|||
48551309|NCT01338870|156207854|FG001|Overall Study|Protocol Violation|2|||
48551310|NCT01338870|156207855|FG002|Overall Study|Protocol Violation|2|||
48551311|NCT01338870|156207856|FG003|Overall Study|Protocol Violation|2|||
48551312|NCT01338870|156207857|FG004|Overall Study|Protocol Violation|1|||
48551313|NCT01338870|156207858|FG005|Overall Study|Protocol Violation|1|||
48551314|NCT01338870|156207853|FG000|Overall Study|Adverse Event|4|||
48551315|NCT01338870|156207854|FG001|Overall Study|Adverse Event|4|||
48551316|NCT01338870|156207855|FG002|Overall Study|Adverse Event|1|||
48551317|NCT01338870|156207856|FG003|Overall Study|Adverse Event|5|||
48551318|NCT01338870|156207857|FG004|Overall Study|Adverse Event|4|||
48551319|NCT01338870|156207858|FG005|Overall Study|Adverse Event|1|||
48613678|NCT03881371|156441445|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48613679|NCT03881371|156441446|FG001|Overall Study|Non-Compliance with Study Drug|2|||
48613680|NCT03881371|156441445|FG000|Overall Study|Physician Decision|3|||
48551320|NCT03336528|156207859|FG000|Overall Study|Protocol Violation|1|||
48551321|NCT03336528|156207860|FG001|Overall Study|Protocol Violation|1|||
48551322|NCT03336528|156207859|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
48551323|NCT03336528|156207860|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
48551324|NCT03336528|156207859|FG000|Overall Study|Did not receive study medication|1|||
48551325|NCT03336528|156207860|FG001|Overall Study|Did not receive study medication|2|||
48551326|NCT01955083|156207863|FG000|Overall Study|Lost to Follow-up|1|||
48551327|NCT01955083|156207864|FG001|Overall Study|Lost to Follow-up|1|||
48551328|NCT00879411|156207866|FG000|Overall Study|lost to follow-up (non-AE)|162|||
48551329|NCT02437903|156207867|FG000|Overall Study|Adverse Event|1|||
48551330|NCT02437903|156207867|FG000|Overall Study|Withdrawal by Subject|1|||
48551331|NCT02437903|156207867|FG000|Overall Study|Lost to Follow-up|3|||
48551332|NCT01333397|156207870|FG000|Overall Study|Lost to Follow-up|1|||
48551333|NCT01333397|156207871|FG001|Overall Study|Lost to Follow-up|0|||
48551334|NCT01333397|156207872|FG002|Overall Study|Lost to Follow-up|0|||
48551335|NCT01333397|156207873|FG003|Overall Study|Lost to Follow-up|1|||
48613681|NCT03881371|156441446|FG001|Overall Study|Physician Decision|3|||
48613682|NCT03881371|156441445|FG000|Overall Study|Withdrawal by Subject|2|||
48613683|NCT03881371|156441446|FG001|Overall Study|Withdrawal by Subject|10|||
48551336|NCT01333397|156207874|FG004|Overall Study|Lost to Follow-up|0|||
48551337|NCT00710866|156207876|FG000|Overall Study|Protocol Violation|5|||
48551338|NCT00710866|156207877|FG001|Overall Study|Protocol Violation|4|||
48551339|NCT00710866|156207876|FG000|Overall Study|Withdrawal by Subject|2|||
48551340|NCT00710866|156207877|FG001|Overall Study|Withdrawal by Subject|1|||
48613684|NCT03881371|156441445|FG000|Overall Study|Discontinuation from Study|1|||
48551341|NCT00710866|156207876|FG000|Overall Study|Lost to Follow-up|1|||
48551342|NCT00710866|156207877|FG001|Overall Study|Lost to Follow-up|0|||
48551343|NCT00710866|156207876|FG000|Overall Study|Failed to meet eligibility|1|||
48551344|NCT00710866|156207877|FG001|Overall Study|Failed to meet eligibility|1|||
48551345|NCT00086281|156207879|FG000|Phase 1|Adverse Event|0|||
48551346|NCT00086281|156207880|FG001|Phase 1|Adverse Event|0|||
48551347|NCT00086281|156207881|FG002|Phase 1|Adverse Event|0|||
48551348|NCT00086281|156207882|FG003|Phase 1|Adverse Event|0|||
48551349|NCT00086281|156207883|FG004|Phase 1|Adverse Event|0|||
48551350|NCT00086281|156207884|FG005|Phase 1|Adverse Event|0|||
48551351|NCT00086281|156207885|FG006|Phase 1|Adverse Event|0|||
48551352|NCT00086281|156207886|FG007|Phase 1|Adverse Event|0|||
48613685|NCT03881371|156441446|FG001|Overall Study|Discontinuation from Study|0|||
48613686|NCT01303419|156441447|FG000|Overall Study|Discontinuation of study|60|||
48613687|NCT01303419|156441447|FG000|Overall Study|Did not complete both imaging methods|5|||
48613688|NCT01303419|156441447|FG000|Overall Study|Did not meet all I/E after screening|31|||
48613689|NCT02709369|156441452|FG000|Overall Study|Lost to Follow-up|15|||
48613690|NCT02709369|156441452|FG000|Overall Study|Withdrawal by Subject|10|||
48613691|NCT02709369|156441452|FG000|Overall Study|Did not received intervention|2|||
48613692|NCT01056536|156441455|FG000|Overall Study|Lost to Follow-up|202|||
48613693|NCT01056536|156441456|FG001|Overall Study|Lost to Follow-up|116|||
48613694|NCT01056536|156441457|FG002|Overall Study|Lost to Follow-up|248|||
48613695|NCT00975923|156441462|FG000|Overall Study|Withdrawal by Subject|0|||
48613696|NCT00975923|156441463|FG001|Overall Study|Withdrawal by Subject|1|||
48613697|NCT01564407|156441479|FG000|Overall Study|Lost to Follow-up|0|||
48613698|NCT01564407|156441480|FG001|Overall Study|Lost to Follow-up|1|||
48613699|NCT01564407|156441481|FG002|Overall Study|Lost to Follow-up|0|||
48613700|NCT01564407|156441482|FG003|Overall Study|Lost to Follow-up|0|||
48613701|NCT01564407|156441483|FG004|Overall Study|Lost to Follow-up|0|||
48613702|NCT01564407|156441479|FG000|Overall Study|Withdrawal by Subject|0|||
48613703|NCT01564407|156441480|FG001|Overall Study|Withdrawal by Subject|1|||
48613704|NCT01564407|156441481|FG002|Overall Study|Withdrawal by Subject|0|||
48613705|NCT01564407|156441482|FG003|Overall Study|Withdrawal by Subject|0|||
48613706|NCT01564407|156441483|FG004|Overall Study|Withdrawal by Subject|0|||
48613707|NCT01564407|156441479|FG000|Overall Study|funding lost, study ended|0|||
48613708|NCT01564407|156441480|FG001|Overall Study|funding lost, study ended|0|||
48613709|NCT01564407|156441481|FG002|Overall Study|funding lost, study ended|0|||
48613710|NCT01564407|156441482|FG003|Overall Study|funding lost, study ended|1|||
48613711|NCT01564407|156441483|FG004|Overall Study|funding lost, study ended|0|||
48613712|NCT01160614|156441484|FG000|Overall Study|Withdrawal by Subject|0|||
48613713|NCT01160614|156441485|FG001|Overall Study|Withdrawal by Subject|2|||
48613714|NCT00768053|156441487|FG000|Overall Study|Adverse Event|10|||
48613715|NCT00768053|156441487|FG000|Overall Study|Lost to Follow-up|1|||
48613716|NCT01452347|156441488|FG000|Overall Study|Adverse Event|2|||
48613717|NCT01452347|156441489|FG001|Overall Study|Adverse Event|1|||
48613718|NCT01452347|156441488|FG000|Overall Study|Non compliance protocol|2|||
48613719|NCT01452347|156441489|FG001|Overall Study|Non compliance protocol|0|||
48613720|NCT01452347|156441488|FG000|Overall Study|Lost to Follow-up|2|||
48613721|NCT01452347|156441489|FG001|Overall Study|Lost to Follow-up|0|||
48613722|NCT01452347|156441488|FG000|Overall Study|Withdrawal by Subject|3|||
48613723|NCT01452347|156441489|FG001|Overall Study|Withdrawal by Subject|3|||
48613724|NCT01452347|156441488|FG000|Overall Study|Not treated|6|||
48613725|NCT01452347|156441489|FG001|Overall Study|Not treated|3|||
48613726|NCT01452347|156441488|FG000|Overall Study|Other reason not defined above|2|||
48613727|NCT01452347|156441489|FG001|Overall Study|Other reason not defined above|0|||
48613728|NCT01179399|156441493|FG000|Overall Study|Adverse Event|1|||
48613729|NCT01179399|156441493|FG000|Overall Study|Lack of Efficacy|30|||
48613730|NCT01179399|156441493|FG000|Overall Study|Withdrawal by Subject|1|||
48613731|NCT03704688|156443295|FG000|Overall Study|Adverse Event|0|||
48613732|NCT03704688|156443296|FG001|Overall Study|Adverse Event|0|||
48613733|NCT03704688|156443297|FG002|Overall Study|Adverse Event|0|||
48613734|NCT03704688|156443298|FG003|Overall Study|Adverse Event|4|||
48613735|NCT03704688|156443299|FG004|Overall Study|Adverse Event|1|||
48613736|NCT03704688|156443300|FG005|Overall Study|Adverse Event|0|||
48613737|NCT03704688|156443295|FG000|Overall Study|Disease Progression|0|||
48613738|NCT03704688|156443296|FG001|Overall Study|Disease Progression|0|||
48613739|NCT03704688|156443297|FG002|Overall Study|Disease Progression|0|||
48613740|NCT03704688|156443298|FG003|Overall Study|Disease Progression|3|||
48613741|NCT03704688|156443299|FG004|Overall Study|Disease Progression|1|||
48551353|NCT00086281|156207887|FG008|Phase 1|Adverse Event|0|||
48551354|NCT00086281|156207888|FG009|Phase 1|Adverse Event|1|||
48551355|NCT00086281|156207889|FG010|Phase 1|Adverse Event|2|||
48551356|NCT00086281|156207890|FG011|Phase 1|Adverse Event|1|||
48613742|NCT03704688|156443300|FG005|Overall Study|Disease Progression|0|||
48613743|NCT03704688|156443295|FG000|Overall Study|Death|0|||
48613744|NCT03704688|156443296|FG001|Overall Study|Death|0|||
48613745|NCT03704688|156443297|FG002|Overall Study|Death|0|||
48551357|NCT00086281|156207891|FG012|Phase 1|Adverse Event|1|||
48551358|NCT00086281|156207892|FG013|Phase 1|Adverse Event|1|||
48551359|NCT00086281|156207893|FG014|Phase 1|Adverse Event|2|||
48551360|NCT00086281|156207879|FG000|Phase 1|Protocol Violation|0|||
48551361|NCT00086281|156207880|FG001|Phase 1|Protocol Violation|0|||
48551362|NCT00086281|156207881|FG002|Phase 1|Protocol Violation|0|||
48551363|NCT00086281|156207882|FG003|Phase 1|Protocol Violation|0|||
48551364|NCT00086281|156207883|FG004|Phase 1|Protocol Violation|0|||
48551365|NCT00086281|156207884|FG005|Phase 1|Protocol Violation|0|||
48551366|NCT00086281|156207885|FG006|Phase 1|Protocol Violation|0|||
48551367|NCT00086281|156207886|FG007|Phase 1|Protocol Violation|0|||
48551368|NCT00086281|156207887|FG008|Phase 1|Protocol Violation|0|||
48551369|NCT00086281|156207888|FG009|Phase 1|Protocol Violation|0|||
48551370|NCT00086281|156207889|FG010|Phase 1|Protocol Violation|1|||
48551371|NCT00086281|156207890|FG011|Phase 1|Protocol Violation|0|||
48551372|NCT00086281|156207891|FG012|Phase 1|Protocol Violation|0|||
48551373|NCT00086281|156207892|FG013|Phase 1|Protocol Violation|0|||
48551374|NCT00086281|156207893|FG014|Phase 1|Protocol Violation|0|||
48551375|NCT00086281|156207879|FG000|Phase 1|Serious Adverse Event|0|||
48551376|NCT00086281|156207880|FG001|Phase 1|Serious Adverse Event|0|||
48551377|NCT00086281|156207881|FG002|Phase 1|Serious Adverse Event|0|||
48551378|NCT00086281|156207882|FG003|Phase 1|Serious Adverse Event|0|||
48551379|NCT00086281|156207883|FG004|Phase 1|Serious Adverse Event|0|||
48551380|NCT00086281|156207884|FG005|Phase 1|Serious Adverse Event|0|||
48613746|NCT03704688|156443298|FG003|Overall Study|Death|0|||
48613747|NCT03704688|156443299|FG004|Overall Study|Death|3|||
48551381|NCT00086281|156207885|FG006|Phase 1|Serious Adverse Event|0|||
48551382|NCT00086281|156207886|FG007|Phase 1|Serious Adverse Event|0|||
48613748|NCT03704688|156443300|FG005|Overall Study|Death|0|||
48613749|NCT00620542|156443301|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
48613750|NCT00620542|156443302|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
48613751|NCT00620542|156443303|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
48551383|NCT00086281|156207887|FG008|Phase 1|Serious Adverse Event|0|||
48551384|NCT00086281|156207888|FG009|Phase 1|Serious Adverse Event|0|||
48551385|NCT00086281|156207889|FG010|Phase 1|Serious Adverse Event|0|||
48551386|NCT00086281|156207890|FG011|Phase 1|Serious Adverse Event|0|||
48551387|NCT00086281|156207891|FG012|Phase 1|Serious Adverse Event|0|||
48551388|NCT00086281|156207892|FG013|Phase 1|Serious Adverse Event|0|||
48551389|NCT00086281|156207893|FG014|Phase 1|Serious Adverse Event|1|||
48551390|NCT00086281|156207879|FG000|Phase 2|Adverse Event|0|||
48551391|NCT00086281|156207880|FG001|Phase 2|Adverse Event|0|||
48551392|NCT00086281|156207881|FG002|Phase 2|Adverse Event|0|||
48551393|NCT00086281|156207882|FG003|Phase 2|Adverse Event|0|||
48551394|NCT00086281|156207883|FG004|Phase 2|Adverse Event|0|||
48551395|NCT00086281|156207884|FG005|Phase 2|Adverse Event|0|||
48551396|NCT00086281|156207885|FG006|Phase 2|Adverse Event|0|||
48551397|NCT00086281|156207886|FG007|Phase 2|Adverse Event|0|||
48551398|NCT00086281|156207887|FG008|Phase 2|Adverse Event|0|||
48551399|NCT00086281|156207888|FG009|Phase 2|Adverse Event|0|||
48551400|NCT00086281|156207889|FG010|Phase 2|Adverse Event|0|||
48551401|NCT00086281|156207890|FG011|Phase 2|Adverse Event|0|||
48551402|NCT00086281|156207891|FG012|Phase 2|Adverse Event|1|||
48551403|NCT00086281|156207892|FG013|Phase 2|Adverse Event|1|||
48551404|NCT00086281|156207893|FG014|Phase 2|Adverse Event|0|||
48551405|NCT04138823|156207894|FG000|Overall Study|Clinical disease progression|0|||
48551406|NCT04138823|156207895|FG001|Overall Study|Clinical disease progression|0|||
48551407|NCT04138823|156207896|FG002|Overall Study|Clinical disease progression|1|||
48551408|NCT04138823|156207894|FG000|Overall Study|Objective disease progression|3|||
48551409|NCT04138823|156207895|FG001|Overall Study|Objective disease progression|2|||
48613752|NCT00620542|156443304|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
48613753|NCT00620542|156443301|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
48613754|NCT00620542|156443302|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
48613755|NCT00620542|156443303|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
48613756|NCT00620542|156443304|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
48613757|NCT00620542|156443301|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
48551410|NCT04138823|156207896|FG002|Overall Study|Objective disease progression|5|||
48551411|NCT00908310|156207902|FG000|Overall Study|Death|37|||
48551412|NCT00908310|156207902|FG000|Overall Study|Withdrawal by Subject|7|||
48551413|NCT00908310|156207902|FG000|Overall Study|Lost to Follow-up|7|||
48551414|NCT00908310|156207902|FG000|Overall Study|Screening failure|5|||
48613758|NCT00620542|156443302|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
48613759|NCT00620542|156443303|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
48613760|NCT00620542|156443304|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
48613761|NCT00620542|156443301|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
48551415|NCT00908310|156207902|FG000|Overall Study|Other reasons|4|||
48551416|NCT03138655|156207903|FG000|Overall Study|Adverse Event|2|||
48551417|NCT03138655|156207904|FG001|Overall Study|Adverse Event|1|||
48551418|NCT03138655|156207905|FG002|Overall Study|Adverse Event|2|||
48551419|NCT03138655|156207906|FG003|Overall Study|Adverse Event|1|||
48551420|NCT03138655|156207907|FG004|Overall Study|Adverse Event|1|||
48551421|NCT03138655|156207908|FG005|Overall Study|Adverse Event|4|||
48551422|NCT03138655|156207909|FG006|Overall Study|Adverse Event|2|||
48613762|NCT00620542|156443302|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
48613763|NCT00620542|156443303|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
48613764|NCT00620542|156443304|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
48613765|NCT00620542|156443301|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
48613766|NCT00620542|156443302|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
48613767|NCT00620542|156443303|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
48613768|NCT00620542|156443304|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
48613769|NCT00620542|156443301|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
48613770|NCT00620542|156443302|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
48613771|NCT00620542|156443303|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
48613772|NCT00620542|156443304|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
48613773|NCT00620542|156443301|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
48613774|NCT00620542|156443302|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
48613775|NCT00620542|156443303|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
48613776|NCT00620542|156443304|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
48613777|NCT00620542|156443301|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
48613778|NCT00620542|156443302|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
48613779|NCT00620542|156443303|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
48613780|NCT00620542|156443304|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
48613781|NCT00620542|156443301|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
48613782|NCT00620542|156443302|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
48613783|NCT00620542|156443303|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
48613784|NCT00620542|156443304|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
48613785|NCT00620542|156443301|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
48613786|NCT00620542|156443302|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
48613787|NCT00620542|156443303|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
48613788|NCT00620542|156443304|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
48613789|NCT00620542|156443301|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
48613790|NCT00620542|156443302|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
48613791|NCT00620542|156443303|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
48613792|NCT00620542|156443304|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
48613793|NCT00620542|156443301|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
48613794|NCT00620542|156443302|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
48613795|NCT00620542|156443303|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
48613796|NCT00620542|156443304|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
48613797|NCT00620542|156443301|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
48613798|NCT00620542|156443302|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
48613799|NCT00620542|156443303|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
48613800|NCT00620542|156443304|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
48613801|NCT00620542|156443301|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
48613802|NCT00620542|156443302|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
48613803|NCT00620542|156443303|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
48613804|NCT00620542|156443304|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
48613805|NCT00620542|156443301|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
48613806|NCT00620542|156443302|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
48613807|NCT00620542|156443303|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
48551423|NCT03138655|156207910|FG007|Overall Study|Adverse Event|2|||
48551424|NCT03138655|156207903|FG000|Overall Study|Withdrawal by Subject|0|||
48551425|NCT03138655|156207904|FG001|Overall Study|Withdrawal by Subject|1|||
48551426|NCT03138655|156207905|FG002|Overall Study|Withdrawal by Subject|0|||
48551427|NCT03138655|156207906|FG003|Overall Study|Withdrawal by Subject|0|||
48551428|NCT03138655|156207907|FG004|Overall Study|Withdrawal by Subject|0|||
48551429|NCT03138655|156207908|FG005|Overall Study|Withdrawal by Subject|0|||
48551430|NCT03138655|156207909|FG006|Overall Study|Withdrawal by Subject|1|||
48551431|NCT03138655|156207910|FG007|Overall Study|Withdrawal by Subject|0|||
48551432|NCT03138655|156207903|FG000|Overall Study|Reason not Specified|1|||
48551433|NCT03138655|156207904|FG001|Overall Study|Reason not Specified|0|||
48551434|NCT03138655|156207905|FG002|Overall Study|Reason not Specified|0|||
48551435|NCT03138655|156207906|FG003|Overall Study|Reason not Specified|2|||
48551436|NCT03138655|156207907|FG004|Overall Study|Reason not Specified|1|||
48551437|NCT03138655|156207908|FG005|Overall Study|Reason not Specified|1|||
48551438|NCT03138655|156207909|FG006|Overall Study|Reason not Specified|0|||
48551439|NCT03138655|156207910|FG007|Overall Study|Reason not Specified|0|||
48551440|NCT03151304|156207913|FG000|Overall Study|Termination of study by Sponsor|23|||
48551441|NCT03151304|156207913|FG000|Overall Study|missing|3|||
48551442|NCT03151304|156207913|FG000|Overall Study|Withdrawal by Subject|8|||
48551443|NCT03151304|156207913|FG000|Overall Study|multiple reasons|30|||
48551444|NCT01220531|156207922|FG000|Overall Study|Death|7|||
48551445|NCT01220531|156207922|FG000|Overall Study|Lost to Follow-up|1|||
48613808|NCT00620542|156443304|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
48613809|NCT02911116|156443309|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48613810|NCT02911116|156443310|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48613811|NCT02911116|156443309|FG000|Overall Study|Lost to Follow-up|0|||
48613812|NCT02911116|156443310|FG001|Overall Study|Lost to Follow-up|1|||
48613813|NCT01482221|156443311|FG000|Overall Study|Lack of Efficacy|1|||
48613814|NCT01482221|156443312|FG001|Overall Study|Lack of Efficacy|0|||
48613815|NCT01482221|156443313|FG002|Overall Study|Lack of Efficacy|1|||
48613816|NCT01482221|156443311|FG000|Overall Study|Lost to Follow-up|3|||
48613817|NCT01482221|156443312|FG001|Overall Study|Lost to Follow-up|2|||
48613818|NCT01482221|156443313|FG002|Overall Study|Lost to Follow-up|1|||
48613819|NCT01482221|156443311|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
48613820|NCT01482221|156443312|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
48613821|NCT01482221|156443313|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
48613822|NCT01482221|156443311|FG000|Overall Study|Condition under Investigation Worsened|3|||
48613823|NCT01482221|156443312|FG001|Overall Study|Condition under Investigation Worsened|2|||
48613824|NCT01482221|156443313|FG002|Overall Study|Condition under Investigation Worsened|4|||
48613825|NCT01482221|156443311|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
48613826|NCT01482221|156443312|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
48613827|NCT01482221|156443313|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
48613828|NCT01482221|156443311|FG000|Overall Study|Adverse Event|1|||
48613829|NCT01482221|156443312|FG001|Overall Study|Adverse Event|7|||
48613830|NCT01482221|156443313|FG002|Overall Study|Adverse Event|3|||
48613831|NCT01482221|156443311|FG000|Overall Study|Withdrawal by Subject|10|||
48613832|NCT01482221|156443312|FG001|Overall Study|Withdrawal by Subject|7|||
48613833|NCT01482221|156443313|FG002|Overall Study|Withdrawal by Subject|12|||
48613834|NCT01482221|156443311|FG000|Overall Study|Incorrect randomization|0|||
48613835|NCT01482221|156443312|FG001|Overall Study|Incorrect randomization|1|||
48613836|NCT01482221|156443313|FG002|Overall Study|Incorrect randomization|0|||
48613837|NCT01482221|156443311|FG000|Overall Study|Physician Decision|0|||
48613838|NCT01482221|156443312|FG001|Overall Study|Physician Decision|1|||
48613839|NCT01482221|156443313|FG002|Overall Study|Physician Decision|0|||
48613840|NCT03677401|156443314|FG000|Overall Study|Adverse Event|4|||
48613841|NCT03677401|156443315|FG001|Overall Study|Adverse Event|14|||
48613842|NCT03677401|156443314|FG000|Overall Study|Lack of Efficacy|3|||
48613843|NCT03677401|156443315|FG001|Overall Study|Lack of Efficacy|1|||
48613844|NCT03677401|156443314|FG000|Overall Study|Withdrawal by Subject|2|||
48613845|NCT03677401|156443315|FG001|Overall Study|Withdrawal by Subject|2|||
48613846|NCT03677401|156443314|FG000|Overall Study|Sponsor decision|0|||
48613847|NCT03677401|156443315|FG001|Overall Study|Sponsor decision|1|||
48613848|NCT03677401|156443314|FG000|Overall Study|Reason Unspecified|1|||
48613849|NCT03677401|156443315|FG001|Overall Study|Reason Unspecified|0|||
48613850|NCT01510756|156443316|FG000|Overall Study|Death|1|||
48613851|NCT01510756|156443316|FG000|Overall Study|Lack of Efficacy|2|||
48613852|NCT01510756|156443316|FG000|Overall Study|Physician Decision|1|||
48613853|NCT02299167|156443319|FG000|Overall Study|patients were excluded from the study|11|||
48613854|NCT02320396|156443320|FG000|Overall Study|Adverse Event|2|||
48613855|NCT02320396|156443321|FG001|Overall Study|Adverse Event|2|||
48551446|NCT04380961|156207928|FG000|Overall Study|Lost to Follow-up|17|||
48551447|NCT04380961|156207929|FG001|Overall Study|Lost to Follow-up|11|||
48551448|NCT04380961|156207928|FG000|Overall Study|Withdrawal by Subject|3|||
48551449|NCT04380961|156207929|FG001|Overall Study|Withdrawal by Subject|0|||
48551450|NCT04380961|156207928|FG000|Overall Study|Death|22|||
48551451|NCT04380961|156207929|FG001|Overall Study|Death|16|||
48551452|NCT04380961|156207928|FG000|Overall Study|Other|1|||
48551453|NCT04380961|156207929|FG001|Overall Study|Other|0|||
48551454|NCT04380961|156207928|FG000|Overall Study|Randomized but Not Treated|1|||
48551455|NCT04380961|156207929|FG001|Overall Study|Randomized but Not Treated|2|||
48551456|NCT04803305|156207930|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
48551457|NCT04803305|156207931|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
48551458|NCT04803305|156207930|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
48613856|NCT02320396|156443320|FG000|Overall Study|Pregnancy|0|||
48613857|NCT02320396|156443321|FG001|Overall Study|Pregnancy|1|||
48613858|NCT02320396|156443320|FG000|Overall Study|Protocol Violation|0|||
48613859|NCT02320396|156443321|FG001|Overall Study|Protocol Violation|1|||
48613860|NCT02320396|156443320|FG000|Overall Study|Withdrawal by Subject|2|||
48613861|NCT02320396|156443321|FG001|Overall Study|Withdrawal by Subject|0|||
48613862|NCT02606253|156443322|FG000|Overall Study|Adverse Event|2|||
48613863|NCT02606253|156443323|FG001|Overall Study|Adverse Event|0|||
48613864|NCT02606253|156443324|FG002|Overall Study|Adverse Event|0|||
48613865|NCT02606253|156443322|FG000|Overall Study|Protocol Violation|2|||
48613866|NCT02606253|156443323|FG001|Overall Study|Protocol Violation|1|||
48551459|NCT04803305|156207931|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
48551460|NCT04803305|156207930|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
48551461|NCT04803305|156207931|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
48551462|NCT04803305|156207930|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
48551463|NCT04803305|156207931|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
48551464|NCT04803305|156207930|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
48551465|NCT04803305|156207931|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
48551466|NCT04803305|156207930|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
48551467|NCT04803305|156207931|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
48551468|NCT04803305|156207930|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
48551469|NCT04803305|156207931|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
48551470|NCT04803305|156207930|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
48551471|NCT04803305|156207931|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
48551472|NCT05513391|156207932|FG000|Overall Study|Adverse Event|1|||
48551473|NCT05513391|156207933|FG001|Overall Study|Adverse Event|0|||
48551474|NCT05513391|156207932|FG000|Overall Study|Protocol Deviation|0|||
48551475|NCT05513391|156207933|FG001|Overall Study|Protocol Deviation|1|||
48551476|NCT05513391|156207932|FG000|Overall Study|Withdrawal by Subject|3|||
48551477|NCT05513391|156207933|FG001|Overall Study|Withdrawal by Subject|1|||
48551478|NCT05513391|156207932|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48551479|NCT05513391|156207933|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48551480|NCT05513391|156207932|FG000|Overall Study|Lost to Follow-up|0|||
48551481|NCT05513391|156207933|FG001|Overall Study|Lost to Follow-up|2|||
48551482|NCT01954745|156207937|FG000|Overall Study|Radiological Progression|11|||
48551483|NCT01954745|156207937|FG000|Overall Study|Clinical Progression|5|||
48551484|NCT01954745|156207937|FG000|Overall Study|Adverse Event|2|||
48551485|NCT01954745|156207937|FG000|Overall Study|Death|1|||
48551486|NCT02434328|156207938|FG000|Overall Study|Adverse Event|9|||
48551487|NCT02434328|156207939|FG001|Overall Study|Adverse Event|4|||
48551488|NCT02434328|156207938|FG000|Overall Study|Lack of Efficacy|0|||
48551489|NCT02434328|156207939|FG001|Overall Study|Lack of Efficacy|2|||
48551490|NCT02434328|156207938|FG000|Overall Study|Physician Decision|0|||
48551491|NCT02434328|156207939|FG001|Overall Study|Physician Decision|1|||
48551492|NCT02434328|156207938|FG000|Overall Study|Withdrawal by Subject|12|||
48551493|NCT02434328|156207939|FG001|Overall Study|Withdrawal by Subject|21|||
48551494|NCT02434328|156207938|FG000|Overall Study|Death|4|||
48551495|NCT02434328|156207939|FG001|Overall Study|Death|7|||
48551496|NCT02434328|156207938|FG000|Overall Study|Lost to Follow-up|1|||
48551497|NCT02434328|156207939|FG001|Overall Study|Lost to Follow-up|6|||
48551498|NCT02434328|156207938|FG000|Overall Study|Other|4|||
48551499|NCT02434328|156207939|FG001|Overall Study|Other|1|||
48551500|NCT04520256|156207940|FG000|Overall Study|Lost to Follow-up|6|||
48551501|NCT04520256|156207941|FG001|Overall Study|Lost to Follow-up|4|||
48551502|NCT04520256|156207942|FG002|Overall Study|Lost to Follow-up|2|||
48551503|NCT04520256|156207943|FG003|Overall Study|Lost to Follow-up|3|||
48551504|NCT04520256|156207944|FG004|Overall Study|Lost to Follow-up|6|||
48551505|NCT04520256|156207945|FG005|Overall Study|Lost to Follow-up|6|||
48551506|NCT04520256|156207946|FG006|Overall Study|Lost to Follow-up|4|||
48551507|NCT04520256|156207947|FG007|Overall Study|Lost to Follow-up|6|||
48551508|NCT04520256|156207948|FG008|Overall Study|Lost to Follow-up|1|||
48551509|NCT04520256|156207949|FG009|Overall Study|Lost to Follow-up|3|||
48551510|NCT04520256|156207950|FG010|Overall Study|Lost to Follow-up|3|||
48551511|NCT04520256|156207951|FG011|Overall Study|Lost to Follow-up|2|||
48551512|NCT04520256|156207952|FG012|Overall Study|Lost to Follow-up|5|||
48551513|NCT04520256|156207953|FG013|Overall Study|Lost to Follow-up|3|||
48551514|NCT04520256|156207954|FG014|Overall Study|Lost to Follow-up|3|||
48551515|NCT04520256|156207955|FG015|Overall Study|Lost to Follow-up|6|||
48551516|NCT04520256|156207956|FG016|Overall Study|Lost to Follow-up|6|||
48551517|NCT04520256|156207957|FG017|Overall Study|Lost to Follow-up|4|||
48551518|NCT04520256|156207958|FG018|Overall Study|Lost to Follow-up|3|||
48551519|NCT04520256|156207959|FG019|Overall Study|Lost to Follow-up|3|||
48551520|NCT04520256|156207960|FG020|Overall Study|Lost to Follow-up|7|||
48551521|NCT04520256|156207961|FG021|Overall Study|Lost to Follow-up|3|||
48551522|NCT04520256|156207962|FG022|Overall Study|Lost to Follow-up|3|||
48551523|NCT04520256|156207963|FG023|Overall Study|Lost to Follow-up|8|||
48551524|NCT04520256|156207964|FG024|Overall Study|Lost to Follow-up|5|||
48551525|NCT04520256|156207965|FG025|Overall Study|Lost to Follow-up|4|||
48551526|NCT04520256|156207966|FG026|Overall Study|Lost to Follow-up|3|||
48551527|NCT04520256|156207967|FG027|Overall Study|Lost to Follow-up|4|||
48551528|NCT04520256|156207968|FG028|Overall Study|Lost to Follow-up|3|||
48551529|NCT04520256|156207969|FG029|Overall Study|Lost to Follow-up|4|||
48551530|NCT04520256|156207970|FG030|Overall Study|Lost to Follow-up|4|||
48551531|NCT04520256|156207971|FG031|Overall Study|Lost to Follow-up|4|||
48551532|NCT00633243|156209959|FG000|Overall Study|Withdrawal by Subject|0|||
48551533|NCT00633243|156209960|FG001|Overall Study|Withdrawal by Subject|1|||
48551534|NCT00633243|156209959|FG000|Overall Study|incarceration|0|||
48551535|NCT00633243|156209960|FG001|Overall Study|incarceration|2|||
48551536|NCT00633243|156209959|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
48551537|NCT00633243|156209960|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
48551538|NCT00633243|156209959|FG000|Overall Study|Not comfortable with self-injecting|0|||
48551539|NCT00633243|156209960|FG001|Overall Study|Not comfortable with self-injecting|1|||
48551540|NCT00633243|156209959|FG000|Overall Study|Mental Health--Depression|0|||
48551541|NCT00633243|156209960|FG001|Overall Study|Mental Health--Depression|1|||
48551542|NCT00633243|156209959|FG000|Overall Study|Couldn't tolerate side-effects|1|||
48551543|NCT00633243|156209960|FG001|Overall Study|Couldn't tolerate side-effects|1|||
48551544|NCT05794503|156209961|FG000|Overall Study|Operation Cancelled|2|||
48551545|NCT05794503|156209962|FG001|Overall Study|Operation Cancelled|0|||
48551546|NCT05794503|156209961|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
48551547|NCT05794503|156209962|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
48551548|NCT05794503|156209961|FG000|Overall Study|Protocol Violation|1|||
48551549|NCT05794503|156209962|FG001|Overall Study|Protocol Violation|0|||
48551550|NCT02886624|156209964|FG000|12-week Post Treatment Follow-up|Death|1|||
48551551|NCT02886624|156209964|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
48551552|NCT03865498|156209966|FG000|Overall Study|Lack of Efficacy|12|||
48551553|NCT03865498|156209967|FG001|Overall Study|Lack of Efficacy|11|||
48551554|NCT03865498|156209966|FG000|Overall Study|Lost to Follow-up|125|||
48551555|NCT03865498|156209967|FG001|Overall Study|Lost to Follow-up|133|||
48551556|NCT03865498|156209966|FG000|Overall Study|Withdrawal by Subject|2|||
48613867|NCT02606253|156443324|FG002|Overall Study|Protocol Violation|0|||
48613868|NCT02606253|156443322|FG000|Overall Study|Physician Decision|1|||
48613869|NCT02606253|156443323|FG001|Overall Study|Physician Decision|1|||
48613870|NCT02606253|156443324|FG002|Overall Study|Physician Decision|0|||
48613871|NCT02969018|156443330|FG000|Overall Study|Adverse Event|2|||
48613872|NCT02969018|156443331|FG001|Overall Study|Adverse Event|4|||
48613873|NCT02969018|156443332|FG002|Overall Study|Adverse Event|1|||
48613874|NCT02969018|156443333|FG003|Overall Study|Adverse Event|2|||
48613875|NCT02969018|156443334|FG004|Overall Study|Adverse Event|0|||
48613876|NCT02969018|156443335|FG005|Overall Study|Adverse Event|1|||
48613877|NCT02969018|156443336|FG006|Overall Study|Adverse Event|2|||
48613878|NCT02969018|156443337|FG007|Overall Study|Adverse Event|0|||
48613879|NCT02969018|156443330|FG000|Overall Study|Lack of Efficacy|0|||
48613880|NCT02969018|156443331|FG001|Overall Study|Lack of Efficacy|1|||
48613881|NCT02969018|156443332|FG002|Overall Study|Lack of Efficacy|0|||
48613882|NCT02969018|156443333|FG003|Overall Study|Lack of Efficacy|0|||
48613883|NCT02969018|156443334|FG004|Overall Study|Lack of Efficacy|1|||
48613884|NCT02969018|156443335|FG005|Overall Study|Lack of Efficacy|1|||
48613885|NCT02969018|156443336|FG006|Overall Study|Lack of Efficacy|1|||
48613886|NCT02969018|156443337|FG007|Overall Study|Lack of Efficacy|1|||
48613887|NCT02969018|156443330|FG000|Overall Study|Lost to Follow-up|1|||
48613888|NCT02969018|156443331|FG001|Overall Study|Lost to Follow-up|2|||
48613889|NCT02969018|156443332|FG002|Overall Study|Lost to Follow-up|2|||
48613890|NCT02969018|156443333|FG003|Overall Study|Lost to Follow-up|0|||
48613891|NCT02969018|156443334|FG004|Overall Study|Lost to Follow-up|1|||
48613892|NCT02969018|156443335|FG005|Overall Study|Lost to Follow-up|1|||
48613893|NCT02969018|156443336|FG006|Overall Study|Lost to Follow-up|0|||
48613894|NCT02969018|156443337|FG007|Overall Study|Lost to Follow-up|1|||
48613895|NCT02969018|156443330|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48613896|NCT02969018|156443331|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48613897|NCT02969018|156443332|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
48613898|NCT02969018|156443333|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48613899|NCT02969018|156443334|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
48613900|NCT02969018|156443335|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48613901|NCT02969018|156443336|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
48613902|NCT02969018|156443337|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
48613903|NCT02969018|156443330|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48613904|NCT02969018|156443331|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48613905|NCT02969018|156443332|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48613906|NCT02969018|156443333|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48613907|NCT02969018|156443334|FG004|Overall Study|Non-Compliance With Study Drug|0|||
48613908|NCT02969018|156443335|FG005|Overall Study|Non-Compliance With Study Drug|0|||
48613909|NCT02969018|156443336|FG006|Overall Study|Non-Compliance With Study Drug|0|||
48613910|NCT02969018|156443337|FG007|Overall Study|Non-Compliance With Study Drug|0|||
48613911|NCT02969018|156443330|FG000|Overall Study|Other|0|||
48613912|NCT02969018|156443331|FG001|Overall Study|Other|0|||
48613913|NCT02969018|156443332|FG002|Overall Study|Other|0|||
48613914|NCT02969018|156443333|FG003|Overall Study|Other|1|||
48613915|NCT02969018|156443334|FG004|Overall Study|Other|0|||
48551557|NCT03865498|156209967|FG001|Overall Study|Withdrawal by Subject|4|||
48551558|NCT00000620|156209968|FG000|Overall Study|Death|86|||
48551559|NCT00000620|156209969|FG001|Overall Study|Death|67|||
48551560|NCT00000620|156209970|FG002|Overall Study|Death|112|||
48551561|NCT00000620|156209971|FG003|Overall Study|Death|126|||
48551562|NCT00000620|156209972|FG004|Overall Study|Death|64|||
48551563|NCT00000620|156209973|FG005|Overall Study|Death|77|||
48551564|NCT00000620|156209974|FG006|Overall Study|Death|91|||
48551565|NCT00000620|156209975|FG007|Overall Study|Death|95|||
48551566|NCT00000620|156209968|FG000|Overall Study|Lost to Follow-up|14|||
48551567|NCT00000620|156209969|FG001|Overall Study|Lost to Follow-up|14|||
48551568|NCT00000620|156209970|FG002|Overall Study|Lost to Follow-up|14|||
48551569|NCT00000620|156209971|FG003|Overall Study|Lost to Follow-up|14|||
48551570|NCT00000620|156209972|FG004|Overall Study|Lost to Follow-up|15|||
48551571|NCT00000620|156209973|FG005|Overall Study|Lost to Follow-up|15|||
48551572|NCT00000620|156209974|FG006|Overall Study|Lost to Follow-up|13|||
48551573|NCT00000620|156209975|FG007|Overall Study|Lost to Follow-up|14|||
48551574|NCT00000620|156209968|FG000|Overall Study|Withdrawal by Subject|40|||
48551575|NCT00000620|156209969|FG001|Overall Study|Withdrawal by Subject|27|||
48551576|NCT00000620|156209970|FG002|Overall Study|Withdrawal by Subject|28|||
48551577|NCT00000620|156209971|FG003|Overall Study|Withdrawal by Subject|27|||
48551578|NCT00000620|156209972|FG004|Overall Study|Withdrawal by Subject|30|||
48551579|NCT00000620|156209973|FG005|Overall Study|Withdrawal by Subject|32|||
48551580|NCT00000620|156209974|FG006|Overall Study|Withdrawal by Subject|32|||
48551581|NCT00000620|156209975|FG007|Overall Study|Withdrawal by Subject|21|||
48551582|NCT00000620|156209968|FG000|Overall Study|missed closeout visit|22|||
48551583|NCT00000620|156209969|FG001|Overall Study|missed closeout visit|28|||
48551584|NCT00000620|156209970|FG002|Overall Study|missed closeout visit|16|||
48551585|NCT00000620|156209971|FG003|Overall Study|missed closeout visit|11|||
48551586|NCT00000620|156209972|FG004|Overall Study|missed closeout visit|26|||
48551587|NCT00000620|156209973|FG005|Overall Study|missed closeout visit|28|||
48551588|NCT00000620|156209974|FG006|Overall Study|missed closeout visit|13|||
48551589|NCT00000620|156209975|FG007|Overall Study|missed closeout visit|16|||
48551590|NCT01851330|156209976|FG000|Overall Study|Lack of Efficacy|10|||
48551591|NCT01851330|156209977|FG001|Overall Study|Lack of Efficacy|9|||
48551592|NCT01851330|156209978|FG002|Overall Study|Lack of Efficacy|2|||
48551593|NCT01851330|156209976|FG000|Overall Study|Lost to Follow-up|1|||
48551594|NCT01851330|156209977|FG001|Overall Study|Lost to Follow-up|6|||
48551595|NCT01851330|156209978|FG002|Overall Study|Lost to Follow-up|9|||
48551596|NCT01851330|156209976|FG000|Overall Study|Withdrew Consent|2|||
48551597|NCT01851330|156209977|FG001|Overall Study|Withdrew Consent|1|||
48551598|NCT01851330|156209978|FG002|Overall Study|Withdrew Consent|0|||
48551599|NCT01851330|156209976|FG000|Overall Study|Investigator's Discretion|0|||
48551600|NCT01851330|156209977|FG001|Overall Study|Investigator's Discretion|0|||
48551601|NCT01851330|156209978|FG002|Overall Study|Investigator's Discretion|1|||
48551602|NCT02901548|156209979|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
48551603|NCT00264550|156209982|FG000|Overall Study|Death|0|||
48551604|NCT00264550|156209983|FG001|Overall Study|Death|3|||
48551605|NCT00264550|156209984|FG002|Overall Study|Death|0|||
48551606|NCT00264550|156209985|FG003|Overall Study|Death|0|||
48551607|NCT00264550|156209982|FG000|Overall Study|Lost to Follow-up|3|||
48551608|NCT00264550|156209983|FG001|Overall Study|Lost to Follow-up|1|||
48551609|NCT00264550|156209984|FG002|Overall Study|Lost to Follow-up|1|||
48551610|NCT00264550|156209985|FG003|Overall Study|Lost to Follow-up|1|||
48551611|NCT00264550|156209982|FG000|Overall Study|Adverse Event|23|||
48551612|NCT00264550|156209983|FG001|Overall Study|Adverse Event|18|||
48551613|NCT00264550|156209984|FG002|Overall Study|Adverse Event|9|||
48551614|NCT00264550|156209985|FG003|Overall Study|Adverse Event|14|||
48551615|NCT00264550|156209982|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48551616|NCT00264550|156209983|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
48551617|NCT00264550|156209984|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
48551618|NCT00264550|156209985|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
48551619|NCT00264550|156209982|FG000|Overall Study|Discontinued oral study agent|0|||
48551620|NCT00264550|156209983|FG001|Overall Study|Discontinued oral study agent|1|||
48551621|NCT00264550|156209984|FG002|Overall Study|Discontinued oral study agent|0|||
48551622|NCT00264550|156209985|FG003|Overall Study|Discontinued oral study agent|0|||
48551623|NCT00264550|156209982|FG000|Overall Study|Other|13|||
48551624|NCT00264550|156209983|FG001|Overall Study|Other|7|||
48551625|NCT00264550|156209984|FG002|Overall Study|Other|3|||
48551626|NCT00264550|156209985|FG003|Overall Study|Other|9|||
48551627|NCT01590797|156209991|FG000|Overall Study|Adverse Event|4|||
48551628|NCT01590797|156209992|FG001|Overall Study|Adverse Event|3|||
48551629|NCT01590797|156209991|FG000|Overall Study|Lack of Efficacy|0|||
48551630|NCT01590797|156209992|FG001|Overall Study|Lack of Efficacy|2|||
48551631|NCT01590797|156209991|FG000|Overall Study|Lost to Follow-up|0|||
48551632|NCT01590797|156209992|FG001|Overall Study|Lost to Follow-up|1|||
48551633|NCT01590797|156209991|FG000|Overall Study|Protocol Violation|4|||
48551634|NCT01590797|156209992|FG001|Overall Study|Protocol Violation|1|||
48551635|NCT01590797|156209991|FG000|Overall Study|Withdrawal by Subject|7|||
48551636|NCT01590797|156209992|FG001|Overall Study|Withdrawal by Subject|5|||
48551637|NCT01590797|156209991|FG000|Overall Study|Other Protocol Specified Criteria|2|||
48551638|NCT01590797|156209992|FG001|Overall Study|Other Protocol Specified Criteria|4|||
48551639|NCT01266031|156209993|FG000|Overall Study|Not treated|0|||
48551640|NCT01266031|156209994|FG001|Overall Study|Not treated|3|||
48551641|NCT01266031|156209995|FG002|Overall Study|Not treated|2|||
48551642|NCT02865460|156209998|FG000|Overall Study|Adverse Event|1|||
48551643|NCT02865460|156209999|FG001|Overall Study|Adverse Event|0|||
48551644|NCT02865460|156209998|FG000|Overall Study|Withdrawal by Subject|1|||
48551645|NCT02865460|156209999|FG001|Overall Study|Withdrawal by Subject|1|||
48551646|NCT02865460|156209998|FG000|Overall Study|Lost to Follow-up|7|||
48551647|NCT02865460|156209999|FG001|Overall Study|Lost to Follow-up|4|||
48551648|NCT02865460|156209998|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
48551649|NCT02865460|156209999|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
48551650|NCT00380744|156210002|FG000|Overall Study|Death|0|||
48551651|NCT00380744|156210003|FG001|Overall Study|Death|0|||
48551652|NCT00380744|156210004|FG002|Overall Study|Death|0|||
48551653|NCT00380744|156210005|FG003|Overall Study|Death|0|||
48551654|NCT00380744|156210006|FG004|Overall Study|Death|0|||
48551655|NCT00380744|156210007|FG005|Overall Study|Death|0|||
48551656|NCT00380744|156210008|FG006|Overall Study|Death|1|||
48551657|NCT00380744|156210002|FG000|Overall Study|Withdrawal by Subject|1|||
48551658|NCT00380744|156210003|FG001|Overall Study|Withdrawal by Subject|0|||
48551659|NCT00380744|156210004|FG002|Overall Study|Withdrawal by Subject|0|||
48551660|NCT00380744|156210005|FG003|Overall Study|Withdrawal by Subject|0|||
48551661|NCT00380744|156210006|FG004|Overall Study|Withdrawal by Subject|0|||
48551662|NCT00380744|156210007|FG005|Overall Study|Withdrawal by Subject|0|||
48551663|NCT00380744|156210008|FG006|Overall Study|Withdrawal by Subject|0|||
48613916|NCT02969018|156443335|FG005|Overall Study|Other|0|||
48613917|NCT02969018|156443336|FG006|Overall Study|Other|0|||
48613918|NCT02969018|156443337|FG007|Overall Study|Other|2|||
48613919|NCT02969018|156443330|FG000|Overall Study|Pregnancy|0|||
48613920|NCT02969018|156443331|FG001|Overall Study|Pregnancy|0|||
48613921|NCT02969018|156443332|FG002|Overall Study|Pregnancy|0|||
48613922|NCT02969018|156443333|FG003|Overall Study|Pregnancy|0|||
48613923|NCT02969018|156443334|FG004|Overall Study|Pregnancy|0|||
48613924|NCT02969018|156443335|FG005|Overall Study|Pregnancy|1|||
48613925|NCT02969018|156443336|FG006|Overall Study|Pregnancy|0|||
48613926|NCT02969018|156443337|FG007|Overall Study|Pregnancy|0|||
48613927|NCT02969018|156443330|FG000|Overall Study|Protocol Violation|0|||
48613928|NCT02969018|156443331|FG001|Overall Study|Protocol Violation|0|||
48613929|NCT02969018|156443332|FG002|Overall Study|Protocol Violation|1|||
48613930|NCT02969018|156443333|FG003|Overall Study|Protocol Violation|1|||
48613931|NCT02969018|156443334|FG004|Overall Study|Protocol Violation|0|||
48551664|NCT01434810|156210009|FG000|Overall Study|Did not receive treatment|11|||
48551665|NCT01434810|156210010|FG001|Overall Study|Did not receive treatment|3|||
48551666|NCT01434810|156210009|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
48551667|NCT01434810|156210010|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
48551668|NCT02508935|156210012|FG000|Overall Study|Withdrawal by Subject|1|||
48551669|NCT02508935|156210012|FG000|Overall Study|Withdrawal by Caregiver|8|||
48551670|NCT02508935|156210012|FG000|Overall Study|Pain Score <4|1|||
48551671|NCT02508935|156210012|FG000|Overall Study|Emesis|3|||
48551672|NCT02508935|156210012|FG000|Overall Study|Adverse Event|3|||
48551673|NCT02508935|156210012|FG000|Overall Study|Protocol Violation|1|||
48551674|NCT02508935|156210012|FG000|Overall Study|Physician Decision|1|||
48551675|NCT02508935|156210012|FG000|Overall Study|Trial terminated by sponsor|5|||
48613932|NCT02969018|156443335|FG005|Overall Study|Protocol Violation|0|||
48613933|NCT02969018|156443336|FG006|Overall Study|Protocol Violation|0|||
48613934|NCT02969018|156443337|FG007|Overall Study|Protocol Violation|0|||
48613935|NCT02969018|156443330|FG000|Overall Study|Withdrawal by Subject|0|||
48613936|NCT02969018|156443331|FG001|Overall Study|Withdrawal by Subject|1|||
48613937|NCT02969018|156443332|FG002|Overall Study|Withdrawal by Subject|2|||
48613938|NCT02969018|156443333|FG003|Overall Study|Withdrawal by Subject|1|||
48613939|NCT02969018|156443334|FG004|Overall Study|Withdrawal by Subject|0|||
48551676|NCT04893018|156210016|FG000|Overall Study|Lost to Follow-up|1|||
48551677|NCT04893018|156210017|FG001|Overall Study|Lost to Follow-up|0|||
48613940|NCT02969018|156443335|FG005|Overall Study|Withdrawal by Subject|4|||
48551678|NCT04893018|156210016|FG000|Overall Study|Withdrawal by Subject|2|||
48551679|NCT04893018|156210017|FG001|Overall Study|Withdrawal by Subject|0|||
48613941|NCT02969018|156443336|FG006|Overall Study|Withdrawal by Subject|4|||
48613942|NCT02969018|156443337|FG007|Overall Study|Withdrawal by Subject|3|||
48613943|NCT00112957|156443338|FG000|Overall Study|Progressive disease|18|||
48613944|NCT00112957|156443338|FG000|Overall Study|Physician Decision|1|||
48613945|NCT02313155|156443344|FG000|Overall Study|Lost to Follow-up|0|||
48613946|NCT02313155|156443345|FG001|Overall Study|Lost to Follow-up|1|||
48613947|NCT01044498|156443349|FG000|Overall Study|Withdrew consent|1|||
48613948|NCT01044498|156443350|FG001|Overall Study|Withdrew consent|1|||
48551680|NCT04893018|156210016|FG000|Overall Study|Study Terminated|1|||
48613949|NCT01044498|156443349|FG000|Overall Study|Adverse Event|1|||
48613950|NCT01044498|156443350|FG001|Overall Study|Adverse Event|1|||
48551681|NCT04893018|156210017|FG001|Overall Study|Study Terminated|2|||
48551682|NCT03106987|156210022|FG000|Overall Study|Death|37|||
48551683|NCT03106987|156210023|FG001|Overall Study|Death|22|||
48551684|NCT03106987|156210024|FG002|Overall Study|Death|12|||
48551685|NCT03106987|156210025|FG003|Overall Study|Death|8|||
48551686|NCT03106987|156210022|FG000|Overall Study|Lost to Follow-up|2|||
48551687|NCT03106987|156210023|FG001|Overall Study|Lost to Follow-up|0|||
48613951|NCT01044498|156443349|FG000|Overall Study|Other|1|||
48613952|NCT01044498|156443350|FG001|Overall Study|Other|0|||
48613953|NCT00724893|156443351|FG000|Overall Study|Adverse Event|76|||
48613954|NCT00724893|156443352|FG001|Overall Study|Adverse Event|142|||
48613955|NCT00724893|156443351|FG000|Overall Study|Withdrawal by Subject|0|||
48613956|NCT00724893|156443352|FG001|Overall Study|Withdrawal by Subject|1|||
48613957|NCT00724893|156443351|FG000|Overall Study|Lack of virologic response|94|||
48613958|NCT00724893|156443352|FG001|Overall Study|Lack of virologic response|202|||
48551688|NCT03106987|156210024|FG002|Overall Study|Lost to Follow-up|2|||
48613959|NCT00724893|156443351|FG000|Overall Study|Reason not specified|193|||
48551689|NCT03106987|156210025|FG003|Overall Study|Lost to Follow-up|2|||
48551690|NCT03106987|156210022|FG000|Overall Study|Withdrawal by Subject|5|||
48551691|NCT03106987|156210023|FG001|Overall Study|Withdrawal by Subject|1|||
48551692|NCT03106987|156210024|FG002|Overall Study|Withdrawal by Subject|4|||
48551693|NCT03106987|156210025|FG003|Overall Study|Withdrawal by Subject|1|||
48551694|NCT01307111|156210028|FG000|IUD Insertion|Lost to Follow-up|2|||
48551695|NCT01307111|156210029|FG001|IUD Insertion|Lost to Follow-up|0|||
48551696|NCT01307111|156210028|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
48551697|NCT01307111|156210029|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
48613960|NCT00724893|156443352|FG001|Overall Study|Reason not specified|7|||
48613961|NCT00724893|156443351|FG000|Overall Study|Patient choice|0|||
48613962|NCT00724893|156443352|FG001|Overall Study|Patient choice|26|||
48613963|NCT00724893|156443351|FG000|Overall Study|Geographic reasons|0|||
48613964|NCT00724893|156443352|FG001|Overall Study|Geographic reasons|11|||
48613965|NCT00724893|156443351|FG000|Overall Study|Incarceration|0|||
48613966|NCT00724893|156443352|FG001|Overall Study|Incarceration|9|||
48551698|NCT02015065|156210030|FG000|Overall Study|Death on study|1|||
48551699|NCT02015065|156210031|FG001|Overall Study|Death on study|2|||
48551700|NCT02015065|156210032|FG002|Overall Study|Death on study|1|||
48551701|NCT01420965|156210033|FG000|Overall Study|Withdrawal by Subject|1|||
48551702|NCT01420965|156210034|FG001|Overall Study|Withdrawal by Subject|0|||
48551703|NCT01420965|156210035|FG002|Overall Study|Withdrawal by Subject|0|||
48551704|NCT01420965|156210033|FG000|Overall Study|Adverse Event|0|||
48551705|NCT01420965|156210034|FG001|Overall Study|Adverse Event|1|||
48551706|NCT01420965|156210035|FG002|Overall Study|Adverse Event|0|||
48551707|NCT02694328|156210049|FG000|Overall Study|Adverse Event|27|||
48551708|NCT02694328|156210050|FG001|Overall Study|Adverse Event|33|||
48551709|NCT02694328|156210049|FG000|Overall Study|Withdrawal by Subject|27|||
48551710|NCT02694328|156210050|FG001|Overall Study|Withdrawal by Subject|23|||
48551711|NCT02694328|156210049|FG000|Overall Study|Lost to Follow-up|26|||
48551712|NCT02694328|156210050|FG001|Overall Study|Lost to Follow-up|22|||
48551713|NCT02694328|156210049|FG000|Overall Study|Noncompliant with study drug|11|||
48551714|NCT02694328|156210050|FG001|Overall Study|Noncompliant with study drug|8|||
48551715|NCT02694328|156210049|FG000|Overall Study|Incarceration|1|||
48551716|NCT02694328|156210050|FG001|Overall Study|Incarceration|1|||
48551717|NCT02694328|156210049|FG000|Overall Study|Lack of Efficacy|1|||
48551718|NCT02694328|156210050|FG001|Overall Study|Lack of Efficacy|2|||
48551719|NCT02694328|156210049|FG000|Overall Study|Pregnancy|1|||
48551720|NCT02694328|156210050|FG001|Overall Study|Pregnancy|1|||
48551721|NCT02694328|156210049|FG000|Overall Study|Protocol Violation|6|||
48551722|NCT02694328|156210050|FG001|Overall Study|Protocol Violation|5|||
48551723|NCT02694328|156210049|FG000|Overall Study|Abnormal Laboratory Value|0|||
48551724|NCT02694328|156210050|FG001|Overall Study|Abnormal Laboratory Value|3|||
48551725|NCT02125877|156210051|FG000|Overall Study|Physician Decision|1|||
48551726|NCT02125877|156210052|FG001|Overall Study|Physician Decision|0|||
48551727|NCT02125877|156210051|FG000|Overall Study|Death|0|||
48551728|NCT02125877|156210052|FG001|Overall Study|Death|1|||
48551729|NCT02125877|156210051|FG000|Overall Study|Administrative problems|0|||
48613967|NCT00724893|156443351|FG000|Overall Study|Substance abuse|0|||
48613968|NCT00724893|156443352|FG001|Overall Study|Substance abuse|3|||
48551730|NCT02125877|156210052|FG001|Overall Study|Administrative problems|1|||
48551731|NCT02125877|156210051|FG000|Overall Study|Participant/guardian decision|0|||
48551732|NCT02125877|156210052|FG001|Overall Study|Participant/guardian decision|2|||
48551733|NCT02125877|156210051|FG000|Overall Study|Withdrawal by Subject|2|||
48613969|NCT00724893|156443351|FG000|Overall Study|Financial reasons|0|||
48613970|NCT00724893|156443352|FG001|Overall Study|Financial reasons|2|||
48613971|NCT00724893|156443351|FG000|Overall Study|Assigned shorter treatment|0|||
48613972|NCT00724893|156443352|FG001|Overall Study|Assigned shorter treatment|2|||
48613973|NCT00724893|156443351|FG000|Overall Study|Lost to Follow-up|0|||
48613974|NCT00724893|156443352|FG001|Overall Study|Lost to Follow-up|52|||
48613975|NCT00724893|156443351|FG000|Overall Study|Unknown, missing data|1|||
48613976|NCT00724893|156443352|FG001|Overall Study|Unknown, missing data|1|||
48613977|NCT01860404|156443353|FG000|Overall Study|Lost to Follow-up|3|||
48551734|NCT02125877|156210052|FG001|Overall Study|Withdrawal by Subject|1|||
48551735|NCT02125877|156210051|FG000|Overall Study|Protocol deviation|4|||
48551736|NCT02125877|156210052|FG001|Overall Study|Protocol deviation|1|||
48551737|NCT02125877|156210051|FG000|Overall Study|Adverse Event|6|||
48551738|NCT02125877|156210052|FG001|Overall Study|Adverse Event|4|||
48551739|NCT01275729|156210054|FG000|Overall Study|Death|3|||
48551740|NCT01275729|156210054|FG000|Overall Study|Withdrawal by Subject|1|||
48613978|NCT01860404|156443354|FG001|Overall Study|Lost to Follow-up|4|||
48613979|NCT01860404|156443355|FG002|Overall Study|Lost to Follow-up|1|||
48613980|NCT01860404|156443356|FG003|Overall Study|Lost to Follow-up|6|||
48613981|NCT01860404|156443357|FG004|Overall Study|Lost to Follow-up|4|||
48551741|NCT02842073|156210055|FG000|Overall Study|Withdrawal by Subject|1|||
48551742|NCT02871492|156210056|FG000|Overall Study|Lost to Follow-up|6|||
48551743|NCT02871492|156210057|FG001|Overall Study|Lost to Follow-up|3|||
48551744|NCT02871492|156210058|FG002|Overall Study|Lost to Follow-up|5|||
48551745|NCT02871492|156210056|FG000|Overall Study|Withdrawal by Subject|0|||
48551746|NCT02871492|156210057|FG001|Overall Study|Withdrawal by Subject|0|||
48551747|NCT02871492|156210058|FG002|Overall Study|Withdrawal by Subject|1|||
48551748|NCT04546724|156210063|FG000|Overall Study|Withdrawal by Subject|145|||
48551749|NCT04546724|156210064|FG001|Overall Study|Withdrawal by Subject|41|||
48551750|NCT04546724|156210063|FG000|Overall Study|Adverse Event|1|||
48551751|NCT04546724|156210064|FG001|Overall Study|Adverse Event|1|||
48551752|NCT04546724|156210063|FG000|Overall Study|Lost to Follow-up|186|||
48551753|NCT04546724|156210064|FG001|Overall Study|Lost to Follow-up|63|||
48551754|NCT04546724|156210063|FG000|Overall Study|Physician Decision|8|||
48551755|NCT04546724|156210064|FG001|Overall Study|Physician Decision|2|||
48551756|NCT04546724|156210063|FG000|Overall Study|Death|2|||
48551757|NCT04546724|156210064|FG001|Overall Study|Death|1|||
48551758|NCT04546724|156210063|FG000|Overall Study|subject has been out of town|1|||
48551759|NCT04546724|156210064|FG001|Overall Study|subject has been out of town|0|||
48551760|NCT04546724|156210063|FG000|Overall Study|subject is incarcerated|2|||
48551761|NCT04546724|156210064|FG001|Overall Study|subject is incarcerated|0|||
48551762|NCT04546724|156210063|FG000|Overall Study|subject is relocating|12|||
48551763|NCT04546724|156210064|FG001|Overall Study|subject is relocating|4|||
48551764|NCT04546724|156210063|FG000|Overall Study|Subject in another study|1|||
48551765|NCT04546724|156210064|FG001|Overall Study|Subject in another study|1|||
48551766|NCT02256436|156210065|FG000|Overall Study|Adverse Event|9|||
48551767|NCT02256436|156210066|FG001|Overall Study|Adverse Event|14|||
48551768|NCT02256436|156210065|FG000|Overall Study|Death|216|||
48551769|NCT02256436|156210066|FG001|Overall Study|Death|208|||
48551770|NCT02256436|156210065|FG000|Overall Study|Lost to Follow-up|1|||
48551771|NCT02256436|156210066|FG001|Overall Study|Lost to Follow-up|2|||
48551772|NCT02256436|156210065|FG000|Overall Study|Physician Decision|1|||
48551773|NCT02256436|156210066|FG001|Overall Study|Physician Decision|0|||
48551774|NCT02256436|156210065|FG000|Overall Study|Protocol Violation|0|||
48551775|NCT02256436|156210066|FG001|Overall Study|Protocol Violation|1|||
48551776|NCT02256436|156210065|FG000|Overall Study|Withdrawal by Subject|26|||
48551777|NCT02256436|156210066|FG001|Overall Study|Withdrawal by Subject|10|||
48551778|NCT02256436|156210065|FG000|Overall Study|Transferred to Extension Study|11|||
48551779|NCT02256436|156210066|FG001|Overall Study|Transferred to Extension Study|23|||
48551780|NCT02256436|156210065|FG000|Overall Study|Did Not Continue on Extension Study|8|||
48551781|NCT02256436|156210066|FG001|Overall Study|Did Not Continue on Extension Study|12|||
48551782|NCT00811928|156210067|FG000|Overall Study|AEs and SAEs Including Death|7|||
48551783|NCT00811928|156210068|FG001|Overall Study|AEs and SAEs Including Death|11|||
48551784|NCT00811928|156210067|FG000|Overall Study|Withdrawal by Subject|18|||
48551785|NCT00811928|156210068|FG001|Overall Study|Withdrawal by Subject|12|||
48551786|NCT00811928|156210067|FG000|Overall Study|Did Not Take Study Drug|3|||
48551787|NCT00811928|156210068|FG001|Overall Study|Did Not Take Study Drug|0|||
48551788|NCT00811928|156210067|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
48551789|NCT00811928|156210068|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
48551790|NCT00811928|156210067|FG000|Overall Study|Investigator Decision|2|||
48551791|NCT00811928|156210068|FG001|Overall Study|Investigator Decision|1|||
48551792|NCT00811928|156210067|FG000|Overall Study|Poor Compliance|2|||
48551793|NCT00811928|156210068|FG001|Overall Study|Poor Compliance|5|||
48551794|NCT04172597|156210069|FG000|Overall Study|Disease Progression|0|||
48551795|NCT04172597|156210070|FG001|Overall Study|Disease Progression|0|||
48551796|NCT04172597|156210071|FG002|Overall Study|Disease Progression|0|||
48551797|NCT04172597|156210072|FG003|Overall Study|Disease Progression|0|||
48551798|NCT04172597|156210073|FG004|Overall Study|Disease Progression|1|||
48613982|NCT01860404|156443353|FG000|Overall Study|Withdrawal by Subject|0|||
48613983|NCT01860404|156443354|FG001|Overall Study|Withdrawal by Subject|0|||
48613984|NCT01860404|156443355|FG002|Overall Study|Withdrawal by Subject|4|||
48613985|NCT01860404|156443356|FG003|Overall Study|Withdrawal by Subject|0|||
48613986|NCT01860404|156443357|FG004|Overall Study|Withdrawal by Subject|0|||
48613987|NCT01910441|156443358|FG000|Overall Study|Sponsor decision|0|||
48551799|NCT00171951|156210074|FG000|Overall Study|Adverse Event|1|||
48551800|NCT00171951|156210074|FG000|Overall Study|Abnormal Laboratory Values|2|||
48551801|NCT00171951|156210074|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48551802|NCT00171951|156210074|FG000|Overall Study|Participants Withdrew Consent|3|||
48551803|NCT00171951|156210074|FG000|Overall Study|New Cancer Therapy|5|||
48551804|NCT00171951|156210074|FG000|Overall Study|Reason not Specified|2|||
48551805|NCT00535405|156210075|FG000|Overall Study|Adverse Event|6|||
48551806|NCT00535405|156210076|FG001|Overall Study|Adverse Event|8|||
48551807|NCT00535405|156210077|FG002|Overall Study|Adverse Event|3|||
48551808|NCT00535405|156210078|FG003|Overall Study|Adverse Event|8|||
48551809|NCT00535405|156210079|FG004|Overall Study|Adverse Event|6|||
48613988|NCT01910441|156443359|FG001|Overall Study|Sponsor decision|2|||
48551810|NCT00535405|156210075|FG000|Overall Study|Lost to Follow-up|1|||
48551811|NCT00535405|156210076|FG001|Overall Study|Lost to Follow-up|3|||
48551812|NCT00535405|156210077|FG002|Overall Study|Lost to Follow-up|3|||
48551813|NCT00535405|156210078|FG003|Overall Study|Lost to Follow-up|2|||
48551814|NCT00535405|156210079|FG004|Overall Study|Lost to Follow-up|1|||
48551815|NCT00535405|156210075|FG000|Overall Study|Physician Decision|3|||
48613989|NCT01910441|156443358|FG000|Overall Study|Lost to Follow-up|6|||
48613990|NCT01910441|156443359|FG001|Overall Study|Lost to Follow-up|5|||
48613991|NCT01910441|156443358|FG000|Overall Study|Withdrawal by Subject|0|||
48613992|NCT01910441|156443359|FG001|Overall Study|Withdrawal by Subject|1|||
48613993|NCT01910441|156443358|FG000|Overall Study|Non-compliance|0|||
48551816|NCT00535405|156210076|FG001|Overall Study|Physician Decision|2|||
48551817|NCT00535405|156210077|FG002|Overall Study|Physician Decision|0|||
48551818|NCT00535405|156210078|FG003|Overall Study|Physician Decision|1|||
48551819|NCT00535405|156210079|FG004|Overall Study|Physician Decision|1|||
48551820|NCT00535405|156210075|FG000|Overall Study|Protocol Violation|2|||
48551821|NCT00535405|156210076|FG001|Overall Study|Protocol Violation|2|||
48551822|NCT00535405|156210077|FG002|Overall Study|Protocol Violation|2|||
48551823|NCT00535405|156210078|FG003|Overall Study|Protocol Violation|1|||
48551824|NCT00535405|156210079|FG004|Overall Study|Protocol Violation|0|||
48551825|NCT00535405|156210075|FG000|Overall Study|Withdrawal by Subject|5|||
48551826|NCT00535405|156210076|FG001|Overall Study|Withdrawal by Subject|11|||
48551827|NCT00535405|156210077|FG002|Overall Study|Withdrawal by Subject|10|||
48551828|NCT00535405|156210078|FG003|Overall Study|Withdrawal by Subject|10|||
48551829|NCT00535405|156210079|FG004|Overall Study|Withdrawal by Subject|8|||
48551830|NCT02290223|156210085|FG000|6 Months|Lost to Follow-up|9|||
48551831|NCT02290223|156210086|FG001|6 Months|Lost to Follow-up|6|||
48551832|NCT02290223|156210085|FG000|6 Months|Withdrawal by Subject|5|||
48551833|NCT02290223|156210086|FG001|6 Months|Withdrawal by Subject|0|||
48551834|NCT02290223|156210085|FG000|6 Months|deceased (not related to study)|2|||
48551835|NCT02290223|156210086|FG001|6 Months|deceased (not related to study)|0|||
48551836|NCT02290223|156210085|FG000|12 Months|Lost to Follow-up|16|||
48551837|NCT02290223|156210086|FG001|12 Months|Lost to Follow-up|10|||
48551838|NCT02290223|156210085|FG000|12 Months|Refusal|0|||
48551839|NCT02290223|156210086|FG001|12 Months|Refusal|1|||
48551840|NCT04036110|156210089|FG000|Overall Study|Lost to Follow-up|3|||
48551841|NCT04036110|156210090|FG001|Overall Study|Lost to Follow-up|2|||
48551842|NCT04036110|156210091|FG002|Overall Study|Lost to Follow-up|1|||
48551843|NCT04036110|156210089|FG000|Overall Study|Study Suspended|4|||
48551844|NCT04036110|156210090|FG001|Overall Study|Study Suspended|5|||
48551845|NCT04036110|156210091|FG002|Overall Study|Study Suspended|1|||
48551846|NCT00534404|156210094|FG000|Overall Study|Death|0|||
48551847|NCT00534404|156210095|FG001|Overall Study|Death|0|||
48551848|NCT00534404|156210096|FG002|Overall Study|Death|2|||
48551849|NCT00534404|156210094|FG000|Overall Study|Withdrawal by Subject|8|||
48551850|NCT00534404|156210095|FG001|Overall Study|Withdrawal by Subject|2|||
48551851|NCT00534404|156210096|FG002|Overall Study|Withdrawal by Subject|38|||
48551852|NCT00534404|156210094|FG000|Overall Study|Removed by study staff|2|||
48551853|NCT00534404|156210095|FG001|Overall Study|Removed by study staff|3|||
48551854|NCT00534404|156210096|FG002|Overall Study|Removed by study staff|1|||
48551855|NCT00534404|156210094|FG000|Overall Study|Lost to Follow-up|170|||
48551856|NCT00534404|156210095|FG001|Overall Study|Lost to Follow-up|138|||
48551857|NCT00534404|156210096|FG002|Overall Study|Lost to Follow-up|201|||
48551858|NCT04759768|156210097|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
48551859|NCT04759768|156210098|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
48551860|NCT04759768|156210097|FG000|Washout (7 Days)|Physician Decision|0|||
48551861|NCT04759768|156210098|FG001|Washout (7 Days)|Physician Decision|1|||
48551862|NCT02996487|156210101|FG000|Overall Study|Lost to Follow-up|1|||
48551863|NCT02996487|156210102|FG001|Overall Study|Lost to Follow-up|1|||
48551864|NCT02996487|156210103|FG002|Overall Study|Lost to Follow-up|0|||
48551865|NCT02996487|156210101|FG000|Overall Study|Death|0|||
48551866|NCT02996487|156210102|FG001|Overall Study|Death|1|||
48551867|NCT02996487|156210103|FG002|Overall Study|Death|0|||
48551868|NCT02996487|156210101|FG000|Overall Study|Withdrawal by Subject|2|||
48551869|NCT02996487|156210102|FG001|Overall Study|Withdrawal by Subject|3|||
48551870|NCT02996487|156210103|FG002|Overall Study|Withdrawal by Subject|0|||
48551871|NCT01130597|156210104|FG000|Overall Study|Protocol-specified (High K+)|1|||
48551872|NCT01130597|156210104|FG000|Overall Study|Adverse Event|4|||
48551873|NCT01130597|156210104|FG000|Overall Study|Death|1|||
48551874|NCT01130597|156210104|FG000|Overall Study|Protocol Violation|1|||
48551875|NCT02759692|156210106|FG000|Period 1|Test article no longer available|1|||
48551876|NCT02759692|156210107|FG001|Period 1|Test article no longer available|1|||
48551877|NCT02759692|156210106|FG000|Period 1|No longer meets eligibility criteria.|1|||
48551878|NCT02759692|156210107|FG001|Period 1|No longer meets eligibility criteria.|0|||
48613994|NCT01910441|156443359|FG001|Overall Study|Non-compliance|1|||
48551879|NCT02759692|156210106|FG000|Period 1|Miss-Randomized|1|||
48551880|NCT02759692|156210107|FG001|Period 1|Miss-Randomized|1|||
48551881|NCT02759692|156210106|FG000|Period 2|Lost to Follow-up|1|||
48551882|NCT02759692|156210107|FG001|Period 2|Lost to Follow-up|0|||
48613995|NCT01910441|156443358|FG000|Overall Study|Adverse Event|1|||
48551883|NCT02759692|156210106|FG000|Period 2|Test article no longer available|0|||
48551884|NCT02759692|156210107|FG001|Period 2|Test article no longer available|1|||
48551885|NCT01862484|156210109|FG000|Overall Study|Lack of Efficacy|1|||
48551886|NCT01862484|156210110|FG001|Overall Study|Lack of Efficacy|1|||
48551887|NCT01862484|156210109|FG000|Overall Study|Lost to Follow-up|1|||
48551888|NCT01862484|156210110|FG001|Overall Study|Lost to Follow-up|2|||
48551889|NCT01862484|156210109|FG000|Overall Study|Protocol Violation|0|||
48551890|NCT01862484|156210110|FG001|Overall Study|Protocol Violation|2|||
48551891|NCT01862484|156210109|FG000|Overall Study|Withdrawal by Subject|0|||
48551892|NCT01862484|156210110|FG001|Overall Study|Withdrawal by Subject|3|||
48551893|NCT03316547|156210115|FG000|Overall Study|Death|3|||
48551894|NCT03316547|156210116|FG001|Overall Study|Death|1|||
48551895|NCT03316547|156210115|FG000|Overall Study|Lost to Follow-up|6|||
48551896|NCT03316547|156210116|FG001|Overall Study|Lost to Follow-up|6|||
48551897|NCT03316547|156210115|FG000|Overall Study|Withdrawal by Subject|3|||
48551898|NCT03316547|156210116|FG001|Overall Study|Withdrawal by Subject|2|||
48551899|NCT03316547|156210115|FG000|Overall Study|Transfer to another hospital|6|||
48551900|NCT03316547|156210116|FG001|Overall Study|Transfer to another hospital|4|||
48551901|NCT00721227|156210117|FG000|Overall Study|Lost to Follow-up|3|||
48551902|NCT00721227|156210118|FG001|Overall Study|Lost to Follow-up|0|||
48551903|NCT00721227|156210117|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
48551904|NCT00721227|156210118|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
48551905|NCT04233073|156210136|FG000|Overall Study|Death|5|||
48551906|NCT03172494|156210142|FG000|Overall Study|Adverse Event|5|||
48551907|NCT03172494|156210143|FG001|Overall Study|Adverse Event|1|||
48551908|NCT03172494|156210144|FG002|Overall Study|Adverse Event|15|||
48551909|NCT03172494|156210142|FG000|Overall Study|Protocol Violation|3|||
48551910|NCT03172494|156210143|FG001|Overall Study|Protocol Violation|2|||
48551911|NCT03172494|156210144|FG002|Overall Study|Protocol Violation|1|||
48551912|NCT03172494|156210142|FG000|Overall Study|Lack of Efficacy|0|||
48551913|NCT03172494|156210143|FG001|Overall Study|Lack of Efficacy|0|||
48551914|NCT03172494|156210144|FG002|Overall Study|Lack of Efficacy|4|||
48551915|NCT03172494|156210142|FG000|Overall Study|Pregnancy|0|||
48551916|NCT03172494|156210143|FG001|Overall Study|Pregnancy|1|||
48551917|NCT03172494|156210144|FG002|Overall Study|Pregnancy|0|||
48551918|NCT03172494|156210142|FG000|Overall Study|Withdrawal by Subject|10|||
48551919|NCT03172494|156210143|FG001|Overall Study|Withdrawal by Subject|8|||
48551920|NCT03172494|156210144|FG002|Overall Study|Withdrawal by Subject|8|||
48551921|NCT03172494|156210142|FG000|Overall Study|Severe hypoglycaemic episode|0|||
48551922|NCT03172494|156210143|FG001|Overall Study|Severe hypoglycaemic episode|0|||
48551923|NCT03172494|156210144|FG002|Overall Study|Severe hypoglycaemic episode|1|||
48551924|NCT03172494|156210142|FG000|Overall Study|Non-compliance towards treatment|2|||
48551925|NCT03172494|156210143|FG001|Overall Study|Non-compliance towards treatment|0|||
48551926|NCT03172494|156210144|FG002|Overall Study|Non-compliance towards treatment|0|||
48551927|NCT02198963|156210145|FG000|Overall Study|Adverse Event|1|||
48551928|NCT02198963|156210145|FG000|Overall Study|Withdrawal by Subject|6|||
48551929|NCT01653912|156210146|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
48551930|NCT01653912|156210147|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
48551931|NCT01653912|156210148|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
48551932|NCT01653912|156210149|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
48551933|NCT01653912|156210150|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
48551934|NCT01653912|156210151|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
48551935|NCT01653912|156210146|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
48551936|NCT01653912|156210147|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
48551937|NCT01653912|156210148|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
48551938|NCT01653912|156210149|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
48551939|NCT01653912|156210150|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
48551940|NCT01653912|156210151|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
48551941|NCT01653912|156210146|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
48551942|NCT01653912|156210147|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
48551943|NCT01653912|156210148|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
48551944|NCT01653912|156210149|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
48551945|NCT01653912|156210150|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
48551946|NCT01653912|156210151|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
48551947|NCT01653912|156210146|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551948|NCT01653912|156210147|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551949|NCT01653912|156210148|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551950|NCT01653912|156210149|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
48551951|NCT01653912|156210150|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551952|NCT01653912|156210151|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551953|NCT01653912|156210146|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
48551954|NCT01653912|156210147|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
48551955|NCT01653912|156210148|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
48551956|NCT01653912|156210149|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
48551957|NCT01653912|156210150|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
48551958|NCT01653912|156210151|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
48551959|NCT01653912|156210146|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
48551960|NCT01653912|156210147|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
48551961|NCT01653912|156210148|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
48551962|NCT01653912|156210149|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
48551963|NCT01653912|156210150|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
48551964|NCT01653912|156210151|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
48551965|NCT01653912|156210146|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551966|NCT01653912|156210147|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551967|NCT01653912|156210148|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551968|NCT01653912|156210149|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551969|NCT01653912|156210150|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
48551970|NCT01653912|156210151|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
48551971|NCT00993421|156210152|FG000|Overall Study|Adverse Event|2|||
48551972|NCT00993421|156210153|FG001|Overall Study|Adverse Event|7|||
48551973|NCT00993421|156210154|FG002|Overall Study|Adverse Event|6|||
48551974|NCT00993421|156210155|FG003|Overall Study|Adverse Event|9|||
48551975|NCT00993421|156210156|FG004|Overall Study|Adverse Event|5|||
48551976|NCT00993421|156210157|FG005|Overall Study|Adverse Event|7|||
48551977|NCT00993421|156210158|FG006|Overall Study|Adverse Event|1|||
48551978|NCT00993421|156210152|FG000|Overall Study|Sponsor Decision|36|||
48551979|NCT00993421|156210153|FG001|Overall Study|Sponsor Decision|31|||
48551980|NCT00993421|156210154|FG002|Overall Study|Sponsor Decision|28|||
48551981|NCT00993421|156210155|FG003|Overall Study|Sponsor Decision|30|||
48551982|NCT00993421|156210156|FG004|Overall Study|Sponsor Decision|38|||
48551983|NCT00993421|156210157|FG005|Overall Study|Sponsor Decision|30|||
48551984|NCT00993421|156210158|FG006|Overall Study|Sponsor Decision|29|||
48551985|NCT00993421|156210152|FG000|Overall Study|Lost to Follow-up|3|||
48551986|NCT00993421|156210153|FG001|Overall Study|Lost to Follow-up|5|||
48551987|NCT00993421|156210154|FG002|Overall Study|Lost to Follow-up|5|||
48551988|NCT00993421|156210155|FG003|Overall Study|Lost to Follow-up|0|||
48551989|NCT00993421|156210156|FG004|Overall Study|Lost to Follow-up|0|||
48551990|NCT00993421|156210157|FG005|Overall Study|Lost to Follow-up|0|||
48551991|NCT00993421|156210158|FG006|Overall Study|Lost to Follow-up|6|||
48551992|NCT00993421|156210152|FG000|Overall Study|Withdrawal by Subject|3|||
48551993|NCT00993421|156210153|FG001|Overall Study|Withdrawal by Subject|2|||
48551994|NCT00993421|156210154|FG002|Overall Study|Withdrawal by Subject|3|||
48551995|NCT00993421|156210155|FG003|Overall Study|Withdrawal by Subject|3|||
48551996|NCT00993421|156210156|FG004|Overall Study|Withdrawal by Subject|3|||
48551997|NCT00993421|156210157|FG005|Overall Study|Withdrawal by Subject|5|||
48551998|NCT00993421|156210158|FG006|Overall Study|Withdrawal by Subject|3|||
48551999|NCT00993421|156210152|FG000|Overall Study|Death|0|||
48552000|NCT00993421|156210153|FG001|Overall Study|Death|0|||
48552001|NCT00993421|156210154|FG002|Overall Study|Death|0|||
48552002|NCT00993421|156210155|FG003|Overall Study|Death|0|||
48552003|NCT00993421|156210156|FG004|Overall Study|Death|0|||
48552004|NCT00993421|156210157|FG005|Overall Study|Death|0|||
48552005|NCT00993421|156210158|FG006|Overall Study|Death|1|||
48552006|NCT00993421|156210152|FG000|Overall Study|Entry Criteria Exclusion|0|||
48552007|NCT00993421|156210153|FG001|Overall Study|Entry Criteria Exclusion|0|||
48552008|NCT00993421|156210154|FG002|Overall Study|Entry Criteria Exclusion|1|||
48552009|NCT00993421|156210155|FG003|Overall Study|Entry Criteria Exclusion|3|||
48552010|NCT00993421|156210156|FG004|Overall Study|Entry Criteria Exclusion|0|||
48552011|NCT00993421|156210157|FG005|Overall Study|Entry Criteria Exclusion|1|||
48552012|NCT00993421|156210158|FG006|Overall Study|Entry Criteria Exclusion|0|||
48552013|NCT00993421|156210152|FG000|Overall Study|Physician Decision|0|||
48552014|NCT00993421|156210153|FG001|Overall Study|Physician Decision|0|||
48552015|NCT00993421|156210154|FG002|Overall Study|Physician Decision|0|||
48552016|NCT00993421|156210155|FG003|Overall Study|Physician Decision|0|||
48552017|NCT00993421|156210156|FG004|Overall Study|Physician Decision|0|||
48552018|NCT00993421|156210157|FG005|Overall Study|Physician Decision|1|||
48552019|NCT00993421|156210158|FG006|Overall Study|Physician Decision|1|||
48552020|NCT00993421|156210152|FG000|Overall Study|Protocol Violation|0|||
48552021|NCT00993421|156210153|FG001|Overall Study|Protocol Violation|0|||
48552022|NCT00993421|156210154|FG002|Overall Study|Protocol Violation|0|||
48552023|NCT00993421|156210155|FG003|Overall Study|Protocol Violation|0|||
48552024|NCT00993421|156210156|FG004|Overall Study|Protocol Violation|0|||
48552025|NCT00993421|156210157|FG005|Overall Study|Protocol Violation|2|||
48552026|NCT00993421|156210158|FG006|Overall Study|Protocol Violation|1|||
48552027|NCT00143390|156210159|FG000|Overall Study|Death|2|||
48552028|NCT00143390|156210160|FG001|Overall Study|Death|0|||
48552029|NCT00143390|156210159|FG000|Overall Study|Not meeting entry criteria|2|||
48552030|NCT00143390|156210160|FG001|Overall Study|Not meeting entry criteria|5|||
48552031|NCT00143390|156210159|FG000|Overall Study|Withdrawal by Subject|4|||
48552032|NCT00143390|156210160|FG001|Overall Study|Withdrawal by Subject|4|||
48552033|NCT00143390|156210159|FG000|Overall Study|Progressive disease|119|||
48552034|NCT00143390|156210160|FG001|Overall Study|Progressive disease|115|||
48552035|NCT00143390|156210159|FG000|Overall Study|Protocol Violation|2|||
48552036|NCT00143390|156210160|FG001|Overall Study|Protocol Violation|0|||
48552037|NCT00143390|156210159|FG000|Overall Study|Study termination|10|||
48552038|NCT00143390|156210160|FG001|Overall Study|Study termination|15|||
48552039|NCT00143390|156210159|FG000|Overall Study|Adverse Event|9|||
48552040|NCT00143390|156210160|FG001|Overall Study|Adverse Event|8|||
48552041|NCT00143390|156210159|FG000|Overall Study|Other|1|||
48552042|NCT00143390|156210160|FG001|Overall Study|Other|2|||
48552043|NCT00041132|156210161|FG000|Overall Study|Adverse Event|19|||
48552044|NCT00041132|156210161|FG000|Overall Study|Death|1|||
48552045|NCT00041132|156210161|FG000|Overall Study|Not Eligible|7|||
48552046|NCT00041132|156210161|FG000|Overall Study|Withdrawal by Subject|1|||
48552047|NCT00041132|156210161|FG000|Overall Study|Physician Decision|2|||
48552048|NCT03086551|156210165|FG000|First Intervention|Failure to meet inclusion criterion|1|||
48552049|NCT03086551|156210166|FG001|First Intervention|Failure to meet inclusion criterion|0|||
48552050|NCT03086551|156210165|FG000|First Intervention|Lost to Follow-up|0|||
48552051|NCT03086551|156210166|FG001|First Intervention|Lost to Follow-up|1|||
48552052|NCT03086551|156210165|FG000|Washout|Lost to Follow-up|1|||
48552053|NCT03086551|156210166|FG001|Washout|Lost to Follow-up|2|||
48552054|NCT03086551|156210165|FG000|Washout|Withdrawal by Subject|2|||
48552055|NCT03086551|156210166|FG001|Washout|Withdrawal by Subject|1|||
48552056|NCT01450683|156210167|FG000|Overall Study|Adverse Event|2|||
48552057|NCT01305044|156212069|FG000|Overall Study|Withdrawal by Subject|3|||
48552058|NCT01305044|156212070|FG001|Overall Study|Withdrawal by Subject|6|||
48552059|NCT02022748|156212077|FG000|Overall Study|Adverse Event|1|||
48552060|NCT02022748|156212078|FG001|Overall Study|Adverse Event|1|||
48552061|NCT02022748|156212079|FG002|Overall Study|Adverse Event|0|||
48552062|NCT02022748|156212077|FG000|Overall Study|Withdrawal by Subject|0|||
48552063|NCT02022748|156212078|FG001|Overall Study|Withdrawal by Subject|1|||
48552064|NCT02022748|156212079|FG002|Overall Study|Withdrawal by Subject|0|||
48552065|NCT01973595|156212080|FG000|Washout|Withdrawal by Subject|1|||
48552066|NCT01973595|156212081|FG001|Washout|Withdrawal by Subject|0|||
48552067|NCT01973595|156212082|FG002|Washout|Withdrawal by Subject|1|||
48552068|NCT01973595|156212083|FG003|Washout|Withdrawal by Subject|0|||
48552069|NCT00233402|156212089|FG000|Overall Study|No pathology data|12|||
48552070|NCT00233402|156212090|FG001|Overall Study|No pathology data|9|||
48552071|NCT00233402|156212089|FG000|Overall Study|No Ta/T1|89|||
48552072|NCT00233402|156212090|FG001|Overall Study|No Ta/T1|94|||
48552073|NCT00233402|156212089|FG000|Overall Study|Lost to follow up etc|3|||
48552074|NCT00233402|156212090|FG001|Overall Study|Lost to follow up etc|21|||
48552075|NCT01243775|156212094|FG000|Overall Study|Withdrawal by Subject|2|||
48552076|NCT01260701|156212099|FG000|Overall Study|Adverse Event|9|||
48552077|NCT01260701|156212099|FG000|Overall Study|Withdrawal by Subject|2|||
48552078|NCT01260701|156212099|FG000|Overall Study|Progression|53|||
48552079|NCT01260701|156212099|FG000|Overall Study|Death|2|||
48552080|NCT01260701|156212099|FG000|Overall Study|Not protocol specified|3|||
48552081|NCT01260701|156212099|FG000|Overall Study|Under review|1|||
48552082|NCT01260701|156212099|FG000|Overall Study|Ineligible|4|||
48552083|NCT01260701|156212099|FG000|Overall Study|Did not begin protocol therapy|1|||
48552084|NCT01753297|156212103|FG000|Overall Study|Lost to Follow-up|7|||
48552085|NCT01753297|156212104|FG001|Overall Study|Lost to Follow-up|2|||
48552086|NCT01753297|156212103|FG000|Overall Study|Withdrawal by Subject|26|||
48552087|NCT01753297|156212104|FG001|Overall Study|Withdrawal by Subject|23|||
48552088|NCT01753297|156212103|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
48552089|NCT01753297|156212104|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
48552090|NCT01753297|156212103|FG000|Overall Study|Death|0|||
48552091|NCT01753297|156212104|FG001|Overall Study|Death|2|||
48552092|NCT01753297|156212103|FG000|Overall Study|Did not attend end of study visit|7|||
48552093|NCT01753297|156212104|FG001|Overall Study|Did not attend end of study visit|8|||
48552094|NCT00230178|156212105|FG000|Overall Study|Adverse Event|1|||
48552095|NCT00230178|156212106|FG001|Overall Study|Adverse Event|5|||
48552096|NCT00230178|156212107|FG002|Overall Study|Adverse Event|2|||
48552097|NCT00230178|156212105|FG000|Overall Study|Withdrawal by Subject|0|||
48552098|NCT00230178|156212106|FG001|Overall Study|Withdrawal by Subject|0|||
48552099|NCT00230178|156212107|FG002|Overall Study|Withdrawal by Subject|1|||
48552100|NCT00230178|156212105|FG000|Overall Study|Various other reasons|3|||
48552101|NCT00230178|156212106|FG001|Overall Study|Various other reasons|2|||
48552102|NCT00230178|156212107|FG002|Overall Study|Various other reasons|4|||
48552103|NCT00901576|156212110|FG000|Second Intervention|Withdrawal by Subject|0|||
48552104|NCT00901576|156212111|FG001|Second Intervention|Withdrawal by Subject|0|||
48552105|NCT00901576|156212112|FG002|Second Intervention|Withdrawal by Subject|0|||
48552106|NCT00901576|156212113|FG003|Second Intervention|Withdrawal by Subject|1|||
48552107|NCT00901576|156212114|FG004|Second Intervention|Withdrawal by Subject|0|||
48552108|NCT00901576|156212115|FG005|Second Intervention|Withdrawal by Subject|1|||
48552109|NCT00901576|156212110|FG000|Second Intervention|Physician Decision|1|||
48552110|NCT00901576|156212111|FG001|Second Intervention|Physician Decision|0|||
48552111|NCT00901576|156212112|FG002|Second Intervention|Physician Decision|0|||
48552112|NCT00901576|156212113|FG003|Second Intervention|Physician Decision|0|||
48552113|NCT00901576|156212114|FG004|Second Intervention|Physician Decision|0|||
48552114|NCT00901576|156212115|FG005|Second Intervention|Physician Decision|0|||
48552115|NCT01068262|156212116|FG000|Overall Study|Adverse Event|2|||
48552116|NCT01068262|156212117|FG001|Overall Study|Adverse Event|0|||
48552117|NCT01068262|156212118|FG002|Overall Study|Adverse Event|1|||
48552118|NCT01068262|156212119|FG003|Overall Study|Adverse Event|0|||
48552119|NCT01068262|156212116|FG000|Overall Study|Protocol Violation|1|||
48552120|NCT01068262|156212117|FG001|Overall Study|Protocol Violation|0|||
48552121|NCT01068262|156212118|FG002|Overall Study|Protocol Violation|0|||
48552122|NCT01068262|156212119|FG003|Overall Study|Protocol Violation|0|||
48552123|NCT01068262|156212116|FG000|Overall Study|Withdrawal by Subject|0|||
48552124|NCT01068262|156212117|FG001|Overall Study|Withdrawal by Subject|1|||
48552125|NCT01068262|156212118|FG002|Overall Study|Withdrawal by Subject|0|||
48552126|NCT01068262|156212119|FG003|Overall Study|Withdrawal by Subject|0|||
48552127|NCT01559389|156212120|FG000|Overall Study|Withdrawal by Subject|20|||
48552128|NCT01559389|156212121|FG001|Overall Study|Withdrawal by Subject|20|||
48552129|NCT00005957|156212126|FG000|Overall Study|No treated|3|||
48552130|NCT00005957|156212127|FG001|Overall Study|No treated|9|||
48552131|NCT00005957|156212126|FG000|Overall Study|Crossover to the other arm|5|||
48552132|NCT00005957|156212127|FG001|Overall Study|Crossover to the other arm|19|||
48552133|NCT01609023|156212128|FG000|Overall Study|Lack of Efficacy|3|||
48552134|NCT01609023|156212128|FG000|Overall Study|Withdrawal by Subject|4|||
48552135|NCT01609023|156212128|FG000|Overall Study|Lost to Follow-up|8|||
48552136|NCT01609023|156212128|FG000|Overall Study|Toxicity|3|||
48552137|NCT01609023|156212128|FG000|Overall Study|Disease progression|10|||
48552138|NCT01609023|156212128|FG000|Overall Study|Physician Decision|2|||
48552139|NCT01609023|156212128|FG000|Overall Study|Death|2|||
48552140|NCT01609023|156212128|FG000|Overall Study|Personal reasons|1|||
48552141|NCT01174043|156212130|FG000|Overall Study|Disease progression|5|||
48552142|NCT01174043|156212130|FG000|Overall Study|Adverse Event|3|||
48552143|NCT01174043|156212130|FG000|Overall Study|Death|1|||
48552144|NCT01174043|156212130|FG000|Overall Study|Withdrawal by Subject|2|||
48552145|NCT02047734|156212131|FG000|Overall Study|Adverse Event|18|||
48552146|NCT02047734|156212132|FG001|Overall Study|Adverse Event|13|||
48552147|NCT02047734|156212133|FG002|Overall Study|Adverse Event|13|||
48552148|NCT02047734|156212131|FG000|Overall Study|Lack of Efficacy|4|||
48552149|NCT02047734|156212132|FG001|Overall Study|Lack of Efficacy|5|||
48552150|NCT02047734|156212133|FG002|Overall Study|Lack of Efficacy|1|||
48552151|NCT02047734|156212131|FG000|Overall Study|Protocol Violation|3|||
48552152|NCT02047734|156212132|FG001|Overall Study|Protocol Violation|1|||
48552153|NCT02047734|156212133|FG002|Overall Study|Protocol Violation|1|||
48552154|NCT02047734|156212131|FG000|Overall Study|Lost to Follow-up|1|||
48552155|NCT02047734|156212132|FG001|Overall Study|Lost to Follow-up|4|||
48552156|NCT02047734|156212133|FG002|Overall Study|Lost to Follow-up|0|||
48552157|NCT02047734|156212131|FG000|Overall Study|Death|0|||
48552158|NCT02047734|156212132|FG001|Overall Study|Death|1|||
48552159|NCT02047734|156212133|FG002|Overall Study|Death|0|||
48552160|NCT02047734|156212131|FG000|Overall Study|Withdrawal by Subject|30|||
48552161|NCT02047734|156212132|FG001|Overall Study|Withdrawal by Subject|31|||
48552162|NCT02047734|156212133|FG002|Overall Study|Withdrawal by Subject|19|||
48552163|NCT02047734|156212131|FG000|Overall Study|Physician Decision|7|||
48552164|NCT02047734|156212132|FG001|Overall Study|Physician Decision|6|||
48552165|NCT02047734|156212133|FG002|Overall Study|Physician Decision|5|||
48552166|NCT02047734|156212131|FG000|Overall Study|Miscellaneous|2|||
48552167|NCT02047734|156212132|FG001|Overall Study|Miscellaneous|4|||
48552168|NCT02047734|156212133|FG002|Overall Study|Miscellaneous|6|||
48552169|NCT02047734|156212131|FG000|Overall Study|Did Not Receive Study Drug|2|||
48552170|NCT02047734|156212132|FG001|Overall Study|Did Not Receive Study Drug|4|||
48552171|NCT02047734|156212133|FG002|Overall Study|Did Not Receive Study Drug|1|||
48552172|NCT01696279|156212134|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
48552173|NCT01696279|156212135|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
48552174|NCT01696279|156212136|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
48552175|NCT01696279|156212137|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
48552176|NCT01696279|156212134|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
48552177|NCT01696279|156212135|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
48552178|NCT01696279|156212136|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
48552179|NCT01696279|156212137|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
48552180|NCT01696279|156212134|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
48552181|NCT01696279|156212135|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
48552182|NCT01696279|156212136|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
48552183|NCT01696279|156212137|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
48552184|NCT01696279|156212134|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
48552185|NCT01696279|156212135|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
48552186|NCT01696279|156212136|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
48552187|NCT01696279|156212137|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
48552188|NCT01696279|156212134|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
48552189|NCT01696279|156212135|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
48552190|NCT01696279|156212136|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
48552191|NCT01696279|156212137|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
48552192|NCT01696279|156212134|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
48552193|NCT01696279|156212135|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
48552194|NCT01696279|156212136|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
48552195|NCT01696279|156212137|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
48552196|NCT01696279|156212134|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
48552197|NCT01696279|156212135|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
48552198|NCT01696279|156212136|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
48552199|NCT01696279|156212137|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
48552200|NCT01696279|156212134|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
48552201|NCT01696279|156212135|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
48552202|NCT01696279|156212136|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
48552203|NCT01696279|156212137|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
48552204|NCT01696279|156212134|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
48552205|NCT01696279|156212135|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
48552206|NCT01696279|156212136|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
48552207|NCT01696279|156212137|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
48552208|NCT01696279|156212134|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
48552209|NCT01696279|156212135|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
48552210|NCT01696279|156212136|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
48552211|NCT01696279|156212137|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
48552212|NCT01696279|156212134|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
48552213|NCT01696279|156212135|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
48552214|NCT01696279|156212136|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
48552215|NCT01696279|156212137|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
48552216|NCT00799825|156212141|FG000|Overall Study|Adverse Event|1|||
48552217|NCT00799825|156212141|FG000|Overall Study|Withdrawal by Subject|6|||
48552218|NCT00799825|156212141|FG000|Overall Study|Lost to Follow-up|38|||
48552219|NCT00799825|156212141|FG000|Overall Study|Pregnancy|3|||
48552220|NCT02439970|156212150|FG000|Overall Study|Study Terminated|2|||
48552221|NCT02439970|156212151|FG001|Overall Study|Study Terminated|3|||
48552222|NCT03201445|156212152|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
48552223|NCT03201445|156212153|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
48552224|NCT03201445|156212152|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
48552225|NCT03201445|156212153|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
48552226|NCT03201445|156212152|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
48552227|NCT03201445|156212153|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
48552228|NCT03201445|156212152|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
48552229|NCT03201445|156212153|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
48552230|NCT03201445|156212152|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
48552231|NCT03201445|156212153|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
48552232|NCT03201445|156212152|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
48552233|NCT03201445|156212153|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
48552234|NCT03201445|156212152|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
48552235|NCT03201445|156212153|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
48552236|NCT03201445|156212152|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
48552237|NCT03201445|156212153|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
48552238|NCT03201445|156212152|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
48552239|NCT03201445|156212153|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
48552240|NCT03201445|156212152|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
48552241|NCT03201445|156212153|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
48552242|NCT03201445|156212152|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
48552243|NCT03201445|156212153|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
48552244|NCT03201445|156212152|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
48552245|NCT03201445|156212153|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
48552246|NCT03201445|156212152|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
48552247|NCT03201445|156212153|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
48552248|NCT03201445|156212152|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
48552249|NCT03201445|156212153|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
48552250|NCT03201445|156212152|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
48552251|NCT03201445|156212153|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
48552252|NCT03201445|156212152|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
48552253|NCT03201445|156212153|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
48552254|NCT03201445|156212152|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
48552255|NCT03201445|156212153|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
48552256|NCT03201445|156212152|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
48552257|NCT03201445|156212153|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
48552258|NCT03201445|156212152|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
48552259|NCT03201445|156212153|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
48552260|NCT03201445|156212152|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
48552261|NCT03201445|156212153|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
48552262|NCT03201445|156212152|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
48552263|NCT03201445|156212153|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
48552264|NCT02952586|156212155|FG000|Lead-In Phase (7 Days)|Death|0|||
48552265|NCT02952586|156212156|FG001|Lead-In Phase (7 Days)|Death|1|||
48552266|NCT02952586|156212155|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
48552267|NCT02952586|156212156|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
48552268|NCT02952586|156212155|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
48552269|NCT02952586|156212156|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
48552270|NCT02952586|156212155|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
48552271|NCT02952586|156212156|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
48552272|NCT02952586|156212155|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
48552273|NCT02952586|156212156|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
48552274|NCT02952586|156212155|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
48552275|NCT02952586|156212156|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
48552276|NCT02952586|156212155|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
48552277|NCT02952586|156212156|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
48552278|NCT02952586|156212155|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
48552279|NCT02952586|156212156|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
48552280|NCT02952586|156212155|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
48552281|NCT02952586|156212156|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
48552282|NCT02952586|156212155|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
48552283|NCT02952586|156212156|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
48552284|NCT02952586|156212155|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
48613996|NCT01910441|156443359|FG001|Overall Study|Adverse Event|0|||
48325486|NCT02357966|155389114|FG002|Overall Study|Physician Decision|0|||
48552285|NCT02952586|156212156|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
48552286|NCT02952586|156212155|FG000|CRT for Cisplatin (63 Days)|Death|3|||
48552287|NCT02952586|156212156|FG001|CRT for Cisplatin (63 Days)|Death|8|||
48552288|NCT02952586|156212155|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
48552289|NCT02952586|156212156|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
48552290|NCT02952586|156212155|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
48552291|NCT02952586|156212156|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
48552292|NCT02952586|156212155|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
48552293|NCT02952586|156212156|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
48552294|NCT02952586|156212155|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
48552295|NCT02952586|156212156|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
48552296|NCT02952586|156212155|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
48552297|NCT02952586|156212156|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
48552298|NCT02952586|156212155|FG000|CRT for Cisplatin (63 Days)|Other|1|||
48552299|NCT02952586|156212156|FG001|CRT for Cisplatin (63 Days)|Other|1|||
48552300|NCT02952586|156212155|FG000|CRT for IMRT (63 Days)|Death|5|||
48552301|NCT02952586|156212156|FG001|CRT for IMRT (63 Days)|Death|8|||
48552302|NCT02952586|156212155|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
48552303|NCT02952586|156212156|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
48552304|NCT02952586|156212155|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
48552305|NCT02952586|156212156|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
48552306|NCT02952586|156212155|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
48552307|NCT02952586|156212156|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
48552308|NCT02952586|156212155|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
48552309|NCT02952586|156212156|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
48552310|NCT02952586|156212155|FG000|CRT for IMRT (63 Days)|Other|1|||
48552311|NCT02952586|156212156|FG001|CRT for IMRT (63 Days)|Other|0|||
48552312|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Death|17|||
48552313|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Death|11|||
48552314|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
48552315|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
48552316|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
48552317|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
48552318|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
48552319|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
48552320|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
48552321|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
48552322|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
48552323|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
48552324|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
48552325|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
48552326|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
48552327|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
48552328|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Other|2|||
48552329|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Other|1|||
48552330|NCT02952586|156212155|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
48552331|NCT02952586|156212156|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
48552332|NCT02952586|156212155|FG000|Follow-Up Phase (90 Days)|Death|12|||
48552333|NCT02952586|156212156|FG001|Follow-Up Phase (90 Days)|Death|10|||
48552334|NCT02952586|156212155|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
48552335|NCT02952586|156212156|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
48552336|NCT02952586|156212155|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
48552337|NCT02952586|156212156|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
48552338|NCT02952586|156212155|FG000|Follow-Up Phase (90 Days)|Other|7|||
48552339|NCT02952586|156212156|FG001|Follow-Up Phase (90 Days)|Other|5|||
48552340|NCT02952586|156212155|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
48552341|NCT02952586|156212156|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
48552342|NCT02952586|156212155|FG000|LT Follow-up (up to 45 Months)|Death|51|||
48552343|NCT02952586|156212156|FG001|LT Follow-up (up to 45 Months)|Death|31|||
48552344|NCT02952586|156212155|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
48552345|NCT02952586|156212156|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
48552346|NCT02952586|156212155|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
48552347|NCT02952586|156212156|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
48552348|NCT02952586|156212155|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
48552349|NCT02952586|156212156|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
48552350|NCT00492778|156212157|FG000|Overall Study|Ineligible by Pathology Review|8|||
48552351|NCT00492778|156212158|FG001|Overall Study|Ineligible by Pathology Review|1|||
48552352|NCT00920790|156212161|FG000|Overall Study|aggravation of general condition|14|||
48552353|NCT02800642|156212162|FG000|Overall Study|Death|3|||
48552354|NCT02800642|156212162|FG000|Overall Study|Other|10|||
48552355|NCT02800642|156212162|FG000|Overall Study|Physician Decision|2|||
48552356|NCT02800642|156212162|FG000|Overall Study|Adverse Event|6|||
48552357|NCT02800642|156212162|FG000|Overall Study|Withdrawal by Subject|3|||
48552358|NCT02800642|156212162|FG000|Overall Study|Lost to Follow-up|1|||
48552359|NCT00996892|156212163|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
48552360|NCT00996892|156212164|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
48552361|NCT00996892|156212165|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
48552362|NCT00996892|156212166|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
48552363|NCT00996892|156212167|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
48552364|NCT00996892|156212168|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
48552365|NCT00996892|156212169|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
48552366|NCT00996892|156212170|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
48552367|NCT00996892|156212171|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
48552368|NCT00996892|156212172|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
48552369|NCT00996892|156212173|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
48552370|NCT00996892|156212174|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
48552371|NCT00996892|156212175|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
48552372|NCT00996892|156212176|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
48552373|NCT00996892|156212177|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
48552374|NCT00996892|156212178|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
48552375|NCT00996892|156212179|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
48552376|NCT00996892|156212180|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
48552377|NCT00996892|156212181|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
48552378|NCT00996892|156212182|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
48552379|NCT00996892|156212163|FG000|Dose-Escalation Stage 1|Death|1|||
48552380|NCT00996892|156212164|FG001|Dose-Escalation Stage 1|Death|0|||
48552381|NCT00996892|156212165|FG002|Dose-Escalation Stage 1|Death|0|||
48552382|NCT00996892|156212166|FG003|Dose-Escalation Stage 1|Death|0|||
48552383|NCT00996892|156212167|FG004|Dose-Escalation Stage 1|Death|0|||
48552384|NCT00996892|156212168|FG005|Dose-Escalation Stage 1|Death|1|||
48552385|NCT00996892|156212169|FG006|Dose-Escalation Stage 1|Death|0|||
48552386|NCT00996892|156212170|FG007|Dose-Escalation Stage 1|Death|0|||
48552387|NCT00996892|156212171|FG008|Dose-Escalation Stage 1|Death|0|||
48552388|NCT00996892|156212172|FG009|Dose-Escalation Stage 1|Death|0|||
48552389|NCT00996892|156212173|FG010|Dose-Escalation Stage 1|Death|0|||
48552390|NCT00996892|156212174|FG011|Dose-Escalation Stage 1|Death|0|||
48552391|NCT00996892|156212175|FG012|Dose-Escalation Stage 1|Death|0|||
48552392|NCT00996892|156212176|FG013|Dose-Escalation Stage 1|Death|0|||
48552393|NCT00996892|156212177|FG014|Dose-Escalation Stage 1|Death|0|||
48552394|NCT00996892|156212178|FG015|Dose-Escalation Stage 1|Death|0|||
48552395|NCT00996892|156212179|FG016|Dose-Escalation Stage 1|Death|0|||
48552396|NCT00996892|156212180|FG017|Dose-Escalation Stage 1|Death|0|||
48552397|NCT00996892|156212181|FG018|Dose-Escalation Stage 1|Death|0|||
48552398|NCT00996892|156212182|FG019|Dose-Escalation Stage 1|Death|0|||
48552399|NCT00996892|156212163|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
48552400|NCT00996892|156212164|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
48552401|NCT00996892|156212165|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
48552402|NCT00996892|156212166|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
48552403|NCT00996892|156212167|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
48552404|NCT00996892|156212168|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
48552405|NCT00996892|156212169|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
48552406|NCT00996892|156212170|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
48552407|NCT00996892|156212171|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
48552408|NCT00996892|156212172|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
48552409|NCT00996892|156212173|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
48552410|NCT00996892|156212174|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
48552411|NCT00996892|156212175|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
48552412|NCT00996892|156212176|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
48552413|NCT00996892|156212177|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
48552414|NCT00996892|156212178|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
48552415|NCT00996892|156212179|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
48552416|NCT00996892|156212180|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
48552417|NCT00996892|156212181|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
48552418|NCT00996892|156212182|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
48552419|NCT00996892|156212163|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552420|NCT00996892|156212164|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
48552421|NCT00996892|156212165|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552422|NCT00996892|156212166|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
48552423|NCT00996892|156212167|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
48552424|NCT00996892|156212168|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
48552425|NCT00996892|156212169|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
48552426|NCT00996892|156212170|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552427|NCT00996892|156212171|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552428|NCT00996892|156212172|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552429|NCT00996892|156212173|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552430|NCT00996892|156212174|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552431|NCT00996892|156212175|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552432|NCT00996892|156212176|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552433|NCT00996892|156212177|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552434|NCT00996892|156212178|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552435|NCT00996892|156212179|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552436|NCT00996892|156212180|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552437|NCT00996892|156212181|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552438|NCT00996892|156212182|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
48552439|NCT00996892|156212163|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
48552440|NCT00996892|156212164|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
48552441|NCT00996892|156212165|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
48552442|NCT00996892|156212166|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
48552443|NCT00996892|156212167|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
48552444|NCT00996892|156212168|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
48552445|NCT00996892|156212169|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
48552446|NCT00996892|156212170|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
48552447|NCT00996892|156212171|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
48552448|NCT00996892|156212172|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
48552449|NCT00996892|156212173|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
48552450|NCT00996892|156212174|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
48552451|NCT00996892|156212175|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
48552452|NCT00996892|156212176|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
48552453|NCT00996892|156212177|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
48552454|NCT00996892|156212178|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
48552455|NCT00996892|156212179|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
48552456|NCT00996892|156212180|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
48552457|NCT00996892|156212181|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
48552458|NCT00996892|156212182|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
48552459|NCT00996892|156212163|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
48552460|NCT00996892|156212164|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
48552461|NCT00996892|156212165|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
48552462|NCT00996892|156212166|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
48552463|NCT00996892|156212167|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
48552464|NCT00996892|156212168|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
48552465|NCT00996892|156212169|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
48552466|NCT00996892|156212170|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
48552467|NCT00996892|156212171|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
48552468|NCT00996892|156212172|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
48552469|NCT00996892|156212173|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
48552470|NCT00996892|156212174|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
48552471|NCT00996892|156212175|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
48552472|NCT00996892|156212176|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
48552473|NCT00996892|156212177|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
48552474|NCT00996892|156212178|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
48552475|NCT00996892|156212179|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
48552476|NCT00996892|156212180|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
48552477|NCT00996892|156212181|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
48552478|NCT00996892|156212182|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
48552479|NCT00996892|156212163|FG000|Dose-Escalation Stage 1A|Death|0|||
48552480|NCT00996892|156212164|FG001|Dose-Escalation Stage 1A|Death|0|||
48552481|NCT00996892|156212165|FG002|Dose-Escalation Stage 1A|Death|0|||
48552482|NCT00996892|156212166|FG003|Dose-Escalation Stage 1A|Death|0|||
48552483|NCT00996892|156212167|FG004|Dose-Escalation Stage 1A|Death|0|||
48552484|NCT00996892|156212168|FG005|Dose-Escalation Stage 1A|Death|0|||
48552485|NCT00996892|156212169|FG006|Dose-Escalation Stage 1A|Death|0|||
48552486|NCT00996892|156212170|FG007|Dose-Escalation Stage 1A|Death|0|||
48552487|NCT00996892|156212171|FG008|Dose-Escalation Stage 1A|Death|0|||
48552488|NCT00996892|156212172|FG009|Dose-Escalation Stage 1A|Death|2|||
48552489|NCT00996892|156212173|FG010|Dose-Escalation Stage 1A|Death|0|||
48552490|NCT00996892|156212174|FG011|Dose-Escalation Stage 1A|Death|1|||
48552491|NCT00996892|156212175|FG012|Dose-Escalation Stage 1A|Death|1|||
48552492|NCT00996892|156212176|FG013|Dose-Escalation Stage 1A|Death|0|||
48552493|NCT00996892|156212177|FG014|Dose-Escalation Stage 1A|Death|0|||
48552494|NCT00996892|156212178|FG015|Dose-Escalation Stage 1A|Death|0|||
48552495|NCT00996892|156212179|FG016|Dose-Escalation Stage 1A|Death|0|||
48552496|NCT00996892|156212180|FG017|Dose-Escalation Stage 1A|Death|0|||
48552497|NCT00996892|156212181|FG018|Dose-Escalation Stage 1A|Death|0|||
48552498|NCT00996892|156212182|FG019|Dose-Escalation Stage 1A|Death|0|||
48552499|NCT00996892|156212163|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
48552500|NCT00996892|156212164|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
48552501|NCT00996892|156212165|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
48552502|NCT00996892|156212166|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
48552503|NCT00996892|156212167|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
48552504|NCT00996892|156212168|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
48552505|NCT00996892|156212169|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
48552506|NCT00996892|156212170|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
48552507|NCT00996892|156212171|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
48552508|NCT00996892|156212172|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
48552509|NCT00996892|156212173|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
48552510|NCT00996892|156212174|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
48552511|NCT00996892|156212175|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
48552512|NCT00996892|156212176|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
48552513|NCT00996892|156212177|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
48552514|NCT00996892|156212178|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
48552515|NCT00996892|156212179|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
48552516|NCT00996892|156212180|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
48552517|NCT00996892|156212181|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
48552518|NCT00996892|156212182|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
48552519|NCT00996892|156212163|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552520|NCT00996892|156212164|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552521|NCT00996892|156212165|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552522|NCT00996892|156212166|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552523|NCT00996892|156212167|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552524|NCT00996892|156212168|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552525|NCT00996892|156212169|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552526|NCT00996892|156212170|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552527|NCT00996892|156212171|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552528|NCT00996892|156212172|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
48552529|NCT00996892|156212173|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
48552530|NCT00996892|156212174|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
48552531|NCT00996892|156212175|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
48552532|NCT00996892|156212176|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552533|NCT00996892|156212177|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552534|NCT00996892|156212178|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552535|NCT00996892|156212179|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552536|NCT00996892|156212180|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552537|NCT00996892|156212181|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552538|NCT00996892|156212182|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
48552539|NCT00996892|156212163|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
48552540|NCT00996892|156212164|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
48552541|NCT00996892|156212165|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
48552542|NCT00996892|156212166|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
48552543|NCT00996892|156212167|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
48552544|NCT00996892|156212168|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
48552545|NCT00996892|156212169|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
48552546|NCT00996892|156212170|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
48552547|NCT00996892|156212171|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
48552548|NCT00996892|156212172|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
48552549|NCT00996892|156212173|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
48552550|NCT00996892|156212174|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
48552551|NCT00996892|156212175|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
48552552|NCT00996892|156212176|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
48552553|NCT00996892|156212177|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
48552554|NCT00996892|156212178|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
48552555|NCT00996892|156212179|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
48552556|NCT00996892|156212180|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
48552557|NCT00996892|156212181|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
48552558|NCT00996892|156212182|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
48552559|NCT00996892|156212163|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
48552560|NCT00996892|156212164|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
48552561|NCT00996892|156212165|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
48552562|NCT00996892|156212166|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
48552563|NCT00996892|156212167|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
48552564|NCT00996892|156212168|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
48552565|NCT00996892|156212169|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
48552566|NCT00996892|156212170|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
48552567|NCT00996892|156212171|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
48552568|NCT00996892|156212172|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
48552569|NCT00996892|156212173|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
48552570|NCT00996892|156212174|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
48552571|NCT00996892|156212175|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
48552572|NCT00996892|156212176|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
48552573|NCT00996892|156212177|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
48552574|NCT00996892|156212178|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
48552575|NCT00996892|156212179|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
48552576|NCT00996892|156212180|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
48552577|NCT00996892|156212181|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
48552578|NCT00996892|156212182|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
48552579|NCT00996892|156212163|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
48552580|NCT00996892|156212164|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
48552581|NCT00996892|156212165|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
48552582|NCT00996892|156212166|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
48552583|NCT00996892|156212167|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
48552584|NCT00996892|156212168|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
48552585|NCT00996892|156212169|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
48552586|NCT00996892|156212170|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
48552587|NCT00996892|156212171|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
48552588|NCT00996892|156212172|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
48552589|NCT00996892|156212173|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
48552590|NCT00996892|156212174|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
48552591|NCT00996892|156212175|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
48552592|NCT00996892|156212176|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
48552593|NCT00996892|156212177|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
48552594|NCT00996892|156212178|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
48552595|NCT00996892|156212179|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
48552596|NCT00996892|156212180|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
48552597|NCT00996892|156212181|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
48552598|NCT00996892|156212182|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
48552599|NCT00996892|156212163|FG000|Expansion Stage 2|Adverse Event|0|||
48552600|NCT00996892|156212164|FG001|Expansion Stage 2|Adverse Event|0|||
48552601|NCT00996892|156212165|FG002|Expansion Stage 2|Adverse Event|0|||
48552602|NCT00996892|156212166|FG003|Expansion Stage 2|Adverse Event|0|||
48552603|NCT00996892|156212167|FG004|Expansion Stage 2|Adverse Event|0|||
48552604|NCT00996892|156212168|FG005|Expansion Stage 2|Adverse Event|0|||
48552605|NCT00996892|156212169|FG006|Expansion Stage 2|Adverse Event|0|||
48552606|NCT00996892|156212170|FG007|Expansion Stage 2|Adverse Event|0|||
48552607|NCT00996892|156212171|FG008|Expansion Stage 2|Adverse Event|0|||
48552608|NCT00996892|156212172|FG009|Expansion Stage 2|Adverse Event|0|||
48552609|NCT00996892|156212173|FG010|Expansion Stage 2|Adverse Event|0|||
48552610|NCT00996892|156212174|FG011|Expansion Stage 2|Adverse Event|0|||
48552611|NCT00996892|156212175|FG012|Expansion Stage 2|Adverse Event|0|||
48552612|NCT00996892|156212176|FG013|Expansion Stage 2|Adverse Event|0|||
48552613|NCT00996892|156212177|FG014|Expansion Stage 2|Adverse Event|0|||
48552614|NCT00996892|156212178|FG015|Expansion Stage 2|Adverse Event|0|||
48552615|NCT00996892|156212179|FG016|Expansion Stage 2|Adverse Event|0|||
48552616|NCT00996892|156212180|FG017|Expansion Stage 2|Adverse Event|0|||
48552617|NCT00996892|156212181|FG018|Expansion Stage 2|Adverse Event|3|||
48552618|NCT00996892|156212182|FG019|Expansion Stage 2|Adverse Event|0|||
48552619|NCT00996892|156212163|FG000|Expansion Stage 2|Death|0|||
48552620|NCT00996892|156212164|FG001|Expansion Stage 2|Death|0|||
48552621|NCT00996892|156212165|FG002|Expansion Stage 2|Death|0|||
48613997|NCT01910441|156443358|FG000|Overall Study|Physician Decision|0|||
48552622|NCT00996892|156212166|FG003|Expansion Stage 2|Death|0|||
48613998|NCT01910441|156443359|FG001|Overall Study|Physician Decision|1|||
48552623|NCT00996892|156212167|FG004|Expansion Stage 2|Death|0|||
48552624|NCT00996892|156212168|FG005|Expansion Stage 2|Death|0|||
48552625|NCT00996892|156212169|FG006|Expansion Stage 2|Death|0|||
48552626|NCT00996892|156212170|FG007|Expansion Stage 2|Death|0|||
48552627|NCT00996892|156212171|FG008|Expansion Stage 2|Death|0|||
48552628|NCT00996892|156212172|FG009|Expansion Stage 2|Death|0|||
48552629|NCT00996892|156212173|FG010|Expansion Stage 2|Death|0|||
48552630|NCT00996892|156212174|FG011|Expansion Stage 2|Death|0|||
48552631|NCT00996892|156212175|FG012|Expansion Stage 2|Death|0|||
48552632|NCT00996892|156212176|FG013|Expansion Stage 2|Death|0|||
48552633|NCT00996892|156212177|FG014|Expansion Stage 2|Death|0|||
48552634|NCT00996892|156212178|FG015|Expansion Stage 2|Death|0|||
48552635|NCT00996892|156212179|FG016|Expansion Stage 2|Death|0|||
48552636|NCT00996892|156212180|FG017|Expansion Stage 2|Death|0|||
48552637|NCT00996892|156212181|FG018|Expansion Stage 2|Death|2|||
48552638|NCT00996892|156212182|FG019|Expansion Stage 2|Death|0|||
48552639|NCT00996892|156212163|FG000|Expansion Stage 2|Physician Decision|0|||
48552640|NCT00996892|156212164|FG001|Expansion Stage 2|Physician Decision|0|||
48552641|NCT00996892|156212165|FG002|Expansion Stage 2|Physician Decision|0|||
48552642|NCT00996892|156212166|FG003|Expansion Stage 2|Physician Decision|0|||
48552643|NCT00996892|156212167|FG004|Expansion Stage 2|Physician Decision|0|||
48552644|NCT00996892|156212168|FG005|Expansion Stage 2|Physician Decision|0|||
48552645|NCT00996892|156212169|FG006|Expansion Stage 2|Physician Decision|0|||
48552646|NCT00996892|156212170|FG007|Expansion Stage 2|Physician Decision|0|||
48552647|NCT00996892|156212171|FG008|Expansion Stage 2|Physician Decision|0|||
48552648|NCT00996892|156212172|FG009|Expansion Stage 2|Physician Decision|0|||
48552649|NCT00996892|156212173|FG010|Expansion Stage 2|Physician Decision|0|||
48552650|NCT00996892|156212174|FG011|Expansion Stage 2|Physician Decision|0|||
48552651|NCT00996892|156212175|FG012|Expansion Stage 2|Physician Decision|0|||
48552652|NCT00996892|156212176|FG013|Expansion Stage 2|Physician Decision|0|||
48552653|NCT00996892|156212177|FG014|Expansion Stage 2|Physician Decision|0|||
48552654|NCT00996892|156212178|FG015|Expansion Stage 2|Physician Decision|0|||
48552655|NCT00996892|156212179|FG016|Expansion Stage 2|Physician Decision|0|||
48552656|NCT00996892|156212180|FG017|Expansion Stage 2|Physician Decision|0|||
48552657|NCT00996892|156212181|FG018|Expansion Stage 2|Physician Decision|1|||
48552658|NCT00996892|156212182|FG019|Expansion Stage 2|Physician Decision|0|||
48552659|NCT00996892|156212163|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
48552660|NCT00996892|156212164|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
48552661|NCT00996892|156212165|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
48552662|NCT00996892|156212166|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
48552663|NCT00996892|156212167|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
48552664|NCT00996892|156212168|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
48552665|NCT00996892|156212169|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
48552666|NCT00996892|156212170|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
48552667|NCT00996892|156212171|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
48552668|NCT00996892|156212172|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
48552669|NCT00996892|156212173|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
48552670|NCT00996892|156212174|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
48552671|NCT00996892|156212175|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
48552672|NCT00996892|156212176|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
48552673|NCT00996892|156212177|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
48552674|NCT00996892|156212178|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
48552675|NCT00996892|156212179|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
48552676|NCT00996892|156212180|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
48552677|NCT00996892|156212181|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
48552678|NCT00996892|156212182|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
48552679|NCT00996892|156212163|FG000|Expansion Stage 2|Disease Progression|0|||
48552680|NCT00996892|156212164|FG001|Expansion Stage 2|Disease Progression|0|||
48552681|NCT00996892|156212165|FG002|Expansion Stage 2|Disease Progression|0|||
48552682|NCT00996892|156212166|FG003|Expansion Stage 2|Disease Progression|0|||
48552683|NCT00996892|156212167|FG004|Expansion Stage 2|Disease Progression|0|||
48552684|NCT00996892|156212168|FG005|Expansion Stage 2|Disease Progression|0|||
48552685|NCT00996892|156212169|FG006|Expansion Stage 2|Disease Progression|0|||
48552686|NCT00996892|156212170|FG007|Expansion Stage 2|Disease Progression|0|||
48552687|NCT00996892|156212171|FG008|Expansion Stage 2|Disease Progression|0|||
48552688|NCT00996892|156212172|FG009|Expansion Stage 2|Disease Progression|0|||
48552689|NCT00996892|156212173|FG010|Expansion Stage 2|Disease Progression|0|||
48552690|NCT00996892|156212174|FG011|Expansion Stage 2|Disease Progression|0|||
48552691|NCT00996892|156212175|FG012|Expansion Stage 2|Disease Progression|0|||
48552692|NCT00996892|156212176|FG013|Expansion Stage 2|Disease Progression|0|||
48552693|NCT00996892|156212177|FG014|Expansion Stage 2|Disease Progression|0|||
48552694|NCT00996892|156212178|FG015|Expansion Stage 2|Disease Progression|0|||
48552695|NCT00996892|156212179|FG016|Expansion Stage 2|Disease Progression|0|||
48552696|NCT00996892|156212180|FG017|Expansion Stage 2|Disease Progression|0|||
48552697|NCT00996892|156212181|FG018|Expansion Stage 2|Disease Progression|28|||
48552698|NCT00996892|156212182|FG019|Expansion Stage 2|Disease Progression|0|||
48552699|NCT00996892|156212163|FG000|Expansion Stage 2A|Adverse Event|0|||
48552700|NCT00996892|156212164|FG001|Expansion Stage 2A|Adverse Event|0|||
48552701|NCT00996892|156212165|FG002|Expansion Stage 2A|Adverse Event|0|||
48552702|NCT00996892|156212166|FG003|Expansion Stage 2A|Adverse Event|0|||
48552703|NCT00996892|156212167|FG004|Expansion Stage 2A|Adverse Event|0|||
48552704|NCT00996892|156212168|FG005|Expansion Stage 2A|Adverse Event|0|||
48552705|NCT00996892|156212169|FG006|Expansion Stage 2A|Adverse Event|0|||
48552706|NCT00996892|156212170|FG007|Expansion Stage 2A|Adverse Event|0|||
48552707|NCT00996892|156212171|FG008|Expansion Stage 2A|Adverse Event|0|||
48552708|NCT00996892|156212172|FG009|Expansion Stage 2A|Adverse Event|0|||
48552709|NCT00996892|156212173|FG010|Expansion Stage 2A|Adverse Event|0|||
48552710|NCT00996892|156212174|FG011|Expansion Stage 2A|Adverse Event|0|||
48552711|NCT00996892|156212175|FG012|Expansion Stage 2A|Adverse Event|0|||
48552712|NCT00996892|156212176|FG013|Expansion Stage 2A|Adverse Event|0|||
48552713|NCT00996892|156212177|FG014|Expansion Stage 2A|Adverse Event|0|||
48552714|NCT00996892|156212178|FG015|Expansion Stage 2A|Adverse Event|0|||
48552715|NCT00996892|156212179|FG016|Expansion Stage 2A|Adverse Event|0|||
48325487|NCT02357966|155389115|FG003|Overall Study|Physician Decision|0|||
48552716|NCT00996892|156212180|FG017|Expansion Stage 2A|Adverse Event|0|||
48552717|NCT00996892|156212181|FG018|Expansion Stage 2A|Adverse Event|0|||
48552718|NCT00996892|156212182|FG019|Expansion Stage 2A|Adverse Event|8|||
48552719|NCT00996892|156212163|FG000|Expansion Stage 2A|Physician Decision|0|||
48552720|NCT00996892|156212164|FG001|Expansion Stage 2A|Physician Decision|0|||
48552721|NCT00996892|156212165|FG002|Expansion Stage 2A|Physician Decision|0|||
48552722|NCT00996892|156212166|FG003|Expansion Stage 2A|Physician Decision|0|||
48552723|NCT00996892|156212167|FG004|Expansion Stage 2A|Physician Decision|0|||
48552724|NCT00996892|156212168|FG005|Expansion Stage 2A|Physician Decision|0|||
48552725|NCT00996892|156212169|FG006|Expansion Stage 2A|Physician Decision|0|||
48552726|NCT00996892|156212170|FG007|Expansion Stage 2A|Physician Decision|0|||
48552727|NCT00996892|156212171|FG008|Expansion Stage 2A|Physician Decision|0|||
48552728|NCT00996892|156212172|FG009|Expansion Stage 2A|Physician Decision|0|||
48552729|NCT00996892|156212173|FG010|Expansion Stage 2A|Physician Decision|0|||
48552730|NCT00996892|156212174|FG011|Expansion Stage 2A|Physician Decision|0|||
48552731|NCT00996892|156212175|FG012|Expansion Stage 2A|Physician Decision|0|||
48552732|NCT00996892|156212176|FG013|Expansion Stage 2A|Physician Decision|0|||
48552733|NCT00996892|156212177|FG014|Expansion Stage 2A|Physician Decision|0|||
48552734|NCT00996892|156212178|FG015|Expansion Stage 2A|Physician Decision|0|||
48552735|NCT00996892|156212179|FG016|Expansion Stage 2A|Physician Decision|0|||
48552736|NCT00996892|156212180|FG017|Expansion Stage 2A|Physician Decision|0|||
48552737|NCT00996892|156212181|FG018|Expansion Stage 2A|Physician Decision|0|||
48552738|NCT00996892|156212182|FG019|Expansion Stage 2A|Physician Decision|2|||
48552739|NCT00996892|156212163|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
48552740|NCT00996892|156212164|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
48552741|NCT00996892|156212165|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
48552742|NCT00996892|156212166|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
48552743|NCT00996892|156212167|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
48552744|NCT00996892|156212168|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
48552745|NCT00996892|156212169|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
48552746|NCT00996892|156212170|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
48552747|NCT00996892|156212171|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
48552748|NCT00996892|156212172|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
48552749|NCT00996892|156212173|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
48552750|NCT00996892|156212174|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
48552751|NCT00996892|156212175|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
48552752|NCT00996892|156212176|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
48552753|NCT00996892|156212177|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
48552754|NCT00996892|156212178|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
48552755|NCT00996892|156212179|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
48552756|NCT00996892|156212180|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
48552757|NCT00996892|156212181|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
48552758|NCT00996892|156212182|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
48552759|NCT00996892|156212163|FG000|Expansion Stage 2A|Disease Progression|0|||
48552760|NCT00996892|156212164|FG001|Expansion Stage 2A|Disease Progression|0|||
48552761|NCT00996892|156212165|FG002|Expansion Stage 2A|Disease Progression|0|||
48552762|NCT00996892|156212166|FG003|Expansion Stage 2A|Disease Progression|0|||
48552763|NCT00996892|156212167|FG004|Expansion Stage 2A|Disease Progression|0|||
48552764|NCT00996892|156212168|FG005|Expansion Stage 2A|Disease Progression|0|||
48552765|NCT00996892|156212169|FG006|Expansion Stage 2A|Disease Progression|0|||
48552766|NCT00996892|156212170|FG007|Expansion Stage 2A|Disease Progression|0|||
48552767|NCT00996892|156212171|FG008|Expansion Stage 2A|Disease Progression|0|||
48552768|NCT00996892|156212172|FG009|Expansion Stage 2A|Disease Progression|0|||
48552769|NCT00996892|156212173|FG010|Expansion Stage 2A|Disease Progression|0|||
48552770|NCT00996892|156212174|FG011|Expansion Stage 2A|Disease Progression|0|||
48552771|NCT00996892|156212175|FG012|Expansion Stage 2A|Disease Progression|0|||
48552772|NCT00996892|156212176|FG013|Expansion Stage 2A|Disease Progression|0|||
48552773|NCT00996892|156212177|FG014|Expansion Stage 2A|Disease Progression|0|||
48552774|NCT00996892|156212178|FG015|Expansion Stage 2A|Disease Progression|0|||
48552775|NCT00996892|156212179|FG016|Expansion Stage 2A|Disease Progression|0|||
48552776|NCT00996892|156212180|FG017|Expansion Stage 2A|Disease Progression|0|||
48552777|NCT00996892|156212181|FG018|Expansion Stage 2A|Disease Progression|0|||
48552778|NCT00996892|156212182|FG019|Expansion Stage 2A|Disease Progression|31|||
48552779|NCT00243412|156212184|FG000|Overall Study|Death|0|||
48552780|NCT00243412|156212185|FG001|Overall Study|Death|1|||
48552781|NCT00243412|156212184|FG000|Overall Study|Adverse Event|4|||
48552782|NCT00243412|156212185|FG001|Overall Study|Adverse Event|2|||
48552783|NCT00243412|156212184|FG000|Overall Study|Lost to Follow-up|0|||
48552784|NCT00243412|156212185|FG001|Overall Study|Lost to Follow-up|1|||
48552785|NCT00243412|156212184|FG000|Overall Study|Physician Decision|1|||
48552786|NCT00243412|156212185|FG001|Overall Study|Physician Decision|1|||
48552787|NCT00243412|156212184|FG000|Overall Study|Withdrawal by Subject|4|||
48552788|NCT00243412|156212185|FG001|Overall Study|Withdrawal by Subject|5|||
48552789|NCT00243412|156212184|FG000|Overall Study|Other|1|||
48552790|NCT00243412|156212185|FG001|Overall Study|Other|1|||
48552791|NCT02764151|156212190|FG000|Overall Study|Subject refused further follow-up|0|||
48552792|NCT02764151|156212191|FG001|Overall Study|Subject refused further follow-up|0|||
48552793|NCT02764151|156212192|FG002|Overall Study|Subject refused further follow-up|0|||
48552794|NCT02764151|156212193|FG003|Overall Study|Subject refused further follow-up|1|||
48552795|NCT02764151|156212190|FG000|Overall Study|Other|0|||
48552796|NCT02764151|156212191|FG001|Overall Study|Other|0|||
48552797|NCT02764151|156212192|FG002|Overall Study|Other|0|||
48552798|NCT02764151|156212193|FG003|Overall Study|Other|2|||
48552799|NCT00708227|156212194|FG000|Overall Study|Physician Decision|0|||
48552800|NCT00708227|156212195|FG001|Overall Study|Physician Decision|3|||
48552801|NCT00708227|156212196|FG002|Overall Study|Physician Decision|1|||
48552802|NCT00708227|156212197|FG003|Overall Study|Physician Decision|2|||
48552803|NCT00708227|156212194|FG000|Overall Study|Withdrawal by Subject|1|||
48552804|NCT00708227|156212195|FG001|Overall Study|Withdrawal by Subject|2|||
48552805|NCT00708227|156212196|FG002|Overall Study|Withdrawal by Subject|0|||
48552806|NCT00708227|156212197|FG003|Overall Study|Withdrawal by Subject|1|||
48552807|NCT00720382|156212199|FG000|Overall Study|Adverse Event|54|||
48552808|NCT00720382|156212200|FG001|Overall Study|Adverse Event|17|||
48552809|NCT00720382|156212199|FG000|Overall Study|Lack of Efficacy|18|||
48552810|NCT00720382|156212200|FG001|Overall Study|Lack of Efficacy|7|||
48552811|NCT00720382|156212199|FG000|Overall Study|Non-Compliance|15|||
48552812|NCT00720382|156212200|FG001|Overall Study|Non-Compliance|5|||
48552813|NCT00720382|156212199|FG000|Overall Study|Withdrawal by Subject|47|||
48552814|NCT00720382|156212200|FG001|Overall Study|Withdrawal by Subject|11|||
48552815|NCT00720382|156212199|FG000|Overall Study|Lost to Follow-up|28|||
48552816|NCT00720382|156212200|FG001|Overall Study|Lost to Follow-up|14|||
48552817|NCT00720382|156212199|FG000|Overall Study|administrative|14|||
48552818|NCT00720382|156212200|FG001|Overall Study|administrative|5|||
48552819|NCT02108912|156212206|FG000|Overall Study|Lost to Follow-up|1|||
48552820|NCT02108912|156212207|FG001|Overall Study|Lost to Follow-up|1|||
48552821|NCT02108912|156212206|FG000|Overall Study|lack of transportation|1|||
48552822|NCT02108912|156212207|FG001|Overall Study|lack of transportation|0|||
48552823|NCT02108912|156212206|FG000|Overall Study|high blood pressure|1|||
48552824|NCT02108912|156212207|FG001|Overall Study|high blood pressure|0|||
48552825|NCT03180645|156212210|FG000|Overall Study|Adverse Event|0|||
48552826|NCT03180645|156212211|FG001|Overall Study|Adverse Event|1|||
48552827|NCT03180645|156212212|FG002|Overall Study|Adverse Event|2|||
48552828|NCT00822692|156212220|FG000|Overall Study|Lost to Follow-up|17|||
48552829|NCT00822692|156212221|FG001|Overall Study|Lost to Follow-up|25|||
48552830|NCT01959295|156212222|FG000|Overall Study|Adverse Event|2|||
48552831|NCT01959295|156212223|FG001|Overall Study|Adverse Event|0|||
48552832|NCT01959295|156212222|FG000|Overall Study|Lost to Follow-up|0|||
48552833|NCT01959295|156212223|FG001|Overall Study|Lost to Follow-up|2|||
48552834|NCT01959295|156212222|FG000|Overall Study|Physician Decision|2|||
48552835|NCT01959295|156212223|FG001|Overall Study|Physician Decision|3|||
48552836|NCT01959295|156212222|FG000|Overall Study|Protocol Violation|16|||
48552837|NCT01959295|156212223|FG001|Overall Study|Protocol Violation|5|||
48552838|NCT01959295|156212222|FG000|Overall Study|Withdrawal by Subject|3|||
48552839|NCT01959295|156212223|FG001|Overall Study|Withdrawal by Subject|1|||
48552840|NCT01959295|156212222|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
48552841|NCT01959295|156212223|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
48552842|NCT00359801|156213717|FG000|Overall Study|Lost to Follow-up|72|||
48552843|NCT00359801|156213718|FG001|Overall Study|Lost to Follow-up|58|||
48552844|NCT00359801|156213717|FG000|Overall Study|Withdrawal by Subject|143|||
48552845|NCT00359801|156213718|FG001|Overall Study|Withdrawal by Subject|96|||
48552846|NCT00359801|156213717|FG000|Overall Study|Other|66|||
48552847|NCT00359801|156213718|FG001|Overall Study|Other|46|||
48552848|NCT00359801|156213717|FG000|Overall Study|Final Status Unknown: missing data|7|||
48552849|NCT00359801|156213718|FG001|Overall Study|Final Status Unknown: missing data|4|||
48552850|NCT00359801|156213717|FG000|Overall Study|Sponsor Decision|17|||
48552851|NCT00359801|156213718|FG001|Overall Study|Sponsor Decision|16|||
48552852|NCT03765788|156213726|FG000|Overall Study|Subject decision|2|||
48552853|NCT03765788|156213727|FG001|Overall Study|Subject decision|3|||
48552854|NCT03765788|156213726|FG000|Overall Study|Physician Decision|2|||
48552855|NCT03765788|156213727|FG001|Overall Study|Physician Decision|4|||
48552856|NCT03765788|156213726|FG000|Overall Study|Death|0|||
48552857|NCT03765788|156213727|FG001|Overall Study|Death|1|||
48552858|NCT03765788|156213726|FG000|Overall Study|Lost to Follow-up|1|||
48552859|NCT03765788|156213727|FG001|Overall Study|Lost to Follow-up|0|||
48552860|NCT01924754|156213728|FG000|Overall Study|Lost to Follow-up|1|||
48552861|NCT01924754|156213729|FG001|Overall Study|Lost to Follow-up|2|||
48552862|NCT01924754|156213730|FG002|Overall Study|Lost to Follow-up|1|||
48552863|NCT01924754|156213728|FG000|Overall Study|Pregnancy|0|||
48552864|NCT01924754|156213729|FG001|Overall Study|Pregnancy|1|||
48552865|NCT01924754|156213730|FG002|Overall Study|Pregnancy|2|||
48552866|NCT01284361|156213735|FG000|Overall Study|Withdrawal by Subject|1|||
48552867|NCT01284361|156213735|FG000|Overall Study|Protocol Violation|5|||
48552868|NCT01284361|156213735|FG000|Overall Study|Adverse Event|1|||
48552869|NCT01284361|156213735|FG000|Overall Study|Lost to Follow-up|2|||
48552870|NCT02929056|156213736|FG000|Overall Study|Lost to Follow-up|0|||
48552871|NCT02929056|156213737|FG001|Overall Study|Lost to Follow-up|1|||
48552872|NCT00663026|156213738|FG000|Overall Study|Lost to Follow-up|1|||
48552873|NCT00663026|156213739|FG001|Overall Study|Lost to Follow-up|0|||
48552874|NCT00663026|156213740|FG002|Overall Study|Lost to Follow-up|0|||
48552875|NCT00663026|156213738|FG000|Overall Study|Other|1|||
48552876|NCT00663026|156213739|FG001|Overall Study|Other|2|||
48552877|NCT00663026|156213740|FG002|Overall Study|Other|0|||
48552878|NCT00663026|156213738|FG000|Overall Study|Adverse Event|0|||
48552879|NCT00663026|156213739|FG001|Overall Study|Adverse Event|2|||
48552880|NCT00663026|156213740|FG002|Overall Study|Adverse Event|3|||
48552881|NCT00663026|156213738|FG000|Overall Study|Caregiver Request|0|||
48552882|NCT00663026|156213739|FG001|Overall Study|Caregiver Request|2|||
48552883|NCT00663026|156213740|FG002|Overall Study|Caregiver Request|0|||
48552884|NCT00663026|156213738|FG000|Overall Study|Withdrawal by Subject|0|||
48552885|NCT00663026|156213739|FG001|Overall Study|Withdrawal by Subject|0|||
48552886|NCT00663026|156213740|FG002|Overall Study|Withdrawal by Subject|1|||
48552887|NCT02245412|156213741|FG000|Treatment Period|Death|1|||
48552888|NCT02245412|156213742|FG001|Treatment Period|Death|1|||
48552889|NCT02245412|156213743|FG002|Treatment Period|Death|0|||
48552890|NCT02245412|156213741|FG000|Treatment Period|Physician Decision|1|||
48552891|NCT02245412|156213742|FG001|Treatment Period|Physician Decision|1|||
48552892|NCT02245412|156213743|FG002|Treatment Period|Physician Decision|0|||
48552893|NCT02245412|156213741|FG000|Treatment Period|Withdrawal by Subject|2|||
48552894|NCT02245412|156213742|FG001|Treatment Period|Withdrawal by Subject|1|||
48552895|NCT02245412|156213743|FG002|Treatment Period|Withdrawal by Subject|0|||
48552896|NCT02245412|156213741|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
48552897|NCT02245412|156213742|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
48552898|NCT02245412|156213743|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
48552899|NCT02245412|156213741|FG000|Follow-Up Period|Death|4|||
48552900|NCT02245412|156213742|FG001|Follow-Up Period|Death|2|||
48552901|NCT02245412|156213743|FG002|Follow-Up Period|Death|1|||
48552902|NCT02245412|156213741|FG000|Follow-Up Period|Physician Decision|1|||
48552903|NCT02245412|156213742|FG001|Follow-Up Period|Physician Decision|0|||
48552904|NCT02245412|156213743|FG002|Follow-Up Period|Physician Decision|0|||
48552905|NCT02245412|156213741|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
48552906|NCT02245412|156213742|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
48552907|NCT02245412|156213743|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
48552908|NCT01056289|156213747|FG000|Open-label Phase|Adverse Event|29|||
48552909|NCT01056289|156213748|FG001|Open-label Phase|Adverse Event|0|||
48552910|NCT01056289|156213749|FG002|Open-label Phase|Adverse Event|0|||
48552911|NCT01056289|156213750|FG003|Open-label Phase|Adverse Event|0|||
48552912|NCT01056289|156213747|FG000|Open-label Phase|Lost to Follow-up|30|||
48552913|NCT01056289|156213748|FG001|Open-label Phase|Lost to Follow-up|0|||
48552914|NCT01056289|156213749|FG002|Open-label Phase|Lost to Follow-up|0|||
48552915|NCT01056289|156213750|FG003|Open-label Phase|Lost to Follow-up|0|||
48552916|NCT01056289|156213747|FG000|Open-label Phase|Other|9|||
48552917|NCT01056289|156213748|FG001|Open-label Phase|Other|0|||
48552918|NCT01056289|156213749|FG002|Open-label Phase|Other|0|||
48552919|NCT01056289|156213750|FG003|Open-label Phase|Other|0|||
48552920|NCT01056289|156213747|FG000|Open-label Phase|Protocol Violation|6|||
48552921|NCT01056289|156213748|FG001|Open-label Phase|Protocol Violation|0|||
48552922|NCT01056289|156213749|FG002|Open-label Phase|Protocol Violation|0|||
48552923|NCT01056289|156213750|FG003|Open-label Phase|Protocol Violation|0|||
48552924|NCT01056289|156213747|FG000|Open-label Phase|Withdrawal by Subject|26|||
48552925|NCT01056289|156213748|FG001|Open-label Phase|Withdrawal by Subject|0|||
48552926|NCT01056289|156213749|FG002|Open-label Phase|Withdrawal by Subject|0|||
48552927|NCT01056289|156213750|FG003|Open-label Phase|Withdrawal by Subject|0|||
48552928|NCT01056289|156213747|FG000|Open-label Phase|Lack of Efficacy|18|||
48552929|NCT01056289|156213748|FG001|Open-label Phase|Lack of Efficacy|0|||
48552930|NCT01056289|156213749|FG002|Open-label Phase|Lack of Efficacy|0|||
48552931|NCT01056289|156213750|FG003|Open-label Phase|Lack of Efficacy|0|||
48552932|NCT01056289|156213747|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
48552933|NCT01056289|156213748|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
48552934|NCT01056289|156213749|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
48552935|NCT01056289|156213750|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
48552936|NCT01056289|156213747|FG000|Double-blind Phase|Adverse Event|0|||
48552937|NCT01056289|156213748|FG001|Double-blind Phase|Adverse Event|1|||
48552938|NCT01056289|156213749|FG002|Double-blind Phase|Adverse Event|2|||
48552939|NCT01056289|156213750|FG003|Double-blind Phase|Adverse Event|1|||
48552940|NCT01056289|156213747|FG000|Double-blind Phase|Lost to Follow-up|0|||
48552941|NCT01056289|156213748|FG001|Double-blind Phase|Lost to Follow-up|2|||
48552942|NCT01056289|156213749|FG002|Double-blind Phase|Lost to Follow-up|2|||
48552943|NCT01056289|156213750|FG003|Double-blind Phase|Lost to Follow-up|2|||
48552944|NCT01056289|156213747|FG000|Double-blind Phase|Other|0|||
48552945|NCT01056289|156213748|FG001|Double-blind Phase|Other|0|||
48552946|NCT01056289|156213749|FG002|Double-blind Phase|Other|1|||
48552947|NCT01056289|156213750|FG003|Double-blind Phase|Other|2|||
48552948|NCT01056289|156213747|FG000|Double-blind Phase|Protocol Violation|0|||
48552949|NCT01056289|156213748|FG001|Double-blind Phase|Protocol Violation|0|||
48552950|NCT01056289|156213749|FG002|Double-blind Phase|Protocol Violation|1|||
48552951|NCT01056289|156213750|FG003|Double-blind Phase|Protocol Violation|1|||
48552952|NCT01056289|156213747|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48552953|NCT01056289|156213748|FG001|Double-blind Phase|Withdrawal by Subject|0|||
48552954|NCT01056289|156213749|FG002|Double-blind Phase|Withdrawal by Subject|4|||
48552955|NCT01056289|156213750|FG003|Double-blind Phase|Withdrawal by Subject|2|||
48552956|NCT01056289|156213747|FG000|Double-blind Phase|Discontinuation symptom|0|||
48552957|NCT01056289|156213748|FG001|Double-blind Phase|Discontinuation symptom|1|||
48552958|NCT01056289|156213749|FG002|Double-blind Phase|Discontinuation symptom|2|||
48552959|NCT01056289|156213750|FG003|Double-blind Phase|Discontinuation symptom|2|||
48552960|NCT01056289|156213747|FG000|Double-blind Phase|Physician Decision|0|||
48552961|NCT01056289|156213748|FG001|Double-blind Phase|Physician Decision|0|||
48552962|NCT01056289|156213749|FG002|Double-blind Phase|Physician Decision|1|||
48552963|NCT01056289|156213750|FG003|Double-blind Phase|Physician Decision|0|||
48552964|NCT02246114|156213751|FG000|Overall Study|miscarriage|1|||
48552965|NCT02246114|156213752|FG001|Overall Study|miscarriage|0|||
48552966|NCT03907878|156213756|FG000|Treatment Period|Withdrawal by Subject|5|||
48552967|NCT03907878|156213756|FG000|Treatment Period|Adverse Event|4|||
48552968|NCT03907878|156213756|FG000|Treatment Period|Lack of Efficacy|1|||
48552969|NCT03907878|156213756|FG000|Treatment Period|Protocol Violation|1|||
48552970|NCT03907878|156213756|FG000|Follow-up Period|Adverse Event|3|||
48552971|NCT03907878|156213756|FG000|Follow-up Period|Withdrawal by Subject|3|||
48552972|NCT01141205|156213758|FG000|Overall Study|Physician Decision|1|||
48552973|NCT01141205|156213759|FG001|Overall Study|Physician Decision|1|||
48552974|NCT01141205|156213758|FG000|Overall Study|Lost to Follow-up|1|||
48552975|NCT01141205|156213759|FG001|Overall Study|Lost to Follow-up|0|||
48552976|NCT01141205|156213758|FG000|Overall Study|Withdrawal by Subject|1|||
48552977|NCT01141205|156213759|FG001|Overall Study|Withdrawal by Subject|1|||
48552978|NCT02114385|156213761|FG000|Overall Study|Withdrawal by Subject|3|||
48552979|NCT02114385|156213762|FG001|Overall Study|Withdrawal by Subject|2|||
48552980|NCT02114385|156213761|FG000|Overall Study|Lost to Follow-up|0|||
48552981|NCT02114385|156213762|FG001|Overall Study|Lost to Follow-up|6|||
48552982|NCT00195338|156213765|FG000|Overall Study|Lost to Follow-up|2|||
48552983|NCT00195338|156213765|FG000|Overall Study|Adverse Event|5|||
48552984|NCT00195338|156213765|FG000|Overall Study|Lack of Efficacy|1|||
48552985|NCT00195338|156213765|FG000|Overall Study|Early closure of the site|4|||
48552986|NCT01557517|156213768|FG000|Overall Study|Death|1|||
48552987|NCT01557517|156213769|FG001|Overall Study|Death|0|||
48552988|NCT01557517|156213768|FG000|Overall Study|Refused further treatment|0|||
48552989|NCT01557517|156213769|FG001|Overall Study|Refused further treatment|2|||
48552990|NCT01557517|156213768|FG000|Overall Study|Adverse Event|0|||
48552991|NCT01557517|156213769|FG001|Overall Study|Adverse Event|2|||
48552992|NCT01557517|156213768|FG000|Overall Study|Pt declined before treatment started|1|||
48552993|NCT01557517|156213769|FG001|Overall Study|Pt declined before treatment started|0|||
48552994|NCT02252406|156213772|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
48552995|NCT02252406|156213773|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
48552996|NCT02252406|156213772|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
48552997|NCT02252406|156213773|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
48552998|NCT02252406|156213772|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
48552999|NCT02252406|156213773|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
48553000|NCT02252406|156213772|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
48553001|NCT02252406|156213773|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
48553002|NCT02252406|156213772|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
48553003|NCT02252406|156213773|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
48553004|NCT00447876|156213774|FG000|Overall Study|Withdrawal by Subject|1|||
48553005|NCT00447876|156213775|FG001|Overall Study|Withdrawal by Subject|4|||
48553006|NCT00447876|156213774|FG000|Overall Study|Lost to Follow-up|1|||
48553007|NCT00447876|156213775|FG001|Overall Study|Lost to Follow-up|0|||
48553008|NCT00447876|156213774|FG000|Overall Study|Deterioration of symptomology|1|||
48553009|NCT00447876|156213775|FG001|Overall Study|Deterioration of symptomology|0|||
48553010|NCT02533180|156213776|FG000|Overall Study|Death|0|||
48553011|NCT02533180|156213777|FG001|Overall Study|Death|2|||
48553012|NCT02533180|156213776|FG000|Overall Study|Lost to Follow-up|0|||
48553013|NCT02533180|156213777|FG001|Overall Study|Lost to Follow-up|1|||
48553014|NCT02533180|156213776|FG000|Overall Study|Physician Decision|0|||
48553015|NCT02533180|156213777|FG001|Overall Study|Physician Decision|1|||
48553016|NCT02533180|156213776|FG000|Overall Study|Withdrawal by Subject|2|||
48553017|NCT02533180|156213777|FG001|Overall Study|Withdrawal by Subject|5|||
48553018|NCT02533180|156213776|FG000|Overall Study|Screen Failure|37|||
48553019|NCT02533180|156213777|FG001|Overall Study|Screen Failure|0|||
48553020|NCT02533180|156213776|FG000|Overall Study|Protocol Deviation|0|||
48553021|NCT02533180|156213777|FG001|Overall Study|Protocol Deviation|1|||
48553022|NCT02533180|156213776|FG000|Overall Study|Non-compliance|0|||
48553023|NCT02533180|156213777|FG001|Overall Study|Non-compliance|1|||
48553024|NCT03583086|156213780|FG000|Overall Study|Death|2|||
48553025|NCT03583086|156213781|FG001|Overall Study|Death|6|||
48553026|NCT03583086|156213782|FG002|Overall Study|Death|12|||
48553027|NCT03583086|156213783|FG003|Overall Study|Death|10|||
48553028|NCT03583086|156213784|FG004|Overall Study|Death|14|||
48553029|NCT03583086|156213785|FG005|Overall Study|Death|14|||
48553030|NCT03583086|156213786|FG006|Overall Study|Death|4|||
48553031|NCT03583086|156213780|FG000|Overall Study|Withdrawal by Subject|0|||
48553032|NCT03583086|156213781|FG001|Overall Study|Withdrawal by Subject|0|||
48553033|NCT03583086|156213782|FG002|Overall Study|Withdrawal by Subject|1|||
48553034|NCT03583086|156213783|FG003|Overall Study|Withdrawal by Subject|0|||
48553035|NCT03583086|156213784|FG004|Overall Study|Withdrawal by Subject|0|||
48553036|NCT03583086|156213785|FG005|Overall Study|Withdrawal by Subject|0|||
48553037|NCT03583086|156213786|FG006|Overall Study|Withdrawal by Subject|1|||
48553038|NCT03583086|156213780|FG000|Overall Study|Refused follow-up|0|||
48553039|NCT03583086|156213781|FG001|Overall Study|Refused follow-up|0|||
48553040|NCT03583086|156213782|FG002|Overall Study|Refused follow-up|1|||
48553041|NCT03583086|156213783|FG003|Overall Study|Refused follow-up|0|||
48553042|NCT03583086|156213784|FG004|Overall Study|Refused follow-up|1|||
48553043|NCT03583086|156213785|FG005|Overall Study|Refused follow-up|0|||
48553044|NCT03583086|156213786|FG006|Overall Study|Refused follow-up|0|||
48553045|NCT03583086|156213780|FG000|Overall Study|Declining Performance Status|0|||
48553046|NCT03583086|156213781|FG001|Overall Study|Declining Performance Status|0|||
48553047|NCT03583086|156213782|FG002|Overall Study|Declining Performance Status|1|||
48553048|NCT03583086|156213783|FG003|Overall Study|Declining Performance Status|0|||
48553049|NCT03583086|156213784|FG004|Overall Study|Declining Performance Status|0|||
48553050|NCT03583086|156213785|FG005|Overall Study|Declining Performance Status|0|||
48553051|NCT03583086|156213786|FG006|Overall Study|Declining Performance Status|0|||
48553052|NCT03583086|156213780|FG000|Overall Study|Still on study|0|||
48553053|NCT03583086|156213781|FG001|Overall Study|Still on study|0|||
48553054|NCT03583086|156213782|FG002|Overall Study|Still on study|0|||
48553055|NCT03583086|156213783|FG003|Overall Study|Still on study|1|||
48553056|NCT03583086|156213784|FG004|Overall Study|Still on study|0|||
48553057|NCT03583086|156213785|FG005|Overall Study|Still on study|0|||
48553058|NCT03583086|156213786|FG006|Overall Study|Still on study|1|||
48553059|NCT03583086|156213780|FG000|Overall Study|Disease progression|0|||
48553060|NCT03583086|156213781|FG001|Overall Study|Disease progression|0|||
48553061|NCT03583086|156213782|FG002|Overall Study|Disease progression|0|||
48553062|NCT03583086|156213783|FG003|Overall Study|Disease progression|0|||
48553063|NCT03583086|156213784|FG004|Overall Study|Disease progression|0|||
48553064|NCT03583086|156213785|FG005|Overall Study|Disease progression|0|||
48553065|NCT03583086|156213786|FG006|Overall Study|Disease progression|1|||
48553066|NCT03583086|156213780|FG000|Overall Study|Undergoing radiation therapy|0|||
48553067|NCT03583086|156213781|FG001|Overall Study|Undergoing radiation therapy|0|||
48553068|NCT03583086|156213782|FG002|Overall Study|Undergoing radiation therapy|0|||
48553069|NCT03583086|156213783|FG003|Overall Study|Undergoing radiation therapy|0|||
48553070|NCT03583086|156213784|FG004|Overall Study|Undergoing radiation therapy|0|||
48553071|NCT03583086|156213785|FG005|Overall Study|Undergoing radiation therapy|0|||
48553072|NCT03583086|156213786|FG006|Overall Study|Undergoing radiation therapy|1|||
48553073|NCT03583086|156213780|FG000|Overall Study|Lost to Follow-up|0|||
48553074|NCT03583086|156213781|FG001|Overall Study|Lost to Follow-up|0|||
48553075|NCT03583086|156213782|FG002|Overall Study|Lost to Follow-up|0|||
48553076|NCT03583086|156213783|FG003|Overall Study|Lost to Follow-up|0|||
48553077|NCT03583086|156213784|FG004|Overall Study|Lost to Follow-up|0|||
48553078|NCT03583086|156213785|FG005|Overall Study|Lost to Follow-up|1|||
48553079|NCT03583086|156213786|FG006|Overall Study|Lost to Follow-up|0|||
48553080|NCT03583086|156213780|FG000|Overall Study|Adverse Event|0|||
48553081|NCT03583086|156213781|FG001|Overall Study|Adverse Event|0|||
48553082|NCT03583086|156213782|FG002|Overall Study|Adverse Event|0|||
48553083|NCT03583086|156213783|FG003|Overall Study|Adverse Event|0|||
48553084|NCT03583086|156213784|FG004|Overall Study|Adverse Event|0|||
48553085|NCT03583086|156213785|FG005|Overall Study|Adverse Event|1|||
48553086|NCT03583086|156213786|FG006|Overall Study|Adverse Event|0|||
48553087|NCT00794339|156213789|FG000|Overall Study|Withdrawal by Subject|3|||
48553088|NCT00794339|156213789|FG000|Overall Study|Ineligible|4|||
48553089|NCT00794339|156213789|FG000|Overall Study|Tx prior to ATSM|3|||
48553090|NCT00794339|156213789|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
48553091|NCT00794339|156213789|FG000|Overall Study|Tx not per protocol|1|||
48553092|NCT01611857|156213790|FG000|Overall Study|Withdrawal by Subject|0|||
48553093|NCT01611857|156213791|FG001|Overall Study|Withdrawal by Subject|2|||
48553094|NCT01085357|156213792|FG000|Overall Study|Adverse Event|1|||
48553095|NCT01085357|156213793|FG001|Overall Study|Adverse Event|1|||
48553096|NCT01085357|156213792|FG000|Overall Study|Subject Decision|4|||
48553097|NCT01085357|156213793|FG001|Overall Study|Subject Decision|3|||
48553098|NCT01085357|156213792|FG000|Overall Study|Investigator Decision|1|||
48553099|NCT01085357|156213793|FG001|Overall Study|Investigator Decision|1|||
48553100|NCT01085357|156213792|FG000|Overall Study|Death|11|||
48553101|NCT01085357|156213793|FG001|Overall Study|Death|1|||
48553102|NCT01085357|156213792|FG000|Overall Study|Lost to Follow-up|2|||
48553103|NCT01085357|156213793|FG001|Overall Study|Lost to Follow-up|0|||
48553104|NCT00396812|156213796|FG000|Overall Study|Physician Decision|1|||
48613999|NCT02949934|156443364|FG000|Natural Drinking Period|Adverse Event|1|||
48614000|NCT02949934|156443365|FG001|Natural Drinking Period|Adverse Event|0|||
48614001|NCT02949934|156443366|FG002|Natural Drinking Period|Adverse Event|0|||
48614002|NCT02949934|156443367|FG003|Natural Drinking Period|Adverse Event|1|||
48614003|NCT02949934|156443368|FG004|Natural Drinking Period|Adverse Event|0|||
48614004|NCT02949934|156443369|FG005|Natural Drinking Period|Adverse Event|0|||
48553105|NCT00306995|156213797|FG000|Study Part I|Withdrawal by Subject|0|||
48553106|NCT00306995|156213798|FG001|Study Part I|Withdrawal by Subject|0|||
48553107|NCT00306995|156213799|FG002|Study Part I|Withdrawal by Subject|0|||
48553108|NCT00306995|156213800|FG003|Study Part I|Withdrawal by Subject|0|||
48553109|NCT00306995|156213801|FG004|Study Part I|Withdrawal by Subject|0|||
48553110|NCT00306995|156213802|FG005|Study Part I|Withdrawal by Subject|0|||
48553111|NCT00306995|156213803|FG006|Study Part I|Withdrawal by Subject|1|||
48553112|NCT00306995|156213797|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
48553113|NCT00306995|156213798|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
48553114|NCT00306995|156213799|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
48614005|NCT02949934|156443364|FG000|Natural Drinking Period|Lost to Follow-up|0|||
48614006|NCT02949934|156443365|FG001|Natural Drinking Period|Lost to Follow-up|0|||
48325488|NCT02357966|155389116|FG004|Overall Study|Physician Decision|1|||
48553115|NCT00306995|156213800|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
48553116|NCT00306995|156213801|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
48553117|NCT00306995|156213802|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
48553118|NCT00306995|156213803|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
48553119|NCT00582010|156213804|FG000|Overall Study|Death|0|||
48553120|NCT00582010|156213805|FG001|Overall Study|Death|1|||
48614007|NCT02949934|156443366|FG002|Natural Drinking Period|Lost to Follow-up|0|||
48553121|NCT03280381|156213806|FG000|Overall Study|Physician Decision|0|||
48614008|NCT02949934|156443367|FG003|Natural Drinking Period|Lost to Follow-up|0|||
48614009|NCT02949934|156443368|FG004|Natural Drinking Period|Lost to Follow-up|1|||
48614010|NCT02949934|156443369|FG005|Natural Drinking Period|Lost to Follow-up|0|||
48614011|NCT02949934|156443364|FG000|Neuroimaging|Protocol Violation|2|||
48614012|NCT02949934|156443365|FG001|Neuroimaging|Protocol Violation|0|||
48614013|NCT02949934|156443366|FG002|Neuroimaging|Protocol Violation|0|||
48614014|NCT02949934|156443367|FG003|Neuroimaging|Protocol Violation|0|||
48614015|NCT02949934|156443368|FG004|Neuroimaging|Protocol Violation|1|||
48614016|NCT02949934|156443369|FG005|Neuroimaging|Protocol Violation|0|||
48614017|NCT02949934|156443364|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
48614018|NCT02949934|156443365|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
48614019|NCT02949934|156443366|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
48614020|NCT02949934|156443367|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
48614021|NCT02949934|156443368|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
48614022|NCT02949934|156443369|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
48614023|NCT02949934|156443364|FG000|Neuroimaging|Not scanned|0|||
48614024|NCT02949934|156443365|FG001|Neuroimaging|Not scanned|0|||
48614025|NCT02949934|156443366|FG002|Neuroimaging|Not scanned|1|||
48614026|NCT02949934|156443367|FG003|Neuroimaging|Not scanned|0|||
48553122|NCT03280381|156213807|FG001|Overall Study|Physician Decision|2|||
48553123|NCT02536846|156213811|FG000|Overall Study|Withdrawal by Subject|1|||
48553124|NCT02593110|156213813|FG000|Overall Study|Withdrawal by Subject|0|||
48553125|NCT02593110|156213814|FG001|Overall Study|Withdrawal by Subject|3|||
48553126|NCT02593110|156213815|FG002|Overall Study|Withdrawal by Subject|3|||
48553127|NCT02593110|156213816|FG003|Overall Study|Withdrawal by Subject|2|||
48553128|NCT02593110|156213813|FG000|Overall Study|Death|0|||
48553129|NCT02593110|156213814|FG001|Overall Study|Death|0|||
48553130|NCT02593110|156213815|FG002|Overall Study|Death|1|||
48553131|NCT02593110|156213816|FG003|Overall Study|Death|0|||
48553132|NCT04414618|156213820|FG000|Overall Study|Death|3|||
48553133|NCT04414618|156213821|FG001|Overall Study|Death|3|||
48553134|NCT04414618|156213820|FG000|Overall Study|Withdrawal by Subject|2|||
48553135|NCT04414618|156213821|FG001|Overall Study|Withdrawal by Subject|1|||
48553136|NCT04414618|156213820|FG000|Overall Study|Lost to Follow-up|2|||
48553137|NCT04414618|156213821|FG001|Overall Study|Lost to Follow-up|3|||
48553138|NCT04414618|156213820|FG000|Overall Study|Physician Decision|1|||
48553139|NCT04414618|156213821|FG001|Overall Study|Physician Decision|0|||
48553140|NCT04974749|156213822|FG000|Overall Study|Withdrawal by Subject|2|||
48553141|NCT04974749|156213822|FG000|Overall Study|Gestation|1|||
48553142|NCT04868500|156213823|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
48553143|NCT04868500|156213824|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
48553144|NCT04868500|156213823|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
48553145|NCT04868500|156213824|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
48553146|NCT02027428|156213825|FG000|Induction|Never treated|7|||
48553147|NCT02027428|156213826|FG001|Induction|Never treated|0|||
48553148|NCT02027428|156213827|FG002|Induction|Never treated|0|||
48553149|NCT02027428|156213825|FG000|Induction|Progressive disease|77|||
48553150|NCT02027428|156213826|FG001|Induction|Progressive disease|0|||
48553151|NCT02027428|156213827|FG002|Induction|Progressive disease|0|||
48553152|NCT02027428|156213825|FG000|Induction|Adverse Event|51|||
48553153|NCT02027428|156213826|FG001|Induction|Adverse Event|0|||
48553154|NCT02027428|156213827|FG002|Induction|Adverse Event|0|||
48553155|NCT02027428|156213825|FG000|Induction|Withdrawal by Subject|22|||
48553156|NCT02027428|156213826|FG001|Induction|Withdrawal by Subject|0|||
48614027|NCT02949934|156443368|FG004|Neuroimaging|Not scanned|0|||
48553157|NCT02027428|156213827|FG002|Induction|Withdrawal by Subject|0|||
48553158|NCT02027428|156213825|FG000|Induction|Death|21|||
48553159|NCT02027428|156213826|FG001|Induction|Death|0|||
48553160|NCT02027428|156213827|FG002|Induction|Death|0|||
48553161|NCT02027428|156213825|FG000|Induction|Symptomatic deterioration|16|||
48553162|NCT02027428|156213826|FG001|Induction|Symptomatic deterioration|0|||
48614028|NCT02949934|156443369|FG005|Neuroimaging|Not scanned|2|||
48614029|NCT02949934|156443364|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
48614030|NCT02949934|156443365|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
48614031|NCT02949934|156443366|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
48553163|NCT02027428|156213827|FG002|Induction|Symptomatic deterioration|0|||
48553164|NCT02027428|156213825|FG000|Induction|Study terminated by sponsor|12|||
48553165|NCT02027428|156213826|FG001|Induction|Study terminated by sponsor|0|||
48553166|NCT02027428|156213827|FG002|Induction|Study terminated by sponsor|0|||
48553167|NCT02027428|156213825|FG000|Induction|Protocol Violation|1|||
48553168|NCT02027428|156213826|FG001|Induction|Protocol Violation|0|||
48553169|NCT02027428|156213827|FG002|Induction|Protocol Violation|0|||
48553170|NCT02027428|156213825|FG000|Induction|Miscellaneous|14|||
48553171|NCT02027428|156213826|FG001|Induction|Miscellaneous|0|||
48553172|NCT02027428|156213827|FG002|Induction|Miscellaneous|0|||
48553173|NCT02027428|156213825|FG000|Induction|Induction Treatment Ongoing|4|||
48553174|NCT02027428|156213826|FG001|Induction|Induction Treatment Ongoing|0|||
48553175|NCT02027428|156213827|FG002|Induction|Induction Treatment Ongoing|0|||
48553176|NCT02027428|156213825|FG000|Maintenance|Death|0|||
48553177|NCT02027428|156213826|FG001|Maintenance|Death|3|||
48553178|NCT02027428|156213827|FG002|Maintenance|Death|2|||
48553179|NCT02027428|156213825|FG000|Maintenance|Adverse Event|0|||
48553180|NCT02027428|156213826|FG001|Maintenance|Adverse Event|21|||
48553181|NCT02027428|156213827|FG002|Maintenance|Adverse Event|1|||
48553182|NCT02027428|156213825|FG000|Maintenance|Progressive disease|0|||
48553183|NCT02027428|156213826|FG001|Maintenance|Progressive disease|84|||
48553184|NCT02027428|156213827|FG002|Maintenance|Progressive disease|47|||
48553185|NCT02027428|156213825|FG000|Maintenance|Symptomatic deterioration|0|||
48553186|NCT02027428|156213826|FG001|Maintenance|Symptomatic deterioration|4|||
48553187|NCT02027428|156213827|FG002|Maintenance|Symptomatic deterioration|1|||
48553188|NCT02027428|156213825|FG000|Maintenance|Withdrawal by Subject|0|||
48553189|NCT02027428|156213826|FG001|Maintenance|Withdrawal by Subject|6|||
48553190|NCT02027428|156213827|FG002|Maintenance|Withdrawal by Subject|5|||
48553191|NCT02027428|156213825|FG000|Maintenance|Protocol Violation|0|||
48553192|NCT02027428|156213826|FG001|Maintenance|Protocol Violation|0|||
48553193|NCT02027428|156213827|FG002|Maintenance|Protocol Violation|1|||
48553194|NCT02027428|156213825|FG000|Maintenance|Other|0|||
48553195|NCT02027428|156213826|FG001|Maintenance|Other|6|||
48553196|NCT02027428|156213827|FG002|Maintenance|Other|3|||
48553197|NCT02027428|156213825|FG000|Survival Follow-up|Death|0|||
48553198|NCT02027428|156213826|FG001|Survival Follow-up|Death|78|||
48553199|NCT02027428|156213827|FG002|Survival Follow-up|Death|45|||
48553200|NCT02027428|156213825|FG000|Survival Follow-up|Lost to Follow-up|0|||
48553201|NCT02027428|156213826|FG001|Survival Follow-up|Lost to Follow-up|1|||
48553202|NCT02027428|156213827|FG002|Survival Follow-up|Lost to Follow-up|1|||
48553203|NCT01098487|156213828|FG000|Overall Study|Adverse Event|22|||
48553204|NCT01098487|156213828|FG000|Overall Study|Lack of Efficacy|11|||
48553205|NCT01098487|156213828|FG000|Overall Study|Withdrawal by Subject|7|||
48553206|NCT01098487|156213828|FG000|Overall Study|Lost to Follow-up|3|||
48553207|NCT01098487|156213828|FG000|Overall Study|Physician Decision|1|||
48553208|NCT03519087|156213829|FG000|Clinic Evaluation|Physician Decision|15|||
48553209|NCT03519087|156213830|FG001|Clinic Evaluation|Physician Decision|18|||
48553210|NCT03519087|156213831|FG002|Clinic Evaluation|Physician Decision|0|||
48553211|NCT03519087|156213832|FG003|Clinic Evaluation|Physician Decision|0|||
48553212|NCT03519087|156213833|FG004|Clinic Evaluation|Physician Decision|0|||
48553213|NCT03519087|156213829|FG000|Clinic Evaluation|Protocol Violation|1|||
48553214|NCT03519087|156213830|FG001|Clinic Evaluation|Protocol Violation|0|||
48553215|NCT03519087|156213831|FG002|Clinic Evaluation|Protocol Violation|0|||
48553216|NCT03519087|156213832|FG003|Clinic Evaluation|Protocol Violation|0|||
48614032|NCT02949934|156443367|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
48614033|NCT02949934|156443368|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
48553217|NCT03519087|156213833|FG004|Clinic Evaluation|Protocol Violation|0|||
48553218|NCT03519087|156213829|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
48553219|NCT03519087|156213830|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
48553220|NCT03519087|156213831|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
48553221|NCT03519087|156213832|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
48553222|NCT03519087|156213833|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
48553223|NCT03519087|156213829|FG000|Re-randomization for Treatment|Not appropriate|2|||
48553224|NCT03519087|156213830|FG001|Re-randomization for Treatment|Not appropriate|3|||
48553225|NCT03519087|156213831|FG002|Re-randomization for Treatment|Not appropriate|0|||
48553226|NCT03519087|156213832|FG003|Re-randomization for Treatment|Not appropriate|0|||
48553227|NCT03519087|156213833|FG004|Re-randomization for Treatment|Not appropriate|0|||
48553228|NCT03519087|156213829|FG000|Laboratory Testing|Lost to Follow-up|0|||
48553229|NCT03519087|156213830|FG001|Laboratory Testing|Lost to Follow-up|0|||
48553230|NCT03519087|156213831|FG002|Laboratory Testing|Lost to Follow-up|2|||
48553231|NCT03519087|156213832|FG003|Laboratory Testing|Lost to Follow-up|3|||
48553232|NCT03519087|156213833|FG004|Laboratory Testing|Lost to Follow-up|6|||
48553233|NCT03519087|156213829|FG000|Laboratory Testing|Protocol Violation|0|||
48553234|NCT03519087|156213830|FG001|Laboratory Testing|Protocol Violation|0|||
48553235|NCT03519087|156213831|FG002|Laboratory Testing|Protocol Violation|0|||
48553236|NCT03519087|156213832|FG003|Laboratory Testing|Protocol Violation|1|||
48553237|NCT03519087|156213833|FG004|Laboratory Testing|Protocol Violation|0|||
48553238|NCT02859142|156213834|FG000|Overall Study|Adverse Event|1|||
48553239|NCT02859142|156213835|FG001|Overall Study|Adverse Event|2|||
48553240|NCT02859142|156213834|FG000|Overall Study|Lost to Follow-up|1|||
48553241|NCT02859142|156213835|FG001|Overall Study|Lost to Follow-up|4|||
48553242|NCT02859142|156213834|FG000|Overall Study|Withdrawal by Subject|2|||
48553243|NCT02859142|156213835|FG001|Overall Study|Withdrawal by Subject|0|||
48553244|NCT02859142|156213834|FG000|Overall Study|Scheduling difficulties|0|||
48553245|NCT02859142|156213835|FG001|Overall Study|Scheduling difficulties|3|||
48553246|NCT01128543|156213837|FG000|Overall Study|Withdrawal by Subject|3|||
48553247|NCT01128543|156213837|FG000|Overall Study|Protocol Violation|1|||
48553248|NCT02466685|156213838|FG000|Overall Study|Adverse Event|5|||
48553249|NCT02466685|156213839|FG001|Overall Study|Adverse Event|2|||
48553250|NCT02466685|156213838|FG000|Overall Study|Lost to Follow-up|1|||
48553251|NCT02466685|156213839|FG001|Overall Study|Lost to Follow-up|1|||
48553252|NCT02466685|156213838|FG000|Overall Study|Withdrawal by Subject|1|||
48553253|NCT02466685|156213839|FG001|Overall Study|Withdrawal by Subject|0|||
48553254|NCT02466685|156213838|FG000|Overall Study|Physician Decision|1|||
48553255|NCT02466685|156213839|FG001|Overall Study|Physician Decision|1|||
48553256|NCT01632280|156213840|FG000|Overall Study|Withdrawal by Subject|1|||
48553257|NCT01632280|156213841|FG001|Overall Study|Withdrawal by Subject|0|||
48553258|NCT01876446|156213842|FG000|Overall Study|Death|0|||
48553259|NCT01876446|156213843|FG001|Overall Study|Death|1|||
48553260|NCT01876446|156213842|FG000|Overall Study|Withdrawal by Subject|1|||
48553261|NCT01876446|156213843|FG001|Overall Study|Withdrawal by Subject|2|||
48553262|NCT01876446|156213842|FG000|Overall Study|Physician Decision|1|||
48553263|NCT01876446|156213843|FG001|Overall Study|Physician Decision|3|||
48553264|NCT01808573|156213849|FG000|Overall Study|Death|212|||
48553265|NCT01808573|156213850|FG001|Overall Study|Death|240|||
48553266|NCT01808573|156213849|FG000|Overall Study|Withdrawal by Subject|12|||
48553267|NCT01808573|156213850|FG001|Overall Study|Withdrawal by Subject|10|||
48553268|NCT01808573|156213849|FG000|Overall Study|Lost to Follow-up|3|||
48553269|NCT01808573|156213850|FG001|Overall Study|Lost to Follow-up|0|||
48553270|NCT01808573|156213849|FG000|Overall Study|Discontinuation of study by sponsor|79|||
48553271|NCT01808573|156213850|FG001|Overall Study|Discontinuation of study by sponsor|64|||
48553272|NCT01808573|156213849|FG000|Overall Study|Randomized in Error|1|||
48553273|NCT01808573|156213850|FG001|Overall Study|Randomized in Error|0|||
48553274|NCT00995774|156213851|FG000|Training Period 2|Withdrawal by Subject|2|||
48553275|NCT00995774|156213852|FG001|Training Period 2|Withdrawal by Subject|0|||
48553276|NCT04208750|156213853|FG000|Overall Study|Lost to Follow-up|16|||
48553277|NCT04208750|156213854|FG001|Overall Study|Lost to Follow-up|15|||
48553278|NCT01523002|156213856|FG000|Period 1|Withdrawal by Subject|1|||
48553279|NCT01523002|156213857|FG001|Period 1|Withdrawal by Subject|3|||
48553280|NCT01523002|156213856|FG000|Period 1|Lost to Follow-up|1|||
48553281|NCT01523002|156213857|FG001|Period 1|Lost to Follow-up|0|||
48553282|NCT01523002|156213856|FG000|Period 1|Adverse Event|0|||
48553283|NCT01523002|156213857|FG001|Period 1|Adverse Event|8|||
48553284|NCT01523002|156213856|FG000|Period 2|Withdrawal by Subject|4|||
48553285|NCT01523002|156213857|FG001|Period 2|Withdrawal by Subject|1|||
48553286|NCT01523002|156213856|FG000|Period 2|Adverse Event|2|||
48553287|NCT01523002|156213857|FG001|Period 2|Adverse Event|5|||
48553288|NCT01523002|156213856|FG000|Period 3|Withdrawal by Subject|1|||
48553289|NCT01523002|156213857|FG001|Period 3|Withdrawal by Subject|0|||
48553290|NCT01523002|156213856|FG000|Period 3|Adverse Event|3|||
48553291|NCT01523002|156213857|FG001|Period 3|Adverse Event|0|||
48553292|NCT03132155|156215770|FG000|Overall Study|Lack of Efficacy|6|||
48553293|NCT03132155|156215770|FG000|Overall Study|Lost to Follow-up|1|||
48553294|NCT03132155|156215770|FG000|Overall Study|Withdrawal by Subject|1|||
48553295|NCT01128179|156215778|FG000|Overall Study|Death|1|||
48553296|NCT01128179|156215779|FG001|Overall Study|Death|0|||
48553297|NCT01128179|156215778|FG000|Overall Study|Protocol Violation|1|||
48553298|NCT01128179|156215779|FG001|Overall Study|Protocol Violation|0|||
48553299|NCT00314951|156215784|FG000|Treatment|Didn't meet criteria for mITT population|16|||
48553300|NCT00314951|156215785|FG001|Treatment|Didn't meet criteria for mITT population|11|||
48553301|NCT00314951|156215784|FG000|Follow-up|mITT failure|44|||
48553302|NCT00314951|156215785|FG001|Follow-up|mITT failure|34|||
48553303|NCT03516513|156215786|FG000|Overall Study|Withdrawal by Subject|2|||
48553304|NCT03516513|156215787|FG001|Overall Study|Withdrawal by Subject|2|||
48553305|NCT03516513|156215788|FG002|Overall Study|Withdrawal by Subject|0|||
48553306|NCT03516513|156215789|FG003|Overall Study|Withdrawal by Subject|0|||
48553307|NCT01228019|156215790|FG000|Overall Study|Dose Violation|70|||
48553308|NCT01228019|156215790|FG000|Overall Study|Duplicate enrollment|1|||
48553309|NCT01228019|156215790|FG000|Overall Study|Missing pre-treatment data|72|||
48553310|NCT01228019|156215790|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
48553311|NCT01228019|156215790|FG000|Overall Study|Violation of Entry Criterion|9|||
48553312|NCT01682811|156215803|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
48553313|NCT01682811|156215804|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
48553314|NCT01682811|156215805|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
48553315|NCT01682811|156215806|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
48553316|NCT01682811|156215807|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
48553317|NCT01682811|156215808|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
48553318|NCT01682811|156215809|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
48553319|NCT01682811|156215803|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
48553320|NCT01682811|156215804|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
48553321|NCT01682811|156215805|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
48553322|NCT01682811|156215806|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
48553323|NCT01682811|156215807|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
48553324|NCT01682811|156215808|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
48553325|NCT01682811|156215809|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
48553326|NCT01682811|156215803|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
48553327|NCT01682811|156215804|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
48553328|NCT01682811|156215805|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
48553329|NCT01682811|156215806|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
48553330|NCT01682811|156215807|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
48553331|NCT01682811|156215808|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
48553332|NCT01682811|156215809|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
48553333|NCT01682811|156215803|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
48553334|NCT01682811|156215804|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
48553335|NCT01682811|156215805|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
48553336|NCT01682811|156215806|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
48553337|NCT01682811|156215807|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
48553338|NCT01682811|156215808|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
48553339|NCT01682811|156215809|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
48553340|NCT03717012|156215812|FG000|Overall Study|Due to trial termination|1|||
48553341|NCT03717012|156215813|FG001|Overall Study|Due to trial termination|2|||
48553342|NCT03717012|156215812|FG000|Overall Study|Protocol Violation|0|||
48553343|NCT03717012|156215813|FG001|Overall Study|Protocol Violation|2|||
48553344|NCT03717012|156215812|FG000|Overall Study|Adverse Event|0|||
48553345|NCT03717012|156215813|FG001|Overall Study|Adverse Event|1|||
48553346|NCT03717012|156215812|FG000|Overall Study|Lung transplant|0|||
48553347|NCT03717012|156215813|FG001|Overall Study|Lung transplant|1|||
48553348|NCT00789035|156215814|FG000|Overall Study|Adverse Event|0|||
48553349|NCT00789035|156215815|FG001|Overall Study|Adverse Event|2|||
48553350|NCT00789035|156215816|FG002|Overall Study|Adverse Event|0|||
48553351|NCT00789035|156215817|FG003|Overall Study|Adverse Event|1|||
48553352|NCT00789035|156215818|FG004|Overall Study|Adverse Event|3|||
48553353|NCT00789035|156215814|FG000|Overall Study|Lack of Efficacy|3|||
48553354|NCT00789035|156215815|FG001|Overall Study|Lack of Efficacy|0|||
48553355|NCT00789035|156215816|FG002|Overall Study|Lack of Efficacy|0|||
48553356|NCT00789035|156215817|FG003|Overall Study|Lack of Efficacy|0|||
48553357|NCT00789035|156215818|FG004|Overall Study|Lack of Efficacy|2|||
48553358|NCT00789035|156215814|FG000|Overall Study|Protocol Violation|1|||
48553359|NCT00789035|156215815|FG001|Overall Study|Protocol Violation|0|||
48553360|NCT00789035|156215816|FG002|Overall Study|Protocol Violation|0|||
48553361|NCT00789035|156215817|FG003|Overall Study|Protocol Violation|0|||
48553362|NCT00789035|156215818|FG004|Overall Study|Protocol Violation|0|||
48553363|NCT00789035|156215814|FG000|Overall Study|Withdrawal by Subject|0|||
48553364|NCT00789035|156215815|FG001|Overall Study|Withdrawal by Subject|2|||
48553365|NCT00789035|156215816|FG002|Overall Study|Withdrawal by Subject|0|||
48553366|NCT00789035|156215817|FG003|Overall Study|Withdrawal by Subject|0|||
48553367|NCT00789035|156215818|FG004|Overall Study|Withdrawal by Subject|0|||
48553368|NCT00789035|156215814|FG000|Overall Study|Other reason not defined above|2|||
48553369|NCT00789035|156215815|FG001|Overall Study|Other reason not defined above|3|||
48553370|NCT00789035|156215816|FG002|Overall Study|Other reason not defined above|1|||
48553371|NCT00789035|156215817|FG003|Overall Study|Other reason not defined above|0|||
48553372|NCT00789035|156215818|FG004|Overall Study|Other reason not defined above|1|||
48553373|NCT00362336|156215819|FG000|Overall Study|Serious Adverse Event|1|||
48553374|NCT00362336|156215820|FG001|Overall Study|Serious Adverse Event|0|||
48553375|NCT00362336|156215821|FG002|Overall Study|Serious Adverse Event|1|||
48553376|NCT00362336|156215819|FG000|Overall Study|Protocol Violation|0|||
48553377|NCT00362336|156215820|FG001|Overall Study|Protocol Violation|0|||
48553378|NCT00362336|156215821|FG002|Overall Study|Protocol Violation|1|||
48553379|NCT00362336|156215819|FG000|Overall Study|Lost to Follow-up|6|||
48553380|NCT00362336|156215820|FG001|Overall Study|Lost to Follow-up|4|||
48553381|NCT00362336|156215821|FG002|Overall Study|Lost to Follow-up|0|||
48553382|NCT00362336|156215819|FG000|Overall Study|Withdrawal by Subject|3|||
48553383|NCT00362336|156215820|FG001|Overall Study|Withdrawal by Subject|3|||
48553384|NCT00362336|156215821|FG002|Overall Study|Withdrawal by Subject|1|||
48553385|NCT00658879|156215822|FG000|Overall Study|Protocol Violation|1|||
48553386|NCT02640690|156215825|FG000|Overall Study|Lost to Follow-up|7|||
48553387|NCT02640690|156215826|FG001|Overall Study|Lost to Follow-up|7|||
48553388|NCT02640690|156215825|FG000|Overall Study|Withdrawal by Subject|16|||
48553389|NCT02640690|156215826|FG001|Overall Study|Withdrawal by Subject|20|||
48553390|NCT02640690|156215825|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
48553391|NCT02640690|156215826|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
48553392|NCT01118975|156215827|FG000|Overall Study|Adverse Event|0|||
48553393|NCT01118975|156215828|FG001|Overall Study|Adverse Event|1|||
48553394|NCT01645787|156215829|FG000|Washout (2 Weeks)|Adverse Event|1|||
48553395|NCT01645787|156215830|FG001|Washout (2 Weeks)|Adverse Event|0|||
48553396|NCT05320887|156215831|FG000|Overall Study|Lost to Follow-up|0|||
48553397|NCT05320887|156215832|FG001|Overall Study|Lost to Follow-up|3|||
48553398|NCT05320887|156215833|FG002|Overall Study|Lost to Follow-up|0|||
48553399|NCT05320887|156215834|FG003|Overall Study|Lost to Follow-up|0|||
48553400|NCT02289456|156215837|FG000|Induction Period|Death|2|||
48553401|NCT02289456|156215837|FG000|Induction Period|Adverse Event|11|||
48553402|NCT02289456|156215837|FG000|Induction Period|Progressive Disease (PD)|4|||
48553403|NCT02289456|156215837|FG000|Induction Period|Symptomatic Deterioration|4|||
48553404|NCT02289456|156215837|FG000|Induction Period|Withdrawal by Subject|2|||
48553405|NCT02289456|156215837|FG000|Induction Period|Miscellaneous|1|||
48553406|NCT02289456|156215837|FG000|Monotherapy Period|Death|1|||
48553407|NCT02289456|156215837|FG000|Monotherapy Period|Adverse Event|1|||
48553408|NCT02289456|156215837|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
48553409|NCT02289456|156215837|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
48553410|NCT02289456|156215837|FG000|Monotherapy Period|Withdrawal by Subject|2|||
48553411|NCT02289456|156215837|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
48553412|NCT02289456|156215837|FG000|Monotherapy Period|Miscellaneous|1|||
48553413|NCT02910011|156215838|FG000|Overall Study|Physician Decision|2|||
48553414|NCT02463357|156215841|FG000|Overall Study|Withdrawal by Subject|1|||
48553415|NCT02463357|156215842|FG001|Overall Study|Withdrawal by Subject|0|||
48553416|NCT02463357|156215843|FG002|Overall Study|Withdrawal by Subject|0|||
48553417|NCT02463357|156215844|FG003|Overall Study|Withdrawal by Subject|0|||
48553418|NCT02463357|156215845|FG004|Overall Study|Withdrawal by Subject|0|||
48553419|NCT02463357|156215841|FG000|Overall Study|Withdrawal by Subject|0|||
48553420|NCT02463357|156215842|FG001|Overall Study|Withdrawal by Subject|0|||
48553421|NCT02463357|156215843|FG002|Overall Study|Withdrawal by Subject|0|||
48553422|NCT02463357|156215844|FG003|Overall Study|Withdrawal by Subject|0|||
48553423|NCT02463357|156215845|FG004|Overall Study|Withdrawal by Subject|1|||
48553424|NCT02460679|156215848|FG000|Overall Study|Investigator Decision|1|||
48553425|NCT02460679|156215848|FG000|Overall Study|Withdrawal by Subject|4|||
48553426|NCT02620579|156215856|FG000|Overall Study|Physician Decision|0|||
48553427|NCT02620579|156215857|FG001|Overall Study|Physician Decision|0|||
48553428|NCT02620579|156215858|FG002|Overall Study|Physician Decision|0|||
48553429|NCT02620579|156215859|FG003|Overall Study|Physician Decision|1|||
48553430|NCT02620579|156215856|FG000|Overall Study|Withdrawal by Subject|0|||
48553431|NCT02620579|156215857|FG001|Overall Study|Withdrawal by Subject|1|||
48553432|NCT02620579|156215858|FG002|Overall Study|Withdrawal by Subject|1|||
48553433|NCT02620579|156215859|FG003|Overall Study|Withdrawal by Subject|0|||
48553434|NCT00796107|156215862|FG000|Overall Study|Lack of Efficacy|1|||
48553435|NCT00796107|156215862|FG000|Overall Study|Progressive Disease|5|||
48553436|NCT02676765|156215863|FG000|Overall Study|Lost to Follow-up|0|||
48553437|NCT02676765|156215864|FG001|Overall Study|Lost to Follow-up|1|||
48553438|NCT03340974|156215865|FG000|Completion of Study -Long Term Follow up|Death|8|||
48553439|NCT03340974|156215866|FG001|Completion of Study -Long Term Follow up|Death|5|||
48553440|NCT03340974|156215867|FG002|Completion of Study -Long Term Follow up|Death|5|||
48553441|NCT03340974|156215868|FG003|Completion of Study -Long Term Follow up|Death|7|||
48553442|NCT03340974|156215865|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
48553443|NCT03340974|156215866|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
48553444|NCT03340974|156215867|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
48553445|NCT03340974|156215868|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
48553446|NCT03340974|156215865|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
48553447|NCT03340974|156215866|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
48553448|NCT03340974|156215867|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
48553449|NCT03340974|156215868|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
48553450|NCT03340974|156215865|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
48553451|NCT03340974|156215866|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
48553452|NCT03340974|156215867|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
48553453|NCT03340974|156215868|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
48553454|NCT02374346|156215875|FG000|Overall Study|operated or discharged during weekend|48|||
48553455|NCT01137071|156215876|FG000|Overall Study|Disease Progression|11|||
48553456|NCT01137071|156215876|FG000|Overall Study|Withdrawal by Subject|2|||
48553457|NCT01137071|156215876|FG000|Overall Study|Wrongly Included|1|||
48553458|NCT02565511|156215877|FG000|Overall Study|Study terminated by Sponsor|35|||
48553459|NCT02565511|156215878|FG001|Overall Study|Study terminated by Sponsor|22|||
48553460|NCT02565511|156215879|FG002|Overall Study|Study terminated by Sponsor|235|||
48553461|NCT02565511|156215880|FG003|Overall Study|Study terminated by Sponsor|156|||
48553462|NCT02565511|156215877|FG000|Overall Study|Withdrawal by Subject|3|||
48553463|NCT02565511|156215878|FG001|Overall Study|Withdrawal by Subject|0|||
48553464|NCT02565511|156215879|FG002|Overall Study|Withdrawal by Subject|12|||
48553465|NCT02565511|156215880|FG003|Overall Study|Withdrawal by Subject|5|||
48553466|NCT02565511|156215877|FG000|Overall Study|Adverse Event|0|||
48553467|NCT02565511|156215878|FG001|Overall Study|Adverse Event|0|||
48553468|NCT02565511|156215879|FG002|Overall Study|Adverse Event|1|||
48553469|NCT02565511|156215880|FG003|Overall Study|Adverse Event|1|||
48553470|NCT02565511|156215877|FG000|Overall Study|Lost to Follow-up|4|||
48553471|NCT02565511|156215878|FG001|Overall Study|Lost to Follow-up|1|||
48553472|NCT02565511|156215879|FG002|Overall Study|Lost to Follow-up|0|||
48553473|NCT02565511|156215880|FG003|Overall Study|Lost to Follow-up|1|||
48553474|NCT02565511|156215877|FG000|Overall Study|Physician Decision|0|||
48553475|NCT02565511|156215878|FG001|Overall Study|Physician Decision|0|||
48553476|NCT02565511|156215879|FG002|Overall Study|Physician Decision|0|||
48553477|NCT02565511|156215880|FG003|Overall Study|Physician Decision|1|||
48553478|NCT02565511|156215877|FG000|Overall Study|Protocol deviation|0|||
48553479|NCT02565511|156215878|FG001|Overall Study|Protocol deviation|0|||
48553480|NCT02565511|156215879|FG002|Overall Study|Protocol deviation|3|||
48553481|NCT02565511|156215880|FG003|Overall Study|Protocol deviation|0|||
48553482|NCT01941498|156215883|FG000|Overall Study|Relocated out of state|1|||
48553483|NCT04807400|156215884|FG000|Overall Study|Adverse Event|2|||
48553484|NCT04807400|156215885|FG001|Overall Study|Adverse Event|3|||
48553485|NCT04807400|156215886|FG002|Overall Study|Adverse Event|3|||
48553486|NCT04807400|156215884|FG000|Overall Study|Death|2|||
48553487|NCT04807400|156215885|FG001|Overall Study|Death|0|||
48553488|NCT04807400|156215886|FG002|Overall Study|Death|0|||
48553489|NCT04807400|156215884|FG000|Overall Study|Lost to Follow-up|8|||
48553490|NCT04807400|156215885|FG001|Overall Study|Lost to Follow-up|6|||
48553491|NCT04807400|156215886|FG002|Overall Study|Lost to Follow-up|6|||
48553492|NCT04807400|156215884|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48553493|NCT04807400|156215885|FG001|Overall Study|Non-Compliance With Study Drug|4|||
48553494|NCT04807400|156215886|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48553495|NCT04807400|156215884|FG000|Overall Study|Participant Decision|20|||
48553496|NCT04807400|156215885|FG001|Overall Study|Participant Decision|19|||
48553497|NCT04807400|156215886|FG002|Overall Study|Participant Decision|26|||
48553498|NCT04807400|156215884|FG000|Overall Study|Physician Decision|0|||
48553499|NCT04807400|156215885|FG001|Overall Study|Physician Decision|1|||
48553500|NCT04807400|156215886|FG002|Overall Study|Physician Decision|0|||
48553501|NCT04807400|156215884|FG000|Overall Study|Protocol Violation|4|||
48553502|NCT04807400|156215885|FG001|Overall Study|Protocol Violation|3|||
48553503|NCT04807400|156215886|FG002|Overall Study|Protocol Violation|7|||
48553504|NCT04807400|156215884|FG000|Overall Study|Withdrawal by Subject|13|||
48553505|NCT04807400|156215885|FG001|Overall Study|Withdrawal by Subject|9|||
48553506|NCT04807400|156215886|FG002|Overall Study|Withdrawal by Subject|20|||
48553507|NCT04807400|156215884|FG000|Overall Study|Mis-randomized|1|||
48553508|NCT04807400|156215885|FG001|Overall Study|Mis-randomized|0|||
48553509|NCT04807400|156215886|FG002|Overall Study|Mis-randomized|0|||
48553510|NCT04194645|156215889|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553511|NCT04194645|156215890|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553512|NCT04194645|156215891|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553513|NCT04194645|156215892|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553514|NCT04194645|156215893|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553515|NCT04194645|156215894|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553516|NCT04194645|156215895|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553517|NCT04194645|156215896|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553518|NCT04194645|156215897|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553519|NCT04194645|156215898|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
48553520|NCT04194645|156215899|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553521|NCT04194645|156215900|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553522|NCT04194645|156215901|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553523|NCT04194645|156215902|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553524|NCT04194645|156215903|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
48553525|NCT00104572|156215907|FG000|Overall Study|Withdrawal by Subject|3|||
48553526|NCT00104572|156215908|FG001|Overall Study|Withdrawal by Subject|3|||
48553527|NCT00104572|156215909|FG002|Overall Study|Withdrawal by Subject|0|||
48553528|NCT00352417|156215910|FG000|Overall Study|Adverse Event|1|||
48553529|NCT00352417|156215911|FG001|Overall Study|Adverse Event|0|||
48553530|NCT00352417|156215910|FG000|Overall Study|Protocol Violation|0|||
48553531|NCT00352417|156215911|FG001|Overall Study|Protocol Violation|2|||
48553532|NCT00352417|156215910|FG000|Overall Study|Withdrawal by Subject|1|||
48553533|NCT00352417|156215911|FG001|Overall Study|Withdrawal by Subject|2|||
48553534|NCT00352417|156215910|FG000|Overall Study|Lost to Follow-up|1|||
48553535|NCT00352417|156215911|FG001|Overall Study|Lost to Follow-up|0|||
48553536|NCT00352417|156215910|FG000|Overall Study|Schedule Change|2|||
48553537|NCT00352417|156215911|FG001|Overall Study|Schedule Change|1|||
48553538|NCT04700137|156215912|FG000|Overall Study|Lost to Follow-up|1|||
48553539|NCT04700137|156215913|FG001|Overall Study|Lost to Follow-up|6|||
48553540|NCT04700137|156215914|FG002|Overall Study|Lost to Follow-up|1|||
48553541|NCT04700137|156215915|FG003|Overall Study|Lost to Follow-up|1|||
48553542|NCT04700137|156215912|FG000|Overall Study|Withdrawal by Subject|0|||
48553543|NCT04700137|156215913|FG001|Overall Study|Withdrawal by Subject|0|||
48553544|NCT04700137|156215914|FG002|Overall Study|Withdrawal by Subject|1|||
48553545|NCT04700137|156215915|FG003|Overall Study|Withdrawal by Subject|0|||
48553546|NCT04700137|156215912|FG000|Overall Study|Death|0|||
48553547|NCT04700137|156215913|FG001|Overall Study|Death|0|||
48553548|NCT04700137|156215914|FG002|Overall Study|Death|1|||
48553549|NCT04700137|156215915|FG003|Overall Study|Death|0|||
48553550|NCT02503787|156215916|FG000|Enrollment|Withdrawal by Subject|6|||
48553551|NCT02503787|156215916|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
48553552|NCT02503787|156215916|FG000|Enrollment|Physician Decision|2|||
48553553|NCT02503787|156215916|FG000|Enrollment|Insurance issue|2|||
48553554|NCT02503787|156215916|FG000|Enrollment|Lost to Follow-up|1|||
48553555|NCT02503787|156215916|FG000|Enrollment|Study closure|1|||
48553556|NCT02503787|156215916|FG000|Enrollment|Adverse Event|1|||
48553557|NCT02503787|156215916|FG000|Enrollment|Protocol Violation|1|||
48553558|NCT02503787|156215916|FG000|Enrollment|Inability to implant system|1|||
48553559|NCT02503787|156215916|FG000|Enrollment|Unable to be programmed|1|||
48553560|NCT02503787|156215916|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
48553561|NCT02503787|156215916|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
48553562|NCT02503787|156215916|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
48553563|NCT02503787|156215916|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
48553564|NCT02503787|156215916|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
48553565|NCT02503787|156215916|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
48553566|NCT02096744|156215917|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
48553567|NCT02096744|156215918|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
48553568|NCT02096744|156215917|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
48553569|NCT02096744|156215918|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
48553570|NCT02096744|156215917|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
48553571|NCT02096744|156215918|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
48553572|NCT04646005|156215927|FG000|Overall Study|Adverse Event|1|||
48553573|NCT04646005|156215927|FG000|Overall Study|Progressive Disease|60|||
48553574|NCT04646005|156215927|FG000|Overall Study|Death|19|||
48553575|NCT04646005|156215927|FG000|Overall Study|Withdrawal by Subject|9|||
48553576|NCT04646005|156215927|FG000|Overall Study|Study Ongoing|24|||
48553577|NCT00281957|156215930|FG000|Overall Study|Adverse Event|7|||
48553578|NCT00281957|156215931|FG001|Overall Study|Adverse Event|2|||
48553579|NCT00281957|156215930|FG000|Overall Study|Death|1|||
48553580|NCT00281957|156215931|FG001|Overall Study|Death|0|||
48553581|NCT00281957|156215930|FG000|Overall Study|Progression/relapse|47|||
48553582|NCT00281957|156215931|FG001|Overall Study|Progression/relapse|35|||
48553583|NCT00281957|156215930|FG000|Overall Study|Not protocol specified|8|||
48553584|NCT00281957|156215931|FG001|Overall Study|Not protocol specified|1|||
48553585|NCT00281957|156215930|FG000|Overall Study|Not eligible|1|||
48553586|NCT00281957|156215931|FG001|Overall Study|Not eligible|2|||
48553587|NCT00281957|156215930|FG000|Overall Study|Did not start treatment|3|||
48553588|NCT00281957|156215931|FG001|Overall Study|Did not start treatment|1|||
48553589|NCT00281957|156215930|FG000|Overall Study|Refusal unrelated to adverse events|0|||
48553590|NCT00281957|156215931|FG001|Overall Study|Refusal unrelated to adverse events|1|||
48553591|NCT03736031|156215935|FG000|Overall Study|Death|2|||
48553592|NCT03736031|156215936|FG001|Overall Study|Death|4|||
48553593|NCT03736031|156215935|FG000|Overall Study|Lost to Follow-up|21|||
48553594|NCT03736031|156215936|FG001|Overall Study|Lost to Follow-up|2|||
48553595|NCT03736031|156215935|FG000|Overall Study|Withdrawal by Subject|9|||
48553596|NCT03736031|156215936|FG001|Overall Study|Withdrawal by Subject|0|||
48553597|NCT00625872|156215939|FG000|Overall Study|Withdrawal by Subject|1|||
48553598|NCT00625872|156215940|FG001|Overall Study|Withdrawal by Subject|0|||
48553599|NCT00625872|156215939|FG000|Overall Study|Does not meet inclusion criteria|1|||
48553600|NCT00625872|156215940|FG001|Overall Study|Does not meet inclusion criteria|0|||
48553601|NCT00625872|156215939|FG000|Overall Study|Terminated by sponsor|2|||
48553602|NCT00625872|156215940|FG001|Overall Study|Terminated by sponsor|5|||
48553603|NCT00625872|156215939|FG000|Overall Study|Randomized but not treated|0|||
48553604|NCT00625872|156215940|FG001|Overall Study|Randomized but not treated|1|||
48553605|NCT01256502|156215943|FG000|Overall Study|Had scaffold removed|4|||
48553606|NCT01256502|156215943|FG000|Overall Study|Personal reasons|5|||
48553607|NCT01256502|156215943|FG000|Overall Study|Protocol deviation|1|||
48553608|NCT02201277|156215944|FG000|Overall Study|Death|3|||
48553609|NCT02201277|156215945|FG001|Overall Study|Death|4|||
48553610|NCT02201277|156215944|FG000|Overall Study|Lost to Follow-up|2|||
48553611|NCT02201277|156215945|FG001|Overall Study|Lost to Follow-up|1|||
48553612|NCT02201277|156215944|FG000|Overall Study|Failed retrieval|1|||
48553613|NCT02201277|156215945|FG001|Overall Study|Failed retrieval|0|||
48553614|NCT02201277|156215944|FG000|Overall Study|Physician Decision|1|||
48553615|NCT02201277|156215945|FG001|Overall Study|Physician Decision|0|||
48553616|NCT03281876|156215950|FG000|Overall Study|Adverse Event|4|||
48553617|NCT03281876|156215951|FG001|Overall Study|Adverse Event|15|||
48553618|NCT03281876|156215950|FG000|Overall Study|Lost to Follow-up|1|||
48553619|NCT03281876|156215951|FG001|Overall Study|Lost to Follow-up|4|||
48553620|NCT03281876|156215950|FG000|Overall Study|Withdrawal by Subject|11|||
48553621|NCT03281876|156215951|FG001|Overall Study|Withdrawal by Subject|15|||
48553622|NCT03281876|156215950|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
48553623|NCT03281876|156215951|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48553624|NCT03281876|156215950|FG000|Overall Study|OTHER|5|||
48553625|NCT03281876|156215951|FG001|Overall Study|OTHER|5|||
48553626|NCT02208089|156215952|FG000|Overall Study|Withdrawal by Subject|1|||
48553627|NCT02208089|156215953|FG001|Overall Study|Withdrawal by Subject|0|||
48553628|NCT02208089|156215952|FG000|Overall Study|Lost to Follow-up|6|||
48553629|NCT02208089|156215953|FG001|Overall Study|Lost to Follow-up|0|||
48553630|NCT00805467|156215954|FG000|Overall Study|Lack of Efficacy|0|||
48553631|NCT00805467|156215955|FG001|Overall Study|Lack of Efficacy|8|||
48553632|NCT00805467|156215956|FG002|Overall Study|Lack of Efficacy|13|||
48553633|NCT00805467|156215957|FG003|Overall Study|Lack of Efficacy|86|||
48553634|NCT00805467|156215954|FG000|Overall Study|Lost to Follow-up|0|||
48553635|NCT00805467|156215955|FG001|Overall Study|Lost to Follow-up|1|||
48553636|NCT00805467|156215956|FG002|Overall Study|Lost to Follow-up|7|||
48553637|NCT00805467|156215957|FG003|Overall Study|Lost to Follow-up|21|||
48553638|NCT00805467|156215954|FG000|Overall Study|Withdrawal by Subject|0|||
48553639|NCT00805467|156215955|FG001|Overall Study|Withdrawal by Subject|6|||
48553640|NCT00805467|156215956|FG002|Overall Study|Withdrawal by Subject|45|||
48553641|NCT00805467|156215957|FG003|Overall Study|Withdrawal by Subject|50|||
48553642|NCT00805467|156215954|FG000|Overall Study|Protocol Violation|0|||
48553643|NCT00805467|156215955|FG001|Overall Study|Protocol Violation|3|||
48553644|NCT00805467|156215956|FG002|Overall Study|Protocol Violation|0|||
48553645|NCT00805467|156215957|FG003|Overall Study|Protocol Violation|5|||
48553646|NCT00805467|156215954|FG000|Overall Study|Adverse Event|0|||
48553647|NCT00805467|156215955|FG001|Overall Study|Adverse Event|13|||
48553648|NCT00805467|156215956|FG002|Overall Study|Adverse Event|26|||
48553649|NCT00805467|156215957|FG003|Overall Study|Adverse Event|57|||
48553650|NCT00805467|156215954|FG000|Overall Study|Death|0|||
48553651|NCT00805467|156215955|FG001|Overall Study|Death|2|||
48553652|NCT00805467|156215956|FG002|Overall Study|Death|7|||
48553653|NCT00805467|156215957|FG003|Overall Study|Death|5|||
48553654|NCT00805467|156215954|FG000|Overall Study|Physician Decision|0|||
48553655|NCT00805467|156215955|FG001|Overall Study|Physician Decision|1|||
48553656|NCT00805467|156215956|FG002|Overall Study|Physician Decision|2|||
48553657|NCT00805467|156215957|FG003|Overall Study|Physician Decision|6|||
48553658|NCT00805467|156215954|FG000|Overall Study|Not reported|0|||
48553659|NCT00805467|156215955|FG001|Overall Study|Not reported|0|||
48553660|NCT00805467|156215956|FG002|Overall Study|Not reported|3|||
48553661|NCT00805467|156215957|FG003|Overall Study|Not reported|7|||
48553662|NCT02443740|156215958|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553663|NCT02443740|156215959|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553664|NCT02443740|156215960|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553665|NCT02443740|156215961|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553666|NCT02443740|156215962|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553667|NCT02443740|156215963|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
48553668|NCT02443740|156215964|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553669|NCT02443740|156215965|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553670|NCT02443740|156215966|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553671|NCT02443740|156215967|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553672|NCT02443740|156215968|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
48553673|NCT02443740|156215958|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
48553674|NCT02443740|156215959|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553675|NCT02443740|156215960|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553676|NCT02443740|156215961|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553677|NCT02443740|156215962|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553678|NCT02443740|156215963|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553679|NCT02443740|156215964|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
48553680|NCT02443740|156215965|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553681|NCT02443740|156215966|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553682|NCT02443740|156215967|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553683|NCT02443740|156215968|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
48553684|NCT02443740|156215958|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553685|NCT02443740|156215959|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553686|NCT02443740|156215960|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553687|NCT02443740|156215961|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553688|NCT02443740|156215962|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553689|NCT02443740|156215963|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
48553690|NCT02443740|156215964|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553691|NCT02443740|156215965|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553692|NCT02443740|156215966|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553693|NCT02443740|156215967|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553694|NCT02443740|156215968|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
48553695|NCT04502212|156215969|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
48553696|NCT04502212|156215969|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
48553697|NCT03953612|156215970|FG000|Overall Study|Randomized but did not start|1|||
48553698|NCT03953612|156215971|FG001|Overall Study|Randomized but did not start|1|||
48553699|NCT03953612|156215972|FG002|Overall Study|Randomized but did not start|1|||
48553700|NCT03953612|156215970|FG000|Overall Study|Withdrawal by Subject|2|||
48553701|NCT03953612|156215971|FG001|Overall Study|Withdrawal by Subject|1|||
48553702|NCT03953612|156215972|FG002|Overall Study|Withdrawal by Subject|0|||
48553703|NCT00489255|156215973|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
48553704|NCT00489255|156215974|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
48553705|NCT00489255|156215973|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
48553706|NCT00489255|156215974|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
48553707|NCT00489255|156215973|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
48553708|NCT00489255|156215974|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
48553709|NCT00489255|156215973|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
48553710|NCT00489255|156215974|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
48553711|NCT00489255|156215973|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
48553712|NCT00489255|156215974|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
48553713|NCT00489255|156215973|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
48553714|NCT00489255|156215974|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
48553715|NCT00489255|156215973|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
48553716|NCT00489255|156215974|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
48553717|NCT00489255|156215973|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
48553718|NCT00489255|156215974|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
48553719|NCT00489255|156215973|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
48553720|NCT00489255|156215974|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
48553721|NCT00489255|156215973|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
48553722|NCT00489255|156215974|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
48553723|NCT00456300|156215975|FG000|Overall Study|Adverse Event|1|||
48553724|NCT00456300|156215976|FG001|Overall Study|Adverse Event|0|||
48553725|NCT03485352|156215977|FG000|Overall Study|Lost to Follow-up|9|||
48553726|NCT02925403|156217562|FG000|Overall Study|Lost to Follow-up|0|||
48553727|NCT02925403|156217563|FG001|Overall Study|Lost to Follow-up|1|||
48553728|NCT00459043|156217564|FG000|Overall Study|Withdrawal by Subject|1|||
48553729|NCT00459043|156217565|FG001|Overall Study|Withdrawal by Subject|0|||
48553730|NCT01392963|156217566|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
48553731|NCT01392963|156217567|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
48553732|NCT01392963|156217566|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
48553733|NCT01392963|156217567|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
48553734|NCT01392963|156217566|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
48553735|NCT01392963|156217567|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
48553736|NCT00805675|156217572|FG000|Overall Study|Adverse Event|0|||
48553737|NCT00805675|156217573|FG001|Overall Study|Adverse Event|0|||
48553738|NCT00805675|156217574|FG002|Overall Study|Adverse Event|1|||
48553739|NCT01957397|156217582|FG000|Test Period 1|sudden leakage/small bag|1|||
48553740|NCT01957397|156217583|FG001|Test Period 1|sudden leakage/small bag|1|||
48553741|NCT01957397|156217582|FG000|Test Period 1|Withdrawal by Subject|1|||
48553742|NCT01957397|156217583|FG001|Test Period 1|Withdrawal by Subject|0|||
48614034|NCT02949934|156443369|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
48614035|NCT02949934|156443364|FG000|Bar Laboratory|Adverse Event|1|||
48614036|NCT02949934|156443365|FG001|Bar Laboratory|Adverse Event|0|||
48614037|NCT02949934|156443366|FG002|Bar Laboratory|Adverse Event|2|||
48614038|NCT02949934|156443367|FG003|Bar Laboratory|Adverse Event|0|||
48614039|NCT02949934|156443368|FG004|Bar Laboratory|Adverse Event|1|||
48614040|NCT02949934|156443369|FG005|Bar Laboratory|Adverse Event|0|||
48614041|NCT02949934|156443364|FG000|Bar Laboratory|Protocol Violation|0|||
48614042|NCT02949934|156443365|FG001|Bar Laboratory|Protocol Violation|0|||
48614043|NCT02949934|156443366|FG002|Bar Laboratory|Protocol Violation|0|||
48614044|NCT02949934|156443367|FG003|Bar Laboratory|Protocol Violation|1|||
48614045|NCT02949934|156443368|FG004|Bar Laboratory|Protocol Violation|0|||
48553743|NCT01957397|156217582|FG000|Test Period 2|Adverse Event|0|||
48553744|NCT01957397|156217583|FG001|Test Period 2|Adverse Event|1|||
48553745|NCT01957397|156217582|FG000|Test Period 3|Adverse Event|1|||
48553746|NCT01957397|156217583|FG001|Test Period 3|Adverse Event|2|||
48553747|NCT01957397|156217582|FG000|Test Period 3|the adhesive did not work|1|||
48553748|NCT01957397|156217583|FG001|Test Period 3|the adhesive did not work|0|||
48553749|NCT01520870|156217585|FG000|Overall Study|Withdrawal by Subject|2|||
48553750|NCT01371539|156217586|FG000|Period One: One Week|Lost to Follow-up|0|||
48553751|NCT01371539|156217587|FG001|Period One: One Week|Lost to Follow-up|1|||
48553752|NCT01371539|156217586|FG000|Period Two: One Week|Lost to Follow-up|0|||
48553753|NCT01371539|156217587|FG001|Period Two: One Week|Lost to Follow-up|1|||
48553754|NCT01371539|156217586|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
48553755|NCT01371539|156217587|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
48553756|NCT01371539|156217586|FG000|Period Two: One Week|Time/job conflict|0|||
48553757|NCT01371539|156217587|FG001|Period Two: One Week|Time/job conflict|1|||
48553758|NCT01399658|156217590|FG000|Overall Study|Ineligible|1|||
48553759|NCT01399658|156217590|FG000|Overall Study|Machine Technical Issue|3|||
48553760|NCT01399658|156217590|FG000|Overall Study|Alternative therapy|1|||
48553761|NCT01399658|156217590|FG000|Overall Study|No reason given|1|||
48553762|NCT01625988|156217591|FG000|Overall Study|Lost to Follow-up|5|||
48553763|NCT01625988|156217592|FG001|Overall Study|Lost to Follow-up|6|||
48614046|NCT02949934|156443369|FG005|Bar Laboratory|Protocol Violation|0|||
48614047|NCT00294398|156443373|FG000|Overall Study|Lost to Follow-up|21|||
48553764|NCT01625988|156217591|FG000|Overall Study|Withdrawal by Subject|8|||
48553765|NCT01625988|156217592|FG001|Overall Study|Withdrawal by Subject|3|||
48553766|NCT01625988|156217591|FG000|Overall Study|Adverse Event|0|||
48553767|NCT01625988|156217592|FG001|Overall Study|Adverse Event|1|||
48614048|NCT00294398|156443374|FG001|Overall Study|Lost to Follow-up|26|||
48614049|NCT03407482|156443377|FG000|Overall Study|Adverse Event|12|||
48614050|NCT03407482|156443377|FG000|Overall Study|Disease Relapse|1|||
48614051|NCT03407482|156443377|FG000|Overall Study|Lost to Follow-up|1|||
48614052|NCT03407482|156443377|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48614053|NCT03407482|156443377|FG000|Overall Study|Pregnancy|2|||
48614054|NCT03407482|156443377|FG000|Overall Study|Protocol Violation|1|||
48614055|NCT03407482|156443377|FG000|Overall Study|Study Terminated By Sponsor|106|||
48614056|NCT03407482|156443377|FG000|Overall Study|Withdrawal by Subject|6|||
48614057|NCT03407482|156443377|FG000|Overall Study|Data Entry Error|1|||
48614058|NCT00424008|156443380|FG000|Overall Study|Adverse Event|8|||
48614059|NCT00424008|156443381|FG001|Overall Study|Adverse Event|6|||
48614060|NCT00424008|156443380|FG000|Overall Study|Lack of Efficacy|40|||
48614061|NCT00424008|156443381|FG001|Overall Study|Lack of Efficacy|34|||
48614062|NCT00424008|156443380|FG000|Overall Study|Lost to Follow-up|1|||
48614063|NCT00424008|156443381|FG001|Overall Study|Lost to Follow-up|2|||
48614064|NCT00424008|156443380|FG000|Overall Study|Withdrawal by Subject|5|||
48614065|NCT00424008|156443381|FG001|Overall Study|Withdrawal by Subject|8|||
48614066|NCT00424008|156443380|FG000|Overall Study|Noncompliance with protocol|13|||
48614067|NCT00424008|156443381|FG001|Overall Study|Noncompliance with protocol|7|||
48614068|NCT00424008|156443380|FG000|Overall Study|Did not meet protocol eligibility|16|||
48614069|NCT00424008|156443381|FG001|Overall Study|Did not meet protocol eligibility|21|||
48614070|NCT00424008|156443380|FG000|Overall Study|Administrative|266|||
48614071|NCT00424008|156443381|FG001|Overall Study|Administrative|257|||
48614072|NCT02593864|156443383|FG000|Overall Study|Withdrawal by Subject|3|||
48614073|NCT02593864|156443383|FG000|Overall Study|Lost to Follow-up|3|||
48614074|NCT04739709|156443384|FG000|Overall Study|Physician Decision|1|||
48614075|NCT04739709|156443385|FG001|Overall Study|Physician Decision|0|||
48614076|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
48614077|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
48614078|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
48614079|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
48614080|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
48614081|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
48614082|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
48553768|NCT01625988|156217591|FG000|Overall Study|Lack of Efficacy|0|||
48553769|NCT01625988|156217592|FG001|Overall Study|Lack of Efficacy|1|||
48553770|NCT01625988|156217591|FG000|Overall Study|Randomized Inappropriately|1|||
48553771|NCT01625988|156217592|FG001|Overall Study|Randomized Inappropriately|0|||
48553772|NCT01625988|156217591|FG000|Overall Study|Protocol Violation|0|||
48553773|NCT01625988|156217592|FG001|Overall Study|Protocol Violation|2|||
48553774|NCT01121562|156217593|FG000|Overall Study|Objective progression or relapse|8|||
48553775|NCT01121562|156217593|FG000|Overall Study|Withdrawal by Subject|1|||
48553776|NCT01121562|156217593|FG000|Overall Study|Adverse Event|1|||
48553777|NCT01121562|156217593|FG000|Overall Study|Sponsor Decision|1|||
48553778|NCT01121562|156217593|FG000|Overall Study|Met study discontinuation criteria|1|||
48553779|NCT01661062|156217594|FG000|Overall Study|Completed Treatment Off Study|3|||
48553780|NCT01661062|156217594|FG000|Overall Study|Withdrawal by Subject|2|||
48614083|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
48553781|NCT04411914|156217595|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
48553782|NCT04411914|156217596|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
48614084|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
48614085|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
48614086|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
48614087|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
48553783|NCT02681510|156217597|FG000|Overall Study|Withdrawal by Subject|1|||
48553784|NCT02681510|156217597|FG000|Overall Study|Lost to Follow-up|9|||
48553785|NCT01495702|156217603|FG000|Randomized Phase|Randomized But Not Treated|1|||
48553786|NCT01495702|156217604|FG001|Randomized Phase|Randomized But Not Treated|4|||
48553787|NCT01495702|156217603|FG000|Randomized Phase|Adverse Event|2|||
48553788|NCT01495702|156217604|FG001|Randomized Phase|Adverse Event|2|||
48553789|NCT01495702|156217603|FG000|Randomized Phase|Death|1|||
48553790|NCT01495702|156217604|FG001|Randomized Phase|Death|0|||
48553791|NCT01495702|156217603|FG000|Randomized Phase|Lack of Efficacy|2|||
48553792|NCT01495702|156217604|FG001|Randomized Phase|Lack of Efficacy|0|||
48553793|NCT01495702|156217603|FG000|Randomized Phase|Investigators Discretion|2|||
48553794|NCT01495702|156217604|FG001|Randomized Phase|Investigators Discretion|0|||
48553795|NCT01495702|156217603|FG000|Randomized Phase|Withdrew Consent|10|||
48553796|NCT01495702|156217604|FG001|Randomized Phase|Withdrew Consent|18|||
48553797|NCT01495702|156217603|FG000|Randomized Phase|Lost to Follow-up|4|||
48553798|NCT01495702|156217604|FG001|Randomized Phase|Lost to Follow-up|3|||
48553799|NCT01495702|156217603|FG000|Randomized Phase|Participant Noncompliance|1|||
48553800|NCT01495702|156217604|FG001|Randomized Phase|Participant Noncompliance|0|||
48553801|NCT01495702|156217603|FG000|Randomized Phase|Protocol Violation|3|||
48553802|NCT01495702|156217604|FG001|Randomized Phase|Protocol Violation|1|||
48553803|NCT00616421|156217605|FG000|Overall Study|Withdrawal by Subject|9|||
48553804|NCT00616421|156217606|FG001|Overall Study|Withdrawal by Subject|11|||
48553805|NCT00616421|156217607|FG002|Overall Study|Withdrawal by Subject|8|||
48553806|NCT00616421|156217605|FG000|Overall Study|Lost to Follow-up|12|||
48553807|NCT00616421|156217606|FG001|Overall Study|Lost to Follow-up|26|||
48553808|NCT00616421|156217607|FG002|Overall Study|Lost to Follow-up|30|||
48553809|NCT00616421|156217605|FG000|Overall Study|Inappropriate enrollment|3|||
48553810|NCT00616421|156217606|FG001|Overall Study|Inappropriate enrollment|0|||
48553811|NCT00616421|156217607|FG002|Overall Study|Inappropriate enrollment|1|||
48553812|NCT00616421|156217605|FG000|Overall Study|Administrative reason|1|||
48553813|NCT00616421|156217606|FG001|Overall Study|Administrative reason|0|||
48553814|NCT00616421|156217607|FG002|Overall Study|Administrative reason|0|||
48553815|NCT00616421|156217605|FG000|Overall Study|Protocol Violation|0|||
48553816|NCT00616421|156217606|FG001|Overall Study|Protocol Violation|1|||
48553817|NCT00616421|156217607|FG002|Overall Study|Protocol Violation|2|||
48553818|NCT00616421|156217605|FG000|Overall Study|Unable to classify|1|||
48553819|NCT00616421|156217606|FG001|Overall Study|Unable to classify|0|||
48553820|NCT00616421|156217607|FG002|Overall Study|Unable to classify|0|||
48553821|NCT04005352|156217608|FG000|Overall Study|Adverse Event|4|||
48553822|NCT04005352|156217609|FG001|Overall Study|Adverse Event|5|||
48553823|NCT04005352|156217608|FG000|Overall Study|Death|4|||
48553824|NCT04005352|156217609|FG001|Overall Study|Death|2|||
48553825|NCT04005352|156217608|FG000|Overall Study|Lost to Follow-up|6|||
48553826|NCT04005352|156217609|FG001|Overall Study|Lost to Follow-up|2|||
48553827|NCT04005352|156217608|FG000|Overall Study|Physician Decision|7|||
48553828|NCT04005352|156217609|FG001|Overall Study|Physician Decision|13|||
48553829|NCT04005352|156217608|FG000|Overall Study|Protocol Violation|0|||
48553830|NCT04005352|156217609|FG001|Overall Study|Protocol Violation|1|||
48553831|NCT04005352|156217608|FG000|Overall Study|Withdrawal by Subject|28|||
48553832|NCT04005352|156217609|FG001|Overall Study|Withdrawal by Subject|38|||
48553833|NCT04152863|156217610|FG000|Overall Study|Death|13|||
48553834|NCT04152863|156217611|FG001|Overall Study|Death|12|||
48553835|NCT04152863|156217612|FG002|Overall Study|Death|7|||
48553836|NCT04152863|156217610|FG000|Overall Study|Physician Decision|1|||
48553837|NCT04152863|156217611|FG001|Overall Study|Physician Decision|1|||
48553838|NCT04152863|156217612|FG002|Overall Study|Physician Decision|1|||
48553839|NCT04152863|156217610|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
48553840|NCT04152863|156217611|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
48553841|NCT04152863|156217612|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
48553842|NCT04152863|156217610|FG000|Overall Study|Withdrawal by Subject|2|||
48553843|NCT04152863|156217611|FG001|Overall Study|Withdrawal by Subject|1|||
48553844|NCT04152863|156217612|FG002|Overall Study|Withdrawal by Subject|3|||
48553845|NCT04315506|156217614|FG000|Overall Study|Lost to Follow-up|74|||
48553846|NCT04315506|156217615|FG001|Overall Study|Lost to Follow-up|82|||
48692910|NCT03137992|156724649|FG003|Washout Period 1|COPD Exacerbation|0|||
48553847|NCT04315506|156217614|FG000|Overall Study|Withdrawal by Subject|8|||
48553848|NCT04315506|156217615|FG001|Overall Study|Withdrawal by Subject|8|||
48553849|NCT04315506|156217614|FG000|Overall Study|Physician Decision|0|||
48553850|NCT04315506|156217615|FG001|Overall Study|Physician Decision|1|||
48553851|NCT02075515|156217624|FG000|Overall Study|Serious Adverse Event|1|||
48553852|NCT02075515|156217625|FG001|Overall Study|Serious Adverse Event|1|||
48553853|NCT02075515|156217626|FG002|Overall Study|Serious Adverse Event|1|||
48553854|NCT02075515|156217624|FG000|Overall Study|Non-Serious Adverse Event|0|||
48553855|NCT02075515|156217625|FG001|Overall Study|Non-Serious Adverse Event|1|||
48553856|NCT02075515|156217626|FG002|Overall Study|Non-Serious Adverse Event|0|||
48553857|NCT02075515|156217624|FG000|Overall Study|Withdrawal by Subject|2|||
48553858|NCT02075515|156217625|FG001|Overall Study|Withdrawal by Subject|0|||
48553859|NCT02075515|156217626|FG002|Overall Study|Withdrawal by Subject|1|||
48553860|NCT02075515|156217624|FG000|Overall Study|Lost to Follow-up|1|||
48553861|NCT02075515|156217625|FG001|Overall Study|Lost to Follow-up|3|||
48553862|NCT02075515|156217626|FG002|Overall Study|Lost to Follow-up|6|||
48553863|NCT01346293|156217631|FG000|Overall Study|Protocol Violation|30|||
48553864|NCT01346293|156217632|FG001|Overall Study|Protocol Violation|9|||
48553865|NCT01346293|156217631|FG000|Overall Study|Lost to Follow-up|21|||
48553866|NCT01346293|156217632|FG001|Overall Study|Lost to Follow-up|8|||
48553867|NCT01346293|156217631|FG000|Overall Study|Withdrawal by Subject|15|||
48553868|NCT01346293|156217632|FG001|Overall Study|Withdrawal by Subject|4|||
48553869|NCT01346293|156217631|FG000|Overall Study|Other|1|||
48553870|NCT01346293|156217632|FG001|Overall Study|Other|0|||
48553871|NCT00958893|156217639|FG000|Overall Study|Study prematurely terminated|4|||
48553872|NCT03656744|156217640|FG000|Overall Study|Adverse Event|1|||
48553873|NCT03656744|156217641|FG001|Overall Study|Adverse Event|4|||
48553874|NCT03656744|156217642|FG002|Overall Study|Adverse Event|1|||
48553875|NCT03656744|156217640|FG000|Overall Study|Protocol Violation|1|||
48553876|NCT03656744|156217641|FG001|Overall Study|Protocol Violation|0|||
48553877|NCT03656744|156217642|FG002|Overall Study|Protocol Violation|0|||
48553878|NCT03656744|156217640|FG000|Overall Study|Lost to Follow-up|2|||
48553879|NCT03656744|156217641|FG001|Overall Study|Lost to Follow-up|2|||
48553880|NCT03656744|156217642|FG002|Overall Study|Lost to Follow-up|0|||
48553881|NCT03656744|156217640|FG000|Overall Study|Withdrawal by Subject|0|||
48553882|NCT03656744|156217641|FG001|Overall Study|Withdrawal by Subject|1|||
48553883|NCT03656744|156217642|FG002|Overall Study|Withdrawal by Subject|0|||
48553884|NCT03656744|156217640|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
48553885|NCT03656744|156217641|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
48553886|NCT03656744|156217642|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
48553887|NCT03076775|156217643|FG000|Overall Study|Lost to Follow-up|1|||
48553888|NCT03076775|156217644|FG001|Overall Study|Lost to Follow-up|0|||
48553889|NCT01783886|156217650|FG000|Overall Study|Lost to Follow-up|0|||
48553890|NCT01783886|156217651|FG001|Overall Study|Lost to Follow-up|3|||
48553891|NCT01783886|156217652|FG002|Overall Study|Lost to Follow-up|0|||
48553892|NCT01783886|156217650|FG000|Overall Study|Protocol deviation|0|||
48553893|NCT01783886|156217651|FG001|Overall Study|Protocol deviation|0|||
48553894|NCT01783886|156217652|FG002|Overall Study|Protocol deviation|2|||
48553895|NCT01783886|156217650|FG000|Overall Study|Withdrawal of consent by participant|1|||
48553896|NCT01783886|156217651|FG001|Overall Study|Withdrawal of consent by participant|3|||
48553897|NCT01783886|156217652|FG002|Overall Study|Withdrawal of consent by participant|4|||
48553898|NCT01783886|156217650|FG000|Overall Study|Adverse Event|4|||
48553899|NCT01783886|156217651|FG001|Overall Study|Adverse Event|5|||
48553900|NCT01783886|156217652|FG002|Overall Study|Adverse Event|4|||
48553901|NCT01332292|156217655|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
48553902|NCT01332292|156217656|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
48553903|NCT01332292|156217655|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
48553904|NCT01332292|156217656|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
48553905|NCT01332292|156217655|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
48553906|NCT01332292|156217656|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
48553907|NCT04542057|156217657|FG000|Overall Study|Death|3|||
48553908|NCT04542057|156217658|FG001|Overall Study|Death|1|||
48553909|NCT04542057|156217657|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
48553910|NCT04542057|156217658|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
48553911|NCT04542057|156217657|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
48553912|NCT04542057|156217658|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
48553913|NCT04542057|156217657|FG000|Overall Study|Adverse Event|15|||
48553914|NCT04542057|156217658|FG001|Overall Study|Adverse Event|6|||
48553915|NCT04542057|156217657|FG000|Overall Study|COVID-19 adverse event|6|||
48553916|NCT04542057|156217658|FG001|Overall Study|COVID-19 adverse event|4|||
48553917|NCT04542057|156217657|FG000|Overall Study|Lack of Efficacy|2|||
48553918|NCT04542057|156217658|FG001|Overall Study|Lack of Efficacy|5|||
48553919|NCT04542057|156217657|FG000|Overall Study|Study terminated by sponsor|1|||
48553920|NCT04542057|156217658|FG001|Overall Study|Study terminated by sponsor|0|||
48553921|NCT04542057|156217657|FG000|Overall Study|Investigator discretion|2|||
48553922|NCT04542057|156217658|FG001|Overall Study|Investigator discretion|1|||
48553923|NCT04542057|156217657|FG000|Overall Study|Withdrawal by Subject|52|||
48553924|NCT04542057|156217658|FG001|Overall Study|Withdrawal by Subject|30|||
48553925|NCT04542057|156217657|FG000|Overall Study|Lost to Follow-up|8|||
48553926|NCT04542057|156217658|FG001|Overall Study|Lost to Follow-up|11|||
48553927|NCT04542057|156217657|FG000|Overall Study|Other|2|||
48553928|NCT04542057|156217658|FG001|Overall Study|Other|2|||
48553929|NCT00396565|156217659|FG000|Overall Study|Physician Decision|3|||
48553930|NCT00396565|156217660|FG001|Overall Study|Physician Decision|1|||
48553931|NCT00396565|156217661|FG002|Overall Study|Physician Decision|2|||
48553932|NCT00396565|156217659|FG000|Overall Study|Adverse Event|5|||
48553933|NCT00396565|156217660|FG001|Overall Study|Adverse Event|13|||
48553934|NCT00396565|156217661|FG002|Overall Study|Adverse Event|3|||
48553935|NCT00396565|156217659|FG000|Overall Study|Withdrawal by Subject|8|||
48553936|NCT00396565|156217660|FG001|Overall Study|Withdrawal by Subject|13|||
48553937|NCT00396565|156217661|FG002|Overall Study|Withdrawal by Subject|1|||
48553938|NCT00396565|156217659|FG000|Overall Study|Lack of Efficacy|32|||
48553939|NCT00396565|156217660|FG001|Overall Study|Lack of Efficacy|64|||
48553940|NCT00396565|156217661|FG002|Overall Study|Lack of Efficacy|11|||
48553941|NCT00796757|156217670|FG000|Overall Study|Withdrawal by Subject|14|||
48553942|NCT00796757|156217670|FG000|Overall Study|Death|61|||
48553943|NCT00796757|156217670|FG000|Overall Study|Protocol Violation|1|||
48553944|NCT00796757|156217670|FG000|Overall Study|Participant noncompliance|1|||
48553945|NCT00796757|156217670|FG000|Overall Study|Investigator's decision|2|||
48553946|NCT00796757|156217670|FG000|Overall Study|Other|7|||
48553947|NCT04388553|156217673|FG000|Overall Study|Protocol Violation|1|||
48553948|NCT04388553|156217674|FG001|Overall Study|Protocol Violation|0|||
48553949|NCT01478373|156217676|FG000|Treatment Phase|Protocol Violation|1|||
48553950|NCT01478373|156217676|FG000|Survival Phase|Adverse Event|8|||
48553951|NCT01478373|156217676|FG000|Survival Phase|Protocol Violation|1|||
48553952|NCT01478373|156217676|FG000|Survival Phase|crossover to another study|2|||
48553953|NCT01478373|156217676|FG000|Survival Phase|Progressive Disease|27|||
48553954|NCT02452476|156217679|FG000|Overall Study|Death|4|||
48553955|NCT02452476|156217680|FG001|Overall Study|Death|7|||
48553956|NCT02452476|156217679|FG000|Overall Study|Lost to Follow-up|1|||
48553957|NCT02452476|156217680|FG001|Overall Study|Lost to Follow-up|1|||
48553958|NCT02452476|156217679|FG000|Overall Study|Physician Decision|1|||
48553959|NCT02452476|156217680|FG001|Overall Study|Physician Decision|1|||
48553960|NCT02452476|156217679|FG000|Overall Study|Not treated|5|||
48553961|NCT02452476|156217680|FG001|Overall Study|Not treated|1|||
48553962|NCT01964976|156217681|FG000|Overall Study|Protocol Violation|31|||
48553963|NCT01512160|156217685|FG000|Overall Study|Lost to Follow-up|1|||
48553964|NCT01512160|156217686|FG001|Overall Study|Lost to Follow-up|0|||
48553965|NCT01512160|156217687|FG002|Overall Study|Lost to Follow-up|0|||
48553966|NCT01512160|156217688|FG003|Overall Study|Lost to Follow-up|0|||
48553967|NCT01512160|156217685|FG000|Overall Study|Withdrawal by Subject|1|||
48553968|NCT01512160|156217686|FG001|Overall Study|Withdrawal by Subject|0|||
48553969|NCT01512160|156217687|FG002|Overall Study|Withdrawal by Subject|0|||
48553970|NCT01512160|156217688|FG003|Overall Study|Withdrawal by Subject|1|||
48553971|NCT00451178|156217705|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
48553972|NCT00451178|156217706|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
48553973|NCT00451178|156217705|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
48553974|NCT00451178|156217706|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
48553975|NCT00451178|156217705|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
48553976|NCT00451178|156217706|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
48553977|NCT00451178|156217705|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
48553978|NCT00451178|156217706|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
48553979|NCT00451178|156217705|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
48553980|NCT00451178|156217706|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
48553981|NCT00451178|156217705|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
48553982|NCT00451178|156217706|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
48553983|NCT00451178|156217705|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
48553984|NCT00451178|156217706|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
48553985|NCT00451178|156217705|FG000|Prior to Maintenance Therapy|PD|2|||
48553986|NCT00451178|156217706|FG001|Prior to Maintenance Therapy|PD|0|||
48553987|NCT00451178|156217705|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
48553988|NCT00451178|156217706|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
48553989|NCT00451178|156217705|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
48614088|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
48614089|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
48614090|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
48553990|NCT00451178|156217706|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
48553991|NCT00451178|156217705|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
48553992|NCT00451178|156217706|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
48553993|NCT00451178|156217705|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
48553994|NCT00451178|156217706|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
48553995|NCT00451178|156217705|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
48553996|NCT00451178|156217706|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
48553997|NCT00451178|156217705|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
48553998|NCT00451178|156217706|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
48553999|NCT00451178|156217705|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
48554000|NCT00451178|156217706|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
48554001|NCT00141778|156217707|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
48554002|NCT00141778|156217708|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
48554003|NCT00141778|156217709|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
48554004|NCT00141778|156217707|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
48554005|NCT00141778|156217708|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
48554006|NCT00141778|156217709|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
48554007|NCT00141778|156217707|FG000|Started Study Medication|Withdrawal by Subject|0|||
48554008|NCT00141778|156217708|FG001|Started Study Medication|Withdrawal by Subject|2|||
48554009|NCT00141778|156217709|FG002|Started Study Medication|Withdrawal by Subject|0|||
48554010|NCT00141778|156217707|FG000|Started Study Medication|Difficulty Swallowing|0|||
48554011|NCT00141778|156217708|FG001|Started Study Medication|Difficulty Swallowing|1|||
48554012|NCT00141778|156217709|FG002|Started Study Medication|Difficulty Swallowing|0|||
48554013|NCT00141778|156217707|FG000|Started Study Medication|Chest Discomfort|0|||
48554014|NCT00141778|156217708|FG001|Started Study Medication|Chest Discomfort|0|||
48554015|NCT00141778|156217709|FG002|Started Study Medication|Chest Discomfort|1|||
48554016|NCT02905032|156217710|FG000|Overall Study|Withdrawal by Subject|2|||
48554017|NCT02905032|156217711|FG001|Overall Study|Withdrawal by Subject|0|||
48554018|NCT02905032|156217712|FG002|Overall Study|Withdrawal by Subject|0|||
48554019|NCT02905032|156217710|FG000|Overall Study|Protocol Violation|6|||
48554020|NCT02905032|156217711|FG001|Overall Study|Protocol Violation|12|||
48554021|NCT02905032|156217712|FG002|Overall Study|Protocol Violation|0|||
48554022|NCT01570686|156219922|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48554023|NCT01570686|156219923|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48554024|NCT01570686|156219922|FG000|Overall Study|Administrative problems|0|||
48554025|NCT01570686|156219923|FG001|Overall Study|Administrative problems|1|||
48554026|NCT01570686|156219922|FG000|Overall Study|Adverse Event|8|||
48554027|NCT01570686|156219923|FG001|Overall Study|Adverse Event|6|||
48554028|NCT01570686|156219922|FG000|Overall Study|Lost to Follow-up|4|||
48554029|NCT01570686|156219923|FG001|Overall Study|Lost to Follow-up|3|||
48554030|NCT01570686|156219922|FG000|Overall Study|Protocol Deviation|3|||
48554031|NCT01570686|156219923|FG001|Overall Study|Protocol Deviation|0|||
48554032|NCT01570686|156219922|FG000|Overall Study|Withdrawal by Subject|4|||
48554033|NCT01570686|156219923|FG001|Overall Study|Withdrawal by Subject|4|||
48554034|NCT01570686|156219922|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48554035|NCT01570686|156219923|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48554036|NCT00369486|156219924|FG000|4-Week Visit|Missed visit|2|||
48554037|NCT00369486|156219925|FG001|4-Week Visit|Missed visit|2|||
48554038|NCT00369486|156219926|FG002|4-Week Visit|Missed visit|0|||
48554039|NCT00369486|156219927|FG003|4-Week Visit|Missed visit|2|||
48554040|NCT00369486|156219928|FG004|4-Week Visit|Missed visit|1|||
48554041|NCT00369486|156219924|FG000|4-Week Visit|Dropped|0|||
48554042|NCT00369486|156219925|FG001|4-Week Visit|Dropped|0|||
48554043|NCT00369486|156219926|FG002|4-Week Visit|Dropped|1|||
48554044|NCT00369486|156219927|FG003|4-Week Visit|Dropped|0|||
48554045|NCT00369486|156219928|FG004|4-Week Visit|Dropped|0|||
48554046|NCT00369486|156219924|FG000|8-Week Visit|Missed visit|0|||
48554047|NCT00369486|156219925|FG001|8-Week Visit|Missed visit|1|||
48554048|NCT00369486|156219926|FG002|8-Week Visit|Missed visit|0|||
48554049|NCT00369486|156219927|FG003|8-Week Visit|Missed visit|0|||
48554050|NCT00369486|156219928|FG004|8-Week Visit|Missed visit|1|||
48554051|NCT00369486|156219924|FG000|8-Week Visit|Dropped|0|||
48554052|NCT00369486|156219925|FG001|8-Week Visit|Dropped|0|||
48554053|NCT00369486|156219926|FG002|8-Week Visit|Dropped|0|||
48554054|NCT00369486|156219927|FG003|8-Week Visit|Dropped|1|||
48554055|NCT00369486|156219928|FG004|8-Week Visit|Dropped|0|||
48554056|NCT00369486|156219924|FG000|17-Week Visit|Missed visit|0|||
48554057|NCT00369486|156219925|FG001|17-Week Visit|Missed visit|0|||
48554058|NCT00369486|156219926|FG002|17-Week Visit|Missed visit|1|||
48554059|NCT00369486|156219927|FG003|17-Week Visit|Missed visit|1|||
48554060|NCT00369486|156219928|FG004|17-Week Visit|Missed visit|1|||
48554061|NCT00369486|156219924|FG000|34-Week Visit|Dropped|0|||
48554062|NCT00369486|156219925|FG001|34-Week Visit|Dropped|1|||
48554063|NCT00369486|156219926|FG002|34-Week Visit|Dropped|1|||
48554064|NCT00369486|156219927|FG003|34-Week Visit|Dropped|3|||
48614091|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
48614092|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
48554065|NCT00369486|156219928|FG004|34-Week Visit|Dropped|3|||
48554066|NCT04003896|156219929|FG000|Overall Study|Withdrawal by Subject|3|||
48554067|NCT04003896|156219929|FG000|Overall Study|Physician Decision|1|||
48554068|NCT00402116|156219930|FG000|Overall Study|Jaw infection after surgery-other|1|||
48554069|NCT00402116|156219931|FG001|Overall Study|Jaw infection after surgery-other|0|||
48554070|NCT00402116|156219932|FG002|Overall Study|Jaw infection after surgery-other|0|||
48554071|NCT00402116|156219930|FG000|Overall Study|Withdrawal by Subject|1|||
48554072|NCT00402116|156219931|FG001|Overall Study|Withdrawal by Subject|0|||
48554073|NCT00402116|156219932|FG002|Overall Study|Withdrawal by Subject|5|||
48554074|NCT00402116|156219930|FG000|Overall Study|Treatment completed per protocol|1|||
48554075|NCT00402116|156219931|FG001|Overall Study|Treatment completed per protocol|1|||
48554076|NCT00402116|156219932|FG002|Overall Study|Treatment completed per protocol|2|||
48554077|NCT00402116|156219930|FG000|Overall Study|other complicating disease|0|||
48554078|NCT00402116|156219931|FG001|Overall Study|other complicating disease|0|||
48554079|NCT00402116|156219932|FG002|Overall Study|other complicating disease|2|||
48554080|NCT00402116|156219930|FG000|Overall Study|Disease Progression|0|||
48554081|NCT00402116|156219931|FG001|Overall Study|Disease Progression|4|||
48554082|NCT00402116|156219932|FG002|Overall Study|Disease Progression|38|||
48554083|NCT00402116|156219930|FG000|Overall Study|mistaken thrombocytopenia|0|||
48614093|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
48614094|NCT01069939|156443386|FG000|Randomised and Included in the Analyses|Removal|1|||
48614095|NCT01069939|156443387|FG001|Randomised and Included in the Analyses|Removal|0|||
48554084|NCT00402116|156219931|FG001|Overall Study|mistaken thrombocytopenia|0|||
48554085|NCT00402116|156219932|FG002|Overall Study|mistaken thrombocytopenia|1|||
48554086|NCT00402116|156219930|FG000|Overall Study|decline related hyponatremia/tumor|0|||
48554087|NCT00402116|156219931|FG001|Overall Study|decline related hyponatremia/tumor|0|||
48554088|NCT00402116|156219932|FG002|Overall Study|decline related hyponatremia/tumor|1|||
48554089|NCT00402116|156219930|FG000|Overall Study|Adverse Event|0|||
48554090|NCT00402116|156219931|FG001|Overall Study|Adverse Event|1|||
48554091|NCT00402116|156219932|FG002|Overall Study|Adverse Event|6|||
48554092|NCT00270855|156219933|FG000|Overall Study|Withdrawal by Subject|8|||
48554093|NCT00270855|156219934|FG001|Overall Study|Withdrawal by Subject|8|||
48554094|NCT00754650|156219935|FG000|Overall Study|Disease Progression|2|||
48554095|NCT02899195|156219936|FG000|Concurrent Durvalumab|Adverse Event|4|||
48554096|NCT02899195|156219936|FG000|Concurrent Durvalumab|Physician Decision|1|||
48554097|NCT02899195|156219936|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
48554098|NCT02899195|156219936|FG000|Concurrent Durvalumab|Progressive Disease|5|||
48554099|NCT02899195|156219936|FG000|Maintenance Durvalumab|Adverse Event|1|||
48554100|NCT02899195|156219936|FG000|Maintenance Durvalumab|Physician Decision|1|||
48554101|NCT02899195|156219936|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
48554102|NCT02899195|156219936|FG000|Maintenance Durvalumab|Progressive Disease|31|||
48554103|NCT03156504|156219943|FG000|Overall Study|Withdrawal by Subject|1|||
48554104|NCT04778904|156219944|FG000|Overall Study|Protocol Violation|1|||
48554105|NCT04778904|156219945|FG001|Overall Study|Protocol Violation|0|||
48554106|NCT04778904|156219946|FG002|Overall Study|Protocol Violation|0|||
48554107|NCT04778904|156219947|FG003|Overall Study|Protocol Violation|0|||
48554108|NCT04778904|156219944|FG000|Overall Study|Withdrawal by Subject|0|||
48554109|NCT04778904|156219945|FG001|Overall Study|Withdrawal by Subject|0|||
48554110|NCT04778904|156219946|FG002|Overall Study|Withdrawal by Subject|1|||
48554111|NCT04778904|156219947|FG003|Overall Study|Withdrawal by Subject|0|||
48554112|NCT02861014|156219955|FG000|Primary Analysis|Adverse Event|7|||
48554113|NCT02861014|156219955|FG000|Primary Analysis|Death|1|||
48554114|NCT02861014|156219955|FG000|Primary Analysis|Lack of Efficacy|3|||
48554115|NCT02861014|156219955|FG000|Primary Analysis|Physician Decision|2|||
48554116|NCT02861014|156219955|FG000|Primary Analysis|Pregnancy|4|||
48554117|NCT02861014|156219955|FG000|Primary Analysis|Protocol Violation|2|||
48554118|NCT02861014|156219955|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
48554119|NCT02861014|156219955|FG000|Primary Analysis|Withdrawal by Subject|14|||
48554120|NCT02861014|156219955|FG000|Primary Analysis|Commercial ocrelizumab|3|||
48554121|NCT02861014|156219955|FG000|Safety Follow-up|Adverse Event|1|||
48554122|NCT02861014|156219955|FG000|Safety Follow-up|Pregnancy|1|||
48554123|NCT02861014|156219955|FG000|Safety Follow-up|Withdrawal by Subject|9|||
48554124|NCT02861014|156219955|FG000|Safety Follow-up|Study terminated by sponsor|1|||
48614096|NCT01913353|156443388|FG000|Overall Study|Adverse Event|2|||
48554125|NCT02861014|156219955|FG000|Safety Follow-up|Physician Decision|1|||
48554126|NCT02861014|156219955|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
48554127|NCT02861014|156219955|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
48554128|NCT00450801|156219956|FG000|Overall Study|Death|1|||
48554129|NCT03203850|156219957|FG000|Overall Study|Subject/guardian decision|4|||
48554130|NCT03203850|156219958|FG001|Overall Study|Subject/guardian decision|3|||
48554131|NCT03203850|156219957|FG000|Overall Study|Adverse Event|3|||
48554132|NCT03203850|156219958|FG001|Overall Study|Adverse Event|0|||
48554133|NCT03203850|156219957|FG000|Overall Study|Death|1|||
48554134|NCT03203850|156219958|FG001|Overall Study|Death|0|||
48554135|NCT02368314|156219959|FG000|Overall Study|Withdrawal by Subject|2|||
48554136|NCT02368314|156219960|FG001|Overall Study|Withdrawal by Subject|1|||
48554137|NCT02368314|156219959|FG000|Overall Study|Adverse Event|1|||
48554138|NCT02368314|156219960|FG001|Overall Study|Adverse Event|2|||
48554139|NCT03452137|156219961|FG000|Overall Study|Death|67|||
48554140|NCT03452137|156219962|FG001|Overall Study|Death|70|||
48614097|NCT01913353|156443389|FG001|Overall Study|Adverse Event|0|||
48554141|NCT03452137|156219961|FG000|Overall Study|Lost to Follow-up|4|||
48554142|NCT03452137|156219962|FG001|Overall Study|Lost to Follow-up|2|||
48554143|NCT03452137|156219961|FG000|Overall Study|Physician Decision|0|||
48614098|NCT01913353|156443388|FG000|Overall Study|Physician Decision|0|||
48614099|NCT01913353|156443389|FG001|Overall Study|Physician Decision|2|||
48614100|NCT01913353|156443388|FG000|Overall Study|Withdrawal by Subject|20|||
48614101|NCT01913353|156443389|FG001|Overall Study|Withdrawal by Subject|6|||
48614102|NCT01913353|156443388|FG000|Overall Study|multiple reasons|10|||
48614103|NCT01913353|156443389|FG001|Overall Study|multiple reasons|7|||
48614104|NCT00462462|156443393|FG000|Overall Study|Physician Decision|0|||
48614105|NCT00462462|156443394|FG001|Overall Study|Physician Decision|1|||
48614106|NCT01685437|156443396|FG000|Overall Study|Withdrawal by Subject|22|||
48614107|NCT01685437|156443396|FG000|Overall Study|Lost to Follow-up|3|||
48614108|NCT01685437|156443396|FG000|Overall Study|Adverse Event|1|||
48614109|NCT01685437|156443396|FG000|Overall Study|Protocol Violation|4|||
48614110|NCT01685437|156443396|FG000|Overall Study|Unable to make visits due to work|1|||
48614111|NCT02875080|156443397|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
48614112|NCT02875080|156443398|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
48614113|NCT02875080|156443399|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
48614114|NCT02114684|156443400|FG000|Overall Study|Death|6|||
48614115|NCT02114684|156443401|FG001|Overall Study|Death|4|||
48614116|NCT02114684|156443400|FG000|Overall Study|Lost to Follow-up|1|||
48554144|NCT03452137|156219962|FG001|Overall Study|Physician Decision|1|||
48554145|NCT03452137|156219961|FG000|Overall Study|Study Terminated by Sponsor|120|||
48554146|NCT03452137|156219962|FG001|Overall Study|Study Terminated by Sponsor|121|||
48554147|NCT03452137|156219961|FG000|Overall Study|Withdrawal by Subject|12|||
48554148|NCT03452137|156219962|FG001|Overall Study|Withdrawal by Subject|9|||
48554149|NCT01721317|156219968|FG000|Overall Study|Study Closed / Terminated|2|||
48614117|NCT02114684|156443401|FG001|Overall Study|Lost to Follow-up|2|||
48614118|NCT02114684|156443400|FG000|Overall Study|Withdrawal by Subject|1|||
48614119|NCT02114684|156443401|FG001|Overall Study|Withdrawal by Subject|2|||
48614120|NCT02114684|156443400|FG000|Overall Study|Relocation|3|||
48614121|NCT02114684|156443401|FG001|Overall Study|Relocation|1|||
48614122|NCT02114684|156443400|FG000|Overall Study|Rifampicin resistant on culture|0|||
48614123|NCT02114684|156443401|FG001|Overall Study|Rifampicin resistant on culture|1|||
48614124|NCT02114684|156443400|FG000|Overall Study|Patient Incarcerated|1|||
48614125|NCT02114684|156443401|FG001|Overall Study|Patient Incarcerated|0|||
48614126|NCT00283959|156443402|FG000|Extension Period|Low Compliance|1|||
48614127|NCT00191100|156443403|FG000|Overall Study|Adverse Event|18|||
48614128|NCT00191100|156443404|FG001|Overall Study|Adverse Event|1|||
48614129|NCT00191100|156443403|FG000|Overall Study|Lost to Follow-up|2|||
48614130|NCT00191100|156443404|FG001|Overall Study|Lost to Follow-up|0|||
48614131|NCT00191100|156443403|FG000|Overall Study|Patient Moved|0|||
48614132|NCT00191100|156443404|FG001|Overall Study|Patient Moved|1|||
48614133|NCT00191100|156443403|FG000|Overall Study|Withdrawal by Subject|9|||
48614134|NCT00191100|156443404|FG001|Overall Study|Withdrawal by Subject|3|||
48614135|NCT00191100|156443403|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
48614136|NCT00191100|156443404|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
48614137|NCT00191100|156443403|FG000|Overall Study|Clinical Relapse|2|||
48614138|NCT00191100|156443404|FG001|Overall Study|Clinical Relapse|1|||
48614139|NCT00191100|156443403|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
48554150|NCT01721317|156219969|FG001|Overall Study|Study Closed / Terminated|2|||
48554151|NCT01721317|156219968|FG000|Overall Study|Physician Decision|0|||
48554152|NCT01721317|156219969|FG001|Overall Study|Physician Decision|1|||
48554153|NCT01721317|156219968|FG000|Overall Study|Withdrawal by Subject|0|||
48554154|NCT01721317|156219969|FG001|Overall Study|Withdrawal by Subject|1|||
48554155|NCT02661217|156219972|FG000|Overall Study|Physician Decision|12|||
48554156|NCT02661217|156219973|FG001|Overall Study|Physician Decision|15|||
48554157|NCT02661217|156219972|FG000|Overall Study|Lost to Follow-up|1|||
48554158|NCT02661217|156219973|FG001|Overall Study|Lost to Follow-up|4|||
48554159|NCT02661217|156219972|FG000|Overall Study|Protocol Deviation|0|||
48554160|NCT02661217|156219973|FG001|Overall Study|Protocol Deviation|4|||
48554161|NCT02661217|156219972|FG000|Overall Study|Non-compliance with study treatment|5|||
48614140|NCT00191100|156443404|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
48614141|NCT00191100|156443403|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
48614142|NCT00191100|156443404|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
48614143|NCT00191100|156443403|FG000|Overall Study|Physician Decision|3|||
48614144|NCT00191100|156443404|FG001|Overall Study|Physician Decision|1|||
48614145|NCT00191100|156443403|FG000|Overall Study|Death from Study Drug Toxicity|2|||
48614146|NCT00191100|156443404|FG001|Overall Study|Death from Study Drug Toxicity|0|||
48614147|NCT00191100|156443403|FG000|Overall Study|Protocol Violation|1|||
48554162|NCT02661217|156219973|FG001|Overall Study|Non-compliance with study treatment|5|||
48554163|NCT02661217|156219972|FG000|Overall Study|Death|21|||
48554164|NCT02661217|156219973|FG001|Overall Study|Death|15|||
48554165|NCT02661217|156219972|FG000|Overall Study|Adverse Event|10|||
48554166|NCT02661217|156219973|FG001|Overall Study|Adverse Event|8|||
48554167|NCT02661217|156219972|FG000|Overall Study|Withdrawal by Subject|15|||
48614148|NCT00191100|156443404|FG001|Overall Study|Protocol Violation|1|||
48614149|NCT00191100|156443403|FG000|Overall Study|Death from Other Cause|1|||
48614150|NCT00191100|156443404|FG001|Overall Study|Death from Other Cause|0|||
48614151|NCT00191100|156443403|FG000|Overall Study|Reason Not Specified|0|||
48614152|NCT00191100|156443404|FG001|Overall Study|Reason Not Specified|1|||
48614153|NCT00165698|156443408|FG000|Overall Study|Adverse Event|2|||
48614154|NCT00165698|156443409|FG001|Overall Study|Adverse Event|10|||
48614155|NCT00165698|156443408|FG000|Overall Study|Lost to Follow-up|2|||
48614156|NCT00165698|156443409|FG001|Overall Study|Lost to Follow-up|2|||
48614157|NCT00165698|156443408|FG000|Overall Study|Withdrawal by Subject|2|||
48614158|NCT00165698|156443409|FG001|Overall Study|Withdrawal by Subject|1|||
48614159|NCT00165698|156443408|FG000|Overall Study|Protocol Violation|1|||
48614160|NCT00165698|156443409|FG001|Overall Study|Protocol Violation|0|||
48614161|NCT00165698|156443408|FG000|Overall Study|Not Taken/Lost the medicine|1|||
48614162|NCT00165698|156443409|FG001|Overall Study|Not Taken/Lost the medicine|2|||
48614163|NCT01026038|156443410|FG000|Overall Study|Lost to Follow-up|1|||
48614164|NCT01026038|156443411|FG001|Overall Study|Lost to Follow-up|1|||
48614165|NCT01026038|156443412|FG002|Overall Study|Lost to Follow-up|0|||
48614166|NCT01397747|156443421|FG000|Overall Study|Multitarget DNA test excluded|689|||
48614167|NCT01397747|156443421|FG000|Overall Study|Colonoscopy excluded|304|||
48614168|NCT01397747|156443421|FG000|Overall Study|FIT excluded|34|||
48614169|NCT02547935|156443422|FG000|Overall Study|Other|0|||
48614170|NCT02547935|156443423|FG001|Overall Study|Other|1|||
48614171|NCT02547935|156443424|FG002|Overall Study|Other|0|||
48614172|NCT02547935|156443422|FG000|Overall Study|Withdrawal by Subject|2|||
48614173|NCT02547935|156443423|FG001|Overall Study|Withdrawal by Subject|3|||
48614174|NCT02547935|156443424|FG002|Overall Study|Withdrawal by Subject|4|||
48614175|NCT02547935|156443422|FG000|Overall Study|Screen Failure|2|||
48614176|NCT02547935|156443423|FG001|Overall Study|Screen Failure|0|||
48614177|NCT02547935|156443424|FG002|Overall Study|Screen Failure|0|||
48614178|NCT02547935|156443422|FG000|Overall Study|Physician Decision|0|||
48614179|NCT02547935|156443423|FG001|Overall Study|Physician Decision|1|||
48614180|NCT02547935|156443424|FG002|Overall Study|Physician Decision|0|||
48614181|NCT02547935|156443422|FG000|Overall Study|Lost to Follow-up|0|||
48614182|NCT02547935|156443423|FG001|Overall Study|Lost to Follow-up|2|||
48614183|NCT02547935|156443424|FG002|Overall Study|Lost to Follow-up|1|||
48614184|NCT02547935|156443422|FG000|Overall Study|Death|1|||
48614185|NCT02547935|156443423|FG001|Overall Study|Death|1|||
48614186|NCT02547935|156443424|FG002|Overall Study|Death|0|||
48614187|NCT03770455|156443431|FG000|Overall Study|Screen failures|3|||
48614188|NCT03572218|156443436|FG000|Overall Study|Lost to Follow-up|3|||
48614189|NCT03572218|156443437|FG001|Overall Study|Lost to Follow-up|2|||
48614190|NCT03572218|156443436|FG000|Overall Study|No longer available for study visits|2|||
48614191|NCT03572218|156443437|FG001|Overall Study|No longer available for study visits|1|||
48614192|NCT03572218|156443436|FG000|Overall Study|No longer interested|1|||
48614193|NCT03572218|156443437|FG001|Overall Study|No longer interested|2|||
48614194|NCT01350973|156443438|FG000|Overall Study|Adverse Event|4|||
48614195|NCT01350973|156443439|FG001|Overall Study|Adverse Event|7|||
48614196|NCT01350973|156443440|FG002|Overall Study|Adverse Event|7|||
48614197|NCT01350973|156443438|FG000|Overall Study|Voluntary Withdrawal|2|||
48614198|NCT01350973|156443439|FG001|Overall Study|Voluntary Withdrawal|1|||
48614199|NCT01350973|156443440|FG002|Overall Study|Voluntary Withdrawal|1|||
48614200|NCT02638493|156443444|FG000|Overall Study|Inability to provide semen samples|2|||
48614201|NCT02638493|156443445|FG001|Overall Study|Inability to provide semen samples|0|||
48614202|NCT02638493|156443446|FG002|Overall Study|Inability to provide semen samples|0|||
48614203|NCT02711137|156445494|FG000|Overall Study|Death|1|||
48614204|NCT02711137|156445495|FG001|Overall Study|Death|4|||
48614205|NCT02711137|156445496|FG002|Overall Study|Death|5|||
48614206|NCT02711137|156445497|FG003|Overall Study|Death|5|||
48614207|NCT02711137|156445498|FG004|Overall Study|Death|3|||
48614208|NCT02711137|156445499|FG005|Overall Study|Death|1|||
48614209|NCT02711137|156445500|FG006|Overall Study|Death|61|||
48614210|NCT02711137|156445501|FG007|Overall Study|Death|3|||
48614211|NCT02711137|156445502|FG008|Overall Study|Death|0|||
48614212|NCT02711137|156445503|FG009|Overall Study|Death|1|||
48614213|NCT02711137|156445504|FG010|Overall Study|Death|1|||
48614214|NCT02711137|156445505|FG011|Overall Study|Death|1|||
48614215|NCT02711137|156445506|FG012|Overall Study|Death|0|||
48614216|NCT02711137|156445507|FG013|Overall Study|Death|0|||
48614217|NCT02711137|156445508|FG014|Overall Study|Death|0|||
48614218|NCT02711137|156445494|FG000|Overall Study|Study Terminated by Sponsor|0|||
48614219|NCT02711137|156445495|FG001|Overall Study|Study Terminated by Sponsor|0|||
48614220|NCT02711137|156445496|FG002|Overall Study|Study Terminated by Sponsor|1|||
48614221|NCT02711137|156445497|FG003|Overall Study|Study Terminated by Sponsor|0|||
48614222|NCT02711137|156445498|FG004|Overall Study|Study Terminated by Sponsor|0|||
48614223|NCT02711137|156445499|FG005|Overall Study|Study Terminated by Sponsor|0|||
48614224|NCT02711137|156445500|FG006|Overall Study|Study Terminated by Sponsor|1|||
48614225|NCT02711137|156445501|FG007|Overall Study|Study Terminated by Sponsor|0|||
48614226|NCT02711137|156445502|FG008|Overall Study|Study Terminated by Sponsor|0|||
48614227|NCT02711137|156445503|FG009|Overall Study|Study Terminated by Sponsor|0|||
48614228|NCT02711137|156445504|FG010|Overall Study|Study Terminated by Sponsor|0|||
48614229|NCT02711137|156445505|FG011|Overall Study|Study Terminated by Sponsor|0|||
48614230|NCT02711137|156445506|FG012|Overall Study|Study Terminated by Sponsor|0|||
48614231|NCT02711137|156445507|FG013|Overall Study|Study Terminated by Sponsor|0|||
48614232|NCT02711137|156445508|FG014|Overall Study|Study Terminated by Sponsor|0|||
48614233|NCT02711137|156445494|FG000|Overall Study|Physician Decision|1|||
48614234|NCT02711137|156445495|FG001|Overall Study|Physician Decision|0|||
48614235|NCT02711137|156445496|FG002|Overall Study|Physician Decision|2|||
48614236|NCT02711137|156445497|FG003|Overall Study|Physician Decision|1|||
48614237|NCT02711137|156445498|FG004|Overall Study|Physician Decision|1|||
48614238|NCT02711137|156445499|FG005|Overall Study|Physician Decision|0|||
48614239|NCT02711137|156445500|FG006|Overall Study|Physician Decision|12|||
48614240|NCT02711137|156445501|FG007|Overall Study|Physician Decision|2|||
48614241|NCT02711137|156445502|FG008|Overall Study|Physician Decision|1|||
48614242|NCT02711137|156445503|FG009|Overall Study|Physician Decision|1|||
48614243|NCT02711137|156445504|FG010|Overall Study|Physician Decision|3|||
48614244|NCT02711137|156445505|FG011|Overall Study|Physician Decision|2|||
48614245|NCT02711137|156445506|FG012|Overall Study|Physician Decision|1|||
48614246|NCT02711137|156445507|FG013|Overall Study|Physician Decision|1|||
48614247|NCT02711137|156445508|FG014|Overall Study|Physician Decision|2|||
48614248|NCT02711137|156445494|FG000|Overall Study|Other|0|||
48614249|NCT02711137|156445495|FG001|Overall Study|Other|1|||
48614250|NCT02711137|156445496|FG002|Overall Study|Other|0|||
48614251|NCT02711137|156445497|FG003|Overall Study|Other|0|||
48614252|NCT02711137|156445498|FG004|Overall Study|Other|0|||
48554168|NCT02661217|156219973|FG001|Overall Study|Withdrawal by Subject|19|||
48554169|NCT02661217|156219972|FG000|Overall Study|Did not enter follow-up epoch|7|||
48554170|NCT02661217|156219973|FG001|Overall Study|Did not enter follow-up epoch|10|||
48554171|NCT02661217|156219972|FG000|Overall Study|Death - no study drug received|1|||
48554172|NCT02661217|156219973|FG001|Overall Study|Death - no study drug received|2|||
48554173|NCT02661217|156219972|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
48554174|NCT02661217|156219973|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
48554175|NCT01644617|156219979|FG000|Overall Study|Withdrawal by Subject|3|||
48554176|NCT01644617|156219980|FG001|Overall Study|Withdrawal by Subject|4|||
48554177|NCT01644617|156219981|FG002|Overall Study|Withdrawal by Subject|1|||
48554178|NCT01644617|156219979|FG000|Overall Study|Lost to Follow-up|0|||
48554179|NCT01644617|156219980|FG001|Overall Study|Lost to Follow-up|1|||
48554180|NCT01644617|156219981|FG002|Overall Study|Lost to Follow-up|0|||
48554181|NCT01644617|156219979|FG000|Overall Study|Adverse Event|3|||
48554182|NCT01644617|156219980|FG001|Overall Study|Adverse Event|0|||
48554183|NCT01644617|156219981|FG002|Overall Study|Adverse Event|6|||
48614253|NCT02711137|156445499|FG005|Overall Study|Other|0|||
48554184|NCT00444587|156219982|FG000|Overall Study|Death|2|||
48554185|NCT00444587|156219983|FG001|Overall Study|Death|1|||
48554186|NCT00444587|156219982|FG000|Overall Study|Progression of the disease|73|||
48554187|NCT00444587|156219983|FG001|Overall Study|Progression of the disease|8|||
48554188|NCT00444587|156219982|FG000|Overall Study|Refused treatment/did not cooperate|4|||
48554189|NCT00444587|156219983|FG001|Overall Study|Refused treatment/did not cooperate|1|||
48554190|NCT00444587|156219982|FG000|Overall Study|Investigator decision|3|||
48554191|NCT00444587|156219983|FG001|Overall Study|Investigator decision|0|||
48554192|NCT00444587|156219982|FG000|Overall Study|Protocol Violation|1|||
48554193|NCT00444587|156219983|FG001|Overall Study|Protocol Violation|0|||
48554194|NCT00444587|156219982|FG000|Overall Study|Missing|0|||
48554195|NCT00444587|156219983|FG001|Overall Study|Missing|5|||
48554196|NCT03593395|156219991|FG000|Overall Study|Lost to Follow-up|48|||
48554197|NCT03593395|156219992|FG001|Overall Study|Lost to Follow-up|3|||
48554198|NCT03593395|156219991|FG000|Overall Study|Withdrawal by Subject|5|||
48554199|NCT03593395|156219992|FG001|Overall Study|Withdrawal by Subject|24|||
48554200|NCT03593395|156219991|FG000|Overall Study|Death|2|||
48554201|NCT03593395|156219992|FG001|Overall Study|Death|3|||
48614254|NCT02711137|156445500|FG006|Overall Study|Other|3|||
48614255|NCT02711137|156445501|FG007|Overall Study|Other|0|||
48614256|NCT02711137|156445502|FG008|Overall Study|Other|0|||
48614257|NCT02711137|156445503|FG009|Overall Study|Other|0|||
48554202|NCT03593395|156219991|FG000|Overall Study|Physician Decision|0|||
48554203|NCT03593395|156219992|FG001|Overall Study|Physician Decision|6|||
48554204|NCT03593395|156219991|FG000|Overall Study|Participant Relocated|19|||
48554205|NCT03593395|156219992|FG001|Overall Study|Participant Relocated|3|||
48614258|NCT02711137|156445504|FG010|Overall Study|Other|0|||
48614259|NCT02711137|156445505|FG011|Overall Study|Other|0|||
48614260|NCT02711137|156445506|FG012|Overall Study|Other|0|||
48554206|NCT03593395|156219991|FG000|Overall Study|No Information|1|||
48554207|NCT03593395|156219992|FG001|Overall Study|No Information|7|||
48554208|NCT03713632|156219993|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
48554209|NCT03713632|156219994|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
48554210|NCT03713632|156219995|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
48554211|NCT03713632|156219996|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
48554212|NCT03713632|156219997|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
48554213|NCT03713632|156219993|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
48554214|NCT03713632|156219994|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
48554215|NCT03713632|156219995|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
48554216|NCT03713632|156219996|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
48554217|NCT03713632|156219997|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
48554218|NCT03713632|156219993|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
48554219|NCT03713632|156219994|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
48554220|NCT03713632|156219995|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
48554221|NCT03713632|156219996|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
48614261|NCT02711137|156445507|FG013|Overall Study|Other|0|||
48614262|NCT02711137|156445508|FG014|Overall Study|Other|1|||
48614263|NCT02711137|156445494|FG000|Overall Study|Withdrawal by Subject|1|||
48554222|NCT03713632|156219997|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
48614264|NCT02711137|156445495|FG001|Overall Study|Withdrawal by Subject|0|||
48554223|NCT03713632|156219993|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
48554224|NCT03713632|156219994|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
48554225|NCT03713632|156219995|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
48554226|NCT03713632|156219996|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
48554227|NCT03713632|156219997|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
48554228|NCT03713632|156219993|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
48554229|NCT03713632|156219994|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
48554230|NCT03713632|156219995|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
48554231|NCT03713632|156219996|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
48554232|NCT03713632|156219997|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
48554233|NCT03713632|156219993|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
48554234|NCT03713632|156219994|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
48554235|NCT03713632|156219995|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
48554236|NCT03713632|156219996|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
48614265|NCT02711137|156445496|FG002|Overall Study|Withdrawal by Subject|0|||
48614266|NCT02711137|156445497|FG003|Overall Study|Withdrawal by Subject|1|||
48614267|NCT02711137|156445498|FG004|Overall Study|Withdrawal by Subject|1|||
48614268|NCT02711137|156445499|FG005|Overall Study|Withdrawal by Subject|0|||
48614269|NCT02711137|156445500|FG006|Overall Study|Withdrawal by Subject|7|||
48614270|NCT02711137|156445501|FG007|Overall Study|Withdrawal by Subject|0|||
48614271|NCT02711137|156445502|FG008|Overall Study|Withdrawal by Subject|0|||
48614272|NCT02711137|156445503|FG009|Overall Study|Withdrawal by Subject|0|||
48614273|NCT02711137|156445504|FG010|Overall Study|Withdrawal by Subject|0|||
48614274|NCT02711137|156445505|FG011|Overall Study|Withdrawal by Subject|0|||
48614275|NCT02711137|156445506|FG012|Overall Study|Withdrawal by Subject|0|||
48614276|NCT02711137|156445507|FG013|Overall Study|Withdrawal by Subject|1|||
48614277|NCT02711137|156445508|FG014|Overall Study|Withdrawal by Subject|0|||
48614278|NCT02711137|156445494|FG000|Overall Study|Lost to Follow-up|1|||
48614279|NCT02711137|156445495|FG001|Overall Study|Lost to Follow-up|0|||
48614280|NCT02711137|156445496|FG002|Overall Study|Lost to Follow-up|0|||
48614281|NCT02711137|156445497|FG003|Overall Study|Lost to Follow-up|0|||
48614282|NCT02711137|156445498|FG004|Overall Study|Lost to Follow-up|0|||
48614283|NCT02711137|156445499|FG005|Overall Study|Lost to Follow-up|0|||
48614284|NCT02711137|156445500|FG006|Overall Study|Lost to Follow-up|2|||
48614285|NCT02711137|156445501|FG007|Overall Study|Lost to Follow-up|0|||
48614286|NCT02711137|156445502|FG008|Overall Study|Lost to Follow-up|0|||
48614287|NCT02711137|156445503|FG009|Overall Study|Lost to Follow-up|0|||
48614288|NCT02711137|156445504|FG010|Overall Study|Lost to Follow-up|0|||
48614289|NCT02711137|156445505|FG011|Overall Study|Lost to Follow-up|0|||
48614290|NCT02711137|156445506|FG012|Overall Study|Lost to Follow-up|0|||
48554237|NCT03713632|156219997|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
48614291|NCT02711137|156445507|FG013|Overall Study|Lost to Follow-up|0|||
48614292|NCT02711137|156445508|FG014|Overall Study|Lost to Follow-up|0|||
48614293|NCT05399771|156445509|FG000|Overall Study|Physician Decision|3|||
48614294|NCT05399771|156445509|FG000|Overall Study|Adverse Event|1|||
48614295|NCT02233413|156445510|FG000|Overall Study|Lost to Follow-up|7|||
48614296|NCT02233413|156445511|FG001|Overall Study|Lost to Follow-up|9|||
48614297|NCT02233413|156445510|FG000|Overall Study|Withdrawal by Subject|4|||
48554238|NCT03713632|156219993|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
48554239|NCT03713632|156219994|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
48554240|NCT03713632|156219995|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
48554241|NCT03713632|156219996|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
48554242|NCT03713632|156219997|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
48554243|NCT03713632|156219993|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
48554244|NCT03713632|156219994|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
48554245|NCT03713632|156219995|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
48554246|NCT03713632|156219996|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
48554247|NCT03713632|156219997|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
48554248|NCT03713632|156219993|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
48554249|NCT03713632|156219994|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
48554250|NCT03713632|156219995|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
48554251|NCT03713632|156219996|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
48554252|NCT03713632|156219997|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
48554253|NCT03713632|156219993|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
48554254|NCT03713632|156219994|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
48554255|NCT03713632|156219995|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
48554256|NCT03713632|156219996|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
48554257|NCT03713632|156219997|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
48554258|NCT03713632|156219993|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
48554259|NCT03713632|156219994|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
48554260|NCT03713632|156219995|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
48554261|NCT03713632|156219996|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
48614298|NCT02233413|156445511|FG001|Overall Study|Withdrawal by Subject|5|||
48554262|NCT03713632|156219997|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
48554263|NCT03713632|156219993|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
48554264|NCT03713632|156219994|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
48554265|NCT03713632|156219995|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
48554266|NCT03713632|156219996|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
48554267|NCT03713632|156219997|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
48554268|NCT03713632|156219993|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
48554269|NCT03713632|156219994|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
48554270|NCT03713632|156219995|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
48554271|NCT03713632|156219996|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
48554272|NCT03713632|156219997|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
48614299|NCT00134719|156445512|FG000|Primary Vaccination Phase|Adverse Event|4|||
48554273|NCT03713632|156219993|FG000|Treatment Period 2 (After Week 16)|Death|0|||
48554274|NCT03713632|156219994|FG001|Treatment Period 2 (After Week 16)|Death|1|||
48554275|NCT03713632|156219995|FG002|Treatment Period 2 (After Week 16)|Death|0|||
48554276|NCT03713632|156219996|FG003|Treatment Period 2 (After Week 16)|Death|0|||
48554277|NCT03713632|156219997|FG004|Treatment Period 2 (After Week 16)|Death|0|||
48614300|NCT00134719|156445513|FG001|Primary Vaccination Phase|Adverse Event|0|||
48614301|NCT00134719|156445514|FG002|Primary Vaccination Phase|Adverse Event|0|||
48554278|NCT03713632|156219993|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
48325489|NCT02357966|155389117|FG005|Overall Study|Physician Decision|0|||
48554279|NCT03713632|156219994|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
48554280|NCT03713632|156219995|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
48554281|NCT03713632|156219996|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
48554282|NCT03713632|156219997|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
48554283|NCT01524978|156220001|FG000|Overall Study|Other|16|||
48554284|NCT01524978|156220002|FG001|Overall Study|Other|2|||
48554285|NCT01524978|156220003|FG002|Overall Study|Other|1|||
48554286|NCT01524978|156220004|FG003|Overall Study|Other|2|||
48554287|NCT01524978|156220005|FG004|Overall Study|Other|1|||
48554288|NCT01524978|156220006|FG005|Overall Study|Other|3|||
48554289|NCT01524978|156220007|FG006|Overall Study|Other|17|||
48554290|NCT01524978|156220008|FG007|Overall Study|Other|1|||
48554291|NCT01524978|156220009|FG008|Overall Study|Other|2|||
48614302|NCT00134719|156445512|FG000|Primary Vaccination Phase|Protocol Violation|1|||
48614303|NCT00134719|156445513|FG001|Primary Vaccination Phase|Protocol Violation|0|||
48554292|NCT01524978|156220010|FG009|Overall Study|Other|2|||
48554293|NCT01524978|156220011|FG010|Overall Study|Other|5|||
48554294|NCT01524978|156220001|FG000|Overall Study|Withdrawal by Subject|12|||
48554295|NCT01524978|156220002|FG001|Overall Study|Withdrawal by Subject|0|||
48554296|NCT01524978|156220003|FG002|Overall Study|Withdrawal by Subject|1|||
48554297|NCT01524978|156220004|FG003|Overall Study|Withdrawal by Subject|1|||
48554298|NCT01524978|156220005|FG004|Overall Study|Withdrawal by Subject|3|||
48554299|NCT01524978|156220006|FG005|Overall Study|Withdrawal by Subject|1|||
48554300|NCT01524978|156220007|FG006|Overall Study|Withdrawal by Subject|6|||
48554301|NCT01524978|156220008|FG007|Overall Study|Withdrawal by Subject|2|||
48554302|NCT01524978|156220009|FG008|Overall Study|Withdrawal by Subject|4|||
48554303|NCT01524978|156220010|FG009|Overall Study|Withdrawal by Subject|0|||
48554304|NCT01524978|156220011|FG010|Overall Study|Withdrawal by Subject|5|||
48554305|NCT01524978|156220001|FG000|Overall Study|Lost to Follow-up|0|||
48554306|NCT01524978|156220002|FG001|Overall Study|Lost to Follow-up|0|||
48554307|NCT01524978|156220003|FG002|Overall Study|Lost to Follow-up|3|||
48554308|NCT01524978|156220004|FG003|Overall Study|Lost to Follow-up|0|||
48554309|NCT01524978|156220005|FG004|Overall Study|Lost to Follow-up|1|||
48554310|NCT01524978|156220006|FG005|Overall Study|Lost to Follow-up|1|||
48554311|NCT01524978|156220007|FG006|Overall Study|Lost to Follow-up|2|||
48554312|NCT01524978|156220008|FG007|Overall Study|Lost to Follow-up|0|||
48554313|NCT01524978|156220009|FG008|Overall Study|Lost to Follow-up|1|||
48554314|NCT01524978|156220010|FG009|Overall Study|Lost to Follow-up|1|||
48554315|NCT01524978|156220011|FG010|Overall Study|Lost to Follow-up|1|||
48554316|NCT01524978|156220001|FG000|Overall Study|Death|34|||
48554317|NCT01524978|156220002|FG001|Overall Study|Death|2|||
48554318|NCT01524978|156220003|FG002|Overall Study|Death|5|||
48554319|NCT01524978|156220004|FG003|Overall Study|Death|24|||
48554320|NCT01524978|156220005|FG004|Overall Study|Death|4|||
48554321|NCT01524978|156220006|FG005|Overall Study|Death|4|||
48554322|NCT01524978|156220007|FG006|Overall Study|Death|1|||
48554323|NCT01524978|156220008|FG007|Overall Study|Death|9|||
48554324|NCT01524978|156220009|FG008|Overall Study|Death|5|||
48554325|NCT01524978|156220010|FG009|Overall Study|Death|6|||
48554326|NCT01524978|156220011|FG010|Overall Study|Death|17|||
48554327|NCT02806024|156220012|FG000|Overall Study|Night Delivery|1|||
48554328|NCT02806024|156220013|FG001|Overall Study|Night Delivery|1|||
48554329|NCT02806024|156220012|FG000|Overall Study|DVT during antepartum admission|0|||
48554330|NCT02806024|156220013|FG001|Overall Study|DVT during antepartum admission|1|||
48554331|NCT00940316|156220024|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
48554332|NCT00940316|156220025|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
48554333|NCT00940316|156220026|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
48554334|NCT00940316|156220024|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
48554335|NCT00940316|156220025|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
48554336|NCT00940316|156220026|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
48554337|NCT00940316|156220024|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
48554338|NCT00940316|156220025|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
48554339|NCT00940316|156220026|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
48554340|NCT00940316|156220024|FG000|Treated After Cycle 5|Adverse Event|0|||
48554341|NCT00940316|156220025|FG001|Treated After Cycle 5|Adverse Event|0|||
48554342|NCT00940316|156220026|FG002|Treated After Cycle 5|Adverse Event|1|||
48554343|NCT00940316|156220024|FG000|Treated After Cycle 5|Progressive disease|0|||
48554344|NCT00940316|156220025|FG001|Treated After Cycle 5|Progressive disease|1|||
48554345|NCT00940316|156220026|FG002|Treated After Cycle 5|Progressive disease|0|||
48554346|NCT05299528|156220027|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
48554347|NCT05299528|156220028|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
48554348|NCT05299528|156220029|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
48554349|NCT05299528|156220030|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
48554350|NCT05299528|156220031|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
48554351|NCT05299528|156220032|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
48554352|NCT05299528|156220033|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
48554353|NCT05299528|156220027|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
48554354|NCT05299528|156220028|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
48554355|NCT05299528|156220029|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
48554356|NCT05299528|156220030|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
48554357|NCT05299528|156220031|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
48554358|NCT05299528|156220032|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
48554359|NCT05299528|156220033|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
48693062|NCT01400698|156724660|FG002|Overall Study|Adverse Event|0|||
48554360|NCT05299528|156220027|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
48554361|NCT05299528|156220028|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
48554362|NCT05299528|156220029|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
48554363|NCT05299528|156220030|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
48554364|NCT05299528|156220031|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
48554365|NCT05299528|156220032|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
48554366|NCT05299528|156220033|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
48554367|NCT01107197|156220034|FG000|Overall Study|Death|12|||
48554368|NCT01107197|156220035|FG001|Overall Study|Death|10|||
48554369|NCT01107197|156220034|FG000|Overall Study|Lost to Follow-up|5|||
48554370|NCT01107197|156220035|FG001|Overall Study|Lost to Follow-up|8|||
48554371|NCT01107197|156220034|FG000|Overall Study|Withdrawal by Subject|3|||
48554372|NCT01107197|156220035|FG001|Overall Study|Withdrawal by Subject|5|||
48554373|NCT02123446|156220036|FG000|Washout Period (1 Day)|Physician Decision|1|||
48554374|NCT02123446|156220037|FG001|Washout Period (1 Day)|Physician Decision|0|||
48554375|NCT04604795|156220038|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
48554376|NCT04604795|156220039|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
48554377|NCT04604795|156220040|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
48554378|NCT04604795|156220041|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
48554379|NCT04604795|156220042|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
48554380|NCT04604795|156220043|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
48554381|NCT04604795|156220044|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
48554382|NCT04604795|156220045|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
48554383|NCT04604795|156220046|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
48554384|NCT04604795|156220047|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
48554385|NCT04604795|156220038|FG000|Part B: Up to Day 14|Adverse Event|0|||
48554386|NCT04604795|156220039|FG001|Part B: Up to Day 14|Adverse Event|0|||
48554387|NCT04604795|156220040|FG002|Part B: Up to Day 14|Adverse Event|0|||
48554388|NCT04604795|156220041|FG003|Part B: Up to Day 14|Adverse Event|0|||
48554389|NCT04604795|156220042|FG004|Part B: Up to Day 14|Adverse Event|2|||
48554390|NCT04604795|156220043|FG005|Part B: Up to Day 14|Adverse Event|1|||
48554391|NCT04604795|156220044|FG006|Part B: Up to Day 14|Adverse Event|0|||
48554392|NCT04604795|156220045|FG007|Part B: Up to Day 14|Adverse Event|0|||
48554393|NCT04604795|156220046|FG008|Part B: Up to Day 14|Adverse Event|0|||
48554394|NCT04604795|156220047|FG009|Part B: Up to Day 14|Adverse Event|0|||
48554395|NCT04604795|156220038|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554396|NCT04604795|156220039|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554397|NCT04604795|156220040|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554398|NCT04604795|156220041|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554399|NCT04604795|156220042|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554400|NCT04604795|156220043|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554401|NCT04604795|156220044|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554402|NCT04604795|156220045|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554403|NCT04604795|156220046|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
48554404|NCT04604795|156220047|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
48554405|NCT04604795|156220038|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554406|NCT04604795|156220039|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554407|NCT04604795|156220040|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554408|NCT04604795|156220041|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554409|NCT04604795|156220042|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554410|NCT04604795|156220043|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554411|NCT04604795|156220044|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554412|NCT04604795|156220045|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554413|NCT04604795|156220046|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
48554414|NCT04604795|156220047|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
48554415|NCT04604795|156220038|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554416|NCT04604795|156220039|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554417|NCT04604795|156220040|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554418|NCT04604795|156220041|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554419|NCT04604795|156220042|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554420|NCT04604795|156220043|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554421|NCT04604795|156220044|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554422|NCT04604795|156220045|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554423|NCT04604795|156220046|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
48554424|NCT04604795|156220047|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
48554425|NCT04604795|156220038|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
48554426|NCT04604795|156220039|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
48554427|NCT04604795|156220040|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
48554428|NCT04604795|156220041|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
48554429|NCT04604795|156220042|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
48614304|NCT00134719|156445514|FG002|Primary Vaccination Phase|Protocol Violation|0|||
48554430|NCT04604795|156220043|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
48554431|NCT04604795|156220044|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
48554432|NCT04604795|156220045|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
48554433|NCT04604795|156220046|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
48554434|NCT04604795|156220047|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
48554435|NCT01301729|156220048|FG000|Overall Study|Withdrawal by Subject|2|||
48614305|NCT00134719|156445512|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
48614306|NCT00134719|156445513|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
48614307|NCT00134719|156445514|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
48614308|NCT00134719|156445512|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
48614309|NCT00134719|156445513|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
48614310|NCT00134719|156445514|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
48614311|NCT00134719|156445512|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
48614312|NCT00134719|156445513|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
48554436|NCT01301729|156220048|FG000|Overall Study|Participant did not Return for Treatment|1|||
48554437|NCT01301729|156220048|FG000|Overall Study|Violated Selection Criteria|1|||
48554438|NCT02289729|156220049|FG000|Overall Study|Lack of Efficacy|3|||
48554439|NCT02289729|156220049|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
48614313|NCT00134719|156445514|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
48614314|NCT00134719|156445512|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
48614315|NCT00134719|156445513|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
48554440|NCT02289729|156220049|FG000|Overall Study|Withdrawal by Subject|1|||
48554441|NCT02289729|156220049|FG000|Overall Study|Death|1|||
48554442|NCT00683657|156220064|FG000|Overall Study|Adverse Event|0|||
48614316|NCT00134719|156445514|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
48614317|NCT00876395|156445515|FG000|Overall Study|Untreated|8|||
48614318|NCT00876395|156445516|FG001|Overall Study|Untreated|1|||
48614319|NCT00876395|156445515|FG000|Overall Study|Adverse Event|63|||
48614320|NCT00876395|156445516|FG001|Overall Study|Adverse Event|11|||
48614321|NCT00876395|156445515|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48614322|NCT00876395|156445516|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48614323|NCT00876395|156445515|FG000|Overall Study|Disease progression|259|||
48614324|NCT00876395|156445516|FG001|Overall Study|Disease progression|162|||
48614325|NCT00876395|156445515|FG000|Overall Study|New cancer therapy|25|||
48614326|NCT00876395|156445516|FG001|Overall Study|New cancer therapy|7|||
48614327|NCT00876395|156445515|FG000|Overall Study|Protocol Violation|5|||
48554443|NCT00683657|156220065|FG001|Overall Study|Adverse Event|1|||
48554444|NCT00683657|156220064|FG000|Overall Study|Subject Withdrew Consent|1|||
48554445|NCT00683657|156220065|FG001|Overall Study|Subject Withdrew Consent|0|||
48554446|NCT01074944|156220067|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
48554447|NCT01074944|156220068|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
48554448|NCT01074944|156220069|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
48614328|NCT00876395|156445516|FG001|Overall Study|Protocol Violation|2|||
48614329|NCT00876395|156445515|FG000|Overall Study|Withdrawal by Subject|66|||
48614330|NCT00876395|156445516|FG001|Overall Study|Withdrawal by Subject|33|||
48614331|NCT00876395|156445515|FG000|Overall Study|Lost to Follow-up|2|||
48554449|NCT01074944|156220070|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
48554450|NCT01074944|156220071|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
48554451|NCT01074944|156220067|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
48554452|NCT01074944|156220068|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
48554453|NCT01074944|156220069|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
48554454|NCT01074944|156220070|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
48554455|NCT01074944|156220071|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
48554456|NCT01074944|156220067|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
48554457|NCT01074944|156220068|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
48554458|NCT01074944|156220069|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
48554459|NCT01074944|156220070|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
48554460|NCT01074944|156220071|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
48554461|NCT01074944|156220067|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
48554462|NCT01074944|156220068|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
48554463|NCT01074944|156220069|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
48554464|NCT01074944|156220070|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
48554465|NCT01074944|156220071|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
48554466|NCT01074944|156220067|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
48554467|NCT01074944|156220068|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
48554468|NCT01074944|156220069|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
48554469|NCT01074944|156220070|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
48554470|NCT01074944|156220071|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
48554471|NCT01074944|156220067|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
48554472|NCT01074944|156220068|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
48554473|NCT01074944|156220069|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
48614332|NCT00876395|156445516|FG001|Overall Study|Lost to Follow-up|0|||
48614333|NCT00876395|156445515|FG000|Overall Study|Administrative problems|39|||
48614334|NCT00876395|156445516|FG001|Overall Study|Administrative problems|23|||
48614335|NCT00876395|156445515|FG000|Overall Study|Death|12|||
48614336|NCT00876395|156445516|FG001|Overall Study|Death|0|||
48554474|NCT01074944|156220070|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
48554475|NCT01074944|156220071|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
48554476|NCT01074944|156220067|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
48554477|NCT01074944|156220068|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
48554478|NCT01074944|156220069|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
48554479|NCT01074944|156220070|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
48554480|NCT01074944|156220071|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
48554481|NCT01074944|156220067|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
48554482|NCT01074944|156220068|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
48554483|NCT01074944|156220069|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
48554484|NCT01074944|156220070|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
48554485|NCT01074944|156220071|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
48554486|NCT01074944|156220067|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
48554487|NCT01074944|156220068|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
48554488|NCT01074944|156220069|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
48554489|NCT01074944|156220070|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
48554490|NCT01074944|156220071|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
48554491|NCT01074944|156220067|FG000|Long Term Treatment|Adverse Event|0|||
48554492|NCT01074944|156220068|FG001|Long Term Treatment|Adverse Event|0|||
48554493|NCT01074944|156220069|FG002|Long Term Treatment|Adverse Event|0|||
48554494|NCT01074944|156220070|FG003|Long Term Treatment|Adverse Event|3|||
48554495|NCT01074944|156220071|FG004|Long Term Treatment|Adverse Event|0|||
48554496|NCT01074944|156220067|FG000|Long Term Treatment|Lost to Follow-up|0|||
48554497|NCT01074944|156220068|FG001|Long Term Treatment|Lost to Follow-up|0|||
48554498|NCT01074944|156220069|FG002|Long Term Treatment|Lost to Follow-up|0|||
48554499|NCT01074944|156220070|FG003|Long Term Treatment|Lost to Follow-up|2|||
48554500|NCT01074944|156220071|FG004|Long Term Treatment|Lost to Follow-up|0|||
48554501|NCT01074944|156220067|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
48554502|NCT01074944|156220068|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
48554503|NCT01074944|156220069|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
48554504|NCT01074944|156220070|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
48554505|NCT01074944|156220071|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
48554506|NCT01074944|156220067|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
48554507|NCT01074944|156220068|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
48554508|NCT01074944|156220069|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
48554509|NCT01074944|156220070|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
48554510|NCT01074944|156220071|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
48554511|NCT01074944|156220067|FG000|Long Term Treatment|Withdrawal by Subject|0|||
48554512|NCT01074944|156220068|FG001|Long Term Treatment|Withdrawal by Subject|0|||
48554513|NCT01074944|156220069|FG002|Long Term Treatment|Withdrawal by Subject|0|||
48554514|NCT01074944|156220070|FG003|Long Term Treatment|Withdrawal by Subject|2|||
48554515|NCT01074944|156220071|FG004|Long Term Treatment|Withdrawal by Subject|0|||
48554516|NCT01074944|156220067|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
48554517|NCT01074944|156220068|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
48554518|NCT01074944|156220069|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
48554519|NCT01074944|156220070|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
48554520|NCT01074944|156220071|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
48554521|NCT01074944|156220067|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
48554522|NCT01074944|156220068|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
48554523|NCT01074944|156220069|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
48554524|NCT01074944|156220070|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
48554525|NCT01074944|156220071|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
48554526|NCT00852202|156220072|FG000|Overall Study|Adverse Event|2|||
48554527|NCT00852202|156220073|FG001|Overall Study|Adverse Event|3|||
48554528|NCT00852202|156220074|FG002|Overall Study|Adverse Event|7|||
48554529|NCT00852202|156220072|FG000|Overall Study|Lack of Efficacy|4|||
48554530|NCT00852202|156220073|FG001|Overall Study|Lack of Efficacy|1|||
48554531|NCT00852202|156220074|FG002|Overall Study|Lack of Efficacy|2|||
48614337|NCT03261401|156445517|FG000|Overall Study|Withdrawal by Subject|0|||
48614338|NCT03261401|156445518|FG001|Overall Study|Withdrawal by Subject|0|||
48614339|NCT03261401|156445519|FG002|Overall Study|Withdrawal by Subject|0|||
48614340|NCT03261401|156445520|FG003|Overall Study|Withdrawal by Subject|0|||
48614341|NCT03261401|156445521|FG004|Overall Study|Withdrawal by Subject|0|||
48614342|NCT03261401|156445522|FG005|Overall Study|Withdrawal by Subject|1|||
48614343|NCT03261401|156445523|FG006|Overall Study|Withdrawal by Subject|0|||
48614344|NCT03261401|156445524|FG007|Overall Study|Withdrawal by Subject|0|||
48614345|NCT03261401|156445525|FG008|Overall Study|Withdrawal by Subject|0|||
48614346|NCT03261401|156445526|FG009|Overall Study|Withdrawal by Subject|0|||
48554532|NCT00852202|156220072|FG000|Overall Study|Protocol Violation|2|||
48554533|NCT00852202|156220073|FG001|Overall Study|Protocol Violation|2|||
48554534|NCT00852202|156220074|FG002|Overall Study|Protocol Violation|7|||
48554535|NCT00852202|156220072|FG000|Overall Study|Withdrawal by Subject|3|||
48554536|NCT00852202|156220073|FG001|Overall Study|Withdrawal by Subject|1|||
48554537|NCT00852202|156220074|FG002|Overall Study|Withdrawal by Subject|2|||
48554538|NCT00852202|156220072|FG000|Overall Study|Lost to Follow-up|5|||
48554539|NCT00852202|156220073|FG001|Overall Study|Lost to Follow-up|5|||
48554540|NCT00852202|156220074|FG002|Overall Study|Lost to Follow-up|6|||
48554541|NCT00852202|156220072|FG000|Overall Study|pregnancy,moving away and surgery|1|||
48554542|NCT00852202|156220073|FG001|Overall Study|pregnancy,moving away and surgery|0|||
48554543|NCT00852202|156220074|FG002|Overall Study|pregnancy,moving away and surgery|2|||
48554544|NCT02348112|156220076|FG000|Overall Study|Withdrawal by Subject|32|||
48554545|NCT02348112|156220077|FG001|Overall Study|Withdrawal by Subject|29|||
48554546|NCT02348112|156220076|FG000|Overall Study|Lost to Follow-up|24|||
48554547|NCT02348112|156220077|FG001|Overall Study|Lost to Follow-up|20|||
48554548|NCT02348112|156220076|FG000|Overall Study|Physician Decision|17|||
48554549|NCT02348112|156220077|FG001|Overall Study|Physician Decision|15|||
48554550|NCT02348112|156220076|FG000|Overall Study|Site closed due to PI leaving|0|||
48554551|NCT02348112|156220077|FG001|Overall Study|Site closed due to PI leaving|30|||
48614347|NCT03261401|156445527|FG010|Overall Study|Withdrawal by Subject|0|||
48614348|NCT03261401|156445528|FG011|Overall Study|Withdrawal by Subject|0|||
48614349|NCT03261401|156445529|FG012|Overall Study|Withdrawal by Subject|0|||
48614350|NCT03261401|156445517|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
48614351|NCT03261401|156445518|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
48614352|NCT03261401|156445519|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
48554552|NCT02348112|156220076|FG000|Overall Study|Sponsor withdrawal|0|||
48554553|NCT02348112|156220077|FG001|Overall Study|Sponsor withdrawal|7|||
48554554|NCT02348112|156220076|FG000|Overall Study|Death|0|||
48554555|NCT02348112|156220077|FG001|Overall Study|Death|1|||
48554556|NCT01408043|156220079|FG000|Overall Study|unable to collect cells|1|||
48554557|NCT03200717|156220088|FG000|Overall Study|Progressive disease|24|||
48554558|NCT03200717|156220089|FG001|Overall Study|Progressive disease|5|||
48554559|NCT03200717|156220088|FG000|Overall Study|Adverse Event|11|||
48554560|NCT03200717|156220089|FG001|Overall Study|Adverse Event|8|||
48554561|NCT03200717|156220088|FG000|Overall Study|Physician Decision|3|||
48554562|NCT03200717|156220089|FG001|Overall Study|Physician Decision|2|||
48554563|NCT03200717|156220088|FG000|Overall Study|Death|2|||
48554564|NCT03200717|156220089|FG001|Overall Study|Death|0|||
48554565|NCT03200717|156220088|FG000|Overall Study|Subject/Guardian Decision|1|||
48554566|NCT03200717|156220089|FG001|Overall Study|Subject/Guardian Decision|0|||
48554567|NCT00972595|156220090|FG000|Period 1|Adverse Event|1|||
48554568|NCT00972595|156220091|FG001|Period 1|Adverse Event|0|||
48554569|NCT02552121|156220092|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
48554570|NCT02552121|156220093|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
48554571|NCT02552121|156220094|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
48554572|NCT02552121|156220095|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
48554573|NCT02552121|156220096|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
48554574|NCT02552121|156220097|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
48554575|NCT02552121|156220098|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
48554576|NCT02552121|156220099|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
48554577|NCT02552121|156220092|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
48554578|NCT02552121|156220093|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
48554579|NCT02552121|156220094|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
48554580|NCT02552121|156220095|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
48554581|NCT02552121|156220096|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
48554582|NCT02552121|156220097|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
48554583|NCT02552121|156220098|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
48554584|NCT02552121|156220099|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
48554585|NCT02552121|156220092|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
48554586|NCT02552121|156220093|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
48554587|NCT02552121|156220094|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
48554588|NCT02552121|156220095|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
48554589|NCT02552121|156220096|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
48554590|NCT02552121|156220097|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
48554591|NCT02552121|156220098|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
48554592|NCT02552121|156220099|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
48554593|NCT02552121|156220092|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
48554594|NCT02552121|156220093|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
48554595|NCT02552121|156220094|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
48614353|NCT03261401|156445520|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
48693063|NCT01400698|156724661|FG003|Overall Study|Adverse Event|0|||
48554596|NCT02552121|156220095|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
48554597|NCT02552121|156220096|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
48554598|NCT02552121|156220097|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
48554599|NCT02552121|156220098|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
48554600|NCT02552121|156220099|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
48554601|NCT02552121|156220092|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
48554602|NCT02552121|156220093|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
48554603|NCT02552121|156220094|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
48554604|NCT02552121|156220095|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
48554605|NCT02552121|156220096|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
48554606|NCT02552121|156220097|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
48554607|NCT02552121|156220098|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
48554608|NCT02552121|156220099|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
48554609|NCT02552121|156220092|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
48554610|NCT02552121|156220093|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
48554611|NCT02552121|156220094|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
48554612|NCT02552121|156220095|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
48554613|NCT02552121|156220096|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
48554614|NCT02552121|156220097|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
48554615|NCT02552121|156220098|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
48554616|NCT02552121|156220099|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
48554617|NCT02552121|156220092|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
48554618|NCT02552121|156220093|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
48554619|NCT02552121|156220094|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
48554620|NCT02552121|156220095|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
48554621|NCT02552121|156220096|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
48614354|NCT03261401|156445521|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
48614355|NCT03261401|156445522|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
48614356|NCT03261401|156445523|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
48614357|NCT03261401|156445524|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
48614358|NCT03261401|156445525|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
48554622|NCT02552121|156220097|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
48554623|NCT02552121|156220098|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
48554624|NCT02552121|156220099|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
48554625|NCT02552121|156220092|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
48554626|NCT02552121|156220093|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
48554627|NCT02552121|156220094|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
48554628|NCT02552121|156220095|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
48554629|NCT02552121|156220096|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
48554630|NCT02552121|156220097|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
48554631|NCT02552121|156220098|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
48554632|NCT02552121|156220099|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
48554633|NCT02552121|156220092|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
48554634|NCT02552121|156220093|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
48554635|NCT02552121|156220094|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
48554636|NCT02552121|156220095|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
48554637|NCT02552121|156220096|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
48554638|NCT02552121|156220097|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
48554639|NCT02552121|156220098|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
48554640|NCT02552121|156220099|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
48554641|NCT02552121|156220092|FG000|Part 2: Cohort Expansion|Death|0|||
48554642|NCT02552121|156220093|FG001|Part 2: Cohort Expansion|Death|0|||
48554643|NCT02552121|156220094|FG002|Part 2: Cohort Expansion|Death|1|||
48554644|NCT02552121|156220095|FG003|Part 2: Cohort Expansion|Death|0|||
48554645|NCT02552121|156220096|FG004|Part 2: Cohort Expansion|Death|0|||
48554646|NCT02552121|156220097|FG005|Part 2: Cohort Expansion|Death|0|||
48554647|NCT02552121|156220098|FG006|Part 2: Cohort Expansion|Death|0|||
48554648|NCT02552121|156220099|FG007|Part 2: Cohort Expansion|Death|0|||
48554649|NCT00786409|156220100|FG000|Overall Study|Withdrawal by Subject|2|||
48554650|NCT00786409|156220100|FG000|Overall Study|Adverse Event|2|||
48614359|NCT03261401|156445526|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
48614360|NCT03261401|156445527|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
48614361|NCT03261401|156445528|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
48614362|NCT03261401|156445529|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
48614363|NCT00970944|156445530|FG000|Overall Study|Death|1|||
48614364|NCT00970944|156445531|FG001|Overall Study|Death|0|||
48554651|NCT00786409|156220100|FG000|Overall Study|Pregnancy|2|||
48614365|NCT00970944|156445530|FG000|Overall Study|Physician Decision|0|||
48614366|NCT00970944|156445531|FG001|Overall Study|Physician Decision|2|||
48554652|NCT00786409|156220100|FG000|Overall Study|Lost to Follow-up|1|||
48554653|NCT00699998|156220101|FG000|Overall Study|Withdrawal by Subject|194|||
48554654|NCT00699998|156220102|FG001|Overall Study|Withdrawal by Subject|83|||
48554655|NCT00699998|156220103|FG002|Overall Study|Withdrawal by Subject|202|||
48554656|NCT00699998|156220104|FG003|Overall Study|Withdrawal by Subject|80|||
48554657|NCT00699998|156220101|FG000|Overall Study|Physician Decision|3|||
48554658|NCT00699998|156220102|FG001|Overall Study|Physician Decision|2|||
48554659|NCT00699998|156220103|FG002|Overall Study|Physician Decision|1|||
48554660|NCT00699998|156220104|FG003|Overall Study|Physician Decision|1|||
48554661|NCT00699998|156220101|FG000|Overall Study|Lost to Follow-up|2|||
48554662|NCT00699998|156220102|FG001|Overall Study|Lost to Follow-up|1|||
48554663|NCT00699998|156220103|FG002|Overall Study|Lost to Follow-up|3|||
48554664|NCT00699998|156220104|FG003|Overall Study|Lost to Follow-up|1|||
48554665|NCT05478252|156220105|FG000|Overall Study|Withdrawal by Subject|2|||
48554666|NCT05478252|156220106|FG001|Overall Study|Withdrawal by Subject|3|||
48554667|NCT05478252|156220105|FG000|Overall Study|Lost to Follow-up|4|||
48614367|NCT02008370|156445532|FG000|Overall Study|Lost to Follow-up|7|||
48614368|NCT00662259|156445533|FG000|Overall Study|Adverse Event|2|||
48614369|NCT00662259|156445534|FG001|Overall Study|Adverse Event|0|||
48614370|NCT02394275|156445538|FG000|Overall Study|Adverse Event|22|||
48614371|NCT02394275|156445538|FG000|Overall Study|Lost to Follow-up|7|||
48614372|NCT01499511|156445539|FG000|Overall Study|Death|1|||
48614373|NCT01499511|156445540|FG001|Overall Study|Death|0|||
48614374|NCT00998946|156445541|FG000|Overall Study|Lost to Follow-up|1|||
48614375|NCT00998946|156445541|FG000|Overall Study|Withdrawal by Subject|1|||
48614376|NCT00998946|156445541|FG000|Overall Study|Death|2|||
48614377|NCT00998946|156445541|FG000|Overall Study|Reason Unspecified|3|||
48554668|NCT05478252|156220106|FG001|Overall Study|Lost to Follow-up|2|||
48554669|NCT05478252|156220105|FG000|Overall Study|Physician Decision|1|||
48554670|NCT05478252|156220106|FG001|Overall Study|Physician Decision|1|||
48554671|NCT05478252|156220105|FG000|Overall Study|Death|1|||
48554672|NCT05478252|156220106|FG001|Overall Study|Death|0|||
48554673|NCT00378573|156222431|FG000|Treatment Period|Adverse Event|9|||
48554674|NCT00378573|156222431|FG000|Treatment Period|Physician Decision|1|||
48554675|NCT00378573|156222431|FG000|Treatment Period|Withdrawal by Subject|2|||
48554676|NCT00378573|156222431|FG000|Treatment Period|Disease Progression|4|||
48554677|NCT00378573|156222431|FG000|Treatment Period|Sponsor decision to close study|1|||
48554678|NCT00378573|156222431|FG000|Follow-up|Death|12|||
48554679|NCT00378573|156222431|FG000|Follow-up|Lost to Follow-up|1|||
48554680|NCT00378573|156222431|FG000|Follow-up|Withdrawal by Subject|1|||
48554681|NCT00196326|156222433|FG000|Overall Study|Did not meet protocol requirements|64|||
48554682|NCT00196326|156222433|FG000|Overall Study|Non-compliance with the protocol|81|||
48554683|NCT00196326|156222433|FG000|Overall Study|Physician Decision|3|||
48554684|NCT00196326|156222433|FG000|Overall Study|Withdrawal by Subject|225|||
48554685|NCT00196326|156222433|FG000|Overall Study|Adverse Event|253|||
48554686|NCT00196326|156222433|FG000|Overall Study|Pregnancy|34|||
48554687|NCT00196326|156222433|FG000|Overall Study|Lost to Follow-up|304|||
48554688|NCT00196326|156222433|FG000|Overall Study|Other|22|||
48554689|NCT00741338|156222434|FG000|Overall Study|Adverse Event|0|||
48554690|NCT00741338|156222435|FG001|Overall Study|Adverse Event|1|||
48554691|NCT02892149|156222451|FG000|Overall Study|Death|262|||
48554692|NCT02892149|156222452|FG001|Overall Study|Death|278|||
48554693|NCT02892149|156222451|FG000|Overall Study|Withdrawal by Subject|53|||
48554694|NCT02892149|156222452|FG001|Overall Study|Withdrawal by Subject|47|||
48554695|NCT02892149|156222451|FG000|Overall Study|Lost to Follow-up|37|||
48614378|NCT00998946|156445541|FG000|Overall Study|Enrolled but not Dosed|2|||
48614379|NCT03915067|156445542|FG000|Overall Study|Adverse Event|0|||
48614380|NCT03915067|156445543|FG001|Overall Study|Adverse Event|0|||
48614381|NCT03915067|156445544|FG002|Overall Study|Adverse Event|1|||
48614382|NCT03915067|156445542|FG000|Overall Study|Withdrawal by Subject|4|||
48614383|NCT03915067|156445543|FG001|Overall Study|Withdrawal by Subject|3|||
48554696|NCT02892149|156222452|FG001|Overall Study|Lost to Follow-up|31|||
48554697|NCT01098474|156222457|FG000|Active Phase|Other|0|||
48554698|NCT01098474|156222458|FG001|Active Phase|Other|0|||
48554699|NCT01098474|156222459|FG002|Active Phase|Other|3|||
48554700|NCT01098474|156222460|FG003|Active Phase|Other|0|||
48554701|NCT01098474|156222461|FG004|Active Phase|Other|0|||
48554702|NCT01098474|156222462|FG005|Active Phase|Other|0|||
48554703|NCT01098474|156222457|FG000|Active Phase|Withdrawal by Subject|1|||
48554704|NCT01098474|156222458|FG001|Active Phase|Withdrawal by Subject|1|||
48554705|NCT01098474|156222459|FG002|Active Phase|Withdrawal by Subject|2|||
48614384|NCT03915067|156445544|FG002|Overall Study|Withdrawal by Subject|0|||
48614385|NCT03915067|156445542|FG000|Overall Study|Lost to Follow-up|3|||
48554706|NCT01098474|156222460|FG003|Active Phase|Withdrawal by Subject|0|||
48554707|NCT01098474|156222461|FG004|Active Phase|Withdrawal by Subject|0|||
48554708|NCT01098474|156222462|FG005|Active Phase|Withdrawal by Subject|0|||
48554709|NCT01098474|156222457|FG000|Active Phase|Lost to Follow-up|1|||
48614386|NCT03915067|156445543|FG001|Overall Study|Lost to Follow-up|2|||
48614387|NCT03915067|156445544|FG002|Overall Study|Lost to Follow-up|0|||
48614388|NCT03915067|156445542|FG000|Overall Study|Protocol Deviation|0|||
48554710|NCT01098474|156222458|FG001|Active Phase|Lost to Follow-up|0|||
48614389|NCT03915067|156445543|FG001|Overall Study|Protocol Deviation|0|||
48614390|NCT03915067|156445544|FG002|Overall Study|Protocol Deviation|1|||
48614391|NCT03915067|156445542|FG000|Overall Study|Covid-19 Related Issues|2|||
48614392|NCT03915067|156445543|FG001|Overall Study|Covid-19 Related Issues|4|||
48614393|NCT03915067|156445544|FG002|Overall Study|Covid-19 Related Issues|4|||
48614394|NCT03915067|156445542|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
48614395|NCT03915067|156445543|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
48614396|NCT03915067|156445544|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
48614397|NCT03317496|156445546|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
48614398|NCT03317496|156445547|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
48614399|NCT03317496|156445548|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
48614400|NCT03317496|156445549|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
48614401|NCT03317496|156445550|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
48614402|NCT03317496|156445546|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
48614403|NCT03317496|156445547|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
48614404|NCT03317496|156445548|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
48614405|NCT03317496|156445549|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
48614406|NCT03317496|156445550|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
48614407|NCT03317496|156445546|FG000|Phase 1b Lead-in: Treatment|Death|0|||
48614408|NCT03317496|156445547|FG001|Phase 1b Lead-in: Treatment|Death|0|||
48614409|NCT03317496|156445548|FG002|Phase 1b Lead-in: Treatment|Death|1|||
48614410|NCT03317496|156445549|FG003|Phase 1b Lead-in: Treatment|Death|0|||
48614411|NCT03317496|156445550|FG004|Phase 1b Lead-in: Treatment|Death|0|||
48614412|NCT03317496|156445546|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
48614413|NCT03317496|156445547|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
48614414|NCT03317496|156445548|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
48614415|NCT03317496|156445549|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
48614416|NCT03317496|156445550|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
48614417|NCT03317496|156445546|FG000|Phase 1b Lead-in: Treatment|Other|2|||
48614418|NCT03317496|156445547|FG001|Phase 1b Lead-in: Treatment|Other|1|||
48614419|NCT03317496|156445548|FG002|Phase 1b Lead-in: Treatment|Other|0|||
48614420|NCT03317496|156445549|FG003|Phase 1b Lead-in: Treatment|Other|0|||
48614421|NCT03317496|156445550|FG004|Phase 1b Lead-in: Treatment|Other|0|||
48554711|NCT01098474|156222459|FG002|Active Phase|Lost to Follow-up|0|||
48554712|NCT01098474|156222460|FG003|Active Phase|Lost to Follow-up|0|||
48554713|NCT01098474|156222461|FG004|Active Phase|Lost to Follow-up|0|||
48554714|NCT01098474|156222462|FG005|Active Phase|Lost to Follow-up|0|||
48554715|NCT01098474|156222457|FG000|Follow Up Phase|Travelled out of study area|0|||
48554716|NCT01098474|156222458|FG001|Follow Up Phase|Travelled out of study area|0|||
48554717|NCT01098474|156222459|FG002|Follow Up Phase|Travelled out of study area|0|||
48554718|NCT01098474|156222460|FG003|Follow Up Phase|Travelled out of study area|0|||
48554719|NCT01098474|156222461|FG004|Follow Up Phase|Travelled out of study area|1|||
48554720|NCT01098474|156222462|FG005|Follow Up Phase|Travelled out of study area|0|||
48554721|NCT01098474|156222457|FG000|Follow Up Phase|Other|0|||
48554722|NCT01098474|156222458|FG001|Follow Up Phase|Other|0|||
48554723|NCT01098474|156222459|FG002|Follow Up Phase|Other|0|||
48614422|NCT03317496|156445546|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
48614423|NCT03317496|156445547|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
48614424|NCT03317496|156445548|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
48614425|NCT03317496|156445549|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
48614426|NCT03317496|156445550|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
48614427|NCT03317496|156445546|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
48614428|NCT03317496|156445547|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
48614429|NCT03317496|156445548|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
48614430|NCT03317496|156445549|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
48614431|NCT03317496|156445550|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
48614432|NCT03317496|156445546|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
48614433|NCT03317496|156445547|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
48614434|NCT03317496|156445548|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
48614435|NCT03317496|156445549|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
48614436|NCT03317496|156445550|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
48614437|NCT03317496|156445546|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
48614438|NCT03317496|156445547|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
48614439|NCT03317496|156445548|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
48614440|NCT03317496|156445549|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
48614441|NCT03317496|156445550|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
48614442|NCT03317496|156445546|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
48614443|NCT03317496|156445547|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
48614444|NCT03317496|156445548|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
48614445|NCT03317496|156445549|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
48614446|NCT03317496|156445550|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
48614447|NCT03317496|156445546|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
48554724|NCT01098474|156222460|FG003|Follow Up Phase|Other|0|||
48554725|NCT01098474|156222461|FG004|Follow Up Phase|Other|0|||
48554726|NCT01098474|156222462|FG005|Follow Up Phase|Other|4|||
48554727|NCT01098474|156222457|FG000|Follow Up Phase|Withdrawal by Subject|0|||
48554728|NCT01098474|156222458|FG001|Follow Up Phase|Withdrawal by Subject|0|||
48554729|NCT01098474|156222459|FG002|Follow Up Phase|Withdrawal by Subject|0|||
48554730|NCT01098474|156222460|FG003|Follow Up Phase|Withdrawal by Subject|2|||
48554731|NCT01098474|156222461|FG004|Follow Up Phase|Withdrawal by Subject|0|||
48554732|NCT01098474|156222462|FG005|Follow Up Phase|Withdrawal by Subject|1|||
48554733|NCT01098474|156222457|FG000|Follow Up Phase|Lost to Follow-up|0|||
48554734|NCT01098474|156222458|FG001|Follow Up Phase|Lost to Follow-up|0|||
48554735|NCT01098474|156222459|FG002|Follow Up Phase|Lost to Follow-up|0|||
48554736|NCT01098474|156222460|FG003|Follow Up Phase|Lost to Follow-up|0|||
48554737|NCT01098474|156222461|FG004|Follow Up Phase|Lost to Follow-up|1|||
48554738|NCT01098474|156222462|FG005|Follow Up Phase|Lost to Follow-up|0|||
48554739|NCT02797171|156222468|FG000|Overall Study|Lost to Follow-up|2|||
48554740|NCT02797171|156222469|FG001|Overall Study|Lost to Follow-up|0|||
48554741|NCT02797171|156222470|FG002|Overall Study|Lost to Follow-up|2|||
48554742|NCT02797171|156222471|FG003|Overall Study|Lost to Follow-up|1|||
48554743|NCT02797171|156222472|FG004|Overall Study|Lost to Follow-up|2|||
48554744|NCT02797171|156222473|FG005|Overall Study|Lost to Follow-up|0|||
48554745|NCT02797171|156222468|FG000|Overall Study|Withdrawal by Subject|1|||
48554746|NCT02797171|156222469|FG001|Overall Study|Withdrawal by Subject|1|||
48554747|NCT02797171|156222470|FG002|Overall Study|Withdrawal by Subject|0|||
48554748|NCT02797171|156222471|FG003|Overall Study|Withdrawal by Subject|0|||
48554749|NCT02797171|156222472|FG004|Overall Study|Withdrawal by Subject|0|||
48554750|NCT02797171|156222473|FG005|Overall Study|Withdrawal by Subject|0|||
48554751|NCT02797171|156222468|FG000|Overall Study|Protocol Violation|1|||
48554752|NCT02797171|156222469|FG001|Overall Study|Protocol Violation|0|||
48614448|NCT03317496|156445547|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
48614449|NCT03317496|156445548|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
48614450|NCT03317496|156445549|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
48614451|NCT03317496|156445550|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
48614452|NCT03317496|156445546|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
48614453|NCT03317496|156445547|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
48614454|NCT03317496|156445548|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
48614455|NCT03317496|156445549|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
48614456|NCT03317496|156445550|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
48614457|NCT03317496|156445546|FG000|Phase 2: Treatment|Adverse Event|0|||
48614458|NCT03317496|156445547|FG001|Phase 2: Treatment|Adverse Event|0|||
48614459|NCT03317496|156445548|FG002|Phase 2: Treatment|Adverse Event|0|||
48614460|NCT03317496|156445549|FG003|Phase 2: Treatment|Adverse Event|0|||
48614461|NCT03317496|156445550|FG004|Phase 2: Treatment|Adverse Event|6|||
48614462|NCT03317496|156445546|FG000|Phase 2: Treatment|Progressive disease|0|||
48614463|NCT03317496|156445547|FG001|Phase 2: Treatment|Progressive disease|0|||
48614464|NCT03317496|156445548|FG002|Phase 2: Treatment|Progressive disease|0|||
48614465|NCT03317496|156445549|FG003|Phase 2: Treatment|Progressive disease|0|||
48614466|NCT03317496|156445550|FG004|Phase 2: Treatment|Progressive disease|22|||
48614467|NCT03317496|156445546|FG000|Phase 2: Treatment|Other|0|||
48614468|NCT03317496|156445547|FG001|Phase 2: Treatment|Other|0|||
48614469|NCT03317496|156445548|FG002|Phase 2: Treatment|Other|0|||
48614470|NCT03317496|156445549|FG003|Phase 2: Treatment|Other|0|||
48614471|NCT03317496|156445550|FG004|Phase 2: Treatment|Other|4|||
48614472|NCT03317496|156445546|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
48614473|NCT03317496|156445547|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
48614474|NCT03317496|156445548|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
48614475|NCT03317496|156445549|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
48614476|NCT03317496|156445550|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
48614477|NCT03317496|156445546|FG000|Phase 2: Treatment|Physician Decision|0|||
48614478|NCT03317496|156445547|FG001|Phase 2: Treatment|Physician Decision|0|||
48614479|NCT03317496|156445548|FG002|Phase 2: Treatment|Physician Decision|0|||
48614480|NCT03317496|156445549|FG003|Phase 2: Treatment|Physician Decision|0|||
48614481|NCT03317496|156445550|FG004|Phase 2: Treatment|Physician Decision|1|||
48614482|NCT03317496|156445546|FG000|Phase 2: Treatment|Death|0|||
48614483|NCT03317496|156445547|FG001|Phase 2: Treatment|Death|0|||
48614484|NCT03317496|156445548|FG002|Phase 2: Treatment|Death|0|||
48614485|NCT03317496|156445549|FG003|Phase 2: Treatment|Death|0|||
48614486|NCT03317496|156445550|FG004|Phase 2: Treatment|Death|1|||
48614487|NCT03317496|156445546|FG000|Phase 2: Follow-up|Death|0|||
48614488|NCT03317496|156445547|FG001|Phase 2: Follow-up|Death|0|||
48614489|NCT03317496|156445548|FG002|Phase 2: Follow-up|Death|0|||
48614490|NCT03317496|156445549|FG003|Phase 2: Follow-up|Death|0|||
48614491|NCT03317496|156445550|FG004|Phase 2: Follow-up|Death|24|||
48554753|NCT02797171|156222470|FG002|Overall Study|Protocol Violation|0|||
48554754|NCT02797171|156222471|FG003|Overall Study|Protocol Violation|0|||
48554755|NCT02797171|156222472|FG004|Overall Study|Protocol Violation|0|||
48554756|NCT02797171|156222473|FG005|Overall Study|Protocol Violation|0|||
48554757|NCT02797171|156222468|FG000|Overall Study|Participant unable to adhere|0|||
48554758|NCT02797171|156222469|FG001|Overall Study|Participant unable to adhere|1|||
48554759|NCT02797171|156222470|FG002|Overall Study|Participant unable to adhere|0|||
48614492|NCT03317496|156445546|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
48614493|NCT03317496|156445547|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
48614494|NCT03317496|156445548|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
48614495|NCT03317496|156445549|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
48614496|NCT03317496|156445550|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
48614497|NCT03317496|156445546|FG000|Phase 2: Follow-up|Other|0|||
48614498|NCT03317496|156445547|FG001|Phase 2: Follow-up|Other|0|||
48614499|NCT03317496|156445548|FG002|Phase 2: Follow-up|Other|0|||
48614500|NCT03317496|156445549|FG003|Phase 2: Follow-up|Other|0|||
48614501|NCT03317496|156445550|FG004|Phase 2: Follow-up|Other|1|||
48614502|NCT03317496|156445546|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
48614503|NCT03317496|156445547|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
48614504|NCT03317496|156445548|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
48614505|NCT03317496|156445549|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
48614506|NCT03317496|156445550|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
48614507|NCT00316004|156445551|FG000|Overall Study|Subject was not given study fluid.|14|||
48614508|NCT00316004|156445552|FG001|Overall Study|Subject was not given study fluid.|14|||
48614509|NCT00316004|156445553|FG002|Overall Study|Subject was not given study fluid.|21|||
48614510|NCT01750346|156445555|FG000|Overall Study|Adverse Event|1|||
48614511|NCT01750346|156445556|FG001|Overall Study|Adverse Event|0|||
48614512|NCT01750346|156445557|FG002|Overall Study|Adverse Event|0|||
48614513|NCT00784875|156445558|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
48614514|NCT00784875|156445559|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
48614515|NCT00784875|156445560|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
48614516|NCT00784875|156445561|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
48614517|NCT00784875|156445558|FG000|Period A - Baseline|Adverse Event|0|||
48614518|NCT00784875|156445559|FG001|Period A - Baseline|Adverse Event|0|||
48614519|NCT00784875|156445560|FG002|Period A - Baseline|Adverse Event|0|||
48614520|NCT00784875|156445561|FG003|Period A - Baseline|Adverse Event|8|||
48614521|NCT00784875|156445558|FG000|Period A - Baseline|Protocol Violation|0|||
48614522|NCT00784875|156445559|FG001|Period A - Baseline|Protocol Violation|0|||
48614523|NCT00784875|156445560|FG002|Period A - Baseline|Protocol Violation|0|||
48614524|NCT00784875|156445561|FG003|Period A - Baseline|Protocol Violation|25|||
48614525|NCT00784875|156445558|FG000|Period A - Baseline|Withdrawal by Subject|0|||
48614526|NCT00784875|156445559|FG001|Period A - Baseline|Withdrawal by Subject|0|||
48614527|NCT00784875|156445560|FG002|Period A - Baseline|Withdrawal by Subject|0|||
48614528|NCT00784875|156445561|FG003|Period A - Baseline|Withdrawal by Subject|27|||
48614529|NCT00784875|156445558|FG000|Period A - Baseline|Physician Decision|0|||
48614530|NCT00784875|156445559|FG001|Period A - Baseline|Physician Decision|0|||
48614531|NCT00784875|156445560|FG002|Period A - Baseline|Physician Decision|0|||
48614532|NCT00784875|156445561|FG003|Period A - Baseline|Physician Decision|2|||
48614533|NCT00784875|156445558|FG000|Period A - Baseline|Sponsor Decision|0|||
48614534|NCT00784875|156445559|FG001|Period A - Baseline|Sponsor Decision|0|||
48614535|NCT00784875|156445560|FG002|Period A - Baseline|Sponsor Decision|0|||
48614536|NCT00784875|156445561|FG003|Period A - Baseline|Sponsor Decision|113|||
48614537|NCT00784875|156445558|FG000|Period A - Baseline|Lost to Follow-up|0|||
48614538|NCT00784875|156445559|FG001|Period A - Baseline|Lost to Follow-up|0|||
48614539|NCT00784875|156445560|FG002|Period A - Baseline|Lost to Follow-up|0|||
48614540|NCT00784875|156445561|FG003|Period A - Baseline|Lost to Follow-up|2|||
48614541|NCT00784875|156445558|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
48614542|NCT00784875|156445559|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
48614543|NCT00784875|156445560|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
48614544|NCT00784875|156445561|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
48614545|NCT00784875|156445558|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
48614546|NCT00784875|156445559|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
48614547|NCT00784875|156445560|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
48614548|NCT00784875|156445561|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
48614549|NCT00784875|156445558|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
48614550|NCT00784875|156445559|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
48614551|NCT00784875|156445560|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
48614552|NCT00784875|156445561|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
48614553|NCT00784875|156445558|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
48614554|NCT00784875|156445559|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
48614555|NCT00784875|156445560|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
48614556|NCT00784875|156445561|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
48614557|NCT00784875|156445558|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
48614558|NCT00784875|156445559|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
48614559|NCT00784875|156445560|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
48614560|NCT00784875|156445561|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
48614561|NCT00784875|156445558|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
48614562|NCT00784875|156445559|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
48614563|NCT00784875|156445560|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
48614564|NCT00784875|156445561|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
48614565|NCT00784875|156445558|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
48614566|NCT00784875|156445559|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
48614567|NCT00784875|156445560|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
48614568|NCT00784875|156445561|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
48614569|NCT00784875|156445558|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
48614570|NCT00784875|156445559|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
48614571|NCT00784875|156445560|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
48614572|NCT00784875|156445561|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
48614573|NCT00784875|156445558|FG000|Period C|Adverse Event|1|||
48614574|NCT00784875|156445559|FG001|Period C|Adverse Event|0|||
48614575|NCT00784875|156445560|FG002|Period C|Adverse Event|4|||
48614576|NCT00784875|156445561|FG003|Period C|Adverse Event|2|||
48614577|NCT00784875|156445558|FG000|Period C|Protocol Violation|0|||
48614578|NCT00784875|156445559|FG001|Period C|Protocol Violation|0|||
48614579|NCT00784875|156445560|FG002|Period C|Protocol Violation|1|||
48614580|NCT00784875|156445561|FG003|Period C|Protocol Violation|2|||
48614581|NCT00784875|156445558|FG000|Period C|Lack of Efficacy|0|||
48614582|NCT00784875|156445559|FG001|Period C|Lack of Efficacy|0|||
48614583|NCT00784875|156445560|FG002|Period C|Lack of Efficacy|1|||
48614584|NCT00784875|156445561|FG003|Period C|Lack of Efficacy|0|||
48614585|NCT00784875|156445558|FG000|Period C|Withdrawal by Subject|1|||
48614586|NCT00784875|156445559|FG001|Period C|Withdrawal by Subject|1|||
48614587|NCT00784875|156445560|FG002|Period C|Withdrawal by Subject|2|||
48614588|NCT00784875|156445561|FG003|Period C|Withdrawal by Subject|0|||
48614589|NCT00784875|156445558|FG000|Period C|Physician Decision|0|||
48614590|NCT00784875|156445559|FG001|Period C|Physician Decision|0|||
48614591|NCT00784875|156445560|FG002|Period C|Physician Decision|1|||
48614592|NCT00784875|156445561|FG003|Period C|Physician Decision|1|||
48614593|NCT00784875|156445558|FG000|Period C|Sponsor Decision|5|||
48614594|NCT00784875|156445559|FG001|Period C|Sponsor Decision|5|||
48614595|NCT00784875|156445560|FG002|Period C|Sponsor Decision|4|||
48614596|NCT00784875|156445561|FG003|Period C|Sponsor Decision|2|||
48614597|NCT00784875|156445558|FG000|Period D|Adverse Event|0|||
48614598|NCT00784875|156445559|FG001|Period D|Adverse Event|2|||
48614599|NCT00784875|156445560|FG002|Period D|Adverse Event|2|||
48614600|NCT00784875|156445561|FG003|Period D|Adverse Event|0|||
48614601|NCT00784875|156445558|FG000|Period D|Protocol Violation|1|||
48614602|NCT00784875|156445559|FG001|Period D|Protocol Violation|0|||
48614603|NCT00784875|156445560|FG002|Period D|Protocol Violation|0|||
48614604|NCT00784875|156445561|FG003|Period D|Protocol Violation|0|||
48614605|NCT00784875|156445558|FG000|Period D|Withdrawal by Subject|2|||
48614606|NCT00784875|156445559|FG001|Period D|Withdrawal by Subject|0|||
48614607|NCT00784875|156445560|FG002|Period D|Withdrawal by Subject|2|||
48614608|NCT00784875|156445561|FG003|Period D|Withdrawal by Subject|0|||
48614609|NCT00784875|156445558|FG000|Period D|Physician Decision|0|||
48614610|NCT00784875|156445559|FG001|Period D|Physician Decision|1|||
48614611|NCT00784875|156445560|FG002|Period D|Physician Decision|0|||
48614612|NCT00784875|156445561|FG003|Period D|Physician Decision|0|||
48614613|NCT00784875|156445558|FG000|Period D|Sponsor Decision|1|||
48614614|NCT00784875|156445559|FG001|Period D|Sponsor Decision|1|||
48614615|NCT00784875|156445560|FG002|Period D|Sponsor Decision|1|||
48614616|NCT00784875|156445561|FG003|Period D|Sponsor Decision|0|||
48614617|NCT00784875|156445558|FG000|Period D|Lost to Follow-up|1|||
48614618|NCT00784875|156445559|FG001|Period D|Lost to Follow-up|0|||
48614619|NCT00784875|156445560|FG002|Period D|Lost to Follow-up|1|||
48614620|NCT00784875|156445561|FG003|Period D|Lost to Follow-up|1|||
48614621|NCT02782468|156445562|FG000|Overall Study|Progressive Disease|2|||
48614622|NCT02782468|156445563|FG001|Overall Study|Progressive Disease|5|||
48614623|NCT02782468|156445564|FG002|Overall Study|Progressive Disease|0|||
48614624|NCT02782468|156445565|FG003|Overall Study|Progressive Disease|4|||
48614625|NCT02782468|156445562|FG000|Overall Study|Adverse Event|0|||
48614626|NCT02782468|156445563|FG001|Overall Study|Adverse Event|2|||
48614627|NCT02782468|156445564|FG002|Overall Study|Adverse Event|2|||
48554760|NCT02797171|156222471|FG003|Overall Study|Participant unable to adhere|0|||
48554761|NCT02797171|156222472|FG004|Overall Study|Participant unable to adhere|0|||
48554762|NCT02797171|156222473|FG005|Overall Study|Participant unable to adhere|0|||
48554763|NCT02797171|156222468|FG000|Overall Study|Not Randomized|0|||
48554764|NCT02797171|156222469|FG001|Overall Study|Not Randomized|0|||
48554765|NCT02797171|156222470|FG002|Overall Study|Not Randomized|0|||
48554766|NCT02797171|156222471|FG003|Overall Study|Not Randomized|0|||
48554767|NCT02797171|156222472|FG004|Overall Study|Not Randomized|0|||
48554768|NCT02797171|156222473|FG005|Overall Study|Not Randomized|1|||
48554769|NCT00595309|156222474|FG000|Overall Study|Lost to Follow-up|1|||
48554770|NCT00595309|156222474|FG000|Overall Study|planned vaccination against yellow fever|1|||
48554771|NCT00595309|156222474|FG000|Overall Study|acute infection after V0|1|||
48554772|NCT00595309|156222474|FG000|Overall Study|personal reason|1|||
48554773|NCT02540083|156222475|FG000|Overall Study|Withdrawal by Subject|16|||
48554774|NCT00101283|156222476|FG000|Overall Study|Withdrawal by Subject|0|||
48554775|NCT00101283|156222477|FG001|Overall Study|Withdrawal by Subject|1|||
48554776|NCT00101283|156222476|FG000|Overall Study|Insurance Refusal|0|||
48554777|NCT00101283|156222477|FG001|Overall Study|Insurance Refusal|1|||
48554778|NCT00101283|156222476|FG000|Overall Study|Prostate Cancer Recurrence|0|||
48554779|NCT00101283|156222477|FG001|Overall Study|Prostate Cancer Recurrence|1|||
48554780|NCT00626561|156222478|FG000|Overall Study|Withdrawal by Subject|2|||
48554781|NCT00626561|156222478|FG000|Overall Study|Disease Progression|2|||
48554782|NCT01720225|156222489|FG000|Overall Study|Withdrawal by Subject|0|||
48554783|NCT01720225|156222490|FG001|Overall Study|Withdrawal by Subject|1|||
48554784|NCT01720225|156222489|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
48554785|NCT01720225|156222490|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
48554786|NCT01372748|156222491|FG000|Overall Study|Lost to Follow-up|16|||
48554787|NCT01372748|156222492|FG001|Overall Study|Lost to Follow-up|34|||
48554788|NCT01372748|156222491|FG000|Overall Study|Withdrawal by Subject|7|||
48554789|NCT01372748|156222492|FG001|Overall Study|Withdrawal by Subject|5|||
48554790|NCT01473407|156222493|FG000|Overall Study|Physician Decision|1|||
48554791|NCT01473407|156222494|FG001|Overall Study|Physician Decision|4|||
48554792|NCT01473407|156222493|FG000|Overall Study|Lost to Follow-up|10|||
48554793|NCT01473407|156222494|FG001|Overall Study|Lost to Follow-up|4|||
48554794|NCT01473407|156222493|FG000|Overall Study|Adverse Event|8|||
48554795|NCT01473407|156222494|FG001|Overall Study|Adverse Event|8|||
48554796|NCT01473407|156222493|FG000|Overall Study|Randomization Error|3|||
48554797|NCT01473407|156222494|FG001|Overall Study|Randomization Error|1|||
48554798|NCT01473407|156222493|FG000|Overall Study|Withdrawal by Subject|4|||
48554799|NCT01473407|156222494|FG001|Overall Study|Withdrawal by Subject|7|||
48554800|NCT01473407|156222493|FG000|Overall Study|Kidney Transplant|7|||
48554801|NCT01473407|156222494|FG001|Overall Study|Kidney Transplant|6|||
48554802|NCT01473407|156222493|FG000|Overall Study|Vacation/Travel|1|||
48554803|NCT01473407|156222494|FG001|Overall Study|Vacation/Travel|1|||
48554804|NCT01473407|156222493|FG000|Overall Study|Elevated Hemoglobin|1|||
48554805|NCT01473407|156222494|FG001|Overall Study|Elevated Hemoglobin|0|||
48554806|NCT01473407|156222493|FG000|Overall Study|Patient Received Aranesp|1|||
48554807|NCT01473407|156222494|FG001|Overall Study|Patient Received Aranesp|0|||
48554808|NCT01473407|156222493|FG000|Overall Study|Patient Lost Green Card Status|1|||
48554809|NCT01473407|156222494|FG001|Overall Study|Patient Lost Green Card Status|0|||
48554810|NCT01473407|156222493|FG000|Overall Study|Temperature Excursion|2|||
48554811|NCT01473407|156222494|FG001|Overall Study|Temperature Excursion|3|||
48554812|NCT01473407|156222493|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
48554813|NCT01473407|156222494|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
48554814|NCT01473407|156222493|FG000|Overall Study|Sponsor's Decision|10|||
48554815|NCT01473407|156222494|FG001|Overall Study|Sponsor's Decision|10|||
48554816|NCT01473407|156222493|FG000|Overall Study|Site Closure|1|||
48554817|NCT01473407|156222494|FG001|Overall Study|Site Closure|0|||
48554818|NCT02422797|156222495|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
48554819|NCT02422797|156222496|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
48554820|NCT02422797|156222495|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
48554821|NCT02422797|156222496|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
48554822|NCT02422797|156222495|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
48554823|NCT02422797|156222496|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
48554824|NCT02422797|156222495|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
48554825|NCT02422797|156222496|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
48554826|NCT02422797|156222495|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
48554827|NCT02422797|156222496|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
48554828|NCT02422797|156222495|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
48554829|NCT02422797|156222496|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
48554830|NCT02422797|156222495|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
48554831|NCT02422797|156222496|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
48554832|NCT02422797|156222495|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
48554833|NCT02422797|156222496|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
48554834|NCT02422797|156222495|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
48554835|NCT02422797|156222496|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
48554836|NCT02422797|156222495|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
48614628|NCT02782468|156445565|FG003|Overall Study|Adverse Event|3|||
48614629|NCT02782468|156445562|FG000|Overall Study|Other|0|||
48614630|NCT02782468|156445563|FG001|Overall Study|Other|0|||
48614631|NCT02782468|156445564|FG002|Overall Study|Other|1|||
48614632|NCT02782468|156445565|FG003|Overall Study|Other|1|||
48614633|NCT02782468|156445562|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
48554837|NCT02422797|156222496|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
48554838|NCT02422797|156222495|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
48554839|NCT02422797|156222496|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
48554840|NCT02422797|156222495|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
48554841|NCT02422797|156222496|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
48554842|NCT02422797|156222495|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
48554843|NCT02422797|156222496|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
48554844|NCT02422797|156222495|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
48554845|NCT02422797|156222496|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
48554846|NCT02422797|156222495|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
48554847|NCT02422797|156222496|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
48554848|NCT02422797|156222495|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
48554849|NCT02422797|156222496|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
48554850|NCT02422797|156222495|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
48554851|NCT02422797|156222496|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
48554852|NCT02422797|156222495|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
48554853|NCT02422797|156222496|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
48554854|NCT02422797|156222495|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
48554855|NCT02422797|156222496|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
48554856|NCT02422797|156222495|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
48554857|NCT02422797|156222496|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
48554858|NCT02422797|156222495|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
48554859|NCT02422797|156222496|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
48554860|NCT04071405|156222497|FG000|Overall Study|Protocol Violation|3|||
48554861|NCT00134901|156222498|FG000|Overall Study|Lost to Follow-up|5|||
48554862|NCT00134901|156222499|FG001|Overall Study|Lost to Follow-up|5|||
48554863|NCT00134901|156222498|FG000|Overall Study|discontinued intervention|12|||
48554864|NCT00134901|156222499|FG001|Overall Study|discontinued intervention|10|||
48554865|NCT00369941|156222500|FG000|Overall Study|Never Treated|1|||
48554866|NCT00369941|156222501|FG001|Overall Study|Never Treated|2|||
48554867|NCT00369941|156222500|FG000|Overall Study|Adverse Event|14|||
48554868|NCT00369941|156222501|FG001|Overall Study|Adverse Event|28|||
48554869|NCT00369941|156222500|FG000|Overall Study|Lack of Efficacy|6|||
48554870|NCT00369941|156222501|FG001|Overall Study|Lack of Efficacy|10|||
48614634|NCT02782468|156445563|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
48614635|NCT02782468|156445564|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
48554871|NCT00369941|156222500|FG000|Overall Study|Lost to Follow-up|12|||
48554872|NCT00369941|156222501|FG001|Overall Study|Lost to Follow-up|22|||
48554873|NCT00369941|156222500|FG000|Overall Study|Protocol Violation|5|||
48554874|NCT00369941|156222501|FG001|Overall Study|Protocol Violation|3|||
48554875|NCT00369941|156222500|FG000|Overall Study|Withdrawal by Subject|5|||
48554876|NCT00369941|156222501|FG001|Overall Study|Withdrawal by Subject|18|||
48554877|NCT00369941|156222500|FG000|Overall Study|Pregnancy|4|||
48554878|NCT00369941|156222501|FG001|Overall Study|Pregnancy|2|||
48554879|NCT00369941|156222500|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
48554880|NCT00369941|156222501|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
48554881|NCT00369941|156222500|FG000|Overall Study|Moved|11|||
48554882|NCT00369941|156222501|FG001|Overall Study|Moved|5|||
48554883|NCT00369941|156222500|FG000|Overall Study|Treatment with Prohibited Medication|3|||
48554884|NCT00369941|156222501|FG001|Overall Study|Treatment with Prohibited Medication|1|||
48554885|NCT00369941|156222500|FG000|Overall Study|Employment Interfered with Study Visits|1|||
48554886|NCT00369941|156222501|FG001|Overall Study|Employment Interfered with Study Visits|0|||
48554887|NCT00369941|156222500|FG000|Overall Study|Study Site Terminated|2|||
48554888|NCT00369941|156222501|FG001|Overall Study|Study Site Terminated|0|||
48554889|NCT00369941|156222500|FG000|Overall Study|Miscellaneous|3|||
48554890|NCT00369941|156222501|FG001|Overall Study|Miscellaneous|3|||
48614636|NCT02782468|156445565|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
48554891|NCT02301390|156222502|FG000|Overall Study|Withdrawal by Subject|3|||
48554892|NCT02301390|156222503|FG001|Overall Study|Withdrawal by Subject|5|||
48554893|NCT02301390|156222502|FG000|Overall Study|Protocol Violation|1|||
48614637|NCT02782468|156445562|FG000|Overall Study|Symptomatic Deterioration|0|||
48554894|NCT02301390|156222503|FG001|Overall Study|Protocol Violation|0|||
48554895|NCT02301390|156222502|FG000|Overall Study|Physician Decision|1|||
48554896|NCT02301390|156222503|FG001|Overall Study|Physician Decision|0|||
48554897|NCT02301390|156222502|FG000|Overall Study|Lost to Follow-up|0|||
48554898|NCT02301390|156222503|FG001|Overall Study|Lost to Follow-up|1|||
48554899|NCT02301390|156222502|FG000|Overall Study|Death|2|||
48554900|NCT02301390|156222503|FG001|Overall Study|Death|2|||
48554901|NCT02301390|156222502|FG000|Overall Study|Procedure not completed|0|||
48554902|NCT02301390|156222503|FG001|Overall Study|Procedure not completed|4|||
48554903|NCT02301390|156222502|FG000|Overall Study|Missed multiple visits|1|||
48554904|NCT02301390|156222503|FG001|Overall Study|Missed multiple visits|1|||
48554905|NCT02301390|156222502|FG000|Overall Study|study terminated|2|||
48554906|NCT02301390|156222503|FG001|Overall Study|study terminated|0|||
48554907|NCT03071276|156222513|FG000|Overall Study|Adverse Event|1|||
48554908|NCT03071276|156222513|FG000|Overall Study|Lack of Efficacy|14|||
48554909|NCT00398866|156222514|FG000|Overall Study|Adverse Event|1|||
48554910|NCT00398866|156222515|FG001|Overall Study|Adverse Event|0|||
48554911|NCT00398866|156222516|FG002|Overall Study|Adverse Event|0|||
48554912|NCT00398866|156222514|FG000|Overall Study|Lack of Efficacy|0|||
48554913|NCT00398866|156222515|FG001|Overall Study|Lack of Efficacy|0|||
48554914|NCT00398866|156222516|FG002|Overall Study|Lack of Efficacy|1|||
48554915|NCT00398866|156222514|FG000|Overall Study|Lost to Follow-up|7|||
48554916|NCT00398866|156222515|FG001|Overall Study|Lost to Follow-up|6|||
48554917|NCT00398866|156222516|FG002|Overall Study|Lost to Follow-up|4|||
48554918|NCT00398866|156222514|FG000|Overall Study|Withdrawal by Subject|5|||
48554919|NCT00398866|156222515|FG001|Overall Study|Withdrawal by Subject|1|||
48554920|NCT00398866|156222516|FG002|Overall Study|Withdrawal by Subject|2|||
48554921|NCT00398866|156222514|FG000|Overall Study|Unable to complete requirements of study|1|||
48554922|NCT00398866|156222515|FG001|Overall Study|Unable to complete requirements of study|1|||
48554923|NCT00398866|156222516|FG002|Overall Study|Unable to complete requirements of study|1|||
48554924|NCT02224157|156222523|FG000|Overall Study|Severe non-compliance to protocol|2|||
48554925|NCT02224157|156222524|FG001|Overall Study|Severe non-compliance to protocol|2|||
48554926|NCT02224157|156222523|FG000|Overall Study|Other|13|||
48554927|NCT02224157|156222524|FG001|Overall Study|Other|10|||
48554928|NCT02224157|156222523|FG000|Overall Study|Subject decision|58|||
48614638|NCT02782468|156445563|FG001|Overall Study|Symptomatic Deterioration|0|||
48554929|NCT02224157|156222524|FG001|Overall Study|Subject decision|50|||
48554930|NCT02224157|156222523|FG000|Overall Study|Prematurely closed site|4|||
48554931|NCT02224157|156222524|FG001|Overall Study|Prematurely closed site|2|||
48554932|NCT02224157|156222523|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
48554933|NCT02224157|156222524|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
48554934|NCT02224157|156222523|FG000|Overall Study|Lost to Follow-up|27|||
48614639|NCT02782468|156445564|FG002|Overall Study|Symptomatic Deterioration|0|||
48614640|NCT02782468|156445565|FG003|Overall Study|Symptomatic Deterioration|1|||
48614641|NCT02782468|156445562|FG000|Overall Study|Withdrawal by Subject|1|||
48614642|NCT02782468|156445563|FG001|Overall Study|Withdrawal by Subject|0|||
48614643|NCT02782468|156445564|FG002|Overall Study|Withdrawal by Subject|0|||
48614644|NCT02782468|156445565|FG003|Overall Study|Withdrawal by Subject|0|||
48614645|NCT00313170|156445566|FG000|Overall Study|Death|2|||
48614646|NCT00313170|156445567|FG001|Overall Study|Death|4|||
48554935|NCT02224157|156222524|FG001|Overall Study|Lost to Follow-up|35|||
48554936|NCT02224157|156222523|FG000|Overall Study|Death|1|||
48554937|NCT02224157|156222524|FG001|Overall Study|Death|1|||
48554938|NCT02224157|156222523|FG000|Overall Study|Adverse Event|1|||
48554939|NCT02224157|156222524|FG001|Overall Study|Adverse Event|3|||
48554940|NCT04324021|156222526|FG000|Overall Study|Adverse Event|1|||
48554941|NCT04324021|156222527|FG001|Overall Study|Adverse Event|0|||
48554942|NCT04324021|156222528|FG002|Overall Study|Adverse Event|0|||
48554943|NCT04324021|156222526|FG000|Overall Study|Lack of Efficacy|0|||
48614647|NCT00313170|156445568|FG002|Overall Study|Death|2|||
48614648|NCT00313170|156445566|FG000|Overall Study|Adverse Event|1|||
48554944|NCT04324021|156222527|FG001|Overall Study|Lack of Efficacy|0|||
48554945|NCT04324021|156222528|FG002|Overall Study|Lack of Efficacy|1|||
48554946|NCT04324021|156222526|FG000|Overall Study|Death|1|||
48554947|NCT04324021|156222527|FG001|Overall Study|Death|1|||
48554948|NCT04324021|156222528|FG002|Overall Study|Death|0|||
48554949|NCT03910673|156222529|FG000|Overall Study|Adverse Event|0|||
48554950|NCT03910673|156222530|FG001|Overall Study|Adverse Event|0|||
48554951|NCT03910673|156222531|FG002|Overall Study|Adverse Event|0|||
48554952|NCT03910673|156222532|FG003|Overall Study|Adverse Event|2|||
48554953|NCT03910673|156222533|FG004|Overall Study|Adverse Event|0|||
48554954|NCT00098774|156222534|FG000|Overall Study|Adverse Event|2|||
48554955|NCT00098774|156222534|FG000|Overall Study|Disease Progression|9|||
48554956|NCT00098774|156222534|FG000|Overall Study|Withdrawal by Subject|1|||
48554957|NCT00098774|156222534|FG000|Overall Study|Failed (to respond) during induction|4|||
48554958|NCT00098774|156222534|FG000|Overall Study|Physician Decision|2|||
48554959|NCT03404674|156222535|FG000|Overall Study|Inability to Attend Future Visits|0|||
48554960|NCT03404674|156222536|FG001|Overall Study|Inability to Attend Future Visits|1|||
48554961|NCT03404674|156222537|FG002|Overall Study|Inability to Attend Future Visits|1|||
48554962|NCT03404674|156222538|FG003|Overall Study|Inability to Attend Future Visits|0|||
48554963|NCT03404674|156222539|FG004|Overall Study|Inability to Attend Future Visits|0|||
48554964|NCT03404674|156222540|FG005|Overall Study|Inability to Attend Future Visits|0|||
48554965|NCT03404674|156222535|FG000|Overall Study|Behavioral Problems|0|||
48554966|NCT03404674|156222536|FG001|Overall Study|Behavioral Problems|0|||
48554967|NCT03404674|156222537|FG002|Overall Study|Behavioral Problems|1|||
48554968|NCT03404674|156222538|FG003|Overall Study|Behavioral Problems|0|||
48554969|NCT03404674|156222539|FG004|Overall Study|Behavioral Problems|0|||
48554970|NCT03404674|156222540|FG005|Overall Study|Behavioral Problems|0|||
48554971|NCT03404674|156222535|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
48554972|NCT03404674|156222536|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
48554973|NCT03404674|156222537|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
48554974|NCT03404674|156222538|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
48554975|NCT03404674|156222539|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
48554976|NCT03404674|156222540|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
48614649|NCT00313170|156445567|FG001|Overall Study|Adverse Event|2|||
48614650|NCT00313170|156445568|FG002|Overall Study|Adverse Event|0|||
48614651|NCT00313170|156445566|FG000|Overall Study|Disease progression|31|||
48554977|NCT03097991|156222541|FG000|Overall Study|Didn't meet study criteria|8|||
48554978|NCT03097991|156222542|FG001|Overall Study|Didn't meet study criteria|0|||
48554979|NCT03097991|156222541|FG000|Overall Study|Withdrawal by Subject|12|||
48554980|NCT03097991|156222542|FG001|Overall Study|Withdrawal by Subject|6|||
48554981|NCT03097991|156222541|FG000|Overall Study|Death of Baby|3|||
48554982|NCT03097991|156222542|FG001|Overall Study|Death of Baby|1|||
48554983|NCT03097991|156222541|FG000|Overall Study|Lost to Follow-up|24|||
48554984|NCT03097991|156222542|FG001|Overall Study|Lost to Follow-up|38|||
48554985|NCT03097991|156222541|FG000|Overall Study|Adverse Event|3|||
48554986|NCT03097991|156222542|FG001|Overall Study|Adverse Event|5|||
48554987|NCT05022212|156222546|FG000|Overall Study|Lost to Follow-up|0|||
48554988|NCT05022212|156222547|FG001|Overall Study|Lost to Follow-up|2|||
48554989|NCT01998841|156222548|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
48554990|NCT01998841|156222549|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
48554991|NCT01998841|156222550|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
48554992|NCT01998841|156222551|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
48554993|NCT01998841|156222552|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
48554994|NCT01998841|156222548|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
48554995|NCT01998841|156222549|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
48554996|NCT01998841|156222550|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
48554997|NCT01998841|156222551|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
48554998|NCT01998841|156222552|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
48554999|NCT02586155|156222553|FG000|Overall Study|Adverse Event|2|||
48555000|NCT02586155|156222554|FG001|Overall Study|Adverse Event|3|||
48555001|NCT02586155|156222553|FG000|Overall Study|Withdrawal by Subject|31|||
48555002|NCT02586155|156222554|FG001|Overall Study|Withdrawal by Subject|24|||
48555003|NCT02586155|156222553|FG000|Overall Study|Lost to Follow-up|7|||
48555004|NCT02586155|156222554|FG001|Overall Study|Lost to Follow-up|13|||
48555005|NCT02586155|156222553|FG000|Overall Study|Death|61|||
48555006|NCT02586155|156222554|FG001|Overall Study|Death|72|||
48555007|NCT02586155|156222553|FG000|Overall Study|Other reasons|26|||
48555008|NCT02586155|156222554|FG001|Overall Study|Other reasons|15|||
48555009|NCT03629184|156222555|FG000|Overall Study|Withdrawal by Subject|2|||
48555010|NCT03629184|156222556|FG001|Overall Study|Withdrawal by Subject|1|||
48555011|NCT03629184|156222555|FG000|Overall Study|Physician Decision|1|||
48555012|NCT03629184|156222556|FG001|Overall Study|Physician Decision|0|||
48555013|NCT01461538|156222557|FG000|Overall Study|Death|15|||
48555014|NCT01461538|156222558|FG001|Overall Study|Death|6|||
48555015|NCT01461538|156222559|FG002|Overall Study|Death|2|||
48555016|NCT01461538|156222557|FG000|Overall Study|Study Stopped by Sponsor|2|||
48555017|NCT01461538|156222558|FG001|Overall Study|Study Stopped by Sponsor|1|||
48555018|NCT01461538|156222559|FG002|Overall Study|Study Stopped by Sponsor|0|||
48555019|NCT01461538|156222557|FG000|Overall Study|Withdrawal by Subject|1|||
48614652|NCT00313170|156445567|FG001|Overall Study|Disease progression|26|||
48555020|NCT01461538|156222558|FG001|Overall Study|Withdrawal by Subject|1|||
48555021|NCT01461538|156222559|FG002|Overall Study|Withdrawal by Subject|0|||
48555022|NCT02729909|156222561|FG000|Overall Study|Lost to Follow-up|0|||
48555023|NCT02729909|156222562|FG001|Overall Study|Lost to Follow-up|1|||
48555024|NCT02729909|156222561|FG000|Overall Study|Lack of Efficacy|0|||
48555025|NCT02729909|156222562|FG001|Overall Study|Lack of Efficacy|2|||
48555026|NCT02729909|156222561|FG000|Overall Study|Significant Protocol Deviation|0|||
48555027|NCT02729909|156222562|FG001|Overall Study|Significant Protocol Deviation|2|||
48555028|NCT02729909|156222561|FG000|Overall Study|Voluntary Withdrawal|1|||
48555029|NCT02729909|156222562|FG001|Overall Study|Voluntary Withdrawal|0|||
48555030|NCT02215967|156222569|FG000|Overall Study|Patient became ineligible for treatment|0|||
48614653|NCT00313170|156445568|FG002|Overall Study|Disease progression|27|||
48614654|NCT00313170|156445566|FG000|Overall Study|Withdrawal by Subject|1|||
48614655|NCT00313170|156445567|FG001|Overall Study|Withdrawal by Subject|0|||
48614656|NCT00313170|156445568|FG002|Overall Study|Withdrawal by Subject|1|||
48614657|NCT00313170|156445566|FG000|Overall Study|Incorrect enrollment|0|||
48614658|NCT00313170|156445567|FG001|Overall Study|Incorrect enrollment|2|||
48614659|NCT00313170|156445568|FG002|Overall Study|Incorrect enrollment|1|||
48614660|NCT00313170|156445566|FG000|Overall Study|Lost to Follow-up|0|||
48614661|NCT00313170|156445567|FG001|Overall Study|Lost to Follow-up|0|||
48614662|NCT00313170|156445568|FG002|Overall Study|Lost to Follow-up|1|||
48614663|NCT00313170|156445566|FG000|Overall Study|Progression (investigators opinion)|1|||
48614664|NCT00313170|156445567|FG001|Overall Study|Progression (investigators opinion)|0|||
48614665|NCT00313170|156445568|FG002|Overall Study|Progression (investigators opinion)|0|||
48614666|NCT01155141|156445580|FG000|Overall Study|Withdrawal by Subject|1|||
48614667|NCT01155141|156445580|FG000|Overall Study|Screen Failure|1|||
48614668|NCT03473197|156445581|FG000|Overall Study|Adverse Event|4|||
48555031|NCT02215967|156222570|FG001|Overall Study|Patient became ineligible for treatment|0|||
48555032|NCT02215967|156222571|FG002|Overall Study|Patient became ineligible for treatment|0|||
48555033|NCT02215967|156222572|FG003|Overall Study|Patient became ineligible for treatment|3|||
48555034|NCT02215967|156222569|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
48555035|NCT02215967|156222570|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
48555036|NCT02215967|156222571|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
48555037|NCT02215967|156222572|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
48555038|NCT03447743|156222574|FG000|Overall Study|Withdrawal by Subject|2|||
48555039|NCT03447743|156222574|FG000|Overall Study|Lost to Follow-up|3|||
48555040|NCT03447743|156222574|FG000|Overall Study|Adverse Event|1|||
48555041|NCT03447743|156222574|FG000|Overall Study|Did not meet criteria to continue|1|||
48555042|NCT02046603|156222575|FG000|Overall Study|Other|11|||
48555043|NCT02046603|156222576|FG001|Overall Study|Other|66|||
48555044|NCT02046603|156222575|FG000|Overall Study|Protocol Violation|0|||
48555045|NCT02046603|156222576|FG001|Overall Study|Protocol Violation|1|||
48555046|NCT02046603|156222575|FG000|Overall Study|Participant/legal guardian decision|1|||
48555047|NCT02046603|156222576|FG001|Overall Study|Participant/legal guardian decision|3|||
48555048|NCT02046603|156222575|FG000|Overall Study|Physician Decision|2|||
48555049|NCT02046603|156222576|FG001|Overall Study|Physician Decision|1|||
48555050|NCT02046603|156222575|FG000|Overall Study|Lost to Follow-up|1|||
48614669|NCT03473197|156445581|FG000|Overall Study|Lost to Follow-up|1|||
48555051|NCT02046603|156222576|FG001|Overall Study|Lost to Follow-up|2|||
48614670|NCT03473197|156445581|FG000|Overall Study|Withdrawal by Subject|5|||
48614671|NCT00785629|156445582|FG000|Overall Study|Adverse Event|2|||
48555052|NCT02046603|156222575|FG000|Overall Study|Death|0|||
48614672|NCT00785629|156445583|FG001|Overall Study|Adverse Event|1|||
48614673|NCT00785629|156445584|FG002|Overall Study|Adverse Event|1|||
48614674|NCT00785629|156445585|FG003|Overall Study|Adverse Event|5|||
48614675|NCT00785629|156445582|FG000|Overall Study|Protocol Violation|1|||
48614676|NCT00785629|156445583|FG001|Overall Study|Protocol Violation|2|||
48614677|NCT00785629|156445584|FG002|Overall Study|Protocol Violation|4|||
48614678|NCT00785629|156445585|FG003|Overall Study|Protocol Violation|5|||
48614679|NCT00785629|156445582|FG000|Overall Study|administrative decision|5|||
48614680|NCT00785629|156445583|FG001|Overall Study|administrative decision|1|||
48614681|NCT00785629|156445584|FG002|Overall Study|administrative decision|3|||
48614682|NCT00785629|156445585|FG003|Overall Study|administrative decision|4|||
48614683|NCT00785629|156445582|FG000|Overall Study|Withdrawal by Subject|0|||
48614684|NCT00785629|156445583|FG001|Overall Study|Withdrawal by Subject|1|||
48614685|NCT00785629|156445584|FG002|Overall Study|Withdrawal by Subject|2|||
48614686|NCT00785629|156445585|FG003|Overall Study|Withdrawal by Subject|2|||
48614687|NCT04919161|156445588|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
48614688|NCT04919161|156445589|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
48614689|NCT04919161|156445588|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
48614690|NCT04919161|156445589|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
48614691|NCT04919161|156445588|FG000|Overall Study|Acute ankle sprain after session 1|0|||
48614692|NCT04919161|156445589|FG001|Overall Study|Acute ankle sprain after session 1|1|||
48614693|NCT02110693|156445595|FG000|Overall Study|Withdrawal by Subject|6|||
48614694|NCT02110693|156445596|FG001|Overall Study|Withdrawal by Subject|7|||
48614695|NCT02110693|156445595|FG000|Overall Study|skipped assessment|15|||
48614696|NCT02110693|156445596|FG001|Overall Study|skipped assessment|18|||
48614697|NCT02110693|156445595|FG000|Overall Study|technical difficulties|6|||
48614698|NCT02110693|156445596|FG001|Overall Study|technical difficulties|4|||
48614699|NCT02110693|156445595|FG000|Overall Study|Other|1|||
48614700|NCT02110693|156445596|FG001|Overall Study|Other|0|||
48555053|NCT02046603|156222576|FG001|Overall Study|Death|1|||
48555054|NCT02046603|156222575|FG000|Overall Study|Adverse Event|0|||
48555055|NCT02046603|156222576|FG001|Overall Study|Adverse Event|1|||
48555056|NCT04779879|156222577|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
48555057|NCT04779879|156222578|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
48555058|NCT04779879|156222579|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
48555059|NCT04779879|156222580|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
48555060|NCT04779879|156222581|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
48555061|NCT04779879|156222582|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
48555062|NCT04779879|156222577|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
48555063|NCT04779879|156222578|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
48555064|NCT04779879|156222579|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
48555065|NCT04779879|156222580|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
48555066|NCT04779879|156222581|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
48555067|NCT04779879|156222582|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
48555068|NCT04779879|156222577|FG000|Part C: Up to Week 36|Death|0|||
48555069|NCT04779879|156222578|FG001|Part C: Up to Week 36|Death|0|||
48555070|NCT04779879|156222579|FG002|Part C: Up to Week 36|Death|0|||
48614701|NCT00447278|156445597|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
48614702|NCT00447278|156445598|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
48614703|NCT00447278|156445597|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
48614704|NCT00447278|156445598|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
48614705|NCT00447278|156445597|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
48614706|NCT00447278|156445598|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
48614707|NCT00447278|156445597|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
48555071|NCT04779879|156222580|FG003|Part C: Up to Week 36|Death|0|||
48555072|NCT04779879|156222581|FG004|Part C: Up to Week 36|Death|0|||
48614708|NCT00447278|156445598|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
48614709|NCT00447278|156445597|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
48614710|NCT00447278|156445598|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
48614711|NCT00447278|156445597|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
48614712|NCT00447278|156445598|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
48614713|NCT00447278|156445597|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
48614714|NCT00447278|156445598|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
48614715|NCT00447278|156445597|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
48614716|NCT00447278|156445598|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
48614717|NCT00447278|156445597|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
48614718|NCT00447278|156445598|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
48614719|NCT00447278|156445597|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
48614720|NCT00447278|156445598|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
48614721|NCT00447278|156445597|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
48614722|NCT00447278|156445598|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
48614723|NCT00447278|156445597|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
48614724|NCT00447278|156445598|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
48614725|NCT00447278|156445597|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
48614726|NCT00447278|156445598|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
48614727|NCT00447278|156445597|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
48614728|NCT00447278|156445598|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
48614729|NCT02595749|156445599|FG000|Overall Study|Withdrawal by Subject|12|||
48614730|NCT02595749|156445600|FG001|Overall Study|Withdrawal by Subject|7|||
48614731|NCT01047501|156445601|FG000|Overall Study|Adverse Event|7|||
48614732|NCT01047501|156445602|FG001|Overall Study|Adverse Event|8|||
48614733|NCT01047501|156445603|FG002|Overall Study|Adverse Event|5|||
48614734|NCT01047501|156445601|FG000|Overall Study|Withdrew Consent|6|||
48614735|NCT01047501|156445602|FG001|Overall Study|Withdrew Consent|2|||
48614736|NCT01047501|156445603|FG002|Overall Study|Withdrew Consent|4|||
48614737|NCT01047501|156445601|FG000|Overall Study|Lost to Follow-up|0|||
48614738|NCT01047501|156445602|FG001|Overall Study|Lost to Follow-up|1|||
48614739|NCT01047501|156445603|FG002|Overall Study|Lost to Follow-up|1|||
48614740|NCT01047501|156445601|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
48614741|NCT01047501|156445602|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
48614742|NCT01047501|156445603|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
48614743|NCT01047501|156445601|FG000|Overall Study|Death|1|||
48614744|NCT01047501|156445602|FG001|Overall Study|Death|0|||
48614745|NCT01047501|156445603|FG002|Overall Study|Death|0|||
48614746|NCT01047501|156445601|FG000|Overall Study|Other discontinuation|1|||
48614747|NCT01047501|156445602|FG001|Overall Study|Other discontinuation|0|||
48614748|NCT01047501|156445603|FG002|Overall Study|Other discontinuation|1|||
48614749|NCT01047501|156445601|FG000|Overall Study|Investigator judgement|0|||
48614750|NCT01047501|156445602|FG001|Overall Study|Investigator judgement|0|||
48614751|NCT01047501|156445603|FG002|Overall Study|Investigator judgement|1|||
48614752|NCT01039675|156445604|FG000|Overall Study|Adverse Event|0|||
48614753|NCT01039675|156445605|FG001|Overall Study|Adverse Event|2|||
48614754|NCT01039675|156445604|FG000|Overall Study|Lack of Efficacy|0|||
48614755|NCT01039675|156445605|FG001|Overall Study|Lack of Efficacy|2|||
48614756|NCT01039675|156445604|FG000|Overall Study|Withdrawal by Subject|0|||
48614757|NCT01039675|156445605|FG001|Overall Study|Withdrawal by Subject|1|||
48614758|NCT01039675|156445604|FG000|Overall Study|Lost to Follow-up|0|||
48614759|NCT01039675|156445605|FG001|Overall Study|Lost to Follow-up|1|||
48614760|NCT01039675|156445604|FG000|Overall Study|Physician Decision|0|||
48614761|NCT01039675|156445605|FG001|Overall Study|Physician Decision|1|||
48614762|NCT01562444|156445606|FG000|Overall Study|Did not meet entry criteria|2|||
48614763|NCT01562444|156445607|FG001|Overall Study|Did not meet entry criteria|0|||
48614764|NCT01562444|156445608|FG002|Overall Study|Did not meet entry criteria|3|||
48614765|NCT01562444|156445606|FG000|Overall Study|Did not comply with blood draw schedule|1|||
48614766|NCT01562444|156445607|FG001|Overall Study|Did not comply with blood draw schedule|0|||
48614767|NCT01562444|156445608|FG002|Overall Study|Did not comply with blood draw schedule|1|||
48614768|NCT01562444|156445606|FG000|Overall Study|Unavailable serological results|0|||
48614769|NCT01562444|156445607|FG001|Overall Study|Unavailable serological results|2|||
48614770|NCT01562444|156445608|FG002|Overall Study|Unavailable serological results|2|||
48555073|NCT04779879|156222582|FG005|Part C: Up to Week 36|Death|1|||
48555074|NCT04779879|156222577|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
48555075|NCT04779879|156222578|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
48555076|NCT04779879|156222579|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
48555077|NCT04779879|156222580|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
48555078|NCT04779879|156222581|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
48555079|NCT04779879|156222582|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
48555080|NCT00640315|156222583|FG000|Overall Study|Withdrawal by Subject|0|||
48555081|NCT00640315|156222584|FG001|Overall Study|Withdrawal by Subject|1|||
48555082|NCT02864992|156224428|FG000|Overall Study|still on treatment|15|||
48555083|NCT02864992|156224429|FG001|Overall Study|still on treatment|1|||
48555084|NCT02864992|156224430|FG002|Overall Study|still on treatment|33|||
48555085|NCT05048329|156224431|FG000|Overall Study|Withdrawal by Subject|1|||
48555086|NCT05048329|156224431|FG000|Overall Study|Screenfail|1|||
48555087|NCT04138043|156224432|FG000|Overall Study|Withdrawal by Subject|0|||
48555088|NCT04138043|156224433|FG001|Overall Study|Withdrawal by Subject|1|||
48555089|NCT03772717|156224434|FG000|Overall Study|Withdrawal by Subject|2|||
48555090|NCT01810302|156224435|FG000|Overall Study|Death|1|||
48555091|NCT01810302|156224436|FG001|Overall Study|Death|0|||
48555092|NCT01810302|156224435|FG000|Overall Study|Physician Decision|0|||
48555093|NCT01810302|156224436|FG001|Overall Study|Physician Decision|1|||
48555094|NCT02856802|156224437|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
48555095|NCT02856802|156224438|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
48614771|NCT01562444|156445606|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
48555096|NCT02856802|156224437|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
48555097|NCT02856802|156224438|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
48555098|NCT02856802|156224437|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
48555099|NCT02856802|156224438|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
48555100|NCT02856802|156224437|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
48555101|NCT02856802|156224438|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
48555102|NCT02856802|156224437|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
48555103|NCT02856802|156224438|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
48555104|NCT02856802|156224437|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
48555105|NCT02856802|156224438|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
48555106|NCT00587860|156224439|FG000|Overall Study|Lost to Follow-up|2|||
48555107|NCT00587860|156224440|FG001|Overall Study|Lost to Follow-up|2|||
48555108|NCT00587860|156224439|FG000|Overall Study|Withdrawal by Subject|3|||
48555109|NCT00587860|156224440|FG001|Overall Study|Withdrawal by Subject|3|||
48555110|NCT01659125|156224444|FG000|Overall Study|Withdrawal by Subject|2|||
48555111|NCT01659125|156224444|FG000|Overall Study|Lost to Follow-up|7|||
48555112|NCT01659125|156224444|FG000|Overall Study|Technical Problem|1|||
48555113|NCT01659125|156224444|FG000|Overall Study|Time Constraints|2|||
48555114|NCT01659125|156224444|FG000|Overall Study|Failed to Start Treatment|2|||
48555115|NCT01396512|156224445|FG000|Overall Study|Withdrawal by Subject|0|||
48555116|NCT01396512|156224446|FG001|Overall Study|Withdrawal by Subject|1|||
48555117|NCT02129608|156224447|FG000|Overall Study|Lost to Follow-up|0|||
48555118|NCT02129608|156224448|FG001|Overall Study|Lost to Follow-up|1|||
48555119|NCT02129608|156224449|FG002|Overall Study|Lost to Follow-up|1|||
48555120|NCT02129608|156224447|FG000|Overall Study|Withdrawal by Subject|0|||
48555121|NCT02129608|156224448|FG001|Overall Study|Withdrawal by Subject|0|||
48555122|NCT02129608|156224449|FG002|Overall Study|Withdrawal by Subject|2|||
48555123|NCT00261443|156224451|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
48555124|NCT00261443|156224452|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
48555125|NCT00261443|156224453|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
48555126|NCT00261443|156224451|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
48555127|NCT00261443|156224452|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
48555128|NCT00261443|156224453|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
48614772|NCT01562444|156445607|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
48614773|NCT01562444|156445608|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
48614774|NCT01562444|156445606|FG000|Overall Study|Protocol forbidden medication|1|||
48614775|NCT01562444|156445607|FG001|Overall Study|Protocol forbidden medication|0|||
48555129|NCT00261443|156224451|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
48614776|NCT01562444|156445608|FG002|Overall Study|Protocol forbidden medication|0|||
48614777|NCT01177410|156445609|FG000|Overall Study|Adverse Event|0|||
48555130|NCT00261443|156224452|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
48555131|NCT00261443|156224453|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
48555132|NCT00261443|156224451|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
48555133|NCT00261443|156224452|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
48555134|NCT00261443|156224453|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
48555135|NCT00261443|156224451|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
48555136|NCT00261443|156224452|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
48555137|NCT00261443|156224453|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
48555138|NCT00261443|156224451|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
48555139|NCT00261443|156224452|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
48555140|NCT00261443|156224453|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
48555141|NCT00261443|156224451|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
48555142|NCT00261443|156224452|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
48555143|NCT00261443|156224453|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
48555144|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
48555145|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
48555146|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
48555147|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
48555148|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
48555149|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
48555150|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
48555151|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
48555152|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
48555153|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
48555154|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
48555155|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
48555156|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
48555157|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
48614778|NCT01177410|156445610|FG001|Overall Study|Adverse Event|2|||
48614779|NCT01177410|156445611|FG002|Overall Study|Adverse Event|2|||
48614780|NCT01177410|156445609|FG000|Overall Study|Withdrawal by Subject|1|||
48614781|NCT01177410|156445610|FG001|Overall Study|Withdrawal by Subject|4|||
48614782|NCT01177410|156445611|FG002|Overall Study|Withdrawal by Subject|3|||
48614783|NCT01177410|156445609|FG000|Overall Study|Lost to Follow-up|0|||
48614784|NCT01177410|156445610|FG001|Overall Study|Lost to Follow-up|1|||
48614785|NCT01177410|156445611|FG002|Overall Study|Lost to Follow-up|0|||
48614786|NCT03483103|156445612|FG000|Pre-Treatment Phase|Other reasons|1|||
48614787|NCT03483103|156445612|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
48614788|NCT03483103|156445612|FG000|Pre-Treatment Phase|Disease-related complications|1|||
48614789|NCT03483103|156445612|FG000|Pre-Treatment Phase|Death|5|||
48614790|NCT03483103|156445612|FG000|Treatment Phase|Withdrawal by Subject|7|||
48614791|NCT03483103|156445612|FG000|Treatment Phase|Other reasons|1|||
48614792|NCT03483103|156445612|FG000|Treatment Phase|Death|23|||
48614793|NCT03483103|156445612|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
48614794|NCT03483103|156445612|FG000|Treatment Phase|Received nonconforming product|1|||
48614795|NCT04727749|156445613|FG000|Overall Study|Lost to Follow-up|10|||
48614796|NCT04727749|156445614|FG001|Overall Study|Lost to Follow-up|3|||
48614797|NCT01555931|156445615|FG000|Overall Study|Lost to Follow-up|2|||
48614798|NCT01555931|156445616|FG001|Overall Study|Lost to Follow-up|5|||
48614799|NCT00429299|156445617|FG000|Overall Study|Disease Progression|1|||
48614800|NCT00429299|156445618|FG001|Overall Study|Disease Progression|1|||
48614801|NCT00429299|156445619|FG002|Overall Study|Disease Progression|0|||
48614802|NCT00429299|156445617|FG000|Overall Study|Adverse Event|2|||
48614803|NCT00429299|156445618|FG001|Overall Study|Adverse Event|5|||
48614804|NCT00429299|156445619|FG002|Overall Study|Adverse Event|1|||
48614805|NCT00429299|156445617|FG000|Overall Study|Protocol Violation|1|||
48614806|NCT00429299|156445618|FG001|Overall Study|Protocol Violation|0|||
48614807|NCT00429299|156445619|FG002|Overall Study|Protocol Violation|0|||
48614808|NCT00429299|156445617|FG000|Overall Study|Withdrawal by Subject|0|||
48614809|NCT00429299|156445618|FG001|Overall Study|Withdrawal by Subject|1|||
48614810|NCT00429299|156445619|FG002|Overall Study|Withdrawal by Subject|3|||
48614811|NCT01180777|156445625|FG000|Overall Study|Protocol Violation|6|||
48555158|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
48555159|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
48614812|NCT01180777|156445625|FG000|Overall Study|Poor lens fit|4|||
48614813|NCT01180777|156445625|FG000|Overall Study|Lost to Follow-up|1|||
48614814|NCT01180777|156445625|FG000|Overall Study|Adverse Event|1|||
48614815|NCT02441283|156445629|FG000|Overall Study|Withdrew consent|15|||
48614816|NCT02441283|156445629|FG000|Overall Study|Lost to Follow-up|42|||
48614817|NCT02441283|156445629|FG000|Overall Study|Death|1|||
48614818|NCT02441283|156445629|FG000|Overall Study|Other, not specified|32|||
48614819|NCT03880565|156445630|FG000|Overall Study|Withdrawal by Subject|1|||
48614820|NCT03880565|156445631|FG001|Overall Study|Withdrawal by Subject|0|||
48614821|NCT00226655|156445633|FG000|Overall Study|Death|13|||
48614822|NCT00226655|156445633|FG000|Overall Study|Withdrawal by Subject|15|||
48555160|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
48614823|NCT00226655|156445633|FG000|Overall Study|Adverse Event|35|||
48614824|NCT00226655|156445633|FG000|Overall Study|Physician Decision|6|||
48614825|NCT00226655|156445633|FG000|Overall Study|Clinical deterioration|10|||
48614826|NCT03329001|156445634|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
48693064|NCT01400698|156724662|FG004|Overall Study|Adverse Event|0|||
48614827|NCT03329001|156445635|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
48614828|NCT03329001|156445636|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
48614829|NCT03329001|156445637|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
48614830|NCT03329001|156445638|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
48614831|NCT03329001|156445639|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
48614832|NCT03329001|156445640|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
48614833|NCT03329001|156445641|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
48614834|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
48614835|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
48614836|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
48614837|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
48614838|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
48614839|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
48614840|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
48614841|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
48614842|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
48614843|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
48614844|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
48614845|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
48614846|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
48614847|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
48614848|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
48614849|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
48614850|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
48614851|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
48614852|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
48614853|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
48614854|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
48614855|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
48614856|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
48614857|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
48555161|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
48555162|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
48555163|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
48555164|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
48555165|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
48555166|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
48614858|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
48614859|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
48614860|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
48555167|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
48614861|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
48614862|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
48614863|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
48614864|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
48614865|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
48614866|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
48614867|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
48614868|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
48614869|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
48614870|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
48614871|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
48614872|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
48555168|NCT00261443|156224451|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
48555169|NCT00261443|156224452|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
48555170|NCT00261443|156224453|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
48555171|NCT00261443|156224451|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
48555172|NCT00261443|156224452|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
48555173|NCT00261443|156224453|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
48555174|NCT00261443|156224451|FG000|3: Assessment of Relapse|Adverse Event|0|||
48555175|NCT00261443|156224452|FG001|3: Assessment of Relapse|Adverse Event|15|||
48555176|NCT00261443|156224453|FG002|3: Assessment of Relapse|Adverse Event|19|||
48555177|NCT00261443|156224451|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
48555178|NCT00261443|156224452|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
48555179|NCT00261443|156224453|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
48555180|NCT00261443|156224451|FG000|3: Assessment of Relapse|Death|0|||
48555181|NCT00261443|156224452|FG001|3: Assessment of Relapse|Death|0|||
48555182|NCT00261443|156224453|FG002|3: Assessment of Relapse|Death|1|||
48555183|NCT00261443|156224451|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
48614873|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
48614874|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
48614875|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
48614876|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
48614877|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
48614878|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
48614879|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
48614880|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
48614881|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
48614882|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
48614883|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
48614884|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
48614885|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
48555184|NCT00261443|156224452|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
48555185|NCT00261443|156224453|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
48555186|NCT00261443|156224451|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
48614886|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
48614887|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
48614888|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
48614889|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
48614890|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
48614891|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
48614892|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
48614893|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
48614894|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
48614895|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
48614896|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
48614897|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
48614898|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
48614899|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
48614900|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
48614901|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
48614902|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
48614903|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
48555187|NCT00261443|156224452|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
48555188|NCT00261443|156224453|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
48555189|NCT00261443|156224451|FG000|3: Assessment of Relapse|Pregnancy|0|||
48555190|NCT00261443|156224452|FG001|3: Assessment of Relapse|Pregnancy|2|||
48555191|NCT00261443|156224453|FG002|3: Assessment of Relapse|Pregnancy|1|||
48555192|NCT00261443|156224451|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
48555193|NCT00261443|156224452|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
48555194|NCT00261443|156224453|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
48555195|NCT00261443|156224451|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
48555196|NCT00261443|156224452|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
48555197|NCT00261443|156224453|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
48555198|NCT00261443|156224451|FG000|3: Assessment of Relapse|Other Reasons|0|||
48555199|NCT00261443|156224452|FG001|3: Assessment of Relapse|Other Reasons|4|||
48555200|NCT00261443|156224453|FG002|3: Assessment of Relapse|Other Reasons|3|||
48555201|NCT00261443|156224451|FG000|4: Extension Phase|Adverse Event|0|||
48555202|NCT00261443|156224452|FG001|4: Extension Phase|Adverse Event|1|||
48555203|NCT00261443|156224453|FG002|4: Extension Phase|Adverse Event|0|||
48555204|NCT00261443|156224451|FG000|4: Extension Phase|Withdrawal by Subject|0|||
48555205|NCT00261443|156224452|FG001|4: Extension Phase|Withdrawal by Subject|1|||
48555206|NCT00261443|156224453|FG002|4: Extension Phase|Withdrawal by Subject|2|||
48555207|NCT00261443|156224451|FG000|4: Extension Phase|Lost to Follow-up|0|||
48555208|NCT00261443|156224452|FG001|4: Extension Phase|Lost to Follow-up|1|||
48555209|NCT00261443|156224453|FG002|4: Extension Phase|Lost to Follow-up|0|||
48614904|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
48614905|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
48555210|NCT02755649|156224454|FG000|Overall Study|Transitioned into OLE study|99|||
48555211|NCT02755649|156224455|FG001|Overall Study|Transitioned into OLE study|98|||
48555212|NCT02755649|156224456|FG002|Overall Study|Transitioned into OLE study|100|||
48555213|NCT02755649|156224454|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
48555214|NCT02755649|156224455|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
48555215|NCT02755649|156224456|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
48555216|NCT02755649|156224454|FG000|Overall Study|Physician Decision|0|||
48555217|NCT02755649|156224455|FG001|Overall Study|Physician Decision|0|||
48555218|NCT02755649|156224456|FG002|Overall Study|Physician Decision|2|||
48555219|NCT02755649|156224454|FG000|Overall Study|Withdrawal by Subject|0|||
48555220|NCT02755649|156224455|FG001|Overall Study|Withdrawal by Subject|1|||
48555221|NCT02755649|156224456|FG002|Overall Study|Withdrawal by Subject|0|||
48555222|NCT02755649|156224454|FG000|Overall Study|Undecided|1|||
48555223|NCT02755649|156224455|FG001|Overall Study|Undecided|0|||
48555224|NCT02755649|156224456|FG002|Overall Study|Undecided|0|||
48555225|NCT00696787|156224457|FG000|Overall Study|Adverse Event|1|||
48555226|NCT00696787|156224458|FG001|Overall Study|Adverse Event|0|||
48555227|NCT00696787|156224459|FG002|Overall Study|Adverse Event|6|||
48555228|NCT00696787|156224457|FG000|Overall Study|Discontinuation by Sponsor|9|||
48555229|NCT00696787|156224458|FG001|Overall Study|Discontinuation by Sponsor|13|||
48555230|NCT00696787|156224459|FG002|Overall Study|Discontinuation by Sponsor|14|||
48555231|NCT00696787|156224457|FG000|Overall Study|Lack of Efficacy|0|||
48555232|NCT00696787|156224458|FG001|Overall Study|Lack of Efficacy|1|||
48555233|NCT00696787|156224459|FG002|Overall Study|Lack of Efficacy|0|||
48555234|NCT00696787|156224457|FG000|Overall Study|Lost to Follow-up|4|||
48555235|NCT00696787|156224458|FG001|Overall Study|Lost to Follow-up|0|||
48555236|NCT00696787|156224459|FG002|Overall Study|Lost to Follow-up|3|||
48555237|NCT00696787|156224457|FG000|Overall Study|Withdrawal by Subject|0|||
48555238|NCT00696787|156224458|FG001|Overall Study|Withdrawal by Subject|3|||
48555239|NCT00696787|156224459|FG002|Overall Study|Withdrawal by Subject|2|||
48555240|NCT00696787|156224457|FG000|Overall Study|Failed to return|1|||
48555241|NCT00696787|156224458|FG001|Overall Study|Failed to return|3|||
48555242|NCT00696787|156224459|FG002|Overall Study|Failed to return|1|||
48555243|NCT00417170|156224460|FG000|Overall Study|Adverse Event|1|||
48555244|NCT00417170|156224461|FG001|Overall Study|Adverse Event|1|||
48555245|NCT00417170|156224460|FG000|Overall Study|Withdrawal by Subject|1|||
48555246|NCT00417170|156224461|FG001|Overall Study|Withdrawal by Subject|1|||
48555247|NCT00417170|156224460|FG000|Overall Study|Lost to Follow-up|0|||
48555248|NCT00417170|156224461|FG001|Overall Study|Lost to Follow-up|1|||
48555249|NCT01286753|156224465|FG000|Overall Study|Adverse Event|7|||
48555250|NCT01286753|156224466|FG001|Overall Study|Adverse Event|6|||
48555251|NCT01286753|156224465|FG000|Overall Study|Progression|11|||
48555252|NCT01286753|156224466|FG001|Overall Study|Progression|13|||
48555253|NCT01286753|156224465|FG000|Overall Study|Refused Treatment|1|||
48555254|NCT01286753|156224466|FG001|Overall Study|Refused Treatment|0|||
48555255|NCT01286753|156224465|FG000|Overall Study|Withdrawal of Consent|0|||
48555256|NCT01286753|156224466|FG001|Overall Study|Withdrawal of Consent|2|||
48555257|NCT01286753|156224465|FG000|Overall Study|Discontinued to Join Extension Study|6|||
48555258|NCT01286753|156224466|FG001|Overall Study|Discontinued to Join Extension Study|4|||
48555259|NCT01286753|156224465|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
48555260|NCT01286753|156224466|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
48555261|NCT02618759|156224470|FG000|Overall Study|Lost to Follow-up|0|||
48555262|NCT02618759|156224471|FG001|Overall Study|Lost to Follow-up|1|||
48555263|NCT02618759|156224470|FG000|Overall Study|Withdrawal by Subject|1|||
48555264|NCT02618759|156224471|FG001|Overall Study|Withdrawal by Subject|0|||
48555265|NCT02618759|156224470|FG000|Overall Study|Other Reasons|1|||
48555266|NCT02618759|156224471|FG001|Overall Study|Other Reasons|4|||
48555267|NCT02126826|156224472|FG000|Overall Study|Withdrawal by Subject|0|||
48555268|NCT02126826|156224473|FG001|Overall Study|Withdrawal by Subject|0|||
48555269|NCT02126826|156224474|FG002|Overall Study|Withdrawal by Subject|0|||
48555270|NCT02126826|156224475|FG003|Overall Study|Withdrawal by Subject|1|||
48555271|NCT02126826|156224476|FG004|Overall Study|Withdrawal by Subject|0|||
48555272|NCT02126826|156224477|FG005|Overall Study|Withdrawal by Subject|0|||
48555273|NCT02126826|156224478|FG006|Overall Study|Withdrawal by Subject|0|||
48555274|NCT02152605|156224479|FG000|Overall Study|Adverse Event|6|||
48555275|NCT02152605|156224480|FG001|Overall Study|Adverse Event|8|||
48555276|NCT02152605|156224479|FG000|Overall Study|Lack of Efficacy|7|||
48555277|NCT02152605|156224480|FG001|Overall Study|Lack of Efficacy|4|||
48555278|NCT02152605|156224479|FG000|Overall Study|Protocol deviation|1|||
48555279|NCT02152605|156224480|FG001|Overall Study|Protocol deviation|4|||
48555280|NCT02152605|156224479|FG000|Overall Study|Lost to Follow-up|1|||
48555281|NCT02152605|156224480|FG001|Overall Study|Lost to Follow-up|0|||
48555282|NCT02152605|156224479|FG000|Overall Study|Withdrew consent|4|||
48555283|NCT02152605|156224480|FG001|Overall Study|Withdrew consent|2|||
48555284|NCT02500043|156224489|FG000|Overall Study|Randomized, but not Treated|2|||
48555285|NCT02500043|156224490|FG001|Overall Study|Randomized, but not Treated|2|||
48555286|NCT02500043|156224489|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
48555287|NCT02500043|156224490|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
48555288|NCT02500043|156224489|FG000|Overall Study|Adverse Event|33|||
48555289|NCT02500043|156224490|FG001|Overall Study|Adverse Event|11|||
48555290|NCT02500043|156224489|FG000|Overall Study|Clinical Progression|54|||
48555291|NCT02500043|156224490|FG001|Overall Study|Clinical Progression|35|||
48555292|NCT02500043|156224489|FG000|Overall Study|Radiological Progression|192|||
48555293|NCT02500043|156224490|FG001|Overall Study|Radiological Progression|110|||
48555294|NCT02500043|156224489|FG000|Overall Study|Physician's Decision|11|||
48555295|NCT02500043|156224490|FG001|Overall Study|Physician's Decision|3|||
48555296|NCT02500043|156224489|FG000|Overall Study|Withdrawal by Subject|14|||
48555297|NCT02500043|156224490|FG001|Overall Study|Withdrawal by Subject|4|||
48555298|NCT02500043|156224489|FG000|Overall Study|Death|11|||
48555299|NCT02500043|156224490|FG001|Overall Study|Death|2|||
48555300|NCT02500043|156224489|FG000|Overall Study|Protocol Deviation|1|||
48555301|NCT02500043|156224490|FG001|Overall Study|Protocol Deviation|0|||
48555302|NCT01371747|156224491|FG000|Overall Study|Adverse Event|4|||
48555303|NCT01371747|156224492|FG001|Overall Study|Adverse Event|2|||
48555304|NCT01371747|156224493|FG002|Overall Study|Adverse Event|7|||
48555305|NCT01371747|156224494|FG003|Overall Study|Adverse Event|2|||
48555306|NCT01371747|156224495|FG004|Overall Study|Adverse Event|2|||
48555307|NCT01371747|156224496|FG005|Overall Study|Adverse Event|2|||
48555308|NCT01371747|156224491|FG000|Overall Study|Death|1|||
48555309|NCT01371747|156224492|FG001|Overall Study|Death|0|||
48555310|NCT01371747|156224493|FG002|Overall Study|Death|4|||
48555311|NCT01371747|156224494|FG003|Overall Study|Death|1|||
48555312|NCT01371747|156224495|FG004|Overall Study|Death|2|||
48555313|NCT01371747|156224496|FG005|Overall Study|Death|0|||
48555314|NCT01371747|156224491|FG000|Overall Study|Abnormal Renal Function|0|||
48555315|NCT01371747|156224492|FG001|Overall Study|Abnormal Renal Function|2|||
48555316|NCT01371747|156224493|FG002|Overall Study|Abnormal Renal Function|0|||
48555317|NCT01371747|156224494|FG003|Overall Study|Abnormal Renal Function|1|||
48555318|NCT01371747|156224495|FG004|Overall Study|Abnormal Renal Function|0|||
48555319|NCT01371747|156224496|FG005|Overall Study|Abnormal Renal Function|1|||
48555320|NCT01371747|156224491|FG000|Overall Study|High Serum Potassium Results|1|||
48555321|NCT01371747|156224492|FG001|Overall Study|High Serum Potassium Results|1|||
48555322|NCT01371747|156224493|FG002|Overall Study|High Serum Potassium Results|1|||
48555323|NCT01371747|156224494|FG003|Overall Study|High Serum Potassium Results|2|||
48555324|NCT01371747|156224495|FG004|Overall Study|High Serum Potassium Results|0|||
48555325|NCT01371747|156224496|FG005|Overall Study|High Serum Potassium Results|2|||
48555326|NCT01371747|156224491|FG000|Overall Study|Low Serum Potassium Results|1|||
48555327|NCT01371747|156224492|FG001|Overall Study|Low Serum Potassium Results|1|||
48555328|NCT01371747|156224493|FG002|Overall Study|Low Serum Potassium Results|1|||
48555329|NCT01371747|156224494|FG003|Overall Study|Low Serum Potassium Results|1|||
48555330|NCT01371747|156224495|FG004|Overall Study|Low Serum Potassium Results|0|||
48555331|NCT01371747|156224496|FG005|Overall Study|Low Serum Potassium Results|3|||
48555332|NCT01371747|156224491|FG000|Overall Study|Protocol Violation|0|||
48555333|NCT01371747|156224492|FG001|Overall Study|Protocol Violation|0|||
48555334|NCT01371747|156224493|FG002|Overall Study|Protocol Violation|1|||
48555335|NCT01371747|156224494|FG003|Overall Study|Protocol Violation|0|||
48555336|NCT01371747|156224495|FG004|Overall Study|Protocol Violation|0|||
48555337|NCT01371747|156224496|FG005|Overall Study|Protocol Violation|0|||
48555338|NCT01371747|156224491|FG000|Overall Study|Non-Compliance|3|||
48555339|NCT01371747|156224492|FG001|Overall Study|Non-Compliance|4|||
48555340|NCT01371747|156224493|FG002|Overall Study|Non-Compliance|3|||
48555341|NCT01371747|156224494|FG003|Overall Study|Non-Compliance|0|||
48555342|NCT01371747|156224495|FG004|Overall Study|Non-Compliance|0|||
48555343|NCT01371747|156224496|FG005|Overall Study|Non-Compliance|1|||
48555344|NCT01371747|156224491|FG000|Overall Study|Physician Decision|0|||
48555345|NCT01371747|156224492|FG001|Overall Study|Physician Decision|0|||
48555346|NCT01371747|156224493|FG002|Overall Study|Physician Decision|0|||
48555347|NCT01371747|156224494|FG003|Overall Study|Physician Decision|0|||
48555348|NCT01371747|156224495|FG004|Overall Study|Physician Decision|1|||
48555349|NCT01371747|156224496|FG005|Overall Study|Physician Decision|0|||
48555350|NCT01371747|156224491|FG000|Overall Study|Withdrawal by Subject|6|||
48555351|NCT01371747|156224492|FG001|Overall Study|Withdrawal by Subject|12|||
48555352|NCT01371747|156224493|FG002|Overall Study|Withdrawal by Subject|5|||
48555353|NCT01371747|156224494|FG003|Overall Study|Withdrawal by Subject|2|||
48555354|NCT01371747|156224495|FG004|Overall Study|Withdrawal by Subject|2|||
48555355|NCT01371747|156224496|FG005|Overall Study|Withdrawal by Subject|4|||
48555356|NCT01371747|156224491|FG000|Overall Study|Other Reasons|2|||
48555357|NCT01371747|156224492|FG001|Overall Study|Other Reasons|1|||
48555358|NCT01371747|156224493|FG002|Overall Study|Other Reasons|2|||
48614906|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
48614907|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
48614908|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
48614909|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
48614910|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
48555359|NCT01371747|156224494|FG003|Overall Study|Other Reasons|0|||
48555360|NCT01371747|156224495|FG004|Overall Study|Other Reasons|0|||
48555361|NCT01371747|156224496|FG005|Overall Study|Other Reasons|1|||
48555362|NCT00580788|156224500|FG000|Overall Study|Adverse Event|0|||
48555363|NCT00580788|156224501|FG001|Overall Study|Adverse Event|0|||
48555364|NCT00580788|156224502|FG002|Overall Study|Adverse Event|0|||
48555365|NCT00580788|156224503|FG003|Overall Study|Adverse Event|1|||
48555366|NCT02685735|156224504|FG000|Overall Study|Missing construct or pain data|23|||
48555367|NCT02685735|156224505|FG001|Overall Study|Missing construct or pain data|22|||
48555368|NCT03066258|156224506|FG000|Overall Study|Death|1|||
48555369|NCT03066258|156224507|FG001|Overall Study|Death|0|||
48555370|NCT03066258|156224508|FG002|Overall Study|Death|0|||
48555371|NCT03066258|156224509|FG003|Overall Study|Death|0|||
48555372|NCT03066258|156224510|FG004|Overall Study|Death|1|||
48555373|NCT02165735|156224511|FG000|Overall Study|Lost to Follow-up|12|||
48555374|NCT02165735|156224512|FG001|Overall Study|Lost to Follow-up|10|||
48555375|NCT02165735|156224511|FG000|Overall Study|Withdrawal by Subject|3|||
48555376|NCT02165735|156224512|FG001|Overall Study|Withdrawal by Subject|0|||
48555377|NCT02165735|156224511|FG000|Overall Study|Participant indicated lack of time|1|||
48555378|NCT02165735|156224512|FG001|Overall Study|Participant indicated lack of time|3|||
48614911|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
48614912|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
48614913|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
48614914|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
48614915|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
48614916|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
48614917|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
48614918|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
48614919|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
48614920|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
48614921|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
48614922|NCT03329001|156445634|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
48614923|NCT03329001|156445635|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
48614924|NCT03329001|156445636|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
48614925|NCT03329001|156445637|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
48614926|NCT03329001|156445638|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
48614927|NCT03329001|156445639|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
48614928|NCT03329001|156445640|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
48555379|NCT02165735|156224511|FG000|Overall Study|Protocol Violation|0|||
48555380|NCT02165735|156224512|FG001|Overall Study|Protocol Violation|1|||
48555381|NCT01427608|156224513|FG000|Overall Study|Death|1|||
48555382|NCT01427608|156224514|FG001|Overall Study|Death|0|||
48555383|NCT01427608|156224513|FG000|Overall Study|Withdrawal by Subject|7|||
48555384|NCT01427608|156224514|FG001|Overall Study|Withdrawal by Subject|3|||
48555385|NCT01427608|156224513|FG000|Overall Study|Relapsed-all cause|13|||
48555386|NCT01427608|156224514|FG001|Overall Study|Relapsed-all cause|34|||
48555387|NCT01427608|156224513|FG000|Overall Study|Events not attributed to study meds|0|||
48614929|NCT03329001|156445641|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
48555388|NCT01427608|156224514|FG001|Overall Study|Events not attributed to study meds|1|||
48614930|NCT03329001|156445634|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
48614931|NCT03329001|156445635|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
48614932|NCT03329001|156445636|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
48614933|NCT03329001|156445637|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
48614934|NCT03329001|156445638|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
48614935|NCT03329001|156445639|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
48614936|NCT03329001|156445640|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
48614937|NCT03329001|156445641|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
48614938|NCT03329001|156445634|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
48614939|NCT03329001|156445635|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
48614940|NCT03329001|156445636|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
48614941|NCT03329001|156445637|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
48614942|NCT03329001|156445638|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
48614943|NCT03329001|156445639|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
48614944|NCT03329001|156445640|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
48614945|NCT03329001|156445641|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
48614946|NCT03329001|156445634|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
48614947|NCT03329001|156445635|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
48614948|NCT03329001|156445636|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
48614949|NCT03329001|156445637|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
48614950|NCT03329001|156445638|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
48614951|NCT03329001|156445639|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
48614952|NCT03329001|156445640|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
48614953|NCT03329001|156445641|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
48614954|NCT03329001|156445634|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
48614955|NCT03329001|156445635|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
48614956|NCT03329001|156445636|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
48614957|NCT03329001|156445637|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
48614958|NCT03329001|156445638|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
48614959|NCT03329001|156445639|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
48614960|NCT03329001|156445640|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
48614961|NCT03329001|156445641|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
48614962|NCT03329001|156445634|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
48614963|NCT03329001|156445635|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
48614964|NCT03329001|156445636|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
48614965|NCT03329001|156445637|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
48614966|NCT03329001|156445638|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
48614967|NCT03329001|156445639|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
48614968|NCT03329001|156445640|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
48614969|NCT03329001|156445641|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
48614970|NCT03329001|156445634|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
48614971|NCT03329001|156445635|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
48614972|NCT03329001|156445636|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
48614973|NCT03329001|156445637|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
48614974|NCT03329001|156445638|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
48614975|NCT03329001|156445639|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
48614976|NCT03329001|156445640|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
48614977|NCT03329001|156445641|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
48614978|NCT03329001|156445634|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
48614979|NCT03329001|156445635|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
48614980|NCT03329001|156445636|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
48614981|NCT03329001|156445637|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
48614982|NCT03329001|156445638|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
48614983|NCT03329001|156445639|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
48614984|NCT03329001|156445640|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
48614985|NCT03329001|156445641|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
48555389|NCT03993379|156224515|FG000|Overall Study|The study was terminated early due to business decision.|0|||
48555390|NCT03993379|156224516|FG001|Overall Study|The study was terminated early due to business decision.|2|||
48555391|NCT03993379|156224517|FG002|Overall Study|The study was terminated early due to business decision.|0|||
48555392|NCT03993379|156224518|FG003|Overall Study|The study was terminated early due to business decision.|0|||
48555393|NCT03993379|156224515|FG000|Overall Study|Withdrawal by Subject|0|||
48555394|NCT03993379|156224516|FG001|Overall Study|Withdrawal by Subject|1|||
48555395|NCT03993379|156224517|FG002|Overall Study|Withdrawal by Subject|0|||
48555396|NCT03993379|156224518|FG003|Overall Study|Withdrawal by Subject|0|||
48555397|NCT00853099|156224519|FG000|Double-blind Period|Adverse Event|7|||
48555398|NCT00853099|156224520|FG001|Double-blind Period|Adverse Event|9|||
48555399|NCT00853099|156224521|FG002|Double-blind Period|Adverse Event|13|||
48555400|NCT00853099|156224522|FG003|Double-blind Period|Adverse Event|0|||
48555401|NCT00853099|156224519|FG000|Double-blind Period|Withdrawal by Subject|2|||
48555402|NCT00853099|156224520|FG001|Double-blind Period|Withdrawal by Subject|3|||
48555403|NCT00853099|156224521|FG002|Double-blind Period|Withdrawal by Subject|0|||
48555404|NCT00853099|156224522|FG003|Double-blind Period|Withdrawal by Subject|0|||
48555405|NCT00853099|156224519|FG000|Double-blind Period|Lack of Efficacy|14|||
48555406|NCT00853099|156224520|FG001|Double-blind Period|Lack of Efficacy|17|||
48555407|NCT00853099|156224521|FG002|Double-blind Period|Lack of Efficacy|16|||
48555408|NCT00853099|156224522|FG003|Double-blind Period|Lack of Efficacy|0|||
48555409|NCT00853099|156224519|FG000|Double-blind Period|Other|0|||
48555410|NCT00853099|156224520|FG001|Double-blind Period|Other|0|||
48555411|NCT00853099|156224521|FG002|Double-blind Period|Other|1|||
48555412|NCT00853099|156224522|FG003|Double-blind Period|Other|0|||
48555413|NCT00853099|156224519|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
48555414|NCT00853099|156224520|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
48555415|NCT00853099|156224521|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
48555416|NCT00853099|156224522|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
48555417|NCT00853099|156224519|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
48555418|NCT00853099|156224520|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
48555419|NCT00853099|156224521|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
48555420|NCT00853099|156224522|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
48555421|NCT00853099|156224519|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
48555422|NCT00853099|156224520|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
48555423|NCT00853099|156224521|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
48555424|NCT00853099|156224522|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
48555425|NCT00853099|156224519|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
48555426|NCT00853099|156224520|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
48555427|NCT00853099|156224521|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
48555428|NCT00853099|156224522|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
48555429|NCT00853099|156224519|FG000|Double-blind + Open-label Periods|Other|0|||
48555430|NCT00853099|156224520|FG001|Double-blind + Open-label Periods|Other|0|||
48555431|NCT00853099|156224521|FG002|Double-blind + Open-label Periods|Other|0|||
48555432|NCT00853099|156224522|FG003|Double-blind + Open-label Periods|Other|6|||
48555433|NCT01027702|156224527|FG000|Overall Study|Received subsequent therapy|1|||
48614986|NCT03329001|156445634|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
48614987|NCT03329001|156445635|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
48614988|NCT03329001|156445636|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
48614989|NCT03329001|156445637|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
48614990|NCT03329001|156445638|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
48614991|NCT03329001|156445639|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
48614992|NCT03329001|156445640|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
48614993|NCT03329001|156445641|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
48614994|NCT03329001|156445634|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
48555434|NCT01027702|156224528|FG001|Overall Study|Received subsequent therapy|2|||
48614995|NCT03329001|156445635|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
48555435|NCT01027702|156224529|FG002|Overall Study|Received subsequent therapy|0|||
48555436|NCT01027702|156224530|FG003|Overall Study|Received subsequent therapy|4|||
48614996|NCT03329001|156445636|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
48614997|NCT03329001|156445637|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
48555437|NCT01027702|156224531|FG004|Overall Study|Received subsequent therapy|1|||
48555438|NCT01027702|156224532|FG005|Overall Study|Received subsequent therapy|0|||
48555439|NCT01027702|156224533|FG006|Overall Study|Received subsequent therapy|1|||
48555440|NCT01027702|156224527|FG000|Overall Study|Death|0|||
48555441|NCT01027702|156224528|FG001|Overall Study|Death|0|||
48555442|NCT01027702|156224529|FG002|Overall Study|Death|1|||
48555443|NCT01027702|156224530|FG003|Overall Study|Death|0|||
48555444|NCT01027702|156224531|FG004|Overall Study|Death|0|||
48555445|NCT01027702|156224532|FG005|Overall Study|Death|0|||
48555446|NCT01027702|156224533|FG006|Overall Study|Death|0|||
48555447|NCT02604407|156224537|FG000|Overall Study|Adverse Event|0|||
48555448|NCT02604407|156224538|FG001|Overall Study|Adverse Event|7|||
48555449|NCT02604407|156224539|FG002|Overall Study|Adverse Event|5|||
48555450|NCT02604407|156224537|FG000|Overall Study|Protocol Violation|2|||
48555451|NCT02604407|156224538|FG001|Overall Study|Protocol Violation|0|||
48555452|NCT02604407|156224539|FG002|Overall Study|Protocol Violation|0|||
48555453|NCT02604407|156224537|FG000|Overall Study|Withdrawal by Subject|3|||
48555454|NCT02604407|156224538|FG001|Overall Study|Withdrawal by Subject|3|||
48555455|NCT02604407|156224539|FG002|Overall Study|Withdrawal by Subject|5|||
48555456|NCT02604407|156224537|FG000|Overall Study|Lost to Follow-up|2|||
48555457|NCT02604407|156224538|FG001|Overall Study|Lost to Follow-up|1|||
48555458|NCT02604407|156224539|FG002|Overall Study|Lost to Follow-up|2|||
48555459|NCT02604407|156224537|FG000|Overall Study|Lack of Efficacy|1|||
48555460|NCT02604407|156224538|FG001|Overall Study|Lack of Efficacy|0|||
48555461|NCT02604407|156224539|FG002|Overall Study|Lack of Efficacy|0|||
48555462|NCT02604407|156224537|FG000|Overall Study|Other|3|||
48555463|NCT02604407|156224538|FG001|Overall Study|Other|1|||
48555464|NCT02604407|156224539|FG002|Overall Study|Other|4|||
48555465|NCT00185588|156224543|FG000|Overall Study|Adverse Event|3|||
48555466|NCT00185588|156224544|FG001|Overall Study|Adverse Event|1|||
48555467|NCT00185588|156224545|FG002|Overall Study|Adverse Event|4|||
48555468|NCT00185588|156224546|FG003|Overall Study|Adverse Event|2|||
48555469|NCT00185588|156224543|FG000|Overall Study|Lost to Follow-up|0|||
48555470|NCT00185588|156224544|FG001|Overall Study|Lost to Follow-up|0|||
48555471|NCT00185588|156224545|FG002|Overall Study|Lost to Follow-up|1|||
48555472|NCT00185588|156224546|FG003|Overall Study|Lost to Follow-up|2|||
48555473|NCT00185588|156224543|FG000|Overall Study|Withdrawal by Subject|0|||
48555474|NCT00185588|156224544|FG001|Overall Study|Withdrawal by Subject|1|||
48555475|NCT00185588|156224545|FG002|Overall Study|Withdrawal by Subject|0|||
48555476|NCT00185588|156224546|FG003|Overall Study|Withdrawal by Subject|0|||
48555477|NCT00185588|156224543|FG000|Overall Study|Physician Decision|0|||
48555478|NCT00185588|156224544|FG001|Overall Study|Physician Decision|0|||
48555479|NCT00185588|156224545|FG002|Overall Study|Physician Decision|1|||
48555480|NCT00185588|156224546|FG003|Overall Study|Physician Decision|0|||
48555481|NCT00403585|156224547|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
48555482|NCT00403585|156224547|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
48555483|NCT00403585|156224547|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
48555484|NCT00661193|156224548|FG000|Overall Study|Adverse Event|2|||
48555485|NCT00661193|156224549|FG001|Overall Study|Adverse Event|1|||
48555486|NCT00661193|156224548|FG000|Overall Study|Withdrawal by Subject|3|||
48555487|NCT00661193|156224549|FG001|Overall Study|Withdrawal by Subject|1|||
48555488|NCT00661193|156224548|FG000|Overall Study|Progression|27|||
48555489|NCT00661193|156224549|FG001|Overall Study|Progression|24|||
48555490|NCT00661193|156224548|FG000|Overall Study|Not protocol specified|1|||
48555491|NCT00661193|156224549|FG001|Overall Study|Not protocol specified|0|||
48555492|NCT01994850|156224552|FG000|Overall Study|Physician Decision|1|||
48555493|NCT01994850|156224552|FG000|Overall Study|Withdrawal by Subject|1|||
48555494|NCT00606632|156224553|FG000|Overall Study|Withdrawal by Subject|13|||
48555495|NCT00606632|156224553|FG000|Overall Study|Miscellaneous reasons|9|||
48555496|NCT04877457|156224556|FG000|Overall Study|Early termination of study due to low enrollment|2|||
48555497|NCT04877457|156224557|FG001|Overall Study|Early termination of study due to low enrollment|1|||
48555498|NCT02324582|156224560|FG000|Overall Study|Screen Failures|0|||
48555499|NCT02324582|156224561|FG001|Overall Study|Screen Failures|5|||
48555500|NCT00246324|156224562|FG000|Overall Study|Withdrawal by Subject|1|||
48555501|NCT02006732|156224563|FG000|Overall Study|Adverse Event|10|||
48555502|NCT02006732|156224564|FG001|Overall Study|Adverse Event|7|||
48555503|NCT02006732|156224565|FG002|Overall Study|Adverse Event|4|||
48555504|NCT02006732|156224566|FG003|Overall Study|Adverse Event|2|||
48555505|NCT02006732|156224563|FG000|Overall Study|Lack of Efficacy|6|||
48555506|NCT02006732|156224564|FG001|Overall Study|Lack of Efficacy|3|||
48555507|NCT02006732|156224565|FG002|Overall Study|Lack of Efficacy|1|||
48555508|NCT02006732|156224566|FG003|Overall Study|Lack of Efficacy|1|||
48555509|NCT02006732|156224563|FG000|Overall Study|Protocol Violation|1|||
48555510|NCT02006732|156224564|FG001|Overall Study|Protocol Violation|1|||
48555511|NCT02006732|156224565|FG002|Overall Study|Protocol Violation|0|||
48555512|NCT02006732|156224566|FG003|Overall Study|Protocol Violation|0|||
48555513|NCT02006732|156224563|FG000|Overall Study|Lost to Follow-up|0|||
48555514|NCT02006732|156224564|FG001|Overall Study|Lost to Follow-up|1|||
48614998|NCT03329001|156445638|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
48614999|NCT03329001|156445639|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
48615000|NCT03329001|156445640|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
48615001|NCT03329001|156445641|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
48615002|NCT03329001|156445634|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
48615003|NCT03329001|156445635|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
48615004|NCT03329001|156445636|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
48615005|NCT03329001|156445637|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
48615006|NCT03329001|156445638|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
48615007|NCT03329001|156445639|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
48615008|NCT03329001|156445640|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
48615009|NCT03329001|156445641|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
48615010|NCT03329001|156445634|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
48615011|NCT03329001|156445635|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
48615012|NCT03329001|156445636|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
48615013|NCT03329001|156445637|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
48615014|NCT03329001|156445638|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
48615015|NCT03329001|156445639|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
48615016|NCT03329001|156445640|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
48615017|NCT03329001|156445641|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
48615018|NCT03329001|156445634|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
48615019|NCT03329001|156445635|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
48615020|NCT03329001|156445636|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
48615021|NCT03329001|156445637|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
48615022|NCT03329001|156445638|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
48615023|NCT03329001|156445639|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
48615024|NCT03329001|156445640|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
48555515|NCT02006732|156224565|FG002|Overall Study|Lost to Follow-up|0|||
48555516|NCT02006732|156224566|FG003|Overall Study|Lost to Follow-up|0|||
48555517|NCT02006732|156224563|FG000|Overall Study|Withdrawal by Subject|3|||
48555518|NCT02006732|156224564|FG001|Overall Study|Withdrawal by Subject|0|||
48555519|NCT02006732|156224565|FG002|Overall Study|Withdrawal by Subject|4|||
48555520|NCT02006732|156224566|FG003|Overall Study|Withdrawal by Subject|1|||
48615025|NCT03329001|156445641|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
48615026|NCT03329001|156445634|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
48615027|NCT03329001|156445635|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
48615028|NCT03329001|156445636|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
48615029|NCT03329001|156445637|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
48615030|NCT03329001|156445638|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
48615031|NCT03329001|156445639|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
48615032|NCT03329001|156445640|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
48555521|NCT00299130|156224567|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
48555522|NCT00299130|156224568|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
48555523|NCT00299130|156224569|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
48555524|NCT00299130|156224567|FG000|Treatment Period (up to 5 Years)|Death|1|||
48555525|NCT00299130|156224568|FG001|Treatment Period (up to 5 Years)|Death|3|||
48555526|NCT00299130|156224569|FG002|Treatment Period (up to 5 Years)|Death|1|||
48555527|NCT00299130|156224567|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
48615033|NCT03329001|156445641|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
48615034|NCT03329001|156445634|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
48615035|NCT03329001|156445635|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
48615036|NCT03329001|156445636|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
48615037|NCT03329001|156445637|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
48615038|NCT03329001|156445638|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
48615039|NCT03329001|156445639|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
48615040|NCT03329001|156445640|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
48615041|NCT03329001|156445641|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
48615042|NCT03329001|156445634|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
48615043|NCT03329001|156445635|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
48615044|NCT03329001|156445636|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
48615045|NCT03329001|156445637|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
48615046|NCT03329001|156445638|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
48615047|NCT03329001|156445639|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
48615048|NCT03329001|156445640|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
48615049|NCT03329001|156445641|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
48615050|NCT03329001|156445634|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
48555528|NCT00299130|156224568|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
48555529|NCT00299130|156224569|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
48555530|NCT00299130|156224567|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
48555531|NCT00299130|156224568|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
48555532|NCT00299130|156224569|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
48555533|NCT00299130|156224567|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
48555534|NCT00299130|156224568|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
48555535|NCT00299130|156224569|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
48555536|NCT00299130|156224567|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
48555537|NCT00299130|156224568|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
48555538|NCT00299130|156224569|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
48555539|NCT00299130|156224567|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
48555540|NCT00299130|156224568|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
48555541|NCT00299130|156224569|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
48555542|NCT00299130|156224567|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
48555543|NCT00299130|156224568|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
48555544|NCT00299130|156224569|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
48555545|NCT00299130|156224567|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
48555546|NCT00299130|156224568|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
48555547|NCT00299130|156224569|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
48615051|NCT03329001|156445635|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
48693065|NCT01400698|156724663|FG005|Overall Study|Adverse Event|0|||
48555548|NCT00299130|156224567|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
48555549|NCT00299130|156224568|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
48555550|NCT00299130|156224569|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
48555551|NCT00299130|156224567|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
48555552|NCT00299130|156224568|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
48555553|NCT00299130|156224569|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
48555554|NCT00299130|156224567|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
48555555|NCT00299130|156224568|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
48555556|NCT00299130|156224569|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
48555557|NCT00299130|156224567|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
48555558|NCT00299130|156224568|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
48555559|NCT00299130|156224569|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
48555560|NCT00299130|156224567|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
48555561|NCT00299130|156224568|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
48615052|NCT03329001|156445636|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
48615053|NCT03329001|156445637|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
48615054|NCT03329001|156445638|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
48555562|NCT00299130|156224569|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
48555563|NCT00299130|156224567|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
48555564|NCT00299130|156224568|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
48555565|NCT00299130|156224569|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
48555566|NCT00299130|156224567|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
48555567|NCT00299130|156224568|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
48555568|NCT00299130|156224569|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
48555569|NCT00299130|156224567|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
48555570|NCT00299130|156224568|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
48555571|NCT00299130|156224569|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
48555572|NCT00948155|156224571|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
48555573|NCT00948155|156224572|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
48555574|NCT00948155|156224571|FG000|Washout 14 Days|Lost to Follow-up|1|||
48555575|NCT00948155|156224572|FG001|Washout 14 Days|Lost to Follow-up|2|||
48555576|NCT02766335|156224573|FG000|Initial Registration|Adverse Event|6|||
48555577|NCT02766335|156224574|FG001|Initial Registration|Adverse Event|3|||
48555578|NCT02766335|156224575|FG002|Initial Registration|Adverse Event|0|||
48555579|NCT02766335|156224573|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
48555580|NCT02766335|156224574|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
48555581|NCT02766335|156224575|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
48555582|NCT02766335|156224573|FG000|Initial Registration|Progression/relapse|49|||
48615055|NCT03329001|156445639|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
48615056|NCT03329001|156445640|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
48615057|NCT03329001|156445641|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
48615058|NCT04327271|156445644|FG000|Overall Study|Death|1|||
48615059|NCT04327271|156445645|FG001|Overall Study|Death|0|||
48615060|NCT04327271|156445644|FG000|Overall Study|Withdrawal by Subject|1|||
48615061|NCT04327271|156445645|FG001|Overall Study|Withdrawal by Subject|0|||
48615062|NCT04327271|156445644|FG000|Overall Study|randomization error (data capture)|4|||
48615063|NCT04327271|156445645|FG001|Overall Study|randomization error (data capture)|3|||
48615064|NCT03637374|156445646|FG000|Overall Study|Death|2|||
48615065|NCT03637374|156445647|FG001|Overall Study|Death|0|||
48615066|NCT01900314|156445648|FG000|Overall Study|Lost to Follow-up|1|||
48615067|NCT01900314|156445649|FG001|Overall Study|Lost to Follow-up|0|||
48615068|NCT01900314|156445648|FG000|Overall Study|Protocol Violation|0|||
48615069|NCT01900314|156445649|FG001|Overall Study|Protocol Violation|1|||
48615070|NCT01900314|156445648|FG000|Overall Study|Withdrawal by Subject|3|||
48615071|NCT01900314|156445649|FG001|Overall Study|Withdrawal by Subject|3|||
48615072|NCT01136915|156445652|FG000|Overall Study|Lost to Follow-up|2|||
48615073|NCT01136915|156445653|FG001|Overall Study|Lost to Follow-up|0|||
48615074|NCT01136915|156445652|FG000|Overall Study|Exclusion criterion met|0|||
48615075|NCT01136915|156445653|FG001|Overall Study|Exclusion criterion met|1|||
48615076|NCT01756235|156445654|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
48555583|NCT02766335|156224574|FG001|Initial Registration|Progression/relapse|15|||
48555584|NCT02766335|156224575|FG002|Initial Registration|Progression/relapse|0|||
48555585|NCT02766335|156224573|FG000|Initial Registration|Death|1|||
48555586|NCT02766335|156224574|FG001|Initial Registration|Death|3|||
48555587|NCT02766335|156224575|FG002|Initial Registration|Death|0|||
48555588|NCT02766335|156224573|FG000|Initial Registration|not protocol specified|1|||
48555589|NCT02766335|156224574|FG001|Initial Registration|not protocol specified|9|||
48555590|NCT02766335|156224575|FG002|Initial Registration|not protocol specified|0|||
48555591|NCT02766335|156224573|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
48555592|NCT02766335|156224574|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
48555593|NCT02766335|156224575|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
48615077|NCT00376506|156445657|FG000|Overall Study|Death|0|||
48615078|NCT00376506|156445658|FG001|Overall Study|Death|2|||
48615079|NCT02403271|156445659|FG000|Period 1|Other varied reasons|1|||
48615080|NCT02403271|156445660|FG001|Period 1|Other varied reasons|0|||
48615081|NCT02403271|156445659|FG000|Period 2|Withdrawal by Subject|0|||
48615082|NCT02403271|156445660|FG001|Period 2|Withdrawal by Subject|14|||
48615083|NCT02403271|156445659|FG000|Period 2|Death|0|||
48555594|NCT02766335|156224573|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
48555595|NCT02766335|156224574|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
48555596|NCT02766335|156224575|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
48555597|NCT02211417|156224576|FG000|Overall Study|Withdrawal by Subject|11|||
48555598|NCT02211417|156224577|FG001|Overall Study|Withdrawal by Subject|8|||
48555599|NCT02211417|156224576|FG000|Overall Study|Protocol Violation|1|||
48555600|NCT02211417|156224577|FG001|Overall Study|Protocol Violation|0|||
48615084|NCT02403271|156445660|FG001|Period 2|Death|84|||
48615085|NCT02403271|156445659|FG000|Period 2|Lost to Follow-up|0|||
48615086|NCT02403271|156445660|FG001|Period 2|Lost to Follow-up|2|||
48615087|NCT02403271|156445659|FG000|Period 2|Study Terminated by Sponsor|0|||
48615088|NCT02403271|156445660|FG001|Period 2|Study Terminated by Sponsor|14|||
48615089|NCT02403271|156445659|FG000|Period 2|Other varied reasons|0|||
48615090|NCT02403271|156445660|FG001|Period 2|Other varied reasons|10|||
48615091|NCT01695746|156445665|FG000|Overall Study|Adverse Event|1|||
48615092|NCT01695746|156445665|FG000|Overall Study|Non-compliance by the participant|3|||
48615093|NCT01695746|156445665|FG000|Overall Study|Protocol Violation|5|||
48615094|NCT01695746|156445665|FG000|Overall Study|Participant not willing to participate|3|||
48615095|NCT01125748|156445668|FG000|Overall Study|Adverse Event|0|||
48615096|NCT01125748|156445669|FG001|Overall Study|Adverse Event|2|||
48615097|NCT01125748|156445668|FG000|Overall Study|Lost to Follow-up|0|||
48615098|NCT01125748|156445669|FG001|Overall Study|Lost to Follow-up|1|||
48615099|NCT01125748|156445668|FG000|Overall Study|Physician Decision|8|||
48615100|NCT01125748|156445669|FG001|Overall Study|Physician Decision|7|||
48615101|NCT01125748|156445668|FG000|Overall Study|Patient Decision to Withdraw|2|||
48615102|NCT01125748|156445669|FG001|Overall Study|Patient Decision to Withdraw|4|||
48615103|NCT04167670|156447300|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
48615104|NCT04167670|156447301|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
48615105|NCT04167670|156447302|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
48615106|NCT04167670|156447300|FG000|Overall Study|Significant protocol deviation|3|||
48615107|NCT04167670|156447301|FG001|Overall Study|Significant protocol deviation|1|||
48615108|NCT04167670|156447302|FG002|Overall Study|Significant protocol deviation|0|||
48615109|NCT04167670|156447300|FG000|Overall Study|Lost to Follow-up|0|||
48615110|NCT04167670|156447301|FG001|Overall Study|Lost to Follow-up|3|||
48615111|NCT04167670|156447302|FG002|Overall Study|Lost to Follow-up|3|||
48615112|NCT04167670|156447300|FG000|Overall Study|Voluntary Withdrawal|0|||
48615113|NCT04167670|156447301|FG001|Overall Study|Voluntary Withdrawal|1|||
48555601|NCT02211417|156224576|FG000|Overall Study|Pregnancy|0|||
48555602|NCT02211417|156224577|FG001|Overall Study|Pregnancy|1|||
48555603|NCT02211417|156224576|FG000|Overall Study|Lost to Follow-up|2|||
48555604|NCT02211417|156224577|FG001|Overall Study|Lost to Follow-up|3|||
48555605|NCT02211417|156224576|FG000|Overall Study|Adverse Event|1|||
48555606|NCT02211417|156224577|FG001|Overall Study|Adverse Event|4|||
48555607|NCT01198132|156224580|FG000|Overall Study|Withdrawal by Subject|4|||
48555608|NCT01198132|156224581|FG001|Overall Study|Withdrawal by Subject|5|||
48555609|NCT01198132|156224580|FG000|Overall Study|Physician Decision|5|||
48555610|NCT01198132|156224581|FG001|Overall Study|Physician Decision|4|||
48555611|NCT01198132|156224580|FG000|Overall Study|Other Unspecified|3|||
48555612|NCT01198132|156224581|FG001|Overall Study|Other Unspecified|6|||
48555613|NCT01198132|156224580|FG000|Overall Study|Lack of Efficacy|2|||
48555614|NCT01198132|156224581|FG001|Overall Study|Lack of Efficacy|3|||
48555615|NCT01198132|156224580|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
48555616|NCT01198132|156224581|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
48555617|NCT01198132|156224580|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
48615114|NCT04167670|156447302|FG002|Overall Study|Voluntary Withdrawal|1|||
48555618|NCT01198132|156224581|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
48555619|NCT01198132|156224580|FG000|Overall Study|Adverse Event|0|||
48555620|NCT01198132|156224581|FG001|Overall Study|Adverse Event|1|||
48555621|NCT01198132|156224580|FG000|Overall Study|Protocol Violation|1|||
48615115|NCT04167670|156447300|FG000|Overall Study|Withdrawal of Consent|4|||
48615116|NCT04167670|156447301|FG001|Overall Study|Withdrawal of Consent|1|||
48615117|NCT04167670|156447302|FG002|Overall Study|Withdrawal of Consent|3|||
48555622|NCT01198132|156224581|FG001|Overall Study|Protocol Violation|0|||
48555623|NCT04052620|156224586|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
48555624|NCT04052620|156224587|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
48555625|NCT04052620|156224586|FG000|Overall Study|Withdrawal by Subject|1|||
48555626|NCT04052620|156224587|FG001|Overall Study|Withdrawal by Subject|0|||
48555627|NCT04052620|156224586|FG000|Overall Study|Lost to Follow-up|1|||
48555628|NCT04052620|156224587|FG001|Overall Study|Lost to Follow-up|1|||
48555629|NCT04052620|156224586|FG000|Overall Study|Adverse Event|1|||
48615118|NCT04167670|156447300|FG000|Overall Study|Miscellaneous|7|||
48615119|NCT04167670|156447301|FG001|Overall Study|Miscellaneous|5|||
48555630|NCT04052620|156224587|FG001|Overall Study|Adverse Event|0|||
48555631|NCT04052620|156224586|FG000|Overall Study|Subject did not meet study Criteria|0|||
48555632|NCT04052620|156224587|FG001|Overall Study|Subject did not meet study Criteria|1|||
48555633|NCT04052620|156224586|FG000|Overall Study|Screened failure, randomized by mistake|0|||
48555634|NCT04052620|156224587|FG001|Overall Study|Screened failure, randomized by mistake|1|||
48555635|NCT04052620|156224586|FG000|Overall Study|Personal reasons|2|||
48555636|NCT04052620|156224587|FG001|Overall Study|Personal reasons|4|||
48555637|NCT04052620|156224586|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
48555638|NCT04052620|156224587|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
48555639|NCT00345631|156224588|FG000|Overall Study|Withdrawal by Subject|1|||
48555640|NCT00345631|156224589|FG001|Overall Study|Withdrawal by Subject|0|||
48555641|NCT00345631|156224590|FG002|Overall Study|Withdrawal by Subject|1|||
48555642|NCT00345631|156224588|FG000|Overall Study|Adverse Event|0|||
48555643|NCT00345631|156224589|FG001|Overall Study|Adverse Event|1|||
48555644|NCT00345631|156224590|FG002|Overall Study|Adverse Event|0|||
48555645|NCT00345631|156224588|FG000|Overall Study|Lost to Follow-up|3|||
48555646|NCT00345631|156224589|FG001|Overall Study|Lost to Follow-up|7|||
48555647|NCT00345631|156224590|FG002|Overall Study|Lost to Follow-up|4|||
48555648|NCT00345631|156224588|FG000|Overall Study|Other reasons|0|||
48555649|NCT00345631|156224589|FG001|Overall Study|Other reasons|0|||
48555650|NCT00345631|156224590|FG002|Overall Study|Other reasons|1|||
48555651|NCT01406574|156224591|FG000|Overall Study|Adverse Event|0|||
48555652|NCT01406574|156224592|FG001|Overall Study|Adverse Event|0|||
48555653|NCT01406574|156224593|FG002|Overall Study|Adverse Event|1|||
48555654|NCT01406574|156224594|FG003|Overall Study|Adverse Event|3|||
48555655|NCT01406574|156224591|FG000|Overall Study|Physician Decision|0|||
48615120|NCT04167670|156447302|FG002|Overall Study|Miscellaneous|3|||
48555656|NCT01406574|156224592|FG001|Overall Study|Physician Decision|0|||
48555657|NCT01406574|156224593|FG002|Overall Study|Physician Decision|0|||
48555658|NCT01406574|156224594|FG003|Overall Study|Physician Decision|1|||
48693066|NCT01400698|156724658|FG000|Overall Study|Other|4|||
48555659|NCT01406574|156224591|FG000|Overall Study|Withdrawal by Subject|0|||
48555660|NCT01406574|156224592|FG001|Overall Study|Withdrawal by Subject|1|||
48555661|NCT01406574|156224593|FG002|Overall Study|Withdrawal by Subject|0|||
48555662|NCT01406574|156224594|FG003|Overall Study|Withdrawal by Subject|0|||
48555663|NCT01406574|156224591|FG000|Overall Study|Definite progression of primary disease|1|||
48555664|NCT01406574|156224592|FG001|Overall Study|Definite progression of primary disease|0|||
48555665|NCT01406574|156224593|FG002|Overall Study|Definite progression of primary disease|0|||
48555666|NCT01406574|156224594|FG003|Overall Study|Definite progression of primary disease|0|||
48555667|NCT01256879|156224595|FG000|Overall Study|Withdrawal by Subject|1|||
48615121|NCT02293499|156447311|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
48615122|NCT02293499|156447312|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
48615123|NCT02293499|156447313|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
48615124|NCT02293499|156447311|FG000|Intervention - Camp|Withdrawal by Subject|3|||
48615125|NCT02293499|156447312|FG001|Intervention - Camp|Withdrawal by Subject|6|||
48615126|NCT02293499|156447313|FG002|Intervention - Camp|Withdrawal by Subject|2|||
48615127|NCT02293499|156447311|FG000|Intervention - Camp|these are those not showing up at camp|24|||
48615128|NCT02293499|156447312|FG001|Intervention - Camp|these are those not showing up at camp|28|||
48615129|NCT02293499|156447313|FG002|Intervention - Camp|these are those not showing up at camp|4|||
48615130|NCT02293499|156447311|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
48615131|NCT02293499|156447312|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
48615132|NCT02293499|156447313|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
48615133|NCT02293499|156447311|FG000|3 Month Follow Up|Lost to Follow-up|14|||
48615134|NCT02293499|156447312|FG001|3 Month Follow Up|Lost to Follow-up|15|||
48615135|NCT02293499|156447313|FG002|3 Month Follow Up|Lost to Follow-up|6|||
48615136|NCT02293499|156447311|FG000|6 Month Follow Up|Lost to Follow-up|17|||
48615137|NCT02293499|156447312|FG001|6 Month Follow Up|Lost to Follow-up|27|||
48615138|NCT02293499|156447313|FG002|6 Month Follow Up|Lost to Follow-up|6|||
48615139|NCT02293499|156447311|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
48615140|NCT02293499|156447312|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
48615141|NCT02293499|156447313|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
48555668|NCT01911273|156224597|FG000|Overall Study|Progression of Disease|1|||
48555669|NCT01911273|156224598|FG001|Overall Study|Progression of Disease|0|||
48555670|NCT01911273|156224597|FG000|Overall Study|Withdrawal by Subject|0|||
48555671|NCT01911273|156224598|FG001|Overall Study|Withdrawal by Subject|2|||
48555672|NCT03552380|156224599|FG000|Study Treatment|Disease Progression|3|||
48555673|NCT03552380|156224600|FG001|Study Treatment|Disease Progression|4|||
48555674|NCT03552380|156224599|FG000|Study Treatment|Adverse Event|2|||
48555675|NCT03552380|156224600|FG001|Study Treatment|Adverse Event|2|||
48555676|NCT03552380|156224599|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
48555677|NCT03552380|156224600|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
48555678|NCT03552380|156224599|FG000|Follow up|Death|3|||
48555679|NCT03552380|156224600|FG001|Follow up|Death|4|||
48555680|NCT03552380|156224599|FG000|Follow up|Site IRB terminated|0|||
48555681|NCT03552380|156224600|FG001|Follow up|Site IRB terminated|1|||
48555682|NCT01308424|156224605|FG000|Baseline Eligibility|Screen Failures|71|||
48555683|NCT01308424|156224606|FG001|Baseline Eligibility|Screen Failures|0|||
48555684|NCT01308424|156224607|FG002|Baseline Eligibility|Screen Failures|0|||
48555685|NCT01308424|156224605|FG000|Randomization|Adverse Event|0|||
48615142|NCT02293499|156447311|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
48615143|NCT02293499|156447312|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
48615144|NCT02293499|156447313|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
48555686|NCT01308424|156224606|FG001|Randomization|Adverse Event|1|||
48555687|NCT01308424|156224607|FG002|Randomization|Adverse Event|1|||
48555688|NCT01308424|156224605|FG000|Randomization|Lost to Follow-up|0|||
48615145|NCT02293499|156447311|FG000|9 Month Follow Up|Lost to Follow-up|24|||
48615146|NCT02293499|156447312|FG001|9 Month Follow Up|Lost to Follow-up|28|||
48555689|NCT01308424|156224606|FG001|Randomization|Lost to Follow-up|1|||
48555690|NCT01308424|156224607|FG002|Randomization|Lost to Follow-up|0|||
48615147|NCT02293499|156447313|FG002|9 Month Follow Up|Lost to Follow-up|4|||
48615148|NCT02293499|156447311|FG000|12 Month Follow Up|Lost to Follow-up|26|||
48615149|NCT02293499|156447312|FG001|12 Month Follow Up|Lost to Follow-up|25|||
48615150|NCT02293499|156447313|FG002|12 Month Follow Up|Lost to Follow-up|6|||
48555691|NCT01308424|156224605|FG000|Randomization|Physician Decision|0|||
48555692|NCT01308424|156224606|FG001|Randomization|Physician Decision|1|||
48615151|NCT02293499|156447311|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
48615152|NCT02293499|156447312|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
48615153|NCT02293499|156447313|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
48615154|NCT02293499|156447311|FG000|15 Month Follow Up|Lost to Follow-up|22|||
48615155|NCT02293499|156447312|FG001|15 Month Follow Up|Lost to Follow-up|22|||
48555693|NCT01308424|156224607|FG002|Randomization|Physician Decision|1|||
48555694|NCT02308124|156224608|FG000|Overall Study|Lost to Follow-up|6|||
48555695|NCT02308124|156224609|FG001|Overall Study|Lost to Follow-up|6|||
48555696|NCT02308124|156224610|FG002|Overall Study|Lost to Follow-up|6|||
48555697|NCT02308124|156224608|FG000|Overall Study|Adverse Event|0|||
48555698|NCT02308124|156224609|FG001|Overall Study|Adverse Event|2|||
48555699|NCT02308124|156224610|FG002|Overall Study|Adverse Event|2|||
48555700|NCT00739063|156224611|FG000|Overall Study|Screen failures|8|||
48555701|NCT02201784|156224612|FG000|Overall Study|Failure to achieve adequate block|2|||
48555702|NCT02201784|156224613|FG001|Overall Study|Failure to achieve adequate block|0|||
48555703|NCT05101343|156224614|FG000|Overall Study|Withdrawal by Subject|2|||
48555704|NCT05101343|156224615|FG001|Overall Study|Withdrawal by Subject|1|||
48555705|NCT04971187|156226185|FG000|Overall Study|Screen failures|2|||
48555706|NCT01443728|156226186|FG000|Overall Study|Lost to Follow-up|2|||
48555707|NCT01443728|156226187|FG001|Overall Study|Lost to Follow-up|0|||
48555708|NCT01443728|156226186|FG000|Overall Study|Withdrawal by Subject|1|||
48555709|NCT01443728|156226187|FG001|Overall Study|Withdrawal by Subject|1|||
48615156|NCT02293499|156447313|FG002|15 Month Follow Up|Lost to Follow-up|7|||
48615157|NCT05417113|156447314|FG000|Overall Study|Lost to Follow-up|2|||
48615158|NCT05417113|156447315|FG001|Overall Study|Lost to Follow-up|2|||
48555710|NCT01443728|156226186|FG000|Overall Study|Adverse Event|0|||
48555711|NCT01443728|156226187|FG001|Overall Study|Adverse Event|2|||
48615159|NCT01022580|156447316|FG000|Overall Study|Death|18|||
48615160|NCT01022580|156447317|FG001|Overall Study|Death|22|||
48615161|NCT01239680|156447320|FG000|Overall Study|Withdrawal by Subject|2|||
48615162|NCT01239680|156447321|FG001|Overall Study|Withdrawal by Subject|0|||
48615163|NCT01631188|156447322|FG000|Overall Study|Physician Decision|75|||
48615164|NCT01431976|156447323|FG000|Overall Study|Adverse Event|6|||
48555712|NCT03301649|156226188|FG000|Overall Study|Need alternate therapy due to live lice|17|||
48555713|NCT03301649|156226189|FG001|Overall Study|Need alternate therapy due to live lice|25|||
48555714|NCT03301649|156226190|FG002|Overall Study|Need alternate therapy due to live lice|81|||
48555715|NCT03301649|156226188|FG000|Overall Study|Lost to Follow-up|11|||
48555716|NCT03301649|156226189|FG001|Overall Study|Lost to Follow-up|11|||
48555717|NCT03301649|156226190|FG002|Overall Study|Lost to Follow-up|3|||
48555718|NCT03301649|156226188|FG000|Overall Study|Protocol Violation|0|||
48555719|NCT03301649|156226189|FG001|Overall Study|Protocol Violation|1|||
48555720|NCT03301649|156226190|FG002|Overall Study|Protocol Violation|1|||
48555721|NCT03301649|156226188|FG000|Overall Study|Withdrawal by Subject|10|||
48555722|NCT03301649|156226189|FG001|Overall Study|Withdrawal by Subject|4|||
48555723|NCT03301649|156226190|FG002|Overall Study|Withdrawal by Subject|0|||
48555724|NCT03301649|156226188|FG000|Overall Study|Other than specified|5|||
48555725|NCT03301649|156226189|FG001|Overall Study|Other than specified|3|||
48555726|NCT03301649|156226190|FG002|Overall Study|Other than specified|0|||
48555727|NCT02964312|156226191|FG000|Overall Study|Lost to Follow-up|28|||
48555728|NCT02964312|156226191|FG000|Overall Study|Withdrawal by Subject|11|||
48555729|NCT02964312|156226191|FG000|Overall Study|Lack of Efficacy|10|||
48555730|NCT02964312|156226191|FG000|Overall Study|Did not consent to long-term FU|14|||
48555731|NCT02964312|156226191|FG000|Overall Study|Death|1|||
48555732|NCT02481869|156226196|FG000|Overall Study|Lost to Follow-up|3|||
48555733|NCT02481869|156226197|FG001|Overall Study|Lost to Follow-up|4|||
48555734|NCT02481869|156226196|FG000|Overall Study|Withdrawal by Subject|2|||
48555735|NCT02481869|156226197|FG001|Overall Study|Withdrawal by Subject|0|||
48555736|NCT00711880|156226198|FG000|Overall Study|Adverse Event|11|||
48555737|NCT00711880|156226199|FG001|Overall Study|Adverse Event|2|||
48555738|NCT00711880|156226198|FG000|Overall Study|Patient non-compliance|1|||
48615165|NCT01431976|156447323|FG000|Overall Study|Lack of Efficacy|2|||
48615166|NCT01431976|156447323|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
48555739|NCT00711880|156226199|FG001|Overall Study|Patient non-compliance|0|||
48555740|NCT00711880|156226198|FG000|Overall Study|Lack of Efficacy|1|||
48555741|NCT00711880|156226199|FG001|Overall Study|Lack of Efficacy|5|||
48555742|NCT03685344|156226205|FG000|Overall Study|Withdrawal by Subject|1|||
48555743|NCT03685344|156226206|FG001|Overall Study|Withdrawal by Subject|1|||
48615167|NCT01431976|156447323|FG000|Overall Study|Physician Decision|1|||
48615168|NCT01431976|156447323|FG000|Overall Study|Withdrawal by Subject|1|||
48555744|NCT03685344|156226207|FG002|Overall Study|Withdrawal by Subject|2|||
48555745|NCT03685344|156226208|FG003|Overall Study|Withdrawal by Subject|0|||
48555746|NCT03685344|156226205|FG000|Overall Study|Physician Decision|1|||
48555747|NCT03685344|156226206|FG001|Overall Study|Physician Decision|1|||
48555748|NCT03685344|156226207|FG002|Overall Study|Physician Decision|5|||
48615169|NCT01033942|156447334|FG000|Overall Study|Withdrawal by Subject|1|||
48615170|NCT01033942|156447335|FG001|Overall Study|Withdrawal by Subject|1|||
48555749|NCT03685344|156226208|FG003|Overall Study|Physician Decision|0|||
48555750|NCT03685344|156226205|FG000|Overall Study|Death|1|||
48555751|NCT03685344|156226206|FG001|Overall Study|Death|1|||
48615171|NCT01033942|156447336|FG002|Overall Study|Withdrawal by Subject|1|||
48615172|NCT01033942|156447334|FG000|Overall Study|Lost to Follow-up|1|||
48555752|NCT03685344|156226207|FG002|Overall Study|Death|0|||
48615173|NCT01033942|156447335|FG001|Overall Study|Lost to Follow-up|0|||
48615174|NCT01033942|156447336|FG002|Overall Study|Lost to Follow-up|0|||
48555753|NCT03685344|156226208|FG003|Overall Study|Death|0|||
48555754|NCT00191191|156226209|FG000|Overall Study|Entry Criteria Exclusion|2|||
48555755|NCT00191191|156226210|FG001|Overall Study|Entry Criteria Exclusion|0|||
48555756|NCT00191191|156226209|FG000|Overall Study|Treated with Another Systemic Agent|1|||
48615175|NCT01033942|156447334|FG000|Overall Study|Enrolled in Extension Study|0|||
48615176|NCT01033942|156447335|FG001|Overall Study|Enrolled in Extension Study|3|||
48615177|NCT01033942|156447336|FG002|Overall Study|Enrolled in Extension Study|0|||
48615178|NCT02693418|156447337|FG000|Overall Study|Lost to Follow-up|1|||
48615179|NCT02693418|156447338|FG001|Overall Study|Lost to Follow-up|2|||
48555757|NCT00191191|156226210|FG001|Overall Study|Treated with Another Systemic Agent|1|||
48555758|NCT00191191|156226209|FG000|Overall Study|Adverse Event|11|||
48555759|NCT00191191|156226210|FG001|Overall Study|Adverse Event|21|||
48555760|NCT00191191|156226209|FG000|Overall Study|Progressive Disease|84|||
48555761|NCT00191191|156226210|FG001|Overall Study|Progressive Disease|72|||
48555762|NCT00191191|156226209|FG000|Overall Study|Toxicity After Dose Reduction|7|||
48555763|NCT00191191|156226210|FG001|Overall Study|Toxicity After Dose Reduction|8|||
48555764|NCT00191191|156226209|FG000|Overall Study|Family/Caregiver Decision|5|||
48555765|NCT00191191|156226210|FG001|Overall Study|Family/Caregiver Decision|7|||
48555766|NCT00191191|156226209|FG000|Overall Study|Lost to Follow-up|1|||
48555767|NCT00191191|156226210|FG001|Overall Study|Lost to Follow-up|0|||
48555768|NCT00191191|156226209|FG000|Overall Study|Physician Decision|3|||
48555769|NCT00191191|156226210|FG001|Overall Study|Physician Decision|2|||
48555770|NCT00191191|156226209|FG000|Overall Study|Good Clinical Practice Violation|0|||
48555771|NCT00191191|156226210|FG001|Overall Study|Good Clinical Practice Violation|1|||
48555772|NCT03348163|156226213|FG000|Overall Study|Withdrawal by Subject|2|||
48555773|NCT03348163|156226214|FG001|Overall Study|Withdrawal by Subject|0|||
48555774|NCT03126435|156226215|FG000|Overall Study|Death|90|||
48555775|NCT03126435|156226216|FG001|Overall Study|Death|84|||
48555776|NCT03126435|156226215|FG000|Overall Study|Lost to Follow-up|4|||
48555777|NCT03126435|156226216|FG001|Overall Study|Lost to Follow-up|3|||
48555778|NCT03126435|156226215|FG000|Overall Study|Physician Decision|0|||
48555779|NCT03126435|156226216|FG001|Overall Study|Physician Decision|1|||
48555780|NCT03126435|156226215|FG000|Overall Study|Withdrawal by Subject|6|||
48555781|NCT03126435|156226216|FG001|Overall Study|Withdrawal by Subject|12|||
48555782|NCT03126435|156226215|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
48555783|NCT03126435|156226216|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
48555784|NCT02756208|156226220|FG000|Overall Study|Withdrawal by Subject|1|||
48555785|NCT02756208|156226221|FG001|Overall Study|Withdrawal by Subject|0|||
48555786|NCT02756208|156226222|FG002|Overall Study|Withdrawal by Subject|1|||
48555787|NCT02756208|156226223|FG003|Overall Study|Withdrawal by Subject|3|||
48555788|NCT02756208|156226220|FG000|Overall Study|Lost to Follow-up|3|||
48555789|NCT02756208|156226221|FG001|Overall Study|Lost to Follow-up|1|||
48615180|NCT02693418|156447339|FG002|Overall Study|Lost to Follow-up|0|||
48615181|NCT02693418|156447340|FG003|Overall Study|Lost to Follow-up|0|||
48615182|NCT02693418|156447341|FG004|Overall Study|Lost to Follow-up|0|||
48615183|NCT02693418|156447337|FG000|Overall Study|Menses during study period|0|||
48615184|NCT02693418|156447338|FG001|Overall Study|Menses during study period|0|||
48615185|NCT02693418|156447339|FG002|Overall Study|Menses during study period|2|||
48615186|NCT02693418|156447340|FG003|Overall Study|Menses during study period|0|||
48615187|NCT02693418|156447341|FG004|Overall Study|Menses during study period|0|||
48615188|NCT02737618|156447342|FG000|Overall Study|Withdrawal by Subject|9|||
48615189|NCT00393367|156447346|FG000|Overall Study|Protocol Violation|2|||
48615190|NCT00393367|156447347|FG001|Overall Study|Protocol Violation|5|||
48615191|NCT00393367|156447346|FG000|Overall Study|Withdrawal by Subject|0|||
48615192|NCT00393367|156447347|FG001|Overall Study|Withdrawal by Subject|2|||
48555790|NCT02756208|156226222|FG002|Overall Study|Lost to Follow-up|1|||
48555791|NCT02756208|156226223|FG003|Overall Study|Lost to Follow-up|1|||
48555792|NCT02756208|156226220|FG000|Overall Study|Physician Decision|1|||
48555793|NCT02756208|156226221|FG001|Overall Study|Physician Decision|0|||
48555794|NCT02756208|156226222|FG002|Overall Study|Physician Decision|0|||
48615193|NCT01432951|156447348|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
48555795|NCT02756208|156226223|FG003|Overall Study|Physician Decision|0|||
48615194|NCT05350423|156447351|FG000|Overall Study|Lost to Follow-up|3|||
48555796|NCT02756208|156226220|FG000|Overall Study|Protocol Violation|0|||
48615195|NCT05350423|156447352|FG001|Overall Study|Lost to Follow-up|3|||
48615196|NCT05350423|156447351|FG000|Overall Study|screen failure|5|||
48615197|NCT05350423|156447352|FG001|Overall Study|screen failure|6|||
48555797|NCT02756208|156226221|FG001|Overall Study|Protocol Violation|1|||
48555798|NCT02756208|156226222|FG002|Overall Study|Protocol Violation|0|||
48555799|NCT02756208|156226223|FG003|Overall Study|Protocol Violation|0|||
48693067|NCT01400698|156724659|FG001|Overall Study|Other|2|||
48555800|NCT02121652|156226224|FG000|Overall Study|Lost to Follow-up|2|||
48555801|NCT02121652|156226225|FG001|Overall Study|Lost to Follow-up|1|||
48555802|NCT02121652|156226224|FG000|Overall Study|Death|1|||
48555803|NCT02121652|156226225|FG001|Overall Study|Death|0|||
48555804|NCT02121652|156226224|FG000|Overall Study|Withdrawal by Subject|3|||
48555805|NCT02121652|156226225|FG001|Overall Study|Withdrawal by Subject|3|||
48555806|NCT02276807|156226227|FG000|Overall Study|Withdrawal by Subject|8|||
48555807|NCT02276807|156226228|FG001|Overall Study|Withdrawal by Subject|7|||
48555808|NCT02276807|156226227|FG000|Overall Study|Lost to Follow-up|10|||
48555809|NCT02276807|156226228|FG001|Overall Study|Lost to Follow-up|10|||
48555810|NCT04841577|156226229|FG000|Overall Study|Adverse Event|5|||
48555811|NCT04841577|156226230|FG001|Overall Study|Adverse Event|10|||
48555812|NCT04841577|156226229|FG000|Overall Study|Lost to Follow-up|8|||
48615198|NCT01018979|156447353|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
48615199|NCT01018979|156447354|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
48615200|NCT01018979|156447353|FG000|Overall Study|Not received at least one dose|0|||
48615201|NCT01018979|156447354|FG001|Overall Study|Not received at least one dose|1|||
48615202|NCT02278354|156447355|FG000|Overall Study|Lost to Follow-up|2|||
48615203|NCT02278354|156447356|FG001|Overall Study|Lost to Follow-up|2|||
48555813|NCT04841577|156226230|FG001|Overall Study|Lost to Follow-up|7|||
48555814|NCT04841577|156226229|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
48555815|NCT04841577|156226230|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
48555816|NCT04841577|156226229|FG000|Overall Study|Other|0|||
48555817|NCT04841577|156226230|FG001|Overall Study|Other|1|||
48555818|NCT00261950|156226237|FG000|Overall Study|Lost to Follow-up|2|||
48555819|NCT00261950|156226237|FG000|Overall Study|Death|6|||
48555820|NCT00261950|156226237|FG000|Overall Study|Withdrawal by Subject|5|||
48555821|NCT00261950|156226237|FG000|Overall Study|Other|1|||
48555822|NCT00261950|156226237|FG000|Overall Study|Physician Decision|1|||
48555823|NCT00261950|156226237|FG000|Overall Study|Protocol specified Criteria|11|||
48555824|NCT03280264|156226240|FG000|Overall Study|Adverse Event|1|||
48555825|NCT03280264|156226240|FG000|Overall Study|Physician Decision|1|||
48555826|NCT03280264|156226240|FG000|Overall Study|Withdrawal by Subject|1|||
48555827|NCT02370238|156226241|FG000|Overall Study|Death|42|||
48555828|NCT02370238|156226242|FG001|Overall Study|Death|35|||
48555829|NCT02370238|156226241|FG000|Overall Study|Lost to Follow-up|1|||
48555830|NCT02370238|156226242|FG001|Overall Study|Lost to Follow-up|3|||
48555831|NCT02370238|156226241|FG000|Overall Study|Withdrawal by Subject|2|||
48555832|NCT02370238|156226242|FG001|Overall Study|Withdrawal by Subject|6|||
48555833|NCT02370238|156226241|FG000|Overall Study|Other|2|||
48555834|NCT02370238|156226242|FG001|Overall Study|Other|1|||
48555835|NCT00445432|156226248|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
48555836|NCT00445432|156226249|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
48555837|NCT00445432|156226250|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
48555838|NCT00445432|156226251|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
48555839|NCT00445432|156226248|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
48555840|NCT00445432|156226249|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
48555841|NCT00445432|156226250|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
48555842|NCT00445432|156226251|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
48555843|NCT00445432|156226248|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
48555844|NCT00445432|156226249|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
48555845|NCT00445432|156226250|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
48555846|NCT00445432|156226251|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
48555847|NCT00445432|156226248|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
48555848|NCT00445432|156226249|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
48555849|NCT00445432|156226250|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
48555850|NCT00445432|156226251|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
48555851|NCT00445432|156226248|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
48555852|NCT00445432|156226249|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
48555853|NCT00445432|156226250|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
48615204|NCT02278354|156447355|FG000|Overall Study|Withdrawal by Subject|0|||
48555854|NCT00445432|156226251|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
48555855|NCT00445432|156226248|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
48615205|NCT02278354|156447356|FG001|Overall Study|Withdrawal by Subject|1|||
48615206|NCT02278354|156447355|FG000|Overall Study|<10 professional fights|2|||
48615207|NCT02278354|156447356|FG001|Overall Study|<10 professional fights|0|||
48615208|NCT03188185|156447360|FG000|Stage 1|Adverse Event|4|||
48555856|NCT00445432|156226249|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
48555857|NCT00445432|156226250|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
48555858|NCT00445432|156226251|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
48555859|NCT00445432|156226248|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
48555860|NCT00445432|156226249|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
48555861|NCT00445432|156226250|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
48555862|NCT00445432|156226251|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
48555863|NCT02290405|156226254|FG000|Overall Study|Withdrawal by Subject|1|||
48555864|NCT02290405|156226255|FG001|Overall Study|Withdrawal by Subject|0|||
48555865|NCT03645863|156226256|FG000|Overall Study|Withdrawal by Subject|1|||
48555866|NCT03645863|156226257|FG001|Overall Study|Withdrawal by Subject|0|||
48555867|NCT03645863|156226258|FG002|Overall Study|Withdrawal by Subject|0|||
48555868|NCT02016183|156226260|FG000|Overall Study|Case Report Forms Uncollected|13|||
48555869|NCT02016183|156226260|FG000|Overall Study|Protocol Violation|52|||
48555870|NCT00996489|156226261|FG000|Overall Study|Device failure|45|||
48555871|NCT00996489|156226261|FG000|Overall Study|Discontinued|116|||
48555872|NCT01070953|156226262|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
48555873|NCT01070953|156226262|FG000|Participants for Safety Evaluation|Off-label use|283|||
48555874|NCT01070953|156226262|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
48555875|NCT01070953|156226262|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
48555876|NCT01070953|156226262|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
48555877|NCT01070953|156226262|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
48555878|NCT01070953|156226262|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
48555879|NCT01070953|156226262|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
48555880|NCT01070953|156226262|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
48555881|NCT01070953|156226262|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
48555882|NCT01755091|156226263|FG000|Overall Study|Withdrawal by Subject|6|||
48555883|NCT01755091|156226264|FG001|Overall Study|Withdrawal by Subject|1|||
48555884|NCT01755091|156226265|FG002|Overall Study|Withdrawal by Subject|3|||
48555885|NCT01755091|156226263|FG000|Overall Study|Adverse Event|1|||
48555886|NCT01755091|156226264|FG001|Overall Study|Adverse Event|1|||
48555887|NCT01755091|156226265|FG002|Overall Study|Adverse Event|1|||
48555888|NCT01755091|156226263|FG000|Overall Study|Lost to Follow-up|1|||
48555889|NCT01755091|156226264|FG001|Overall Study|Lost to Follow-up|0|||
48555890|NCT01755091|156226265|FG002|Overall Study|Lost to Follow-up|1|||
48555891|NCT01755091|156226263|FG000|Overall Study|Physician Decision|1|||
48555892|NCT01755091|156226264|FG001|Overall Study|Physician Decision|1|||
48555893|NCT01755091|156226265|FG002|Overall Study|Physician Decision|2|||
48555894|NCT03142191|156226266|FG000|Placebo Controlled Period|Death|0|||
48555895|NCT03142191|156226267|FG001|Placebo Controlled Period|Death|1|||
48555896|NCT03142191|156226268|FG002|Placebo Controlled Period|Death|1|||
48555897|NCT03142191|156226269|FG003|Placebo Controlled Period|Death|0|||
48555898|NCT03142191|156226270|FG004|Placebo Controlled Period|Death|0|||
48555899|NCT03142191|156226266|FG000|Placebo Controlled Period|Adverse Event|4|||
48555900|NCT03142191|156226267|FG001|Placebo Controlled Period|Adverse Event|5|||
48555901|NCT03142191|156226268|FG002|Placebo Controlled Period|Adverse Event|1|||
48555902|NCT03142191|156226269|FG003|Placebo Controlled Period|Adverse Event|0|||
48555903|NCT03142191|156226270|FG004|Placebo Controlled Period|Adverse Event|0|||
48555904|NCT03142191|156226266|FG000|Placebo Controlled Period|Progressive Disease|1|||
48615209|NCT03188185|156447361|FG001|Stage 1|Adverse Event|12|||
48325490|NCT03577106|155389118|FG000|Overall Study|Withdrawal by Subject|3|||
48325491|NCT01579318|155389120|FG000|Overall Study|Disease Progression|1|||
48325492|NCT02797132|155389123|FG000|Part A (15 Days)|Adverse Event|1|||
48325493|NCT02797132|155389123|FG000|Part B (24 Weeks)|Adverse Event|3|||
48325494|NCT00442104|155389124|FG000|Overall Study|Adverse Event|5|||
48325495|NCT00442104|155389124|FG000|Overall Study|Death|2|||
48555905|NCT03142191|156226267|FG001|Placebo Controlled Period|Progressive Disease|0|||
48555906|NCT03142191|156226268|FG002|Placebo Controlled Period|Progressive Disease|1|||
48555907|NCT03142191|156226269|FG003|Placebo Controlled Period|Progressive Disease|0|||
48325496|NCT00442104|155389124|FG000|Overall Study|Lost to Follow-up|3|||
48325497|NCT00442104|155389124|FG000|Overall Study|Withdrawal by Subject|5|||
48325498|NCT00442104|155389124|FG000|Overall Study|Insufficient Clinical Response|10|||
48325499|NCT00442104|155389124|FG000|Overall Study|Other|21|||
48555908|NCT03142191|156226270|FG004|Placebo Controlled Period|Progressive Disease|0|||
48555909|NCT03142191|156226266|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
48555910|NCT03142191|156226267|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
48555911|NCT03142191|156226268|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
48555912|NCT03142191|156226269|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
48555913|NCT03142191|156226270|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
48555914|NCT03142191|156226266|FG000|Placebo Controlled Period|Other Reasons|1|||
48615210|NCT03188185|156447362|FG002|Stage 1|Adverse Event|0|||
48615211|NCT03188185|156447363|FG003|Stage 1|Adverse Event|0|||
48615212|NCT03188185|156447360|FG000|Stage 1|Lack of Efficacy|0|||
48615213|NCT03188185|156447361|FG001|Stage 1|Lack of Efficacy|2|||
48615214|NCT03188185|156447362|FG002|Stage 1|Lack of Efficacy|0|||
48615215|NCT03188185|156447363|FG003|Stage 1|Lack of Efficacy|0|||
48325500|NCT00442104|155389124|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
48555915|NCT03142191|156226267|FG001|Placebo Controlled Period|Other Reasons|0|||
48555916|NCT03142191|156226268|FG002|Placebo Controlled Period|Other Reasons|0|||
48555917|NCT03142191|156226269|FG003|Placebo Controlled Period|Other Reasons|0|||
48615216|NCT03188185|156447360|FG000|Stage 1|Lost to Follow-up|6|||
48615217|NCT03188185|156447361|FG001|Stage 1|Lost to Follow-up|1|||
48615218|NCT03188185|156447362|FG002|Stage 1|Lost to Follow-up|0|||
48325501|NCT03601715|155389125|FG000|Second Intervention|Lost to Follow-up|1|||
48325502|NCT03601715|155389126|FG001|Second Intervention|Lost to Follow-up|1|||
48325503|NCT03601715|155389127|FG002|Second Intervention|Lost to Follow-up|0|||
48325504|NCT02502526|155389130|FG000|Overall Study|Lost to Follow-up|2|||
48615219|NCT03188185|156447363|FG003|Stage 1|Lost to Follow-up|0|||
48615220|NCT03188185|156447360|FG000|Stage 1|Withdrawal by Subject|9|||
48615221|NCT03188185|156447361|FG001|Stage 1|Withdrawal by Subject|0|||
48615222|NCT03188185|156447362|FG002|Stage 1|Withdrawal by Subject|0|||
48615223|NCT03188185|156447363|FG003|Stage 1|Withdrawal by Subject|0|||
48615224|NCT03188185|156447360|FG000|Stage 1|Identified as a professional patient|0|||
48615225|NCT03188185|156447361|FG001|Stage 1|Identified as a professional patient|1|||
48615226|NCT03188185|156447362|FG002|Stage 1|Identified as a professional patient|0|||
48615227|NCT03188185|156447363|FG003|Stage 1|Identified as a professional patient|0|||
48615228|NCT03188185|156447360|FG000|Stage 2|Adverse Event|0|||
48615229|NCT03188185|156447361|FG001|Stage 2|Adverse Event|0|||
48615230|NCT03188185|156447362|FG002|Stage 2|Adverse Event|2|||
48615231|NCT03188185|156447363|FG003|Stage 2|Adverse Event|4|||
48615232|NCT03188185|156447360|FG000|Stage 2|Lack of Efficacy|0|||
48615233|NCT03188185|156447361|FG001|Stage 2|Lack of Efficacy|0|||
48615234|NCT03188185|156447362|FG002|Stage 2|Lack of Efficacy|3|||
48325505|NCT02502526|155389131|FG001|Overall Study|Lost to Follow-up|2|||
48325506|NCT02502526|155389132|FG002|Overall Study|Lost to Follow-up|3|||
48555918|NCT03142191|156226270|FG004|Placebo Controlled Period|Other Reasons|0|||
48555919|NCT03142191|156226266|FG000|Active Treatment Extension Period|Death|2|||
48615235|NCT03188185|156447363|FG003|Stage 2|Lack of Efficacy|0|||
48615236|NCT03188185|156447360|FG000|Stage 2|Lost to Follow-up|0|||
48615237|NCT03188185|156447361|FG001|Stage 2|Lost to Follow-up|0|||
48615238|NCT03188185|156447362|FG002|Stage 2|Lost to Follow-up|1|||
48615239|NCT03188185|156447363|FG003|Stage 2|Lost to Follow-up|0|||
48325507|NCT02502526|155389130|FG000|Overall Study|Withdrawal by Subject|0|||
48615240|NCT03188185|156447360|FG000|Stage 2|Physician Decision|0|||
48615241|NCT03188185|156447361|FG001|Stage 2|Physician Decision|0|||
48615242|NCT03188185|156447362|FG002|Stage 2|Physician Decision|0|||
48555920|NCT03142191|156226267|FG001|Active Treatment Extension Period|Death|1|||
48555921|NCT03142191|156226268|FG002|Active Treatment Extension Period|Death|1|||
48555922|NCT03142191|156226269|FG003|Active Treatment Extension Period|Death|1|||
48555923|NCT03142191|156226270|FG004|Active Treatment Extension Period|Death|0|||
48555924|NCT03142191|156226266|FG000|Active Treatment Extension Period|Adverse Event|6|||
48555925|NCT03142191|156226267|FG001|Active Treatment Extension Period|Adverse Event|5|||
48555926|NCT03142191|156226268|FG002|Active Treatment Extension Period|Adverse Event|4|||
48555927|NCT03142191|156226269|FG003|Active Treatment Extension Period|Adverse Event|1|||
48555928|NCT03142191|156226270|FG004|Active Treatment Extension Period|Adverse Event|0|||
48555929|NCT03142191|156226266|FG000|Active Treatment Extension Period|Progressive Disease|10|||
48555930|NCT03142191|156226267|FG001|Active Treatment Extension Period|Progressive Disease|5|||
48555931|NCT03142191|156226268|FG002|Active Treatment Extension Period|Progressive Disease|4|||
48555932|NCT03142191|156226269|FG003|Active Treatment Extension Period|Progressive Disease|1|||
48555933|NCT03142191|156226270|FG004|Active Treatment Extension Period|Progressive Disease|2|||
48555934|NCT03142191|156226266|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
48555935|NCT03142191|156226267|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
48555936|NCT03142191|156226268|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
48555937|NCT03142191|156226269|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
48555938|NCT03142191|156226270|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
48555939|NCT03142191|156226266|FG000|Active Treatment Extension Period|Physician Decision|2|||
48555940|NCT03142191|156226267|FG001|Active Treatment Extension Period|Physician Decision|0|||
48555941|NCT03142191|156226268|FG002|Active Treatment Extension Period|Physician Decision|0|||
48555942|NCT03142191|156226269|FG003|Active Treatment Extension Period|Physician Decision|0|||
48555943|NCT03142191|156226270|FG004|Active Treatment Extension Period|Physician Decision|0|||
48555944|NCT03142191|156226266|FG000|Active Treatment Extension Period|Other Reasons|3|||
48555945|NCT03142191|156226267|FG001|Active Treatment Extension Period|Other Reasons|3|||
48555946|NCT03142191|156226268|FG002|Active Treatment Extension Period|Other Reasons|3|||
48555947|NCT03142191|156226269|FG003|Active Treatment Extension Period|Other Reasons|8|||
48555948|NCT03142191|156226270|FG004|Active Treatment Extension Period|Other Reasons|3|||
48555949|NCT03142191|156226266|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
48555950|NCT03142191|156226267|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
48555951|NCT03142191|156226268|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
48555952|NCT03142191|156226269|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
48555953|NCT03142191|156226270|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
48555954|NCT01320293|156226271|FG000|Overall Study|Lack of Efficacy|1|||
48555955|NCT01320293|156226271|FG000|Overall Study|Adverse Event|1|||
48555956|NCT00461253|156226272|FG000|Overall Study|Death|985|||
48555957|NCT00461253|156226273|FG001|Overall Study|Death|0|||
48555958|NCT00461253|156226272|FG000|Overall Study|Protocol Violation|613|||
48555959|NCT00461253|156226273|FG001|Overall Study|Protocol Violation|236|||
48555960|NCT00461253|156226272|FG000|Overall Study|no response|2609|||
48555961|NCT00461253|156226273|FG001|Overall Study|no response|11789|||
48555962|NCT00461253|156226272|FG000|Overall Study|administrative|773|||
48555963|NCT00461253|156226273|FG001|Overall Study|administrative|7773|||
48555964|NCT00397514|156226279|FG000|Overall Study|Withdrawal by Subject|1|||
48555965|NCT00397514|156226279|FG000|Overall Study|Pacing wire malfunction|1|||
48555966|NCT00397514|156226279|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
48555967|NCT00397514|156226279|FG000|Overall Study|early extubation|2|||
48555968|NCT00397514|156226279|FG000|Overall Study|poor echocardiographic windows|1|||
48555969|NCT00445146|156226280|FG000|Overall Study|Withdrew Consent|29|||
48555970|NCT00445146|156226280|FG000|Overall Study|Lack of Efficacy|28|||
48555971|NCT00445146|156226280|FG000|Overall Study|Investigator's Discretion|22|||
48555972|NCT00445146|156226280|FG000|Overall Study|Adverse Event|13|||
48555973|NCT00445146|156226280|FG000|Overall Study|Lost to Follow-up|13|||
48555974|NCT00445146|156226280|FG000|Overall Study|Death|9|||
48555975|NCT00445146|156226280|FG000|Overall Study|Protocol Violation|4|||
48555976|NCT00445146|156226280|FG000|Overall Study|Pregnancy|1|||
48555977|NCT00193050|156226281|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
48555978|NCT00193050|156226281|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
48555979|NCT00193050|156226281|FG000|Neoadjuvant Treatment|Physician Decision|2|||
48555980|NCT00193050|156226281|FG000|Neoadjuvant Treatment|Adverse Event|2|||
48555981|NCT00193050|156226281|FG000|Adjuvant|Physician Decision|5|||
48555982|NCT00193050|156226281|FG000|Adjuvant|Intercurrent Hospitalization|3|||
48555983|NCT00193050|156226281|FG000|Adjuvant|Lack of Efficacy|2|||
48555984|NCT02431364|156226282|FG000|Overall Study|Adverse Event|0|||
48555985|NCT02431364|156226283|FG001|Overall Study|Adverse Event|1|||
48555986|NCT02431364|156226284|FG002|Overall Study|Adverse Event|0|||
48555987|NCT02431364|156226285|FG003|Overall Study|Adverse Event|0|||
48555988|NCT02431364|156226286|FG004|Overall Study|Adverse Event|0|||
48615243|NCT03188185|156447363|FG003|Stage 2|Physician Decision|1|||
48555989|NCT02431364|156226282|FG000|Overall Study|Randomized but never treated|0|||
48555990|NCT02431364|156226283|FG001|Overall Study|Randomized but never treated|0|||
48555991|NCT02431364|156226284|FG002|Overall Study|Randomized but never treated|0|||
48555992|NCT02431364|156226285|FG003|Overall Study|Randomized but never treated|1|||
48555993|NCT02431364|156226286|FG004|Overall Study|Randomized but never treated|0|||
48555994|NCT00061932|156226287|FG000|Overall Study|Withdrawal by Subject|13|||
48555995|NCT00061932|156226288|FG001|Overall Study|Withdrawal by Subject|4|||
48555996|NCT00916383|156226289|FG000|Overall Study|Adverse Event|1|||
48555997|NCT00916383|156226289|FG000|Overall Study|Death|1|||
48555998|NCT00916383|156226289|FG000|Overall Study|Protocol Violation|1|||
48555999|NCT00258960|156226290|FG000|Overall Study|Death|2|||
48556000|NCT00258960|156226290|FG000|Overall Study|Disease Progression|7|||
48556001|NCT00258960|156226290|FG000|Overall Study|Adverse Event|4|||
48556002|NCT00258960|156226290|FG000|Overall Study|Physician Decision|1|||
48556003|NCT00258960|156226290|FG000|Overall Study|Withdrawal by Subject|1|||
48556004|NCT00258960|156226290|FG000|Overall Study|Mistake|2|||
48556005|NCT02899962|156226291|FG000|Open-label Phase|Adverse Event|2|||
48556006|NCT02899962|156226292|FG001|Open-label Phase|Adverse Event|0|||
48556007|NCT02899962|156226293|FG002|Open-label Phase|Adverse Event|0|||
48556008|NCT02899962|156226291|FG000|Open-label Phase|Lost to Follow-up|9|||
48556009|NCT02899962|156226292|FG001|Open-label Phase|Lost to Follow-up|0|||
48556010|NCT02899962|156226293|FG002|Open-label Phase|Lost to Follow-up|0|||
48556011|NCT02899962|156226291|FG000|Open-label Phase|Other reasons|9|||
48556012|NCT02899962|156226292|FG001|Open-label Phase|Other reasons|0|||
48556013|NCT02899962|156226293|FG002|Open-label Phase|Other reasons|0|||
48556014|NCT02899962|156226291|FG000|Open-label Phase|Withdrawal by Subject|7|||
48556015|NCT02899962|156226292|FG001|Open-label Phase|Withdrawal by Subject|0|||
48556016|NCT02899962|156226293|FG002|Open-label Phase|Withdrawal by Subject|0|||
48556017|NCT02899962|156226291|FG000|Maintenance Phase|Adverse Event|0|||
48556018|NCT02899962|156226292|FG001|Maintenance Phase|Adverse Event|2|||
48556019|NCT02899962|156226293|FG002|Maintenance Phase|Adverse Event|1|||
48556020|NCT02899962|156226291|FG000|Maintenance Phase|Death|0|||
48556021|NCT02899962|156226292|FG001|Maintenance Phase|Death|0|||
48556022|NCT02899962|156226293|FG002|Maintenance Phase|Death|1|||
48556023|NCT02899962|156226291|FG000|Maintenance Phase|Lack of Efficacy|0|||
48556024|NCT02899962|156226292|FG001|Maintenance Phase|Lack of Efficacy|20|||
48556025|NCT02899962|156226293|FG002|Maintenance Phase|Lack of Efficacy|16|||
48556026|NCT02899962|156226291|FG000|Maintenance Phase|Lost to Follow-up|0|||
48556027|NCT02899962|156226292|FG001|Maintenance Phase|Lost to Follow-up|12|||
48556028|NCT02899962|156226293|FG002|Maintenance Phase|Lost to Follow-up|14|||
48556029|NCT02899962|156226291|FG000|Maintenance Phase|Other reasons|0|||
48556030|NCT02899962|156226292|FG001|Maintenance Phase|Other reasons|9|||
48556031|NCT02899962|156226293|FG002|Maintenance Phase|Other reasons|13|||
48556032|NCT02899962|156226291|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
48556033|NCT02899962|156226292|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
48556034|NCT02899962|156226293|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
48556035|NCT02899962|156226291|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
48556036|NCT02899962|156226292|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
48556037|NCT02899962|156226293|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
48556038|NCT02899962|156226291|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48556039|NCT02899962|156226292|FG001|Maintenance Phase|Withdrawal by Subject|30|||
48556040|NCT02899962|156226293|FG002|Maintenance Phase|Withdrawal by Subject|36|||
48556041|NCT02492867|156226294|FG000|Overall Study|Alternate therapy|1|||
48556042|NCT02492867|156226294|FG000|Overall Study|Withdrawal by Subject|2|||
48556043|NCT02492867|156226294|FG000|Overall Study|Disease progression after treatment started|1|||
48556044|NCT02492867|156226294|FG000|Overall Study|Death|1|||
48556045|NCT00473590|156226295|FG000|Overall Study|Adverse Event|3|||
48556046|NCT00473590|156226296|FG001|Overall Study|Adverse Event|3|||
48556047|NCT00473590|156226295|FG000|Overall Study|Death|4|||
48556048|NCT00473590|156226296|FG001|Overall Study|Death|2|||
48556049|NCT00473590|156226295|FG000|Overall Study|Progression not resulting in death|24|||
48556050|NCT00473590|156226296|FG001|Overall Study|Progression not resulting in death|20|||
48556051|NCT00473590|156226295|FG000|Overall Study|Non-protocol-specified therapy|7|||
48556052|NCT00473590|156226296|FG001|Overall Study|Non-protocol-specified therapy|5|||
48556053|NCT00473590|156226295|FG000|Overall Study|Physician Decision|2|||
48556054|NCT00473590|156226296|FG001|Overall Study|Physician Decision|4|||
48556055|NCT00473590|156226295|FG000|Overall Study|Withdrawal by Subject|5|||
48556056|NCT00473590|156226296|FG001|Overall Study|Withdrawal by Subject|3|||
48556057|NCT00473590|156226295|FG000|Overall Study|Other|0|||
48556058|NCT00473590|156226296|FG001|Overall Study|Other|1|||
48556059|NCT01112059|156226297|FG000|Overall Study|Withdrawal by Subject|1|||
48556060|NCT01112059|156226298|FG001|Overall Study|Withdrawal by Subject|0|||
48556061|NCT01245283|156226301|FG000|Overall Study|Lost to Follow-up|14|||
48556062|NCT01245283|156226302|FG001|Overall Study|Lost to Follow-up|11|||
48556063|NCT01245283|156226303|FG002|Overall Study|Lost to Follow-up|11|||
48556064|NCT01982955|156226314|FG000|Overall Study|Randomized but not treated|0|||
48556065|NCT01982955|156226315|FG001|Overall Study|Randomized but not treated|0|||
48556066|NCT01982955|156226316|FG002|Overall Study|Randomized but not treated|0|||
48556067|NCT01982955|156226317|FG003|Overall Study|Randomized but not treated|1|||
48556068|NCT01982955|156226318|FG004|Overall Study|Randomized but not treated|0|||
48556069|NCT01821807|156226319|FG000|Overall Study|Lost to Follow-up|3|||
48556070|NCT01821807|156226320|FG001|Overall Study|Lost to Follow-up|1|||
48556071|NCT03092219|156227984|FG000|Overall Study|Protocol Violation|7|||
48556072|NCT03092219|156227985|FG001|Overall Study|Protocol Violation|4|||
48556073|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #1|24|||
48556074|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #1|0|||
48556075|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
48556076|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
48556077|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
48556078|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556079|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
48556080|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
48556081|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
48556082|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
48556083|NCT03888066|156227986|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
48556084|NCT03888066|156227987|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556085|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
48556086|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556087|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
48556088|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
48556089|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
48556090|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556091|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
48556092|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556093|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #2|5|||
48556094|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #2|0|||
48556095|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
48556096|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
48556097|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
48556098|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
48556099|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
48556100|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
48556101|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #3|11|||
48556102|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #3|0|||
48556103|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
48556104|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
48556105|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
48556106|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
48556107|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
48556108|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556109|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #4|3|||
48556110|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #4|0|||
48556111|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
48556112|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
48556113|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
48556114|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
48556115|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
48556116|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
48556117|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
48556118|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
48556119|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
48556120|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556121|NCT03888066|156227986|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
48556122|NCT03888066|156227987|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
48556123|NCT03888066|156227986|FG000|Run-in Phase|AE (Adverse Event)|17|||
48556124|NCT03888066|156227987|FG001|Run-in Phase|AE (Adverse Event)|0|||
48556125|NCT03888066|156227986|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
48615244|NCT03188185|156447360|FG000|Stage 2|Withdrawal by Subject|0|||
48615245|NCT03188185|156447361|FG001|Stage 2|Withdrawal by Subject|0|||
48615246|NCT03188185|156447362|FG002|Stage 2|Withdrawal by Subject|3|||
48615247|NCT03188185|156447363|FG003|Stage 2|Withdrawal by Subject|1|||
48615248|NCT00790036|156447364|FG000|Overall Study|Abnormal lab values|3|||
48615249|NCT00790036|156447365|FG001|Overall Study|Abnormal lab values|2|||
48615250|NCT00790036|156447364|FG000|Overall Study|Administrative problems|5|||
48615251|NCT00790036|156447365|FG001|Overall Study|Administrative problems|9|||
48615252|NCT00790036|156447364|FG000|Overall Study|Adverse Event|113|||
48615253|NCT00790036|156447365|FG001|Overall Study|Adverse Event|44|||
48615254|NCT00790036|156447364|FG000|Overall Study|Death|1|||
48615255|NCT00790036|156447365|FG001|Overall Study|Death|0|||
48615256|NCT00790036|156447364|FG000|Overall Study|Disease progression|24|||
48615257|NCT00790036|156447365|FG001|Overall Study|Disease progression|48|||
48615258|NCT00790036|156447364|FG000|Overall Study|Lost to Follow-up|1|||
48615259|NCT00790036|156447365|FG001|Overall Study|Lost to Follow-up|2|||
48615260|NCT00790036|156447364|FG000|Overall Study|Protocol Violation|10|||
48615261|NCT00790036|156447365|FG001|Overall Study|Protocol Violation|2|||
48615262|NCT00790036|156447364|FG000|Overall Study|Withdrawal by Subject|18|||
48615263|NCT00790036|156447365|FG001|Overall Study|Withdrawal by Subject|7|||
48615264|NCT00790036|156447364|FG000|Overall Study|Subject/guardian decision|20|||
48615265|NCT00790036|156447365|FG001|Overall Study|Subject/guardian decision|7|||
48615266|NCT02612155|156447366|FG000|Overall Study|Death|1|||
48615267|NCT02612155|156447367|FG001|Overall Study|Death|1|||
48615268|NCT02612155|156447366|FG000|Overall Study|Lost to Follow-up|2|||
48615269|NCT02612155|156447367|FG001|Overall Study|Lost to Follow-up|2|||
48615270|NCT00866320|156447368|FG000|Overall Study|Withdrawal by Subject|4|||
48615271|NCT00866320|156447368|FG000|Overall Study|Death|2|||
48615272|NCT00580840|156447371|FG000|Run-in|Adverse Event|17|||
48615273|NCT00580840|156447372|FG001|Run-in|Adverse Event|0|||
48556126|NCT03888066|156227987|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
48556127|NCT03888066|156227986|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
48556128|NCT03888066|156227987|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48615274|NCT00580840|156447373|FG002|Run-in|Adverse Event|0|||
48615275|NCT00580840|156447374|FG003|Run-in|Adverse Event|0|||
48615276|NCT00580840|156447371|FG000|Run-in|Lack of Efficacy|93|||
48615277|NCT00580840|156447372|FG001|Run-in|Lack of Efficacy|0|||
48615278|NCT00580840|156447373|FG002|Run-in|Lack of Efficacy|0|||
48556129|NCT03888066|156227986|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
48556130|NCT03888066|156227987|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556131|NCT03888066|156227986|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
48556132|NCT03888066|156227987|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
48556133|NCT03888066|156227986|FG000|Run-in Phase|Withdrawal by Subject|43|||
48556134|NCT03888066|156227987|FG001|Run-in Phase|Withdrawal by Subject|0|||
48556135|NCT03888066|156227986|FG000|Run-in Phase|AE; Physician Decision|1|||
48556136|NCT03888066|156227987|FG001|Run-in Phase|AE; Physician Decision|0|||
48556137|NCT03888066|156227986|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
48556138|NCT03888066|156227987|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
48556139|NCT03888066|156227986|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
48556140|NCT03888066|156227987|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
48556141|NCT03888066|156227986|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
48556142|NCT03888066|156227987|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
48556143|NCT03888066|156227986|FG000|Run-in Phase|Death|1|||
48556144|NCT03888066|156227987|FG001|Run-in Phase|Death|0|||
48556145|NCT03888066|156227986|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
48556146|NCT03888066|156227987|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
48556147|NCT03888066|156227986|FG000|Run-in Phase|Physician Decision|1|||
48556148|NCT03888066|156227987|FG001|Run-in Phase|Physician Decision|0|||
48556149|NCT03888066|156227986|FG000|Run-in Phase|Protocol Violation|13|||
48556150|NCT03888066|156227987|FG001|Run-in Phase|Protocol Violation|0|||
48556151|NCT03888066|156227986|FG000|Run-in Phase|Sponsor Request|34|||
48556152|NCT03888066|156227987|FG001|Run-in Phase|Sponsor Request|0|||
48556153|NCT03888066|156227986|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
48556154|NCT03888066|156227987|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
48556155|NCT03888066|156227986|FG000|Run-in Phase|Withdrawal Of Consent|1|||
48556156|NCT03888066|156227987|FG001|Run-in Phase|Withdrawal Of Consent|0|||
48615279|NCT00580840|156447374|FG003|Run-in|Lack of Efficacy|0|||
48615280|NCT00580840|156447371|FG000|Run-in|Loss of Efficacy|1|||
48615281|NCT00580840|156447372|FG001|Run-in|Loss of Efficacy|0|||
48615282|NCT00580840|156447373|FG002|Run-in|Loss of Efficacy|0|||
48615283|NCT00580840|156447374|FG003|Run-in|Loss of Efficacy|0|||
48615284|NCT00580840|156447371|FG000|Run-in|Lost to Follow-up|4|||
48615285|NCT00580840|156447372|FG001|Run-in|Lost to Follow-up|0|||
48615286|NCT00580840|156447373|FG002|Run-in|Lost to Follow-up|0|||
48615287|NCT00580840|156447374|FG003|Run-in|Lost to Follow-up|0|||
48615288|NCT00580840|156447371|FG000|Run-in|Withdrawal by Subject|5|||
48615289|NCT00580840|156447372|FG001|Run-in|Withdrawal by Subject|0|||
48615290|NCT00580840|156447373|FG002|Run-in|Withdrawal by Subject|0|||
48615291|NCT00580840|156447374|FG003|Run-in|Withdrawal by Subject|0|||
48615292|NCT00580840|156447371|FG000|Run-in|Other: Per Sponsor Request|2|||
48615293|NCT00580840|156447372|FG001|Run-in|Other: Per Sponsor Request|0|||
48615294|NCT00580840|156447373|FG002|Run-in|Other: Per Sponsor Request|0|||
48615295|NCT00580840|156447374|FG003|Run-in|Other: Per Sponsor Request|0|||
48615296|NCT00580840|156447371|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
48615297|NCT00580840|156447372|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
48615298|NCT00580840|156447373|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
48615299|NCT00580840|156447374|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
48615300|NCT00580840|156447371|FG000|Run-in|Other: Exclusionary Lab Value|1|||
48615301|NCT00580840|156447372|FG001|Run-in|Other: Exclusionary Lab Value|0|||
48615302|NCT00580840|156447373|FG002|Run-in|Other: Exclusionary Lab Value|0|||
48615303|NCT00580840|156447374|FG003|Run-in|Other: Exclusionary Lab Value|0|||
48615304|NCT00580840|156447371|FG000|Double-Blind|Adverse Event|0|||
48615305|NCT00580840|156447372|FG001|Double-Blind|Adverse Event|3|||
48556157|NCT03888066|156227986|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
48556158|NCT03888066|156227987|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
48556159|NCT03888066|156227986|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
48556160|NCT03888066|156227987|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
48556161|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
48556162|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
48556163|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
48556164|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
48556165|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
48556166|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
48556167|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
48556168|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
48556169|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
48556170|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
48556171|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
48556172|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
48556173|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
48556174|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
48556175|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
48615306|NCT00580840|156447373|FG002|Double-Blind|Adverse Event|4|||
48615307|NCT00580840|156447374|FG003|Double-Blind|Adverse Event|1|||
48615308|NCT00580840|156447371|FG000|Double-Blind|Loss of Efficacy|0|||
48615309|NCT00580840|156447372|FG001|Double-Blind|Loss of Efficacy|1|||
48615310|NCT00580840|156447373|FG002|Double-Blind|Loss of Efficacy|2|||
48615311|NCT00580840|156447374|FG003|Double-Blind|Loss of Efficacy|10|||
48615312|NCT00580840|156447371|FG000|Double-Blind|Lost to Follow-up|0|||
48615313|NCT00580840|156447372|FG001|Double-Blind|Lost to Follow-up|1|||
48615314|NCT00580840|156447373|FG002|Double-Blind|Lost to Follow-up|0|||
48615315|NCT00580840|156447374|FG003|Double-Blind|Lost to Follow-up|2|||
48615316|NCT00580840|156447371|FG000|Double-Blind|Withdrawal by Subject|0|||
48556176|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
48556177|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
48556178|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
48556179|NCT03888066|156227986|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
48556180|NCT03888066|156227987|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
48556181|NCT03278626|156227988|FG000|Overall Study|Death|2|||
48556182|NCT03278626|156227988|FG000|Overall Study|Toxicity|1|||
48556183|NCT03278626|156227988|FG000|Overall Study|Disease Progression|2|||
48556184|NCT05013008|156227993|FG000|Overall Study|Exclusion from mBFAS|5|||
48556185|NCT05013008|156227994|FG001|Overall Study|Exclusion from mBFAS|25|||
48556186|NCT02856555|156227995|FG000|Overall Study|Adverse Event|1|||
48556187|NCT02856555|156227996|FG001|Overall Study|Adverse Event|0|||
48556188|NCT02856555|156227997|FG002|Overall Study|Adverse Event|0|||
48556189|NCT02856555|156227995|FG000|Overall Study|Lost to Follow-up|1|||
48556190|NCT02856555|156227996|FG001|Overall Study|Lost to Follow-up|3|||
48556191|NCT02856555|156227997|FG002|Overall Study|Lost to Follow-up|0|||
48556192|NCT02856555|156227995|FG000|Overall Study|Withdrawal by Subject|3|||
48556193|NCT02856555|156227996|FG001|Overall Study|Withdrawal by Subject|0|||
48556194|NCT02856555|156227997|FG002|Overall Study|Withdrawal by Subject|0|||
48556195|NCT02856555|156227995|FG000|Overall Study|Randomized but Never Treated|0|||
48556196|NCT02856555|156227996|FG001|Overall Study|Randomized but Never Treated|1|||
48556197|NCT02856555|156227997|FG002|Overall Study|Randomized but Never Treated|0|||
48556198|NCT02717455|156227998|FG000|Overall Study|Adverse Event|1|||
48556199|NCT02717455|156227999|FG001|Overall Study|Adverse Event|0|||
48556200|NCT02717455|156228000|FG002|Overall Study|Adverse Event|0|||
48615317|NCT00580840|156447372|FG001|Double-Blind|Withdrawal by Subject|1|||
48615318|NCT00580840|156447373|FG002|Double-Blind|Withdrawal by Subject|2|||
48615319|NCT00580840|156447374|FG003|Double-Blind|Withdrawal by Subject|2|||
48615320|NCT00580840|156447371|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
48615321|NCT00580840|156447372|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
48615322|NCT00580840|156447373|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
48615323|NCT00580840|156447374|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
48556201|NCT02717455|156228001|FG003|Overall Study|Adverse Event|2|||
48556202|NCT02717455|156228002|FG004|Overall Study|Adverse Event|2|||
48556203|NCT02717455|156228003|FG005|Overall Study|Adverse Event|2|||
48615324|NCT00580840|156447371|FG000|Double-Blind|Other: Forbidden Medication|0|||
48615325|NCT00580840|156447372|FG001|Double-Blind|Other: Forbidden Medication|0|||
48615326|NCT00580840|156447373|FG002|Double-Blind|Other: Forbidden Medication|1|||
48615327|NCT00580840|156447374|FG003|Double-Blind|Other: Forbidden Medication|0|||
48615328|NCT02315625|156447377|FG000|First Intervention|Disease Progression|1|||
48615329|NCT02315625|156447378|FG001|First Intervention|Disease Progression|0|||
48615330|NCT02315625|156447377|FG000|Second Intervention|Physician Decision|2|||
48615331|NCT02315625|156447378|FG001|Second Intervention|Physician Decision|1|||
48615332|NCT02315625|156447377|FG000|Second Intervention|Study closure|1|||
48615333|NCT02315625|156447378|FG001|Second Intervention|Study closure|0|||
48615334|NCT02315625|156447377|FG000|Second Intervention|Disease Progression|1|||
48615335|NCT02315625|156447378|FG001|Second Intervention|Disease Progression|0|||
48615336|NCT01402700|156447379|FG000|Overall Study|Death|3|||
48615337|NCT01402700|156447379|FG000|Overall Study|Withdrawal by Subject|3|||
48615338|NCT01402700|156447379|FG000|Overall Study|Missed Visit|1|||
48615339|NCT02187055|156447384|FG000|Overall Study|Lack of Efficacy|10|||
48615340|NCT02187055|156447385|FG001|Overall Study|Lack of Efficacy|3|||
48615341|NCT02187055|156447386|FG002|Overall Study|Lack of Efficacy|7|||
48615342|NCT02187055|156447384|FG000|Overall Study|Lost to Follow-up|2|||
48615343|NCT02187055|156447385|FG001|Overall Study|Lost to Follow-up|7|||
48615344|NCT02187055|156447386|FG002|Overall Study|Lost to Follow-up|3|||
48615345|NCT02187055|156447384|FG000|Overall Study|No longer meets eligibility criteria|0|||
48615346|NCT02187055|156447385|FG001|Overall Study|No longer meets eligibility criteria|2|||
48615347|NCT02187055|156447386|FG002|Overall Study|No longer meets eligibility criteria|0|||
48615348|NCT02187055|156447384|FG000|Overall Study|No longer willing to participate|6|||
48615349|NCT02187055|156447385|FG001|Overall Study|No longer willing to participate|8|||
48615350|NCT02187055|156447386|FG002|Overall Study|No longer willing to participate|10|||
48615351|NCT02187055|156447384|FG000|Overall Study|Other|5|||
48615352|NCT02187055|156447385|FG001|Overall Study|Other|6|||
48615353|NCT02187055|156447386|FG002|Overall Study|Other|3|||
48556204|NCT02717455|156227998|FG000|Overall Study|Withdrawal by Subject|1|||
48556205|NCT02717455|156227999|FG001|Overall Study|Withdrawal by Subject|1|||
48556206|NCT02717455|156228000|FG002|Overall Study|Withdrawal by Subject|0|||
48615354|NCT02187055|156447384|FG000|Overall Study|Protocol Violation|9|||
48615355|NCT02187055|156447385|FG001|Overall Study|Protocol Violation|9|||
48615356|NCT02187055|156447386|FG002|Overall Study|Protocol Violation|4|||
48615357|NCT02187055|156447384|FG000|Overall Study|Pregnancy|3|||
48615358|NCT02187055|156447385|FG001|Overall Study|Pregnancy|1|||
48615359|NCT02187055|156447386|FG002|Overall Study|Pregnancy|0|||
48556207|NCT02717455|156228001|FG003|Overall Study|Withdrawal by Subject|2|||
48556208|NCT02717455|156228002|FG004|Overall Study|Withdrawal by Subject|2|||
48556209|NCT02717455|156228003|FG005|Overall Study|Withdrawal by Subject|1|||
48615360|NCT02187055|156447384|FG000|Overall Study|Withdrawal by Subject|11|||
48615361|NCT02187055|156447385|FG001|Overall Study|Withdrawal by Subject|11|||
48615362|NCT02187055|156447386|FG002|Overall Study|Withdrawal by Subject|11|||
48556210|NCT02717455|156227998|FG000|Overall Study|Death|1|||
48556211|NCT02717455|156227999|FG001|Overall Study|Death|0|||
48556212|NCT02717455|156228000|FG002|Overall Study|Death|0|||
48556213|NCT02717455|156228001|FG003|Overall Study|Death|0|||
48556214|NCT02717455|156228002|FG004|Overall Study|Death|1|||
48556215|NCT02717455|156228003|FG005|Overall Study|Death|0|||
48556216|NCT02717455|156227998|FG000|Overall Study|Did not receive study drug|0|||
48556217|NCT02717455|156227999|FG001|Overall Study|Did not receive study drug|0|||
48556218|NCT02717455|156228000|FG002|Overall Study|Did not receive study drug|0|||
48556219|NCT02717455|156228001|FG003|Overall Study|Did not receive study drug|1|||
48615363|NCT02187055|156447384|FG000|Overall Study|Adverse Event|21|||
48556220|NCT02717455|156228002|FG004|Overall Study|Did not receive study drug|0|||
48556221|NCT02717455|156228003|FG005|Overall Study|Did not receive study drug|1|||
48556222|NCT02717455|156227998|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
48615364|NCT02187055|156447385|FG001|Overall Study|Adverse Event|26|||
48615365|NCT02187055|156447386|FG002|Overall Study|Adverse Event|36|||
48615366|NCT02187055|156447384|FG000|Overall Study|Death|2|||
48615367|NCT02187055|156447385|FG001|Overall Study|Death|0|||
48615368|NCT02187055|156447386|FG002|Overall Study|Death|0|||
48615369|NCT02965833|156447387|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
48556223|NCT02717455|156227999|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
48556224|NCT02717455|156228000|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
48556225|NCT02717455|156228001|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
48556226|NCT02717455|156228002|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
48556227|NCT02717455|156228003|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
48556228|NCT02717455|156227998|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
48556229|NCT02717455|156227999|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
48556230|NCT02717455|156228000|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
48556231|NCT02717455|156228001|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
48556232|NCT02717455|156228002|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
48556233|NCT02717455|156228003|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
48556234|NCT03333941|156228004|FG000|Overall Study|Lost to Follow-up|10|||
48556235|NCT03333941|156228004|FG000|Overall Study|Death|2|||
48556236|NCT03333941|156228004|FG000|Overall Study|Adverse Event|1|||
48556237|NCT00233948|156228007|FG000|Overall Study|Adverse Event|1|||
48556238|NCT00233948|156228008|FG001|Overall Study|Adverse Event|0|||
48556239|NCT00233948|156228009|FG002|Overall Study|Adverse Event|0|||
48556240|NCT00233948|156228010|FG003|Overall Study|Adverse Event|0|||
48556241|NCT00233948|156228011|FG004|Overall Study|Adverse Event|0|||
48556242|NCT00233948|156228012|FG005|Overall Study|Adverse Event|0|||
48556243|NCT02862730|156228013|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
48556244|NCT02862730|156228014|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
48556245|NCT02862730|156228015|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
48556246|NCT02862730|156228016|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
48556247|NCT02862730|156228017|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
48556248|NCT02862730|156228018|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
48556249|NCT02862730|156228019|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
48556250|NCT02862730|156228013|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
48615370|NCT02965833|156447388|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
48615371|NCT02965833|156447387|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
48556251|NCT02862730|156228014|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
48556252|NCT02862730|156228015|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
48556253|NCT02862730|156228016|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
48556254|NCT02862730|156228017|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
48556255|NCT02862730|156228018|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
48556256|NCT02862730|156228019|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
48556257|NCT02862730|156228013|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
48556258|NCT02862730|156228014|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
48556259|NCT02862730|156228015|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
48556260|NCT02862730|156228016|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
48556261|NCT02862730|156228017|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
48556262|NCT02862730|156228018|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
48556263|NCT02862730|156228019|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
48556264|NCT02862730|156228013|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
48556265|NCT02862730|156228014|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
48556266|NCT02862730|156228015|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
48556267|NCT02862730|156228016|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
48556268|NCT02862730|156228017|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
48556269|NCT02862730|156228018|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
48556270|NCT02862730|156228019|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
48556271|NCT00704132|156228024|FG000|Overall Study|Clinical Adverse Experience|1|||
48556272|NCT00704132|156228025|FG001|Overall Study|Clinical Adverse Experience|0|||
48556273|NCT00704132|156228024|FG000|Overall Study|Lack of Efficacy|0|||
48556274|NCT00704132|156228025|FG001|Overall Study|Lack of Efficacy|1|||
48556275|NCT00704132|156228024|FG000|Overall Study|Withdrawal by Subject|0|||
48556276|NCT00704132|156228025|FG001|Overall Study|Withdrawal by Subject|1|||
48615372|NCT02965833|156447388|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
48615373|NCT02965833|156447387|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
48556277|NCT03908437|156228026|FG000|Overall Study|Death|0|||
48556278|NCT03908437|156228027|FG001|Overall Study|Death|1|||
48556279|NCT03908437|156228026|FG000|Overall Study|Lost to Follow-up|31|||
48556280|NCT03908437|156228027|FG001|Overall Study|Lost to Follow-up|24|||
48556281|NCT00442962|156228028|FG000|Overall Study|Pregnancy|1|||
48556282|NCT00442962|156228028|FG000|Overall Study|Lost to Follow-up|7|||
48556283|NCT05445492|156228029|FG000|Overall Study|Physician Decision|1|||
48556284|NCT04238650|156228031|FG000|Overall Study|Withdrawal by Subject|0|||
48556285|NCT04238650|156228032|FG001|Overall Study|Withdrawal by Subject|1|||
48556286|NCT04289363|156228033|FG000|Overall Study|Lost to Follow-up|14|||
48556287|NCT04289363|156228034|FG001|Overall Study|Lost to Follow-up|0|||
48556288|NCT03633825|156228036|FG000|Enrollment|Did not post on network|5066|||
48556289|NCT03633825|156228037|FG001|Enrollment|Did not post on network|5080|||
48556290|NCT03633825|156228036|FG000|Enrollment|Post not classified as crisis|13967|||
48556291|NCT03633825|156228037|FG001|Enrollment|Post not classified as crisis|13757|||
48556292|NCT03633825|156228036|FG000|Follow up|Lost to Follow-up|478|||
48556293|NCT03633825|156228037|FG001|Follow up|Lost to Follow-up|450|||
48556294|NCT02445963|156228041|FG000|Overall Study|Lost to Follow-up|1|||
48556295|NCT02445963|156228042|FG001|Overall Study|Lost to Follow-up|0|||
48556296|NCT02445963|156228043|FG002|Overall Study|Lost to Follow-up|0|||
48556297|NCT02445963|156228044|FG003|Overall Study|Lost to Follow-up|0|||
48556298|NCT02445963|156228041|FG000|Overall Study|Change in employment|1|||
48556299|NCT02445963|156228042|FG001|Overall Study|Change in employment|0|||
48556300|NCT02445963|156228043|FG002|Overall Study|Change in employment|0|||
48556301|NCT02445963|156228044|FG003|Overall Study|Change in employment|0|||
48556302|NCT02445963|156228041|FG000|Overall Study|Symptoms post-vaccination|0|||
48556303|NCT02445963|156228042|FG001|Overall Study|Symptoms post-vaccination|0|||
48556304|NCT02445963|156228043|FG002|Overall Study|Symptoms post-vaccination|1|||
48556305|NCT02445963|156228044|FG003|Overall Study|Symptoms post-vaccination|0|||
48556306|NCT02585778|156228049|FG000|Overall Study|Adverse Event|17|||
48556307|NCT02585778|156228050|FG001|Overall Study|Adverse Event|4|||
48556308|NCT02585778|156228049|FG000|Overall Study|Participant did not wish to continue|9|||
48556309|NCT02585778|156228050|FG001|Overall Study|Participant did not wish to continue|4|||
48556310|NCT02585778|156228049|FG000|Overall Study|Poor compliance to study protocol|0|||
48556311|NCT02585778|156228050|FG001|Overall Study|Poor compliance to study protocol|2|||
48556312|NCT02585778|156228049|FG000|Overall Study|Death|0|||
48556313|NCT02585778|156228050|FG001|Overall Study|Death|1|||
48556314|NCT02585778|156228049|FG000|Overall Study|Randomized but not treated|1|||
48556315|NCT02585778|156228050|FG001|Overall Study|Randomized but not treated|2|||
48556316|NCT02585778|156228049|FG000|Overall Study|Other than specified above|6|||
48556317|NCT02585778|156228050|FG001|Overall Study|Other than specified above|2|||
48556318|NCT00182325|156228053|FG000|Overall Study|Lost to Follow-up|7|||
48556319|NCT00182325|156228054|FG001|Overall Study|Lost to Follow-up|7|||
48556320|NCT00182325|156228053|FG000|Overall Study|Miscarriage|5|||
48556321|NCT00182325|156228054|FG001|Overall Study|Miscarriage|3|||
48556322|NCT00182325|156228053|FG000|Overall Study|Did not complete survey|22|||
48556323|NCT00182325|156228054|FG001|Overall Study|Did not complete survey|43|||
48556324|NCT02017015|156228055|FG000|Overall Study|Adverse Event|9|||
48556325|NCT02017015|156228055|FG000|Overall Study|Withdrawal by Subject|21|||
48556326|NCT02017015|156228055|FG000|Overall Study|Death|4|||
48556327|NCT02017015|156228055|FG000|Overall Study|Progressive Disease|31|||
48556328|NCT02017015|156228055|FG000|Overall Study|Non-compliance with study drug|2|||
48556329|NCT02017015|156228055|FG000|Overall Study|Physician Decision|2|||
48556330|NCT02789137|156228056|FG000|Overall Study|Dropped out/Died|58|||
48556331|NCT00799058|156228057|FG000|Overall Study|Withdrawal by Subject|2|||
48556332|NCT00799058|156228058|FG001|Overall Study|Withdrawal by Subject|2|||
48556333|NCT00799058|156228059|FG002|Overall Study|Withdrawal by Subject|2|||
48556334|NCT00799058|156228057|FG000|Overall Study|Lost to Follow-up|1|||
48556335|NCT00799058|156228058|FG001|Overall Study|Lost to Follow-up|2|||
48556336|NCT00799058|156228059|FG002|Overall Study|Lost to Follow-up|1|||
48556337|NCT00799058|156228057|FG000|Overall Study|Adverse Event|0|||
48556338|NCT00799058|156228058|FG001|Overall Study|Adverse Event|2|||
48556339|NCT00799058|156228059|FG002|Overall Study|Adverse Event|0|||
48615374|NCT02965833|156447388|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
48556340|NCT00799058|156228057|FG000|Overall Study|Pregnancy|1|||
48556341|NCT00799058|156228058|FG001|Overall Study|Pregnancy|0|||
48556342|NCT00799058|156228059|FG002|Overall Study|Pregnancy|0|||
48556343|NCT00799058|156228057|FG000|Overall Study|Not adherent|3|||
48556344|NCT00799058|156228058|FG001|Overall Study|Not adherent|2|||
48556345|NCT00799058|156228059|FG002|Overall Study|Not adherent|1|||
48556346|NCT00799058|156228057|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
48556347|NCT00799058|156228058|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
48556348|NCT00799058|156228059|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
48556349|NCT00799058|156228057|FG000|Overall Study|IP dispensing error|1|||
48556350|NCT00799058|156228058|FG001|Overall Study|IP dispensing error|0|||
48556351|NCT00799058|156228059|FG002|Overall Study|IP dispensing error|0|||
48556352|NCT00799058|156228057|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
48556353|NCT00799058|156228058|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
48556354|NCT00799058|156228059|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
48556355|NCT00799058|156228057|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
48556356|NCT00799058|156228058|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
48556357|NCT00799058|156228059|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
48556358|NCT00799058|156228057|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
48556359|NCT00799058|156228058|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
48556360|NCT00799058|156228059|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
48556361|NCT00799058|156228057|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
48556362|NCT00799058|156228058|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
48556363|NCT00799058|156228059|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
48556364|NCT04578535|156228062|FG000|Overall Study|Lost to Follow-up|1|||
48556365|NCT04578535|156228063|FG001|Overall Study|Lost to Follow-up|0|||
48556366|NCT04578535|156228064|FG002|Overall Study|Lost to Follow-up|0|||
48556367|NCT04578535|156228065|FG003|Overall Study|Lost to Follow-up|1|||
48556368|NCT04578535|156228066|FG004|Overall Study|Lost to Follow-up|0|||
48556369|NCT04578535|156228067|FG005|Overall Study|Lost to Follow-up|2|||
48556370|NCT04578535|156228062|FG000|Overall Study|Pregnancy|1|||
48556371|NCT04578535|156228063|FG001|Overall Study|Pregnancy|0|||
48556372|NCT04578535|156228064|FG002|Overall Study|Pregnancy|0|||
48556373|NCT04578535|156228065|FG003|Overall Study|Pregnancy|0|||
48556374|NCT04578535|156228066|FG004|Overall Study|Pregnancy|0|||
48556375|NCT04578535|156228067|FG005|Overall Study|Pregnancy|0|||
48556376|NCT04578535|156228062|FG000|Overall Study|Withdrawal by Subject|0|||
48556377|NCT04578535|156228063|FG001|Overall Study|Withdrawal by Subject|0|||
48556378|NCT04578535|156228064|FG002|Overall Study|Withdrawal by Subject|0|||
48556379|NCT04578535|156228065|FG003|Overall Study|Withdrawal by Subject|1|||
48556380|NCT04578535|156228066|FG004|Overall Study|Withdrawal by Subject|1|||
48556381|NCT04578535|156228067|FG005|Overall Study|Withdrawal by Subject|5|||
48556382|NCT04578535|156228062|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
48556383|NCT04578535|156228063|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
48556384|NCT04578535|156228064|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
48556385|NCT04578535|156228065|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
48556386|NCT04578535|156228066|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
48556387|NCT04578535|156228067|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
48556388|NCT00490841|156228074|FG000|Overall Study|Death|5|||
48556389|NCT00490841|156228074|FG000|Overall Study|Withdrawal by Subject|4|||
48556390|NCT00490841|156228074|FG000|Overall Study|Lost to Follow-up|1|||
48556391|NCT00490841|156228074|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
48556392|NCT01277211|156228091|FG000|Overall Study|Adverse Event|60|||
48556393|NCT01277211|156228092|FG001|Overall Study|Adverse Event|22|||
48615375|NCT02965833|156447387|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
48615376|NCT02965833|156447388|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
48615377|NCT02965833|156447387|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
48556394|NCT01277211|156228091|FG000|Overall Study|Pregnancy|9|||
48556395|NCT01277211|156228092|FG001|Overall Study|Pregnancy|4|||
48556396|NCT01277211|156228091|FG000|Overall Study|Lost to Follow-up|14|||
48556397|NCT01277211|156228092|FG001|Overall Study|Lost to Follow-up|9|||
48556398|NCT01277211|156228091|FG000|Overall Study|Did not wish to continue|17|||
48556399|NCT01277211|156228092|FG001|Overall Study|Did not wish to continue|0|||
48556400|NCT01277211|156228091|FG000|Overall Study|Withdrew Consent|9|||
48556401|NCT01277211|156228092|FG001|Overall Study|Withdrew Consent|9|||
48556402|NCT01277211|156228091|FG000|Overall Study|Non-compliance with protocol|13|||
48556403|NCT01277211|156228092|FG001|Overall Study|Non-compliance with protocol|4|||
48556404|NCT01277211|156228091|FG000|Overall Study|Did not meet protocol eligibility|1|||
48556405|NCT01277211|156228092|FG001|Overall Study|Did not meet protocol eligibility|0|||
48693068|NCT01400698|156724660|FG002|Overall Study|Other|0|||
48615378|NCT02965833|156447388|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
48556406|NCT01277211|156228091|FG000|Overall Study|Administrative|3|||
48556407|NCT01277211|156228092|FG001|Overall Study|Administrative|0|||
48556408|NCT01277211|156228091|FG000|Overall Study|Pregnancy wish|0|||
48556409|NCT01277211|156228092|FG001|Overall Study|Pregnancy wish|2|||
48556410|NCT01277211|156228091|FG000|Overall Study|Discontinued prior to treatment|24|||
48556411|NCT01277211|156228092|FG001|Overall Study|Discontinued prior to treatment|13|||
48615379|NCT03010501|156447390|FG000|Study Week 1|Withdrawal by Subject|2|||
48615380|NCT03010501|156447391|FG001|Study Week 1|Withdrawal by Subject|1|||
48615381|NCT03010501|156447392|FG002|Study Week 1|Withdrawal by Subject|0|||
48615382|NCT03010501|156447393|FG003|Study Week 1|Withdrawal by Subject|2|||
48615383|NCT03010501|156447394|FG004|Study Week 1|Withdrawal by Subject|0|||
48615384|NCT03010501|156447395|FG005|Study Week 1|Withdrawal by Subject|0|||
48615385|NCT03010501|156447390|FG000|Study Week 3|Withdrawal by Subject|0|||
48615386|NCT03010501|156447391|FG001|Study Week 3|Withdrawal by Subject|0|||
48615387|NCT03010501|156447392|FG002|Study Week 3|Withdrawal by Subject|0|||
48615388|NCT03010501|156447393|FG003|Study Week 3|Withdrawal by Subject|1|||
48615389|NCT03010501|156447394|FG004|Study Week 3|Withdrawal by Subject|0|||
48615390|NCT03010501|156447395|FG005|Study Week 3|Withdrawal by Subject|0|||
48615391|NCT02184156|156447396|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
48615392|NCT02184156|156447397|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
48615393|NCT02184156|156447396|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
48615394|NCT02184156|156447397|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
48615395|NCT03003468|156447403|FG000|Overall Study|Withdrawal by Subject|0|||
48615396|NCT03003468|156447404|FG001|Overall Study|Withdrawal by Subject|0|||
48615397|NCT03003468|156447405|FG002|Overall Study|Withdrawal by Subject|1|||
48615398|NCT03003468|156447403|FG000|Overall Study|No measurable lesions|0|||
48615399|NCT03003468|156447404|FG001|Overall Study|No measurable lesions|0|||
48615400|NCT03003468|156447405|FG002|Overall Study|No measurable lesions|1|||
48615401|NCT00421993|156447410|FG000|Overall Study|Withdrawal by Subject|22|||
48615402|NCT00421993|156447411|FG001|Overall Study|Withdrawal by Subject|23|||
48615403|NCT00421993|156447412|FG002|Overall Study|Withdrawal by Subject|23|||
48615404|NCT00421993|156447413|FG003|Overall Study|Withdrawal by Subject|24|||
48615405|NCT00421993|156447410|FG000|Overall Study|Lost to Follow-up|18|||
48615406|NCT00421993|156447411|FG001|Overall Study|Lost to Follow-up|19|||
48615407|NCT00421993|156447412|FG002|Overall Study|Lost to Follow-up|22|||
48615408|NCT00421993|156447413|FG003|Overall Study|Lost to Follow-up|20|||
48615409|NCT00421993|156447410|FG000|Overall Study|Adverse Event|11|||
48615410|NCT00421993|156447411|FG001|Overall Study|Adverse Event|1|||
48615411|NCT00421993|156447412|FG002|Overall Study|Adverse Event|6|||
48615412|NCT00421993|156447413|FG003|Overall Study|Adverse Event|4|||
48615413|NCT00421993|156447410|FG000|Overall Study|Protocol Violation|2|||
48615414|NCT00421993|156447411|FG001|Overall Study|Protocol Violation|2|||
48615415|NCT00421993|156447412|FG002|Overall Study|Protocol Violation|0|||
48615416|NCT00421993|156447413|FG003|Overall Study|Protocol Violation|1|||
48615417|NCT00421993|156447410|FG000|Overall Study|Lack of Efficacy|0|||
48615418|NCT00421993|156447411|FG001|Overall Study|Lack of Efficacy|3|||
48556412|NCT00770328|156228093|FG000|Overall Study|Adverse Event|11|||
48556413|NCT00770328|156228094|FG001|Overall Study|Adverse Event|2|||
48556414|NCT00770328|156228093|FG000|Overall Study|Lost to Follow-up|2|||
48556415|NCT00770328|156228094|FG001|Overall Study|Lost to Follow-up|2|||
48556416|NCT00129545|156228095|FG000|Overall Study|Death|5|||
48556417|NCT00129545|156228096|FG001|Overall Study|Death|60|||
48556418|NCT00129545|156228097|FG002|Overall Study|Death|44|||
48556419|NCT00129545|156228095|FG000|Overall Study|Withdrawal by Subject|3|||
48615419|NCT00421993|156447412|FG002|Overall Study|Lack of Efficacy|0|||
48615420|NCT00421993|156447413|FG003|Overall Study|Lack of Efficacy|5|||
48615421|NCT00421993|156447410|FG000|Overall Study|Pregnancy|0|||
48615422|NCT00421993|156447411|FG001|Overall Study|Pregnancy|1|||
48615423|NCT00421993|156447412|FG002|Overall Study|Pregnancy|1|||
48615424|NCT00421993|156447413|FG003|Overall Study|Pregnancy|2|||
48615425|NCT00421993|156447410|FG000|Overall Study|Subject transportation issues|0|||
48615426|NCT00421993|156447411|FG001|Overall Study|Subject transportation issues|0|||
48615427|NCT00421993|156447412|FG002|Overall Study|Subject transportation issues|0|||
48615428|NCT00421993|156447413|FG003|Overall Study|Subject transportation issues|1|||
48615429|NCT01214720|156447424|FG000|Overall Study|Alive and still on treatment|34|||
48615430|NCT01214720|156447425|FG001|Overall Study|Alive and still on treatment|18|||
48615431|NCT01214720|156447424|FG000|Overall Study|Alive and in follow-up|45|||
48615432|NCT01214720|156447425|FG001|Overall Study|Alive and in follow-up|48|||
48556420|NCT00129545|156228096|FG001|Overall Study|Withdrawal by Subject|18|||
48556421|NCT00129545|156228097|FG002|Overall Study|Withdrawal by Subject|44|||
48556422|NCT00129545|156228095|FG000|Overall Study|Lost to Follow-up|2|||
48556423|NCT00129545|156228096|FG001|Overall Study|Lost to Follow-up|22|||
48556424|NCT00129545|156228097|FG002|Overall Study|Lost to Follow-up|13|||
48556425|NCT00129545|156228095|FG000|Overall Study|Physician Decision|0|||
48556426|NCT00129545|156228096|FG001|Overall Study|Physician Decision|3|||
48556427|NCT00129545|156228097|FG002|Overall Study|Physician Decision|10|||
48556428|NCT00129545|156228095|FG000|Overall Study|Device not implanted|16|||
48556429|NCT00129545|156228096|FG001|Overall Study|Device not implanted|61|||
48556430|NCT00129545|156228097|FG002|Overall Study|Device not implanted|0|||
48556431|NCT04660331|156228102|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
48556432|NCT04660331|156228103|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
48556433|NCT04660331|156228104|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
48556434|NCT03452943|156228105|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
48556435|NCT03452943|156228106|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
48556436|NCT03452943|156228105|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
48556437|NCT03452943|156228106|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
48556438|NCT03452943|156228105|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
48556439|NCT03452943|156228106|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
48556440|NCT03452943|156228105|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
48615433|NCT01214720|156447424|FG000|Overall Study|Lost to Follow-up|6|||
48615434|NCT01214720|156447425|FG001|Overall Study|Lost to Follow-up|2|||
48615435|NCT02347787|156447426|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
48615436|NCT02347787|156447427|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
48556441|NCT03452943|156228106|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
48556442|NCT03452943|156228105|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
48556443|NCT03452943|156228106|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
48615437|NCT02347787|156447426|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
48556444|NCT03452943|156228105|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
48556445|NCT03452943|156228106|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
48556446|NCT01130493|156228107|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
48556447|NCT01130493|156228108|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
48556448|NCT01130493|156228109|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
48556449|NCT01130493|156228107|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
48556450|NCT01130493|156228108|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
48556451|NCT01130493|156228109|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
48556452|NCT01130493|156228107|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
48556453|NCT01130493|156228108|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
48556454|NCT01130493|156228109|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
48556455|NCT01130493|156228107|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
48556456|NCT01130493|156228108|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
48556457|NCT01130493|156228109|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
48556458|NCT01130493|156228107|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
48556459|NCT01130493|156228108|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
48556460|NCT01130493|156228109|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
48556461|NCT01130493|156228107|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
48556462|NCT01130493|156228108|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
48556463|NCT01130493|156228109|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
48556464|NCT01130493|156228107|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
48556465|NCT01130493|156228108|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
48556466|NCT01130493|156228109|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
48556467|NCT01130493|156228107|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
48556468|NCT01130493|156228108|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
48556469|NCT01130493|156228109|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
48556470|NCT01130493|156228107|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
48556471|NCT01130493|156228108|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
48556472|NCT01130493|156228109|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
48556473|NCT01130493|156228107|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
48556474|NCT01130493|156228108|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
48556475|NCT01130493|156228109|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
48556476|NCT01130493|156228107|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
48556477|NCT01130493|156228108|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
48556478|NCT01130493|156228109|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
48556479|NCT01130493|156228107|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
48556480|NCT01130493|156228108|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
48556481|NCT01130493|156228109|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
48556482|NCT01130493|156228107|FG000|Part 2: OLE|Adverse Event|0|||
48556483|NCT01130493|156228108|FG001|Part 2: OLE|Adverse Event|2|||
48556484|NCT01130493|156228109|FG002|Part 2: OLE|Adverse Event|1|||
48556485|NCT01130493|156228107|FG000|Part 2: OLE|Withdrawal by Subject|0|||
48556486|NCT01130493|156228108|FG001|Part 2: OLE|Withdrawal by Subject|1|||
48556487|NCT01130493|156228109|FG002|Part 2: OLE|Withdrawal by Subject|4|||
48615438|NCT02347787|156447427|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
48615439|NCT02347787|156447426|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
48615440|NCT02347787|156447427|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
48615441|NCT02347787|156447426|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
48615442|NCT02347787|156447427|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
48615443|NCT01980888|156447428|FG000|Overall Study|Study Terminated by Sponsor|116|||
48615444|NCT01980888|156447429|FG001|Overall Study|Study Terminated by Sponsor|122|||
48556488|NCT03125798|156228111|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
48556489|NCT03125798|156228112|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
48556490|NCT03125798|156228111|FG000|Overall Study|Conversion to thoracotomy|7|||
48556491|NCT03125798|156228112|FG001|Overall Study|Conversion to thoracotomy|7|||
48556492|NCT02854527|156228114|FG000|Overall Study|Adverse Event|0|||
48556493|NCT02854527|156228115|FG001|Overall Study|Adverse Event|0|||
48556494|NCT02854527|156228116|FG002|Overall Study|Adverse Event|0|||
48556495|NCT02854527|156228117|FG003|Overall Study|Adverse Event|0|||
48556496|NCT02854527|156228118|FG004|Overall Study|Adverse Event|1|||
48556497|NCT02854527|156228119|FG005|Overall Study|Adverse Event|0|||
48556498|NCT02854527|156228120|FG006|Overall Study|Adverse Event|0|||
48556499|NCT02854527|156228121|FG007|Overall Study|Adverse Event|0|||
48556500|NCT02854527|156228122|FG008|Overall Study|Adverse Event|0|||
48556501|NCT02854527|156228123|FG009|Overall Study|Adverse Event|0|||
48556502|NCT02854527|156228114|FG000|Overall Study|Lost to Follow-up|0|||
48556503|NCT02854527|156228115|FG001|Overall Study|Lost to Follow-up|0|||
48556504|NCT02854527|156228116|FG002|Overall Study|Lost to Follow-up|0|||
48556505|NCT02854527|156228117|FG003|Overall Study|Lost to Follow-up|1|||
48556506|NCT02854527|156228118|FG004|Overall Study|Lost to Follow-up|0|||
48556507|NCT02854527|156228119|FG005|Overall Study|Lost to Follow-up|0|||
48556508|NCT02854527|156228120|FG006|Overall Study|Lost to Follow-up|0|||
48556509|NCT02854527|156228121|FG007|Overall Study|Lost to Follow-up|0|||
48556510|NCT02854527|156228122|FG008|Overall Study|Lost to Follow-up|0|||
48556511|NCT02854527|156228123|FG009|Overall Study|Lost to Follow-up|0|||
48556512|NCT02430480|156228124|FG000|Overall Study|Death|1|||
48556513|NCT02430480|156228124|FG000|Overall Study|Anesthesia concerns|1|||
48556514|NCT02430480|156228124|FG000|Overall Study|Progressed on treatment|1|||
48556515|NCT02461160|156228125|FG000|Overall Study|Lost to Follow-up|0|||
48556516|NCT02461160|156228126|FG001|Overall Study|Lost to Follow-up|0|||
48556517|NCT02461160|156228127|FG002|Overall Study|Lost to Follow-up|0|||
48556518|NCT02461160|156228128|FG003|Overall Study|Lost to Follow-up|0|||
48556519|NCT02461160|156228129|FG004|Overall Study|Lost to Follow-up|0|||
48556520|NCT02461160|156228130|FG005|Overall Study|Lost to Follow-up|0|||
48556521|NCT02461160|156228131|FG006|Overall Study|Lost to Follow-up|0|||
48556522|NCT02461160|156228132|FG007|Overall Study|Lost to Follow-up|1|||
48556523|NCT02461160|156228133|FG008|Overall Study|Lost to Follow-up|0|||
48556524|NCT02461160|156228134|FG009|Overall Study|Lost to Follow-up|0|||
48556525|NCT02461160|156228135|FG010|Overall Study|Lost to Follow-up|0|||
48556526|NCT02461160|156228136|FG011|Overall Study|Lost to Follow-up|0|||
48556527|NCT02461160|156228137|FG012|Overall Study|Lost to Follow-up|0|||
48556528|NCT02072980|156228138|FG000|Period 2, Second Wear|Adverse Event|0|||
48556529|NCT02072980|156228139|FG001|Period 2, Second Wear|Adverse Event|1|||
48556530|NCT00946920|156228140|FG000|Overall Study|Withdrawal by Subject|28|||
48556531|NCT00946920|156228141|FG001|Overall Study|Withdrawal by Subject|15|||
48556532|NCT00946920|156228140|FG000|Overall Study|Lost to Follow-up|2|||
48556533|NCT00946920|156228141|FG001|Overall Study|Lost to Follow-up|2|||
48556534|NCT00946920|156228140|FG000|Overall Study|Physician Decision|5|||
48556535|NCT00946920|156228141|FG001|Overall Study|Physician Decision|2|||
48556536|NCT00946920|156228140|FG000|Overall Study|Adverse Event|41|||
48556537|NCT00946920|156228141|FG001|Overall Study|Adverse Event|14|||
48556538|NCT00946920|156228140|FG000|Overall Study|Protocol Violation|16|||
48556539|NCT00946920|156228141|FG001|Overall Study|Protocol Violation|8|||
48556540|NCT00946920|156228140|FG000|Overall Study|Miscellaneous reasons|18|||
48556541|NCT00946920|156228141|FG001|Overall Study|Miscellaneous reasons|3|||
48556542|NCT05093829|156228142|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
48556543|NCT05093829|156228143|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
48556544|NCT05093829|156228144|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
48556545|NCT05093829|156228145|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
48615445|NCT01980888|156447428|FG000|Overall Study|Withdrew Consent|17|||
48615446|NCT01980888|156447429|FG001|Overall Study|Withdrew Consent|6|||
48556546|NCT05093829|156228146|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
48556547|NCT00625820|156228151|FG000|Overall Study|Withdrawal by Subject|1|||
48556548|NCT04146012|156228156|FG000|Overall Study|Study Terminated|30|||
48615447|NCT01980888|156447428|FG000|Overall Study|Investigator's Discretion|8|||
48556549|NCT04146012|156228157|FG001|Overall Study|Study Terminated|15|||
48556550|NCT00866359|156228160|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
48556551|NCT00866359|156228161|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
48556552|NCT00866359|156228162|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
48556553|NCT00866359|156228163|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
48556554|NCT00866359|156228160|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
48556555|NCT00866359|156228161|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
48556556|NCT00866359|156228162|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
48556557|NCT00866359|156228163|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
48556558|NCT00866359|156228160|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
48556559|NCT00866359|156228161|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
48556560|NCT00866359|156228162|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
48556561|NCT00866359|156228163|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
48556562|NCT00866359|156228160|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
48556563|NCT00866359|156228161|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
48556564|NCT00866359|156228162|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
48556565|NCT00866359|156228163|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
48556566|NCT00866359|156228160|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
48615448|NCT01980888|156447429|FG001|Overall Study|Investigator's Discretion|3|||
48615449|NCT01980888|156447428|FG000|Overall Study|Non-Compliance with Study Drug|3|||
48615450|NCT01980888|156447429|FG001|Overall Study|Non-Compliance with Study Drug|2|||
48615451|NCT01751685|156447431|FG000|6-mo Followup|Missed study visit|1|||
48556567|NCT00866359|156228161|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
48556568|NCT00866359|156228162|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
48556569|NCT00866359|156228163|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
48556570|NCT00866359|156228160|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
48556571|NCT00866359|156228161|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
48556572|NCT00866359|156228162|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
48615452|NCT01751685|156447432|FG001|6-mo Followup|Missed study visit|0|||
48615453|NCT01751685|156447431|FG000|6-mo Followup|Withdrawal by Subject|2|||
48615454|NCT01751685|156447432|FG001|6-mo Followup|Withdrawal by Subject|2|||
48615455|NCT01751685|156447431|FG000|6-mo Followup|Lost to Follow-up|0|||
48615456|NCT01751685|156447432|FG001|6-mo Followup|Lost to Follow-up|1|||
48615457|NCT01751685|156447431|FG000|12-mo Followup|Lost to Follow-up|5|||
48615458|NCT01751685|156447432|FG001|12-mo Followup|Lost to Follow-up|0|||
48615459|NCT04625972|156447433|FG000|Overall Study|Death|3|||
48615460|NCT04625972|156447434|FG001|Overall Study|Death|2|||
48615461|NCT04625972|156447433|FG000|Overall Study|Lost to Follow-up|82|||
48615462|NCT04625972|156447434|FG001|Overall Study|Lost to Follow-up|38|||
48615463|NCT04625972|156447433|FG000|Overall Study|Physician Decision|2|||
48615464|NCT04625972|156447434|FG001|Overall Study|Physician Decision|0|||
48615465|NCT04625972|156447433|FG000|Overall Study|Protocol Violation|0|||
48615466|NCT04625972|156447434|FG001|Overall Study|Protocol Violation|1|||
48615467|NCT04625972|156447433|FG000|Overall Study|Withdrawal by Subject|37|||
48615468|NCT04625972|156447434|FG001|Overall Study|Withdrawal by Subject|24|||
48615469|NCT04625972|156447433|FG000|Overall Study|Not specified elsewhere|8|||
48615470|NCT04625972|156447434|FG001|Overall Study|Not specified elsewhere|6|||
48615471|NCT01107457|156447438|FG000|Part A|Adverse Event|1|||
48615472|NCT01107457|156447439|FG001|Part A|Adverse Event|2|||
48615473|NCT01107457|156447440|FG002|Part A|Adverse Event|1|||
48615474|NCT01107457|156447441|FG003|Part A|Adverse Event|0|||
48615475|NCT01107457|156447442|FG004|Part A|Adverse Event|0|||
48615476|NCT01107457|156447443|FG005|Part A|Adverse Event|0|||
48615477|NCT01107457|156447438|FG000|Part A|Withdrawal by Subject|3|||
48615478|NCT01107457|156447439|FG001|Part A|Withdrawal by Subject|3|||
48615479|NCT01107457|156447440|FG002|Part A|Withdrawal by Subject|0|||
48615480|NCT01107457|156447441|FG003|Part A|Withdrawal by Subject|3|||
48615481|NCT01107457|156447442|FG004|Part A|Withdrawal by Subject|1|||
48615482|NCT01107457|156447443|FG005|Part A|Withdrawal by Subject|0|||
48615483|NCT01107457|156447438|FG000|Part A|Lost to Follow-up|0|||
48615484|NCT01107457|156447439|FG001|Part A|Lost to Follow-up|1|||
48615485|NCT01107457|156447440|FG002|Part A|Lost to Follow-up|0|||
48556573|NCT00866359|156228163|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
48556574|NCT02633787|156228164|FG000|Overall Study|Withdrawal by Subject|1|||
48615486|NCT01107457|156447441|FG003|Part A|Lost to Follow-up|0|||
48615487|NCT01107457|156447442|FG004|Part A|Lost to Follow-up|0|||
48615488|NCT01107457|156447443|FG005|Part A|Lost to Follow-up|0|||
48615489|NCT01107457|156447438|FG000|Part A|Lack of Efficacy|1|||
48615490|NCT01107457|156447439|FG001|Part A|Lack of Efficacy|0|||
48615491|NCT01107457|156447440|FG002|Part A|Lack of Efficacy|0|||
48615492|NCT01107457|156447441|FG003|Part A|Lack of Efficacy|0|||
48615493|NCT01107457|156447442|FG004|Part A|Lack of Efficacy|0|||
48615494|NCT01107457|156447443|FG005|Part A|Lack of Efficacy|0|||
48615495|NCT01107457|156447438|FG000|Part A|Protocol Violation|0|||
48615496|NCT01107457|156447439|FG001|Part A|Protocol Violation|1|||
48615497|NCT01107457|156447440|FG002|Part A|Protocol Violation|0|||
48615498|NCT01107457|156447441|FG003|Part A|Protocol Violation|0|||
48615499|NCT01107457|156447442|FG004|Part A|Protocol Violation|0|||
48615500|NCT01107457|156447443|FG005|Part A|Protocol Violation|0|||
48615501|NCT01107457|156447438|FG000|Part B and C|Adverse Event|0|||
48615502|NCT01107457|156447439|FG001|Part B and C|Adverse Event|0|||
48615503|NCT01107457|156447440|FG002|Part B and C|Adverse Event|0|||
48615504|NCT01107457|156447441|FG003|Part B and C|Adverse Event|0|||
48615505|NCT01107457|156447442|FG004|Part B and C|Adverse Event|0|||
48615506|NCT01107457|156447443|FG005|Part B and C|Adverse Event|12|||
48615507|NCT01107457|156447438|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
48615508|NCT01107457|156447439|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
48556575|NCT00584454|156228167|FG000|Overall Study|Adverse Event|1|||
48556576|NCT00584454|156228167|FG000|Overall Study|Relocation|1|||
48556577|NCT00584454|156228167|FG000|Overall Study|Clinical Hold|2|||
48556578|NCT02404805|156228168|FG000|Overall Study|Withdrawal by Subject|1|||
48556579|NCT02404805|156228169|FG001|Overall Study|Withdrawal by Subject|0|||
48556580|NCT02404805|156228170|FG002|Overall Study|Withdrawal by Subject|0|||
48556581|NCT02404805|156228171|FG003|Overall Study|Withdrawal by Subject|0|||
48556582|NCT02404805|156228172|FG004|Overall Study|Withdrawal by Subject|0|||
48556583|NCT02404805|156228173|FG005|Overall Study|Withdrawal by Subject|0|||
48556584|NCT02163057|156228174|FG000|Overall Study|Participant Refusal to Continue|2|||
48556585|NCT02163057|156228175|FG001|Overall Study|Participant Refusal to Continue|2|||
48556586|NCT02163057|156228174|FG000|Overall Study|Participant Significant Noncompliance|0|||
48556587|NCT02163057|156228175|FG001|Overall Study|Participant Significant Noncompliance|1|||
48556588|NCT02163057|156228174|FG000|Overall Study|Progression of Disease|1|||
48556589|NCT02163057|156228175|FG001|Overall Study|Progression of Disease|2|||
48556590|NCT01625091|156228176|FG000|Intervention|Death|1|||
48556591|NCT01625091|156228177|FG001|Intervention|Death|1|||
48556592|NCT01625091|156228176|FG000|Intervention|Withdrawal by Subject|4|||
48556593|NCT01625091|156228177|FG001|Intervention|Withdrawal by Subject|1|||
48556594|NCT01625091|156228176|FG000|Intervention|Adverse Event|0|||
48556595|NCT01625091|156228177|FG001|Intervention|Adverse Event|2|||
48556596|NCT01625091|156228176|FG000|Intervention|Lost to Follow-up|4|||
48556597|NCT01625091|156228177|FG001|Intervention|Lost to Follow-up|4|||
48556598|NCT01625091|156228176|FG000|Intervention|Study termination|2|||
48556599|NCT01625091|156228177|FG001|Intervention|Study termination|3|||
48556600|NCT01625091|156228176|FG000|Post-intervention|Death|0|||
48556601|NCT01625091|156228177|FG001|Post-intervention|Death|1|||
48556602|NCT01625091|156228176|FG000|Post-intervention|Lost to Follow-up|2|||
48556603|NCT01625091|156228177|FG001|Post-intervention|Lost to Follow-up|0|||
48556604|NCT01625091|156228176|FG000|Post-intervention|Study termination|2|||
48556605|NCT01625091|156228177|FG001|Post-intervention|Study termination|1|||
48556606|NCT00858273|156228178|FG000|Overall Study|Protocol Violation|3|||
48556607|NCT00858273|156228179|FG001|Overall Study|Protocol Violation|5|||
48556608|NCT01433055|156229653|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
48615509|NCT01107457|156447440|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
48615510|NCT01107457|156447441|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
48615511|NCT01107457|156447442|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
48615512|NCT01107457|156447443|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
48615513|NCT01107457|156447438|FG000|Part B and C|Physician Decision|0|||
48615514|NCT01107457|156447439|FG001|Part B and C|Physician Decision|0|||
48556609|NCT01433055|156229654|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
48556610|NCT01433055|156229653|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
48556611|NCT01433055|156229654|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
48556612|NCT02094417|156229655|FG000|Overall Study|Adverse Event|0|||
48556613|NCT02094417|156229656|FG001|Overall Study|Adverse Event|0|||
48556614|NCT02094417|156229657|FG002|Overall Study|Adverse Event|0|||
48556615|NCT02094417|156229658|FG003|Overall Study|Adverse Event|1|||
48556616|NCT02094417|156229655|FG000|Overall Study|Eligibility criteria|0|||
48556617|NCT02094417|156229656|FG001|Overall Study|Eligibility criteria|1|||
48556618|NCT02094417|156229657|FG002|Overall Study|Eligibility criteria|0|||
48556619|NCT02094417|156229658|FG003|Overall Study|Eligibility criteria|0|||
48556620|NCT02094417|156229655|FG000|Overall Study|No responder|4|||
48556621|NCT02094417|156229656|FG001|Overall Study|No responder|4|||
48556622|NCT02094417|156229657|FG002|Overall Study|No responder|4|||
48556623|NCT02094417|156229658|FG003|Overall Study|No responder|3|||
48556624|NCT02094417|156229655|FG000|Overall Study|Unable to conduct observations or assess|0|||
48615515|NCT01107457|156447440|FG002|Part B and C|Physician Decision|0|||
48556625|NCT02094417|156229656|FG001|Overall Study|Unable to conduct observations or assess|1|||
48556626|NCT02094417|156229657|FG002|Overall Study|Unable to conduct observations or assess|0|||
48556627|NCT02094417|156229658|FG003|Overall Study|Unable to conduct observations or assess|0|||
48556628|NCT02094417|156229655|FG000|Overall Study|Withdrawal by Subject|1|||
48556629|NCT02094417|156229656|FG001|Overall Study|Withdrawal by Subject|2|||
48556630|NCT02094417|156229657|FG002|Overall Study|Withdrawal by Subject|1|||
48556631|NCT02094417|156229658|FG003|Overall Study|Withdrawal by Subject|3|||
48556632|NCT03573830|156229659|FG000|Overall Study|Dropped without completing treatment|0|||
48615516|NCT01107457|156447441|FG003|Part B and C|Physician Decision|0|||
48615517|NCT01107457|156447442|FG004|Part B and C|Physician Decision|0|||
48556633|NCT03573830|156229660|FG001|Overall Study|Dropped without completing treatment|7|||
48556634|NCT03573830|156229659|FG000|Overall Study|Lost to Follow-up|4|||
48615518|NCT01107457|156447443|FG005|Part B and C|Physician Decision|3|||
48615519|NCT01107457|156447438|FG000|Part B and C|Lack of Efficacy|0|||
48615520|NCT01107457|156447439|FG001|Part B and C|Lack of Efficacy|0|||
48615521|NCT01107457|156447440|FG002|Part B and C|Lack of Efficacy|0|||
48615522|NCT01107457|156447441|FG003|Part B and C|Lack of Efficacy|0|||
48615523|NCT01107457|156447442|FG004|Part B and C|Lack of Efficacy|0|||
48615524|NCT01107457|156447443|FG005|Part B and C|Lack of Efficacy|7|||
48615525|NCT01107457|156447438|FG000|Part B and C|Lost to Follow-up|0|||
48615526|NCT01107457|156447439|FG001|Part B and C|Lost to Follow-up|0|||
48615527|NCT01107457|156447440|FG002|Part B and C|Lost to Follow-up|0|||
48615528|NCT01107457|156447441|FG003|Part B and C|Lost to Follow-up|0|||
48615529|NCT01107457|156447442|FG004|Part B and C|Lost to Follow-up|0|||
48615530|NCT01107457|156447443|FG005|Part B and C|Lost to Follow-up|10|||
48615531|NCT01107457|156447438|FG000|Part B and C|Protocol Violation|0|||
48615532|NCT01107457|156447439|FG001|Part B and C|Protocol Violation|0|||
48615533|NCT01107457|156447440|FG002|Part B and C|Protocol Violation|0|||
48615534|NCT01107457|156447441|FG003|Part B and C|Protocol Violation|0|||
48615535|NCT01107457|156447442|FG004|Part B and C|Protocol Violation|0|||
48615536|NCT01107457|156447443|FG005|Part B and C|Protocol Violation|1|||
48615537|NCT01107457|156447438|FG000|Part B and C|Sponsor Decision|0|||
48615538|NCT01107457|156447439|FG001|Part B and C|Sponsor Decision|0|||
48615539|NCT01107457|156447440|FG002|Part B and C|Sponsor Decision|0|||
48615540|NCT01107457|156447441|FG003|Part B and C|Sponsor Decision|0|||
48615541|NCT01107457|156447442|FG004|Part B and C|Sponsor Decision|0|||
48615542|NCT01107457|156447443|FG005|Part B and C|Sponsor Decision|66|||
48615543|NCT01107457|156447438|FG000|Part B and C|Withdrawal by Subject|0|||
48615544|NCT01107457|156447439|FG001|Part B and C|Withdrawal by Subject|0|||
48615545|NCT01107457|156447440|FG002|Part B and C|Withdrawal by Subject|0|||
48615546|NCT01107457|156447441|FG003|Part B and C|Withdrawal by Subject|0|||
48615547|NCT01107457|156447442|FG004|Part B and C|Withdrawal by Subject|0|||
48615548|NCT01107457|156447443|FG005|Part B and C|Withdrawal by Subject|16|||
48615549|NCT01107457|156447438|FG000|Part B and C|Clinical Relapse|0|||
48556635|NCT03573830|156229660|FG001|Overall Study|Lost to Follow-up|0|||
48556636|NCT00733005|156229661|FG000|Overall Study|Adverse Event|0|||
48556637|NCT00733005|156229662|FG001|Overall Study|Adverse Event|1|||
48556638|NCT00733005|156229661|FG000|Overall Study|Treatment Failure|0|||
48556639|NCT00733005|156229662|FG001|Overall Study|Treatment Failure|1|||
48556640|NCT00733005|156229661|FG000|Overall Study|Withdrawal by Subject|0|||
48556641|NCT00733005|156229662|FG001|Overall Study|Withdrawal by Subject|1|||
48556642|NCT00733005|156229661|FG000|Overall Study|Protocol Violation|2|||
48556643|NCT00733005|156229662|FG001|Overall Study|Protocol Violation|0|||
48556644|NCT01769456|156229663|FG000|Overall Study|Lost to Follow-up|19|||
48556645|NCT01769456|156229663|FG000|Overall Study|Withdrawal by Subject|3|||
48556646|NCT01769456|156229663|FG000|Overall Study|Did not receive PCC intervention|6|||
48556647|NCT01769456|156229663|FG000|Overall Study|Moved out of the area|3|||
48556648|NCT01769456|156229663|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
48556649|NCT01769456|156229663|FG000|Overall Study|Parental request to youth to withdraw|1|||
48556650|NCT01403051|156229664|FG000|Overall Study|Protocol Violation|2|||
48556651|NCT01403051|156229665|FG001|Overall Study|Protocol Violation|0|||
48556652|NCT01403051|156229664|FG000|Overall Study|Death|1|||
48556653|NCT01403051|156229665|FG001|Overall Study|Death|0|||
48556654|NCT01403051|156229664|FG000|Overall Study|Withdrawal by Subject|2|||
48556655|NCT01403051|156229665|FG001|Overall Study|Withdrawal by Subject|1|||
48556656|NCT01403051|156229664|FG000|Overall Study|Lost to Follow-up|5|||
48556657|NCT01403051|156229665|FG001|Overall Study|Lost to Follow-up|5|||
48556658|NCT03971474|156229679|FG000|Overall Study|Adverse Event|11|||
48556659|NCT03971474|156229680|FG001|Overall Study|Adverse Event|7|||
48556660|NCT03971474|156229679|FG000|Overall Study|Refusal unrelated to adverse event|5|||
48556661|NCT03971474|156229680|FG001|Overall Study|Refusal unrelated to adverse event|1|||
48556662|NCT03971474|156229679|FG000|Overall Study|Progression/relapse|40|||
48556663|NCT03971474|156229680|FG001|Overall Study|Progression/relapse|47|||
48556664|NCT03971474|156229679|FG000|Overall Study|Death|6|||
48556665|NCT03971474|156229680|FG001|Overall Study|Death|3|||
48556666|NCT03971474|156229679|FG000|Overall Study|Other - not protocol specified|5|||
48556667|NCT03971474|156229680|FG001|Overall Study|Other - not protocol specified|4|||
48556668|NCT03971474|156229679|FG000|Overall Study|On treatment|0|||
48556669|NCT03971474|156229680|FG001|Overall Study|On treatment|7|||
48556670|NCT01811472|156229682|FG000|Overall Study|Adverse Event|1|||
48556671|NCT01811472|156229683|FG001|Overall Study|Adverse Event|0|||
48556672|NCT01811472|156229684|FG002|Overall Study|Adverse Event|4|||
48556673|NCT01811472|156229682|FG000|Overall Study|Lost to Follow-up|0|||
48556674|NCT01811472|156229683|FG001|Overall Study|Lost to Follow-up|0|||
48556675|NCT01811472|156229684|FG002|Overall Study|Lost to Follow-up|1|||
48556676|NCT01811472|156229682|FG000|Overall Study|Subject/guardian decision|1|||
48556677|NCT01811472|156229683|FG001|Overall Study|Subject/guardian decision|0|||
48556678|NCT01811472|156229684|FG002|Overall Study|Subject/guardian decision|0|||
48615550|NCT01107457|156447439|FG001|Part B and C|Clinical Relapse|0|||
48615551|NCT01107457|156447440|FG002|Part B and C|Clinical Relapse|0|||
48615552|NCT01107457|156447441|FG003|Part B and C|Clinical Relapse|0|||
48556679|NCT03288714|156229687|FG000|Overall Study|Lost to Follow-up|2|||
48556680|NCT03288714|156229688|FG001|Overall Study|Lost to Follow-up|1|||
48556681|NCT03288714|156229687|FG000|Overall Study|Non-compliance with study schedule|2|||
48556682|NCT03288714|156229688|FG001|Overall Study|Non-compliance with study schedule|0|||
48556683|NCT03288714|156229687|FG000|Overall Study|Withdrawal by Subject|3|||
48556684|NCT03288714|156229688|FG001|Overall Study|Withdrawal by Subject|1|||
48556685|NCT03288714|156229687|FG000|Overall Study|Clinical Worsening|2|||
48556686|NCT03288714|156229688|FG001|Overall Study|Clinical Worsening|1|||
48556687|NCT03288714|156229687|FG000|Overall Study|Adverse Event|1|||
48556688|NCT03288714|156229688|FG001|Overall Study|Adverse Event|0|||
48556689|NCT01023035|156229689|FG000|Treatment Period|Adverse Event|27|||
48556690|NCT01023035|156229690|FG001|Treatment Period|Adverse Event|32|||
48556691|NCT01023035|156229691|FG002|Treatment Period|Adverse Event|50|||
48556692|NCT01023035|156229689|FG000|Treatment Period|Non-Medical Reasons|19|||
48556693|NCT01023035|156229690|FG001|Treatment Period|Non-Medical Reasons|22|||
48556694|NCT01023035|156229691|FG002|Treatment Period|Non-Medical Reasons|44|||
48556695|NCT01023035|156229689|FG000|Treatment Period|Treatment Failure|26|||
48556696|NCT01023035|156229690|FG001|Treatment Period|Treatment Failure|31|||
48556697|NCT01023035|156229691|FG002|Treatment Period|Treatment Failure|24|||
48556698|NCT01023035|156229689|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
48556699|NCT01023035|156229690|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
48556700|NCT01023035|156229691|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
48615553|NCT01107457|156447442|FG004|Part B and C|Clinical Relapse|0|||
48615554|NCT01107457|156447443|FG005|Part B and C|Clinical Relapse|4|||
48615555|NCT03738215|156447459|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
48615556|NCT03738215|156447460|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
48556701|NCT01023035|156229689|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
48556702|NCT01023035|156229690|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
48556703|NCT01023035|156229691|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
48556704|NCT01807065|156229692|FG000|Overall Study|Receive no sip-T due to IV access|1|||
48556705|NCT01807065|156229693|FG001|Overall Study|Receive no sip-T due to IV access|1|||
48556706|NCT01153425|156229696|FG000|Overall Study|Withdrawal by Subject|3|||
48556707|NCT01153425|156229697|FG001|Overall Study|Withdrawal by Subject|3|||
48556708|NCT01937871|156229700|FG000|Overall Study|Adverse Event|6|||
48556709|NCT01937871|156229701|FG001|Overall Study|Adverse Event|6|||
48556710|NCT01937871|156229702|FG002|Overall Study|Adverse Event|2|||
48556711|NCT01937871|156229700|FG000|Overall Study|Lost to Follow-up|8|||
48556712|NCT01937871|156229701|FG001|Overall Study|Lost to Follow-up|2|||
48556713|NCT01937871|156229702|FG002|Overall Study|Lost to Follow-up|4|||
48556714|NCT01937871|156229700|FG000|Overall Study|Withdrawal by Subject|9|||
48556715|NCT01937871|156229701|FG001|Overall Study|Withdrawal by Subject|6|||
48556716|NCT01937871|156229702|FG002|Overall Study|Withdrawal by Subject|4|||
48615557|NCT03738215|156447461|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
48615558|NCT03738215|156447459|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
48615559|NCT03738215|156447460|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
48615560|NCT03738215|156447461|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48615561|NCT03738215|156447459|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
48615562|NCT03738215|156447460|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
48615563|NCT03738215|156447461|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
48615564|NCT03738215|156447459|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
48615565|NCT03738215|156447460|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
48615566|NCT03738215|156447461|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
48693069|NCT01400698|156724661|FG003|Overall Study|Other|2|||
48556717|NCT01937871|156229700|FG000|Overall Study|Physician Decision|0|||
48556718|NCT01937871|156229701|FG001|Overall Study|Physician Decision|1|||
48556719|NCT01937871|156229702|FG002|Overall Study|Physician Decision|0|||
48556720|NCT01937871|156229700|FG000|Overall Study|Entry Criteria Not Met|1|||
48556721|NCT01937871|156229701|FG001|Overall Study|Entry Criteria Not Met|2|||
48556722|NCT01937871|156229702|FG002|Overall Study|Entry Criteria Not Met|1|||
48556723|NCT00970593|156229705|FG000|Overall Study|Adverse Event|1|||
48556724|NCT00970593|156229706|FG001|Overall Study|Adverse Event|1|||
48556725|NCT00970593|156229707|FG002|Overall Study|Adverse Event|0|||
48556726|NCT00970593|156229708|FG003|Overall Study|Adverse Event|0|||
48556727|NCT00970593|156229709|FG004|Overall Study|Adverse Event|0|||
48556728|NCT00970593|156229710|FG005|Overall Study|Adverse Event|0|||
48556729|NCT00970593|156229711|FG006|Overall Study|Adverse Event|0|||
48556730|NCT00970593|156229705|FG000|Overall Study|Discontinuation of study by sponsor|0|||
48556731|NCT00970593|156229706|FG001|Overall Study|Discontinuation of study by sponsor|0|||
48556732|NCT00970593|156229707|FG002|Overall Study|Discontinuation of study by sponsor|5|||
48556733|NCT00970593|156229708|FG003|Overall Study|Discontinuation of study by sponsor|0|||
48556734|NCT00970593|156229709|FG004|Overall Study|Discontinuation of study by sponsor|0|||
48556735|NCT00970593|156229710|FG005|Overall Study|Discontinuation of study by sponsor|0|||
48556736|NCT00970593|156229711|FG006|Overall Study|Discontinuation of study by sponsor|2|||
48556737|NCT00970593|156229705|FG000|Overall Study|Withdrawal by Subject|0|||
48556738|NCT00970593|156229706|FG001|Overall Study|Withdrawal by Subject|0|||
48556739|NCT00970593|156229707|FG002|Overall Study|Withdrawal by Subject|1|||
48556740|NCT00970593|156229708|FG003|Overall Study|Withdrawal by Subject|0|||
48556741|NCT00970593|156229709|FG004|Overall Study|Withdrawal by Subject|0|||
48556742|NCT00970593|156229710|FG005|Overall Study|Withdrawal by Subject|0|||
48556743|NCT00970593|156229711|FG006|Overall Study|Withdrawal by Subject|0|||
48556744|NCT00524420|156229718|FG000|Overall Study|Lack of Efficacy|1|||
48556745|NCT00524420|156229719|FG001|Overall Study|Lack of Efficacy|0|||
48556746|NCT00577863|156229720|FG000|Overall Study|Adverse Event|4|||
48556747|NCT00577863|156229721|FG001|Overall Study|Adverse Event|2|||
48556748|NCT00577863|156229720|FG000|Overall Study|Death|1|||
48556749|NCT00577863|156229721|FG001|Overall Study|Death|0|||
48556750|NCT00577863|156229720|FG000|Overall Study|Lost to Follow-up|2|||
48556751|NCT00577863|156229721|FG001|Overall Study|Lost to Follow-up|2|||
48556752|NCT00577863|156229720|FG000|Overall Study|Entry Criteria Exclusion|1|||
48556753|NCT00577863|156229721|FG001|Overall Study|Entry Criteria Exclusion|0|||
48556754|NCT00577863|156229720|FG000|Overall Study|Withdrawal by Subject|0|||
48556755|NCT00577863|156229721|FG001|Overall Study|Withdrawal by Subject|2|||
48556756|NCT00577863|156229720|FG000|Overall Study|Sponsor Decision|2|||
48556757|NCT00577863|156229721|FG001|Overall Study|Sponsor Decision|7|||
48556758|NCT00577863|156229720|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
48556759|NCT00577863|156229721|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
48556760|NCT01482312|156229725|FG000|Period 1, 90 Minutes of Wear|Other|1|||
48556761|NCT01482312|156229726|FG001|Period 1, 90 Minutes of Wear|Other|0|||
48556762|NCT01482312|156229727|FG002|Period 1, 90 Minutes of Wear|Other|0|||
48556763|NCT01482312|156229725|FG000|Period 2, 90 Minutes of Wear|Other|1|||
48556764|NCT01482312|156229726|FG001|Period 2, 90 Minutes of Wear|Other|0|||
48556765|NCT01482312|156229727|FG002|Period 2, 90 Minutes of Wear|Other|0|||
48556766|NCT02738138|156229730|FG000|Overall Study|Adverse Event|0|||
48556767|NCT02738138|156229731|FG001|Overall Study|Adverse Event|1|||
48556768|NCT02738138|156229730|FG000|Overall Study|Lost to Follow-up|2|||
48556769|NCT02738138|156229731|FG001|Overall Study|Lost to Follow-up|0|||
48556770|NCT02738138|156229730|FG000|Overall Study|Other - not further specified|1|||
48556771|NCT02738138|156229731|FG001|Overall Study|Other - not further specified|0|||
48556772|NCT00613171|156229737|FG000|Overall Study|Adverse Event|7|||
48556773|NCT00613171|156229737|FG000|Overall Study|Withdrawal by Subject|3|||
48556774|NCT00613171|156229737|FG000|Overall Study|Reason not Specified|4|||
48556775|NCT03154125|156229738|FG000|Overall Study|Lost to Follow-up|11|||
48556776|NCT03154125|156229739|FG001|Overall Study|Lost to Follow-up|11|||
48556777|NCT03154125|156229740|FG002|Overall Study|Lost to Follow-up|0|||
48556778|NCT03154125|156229738|FG000|Overall Study|Withdrawal by Subject|49|||
48556779|NCT03154125|156229739|FG001|Overall Study|Withdrawal by Subject|55|||
48556780|NCT03154125|156229740|FG002|Overall Study|Withdrawal by Subject|8|||
48556781|NCT03154125|156229738|FG000|Overall Study|Physician Decision|13|||
48556782|NCT03154125|156229739|FG001|Overall Study|Physician Decision|6|||
48556783|NCT03154125|156229740|FG002|Overall Study|Physician Decision|0|||
48556784|NCT03154125|156229738|FG000|Overall Study|Protocol Violation|3|||
48556785|NCT03154125|156229739|FG001|Overall Study|Protocol Violation|5|||
48556786|NCT03154125|156229740|FG002|Overall Study|Protocol Violation|0|||
48556787|NCT03639779|156229745|FG000|Overall Study|Lost to Follow-up|1|||
48556788|NCT02189837|156229749|FG000|Overall Study|Withdrawal by Subject|2|||
48556789|NCT02189837|156229750|FG001|Overall Study|Withdrawal by Subject|1|||
48556790|NCT02189837|156229751|FG002|Overall Study|Withdrawal by Subject|3|||
48556791|NCT02189837|156229752|FG003|Overall Study|Withdrawal by Subject|1|||
48556792|NCT02189837|156229749|FG000|Overall Study|Sponsor Decision|0|||
48556793|NCT02189837|156229750|FG001|Overall Study|Sponsor Decision|0|||
48556794|NCT02189837|156229751|FG002|Overall Study|Sponsor Decision|0|||
48556795|NCT02189837|156229752|FG003|Overall Study|Sponsor Decision|1|||
48556796|NCT02088697|156229755|FG000|Period I|Physician Decision|1|||
48556797|NCT02088697|156229756|FG001|Period I|Physician Decision|4|||
48556798|NCT02088697|156229755|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
48556799|NCT02088697|156229756|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
48556800|NCT00810511|156229757|FG000|Overall Study|Protocol Violation|0|||
48556801|NCT00810511|156229758|FG001|Overall Study|Protocol Violation|1|||
48556802|NCT00810511|156229757|FG000|Overall Study|Lack of Efficacy|9|||
48556803|NCT00810511|156229758|FG001|Overall Study|Lack of Efficacy|1|||
48556804|NCT00810511|156229757|FG000|Overall Study|death in the family|0|||
48556805|NCT00810511|156229758|FG001|Overall Study|death in the family|1|||
48556806|NCT00810511|156229757|FG000|Overall Study|Lost to Follow-up|1|||
48556807|NCT00810511|156229758|FG001|Overall Study|Lost to Follow-up|0|||
48556808|NCT00810511|156229757|FG000|Overall Study|deposits on contact lens|0|||
48556809|NCT00810511|156229758|FG001|Overall Study|deposits on contact lens|1|||
48556810|NCT01042093|156229762|FG000|Overall Study|Protocol Violation|2|||
48556811|NCT01042093|156229763|FG001|Overall Study|Protocol Violation|2|||
48556812|NCT01042093|156229764|FG002|Overall Study|Protocol Violation|2|||
48556813|NCT01042093|156229765|FG003|Overall Study|Protocol Violation|3|||
48556814|NCT01042093|156229762|FG000|Overall Study|Withdrawal by Subject|0|||
48556815|NCT01042093|156229763|FG001|Overall Study|Withdrawal by Subject|0|||
48556816|NCT01042093|156229764|FG002|Overall Study|Withdrawal by Subject|0|||
48556817|NCT01042093|156229765|FG003|Overall Study|Withdrawal by Subject|1|||
48556818|NCT04123405|156229766|FG000|Overall Study|Adverse Event|1|||
48556819|NCT04123405|156229767|FG001|Overall Study|Adverse Event|2|||
48556820|NCT04123405|156229768|FG002|Overall Study|Adverse Event|3|||
48556821|NCT04123405|156229769|FG003|Overall Study|Adverse Event|3|||
48556822|NCT04123405|156229766|FG000|Overall Study|Exclusion criteria met|1|||
48556823|NCT04123405|156229767|FG001|Overall Study|Exclusion criteria met|2|||
48615567|NCT03738215|156447459|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
48556824|NCT04123405|156229768|FG002|Overall Study|Exclusion criteria met|0|||
48556825|NCT04123405|156229769|FG003|Overall Study|Exclusion criteria met|2|||
48556826|NCT04123405|156229766|FG000|Overall Study|Withdrawal by Subject|1|||
48556827|NCT04123405|156229767|FG001|Overall Study|Withdrawal by Subject|3|||
48556828|NCT04123405|156229768|FG002|Overall Study|Withdrawal by Subject|0|||
48556829|NCT04123405|156229769|FG003|Overall Study|Withdrawal by Subject|2|||
48556830|NCT04123405|156229766|FG000|Overall Study|Contact to subject lost|0|||
48556831|NCT04123405|156229767|FG001|Overall Study|Contact to subject lost|0|||
48556832|NCT04123405|156229768|FG002|Overall Study|Contact to subject lost|0|||
48556833|NCT04123405|156229769|FG003|Overall Study|Contact to subject lost|1|||
48556834|NCT04123405|156229766|FG000|Overall Study|screening failure|1|||
48556835|NCT04123405|156229767|FG001|Overall Study|screening failure|0|||
48556836|NCT04123405|156229768|FG002|Overall Study|screening failure|0|||
48556837|NCT04123405|156229769|FG003|Overall Study|screening failure|0|||
48556838|NCT05024747|156229770|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
48556839|NCT05024747|156229771|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
48556840|NCT05024747|156229770|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
48556841|NCT05024747|156229771|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
48556842|NCT05024747|156229770|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
48556843|NCT05024747|156229771|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
48556844|NCT03594071|156229772|FG000|Overall Study|Re-operation|3|||
48556845|NCT03594071|156229772|FG000|Overall Study|Missed visit|2|||
48556846|NCT03624192|156229773|FG000|Overall Study|Lost to Follow-up|1|||
48556847|NCT03624192|156229774|FG001|Overall Study|Lost to Follow-up|1|||
48556848|NCT01108718|156229775|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
48556849|NCT01108718|156229776|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
48556850|NCT01841593|156229777|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
48556851|NCT01841593|156229778|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
48556852|NCT01841593|156229777|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
48556853|NCT01841593|156229778|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
48556854|NCT02756611|156229779|FG000|Overall Study|Death|70|||
48556855|NCT02756611|156229779|FG000|Overall Study|Withdrawal by Subject|2|||
48556856|NCT02756611|156229779|FG000|Overall Study|Lost to Follow-up|3|||
48556857|NCT02756611|156229779|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
48556858|NCT02756611|156229779|FG000|Overall Study|Other|10|||
48556859|NCT03323398|156229782|FG000|Overall Study|Other than Specified|0|||
48556860|NCT03323398|156229783|FG001|Overall Study|Other than Specified|1|||
48556861|NCT03323398|156229784|FG002|Overall Study|Other than Specified|2|||
48556862|NCT03323398|156229785|FG003|Overall Study|Other than Specified|0|||
48556863|NCT03323398|156229786|FG004|Overall Study|Other than Specified|0|||
48556864|NCT03323398|156229787|FG005|Overall Study|Other than Specified|0|||
48556865|NCT03323398|156229788|FG006|Overall Study|Other than Specified|1|||
48556866|NCT03323398|156229789|FG007|Overall Study|Other than Specified|0|||
48556867|NCT03323398|156229790|FG008|Overall Study|Other than Specified|2|||
48556868|NCT03323398|156229782|FG000|Overall Study|Lost to Follow-up|1|||
48556869|NCT03323398|156229783|FG001|Overall Study|Lost to Follow-up|2|||
48556870|NCT03323398|156229784|FG002|Overall Study|Lost to Follow-up|1|||
48556871|NCT03323398|156229785|FG003|Overall Study|Lost to Follow-up|0|||
48556872|NCT03323398|156229786|FG004|Overall Study|Lost to Follow-up|0|||
48556873|NCT03323398|156229787|FG005|Overall Study|Lost to Follow-up|0|||
48556874|NCT03323398|156229788|FG006|Overall Study|Lost to Follow-up|0|||
48556875|NCT03323398|156229789|FG007|Overall Study|Lost to Follow-up|0|||
48556876|NCT03323398|156229790|FG008|Overall Study|Lost to Follow-up|0|||
48556877|NCT03323398|156229782|FG000|Overall Study|Death|4|||
48556878|NCT03323398|156229783|FG001|Overall Study|Death|6|||
48556879|NCT03323398|156229784|FG002|Overall Study|Death|2|||
48556880|NCT03323398|156229785|FG003|Overall Study|Death|2|||
48556881|NCT03323398|156229786|FG004|Overall Study|Death|1|||
48556882|NCT03323398|156229787|FG005|Overall Study|Death|2|||
48556883|NCT03323398|156229788|FG006|Overall Study|Death|0|||
48556884|NCT03323398|156229789|FG007|Overall Study|Death|0|||
48556885|NCT03323398|156229790|FG008|Overall Study|Death|6|||
48615568|NCT03738215|156447460|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
48615569|NCT03738215|156447461|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
48615570|NCT03738215|156447459|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
48615571|NCT03738215|156447460|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
48615572|NCT03738215|156447461|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
48615573|NCT03738215|156447459|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
48615574|NCT03738215|156447460|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
48615575|NCT03738215|156447461|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
48615576|NCT03738215|156447459|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
48615577|NCT03738215|156447460|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
48615578|NCT03738215|156447461|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
48615579|NCT03738215|156447459|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
48615580|NCT03738215|156447460|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
48615581|NCT03738215|156447461|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
48615582|NCT03738215|156447459|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
48615583|NCT03738215|156447460|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
48615584|NCT03738215|156447461|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
48615585|NCT04073407|156447464|FG000|Part 1|Withdrawal by Subject|1|||
48615586|NCT04073407|156447465|FG001|Part 1|Withdrawal by Subject|0|||
48615587|NCT04073407|156447464|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
48615588|NCT04073407|156447465|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
48615589|NCT04073407|156447464|FG000|Part 2|Withdrawal by Subject|0|||
48615590|NCT04073407|156447465|FG001|Part 2|Withdrawal by Subject|1|||
48630328|NCT03331354|156504919|FG001|Overall Study|Found employment before initiated active intervention|4|||
48630329|NCT03685149|156504920|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
48630330|NCT03685149|156504921|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
48630331|NCT03685149|156504920|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48630332|NCT03685149|156504921|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
48630333|NCT03685149|156504920|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
48630334|NCT03685149|156504921|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
48630335|NCT00113373|156504924|FG000|Overall Study|Ineligible: wrong primary|1|||
48630336|NCT00113373|156504924|FG000|Overall Study|Ineligible: second primary|1|||
48630337|NCT00113373|156504924|FG000|Overall Study|Never Treated|1|||
48630338|NCT02526290|156504929|FG000|Overall Study|Adverse Event|3|||
48630339|NCT02526290|156504929|FG000|Overall Study|Withdrawal by Subject|4|||
48630340|NCT02526290|156504929|FG000|Overall Study|Physician Decision|1|||
48556886|NCT03323398|156229782|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
48556887|NCT03323398|156229783|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
48556888|NCT03323398|156229784|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
48556889|NCT03323398|156229785|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
48556890|NCT03323398|156229786|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
48556891|NCT03323398|156229787|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
48556892|NCT03323398|156229788|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
48556893|NCT03323398|156229789|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
48556894|NCT03323398|156229790|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
48556895|NCT03323398|156229782|FG000|Overall Study|Withdrawal by Subject|2|||
48556896|NCT03323398|156229783|FG001|Overall Study|Withdrawal by Subject|1|||
48556897|NCT03323398|156229784|FG002|Overall Study|Withdrawal by Subject|3|||
48556898|NCT03323398|156229785|FG003|Overall Study|Withdrawal by Subject|0|||
48556899|NCT03323398|156229786|FG004|Overall Study|Withdrawal by Subject|0|||
48556900|NCT03323398|156229787|FG005|Overall Study|Withdrawal by Subject|1|||
48556901|NCT03323398|156229788|FG006|Overall Study|Withdrawal by Subject|0|||
48556902|NCT03323398|156229789|FG007|Overall Study|Withdrawal by Subject|0|||
48556903|NCT03323398|156229790|FG008|Overall Study|Withdrawal by Subject|0|||
48556904|NCT03323398|156229782|FG000|Overall Study|Participant was Put on Hospice|0|||
48556905|NCT03323398|156229783|FG001|Overall Study|Participant was Put on Hospice|0|||
48556906|NCT03323398|156229784|FG002|Overall Study|Participant was Put on Hospice|0|||
48556907|NCT03323398|156229785|FG003|Overall Study|Participant was Put on Hospice|0|||
48556908|NCT03323398|156229786|FG004|Overall Study|Participant was Put on Hospice|0|||
48556909|NCT03323398|156229787|FG005|Overall Study|Participant was Put on Hospice|0|||
48630341|NCT02082977|156504930|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
48630342|NCT02082977|156504931|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
48630343|NCT02082977|156504932|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
48630344|NCT02082977|156504933|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
48556910|NCT03323398|156229788|FG006|Overall Study|Participant was Put on Hospice|1|||
48556911|NCT03323398|156229789|FG007|Overall Study|Participant was Put on Hospice|0|||
48556912|NCT03323398|156229790|FG008|Overall Study|Participant was Put on Hospice|0|||
48556913|NCT03323398|156229782|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
48556914|NCT03323398|156229783|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
48556915|NCT03323398|156229784|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
48556916|NCT03323398|156229785|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
48556917|NCT03323398|156229786|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
48556918|NCT03323398|156229787|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
48556919|NCT03323398|156229788|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
48556920|NCT03323398|156229789|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
48556921|NCT03323398|156229790|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
48556922|NCT03567980|156229799|FG000|Overall Study|Adverse Event|1|||
48556923|NCT03296527|156229800|FG000|Overall Study|Adverse Event|15|||
48556924|NCT03296527|156229801|FG001|Overall Study|Adverse Event|33|||
48556925|NCT03296527|156229800|FG000|Overall Study|Protocol Deviation|4|||
48556926|NCT03296527|156229801|FG001|Overall Study|Protocol Deviation|0|||
48556927|NCT03296527|156229800|FG000|Overall Study|Participant withdrew consent|3|||
48556928|NCT03296527|156229801|FG001|Overall Study|Participant withdrew consent|1|||
48556929|NCT03296527|156229800|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
48556930|NCT03296527|156229801|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
48556931|NCT03296527|156229800|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
48556932|NCT03296527|156229801|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
48556933|NCT03296527|156229800|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
48556934|NCT03296527|156229801|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
48556935|NCT03296527|156229800|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
48556936|NCT03296527|156229801|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
48556937|NCT03296527|156229800|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
48556938|NCT03296527|156229801|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
48556939|NCT01610492|156229802|FG000|Overall Study|Adverse Event|1|||
48556940|NCT01610492|156229802|FG000|Overall Study|Lack of Efficacy|3|||
48556941|NCT01610492|156229802|FG000|Overall Study|Other: Reached stopping criteria|1|||
48556942|NCT01610492|156229802|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
48556943|NCT03093259|156229804|FG000|Overall Study|Adverse Event|1|||
48556944|NCT03093259|156229805|FG001|Overall Study|Adverse Event|0|||
48556945|NCT03093259|156229804|FG000|Overall Study|Withdrawal by Subject|1|||
48556946|NCT03093259|156229805|FG001|Overall Study|Withdrawal by Subject|0|||
48556947|NCT02575833|156229806|FG000|Overall Study|Withdrawal by Subject|0|||
48556948|NCT02575833|156229807|FG001|Overall Study|Withdrawal by Subject|1|||
48556949|NCT02575833|156229806|FG000|Overall Study|Lost to Follow-up|1|||
48556950|NCT02575833|156229807|FG001|Overall Study|Lost to Follow-up|0|||
48556951|NCT01757275|156229810|FG000|Overall Study|Lost to Follow-up|1|||
48556952|NCT01757275|156229811|FG001|Overall Study|Lost to Follow-up|2|||
48556953|NCT01757275|156229810|FG000|Overall Study|Adverse Event|3|||
48556954|NCT01757275|156229811|FG001|Overall Study|Adverse Event|3|||
48556955|NCT01757275|156229810|FG000|Overall Study|Withdrawal by Subject|2|||
48556956|NCT01757275|156229811|FG001|Overall Study|Withdrawal by Subject|4|||
48556957|NCT01757275|156229810|FG000|Overall Study|Not treated|3|||
48556958|NCT01757275|156229811|FG001|Overall Study|Not treated|4|||
48556959|NCT04782076|156229814|FG000|Overall Study|Family Emergency|1|||
48556960|NCT01154231|156229815|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
48556961|NCT01154231|156229815|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
48556962|NCT00266630|156231530|FG000|Overall Study|Adverse Event|8|||
48556963|NCT00266630|156231531|FG001|Overall Study|Adverse Event|6|||
48556964|NCT00266630|156231530|FG000|Overall Study|Lack of Efficacy|1|||
48556965|NCT00266630|156231531|FG001|Overall Study|Lack of Efficacy|4|||
48556966|NCT00266630|156231530|FG000|Overall Study|Entry Criteria not met|1|||
48615591|NCT02034591|156448580|FG000|Overall Study|Withdrawal by Subject|0|||
48615592|NCT02034591|156448581|FG001|Overall Study|Withdrawal by Subject|0|||
48615593|NCT02034591|156448582|FG002|Overall Study|Withdrawal by Subject|0|||
48615594|NCT02034591|156448583|FG003|Overall Study|Withdrawal by Subject|0|||
48615595|NCT02034591|156448584|FG004|Overall Study|Withdrawal by Subject|1|||
48615596|NCT02034591|156448585|FG005|Overall Study|Withdrawal by Subject|0|||
48556967|NCT00266630|156231531|FG001|Overall Study|Entry Criteria not met|0|||
48556968|NCT00266630|156231530|FG000|Overall Study|Protocol Violation|1|||
48556969|NCT00266630|156231531|FG001|Overall Study|Protocol Violation|3|||
48615597|NCT02536794|156448588|FG000|Reached 1st Response Assessment|Adverse Event|2|||
48556970|NCT00266630|156231530|FG000|Overall Study|Physician Decision|1|||
48556971|NCT00266630|156231531|FG001|Overall Study|Physician Decision|2|||
48556972|NCT00266630|156231530|FG000|Overall Study|Withdrawal by Subject|10|||
48556973|NCT00266630|156231531|FG001|Overall Study|Withdrawal by Subject|2|||
48556974|NCT00266630|156231530|FG000|Overall Study|Lost to Follow-up|1|||
48556975|NCT00266630|156231531|FG001|Overall Study|Lost to Follow-up|0|||
48556976|NCT00266630|156231530|FG000|Overall Study|Other|19|||
48556977|NCT00266630|156231531|FG001|Overall Study|Other|11|||
48556978|NCT03410056|156231532|FG000|Overall Study|Decision by Sponsor|0|||
48556979|NCT03410056|156231533|FG001|Overall Study|Decision by Sponsor|0|||
48556980|NCT03410056|156231534|FG002|Overall Study|Decision by Sponsor|3|||
48556981|NCT03410056|156231535|FG003|Overall Study|Decision by Sponsor|0|||
48556982|NCT03410056|156231536|FG004|Overall Study|Decision by Sponsor|0|||
48556983|NCT03410056|156231537|FG005|Overall Study|Decision by Sponsor|0|||
48556984|NCT03410056|156231538|FG006|Overall Study|Decision by Sponsor|0|||
48556985|NCT03410056|156231532|FG000|Overall Study|Withdrawal by Subject|0|||
48556986|NCT03410056|156231533|FG001|Overall Study|Withdrawal by Subject|2|||
48556987|NCT03410056|156231534|FG002|Overall Study|Withdrawal by Subject|5|||
48556988|NCT03410056|156231535|FG003|Overall Study|Withdrawal by Subject|5|||
48556989|NCT03410056|156231536|FG004|Overall Study|Withdrawal by Subject|0|||
48556990|NCT03410056|156231537|FG005|Overall Study|Withdrawal by Subject|0|||
48556991|NCT03410056|156231538|FG006|Overall Study|Withdrawal by Subject|0|||
48556992|NCT01699815|156231544|FG000|Overall Study|Protocol Violation|4|||
48556993|NCT01699815|156231545|FG001|Overall Study|Protocol Violation|7|||
48556994|NCT01699815|156231544|FG000|Overall Study|record could not be located|1|||
48556995|NCT01699815|156231545|FG001|Overall Study|record could not be located|0|||
48556996|NCT01699815|156231544|FG000|Overall Study|Adverse Event|0|||
48556997|NCT01699815|156231545|FG001|Overall Study|Adverse Event|1|||
48556998|NCT02501928|156231546|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48556999|NCT02501928|156231547|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
48557000|NCT02501928|156231548|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
48557001|NCT02501928|156231549|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
48557002|NCT02501928|156231550|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
48557003|NCT02501928|156231551|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
48557004|NCT00344448|156231554|FG000|Screening|Withdrawal by Subject|0|||
48557005|NCT00344448|156231555|FG001|Screening|Withdrawal by Subject|1|||
48557006|NCT00344448|156231554|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
48557007|NCT00344448|156231555|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
48557008|NCT00344448|156231554|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
48557009|NCT00344448|156231555|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
48557010|NCT00344448|156231554|FG000|Open Label|Withdrawal by Subject|1|||
48557011|NCT00344448|156231555|FG001|Open Label|Withdrawal by Subject|1|||
48557012|NCT00344448|156231554|FG000|Open Label|Study terminated|1|||
48557013|NCT00344448|156231555|FG001|Open Label|Study terminated|0|||
48557014|NCT02203357|156231556|FG000|Overall Study|Lost to Follow-up|58|||
48557015|NCT02203357|156231557|FG001|Overall Study|Lost to Follow-up|66|||
48557016|NCT02203357|156231558|FG002|Overall Study|Lost to Follow-up|70|||
48557017|NCT03305848|156231563|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
48557018|NCT03305848|156231563|FG000|Overall Study|Physician Decision|2|||
48557019|NCT00356525|156231565|FG000|Overall Study|Progressive Disease|8|||
48557020|NCT00356525|156231566|FG001|Overall Study|Progressive Disease|5|||
48557021|NCT00356525|156231567|FG002|Overall Study|Progressive Disease|4|||
48557022|NCT00356525|156231568|FG003|Overall Study|Progressive Disease|2|||
48557023|NCT00356525|156231565|FG000|Overall Study|Adverse Event|1|||
48557024|NCT00356525|156231566|FG001|Overall Study|Adverse Event|3|||
48557025|NCT00356525|156231567|FG002|Overall Study|Adverse Event|1|||
48557026|NCT00356525|156231568|FG003|Overall Study|Adverse Event|1|||
48557027|NCT00356525|156231565|FG000|Overall Study|Lost to Follow-up|1|||
48557028|NCT00356525|156231566|FG001|Overall Study|Lost to Follow-up|0|||
48557029|NCT00356525|156231567|FG002|Overall Study|Lost to Follow-up|0|||
48557030|NCT00356525|156231568|FG003|Overall Study|Lost to Follow-up|0|||
48557031|NCT00356525|156231565|FG000|Overall Study|Physician Decision|2|||
48557032|NCT00356525|156231566|FG001|Overall Study|Physician Decision|2|||
48557033|NCT00356525|156231567|FG002|Overall Study|Physician Decision|2|||
48557034|NCT00356525|156231568|FG003|Overall Study|Physician Decision|1|||
48557035|NCT00356525|156231565|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
48557036|NCT00356525|156231566|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
48615598|NCT02536794|156448588|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
48557037|NCT00356525|156231567|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
48557038|NCT00356525|156231568|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
48557039|NCT00356525|156231565|FG000|Overall Study|Withdrawal by Subject|1|||
48557040|NCT00356525|156231566|FG001|Overall Study|Withdrawal by Subject|1|||
48557041|NCT00356525|156231567|FG002|Overall Study|Withdrawal by Subject|0|||
48557042|NCT00356525|156231568|FG003|Overall Study|Withdrawal by Subject|3|||
48557043|NCT00356525|156231565|FG000|Overall Study|Death|0|||
48557044|NCT00356525|156231566|FG001|Overall Study|Death|0|||
48557045|NCT00356525|156231567|FG002|Overall Study|Death|0|||
48557046|NCT00356525|156231568|FG003|Overall Study|Death|1|||
48557047|NCT00356525|156231565|FG000|Overall Study|Sponsor Decision|0|||
48557048|NCT00356525|156231566|FG001|Overall Study|Sponsor Decision|0|||
48557049|NCT00356525|156231567|FG002|Overall Study|Sponsor Decision|0|||
48557050|NCT00356525|156231568|FG003|Overall Study|Sponsor Decision|1|||
48557051|NCT02719184|156231585|FG000|Overall Study|Other than listed|1|||
48557052|NCT02719184|156231586|FG001|Overall Study|Other than listed|12|||
48557053|NCT02719184|156231587|FG002|Overall Study|Other than listed|13|||
48557054|NCT02719184|156231588|FG003|Overall Study|Other than listed|22|||
48557055|NCT02719184|156231589|FG004|Overall Study|Other than listed|9|||
48557056|NCT02719184|156231585|FG000|Overall Study|Withdrawal by Subject|5|||
48557057|NCT02719184|156231586|FG001|Overall Study|Withdrawal by Subject|3|||
48557058|NCT02719184|156231587|FG002|Overall Study|Withdrawal by Subject|6|||
48557059|NCT02719184|156231588|FG003|Overall Study|Withdrawal by Subject|6|||
48557060|NCT02719184|156231589|FG004|Overall Study|Withdrawal by Subject|0|||
48557061|NCT02719184|156231585|FG000|Overall Study|Lost to Follow-up|0|||
48557062|NCT02719184|156231586|FG001|Overall Study|Lost to Follow-up|4|||
48557063|NCT02719184|156231587|FG002|Overall Study|Lost to Follow-up|1|||
48557064|NCT02719184|156231588|FG003|Overall Study|Lost to Follow-up|3|||
48557065|NCT02719184|156231589|FG004|Overall Study|Lost to Follow-up|0|||
48557066|NCT02719184|156231585|FG000|Overall Study|Protocol Violation|0|||
48557067|NCT02719184|156231586|FG001|Overall Study|Protocol Violation|3|||
48557068|NCT02719184|156231587|FG002|Overall Study|Protocol Violation|0|||
48557069|NCT02719184|156231588|FG003|Overall Study|Protocol Violation|2|||
48557070|NCT02719184|156231589|FG004|Overall Study|Protocol Violation|0|||
48557071|NCT02719184|156231585|FG000|Overall Study|Adverse Event|0|||
48557072|NCT02719184|156231586|FG001|Overall Study|Adverse Event|0|||
48557073|NCT02719184|156231587|FG002|Overall Study|Adverse Event|0|||
48557074|NCT02719184|156231588|FG003|Overall Study|Adverse Event|3|||
48557075|NCT02719184|156231589|FG004|Overall Study|Adverse Event|0|||
48557076|NCT01597778|156231590|FG000|Overall Study|Death|7|||
48557077|NCT01597778|156231591|FG001|Overall Study|Death|10|||
48557078|NCT01597778|156231590|FG000|Overall Study|Withdrawal by Subject|3|||
48557079|NCT01597778|156231591|FG001|Overall Study|Withdrawal by Subject|4|||
48557080|NCT01597778|156231590|FG000|Overall Study|Adverse Event|1|||
48557081|NCT01597778|156231591|FG001|Overall Study|Adverse Event|1|||
48557082|NCT01597778|156231590|FG000|Overall Study|Protocol Violation|1|||
48557083|NCT01597778|156231591|FG001|Overall Study|Protocol Violation|11|||
48557084|NCT01597778|156231590|FG000|Overall Study|Transplanted off protocol|2|||
48557085|NCT01597778|156231591|FG001|Overall Study|Transplanted off protocol|3|||
48557086|NCT02413229|156231592|FG000|Overall Study|Adverse Event|0|||
48615599|NCT02536794|156448588|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
48615600|NCT02536794|156448588|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
48557087|NCT02413229|156231593|FG001|Overall Study|Adverse Event|0|||
48557088|NCT02413229|156231594|FG002|Overall Study|Adverse Event|0|||
48557089|NCT02413229|156231595|FG003|Overall Study|Adverse Event|1|||
48557090|NCT02413229|156231596|FG004|Overall Study|Adverse Event|0|||
48557091|NCT02413229|156231597|FG005|Overall Study|Adverse Event|0|||
48557092|NCT02413229|156231598|FG006|Overall Study|Adverse Event|0|||
48557093|NCT02413229|156231599|FG007|Overall Study|Adverse Event|1|||
48557094|NCT02413229|156231592|FG000|Overall Study|Lost to Follow-up|0|||
48557095|NCT02413229|156231593|FG001|Overall Study|Lost to Follow-up|0|||
48557096|NCT02413229|156231594|FG002|Overall Study|Lost to Follow-up|1|||
48557097|NCT02413229|156231595|FG003|Overall Study|Lost to Follow-up|0|||
48557098|NCT02413229|156231596|FG004|Overall Study|Lost to Follow-up|2|||
48557099|NCT02413229|156231597|FG005|Overall Study|Lost to Follow-up|0|||
48557100|NCT02413229|156231598|FG006|Overall Study|Lost to Follow-up|0|||
48557101|NCT02413229|156231599|FG007|Overall Study|Lost to Follow-up|0|||
48557102|NCT02413229|156231592|FG000|Overall Study|Withdrawal by Subject|1|||
48557103|NCT02413229|156231593|FG001|Overall Study|Withdrawal by Subject|1|||
48557104|NCT02413229|156231594|FG002|Overall Study|Withdrawal by Subject|0|||
48557105|NCT02413229|156231595|FG003|Overall Study|Withdrawal by Subject|0|||
48557106|NCT02413229|156231596|FG004|Overall Study|Withdrawal by Subject|1|||
48557107|NCT02413229|156231597|FG005|Overall Study|Withdrawal by Subject|0|||
48557108|NCT02413229|156231598|FG006|Overall Study|Withdrawal by Subject|0|||
48557109|NCT02413229|156231599|FG007|Overall Study|Withdrawal by Subject|2|||
48615601|NCT02536794|156448588|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
48615602|NCT02536794|156448588|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
48615603|NCT02316613|156448591|FG000|Overall Study|Death|63|||
48615604|NCT02316613|156448591|FG000|Overall Study|Lost to Follow-up|9|||
48615605|NCT02316613|156448591|FG000|Overall Study|Lymphoma transformation|2|||
48615606|NCT02316613|156448591|FG000|Overall Study|Participant moved/changed medical team|11|||
48615607|NCT02316613|156448591|FG000|Overall Study|No data and duplicate cases|5|||
48615608|NCT02316613|156448591|FG000|Overall Study|Did not met selection criteria|14|||
48557110|NCT02413229|156231592|FG000|Overall Study|Progressive Disease|0|||
48557111|NCT02413229|156231593|FG001|Overall Study|Progressive Disease|0|||
48557112|NCT02413229|156231594|FG002|Overall Study|Progressive Disease|0|||
48557113|NCT02413229|156231595|FG003|Overall Study|Progressive Disease|0|||
48630345|NCT02082977|156504934|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
48557114|NCT02413229|156231596|FG004|Overall Study|Progressive Disease|0|||
48557115|NCT02413229|156231597|FG005|Overall Study|Progressive Disease|0|||
48557116|NCT02413229|156231598|FG006|Overall Study|Progressive Disease|0|||
48557117|NCT02413229|156231599|FG007|Overall Study|Progressive Disease|1|||
48557118|NCT02932462|156231600|FG000|Overall Study|Adverse Event|1|||
48557119|NCT02932462|156231601|FG001|Overall Study|Adverse Event|2|||
48557120|NCT02932462|156231600|FG000|Overall Study|Lost to Follow-up|4|||
48557121|NCT02932462|156231601|FG001|Overall Study|Lost to Follow-up|1|||
48615609|NCT00973973|156448592|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
48557122|NCT02932462|156231600|FG000|Overall Study|Protocol Violation|0|||
48557123|NCT02932462|156231601|FG001|Overall Study|Protocol Violation|5|||
48630346|NCT02082977|156504935|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
48557124|NCT02932462|156231600|FG000|Overall Study|Withdrawal by Subject|1|||
48557125|NCT02932462|156231601|FG001|Overall Study|Withdrawal by Subject|4|||
48557126|NCT02932462|156231600|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48557127|NCT02932462|156231601|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48557128|NCT02932462|156231600|FG000|Overall Study|Progressive Disease|1|||
48557129|NCT02932462|156231601|FG001|Overall Study|Progressive Disease|0|||
48557130|NCT00470535|156231602|FG000|Overall Study|Disease Progression|13|||
48557131|NCT00470535|156231602|FG000|Overall Study|Withdrawal by Subject|1|||
48557132|NCT00470535|156231602|FG000|Overall Study|Adverse Event|1|||
48557133|NCT00470535|156231602|FG000|Overall Study|Death|1|||
48557134|NCT00470535|156231602|FG000|Overall Study|Other|2|||
48557135|NCT01200069|156231608|FG000|Overall Study|Withdrawal by Subject|0|||
48557136|NCT01200069|156231609|FG001|Overall Study|Withdrawal by Subject|1|||
48557137|NCT01750190|156231610|FG000|Overall Study|Adverse Event|47|||
48557138|NCT01750190|156231611|FG001|Overall Study|Adverse Event|19|||
48557139|NCT01750190|156231610|FG000|Overall Study|Death|38|||
48557140|NCT01750190|156231611|FG001|Overall Study|Death|11|||
48557141|NCT01750190|156231610|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
48557142|NCT01750190|156231611|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
48557143|NCT01750190|156231610|FG000|Overall Study|Lost to Follow-up|28|||
48557144|NCT01750190|156231611|FG001|Overall Study|Lost to Follow-up|7|||
48557145|NCT01750190|156231610|FG000|Overall Study|Physician Decision|16|||
48557146|NCT01750190|156231611|FG001|Overall Study|Physician Decision|17|||
48557147|NCT01750190|156231610|FG000|Overall Study|Protocol Violation|6|||
48557148|NCT01750190|156231611|FG001|Overall Study|Protocol Violation|5|||
48557149|NCT01750190|156231610|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
48557150|NCT01750190|156231611|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
48615610|NCT00973973|156448593|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
48615611|NCT00973973|156448592|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
48615612|NCT00973973|156448593|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
48615613|NCT00973973|156448592|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
48615614|NCT00973973|156448593|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
48615615|NCT00973973|156448592|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
48615616|NCT00973973|156448593|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
48615617|NCT00973973|156448592|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
48615618|NCT00973973|156448593|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
48615619|NCT00973973|156448592|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
48615620|NCT00973973|156448593|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
48615621|NCT00973973|156448592|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
48615622|NCT00973973|156448593|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
48615623|NCT00973973|156448592|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
48615624|NCT00973973|156448593|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
48615625|NCT00973973|156448592|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
48615626|NCT00973973|156448593|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
48615627|NCT00973973|156448592|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
48615628|NCT00973973|156448593|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
48557151|NCT01750190|156231610|FG000|Overall Study|Withdrawal by Subject|83|||
48557152|NCT01750190|156231611|FG001|Overall Study|Withdrawal by Subject|89|||
48557153|NCT01750190|156231610|FG000|Overall Study|Kidney Transplant|8|||
48557154|NCT01750190|156231611|FG001|Overall Study|Kidney Transplant|4|||
48557155|NCT01750190|156231610|FG000|Overall Study|Dialysis|22|||
48557156|NCT01750190|156231611|FG001|Overall Study|Dialysis|8|||
48557157|NCT01750190|156231610|FG000|Overall Study|Other than Specified|13|||
48615629|NCT00973973|156448592|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
48557158|NCT01750190|156231611|FG001|Overall Study|Other than Specified|4|||
48557159|NCT02009722|156231612|FG000|Overall Study|Protocol Violation|1|||
48557160|NCT02009722|156231613|FG001|Overall Study|Protocol Violation|2|||
48557161|NCT02009722|156231612|FG000|Overall Study|Did not receive intervention|0|||
48557162|NCT02009722|156231613|FG001|Overall Study|Did not receive intervention|1|||
48557163|NCT02955212|156231614|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
48557164|NCT02955212|156231615|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
48557165|NCT02955212|156231614|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
48557166|NCT02955212|156231615|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
48557167|NCT02955212|156231614|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
48557168|NCT02955212|156231615|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
48557169|NCT02955212|156231614|FG000|Period 1: Double-blind Treatment Period|Other|3|||
48557170|NCT02955212|156231615|FG001|Period 1: Double-blind Treatment Period|Other|2|||
48557171|NCT02955212|156231614|FG000|Period 2: Open-label Extension|Adverse Event|11|||
48557172|NCT02955212|156231615|FG001|Period 2: Open-label Extension|Adverse Event|7|||
48557173|NCT02955212|156231614|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
48557174|NCT02955212|156231615|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
48615630|NCT00973973|156448593|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
48615631|NCT00973973|156448592|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
48615632|NCT00973973|156448593|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
48557175|NCT02955212|156231614|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
48557176|NCT02955212|156231615|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
48557177|NCT02955212|156231614|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
48557178|NCT02955212|156231615|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
48557179|NCT02955212|156231614|FG000|Period 2: Open-label Extension|Other|2|||
48557180|NCT02955212|156231615|FG001|Period 2: Open-label Extension|Other|4|||
48557181|NCT02287922|156231616|FG000|Overall Study|Adverse Event|1|||
48557182|NCT02287922|156231617|FG001|Overall Study|Adverse Event|1|||
48557183|NCT02287922|156231618|FG002|Overall Study|Adverse Event|3|||
48557184|NCT02287922|156231619|FG003|Overall Study|Adverse Event|4|||
48557185|NCT02287922|156231616|FG000|Overall Study|Withdrawal by Subject|1|||
48557186|NCT02287922|156231617|FG001|Overall Study|Withdrawal by Subject|1|||
48557187|NCT02287922|156231618|FG002|Overall Study|Withdrawal by Subject|1|||
48557188|NCT02287922|156231619|FG003|Overall Study|Withdrawal by Subject|2|||
48557189|NCT02287922|156231616|FG000|Overall Study|Lost to Follow-up|0|||
48557190|NCT02287922|156231617|FG001|Overall Study|Lost to Follow-up|0|||
48557191|NCT02287922|156231618|FG002|Overall Study|Lost to Follow-up|1|||
48557192|NCT02287922|156231619|FG003|Overall Study|Lost to Follow-up|0|||
48557193|NCT02287922|156231616|FG000|Overall Study|Sponsor's decision|0|||
48557194|NCT02287922|156231617|FG001|Overall Study|Sponsor's decision|0|||
48557195|NCT02287922|156231618|FG002|Overall Study|Sponsor's decision|0|||
48557196|NCT02287922|156231619|FG003|Overall Study|Sponsor's decision|1|||
48557197|NCT02287922|156231616|FG000|Overall Study|Other|1|||
48557198|NCT02287922|156231617|FG001|Overall Study|Other|0|||
48557199|NCT02287922|156231618|FG002|Overall Study|Other|2|||
48557200|NCT02287922|156231619|FG003|Overall Study|Other|0|||
48557201|NCT01487525|156231637|FG000|Overall Study|Withdrawal by Subject|0|||
48557202|NCT01487525|156231638|FG001|Overall Study|Withdrawal by Subject|1|||
48557203|NCT01169350|156231652|FG000|Overall Study|Physician Decision|3|||
48557204|NCT01169350|156231652|FG000|Overall Study|Lost to Follow-up|2|||
48557205|NCT03367819|156231653|FG000|Overall Study|Adverse Event|4|||
48557206|NCT03367819|156231654|FG001|Overall Study|Adverse Event|4|||
48557207|NCT03367819|156231653|FG000|Overall Study|Progressive Disease|15|||
48557208|NCT03367819|156231654|FG001|Overall Study|Progressive Disease|13|||
48557209|NCT03367819|156231653|FG000|Overall Study|Withdrawal by Subject|1|||
48557210|NCT03367819|156231654|FG001|Overall Study|Withdrawal by Subject|0|||
48557211|NCT03367819|156231653|FG000|Overall Study|Other|4|||
48557212|NCT03367819|156231654|FG001|Overall Study|Other|2|||
48557213|NCT00550459|156231655|FG000|Overall Study|Adverse Event|0|||
48557214|NCT00550459|156231656|FG001|Overall Study|Adverse Event|2|||
48557215|NCT00550459|156231655|FG000|Overall Study|Withdrawal by Subject|1|||
48557216|NCT00550459|156231656|FG001|Overall Study|Withdrawal by Subject|1|||
48557217|NCT01401452|156231657|FG000|Overall Study|Adverse reaction|9|||
48557218|NCT01401452|156231657|FG000|Overall Study|Lost to Follow-up|12|||
48557219|NCT01401452|156231657|FG000|Overall Study|Lack of Efficacy|30|||
48557220|NCT01401452|156231657|FG000|Overall Study|Participant developed breast cancer|1|||
48557221|NCT01401452|156231657|FG000|Overall Study|Tx stopped due to financial reasons|1|||
48557222|NCT01401452|156231657|FG000|Overall Study|Tx stopped by psychiatrist|1|||
48557223|NCT01401452|156231657|FG000|Overall Study|No more visits within the 36 wk followup|4|||
48557224|NCT01401452|156231657|FG000|Overall Study|Subject did not come to follow up visits|2|||
48557225|NCT01401452|156231657|FG000|Overall Study|Subject didn't return for routine visits|1|||
48557226|NCT01401452|156231657|FG000|Overall Study|Subject moved to another city|1|||
48557227|NCT01401452|156231657|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
48557228|NCT01401452|156231657|FG000|Overall Study|Psoriatic arthritis|1|||
48557229|NCT01401452|156231657|FG000|Overall Study|Participant stopped Tx|2|||
48557230|NCT01401452|156231657|FG000|Overall Study|Discontinuation for personal reasons|1|||
48557231|NCT01401452|156231657|FG000|Overall Study|Treatment failure|1|||
48557232|NCT01401452|156231657|FG000|Overall Study|Unsatisfactory output|1|||
48557233|NCT01401452|156231657|FG000|Overall Study|Subject withdrew because of Tx success|1|||
48557234|NCT01401452|156231657|FG000|Overall Study|Subject chose to discontinue treatment|1|||
48557235|NCT01401452|156231657|FG000|Overall Study|Participant withdrew consent|1|||
48557236|NCT01742897|156231658|FG000|Overall Study|Adverse Event|3|||
48557237|NCT01742897|156231658|FG000|Overall Study|Withdrawal by Subject|1|||
48557238|NCT01742897|156231658|FG000|Overall Study|Other|1|||
48557239|NCT01597973|156231659|FG000|Overall Study|Found ineligible before study medication started|4|||
48557240|NCT01597973|156231660|FG001|Overall Study|Found ineligible before study medication started|2|||
48557241|NCT01597973|156231659|FG000|Overall Study|Eligible pathogen not confirmed|14|||
48557242|NCT01597973|156231660|FG001|Overall Study|Eligible pathogen not confirmed|15|||
48557243|NCT01597973|156231659|FG000|Overall Study|LAR not authorized to consent|0|||
48557244|NCT01597973|156231660|FG001|Overall Study|LAR not authorized to consent|1|||
48557245|NCT01597973|156231659|FG000|Overall Study|Ineligible due to early seizures|1|||
48557246|NCT01597973|156231660|FG001|Overall Study|Ineligible due to early seizures|0|||
48557247|NCT01597973|156231659|FG000|Overall Study|Ineligible due to non-target infection|1|||
48557248|NCT01597973|156231660|FG001|Overall Study|Ineligible due to non-target infection|1|||
48557249|NCT01565889|156231661|FG000|Part A|Withdrawal by Subject|1|||
48557250|NCT01565889|156231662|FG001|Part A|Withdrawal by Subject|0|||
48557251|NCT01565889|156231663|FG002|Part A|Withdrawal by Subject|0|||
48557252|NCT01565889|156231664|FG003|Part A|Withdrawal by Subject|0|||
48557253|NCT01565889|156231665|FG004|Part A|Withdrawal by Subject|0|||
48557254|NCT01565889|156231666|FG005|Part A|Withdrawal by Subject|0|||
48557255|NCT01565889|156231661|FG000|Part B|Withdrawal by Subject|0|||
48557256|NCT01565889|156231662|FG001|Part B|Withdrawal by Subject|0|||
48557257|NCT01565889|156231663|FG002|Part B|Withdrawal by Subject|0|||
48557258|NCT01565889|156231664|FG003|Part B|Withdrawal by Subject|0|||
48557259|NCT01565889|156231665|FG004|Part B|Withdrawal by Subject|0|||
48557260|NCT01565889|156231666|FG005|Part B|Withdrawal by Subject|1|||
48557261|NCT01565889|156231661|FG000|Part B|Lack of Efficacy|0|||
48557262|NCT01565889|156231662|FG001|Part B|Lack of Efficacy|0|||
48557263|NCT01565889|156231663|FG002|Part B|Lack of Efficacy|0|||
48557264|NCT01565889|156231664|FG003|Part B|Lack of Efficacy|0|||
48557265|NCT01565889|156231665|FG004|Part B|Lack of Efficacy|0|||
48557266|NCT01565889|156231666|FG005|Part B|Lack of Efficacy|2|||
48557267|NCT01565889|156231661|FG000|Part B|Lost to Follow-up|0|||
48557268|NCT01565889|156231662|FG001|Part B|Lost to Follow-up|0|||
48557269|NCT01565889|156231663|FG002|Part B|Lost to Follow-up|0|||
48557270|NCT01565889|156231664|FG003|Part B|Lost to Follow-up|0|||
48557271|NCT01565889|156231665|FG004|Part B|Lost to Follow-up|0|||
48557272|NCT01565889|156231666|FG005|Part B|Lost to Follow-up|1|||
48557273|NCT00768248|156231667|FG000|Overall Study|Research coordinator didn't collect data|1|||
48557274|NCT00768248|156231668|FG001|Overall Study|Research coordinator didn't collect data|1|||
48557275|NCT02553772|156231672|FG000|Overall Study|Adverse Event|2|||
48557276|NCT02553772|156231673|FG001|Overall Study|Adverse Event|3|||
48557277|NCT02553772|156231672|FG000|Overall Study|Lost to Follow-up|2|||
48557278|NCT02553772|156231673|FG001|Overall Study|Lost to Follow-up|1|||
48557279|NCT02553772|156231672|FG000|Overall Study|Withdrawal of Consent|1|||
48557280|NCT02553772|156231673|FG001|Overall Study|Withdrawal of Consent|1|||
48557281|NCT02553772|156231672|FG000|Overall Study|Lack of Efficacy|1|||
48557282|NCT02553772|156231673|FG001|Overall Study|Lack of Efficacy|0|||
48557283|NCT02553772|156231672|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48557284|NCT02553772|156231673|FG001|Overall Study|Other Miscellaneous Reasons|1|||
48557285|NCT02723344|156231676|FG000|Overall Study|Lost to Follow-up|0|||
48557286|NCT02723344|156231677|FG001|Overall Study|Lost to Follow-up|4|||
48557287|NCT01547390|156231680|FG000|Overall Study|Withdrawal by Subject|10|||
48557288|NCT01547390|156231681|FG001|Overall Study|Withdrawal by Subject|7|||
48557289|NCT01547390|156231680|FG000|Overall Study|termination of pregnancy|0|||
48557290|NCT01547390|156231681|FG001|Overall Study|termination of pregnancy|1|||
48557291|NCT01547390|156231680|FG000|Overall Study|Lost to Follow-up|0|||
48557292|NCT01547390|156231681|FG001|Overall Study|Lost to Follow-up|2|||
48557293|NCT01547390|156231680|FG000|Overall Study|Adverse Event|3|||
48557294|NCT01547390|156231681|FG001|Overall Study|Adverse Event|0|||
48557295|NCT01459783|156231684|FG000|Baseline to 6 Months|Death|1|||
48557296|NCT01459783|156231685|FG001|Baseline to 6 Months|Death|0|||
48557297|NCT01459783|156231684|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
48557298|NCT01459783|156231685|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
48557299|NCT01459783|156231684|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
48557300|NCT01459783|156231685|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
48557301|NCT01459783|156231684|FG000|6 Months to 12 Months|Death|0|||
48557302|NCT01459783|156231685|FG001|6 Months to 12 Months|Death|1|||
48557303|NCT01459783|156231684|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
48557304|NCT01459783|156231685|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
48557305|NCT01459783|156231684|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
48557306|NCT01459783|156231685|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
48557307|NCT01459783|156231684|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
48557308|NCT01459783|156231685|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
48557309|NCT01326845|156231686|FG000|Overall Study|Administrative Problems|5|||
48557310|NCT01326845|156231687|FG001|Overall Study|Administrative Problems|2|||
48557311|NCT01326845|156231686|FG000|Overall Study|Adverse Event|1|||
48557312|NCT01326845|156231687|FG001|Overall Study|Adverse Event|0|||
48557313|NCT01326845|156231686|FG000|Overall Study|Misisng|1|||
48557314|NCT01326845|156231687|FG001|Overall Study|Misisng|3|||
48557315|NCT02524847|156231688|FG000|Overall Study|Adverse Event|4|||
48557316|NCT02524847|156231688|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
48557317|NCT02524847|156231688|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
48557318|NCT02524847|156231688|FG000|Overall Study|Death|1|||
48557319|NCT02524847|156231688|FG000|Overall Study|Reason not Specified|1|||
48557320|NCT05244122|156233670|FG000|Overall Study|Withdrawal by Subject|318|||
48557321|NCT04981717|156233671|FG000|Overall Study|Protocol Violation|0|||
48557322|NCT04981717|156233672|FG001|Overall Study|Protocol Violation|3|||
48557323|NCT04981717|156233671|FG000|Overall Study|Adverse Event|1|||
48557324|NCT04981717|156233672|FG001|Overall Study|Adverse Event|3|||
48557325|NCT04981717|156233671|FG000|Overall Study|Pregnancy|1|||
48557326|NCT04981717|156233672|FG001|Overall Study|Pregnancy|0|||
48557327|NCT04981717|156233671|FG000|Overall Study|Physician Decision|1|||
48557328|NCT04981717|156233672|FG001|Overall Study|Physician Decision|0|||
48557329|NCT04981717|156233671|FG000|Overall Study|Sponsor Request|157|||
48557330|NCT04981717|156233672|FG001|Overall Study|Sponsor Request|172|||
48557331|NCT04981717|156233671|FG000|Overall Study|Lost to Follow-up|4|||
48557332|NCT04981717|156233672|FG001|Overall Study|Lost to Follow-up|5|||
48557333|NCT04981717|156233671|FG000|Overall Study|Withdrawal by Subject|50|||
48557334|NCT04981717|156233672|FG001|Overall Study|Withdrawal by Subject|37|||
48557335|NCT00678210|156233678|FG000|Overall Study|Adverse Event|1|||
48557336|NCT00678210|156233679|FG001|Overall Study|Adverse Event|2|||
48557337|NCT00678210|156233680|FG002|Overall Study|Adverse Event|3|||
48557338|NCT00678210|156233681|FG003|Overall Study|Adverse Event|3|||
48557339|NCT00678210|156233678|FG000|Overall Study|Lack of Efficacy|2|||
48557340|NCT00678210|156233679|FG001|Overall Study|Lack of Efficacy|3|||
48557341|NCT00678210|156233680|FG002|Overall Study|Lack of Efficacy|1|||
48557342|NCT00678210|156233681|FG003|Overall Study|Lack of Efficacy|9|||
48557343|NCT00678210|156233678|FG000|Overall Study|Lost to Follow-up|4|||
48557344|NCT00678210|156233679|FG001|Overall Study|Lost to Follow-up|2|||
48557345|NCT00678210|156233680|FG002|Overall Study|Lost to Follow-up|0|||
48557346|NCT00678210|156233681|FG003|Overall Study|Lost to Follow-up|1|||
48557347|NCT00678210|156233678|FG000|Overall Study|Withdrawal by Subject|3|||
48557348|NCT00678210|156233679|FG001|Overall Study|Withdrawal by Subject|4|||
48557349|NCT00678210|156233680|FG002|Overall Study|Withdrawal by Subject|1|||
48557350|NCT00678210|156233681|FG003|Overall Study|Withdrawal by Subject|7|||
48557351|NCT00678210|156233678|FG000|Overall Study|Other|1|||
48557352|NCT00678210|156233679|FG001|Overall Study|Other|0|||
48557353|NCT00678210|156233680|FG002|Overall Study|Other|1|||
48557354|NCT00678210|156233681|FG003|Overall Study|Other|0|||
48557355|NCT03284723|156233682|FG000|Overall Study|Death|0|||
48557356|NCT03284723|156233683|FG001|Overall Study|Death|0|||
48557357|NCT03284723|156233684|FG002|Overall Study|Death|0|||
48557358|NCT03284723|156233685|FG003|Overall Study|Death|1|||
48557359|NCT03284723|156233686|FG004|Overall Study|Death|0|||
48557360|NCT03284723|156233687|FG005|Overall Study|Death|0|||
48557361|NCT03284723|156233688|FG006|Overall Study|Death|1|||
48557362|NCT03284723|156233689|FG007|Overall Study|Death|0|||
48557363|NCT03284723|156233690|FG008|Overall Study|Death|0|||
48557364|NCT03284723|156233691|FG009|Overall Study|Death|2|||
48557365|NCT03284723|156233692|FG010|Overall Study|Death|1|||
48557366|NCT03284723|156233693|FG011|Overall Study|Death|0|||
48557367|NCT03284723|156233682|FG000|Overall Study|Lost to Follow-up|0|||
48557368|NCT03284723|156233683|FG001|Overall Study|Lost to Follow-up|0|||
48557369|NCT03284723|156233684|FG002|Overall Study|Lost to Follow-up|0|||
48557370|NCT03284723|156233685|FG003|Overall Study|Lost to Follow-up|0|||
48557371|NCT03284723|156233686|FG004|Overall Study|Lost to Follow-up|0|||
48557372|NCT03284723|156233687|FG005|Overall Study|Lost to Follow-up|2|||
48557373|NCT03284723|156233688|FG006|Overall Study|Lost to Follow-up|1|||
48557374|NCT03284723|156233689|FG007|Overall Study|Lost to Follow-up|0|||
48557375|NCT03284723|156233690|FG008|Overall Study|Lost to Follow-up|0|||
48557376|NCT03284723|156233691|FG009|Overall Study|Lost to Follow-up|2|||
48557377|NCT03284723|156233692|FG010|Overall Study|Lost to Follow-up|0|||
48557378|NCT03284723|156233693|FG011|Overall Study|Lost to Follow-up|0|||
48557379|NCT03284723|156233682|FG000|Overall Study|Study Terminated By Sponsor|0|||
48557380|NCT03284723|156233683|FG001|Overall Study|Study Terminated By Sponsor|0|||
48557381|NCT03284723|156233684|FG002|Overall Study|Study Terminated By Sponsor|0|||
48557382|NCT03284723|156233685|FG003|Overall Study|Study Terminated By Sponsor|0|||
48557383|NCT03284723|156233686|FG004|Overall Study|Study Terminated By Sponsor|1|||
48557384|NCT03284723|156233687|FG005|Overall Study|Study Terminated By Sponsor|0|||
48557385|NCT03284723|156233688|FG006|Overall Study|Study Terminated By Sponsor|0|||
48557386|NCT03284723|156233689|FG007|Overall Study|Study Terminated By Sponsor|0|||
48557387|NCT03284723|156233690|FG008|Overall Study|Study Terminated By Sponsor|1|||
48557388|NCT03284723|156233691|FG009|Overall Study|Study Terminated By Sponsor|1|||
48557389|NCT03284723|156233692|FG010|Overall Study|Study Terminated By Sponsor|1|||
48557390|NCT03284723|156233693|FG011|Overall Study|Study Terminated By Sponsor|1|||
48557391|NCT03284723|156233682|FG000|Overall Study|Withdrawal by Subject|0|||
48557392|NCT03284723|156233683|FG001|Overall Study|Withdrawal by Subject|0|||
48557393|NCT03284723|156233684|FG002|Overall Study|Withdrawal by Subject|0|||
48557394|NCT03284723|156233685|FG003|Overall Study|Withdrawal by Subject|0|||
48557395|NCT03284723|156233686|FG004|Overall Study|Withdrawal by Subject|5|||
48557396|NCT03284723|156233687|FG005|Overall Study|Withdrawal by Subject|3|||
48557397|NCT03284723|156233688|FG006|Overall Study|Withdrawal by Subject|1|||
48557398|NCT03284723|156233689|FG007|Overall Study|Withdrawal by Subject|0|||
48557399|NCT03284723|156233690|FG008|Overall Study|Withdrawal by Subject|6|||
48557400|NCT03284723|156233691|FG009|Overall Study|Withdrawal by Subject|0|||
48557401|NCT03284723|156233692|FG010|Overall Study|Withdrawal by Subject|3|||
48557402|NCT03284723|156233693|FG011|Overall Study|Withdrawal by Subject|1|||
48557403|NCT03284723|156233682|FG000|Overall Study|Other|1|||
48557404|NCT03284723|156233683|FG001|Overall Study|Other|0|||
48557405|NCT03284723|156233684|FG002|Overall Study|Other|1|||
48557406|NCT03284723|156233685|FG003|Overall Study|Other|0|||
48557407|NCT03284723|156233686|FG004|Overall Study|Other|1|||
48557408|NCT03284723|156233687|FG005|Overall Study|Other|0|||
48557409|NCT03284723|156233688|FG006|Overall Study|Other|0|||
48557410|NCT03284723|156233689|FG007|Overall Study|Other|0|||
48557411|NCT03284723|156233690|FG008|Overall Study|Other|0|||
48557412|NCT03284723|156233691|FG009|Overall Study|Other|0|||
48557413|NCT03284723|156233692|FG010|Overall Study|Other|1|||
48557414|NCT03284723|156233693|FG011|Overall Study|Other|0|||
48557415|NCT03284723|156233682|FG000|Overall Study|Adverse Event|0|||
48557416|NCT03284723|156233683|FG001|Overall Study|Adverse Event|0|||
48557417|NCT03284723|156233684|FG002|Overall Study|Adverse Event|0|||
48557418|NCT03284723|156233685|FG003|Overall Study|Adverse Event|0|||
48557419|NCT03284723|156233686|FG004|Overall Study|Adverse Event|0|||
48557420|NCT03284723|156233687|FG005|Overall Study|Adverse Event|0|||
48557421|NCT03284723|156233688|FG006|Overall Study|Adverse Event|0|||
48557422|NCT03284723|156233689|FG007|Overall Study|Adverse Event|0|||
48557423|NCT03284723|156233690|FG008|Overall Study|Adverse Event|1|||
48557424|NCT03284723|156233691|FG009|Overall Study|Adverse Event|0|||
48557425|NCT03284723|156233692|FG010|Overall Study|Adverse Event|0|||
48557426|NCT03284723|156233693|FG011|Overall Study|Adverse Event|0|||
48557427|NCT02207634|156233694|FG000|Overall Study|Withdrawal by Subject|21|||
48557428|NCT02207634|156233695|FG001|Overall Study|Withdrawal by Subject|31|||
48557429|NCT02207634|156233694|FG000|Overall Study|Lost to Follow-up|1|||
48557430|NCT02207634|156233695|FG001|Overall Study|Lost to Follow-up|0|||
48557431|NCT04825912|156233696|FG000|Overall Study|Death|3|||
48557432|NCT04825912|156233696|FG000|Overall Study|Withdrawal by Subject|1|||
48557433|NCT00615199|156233697|FG000|Overall Study|Adverse Event|3|||
48557434|NCT00615199|156233698|FG001|Overall Study|Adverse Event|1|||
48557435|NCT00615199|156233699|FG002|Overall Study|Adverse Event|1|||
48557436|NCT00615199|156233700|FG003|Overall Study|Adverse Event|0|||
48557437|NCT00615199|156233697|FG000|Overall Study|Lack of Efficacy|2|||
48557438|NCT00615199|156233698|FG001|Overall Study|Lack of Efficacy|0|||
48557439|NCT00615199|156233699|FG002|Overall Study|Lack of Efficacy|0|||
48557440|NCT00615199|156233700|FG003|Overall Study|Lack of Efficacy|1|||
48557441|NCT00615199|156233697|FG000|Overall Study|Lost to Follow-up|1|||
48557442|NCT00615199|156233698|FG001|Overall Study|Lost to Follow-up|0|||
48557443|NCT00615199|156233699|FG002|Overall Study|Lost to Follow-up|0|||
48557444|NCT00615199|156233700|FG003|Overall Study|Lost to Follow-up|0|||
48557445|NCT00615199|156233697|FG000|Overall Study|Other|0|||
48557446|NCT00615199|156233698|FG001|Overall Study|Other|0|||
48557447|NCT00615199|156233699|FG002|Overall Study|Other|0|||
48557448|NCT00615199|156233700|FG003|Overall Study|Other|1|||
48557449|NCT00615199|156233697|FG000|Overall Study|Withdrawal by Subject|2|||
48557450|NCT00615199|156233698|FG001|Overall Study|Withdrawal by Subject|1|||
48557451|NCT00615199|156233699|FG002|Overall Study|Withdrawal by Subject|0|||
48557452|NCT00615199|156233700|FG003|Overall Study|Withdrawal by Subject|0|||
48557453|NCT01090414|156233703|FG000|Study 101-99|Progressive Disease|28|||
48557454|NCT01090414|156233704|FG001|Study 101-99|Progressive Disease|48|||
48557455|NCT01090414|156233705|FG002|Study 101-99|Progressive Disease|10|||
48557456|NCT01090414|156233706|FG003|Study 101-99|Progressive Disease|4|||
48557457|NCT01090414|156233703|FG000|Study 101-99|Adverse Event|10|||
48557458|NCT01090414|156233704|FG001|Study 101-99|Adverse Event|28|||
48557459|NCT01090414|156233705|FG002|Study 101-99|Adverse Event|18|||
48557460|NCT01090414|156233706|FG003|Study 101-99|Adverse Event|0|||
48557461|NCT01090414|156233703|FG000|Study 101-99|Investigator Request|1|||
48557462|NCT01090414|156233704|FG001|Study 101-99|Investigator Request|11|||
48557463|NCT01090414|156233705|FG002|Study 101-99|Investigator Request|4|||
48557464|NCT01090414|156233706|FG003|Study 101-99|Investigator Request|0|||
48557465|NCT01090414|156233703|FG000|Study 101-99|Death|3|||
48557466|NCT01090414|156233704|FG001|Study 101-99|Death|8|||
48557467|NCT01090414|156233705|FG002|Study 101-99|Death|1|||
48557468|NCT01090414|156233706|FG003|Study 101-99|Death|0|||
48557469|NCT01090414|156233703|FG000|Study 101-99|Sponsor Discontinued Study|0|||
48557470|NCT01090414|156233704|FG001|Study 101-99|Sponsor Discontinued Study|7|||
48557471|NCT01090414|156233705|FG002|Study 101-99|Sponsor Discontinued Study|5|||
48557472|NCT01090414|156233706|FG003|Study 101-99|Sponsor Discontinued Study|0|||
48557473|NCT01090414|156233703|FG000|Study 101-99|Other (Unknown Reasons)|3|||
48557474|NCT01090414|156233704|FG001|Study 101-99|Other (Unknown Reasons)|3|||
48557475|NCT01090414|156233705|FG002|Study 101-99|Other (Unknown Reasons)|0|||
48557476|NCT01090414|156233706|FG003|Study 101-99|Other (Unknown Reasons)|0|||
48557477|NCT01090414|156233703|FG000|Study 101-99|Withdrew Consent|0|||
48557478|NCT01090414|156233704|FG001|Study 101-99|Withdrew Consent|2|||
48557479|NCT01090414|156233705|FG002|Study 101-99|Withdrew Consent|3|||
48557480|NCT01090414|156233706|FG003|Study 101-99|Withdrew Consent|1|||
48557481|NCT01090414|156233703|FG000|Study 101-99|Participant Request|3|||
48557482|NCT01090414|156233704|FG001|Study 101-99|Participant Request|1|||
48557483|NCT01090414|156233705|FG002|Study 101-99|Participant Request|0|||
48557484|NCT01090414|156233706|FG003|Study 101-99|Participant Request|0|||
48557485|NCT01295320|156233709|FG000|Overall Study|Adverse Event|2|||
48557486|NCT01295320|156233709|FG000|Overall Study|Lost to Follow-up|4|||
48557487|NCT01295320|156233709|FG000|Overall Study|Withdrawal by Subject|2|||
48557488|NCT01295320|156233709|FG000|Overall Study|Subject was bedridden|1|||
48557489|NCT01295320|156233709|FG000|Overall Study|Unable to travel|1|||
48557490|NCT00462904|156233710|FG000|Overall Study|Lost to Follow-up|1|||
48557491|NCT00652340|156233711|FG000|Overall Study|Had not progressed.|4|||
48557492|NCT00652340|156233712|FG001|Overall Study|Had not progressed.|3|||
48557493|NCT01995513|156233713|FG000|Period 1: First Open Label Treatment|Other|34|||
48557494|NCT01995513|156233714|FG001|Period 1: First Open Label Treatment|Other|0|||
48557495|NCT01995513|156233715|FG002|Period 1: First Open Label Treatment|Other|0|||
48557496|NCT01995513|156233716|FG003|Period 1: First Open Label Treatment|Other|0|||
48557497|NCT01995513|156233713|FG000|Period 1: First Open Label Treatment|Death|14|||
48557498|NCT01995513|156233714|FG001|Period 1: First Open Label Treatment|Death|0|||
48557499|NCT01995513|156233715|FG002|Period 1: First Open Label Treatment|Death|0|||
48557500|NCT01995513|156233716|FG003|Period 1: First Open Label Treatment|Death|0|||
48557501|NCT01995513|156233713|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
48557502|NCT01995513|156233714|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
48557503|NCT01995513|156233715|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
48557504|NCT01995513|156233716|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
48557505|NCT01995513|156233713|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
48557506|NCT01995513|156233714|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
48557507|NCT01995513|156233715|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
48557508|NCT01995513|156233716|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
48557509|NCT01995513|156233713|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
48557510|NCT01995513|156233714|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
48557511|NCT01995513|156233715|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
48557512|NCT01995513|156233716|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
48557513|NCT01995513|156233713|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
48557514|NCT01995513|156233714|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
48557515|NCT01995513|156233715|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
48557516|NCT01995513|156233716|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
48557517|NCT01995513|156233713|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
48557518|NCT01995513|156233714|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
48557519|NCT01995513|156233715|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
48557520|NCT01995513|156233716|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
48557521|NCT01995513|156233713|FG000|Period 1: Second Open Label Treatment|Other|0|||
48557522|NCT01995513|156233714|FG001|Period 1: Second Open Label Treatment|Other|2|||
48557523|NCT01995513|156233715|FG002|Period 1: Second Open Label Treatment|Other|0|||
48557524|NCT01995513|156233716|FG003|Period 1: Second Open Label Treatment|Other|0|||
48557525|NCT01995513|156233713|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
48557526|NCT01995513|156233714|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
48557527|NCT01995513|156233715|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
48557528|NCT01995513|156233716|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
48557529|NCT01995513|156233713|FG000|Period 2: Double Blind Treatment|Death|0|||
48557530|NCT01995513|156233714|FG001|Period 2: Double Blind Treatment|Death|0|||
48557531|NCT01995513|156233715|FG002|Period 2: Double Blind Treatment|Death|0|||
48557532|NCT01995513|156233716|FG003|Period 2: Double Blind Treatment|Death|1|||
48557533|NCT01995513|156233713|FG000|Period 2: Double Blind Treatment|Other|0|||
48557534|NCT01995513|156233714|FG001|Period 2: Double Blind Treatment|Other|0|||
48557535|NCT01995513|156233715|FG002|Period 2: Double Blind Treatment|Other|3|||
48557536|NCT01995513|156233716|FG003|Period 2: Double Blind Treatment|Other|3|||
48615633|NCT01245751|156448595|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
48557537|NCT01995513|156233713|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
48557538|NCT01995513|156233714|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
48557539|NCT01995513|156233715|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
48615634|NCT01245751|156448596|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
48557540|NCT01995513|156233716|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
48615635|NCT01245751|156448597|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
48557541|NCT01995513|156233713|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
48557542|NCT01995513|156233714|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
48557543|NCT01995513|156233715|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
48557544|NCT01995513|156233716|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
48557545|NCT01995513|156233713|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
48557546|NCT01995513|156233714|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
48557547|NCT01995513|156233715|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
48557548|NCT01995513|156233716|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
48557549|NCT01995513|156233713|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
48557550|NCT01995513|156233714|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
48557551|NCT01995513|156233715|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
48557552|NCT01995513|156233716|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
48557553|NCT02439216|156233717|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
48557554|NCT02439216|156233718|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
48557555|NCT02439216|156233719|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
48557556|NCT02439216|156233720|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
48557557|NCT02439216|156233721|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
48557558|NCT02439216|156233722|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
48557559|NCT02439216|156233723|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
48557560|NCT02439216|156233724|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
48557561|NCT02439216|156233725|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
48557562|NCT02439216|156233717|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
48557563|NCT02439216|156233718|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
48557564|NCT02439216|156233719|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
48557565|NCT02439216|156233720|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
48557566|NCT02439216|156233721|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
48557567|NCT02439216|156233722|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
48557568|NCT02439216|156233723|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
48557569|NCT02439216|156233724|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
48557570|NCT02439216|156233725|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
48557571|NCT02439216|156233717|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
48557572|NCT02439216|156233718|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
48557573|NCT02439216|156233719|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
48557574|NCT02439216|156233720|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
48557575|NCT02439216|156233721|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
48557576|NCT02439216|156233722|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
48557577|NCT02439216|156233723|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
48557578|NCT02439216|156233724|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
48557579|NCT02439216|156233725|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
48557580|NCT02439216|156233717|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
48557581|NCT02439216|156233718|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
48557582|NCT02439216|156233719|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
48557583|NCT02439216|156233720|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
48557584|NCT02439216|156233721|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
48557585|NCT02439216|156233722|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
48557586|NCT02439216|156233723|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
48557587|NCT02439216|156233724|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
48557588|NCT02439216|156233725|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
48557589|NCT02439216|156233717|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
48557590|NCT02439216|156233718|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
48557591|NCT02439216|156233719|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
48557592|NCT02439216|156233720|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
48557593|NCT02439216|156233721|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
48557594|NCT02439216|156233722|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
48557595|NCT02439216|156233723|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
48557596|NCT02439216|156233724|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
48557597|NCT02439216|156233725|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
48557598|NCT02652949|156233726|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
48557599|NCT02652949|156233726|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
48557600|NCT02652949|156233726|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
48557601|NCT02652949|156233726|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
48557602|NCT02652949|156233726|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
48557603|NCT02652949|156233726|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
48557604|NCT02652949|156233726|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
48557605|NCT02652949|156233726|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
48557606|NCT02652949|156233726|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
48557607|NCT02652949|156233726|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
48557608|NCT02652949|156233726|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
48557609|NCT02652949|156233726|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
48557610|NCT02652949|156233726|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
48557611|NCT02652949|156233726|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
48557612|NCT02652949|156233726|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
48557613|NCT02652949|156233726|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
48557614|NCT02652949|156233726|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
48557615|NCT01439802|156233730|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
48557616|NCT01439802|156233730|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
48557617|NCT02094300|156233731|FG000|Overall Study|Death|7|||
48557618|NCT02094300|156233731|FG000|Overall Study|Lost to Follow-up|10|||
48557619|NCT02094300|156233731|FG000|Overall Study|Still be eligible for follow-up|3|||
48557620|NCT01232452|156233732|FG000|Overall Study|Adverse Event|17|||
48557621|NCT01232452|156233733|FG001|Overall Study|Adverse Event|15|||
48557622|NCT01232452|156233732|FG000|Overall Study|Withdrawal by Subject|11|||
48557623|NCT01232452|156233733|FG001|Overall Study|Withdrawal by Subject|8|||
48557624|NCT01232452|156233732|FG000|Overall Study|Physician Decision|8|||
48557625|NCT01232452|156233733|FG001|Overall Study|Physician Decision|12|||
48557626|NCT01232452|156233732|FG000|Overall Study|Protocol entry criterion not met|0|||
48557627|NCT01232452|156233733|FG001|Overall Study|Protocol entry criterion not met|2|||
48557628|NCT01232452|156233732|FG000|Overall Study|Sponsor Decision|3|||
48557629|NCT01232452|156233733|FG001|Overall Study|Sponsor Decision|1|||
48557630|NCT01232452|156233732|FG000|Overall Study|Protocol Violation|0|||
48557631|NCT01232452|156233733|FG001|Overall Study|Protocol Violation|1|||
48557632|NCT04108299|156233734|FG000|Overall Study|Not interested in participating|2|||
48557633|NCT04108299|156233735|FG001|Overall Study|Not interested in participating|1|||
48557634|NCT04108299|156233736|FG002|Overall Study|Not interested in participating|2|||
48557635|NCT04108299|156233737|FG003|Overall Study|Not interested in participating|1|||
48557636|NCT03682107|156233742|FG000|Overall Study|Withdrawal by Subject|0|||
48557637|NCT03682107|156233743|FG001|Overall Study|Withdrawal by Subject|1|||
48557638|NCT03682107|156233744|FG002|Overall Study|Withdrawal by Subject|0|||
48557639|NCT03682107|156233745|FG003|Overall Study|Withdrawal by Subject|0|||
48557640|NCT03682107|156233746|FG004|Overall Study|Withdrawal by Subject|0|||
48557641|NCT00247676|156233750|FG000|Overall Study|Death|5|||
48557642|NCT00247676|156233750|FG000|Overall Study|Adverse Event|11|||
48557643|NCT00247676|156233750|FG000|Overall Study|Lack of Efficacy|15|||
48557644|NCT00247676|156233750|FG000|Overall Study|Other|3|||
48557645|NCT00247676|156233750|FG000|Overall Study|Withdrawal by Subject|2|||
48557646|NCT00662649|156233751|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
48557647|NCT00662649|156233752|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
48557648|NCT00662649|156233753|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
48557649|NCT00662649|156233754|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
48557650|NCT00662649|156233755|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
48557651|NCT00662649|156233751|FG000|Core Study (24 Months)|Adverse Event|22|||
48557652|NCT00662649|156233752|FG001|Core Study (24 Months)|Adverse Event|13|||
48557653|NCT00662649|156233753|FG002|Core Study (24 Months)|Adverse Event|18|||
48557654|NCT00662649|156233754|FG003|Core Study (24 Months)|Adverse Event|0|||
48557655|NCT00662649|156233755|FG004|Core Study (24 Months)|Adverse Event|0|||
48557656|NCT00662649|156233751|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
48557657|NCT00662649|156233752|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
48557658|NCT00662649|156233753|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
48557659|NCT00662649|156233754|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
48557660|NCT00662649|156233755|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
48557661|NCT00662649|156233751|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
48557662|NCT00662649|156233752|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
48557663|NCT00662649|156233753|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
48557664|NCT00662649|156233754|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
48557665|NCT00662649|156233755|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
48557666|NCT00662649|156233751|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
48557667|NCT00662649|156233752|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
48557668|NCT00662649|156233753|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
48557669|NCT00662649|156233754|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
48557670|NCT00662649|156233755|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
48557671|NCT00662649|156233751|FG000|Core Study (24 Months)|Protocol Violation|5|||
48557672|NCT00662649|156233752|FG001|Core Study (24 Months)|Protocol Violation|5|||
48557673|NCT00662649|156233753|FG002|Core Study (24 Months)|Protocol Violation|4|||
48557674|NCT00662649|156233754|FG003|Core Study (24 Months)|Protocol Violation|0|||
48557675|NCT00662649|156233755|FG004|Core Study (24 Months)|Protocol Violation|0|||
48557676|NCT00662649|156233751|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
48557677|NCT00662649|156233752|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
48557678|NCT00662649|156233753|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
48557679|NCT00662649|156233754|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
48557680|NCT00662649|156233755|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
48557681|NCT00662649|156233751|FG000|Core Study (24 Months)|Death|1|||
48557682|NCT00662649|156233752|FG001|Core Study (24 Months)|Death|0|||
48557683|NCT00662649|156233753|FG002|Core Study (24 Months)|Death|2|||
48557684|NCT00662649|156233754|FG003|Core Study (24 Months)|Death|0|||
48557685|NCT00662649|156233755|FG004|Core Study (24 Months)|Death|0|||
48557686|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
48557687|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
48557688|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
48557689|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
48557690|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
48557691|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
48557692|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
48557693|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
48615636|NCT01245751|156448598|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
48615637|NCT01245751|156448595|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
48615638|NCT01245751|156448596|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
48615639|NCT01245751|156448597|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
48615640|NCT01245751|156448598|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
48615641|NCT01245751|156448595|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
48615642|NCT01245751|156448596|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
48615643|NCT01245751|156448597|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
48615644|NCT01245751|156448598|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
48615645|NCT00845182|156448607|FG000|Overall Study|Lost to Follow-up|3|||
48615646|NCT00845182|156448608|FG001|Overall Study|Lost to Follow-up|3|||
48615647|NCT00845182|156448609|FG002|Overall Study|Lost to Follow-up|4|||
48615648|NCT00845182|156448607|FG000|Overall Study|Adverse Event|0|||
48615649|NCT00845182|156448608|FG001|Overall Study|Adverse Event|1|||
48615650|NCT00845182|156448609|FG002|Overall Study|Adverse Event|1|||
48615651|NCT00845182|156448607|FG000|Overall Study|Physician Decision|0|||
48615652|NCT00845182|156448608|FG001|Overall Study|Physician Decision|0|||
48615653|NCT00845182|156448609|FG002|Overall Study|Physician Decision|1|||
48615654|NCT00762788|156448611|FG000|Overall Study|Lost to Follow-up|26|||
48615655|NCT00762788|156448612|FG001|Overall Study|Lost to Follow-up|37|||
48615656|NCT00762788|156448613|FG002|Overall Study|Lost to Follow-up|21|||
48557694|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
48557695|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
48557696|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
48557697|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
48557698|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
48557699|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
48557700|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
48557701|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
48557702|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
48557703|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
48557704|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
48557705|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
48557706|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
48557707|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
48557708|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
48557709|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
48557710|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
48557711|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
48557712|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
48615657|NCT00762788|156448614|FG003|Overall Study|Lost to Follow-up|26|||
48615658|NCT00762788|156448615|FG004|Overall Study|Lost to Follow-up|13|||
48615659|NCT00762788|156448616|FG005|Overall Study|Lost to Follow-up|21|||
48557713|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
48557714|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
48557715|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
48557716|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
48557717|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
48615660|NCT01625182|156448617|FG000|Overall Study|Administrative problems|1|||
48615661|NCT01625182|156448618|FG001|Overall Study|Administrative problems|0|||
48615662|NCT01625182|156448617|FG000|Overall Study|Protocol deviation|0|||
48615663|NCT01625182|156448618|FG001|Overall Study|Protocol deviation|2|||
48615664|NCT01625182|156448617|FG000|Overall Study|Adverse Event|2|||
48615665|NCT01625182|156448618|FG001|Overall Study|Adverse Event|0|||
48615666|NCT01625182|156448617|FG000|Overall Study|Withdrawal by Subject|5|||
48615667|NCT01625182|156448618|FG001|Overall Study|Withdrawal by Subject|1|||
48615668|NCT01625182|156448617|FG000|Overall Study|Lack of Efficacy|12|||
48615669|NCT01625182|156448618|FG001|Overall Study|Lack of Efficacy|8|||
48615670|NCT01348698|156448623|FG000|Overall Study|Does not meet lesion size criteria|1|||
48615671|NCT01348698|156448623|FG000|Overall Study|Death|3|||
48615672|NCT01348698|156448623|FG000|Overall Study|PI decision to close study|68|||
48615673|NCT01500083|156448624|FG000|Overall Study|Adverse Event|4|||
48615674|NCT01500083|156448625|FG001|Overall Study|Adverse Event|17|||
48615675|NCT01500083|156448624|FG000|Overall Study|Death|0|||
48615676|NCT01500083|156448625|FG001|Overall Study|Death|2|||
48615677|NCT01500083|156448624|FG000|Overall Study|Lost to Follow-up|1|||
48615678|NCT01500083|156448625|FG001|Overall Study|Lost to Follow-up|0|||
48615679|NCT01500083|156448624|FG000|Overall Study|Withdrawal of Consent|0|||
48615680|NCT01500083|156448625|FG001|Overall Study|Withdrawal of Consent|1|||
48615681|NCT01500083|156448624|FG000|Overall Study|Disease Progression|2|||
48615682|NCT01500083|156448625|FG001|Overall Study|Disease Progression|10|||
48615683|NCT01500083|156448624|FG000|Overall Study|Investigator Discretion|3|||
48615684|NCT01500083|156448625|FG001|Overall Study|Investigator Discretion|8|||
48615685|NCT01500083|156448624|FG000|Overall Study|Other Reasons|2|||
48615686|NCT01500083|156448625|FG001|Overall Study|Other Reasons|5|||
48615687|NCT01200355|156448626|FG000|Overall Study|Death|7|||
48615688|NCT01200355|156448627|FG001|Overall Study|Death|2|||
48615689|NCT05607043|156448630|FG000|Overall Study|Lost to Follow-up|2|||
48615690|NCT00471354|156448634|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
48615691|NCT00471354|156448634|FG000|Overall Study|Adverse Event|13|||
48615692|NCT00471354|156448634|FG000|Overall Study|Protocol Violation|12|||
48615693|NCT00471354|156448634|FG000|Overall Study|Withdrawal by Subject|1|||
48615694|NCT00471354|156448634|FG000|Overall Study|Physician Decision|4|||
48615695|NCT00471354|156448634|FG000|Overall Study|Sponsor Decision|1|||
48615696|NCT00471354|156448634|FG000|Overall Study|Lost to Follow-up|3|||
48615697|NCT00471354|156448634|FG000|Overall Study|Lack of Efficacy|5|||
48615698|NCT00471354|156448634|FG000|Overall Study|Patient/Caregiver Decision|12|||
48615699|NCT01481779|156448635|FG000|Overall Study|Adverse Event|23|||
48615700|NCT01481779|156448636|FG001|Overall Study|Adverse Event|5|||
48615701|NCT01481779|156448635|FG000|Overall Study|Lost to Follow-up|3|||
48615702|NCT01481779|156448636|FG001|Overall Study|Lost to Follow-up|2|||
48615703|NCT01481779|156448635|FG000|Overall Study|Protocol Violation|2|||
48615704|NCT01481779|156448636|FG001|Overall Study|Protocol Violation|3|||
48615705|NCT01481779|156448635|FG000|Overall Study|Withdrawal by Subject|26|||
48615706|NCT01481779|156448636|FG001|Overall Study|Withdrawal by Subject|13|||
48615707|NCT01481779|156448635|FG000|Overall Study|Physician Decision|13|||
48615708|NCT01481779|156448636|FG001|Overall Study|Physician Decision|4|||
48615709|NCT01481779|156448635|FG000|Overall Study|Sponsor Decision|3|||
48615710|NCT01481779|156448636|FG001|Overall Study|Sponsor Decision|1|||
48615711|NCT01922011|156448637|FG000|Overall Study|Protocol Violation|0|||
48615712|NCT01922011|156448638|FG001|Overall Study|Protocol Violation|1|||
48615713|NCT01922011|156448637|FG000|Overall Study|Physician Decision|0|||
48615714|NCT01922011|156448638|FG001|Overall Study|Physician Decision|1|||
48615715|NCT01922011|156448637|FG000|Overall Study|Parent/Guardian Decision|3|||
48615716|NCT01922011|156448638|FG001|Overall Study|Parent/Guardian Decision|0|||
48615717|NCT01922011|156448637|FG000|Overall Study|Lost to Follow-up|0|||
48615718|NCT01922011|156448638|FG001|Overall Study|Lost to Follow-up|1|||
48615719|NCT01922011|156448637|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
48615720|NCT01922011|156448638|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
48615721|NCT01922011|156448637|FG000|Overall Study|Not Treated|1|||
48615722|NCT01922011|156448638|FG001|Overall Study|Not Treated|0|||
48615723|NCT01922011|156448637|FG000|Overall Study|Lack of willing home health agency|1|||
48615724|NCT01922011|156448638|FG001|Overall Study|Lack of willing home health agency|0|||
48615725|NCT01922011|156448637|FG000|Overall Study|Randomized in error|1|||
48615726|NCT01922011|156448638|FG001|Overall Study|Randomized in error|0|||
48615727|NCT01859741|156448639|FG000|Overall Study|Death|3|||
48615728|NCT01859741|156448640|FG001|Overall Study|Death|2|||
48615729|NCT01859741|156448641|FG002|Overall Study|Death|4|||
48615730|NCT01859741|156448642|FG003|Overall Study|Death|3|||
48615731|NCT01859741|156448643|FG004|Overall Study|Death|5|||
48615732|NCT01859741|156448644|FG005|Overall Study|Death|4|||
48615733|NCT01859741|156448645|FG006|Overall Study|Death|51|||
48615734|NCT01859741|156448646|FG007|Overall Study|Death|51|||
48615735|NCT01859741|156448639|FG000|Overall Study|Lost to Follow-up|0|||
48615736|NCT01859741|156448640|FG001|Overall Study|Lost to Follow-up|0|||
48615737|NCT01859741|156448641|FG002|Overall Study|Lost to Follow-up|0|||
48615738|NCT01859741|156448642|FG003|Overall Study|Lost to Follow-up|0|||
48615739|NCT01859741|156448643|FG004|Overall Study|Lost to Follow-up|0|||
48615740|NCT01859741|156448644|FG005|Overall Study|Lost to Follow-up|1|||
48557718|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
48557719|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
48557720|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
48557721|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
48557722|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
48557723|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
48557724|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
48557725|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
48615741|NCT01859741|156448645|FG006|Overall Study|Lost to Follow-up|0|||
48615742|NCT01859741|156448646|FG007|Overall Study|Lost to Follow-up|4|||
48615743|NCT01859741|156448639|FG000|Overall Study|Withdrawal by Subject|0|||
48615744|NCT01859741|156448640|FG001|Overall Study|Withdrawal by Subject|1|||
48615745|NCT01859741|156448641|FG002|Overall Study|Withdrawal by Subject|2|||
48615746|NCT01859741|156448642|FG003|Overall Study|Withdrawal by Subject|0|||
48615747|NCT01859741|156448643|FG004|Overall Study|Withdrawal by Subject|0|||
48615748|NCT01859741|156448644|FG005|Overall Study|Withdrawal by Subject|1|||
48615749|NCT01859741|156448645|FG006|Overall Study|Withdrawal by Subject|1|||
48615750|NCT01859741|156448646|FG007|Overall Study|Withdrawal by Subject|1|||
48615751|NCT01859741|156448639|FG000|Overall Study|Study Terminated by Sponsor|0|||
48615752|NCT01859741|156448640|FG001|Overall Study|Study Terminated by Sponsor|0|||
48615753|NCT01859741|156448641|FG002|Overall Study|Study Terminated by Sponsor|0|||
48615754|NCT01859741|156448642|FG003|Overall Study|Study Terminated by Sponsor|0|||
48615755|NCT01859741|156448643|FG004|Overall Study|Study Terminated by Sponsor|1|||
48557726|NCT00662649|156233751|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
48557727|NCT00662649|156233752|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
48557728|NCT00662649|156233753|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
48557729|NCT00662649|156233754|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
48557730|NCT00662649|156233755|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
48557731|NCT02288312|156233759|FG000|Overall Study|Pregnancy|1|||
48557732|NCT02288312|156233760|FG001|Overall Study|Pregnancy|0|||
48615756|NCT01859741|156448644|FG005|Overall Study|Study Terminated by Sponsor|0|||
48615757|NCT01859741|156448645|FG006|Overall Study|Study Terminated by Sponsor|16|||
48615758|NCT01859741|156448646|FG007|Overall Study|Study Terminated by Sponsor|14|||
48615759|NCT01859741|156448639|FG000|Overall Study|Other|0|||
48615760|NCT01859741|156448640|FG001|Overall Study|Other|0|||
48615761|NCT01859741|156448641|FG002|Overall Study|Other|0|||
48615762|NCT01859741|156448642|FG003|Overall Study|Other|0|||
48615763|NCT01859741|156448643|FG004|Overall Study|Other|0|||
48615764|NCT01859741|156448644|FG005|Overall Study|Other|0|||
48615765|NCT01859741|156448645|FG006|Overall Study|Other|2|||
48615766|NCT01859741|156448646|FG007|Overall Study|Other|0|||
48615767|NCT02568423|156448647|FG000|Overall Study|Lost to Follow-up|0|||
48615768|NCT02568423|156448648|FG001|Overall Study|Lost to Follow-up|2|||
48615769|NCT02568423|156448649|FG002|Overall Study|Lost to Follow-up|0|||
48615770|NCT02568423|156448650|FG003|Overall Study|Lost to Follow-up|0|||
48615771|NCT02568423|156448651|FG004|Overall Study|Lost to Follow-up|0|||
48615772|NCT02568423|156448652|FG005|Overall Study|Lost to Follow-up|0|||
48615773|NCT02568423|156448653|FG006|Overall Study|Lost to Follow-up|0|||
48615774|NCT02568423|156448654|FG007|Overall Study|Lost to Follow-up|0|||
48615775|NCT02568423|156448647|FG000|Overall Study|Physician Decision|0|||
48615776|NCT02568423|156448648|FG001|Overall Study|Physician Decision|0|||
48615777|NCT02568423|156448649|FG002|Overall Study|Physician Decision|0|||
48615778|NCT02568423|156448650|FG003|Overall Study|Physician Decision|0|||
48615779|NCT02568423|156448651|FG004|Overall Study|Physician Decision|0|||
48615780|NCT02568423|156448652|FG005|Overall Study|Physician Decision|1|||
48557733|NCT02288312|156233761|FG002|Overall Study|Pregnancy|0|||
48557734|NCT04342819|156233765|FG000|Overall Study|Declined|4|||
48615781|NCT02568423|156448653|FG006|Overall Study|Physician Decision|0|||
48615782|NCT02568423|156448654|FG007|Overall Study|Physician Decision|0|||
48615783|NCT00081458|156448657|FG000|Overall Study|Adverse Event|1|||
48615784|NCT00081458|156448658|FG001|Overall Study|Adverse Event|5|||
48615785|NCT00081458|156448659|FG002|Overall Study|Adverse Event|2|||
48615786|NCT00081458|156448657|FG000|Overall Study|Withdrawal by Subject|0|||
48615787|NCT00081458|156448658|FG001|Overall Study|Withdrawal by Subject|3|||
48615788|NCT00081458|156448659|FG002|Overall Study|Withdrawal by Subject|1|||
48615789|NCT00081458|156448657|FG000|Overall Study|Randomized but not dosed|0|||
48615790|NCT00081458|156448658|FG001|Overall Study|Randomized but not dosed|0|||
48630347|NCT02082977|156504936|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
48615791|NCT00081458|156448659|FG002|Overall Study|Randomized but not dosed|1|||
48615792|NCT01995201|156448660|FG000|From Baseline Until Week 24|Adverse Event|4|||
48615793|NCT01995201|156448661|FG001|From Baseline Until Week 24|Adverse Event|15|||
48615794|NCT01995201|156448662|FG002|From Baseline Until Week 24|Adverse Event|0|||
48615795|NCT01995201|156448663|FG003|From Baseline Until Week 24|Adverse Event|0|||
48615796|NCT01995201|156448664|FG004|From Baseline Until Week 24|Adverse Event|0|||
48615797|NCT01995201|156448665|FG005|From Baseline Until Week 24|Adverse Event|0|||
48615798|NCT01995201|156448666|FG006|From Baseline Until Week 24|Adverse Event|0|||
48615799|NCT01995201|156448660|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
48615800|NCT01995201|156448661|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
48615801|NCT01995201|156448662|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
48615802|NCT01995201|156448663|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
48615803|NCT01995201|156448664|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
48615804|NCT01995201|156448665|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
48615805|NCT01995201|156448666|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
48615806|NCT01995201|156448660|FG000|From Baseline Until Week 24|Death|0|||
48615807|NCT01995201|156448661|FG001|From Baseline Until Week 24|Death|1|||
48615808|NCT01995201|156448662|FG002|From Baseline Until Week 24|Death|0|||
48615809|NCT01995201|156448663|FG003|From Baseline Until Week 24|Death|0|||
48615810|NCT01995201|156448664|FG004|From Baseline Until Week 24|Death|0|||
48615811|NCT01995201|156448665|FG005|From Baseline Until Week 24|Death|0|||
48615812|NCT01995201|156448666|FG006|From Baseline Until Week 24|Death|0|||
48615813|NCT01995201|156448660|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
48615814|NCT01995201|156448661|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
48615815|NCT01995201|156448662|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
48615816|NCT01995201|156448663|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
48615817|NCT01995201|156448664|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
48557735|NCT04342819|156233765|FG000|Overall Study|Not meeeting selection criteria|1|||
48557736|NCT00911300|156233772|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
48557737|NCT00911300|156233773|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
48557738|NCT00911300|156233772|FG000|Overall Study|Death|1|||
48557739|NCT00911300|156233773|FG001|Overall Study|Death|0|||
48557740|NCT00911300|156233772|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
48557741|NCT00911300|156233773|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
48557742|NCT00911300|156233772|FG000|Overall Study|Adverse Event|14|||
48557743|NCT00911300|156233773|FG001|Overall Study|Adverse Event|6|||
48557744|NCT00911300|156233772|FG000|Overall Study|Protocol Violation|3|||
48557745|NCT00911300|156233773|FG001|Overall Study|Protocol Violation|2|||
48557746|NCT00911300|156233772|FG000|Overall Study|Consent Withdrawn|4|||
48557747|NCT00911300|156233773|FG001|Overall Study|Consent Withdrawn|12|||
48557748|NCT00911300|156233772|FG000|Overall Study|Coronary Angiography Performed|1|||
48557749|NCT00911300|156233773|FG001|Overall Study|Coronary Angiography Performed|0|||
48557750|NCT00911300|156233772|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
48557751|NCT00911300|156233773|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
48557752|NCT00911300|156233772|FG000|Overall Study|Received Commercial Treatment|1|||
48557753|NCT00911300|156233773|FG001|Overall Study|Received Commercial Treatment|0|||
48557754|NCT00911300|156233772|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
48557755|NCT00911300|156233773|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
48557756|NCT00911300|156233772|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
48557757|NCT00911300|156233773|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
48557758|NCT00911300|156233772|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
48557759|NCT00911300|156233773|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
48557760|NCT00911300|156233772|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
48557761|NCT00911300|156233773|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
48557762|NCT00911300|156233772|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
48557763|NCT00911300|156233773|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
48557764|NCT00911300|156233772|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
48557765|NCT00911300|156233773|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
48557766|NCT00911300|156233772|FG000|Overall Study|International Normalized Ratio Too High|0|||
48735647|NCT02215096|156883706|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
48557767|NCT00911300|156233773|FG001|Overall Study|International Normalized Ratio Too High|1|||
48557768|NCT00911300|156233772|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
48557769|NCT00911300|156233773|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
48557770|NCT00911300|156233772|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
48557771|NCT00911300|156233773|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
48557772|NCT00911300|156233772|FG000|Overall Study|Physician Decision|0|||
48615818|NCT01995201|156448665|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
48615819|NCT01995201|156448666|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
48557773|NCT00911300|156233773|FG001|Overall Study|Physician Decision|1|||
48557774|NCT00911300|156233772|FG000|Overall Study|Treatment Stopped by Mistake|0|||
48557775|NCT00911300|156233773|FG001|Overall Study|Treatment Stopped by Mistake|1|||
48557776|NCT00911300|156233772|FG000|Overall Study|Randomized; No Study Medication Received|0|||
48557777|NCT00911300|156233773|FG001|Overall Study|Randomized; No Study Medication Received|2|||
48557778|NCT00742209|156233775|FG000|Overall Study|Adverse Event|11|||
48557779|NCT00742209|156233776|FG001|Overall Study|Adverse Event|4|||
48557780|NCT00742209|156233777|FG002|Overall Study|Adverse Event|17|||
48557781|NCT00742209|156233778|FG003|Overall Study|Adverse Event|16|||
48557782|NCT00742209|156233779|FG004|Overall Study|Adverse Event|13|||
48557783|NCT00742209|156233775|FG000|Overall Study|Participant Withdrew Consent|8|||
48557784|NCT00742209|156233776|FG001|Overall Study|Participant Withdrew Consent|4|||
48557785|NCT00742209|156233777|FG002|Overall Study|Participant Withdrew Consent|14|||
48557786|NCT00742209|156233778|FG003|Overall Study|Participant Withdrew Consent|7|||
48557787|NCT00742209|156233779|FG004|Overall Study|Participant Withdrew Consent|4|||
48557788|NCT00742209|156233775|FG000|Overall Study|Protocol Violation|6|||
48557789|NCT00742209|156233776|FG001|Overall Study|Protocol Violation|5|||
48557790|NCT00742209|156233777|FG002|Overall Study|Protocol Violation|4|||
48557791|NCT00742209|156233778|FG003|Overall Study|Protocol Violation|5|||
48557792|NCT00742209|156233779|FG004|Overall Study|Protocol Violation|3|||
48557793|NCT00742209|156233775|FG000|Overall Study|Lost to Follow-up|3|||
48557794|NCT00742209|156233776|FG001|Overall Study|Lost to Follow-up|4|||
48557795|NCT00742209|156233777|FG002|Overall Study|Lost to Follow-up|5|||
48557796|NCT00742209|156233778|FG003|Overall Study|Lost to Follow-up|5|||
48557797|NCT00742209|156233779|FG004|Overall Study|Lost to Follow-up|3|||
48615820|NCT01995201|156448660|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
48615821|NCT01995201|156448661|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
48615822|NCT01995201|156448662|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
48615823|NCT01995201|156448663|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
48615824|NCT01995201|156448664|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
48615825|NCT01995201|156448665|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
48615826|NCT01995201|156448666|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
48615827|NCT01995201|156448660|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
48615828|NCT01995201|156448661|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
48615829|NCT01995201|156448662|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
48557798|NCT00742209|156233775|FG000|Overall Study|Lack of Efficacy|6|||
48557799|NCT00742209|156233776|FG001|Overall Study|Lack of Efficacy|1|||
48557800|NCT00742209|156233777|FG002|Overall Study|Lack of Efficacy|1|||
48557801|NCT00742209|156233778|FG003|Overall Study|Lack of Efficacy|3|||
48557802|NCT00742209|156233779|FG004|Overall Study|Lack of Efficacy|1|||
48557803|NCT00742209|156233775|FG000|Overall Study|Investigator Discretion|0|||
48557804|NCT00742209|156233776|FG001|Overall Study|Investigator Discretion|0|||
48557805|NCT00742209|156233777|FG002|Overall Study|Investigator Discretion|5|||
48557806|NCT00742209|156233778|FG003|Overall Study|Investigator Discretion|1|||
48557807|NCT00742209|156233779|FG004|Overall Study|Investigator Discretion|1|||
48557808|NCT03022370|156233780|FG000|Overall Study|Death|6|||
48557809|NCT03022370|156233781|FG001|Overall Study|Death|12|||
48615830|NCT01995201|156448663|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
48615831|NCT01995201|156448664|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
48557810|NCT03022370|156233780|FG000|Overall Study|Lost to Follow-up|174|||
48557811|NCT03022370|156233781|FG001|Overall Study|Lost to Follow-up|109|||
48557812|NCT00129389|156233782|FG000|Overall Study|Adverse Event|19|||
48557813|NCT00129389|156233783|FG001|Overall Study|Adverse Event|87|||
48557814|NCT00129389|156233782|FG000|Overall Study|Death|0|||
48557815|NCT00129389|156233783|FG001|Overall Study|Death|1|||
48557816|NCT00129389|156233782|FG000|Overall Study|Lost to Follow-up|2|||
48557817|NCT00129389|156233783|FG001|Overall Study|Lost to Follow-up|1|||
48557818|NCT00129389|156233782|FG000|Overall Study|Physician Decision|0|||
48557819|NCT00129389|156233783|FG001|Overall Study|Physician Decision|4|||
48557820|NCT00129389|156233782|FG000|Overall Study|Protocol Violation|0|||
48557821|NCT00129389|156233783|FG001|Overall Study|Protocol Violation|6|||
48557822|NCT00129389|156233782|FG000|Overall Study|Withdrawal by Subject|9|||
48615832|NCT01995201|156448665|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
48557823|NCT00129389|156233783|FG001|Overall Study|Withdrawal by Subject|23|||
48557824|NCT00129389|156233782|FG000|Overall Study|Relapse|1|||
48557825|NCT00129389|156233783|FG001|Overall Study|Relapse|0|||
48557826|NCT00129389|156233782|FG000|Overall Study|Not eligible|1|||
48557827|NCT00129389|156233783|FG001|Overall Study|Not eligible|2|||
48557828|NCT00129389|156233782|FG000|Overall Study|Crossed to the other arm|1|||
48557829|NCT00129389|156233783|FG001|Overall Study|Crossed to the other arm|16|||
48557830|NCT00725491|156233784|FG000|Overall Study|Adverse Event|3|||
48557831|NCT00725491|156233785|FG001|Overall Study|Adverse Event|2|||
48557832|NCT00725491|156233784|FG000|Overall Study|Pregnancy|0|||
48557833|NCT00725491|156233785|FG001|Overall Study|Pregnancy|3|||
48557834|NCT00725491|156233784|FG000|Overall Study|Risk for hyperstimulation|2|||
48557835|NCT00725491|156233785|FG001|Overall Study|Risk for hyperstimulation|9|||
48557836|NCT00725491|156233784|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
48557837|NCT00725491|156233785|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
48557838|NCT00725491|156233784|FG000|Overall Study|Fertilization failure|0|||
48557839|NCT00725491|156233785|FG001|Overall Study|Fertilization failure|1|||
48557840|NCT00725491|156233784|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
48557841|NCT00725491|156233785|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
48557842|NCT00668317|156233790|FG000|Overall Study|Adverse Event|2|||
48557843|NCT04428034|156233797|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
48557844|NCT00699816|156233798|FG000|Overall Study|Protocol Violation|1|||
48557845|NCT00699816|156233799|FG001|Overall Study|Protocol Violation|3|||
48557846|NCT02454933|156233808|FG000|Overall Study|Progressive disease|10|||
48557847|NCT02454933|156233809|FG001|Overall Study|Progressive disease|7|||
48557848|NCT02454933|156233808|FG000|Overall Study|Adverse Event|1|||
48557849|NCT02454933|156233809|FG001|Overall Study|Adverse Event|1|||
48557850|NCT02454933|156233808|FG000|Overall Study|Withdrawal by Subject|0|||
48557851|NCT02454933|156233809|FG001|Overall Study|Withdrawal by Subject|3|||
48557852|NCT02454933|156233808|FG000|Overall Study|Lost to Follow-up|1|||
48557853|NCT02454933|156233809|FG001|Overall Study|Lost to Follow-up|0|||
48557854|NCT01895777|156233810|FG000|Overall Study|Adverse Event|1|||
48557855|NCT01895777|156233811|FG001|Overall Study|Adverse Event|2|||
48557856|NCT01895777|156233810|FG000|Overall Study|Lost to Follow-up|2|||
48557857|NCT01895777|156233811|FG001|Overall Study|Lost to Follow-up|0|||
48557858|NCT01895777|156233810|FG000|Overall Study|Not treated|1|||
48557859|NCT01895777|156233811|FG001|Overall Study|Not treated|0|||
48557860|NCT01895777|156233810|FG000|Overall Study|Other reasons|3|||
48557861|NCT01895777|156233811|FG001|Overall Study|Other reasons|2|||
48557862|NCT01895777|156233810|FG000|Overall Study|Non-compliance with the CTP|2|||
48557863|NCT01895777|156233811|FG001|Overall Study|Non-compliance with the CTP|1|||
48557864|NCT02635984|156233812|FG000|Overall Study|Lost to Follow-up|2|||
48557865|NCT02635984|156233813|FG001|Overall Study|Lost to Follow-up|4|||
48557866|NCT02635984|156233812|FG000|Overall Study|Study Arm Closed|1|||
48557867|NCT02635984|156233813|FG001|Overall Study|Study Arm Closed|0|||
48557868|NCT00307086|156233814|FG000|Overall Study|ineligible|5|||
48557869|NCT03541317|156233815|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
48615833|NCT01995201|156448666|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
48615834|NCT01995201|156448660|FG000|From Baseline Until Week 24|Physician Decision|0|||
48557870|NCT03541317|156233816|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
48557871|NCT03541317|156233817|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
48557872|NCT03541317|156233818|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
48557873|NCT03541317|156233819|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
48557874|NCT03541317|156233820|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
48557875|NCT02969044|156233821|FG000|Overall Study|Withdrawal by Subject|2|||
48557876|NCT02969044|156233822|FG001|Overall Study|Withdrawal by Subject|6|||
48557877|NCT02969044|156233821|FG000|Overall Study|Adverse Event|3|||
48557878|NCT02969044|156233822|FG001|Overall Study|Adverse Event|0|||
48557879|NCT00879086|156233825|FG000|Overall Study|Adverse Event|3|||
48557880|NCT00879086|156233826|FG001|Overall Study|Adverse Event|15|||
48557881|NCT00879086|156233825|FG000|Overall Study|Participant choice|2|||
48557882|NCT00879086|156233826|FG001|Overall Study|Participant choice|2|||
48557883|NCT00879086|156233825|FG000|Overall Study|Progression of disease|40|||
48557884|NCT00879086|156233826|FG001|Overall Study|Progression of disease|26|||
48557885|NCT00879086|156233825|FG000|Overall Study|Withdrawal of consent|2|||
48557886|NCT00879086|156233826|FG001|Overall Study|Withdrawal of consent|1|||
48557887|NCT00879086|156233825|FG000|Overall Study|Other|4|||
48557888|NCT00879086|156233826|FG001|Overall Study|Other|6|||
48557889|NCT00879086|156233825|FG000|Overall Study|Death|1|||
48557890|NCT00879086|156233826|FG001|Overall Study|Death|2|||
48557891|NCT01149863|156233827|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
48557892|NCT00111241|156233828|FG000|Overall Study|Lost to Follow-up|1|||
48557893|NCT00111241|156233829|FG001|Overall Study|Lost to Follow-up|0|||
48557894|NCT00111241|156233828|FG000|Overall Study|Withdrawal by Subject|4|||
48557895|NCT00111241|156233829|FG001|Overall Study|Withdrawal by Subject|0|||
48557896|NCT00111241|156233828|FG000|Overall Study|Protocol Violation|9|||
48557897|NCT00111241|156233829|FG001|Overall Study|Protocol Violation|8|||
48557898|NCT00111241|156233828|FG000|Overall Study|Adverse Event|1|||
48557899|NCT00111241|156233829|FG001|Overall Study|Adverse Event|0|||
48557900|NCT04728802|156233830|FG000|Overall Study|Withdrawal by Subject|4|||
48557901|NCT04728802|156233831|FG001|Overall Study|Withdrawal by Subject|20|||
48557902|NCT04728802|156233830|FG000|Overall Study|Physician Decision|7|||
48557903|NCT04728802|156233831|FG001|Overall Study|Physician Decision|7|||
48557904|NCT04728802|156233830|FG000|Overall Study|Protocol Violation|10|||
48557905|NCT04728802|156233831|FG001|Overall Study|Protocol Violation|4|||
48557906|NCT04728802|156233830|FG000|Overall Study|Transfer|1|||
48557907|NCT04728802|156233831|FG001|Overall Study|Transfer|0|||
48557908|NCT04728802|156233830|FG000|Overall Study|Death|4|||
48557909|NCT04728802|156233831|FG001|Overall Study|Death|5|||
48557910|NCT04728802|156233830|FG000|Overall Study|Other|3|||
48557911|NCT04728802|156233831|FG001|Overall Study|Other|0|||
48557912|NCT01640249|156233833|FG000|Period 1|Withdrawal by Subject|1|||
48557913|NCT01640249|156233834|FG001|Period 1|Withdrawal by Subject|0|||
48557914|NCT01640249|156233835|FG002|Period 1|Withdrawal by Subject|0|||
48557915|NCT01640249|156233836|FG003|Period 1|Withdrawal by Subject|0|||
48557916|NCT01640249|156233837|FG004|Period 1|Withdrawal by Subject|0|||
48557917|NCT01640249|156233838|FG005|Period 1|Withdrawal by Subject|1|||
48557918|NCT01640249|156233839|FG006|Period 1|Withdrawal by Subject|0|||
48557919|NCT04650204|156233851|FG000|Overall Study|Study was Terminated|2|||
48557920|NCT04650204|156233852|FG001|Overall Study|Study was Terminated|1|||
48557921|NCT02601014|156233853|FG000|Overall Study|Adverse Event|3|||
48557922|NCT02601014|156233854|FG001|Overall Study|Adverse Event|3|||
48557923|NCT02601014|156233853|FG000|Overall Study|Death|3|||
48557924|NCT02601014|156233854|FG001|Overall Study|Death|1|||
48557925|NCT02601014|156233853|FG000|Overall Study|Disease progression|4|||
48557926|NCT02601014|156233854|FG001|Overall Study|Disease progression|8|||
48557927|NCT04352101|156233855|FG000|Overall Study|Physician Decision|2|||
48557928|NCT04352101|156233856|FG001|Overall Study|Physician Decision|1|||
48557929|NCT04211831|156233857|FG000|Overall Study|Withdrawal by Subject|4|||
48557930|NCT04211831|156233858|FG001|Overall Study|Withdrawal by Subject|1|||
48557931|NCT04211831|156233859|FG002|Overall Study|Withdrawal by Subject|1|||
48557932|NCT04211831|156233857|FG000|Overall Study|Protocol Violation|0|||
48557933|NCT04211831|156233858|FG001|Overall Study|Protocol Violation|0|||
48557934|NCT04211831|156233859|FG002|Overall Study|Protocol Violation|1|||
48557935|NCT04211831|156233857|FG000|Overall Study|Adverse Event|0|||
48557936|NCT04211831|156233858|FG001|Overall Study|Adverse Event|1|||
48557937|NCT04211831|156233859|FG002|Overall Study|Adverse Event|0|||
48557938|NCT04211831|156233857|FG000|Overall Study|Lack of Efficacy|0|||
48557939|NCT04211831|156233858|FG001|Overall Study|Lack of Efficacy|0|||
48557940|NCT04211831|156233859|FG002|Overall Study|Lack of Efficacy|1|||
48557941|NCT04211831|156233857|FG000|Overall Study|Lost to Follow-up|0|||
48557942|NCT04211831|156233858|FG001|Overall Study|Lost to Follow-up|0|||
48557943|NCT04211831|156233859|FG002|Overall Study|Lost to Follow-up|2|||
48557944|NCT04211831|156233857|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
48557945|NCT04211831|156233858|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
48557946|NCT04211831|156233859|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
48557947|NCT04211831|156233857|FG000|Overall Study|Other|0|||
48557948|NCT04211831|156233858|FG001|Overall Study|Other|1|||
48557949|NCT04211831|156233859|FG002|Overall Study|Other|0|||
48615835|NCT01995201|156448661|FG001|From Baseline Until Week 24|Physician Decision|2|||
48615836|NCT01995201|156448662|FG002|From Baseline Until Week 24|Physician Decision|0|||
48615837|NCT01995201|156448663|FG003|From Baseline Until Week 24|Physician Decision|0|||
48615838|NCT01995201|156448664|FG004|From Baseline Until Week 24|Physician Decision|0|||
48615839|NCT01995201|156448665|FG005|From Baseline Until Week 24|Physician Decision|0|||
48615840|NCT01995201|156448666|FG006|From Baseline Until Week 24|Physician Decision|0|||
48615841|NCT01995201|156448660|FG000|From Baseline Until Week 24|Protocol Violation|0|||
48615842|NCT01995201|156448661|FG001|From Baseline Until Week 24|Protocol Violation|9|||
48615843|NCT01995201|156448662|FG002|From Baseline Until Week 24|Protocol Violation|0|||
48615844|NCT01995201|156448663|FG003|From Baseline Until Week 24|Protocol Violation|0|||
48615845|NCT01995201|156448664|FG004|From Baseline Until Week 24|Protocol Violation|0|||
48615846|NCT01995201|156448665|FG005|From Baseline Until Week 24|Protocol Violation|0|||
48615847|NCT01995201|156448666|FG006|From Baseline Until Week 24|Protocol Violation|0|||
48615848|NCT01995201|156448660|FG000|From Week 24 Until Week 48|Adverse Event|0|||
48615849|NCT01995201|156448661|FG001|From Week 24 Until Week 48|Adverse Event|0|||
48615850|NCT01995201|156448662|FG002|From Week 24 Until Week 48|Adverse Event|2|||
48615851|NCT01995201|156448663|FG003|From Week 24 Until Week 48|Adverse Event|1|||
48615852|NCT01995201|156448664|FG004|From Week 24 Until Week 48|Adverse Event|1|||
48615853|NCT01995201|156448665|FG005|From Week 24 Until Week 48|Adverse Event|3|||
48615854|NCT01995201|156448666|FG006|From Week 24 Until Week 48|Adverse Event|1|||
48615855|NCT01995201|156448660|FG000|From Week 24 Until Week 48|Death|0|||
48615856|NCT01995201|156448661|FG001|From Week 24 Until Week 48|Death|0|||
48615857|NCT01995201|156448662|FG002|From Week 24 Until Week 48|Death|0|||
48615858|NCT01995201|156448663|FG003|From Week 24 Until Week 48|Death|0|||
48557950|NCT01168427|156233860|FG000|Overall Study|Patient exited prior to implant|1|||
48557951|NCT00982657|156233861|FG000|Overall Study|Death|1|||
48557952|NCT00982657|156233862|FG001|Overall Study|Death|0|||
48557953|NCT00982657|156233863|FG002|Overall Study|Death|1|||
48557954|NCT00982657|156233864|FG003|Overall Study|Death|1|||
48557955|NCT00982657|156233861|FG000|Overall Study|Withdrawal by Subject|0|||
48615859|NCT01995201|156448664|FG004|From Week 24 Until Week 48|Death|0|||
48615860|NCT01995201|156448665|FG005|From Week 24 Until Week 48|Death|2|||
48615861|NCT01995201|156448666|FG006|From Week 24 Until Week 48|Death|0|||
48557956|NCT00982657|156233862|FG001|Overall Study|Withdrawal by Subject|0|||
48557957|NCT00982657|156233863|FG002|Overall Study|Withdrawal by Subject|1|||
48615862|NCT01995201|156448660|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
48615863|NCT01995201|156448661|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
48615864|NCT01995201|156448662|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
48615865|NCT01995201|156448663|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
48615866|NCT01995201|156448664|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
48557958|NCT00982657|156233864|FG003|Overall Study|Withdrawal by Subject|3|||
48557959|NCT00982657|156233861|FG000|Overall Study|Other|0|||
48557960|NCT00982657|156233862|FG001|Overall Study|Other|0|||
48557961|NCT00982657|156233863|FG002|Overall Study|Other|0|||
48557962|NCT00982657|156233864|FG003|Overall Study|Other|4|||
48557963|NCT00982657|156233861|FG000|Overall Study|On going at date of cut-off|0|||
48557964|NCT00982657|156233862|FG001|Overall Study|On going at date of cut-off|0|||
48557965|NCT00982657|156233863|FG002|Overall Study|On going at date of cut-off|0|||
48615867|NCT01995201|156448665|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
48615868|NCT01995201|156448666|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
48615869|NCT01995201|156448660|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
48615870|NCT01995201|156448661|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
48615871|NCT01995201|156448662|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
48615872|NCT01995201|156448663|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
48615873|NCT01995201|156448664|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
48615874|NCT01995201|156448665|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
48615875|NCT01995201|156448666|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
48615876|NCT01995201|156448660|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
48615877|NCT01995201|156448661|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
48615878|NCT01995201|156448662|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
48557966|NCT00982657|156233864|FG003|Overall Study|On going at date of cut-off|1|||
48557967|NCT01891864|156233866|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
48557968|NCT01891864|156233867|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
48557969|NCT01891864|156233868|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
48557970|NCT01891864|156233869|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
48557971|NCT01891864|156233870|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
48557972|NCT01891864|156233871|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
48557973|NCT01891864|156233866|FG000|Treatment Period 1|Physician Decision|0|||
48557974|NCT01891864|156233867|FG001|Treatment Period 1|Physician Decision|1|||
48557975|NCT01891864|156233868|FG002|Treatment Period 1|Physician Decision|0|||
48557976|NCT01891864|156233869|FG003|Treatment Period 1|Physician Decision|0|||
48557977|NCT01891864|156233870|FG004|Treatment Period 1|Physician Decision|0|||
48557978|NCT01891864|156233871|FG005|Treatment Period 1|Physician Decision|0|||
48557979|NCT01891864|156233866|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
48557980|NCT01891864|156233867|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
48557981|NCT01891864|156233868|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
48557982|NCT01891864|156233869|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
48557983|NCT01891864|156233870|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
48615879|NCT01995201|156448663|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
48615880|NCT01995201|156448664|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
48615881|NCT01995201|156448665|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
48615882|NCT01995201|156448666|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
48615883|NCT01995201|156448660|FG000|From Week 24 Until Week 48|Physician Decision|0|||
48615884|NCT01995201|156448661|FG001|From Week 24 Until Week 48|Physician Decision|0|||
48615885|NCT01995201|156448662|FG002|From Week 24 Until Week 48|Physician Decision|0|||
48615886|NCT01995201|156448663|FG003|From Week 24 Until Week 48|Physician Decision|0|||
48557984|NCT01891864|156233871|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
48615887|NCT01995201|156448664|FG004|From Week 24 Until Week 48|Physician Decision|1|||
48615888|NCT01995201|156448665|FG005|From Week 24 Until Week 48|Physician Decision|0|||
48615889|NCT01995201|156448666|FG006|From Week 24 Until Week 48|Physician Decision|0|||
48615890|NCT01995201|156448660|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
48557985|NCT01891864|156233866|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
48557986|NCT01891864|156233867|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
48557987|NCT01891864|156233868|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
48557988|NCT01891864|156233869|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
48615891|NCT01995201|156448661|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
48615892|NCT01995201|156448662|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
48557989|NCT01891864|156233870|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
48557990|NCT01891864|156233871|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
48557991|NCT01891864|156233866|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48557992|NCT01891864|156233867|FG001|Treatment Period 1|Withdrawal by Subject|5|||
48557993|NCT01891864|156233868|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48557994|NCT01891864|156233869|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48557995|NCT01891864|156233870|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48557996|NCT01891864|156233871|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48557997|NCT01891864|156233866|FG000|Treatment Period 1|Lost to Follow-up|1|||
48557998|NCT01891864|156233867|FG001|Treatment Period 1|Lost to Follow-up|0|||
48557999|NCT01891864|156233868|FG002|Treatment Period 1|Lost to Follow-up|0|||
48558000|NCT01891864|156233869|FG003|Treatment Period 1|Lost to Follow-up|0|||
48558001|NCT01891864|156233870|FG004|Treatment Period 1|Lost to Follow-up|0|||
48558002|NCT01891864|156233871|FG005|Treatment Period 1|Lost to Follow-up|0|||
48615893|NCT01995201|156448663|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
48615894|NCT01995201|156448664|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
48615895|NCT01995201|156448665|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
48615896|NCT01995201|156448666|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
48615897|NCT01104766|156448668|FG000|Overall Study|Did not meet inc/exc criteria|1|||
48615898|NCT01104766|156448669|FG001|Overall Study|Did not meet inc/exc criteria|0|||
48615899|NCT01104766|156448670|FG002|Overall Study|Did not meet inc/exc criteria|0|||
48615900|NCT01104766|156448671|FG003|Overall Study|Did not meet inc/exc criteria|0|||
48558003|NCT01891864|156233866|FG000|Treatment Period 2|Protocol Violation|0|||
48615901|NCT01104766|156448668|FG000|Overall Study|Adverse Event|17|||
48615902|NCT01104766|156448669|FG001|Overall Study|Adverse Event|15|||
48615903|NCT01104766|156448670|FG002|Overall Study|Adverse Event|20|||
48615904|NCT01104766|156448671|FG003|Overall Study|Adverse Event|14|||
48615905|NCT01104766|156448668|FG000|Overall Study|Lack of Efficacy|20|||
48558004|NCT01891864|156233867|FG001|Treatment Period 2|Protocol Violation|0|||
48615906|NCT01104766|156448669|FG001|Overall Study|Lack of Efficacy|15|||
48615907|NCT01104766|156448670|FG002|Overall Study|Lack of Efficacy|14|||
48558005|NCT01891864|156233868|FG002|Treatment Period 2|Protocol Violation|0|||
48558006|NCT01891864|156233869|FG003|Treatment Period 2|Protocol Violation|1|||
48558007|NCT01891864|156233870|FG004|Treatment Period 2|Protocol Violation|0|||
48615908|NCT01104766|156448671|FG003|Overall Study|Lack of Efficacy|8|||
48615909|NCT01104766|156448668|FG000|Overall Study|Protocol Violation|2|||
48558008|NCT01891864|156233871|FG005|Treatment Period 2|Protocol Violation|0|||
48558009|NCT01891864|156233866|FG000|Treatment Period 2|Physician Decision|0|||
48558010|NCT01891864|156233867|FG001|Treatment Period 2|Physician Decision|0|||
48558011|NCT01891864|156233868|FG002|Treatment Period 2|Physician Decision|1|||
48558012|NCT01891864|156233869|FG003|Treatment Period 2|Physician Decision|0|||
48558013|NCT01891864|156233870|FG004|Treatment Period 2|Physician Decision|0|||
48558014|NCT01891864|156233871|FG005|Treatment Period 2|Physician Decision|0|||
48558015|NCT01891864|156233866|FG000|Treatment Period 2|Site Termination|0|||
48558016|NCT01891864|156233867|FG001|Treatment Period 2|Site Termination|0|||
48558017|NCT01891864|156233868|FG002|Treatment Period 2|Site Termination|1|||
48558018|NCT01891864|156233869|FG003|Treatment Period 2|Site Termination|2|||
48558019|NCT01891864|156233870|FG004|Treatment Period 2|Site Termination|0|||
48558020|NCT01891864|156233871|FG005|Treatment Period 2|Site Termination|0|||
48558021|NCT01891864|156233866|FG000|Treatment Period 2|Lack of Efficacy|0|||
48558022|NCT01891864|156233867|FG001|Treatment Period 2|Lack of Efficacy|0|||
48558023|NCT01891864|156233868|FG002|Treatment Period 2|Lack of Efficacy|1|||
48558024|NCT01891864|156233869|FG003|Treatment Period 2|Lack of Efficacy|0|||
48558025|NCT01891864|156233870|FG004|Treatment Period 2|Lack of Efficacy|1|||
48558026|NCT01891864|156233871|FG005|Treatment Period 2|Lack of Efficacy|0|||
48558027|NCT01891864|156233866|FG000|Treatment Period 2|Adverse Event|0|||
48558028|NCT01891864|156233867|FG001|Treatment Period 2|Adverse Event|0|||
48558029|NCT01891864|156233868|FG002|Treatment Period 2|Adverse Event|1|||
48558030|NCT01891864|156233869|FG003|Treatment Period 2|Adverse Event|2|||
48558031|NCT01891864|156233870|FG004|Treatment Period 2|Adverse Event|0|||
48558032|NCT01891864|156233871|FG005|Treatment Period 2|Adverse Event|4|||
48558033|NCT01891864|156233866|FG000|Treatment Period 2|Termination of Site|0|||
48558034|NCT01891864|156233867|FG001|Treatment Period 2|Termination of Site|0|||
48558035|NCT01891864|156233868|FG002|Treatment Period 2|Termination of Site|0|||
48558036|NCT01891864|156233869|FG003|Treatment Period 2|Termination of Site|0|||
48558037|NCT01891864|156233870|FG004|Treatment Period 2|Termination of Site|2|||
48558038|NCT01891864|156233871|FG005|Treatment Period 2|Termination of Site|0|||
48558039|NCT01891864|156233866|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48558040|NCT01891864|156233867|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48558041|NCT01891864|156233868|FG002|Treatment Period 2|Withdrawal by Subject|3|||
48558042|NCT01891864|156233869|FG003|Treatment Period 2|Withdrawal by Subject|4|||
48558043|NCT01891864|156233870|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48558044|NCT01891864|156233871|FG005|Treatment Period 2|Withdrawal by Subject|1|||
48615910|NCT01104766|156448669|FG001|Overall Study|Protocol Violation|0|||
48615911|NCT01104766|156448670|FG002|Overall Study|Protocol Violation|0|||
48615912|NCT01104766|156448671|FG003|Overall Study|Protocol Violation|0|||
48615913|NCT01104766|156448668|FG000|Overall Study|Withdrawal by Subject|17|||
48615914|NCT01104766|156448669|FG001|Overall Study|Withdrawal by Subject|19|||
48615915|NCT01104766|156448670|FG002|Overall Study|Withdrawal by Subject|25|||
48615916|NCT01104766|156448671|FG003|Overall Study|Withdrawal by Subject|15|||
48615917|NCT01104766|156448668|FG000|Overall Study|Lost to Follow-up|1|||
48615918|NCT01104766|156448669|FG001|Overall Study|Lost to Follow-up|2|||
48615919|NCT01104766|156448670|FG002|Overall Study|Lost to Follow-up|1|||
48615920|NCT01104766|156448671|FG003|Overall Study|Lost to Follow-up|1|||
48615921|NCT01341470|156448672|FG000|Overall Study|Sponsor decision|0|||
48615922|NCT01341470|156448673|FG001|Overall Study|Sponsor decision|0|||
48615923|NCT01341470|156448674|FG002|Overall Study|Sponsor decision|1|||
48615924|NCT01341470|156448675|FG003|Overall Study|Sponsor decision|1|||
48615925|NCT01341470|156448676|FG004|Overall Study|Sponsor decision|0|||
48615926|NCT01341470|156448677|FG005|Overall Study|Sponsor decision|1|||
48558045|NCT01891864|156233866|FG000|Extension Period|Lack of Efficacy|0|||
48558046|NCT01891864|156233867|FG001|Extension Period|Lack of Efficacy|0|||
48615927|NCT00997126|156448679|FG000|Overall Study|Physician Decision|7|||
48558047|NCT01891864|156233868|FG002|Extension Period|Lack of Efficacy|0|||
48558048|NCT01891864|156233869|FG003|Extension Period|Lack of Efficacy|1|||
48558049|NCT01891864|156233870|FG004|Extension Period|Lack of Efficacy|1|||
48558050|NCT01891864|156233871|FG005|Extension Period|Lack of Efficacy|0|||
48558051|NCT01891864|156233866|FG000|Extension Period|Pregnancy|0|||
48558052|NCT01891864|156233867|FG001|Extension Period|Pregnancy|0|||
48558053|NCT01891864|156233868|FG002|Extension Period|Pregnancy|1|||
48558054|NCT01891864|156233869|FG003|Extension Period|Pregnancy|0|||
48558055|NCT01891864|156233870|FG004|Extension Period|Pregnancy|0|||
48558056|NCT01891864|156233871|FG005|Extension Period|Pregnancy|0|||
48558057|NCT01891864|156233866|FG000|Extension Period|Adverse Event|0|||
48558058|NCT01891864|156233867|FG001|Extension Period|Adverse Event|0|||
48558059|NCT01891864|156233868|FG002|Extension Period|Adverse Event|4|||
48615928|NCT00997126|156448680|FG001|Overall Study|Physician Decision|11|||
48615929|NCT00303628|156448682|FG000|Overall Study|Disease progression|0|||
48615930|NCT00303628|156448683|FG001|Overall Study|Disease progression|1|||
48615931|NCT00303628|156448682|FG000|Overall Study|Adverse Event|26|||
48615932|NCT00303628|156448683|FG001|Overall Study|Adverse Event|36|||
48558060|NCT01891864|156233869|FG003|Extension Period|Adverse Event|2|||
48558061|NCT01891864|156233870|FG004|Extension Period|Adverse Event|2|||
48558062|NCT01891864|156233871|FG005|Extension Period|Adverse Event|0|||
48558063|NCT01891864|156233866|FG000|Extension Period|Withdrawal by Subject|0|||
48558064|NCT01891864|156233867|FG001|Extension Period|Withdrawal by Subject|0|||
48558065|NCT01891864|156233868|FG002|Extension Period|Withdrawal by Subject|1|||
48558066|NCT01891864|156233869|FG003|Extension Period|Withdrawal by Subject|2|||
48558067|NCT01891864|156233870|FG004|Extension Period|Withdrawal by Subject|4|||
48558068|NCT01891864|156233871|FG005|Extension Period|Withdrawal by Subject|0|||
48558069|NCT01891864|156233866|FG000|Extension Period|Lost to Follow-up|0|||
48558070|NCT01891864|156233867|FG001|Extension Period|Lost to Follow-up|0|||
48558071|NCT01891864|156233868|FG002|Extension Period|Lost to Follow-up|2|||
48558072|NCT01891864|156233869|FG003|Extension Period|Lost to Follow-up|0|||
48558073|NCT01891864|156233870|FG004|Extension Period|Lost to Follow-up|0|||
48558074|NCT01891864|156233871|FG005|Extension Period|Lost to Follow-up|0|||
48558075|NCT01564537|156235491|FG000|Overall Study|Site Terminated by Sponsor|1|||
48558076|NCT01564537|156235492|FG001|Overall Study|Site Terminated by Sponsor|0|||
48558077|NCT01564537|156235491|FG000|Overall Study|Withdrawal by Subject|12|||
48558078|NCT01564537|156235492|FG001|Overall Study|Withdrawal by Subject|14|||
48558079|NCT01564537|156235491|FG000|Overall Study|Lost to Follow-up|7|||
48558080|NCT01564537|156235492|FG001|Overall Study|Lost to Follow-up|3|||
48615933|NCT00303628|156448682|FG000|Overall Study|Death|0|||
48615934|NCT00303628|156448683|FG001|Overall Study|Death|1|||
48558081|NCT01564537|156235491|FG000|Overall Study|Reason not specified|81|||
48558082|NCT01564537|156235492|FG001|Overall Study|Reason not specified|82|||
48558083|NCT02077140|156235494|FG000|Overall Study|Lost to Follow-up|4|||
48558084|NCT02077140|156235495|FG001|Overall Study|Lost to Follow-up|1|||
48558085|NCT02077140|156235496|FG002|Overall Study|Lost to Follow-up|2|||
48558086|NCT02077140|156235497|FG003|Overall Study|Lost to Follow-up|2|||
48558087|NCT02077140|156235498|FG004|Overall Study|Lost to Follow-up|3|||
48558088|NCT02077140|156235494|FG000|Overall Study|Withdrawal by Subject|0|||
48558089|NCT02077140|156235495|FG001|Overall Study|Withdrawal by Subject|1|||
48558090|NCT02077140|156235496|FG002|Overall Study|Withdrawal by Subject|0|||
48558091|NCT02077140|156235497|FG003|Overall Study|Withdrawal by Subject|2|||
48558092|NCT02077140|156235498|FG004|Overall Study|Withdrawal by Subject|2|||
48558093|NCT00887289|156235499|FG000|Overall Study|Lack of Efficacy|14|||
48558094|NCT00887289|156235499|FG000|Overall Study|Adverse Event|27|||
48558095|NCT00887289|156235499|FG000|Overall Study|Withdrawal by Subject|26|||
48615935|NCT00303628|156448682|FG000|Overall Study|Withdrawal by Subject|11|||
48615936|NCT00303628|156448683|FG001|Overall Study|Withdrawal by Subject|20|||
48615937|NCT00303628|156448682|FG000|Overall Study|Alternative therapy|2|||
48615938|NCT00303628|156448683|FG001|Overall Study|Alternative therapy|0|||
48615939|NCT00303628|156448682|FG000|Overall Study|Other complicating disease|0|||
48615940|NCT00303628|156448683|FG001|Overall Study|Other complicating disease|1|||
48615941|NCT00303628|156448682|FG000|Overall Study|Not start protocol therapy|3|||
48558096|NCT00887289|156235499|FG000|Overall Study|Lost to Follow-up|8|||
48615942|NCT00303628|156448683|FG001|Overall Study|Not start protocol therapy|5|||
48558097|NCT00887289|156235499|FG000|Overall Study|Other|20|||
48558098|NCT00591773|156235502|FG000|Overall Study|Adverse Event|9|||
48558099|NCT00591773|156235503|FG001|Overall Study|Adverse Event|9|||
48558100|NCT00591773|156235504|FG002|Overall Study|Adverse Event|6|||
48558101|NCT00591773|156235502|FG000|Overall Study|Protocol Violation|2|||
48558102|NCT00591773|156235503|FG001|Overall Study|Protocol Violation|3|||
48558103|NCT00591773|156235504|FG002|Overall Study|Protocol Violation|0|||
48615943|NCT00303628|156448682|FG000|Overall Study|Other|8|||
48615944|NCT00303628|156448683|FG001|Overall Study|Other|9|||
48558104|NCT00591773|156235502|FG000|Overall Study|Lost to Follow-up|1|||
48558105|NCT00591773|156235503|FG001|Overall Study|Lost to Follow-up|4|||
48558106|NCT00591773|156235504|FG002|Overall Study|Lost to Follow-up|1|||
48558107|NCT00591773|156235502|FG000|Overall Study|Withdrawal by Subject|2|||
48558108|NCT00591773|156235503|FG001|Overall Study|Withdrawal by Subject|5|||
48558109|NCT00591773|156235504|FG002|Overall Study|Withdrawal by Subject|3|||
48615945|NCT00005047|156448693|FG000|Overall Study|Withdrawal by Subject|12|||
48615946|NCT00005047|156448694|FG001|Overall Study|Withdrawal by Subject|0|||
48615947|NCT00005047|156448695|FG002|Overall Study|Withdrawal by Subject|0|||
48615948|NCT00005047|156448696|FG003|Overall Study|Withdrawal by Subject|0|||
48558110|NCT00591773|156235502|FG000|Overall Study|Lack of Efficacy|1|||
48558111|NCT00591773|156235503|FG001|Overall Study|Lack of Efficacy|2|||
48558112|NCT00591773|156235504|FG002|Overall Study|Lack of Efficacy|2|||
48558113|NCT00591773|156235502|FG000|Overall Study|Other|1|||
48558114|NCT00591773|156235503|FG001|Overall Study|Other|1|||
48558115|NCT00591773|156235504|FG002|Overall Study|Other|4|||
48558116|NCT00459355|156235505|FG000|Overall Study|Subject no longer met inc criteria|20|||
48558117|NCT00459355|156235506|FG001|Overall Study|Subject no longer met inc criteria|18|||
48558118|NCT03022084|156235517|FG000|Overall Study|Lost to Follow-up|2|||
48558119|NCT03022084|156235518|FG001|Overall Study|Lost to Follow-up|3|||
48558120|NCT01026194|156235519|FG000|Period 1：Double Blind Period|Adverse Event|2|||
48558121|NCT01026194|156235520|FG001|Period 1：Double Blind Period|Adverse Event|1|||
48558122|NCT01026194|156235519|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
48558123|NCT01026194|156235520|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
48558124|NCT01026194|156235519|FG000|Period 1：Double Blind Period|Physician Decision|0|||
48615949|NCT00005047|156448693|FG000|Overall Study|Adverse Event|5|||
48615950|NCT00005047|156448694|FG001|Overall Study|Adverse Event|0|||
48615951|NCT00005047|156448695|FG002|Overall Study|Adverse Event|0|||
48615952|NCT00005047|156448696|FG003|Overall Study|Adverse Event|0|||
48615953|NCT00005047|156448693|FG000|Overall Study|Lost to Follow-up|1|||
48615954|NCT00005047|156448694|FG001|Overall Study|Lost to Follow-up|0|||
48615955|NCT00005047|156448695|FG002|Overall Study|Lost to Follow-up|0|||
48615956|NCT00005047|156448696|FG003|Overall Study|Lost to Follow-up|0|||
48615957|NCT00005047|156448693|FG000|Overall Study|Lack of Efficacy|1|||
48615958|NCT00005047|156448694|FG001|Overall Study|Lack of Efficacy|0|||
48615959|NCT00005047|156448695|FG002|Overall Study|Lack of Efficacy|0|||
48615960|NCT00005047|156448696|FG003|Overall Study|Lack of Efficacy|0|||
48615961|NCT00303953|156448697|FG000|Overall Study|Ineligible|1|||
48615962|NCT00303953|156448697|FG000|Overall Study|Death|1|||
48615963|NCT00303953|156448697|FG000|Overall Study|Adverse Event|4|||
48615964|NCT00303953|156448697|FG000|Overall Study|Lack of Efficacy|12|||
48615965|NCT00303953|156448697|FG000|Overall Study|Physician Decision|1|||
48615966|NCT00021255|156448698|FG000|Overall Study|Death|1|||
48615967|NCT00021255|156448699|FG001|Overall Study|Death|0|||
48615968|NCT00021255|156448700|FG002|Overall Study|Death|2|||
48615969|NCT00021255|156448698|FG000|Overall Study|Breast cancer relapse|5|||
48615970|NCT00021255|156448699|FG001|Overall Study|Breast cancer relapse|18|||
48615971|NCT00021255|156448700|FG002|Overall Study|Breast cancer relapse|11|||
48615972|NCT00021255|156448698|FG000|Overall Study|Second primary malignancy|0|||
48615973|NCT00021255|156448699|FG001|Overall Study|Second primary malignancy|4|||
48615974|NCT00021255|156448700|FG002|Overall Study|Second primary malignancy|1|||
48615975|NCT00021255|156448698|FG000|Overall Study|Withdrawal by Subject|41|||
48615976|NCT00021255|156448699|FG001|Overall Study|Withdrawal by Subject|64|||
48615977|NCT00021255|156448700|FG002|Overall Study|Withdrawal by Subject|26|||
48615978|NCT00021255|156448698|FG000|Overall Study|Lost to Follow-up|0|||
48615979|NCT00021255|156448699|FG001|Overall Study|Lost to Follow-up|2|||
48615980|NCT00021255|156448700|FG002|Overall Study|Lost to Follow-up|3|||
48558125|NCT01026194|156235520|FG001|Period 1：Double Blind Period|Physician Decision|4|||
48558126|NCT01026194|156235519|FG000|Period 2：Open-label Period|Adverse Event|4|||
48558127|NCT01026194|156235520|FG001|Period 2：Open-label Period|Adverse Event|5|||
48615981|NCT00021255|156448698|FG000|Overall Study|Cardiac toxicity|0|||
48615982|NCT00021255|156448699|FG001|Overall Study|Cardiac toxicity|61|||
48615983|NCT00021255|156448700|FG002|Overall Study|Cardiac toxicity|32|||
48615984|NCT00021255|156448698|FG000|Overall Study|Herceptin toxicity|0|||
48615985|NCT00021255|156448699|FG001|Overall Study|Herceptin toxicity|22|||
48558128|NCT01026194|156235519|FG000|Period 2：Open-label Period|Physician Decision|3|||
48615986|NCT00021255|156448700|FG002|Overall Study|Herceptin toxicity|6|||
48615987|NCT00021255|156448698|FG000|Overall Study|Adverse Event|46|||
48615988|NCT00021255|156448699|FG001|Overall Study|Adverse Event|30|||
48615989|NCT00021255|156448700|FG002|Overall Study|Adverse Event|18|||
48558129|NCT01026194|156235520|FG001|Period 2：Open-label Period|Physician Decision|1|||
48558130|NCT01026194|156235519|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
48558131|NCT01026194|156235520|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
48558132|NCT01866826|156235521|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
48615990|NCT00021255|156448698|FG000|Overall Study|Protocol Violation|0|||
48615991|NCT00021255|156448699|FG001|Overall Study|Protocol Violation|2|||
48615992|NCT00021255|156448700|FG002|Overall Study|Protocol Violation|0|||
48615993|NCT00021255|156448698|FG000|Overall Study|Other than specified above|0|||
48615994|NCT00021255|156448699|FG001|Overall Study|Other than specified above|38|||
48615995|NCT00021255|156448700|FG002|Overall Study|Other than specified above|19|||
48558133|NCT01866826|156235522|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
48558134|NCT01866826|156235521|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
48558135|NCT01866826|156235522|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
48615996|NCT00021255|156448698|FG000|Overall Study|Missing|0|||
48615997|NCT00021255|156448699|FG001|Overall Study|Missing|27|||
48615998|NCT00021255|156448700|FG002|Overall Study|Missing|13|||
48615999|NCT00021255|156448698|FG000|Overall Study|Randomized but not treated|28|||
48616000|NCT00021255|156448699|FG001|Overall Study|Randomized but not treated|2|||
48616001|NCT00021255|156448700|FG002|Overall Study|Randomized but not treated|18|||
48616002|NCT03370302|156448704|FG000|Dose Escalation Phase|Other|0|||
48616003|NCT03370302|156448705|FG001|Dose Escalation Phase|Other|1|||
48616004|NCT03370302|156448706|FG002|Dose Escalation Phase|Other|1|||
48616005|NCT03370302|156448707|FG003|Dose Escalation Phase|Other|0|||
48616006|NCT03370302|156448708|FG004|Dose Escalation Phase|Other|0|||
48616007|NCT03370302|156448709|FG005|Dose Escalation Phase|Other|0|||
48616008|NCT03370302|156448704|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48616009|NCT03370302|156448705|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
48616010|NCT03370302|156448706|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
48616011|NCT03370302|156448707|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48616012|NCT03370302|156448708|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
48616013|NCT03370302|156448709|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
48616014|NCT03370302|156448704|FG000|Dose Escalation Phase|Adverse Event|1|||
48616015|NCT03370302|156448705|FG001|Dose Escalation Phase|Adverse Event|0|||
48616016|NCT03370302|156448706|FG002|Dose Escalation Phase|Adverse Event|2|||
48558136|NCT01866826|156235521|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
48558137|NCT01866826|156235522|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
48558138|NCT02493660|156235523|FG000|Overall Study|Physician Decision|0|||
48616017|NCT03370302|156448707|FG003|Dose Escalation Phase|Adverse Event|0|||
48616018|NCT03370302|156448708|FG004|Dose Escalation Phase|Adverse Event|0|||
48558139|NCT02493660|156235524|FG001|Overall Study|Physician Decision|1|||
48616019|NCT03370302|156448709|FG005|Dose Escalation Phase|Adverse Event|0|||
48616020|NCT03370302|156448704|FG000|Dose Escalation Phase|Progressive Disease|2|||
48616021|NCT03370302|156448705|FG001|Dose Escalation Phase|Progressive Disease|4|||
48616022|NCT03370302|156448706|FG002|Dose Escalation Phase|Progressive Disease|2|||
48616023|NCT03370302|156448707|FG003|Dose Escalation Phase|Progressive Disease|0|||
48616024|NCT03370302|156448708|FG004|Dose Escalation Phase|Progressive Disease|3|||
48616025|NCT03370302|156448709|FG005|Dose Escalation Phase|Progressive Disease|1|||
48616026|NCT03370302|156448704|FG000|Dose Expansion Phase|Progressive Disease|0|||
48616027|NCT03370302|156448705|FG001|Dose Expansion Phase|Progressive Disease|0|||
48616028|NCT03370302|156448706|FG002|Dose Expansion Phase|Progressive Disease|0|||
48616029|NCT03370302|156448707|FG003|Dose Expansion Phase|Progressive Disease|6|||
48616030|NCT03370302|156448708|FG004|Dose Expansion Phase|Progressive Disease|0|||
48558140|NCT02493660|156235523|FG000|Overall Study|Adverse Event|4|||
48558141|NCT02493660|156235524|FG001|Overall Study|Adverse Event|2|||
48558142|NCT02493660|156235523|FG000|Overall Study|Withdrawal by Subject|2|||
48558143|NCT02493660|156235524|FG001|Overall Study|Withdrawal by Subject|3|||
48558144|NCT02493660|156235523|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
48558145|NCT02493660|156235524|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
48558146|NCT02493660|156235523|FG000|Overall Study|Protocol Violation|0|||
48558147|NCT02493660|156235524|FG001|Overall Study|Protocol Violation|1|||
48558148|NCT02493660|156235523|FG000|Overall Study|Death|0|||
48558149|NCT02493660|156235524|FG001|Overall Study|Death|1|||
48558150|NCT02493660|156235523|FG000|Overall Study|Lost to Follow-up|2|||
48558151|NCT02493660|156235524|FG001|Overall Study|Lost to Follow-up|4|||
48558152|NCT00709995|156235525|FG000|Overall Study|Adverse Event|4|||
48558153|NCT00709995|156235526|FG001|Overall Study|Adverse Event|2|||
48558154|NCT00709995|156235525|FG000|Overall Study|Withdrawal by Subject|1|||
48558155|NCT00709995|156235526|FG001|Overall Study|Withdrawal by Subject|3|||
48558156|NCT01276041|156235527|FG000|Overall Study|Adverse Event|2|||
48558157|NCT01276041|156235527|FG000|Overall Study|Protocol Violation|1|||
48558158|NCT02070965|156235530|FG000|Overall Study|Lost to Follow-up|0|||
48558159|NCT02070965|156235531|FG001|Overall Study|Lost to Follow-up|1|||
48558160|NCT02070965|156235532|FG002|Overall Study|Lost to Follow-up|0|||
48558161|NCT02070965|156235530|FG000|Overall Study|Withdrawal by Subject|1|||
48558162|NCT02070965|156235531|FG001|Overall Study|Withdrawal by Subject|1|||
48558163|NCT02070965|156235532|FG002|Overall Study|Withdrawal by Subject|1|||
48558164|NCT02070965|156235530|FG000|Overall Study|Subject moved|1|||
48558165|NCT02070965|156235531|FG001|Overall Study|Subject moved|0|||
48558166|NCT02070965|156235532|FG002|Overall Study|Subject moved|0|||
48558167|NCT00560391|156235533|FG000|Overall Study|Still on treatment|0|||
48558168|NCT00560391|156235534|FG001|Overall Study|Still on treatment|0|||
48558169|NCT00560391|156235535|FG002|Overall Study|Still on treatment|0|||
48558170|NCT00560391|156235536|FG003|Overall Study|Still on treatment|1|||
48558171|NCT00560391|156235537|FG004|Overall Study|Still on treatment|2|||
48558172|NCT04447040|156235538|FG000|Overall Study|Lost to Follow-up|2|||
48558173|NCT04447040|156235539|FG001|Overall Study|Lost to Follow-up|1|||
48558174|NCT04447040|156235540|FG002|Overall Study|Lost to Follow-up|3|||
48558175|NCT04447040|156235541|FG003|Overall Study|Lost to Follow-up|3|||
48558176|NCT04447040|156235542|FG004|Overall Study|Lost to Follow-up|1|||
48558177|NCT04447040|156235543|FG005|Overall Study|Lost to Follow-up|3|||
48558178|NCT04447040|156235538|FG000|Overall Study|Withdrawal by Subject|0|||
48558179|NCT04447040|156235539|FG001|Overall Study|Withdrawal by Subject|1|||
48558180|NCT04447040|156235540|FG002|Overall Study|Withdrawal by Subject|1|||
48558181|NCT04447040|156235541|FG003|Overall Study|Withdrawal by Subject|1|||
48558182|NCT04447040|156235542|FG004|Overall Study|Withdrawal by Subject|0|||
48558183|NCT04447040|156235543|FG005|Overall Study|Withdrawal by Subject|0|||
48558184|NCT00838526|156235544|FG000|Overall Study|Adverse Event|3|||
48558185|NCT00838526|156235545|FG001|Overall Study|Adverse Event|12|||
48558186|NCT00838526|156235544|FG000|Overall Study|Lost to Follow-up|4|||
48558187|NCT00838526|156235545|FG001|Overall Study|Lost to Follow-up|12|||
48558188|NCT00838526|156235544|FG000|Overall Study|Withdrawal by Subject|4|||
48558189|NCT00838526|156235545|FG001|Overall Study|Withdrawal by Subject|5|||
48558190|NCT00838526|156235544|FG000|Overall Study|Lack of Efficacy|2|||
48558191|NCT00838526|156235545|FG001|Overall Study|Lack of Efficacy|3|||
48558192|NCT00838526|156235544|FG000|Overall Study|Other|11|||
48558193|NCT00838526|156235545|FG001|Overall Study|Other|7|||
48558194|NCT01526057|156235548|FG000|Overall Study|Withdrawal by Subject|3|||
48558195|NCT01526057|156235549|FG001|Overall Study|Withdrawal by Subject|2|||
48558196|NCT01526057|156235550|FG002|Overall Study|Withdrawal by Subject|2|||
48558197|NCT01526057|156235548|FG000|Overall Study|Adverse Event|3|||
48558198|NCT01526057|156235549|FG001|Overall Study|Adverse Event|1|||
48558199|NCT01526057|156235550|FG002|Overall Study|Adverse Event|1|||
48558200|NCT01526057|156235548|FG000|Overall Study|Death|1|||
48558201|NCT01526057|156235549|FG001|Overall Study|Death|0|||
48558202|NCT01526057|156235550|FG002|Overall Study|Death|0|||
48558203|NCT01526057|156235548|FG000|Overall Study|Lost to Follow-up|1|||
48558204|NCT01526057|156235549|FG001|Overall Study|Lost to Follow-up|0|||
48558205|NCT01526057|156235550|FG002|Overall Study|Lost to Follow-up|1|||
48558206|NCT01526057|156235548|FG000|Overall Study|Other|1|||
48558207|NCT01526057|156235549|FG001|Overall Study|Other|0|||
48616031|NCT03370302|156448709|FG005|Dose Expansion Phase|Progressive Disease|0|||
48616032|NCT00118287|156448710|FG000|Overall Study|Intracranial haemorrhage|1|||
48616033|NCT00118287|156448710|FG000|Overall Study|Muscle pain|1|||
48616034|NCT02530242|156448712|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
48616035|NCT02530242|156448713|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
48616036|NCT01727154|156448715|FG000|Overall Study|Death|17|||
48616037|NCT01727154|156448715|FG000|Overall Study|Withdrawal by Subject|14|||
48616038|NCT01727154|156448715|FG000|Overall Study|Subject Withdrew Consent|18|||
48616039|NCT01727154|156448715|FG000|Overall Study|Study Terminated|6|||
48616040|NCT01727154|156448715|FG000|Overall Study|No Discontinuation Documentation|4|||
48616041|NCT01407367|156448717|FG000|Overall Study|Death|24|||
48616042|NCT01407367|156448718|FG001|Overall Study|Death|32|||
48616043|NCT01407367|156448717|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
48616044|NCT01407367|156448718|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
48616045|NCT01407367|156448717|FG000|Overall Study|Withdrawal by Subject|4|||
48616046|NCT01407367|156448718|FG001|Overall Study|Withdrawal by Subject|15|||
48616047|NCT01407367|156448717|FG000|Overall Study|Lost to Follow-up|0|||
48616048|NCT01407367|156448718|FG001|Overall Study|Lost to Follow-up|2|||
48616049|NCT04333498|156450518|FG000|Overall Study|Lost to Follow-up|1|||
48616050|NCT04333498|156450519|FG001|Overall Study|Lost to Follow-up|0|||
48616051|NCT04333498|156450518|FG000|Overall Study|Lost to Follow-up|0|||
48616052|NCT04333498|156450519|FG001|Overall Study|Lost to Follow-up|1|||
48616053|NCT00143507|156450521|FG000|Overall Study|Death|572|||
48616054|NCT00143507|156450522|FG001|Overall Study|Death|547|||
48616055|NCT00143507|156450521|FG000|Overall Study|Withdrawal by Subject|114|||
48616056|NCT00143507|156450522|FG001|Overall Study|Withdrawal by Subject|102|||
48616057|NCT00143507|156450521|FG000|Overall Study|Lost to Follow-up|1|||
48616058|NCT00143507|156450522|FG001|Overall Study|Lost to Follow-up|0|||
48616059|NCT00143507|156450521|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
48616060|NCT00143507|156450522|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
48616061|NCT00484159|156450523|FG000|Overall Study|Lost to Follow-up|1|||
48616062|NCT00484159|156450524|FG001|Overall Study|Lost to Follow-up|1|||
48616063|NCT00484159|156450525|FG002|Overall Study|Lost to Follow-up|0|||
48616064|NCT00177671|156450526|FG000|Overall Study|Withdrawal by Subject|5|||
48616065|NCT00177671|156450527|FG001|Overall Study|Withdrawal by Subject|6|||
48616066|NCT00177671|156450526|FG000|Overall Study|medical complications|2|||
48616067|NCT00177671|156450527|FG001|Overall Study|medical complications|0|||
48616068|NCT00177671|156450526|FG000|Overall Study|Adverse Event|6|||
48616069|NCT00177671|156450527|FG001|Overall Study|Adverse Event|0|||
48616070|NCT00177671|156450526|FG000|Overall Study|Physician Decision|12|||
48616071|NCT00177671|156450527|FG001|Overall Study|Physician Decision|8|||
48616072|NCT00327171|156450533|FG000|Overall Study|Did not receive study medication|3|||
48616073|NCT00327171|156450534|FG001|Overall Study|Did not receive study medication|0|||
48616074|NCT00327171|156450533|FG000|Overall Study|Adverse Event|23|||
48616075|NCT00327171|156450534|FG001|Overall Study|Adverse Event|23|||
48616076|NCT00327171|156450533|FG000|Overall Study|Disease progression/lack of efficacy|68|||
48616077|NCT00327171|156450534|FG001|Overall Study|Disease progression/lack of efficacy|69|||
48616078|NCT00327171|156450533|FG000|Overall Study|Investigator/participant request|1|||
48616079|NCT00327171|156450534|FG001|Overall Study|Investigator/participant request|8|||
48616080|NCT00327171|156450533|FG000|Overall Study|Clinical progression|12|||
48616081|NCT00327171|156450534|FG001|Overall Study|Clinical progression|8|||
48616082|NCT00327171|156450533|FG000|Overall Study|Undisclosed history of ischemia|0|||
48616083|NCT00327171|156450534|FG001|Overall Study|Undisclosed history of ischemia|1|||
48616084|NCT00327171|156450533|FG000|Overall Study|Other|1|||
48616085|NCT00327171|156450534|FG001|Overall Study|Other|0|||
48616086|NCT01771913|156450535|FG000|Overall Study|Withdrawal by Subject|1|||
48616087|NCT01771913|156450536|FG001|Overall Study|Withdrawal by Subject|0|||
48616088|NCT01363440|156450537|FG000|Overall Study|Adverse Event|5|||
48616089|NCT01363440|156450538|FG001|Overall Study|Adverse Event|4|||
48616090|NCT01363440|156450539|FG002|Overall Study|Adverse Event|4|||
48616091|NCT01363440|156450537|FG000|Overall Study|Death|3|||
48616092|NCT01363440|156450538|FG001|Overall Study|Death|7|||
48616093|NCT01363440|156450539|FG002|Overall Study|Death|5|||
48616094|NCT01363440|156450537|FG000|Overall Study|Withdrawal by Subject|9|||
48616095|NCT01363440|156450538|FG001|Overall Study|Withdrawal by Subject|11|||
48616096|NCT01363440|156450539|FG002|Overall Study|Withdrawal by Subject|11|||
48616097|NCT01363440|156450537|FG000|Overall Study|Lost to Follow-up|2|||
48616098|NCT01363440|156450538|FG001|Overall Study|Lost to Follow-up|4|||
48616099|NCT01363440|156450539|FG002|Overall Study|Lost to Follow-up|5|||
48616100|NCT01363440|156450537|FG000|Overall Study|Other|4|||
48616101|NCT01363440|156450538|FG001|Overall Study|Other|5|||
48616102|NCT01363440|156450539|FG002|Overall Study|Other|2|||
48616103|NCT03695094|156450540|FG000|Overall Study|Adverse Event|1|||
48616104|NCT03695094|156450541|FG001|Overall Study|Adverse Event|1|||
48616105|NCT03695094|156450540|FG000|Overall Study|Withdrawal by Subject|1|||
48616106|NCT03695094|156450541|FG001|Overall Study|Withdrawal by Subject|0|||
48616107|NCT00266812|156450542|FG000|Overall Study|Disease Progression|9|||
48558208|NCT01526057|156235550|FG002|Overall Study|Other|1|||
48558209|NCT01526057|156235548|FG000|Overall Study|Protocol Violation|0|||
48558210|NCT01526057|156235549|FG001|Overall Study|Protocol Violation|0|||
48558211|NCT01526057|156235550|FG002|Overall Study|Protocol Violation|1|||
48558212|NCT00955617|156235551|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
48558213|NCT00955617|156235552|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
48558214|NCT00955617|156235551|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
48558215|NCT00955617|156235552|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
48558216|NCT00955617|156235551|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
48558217|NCT00955617|156235552|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
48558218|NCT00955617|156235551|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
48558219|NCT00955617|156235552|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
48558220|NCT02115607|156235553|FG000|Overall Study|Withdrawal by Subject|1|||
48558221|NCT00214383|156235554|FG000|Overall Study|Lost to Follow-up|16|||
48558222|NCT00214383|156235555|FG001|Overall Study|Lost to Follow-up|26|||
48558223|NCT00654095|156235556|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
48558224|NCT00654095|156235556|FG000|Overall Study|Elevated triglyceride level (2)|1|||
48558225|NCT00654095|156235556|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
48558226|NCT00654095|156235556|FG000|Overall Study|Adverse Event|11|||
48558227|NCT00654095|156235556|FG000|Overall Study|Withdrawal by Subject|5|||
48558228|NCT00654095|156235556|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
48558229|NCT00654095|156235556|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
48558230|NCT00654095|156235556|FG000|Overall Study|Did not meet inclusion criteria|1|||
48558231|NCT00758524|156235557|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
48558232|NCT00758524|156235558|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
48558233|NCT00758524|156235559|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
48616108|NCT00266812|156450543|FG001|Overall Study|Disease Progression|3|||
48616109|NCT00266812|156450542|FG000|Overall Study|Death|5|||
48558234|NCT00758524|156235560|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48616110|NCT00266812|156450543|FG001|Overall Study|Death|4|||
48558235|NCT00758524|156235561|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
48558236|NCT00758524|156235562|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
48558237|NCT00758524|156235563|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48616111|NCT00266812|156450542|FG000|Overall Study|Adverse Event|3|||
48616112|NCT00266812|156450543|FG001|Overall Study|Adverse Event|1|||
48616113|NCT00266812|156450542|FG000|Overall Study|Protocol Violation|0|||
48616114|NCT00266812|156450543|FG001|Overall Study|Protocol Violation|1|||
48616115|NCT00266812|156450542|FG000|Overall Study|Withdrawal by Subject|0|||
48616116|NCT00266812|156450543|FG001|Overall Study|Withdrawal by Subject|2|||
48616117|NCT00266812|156450542|FG000|Overall Study|Discontinued before starting study drug|4|||
48616118|NCT00266812|156450543|FG001|Overall Study|Discontinued before starting study drug|0|||
48616119|NCT02323334|156450545|FG000|Period 3|Lost to Follow-up|0|||
48616120|NCT02323334|156450546|FG001|Period 3|Lost to Follow-up|0|||
48616121|NCT02323334|156450547|FG002|Period 3|Lost to Follow-up|1|||
48616122|NCT02323334|156450548|FG003|Period 3|Lost to Follow-up|0|||
48616123|NCT02323334|156450549|FG004|Period 3|Lost to Follow-up|0|||
48616124|NCT02323334|156450550|FG005|Period 3|Lost to Follow-up|0|||
48616125|NCT02323334|156450551|FG006|Period 3|Lost to Follow-up|0|||
48616126|NCT02323334|156450552|FG007|Period 3|Lost to Follow-up|0|||
48616127|NCT02323334|156450553|FG008|Period 3|Lost to Follow-up|0|||
48616128|NCT02323334|156450554|FG009|Period 3|Lost to Follow-up|0|||
48616129|NCT02323334|156450555|FG010|Period 3|Lost to Follow-up|0|||
48616130|NCT02323334|156450556|FG011|Period 3|Lost to Follow-up|0|||
48616131|NCT02323334|156450557|FG012|Period 3|Lost to Follow-up|0|||
48616132|NCT02323334|156450558|FG013|Period 3|Lost to Follow-up|0|||
48616133|NCT02323334|156450559|FG014|Period 3|Lost to Follow-up|0|||
48616134|NCT02323334|156450560|FG015|Period 3|Lost to Follow-up|0|||
48616135|NCT02323334|156450561|FG016|Period 3|Lost to Follow-up|0|||
48616136|NCT02323334|156450545|FG000|Period 3|Withdrawal by Subject|1|||
48616137|NCT02323334|156450546|FG001|Period 3|Withdrawal by Subject|0|||
48616138|NCT02323334|156450547|FG002|Period 3|Withdrawal by Subject|0|||
48616139|NCT02323334|156450548|FG003|Period 3|Withdrawal by Subject|0|||
48616140|NCT02323334|156450549|FG004|Period 3|Withdrawal by Subject|0|||
48616141|NCT02323334|156450550|FG005|Period 3|Withdrawal by Subject|0|||
48616142|NCT02323334|156450551|FG006|Period 3|Withdrawal by Subject|0|||
48616143|NCT02323334|156450552|FG007|Period 3|Withdrawal by Subject|0|||
48616144|NCT02323334|156450553|FG008|Period 3|Withdrawal by Subject|0|||
48616145|NCT02323334|156450554|FG009|Period 3|Withdrawal by Subject|0|||
48616146|NCT02323334|156450555|FG010|Period 3|Withdrawal by Subject|0|||
48616147|NCT02323334|156450556|FG011|Period 3|Withdrawal by Subject|0|||
48616148|NCT02323334|156450557|FG012|Period 3|Withdrawal by Subject|0|||
48616149|NCT02323334|156450558|FG013|Period 3|Withdrawal by Subject|0|||
48616150|NCT02323334|156450559|FG014|Period 3|Withdrawal by Subject|0|||
48616151|NCT02323334|156450560|FG015|Period 3|Withdrawal by Subject|0|||
48616152|NCT02323334|156450561|FG016|Period 3|Withdrawal by Subject|0|||
48616153|NCT01617967|156450563|FG000|Overall Study|Protocol Violation|0|||
48616154|NCT01617967|156450564|FG001|Overall Study|Protocol Violation|0|||
48616155|NCT01617967|156450565|FG002|Overall Study|Protocol Violation|0|||
48616156|NCT01617967|156450566|FG003|Overall Study|Protocol Violation|1|||
48616157|NCT01617967|156450567|FG004|Overall Study|Protocol Violation|0|||
48616158|NCT01617967|156450568|FG005|Overall Study|Protocol Violation|0|||
48616159|NCT01617967|156450563|FG000|Overall Study|Withdrawal by Subject|0|||
48558238|NCT00758524|156235564|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558239|NCT00758524|156235565|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558240|NCT00758524|156235566|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558241|NCT00758524|156235567|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558242|NCT00758524|156235568|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558243|NCT00758524|156235569|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558244|NCT00758524|156235570|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558245|NCT00758524|156235571|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558246|NCT00758524|156235572|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558247|NCT00758524|156235573|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
48558248|NCT00758524|156235557|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
48558249|NCT00758524|156235558|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558250|NCT00758524|156235559|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
48558251|NCT00758524|156235560|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
48558252|NCT00758524|156235561|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
48558253|NCT00758524|156235562|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
48558254|NCT00758524|156235563|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558255|NCT00758524|156235564|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558256|NCT00758524|156235565|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558257|NCT00758524|156235566|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558258|NCT00758524|156235567|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558259|NCT00758524|156235568|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558260|NCT00758524|156235569|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558261|NCT00758524|156235570|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558262|NCT00758524|156235571|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558263|NCT00758524|156235572|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48558264|NCT00758524|156235573|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
48616160|NCT01617967|156450564|FG001|Overall Study|Withdrawal by Subject|0|||
48616161|NCT01617967|156450565|FG002|Overall Study|Withdrawal by Subject|0|||
48616162|NCT01617967|156450566|FG003|Overall Study|Withdrawal by Subject|0|||
48616163|NCT01617967|156450567|FG004|Overall Study|Withdrawal by Subject|0|||
48616164|NCT01617967|156450568|FG005|Overall Study|Withdrawal by Subject|1|||
48616165|NCT01617967|156450563|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
48616166|NCT01617967|156450564|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
48616167|NCT01617967|156450565|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
48616168|NCT01617967|156450566|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
48558265|NCT00758524|156235557|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
48558266|NCT00758524|156235558|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
48558267|NCT00758524|156235559|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
48558268|NCT00758524|156235560|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
48558269|NCT00758524|156235561|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
48558270|NCT00758524|156235562|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
48558271|NCT00758524|156235563|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558272|NCT00758524|156235564|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558273|NCT00758524|156235565|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558274|NCT00758524|156235566|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558275|NCT00758524|156235567|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558276|NCT00758524|156235568|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558277|NCT00758524|156235569|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558278|NCT00758524|156235570|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558279|NCT00758524|156235571|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558280|NCT00758524|156235572|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558281|NCT00758524|156235573|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
48558282|NCT00758524|156235557|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558283|NCT00758524|156235558|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
48558284|NCT00758524|156235559|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
48558285|NCT00758524|156235560|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558286|NCT00758524|156235561|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
48558287|NCT00758524|156235562|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
48558288|NCT00758524|156235563|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558289|NCT00758524|156235564|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558290|NCT00758524|156235565|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558291|NCT00758524|156235566|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558292|NCT00758524|156235567|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558293|NCT00758524|156235568|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558294|NCT00758524|156235569|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558295|NCT00758524|156235570|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558296|NCT00758524|156235571|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558297|NCT00758524|156235572|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558298|NCT00758524|156235573|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
48558299|NCT00758524|156235557|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558300|NCT00758524|156235558|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558301|NCT00758524|156235559|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
48558302|NCT00758524|156235560|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
48558303|NCT00758524|156235561|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558304|NCT00758524|156235562|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558305|NCT00758524|156235563|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48616169|NCT01617967|156450567|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
48616170|NCT01617967|156450568|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
48616171|NCT02362451|156450573|FG000|Overall Study|Withdrawal by Subject|0|||
48616172|NCT02362451|156450574|FG001|Overall Study|Withdrawal by Subject|1|||
48616173|NCT02362451|156450573|FG000|Overall Study|Lack of Efficacy|2|||
48616174|NCT02362451|156450574|FG001|Overall Study|Lack of Efficacy|0|||
48616175|NCT02362451|156450573|FG000|Overall Study|Progression|1|||
48616176|NCT02362451|156450574|FG001|Overall Study|Progression|0|||
48616177|NCT02362451|156450573|FG000|Overall Study|Participant chose other therapy.|1|||
48616178|NCT02362451|156450574|FG001|Overall Study|Participant chose other therapy.|0|||
48616179|NCT01732783|156450575|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
48616180|NCT01732783|156450576|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
48616181|NCT01732783|156450577|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
48616182|NCT01732783|156450575|FG000|Overall Study|Death|13|||
48616183|NCT01732783|156450576|FG001|Overall Study|Death|4|||
48616184|NCT01732783|156450577|FG002|Overall Study|Death|1|||
48616185|NCT01732783|156450575|FG000|Overall Study|Lost to Follow-up|7|||
48616186|NCT01732783|156450576|FG001|Overall Study|Lost to Follow-up|1|||
48616187|NCT01732783|156450577|FG002|Overall Study|Lost to Follow-up|1|||
48616188|NCT01732783|156450575|FG000|Overall Study|Administrative Decision|8|||
48616189|NCT01732783|156450576|FG001|Overall Study|Administrative Decision|2|||
48616190|NCT01732783|156450577|FG002|Overall Study|Administrative Decision|1|||
48558306|NCT00758524|156235564|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558307|NCT00758524|156235565|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558308|NCT00758524|156235566|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558309|NCT00758524|156235567|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558310|NCT00758524|156235568|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558311|NCT00758524|156235569|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558312|NCT00758524|156235570|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558313|NCT00758524|156235571|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558314|NCT00758524|156235572|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558315|NCT00758524|156235573|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
48558316|NCT00758524|156235557|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558317|NCT00758524|156235558|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558318|NCT00758524|156235559|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558319|NCT00758524|156235560|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558320|NCT00758524|156235561|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
48558321|NCT00758524|156235562|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558322|NCT00758524|156235563|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558323|NCT00758524|156235564|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558324|NCT00758524|156235565|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558325|NCT00758524|156235566|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558326|NCT00758524|156235567|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558327|NCT00758524|156235568|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558328|NCT00758524|156235569|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558329|NCT00758524|156235570|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558330|NCT00758524|156235571|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558331|NCT00758524|156235572|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558332|NCT00758524|156235573|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
48558333|NCT00758524|156235557|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558334|NCT00758524|156235558|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
48558335|NCT00758524|156235559|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558336|NCT00758524|156235560|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558337|NCT00758524|156235561|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558338|NCT00758524|156235562|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48630348|NCT02082977|156504937|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
48558339|NCT00758524|156235563|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558340|NCT00758524|156235564|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558341|NCT00758524|156235565|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558342|NCT00758524|156235566|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558343|NCT00758524|156235567|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558344|NCT00758524|156235568|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558345|NCT00758524|156235569|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558346|NCT00758524|156235570|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558347|NCT00758524|156235571|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48558348|NCT00758524|156235572|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48616191|NCT01732783|156450575|FG000|Overall Study|Withdrawal by Subject|1|||
48616192|NCT01732783|156450576|FG001|Overall Study|Withdrawal by Subject|0|||
48616193|NCT01732783|156450577|FG002|Overall Study|Withdrawal by Subject|0|||
48616194|NCT03086343|156450578|FG000|Period 1|Adverse Event|7|||
48616195|NCT03086343|156450579|FG001|Period 1|Adverse Event|7|||
48616196|NCT03086343|156450580|FG002|Period 1|Adverse Event|0|||
48616197|NCT03086343|156450581|FG003|Period 1|Adverse Event|1|||
48616198|NCT03086343|156450578|FG000|Period 1|Withdrawal by Subject|6|||
48616199|NCT03086343|156450579|FG001|Period 1|Withdrawal by Subject|10|||
48616200|NCT03086343|156450580|FG002|Period 1|Withdrawal by Subject|0|||
48616201|NCT03086343|156450581|FG003|Period 1|Withdrawal by Subject|0|||
48616202|NCT03086343|156450578|FG000|Period 1|Lost to Follow-up|1|||
48616203|NCT03086343|156450579|FG001|Period 1|Lost to Follow-up|3|||
48558349|NCT00758524|156235573|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
48616204|NCT03086343|156450580|FG002|Period 1|Lost to Follow-up|1|||
48616205|NCT03086343|156450581|FG003|Period 1|Lost to Follow-up|0|||
48616206|NCT03086343|156450578|FG000|Period 1|Other, Not Specified|10|||
48558350|NCT00758524|156235557|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558351|NCT00758524|156235558|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
48558352|NCT00758524|156235559|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558353|NCT00758524|156235560|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558354|NCT00758524|156235561|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558355|NCT00758524|156235562|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558356|NCT00758524|156235563|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558357|NCT00758524|156235564|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558358|NCT00758524|156235565|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558359|NCT00758524|156235566|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558360|NCT00758524|156235567|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558361|NCT00758524|156235568|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558362|NCT00758524|156235569|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558363|NCT00758524|156235570|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558364|NCT00758524|156235571|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558365|NCT00758524|156235572|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558366|NCT00758524|156235573|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
48558367|NCT00758524|156235557|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558368|NCT00758524|156235558|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558369|NCT00758524|156235559|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558370|NCT00758524|156235560|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558371|NCT00758524|156235561|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558372|NCT00758524|156235562|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558373|NCT00758524|156235563|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558374|NCT00758524|156235564|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558375|NCT00758524|156235565|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
48558376|NCT00758524|156235566|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48616207|NCT03086343|156450579|FG001|Period 1|Other, Not Specified|12|||
48616208|NCT03086343|156450580|FG002|Period 1|Other, Not Specified|2|||
48616209|NCT03086343|156450581|FG003|Period 1|Other, Not Specified|1|||
48616210|NCT03086343|156450578|FG000|Period 1|Missing|1|||
48616211|NCT03086343|156450579|FG001|Period 1|Missing|0|||
48616212|NCT03086343|156450580|FG002|Period 1|Missing|0|||
48558377|NCT00758524|156235567|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558378|NCT00758524|156235568|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558379|NCT00758524|156235569|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558380|NCT00758524|156235570|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558381|NCT00758524|156235571|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558382|NCT00758524|156235572|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558383|NCT00758524|156235573|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
48558384|NCT00758524|156235557|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558385|NCT00758524|156235558|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558386|NCT00758524|156235559|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558387|NCT00758524|156235560|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558388|NCT00758524|156235561|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558389|NCT00758524|156235562|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558390|NCT00758524|156235563|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
48558391|NCT00758524|156235564|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558392|NCT00758524|156235565|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558393|NCT00758524|156235566|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558394|NCT00758524|156235567|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558395|NCT00758524|156235568|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558396|NCT00758524|156235569|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558397|NCT00758524|156235570|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558398|NCT00758524|156235571|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558399|NCT00758524|156235572|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558400|NCT00758524|156235573|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
48558401|NCT04176250|156235574|FG000|Overall Study|Adverse Event|0|||
48558402|NCT04176250|156235575|FG001|Overall Study|Adverse Event|1|||
48558403|NCT04176250|156235576|FG002|Overall Study|Adverse Event|0|||
48558404|NCT04176250|156235577|FG003|Overall Study|Adverse Event|1|||
48558405|NCT04176250|156235578|FG004|Overall Study|Adverse Event|0|||
48558406|NCT04176250|156235579|FG005|Overall Study|Adverse Event|1|||
48558407|NCT04176250|156235574|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
48558408|NCT04176250|156235575|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
48558409|NCT04176250|156235576|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
48558410|NCT04176250|156235577|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
48558411|NCT04176250|156235578|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
48558412|NCT04176250|156235579|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
48558413|NCT04176250|156235574|FG000|Overall Study|Withdrawal by Subject|0|||
48558414|NCT04176250|156235575|FG001|Overall Study|Withdrawal by Subject|0|||
48558415|NCT04176250|156235576|FG002|Overall Study|Withdrawal by Subject|0|||
48558416|NCT04176250|156235577|FG003|Overall Study|Withdrawal by Subject|0|||
48558417|NCT04176250|156235578|FG004|Overall Study|Withdrawal by Subject|0|||
48558418|NCT04176250|156235579|FG005|Overall Study|Withdrawal by Subject|1|||
48558419|NCT04176250|156235574|FG000|Overall Study|Randomized in error|0|||
48558420|NCT04176250|156235575|FG001|Overall Study|Randomized in error|0|||
48558421|NCT04176250|156235576|FG002|Overall Study|Randomized in error|0|||
48558422|NCT04176250|156235577|FG003|Overall Study|Randomized in error|0|||
48558423|NCT04176250|156235578|FG004|Overall Study|Randomized in error|1|||
48558424|NCT04176250|156235579|FG005|Overall Study|Randomized in error|0|||
48558425|NCT01870778|156235581|FG000|Overall Study|Withdrawal by Subject|8|||
48558426|NCT01870778|156235582|FG001|Overall Study|Withdrawal by Subject|7|||
48558427|NCT01870778|156235581|FG000|Overall Study|Lost to Follow-up|0|||
48558428|NCT01870778|156235582|FG001|Overall Study|Lost to Follow-up|2|||
48616213|NCT03086343|156450581|FG003|Period 1|Missing|0|||
48558429|NCT00065156|156235583|FG000|Overall Study|Adverse Event|37|||
48558430|NCT00065156|156235583|FG000|Overall Study|Lack of Efficacy|52|||
48558431|NCT00065156|156235583|FG000|Overall Study|Withdrawal by Subject|8|||
48616214|NCT03086343|156450578|FG000|Period 2|Adverse Event|20|||
48558432|NCT00065156|156235583|FG000|Overall Study|Lost to Follow-up|1|||
48558433|NCT00065156|156235583|FG000|Overall Study|Death|11|||
48558434|NCT00065156|156235583|FG000|Overall Study|Study Closed by Sponsor|2|||
48558435|NCT00065156|156235583|FG000|Overall Study|Disease Progression|7|||
48558436|NCT00065156|156235583|FG000|Overall Study|Investigator Decision|2|||
48616215|NCT03086343|156450579|FG001|Period 2|Adverse Event|11|||
48616216|NCT03086343|156450580|FG002|Period 2|Adverse Event|1|||
48616217|NCT03086343|156450581|FG003|Period 2|Adverse Event|2|||
48616218|NCT03086343|156450578|FG000|Period 2|Withdrawal by Subject|15|||
48616219|NCT03086343|156450579|FG001|Period 2|Withdrawal by Subject|25|||
48616220|NCT03086343|156450580|FG002|Period 2|Withdrawal by Subject|2|||
48616221|NCT03086343|156450581|FG003|Period 2|Withdrawal by Subject|2|||
48616222|NCT03086343|156450578|FG000|Period 2|Lost to Follow-up|6|||
48616223|NCT03086343|156450579|FG001|Period 2|Lost to Follow-up|11|||
48616224|NCT03086343|156450580|FG002|Period 2|Lost to Follow-up|1|||
48616225|NCT03086343|156450581|FG003|Period 2|Lost to Follow-up|0|||
48616226|NCT03086343|156450578|FG000|Period 2|COVID-19 Infection|5|||
48616227|NCT03086343|156450579|FG001|Period 2|COVID-19 Infection|0|||
48616228|NCT03086343|156450580|FG002|Period 2|COVID-19 Infection|0|||
48616229|NCT03086343|156450581|FG003|Period 2|COVID-19 Infection|0|||
48616230|NCT03086343|156450578|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
48616231|NCT03086343|156450579|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
48616232|NCT03086343|156450580|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
48616233|NCT03086343|156450581|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
48616234|NCT03086343|156450578|FG000|Period 2|Other, Not Specified|23|||
48616235|NCT03086343|156450579|FG001|Period 2|Other, Not Specified|22|||
48616236|NCT03086343|156450580|FG002|Period 2|Other, Not Specified|2|||
48558437|NCT00065156|156235583|FG000|Overall Study|Non-Compliance|2|||
48558438|NCT00065156|156235583|FG000|Overall Study|Loss of Response|1|||
48558439|NCT00065156|156235583|FG000|Overall Study|Secondary Malign Disease|1|||
48558440|NCT05317312|156235584|FG000|Overall Study|Withdrawal by Subject|0|||
48558441|NCT05317312|156235585|FG001|Overall Study|Withdrawal by Subject|1|||
48558442|NCT05317312|156235586|FG002|Overall Study|Withdrawal by Subject|0|||
48558443|NCT05317312|156235587|FG003|Overall Study|Withdrawal by Subject|0|||
48558444|NCT05317312|156235584|FG000|Overall Study|Lost to Follow-up|0|||
48558445|NCT05317312|156235585|FG001|Overall Study|Lost to Follow-up|0|||
48558446|NCT05317312|156235586|FG002|Overall Study|Lost to Follow-up|0|||
48558447|NCT05317312|156235587|FG003|Overall Study|Lost to Follow-up|1|||
48558448|NCT05317312|156235584|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
48558449|NCT05317312|156235585|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
48558450|NCT05317312|156235586|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
48616237|NCT03086343|156450581|FG003|Period 2|Other, Not Specified|4|||
48616238|NCT02447029|156450584|FG000|Overall Study|Withdrawal by Subject|3|||
48616239|NCT02447029|156450585|FG001|Overall Study|Withdrawal by Subject|2|||
48558451|NCT05317312|156235587|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
48616240|NCT00726557|156450586|FG000|Overall Study|Screening failure|4|||
48616241|NCT00726557|156450586|FG000|Overall Study|No end of treatment documentation|37|||
48616242|NCT00726557|156450586|FG000|Overall Study|No follow-up documentation available|55|||
48616243|NCT00726557|156450586|FG000|Overall Study|Treatment less than 3 months|17|||
48616244|NCT00726557|156450586|FG000|Overall Study|Inclusion criteria not met|15|||
48616245|NCT03147287|156450589|FG000|Overall Study|Randomized Not Treated|2|||
48616246|NCT03147287|156450590|FG001|Overall Study|Randomized Not Treated|1|||
48616247|NCT03147287|156450591|FG002|Overall Study|Randomized Not Treated|1|||
48616248|NCT03147287|156450589|FG000|Overall Study|Progressive Disease RECIST|31|||
48616249|NCT03147287|156450590|FG001|Overall Study|Progressive Disease RECIST|72|||
48558452|NCT00312338|156235588|FG000|Overall Study|Adverse Event|7|||
48558453|NCT00312338|156235589|FG001|Overall Study|Adverse Event|2|||
48558454|NCT00312338|156235588|FG000|Overall Study|Lost to Follow-up|9|||
48558455|NCT00312338|156235589|FG001|Overall Study|Lost to Follow-up|1|||
48616250|NCT03147287|156450591|FG002|Overall Study|Progressive Disease RECIST|32|||
48616251|NCT03147287|156450589|FG000|Overall Study|Progressive Disease not RECIST|13|||
48616252|NCT03147287|156450590|FG001|Overall Study|Progressive Disease not RECIST|21|||
48616253|NCT03147287|156450591|FG002|Overall Study|Progressive Disease not RECIST|13|||
48616254|NCT03147287|156450589|FG000|Overall Study|Physician Decision|1|||
48616255|NCT03147287|156450590|FG001|Overall Study|Physician Decision|2|||
48616256|NCT03147287|156450591|FG002|Overall Study|Physician Decision|1|||
48558456|NCT00312338|156235588|FG000|Overall Study|Withdrawal by Subject|4|||
48558457|NCT00312338|156235589|FG001|Overall Study|Withdrawal by Subject|0|||
48558458|NCT00312338|156235588|FG000|Overall Study|Subsequent infection|2|||
48558459|NCT00312338|156235589|FG001|Overall Study|Subsequent infection|0|||
48558460|NCT01330303|156235590|FG000|Period 1|Adverse Event|1|||
48558461|NCT01330303|156235591|FG001|Period 1|Adverse Event|0|||
48558462|NCT01330303|156235590|FG000|Period 1|Protocol Violation|0|||
48558463|NCT01330303|156235591|FG001|Period 1|Protocol Violation|1|||
48558464|NCT01330303|156235590|FG000|Period 1|Withdrawal by Subject|0|||
48558465|NCT01330303|156235591|FG001|Period 1|Withdrawal by Subject|1|||
48558466|NCT00100828|156235592|FG000|Overall Study|Physician Decision|6|||
48558467|NCT00262028|156235593|FG000|Overall Study|Withdrawal by Subject|6|||
48558468|NCT00262028|156235594|FG001|Overall Study|Withdrawal by Subject|3|||
48558469|NCT00262028|156235595|FG002|Overall Study|Withdrawal by Subject|6|||
48558470|NCT00262028|156235596|FG003|Overall Study|Withdrawal by Subject|5|||
48558471|NCT00262028|156235597|FG004|Overall Study|Withdrawal by Subject|2|||
48558472|NCT00262028|156235598|FG005|Overall Study|Withdrawal by Subject|3|||
48558473|NCT00262028|156235599|FG006|Overall Study|Withdrawal by Subject|5|||
48558474|NCT00262028|156235600|FG007|Overall Study|Withdrawal by Subject|7|||
48558475|NCT00262028|156235601|FG008|Overall Study|Withdrawal by Subject|2|||
48558476|NCT00262028|156235593|FG000|Overall Study|Lost to Follow-up|7|||
48558477|NCT00262028|156235594|FG001|Overall Study|Lost to Follow-up|7|||
48558478|NCT00262028|156235595|FG002|Overall Study|Lost to Follow-up|5|||
48558479|NCT00262028|156235596|FG003|Overall Study|Lost to Follow-up|5|||
48558480|NCT00262028|156235597|FG004|Overall Study|Lost to Follow-up|4|||
48558481|NCT00262028|156235598|FG005|Overall Study|Lost to Follow-up|3|||
48558482|NCT00262028|156235599|FG006|Overall Study|Lost to Follow-up|3|||
48558483|NCT00262028|156235600|FG007|Overall Study|Lost to Follow-up|5|||
48558484|NCT00262028|156235601|FG008|Overall Study|Lost to Follow-up|6|||
48558485|NCT00262028|156235593|FG000|Overall Study|Administrative Reason|11|||
48558486|NCT00262028|156235594|FG001|Overall Study|Administrative Reason|14|||
48558487|NCT00262028|156235595|FG002|Overall Study|Administrative Reason|9|||
48558488|NCT00262028|156235596|FG003|Overall Study|Administrative Reason|12|||
48558489|NCT00262028|156235597|FG004|Overall Study|Administrative Reason|6|||
48558490|NCT00262028|156235598|FG005|Overall Study|Administrative Reason|7|||
48558491|NCT00262028|156235599|FG006|Overall Study|Administrative Reason|4|||
48558492|NCT00262028|156235600|FG007|Overall Study|Administrative Reason|6|||
48558493|NCT00262028|156235601|FG008|Overall Study|Administrative Reason|10|||
48558494|NCT00262028|156235593|FG000|Overall Study|Protocol Violation|0|||
48558495|NCT00262028|156235594|FG001|Overall Study|Protocol Violation|0|||
48558496|NCT00262028|156235595|FG002|Overall Study|Protocol Violation|0|||
48558497|NCT00262028|156235596|FG003|Overall Study|Protocol Violation|1|||
48558498|NCT00262028|156235597|FG004|Overall Study|Protocol Violation|0|||
48558499|NCT00262028|156235598|FG005|Overall Study|Protocol Violation|0|||
48558500|NCT00262028|156235599|FG006|Overall Study|Protocol Violation|0|||
48558501|NCT00262028|156235600|FG007|Overall Study|Protocol Violation|0|||
48558502|NCT00262028|156235601|FG008|Overall Study|Protocol Violation|0|||
48558503|NCT00262028|156235593|FG000|Overall Study|Unable to classify|0|||
48558504|NCT00262028|156235594|FG001|Overall Study|Unable to classify|3|||
48558505|NCT00262028|156235595|FG002|Overall Study|Unable to classify|0|||
48558506|NCT00262028|156235596|FG003|Overall Study|Unable to classify|0|||
48558507|NCT00262028|156235597|FG004|Overall Study|Unable to classify|0|||
48558508|NCT00262028|156235598|FG005|Overall Study|Unable to classify|0|||
48558509|NCT00262028|156235599|FG006|Overall Study|Unable to classify|0|||
48558510|NCT00262028|156235600|FG007|Overall Study|Unable to classify|0|||
48558511|NCT00262028|156235601|FG008|Overall Study|Unable to classify|1|||
48558512|NCT03817190|156235602|FG000|Overall Study|Early Termination|13|||
48558513|NCT03817190|156235603|FG001|Overall Study|Early Termination|20|||
48558514|NCT03817190|156235602|FG000|Overall Study|Adverse Event|10|||
48558515|NCT03817190|156235603|FG001|Overall Study|Adverse Event|17|||
48558516|NCT03817190|156235602|FG000|Overall Study|Withdrawal by Subject|12|||
48558517|NCT03817190|156235603|FG001|Overall Study|Withdrawal by Subject|8|||
48558518|NCT03817190|156235602|FG000|Overall Study|Lost to Follow-up|11|||
48558519|NCT03817190|156235603|FG001|Overall Study|Lost to Follow-up|7|||
48558520|NCT03817190|156235602|FG000|Overall Study|Lack of Efficacy|7|||
48558521|NCT03817190|156235603|FG001|Overall Study|Lack of Efficacy|5|||
48558522|NCT03817190|156235602|FG000|Overall Study|Investigator Decision|5|||
48558523|NCT03817190|156235603|FG001|Overall Study|Investigator Decision|1|||
48558524|NCT03817190|156235602|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
48558525|NCT03817190|156235603|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
48558526|NCT03817190|156235602|FG000|Overall Study|Lack of Contact|1|||
48558527|NCT03817190|156235603|FG001|Overall Study|Lack of Contact|0|||
48558528|NCT03817190|156235602|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
48558529|NCT03817190|156235603|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
48558530|NCT01197911|156235604|FG000|Overall Study|Adverse Event|0|||
48558531|NCT01197911|156235605|FG001|Overall Study|Adverse Event|0|||
48558532|NCT01197911|156235606|FG002|Overall Study|Adverse Event|1|||
48558533|NCT01306305|156235607|FG000|Overall Study|Lost to Follow-up|1|||
48558534|NCT01306305|156235608|FG001|Overall Study|Lost to Follow-up|0|||
48558535|NCT01306305|156235607|FG000|Overall Study|Withdrew consent|1|||
48558536|NCT01306305|156235608|FG001|Overall Study|Withdrew consent|0|||
48558537|NCT02235454|156235609|FG000|Overall Study|Withdrawal by Subject|2|||
48558538|NCT00931411|156235610|FG000|First Intervention - 42 Days|Adverse Event|2|||
48558539|NCT00931411|156235611|FG001|First Intervention - 42 Days|Adverse Event|3|||
48558540|NCT00931411|156235610|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
48558541|NCT00931411|156235611|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
48558542|NCT00931411|156235610|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
48558543|NCT00931411|156235611|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
48558544|NCT00610129|156235612|FG000|Overall Study|Not treated since patients ineligible|3|||
48558545|NCT02964247|156235613|FG000|Overall Study|Lost to Follow-up|2|||
48558546|NCT02964247|156235614|FG001|Overall Study|Lost to Follow-up|0|||
48558547|NCT02964247|156235613|FG000|Overall Study|Withdrawal by Subject|1|||
48558548|NCT02964247|156235614|FG001|Overall Study|Withdrawal by Subject|2|||
48558549|NCT03759392|156235616|FG000|Overall Study|Adverse Event|12|||
48558550|NCT03759392|156235617|FG001|Overall Study|Adverse Event|4|||
48558551|NCT03759392|156235616|FG000|Overall Study|Death|2|||
48558552|NCT03759392|156235617|FG001|Overall Study|Death|1|||
48558553|NCT03759392|156235616|FG000|Overall Study|Withdrawal by Subject|2|||
48558554|NCT03759392|156235617|FG001|Overall Study|Withdrawal by Subject|0|||
48558555|NCT03759392|156235616|FG000|Overall Study|Protocol Violation|2|||
48558556|NCT03759392|156235617|FG001|Overall Study|Protocol Violation|0|||
48558557|NCT03759392|156235616|FG000|Overall Study|Physician Decision|0|||
48558558|NCT03759392|156235617|FG001|Overall Study|Physician Decision|1|||
48558559|NCT03759392|156235616|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
48558560|NCT03759392|156235617|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
48558561|NCT03759392|156235616|FG000|Overall Study|No longer able to take medicines|1|||
48558562|NCT03759392|156235617|FG001|Overall Study|No longer able to take medicines|0|||
48558563|NCT03759392|156235616|FG000|Overall Study|Stopped taking study drug|1|||
48558564|NCT03759392|156235617|FG001|Overall Study|Stopped taking study drug|0|||
48558565|NCT02623725|156235618|FG000|Overall Study|Non compliance with protocol|9|||
48558566|NCT02623725|156235619|FG001|Overall Study|Non compliance with protocol|3|||
48558567|NCT02623725|156235618|FG000|Overall Study|Serious adverse event|0|||
48558568|NCT02623725|156235619|FG001|Overall Study|Serious adverse event|2|||
48558569|NCT02623725|156235618|FG000|Overall Study|Withdrawal by Subject|7|||
48558570|NCT02623725|156235619|FG001|Overall Study|Withdrawal by Subject|1|||
48558571|NCT02040805|156235623|FG000|Overall Study|Lost to Follow-up|14|||
48558572|NCT02040805|156235624|FG001|Overall Study|Lost to Follow-up|9|||
48558573|NCT02040805|156235623|FG000|Overall Study|Withdrawal by Subject|28|||
48558574|NCT02040805|156235624|FG001|Overall Study|Withdrawal by Subject|41|||
48558575|NCT04720105|156235625|FG000|Overall Study|Lack of Efficacy|1|||
48558576|NCT04720105|156235625|FG000|Overall Study|Lost to Follow-up|1|||
48558577|NCT04720105|156235625|FG000|Overall Study|Withdrawal by Subject|3|||
48558578|NCT00974922|156237494|FG000|Overall Study|study terminated|24|||
48558579|NCT00287586|156237495|FG000|Overall Study|Withdrew Consent|19|||
48558580|NCT00287586|156237496|FG001|Overall Study|Withdrew Consent|30|||
48558581|NCT00287586|156237495|FG000|Overall Study|Lost to Follow-up|5|||
48558582|NCT00287586|156237496|FG001|Overall Study|Lost to Follow-up|4|||
48558583|NCT00287586|156237495|FG000|Overall Study|Death|2|||
48558584|NCT00287586|156237496|FG001|Overall Study|Death|3|||
48558585|NCT00287586|156237495|FG000|Overall Study|Elevated Hematocrit|3|||
48558586|NCT00287586|156237496|FG001|Overall Study|Elevated Hematocrit|0|||
48558587|NCT00287586|156237495|FG000|Overall Study|Rash|3|||
48558588|NCT00287586|156237496|FG001|Overall Study|Rash|0|||
48558589|NCT00287586|156237495|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
48558590|NCT00287586|156237496|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
48558591|NCT00287586|156237495|FG000|Overall Study|Stroke|2|||
48558592|NCT00287586|156237496|FG001|Overall Study|Stroke|0|||
48558593|NCT00287586|156237495|FG000|Overall Study|Myocardial Infarction|1|||
48558594|NCT00287586|156237496|FG001|Overall Study|Myocardial Infarction|0|||
48558595|NCT00287586|156237495|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
48558596|NCT00287586|156237496|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
48558597|NCT00287586|156237495|FG000|Overall Study|Cognitive Impairment|1|||
48558598|NCT00287586|156237496|FG001|Overall Study|Cognitive Impairment|0|||
48558599|NCT00287586|156237495|FG000|Overall Study|Pancreatic Cancer|1|||
48558600|NCT00287586|156237496|FG001|Overall Study|Pancreatic Cancer|3|||
48558601|NCT00287586|156237495|FG000|Overall Study|Sleep Apnea|1|||
48558602|NCT00287586|156237496|FG001|Overall Study|Sleep Apnea|0|||
48558603|NCT00287586|156237495|FG000|Overall Study|Shoulder Pain|1|||
48558604|NCT00287586|156237496|FG001|Overall Study|Shoulder Pain|0|||
48558605|NCT00287586|156237495|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
48558606|NCT00287586|156237496|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
48558607|NCT00287586|156237495|FG000|Overall Study|Nonadherence|1|||
48558608|NCT00287586|156237496|FG001|Overall Study|Nonadherence|1|||
48558609|NCT00287586|156237495|FG000|Overall Study|Enrolled in Another Study|1|||
48558610|NCT00287586|156237496|FG001|Overall Study|Enrolled in Another Study|0|||
48558611|NCT00287586|156237495|FG000|Overall Study|Major Depression|0|||
48558612|NCT00287586|156237496|FG001|Overall Study|Major Depression|2|||
48558613|NCT00287586|156237495|FG000|Overall Study|Lung Cancer|0|||
48558614|NCT00287586|156237496|FG001|Overall Study|Lung Cancer|2|||
48558615|NCT00287586|156237495|FG000|Overall Study|Elevated IPSS Score|0|||
48558616|NCT00287586|156237496|FG001|Overall Study|Elevated IPSS Score|1|||
48558617|NCT00287586|156237495|FG000|Overall Study|Retroperitoneal Cancer|0|||
48558618|NCT00287586|156237496|FG001|Overall Study|Retroperitoneal Cancer|1|||
48558619|NCT00287586|156237495|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
48558620|NCT00287586|156237496|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
48558621|NCT00287586|156237495|FG000|Overall Study|Mood Swings and Irritability|0|||
48558622|NCT00287586|156237496|FG001|Overall Study|Mood Swings and Irritability|1|||
48558623|NCT00287586|156237495|FG000|Overall Study|Bradycardia|0|||
48558624|NCT00287586|156237496|FG001|Overall Study|Bradycardia|1|||
48558625|NCT00287586|156237495|FG000|Overall Study|Itchy Swollen Eyes|0|||
48558626|NCT00287586|156237496|FG001|Overall Study|Itchy Swollen Eyes|1|||
48558627|NCT00287586|156237495|FG000|Overall Study|Recurrent Melanoma|0|||
48558628|NCT00287586|156237496|FG001|Overall Study|Recurrent Melanoma|1|||
48558629|NCT02135614|156237499|FG000|Overall Study|Randomized but Not Treated|2|||
48558630|NCT02135614|156237500|FG001|Overall Study|Randomized but Not Treated|1|||
48558631|NCT02135614|156237499|FG000|Overall Study|Adverse Event|0|||
48558632|NCT02135614|156237500|FG001|Overall Study|Adverse Event|1|||
48558633|NCT02135614|156237499|FG000|Overall Study|Death|1|||
48558634|NCT02135614|156237500|FG001|Overall Study|Death|0|||
48616257|NCT03147287|156450589|FG000|Overall Study|Intercurrent illness|0|||
48616258|NCT03147287|156450590|FG001|Overall Study|Intercurrent illness|1|||
48616259|NCT03147287|156450591|FG002|Overall Study|Intercurrent illness|0|||
48616260|NCT03147287|156450589|FG000|Overall Study|Withdrawal by Subject|2|||
48616261|NCT03147287|156450590|FG001|Overall Study|Withdrawal by Subject|3|||
48616262|NCT03147287|156450591|FG002|Overall Study|Withdrawal by Subject|2|||
48616263|NCT03147287|156450589|FG000|Overall Study|Patient Non-Compliance|0|||
48616264|NCT03147287|156450590|FG001|Overall Study|Patient Non-Compliance|2|||
48616265|NCT03147287|156450591|FG002|Overall Study|Patient Non-Compliance|0|||
48616266|NCT03147287|156450589|FG000|Overall Study|Patient moved|0|||
48616267|NCT03147287|156450590|FG001|Overall Study|Patient moved|1|||
48616268|NCT03147287|156450591|FG002|Overall Study|Patient moved|0|||
48616269|NCT03147287|156450589|FG000|Overall Study|Arm A crossover without PD|1|||
48616270|NCT03147287|156450590|FG001|Overall Study|Arm A crossover without PD|0|||
48616271|NCT03147287|156450591|FG002|Overall Study|Arm A crossover without PD|0|||
48616272|NCT03147287|156450589|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
48616273|NCT03147287|156450590|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
48616274|NCT03147287|156450591|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
48616275|NCT01898130|156450592|FG000|Treatment|Withdrawal by Subject|2|||
48616276|NCT01898130|156450592|FG000|Treatment|Progressive Disease|4|||
48616277|NCT01898130|156450592|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
48616278|NCT02930941|156450597|FG000|Overall Study|Lost to Follow-up|1|||
48616279|NCT02930941|156450598|FG001|Overall Study|Lost to Follow-up|2|||
48616280|NCT04398134|156450601|FG000|Overall Study|Adverse Event|0|||
48616281|NCT04398134|156450602|FG001|Overall Study|Adverse Event|0|||
48616282|NCT04398134|156450603|FG002|Overall Study|Adverse Event|1|||
48616283|NCT04398134|156450604|FG003|Overall Study|Adverse Event|0|||
48616284|NCT04398134|156450601|FG000|Overall Study|Withdrawal by Subject|2|||
48616285|NCT04398134|156450602|FG001|Overall Study|Withdrawal by Subject|0|||
48616286|NCT04398134|156450603|FG002|Overall Study|Withdrawal by Subject|0|||
48616287|NCT04398134|156450604|FG003|Overall Study|Withdrawal by Subject|1|||
48616288|NCT04398134|156450601|FG000|Overall Study|Study Terminated by Sponsor|30|||
48616289|NCT04398134|156450602|FG001|Overall Study|Study Terminated by Sponsor|11|||
48616290|NCT04398134|156450603|FG002|Overall Study|Study Terminated by Sponsor|32|||
48616291|NCT04398134|156450604|FG003|Overall Study|Study Terminated by Sponsor|11|||
48616292|NCT00976898|156450605|FG000|Overall Study|Protocol Violation|1|||
48616293|NCT00976898|156450605|FG000|Overall Study|Adverse Event|1|||
48616294|NCT00976898|156450605|FG000|Overall Study|Physician Decision|1|||
48616295|NCT00976898|156450605|FG000|Overall Study|Liver Transplant|1|||
48616296|NCT00976898|156450605|FG000|Overall Study|Progressive Disease|1|||
48616297|NCT00103506|156450608|FG000|Overall Study|Study closed by sponsor|34|||
48616298|NCT00103506|156450609|FG001|Overall Study|Study closed by sponsor|37|||
48616299|NCT00103506|156450608|FG000|Overall Study|Death|257|||
48616300|NCT00103506|156450609|FG001|Overall Study|Death|253|||
48616301|NCT00103506|156450608|FG000|Overall Study|Lost to Follow-up|13|||
48616302|NCT00103506|156450609|FG001|Overall Study|Lost to Follow-up|13|||
48616303|NCT00103506|156450608|FG000|Overall Study|Withdrawal by Subject|18|||
48616304|NCT00103506|156450609|FG001|Overall Study|Withdrawal by Subject|21|||
48616305|NCT02153827|156450610|FG000|Overall Study|Lost to Follow-up|3|||
48616306|NCT02153827|156450611|FG001|Overall Study|Lost to Follow-up|9|||
48616307|NCT04167462|156450612|FG000|Overall Study|Other reasons|3|||
48616308|NCT04167462|156450613|FG001|Overall Study|Other reasons|2|||
48616309|NCT04167462|156450612|FG000|Overall Study|Withdrawal by Subject|6|||
48616310|NCT04167462|156450613|FG001|Overall Study|Withdrawal by Subject|7|||
48558635|NCT02135614|156237499|FG000|Overall Study|Investigator's Discretion|0|||
48558636|NCT02135614|156237500|FG001|Overall Study|Investigator's Discretion|1|||
48558637|NCT02135614|156237499|FG000|Overall Study|Withdrew Consent|2|||
48558638|NCT02135614|156237500|FG001|Overall Study|Withdrew Consent|2|||
48558639|NCT02135614|156237499|FG000|Overall Study|Lost to Follow-up|3|||
48558640|NCT02135614|156237500|FG001|Overall Study|Lost to Follow-up|0|||
48558641|NCT01009814|156237501|FG000|Overall Study|No longer met study criteria|1|||
48616311|NCT04167462|156450612|FG000|Overall Study|Adverse Event|4|||
48616312|NCT04167462|156450613|FG001|Overall Study|Adverse Event|0|||
48616313|NCT04167462|156450612|FG000|Overall Study|Pregnancy|1|||
48616314|NCT04167462|156450613|FG001|Overall Study|Pregnancy|0|||
48616315|NCT04167462|156450612|FG000|Overall Study|Lack of Efficacy|0|||
48616316|NCT04167462|156450613|FG001|Overall Study|Lack of Efficacy|1|||
48616317|NCT03331562|156450616|FG000|Overall Study|Adverse Event|2|||
48558642|NCT01009814|156237502|FG001|Overall Study|No longer met study criteria|1|||
48558643|NCT01009814|156237503|FG002|Overall Study|No longer met study criteria|0|||
48616318|NCT03331562|156450617|FG001|Overall Study|Adverse Event|0|||
48616319|NCT03331562|156450616|FG000|Overall Study|Death|1|||
48616320|NCT03331562|156450617|FG001|Overall Study|Death|0|||
48616321|NCT03718000|156450618|FG000|Overall Study|Relocation|2|||
48616322|NCT03718000|156450619|FG001|Overall Study|Relocation|4|||
48616323|NCT03718000|156450618|FG000|Overall Study|Pregnancy|0|||
48616324|NCT03718000|156450619|FG001|Overall Study|Pregnancy|1|||
48616325|NCT02202616|156450626|FG000|Overall Study|Screen failed|24|||
48616326|NCT02202616|156450626|FG000|Overall Study|Adverse Event|32|||
48616327|NCT02202616|156450626|FG000|Overall Study|Protocol deviation|18|||
48616328|NCT02202616|156450626|FG000|Overall Study|Patient withdrew consent|12|||
48616329|NCT02202616|156450626|FG000|Overall Study|Lost to Follow-up|6|||
48616330|NCT02202616|156450626|FG000|Overall Study|Administrative problems|6|||
48616331|NCT02202616|156450626|FG000|Overall Study|Abnormal test procedure result|1|||
48616332|NCT02202616|156450626|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48616333|NCT00367458|156450627|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
48616334|NCT00367458|156450628|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
48616335|NCT01129128|156450631|FG000|Overall Study|Lost to Follow-up|2|||
48616336|NCT01129128|156450632|FG001|Overall Study|Lost to Follow-up|2|||
48616337|NCT01129128|156450633|FG002|Overall Study|Lost to Follow-up|1|||
48616338|NCT01129128|156450631|FG000|Overall Study|Protocol Violation|0|||
48616339|NCT01129128|156450632|FG001|Overall Study|Protocol Violation|1|||
48616340|NCT01129128|156450633|FG002|Overall Study|Protocol Violation|0|||
48616341|NCT01129128|156450631|FG000|Overall Study|Withdrawal by Subject|0|||
48616342|NCT01129128|156450632|FG001|Overall Study|Withdrawal by Subject|1|||
48616343|NCT01129128|156450633|FG002|Overall Study|Withdrawal by Subject|3|||
48616344|NCT01129128|156450631|FG000|Overall Study|Physician Decision|1|||
48616345|NCT01129128|156450632|FG001|Overall Study|Physician Decision|0|||
48616346|NCT01129128|156450633|FG002|Overall Study|Physician Decision|0|||
48616347|NCT00961415|156450634|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
48616348|NCT00961415|156450635|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
48616349|NCT00961415|156450636|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
48616350|NCT00961415|156450634|FG000|Induction Treatment Phase|Death|77|||
48616351|NCT00961415|156450635|FG001|Induction Treatment Phase|Death|0|||
48616352|NCT00961415|156450636|FG002|Induction Treatment Phase|Death|0|||
48558644|NCT01009814|156237504|FG003|Overall Study|No longer met study criteria|0|||
48558645|NCT01009814|156237505|FG004|Overall Study|No longer met study criteria|0|||
48558646|NCT00618371|156237506|FG000|Overall Study|Withdrawal by Subject|2|||
48558647|NCT02653625|156237510|FG000|Overall Study|Adverse Event|1|||
48558648|NCT02653625|156237510|FG000|Overall Study|Non-compliance with Study Drug|1|||
48558649|NCT02653625|156237510|FG000|Overall Study|Protocol Violation|1|||
48558650|NCT02653625|156237510|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
48558651|NCT05219448|156237513|FG000|Overall Study|Lost to Follow-up|9|||
48558652|NCT05219448|156237514|FG001|Overall Study|Lost to Follow-up|0|||
48558653|NCT01050530|156237515|FG000|Overall Study|Adverse Event|6|||
48558654|NCT01050530|156237516|FG001|Overall Study|Adverse Event|3|||
48558655|NCT01050530|156237515|FG000|Overall Study|Lack of Efficacy|1|||
48558656|NCT01050530|156237516|FG001|Overall Study|Lack of Efficacy|4|||
48558657|NCT01050530|156237515|FG000|Overall Study|Withdrawal by Subject|0|||
48558658|NCT01050530|156237516|FG001|Overall Study|Withdrawal by Subject|3|||
48558659|NCT01050530|156237515|FG000|Overall Study|Protocol Violation|1|||
48558660|NCT01050530|156237516|FG001|Overall Study|Protocol Violation|0|||
48558661|NCT00545714|156237524|FG000|Induction Phase (6 Months)|Physician Decision|3|||
48558662|NCT00545714|156237524|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
48558663|NCT00545714|156237524|FG000|Induction Phase (6 Months)|Disease Progression|1|||
48558664|NCT00545714|156237524|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
48558665|NCT00545714|156237524|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
48558666|NCT00545714|156237524|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
48558667|NCT00545714|156237524|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
48558668|NCT00545714|156237524|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
48558669|NCT00545714|156237524|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
48616353|NCT00961415|156450634|FG000|Induction Treatment Phase|Protocol Violation|1|||
48616354|NCT00961415|156450635|FG001|Induction Treatment Phase|Protocol Violation|0|||
48616355|NCT00961415|156450636|FG002|Induction Treatment Phase|Protocol Violation|0|||
48616356|NCT00961415|156450634|FG000|Induction Treatment Phase|Physician Decision|2|||
48616357|NCT00961415|156450635|FG001|Induction Treatment Phase|Physician Decision|0|||
48616358|NCT00961415|156450636|FG002|Induction Treatment Phase|Physician Decision|0|||
48616359|NCT00961415|156450634|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
48616360|NCT00961415|156450635|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
48616361|NCT00961415|156450636|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
48616362|NCT00961415|156450634|FG000|Induction Treatment Phase|Other Reason|5|||
48558670|NCT00545714|156237524|FG000|Maintenance Phase (36 Months)|Death|2|||
48616363|NCT00961415|156450635|FG001|Induction Treatment Phase|Other Reason|0|||
48616364|NCT00961415|156450636|FG002|Induction Treatment Phase|Other Reason|0|||
48616365|NCT00961415|156450634|FG000|Maintenance Treatment Phase|Death|0|||
48616366|NCT00961415|156450635|FG001|Maintenance Treatment Phase|Death|42|||
48616367|NCT00961415|156450636|FG002|Maintenance Treatment Phase|Death|34|||
48616368|NCT00961415|156450634|FG000|Maintenance Treatment Phase|Investigators decision|0|||
48616369|NCT00961415|156450635|FG001|Maintenance Treatment Phase|Investigators decision|2|||
48616370|NCT00961415|156450636|FG002|Maintenance Treatment Phase|Investigators decision|0|||
48616371|NCT00961415|156450634|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48616372|NCT00961415|156450635|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
48616373|NCT00961415|156450636|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
48558671|NCT00638508|156237525|FG000|Overall Study|Physician Decision|5|||
48558672|NCT00638508|156237526|FG001|Overall Study|Physician Decision|2|||
48558673|NCT01495000|156237529|FG000|Overall Study|Lost to Follow-up|2|||
48558674|NCT01495000|156237530|FG001|Overall Study|Lost to Follow-up|2|||
48558675|NCT01495000|156237529|FG000|Overall Study|Protocol Violation|1|||
48558676|NCT01495000|156237530|FG001|Overall Study|Protocol Violation|0|||
48558677|NCT01495000|156237529|FG000|Overall Study|Withdrawal by Subject|10|||
48558678|NCT01495000|156237530|FG001|Overall Study|Withdrawal by Subject|10|||
48558679|NCT00370552|156237533|FG000|Overall Study|Adverse Event|2|||
48558680|NCT00370552|156237534|FG001|Overall Study|Adverse Event|2|||
48558681|NCT00370552|156237535|FG002|Overall Study|Adverse Event|2|||
48558682|NCT00370552|156237533|FG000|Overall Study|Disease progression|23|||
48558683|NCT00370552|156237534|FG001|Overall Study|Disease progression|23|||
48558684|NCT00370552|156237535|FG002|Overall Study|Disease progression|15|||
48558685|NCT00370552|156237533|FG000|Overall Study|Maximum clinical benefit|3|||
48558686|NCT00370552|156237534|FG001|Overall Study|Maximum clinical benefit|5|||
48558687|NCT00370552|156237535|FG002|Overall Study|Maximum clinical benefit|5|||
48558688|NCT00370552|156237533|FG000|Overall Study|Poor or noncompliance|0|||
48558689|NCT00370552|156237534|FG001|Overall Study|Poor or noncompliance|0|||
48558690|NCT00370552|156237535|FG002|Overall Study|Poor or noncompliance|1|||
48558691|NCT00370552|156237533|FG000|Overall Study|Study drug toxicity|11|||
48558692|NCT00370552|156237534|FG001|Overall Study|Study drug toxicity|8|||
48558693|NCT00370552|156237535|FG002|Overall Study|Study drug toxicity|6|||
48558694|NCT00370552|156237533|FG000|Overall Study|Withdrawal by Subject|2|||
48558695|NCT00370552|156237534|FG001|Overall Study|Withdrawal by Subject|0|||
48558696|NCT00370552|156237535|FG002|Overall Study|Withdrawal by Subject|1|||
48558697|NCT00370552|156237533|FG000|Overall Study|Still on treatment|1|||
48558698|NCT00370552|156237534|FG001|Overall Study|Still on treatment|3|||
48558699|NCT00370552|156237535|FG002|Overall Study|Still on treatment|2|||
48558700|NCT00370552|156237533|FG000|Overall Study|Never treated|1|||
48558701|NCT00370552|156237534|FG001|Overall Study|Never treated|0|||
48558702|NCT00370552|156237535|FG002|Overall Study|Never treated|0|||
48558703|NCT00370552|156237533|FG000|Overall Study|Physician Decision|1|||
48558704|NCT00370552|156237534|FG001|Overall Study|Physician Decision|1|||
48558705|NCT00370552|156237535|FG002|Overall Study|Physician Decision|0|||
48558706|NCT00370552|156237533|FG000|Overall Study|Investigator decision|2|||
48558707|NCT00370552|156237534|FG001|Overall Study|Investigator decision|1|||
48558708|NCT00370552|156237535|FG002|Overall Study|Investigator decision|0|||
48558709|NCT00370552|156237533|FG000|Overall Study|High risk of allergic reaction|0|||
48558710|NCT00370552|156237534|FG001|Overall Study|High risk of allergic reaction|1|||
48558711|NCT00370552|156237535|FG002|Overall Study|High risk of allergic reaction|0|||
48558712|NCT00370552|156237533|FG000|Overall Study|Planned radiation for palliation|0|||
48558713|NCT00370552|156237534|FG001|Overall Study|Planned radiation for palliation|1|||
48558714|NCT00370552|156237535|FG002|Overall Study|Planned radiation for palliation|0|||
48558715|NCT02556801|156237538|FG000|Overall Study|Lost to Follow-up|1|||
48558716|NCT02556801|156237539|FG001|Overall Study|Lost to Follow-up|0|||
48558717|NCT02556801|156237540|FG002|Overall Study|Lost to Follow-up|2|||
48558718|NCT02556801|156237541|FG003|Overall Study|Lost to Follow-up|0|||
48558719|NCT02556801|156237538|FG000|Overall Study|Withdrawal by Subject|1|||
48558720|NCT02556801|156237539|FG001|Overall Study|Withdrawal by Subject|1|||
48558721|NCT02556801|156237540|FG002|Overall Study|Withdrawal by Subject|1|||
48558722|NCT02556801|156237541|FG003|Overall Study|Withdrawal by Subject|0|||
48558723|NCT02556801|156237538|FG000|Overall Study|Protocol Violation|0|||
48558724|NCT02556801|156237539|FG001|Overall Study|Protocol Violation|3|||
48558725|NCT02556801|156237540|FG002|Overall Study|Protocol Violation|1|||
48558726|NCT02556801|156237541|FG003|Overall Study|Protocol Violation|1|||
48558727|NCT02556801|156237538|FG000|Overall Study|Adverse Event|0|||
48558728|NCT02556801|156237539|FG001|Overall Study|Adverse Event|2|||
48558729|NCT02556801|156237540|FG002|Overall Study|Adverse Event|0|||
48558730|NCT02556801|156237541|FG003|Overall Study|Adverse Event|3|||
48558731|NCT02556801|156237538|FG000|Overall Study|Pregnancy|0|||
48558732|NCT02556801|156237539|FG001|Overall Study|Pregnancy|1|||
48558733|NCT02556801|156237540|FG002|Overall Study|Pregnancy|0|||
48558734|NCT02556801|156237541|FG003|Overall Study|Pregnancy|0|||
48558735|NCT02556801|156237538|FG000|Overall Study|Personal reasons patient|0|||
48558736|NCT02556801|156237539|FG001|Overall Study|Personal reasons patient|0|||
48558737|NCT02556801|156237540|FG002|Overall Study|Personal reasons patient|0|||
48616374|NCT00961415|156450634|FG000|Maintenance Treatment Phase|Other reason|0|||
48558738|NCT02556801|156237541|FG003|Overall Study|Personal reasons patient|1|||
48558739|NCT00485264|156237544|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
48558740|NCT00485264|156237545|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
48616375|NCT00961415|156450635|FG001|Maintenance Treatment Phase|Other reason|1|||
48616376|NCT00961415|156450636|FG002|Maintenance Treatment Phase|Other reason|3|||
48616377|NCT04666298|156450637|FG000|Overall Study|Subject decision|1|||
48616378|NCT04666298|156450638|FG001|Overall Study|Subject decision|0|||
48616379|NCT04666298|156450639|FG002|Overall Study|Subject decision|0|||
48616380|NCT04666298|156450640|FG003|Overall Study|Subject decision|2|||
48558741|NCT00485264|156237546|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
48558742|NCT00485264|156237547|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
48558743|NCT00485264|156237548|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
48558744|NCT00485264|156237549|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
48558745|NCT00485264|156237544|FG000|Overall Study|Death|1|||
48558746|NCT00485264|156237545|FG001|Overall Study|Death|0|||
48558747|NCT00485264|156237546|FG002|Overall Study|Death|0|||
48558748|NCT00485264|156237547|FG003|Overall Study|Death|0|||
48558749|NCT00485264|156237548|FG004|Overall Study|Death|1|||
48558750|NCT00485264|156237549|FG005|Overall Study|Death|0|||
48558751|NCT00485264|156237544|FG000|Overall Study|Adverse Event|1|||
48558752|NCT00485264|156237545|FG001|Overall Study|Adverse Event|0|||
48558753|NCT00485264|156237546|FG002|Overall Study|Adverse Event|2|||
48558754|NCT00485264|156237547|FG003|Overall Study|Adverse Event|3|||
48558755|NCT00485264|156237548|FG004|Overall Study|Adverse Event|1|||
48558756|NCT00485264|156237549|FG005|Overall Study|Adverse Event|3|||
48558757|NCT00485264|156237544|FG000|Overall Study|Pregnancy|4|||
48558758|NCT00485264|156237545|FG001|Overall Study|Pregnancy|0|||
48558759|NCT00485264|156237546|FG002|Overall Study|Pregnancy|0|||
48558760|NCT00485264|156237547|FG003|Overall Study|Pregnancy|0|||
48558761|NCT00485264|156237548|FG004|Overall Study|Pregnancy|0|||
48558762|NCT00485264|156237549|FG005|Overall Study|Pregnancy|0|||
48558763|NCT00485264|156237544|FG000|Overall Study|Disallowed Medication|0|||
48558764|NCT00485264|156237545|FG001|Overall Study|Disallowed Medication|0|||
48558765|NCT00485264|156237546|FG002|Overall Study|Disallowed Medication|0|||
48558766|NCT00485264|156237547|FG003|Overall Study|Disallowed Medication|0|||
48558767|NCT00485264|156237548|FG004|Overall Study|Disallowed Medication|0|||
48558768|NCT00485264|156237549|FG005|Overall Study|Disallowed Medication|1|||
48558769|NCT00485264|156237544|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
48558770|NCT00485264|156237545|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
48558771|NCT00485264|156237546|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
48558772|NCT00485264|156237547|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
48558773|NCT00485264|156237548|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
48558774|NCT00485264|156237549|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
48558775|NCT00485264|156237544|FG000|Overall Study|Lack of Efficacy|0|||
48558776|NCT00485264|156237545|FG001|Overall Study|Lack of Efficacy|1|||
48558777|NCT00485264|156237546|FG002|Overall Study|Lack of Efficacy|0|||
48558778|NCT00485264|156237547|FG003|Overall Study|Lack of Efficacy|0|||
48558779|NCT00485264|156237548|FG004|Overall Study|Lack of Efficacy|0|||
48558780|NCT00485264|156237549|FG005|Overall Study|Lack of Efficacy|0|||
48558781|NCT00485264|156237544|FG000|Overall Study|Guardian Consent Withdrawn|1|||
48558782|NCT00485264|156237545|FG001|Overall Study|Guardian Consent Withdrawn|0|||
48558783|NCT00485264|156237546|FG002|Overall Study|Guardian Consent Withdrawn|0|||
48558784|NCT00485264|156237547|FG003|Overall Study|Guardian Consent Withdrawn|0|||
48558785|NCT00485264|156237548|FG004|Overall Study|Guardian Consent Withdrawn|1|||
48616381|NCT04666298|156450637|FG000|Overall Study|Death|1|||
48616382|NCT04666298|156450638|FG001|Overall Study|Death|0|||
48616383|NCT04666298|156450639|FG002|Overall Study|Death|0|||
48616384|NCT04666298|156450640|FG003|Overall Study|Death|0|||
48616385|NCT04666298|156450637|FG000|Overall Study|Lost to Follow-up|0|||
48616386|NCT04666298|156450638|FG001|Overall Study|Lost to Follow-up|0|||
48616387|NCT04666298|156450639|FG002|Overall Study|Lost to Follow-up|0|||
48558786|NCT00485264|156237549|FG005|Overall Study|Guardian Consent Withdrawn|0|||
48558787|NCT00485264|156237544|FG000|Overall Study|Physician Decision|0|||
48616388|NCT04666298|156450640|FG003|Overall Study|Lost to Follow-up|1|||
48558788|NCT00485264|156237545|FG001|Overall Study|Physician Decision|2|||
48616389|NCT04666298|156450637|FG000|Overall Study|Physician Decision|0|||
48616390|NCT04666298|156450638|FG001|Overall Study|Physician Decision|0|||
48558789|NCT00485264|156237546|FG002|Overall Study|Physician Decision|0|||
48558790|NCT00485264|156237547|FG003|Overall Study|Physician Decision|0|||
48558791|NCT00485264|156237548|FG004|Overall Study|Physician Decision|0|||
48558792|NCT00485264|156237549|FG005|Overall Study|Physician Decision|0|||
48616391|NCT04666298|156450639|FG002|Overall Study|Physician Decision|0|||
48558793|NCT00485264|156237544|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
48558794|NCT00485264|156237545|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
48558795|NCT00485264|156237546|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
48558796|NCT00485264|156237547|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
48558797|NCT00485264|156237548|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
48558798|NCT00485264|156237549|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
48616392|NCT04666298|156450640|FG003|Overall Study|Physician Decision|1|||
48616393|NCT04666298|156450637|FG000|Overall Study|Protocol deviation|0|||
48616394|NCT04666298|156450638|FG001|Overall Study|Protocol deviation|0|||
48616395|NCT04666298|156450639|FG002|Overall Study|Protocol deviation|1|||
48616396|NCT04666298|156450640|FG003|Overall Study|Protocol deviation|0|||
48616397|NCT01311661|156450643|FG000|Overall Study|Adverse Event|2|||
48616398|NCT01311661|156450643|FG000|Overall Study|Protocol Violation|3|||
48616399|NCT01311661|156450643|FG000|Overall Study|Withdrawal by Subject|2|||
48616400|NCT01334515|156450644|FG000|Overall Study|Adverse Event|1|||
48616401|NCT01334515|156450645|FG001|Overall Study|Adverse Event|6|||
48616402|NCT01334515|156450644|FG000|Overall Study|Death|1|||
48616403|NCT01334515|156450645|FG001|Overall Study|Death|0|||
48616404|NCT01334515|156450644|FG000|Overall Study|Lack of Efficacy|8|||
48616405|NCT01334515|156450645|FG001|Overall Study|Lack of Efficacy|21|||
48616406|NCT01334515|156450644|FG000|Overall Study|Physician Decision|1|||
48616407|NCT01334515|156450645|FG001|Overall Study|Physician Decision|1|||
48616408|NCT01334515|156450644|FG000|Overall Study|Withdrawal by Subject|1|||
48558799|NCT00485264|156237544|FG000|Overall Study|Not Able to Attend Clinic|5|||
48558800|NCT00485264|156237545|FG001|Overall Study|Not Able to Attend Clinic|0|||
48558801|NCT00485264|156237546|FG002|Overall Study|Not Able to Attend Clinic|0|||
48558802|NCT00485264|156237547|FG003|Overall Study|Not Able to Attend Clinic|1|||
48558803|NCT00485264|156237548|FG004|Overall Study|Not Able to Attend Clinic|1|||
48558804|NCT00485264|156237549|FG005|Overall Study|Not Able to Attend Clinic|2|||
48558805|NCT00485264|156237544|FG000|Overall Study|Non-Compliant|17|||
48558806|NCT00485264|156237545|FG001|Overall Study|Non-Compliant|2|||
48558807|NCT00485264|156237546|FG002|Overall Study|Non-Compliant|1|||
48558808|NCT00485264|156237547|FG003|Overall Study|Non-Compliant|0|||
48558809|NCT00485264|156237548|FG004|Overall Study|Non-Compliant|1|||
48558810|NCT00485264|156237549|FG005|Overall Study|Non-Compliant|0|||
48558811|NCT00485264|156237544|FG000|Overall Study|Lost to Follow-up|2|||
48558812|NCT00485264|156237545|FG001|Overall Study|Lost to Follow-up|1|||
48558813|NCT00485264|156237546|FG002|Overall Study|Lost to Follow-up|1|||
48558814|NCT00485264|156237547|FG003|Overall Study|Lost to Follow-up|0|||
48558815|NCT00485264|156237548|FG004|Overall Study|Lost to Follow-up|0|||
48558816|NCT00485264|156237549|FG005|Overall Study|Lost to Follow-up|1|||
48558817|NCT00485264|156237544|FG000|Overall Study|Other Reason|3|||
48558818|NCT00485264|156237545|FG001|Overall Study|Other Reason|0|||
48558819|NCT00485264|156237546|FG002|Overall Study|Other Reason|0|||
48558820|NCT00485264|156237547|FG003|Overall Study|Other Reason|0|||
48558821|NCT00485264|156237548|FG004|Overall Study|Other Reason|0|||
48558822|NCT00485264|156237549|FG005|Overall Study|Other Reason|0|||
48558823|NCT03668808|156237550|FG000|First Intervention|Withdrawal by Subject|2|||
48558824|NCT03668808|156237551|FG001|First Intervention|Withdrawal by Subject|2|||
48616409|NCT01334515|156450645|FG001|Overall Study|Withdrawal by Subject|1|||
48616410|NCT00604383|156450646|FG000|Overall Study|Withdrawal by Subject|33|||
48558825|NCT02273388|156237552|FG000|Overall Study|Adverse Event|0|||
48558826|NCT02273388|156237553|FG001|Overall Study|Adverse Event|0|||
48558827|NCT02273388|156237554|FG002|Overall Study|Adverse Event|0|||
48558828|NCT02273388|156237555|FG003|Overall Study|Adverse Event|0|||
48558829|NCT02273388|156237556|FG004|Overall Study|Adverse Event|0|||
48558830|NCT02273388|156237557|FG005|Overall Study|Adverse Event|0|||
48616411|NCT00604383|156450647|FG001|Overall Study|Withdrawal by Subject|31|||
48616412|NCT00604383|156450646|FG000|Overall Study|Lost to Follow-up|24|||
48558831|NCT02273388|156237558|FG006|Overall Study|Adverse Event|1|||
48558832|NCT02273388|156237559|FG007|Overall Study|Adverse Event|2|||
48558833|NCT02273388|156237560|FG008|Overall Study|Adverse Event|0|||
48558834|NCT02273388|156237561|FG009|Overall Study|Adverse Event|0|||
48558835|NCT02273388|156237562|FG010|Overall Study|Adverse Event|0|||
48558836|NCT02273388|156237563|FG011|Overall Study|Adverse Event|0|||
48558837|NCT02273388|156237552|FG000|Overall Study|Adverse Event study disease worse|4|||
48558838|NCT02273388|156237553|FG001|Overall Study|Adverse Event study disease worse|3|||
48558839|NCT02273388|156237554|FG002|Overall Study|Adverse Event study disease worse|3|||
48558840|NCT02273388|156237555|FG003|Overall Study|Adverse Event study disease worse|2|||
48558841|NCT02273388|156237556|FG004|Overall Study|Adverse Event study disease worse|4|||
48558842|NCT02273388|156237557|FG005|Overall Study|Adverse Event study disease worse|3|||
48558843|NCT02273388|156237558|FG006|Overall Study|Adverse Event study disease worse|14|||
48558844|NCT02273388|156237559|FG007|Overall Study|Adverse Event study disease worse|6|||
48558845|NCT02273388|156237560|FG008|Overall Study|Adverse Event study disease worse|6|||
48558846|NCT02273388|156237561|FG009|Overall Study|Adverse Event study disease worse|5|||
48558847|NCT02273388|156237562|FG010|Overall Study|Adverse Event study disease worse|10|||
48558848|NCT02273388|156237563|FG011|Overall Study|Adverse Event study disease worse|1|||
48558849|NCT02273388|156237552|FG000|Overall Study|Sponsor decision|0|||
48558850|NCT02273388|156237553|FG001|Overall Study|Sponsor decision|0|||
48558851|NCT02273388|156237554|FG002|Overall Study|Sponsor decision|0|||
48558852|NCT02273388|156237555|FG003|Overall Study|Sponsor decision|0|||
48558853|NCT02273388|156237556|FG004|Overall Study|Sponsor decision|0|||
48558854|NCT02273388|156237557|FG005|Overall Study|Sponsor decision|0|||
48558855|NCT02273388|156237558|FG006|Overall Study|Sponsor decision|0|||
48558856|NCT02273388|156237559|FG007|Overall Study|Sponsor decision|0|||
48558857|NCT02273388|156237560|FG008|Overall Study|Sponsor decision|0|||
48558858|NCT02273388|156237561|FG009|Overall Study|Sponsor decision|0|||
48558859|NCT02273388|156237562|FG010|Overall Study|Sponsor decision|0|||
48558860|NCT02273388|156237563|FG011|Overall Study|Sponsor decision|1|||
48558861|NCT01289678|156237564|FG000|Overall Study|Physician Decision|6|||
48558862|NCT03500198|156237575|FG000|Overall Study|Lost to Follow-up|0|||
48558863|NCT03500198|156237576|FG001|Overall Study|Lost to Follow-up|1|||
48558864|NCT00322712|156237577|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
48558865|NCT03267212|156237578|FG000|First Intervention|Lost to Follow-up|0|||
48558866|NCT03267212|156237579|FG001|First Intervention|Lost to Follow-up|2|||
48558867|NCT03267212|156237578|FG000|First Intervention|Withdrawal by Subject|1|||
48558868|NCT03267212|156237579|FG001|First Intervention|Withdrawal by Subject|1|||
48558869|NCT03267212|156237578|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
48558870|NCT03267212|156237579|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
48558871|NCT02071225|156237580|FG000|Overall Study|Withdrawal of Consent|2|||
48558872|NCT02071225|156237580|FG000|Overall Study|Protocol Deviation|1|||
48558873|NCT02071225|156237580|FG000|Overall Study|Lost to Follow-up|2|||
48558874|NCT02071225|156237580|FG000|Overall Study|Death|25|||
48558875|NCT01526655|156237583|FG000|Overall Study|Withdrawal by Subject|0|||
48558876|NCT01526655|156237584|FG001|Overall Study|Withdrawal by Subject|1|||
48558877|NCT01514461|156237585|FG000|Overall Study|Adverse Event|2|||
48558878|NCT01514461|156237586|FG001|Overall Study|Adverse Event|1|||
48558879|NCT01514461|156237587|FG002|Overall Study|Adverse Event|3|||
48558880|NCT01514461|156237585|FG000|Overall Study|Physician Decision|1|||
48558881|NCT01514461|156237586|FG001|Overall Study|Physician Decision|1|||
48558882|NCT01514461|156237587|FG002|Overall Study|Physician Decision|0|||
48558883|NCT01514461|156237585|FG000|Overall Study|Patient/guardian decision|1|||
48558884|NCT01514461|156237586|FG001|Overall Study|Patient/guardian decision|1|||
48558885|NCT01514461|156237587|FG002|Overall Study|Patient/guardian decision|1|||
48558886|NCT01514461|156237585|FG000|Overall Study|Death|1|||
48558887|NCT01514461|156237586|FG001|Overall Study|Death|0|||
48558888|NCT01514461|156237587|FG002|Overall Study|Death|0|||
48558889|NCT03889886|156237588|FG000|Overall Study|Other|0|||
48558890|NCT03889886|156237589|FG001|Overall Study|Other|1|||
48558891|NCT03889886|156237590|FG002|Overall Study|Other|0|||
48558892|NCT03889886|156237591|FG003|Overall Study|Other|1|||
48558893|NCT03889886|156237588|FG000|Overall Study|Withdrawal by Subject|0|||
48558894|NCT03889886|156237589|FG001|Overall Study|Withdrawal by Subject|0|||
48558895|NCT03889886|156237590|FG002|Overall Study|Withdrawal by Subject|1|||
48558896|NCT03889886|156237591|FG003|Overall Study|Withdrawal by Subject|0|||
48558897|NCT03889886|156237588|FG000|Overall Study|Adverse Event|0|||
48558898|NCT03889886|156237589|FG001|Overall Study|Adverse Event|0|||
48558899|NCT03889886|156237590|FG002|Overall Study|Adverse Event|0|||
48558900|NCT03889886|156237591|FG003|Overall Study|Adverse Event|6|||
48558901|NCT01569295|156237593|FG000|Overall Study|Progressive Disease|75|||
48558902|NCT01569295|156237594|FG001|Overall Study|Progressive Disease|139|||
48558903|NCT01569295|156237593|FG000|Overall Study|Adverse Event|39|||
48558904|NCT01569295|156237594|FG001|Overall Study|Adverse Event|14|||
48558905|NCT01569295|156237593|FG000|Overall Study|Withdrawal by Subject|25|||
48616413|NCT00604383|156450647|FG001|Overall Study|Lost to Follow-up|19|||
48616414|NCT00604383|156450646|FG000|Overall Study|Death|14|||
48616415|NCT00604383|156450647|FG001|Overall Study|Death|22|||
48616416|NCT00604383|156450646|FG000|Overall Study|Adverse Event|16|||
48616417|NCT00604383|156450647|FG001|Overall Study|Adverse Event|9|||
48616418|NCT00604383|156450646|FG000|Overall Study|Physician Decision|0|||
48616419|NCT00604383|156450647|FG001|Overall Study|Physician Decision|3|||
48616420|NCT02287025|156450648|FG000|Overall Study|Not treated|2|||
48616421|NCT02287025|156450649|FG001|Overall Study|Not treated|0|||
48616422|NCT02287025|156450648|FG000|Overall Study|Progression of disease|3|||
48616423|NCT02287025|156450649|FG001|Overall Study|Progression of disease|2|||
48616424|NCT02287025|156450648|FG000|Overall Study|Adverse Event|2|||
48616425|NCT02287025|156450649|FG001|Overall Study|Adverse Event|4|||
48616426|NCT02287025|156450648|FG000|Overall Study|Withdrawal by Subject|2|||
48616427|NCT02287025|156450649|FG001|Overall Study|Withdrawal by Subject|2|||
48616428|NCT02287025|156450648|FG000|Overall Study|Screening failed|1|||
48616429|NCT02287025|156450649|FG001|Overall Study|Screening failed|1|||
48616430|NCT00899847|156450650|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
48616431|NCT00221104|156450659|FG000|Overall Study|Adverse Event|1|||
48558906|NCT01569295|156237594|FG001|Overall Study|Withdrawal by Subject|12|||
48558907|NCT01569295|156237593|FG000|Overall Study|Death|19|||
48558908|NCT01569295|156237594|FG001|Overall Study|Death|15|||
48558909|NCT01569295|156237593|FG000|Overall Study|Physician Decision|13|||
48558910|NCT01569295|156237594|FG001|Overall Study|Physician Decision|18|||
48616432|NCT00221104|156450660|FG001|Overall Study|Adverse Event|0|||
48558911|NCT01569295|156237593|FG000|Overall Study|Study Terminated by Sponsor|24|||
48558912|NCT01569295|156237594|FG001|Overall Study|Study Terminated by Sponsor|2|||
48558913|NCT01569295|156237593|FG000|Overall Study|Other Reason not Specified|3|||
48558914|NCT01569295|156237594|FG001|Overall Study|Other Reason not Specified|5|||
48558915|NCT01569295|156237593|FG000|Overall Study|Non-Compliance with Study Drug|6|||
48558916|NCT01569295|156237594|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48558917|NCT01569295|156237593|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
48558918|NCT01569295|156237594|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
48558919|NCT01569295|156237593|FG000|Overall Study|Lost to Follow-up|1|||
48558920|NCT01569295|156237594|FG001|Overall Study|Lost to Follow-up|1|||
48558921|NCT02058069|156237595|FG000|Overall Study|Exclusion due to implant size|5|||
48558922|NCT02058069|156237595|FG000|Overall Study|Withdrawal by Subject|6|||
48558923|NCT01254643|156237602|FG000|Overall Study|Withdrawal by Subject|1|||
48558924|NCT01626690|156237604|FG000|Overall Study|Protocol Violation|1|||
48558925|NCT01626690|156237605|FG001|Overall Study|Protocol Violation|0|||
48558926|NCT01626690|156237604|FG000|Overall Study|Adverse Event|1|||
48558927|NCT01626690|156237605|FG001|Overall Study|Adverse Event|0|||
48558928|NCT02286843|156237609|FG000|Overall Study|Not Treated|4|||
48558929|NCT02286843|156237609|FG000|Overall Study|Protocol Violation|1|||
48558930|NCT02286843|156237609|FG000|Overall Study|Withdrawal by Subject|1|||
48558931|NCT00235755|156237610|FG000|4-Week Titration Phase|Adverse Event|6|||
48558932|NCT00235755|156237611|FG001|4-Week Titration Phase|Adverse Event|14|||
48558933|NCT00235755|156237612|FG002|4-Week Titration Phase|Adverse Event|20|||
48558934|NCT00235755|156237610|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
48558935|NCT00235755|156237611|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
48558936|NCT00235755|156237612|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
48558937|NCT00235755|156237610|FG000|4-Week Titration Phase|Protocol Violation|2|||
48558938|NCT00235755|156237611|FG001|4-Week Titration Phase|Protocol Violation|2|||
48558939|NCT00235755|156237612|FG002|4-Week Titration Phase|Protocol Violation|1|||
48558940|NCT00235755|156237610|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
48558941|NCT00235755|156237611|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
48558942|NCT00235755|156237612|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
48558943|NCT00235755|156237610|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
48558944|NCT00235755|156237611|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
48558945|NCT00235755|156237612|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
48558946|NCT00235755|156237610|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
48558947|NCT00235755|156237611|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
48558948|NCT00235755|156237612|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
48558949|NCT00235755|156237610|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
48558950|NCT00235755|156237611|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
48558951|NCT00235755|156237612|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
48558952|NCT00235755|156237610|FG000|12-Week Maintenance Phase|Adverse Event|8|||
48558953|NCT00235755|156237611|FG001|12-Week Maintenance Phase|Adverse Event|12|||
48558954|NCT00235755|156237612|FG002|12-Week Maintenance Phase|Adverse Event|26|||
48558955|NCT00235755|156237610|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
48558956|NCT00235755|156237611|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
48558957|NCT00235755|156237612|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
48558958|NCT00235755|156237610|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
48558959|NCT00235755|156237611|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
48558960|NCT00235755|156237612|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
48558961|NCT00235755|156237610|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
48558962|NCT00235755|156237611|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
48558963|NCT00235755|156237612|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
48558964|NCT00235755|156237610|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
48558965|NCT00235755|156237611|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
48558966|NCT00235755|156237612|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
48558967|NCT00235755|156237610|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
48558968|NCT00235755|156237611|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
48558969|NCT00235755|156237612|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
48558970|NCT03518008|156237613|FG000|Period 2, Second Week of Wear|Family emergency|0|||
48558971|NCT03518008|156237614|FG001|Period 2, Second Week of Wear|Family emergency|1|||
48558972|NCT01147068|156237616|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
48558973|NCT01147068|156237617|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
48558974|NCT01147068|156237618|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
48558975|NCT01147068|156237619|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
48558976|NCT01147068|156237620|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
48558977|NCT01147068|156237621|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
48558978|NCT01147068|156237622|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
48558979|NCT01147068|156237616|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
48558980|NCT01147068|156237617|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
48558981|NCT01147068|156237618|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
48558982|NCT01147068|156237619|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
48558983|NCT01147068|156237620|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
48558984|NCT01147068|156237621|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
48558985|NCT01147068|156237622|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
48558986|NCT01147068|156237616|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
48558987|NCT01147068|156237617|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
48558988|NCT01147068|156237618|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
48558989|NCT01147068|156237619|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
48558990|NCT01147068|156237620|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
48558991|NCT01147068|156237621|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
48558992|NCT01147068|156237622|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
48558993|NCT01147068|156237616|FG000|Subjects That Received 2nd Dose|Other|0|||
48558994|NCT01147068|156237617|FG001|Subjects That Received 2nd Dose|Other|3|||
48558995|NCT01147068|156237618|FG002|Subjects That Received 2nd Dose|Other|3|||
48558996|NCT01147068|156237619|FG003|Subjects That Received 2nd Dose|Other|0|||
48616433|NCT00221104|156450659|FG000|Overall Study|Physician Decision|1|||
48558997|NCT01147068|156237620|FG004|Subjects That Received 2nd Dose|Other|1|||
48558998|NCT01147068|156237621|FG005|Subjects That Received 2nd Dose|Other|0|||
48558999|NCT01147068|156237622|FG006|Subjects That Received 2nd Dose|Other|0|||
48559000|NCT01147068|156237616|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
48559001|NCT01147068|156237617|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
48559002|NCT01147068|156237618|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
48559003|NCT01147068|156237619|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
48559004|NCT01147068|156237620|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
48559005|NCT01147068|156237621|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
48559006|NCT01147068|156237622|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
48559007|NCT01147068|156237616|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
48559008|NCT01147068|156237617|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
48559009|NCT01147068|156237618|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
48559010|NCT01147068|156237619|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
48559011|NCT01147068|156237620|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
48559012|NCT01147068|156237621|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
48559013|NCT01147068|156237622|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
48559014|NCT01147068|156237616|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
48559015|NCT01147068|156237617|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
48559016|NCT01147068|156237618|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
48559017|NCT01147068|156237619|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
48559018|NCT01147068|156237620|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
48559019|NCT01147068|156237621|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
48559020|NCT01147068|156237622|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
48559021|NCT00122382|156237628|FG000|Double-Blind Study|Adverse Event|9|||
48616434|NCT00221104|156450660|FG001|Overall Study|Physician Decision|0|||
48616435|NCT00221104|156450659|FG000|Overall Study|Protocol Violation|2|||
48616436|NCT00221104|156450660|FG001|Overall Study|Protocol Violation|0|||
48616437|NCT00221104|156450659|FG000|Overall Study|Withdrawal by Subject|42|||
48616438|NCT00221104|156450660|FG001|Overall Study|Withdrawal by Subject|29|||
48616439|NCT00221104|156450659|FG000|Overall Study|Others|37|||
48616440|NCT00221104|156450660|FG001|Overall Study|Others|47|||
48616441|NCT00876343|156450661|FG000|Overall Study|Adverse Event|7|||
48616442|NCT00876343|156450662|FG001|Overall Study|Adverse Event|8|||
48616443|NCT00876343|156450663|FG002|Overall Study|Adverse Event|2|||
48616444|NCT00876343|156450661|FG000|Overall Study|Withdrawal by Subject|4|||
48616445|NCT00876343|156450662|FG001|Overall Study|Withdrawal by Subject|4|||
48616446|NCT00876343|156450663|FG002|Overall Study|Withdrawal by Subject|3|||
48616447|NCT00876343|156450661|FG000|Overall Study|Lack of Efficacy|0|||
48616448|NCT00876343|156450662|FG001|Overall Study|Lack of Efficacy|0|||
48616449|NCT00876343|156450663|FG002|Overall Study|Lack of Efficacy|1|||
48616450|NCT00876343|156450661|FG000|Overall Study|Protocol Violation|4|||
48616451|NCT00876343|156450662|FG001|Overall Study|Protocol Violation|1|||
48616452|NCT00876343|156450663|FG002|Overall Study|Protocol Violation|1|||
48616453|NCT00876343|156450661|FG000|Overall Study|Physician Decision|0|||
48616454|NCT00876343|156450662|FG001|Overall Study|Physician Decision|1|||
48616455|NCT00876343|156450663|FG002|Overall Study|Physician Decision|1|||
48616456|NCT00876343|156450661|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
48616457|NCT00876343|156450662|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
48616458|NCT00876343|156450663|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
48616459|NCT00876343|156450661|FG000|Overall Study|Change of residence or other commitments|2|||
48616460|NCT00876343|156450662|FG001|Overall Study|Change of residence or other commitments|2|||
48616461|NCT00876343|156450663|FG002|Overall Study|Change of residence or other commitments|3|||
48616462|NCT01279200|156450666|FG000|Overall Study|Withdrawal by Subject|1|||
48616463|NCT01279200|156450667|FG001|Overall Study|Withdrawal by Subject|3|||
48616464|NCT01279200|156450666|FG000|Overall Study|Patient withdrawal due to high cost|0|||
48616465|NCT01279200|156450667|FG001|Overall Study|Patient withdrawal due to high cost|1|||
48616466|NCT01279200|156450666|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
48616467|NCT01279200|156450667|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
48616468|NCT01279200|156450666|FG000|Overall Study|ultrasound screening failure|0|||
48616469|NCT01279200|156450667|FG001|Overall Study|ultrasound screening failure|1|||
48616470|NCT01279200|156450666|FG000|Overall Study|Lost to Follow-up|0|||
48559022|NCT00122382|156237629|FG001|Double-Blind Study|Adverse Event|11|||
48559023|NCT00122382|156237630|FG002|Double-Blind Study|Adverse Event|0|||
48559024|NCT00122382|156237628|FG000|Double-Blind Study|Death|2|||
48559025|NCT00122382|156237629|FG001|Double-Blind Study|Death|2|||
48559026|NCT00122382|156237630|FG002|Double-Blind Study|Death|0|||
48559027|NCT00122382|156237628|FG000|Double-Blind Study|Lack of Efficacy|0|||
48559028|NCT00122382|156237629|FG001|Double-Blind Study|Lack of Efficacy|8|||
48559029|NCT00122382|156237630|FG002|Double-Blind Study|Lack of Efficacy|0|||
48559030|NCT00122382|156237628|FG000|Double-Blind Study|Lost to Follow-up|2|||
48559031|NCT00122382|156237629|FG001|Double-Blind Study|Lost to Follow-up|1|||
48559032|NCT00122382|156237630|FG002|Double-Blind Study|Lost to Follow-up|0|||
48559033|NCT00122382|156237628|FG000|Double-Blind Study|Pregnancy|2|||
48559034|NCT00122382|156237629|FG001|Double-Blind Study|Pregnancy|0|||
48559035|NCT00122382|156237630|FG002|Double-Blind Study|Pregnancy|0|||
48559036|NCT00122382|156237628|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
48559037|NCT00122382|156237629|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
48559038|NCT00122382|156237630|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
48559039|NCT00122382|156237628|FG000|Double-Blind Study|Withdrawal of Consent|7|||
48559040|NCT00122382|156237629|FG001|Double-Blind Study|Withdrawal of Consent|3|||
48559041|NCT00122382|156237630|FG002|Double-Blind Study|Withdrawal of Consent|0|||
48559042|NCT00122382|156237628|FG000|Double-Blind Study|Protocol Violation|1|||
48559043|NCT00122382|156237629|FG001|Double-Blind Study|Protocol Violation|0|||
48559044|NCT00122382|156237630|FG002|Double-Blind Study|Protocol Violation|0|||
48559045|NCT00122382|156237628|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
48559046|NCT00122382|156237629|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
48559047|NCT00122382|156237630|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
48559048|NCT00122382|156237628|FG000|Double-Blind Study|Randomized but not treated|0|||
48616471|NCT01279200|156450667|FG001|Overall Study|Lost to Follow-up|1|||
48616472|NCT01279200|156450666|FG000|Overall Study|Adverse Event|1|||
48559049|NCT00122382|156237629|FG001|Double-Blind Study|Randomized but not treated|2|||
48559050|NCT00122382|156237630|FG002|Double-Blind Study|Randomized but not treated|0|||
48559051|NCT00122382|156237628|FG000|Open-Label Study|Adverse Event|0|||
48559052|NCT00122382|156237629|FG001|Open-Label Study|Adverse Event|0|||
48559053|NCT00122382|156237630|FG002|Open-Label Study|Adverse Event|11|||
48559054|NCT00122382|156237628|FG000|Open-Label Study|Death|0|||
48559055|NCT00122382|156237629|FG001|Open-Label Study|Death|0|||
48559056|NCT00122382|156237630|FG002|Open-Label Study|Death|2|||
48559057|NCT00122382|156237628|FG000|Open-Label Study|Lack of Efficacy|0|||
48559058|NCT00122382|156237629|FG001|Open-Label Study|Lack of Efficacy|0|||
48559059|NCT00122382|156237630|FG002|Open-Label Study|Lack of Efficacy|3|||
48559060|NCT00122382|156237628|FG000|Open-Label Study|Lost to Follow-up|0|||
48559061|NCT00122382|156237629|FG001|Open-Label Study|Lost to Follow-up|0|||
48559062|NCT00122382|156237630|FG002|Open-Label Study|Lost to Follow-up|3|||
48559063|NCT00122382|156237628|FG000|Open-Label Study|Pregnancy|0|||
48559064|NCT00122382|156237629|FG001|Open-Label Study|Pregnancy|0|||
48559065|NCT00122382|156237630|FG002|Open-Label Study|Pregnancy|2|||
48559066|NCT00122382|156237628|FG000|Open-Label Study|Poor/Non-Compliance|0|||
48559067|NCT00122382|156237629|FG001|Open-Label Study|Poor/Non-Compliance|0|||
48559068|NCT00122382|156237630|FG002|Open-Label Study|Poor/Non-Compliance|1|||
48559069|NCT00122382|156237628|FG000|Open-Label Study|Withdrawal of Consent|0|||
48559070|NCT00122382|156237629|FG001|Open-Label Study|Withdrawal of Consent|0|||
48616473|NCT01279200|156450667|FG001|Overall Study|Adverse Event|0|||
48559071|NCT00122382|156237630|FG002|Open-Label Study|Withdrawal of Consent|4|||
48559072|NCT00725920|156237631|FG000|Overall Study|Lack of Efficacy|3|||
48559073|NCT00725920|156237632|FG001|Overall Study|Lack of Efficacy|6|||
48559074|NCT02456740|156237636|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
48559075|NCT02456740|156237637|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
48559076|NCT02456740|156237638|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
48616474|NCT01901562|156450669|FG000|Overall Study|Protocol Violation|5|||
48559077|NCT02456740|156237639|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
48559078|NCT02456740|156237640|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
48559079|NCT02456740|156237641|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
48559080|NCT02456740|156237642|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
48559081|NCT02456740|156237643|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
48559082|NCT02456740|156237644|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
48559083|NCT02456740|156237636|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
48630349|NCT02082977|156504938|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
48559084|NCT02456740|156237637|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
48559085|NCT02456740|156237638|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
48559086|NCT02456740|156237639|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
48559087|NCT02456740|156237640|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
48559088|NCT02456740|156237641|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
48559089|NCT02456740|156237642|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
48559090|NCT02456740|156237643|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
48559091|NCT02456740|156237644|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
48559092|NCT02456740|156237636|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
48559093|NCT02456740|156237637|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
48559094|NCT02456740|156237638|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
48559095|NCT02456740|156237639|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
48559096|NCT02456740|156237640|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
48559097|NCT02456740|156237641|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
48616475|NCT01901562|156450669|FG000|Overall Study|Excluded intraoperatively|4|||
48616476|NCT02112552|156450670|FG000|Overall Study|Withdrawal by Subject|1|||
48616477|NCT02112552|156450670|FG000|Overall Study|Adverse Event|1|||
48616478|NCT00774748|156450671|FG000|Overall Study|Lost to Follow-up|3|||
48616479|NCT03349515|156450674|FG000|Overall Study|Lack of Efficacy|2|||
48559098|NCT02456740|156237642|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
48559099|NCT02456740|156237643|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
48559100|NCT02456740|156237644|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
48559101|NCT02456740|156237636|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
48559102|NCT02456740|156237637|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
48559103|NCT02456740|156237638|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
48559104|NCT02456740|156237639|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
48559105|NCT02456740|156237640|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
48559106|NCT02456740|156237641|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
48559107|NCT02456740|156237642|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
48559108|NCT02456740|156237643|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
48559109|NCT02456740|156237644|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
48559110|NCT02456740|156237636|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48559111|NCT02456740|156237637|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48559112|NCT02456740|156237638|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
48559113|NCT02456740|156237639|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
48559114|NCT02456740|156237640|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
48616480|NCT03349515|156450675|FG001|Overall Study|Lack of Efficacy|0|||
48616481|NCT03349515|156450674|FG000|Overall Study|Physician Decision|3|||
48616482|NCT03349515|156450675|FG001|Overall Study|Physician Decision|1|||
48616483|NCT02336503|156450676|FG000|Overall Study|Lost to Follow-up|0|||
48559115|NCT02456740|156237641|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
48559116|NCT02456740|156237642|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
48559117|NCT02456740|156237643|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
48559118|NCT02456740|156237644|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
48559119|NCT02456740|156237636|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
48616484|NCT02336503|156450677|FG001|Overall Study|Lost to Follow-up|3|||
48616485|NCT02336503|156450678|FG002|Overall Study|Lost to Follow-up|0|||
48616486|NCT02336503|156450679|FG003|Overall Study|Lost to Follow-up|2|||
48616487|NCT02336503|156450676|FG000|Overall Study|Withdrawal by Subject|2|||
48616488|NCT02336503|156450677|FG001|Overall Study|Withdrawal by Subject|0|||
48616489|NCT02336503|156450678|FG002|Overall Study|Withdrawal by Subject|0|||
48616490|NCT02336503|156450679|FG003|Overall Study|Withdrawal by Subject|4|||
48616491|NCT02336503|156450676|FG000|Overall Study|Adverse Event|0|||
48616492|NCT02336503|156450677|FG001|Overall Study|Adverse Event|0|||
48616493|NCT02336503|156450678|FG002|Overall Study|Adverse Event|1|||
48616494|NCT02336503|156450679|FG003|Overall Study|Adverse Event|0|||
48616495|NCT00896233|156450680|FG000|Overall Study|Claustrophobia during MRI|1|||
48616496|NCT00088153|156450681|FG000|Overall Study|Physician Decision|3|||
48616497|NCT00088153|156450682|FG001|Overall Study|Physician Decision|3|||
48616498|NCT00088153|156450681|FG000|Overall Study|Withdrawal by Subject|10|||
48559120|NCT02456740|156237637|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
48616499|NCT00088153|156450682|FG001|Overall Study|Withdrawal by Subject|10|||
48616500|NCT00088153|156450681|FG000|Overall Study|Lost to Follow-up|11|||
48616501|NCT00088153|156450682|FG001|Overall Study|Lost to Follow-up|12|||
48616502|NCT02232698|156450685|FG000|Overall Study|Pregnancy|1|||
48616503|NCT02232698|156450686|FG001|Overall Study|Pregnancy|1|||
48616504|NCT02232698|156450685|FG000|Overall Study|Met exclusion criteria|1|||
48616505|NCT02232698|156450686|FG001|Overall Study|Met exclusion criteria|1|||
48616506|NCT02232698|156450685|FG000|Overall Study|Had device-associated symptoms|7|||
48616507|NCT02232698|156450686|FG001|Overall Study|Had device-associated symptoms|0|||
48616508|NCT02232698|156450685|FG000|Overall Study|Non-compliance with study device|1|||
48616509|NCT02232698|156450686|FG001|Overall Study|Non-compliance with study device|4|||
48616510|NCT02232698|156450685|FG000|Overall Study|Allocated to control group|0|||
48616511|NCT02232698|156450686|FG001|Overall Study|Allocated to control group|3|||
48616512|NCT02232698|156450685|FG000|Overall Study|Withdrawal by Subject|0|||
48616513|NCT02232698|156450686|FG001|Overall Study|Withdrawal by Subject|11|||
48616514|NCT01327703|156450687|FG000|Second Treatment Period|Adverse Event|1|||
48616515|NCT01327703|156450688|FG001|Second Treatment Period|Adverse Event|1|||
48616516|NCT01327703|156450687|FG000|Second Treatment Period|Protocol Violation|0|||
48616517|NCT01327703|156450688|FG001|Second Treatment Period|Protocol Violation|1|||
48616518|NCT00977561|156450689|FG000|Overall Study|Death|3|||
48616519|NCT00977561|156450690|FG001|Overall Study|Death|2|||
48616520|NCT00977561|156450689|FG000|Overall Study|Study terminated|0|||
48559121|NCT02456740|156237638|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
48559122|NCT02456740|156237639|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
48559123|NCT02456740|156237640|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
48559124|NCT02456740|156237641|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
48559125|NCT02456740|156237642|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
48559126|NCT02456740|156237643|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
48559127|NCT02456740|156237644|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
48616521|NCT00977561|156450690|FG001|Overall Study|Study terminated|2|||
48616522|NCT00977561|156450689|FG000|Overall Study|Other|2|||
48616523|NCT00977561|156450690|FG001|Overall Study|Other|0|||
48616524|NCT00433537|156450691|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
48616525|NCT00433537|156450692|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
48616526|NCT00433537|156450693|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
48616527|NCT00433537|156450691|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
48559128|NCT02456740|156237636|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48559129|NCT02456740|156237637|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48559130|NCT02456740|156237638|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
48616528|NCT00433537|156450692|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
48616529|NCT00433537|156450693|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
48616530|NCT00433537|156450691|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
48616531|NCT00433537|156450692|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
48616532|NCT00433537|156450693|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
48616533|NCT00433537|156450691|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
48630350|NCT02082977|156504939|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
48559131|NCT02456740|156237639|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
48559132|NCT02456740|156237640|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
48559133|NCT02456740|156237641|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
48559134|NCT02456740|156237642|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
48559135|NCT02456740|156237643|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
48559136|NCT02456740|156237644|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
48559137|NCT03918629|156237645|FG000|Overall Study|Adverse Event|19|||
48559138|NCT03918629|156237646|FG001|Overall Study|Adverse Event|20|||
48616534|NCT00433537|156450692|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
48616535|NCT00433537|156450693|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
48616536|NCT00433537|156450691|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
48616537|NCT00433537|156450692|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
48559139|NCT03918629|156237645|FG000|Overall Study|Death|14|||
48693070|NCT01400698|156724662|FG004|Overall Study|Other|1|||
48616538|NCT00433537|156450693|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
48616539|NCT00433537|156450691|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
48616540|NCT00433537|156450692|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
48559140|NCT03918629|156237646|FG001|Overall Study|Death|7|||
48559141|NCT03918629|156237645|FG000|Overall Study|Lost to Follow-up|36|||
48559142|NCT03918629|156237646|FG001|Overall Study|Lost to Follow-up|28|||
48559143|NCT03918629|156237645|FG000|Overall Study|Physician Decision|1|||
48559144|NCT03918629|156237646|FG001|Overall Study|Physician Decision|0|||
48559145|NCT03918629|156237645|FG000|Overall Study|Protocol Violation|7|||
48559146|NCT03918629|156237646|FG001|Overall Study|Protocol Violation|4|||
48616541|NCT00433537|156450693|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
48616542|NCT00433537|156450691|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
48616543|NCT00433537|156450692|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
48616544|NCT00433537|156450693|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
48616545|NCT00433537|156450691|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
48616546|NCT00433537|156450692|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
48616547|NCT00433537|156450693|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
48559147|NCT03918629|156237645|FG000|Overall Study|Withdrawal by Subject|47|||
48559148|NCT03918629|156237646|FG001|Overall Study|Withdrawal by Subject|47|||
48559149|NCT03918629|156237645|FG000|Overall Study|Other|7|||
48559150|NCT03918629|156237646|FG001|Overall Study|Other|11|||
48559151|NCT03918629|156237645|FG000|Overall Study|Randomized but not vaccinated|2|||
48559152|NCT03918629|156237646|FG001|Overall Study|Randomized but not vaccinated|1|||
48559153|NCT00967330|156237647|FG000|Overall Study|Protocol Violation|3|||
48559154|NCT00967330|156237648|FG001|Overall Study|Protocol Violation|4|||
48559155|NCT00967330|156237647|FG000|Overall Study|Regular|10|||
48559156|NCT00967330|156237648|FG001|Overall Study|Regular|3|||
48559157|NCT00967330|156237647|FG000|Overall Study|Withdrawal by Subject|6|||
48559158|NCT00967330|156237648|FG001|Overall Study|Withdrawal by Subject|0|||
48559159|NCT00967330|156237647|FG000|Overall Study|Lost to Follow-up|1|||
48559160|NCT00967330|156237648|FG001|Overall Study|Lost to Follow-up|1|||
48559161|NCT00967330|156237647|FG000|Overall Study|Death|102|||
48559162|NCT00967330|156237648|FG001|Overall Study|Death|51|||
48559163|NCT00967330|156237647|FG000|Overall Study|Severe protocol deviation|0|||
48559164|NCT00967330|156237648|FG001|Overall Study|Severe protocol deviation|1|||
48559165|NCT01288079|156237650|FG000|Overall Study|Withdrawal by Subject|2|||
48559166|NCT01288079|156237651|FG001|Overall Study|Withdrawal by Subject|4|||
48559167|NCT01288079|156237652|FG002|Overall Study|Withdrawal by Subject|1|||
48559168|NCT01288079|156237653|FG003|Overall Study|Withdrawal by Subject|0|||
48559169|NCT01288079|156237650|FG000|Overall Study|Adverse Event|2|||
48559170|NCT01288079|156237651|FG001|Overall Study|Adverse Event|1|||
48559171|NCT01288079|156237652|FG002|Overall Study|Adverse Event|2|||
48559172|NCT01288079|156237653|FG003|Overall Study|Adverse Event|3|||
48559173|NCT01288079|156237650|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
48559174|NCT01288079|156237651|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
48559175|NCT01288079|156237652|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
48559176|NCT01288079|156237653|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
48559177|NCT01288079|156237650|FG000|Overall Study|Condition under Investigation Worsened|0|||
48559178|NCT01288079|156237651|FG001|Overall Study|Condition under Investigation Worsened|0|||
48559179|NCT01288079|156237652|FG002|Overall Study|Condition under Investigation Worsened|0|||
48559180|NCT01288079|156237653|FG003|Overall Study|Condition under Investigation Worsened|1|||
48559181|NCT01288079|156237650|FG000|Overall Study|Lack of Efficacy|2|||
48559182|NCT01288079|156237651|FG001|Overall Study|Lack of Efficacy|2|||
48559183|NCT01288079|156237652|FG002|Overall Study|Lack of Efficacy|0|||
48559184|NCT01288079|156237653|FG003|Overall Study|Lack of Efficacy|2|||
48559185|NCT01288079|156237650|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
48559186|NCT01288079|156237651|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
48559187|NCT01288079|156237652|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
48559188|NCT01288079|156237653|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
48559189|NCT01288079|156237650|FG000|Overall Study|Lost to Follow-up|1|||
48559190|NCT01288079|156237651|FG001|Overall Study|Lost to Follow-up|1|||
48559191|NCT01288079|156237652|FG002|Overall Study|Lost to Follow-up|1|||
48559192|NCT01288079|156237653|FG003|Overall Study|Lost to Follow-up|0|||
48559193|NCT01288079|156237650|FG000|Overall Study|Other or Study Termination|11|||
48559194|NCT01288079|156237651|FG001|Overall Study|Other or Study Termination|15|||
48559195|NCT01288079|156237652|FG002|Overall Study|Other or Study Termination|14|||
48559196|NCT01288079|156237653|FG003|Overall Study|Other or Study Termination|8|||
48559197|NCT01530464|156237654|FG000|Washout (24h)|Withdrawal by Subject|1|||
48559198|NCT01530464|156237655|FG001|Washout (24h)|Withdrawal by Subject|0|||
48559199|NCT01530464|156237654|FG000|Washout (24h)|Withdrawal by Subject|0|||
48559200|NCT01530464|156237655|FG001|Washout (24h)|Withdrawal by Subject|1|||
48559201|NCT02698163|156237657|FG000|Overall Study|Lost to Follow-up|0|||
48559202|NCT02698163|156237658|FG001|Overall Study|Lost to Follow-up|1|||
48559203|NCT01213966|156237659|FG000|Overall Study|Protocol Violation|1|||
48559204|NCT01213966|156237660|FG001|Overall Study|Protocol Violation|0|||
48559205|NCT01213966|156237661|FG002|Overall Study|Protocol Violation|3|||
48559206|NCT01213966|156237662|FG003|Overall Study|Protocol Violation|1|||
48559207|NCT05373108|156237663|FG000|Overall Study|Withdrawal by Subject|2|||
48559208|NCT02892331|156237665|FG000|Overall Study|Withdrawal by Subject|0|||
48559209|NCT02892331|156237666|FG001|Overall Study|Withdrawal by Subject|1|||
48559210|NCT02892331|156237667|FG002|Overall Study|Withdrawal by Subject|1|||
48559211|NCT02892331|156237665|FG000|Overall Study|Sick family member|0|||
48559212|NCT02892331|156237666|FG001|Overall Study|Sick family member|0|||
48559213|NCT02892331|156237667|FG002|Overall Study|Sick family member|1|||
48559214|NCT02892331|156237665|FG000|Overall Study|Corona virus pandemic|1|||
48559215|NCT02892331|156237666|FG001|Overall Study|Corona virus pandemic|0|||
48559216|NCT02892331|156237667|FG002|Overall Study|Corona virus pandemic|1|||
48559217|NCT02892331|156237665|FG000|Overall Study|Lost to Follow-up|1|||
48559218|NCT02892331|156237666|FG001|Overall Study|Lost to Follow-up|0|||
48559219|NCT02892331|156237667|FG002|Overall Study|Lost to Follow-up|1|||
48559220|NCT02892331|156237665|FG000|Overall Study|Blood pressure was too elevated|0|||
48559221|NCT02892331|156237666|FG001|Overall Study|Blood pressure was too elevated|1|||
48559222|NCT02892331|156237667|FG002|Overall Study|Blood pressure was too elevated|0|||
48616548|NCT00433537|156450691|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
48616549|NCT00433537|156450692|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
48616550|NCT00433537|156450693|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
48616551|NCT01428128|156450694|FG000|Overall Study|Withdrawal by Subject|4|||
48616552|NCT01428128|156450694|FG000|Overall Study|Screen failure by p53|10|||
48616553|NCT01428128|156450694|FG000|Overall Study|Received Neulasta in one cycle|2|||
48616554|NCT01428128|156450694|FG000|Overall Study|Adverse Event|1|||
48616555|NCT04124965|156450695|FG000|Overall Study|Adverse event, non-fatal|3|||
48616556|NCT04124965|156450696|FG001|Overall Study|Adverse event, non-fatal|1|||
48616557|NCT04124965|156450695|FG000|Overall Study|Withdrawal by Subject|1|||
48616558|NCT04124965|156450696|FG001|Overall Study|Withdrawal by Subject|1|||
48616559|NCT04124965|156450695|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
48616560|NCT04124965|156450696|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
48616561|NCT04124965|156450695|FG000|Overall Study|Pregnancy|1|||
48616562|NCT04124965|156450696|FG001|Overall Study|Pregnancy|0|||
48616563|NCT04124965|156450695|FG000|Overall Study|Sponsor and participant decision|0|||
48616564|NCT04124965|156450696|FG001|Overall Study|Sponsor and participant decision|1|||
48616565|NCT04124965|156450695|FG000|Overall Study|Personal surgery|0|||
48616566|NCT04124965|156450696|FG001|Overall Study|Personal surgery|1|||
48616567|NCT04124965|156450695|FG000|Overall Study|Physician Decision|0|||
48616568|NCT04124965|156450696|FG001|Overall Study|Physician Decision|1|||
48616569|NCT01033071|156450701|FG000|Overall Study|Adverse Event|28|||
48616570|NCT01033071|156450702|FG001|Overall Study|Adverse Event|51|||
48616571|NCT01033071|156450703|FG002|Overall Study|Adverse Event|26|||
48616572|NCT01033071|156450701|FG000|Overall Study|Protocol Violation|0|||
48559223|NCT02892331|156237665|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
48559224|NCT02892331|156237666|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
48559225|NCT02892331|156237667|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
48616573|NCT01033071|156450702|FG001|Overall Study|Protocol Violation|2|||
48616574|NCT01033071|156450703|FG002|Overall Study|Protocol Violation|1|||
48616575|NCT01033071|156450701|FG000|Overall Study|Lost to Follow-up|4|||
48616576|NCT01033071|156450702|FG001|Overall Study|Lost to Follow-up|5|||
48616577|NCT01033071|156450703|FG002|Overall Study|Lost to Follow-up|5|||
48616578|NCT01033071|156450701|FG000|Overall Study|Withdrawal by Subject|17|||
48559226|NCT01133067|156237673|FG000|Overall Study|Death|136|||
48559227|NCT01133067|156237673|FG000|Overall Study|Lost to Follow-up|3|||
48559228|NCT03539302|156237674|FG000|Overall Study|Spontaneous cardio version|0|||
48559229|NCT03539302|156237675|FG001|Overall Study|Spontaneous cardio version|0|||
48559230|NCT03539302|156237676|FG002|Overall Study|Spontaneous cardio version|0|||
48559231|NCT03539302|156237677|FG003|Overall Study|Spontaneous cardio version|0|||
48559232|NCT03539302|156237678|FG004|Overall Study|Spontaneous cardio version|0|||
48559233|NCT03539302|156237679|FG005|Overall Study|Spontaneous cardio version|1|||
48559234|NCT03539302|156237680|FG006|Overall Study|Spontaneous cardio version|1|||
48559235|NCT00740636|156237681|FG000|Overall Study|Adverse Event|0|||
48559236|NCT00740636|156237682|FG001|Overall Study|Adverse Event|2|||
48559237|NCT00740636|156237681|FG000|Overall Study|Patient Ineligible|0|||
48559238|NCT00740636|156237682|FG001|Overall Study|Patient Ineligible|1|||
48559239|NCT00740636|156237681|FG000|Overall Study|Patient Not Treated|0|||
48559240|NCT00740636|156237682|FG001|Overall Study|Patient Not Treated|1|||
48559241|NCT00740636|156237681|FG000|Overall Study|Progressive Disease|1|||
48559242|NCT00740636|156237682|FG001|Overall Study|Progressive Disease|0|||
48559243|NCT00740636|156237681|FG000|Overall Study|Death|1|||
48559244|NCT00740636|156237682|FG001|Overall Study|Death|0|||
48559245|NCT01762800|156239973|FG000|Overall Study|Adverse Event|8|||
48559246|NCT01762800|156239974|FG001|Overall Study|Adverse Event|13|||
48559247|NCT01762800|156239973|FG000|Overall Study|Lack of Efficacy|3|||
48559248|NCT01762800|156239974|FG001|Overall Study|Lack of Efficacy|2|||
48559249|NCT01762800|156239973|FG000|Overall Study|Study Closed/Terminated|0|||
48559250|NCT01762800|156239974|FG001|Overall Study|Study Closed/Terminated|1|||
48559251|NCT01762800|156239973|FG000|Overall Study|Physician Decision|1|||
48559252|NCT01762800|156239974|FG001|Overall Study|Physician Decision|1|||
48559253|NCT01762800|156239973|FG000|Overall Study|Withdrawal by Subject|7|||
48559254|NCT01762800|156239974|FG001|Overall Study|Withdrawal by Subject|4|||
48559255|NCT05377749|156239975|FG000|3 Weeks|Lost to Follow-up|2|||
48559256|NCT05377749|156239976|FG001|3 Weeks|Lost to Follow-up|4|||
48559257|NCT05377749|156239975|FG000|3 Weeks|Withdrawal by Subject|1|||
48559258|NCT05377749|156239976|FG001|3 Weeks|Withdrawal by Subject|1|||
48559259|NCT00064987|156239977|FG000|Overall Study|Physician Decision|3|||
48559260|NCT00064987|156239978|FG001|Overall Study|Physician Decision|0|||
48559261|NCT00451204|156239979|FG000|Overall Study|Adverse Event|4|||
48559262|NCT00451204|156239980|FG001|Overall Study|Adverse Event|6|||
48559263|NCT00451204|156239979|FG000|Overall Study|Lack of Efficacy|4|||
48559264|NCT00451204|156239980|FG001|Overall Study|Lack of Efficacy|4|||
48559265|NCT00451204|156239979|FG000|Overall Study|Lost to Follow-up|4|||
48559266|NCT00451204|156239980|FG001|Overall Study|Lost to Follow-up|4|||
48559267|NCT00451204|156239979|FG000|Overall Study|Protocol Violation|1|||
48559268|NCT00451204|156239980|FG001|Overall Study|Protocol Violation|0|||
48559269|NCT00451204|156239979|FG000|Overall Study|Patient refusal|8|||
48559270|NCT00451204|156239980|FG001|Overall Study|Patient refusal|4|||
48559271|NCT00451204|156239979|FG000|Overall Study|Other|1|||
48559272|NCT00451204|156239980|FG001|Overall Study|Other|2|||
48559273|NCT02548156|156239983|FG000|Washout Period 1|Lost to Follow-up|0|||
48559274|NCT02548156|156239984|FG001|Washout Period 1|Lost to Follow-up|0|||
48559275|NCT02548156|156239985|FG002|Washout Period 1|Lost to Follow-up|0|||
48559276|NCT02548156|156239986|FG003|Washout Period 1|Lost to Follow-up|0|||
48559277|NCT02548156|156239987|FG004|Washout Period 1|Lost to Follow-up|1|||
48559278|NCT02548156|156239988|FG005|Washout Period 1|Lost to Follow-up|0|||
48559279|NCT02515331|156239989|FG000|Overall Study|Withdrawal by Subject|0|||
48559280|NCT02515331|156239990|FG001|Overall Study|Withdrawal by Subject|0|||
48559281|NCT02515331|156239991|FG002|Overall Study|Withdrawal by Subject|1|||
48559282|NCT02515331|156239989|FG000|Overall Study|Protocol deviation|0|||
48559283|NCT02515331|156239990|FG001|Overall Study|Protocol deviation|0|||
48559284|NCT02515331|156239991|FG002|Overall Study|Protocol deviation|3|||
48559285|NCT02515331|156239989|FG000|Overall Study|Adverse Event|2|||
48559286|NCT02515331|156239990|FG001|Overall Study|Adverse Event|0|||
48559287|NCT02515331|156239991|FG002|Overall Study|Adverse Event|0|||
48559288|NCT00124748|156239992|FG000|Overall Study|Adverse Event|8|||
48559289|NCT00124748|156239993|FG001|Overall Study|Adverse Event|39|||
48559290|NCT00124748|156239992|FG000|Overall Study|Abnormal laboratory Value|2|||
48559291|NCT00124748|156239993|FG001|Overall Study|Abnormal laboratory Value|2|||
48559292|NCT00124748|156239992|FG000|Overall Study|Abnormal Procedure|0|||
48559293|NCT00124748|156239993|FG001|Overall Study|Abnormal Procedure|1|||
48559294|NCT00124748|156239992|FG000|Overall Study|Lack of Efficacy|20|||
48559295|NCT00124748|156239993|FG001|Overall Study|Lack of Efficacy|41|||
48693071|NCT01400698|156724663|FG005|Overall Study|Other|0|||
48616579|NCT01033071|156450702|FG001|Overall Study|Withdrawal by Subject|14|||
48616580|NCT01033071|156450703|FG002|Overall Study|Withdrawal by Subject|11|||
48616581|NCT01033071|156450701|FG000|Overall Study|Lack of Efficacy|0|||
48616582|NCT01033071|156450702|FG001|Overall Study|Lack of Efficacy|1|||
48616583|NCT01033071|156450703|FG002|Overall Study|Lack of Efficacy|1|||
48616584|NCT01033071|156450701|FG000|Overall Study|Other|6|||
48616585|NCT01033071|156450702|FG001|Overall Study|Other|4|||
48616586|NCT01033071|156450703|FG002|Overall Study|Other|3|||
48616587|NCT01127061|156452928|FG000|Overall Study|Lost to Follow-up|7|||
48616588|NCT01127061|156452929|FG001|Overall Study|Lost to Follow-up|10|||
48616589|NCT01127061|156452928|FG000|Overall Study|Physician Decision|3|||
48616590|NCT01127061|156452929|FG001|Overall Study|Physician Decision|3|||
48616591|NCT03595748|156452932|FG000|Overall Study|Death|11|||
48616592|NCT03595748|156452933|FG001|Overall Study|Death|12|||
48616593|NCT03595748|156452932|FG000|Overall Study|Withdrawal by Subject|28|||
48616594|NCT03595748|156452933|FG001|Overall Study|Withdrawal by Subject|29|||
48616595|NCT03595748|156452932|FG000|Overall Study|Protocol Violation|0|||
48616596|NCT03595748|156452933|FG001|Overall Study|Protocol Violation|1|||
48559296|NCT00124748|156239992|FG000|Overall Study|No longer requires study drug|1|||
48559297|NCT00124748|156239993|FG001|Overall Study|No longer requires study drug|1|||
48559298|NCT00124748|156239992|FG000|Overall Study|Protocol Violation|3|||
48559299|NCT00124748|156239993|FG001|Overall Study|Protocol Violation|1|||
48559300|NCT00124748|156239992|FG000|Overall Study|Withdrawal by Subject|5|||
48559301|NCT00124748|156239993|FG001|Overall Study|Withdrawal by Subject|15|||
48559302|NCT00124748|156239992|FG000|Overall Study|Lost to Follow-up|2|||
48559303|NCT00124748|156239993|FG001|Overall Study|Lost to Follow-up|7|||
48559304|NCT00124748|156239992|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
48559305|NCT00124748|156239993|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
48616597|NCT00479232|156452936|FG000|Overall Study|Adverse Event|0|||
48616598|NCT00479232|156452937|FG001|Overall Study|Adverse Event|0|||
48616599|NCT00479232|156452938|FG002|Overall Study|Adverse Event|5|||
48616600|NCT00479232|156452939|FG003|Overall Study|Adverse Event|0|||
48616601|NCT00479232|156452940|FG004|Overall Study|Adverse Event|0|||
48616602|NCT00479232|156452941|FG005|Overall Study|Adverse Event|10|||
48616603|NCT00479232|156452936|FG000|Overall Study|Deviation from Protocol|0|||
48616604|NCT00479232|156452937|FG001|Overall Study|Deviation from Protocol|0|||
48559306|NCT00124748|156239992|FG000|Overall Study|Death|1|||
48559307|NCT00124748|156239993|FG001|Overall Study|Death|3|||
48559308|NCT03499067|156239996|FG000|First Intervention|Physician Decision|2|||
48559309|NCT03499067|156239997|FG001|First Intervention|Physician Decision|1|||
48559310|NCT03499067|156239996|FG000|First Intervention|Withdrawal by Subject|3|||
48559311|NCT03499067|156239997|FG001|First Intervention|Withdrawal by Subject|6|||
48559312|NCT00280735|156240005|FG000|Overall Study|Adverse Event|5|||
48559313|NCT00280735|156240005|FG000|Overall Study|Lack of Efficacy|3|||
48559314|NCT00280735|156240005|FG000|Overall Study|Withdrawal by Subject|8|||
48559315|NCT00280735|156240005|FG000|Overall Study|Intercurrent Illness|2|||
48559316|NCT04753216|156240006|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
48559317|NCT04753216|156240006|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
48559318|NCT04753216|156240006|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
48559319|NCT00595621|156240007|FG000|Open Label Run in|Adverse Event|1|||
48559320|NCT00595621|156240008|FG001|Open Label Run in|Adverse Event|0|||
48559321|NCT00595621|156240007|FG000|Open Label Run in|Physician Decision|1|||
48559322|NCT00595621|156240008|FG001|Open Label Run in|Physician Decision|0|||
48559323|NCT00595621|156240007|FG000|Open Label Run in|Withdrawal by Subject|1|||
48559324|NCT00595621|156240008|FG001|Open Label Run in|Withdrawal by Subject|0|||
48559325|NCT00595621|156240007|FG000|Randomization and Study|Adverse Event|2|||
48559326|NCT00595621|156240008|FG001|Randomization and Study|Adverse Event|0|||
48559327|NCT00595621|156240007|FG000|Randomization and Study|Withdrawal by Subject|0|||
48559328|NCT00595621|156240008|FG001|Randomization and Study|Withdrawal by Subject|1|||
48559329|NCT02440464|156240010|FG000|Overall Study|Withdrawal by Subject|3|||
48559330|NCT02440464|156240011|FG001|Overall Study|Withdrawal by Subject|2|||
48559331|NCT00276484|156240012|FG000|Overall Study|Adverse Event|4|||
48559332|NCT00276484|156240013|FG001|Overall Study|Adverse Event|7|||
48559333|NCT00276484|156240012|FG000|Overall Study|Lost to Follow-up|1|||
48559334|NCT00276484|156240013|FG001|Overall Study|Lost to Follow-up|1|||
48559335|NCT00276484|156240012|FG000|Overall Study|Protocol Violation|0|||
48559336|NCT00276484|156240013|FG001|Overall Study|Protocol Violation|1|||
48559337|NCT00276484|156240012|FG000|Overall Study|Withdrawal by Subject|4|||
48559338|NCT00276484|156240013|FG001|Overall Study|Withdrawal by Subject|3|||
48559339|NCT00276484|156240012|FG000|Overall Study|Could not take time off work|0|||
48559340|NCT00276484|156240013|FG001|Overall Study|Could not take time off work|1|||
48559341|NCT02001987|156240016|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
48559342|NCT02001987|156240016|FG000|Core Study Period (24 Weeks)|Death|1|||
48559343|NCT02001987|156240016|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
48559344|NCT02001987|156240016|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
48559345|NCT02001987|156240016|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
48559346|NCT02001987|156240016|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
48559347|NCT02001987|156240016|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
48559348|NCT02001987|156240016|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
48559349|NCT02001987|156240016|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
48616605|NCT00479232|156452938|FG002|Overall Study|Deviation from Protocol|1|||
48559350|NCT02001987|156240016|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
48559351|NCT02001987|156240016|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
48559352|NCT02001987|156240016|FG000|LTE Period (52 Weeks)|Other|3|||
48559353|NCT02064296|156240031|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
48559354|NCT02064296|156240032|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
48559355|NCT02064296|156240033|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
48559356|NCT02064296|156240031|FG000|Intervention|Withdrawal by Subject|0|||
48559357|NCT02064296|156240032|FG001|Intervention|Withdrawal by Subject|1|||
48559358|NCT02064296|156240033|FG002|Intervention|Withdrawal by Subject|2|||
48559359|NCT02392481|156240034|FG000|Overall Study|Adverse Event|0|||
48559360|NCT02392481|156240035|FG001|Overall Study|Adverse Event|0|||
48559361|NCT02392481|156240036|FG002|Overall Study|Adverse Event|1|||
48559362|NCT02392481|156240037|FG003|Overall Study|Adverse Event|2|||
48559363|NCT02392481|156240034|FG000|Overall Study|Withdrawal by Subject|0|||
48559364|NCT02392481|156240035|FG001|Overall Study|Withdrawal by Subject|0|||
48559365|NCT02392481|156240036|FG002|Overall Study|Withdrawal by Subject|1|||
48559366|NCT02392481|156240037|FG003|Overall Study|Withdrawal by Subject|0|||
48559367|NCT03334435|156240038|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
48559368|NCT03334435|156240039|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
48559369|NCT03334435|156240040|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
48559370|NCT03334435|156240041|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
48559371|NCT03334435|156240042|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
48559372|NCT03334435|156240043|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559373|NCT03334435|156240044|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559374|NCT03334435|156240045|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559375|NCT03334435|156240046|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559376|NCT03334435|156240047|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559377|NCT03334435|156240048|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559378|NCT03334435|156240049|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559379|NCT03334435|156240050|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559380|NCT03334435|156240051|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559381|NCT03334435|156240052|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
48559382|NCT03334435|156240038|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
48559383|NCT03334435|156240039|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
48559384|NCT03334435|156240040|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
48559385|NCT03334435|156240041|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
48559386|NCT03334435|156240042|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
48559387|NCT03334435|156240043|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559388|NCT03334435|156240044|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559389|NCT03334435|156240045|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559390|NCT03334435|156240046|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559391|NCT03334435|156240047|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559392|NCT03334435|156240048|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559393|NCT03334435|156240049|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559394|NCT03334435|156240050|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559395|NCT03334435|156240051|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559396|NCT03334435|156240052|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
48559397|NCT03334435|156240038|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
48559398|NCT03334435|156240039|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
48559399|NCT03334435|156240040|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
48559400|NCT03334435|156240041|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
48559401|NCT03334435|156240042|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
48559402|NCT03334435|156240043|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559403|NCT03334435|156240044|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559404|NCT03334435|156240045|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48616606|NCT00479232|156452939|FG003|Overall Study|Deviation from Protocol|0|||
48616607|NCT00479232|156452940|FG004|Overall Study|Deviation from Protocol|0|||
48559405|NCT03334435|156240046|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559406|NCT03334435|156240047|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559407|NCT03334435|156240048|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559408|NCT03334435|156240049|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559409|NCT03334435|156240050|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559410|NCT03334435|156240051|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559411|NCT03334435|156240052|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
48559412|NCT03334435|156240038|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
48559413|NCT03334435|156240039|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
48559414|NCT03334435|156240040|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
48559415|NCT03334435|156240041|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
48559416|NCT03334435|156240042|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
48559417|NCT03334435|156240043|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559418|NCT03334435|156240044|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559419|NCT03334435|156240045|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559420|NCT03334435|156240046|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559421|NCT03334435|156240047|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559422|NCT03334435|156240048|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559423|NCT03334435|156240049|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559424|NCT03334435|156240050|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559425|NCT03334435|156240051|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559426|NCT03334435|156240052|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
48559427|NCT03334435|156240038|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
48559428|NCT03334435|156240039|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559429|NCT03334435|156240040|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
48559430|NCT03334435|156240041|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
48559431|NCT03334435|156240042|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
48559432|NCT03334435|156240043|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559433|NCT03334435|156240044|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559434|NCT03334435|156240045|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559435|NCT03334435|156240046|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559436|NCT03334435|156240047|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559437|NCT03334435|156240048|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559438|NCT03334435|156240049|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559439|NCT03334435|156240050|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559440|NCT03334435|156240051|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559441|NCT03334435|156240052|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
48559442|NCT03334435|156240038|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559443|NCT03334435|156240039|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559444|NCT03334435|156240040|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559445|NCT03334435|156240041|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
48559446|NCT03334435|156240042|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559447|NCT03334435|156240043|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559448|NCT03334435|156240044|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559449|NCT03334435|156240045|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559450|NCT03334435|156240046|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559451|NCT03334435|156240047|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559452|NCT03334435|156240048|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559453|NCT03334435|156240049|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559454|NCT03334435|156240050|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559455|NCT03334435|156240051|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559456|NCT03334435|156240052|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
48559457|NCT03334435|156240038|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559458|NCT03334435|156240039|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
48559459|NCT03334435|156240040|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
48559460|NCT03334435|156240041|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
48616608|NCT00479232|156452941|FG005|Overall Study|Deviation from Protocol|0|||
48616609|NCT00479232|156452936|FG000|Overall Study|Lack of Efficacy|0|||
48616610|NCT00479232|156452937|FG001|Overall Study|Lack of Efficacy|0|||
48616611|NCT00479232|156452938|FG002|Overall Study|Lack of Efficacy|2|||
48616612|NCT00479232|156452939|FG003|Overall Study|Lack of Efficacy|0|||
48616613|NCT00479232|156452940|FG004|Overall Study|Lack of Efficacy|0|||
48559461|NCT03334435|156240042|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
48559462|NCT03334435|156240043|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
48616614|NCT00479232|156452941|FG005|Overall Study|Lack of Efficacy|4|||
48616615|NCT00479232|156452936|FG000|Overall Study|Physician Decision|0|||
48559463|NCT03334435|156240044|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559464|NCT03334435|156240045|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559465|NCT03334435|156240046|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559466|NCT03334435|156240047|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559467|NCT03334435|156240048|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559468|NCT03334435|156240049|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559469|NCT03334435|156240050|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559470|NCT03334435|156240051|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559471|NCT03334435|156240052|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
48559472|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
48559473|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
48559474|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
48559475|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
48559476|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
48559477|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
48559478|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
48559479|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
48559480|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
48559481|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
48559482|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
48559483|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
48559484|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
48559485|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
48559486|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
48559487|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
48559488|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
48559489|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
48559490|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
48559491|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
48559492|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
48559493|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
48559494|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
48559495|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
48559496|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
48559497|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
48559498|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
48559499|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
48559500|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
48559501|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
48559502|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
48559503|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
48559504|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
48559505|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
48559506|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
48559507|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
48559508|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
48559509|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
48559510|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
48559511|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
48559512|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
48559513|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
48559514|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
48559515|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
48559516|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
48559517|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
48559518|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
48559519|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
48559520|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
48559521|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
48559522|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
48559523|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
48559524|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
48559525|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
48559526|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
48559527|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
48559528|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
48559529|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
48559530|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
48616616|NCT00479232|156452937|FG001|Overall Study|Physician Decision|0|||
48559531|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
48559532|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
48559533|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
48559534|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
48559535|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
48559536|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
48559537|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
48559538|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
48559539|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
48559540|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
48559541|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
48559542|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
48559543|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
48559544|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
48559545|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
48559546|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
48559547|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559548|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559549|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559550|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559551|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48616617|NCT00479232|156452938|FG002|Overall Study|Physician Decision|2|||
48616618|NCT00479232|156452939|FG003|Overall Study|Physician Decision|0|||
48616619|NCT00479232|156452940|FG004|Overall Study|Physician Decision|0|||
48616620|NCT00479232|156452941|FG005|Overall Study|Physician Decision|1|||
48616621|NCT00479232|156452936|FG000|Overall Study|Progressive Disease|3|||
48616622|NCT00479232|156452937|FG001|Overall Study|Progressive Disease|1|||
48616623|NCT00479232|156452938|FG002|Overall Study|Progressive Disease|12|||
48616624|NCT00479232|156452939|FG003|Overall Study|Progressive Disease|3|||
48616625|NCT00479232|156452940|FG004|Overall Study|Progressive Disease|3|||
48616626|NCT00479232|156452941|FG005|Overall Study|Progressive Disease|12|||
48616627|NCT00479232|156452936|FG000|Overall Study|Withdrew Consent|0|||
48616628|NCT00479232|156452937|FG001|Overall Study|Withdrew Consent|2|||
48616629|NCT00479232|156452938|FG002|Overall Study|Withdrew Consent|6|||
48616630|NCT00479232|156452939|FG003|Overall Study|Withdrew Consent|0|||
48616631|NCT00479232|156452940|FG004|Overall Study|Withdrew Consent|1|||
48616632|NCT00479232|156452941|FG005|Overall Study|Withdrew Consent|3|||
48616633|NCT00690898|156452947|FG000|SCREENING|Screen failure|18|||
48616634|NCT00690898|156452947|FG000|TREATMENT|Adverse Event|3|||
48616635|NCT00690898|156452947|FG000|TREATMENT|Lack of Efficacy|18|||
48616636|NCT00690898|156452947|FG000|TREATMENT|Withdrawal by Subject|4|||
48616637|NCT00690898|156452947|FG000|TREATMENT|Other (not otherwise specified)|1|||
48616638|NCT03807843|156452950|FG000|Overall Study|Lost to Follow-up|1|||
48616639|NCT03807843|156452951|FG001|Overall Study|Lost to Follow-up|0|||
48616640|NCT01312129|156452952|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
48616641|NCT01312129|156452953|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
48616642|NCT03720847|156452954|FG000|Washout|Physician Decision|1|||
48616643|NCT03720847|156452955|FG001|Washout|Physician Decision|2|||
48616644|NCT03022630|156452956|FG000|Overall Study|Death|9|||
48616645|NCT03022630|156452957|FG001|Overall Study|Death|7|||
48616646|NCT03022630|156452956|FG000|Overall Study|Withdrawal by Subject|0|||
48616647|NCT03022630|156452957|FG001|Overall Study|Withdrawal by Subject|5|||
48616648|NCT00884949|156452958|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
48616649|NCT00884949|156452958|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
48616650|NCT01807520|156452959|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
48616651|NCT01807520|156452960|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
48616652|NCT01807520|156452961|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
48559552|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559553|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559554|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559555|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559556|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559557|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559558|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
48559559|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559560|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
48559561|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
48559562|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559563|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559564|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559565|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559566|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559567|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
48559568|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559569|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559570|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559571|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559572|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559573|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559574|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559575|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
48559576|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
48559577|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
48559578|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
48559579|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
48559580|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
48559581|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
48559582|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
48559583|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
48559584|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
48559585|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
48559586|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
48559587|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
48559588|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
48559589|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
48559590|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
48559591|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
48559592|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559593|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559594|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559595|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559596|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559597|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
48559598|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
48559599|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559600|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559601|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559602|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
48559603|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
48559604|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
48559605|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
48559606|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
48559607|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559608|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559609|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559610|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559611|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559612|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
48559613|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559614|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559615|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48616653|NCT01807520|156452962|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
48616654|NCT01807520|156452963|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
48616655|NCT01807520|156452964|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
48616656|NCT01807520|156452965|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
48616657|NCT01807520|156452959|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
48616658|NCT01807520|156452960|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
48616659|NCT01807520|156452961|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
48616660|NCT01807520|156452962|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
48616661|NCT01807520|156452963|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
48616662|NCT01807520|156452964|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
48616663|NCT01807520|156452965|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
48616664|NCT01807520|156452959|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
48616665|NCT01807520|156452960|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
48616666|NCT01807520|156452961|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
48616667|NCT01807520|156452962|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
48616668|NCT01807520|156452963|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
48616669|NCT01807520|156452964|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
48616670|NCT01807520|156452965|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
48616671|NCT01807520|156452959|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
48616672|NCT01807520|156452960|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
48616673|NCT01807520|156452961|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
48616674|NCT01807520|156452962|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
48616675|NCT01807520|156452963|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
48616676|NCT01807520|156452964|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
48616677|NCT01807520|156452965|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
48616678|NCT01807520|156452959|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
48616679|NCT01807520|156452960|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
48616680|NCT01807520|156452961|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
48559616|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559617|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
48559618|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559619|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559620|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
48559621|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
48559622|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48559623|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48559624|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48559625|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48559626|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48559627|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48559628|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48616681|NCT01807520|156452962|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
48616682|NCT01807520|156452963|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
48616683|NCT01807520|156452964|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
48616684|NCT01807520|156452965|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
48616685|NCT01807520|156452959|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
48616686|NCT01807520|156452960|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
48559629|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
48559630|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
48616687|NCT01807520|156452961|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
48616688|NCT01807520|156452962|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
48616689|NCT01807520|156452963|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
48616690|NCT01807520|156452964|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
48616691|NCT01807520|156452965|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
48616692|NCT01807520|156452959|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
48616693|NCT01807520|156452960|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
48616694|NCT01807520|156452961|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
48616695|NCT01807520|156452962|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
48616696|NCT01807520|156452963|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
48616697|NCT01807520|156452964|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
48616698|NCT01807520|156452965|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
48616699|NCT01807520|156452959|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
48559631|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48616700|NCT01807520|156452960|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
48616701|NCT01807520|156452961|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
48616702|NCT01807520|156452962|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
48616703|NCT01807520|156452963|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
48616704|NCT01807520|156452964|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
48616705|NCT01807520|156452965|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
48616706|NCT01807520|156452959|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
48616707|NCT01807520|156452960|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
48616708|NCT01807520|156452961|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
48616709|NCT01807520|156452962|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
48616710|NCT01807520|156452963|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
48616711|NCT01807520|156452964|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
48616712|NCT01807520|156452965|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
48616713|NCT01807520|156452959|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
48616714|NCT01807520|156452960|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
48616715|NCT01807520|156452961|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
48616716|NCT01807520|156452962|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
48616717|NCT01807520|156452963|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
48616718|NCT01807520|156452964|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
48616719|NCT01807520|156452965|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
48616720|NCT01807520|156452959|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
48616721|NCT01807520|156452960|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
48616722|NCT01807520|156452961|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
48616723|NCT01807520|156452962|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
48616724|NCT01807520|156452963|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
48616725|NCT01807520|156452964|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
48616726|NCT01807520|156452965|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
48616727|NCT01807520|156452959|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
48616728|NCT01807520|156452960|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
48616729|NCT01807520|156452961|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
48616730|NCT01807520|156452962|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
48616731|NCT01807520|156452963|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
48616732|NCT01807520|156452964|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
48616733|NCT01807520|156452965|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
48616734|NCT01807520|156452959|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
48616735|NCT01807520|156452960|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
48616736|NCT01807520|156452961|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
48616737|NCT01807520|156452962|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
48616738|NCT01807520|156452963|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
48616739|NCT01807520|156452964|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
48616740|NCT01807520|156452965|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
48616741|NCT01807520|156452959|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
48616742|NCT01807520|156452960|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
48616743|NCT01807520|156452961|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
48616744|NCT01807520|156452962|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
48616745|NCT01807520|156452963|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
48616746|NCT01807520|156452964|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
48616747|NCT01807520|156452965|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
48616748|NCT01807520|156452959|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
48616749|NCT01807520|156452960|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
48616750|NCT01807520|156452961|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
48616751|NCT01807520|156452962|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
48616752|NCT01807520|156452963|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
48616753|NCT01807520|156452964|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
48616754|NCT01807520|156452965|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
48616755|NCT01807520|156452959|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
48616756|NCT01807520|156452960|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
48616757|NCT01807520|156452961|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
48616758|NCT01807520|156452962|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
48616759|NCT01807520|156452963|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
48616760|NCT01807520|156452964|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
48616761|NCT01807520|156452965|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
48616762|NCT01807520|156452959|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
48616763|NCT01807520|156452960|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
48616764|NCT01807520|156452961|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
48616765|NCT01807520|156452962|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
48616766|NCT01807520|156452963|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
48616767|NCT01807520|156452964|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
48616768|NCT01807520|156452965|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
48616769|NCT00639379|156452968|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
48616770|NCT00639379|156452969|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
48616771|NCT00639379|156452968|FG000|Period 1 - 2 Weeks|lens issue|3|||
48616772|NCT00639379|156452969|FG001|Period 1 - 2 Weeks|lens issue|0|||
48616773|NCT00924651|156452972|FG000|Overall Study|Chemo started too soon|2|||
48616774|NCT00924651|156452973|FG001|Overall Study|Chemo started too soon|3|||
48616775|NCT00924651|156452972|FG000|Overall Study|No Reason|3|||
48616776|NCT00924651|156452973|FG001|Overall Study|No Reason|7|||
48616777|NCT00924651|156452972|FG000|Overall Study|Overwhelmed|6|||
48616778|NCT00924651|156452973|FG001|Overall Study|Overwhelmed|6|||
48616779|NCT00924651|156452972|FG000|Overall Study|Noncompliant|1|||
48616780|NCT00924651|156452973|FG001|Overall Study|Noncompliant|4|||
48616781|NCT00924651|156452972|FG000|Overall Study|Medical|1|||
48616782|NCT00924651|156452973|FG001|Overall Study|Medical|3|||
48616783|NCT00924651|156452972|FG000|Overall Study|Changed Mind|10|||
48616784|NCT00924651|156452973|FG001|Overall Study|Changed Mind|1|||
48616785|NCT00924651|156452972|FG000|Overall Study|Incomplete Form|2|||
48616786|NCT00924651|156452973|FG001|Overall Study|Incomplete Form|1|||
48616787|NCT00729586|156452974|FG000|Overall Study|Ineligible|0|||
48616788|NCT00729586|156452975|FG001|Overall Study|Ineligible|1|||
48559632|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
48559633|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
48559634|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
48559635|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48616789|NCT00729586|156452974|FG000|Overall Study|never treated|1|||
48559636|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
48559637|NCT03334435|156240038|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559638|NCT03334435|156240039|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559639|NCT03334435|156240040|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559640|NCT03334435|156240041|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559641|NCT03334435|156240042|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559642|NCT03334435|156240043|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559643|NCT03334435|156240044|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559644|NCT03334435|156240045|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559645|NCT03334435|156240046|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559646|NCT03334435|156240047|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559647|NCT03334435|156240048|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559648|NCT03334435|156240049|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
48559649|NCT03334435|156240050|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
48559650|NCT03334435|156240051|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
48559651|NCT03334435|156240052|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
48559652|NCT02502149|156240054|FG000|Intermediate|Discontinued prematurely|1|||
48559653|NCT02502149|156240055|FG001|Intermediate|Discontinued prematurely|0|||
48559654|NCT02502149|156240056|FG002|Intermediate|Discontinued prematurely|0|||
48616790|NCT00729586|156452975|FG001|Overall Study|never treated|0|||
48616791|NCT00972738|156452981|FG000|Overall Study|Adverse Event|7|||
48616792|NCT00972738|156452982|FG001|Overall Study|Adverse Event|1|||
48616793|NCT00972738|156452983|FG002|Overall Study|Adverse Event|8|||
48616794|NCT00972738|156452981|FG000|Overall Study|Protocol Violation|2|||
48616795|NCT00972738|156452982|FG001|Overall Study|Protocol Violation|1|||
48616796|NCT00972738|156452983|FG002|Overall Study|Protocol Violation|3|||
48616797|NCT00972738|156452981|FG000|Overall Study|Lost to Follow-up|1|||
48616798|NCT00972738|156452982|FG001|Overall Study|Lost to Follow-up|0|||
48616799|NCT00972738|156452983|FG002|Overall Study|Lost to Follow-up|1|||
48616800|NCT00972738|156452981|FG000|Overall Study|Lack of Efficacy|5|||
48616801|NCT00972738|156452982|FG001|Overall Study|Lack of Efficacy|1|||
48559655|NCT02502149|156240057|FG003|Intermediate|Discontinued prematurely|0|||
48616802|NCT00972738|156452983|FG002|Overall Study|Lack of Efficacy|11|||
48616803|NCT00972738|156452981|FG000|Overall Study|Withdrawal by Subject|5|||
48616804|NCT00972738|156452982|FG001|Overall Study|Withdrawal by Subject|1|||
48616805|NCT00972738|156452983|FG002|Overall Study|Withdrawal by Subject|4|||
48616806|NCT00972738|156452981|FG000|Overall Study|Moved|0|||
48616807|NCT00972738|156452982|FG001|Overall Study|Moved|0|||
48559656|NCT02502149|156240058|FG004|Intermediate|Discontinued prematurely|0|||
48559657|NCT03922321|156240059|FG000|Overall Study|Participant Moved|1|||
48559658|NCT03922321|156240059|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
48616808|NCT00972738|156452983|FG002|Overall Study|Moved|1|||
48616809|NCT00972738|156452981|FG000|Overall Study|Other|1|||
48616810|NCT00972738|156452982|FG001|Overall Study|Other|2|||
48616811|NCT00972738|156452983|FG002|Overall Study|Other|1|||
48616812|NCT02513199|156452984|FG000|Treatment|Death|1|||
48616813|NCT02513199|156452984|FG000|Treatment|Lost to Follow-up|1|||
48616814|NCT02513199|156452984|FG000|Follow-Up|Death|11|||
48616815|NCT00614393|156452985|FG000|Overall Study|Adverse Event|20|||
48616816|NCT00614393|156452986|FG001|Overall Study|Adverse Event|2|||
48616817|NCT00614393|156452987|FG002|Overall Study|Adverse Event|3|||
48616818|NCT00614393|156452988|FG003|Overall Study|Adverse Event|13|||
48616819|NCT00614393|156452989|FG004|Overall Study|Adverse Event|21|||
48616820|NCT00614393|156452985|FG000|Overall Study|Lost to Follow-up|0|||
48616821|NCT00614393|156452986|FG001|Overall Study|Lost to Follow-up|0|||
48616822|NCT00614393|156452987|FG002|Overall Study|Lost to Follow-up|0|||
48616823|NCT00614393|156452988|FG003|Overall Study|Lost to Follow-up|1|||
48559659|NCT01431079|156240060|FG000|Overall Study|Lost to Follow-up|35|||
48616824|NCT00614393|156452989|FG004|Overall Study|Lost to Follow-up|2|||
48616825|NCT00614393|156452985|FG000|Overall Study|Physician Decision|17|||
48616826|NCT00614393|156452986|FG001|Overall Study|Physician Decision|0|||
48559660|NCT01431079|156240061|FG001|Overall Study|Lost to Follow-up|39|||
48559661|NCT04747470|156240062|FG000|Overall Study|Death|0|||
48559662|NCT04747470|156240063|FG001|Overall Study|Death|3|||
48559663|NCT04747470|156240064|FG002|Overall Study|Death|2|||
48559664|NCT04747470|156240065|FG003|Overall Study|Death|2|||
48559665|NCT04747470|156240066|FG004|Overall Study|Death|2|||
48559666|NCT04747470|156240067|FG005|Overall Study|Death|0|||
48559667|NCT04747470|156240068|FG006|Overall Study|Death|0|||
48559668|NCT04747470|156240069|FG007|Overall Study|Death|0|||
48559669|NCT04747470|156240070|FG008|Overall Study|Death|0|||
48559670|NCT04747470|156240071|FG009|Overall Study|Death|0|||
48559671|NCT04747470|156240072|FG010|Overall Study|Death|0|||
48559672|NCT04747470|156240062|FG000|Overall Study|Withdrew Consent|0|||
48559673|NCT04747470|156240063|FG001|Overall Study|Withdrew Consent|0|||
48616827|NCT00614393|156452987|FG002|Overall Study|Physician Decision|1|||
48616828|NCT00614393|156452988|FG003|Overall Study|Physician Decision|8|||
48616829|NCT00614393|156452989|FG004|Overall Study|Physician Decision|9|||
48616830|NCT00614393|156452985|FG000|Overall Study|Progressive Disease|118|||
48616831|NCT00614393|156452986|FG001|Overall Study|Progressive Disease|5|||
48616832|NCT00614393|156452987|FG002|Overall Study|Progressive Disease|5|||
48616833|NCT00614393|156452988|FG003|Overall Study|Progressive Disease|138|||
48616834|NCT00614393|156452989|FG004|Overall Study|Progressive Disease|130|||
48616835|NCT00614393|156452985|FG000|Overall Study|Protocol Violation|1|||
48616836|NCT00614393|156452986|FG001|Overall Study|Protocol Violation|0|||
48616837|NCT00614393|156452987|FG002|Overall Study|Protocol Violation|0|||
48616838|NCT00614393|156452988|FG003|Overall Study|Protocol Violation|0|||
48559674|NCT04747470|156240064|FG002|Overall Study|Withdrew Consent|0|||
48559675|NCT04747470|156240065|FG003|Overall Study|Withdrew Consent|1|||
48559676|NCT04747470|156240066|FG004|Overall Study|Withdrew Consent|0|||
48559677|NCT04747470|156240067|FG005|Overall Study|Withdrew Consent|0|||
48559678|NCT04747470|156240068|FG006|Overall Study|Withdrew Consent|0|||
48616839|NCT00614393|156452989|FG004|Overall Study|Protocol Violation|0|||
48616840|NCT00614393|156452985|FG000|Overall Study|Terminated by Sponsor|0|||
48616841|NCT00614393|156452986|FG001|Overall Study|Terminated by Sponsor|0|||
48616842|NCT00614393|156452987|FG002|Overall Study|Terminated by Sponsor|0|||
48616843|NCT00614393|156452988|FG003|Overall Study|Terminated by Sponsor|0|||
48559679|NCT04747470|156240069|FG007|Overall Study|Withdrew Consent|0|||
48559680|NCT04747470|156240070|FG008|Overall Study|Withdrew Consent|0|||
48559681|NCT04747470|156240071|FG009|Overall Study|Withdrew Consent|0|||
48559682|NCT04747470|156240072|FG010|Overall Study|Withdrew Consent|0|||
48559683|NCT04747470|156240062|FG000|Overall Study|Study Terminated by Sponsor|0|||
48559684|NCT04747470|156240063|FG001|Overall Study|Study Terminated by Sponsor|0|||
48559685|NCT04747470|156240064|FG002|Overall Study|Study Terminated by Sponsor|1|||
48559686|NCT04747470|156240065|FG003|Overall Study|Study Terminated by Sponsor|0|||
48559687|NCT04747470|156240066|FG004|Overall Study|Study Terminated by Sponsor|2|||
48559688|NCT04747470|156240067|FG005|Overall Study|Study Terminated by Sponsor|0|||
48559689|NCT04747470|156240068|FG006|Overall Study|Study Terminated by Sponsor|0|||
48559690|NCT04747470|156240069|FG007|Overall Study|Study Terminated by Sponsor|0|||
48559691|NCT04747470|156240070|FG008|Overall Study|Study Terminated by Sponsor|0|||
48559692|NCT04747470|156240071|FG009|Overall Study|Study Terminated by Sponsor|0|||
48559693|NCT04747470|156240072|FG010|Overall Study|Study Terminated by Sponsor|0|||
48559694|NCT02548832|156240073|FG000|Overall Study|Lost to Follow-up|2|||
48559695|NCT02548832|156240074|FG001|Overall Study|Lost to Follow-up|2|||
48559696|NCT02548832|156240075|FG002|Overall Study|Lost to Follow-up|2|||
48559697|NCT02790437|156240079|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
48559698|NCT02790437|156240080|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
48616844|NCT00614393|156452989|FG004|Overall Study|Terminated by Sponsor|1|||
48616845|NCT00614393|156452985|FG000|Overall Study|Withdrawal by Subject|20|||
48559699|NCT02790437|156240079|FG000|Overall Study|Adverse Event|1|||
48559700|NCT02790437|156240080|FG001|Overall Study|Adverse Event|0|||
48559701|NCT02790437|156240079|FG000|Overall Study|Withdrawal by Subject|1|||
48559702|NCT02790437|156240080|FG001|Overall Study|Withdrawal by Subject|0|||
48559703|NCT01202175|156240081|FG000|Overall Study|Lost to Follow-up|2|||
48559704|NCT01202175|156240081|FG000|Overall Study|Withdrawal by Subject|1|||
48559705|NCT01202175|156240081|FG000|Overall Study|Adverse Event|2|||
48559706|NCT03565900|156240084|FG000|Overall Study|Disposition Unknown|4|||
48559707|NCT03565900|156240085|FG001|Overall Study|Disposition Unknown|1|||
48559708|NCT03565900|156240084|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48559709|NCT03565900|156240085|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
48559710|NCT03565900|156240084|FG000|Overall Study|Withdrawal by Subject|4|||
48559711|NCT03565900|156240085|FG001|Overall Study|Withdrawal by Subject|5|||
48559712|NCT03565900|156240084|FG000|Overall Study|Randomized By Mistake|0|||
48559713|NCT03565900|156240085|FG001|Overall Study|Randomized By Mistake|2|||
48559714|NCT03565900|156240084|FG000|Overall Study|Physician Decision|7|||
48559715|NCT03565900|156240085|FG001|Overall Study|Physician Decision|11|||
48559716|NCT03565900|156240084|FG000|Overall Study|Death|9|||
48559717|NCT03565900|156240085|FG001|Overall Study|Death|7|||
48559718|NCT02968576|156240086|FG000|Overall Study|Pregnancy|0|||
48559719|NCT02968576|156240087|FG001|Overall Study|Pregnancy|1|||
48559720|NCT03345420|156240088|FG000|Overall Study|Withdrawal by Subject|1|||
48559721|NCT04688671|156240089|FG000|Overall Study|Adverse Event|3|||
48559722|NCT04688671|156240090|FG001|Overall Study|Adverse Event|1|||
48559723|NCT04688671|156240089|FG000|Overall Study|Withdrawal by Subject|3|||
48559724|NCT04688671|156240090|FG001|Overall Study|Withdrawal by Subject|1|||
48559725|NCT04688671|156240089|FG000|Overall Study|Lack of Efficacy|1|||
48559726|NCT04688671|156240090|FG001|Overall Study|Lack of Efficacy|1|||
48559727|NCT04688671|156240089|FG000|Overall Study|Protocol Violation|1|||
48559728|NCT04688671|156240090|FG001|Overall Study|Protocol Violation|0|||
48559729|NCT04688671|156240089|FG000|Overall Study|Lost to Follow-up|0|||
48559730|NCT04688671|156240090|FG001|Overall Study|Lost to Follow-up|1|||
48559731|NCT04583735|156240094|FG000|Double-masked Treatment Period|Adverse Event|0|||
48559732|NCT04583735|156240095|FG001|Double-masked Treatment Period|Adverse Event|1|||
48559733|NCT04583735|156240094|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
48559734|NCT04583735|156240095|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
48559735|NCT04583735|156240094|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
48559736|NCT04583735|156240095|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
48559737|NCT04583735|156240094|FG000|Open-label Treatment Period|Adverse Event|1|||
48559738|NCT04583735|156240095|FG001|Open-label Treatment Period|Adverse Event|1|||
48559739|NCT04583735|156240094|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
48559740|NCT04583735|156240095|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48559741|NCT04583735|156240094|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
48559742|NCT04583735|156240095|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
48559743|NCT01176513|156240096|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
48559744|NCT00124917|156240097|FG000|Overall Study|Physician Decision|3|||
48559745|NCT01060072|156240098|FG000|Overall Study|Adverse Event|1|||
48559746|NCT01060072|156240099|FG001|Overall Study|Adverse Event|1|||
48559747|NCT01060072|156240098|FG000|Overall Study|Physician Decision|0|||
48559748|NCT01060072|156240099|FG001|Overall Study|Physician Decision|2|||
48559749|NCT01060072|156240098|FG000|Overall Study|Protocol Violation|0|||
48616846|NCT00614393|156452986|FG001|Overall Study|Withdrawal by Subject|1|||
48559750|NCT01060072|156240099|FG001|Overall Study|Protocol Violation|1|||
48559751|NCT01060072|156240098|FG000|Overall Study|Acute cholecystitis|1|||
48559752|NCT01060072|156240099|FG001|Overall Study|Acute cholecystitis|0|||
48559753|NCT01060072|156240098|FG000|Overall Study|Excluded Medications|0|||
48559754|NCT01060072|156240099|FG001|Overall Study|Excluded Medications|1|||
48559755|NCT02105987|156240100|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
48559756|NCT02105987|156240101|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
48559757|NCT02105987|156240102|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
48559758|NCT02105987|156240103|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
48559759|NCT02105987|156240104|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
48559760|NCT02105987|156240105|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
48559761|NCT02105987|156240100|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
48559762|NCT02105987|156240101|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
48559763|NCT02105987|156240102|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
48559764|NCT02105987|156240103|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
48559765|NCT02105987|156240104|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
48559766|NCT02105987|156240105|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
48559767|NCT02105987|156240100|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
48559768|NCT02105987|156240101|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
48559769|NCT02105987|156240102|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
48559770|NCT02105987|156240103|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
48559771|NCT02105987|156240104|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
48559772|NCT02105987|156240105|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
48559773|NCT02105987|156240100|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
48559774|NCT02105987|156240101|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
48559775|NCT02105987|156240102|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
48559776|NCT02105987|156240103|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
48559777|NCT02105987|156240104|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
48559778|NCT02105987|156240105|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
48559779|NCT02105987|156240100|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
48559780|NCT02105987|156240101|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
48559781|NCT02105987|156240102|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
48559782|NCT02105987|156240103|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
48559783|NCT02105987|156240104|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
48559784|NCT02105987|156240105|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
48559785|NCT02105987|156240100|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
48559786|NCT02105987|156240101|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
48559787|NCT02105987|156240102|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
48559788|NCT02105987|156240103|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
48559789|NCT02105987|156240104|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
48559790|NCT02105987|156240105|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
48559791|NCT02105987|156240100|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
48559792|NCT02105987|156240101|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
48559793|NCT02105987|156240102|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
48559794|NCT02105987|156240103|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
48559795|NCT02105987|156240104|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
48559796|NCT02105987|156240105|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
48559797|NCT02105987|156240100|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
48559798|NCT02105987|156240101|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
48559799|NCT02105987|156240102|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
48559800|NCT02105987|156240103|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
48559801|NCT02105987|156240104|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
48559802|NCT02105987|156240105|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
48559803|NCT02105987|156240100|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
48559804|NCT02105987|156240101|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
48559805|NCT02105987|156240102|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
48559806|NCT02105987|156240103|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
48559807|NCT02105987|156240104|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
48559808|NCT02105987|156240105|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
48559809|NCT02105987|156240100|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
48559810|NCT02105987|156240101|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
48559811|NCT02105987|156240102|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
48559812|NCT02105987|156240103|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
48559813|NCT02105987|156240104|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
48559814|NCT02105987|156240105|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
48693072|NCT01350999|156724664|FG000|Overall Study|Adverse Event|4|||
48559815|NCT02105987|156240100|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
48559816|NCT02105987|156240101|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
48559817|NCT02105987|156240102|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
48559818|NCT02105987|156240103|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
48559819|NCT02105987|156240104|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
48559820|NCT02105987|156240105|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
48559821|NCT02105987|156240100|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
48559822|NCT02105987|156240101|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
48559823|NCT02105987|156240102|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
48559824|NCT02105987|156240103|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
48559825|NCT02105987|156240104|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
48559826|NCT02105987|156240105|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
48559827|NCT02105987|156240100|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
48559828|NCT02105987|156240101|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
48559829|NCT02105987|156240102|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
48559830|NCT02105987|156240103|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
48559831|NCT02105987|156240104|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
48559832|NCT02105987|156240105|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
48559833|NCT02105987|156240100|FG000|Continuation Phase|Protocol Violation|0|||
48559834|NCT02105987|156240101|FG001|Continuation Phase|Protocol Violation|0|||
48559835|NCT02105987|156240102|FG002|Continuation Phase|Protocol Violation|0|||
48559836|NCT02105987|156240103|FG003|Continuation Phase|Protocol Violation|0|||
48559837|NCT02105987|156240104|FG004|Continuation Phase|Protocol Violation|1|||
48559838|NCT02105987|156240105|FG005|Continuation Phase|Protocol Violation|0|||
48559839|NCT05271175|156240106|FG000|One Week Follow up|Lost to Follow-up|10|||
48559840|NCT05271175|156240107|FG001|One Week Follow up|Lost to Follow-up|7|||
48559841|NCT05271175|156240108|FG002|One Week Follow up|Lost to Follow-up|5|||
48559842|NCT05271175|156240106|FG000|One Month Follow up|Lost to Follow-up|12|||
48559843|NCT05271175|156240107|FG001|One Month Follow up|Lost to Follow-up|7|||
48559844|NCT05271175|156240108|FG002|One Month Follow up|Lost to Follow-up|9|||
48559845|NCT05271175|156240106|FG000|Six Months Follow up|Lost to Follow-up|8|||
48559846|NCT05271175|156240107|FG001|Six Months Follow up|Lost to Follow-up|2|||
48559847|NCT05271175|156240108|FG002|Six Months Follow up|Lost to Follow-up|2|||
48559848|NCT01709500|156240109|FG000|Overall Study|Randomized but not treated|0|||
48559849|NCT01709500|156240110|FG001|Overall Study|Randomized but not treated|1|||
48559850|NCT01709500|156240109|FG000|Overall Study|Adverse Event|5|||
48559851|NCT01709500|156240110|FG001|Overall Study|Adverse Event|1|||
48559852|NCT01709500|156240109|FG000|Overall Study|Poor compliance to protocol|2|||
48559853|NCT01709500|156240110|FG001|Overall Study|Poor compliance to protocol|1|||
48559854|NCT01709500|156240109|FG000|Overall Study|Other|3|||
48559855|NCT01709500|156240110|FG001|Overall Study|Other|1|||
48559856|NCT01709500|156240109|FG000|Overall Study|Related to IMP administration|1|||
48559857|NCT01709500|156240110|FG001|Overall Study|Related to IMP administration|0|||
48559858|NCT01709500|156240109|FG000|Overall Study|Treatment ongoing|156|||
48559859|NCT01709500|156240110|FG001|Overall Study|Treatment ongoing|78|||
48559860|NCT01982682|156240111|FG000|Overall Study|Physician Decision|1|||
48559861|NCT02387840|156240113|FG000|Overall Study|Death|0|||
48559862|NCT02387840|156240114|FG001|Overall Study|Death|0|||
48559863|NCT02387840|156240115|FG002|Overall Study|Death|0|||
48559864|NCT02387840|156240116|FG003|Overall Study|Death|0|||
48559865|NCT02387840|156240117|FG004|Overall Study|Death|0|||
48559866|NCT02387840|156240118|FG005|Overall Study|Death|1|||
48559867|NCT00908544|156240119|FG000|Overall Study|Withdrawal by Subject|2|||
48559868|NCT00908544|156240120|FG001|Overall Study|Withdrawal by Subject|4|||
48559869|NCT00908544|156240119|FG000|Overall Study|Lack of Efficacy|0|||
48559870|NCT00908544|156240120|FG001|Overall Study|Lack of Efficacy|1|||
48559871|NCT00908544|156240119|FG000|Overall Study|Pregnancy|1|||
48559872|NCT00908544|156240120|FG001|Overall Study|Pregnancy|0|||
48559873|NCT00908544|156240119|FG000|Overall Study|Relocation abroad|1|||
48559874|NCT00908544|156240120|FG001|Overall Study|Relocation abroad|1|||
48559875|NCT00908544|156240119|FG000|Overall Study|Unable to visit sutdy center|1|||
48559876|NCT00908544|156240120|FG001|Overall Study|Unable to visit sutdy center|0|||
48559877|NCT03170544|156240121|FG000|Part 1|Lost to Follow-up|1|||
48559878|NCT03170544|156240122|FG001|Part 1|Lost to Follow-up|0|||
48559879|NCT03170544|156240123|FG002|Part 1|Lost to Follow-up|0|||
48559880|NCT03170544|156240124|FG003|Part 1|Lost to Follow-up|0|||
48559881|NCT03170544|156240125|FG004|Part 1|Lost to Follow-up|0|||
48559882|NCT03170544|156240126|FG005|Part 1|Lost to Follow-up|0|||
48559883|NCT03170544|156240127|FG006|Part 1|Lost to Follow-up|0|||
48559884|NCT03170544|156240128|FG007|Part 1|Lost to Follow-up|0|||
48559885|NCT03170544|156240129|FG008|Part 1|Lost to Follow-up|0|||
48559886|NCT03170544|156240130|FG009|Part 1|Lost to Follow-up|0|||
48559887|NCT03170544|156240131|FG010|Part 1|Lost to Follow-up|0|||
48559888|NCT03170544|156240132|FG011|Part 1|Lost to Follow-up|0|||
48559889|NCT03170544|156240121|FG000|Part 1|Not treated|0|||
48559890|NCT03170544|156240122|FG001|Part 1|Not treated|0|||
48559891|NCT03170544|156240123|FG002|Part 1|Not treated|0|||
48559892|NCT03170544|156240124|FG003|Part 1|Not treated|1|||
48559893|NCT03170544|156240125|FG004|Part 1|Not treated|0|||
48559894|NCT03170544|156240126|FG005|Part 1|Not treated|0|||
48559895|NCT03170544|156240127|FG006|Part 1|Not treated|0|||
48559896|NCT03170544|156240128|FG007|Part 1|Not treated|0|||
48559897|NCT03170544|156240129|FG008|Part 1|Not treated|0|||
48559898|NCT03170544|156240130|FG009|Part 1|Not treated|0|||
48559899|NCT03170544|156240131|FG010|Part 1|Not treated|0|||
48559900|NCT03170544|156240132|FG011|Part 1|Not treated|0|||
48559901|NCT00752128|156240141|FG000|Overall Study|Withdrawal by Subject|4|||
48559902|NCT04515147|156240145|FG000|Overall Study|Withdrawal by Subject|1|||
48559903|NCT04515147|156240146|FG001|Overall Study|Withdrawal by Subject|0|||
48559904|NCT04515147|156240147|FG002|Overall Study|Withdrawal by Subject|10|||
48559905|NCT04515147|156240148|FG003|Overall Study|Withdrawal by Subject|18|||
48559906|NCT04515147|156240149|FG004|Overall Study|Withdrawal by Subject|1|||
48559907|NCT04515147|156240150|FG005|Overall Study|Withdrawal by Subject|8|||
48559908|NCT04515147|156240145|FG000|Overall Study|Lost to Follow-up|0|||
48559909|NCT04515147|156240146|FG001|Overall Study|Lost to Follow-up|1|||
48559910|NCT04515147|156240147|FG002|Overall Study|Lost to Follow-up|5|||
48559911|NCT04515147|156240148|FG003|Overall Study|Lost to Follow-up|6|||
48559912|NCT04515147|156240149|FG004|Overall Study|Lost to Follow-up|2|||
48559913|NCT04515147|156240150|FG005|Overall Study|Lost to Follow-up|1|||
48559914|NCT04515147|156240145|FG000|Overall Study|Adverse Event|0|||
48559915|NCT04515147|156240146|FG001|Overall Study|Adverse Event|0|||
48559916|NCT04515147|156240147|FG002|Overall Study|Adverse Event|0|||
48559917|NCT04515147|156240148|FG003|Overall Study|Adverse Event|2|||
48559918|NCT04515147|156240149|FG004|Overall Study|Adverse Event|0|||
48559919|NCT04515147|156240150|FG005|Overall Study|Adverse Event|0|||
48559920|NCT04515147|156240145|FG000|Overall Study|Miscellaneous|0|||
48559921|NCT04515147|156240146|FG001|Overall Study|Miscellaneous|0|||
48559922|NCT04515147|156240147|FG002|Overall Study|Miscellaneous|0|||
48559923|NCT04515147|156240148|FG003|Overall Study|Miscellaneous|1|||
48559924|NCT04515147|156240149|FG004|Overall Study|Miscellaneous|0|||
48559925|NCT04515147|156240150|FG005|Overall Study|Miscellaneous|1|||
48559926|NCT03591874|156240153|FG000|Overall Study|Adverse Event|4|||
48559927|NCT03591874|156240154|FG001|Overall Study|Adverse Event|0|||
48559928|NCT03591874|156240153|FG000|Overall Study|Withdrawal by Subject|2|||
48559929|NCT03591874|156240154|FG001|Overall Study|Withdrawal by Subject|1|||
48559930|NCT03591874|156240153|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
48559931|NCT03591874|156240154|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
48559932|NCT03591874|156240153|FG000|Overall Study|On Study at Time of Study Termination|12|||
48559933|NCT03591874|156240154|FG001|Overall Study|On Study at Time of Study Termination|6|||
48559934|NCT04564092|156240155|FG000|Overall Study|Withdrawal by Subject|1|||
48559935|NCT00570063|156240156|FG000|Overall Study|Adverse Event|4|||
48559936|NCT00570063|156240157|FG001|Overall Study|Adverse Event|1|||
48559937|NCT00570063|156240156|FG000|Overall Study|Lack of Efficacy|0|||
48559938|NCT00570063|156240157|FG001|Overall Study|Lack of Efficacy|1|||
48559939|NCT00570063|156240156|FG000|Overall Study|Withdrawal by Subject|4|||
48559940|NCT00570063|156240157|FG001|Overall Study|Withdrawal by Subject|3|||
48559941|NCT00570063|156240156|FG000|Overall Study|Sponsor's Decision|7|||
48559942|NCT00570063|156240157|FG001|Overall Study|Sponsor's Decision|3|||
48559943|NCT00071110|156240158|FG000|Overall Study|Protocol Violation|0|||
48559944|NCT00071110|156240159|FG001|Overall Study|Protocol Violation|4|||
48559945|NCT02969382|156242703|FG000|Overall Study|Adverse Event|8|||
48559946|NCT02969382|156242704|FG001|Overall Study|Adverse Event|10|||
48559947|NCT02969382|156242703|FG000|Overall Study|Lack of Efficacy|4|||
48559948|NCT02969382|156242704|FG001|Overall Study|Lack of Efficacy|5|||
48559949|NCT02969382|156242703|FG000|Overall Study|Death|0|||
48559950|NCT02969382|156242704|FG001|Overall Study|Death|1|||
48559951|NCT02969382|156242703|FG000|Overall Study|PROTOCOL DEVIATION|0|||
48559952|NCT02969382|156242704|FG001|Overall Study|PROTOCOL DEVIATION|1|||
48559953|NCT02969382|156242703|FG000|Overall Study|Withdrawal by Subject|14|||
48559954|NCT02969382|156242704|FG001|Overall Study|Withdrawal by Subject|9|||
48559955|NCT02640482|156242707|FG000|Overall Study|Lost to Follow-up|3|||
48559956|NCT02640482|156242708|FG001|Overall Study|Lost to Follow-up|0|||
48559957|NCT01173120|156242710|FG000|Overall Study|Lack of Efficacy|2|||
48559958|NCT01173120|156242710|FG000|Overall Study|Lost to Follow-up|1|||
48559959|NCT01173120|156242710|FG000|Overall Study|Participant Decision|2|||
48559960|NCT01173120|156242710|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
48559961|NCT01173120|156242710|FG000|Overall Study|Switch-Participant Decision|12|||
48559962|NCT01173120|156242710|FG000|Overall Study|Switch-Difficulty With Device|12|||
48559963|NCT02090725|156242711|FG000|Overall Study|Withdrawal by Subject|1|||
48559964|NCT02090725|156242711|FG000|Overall Study|participants moved from area|3|||
48559965|NCT03408639|156242712|FG000|Overall Study|Death|5|||
48559966|NCT03408639|156242713|FG001|Overall Study|Death|5|||
48559967|NCT03408639|156242712|FG000|Overall Study|Lost to Follow-up|1|||
48616847|NCT00614393|156452987|FG002|Overall Study|Withdrawal by Subject|1|||
48616848|NCT00614393|156452988|FG003|Overall Study|Withdrawal by Subject|16|||
48559968|NCT03408639|156242713|FG001|Overall Study|Lost to Follow-up|4|||
48559969|NCT03408639|156242712|FG000|Overall Study|Withdrawal by Subject|2|||
48559970|NCT03408639|156242713|FG001|Overall Study|Withdrawal by Subject|7|||
48559971|NCT03408639|156242712|FG000|Overall Study|Physician Decision|3|||
48559972|NCT03408639|156242713|FG001|Overall Study|Physician Decision|6|||
48559973|NCT03055624|156242721|FG000|Overall Study|Study closed|9|||
48559974|NCT00764881|156242722|FG000|Overall Study|Adverse Event|5|||
48559975|NCT00764881|156242723|FG001|Overall Study|Adverse Event|1|||
48559976|NCT00764881|156242722|FG000|Overall Study|Withdrawal by Subject|1|||
48559977|NCT00764881|156242723|FG001|Overall Study|Withdrawal by Subject|3|||
48559978|NCT00764881|156242722|FG000|Overall Study|Protocol Violation|2|||
48559979|NCT00764881|156242723|FG001|Overall Study|Protocol Violation|2|||
48559980|NCT00764881|156242722|FG000|Overall Study|Lost to Follow-up|2|||
48559981|NCT00764881|156242723|FG001|Overall Study|Lost to Follow-up|0|||
48559982|NCT00764881|156242722|FG000|Overall Study|Noncompliant|1|||
48559983|NCT00764881|156242723|FG001|Overall Study|Noncompliant|0|||
48559984|NCT00764881|156242722|FG000|Overall Study|Accidentally discontinued study drug|1|||
48559985|NCT00764881|156242723|FG001|Overall Study|Accidentally discontinued study drug|0|||
48559986|NCT00764881|156242722|FG000|Overall Study|Wished to become pregnant|1|||
48559987|NCT00764881|156242723|FG001|Overall Study|Wished to become pregnant|0|||
48559988|NCT00764881|156242722|FG000|Overall Study|Carcinoma detected|1|||
48559989|NCT00764881|156242723|FG001|Overall Study|Carcinoma detected|0|||
48559990|NCT00764881|156242722|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
48559991|NCT00764881|156242723|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
48559992|NCT00764881|156242722|FG000|Overall Study|no treatment or no observation|2|||
48559993|NCT00764881|156242723|FG001|Overall Study|no treatment or no observation|2|||
48559994|NCT01499095|156242724|FG000|Overall Study|Randomized But Not Treated|1|||
48559995|NCT01499095|156242725|FG001|Overall Study|Randomized But Not Treated|1|||
48559996|NCT01499095|156242724|FG000|Overall Study|Adverse Event|12|||
48559997|NCT01499095|156242725|FG001|Overall Study|Adverse Event|7|||
48559998|NCT01499095|156242724|FG000|Overall Study|Lack of Efficacy|2|||
48559999|NCT01499095|156242725|FG001|Overall Study|Lack of Efficacy|1|||
48560000|NCT01499095|156242724|FG000|Overall Study|Protocol Violation|6|||
48560001|NCT01499095|156242725|FG001|Overall Study|Protocol Violation|7|||
48560002|NCT01499095|156242724|FG000|Overall Study|Received Rescue Therapy|32|||
48560003|NCT01499095|156242725|FG001|Overall Study|Received Rescue Therapy|40|||
48560004|NCT01499095|156242724|FG000|Overall Study|Diverse Reasons|22|||
48560005|NCT01499095|156242725|FG001|Overall Study|Diverse Reasons|25|||
48560006|NCT01499095|156242724|FG000|Overall Study|Lost to Follow-up|6|||
48560007|NCT01499095|156242725|FG001|Overall Study|Lost to Follow-up|4|||
48560008|NCT01499095|156242724|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
48560009|NCT01499095|156242725|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
48560010|NCT01499095|156242724|FG000|Overall Study|Hypoglycemia|3|||
48560011|NCT01499095|156242725|FG001|Overall Study|Hypoglycemia|1|||
48560012|NCT01499095|156242724|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
48560013|NCT01499095|156242725|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
48560014|NCT01499095|156242724|FG000|Overall Study|Change in Injection Schedule|2|||
48560015|NCT01499095|156242725|FG001|Overall Study|Change in Injection Schedule|0|||
48560016|NCT01499095|156242724|FG000|Overall Study|Perceived Lack of Efficacy|1|||
48560017|NCT01499095|156242725|FG001|Overall Study|Perceived Lack of Efficacy|1|||
48560018|NCT01214655|156242729|FG000|Part A|Progressive Disease|7|||
48560019|NCT01214655|156242730|FG001|Part A|Progressive Disease|0|||
48560020|NCT01214655|156242731|FG002|Part A|Progressive Disease|0|||
48560021|NCT01214655|156242729|FG000|Part A|Physician Decision|1|||
48560022|NCT01214655|156242730|FG001|Part A|Physician Decision|0|||
48560023|NCT01214655|156242731|FG002|Part A|Physician Decision|0|||
48560024|NCT01214655|156242729|FG000|Part B|Progressive disease|0|||
48560025|NCT01214655|156242730|FG001|Part B|Progressive disease|10|||
48560026|NCT01214655|156242731|FG002|Part B|Progressive disease|0|||
48560027|NCT01214655|156242729|FG000|Part B|Death|0|||
48560028|NCT01214655|156242730|FG001|Part B|Death|1|||
48560029|NCT01214655|156242731|FG002|Part B|Death|0|||
48560030|NCT01214655|156242729|FG000|Part B|Withdrawal by Subject|0|||
48560031|NCT01214655|156242730|FG001|Part B|Withdrawal by Subject|2|||
48560032|NCT01214655|156242731|FG002|Part B|Withdrawal by Subject|0|||
48560033|NCT01214655|156242729|FG000|Part C|Progressive Disease|0|||
48560034|NCT01214655|156242730|FG001|Part C|Progressive Disease|0|||
48560035|NCT01214655|156242731|FG002|Part C|Progressive Disease|5|||
48560036|NCT01214655|156242729|FG000|Part C|Death|0|||
48560037|NCT01214655|156242730|FG001|Part C|Death|0|||
48560038|NCT01214655|156242731|FG002|Part C|Death|1|||
48560039|NCT01214655|156242729|FG000|Part C|Physician Decision|0|||
48560040|NCT01214655|156242730|FG001|Part C|Physician Decision|0|||
48560041|NCT01214655|156242731|FG002|Part C|Physician Decision|1|||
48560042|NCT00113763|156242732|FG000|Overall Study|Adverse Event|5|||
48560043|NCT00113763|156242733|FG001|Overall Study|Adverse Event|2|||
48560044|NCT00113763|156242732|FG000|Overall Study|Disease Progression|28|||
48560045|NCT00113763|156242733|FG001|Overall Study|Disease Progression|14|||
48560046|NCT00113763|156242732|FG000|Overall Study|Lost to Follow-up|10|||
48560047|NCT00113763|156242733|FG001|Overall Study|Lost to Follow-up|0|||
48560048|NCT00113763|156242732|FG000|Overall Study|Withdrawal by Subject|1|||
48560049|NCT00113763|156242733|FG001|Overall Study|Withdrawal by Subject|4|||
48560050|NCT00113763|156242732|FG000|Overall Study|Other|27|||
48560051|NCT00113763|156242733|FG001|Overall Study|Other|6|||
48560052|NCT00113763|156242732|FG000|Overall Study|Non-compliance|1|||
48560053|NCT00113763|156242733|FG001|Overall Study|Non-compliance|0|||
48560054|NCT00113763|156242732|FG000|Overall Study|Ongoing|1|||
48560055|NCT00113763|156242733|FG001|Overall Study|Ongoing|0|||
48560056|NCT00517881|156242734|FG000|Overall Study|Protocol Violation|2|||
48560057|NCT00517881|156242734|FG000|Overall Study|Adverse Event|1|||
48560058|NCT00517881|156242734|FG000|Overall Study|Renal transplantation|2|||
48560059|NCT01207583|156242737|FG000|Overall Study|Withdrawal by Subject|0|||
48560060|NCT01207583|156242738|FG001|Overall Study|Withdrawal by Subject|3|||
48560061|NCT01207583|156242739|FG002|Overall Study|Withdrawal by Subject|1|||
48560062|NCT01207583|156242737|FG000|Overall Study|Participant failed to return|1|||
48560063|NCT01207583|156242738|FG001|Overall Study|Participant failed to return|0|||
48560064|NCT01207583|156242739|FG002|Overall Study|Participant failed to return|0|||
48560065|NCT01207583|156242737|FG000|Overall Study|Lost to Follow-up|0|||
48560066|NCT01207583|156242738|FG001|Overall Study|Lost to Follow-up|2|||
48560067|NCT01207583|156242739|FG002|Overall Study|Lost to Follow-up|0|||
48560068|NCT00324987|156242743|FG000|Overall Study|Adverse Event|2|||
48560069|NCT00324987|156242744|FG001|Overall Study|Adverse Event|1|||
48560070|NCT00324987|156242743|FG000|Overall Study|Withdrawal by Subject|1|||
48560071|NCT00324987|156242744|FG001|Overall Study|Withdrawal by Subject|1|||
48560072|NCT00324987|156242743|FG000|Overall Study|Progression|1|||
48560073|NCT00324987|156242744|FG001|Overall Study|Progression|1|||
48560074|NCT00324987|156242743|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
48560075|NCT00324987|156242744|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
48560076|NCT01965860|156242745|FG000|Overall Study|Pregnancy|1|||
48560077|NCT01965860|156242746|FG001|Overall Study|Pregnancy|0|||
48560078|NCT01965860|156242747|FG002|Overall Study|Pregnancy|1|||
48560079|NCT01965860|156242745|FG000|Overall Study|Logistics|1|||
48560080|NCT01965860|156242746|FG001|Overall Study|Logistics|0|||
48560081|NCT01965860|156242747|FG002|Overall Study|Logistics|0|||
48560082|NCT01342081|156242748|FG000|Overall Study|Did not receive allocated intervention|0|||
48560083|NCT01342081|156242749|FG001|Overall Study|Did not receive allocated intervention|0|||
48560084|NCT01342081|156242750|FG002|Overall Study|Did not receive allocated intervention|1|||
48560085|NCT01342081|156242748|FG000|Overall Study|Adverse Event|1|||
48560086|NCT01342081|156242749|FG001|Overall Study|Adverse Event|0|||
48560087|NCT01342081|156242750|FG002|Overall Study|Adverse Event|0|||
48560088|NCT01342081|156242748|FG000|Overall Study|Physician Decision|0|||
48560089|NCT01342081|156242749|FG001|Overall Study|Physician Decision|1|||
48560090|NCT01342081|156242750|FG002|Overall Study|Physician Decision|0|||
48693073|NCT01350999|156724665|FG001|Overall Study|Adverse Event|9|||
48560091|NCT01342081|156242748|FG000|Overall Study|Withdrawal by Subject|1|||
48560092|NCT01342081|156242749|FG001|Overall Study|Withdrawal by Subject|1|||
48560093|NCT01342081|156242750|FG002|Overall Study|Withdrawal by Subject|0|||
48560094|NCT02222922|156242753|FG000|Overall Study|Death|0|||
48560095|NCT02222922|156242754|FG001|Overall Study|Death|0|||
48560096|NCT02222922|156242755|FG002|Overall Study|Death|0|||
48560097|NCT02222922|156242756|FG003|Overall Study|Death|0|||
48560098|NCT02222922|156242757|FG004|Overall Study|Death|13|||
48560099|NCT02222922|156242758|FG005|Overall Study|Death|0|||
48560100|NCT02222922|156242759|FG006|Overall Study|Death|0|||
48560101|NCT02222922|156242760|FG007|Overall Study|Death|0|||
48560102|NCT02222922|156242761|FG008|Overall Study|Death|2|||
48560103|NCT02222922|156242753|FG000|Overall Study|Lost to Follow-up|0|||
48560104|NCT02222922|156242754|FG001|Overall Study|Lost to Follow-up|0|||
48560105|NCT02222922|156242755|FG002|Overall Study|Lost to Follow-up|1|||
48560106|NCT02222922|156242756|FG003|Overall Study|Lost to Follow-up|0|||
48560107|NCT02222922|156242757|FG004|Overall Study|Lost to Follow-up|9|||
48560108|NCT02222922|156242758|FG005|Overall Study|Lost to Follow-up|1|||
48560109|NCT02222922|156242759|FG006|Overall Study|Lost to Follow-up|0|||
48560110|NCT02222922|156242760|FG007|Overall Study|Lost to Follow-up|0|||
48560111|NCT02222922|156242761|FG008|Overall Study|Lost to Follow-up|0|||
48560112|NCT02222922|156242753|FG000|Overall Study|Other|0|||
48560113|NCT02222922|156242754|FG001|Overall Study|Other|0|||
48560114|NCT02222922|156242755|FG002|Overall Study|Other|0|||
48560115|NCT02222922|156242756|FG003|Overall Study|Other|2|||
48560116|NCT02222922|156242757|FG004|Overall Study|Other|10|||
48560117|NCT02222922|156242758|FG005|Overall Study|Other|2|||
48560118|NCT02222922|156242759|FG006|Overall Study|Other|2|||
48560119|NCT02222922|156242760|FG007|Overall Study|Other|4|||
48560120|NCT02222922|156242761|FG008|Overall Study|Other|1|||
48560121|NCT02222922|156242753|FG000|Overall Study|Participant refused further follow-up|1|||
48560122|NCT02222922|156242754|FG001|Overall Study|Participant refused further follow-up|0|||
48560123|NCT02222922|156242755|FG002|Overall Study|Participant refused further follow-up|0|||
48560124|NCT02222922|156242756|FG003|Overall Study|Participant refused further follow-up|1|||
48560125|NCT02222922|156242757|FG004|Overall Study|Participant refused further follow-up|6|||
48560126|NCT02222922|156242758|FG005|Overall Study|Participant refused further follow-up|0|||
48560127|NCT02222922|156242759|FG006|Overall Study|Participant refused further follow-up|0|||
48560128|NCT02222922|156242760|FG007|Overall Study|Participant refused further follow-up|0|||
48560129|NCT02222922|156242761|FG008|Overall Study|Participant refused further follow-up|3|||
48560130|NCT03832686|156242762|FG000|Overall Study|Lost to Follow-up|6|||
48560131|NCT03832686|156242763|FG001|Overall Study|Lost to Follow-up|9|||
48560132|NCT03832686|156242762|FG000|Overall Study|Discontinued Intervention|5|||
48560133|NCT03832686|156242763|FG001|Overall Study|Discontinued Intervention|4|||
48560134|NCT03597295|156242777|FG000|Overall Study|Death|70|||
48560135|NCT03597295|156242777|FG000|Overall Study|Lost to Follow-up|7|||
48560136|NCT04067050|156242778|FG000|One Month|Lost to Follow-up|4|||
48560137|NCT04067050|156242779|FG001|One Month|Lost to Follow-up|0|||
48560138|NCT04067050|156242778|FG000|Two Month|Lost to Follow-up|1|||
48560139|NCT04067050|156242779|FG001|Two Month|Lost to Follow-up|0|||
48560140|NCT04067050|156242778|FG000|Two Month|Adverse Event|1|||
48560141|NCT04067050|156242779|FG001|Two Month|Adverse Event|0|||
48560142|NCT03359850|156242780|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
48560143|NCT03359850|156242781|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
48560144|NCT03359850|156242780|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
48560145|NCT03359850|156242781|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
48560146|NCT03359850|156242780|FG000|Extension Phase (Up to 28 Months)|Death|2|||
48560147|NCT03359850|156242781|FG001|Extension Phase (Up to 28 Months)|Death|4|||
48560148|NCT03359850|156242780|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
48560149|NCT03359850|156242781|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
48560150|NCT03359850|156242780|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
48560151|NCT03359850|156242781|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
48560152|NCT04720053|156242784|FG000|Overall Study|Lost to Follow-up|12|||
48560153|NCT00942357|156242793|FG000|Overall Study|Ineligible|37|||
48560154|NCT00942357|156242794|FG001|Overall Study|Ineligible|40|||
48560155|NCT01960257|156242797|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
48560156|NCT01960257|156242798|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
48560157|NCT01960257|156242799|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
48560158|NCT01960257|156242797|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
48560159|NCT01960257|156242798|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
48560160|NCT01960257|156242799|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
48560161|NCT01960257|156242797|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
48560162|NCT01960257|156242798|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
48560163|NCT01960257|156242799|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
48560164|NCT03817125|156242803|FG000|Overall Study|Adverse Event|1|||
48560165|NCT03817125|156242804|FG001|Overall Study|Adverse Event|0|||
48560166|NCT03817125|156242803|FG000|Overall Study|Physician Decision|0|||
48560167|NCT03817125|156242804|FG001|Overall Study|Physician Decision|1|||
48560168|NCT03817125|156242803|FG000|Overall Study|Lack of Efficacy|1|||
48560169|NCT03817125|156242804|FG001|Overall Study|Lack of Efficacy|5|||
48560170|NCT02002221|156242805|FG000|Overall Study|Adverse Event|2|||
48560171|NCT02002221|156242806|FG001|Overall Study|Adverse Event|1|||
48560172|NCT02002221|156242805|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48560173|NCT02002221|156242806|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48560174|NCT02002221|156242805|FG000|Overall Study|Patient withdrew consent|0|||
48560175|NCT02002221|156242806|FG001|Overall Study|Patient withdrew consent|1|||
48560176|NCT00942084|156242807|FG000|Overall Study|Death|2|||
48560177|NCT01350271|156242808|FG000|Overall Study|Lost to Follow-up|21|||
48560178|NCT01350271|156242809|FG001|Overall Study|Lost to Follow-up|17|||
48560179|NCT01350271|156242810|FG002|Overall Study|Lost to Follow-up|26|||
48560180|NCT02906670|156242814|FG000|Cohort 1, QW|Radiological Progression|1|||
48560181|NCT02906670|156242815|FG001|Cohort 1, QW|Radiological Progression|0|||
48560182|NCT02906670|156242816|FG002|Cohort 1, QW|Radiological Progression|0|||
48560183|NCT02906670|156242817|FG003|Cohort 1, QW|Radiological Progression|0|||
48560184|NCT02906670|156242818|FG004|Cohort 1, QW|Radiological Progression|0|||
48560185|NCT02906670|156242819|FG005|Cohort 1, QW|Radiological Progression|0|||
48560186|NCT02906670|156242820|FG006|Cohort 1, QW|Radiological Progression|0|||
48560187|NCT02906670|156242821|FG007|Cohort 1, QW|Radiological Progression|0|||
48560188|NCT02906670|156242822|FG008|Cohort 1, QW|Radiological Progression|0|||
48560189|NCT02906670|156242823|FG009|Cohort 1, QW|Radiological Progression|0|||
48560190|NCT02906670|156242814|FG000|Cohort 2, QW|Radiological Progression|0|||
48560191|NCT02906670|156242815|FG001|Cohort 2, QW|Radiological Progression|1|||
48560192|NCT02906670|156242816|FG002|Cohort 2, QW|Radiological Progression|0|||
48560193|NCT02906670|156242817|FG003|Cohort 2, QW|Radiological Progression|0|||
48560194|NCT02906670|156242818|FG004|Cohort 2, QW|Radiological Progression|0|||
48560195|NCT02906670|156242819|FG005|Cohort 2, QW|Radiological Progression|0|||
48560196|NCT02906670|156242820|FG006|Cohort 2, QW|Radiological Progression|0|||
48560197|NCT02906670|156242821|FG007|Cohort 2, QW|Radiological Progression|0|||
48560198|NCT02906670|156242822|FG008|Cohort 2, QW|Radiological Progression|0|||
48560199|NCT02906670|156242823|FG009|Cohort 2, QW|Radiological Progression|0|||
48560200|NCT02906670|156242814|FG000|Cohort 3, QW|Radiological Progression|0|||
48560201|NCT02906670|156242815|FG001|Cohort 3, QW|Radiological Progression|0|||
48560202|NCT02906670|156242816|FG002|Cohort 3, QW|Radiological Progression|2|||
48560203|NCT02906670|156242817|FG003|Cohort 3, QW|Radiological Progression|0|||
48560204|NCT02906670|156242818|FG004|Cohort 3, QW|Radiological Progression|0|||
48560205|NCT02906670|156242819|FG005|Cohort 3, QW|Radiological Progression|0|||
48560206|NCT02906670|156242820|FG006|Cohort 3, QW|Radiological Progression|0|||
48560207|NCT02906670|156242821|FG007|Cohort 3, QW|Radiological Progression|0|||
48560208|NCT02906670|156242822|FG008|Cohort 3, QW|Radiological Progression|0|||
48560209|NCT02906670|156242823|FG009|Cohort 3, QW|Radiological Progression|0|||
48560210|NCT02906670|156242814|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560211|NCT02906670|156242815|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560212|NCT02906670|156242816|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
48560213|NCT02906670|156242817|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560214|NCT02906670|156242818|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560215|NCT02906670|156242819|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560216|NCT02906670|156242820|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560217|NCT02906670|156242821|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560218|NCT02906670|156242822|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560219|NCT02906670|156242823|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
48560220|NCT02906670|156242814|FG000|Cohort 4, Q2W|Radiological Progression|0|||
48560221|NCT02906670|156242815|FG001|Cohort 4, Q2W|Radiological Progression|0|||
48560222|NCT02906670|156242816|FG002|Cohort 4, Q2W|Radiological Progression|0|||
48560223|NCT02906670|156242817|FG003|Cohort 4, Q2W|Radiological Progression|0|||
48560224|NCT02906670|156242818|FG004|Cohort 4, Q2W|Radiological Progression|0|||
48560225|NCT02906670|156242819|FG005|Cohort 4, Q2W|Radiological Progression|1|||
48560226|NCT02906670|156242820|FG006|Cohort 4, Q2W|Radiological Progression|0|||
48560227|NCT02906670|156242821|FG007|Cohort 4, Q2W|Radiological Progression|0|||
48560228|NCT02906670|156242822|FG008|Cohort 4, Q2W|Radiological Progression|0|||
48560229|NCT02906670|156242823|FG009|Cohort 4, Q2W|Radiological Progression|0|||
48560230|NCT02906670|156242814|FG000|Cohort 4, Q2W|Clinical Progression|0|||
48560231|NCT02906670|156242815|FG001|Cohort 4, Q2W|Clinical Progression|0|||
48560232|NCT02906670|156242816|FG002|Cohort 4, Q2W|Clinical Progression|0|||
48560233|NCT02906670|156242817|FG003|Cohort 4, Q2W|Clinical Progression|0|||
48560234|NCT02906670|156242818|FG004|Cohort 4, Q2W|Clinical Progression|0|||
48560235|NCT02906670|156242819|FG005|Cohort 4, Q2W|Clinical Progression|2|||
48560236|NCT02906670|156242820|FG006|Cohort 4, Q2W|Clinical Progression|0|||
48560237|NCT02906670|156242821|FG007|Cohort 4, Q2W|Clinical Progression|0|||
48560238|NCT02906670|156242822|FG008|Cohort 4, Q2W|Clinical Progression|0|||
48560239|NCT02906670|156242823|FG009|Cohort 4, Q2W|Clinical Progression|0|||
48560240|NCT02906670|156242814|FG000|Cohort 5, Q2W|Radiological Progression|0|||
48560241|NCT02906670|156242815|FG001|Cohort 5, Q2W|Radiological Progression|0|||
48560242|NCT02906670|156242816|FG002|Cohort 5, Q2W|Radiological Progression|0|||
48560243|NCT02906670|156242817|FG003|Cohort 5, Q2W|Radiological Progression|0|||
48560244|NCT02906670|156242818|FG004|Cohort 5, Q2W|Radiological Progression|0|||
48560245|NCT02906670|156242819|FG005|Cohort 5, Q2W|Radiological Progression|0|||
48560246|NCT02906670|156242820|FG006|Cohort 5, Q2W|Radiological Progression|4|||
48560247|NCT02906670|156242821|FG007|Cohort 5, Q2W|Radiological Progression|0|||
48560248|NCT02906670|156242822|FG008|Cohort 5, Q2W|Radiological Progression|0|||
48560249|NCT02906670|156242823|FG009|Cohort 5, Q2W|Radiological Progression|0|||
48560250|NCT02906670|156242814|FG000|Cohort 5, Q2W|Clinical Progression|0|||
48560251|NCT02906670|156242815|FG001|Cohort 5, Q2W|Clinical Progression|0|||
48560252|NCT02906670|156242816|FG002|Cohort 5, Q2W|Clinical Progression|0|||
48560253|NCT02906670|156242817|FG003|Cohort 5, Q2W|Clinical Progression|0|||
48560254|NCT02906670|156242818|FG004|Cohort 5, Q2W|Clinical Progression|0|||
48560255|NCT02906670|156242819|FG005|Cohort 5, Q2W|Clinical Progression|0|||
48560256|NCT02906670|156242820|FG006|Cohort 5, Q2W|Clinical Progression|1|||
48560257|NCT02906670|156242821|FG007|Cohort 5, Q2W|Clinical Progression|0|||
48560258|NCT02906670|156242822|FG008|Cohort 5, Q2W|Clinical Progression|0|||
48560259|NCT02906670|156242823|FG009|Cohort 5, Q2W|Clinical Progression|0|||
48560260|NCT02906670|156242814|FG000|Cohort 5, Q2W|Adverse Event|0|||
48560261|NCT02906670|156242815|FG001|Cohort 5, Q2W|Adverse Event|0|||
48560262|NCT02906670|156242816|FG002|Cohort 5, Q2W|Adverse Event|0|||
48560263|NCT02906670|156242817|FG003|Cohort 5, Q2W|Adverse Event|0|||
48560264|NCT02906670|156242818|FG004|Cohort 5, Q2W|Adverse Event|0|||
48560265|NCT02906670|156242819|FG005|Cohort 5, Q2W|Adverse Event|0|||
48560266|NCT02906670|156242820|FG006|Cohort 5, Q2W|Adverse Event|1|||
48560267|NCT02906670|156242821|FG007|Cohort 5, Q2W|Adverse Event|0|||
48560268|NCT02906670|156242822|FG008|Cohort 5, Q2W|Adverse Event|0|||
48560269|NCT02906670|156242823|FG009|Cohort 5, Q2W|Adverse Event|0|||
48560270|NCT02906670|156242814|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560271|NCT02906670|156242815|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560272|NCT02906670|156242816|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560273|NCT02906670|156242817|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560274|NCT02906670|156242818|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560275|NCT02906670|156242819|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560276|NCT02906670|156242820|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
48560277|NCT02906670|156242821|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560278|NCT02906670|156242822|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560279|NCT02906670|156242823|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
48560280|NCT02906670|156242814|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
48560281|NCT02906670|156242815|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
48560282|NCT02906670|156242816|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
48560283|NCT02906670|156242817|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
48560284|NCT02906670|156242818|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
48560285|NCT02906670|156242819|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
48560286|NCT02906670|156242820|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
48560287|NCT02906670|156242821|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
48560288|NCT02906670|156242822|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
48560289|NCT02906670|156242823|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
48560290|NCT02906670|156242814|FG000|Cohort 5P, Q2W|Adverse Event|0|||
48560291|NCT02906670|156242815|FG001|Cohort 5P, Q2W|Adverse Event|0|||
48560292|NCT02906670|156242816|FG002|Cohort 5P, Q2W|Adverse Event|0|||
48560293|NCT02906670|156242817|FG003|Cohort 5P, Q2W|Adverse Event|0|||
48560294|NCT02906670|156242818|FG004|Cohort 5P, Q2W|Adverse Event|0|||
48560295|NCT02906670|156242819|FG005|Cohort 5P, Q2W|Adverse Event|0|||
48560296|NCT02906670|156242820|FG006|Cohort 5P, Q2W|Adverse Event|0|||
48560297|NCT02906670|156242821|FG007|Cohort 5P, Q2W|Adverse Event|1|||
48560298|NCT02906670|156242822|FG008|Cohort 5P, Q2W|Adverse Event|0|||
48560299|NCT02906670|156242823|FG009|Cohort 5P, Q2W|Adverse Event|0|||
48560300|NCT02906670|156242814|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
48560301|NCT02906670|156242815|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
48560302|NCT02906670|156242816|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
48560303|NCT02906670|156242817|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
48560304|NCT02906670|156242818|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
48560305|NCT02906670|156242819|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
48560306|NCT02906670|156242820|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
48560307|NCT02906670|156242821|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
48560308|NCT02906670|156242822|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
48560309|NCT02906670|156242823|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
48560310|NCT02906670|156242814|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
48560311|NCT02906670|156242815|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
48560312|NCT02906670|156242816|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
48560313|NCT02906670|156242817|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
48560314|NCT02906670|156242818|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
48560315|NCT02906670|156242819|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
48560316|NCT02906670|156242820|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
48560317|NCT02906670|156242821|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
48560318|NCT02906670|156242822|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
48560319|NCT02906670|156242823|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
48560320|NCT02906670|156242814|FG000|Cohort 4P, QW|Radiological Progression|0|||
48560321|NCT02906670|156242815|FG001|Cohort 4P, QW|Radiological Progression|0|||
48560322|NCT02906670|156242816|FG002|Cohort 4P, QW|Radiological Progression|0|||
48560323|NCT02906670|156242817|FG003|Cohort 4P, QW|Radiological Progression|3|||
48560324|NCT02906670|156242818|FG004|Cohort 4P, QW|Radiological Progression|0|||
48560325|NCT02906670|156242819|FG005|Cohort 4P, QW|Radiological Progression|0|||
48560326|NCT02906670|156242820|FG006|Cohort 4P, QW|Radiological Progression|0|||
48560327|NCT02906670|156242821|FG007|Cohort 4P, QW|Radiological Progression|0|||
48560328|NCT02906670|156242822|FG008|Cohort 4P, QW|Radiological Progression|0|||
48560329|NCT02906670|156242823|FG009|Cohort 4P, QW|Radiological Progression|0|||
48560330|NCT02906670|156242814|FG000|Cohort 7P, Q2W|Adverse Event|0|||
48560331|NCT02906670|156242815|FG001|Cohort 7P, Q2W|Adverse Event|0|||
48560332|NCT02906670|156242816|FG002|Cohort 7P, Q2W|Adverse Event|0|||
48560333|NCT02906670|156242817|FG003|Cohort 7P, Q2W|Adverse Event|0|||
48560334|NCT02906670|156242818|FG004|Cohort 7P, Q2W|Adverse Event|0|||
48560335|NCT02906670|156242819|FG005|Cohort 7P, Q2W|Adverse Event|0|||
48560336|NCT02906670|156242820|FG006|Cohort 7P, Q2W|Adverse Event|0|||
48560337|NCT02906670|156242821|FG007|Cohort 7P, Q2W|Adverse Event|0|||
48616849|NCT00614393|156452989|FG004|Overall Study|Withdrawal by Subject|13|||
48616850|NCT00614393|156452985|FG000|Overall Study|Other|4|||
48616851|NCT00614393|156452986|FG001|Overall Study|Other|0|||
48616852|NCT00614393|156452987|FG002|Overall Study|Other|0|||
48616853|NCT00614393|156452988|FG003|Overall Study|Other|4|||
48616854|NCT00614393|156452989|FG004|Overall Study|Other|2|||
48616855|NCT00614393|156452985|FG000|Overall Study|Not Treated|0|||
48616856|NCT00614393|156452986|FG001|Overall Study|Not Treated|0|||
48616857|NCT00614393|156452987|FG002|Overall Study|Not Treated|0|||
48560338|NCT02906670|156242822|FG008|Cohort 7P, Q2W|Adverse Event|0|||
48560339|NCT02906670|156242823|FG009|Cohort 7P, Q2W|Adverse Event|1|||
48560340|NCT02906670|156242814|FG000|Cohort 7P, Q2W|Physician Decision|0|||
48616858|NCT00614393|156452988|FG003|Overall Study|Not Treated|0|||
48560341|NCT02906670|156242815|FG001|Cohort 7P, Q2W|Physician Decision|0|||
48560342|NCT02906670|156242816|FG002|Cohort 7P, Q2W|Physician Decision|0|||
48560343|NCT02906670|156242817|FG003|Cohort 7P, Q2W|Physician Decision|0|||
48560344|NCT02906670|156242818|FG004|Cohort 7P, Q2W|Physician Decision|0|||
48560345|NCT02906670|156242819|FG005|Cohort 7P, Q2W|Physician Decision|0|||
48560346|NCT02906670|156242820|FG006|Cohort 7P, Q2W|Physician Decision|0|||
48560347|NCT02906670|156242821|FG007|Cohort 7P, Q2W|Physician Decision|0|||
48560348|NCT02906670|156242822|FG008|Cohort 7P, Q2W|Physician Decision|0|||
48560349|NCT02906670|156242823|FG009|Cohort 7P, Q2W|Physician Decision|1|||
48560350|NCT02906670|156242814|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48560351|NCT02906670|156242815|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48560352|NCT02906670|156242816|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48616859|NCT00614393|156452989|FG004|Overall Study|Not Treated|2|||
48560353|NCT02906670|156242817|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48560354|NCT02906670|156242818|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48560355|NCT02906670|156242819|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48560356|NCT02906670|156242820|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48560357|NCT02906670|156242821|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48560358|NCT02906670|156242822|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
48560359|NCT02906670|156242823|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
48560360|NCT02906670|156242814|FG000|Cohort 5P, QW|Radiological Progression|0|||
48560361|NCT02906670|156242815|FG001|Cohort 5P, QW|Radiological Progression|0|||
48560362|NCT02906670|156242816|FG002|Cohort 5P, QW|Radiological Progression|0|||
48560363|NCT02906670|156242817|FG003|Cohort 5P, QW|Radiological Progression|0|||
48560364|NCT02906670|156242818|FG004|Cohort 5P, QW|Radiological Progression|3|||
48560365|NCT02906670|156242819|FG005|Cohort 5P, QW|Radiological Progression|0|||
48560366|NCT02906670|156242820|FG006|Cohort 5P, QW|Radiological Progression|0|||
48560367|NCT02906670|156242821|FG007|Cohort 5P, QW|Radiological Progression|0|||
48560368|NCT02906670|156242822|FG008|Cohort 5P, QW|Radiological Progression|0|||
48560369|NCT02906670|156242823|FG009|Cohort 5P, QW|Radiological Progression|0|||
48560370|NCT01349192|156242824|FG000|Overall Study|Protocol Violation|0|||
48560371|NCT01349192|156242825|FG001|Overall Study|Protocol Violation|1|||
48560372|NCT01349192|156242824|FG000|Overall Study|Withdrawal by Subject|0|||
48560373|NCT01349192|156242825|FG001|Overall Study|Withdrawal by Subject|2|||
48560374|NCT01349192|156242824|FG000|Overall Study|Lost to Follow-up|1|||
48560375|NCT01349192|156242825|FG001|Overall Study|Lost to Follow-up|3|||
48560376|NCT01349192|156242824|FG000|Overall Study|Failure to adhere to Protocol|2|||
48560377|NCT01349192|156242825|FG001|Overall Study|Failure to adhere to Protocol|0|||
48560378|NCT00837148|156242826|FG000|Overall Study|Adverse Event|1|||
48560379|NCT00837148|156242826|FG000|Overall Study|Death|1|||
48560380|NCT01262872|156242827|FG000|Step 2|Death|0|||
48560381|NCT01262872|156242828|FG001|Step 2|Death|0|||
48560382|NCT01262872|156242829|FG002|Step 2|Death|0|||
48560383|NCT01262872|156242830|FG003|Step 2|Death|1|||
48560384|NCT01262872|156242831|FG004|Step 2|Death|0|||
48560385|NCT01262872|156242832|FG005|Step 2|Death|2|||
48560386|NCT01262872|156242833|FG006|Step 2|Death|2|||
48560387|NCT01262872|156242834|FG007|Step 2|Death|1|||
48560388|NCT01262872|156242827|FG000|Step 2|Protocol Violation|0|||
48560389|NCT01262872|156242828|FG001|Step 2|Protocol Violation|0|||
48560390|NCT01262872|156242829|FG002|Step 2|Protocol Violation|1|||
48560391|NCT01262872|156242830|FG003|Step 2|Protocol Violation|0|||
48560392|NCT01262872|156242831|FG004|Step 2|Protocol Violation|0|||
48560393|NCT01262872|156242832|FG005|Step 2|Protocol Violation|0|||
48560394|NCT01262872|156242833|FG006|Step 2|Protocol Violation|3|||
48560395|NCT01262872|156242834|FG007|Step 2|Protocol Violation|1|||
48560396|NCT01262872|156242827|FG000|Step 2|Withdrawal by Subject|0|||
48560397|NCT01262872|156242828|FG001|Step 2|Withdrawal by Subject|0|||
48560398|NCT01262872|156242829|FG002|Step 2|Withdrawal by Subject|4|||
48560399|NCT01262872|156242830|FG003|Step 2|Withdrawal by Subject|6|||
48560400|NCT01262872|156242831|FG004|Step 2|Withdrawal by Subject|3|||
48560401|NCT01262872|156242832|FG005|Step 2|Withdrawal by Subject|1|||
48560402|NCT01262872|156242833|FG006|Step 2|Withdrawal by Subject|2|||
48560403|NCT01262872|156242834|FG007|Step 2|Withdrawal by Subject|1|||
48560404|NCT01262872|156242827|FG000|Step 2|Migrated/moved from study area|0|||
48560405|NCT01262872|156242828|FG001|Step 2|Migrated/moved from study area|0|||
48560406|NCT01262872|156242829|FG002|Step 2|Migrated/moved from study area|4|||
48560407|NCT01262872|156242830|FG003|Step 2|Migrated/moved from study area|3|||
48560408|NCT01262872|156242831|FG004|Step 2|Migrated/moved from study area|2|||
48560409|NCT01262872|156242832|FG005|Step 2|Migrated/moved from study area|6|||
48560410|NCT01262872|156242833|FG006|Step 2|Migrated/moved from study area|2|||
48560411|NCT01262872|156242834|FG007|Step 2|Migrated/moved from study area|3|||
48560412|NCT01383174|156242835|FG000|3 Month Assessment|Death|0|||
48560413|NCT01383174|156242836|FG001|3 Month Assessment|Death|1|||
48560414|NCT01383174|156242835|FG000|3 Month Assessment|Lost to Follow-up|2|||
48560415|NCT01383174|156242836|FG001|3 Month Assessment|Lost to Follow-up|0|||
48560416|NCT01383174|156242835|FG000|3 Month Assessment|Refused to complete|4|||
48616860|NCT02260986|156452991|FG000|Overall Study|Adverse Event|24|||
48560417|NCT01383174|156242836|FG001|3 Month Assessment|Refused to complete|0|||
48560418|NCT01383174|156242835|FG000|6 Month Assessment|Lost to Follow-up|1|||
48560419|NCT01383174|156242836|FG001|6 Month Assessment|Lost to Follow-up|1|||
48560420|NCT01383174|156242835|FG000|6 Month Assessment|Refused to complete|4|||
48560421|NCT01383174|156242836|FG001|6 Month Assessment|Refused to complete|0|||
48560422|NCT00153179|156242842|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
48560423|NCT00153179|156242843|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
48560424|NCT00153179|156242844|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
48560425|NCT00153179|156242845|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
48560426|NCT02291237|156242847|FG000|Overall Study|Study Terminated by Sponsor|72|||
48560427|NCT02291237|156242848|FG001|Overall Study|Study Terminated by Sponsor|67|||
48560428|NCT02291237|156242847|FG000|Overall Study|Adverse Event|1|||
48560429|NCT02291237|156242848|FG001|Overall Study|Adverse Event|3|||
48560430|NCT02291237|156242847|FG000|Overall Study|Investigator's Discretion|0|||
48560431|NCT02291237|156242848|FG001|Overall Study|Investigator's Discretion|3|||
48560432|NCT02291237|156242847|FG000|Overall Study|Withdrew Consent|11|||
48560433|NCT02291237|156242848|FG001|Overall Study|Withdrew Consent|11|||
48560434|NCT02291237|156242847|FG000|Overall Study|Lost to Follow-up|0|||
48560435|NCT02291237|156242848|FG001|Overall Study|Lost to Follow-up|2|||
48560436|NCT02291237|156242847|FG000|Overall Study|Subject Required Prohibited Medication|2|||
48560437|NCT02291237|156242848|FG001|Overall Study|Subject Required Prohibited Medication|0|||
48560438|NCT04135937|156242849|FG000|Overall Study|Lost to Follow-up|2|||
48560439|NCT04135937|156242849|FG000|Overall Study|Withdrawal by Subject|1|||
48560440|NCT02166333|156242853|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
48560441|NCT02166333|156242854|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
48560442|NCT02166333|156242855|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
48560443|NCT02166333|156242856|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
48560444|NCT02166333|156242857|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
48560445|NCT02166333|156242858|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
48560446|NCT02166333|156242853|FG000|Stage 1|Death|4|||
48560447|NCT02166333|156242854|FG001|Stage 1|Death|0|||
48560448|NCT02166333|156242855|FG002|Stage 1|Death|2|||
48560449|NCT02166333|156242856|FG003|Stage 1|Death|0|||
48560450|NCT02166333|156242857|FG004|Stage 1|Death|3|||
48560451|NCT02166333|156242858|FG005|Stage 1|Death|2|||
48560452|NCT02166333|156242853|FG000|Stage 1|Lost to Follow-up|12|||
48560453|NCT02166333|156242854|FG001|Stage 1|Lost to Follow-up|0|||
48560454|NCT02166333|156242855|FG002|Stage 1|Lost to Follow-up|6|||
48560455|NCT02166333|156242856|FG003|Stage 1|Lost to Follow-up|0|||
48560456|NCT02166333|156242857|FG004|Stage 1|Lost to Follow-up|3|||
48560457|NCT02166333|156242858|FG005|Stage 1|Lost to Follow-up|3|||
48560458|NCT02166333|156242853|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
48560459|NCT02166333|156242854|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
48560460|NCT02166333|156242855|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
48560461|NCT02166333|156242856|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
48560462|NCT02166333|156242857|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
48560463|NCT02166333|156242858|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
48560464|NCT02166333|156242853|FG000|Stage 2|Death|4|||
48560465|NCT02166333|156242854|FG001|Stage 2|Death|2|||
48560466|NCT02166333|156242855|FG002|Stage 2|Death|1|||
48560467|NCT02166333|156242856|FG003|Stage 2|Death|0|||
48560468|NCT02166333|156242857|FG004|Stage 2|Death|0|||
48560469|NCT02166333|156242858|FG005|Stage 2|Death|1|||
48560470|NCT02166333|156242853|FG000|Stage 2|Lost to Follow-up|23|||
48560471|NCT02166333|156242854|FG001|Stage 2|Lost to Follow-up|4|||
48560472|NCT02166333|156242855|FG002|Stage 2|Lost to Follow-up|11|||
48560473|NCT02166333|156242856|FG003|Stage 2|Lost to Follow-up|9|||
48560474|NCT02166333|156242857|FG004|Stage 2|Lost to Follow-up|3|||
48560475|NCT02166333|156242858|FG005|Stage 2|Lost to Follow-up|6|||
48560476|NCT02269098|156242859|FG000|Overall Study|Lost to Follow-up|14|||
48560477|NCT02269098|156242860|FG001|Overall Study|Lost to Follow-up|9|||
48560478|NCT00503698|156242861|FG000|Overall Study|Protocol Violation|5|||
48560479|NCT00503698|156242862|FG001|Overall Study|Protocol Violation|6|||
48560480|NCT00503698|156242861|FG000|Overall Study|Adverse Event|52|||
48560481|NCT00503698|156242862|FG001|Overall Study|Adverse Event|41|||
48560482|NCT00503698|156242861|FG000|Overall Study|Death|1|||
48560483|NCT00503698|156242862|FG001|Overall Study|Death|0|||
48560484|NCT00503698|156242861|FG000|Overall Study|Lack of Efficacy|3|||
48560485|NCT00503698|156242862|FG001|Overall Study|Lack of Efficacy|4|||
48560486|NCT00503698|156242861|FG000|Overall Study|Trial terminated|216|||
48560487|NCT00503698|156242862|FG001|Overall Study|Trial terminated|253|||
48560488|NCT00503698|156242861|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
48560489|NCT00503698|156242862|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
48560490|NCT00503698|156242861|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
48560491|NCT00503698|156242862|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
48560492|NCT00503698|156242861|FG000|Overall Study|Any condition in exclusion criteria|4|||
48560493|NCT00503698|156242862|FG001|Overall Study|Any condition in exclusion criteria|6|||
48560494|NCT00503698|156242861|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
48560495|NCT00503698|156242862|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
48560496|NCT00503698|156242861|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
48560497|NCT00503698|156242862|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
48560498|NCT00503698|156242861|FG000|Overall Study|Critically ill|2|||
48560499|NCT00503698|156242862|FG001|Overall Study|Critically ill|0|||
48560500|NCT00503698|156242861|FG000|Overall Study|Unclassified|48|||
48560501|NCT00503698|156242862|FG001|Overall Study|Unclassified|32|||
48560502|NCT00503698|156242861|FG000|Overall Study|Not exposed to trial drug|11|||
48560503|NCT00503698|156242862|FG001|Overall Study|Not exposed to trial drug|6|||
48560504|NCT03411863|156242867|FG000|Overall Study|Withdrawal by Subject|3|||
48560505|NCT03411863|156242868|FG001|Overall Study|Withdrawal by Subject|1|||
48560506|NCT03411863|156242867|FG000|Overall Study|Physician Decision|0|||
48560507|NCT03411863|156242868|FG001|Overall Study|Physician Decision|1|||
48560508|NCT01197534|156242869|FG000|Overall Study|Not reported|16|||
48560509|NCT01197534|156242870|FG001|Overall Study|Not reported|10|||
48560510|NCT01197534|156242871|FG002|Overall Study|Not reported|16|||
48560511|NCT01197534|156242869|FG000|Overall Study|Enrolment in long term extension|57|||
48560512|NCT01197534|156242870|FG001|Overall Study|Enrolment in long term extension|66|||
48560513|NCT01197534|156242871|FG002|Overall Study|Enrolment in long term extension|119|||
48560514|NCT01197534|156242869|FG000|Overall Study|Severe non-compliance to protocol|3|||
48560515|NCT01197534|156242870|FG001|Overall Study|Severe non-compliance to protocol|4|||
48560516|NCT01197534|156242871|FG002|Overall Study|Severe non-compliance to protocol|1|||
48560517|NCT01197534|156242869|FG000|Overall Study|Lack of therapeutic response|9|||
48560518|NCT01197534|156242870|FG001|Overall Study|Lack of therapeutic response|4|||
48560519|NCT01197534|156242871|FG002|Overall Study|Lack of therapeutic response|9|||
48560520|NCT01197534|156242869|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
48560521|NCT01197534|156242870|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
48560522|NCT01197534|156242871|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
48560523|NCT01197534|156242869|FG000|Overall Study|Lost to Follow-up|1|||
48560524|NCT01197534|156242870|FG001|Overall Study|Lost to Follow-up|4|||
48560525|NCT01197534|156242871|FG002|Overall Study|Lost to Follow-up|2|||
48560526|NCT01197534|156242869|FG000|Overall Study|Adverse Event|35|||
48560527|NCT01197534|156242870|FG001|Overall Study|Adverse Event|36|||
48560528|NCT01197534|156242871|FG002|Overall Study|Adverse Event|24|||
48560529|NCT00682786|156242872|FG000|Overall Study|Withdrawal by Subject|2|||
48560530|NCT00682786|156242873|FG001|Overall Study|Withdrawal by Subject|2|||
48560531|NCT00682786|156242872|FG000|Overall Study|Did not receive irinotecan|0|||
48560532|NCT00682786|156242873|FG001|Overall Study|Did not receive irinotecan|1|||
48560533|NCT02286713|156242874|FG000|One Week Follow-Up|Death|1|||
48560534|NCT02286713|156242875|FG001|One Week Follow-Up|Death|0|||
48560535|NCT02286713|156242874|FG000|One Week Follow-Up|Lost to Follow-up|17|||
48560536|NCT02286713|156242875|FG001|One Week Follow-Up|Lost to Follow-up|21|||
48560537|NCT02286713|156242874|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
48560538|NCT02286713|156242875|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
48560539|NCT02286713|156242874|FG000|Three Month Follow-Up|Death|1|||
48560540|NCT02286713|156242875|FG001|Three Month Follow-Up|Death|1|||
48560541|NCT02286713|156242874|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
48560542|NCT02286713|156242875|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
48560543|NCT02286713|156242874|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
48560544|NCT02286713|156242875|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
48560545|NCT02286713|156242874|FG000|Six Month Follow-Up|Death|2|||
48560546|NCT02286713|156242875|FG001|Six Month Follow-Up|Death|0|||
48560547|NCT02286713|156242874|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
48560548|NCT02286713|156242875|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
48560549|NCT03644342|156242877|FG000|Overall Study|Adverse Event|2|||
48560550|NCT03644342|156242878|FG001|Overall Study|Adverse Event|0|||
48560551|NCT03644342|156242877|FG000|Overall Study|Protocol Violation|0|||
48560552|NCT03644342|156242878|FG001|Overall Study|Protocol Violation|1|||
48560553|NCT04314037|156242879|FG000|Treatment Period 2|Adverse Event|1|||
48560554|NCT04314037|156242880|FG001|Treatment Period 2|Adverse Event|0|||
48560555|NCT04314037|156242879|FG000|Treatment Period 3|Protocol Violation|1|||
48560556|NCT04314037|156242880|FG001|Treatment Period 3|Protocol Violation|0|||
48560557|NCT04314037|156242879|FG000|Treatment Period 3|Adverse Event|0|||
48560558|NCT04314037|156242880|FG001|Treatment Period 3|Adverse Event|1|||
48560559|NCT05966584|156242881|FG000|Overall Study|Lost to Follow-up|1|||
48560560|NCT03657797|156244482|FG000|Overall Study|Lost to Follow-up|0|||
48560561|NCT03657797|156244483|FG001|Overall Study|Lost to Follow-up|1|||
48560562|NCT03657797|156244484|FG002|Overall Study|Lost to Follow-up|1|||
48560563|NCT03657797|156244485|FG003|Overall Study|Lost to Follow-up|0|||
48560564|NCT03657797|156244482|FG000|Overall Study|Physician Decision|0|||
48560565|NCT03657797|156244483|FG001|Overall Study|Physician Decision|1|||
48560566|NCT03657797|156244484|FG002|Overall Study|Physician Decision|0|||
48560567|NCT03657797|156244485|FG003|Overall Study|Physician Decision|0|||
48560568|NCT03657797|156244482|FG000|Overall Study|Withdrawal by Subject|0|||
48560569|NCT03657797|156244483|FG001|Overall Study|Withdrawal by Subject|1|||
48560570|NCT03657797|156244484|FG002|Overall Study|Withdrawal by Subject|2|||
48560571|NCT03657797|156244485|FG003|Overall Study|Withdrawal by Subject|0|||
48560572|NCT03657797|156244482|FG000|Overall Study|Adverse Event|0|||
48560573|NCT03657797|156244483|FG001|Overall Study|Adverse Event|0|||
48560574|NCT03657797|156244484|FG002|Overall Study|Adverse Event|2|||
48560575|NCT03657797|156244485|FG003|Overall Study|Adverse Event|0|||
48560576|NCT00725283|156244488|FG000|Overall Study|Missing Code|3|||
48560577|NCT00725283|156244488|FG000|Overall Study|Death|5|||
48560578|NCT00725283|156244488|FG000|Overall Study|Other|6|||
48560579|NCT00725283|156244488|FG000|Overall Study|Withdrawal by Subject|10|||
48560580|NCT01368497|156244489|FG000|Overall Study|Lost to Follow-up|2|||
48560581|NCT03103087|156244490|FG000|Overall Study|Did not receive any study drug|1|||
48560582|NCT03103087|156244491|FG001|Overall Study|Did not receive any study drug|0|||
48560583|NCT03103087|156244492|FG002|Overall Study|Did not receive any study drug|0|||
48560584|NCT03103087|156244490|FG000|Overall Study|Protocol Violation|1|||
48560585|NCT03103087|156244491|FG001|Overall Study|Protocol Violation|2|||
48560586|NCT03103087|156244492|FG002|Overall Study|Protocol Violation|1|||
48560587|NCT03103087|156244490|FG000|Overall Study|Lack of Efficacy|2|||
48560588|NCT03103087|156244491|FG001|Overall Study|Lack of Efficacy|1|||
48560589|NCT03103087|156244492|FG002|Overall Study|Lack of Efficacy|1|||
48560590|NCT03103087|156244490|FG000|Overall Study|Pregnancy|0|||
48560591|NCT03103087|156244491|FG001|Overall Study|Pregnancy|0|||
48560592|NCT03103087|156244492|FG002|Overall Study|Pregnancy|1|||
48560593|NCT03103087|156244490|FG000|Overall Study|Adverse Event|2|||
48560594|NCT03103087|156244491|FG001|Overall Study|Adverse Event|15|||
48560595|NCT03103087|156244492|FG002|Overall Study|Adverse Event|6|||
48560596|NCT03103087|156244490|FG000|Overall Study|Withdrawal by Subject|13|||
48560597|NCT03103087|156244491|FG001|Overall Study|Withdrawal by Subject|6|||
48560598|NCT03103087|156244492|FG002|Overall Study|Withdrawal by Subject|6|||
48560599|NCT03103087|156244490|FG000|Overall Study|Lost to Follow-up|4|||
48560600|NCT03103087|156244491|FG001|Overall Study|Lost to Follow-up|2|||
48560601|NCT03103087|156244492|FG002|Overall Study|Lost to Follow-up|7|||
48560602|NCT03103087|156244490|FG000|Overall Study|Other reason not reported|1|||
48560603|NCT03103087|156244491|FG001|Overall Study|Other reason not reported|3|||
48560604|NCT03103087|156244492|FG002|Overall Study|Other reason not reported|5|||
48560605|NCT03052751|156244493|FG000|Dosing Period 1|Adverse Event|0|||
48560606|NCT03052751|156244494|FG001|Dosing Period 1|Adverse Event|1|||
48560607|NCT03052751|156244495|FG002|Dosing Period 1|Adverse Event|0|||
48560608|NCT03052751|156244496|FG003|Dosing Period 1|Adverse Event|0|||
48616861|NCT02260986|156452992|FG001|Overall Study|Adverse Event|0|||
48616862|NCT02260986|156452993|FG002|Overall Study|Adverse Event|11|||
48616863|NCT02260986|156452991|FG000|Overall Study|Lack of Efficacy|27|||
48616864|NCT02260986|156452992|FG001|Overall Study|Lack of Efficacy|3|||
48616865|NCT02260986|156452993|FG002|Overall Study|Lack of Efficacy|0|||
48616866|NCT02260986|156452991|FG000|Overall Study|Protocol Violation|14|||
48616867|NCT02260986|156452992|FG001|Overall Study|Protocol Violation|5|||
48560609|NCT03052751|156244497|FG004|Dosing Period 1|Adverse Event|0|||
48560610|NCT03052751|156244498|FG005|Dosing Period 1|Adverse Event|0|||
48560611|NCT03052751|156244493|FG000|Dosing Period 2|Adverse Event|0|||
48560612|NCT03052751|156244494|FG001|Dosing Period 2|Adverse Event|0|||
48560613|NCT03052751|156244495|FG002|Dosing Period 2|Adverse Event|3|||
48560614|NCT03052751|156244496|FG003|Dosing Period 2|Adverse Event|0|||
48560615|NCT03052751|156244497|FG004|Dosing Period 2|Adverse Event|0|||
48560616|NCT03052751|156244498|FG005|Dosing Period 2|Adverse Event|0|||
48560617|NCT03052751|156244493|FG000|Observation Period|Adverse Event|0|||
48560618|NCT03052751|156244494|FG001|Observation Period|Adverse Event|0|||
48560619|NCT03052751|156244495|FG002|Observation Period|Adverse Event|0|||
48560620|NCT03052751|156244496|FG003|Observation Period|Adverse Event|0|||
48560621|NCT03052751|156244497|FG004|Observation Period|Adverse Event|1|||
48560622|NCT03052751|156244498|FG005|Observation Period|Adverse Event|0|||
48560623|NCT03743415|156244499|FG000|Overall Study|Death|5|||
48560624|NCT03743415|156244500|FG001|Overall Study|Death|3|||
48560625|NCT03743415|156244501|FG002|Overall Study|Death|1|||
48560626|NCT03743415|156244502|FG003|Overall Study|Death|4|||
48560627|NCT03743415|156244503|FG004|Overall Study|Death|0|||
48560628|NCT03743415|156244504|FG005|Overall Study|Death|0|||
48560629|NCT03743415|156244505|FG006|Overall Study|Death|0|||
48560630|NCT03743415|156244506|FG007|Overall Study|Death|0|||
48560631|NCT03743415|156244507|FG008|Overall Study|Death|1|||
48560632|NCT03743415|156244508|FG009|Overall Study|Death|0|||
48560633|NCT03743415|156244499|FG000|Overall Study|Withdrawal by Subject|1|||
48560634|NCT03743415|156244500|FG001|Overall Study|Withdrawal by Subject|0|||
48560635|NCT03743415|156244501|FG002|Overall Study|Withdrawal by Subject|4|||
48560636|NCT03743415|156244502|FG003|Overall Study|Withdrawal by Subject|5|||
48560637|NCT03743415|156244503|FG004|Overall Study|Withdrawal by Subject|5|||
48560638|NCT03743415|156244504|FG005|Overall Study|Withdrawal by Subject|2|||
48560639|NCT03743415|156244505|FG006|Overall Study|Withdrawal by Subject|2|||
48560640|NCT03743415|156244506|FG007|Overall Study|Withdrawal by Subject|5|||
48560641|NCT03743415|156244507|FG008|Overall Study|Withdrawal by Subject|9|||
48560642|NCT03743415|156244508|FG009|Overall Study|Withdrawal by Subject|10|||
48560643|NCT03743415|156244499|FG000|Overall Study|Lost to Follow-up|2|||
48560644|NCT03743415|156244500|FG001|Overall Study|Lost to Follow-up|0|||
48560645|NCT03743415|156244501|FG002|Overall Study|Lost to Follow-up|2|||
48560646|NCT03743415|156244502|FG003|Overall Study|Lost to Follow-up|1|||
48560647|NCT03743415|156244503|FG004|Overall Study|Lost to Follow-up|1|||
48560648|NCT03743415|156244504|FG005|Overall Study|Lost to Follow-up|0|||
48560649|NCT03743415|156244505|FG006|Overall Study|Lost to Follow-up|1|||
48560650|NCT03743415|156244506|FG007|Overall Study|Lost to Follow-up|4|||
48560651|NCT03743415|156244507|FG008|Overall Study|Lost to Follow-up|13|||
48560652|NCT03743415|156244508|FG009|Overall Study|Lost to Follow-up|13|||
48560653|NCT02762929|156244509|FG000|Overall Study|Adverse Event|0|||
48560654|NCT02762929|156244510|FG001|Overall Study|Adverse Event|0|||
48560655|NCT02762929|156244511|FG002|Overall Study|Adverse Event|0|||
48560656|NCT02762929|156244512|FG003|Overall Study|Adverse Event|1|||
48560657|NCT02762929|156244513|FG004|Overall Study|Adverse Event|0|||
48560658|NCT02762929|156244514|FG005|Overall Study|Adverse Event|0|||
48560659|NCT02762929|156244509|FG000|Overall Study|Lost to Follow-up|1|||
48560660|NCT02762929|156244510|FG001|Overall Study|Lost to Follow-up|2|||
48560661|NCT02762929|156244511|FG002|Overall Study|Lost to Follow-up|0|||
48560662|NCT02762929|156244512|FG003|Overall Study|Lost to Follow-up|1|||
48560663|NCT02762929|156244513|FG004|Overall Study|Lost to Follow-up|0|||
48560664|NCT02762929|156244514|FG005|Overall Study|Lost to Follow-up|0|||
48560665|NCT02762929|156244509|FG000|Overall Study|Withdrawal by Subject|0|||
48560666|NCT02762929|156244510|FG001|Overall Study|Withdrawal by Subject|1|||
48560667|NCT02762929|156244511|FG002|Overall Study|Withdrawal by Subject|0|||
48560668|NCT02762929|156244512|FG003|Overall Study|Withdrawal by Subject|0|||
48560669|NCT02762929|156244513|FG004|Overall Study|Withdrawal by Subject|0|||
48560670|NCT02762929|156244514|FG005|Overall Study|Withdrawal by Subject|0|||
48560671|NCT02762929|156244509|FG000|Overall Study|exclusionary medication disclosed late|0|||
48560672|NCT02762929|156244510|FG001|Overall Study|exclusionary medication disclosed late|0|||
48560673|NCT02762929|156244511|FG002|Overall Study|exclusionary medication disclosed late|0|||
48560674|NCT02762929|156244512|FG003|Overall Study|exclusionary medication disclosed late|1|||
48560675|NCT02762929|156244513|FG004|Overall Study|exclusionary medication disclosed late|0|||
48560676|NCT02762929|156244514|FG005|Overall Study|exclusionary medication disclosed late|0|||
48560677|NCT01567462|156244515|FG000|Overall Study|Withdrawal by Subject|4|||
48560678|NCT01567462|156244516|FG001|Overall Study|Withdrawal by Subject|7|||
48560679|NCT02656303|156244517|FG000|Overall Study|Adverse Event|3|||
48560680|NCT02656303|156244518|FG001|Overall Study|Adverse Event|2|||
48560681|NCT02656303|156244519|FG002|Overall Study|Adverse Event|0|||
48560682|NCT02656303|156244517|FG000|Overall Study|Death|12|||
48560683|NCT02656303|156244518|FG001|Overall Study|Death|4|||
48560684|NCT02656303|156244519|FG002|Overall Study|Death|1|||
48560685|NCT02656303|156244517|FG000|Overall Study|Lack of Efficacy|1|||
48560686|NCT02656303|156244518|FG001|Overall Study|Lack of Efficacy|0|||
48560687|NCT02656303|156244519|FG002|Overall Study|Lack of Efficacy|0|||
48560688|NCT02656303|156244517|FG000|Overall Study|Non-Compliance with Study|1|||
48560689|NCT02656303|156244518|FG001|Overall Study|Non-Compliance with Study|1|||
48560690|NCT02656303|156244519|FG002|Overall Study|Non-Compliance with Study|0|||
48560691|NCT02656303|156244517|FG000|Overall Study|Investigator Decision|2|||
48560692|NCT02656303|156244518|FG001|Overall Study|Investigator Decision|1|||
48560693|NCT02656303|156244519|FG002|Overall Study|Investigator Decision|0|||
48560694|NCT02656303|156244517|FG000|Overall Study|Progressive Disease|25|||
48560695|NCT02656303|156244518|FG001|Overall Study|Progressive Disease|14|||
48560696|NCT02656303|156244519|FG002|Overall Study|Progressive Disease|10|||
48560697|NCT02656303|156244517|FG000|Overall Study|Study Terminated by Sponsor|20|||
48616868|NCT02260986|156452993|FG002|Overall Study|Protocol Violation|16|||
48616869|NCT02260986|156452991|FG000|Overall Study|Car accident|0|||
48616870|NCT02260986|156452992|FG001|Overall Study|Car accident|0|||
48616871|NCT02260986|156452993|FG002|Overall Study|Car accident|1|||
48616872|NCT02260986|156452991|FG000|Overall Study|Withdrawal by Subject|17|||
48616873|NCT02260986|156452992|FG001|Overall Study|Withdrawal by Subject|4|||
48616874|NCT02260986|156452993|FG002|Overall Study|Withdrawal by Subject|9|||
48616875|NCT02260986|156452991|FG000|Overall Study|Incorrect randomization|0|||
48616876|NCT02260986|156452992|FG001|Overall Study|Incorrect randomization|1|||
48616877|NCT02260986|156452993|FG002|Overall Study|Incorrect randomization|0|||
48616878|NCT02260986|156452991|FG000|Overall Study|Lack of investigation product supply|2|||
48616879|NCT02260986|156452992|FG001|Overall Study|Lack of investigation product supply|0|||
48616880|NCT02260986|156452993|FG002|Overall Study|Lack of investigation product supply|1|||
48616881|NCT02260986|156452991|FG000|Overall Study|Lost to Follow-up|4|||
48616882|NCT02260986|156452992|FG001|Overall Study|Lost to Follow-up|0|||
48560698|NCT02656303|156244518|FG001|Overall Study|Study Terminated by Sponsor|7|||
48560699|NCT02656303|156244519|FG002|Overall Study|Study Terminated by Sponsor|5|||
48560700|NCT02656303|156244517|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
48560701|NCT02656303|156244518|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
48560702|NCT02656303|156244519|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
48560703|NCT02656303|156244517|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
48560704|NCT02656303|156244518|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
48560705|NCT02656303|156244519|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
48560706|NCT02656303|156244517|FG000|Overall Study|Reason not Specified|1|||
48560707|NCT02656303|156244518|FG001|Overall Study|Reason not Specified|1|||
48560708|NCT02656303|156244519|FG002|Overall Study|Reason not Specified|2|||
48560709|NCT00413699|156244520|FG000|Initial Period|Death|25|||
48560710|NCT00413699|156244521|FG001|Initial Period|Death|30|||
48560711|NCT00413699|156244522|FG002|Initial Period|Death|0|||
48560712|NCT00413699|156244520|FG000|Initial Period|Lack of Efficacy|59|||
48560713|NCT00413699|156244521|FG001|Initial Period|Lack of Efficacy|115|||
48616883|NCT02260986|156452993|FG002|Overall Study|Lost to Follow-up|3|||
48616884|NCT02260986|156452991|FG000|Overall Study|Pregnancy|2|||
48616885|NCT02260986|156452992|FG001|Overall Study|Pregnancy|0|||
48616886|NCT02260986|156452993|FG002|Overall Study|Pregnancy|0|||
48616887|NCT00853385|156452994|FG000|Overall Study|Death|0|||
48560714|NCT00413699|156244522|FG002|Initial Period|Lack of Efficacy|0|||
48560715|NCT00413699|156244520|FG000|Initial Period|Lost to Follow-up|31|||
48560716|NCT00413699|156244521|FG001|Initial Period|Lost to Follow-up|101|||
48560717|NCT00413699|156244522|FG002|Initial Period|Lost to Follow-up|0|||
48560718|NCT00413699|156244520|FG000|Initial Period|Protocol Violation|38|||
48560719|NCT00413699|156244521|FG001|Initial Period|Protocol Violation|89|||
48560720|NCT00413699|156244522|FG002|Initial Period|Protocol Violation|0|||
48560721|NCT00413699|156244520|FG000|Initial Period|Pregnancy|10|||
48560722|NCT00413699|156244521|FG001|Initial Period|Pregnancy|8|||
48560723|NCT00413699|156244522|FG002|Initial Period|Pregnancy|0|||
48560724|NCT00413699|156244520|FG000|Initial Period|Did not meet entrance criteria|2|||
48560725|NCT00413699|156244521|FG001|Initial Period|Did not meet entrance criteria|2|||
48560726|NCT00413699|156244522|FG002|Initial Period|Did not meet entrance criteria|0|||
48560727|NCT00413699|156244520|FG000|Initial Period|Medication error without adverse event|0|||
48560728|NCT00413699|156244521|FG001|Initial Period|Medication error without adverse event|1|||
48560729|NCT00413699|156244522|FG002|Initial Period|Medication error without adverse event|0|||
48560730|NCT00413699|156244520|FG000|Initial Period|Study terminated by Sponsor|0|||
48560731|NCT00413699|156244521|FG001|Initial Period|Study terminated by Sponsor|1|||
48560732|NCT00413699|156244522|FG002|Initial Period|Study terminated by Sponsor|0|||
48560733|NCT00413699|156244520|FG000|Initial Period|Other|67|||
48560734|NCT00413699|156244521|FG001|Initial Period|Other|211|||
48560735|NCT00413699|156244522|FG002|Initial Period|Other|0|||
48560736|NCT00413699|156244520|FG000|Initial Period|Adverse event related to study drug|178|||
48560737|NCT00413699|156244521|FG001|Initial Period|Adverse event related to study drug|527|||
48560738|NCT00413699|156244522|FG002|Initial Period|Adverse event related to study drug|0|||
48560739|NCT00413699|156244520|FG000|Initial Period|Adverse event not related to study drug|113|||
48560740|NCT00413699|156244521|FG001|Initial Period|Adverse event not related to study drug|248|||
48560741|NCT00413699|156244522|FG002|Initial Period|Adverse event not related to study drug|0|||
48560742|NCT00413699|156244520|FG000|Initial Period|Missing end of study page|0|||
48560743|NCT00413699|156244521|FG001|Initial Period|Missing end of study page|4|||
48560744|NCT00413699|156244522|FG002|Initial Period|Missing end of study page|0|||
48560745|NCT00413699|156244520|FG000|Initial Period|No longer willing to participate|116|||
48560746|NCT00413699|156244521|FG001|Initial Period|No longer willing to participate|368|||
48560747|NCT00413699|156244522|FG002|Initial Period|No longer willing to participate|0|||
48560748|NCT00413699|156244520|FG000|Extension Period|No Longer Willing to Participate|0|||
48560749|NCT00413699|156244521|FG001|Extension Period|No Longer Willing to Participate|0|||
48560750|NCT00413699|156244522|FG002|Extension Period|No Longer Willing to Participate|2|||
48560751|NCT00413699|156244520|FG000|Extension Period|Protocol Violation|0|||
48560752|NCT00413699|156244521|FG001|Extension Period|Protocol Violation|0|||
48560753|NCT00413699|156244522|FG002|Extension Period|Protocol Violation|1|||
48560754|NCT00413699|156244520|FG000|Extension Period|Adverse Event|0|||
48560755|NCT00413699|156244521|FG001|Extension Period|Adverse Event|0|||
48560756|NCT00413699|156244522|FG002|Extension Period|Adverse Event|2|||
48560757|NCT01383707|156244525|FG000|Overall Study|Consent withdrawal|6|||
48560758|NCT01383707|156244525|FG000|Overall Study|Death|19|||
48560759|NCT01383707|156244525|FG000|Overall Study|Other|8|||
48560760|NCT01383707|156244525|FG000|Overall Study|Sponsor's decision|2|||
48560761|NCT01383707|156244525|FG000|Overall Study|Adverse Event|14|||
48560762|NCT01383707|156244525|FG000|Overall Study|Progressive disease|23|||
48560763|NCT01609790|156244536|FG000|Overall Study|Protocol Violation|1|||
48560764|NCT01609790|156244537|FG001|Overall Study|Protocol Violation|7|||
48560765|NCT01609790|156244538|FG002|Overall Study|Protocol Violation|8|||
48560766|NCT01942993|156244566|FG000|Overall Study|Lost to Follow-up|1|||
48560767|NCT01942993|156244566|FG000|Overall Study|Physician Decision|1|||
48560768|NCT04421131|156244567|FG000|Overall Study|Lost to Follow-up|1|||
48560769|NCT04421131|156244567|FG000|Overall Study|Protocol Violation|2|||
48560770|NCT04421131|156244567|FG000|Overall Study|App crashed|5|||
48560771|NCT03749330|156244568|FG000|Overall Study|Clinicians left work in the CICU|0|||
48560772|NCT03749330|156244569|FG001|Overall Study|Clinicians left work in the CICU|2|||
48560773|NCT03749330|156244570|FG002|Overall Study|Clinicians left work in the CICU|0|||
48560774|NCT03749330|156244571|FG003|Overall Study|Clinicians left work in the CICU|0|||
48560775|NCT03749330|156244572|FG004|Overall Study|Clinicians left work in the CICU|0|||
48560776|NCT03749330|156244573|FG005|Overall Study|Clinicians left work in the CICU|0|||
48560777|NCT02342678|156244577|FG000|Overall Study|Lost to Follow-up|0|||
48560778|NCT02342678|156244578|FG001|Overall Study|Lost to Follow-up|1|||
48560779|NCT02342678|156244577|FG000|Overall Study|Too busy to complete study|0|||
48560780|NCT02342678|156244578|FG001|Overall Study|Too busy to complete study|2|||
48560781|NCT02342678|156244577|FG000|Overall Study|Family illness/emergency|0|||
48560782|NCT02342678|156244578|FG001|Overall Study|Family illness/emergency|1|||
48560783|NCT02342678|156244577|FG000|Overall Study|Illness/medical reason|1|||
48560784|NCT02342678|156244578|FG001|Overall Study|Illness/medical reason|1|||
48560785|NCT02860546|156244579|FG000|Overall Study|Clinical Progression|6|||
48560786|NCT02860546|156244579|FG000|Overall Study|Radiological Progression|12|||
48560787|NCT02942017|156244581|FG000|Overall Study|Adverse Event|0|||
48560788|NCT02942017|156244582|FG001|Overall Study|Adverse Event|1|||
48560789|NCT02942017|156244581|FG000|Overall Study|Withdrawal by Subject|0|||
48560790|NCT02942017|156244582|FG001|Overall Study|Withdrawal by Subject|1|||
48560791|NCT02942017|156244581|FG000|Overall Study|Lost to Follow-up|1|||
48560792|NCT02942017|156244582|FG001|Overall Study|Lost to Follow-up|1|||
48560793|NCT02942017|156244581|FG000|Overall Study|Randomized but not dosed|1|||
48560794|NCT02942017|156244582|FG001|Overall Study|Randomized but not dosed|3|||
48560795|NCT01651117|156244583|FG000|Overall Study|Death|2|||
48560796|NCT01651117|156244584|FG001|Overall Study|Death|3|||
48560797|NCT01651117|156244585|FG002|Overall Study|Death|2|||
48560798|NCT01651117|156244586|FG003|Overall Study|Death|2|||
48560799|NCT02714218|156244587|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48560800|NCT02714218|156244588|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
48560801|NCT02714218|156244589|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48560802|NCT02714218|156244587|FG000|Pre-Treatment Period|Other reasons|0|||
48560803|NCT02714218|156244588|FG001|Pre-Treatment Period|Other reasons|1|||
48560804|NCT02714218|156244589|FG002|Pre-Treatment Period|Other reasons|0|||
48560805|NCT02714218|156244587|FG000|Treatment Period|Disease Progression|55|||
48560806|NCT02714218|156244588|FG001|Treatment Period|Disease Progression|52|||
48560807|NCT02714218|156244589|FG002|Treatment Period|Disease Progression|14|||
48560808|NCT02714218|156244587|FG000|Treatment Period|Study drug toxicity|46|||
48616888|NCT00853385|156452995|FG001|Overall Study|Death|0|||
48560809|NCT02714218|156244588|FG001|Treatment Period|Study drug toxicity|70|||
48560810|NCT02714218|156244589|FG002|Treatment Period|Study drug toxicity|6|||
48560811|NCT02714218|156244587|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
48560812|NCT02714218|156244588|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
48560813|NCT02714218|156244589|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
48560814|NCT02714218|156244587|FG000|Treatment Period|Request to discontinue treatment|1|||
48560815|NCT02714218|156244588|FG001|Treatment Period|Request to discontinue treatment|4|||
48560816|NCT02714218|156244589|FG002|Treatment Period|Request to discontinue treatment|1|||
48560817|NCT02714218|156244587|FG000|Treatment Period|Participant withdrew consent|2|||
48560818|NCT02714218|156244588|FG001|Treatment Period|Participant withdrew consent|2|||
48560819|NCT02714218|156244589|FG002|Treatment Period|Participant withdrew consent|0|||
48560820|NCT02714218|156244587|FG000|Treatment Period|Maximum clinical benefit|4|||
48560821|NCT02714218|156244588|FG001|Treatment Period|Maximum clinical benefit|2|||
48560822|NCT02714218|156244589|FG002|Treatment Period|Maximum clinical benefit|0|||
48560823|NCT02714218|156244587|FG000|Treatment Period|Administrative reason by sponsor|2|||
48560824|NCT02714218|156244588|FG001|Treatment Period|Administrative reason by sponsor|1|||
48560825|NCT02714218|156244589|FG002|Treatment Period|Administrative reason by sponsor|0|||
48560826|NCT02714218|156244587|FG000|Treatment Period|Other reasons|6|||
48560827|NCT02714218|156244588|FG001|Treatment Period|Other reasons|6|||
48560828|NCT02714218|156244589|FG002|Treatment Period|Other reasons|0|||
48560829|NCT02714218|156244587|FG000|Treatment Period|Completed treatment as per protocol|36|||
48560830|NCT02714218|156244588|FG001|Treatment Period|Completed treatment as per protocol|27|||
48560831|NCT02714218|156244589|FG002|Treatment Period|Completed treatment as per protocol|3|||
48560832|NCT02714218|156244587|FG000|Treatment Period|Not reported|9|||
48560833|NCT02714218|156244588|FG001|Treatment Period|Not reported|6|||
48560834|NCT02714218|156244589|FG002|Treatment Period|Not reported|0|||
48560835|NCT01622673|156244590|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48560836|NCT01622673|156244591|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48560837|NCT01622673|156244592|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48560838|NCT01622673|156244593|FG003|Treatment Period 1|Withdrawal by Subject|1|||
48560839|NCT01622673|156244594|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48560840|NCT01622673|156244595|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48560841|NCT01622673|156244590|FG000|Treatment Period 1|Protocol Violation|0|||
48560842|NCT01622673|156244591|FG001|Treatment Period 1|Protocol Violation|1|||
48560843|NCT01622673|156244592|FG002|Treatment Period 1|Protocol Violation|0|||
48560844|NCT01622673|156244593|FG003|Treatment Period 1|Protocol Violation|0|||
48560845|NCT01622673|156244594|FG004|Treatment Period 1|Protocol Violation|0|||
48560846|NCT01622673|156244595|FG005|Treatment Period 1|Protocol Violation|0|||
48560847|NCT01622673|156244590|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48560848|NCT01622673|156244591|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48560849|NCT01622673|156244592|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48560850|NCT01622673|156244593|FG003|Treatment Period 2|Withdrawal by Subject|1|||
48560851|NCT01622673|156244594|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48560852|NCT01622673|156244595|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48560853|NCT01622673|156244590|FG000|Treatment Period 3|Protocol Violation|0|||
48560854|NCT01622673|156244591|FG001|Treatment Period 3|Protocol Violation|1|||
48560855|NCT01622673|156244592|FG002|Treatment Period 3|Protocol Violation|0|||
48560856|NCT01622673|156244593|FG003|Treatment Period 3|Protocol Violation|0|||
48560857|NCT01622673|156244594|FG004|Treatment Period 3|Protocol Violation|0|||
48560858|NCT01622673|156244595|FG005|Treatment Period 3|Protocol Violation|0|||
48560859|NCT01753570|156244598|FG000|Overall Study|Adverse Event|1|||
48560860|NCT01753570|156244599|FG001|Overall Study|Adverse Event|0|||
48560861|NCT01753570|156244600|FG002|Overall Study|Adverse Event|1|||
48560862|NCT01753570|156244598|FG000|Overall Study|Physician Decision|0|||
48560863|NCT01753570|156244599|FG001|Overall Study|Physician Decision|1|||
48560864|NCT01753570|156244600|FG002|Overall Study|Physician Decision|0|||
48560865|NCT01753570|156244598|FG000|Overall Study|Withdrawal by Subject|1|||
48616889|NCT00853385|156452996|FG002|Overall Study|Death|0|||
48560866|NCT01753570|156244599|FG001|Overall Study|Withdrawal by Subject|4|||
48560867|NCT01753570|156244600|FG002|Overall Study|Withdrawal by Subject|0|||
48560868|NCT02301169|156244601|FG000|Overall Study|Adverse Event|1|||
48560869|NCT02301169|156244602|FG001|Overall Study|Adverse Event|0|||
48560870|NCT00380874|156244605|FG000|Overall Study|Adverse Event|7|||
48560871|NCT00380874|156244606|FG001|Overall Study|Adverse Event|7|||
48560872|NCT00380874|156244605|FG000|Overall Study|Death|1|||
48560873|NCT00380874|156244606|FG001|Overall Study|Death|0|||
48560874|NCT00380874|156244605|FG000|Overall Study|Withdrawal by Subject|2|||
48560875|NCT00380874|156244606|FG001|Overall Study|Withdrawal by Subject|1|||
48560876|NCT00380874|156244605|FG000|Overall Study|Not related to study drug|3|||
48560877|NCT00380874|156244606|FG001|Overall Study|Not related to study drug|2|||
48560878|NCT03839628|156244607|FG000|Overall Study|Withdrawal by Subject|1|||
48560879|NCT00720213|156244610|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
48560880|NCT00720213|156244611|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
48560881|NCT00720213|156244612|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
48560882|NCT01198470|156244613|FG000|Overall Study|Adverse Event|2|||
48560883|NCT00470470|156244616|FG000|Overall Study|Adverse Event|2|||
48560884|NCT00470470|156244616|FG000|Overall Study|Death|2|||
48560885|NCT00470470|156244616|FG000|Overall Study|Not treated|1|||
48560886|NCT01787292|156244617|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
48560887|NCT01787292|156244618|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
48560888|NCT01787292|156244617|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
48560889|NCT01787292|156244618|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
48560890|NCT01522456|156244619|FG000|Overall Study|Adverse Event|2|||
48560891|NCT01522456|156244619|FG000|Overall Study|Lost to Follow-up|2|||
48560892|NCT01522456|156244619|FG000|Overall Study|Withdrawal by Subject|2|||
48560893|NCT01522456|156244619|FG000|Overall Study|Pregnancy|1|||
48560894|NCT01522456|156244619|FG000|Overall Study|Tolerability Assessment|1|||
48560895|NCT03181633|156244620|FG000|Overall Study|Withdrawal by Subject|1|||
48560896|NCT03181633|156244620|FG000|Overall Study|Missing follow-up visit|1|||
48560897|NCT01153815|156244621|FG000|Overall Study|Adverse Event|3|||
48560898|NCT01153815|156244622|FG001|Overall Study|Adverse Event|1|||
48560899|NCT01153815|156244621|FG000|Overall Study|Withdrawal by Subject|6|||
48560900|NCT01153815|156244622|FG001|Overall Study|Withdrawal by Subject|4|||
48560901|NCT02174627|156244625|FG000|Overall Study|Missing|0|||
48560902|NCT02174627|156244626|FG001|Overall Study|Missing|1|||
48560903|NCT02174627|156244625|FG000|Overall Study|Incorrect enrolment before randomization|0|||
48560904|NCT02174627|156244626|FG001|Overall Study|Incorrect enrolment before randomization|1|||
48560905|NCT02174627|156244625|FG000|Overall Study|Participant decision|84|||
48560906|NCT02174627|156244626|FG001|Overall Study|Participant decision|128|||
48560907|NCT00349973|156244627|FG000|Overall Study|Adverse Event|3|||
48560908|NCT00349973|156244628|FG001|Overall Study|Adverse Event|3|||
48560909|NCT00349973|156244627|FG000|Overall Study|Withdrawal by Subject|1|||
48560910|NCT00349973|156244628|FG001|Overall Study|Withdrawal by Subject|0|||
48560911|NCT01924689|156244631|FG000|Overall Study|Death|0|||
48560912|NCT01924689|156244632|FG001|Overall Study|Death|1|||
48560913|NCT01924689|156244633|FG002|Overall Study|Death|0|||
48560914|NCT01924689|156244634|FG003|Overall Study|Death|1|||
48560915|NCT01924689|156244635|FG004|Overall Study|Death|0|||
48560916|NCT01924689|156244636|FG005|Overall Study|Death|0|||
48560917|NCT01924689|156244631|FG000|Overall Study|Disease progression|0|||
48560918|NCT01924689|156244632|FG001|Overall Study|Disease progression|0|||
48560919|NCT01924689|156244633|FG002|Overall Study|Disease progression|2|||
48560920|NCT01924689|156244634|FG003|Overall Study|Disease progression|0|||
48560921|NCT01924689|156244635|FG004|Overall Study|Disease progression|3|||
48616890|NCT00853385|156452997|FG003|Overall Study|Death|0|||
48560922|NCT01924689|156244636|FG005|Overall Study|Disease progression|2|||
48560923|NCT01924689|156244631|FG000|Overall Study|New therapy or study|3|||
48560924|NCT01924689|156244632|FG001|Overall Study|New therapy or study|2|||
48560925|NCT01924689|156244633|FG002|Overall Study|New therapy or study|1|||
48560926|NCT01924689|156244634|FG003|Overall Study|New therapy or study|4|||
48560927|NCT01924689|156244635|FG004|Overall Study|New therapy or study|2|||
48560928|NCT01924689|156244636|FG005|Overall Study|New therapy or study|0|||
48560929|NCT01924689|156244631|FG000|Overall Study|Withdrawal of consent|0|||
48560930|NCT01924689|156244632|FG001|Overall Study|Withdrawal of consent|0|||
48560931|NCT01924689|156244633|FG002|Overall Study|Withdrawal of consent|1|||
48560932|NCT01924689|156244634|FG003|Overall Study|Withdrawal of consent|1|||
48560933|NCT01924689|156244635|FG004|Overall Study|Withdrawal of consent|0|||
48560934|NCT01924689|156244636|FG005|Overall Study|Withdrawal of consent|0|||
48560935|NCT01924689|156244631|FG000|Overall Study|Other|0|||
48560936|NCT01924689|156244632|FG001|Overall Study|Other|0|||
48560937|NCT01924689|156244633|FG002|Overall Study|Other|0|||
48560938|NCT01924689|156244634|FG003|Overall Study|Other|0|||
48560939|NCT01924689|156244635|FG004|Overall Study|Other|1|||
48560940|NCT01924689|156244636|FG005|Overall Study|Other|0|||
48560941|NCT04495829|156244644|FG000|Overall Study|Lost to Follow-up|2|||
48560942|NCT04495829|156244644|FG000|Overall Study|Inclusion criterion not met|3|||
48560943|NCT02107131|156244645|FG000|Overall Study|Lost to Follow-up|4|||
48560944|NCT02107131|156244646|FG001|Overall Study|Lost to Follow-up|4|||
48560945|NCT02107131|156244645|FG000|Overall Study|Physician Decision|1|||
48560946|NCT02107131|156244646|FG001|Overall Study|Physician Decision|0|||
48560947|NCT02107131|156244645|FG000|Overall Study|Withdrawal by Subject|2|||
48560948|NCT02107131|156244646|FG001|Overall Study|Withdrawal by Subject|0|||
48560949|NCT02107131|156244645|FG000|Overall Study|mental instability|1|||
48560950|NCT02107131|156244646|FG001|Overall Study|mental instability|0|||
48560951|NCT02107131|156244645|FG000|Overall Study|Death|0|||
48560952|NCT02107131|156244646|FG001|Overall Study|Death|1|||
48560953|NCT02107131|156244645|FG000|Overall Study|Protocol Violation|0|||
48560954|NCT02107131|156244646|FG001|Overall Study|Protocol Violation|4|||
48560955|NCT02548143|156244650|FG000|Overall Study|Adverse Event|1|||
48560956|NCT02548143|156244651|FG001|Overall Study|Adverse Event|0|||
48560957|NCT02548143|156244650|FG000|Overall Study|Withdrawal by Subject|0|||
48560958|NCT02548143|156244651|FG001|Overall Study|Withdrawal by Subject|1|||
48560959|NCT00697463|156244655|FG000|Overall Study|Withdrawal by Subject|1|||
48560960|NCT02747108|156244656|FG000|Overall Study|Death|2|||
48560961|NCT02747108|156244657|FG001|Overall Study|Death|2|||
48560962|NCT02747108|156244656|FG000|Overall Study|Withdrawal by Subject|1|||
48560963|NCT02747108|156244657|FG001|Overall Study|Withdrawal by Subject|0|||
48560964|NCT02747108|156244656|FG000|Overall Study|Protocol Violation|2|||
48560965|NCT02747108|156244657|FG001|Overall Study|Protocol Violation|0|||
48560966|NCT03564119|156244658|FG000|Overall Study|Adverse Event|4|||
48560967|NCT03564119|156244659|FG001|Overall Study|Adverse Event|0|||
48560968|NCT03564119|156244658|FG000|Overall Study|Lost to Follow-up|1|||
48560969|NCT03564119|156244659|FG001|Overall Study|Lost to Follow-up|4|||
48560970|NCT03564119|156244658|FG000|Overall Study|Protocol Violation|1|||
48560971|NCT03564119|156244659|FG001|Overall Study|Protocol Violation|0|||
48560972|NCT03564119|156244658|FG000|Overall Study|Withdrawal by Subject|9|||
48560973|NCT03564119|156244659|FG001|Overall Study|Withdrawal by Subject|4|||
48560974|NCT03564119|156244658|FG000|Overall Study|Other Than Specified|0|||
48560975|NCT03564119|156244659|FG001|Overall Study|Other Than Specified|1|||
48560976|NCT02157376|156244663|FG000|Overall Study|Death|10|||
48560977|NCT02157376|156244664|FG001|Overall Study|Death|4|||
48560978|NCT02157376|156244663|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48560979|NCT02157376|156244664|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48560980|NCT02157376|156244663|FG000|Overall Study|Withdrawal by Subject|3|||
48560981|NCT02157376|156244664|FG001|Overall Study|Withdrawal by Subject|8|||
48560982|NCT02157376|156244663|FG000|Overall Study|Not treated|8|||
48560983|NCT02157376|156244664|FG001|Overall Study|Not treated|3|||
48560984|NCT02157376|156244663|FG000|Overall Study|Investigator's misjudgement|1|||
48560985|NCT02157376|156244664|FG001|Overall Study|Investigator's misjudgement|2|||
48560986|NCT04358081|156246230|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
48560987|NCT04358081|156246231|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
48560988|NCT04358081|156246232|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
48560989|NCT04358081|156246230|FG000|Treatment Phase of Study|Adverse Event|1|||
48560990|NCT04358081|156246231|FG001|Treatment Phase of Study|Adverse Event|0|||
48560991|NCT04358081|156246232|FG002|Treatment Phase of Study|Adverse Event|1|||
48560992|NCT04358081|156246230|FG000|Treatment Phase of Study|Physician Decision|2|||
48560993|NCT04358081|156246231|FG001|Treatment Phase of Study|Physician Decision|0|||
48560994|NCT04358081|156246232|FG002|Treatment Phase of Study|Physician Decision|1|||
48560995|NCT04358081|156246230|FG000|Treatment Phase of Study|Protocol Violation|1|||
48560996|NCT04358081|156246231|FG001|Treatment Phase of Study|Protocol Violation|0|||
48560997|NCT04358081|156246232|FG002|Treatment Phase of Study|Protocol Violation|0|||
48560998|NCT04358081|156246230|FG000|Study Completion Phase|Death|0|||
48560999|NCT04358081|156246231|FG001|Study Completion Phase|Death|0|||
48561000|NCT04358081|156246232|FG002|Study Completion Phase|Death|1|||
48561001|NCT04358081|156246230|FG000|Study Completion Phase|Lost to Follow-up|1|||
48561002|NCT04358081|156246231|FG001|Study Completion Phase|Lost to Follow-up|0|||
48561003|NCT04358081|156246232|FG002|Study Completion Phase|Lost to Follow-up|1|||
48561004|NCT01130532|156246233|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
48561005|NCT01130532|156246234|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
48561006|NCT01130532|156246235|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
48561007|NCT01130532|156246236|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
48561008|NCT01130532|156246233|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
48561009|NCT01130532|156246234|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
48561010|NCT01130532|156246235|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
48561011|NCT01130532|156246236|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
48561012|NCT01130532|156246233|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
48561013|NCT01130532|156246234|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
48561014|NCT01130532|156246235|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
48561015|NCT01130532|156246236|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
48561016|NCT01130532|156246233|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
48561017|NCT01130532|156246234|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
48561018|NCT01130532|156246235|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
48561019|NCT01130532|156246236|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
48561020|NCT01130532|156246233|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
48561021|NCT01130532|156246234|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
48561022|NCT01130532|156246235|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
48561023|NCT01130532|156246236|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
48561024|NCT01130532|156246233|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
48561025|NCT01130532|156246234|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
48561026|NCT01130532|156246235|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
48561027|NCT01130532|156246236|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
48561028|NCT01130532|156246233|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
48561029|NCT01130532|156246234|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
48561030|NCT01130532|156246235|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
48561031|NCT01130532|156246236|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
48561032|NCT01130532|156246233|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
48561033|NCT01130532|156246234|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
48561034|NCT01130532|156246235|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
48561035|NCT01130532|156246236|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
48561036|NCT01130532|156246233|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
48561037|NCT01130532|156246234|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
48561038|NCT01130532|156246235|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
48561039|NCT01130532|156246236|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
48561040|NCT01130532|156246233|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
48561041|NCT01130532|156246234|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
48561042|NCT01130532|156246235|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
48561043|NCT01130532|156246236|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
48561044|NCT01130532|156246233|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
48561045|NCT01130532|156246234|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
48561046|NCT01130532|156246235|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
48561047|NCT01130532|156246236|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
48561048|NCT02847260|156246243|FG000|Overall Study|Adverse Event|3|||
48561049|NCT02847260|156246243|FG000|Overall Study|Withdrawal by Subject|2|||
48616891|NCT00853385|156452998|FG004|Overall Study|Death|1|||
48616892|NCT00853385|156452994|FG000|Overall Study|Adverse Event|24|||
48616893|NCT00853385|156452995|FG001|Overall Study|Adverse Event|24|||
48616894|NCT00853385|156452996|FG002|Overall Study|Adverse Event|2|||
48616895|NCT00853385|156452997|FG003|Overall Study|Adverse Event|5|||
48616896|NCT00853385|156452998|FG004|Overall Study|Adverse Event|22|||
48616897|NCT00853385|156452994|FG000|Overall Study|Lack of Efficacy|6|||
48616898|NCT00853385|156452995|FG001|Overall Study|Lack of Efficacy|7|||
48616899|NCT00853385|156452996|FG002|Overall Study|Lack of Efficacy|3|||
48616900|NCT00853385|156452997|FG003|Overall Study|Lack of Efficacy|3|||
48616901|NCT00853385|156452998|FG004|Overall Study|Lack of Efficacy|6|||
48616902|NCT00853385|156452994|FG000|Overall Study|Lost to Follow-up|2|||
48616903|NCT00853385|156452995|FG001|Overall Study|Lost to Follow-up|1|||
48616904|NCT00853385|156452996|FG002|Overall Study|Lost to Follow-up|0|||
48616905|NCT00853385|156452997|FG003|Overall Study|Lost to Follow-up|0|||
48616906|NCT00853385|156452998|FG004|Overall Study|Lost to Follow-up|0|||
48616907|NCT00853385|156452994|FG000|Overall Study|Withdrawal by Subject|4|||
48616908|NCT00853385|156452995|FG001|Overall Study|Withdrawal by Subject|2|||
48616909|NCT00853385|156452996|FG002|Overall Study|Withdrawal by Subject|0|||
48616910|NCT00853385|156452997|FG003|Overall Study|Withdrawal by Subject|1|||
48561050|NCT02847260|156246243|FG000|Overall Study|Clinical Deterioration|1|||
48561051|NCT02847260|156246243|FG000|Overall Study|Physician Decision|1|||
48616911|NCT00853385|156452998|FG004|Overall Study|Withdrawal by Subject|1|||
48561052|NCT00118157|156246245|FG000|Overall Study|Adverse Event|2|||
48561053|NCT00118157|156246245|FG000|Overall Study|Death|8|||
48561054|NCT00118157|156246245|FG000|Overall Study|Withdrawal by Subject|2|||
48561055|NCT01062425|156246246|FG000|Overall Study|Protocol Violation|3|||
48561056|NCT01062425|156246247|FG001|Overall Study|Protocol Violation|6|||
48561057|NCT01973439|156246248|FG000|Overall Study|Lost samples from one PK Day|2|||
48561058|NCT01973439|156246248|FG000|Overall Study|Vomiting after commencing once daily|1|||
48561059|NCT01973439|156246248|FG000|Overall Study|PK curve incomplete|2|||
48561060|NCT02038010|156246249|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
48561061|NCT02038010|156246250|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
48616912|NCT00853385|156452994|FG000|Overall Study|Other|18|||
48616913|NCT00853385|156452995|FG001|Overall Study|Other|9|||
48561062|NCT02038010|156246251|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
48561063|NCT02038010|156246252|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
48561064|NCT02038010|156246249|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
48561065|NCT02038010|156246250|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
48561066|NCT02038010|156246251|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
48561067|NCT02038010|156246252|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
48561068|NCT02038010|156246249|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
48561069|NCT02038010|156246250|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
48561070|NCT02038010|156246251|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
48561071|NCT02038010|156246252|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
48561072|NCT02038010|156246249|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
48561073|NCT02038010|156246250|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
48561074|NCT02038010|156246251|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
48561075|NCT02038010|156246252|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
48561076|NCT02038010|156246249|FG000|Follow Up|Death|4|||
48561077|NCT02038010|156246250|FG001|Follow Up|Death|3|||
48561078|NCT02038010|156246251|FG002|Follow Up|Death|0|||
48561079|NCT02038010|156246252|FG003|Follow Up|Death|0|||
48561080|NCT02038010|156246249|FG000|Follow Up|Other|3|||
48561081|NCT02038010|156246250|FG001|Follow Up|Other|0|||
48561082|NCT02038010|156246251|FG002|Follow Up|Other|0|||
48561083|NCT02038010|156246252|FG003|Follow Up|Other|0|||
48561084|NCT03347110|156246257|FG000|Overall Study|Other (Participant is incarcerated)|1|||
48561085|NCT03347110|156246257|FG000|Overall Study|Withdrawal by Subject|9|||
48561086|NCT03347110|156246257|FG000|Overall Study|Lost to Follow-up|1|||
48561087|NCT03347110|156246257|FG000|Overall Study|Lack of Efficacy|2|||
48561088|NCT03347110|156246257|FG000|Overall Study|Adverse Event, non-fatal|9|||
48561089|NCT01998919|156246261|FG000|Overall Study|Death|2|||
48561090|NCT01998919|156246262|FG001|Overall Study|Death|2|||
48561091|NCT01998919|156246261|FG000|Overall Study|Adverse Event|0|||
48561092|NCT01998919|156246262|FG001|Overall Study|Adverse Event|5|||
48561093|NCT01998919|156246261|FG000|Overall Study|Disease progression|31|||
48561094|NCT01998919|156246262|FG001|Overall Study|Disease progression|22|||
48616914|NCT00853385|156452996|FG002|Overall Study|Other|4|||
48616915|NCT00853385|156452997|FG003|Overall Study|Other|4|||
48616916|NCT00853385|156452998|FG004|Overall Study|Other|12|||
48616917|NCT00915525|156452999|FG000|Overall Study|Protocol Violation|9|||
48616918|NCT00915525|156453000|FG001|Overall Study|Protocol Violation|4|||
48616919|NCT00915525|156452999|FG000|Overall Study|Withdrawal by Subject|59|||
48616920|NCT00915525|156453000|FG001|Overall Study|Withdrawal by Subject|21|||
48616921|NCT00915525|156452999|FG000|Overall Study|Lost to Follow-up|27|||
48616922|NCT00915525|156453000|FG001|Overall Study|Lost to Follow-up|16|||
48616923|NCT00915525|156452999|FG000|Overall Study|Pregnancy|2|||
48616924|NCT00915525|156453000|FG001|Overall Study|Pregnancy|0|||
48616925|NCT00915525|156452999|FG000|Overall Study|Lack of Efficacy|15|||
48616926|NCT00915525|156453000|FG001|Overall Study|Lack of Efficacy|32|||
48616927|NCT00915525|156452999|FG000|Overall Study|Adverse Event|29|||
48616928|NCT00915525|156453000|FG001|Overall Study|Adverse Event|13|||
48616929|NCT00915525|156452999|FG000|Overall Study|Missing|12|||
48616930|NCT00915525|156453000|FG001|Overall Study|Missing|1|||
48616931|NCT00915525|156452999|FG000|Overall Study|Other Reason|35|||
48616932|NCT00915525|156453000|FG001|Overall Study|Other Reason|12|||
48616933|NCT00915525|156452999|FG000|Overall Study|Site Closed|27|||
48616934|NCT00915525|156453000|FG001|Overall Study|Site Closed|9|||
48616935|NCT00915525|156452999|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
48616936|NCT00915525|156453000|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
48616937|NCT00915525|156452999|FG000|Overall Study|Study Burden|28|||
48616938|NCT00915525|156453000|FG001|Overall Study|Study Burden|12|||
48616939|NCT00915525|156452999|FG000|Overall Study|Non-Compliance|3|||
48616940|NCT00915525|156453000|FG001|Overall Study|Non-Compliance|1|||
48616941|NCT00915525|156452999|FG000|Overall Study|Patient Moved|15|||
48561095|NCT01998919|156246261|FG000|Overall Study|Withdrawal by Subject|2|||
48561096|NCT01998919|156246262|FG001|Overall Study|Withdrawal by Subject|4|||
48561097|NCT01998919|156246261|FG000|Overall Study|Lost to Follow-up|2|||
48561098|NCT01998919|156246262|FG001|Overall Study|Lost to Follow-up|0|||
48561099|NCT01998919|156246261|FG000|Overall Study|Other|5|||
48616942|NCT00915525|156453000|FG001|Overall Study|Patient Moved|9|||
48616943|NCT01432327|156453003|FG000|Posttest 3 Months|depression|3|||
48616944|NCT01432327|156453004|FG001|Posttest 3 Months|depression|0|||
48561100|NCT01998919|156246262|FG001|Overall Study|Other|2|||
48561101|NCT00116779|156246263|FG000|Overall Study|Adverse Event|4|||
48561102|NCT00116779|156246264|FG001|Overall Study|Adverse Event|2|||
48561103|NCT00116779|156246263|FG000|Overall Study|Protocol Violation|1|||
48561104|NCT00116779|156246264|FG001|Overall Study|Protocol Violation|4|||
48561105|NCT00116779|156246263|FG000|Overall Study|Withdrawal by Subject|4|||
48561106|NCT00116779|156246264|FG001|Overall Study|Withdrawal by Subject|1|||
48561107|NCT00116779|156246263|FG000|Overall Study|Inadequate testosterone suppression|7|||
48561108|NCT00116779|156246264|FG001|Overall Study|Inadequate testosterone suppression|9|||
48561109|NCT00116779|156246263|FG000|Overall Study|Physician Decision|3|||
48561110|NCT00116779|156246264|FG001|Overall Study|Physician Decision|1|||
48561111|NCT00116779|156246263|FG000|Overall Study|Elevated PSA levels|2|||
48561112|NCT00116779|156246264|FG001|Overall Study|Elevated PSA levels|2|||
48561113|NCT02105467|156246267|FG000|Period 1|Lost to Follow-up|1|||
48561114|NCT02105467|156246268|FG001|Period 1|Lost to Follow-up|0|||
48561115|NCT02105467|156246267|FG000|Period 1|Death|1|||
48561116|NCT02105467|156246268|FG001|Period 1|Death|0|||
48616945|NCT01432327|156453005|FG002|Posttest 3 Months|depression|0|||
48561117|NCT02105467|156246267|FG000|Period 2|Lost to Follow-up|1|||
48561118|NCT02105467|156246268|FG001|Period 2|Lost to Follow-up|0|||
48561119|NCT02105467|156246267|FG000|Period 2|Death|1|||
48561120|NCT02105467|156246268|FG001|Period 2|Death|0|||
48561121|NCT02105467|156246267|FG000|Period 2|Withdrawal by Subject|0|||
48561122|NCT02105467|156246268|FG001|Period 2|Withdrawal by Subject|2|||
48561123|NCT02105467|156246267|FG000|Period 3|Lost to Follow-up|0|||
48561124|NCT02105467|156246268|FG001|Period 3|Lost to Follow-up|1|||
48561125|NCT03270657|156246269|FG000|Overall Study|Withdrawal by Subject|1|||
48561126|NCT02383017|156246274|FG000|Overall Study|Injury Sustained Outside Study|1|||
48561127|NCT02383017|156246275|FG001|Overall Study|Injury Sustained Outside Study|0|||
48561128|NCT02383017|156246274|FG000|Overall Study|Compliance|3|||
48561129|NCT02383017|156246275|FG001|Overall Study|Compliance|2|||
48561130|NCT02383017|156246274|FG000|Overall Study|Found to be Hypogonadal|1|||
48561131|NCT02383017|156246275|FG001|Overall Study|Found to be Hypogonadal|0|||
48561132|NCT01037218|156246276|FG000|Overall Study|Adverse Event|4|||
48561133|NCT01037218|156246277|FG001|Overall Study|Adverse Event|2|||
48561134|NCT01037218|156246278|FG002|Overall Study|Adverse Event|2|||
48561135|NCT01037218|156246279|FG003|Overall Study|Adverse Event|1|||
48561136|NCT01037218|156246276|FG000|Overall Study|Lack of Efficacy|0|||
48616946|NCT01432327|156453006|FG003|Posttest 3 Months|depression|0|||
48616947|NCT01432327|156453003|FG000|Posttest 3 Months|Lost to Follow-up|1|||
48561137|NCT01037218|156246277|FG001|Overall Study|Lack of Efficacy|2|||
48616948|NCT01432327|156453004|FG001|Posttest 3 Months|Lost to Follow-up|0|||
48561138|NCT01037218|156246278|FG002|Overall Study|Lack of Efficacy|1|||
48561139|NCT01037218|156246279|FG003|Overall Study|Lack of Efficacy|5|||
48561140|NCT01037218|156246276|FG000|Overall Study|Lost to Follow-up|3|||
48561141|NCT01037218|156246277|FG001|Overall Study|Lost to Follow-up|5|||
48616949|NCT01432327|156453005|FG002|Posttest 3 Months|Lost to Follow-up|2|||
48616950|NCT01432327|156453006|FG003|Posttest 3 Months|Lost to Follow-up|1|||
48561142|NCT01037218|156246278|FG002|Overall Study|Lost to Follow-up|4|||
48561143|NCT01037218|156246279|FG003|Overall Study|Lost to Follow-up|2|||
48561144|NCT01037218|156246276|FG000|Overall Study|Withdrawal by Subject|6|||
48561145|NCT01037218|156246277|FG001|Overall Study|Withdrawal by Subject|7|||
48561146|NCT01037218|156246278|FG002|Overall Study|Withdrawal by Subject|7|||
48561147|NCT01037218|156246279|FG003|Overall Study|Withdrawal by Subject|4|||
48561148|NCT01037218|156246276|FG000|Overall Study|Partner Withdrew Consent|0|||
48561149|NCT01037218|156246277|FG001|Overall Study|Partner Withdrew Consent|3|||
48561150|NCT01037218|156246278|FG002|Overall Study|Partner Withdrew Consent|2|||
48561151|NCT01037218|156246279|FG003|Overall Study|Partner Withdrew Consent|1|||
48561152|NCT01037218|156246276|FG000|Overall Study|Protocol Violation|0|||
48561153|NCT01037218|156246277|FG001|Overall Study|Protocol Violation|0|||
48561154|NCT01037218|156246278|FG002|Overall Study|Protocol Violation|2|||
48561155|NCT01037218|156246279|FG003|Overall Study|Protocol Violation|2|||
48561156|NCT01037218|156246276|FG000|Overall Study|Various|3|||
48561157|NCT01037218|156246277|FG001|Overall Study|Various|2|||
48561158|NCT01037218|156246278|FG002|Overall Study|Various|3|||
48561159|NCT01037218|156246279|FG003|Overall Study|Various|1|||
48561160|NCT01321879|156246284|FG000|Overall Study|Lack of Efficacy|5|||
48561161|NCT01321879|156246284|FG000|Overall Study|Adverse Event|5|||
48561162|NCT01321879|156246284|FG000|Overall Study|Death|3|||
48561163|NCT01321879|156246284|FG000|Overall Study|Withdrawal by Subject|1|||
48561164|NCT00897715|156246285|FG000|Overall Study|Lost to Follow-up|0|||
48561165|NCT00897715|156246286|FG001|Overall Study|Lost to Follow-up|1|||
48561166|NCT00897715|156246285|FG000|Overall Study|Physician Decision|1|||
48561167|NCT00897715|156246286|FG001|Overall Study|Physician Decision|0|||
48561168|NCT00897715|156246285|FG000|Overall Study|increased risk of infection|1|||
48561169|NCT00897715|156246286|FG001|Overall Study|increased risk of infection|0|||
48561170|NCT00958828|156246287|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
48561171|NCT00958828|156246288|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
48561172|NCT00958828|156246287|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
48561173|NCT00958828|156246288|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
48561174|NCT00468819|156246292|FG000|Overall Study|Withdrawal by Subject|4|||
48561175|NCT00468819|156246293|FG001|Overall Study|Withdrawal by Subject|0|||
48561176|NCT00468819|156246294|FG002|Overall Study|Withdrawal by Subject|1|||
48561177|NCT00468819|156246292|FG000|Overall Study|Lost to Follow-up|0|||
48561178|NCT00468819|156246293|FG001|Overall Study|Lost to Follow-up|0|||
48561179|NCT00468819|156246294|FG002|Overall Study|Lost to Follow-up|1|||
48561180|NCT00468819|156246292|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
48561181|NCT00468819|156246293|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
48561182|NCT00468819|156246294|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
48561183|NCT02088177|156246297|FG000|Overall Study|Lost to Follow-up|3|||
48561184|NCT03472014|156246298|FG000|Overall Study|Lost to Follow-up|4|||
48561185|NCT02075203|156246301|FG000|Overall Study|Withdrawal by Subject|1|||
48561186|NCT02075203|156246302|FG001|Overall Study|Withdrawal by Subject|0|||
48561187|NCT02075203|156246303|FG002|Overall Study|Withdrawal by Subject|1|||
48561188|NCT02075203|156246301|FG000|Overall Study|Adverse Event|1|||
48561189|NCT02075203|156246302|FG001|Overall Study|Adverse Event|0|||
48561190|NCT02075203|156246303|FG002|Overall Study|Adverse Event|0|||
48561191|NCT02075203|156246301|FG000|Overall Study|participant refused to use contraception|1|||
48561192|NCT02075203|156246302|FG001|Overall Study|participant refused to use contraception|0|||
48561193|NCT02075203|156246303|FG002|Overall Study|participant refused to use contraception|0|||
48561194|NCT00455403|156246304|FG000|Overall Study|Lost to Follow-up|2|||
48561195|NCT00455403|156246305|FG001|Overall Study|Lost to Follow-up|1|||
48561196|NCT00455403|156246304|FG000|Overall Study|Withdrawal by Subject|1|||
48561197|NCT00455403|156246305|FG001|Overall Study|Withdrawal by Subject|3|||
48561198|NCT00455403|156246304|FG000|Overall Study|Protocol Violation|0|||
48561199|NCT00455403|156246305|FG001|Overall Study|Protocol Violation|2|||
48561200|NCT03875508|156246310|FG000|Overall Study|Adverse Event|1|||
48561201|NCT03875508|156246310|FG000|Overall Study|Lost to Follow-up|8|||
48561202|NCT03875508|156246310|FG000|Overall Study|Lack of Efficacy|1|||
48561203|NCT03875508|156246310|FG000|Overall Study|Other, not specified|2|||
48561204|NCT03214224|156246311|FG000|Overall Study|Protocol Violation|1|||
48561205|NCT03214224|156246311|FG000|Overall Study|Withdrawal by Subject|2|||
48561206|NCT03214224|156246311|FG000|Overall Study|Practice controls or therapists|6|||
48561207|NCT03620708|156246312|FG000|Overall Study|Lost to Follow-up|1|||
48561208|NCT03620708|156246313|FG001|Overall Study|Lost to Follow-up|1|||
48561209|NCT03620708|156246314|FG002|Overall Study|Lost to Follow-up|2|||
48561210|NCT03620708|156246312|FG000|Overall Study|Withdrawal by Subject|0|||
48561211|NCT03620708|156246313|FG001|Overall Study|Withdrawal by Subject|0|||
48561212|NCT03620708|156246314|FG002|Overall Study|Withdrawal by Subject|1|||
48561213|NCT01269918|156246318|FG000|Overall Study|Did not receive study drug|0|||
48561214|NCT01269918|156246319|FG001|Overall Study|Did not receive study drug|3|||
48561215|NCT00666328|156246322|FG000|Overall Study|Death|2|||
48561216|NCT00666328|156246322|FG000|Overall Study|Lost to Follow-up|2|||
48561217|NCT00666328|156246322|FG000|Overall Study|No longer met eligibility criteria|1|||
48561218|NCT03571828|156246323|FG000|Overall Study|Withdrawal by Subject|1|||
48561219|NCT03571828|156246324|FG001|Overall Study|Withdrawal by Subject|0|||
48561220|NCT03571828|156246323|FG000|Overall Study|Decision by sponsor|5|||
48561221|NCT03571828|156246324|FG001|Overall Study|Decision by sponsor|1|||
48561222|NCT03571828|156246323|FG000|Overall Study|Death|2|||
48561223|NCT03571828|156246324|FG001|Overall Study|Death|0|||
48561224|NCT03743051|156246325|FG000|Overall Study|Adverse Event|5|||
48561225|NCT03743051|156246326|FG001|Overall Study|Adverse Event|9|||
48561226|NCT03743051|156246325|FG000|Overall Study|Death|27|||
48561227|NCT03743051|156246326|FG001|Overall Study|Death|26|||
48561228|NCT03743051|156246325|FG000|Overall Study|Lost to Follow-up|4|||
48561229|NCT03743051|156246326|FG001|Overall Study|Lost to Follow-up|8|||
48561230|NCT03743051|156246325|FG000|Overall Study|Withdrawal by Subject|32|||
48561231|NCT03743051|156246326|FG001|Overall Study|Withdrawal by Subject|19|||
48561232|NCT03743051|156246325|FG000|Overall Study|Physician Decision|10|||
48561233|NCT03743051|156246326|FG001|Overall Study|Physician Decision|15|||
48561234|NCT03743051|156246325|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
48561235|NCT03743051|156246326|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
48561236|NCT03866577|156246327|FG000|Overall Study|Protocol Violation|0|||
48561237|NCT03866577|156246328|FG001|Overall Study|Protocol Violation|0|||
48561238|NCT03866577|156246329|FG002|Overall Study|Protocol Violation|0|||
48561239|NCT03866577|156246330|FG003|Overall Study|Protocol Violation|0|||
48561240|NCT03866577|156246331|FG004|Overall Study|Protocol Violation|0|||
48561241|NCT03866577|156246332|FG005|Overall Study|Protocol Violation|0|||
48561242|NCT03866577|156246333|FG006|Overall Study|Protocol Violation|0|||
48561243|NCT03866577|156246334|FG007|Overall Study|Protocol Violation|0|||
48561244|NCT03866577|156246335|FG008|Overall Study|Protocol Violation|0|||
48561245|NCT03866577|156246336|FG009|Overall Study|Protocol Violation|0|||
48561246|NCT03866577|156246337|FG010|Overall Study|Protocol Violation|0|||
48561247|NCT03866577|156246338|FG011|Overall Study|Protocol Violation|1|||
48561248|NCT03866577|156246339|FG012|Overall Study|Protocol Violation|0|||
48561249|NCT03866577|156246327|FG000|Overall Study|Withdrawal by Subject|0|||
48561250|NCT03866577|156246328|FG001|Overall Study|Withdrawal by Subject|0|||
48561251|NCT03866577|156246329|FG002|Overall Study|Withdrawal by Subject|0|||
48561252|NCT03866577|156246330|FG003|Overall Study|Withdrawal by Subject|0|||
48561253|NCT03866577|156246331|FG004|Overall Study|Withdrawal by Subject|0|||
48561254|NCT03866577|156246332|FG005|Overall Study|Withdrawal by Subject|0|||
48561255|NCT03866577|156246333|FG006|Overall Study|Withdrawal by Subject|0|||
48561256|NCT03866577|156246334|FG007|Overall Study|Withdrawal by Subject|0|||
48561257|NCT03866577|156246335|FG008|Overall Study|Withdrawal by Subject|1|||
48561258|NCT03866577|156246336|FG009|Overall Study|Withdrawal by Subject|1|||
48561259|NCT03866577|156246337|FG010|Overall Study|Withdrawal by Subject|0|||
48561260|NCT03866577|156246338|FG011|Overall Study|Withdrawal by Subject|0|||
48561261|NCT03866577|156246339|FG012|Overall Study|Withdrawal by Subject|0|||
48561262|NCT03866577|156246327|FG000|Overall Study|Not qualified for IVIg infusion|0|||
48561263|NCT03866577|156246328|FG001|Overall Study|Not qualified for IVIg infusion|0|||
48561264|NCT03866577|156246329|FG002|Overall Study|Not qualified for IVIg infusion|0|||
48561265|NCT03866577|156246330|FG003|Overall Study|Not qualified for IVIg infusion|0|||
48561266|NCT03866577|156246331|FG004|Overall Study|Not qualified for IVIg infusion|0|||
48561267|NCT03866577|156246332|FG005|Overall Study|Not qualified for IVIg infusion|0|||
48561268|NCT03866577|156246333|FG006|Overall Study|Not qualified for IVIg infusion|0|||
48561269|NCT03866577|156246334|FG007|Overall Study|Not qualified for IVIg infusion|0|||
48561270|NCT03866577|156246335|FG008|Overall Study|Not qualified for IVIg infusion|0|||
48561271|NCT03866577|156246336|FG009|Overall Study|Not qualified for IVIg infusion|1|||
48561272|NCT03866577|156246337|FG010|Overall Study|Not qualified for IVIg infusion|0|||
48561273|NCT03866577|156246338|FG011|Overall Study|Not qualified for IVIg infusion|0|||
48561274|NCT03866577|156246339|FG012|Overall Study|Not qualified for IVIg infusion|0|||
48561275|NCT03380429|156246342|FG000|Overall Study|Physician Decision|0|||
48561276|NCT03380429|156246343|FG001|Overall Study|Physician Decision|1|||
48561277|NCT03380429|156246344|FG002|Overall Study|Physician Decision|0|||
48561278|NCT03380429|156246345|FG003|Overall Study|Physician Decision|1|||
48561279|NCT03380429|156246346|FG004|Overall Study|Physician Decision|1|||
48561280|NCT03380429|156246342|FG000|Overall Study|Withdrawal by Subject|3|||
48561281|NCT03380429|156246343|FG001|Overall Study|Withdrawal by Subject|3|||
48561282|NCT03380429|156246344|FG002|Overall Study|Withdrawal by Subject|5|||
48561283|NCT03380429|156246345|FG003|Overall Study|Withdrawal by Subject|2|||
48561284|NCT03380429|156246346|FG004|Overall Study|Withdrawal by Subject|1|||
48561285|NCT03380429|156246342|FG000|Overall Study|Lost to Follow-up|0|||
48561286|NCT03380429|156246343|FG001|Overall Study|Lost to Follow-up|2|||
48561287|NCT03380429|156246344|FG002|Overall Study|Lost to Follow-up|4|||
48561288|NCT03380429|156246345|FG003|Overall Study|Lost to Follow-up|3|||
48561289|NCT03380429|156246346|FG004|Overall Study|Lost to Follow-up|1|||
48561290|NCT03380429|156246342|FG000|Overall Study|Protocol Violation|1|||
48561291|NCT03380429|156246343|FG001|Overall Study|Protocol Violation|0|||
48561292|NCT03380429|156246344|FG002|Overall Study|Protocol Violation|1|||
48561293|NCT03380429|156246345|FG003|Overall Study|Protocol Violation|0|||
48561294|NCT03380429|156246346|FG004|Overall Study|Protocol Violation|1|||
48561295|NCT03380429|156246342|FG000|Overall Study|Lack of Efficacy|0|||
48561296|NCT03380429|156246343|FG001|Overall Study|Lack of Efficacy|0|||
48561297|NCT03380429|156246344|FG002|Overall Study|Lack of Efficacy|0|||
48561298|NCT03380429|156246345|FG003|Overall Study|Lack of Efficacy|2|||
48561299|NCT03380429|156246346|FG004|Overall Study|Lack of Efficacy|1|||
48561300|NCT03380429|156246342|FG000|Overall Study|Adverse Event|1|||
48561301|NCT03380429|156246343|FG001|Overall Study|Adverse Event|1|||
48561302|NCT03380429|156246344|FG002|Overall Study|Adverse Event|1|||
48561303|NCT03380429|156246345|FG003|Overall Study|Adverse Event|2|||
48561304|NCT03380429|156246346|FG004|Overall Study|Adverse Event|0|||
48561305|NCT01000155|156246350|FG000|Overall Study|Withdrawal by Subject|1|||
48561306|NCT01000155|156246350|FG000|Overall Study|Adverse Event|1|||
48561307|NCT01215136|156246353|FG000|Overall Study|Adverse Event|2|||
48561308|NCT01215136|156246354|FG001|Overall Study|Adverse Event|9|||
48561309|NCT01215136|156246353|FG000|Overall Study|Disease Progression|3|||
48561310|NCT01215136|156246354|FG001|Overall Study|Disease Progression|14|||
48561311|NCT01215136|156246353|FG000|Overall Study|Symptomatic Deterioration|1|||
48561312|NCT01215136|156246354|FG001|Overall Study|Symptomatic Deterioration|1|||
48561313|NCT01215136|156246353|FG000|Overall Study|Death|0|||
48561314|NCT01215136|156246354|FG001|Overall Study|Death|2|||
48561315|NCT01215136|156246353|FG000|Overall Study|Withdrawal by Subject|0|||
48561316|NCT01215136|156246354|FG001|Overall Study|Withdrawal by Subject|1|||
48561317|NCT03164551|156246357|FG000|Overall Study|Imaging discontinued prior completion|8|||
48561318|NCT03164551|156246358|FG001|Overall Study|Imaging discontinued prior completion|0|||
48561319|NCT03164551|156246357|FG000|Overall Study|Participant was non-compliant|1|||
48561320|NCT03164551|156246358|FG001|Overall Study|Participant was non-compliant|0|||
48561321|NCT03164551|156246357|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
48561322|NCT03164551|156246358|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
48561323|NCT03164551|156246357|FG000|Overall Study|Other|8|||
48561324|NCT03164551|156246358|FG001|Overall Study|Other|2|||
48561325|NCT01515423|156246359|FG000|Open Label Phase|Adverse Event|57|||
48561326|NCT01515423|156246360|FG001|Open Label Phase|Adverse Event|0|||
48561327|NCT01515423|156246361|FG002|Open Label Phase|Adverse Event|0|||
48561328|NCT01515423|156246359|FG000|Open Label Phase|Death|2|||
48561329|NCT01515423|156246360|FG001|Open Label Phase|Death|0|||
48561330|NCT01515423|156246361|FG002|Open Label Phase|Death|0|||
48561331|NCT01515423|156246359|FG000|Open Label Phase|Lack of Efficacy|117|||
48561332|NCT01515423|156246360|FG001|Open Label Phase|Lack of Efficacy|0|||
48561333|NCT01515423|156246361|FG002|Open Label Phase|Lack of Efficacy|0|||
48561334|NCT01515423|156246359|FG000|Open Label Phase|Lost to Follow-up|21|||
48561335|NCT01515423|156246360|FG001|Open Label Phase|Lost to Follow-up|0|||
48561336|NCT01515423|156246361|FG002|Open Label Phase|Lost to Follow-up|0|||
48561337|NCT01515423|156246359|FG000|Open Label Phase|Withdrawal by Subject|118|||
48561338|NCT01515423|156246360|FG001|Open Label Phase|Withdrawal by Subject|0|||
48561339|NCT01515423|156246361|FG002|Open Label Phase|Withdrawal by Subject|0|||
48561340|NCT01515423|156246359|FG000|Open Label Phase|excluded from DB Phase|70|||
48561341|NCT01515423|156246360|FG001|Open Label Phase|excluded from DB Phase|0|||
48561342|NCT01515423|156246361|FG002|Open Label Phase|excluded from DB Phase|0|||
48561343|NCT01515423|156246359|FG000|Open Label Phase|Other|28|||
48561344|NCT01515423|156246360|FG001|Open Label Phase|Other|0|||
48561345|NCT01515423|156246361|FG002|Open Label Phase|Other|0|||
48561346|NCT01515423|156246359|FG000|DOUBLE BLIND|Adverse Event|0|||
48561347|NCT01515423|156246360|FG001|DOUBLE BLIND|Adverse Event|15|||
48561348|NCT01515423|156246361|FG002|DOUBLE BLIND|Adverse Event|13|||
48561349|NCT01515423|156246359|FG000|DOUBLE BLIND|Death|0|||
48561350|NCT01515423|156246360|FG001|DOUBLE BLIND|Death|1|||
48561351|NCT01515423|156246361|FG002|DOUBLE BLIND|Death|2|||
48561352|NCT01515423|156246359|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
48561353|NCT01515423|156246360|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
48561354|NCT01515423|156246361|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
48561355|NCT01515423|156246359|FG000|DOUBLE BLIND|Pregnancy|0|||
48561356|NCT01515423|156246360|FG001|DOUBLE BLIND|Pregnancy|2|||
48561357|NCT01515423|156246361|FG002|DOUBLE BLIND|Pregnancy|0|||
48561358|NCT01515423|156246359|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
48561359|NCT01515423|156246360|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
48561360|NCT01515423|156246361|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
48561361|NCT01515423|156246359|FG000|DOUBLE BLIND|Other|0|||
48561362|NCT01515423|156246360|FG001|DOUBLE BLIND|Other|6|||
48561363|NCT01515423|156246361|FG002|DOUBLE BLIND|Other|12|||
48561364|NCT01515423|156246359|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
48561365|NCT01515423|156246360|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
48561366|NCT01515423|156246361|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
48616951|NCT01432327|156453003|FG000|Posttest 3 Months|Allergic reaction|0|||
48561367|NCT01707290|156246372|FG000|Overall Study|Adverse event (AE)|1|||
48561368|NCT01707290|156246373|FG001|Overall Study|Adverse event (AE)|0|||
48561369|NCT01707290|156246372|FG000|Overall Study|Physician Decision|1|||
48561370|NCT01707290|156246373|FG001|Overall Study|Physician Decision|0|||
48561371|NCT01707290|156246372|FG000|Overall Study|Lost to Follow-up|3|||
48561372|NCT01707290|156246373|FG001|Overall Study|Lost to Follow-up|0|||
48561373|NCT01707290|156246372|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
48561374|NCT01707290|156246373|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
48561375|NCT01707290|156246372|FG000|Overall Study|Commercial drug available|60|||
48561376|NCT01707290|156246373|FG001|Overall Study|Commercial drug available|1|||
48561377|NCT01707290|156246372|FG000|Overall Study|Other unspecified|17|||
48561378|NCT01707290|156246373|FG001|Overall Study|Other unspecified|0|||
48561379|NCT02654054|156246379|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
48561380|NCT02654054|156246380|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
48561381|NCT02654054|156246381|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
48561382|NCT02654054|156246379|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
48561383|NCT02654054|156246380|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48561384|NCT02654054|156246381|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
48561385|NCT02654054|156246379|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
48561386|NCT02654054|156246380|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
48561387|NCT02654054|156246381|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
48561388|NCT02654054|156246379|FG000|Post-Treatment Follow-Up Period|Other|1|||
48561389|NCT02654054|156246380|FG001|Post-Treatment Follow-Up Period|Other|0|||
48561390|NCT02654054|156246381|FG002|Post-Treatment Follow-Up Period|Other|4|||
48561391|NCT02654054|156246379|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
48561392|NCT02654054|156246380|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
48561393|NCT02654054|156246381|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
48561394|NCT01777282|156246382|FG000|Overall Study|Persistent Hyperglycemia|0|||
48561395|NCT01777282|156246383|FG001|Overall Study|Persistent Hyperglycemia|0|||
48561396|NCT01777282|156246384|FG002|Overall Study|Persistent Hyperglycemia|1|||
48616952|NCT01432327|156453004|FG001|Posttest 3 Months|Allergic reaction|2|||
48616953|NCT01432327|156453005|FG002|Posttest 3 Months|Allergic reaction|0|||
48616954|NCT01432327|156453006|FG003|Posttest 3 Months|Allergic reaction|0|||
48616955|NCT01432327|156453003|FG000|Posttest 6 Months|Lost to Follow-up|0|||
48561397|NCT01777282|156246385|FG003|Overall Study|Persistent Hyperglycemia|0|||
48561398|NCT01777282|156246386|FG004|Overall Study|Persistent Hyperglycemia|0|||
48561399|NCT01777282|156246382|FG000|Overall Study|New Antidiabetic Medication|0|||
48561400|NCT01777282|156246383|FG001|Overall Study|New Antidiabetic Medication|0|||
48561401|NCT01777282|156246384|FG002|Overall Study|New Antidiabetic Medication|1|||
48561402|NCT01777282|156246385|FG003|Overall Study|New Antidiabetic Medication|0|||
48561403|NCT01777282|156246386|FG004|Overall Study|New Antidiabetic Medication|0|||
48561404|NCT01777282|156246382|FG000|Overall Study|Adverse Event|4|||
48561405|NCT01777282|156246383|FG001|Overall Study|Adverse Event|4|||
48561406|NCT01777282|156246384|FG002|Overall Study|Adverse Event|2|||
48561407|NCT01777282|156246385|FG003|Overall Study|Adverse Event|1|||
48561408|NCT01777282|156246386|FG004|Overall Study|Adverse Event|3|||
48561409|NCT01777282|156246382|FG000|Overall Study|Withdrawal by Subject|4|||
48561410|NCT01777282|156246383|FG001|Overall Study|Withdrawal by Subject|0|||
48561411|NCT01777282|156246384|FG002|Overall Study|Withdrawal by Subject|0|||
48561412|NCT01777282|156246385|FG003|Overall Study|Withdrawal by Subject|1|||
48561413|NCT01777282|156246386|FG004|Overall Study|Withdrawal by Subject|2|||
48561414|NCT01777282|156246382|FG000|Overall Study|Protocol Violation|2|||
48561415|NCT01777282|156246383|FG001|Overall Study|Protocol Violation|0|||
48561416|NCT01777282|156246384|FG002|Overall Study|Protocol Violation|1|||
48561417|NCT01777282|156246385|FG003|Overall Study|Protocol Violation|0|||
48561418|NCT01777282|156246386|FG004|Overall Study|Protocol Violation|2|||
48561419|NCT01777282|156246382|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
48561420|NCT01777282|156246383|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
48561421|NCT01777282|156246384|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
48561422|NCT01777282|156246385|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
48561423|NCT01777282|156246386|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
48561424|NCT00359424|156246387|FG000|Overall Study|Death|99|||
48561425|NCT00359424|156246388|FG001|Overall Study|Death|58|||
48561426|NCT00359424|156246387|FG000|Overall Study|Lost to Follow-up|19|||
48561427|NCT00359424|156246388|FG001|Overall Study|Lost to Follow-up|7|||
48561428|NCT00359424|156246387|FG000|Overall Study|Withdrawal by Subject|10|||
48561429|NCT00359424|156246388|FG001|Overall Study|Withdrawal by Subject|2|||
48561430|NCT00359424|156246387|FG000|Overall Study|follow up not conducted|2|||
48561431|NCT00359424|156246388|FG001|Overall Study|follow up not conducted|0|||
48561432|NCT02568189|156246393|FG000|Overall Study|Protocol Violation|0|||
48561433|NCT02568189|156246394|FG001|Overall Study|Protocol Violation|0|||
48561434|NCT02568189|156246395|FG002|Overall Study|Protocol Violation|19|||
48561435|NCT02568189|156246396|FG003|Overall Study|Protocol Violation|18|||
48561436|NCT03631706|156246397|FG000|Overall Study|Randomized, not treated|1|||
48561437|NCT03631706|156246398|FG001|Overall Study|Randomized, not treated|0|||
48561438|NCT03631706|156246397|FG000|Overall Study|Treatment ongoing|26|||
48561439|NCT03631706|156246398|FG001|Overall Study|Treatment ongoing|57|||
48561440|NCT03631706|156246397|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
48561441|NCT03631706|156246398|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
48561442|NCT02115269|156248748|FG000|Overall Study|Lost to Follow-up|43|||
48561443|NCT02115269|156248748|FG000|Overall Study|Did not complete patient diary|3|||
48561444|NCT02115269|156248748|FG000|Overall Study|Moved to another city|7|||
48561445|NCT02115269|156248748|FG000|Overall Study|Withdrawal by Subject|2|||
48561446|NCT02115269|156248748|FG000|Overall Study|Didn't take study drug|2|||
48616956|NCT01432327|156453004|FG001|Posttest 6 Months|Lost to Follow-up|0|||
48616957|NCT01432327|156453005|FG002|Posttest 6 Months|Lost to Follow-up|3|||
48616958|NCT01432327|156453006|FG003|Posttest 6 Months|Lost to Follow-up|2|||
48616959|NCT01432327|156453003|FG000|Posttest 6 Months|Allergic reaction|0|||
48616960|NCT01432327|156453004|FG001|Posttest 6 Months|Allergic reaction|0|||
48616961|NCT01432327|156453005|FG002|Posttest 6 Months|Allergic reaction|1|||
48616962|NCT01432327|156453006|FG003|Posttest 6 Months|Allergic reaction|0|||
48561447|NCT00711243|156248749|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
48561448|NCT00711243|156248750|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
48561449|NCT00711243|156248751|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
48616963|NCT01432327|156453003|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
48616964|NCT01432327|156453004|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
48561450|NCT00711243|156248752|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
48561451|NCT00711243|156248753|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
48561452|NCT00711243|156248754|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
48561453|NCT00711243|156248749|FG000|Reached First Response/4 Cycles|Death|0|||
48561454|NCT00711243|156248750|FG001|Reached First Response/4 Cycles|Death|0|||
48561455|NCT00711243|156248751|FG002|Reached First Response/4 Cycles|Death|0|||
48561456|NCT00711243|156248752|FG003|Reached First Response/4 Cycles|Death|0|||
48561457|NCT00711243|156248753|FG004|Reached First Response/4 Cycles|Death|0|||
48561458|NCT00711243|156248754|FG005|Reached First Response/4 Cycles|Death|2|||
48561459|NCT00711243|156248749|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
48561460|NCT00711243|156248750|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
48561461|NCT00711243|156248751|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
48561462|NCT00711243|156248752|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
48561463|NCT00711243|156248753|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
48561464|NCT00711243|156248754|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
48561465|NCT00711243|156248749|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
48561466|NCT00711243|156248750|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
48561467|NCT00711243|156248751|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
48561468|NCT00711243|156248752|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
48561469|NCT00711243|156248753|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
48561470|NCT00711243|156248754|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
48561471|NCT00711243|156248749|FG000|Treated Cycle 5 After First Response|Death|0|||
48561472|NCT00711243|156248750|FG001|Treated Cycle 5 After First Response|Death|0|||
48561473|NCT00711243|156248751|FG002|Treated Cycle 5 After First Response|Death|0|||
48561474|NCT00711243|156248752|FG003|Treated Cycle 5 After First Response|Death|0|||
48561475|NCT00711243|156248753|FG004|Treated Cycle 5 After First Response|Death|0|||
48561476|NCT00711243|156248754|FG005|Treated Cycle 5 After First Response|Death|2|||
48561477|NCT00711243|156248749|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
48561478|NCT00711243|156248750|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
48561479|NCT00711243|156248751|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
48561480|NCT00711243|156248752|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
48561481|NCT00711243|156248753|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
48561482|NCT00711243|156248754|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
48561483|NCT00711243|156248749|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
48561484|NCT00711243|156248750|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
48561485|NCT00711243|156248751|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
48561486|NCT00711243|156248752|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
48561487|NCT00711243|156248753|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
48561488|NCT00711243|156248754|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
48561489|NCT00886015|156248756|FG000|Overall Study|Death|0|||
48561490|NCT00886015|156248757|FG001|Overall Study|Death|2|||
48561491|NCT00075816|156248758|FG000|Overall Study|Did not undergo transplantation|14|||
48561492|NCT00075816|156248759|FG001|Overall Study|Did not undergo transplantation|11|||
48561493|NCT00696423|156248760|FG000|Overall Study|Lost to Follow-up|0|||
48561494|NCT00696423|156248761|FG001|Overall Study|Lost to Follow-up|5|||
48561495|NCT03511105|156248762|FG000|Overall Study|Adverse Event|1|||
48561496|NCT03511105|156248763|FG001|Overall Study|Adverse Event|0|||
48561497|NCT03511105|156248762|FG000|Overall Study|Withdrew consent|1|||
48561498|NCT03511105|156248763|FG001|Overall Study|Withdrew consent|0|||
48561499|NCT01823328|156248764|FG000|Overall Study|Withdrawal by Subject|8|||
48561500|NCT01823328|156248765|FG001|Overall Study|Withdrawal by Subject|6|||
48561501|NCT01977417|156248766|FG000|Overall Study|Adverse Event|1|||
48561502|NCT01977417|156248767|FG001|Overall Study|Adverse Event|0|||
48561503|NCT01977417|156248766|FG000|Overall Study|Withdrawal by Subject|2|||
48561504|NCT01977417|156248767|FG001|Overall Study|Withdrawal by Subject|4|||
48561505|NCT01977417|156248766|FG000|Overall Study|Female enrollment goal met|0|||
48616965|NCT01432327|156453005|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
48616966|NCT01432327|156453006|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
48616967|NCT01432327|156453003|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
48616968|NCT01432327|156453004|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
48616969|NCT01432327|156453005|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
48616970|NCT01432327|156453006|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
48616971|NCT01432327|156453003|FG000|Posttest 1 Year|Lost to Follow-up|0|||
48561506|NCT01977417|156248767|FG001|Overall Study|Female enrollment goal met|2|||
48561507|NCT02013817|156248768|FG000|Overall Study|Adverse Event|12|||
48561508|NCT02013817|156248768|FG000|Overall Study|Withdrawal by Subject|4|||
48561509|NCT02013817|156248768|FG000|Overall Study|Death|2|||
48561510|NCT02013817|156248768|FG000|Overall Study|Other|9|||
48561511|NCT01068860|156248773|FG000|Overall Study|Withdrawal by Subject|0|||
48561512|NCT01068860|156248774|FG001|Overall Study|Withdrawal by Subject|0|||
48561513|NCT01068860|156248775|FG002|Overall Study|Withdrawal by Subject|0|||
48561514|NCT01068860|156248776|FG003|Overall Study|Withdrawal by Subject|0|||
48561515|NCT01068860|156248777|FG004|Overall Study|Withdrawal by Subject|0|||
48616972|NCT01432327|156453004|FG001|Posttest 1 Year|Lost to Follow-up|0|||
48616973|NCT01432327|156453005|FG002|Posttest 1 Year|Lost to Follow-up|4|||
48616974|NCT01432327|156453006|FG003|Posttest 1 Year|Lost to Follow-up|2|||
48616975|NCT01432327|156453003|FG000|Posttest 1 Year|Allergic reaction|0|||
48616976|NCT01432327|156453004|FG001|Posttest 1 Year|Allergic reaction|0|||
48616977|NCT01432327|156453005|FG002|Posttest 1 Year|Allergic reaction|1|||
48616978|NCT01432327|156453006|FG003|Posttest 1 Year|Allergic reaction|1|||
48561516|NCT01068860|156248778|FG005|Overall Study|Withdrawal by Subject|2|||
48561517|NCT01068860|156248779|FG006|Overall Study|Withdrawal by Subject|0|||
48561518|NCT01068860|156248780|FG007|Overall Study|Withdrawal by Subject|0|||
48561519|NCT01068860|156248781|FG008|Overall Study|Withdrawal by Subject|0|||
48616979|NCT01001104|156453007|FG000|Overall Study|Adverse Event|2|||
48616980|NCT01001104|156453008|FG001|Overall Study|Adverse Event|1|||
48616981|NCT01001104|156453009|FG002|Overall Study|Adverse Event|0|||
48616982|NCT01001104|156453010|FG003|Overall Study|Adverse Event|0|||
48616983|NCT01001104|156453007|FG000|Overall Study|Lost to Follow-up|0|||
48561520|NCT01068860|156248782|FG009|Overall Study|Withdrawal by Subject|3|||
48561521|NCT01068860|156248773|FG000|Overall Study|Administrative problems; misrandomized|0|||
48561522|NCT01068860|156248774|FG001|Overall Study|Administrative problems; misrandomized|0|||
48561523|NCT01068860|156248775|FG002|Overall Study|Administrative problems; misrandomized|0|||
48561524|NCT01068860|156248776|FG003|Overall Study|Administrative problems; misrandomized|1|||
48561525|NCT01068860|156248777|FG004|Overall Study|Administrative problems; misrandomized|0|||
48561526|NCT01068860|156248778|FG005|Overall Study|Administrative problems; misrandomized|0|||
48561527|NCT01068860|156248779|FG006|Overall Study|Administrative problems; misrandomized|0|||
48561528|NCT01068860|156248780|FG007|Overall Study|Administrative problems; misrandomized|0|||
48561529|NCT01068860|156248781|FG008|Overall Study|Administrative problems; misrandomized|0|||
48561530|NCT01068860|156248782|FG009|Overall Study|Administrative problems; misrandomized|1|||
48561531|NCT01068860|156248773|FG000|Overall Study|Lost to Follow-up|0|||
48561532|NCT01068860|156248774|FG001|Overall Study|Lost to Follow-up|1|||
48561533|NCT01068860|156248775|FG002|Overall Study|Lost to Follow-up|0|||
48561534|NCT01068860|156248776|FG003|Overall Study|Lost to Follow-up|0|||
48561535|NCT01068860|156248777|FG004|Overall Study|Lost to Follow-up|0|||
48561536|NCT01068860|156248778|FG005|Overall Study|Lost to Follow-up|0|||
48561537|NCT01068860|156248779|FG006|Overall Study|Lost to Follow-up|0|||
48561538|NCT01068860|156248780|FG007|Overall Study|Lost to Follow-up|0|||
48561539|NCT01068860|156248781|FG008|Overall Study|Lost to Follow-up|0|||
48561540|NCT01068860|156248782|FG009|Overall Study|Lost to Follow-up|0|||
48561541|NCT02676882|156248783|FG000|Overall Study|Adverse Event|1|||
48561542|NCT02676882|156248784|FG001|Overall Study|Adverse Event|0|||
48561543|NCT02676882|156248783|FG000|Overall Study|Lost to Follow-up|1|||
48561544|NCT02676882|156248784|FG001|Overall Study|Lost to Follow-up|0|||
48561545|NCT02676882|156248783|FG000|Overall Study|Withdrawal by Subject|1|||
48561546|NCT02676882|156248784|FG001|Overall Study|Withdrawal by Subject|2|||
48561547|NCT02568072|156248785|FG000|Overall Study|Unavailable for appointment|23|||
48561548|NCT02568072|156248785|FG000|Overall Study|Unable to contact|3|||
48561549|NCT02568072|156248785|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
48561550|NCT02568072|156248785|FG000|Overall Study|Withdrawal by Subject|1|||
48561551|NCT02568072|156248785|FG000|Overall Study|Sustained injury, marathon not run|24|||
48561552|NCT00460603|156248789|FG000|Phase 1|Death|1|||
48561553|NCT00460603|156248790|FG001|Phase 1|Death|0|||
48561554|NCT00460603|156248791|FG002|Phase 1|Death|0|||
48561555|NCT00460603|156248792|FG003|Phase 1|Death|2|||
48561556|NCT00460603|156248793|FG004|Phase 1|Death|0|||
48561557|NCT00460603|156248794|FG005|Phase 1|Death|0|||
48561558|NCT00460603|156248795|FG006|Phase 1|Death|0|||
48561559|NCT00460603|156248796|FG007|Phase 1|Death|0|||
48561560|NCT00460603|156248797|FG008|Phase 1|Death|1|||
48561561|NCT00460603|156248798|FG009|Phase 1|Death|0|||
48561562|NCT00460603|156248799|FG010|Phase 1|Death|0|||
48561563|NCT00460603|156248800|FG011|Phase 1|Death|0|||
48561564|NCT00460603|156248789|FG000|Phase 1|Adverse Event|3|||
48561565|NCT00460603|156248790|FG001|Phase 1|Adverse Event|1|||
48616984|NCT01001104|156453008|FG001|Overall Study|Lost to Follow-up|0|||
48616985|NCT01001104|156453009|FG002|Overall Study|Lost to Follow-up|1|||
48616986|NCT01001104|156453010|FG003|Overall Study|Lost to Follow-up|0|||
48616987|NCT01001104|156453007|FG000|Overall Study|Entry Criteria Not Met|0|||
48616988|NCT01001104|156453008|FG001|Overall Study|Entry Criteria Not Met|0|||
48616989|NCT01001104|156453009|FG002|Overall Study|Entry Criteria Not Met|0|||
48616990|NCT01001104|156453010|FG003|Overall Study|Entry Criteria Not Met|1|||
48616991|NCT01001104|156453007|FG000|Overall Study|Withdrawal by Subject|0|||
48561566|NCT00460603|156248791|FG002|Phase 1|Adverse Event|1|||
48561567|NCT00460603|156248792|FG003|Phase 1|Adverse Event|2|||
48561568|NCT00460603|156248793|FG004|Phase 1|Adverse Event|0|||
48561569|NCT00460603|156248794|FG005|Phase 1|Adverse Event|0|||
48561570|NCT00460603|156248795|FG006|Phase 1|Adverse Event|3|||
48561571|NCT00460603|156248796|FG007|Phase 1|Adverse Event|0|||
48561572|NCT00460603|156248797|FG008|Phase 1|Adverse Event|4|||
48561573|NCT00460603|156248798|FG009|Phase 1|Adverse Event|0|||
48561574|NCT00460603|156248799|FG010|Phase 1|Adverse Event|0|||
48561575|NCT00460603|156248800|FG011|Phase 1|Adverse Event|0|||
48561576|NCT00460603|156248789|FG000|Phase 1|Lack of Efficacy|1|||
48561577|NCT00460603|156248790|FG001|Phase 1|Lack of Efficacy|0|||
48561578|NCT00460603|156248791|FG002|Phase 1|Lack of Efficacy|1|||
48561579|NCT00460603|156248792|FG003|Phase 1|Lack of Efficacy|2|||
48561580|NCT00460603|156248793|FG004|Phase 1|Lack of Efficacy|2|||
48561581|NCT00460603|156248794|FG005|Phase 1|Lack of Efficacy|2|||
48561582|NCT00460603|156248795|FG006|Phase 1|Lack of Efficacy|2|||
48561583|NCT00460603|156248796|FG007|Phase 1|Lack of Efficacy|2|||
48561584|NCT00460603|156248797|FG008|Phase 1|Lack of Efficacy|11|||
48561585|NCT00460603|156248798|FG009|Phase 1|Lack of Efficacy|0|||
48561586|NCT00460603|156248799|FG010|Phase 1|Lack of Efficacy|0|||
48561587|NCT00460603|156248800|FG011|Phase 1|Lack of Efficacy|0|||
48561588|NCT00460603|156248789|FG000|Phase 1|Withdrawal by Subject|1|||
48561589|NCT00460603|156248790|FG001|Phase 1|Withdrawal by Subject|2|||
48561590|NCT00460603|156248791|FG002|Phase 1|Withdrawal by Subject|1|||
48561591|NCT00460603|156248792|FG003|Phase 1|Withdrawal by Subject|1|||
48561592|NCT00460603|156248793|FG004|Phase 1|Withdrawal by Subject|3|||
48561593|NCT00460603|156248794|FG005|Phase 1|Withdrawal by Subject|0|||
48561594|NCT00460603|156248795|FG006|Phase 1|Withdrawal by Subject|1|||
48561595|NCT00460603|156248796|FG007|Phase 1|Withdrawal by Subject|0|||
48561596|NCT00460603|156248797|FG008|Phase 1|Withdrawal by Subject|2|||
48561597|NCT00460603|156248798|FG009|Phase 1|Withdrawal by Subject|0|||
48561598|NCT00460603|156248799|FG010|Phase 1|Withdrawal by Subject|0|||
48561599|NCT00460603|156248800|FG011|Phase 1|Withdrawal by Subject|0|||
48561600|NCT00460603|156248789|FG000|Phase 1|Other|0|||
48561601|NCT00460603|156248790|FG001|Phase 1|Other|3|||
48561602|NCT00460603|156248791|FG002|Phase 1|Other|1|||
48561603|NCT00460603|156248792|FG003|Phase 1|Other|1|||
48561604|NCT00460603|156248793|FG004|Phase 1|Other|1|||
48561605|NCT00460603|156248794|FG005|Phase 1|Other|2|||
48561606|NCT00460603|156248795|FG006|Phase 1|Other|0|||
48561607|NCT00460603|156248796|FG007|Phase 1|Other|1|||
48561608|NCT00460603|156248797|FG008|Phase 1|Other|0|||
48561609|NCT00460603|156248798|FG009|Phase 1|Other|0|||
48561610|NCT00460603|156248799|FG010|Phase 1|Other|0|||
48561611|NCT00460603|156248800|FG011|Phase 1|Other|0|||
48561612|NCT00460603|156248789|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561613|NCT00460603|156248790|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561614|NCT00460603|156248791|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561615|NCT00460603|156248792|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561616|NCT00460603|156248793|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561617|NCT00460603|156248794|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561618|NCT00460603|156248795|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561619|NCT00460603|156248796|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561620|NCT00460603|156248797|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561621|NCT00460603|156248798|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
48561622|NCT00460603|156248799|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48616992|NCT01001104|156453008|FG001|Overall Study|Withdrawal by Subject|0|||
48616993|NCT01001104|156453009|FG002|Overall Study|Withdrawal by Subject|0|||
48561623|NCT00460603|156248800|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
48561624|NCT00460603|156248789|FG000|Phase 2|Adverse Event|0|||
48561625|NCT00460603|156248790|FG001|Phase 2|Adverse Event|0|||
48561626|NCT00460603|156248791|FG002|Phase 2|Adverse Event|0|||
48561627|NCT00460603|156248792|FG003|Phase 2|Adverse Event|0|||
48561628|NCT00460603|156248793|FG004|Phase 2|Adverse Event|0|||
48561629|NCT00460603|156248794|FG005|Phase 2|Adverse Event|0|||
48561630|NCT00460603|156248795|FG006|Phase 2|Adverse Event|0|||
48561631|NCT00460603|156248796|FG007|Phase 2|Adverse Event|0|||
48561632|NCT00460603|156248797|FG008|Phase 2|Adverse Event|0|||
48561633|NCT00460603|156248798|FG009|Phase 2|Adverse Event|12|||
48561634|NCT00460603|156248799|FG010|Phase 2|Adverse Event|9|||
48561635|NCT00460603|156248800|FG011|Phase 2|Adverse Event|10|||
48561636|NCT00460603|156248789|FG000|Phase 2|Death|0|||
48561637|NCT00460603|156248790|FG001|Phase 2|Death|0|||
48561638|NCT00460603|156248791|FG002|Phase 2|Death|0|||
48561639|NCT00460603|156248792|FG003|Phase 2|Death|0|||
48561640|NCT00460603|156248793|FG004|Phase 2|Death|0|||
48561641|NCT00460603|156248794|FG005|Phase 2|Death|0|||
48561642|NCT00460603|156248795|FG006|Phase 2|Death|0|||
48561643|NCT00460603|156248796|FG007|Phase 2|Death|0|||
48561644|NCT00460603|156248797|FG008|Phase 2|Death|0|||
48561645|NCT00460603|156248798|FG009|Phase 2|Death|4|||
48561646|NCT00460603|156248799|FG010|Phase 2|Death|2|||
48561647|NCT00460603|156248800|FG011|Phase 2|Death|2|||
48561648|NCT00460603|156248789|FG000|Phase 2|Protocol Violation|0|||
48561649|NCT00460603|156248790|FG001|Phase 2|Protocol Violation|0|||
48561650|NCT00460603|156248791|FG002|Phase 2|Protocol Violation|0|||
48561651|NCT00460603|156248792|FG003|Phase 2|Protocol Violation|0|||
48561652|NCT00460603|156248793|FG004|Phase 2|Protocol Violation|0|||
48561653|NCT00460603|156248794|FG005|Phase 2|Protocol Violation|0|||
48561654|NCT00460603|156248795|FG006|Phase 2|Protocol Violation|0|||
48561655|NCT00460603|156248796|FG007|Phase 2|Protocol Violation|0|||
48561656|NCT00460603|156248797|FG008|Phase 2|Protocol Violation|0|||
48561657|NCT00460603|156248798|FG009|Phase 2|Protocol Violation|1|||
48561658|NCT00460603|156248799|FG010|Phase 2|Protocol Violation|1|||
48561659|NCT00460603|156248800|FG011|Phase 2|Protocol Violation|0|||
48561660|NCT00460603|156248789|FG000|Phase 2|Lost to Follow-up|0|||
48561661|NCT00460603|156248790|FG001|Phase 2|Lost to Follow-up|0|||
48561662|NCT00460603|156248791|FG002|Phase 2|Lost to Follow-up|0|||
48561663|NCT00460603|156248792|FG003|Phase 2|Lost to Follow-up|0|||
48561664|NCT00460603|156248793|FG004|Phase 2|Lost to Follow-up|0|||
48561665|NCT00460603|156248794|FG005|Phase 2|Lost to Follow-up|0|||
48561666|NCT00460603|156248795|FG006|Phase 2|Lost to Follow-up|0|||
48561667|NCT00460603|156248796|FG007|Phase 2|Lost to Follow-up|0|||
48561668|NCT00460603|156248797|FG008|Phase 2|Lost to Follow-up|0|||
48561669|NCT00460603|156248798|FG009|Phase 2|Lost to Follow-up|1|||
48561670|NCT00460603|156248799|FG010|Phase 2|Lost to Follow-up|0|||
48561671|NCT00460603|156248800|FG011|Phase 2|Lost to Follow-up|0|||
48561672|NCT00460603|156248789|FG000|Phase 2|Other|0|||
48561673|NCT00460603|156248790|FG001|Phase 2|Other|0|||
48561674|NCT00460603|156248791|FG002|Phase 2|Other|0|||
48561675|NCT00460603|156248792|FG003|Phase 2|Other|0|||
48561676|NCT00460603|156248793|FG004|Phase 2|Other|0|||
48561677|NCT00460603|156248794|FG005|Phase 2|Other|0|||
48561678|NCT00460603|156248795|FG006|Phase 2|Other|0|||
48561679|NCT00460603|156248796|FG007|Phase 2|Other|0|||
48561680|NCT00460603|156248797|FG008|Phase 2|Other|0|||
48616994|NCT01001104|156453010|FG003|Overall Study|Withdrawal by Subject|2|||
48616995|NCT02397837|156453015|FG000|Overall Study|Withdrawal by Subject|6|||
48616996|NCT02397837|156453016|FG001|Overall Study|Withdrawal by Subject|5|||
48561681|NCT00460603|156248798|FG009|Phase 2|Other|6|||
48561682|NCT00460603|156248799|FG010|Phase 2|Other|16|||
48561683|NCT00460603|156248800|FG011|Phase 2|Other|7|||
48561684|NCT00460603|156248789|FG000|Phase 2|Objective Progression or Relapse|0|||
48561685|NCT00460603|156248790|FG001|Phase 2|Objective Progression or Relapse|0|||
48561686|NCT00460603|156248791|FG002|Phase 2|Objective Progression or Relapse|0|||
48561687|NCT00460603|156248792|FG003|Phase 2|Objective Progression or Relapse|0|||
48561688|NCT00460603|156248793|FG004|Phase 2|Objective Progression or Relapse|0|||
48561689|NCT00460603|156248794|FG005|Phase 2|Objective Progression or Relapse|0|||
48561690|NCT00460603|156248795|FG006|Phase 2|Objective Progression or Relapse|0|||
48561691|NCT00460603|156248796|FG007|Phase 2|Objective Progression or Relapse|0|||
48561692|NCT00460603|156248797|FG008|Phase 2|Objective Progression or Relapse|0|||
48561693|NCT00460603|156248798|FG009|Phase 2|Objective Progression or Relapse|9|||
48561694|NCT00460603|156248799|FG010|Phase 2|Objective Progression or Relapse|10|||
48561695|NCT00460603|156248800|FG011|Phase 2|Objective Progression or Relapse|17|||
48561696|NCT00460603|156248789|FG000|Phase 2|Global Deterioration of Health Status|0|||
48561697|NCT00460603|156248790|FG001|Phase 2|Global Deterioration of Health Status|0|||
48561698|NCT00460603|156248791|FG002|Phase 2|Global Deterioration of Health Status|0|||
48561699|NCT00460603|156248792|FG003|Phase 2|Global Deterioration of Health Status|0|||
48561700|NCT00460603|156248793|FG004|Phase 2|Global Deterioration of Health Status|0|||
48561701|NCT00460603|156248794|FG005|Phase 2|Global Deterioration of Health Status|0|||
48561702|NCT00460603|156248795|FG006|Phase 2|Global Deterioration of Health Status|0|||
48561703|NCT00460603|156248796|FG007|Phase 2|Global Deterioration of Health Status|0|||
48616997|NCT02397837|156453015|FG000|Overall Study|Physician Decision|1|||
48561704|NCT00460603|156248797|FG008|Phase 2|Global Deterioration of Health Status|0|||
48561705|NCT00460603|156248798|FG009|Phase 2|Global Deterioration of Health Status|0|||
48561706|NCT00460603|156248799|FG010|Phase 2|Global Deterioration of Health Status|1|||
48561707|NCT00460603|156248800|FG011|Phase 2|Global Deterioration of Health Status|0|||
48561708|NCT00460603|156248789|FG000|Phase 2|Withdrawal by Subject|0|||
48561709|NCT00460603|156248790|FG001|Phase 2|Withdrawal by Subject|0|||
48561710|NCT00460603|156248791|FG002|Phase 2|Withdrawal by Subject|0|||
48561711|NCT00460603|156248792|FG003|Phase 2|Withdrawal by Subject|0|||
48561712|NCT00460603|156248793|FG004|Phase 2|Withdrawal by Subject|0|||
48561713|NCT00460603|156248794|FG005|Phase 2|Withdrawal by Subject|0|||
48561714|NCT00460603|156248795|FG006|Phase 2|Withdrawal by Subject|0|||
48561715|NCT00460603|156248796|FG007|Phase 2|Withdrawal by Subject|0|||
48561716|NCT00460603|156248797|FG008|Phase 2|Withdrawal by Subject|0|||
48561717|NCT00460603|156248798|FG009|Phase 2|Withdrawal by Subject|5|||
48561718|NCT00460603|156248799|FG010|Phase 2|Withdrawal by Subject|4|||
48561719|NCT00460603|156248800|FG011|Phase 2|Withdrawal by Subject|5|||
48561720|NCT00460603|156248789|FG000|Phase 2|Randomized, but not treated|0|||
48561721|NCT00460603|156248790|FG001|Phase 2|Randomized, but not treated|0|||
48561722|NCT00460603|156248791|FG002|Phase 2|Randomized, but not treated|0|||
48561723|NCT00460603|156248792|FG003|Phase 2|Randomized, but not treated|0|||
48561724|NCT00460603|156248793|FG004|Phase 2|Randomized, but not treated|0|||
48561725|NCT00460603|156248794|FG005|Phase 2|Randomized, but not treated|0|||
48561726|NCT00460603|156248795|FG006|Phase 2|Randomized, but not treated|0|||
48561727|NCT00460603|156248796|FG007|Phase 2|Randomized, but not treated|0|||
48561728|NCT00460603|156248797|FG008|Phase 2|Randomized, but not treated|0|||
48561729|NCT00460603|156248798|FG009|Phase 2|Randomized, but not treated|3|||
48561730|NCT00460603|156248799|FG010|Phase 2|Randomized, but not treated|0|||
48561731|NCT00460603|156248800|FG011|Phase 2|Randomized, but not treated|0|||
48561732|NCT01071915|156248802|FG000|Overall Study|Adverse Event|3|||
48561733|NCT01071915|156248802|FG000|Overall Study|Physician Decision|2|||
48561734|NCT01071915|156248802|FG000|Overall Study|Withdrawal by Subject|2|||
48561735|NCT01071915|156248802|FG000|Overall Study|Miscellaneous Reasons|2|||
48561736|NCT02687451|156248803|FG000|Overall Study|Withdrawal by Subject|1|||
48561737|NCT02687451|156248804|FG001|Overall Study|Withdrawal by Subject|0|||
48561738|NCT02687451|156248805|FG002|Overall Study|Withdrawal by Subject|0|||
48561739|NCT02687451|156248806|FG003|Overall Study|Withdrawal by Subject|0|||
48561740|NCT02687451|156248807|FG004|Overall Study|Withdrawal by Subject|0|||
48561741|NCT02687451|156248808|FG005|Overall Study|Withdrawal by Subject|1|||
48561742|NCT00927589|156248815|FG000|Overall Study|Death|1|||
48561743|NCT00927589|156248815|FG000|Overall Study|Physician Decision|1|||
48561744|NCT00927589|156248815|FG000|Overall Study|Withdrawal by Subject|3|||
48561745|NCT00927589|156248815|FG000|Overall Study|Adverse Event|2|||
48561746|NCT00927589|156248815|FG000|Overall Study|Disease Progression|8|||
48561747|NCT00927589|156248815|FG000|Overall Study|Non-compliance|1|||
48561748|NCT00114140|156248817|FG000|Overall Study|Protocol Violation|7|||
48561749|NCT00513240|156248818|FG000|Overall Study|Did not have intended surgery|3|||
48561750|NCT00513240|156248819|FG001|Overall Study|Did not have intended surgery|0|||
48561751|NCT00513240|156248818|FG000|Overall Study|Death|3|||
48561752|NCT00513240|156248819|FG001|Overall Study|Death|3|||
48561753|NCT00513240|156248818|FG000|Overall Study|Withdrawal by Subject|7|||
48561754|NCT00513240|156248819|FG001|Overall Study|Withdrawal by Subject|4|||
48561755|NCT01518322|156248820|FG000|Overall Study|FeNO measurement was missing|13|||
48561756|NCT00707239|156248821|FG000|Overall Study|Adverse Event|5|||
48561757|NCT00707239|156248822|FG001|Overall Study|Adverse Event|3|||
48561758|NCT00707239|156248823|FG002|Overall Study|Adverse Event|2|||
48561759|NCT00707239|156248821|FG000|Overall Study|Death|3|||
48561760|NCT00707239|156248822|FG001|Overall Study|Death|1|||
48561761|NCT00707239|156248823|FG002|Overall Study|Death|3|||
48561762|NCT00707239|156248821|FG000|Overall Study|Physician Decision|1|||
48561763|NCT00707239|156248822|FG001|Overall Study|Physician Decision|1|||
48561764|NCT00707239|156248823|FG002|Overall Study|Physician Decision|2|||
48561765|NCT00707239|156248821|FG000|Overall Study|Protocol Violation|0|||
48561766|NCT00707239|156248822|FG001|Overall Study|Protocol Violation|0|||
48561767|NCT00707239|156248823|FG002|Overall Study|Protocol Violation|1|||
48561768|NCT00707239|156248821|FG000|Overall Study|Lack of Efficacy|1|||
48561769|NCT00707239|156248822|FG001|Overall Study|Lack of Efficacy|2|||
48561770|NCT00707239|156248823|FG002|Overall Study|Lack of Efficacy|0|||
48561771|NCT00707239|156248821|FG000|Overall Study|Randomized, but not treated|1|||
48561772|NCT00707239|156248822|FG001|Overall Study|Randomized, but not treated|1|||
48561773|NCT00707239|156248823|FG002|Overall Study|Randomized, but not treated|1|||
48561774|NCT00707239|156248821|FG000|Overall Study|Other|8|||
48616998|NCT02397837|156453016|FG001|Overall Study|Physician Decision|1|||
48616999|NCT03320369|156453017|FG000|Overall Study|Adverse Event|1|||
48617000|NCT03320369|156453017|FG000|Overall Study|Withdrawal by Subject|2|||
48617001|NCT01002105|156453018|FG000|Overall Study|Lost to Follow-up|10|||
48617002|NCT01002105|156453019|FG001|Overall Study|Lost to Follow-up|16|||
48617003|NCT01002105|156453018|FG000|Overall Study|non compliance|5|||
48617004|NCT01002105|156453019|FG001|Overall Study|non compliance|3|||
48617005|NCT01002105|156453018|FG000|Overall Study|condition worsened|4|||
48617006|NCT01002105|156453019|FG001|Overall Study|condition worsened|2|||
48617007|NCT01793935|156453020|FG000|Overall Study|Pregnancy|1|||
48617008|NCT01793935|156453021|FG001|Overall Study|Pregnancy|0|||
48617009|NCT01793935|156453020|FG000|Overall Study|Protocol Violation|2|||
48617010|NCT01793935|156453021|FG001|Overall Study|Protocol Violation|1|||
48617011|NCT01793935|156453020|FG000|Overall Study|Adverse Event|2|||
48617012|NCT01793935|156453021|FG001|Overall Study|Adverse Event|0|||
48617013|NCT01793935|156453020|FG000|Overall Study|Patient did not take study medication|1|||
48617014|NCT01793935|156453021|FG001|Overall Study|Patient did not take study medication|1|||
48617015|NCT01793935|156453020|FG000|Overall Study|Lost to Follow-up|0|||
48617016|NCT01793935|156453021|FG001|Overall Study|Lost to Follow-up|1|||
48617017|NCT02506036|156453022|FG000|First Intervention (4-6 Weeks)|Death|1|||
48617018|NCT02506036|156453023|FG001|First Intervention (4-6 Weeks)|Death|0|||
48617019|NCT02506036|156453022|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
48617020|NCT02506036|156453023|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
48617021|NCT02506036|156453022|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
48617022|NCT02506036|156453023|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
48617023|NCT02265744|156453035|FG000|Overall Study|Poor/Non-compliance|1|||
48617024|NCT02265744|156453036|FG001|Overall Study|Poor/Non-compliance|1|||
48617025|NCT02265744|156453037|FG002|Overall Study|Poor/Non-compliance|0|||
48617026|NCT02265744|156453038|FG003|Overall Study|Poor/Non-compliance|0|||
48617027|NCT02265744|156453039|FG004|Overall Study|Poor/Non-compliance|2|||
48617028|NCT02265744|156453035|FG000|Overall Study|Lost to Follow-up|0|||
48617029|NCT02265744|156453036|FG001|Overall Study|Lost to Follow-up|0|||
48617030|NCT02265744|156453037|FG002|Overall Study|Lost to Follow-up|0|||
48617031|NCT02265744|156453038|FG003|Overall Study|Lost to Follow-up|1|||
48617032|NCT02265744|156453039|FG004|Overall Study|Lost to Follow-up|0|||
48617033|NCT02265744|156453035|FG000|Overall Study|Death|0|||
48617034|NCT02265744|156453036|FG001|Overall Study|Death|0|||
48617035|NCT02265744|156453037|FG002|Overall Study|Death|0|||
48617036|NCT02265744|156453038|FG003|Overall Study|Death|2|||
48617037|NCT02265744|156453039|FG004|Overall Study|Death|0|||
48617038|NCT02265744|156453035|FG000|Overall Study|Withdrawal by Subject|2|||
48617039|NCT02265744|156453036|FG001|Overall Study|Withdrawal by Subject|0|||
48617040|NCT02265744|156453037|FG002|Overall Study|Withdrawal by Subject|0|||
48617041|NCT02265744|156453038|FG003|Overall Study|Withdrawal by Subject|2|||
48617042|NCT02265744|156453039|FG004|Overall Study|Withdrawal by Subject|0|||
48617043|NCT02265744|156453035|FG000|Overall Study|Participant request to discontinue|2|||
48617044|NCT02265744|156453036|FG001|Overall Study|Participant request to discontinue|2|||
48617045|NCT02265744|156453037|FG002|Overall Study|Participant request to discontinue|2|||
48617046|NCT02265744|156453038|FG003|Overall Study|Participant request to discontinue|0|||
48617047|NCT02265744|156453039|FG004|Overall Study|Participant request to discontinue|0|||
48617048|NCT02265744|156453035|FG000|Overall Study|Adverse Event|8|||
48617049|NCT02265744|156453036|FG001|Overall Study|Adverse Event|4|||
48617050|NCT02265744|156453037|FG002|Overall Study|Adverse Event|9|||
48617051|NCT02265744|156453038|FG003|Overall Study|Adverse Event|8|||
48617052|NCT02265744|156453039|FG004|Overall Study|Adverse Event|2|||
48617053|NCT02265744|156453035|FG000|Overall Study|Lack of Efficacy|2|||
48617054|NCT02265744|156453036|FG001|Overall Study|Lack of Efficacy|4|||
48617055|NCT02265744|156453037|FG002|Overall Study|Lack of Efficacy|3|||
48617056|NCT02265744|156453038|FG003|Overall Study|Lack of Efficacy|4|||
48561775|NCT00707239|156248822|FG001|Overall Study|Other|3|||
48561776|NCT00707239|156248823|FG002|Overall Study|Other|5|||
48561777|NCT01103180|156248826|FG000|Overall Study|Withdrawal by Subject|8|||
48617057|NCT02265744|156453039|FG004|Overall Study|Lack of Efficacy|5|||
48617058|NCT02265744|156453035|FG000|Overall Study|Reason not provided by Investigator|1|||
48617059|NCT02265744|156453036|FG001|Overall Study|Reason not provided by Investigator|0|||
48617060|NCT02265744|156453037|FG002|Overall Study|Reason not provided by Investigator|0|||
48617061|NCT02265744|156453038|FG003|Overall Study|Reason not provided by Investigator|2|||
48617062|NCT02265744|156453039|FG004|Overall Study|Reason not provided by Investigator|0|||
48617063|NCT02265744|156453035|FG000|Overall Study|Administrative reason by sponsor|3|||
48617064|NCT02265744|156453036|FG001|Overall Study|Administrative reason by sponsor|2|||
48617065|NCT02265744|156453037|FG002|Overall Study|Administrative reason by sponsor|2|||
48561778|NCT01103180|156248827|FG001|Overall Study|Withdrawal by Subject|13|||
48561779|NCT01103180|156248826|FG000|Overall Study|Lost to Follow-up|13|||
48561780|NCT01103180|156248827|FG001|Overall Study|Lost to Follow-up|7|||
48561781|NCT01103180|156248826|FG000|Overall Study|Physician Decision|1|||
48561782|NCT01103180|156248827|FG001|Overall Study|Physician Decision|0|||
48561783|NCT01103180|156248826|FG000|Overall Study|Protocol Violation|0|||
48561784|NCT01103180|156248827|FG001|Overall Study|Protocol Violation|1|||
48561785|NCT01778530|156248828|FG000|Overall Study|Progression on study|1|||
48561786|NCT01778530|156248828|FG000|Overall Study|Adverse event/side effect|1|||
48561787|NCT03871543|156248830|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
48561788|NCT03871543|156248830|FG000|Period 1|Investigator Error|1|||
48561789|NCT03871543|156248830|FG000|Period 1|Protocol Violation|2|||
48561790|NCT03871543|156248830|FG000|Period 1|COVID-19 Related|1|||
48561791|NCT03871543|156248830|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
48561792|NCT03871543|156248830|FG000|Period 1|Withdrawal by Subject|10|||
48617066|NCT02265744|156453038|FG003|Overall Study|Administrative reason by sponsor|3|||
48617067|NCT02265744|156453039|FG004|Overall Study|Administrative reason by sponsor|3|||
48561793|NCT03871543|156248830|FG000|Period 2|Adverse Event|1|||
48561794|NCT03871543|156248830|FG000|Period 2|Withdrawal by Subject|1|||
48561795|NCT02505217|156248831|FG000|Overall Study|Withdrawal by Subject|1|||
48561796|NCT02505217|156248832|FG001|Overall Study|Withdrawal by Subject|2|||
48561797|NCT02792517|156248838|FG000|Overall Study|Withdrawal by Subject|10|||
48561798|NCT02792517|156248838|FG000|Overall Study|Decision by Sponsor|7|||
48561799|NCT02792517|156248838|FG000|Overall Study|Lost to Follow-up|3|||
48561800|NCT00110396|156248839|FG000|Overall Study|Adverse Event|15|||
48561801|NCT00110396|156248839|FG000|Overall Study|Lost to Follow-up|1|||
48561802|NCT00110396|156248839|FG000|Overall Study|Administration of plasmapheresis|1|||
48561803|NCT00110396|156248839|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
48561804|NCT00110396|156248839|FG000|Overall Study|Lack of Efficacy|1|||
48561805|NCT00110396|156248839|FG000|Overall Study|Decided not to continue treatment|1|||
48561806|NCT00110396|156248839|FG000|Overall Study|Patient non-compliance|1|||
48561807|NCT00110396|156248839|FG000|Overall Study|Patient refused to continue|1|||
48561808|NCT00110396|156248839|FG000|Overall Study|Patient refused to participate|1|||
48561809|NCT00110396|156248839|FG000|Overall Study|Patient will|1|||
48561810|NCT00110396|156248839|FG000|Overall Study|Patient's decision|1|||
48561811|NCT00110396|156248839|FG000|Overall Study|Participation in MS vaccine study|1|||
48561812|NCT00110396|156248839|FG000|Overall Study|Pregnancy|1|||
48561813|NCT00110396|156248839|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
48561814|NCT00110396|156248839|FG000|Overall Study|Protocol Violation|2|||
48561815|NCT00110396|156248839|FG000|Overall Study|Patient refused to come back|1|||
48561816|NCT00110396|156248839|FG000|Overall Study|The patient has refused|2|||
48561817|NCT00110396|156248839|FG000|Overall Study|The patient has refused to visit site|1|||
48561818|NCT00110396|156248839|FG000|Overall Study|Patient is to be administered copaxone|1|||
48561819|NCT01894919|156248840|FG000|Overall Study|Withdrawal by Subject|1|||
48561820|NCT01894919|156248841|FG001|Overall Study|Withdrawal by Subject|0|||
48561821|NCT01894919|156248842|FG002|Overall Study|Withdrawal by Subject|0|||
48561822|NCT01894919|156248843|FG003|Overall Study|Withdrawal by Subject|0|||
48561823|NCT01894919|156248844|FG004|Overall Study|Withdrawal by Subject|1|||
48561824|NCT01894919|156248845|FG005|Overall Study|Withdrawal by Subject|0|||
48561825|NCT01894919|156248846|FG006|Overall Study|Withdrawal by Subject|0|||
48561826|NCT01894919|156248847|FG007|Overall Study|Withdrawal by Subject|0|||
48561827|NCT01894919|156248848|FG008|Overall Study|Withdrawal by Subject|0|||
48561828|NCT01894919|156248849|FG009|Overall Study|Withdrawal by Subject|1|||
48561829|NCT01894919|156248850|FG010|Overall Study|Withdrawal by Subject|1|||
48561830|NCT01894919|156248851|FG011|Overall Study|Withdrawal by Subject|0|||
48561831|NCT01894919|156248852|FG012|Overall Study|Withdrawal by Subject|0|||
48561832|NCT01894919|156248840|FG000|Overall Study|Adverse Event|0|||
48561833|NCT01894919|156248841|FG001|Overall Study|Adverse Event|0|||
48561834|NCT01894919|156248842|FG002|Overall Study|Adverse Event|0|||
48561835|NCT01894919|156248843|FG003|Overall Study|Adverse Event|0|||
48561836|NCT01894919|156248844|FG004|Overall Study|Adverse Event|0|||
48561837|NCT01894919|156248845|FG005|Overall Study|Adverse Event|0|||
48561838|NCT01894919|156248846|FG006|Overall Study|Adverse Event|0|||
48561839|NCT01894919|156248847|FG007|Overall Study|Adverse Event|0|||
48561840|NCT01894919|156248848|FG008|Overall Study|Adverse Event|0|||
48561841|NCT01894919|156248849|FG009|Overall Study|Adverse Event|0|||
48561842|NCT01894919|156248850|FG010|Overall Study|Adverse Event|1|||
48561843|NCT01894919|156248851|FG011|Overall Study|Adverse Event|0|||
48561844|NCT01894919|156248852|FG012|Overall Study|Adverse Event|0|||
48561845|NCT01894919|156248840|FG000|Overall Study|Other-Unspecified|1|||
48561846|NCT01894919|156248841|FG001|Overall Study|Other-Unspecified|0|||
48561847|NCT01894919|156248842|FG002|Overall Study|Other-Unspecified|0|||
48561848|NCT01894919|156248843|FG003|Overall Study|Other-Unspecified|0|||
48561849|NCT01894919|156248844|FG004|Overall Study|Other-Unspecified|0|||
48561850|NCT01894919|156248845|FG005|Overall Study|Other-Unspecified|0|||
48561851|NCT01894919|156248846|FG006|Overall Study|Other-Unspecified|0|||
48561852|NCT01894919|156248847|FG007|Overall Study|Other-Unspecified|0|||
48561853|NCT01894919|156248848|FG008|Overall Study|Other-Unspecified|0|||
48561854|NCT01894919|156248849|FG009|Overall Study|Other-Unspecified|0|||
48561855|NCT01894919|156248850|FG010|Overall Study|Other-Unspecified|0|||
48561856|NCT01894919|156248851|FG011|Overall Study|Other-Unspecified|0|||
48561857|NCT01894919|156248852|FG012|Overall Study|Other-Unspecified|0|||
48561858|NCT01894919|156248840|FG000|Overall Study|Lost to Follow-up|0|||
48561859|NCT01894919|156248841|FG001|Overall Study|Lost to Follow-up|0|||
48561860|NCT01894919|156248842|FG002|Overall Study|Lost to Follow-up|0|||
48561861|NCT01894919|156248843|FG003|Overall Study|Lost to Follow-up|0|||
48561862|NCT01894919|156248844|FG004|Overall Study|Lost to Follow-up|2|||
48561863|NCT01894919|156248845|FG005|Overall Study|Lost to Follow-up|0|||
48561864|NCT01894919|156248846|FG006|Overall Study|Lost to Follow-up|0|||
48561865|NCT01894919|156248847|FG007|Overall Study|Lost to Follow-up|0|||
48561866|NCT01894919|156248848|FG008|Overall Study|Lost to Follow-up|0|||
48561867|NCT01894919|156248849|FG009|Overall Study|Lost to Follow-up|0|||
48561868|NCT01894919|156248850|FG010|Overall Study|Lost to Follow-up|0|||
48561869|NCT01894919|156248851|FG011|Overall Study|Lost to Follow-up|0|||
48561870|NCT01894919|156248852|FG012|Overall Study|Lost to Follow-up|0|||
48561871|NCT00882518|156248853|FG000|Overall Study|Adverse Event|9|||
48561872|NCT00882518|156248854|FG001|Overall Study|Adverse Event|18|||
48561873|NCT00882518|156248853|FG000|Overall Study|Withdrawal by Subject|9|||
48561874|NCT00882518|156248854|FG001|Overall Study|Withdrawal by Subject|13|||
48561875|NCT00882518|156248853|FG000|Overall Study|Lack of Efficacy|12|||
48561876|NCT00882518|156248854|FG001|Overall Study|Lack of Efficacy|9|||
48561877|NCT00882518|156248853|FG000|Overall Study|Severe non-compliance to protocol|3|||
48561878|NCT00882518|156248854|FG001|Overall Study|Severe non-compliance to protocol|1|||
48561879|NCT00882518|156248853|FG000|Overall Study|Incorrect enrolment|4|||
48561880|NCT00882518|156248854|FG001|Overall Study|Incorrect enrolment|2|||
48561881|NCT00882518|156248853|FG000|Overall Study|Central lab closure for National day|1|||
48561882|NCT00882518|156248854|FG001|Overall Study|Central lab closure for National day|0|||
48561883|NCT00882518|156248853|FG000|Overall Study|Allocating random number by mistake|0|||
48561884|NCT00882518|156248854|FG001|Overall Study|Allocating random number by mistake|1|||
48561885|NCT02414958|156248857|FG000|Overall Study|Adverse Event|6|||
48561886|NCT02414958|156248858|FG001|Overall Study|Adverse Event|6|||
48561887|NCT02414958|156248859|FG002|Overall Study|Adverse Event|3|||
48561888|NCT02414958|156248857|FG000|Overall Study|Protocol Violation|10|||
48735648|NCT02215096|156883707|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
48735649|NCT02215096|156883708|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
48735650|NCT02215096|156883709|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
48735651|NCT02215096|156883705|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
48561889|NCT02414958|156248858|FG001|Overall Study|Protocol Violation|3|||
48561890|NCT02414958|156248859|FG002|Overall Study|Protocol Violation|1|||
48561891|NCT02414958|156248857|FG000|Overall Study|Lost to Follow-up|7|||
48561892|NCT02414958|156248858|FG001|Overall Study|Lost to Follow-up|4|||
48561893|NCT02414958|156248859|FG002|Overall Study|Lost to Follow-up|0|||
48561894|NCT02414958|156248857|FG000|Overall Study|Withdrawal by Subject|5|||
48561895|NCT02414958|156248858|FG001|Overall Study|Withdrawal by Subject|3|||
48561896|NCT02414958|156248859|FG002|Overall Study|Withdrawal by Subject|5|||
48561897|NCT02414958|156248857|FG000|Overall Study|Other than specified|4|||
48561898|NCT02414958|156248858|FG001|Overall Study|Other than specified|4|||
48561899|NCT02414958|156248859|FG002|Overall Study|Other than specified|5|||
48561900|NCT00350207|156248860|FG000|Overall Study|Adverse Event|5|||
48561901|NCT00350207|156248861|FG001|Overall Study|Adverse Event|2|||
48561902|NCT00350207|156248862|FG002|Overall Study|Adverse Event|2|||
48561903|NCT00350207|156248860|FG000|Overall Study|Lack of Efficacy|1|||
48561904|NCT00350207|156248861|FG001|Overall Study|Lack of Efficacy|0|||
48561905|NCT00350207|156248862|FG002|Overall Study|Lack of Efficacy|2|||
48561906|NCT00350207|156248860|FG000|Overall Study|Lost to Follow-up|1|||
48561907|NCT00350207|156248861|FG001|Overall Study|Lost to Follow-up|0|||
48561908|NCT00350207|156248862|FG002|Overall Study|Lost to Follow-up|1|||
48561909|NCT00350207|156248860|FG000|Overall Study|Withdrawal by Subject|0|||
48561910|NCT00350207|156248861|FG001|Overall Study|Withdrawal by Subject|1|||
48561911|NCT00350207|156248862|FG002|Overall Study|Withdrawal by Subject|1|||
48561912|NCT00350207|156248860|FG000|Overall Study|Other|1|||
48561913|NCT00350207|156248861|FG001|Overall Study|Other|3|||
48561914|NCT00350207|156248862|FG002|Overall Study|Other|1|||
48561915|NCT01433471|156248863|FG000|Overall Study|Withdrawal by Subject|0|||
48561916|NCT01433471|156248864|FG001|Overall Study|Withdrawal by Subject|1|||
48561917|NCT03711188|156248865|FG000|Overall Study|Disease progression|11|||
48561918|NCT03711188|156248865|FG000|Overall Study|Adverse Event|1|||
48561919|NCT00568451|156248866|FG000|Overall Study|Disease Progression|0|||
48561920|NCT00568451|156248867|FG001|Overall Study|Disease Progression|0|||
48561921|NCT00568451|156248868|FG002|Overall Study|Disease Progression|2|||
48561922|NCT00568451|156248869|FG003|Overall Study|Disease Progression|7|||
48561923|NCT03238651|156248870|FG000|Overall Study|Other|0|||
48561924|NCT03238651|156248871|FG001|Overall Study|Other|0|||
48561925|NCT03238651|156248872|FG002|Overall Study|Other|0|||
48561926|NCT03238651|156248873|FG003|Overall Study|Other|0|||
48561927|NCT03238651|156248874|FG004|Overall Study|Other|1|||
48561928|NCT03238651|156248870|FG000|Overall Study|Progressive Disease|2|||
48561929|NCT03238651|156248871|FG001|Overall Study|Progressive Disease|2|||
48561930|NCT03238651|156248872|FG002|Overall Study|Progressive Disease|2|||
48561931|NCT03238651|156248873|FG003|Overall Study|Progressive Disease|2|||
48561932|NCT03238651|156248874|FG004|Overall Study|Progressive Disease|0|||
48561933|NCT03238651|156248870|FG000|Overall Study|Withdrawal by Subject|0|||
48561934|NCT03238651|156248871|FG001|Overall Study|Withdrawal by Subject|1|||
48561935|NCT03238651|156248872|FG002|Overall Study|Withdrawal by Subject|0|||
48561936|NCT03238651|156248873|FG003|Overall Study|Withdrawal by Subject|1|||
48561937|NCT03238651|156248874|FG004|Overall Study|Withdrawal by Subject|0|||
48561938|NCT03238651|156248870|FG000|Overall Study|Adverse Event|1|||
48561939|NCT03238651|156248871|FG001|Overall Study|Adverse Event|3|||
48561940|NCT03238651|156248872|FG002|Overall Study|Adverse Event|2|||
48561941|NCT03238651|156248873|FG003|Overall Study|Adverse Event|0|||
48561942|NCT03238651|156248874|FG004|Overall Study|Adverse Event|0|||
48561943|NCT00495391|156248875|FG000|Overall Study|Lack of Efficacy|34|||
48561944|NCT00495391|156248876|FG001|Overall Study|Lack of Efficacy|18|||
48561945|NCT00495391|156248875|FG000|Overall Study|Withdrawal by Subject|2|||
48561946|NCT00495391|156248876|FG001|Overall Study|Withdrawal by Subject|3|||
48561947|NCT02314026|156248879|FG000|Overall Study|Protocol Violation|28|||
48561948|NCT01808066|156248883|FG000|Overall Study|Withdrawal by Subject|15|||
48561949|NCT01127256|156248888|FG000|Overall Study|Adverse Event|13|||
48561950|NCT01127256|156248889|FG001|Overall Study|Adverse Event|13|||
48561951|NCT01127256|156248888|FG000|Overall Study|Lack of Efficacy|4|||
48561952|NCT01127256|156248889|FG001|Overall Study|Lack of Efficacy|0|||
48561953|NCT01127256|156248888|FG000|Overall Study|Lost to Follow-up|16|||
48561954|NCT01127256|156248889|FG001|Overall Study|Lost to Follow-up|17|||
48561955|NCT01127256|156248888|FG000|Overall Study|Withdrawal by Subject|5|||
48561956|NCT01127256|156248889|FG001|Overall Study|Withdrawal by Subject|9|||
48561957|NCT01127256|156248888|FG000|Overall Study|Protocol Violation|1|||
48561958|NCT01127256|156248889|FG001|Overall Study|Protocol Violation|0|||
48561959|NCT01532934|156248890|FG000|Overall Study|Lost to Follow-up|11|||
48561960|NCT01532934|156248891|FG001|Overall Study|Lost to Follow-up|11|||
48561961|NCT01532934|156248890|FG000|Overall Study|In controlled environment|3|||
48561962|NCT01532934|156248891|FG001|Overall Study|In controlled environment|2|||
48561963|NCT00729937|156248892|FG000|Overall Study|Lost to Follow-up|49|||
48561964|NCT00729937|156248893|FG001|Overall Study|Lost to Follow-up|58|||
48561965|NCT00729937|156248894|FG002|Overall Study|Lost to Follow-up|18|||
48561966|NCT00729937|156248895|FG003|Overall Study|Lost to Follow-up|33|||
48561967|NCT00729937|156248896|FG004|Overall Study|Lost to Follow-up|18|||
48561968|NCT00729937|156248897|FG005|Overall Study|Lost to Follow-up|23|||
48561969|NCT00729937|156248892|FG000|Overall Study|Physician Decision|7|||
48561970|NCT00729937|156248893|FG001|Overall Study|Physician Decision|16|||
48561971|NCT00729937|156248894|FG002|Overall Study|Physician Decision|2|||
48561972|NCT00729937|156248895|FG003|Overall Study|Physician Decision|0|||
48561973|NCT00729937|156248896|FG004|Overall Study|Physician Decision|5|||
48561974|NCT00729937|156248897|FG005|Overall Study|Physician Decision|8|||
48561975|NCT00729937|156248892|FG000|Overall Study|Death|1|||
48561976|NCT00729937|156248893|FG001|Overall Study|Death|0|||
48561977|NCT00729937|156248894|FG002|Overall Study|Death|1|||
48561978|NCT00729937|156248895|FG003|Overall Study|Death|0|||
48561979|NCT00729937|156248896|FG004|Overall Study|Death|0|||
48561980|NCT00729937|156248897|FG005|Overall Study|Death|1|||
48561981|NCT00729937|156248892|FG000|Overall Study|Withdrawal by Subject|3|||
48561982|NCT00729937|156248893|FG001|Overall Study|Withdrawal by Subject|5|||
48561983|NCT00729937|156248894|FG002|Overall Study|Withdrawal by Subject|6|||
48561984|NCT00729937|156248895|FG003|Overall Study|Withdrawal by Subject|0|||
48561985|NCT00729937|156248896|FG004|Overall Study|Withdrawal by Subject|4|||
48561986|NCT00729937|156248897|FG005|Overall Study|Withdrawal by Subject|2|||
48561987|NCT00729937|156248892|FG000|Overall Study|Randomized but not treated|12|||
48561988|NCT00729937|156248893|FG001|Overall Study|Randomized but not treated|6|||
48561989|NCT00729937|156248894|FG002|Overall Study|Randomized but not treated|1|||
48561990|NCT00729937|156248895|FG003|Overall Study|Randomized but not treated|0|||
48561991|NCT00729937|156248896|FG004|Overall Study|Randomized but not treated|1|||
48561992|NCT00729937|156248897|FG005|Overall Study|Randomized but not treated|3|||
48561993|NCT00729937|156248892|FG000|Overall Study|Did not meet eligibility criteria|2|||
48561994|NCT00729937|156248893|FG001|Overall Study|Did not meet eligibility criteria|1|||
48561995|NCT00729937|156248894|FG002|Overall Study|Did not meet eligibility criteria|0|||
48561996|NCT00729937|156248895|FG003|Overall Study|Did not meet eligibility criteria|0|||
48561997|NCT00729937|156248896|FG004|Overall Study|Did not meet eligibility criteria|0|||
48561998|NCT00729937|156248897|FG005|Overall Study|Did not meet eligibility criteria|0|||
48561999|NCT00729937|156248892|FG000|Overall Study|Incarcerated|0|||
48562000|NCT00729937|156248893|FG001|Overall Study|Incarcerated|2|||
48562001|NCT00729937|156248894|FG002|Overall Study|Incarcerated|1|||
48562002|NCT00729937|156248895|FG003|Overall Study|Incarcerated|1|||
48562003|NCT00729937|156248896|FG004|Overall Study|Incarcerated|0|||
48562004|NCT00729937|156248897|FG005|Overall Study|Incarcerated|0|||
48562005|NCT04871776|156248900|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
48693074|NCT01350999|156724666|FG002|Overall Study|Adverse Event|10|||
48562006|NCT04871776|156248901|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
48562007|NCT04871776|156248902|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
48562008|NCT04871776|156248900|FG000|Overall Study|Did not meet eligibility criteria|1|||
48562009|NCT04871776|156248901|FG001|Overall Study|Did not meet eligibility criteria|1|||
48562010|NCT04871776|156248902|FG002|Overall Study|Did not meet eligibility criteria|1|||
48562011|NCT00273182|156248903|FG000|Overall Study|Death|450|||
48562012|NCT00273182|156248903|FG000|Overall Study|Lost to Follow-up|88|||
48562013|NCT00273182|156248903|FG000|Overall Study|Withdrawal by Subject|257|||
48562014|NCT00273182|156248903|FG000|Overall Study|Device/System Explant|154|||
48562015|NCT00273182|156248903|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
48562016|NCT00420420|156248904|FG000|Overall Study|Adverse Event|5|||
48562017|NCT00420420|156248905|FG001|Overall Study|Adverse Event|3|||
48562018|NCT00420420|156248904|FG000|Overall Study|Protocol Violation|1|||
48562019|NCT00420420|156248905|FG001|Overall Study|Protocol Violation|1|||
48562020|NCT00420420|156248904|FG000|Overall Study|Withdrawal by Subject|1|||
48562021|NCT00420420|156248905|FG001|Overall Study|Withdrawal by Subject|0|||
48562022|NCT00420420|156248904|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
48562023|NCT00420420|156248905|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
48562024|NCT01131455|156248911|FG000|Overall Study|Death of PI|6|||
48562025|NCT01131455|156248912|FG001|Overall Study|Death of PI|4|||
48617068|NCT02265744|156453035|FG000|Overall Study|Subject no longer meets study criteria|0|||
48617069|NCT02265744|156453036|FG001|Overall Study|Subject no longer meets study criteria|0|||
48617070|NCT02265744|156453037|FG002|Overall Study|Subject no longer meets study criteria|0|||
48617071|NCT02265744|156453038|FG003|Overall Study|Subject no longer meets study criteria|0|||
48562026|NCT01131455|156248913|FG002|Overall Study|Death of PI|0|||
48562027|NCT02259010|156248916|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
48562028|NCT02462603|156248919|FG000|Overall Study|Investigator Decision|1|||
48562029|NCT02462603|156248919|FG000|Overall Study|Non-Compliance|1|||
48562030|NCT02462603|156248919|FG000|Overall Study|Withdrawal by Subject|2|||
48562031|NCT00634036|156248920|FG000|Overall Study|Lost to Follow-up|1|||
48562032|NCT00634036|156248921|FG001|Overall Study|Lost to Follow-up|1|||
48562033|NCT00634036|156248920|FG000|Overall Study|Withdrawal by Subject|1|||
48562034|NCT00634036|156248921|FG001|Overall Study|Withdrawal by Subject|1|||
48562035|NCT03194542|156248922|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
48562036|NCT03194542|156248923|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
48562037|NCT03194542|156248924|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
48562038|NCT03194542|156248925|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
48562039|NCT03194542|156248922|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
48562040|NCT03194542|156248923|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
48562041|NCT03194542|156248924|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
48562042|NCT03194542|156248925|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
48562043|NCT03194542|156248922|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
48562044|NCT03194542|156248923|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
48562045|NCT03194542|156248924|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
48562046|NCT03194542|156248925|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
48562047|NCT03194542|156248922|FG000|Overall Study|Loss of Response|4|||
48562048|NCT03194542|156248923|FG001|Overall Study|Loss of Response|2|||
48562049|NCT03194542|156248924|FG002|Overall Study|Loss of Response|3|||
48562050|NCT03194542|156248925|FG003|Overall Study|Loss of Response|4|||
48562051|NCT03194542|156248922|FG000|Overall Study|Physician Decision|0|||
48562052|NCT03194542|156248923|FG001|Overall Study|Physician Decision|1|||
48562053|NCT03194542|156248924|FG002|Overall Study|Physician Decision|0|||
48562054|NCT03194542|156248925|FG003|Overall Study|Physician Decision|0|||
48562055|NCT03194542|156248922|FG000|Overall Study|Lack of Efficacy|2|||
48562056|NCT03194542|156248923|FG001|Overall Study|Lack of Efficacy|2|||
48562057|NCT03194542|156248924|FG002|Overall Study|Lack of Efficacy|2|||
48562058|NCT03194542|156248925|FG003|Overall Study|Lack of Efficacy|6|||
48562059|NCT03194542|156248922|FG000|Overall Study|Withdrawal by Subject|2|||
48562060|NCT03194542|156248923|FG001|Overall Study|Withdrawal by Subject|1|||
48562061|NCT03194542|156248924|FG002|Overall Study|Withdrawal by Subject|5|||
48562062|NCT03194542|156248925|FG003|Overall Study|Withdrawal by Subject|4|||
48562063|NCT03194542|156248922|FG000|Overall Study|Progressive Disease|1|||
48562064|NCT03194542|156248923|FG001|Overall Study|Progressive Disease|0|||
48617072|NCT02265744|156453039|FG004|Overall Study|Subject no longer meets study criteria|1|||
48735652|NCT02215096|156883706|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
48735653|NCT02215096|156883707|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
48735654|NCT02215096|156883708|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
48562065|NCT03194542|156248924|FG002|Overall Study|Progressive Disease|1|||
48562066|NCT03194542|156248925|FG003|Overall Study|Progressive Disease|1|||
48562067|NCT03194542|156248922|FG000|Overall Study|Adverse Event|1|||
48562068|NCT03194542|156248923|FG001|Overall Study|Adverse Event|2|||
48562069|NCT03194542|156248924|FG002|Overall Study|Adverse Event|0|||
48562070|NCT03194542|156248925|FG003|Overall Study|Adverse Event|5|||
48562071|NCT03194542|156248922|FG000|Overall Study|Death|1|||
48562072|NCT03194542|156248923|FG001|Overall Study|Death|2|||
48562073|NCT03194542|156248924|FG002|Overall Study|Death|0|||
48562074|NCT03194542|156248925|FG003|Overall Study|Death|5|||
48562075|NCT03194542|156248922|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
48562076|NCT03194542|156248923|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
48562077|NCT03194542|156248924|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
48562078|NCT03194542|156248925|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
48562079|NCT03307252|156248926|FG000|Part 2, Period 1|Treatment not received|0|||
48562080|NCT03307252|156248927|FG001|Part 2, Period 1|Treatment not received|0|||
48562081|NCT03307252|156248928|FG002|Part 2, Period 1|Treatment not received|0|||
48562082|NCT03307252|156248929|FG003|Part 2, Period 1|Treatment not received|0|||
48562083|NCT03307252|156248930|FG004|Part 2, Period 1|Treatment not received|0|||
48562084|NCT03307252|156248931|FG005|Part 2, Period 1|Treatment not received|1|||
48562085|NCT03307252|156248932|FG006|Part 2, Period 1|Treatment not received|0|||
48562086|NCT03307252|156248933|FG007|Part 2, Period 1|Treatment not received|0|||
48562087|NCT03307252|156248934|FG008|Part 2, Period 1|Treatment not received|0|||
48562088|NCT03307252|156248935|FG009|Part 2, Period 1|Treatment not received|0|||
48562089|NCT03307252|156248936|FG010|Part 2, Period 1|Treatment not received|0|||
48562090|NCT03307252|156248926|FG000|Part 2, Period 3|Other than listed|0|||
48562091|NCT03307252|156248927|FG001|Part 2, Period 3|Other than listed|0|||
48562092|NCT03307252|156248928|FG002|Part 2, Period 3|Other than listed|0|||
48562093|NCT03307252|156248929|FG003|Part 2, Period 3|Other than listed|0|||
48562094|NCT03307252|156248930|FG004|Part 2, Period 3|Other than listed|1|||
48562095|NCT03307252|156248931|FG005|Part 2, Period 3|Other than listed|0|||
48562096|NCT03307252|156248932|FG006|Part 2, Period 3|Other than listed|0|||
48562097|NCT03307252|156248933|FG007|Part 2, Period 3|Other than listed|0|||
48562098|NCT03307252|156248934|FG008|Part 2, Period 3|Other than listed|0|||
48562099|NCT03307252|156248935|FG009|Part 2, Period 3|Other than listed|0|||
48562100|NCT03307252|156248936|FG010|Part 2, Period 3|Other than listed|0|||
48562101|NCT03307252|156248926|FG000|Part 2, Period 4|Other than listed|0|||
48562102|NCT03307252|156248927|FG001|Part 2, Period 4|Other than listed|0|||
48562103|NCT03307252|156248928|FG002|Part 2, Period 4|Other than listed|0|||
48562104|NCT03307252|156248929|FG003|Part 2, Period 4|Other than listed|0|||
48562105|NCT03307252|156248930|FG004|Part 2, Period 4|Other than listed|0|||
48562106|NCT03307252|156248931|FG005|Part 2, Period 4|Other than listed|0|||
48562107|NCT03307252|156248932|FG006|Part 2, Period 4|Other than listed|1|||
48562108|NCT03307252|156248933|FG007|Part 2, Period 4|Other than listed|0|||
48562109|NCT03307252|156248934|FG008|Part 2, Period 4|Other than listed|0|||
48562110|NCT03307252|156248935|FG009|Part 2, Period 4|Other than listed|0|||
48562111|NCT03307252|156248936|FG010|Part 2, Period 4|Other than listed|0|||
48562112|NCT03307252|156248926|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562113|NCT03307252|156248927|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562114|NCT03307252|156248928|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562115|NCT03307252|156248929|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562116|NCT03307252|156248930|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562117|NCT03307252|156248931|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562118|NCT03307252|156248932|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562119|NCT03307252|156248933|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48617073|NCT02265744|156453035|FG000|Overall Study|Pregnancy|1|||
48617074|NCT02265744|156453036|FG001|Overall Study|Pregnancy|2|||
48617075|NCT02265744|156453037|FG002|Overall Study|Pregnancy|1|||
48617076|NCT02265744|156453038|FG003|Overall Study|Pregnancy|1|||
48617077|NCT02265744|156453039|FG004|Overall Study|Pregnancy|0|||
48617078|NCT03097315|156453046|FG000|Overall Study|Withdrawal by Subject|1|||
48617079|NCT05161936|156453047|FG000|Overall Study|Study terminated by Sponsor|1|||
48617080|NCT05161936|156453048|FG001|Overall Study|Study terminated by Sponsor|0|||
48617081|NCT05161936|156453049|FG002|Overall Study|Study terminated by Sponsor|0|||
48562120|NCT03307252|156248934|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562121|NCT03307252|156248935|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
48562122|NCT03307252|156248936|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
48562123|NCT03517540|156248937|FG000|Overall Study|Protocol Violation|2|||
48562124|NCT03517540|156248938|FG001|Overall Study|Protocol Violation|0|||
48562125|NCT03517540|156248939|FG002|Overall Study|Protocol Violation|0|||
48562126|NCT03517540|156248940|FG003|Overall Study|Protocol Violation|1|||
48562127|NCT03517540|156248937|FG000|Overall Study|Adverse Event|9|||
48562128|NCT03517540|156248938|FG001|Overall Study|Adverse Event|3|||
48562129|NCT03517540|156248939|FG002|Overall Study|Adverse Event|8|||
48562130|NCT03517540|156248940|FG003|Overall Study|Adverse Event|1|||
48562131|NCT03517540|156248937|FG000|Overall Study|Withdrawal by Subject|3|||
48562132|NCT03517540|156248938|FG001|Overall Study|Withdrawal by Subject|4|||
48562133|NCT03517540|156248939|FG002|Overall Study|Withdrawal by Subject|1|||
48562134|NCT03517540|156248940|FG003|Overall Study|Withdrawal by Subject|3|||
48562135|NCT04762160|156248943|FG000|Overall Study|Study terminated early due to business reasons|5|||
48562136|NCT03859427|156248945|FG000|Overall Study|Withdrawal by Subject|4|||
48562137|NCT03859427|156248946|FG001|Overall Study|Withdrawal by Subject|7|||
48562138|NCT03859427|156248945|FG000|Overall Study|Decision by sponsor|0|||
48562139|NCT03859427|156248946|FG001|Overall Study|Decision by sponsor|3|||
48562140|NCT03859427|156248945|FG000|Overall Study|Lost to Follow-up|3|||
48562141|NCT03859427|156248946|FG001|Overall Study|Lost to Follow-up|2|||
48562142|NCT03859427|156248945|FG000|Overall Study|Death|22|||
48562143|NCT03859427|156248946|FG001|Overall Study|Death|25|||
48562144|NCT00529373|156248947|FG000|Base Study|Adverse Event|525|||
48562145|NCT00529373|156248948|FG001|Base Study|Adverse Event|470|||
48562146|NCT00529373|156248947|FG000|Base Study|Lack of Efficacy|16|||
48562147|NCT00529373|156248948|FG001|Base Study|Lack of Efficacy|75|||
48562148|NCT00529373|156248947|FG000|Base Study|Lost to Follow-up|221|||
48562149|NCT00529373|156248948|FG001|Base Study|Lost to Follow-up|208|||
48562150|NCT00529373|156248947|FG000|Base Study|Other Protocol Specified Criteria|19|||
48562151|NCT00529373|156248948|FG001|Base Study|Other Protocol Specified Criteria|20|||
48562152|NCT00529373|156248947|FG000|Base Study|Physician Decision|60|||
48562153|NCT00529373|156248948|FG001|Base Study|Physician Decision|52|||
48562154|NCT00529373|156248947|FG000|Base Study|Protocol Violation|48|||
48562155|NCT00529373|156248948|FG001|Base Study|Protocol Violation|38|||
48562156|NCT00529373|156248947|FG000|Base Study|Withdrawal by Subject|1062|||
48562157|NCT00529373|156248948|FG001|Base Study|Withdrawal by Subject|967|||
48562158|NCT00529373|156248947|FG000|Base Study|Did not continue into Extension|1795|||
48562159|NCT00529373|156248948|FG001|Base Study|Did not continue into Extension|2238|||
48562160|NCT00529373|156248947|FG000|First Extension Study|Adverse Event|162|||
48562161|NCT00529373|156248948|FG001|First Extension Study|Adverse Event|142|||
48562162|NCT00529373|156248947|FG000|First Extension Study|Lack of Efficacy|65|||
48562163|NCT00529373|156248948|FG001|First Extension Study|Lack of Efficacy|427|||
48562164|NCT00529373|156248947|FG000|First Extension Study|Lost to Follow-up|41|||
48562165|NCT00529373|156248948|FG001|First Extension Study|Lost to Follow-up|37|||
48562166|NCT00529373|156248947|FG000|First Extension Study|Other|27|||
48562167|NCT00529373|156248948|FG001|First Extension Study|Other|47|||
48562168|NCT00529373|156248947|FG000|First Extension Study|Physician Decision|50|||
48562169|NCT00529373|156248948|FG001|First Extension Study|Physician Decision|45|||
48617082|NCT05161936|156453047|FG000|Overall Study|Withdrawal by Subject|0|||
48562170|NCT00529373|156248947|FG000|First Extension Study|Protocol Violation|16|||
48617083|NCT05161936|156453048|FG001|Overall Study|Withdrawal by Subject|0|||
48562171|NCT00529373|156248948|FG001|First Extension Study|Protocol Violation|13|||
48562172|NCT00529373|156248947|FG000|First Extension Study|Withdrawal by Subject|296|||
48562173|NCT00529373|156248948|FG001|First Extension Study|Withdrawal by Subject|287|||
48562174|NCT00529373|156248947|FG000|First Extension Study|Disposition record non-existing|0|||
48562175|NCT00529373|156248948|FG001|First Extension Study|Disposition record non-existing|1|||
48562176|NCT00529373|156248947|FG000|First Extension Study|Discontinued after 5 years completion|208|||
48562177|NCT00529373|156248948|FG001|First Extension Study|Discontinued after 5 years completion|346|||
48562178|NCT00529373|156248947|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
48562179|NCT00529373|156248948|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
48562180|NCT00529373|156248947|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
48562181|NCT00529373|156248948|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
48562182|NCT00529373|156248947|FG000|Second Extension Study|Adverse Event|101|||
48562183|NCT00529373|156248948|FG001|Second Extension Study|Adverse Event|51|||
48562184|NCT00529373|156248947|FG000|Second Extension Study|Lack of Efficacy|7|||
48562185|NCT00529373|156248948|FG001|Second Extension Study|Lack of Efficacy|15|||
48562186|NCT00529373|156248947|FG000|Second Extension Study|Lost to Follow-up|18|||
48562187|NCT00529373|156248948|FG001|Second Extension Study|Lost to Follow-up|12|||
48562188|NCT00529373|156248947|FG000|Second Extension Study|Other|7|||
48562189|NCT00529373|156248948|FG001|Second Extension Study|Other|12|||
48562190|NCT00529373|156248947|FG000|Second Extension Study|Physician Decision|63|||
48562191|NCT00529373|156248948|FG001|Second Extension Study|Physician Decision|26|||
48562192|NCT00529373|156248947|FG000|Second Extension Study|Protocol Violation|2|||
48562193|NCT00529373|156248948|FG001|Second Extension Study|Protocol Violation|1|||
48562194|NCT00529373|156248947|FG000|Second Extension Study|Withdrawal by Subject|97|||
48562195|NCT00529373|156248948|FG001|Second Extension Study|Withdrawal by Subject|75|||
48562196|NCT00529373|156248947|FG000|Second Extension Study|Status Missing|5|||
48562197|NCT00529373|156248948|FG001|Second Extension Study|Status Missing|5|||
48562198|NCT01831635|156248949|FG000|Overall Study|Withdrawal by Subject|0|||
48562199|NCT01831635|156248950|FG001|Overall Study|Withdrawal by Subject|2|||
48562200|NCT01831635|156248951|FG002|Overall Study|Withdrawal by Subject|0|||
48562201|NCT03655405|156248961|FG000|Overall Study|Death after initial data collection|4|||
48562202|NCT03655405|156248962|FG001|Overall Study|Death after initial data collection|2|||
48562203|NCT03655405|156248961|FG000|Overall Study|Died before initial data collection|1|||
48562204|NCT03655405|156248962|FG001|Overall Study|Died before initial data collection|2|||
48562205|NCT03655405|156248961|FG000|Overall Study|Protocol Violation|0|||
48562206|NCT03655405|156248962|FG001|Overall Study|Protocol Violation|1|||
48562207|NCT00979654|156248963|FG000|Overall Study|Lost to Follow-up|1|||
48562208|NCT00979654|156248963|FG000|Overall Study|Withdrawal by Subject|22|||
48562209|NCT00979654|156248963|FG000|Overall Study|Death|1|||
48562210|NCT00979654|156248963|FG000|Overall Study|Lack of Efficacy|6|||
48562211|NCT00979654|156248963|FG000|Overall Study|Adverse Event|1|||
48562212|NCT00979654|156248963|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
48562213|NCT00979654|156248963|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
48562214|NCT00979654|156248963|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
48562215|NCT00979654|156248963|FG000|Overall Study|Serious Adverse Event|1|||
48562216|NCT00979654|156248963|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
48562217|NCT01408303|156248964|FG000|Overall Study|Adverse Event|3|||
48562218|NCT01408303|156248965|FG001|Overall Study|Adverse Event|7|||
48562219|NCT01408303|156248966|FG002|Overall Study|Adverse Event|2|||
48562220|NCT01408303|156248964|FG000|Overall Study|Lost to Follow-up|0|||
48562221|NCT01408303|156248965|FG001|Overall Study|Lost to Follow-up|1|||
48562222|NCT01408303|156248966|FG002|Overall Study|Lost to Follow-up|2|||
48562223|NCT01408303|156248964|FG000|Overall Study|Withdrawal by Subject|2|||
48562224|NCT01408303|156248965|FG001|Overall Study|Withdrawal by Subject|3|||
48562225|NCT01408303|156248966|FG002|Overall Study|Withdrawal by Subject|1|||
48562226|NCT01408303|156248964|FG000|Overall Study|Protocol Violation|0|||
48562227|NCT01408303|156248965|FG001|Overall Study|Protocol Violation|1|||
48562228|NCT01408303|156248966|FG002|Overall Study|Protocol Violation|0|||
48562229|NCT01408303|156248964|FG000|Overall Study|Noncompliance|1|||
48562230|NCT01408303|156248965|FG001|Overall Study|Noncompliance|0|||
48562231|NCT01408303|156248966|FG002|Overall Study|Noncompliance|1|||
48562232|NCT02810457|156250452|FG000|Overall Study|Randomised but no treatment received|2|||
48562233|NCT02810457|156250453|FG001|Overall Study|Randomised but no treatment received|1|||
48562234|NCT02810457|156250452|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
48562235|NCT02810457|156250453|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
48562236|NCT02810457|156250452|FG000|Overall Study|Adverse Event|37|||
48562237|NCT02810457|156250453|FG001|Overall Study|Adverse Event|43|||
48562238|NCT02810457|156250452|FG000|Overall Study|Patient decision|31|||
48562239|NCT02810457|156250453|FG001|Overall Study|Patient decision|35|||
48562240|NCT02810457|156250452|FG000|Overall Study|Patient lost to follow-up|2|||
48562241|NCT02810457|156250453|FG001|Overall Study|Patient lost to follow-up|2|||
48562242|NCT02810457|156250452|FG000|Overall Study|Death|39|||
48562243|NCT02810457|156250453|FG001|Overall Study|Death|28|||
48562244|NCT02810457|156250452|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
48562245|NCT02810457|156250453|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
48562246|NCT02810457|156250452|FG000|Overall Study|Clinical progression|15|||
48562247|NCT02810457|156250453|FG001|Overall Study|Clinical progression|16|||
48562248|NCT02810457|156250452|FG000|Overall Study|Investigator decision|3|||
48562249|NCT02810457|156250453|FG001|Overall Study|Investigator decision|2|||
48562250|NCT02810457|156250452|FG000|Overall Study|Patient ineligibility|3|||
48562251|NCT02810457|156250453|FG001|Overall Study|Patient ineligibility|0|||
48562252|NCT02810457|156250452|FG000|Overall Study|Miscalculated PD|1|||
48562253|NCT02810457|156250453|FG001|Overall Study|Miscalculated PD|0|||
48562254|NCT02810457|156250452|FG000|Overall Study|Physician Decision|0|||
48562255|NCT02810457|156250453|FG001|Overall Study|Physician Decision|1|||
48562256|NCT00443729|156250454|FG000|Overall Study|Never Treated|0|||
48562257|NCT00443729|156250455|FG001|Overall Study|Never Treated|1|||
48562258|NCT00443729|156250454|FG000|Overall Study|Lack of Efficacy|4|||
48562259|NCT00443729|156250455|FG001|Overall Study|Lack of Efficacy|2|||
48562260|NCT00443729|156250454|FG000|Overall Study|Lost to Follow-up|0|||
48562261|NCT00443729|156250455|FG001|Overall Study|Lost to Follow-up|1|||
48562262|NCT00443729|156250454|FG000|Overall Study|Physician Decision|2|||
48562263|NCT00443729|156250455|FG001|Overall Study|Physician Decision|1|||
48562264|NCT00443729|156250454|FG000|Overall Study|Protocol Violation|1|||
48562265|NCT00443729|156250455|FG001|Overall Study|Protocol Violation|1|||
48562266|NCT00443729|156250454|FG000|Overall Study|Withdrawal by Subject|3|||
48562267|NCT00443729|156250455|FG001|Overall Study|Withdrawal by Subject|1|||
48562268|NCT04173507|156250456|FG000|Overall Study|On Treatment|3|||
48562269|NCT04173507|156250456|FG000|Overall Study|Adverse Event|3|||
48562270|NCT04173507|156250456|FG000|Overall Study|Progression/Relapse|34|||
48562271|NCT04173507|156250456|FG000|Overall Study|Death|2|||
48562272|NCT01125189|156250457|FG000|Treatment Period|Lack of Efficacy|15|||
48562273|NCT01125189|156250458|FG001|Treatment Period|Lack of Efficacy|18|||
48562274|NCT01125189|156250459|FG002|Treatment Period|Lack of Efficacy|25|||
48562275|NCT01125189|156250457|FG000|Treatment Period|Adverse Event|7|||
48562276|NCT01125189|156250458|FG001|Treatment Period|Adverse Event|8|||
48562277|NCT01125189|156250459|FG002|Treatment Period|Adverse Event|8|||
48562278|NCT01125189|156250457|FG000|Treatment Period|Withdrawal by Subject|3|||
48562279|NCT01125189|156250458|FG001|Treatment Period|Withdrawal by Subject|1|||
48562280|NCT01125189|156250459|FG002|Treatment Period|Withdrawal by Subject|1|||
48562281|NCT01125189|156250457|FG000|Treatment Period|Death|1|||
48562282|NCT01125189|156250458|FG001|Treatment Period|Death|0|||
48562283|NCT01125189|156250459|FG002|Treatment Period|Death|0|||
48562284|NCT01125189|156250457|FG000|Treatment Period|Lost to Follow-up|1|||
48562285|NCT01125189|156250458|FG001|Treatment Period|Lost to Follow-up|2|||
48562286|NCT01125189|156250459|FG002|Treatment Period|Lost to Follow-up|1|||
48562287|NCT01125189|156250457|FG000|Treatment Period|Poor compliance/noncompliance|0|||
48562288|NCT01125189|156250458|FG001|Treatment Period|Poor compliance/noncompliance|1|||
48562289|NCT01125189|156250459|FG002|Treatment Period|Poor compliance/noncompliance|0|||
48562290|NCT01125189|156250457|FG000|Treatment Period|Participants requested to discontinue|1|||
48562291|NCT01125189|156250458|FG001|Treatment Period|Participants requested to discontinue|3|||
48562292|NCT01125189|156250459|FG002|Treatment Period|Participants requested to discontinue|4|||
48562293|NCT01125189|156250457|FG000|Treatment Period|Other reasons|1|||
48562294|NCT01125189|156250458|FG001|Treatment Period|Other reasons|1|||
48562295|NCT01125189|156250459|FG002|Treatment Period|Other reasons|0|||
48562296|NCT01125189|156250457|FG000|Treatment Period|Completed 24 week treatment period only|2|||
48562297|NCT01125189|156250458|FG001|Treatment Period|Completed 24 week treatment period only|1|||
48562298|NCT01125189|156250459|FG002|Treatment Period|Completed 24 week treatment period only|2|||
48562299|NCT01125189|156250457|FG000|Follow up Period|Withdrawal by Subject|3|||
48562300|NCT01125189|156250458|FG001|Follow up Period|Withdrawal by Subject|2|||
48562301|NCT01125189|156250459|FG002|Follow up Period|Withdrawal by Subject|5|||
48562302|NCT01125189|156250457|FG000|Follow up Period|Death|1|||
48562303|NCT01125189|156250458|FG001|Follow up Period|Death|0|||
48562304|NCT01125189|156250459|FG002|Follow up Period|Death|0|||
48562305|NCT01125189|156250457|FG000|Follow up Period|Lost to Follow-up|12|||
48562306|NCT01125189|156250458|FG001|Follow up Period|Lost to Follow-up|9|||
48562307|NCT01125189|156250459|FG002|Follow up Period|Lost to Follow-up|6|||
48562308|NCT01125189|156250457|FG000|Follow up Period|Other reasons|4|||
48562309|NCT01125189|156250458|FG001|Follow up Period|Other reasons|4|||
48562310|NCT01125189|156250459|FG002|Follow up Period|Other reasons|5|||
48562311|NCT01641640|156250461|FG000|Overall Study|Enrolled but not treated|1|||
48562312|NCT01641640|156250461|FG000|Overall Study|Efficacy failure|29|||
48562313|NCT01641640|156250461|FG000|Overall Study|Lost to Follow-up|3|||
48562314|NCT01641640|156250461|FG000|Overall Study|Withdrawal by Subject|2|||
48562315|NCT01641640|156250461|FG000|Overall Study|Adverse Event|1|||
48562316|NCT00289848|156250462|FG000|Overall Study|Adverse Event|6|||
48562317|NCT00289848|156250463|FG001|Overall Study|Adverse Event|4|||
48562318|NCT00289848|156250462|FG000|Overall Study|Death|1|||
48562319|NCT00289848|156250463|FG001|Overall Study|Death|0|||
48562320|NCT00289848|156250462|FG000|Overall Study|Lack of Efficacy|20|||
48562321|NCT00289848|156250463|FG001|Overall Study|Lack of Efficacy|24|||
48562322|NCT00289848|156250462|FG000|Overall Study|Lost to Follow-up|3|||
48562323|NCT00289848|156250463|FG001|Overall Study|Lost to Follow-up|1|||
48562324|NCT00289848|156250462|FG000|Overall Study|Protocol Violation|5|||
48562325|NCT00289848|156250463|FG001|Overall Study|Protocol Violation|2|||
48562326|NCT00289848|156250462|FG000|Overall Study|Withdrawal by Subject|5|||
48562327|NCT00289848|156250463|FG001|Overall Study|Withdrawal by Subject|11|||
48562328|NCT00289848|156250462|FG000|Overall Study|Patient Moved|6|||
48562329|NCT00289848|156250463|FG001|Overall Study|Patient Moved|2|||
48562330|NCT00289848|156250462|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
48562331|NCT00289848|156250463|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
48562332|NCT00162981|156250469|FG000|Overall Study|Adverse Event|2|||
48562333|NCT00162981|156250470|FG001|Overall Study|Adverse Event|5|||
48562334|NCT00162981|156250469|FG000|Overall Study|Withdrawal by Subject|1|||
48562335|NCT00162981|156250470|FG001|Overall Study|Withdrawal by Subject|1|||
48562336|NCT00162981|156250469|FG000|Overall Study|Physician Decision|1|||
48562337|NCT00162981|156250470|FG001|Overall Study|Physician Decision|0|||
48562338|NCT00991887|156250481|FG000|Overall Study|Lost to Follow-up|2|||
48562339|NCT00991887|156250482|FG001|Overall Study|Lost to Follow-up|1|||
48562340|NCT01753999|156250484|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
48562341|NCT01753999|156250485|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
48562342|NCT01753999|156250484|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
48617084|NCT05161936|156453049|FG002|Overall Study|Withdrawal by Subject|1|||
48617085|NCT01560988|156453052|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
48617086|NCT01560988|156453053|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
48562343|NCT01753999|156250485|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
48562344|NCT01753999|156250484|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
48562345|NCT01753999|156250485|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
48562346|NCT01753999|156250484|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
48562347|NCT01753999|156250485|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
48562348|NCT01753999|156250484|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
48562349|NCT01753999|156250485|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
48562350|NCT01753999|156250484|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
48562351|NCT01753999|156250485|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
48562352|NCT04030299|156250486|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
48562353|NCT04030299|156250486|FG000|Overall Study|Withdrawal by Subject|3|||
48562354|NCT00711087|156250487|FG000|Overall Study|Lost to Follow-up|1|||
48562355|NCT00711087|156250488|FG001|Overall Study|Lost to Follow-up|0|||
48562356|NCT02137252|156250491|FG000|Overall Study|trial terminated early|2|||
48562357|NCT02137252|156250492|FG001|Overall Study|trial terminated early|1|||
48562358|NCT00793871|156250494|FG000|Overall Study|Death|50|||
48562359|NCT00793871|156250494|FG000|Overall Study|Lost to Follow-up|3|||
48562360|NCT00793871|156250494|FG000|Overall Study|Study terminated by the Sponsor|7|||
48562361|NCT04509076|156250495|FG000|Overall Study|Withdrawal by Subject|1|||
48562362|NCT04509076|156250496|FG001|Overall Study|Withdrawal by Subject|2|||
48562363|NCT04509076|156250495|FG000|Overall Study|Lost to Follow-up|1|||
48562364|NCT04509076|156250496|FG001|Overall Study|Lost to Follow-up|2|||
48562365|NCT02500589|156250497|FG000|Overall Study|Withdrawal by Subject|11|||
48562366|NCT02500589|156250498|FG001|Overall Study|Withdrawal by Subject|14|||
48562367|NCT02500589|156250497|FG000|Overall Study|Lost to Follow-up|10|||
48562368|NCT02500589|156250498|FG001|Overall Study|Lost to Follow-up|12|||
48562369|NCT02500589|156250497|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
48562370|NCT02500589|156250498|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
48562371|NCT02500589|156250497|FG000|Overall Study|Death|7|||
48562372|NCT02500589|156250498|FG001|Overall Study|Death|5|||
48562373|NCT02712320|156250499|FG000|Overall Study|Lost to Follow-up|1|||
48562374|NCT02712320|156250499|FG000|Overall Study|Withdrawal by Subject|1|||
48562375|NCT02712320|156250499|FG000|Overall Study|Transferred to another facility|1|||
48562376|NCT02712320|156250499|FG000|Overall Study|Treating with the prohibited medications|2|||
48562377|NCT00245466|156250502|FG000|Overall Study|Adverse Event|2|||
48562378|NCT00245466|156250503|FG001|Overall Study|Adverse Event|8|||
48562379|NCT00245466|156250504|FG002|Overall Study|Adverse Event|4|||
48562380|NCT00245466|156250502|FG000|Overall Study|Low prostate specific antigen suppr|16|||
48562381|NCT00245466|156250503|FG001|Overall Study|Low prostate specific antigen suppr|14|||
48562382|NCT00245466|156250504|FG002|Overall Study|Low prostate specific antigen suppr|5|||
48562383|NCT00245466|156250502|FG000|Overall Study|Insufficient testosterone suppr|12|||
48562384|NCT00245466|156250503|FG001|Overall Study|Insufficient testosterone suppr|12|||
48562385|NCT00245466|156250504|FG002|Overall Study|Insufficient testosterone suppr|21|||
48562386|NCT00245466|156250502|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
48562387|NCT00245466|156250503|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
48562388|NCT00245466|156250504|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
48562389|NCT00245466|156250502|FG000|Overall Study|Withdrawal by Subject|2|||
48562390|NCT00245466|156250503|FG001|Overall Study|Withdrawal by Subject|2|||
48562391|NCT00245466|156250504|FG002|Overall Study|Withdrawal by Subject|1|||
48562392|NCT00245466|156250502|FG000|Overall Study|Lost to Follow-up|3|||
48562393|NCT00245466|156250503|FG001|Overall Study|Lost to Follow-up|0|||
48562394|NCT00245466|156250504|FG002|Overall Study|Lost to Follow-up|0|||
48562395|NCT00245466|156250502|FG000|Overall Study|Disease progression|0|||
48562396|NCT00245466|156250503|FG001|Overall Study|Disease progression|3|||
48562397|NCT00245466|156250504|FG002|Overall Study|Disease progression|1|||
48562398|NCT00245466|156250502|FG000|Overall Study|Protocol Violation|1|||
48562399|NCT00245466|156250503|FG001|Overall Study|Protocol Violation|2|||
48562400|NCT00245466|156250504|FG002|Overall Study|Protocol Violation|2|||
48562401|NCT00245466|156250502|FG000|Overall Study|Death|0|||
48562402|NCT00245466|156250503|FG001|Overall Study|Death|2|||
48562403|NCT00245466|156250504|FG002|Overall Study|Death|0|||
48562404|NCT00245466|156250502|FG000|Overall Study|Administrative reasons|0|||
48562405|NCT00245466|156250503|FG001|Overall Study|Administrative reasons|1|||
48562406|NCT00245466|156250504|FG002|Overall Study|Administrative reasons|0|||
48562407|NCT03802825|156250505|FG000|Overall Study|Lost to follow-up for intervention|12|||
48562408|NCT03802825|156250506|FG001|Overall Study|Lost to follow-up for intervention|3|||
48562409|NCT03802825|156250505|FG000|Overall Study|Received only 1 component of intervention|0|||
48562410|NCT03802825|156250506|FG001|Overall Study|Received only 1 component of intervention|13|||
48562411|NCT02288325|156250507|FG000|Run-in Period|Adverse Event|48|||
48562412|NCT02288325|156250508|FG001|Run-in Period|Adverse Event|0|||
48562413|NCT02288325|156250509|FG002|Run-in Period|Adverse Event|0|||
48562414|NCT02288325|156250507|FG000|Run-in Period|Lack of Efficacy|16|||
48562415|NCT02288325|156250508|FG001|Run-in Period|Lack of Efficacy|0|||
48562416|NCT02288325|156250509|FG002|Run-in Period|Lack of Efficacy|0|||
48562417|NCT02288325|156250507|FG000|Run-in Period|Withdrawal of Consent|28|||
48562418|NCT02288325|156250508|FG001|Run-in Period|Withdrawal of Consent|0|||
48562419|NCT02288325|156250509|FG002|Run-in Period|Withdrawal of Consent|0|||
48562420|NCT02288325|156250507|FG000|Run-in Period|Lost to Follow-up|25|||
48562421|NCT02288325|156250508|FG001|Run-in Period|Lost to Follow-up|0|||
48562422|NCT02288325|156250509|FG002|Run-in Period|Lost to Follow-up|0|||
48562423|NCT02288325|156250507|FG000|Run-in Period|Protocol Violation|17|||
48562424|NCT02288325|156250508|FG001|Run-in Period|Protocol Violation|0|||
48562425|NCT02288325|156250509|FG002|Run-in Period|Protocol Violation|0|||
48562426|NCT02288325|156250507|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
48562427|NCT02288325|156250508|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
48562428|NCT02288325|156250509|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
48562429|NCT02288325|156250507|FG000|Run-in Period|Reason not Specified|8|||
48562430|NCT02288325|156250508|FG001|Run-in Period|Reason not Specified|0|||
48562431|NCT02288325|156250509|FG002|Run-in Period|Reason not Specified|0|||
48562432|NCT02288325|156250507|FG000|Stabilization Period|Adverse Event|13|||
48562433|NCT02288325|156250508|FG001|Stabilization Period|Adverse Event|0|||
48562434|NCT02288325|156250509|FG002|Stabilization Period|Adverse Event|0|||
48562435|NCT02288325|156250507|FG000|Stabilization Period|Lack of Efficacy|22|||
48562436|NCT02288325|156250508|FG001|Stabilization Period|Lack of Efficacy|0|||
48562437|NCT02288325|156250509|FG002|Stabilization Period|Lack of Efficacy|0|||
48562438|NCT02288325|156250507|FG000|Stabilization Period|Withdrawal of Consent|23|||
48562439|NCT02288325|156250508|FG001|Stabilization Period|Withdrawal of Consent|0|||
48562440|NCT02288325|156250509|FG002|Stabilization Period|Withdrawal of Consent|0|||
48562441|NCT02288325|156250507|FG000|Stabilization Period|Lost to Follow-up|12|||
48562442|NCT02288325|156250508|FG001|Stabilization Period|Lost to Follow-up|0|||
48562443|NCT02288325|156250509|FG002|Stabilization Period|Lost to Follow-up|0|||
48562444|NCT02288325|156250507|FG000|Stabilization Period|Protocol Violation|8|||
48562445|NCT02288325|156250508|FG001|Stabilization Period|Protocol Violation|0|||
48562446|NCT02288325|156250509|FG002|Stabilization Period|Protocol Violation|0|||
48562447|NCT02288325|156250507|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
48562448|NCT02288325|156250508|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
48562449|NCT02288325|156250509|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
48562450|NCT02288325|156250507|FG000|Stabilization Period|Reason not Specified|15|||
48562451|NCT02288325|156250508|FG001|Stabilization Period|Reason not Specified|0|||
48562452|NCT02288325|156250509|FG002|Stabilization Period|Reason not Specified|0|||
48562453|NCT02288325|156250507|FG000|Double-blind Treatment Period|Adverse Event|0|||
48562454|NCT02288325|156250508|FG001|Double-blind Treatment Period|Adverse Event|2|||
48562455|NCT02288325|156250509|FG002|Double-blind Treatment Period|Adverse Event|5|||
48562456|NCT02288325|156250507|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
48562457|NCT02288325|156250508|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
48562458|NCT02288325|156250509|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
48562459|NCT02288325|156250507|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48562460|NCT02288325|156250508|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
48562461|NCT02288325|156250509|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
48562462|NCT02288325|156250507|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48562463|NCT02288325|156250508|FG001|Double-blind Treatment Period|Protocol Violation|1|||
48562464|NCT02288325|156250509|FG002|Double-blind Treatment Period|Protocol Violation|2|||
48562465|NCT02288325|156250507|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
48562466|NCT02288325|156250508|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
48562467|NCT02288325|156250509|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
48562468|NCT02288325|156250507|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
48562469|NCT02288325|156250508|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
48562470|NCT02288325|156250509|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
48562471|NCT03885661|156250510|FG000|Overall Study|Withdrawal by Subject|0|||
48562472|NCT03885661|156250511|FG001|Overall Study|Withdrawal by Subject|1|||
48562473|NCT03885661|156250510|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
48562474|NCT03885661|156250511|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
48562475|NCT03652051|156250514|FG000|Stage 1|Adverse Event|0|||
48562476|NCT03652051|156250515|FG001|Stage 1|Adverse Event|5|||
48562477|NCT03652051|156250516|FG002|Stage 1|Adverse Event|7|||
48562478|NCT03652051|156250517|FG003|Stage 1|Adverse Event|1|||
48562479|NCT03652051|156250514|FG000|Stage 1|Withdrawal by Subject|0|||
48562480|NCT03652051|156250515|FG001|Stage 1|Withdrawal by Subject|0|||
48562481|NCT03652051|156250516|FG002|Stage 1|Withdrawal by Subject|1|||
48562482|NCT03652051|156250517|FG003|Stage 1|Withdrawal by Subject|0|||
48562483|NCT03652051|156250514|FG000|Stage 2|Adverse Event|0|||
48562484|NCT03652051|156250515|FG001|Stage 2|Adverse Event|2|||
48562485|NCT03652051|156250516|FG002|Stage 2|Adverse Event|1|||
48562486|NCT03652051|156250517|FG003|Stage 2|Adverse Event|0|||
48562487|NCT03652051|156250514|FG000|Stage 2|Protocol Violation|0|||
48562488|NCT03652051|156250515|FG001|Stage 2|Protocol Violation|1|||
48562489|NCT03652051|156250516|FG002|Stage 2|Protocol Violation|6|||
48562490|NCT03652051|156250517|FG003|Stage 2|Protocol Violation|0|||
48562491|NCT03652051|156250514|FG000|Stage 2|Lost to Follow-up|0|||
48562492|NCT03652051|156250515|FG001|Stage 2|Lost to Follow-up|2|||
48562493|NCT03652051|156250516|FG002|Stage 2|Lost to Follow-up|0|||
48562494|NCT03652051|156250517|FG003|Stage 2|Lost to Follow-up|3|||
48562495|NCT03652051|156250514|FG000|Stage 2|Withdrawal by Subject|0|||
48562496|NCT03652051|156250515|FG001|Stage 2|Withdrawal by Subject|11|||
48562497|NCT03652051|156250516|FG002|Stage 2|Withdrawal by Subject|9|||
48562498|NCT03652051|156250517|FG003|Stage 2|Withdrawal by Subject|3|||
48562499|NCT05266053|156250518|FG000|Overall Study|Withdrawal by Subject|8|||
48562500|NCT05266053|156250519|FG001|Overall Study|Withdrawal by Subject|4|||
48562501|NCT02232984|156250523|FG000|Overall Study|Withdrawal by Subject|5|||
48562502|NCT02232984|156250523|FG000|Overall Study|Death|1|||
48562503|NCT02232984|156250523|FG000|Overall Study|Investigator withdrawal|10|||
48562504|NCT02232984|156250523|FG000|Overall Study|Device implant unsuccessful|53|||
48562505|NCT02232984|156250523|FG000|Overall Study|not disclosed by site|7|||
48562506|NCT02232984|156250523|FG000|Overall Study|Protocol Violation|1|||
48562507|NCT01113892|156250524|FG000|Overall Study|Lost to Follow-up|2|||
48562508|NCT01113892|156250525|FG001|Overall Study|Lost to Follow-up|2|||
48562509|NCT01113892|156250524|FG000|Overall Study|Withdrawal by Subject|1|||
48562510|NCT01113892|156250525|FG001|Overall Study|Withdrawal by Subject|1|||
48562511|NCT01113892|156250524|FG000|Overall Study|Death|2|||
48562512|NCT01113892|156250525|FG001|Overall Study|Death|4|||
48562513|NCT01113892|156250524|FG000|Overall Study|Graft no longer evaluable|9|||
48562514|NCT01113892|156250525|FG001|Overall Study|Graft no longer evaluable|9|||
48562515|NCT01343043|156250529|FG000|Overall Study|Disease progression before treatment|1|||
48562516|NCT01343043|156250530|FG001|Overall Study|Disease progression before treatment|0|||
48562517|NCT01343043|156250531|FG002|Overall Study|Disease progression before treatment|0|||
48562518|NCT01343043|156250532|FG003|Overall Study|Disease progression before treatment|0|||
48562519|NCT01343043|156250529|FG000|Overall Study|Withdrawal by Subject|1|||
48562520|NCT01343043|156250530|FG001|Overall Study|Withdrawal by Subject|0|||
48562521|NCT01343043|156250531|FG002|Overall Study|Withdrawal by Subject|0|||
48562522|NCT01343043|156250532|FG003|Overall Study|Withdrawal by Subject|0|||
48562523|NCT01343043|156250529|FG000|Overall Study|Death|1|||
48562524|NCT01343043|156250530|FG001|Overall Study|Death|1|||
48562525|NCT01343043|156250531|FG002|Overall Study|Death|0|||
48562526|NCT01343043|156250532|FG003|Overall Study|Death|1|||
48562527|NCT02394600|156250533|FG000|Overall Study|Adverse Event|3|||
48562528|NCT02394600|156250534|FG001|Overall Study|Adverse Event|0|||
48562529|NCT02394600|156250533|FG000|Overall Study|Lost to Follow-up|0|||
48562530|NCT02394600|156250534|FG001|Overall Study|Lost to Follow-up|1|||
48562531|NCT02394600|156250533|FG000|Overall Study|Withdrawal by Subject|0|||
48562532|NCT02394600|156250534|FG001|Overall Study|Withdrawal by Subject|1|||
48562533|NCT02394600|156250533|FG000|Overall Study|Protocol Violation|1|||
48562534|NCT02394600|156250534|FG001|Overall Study|Protocol Violation|0|||
48562535|NCT03534687|156250535|FG000|Overall Study|Lost to Follow-up|7|||
48562536|NCT03534687|156250536|FG001|Overall Study|Lost to Follow-up|2|||
48562537|NCT01791894|156250537|FG000|Overall Study|Adverse Event|1|||
48562538|NCT02949973|156250540|FG000|Overall Study|Physician Decision|1|||
48562539|NCT01125917|156250541|FG000|Overall Study|Adverse Event|43|||
48562540|NCT01125917|156250541|FG000|Overall Study|Lost to Follow-up|23|||
48562541|NCT01125917|156250541|FG000|Overall Study|Withdrawal by Subject|31|||
48562542|NCT01125917|156250541|FG000|Overall Study|Administrative|223|||
48562543|NCT01125917|156250541|FG000|Overall Study|Lack of Efficacy|19|||
48562544|NCT01786993|156250542|FG000|Overall Study|Death|6|||
48562545|NCT01786993|156250543|FG001|Overall Study|Death|7|||
48562546|NCT01786993|156250542|FG000|Overall Study|Withdrawal by Subject|3|||
48562547|NCT01786993|156250543|FG001|Overall Study|Withdrawal by Subject|2|||
48562548|NCT01786993|156250542|FG000|Overall Study|Lost to Follow-up|0|||
48562549|NCT01786993|156250543|FG001|Overall Study|Lost to Follow-up|1|||
48562550|NCT01786993|156250542|FG000|Overall Study|Subject Non-Compliance|1|||
48562551|NCT01786993|156250543|FG001|Overall Study|Subject Non-Compliance|0|||
48562552|NCT01786993|156250542|FG000|Overall Study|System Explant|1|||
48562553|NCT01786993|156250543|FG001|Overall Study|System Explant|0|||
48562554|NCT01786993|156250542|FG000|Overall Study|Hospice Admission|1|||
48562555|NCT01786993|156250543|FG001|Overall Study|Hospice Admission|0|||
48562556|NCT03896022|156250548|FG000|Overall Study|Withdrawal by Subject|1|||
48562557|NCT03896022|156250549|FG001|Overall Study|Withdrawal by Subject|0|||
48562558|NCT03896022|156250550|FG002|Overall Study|Withdrawal by Subject|0|||
48562559|NCT03896022|156250548|FG000|Overall Study|Did not have procedure|3|||
48562560|NCT03896022|156250549|FG001|Overall Study|Did not have procedure|0|||
48562561|NCT03896022|156250550|FG002|Overall Study|Did not have procedure|0|||
48562562|NCT00226499|156250558|FG000|Overall Study|Adverse Event|10|||
48562563|NCT00226499|156250559|FG001|Overall Study|Adverse Event|6|||
48562564|NCT00226499|156250560|FG002|Overall Study|Adverse Event|3|||
48562565|NCT00226499|156250558|FG000|Overall Study|Others|1064|||
48562566|NCT00226499|156250559|FG001|Overall Study|Others|1066|||
48562567|NCT00226499|156250560|FG002|Overall Study|Others|356|||
48562568|NCT02712554|156250561|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
48562569|NCT02712554|156250562|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
48562570|NCT02712554|156250561|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
48562571|NCT02712554|156250562|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
48562572|NCT02712554|156250561|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
48562573|NCT02712554|156250562|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
48562574|NCT02712554|156250561|FG000|Part B: Qualification Phase|Adverse Event|0|||
48562575|NCT02712554|156250562|FG001|Part B: Qualification Phase|Adverse Event|1|||
48562576|NCT02712554|156250561|FG000|Part B: Treatment Phase|Adverse Event|0|||
48562577|NCT02712554|156250562|FG001|Part B: Treatment Phase|Adverse Event|1|||
48562578|NCT02712554|156250561|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
48562579|NCT02712554|156250562|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
48562580|NCT02712554|156250561|FG000|Part B: Treatment Phase|Other|0|||
48562581|NCT02712554|156250562|FG001|Part B: Treatment Phase|Other|1|||
48562582|NCT01554527|156250564|FG000|Overall Study|Withdrawal by Subject|1|||
48562583|NCT01554527|156250565|FG001|Overall Study|Withdrawal by Subject|0|||
48562584|NCT01554527|156250566|FG002|Overall Study|Withdrawal by Subject|3|||
48562585|NCT01554527|156250564|FG000|Overall Study|Lost to Follow-up|0|||
48562586|NCT01554527|156250565|FG001|Overall Study|Lost to Follow-up|0|||
48562587|NCT01554527|156250566|FG002|Overall Study|Lost to Follow-up|4|||
48562588|NCT01554527|156250564|FG000|Overall Study|Physician Decision|0|||
48562589|NCT01554527|156250565|FG001|Overall Study|Physician Decision|0|||
48562590|NCT01554527|156250566|FG002|Overall Study|Physician Decision|1|||
48562591|NCT00856492|156250569|FG000|Overall Study|Ineligible or withdrew consent|1|||
48562592|NCT00856492|156250570|FG001|Overall Study|Ineligible or withdrew consent|1|||
48562593|NCT00856492|156250571|FG002|Overall Study|Ineligible or withdrew consent|2|||
48562594|NCT02503540|156250572|FG000|Overall Study|Death|2|||
48562595|NCT02503540|156250572|FG000|Overall Study|Withdrawal by Subject|1|||
48562596|NCT01074268|156250573|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
48562597|NCT01074268|156250574|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
48562598|NCT01074268|156250573|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
48562599|NCT01074268|156250574|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
48562600|NCT01074268|156250573|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
48562601|NCT01074268|156250574|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
48562602|NCT01074268|156250573|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
48562603|NCT01074268|156250574|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
48562604|NCT01074268|156250573|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
48562605|NCT01074268|156250574|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
48562606|NCT01074268|156250573|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
48562607|NCT01074268|156250574|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
48562608|NCT01074268|156250573|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
48562609|NCT01074268|156250574|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
48562610|NCT01074268|156250573|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
48562611|NCT01074268|156250574|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
48562612|NCT01074268|156250573|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
48562613|NCT01074268|156250574|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
48562614|NCT01863667|156250575|FG000|Overall Study|Adverse Event|1|||
48562615|NCT01863667|156250576|FG001|Overall Study|Adverse Event|0|||
48562616|NCT01863667|156250575|FG000|Overall Study|Study terminated by Sponsor|30|||
48562617|NCT01863667|156250576|FG001|Overall Study|Study terminated by Sponsor|30|||
48562618|NCT01863667|156250575|FG000|Overall Study|Withdrawal by Subject|2|||
48562619|NCT01863667|156250576|FG001|Overall Study|Withdrawal by Subject|2|||
48562620|NCT01662492|156250579|FG000|Overall Study|Other miscellaneous reasons.|1|||
48562621|NCT01662492|156250580|FG001|Overall Study|Other miscellaneous reasons.|0|||
48562622|NCT01662492|156250581|FG002|Overall Study|Other miscellaneous reasons.|1|||
48562623|NCT01662492|156250579|FG000|Overall Study|Withdrawal by Subject|0|||
48562624|NCT01662492|156250580|FG001|Overall Study|Withdrawal by Subject|0|||
48562625|NCT01662492|156250581|FG002|Overall Study|Withdrawal by Subject|1|||
48562626|NCT01662492|156250579|FG000|Overall Study|Protocol Violation|1|||
48562627|NCT01662492|156250580|FG001|Overall Study|Protocol Violation|0|||
48562628|NCT01662492|156250581|FG002|Overall Study|Protocol Violation|0|||
48562629|NCT01662492|156250579|FG000|Overall Study|Lost to Follow-up|0|||
48562630|NCT01662492|156250580|FG001|Overall Study|Lost to Follow-up|0|||
48562631|NCT01662492|156250581|FG002|Overall Study|Lost to Follow-up|2|||
48562632|NCT01662492|156250579|FG000|Overall Study|Lack of Efficacy|1|||
48562633|NCT01662492|156250580|FG001|Overall Study|Lack of Efficacy|1|||
48562634|NCT01662492|156250581|FG002|Overall Study|Lack of Efficacy|2|||
48562635|NCT01591096|156250584|FG000|Overall Study|Adverse Event|1|||
48562636|NCT00315458|156250587|FG000|Overall Study|Administrative|0|||
48562637|NCT00315458|156250588|FG001|Overall Study|Administrative|3|||
48562638|NCT00315458|156250589|FG002|Overall Study|Administrative|8|||
48562639|NCT00315458|156250590|FG003|Overall Study|Administrative|21|||
48562640|NCT00315458|156250587|FG000|Overall Study|Adverse Event|2|||
48562641|NCT00315458|156250588|FG001|Overall Study|Adverse Event|4|||
48562642|NCT00315458|156250589|FG002|Overall Study|Adverse Event|23|||
48562643|NCT00315458|156250590|FG003|Overall Study|Adverse Event|3|||
48562644|NCT00315458|156250587|FG000|Overall Study|Lost to Follow-up|1|||
48562645|NCT00315458|156250588|FG001|Overall Study|Lost to Follow-up|2|||
48562646|NCT00315458|156250589|FG002|Overall Study|Lost to Follow-up|0|||
48562647|NCT00315458|156250590|FG003|Overall Study|Lost to Follow-up|2|||
48562648|NCT00315458|156250587|FG000|Overall Study|Withdrawal by Subject|0|||
48562649|NCT00315458|156250588|FG001|Overall Study|Withdrawal by Subject|3|||
48562650|NCT00315458|156250589|FG002|Overall Study|Withdrawal by Subject|0|||
48562651|NCT00315458|156250590|FG003|Overall Study|Withdrawal by Subject|2|||
48562652|NCT00315458|156250587|FG000|Overall Study|Lack of Efficacy|0|||
48562653|NCT00315458|156250588|FG001|Overall Study|Lack of Efficacy|0|||
48562654|NCT00315458|156250589|FG002|Overall Study|Lack of Efficacy|20|||
48562655|NCT00315458|156250590|FG003|Overall Study|Lack of Efficacy|1|||
48562656|NCT00315458|156250587|FG000|Overall Study|Did not qualify|0|||
48562657|NCT00315458|156250588|FG001|Overall Study|Did not qualify|0|||
48562658|NCT00315458|156250589|FG002|Overall Study|Did not qualify|1|||
48562659|NCT00315458|156250590|FG003|Overall Study|Did not qualify|0|||
48562660|NCT01207687|156250593|FG000|Overall Study|Adverse Event|1|||
48562661|NCT01207687|156250593|FG000|Overall Study|Withdrawal by Subject|1|||
48562662|NCT02630251|156252448|FG000|Overall Study|Physician Decision|0|||
48562663|NCT02630251|156252449|FG001|Overall Study|Physician Decision|0|||
48562664|NCT02630251|156252450|FG002|Overall Study|Physician Decision|1|||
48562665|NCT02630251|156252451|FG003|Overall Study|Physician Decision|0|||
48562666|NCT02907177|156252452|FG000|Overall Study|Death|0|||
48562667|NCT02907177|156252453|FG001|Overall Study|Death|1|||
48562668|NCT02907177|156252452|FG000|Overall Study|Physician Decision|3|||
48562669|NCT02907177|156252453|FG001|Overall Study|Physician Decision|3|||
48562670|NCT02907177|156252452|FG000|Overall Study|Withdrawal by Subject|15|||
48562671|NCT02907177|156252453|FG001|Overall Study|Withdrawal by Subject|7|||
48562672|NCT02907177|156252452|FG000|Overall Study|Sponsor's Decision|50|||
48562673|NCT02907177|156252453|FG001|Overall Study|Sponsor's Decision|57|||
48562674|NCT01842438|156252454|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
48562675|NCT01842438|156252455|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
48562676|NCT01842438|156252454|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
48562677|NCT01842438|156252455|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
48562678|NCT01842438|156252454|FG000|T2: 6month Follow-up|Death|0|||
48562679|NCT01842438|156252455|FG001|T2: 6month Follow-up|Death|1|||
48562680|NCT01692626|156252459|FG000|Overall Study|Death|0|||
48562681|NCT01692626|156252460|FG001|Overall Study|Death|1|||
48562682|NCT01692626|156252459|FG000|Overall Study|Adverse Event|2|||
48562683|NCT01692626|156252460|FG001|Overall Study|Adverse Event|3|||
48562684|NCT01692626|156252459|FG000|Overall Study|Protocol Violation|1|||
48562685|NCT01692626|156252460|FG001|Overall Study|Protocol Violation|2|||
48562686|NCT01692626|156252459|FG000|Overall Study|Withdrawal by Subject|1|||
48562687|NCT01692626|156252460|FG001|Overall Study|Withdrawal by Subject|0|||
48562688|NCT00782626|156252461|FG000|Overall Study|Adverse Event|1|||
48562689|NCT00782626|156252461|FG000|Overall Study|Progressive Disease|5|||
48562690|NCT00782626|156252461|FG000|Overall Study|Other Complicating Disease|1|||
48562691|NCT03989102|156252462|FG000|Year 1|Withdrawal by Subject|6|||
48562692|NCT03989102|156252463|FG001|Year 1|Withdrawal by Subject|2|||
48562693|NCT03989102|156252464|FG002|Year 1|Withdrawal by Subject|7|||
48562694|NCT03989102|156252462|FG000|Year 1|Lost to Follow-up|5|||
48562695|NCT03989102|156252463|FG001|Year 1|Lost to Follow-up|2|||
48562696|NCT03989102|156252464|FG002|Year 1|Lost to Follow-up|5|||
48562697|NCT03989102|156252462|FG000|Year 1|Subject met withdrawal criteria|1|||
48562698|NCT03989102|156252463|FG001|Year 1|Subject met withdrawal criteria|0|||
48562699|NCT03989102|156252464|FG002|Year 1|Subject met withdrawal criteria|1|||
48562700|NCT03989102|156252462|FG000|Year 2|Lost to Follow-up|7|||
48562701|NCT03989102|156252463|FG001|Year 2|Lost to Follow-up|3|||
48562702|NCT03989102|156252464|FG002|Year 2|Lost to Follow-up|4|||
48562703|NCT03989102|156252462|FG000|Year 2|Withdrawal by Subject|3|||
48562704|NCT03989102|156252463|FG001|Year 2|Withdrawal by Subject|1|||
48562705|NCT03989102|156252464|FG002|Year 2|Withdrawal by Subject|2|||
48562706|NCT03989102|156252462|FG000|Year 2|Subject non-compliant|3|||
48562707|NCT03989102|156252463|FG001|Year 2|Subject non-compliant|2|||
48562708|NCT03989102|156252464|FG002|Year 2|Subject non-compliant|0|||
48562709|NCT03989102|156252462|FG000|Year 2|Travel|1|||
48562710|NCT03989102|156252463|FG001|Year 2|Travel|0|||
48562711|NCT03989102|156252464|FG002|Year 2|Travel|1|||
48562712|NCT03989102|156252462|FG000|Year 2|P16 missing|4|||
48562713|NCT03989102|156252463|FG001|Year 2|P16 missing|2|||
48562714|NCT03989102|156252464|FG002|Year 2|P16 missing|1|||
48562715|NCT03989102|156252462|FG000|Year 2|P11 missing|1|||
48562716|NCT03989102|156252463|FG001|Year 2|P11 missing|3|||
48562717|NCT03989102|156252464|FG002|Year 2|P11 missing|7|||
48562718|NCT03989102|156252462|FG000|Year 2|Definitive displacement outside the study site|0|||
48562719|NCT03989102|156252463|FG001|Year 2|Definitive displacement outside the study site|1|||
48562720|NCT03989102|156252464|FG002|Year 2|Definitive displacement outside the study site|0|||
48562721|NCT03989102|156252462|FG000|Year 2|Subject missed last study visit|0|||
48562722|NCT03989102|156252463|FG001|Year 2|Subject missed last study visit|1|||
48562723|NCT03989102|156252464|FG002|Year 2|Subject missed last study visit|0|||
48562724|NCT03989102|156252462|FG000|Year 2|Death|0|||
48562725|NCT03989102|156252463|FG001|Year 2|Death|1|||
48562726|NCT03989102|156252464|FG002|Year 2|Death|0|||
48562727|NCT03989102|156252462|FG000|Year 2|Subject not reachable|0|||
48562728|NCT03989102|156252463|FG001|Year 2|Subject not reachable|0|||
48562729|NCT03989102|156252464|FG002|Year 2|Subject not reachable|1|||
48562730|NCT03989102|156252462|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
48562731|NCT03989102|156252463|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
48562732|NCT03989102|156252464|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
48562733|NCT03989102|156252462|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
48562734|NCT03989102|156252463|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
48562735|NCT03989102|156252464|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
48562736|NCT03989102|156252462|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
48562737|NCT03989102|156252463|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
48562738|NCT03989102|156252464|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
48562739|NCT03989102|156252462|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
48562740|NCT03989102|156252463|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
48562741|NCT03989102|156252464|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
48562742|NCT03989102|156252462|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
48562743|NCT03989102|156252463|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
48562744|NCT03989102|156252464|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
48562745|NCT03989102|156252462|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
48562746|NCT03989102|156252463|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
48562747|NCT03989102|156252464|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
48562748|NCT01402570|156252467|FG000|Overall Study|Adverse Event|1|||
48562749|NCT01467713|156252468|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
48562750|NCT01467713|156252469|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
48562751|NCT01467713|156252470|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
48562752|NCT01467713|156252471|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
48562753|NCT01467713|156252468|FG000|Overall Study|Major Protocol Deviation|2|||
48562754|NCT01467713|156252469|FG001|Overall Study|Major Protocol Deviation|4|||
48562755|NCT01467713|156252470|FG002|Overall Study|Major Protocol Deviation|4|||
48562756|NCT01467713|156252471|FG003|Overall Study|Major Protocol Deviation|1|||
48562757|NCT01467713|156252468|FG000|Overall Study|Lost to Follow-up|9|||
48562758|NCT01467713|156252469|FG001|Overall Study|Lost to Follow-up|12|||
48562759|NCT01467713|156252470|FG002|Overall Study|Lost to Follow-up|6|||
48562760|NCT01467713|156252471|FG003|Overall Study|Lost to Follow-up|9|||
48562761|NCT01467713|156252468|FG000|Overall Study|Voluntary Withdrawal|18|||
48562762|NCT01467713|156252469|FG001|Overall Study|Voluntary Withdrawal|14|||
48562763|NCT01467713|156252470|FG002|Overall Study|Voluntary Withdrawal|21|||
48562764|NCT01467713|156252471|FG003|Overall Study|Voluntary Withdrawal|20|||
48562765|NCT01467713|156252468|FG000|Overall Study|Study Termination|23|||
48562766|NCT01467713|156252469|FG001|Overall Study|Study Termination|33|||
48562767|NCT01467713|156252470|FG002|Overall Study|Study Termination|28|||
48562768|NCT01467713|156252471|FG003|Overall Study|Study Termination|29|||
48562769|NCT01467713|156252468|FG000|Overall Study|Pregnancy|0|||
48562770|NCT01467713|156252469|FG001|Overall Study|Pregnancy|1|||
48562771|NCT01467713|156252470|FG002|Overall Study|Pregnancy|1|||
48617087|NCT01560988|156453052|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
48562772|NCT01467713|156252471|FG003|Overall Study|Pregnancy|3|||
48562773|NCT01467713|156252468|FG000|Overall Study|Relapse|35|||
48562774|NCT01467713|156252469|FG001|Overall Study|Relapse|25|||
48562775|NCT01467713|156252470|FG002|Overall Study|Relapse|28|||
48562776|NCT01467713|156252471|FG003|Overall Study|Relapse|35|||
48562777|NCT01467713|156252468|FG000|Overall Study|Reason not Specified|6|||
48562778|NCT01467713|156252469|FG001|Overall Study|Reason not Specified|11|||
48562779|NCT01467713|156252470|FG002|Overall Study|Reason not Specified|8|||
48562780|NCT01467713|156252471|FG003|Overall Study|Reason not Specified|7|||
48562781|NCT04909853|156252472|FG000|Part 1|Assigned but not treated|0|||
48562782|NCT04909853|156252473|FG001|Part 1|Assigned but not treated|0|||
48562783|NCT04909853|156252474|FG002|Part 1|Assigned but not treated|1|||
48562784|NCT04909853|156252475|FG003|Part 1|Assigned but not treated|0|||
48617088|NCT01560988|156453053|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
48562785|NCT04909853|156252472|FG000|Part 2|Adverse Event|0|||
48562786|NCT04909853|156252473|FG001|Part 2|Adverse Event|0|||
48562787|NCT04909853|156252474|FG002|Part 2|Adverse Event|0|||
48562788|NCT04909853|156252475|FG003|Part 2|Adverse Event|1|||
48562789|NCT03642262|156252476|FG000|Period 1|Withdrawal by Subject|1|||
48562790|NCT03642262|156252477|FG001|Period 1|Withdrawal by Subject|1|||
48562791|NCT03642262|156252476|FG000|Period 1|Adverse Event|0|||
48562792|NCT03642262|156252477|FG001|Period 1|Adverse Event|1|||
48562793|NCT01234350|156252478|FG000|Overall Study|Adverse Event|277|||
48562794|NCT01234350|156252479|FG001|Overall Study|Adverse Event|92|||
48562795|NCT01234350|156252478|FG000|Overall Study|Withdrawal by Subject|61|||
48562796|NCT01234350|156252479|FG001|Overall Study|Withdrawal by Subject|36|||
48562797|NCT01234350|156252478|FG000|Overall Study|Lost to Follow-up|115|||
48562798|NCT01234350|156252479|FG001|Overall Study|Lost to Follow-up|47|||
48562799|NCT01234350|156252478|FG000|Overall Study|Covers a diverse set of reasons|234|||
48562800|NCT01234350|156252479|FG001|Overall Study|Covers a diverse set of reasons|92|||
48562801|NCT01199939|156252482|FG000|Overall Study|Adverse Event|4|||
48562802|NCT01199939|156252482|FG000|Overall Study|Protocol Violation|3|||
48562803|NCT01199939|156252482|FG000|Overall Study|Lost to Follow-up|2|||
48562804|NCT01199939|156252482|FG000|Overall Study|Reached a virologic endpoint|4|||
48562805|NCT04620746|156252483|FG000|Overall Study|Adverse Event|2|||
48562806|NCT04620746|156252484|FG001|Overall Study|Adverse Event|0|||
48562807|NCT04620746|156252483|FG000|Overall Study|Uniterpretable skin test|1|||
48562808|NCT04620746|156252484|FG001|Overall Study|Uniterpretable skin test|0|||
48562809|NCT04620746|156252483|FG000|Overall Study|Withdrawal by Subject|0|||
48562810|NCT04620746|156252484|FG001|Overall Study|Withdrawal by Subject|1|||
48562811|NCT00811733|156252493|FG000|Overall Study|Investigator Discretion|10|||
48562812|NCT00811733|156252494|FG001|Overall Study|Investigator Discretion|8|||
48562813|NCT00811733|156252493|FG000|Overall Study|Withdrawal by Subject|1|||
48562814|NCT00811733|156252494|FG001|Overall Study|Withdrawal by Subject|2|||
48562815|NCT00856193|156252495|FG000|Period 2|Abnormal test procedure results|0|||
48562816|NCT00856193|156252496|FG001|Period 2|Abnormal test procedure results|1|||
48562817|NCT00856193|156252495|FG000|Period 2|Lost to Follow-up|0|||
48562818|NCT00856193|156252496|FG001|Period 2|Lost to Follow-up|1|||
48562819|NCT05064397|156252497|FG000|Overall Study|Adverse Event|4|||
48562820|NCT05064397|156252497|FG000|Overall Study|Lack of Efficacy|12|||
48562821|NCT05064397|156252497|FG000|Overall Study|Withdrawal by Subject|3|||
48562822|NCT05064397|156252497|FG000|Overall Study|Lost to Follow-up|1|||
48562823|NCT05064397|156252497|FG000|Overall Study|Other reasons|3|||
48562824|NCT04341363|156252499|FG000|Overall Study|Adverse Event|1|||
48562825|NCT04341363|156252499|FG000|Overall Study|Withdrawal by Subject|1|||
48562826|NCT00063934|156252500|FG000|Overall Study|Ineligible|1|||
48562827|NCT03351608|156252501|FG000|Overall Study|Lost to Follow-up|0|||
48562828|NCT03351608|156252502|FG001|Overall Study|Lost to Follow-up|1|||
48562829|NCT03351608|156252503|FG002|Overall Study|Lost to Follow-up|1|||
48562830|NCT03351608|156252504|FG003|Overall Study|Lost to Follow-up|1|||
48562831|NCT03351608|156252505|FG004|Overall Study|Lost to Follow-up|1|||
48562832|NCT03351608|156252501|FG000|Overall Study|Physician Decision|1|||
48562833|NCT03351608|156252502|FG001|Overall Study|Physician Decision|0|||
48562834|NCT03351608|156252503|FG002|Overall Study|Physician Decision|0|||
48562835|NCT03351608|156252504|FG003|Overall Study|Physician Decision|2|||
48562836|NCT03351608|156252505|FG004|Overall Study|Physician Decision|1|||
48562837|NCT03351608|156252501|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
48562838|NCT03351608|156252502|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
48562839|NCT03351608|156252503|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
48562840|NCT03351608|156252504|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
48562841|NCT03351608|156252505|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
48562842|NCT03351608|156252501|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48562843|NCT03351608|156252502|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48562844|NCT03351608|156252503|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48562845|NCT03351608|156252504|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48562846|NCT03351608|156252505|FG004|Overall Study|Withdrawal by parent/guardian|0|||
48562847|NCT03351608|156252501|FG000|Overall Study|Other|0|||
48562848|NCT03351608|156252502|FG001|Overall Study|Other|1|||
48562849|NCT03351608|156252503|FG002|Overall Study|Other|1|||
48562850|NCT03351608|156252504|FG003|Overall Study|Other|3|||
48562851|NCT03351608|156252505|FG004|Overall Study|Other|0|||
48562852|NCT02550561|156252513|FG000|Overall Study|Lost to Follow-up|5|||
48562853|NCT02550561|156252513|FG000|Overall Study|Withdrawal by Subject|1|||
48562854|NCT01958437|156252515|FG000|Overall Study|Incidental MRI findings|0|||
48562855|NCT01958437|156252516|FG001|Overall Study|Incidental MRI findings|0|||
48562856|NCT01958437|156252517|FG002|Overall Study|Incidental MRI findings|1|||
48562857|NCT01958437|156252518|FG003|Overall Study|Incidental MRI findings|1|||
48562858|NCT03428152|156252523|FG000|Overall Study|Physician Decision|4|||
48562859|NCT03428152|156252524|FG001|Overall Study|Physician Decision|2|||
48562860|NCT03428152|156252523|FG000|Overall Study|Protocol Violation|3|||
48562861|NCT03428152|156252524|FG001|Overall Study|Protocol Violation|5|||
48562862|NCT03428152|156252523|FG000|Overall Study|Lack of Efficacy|0|||
48562863|NCT03428152|156252524|FG001|Overall Study|Lack of Efficacy|4|||
48562864|NCT01686373|156252525|FG000|Overall Study|Lost to Follow-up|3|||
48562865|NCT01686373|156252526|FG001|Overall Study|Lost to Follow-up|0|||
48562866|NCT01686373|156252525|FG000|Overall Study|Withdrawal by Subject|0|||
48562867|NCT01686373|156252526|FG001|Overall Study|Withdrawal by Subject|1|||
48562868|NCT01686373|156252525|FG000|Overall Study|Adverse Event|0|||
48562869|NCT01686373|156252526|FG001|Overall Study|Adverse Event|1|||
48562870|NCT02996968|156252527|FG000|Overall Study|Withdrawal by Subject|1|||
48562871|NCT02996968|156252528|FG001|Overall Study|Withdrawal by Subject|0|||
48562872|NCT00712712|156252535|FG000|Overall Study|Protocol Violation|11|||
48562873|NCT00712712|156252535|FG000|Overall Study|Radiofrequency not done|3|||
48562874|NCT00712712|156252535|FG000|Overall Study|Death|8|||
48562875|NCT00712712|156252535|FG000|Overall Study|Withdrawal by Subject|1|||
48562876|NCT01252095|156252541|FG000|Overall Study|Disease progression|1|||
48562877|NCT01252095|156252542|FG001|Overall Study|Disease progression|0|||
48562878|NCT01420068|156252545|FG000|Overall Study|Administrative problems|1|||
48562879|NCT01420068|156252546|FG001|Overall Study|Administrative problems|3|||
48562880|NCT01420068|156252545|FG000|Overall Study|Withdrawal by Subject|1|||
48562881|NCT01420068|156252546|FG001|Overall Study|Withdrawal by Subject|2|||
48562882|NCT02268916|156252547|FG000|Overall Study|Lost to Follow-up|1|||
48562883|NCT02268916|156252548|FG001|Overall Study|Lost to Follow-up|1|||
48562884|NCT02268916|156252547|FG000|Overall Study|Withdrawal by Subject|6|||
48562885|NCT02268916|156252548|FG001|Overall Study|Withdrawal by Subject|5|||
48562886|NCT02268916|156252547|FG000|Overall Study|Participant did not have diabetes|1|||
48562887|NCT02268916|156252548|FG001|Overall Study|Participant did not have diabetes|0|||
48562888|NCT02268916|156252547|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
48562889|NCT02268916|156252548|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
48562890|NCT02418949|156252555|FG000|Overall Study|Withdrawal by Subject|1|||
48562891|NCT02418949|156252556|FG001|Overall Study|Withdrawal by Subject|0|||
48562892|NCT02418949|156252557|FG002|Overall Study|Withdrawal by Subject|1|||
48562893|NCT02418949|156252558|FG003|Overall Study|Withdrawal by Subject|1|||
48562894|NCT02418949|156252555|FG000|Overall Study|Lost to Follow-up|1|||
48562895|NCT02418949|156252556|FG001|Overall Study|Lost to Follow-up|0|||
48562896|NCT02418949|156252557|FG002|Overall Study|Lost to Follow-up|1|||
48562897|NCT02418949|156252558|FG003|Overall Study|Lost to Follow-up|0|||
48562898|NCT02418949|156252555|FG000|Overall Study|Physician Decision|1|||
48562899|NCT02418949|156252556|FG001|Overall Study|Physician Decision|1|||
48562900|NCT02418949|156252557|FG002|Overall Study|Physician Decision|1|||
48562901|NCT02418949|156252558|FG003|Overall Study|Physician Decision|0|||
48562902|NCT01139775|156252559|FG000|Overall Study|Adverse Event|0|||
48562903|NCT01139775|156252560|FG001|Overall Study|Adverse Event|6|||
48562904|NCT01139775|156252561|FG002|Overall Study|Adverse Event|2|||
48562905|NCT01139775|156252559|FG000|Overall Study|Protocol Violation|0|||
48562906|NCT01139775|156252560|FG001|Overall Study|Protocol Violation|5|||
48562907|NCT01139775|156252561|FG002|Overall Study|Protocol Violation|0|||
48562908|NCT01139775|156252559|FG000|Overall Study|Withdrawal by Subject|1|||
48562909|NCT01139775|156252560|FG001|Overall Study|Withdrawal by Subject|0|||
48562910|NCT01139775|156252561|FG002|Overall Study|Withdrawal by Subject|2|||
48617089|NCT01560988|156453052|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
48562911|NCT01139775|156252559|FG000|Overall Study|Physician Decision|0|||
48562912|NCT01139775|156252560|FG001|Overall Study|Physician Decision|2|||
48562913|NCT01139775|156252561|FG002|Overall Study|Physician Decision|2|||
48562914|NCT00365794|156252562|FG000|Overall Study|Withdrawal by Subject|2|||
48562915|NCT03926117|156252563|FG000|Overall Study|Unclassified|1|||
48562916|NCT03926117|156252564|FG001|Overall Study|Unclassified|4|||
48562917|NCT03926117|156252565|FG002|Overall Study|Unclassified|1|||
48562918|NCT03926117|156252566|FG003|Overall Study|Unclassified|4|||
48562919|NCT03926117|156252563|FG000|Overall Study|Withdrawal by Subject|3|||
48562920|NCT03926117|156252564|FG001|Overall Study|Withdrawal by Subject|0|||
48562921|NCT03926117|156252565|FG002|Overall Study|Withdrawal by Subject|1|||
48562922|NCT03926117|156252566|FG003|Overall Study|Withdrawal by Subject|1|||
48562923|NCT03926117|156252563|FG000|Overall Study|Lost to Follow-up|0|||
48562924|NCT03926117|156252564|FG001|Overall Study|Lost to Follow-up|2|||
48562925|NCT03926117|156252565|FG002|Overall Study|Lost to Follow-up|1|||
48562926|NCT03926117|156252566|FG003|Overall Study|Lost to Follow-up|0|||
48562927|NCT03926117|156252563|FG000|Overall Study|Adverse Event|1|||
48562928|NCT03926117|156252564|FG001|Overall Study|Adverse Event|2|||
48562929|NCT03926117|156252565|FG002|Overall Study|Adverse Event|3|||
48562930|NCT03926117|156252566|FG003|Overall Study|Adverse Event|1|||
48562931|NCT03926117|156252563|FG000|Overall Study|Randomized but not treated|1|||
48562932|NCT03926117|156252564|FG001|Overall Study|Randomized but not treated|1|||
48562933|NCT03926117|156252565|FG002|Overall Study|Randomized but not treated|0|||
48562934|NCT03926117|156252566|FG003|Overall Study|Randomized but not treated|1|||
48562935|NCT00586703|156252570|FG000|Overall Study|Death|12|||
48562936|NCT01422213|156252573|FG000|Overall Study|Adverse Event|8|||
48562937|NCT01422213|156252574|FG001|Overall Study|Adverse Event|7|||
48562938|NCT01422213|156252575|FG002|Overall Study|Adverse Event|11|||
48562939|NCT01422213|156252573|FG000|Overall Study|Lack of Efficacy|10|||
48562940|NCT01422213|156252574|FG001|Overall Study|Lack of Efficacy|2|||
48562941|NCT01422213|156252575|FG002|Overall Study|Lack of Efficacy|2|||
48562942|NCT01422213|156252573|FG000|Overall Study|Non-compliance with study drug|0|||
48562943|NCT01422213|156252574|FG001|Overall Study|Non-compliance with study drug|1|||
48562944|NCT01422213|156252575|FG002|Overall Study|Non-compliance with study drug|0|||
48562945|NCT01422213|156252573|FG000|Overall Study|Protocol Violation|0|||
48562946|NCT01422213|156252574|FG001|Overall Study|Protocol Violation|2|||
48562947|NCT01422213|156252575|FG002|Overall Study|Protocol Violation|4|||
48562948|NCT01422213|156252573|FG000|Overall Study|Withdrawal of Consent|7|||
48562949|NCT01422213|156252574|FG001|Overall Study|Withdrawal of Consent|3|||
48562950|NCT01422213|156252575|FG002|Overall Study|Withdrawal of Consent|5|||
48562951|NCT01422213|156252573|FG000|Overall Study|Lost to Follow-up|3|||
48562952|NCT01422213|156252574|FG001|Overall Study|Lost to Follow-up|3|||
48562953|NCT01422213|156252575|FG002|Overall Study|Lost to Follow-up|5|||
48562954|NCT01422213|156252573|FG000|Overall Study|Administrative or Other Reason(s)|5|||
48562955|NCT01422213|156252574|FG001|Overall Study|Administrative or Other Reason(s)|4|||
48562956|NCT01422213|156252575|FG002|Overall Study|Administrative or Other Reason(s)|2|||
48562957|NCT01827111|156252580|FG000|Overall Study|Disease Progression|1|||
48562958|NCT01052480|156252584|FG000|Overall Study|Lost to Follow-up|3|||
48562959|NCT01052480|156252585|FG001|Overall Study|Lost to Follow-up|3|||
48562960|NCT01052480|156252584|FG000|Overall Study|Protocol Violation|1|||
48562961|NCT01052480|156252585|FG001|Overall Study|Protocol Violation|0|||
48562962|NCT01052480|156252584|FG000|Overall Study|Withdrawal by Subject|3|||
48562963|NCT01052480|156252585|FG001|Overall Study|Withdrawal by Subject|7|||
48562964|NCT01052480|156252584|FG000|Overall Study|Physician Decision|0|||
48562965|NCT01052480|156252585|FG001|Overall Study|Physician Decision|2|||
48562966|NCT01052480|156252584|FG000|Overall Study|Death|1|||
48562967|NCT01052480|156252585|FG001|Overall Study|Death|5|||
48562968|NCT01956773|156252588|FG000|Overall Study|Lost to Follow-up|628|||
48562969|NCT01956773|156252589|FG001|Overall Study|Lost to Follow-up|1|||
48562970|NCT03627546|156252598|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
48562971|NCT03627546|156252599|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
48562972|NCT03627546|156252600|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
48562973|NCT03627546|156252598|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
48562974|NCT03627546|156252599|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
48562975|NCT03627546|156252600|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
48562976|NCT01578239|156252601|FG000|Treatment Period|Progressive Disease|19|||
48562977|NCT01578239|156252602|FG001|Treatment Period|Progressive Disease|64|||
48562978|NCT01578239|156252601|FG000|Treatment Period|Physician Decision|17|||
48562979|NCT01578239|156252602|FG001|Treatment Period|Physician Decision|17|||
48562980|NCT01578239|156252601|FG000|Treatment Period|Adverse Event|13|||
48562981|NCT01578239|156252602|FG001|Treatment Period|Adverse Event|10|||
48562982|NCT01578239|156252601|FG000|Treatment Period|Non-compliance|2|||
48562983|NCT01578239|156252602|FG001|Treatment Period|Non-compliance|0|||
48562984|NCT01578239|156252601|FG000|Treatment Period|Withdrawal by Subject|10|||
48562985|NCT01578239|156252602|FG001|Treatment Period|Withdrawal by Subject|9|||
48562986|NCT01578239|156252601|FG000|Treatment Period|Other|6|||
48562987|NCT01578239|156252602|FG001|Treatment Period|Other|1|||
48562988|NCT01578239|156252601|FG000|Long-term Follow-Up Period|Death|69|||
48562989|NCT01578239|156252602|FG001|Long-term Follow-Up Period|Death|64|||
48562990|NCT01578239|156252601|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
48562991|NCT01578239|156252602|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
48562992|NCT01578239|156252601|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
48562993|NCT01578239|156252602|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
48562994|NCT01578239|156252601|FG000|Long-term Follow-Up Period|Other|2|||
48562995|NCT01578239|156252602|FG001|Long-term Follow-Up Period|Other|2|||
48562996|NCT00615550|156252604|FG000|Overall Study|Lost to Follow-up|6|||
48562997|NCT00615550|156252605|FG001|Overall Study|Lost to Follow-up|1|||
48562998|NCT00564850|156252606|FG000|Overall Study|Protocol Violation|2|||
48562999|NCT02220764|156252607|FG000|Overall Study|Lost to Follow-up|3|||
48563000|NCT02220764|156252608|FG001|Overall Study|Lost to Follow-up|1|||
48563001|NCT02220764|156252607|FG000|Overall Study|Death|1|||
48563002|NCT02220764|156252608|FG001|Overall Study|Death|0|||
48563003|NCT02347813|156252609|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
48563004|NCT02347813|156252610|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
48563005|NCT02347813|156252609|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
48563006|NCT02347813|156252610|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
48563007|NCT02640664|156252613|FG000|Epoch 1|Withdrawal of informed consent|1|||
48563008|NCT02640664|156252614|FG001|Epoch 1|Withdrawal of informed consent|0|||
48563009|NCT02640664|156252615|FG002|Epoch 1|Withdrawal of informed consent|0|||
48563010|NCT02640664|156252613|FG000|Epoch 1|Death|0|||
48563011|NCT02640664|156252614|FG001|Epoch 1|Death|0|||
48563012|NCT02640664|156252615|FG002|Epoch 1|Death|1|||
48563013|NCT02640664|156252613|FG000|Epoch 2|Withdrawal of informed consent|3|||
48563014|NCT02640664|156252614|FG001|Epoch 2|Withdrawal of informed consent|4|||
48563015|NCT02640664|156252615|FG002|Epoch 2|Withdrawal of informed consent|2|||
48563016|NCT02640664|156252613|FG000|Epoch 2|Subject/guardian decision|0|||
48563017|NCT02640664|156252614|FG001|Epoch 2|Subject/guardian decision|2|||
48563018|NCT02640664|156252615|FG002|Epoch 2|Subject/guardian decision|2|||
48563019|NCT02640664|156252613|FG000|Epoch 2|Lost to Follow-up|3|||
48563020|NCT02640664|156252614|FG001|Epoch 2|Lost to Follow-up|4|||
48563021|NCT02640664|156252615|FG002|Epoch 2|Lost to Follow-up|1|||
48563022|NCT02640664|156252613|FG000|Epoch 2|Death|0|||
48563023|NCT02640664|156252614|FG001|Epoch 2|Death|0|||
48563024|NCT02640664|156252615|FG002|Epoch 2|Death|1|||
48563025|NCT01537042|156252616|FG000|Overall Study|Adverse Event|0|||
48563026|NCT01537042|156252617|FG001|Overall Study|Adverse Event|2|||
48563027|NCT01537042|156252616|FG000|Overall Study|Lack of Efficacy|0|||
48563028|NCT01537042|156252617|FG001|Overall Study|Lack of Efficacy|1|||
48563029|NCT01537042|156252616|FG000|Overall Study|Protocol Violation|0|||
48563030|NCT01537042|156252617|FG001|Overall Study|Protocol Violation|1|||
48563031|NCT01537042|156252616|FG000|Overall Study|Other|0|||
48563032|NCT01537042|156252617|FG001|Overall Study|Other|1|||
48563033|NCT01991743|156252621|FG000|Overall Study|external cephalic version not performed|0|||
48563034|NCT01991743|156252622|FG001|Overall Study|external cephalic version not performed|0|||
48563035|NCT01991743|156252623|FG002|Overall Study|external cephalic version not performed|1|||
48563036|NCT01991743|156252624|FG003|Overall Study|external cephalic version not performed|0|||
48563037|NCT01119859|156252625|FG000|Overall Study|Adverse Event|9|||
48563038|NCT01119859|156252626|FG001|Overall Study|Adverse Event|10|||
48563039|NCT01119859|156252625|FG000|Overall Study|Death|2|||
48563040|NCT01119859|156252626|FG001|Overall Study|Death|0|||
48563041|NCT01119859|156252625|FG000|Overall Study|Insufficient therapeutic response|7|||
48563042|NCT01119859|156252626|FG001|Overall Study|Insufficient therapeutic response|14|||
48563043|NCT01119859|156252625|FG000|Overall Study|Refused treatment|3|||
48563044|NCT01119859|156252626|FG001|Overall Study|Refused treatment|6|||
48563045|NCT01119859|156252625|FG000|Overall Study|Failure to return|3|||
48563046|NCT01119859|156252626|FG001|Overall Study|Failure to return|0|||
48563047|NCT01167140|156252627|FG000|Overall Study|Withdrawal by Subject|1|||
48563048|NCT03805412|156252628|FG000|Overall Study|Lost to Follow-up|0|||
48563049|NCT03805412|156252629|FG001|Overall Study|Lost to Follow-up|1|||
48563050|NCT04846569|156254413|FG000|Overall Study|Withdrawal by Subject|3|||
48563051|NCT04846569|156254414|FG001|Overall Study|Withdrawal by Subject|1|||
48563052|NCT02832687|156254417|FG000|Overall Study|Adverse Event|0|||
48563053|NCT02832687|156254418|FG001|Overall Study|Adverse Event|2|||
48563054|NCT04054765|156254423|FG000|Baseline|Withdrawal by Subject|5|||
48563055|NCT04054765|156254424|FG001|Baseline|Withdrawal by Subject|3|||
48563056|NCT04054765|156254423|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
48563057|NCT04054765|156254424|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
48563058|NCT04054765|156254423|FG000|3-month Follow up|Withdrawal by Subject|0|||
48563059|NCT04054765|156254424|FG001|3-month Follow up|Withdrawal by Subject|3|||
48563060|NCT04054765|156254423|FG000|6-month Follow up|Lost to Follow-up|32|||
48563061|NCT04054765|156254424|FG001|6-month Follow up|Lost to Follow-up|32|||
48563062|NCT01962103|156254425|FG000|Phase 1|Adverse Event|4|||
48563063|NCT01962103|156254426|FG001|Phase 1|Adverse Event|0|||
48563064|NCT01962103|156254427|FG002|Phase 1|Adverse Event|2|||
48563065|NCT01962103|156254428|FG003|Phase 1|Adverse Event|1|||
48563066|NCT01962103|156254429|FG004|Phase 1|Adverse Event|2|||
48563067|NCT01962103|156254430|FG005|Phase 1|Adverse Event|2|||
48563068|NCT01962103|156254431|FG006|Phase 1|Adverse Event|0|||
48563069|NCT01962103|156254432|FG007|Phase 1|Adverse Event|0|||
48563070|NCT01962103|156254433|FG008|Phase 1|Adverse Event|0|||
48563071|NCT01962103|156254425|FG000|Phase 1|Progressive Disease|8|||
48563072|NCT01962103|156254426|FG001|Phase 1|Progressive Disease|6|||
48563073|NCT01962103|156254427|FG002|Phase 1|Progressive Disease|8|||
48563074|NCT01962103|156254428|FG003|Phase 1|Progressive Disease|4|||
48563075|NCT01962103|156254429|FG004|Phase 1|Progressive Disease|5|||
48563076|NCT01962103|156254430|FG005|Phase 1|Progressive Disease|4|||
48563077|NCT01962103|156254431|FG006|Phase 1|Progressive Disease|0|||
48563078|NCT01962103|156254432|FG007|Phase 1|Progressive Disease|0|||
48563079|NCT01962103|156254433|FG008|Phase 1|Progressive Disease|0|||
48563080|NCT01962103|156254425|FG000|Phase 1|Withdrawal by Subject|0|||
48563081|NCT01962103|156254426|FG001|Phase 1|Withdrawal by Subject|0|||
48563082|NCT01962103|156254427|FG002|Phase 1|Withdrawal by Subject|0|||
48563083|NCT01962103|156254428|FG003|Phase 1|Withdrawal by Subject|2|||
48563084|NCT01962103|156254429|FG004|Phase 1|Withdrawal by Subject|0|||
48563085|NCT01962103|156254430|FG005|Phase 1|Withdrawal by Subject|0|||
48563086|NCT01962103|156254431|FG006|Phase 1|Withdrawal by Subject|0|||
48563087|NCT01962103|156254432|FG007|Phase 1|Withdrawal by Subject|0|||
48563088|NCT01962103|156254433|FG008|Phase 1|Withdrawal by Subject|0|||
48563089|NCT01962103|156254425|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
48563090|NCT01962103|156254426|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
48563091|NCT01962103|156254427|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
48563092|NCT01962103|156254428|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
48563093|NCT01962103|156254429|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
48563094|NCT01962103|156254430|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
48563095|NCT01962103|156254431|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
48563096|NCT01962103|156254432|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
48563097|NCT01962103|156254433|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
48563098|NCT01962103|156254425|FG000|Phase 1|Physician Decision|0|||
48563099|NCT01962103|156254426|FG001|Phase 1|Physician Decision|0|||
48563100|NCT01962103|156254427|FG002|Phase 1|Physician Decision|0|||
48563101|NCT01962103|156254428|FG003|Phase 1|Physician Decision|1|||
48563102|NCT01962103|156254429|FG004|Phase 1|Physician Decision|0|||
48563103|NCT01962103|156254430|FG005|Phase 1|Physician Decision|0|||
48563104|NCT01962103|156254431|FG006|Phase 1|Physician Decision|0|||
48563105|NCT01962103|156254432|FG007|Phase 1|Physician Decision|0|||
48563106|NCT01962103|156254433|FG008|Phase 1|Physician Decision|0|||
48563107|NCT01962103|156254425|FG000|Phase 1|Symptomatic Deterioration|3|||
48563108|NCT01962103|156254426|FG001|Phase 1|Symptomatic Deterioration|2|||
48563109|NCT01962103|156254427|FG002|Phase 1|Symptomatic Deterioration|2|||
48563110|NCT01962103|156254428|FG003|Phase 1|Symptomatic Deterioration|2|||
48563111|NCT01962103|156254429|FG004|Phase 1|Symptomatic Deterioration|1|||
48563112|NCT01962103|156254430|FG005|Phase 1|Symptomatic Deterioration|1|||
48563113|NCT01962103|156254431|FG006|Phase 1|Symptomatic Deterioration|0|||
48563114|NCT01962103|156254432|FG007|Phase 1|Symptomatic Deterioration|0|||
48563115|NCT01962103|156254433|FG008|Phase 1|Symptomatic Deterioration|0|||
48563116|NCT01962103|156254425|FG000|Phase 1|Miscellaneous|1|||
48563117|NCT01962103|156254426|FG001|Phase 1|Miscellaneous|0|||
48563118|NCT01962103|156254427|FG002|Phase 1|Miscellaneous|0|||
48563119|NCT01962103|156254428|FG003|Phase 1|Miscellaneous|0|||
48563120|NCT01962103|156254429|FG004|Phase 1|Miscellaneous|0|||
48563121|NCT01962103|156254430|FG005|Phase 1|Miscellaneous|0|||
48563122|NCT01962103|156254431|FG006|Phase 1|Miscellaneous|0|||
48563123|NCT01962103|156254432|FG007|Phase 1|Miscellaneous|0|||
48563124|NCT01962103|156254433|FG008|Phase 1|Miscellaneous|0|||
48563125|NCT01962103|156254425|FG000|Phase 2|Adverse Event|0|||
48563126|NCT01962103|156254426|FG001|Phase 2|Adverse Event|0|||
48563127|NCT01962103|156254427|FG002|Phase 2|Adverse Event|0|||
48563128|NCT01962103|156254428|FG003|Phase 2|Adverse Event|0|||
48563129|NCT01962103|156254429|FG004|Phase 2|Adverse Event|0|||
48563130|NCT01962103|156254430|FG005|Phase 2|Adverse Event|0|||
48563131|NCT01962103|156254431|FG006|Phase 2|Adverse Event|1|||
48563132|NCT01962103|156254432|FG007|Phase 2|Adverse Event|0|||
48563133|NCT01962103|156254433|FG008|Phase 2|Adverse Event|3|||
48563134|NCT01962103|156254425|FG000|Phase 2|Progressive Disease|0|||
48563135|NCT01962103|156254426|FG001|Phase 2|Progressive Disease|0|||
48563136|NCT01962103|156254427|FG002|Phase 2|Progressive Disease|0|||
48563137|NCT01962103|156254428|FG003|Phase 2|Progressive Disease|0|||
48563138|NCT01962103|156254429|FG004|Phase 2|Progressive Disease|0|||
48563139|NCT01962103|156254430|FG005|Phase 2|Progressive Disease|0|||
48563140|NCT01962103|156254431|FG006|Phase 2|Progressive Disease|11|||
48563141|NCT01962103|156254432|FG007|Phase 2|Progressive Disease|12|||
48563142|NCT01962103|156254433|FG008|Phase 2|Progressive Disease|11|||
48563143|NCT01962103|156254425|FG000|Phase 2|Symptomatic Deterioration|0|||
48563144|NCT01962103|156254426|FG001|Phase 2|Symptomatic Deterioration|0|||
48563145|NCT01962103|156254427|FG002|Phase 2|Symptomatic Deterioration|0|||
48563146|NCT01962103|156254428|FG003|Phase 2|Symptomatic Deterioration|0|||
48563147|NCT01962103|156254429|FG004|Phase 2|Symptomatic Deterioration|0|||
48563148|NCT01962103|156254430|FG005|Phase 2|Symptomatic Deterioration|0|||
48563149|NCT01962103|156254431|FG006|Phase 2|Symptomatic Deterioration|2|||
48563150|NCT01962103|156254432|FG007|Phase 2|Symptomatic Deterioration|2|||
48563151|NCT01962103|156254433|FG008|Phase 2|Symptomatic Deterioration|0|||
48563152|NCT01930162|156254436|FG000|Overall Study|Abnormal test procedure result(s)|4|||
48563153|NCT01930162|156254436|FG000|Overall Study|Death|1|||
48563154|NCT05344560|156254437|FG000|Period 1|Subject out of visit window|1|||
48563155|NCT05344560|156254438|FG001|Period 1|Subject out of visit window|1|||
48563156|NCT05344560|156254437|FG000|Period 2|Covid-19 Related|1|||
48563157|NCT05344560|156254438|FG001|Period 2|Covid-19 Related|0|||
48563158|NCT05344560|156254437|FG000|Period 2|Adverse Event|1|||
48563159|NCT05344560|156254438|FG001|Period 2|Adverse Event|0|||
48563160|NCT05344560|156254437|FG000|Period 2|Subject out of visit window|1|||
48563161|NCT05344560|156254438|FG001|Period 2|Subject out of visit window|1|||
48563162|NCT05344560|156254437|FG000|Period 3|Subject out of visit window|1|||
48563163|NCT05344560|156254438|FG001|Period 3|Subject out of visit window|0|||
48563164|NCT02877004|156254439|FG000|Overall Study|Pregnancy|0|||
48563165|NCT02877004|156254440|FG001|Overall Study|Pregnancy|0|||
48563166|NCT02877004|156254441|FG002|Overall Study|Pregnancy|1|||
48563167|NCT00840749|156254442|FG000|Overall Study|Death|1|||
48563168|NCT00840749|156254443|FG001|Overall Study|Death|2|||
48563169|NCT00840749|156254442|FG000|Overall Study|not treated on study arm|11|||
48563170|NCT00840749|156254443|FG001|Overall Study|not treated on study arm|11|||
48563171|NCT00840749|156254442|FG000|Overall Study|study closed|19|||
48563172|NCT00840749|156254443|FG001|Overall Study|study closed|14|||
48563173|NCT02727478|156254444|FG000|Overall Study|Withdrawal by Subject|8|||
48563174|NCT02727478|156254445|FG001|Overall Study|Withdrawal by Subject|10|||
48563175|NCT02962648|156254446|FG000|Overall Study|Withdrawal by Subject|3|||
48563176|NCT02962648|156254446|FG000|Overall Study|Lost to Follow-up|3|||
48563177|NCT02962648|156254446|FG000|Overall Study|Physician Decision|1|||
48563178|NCT02962648|156254446|FG000|Overall Study|Subject had problems with transportation|2|||
48563179|NCT00395629|156254451|FG000|Core Study|Adverse Event|0|||
48563180|NCT00395629|156254452|FG001|Core Study|Adverse Event|3|||
48563181|NCT00395629|156254453|FG002|Core Study|Adverse Event|4|||
48563182|NCT00395629|156254451|FG000|Core Study|Abnormal laboratory value(s)|0|||
48563183|NCT00395629|156254452|FG001|Core Study|Abnormal laboratory value(s)|0|||
48563184|NCT00395629|156254453|FG002|Core Study|Abnormal laboratory value(s)|1|||
48563185|NCT00395629|156254451|FG000|Core Study|Protocol Violation|1|||
48563186|NCT00395629|156254452|FG001|Core Study|Protocol Violation|0|||
48563187|NCT00395629|156254453|FG002|Core Study|Protocol Violation|0|||
48563188|NCT00395629|156254451|FG000|Core Study|Withdrawal by Subject|0|||
48563189|NCT00395629|156254452|FG001|Core Study|Withdrawal by Subject|1|||
48563190|NCT00395629|156254453|FG002|Core Study|Withdrawal by Subject|1|||
48563191|NCT00395629|156254451|FG000|Core Study|Lost to Follow-up|0|||
48563192|NCT00395629|156254452|FG001|Core Study|Lost to Follow-up|0|||
48563193|NCT00395629|156254453|FG002|Core Study|Lost to Follow-up|1|||
48563194|NCT00395629|156254451|FG000|Extension Study|Adverse Event|0|||
48563195|NCT00395629|156254452|FG001|Extension Study|Adverse Event|0|||
48563196|NCT00395629|156254453|FG002|Extension Study|Adverse Event|2|||
48563197|NCT00395629|156254451|FG000|Extension Study|Administrative problems|0|||
48563198|NCT00395629|156254452|FG001|Extension Study|Administrative problems|0|||
48563199|NCT00395629|156254453|FG002|Extension Study|Administrative problems|1|||
48563200|NCT01051960|156254454|FG000|Overall Study|Adverse Event|1|||
48563201|NCT00360282|156254455|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
48563202|NCT00360282|156254456|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
48563203|NCT00360282|156254457|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
48563204|NCT00360282|156254458|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
48563205|NCT00360282|156254455|FG000|Second Intervention|Adverse Event|0|||
48563206|NCT00360282|156254456|FG001|Second Intervention|Adverse Event|1|||
48563207|NCT00360282|156254457|FG002|Second Intervention|Adverse Event|0|||
48563208|NCT00360282|156254458|FG003|Second Intervention|Adverse Event|0|||
48563209|NCT01277601|156254459|FG000|Overall Study|Adverse Event|5|||
48563210|NCT01277601|156254460|FG001|Overall Study|Adverse Event|3|||
48563211|NCT01277601|156254461|FG002|Overall Study|Adverse Event|0|||
48563212|NCT01277601|156254462|FG003|Overall Study|Adverse Event|7|||
48563213|NCT01277601|156254459|FG000|Overall Study|Withdrawal by Subject|18|||
48563214|NCT01277601|156254460|FG001|Overall Study|Withdrawal by Subject|21|||
48563215|NCT01277601|156254461|FG002|Overall Study|Withdrawal by Subject|8|||
48563216|NCT01277601|156254462|FG003|Overall Study|Withdrawal by Subject|17|||
48563217|NCT01277601|156254459|FG000|Overall Study|Lost to Follow-up|7|||
48563218|NCT01277601|156254460|FG001|Overall Study|Lost to Follow-up|9|||
48563219|NCT01277601|156254461|FG002|Overall Study|Lost to Follow-up|4|||
48563220|NCT01277601|156254462|FG003|Overall Study|Lost to Follow-up|2|||
48563221|NCT01277601|156254459|FG000|Overall Study|Physician Decision|3|||
48563222|NCT01277601|156254460|FG001|Overall Study|Physician Decision|5|||
48563223|NCT01277601|156254461|FG002|Overall Study|Physician Decision|1|||
48563224|NCT01277601|156254462|FG003|Overall Study|Physician Decision|6|||
48563225|NCT01277601|156254459|FG000|Overall Study|Pregnancy|2|||
48563226|NCT01277601|156254460|FG001|Overall Study|Pregnancy|2|||
48563227|NCT01277601|156254461|FG002|Overall Study|Pregnancy|4|||
48563228|NCT01277601|156254462|FG003|Overall Study|Pregnancy|1|||
48563229|NCT01277601|156254459|FG000|Overall Study|Noncompliance with Study Drug|1|||
48563230|NCT01277601|156254460|FG001|Overall Study|Noncompliance with Study Drug|3|||
48563231|NCT01277601|156254461|FG002|Overall Study|Noncompliance with Study Drug|2|||
48563232|NCT01277601|156254462|FG003|Overall Study|Noncompliance with Study Drug|0|||
48563233|NCT01277601|156254459|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
48563234|NCT01277601|156254460|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
48563235|NCT01277601|156254461|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
48563236|NCT01277601|156254462|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
48563237|NCT01277601|156254459|FG000|Overall Study|Protocol Violation|0|||
48563238|NCT01277601|156254460|FG001|Overall Study|Protocol Violation|2|||
48563239|NCT01277601|156254461|FG002|Overall Study|Protocol Violation|5|||
48563240|NCT01277601|156254462|FG003|Overall Study|Protocol Violation|0|||
48563241|NCT01277601|156254459|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
48563242|NCT01277601|156254460|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
48563243|NCT01277601|156254461|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
48563244|NCT01277601|156254462|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
48563245|NCT00808210|156254467|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
48563246|NCT00808210|156254468|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
48563247|NCT00808210|156254467|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
48563248|NCT00808210|156254468|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
48563249|NCT00808210|156254467|FG000|Double-Blind TX Period|Adverse Event|0|||
48563250|NCT00808210|156254468|FG001|Double-Blind TX Period|Adverse Event|1|||
48563251|NCT00808210|156254467|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
48563252|NCT00808210|156254468|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
48563253|NCT00808210|156254467|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
48563254|NCT00808210|156254468|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
48563255|NCT00808210|156254467|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
48563256|NCT00808210|156254468|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
48563257|NCT02044302|156254477|FG000|Overall Study|study terminated|2|||
48563258|NCT02044302|156254478|FG001|Overall Study|study terminated|0|||
48563259|NCT00502242|156254480|FG000|Overall Study|Lack of Efficacy|1|||
48563260|NCT00502242|156254481|FG001|Overall Study|Lack of Efficacy|11|||
48563261|NCT00502242|156254480|FG000|Overall Study|Adverse Event|31|||
48563262|NCT00502242|156254481|FG001|Overall Study|Adverse Event|20|||
48563263|NCT00502242|156254480|FG000|Overall Study|Physician Decision|2|||
48563264|NCT00502242|156254481|FG001|Overall Study|Physician Decision|3|||
48563265|NCT00502242|156254480|FG000|Overall Study|Other - Unspecified|8|||
48563266|NCT00502242|156254481|FG001|Overall Study|Other - Unspecified|14|||
48563267|NCT00502242|156254480|FG000|Overall Study|Protocol Violation|3|||
48563268|NCT00502242|156254481|FG001|Overall Study|Protocol Violation|1|||
48563269|NCT00502242|156254480|FG000|Overall Study|Withdrawal by Subject|6|||
48563270|NCT00502242|156254481|FG001|Overall Study|Withdrawal by Subject|7|||
48563271|NCT04537078|156254482|FG000|Overall Study|Protocol Violation|3|||
48563272|NCT04537078|156254483|FG001|Overall Study|Protocol Violation|2|||
48563273|NCT04537078|156254482|FG000|Overall Study|Lost to Follow-up|1|||
48563274|NCT04537078|156254483|FG001|Overall Study|Lost to Follow-up|0|||
48563275|NCT04537078|156254482|FG000|Overall Study|Withdrawal by Subject|0|||
48563276|NCT04537078|156254483|FG001|Overall Study|Withdrawal by Subject|1|||
48563277|NCT01671007|156254484|FG000|Overall Study|Other reasons than listed|166|||
48563278|NCT01671007|156254485|FG001|Overall Study|Other reasons than listed|373|||
48563279|NCT01671007|156254486|FG002|Overall Study|Other reasons than listed|197|||
48563280|NCT01671007|156254487|FG003|Overall Study|Other reasons than listed|228|||
48563281|NCT01671007|156254488|FG004|Overall Study|Other reasons than listed|14|||
48563282|NCT01671007|156254489|FG005|Overall Study|Other reasons than listed|71|||
48563283|NCT01671007|156254490|FG006|Overall Study|Other reasons than listed|17|||
48563284|NCT01671007|156254491|FG007|Overall Study|Other reasons than listed|66|||
48563285|NCT01671007|156254492|FG008|Overall Study|Other reasons than listed|0|||
48563286|NCT01671007|156254484|FG000|Overall Study|Withdrawal by Subject|36|||
48563287|NCT01671007|156254485|FG001|Overall Study|Withdrawal by Subject|59|||
48563288|NCT01671007|156254486|FG002|Overall Study|Withdrawal by Subject|53|||
48563289|NCT01671007|156254487|FG003|Overall Study|Withdrawal by Subject|58|||
48563290|NCT01671007|156254488|FG004|Overall Study|Withdrawal by Subject|4|||
48563291|NCT01671007|156254489|FG005|Overall Study|Withdrawal by Subject|15|||
48563292|NCT01671007|156254490|FG006|Overall Study|Withdrawal by Subject|1|||
48563293|NCT01671007|156254491|FG007|Overall Study|Withdrawal by Subject|19|||
48563294|NCT01671007|156254492|FG008|Overall Study|Withdrawal by Subject|0|||
48563295|NCT01671007|156254484|FG000|Overall Study|Lost to Follow-up|93|||
48563296|NCT01671007|156254485|FG001|Overall Study|Lost to Follow-up|142|||
48563297|NCT01671007|156254486|FG002|Overall Study|Lost to Follow-up|91|||
48563298|NCT01671007|156254487|FG003|Overall Study|Lost to Follow-up|63|||
48563299|NCT01671007|156254488|FG004|Overall Study|Lost to Follow-up|7|||
48563300|NCT01671007|156254489|FG005|Overall Study|Lost to Follow-up|20|||
48563301|NCT01671007|156254490|FG006|Overall Study|Lost to Follow-up|2|||
48563302|NCT01671007|156254491|FG007|Overall Study|Lost to Follow-up|28|||
48563303|NCT01671007|156254492|FG008|Overall Study|Lost to Follow-up|0|||
48563304|NCT01671007|156254484|FG000|Overall Study|No end of study case report form|3|||
48563305|NCT01671007|156254485|FG001|Overall Study|No end of study case report form|1|||
48563306|NCT01671007|156254486|FG002|Overall Study|No end of study case report form|0|||
48563307|NCT01671007|156254487|FG003|Overall Study|No end of study case report form|2|||
48563308|NCT01671007|156254488|FG004|Overall Study|No end of study case report form|0|||
48563309|NCT01671007|156254489|FG005|Overall Study|No end of study case report form|0|||
48563310|NCT01671007|156254490|FG006|Overall Study|No end of study case report form|0|||
48563311|NCT01671007|156254491|FG007|Overall Study|No end of study case report form|0|||
48563312|NCT01671007|156254492|FG008|Overall Study|No end of study case report form|0|||
48563313|NCT01671007|156254484|FG000|Overall Study|Not eligible|23|||
48563314|NCT01671007|156254485|FG001|Overall Study|Not eligible|76|||
48563315|NCT01671007|156254486|FG002|Overall Study|Not eligible|25|||
48563316|NCT01671007|156254487|FG003|Overall Study|Not eligible|17|||
48563317|NCT01671007|156254488|FG004|Overall Study|Not eligible|0|||
48563318|NCT01671007|156254489|FG005|Overall Study|Not eligible|6|||
48563319|NCT01671007|156254490|FG006|Overall Study|Not eligible|1|||
48563320|NCT01671007|156254491|FG007|Overall Study|Not eligible|19|||
48563321|NCT01671007|156254492|FG008|Overall Study|Not eligible|0|||
48563322|NCT03817853|156254493|FG000|Induction Phase|Adverse Event|5|||
48563323|NCT03817853|156254494|FG001|Induction Phase|Adverse Event|0|||
48563324|NCT03817853|156254495|FG002|Induction Phase|Adverse Event|0|||
48563325|NCT03817853|156254493|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
48563326|NCT03817853|156254494|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
48563327|NCT03817853|156254495|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
48563328|NCT03817853|156254493|FG000|Induction Phase|Physician Decision|2|||
48563329|NCT03817853|156254494|FG001|Induction Phase|Physician Decision|0|||
48563330|NCT03817853|156254495|FG002|Induction Phase|Physician Decision|0|||
48563331|NCT03817853|156254493|FG000|Induction Phase|Progressive Disease|6|||
48563332|NCT03817853|156254494|FG001|Induction Phase|Progressive Disease|0|||
48563333|NCT03817853|156254495|FG002|Induction Phase|Progressive Disease|0|||
48563334|NCT03817853|156254493|FG000|Induction Phase|Withdrawal by Subject|4|||
48563335|NCT03817853|156254494|FG001|Induction Phase|Withdrawal by Subject|0|||
48563336|NCT03817853|156254495|FG002|Induction Phase|Withdrawal by Subject|0|||
48563337|NCT03817853|156254493|FG000|Maintenance Phase|Adverse Event|0|||
48563338|NCT03817853|156254494|FG001|Maintenance Phase|Adverse Event|8|||
48563339|NCT03817853|156254495|FG002|Maintenance Phase|Adverse Event|0|||
48563340|NCT03817853|156254493|FG000|Maintenance Phase|Death|0|||
48563341|NCT03817853|156254494|FG001|Maintenance Phase|Death|5|||
48563342|NCT03817853|156254495|FG002|Maintenance Phase|Death|0|||
48563343|NCT03817853|156254493|FG000|Maintenance Phase|Progressive Disease|0|||
48563344|NCT03817853|156254494|FG001|Maintenance Phase|Progressive Disease|7|||
48563345|NCT03817853|156254495|FG002|Maintenance Phase|Progressive Disease|0|||
48563346|NCT03817853|156254493|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48563347|NCT03817853|156254494|FG001|Maintenance Phase|Withdrawal by Subject|2|||
48563348|NCT03817853|156254495|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48563349|NCT03817853|156254493|FG000|Maintenance Phase|Physician Decision|0|||
48563350|NCT03817853|156254494|FG001|Maintenance Phase|Physician Decision|1|||
48563351|NCT03817853|156254495|FG002|Maintenance Phase|Physician Decision|0|||
48563352|NCT03817853|156254493|FG000|Maintenance Phase|Various reasons|0|||
48563353|NCT03817853|156254494|FG001|Maintenance Phase|Various reasons|4|||
48563354|NCT03817853|156254495|FG002|Maintenance Phase|Various reasons|0|||
48563355|NCT03817853|156254493|FG000|Maintenance Phase|Protocol Deviation|0|||
48563356|NCT03817853|156254494|FG001|Maintenance Phase|Protocol Deviation|1|||
48563357|NCT03817853|156254495|FG002|Maintenance Phase|Protocol Deviation|0|||
48563358|NCT03817853|156254493|FG000|Follow-up Phase|Adverse Event|0|||
48563359|NCT03817853|156254494|FG001|Follow-up Phase|Adverse Event|0|||
48563360|NCT03817853|156254495|FG002|Follow-up Phase|Adverse Event|2|||
48563361|NCT03817853|156254493|FG000|Follow-up Phase|Death|0|||
48563362|NCT03817853|156254494|FG001|Follow-up Phase|Death|0|||
48563363|NCT03817853|156254495|FG002|Follow-up Phase|Death|1|||
48563364|NCT03817853|156254493|FG000|Follow-up Phase|Progressive Disease|0|||
48563365|NCT03817853|156254494|FG001|Follow-up Phase|Progressive Disease|0|||
48563366|NCT03817853|156254495|FG002|Follow-up Phase|Progressive Disease|3|||
48563367|NCT03817853|156254493|FG000|Follow-up Phase|Withdrawal by Subject|0|||
48563368|NCT03817853|156254494|FG001|Follow-up Phase|Withdrawal by Subject|0|||
48563369|NCT03817853|156254495|FG002|Follow-up Phase|Withdrawal by Subject|1|||
48563370|NCT01836471|156254496|FG000|Overall Study|Pregnancy|1|||
48563371|NCT01836471|156254497|FG001|Overall Study|Pregnancy|0|||
48563372|NCT01836471|156254498|FG002|Overall Study|Pregnancy|0|||
48563373|NCT01836471|156254499|FG003|Overall Study|Pregnancy|0|||
48563374|NCT01836471|156254500|FG004|Overall Study|Pregnancy|0|||
48563375|NCT01836471|156254496|FG000|Overall Study|Withdrawal by Subject|3|||
48563376|NCT01836471|156254497|FG001|Overall Study|Withdrawal by Subject|4|||
48563377|NCT01836471|156254498|FG002|Overall Study|Withdrawal by Subject|1|||
48563378|NCT01836471|156254499|FG003|Overall Study|Withdrawal by Subject|0|||
48563379|NCT01836471|156254500|FG004|Overall Study|Withdrawal by Subject|2|||
48563380|NCT01836471|156254496|FG000|Overall Study|Physician Decision|0|||
48563381|NCT01836471|156254497|FG001|Overall Study|Physician Decision|1|||
48563382|NCT01836471|156254498|FG002|Overall Study|Physician Decision|0|||
48563383|NCT01836471|156254499|FG003|Overall Study|Physician Decision|0|||
48563384|NCT01836471|156254500|FG004|Overall Study|Physician Decision|0|||
48563385|NCT01836471|156254496|FG000|Overall Study|Lost to Follow-up|0|||
48563386|NCT01836471|156254497|FG001|Overall Study|Lost to Follow-up|0|||
48563387|NCT01836471|156254498|FG002|Overall Study|Lost to Follow-up|0|||
48563388|NCT01836471|156254499|FG003|Overall Study|Lost to Follow-up|1|||
48563389|NCT01836471|156254500|FG004|Overall Study|Lost to Follow-up|1|||
48563390|NCT01836471|156254496|FG000|Overall Study|Adverse Event|6|||
48563391|NCT01836471|156254497|FG001|Overall Study|Adverse Event|3|||
48563392|NCT01836471|156254498|FG002|Overall Study|Adverse Event|1|||
48563393|NCT01836471|156254499|FG003|Overall Study|Adverse Event|1|||
48563394|NCT01836471|156254500|FG004|Overall Study|Adverse Event|2|||
48563395|NCT01836471|156254496|FG000|Overall Study|Non compliance with tx|1|||
48563396|NCT01836471|156254497|FG001|Overall Study|Non compliance with tx|1|||
48617090|NCT01560988|156453053|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
48563397|NCT01836471|156254498|FG002|Overall Study|Non compliance with tx|0|||
48563398|NCT01836471|156254499|FG003|Overall Study|Non compliance with tx|0|||
48563399|NCT01836471|156254500|FG004|Overall Study|Non compliance with tx|0|||
48563400|NCT01283464|156254511|FG000|Overall Study|Lost to Follow-up|0|||
48563401|NCT01283464|156254512|FG001|Overall Study|Lost to Follow-up|1|||
48563402|NCT01283464|156254511|FG000|Overall Study|Withdrawal by Subject|1|||
48563403|NCT01283464|156254512|FG001|Overall Study|Withdrawal by Subject|0|||
48563404|NCT01283464|156254511|FG000|Overall Study|Physician Decision|1|||
48563405|NCT01283464|156254512|FG001|Overall Study|Physician Decision|0|||
48563406|NCT03762265|156254513|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
48563407|NCT03762265|156254514|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
48563408|NCT03762265|156254513|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
48563409|NCT03762265|156254514|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
48563410|NCT03762265|156254513|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
48563411|NCT03762265|156254514|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
48563412|NCT03762265|156254513|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
48563413|NCT03762265|156254514|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
48563414|NCT03762265|156254513|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
48563415|NCT03762265|156254514|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
48563416|NCT03762265|156254513|FG000|BT Period: Weeks 1 to 37|Other|0|||
48563417|NCT03762265|156254514|FG001|BT Period: Weeks 1 to 37|Other|1|||
48563418|NCT03762265|156254513|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
48563419|NCT03762265|156254514|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
48563420|NCT03762265|156254513|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
48563421|NCT03762265|156254514|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
48563422|NCT03762265|156254513|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
48563423|NCT03762265|156254514|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
48563424|NCT03762265|156254513|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
48563425|NCT03762265|156254514|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
48563426|NCT03762265|156254513|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
48563427|NCT03762265|156254514|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
48563428|NCT03762265|156254513|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
48563429|NCT03762265|156254514|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
48563430|NCT03762265|156254513|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
48563431|NCT03762265|156254514|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
48563432|NCT03762265|156254513|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
48563433|NCT03762265|156254514|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
48563434|NCT03762265|156254513|FG000|LTE Period: Weeks 61 to 109|Other|1|||
48563435|NCT03762265|156254514|FG001|LTE Period: Weeks 61 to 109|Other|0|||
48563436|NCT00745901|156254519|FG000|Overall Study|Adverse Event|3|||
48563437|NCT00745901|156254520|FG001|Overall Study|Adverse Event|4|||
48563438|NCT00745901|156254519|FG000|Overall Study|Protocol Violation|0|||
48563439|NCT00745901|156254520|FG001|Overall Study|Protocol Violation|1|||
48563440|NCT00745901|156254519|FG000|Overall Study|Withdrawal by Subject|1|||
48563441|NCT00745901|156254520|FG001|Overall Study|Withdrawal by Subject|0|||
48563442|NCT00745901|156254519|FG000|Overall Study|Lost to Follow-up|7|||
48563443|NCT00745901|156254520|FG001|Overall Study|Lost to Follow-up|4|||
48563444|NCT00745901|156254519|FG000|Overall Study|Pregnancy|2|||
48563445|NCT00745901|156254520|FG001|Overall Study|Pregnancy|4|||
48563446|NCT00745901|156254519|FG000|Overall Study|Lack of compliance|2|||
48563447|NCT00745901|156254520|FG001|Overall Study|Lack of compliance|2|||
48563448|NCT00745901|156254519|FG000|Overall Study|Patient's next menses did not start with|1|||
48563449|NCT00745901|156254520|FG001|Overall Study|Patient's next menses did not start with|0|||
48563450|NCT00745901|156254519|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
48563451|NCT00745901|156254520|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
48563452|NCT00745901|156254519|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
48563453|NCT00745901|156254520|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
48563454|NCT00745901|156254519|FG000|Overall Study|Patient didn't take any study medication|7|||
48563455|NCT00745901|156254520|FG001|Overall Study|Patient didn't take any study medication|3|||
48563456|NCT02554682|156254521|FG000|Overall Study|Lost to Follow-up|11|||
48563457|NCT02554682|156254522|FG001|Overall Study|Lost to Follow-up|9|||
48563458|NCT02554682|156254523|FG002|Overall Study|Lost to Follow-up|4|||
48563459|NCT02554682|156254524|FG003|Overall Study|Lost to Follow-up|3|||
48563460|NCT02554682|156254525|FG004|Overall Study|Lost to Follow-up|2|||
48563461|NCT02554682|156254526|FG005|Overall Study|Lost to Follow-up|1|||
48563462|NCT02554682|156254527|FG006|Overall Study|Lost to Follow-up|6|||
48563463|NCT02554682|156254528|FG007|Overall Study|Lost to Follow-up|6|||
48563464|NCT02554682|156254529|FG008|Overall Study|Lost to Follow-up|2|||
48563465|NCT02554682|156254530|FG009|Overall Study|Lost to Follow-up|2|||
48563466|NCT02554682|156254521|FG000|Overall Study|Withdrawal by Subject|2|||
48563467|NCT02554682|156254522|FG001|Overall Study|Withdrawal by Subject|1|||
48563468|NCT02554682|156254523|FG002|Overall Study|Withdrawal by Subject|0|||
48563469|NCT02554682|156254524|FG003|Overall Study|Withdrawal by Subject|0|||
48563470|NCT02554682|156254525|FG004|Overall Study|Withdrawal by Subject|0|||
48563471|NCT02554682|156254526|FG005|Overall Study|Withdrawal by Subject|0|||
48563472|NCT02554682|156254527|FG006|Overall Study|Withdrawal by Subject|0|||
48563473|NCT02554682|156254528|FG007|Overall Study|Withdrawal by Subject|0|||
48563474|NCT02554682|156254529|FG008|Overall Study|Withdrawal by Subject|0|||
48563475|NCT02554682|156254530|FG009|Overall Study|Withdrawal by Subject|0|||
48563476|NCT02554682|156254521|FG000|Overall Study|Physician Decision|2|||
48563477|NCT02554682|156254522|FG001|Overall Study|Physician Decision|2|||
48563478|NCT02554682|156254523|FG002|Overall Study|Physician Decision|0|||
48563479|NCT02554682|156254524|FG003|Overall Study|Physician Decision|0|||
48563480|NCT02554682|156254525|FG004|Overall Study|Physician Decision|0|||
48563481|NCT02554682|156254526|FG005|Overall Study|Physician Decision|0|||
48563482|NCT02554682|156254527|FG006|Overall Study|Physician Decision|0|||
48563483|NCT02554682|156254528|FG007|Overall Study|Physician Decision|0|||
48563484|NCT02554682|156254529|FG008|Overall Study|Physician Decision|0|||
48563485|NCT02554682|156254530|FG009|Overall Study|Physician Decision|0|||
48563486|NCT00806403|156254531|FG000|Overall Study|Death|4|||
48563487|NCT00806403|156254532|FG001|Overall Study|Death|3|||
48563488|NCT00014495|156254537|FG000|Overall Study|Death|0|||
48563489|NCT00014495|156254538|FG001|Overall Study|Death|0|||
48563490|NCT00014495|156254539|FG002|Overall Study|Death|1|||
48563491|NCT00014495|156254540|FG003|Overall Study|Death|0|||
48563492|NCT00014495|156254537|FG000|Overall Study|Clinical deterioration|0|||
48563493|NCT00014495|156254538|FG001|Overall Study|Clinical deterioration|0|||
48563494|NCT00014495|156254539|FG002|Overall Study|Clinical deterioration|0|||
48563495|NCT00014495|156254540|FG003|Overall Study|Clinical deterioration|1|||
48563496|NCT01882985|156254541|FG000|Overall Study|Lost to Follow-up|1|||
48563497|NCT01882985|156254541|FG000|Overall Study|Withdrawal by Subject|1|||
48563498|NCT00450437|156254542|FG000|Overall Study|Withdrawal by Subject|10|||
48563499|NCT00450437|156254543|FG001|Overall Study|Withdrawal by Subject|2|||
48563500|NCT00450437|156254544|FG002|Overall Study|Withdrawal by Subject|0|||
48563501|NCT00450437|156254545|FG003|Overall Study|Withdrawal by Subject|1|||
48563502|NCT00450437|156254542|FG000|Overall Study|Lost to Follow-up|31|||
48563503|NCT00450437|156254543|FG001|Overall Study|Lost to Follow-up|12|||
48563504|NCT00450437|156254544|FG002|Overall Study|Lost to Follow-up|19|||
48563505|NCT00450437|156254545|FG003|Overall Study|Lost to Follow-up|9|||
48563506|NCT00450437|156254542|FG000|Overall Study|Protocol Violation|0|||
48563507|NCT00450437|156254543|FG001|Overall Study|Protocol Violation|1|||
48563508|NCT00450437|156254544|FG002|Overall Study|Protocol Violation|0|||
48563509|NCT00450437|156254545|FG003|Overall Study|Protocol Violation|1|||
48563510|NCT00450437|156254542|FG000|Overall Study|Inappropriate enrollment|4|||
48563511|NCT00450437|156254543|FG001|Overall Study|Inappropriate enrollment|1|||
48563512|NCT00450437|156254544|FG002|Overall Study|Inappropriate enrollment|3|||
48563513|NCT00450437|156254545|FG003|Overall Study|Inappropriate enrollment|0|||
48563514|NCT00450437|156254542|FG000|Overall Study|Administrative reason|0|||
48563515|NCT00450437|156254543|FG001|Overall Study|Administrative reason|0|||
48563516|NCT00450437|156254544|FG002|Overall Study|Administrative reason|1|||
48563517|NCT00450437|156254545|FG003|Overall Study|Administrative reason|0|||
48563518|NCT00450437|156254542|FG000|Overall Study|Unable to Classify|1|||
48563519|NCT00450437|156254543|FG001|Overall Study|Unable to Classify|0|||
48563520|NCT00450437|156254544|FG002|Overall Study|Unable to Classify|1|||
48563521|NCT00450437|156254545|FG003|Overall Study|Unable to Classify|0|||
48563522|NCT01890122|156254546|FG000|Overall Study|Adverse Event|1|||
48563523|NCT01890122|156254547|FG001|Overall Study|Adverse Event|1|||
48563524|NCT01890122|156254548|FG002|Overall Study|Adverse Event|1|||
48563525|NCT01890122|156254549|FG003|Overall Study|Adverse Event|2|||
48563526|NCT01890122|156254546|FG000|Overall Study|Major Protocol Deviation|3|||
48563527|NCT01890122|156254547|FG001|Overall Study|Major Protocol Deviation|1|||
48563528|NCT01890122|156254548|FG002|Overall Study|Major Protocol Deviation|0|||
48563529|NCT01890122|156254549|FG003|Overall Study|Major Protocol Deviation|1|||
48563530|NCT01890122|156254546|FG000|Overall Study|Lost to Follow-up|0|||
48563531|NCT01890122|156254547|FG001|Overall Study|Lost to Follow-up|1|||
48563532|NCT01890122|156254548|FG002|Overall Study|Lost to Follow-up|2|||
48563533|NCT01890122|156254549|FG003|Overall Study|Lost to Follow-up|2|||
48563534|NCT01890122|156254546|FG000|Overall Study|Voluntary Withdrawal|8|||
48563535|NCT01890122|156254547|FG001|Overall Study|Voluntary Withdrawal|8|||
48563536|NCT01890122|156254548|FG002|Overall Study|Voluntary Withdrawal|2|||
48563537|NCT01890122|156254549|FG003|Overall Study|Voluntary Withdrawal|11|||
48563538|NCT01890122|156254546|FG000|Overall Study|Lack of Efficacy|14|||
48563539|NCT01890122|156254547|FG001|Overall Study|Lack of Efficacy|24|||
48563540|NCT01890122|156254548|FG002|Overall Study|Lack of Efficacy|7|||
48563541|NCT01890122|156254549|FG003|Overall Study|Lack of Efficacy|41|||
48563542|NCT01890122|156254546|FG000|Overall Study|Reason not Specified|0|||
48563543|NCT01890122|156254547|FG001|Overall Study|Reason not Specified|1|||
48563544|NCT01890122|156254548|FG002|Overall Study|Reason not Specified|1|||
48563545|NCT01890122|156254549|FG003|Overall Study|Reason not Specified|2|||
48563546|NCT01890122|156254546|FG000|Overall Study|Randomized but not Treated|1|||
48563547|NCT01890122|156254547|FG001|Overall Study|Randomized but not Treated|1|||
48563548|NCT01890122|156254548|FG002|Overall Study|Randomized but not Treated|0|||
48563549|NCT01890122|156254549|FG003|Overall Study|Randomized but not Treated|0|||
48563550|NCT00314327|156254554|FG000|Overall Study|Withdrawal by Subject|1|||
48563551|NCT02741076|156254555|FG000|Overall Study|Adverse Event|0|||
48563552|NCT02741076|156254556|FG001|Overall Study|Adverse Event|1|||
48563553|NCT02741076|156254557|FG002|Overall Study|Adverse Event|1|||
48563554|NCT02741076|156254558|FG003|Overall Study|Adverse Event|0|||
48563555|NCT02741076|156254555|FG000|Overall Study|Lack of Efficacy|1|||
48563556|NCT02741076|156254556|FG001|Overall Study|Lack of Efficacy|0|||
48563557|NCT02741076|156254557|FG002|Overall Study|Lack of Efficacy|0|||
48563558|NCT02741076|156254558|FG003|Overall Study|Lack of Efficacy|0|||
48563559|NCT02741076|156254555|FG000|Overall Study|Withdrawal by Subject|0|||
48563560|NCT02741076|156254556|FG001|Overall Study|Withdrawal by Subject|1|||
48563561|NCT02741076|156254557|FG002|Overall Study|Withdrawal by Subject|0|||
48563562|NCT02741076|156254558|FG003|Overall Study|Withdrawal by Subject|0|||
48563563|NCT02741076|156254555|FG000|Overall Study|Sponsor Request|2|||
48563564|NCT02741076|156254556|FG001|Overall Study|Sponsor Request|3|||
48563565|NCT02741076|156254557|FG002|Overall Study|Sponsor Request|0|||
48563566|NCT02741076|156254558|FG003|Overall Study|Sponsor Request|1|||
48563567|NCT02741076|156254555|FG000|Overall Study|No additional information available|0|||
48563568|NCT02741076|156254556|FG001|Overall Study|No additional information available|0|||
48563569|NCT02741076|156254557|FG002|Overall Study|No additional information available|1|||
48563570|NCT02741076|156254558|FG003|Overall Study|No additional information available|1|||
48563571|NCT02837731|156254559|FG000|Allocation|Admitted to General Floor|3|||
48563572|NCT02837731|156254560|FG001|Allocation|Admitted to General Floor|4|||
48563573|NCT02837731|156254559|FG000|Allocation|Immediate surgery/withdrew|2|||
48563574|NCT02837731|156254560|FG001|Allocation|Immediate surgery/withdrew|0|||
48563575|NCT02837731|156254559|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
48563576|NCT02837731|156254560|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
48563577|NCT02837731|156254559|FG000|Allocation|Withdrawal by Subject|2|||
48563578|NCT02837731|156254560|FG001|Allocation|Withdrawal by Subject|0|||
48563579|NCT02837731|156254559|FG000|Allocation|Device not available|1|||
48563580|NCT02837731|156254560|FG001|Allocation|Device not available|0|||
48563581|NCT02837731|156254559|FG000|Allocation|Protocol not implemented|7|||
48563582|NCT02837731|156254560|FG001|Allocation|Protocol not implemented|0|||
48563583|NCT02837731|156254559|FG000|Allocation|Moribund/Do not resuscitate|2|||
48563584|NCT02837731|156254560|FG001|Allocation|Moribund/Do not resuscitate|0|||
48563585|NCT02837731|156254559|FG000|Allocation|Did not meet sepsis criteria|1|||
48563586|NCT02837731|156254560|FG001|Allocation|Did not meet sepsis criteria|2|||
48563587|NCT02837731|156254559|FG000|Allocation|Known aortic abnormalities|0|||
48563588|NCT02837731|156254560|FG001|Allocation|Known aortic abnormalities|1|||
48563589|NCT01779440|156254564|FG000|Overall Study|Withdrawal by Subject|3|||
48563590|NCT01779440|156254565|FG001|Overall Study|Withdrawal by Subject|5|||
48563591|NCT02965573|156254566|FG000|Overall Study|Lack of Efficacy|1|||
48563592|NCT02965573|156254567|FG001|Overall Study|Lack of Efficacy|0|||
48563593|NCT01205269|156254568|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
48563594|NCT01205269|156254569|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
48563595|NCT01205269|156254570|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
48563596|NCT01205269|156254571|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
48563597|NCT01205269|156254572|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
48617091|NCT02541903|156453054|FG000|Overall Study|Death|1|||
48617092|NCT02421510|156453055|FG000|Overall Study|Other|4|||
48617093|NCT02421510|156453056|FG001|Overall Study|Other|2|||
48617094|NCT02421510|156453057|FG002|Overall Study|Other|3|||
48617095|NCT02421510|156453055|FG000|Overall Study|Protocol Violation|1|||
48617096|NCT02421510|156453056|FG001|Overall Study|Protocol Violation|2|||
48617097|NCT02421510|156453057|FG002|Overall Study|Protocol Violation|0|||
48617098|NCT02421510|156453055|FG000|Overall Study|Death|1|||
48617099|NCT02421510|156453056|FG001|Overall Study|Death|0|||
48617100|NCT02421510|156453057|FG002|Overall Study|Death|0|||
48617101|NCT02421510|156453055|FG000|Overall Study|Noncompliance with study drug|1|||
48617102|NCT02421510|156453056|FG001|Overall Study|Noncompliance with study drug|0|||
48617103|NCT02421510|156453057|FG002|Overall Study|Noncompliance with study drug|0|||
48617104|NCT02421510|156453055|FG000|Overall Study|Physician Decision|1|||
48617105|NCT02421510|156453056|FG001|Overall Study|Physician Decision|1|||
48617106|NCT02421510|156453057|FG002|Overall Study|Physician Decision|3|||
48617107|NCT02421510|156453055|FG000|Overall Study|Adverse Event|9|||
48617108|NCT02421510|156453056|FG001|Overall Study|Adverse Event|10|||
48617109|NCT02421510|156453057|FG002|Overall Study|Adverse Event|18|||
48617110|NCT02421510|156453055|FG000|Overall Study|Pregnancy|1|||
48617111|NCT02421510|156453056|FG001|Overall Study|Pregnancy|1|||
48617112|NCT02421510|156453057|FG002|Overall Study|Pregnancy|0|||
48617113|NCT02421510|156453055|FG000|Overall Study|Withdrawal by Subject|14|||
48617114|NCT02421510|156453056|FG001|Overall Study|Withdrawal by Subject|18|||
48617115|NCT02421510|156453057|FG002|Overall Study|Withdrawal by Subject|12|||
48617116|NCT02421510|156453055|FG000|Overall Study|Lost to Follow-up|1|||
48617117|NCT02421510|156453056|FG001|Overall Study|Lost to Follow-up|1|||
48617118|NCT02421510|156453057|FG002|Overall Study|Lost to Follow-up|0|||
48617119|NCT02691663|156453058|FG000|Overall Study|Screen failure after baseline|2|||
48617120|NCT02691663|156453059|FG001|Overall Study|Screen failure after baseline|2|||
48617121|NCT02691663|156453058|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
48617122|NCT02691663|156453059|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
48617123|NCT02691663|156453058|FG000|Overall Study|Withdrawn after Follow up 2|1|||
48617124|NCT02691663|156453059|FG001|Overall Study|Withdrawn after Follow up 2|1|||
48617125|NCT02691663|156453058|FG000|Overall Study|Lost to Follow-up|3|||
48563598|NCT01205269|156254573|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
48563599|NCT01804946|156254574|FG000|Overall Study|Protocol Violation|1|||
48563600|NCT01804946|156254575|FG001|Overall Study|Protocol Violation|0|||
48617126|NCT02691663|156453059|FG001|Overall Study|Lost to Follow-up|2|||
48617127|NCT04925934|156453060|FG000|Overall Study|Adverse Event|1|||
48563601|NCT01804946|156254574|FG000|Overall Study|Adverse Event|0|||
48563602|NCT01804946|156254575|FG001|Overall Study|Adverse Event|1|||
48563603|NCT01804946|156254574|FG000|Overall Study|Insufficient data available|0|||
48563604|NCT01804946|156254575|FG001|Overall Study|Insufficient data available|1|||
48563605|NCT01804946|156254574|FG000|Overall Study|Do not meet inclusion criteria|1|||
48563606|NCT01804946|156254575|FG001|Overall Study|Do not meet inclusion criteria|2|||
48563607|NCT00987337|156254576|FG000|Overall Study|Adverse Event|10|||
48563608|NCT00987337|156254577|FG001|Overall Study|Adverse Event|9|||
48563609|NCT00987337|156254578|FG002|Overall Study|Adverse Event|8|||
48563610|NCT00987337|156254576|FG000|Overall Study|Insufficient Virologic Response|10|||
48563611|NCT00987337|156254577|FG001|Overall Study|Insufficient Virologic Response|7|||
48563612|NCT00987337|156254578|FG002|Overall Study|Insufficient Virologic Response|12|||
48563613|NCT00987337|156254576|FG000|Overall Study|Virologic Breakthrough|2|||
48563614|NCT00987337|156254577|FG001|Overall Study|Virologic Breakthrough|2|||
48563615|NCT00987337|156254578|FG002|Overall Study|Virologic Breakthrough|8|||
48563616|NCT00987337|156254576|FG000|Overall Study|Lost to Follow-up|10|||
48563617|NCT00987337|156254577|FG001|Overall Study|Lost to Follow-up|6|||
48563618|NCT00987337|156254578|FG002|Overall Study|Lost to Follow-up|2|||
48563619|NCT00987337|156254576|FG000|Overall Study|Withdrawal by Subject|6|||
48563620|NCT00987337|156254577|FG001|Overall Study|Withdrawal by Subject|9|||
48563621|NCT00987337|156254578|FG002|Overall Study|Withdrawal by Subject|9|||
48563622|NCT00987337|156254576|FG000|Overall Study|Other|0|||
48563623|NCT00987337|156254577|FG001|Overall Study|Other|2|||
48563624|NCT00987337|156254578|FG002|Overall Study|Other|5|||
48563625|NCT00987337|156254576|FG000|Overall Study|Protocol Violation|1|||
48563626|NCT00987337|156254577|FG001|Overall Study|Protocol Violation|0|||
48563627|NCT00987337|156254578|FG002|Overall Study|Protocol Violation|2|||
48563628|NCT00987337|156254576|FG000|Overall Study|Participant Relapsed|18|||
48563629|NCT00987337|156254577|FG001|Overall Study|Participant Relapsed|20|||
48563630|NCT00987337|156254578|FG002|Overall Study|Participant Relapsed|5|||
48563631|NCT02859337|156254579|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
48563632|NCT02859337|156254580|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
48563633|NCT02859337|156254581|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
48563634|NCT02859337|156254579|FG000|Overall Study|Withdrawal by Subject|3|||
48563635|NCT02859337|156254580|FG001|Overall Study|Withdrawal by Subject|1|||
48563636|NCT02859337|156254581|FG002|Overall Study|Withdrawal by Subject|0|||
48563637|NCT02859337|156254579|FG000|Overall Study|Lost to Follow-up|1|||
48563638|NCT02859337|156254580|FG001|Overall Study|Lost to Follow-up|0|||
48563639|NCT02859337|156254581|FG002|Overall Study|Lost to Follow-up|0|||
48563640|NCT03830333|156254582|FG000|Overall Study|Death|0|||
48563641|NCT03830333|156254583|FG001|Overall Study|Death|1|||
48563642|NCT03830333|156254582|FG000|Overall Study|Withdrawal by Subject|5|||
48563643|NCT03830333|156254583|FG001|Overall Study|Withdrawal by Subject|1|||
48563644|NCT03830333|156254582|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
48563645|NCT03830333|156254583|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
48563646|NCT00722137|156254584|FG000|Overall Study|Overt Disease Progression|5|||
48563647|NCT00722137|156254585|FG001|Overall Study|Overt Disease Progression|4|||
48563648|NCT00722137|156254584|FG000|Overall Study|Adverse Event|17|||
48563649|NCT00722137|156254585|FG001|Overall Study|Adverse Event|21|||
48563650|NCT00722137|156254584|FG000|Overall Study|Death|12|||
48563651|NCT00722137|156254585|FG001|Overall Study|Death|7|||
48563652|NCT00722137|156254584|FG000|Overall Study|Withdrawal by Subject|6|||
48563653|NCT00722137|156254585|FG001|Overall Study|Withdrawal by Subject|9|||
48563654|NCT00722137|156254584|FG000|Overall Study|Other Reason Unknown|3|||
48563655|NCT00722137|156254585|FG001|Overall Study|Other Reason Unknown|4|||
48563656|NCT00722137|156254584|FG000|Overall Study|Randomized But Not Treated|2|||
48563657|NCT00722137|156254585|FG001|Overall Study|Randomized But Not Treated|3|||
48563658|NCT00523848|156254586|FG000|Overall Study|Adverse Event|11|||
48563659|NCT00523848|156254586|FG000|Overall Study|Withdrawal by Subject|2|||
48563660|NCT00523848|156254586|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
48563661|NCT00523848|156254586|FG000|Overall Study|Disease Progression|5|||
48563662|NCT00523848|156254586|FG000|Overall Study|Other, unspecified|4|||
48563663|NCT01445730|156254587|FG000|Overall Study|Adverse Event|1|||
48563664|NCT01445730|156254587|FG000|Overall Study|For the advice of a dentist|1|||
48563665|NCT01445730|156254587|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
48563666|NCT02729025|156254588|FG000|Overall Study|Sponsor Decision|0|||
48563667|NCT02729025|156254589|FG001|Overall Study|Sponsor Decision|1|||
48563668|NCT00603473|156254590|FG000|Overall Study|Adverse Event|4|||
48563669|NCT00603473|156254590|FG000|Overall Study|Lack of Efficacy|4|||
48563670|NCT00603473|156254590|FG000|Overall Study|Protocol Violation|1|||
48563671|NCT01367886|156254595|FG000|Overall Study|Lost to Follow-up|4|||
48563672|NCT01367886|156254595|FG000|Overall Study|Lack of Efficacy|2|||
48563673|NCT01367886|156254595|FG000|Overall Study|Death|1|||
48563674|NCT04577404|156254596|FG000|Overall Study|Adverse Event|31|||
48563675|NCT04577404|156254596|FG000|Overall Study|Death|1|||
48563676|NCT04577404|156254596|FG000|Overall Study|Lack of Efficacy|3|||
48563677|NCT04577404|156254596|FG000|Overall Study|Physician Decision|7|||
48563678|NCT04577404|156254596|FG000|Overall Study|Withdrawal by Subject|21|||
48563679|NCT04577404|156254596|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
48563680|NCT00985504|156254601|FG000|Acute Treatment Period|Adverse Event|3|||
48563681|NCT00985504|156254602|FG001|Acute Treatment Period|Adverse Event|4|||
48563682|NCT00985504|156254601|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
48563683|NCT00985504|156254602|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
48563684|NCT00985504|156254601|FG000|Acute Treatment Period|Protocol Violation|2|||
48563685|NCT00985504|156254602|FG001|Acute Treatment Period|Protocol Violation|0|||
48563686|NCT00985504|156254601|FG000|Acute Treatment Period|Sponsor Decision|0|||
48563687|NCT00985504|156254602|FG001|Acute Treatment Period|Sponsor Decision|1|||
48563688|NCT00985504|156254601|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
48563689|NCT00985504|156254602|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
48563690|NCT00985504|156254601|FG000|Optimization Period|Adverse Event|7|||
48563691|NCT00985504|156254602|FG001|Optimization Period|Adverse Event|9|||
48563692|NCT00985504|156254601|FG000|Optimization Period|Death|0|||
48563693|NCT00985504|156254602|FG001|Optimization Period|Death|1|||
48563694|NCT00985504|156254601|FG000|Optimization Period|Lack of Efficacy|5|||
48563695|NCT00985504|156254602|FG001|Optimization Period|Lack of Efficacy|3|||
48563696|NCT00985504|156254601|FG000|Optimization Period|Lost to Follow-up|0|||
48563697|NCT00985504|156254602|FG001|Optimization Period|Lost to Follow-up|1|||
48563698|NCT00985504|156254601|FG000|Optimization Period|Physician Decision|1|||
48563699|NCT00985504|156254602|FG001|Optimization Period|Physician Decision|0|||
48563700|NCT00985504|156254601|FG000|Optimization Period|Protocol Violation|3|||
48563701|NCT00985504|156254602|FG001|Optimization Period|Protocol Violation|1|||
48563702|NCT00985504|156254601|FG000|Optimization Period|Withdrawal by Subject|10|||
48563703|NCT00985504|156254602|FG001|Optimization Period|Withdrawal by Subject|8|||
48563704|NCT02389829|156254614|FG000|Overall Study|Lost to Follow-up|0|||
48563705|NCT02389829|156254615|FG001|Overall Study|Lost to Follow-up|1|||
48563706|NCT04982575|156256510|FG000|Overall Study|Withdrawal by Subject|2|||
48563707|NCT04982575|156256511|FG001|Overall Study|Withdrawal by Subject|0|||
48563708|NCT04982575|156256512|FG002|Overall Study|Withdrawal by Subject|2|||
48563709|NCT00855894|156256513|FG000|Overall Study|Death|31|||
48563710|NCT00855894|156256513|FG000|Overall Study|Patient's decision|1|||
48563711|NCT00855894|156256513|FG000|Overall Study|Disease progression|1|||
48563712|NCT01557504|156256514|FG000|Overall Study|Physician Decision|1|||
48563713|NCT01557504|156256515|FG001|Overall Study|Physician Decision|0|||
48563714|NCT04231825|156256516|FG000|Overall Study|Protocol Violation|3|||
48563715|NCT04231825|156256517|FG001|Overall Study|Protocol Violation|3|||
48563716|NCT04231825|156256516|FG000|Overall Study|Lost to Follow-up|0|||
48563717|NCT04231825|156256517|FG001|Overall Study|Lost to Follow-up|1|||
48563718|NCT01321749|156256525|FG000|Overall Study|Lost to Follow-up|4|||
48563719|NCT01321749|156256526|FG001|Overall Study|Lost to Follow-up|11|||
48563720|NCT01321749|156256525|FG000|Overall Study|Protocol Violation|4|||
48563721|NCT01321749|156256526|FG001|Overall Study|Protocol Violation|7|||
48563722|NCT01321749|156256525|FG000|Overall Study|Withdrawal by Subject|5|||
48563723|NCT01321749|156256526|FG001|Overall Study|Withdrawal by Subject|4|||
48563724|NCT00077207|156256530|FG000|Overall Study|Adverse Event|5|||
48563725|NCT00077207|156256530|FG000|Overall Study|Lack of Efficacy|12|||
48617128|NCT04925934|156453061|FG001|Overall Study|Adverse Event|0|||
48563726|NCT00077207|156256530|FG000|Overall Study|Physician Decision|6|||
48563727|NCT00077207|156256530|FG000|Overall Study|Withdrawal by Subject|6|||
48563728|NCT00077207|156256530|FG000|Overall Study|Ineligible|1|||
48563729|NCT02572570|156256531|FG000|Overall Study|Study Terminated|27|||
48563730|NCT01290068|156256534|FG000|Overall Study|Adverse Event|1|||
48563731|NCT01290068|156256535|FG001|Overall Study|Adverse Event|3|||
48563732|NCT01290068|156256534|FG000|Overall Study|Lost to Follow-up|3|||
48563733|NCT01290068|156256535|FG001|Overall Study|Lost to Follow-up|0|||
48563734|NCT01290068|156256534|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
48563735|NCT01290068|156256535|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
48563736|NCT01290068|156256534|FG000|Overall Study|Other|3|||
48563737|NCT01290068|156256535|FG001|Overall Study|Other|1|||
48563738|NCT02633293|156256536|FG000|Overall Study|Death|56|||
48563739|NCT02633293|156256536|FG000|Overall Study|Progressive Disease|12|||
48563740|NCT02633293|156256536|FG000|Overall Study|Adverse Event|29|||
48563741|NCT02633293|156256536|FG000|Overall Study|Withdrawal by Subject|41|||
48563742|NCT02633293|156256536|FG000|Overall Study|Protocol Violation|1|||
48563743|NCT02633293|156256536|FG000|Overall Study|Lost to Follow-up|1|||
48563744|NCT02633293|156256536|FG000|Overall Study|Study Terminated by Sponsor|24|||
48563745|NCT02633293|156256536|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
48563746|NCT02633293|156256536|FG000|Overall Study|Lung Transplant|5|||
48563747|NCT02633293|156256536|FG000|Overall Study|Lack of Efficacy|2|||
48563748|NCT02633293|156256536|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
48563749|NCT01017874|156256537|FG000|Overall Study|Withdrawal by Subject|23|||
48563750|NCT01017874|156256538|FG001|Overall Study|Withdrawal by Subject|20|||
48563751|NCT01017874|156256537|FG000|Overall Study|Sponsor decision|3|||
48563752|NCT01017874|156256538|FG001|Overall Study|Sponsor decision|1|||
48563753|NCT01017874|156256537|FG000|Overall Study|Lost to Follow-up|3|||
48563754|NCT01017874|156256538|FG001|Overall Study|Lost to Follow-up|2|||
48563755|NCT01017874|156256537|FG000|Overall Study|Physician Decision|1|||
48563756|NCT01017874|156256538|FG001|Overall Study|Physician Decision|3|||
48563757|NCT00925704|156256539|FG000|First Intervention|Withdrew consent|0|||
48563758|NCT00925704|156256540|FG001|First Intervention|Withdrew consent|0|||
48563759|NCT00925704|156256541|FG002|First Intervention|Withdrew consent|0|||
48563760|NCT00925704|156256542|FG003|First Intervention|Withdrew consent|1|||
48563761|NCT00925704|156256543|FG004|First Intervention|Withdrew consent|1|||
48563762|NCT00925704|156256544|FG005|First Intervention|Withdrew consent|0|||
48563763|NCT00925704|156256539|FG000|Second Intervention|Withdrawal by Subject|1|||
48563764|NCT00925704|156256540|FG001|Second Intervention|Withdrawal by Subject|0|||
48563765|NCT00925704|156256541|FG002|Second Intervention|Withdrawal by Subject|0|||
48563766|NCT00925704|156256542|FG003|Second Intervention|Withdrawal by Subject|0|||
48563767|NCT00925704|156256543|FG004|Second Intervention|Withdrawal by Subject|1|||
48563768|NCT00925704|156256544|FG005|Second Intervention|Withdrawal by Subject|0|||
48563769|NCT00925704|156256539|FG000|Third Intervention|Withdrew consent|0|||
48563770|NCT00925704|156256540|FG001|Third Intervention|Withdrew consent|0|||
48563771|NCT00925704|156256541|FG002|Third Intervention|Withdrew consent|0|||
48563772|NCT00925704|156256542|FG003|Third Intervention|Withdrew consent|0|||
48563773|NCT00925704|156256543|FG004|Third Intervention|Withdrew consent|0|||
48563774|NCT00925704|156256544|FG005|Third Intervention|Withdrew consent|1|||
48563775|NCT03207815|156256545|FG000|Overall Study|Protocol Violation|3|||
48563776|NCT03207815|156256546|FG001|Overall Study|Protocol Violation|1|||
48563777|NCT03207815|156256545|FG000|Overall Study|Adverse Event|1|||
48563778|NCT03207815|156256546|FG001|Overall Study|Adverse Event|2|||
48563779|NCT03207815|156256545|FG000|Overall Study|Lost to Follow-up|1|||
48563780|NCT03207815|156256546|FG001|Overall Study|Lost to Follow-up|2|||
48563781|NCT03207815|156256545|FG000|Overall Study|Investigator's Discretion|1|||
48563782|NCT03207815|156256546|FG001|Overall Study|Investigator's Discretion|1|||
48563783|NCT03207815|156256545|FG000|Overall Study|Lack of Efficacy|0|||
48563784|NCT03207815|156256546|FG001|Overall Study|Lack of Efficacy|1|||
48563785|NCT03207815|156256545|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
48563786|NCT03207815|156256546|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
48563787|NCT03207815|156256545|FG000|Overall Study|Withdrew Consent|1|||
48563788|NCT03207815|156256546|FG001|Overall Study|Withdrew Consent|0|||
48563789|NCT05370040|156256547|FG000|Overall Study|Lost to Follow-up|0|||
48563790|NCT05370040|156256548|FG001|Overall Study|Lost to Follow-up|0|||
48563791|NCT05370040|156256549|FG002|Overall Study|Lost to Follow-up|1|||
48563792|NCT05370040|156256550|FG003|Overall Study|Lost to Follow-up|0|||
48563793|NCT05370040|156256551|FG004|Overall Study|Lost to Follow-up|1|||
48563794|NCT05370040|156256552|FG005|Overall Study|Lost to Follow-up|0|||
48563795|NCT02569801|156256553|FG000|Overall Study|Withdrawal by Subject|9|||
48563796|NCT02569801|156256554|FG001|Overall Study|Withdrawal by Subject|9|||
48563797|NCT02569801|156256553|FG000|Overall Study|Sponsor Decision|13|||
48563798|NCT02569801|156256554|FG001|Overall Study|Sponsor Decision|14|||
48563799|NCT02569801|156256553|FG000|Overall Study|Progressive Disease|2|||
48563800|NCT02569801|156256554|FG001|Overall Study|Progressive Disease|7|||
48563801|NCT02569801|156256553|FG000|Overall Study|Lost to Follow-up|0|||
48563802|NCT02569801|156256554|FG001|Overall Study|Lost to Follow-up|1|||
48563803|NCT02569801|156256553|FG000|Overall Study|Death|12|||
48563804|NCT02569801|156256554|FG001|Overall Study|Death|4|||
48563805|NCT00391768|156256555|FG000|Overall Study|Withdrawal by Subject|0|||
48563806|NCT00391768|156256556|FG001|Overall Study|Withdrawal by Subject|0|||
48563807|NCT00391768|156256557|FG002|Overall Study|Withdrawal by Subject|1|||
48563808|NCT00391768|156256558|FG003|Overall Study|Withdrawal by Subject|0|||
48563809|NCT00391768|156256559|FG004|Overall Study|Withdrawal by Subject|0|||
48563810|NCT00391768|156256560|FG005|Overall Study|Withdrawal by Subject|1|||
48563811|NCT00391768|156256561|FG006|Overall Study|Withdrawal by Subject|1|||
48563812|NCT00391768|156256555|FG000|Overall Study|Lost to Follow-up|0|||
48563813|NCT00391768|156256556|FG001|Overall Study|Lost to Follow-up|0|||
48563814|NCT00391768|156256557|FG002|Overall Study|Lost to Follow-up|0|||
48563815|NCT00391768|156256558|FG003|Overall Study|Lost to Follow-up|1|||
48617129|NCT04925934|156453062|FG002|Overall Study|Adverse Event|0|||
48617130|NCT04925934|156453060|FG000|Overall Study|Lost to Follow-up|2|||
48617131|NCT04925934|156453061|FG001|Overall Study|Lost to Follow-up|0|||
48617132|NCT04925934|156453062|FG002|Overall Study|Lost to Follow-up|1|||
48617133|NCT04925934|156453060|FG000|Overall Study|Death|0|||
48617134|NCT04925934|156453061|FG001|Overall Study|Death|1|||
48617135|NCT04925934|156453062|FG002|Overall Study|Death|0|||
48617136|NCT04925934|156453060|FG000|Overall Study|Withdrawal by Subject|8|||
48617137|NCT04925934|156453061|FG001|Overall Study|Withdrawal by Subject|5|||
48617138|NCT04925934|156453062|FG002|Overall Study|Withdrawal by Subject|9|||
48617139|NCT04925934|156453060|FG000|Overall Study|Other|2|||
48617140|NCT04925934|156453061|FG001|Overall Study|Other|2|||
48617141|NCT04925934|156453062|FG002|Overall Study|Other|2|||
48617142|NCT04925934|156453060|FG000|Overall Study|Eastern European Conflict|7|||
48617143|NCT04925934|156453061|FG001|Overall Study|Eastern European Conflict|3|||
48617144|NCT04925934|156453062|FG002|Overall Study|Eastern European Conflict|2|||
48563816|NCT00391768|156256559|FG004|Overall Study|Lost to Follow-up|2|||
48563817|NCT00391768|156256560|FG005|Overall Study|Lost to Follow-up|2|||
48563818|NCT00391768|156256561|FG006|Overall Study|Lost to Follow-up|3|||
48617145|NCT01149538|156453064|FG000|Overall Study|Lost to Follow-up|0|||
48617146|NCT01149538|156453065|FG001|Overall Study|Lost to Follow-up|1|||
48563819|NCT00428246|156256562|FG000|Overall Study|Withdrawal by Subject|0|||
48563820|NCT00428246|156256563|FG001|Overall Study|Withdrawal by Subject|0|||
48563821|NCT00428246|156256564|FG002|Overall Study|Withdrawal by Subject|1|||
48563822|NCT00428246|156256562|FG000|Overall Study|Adverse Event|1|||
48563823|NCT00428246|156256563|FG001|Overall Study|Adverse Event|0|||
48563824|NCT00428246|156256564|FG002|Overall Study|Adverse Event|0|||
48563825|NCT01293695|156256565|FG000|Overall Study|Withdrawal by Subject|7|||
48563826|NCT01293695|156256566|FG001|Overall Study|Withdrawal by Subject|1|||
48563827|NCT01293695|156256565|FG000|Overall Study|Lost to Follow-up|8|||
48563828|NCT01293695|156256566|FG001|Overall Study|Lost to Follow-up|6|||
48563829|NCT01960413|156256569|FG000|Overall Study|Withdrawal by Subject|1|||
48563830|NCT01960413|156256570|FG001|Overall Study|Withdrawal by Subject|1|||
48563831|NCT01960413|156256569|FG000|Overall Study|Physician Decision|1|||
48563832|NCT01960413|156256570|FG001|Overall Study|Physician Decision|0|||
48563833|NCT01960413|156256569|FG000|Overall Study|Lost to Follow-up|2|||
48563834|NCT01960413|156256570|FG001|Overall Study|Lost to Follow-up|0|||
48563835|NCT00778817|156256583|FG000|Overall Study|Adverse Event|2|||
48563836|NCT00778817|156256583|FG000|Overall Study|Withdrawal by Subject|2|||
48563837|NCT01620138|156256584|FG000|Overall Study|Withdrawal by Subject|3|||
48563838|NCT01620138|156256585|FG001|Overall Study|Withdrawal by Subject|0|||
48563839|NCT01620138|156256584|FG000|Overall Study|Lack of Efficacy|1|||
48563840|NCT01620138|156256585|FG001|Overall Study|Lack of Efficacy|0|||
48563841|NCT01620138|156256584|FG000|Overall Study|Adverse Event|2|||
48563842|NCT01620138|156256585|FG001|Overall Study|Adverse Event|0|||
48563843|NCT01082328|156256588|FG000|Overall Study|Adverse Event|1|||
48563844|NCT02285361|156256591|FG000|Overall Study|Protocol Violation|43|||
48563845|NCT02285361|156256591|FG000|Overall Study|Lost to Follow-up|5|||
48563846|NCT02285361|156256591|FG000|Overall Study|Not taken GIOTRIF|2|||
48563847|NCT02285361|156256591|FG000|Overall Study|Consented prior to the contract date|1|||
48563848|NCT00957801|156256592|FG000|Overall Study|Withdrawal by Subject|0|||
48563849|NCT00957801|156256593|FG001|Overall Study|Withdrawal by Subject|0|||
48563850|NCT00957801|156256594|FG002|Overall Study|Withdrawal by Subject|0|||
48563851|NCT00957801|156256595|FG003|Overall Study|Withdrawal by Subject|1|||
48563852|NCT00031590|156256596|FG000|Overall Study|Adverse Event|1|||
48563853|NCT00031590|156256596|FG000|Overall Study|Withdrawal by parents|2|||
48563854|NCT02059135|156256601|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
48563855|NCT02059135|156256602|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
48563856|NCT02059135|156256601|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
48563857|NCT02059135|156256602|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
48617147|NCT01149538|156453064|FG000|Overall Study|Withdrawal by Subject|5|||
48563858|NCT02059135|156256601|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
48563859|NCT02059135|156256602|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
48563860|NCT02059135|156256601|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
48617148|NCT01149538|156453065|FG001|Overall Study|Withdrawal by Subject|3|||
48563861|NCT02059135|156256602|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
48563862|NCT02059135|156256601|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
48563863|NCT02059135|156256602|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
48563864|NCT02059135|156256601|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
48563865|NCT02059135|156256602|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
48563866|NCT02059135|156256601|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
48563867|NCT02059135|156256602|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
48563868|NCT02059135|156256601|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
48563869|NCT02059135|156256602|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
48563870|NCT02356588|156256603|FG000|Overall Study|Lack of Efficacy|4|||
48563871|NCT02356588|156256604|FG001|Overall Study|Lack of Efficacy|10|||
48563872|NCT02356588|156256603|FG000|Overall Study|Adverse Event|0|||
48563873|NCT02356588|156256604|FG001|Overall Study|Adverse Event|2|||
48563874|NCT02356588|156256603|FG000|Overall Study|Withdrawal by Subject|1|||
48563875|NCT02356588|156256604|FG001|Overall Study|Withdrawal by Subject|0|||
48563876|NCT02356588|156256603|FG000|Overall Study|Protocol Violation|0|||
48563877|NCT02356588|156256604|FG001|Overall Study|Protocol Violation|1|||
48563878|NCT00884117|156256607|FG000|Overall Study|Adverse Event|2|||
48563879|NCT00884117|156256607|FG000|Overall Study|Withdrawal by Subject|89|||
48563880|NCT00884117|156256607|FG000|Overall Study|Death|3|||
48563881|NCT00884117|156256607|FG000|Overall Study|Lost to Follow-up|143|||
48563882|NCT00884117|156256607|FG000|Overall Study|Other|12|||
48563883|NCT04526288|156256612|FG000|Overall Study|Disease Progression|1|||
48563884|NCT04526288|156256613|FG001|Overall Study|Disease Progression|0|||
48563885|NCT00984542|156256614|FG000|Overall Study|disease progression|19|||
48563886|NCT00984542|156256614|FG000|Overall Study|toxicity|7|||
48563887|NCT00984542|156256614|FG000|Overall Study|Death|7|||
48563888|NCT00984542|156256614|FG000|Overall Study|complicating disease|3|||
48563889|NCT00984542|156256614|FG000|Overall Study|Withdrawal by Subject|3|||
48563890|NCT00984542|156256614|FG000|Overall Study|clinical deterioration|2|||
48563891|NCT00828568|156256621|FG000|Randomized|Withdrawal by Subject|1|||
48563892|NCT00828568|156256622|FG001|Randomized|Withdrawal by Subject|0|||
48563893|NCT00828568|156256623|FG002|Randomized|Withdrawal by Subject|2|||
48563894|NCT00828568|156256621|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
48563895|NCT00828568|156256622|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
48563896|NCT00828568|156256623|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
48563897|NCT00828568|156256621|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
48563898|NCT00828568|156256622|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
48563899|NCT00828568|156256623|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
48563900|NCT00828568|156256621|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
48563901|NCT00828568|156256622|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
48563902|NCT00828568|156256623|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
48563903|NCT00828568|156256621|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
48563904|NCT00828568|156256622|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
48563905|NCT00828568|156256623|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
48563906|NCT02522884|156256658|FG000|Overall Study|Withdrawal by Subject|6|||
48563907|NCT02522884|156256658|FG000|Overall Study|Death|3|||
48563908|NCT02522884|156256658|FG000|Overall Study|Missed 12-month Follow-up|9|||
48563909|NCT02062450|156256661|FG000|Overall Study|No follow-up visit|124|||
48563910|NCT01129557|156256667|FG000|Overall Study|Adverse Event|1|||
48563911|NCT01129557|156256668|FG001|Overall Study|Adverse Event|2|||
48563912|NCT01129557|156256669|FG002|Overall Study|Adverse Event|2|||
48563913|NCT01129557|156256667|FG000|Overall Study|Novartis terminated study early|3|||
48563914|NCT01129557|156256668|FG001|Overall Study|Novartis terminated study early|3|||
48563915|NCT01129557|156256669|FG002|Overall Study|Novartis terminated study early|2|||
48563916|NCT01173523|156256670|FG000|Overall Study|Clinical Progression|1|||
48563917|NCT01173523|156256671|FG001|Overall Study|Clinical Progression|1|||
48563918|NCT01173523|156256670|FG000|Overall Study|Progressive Disease|10|||
48563919|NCT01173523|156256671|FG001|Overall Study|Progressive Disease|8|||
48563920|NCT01173523|156256670|FG000|Overall Study|Other|2|||
48563921|NCT01173523|156256671|FG001|Overall Study|Other|3|||
48563922|NCT00739882|156256673|FG000|Double-blind Period|Adverse Event|1|||
48563923|NCT00739882|156256674|FG001|Double-blind Period|Adverse Event|2|||
48563924|NCT00739882|156256673|FG000|Double-blind Period|Protocol Violation|1|||
48563925|NCT00739882|156256674|FG001|Double-blind Period|Protocol Violation|0|||
48563926|NCT00739882|156256673|FG000|Double-blind Period|Lack of Efficacy|1|||
48563927|NCT00739882|156256674|FG001|Double-blind Period|Lack of Efficacy|1|||
48617149|NCT01529268|156453068|FG000|Overall Study|Lost to Follow-up|9|||
48563928|NCT00739882|156256673|FG000|Double-blind Period|Other|16|||
48563929|NCT00739882|156256674|FG001|Double-blind Period|Other|8|||
48563930|NCT00739882|156256673|FG000|Open-label Period|Adverse Event|1|||
48563931|NCT00739882|156256674|FG001|Open-label Period|Adverse Event|0|||
48563932|NCT00739882|156256673|FG000|Open-label Period|Other|9|||
48563933|NCT00739882|156256674|FG001|Open-label Period|Other|5|||
48563934|NCT01486446|156256675|FG000|Overall Study|Adverse Event|1|||
48563935|NCT01486446|156256676|FG001|Overall Study|Adverse Event|0|||
48563936|NCT01801865|156256677|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
48563937|NCT01801865|156256677|FG000|Overall Study|Physician Decision|7|||
48563938|NCT03711786|156256679|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
48563939|NCT03711786|156256680|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
48563940|NCT03711786|156256679|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
48563941|NCT03711786|156256680|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
48563942|NCT03711786|156256679|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
48563943|NCT03711786|156256680|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
48563944|NCT03711786|156256679|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
48563945|NCT03711786|156256680|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
48563946|NCT03711786|156256679|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
48563947|NCT03711786|156256680|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
48563948|NCT03711786|156256679|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
48563949|NCT03711786|156256680|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
48563950|NCT00669669|156256681|FG000|Overall Study|To late to start treatment|1|||
48563951|NCT00086619|156256687|FG000|Overall Study|Withdrawal by Subject|6|||
48563952|NCT00086619|156256688|FG001|Overall Study|Withdrawal by Subject|6|||
48563953|NCT00086619|156256687|FG000|Overall Study|Adverse Event|8|||
48563954|NCT00086619|156256688|FG001|Overall Study|Adverse Event|10|||
48563955|NCT00086619|156256687|FG000|Overall Study|Protocol Violation|1|||
48563956|NCT00086619|156256688|FG001|Overall Study|Protocol Violation|1|||
48563957|NCT04390113|156256689|FG000|Overall Study|Not Treated|0|||
48563958|NCT04390113|156256690|FG001|Overall Study|Not Treated|1|||
48563959|NCT04390113|156256689|FG000|Overall Study|Adverse Event|1|||
48563960|NCT04390113|156256690|FG001|Overall Study|Adverse Event|0|||
48563961|NCT04390113|156256689|FG000|Overall Study|Death|2|||
48563962|NCT04390113|156256690|FG001|Overall Study|Death|1|||
48563963|NCT04390113|156256689|FG000|Overall Study|Physician Decision|1|||
48563964|NCT04390113|156256690|FG001|Overall Study|Physician Decision|3|||
48563965|NCT04390113|156256689|FG000|Overall Study|Study Terminated by Sponsor|5|||
48563966|NCT04390113|156256690|FG001|Overall Study|Study Terminated by Sponsor|3|||
48563967|NCT04390113|156256689|FG000|Overall Study|Withdrawal by Subject|10|||
48563968|NCT04390113|156256690|FG001|Overall Study|Withdrawal by Subject|5|||
48563969|NCT04390113|156256689|FG000|Overall Study|Other|1|||
48563970|NCT04390113|156256690|FG001|Overall Study|Other|0|||
48563971|NCT04390113|156256689|FG000|Overall Study|Missing|0|||
48563972|NCT04390113|156256690|FG001|Overall Study|Missing|1|||
48563973|NCT02872714|156256691|FG000|Overall Study|Progressive Disease|1|||
48563974|NCT02872714|156256692|FG001|Overall Study|Progressive Disease|2|||
48563975|NCT02872714|156256693|FG002|Overall Study|Progressive Disease|0|||
48563976|NCT02872714|156256694|FG003|Overall Study|Progressive Disease|0|||
48563977|NCT02872714|156256695|FG004|Overall Study|Progressive Disease|0|||
48563978|NCT02872714|156256691|FG000|Overall Study|Death|87|||
48563979|NCT02872714|156256692|FG001|Overall Study|Death|36|||
48563980|NCT02872714|156256693|FG002|Overall Study|Death|8|||
48563981|NCT02872714|156256694|FG003|Overall Study|Death|81|||
48563982|NCT02872714|156256695|FG004|Overall Study|Death|2|||
48563983|NCT02872714|156256691|FG000|Overall Study|Lost to Follow-up|2|||
48563984|NCT02872714|156256692|FG001|Overall Study|Lost to Follow-up|1|||
48563985|NCT02872714|156256693|FG002|Overall Study|Lost to Follow-up|0|||
48563986|NCT02872714|156256694|FG003|Overall Study|Lost to Follow-up|3|||
48563987|NCT02872714|156256695|FG004|Overall Study|Lost to Follow-up|0|||
48563988|NCT02872714|156256691|FG000|Overall Study|Physician Decision|0|||
48563989|NCT02872714|156256692|FG001|Overall Study|Physician Decision|0|||
48563990|NCT02872714|156256693|FG002|Overall Study|Physician Decision|0|||
48563991|NCT02872714|156256694|FG003|Overall Study|Physician Decision|1|||
48563992|NCT02872714|156256695|FG004|Overall Study|Physician Decision|0|||
48563993|NCT02872714|156256691|FG000|Overall Study|Withdrawal by Subject|1|||
48563994|NCT02872714|156256692|FG001|Overall Study|Withdrawal by Subject|3|||
48563995|NCT02872714|156256693|FG002|Overall Study|Withdrawal by Subject|0|||
48563996|NCT02872714|156256694|FG003|Overall Study|Withdrawal by Subject|2|||
48563997|NCT02872714|156256695|FG004|Overall Study|Withdrawal by Subject|0|||
48563998|NCT02872714|156256691|FG000|Overall Study|Captured as Other|2|||
48563999|NCT02872714|156256692|FG001|Overall Study|Captured as Other|0|||
48564000|NCT02872714|156256693|FG002|Overall Study|Captured as Other|0|||
48564001|NCT02872714|156256694|FG003|Overall Study|Captured as Other|1|||
48564002|NCT02872714|156256695|FG004|Overall Study|Captured as Other|0|||
48564003|NCT00848718|156256696|FG000|Overall Study|Adverse Event|2|||
48564004|NCT00848718|156256697|FG001|Overall Study|Adverse Event|2|||
48564005|NCT00848718|156256698|FG002|Overall Study|Adverse Event|1|||
48564006|NCT00848718|156256699|FG003|Overall Study|Adverse Event|1|||
48564007|NCT00848718|156256700|FG004|Overall Study|Adverse Event|1|||
48564008|NCT00848718|156256701|FG005|Overall Study|Adverse Event|0|||
48564009|NCT00848718|156256702|FG006|Overall Study|Adverse Event|0|||
48564010|NCT00848718|156256703|FG007|Overall Study|Adverse Event|1|||
48564011|NCT00848718|156256704|FG008|Overall Study|Adverse Event|1|||
48564012|NCT00848718|156256705|FG009|Overall Study|Adverse Event|0|||
48564013|NCT00848718|156256706|FG010|Overall Study|Adverse Event|0|||
48564014|NCT00848718|156256707|FG011|Overall Study|Adverse Event|0|||
48564015|NCT00848718|156256708|FG012|Overall Study|Adverse Event|2|||
48564016|NCT00848718|156256696|FG000|Overall Study|Lack of Efficacy|0|||
48564017|NCT00848718|156256697|FG001|Overall Study|Lack of Efficacy|0|||
48564018|NCT00848718|156256698|FG002|Overall Study|Lack of Efficacy|1|||
48564019|NCT00848718|156256699|FG003|Overall Study|Lack of Efficacy|0|||
48564020|NCT00848718|156256700|FG004|Overall Study|Lack of Efficacy|0|||
48564021|NCT00848718|156256701|FG005|Overall Study|Lack of Efficacy|0|||
48564022|NCT00848718|156256702|FG006|Overall Study|Lack of Efficacy|1|||
48564023|NCT00848718|156256703|FG007|Overall Study|Lack of Efficacy|0|||
48564024|NCT00848718|156256704|FG008|Overall Study|Lack of Efficacy|0|||
48564025|NCT00848718|156256705|FG009|Overall Study|Lack of Efficacy|0|||
48564026|NCT00848718|156256706|FG010|Overall Study|Lack of Efficacy|0|||
48564027|NCT00848718|156256707|FG011|Overall Study|Lack of Efficacy|0|||
48564028|NCT00848718|156256708|FG012|Overall Study|Lack of Efficacy|0|||
48564029|NCT00848718|156256696|FG000|Overall Study|Physician Decision|0|||
48564030|NCT00848718|156256697|FG001|Overall Study|Physician Decision|1|||
48564031|NCT00848718|156256698|FG002|Overall Study|Physician Decision|0|||
48564032|NCT00848718|156256699|FG003|Overall Study|Physician Decision|0|||
48564033|NCT00848718|156256700|FG004|Overall Study|Physician Decision|1|||
48564034|NCT00848718|156256701|FG005|Overall Study|Physician Decision|1|||
48564035|NCT00848718|156256702|FG006|Overall Study|Physician Decision|0|||
48564036|NCT00848718|156256703|FG007|Overall Study|Physician Decision|0|||
48564037|NCT00848718|156256704|FG008|Overall Study|Physician Decision|1|||
48564038|NCT00848718|156256705|FG009|Overall Study|Physician Decision|2|||
48564039|NCT00848718|156256706|FG010|Overall Study|Physician Decision|0|||
48564040|NCT00848718|156256707|FG011|Overall Study|Physician Decision|0|||
48564041|NCT00848718|156256708|FG012|Overall Study|Physician Decision|1|||
48564042|NCT00848718|156256696|FG000|Overall Study|Progressive disease before treatment|1|||
48564043|NCT00848718|156256697|FG001|Overall Study|Progressive disease before treatment|5|||
48564044|NCT00848718|156256698|FG002|Overall Study|Progressive disease before treatment|1|||
48564045|NCT00848718|156256699|FG003|Overall Study|Progressive disease before treatment|3|||
48564046|NCT00848718|156256700|FG004|Overall Study|Progressive disease before treatment|4|||
48564047|NCT00848718|156256701|FG005|Overall Study|Progressive disease before treatment|4|||
48564048|NCT00848718|156256702|FG006|Overall Study|Progressive disease before treatment|2|||
48564049|NCT00848718|156256703|FG007|Overall Study|Progressive disease before treatment|1|||
48564050|NCT00848718|156256704|FG008|Overall Study|Progressive disease before treatment|2|||
48564051|NCT00848718|156256705|FG009|Overall Study|Progressive disease before treatment|7|||
48564052|NCT00848718|156256706|FG010|Overall Study|Progressive disease before treatment|3|||
48564053|NCT00848718|156256707|FG011|Overall Study|Progressive disease before treatment|6|||
48564054|NCT00848718|156256708|FG012|Overall Study|Progressive disease before treatment|2|||
48564055|NCT00848718|156256696|FG000|Overall Study|Protocol Violation|0|||
48564056|NCT00848718|156256697|FG001|Overall Study|Protocol Violation|1|||
48564057|NCT00848718|156256698|FG002|Overall Study|Protocol Violation|0|||
48564058|NCT00848718|156256699|FG003|Overall Study|Protocol Violation|0|||
48564059|NCT00848718|156256700|FG004|Overall Study|Protocol Violation|0|||
48564060|NCT00848718|156256701|FG005|Overall Study|Protocol Violation|0|||
48564061|NCT00848718|156256702|FG006|Overall Study|Protocol Violation|0|||
48564062|NCT00848718|156256703|FG007|Overall Study|Protocol Violation|1|||
48564063|NCT00848718|156256704|FG008|Overall Study|Protocol Violation|0|||
48564064|NCT00848718|156256705|FG009|Overall Study|Protocol Violation|0|||
48564065|NCT00848718|156256706|FG010|Overall Study|Protocol Violation|0|||
48564066|NCT00848718|156256707|FG011|Overall Study|Protocol Violation|0|||
48564067|NCT00848718|156256708|FG012|Overall Study|Protocol Violation|1|||
48564068|NCT00848718|156256696|FG000|Overall Study|Withdrawal by Subject|1|||
48564069|NCT00848718|156256697|FG001|Overall Study|Withdrawal by Subject|0|||
48564070|NCT00848718|156256698|FG002|Overall Study|Withdrawal by Subject|0|||
48564071|NCT00848718|156256699|FG003|Overall Study|Withdrawal by Subject|1|||
48564072|NCT00848718|156256700|FG004|Overall Study|Withdrawal by Subject|0|||
48564073|NCT00848718|156256701|FG005|Overall Study|Withdrawal by Subject|0|||
48564074|NCT00848718|156256702|FG006|Overall Study|Withdrawal by Subject|0|||
48564075|NCT00848718|156256703|FG007|Overall Study|Withdrawal by Subject|0|||
48564076|NCT00848718|156256704|FG008|Overall Study|Withdrawal by Subject|0|||
48564077|NCT00848718|156256705|FG009|Overall Study|Withdrawal by Subject|0|||
48564078|NCT00848718|156256706|FG010|Overall Study|Withdrawal by Subject|1|||
48564079|NCT00848718|156256707|FG011|Overall Study|Withdrawal by Subject|0|||
48564080|NCT00848718|156256708|FG012|Overall Study|Withdrawal by Subject|0|||
48564081|NCT00848718|156256696|FG000|Overall Study|Progressive disease during treatment|3|||
48564082|NCT00848718|156256697|FG001|Overall Study|Progressive disease during treatment|0|||
48564083|NCT00848718|156256698|FG002|Overall Study|Progressive disease during treatment|3|||
48564084|NCT00848718|156256699|FG003|Overall Study|Progressive disease during treatment|0|||
48564085|NCT00848718|156256700|FG004|Overall Study|Progressive disease during treatment|0|||
48564086|NCT00848718|156256701|FG005|Overall Study|Progressive disease during treatment|0|||
48564087|NCT00848718|156256702|FG006|Overall Study|Progressive disease during treatment|0|||
48564088|NCT00848718|156256703|FG007|Overall Study|Progressive disease during treatment|2|||
48564089|NCT00848718|156256704|FG008|Overall Study|Progressive disease during treatment|0|||
48564090|NCT00848718|156256705|FG009|Overall Study|Progressive disease during treatment|0|||
48564091|NCT00848718|156256706|FG010|Overall Study|Progressive disease during treatment|0|||
48564092|NCT00848718|156256707|FG011|Overall Study|Progressive disease during treatment|0|||
48564093|NCT00848718|156256708|FG012|Overall Study|Progressive disease during treatment|2|||
48564094|NCT00489918|156256709|FG000|Overall Study|Withdrawal by Subject|2|||
48564095|NCT00489918|156256710|FG001|Overall Study|Withdrawal by Subject|1|||
48564096|NCT00489918|156256711|FG002|Overall Study|Withdrawal by Subject|1|||
48564097|NCT00489918|156256712|FG003|Overall Study|Withdrawal by Subject|0|||
48564098|NCT00489918|156256713|FG004|Overall Study|Withdrawal by Subject|1|||
48564099|NCT00489918|156256709|FG000|Overall Study|Adverse Event|0|||
48564100|NCT00489918|156256710|FG001|Overall Study|Adverse Event|1|||
48564101|NCT00489918|156256711|FG002|Overall Study|Adverse Event|1|||
48564102|NCT00489918|156256712|FG003|Overall Study|Adverse Event|0|||
48564103|NCT00489918|156256713|FG004|Overall Study|Adverse Event|0|||
48564104|NCT00489918|156256709|FG000|Overall Study|Lost to Follow-up|0|||
48564105|NCT00489918|156256710|FG001|Overall Study|Lost to Follow-up|0|||
48564106|NCT00489918|156256711|FG002|Overall Study|Lost to Follow-up|1|||
48564107|NCT00489918|156256712|FG003|Overall Study|Lost to Follow-up|1|||
48564108|NCT00489918|156256713|FG004|Overall Study|Lost to Follow-up|0|||
48564109|NCT00489918|156256709|FG000|Overall Study|Physician Decision|0|||
48564110|NCT00489918|156256710|FG001|Overall Study|Physician Decision|0|||
48564111|NCT00489918|156256711|FG002|Overall Study|Physician Decision|1|||
48564112|NCT00489918|156256712|FG003|Overall Study|Physician Decision|0|||
48564113|NCT00489918|156256713|FG004|Overall Study|Physician Decision|0|||
48564114|NCT02748213|156256714|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
48564115|NCT02748213|156256715|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
48564116|NCT02748213|156256714|FG000|Overall Study|Abnormal Laboratory Test|1|||
48564117|NCT02748213|156256715|FG001|Overall Study|Abnormal Laboratory Test|0|||
48564118|NCT02748213|156256714|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
48564119|NCT02748213|156256715|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
48564120|NCT02748213|156256714|FG000|Overall Study|Death|5|||
48564121|NCT02748213|156256715|FG001|Overall Study|Death|3|||
48564122|NCT02748213|156256714|FG000|Overall Study|Insufficient Therapeutic Response|56|||
48564123|NCT02748213|156256715|FG001|Overall Study|Insufficient Therapeutic Response|57|||
48564124|NCT02748213|156256714|FG000|Overall Study|Violation of Selection Criteria|2|||
48564125|NCT02748213|156256715|FG001|Overall Study|Violation of Selection Criteria|0|||
48564126|NCT02748213|156256714|FG000|Overall Study|Protocol Violation|6|||
48564127|NCT02748213|156256715|FG001|Overall Study|Protocol Violation|4|||
48564128|NCT02748213|156256714|FG000|Overall Study|Refused Treatment*|6|||
48564129|NCT02748213|156256715|FG001|Overall Study|Refused Treatment*|6|||
48564130|NCT02748213|156256714|FG000|Overall Study|Failure to Return|1|||
48564131|NCT02748213|156256715|FG001|Overall Study|Failure to Return|0|||
48564132|NCT02748213|156256714|FG000|Overall Study|Other|30|||
48564133|NCT02748213|156256715|FG001|Overall Study|Other|29|||
48564134|NCT00708461|156256720|FG000|Overall Study|Lost to Follow-up|18|||
48564135|NCT00708461|156256721|FG001|Overall Study|Lost to Follow-up|11|||
48564136|NCT00708461|156256720|FG000|Overall Study|Withdrawal by Subject|8|||
48564137|NCT00708461|156256721|FG001|Overall Study|Withdrawal by Subject|9|||
48564138|NCT00708461|156256720|FG000|Overall Study|left workforce|115|||
48564139|NCT00708461|156256721|FG001|Overall Study|left workforce|180|||
48564140|NCT01611883|156256722|FG000|Overall Study|Adverse Event|1|||
48564141|NCT01611883|156256723|FG001|Overall Study|Adverse Event|1|||
48564142|NCT04200651|156256726|FG000|Overall Study|Moved to another country during follow-up|2|||
48564143|NCT04200651|156256727|FG001|Overall Study|Moved to another country during follow-up|2|||
48564144|NCT04200651|156256726|FG000|Overall Study|Lost to Follow-up|1|||
48564145|NCT04200651|156256727|FG001|Overall Study|Lost to Follow-up|3|||
48564146|NCT03379727|156256732|FG000|Overall Study|Lack of Efficacy|73|||
48564147|NCT03379727|156256732|FG000|Overall Study|Adverse Event|32|||
48564148|NCT03379727|156256732|FG000|Overall Study|Death|18|||
48564149|NCT03379727|156256732|FG000|Overall Study|Patient/guardian decision|17|||
48564150|NCT03379727|156256732|FG000|Overall Study|Physician Decision|104|||
48564151|NCT03379727|156256732|FG000|Overall Study|Protocol Violation|4|||
48564152|NCT03379727|156256732|FG000|Overall Study|Lost to Follow-up|1|||
48564153|NCT00030901|156256733|FG000|Initial Registration|Ineligible|167|||
48564154|NCT00030901|156256734|FG001|Initial Registration|Ineligible|0|||
48564155|NCT00030901|156256735|FG002|Initial Registration|Ineligible|0|||
48564156|NCT00030901|156256733|FG000|Randomization|Adverse Event|0|||
48564157|NCT00030901|156256734|FG001|Randomization|Adverse Event|11|||
48564158|NCT00030901|156256735|FG002|Randomization|Adverse Event|7|||
48564159|NCT00030901|156256733|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
48564160|NCT00030901|156256734|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
48564161|NCT00030901|156256735|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
48564162|NCT00030901|156256733|FG000|Randomization|Progression/Relapse|0|||
48564163|NCT00030901|156256734|FG001|Randomization|Progression/Relapse|22|||
48564164|NCT00030901|156256735|FG002|Randomization|Progression/Relapse|21|||
48564165|NCT00030901|156256733|FG000|Randomization|Death|0|||
48564166|NCT00030901|156256734|FG001|Randomization|Death|1|||
48564167|NCT00030901|156256735|FG002|Randomization|Death|3|||
48564168|NCT00030901|156256733|FG000|Randomization|Other|0|||
48564169|NCT00030901|156256734|FG001|Randomization|Other|36|||
48564170|NCT00030901|156256735|FG002|Randomization|Other|33|||
48564171|NCT00030901|156256733|FG000|Randomization|Ineligible|0|||
48564172|NCT00030901|156256734|FG001|Randomization|Ineligible|15|||
48564173|NCT00030901|156256735|FG002|Randomization|Ineligible|14|||
48564174|NCT01134939|156256738|FG000|Overall Study|Adverse Event|9|||
48564175|NCT01134939|156256739|FG001|Overall Study|Adverse Event|3|||
48564176|NCT01134939|156256740|FG002|Overall Study|Adverse Event|4|||
48564177|NCT01134939|156256741|FG003|Overall Study|Adverse Event|5|||
48564178|NCT01134939|156256742|FG004|Overall Study|Adverse Event|5|||
48564179|NCT01134939|156256743|FG005|Overall Study|Adverse Event|5|||
48564180|NCT01134939|156256744|FG006|Overall Study|Adverse Event|1|||
48564181|NCT01134939|156256745|FG007|Overall Study|Adverse Event|0|||
48564182|NCT01134939|156256738|FG000|Overall Study|Lack of Efficacy|2|||
48564183|NCT01134939|156256739|FG001|Overall Study|Lack of Efficacy|5|||
48564184|NCT01134939|156256740|FG002|Overall Study|Lack of Efficacy|1|||
48564185|NCT01134939|156256741|FG003|Overall Study|Lack of Efficacy|0|||
48564186|NCT01134939|156256742|FG004|Overall Study|Lack of Efficacy|3|||
48564187|NCT01134939|156256743|FG005|Overall Study|Lack of Efficacy|0|||
48564188|NCT01134939|156256744|FG006|Overall Study|Lack of Efficacy|1|||
48564189|NCT01134939|156256745|FG007|Overall Study|Lack of Efficacy|0|||
48564190|NCT01134939|156256738|FG000|Overall Study|Lost to Follow-up|2|||
48564191|NCT01134939|156256739|FG001|Overall Study|Lost to Follow-up|3|||
48564192|NCT01134939|156256740|FG002|Overall Study|Lost to Follow-up|0|||
48564193|NCT01134939|156256741|FG003|Overall Study|Lost to Follow-up|1|||
48564194|NCT01134939|156256742|FG004|Overall Study|Lost to Follow-up|2|||
48564195|NCT01134939|156256743|FG005|Overall Study|Lost to Follow-up|1|||
48564196|NCT01134939|156256744|FG006|Overall Study|Lost to Follow-up|0|||
48564197|NCT01134939|156256745|FG007|Overall Study|Lost to Follow-up|0|||
48564198|NCT01134939|156256738|FG000|Overall Study|Death|0|||
48564199|NCT01134939|156256739|FG001|Overall Study|Death|1|||
48564200|NCT01134939|156256740|FG002|Overall Study|Death|0|||
48564201|NCT01134939|156256741|FG003|Overall Study|Death|0|||
48564202|NCT01134939|156256742|FG004|Overall Study|Death|0|||
48564203|NCT01134939|156256743|FG005|Overall Study|Death|0|||
48564204|NCT01134939|156256744|FG006|Overall Study|Death|0|||
48564205|NCT01134939|156256745|FG007|Overall Study|Death|0|||
48564206|NCT01134939|156256738|FG000|Overall Study|Termination page not available|4|||
48564207|NCT01134939|156256739|FG001|Overall Study|Termination page not available|6|||
48564208|NCT01134939|156256740|FG002|Overall Study|Termination page not available|5|||
48564209|NCT01134939|156256741|FG003|Overall Study|Termination page not available|8|||
48564210|NCT01134939|156256742|FG004|Overall Study|Termination page not available|0|||
48564211|NCT01134939|156256743|FG005|Overall Study|Termination page not available|3|||
48564212|NCT01134939|156256744|FG006|Overall Study|Termination page not available|7|||
48564213|NCT01134939|156256745|FG007|Overall Study|Termination page not available|0|||
48564214|NCT00733421|156256746|FG000|Overall Study|Withdrawal by Subject|1|||
48617150|NCT01529268|156453069|FG001|Overall Study|Lost to Follow-up|3|||
48564215|NCT00733421|156256747|FG001|Overall Study|Withdrawal by Subject|1|||
48585053|NCT01546038|156333752|FG000|Overall Study|: Randomized, not treated|0|||
48585054|NCT01546038|156333753|FG001|Overall Study|: Randomized, not treated|0|||
48585055|NCT01546038|156333754|FG002|Overall Study|: Randomized, not treated|0|||
48585056|NCT01546038|156333755|FG003|Overall Study|: Randomized, not treated|0|||
48585057|NCT01546038|156333756|FG004|Overall Study|: Randomized, not treated|0|||
48585058|NCT01546038|156333757|FG005|Overall Study|: Randomized, not treated|0|||
48585059|NCT01546038|156333758|FG006|Overall Study|: Randomized, not treated|2|||
48585060|NCT01546038|156333759|FG007|Overall Study|: Randomized, not treated|4|||
48585061|NCT01546038|156333760|FG008|Overall Study|: Randomized, not treated|3|||
48585062|NCT01711619|156333761|FG000|Overall Study|Early study termination|10|||
48585063|NCT01711619|156333762|FG001|Overall Study|Early study termination|14|||
48585064|NCT01711619|156333761|FG000|Overall Study|Withdrawal by Subject|3|||
48585065|NCT01711619|156333762|FG001|Overall Study|Withdrawal by Subject|7|||
48585066|NCT01711619|156333761|FG000|Overall Study|Protocol Violation|2|||
48585067|NCT01711619|156333762|FG001|Overall Study|Protocol Violation|3|||
48585068|NCT01711619|156333761|FG000|Overall Study|Adverse Event|2|||
48585069|NCT01711619|156333762|FG001|Overall Study|Adverse Event|0|||
48585070|NCT01711619|156333761|FG000|Overall Study|Lost to Follow-up|1|||
48585071|NCT01711619|156333762|FG001|Overall Study|Lost to Follow-up|0|||
48585072|NCT00334802|156333763|FG000|Overall Study|Progressive Disease|2|||
48585073|NCT00334802|156333764|FG001|Overall Study|Progressive Disease|24|||
48585074|NCT00334802|156333763|FG000|Overall Study|Toxicity|1|||
48585075|NCT00334802|156333764|FG001|Overall Study|Toxicity|5|||
48585076|NCT00334802|156333763|FG000|Overall Study|Lack of Efficacy|1|||
48585077|NCT00334802|156333764|FG001|Overall Study|Lack of Efficacy|3|||
48585078|NCT00334802|156333763|FG000|Overall Study|Patient Condition Aggrevated|1|||
48585079|NCT00334802|156333764|FG001|Overall Study|Patient Condition Aggrevated|0|||
48585080|NCT00334802|156333763|FG000|Overall Study|Physician Decision|1|||
48585081|NCT00334802|156333764|FG001|Overall Study|Physician Decision|0|||
48585082|NCT00334802|156333763|FG000|Overall Study|Withdrawal by Subject|0|||
48585083|NCT00334802|156333764|FG001|Overall Study|Withdrawal by Subject|4|||
48585084|NCT00334802|156333763|FG000|Overall Study|Adverse Event|0|||
48585085|NCT00334802|156333764|FG001|Overall Study|Adverse Event|3|||
48585086|NCT00334802|156333763|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
48585087|NCT00334802|156333764|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
48585088|NCT01634659|156333765|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
48585089|NCT01634659|156333766|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
48585090|NCT01634659|156333765|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
48585091|NCT01634659|156333766|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
48585092|NCT00503997|156333771|FG000|Overall Study|disease progression|1|||
48585093|NCT00503997|156333771|FG000|Overall Study|Adverse Event|5|||
48585094|NCT00503997|156333771|FG000|Overall Study|Death|1|||
48585095|NCT00503997|156333771|FG000|Overall Study|Withdrawal by Subject|1|||
48585096|NCT01606748|156333772|FG000|Overall Study|Adverse Event|1|||
48585097|NCT01606748|156333773|FG001|Overall Study|Adverse Event|0|||
48585098|NCT01606748|156333772|FG000|Overall Study|Progressive Disease|1|||
48585099|NCT01606748|156333773|FG001|Overall Study|Progressive Disease|0|||
48585100|NCT01606748|156333772|FG000|Overall Study|Withdrawal by Subject|1|||
48585101|NCT01606748|156333773|FG001|Overall Study|Withdrawal by Subject|0|||
48585102|NCT04299048|156333774|FG000|Overall Study|Death|1|||
48585103|NCT04299048|156333774|FG000|Overall Study|Global deterioration of health status|2|||
48585104|NCT04299048|156333774|FG000|Overall Study|Enrolled and not treated|1|||
48585105|NCT03578146|156333775|FG000|Overall Study|Did Not Receive Treatment|1|||
48585106|NCT03578146|156333776|FG001|Overall Study|Did Not Receive Treatment|0|||
48585107|NCT03578146|156333777|FG002|Overall Study|Did Not Receive Treatment|0|||
48585108|NCT03578146|156333778|FG003|Overall Study|Did Not Receive Treatment|0|||
48585109|NCT03578146|156333779|FG004|Overall Study|Did Not Receive Treatment|0|||
48585110|NCT03578146|156333780|FG005|Overall Study|Did Not Receive Treatment|2|||
48585111|NCT03578146|156333775|FG000|Overall Study|Lost to Follow-up|0|||
48585112|NCT03578146|156333776|FG001|Overall Study|Lost to Follow-up|1|||
48585113|NCT03578146|156333777|FG002|Overall Study|Lost to Follow-up|1|||
48585114|NCT03578146|156333778|FG003|Overall Study|Lost to Follow-up|0|||
48585115|NCT03578146|156333779|FG004|Overall Study|Lost to Follow-up|0|||
48585116|NCT03578146|156333780|FG005|Overall Study|Lost to Follow-up|1|||
48585117|NCT01706575|156333782|FG000|Overall Study|Participant Withdrew Consent|4|||
48564216|NCT02750618|156258991|FG000|Overall Study|Withdrawal by Subject|1|||
48564217|NCT04179838|156258992|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
48564218|NCT04179838|156258993|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
48564219|NCT04179838|156258992|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
48564220|NCT04179838|156258993|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
48564221|NCT02366689|156259006|FG000|Overall Study|Withdrawal by Subject|1|||
48564222|NCT02366689|156259007|FG001|Overall Study|Withdrawal by Subject|0|||
48564223|NCT02366689|156259008|FG002|Overall Study|Withdrawal by Subject|1|||
48564224|NCT02366689|156259006|FG000|Overall Study|Lost to Follow-up|3|||
48564225|NCT02366689|156259007|FG001|Overall Study|Lost to Follow-up|2|||
48564226|NCT02366689|156259008|FG002|Overall Study|Lost to Follow-up|0|||
48564227|NCT02366689|156259006|FG000|Overall Study|Pregnancy|0|||
48564228|NCT02366689|156259007|FG001|Overall Study|Pregnancy|1|||
48564229|NCT02366689|156259008|FG002|Overall Study|Pregnancy|1|||
48564230|NCT02019472|156259009|FG000|Overall Study|Adverse Event|14|||
48564231|NCT02019472|156259010|FG001|Overall Study|Adverse Event|23|||
48564232|NCT02019472|156259011|FG002|Overall Study|Adverse Event|17|||
48564233|NCT02019472|156259009|FG000|Overall Study|Death|0|||
48564234|NCT02019472|156259010|FG001|Overall Study|Death|1|||
48564235|NCT02019472|156259011|FG002|Overall Study|Death|1|||
48564236|NCT02019472|156259009|FG000|Overall Study|Lack of Efficacy|7|||
48564237|NCT02019472|156259010|FG001|Overall Study|Lack of Efficacy|4|||
48564238|NCT02019472|156259011|FG002|Overall Study|Lack of Efficacy|4|||
48564239|NCT02019472|156259009|FG000|Overall Study|Lost to Follow-up|0|||
48564240|NCT02019472|156259010|FG001|Overall Study|Lost to Follow-up|2|||
48564241|NCT02019472|156259011|FG002|Overall Study|Lost to Follow-up|1|||
48564242|NCT02019472|156259009|FG000|Overall Study|Physician Decision|1|||
48564243|NCT02019472|156259010|FG001|Overall Study|Physician Decision|2|||
48564244|NCT02019472|156259011|FG002|Overall Study|Physician Decision|0|||
48564245|NCT02019472|156259009|FG000|Overall Study|Pregnancy|1|||
48564246|NCT02019472|156259010|FG001|Overall Study|Pregnancy|2|||
48564247|NCT02019472|156259011|FG002|Overall Study|Pregnancy|2|||
48564248|NCT02019472|156259009|FG000|Overall Study|Withdrawal by Subject|11|||
48564249|NCT02019472|156259010|FG001|Overall Study|Withdrawal by Subject|10|||
48564250|NCT02019472|156259011|FG002|Overall Study|Withdrawal by Subject|11|||
48564251|NCT02019472|156259009|FG000|Overall Study|Other|3|||
48564252|NCT02019472|156259010|FG001|Overall Study|Other|8|||
48564253|NCT02019472|156259011|FG002|Overall Study|Other|6|||
48564254|NCT02763046|156259012|FG000|Overall Study|Adverse Event|5|||
48564255|NCT02763046|156259013|FG001|Overall Study|Adverse Event|4|||
48564256|NCT02763046|156259014|FG002|Overall Study|Adverse Event|0|||
48564257|NCT02763046|156259012|FG000|Overall Study|Lack of Efficacy|1|||
48564258|NCT02763046|156259013|FG001|Overall Study|Lack of Efficacy|1|||
48564259|NCT02763046|156259014|FG002|Overall Study|Lack of Efficacy|3|||
48564260|NCT02763046|156259012|FG000|Overall Study|Physician Decision|1|||
48564261|NCT02763046|156259013|FG001|Overall Study|Physician Decision|0|||
48564262|NCT02763046|156259014|FG002|Overall Study|Physician Decision|1|||
48564263|NCT02763046|156259012|FG000|Overall Study|Subject/guardian decision|2|||
48564264|NCT02763046|156259013|FG001|Overall Study|Subject/guardian decision|0|||
48564265|NCT02763046|156259014|FG002|Overall Study|Subject/guardian decision|4|||
48564266|NCT01662635|156259015|FG000|Overall Study|scarce samples for evaluation|30|||
48564267|NCT00513695|156259016|FG000|Overall Study|Discontinued therapy|2|||
48564268|NCT00513695|156259016|FG000|Overall Study|Progression prior to surgery|3|||
48564269|NCT01217112|156259019|FG000|Overall Study|Adverse Event|0|||
48564270|NCT01217112|156259020|FG001|Overall Study|Adverse Event|2|||
48564271|NCT01217112|156259021|FG002|Overall Study|Adverse Event|0|||
48564272|NCT01217112|156259022|FG003|Overall Study|Adverse Event|2|||
48564273|NCT01217112|156259023|FG004|Overall Study|Adverse Event|0|||
48564274|NCT01217112|156259019|FG000|Overall Study|Withdrawal by Subject|0|||
48564275|NCT01217112|156259020|FG001|Overall Study|Withdrawal by Subject|0|||
48564276|NCT01217112|156259021|FG002|Overall Study|Withdrawal by Subject|1|||
48564277|NCT01217112|156259022|FG003|Overall Study|Withdrawal by Subject|0|||
48564278|NCT01217112|156259023|FG004|Overall Study|Withdrawal by Subject|0|||
48564279|NCT01217112|156259019|FG000|Overall Study|Physician Decision|0|||
48564280|NCT01217112|156259020|FG001|Overall Study|Physician Decision|0|||
48564281|NCT01217112|156259021|FG002|Overall Study|Physician Decision|0|||
48564282|NCT01217112|156259022|FG003|Overall Study|Physician Decision|0|||
48564283|NCT01217112|156259023|FG004|Overall Study|Physician Decision|1|||
48564284|NCT02157935|156259026|FG000|Overall Study|Withdrawal by Subject|25|||
48564285|NCT02157935|156259027|FG001|Overall Study|Withdrawal by Subject|39|||
48564286|NCT02157935|156259026|FG000|Overall Study|Screen failure|1|||
48564287|NCT02157935|156259027|FG001|Overall Study|Screen failure|2|||
48564288|NCT02157935|156259026|FG000|Overall Study|Protocol Violation|1|||
48564289|NCT02157935|156259027|FG001|Overall Study|Protocol Violation|0|||
48564290|NCT02157935|156259026|FG000|Overall Study|Progressive disease|0|||
48564291|NCT02157935|156259027|FG001|Overall Study|Progressive disease|2|||
48564292|NCT02157935|156259026|FG000|Overall Study|Other|5|||
48564293|NCT02157935|156259027|FG001|Overall Study|Other|12|||
48564294|NCT02157935|156259026|FG000|Overall Study|Lack of Efficacy|0|||
48564295|NCT02157935|156259027|FG001|Overall Study|Lack of Efficacy|1|||
48564296|NCT02157935|156259026|FG000|Overall Study|Death|4|||
48564297|NCT02157935|156259027|FG001|Overall Study|Death|4|||
48564298|NCT02157935|156259026|FG000|Overall Study|Adverse Event|3|||
48564299|NCT02157935|156259027|FG001|Overall Study|Adverse Event|5|||
48564300|NCT02570308|156259029|FG000|Overall Study|Death|1|||
48564301|NCT02570308|156259030|FG001|Overall Study|Death|5|||
48564302|NCT02570308|156259031|FG002|Overall Study|Death|4|||
48564303|NCT02570308|156259032|FG003|Overall Study|Death|4|||
48564304|NCT02570308|156259033|FG004|Overall Study|Death|69|||
48564305|NCT02570308|156259029|FG000|Overall Study|Lost to Follow-up|0|||
48564306|NCT02570308|156259030|FG001|Overall Study|Lost to Follow-up|0|||
48564307|NCT02570308|156259031|FG002|Overall Study|Lost to Follow-up|0|||
48564308|NCT02570308|156259032|FG003|Overall Study|Lost to Follow-up|0|||
48564309|NCT02570308|156259033|FG004|Overall Study|Lost to Follow-up|2|||
48564310|NCT02570308|156259029|FG000|Overall Study|Withdrawal by Subject|0|||
48564311|NCT02570308|156259030|FG001|Overall Study|Withdrawal by Subject|0|||
48564312|NCT02570308|156259031|FG002|Overall Study|Withdrawal by Subject|0|||
48564313|NCT02570308|156259032|FG003|Overall Study|Withdrawal by Subject|0|||
48564314|NCT02570308|156259033|FG004|Overall Study|Withdrawal by Subject|1|||
48564315|NCT02570308|156259029|FG000|Overall Study|Other|0|||
48564316|NCT02570308|156259030|FG001|Overall Study|Other|0|||
48564317|NCT02570308|156259031|FG002|Overall Study|Other|0|||
48564318|NCT02570308|156259032|FG003|Overall Study|Other|0|||
48564319|NCT02570308|156259033|FG004|Overall Study|Other|2|||
48564320|NCT03877068|156259036|FG000|Overall Study|Physician Decision|9|||
48564321|NCT03877068|156259037|FG001|Overall Study|Physician Decision|3|||
48564322|NCT00314340|156259038|FG000|Overall Study|lost interest|1|||
48564323|NCT02069015|156259039|FG000|Overall Study|Lost to Follow-up|39|||
48564324|NCT02069015|156259040|FG001|Overall Study|Lost to Follow-up|32|||
48564325|NCT02069015|156259039|FG000|Overall Study|Withdrawal by Subject|1|||
48564326|NCT02069015|156259040|FG001|Overall Study|Withdrawal by Subject|1|||
48564327|NCT02861807|156259041|FG000|Overall Study|Lost to Follow-up|7|||
48564328|NCT02861807|156259042|FG001|Overall Study|Lost to Follow-up|6|||
48564329|NCT02861807|156259041|FG000|Overall Study|Withdrawal by Subject|5|||
48564330|NCT02861807|156259042|FG001|Overall Study|Withdrawal by Subject|8|||
48564331|NCT02509507|156259043|FG000|Overall Study|Death|21|||
48564332|NCT02509507|156259044|FG001|Overall Study|Death|3|||
48564333|NCT02509507|156259045|FG002|Overall Study|Death|22|||
48564334|NCT02509507|156259046|FG003|Overall Study|Death|14|||
48564335|NCT02509507|156259047|FG004|Overall Study|Death|8|||
48564336|NCT02509507|156259048|FG005|Overall Study|Death|12|||
48564337|NCT02509507|156259049|FG006|Overall Study|Death|5|||
48564338|NCT02509507|156259050|FG007|Overall Study|Death|4|||
48564339|NCT02509507|156259051|FG008|Overall Study|Death|8|||
48564340|NCT02509507|156259043|FG000|Overall Study|Lost to Follow-up|0|||
48564341|NCT02509507|156259044|FG001|Overall Study|Lost to Follow-up|1|||
48564342|NCT02509507|156259045|FG002|Overall Study|Lost to Follow-up|0|||
48564343|NCT02509507|156259046|FG003|Overall Study|Lost to Follow-up|0|||
48564344|NCT02509507|156259047|FG004|Overall Study|Lost to Follow-up|0|||
48564345|NCT02509507|156259048|FG005|Overall Study|Lost to Follow-up|2|||
48564346|NCT02509507|156259049|FG006|Overall Study|Lost to Follow-up|0|||
48564347|NCT02509507|156259050|FG007|Overall Study|Lost to Follow-up|0|||
48564348|NCT02509507|156259051|FG008|Overall Study|Lost to Follow-up|0|||
48564349|NCT02509507|156259043|FG000|Overall Study|Withdrawal by Subject|2|||
48564350|NCT02509507|156259044|FG001|Overall Study|Withdrawal by Subject|0|||
48564351|NCT02509507|156259045|FG002|Overall Study|Withdrawal by Subject|1|||
48564352|NCT02509507|156259046|FG003|Overall Study|Withdrawal by Subject|4|||
48564353|NCT02509507|156259047|FG004|Overall Study|Withdrawal by Subject|1|||
48564354|NCT02509507|156259048|FG005|Overall Study|Withdrawal by Subject|3|||
48564355|NCT02509507|156259049|FG006|Overall Study|Withdrawal by Subject|4|||
48564356|NCT02509507|156259050|FG007|Overall Study|Withdrawal by Subject|0|||
48564357|NCT02509507|156259051|FG008|Overall Study|Withdrawal by Subject|1|||
48564358|NCT00791778|156259052|FG000|Double-blind Treatment|Adverse Event|49|||
48564359|NCT00791778|156259053|FG001|Double-blind Treatment|Adverse Event|9|||
48564360|NCT00791778|156259052|FG000|Double-blind Treatment|Physician Decision|6|||
48564361|NCT00791778|156259053|FG001|Double-blind Treatment|Physician Decision|26|||
48564362|NCT00791778|156259052|FG000|Double-blind Treatment|Protocol Violation|0|||
48564363|NCT00791778|156259053|FG001|Double-blind Treatment|Protocol Violation|4|||
48564364|NCT00791778|156259052|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
48564365|NCT00791778|156259053|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
48564366|NCT00791778|156259052|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
48564367|NCT00791778|156259053|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
48564368|NCT00791778|156259052|FG000|Follow-up|Withdrawal by Subject|3|||
48564369|NCT00791778|156259053|FG001|Follow-up|Withdrawal by Subject|0|||
48564370|NCT00791778|156259052|FG000|Follow-up|Lost to Follow-up|2|||
48564371|NCT00791778|156259053|FG001|Follow-up|Lost to Follow-up|1|||
48564372|NCT03051100|156259054|FG000|Overall Study|Withdrawal by Subject|1|||
48564373|NCT03051100|156259055|FG001|Overall Study|Withdrawal by Subject|0|||
48564374|NCT03442751|156259056|FG000|Overall Study|Withdrawal by Subject|3|||
48564375|NCT03442751|156259057|FG001|Overall Study|Withdrawal by Subject|1|||
48564376|NCT03442751|156259056|FG000|Overall Study|Lost to Follow-up|3|||
48564377|NCT03442751|156259057|FG001|Overall Study|Lost to Follow-up|0|||
48564378|NCT00444535|156259059|FG000|Overall Study|Withdrawal by Subject|5|||
48564379|NCT00444535|156259059|FG000|Overall Study|Physician Decision|5|||
48564380|NCT00444535|156259059|FG000|Overall Study|progressive disease|1|||
48564381|NCT00444535|156259059|FG000|Overall Study|Adverse Event|2|||
48564382|NCT01418378|156259060|FG000|Overall Study|Death|1|||
48564383|NCT01418378|156259061|FG001|Overall Study|Death|2|||
48564384|NCT01418378|156259060|FG000|Overall Study|Physician Decision|0|||
48564385|NCT01418378|156259061|FG001|Overall Study|Physician Decision|1|||
48564386|NCT01418378|156259060|FG000|Overall Study|ligament imbalance|0|||
48564387|NCT01418378|156259061|FG001|Overall Study|ligament imbalance|1|||
48564388|NCT01418378|156259060|FG000|Overall Study|developed chronic myopathy|0|||
48564389|NCT01418378|156259061|FG001|Overall Study|developed chronic myopathy|1|||
48564390|NCT00191477|156259064|FG000|Overall Study|Tumor Recurrence|49|||
48564391|NCT00191477|156259065|FG001|Overall Study|Tumor Recurrence|48|||
48564392|NCT00191477|156259064|FG000|Overall Study|Death, Study Disease|1|||
48564393|NCT00191477|156259065|FG001|Overall Study|Death, Study Disease|1|||
48564394|NCT00191477|156259064|FG000|Overall Study|Death, Other Cause|3|||
48564395|NCT00191477|156259065|FG001|Overall Study|Death, Other Cause|6|||
48564396|NCT00191477|156259064|FG000|Overall Study|Lost to Follow-up|23|||
48564397|NCT00191477|156259065|FG001|Overall Study|Lost to Follow-up|21|||
48564398|NCT00191477|156259064|FG000|Overall Study|Protocol Violation|1|||
48564399|NCT00191477|156259065|FG001|Overall Study|Protocol Violation|1|||
48564400|NCT00191477|156259064|FG000|Overall Study|Treatment Change|2|||
48564401|NCT00191477|156259065|FG001|Overall Study|Treatment Change|0|||
48564402|NCT00191477|156259064|FG000|Overall Study|Withdrawal by Subject|2|||
48564403|NCT00191477|156259065|FG001|Overall Study|Withdrawal by Subject|0|||
48564404|NCT00191477|156259064|FG000|Overall Study|Other|2|||
48564405|NCT00191477|156259065|FG001|Overall Study|Other|0|||
48564406|NCT00191477|156259064|FG000|Overall Study|Not Eligible|41|||
48564407|NCT00191477|156259065|FG001|Overall Study|Not Eligible|38|||
48564408|NCT00191477|156259064|FG000|Overall Study|Pathological Specimen Lost|1|||
48564409|NCT00191477|156259065|FG001|Overall Study|Pathological Specimen Lost|0|||
48564410|NCT00191477|156259064|FG000|Overall Study|Discontinued Prior to Instillation|13|||
48564411|NCT00191477|156259065|FG001|Overall Study|Discontinued Prior to Instillation|14|||
48564412|NCT05000164|156259067|FG000|Overall Study|Adverse Event|1|||
48564413|NCT05000164|156259067|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
48564414|NCT05000164|156259067|FG000|Overall Study|Lens Discomfort|3|||
48564415|NCT05000164|156259067|FG000|Overall Study|Withdrew Consent during Study|2|||
48564416|NCT05000164|156259067|FG000|Overall Study|Subject Withdrawn by PI|2|||
48564417|NCT05000164|156259067|FG000|Overall Study|Other Fractured Test Article|1|||
48564418|NCT01568892|156259070|FG000|Open-label Phase|Adverse Event|2|||
48564419|NCT01568892|156259071|FG001|Open-label Phase|Adverse Event|0|||
48564420|NCT01568892|156259070|FG000|Open-label Phase|Lack of Efficacy|4|||
48564421|NCT01568892|156259071|FG001|Open-label Phase|Lack of Efficacy|2|||
48564422|NCT01568892|156259070|FG000|Open-label Phase|Lost to Follow-up|0|||
48564423|NCT01568892|156259071|FG001|Open-label Phase|Lost to Follow-up|1|||
48564424|NCT01415518|156259085|FG000|Overall Study|Withdrawal by Subject|2|||
48564425|NCT01415518|156259086|FG001|Overall Study|Withdrawal by Subject|12|||
48564426|NCT01415518|156259085|FG000|Overall Study|Protocol Violation|6|||
48564427|NCT01415518|156259086|FG001|Overall Study|Protocol Violation|8|||
48564428|NCT01415518|156259085|FG000|Overall Study|Lost to Follow-up|3|||
48564429|NCT01415518|156259086|FG001|Overall Study|Lost to Follow-up|5|||
48564430|NCT01415518|156259085|FG000|Overall Study|Adverse Event|3|||
48564431|NCT01415518|156259086|FG001|Overall Study|Adverse Event|4|||
48564432|NCT01415518|156259085|FG000|Overall Study|Death|1|||
48564433|NCT01415518|156259086|FG001|Overall Study|Death|1|||
48564434|NCT01415518|156259085|FG000|Overall Study|Condition under Investigation Worsened|1|||
48564435|NCT01415518|156259086|FG001|Overall Study|Condition under Investigation Worsened|1|||
48564436|NCT02857816|156259087|FG000|Overall Study|Screen Failure|33|||
48564437|NCT02857816|156259087|FG000|Overall Study|Withdrawal by Subject|4|||
48564438|NCT02857816|156259087|FG000|Overall Study|Lost to Follow-up|1|||
48564439|NCT00765102|156259088|FG000|Overall Study|Progressive disease|18|||
48564440|NCT00765102|156259088|FG000|Overall Study|Adverse Event|6|||
48564441|NCT00765102|156259088|FG000|Overall Study|Physician Decision|4|||
48564442|NCT00765102|156259088|FG000|Overall Study|Withdrawal by Subject|2|||
48564443|NCT00765102|156259088|FG000|Overall Study|Protocol Violation|1|||
48564444|NCT02291510|156259089|FG000|Overall Study|Adverse Event|0|||
48564445|NCT02291510|156259090|FG001|Overall Study|Adverse Event|0|||
48564446|NCT02291510|156259091|FG002|Overall Study|Adverse Event|0|||
48564447|NCT02291510|156259092|FG003|Overall Study|Adverse Event|1|||
48564448|NCT00789854|156259099|FG000|Overall Study|Adverse Event|28|||
48564449|NCT00789854|156259100|FG001|Overall Study|Adverse Event|23|||
48564450|NCT00789854|156259101|FG002|Overall Study|Adverse Event|18|||
48564451|NCT00789854|156259099|FG000|Overall Study|Lost to Follow-up|1|||
48564452|NCT00789854|156259100|FG001|Overall Study|Lost to Follow-up|1|||
48564453|NCT00789854|156259101|FG002|Overall Study|Lost to Follow-up|4|||
48564454|NCT00789854|156259099|FG000|Overall Study|Withdrawal by Subject|9|||
48564455|NCT00789854|156259100|FG001|Overall Study|Withdrawal by Subject|6|||
48564456|NCT00789854|156259101|FG002|Overall Study|Withdrawal by Subject|17|||
48564457|NCT00789854|156259099|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48564458|NCT00789854|156259100|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
48564459|NCT00789854|156259101|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
48564460|NCT00789854|156259099|FG000|Overall Study|Severe non-compliance to the protocol|3|||
48564461|NCT00789854|156259100|FG001|Overall Study|Severe non-compliance to the protocol|0|||
48564462|NCT00789854|156259101|FG002|Overall Study|Severe non-compliance to the protocol|0|||
48564463|NCT00789854|156259099|FG000|Overall Study|Safety reasons|0|||
48564464|NCT00789854|156259100|FG001|Overall Study|Safety reasons|0|||
48564465|NCT00789854|156259101|FG002|Overall Study|Safety reasons|2|||
48564466|NCT00789854|156259099|FG000|Overall Study|Other|6|||
48564467|NCT00789854|156259100|FG001|Overall Study|Other|0|||
48564468|NCT00789854|156259101|FG002|Overall Study|Other|5|||
48564469|NCT02576847|156259102|FG000|Overall Study|Adverse Event|27|||
48564470|NCT02576847|156259102|FG000|Overall Study|Lost to Follow-up|22|||
48564471|NCT02576847|156259102|FG000|Overall Study|Physician Decision|1|||
48564472|NCT02576847|156259102|FG000|Overall Study|Pregnancy|1|||
48564473|NCT02576847|156259102|FG000|Overall Study|Protocol Violation|3|||
48564474|NCT02576847|156259102|FG000|Overall Study|Withdrawal by Subject|78|||
48564475|NCT02576847|156259102|FG000|Overall Study|Other|5|||
48564476|NCT03850483|156259103|FG000|Treatment for Stage 1|Adverse Event|1|||
48564477|NCT03850483|156259104|FG001|Treatment for Stage 1|Adverse Event|1|||
48564478|NCT03850483|156259105|FG002|Treatment for Stage 1|Adverse Event|3|||
48564479|NCT03850483|156259106|FG003|Treatment for Stage 1|Adverse Event|0|||
48564480|NCT03850483|156259107|FG004|Treatment for Stage 1|Adverse Event|2|||
48564481|NCT03850483|156259108|FG005|Treatment for Stage 1|Adverse Event|0|||
48564482|NCT03850483|156259109|FG006|Treatment for Stage 1|Adverse Event|2|||
48617151|NCT01529268|156453068|FG000|Overall Study|Moved|3|||
48564483|NCT03850483|156259110|FG007|Treatment for Stage 1|Adverse Event|2|||
48564484|NCT03850483|156259111|FG008|Treatment for Stage 1|Adverse Event|0|||
48564485|NCT03850483|156259112|FG009|Treatment for Stage 1|Adverse Event|0|||
48564486|NCT03850483|156259103|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
48564487|NCT03850483|156259104|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
48564488|NCT03850483|156259105|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
48564489|NCT03850483|156259106|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
48564490|NCT03850483|156259107|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
48564491|NCT03850483|156259108|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
48564492|NCT03850483|156259109|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
48564493|NCT03850483|156259110|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
48564494|NCT03850483|156259111|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
48564495|NCT03850483|156259112|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
48564496|NCT03850483|156259103|FG000|Treatment for Stage 1|Protocol Violation|1|||
48564497|NCT03850483|156259104|FG001|Treatment for Stage 1|Protocol Violation|0|||
48564498|NCT03850483|156259105|FG002|Treatment for Stage 1|Protocol Violation|0|||
48564499|NCT03850483|156259106|FG003|Treatment for Stage 1|Protocol Violation|0|||
48564500|NCT03850483|156259107|FG004|Treatment for Stage 1|Protocol Violation|0|||
48564501|NCT03850483|156259108|FG005|Treatment for Stage 1|Protocol Violation|0|||
48564502|NCT03850483|156259109|FG006|Treatment for Stage 1|Protocol Violation|1|||
48564503|NCT03850483|156259110|FG007|Treatment for Stage 1|Protocol Violation|0|||
48564504|NCT03850483|156259111|FG008|Treatment for Stage 1|Protocol Violation|0|||
48564505|NCT03850483|156259112|FG009|Treatment for Stage 1|Protocol Violation|0|||
48564506|NCT03850483|156259103|FG000|Treatment for Stage 1|Physician Decision|0|||
48564507|NCT03850483|156259104|FG001|Treatment for Stage 1|Physician Decision|0|||
48617152|NCT01529268|156453069|FG001|Overall Study|Moved|0|||
48564508|NCT03850483|156259105|FG002|Treatment for Stage 1|Physician Decision|0|||
48564509|NCT03850483|156259106|FG003|Treatment for Stage 1|Physician Decision|0|||
48564510|NCT03850483|156259107|FG004|Treatment for Stage 1|Physician Decision|0|||
48564511|NCT03850483|156259108|FG005|Treatment for Stage 1|Physician Decision|1|||
48564512|NCT03850483|156259109|FG006|Treatment for Stage 1|Physician Decision|0|||
48564513|NCT03850483|156259110|FG007|Treatment for Stage 1|Physician Decision|0|||
48564514|NCT03850483|156259111|FG008|Treatment for Stage 1|Physician Decision|0|||
48564515|NCT03850483|156259112|FG009|Treatment for Stage 1|Physician Decision|0|||
48564516|NCT03850483|156259103|FG000|Treatment for Stage 1|Other|0|||
48564517|NCT03850483|156259104|FG001|Treatment for Stage 1|Other|0|||
48564518|NCT03850483|156259105|FG002|Treatment for Stage 1|Other|0|||
48564519|NCT03850483|156259106|FG003|Treatment for Stage 1|Other|0|||
48564520|NCT03850483|156259107|FG004|Treatment for Stage 1|Other|2|||
48564521|NCT03850483|156259108|FG005|Treatment for Stage 1|Other|1|||
48564522|NCT03850483|156259109|FG006|Treatment for Stage 1|Other|0|||
48564523|NCT03850483|156259110|FG007|Treatment for Stage 1|Other|0|||
48564524|NCT03850483|156259111|FG008|Treatment for Stage 1|Other|0|||
48564525|NCT03850483|156259112|FG009|Treatment for Stage 1|Other|0|||
48564526|NCT03850483|156259103|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564527|NCT03850483|156259104|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564528|NCT03850483|156259105|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
48564529|NCT03850483|156259106|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564530|NCT03850483|156259107|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564531|NCT03850483|156259108|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564532|NCT03850483|156259109|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564533|NCT03850483|156259110|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564534|NCT03850483|156259111|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564535|NCT03850483|156259112|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
48564536|NCT03850483|156259103|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48564537|NCT03850483|156259104|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48564538|NCT03850483|156259105|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48564539|NCT03850483|156259106|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48564540|NCT03850483|156259107|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48564541|NCT03850483|156259108|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
48564542|NCT03850483|156259109|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48564543|NCT03850483|156259110|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48564544|NCT03850483|156259111|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48617153|NCT00387127|156453070|FG000|Overall Study|Lost to Follow-up|0|||
48564545|NCT03850483|156259112|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
48564546|NCT03850483|156259103|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
48564547|NCT03850483|156259104|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
48564548|NCT03850483|156259105|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
48564549|NCT03850483|156259106|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
48564550|NCT03850483|156259107|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
48564551|NCT03850483|156259108|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
48564552|NCT03850483|156259109|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
48564553|NCT03850483|156259110|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
48564554|NCT03850483|156259111|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
48564555|NCT03850483|156259112|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
48564556|NCT03850483|156259103|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
48564557|NCT03850483|156259104|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
48564558|NCT03850483|156259105|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
48564559|NCT03850483|156259106|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
48564560|NCT03850483|156259107|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
48564561|NCT03850483|156259108|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
48564562|NCT03850483|156259109|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
48564563|NCT03850483|156259110|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
48564564|NCT03850483|156259111|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
48564565|NCT03850483|156259112|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
48564566|NCT03850483|156259103|FG000|Treatment for Stage 1|Death|0|||
48564567|NCT03850483|156259104|FG001|Treatment for Stage 1|Death|0|||
48564568|NCT03850483|156259105|FG002|Treatment for Stage 1|Death|0|||
48564569|NCT03850483|156259106|FG003|Treatment for Stage 1|Death|0|||
48564570|NCT03850483|156259107|FG004|Treatment for Stage 1|Death|0|||
48564571|NCT03850483|156259108|FG005|Treatment for Stage 1|Death|1|||
48564572|NCT03850483|156259109|FG006|Treatment for Stage 1|Death|0|||
48564573|NCT03850483|156259110|FG007|Treatment for Stage 1|Death|0|||
48564574|NCT03850483|156259111|FG008|Treatment for Stage 1|Death|0|||
48564575|NCT03850483|156259112|FG009|Treatment for Stage 1|Death|0|||
48564576|NCT03850483|156259103|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
48564577|NCT03850483|156259104|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
48564578|NCT03850483|156259105|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
48564579|NCT03850483|156259106|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
48564580|NCT03850483|156259107|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
48564581|NCT03850483|156259108|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
48564582|NCT03850483|156259109|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
48564583|NCT03850483|156259110|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
48564584|NCT03850483|156259111|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
48564585|NCT03850483|156259112|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
48564586|NCT03850483|156259103|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
48564587|NCT03850483|156259104|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
48564588|NCT03850483|156259105|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
48564589|NCT03850483|156259106|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
48564590|NCT03850483|156259107|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
48564591|NCT03850483|156259108|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
48564592|NCT03850483|156259109|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
48564593|NCT03850483|156259110|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
48564594|NCT03850483|156259111|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
48564595|NCT03850483|156259112|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
48564596|NCT03850483|156259103|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
48564597|NCT03850483|156259104|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
48564598|NCT03850483|156259105|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
48564599|NCT03850483|156259106|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
48564600|NCT03850483|156259107|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
48564601|NCT03850483|156259108|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
48564602|NCT03850483|156259109|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
48564603|NCT03850483|156259110|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
48564604|NCT03850483|156259111|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
48564605|NCT03850483|156259112|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
48564606|NCT03850483|156259103|FG000|Follow-up for Stage 1|Physician Decision|0|||
48564607|NCT03850483|156259104|FG001|Follow-up for Stage 1|Physician Decision|0|||
48564608|NCT03850483|156259105|FG002|Follow-up for Stage 1|Physician Decision|0|||
48564609|NCT03850483|156259106|FG003|Follow-up for Stage 1|Physician Decision|0|||
48564610|NCT03850483|156259107|FG004|Follow-up for Stage 1|Physician Decision|1|||
48564611|NCT03850483|156259108|FG005|Follow-up for Stage 1|Physician Decision|0|||
48564612|NCT03850483|156259109|FG006|Follow-up for Stage 1|Physician Decision|1|||
48564613|NCT03850483|156259110|FG007|Follow-up for Stage 1|Physician Decision|0|||
48564614|NCT03850483|156259111|FG008|Follow-up for Stage 1|Physician Decision|0|||
48564615|NCT03850483|156259112|FG009|Follow-up for Stage 1|Physician Decision|0|||
48564616|NCT03850483|156259103|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
48564617|NCT03850483|156259104|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
48564618|NCT03850483|156259105|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
48564619|NCT03850483|156259106|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
48564620|NCT03850483|156259107|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
48564621|NCT03850483|156259108|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
48564622|NCT03850483|156259109|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
48564623|NCT03850483|156259110|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
48564624|NCT03850483|156259111|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
48564625|NCT03850483|156259112|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
48564626|NCT03850483|156259103|FG000|Follow-up for Stage 1|Adverse Event|0|||
48564627|NCT03850483|156259104|FG001|Follow-up for Stage 1|Adverse Event|0|||
48564628|NCT03850483|156259105|FG002|Follow-up for Stage 1|Adverse Event|1|||
48564629|NCT03850483|156259106|FG003|Follow-up for Stage 1|Adverse Event|0|||
48564630|NCT03850483|156259107|FG004|Follow-up for Stage 1|Adverse Event|0|||
48564631|NCT03850483|156259108|FG005|Follow-up for Stage 1|Adverse Event|1|||
48564632|NCT03850483|156259109|FG006|Follow-up for Stage 1|Adverse Event|0|||
48564633|NCT03850483|156259110|FG007|Follow-up for Stage 1|Adverse Event|0|||
48564634|NCT03850483|156259111|FG008|Follow-up for Stage 1|Adverse Event|0|||
48564635|NCT03850483|156259112|FG009|Follow-up for Stage 1|Adverse Event|0|||
48564636|NCT03850483|156259103|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
48564637|NCT03850483|156259104|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
48564638|NCT03850483|156259105|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
48564639|NCT03850483|156259106|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
48564640|NCT03850483|156259107|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
48564641|NCT03850483|156259108|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
48564642|NCT03850483|156259109|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
48564643|NCT03850483|156259110|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
48564644|NCT03850483|156259111|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
48564645|NCT03850483|156259112|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
48564646|NCT03850483|156259103|FG000|Follow-up for Stage 1|Other|0|||
48564647|NCT03850483|156259104|FG001|Follow-up for Stage 1|Other|2|||
48564648|NCT03850483|156259105|FG002|Follow-up for Stage 1|Other|0|||
48564649|NCT03850483|156259106|FG003|Follow-up for Stage 1|Other|2|||
48564650|NCT03850483|156259107|FG004|Follow-up for Stage 1|Other|0|||
48564651|NCT03850483|156259108|FG005|Follow-up for Stage 1|Other|1|||
48564652|NCT03850483|156259109|FG006|Follow-up for Stage 1|Other|0|||
48564653|NCT03850483|156259110|FG007|Follow-up for Stage 1|Other|0|||
48564654|NCT03850483|156259111|FG008|Follow-up for Stage 1|Other|0|||
48564655|NCT03850483|156259112|FG009|Follow-up for Stage 1|Other|0|||
48564656|NCT03850483|156259103|FG000|Treatment for Stage 2|Adverse Event|0|||
48564657|NCT03850483|156259104|FG001|Treatment for Stage 2|Adverse Event|0|||
48564658|NCT03850483|156259105|FG002|Treatment for Stage 2|Adverse Event|0|||
48564659|NCT03850483|156259106|FG003|Treatment for Stage 2|Adverse Event|0|||
48564660|NCT03850483|156259107|FG004|Treatment for Stage 2|Adverse Event|0|||
48564661|NCT03850483|156259108|FG005|Treatment for Stage 2|Adverse Event|0|||
48564662|NCT03850483|156259109|FG006|Treatment for Stage 2|Adverse Event|0|||
48564663|NCT03850483|156259110|FG007|Treatment for Stage 2|Adverse Event|0|||
48564664|NCT03850483|156259111|FG008|Treatment for Stage 2|Adverse Event|0|||
48564665|NCT03850483|156259112|FG009|Treatment for Stage 2|Adverse Event|1|||
48564666|NCT03850483|156259103|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
48564667|NCT03850483|156259104|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
48564668|NCT03850483|156259105|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
48564669|NCT03850483|156259106|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
48564670|NCT03850483|156259107|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
48564671|NCT03850483|156259108|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
48564672|NCT03850483|156259109|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
48564673|NCT03850483|156259110|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
48564674|NCT03850483|156259111|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
48564675|NCT03850483|156259112|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
48564676|NCT03850483|156259103|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
48564677|NCT03850483|156259104|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
48564678|NCT03850483|156259105|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
48564679|NCT03850483|156259106|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
48564680|NCT03850483|156259107|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
48564681|NCT03850483|156259108|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
48564682|NCT03850483|156259109|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
48617154|NCT00387127|156453071|FG001|Overall Study|Lost to Follow-up|4|||
48564683|NCT03850483|156259110|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
48564684|NCT03850483|156259111|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
48564685|NCT03850483|156259112|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
48564686|NCT03850483|156259103|FG000|Treatment for Stage 2|Physician Decision|0|||
48564687|NCT03850483|156259104|FG001|Treatment for Stage 2|Physician Decision|0|||
48564688|NCT03850483|156259105|FG002|Treatment for Stage 2|Physician Decision|0|||
48564689|NCT03850483|156259106|FG003|Treatment for Stage 2|Physician Decision|0|||
48564690|NCT03850483|156259107|FG004|Treatment for Stage 2|Physician Decision|0|||
48564691|NCT03850483|156259108|FG005|Treatment for Stage 2|Physician Decision|0|||
48564692|NCT03850483|156259109|FG006|Treatment for Stage 2|Physician Decision|0|||
48564693|NCT03850483|156259110|FG007|Treatment for Stage 2|Physician Decision|0|||
48564694|NCT03850483|156259111|FG008|Treatment for Stage 2|Physician Decision|0|||
48564695|NCT03850483|156259112|FG009|Treatment for Stage 2|Physician Decision|1|||
48564696|NCT03850483|156259103|FG000|Treatment for Stage 2|Protocol Violation|0|||
48564697|NCT03850483|156259104|FG001|Treatment for Stage 2|Protocol Violation|0|||
48564698|NCT03850483|156259105|FG002|Treatment for Stage 2|Protocol Violation|0|||
48564699|NCT03850483|156259106|FG003|Treatment for Stage 2|Protocol Violation|0|||
48564700|NCT03850483|156259107|FG004|Treatment for Stage 2|Protocol Violation|0|||
48564701|NCT03850483|156259108|FG005|Treatment for Stage 2|Protocol Violation|0|||
48564702|NCT03850483|156259109|FG006|Treatment for Stage 2|Protocol Violation|0|||
48564703|NCT03850483|156259110|FG007|Treatment for Stage 2|Protocol Violation|0|||
48564704|NCT03850483|156259111|FG008|Treatment for Stage 2|Protocol Violation|1|||
48564705|NCT03850483|156259112|FG009|Treatment for Stage 2|Protocol Violation|0|||
48564706|NCT03850483|156259103|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
48564707|NCT03850483|156259104|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
48564708|NCT03850483|156259105|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
48564709|NCT03850483|156259106|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
48564710|NCT03850483|156259107|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
48564711|NCT03850483|156259108|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
48564712|NCT03850483|156259109|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
48564713|NCT03850483|156259110|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
48564714|NCT03850483|156259111|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
48564715|NCT03850483|156259112|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
48564716|NCT03850483|156259103|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564717|NCT03850483|156259104|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564718|NCT03850483|156259105|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564719|NCT03850483|156259106|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564720|NCT03850483|156259107|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564721|NCT03850483|156259108|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564722|NCT03850483|156259109|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564723|NCT03850483|156259110|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564724|NCT03850483|156259111|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
48564725|NCT03850483|156259112|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
48564726|NCT03850483|156259103|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
48564727|NCT03850483|156259104|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
48564728|NCT03850483|156259105|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
48564729|NCT03850483|156259106|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
48564730|NCT03850483|156259107|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
48564731|NCT03850483|156259108|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
48564732|NCT03850483|156259109|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
48564733|NCT03850483|156259110|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
48564734|NCT03850483|156259111|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
48564735|NCT03850483|156259112|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
48564736|NCT03850483|156259103|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
48564737|NCT03850483|156259104|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
48564738|NCT03850483|156259105|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
48564739|NCT03850483|156259106|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
48564740|NCT03850483|156259107|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
48564741|NCT03850483|156259108|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
48564742|NCT03850483|156259109|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
48564743|NCT03850483|156259110|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
48564744|NCT03850483|156259111|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
48564745|NCT03850483|156259112|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
48564746|NCT03850483|156259103|FG000|Follow-up For Stage 2|Other|0|||
48564747|NCT03850483|156259104|FG001|Follow-up For Stage 2|Other|0|||
48564748|NCT03850483|156259105|FG002|Follow-up For Stage 2|Other|0|||
48564749|NCT03850483|156259106|FG003|Follow-up For Stage 2|Other|0|||
48564750|NCT03850483|156259107|FG004|Follow-up For Stage 2|Other|0|||
48564751|NCT03850483|156259108|FG005|Follow-up For Stage 2|Other|0|||
48564752|NCT03850483|156259109|FG006|Follow-up For Stage 2|Other|0|||
48564753|NCT03850483|156259110|FG007|Follow-up For Stage 2|Other|0|||
48564754|NCT03850483|156259111|FG008|Follow-up For Stage 2|Other|0|||
48564755|NCT03850483|156259112|FG009|Follow-up For Stage 2|Other|1|||
48564756|NCT01806051|156259115|FG000|Overall Study|Withdrawal by Subject|6|||
48564757|NCT02418182|156259116|FG000|Overall Study|Unable to re-consent|18|||
48564758|NCT02418182|156259117|FG001|Overall Study|Unable to re-consent|15|||
48564759|NCT02418182|156259116|FG000|Overall Study|Lost to Follow-up|0|||
48564760|NCT02418182|156259117|FG001|Overall Study|Lost to Follow-up|2|||
48564761|NCT04305327|156259118|FG000|Overall Study|Study early termination|2|||
48564762|NCT04305327|156259119|FG001|Overall Study|Study early termination|5|||
48564763|NCT04305327|156259120|FG002|Overall Study|Study early termination|2|||
48564764|NCT04305327|156259121|FG003|Overall Study|Study early termination|2|||
48564765|NCT04305327|156259118|FG000|Overall Study|Withdrawal by Subject|0|||
48564766|NCT04305327|156259119|FG001|Overall Study|Withdrawal by Subject|1|||
48564767|NCT04305327|156259120|FG002|Overall Study|Withdrawal by Subject|0|||
48564768|NCT04305327|156259121|FG003|Overall Study|Withdrawal by Subject|0|||
48564769|NCT01205776|156259122|FG000|Overall Study|Lost to Follow-up|53|||
48564770|NCT01205776|156259123|FG001|Overall Study|Lost to Follow-up|61|||
48564771|NCT01205776|156259122|FG000|Overall Study|Withdrawal by Subject|11|||
48564772|NCT01205776|156259123|FG001|Overall Study|Withdrawal by Subject|34|||
48564773|NCT01796392|156259124|FG000|Overall Study|Withdrawal by Subject|2|||
48564774|NCT01796392|156259125|FG001|Overall Study|Withdrawal by Subject|0|||
48564775|NCT01796392|156259124|FG000|Overall Study|Death|5|||
48564776|NCT01796392|156259125|FG001|Overall Study|Death|1|||
48564777|NCT01796392|156259124|FG000|Overall Study|Excluded for medical reasons|1|||
48564778|NCT01796392|156259125|FG001|Overall Study|Excluded for medical reasons|2|||
48564779|NCT01796392|156259124|FG000|Overall Study|Lost to Follow-up|1|||
48564780|NCT01796392|156259125|FG001|Overall Study|Lost to Follow-up|0|||
48564781|NCT03170362|156259126|FG000|Overall Study|Death|2|||
48564782|NCT03170362|156259127|FG001|Overall Study|Death|2|||
48564783|NCT03170362|156259126|FG000|Overall Study|Withdrawal by Subject|23|||
48564784|NCT03170362|156259127|FG001|Overall Study|Withdrawal by Subject|22|||
48564785|NCT03170362|156259126|FG000|Overall Study|Lost to Follow-up|187|||
48564786|NCT03170362|156259127|FG001|Overall Study|Lost to Follow-up|167|||
48564787|NCT02362360|156259128|FG000|Period 1|Lack of Efficacy|1|||
48564788|NCT02362360|156259129|FG001|Period 1|Lack of Efficacy|0|||
48564789|NCT02362360|156259128|FG000|Period 1|Withdrawal by Subject|2|||
48564790|NCT02362360|156259129|FG001|Period 1|Withdrawal by Subject|1|||
48564791|NCT00734994|156259130|FG000|Overall Study|Withdrawal by Subject|1|||
48564792|NCT03225105|156259131|FG000|Overall Study|Withdrawal by Subject|1|||
48564793|NCT03225105|156259132|FG001|Overall Study|Withdrawal by Subject|0|||
48564794|NCT03225105|156259133|FG002|Overall Study|Withdrawal by Subject|0|||
48564795|NCT03225105|156259134|FG003|Overall Study|Withdrawal by Subject|0|||
48564796|NCT03225105|156259131|FG000|Overall Study|Death|0|||
48564797|NCT03225105|156259132|FG001|Overall Study|Death|4|||
48564798|NCT03225105|156259133|FG002|Overall Study|Death|2|||
48564799|NCT03225105|156259134|FG003|Overall Study|Death|0|||
48564800|NCT03225105|156259131|FG000|Overall Study|Study termination per Sponsor Decision|2|||
48564801|NCT03225105|156259132|FG001|Overall Study|Study termination per Sponsor Decision|0|||
48564802|NCT03225105|156259133|FG002|Overall Study|Study termination per Sponsor Decision|3|||
48564803|NCT03225105|156259134|FG003|Overall Study|Study termination per Sponsor Decision|3|||
48564804|NCT02445248|156260708|FG000|Overall Study|Death|45|||
48564805|NCT02445248|156260709|FG001|Overall Study|Death|12|||
48564806|NCT02445248|156260708|FG000|Overall Study|Progressive disease|13|||
48564807|NCT02445248|156260709|FG001|Overall Study|Progressive disease|1|||
48564808|NCT02445248|156260708|FG000|Overall Study|Subject decision|8|||
48564809|NCT02445248|156260709|FG001|Overall Study|Subject decision|0|||
48564810|NCT02445248|156260708|FG000|Overall Study|Physician Decision|5|||
48564811|NCT02445248|156260709|FG001|Overall Study|Physician Decision|0|||
48564812|NCT02445248|156260708|FG000|Overall Study|Adverse Event|1|||
48564813|NCT02445248|156260709|FG001|Overall Study|Adverse Event|0|||
48564814|NCT02445248|156260708|FG000|Overall Study|Lost to Follow-up|1|||
48617155|NCT00387127|156453070|FG000|Overall Study|Death|16|||
48564815|NCT02445248|156260709|FG001|Overall Study|Lost to Follow-up|0|||
48564816|NCT01922037|156260710|FG000|Overall Study|Withdrawal by Subject|2|||
48564817|NCT01922037|156260711|FG001|Overall Study|Withdrawal by Subject|44|||
48564818|NCT01922037|156260710|FG000|Overall Study|Adverse Event|1|||
48564819|NCT01922037|156260711|FG001|Overall Study|Adverse Event|7|||
48564820|NCT01922037|156260710|FG000|Overall Study|Death|0|||
48564821|NCT01922037|156260711|FG001|Overall Study|Death|5|||
48564822|NCT01922037|156260710|FG000|Overall Study|Pregnancy|0|||
48564823|NCT01922037|156260711|FG001|Overall Study|Pregnancy|2|||
48564824|NCT01922037|156260710|FG000|Overall Study|Participant non-compliance|4|||
48564825|NCT01922037|156260711|FG001|Overall Study|Participant non-compliance|46|||
48564826|NCT01922037|156260710|FG000|Overall Study|Investigator/Sponsor decision|1|||
48564827|NCT01922037|156260711|FG001|Overall Study|Investigator/Sponsor decision|4|||
48564828|NCT01922037|156260710|FG000|Overall Study|Other unspecified|2|||
48564829|NCT01922037|156260711|FG001|Overall Study|Other unspecified|66|||
48564830|NCT03493854|156260712|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
48564831|NCT03493854|156260713|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
48564832|NCT03493854|156260712|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
48564833|NCT03493854|156260713|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
48564834|NCT03493854|156260712|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
48564835|NCT03493854|156260713|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
48564836|NCT03493854|156260712|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
48564837|NCT03493854|156260713|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
48564838|NCT03493854|156260712|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
48564839|NCT03493854|156260713|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
48564840|NCT03493854|156260712|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
48564841|NCT03493854|156260713|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
48564842|NCT03493854|156260712|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
48564843|NCT03493854|156260713|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
48564844|NCT03493854|156260712|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
48564845|NCT03493854|156260713|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
48564846|NCT03493854|156260712|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
48564847|NCT03493854|156260713|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
48564848|NCT03493854|156260712|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
48564849|NCT03493854|156260713|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
48564850|NCT03493854|156260712|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
48564851|NCT03493854|156260713|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
48564852|NCT03493854|156260712|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
48564853|NCT03493854|156260713|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
48564854|NCT03493854|156260712|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
48564855|NCT03493854|156260713|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
48564856|NCT03493854|156260712|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
48564857|NCT03493854|156260713|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
48564858|NCT03493854|156260712|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
48564859|NCT03493854|156260713|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
48564860|NCT03493854|156260712|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
48564861|NCT03493854|156260713|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
48564862|NCT03493854|156260712|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
48564863|NCT03493854|156260713|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
48564864|NCT03493854|156260712|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
48564865|NCT03493854|156260713|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
48564866|NCT04565145|156260718|FG000|Overall Study|Withdrawal by Subject|1|||
48564867|NCT04565145|156260719|FG001|Overall Study|Withdrawal by Subject|1|||
48564868|NCT00536939|156260720|FG000|Overall Study|Withdrawal by Subject|1|||
48564869|NCT00536939|156260721|FG001|Overall Study|Withdrawal by Subject|0|||
48564870|NCT00536939|156260720|FG000|Overall Study|Other Complicating Disease|1|||
48564871|NCT00536939|156260721|FG001|Overall Study|Other Complicating Disease|0|||
48564872|NCT05506046|156260724|FG000|Overall Study|Lost to Follow-up|89|||
48564873|NCT05506046|156260725|FG001|Overall Study|Lost to Follow-up|101|||
48564874|NCT05506046|156260726|FG002|Overall Study|Lost to Follow-up|102|||
48564875|NCT05506046|156260727|FG003|Overall Study|Lost to Follow-up|99|||
48564876|NCT05061693|156260728|FG000|Overall Study|Adverse Event|1|||
48564877|NCT05061693|156260729|FG001|Overall Study|Adverse Event|1|||
48564878|NCT05061693|156260730|FG002|Overall Study|Adverse Event|1|||
48564879|NCT05061693|156260731|FG003|Overall Study|Adverse Event|0|||
48564880|NCT05061693|156260728|FG000|Overall Study|Death|0|||
48564881|NCT05061693|156260729|FG001|Overall Study|Death|1|||
48564882|NCT05061693|156260730|FG002|Overall Study|Death|0|||
48564883|NCT05061693|156260731|FG003|Overall Study|Death|0|||
48564884|NCT05061693|156260728|FG000|Overall Study|Lack of Efficacy|1|||
48564885|NCT05061693|156260729|FG001|Overall Study|Lack of Efficacy|0|||
48564886|NCT05061693|156260730|FG002|Overall Study|Lack of Efficacy|0|||
48564887|NCT05061693|156260731|FG003|Overall Study|Lack of Efficacy|0|||
48564888|NCT05061693|156260728|FG000|Overall Study|Lost to Follow-up|0|||
48564889|NCT05061693|156260729|FG001|Overall Study|Lost to Follow-up|0|||
48564890|NCT05061693|156260730|FG002|Overall Study|Lost to Follow-up|1|||
48564891|NCT05061693|156260731|FG003|Overall Study|Lost to Follow-up|0|||
48564892|NCT05061693|156260728|FG000|Overall Study|Protocol Violation|1|||
48564893|NCT05061693|156260729|FG001|Overall Study|Protocol Violation|1|||
48564894|NCT05061693|156260730|FG002|Overall Study|Protocol Violation|1|||
48564895|NCT05061693|156260731|FG003|Overall Study|Protocol Violation|2|||
48564896|NCT05061693|156260728|FG000|Overall Study|Withdrawal by Subject|2|||
48564897|NCT05061693|156260729|FG001|Overall Study|Withdrawal by Subject|4|||
48564898|NCT05061693|156260730|FG002|Overall Study|Withdrawal by Subject|2|||
48564899|NCT05061693|156260731|FG003|Overall Study|Withdrawal by Subject|2|||
48564900|NCT00449865|156260732|FG000|Overall Study|Withdrawal by Subject|110|||
48564901|NCT00449865|156260733|FG001|Overall Study|Withdrawal by Subject|110|||
48564902|NCT00449865|156260732|FG000|Overall Study|Lost to Follow-up|36|||
48564903|NCT00449865|156260733|FG001|Overall Study|Lost to Follow-up|37|||
48564904|NCT00449865|156260732|FG000|Overall Study|Physician Decision|13|||
48564905|NCT00449865|156260733|FG001|Overall Study|Physician Decision|12|||
48564906|NCT00449865|156260732|FG000|Overall Study|Death|31|||
48564907|NCT00449865|156260733|FG001|Overall Study|Death|40|||
48564908|NCT00449865|156260732|FG000|Overall Study|Protocol Violation|8|||
48564909|NCT00449865|156260733|FG001|Overall Study|Protocol Violation|7|||
48564910|NCT00449865|156260732|FG000|Overall Study|Study was stopped|324|||
48564911|NCT00449865|156260733|FG001|Overall Study|Study was stopped|328|||
48564912|NCT02626026|156260734|FG000|Overall Study|Randomized but Never Treated|0|||
48564913|NCT02626026|156260735|FG001|Overall Study|Randomized but Never Treated|0|||
48564914|NCT02626026|156260736|FG002|Overall Study|Randomized but Never Treated|0|||
48564915|NCT02626026|156260737|FG003|Overall Study|Randomized but Never Treated|0|||
48564916|NCT02626026|156260738|FG004|Overall Study|Randomized but Never Treated|1|||
48564917|NCT02626026|156260739|FG005|Overall Study|Randomized but Never Treated|0|||
48564918|NCT01778855|156260740|FG000|Overall Study|Death|0|||
48564919|NCT01778855|156260741|FG001|Overall Study|Death|1|||
48564920|NCT00406367|156260742|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
48564921|NCT00406367|156260743|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
48564922|NCT00406367|156260742|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
48564923|NCT00406367|156260743|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
48564924|NCT00406367|156260742|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
48564925|NCT00406367|156260743|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
48564926|NCT00406367|156260742|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
48564927|NCT00406367|156260743|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
48564928|NCT00406367|156260742|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
48564929|NCT00406367|156260743|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
48564930|NCT00406367|156260742|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
48564931|NCT00406367|156260743|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
48564932|NCT00406367|156260742|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
48564933|NCT00406367|156260743|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
48564934|NCT00406367|156260742|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
48564935|NCT00406367|156260743|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
48564936|NCT00406367|156260742|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
48564937|NCT00406367|156260743|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
48564938|NCT00406367|156260742|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
48564939|NCT00406367|156260743|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
48564940|NCT00406367|156260742|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
48564941|NCT00406367|156260743|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
48564942|NCT00406367|156260742|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
48564943|NCT00406367|156260743|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
48564944|NCT00171210|156260745|FG000|Overall Study|Adverse Event|16|||
48564945|NCT00171210|156260746|FG001|Overall Study|Adverse Event|27|||
48564946|NCT00171210|156260745|FG000|Overall Study|Abnormal laboratory value(s)|6|||
48564947|NCT00171210|156260746|FG001|Overall Study|Abnormal laboratory value(s)|3|||
48564948|NCT00171210|156260745|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48564949|NCT00171210|156260746|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48564950|NCT00171210|156260745|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
48564951|NCT00171210|156260746|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
48564952|NCT00171210|156260745|FG000|Overall Study|Protocol Violation|0|||
48564953|NCT00171210|156260746|FG001|Overall Study|Protocol Violation|2|||
48564954|NCT00171210|156260745|FG000|Overall Study|Withdrawal by Subject|32|||
48564955|NCT00171210|156260746|FG001|Overall Study|Withdrawal by Subject|30|||
48564956|NCT00171210|156260745|FG000|Overall Study|Lost to Follow-up|1|||
48564957|NCT00171210|156260746|FG001|Overall Study|Lost to Follow-up|0|||
48564958|NCT00171210|156260745|FG000|Overall Study|Administrative problems|1|||
48564959|NCT00171210|156260746|FG001|Overall Study|Administrative problems|1|||
48564960|NCT00171210|156260745|FG000|Overall Study|Death|2|||
48564961|NCT00171210|156260746|FG001|Overall Study|Death|3|||
48564962|NCT00171210|156260745|FG000|Overall Study|Stopped at end of core|0|||
48564963|NCT00171210|156260746|FG001|Overall Study|Stopped at end of core|32|||
48564964|NCT00171210|156260745|FG000|Overall Study|Stopped at end of extension 1|0|||
48564965|NCT00171210|156260746|FG001|Overall Study|Stopped at end of extension 1|1|||
48564966|NCT03150719|156260747|FG000|Overall Study|Adverse Event|0|||
48564967|NCT03150719|156260748|FG001|Overall Study|Adverse Event|1|||
48564968|NCT03150719|156260747|FG000|Overall Study|Death|0|||
48564969|NCT03150719|156260748|FG001|Overall Study|Death|1|||
48564970|NCT03150719|156260747|FG000|Overall Study|Other|1|||
48564971|NCT03150719|156260748|FG001|Overall Study|Other|0|||
48564972|NCT01006122|156260751|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
48564973|NCT01006122|156260752|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
48564974|NCT01006122|156260751|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
48564975|NCT01006122|156260752|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
48564976|NCT01006122|156260751|FG000|First Double-blind Intervention Period|Pregnancy|0|||
48564977|NCT01006122|156260752|FG001|First Double-blind Intervention Period|Pregnancy|1|||
48564978|NCT01006122|156260751|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
48564979|NCT01006122|156260752|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
48564980|NCT01006122|156260751|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
48564981|NCT01006122|156260752|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
48564982|NCT01006122|156260751|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
48564983|NCT01006122|156260752|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
48564984|NCT01006122|156260751|FG000|First Double-blind Intervention Period|Other|3|||
48564985|NCT01006122|156260752|FG001|First Double-blind Intervention Period|Other|0|||
48564986|NCT01006122|156260751|FG000|First Double-blind Intervention Period|Adverse Event|0|||
48564987|NCT01006122|156260752|FG001|First Double-blind Intervention Period|Adverse Event|4|||
48564988|NCT01006122|156260751|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
48564989|NCT01006122|156260752|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
48564990|NCT01006122|156260751|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
48564991|NCT01006122|156260752|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
48564992|NCT01006122|156260751|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
48564993|NCT01006122|156260752|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
48564994|NCT01006122|156260751|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
48564995|NCT01006122|156260752|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
48564996|NCT01006122|156260751|FG000|Second Double-blind Intervention Period|Death|0|||
48564997|NCT01006122|156260752|FG001|Second Double-blind Intervention Period|Death|1|||
48564998|NCT03776357|156260755|FG000|Overall Study|Lost to Follow-up|3|||
48564999|NCT03660930|156260756|FG000|Overall Study|Adverse Event|0|||
48565000|NCT03660930|156260757|FG001|Overall Study|Adverse Event|0|||
48565001|NCT03660930|156260758|FG002|Overall Study|Adverse Event|0|||
48565002|NCT03660930|156260759|FG003|Overall Study|Adverse Event|2|||
48565003|NCT03660930|156260760|FG004|Overall Study|Adverse Event|0|||
48565004|NCT03660930|156260761|FG005|Overall Study|Adverse Event|1|||
48565005|NCT03660930|156260762|FG006|Overall Study|Adverse Event|0|||
48565006|NCT03660930|156260763|FG007|Overall Study|Adverse Event|0|||
48565007|NCT03660930|156260756|FG000|Overall Study|Withdrawal by Subject|0|||
48565008|NCT03660930|156260757|FG001|Overall Study|Withdrawal by Subject|0|||
48565009|NCT03660930|156260758|FG002|Overall Study|Withdrawal by Subject|0|||
48565010|NCT03660930|156260759|FG003|Overall Study|Withdrawal by Subject|0|||
48565011|NCT03660930|156260760|FG004|Overall Study|Withdrawal by Subject|0|||
48565012|NCT03660930|156260761|FG005|Overall Study|Withdrawal by Subject|1|||
48565013|NCT03660930|156260762|FG006|Overall Study|Withdrawal by Subject|0|||
48565014|NCT03660930|156260763|FG007|Overall Study|Withdrawal by Subject|0|||
48565015|NCT03660930|156260756|FG000|Overall Study|On Treatment|0|||
48565016|NCT03660930|156260757|FG001|Overall Study|On Treatment|0|||
48565017|NCT03660930|156260758|FG002|Overall Study|On Treatment|0|||
48565018|NCT03660930|156260759|FG003|Overall Study|On Treatment|0|||
48565019|NCT03660930|156260760|FG004|Overall Study|On Treatment|0|||
48565020|NCT03660930|156260761|FG005|Overall Study|On Treatment|0|||
48565021|NCT03660930|156260762|FG006|Overall Study|On Treatment|0|||
48565022|NCT03660930|156260763|FG007|Overall Study|On Treatment|1|||
48565023|NCT03660930|156260756|FG000|Overall Study|In Follow-up|0|||
48565024|NCT03660930|156260757|FG001|Overall Study|In Follow-up|0|||
48565025|NCT03660930|156260758|FG002|Overall Study|In Follow-up|0|||
48565026|NCT03660930|156260759|FG003|Overall Study|In Follow-up|0|||
48565027|NCT03660930|156260760|FG004|Overall Study|In Follow-up|0|||
48565028|NCT03660930|156260761|FG005|Overall Study|In Follow-up|0|||
48565029|NCT03660930|156260762|FG006|Overall Study|In Follow-up|1|||
48565030|NCT03660930|156260763|FG007|Overall Study|In Follow-up|2|||
48565031|NCT03473925|156260764|FG000|Overall Study|Death|48|||
48565032|NCT03473925|156260765|FG001|Overall Study|Death|44|||
48565033|NCT03473925|156260764|FG000|Overall Study|Sponsor Decision|2|||
48565034|NCT03473925|156260765|FG001|Overall Study|Sponsor Decision|7|||
48565035|NCT03473925|156260764|FG000|Overall Study|Withdrawal by Subject|1|||
48565036|NCT03473925|156260765|FG001|Overall Study|Withdrawal by Subject|3|||
48565037|NCT03473925|156260764|FG000|Overall Study|Not Treated|1|||
48565038|NCT03473925|156260765|FG001|Overall Study|Not Treated|1|||
48565039|NCT03922308|156260766|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
48565040|NCT03922308|156260767|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
48565041|NCT03922308|156260768|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
48565042|NCT03922308|156260766|FG000|Overall Study|Lost to Follow-up|1|||
48565043|NCT03922308|156260767|FG001|Overall Study|Lost to Follow-up|0|||
48565044|NCT03922308|156260768|FG002|Overall Study|Lost to Follow-up|0|||
48565045|NCT03922308|156260766|FG000|Overall Study|Reason not Specified|0|||
48565046|NCT03922308|156260767|FG001|Overall Study|Reason not Specified|2|||
48565047|NCT03922308|156260768|FG002|Overall Study|Reason not Specified|1|||
48565048|NCT02454608|156260769|FG000|Double-Blind Period|Lack of Efficacy|0|||
48565049|NCT02454608|156260770|FG001|Double-Blind Period|Lack of Efficacy|2|||
48565050|NCT02454608|156260771|FG002|Double-Blind Period|Lack of Efficacy|0|||
48565051|NCT02454608|156260769|FG000|Open Label Period|Lost to Follow-up|0|||
48565052|NCT02454608|156260770|FG001|Open Label Period|Lost to Follow-up|0|||
48565053|NCT02454608|156260771|FG002|Open Label Period|Lost to Follow-up|11|||
48565054|NCT02454608|156260769|FG000|Open Label Period|Withdrawal by Subject|0|||
48565055|NCT02454608|156260770|FG001|Open Label Period|Withdrawal by Subject|0|||
48565056|NCT02454608|156260771|FG002|Open Label Period|Withdrawal by Subject|8|||
48565057|NCT01431716|156260772|FG000|Overall Study|Withdrawal of consent|1|||
48565058|NCT01812109|156260779|FG000|Overall Study|research personnel delay|16|||
48565059|NCT01812109|156260779|FG000|Overall Study|NIRS Unattainable|17|||
48565060|NCT05005507|156260780|FG000|Overall Study|Premature termination of study|1|||
48565061|NCT01286467|156260787|FG000|Overall Study|Death|1|||
48565062|NCT01286467|156260788|FG001|Overall Study|Death|1|||
48565063|NCT01286467|156260789|FG002|Overall Study|Death|1|||
48565064|NCT01286467|156260790|FG003|Overall Study|Death|0|||
48565065|NCT01286467|156260787|FG000|Overall Study|Lost to Follow-up|0|||
48565066|NCT01286467|156260788|FG001|Overall Study|Lost to Follow-up|0|||
48565067|NCT01286467|156260789|FG002|Overall Study|Lost to Follow-up|0|||
48565068|NCT01286467|156260790|FG003|Overall Study|Lost to Follow-up|1|||
48565069|NCT01286467|156260787|FG000|Overall Study|Withdrawal by Subject|0|||
48565070|NCT01286467|156260788|FG001|Overall Study|Withdrawal by Subject|0|||
48565071|NCT01286467|156260789|FG002|Overall Study|Withdrawal by Subject|1|||
48565072|NCT01286467|156260790|FG003|Overall Study|Withdrawal by Subject|0|||
48565073|NCT01286467|156260787|FG000|Overall Study|Physician Decision|0|||
48565074|NCT01286467|156260788|FG001|Overall Study|Physician Decision|0|||
48565075|NCT01286467|156260789|FG002|Overall Study|Physician Decision|0|||
48565076|NCT01286467|156260790|FG003|Overall Study|Physician Decision|1|||
48565077|NCT01286467|156260787|FG000|Overall Study|Disease progression|3|||
48565078|NCT01286467|156260788|FG001|Overall Study|Disease progression|2|||
48565079|NCT01286467|156260789|FG002|Overall Study|Disease progression|2|||
48565080|NCT01286467|156260790|FG003|Overall Study|Disease progression|3|||
48565081|NCT01286467|156260787|FG000|Overall Study|Adverse Event|0|||
48565082|NCT01286467|156260788|FG001|Overall Study|Adverse Event|1|||
48565083|NCT01286467|156260789|FG002|Overall Study|Adverse Event|2|||
48565084|NCT01286467|156260790|FG003|Overall Study|Adverse Event|3|||
48565085|NCT01286467|156260787|FG000|Overall Study|Study drug stop longer than 14 days|0|||
48565086|NCT01286467|156260788|FG001|Overall Study|Study drug stop longer than 14 days|0|||
48565087|NCT01286467|156260789|FG002|Overall Study|Study drug stop longer than 14 days|1|||
48565088|NCT01286467|156260790|FG003|Overall Study|Study drug stop longer than 14 days|0|||
48565089|NCT02513160|156260793|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
48565090|NCT02513160|156260794|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
48565091|NCT02513160|156260795|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
48565092|NCT02513160|156260796|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
48565093|NCT02513160|156260793|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
48565094|NCT02513160|156260794|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
48585118|NCT01706575|156333782|FG000|Overall Study|Lost to Follow-up|2|||
48585119|NCT01706575|156333782|FG000|Overall Study|Started but not Treated|6|||
48585120|NCT01094782|156333783|FG000|Overall Study|Withdrawal by Subject|5|||
48585121|NCT01094782|156333784|FG001|Overall Study|Withdrawal by Subject|5|||
48565095|NCT02513160|156260795|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
48565096|NCT02513160|156260796|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
48565097|NCT02513160|156260793|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
48565098|NCT02513160|156260794|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
48565099|NCT02513160|156260795|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
48565100|NCT02513160|156260796|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
48565101|NCT02513160|156260793|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
48565102|NCT02513160|156260794|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
48565103|NCT02513160|156260795|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
48617156|NCT00387127|156453071|FG001|Overall Study|Death|16|||
48565104|NCT02513160|156260796|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
48565105|NCT02513160|156260793|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
48565106|NCT02513160|156260794|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
48565107|NCT02513160|156260795|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
48565108|NCT02513160|156260796|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
48565109|NCT02513160|156260793|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
48565110|NCT02513160|156260794|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
48565111|NCT02513160|156260795|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
48565112|NCT02513160|156260796|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
48565113|NCT02513160|156260793|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
48565114|NCT02513160|156260794|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
48565115|NCT02513160|156260795|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
48565116|NCT02513160|156260796|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
48565117|NCT02513160|156260793|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
48565118|NCT02513160|156260794|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
48565119|NCT02513160|156260795|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
48565120|NCT02513160|156260796|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
48565121|NCT02513160|156260793|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
48565122|NCT02513160|156260794|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
48565123|NCT02513160|156260795|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
48565124|NCT02513160|156260796|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
48565125|NCT02513160|156260793|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
48565126|NCT02513160|156260794|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
48565127|NCT02513160|156260795|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
48565128|NCT02513160|156260796|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
48565129|NCT02513160|156260793|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
48565130|NCT02513160|156260794|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
48565131|NCT02513160|156260795|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
48565132|NCT02513160|156260796|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
48565133|NCT02513160|156260793|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
48565134|NCT02513160|156260794|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
48565135|NCT02513160|156260795|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
48565136|NCT02513160|156260796|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
48565137|NCT03020992|156260797|FG000|Overall Study|Adverse Event|5|||
48565138|NCT03020992|156260797|FG000|Overall Study|Withdrawal by Subject|1|||
48565139|NCT01697748|156260798|FG000|Overall Study|ineligible skin incision|1|||
48565140|NCT01697748|156260799|FG001|Overall Study|ineligible skin incision|2|||
48565141|NCT01697748|156260798|FG000|Overall Study|ineligible uterine incision|4|||
48565142|NCT01697748|156260799|FG001|Overall Study|ineligible uterine incision|1|||
48565143|NCT01697748|156260798|FG000|Overall Study|Lost to Follow-up|53|||
48565144|NCT01697748|156260799|FG001|Overall Study|Lost to Follow-up|65|||
48565145|NCT01928472|156260802|FG000|Overall Study|Death|0|||
48565146|NCT01928472|156260803|FG001|Overall Study|Death|0|||
48565147|NCT01928472|156260804|FG002|Overall Study|Death|1|||
48565148|NCT01928472|156260805|FG003|Overall Study|Death|0|||
48565149|NCT01928472|156260802|FG000|Overall Study|Withdrawal by Subject|4|||
48565150|NCT01928472|156260803|FG001|Overall Study|Withdrawal by Subject|4|||
48565151|NCT01928472|156260804|FG002|Overall Study|Withdrawal by Subject|1|||
48565152|NCT01928472|156260805|FG003|Overall Study|Withdrawal by Subject|2|||
48565153|NCT01928472|156260802|FG000|Overall Study|Lost to Follow-up|2|||
48565154|NCT01928472|156260803|FG001|Overall Study|Lost to Follow-up|3|||
48617157|NCT00387127|156453070|FG000|Overall Study|Physician Decision|0|||
48617158|NCT00387127|156453071|FG001|Overall Study|Physician Decision|1|||
48617159|NCT00387127|156453070|FG000|Overall Study|Withdrawal by Subject|3|||
48617160|NCT00387127|156453071|FG001|Overall Study|Withdrawal by Subject|2|||
48617161|NCT00387127|156453070|FG000|Overall Study|Required by Protocol Amendment #4|12|||
48617162|NCT00387127|156453071|FG001|Overall Study|Required by Protocol Amendment #4|10|||
48617163|NCT00387127|156453070|FG000|Overall Study|Serious Adverse Event|1|||
48617164|NCT00387127|156453071|FG001|Overall Study|Serious Adverse Event|1|||
48617165|NCT00387127|156453070|FG000|Overall Study|Sponsor Unblinded|1|||
48617166|NCT00387127|156453071|FG001|Overall Study|Sponsor Unblinded|0|||
48617167|NCT00927082|156453074|FG000|Overall Study|Lost to Follow-up|9|||
48617168|NCT00927082|156453075|FG001|Overall Study|Lost to Follow-up|8|||
48617169|NCT00927082|156453076|FG002|Overall Study|Lost to Follow-up|12|||
48617170|NCT00927082|156453077|FG003|Overall Study|Lost to Follow-up|16|||
48565155|NCT01928472|156260804|FG002|Overall Study|Lost to Follow-up|4|||
48565156|NCT01928472|156260805|FG003|Overall Study|Lost to Follow-up|0|||
48565157|NCT01928472|156260802|FG000|Overall Study|Administrative Reason|2|||
48565158|NCT01928472|156260803|FG001|Overall Study|Administrative Reason|1|||
48565159|NCT01928472|156260804|FG002|Overall Study|Administrative Reason|0|||
48565160|NCT01928472|156260805|FG003|Overall Study|Administrative Reason|0|||
48565161|NCT01928472|156260802|FG000|Overall Study|Unclassified|0|||
48565162|NCT01928472|156260803|FG001|Overall Study|Unclassified|0|||
48565163|NCT01928472|156260804|FG002|Overall Study|Unclassified|1|||
48565164|NCT01928472|156260805|FG003|Overall Study|Unclassified|0|||
48565165|NCT04335123|156260806|FG000|Overall Study|Withdrawal by Subject|2|||
48565166|NCT04335123|156260807|FG001|Overall Study|Withdrawal by Subject|0|||
48565167|NCT04335123|156260806|FG000|Overall Study|Physician Decision|2|||
48565168|NCT04335123|156260807|FG001|Overall Study|Physician Decision|0|||
48565169|NCT01757535|156260812|FG000|Overall Study|Disease Relapse|143|||
48565170|NCT01757535|156260813|FG001|Overall Study|Disease Relapse|180|||
48565171|NCT01757535|156260812|FG000|Overall Study|Adverse Event|29|||
48565172|NCT01757535|156260813|FG001|Overall Study|Adverse Event|11|||
48565173|NCT01757535|156260812|FG000|Overall Study|Withdrawal by Subject|9|||
48565174|NCT01757535|156260813|FG001|Overall Study|Withdrawal by Subject|13|||
48565175|NCT01757535|156260812|FG000|Overall Study|Miscellaneous|5|||
48565176|NCT01757535|156260813|FG001|Overall Study|Miscellaneous|2|||
48565177|NCT01757535|156260812|FG000|Overall Study|Physician Decision|6|||
48565178|NCT01757535|156260813|FG001|Overall Study|Physician Decision|0|||
48565179|NCT01757535|156260812|FG000|Overall Study|Death|1|||
48565180|NCT01757535|156260813|FG001|Overall Study|Death|2|||
48565181|NCT01753310|156260814|FG000|Overall Study|Entered into open label extension study|25|||
48617171|NCT00927082|156453074|FG000|Overall Study|Withdrawal by Subject|3|||
48617172|NCT00927082|156453075|FG001|Overall Study|Withdrawal by Subject|2|||
48565182|NCT01753310|156260815|FG001|Overall Study|Entered into open label extension study|22|||
48565183|NCT01753310|156260814|FG000|Overall Study|Adverse Event|1|||
48565184|NCT01753310|156260815|FG001|Overall Study|Adverse Event|0|||
48565185|NCT01753310|156260814|FG000|Overall Study|Lost to Follow-up|2|||
48565186|NCT01753310|156260815|FG001|Overall Study|Lost to Follow-up|0|||
48565187|NCT01753310|156260814|FG000|Overall Study|Subject decision|2|||
48565188|NCT01753310|156260815|FG001|Overall Study|Subject decision|2|||
48565189|NCT01753310|156260814|FG000|Overall Study|Sponsor decision|1|||
48565190|NCT01753310|156260815|FG001|Overall Study|Sponsor decision|0|||
48565191|NCT01753310|156260814|FG000|Overall Study|Withdrawal by Subject|1|||
48565192|NCT01753310|156260815|FG001|Overall Study|Withdrawal by Subject|0|||
48565193|NCT02946463|156260817|FG000|Primary Evaluation Period|Physician Decision|0|||
48565194|NCT02946463|156260818|FG001|Primary Evaluation Period|Physician Decision|1|||
48565195|NCT02946463|156260819|FG002|Primary Evaluation Period|Physician Decision|0|||
48565196|NCT02946463|156260820|FG003|Primary Evaluation Period|Physician Decision|0|||
48565197|NCT02946463|156260817|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
48565198|NCT02946463|156260818|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
48565199|NCT02946463|156260819|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
48565200|NCT02946463|156260820|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
48565201|NCT02946463|156260817|FG000|Extension Period|Death|4|||
48565202|NCT02946463|156260818|FG001|Extension Period|Death|4|||
48565203|NCT02946463|156260819|FG002|Extension Period|Death|0|||
48565204|NCT02946463|156260820|FG003|Extension Period|Death|0|||
48565205|NCT02946463|156260817|FG000|Extension Period|Withdrawal by Subject|4|||
48565206|NCT02946463|156260818|FG001|Extension Period|Withdrawal by Subject|3|||
48565207|NCT02946463|156260819|FG002|Extension Period|Withdrawal by Subject|0|||
48565208|NCT02946463|156260820|FG003|Extension Period|Withdrawal by Subject|0|||
48565209|NCT02946463|156260817|FG000|Extension Period|Other than specified|2|||
48565210|NCT02946463|156260818|FG001|Extension Period|Other than specified|3|||
48565211|NCT02946463|156260819|FG002|Extension Period|Other than specified|2|||
48565212|NCT02946463|156260820|FG003|Extension Period|Other than specified|0|||
48565213|NCT02946463|156260817|FG000|Extension Period|Physician Decision|1|||
48565214|NCT02946463|156260818|FG001|Extension Period|Physician Decision|4|||
48565215|NCT02946463|156260819|FG002|Extension Period|Physician Decision|0|||
48565216|NCT02946463|156260820|FG003|Extension Period|Physician Decision|0|||
48565217|NCT02946463|156260817|FG000|Extension Period|Pregnancy|3|||
48565218|NCT02946463|156260818|FG001|Extension Period|Pregnancy|1|||
48565219|NCT02946463|156260819|FG002|Extension Period|Pregnancy|0|||
48565220|NCT02946463|156260820|FG003|Extension Period|Pregnancy|0|||
48565221|NCT02946463|156260817|FG000|Extension Period|Adverse Event|1|||
48565222|NCT02946463|156260818|FG001|Extension Period|Adverse Event|2|||
48565223|NCT02946463|156260819|FG002|Extension Period|Adverse Event|0|||
48565224|NCT02946463|156260820|FG003|Extension Period|Adverse Event|0|||
48565225|NCT02946463|156260817|FG000|Extension Period|Lost to Follow-up|1|||
48565226|NCT02946463|156260818|FG001|Extension Period|Lost to Follow-up|0|||
48565227|NCT02946463|156260819|FG002|Extension Period|Lost to Follow-up|0|||
48565228|NCT02946463|156260820|FG003|Extension Period|Lost to Follow-up|0|||
48565229|NCT00634803|156260821|FG000|Overall Study|Lost to Follow-up|6|||
48565230|NCT00634803|156260822|FG001|Overall Study|Lost to Follow-up|7|||
48565231|NCT00634803|156260823|FG002|Overall Study|Lost to Follow-up|7|||
48565232|NCT02169271|156260824|FG000|Overall Study|Protocol Violation|1|||
48565233|NCT02169271|156260825|FG001|Overall Study|Protocol Violation|2|||
48565234|NCT01168232|156260826|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
48565235|NCT01168232|156260826|FG000|Overall Study|Ineligible- Wrong cell type|6|||
48565236|NCT01168232|156260826|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
48565237|NCT02644668|156260828|FG000|Overall Study|Adverse Event|2|||
48565238|NCT02644668|156260829|FG001|Overall Study|Adverse Event|0|||
48565239|NCT02644668|156260830|FG002|Overall Study|Adverse Event|1|||
48565240|NCT02644668|156260828|FG000|Overall Study|Protocol Violation|0|||
48565241|NCT02644668|156260829|FG001|Overall Study|Protocol Violation|0|||
48565242|NCT02644668|156260830|FG002|Overall Study|Protocol Violation|1|||
48565243|NCT02644668|156260828|FG000|Overall Study|Withdrawal by Subject|0|||
48565244|NCT02644668|156260829|FG001|Overall Study|Withdrawal by Subject|0|||
48565245|NCT02644668|156260830|FG002|Overall Study|Withdrawal by Subject|1|||
48565246|NCT01067105|156260835|FG000|Overall Study|Adverse Event|14|||
48565247|NCT01067105|156260835|FG000|Overall Study|Protocol Violation|48|||
48565248|NCT01067105|156260835|FG000|Overall Study|Withdrawal by Subject|36|||
48565249|NCT01067105|156260835|FG000|Overall Study|Lost to Follow-up|6|||
48565250|NCT01067105|156260835|FG000|Overall Study|Physician Decision|6|||
48565251|NCT01067105|156260835|FG000|Overall Study|Other|31|||
48565252|NCT02547220|156260838|FG000|Overall Study|Withdrawal by Subject|1|||
48565253|NCT02547220|156260839|FG001|Overall Study|Withdrawal by Subject|0|||
48565254|NCT02547220|156260838|FG000|Overall Study|Study terminated by sponsor|18|||
48565255|NCT02547220|156260839|FG001|Overall Study|Study terminated by sponsor|20|||
48565256|NCT01120184|156262760|FG000|Overall Study|Adverse Event|0|||
48565257|NCT01120184|156262761|FG001|Overall Study|Adverse Event|1|||
48565258|NCT01120184|156262762|FG002|Overall Study|Adverse Event|0|||
48565259|NCT01120184|156262760|FG000|Overall Study|Lost to Follow-up|13|||
48565260|NCT01120184|156262761|FG001|Overall Study|Lost to Follow-up|13|||
48565261|NCT01120184|156262762|FG002|Overall Study|Lost to Follow-up|11|||
48565262|NCT01120184|156262760|FG000|Overall Study|Physician Decision|9|||
48565263|NCT01120184|156262761|FG001|Overall Study|Physician Decision|1|||
48565264|NCT01120184|156262762|FG002|Overall Study|Physician Decision|3|||
48565265|NCT01120184|156262760|FG000|Overall Study|Reason not Specified|8|||
48565266|NCT01120184|156262761|FG001|Overall Study|Reason not Specified|3|||
48565267|NCT01120184|156262762|FG002|Overall Study|Reason not Specified|12|||
48565268|NCT01120184|156262760|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
48565269|NCT01120184|156262761|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
48565270|NCT01120184|156262762|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
48565271|NCT01120184|156262760|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
48565272|NCT01120184|156262761|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
48565273|NCT01120184|156262762|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
48565274|NCT01120184|156262760|FG000|Overall Study|Death|170|||
48565275|NCT01120184|156262761|FG001|Overall Study|Death|176|||
48565276|NCT01120184|156262762|FG002|Overall Study|Death|169|||
48565277|NCT01417156|156262763|FG000|Overall Study|Adverse Event|12|||
48565278|NCT01417156|156262763|FG000|Overall Study|Protocol Violation|2|||
48565279|NCT02596971|156262764|FG000|Overall Study|Death|5|||
48565280|NCT02596971|156262765|FG001|Overall Study|Death|1|||
48565281|NCT02596971|156262766|FG002|Overall Study|Death|5|||
48565282|NCT02596971|156262764|FG000|Overall Study|Withdrawal by Subject|5|||
48565283|NCT02596971|156262765|FG001|Overall Study|Withdrawal by Subject|1|||
48565284|NCT02596971|156262766|FG002|Overall Study|Withdrawal by Subject|4|||
48565285|NCT03192488|156262767|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
48565286|NCT03192488|156262768|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
48565287|NCT03192488|156262769|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
48565288|NCT03192488|156262770|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
48565289|NCT03192488|156262771|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
48565290|NCT03192488|156262772|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
48565291|NCT03192488|156262767|FG000|Third Intervention (d1)|Adverse Event|0|||
48565292|NCT03192488|156262768|FG001|Third Intervention (d1)|Adverse Event|0|||
48565293|NCT03192488|156262769|FG002|Third Intervention (d1)|Adverse Event|0|||
48565294|NCT03192488|156262770|FG003|Third Intervention (d1)|Adverse Event|0|||
48565295|NCT03192488|156262771|FG004|Third Intervention (d1)|Adverse Event|1|||
48565296|NCT03192488|156262772|FG005|Third Intervention (d1)|Adverse Event|0|||
48565297|NCT02525783|156262775|FG000|Overall Study|Lost to Follow-up|10|||
48565298|NCT01401361|156262776|FG000|Overall Study|Withdrawal by Subject|16|||
48565299|NCT01401361|156262776|FG000|Overall Study|Lack of Efficacy|6|||
48565300|NCT01401361|156262776|FG000|Overall Study|Physician Decision|1|||
48565301|NCT01401361|156262776|FG000|Overall Study|Lost to Follow-up|3|||
48565302|NCT01401361|156262776|FG000|Overall Study|Subject/family decision post procedure|2|||
48565303|NCT03283566|156262781|FG000|Overall Study|Lost to Follow-up|1|||
48565304|NCT03283566|156262782|FG001|Overall Study|Lost to Follow-up|2|||
48565305|NCT00595920|156262783|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
48565306|NCT00351468|156262785|FG000|Overall Study|Adverse Event|42|||
48565307|NCT00351468|156262785|FG000|Overall Study|Withdrawal by Subject|39|||
48565308|NCT00351468|156262785|FG000|Overall Study|Various -follow up w clinical team|39|||
48565309|NCT00351468|156262785|FG000|Overall Study|Lack of Efficacy|32|||
48565310|NCT00351468|156262785|FG000|Overall Study|Non-compliance|8|||
48565311|NCT00351468|156262785|FG000|Overall Study|Lost to Follow-up|4|||
48565312|NCT00351468|156262785|FG000|Overall Study|Protocol Violation|3|||
48565313|NCT03048747|156262786|FG000|Overall Study|Adverse Event|2|||
48565314|NCT03048747|156262786|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
48565315|NCT03048747|156262786|FG000|Overall Study|Physician Decision|1|||
48565316|NCT00824772|156262787|FG000|Overall Study|Withdrawal by Subject|8|||
48565317|NCT03588910|156262788|FG000|Overall Study|Withdrawal by Subject|1|||
48565318|NCT03588910|156262789|FG001|Overall Study|Withdrawal by Subject|0|||
48565319|NCT03588910|156262788|FG000|Overall Study|Allergy|2|||
48565320|NCT03588910|156262789|FG001|Overall Study|Allergy|0|||
48565321|NCT03588910|156262788|FG000|Overall Study|Protocol Violation|0|||
48565322|NCT03588910|156262789|FG001|Overall Study|Protocol Violation|3|||
48565323|NCT03588910|156262788|FG000|Overall Study|Did not complete Day 1 Survey|5|||
48565324|NCT03588910|156262789|FG001|Overall Study|Did not complete Day 1 Survey|10|||
48565325|NCT03588910|156262788|FG000|Overall Study|Did not complete Day 7 Survey|5|||
48565326|NCT03588910|156262789|FG001|Overall Study|Did not complete Day 7 Survey|2|||
48565327|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
48565328|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
48565329|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
48565330|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
48565331|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
48565332|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
48565333|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
48565334|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
48565335|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
48565336|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
48565337|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
48565338|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
48565339|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
48565340|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
48565341|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
48565342|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
48565343|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
48565344|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
48565345|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
48565346|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
48565347|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
48565348|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
48565349|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
48565350|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
48565351|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
48565352|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
48565353|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
48565354|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
48565355|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
48565356|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
48565357|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
48565358|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
48565359|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
48565360|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
48565361|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
48565362|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
48565363|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
48565364|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
48565365|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
48565366|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
48565367|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
48565368|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
48565369|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
48565370|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
48565371|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
48565372|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
48565373|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
48565374|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
48565375|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
48565376|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
48565377|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
48565378|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
48565379|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Site closed|0|||
48565380|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Site closed|0|||
48565381|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Site closed|1|||
48565382|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Site closed|0|||
48565383|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
48565384|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
48565385|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
48565386|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
48565387|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
48565388|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
48565389|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
48565390|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
48565391|NCT00838903|156262790|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
48565392|NCT00838903|156262791|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
48565393|NCT00838903|156262792|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
48565394|NCT00838903|156262793|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
48565395|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
48565396|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
48565397|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
48565398|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
48565399|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
48565400|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
48565401|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
48565402|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
48565403|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
48565404|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
48565405|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
48565406|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
48565407|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
48565408|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
48565409|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
48565410|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
48565411|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
48565412|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
48565413|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
48565414|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
48565415|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
48565416|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
48565417|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
48565418|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
48565419|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
48565420|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
48565421|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
48565422|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
48565423|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
48565424|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
48565425|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
48565426|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
48565427|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
48565428|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
48565429|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
48565430|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
48565431|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
48565432|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
48565433|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
48565434|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
48565435|NCT00838903|156262790|FG000|Follow-up Period (8 Weeks)|Missing|1|||
48565436|NCT00838903|156262791|FG001|Follow-up Period (8 Weeks)|Missing|2|||
48565437|NCT00838903|156262792|FG002|Follow-up Period (8 Weeks)|Missing|1|||
48565438|NCT00838903|156262793|FG003|Follow-up Period (8 Weeks)|Missing|1|||
48565439|NCT00818766|156262794|FG000|Overall Study|Could not be Contacted on Day 28|11|||
48565440|NCT00818766|156262795|FG001|Overall Study|Could not be Contacted on Day 28|10|||
48565441|NCT00818766|156262794|FG000|Overall Study|Death|1|||
48565442|NCT00818766|156262795|FG001|Overall Study|Death|0|||
48565443|NCT00818766|156262794|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
48565444|NCT00818766|156262795|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
48565445|NCT03096314|156262796|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
48565446|NCT03096314|156262797|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
48565447|NCT02512302|156262798|FG000|Period 1|Adverse Event|0|||
48565448|NCT02512302|156262799|FG001|Period 1|Adverse Event|1|||
48565449|NCT02512302|156262800|FG002|Period 1|Adverse Event|0|||
48565450|NCT02512302|156262801|FG003|Period 1|Adverse Event|0|||
48565451|NCT02512302|156262802|FG004|Period 1|Adverse Event|0|||
48565452|NCT02512302|156262803|FG005|Period 1|Adverse Event|0|||
48565453|NCT02512302|156262804|FG006|Period 1|Adverse Event|0|||
48565454|NCT02512302|156262805|FG007|Period 1|Adverse Event|0|||
48565455|NCT02512302|156262806|FG008|Period 1|Adverse Event|0|||
48565456|NCT02512302|156262807|FG009|Period 1|Adverse Event|0|||
48565457|NCT02512302|156262798|FG000|Period 2|Adverse Event|0|||
48565458|NCT02512302|156262799|FG001|Period 2|Adverse Event|0|||
48565459|NCT02512302|156262800|FG002|Period 2|Adverse Event|0|||
48565460|NCT02512302|156262801|FG003|Period 2|Adverse Event|0|||
48565461|NCT02512302|156262802|FG004|Period 2|Adverse Event|0|||
48565462|NCT02512302|156262803|FG005|Period 2|Adverse Event|0|||
48565463|NCT02512302|156262804|FG006|Period 2|Adverse Event|0|||
48565464|NCT02512302|156262805|FG007|Period 2|Adverse Event|0|||
48565465|NCT02512302|156262806|FG008|Period 2|Adverse Event|0|||
48565466|NCT02512302|156262807|FG009|Period 2|Adverse Event|1|||
48565467|NCT02512302|156262798|FG000|Period 3|Lost to Follow-up|0|||
48565468|NCT02512302|156262799|FG001|Period 3|Lost to Follow-up|0|||
48565469|NCT02512302|156262800|FG002|Period 3|Lost to Follow-up|1|||
48565470|NCT02512302|156262801|FG003|Period 3|Lost to Follow-up|0|||
48565471|NCT02512302|156262802|FG004|Period 3|Lost to Follow-up|0|||
48617173|NCT00927082|156453076|FG002|Overall Study|Withdrawal by Subject|7|||
48565472|NCT02512302|156262803|FG005|Period 3|Lost to Follow-up|0|||
48565473|NCT02512302|156262804|FG006|Period 3|Lost to Follow-up|0|||
48565474|NCT02512302|156262805|FG007|Period 3|Lost to Follow-up|0|||
48565475|NCT02512302|156262806|FG008|Period 3|Lost to Follow-up|0|||
48565476|NCT02512302|156262807|FG009|Period 3|Lost to Follow-up|0|||
48565477|NCT02512302|156262798|FG000|Period 4|Adverse Event|0|||
48565478|NCT02512302|156262799|FG001|Period 4|Adverse Event|0|||
48565479|NCT02512302|156262800|FG002|Period 4|Adverse Event|0|||
48565480|NCT02512302|156262801|FG003|Period 4|Adverse Event|0|||
48565481|NCT02512302|156262802|FG004|Period 4|Adverse Event|0|||
48565482|NCT02512302|156262803|FG005|Period 4|Adverse Event|0|||
48565483|NCT02512302|156262804|FG006|Period 4|Adverse Event|1|||
48565484|NCT02512302|156262805|FG007|Period 4|Adverse Event|0|||
48565485|NCT02512302|156262806|FG008|Period 4|Adverse Event|0|||
48565486|NCT02512302|156262807|FG009|Period 4|Adverse Event|0|||
48565487|NCT04570670|156262817|FG000|Overall Study|Withdrawal by Subject|1|||
48565488|NCT04570670|156262818|FG001|Overall Study|Withdrawal by Subject|0|||
48565489|NCT01790984|156262826|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
48565490|NCT01790984|156262827|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
48565491|NCT01790984|156262828|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
48565492|NCT01790984|156262829|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
48565493|NCT03187301|156262830|FG000|Titration Period|Adverse Event|0|||
48565494|NCT03187301|156262831|FG001|Titration Period|Adverse Event|0|||
48565495|NCT03187301|156262832|FG002|Titration Period|Adverse Event|0|||
48565496|NCT03187301|156262833|FG003|Titration Period|Adverse Event|0|||
48565497|NCT03187301|156262834|FG004|Titration Period|Adverse Event|0|||
48565498|NCT03187301|156262835|FG005|Titration Period|Adverse Event|0|||
48565499|NCT03187301|156262836|FG006|Titration Period|Adverse Event|5|||
48565500|NCT03187301|156262830|FG000|Titration Period|Withdrawal by Subject|0|||
48565501|NCT03187301|156262831|FG001|Titration Period|Withdrawal by Subject|0|||
48565502|NCT03187301|156262832|FG002|Titration Period|Withdrawal by Subject|0|||
48565503|NCT03187301|156262833|FG003|Titration Period|Withdrawal by Subject|0|||
48565504|NCT03187301|156262834|FG004|Titration Period|Withdrawal by Subject|0|||
48565505|NCT03187301|156262835|FG005|Titration Period|Withdrawal by Subject|0|||
48565506|NCT03187301|156262836|FG006|Titration Period|Withdrawal by Subject|1|||
48565507|NCT03187301|156262830|FG000|Titration Period|Exclusion Criteria Met|0|||
48565508|NCT03187301|156262831|FG001|Titration Period|Exclusion Criteria Met|0|||
48565509|NCT03187301|156262832|FG002|Titration Period|Exclusion Criteria Met|0|||
48565510|NCT03187301|156262833|FG003|Titration Period|Exclusion Criteria Met|0|||
48565511|NCT03187301|156262834|FG004|Titration Period|Exclusion Criteria Met|0|||
48565512|NCT03187301|156262835|FG005|Titration Period|Exclusion Criteria Met|0|||
48565513|NCT03187301|156262836|FG006|Titration Period|Exclusion Criteria Met|1|||
48565514|NCT03187301|156262830|FG000|Pre-Intervention|Withdrawal by Subject|1|||
48565515|NCT03187301|156262831|FG001|Pre-Intervention|Withdrawal by Subject|0|||
48565516|NCT03187301|156262832|FG002|Pre-Intervention|Withdrawal by Subject|0|||
48565517|NCT03187301|156262833|FG003|Pre-Intervention|Withdrawal by Subject|0|||
48565518|NCT03187301|156262834|FG004|Pre-Intervention|Withdrawal by Subject|0|||
48565519|NCT03187301|156262835|FG005|Pre-Intervention|Withdrawal by Subject|0|||
48565520|NCT03187301|156262836|FG006|Pre-Intervention|Withdrawal by Subject|0|||
48565521|NCT03313180|156262838|FG000|Overall Study|Adverse Event|120|||
48617174|NCT00927082|156453077|FG003|Overall Study|Withdrawal by Subject|2|||
48565522|NCT03313180|156262838|FG000|Overall Study|Lost to Follow-up|3|||
48565523|NCT03313180|156262838|FG000|Overall Study|Withdrawal by Subject|39|||
48565524|NCT03313180|156262838|FG000|Overall Study|Other than listed above|15|||
48565525|NCT03313180|156262838|FG000|Overall Study|Covid-19 related|2|||
48565526|NCT01966120|156262839|FG000|Overall Study|Withdrawal by Subject|0|||
48565527|NCT01966120|156262840|FG001|Overall Study|Withdrawal by Subject|5|||
48565528|NCT01966120|156262839|FG000|Overall Study|Lost to Follow-up|1|||
48565529|NCT01966120|156262840|FG001|Overall Study|Lost to Follow-up|1|||
48565530|NCT03335475|156262842|FG000|Overall Study|Did not wear accelerometer|4|||
48565531|NCT03335475|156262843|FG001|Overall Study|Did not wear accelerometer|0|||
48565532|NCT03335475|156262842|FG000|Overall Study|Withdrawal by Subject|0|||
48565533|NCT03335475|156262843|FG001|Overall Study|Withdrawal by Subject|1|||
48565534|NCT01058642|156262844|FG000|Treatment Period 1|Adverse Event|0|||
48565535|NCT01058642|156262845|FG001|Treatment Period 1|Adverse Event|1|||
48565536|NCT01058642|156262846|FG002|Treatment Period 1|Adverse Event|1|||
48565537|NCT01058642|156262847|FG003|Treatment Period 1|Adverse Event|0|||
48565538|NCT01058642|156262844|FG000|Treatment Period 1|Physician Decision|0|||
48617175|NCT00927082|156453074|FG000|Overall Study|Death|0|||
48617176|NCT00927082|156453075|FG001|Overall Study|Death|0|||
48565539|NCT01058642|156262845|FG001|Treatment Period 1|Physician Decision|0|||
48565540|NCT01058642|156262846|FG002|Treatment Period 1|Physician Decision|1|||
48565541|NCT01058642|156262847|FG003|Treatment Period 1|Physician Decision|0|||
48565542|NCT01058642|156262844|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48565543|NCT01058642|156262845|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48565544|NCT01058642|156262846|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48565545|NCT01058642|156262847|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48565546|NCT01058642|156262844|FG000|Treatment Period 1|Lack of Efficacy|0|||
48565547|NCT01058642|156262845|FG001|Treatment Period 1|Lack of Efficacy|0|||
48565548|NCT01058642|156262846|FG002|Treatment Period 1|Lack of Efficacy|0|||
48565549|NCT01058642|156262847|FG003|Treatment Period 1|Lack of Efficacy|1|||
48565550|NCT01058642|156262844|FG000|Treatment Period 1|Protocol Violation|0|||
48565551|NCT01058642|156262845|FG001|Treatment Period 1|Protocol Violation|0|||
48565552|NCT01058642|156262846|FG002|Treatment Period 1|Protocol Violation|0|||
48565553|NCT01058642|156262847|FG003|Treatment Period 1|Protocol Violation|1|||
48565554|NCT01058642|156262844|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
48565555|NCT01058642|156262845|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
48565556|NCT01058642|156262846|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
48565557|NCT01058642|156262847|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
48565558|NCT04498182|156262850|FG000|Overall Study|Adverse Event|2|||
48565559|NCT04498182|156262851|FG001|Overall Study|Adverse Event|3|||
48565560|NCT04498182|156262852|FG002|Overall Study|Adverse Event|2|||
48565561|NCT04498182|156262850|FG000|Overall Study|Withdrawal of Consent|3|||
48565562|NCT04498182|156262851|FG001|Overall Study|Withdrawal of Consent|4|||
48565563|NCT04498182|156262852|FG002|Overall Study|Withdrawal of Consent|3|||
48617177|NCT00927082|156453076|FG002|Overall Study|Death|1|||
48565564|NCT04498182|156262850|FG000|Overall Study|Non-Compliant|1|||
48565565|NCT04498182|156262851|FG001|Overall Study|Non-Compliant|0|||
48565566|NCT04498182|156262852|FG002|Overall Study|Non-Compliant|1|||
48565567|NCT04498182|156262850|FG000|Overall Study|Lost to Follow-up|0|||
48565568|NCT04498182|156262851|FG001|Overall Study|Lost to Follow-up|0|||
48565569|NCT04498182|156262852|FG002|Overall Study|Lost to Follow-up|1|||
48565570|NCT04498182|156262850|FG000|Overall Study|Investigator Decision|0|||
48565571|NCT04498182|156262851|FG001|Overall Study|Investigator Decision|0|||
48565572|NCT04498182|156262852|FG002|Overall Study|Investigator Decision|1|||
48565573|NCT04498182|156262850|FG000|Overall Study|Protocol Violation|1|||
48565574|NCT04498182|156262851|FG001|Overall Study|Protocol Violation|0|||
48565575|NCT04498182|156262852|FG002|Overall Study|Protocol Violation|2|||
48565576|NCT01704495|156262853|FG000|Subjects Randomized|Other Reason|3|||
48565577|NCT01704495|156262854|FG001|Subjects Randomized|Other Reason|2|||
48565578|NCT01704495|156262855|FG002|Subjects Randomized|Other Reason|3|||
48565579|NCT01704495|156262856|FG003|Subjects Randomized|Other Reason|2|||
48565580|NCT01704495|156262853|FG000|Subjects Randomized|Discontinuation criteria met|4|||
48565581|NCT01704495|156262854|FG001|Subjects Randomized|Discontinuation criteria met|2|||
48565582|NCT01704495|156262855|FG002|Subjects Randomized|Discontinuation criteria met|2|||
48565583|NCT01704495|156262856|FG003|Subjects Randomized|Discontinuation criteria met|0|||
48565584|NCT01704495|156262853|FG000|Subjects Randomized|Adverse Event|8|||
48565585|NCT01704495|156262854|FG001|Subjects Randomized|Adverse Event|2|||
48565586|NCT01704495|156262855|FG002|Subjects Randomized|Adverse Event|0|||
48565587|NCT01704495|156262856|FG003|Subjects Randomized|Adverse Event|7|||
48565588|NCT01704495|156262853|FG000|Subjects Randomized|Withdrawal by Subject|5|||
48565589|NCT01704495|156262854|FG001|Subjects Randomized|Withdrawal by Subject|5|||
48565590|NCT01704495|156262855|FG002|Subjects Randomized|Withdrawal by Subject|5|||
48565591|NCT01704495|156262856|FG003|Subjects Randomized|Withdrawal by Subject|5|||
48565592|NCT01704495|156262853|FG000|Subjects Randomized|Protocol Violation|1|||
48565593|NCT01704495|156262854|FG001|Subjects Randomized|Protocol Violation|1|||
48565594|NCT01704495|156262855|FG002|Subjects Randomized|Protocol Violation|2|||
48565595|NCT01704495|156262856|FG003|Subjects Randomized|Protocol Violation|0|||
48565596|NCT01704495|156262853|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
48565597|NCT01704495|156262854|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
48565598|NCT01704495|156262855|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
48565599|NCT01704495|156262856|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
48565600|NCT01704495|156262853|FG000|Optional Safety Extension|Adverse Event|0|||
48565601|NCT01704495|156262854|FG001|Optional Safety Extension|Adverse Event|4|||
48565602|NCT01704495|156262855|FG002|Optional Safety Extension|Adverse Event|0|||
48565603|NCT01704495|156262856|FG003|Optional Safety Extension|Adverse Event|1|||
48565604|NCT01704495|156262853|FG000|Optional Safety Extension|Other reason|27|||
48565605|NCT01704495|156262854|FG001|Optional Safety Extension|Other reason|29|||
48565606|NCT01704495|156262855|FG002|Optional Safety Extension|Other reason|30|||
48565607|NCT01704495|156262856|FG003|Optional Safety Extension|Other reason|28|||
48565608|NCT01704495|156262853|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
48565609|NCT01704495|156262854|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
48565610|NCT01704495|156262855|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
48565611|NCT01704495|156262856|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
48565612|NCT01256450|156262857|FG000|Open-label Titration|Adverse Event|39|||
48565613|NCT01256450|156262858|FG001|Open-label Titration|Adverse Event|0|||
48565614|NCT01256450|156262859|FG002|Open-label Titration|Adverse Event|0|||
48565615|NCT01256450|156262857|FG000|Open-label Titration|Lost to Follow-up|7|||
48565616|NCT01256450|156262858|FG001|Open-label Titration|Lost to Follow-up|0|||
48565617|NCT01256450|156262859|FG002|Open-label Titration|Lost to Follow-up|0|||
48565618|NCT01256450|156262857|FG000|Open-label Titration|Lack of analgesic effect|30|||
48565619|NCT01256450|156262858|FG001|Open-label Titration|Lack of analgesic effect|0|||
48565620|NCT01256450|156262859|FG002|Open-label Titration|Lack of analgesic effect|0|||
48565621|NCT01256450|156262857|FG000|Open-label Titration|Non-compliance|9|||
48565622|NCT01256450|156262858|FG001|Open-label Titration|Non-compliance|0|||
48565623|NCT01256450|156262859|FG002|Open-label Titration|Non-compliance|0|||
48565624|NCT01256450|156262857|FG000|Open-label Titration|Screen failure|1|||
48565625|NCT01256450|156262858|FG001|Open-label Titration|Screen failure|0|||
48565626|NCT01256450|156262859|FG002|Open-label Titration|Screen failure|0|||
48565627|NCT01256450|156262857|FG000|Open-label Titration|Other|13|||
48565628|NCT01256450|156262858|FG001|Open-label Titration|Other|0|||
48565629|NCT01256450|156262859|FG002|Open-label Titration|Other|0|||
48565630|NCT01256450|156262857|FG000|Double-blind Treatment|Adverse Event|0|||
48565631|NCT01256450|156262858|FG001|Double-blind Treatment|Adverse Event|8|||
48565632|NCT01256450|156262859|FG002|Double-blind Treatment|Adverse Event|6|||
48565633|NCT01256450|156262857|FG000|Double-blind Treatment|Lost to Follow-up|0|||
48565634|NCT01256450|156262858|FG001|Double-blind Treatment|Lost to Follow-up|1|||
48565635|NCT01256450|156262859|FG002|Double-blind Treatment|Lost to Follow-up|7|||
48565636|NCT01256450|156262857|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
48565637|NCT01256450|156262858|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
48565638|NCT01256450|156262859|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
48565639|NCT01256450|156262857|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
48565640|NCT01256450|156262858|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
48565641|NCT01256450|156262859|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
48565642|NCT01256450|156262857|FG000|Double-blind Treatment|Non-compliance|0|||
48565643|NCT01256450|156262858|FG001|Double-blind Treatment|Non-compliance|5|||
48565644|NCT01256450|156262859|FG002|Double-blind Treatment|Non-compliance|4|||
48565645|NCT01256450|156262857|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
48565646|NCT01256450|156262858|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
48565647|NCT01256450|156262859|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
48565648|NCT01256450|156262857|FG000|Double-blind Treatment|Other|0|||
48565649|NCT01256450|156262858|FG001|Double-blind Treatment|Other|9|||
48565650|NCT01256450|156262859|FG002|Double-blind Treatment|Other|12|||
48565651|NCT02510664|156262861|FG000|Overall Study|Transferred Care|9|||
48565652|NCT02510664|156262862|FG001|Overall Study|Transferred Care|9|||
48565653|NCT02510664|156262863|FG002|Overall Study|Transferred Care|0|||
48565654|NCT02510664|156262861|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
48565655|NCT02510664|156262862|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
48565656|NCT02510664|156262863|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
48565657|NCT02510664|156262861|FG000|Overall Study|Time Constraints|1|||
48565658|NCT02510664|156262862|FG001|Overall Study|Time Constraints|1|||
48565659|NCT02510664|156262863|FG002|Overall Study|Time Constraints|0|||
48565660|NCT02375971|156262864|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
48565661|NCT02375971|156262865|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
48565662|NCT02375971|156262866|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
48565663|NCT02375971|156262864|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
48565664|NCT02375971|156262865|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
48565665|NCT02375971|156262866|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
48565666|NCT02375971|156262864|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
48565667|NCT02375971|156262865|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
48565668|NCT02375971|156262866|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
48565669|NCT02375971|156262864|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
48565670|NCT02375971|156262865|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
48565671|NCT02375971|156262866|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
48565672|NCT02375971|156262864|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
48565673|NCT02375971|156262865|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
48565674|NCT02375971|156262866|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
48565675|NCT02375971|156262864|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
48565676|NCT02375971|156262865|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
48565677|NCT02375971|156262866|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
48565678|NCT02375971|156262864|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
48565679|NCT02375971|156262865|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
48565680|NCT02375971|156262866|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
48565681|NCT02375971|156262864|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
48565682|NCT02375971|156262865|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
48565683|NCT02375971|156262866|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
48565684|NCT00679211|156262867|FG000|Overall Study|Progressive disease|82|||
48565685|NCT00679211|156262867|FG000|Overall Study|Adverse Event|7|||
48565686|NCT00679211|156262867|FG000|Overall Study|Withdrawal by Subject|2|||
48565687|NCT00679211|156262867|FG000|Overall Study|Physician Decision|5|||
48565688|NCT00679211|156262867|FG000|Overall Study|Refused to undergo protocol procedures|1|||
48565689|NCT00679211|156262867|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
48565690|NCT00679211|156262867|FG000|Overall Study|Other|1|||
48565691|NCT01051791|156262874|FG000|Overall Study|Failed screening|3|||
48565692|NCT01051791|156262874|FG000|Overall Study|Withdrawal by Subject|1|||
48565693|NCT02841995|156262880|FG000|Overall Study|Disease progression|5|||
48565694|NCT02841995|156262881|FG001|Overall Study|Disease progression|11|||
48565695|NCT02841995|156262882|FG002|Overall Study|Disease progression|8|||
48565696|NCT02841995|156262880|FG000|Overall Study|Withdrawal by Subject|2|||
48565697|NCT02841995|156262881|FG001|Overall Study|Withdrawal by Subject|4|||
48565698|NCT02841995|156262882|FG002|Overall Study|Withdrawal by Subject|4|||
48565699|NCT02841995|156262880|FG000|Overall Study|Adverse Event|2|||
48565700|NCT02841995|156262881|FG001|Overall Study|Adverse Event|0|||
48565701|NCT02841995|156262882|FG002|Overall Study|Adverse Event|1|||
48565702|NCT02841995|156262880|FG000|Overall Study|Investigator decision|2|||
48565703|NCT02841995|156262881|FG001|Overall Study|Investigator decision|0|||
48565704|NCT02841995|156262882|FG002|Overall Study|Investigator decision|1|||
48565705|NCT02841995|156262880|FG000|Overall Study|Death|0|||
48565706|NCT02841995|156262881|FG001|Overall Study|Death|0|||
48565707|NCT02841995|156262882|FG002|Overall Study|Death|2|||
48565708|NCT02841995|156262880|FG000|Overall Study|Noncompliance to protocol|1|||
48565709|NCT02841995|156262881|FG001|Overall Study|Noncompliance to protocol|0|||
48565710|NCT02841995|156262882|FG002|Overall Study|Noncompliance to protocol|0|||
48565711|NCT02841995|156262880|FG000|Overall Study|Sponsor decision|1|||
48565712|NCT02841995|156262881|FG001|Overall Study|Sponsor decision|0|||
48565713|NCT02841995|156262882|FG002|Overall Study|Sponsor decision|0|||
48565714|NCT02841995|156262880|FG000|Overall Study|Other|4|||
48565715|NCT02841995|156262881|FG001|Overall Study|Other|1|||
48565716|NCT02841995|156262882|FG002|Overall Study|Other|5|||
48565717|NCT00594165|156262889|FG000|Overall Study|Major protocol violation|1|||
48565718|NCT00594165|156262889|FG000|Overall Study|Lack of Efficacy|12|||
48565719|NCT00594165|156262889|FG000|Overall Study|Adverse Event|52|||
48565720|NCT00594165|156262889|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
48565721|NCT00594165|156262889|FG000|Overall Study|Subject withdrew consent|27|||
48565722|NCT00594165|156262889|FG000|Overall Study|Study ended per sponsor|102|||
48565723|NCT00594165|156262889|FG000|Overall Study|Lost to Follow-up|4|||
48565724|NCT00594165|156262889|FG000|Overall Study|Other: PI discretion|5|||
48565725|NCT00594165|156262889|FG000|Overall Study|Other: Subject moving|3|||
48565726|NCT00594165|156262889|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
48565727|NCT00594165|156262889|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
48565728|NCT00594165|156262889|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
48565729|NCT00594165|156262889|FG000|Overall Study|Other: Site terminated participation|2|||
48565730|NCT04387435|156262890|FG000|Overall Study|Physician Decision|1|||
48565731|NCT04830969|156262893|FG000|Overall Study|Withdrawal by Subject|6|||
48565732|NCT04830969|156262894|FG001|Overall Study|Withdrawal by Subject|2|||
48565733|NCT04830969|156262893|FG000|Overall Study|Protocol Violation|3|||
48565734|NCT04830969|156262894|FG001|Overall Study|Protocol Violation|9|||
48565735|NCT04830969|156262893|FG000|Overall Study|Lost to Follow-up|4|||
48565736|NCT04830969|156262894|FG001|Overall Study|Lost to Follow-up|4|||
48565737|NCT00403481|156262895|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
48565738|NCT00403481|156262895|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
48565739|NCT00403481|156262895|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
48565740|NCT00403481|156262895|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
48565741|NCT00403481|156262895|FG000|Olm 40 mg|Adverse Event|2|||
48565742|NCT00403481|156262895|FG000|Olm 40 mg|Protocol Violation|1|||
48565743|NCT00403481|156262895|FG000|Olm 40 mg|Withdrawal by Subject|1|||
48617178|NCT00927082|156453077|FG003|Overall Study|Death|0|||
48565744|NCT00403481|156262895|FG000|Olm 40 mg|Other|1|||
48617179|NCT00927082|156453074|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
48565745|NCT00403481|156262895|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
48565746|NCT00403481|156262895|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
48565747|NCT00403481|156262895|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
48565748|NCT00403481|156262895|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
48565749|NCT00403481|156262895|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
48565750|NCT00403481|156262895|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
48565751|NCT00931528|156262898|FG000|Overall Study|Protocol Violation|9|||
48565752|NCT00931528|156262899|FG001|Overall Study|Protocol Violation|12|||
48565753|NCT00931528|156262898|FG000|Overall Study|Withdrawal by Subject|4|||
48565754|NCT00931528|156262899|FG001|Overall Study|Withdrawal by Subject|12|||
48565755|NCT00931528|156262898|FG000|Overall Study|Lost to Follow-up|6|||
48565756|NCT00931528|156262899|FG001|Overall Study|Lost to Follow-up|13|||
48617180|NCT00927082|156453075|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
48565757|NCT00931528|156262898|FG000|Overall Study|Assessment outside of Time Frame|22|||
48565758|NCT00931528|156262899|FG001|Overall Study|Assessment outside of Time Frame|23|||
48565759|NCT01422889|156262900|FG000|Overall Study|No Data Entered for Study Stent|9|||
48565760|NCT02091089|156262901|FG000|Overall Study|Lost to Follow-up|2|||
48565761|NCT02929589|156262902|FG000|Overall Study|Withdrawal by Subject|1|||
48565762|NCT02929589|156262903|FG001|Overall Study|Withdrawal by Subject|0|||
48565763|NCT02929589|156262904|FG002|Overall Study|Withdrawal by Subject|0|||
48565764|NCT02929589|156262905|FG003|Overall Study|Withdrawal by Subject|0|||
48565765|NCT02929589|156262902|FG000|Overall Study|Physician Decision|2|||
48565766|NCT02929589|156262903|FG001|Overall Study|Physician Decision|0|||
48565767|NCT02929589|156262904|FG002|Overall Study|Physician Decision|0|||
48565768|NCT02929589|156262905|FG003|Overall Study|Physician Decision|0|||
48565769|NCT00396656|156262907|FG000|First Treatment Period|Withdrawal by Subject|0|||
48565770|NCT00396656|156262908|FG001|First Treatment Period|Withdrawal by Subject|2|||
48565771|NCT00396656|156262907|FG000|Second Treatment Period|Adverse Event|0|||
48565772|NCT00396656|156262908|FG001|Second Treatment Period|Adverse Event|1|||
48565773|NCT03193853|156262909|FG000|Overall Study|Death|6|||
48565774|NCT01749826|156262910|FG000|Overall Study|Study Terminated|20|||
48565775|NCT01749826|156262911|FG001|Overall Study|Study Terminated|0|||
48565776|NCT01730053|156262912|FG000|Overall Study|Participant moved|0|||
48565777|NCT01730053|156262913|FG001|Overall Study|Participant moved|0|||
48565778|NCT01730053|156262914|FG002|Overall Study|Participant moved|1|||
48565779|NCT01730053|156262915|FG003|Overall Study|Participant moved|0|||
48565780|NCT01730053|156262916|FG004|Overall Study|Participant moved|0|||
48565781|NCT01730053|156262917|FG005|Overall Study|Participant moved|0|||
48565782|NCT01730053|156262912|FG000|Overall Study|Physician Decision|0|||
48565783|NCT01730053|156262913|FG001|Overall Study|Physician Decision|0|||
48565784|NCT01730053|156262914|FG002|Overall Study|Physician Decision|0|||
48565785|NCT01730053|156262915|FG003|Overall Study|Physician Decision|1|||
48565786|NCT01730053|156262916|FG004|Overall Study|Physician Decision|0|||
48565787|NCT01730053|156262917|FG005|Overall Study|Physician Decision|0|||
48565788|NCT01730053|156262912|FG000|Overall Study|Adverse Event|2|||
48565789|NCT01730053|156262913|FG001|Overall Study|Adverse Event|6|||
48565790|NCT01730053|156262914|FG002|Overall Study|Adverse Event|3|||
48565791|NCT01730053|156262915|FG003|Overall Study|Adverse Event|3|||
48565792|NCT01730053|156262916|FG004|Overall Study|Adverse Event|2|||
48565793|NCT01730053|156262917|FG005|Overall Study|Adverse Event|2|||
48565794|NCT01730053|156262912|FG000|Overall Study|Poor compliance to protocol|1|||
48565795|NCT01730053|156262913|FG001|Overall Study|Poor compliance to protocol|2|||
48565796|NCT01730053|156262914|FG002|Overall Study|Poor compliance to protocol|2|||
48565797|NCT01730053|156262915|FG003|Overall Study|Poor compliance to protocol|0|||
48565798|NCT01730053|156262916|FG004|Overall Study|Poor compliance to protocol|0|||
48565799|NCT01730053|156262917|FG005|Overall Study|Poor compliance to protocol|2|||
48565800|NCT01730053|156262912|FG000|Overall Study|Other than specified|2|||
48565801|NCT01730053|156262913|FG001|Overall Study|Other than specified|6|||
48565802|NCT01730053|156262914|FG002|Overall Study|Other than specified|5|||
48565803|NCT01730053|156262915|FG003|Overall Study|Other than specified|4|||
48565804|NCT01730053|156262916|FG004|Overall Study|Other than specified|7|||
48565805|NCT01730053|156262917|FG005|Overall Study|Other than specified|9|||
48565806|NCT00764660|156262918|FG000|Overall Study|Adverse Event|6|||
48565807|NCT00764660|156262919|FG001|Overall Study|Adverse Event|3|||
48565808|NCT00764660|156262918|FG000|Overall Study|Lost to Follow-up|3|||
48565809|NCT00764660|156262919|FG001|Overall Study|Lost to Follow-up|4|||
48565810|NCT00764660|156262918|FG000|Overall Study|Withdrawal by Subject|7|||
48565811|NCT00764660|156262919|FG001|Overall Study|Withdrawal by Subject|3|||
48565812|NCT00764660|156262918|FG000|Overall Study|Noncompliance With Protocol|5|||
48565813|NCT00764660|156262919|FG001|Overall Study|Noncompliance With Protocol|1|||
48565814|NCT00764660|156262918|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
48565815|NCT00764660|156262919|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
48565816|NCT04031846|156262922|FG000|Overall Study|Lost to Follow-up|4|||
48565817|NCT04031846|156262923|FG001|Overall Study|Lost to Follow-up|4|||
48565818|NCT04031846|156262922|FG000|Overall Study|Physician Decision|0|||
48565819|NCT04031846|156262923|FG001|Overall Study|Physician Decision|1|||
48565820|NCT04031846|156262922|FG000|Overall Study|Protocol Violation|1|||
48565821|NCT04031846|156262923|FG001|Overall Study|Protocol Violation|1|||
48565822|NCT04031846|156262922|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
48565823|NCT04031846|156262923|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
48565824|NCT00550043|156262924|FG000|Overall Study|Adverse Event|0|||
48565825|NCT00550043|156262925|FG001|Overall Study|Adverse Event|0|||
48565826|NCT00550043|156262926|FG002|Overall Study|Adverse Event|0|||
48565827|NCT00550043|156262927|FG003|Overall Study|Adverse Event|1|||
48565828|NCT00550043|156262928|FG004|Overall Study|Adverse Event|1|||
48565829|NCT00550043|156262924|FG000|Overall Study|Subject Withdrew Consent|0|||
48565830|NCT00550043|156262925|FG001|Overall Study|Subject Withdrew Consent|2|||
48565831|NCT00550043|156262926|FG002|Overall Study|Subject Withdrew Consent|1|||
48565832|NCT00550043|156262927|FG003|Overall Study|Subject Withdrew Consent|0|||
48565833|NCT00550043|156262928|FG004|Overall Study|Subject Withdrew Consent|0|||
48565834|NCT00550043|156262924|FG000|Overall Study|Other Reasons- Unspecified|0|||
48565835|NCT00550043|156262925|FG001|Overall Study|Other Reasons- Unspecified|1|||
48565836|NCT00550043|156262926|FG002|Overall Study|Other Reasons- Unspecified|0|||
48565837|NCT00550043|156262927|FG003|Overall Study|Other Reasons- Unspecified|1|||
48565838|NCT00550043|156262928|FG004|Overall Study|Other Reasons- Unspecified|0|||
48565839|NCT02172664|156264148|FG000|Overall Study|Lost to Follow-up|4|||
48565840|NCT02172664|156264149|FG001|Overall Study|Lost to Follow-up|4|||
48565841|NCT02172664|156264148|FG000|Overall Study|Death|1|||
48565842|NCT02172664|156264149|FG001|Overall Study|Death|1|||
48565843|NCT02172664|156264148|FG000|Overall Study|Moved out of area|1|||
48565844|NCT02172664|156264149|FG001|Overall Study|Moved out of area|1|||
48565845|NCT00866281|156264150|FG000|Overall Study|Adverse Event|1|||
48565846|NCT00866281|156264151|FG001|Overall Study|Adverse Event|0|||
48565847|NCT00866281|156264150|FG000|Overall Study|Withdrawal by participants|3|||
48565848|NCT00866281|156264151|FG001|Overall Study|Withdrawal by participants|0|||
48565849|NCT00866281|156264150|FG000|Overall Study|Disease progression|3|||
48565850|NCT00866281|156264151|FG001|Overall Study|Disease progression|11|||
48565851|NCT00866281|156264150|FG000|Overall Study|New cancer therapy|0|||
48565852|NCT00866281|156264151|FG001|Overall Study|New cancer therapy|4|||
48565853|NCT00611923|156264152|FG000|Overall Study|Withdrawal by Subject|2|||
48565854|NCT00611923|156264153|FG001|Overall Study|Withdrawal by Subject|2|||
48565855|NCT01894841|156264156|FG000|Overall Study|Withdrawal by Subject|9|||
48565856|NCT01894841|156264157|FG001|Overall Study|Withdrawal by Subject|4|||
48565857|NCT01894841|156264156|FG000|Overall Study|Withdrawn by investigator|2|||
48565858|NCT01894841|156264157|FG001|Overall Study|Withdrawn by investigator|2|||
48565859|NCT01894841|156264156|FG000|Overall Study|Lost to Follow-up|7|||
48565860|NCT01894841|156264157|FG001|Overall Study|Lost to Follow-up|3|||
48565861|NCT01100086|156264158|FG000|Period 1|Withdrawal by Subject|1|||
48565862|NCT01100086|156264159|FG001|Period 1|Withdrawal by Subject|0|||
48565863|NCT00471822|156264160|FG000|Overall Study|Protocol Violation|2|||
48565864|NCT00739661|156264161|FG000|Overall Study|Adverse Event|2|||
48565865|NCT00739661|156264162|FG001|Overall Study|Adverse Event|0|||
48565866|NCT00739661|156264161|FG000|Overall Study|Physician decision to withdraw patient|1|||
48565867|NCT00739661|156264162|FG001|Overall Study|Physician decision to withdraw patient|0|||
48565868|NCT00739661|156264161|FG000|Overall Study|Patient decision to withdraw|9|||
48565869|NCT00739661|156264162|FG001|Overall Study|Patient decision to withdraw|4|||
48565870|NCT00739661|156264161|FG000|Overall Study|Disease progression, radiographic|33|||
48565871|NCT00739661|156264162|FG001|Overall Study|Disease progression, radiographic|37|||
48565872|NCT00739661|156264161|FG000|Overall Study|Reason for discontinuation not available|1|||
48565873|NCT00739661|156264162|FG001|Overall Study|Reason for discontinuation not available|1|||
48565874|NCT00529087|156264163|FG000|Overall Study|Adverse Event|10|||
48565875|NCT00529087|156264164|FG001|Overall Study|Adverse Event|13|||
48565876|NCT00529087|156264165|FG002|Overall Study|Adverse Event|4|||
48565877|NCT00529087|156264163|FG000|Overall Study|Lost to Follow-up|6|||
48565878|NCT00529087|156264164|FG001|Overall Study|Lost to Follow-up|4|||
48565879|NCT00529087|156264165|FG002|Overall Study|Lost to Follow-up|1|||
48565880|NCT00529087|156264163|FG000|Overall Study|Protocol Violation|8|||
48565881|NCT00529087|156264164|FG001|Overall Study|Protocol Violation|7|||
48565882|NCT00529087|156264165|FG002|Overall Study|Protocol Violation|6|||
48565883|NCT00529087|156264163|FG000|Overall Study|Withdrawal by Subject|3|||
48565884|NCT00529087|156264164|FG001|Overall Study|Withdrawal by Subject|3|||
48565885|NCT00529087|156264165|FG002|Overall Study|Withdrawal by Subject|3|||
48565886|NCT00529087|156264163|FG000|Overall Study|Protocol deviation|1|||
48565887|NCT00529087|156264164|FG001|Overall Study|Protocol deviation|1|||
48565888|NCT00529087|156264165|FG002|Overall Study|Protocol deviation|2|||
48565889|NCT00461630|156264166|FG000|Overall Study|Death|798|||
48565890|NCT00461630|156264167|FG001|Overall Study|Death|732|||
48565891|NCT00461630|156264166|FG000|Overall Study|Lost to Follow-up|108|||
48565892|NCT00461630|156264167|FG001|Overall Study|Lost to Follow-up|95|||
48565893|NCT01346696|156264168|FG000|Overall Study|Death|1|||
48565894|NCT04630002|156264170|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
48565895|NCT04630002|156264171|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
48565896|NCT04630002|156264172|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
48565897|NCT04630002|156264170|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
48565898|NCT04630002|156264171|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
48565899|NCT04630002|156264172|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
48565900|NCT04630002|156264170|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
48565901|NCT04630002|156264171|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
48565902|NCT04630002|156264172|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
48565903|NCT04630002|156264170|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
48565904|NCT04630002|156264171|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
48565905|NCT04630002|156264172|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
48565906|NCT04630002|156264170|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
48565907|NCT04630002|156264171|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
48565908|NCT04630002|156264172|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
48565909|NCT04630002|156264170|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
48565910|NCT04630002|156264171|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
48565911|NCT04630002|156264172|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
48565912|NCT04630002|156264170|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
48565913|NCT04630002|156264171|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
48565914|NCT04630002|156264172|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
48565915|NCT04630002|156264170|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
48565916|NCT04630002|156264171|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
48565917|NCT04630002|156264172|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
48565918|NCT00839800|156264175|FG000|Overall Study|Adverse Event|8|||
48565919|NCT00839800|156264176|FG001|Overall Study|Adverse Event|12|||
48565920|NCT00839800|156264175|FG000|Overall Study|Lost to Follow-up|31|||
48565921|NCT00839800|156264176|FG001|Overall Study|Lost to Follow-up|26|||
48565922|NCT00839800|156264175|FG000|Overall Study|Withdrawal by Subject|28|||
48565923|NCT00839800|156264176|FG001|Overall Study|Withdrawal by Subject|34|||
48565924|NCT00839800|156264175|FG000|Overall Study|Incorrect Enrolment|3|||
48565925|NCT00839800|156264176|FG001|Overall Study|Incorrect Enrolment|3|||
48565926|NCT00839800|156264175|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
48565927|NCT00839800|156264176|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
48565928|NCT00839800|156264175|FG000|Overall Study|Safety Reasons|2|||
48565929|NCT00839800|156264176|FG001|Overall Study|Safety Reasons|1|||
48565930|NCT00839800|156264175|FG000|Overall Study|Other|8|||
48565931|NCT00839800|156264176|FG001|Overall Study|Other|14|||
48565932|NCT00839800|156264175|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
48565933|NCT00839800|156264176|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
48565934|NCT02182843|156264186|FG000|Overall Study|Withdrawal by Subject|7|||
48565935|NCT02182843|156264186|FG000|Overall Study|Lost to Follow-up|2|||
48565936|NCT02182843|156264186|FG000|Overall Study|Adverse Event|1|||
48565937|NCT00288626|156264189|FG000|Overall Study|Death|3|||
48565938|NCT00288626|156264189|FG000|Overall Study|Withdrawal by Subject|4|||
48565939|NCT03751098|156264198|FG000|Overall Study|Withdrawal by Subject|0|||
48565940|NCT03751098|156264199|FG001|Overall Study|Withdrawal by Subject|1|||
48565941|NCT00997373|156264200|FG000|Overall Study|Withdrawal by Subject|5|||
48565942|NCT00997373|156264201|FG001|Overall Study|Withdrawal by Subject|0|||
48565943|NCT00997373|156264200|FG000|Overall Study|wrong tumor type|4|||
48565944|NCT00997373|156264201|FG001|Overall Study|wrong tumor type|0|||
48565945|NCT00997373|156264200|FG000|Overall Study|could not have hysterectomy|6|||
48565946|NCT00997373|156264201|FG001|Overall Study|could not have hysterectomy|0|||
48565947|NCT04578457|156264202|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
48565948|NCT04578457|156264202|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
48565949|NCT04578457|156264202|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
48565950|NCT04578457|156264202|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
48565951|NCT00832455|156264203|FG000|Overall Study|Adverse Event|13|||
48565952|NCT00832455|156264203|FG000|Overall Study|Lost to Follow-up|26|||
48565953|NCT00832455|156264203|FG000|Overall Study|Protocol Violation|4|||
48565954|NCT00832455|156264203|FG000|Overall Study|Withdrawal by Subject|17|||
48565955|NCT00832455|156264203|FG000|Overall Study|Screening Failure|2|||
48565956|NCT00832455|156264203|FG000|Overall Study|Stopped Medication|4|||
48565957|NCT00832455|156264203|FG000|Overall Study|Parent misunderstood study|1|||
48565958|NCT00832455|156264203|FG000|Overall Study|Parent dissatisfied|1|||
48565959|NCT00832455|156264203|FG000|Overall Study|No improvement|3|||
48565960|NCT00832455|156264203|FG000|Overall Study|Patient moved|1|||
48565961|NCT04013672|156264205|FG000|Overall Study|Withdrawal by Subject|3|||
48565962|NCT04013672|156264206|FG001|Overall Study|Withdrawal by Subject|0|||
48565963|NCT04013672|156264205|FG000|Overall Study|Death|1|||
48565964|NCT04013672|156264206|FG001|Overall Study|Death|0|||
48565965|NCT04013672|156264205|FG000|Overall Study|Physician Decision|5|||
48565966|NCT04013672|156264206|FG001|Overall Study|Physician Decision|0|||
48565967|NCT04021914|156264208|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
48565968|NCT03809663|156264214|FG000|Overall Study|Decision by sponsor|24|||
48565969|NCT03809663|156264215|FG001|Overall Study|Decision by sponsor|18|||
48565970|NCT03809663|156264216|FG002|Overall Study|Decision by sponsor|20|||
48565971|NCT03809663|156264217|FG003|Overall Study|Decision by sponsor|20|||
48565972|NCT03809663|156264218|FG004|Overall Study|Decision by sponsor|0|||
48565973|NCT03809663|156264219|FG005|Overall Study|Decision by sponsor|0|||
48565974|NCT03809663|156264214|FG000|Overall Study|Withdrawal by Subject|26|||
48565975|NCT03809663|156264215|FG001|Overall Study|Withdrawal by Subject|22|||
48565976|NCT03809663|156264216|FG002|Overall Study|Withdrawal by Subject|27|||
48565977|NCT03809663|156264217|FG003|Overall Study|Withdrawal by Subject|26|||
48565978|NCT03809663|156264218|FG004|Overall Study|Withdrawal by Subject|0|||
48565979|NCT03809663|156264219|FG005|Overall Study|Withdrawal by Subject|0|||
48565980|NCT03809663|156264214|FG000|Overall Study|Lost to Follow-up|1|||
48565981|NCT03809663|156264215|FG001|Overall Study|Lost to Follow-up|4|||
48565982|NCT03809663|156264216|FG002|Overall Study|Lost to Follow-up|1|||
48565983|NCT03809663|156264217|FG003|Overall Study|Lost to Follow-up|1|||
48565984|NCT03809663|156264218|FG004|Overall Study|Lost to Follow-up|0|||
48565985|NCT03809663|156264219|FG005|Overall Study|Lost to Follow-up|0|||
48565986|NCT02755103|156264220|FG000|Overall Study|Lost to Follow-up|17|||
48565987|NCT02755103|156264221|FG001|Overall Study|Lost to Follow-up|15|||
48565988|NCT02755103|156264220|FG000|Overall Study|Death|0|||
48565989|NCT02755103|156264221|FG001|Overall Study|Death|1|||
48565990|NCT02755103|156264220|FG000|Overall Study|Physician Decision|0|||
48565991|NCT02755103|156264221|FG001|Overall Study|Physician Decision|1|||
48565992|NCT02755103|156264220|FG000|Overall Study|Pregnancy|0|||
48565993|NCT02755103|156264221|FG001|Overall Study|Pregnancy|1|||
48565994|NCT02755103|156264220|FG000|Overall Study|Withdrawal by Subject|3|||
48565995|NCT02755103|156264221|FG001|Overall Study|Withdrawal by Subject|0|||
48565996|NCT02275819|156264226|FG000|Overall Study|Adverse Event|0|||
48565997|NCT02275819|156264227|FG001|Overall Study|Adverse Event|1|||
48565998|NCT02343939|156264231|FG000|Overall Study|Death|0|||
48565999|NCT02343939|156264232|FG001|Overall Study|Death|15|||
48566000|NCT02343939|156264233|FG002|Overall Study|Death|4|||
48566001|NCT02343939|156264234|FG003|Overall Study|Death|2|||
48566002|NCT02343939|156264235|FG004|Overall Study|Death|5|||
48566003|NCT02343939|156264236|FG005|Overall Study|Death|11|||
48566004|NCT02343939|156264237|FG006|Overall Study|Death|8|||
48566005|NCT02343939|156264238|FG007|Overall Study|Death|22|||
48566006|NCT02343939|156264239|FG008|Overall Study|Death|1|||
48566007|NCT02343939|156264231|FG000|Overall Study|Study terminated by sponsor|0|||
48566008|NCT02343939|156264232|FG001|Overall Study|Study terminated by sponsor|27|||
48566009|NCT02343939|156264233|FG002|Overall Study|Study terminated by sponsor|0|||
48566010|NCT02343939|156264234|FG003|Overall Study|Study terminated by sponsor|1|||
48566011|NCT02343939|156264235|FG004|Overall Study|Study terminated by sponsor|1|||
48566012|NCT02343939|156264236|FG005|Overall Study|Study terminated by sponsor|5|||
48566013|NCT02343939|156264237|FG006|Overall Study|Study terminated by sponsor|3|||
48566014|NCT02343939|156264238|FG007|Overall Study|Study terminated by sponsor|4|||
48566015|NCT02343939|156264239|FG008|Overall Study|Study terminated by sponsor|0|||
48566016|NCT02343939|156264231|FG000|Overall Study|Withdrew consent|3|||
48566017|NCT02343939|156264232|FG001|Overall Study|Withdrew consent|6|||
48566018|NCT02343939|156264233|FG002|Overall Study|Withdrew consent|1|||
48566019|NCT02343939|156264234|FG003|Overall Study|Withdrew consent|2|||
48566020|NCT02343939|156264235|FG004|Overall Study|Withdrew consent|2|||
48566021|NCT02343939|156264236|FG005|Overall Study|Withdrew consent|0|||
48566022|NCT02343939|156264237|FG006|Overall Study|Withdrew consent|0|||
48566023|NCT02343939|156264238|FG007|Overall Study|Withdrew consent|8|||
48566024|NCT02343939|156264239|FG008|Overall Study|Withdrew consent|6|||
48566025|NCT02343939|156264231|FG000|Overall Study|Treatment failure|0|||
48566026|NCT02343939|156264232|FG001|Overall Study|Treatment failure|0|||
48566027|NCT02343939|156264233|FG002|Overall Study|Treatment failure|0|||
48566028|NCT02343939|156264234|FG003|Overall Study|Treatment failure|0|||
48566029|NCT02343939|156264235|FG004|Overall Study|Treatment failure|0|||
48566030|NCT02343939|156264236|FG005|Overall Study|Treatment failure|0|||
48566031|NCT02343939|156264237|FG006|Overall Study|Treatment failure|2|||
48566032|NCT02343939|156264238|FG007|Overall Study|Treatment failure|1|||
48566033|NCT02343939|156264239|FG008|Overall Study|Treatment failure|0|||
48566034|NCT02343939|156264231|FG000|Overall Study|Investigator's discretion|0|||
48566035|NCT02343939|156264232|FG001|Overall Study|Investigator's discretion|0|||
48566036|NCT02343939|156264233|FG002|Overall Study|Investigator's discretion|0|||
48566037|NCT02343939|156264234|FG003|Overall Study|Investigator's discretion|1|||
48566038|NCT02343939|156264235|FG004|Overall Study|Investigator's discretion|0|||
48566039|NCT02343939|156264236|FG005|Overall Study|Investigator's discretion|0|||
48566040|NCT02343939|156264237|FG006|Overall Study|Investigator's discretion|1|||
48566041|NCT02343939|156264238|FG007|Overall Study|Investigator's discretion|0|||
48566042|NCT02343939|156264239|FG008|Overall Study|Investigator's discretion|0|||
48566043|NCT02343939|156264231|FG000|Overall Study|Adverse Event|0|||
48566044|NCT02343939|156264232|FG001|Overall Study|Adverse Event|0|||
48566045|NCT02343939|156264233|FG002|Overall Study|Adverse Event|0|||
48566046|NCT02343939|156264234|FG003|Overall Study|Adverse Event|0|||
48566047|NCT02343939|156264235|FG004|Overall Study|Adverse Event|0|||
48566048|NCT02343939|156264236|FG005|Overall Study|Adverse Event|1|||
48566049|NCT02343939|156264237|FG006|Overall Study|Adverse Event|0|||
48566050|NCT02343939|156264238|FG007|Overall Study|Adverse Event|0|||
48566051|NCT02343939|156264239|FG008|Overall Study|Adverse Event|0|||
48566052|NCT02343939|156264231|FG000|Overall Study|Never Treated With ENTO|0|||
48566053|NCT02343939|156264232|FG001|Overall Study|Never Treated With ENTO|0|||
48566054|NCT02343939|156264233|FG002|Overall Study|Never Treated With ENTO|0|||
48566055|NCT02343939|156264234|FG003|Overall Study|Never Treated With ENTO|0|||
48566056|NCT02343939|156264235|FG004|Overall Study|Never Treated With ENTO|0|||
48566057|NCT02343939|156264236|FG005|Overall Study|Never Treated With ENTO|0|||
48566058|NCT02343939|156264237|FG006|Overall Study|Never Treated With ENTO|1|||
48566059|NCT02343939|156264238|FG007|Overall Study|Never Treated With ENTO|2|||
48566060|NCT02343939|156264239|FG008|Overall Study|Never Treated With ENTO|0|||
48566061|NCT01441765|156264245|FG000|Overall Study|Death|1|||
48566062|NCT01441765|156264246|FG001|Overall Study|Death|0|||
48566063|NCT00454363|156264247|FG000|Overall Study|Adverse Event|1|||
48566064|NCT00454363|156264248|FG001|Overall Study|Adverse Event|2|||
48566065|NCT00454363|156264247|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
48566066|NCT00454363|156264248|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
48566067|NCT00552396|156264257|FG000|Overall Study|protocol withdrawal criteria|3|||
48566068|NCT00552396|156264258|FG001|Overall Study|protocol withdrawal criteria|3|||
48566069|NCT00552396|156264259|FG002|Overall Study|protocol withdrawal criteria|3|||
48566070|NCT00552396|156264260|FG003|Overall Study|protocol withdrawal criteria|6|||
48566071|NCT00552396|156264261|FG004|Overall Study|protocol withdrawal criteria|3|||
48566072|NCT00552396|156264262|FG005|Overall Study|protocol withdrawal criteria|3|||
48566073|NCT00552396|156264263|FG006|Overall Study|protocol withdrawal criteria|9|||
48566074|NCT04185220|156264264|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
48566075|NCT04185220|156264265|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
48566076|NCT04185220|156264264|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
48566077|NCT04185220|156264265|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
48566078|NCT02431676|156264266|FG000|Overall Study|no lab obtained|0|||
48566079|NCT02431676|156264267|FG001|Overall Study|no lab obtained|1|||
48566080|NCT02431676|156264268|FG002|Overall Study|no lab obtained|2|||
48566081|NCT00571727|156264270|FG000|Overall Study|Did not enter in this study|1|||
48566082|NCT00571727|156264270|FG000|Overall Study|Non-compliance|4|||
48566083|NCT00571727|156264270|FG000|Overall Study|Lost to Follow-up|30|||
48566084|NCT00571727|156264270|FG000|Overall Study|Poor growth|1|||
48566085|NCT00571727|156264270|FG000|Overall Study|Parent/patient decision|2|||
48566086|NCT00571727|156264270|FG000|Overall Study|Participant transferred to commercial drug|14|||
48566087|NCT00571727|156264270|FG000|Overall Study|Unable to provide study drug|6|||
48566088|NCT00571727|156264270|FG000|Overall Study|On-treatment at end of study|8|||
48566089|NCT00683618|156265720|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
48566090|NCT00683618|156265721|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
48566091|NCT00683618|156265722|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
48566092|NCT00683618|156265720|FG000|Randomised Treatment Period|Protocol Violation|0|||
48566093|NCT00683618|156265721|FG001|Randomised Treatment Period|Protocol Violation|1|||
48566094|NCT00683618|156265722|FG002|Randomised Treatment Period|Protocol Violation|0|||
48566095|NCT00683618|156265720|FG000|Randomised Treatment Period|Adverse Event|2|||
48566096|NCT00683618|156265721|FG001|Randomised Treatment Period|Adverse Event|0|||
48566097|NCT00683618|156265722|FG002|Randomised Treatment Period|Adverse Event|2|||
48566098|NCT00683618|156265720|FG000|Randomised Treatment Period|Reason not provided|0|||
48566099|NCT00683618|156265721|FG001|Randomised Treatment Period|Reason not provided|0|||
48566100|NCT00683618|156265722|FG002|Randomised Treatment Period|Reason not provided|2|||
48566101|NCT00683618|156265720|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
48566102|NCT00683618|156265721|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
48566103|NCT00683618|156265722|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
48566104|NCT00683618|156265720|FG000|Extension Treatment Period|Adverse Event|1|||
48566105|NCT00683618|156265721|FG001|Extension Treatment Period|Adverse Event|0|||
48566106|NCT00683618|156265722|FG002|Extension Treatment Period|Adverse Event|0|||
48566107|NCT00683618|156265720|FG000|Extension Treatment Period|Protocol Violation|1|||
48566108|NCT00683618|156265721|FG001|Extension Treatment Period|Protocol Violation|0|||
48566109|NCT00683618|156265722|FG002|Extension Treatment Period|Protocol Violation|0|||
48566110|NCT02764762|156265724|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48566111|NCT02764762|156265724|FG000|Overall Study|Lost to Follow-up|4|||
48566112|NCT02764762|156265724|FG000|Overall Study|Voluntary Withdrawal|8|||
48566113|NCT02764762|156265724|FG000|Overall Study|Site Termination|1|||
48566114|NCT02764762|156265724|FG000|Overall Study|Lack of Efficacy|16|||
48566115|NCT02764762|156265724|FG000|Overall Study|Reason not Specified|1|||
48566116|NCT01002989|156265725|FG000|Overall Study|exclusion criteria, no consent|5|||
48566117|NCT02760004|156265726|FG000|Overall Study|Lost to Follow-up|13|||
48566118|NCT02760004|156265727|FG001|Overall Study|Lost to Follow-up|22|||
48566119|NCT02954601|156265728|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
48566120|NCT02954601|156265729|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
48566121|NCT02954601|156265730|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
48566122|NCT02954601|156265731|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
48566123|NCT03852472|156265732|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
48566124|NCT03852472|156265733|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
48566125|NCT03852472|156265734|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
48566126|NCT03852472|156265735|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
48566127|NCT03852472|156265736|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
48566128|NCT03852472|156265732|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
48566129|NCT03852472|156265733|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
48566130|NCT03852472|156265734|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
48566131|NCT03852472|156265735|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
48617181|NCT00927082|156453076|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
48617182|NCT00927082|156453077|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
48617183|NCT01786109|156453078|FG000|Overall Study|fail manometry barostat tube placement|1|||
48617184|NCT01786109|156453079|FG001|Overall Study|fail manometry barostat tube placement|0|||
48566132|NCT03852472|156265736|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
48566133|NCT03852472|156265732|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
48566134|NCT03852472|156265733|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
48566135|NCT03852472|156265734|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
48566136|NCT03852472|156265735|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
48617185|NCT01786109|156453080|FG002|Overall Study|fail manometry barostat tube placement|0|||
48617186|NCT01786109|156453078|FG000|Overall Study|unrelated illness|0|||
48617187|NCT01786109|156453079|FG001|Overall Study|unrelated illness|0|||
48566137|NCT03852472|156265736|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
48566138|NCT03852472|156265732|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
48566139|NCT03852472|156265733|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
48566140|NCT03852472|156265734|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
48566141|NCT03852472|156265735|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
48566142|NCT03852472|156265736|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
48566143|NCT03852472|156265732|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
48566144|NCT03852472|156265733|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
48566145|NCT03852472|156265734|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
48566146|NCT03852472|156265735|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
48566147|NCT03852472|156265736|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
48566148|NCT03852472|156265732|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
48566149|NCT03852472|156265733|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
48566150|NCT03852472|156265734|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
48566151|NCT03852472|156265735|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
48566152|NCT03852472|156265736|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
48566153|NCT03852472|156265732|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
48566154|NCT03852472|156265733|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
48566155|NCT03852472|156265734|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
48566156|NCT03852472|156265735|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
48566157|NCT03852472|156265736|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
48566158|NCT03852472|156265732|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
48566159|NCT03852472|156265733|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
48566160|NCT03852472|156265734|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
48566161|NCT03852472|156265735|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
48566162|NCT03852472|156265736|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
48566163|NCT03852472|156265732|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
48566164|NCT03852472|156265733|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
48566165|NCT03852472|156265734|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
48566166|NCT03852472|156265735|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
48566167|NCT03852472|156265736|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
48566168|NCT03852472|156265732|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
48566169|NCT03852472|156265733|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
48566170|NCT03852472|156265734|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
48566171|NCT03852472|156265735|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
48566172|NCT03852472|156265736|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
48566173|NCT03852472|156265732|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
48566174|NCT03852472|156265733|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
48566175|NCT03852472|156265734|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
48566176|NCT03852472|156265735|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
48566177|NCT03852472|156265736|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
48566178|NCT03852472|156265732|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
48566179|NCT03852472|156265733|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
48566180|NCT03852472|156265734|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
48566181|NCT03852472|156265735|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
48566182|NCT03852472|156265736|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
48566183|NCT03852472|156265732|FG000|Period 2 - Week 44|Adverse Event|0|||
48566184|NCT03852472|156265733|FG001|Period 2 - Week 44|Adverse Event|3|||
48566185|NCT03852472|156265734|FG002|Period 2 - Week 44|Adverse Event|1|||
48566186|NCT03852472|156265735|FG003|Period 2 - Week 44|Adverse Event|2|||
48566187|NCT03852472|156265736|FG004|Period 2 - Week 44|Adverse Event|2|||
48566188|NCT03852472|156265732|FG000|Period 2 - Week 44|COVID-19 Related|0|||
48566189|NCT03852472|156265733|FG001|Period 2 - Week 44|COVID-19 Related|0|||
48566190|NCT03852472|156265734|FG002|Period 2 - Week 44|COVID-19 Related|0|||
48566191|NCT03852472|156265735|FG003|Period 2 - Week 44|COVID-19 Related|1|||
48566192|NCT03852472|156265736|FG004|Period 2 - Week 44|COVID-19 Related|0|||
48566193|NCT03852472|156265732|FG000|Period 2 - Week 44|Reason not stated|0|||
48566194|NCT03852472|156265733|FG001|Period 2 - Week 44|Reason not stated|0|||
48566195|NCT03852472|156265734|FG002|Period 2 - Week 44|Reason not stated|0|||
48566196|NCT03852472|156265735|FG003|Period 2 - Week 44|Reason not stated|0|||
48566197|NCT03852472|156265736|FG004|Period 2 - Week 44|Reason not stated|1|||
48566198|NCT00442897|156265738|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
48566199|NCT00442897|156265739|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
48566200|NCT00442897|156265738|FG000|Base Study (12 Week Follow-up)|Death|0|||
48566201|NCT00442897|156265739|FG001|Base Study (12 Week Follow-up)|Death|1|||
48566202|NCT00442897|156265738|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
48566203|NCT00442897|156265739|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
48566204|NCT00442897|156265738|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
48566205|NCT00442897|156265739|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
48566206|NCT00442897|156265738|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
48566207|NCT00442897|156265739|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
48566208|NCT00442897|156265738|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
48566209|NCT00442897|156265739|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
48566210|NCT00442897|156265738|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
48566211|NCT00442897|156265739|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
48566212|NCT00442897|156265738|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
48566213|NCT00442897|156265739|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
48566214|NCT00891020|156265743|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
48566215|NCT00891020|156265744|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
48566216|NCT00891020|156265745|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
48566217|NCT00891020|156265743|FG000|24 Week Treatment Period|Death|0|||
48566218|NCT00891020|156265744|FG001|24 Week Treatment Period|Death|2|||
48566219|NCT00891020|156265745|FG002|24 Week Treatment Period|Death|0|||
48566220|NCT00891020|156265743|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
48566221|NCT00891020|156265744|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
48566222|NCT00891020|156265745|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
48566223|NCT00891020|156265743|FG000|24 Week Treatment Period|Failure to return|4|||
48566224|NCT00891020|156265744|FG001|24 Week Treatment Period|Failure to return|5|||
48566225|NCT00891020|156265745|FG002|24 Week Treatment Period|Failure to return|5|||
48566226|NCT00891020|156265743|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
48566227|NCT00891020|156265744|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
48566228|NCT00891020|156265745|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
48566229|NCT00891020|156265743|FG000|24 Week Treatment Period|Other protocol violation|1|||
48566230|NCT00891020|156265744|FG001|24 Week Treatment Period|Other protocol violation|1|||
48566231|NCT00891020|156265745|FG002|24 Week Treatment Period|Other protocol violation|2|||
48566232|NCT00891020|156265743|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
48566233|NCT00891020|156265744|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
48566234|NCT00891020|156265745|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
48566235|NCT00891020|156265743|FG000|24 Week Treatment Period|Withdrew consent|6|||
48566236|NCT00891020|156265744|FG001|24 Week Treatment Period|Withdrew consent|3|||
48566237|NCT00891020|156265745|FG002|24 Week Treatment Period|Withdrew consent|15|||
48566238|NCT00891020|156265743|FG000|24 Week Treatment Period|Administrative/Other|5|||
48566239|NCT00891020|156265744|FG001|24 Week Treatment Period|Administrative/Other|6|||
48566240|NCT00891020|156265745|FG002|24 Week Treatment Period|Administrative/Other|1|||
48566241|NCT00891020|156265743|FG000|Long-term Extension Period|Adverse Event|1|||
48566242|NCT00891020|156265744|FG001|Long-term Extension Period|Adverse Event|11|||
48566243|NCT00891020|156265745|FG002|Long-term Extension Period|Adverse Event|10|||
48566244|NCT00891020|156265743|FG000|Long-term Extension Period|Death|0|||
48566245|NCT00891020|156265744|FG001|Long-term Extension Period|Death|0|||
48566246|NCT00891020|156265745|FG002|Long-term Extension Period|Death|1|||
48566247|NCT00891020|156265743|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
48566248|NCT00891020|156265744|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
48566249|NCT00891020|156265745|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
48566250|NCT00891020|156265743|FG000|Long-term Extension Period|Protocol Violation|0|||
48566251|NCT00891020|156265744|FG001|Long-term Extension Period|Protocol Violation|1|||
48566252|NCT00891020|156265745|FG002|Long-term Extension Period|Protocol Violation|1|||
48566253|NCT00891020|156265743|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
48566254|NCT00891020|156265744|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
48566255|NCT00891020|156265745|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
48566256|NCT00891020|156265743|FG000|Long-term Extension Period|Failure to return|0|||
48566257|NCT00891020|156265744|FG001|Long-term Extension Period|Failure to return|2|||
48566258|NCT00891020|156265745|FG002|Long-term Extension Period|Failure to return|3|||
48566259|NCT00891020|156265743|FG000|Long-term Extension Period|Administrative|1|||
48566260|NCT00891020|156265744|FG001|Long-term Extension Period|Administrative|2|||
48566261|NCT00891020|156265745|FG002|Long-term Extension Period|Administrative|2|||
48566262|NCT02588612|156265746|FG000|Overall Study|Physician Decision|1|||
48566263|NCT02588612|156265746|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
48566264|NCT02588612|156265746|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
48566265|NCT02588612|156265746|FG000|Overall Study|Death prior to T-cell infusion|1|||
48566266|NCT03866512|156265747|FG000|Overall Study|Lost to Follow-up|1|||
48566267|NCT03866512|156265748|FG001|Overall Study|Lost to Follow-up|2|||
48566268|NCT03866512|156265749|FG002|Overall Study|Lost to Follow-up|1|||
48566269|NCT03866512|156265747|FG000|Overall Study|Cannulation issues|0|||
48566270|NCT03866512|156265748|FG001|Overall Study|Cannulation issues|1|||
48566271|NCT03866512|156265749|FG002|Overall Study|Cannulation issues|2|||
48566272|NCT00320710|156265750|FG000|Overall Study|Disease progression|24|||
48566273|NCT00320710|156265751|FG001|Overall Study|Disease progression|19|||
48566274|NCT00320710|156265752|FG002|Overall Study|Disease progression|2|||
48566275|NCT00320710|156265750|FG000|Overall Study|Death|10|||
48566276|NCT00320710|156265751|FG001|Overall Study|Death|7|||
48566277|NCT00320710|156265752|FG002|Overall Study|Death|1|||
48566278|NCT00320710|156265750|FG000|Overall Study|Administrative problems|1|||
48566279|NCT00320710|156265751|FG001|Overall Study|Administrative problems|2|||
48566280|NCT00320710|156265752|FG002|Overall Study|Administrative problems|0|||
48566281|NCT00320710|156265750|FG000|Overall Study|Withdrawal by Subject|20|||
48566282|NCT00320710|156265751|FG001|Overall Study|Withdrawal by Subject|26|||
48566283|NCT00320710|156265752|FG002|Overall Study|Withdrawal by Subject|1|||
48566284|NCT00320710|156265750|FG000|Overall Study|Protocol Violation|6|||
48566285|NCT00320710|156265751|FG001|Overall Study|Protocol Violation|5|||
48566286|NCT00320710|156265752|FG002|Overall Study|Protocol Violation|0|||
48566287|NCT00320710|156265750|FG000|Overall Study|Abnormal test procedure result(s)|2|||
48566288|NCT00320710|156265751|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48566289|NCT00320710|156265752|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48566290|NCT00320710|156265750|FG000|Overall Study|Abnormal laboratory value(s)|12|||
48566291|NCT00320710|156265751|FG001|Overall Study|Abnormal laboratory value(s)|3|||
48566292|NCT00320710|156265752|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48566293|NCT00320710|156265750|FG000|Overall Study|Adverse Event|18|||
48566294|NCT00320710|156265751|FG001|Overall Study|Adverse Event|14|||
48566295|NCT00320710|156265752|FG002|Overall Study|Adverse Event|1|||
48566296|NCT00320710|156265750|FG000|Overall Study|Lost to Follow-up|1|||
48566297|NCT00320710|156265751|FG001|Overall Study|Lost to Follow-up|0|||
48566298|NCT00320710|156265752|FG002|Overall Study|Lost to Follow-up|0|||
48566299|NCT02801617|156265753|FG000|Overall Study|Protocol Violation|2|||
48566300|NCT02801617|156265754|FG001|Overall Study|Protocol Violation|6|||
48566301|NCT01372618|156265755|FG000|Overall Study|PI Died. Study Terminated|9|||
48566302|NCT03448419|156265765|FG000|Overall Study|Adverse Event|10|||
48566303|NCT03448419|156265766|FG001|Overall Study|Adverse Event|9|||
48566304|NCT03448419|156265765|FG000|Overall Study|Lost to Follow-up|0|||
48566305|NCT03448419|156265766|FG001|Overall Study|Lost to Follow-up|2|||
48566306|NCT03448419|156265765|FG000|Overall Study|Withdrawal by Subject|3|||
48566307|NCT03448419|156265766|FG001|Overall Study|Withdrawal by Subject|1|||
48566308|NCT03448419|156265765|FG000|Overall Study|Not treated|0|||
48566309|NCT03448419|156265766|FG001|Overall Study|Not treated|1|||
48566310|NCT03448419|156265765|FG000|Overall Study|Patient did not attend all visits|0|||
48566311|NCT03448419|156265766|FG001|Overall Study|Patient did not attend all visits|2|||
48566312|NCT03448419|156265765|FG000|Overall Study|Withdrawn by Sponsor|0|||
48566313|NCT03448419|156265766|FG001|Overall Study|Withdrawn by Sponsor|1|||
48566314|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
48566315|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
48566316|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
48566317|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
48566318|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
48566319|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
48566320|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
48566321|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
48566322|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
48566323|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
48566324|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
48566325|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
48566326|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
48566327|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
48566328|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
48566329|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
48566330|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
48566331|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
48566332|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
48566333|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
48566334|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
48566335|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
48566336|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
48566337|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
48617188|NCT01786109|156453080|FG002|Overall Study|unrelated illness|1|||
48566338|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
48566339|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
48566340|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
48566341|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
48566342|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
48566343|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
48566344|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
48566345|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
48566346|NCT00506415|156265768|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
48566347|NCT00506415|156265769|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
48566348|NCT00506415|156265770|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
48566349|NCT00506415|156265771|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
48566350|NCT00506415|156265768|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
48566351|NCT00506415|156265769|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
48566352|NCT00506415|156265770|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
48566353|NCT00506415|156265771|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
48566354|NCT00506415|156265768|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
48566355|NCT00506415|156265769|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
48566356|NCT00506415|156265770|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
48566357|NCT00506415|156265771|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
48566358|NCT00506415|156265768|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
48566359|NCT00506415|156265769|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
48566360|NCT00506415|156265770|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
48566361|NCT00506415|156265771|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
48566362|NCT00506415|156265768|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
48566363|NCT00506415|156265769|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
48566364|NCT00506415|156265770|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
48566365|NCT00506415|156265771|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
48566366|NCT00506415|156265768|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
48566367|NCT00506415|156265769|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
48566368|NCT00506415|156265770|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
48566369|NCT00506415|156265771|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
48566370|NCT00506415|156265768|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
48566371|NCT00506415|156265769|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
48566372|NCT00506415|156265770|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
48566373|NCT00506415|156265771|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
48566374|NCT00506415|156265768|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
48566375|NCT00506415|156265769|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
48566376|NCT00506415|156265770|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
48566377|NCT00506415|156265771|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
48566378|NCT00506415|156265768|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
48566379|NCT00506415|156265769|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
48566380|NCT00506415|156265770|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
48566381|NCT00506415|156265771|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
48566382|NCT00506415|156265768|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
48566383|NCT00506415|156265769|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
48566384|NCT00506415|156265770|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
48566385|NCT00506415|156265771|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
48566386|NCT00506415|156265768|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
48566387|NCT00506415|156265769|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
48566388|NCT00506415|156265770|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
48566389|NCT00506415|156265771|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
48566390|NCT00506415|156265768|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
48566391|NCT00506415|156265769|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
48566392|NCT00506415|156265770|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
48566393|NCT00506415|156265771|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
48566394|NCT00506415|156265768|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
48566395|NCT00506415|156265769|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
48566396|NCT00506415|156265770|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
48566397|NCT00506415|156265771|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
48566398|NCT00506415|156265768|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
48566399|NCT00506415|156265769|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
48566400|NCT00506415|156265770|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
48566401|NCT00506415|156265771|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
48566402|NCT00506415|156265768|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
48566403|NCT00506415|156265769|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
48566404|NCT00506415|156265770|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
48566405|NCT00506415|156265771|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
48566406|NCT00506415|156265768|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
48566407|NCT00506415|156265769|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
48566408|NCT00506415|156265770|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
48566409|NCT00506415|156265771|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
48566410|NCT01954056|156265772|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
48566411|NCT01954056|156265773|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
48566412|NCT03376789|156265775|FG000|Overall Study|Withdrawal by Subject|3|||
48566413|NCT03376789|156265776|FG001|Overall Study|Withdrawal by Subject|5|||
48566414|NCT03376789|156265775|FG000|Overall Study|Protocol Violation|0|||
48566415|NCT03376789|156265776|FG001|Overall Study|Protocol Violation|1|||
48566416|NCT03376789|156265775|FG000|Overall Study|Adverse Event|0|||
48566417|NCT03376789|156265776|FG001|Overall Study|Adverse Event|1|||
48566418|NCT03376789|156265775|FG000|Overall Study|Lost to Follow-up|1|||
48566419|NCT03376789|156265776|FG001|Overall Study|Lost to Follow-up|1|||
48566420|NCT03376789|156265775|FG000|Overall Study|Per sponsor due to noncompliance|1|||
48566421|NCT03376789|156265776|FG001|Overall Study|Per sponsor due to noncompliance|0|||
48566422|NCT03376789|156265775|FG000|Overall Study|Subject off study medication|0|||
48566423|NCT03376789|156265776|FG001|Overall Study|Subject off study medication|1|||
48566424|NCT01703260|156265777|FG000|Overall Study|Adverse Event|1|||
48566425|NCT01703260|156265778|FG001|Overall Study|Adverse Event|2|||
48566426|NCT01703260|156265779|FG002|Overall Study|Adverse Event|2|||
48566427|NCT01703260|156265777|FG000|Overall Study|Lost to Follow-up|1|||
48566428|NCT01703260|156265778|FG001|Overall Study|Lost to Follow-up|0|||
48566429|NCT01703260|156265779|FG002|Overall Study|Lost to Follow-up|0|||
48566430|NCT01703260|156265777|FG000|Overall Study|Withdrawal by Subject|0|||
48566431|NCT01703260|156265778|FG001|Overall Study|Withdrawal by Subject|0|||
48566432|NCT01703260|156265779|FG002|Overall Study|Withdrawal by Subject|1|||
48566433|NCT01703260|156265777|FG000|Overall Study|Study Termination|1|||
48566434|NCT01703260|156265778|FG001|Overall Study|Study Termination|2|||
48566435|NCT01703260|156265779|FG002|Overall Study|Study Termination|0|||
48566436|NCT04090060|156265780|FG000|Overall Study|Lost to Follow-up|76|||
48566437|NCT04090060|156265781|FG001|Overall Study|Lost to Follow-up|77|||
48566438|NCT04615403|156265784|FG000|Overall Study|Death|1|||
48566439|NCT03337113|156265787|FG000|Overall Study|Adverse Event|1|||
48566440|NCT03337113|156265788|FG001|Overall Study|Adverse Event|1|||
48566441|NCT03337113|156265789|FG002|Overall Study|Adverse Event|0|||
48566442|NCT03337113|156265790|FG003|Overall Study|Adverse Event|1|||
48566443|NCT03337113|156265787|FG000|Overall Study|Physician Decision|0|||
48566444|NCT03337113|156265788|FG001|Overall Study|Physician Decision|2|||
48566445|NCT03337113|156265789|FG002|Overall Study|Physician Decision|0|||
48566446|NCT03337113|156265790|FG003|Overall Study|Physician Decision|1|||
48566447|NCT03337113|156265787|FG000|Overall Study|Withdrawal by Subject|0|||
48566448|NCT03337113|156265788|FG001|Overall Study|Withdrawal by Subject|0|||
48566449|NCT03337113|156265789|FG002|Overall Study|Withdrawal by Subject|1|||
48566450|NCT03337113|156265790|FG003|Overall Study|Withdrawal by Subject|0|||
48566451|NCT03526861|156265791|FG000|Initial Treatment Period|Not dosed|1|||
48566452|NCT03526861|156265792|FG001|Initial Treatment Period|Not dosed|1|||
48566453|NCT03526861|156265793|FG002|Initial Treatment Period|Not dosed|1|||
48566454|NCT03526861|156265794|FG003|Initial Treatment Period|Not dosed|0|||
48566455|NCT03526861|156265795|FG004|Initial Treatment Period|Not dosed|0|||
48566456|NCT03526861|156265796|FG005|Initial Treatment Period|Not dosed|0|||
48566457|NCT03526861|156265797|FG006|Initial Treatment Period|Not dosed|0|||
48566458|NCT03526861|156265798|FG007|Initial Treatment Period|Not dosed|0|||
48566459|NCT03526861|156265799|FG008|Initial Treatment Period|Not dosed|0|||
48566460|NCT03526861|156265791|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
48566461|NCT03526861|156265792|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
48566462|NCT03526861|156265793|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
48566463|NCT03526861|156265794|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566464|NCT03526861|156265795|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566465|NCT03526861|156265796|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566466|NCT03526861|156265797|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566467|NCT03526861|156265798|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566468|NCT03526861|156265799|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566469|NCT03526861|156265791|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
48566470|NCT03526861|156265792|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
48566471|NCT03526861|156265793|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
48566472|NCT03526861|156265794|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
48566473|NCT03526861|156265795|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
48566474|NCT03526861|156265796|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
48566475|NCT03526861|156265797|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
48566476|NCT03526861|156265798|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
48566477|NCT03526861|156265799|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
48566478|NCT03526861|156265791|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566479|NCT03526861|156265792|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566480|NCT03526861|156265793|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566481|NCT03526861|156265794|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
48566482|NCT03526861|156265795|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
48566483|NCT03526861|156265796|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566484|NCT03526861|156265797|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
48566485|NCT03526861|156265798|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566486|NCT03526861|156265799|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566487|NCT03526861|156265791|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
48566488|NCT03526861|156265792|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
48566489|NCT03526861|156265793|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
48566490|NCT03526861|156265794|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
48566491|NCT03526861|156265795|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
48566492|NCT03526861|156265796|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
48566493|NCT03526861|156265797|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
48566494|NCT03526861|156265798|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
48566495|NCT03526861|156265799|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
48566496|NCT03526861|156265791|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566497|NCT03526861|156265792|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566498|NCT03526861|156265793|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566499|NCT03526861|156265794|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
48566500|NCT03526861|156265795|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566501|NCT03526861|156265796|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566502|NCT03526861|156265797|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566503|NCT03526861|156265798|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48585122|NCT01094782|156333785|FG002|Overall Study|Withdrawal by Subject|1|||
48566504|NCT03526861|156265799|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566505|NCT03526861|156265791|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566506|NCT03526861|156265792|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566507|NCT03526861|156265793|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566508|NCT03526861|156265794|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566509|NCT03526861|156265795|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566510|NCT03526861|156265796|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566511|NCT03526861|156265797|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566512|NCT03526861|156265798|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
48566513|NCT03526861|156265799|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
48566514|NCT03526861|156265791|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
48566515|NCT03526861|156265792|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
48566516|NCT03526861|156265793|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
48566517|NCT03526861|156265794|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
48566518|NCT03526861|156265795|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
48566519|NCT03526861|156265796|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
48566520|NCT03526861|156265797|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
48566521|NCT03526861|156265798|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
48566522|NCT03526861|156265799|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
48566523|NCT03526861|156265791|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566524|NCT03526861|156265792|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566525|NCT03526861|156265793|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566526|NCT03526861|156265794|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566527|NCT03526861|156265795|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566528|NCT03526861|156265796|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566529|NCT03526861|156265797|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48566530|NCT03526861|156265798|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
48585123|NCT01094782|156333786|FG003|Overall Study|Withdrawal by Subject|5|||
48566531|NCT03526861|156265799|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
48566532|NCT04548193|156265805|FG000|Overall Study|Lost to Follow-up|0|||
48566533|NCT04548193|156265806|FG001|Overall Study|Lost to Follow-up|1|||
48566534|NCT04548193|156265805|FG000|Overall Study|Death|0|||
48566535|NCT04548193|156265806|FG001|Overall Study|Death|1|||
48566536|NCT04548193|156265805|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
48566537|NCT04548193|156265806|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
48566538|NCT04548193|156265805|FG000|Overall Study|Withdrawal by Subject|2|||
48566539|NCT04548193|156265806|FG001|Overall Study|Withdrawal by Subject|2|||
48566540|NCT03168711|156265807|FG000|Overall Study|Adverse Event|2|||
48566541|NCT03168711|156265808|FG001|Overall Study|Adverse Event|0|||
48566542|NCT03168711|156265807|FG000|Overall Study|Withdrawal by Subject|0|||
48566543|NCT03168711|156265808|FG001|Overall Study|Withdrawal by Subject|1|||
48566544|NCT03168711|156265807|FG000|Overall Study|Death|0|||
48566545|NCT03168711|156265808|FG001|Overall Study|Death|1|||
48566546|NCT00630825|156265813|FG000|Overall Study|Adverse Event|4|||
48566547|NCT00630825|156265814|FG001|Overall Study|Adverse Event|4|||
48566548|NCT00630825|156265815|FG002|Overall Study|Adverse Event|3|||
48566549|NCT00630825|156265816|FG003|Overall Study|Adverse Event|1|||
48566550|NCT00630825|156265813|FG000|Overall Study|Entry Criteria Not Met|1|||
48566551|NCT00630825|156265814|FG001|Overall Study|Entry Criteria Not Met|0|||
48566552|NCT00630825|156265815|FG002|Overall Study|Entry Criteria Not Met|2|||
48566553|NCT00630825|156265816|FG003|Overall Study|Entry Criteria Not Met|1|||
48566554|NCT00630825|156265813|FG000|Overall Study|Lost to Follow-up|1|||
48566555|NCT00630825|156265814|FG001|Overall Study|Lost to Follow-up|1|||
48566556|NCT00630825|156265815|FG002|Overall Study|Lost to Follow-up|1|||
48566557|NCT00630825|156265816|FG003|Overall Study|Lost to Follow-up|1|||
48566558|NCT00630825|156265813|FG000|Overall Study|Physician Decision|1|||
48566559|NCT00630825|156265814|FG001|Overall Study|Physician Decision|0|||
48566560|NCT00630825|156265815|FG002|Overall Study|Physician Decision|0|||
48566561|NCT00630825|156265816|FG003|Overall Study|Physician Decision|0|||
48566562|NCT00630825|156265813|FG000|Overall Study|Withdrawal by Subject|2|||
48566563|NCT00630825|156265814|FG001|Overall Study|Withdrawal by Subject|2|||
48566564|NCT00630825|156265815|FG002|Overall Study|Withdrawal by Subject|2|||
48566565|NCT00630825|156265816|FG003|Overall Study|Withdrawal by Subject|3|||
48566566|NCT04177095|156265817|FG000|Overall Study|Withdrawal by Subject|3|||
48566567|NCT04177095|156265817|FG000|Overall Study|Screen Failure|3|||
48566568|NCT04177095|156265817|FG000|Overall Study|Problems with the Trugraf assay|1|||
48566569|NCT02792062|156265828|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
48566570|NCT02792062|156265829|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
48566571|NCT02792062|156265830|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
48566572|NCT02792062|156265831|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
48566573|NCT02792062|156265832|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
48566574|NCT02792062|156265833|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
48566575|NCT01081769|156265837|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
48566576|NCT01081769|156265838|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
48566577|NCT01081769|156265837|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
48566578|NCT01081769|156265838|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
48566579|NCT01081769|156265837|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
48566580|NCT01081769|156265838|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
48566581|NCT01081769|156265837|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
48566582|NCT01081769|156265838|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
48566583|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Adverse Event|14|||
48566584|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Adverse Event|11|||
48566585|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Death|1|||
48566586|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Death|1|||
48566587|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
48566588|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
48566589|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
48566590|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
48566591|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Pregnancy|1|||
48566592|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Pregnancy|0|||
48566593|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
48566594|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
48566595|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
48566596|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
48566597|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Other|0|||
48617189|NCT01786109|156453078|FG000|Overall Study|adverse effects colon preparation|0|||
48566598|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Other|1|||
48566599|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Ineligibility|3|||
48617190|NCT01786109|156453079|FG001|Overall Study|adverse effects colon preparation|0|||
48617191|NCT01786109|156453080|FG002|Overall Study|adverse effects colon preparation|1|||
48617192|NCT03983109|156453081|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
48617193|NCT03983109|156453082|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
48617194|NCT04149353|156453083|FG000|Overall Study|Study terminated|1|||
48617195|NCT00849472|156453084|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
48617196|NCT00849472|156453084|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
48617197|NCT00849472|156453084|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
48617198|NCT00849472|156453084|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
48617199|NCT00849472|156453084|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
48617200|NCT00849472|156453084|FG000|Weekly Paclitaxel|Disease Progression|1|||
48617201|NCT00849472|156453084|FG000|Weekly Paclitaxel|Adverse Event|11|||
48617202|NCT00849472|156453084|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
48617203|NCT00849472|156453084|FG000|Weekly Paclitaxel|Physician Decision|3|||
48617204|NCT00849472|156453084|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
48617205|NCT00849472|156453084|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
48617206|NCT00849472|156453084|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
48566600|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Ineligibility|4|||
48566601|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
48566602|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
48566603|NCT01081769|156265837|FG000|CORE Intent-To-Treat|Patient Moved|2|||
48566604|NCT01081769|156265838|FG001|CORE Intent-To-Treat|Patient Moved|2|||
48566605|NCT00558467|156265841|FG000|Overall Study|Adverse Event|1|||
48566606|NCT00558467|156265842|FG001|Overall Study|Adverse Event|2|||
48566607|NCT00558467|156265841|FG000|Overall Study|Lack of Efficacy|0|||
48617207|NCT00849472|156453084|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
48617208|NCT00849472|156453084|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
48566608|NCT00558467|156265842|FG001|Overall Study|Lack of Efficacy|1|||
48566609|NCT00558467|156265841|FG000|Overall Study|Patient moving out of state|0|||
48566610|NCT00558467|156265842|FG001|Overall Study|Patient moving out of state|1|||
48566611|NCT02176655|156265845|FG000|Overall Study|Subjects did not treat|6|||
48566612|NCT00558701|156265863|FG000|Overall Study|Protocol Deviations|1|||
48566613|NCT00558701|156265864|FG001|Overall Study|Protocol Deviations|4|||
48566614|NCT01139125|156265866|FG000|Overall Study|Withdrawal by Subject|1|||
48566615|NCT00765336|156265867|FG000|Overall Study|Protocol Violation|4|||
48566616|NCT00765336|156265868|FG001|Overall Study|Protocol Violation|2|||
48566617|NCT00765336|156265867|FG000|Overall Study|Withdrawal by Subject|6|||
48566618|NCT00765336|156265868|FG001|Overall Study|Withdrawal by Subject|4|||
48566619|NCT00765336|156265867|FG000|Overall Study|Lost to Follow-up|7|||
48566620|NCT00765336|156265868|FG001|Overall Study|Lost to Follow-up|9|||
48566621|NCT00765336|156265867|FG000|Overall Study|Adverse Event|2|||
48566622|NCT00765336|156265868|FG001|Overall Study|Adverse Event|1|||
48566623|NCT01303172|156265869|FG000|Overall Study|Physician Decision|9|||
48566624|NCT01303172|156265870|FG001|Overall Study|Physician Decision|6|||
48566625|NCT01303172|156265869|FG000|Overall Study|Adverse Event|5|||
48617209|NCT00849472|156453084|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
48617210|NCT00849472|156453084|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
48617211|NCT00849472|156453084|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
48617212|NCT02068599|156453085|FG000|Overall Study|Adverse Event|4|||
48617213|NCT02068599|156453086|FG001|Overall Study|Adverse Event|1|||
48617214|NCT02068599|156453087|FG002|Overall Study|Adverse Event|1|||
48617215|NCT02068599|156453085|FG000|Overall Study|Withdrawal by Subject|2|||
48617216|NCT02068599|156453086|FG001|Overall Study|Withdrawal by Subject|7|||
48617217|NCT02068599|156453087|FG002|Overall Study|Withdrawal by Subject|5|||
48617218|NCT02068599|156453085|FG000|Overall Study|Protocol Violation|4|||
48617219|NCT02068599|156453086|FG001|Overall Study|Protocol Violation|2|||
48617220|NCT02068599|156453087|FG002|Overall Study|Protocol Violation|3|||
48617221|NCT02068599|156453085|FG000|Overall Study|Lost to Follow-up|1|||
48617222|NCT02068599|156453086|FG001|Overall Study|Lost to Follow-up|0|||
48617223|NCT02068599|156453087|FG002|Overall Study|Lost to Follow-up|0|||
48617224|NCT02068599|156453085|FG000|Overall Study|Lack of Efficacy|0|||
48617225|NCT02068599|156453086|FG001|Overall Study|Lack of Efficacy|0|||
48617226|NCT02068599|156453087|FG002|Overall Study|Lack of Efficacy|3|||
48617227|NCT02068599|156453085|FG000|Overall Study|Noncompliance|0|||
48617228|NCT02068599|156453086|FG001|Overall Study|Noncompliance|0|||
48617229|NCT02068599|156453087|FG002|Overall Study|Noncompliance|1|||
48617230|NCT02762604|156453088|FG000|Overall Study|Lost to Follow-up|2|||
48617231|NCT02762604|156453089|FG001|Overall Study|Lost to Follow-up|7|||
48617232|NCT02762604|156453088|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
48617233|NCT02762604|156453089|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
48566626|NCT01303172|156265870|FG001|Overall Study|Adverse Event|2|||
48566627|NCT01303172|156265869|FG000|Overall Study|Withdrawal by Subject|4|||
48566628|NCT01303172|156265870|FG001|Overall Study|Withdrawal by Subject|2|||
48566629|NCT01303172|156265869|FG000|Overall Study|Death|20|||
48566630|NCT01303172|156265870|FG001|Overall Study|Death|7|||
48566631|NCT01303172|156265869|FG000|Overall Study|Lack of Efficacy|25|||
48566632|NCT01303172|156265870|FG001|Overall Study|Lack of Efficacy|17|||
48566633|NCT02589639|156265875|FG000|Overall Study|Lost to Follow-up|1|||
48566634|NCT02589639|156265876|FG001|Overall Study|Lost to Follow-up|0|||
48566635|NCT02589639|156265877|FG002|Overall Study|Lost to Follow-up|0|||
48566636|NCT02589639|156265875|FG000|Overall Study|Protocol Violation|1|||
48566637|NCT02589639|156265876|FG001|Overall Study|Protocol Violation|0|||
48566638|NCT02589639|156265877|FG002|Overall Study|Protocol Violation|0|||
48566639|NCT02589639|156265875|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
48566640|NCT02589639|156265876|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
48617234|NCT01405911|156453090|FG000|Overall Study|Pre-treatment lab AE|0|||
48617235|NCT01405911|156453091|FG001|Overall Study|Pre-treatment lab AE|1|||
48617236|NCT01405911|156453092|FG002|Overall Study|Pre-treatment lab AE|0|||
48617237|NCT01405911|156453090|FG000|Overall Study|Lost to Follow-up|0|||
48617238|NCT01405911|156453091|FG001|Overall Study|Lost to Follow-up|1|||
48617239|NCT01405911|156453092|FG002|Overall Study|Lost to Follow-up|0|||
48617240|NCT01405911|156453090|FG000|Overall Study|Protocol Violation|1|||
48566641|NCT02589639|156265877|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
48566642|NCT02589639|156265875|FG000|Overall Study|Adverse Event|4|||
48566643|NCT02589639|156265876|FG001|Overall Study|Adverse Event|5|||
48566644|NCT02589639|156265877|FG002|Overall Study|Adverse Event|3|||
48566645|NCT02589639|156265875|FG000|Overall Study|Other reason than specified above|1|||
48566646|NCT02589639|156265876|FG001|Overall Study|Other reason than specified above|2|||
48566647|NCT02589639|156265877|FG002|Overall Study|Other reason than specified above|1|||
48566648|NCT02589639|156265875|FG000|Overall Study|Not Treated|0|||
48566649|NCT02589639|156265876|FG001|Overall Study|Not Treated|3|||
48566650|NCT02589639|156265877|FG002|Overall Study|Not Treated|0|||
48566651|NCT02203721|156265878|FG000|Overall Study|Lost to Follow-up|1|||
48566652|NCT02203721|156265879|FG001|Overall Study|Lost to Follow-up|0|||
48566653|NCT02203721|156265878|FG000|Overall Study|Death|0|||
48566654|NCT02203721|156265879|FG001|Overall Study|Death|2|||
48566655|NCT02203721|156265878|FG000|Overall Study|Illness|0|||
48566656|NCT02203721|156265879|FG001|Overall Study|Illness|1|||
48566657|NCT01276756|156265880|FG000|Overall Study|Lost to Follow-up|2|||
48566658|NCT01276756|156265881|FG001|Overall Study|Lost to Follow-up|0|||
48566659|NCT01276756|156265880|FG000|Overall Study|Adverse Event|3|||
48566660|NCT01276756|156265881|FG001|Overall Study|Adverse Event|2|||
48566661|NCT01209520|156265882|FG000|Overall Study|Withdrawal by Subject|3|||
48566662|NCT02887183|156265886|FG000|Overall Study|Adverse Event|44|||
48566663|NCT02887183|156265886|FG000|Overall Study|Death|30|||
48566664|NCT02887183|156265886|FG000|Overall Study|Pregnancy|1|||
48566665|NCT02887183|156265886|FG000|Overall Study|Protocol Violation|6|||
48566666|NCT02887183|156265886|FG000|Overall Study|Technical Problems|2|||
48566667|NCT02887183|156265886|FG000|Overall Study|Lost to Follow-up|13|||
48566668|NCT02887183|156265886|FG000|Overall Study|Physician Decision|10|||
48566669|NCT02887183|156265886|FG000|Overall Study|Withdrawal by Subject|35|||
48566670|NCT01031680|156265887|FG000|Overall Study|Adverse Event|8|||
48566671|NCT01031680|156265888|FG001|Overall Study|Adverse Event|3|||
48566672|NCT01031680|156265887|FG000|Overall Study|Lost to Follow-up|2|||
48566673|NCT01031680|156265888|FG001|Overall Study|Lost to Follow-up|10|||
48566674|NCT01031680|156265887|FG000|Overall Study|Withdrawal by Subject|12|||
48566675|NCT01031680|156265888|FG001|Overall Study|Withdrawal by Subject|16|||
48566676|NCT01031680|156265887|FG000|Overall Study|Death|2|||
48566677|NCT01031680|156265888|FG001|Overall Study|Death|1|||
48566678|NCT01031680|156265887|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
48566679|NCT01031680|156265888|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
48566680|NCT01031680|156265887|FG000|Overall Study|Poor/Non-compliance|5|||
48566681|NCT01031680|156265888|FG001|Overall Study|Poor/Non-compliance|6|||
48566682|NCT01031680|156265887|FG000|Overall Study|Safety|1|||
48566683|NCT01031680|156265888|FG001|Overall Study|Safety|0|||
48566684|NCT01031680|156265887|FG000|Overall Study|Incorrect Enrolment|1|||
48566685|NCT01031680|156265888|FG001|Overall Study|Incorrect Enrolment|2|||
48566686|NCT01031680|156265887|FG000|Overall Study|Administrative Reason by Sponsor|0|||
48566687|NCT01031680|156265888|FG001|Overall Study|Administrative Reason by Sponsor|1|||
48566688|NCT01031680|156265887|FG000|Overall Study|Various|0|||
48566689|NCT01031680|156265888|FG001|Overall Study|Various|2|||
48566690|NCT00318474|156267224|FG000|Overall Study|Adverse Event|1|||
48566691|NCT00318474|156267225|FG001|Overall Study|Adverse Event|1|||
48566692|NCT00318474|156267224|FG000|Overall Study|Lost to Follow-up|0|||
48566693|NCT00318474|156267225|FG001|Overall Study|Lost to Follow-up|1|||
48566694|NCT00318474|156267224|FG000|Overall Study|Pregnancy|0|||
48566695|NCT00318474|156267225|FG001|Overall Study|Pregnancy|2|||
48617241|NCT01405911|156453091|FG001|Overall Study|Protocol Violation|0|||
48617242|NCT01405911|156453092|FG002|Overall Study|Protocol Violation|0|||
48617243|NCT01405911|156453090|FG000|Overall Study|Withdrawal by Subject|3|||
48617244|NCT01405911|156453091|FG001|Overall Study|Withdrawal by Subject|1|||
48617245|NCT01405911|156453092|FG002|Overall Study|Withdrawal by Subject|1|||
48617246|NCT00004859|156453103|FG000|Overall Study|Lack of Efficacy|43|||
48617247|NCT00004859|156453104|FG001|Overall Study|Lack of Efficacy|113|||
48617248|NCT00004859|156453103|FG000|Overall Study|Adverse Event|31|||
48566696|NCT00318474|156267224|FG000|Overall Study|Protocol Violation|1|||
48566697|NCT00318474|156267225|FG001|Overall Study|Protocol Violation|0|||
48566698|NCT00318474|156267224|FG000|Overall Study|Withdrawal by Subject|3|||
48566699|NCT00318474|156267225|FG001|Overall Study|Withdrawal by Subject|2|||
48566700|NCT00318474|156267224|FG000|Overall Study|Fall in GFR|3|||
48566701|NCT00318474|156267225|FG001|Overall Study|Fall in GFR|3|||
48566702|NCT00318474|156267224|FG000|Overall Study|Post-therapy hyperflycemia|0|||
48566703|NCT00318474|156267225|FG001|Overall Study|Post-therapy hyperflycemia|1|||
48617249|NCT00004859|156453104|FG001|Overall Study|Adverse Event|93|||
48617250|NCT00004859|156453103|FG000|Overall Study|Death|5|||
48566704|NCT00318474|156267224|FG000|Overall Study|Trial terminated|10|||
48566705|NCT00318474|156267225|FG001|Overall Study|Trial terminated|7|||
48566706|NCT00298272|156267226|FG000|Double-blind Phase|Adverse Event|2|||
48566707|NCT00298272|156267227|FG001|Double-blind Phase|Adverse Event|0|||
48617251|NCT00004859|156453104|FG001|Overall Study|Death|5|||
48617252|NCT00004859|156453103|FG000|Overall Study|Withdrawal by Subject|7|||
48617253|NCT00004859|156453104|FG001|Overall Study|Withdrawal by Subject|33|||
48617254|NCT00004859|156453103|FG000|Overall Study|Protocol Violation|2|||
48566708|NCT00298272|156267226|FG000|Double-blind Phase|Failure to Return|2|||
48617255|NCT00004859|156453104|FG001|Overall Study|Protocol Violation|2|||
48617256|NCT00004859|156453103|FG000|Overall Study|other disease|0|||
48617257|NCT00004859|156453104|FG001|Overall Study|other disease|3|||
48617258|NCT00004859|156453103|FG000|Overall Study|error|3|||
48617259|NCT00004859|156453104|FG001|Overall Study|error|1|||
48617260|NCT00004859|156453103|FG000|Overall Study|missing data|14|||
48617261|NCT00004859|156453104|FG001|Overall Study|missing data|11|||
48617262|NCT00004859|156453103|FG000|Overall Study|Other|13|||
48617263|NCT00004859|156453104|FG001|Overall Study|Other|21|||
48617264|NCT00855582|156456200|FG000|Overall Study|Adverse Event|2|||
48617265|NCT00855582|156456201|FG001|Overall Study|Adverse Event|6|||
48617266|NCT00855582|156456202|FG002|Overall Study|Adverse Event|3|||
48617267|NCT00855582|156456200|FG000|Overall Study|Death|1|||
48617268|NCT00855582|156456201|FG001|Overall Study|Death|0|||
48617269|NCT00855582|156456202|FG002|Overall Study|Death|0|||
48617270|NCT00855582|156456200|FG000|Overall Study|Lack of Efficacy|1|||
48617271|NCT00855582|156456201|FG001|Overall Study|Lack of Efficacy|3|||
48617272|NCT00855582|156456202|FG002|Overall Study|Lack of Efficacy|8|||
48617273|NCT00855582|156456200|FG000|Overall Study|Lost to Follow-up|1|||
48617274|NCT00855582|156456201|FG001|Overall Study|Lost to Follow-up|3|||
48617275|NCT00855582|156456202|FG002|Overall Study|Lost to Follow-up|1|||
48617276|NCT00855582|156456200|FG000|Overall Study|Physician Decision|0|||
48617277|NCT00855582|156456201|FG001|Overall Study|Physician Decision|0|||
48617278|NCT00855582|156456202|FG002|Overall Study|Physician Decision|1|||
48617279|NCT00855582|156456200|FG000|Overall Study|Protocol Violation|6|||
48617280|NCT00855582|156456201|FG001|Overall Study|Protocol Violation|2|||
48617281|NCT00855582|156456202|FG002|Overall Study|Protocol Violation|6|||
48617282|NCT00855582|156456200|FG000|Overall Study|Entry Criteria Not Met|8|||
48617283|NCT00855582|156456201|FG001|Overall Study|Entry Criteria Not Met|6|||
48617284|NCT00855582|156456202|FG002|Overall Study|Entry Criteria Not Met|3|||
48617285|NCT00855582|156456200|FG000|Overall Study|Withdrawal by Subject|7|||
48617286|NCT00855582|156456201|FG001|Overall Study|Withdrawal by Subject|4|||
48617287|NCT00855582|156456202|FG002|Overall Study|Withdrawal by Subject|8|||
48566709|NCT00298272|156267227|FG001|Double-blind Phase|Failure to Return|0|||
48566710|NCT00298272|156267226|FG000|Double-blind Phase|Protocol Violation|2|||
48566711|NCT00298272|156267227|FG001|Double-blind Phase|Protocol Violation|0|||
48566712|NCT00298272|156267226|FG000|Double-blind Phase|Withdrawal by Subject|2|||
48566713|NCT00298272|156267227|FG001|Double-blind Phase|Withdrawal by Subject|0|||
48566714|NCT00298272|156267226|FG000|Open Label Retreatment Phase|Adverse Event|1|||
48566715|NCT00298272|156267227|FG001|Open Label Retreatment Phase|Adverse Event|2|||
48566716|NCT00298272|156267226|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
48566717|NCT00298272|156267227|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
48566718|NCT00298272|156267226|FG000|Open Label Retreatment Phase|Failure to Return|1|||
48566719|NCT00298272|156267227|FG001|Open Label Retreatment Phase|Failure to Return|0|||
48566720|NCT00298272|156267226|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
48566721|NCT00298272|156267227|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
48566722|NCT00298272|156267226|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
48566723|NCT00298272|156267227|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
48566724|NCT00298272|156267226|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
48566725|NCT00298272|156267227|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
48566726|NCT00298272|156267226|FG000|Safety Follow-up Phase|Failure to Return|1|||
48566727|NCT00298272|156267227|FG001|Safety Follow-up Phase|Failure to Return|1|||
48566728|NCT00298272|156267226|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
48566729|NCT00298272|156267227|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
48566730|NCT00298272|156267226|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
48566731|NCT00298272|156267227|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
48566732|NCT01164579|156267236|FG000|Overall Study|Lack of Efficacy|0|||
48566733|NCT01164579|156267237|FG001|Overall Study|Lack of Efficacy|0|||
48566734|NCT01164579|156267238|FG002|Overall Study|Lack of Efficacy|6|||
48566735|NCT01164579|156267236|FG000|Overall Study|Lost to Follow-up|1|||
48566736|NCT01164579|156267237|FG001|Overall Study|Lost to Follow-up|1|||
48566737|NCT01164579|156267238|FG002|Overall Study|Lost to Follow-up|0|||
48566738|NCT01164579|156267236|FG000|Overall Study|Withdrawal by Subject|2|||
48566739|NCT01164579|156267237|FG001|Overall Study|Withdrawal by Subject|5|||
48566740|NCT01164579|156267238|FG002|Overall Study|Withdrawal by Subject|3|||
48566741|NCT01164579|156267236|FG000|Overall Study|Protocol Violation|0|||
48566742|NCT01164579|156267237|FG001|Overall Study|Protocol Violation|1|||
48566743|NCT01164579|156267238|FG002|Overall Study|Protocol Violation|2|||
48566744|NCT01164579|156267236|FG000|Overall Study|Adverse Event|4|||
48566745|NCT01164579|156267237|FG001|Overall Study|Adverse Event|2|||
48566746|NCT01164579|156267238|FG002|Overall Study|Adverse Event|5|||
48566747|NCT01164579|156267236|FG000|Overall Study|Reason not specified|1|||
48566748|NCT01164579|156267237|FG001|Overall Study|Reason not specified|0|||
48566749|NCT01164579|156267238|FG002|Overall Study|Reason not specified|0|||
48566750|NCT03340454|156267241|FG000|Overall Study|Lost to Follow-up|0|||
48617288|NCT00835978|156456203|FG000|Overall Study|Death|33|||
48617289|NCT00835978|156456204|FG001|Overall Study|Death|40|||
48617290|NCT00835978|156456205|FG002|Overall Study|Death|49|||
48617291|NCT00835978|156456206|FG003|Overall Study|Death|4|||
48617292|NCT00835978|156456203|FG000|Overall Study|Lost to Follow-up|3|||
48617293|NCT00835978|156456204|FG001|Overall Study|Lost to Follow-up|4|||
48566751|NCT03340454|156267242|FG001|Overall Study|Lost to Follow-up|4|||
48566752|NCT02042014|156267244|FG000|Overall Study|Adverse Event|1|||
48566753|NCT02042014|156267244|FG000|Overall Study|Physician Decision|7|||
48566754|NCT02844543|156267248|FG000|Overall Study|Withdrawal by Subject|4|||
48566755|NCT02844543|156267248|FG000|Overall Study|Did not meet eligibility criteria|1|||
48566756|NCT02198664|156267249|FG000|Overall Study|Adverse Event|2|||
48566757|NCT02198664|156267250|FG001|Overall Study|Adverse Event|0|||
48566758|NCT02198664|156267249|FG000|Overall Study|Withdrawal by Subject|11|||
48566759|NCT02198664|156267250|FG001|Overall Study|Withdrawal by Subject|8|||
48566760|NCT02198664|156267249|FG000|Overall Study|Failure to tolerate|2|||
48566761|NCT02198664|156267250|FG001|Overall Study|Failure to tolerate|0|||
48566762|NCT02198664|156267249|FG000|Overall Study|Not stated|1|||
48566763|NCT02198664|156267250|FG001|Overall Study|Not stated|0|||
48566764|NCT02556775|156267251|FG000|Overall Study|Withdrawal by Subject|1|||
48566765|NCT02556775|156267252|FG001|Overall Study|Withdrawal by Subject|0|||
48566766|NCT02556775|156267253|FG002|Overall Study|Withdrawal by Subject|1|||
48566767|NCT02556775|156267254|FG003|Overall Study|Withdrawal by Subject|0|||
48566768|NCT02556775|156267251|FG000|Overall Study|Lost to Follow-up|1|||
48566769|NCT02556775|156267252|FG001|Overall Study|Lost to Follow-up|0|||
48566770|NCT02556775|156267253|FG002|Overall Study|Lost to Follow-up|0|||
48566771|NCT02556775|156267254|FG003|Overall Study|Lost to Follow-up|0|||
48566772|NCT01346059|156267255|FG000|Overall Study|Withdrawal by Subject|1|||
48566773|NCT01346059|156267256|FG001|Overall Study|Withdrawal by Subject|0|||
48566774|NCT00777296|156267257|FG000|Overall Study|Adverse Event|0|||
48566775|NCT00777296|156267258|FG001|Overall Study|Adverse Event|1|||
48566776|NCT00777296|156267259|FG002|Overall Study|Adverse Event|0|||
48566777|NCT00777296|156267260|FG003|Overall Study|Adverse Event|1|||
48566778|NCT00777296|156267257|FG000|Overall Study|Withdrawal by Subject|1|||
48566779|NCT00777296|156267258|FG001|Overall Study|Withdrawal by Subject|0|||
48566780|NCT00777296|156267259|FG002|Overall Study|Withdrawal by Subject|0|||
48566781|NCT00777296|156267260|FG003|Overall Study|Withdrawal by Subject|0|||
48566782|NCT00777296|156267257|FG000|Overall Study|CRF form not completed|0|||
48566783|NCT00777296|156267258|FG001|Overall Study|CRF form not completed|0|||
48566784|NCT00777296|156267259|FG002|Overall Study|CRF form not completed|2|||
48566785|NCT00777296|156267260|FG003|Overall Study|CRF form not completed|0|||
48566786|NCT02211209|156267270|FG000|Overall Study|Investigator judgment|0|||
48566787|NCT02211209|156267271|FG001|Overall Study|Investigator judgment|1|||
48566788|NCT02211209|156267270|FG000|Overall Study|Voluntary withdrawal|1|||
48566789|NCT02211209|156267271|FG001|Overall Study|Voluntary withdrawal|4|||
48566790|NCT02211209|156267270|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
48566791|NCT02211209|156267271|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
48566792|NCT02211209|156267270|FG000|Overall Study|Reason Not Specified|1|||
48566793|NCT02211209|156267271|FG001|Overall Study|Reason Not Specified|0|||
48566794|NCT00507455|156267272|FG000|Overall Study|Adverse Event|3|||
48566795|NCT00507455|156267273|FG001|Overall Study|Adverse Event|3|||
48566796|NCT00507455|156267274|FG002|Overall Study|Adverse Event|6|||
48566797|NCT00507455|156267272|FG000|Overall Study|Withdrawal by Subject|2|||
48566798|NCT00507455|156267273|FG001|Overall Study|Withdrawal by Subject|1|||
48566799|NCT00507455|156267274|FG002|Overall Study|Withdrawal by Subject|2|||
48566800|NCT00507455|156267272|FG000|Overall Study|Protocol Violation|4|||
48566801|NCT00507455|156267273|FG001|Overall Study|Protocol Violation|1|||
48566802|NCT00507455|156267274|FG002|Overall Study|Protocol Violation|1|||
48566803|NCT00507455|156267272|FG000|Overall Study|Lost to Follow-up|2|||
48566804|NCT00507455|156267273|FG001|Overall Study|Lost to Follow-up|0|||
48566805|NCT00507455|156267274|FG002|Overall Study|Lost to Follow-up|2|||
48566806|NCT00507455|156267272|FG000|Overall Study|Lack of Efficacy|0|||
48566807|NCT00507455|156267273|FG001|Overall Study|Lack of Efficacy|1|||
48566808|NCT00507455|156267274|FG002|Overall Study|Lack of Efficacy|0|||
48566809|NCT00507455|156267272|FG000|Overall Study|Other - miscellaneous reason|1|||
48566810|NCT00507455|156267273|FG001|Overall Study|Other - miscellaneous reason|0|||
48566811|NCT00507455|156267274|FG002|Overall Study|Other - miscellaneous reason|1|||
48566812|NCT03876743|156267275|FG000|Overall Study|Lost to Follow-up|6|||
48566813|NCT03876743|156267276|FG001|Overall Study|Lost to Follow-up|4|||
48566814|NCT03876743|156267277|FG002|Overall Study|Lost to Follow-up|4|||
48566815|NCT03876743|156267278|FG003|Overall Study|Lost to Follow-up|7|||
48566816|NCT03889418|156267279|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
48566817|NCT03889418|156267280|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566818|NCT03889418|156267281|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566819|NCT03889418|156267282|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566820|NCT03889418|156267283|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566821|NCT03889418|156267284|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566822|NCT03889418|156267285|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566823|NCT03889418|156267286|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566824|NCT03889418|156267287|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566825|NCT03889418|156267288|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
48566826|NCT03889418|156267279|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
48566827|NCT03889418|156267280|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
48566828|NCT03889418|156267281|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
48566829|NCT03889418|156267282|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
48566830|NCT03889418|156267283|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
48566831|NCT03889418|156267284|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
48566832|NCT03889418|156267285|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
48566833|NCT03889418|156267286|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
48566834|NCT03889418|156267287|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
48566835|NCT03889418|156267288|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
48566836|NCT03889418|156267279|FG000|October-December 2019 (Month 7-9)|Death|0|||
48566837|NCT03889418|156267280|FG001|October-December 2019 (Month 7-9)|Death|0|||
48566838|NCT03889418|156267281|FG002|October-December 2019 (Month 7-9)|Death|0|||
48566839|NCT03889418|156267282|FG003|October-December 2019 (Month 7-9)|Death|0|||
48566840|NCT03889418|156267283|FG004|October-December 2019 (Month 7-9)|Death|0|||
48566841|NCT03889418|156267284|FG005|October-December 2019 (Month 7-9)|Death|0|||
48566842|NCT03889418|156267285|FG006|October-December 2019 (Month 7-9)|Death|0|||
48566843|NCT03889418|156267286|FG007|October-December 2019 (Month 7-9)|Death|0|||
48566844|NCT03889418|156267287|FG008|October-December 2019 (Month 7-9)|Death|1|||
48566845|NCT03889418|156267288|FG009|October-December 2019 (Month 7-9)|Death|0|||
48566846|NCT03889418|156267279|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
48566847|NCT03889418|156267280|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
48566848|NCT03889418|156267281|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
48566849|NCT03889418|156267282|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
48566850|NCT03889418|156267283|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
48566851|NCT03889418|156267284|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
48566852|NCT03889418|156267285|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
48566853|NCT03889418|156267286|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
48566854|NCT03889418|156267287|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
48566855|NCT03889418|156267288|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
48566856|NCT03889418|156267279|FG000|April - June 2020 (Month 13-15)|Death|0|||
48566857|NCT03889418|156267280|FG001|April - June 2020 (Month 13-15)|Death|1|||
48566858|NCT03889418|156267281|FG002|April - June 2020 (Month 13-15)|Death|0|||
48566859|NCT03889418|156267282|FG003|April - June 2020 (Month 13-15)|Death|0|||
48566860|NCT03889418|156267283|FG004|April - June 2020 (Month 13-15)|Death|0|||
48566861|NCT03889418|156267284|FG005|April - June 2020 (Month 13-15)|Death|0|||
48566862|NCT03889418|156267285|FG006|April - June 2020 (Month 13-15)|Death|0|||
48566863|NCT03889418|156267286|FG007|April - June 2020 (Month 13-15)|Death|0|||
48566864|NCT03889418|156267287|FG008|April - June 2020 (Month 13-15)|Death|0|||
48566865|NCT03889418|156267288|FG009|April - June 2020 (Month 13-15)|Death|0|||
48566866|NCT03889418|156267279|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566867|NCT03889418|156267280|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566868|NCT03889418|156267281|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566869|NCT03889418|156267282|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
48566870|NCT03889418|156267283|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566871|NCT03889418|156267284|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566872|NCT03889418|156267285|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566873|NCT03889418|156267286|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566874|NCT03889418|156267287|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566875|NCT03889418|156267288|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
48566876|NCT03889418|156267279|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
48566877|NCT03889418|156267280|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
48566878|NCT03889418|156267281|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
48566879|NCT03889418|156267282|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
48566880|NCT03889418|156267283|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
48566881|NCT03889418|156267284|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
48566882|NCT03889418|156267285|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
48566883|NCT03889418|156267286|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
48566884|NCT03889418|156267287|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
48566885|NCT03889418|156267288|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
48566886|NCT03889418|156267279|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
48566887|NCT03889418|156267280|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
48566888|NCT03889418|156267281|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
48566889|NCT03889418|156267282|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
48566890|NCT03889418|156267283|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
48566891|NCT03889418|156267284|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
48566892|NCT03889418|156267285|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
48566893|NCT03889418|156267286|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
48566894|NCT03889418|156267287|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
48566895|NCT03889418|156267288|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
48566896|NCT02019264|156267289|FG000|Overall Study|Not treated|6|||
48566897|NCT02019264|156267290|FG001|Overall Study|Not treated|4|||
48566898|NCT02019264|156267289|FG000|Overall Study|Lost to Follow-up|50|||
48566899|NCT02019264|156267290|FG001|Overall Study|Lost to Follow-up|47|||
48566900|NCT02019264|156267289|FG000|Overall Study|Withdrawal by Subject|142|||
48566901|NCT02019264|156267290|FG001|Overall Study|Withdrawal by Subject|117|||
48566902|NCT02019264|156267289|FG000|Overall Study|Administrative reason|36|||
48566903|NCT02019264|156267290|FG001|Overall Study|Administrative reason|28|||
48566904|NCT02019264|156267289|FG000|Overall Study|Missing|14|||
48566905|NCT02019264|156267290|FG001|Overall Study|Missing|11|||
48566906|NCT06110494|156267293|FG000|Overall Study|Protocol Violation|2|||
48566907|NCT06110494|156267294|FG001|Overall Study|Protocol Violation|0|||
48566908|NCT06110494|156267295|FG002|Overall Study|Protocol Violation|1|||
48566909|NCT06110494|156267293|FG000|Overall Study|Dixon's test for outlier analysis|1|||
48566910|NCT06110494|156267294|FG001|Overall Study|Dixon's test for outlier analysis|1|||
48566911|NCT06110494|156267295|FG002|Overall Study|Dixon's test for outlier analysis|0|||
48566912|NCT00427648|156267297|FG000|Overall Study|Protocol Violation|1|||
48566913|NCT00427648|156267298|FG001|Overall Study|Protocol Violation|2|||
48566914|NCT00427648|156267297|FG000|Overall Study|Adverse Event|0|||
48566915|NCT00427648|156267298|FG001|Overall Study|Adverse Event|1|||
48566916|NCT03570619|156267301|FG000|Overall Study|Adverse Event|2|||
48566917|NCT03570619|156267302|FG001|Overall Study|Adverse Event|0|||
48566918|NCT03570619|156267303|FG002|Overall Study|Adverse Event|1|||
48566919|NCT03570619|156267301|FG000|Overall Study|new diagnosis of new malignancy|1|||
48566920|NCT03570619|156267302|FG001|Overall Study|new diagnosis of new malignancy|0|||
48566921|NCT03570619|156267303|FG002|Overall Study|new diagnosis of new malignancy|0|||
48566922|NCT03570619|156267301|FG000|Overall Study|Physician Decision|1|||
48566923|NCT03570619|156267302|FG001|Overall Study|Physician Decision|1|||
48566924|NCT03570619|156267303|FG002|Overall Study|Physician Decision|0|||
48566925|NCT03570619|156267301|FG000|Overall Study|Withdrawal by Subject|0|||
48566926|NCT03570619|156267302|FG001|Overall Study|Withdrawal by Subject|2|||
48566927|NCT03570619|156267303|FG002|Overall Study|Withdrawal by Subject|0|||
48566928|NCT01297517|156267304|FG000|Overall Study|Adverse Event|21|||
48566929|NCT01297517|156267305|FG001|Overall Study|Adverse Event|7|||
48566930|NCT01297517|156267306|FG002|Overall Study|Adverse Event|16|||
48566931|NCT01297517|156267304|FG000|Overall Study|Lost to Follow-up|1|||
48566932|NCT01297517|156267305|FG001|Overall Study|Lost to Follow-up|0|||
48566933|NCT01297517|156267306|FG002|Overall Study|Lost to Follow-up|1|||
48566934|NCT01297517|156267304|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
48566935|NCT01297517|156267305|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
48566936|NCT01297517|156267306|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
48566937|NCT01297517|156267304|FG000|Overall Study|Noncompliance|1|||
48566938|NCT01297517|156267305|FG001|Overall Study|Noncompliance|0|||
48566939|NCT01297517|156267306|FG002|Overall Study|Noncompliance|0|||
48566940|NCT01297517|156267304|FG000|Overall Study|Protocol Violation|1|||
48566941|NCT01297517|156267305|FG001|Overall Study|Protocol Violation|1|||
48566942|NCT01297517|156267306|FG002|Overall Study|Protocol Violation|1|||
48566943|NCT01297517|156267304|FG000|Overall Study|Inadequate Control of IOP|1|||
48566944|NCT01297517|156267305|FG001|Overall Study|Inadequate Control of IOP|1|||
48566945|NCT01297517|156267306|FG002|Overall Study|Inadequate Control of IOP|2|||
48566946|NCT00954941|156267307|FG000|Overall Study|Received treatment at home|1|||
48566947|NCT00954941|156267308|FG001|Overall Study|Received treatment at home|0|||
48566948|NCT00954941|156267307|FG000|Overall Study|Withdrawal by Subject|1|||
48566949|NCT00954941|156267308|FG001|Overall Study|Withdrawal by Subject|0|||
48566950|NCT00954941|156267307|FG000|Overall Study|Insurance Denial|2|||
48566951|NCT00954941|156267308|FG001|Overall Study|Insurance Denial|2|||
48566952|NCT00954941|156267307|FG000|Overall Study|Physician Decision|2|||
48566953|NCT00954941|156267308|FG001|Overall Study|Physician Decision|2|||
48566954|NCT00954941|156267307|FG000|Overall Study|Ineligible|2|||
48566955|NCT00954941|156267308|FG001|Overall Study|Ineligible|2|||
48566956|NCT00954941|156267307|FG000|Overall Study|Adverse Event|0|||
48566957|NCT00954941|156267308|FG001|Overall Study|Adverse Event|1|||
48566958|NCT00410813|156267309|FG000|Overall Study|Adverse Event|6|||
48566959|NCT00410813|156267310|FG001|Overall Study|Adverse Event|11|||
48566960|NCT00410813|156267309|FG000|Overall Study|Progression|32|||
48566961|NCT00410813|156267310|FG001|Overall Study|Progression|21|||
48566962|NCT00410813|156267309|FG000|Overall Study|Not protocol specified|3|||
48566963|NCT00410813|156267310|FG001|Overall Study|Not protocol specified|4|||
48566964|NCT00410813|156267309|FG000|Overall Study|Ineligible|2|||
48566965|NCT00410813|156267310|FG001|Overall Study|Ineligible|4|||
48566966|NCT00410813|156267309|FG000|Overall Study|Death|0|||
48566967|NCT00410813|156267310|FG001|Overall Study|Death|2|||
48566968|NCT01609296|156267311|FG000|Overall Study|Death|253|||
48566969|NCT01609296|156267311|FG000|Overall Study|Withdrawal by Subject|151|||
48566970|NCT01609296|156267311|FG000|Overall Study|Lost to Follow-up|21|||
48566971|NCT01609296|156267311|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
48566972|NCT01609296|156267311|FG000|Overall Study|missed visit but known to be alive|28|||
48566973|NCT01288937|156267312|FG000|Overall Study|Adverse Event|1|||
48566974|NCT01288937|156267313|FG001|Overall Study|Adverse Event|0|||
48566975|NCT01580670|156267314|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
48566976|NCT01580670|156267314|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
48566977|NCT02684097|156267315|FG000|Overall Study|Lack of Efficacy|13|||
48566978|NCT02684097|156267316|FG001|Overall Study|Lack of Efficacy|6|||
48566979|NCT00460811|156267317|FG000|Overall Study|Adverse Event|4|||
48566980|NCT00460811|156267318|FG001|Overall Study|Adverse Event|6|||
48566981|NCT00460811|156267319|FG002|Overall Study|Adverse Event|3|||
48566982|NCT00460811|156267320|FG003|Overall Study|Adverse Event|10|||
48566983|NCT00460811|156267321|FG004|Overall Study|Adverse Event|2|||
48566984|NCT00460811|156267317|FG000|Overall Study|Noncompliance|1|||
48566985|NCT00460811|156267318|FG001|Overall Study|Noncompliance|0|||
48566986|NCT00460811|156267319|FG002|Overall Study|Noncompliance|0|||
48566987|NCT00460811|156267320|FG003|Overall Study|Noncompliance|2|||
48566988|NCT00460811|156267321|FG004|Overall Study|Noncompliance|1|||
48566989|NCT00460811|156267317|FG000|Overall Study|Withdrawal by Subject|7|||
48566990|NCT00460811|156267318|FG001|Overall Study|Withdrawal by Subject|7|||
48566991|NCT00460811|156267319|FG002|Overall Study|Withdrawal by Subject|6|||
48566992|NCT00460811|156267320|FG003|Overall Study|Withdrawal by Subject|3|||
48566993|NCT00460811|156267321|FG004|Overall Study|Withdrawal by Subject|11|||
48566994|NCT00460811|156267317|FG000|Overall Study|Physician Decision|1|||
48566995|NCT00460811|156267318|FG001|Overall Study|Physician Decision|0|||
48566996|NCT00460811|156267319|FG002|Overall Study|Physician Decision|0|||
48566997|NCT00460811|156267320|FG003|Overall Study|Physician Decision|0|||
48566998|NCT00460811|156267321|FG004|Overall Study|Physician Decision|0|||
48566999|NCT00460811|156267317|FG000|Overall Study|Lost to Follow-up|3|||
48567000|NCT00460811|156267318|FG001|Overall Study|Lost to Follow-up|2|||
48567001|NCT00460811|156267319|FG002|Overall Study|Lost to Follow-up|5|||
48567002|NCT00460811|156267320|FG003|Overall Study|Lost to Follow-up|3|||
48567003|NCT00460811|156267321|FG004|Overall Study|Lost to Follow-up|6|||
48567004|NCT00462709|156267322|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
48567005|NCT00462709|156267322|FG000|Overall Study|Lost to Follow-up|10|||
48567006|NCT00462709|156267322|FG000|Overall Study|Withdrawal by Subject|8|||
48567007|NCT00462709|156267322|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
48567008|NCT00462709|156267322|FG000|Overall Study|Death|2|||
48567009|NCT00462709|156267322|FG000|Overall Study|Logistical reasons|2|||
48567010|NCT00462709|156267322|FG000|Overall Study|Physician Decision|1|||
48567011|NCT00462709|156267322|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
48567012|NCT02097745|156267323|FG000|Overall Study|Adverse Event|25|||
48567013|NCT02097745|156267323|FG000|Overall Study|Death|16|||
48567014|NCT02097745|156267323|FG000|Overall Study|Failure to Return|14|||
48567015|NCT02097745|156267323|FG000|Overall Study|Administrative/Other|27|||
48567016|NCT02097745|156267323|FG000|Overall Study|Reason Not Specified|96|||
48567017|NCT02159053|156267324|FG000|Overall Study|Death|2|||
48567018|NCT02159053|156267325|FG001|Overall Study|Death|0|||
48567019|NCT02159053|156267326|FG002|Overall Study|Death|1|||
48567020|NCT02159053|156267324|FG000|Overall Study|Physician Decision|0|||
48567021|NCT02159053|156267325|FG001|Overall Study|Physician Decision|1|||
48567022|NCT02159053|156267326|FG002|Overall Study|Physician Decision|1|||
48567023|NCT02159053|156267324|FG000|Overall Study|Lack of Efficacy|3|||
48567024|NCT02159053|156267325|FG001|Overall Study|Lack of Efficacy|4|||
48567025|NCT02159053|156267326|FG002|Overall Study|Lack of Efficacy|7|||
48567026|NCT02159053|156267324|FG000|Overall Study|Adverse Event|7|||
48567027|NCT02159053|156267325|FG001|Overall Study|Adverse Event|6|||
48567028|NCT02159053|156267326|FG002|Overall Study|Adverse Event|5|||
48567029|NCT02159053|156267324|FG000|Overall Study|Participants/guardian decision|8|||
48567030|NCT02159053|156267325|FG001|Overall Study|Participants/guardian decision|10|||
48567031|NCT02159053|156267326|FG002|Overall Study|Participants/guardian decision|6|||
48567032|NCT02821754|156267327|FG000|Overall Study|Procedure not required prior to amendment change|13|||
48567033|NCT02821754|156267328|FG001|Overall Study|Procedure not required prior to amendment change|11|||
48567034|NCT02821754|156267329|FG002|Overall Study|Procedure not required prior to amendment change|0|||
48567035|NCT02821754|156267327|FG000|Overall Study|Participant's Clinical status|2|||
48567036|NCT02821754|156267328|FG001|Overall Study|Participant's Clinical status|0|||
48567037|NCT02821754|156267329|FG002|Overall Study|Participant's Clinical status|0|||
48567038|NCT02821754|156267327|FG000|Overall Study|Participant removed for noncompliance|1|||
48567039|NCT02821754|156267328|FG001|Overall Study|Participant removed for noncompliance|0|||
48567040|NCT02821754|156267329|FG002|Overall Study|Participant removed for noncompliance|0|||
48567041|NCT02821754|156267327|FG000|Overall Study|Drug not available.|0|||
48567042|NCT02821754|156267328|FG001|Overall Study|Drug not available.|0|||
48567043|NCT02821754|156267329|FG002|Overall Study|Drug not available.|1|||
48567044|NCT02821754|156267327|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
48567045|NCT02821754|156267328|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
48567046|NCT02821754|156267329|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
48567047|NCT02151851|156267340|FG000|Overall Study|Lack of Efficacy|67|||
48567048|NCT02151851|156267341|FG001|Overall Study|Lack of Efficacy|94|||
48567049|NCT02151851|156267340|FG000|Overall Study|Protocol Violation|0|||
48567050|NCT02151851|156267341|FG001|Overall Study|Protocol Violation|1|||
48567051|NCT02151851|156267340|FG000|Overall Study|Withdrawal by Subject|2|||
48567052|NCT02151851|156267341|FG001|Overall Study|Withdrawal by Subject|5|||
48567053|NCT02151851|156267340|FG000|Overall Study|Medical impairment|1|||
48567054|NCT02151851|156267341|FG001|Overall Study|Medical impairment|0|||
48567055|NCT02151851|156267340|FG000|Overall Study|Low compliance to study visits|0|||
48567056|NCT02151851|156267341|FG001|Overall Study|Low compliance to study visits|1|||
48567057|NCT02151851|156267340|FG000|Overall Study|Subject entered into study in error|0|||
48567058|NCT02151851|156267341|FG001|Overall Study|Subject entered into study in error|1|||
48567059|NCT02151851|156267340|FG000|Overall Study|Adverse Event|6|||
48567060|NCT02151851|156267341|FG001|Overall Study|Adverse Event|28|||
48567061|NCT02593097|156267342|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
48567062|NCT02593097|156267343|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
48567063|NCT02593097|156267342|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
48567064|NCT02593097|156267343|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
48567065|NCT02593097|156267342|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
48567066|NCT02593097|156267343|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
48567067|NCT02593097|156267342|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
48617294|NCT00835978|156456205|FG002|Overall Study|Lost to Follow-up|2|||
48617295|NCT00835978|156456206|FG003|Overall Study|Lost to Follow-up|1|||
48617296|NCT00835978|156456203|FG000|Overall Study|Other|5|||
48567068|NCT02593097|156267343|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
48567069|NCT02593097|156267342|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
48567070|NCT02593097|156267343|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
48567071|NCT01896128|156267344|FG000|Overall Study|Withdrawal by Subject|3|||
48567072|NCT01896128|156267345|FG001|Overall Study|Withdrawal by Subject|3|||
48567073|NCT03682848|156267346|FG000|Overall Study|Withdrawal by Subject|2|||
48567074|NCT03682848|156267346|FG000|Overall Study|Site closed|5|||
48567075|NCT03682848|156267346|FG000|Overall Study|Protocol Deviation|1|||
48567076|NCT03682848|156267346|FG000|Overall Study|Adverse Event|1|||
48567077|NCT00961350|156267347|FG000|Overall Study|Adverse Event|18|||
48567078|NCT00961350|156267348|FG001|Overall Study|Adverse Event|33|||
48567079|NCT00961350|156267347|FG000|Overall Study|Withdrawal by Subject|10|||
48567080|NCT00961350|156267348|FG001|Overall Study|Withdrawal by Subject|10|||
48567081|NCT00961350|156267347|FG000|Overall Study|Lost to Follow-up|3|||
48567082|NCT00961350|156267348|FG001|Overall Study|Lost to Follow-up|3|||
48567083|NCT00961350|156267347|FG000|Overall Study|Misc|16|||
48617297|NCT00835978|156456204|FG001|Overall Study|Other|1|||
48617298|NCT00835978|156456205|FG002|Overall Study|Other|8|||
48617299|NCT00835978|156456206|FG003|Overall Study|Other|0|||
48617300|NCT00835978|156456203|FG000|Overall Study|Objective progression or relapse|2|||
48567084|NCT00961350|156267348|FG001|Overall Study|Misc|21|||
48567085|NCT03478644|156267349|FG000|Phase 2|Withdrawal by Subject|2|||
48567086|NCT03478644|156267350|FG001|Phase 2|Withdrawal by Subject|1|||
48567087|NCT03478644|156267349|FG000|Phase 2|Lost to Follow-up|1|||
48567088|NCT03478644|156267350|FG001|Phase 2|Lost to Follow-up|0|||
48617301|NCT00835978|156456204|FG001|Overall Study|Objective progression or relapse|0|||
48617302|NCT00835978|156456205|FG002|Overall Study|Objective progression or relapse|1|||
48617303|NCT00835978|156456206|FG003|Overall Study|Objective progression or relapse|0|||
48617304|NCT00835978|156456203|FG000|Overall Study|Adverse Event|1|||
48567089|NCT01029782|156267354|FG000|Overall Study|Lost to Follow-up|2|||
48567090|NCT01029782|156267355|FG001|Overall Study|Lost to Follow-up|2|||
48567091|NCT01029782|156267354|FG000|Overall Study|Diagnosis changed|1|||
48567092|NCT01029782|156267355|FG001|Overall Study|Diagnosis changed|1|||
48567093|NCT01029782|156267354|FG000|Overall Study|Adverse Event|0|||
48567094|NCT01029782|156267355|FG001|Overall Study|Adverse Event|1|||
48617305|NCT00835978|156456204|FG001|Overall Study|Adverse Event|0|||
48617306|NCT00835978|156456205|FG002|Overall Study|Adverse Event|1|||
48617307|NCT00835978|156456206|FG003|Overall Study|Adverse Event|0|||
48617308|NCT00835978|156456203|FG000|Overall Study|Withdrawal by Subject|0|||
48567095|NCT01029782|156267354|FG000|Overall Study|Physician Decision|0|||
48567096|NCT01029782|156267355|FG001|Overall Study|Physician Decision|1|||
48567097|NCT01029782|156267354|FG000|Overall Study|Protocol Violation|0|||
48567098|NCT01029782|156267355|FG001|Overall Study|Protocol Violation|2|||
48567099|NCT01029782|156267354|FG000|Overall Study|Withdrawal by Subject|0|||
48567100|NCT01029782|156267355|FG001|Overall Study|Withdrawal by Subject|1|||
48567101|NCT03349060|156269109|FG000|Overall Study|Adverse Event|9|||
48567102|NCT03349060|156269110|FG001|Overall Study|Adverse Event|9|||
48567103|NCT03349060|156269111|FG002|Overall Study|Adverse Event|7|||
48567104|NCT03349060|156269109|FG000|Overall Study|Lack of Efficacy|1|||
48567105|NCT03349060|156269110|FG001|Overall Study|Lack of Efficacy|0|||
48567106|NCT03349060|156269111|FG002|Overall Study|Lack of Efficacy|2|||
48567107|NCT03349060|156269109|FG000|Overall Study|Lost to Follow-up|2|||
48567108|NCT03349060|156269110|FG001|Overall Study|Lost to Follow-up|1|||
48567109|NCT03349060|156269111|FG002|Overall Study|Lost to Follow-up|1|||
48567110|NCT03349060|156269109|FG000|Overall Study|Protocol Violation|2|||
48567111|NCT03349060|156269110|FG001|Overall Study|Protocol Violation|2|||
48567112|NCT03349060|156269111|FG002|Overall Study|Protocol Violation|1|||
48567113|NCT03349060|156269109|FG000|Overall Study|Withdrawal by Subject|5|||
48567114|NCT03349060|156269110|FG001|Overall Study|Withdrawal by Subject|3|||
48567115|NCT03349060|156269111|FG002|Overall Study|Withdrawal by Subject|4|||
48567116|NCT03349060|156269109|FG000|Overall Study|Medication error,no linked adverse event|0|||
48567117|NCT03349060|156269110|FG001|Overall Study|Medication error,no linked adverse event|0|||
48567118|NCT03349060|156269111|FG002|Overall Study|Medication error,no linked adverse event|1|||
48567119|NCT03349060|156269109|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48567120|NCT03349060|156269110|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
48567121|NCT03349060|156269111|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
48567122|NCT03349060|156269109|FG000|Overall Study|Other|2|||
48567123|NCT03349060|156269110|FG001|Overall Study|Other|1|||
48567124|NCT03349060|156269111|FG002|Overall Study|Other|0|||
48567125|NCT01068678|156269116|FG000|Overall Study|Lack of Efficacy|3|||
48567126|NCT01068678|156269117|FG001|Overall Study|Lack of Efficacy|2|||
48567127|NCT01068678|156269116|FG000|Overall Study|Protocol Violation|5|||
48567128|NCT01068678|156269117|FG001|Overall Study|Protocol Violation|1|||
48567129|NCT01068678|156269116|FG000|Overall Study|Withdrawal criteria|12|||
48567130|NCT01068678|156269117|FG001|Overall Study|Withdrawal criteria|6|||
48567131|NCT01068678|156269116|FG000|Overall Study|Unclassified|18|||
48567132|NCT01068678|156269117|FG001|Overall Study|Unclassified|15|||
48567133|NCT01996241|156269125|FG000|Overall Study|Lost to Follow-up|252|||
48567134|NCT01996241|156269126|FG001|Overall Study|Lost to Follow-up|235|||
48567135|NCT00086684|156269127|FG000|Overall Study|Adverse Event|12|||
48567136|NCT00086684|156269128|FG001|Overall Study|Adverse Event|17|||
48567137|NCT00086684|156269129|FG002|Overall Study|Adverse Event|14|||
48567138|NCT00086684|156269127|FG000|Overall Study|Lack of Efficacy|6|||
48567139|NCT00086684|156269128|FG001|Overall Study|Lack of Efficacy|6|||
48567140|NCT00086684|156269129|FG002|Overall Study|Lack of Efficacy|5|||
48567141|NCT00086684|156269127|FG000|Overall Study|Lost to Follow-up|15|||
48567142|NCT00086684|156269128|FG001|Overall Study|Lost to Follow-up|8|||
48567143|NCT00086684|156269129|FG002|Overall Study|Lost to Follow-up|10|||
48567144|NCT00086684|156269127|FG000|Overall Study|Protocol Violation|8|||
48567145|NCT00086684|156269128|FG001|Overall Study|Protocol Violation|3|||
48567146|NCT00086684|156269129|FG002|Overall Study|Protocol Violation|0|||
48567147|NCT00086684|156269127|FG000|Overall Study|Withdrawal by Subject|0|||
48567148|NCT00086684|156269128|FG001|Overall Study|Withdrawal by Subject|4|||
48567149|NCT00086684|156269129|FG002|Overall Study|Withdrawal by Subject|10|||
48567150|NCT00086684|156269127|FG000|Overall Study|NONCOMPLIANCE|5|||
48567151|NCT00086684|156269128|FG001|Overall Study|NONCOMPLIANCE|7|||
48567152|NCT00086684|156269129|FG002|Overall Study|NONCOMPLIANCE|6|||
48567153|NCT00086684|156269127|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
48567154|NCT00086684|156269128|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
48567155|NCT00086684|156269129|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
48567156|NCT00086684|156269127|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
48567157|NCT00086684|156269128|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
48567158|NCT00086684|156269129|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
48567159|NCT00086684|156269127|FG000|Overall Study|Other|4|||
48567160|NCT00086684|156269128|FG001|Overall Study|Other|2|||
48567161|NCT00086684|156269129|FG002|Overall Study|Other|3|||
48567162|NCT00915018|156269134|FG000|Overall Study|Death|75|||
48567163|NCT00915018|156269135|FG001|Overall Study|Death|70|||
48567164|NCT00915018|156269134|FG000|Overall Study|Lost to Follow-up|10|||
48567165|NCT00915018|156269135|FG001|Overall Study|Lost to Follow-up|5|||
48567166|NCT00915018|156269134|FG000|Overall Study|Withdrawal by Subject|38|||
48567167|NCT00915018|156269135|FG001|Overall Study|Withdrawal by Subject|27|||
48567168|NCT00915018|156269134|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
48567169|NCT00915018|156269135|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
48567170|NCT01611935|156269136|FG000|Overall Study|Family Declined Participation|1|||
48567171|NCT01611935|156269137|FG001|Overall Study|Family Declined Participation|0|||
48567172|NCT00457002|156269138|FG000|Overall Study|Death|40|||
48567173|NCT00457002|156269139|FG001|Overall Study|Death|47|||
48567174|NCT00457002|156269138|FG000|Overall Study|Adverse Event|284|||
48567175|NCT00457002|156269139|FG001|Overall Study|Adverse Event|260|||
48567176|NCT00457002|156269138|FG000|Overall Study|Withdrawal by Subject|299|||
48567177|NCT00457002|156269139|FG001|Overall Study|Withdrawal by Subject|271|||
48567178|NCT00457002|156269138|FG000|Overall Study|Lost to Follow-up|72|||
48567179|NCT00457002|156269139|FG001|Overall Study|Lost to Follow-up|71|||
48567180|NCT00457002|156269138|FG000|Overall Study|Poor/Non-compliance|46|||
48567181|NCT00457002|156269139|FG001|Overall Study|Poor/Non-compliance|33|||
48567182|NCT00457002|156269138|FG000|Overall Study|No longer met criteria|41|||
48567183|NCT00457002|156269139|FG001|Overall Study|No longer met criteria|37|||
48567184|NCT00457002|156269138|FG000|Overall Study|Administrative reason by Sponsor|1|||
48567185|NCT00457002|156269139|FG001|Overall Study|Administrative reason by Sponsor|0|||
48567186|NCT00457002|156269138|FG000|Overall Study|non-specified|29|||
48567187|NCT00457002|156269139|FG001|Overall Study|non-specified|38|||
48567188|NCT00457002|156269138|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
48567189|NCT00457002|156269139|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
48567190|NCT02547428|156269147|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
48567191|NCT02547428|156269148|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
48567192|NCT02547428|156269147|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
48567193|NCT02547428|156269148|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
48567194|NCT02547428|156269147|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
48567195|NCT02547428|156269148|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
48567196|NCT02547428|156269147|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
48567197|NCT02547428|156269148|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
48567198|NCT02547428|156269147|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
48567199|NCT02547428|156269148|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
48567200|NCT02547428|156269147|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
48567201|NCT02547428|156269148|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
48567202|NCT02547428|156269147|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
48567203|NCT02547428|156269148|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
48567204|NCT02547428|156269147|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
48567205|NCT02547428|156269148|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
48567206|NCT03318861|156269149|FG000|Overall Study|Death|2|||
48567207|NCT03318861|156269150|FG001|Overall Study|Death|3|||
48567208|NCT03318861|156269151|FG002|Overall Study|Death|3|||
48567209|NCT03318861|156269152|FG003|Overall Study|Death|2|||
48567210|NCT03318861|156269153|FG004|Overall Study|Death|2|||
48567211|NCT03318861|156269149|FG000|Overall Study|Enrolled But Never Treated|0|||
48567212|NCT03318861|156269150|FG001|Overall Study|Enrolled But Never Treated|1|||
48567213|NCT03318861|156269151|FG002|Overall Study|Enrolled But Never Treated|0|||
48567214|NCT03318861|156269152|FG003|Overall Study|Enrolled But Never Treated|1|||
48567215|NCT03318861|156269153|FG004|Overall Study|Enrolled But Never Treated|1|||
48567216|NCT03318861|156269149|FG000|Overall Study|Informed Consent Withdraw|0|||
48567217|NCT03318861|156269150|FG001|Overall Study|Informed Consent Withdraw|0|||
48567218|NCT03318861|156269151|FG002|Overall Study|Informed Consent Withdraw|0|||
48567219|NCT03318861|156269152|FG003|Overall Study|Informed Consent Withdraw|1|||
48567220|NCT03318861|156269153|FG004|Overall Study|Informed Consent Withdraw|0|||
48567221|NCT03318861|156269149|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
48567222|NCT03318861|156269150|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
48567223|NCT03318861|156269151|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
48567224|NCT03318861|156269152|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
48567225|NCT03318861|156269153|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
48567226|NCT00917852|156269155|FG000|Overall Study|Death|6|||
48567227|NCT00471081|156269156|FG000|Active Phase|Protocol Violation|1|||
48567228|NCT00471081|156269157|FG001|Active Phase|Protocol Violation|1|||
48567229|NCT00471081|156269156|FG000|Active Phase|Withdrawal by Subject|0|||
48567230|NCT00471081|156269157|FG001|Active Phase|Withdrawal by Subject|3|||
48567231|NCT00471081|156269156|FG000|Active Phase|Lost to Follow-up|0|||
48567232|NCT00471081|156269157|FG001|Active Phase|Lost to Follow-up|1|||
48567233|NCT00471081|156269156|FG000|Active Phase|Lost health plan/insurance|1|||
48567234|NCT00471081|156269157|FG001|Active Phase|Lost health plan/insurance|8|||
48567235|NCT00471081|156269156|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
48567236|NCT00471081|156269157|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
48567237|NCT00471081|156269156|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
48567238|NCT00471081|156269157|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
48567239|NCT00471081|156269156|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
48567240|NCT00471081|156269157|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
48567241|NCT01479465|156269160|FG000|Overall Study|Disease Progression|9|||
48567242|NCT01479465|156269161|FG001|Overall Study|Disease Progression|61|||
48567243|NCT01479465|156269162|FG002|Overall Study|Disease Progression|65|||
48567244|NCT01479465|156269163|FG003|Overall Study|Disease Progression|70|||
48567245|NCT01479465|156269160|FG000|Overall Study|Study Discontinued by Sponsor|0|||
48567246|NCT01479465|156269161|FG001|Overall Study|Study Discontinued by Sponsor|7|||
48567247|NCT01479465|156269162|FG002|Overall Study|Study Discontinued by Sponsor|5|||
48567248|NCT01479465|156269163|FG003|Overall Study|Study Discontinued by Sponsor|3|||
48617309|NCT00835978|156456204|FG001|Overall Study|Withdrawal by Subject|3|||
48567249|NCT01479465|156269160|FG000|Overall Study|Adverse Event|0|||
48567250|NCT01479465|156269161|FG001|Overall Study|Adverse Event|3|||
48567251|NCT01479465|156269162|FG002|Overall Study|Adverse Event|6|||
48567252|NCT01479465|156269163|FG003|Overall Study|Adverse Event|4|||
48567253|NCT01479465|156269160|FG000|Overall Study|Investigator Discretion|1|||
48567254|NCT01479465|156269161|FG001|Overall Study|Investigator Discretion|4|||
48567255|NCT01479465|156269162|FG002|Overall Study|Investigator Discretion|2|||
48567256|NCT01479465|156269163|FG003|Overall Study|Investigator Discretion|4|||
48567257|NCT01479465|156269160|FG000|Overall Study|Subject Request|1|||
48567258|NCT01479465|156269161|FG001|Overall Study|Subject Request|3|||
48567259|NCT01479465|156269162|FG002|Overall Study|Subject Request|4|||
48567260|NCT01479465|156269163|FG003|Overall Study|Subject Request|2|||
48567261|NCT01479465|156269160|FG000|Overall Study|Subject Withdrew Consent|0|||
48567262|NCT01479465|156269161|FG001|Overall Study|Subject Withdrew Consent|5|||
48567263|NCT01479465|156269162|FG002|Overall Study|Subject Withdrew Consent|2|||
48567264|NCT01479465|156269163|FG003|Overall Study|Subject Withdrew Consent|1|||
48567265|NCT01479465|156269160|FG000|Overall Study|Protocol Violation|0|||
48567266|NCT01479465|156269161|FG001|Overall Study|Protocol Violation|1|||
48567267|NCT01479465|156269162|FG002|Overall Study|Protocol Violation|1|||
48567268|NCT01479465|156269163|FG003|Overall Study|Protocol Violation|0|||
48567269|NCT01479465|156269160|FG000|Overall Study|Death|0|||
48567270|NCT01479465|156269161|FG001|Overall Study|Death|0|||
48567271|NCT01479465|156269162|FG002|Overall Study|Death|0|||
48567272|NCT01479465|156269163|FG003|Overall Study|Death|1|||
48567273|NCT01479465|156269160|FG000|Overall Study|Lost to Follow-up|0|||
48567274|NCT01479465|156269161|FG001|Overall Study|Lost to Follow-up|0|||
48567275|NCT01479465|156269162|FG002|Overall Study|Lost to Follow-up|1|||
48567276|NCT01479465|156269163|FG003|Overall Study|Lost to Follow-up|0|||
48567277|NCT03103152|156269171|FG000|Overall Study|Physician Decision|5|||
48567278|NCT03103152|156269172|FG001|Overall Study|Physician Decision|2|||
48567279|NCT03103152|156269173|FG002|Overall Study|Physician Decision|6|||
48567280|NCT03103152|156269174|FG003|Overall Study|Physician Decision|3|||
48567281|NCT03103152|156269175|FG004|Overall Study|Physician Decision|3|||
48567282|NCT03103152|156269176|FG005|Overall Study|Physician Decision|1|||
48567283|NCT03103152|156269171|FG000|Overall Study|Protocol Violation|2|||
48567284|NCT03103152|156269172|FG001|Overall Study|Protocol Violation|2|||
48567285|NCT03103152|156269173|FG002|Overall Study|Protocol Violation|1|||
48567286|NCT03103152|156269174|FG003|Overall Study|Protocol Violation|2|||
48567287|NCT03103152|156269175|FG004|Overall Study|Protocol Violation|1|||
48567288|NCT03103152|156269176|FG005|Overall Study|Protocol Violation|1|||
48567289|NCT03103152|156269171|FG000|Overall Study|Inter-current illness|0|||
48567290|NCT03103152|156269172|FG001|Overall Study|Inter-current illness|0|||
48567291|NCT03103152|156269173|FG002|Overall Study|Inter-current illness|1|||
48567292|NCT03103152|156269174|FG003|Overall Study|Inter-current illness|0|||
48567293|NCT03103152|156269175|FG004|Overall Study|Inter-current illness|0|||
48567294|NCT03103152|156269176|FG005|Overall Study|Inter-current illness|0|||
48567295|NCT03103152|156269171|FG000|Overall Study|Death|0|||
48567296|NCT03103152|156269172|FG001|Overall Study|Death|1|||
48567297|NCT03103152|156269173|FG002|Overall Study|Death|0|||
48567298|NCT03103152|156269174|FG003|Overall Study|Death|0|||
48567299|NCT03103152|156269175|FG004|Overall Study|Death|0|||
48567300|NCT03103152|156269176|FG005|Overall Study|Death|0|||
48567301|NCT03103152|156269171|FG000|Overall Study|Adverse Event|0|||
48567302|NCT03103152|156269172|FG001|Overall Study|Adverse Event|0|||
48567303|NCT03103152|156269173|FG002|Overall Study|Adverse Event|1|||
48567304|NCT03103152|156269174|FG003|Overall Study|Adverse Event|0|||
48567305|NCT03103152|156269175|FG004|Overall Study|Adverse Event|0|||
48567306|NCT03103152|156269176|FG005|Overall Study|Adverse Event|1|||
48567307|NCT03103152|156269171|FG000|Overall Study|Withdrawal by Subject|1|||
48567308|NCT03103152|156269172|FG001|Overall Study|Withdrawal by Subject|0|||
48567309|NCT03103152|156269173|FG002|Overall Study|Withdrawal by Subject|1|||
48567310|NCT03103152|156269174|FG003|Overall Study|Withdrawal by Subject|1|||
48567311|NCT03103152|156269175|FG004|Overall Study|Withdrawal by Subject|1|||
48567312|NCT03103152|156269176|FG005|Overall Study|Withdrawal by Subject|1|||
48567313|NCT03103152|156269171|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
48567314|NCT03103152|156269172|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
48567315|NCT03103152|156269173|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
48567316|NCT03103152|156269174|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
48567317|NCT03103152|156269175|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
48567318|NCT03103152|156269176|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
48567319|NCT03103152|156269171|FG000|Overall Study|Unacceptable side effects|0|||
48567320|NCT03103152|156269172|FG001|Overall Study|Unacceptable side effects|0|||
48567321|NCT03103152|156269173|FG002|Overall Study|Unacceptable side effects|0|||
48567322|NCT03103152|156269174|FG003|Overall Study|Unacceptable side effects|0|||
48567323|NCT03103152|156269175|FG004|Overall Study|Unacceptable side effects|0|||
48567324|NCT03103152|156269176|FG005|Overall Study|Unacceptable side effects|1|||
48567325|NCT03103152|156269171|FG000|Overall Study|Lost to Follow-up|0|||
48567326|NCT03103152|156269172|FG001|Overall Study|Lost to Follow-up|1|||
48567327|NCT03103152|156269173|FG002|Overall Study|Lost to Follow-up|0|||
48567328|NCT03103152|156269174|FG003|Overall Study|Lost to Follow-up|1|||
48567329|NCT03103152|156269175|FG004|Overall Study|Lost to Follow-up|0|||
48567330|NCT03103152|156269176|FG005|Overall Study|Lost to Follow-up|1|||
48567331|NCT03103152|156269171|FG000|Overall Study|Testicular pain|0|||
48567332|NCT03103152|156269172|FG001|Overall Study|Testicular pain|0|||
48567333|NCT03103152|156269173|FG002|Overall Study|Testicular pain|0|||
48567334|NCT03103152|156269174|FG003|Overall Study|Testicular pain|1|||
48567335|NCT03103152|156269175|FG004|Overall Study|Testicular pain|0|||
48567336|NCT03103152|156269176|FG005|Overall Study|Testicular pain|0|||
48567337|NCT00092118|156269177|FG000|Overall Study|Adverse Event|35|||
48567338|NCT00092118|156269178|FG001|Overall Study|Adverse Event|32|||
48567339|NCT00092118|156269177|FG000|Overall Study|Lack of Efficacy|12|||
48567340|NCT00092118|156269178|FG001|Overall Study|Lack of Efficacy|14|||
48567341|NCT00092118|156269177|FG000|Overall Study|Lost to Follow-up|4|||
48567342|NCT00092118|156269178|FG001|Overall Study|Lost to Follow-up|3|||
48567343|NCT00092118|156269177|FG000|Overall Study|Protocol Violation|23|||
48567344|NCT00092118|156269178|FG001|Overall Study|Protocol Violation|25|||
48567345|NCT00092118|156269177|FG000|Overall Study|Withdrawal by Subject|4|||
48567346|NCT00092118|156269178|FG001|Overall Study|Withdrawal by Subject|10|||
48567347|NCT00092118|156269177|FG000|Overall Study|Other|6|||
48567348|NCT00092118|156269178|FG001|Overall Study|Other|5|||
48567349|NCT05027451|156269179|FG000|Overall Study|Lost to Follow-up|1|||
48567350|NCT05027451|156269180|FG001|Overall Study|Lost to Follow-up|1|||
48567351|NCT03123393|156269181|FG000|Overall Study|Study Terminated by Sponsor|6|||
48567352|NCT03123393|156269182|FG001|Overall Study|Study Terminated by Sponsor|9|||
48567353|NCT03123393|156269181|FG000|Overall Study|Withdrawal by Subject|2|||
48567354|NCT03123393|156269182|FG001|Overall Study|Withdrawal by Subject|1|||
48567355|NCT03123393|156269181|FG000|Overall Study|Reason not Specified|13|||
48567356|NCT03123393|156269182|FG001|Overall Study|Reason not Specified|13|||
48567357|NCT00105079|156269185|FG000|Overall Study|Adverse Event|5|||
48567358|NCT00105079|156269186|FG001|Overall Study|Adverse Event|12|||
48567359|NCT00105079|156269185|FG000|Overall Study|Death|3|||
48567360|NCT00105079|156269186|FG001|Overall Study|Death|1|||
48567361|NCT00105079|156269185|FG000|Overall Study|Lost to Follow-up|12|||
48567362|NCT00105079|156269186|FG001|Overall Study|Lost to Follow-up|12|||
48567363|NCT00105079|156269185|FG000|Overall Study|Lack of Efficacy|9|||
48567364|NCT00105079|156269186|FG001|Overall Study|Lack of Efficacy|3|||
48567365|NCT00105079|156269185|FG000|Overall Study|Refused treatment|6|||
48567366|NCT00105079|156269186|FG001|Overall Study|Refused treatment|4|||
48567367|NCT00105079|156269185|FG000|Overall Study|Violation of selection criteria at entry|0|||
48567368|NCT00105079|156269186|FG001|Overall Study|Violation of selection criteria at entry|2|||
48567369|NCT00105079|156269185|FG000|Overall Study|Protocol Violation|1|||
48567370|NCT00105079|156269186|FG001|Overall Study|Protocol Violation|0|||
48567371|NCT00105079|156269185|FG000|Overall Study|Other|3|||
48567372|NCT00105079|156269186|FG001|Overall Study|Other|1|||
48567373|NCT01464593|156269187|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
48567374|NCT01866111|156269188|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
48567375|NCT01866111|156269189|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
48567376|NCT01866111|156269190|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
48567377|NCT01866111|156269191|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
48567378|NCT01866111|156269188|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
48567379|NCT01866111|156269189|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
48567380|NCT01866111|156269190|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
48567381|NCT01866111|156269191|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
48567382|NCT00302328|156269194|FG000|Overall Study|Physician Decision|0|||
48567383|NCT00302328|156269195|FG001|Overall Study|Physician Decision|1|||
48567384|NCT00302328|156269196|FG002|Overall Study|Physician Decision|0|||
48567385|NCT04411810|156269199|FG000|Overall Study|Screen failure|1|||
48567386|NCT04411810|156269199|FG000|Overall Study|Withdrawal by Subject|1|||
48567387|NCT04537234|156269200|FG000|Overall Study|Withdrawal by Subject|2|||
48567388|NCT04537234|156269201|FG001|Overall Study|Withdrawal by Subject|0|||
48567389|NCT01920958|156269202|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
48567390|NCT02490371|156269205|FG000|Overall Study|Lost to Follow-up|1|||
48567391|NCT02490371|156269206|FG001|Overall Study|Lost to Follow-up|1|||
48567392|NCT01718535|156269208|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
48567393|NCT01718535|156269209|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
48567394|NCT01718535|156269210|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
48567395|NCT01718535|156269211|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
48567396|NCT01718535|156269212|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
48567397|NCT01718535|156269213|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
48567398|NCT01718535|156269214|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
48567399|NCT01718535|156269215|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
48567400|NCT01718535|156269216|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
48567401|NCT01718535|156269217|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
48567402|NCT02914613|156269218|FG000|Overall Study|Withdrawal by Subject|1|||
48567403|NCT02914613|156269219|FG001|Overall Study|Withdrawal by Subject|2|||
48567404|NCT02914613|156269218|FG000|Overall Study|Adverse Event|1|||
48567405|NCT02914613|156269219|FG001|Overall Study|Adverse Event|0|||
48567406|NCT01163851|156269222|FG000|Overall Study|Site Closure|0|||
48567407|NCT01163851|156269223|FG001|Overall Study|Site Closure|1|||
48567408|NCT01163851|156269222|FG000|Overall Study|Enrolled but not treated|1|||
48567409|NCT01163851|156269223|FG001|Overall Study|Enrolled but not treated|0|||
48567410|NCT00026494|156269224|FG000|Overall Study|Withdrawal by Subject|1|||
48567411|NCT00026494|156269225|FG001|Overall Study|Withdrawal by Subject|0|||
48567412|NCT00026494|156269226|FG002|Overall Study|Withdrawal by Subject|1|||
48567413|NCT00026494|156269227|FG003|Overall Study|Withdrawal by Subject|0|||
48567414|NCT00026494|156269224|FG000|Overall Study|Patient non-compliance|1|||
48567415|NCT00026494|156269225|FG001|Overall Study|Patient non-compliance|0|||
48567416|NCT00026494|156269226|FG002|Overall Study|Patient non-compliance|0|||
48567417|NCT00026494|156269227|FG003|Overall Study|Patient non-compliance|0|||
48567418|NCT00026494|156269224|FG000|Overall Study|Patient not treated|0|||
48567419|NCT00026494|156269225|FG001|Overall Study|Patient not treated|0|||
48567420|NCT00026494|156269226|FG002|Overall Study|Patient not treated|2|||
48567421|NCT00026494|156269227|FG003|Overall Study|Patient not treated|0|||
48567422|NCT00026494|156269224|FG000|Overall Study|Clinical progression|0|||
48567423|NCT00026494|156269225|FG001|Overall Study|Clinical progression|0|||
48567424|NCT00026494|156269226|FG002|Overall Study|Clinical progression|3|||
48567425|NCT00026494|156269227|FG003|Overall Study|Clinical progression|0|||
48567426|NCT02748356|156269228|FG000|Overall Study|Withdrawal by Subject|1|||
48567427|NCT00478777|156269232|FG000|Overall Study|Adverse Event|29|||
48567428|NCT00478777|156269232|FG000|Overall Study|Lack of Efficacy|23|||
48567429|NCT00478777|156269232|FG000|Overall Study|Withdrawal by Subject|4|||
48567430|NCT00478777|156269232|FG000|Overall Study|Death|3|||
48567431|NCT00478777|156269232|FG000|Overall Study|Protocol Violation|3|||
48567432|NCT00478777|156269232|FG000|Overall Study|Lost to Follow-up|3|||
48567433|NCT00478777|156269232|FG000|Overall Study|Physician Decision|1|||
48567434|NCT00478777|156269232|FG000|Overall Study|Intolerance of therapy|1|||
48567435|NCT00478777|156269232|FG000|Overall Study|Lack of compliance|1|||
48567436|NCT00478777|156269232|FG000|Overall Study|Lymphocytes infusion|1|||
48567437|NCT00478777|156269232|FG000|Overall Study|End of therapy|2|||
48567438|NCT00478777|156269232|FG000|Overall Study|Not treated with lenalidomide|6|||
48567439|NCT00364923|156269233|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
48567440|NCT00364923|156269233|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
48567441|NCT00425750|156269234|FG000|Overall Study|Death|1|||
48567442|NCT00425750|156269234|FG000|Overall Study|Withdrawal by Subject|3|||
48567443|NCT00425750|156269234|FG000|Overall Study|Adverse Event|3|||
48567444|NCT00425750|156269234|FG000|Overall Study|Progression of disease|18|||
48567445|NCT02099110|156269237|FG000|Overall Study|Protocol Violation|2|||
48567446|NCT02099110|156269238|FG001|Overall Study|Protocol Violation|1|||
48567447|NCT02099110|156269239|FG002|Overall Study|Protocol Violation|0|||
48567448|NCT02099110|156269240|FG003|Overall Study|Protocol Violation|3|||
48567449|NCT02099110|156269241|FG004|Overall Study|Protocol Violation|1|||
48567450|NCT02099110|156269237|FG000|Overall Study|Participant moved|1|||
48567451|NCT02099110|156269238|FG001|Overall Study|Participant moved|1|||
48567452|NCT02099110|156269239|FG002|Overall Study|Participant moved|1|||
48567453|NCT02099110|156269240|FG003|Overall Study|Participant moved|0|||
48567454|NCT02099110|156269241|FG004|Overall Study|Participant moved|2|||
48567455|NCT02099110|156269237|FG000|Overall Study|Withdrawal by Subject|7|||
48567456|NCT02099110|156269238|FG001|Overall Study|Withdrawal by Subject|11|||
48567457|NCT02099110|156269239|FG002|Overall Study|Withdrawal by Subject|13|||
48567458|NCT02099110|156269240|FG003|Overall Study|Withdrawal by Subject|9|||
48567459|NCT02099110|156269241|FG004|Overall Study|Withdrawal by Subject|13|||
48567460|NCT02099110|156269237|FG000|Overall Study|Adverse Event|3|||
48567461|NCT02099110|156269238|FG001|Overall Study|Adverse Event|5|||
48567462|NCT02099110|156269239|FG002|Overall Study|Adverse Event|2|||
48567463|NCT02099110|156269240|FG003|Overall Study|Adverse Event|3|||
48567464|NCT02099110|156269241|FG004|Overall Study|Adverse Event|2|||
48567465|NCT02099110|156269237|FG000|Overall Study|Lost to Follow-up|6|||
48567466|NCT02099110|156269238|FG001|Overall Study|Lost to Follow-up|12|||
48567467|NCT02099110|156269239|FG002|Overall Study|Lost to Follow-up|11|||
48567468|NCT02099110|156269240|FG003|Overall Study|Lost to Follow-up|5|||
48567469|NCT02099110|156269241|FG004|Overall Study|Lost to Follow-up|6|||
48567470|NCT02099110|156269237|FG000|Overall Study|Death|0|||
48567471|NCT02099110|156269238|FG001|Overall Study|Death|1|||
48567472|NCT02099110|156269239|FG002|Overall Study|Death|0|||
48567473|NCT02099110|156269240|FG003|Overall Study|Death|0|||
48567474|NCT02099110|156269241|FG004|Overall Study|Death|0|||
48567475|NCT02099110|156269237|FG000|Overall Study|Screen failure|0|||
48567476|NCT02099110|156269238|FG001|Overall Study|Screen failure|0|||
48567477|NCT02099110|156269239|FG002|Overall Study|Screen failure|0|||
48567478|NCT02099110|156269240|FG003|Overall Study|Screen failure|0|||
48567479|NCT02099110|156269241|FG004|Overall Study|Screen failure|1|||
48567480|NCT02099110|156269237|FG000|Overall Study|Non-compliance with study drug|2|||
48567481|NCT02099110|156269238|FG001|Overall Study|Non-compliance with study drug|0|||
48567482|NCT02099110|156269239|FG002|Overall Study|Non-compliance with study drug|0|||
48567483|NCT02099110|156269240|FG003|Overall Study|Non-compliance with study drug|0|||
48567484|NCT02099110|156269241|FG004|Overall Study|Non-compliance with study drug|1|||
48567485|NCT02099110|156269237|FG000|Overall Study|Physician Decision|3|||
48567486|NCT02099110|156269238|FG001|Overall Study|Physician Decision|0|||
48567487|NCT02099110|156269239|FG002|Overall Study|Physician Decision|1|||
48567488|NCT02099110|156269240|FG003|Overall Study|Physician Decision|2|||
48567489|NCT02099110|156269241|FG004|Overall Study|Physician Decision|1|||
48567490|NCT01609010|156269242|FG000|Overall Study|Stable disease (SD)|22|||
48567491|NCT01609010|156269243|FG001|Overall Study|Stable disease (SD)|16|||
48567492|NCT01609010|156269242|FG000|Overall Study|Progressive disease (PD)|8|||
48567493|NCT01609010|156269243|FG001|Overall Study|Progressive disease (PD)|10|||
48567494|NCT01609010|156269242|FG000|Overall Study|Adverse Event|3|||
48567495|NCT01609010|156269243|FG001|Overall Study|Adverse Event|6|||
48567496|NCT01609010|156269242|FG000|Overall Study|Withdrawal by Subject|2|||
48567497|NCT01609010|156269243|FG001|Overall Study|Withdrawal by Subject|2|||
48567498|NCT01609010|156269242|FG000|Overall Study|Other|2|||
48567499|NCT01609010|156269243|FG001|Overall Study|Other|0|||
48567500|NCT01609010|156269242|FG000|Overall Study|Other malignancy|1|||
48567501|NCT01609010|156269243|FG001|Overall Study|Other malignancy|0|||
48567502|NCT01609010|156269242|FG000|Overall Study|Pathology review|2|||
48567503|NCT01609010|156269243|FG001|Overall Study|Pathology review|1|||
48567504|NCT01609010|156269242|FG000|Overall Study|Protocol Violation|1|||
48567505|NCT01609010|156269243|FG001|Overall Study|Protocol Violation|1|||
48567506|NCT01609010|156269242|FG000|Overall Study|New cancer|1|||
48567507|NCT01609010|156269243|FG001|Overall Study|New cancer|0|||
48567508|NCT01609010|156269242|FG000|Overall Study|Lost to Follow-up|1|||
48567509|NCT01609010|156269243|FG001|Overall Study|Lost to Follow-up|1|||
48567510|NCT01435460|156269244|FG000|Overall Study|Adverse Event|2|||
48567511|NCT01435460|156269245|FG001|Overall Study|Adverse Event|1|||
48567512|NCT01435460|156269244|FG000|Overall Study|Lost to Follow-up|6|||
48567513|NCT01435460|156269245|FG001|Overall Study|Lost to Follow-up|1|||
48567514|NCT01435460|156269244|FG000|Overall Study|Withdrawal by Subject|1|||
48567515|NCT01435460|156269245|FG001|Overall Study|Withdrawal by Subject|3|||
48567516|NCT01435460|156269244|FG000|Overall Study|Protocol Violation|0|||
48567517|NCT01435460|156269245|FG001|Overall Study|Protocol Violation|1|||
48567518|NCT01435460|156269244|FG000|Overall Study|Did not meet eligibility criteria|2|||
48567519|NCT01435460|156269245|FG001|Overall Study|Did not meet eligibility criteria|0|||
48567520|NCT04152837|156269252|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
48567521|NCT04152837|156269252|FG000|Maintenance Period|Adverse Event|1|||
48567522|NCT04152837|156269252|FG000|Maintenance Period|Withdrawal by Subject|1|||
48567523|NCT04152837|156269252|FG000|Maintenance Period|Sponsor Termination of Study|2|||
48567524|NCT00586820|156269256|FG000|Overall Study|Unsuccessful PCI|1|||
48567525|NCT00586820|156269257|FG001|Overall Study|Unsuccessful PCI|0|||
48567526|NCT03887442|156269261|FG000|Overall Study|Adverse Event|1|||
48567527|NCT03887442|156269262|FG001|Overall Study|Adverse Event|0|||
48567528|NCT00757042|156269263|FG000|Overall Study|Lost to Follow-up|0|||
48567529|NCT00757042|156269264|FG001|Overall Study|Lost to Follow-up|0|||
48567530|NCT00757042|156269265|FG002|Overall Study|Lost to Follow-up|0|||
48567531|NCT00757042|156269266|FG003|Overall Study|Lost to Follow-up|0|||
48567532|NCT00757042|156269267|FG004|Overall Study|Lost to Follow-up|0|||
48567533|NCT00757042|156269268|FG005|Overall Study|Lost to Follow-up|0|||
48567534|NCT00757042|156269269|FG006|Overall Study|Lost to Follow-up|0|||
48567535|NCT00757042|156269270|FG007|Overall Study|Lost to Follow-up|0|||
48567536|NCT00757042|156269271|FG008|Overall Study|Lost to Follow-up|1|||
48567537|NCT00757042|156269272|FG009|Overall Study|Lost to Follow-up|0|||
48567538|NCT00757042|156269273|FG010|Overall Study|Lost to Follow-up|0|||
48567539|NCT00757042|156269263|FG000|Overall Study|Ineligibility Determined|0|||
48567540|NCT00757042|156269264|FG001|Overall Study|Ineligibility Determined|0|||
48567541|NCT00757042|156269265|FG002|Overall Study|Ineligibility Determined|0|||
48567542|NCT00757042|156269266|FG003|Overall Study|Ineligibility Determined|0|||
48567543|NCT00757042|156269267|FG004|Overall Study|Ineligibility Determined|0|||
48567544|NCT00757042|156269268|FG005|Overall Study|Ineligibility Determined|0|||
48567545|NCT00757042|156269269|FG006|Overall Study|Ineligibility Determined|0|||
48567546|NCT00757042|156269270|FG007|Overall Study|Ineligibility Determined|0|||
48567547|NCT00757042|156269271|FG008|Overall Study|Ineligibility Determined|0|||
48567548|NCT00757042|156269272|FG009|Overall Study|Ineligibility Determined|0|||
48567549|NCT00757042|156269273|FG010|Overall Study|Ineligibility Determined|1|||
48567550|NCT00757042|156269263|FG000|Overall Study|Withdrawal by Subject|0|||
48567551|NCT00757042|156269264|FG001|Overall Study|Withdrawal by Subject|0|||
48567552|NCT00757042|156269265|FG002|Overall Study|Withdrawal by Subject|0|||
48567553|NCT00757042|156269266|FG003|Overall Study|Withdrawal by Subject|0|||
48567554|NCT00757042|156269267|FG004|Overall Study|Withdrawal by Subject|0|||
48567555|NCT00757042|156269268|FG005|Overall Study|Withdrawal by Subject|0|||
48567556|NCT00757042|156269269|FG006|Overall Study|Withdrawal by Subject|0|||
48567557|NCT00757042|156269270|FG007|Overall Study|Withdrawal by Subject|0|||
48567558|NCT00757042|156269271|FG008|Overall Study|Withdrawal by Subject|0|||
48567559|NCT00757042|156269272|FG009|Overall Study|Withdrawal by Subject|1|||
48567560|NCT00757042|156269273|FG010|Overall Study|Withdrawal by Subject|0|||
48567561|NCT03319732|156269278|FG000|Overall Study|Adverse Event|40|||
48567562|NCT03319732|156269278|FG000|Overall Study|Withdrawal by Subject|50|||
48567563|NCT03319732|156269278|FG000|Overall Study|MS relapse|10|||
48567564|NCT03319732|156269278|FG000|Overall Study|reason not specified|5|||
48567565|NCT00556933|156269280|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
48567566|NCT00556933|156269281|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
48567567|NCT00556933|156269282|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
48567568|NCT00556933|156269283|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
48567569|NCT00556933|156269280|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
48567570|NCT00556933|156269281|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
48567571|NCT00556933|156269282|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
48567572|NCT00556933|156269283|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
48567573|NCT00556933|156269280|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
48567574|NCT00556933|156269281|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
48567575|NCT00556933|156269282|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
48567576|NCT00556933|156269283|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
48567577|NCT00556933|156269280|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
48567578|NCT00556933|156269281|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
48567579|NCT00556933|156269282|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
48567580|NCT00556933|156269283|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
48567581|NCT00556933|156269280|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
48567582|NCT00556933|156269281|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
48567583|NCT00556933|156269282|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
48567584|NCT00556933|156269283|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
48567585|NCT00556933|156269280|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
48567586|NCT00556933|156269281|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
48567587|NCT00556933|156269282|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
48567588|NCT00556933|156269283|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
48567589|NCT00556933|156269280|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
48567590|NCT00556933|156269281|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
48567591|NCT00556933|156269282|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
48567592|NCT00556933|156269283|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
48567593|NCT00556933|156269280|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
48567594|NCT00556933|156269281|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
48567595|NCT00556933|156269282|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
48567596|NCT00556933|156269283|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
48567597|NCT00556933|156269280|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
48567598|NCT00556933|156269281|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
48567599|NCT00556933|156269282|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
48567600|NCT00556933|156269283|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
48567601|NCT00556933|156269280|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
48567602|NCT00556933|156269281|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
48567603|NCT00556933|156269282|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
48567604|NCT00556933|156269283|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
48567605|NCT00556933|156269280|FG000|CNI Withdrawal vs. Minimization|Death|0|||
48567606|NCT00556933|156269281|FG001|CNI Withdrawal vs. Minimization|Death|0|||
48567607|NCT00556933|156269282|FG002|CNI Withdrawal vs. Minimization|Death|0|||
48567608|NCT00556933|156269283|FG003|CNI Withdrawal vs. Minimization|Death|1|||
48567609|NCT02654977|156269287|FG000|Overall Study|Death|1|||
48567610|NCT02654977|156269287|FG000|Overall Study|Lost to Follow-up|1|||
48567611|NCT02654977|156269287|FG000|Overall Study|Adverse Event|1|||
48567612|NCT02654977|156269287|FG000|Overall Study|Withdrawal by Subject|1|||
48567613|NCT02654977|156269287|FG000|Overall Study|Lack of Efficacy|3|||
48567614|NCT00430573|156269288|FG000|Overall Study|Withdrawal by Subject|5|||
48567615|NCT01921101|156269289|FG000|Overall Study|Death|16|||
48567616|NCT01921101|156269290|FG001|Overall Study|Death|6|||
48567617|NCT00767455|156269293|FG000|Overall Study|Investigator error|19|||
48567618|NCT01623310|156270772|FG000|Overall Study|Adverse Event|21|||
48567619|NCT01623310|156270772|FG000|Overall Study|Lost to Follow-up|18|||
48567620|NCT01623310|156270772|FG000|Overall Study|Lack of Efficacy|6|||
48567621|NCT01623310|156270772|FG000|Overall Study|Protocol Violation|6|||
48567622|NCT01623310|156270772|FG000|Overall Study|Withdrawal by Subject|25|||
48567623|NCT01623310|156270772|FG000|Overall Study|Became potentially child-bearing|1|||
48567624|NCT01623310|156270772|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
48567625|NCT01623310|156270772|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
48567626|NCT03056638|156270773|FG000|Overall Study|Death|1|||
48567627|NCT03056638|156270774|FG001|Overall Study|Death|0|||
48567628|NCT04168112|156270775|FG000|Overall Study|Lost to Follow-up|1|||
48567629|NCT04168112|156270776|FG001|Overall Study|Lost to Follow-up|0|||
48567630|NCT04168112|156270775|FG000|Overall Study|Withdrawal by Subject|1|||
48567631|NCT04168112|156270776|FG001|Overall Study|Withdrawal by Subject|0|||
48567632|NCT01735916|156270777|FG000|Overall Study|Subject not eligible to be randomized|11|||
48567633|NCT01735916|156270778|FG001|Overall Study|Subject not eligible to be randomized|0|||
48567634|NCT01735916|156270779|FG002|Overall Study|Subject not eligible to be randomized|0|||
48567635|NCT01735916|156270777|FG000|Overall Study|Early termination of study by sponsor|4|||
48567636|NCT01735916|156270778|FG001|Overall Study|Early termination of study by sponsor|19|||
48567637|NCT01735916|156270779|FG002|Overall Study|Early termination of study by sponsor|7|||
48567638|NCT01735916|156270777|FG000|Overall Study|Withdrawal by Subject|3|||
48567639|NCT01735916|156270778|FG001|Overall Study|Withdrawal by Subject|0|||
48567640|NCT01735916|156270779|FG002|Overall Study|Withdrawal by Subject|0|||
48567641|NCT02844933|156270780|FG000|Overall Study|Discontinued due to premature termination of study|3|||
48567642|NCT02844933|156270781|FG001|Overall Study|Discontinued due to premature termination of study|2|||
48567643|NCT02275546|156270788|FG000|Treatment Period 2|Withdrawal by Subject|2|||
48567644|NCT02275546|156270789|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48567645|NCT02275546|156270788|FG000|Treatment Period 2|Protocol Violation|0|||
48567646|NCT02275546|156270789|FG001|Treatment Period 2|Protocol Violation|1|||
48567647|NCT02955355|156270793|FG000|Overall Study|Adverse Event|4|||
48567648|NCT02955355|156270793|FG000|Overall Study|Death|1|||
48567649|NCT02955355|156270793|FG000|Overall Study|Physician Decision|21|||
48567650|NCT02955355|156270793|FG000|Overall Study|Site Terminated by Sponsor|35|||
48567651|NCT02955355|156270793|FG000|Overall Study|Withdrawal by Subject|19|||
48567652|NCT02955355|156270793|FG000|Overall Study|Reason Not Specified|5|||
48567653|NCT02612623|156270794|FG000|Overall Study|Withdrawal by Subject|0|||
48567654|NCT02612623|156270795|FG001|Overall Study|Withdrawal by Subject|1|||
48567655|NCT02612623|156270796|FG002|Overall Study|Withdrawal by Subject|0|||
48567656|NCT02612623|156270797|FG003|Overall Study|Withdrawal by Subject|0|||
48617310|NCT00835978|156456205|FG002|Overall Study|Withdrawal by Subject|0|||
48617311|NCT00835978|156456206|FG003|Overall Study|Withdrawal by Subject|5|||
48567657|NCT02612623|156270794|FG000|Overall Study|Adverse Event|1|||
48567658|NCT02612623|156270795|FG001|Overall Study|Adverse Event|0|||
48567659|NCT02612623|156270796|FG002|Overall Study|Adverse Event|1|||
48567660|NCT02612623|156270797|FG003|Overall Study|Adverse Event|0|||
48567661|NCT04227197|156270798|FG000|Randomization|Protocol Violation|1|||
48567662|NCT04227197|156270799|FG001|Randomization|Protocol Violation|0|||
48567663|NCT04227197|156270798|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
48567664|NCT04227197|156270799|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
48617312|NCT00835978|156456203|FG000|Overall Study|Study terminated by sponsor|12|||
48617313|NCT00835978|156456204|FG001|Overall Study|Study terminated by sponsor|8|||
48617314|NCT00835978|156456205|FG002|Overall Study|Study terminated by sponsor|30|||
48617315|NCT00835978|156456206|FG003|Overall Study|Study terminated by sponsor|0|||
48617316|NCT01013753|156456207|FG000|Overall Study|Adverse Event|8|||
48617317|NCT01013753|156456207|FG000|Overall Study|Protocol Violation|3|||
48617318|NCT01013753|156456207|FG000|Overall Study|Lost to Follow-up|1|||
48617319|NCT01013753|156456207|FG000|Overall Study|Withdrawal by Subject|2|||
48617320|NCT01013753|156456207|FG000|Overall Study|Other|2|||
48617321|NCT04575324|156456208|FG000|Overall Study|Lost to Follow-up|29|||
48617322|NCT04575324|156456209|FG001|Overall Study|Lost to Follow-up|25|||
48617323|NCT04575324|156456208|FG000|Overall Study|Death|1|||
48617324|NCT04575324|156456209|FG001|Overall Study|Death|2|||
48617325|NCT04575324|156456208|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
48567665|NCT04227197|156270798|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
48567666|NCT04227197|156270799|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
48567667|NCT04227197|156270798|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
48567668|NCT04227197|156270799|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
48567669|NCT04227197|156270798|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
48567670|NCT04227197|156270799|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
48567671|NCT04227197|156270798|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
48567672|NCT04227197|156270799|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
48567673|NCT04227197|156270798|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
48567674|NCT04227197|156270799|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
48567675|NCT00833105|156270800|FG000|Overall Study|Withdrawal by Subject|1|||
48567676|NCT00833105|156270800|FG000|Overall Study|Adverse Event|2|||
48567677|NCT00570141|156270801|FG000|Overall Study|Adverse Event|1|||
48567678|NCT00570141|156270801|FG000|Overall Study|Missed visits|1|||
48567679|NCT00570141|156270801|FG000|Overall Study|Lost to Follow-up|1|||
48567680|NCT04390503|156270802|FG000|Overall Study|Physician Decision|2|||
48567681|NCT04390503|156270803|FG001|Overall Study|Physician Decision|1|||
48567682|NCT04390503|156270802|FG000|Overall Study|Adverse Event|1|||
48567683|NCT04390503|156270803|FG001|Overall Study|Adverse Event|0|||
48567684|NCT00356603|156270804|FG000|Overall Study|Other|6|||
48567685|NCT00356603|156270805|FG001|Overall Study|Other|3|||
48567686|NCT03309943|156270806|FG000|Overall Study|Withdrawal by Subject|0|||
48567687|NCT03309943|156270807|FG001|Overall Study|Withdrawal by Subject|1|||
48567688|NCT03309943|156270806|FG000|Overall Study|Inappropriate behavior towards staff|0|||
48567689|NCT03309943|156270807|FG001|Overall Study|Inappropriate behavior towards staff|1|||
48567690|NCT00931255|156270808|FG000|Overall Study|Follow up biopsy not done|2|||
48567691|NCT00931255|156270809|FG001|Overall Study|Follow up biopsy not done|3|||
48567692|NCT00658723|156270810|FG000|Overall Study|Lost to Follow-up|0|||
48567693|NCT00658723|156270811|FG001|Overall Study|Lost to Follow-up|2|||
48567694|NCT00658723|156270812|FG002|Overall Study|Lost to Follow-up|2|||
48567695|NCT00658723|156270810|FG000|Overall Study|Death|2|||
48567696|NCT00658723|156270811|FG001|Overall Study|Death|1|||
48567697|NCT00658723|156270812|FG002|Overall Study|Death|4|||
48567698|NCT00658723|156270810|FG000|Overall Study|Scheduling Issue|1|||
48567699|NCT00658723|156270811|FG001|Overall Study|Scheduling Issue|1|||
48567700|NCT00658723|156270812|FG002|Overall Study|Scheduling Issue|0|||
48567701|NCT00658723|156270810|FG000|Overall Study|Withdrawal by Subject|1|||
48567702|NCT00658723|156270811|FG001|Overall Study|Withdrawal by Subject|0|||
48567703|NCT00658723|156270812|FG002|Overall Study|Withdrawal by Subject|1|||
48567704|NCT01372995|156270813|FG000|Overall Study|Spouse withdrew participant from study|0|||
48567705|NCT01372995|156270814|FG001|Overall Study|Spouse withdrew participant from study|1|||
48567706|NCT01372995|156270815|FG002|Overall Study|Spouse withdrew participant from study|0|||
48567707|NCT01372995|156270813|FG000|Overall Study|Physician Decision|0|||
48567708|NCT01372995|156270814|FG001|Overall Study|Physician Decision|0|||
48567709|NCT01372995|156270815|FG002|Overall Study|Physician Decision|1|||
48567710|NCT00386360|156270827|FG000|Overall Study|Adverse Event|4|||
48567711|NCT00386360|156270828|FG001|Overall Study|Adverse Event|2|||
48567712|NCT00386360|156270827|FG000|Overall Study|Physician Decision|2|||
48567713|NCT00386360|156270828|FG001|Overall Study|Physician Decision|2|||
48567714|NCT00386360|156270827|FG000|Overall Study|Lost to Follow-up|0|||
48567715|NCT00386360|156270828|FG001|Overall Study|Lost to Follow-up|2|||
48567716|NCT00386360|156270827|FG000|Overall Study|Protocol Violation|0|||
48567717|NCT00386360|156270828|FG001|Overall Study|Protocol Violation|3|||
48567718|NCT00386360|156270827|FG000|Overall Study|Withdrawal by Subject|3|||
48567719|NCT00386360|156270828|FG001|Overall Study|Withdrawal by Subject|6|||
48567720|NCT00386360|156270827|FG000|Overall Study|Did not take any study medication|0|||
48567721|NCT00386360|156270828|FG001|Overall Study|Did not take any study medication|2|||
48567722|NCT01314872|156270829|FG000|Treatment Period 1|Protocol Violation|2|||
48567723|NCT01314872|156270830|FG001|Treatment Period 1|Protocol Violation|1|||
48567724|NCT01314872|156270831|FG002|Treatment Period 1|Protocol Violation|1|||
48617326|NCT04575324|156456209|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
48567725|NCT01314872|156270832|FG003|Treatment Period 1|Protocol Violation|0|||
48567726|NCT01314872|156270833|FG004|Treatment Period 1|Protocol Violation|1|||
48567727|NCT01314872|156270834|FG005|Treatment Period 1|Protocol Violation|0|||
48567728|NCT01314872|156270835|FG006|Treatment Period 1|Protocol Violation|0|||
48567729|NCT01314872|156270836|FG007|Treatment Period 1|Protocol Violation|0|||
48567730|NCT01314872|156270837|FG008|Treatment Period 1|Protocol Violation|0|||
48567731|NCT01314872|156270838|FG009|Treatment Period 1|Protocol Violation|1|||
48567732|NCT01314872|156270839|FG010|Treatment Period 1|Protocol Violation|1|||
48567733|NCT01314872|156270840|FG011|Treatment Period 1|Protocol Violation|0|||
48567734|NCT01314872|156270841|FG012|Treatment Period 1|Protocol Violation|0|||
48567735|NCT01314872|156270842|FG013|Treatment Period 1|Protocol Violation|0|||
48617327|NCT02097277|156456210|FG000|Overall Study|Subject no longer meets study criteria|0|||
48567736|NCT01314872|156270843|FG014|Treatment Period 1|Protocol Violation|0|||
48567737|NCT01314872|156270829|FG000|Treatment Period 1|Physician Decision|0|||
48567738|NCT01314872|156270830|FG001|Treatment Period 1|Physician Decision|1|||
48567739|NCT01314872|156270831|FG002|Treatment Period 1|Physician Decision|0|||
48567740|NCT01314872|156270832|FG003|Treatment Period 1|Physician Decision|1|||
48567741|NCT01314872|156270833|FG004|Treatment Period 1|Physician Decision|0|||
48567742|NCT01314872|156270834|FG005|Treatment Period 1|Physician Decision|0|||
48567743|NCT01314872|156270835|FG006|Treatment Period 1|Physician Decision|0|||
48567744|NCT01314872|156270836|FG007|Treatment Period 1|Physician Decision|0|||
48567745|NCT01314872|156270837|FG008|Treatment Period 1|Physician Decision|0|||
48567746|NCT01314872|156270838|FG009|Treatment Period 1|Physician Decision|1|||
48567747|NCT01314872|156270839|FG010|Treatment Period 1|Physician Decision|0|||
48567748|NCT01314872|156270840|FG011|Treatment Period 1|Physician Decision|0|||
48567749|NCT01314872|156270841|FG012|Treatment Period 1|Physician Decision|0|||
48567750|NCT01314872|156270842|FG013|Treatment Period 1|Physician Decision|0|||
48617328|NCT02097277|156456211|FG001|Overall Study|Subject no longer meets study criteria|1|||
48617329|NCT02097277|156456212|FG002|Overall Study|Subject no longer meets study criteria|0|||
48617330|NCT02097277|156456213|FG003|Overall Study|Subject no longer meets study criteria|1|||
48617331|NCT02097277|156456214|FG004|Overall Study|Subject no longer meets study criteria|0|||
48617332|NCT02097277|156456210|FG000|Overall Study|Subject request to discontinue treatment|0|||
48567751|NCT01314872|156270843|FG014|Treatment Period 1|Physician Decision|0|||
48567752|NCT01314872|156270829|FG000|Treatment Period 1|Lack of Efficacy|1|||
48617333|NCT02097277|156456211|FG001|Overall Study|Subject request to discontinue treatment|0|||
48617334|NCT02097277|156456212|FG002|Overall Study|Subject request to discontinue treatment|0|||
48567753|NCT01314872|156270830|FG001|Treatment Period 1|Lack of Efficacy|0|||
48567754|NCT01314872|156270831|FG002|Treatment Period 1|Lack of Efficacy|0|||
48567755|NCT01314872|156270832|FG003|Treatment Period 1|Lack of Efficacy|0|||
48617335|NCT02097277|156456213|FG003|Overall Study|Subject request to discontinue treatment|0|||
48567756|NCT01314872|156270833|FG004|Treatment Period 1|Lack of Efficacy|0|||
48567757|NCT01314872|156270834|FG005|Treatment Period 1|Lack of Efficacy|1|||
48567758|NCT01314872|156270835|FG006|Treatment Period 1|Lack of Efficacy|0|||
48567759|NCT01314872|156270836|FG007|Treatment Period 1|Lack of Efficacy|2|||
48567760|NCT01314872|156270837|FG008|Treatment Period 1|Lack of Efficacy|0|||
48567761|NCT01314872|156270838|FG009|Treatment Period 1|Lack of Efficacy|0|||
48567762|NCT01314872|156270839|FG010|Treatment Period 1|Lack of Efficacy|0|||
48567763|NCT01314872|156270840|FG011|Treatment Period 1|Lack of Efficacy|0|||
48567764|NCT01314872|156270841|FG012|Treatment Period 1|Lack of Efficacy|0|||
48567765|NCT01314872|156270842|FG013|Treatment Period 1|Lack of Efficacy|0|||
48567766|NCT01314872|156270843|FG014|Treatment Period 1|Lack of Efficacy|0|||
48567767|NCT01314872|156270829|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
48567768|NCT01314872|156270830|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
48567769|NCT01314872|156270831|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
48567770|NCT01314872|156270832|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
48567771|NCT01314872|156270833|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
48567772|NCT01314872|156270834|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
48567773|NCT01314872|156270835|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
48567774|NCT01314872|156270836|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
48567775|NCT01314872|156270837|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
48567776|NCT01314872|156270838|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
48567777|NCT01314872|156270839|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
48567778|NCT01314872|156270840|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
48567779|NCT01314872|156270841|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
48567780|NCT01314872|156270842|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
48567781|NCT01314872|156270843|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
48567782|NCT01314872|156270829|FG000|Treatment Period 1|Withdrawal by Subject|3|||
48567783|NCT01314872|156270830|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48567784|NCT01314872|156270831|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48567785|NCT01314872|156270832|FG003|Treatment Period 1|Withdrawal by Subject|2|||
48567786|NCT01314872|156270833|FG004|Treatment Period 1|Withdrawal by Subject|3|||
48567787|NCT01314872|156270834|FG005|Treatment Period 1|Withdrawal by Subject|1|||
48567788|NCT01314872|156270835|FG006|Treatment Period 1|Withdrawal by Subject|3|||
48567789|NCT01314872|156270836|FG007|Treatment Period 1|Withdrawal by Subject|2|||
48567790|NCT01314872|156270837|FG008|Treatment Period 1|Withdrawal by Subject|2|||
48567791|NCT01314872|156270838|FG009|Treatment Period 1|Withdrawal by Subject|2|||
48567792|NCT01314872|156270839|FG010|Treatment Period 1|Withdrawal by Subject|1|||
48567793|NCT01314872|156270840|FG011|Treatment Period 1|Withdrawal by Subject|0|||
48567794|NCT01314872|156270841|FG012|Treatment Period 1|Withdrawal by Subject|0|||
48567795|NCT01314872|156270842|FG013|Treatment Period 1|Withdrawal by Subject|0|||
48567796|NCT01314872|156270843|FG014|Treatment Period 1|Withdrawal by Subject|0|||
48567797|NCT01314872|156270829|FG000|Treatment Period 1|Lost to Follow-up|0|||
48567798|NCT01314872|156270830|FG001|Treatment Period 1|Lost to Follow-up|1|||
48567799|NCT01314872|156270831|FG002|Treatment Period 1|Lost to Follow-up|2|||
48567800|NCT01314872|156270832|FG003|Treatment Period 1|Lost to Follow-up|2|||
48567801|NCT01314872|156270833|FG004|Treatment Period 1|Lost to Follow-up|1|||
48567802|NCT01314872|156270834|FG005|Treatment Period 1|Lost to Follow-up|1|||
48567803|NCT01314872|156270835|FG006|Treatment Period 1|Lost to Follow-up|1|||
48567804|NCT01314872|156270836|FG007|Treatment Period 1|Lost to Follow-up|1|||
48567805|NCT01314872|156270837|FG008|Treatment Period 1|Lost to Follow-up|1|||
48567806|NCT01314872|156270838|FG009|Treatment Period 1|Lost to Follow-up|0|||
48567807|NCT01314872|156270839|FG010|Treatment Period 1|Lost to Follow-up|0|||
48567808|NCT01314872|156270840|FG011|Treatment Period 1|Lost to Follow-up|0|||
48567809|NCT01314872|156270841|FG012|Treatment Period 1|Lost to Follow-up|0|||
48567810|NCT01314872|156270842|FG013|Treatment Period 1|Lost to Follow-up|0|||
48567811|NCT01314872|156270843|FG014|Treatment Period 1|Lost to Follow-up|0|||
48567812|NCT01314872|156270829|FG000|Period 2|Protocol Violation|0|||
48567813|NCT01314872|156270830|FG001|Period 2|Protocol Violation|0|||
48567814|NCT01314872|156270831|FG002|Period 2|Protocol Violation|0|||
48617336|NCT02097277|156456214|FG004|Overall Study|Subject request to discontinue treatment|1|||
48567815|NCT01314872|156270832|FG003|Period 2|Protocol Violation|0|||
48567816|NCT01314872|156270833|FG004|Period 2|Protocol Violation|0|||
48567817|NCT01314872|156270834|FG005|Period 2|Protocol Violation|0|||
48567818|NCT01314872|156270835|FG006|Period 2|Protocol Violation|0|||
48567819|NCT01314872|156270836|FG007|Period 2|Protocol Violation|0|||
48567820|NCT01314872|156270837|FG008|Period 2|Protocol Violation|0|||
48567821|NCT01314872|156270838|FG009|Period 2|Protocol Violation|0|||
48567822|NCT01314872|156270839|FG010|Period 2|Protocol Violation|0|||
48567823|NCT01314872|156270840|FG011|Period 2|Protocol Violation|3|||
48567824|NCT01314872|156270841|FG012|Period 2|Protocol Violation|3|||
48567825|NCT01314872|156270842|FG013|Period 2|Protocol Violation|2|||
48567826|NCT01314872|156270843|FG014|Period 2|Protocol Violation|0|||
48567827|NCT01314872|156270829|FG000|Period 2|Non-compliance with study drug|0|||
48567828|NCT01314872|156270830|FG001|Period 2|Non-compliance with study drug|0|||
48567829|NCT01314872|156270831|FG002|Period 2|Non-compliance with study drug|0|||
48567830|NCT01314872|156270832|FG003|Period 2|Non-compliance with study drug|0|||
48567831|NCT01314872|156270833|FG004|Period 2|Non-compliance with study drug|0|||
48567832|NCT01314872|156270834|FG005|Period 2|Non-compliance with study drug|0|||
48567833|NCT01314872|156270835|FG006|Period 2|Non-compliance with study drug|0|||
48567834|NCT01314872|156270836|FG007|Period 2|Non-compliance with study drug|0|||
48567835|NCT01314872|156270837|FG008|Period 2|Non-compliance with study drug|0|||
48567836|NCT01314872|156270838|FG009|Period 2|Non-compliance with study drug|0|||
48567837|NCT01314872|156270839|FG010|Period 2|Non-compliance with study drug|0|||
48567838|NCT01314872|156270840|FG011|Period 2|Non-compliance with study drug|3|||
48567839|NCT01314872|156270841|FG012|Period 2|Non-compliance with study drug|3|||
48567840|NCT01314872|156270842|FG013|Period 2|Non-compliance with study drug|1|||
48567841|NCT01314872|156270843|FG014|Period 2|Non-compliance with study drug|2|||
48567842|NCT01314872|156270829|FG000|Period 2|Lack of Efficacy|0|||
48567843|NCT01314872|156270830|FG001|Period 2|Lack of Efficacy|0|||
48567844|NCT01314872|156270831|FG002|Period 2|Lack of Efficacy|0|||
48567845|NCT01314872|156270832|FG003|Period 2|Lack of Efficacy|0|||
48567846|NCT01314872|156270833|FG004|Period 2|Lack of Efficacy|0|||
48567847|NCT01314872|156270834|FG005|Period 2|Lack of Efficacy|0|||
48567848|NCT01314872|156270835|FG006|Period 2|Lack of Efficacy|0|||
48567849|NCT01314872|156270836|FG007|Period 2|Lack of Efficacy|0|||
48567850|NCT01314872|156270837|FG008|Period 2|Lack of Efficacy|0|||
48567851|NCT01314872|156270838|FG009|Period 2|Lack of Efficacy|0|||
48567852|NCT01314872|156270839|FG010|Period 2|Lack of Efficacy|0|||
48567853|NCT01314872|156270840|FG011|Period 2|Lack of Efficacy|7|||
48567854|NCT01314872|156270841|FG012|Period 2|Lack of Efficacy|12|||
48567855|NCT01314872|156270842|FG013|Period 2|Lack of Efficacy|9|||
48567856|NCT01314872|156270843|FG014|Period 2|Lack of Efficacy|2|||
48567857|NCT01314872|156270829|FG000|Period 2|Pregnancy|0|||
48567858|NCT01314872|156270830|FG001|Period 2|Pregnancy|0|||
48567859|NCT01314872|156270831|FG002|Period 2|Pregnancy|0|||
48567860|NCT01314872|156270832|FG003|Period 2|Pregnancy|0|||
48567861|NCT01314872|156270833|FG004|Period 2|Pregnancy|0|||
48567862|NCT01314872|156270834|FG005|Period 2|Pregnancy|0|||
48567863|NCT01314872|156270835|FG006|Period 2|Pregnancy|0|||
48567864|NCT01314872|156270836|FG007|Period 2|Pregnancy|0|||
48567865|NCT01314872|156270837|FG008|Period 2|Pregnancy|0|||
48567866|NCT01314872|156270838|FG009|Period 2|Pregnancy|0|||
48567867|NCT01314872|156270839|FG010|Period 2|Pregnancy|0|||
48567868|NCT01314872|156270840|FG011|Period 2|Pregnancy|0|||
48617337|NCT02097277|156456210|FG000|Overall Study|Lost to Follow-up|0|||
48617338|NCT02097277|156456211|FG001|Overall Study|Lost to Follow-up|1|||
48617339|NCT02097277|156456212|FG002|Overall Study|Lost to Follow-up|1|||
48617340|NCT02097277|156456213|FG003|Overall Study|Lost to Follow-up|0|||
48617341|NCT02097277|156456214|FG004|Overall Study|Lost to Follow-up|0|||
48617342|NCT02097277|156456210|FG000|Overall Study|Withdrawal by Subject|2|||
48617343|NCT02097277|156456211|FG001|Overall Study|Withdrawal by Subject|1|||
48617344|NCT02097277|156456212|FG002|Overall Study|Withdrawal by Subject|0|||
48617345|NCT02097277|156456213|FG003|Overall Study|Withdrawal by Subject|1|||
48617346|NCT02097277|156456214|FG004|Overall Study|Withdrawal by Subject|0|||
48617347|NCT02097277|156456210|FG000|Overall Study|Adverse Event|0|||
48617348|NCT02097277|156456211|FG001|Overall Study|Adverse Event|0|||
48617349|NCT02097277|156456212|FG002|Overall Study|Adverse Event|1|||
48617350|NCT02097277|156456213|FG003|Overall Study|Adverse Event|2|||
48617351|NCT02097277|156456214|FG004|Overall Study|Adverse Event|0|||
48617352|NCT02582632|156456216|FG000|Overall Study|Other|1|||
48617353|NCT05427916|156456217|FG000|Overall Study|Adverse Event|3|||
48617354|NCT05427916|156456218|FG001|Overall Study|Adverse Event|0|||
48617355|NCT05427916|156456217|FG000|Overall Study|Lack of Efficacy|6|||
48617356|NCT05427916|156456218|FG001|Overall Study|Lack of Efficacy|0|||
48617357|NCT05427916|156456217|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
48617358|NCT05427916|156456218|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
48617359|NCT01257542|156456221|FG000|Overall Study|Protocol Violation|3|||
48617360|NCT01257542|156456222|FG001|Overall Study|Protocol Violation|5|||
48617361|NCT01257542|156456221|FG000|Overall Study|Withdrawal by Subject|0|||
48617362|NCT01257542|156456222|FG001|Overall Study|Withdrawal by Subject|2|||
48617363|NCT00790933|156456223|FG000|Overall Study|Adverse Event|94|||
48617364|NCT00790933|156456224|FG001|Overall Study|Adverse Event|119|||
48567869|NCT01314872|156270841|FG012|Period 2|Pregnancy|0|||
48567870|NCT01314872|156270842|FG013|Period 2|Pregnancy|0|||
48567871|NCT01314872|156270843|FG014|Period 2|Pregnancy|1|||
48567872|NCT01314872|156270829|FG000|Period 2|Study terminated by Sponsor|0|||
48567873|NCT01314872|156270830|FG001|Period 2|Study terminated by Sponsor|0|||
48567874|NCT01314872|156270831|FG002|Period 2|Study terminated by Sponsor|0|||
48567875|NCT01314872|156270832|FG003|Period 2|Study terminated by Sponsor|0|||
48617365|NCT00790933|156456225|FG002|Overall Study|Adverse Event|65|||
48617366|NCT00790933|156456226|FG003|Overall Study|Adverse Event|5|||
48617367|NCT00790933|156456227|FG004|Overall Study|Adverse Event|69|||
48617368|NCT00790933|156456223|FG000|Overall Study|Protocol Violation(s)|8|||
48617369|NCT00790933|156456224|FG001|Overall Study|Protocol Violation(s)|18|||
48617370|NCT00790933|156456225|FG002|Overall Study|Protocol Violation(s)|7|||
48567876|NCT01314872|156270833|FG004|Period 2|Study terminated by Sponsor|0|||
48567877|NCT01314872|156270834|FG005|Period 2|Study terminated by Sponsor|0|||
48567878|NCT01314872|156270835|FG006|Period 2|Study terminated by Sponsor|0|||
48567879|NCT01314872|156270836|FG007|Period 2|Study terminated by Sponsor|0|||
48567880|NCT01314872|156270837|FG008|Period 2|Study terminated by Sponsor|0|||
48617371|NCT00790933|156456226|FG003|Overall Study|Protocol Violation(s)|0|||
48567881|NCT01314872|156270838|FG009|Period 2|Study terminated by Sponsor|0|||
48567882|NCT01314872|156270839|FG010|Period 2|Study terminated by Sponsor|0|||
48567883|NCT01314872|156270840|FG011|Period 2|Study terminated by Sponsor|2|||
48567884|NCT01314872|156270841|FG012|Period 2|Study terminated by Sponsor|2|||
48567885|NCT01314872|156270842|FG013|Period 2|Study terminated by Sponsor|3|||
48567886|NCT01314872|156270843|FG014|Period 2|Study terminated by Sponsor|0|||
48567887|NCT01314872|156270829|FG000|Period 2|Adverse event, non-fatal|0|||
48567888|NCT01314872|156270830|FG001|Period 2|Adverse event, non-fatal|0|||
48567889|NCT01314872|156270831|FG002|Period 2|Adverse event, non-fatal|0|||
48567890|NCT01314872|156270832|FG003|Period 2|Adverse event, non-fatal|0|||
48567891|NCT01314872|156270833|FG004|Period 2|Adverse event, non-fatal|0|||
48567892|NCT01314872|156270834|FG005|Period 2|Adverse event, non-fatal|0|||
48567893|NCT01314872|156270835|FG006|Period 2|Adverse event, non-fatal|0|||
48567894|NCT01314872|156270836|FG007|Period 2|Adverse event, non-fatal|0|||
48567895|NCT01314872|156270837|FG008|Period 2|Adverse event, non-fatal|0|||
48567896|NCT01314872|156270838|FG009|Period 2|Adverse event, non-fatal|0|||
48567897|NCT01314872|156270839|FG010|Period 2|Adverse event, non-fatal|0|||
48567898|NCT01314872|156270840|FG011|Period 2|Adverse event, non-fatal|13|||
48567899|NCT01314872|156270841|FG012|Period 2|Adverse event, non-fatal|16|||
48567900|NCT01314872|156270842|FG013|Period 2|Adverse event, non-fatal|24|||
48567901|NCT01314872|156270843|FG014|Period 2|Adverse event, non-fatal|9|||
48567902|NCT01314872|156270829|FG000|Period 2|Withdrawal by Subject|0|||
48567903|NCT01314872|156270830|FG001|Period 2|Withdrawal by Subject|0|||
48567904|NCT01314872|156270831|FG002|Period 2|Withdrawal by Subject|0|||
48567905|NCT01314872|156270832|FG003|Period 2|Withdrawal by Subject|0|||
48567906|NCT01314872|156270833|FG004|Period 2|Withdrawal by Subject|0|||
48567907|NCT01314872|156270834|FG005|Period 2|Withdrawal by Subject|0|||
48567908|NCT01314872|156270835|FG006|Period 2|Withdrawal by Subject|0|||
48567909|NCT01314872|156270836|FG007|Period 2|Withdrawal by Subject|0|||
48567910|NCT01314872|156270837|FG008|Period 2|Withdrawal by Subject|0|||
48567911|NCT01314872|156270838|FG009|Period 2|Withdrawal by Subject|0|||
48567912|NCT01314872|156270839|FG010|Period 2|Withdrawal by Subject|0|||
48567913|NCT01314872|156270840|FG011|Period 2|Withdrawal by Subject|14|||
48567914|NCT01314872|156270841|FG012|Period 2|Withdrawal by Subject|17|||
48567915|NCT01314872|156270842|FG013|Period 2|Withdrawal by Subject|12|||
48567916|NCT01314872|156270843|FG014|Period 2|Withdrawal by Subject|4|||
48567917|NCT01314872|156270829|FG000|Period 2|Lost to Follow-up|0|||
48567918|NCT01314872|156270830|FG001|Period 2|Lost to Follow-up|0|||
48567919|NCT01314872|156270831|FG002|Period 2|Lost to Follow-up|0|||
48567920|NCT01314872|156270832|FG003|Period 2|Lost to Follow-up|0|||
48567921|NCT01314872|156270833|FG004|Period 2|Lost to Follow-up|0|||
48567922|NCT01314872|156270834|FG005|Period 2|Lost to Follow-up|0|||
48567923|NCT01314872|156270835|FG006|Period 2|Lost to Follow-up|0|||
48567924|NCT01314872|156270836|FG007|Period 2|Lost to Follow-up|0|||
48567925|NCT01314872|156270837|FG008|Period 2|Lost to Follow-up|0|||
48567926|NCT01314872|156270838|FG009|Period 2|Lost to Follow-up|0|||
48567927|NCT01314872|156270839|FG010|Period 2|Lost to Follow-up|0|||
48567928|NCT01314872|156270840|FG011|Period 2|Lost to Follow-up|6|||
48567929|NCT01314872|156270841|FG012|Period 2|Lost to Follow-up|7|||
48567930|NCT01314872|156270842|FG013|Period 2|Lost to Follow-up|2|||
48567931|NCT01314872|156270843|FG014|Period 2|Lost to Follow-up|6|||
48567932|NCT02230904|156270844|FG000|Overall Study|Safety follow up could not take place|0|||
48567933|NCT02230904|156270845|FG001|Overall Study|Safety follow up could not take place|1|||
48567934|NCT00628212|156270846|FG000|Overall Study|Adverse Event|2|||
48567935|NCT00628212|156270847|FG001|Overall Study|Adverse Event|0|||
48617372|NCT00790933|156456227|FG004|Overall Study|Protocol Violation(s)|12|||
48567936|NCT00628212|156270848|FG002|Overall Study|Adverse Event|1|||
48567937|NCT00628212|156270849|FG003|Overall Study|Adverse Event|2|||
48567938|NCT00628212|156270846|FG000|Overall Study|Physician Decision|1|||
48567939|NCT00628212|156270847|FG001|Overall Study|Physician Decision|1|||
48567940|NCT00628212|156270848|FG002|Overall Study|Physician Decision|2|||
48567941|NCT00628212|156270849|FG003|Overall Study|Physician Decision|3|||
48567942|NCT01592786|156270850|FG000|Overall Study|Adverse Event|60|||
48567943|NCT01592786|156270850|FG000|Overall Study|Lack of Efficacy|19|||
48567944|NCT01592786|156270850|FG000|Overall Study|Protocol Violation|14|||
48567945|NCT01592786|156270850|FG000|Overall Study|Withdrawal by Subject|23|||
48567946|NCT01592786|156270850|FG000|Overall Study|Lost to Follow-up|19|||
48567947|NCT01592786|156270850|FG000|Overall Study|Other|3|||
48567948|NCT02025725|156270851|FG000|Overall Study|Adverse Event|5|||
48567949|NCT02025725|156270852|FG001|Overall Study|Adverse Event|0|||
48567950|NCT02025725|156270851|FG000|Overall Study|Lost to Follow-up|2|||
48567951|NCT02025725|156270852|FG001|Overall Study|Lost to Follow-up|0|||
48617373|NCT00790933|156456223|FG000|Overall Study|Lack of Efficacy|192|||
48617374|NCT00790933|156456224|FG001|Overall Study|Lack of Efficacy|176|||
48617375|NCT00790933|156456225|FG002|Overall Study|Lack of Efficacy|130|||
48567952|NCT02025725|156270851|FG000|Overall Study|Protocol Violation|1|||
48567953|NCT02025725|156270852|FG001|Overall Study|Protocol Violation|1|||
48567954|NCT02025725|156270851|FG000|Overall Study|Withdrawal by Subject|3|||
48567955|NCT02025725|156270852|FG001|Overall Study|Withdrawal by Subject|2|||
48567956|NCT02025725|156270851|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
48567957|NCT02025725|156270852|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
48567958|NCT00610155|156270853|FG000|Period 1|Withdrawal by Subject|0|||
48567959|NCT00610155|156270854|FG001|Period 1|Withdrawal by Subject|0|||
48567960|NCT00610155|156270855|FG002|Period 1|Withdrawal by Subject|1|||
48567961|NCT00610155|156270856|FG003|Period 1|Withdrawal by Subject|0|||
48567962|NCT00610155|156270857|FG004|Period 1|Withdrawal by Subject|0|||
48567963|NCT00610155|156270858|FG005|Period 1|Withdrawal by Subject|0|||
48567964|NCT00610155|156270853|FG000|Period 3|Adverse Event|1|||
48567965|NCT00610155|156270854|FG001|Period 3|Adverse Event|0|||
48567966|NCT00610155|156270855|FG002|Period 3|Adverse Event|0|||
48567967|NCT00610155|156270856|FG003|Period 3|Adverse Event|0|||
48567968|NCT00610155|156270857|FG004|Period 3|Adverse Event|0|||
48567969|NCT00610155|156270858|FG005|Period 3|Adverse Event|0|||
48567970|NCT00347958|156270861|FG000|Overall Study|Adverse Event|1|||
48567971|NCT00347958|156270861|FG000|Overall Study|Protocol Violation|2|||
48567972|NCT00347958|156270861|FG000|Overall Study|Withdrawal by Subject|1|||
48567973|NCT01464424|156270862|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
48567974|NCT01464424|156270863|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
48567975|NCT01560234|156270864|FG000|Overall Study|Lost to Follow-up|3|||
48567976|NCT01560234|156270865|FG001|Overall Study|Lost to Follow-up|0|||
48567977|NCT01560234|156270866|FG002|Overall Study|Lost to Follow-up|1|||
48567978|NCT01560234|156270867|FG003|Overall Study|Lost to Follow-up|0|||
48567979|NCT01560234|156270868|FG004|Overall Study|Lost to Follow-up|0|||
48567980|NCT01560234|156270869|FG005|Overall Study|Lost to Follow-up|2|||
48567981|NCT01560234|156270870|FG006|Overall Study|Lost to Follow-up|0|||
48567982|NCT01560234|156270871|FG007|Overall Study|Lost to Follow-up|2|||
48567983|NCT01464333|156270876|FG000|Overall Study|Adverse Event|34|||
48617376|NCT00790933|156456226|FG003|Overall Study|Lack of Efficacy|1|||
48567984|NCT01464333|156270876|FG000|Overall Study|Lack of Efficacy|72|||
48567985|NCT01464333|156270876|FG000|Overall Study|Withdrawal by Subject|11|||
48567986|NCT01464333|156270876|FG000|Overall Study|Other|4|||
48567987|NCT01464333|156270876|FG000|Overall Study|No Hospital Visit|42|||
48567988|NCT03482453|156270877|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567989|NCT03482453|156270878|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567990|NCT03482453|156270879|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567991|NCT03482453|156270880|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567992|NCT03482453|156270881|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567993|NCT03482453|156270882|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567994|NCT03482453|156270883|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567995|NCT03482453|156270884|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567996|NCT03482453|156270885|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567997|NCT03482453|156270886|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48567998|NCT03482453|156270887|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
48567999|NCT03482453|156270888|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
48568000|NCT01726270|156270889|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
48568001|NCT01726270|156270889|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
48568002|NCT01726270|156270889|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
48568003|NCT01726270|156270889|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
48568004|NCT01726270|156270889|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
48568005|NCT01726270|156270889|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
48568006|NCT01073605|156270891|FG000|Overall Study|Ongoing at Cutoff Date|1|||
48568007|NCT01073605|156270892|FG001|Overall Study|Ongoing at Cutoff Date|1|||
48568008|NCT01073605|156270893|FG002|Overall Study|Ongoing at Cutoff Date|0|||
48568009|NCT01073605|156270891|FG000|Overall Study|Adverse Event|2|||
48568010|NCT01073605|156270892|FG001|Overall Study|Adverse Event|1|||
48568011|NCT01073605|156270893|FG002|Overall Study|Adverse Event|0|||
48568012|NCT01073605|156270891|FG000|Overall Study|Lost to Follow-up|3|||
48568013|NCT01073605|156270892|FG001|Overall Study|Lost to Follow-up|4|||
48568014|NCT01073605|156270893|FG002|Overall Study|Lost to Follow-up|9|||
48568015|NCT01073605|156270891|FG000|Overall Study|Other|25|||
48568016|NCT01073605|156270892|FG001|Overall Study|Other|21|||
48568017|NCT01073605|156270893|FG002|Overall Study|Other|29|||
48568018|NCT01073605|156270891|FG000|Overall Study|Withdrawal by Subject|31|||
48568019|NCT01073605|156270892|FG001|Overall Study|Withdrawal by Subject|39|||
48568020|NCT01073605|156270893|FG002|Overall Study|Withdrawal by Subject|22|||
48568021|NCT01073605|156270891|FG000|Overall Study|Randomized But Not Treated|0|||
48568022|NCT01073605|156270892|FG001|Overall Study|Randomized But Not Treated|1|||
48568023|NCT01073605|156270893|FG002|Overall Study|Randomized But Not Treated|1|||
48568024|NCT02187198|156270894|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
48568025|NCT02187198|156270895|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
48568026|NCT02187198|156270894|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
48568027|NCT02187198|156270895|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
48568028|NCT00546377|156270896|FG000|Overall Study|Deemed ineligible|1|||
48568029|NCT00546377|156270896|FG000|Overall Study|Adverse Event|6|||
48568030|NCT02068508|156270897|FG000|Overall Study|Case report forms uncollected|27|||
48568031|NCT02068508|156270897|FG000|Overall Study|Patient did not visit the study site|1|||
48568032|NCT02068508|156270897|FG000|Overall Study|Protocol Violation|4|||
48568033|NCT02064816|156270898|FG000|Overall Study|Adverse Event|3|||
48568034|NCT02064816|156270899|FG001|Overall Study|Adverse Event|2|||
48568035|NCT02064816|156270898|FG000|Overall Study|Withdrawal by Subject|2|||
48568036|NCT02064816|156270899|FG001|Overall Study|Withdrawal by Subject|1|||
48568037|NCT02064816|156270898|FG000|Overall Study|Lost to Follow-up|2|||
48568038|NCT02064816|156270899|FG001|Overall Study|Lost to Follow-up|1|||
48568039|NCT02064816|156270898|FG000|Overall Study|Therapeutic failure|0|||
48568040|NCT02064816|156270899|FG001|Overall Study|Therapeutic failure|1|||
48568041|NCT02064816|156270898|FG000|Overall Study|Other|1|||
48568042|NCT02064816|156270899|FG001|Overall Study|Other|3|||
48568043|NCT03278613|156270900|FG000|Overall Study|Lost to Follow-up|3|||
48568044|NCT03278613|156270901|FG001|Overall Study|Lost to Follow-up|1|||
48568045|NCT01218087|156270906|FG000|Overall Study|Death|2|||
48568046|NCT01218087|156270907|FG001|Overall Study|Death|1|||
48568047|NCT01218087|156270906|FG000|Overall Study|Withdrawal by Subject|5|||
48568048|NCT01218087|156270907|FG001|Overall Study|Withdrawal by Subject|0|||
48568049|NCT01218087|156270906|FG000|Overall Study|Transferred|8|||
48568050|NCT01218087|156270907|FG001|Overall Study|Transferred|5|||
48617377|NCT00790933|156456227|FG004|Overall Study|Lack of Efficacy|121|||
48568051|NCT02195869|156270908|FG000|Overall Study|cGVHD Progression|5|||
48568052|NCT02195869|156270908|FG000|Overall Study|Malignancy Progression/relapse|2|||
48568053|NCT02195869|156270908|FG000|Overall Study|Adverse Event|15|||
48568054|NCT02195869|156270908|FG000|Overall Study|Withdrawal by Subject|7|||
48568055|NCT02195869|156270908|FG000|Overall Study|Physician Decision|4|||
48568056|NCT02195869|156270908|FG000|Overall Study|Study Terminated by Sponsor|7|||
48568057|NCT02195869|156270908|FG000|Overall Study|Noncompliance with study drug|2|||
48568058|NCT02073929|156270909|FG000|Overall Study|Lost to Follow-up|2|||
48568059|NCT02073929|156270910|FG001|Overall Study|Lost to Follow-up|1|||
48568060|NCT02073929|156270909|FG000|Overall Study|Adverse Event|2|||
48568061|NCT02073929|156270910|FG001|Overall Study|Adverse Event|1|||
48568062|NCT02073929|156270909|FG000|Overall Study|Withdrawal by Subject|0|||
48568063|NCT02073929|156270910|FG001|Overall Study|Withdrawal by Subject|1|||
48568064|NCT00789698|156270911|FG000|Overall Study|Lack of Efficacy|10|||
48568065|NCT00789698|156270912|FG001|Overall Study|Lack of Efficacy|4|||
48568066|NCT00789698|156270913|FG002|Overall Study|Lack of Efficacy|5|||
48568067|NCT00789698|156270914|FG003|Overall Study|Lack of Efficacy|18|||
48568068|NCT00789698|156270911|FG000|Overall Study|Adverse Event|5|||
48568069|NCT00789698|156270912|FG001|Overall Study|Adverse Event|5|||
48568070|NCT00789698|156270913|FG002|Overall Study|Adverse Event|3|||
48568071|NCT00789698|156270914|FG003|Overall Study|Adverse Event|4|||
48568072|NCT00789698|156270911|FG000|Overall Study|Lost to Follow-up|5|||
48617378|NCT00790933|156456223|FG000|Overall Study|Study Terminated by Sponsor|0|||
48617379|NCT00790933|156456224|FG001|Overall Study|Study Terminated by Sponsor|0|||
48617380|NCT00790933|156456225|FG002|Overall Study|Study Terminated by Sponsor|1|||
48617381|NCT00790933|156456226|FG003|Overall Study|Study Terminated by Sponsor|0|||
48617382|NCT00790933|156456227|FG004|Overall Study|Study Terminated by Sponsor|0|||
48617383|NCT00790933|156456223|FG000|Overall Study|Withdrawal by Subject|123|||
48617384|NCT00790933|156456224|FG001|Overall Study|Withdrawal by Subject|120|||
48617385|NCT00790933|156456225|FG002|Overall Study|Withdrawal by Subject|52|||
48617386|NCT00790933|156456226|FG003|Overall Study|Withdrawal by Subject|6|||
48617387|NCT00790933|156456227|FG004|Overall Study|Withdrawal by Subject|50|||
48617388|NCT00790933|156456223|FG000|Overall Study|Lost to Follow-up|13|||
48568073|NCT00789698|156270912|FG001|Overall Study|Lost to Follow-up|5|||
48568074|NCT00789698|156270913|FG002|Overall Study|Lost to Follow-up|2|||
48568075|NCT00789698|156270914|FG003|Overall Study|Lost to Follow-up|9|||
48568076|NCT00789698|156270911|FG000|Overall Study|Protocol Violation|6|||
48617389|NCT00790933|156456224|FG001|Overall Study|Lost to Follow-up|31|||
48568077|NCT00789698|156270912|FG001|Overall Study|Protocol Violation|1|||
48568078|NCT00789698|156270913|FG002|Overall Study|Protocol Violation|2|||
48568079|NCT00789698|156270914|FG003|Overall Study|Protocol Violation|1|||
48568080|NCT00789698|156270911|FG000|Overall Study|Withdrawal by Subject|14|||
48568081|NCT00789698|156270912|FG001|Overall Study|Withdrawal by Subject|15|||
48568082|NCT00789698|156270913|FG002|Overall Study|Withdrawal by Subject|12|||
48568083|NCT00789698|156270914|FG003|Overall Study|Withdrawal by Subject|19|||
48568084|NCT00789698|156270911|FG000|Overall Study|Administrative|0|||
48568085|NCT00789698|156270912|FG001|Overall Study|Administrative|3|||
48568086|NCT00789698|156270913|FG002|Overall Study|Administrative|3|||
48617390|NCT00790933|156456225|FG002|Overall Study|Lost to Follow-up|10|||
48568087|NCT00789698|156270914|FG003|Overall Study|Administrative|1|||
48568088|NCT01208974|156270916|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
48568089|NCT01208974|156270917|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
48568090|NCT01208974|156270918|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
48568091|NCT01208974|156270919|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
48568092|NCT01208974|156270916|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
48568093|NCT01208974|156270917|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
48568094|NCT01208974|156270918|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
48568095|NCT01208974|156270919|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
48568096|NCT01208974|156270916|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
48568097|NCT01208974|156270917|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
48568098|NCT01208974|156270918|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
48617391|NCT00790933|156456226|FG003|Overall Study|Lost to Follow-up|1|||
48568099|NCT01208974|156270919|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
48568100|NCT01500382|156270920|FG000|Washout Period|Study site went out of business|0|||
48568101|NCT01500382|156270921|FG001|Washout Period|Study site went out of business|0|||
48568102|NCT01500382|156270922|FG002|Washout Period|Study site went out of business|1|||
48568103|NCT01500382|156270923|FG003|Washout Period|Study site went out of business|0|||
48568104|NCT02861586|156272635|FG000|Overall Study|Withdrawal by Subject|1|||
48568105|NCT02861586|156272636|FG001|Overall Study|Withdrawal by Subject|2|||
48568106|NCT02861586|156272637|FG002|Overall Study|Withdrawal by Subject|0|||
48568107|NCT02861586|156272638|FG003|Overall Study|Withdrawal by Subject|0|||
48568108|NCT02861586|156272639|FG004|Overall Study|Withdrawal by Subject|0|||
48568109|NCT02861586|156272640|FG005|Overall Study|Withdrawal by Subject|1|||
48568110|NCT02861586|156272641|FG006|Overall Study|Withdrawal by Subject|1|||
48568111|NCT02861586|156272642|FG007|Overall Study|Withdrawal by Subject|0|||
48568112|NCT02861586|156272635|FG000|Overall Study|Lost to Follow-up|3|||
48568113|NCT02861586|156272636|FG001|Overall Study|Lost to Follow-up|1|||
48568114|NCT02861586|156272637|FG002|Overall Study|Lost to Follow-up|1|||
48568115|NCT02861586|156272638|FG003|Overall Study|Lost to Follow-up|0|||
48568116|NCT02861586|156272639|FG004|Overall Study|Lost to Follow-up|0|||
48568117|NCT02861586|156272640|FG005|Overall Study|Lost to Follow-up|3|||
48568118|NCT02861586|156272641|FG006|Overall Study|Lost to Follow-up|0|||
48568119|NCT02861586|156272642|FG007|Overall Study|Lost to Follow-up|0|||
48568120|NCT02861586|156272635|FG000|Overall Study|Adverse Event|0|||
48568121|NCT02861586|156272636|FG001|Overall Study|Adverse Event|0|||
48568122|NCT02861586|156272637|FG002|Overall Study|Adverse Event|0|||
48568123|NCT02861586|156272638|FG003|Overall Study|Adverse Event|0|||
48568124|NCT02861586|156272639|FG004|Overall Study|Adverse Event|0|||
48568125|NCT02861586|156272640|FG005|Overall Study|Adverse Event|1|||
48568126|NCT02861586|156272641|FG006|Overall Study|Adverse Event|0|||
48568127|NCT02861586|156272642|FG007|Overall Study|Adverse Event|0|||
48568128|NCT00754234|156272643|FG000|Overall Study|Withdrawal by Subject|3|||
48568129|NCT00651261|156272644|FG000|Overall Study|Adverse Event|32|||
48568130|NCT00651261|156272645|FG001|Overall Study|Adverse Event|22|||
48568131|NCT00651261|156272644|FG000|Overall Study|Death|18|||
48568132|NCT00651261|156272645|FG001|Overall Study|Death|18|||
48568133|NCT00651261|156272644|FG000|Overall Study|Withdrawal by Subject|22|||
48568134|NCT00651261|156272645|FG001|Overall Study|Withdrawal by Subject|40|||
48617392|NCT00790933|156456227|FG004|Overall Study|Lost to Follow-up|15|||
48568135|NCT00651261|156272644|FG000|Overall Study|Induction failure|24|||
48568136|NCT00651261|156272645|FG001|Overall Study|Induction failure|35|||
48568137|NCT00651261|156272644|FG000|Overall Study|Disease progression|58|||
48568138|NCT00651261|156272645|FG001|Overall Study|Disease progression|58|||
48568139|NCT00651261|156272644|FG000|Overall Study|Alternative therapy|109|||
48568140|NCT00651261|156272645|FG001|Overall Study|Alternative therapy|107|||
48568141|NCT00651261|156272644|FG000|Overall Study|Other disease or participant decisions|23|||
48568142|NCT00651261|156272645|FG001|Overall Study|Other disease or participant decisions|23|||
48568143|NCT00651261|156272644|FG000|Overall Study|Never treated|5|||
48568144|NCT00651261|156272645|FG001|Overall Study|Never treated|3|||
48568145|NCT00454246|156272651|FG000|Overall Study|Adverse Event|2|||
48568146|NCT00454246|156272652|FG001|Overall Study|Adverse Event|2|||
48617393|NCT00790933|156456223|FG000|Overall Study|Reason Not Specified|8|||
48568147|NCT00454246|156272653|FG002|Overall Study|Adverse Event|0|||
48568148|NCT00454246|156272651|FG000|Overall Study|Violation of selection criteria at entry|6|||
48568149|NCT00454246|156272652|FG001|Overall Study|Violation of selection criteria at entry|0|||
48568150|NCT00454246|156272653|FG002|Overall Study|Violation of selection criteria at entry|0|||
48568151|NCT00454246|156272651|FG000|Overall Study|Protocol Violation|1|||
48568152|NCT00454246|156272652|FG001|Overall Study|Protocol Violation|0|||
48568153|NCT00454246|156272653|FG002|Overall Study|Protocol Violation|0|||
48568154|NCT00454246|156272651|FG000|Overall Study|Refused Treatment|1|||
48568155|NCT00454246|156272652|FG001|Overall Study|Refused Treatment|1|||
48568156|NCT00454246|156272653|FG002|Overall Study|Refused Treatment|0|||
48568157|NCT00454246|156272651|FG000|Overall Study|Failure to return|1|||
48568158|NCT00454246|156272652|FG001|Overall Study|Failure to return|0|||
48568159|NCT00454246|156272653|FG002|Overall Study|Failure to return|0|||
48568160|NCT00454246|156272651|FG000|Overall Study|Early termination of study|62|||
48568161|NCT00454246|156272652|FG001|Overall Study|Early termination of study|26|||
48568162|NCT00454246|156272653|FG002|Overall Study|Early termination of study|9|||
48568163|NCT02283268|156272654|FG000|Overall Study|Withdrawal by Subject|1|||
48568164|NCT00333983|156272655|FG000|Overall Study|Lost to Follow-up|2|||
48568165|NCT00333983|156272656|FG001|Overall Study|Lost to Follow-up|1|||
48568166|NCT00333983|156272657|FG002|Overall Study|Lost to Follow-up|0|||
48568167|NCT00333983|156272655|FG000|Overall Study|Adverse Event|1|||
48568168|NCT00333983|156272656|FG001|Overall Study|Adverse Event|1|||
48568169|NCT00333983|156272657|FG002|Overall Study|Adverse Event|1|||
48568170|NCT00333983|156272655|FG000|Overall Study|Withdrawal by Subject|0|||
48568171|NCT00333983|156272656|FG001|Overall Study|Withdrawal by Subject|3|||
48568172|NCT00333983|156272657|FG002|Overall Study|Withdrawal by Subject|1|||
48568173|NCT02898597|156272658|FG000|Overall Study|Protocol Violation|4|||
48568174|NCT02898597|156272659|FG001|Overall Study|Protocol Violation|2|||
48617394|NCT00790933|156456224|FG001|Overall Study|Reason Not Specified|16|||
48568175|NCT02898597|156272658|FG000|Overall Study|Lost to Follow-up|0|||
48568176|NCT02898597|156272659|FG001|Overall Study|Lost to Follow-up|9|||
48568177|NCT02898597|156272658|FG000|Overall Study|Death|0|||
48568178|NCT02898597|156272659|FG001|Overall Study|Death|1|||
48568179|NCT02530125|156272665|FG000|Completed Treatment|Early termination of study|1|||
48568180|NCT02530125|156272665|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
48568181|NCT03656068|156272666|FG000|Overall Study|Withdrawal by Subject|4|||
48568182|NCT03656068|156272666|FG000|Overall Study|Adverse Event|1|||
48568183|NCT01681212|156272668|FG000|Overall Study|No longer met study criteria|5|||
48568184|NCT01681212|156272668|FG000|Overall Study|Administrative reason by sponsor|1|||
48568185|NCT00789373|156272672|FG000|Induction|Adverse Event|64|||
48568186|NCT00789373|156272673|FG001|Induction|Adverse Event|0|||
48568187|NCT00789373|156272674|FG002|Induction|Adverse Event|0|||
48568188|NCT00789373|156272672|FG000|Induction|Death Due to study disease|24|||
48568189|NCT00789373|156272673|FG001|Induction|Death Due to study disease|0|||
48568190|NCT00789373|156272674|FG002|Induction|Death Due to study disease|0|||
48568191|NCT00789373|156272672|FG000|Induction|Death due to adverse event|19|||
48568192|NCT00789373|156272673|FG001|Induction|Death due to adverse event|0|||
48568193|NCT00789373|156272674|FG002|Induction|Death due to adverse event|0|||
48568194|NCT00789373|156272672|FG000|Induction|Death due to toxicity|11|||
48568195|NCT00789373|156272673|FG001|Induction|Death due to toxicity|0|||
48568196|NCT00789373|156272674|FG002|Induction|Death due to toxicity|0|||
48568197|NCT00789373|156272672|FG000|Induction|Death due to procedure|1|||
48568198|NCT00789373|156272673|FG001|Induction|Death due to procedure|0|||
48568199|NCT00789373|156272674|FG002|Induction|Death due to procedure|0|||
48568200|NCT00789373|156272672|FG000|Induction|Investigator decision|7|||
48568201|NCT00789373|156272673|FG001|Induction|Investigator decision|0|||
48568202|NCT00789373|156272674|FG002|Induction|Investigator decision|0|||
48568203|NCT00789373|156272672|FG000|Induction|Protocol entry criteria not met|9|||
48568204|NCT00789373|156272673|FG001|Induction|Protocol entry criteria not met|0|||
48568205|NCT00789373|156272674|FG002|Induction|Protocol entry criteria not met|0|||
48568206|NCT00789373|156272672|FG000|Induction|Lost to Follow-up|6|||
48568207|NCT00789373|156272673|FG001|Induction|Lost to Follow-up|0|||
48568208|NCT00789373|156272674|FG002|Induction|Lost to Follow-up|0|||
48568209|NCT00789373|156272672|FG000|Induction|Protocol Violation|1|||
48568210|NCT00789373|156272673|FG001|Induction|Protocol Violation|0|||
48568211|NCT00789373|156272674|FG002|Induction|Protocol Violation|0|||
48568212|NCT00789373|156272672|FG000|Induction|Progressive Disease|220|||
48568213|NCT00789373|156272673|FG001|Induction|Progressive Disease|0|||
48568214|NCT00789373|156272674|FG002|Induction|Progressive Disease|0|||
48568215|NCT00789373|156272672|FG000|Induction|Withdrawal by Subject|37|||
48568216|NCT00789373|156272673|FG001|Induction|Withdrawal by Subject|0|||
48568217|NCT00789373|156272674|FG002|Induction|Withdrawal by Subject|0|||
48568218|NCT00789373|156272672|FG000|Maintenance|Adverse Event|0|||
48568219|NCT00789373|156272673|FG001|Maintenance|Adverse Event|65|||
48568220|NCT00789373|156272674|FG002|Maintenance|Adverse Event|12|||
48568221|NCT00789373|156272672|FG000|Maintenance|Death due to study disease|0|||
48568222|NCT00789373|156272673|FG001|Maintenance|Death due to study disease|3|||
48568223|NCT00789373|156272674|FG002|Maintenance|Death due to study disease|1|||
48568224|NCT00789373|156272672|FG000|Maintenance|Death due to adverse event|0|||
48568225|NCT00789373|156272673|FG001|Maintenance|Death due to adverse event|4|||
48568226|NCT00789373|156272674|FG002|Maintenance|Death due to adverse event|1|||
48568227|NCT00789373|156272672|FG000|Maintenance|Death due to toxicity|0|||
48568228|NCT00789373|156272673|FG001|Maintenance|Death due to toxicity|1|||
48568229|NCT00789373|156272674|FG002|Maintenance|Death due to toxicity|2|||
48568230|NCT00789373|156272672|FG000|Maintenance|Investigator Decision|0|||
48568231|NCT00789373|156272673|FG001|Maintenance|Investigator Decision|4|||
48568232|NCT00789373|156272674|FG002|Maintenance|Investigator Decision|2|||
48568233|NCT00789373|156272672|FG000|Maintenance|Protocol entry criteria not met|0|||
48568234|NCT00789373|156272673|FG001|Maintenance|Protocol entry criteria not met|2|||
48568235|NCT00789373|156272674|FG002|Maintenance|Protocol entry criteria not met|0|||
48568236|NCT00789373|156272672|FG000|Maintenance|Lost to Follow-up|0|||
48568237|NCT00789373|156272673|FG001|Maintenance|Lost to Follow-up|2|||
48568238|NCT00789373|156272674|FG002|Maintenance|Lost to Follow-up|0|||
48568239|NCT00789373|156272672|FG000|Maintenance|Progressive Disease|0|||
48568240|NCT00789373|156272673|FG001|Maintenance|Progressive Disease|253|||
48568241|NCT00789373|156272674|FG002|Maintenance|Progressive Disease|152|||
48568242|NCT00789373|156272672|FG000|Maintenance|Withdrawal by Subject|0|||
48568243|NCT00789373|156272673|FG001|Maintenance|Withdrawal by Subject|21|||
48568244|NCT00789373|156272674|FG002|Maintenance|Withdrawal by Subject|8|||
48568245|NCT00789373|156272672|FG000|Maintenance|Sponsor Decision|0|||
48568246|NCT00789373|156272673|FG001|Maintenance|Sponsor Decision|0|||
48568247|NCT00789373|156272674|FG002|Maintenance|Sponsor Decision|2|||
48568248|NCT00789373|156272672|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
48568249|NCT00789373|156272673|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
48568250|NCT00789373|156272674|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
48568251|NCT05393037|156272682|FG000|Overall Study|Death|1|||
48568252|NCT05393037|156272683|FG001|Overall Study|Death|0|||
48568253|NCT05393037|156272682|FG000|Overall Study|Lost to Follow-up|1|||
48568254|NCT05393037|156272683|FG001|Overall Study|Lost to Follow-up|1|||
48568255|NCT05393037|156272682|FG000|Overall Study|Withdrawal by Subject|2|||
48568256|NCT05393037|156272683|FG001|Overall Study|Withdrawal by Subject|4|||
48568257|NCT05393037|156272682|FG000|Overall Study|Ongoing|152|||
48568258|NCT05393037|156272683|FG001|Overall Study|Ongoing|0|||
48568259|NCT02122887|156272684|FG000|Overall Study|Withdrawal by Subject|20|||
48568260|NCT02122887|156272685|FG001|Overall Study|Withdrawal by Subject|2|||
48568261|NCT02476578|156272686|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
48568262|NCT02476578|156272687|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
48568263|NCT02476578|156272686|FG000|Overall Study|Lost to Follow-up|6|||
48568264|NCT02476578|156272687|FG001|Overall Study|Lost to Follow-up|13|||
48568265|NCT05047211|156272690|FG000|Overall Study|Lost to Follow-up|8|||
48568266|NCT05047211|156272691|FG001|Overall Study|Lost to Follow-up|5|||
48568267|NCT04938180|156272693|FG000|Overall Study|Adverse Event|1|||
48568268|NCT03018080|156272694|FG000|Overall Study|Death|12|||
48568269|NCT03018080|156272695|FG001|Overall Study|Death|19|||
48568270|NCT00740792|156272696|FG000|Overall Study|Adverse Event|3|||
48568271|NCT00740792|156272697|FG001|Overall Study|Adverse Event|1|||
48568272|NCT00740792|156272698|FG002|Overall Study|Adverse Event|1|||
48568273|NCT00740792|156272699|FG003|Overall Study|Adverse Event|3|||
48568274|NCT00740792|156272696|FG000|Overall Study|Lack of Efficacy|1|||
48568275|NCT00740792|156272697|FG001|Overall Study|Lack of Efficacy|1|||
48568276|NCT00740792|156272698|FG002|Overall Study|Lack of Efficacy|0|||
48568277|NCT00740792|156272699|FG003|Overall Study|Lack of Efficacy|3|||
48568278|NCT00740792|156272696|FG000|Overall Study|Lost to Follow-up|2|||
48568279|NCT00740792|156272697|FG001|Overall Study|Lost to Follow-up|1|||
48568280|NCT00740792|156272698|FG002|Overall Study|Lost to Follow-up|0|||
48568281|NCT00740792|156272699|FG003|Overall Study|Lost to Follow-up|0|||
48568282|NCT00740792|156272696|FG000|Overall Study|Protocol Violation|0|||
48568283|NCT00740792|156272697|FG001|Overall Study|Protocol Violation|1|||
48568284|NCT00740792|156272698|FG002|Overall Study|Protocol Violation|0|||
48568285|NCT00740792|156272699|FG003|Overall Study|Protocol Violation|2|||
48568286|NCT00740792|156272696|FG000|Overall Study|Withdrawal by Subject|1|||
48568287|NCT00740792|156272697|FG001|Overall Study|Withdrawal by Subject|1|||
48568288|NCT00740792|156272698|FG002|Overall Study|Withdrawal by Subject|0|||
48568289|NCT00740792|156272699|FG003|Overall Study|Withdrawal by Subject|0|||
48568290|NCT00740792|156272696|FG000|Overall Study|administrative|3|||
48568291|NCT00740792|156272697|FG001|Overall Study|administrative|3|||
48568292|NCT00740792|156272698|FG002|Overall Study|administrative|8|||
48568293|NCT00740792|156272699|FG003|Overall Study|administrative|2|||
48568294|NCT01284348|156272700|FG000|Overall Study|Death|1|||
48568295|NCT01284348|156272701|FG001|Overall Study|Death|1|||
48568296|NCT01284348|156272700|FG000|Overall Study|Withdrew consent|0|||
48568297|NCT01284348|156272701|FG001|Overall Study|Withdrew consent|1|||
48568298|NCT01284348|156272700|FG000|Overall Study|Status not recorded|9|||
48568299|NCT01284348|156272701|FG001|Overall Study|Status not recorded|10|||
48568300|NCT04707469|156272702|FG000|Overall Study|Site closure|0|||
48568301|NCT04707469|156272703|FG001|Overall Study|Site closure|2|||
48568302|NCT04707469|156272704|FG002|Overall Study|Site closure|0|||
48568303|NCT04707469|156272702|FG000|Overall Study|Physician Decision|2|||
48568304|NCT04707469|156272703|FG001|Overall Study|Physician Decision|2|||
48568305|NCT04707469|156272704|FG002|Overall Study|Physician Decision|2|||
48568306|NCT04707469|156272702|FG000|Overall Study|Death|1|||
48568307|NCT04707469|156272703|FG001|Overall Study|Death|6|||
48568308|NCT04707469|156272704|FG002|Overall Study|Death|2|||
48568309|NCT04707469|156272702|FG000|Overall Study|Lost to Follow-up|9|||
48568310|NCT04707469|156272703|FG001|Overall Study|Lost to Follow-up|19|||
48568311|NCT04707469|156272704|FG002|Overall Study|Lost to Follow-up|14|||
48568312|NCT04707469|156272702|FG000|Overall Study|Withdrawal by Subject|17|||
48568313|NCT04707469|156272703|FG001|Overall Study|Withdrawal by Subject|16|||
48568314|NCT04707469|156272704|FG002|Overall Study|Withdrawal by Subject|12|||
48568315|NCT03321968|156272705|FG000|Overall Study|Withdrawal by Subject|1|||
48568316|NCT03321968|156272706|FG001|Overall Study|Withdrawal by Subject|2|||
48568317|NCT03321968|156272707|FG002|Overall Study|Withdrawal by Subject|1|||
48568318|NCT03321968|156272705|FG000|Overall Study|Lost to Follow-up|2|||
48568319|NCT03321968|156272706|FG001|Overall Study|Lost to Follow-up|0|||
48568320|NCT03321968|156272707|FG002|Overall Study|Lost to Follow-up|1|||
48568321|NCT03321968|156272705|FG000|Overall Study|Other than specified|0|||
48568322|NCT03321968|156272706|FG001|Overall Study|Other than specified|0|||
48568323|NCT03321968|156272707|FG002|Overall Study|Other than specified|1|||
48568324|NCT01964222|156272708|FG000|Overall Study|Lost to Follow-up|7|||
48568325|NCT01964222|156272709|FG001|Overall Study|Lost to Follow-up|5|||
48568326|NCT01964222|156272708|FG000|Overall Study|Withdrawal by Subject|6|||
48568327|NCT01964222|156272709|FG001|Overall Study|Withdrawal by Subject|6|||
48568328|NCT01964222|156272708|FG000|Overall Study|Screening Failure|2|||
48568329|NCT01964222|156272709|FG001|Overall Study|Screening Failure|0|||
48568330|NCT01684423|156272718|FG000|Overall Study|Withdrawal by Subject|0|||
48568331|NCT01684423|156272719|FG001|Overall Study|Withdrawal by Subject|0|||
48568332|NCT01684423|156272720|FG002|Overall Study|Withdrawal by Subject|1|||
48568333|NCT01684423|156272721|FG003|Overall Study|Withdrawal by Subject|0|||
48568334|NCT01684423|156272722|FG004|Overall Study|Withdrawal by Subject|0|||
48568335|NCT03192306|156272725|FG000|Overall Study|Did not treat cold sore during study|149|||
48568336|NCT03192306|156272726|FG001|Overall Study|Did not treat cold sore during study|143|||
48568337|NCT03192306|156272725|FG000|Overall Study|Withdrawal by Subject|1|||
48568338|NCT03192306|156272726|FG001|Overall Study|Withdrawal by Subject|1|||
48568339|NCT03192306|156272725|FG000|Overall Study|Lost to Follow-up|1|||
48568340|NCT03192306|156272726|FG001|Overall Study|Lost to Follow-up|0|||
48568341|NCT03192306|156272725|FG000|Overall Study|Protocol Violation|1|||
48568342|NCT03192306|156272726|FG001|Overall Study|Protocol Violation|1|||
48568343|NCT04164732|156272727|FG000|Treatment run-in Period|Adverse Event|4|||
48568344|NCT04164732|156272728|FG001|Treatment run-in Period|Adverse Event|0|||
48568345|NCT04164732|156272729|FG002|Treatment run-in Period|Adverse Event|0|||
48568346|NCT04164732|156272727|FG000|Treatment run-in Period|Physician Decision|1|||
48568347|NCT04164732|156272728|FG001|Treatment run-in Period|Physician Decision|0|||
48568348|NCT04164732|156272729|FG002|Treatment run-in Period|Physician Decision|0|||
48568349|NCT04164732|156272727|FG000|Treatment run-in Period|Screen Failure|1|||
48568350|NCT04164732|156272728|FG001|Treatment run-in Period|Screen Failure|0|||
48568351|NCT04164732|156272729|FG002|Treatment run-in Period|Screen Failure|0|||
48568352|NCT04164732|156272727|FG000|Randomized Treatment Period|Adverse Event|0|||
48568353|NCT04164732|156272728|FG001|Randomized Treatment Period|Adverse Event|1|||
48568354|NCT04164732|156272729|FG002|Randomized Treatment Period|Adverse Event|0|||
48568355|NCT04164732|156272727|FG000|Randomized Treatment Period|Protocol Deviation|0|||
48568356|NCT04164732|156272728|FG001|Randomized Treatment Period|Protocol Deviation|1|||
48568357|NCT04164732|156272729|FG002|Randomized Treatment Period|Protocol Deviation|1|||
48568358|NCT04164732|156272727|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
48568359|NCT04164732|156272728|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
48568360|NCT04164732|156272729|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
48568361|NCT01455597|156272730|FG000|Overall Study|Adverse Event|7|||
48568362|NCT01455597|156272731|FG001|Overall Study|Adverse Event|0|||
48568363|NCT01455597|156272732|FG002|Overall Study|Adverse Event|5|||
48568364|NCT01455597|156272733|FG003|Overall Study|Adverse Event|1|||
48568365|NCT01455597|156272730|FG000|Overall Study|Lack of Efficacy|0|||
48568366|NCT01455597|156272731|FG001|Overall Study|Lack of Efficacy|1|||
48568367|NCT01455597|156272732|FG002|Overall Study|Lack of Efficacy|2|||
48568368|NCT01455597|156272733|FG003|Overall Study|Lack of Efficacy|0|||
48568369|NCT01455597|156272730|FG000|Overall Study|Lost to Follow-up|3|||
48568370|NCT01455597|156272731|FG001|Overall Study|Lost to Follow-up|0|||
48617395|NCT00790933|156456225|FG002|Overall Study|Reason Not Specified|4|||
48568371|NCT01455597|156272732|FG002|Overall Study|Lost to Follow-up|2|||
48568372|NCT01455597|156272733|FG003|Overall Study|Lost to Follow-up|1|||
48568373|NCT01455597|156272730|FG000|Overall Study|Withdrew Consent|6|||
48568374|NCT01455597|156272731|FG001|Overall Study|Withdrew Consent|5|||
48568375|NCT01455597|156272732|FG002|Overall Study|Withdrew Consent|8|||
48568376|NCT01455597|156272733|FG003|Overall Study|Withdrew Consent|5|||
48735655|NCT02215096|156883709|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
48568377|NCT01455597|156272730|FG000|Overall Study|Reason not Specified|1|||
48568378|NCT01455597|156272731|FG001|Overall Study|Reason not Specified|2|||
48568379|NCT01455597|156272732|FG002|Overall Study|Reason not Specified|3|||
48568380|NCT01455597|156272733|FG003|Overall Study|Reason not Specified|3|||
48568381|NCT03512210|156272735|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
48568382|NCT03512210|156272735|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
48568383|NCT03512210|156272735|FG000|Step 2:Post-MINMON|Death|2|||
48568384|NCT03512210|156272735|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
48568385|NCT03512210|156272735|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
48568386|NCT01737710|156272736|FG000|Overall Study|Lost to Follow-up|0|||
48735656|NCT02215096|156883705|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
48568387|NCT01737710|156272737|FG001|Overall Study|Lost to Follow-up|2|||
48568388|NCT01737710|156272738|FG002|Overall Study|Lost to Follow-up|2|||
48568389|NCT01737710|156272739|FG003|Overall Study|Lost to Follow-up|0|||
48568390|NCT01737710|156272740|FG004|Overall Study|Lost to Follow-up|0|||
48568391|NCT01737710|156272736|FG000|Overall Study|Withdrawal by Subject|1|||
48568392|NCT01737710|156272737|FG001|Overall Study|Withdrawal by Subject|1|||
48568393|NCT01737710|156272738|FG002|Overall Study|Withdrawal by Subject|1|||
48568394|NCT01737710|156272739|FG003|Overall Study|Withdrawal by Subject|0|||
48568395|NCT01737710|156272740|FG004|Overall Study|Withdrawal by Subject|0|||
48568396|NCT01737710|156272736|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
48568397|NCT01737710|156272737|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
48568398|NCT01737710|156272738|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
48568399|NCT01737710|156272739|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
48568400|NCT01737710|156272740|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
48568401|NCT03412734|156272742|FG000|Overall Study|Incorrect labeling of samples|2|||
48568402|NCT03412734|156272743|FG001|Overall Study|Incorrect labeling of samples|0|||
48568403|NCT03412734|156272742|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
48568404|NCT03412734|156272743|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
48568405|NCT00356135|156272744|FG000|Overall Study|Protocol Violation|1|||
48568406|NCT00356135|156272745|FG001|Overall Study|Protocol Violation|0|||
48568407|NCT00356135|156272746|FG002|Overall Study|Protocol Violation|0|||
48568408|NCT00356135|156272744|FG000|Overall Study|Adverse Event|1|||
48568409|NCT00356135|156272745|FG001|Overall Study|Adverse Event|0|||
48568410|NCT00356135|156272746|FG002|Overall Study|Adverse Event|0|||
48568411|NCT00356135|156272744|FG000|Overall Study|Lost to Follow-up|0|||
48568412|NCT00356135|156272745|FG001|Overall Study|Lost to Follow-up|0|||
48568413|NCT00356135|156272746|FG002|Overall Study|Lost to Follow-up|1|||
48568414|NCT00356135|156272744|FG000|Overall Study|Physician Decision|1|||
48568415|NCT00356135|156272745|FG001|Overall Study|Physician Decision|1|||
48568416|NCT00356135|156272746|FG002|Overall Study|Physician Decision|1|||
48568417|NCT00356135|156272744|FG000|Overall Study|Subject non-compliance|1|||
48568418|NCT00356135|156272745|FG001|Overall Study|Subject non-compliance|1|||
48568419|NCT00356135|156272746|FG002|Overall Study|Subject non-compliance|3|||
48568420|NCT01575834|156272747|FG000|Overall Study|Withdrawal by Subject|352|||
48568421|NCT01575834|156272748|FG001|Overall Study|Withdrawal by Subject|390|||
48568422|NCT01575834|156272747|FG000|Overall Study|Death|81|||
48568423|NCT01575834|156272748|FG001|Overall Study|Death|74|||
48568424|NCT01575834|156272747|FG000|Overall Study|Other|70|||
48568425|NCT01575834|156272748|FG001|Overall Study|Other|70|||
48568426|NCT01575834|156272747|FG000|Overall Study|Adverse Event|63|||
48568427|NCT01575834|156272748|FG001|Overall Study|Adverse Event|61|||
48568428|NCT01575834|156272747|FG000|Overall Study|Lost to Follow-up|55|||
48568429|NCT01575834|156272748|FG001|Overall Study|Lost to Follow-up|68|||
48568430|NCT01575834|156272747|FG000|Overall Study|Noncompliance|52|||
48568431|NCT01575834|156272748|FG001|Overall Study|Noncompliance|27|||
48568432|NCT01575834|156272747|FG000|Overall Study|Administrative decision|15|||
48568433|NCT01575834|156272748|FG001|Overall Study|Administrative decision|33|||
48568434|NCT01575834|156272747|FG000|Overall Study|Ineligibility Determined|5|||
48568435|NCT01575834|156272748|FG001|Overall Study|Ineligibility Determined|8|||
48568436|NCT01575834|156272747|FG000|Overall Study|Protocol Deviation|4|||
48568437|NCT01575834|156272748|FG001|Overall Study|Protocol Deviation|3|||
48568438|NCT01575834|156272747|FG000|Overall Study|Requirement for Alternative Therapy|2|||
48568439|NCT01575834|156272748|FG001|Overall Study|Requirement for Alternative Therapy|4|||
48568440|NCT00912743|156272749|FG000|Overall Study|Adverse Event|3|||
48568441|NCT00912743|156272750|FG001|Overall Study|Adverse Event|1|||
48568442|NCT00912743|156272749|FG000|Overall Study|Lack of Efficacy|9|||
48568443|NCT00912743|156272750|FG001|Overall Study|Lack of Efficacy|18|||
48568444|NCT00912743|156272749|FG000|Overall Study|Toxicity|0|||
48568445|NCT00912743|156272750|FG001|Overall Study|Toxicity|1|||
48568446|NCT00912743|156272749|FG000|Overall Study|End of treatment form was not collected|1|||
48568447|NCT00912743|156272750|FG001|Overall Study|End of treatment form was not collected|0|||
48568448|NCT00423332|156272751|FG000|Overall Study|Adverse Event|6|||
48568449|NCT00423332|156272752|FG001|Overall Study|Adverse Event|2|||
48568450|NCT00423332|156272751|FG000|Overall Study|Withdrawal by Subject|1|||
48568451|NCT00423332|156272752|FG001|Overall Study|Withdrawal by Subject|0|||
48568452|NCT00423332|156272751|FG000|Overall Study|Condition under investigation worsened|1|||
48568453|NCT00423332|156272752|FG001|Overall Study|Condition under investigation worsened|1|||
48568454|NCT00423332|156272751|FG000|Overall Study|Progressive at Week 6|0|||
48568455|NCT00423332|156272752|FG001|Overall Study|Progressive at Week 6|1|||
48568456|NCT00423332|156272751|FG000|Overall Study|Unblinded before 12 weeks|1|||
48568457|NCT00423332|156272752|FG001|Overall Study|Unblinded before 12 weeks|3|||
48568458|NCT02155283|156272754|FG000|Overall Study|Lost to Follow-up|3|||
48617396|NCT00790933|156456226|FG003|Overall Study|Reason Not Specified|1|||
48568459|NCT02155283|156272754|FG000|Overall Study|Withdrawal by Subject|1|||
48568460|NCT02155283|156272754|FG000|Overall Study|Protocol Violation|3|||
48568461|NCT00488644|156272759|FG000|Overall Study|Not Eligible|1|||
48568462|NCT00488644|156272759|FG000|Overall Study|Not Evaluable|1|||
48568463|NCT00996125|156272761|FG000|Overall Study|Adverse Event|0|||
48568464|NCT00996125|156272762|FG001|Overall Study|Adverse Event|2|||
48617397|NCT00790933|156456227|FG004|Overall Study|Reason Not Specified|9|||
48568465|NCT00996125|156272761|FG000|Overall Study|Lost to Follow-up|1|||
48568466|NCT00996125|156272762|FG001|Overall Study|Lost to Follow-up|6|||
48568467|NCT00996125|156272761|FG000|Overall Study|Withdrawal by Subject|4|||
48568468|NCT00996125|156272762|FG001|Overall Study|Withdrawal by Subject|3|||
48568469|NCT02518048|156272767|FG000|Overall Study|Withdrawal by Subject|1|||
48568470|NCT01470248|156272768|FG000|Overall Study|Withdrawal by Subject|1|||
48568471|NCT01757184|156272769|FG000|Double-blind Period|Adverse Event|1|||
48568472|NCT01757184|156272770|FG001|Double-blind Period|Adverse Event|0|||
48568473|NCT01757184|156272771|FG002|Double-blind Period|Adverse Event|0|||
48568474|NCT01757184|156272772|FG003|Double-blind Period|Adverse Event|0|||
48568475|NCT01757184|156272769|FG000|Open-label Period|Lost to Follow-up|0|||
48568476|NCT01757184|156272770|FG001|Open-label Period|Lost to Follow-up|0|||
48568477|NCT01757184|156272771|FG002|Open-label Period|Lost to Follow-up|2|||
48568478|NCT01757184|156272772|FG003|Open-label Period|Lost to Follow-up|0|||
48568479|NCT01757184|156272769|FG000|Open-label Period|Withdrawal by Subject|0|||
48568480|NCT01757184|156272770|FG001|Open-label Period|Withdrawal by Subject|0|||
48568481|NCT01757184|156272771|FG002|Open-label Period|Withdrawal by Subject|1|||
48568482|NCT01757184|156272772|FG003|Open-label Period|Withdrawal by Subject|1|||
48568483|NCT01757184|156272769|FG000|Open-label Period|Discontinued by Sponsor|0|||
48568484|NCT01757184|156272770|FG001|Open-label Period|Discontinued by Sponsor|0|||
48568485|NCT01757184|156272771|FG002|Open-label Period|Discontinued by Sponsor|1|||
48568486|NCT01757184|156272772|FG003|Open-label Period|Discontinued by Sponsor|2|||
48568487|NCT00703157|156272777|FG000|Overall Study|Lost to Follow-up|0|||
48568488|NCT00703157|156272778|FG001|Overall Study|Lost to Follow-up|1|||
48568489|NCT00703157|156272777|FG000|Overall Study|source data permanently lost/ other|4|||
48568490|NCT00703157|156272778|FG001|Overall Study|source data permanently lost/ other|1|||
48568491|NCT01706939|156272779|FG000|Pre Randomization|Screen Failure|1|||
48568492|NCT01706939|156272780|FG001|Pre Randomization|Screen Failure|0|||
48568493|NCT01706939|156272781|FG002|Pre Randomization|Screen Failure|0|||
48568494|NCT01706939|156272779|FG000|Pre Randomization|Ineligible for Randomization|1|||
48568495|NCT01706939|156272780|FG001|Pre Randomization|Ineligible for Randomization|0|||
48568496|NCT01706939|156272781|FG002|Pre Randomization|Ineligible for Randomization|0|||
48568497|NCT01706939|156272779|FG000|Pre Randomization|Withdrawal by Subject|1|||
48568498|NCT01706939|156272780|FG001|Pre Randomization|Withdrawal by Subject|0|||
48568499|NCT01706939|156272781|FG002|Pre Randomization|Withdrawal by Subject|0|||
48568500|NCT01706939|156272779|FG000|Randomization|Insufficient QoL survey compliance|0|||
48568501|NCT01706939|156272780|FG001|Randomization|Insufficient QoL survey compliance|1|||
48568502|NCT01706939|156272781|FG002|Randomization|Insufficient QoL survey compliance|1|||
48568503|NCT01706939|156272779|FG000|Randomization|Progression of disease|0|||
48568504|NCT01706939|156272780|FG001|Randomization|Progression of disease|2|||
48568505|NCT01706939|156272781|FG002|Randomization|Progression of disease|1|||
48568506|NCT02858583|156272782|FG000|Overall Study|Declined consent|1|||
48568507|NCT02858583|156272783|FG001|Overall Study|Declined consent|1|||
48568508|NCT03759587|156272784|FG000|Overall Study|Adverse Event|5|||
48568509|NCT03759587|156272784|FG000|Overall Study|Progressive Disease|10|||
48568510|NCT03759587|156272784|FG000|Overall Study|Site Terminated by Sponsor|3|||
48568511|NCT03759587|156272784|FG000|Overall Study|Withdrawal by Subject|1|||
48568512|NCT00347009|156272785|FG000|Overall Study|Death|1|||
48568513|NCT00347009|156272785|FG000|Overall Study|Adverse Event|6|||
48568514|NCT00347009|156272785|FG000|Overall Study|Withdrawal by Subject|3|||
48568515|NCT00347009|156272785|FG000|Overall Study|Physician Decision|5|||
48568516|NCT00347009|156272785|FG000|Overall Study|Lost to Follow-up|4|||
48568517|NCT00347009|156272785|FG000|Overall Study|Protocol Violation|2|||
48568518|NCT00347009|156272785|FG000|Overall Study|Adverse Laboratory Experience|1|||
48568519|NCT00347009|156272785|FG000|Overall Study|Insufficient Viral Suppression|3|||
48568520|NCT00347009|156272785|FG000|Overall Study|Increased ALT/HBV DNA|1|||
48568521|NCT00347009|156272785|FG000|Overall Study|Serious Adverse Event|1|||
48568522|NCT00591565|156272786|FG000|Overall Study|lost follow up, withdrawn|5|||
48568523|NCT00665431|156272788|FG000|Overall Study|Adverse Event|16|||
48568524|NCT00665431|156272789|FG001|Overall Study|Adverse Event|22|||
48568525|NCT00665431|156272790|FG002|Overall Study|Adverse Event|6|||
48568526|NCT00665431|156272788|FG000|Overall Study|Withdrawal by Subject|17|||
48568527|NCT00665431|156272789|FG001|Overall Study|Withdrawal by Subject|25|||
48568528|NCT00665431|156272790|FG002|Overall Study|Withdrawal by Subject|15|||
48568529|NCT00665431|156272788|FG000|Overall Study|Lost to Follow-up|3|||
48568530|NCT00665431|156272789|FG001|Overall Study|Lost to Follow-up|3|||
48568531|NCT00665431|156272790|FG002|Overall Study|Lost to Follow-up|1|||
48568532|NCT00665431|156272788|FG000|Overall Study|Other|4|||
48568533|NCT00665431|156272789|FG001|Overall Study|Other|7|||
48568534|NCT00665431|156272790|FG002|Overall Study|Other|2|||
48568535|NCT02134015|156272793|FG000|Overall Study|Protocol Violation|0|||
48568536|NCT02134015|156272794|FG001|Overall Study|Protocol Violation|1|||
48568537|NCT02134015|156272793|FG000|Overall Study|Death|2|||
48568538|NCT02134015|156272794|FG001|Overall Study|Death|1|||
48568539|NCT02134015|156272793|FG000|Overall Study|Reason not provided|1|||
48568540|NCT02134015|156272794|FG001|Overall Study|Reason not provided|2|||
48568541|NCT02134015|156272793|FG000|Overall Study|Clinical progression|14|||
48568542|NCT02134015|156272794|FG001|Overall Study|Clinical progression|7|||
48568543|NCT02134015|156272793|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
48568544|NCT02134015|156272794|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
48568545|NCT02134015|156272793|FG000|Overall Study|Study terminated by sponsor|2|||
48568546|NCT02134015|156272794|FG001|Overall Study|Study terminated by sponsor|3|||
48568547|NCT02134015|156272793|FG000|Overall Study|Adverse Event|9|||
48568548|NCT02134015|156272794|FG001|Overall Study|Adverse Event|10|||
48568549|NCT02134015|156272793|FG000|Overall Study|Withdrawal by Subject|3|||
48568550|NCT02134015|156272794|FG001|Overall Study|Withdrawal by Subject|7|||
48568551|NCT01134107|156275436|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
48568552|NCT01134107|156275437|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
48568553|NCT01134107|156275436|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
48568554|NCT01134107|156275437|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
48568555|NCT01134107|156275436|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
48568556|NCT01134107|156275437|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
48568557|NCT01134107|156275436|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
48568558|NCT01134107|156275437|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
48568559|NCT01134107|156275436|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
48568560|NCT01134107|156275437|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
48568561|NCT01134107|156275436|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
48568562|NCT01134107|156275437|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
48568563|NCT01134107|156275436|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
48568564|NCT01134107|156275437|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
48568565|NCT00687271|156275438|FG000|Overall Study|Adverse Event|1|||
48568566|NCT00687271|156275439|FG001|Overall Study|Adverse Event|3|||
48568567|NCT00687271|156275440|FG002|Overall Study|Adverse Event|1|||
48568568|NCT00687271|156275441|FG003|Overall Study|Adverse Event|0|||
48568569|NCT00687271|156275438|FG000|Overall Study|Lost to Follow-up|0|||
48568570|NCT00687271|156275439|FG001|Overall Study|Lost to Follow-up|1|||
48568571|NCT00687271|156275440|FG002|Overall Study|Lost to Follow-up|0|||
48568572|NCT00687271|156275441|FG003|Overall Study|Lost to Follow-up|0|||
48568573|NCT00687271|156275438|FG000|Overall Study|Protocol Violation|2|||
48568574|NCT00687271|156275439|FG001|Overall Study|Protocol Violation|1|||
48568575|NCT00687271|156275440|FG002|Overall Study|Protocol Violation|1|||
48568576|NCT00687271|156275441|FG003|Overall Study|Protocol Violation|0|||
48568577|NCT00687271|156275438|FG000|Overall Study|Withdrawal by Subject|0|||
48568578|NCT00687271|156275439|FG001|Overall Study|Withdrawal by Subject|1|||
48568579|NCT00687271|156275440|FG002|Overall Study|Withdrawal by Subject|3|||
48568580|NCT00687271|156275441|FG003|Overall Study|Withdrawal by Subject|0|||
48568581|NCT02484456|156275443|FG000|Washout Period|Withdrawal by Subject|0|||
48568582|NCT02484456|156275444|FG001|Washout Period|Withdrawal by Subject|1|||
48568583|NCT02484456|156275443|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
48568584|NCT02484456|156275444|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
48568585|NCT02484456|156275443|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
48568586|NCT02484456|156275444|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
48568587|NCT02484456|156275443|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
48568588|NCT02484456|156275444|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
48568589|NCT00955409|156275445|FG000|Overall Study|Lack of Efficacy|1|||
48568590|NCT00955409|156275446|FG001|Overall Study|Lack of Efficacy|0|||
48568591|NCT00955409|156275447|FG002|Overall Study|Lack of Efficacy|0|||
48568592|NCT00955409|156275448|FG003|Overall Study|Lack of Efficacy|0|||
48568593|NCT00955409|156275449|FG004|Overall Study|Lack of Efficacy|0|||
48568594|NCT00955409|156275450|FG005|Overall Study|Lack of Efficacy|0|||
48568595|NCT00955409|156275451|FG006|Overall Study|Lack of Efficacy|0|||
48568596|NCT00955409|156275452|FG007|Overall Study|Lack of Efficacy|0|||
48568597|NCT00955409|156275453|FG008|Overall Study|Lack of Efficacy|0|||
48568598|NCT00955409|156275454|FG009|Overall Study|Lack of Efficacy|0|||
48568599|NCT00955409|156275445|FG000|Overall Study|Withdrawal by Subject|1|||
48568600|NCT00955409|156275446|FG001|Overall Study|Withdrawal by Subject|0|||
48568601|NCT00955409|156275447|FG002|Overall Study|Withdrawal by Subject|5|||
48568602|NCT00955409|156275448|FG003|Overall Study|Withdrawal by Subject|2|||
48568603|NCT00955409|156275449|FG004|Overall Study|Withdrawal by Subject|0|||
48568604|NCT00955409|156275450|FG005|Overall Study|Withdrawal by Subject|0|||
48568605|NCT00955409|156275451|FG006|Overall Study|Withdrawal by Subject|2|||
48568606|NCT00955409|156275452|FG007|Overall Study|Withdrawal by Subject|0|||
48568607|NCT00955409|156275453|FG008|Overall Study|Withdrawal by Subject|1|||
48568608|NCT00955409|156275454|FG009|Overall Study|Withdrawal by Subject|0|||
48568609|NCT00955409|156275445|FG000|Overall Study|Caregiver Request|2|||
48568610|NCT00955409|156275446|FG001|Overall Study|Caregiver Request|0|||
48568611|NCT00955409|156275447|FG002|Overall Study|Caregiver Request|6|||
48568612|NCT00955409|156275448|FG003|Overall Study|Caregiver Request|5|||
48568613|NCT00955409|156275449|FG004|Overall Study|Caregiver Request|0|||
48568614|NCT00955409|156275450|FG005|Overall Study|Caregiver Request|2|||
48568615|NCT00955409|156275451|FG006|Overall Study|Caregiver Request|3|||
48568616|NCT00955409|156275452|FG007|Overall Study|Caregiver Request|1|||
48568617|NCT00955409|156275453|FG008|Overall Study|Caregiver Request|3|||
48568618|NCT00955409|156275454|FG009|Overall Study|Caregiver Request|0|||
48568619|NCT00955409|156275445|FG000|Overall Study|Investigator Request|0|||
48568620|NCT00955409|156275446|FG001|Overall Study|Investigator Request|0|||
48568621|NCT00955409|156275447|FG002|Overall Study|Investigator Request|1|||
48568622|NCT00955409|156275448|FG003|Overall Study|Investigator Request|0|||
48568623|NCT00955409|156275449|FG004|Overall Study|Investigator Request|0|||
48568624|NCT00955409|156275450|FG005|Overall Study|Investigator Request|0|||
48568625|NCT00955409|156275451|FG006|Overall Study|Investigator Request|0|||
48568626|NCT00955409|156275452|FG007|Overall Study|Investigator Request|0|||
48568627|NCT00955409|156275453|FG008|Overall Study|Investigator Request|0|||
48568628|NCT00955409|156275454|FG009|Overall Study|Investigator Request|0|||
48568629|NCT00955409|156275445|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
48568630|NCT00955409|156275446|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48568631|NCT00955409|156275447|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
48568632|NCT00955409|156275448|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
48568633|NCT00955409|156275449|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
48568634|NCT00955409|156275450|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
48568635|NCT00955409|156275451|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
48568636|NCT00955409|156275452|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
48568637|NCT00955409|156275453|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
48568638|NCT00955409|156275454|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
48568639|NCT00955409|156275445|FG000|Overall Study|Lost to Follow-up|0|||
48568640|NCT00955409|156275446|FG001|Overall Study|Lost to Follow-up|0|||
48568641|NCT00955409|156275447|FG002|Overall Study|Lost to Follow-up|1|||
48568642|NCT00955409|156275448|FG003|Overall Study|Lost to Follow-up|0|||
48568643|NCT00955409|156275449|FG004|Overall Study|Lost to Follow-up|0|||
48568644|NCT00955409|156275450|FG005|Overall Study|Lost to Follow-up|0|||
48568645|NCT00955409|156275451|FG006|Overall Study|Lost to Follow-up|1|||
48568646|NCT00955409|156275452|FG007|Overall Study|Lost to Follow-up|0|||
48568647|NCT00955409|156275453|FG008|Overall Study|Lost to Follow-up|0|||
48568648|NCT00955409|156275454|FG009|Overall Study|Lost to Follow-up|0|||
48568649|NCT00955409|156275445|FG000|Overall Study|Failed to Return|2|||
48568650|NCT00955409|156275446|FG001|Overall Study|Failed to Return|0|||
48568651|NCT00955409|156275447|FG002|Overall Study|Failed to Return|0|||
48568652|NCT00955409|156275448|FG003|Overall Study|Failed to Return|0|||
48568653|NCT00955409|156275449|FG004|Overall Study|Failed to Return|0|||
48568654|NCT00955409|156275450|FG005|Overall Study|Failed to Return|0|||
48568655|NCT00955409|156275451|FG006|Overall Study|Failed to Return|0|||
48568656|NCT00955409|156275452|FG007|Overall Study|Failed to Return|2|||
48568657|NCT00955409|156275453|FG008|Overall Study|Failed to Return|0|||
48568658|NCT00955409|156275454|FG009|Overall Study|Failed to Return|0|||
48568659|NCT00955409|156275445|FG000|Overall Study|Adverse Event (AE)|2|||
48568660|NCT00955409|156275446|FG001|Overall Study|Adverse Event (AE)|0|||
48568661|NCT00955409|156275447|FG002|Overall Study|Adverse Event (AE)|0|||
48568662|NCT00955409|156275448|FG003|Overall Study|Adverse Event (AE)|0|||
48568663|NCT00955409|156275449|FG004|Overall Study|Adverse Event (AE)|0|||
48568664|NCT00955409|156275450|FG005|Overall Study|Adverse Event (AE)|1|||
48568665|NCT00955409|156275451|FG006|Overall Study|Adverse Event (AE)|2|||
48568666|NCT00955409|156275452|FG007|Overall Study|Adverse Event (AE)|0|||
48568667|NCT00955409|156275453|FG008|Overall Study|Adverse Event (AE)|2|||
48568668|NCT00955409|156275454|FG009|Overall Study|Adverse Event (AE)|0|||
48568669|NCT00955409|156275445|FG000|Overall Study|Reason not Specified|2|||
48568670|NCT00955409|156275446|FG001|Overall Study|Reason not Specified|1|||
48568671|NCT00955409|156275447|FG002|Overall Study|Reason not Specified|13|||
48568672|NCT00955409|156275448|FG003|Overall Study|Reason not Specified|1|||
48568673|NCT00955409|156275449|FG004|Overall Study|Reason not Specified|2|||
48568674|NCT00955409|156275450|FG005|Overall Study|Reason not Specified|0|||
48568675|NCT00955409|156275451|FG006|Overall Study|Reason not Specified|16|||
48568676|NCT00955409|156275452|FG007|Overall Study|Reason not Specified|0|||
48568677|NCT00955409|156275453|FG008|Overall Study|Reason not Specified|8|||
48568678|NCT00955409|156275454|FG009|Overall Study|Reason not Specified|1|||
48568679|NCT05326529|156275459|FG000|Overall Study|Lack of Efficacy|0|||
48568680|NCT05326529|156275460|FG001|Overall Study|Lack of Efficacy|1|||
48568681|NCT05326529|156275461|FG002|Overall Study|Lack of Efficacy|0|||
48568682|NCT05326529|156275459|FG000|Overall Study|Physician Decision|0|||
48568683|NCT05326529|156275460|FG001|Overall Study|Physician Decision|0|||
48568684|NCT05326529|156275461|FG002|Overall Study|Physician Decision|2|||
48568685|NCT00468481|156275464|FG000|Overall Study|Adverse Event|13|||
48568686|NCT00468481|156275465|FG001|Overall Study|Adverse Event|3|||
48568687|NCT00468481|156275464|FG000|Overall Study|Lost to Follow-up|25|||
48568688|NCT00468481|156275465|FG001|Overall Study|Lost to Follow-up|8|||
48568689|NCT00468481|156275464|FG000|Overall Study|Pregnancy|2|||
48568690|NCT00468481|156275465|FG001|Overall Study|Pregnancy|0|||
48568691|NCT00468481|156275464|FG000|Overall Study|Protocol Violation|18|||
48568692|NCT00468481|156275465|FG001|Overall Study|Protocol Violation|8|||
48568693|NCT00468481|156275464|FG000|Overall Study|Withdrawal by Subject|12|||
48568694|NCT00468481|156275465|FG001|Overall Study|Withdrawal by Subject|3|||
48568695|NCT00468481|156275464|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
48568696|NCT00468481|156275465|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
48568697|NCT00468481|156275464|FG000|Overall Study|Prohibited Medication|1|||
48568698|NCT00468481|156275465|FG001|Overall Study|Prohibited Medication|1|||
48568699|NCT00468481|156275464|FG000|Overall Study|Egg Donor|1|||
48568700|NCT00468481|156275465|FG001|Overall Study|Egg Donor|0|||
48568701|NCT00468481|156275464|FG000|Overall Study|Moved out of area|4|||
48568702|NCT00468481|156275465|FG001|Overall Study|Moved out of area|1|||
48568703|NCT00468481|156275464|FG000|Overall Study|Non-Compliance|5|||
48568704|NCT00468481|156275465|FG001|Overall Study|Non-Compliance|0|||
48568705|NCT00468481|156275464|FG000|Overall Study|Other|6|||
48568706|NCT00468481|156275465|FG001|Overall Study|Other|0|||
48568707|NCT00154284|156275466|FG000|Overall Study|Adverse Event|6|||
48568708|NCT00154284|156275467|FG001|Overall Study|Adverse Event|9|||
48568709|NCT00154284|156275466|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48568710|NCT00154284|156275467|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48568711|NCT00154284|156275466|FG000|Overall Study|Lack of Efficacy|1|||
48568712|NCT00154284|156275467|FG001|Overall Study|Lack of Efficacy|2|||
48568713|NCT00154284|156275466|FG000|Overall Study|Protocol Violation|0|||
48568714|NCT00154284|156275467|FG001|Overall Study|Protocol Violation|1|||
48568715|NCT00593684|156275469|FG000|Overall Study|Death|2|||
48568716|NCT00593684|156275470|FG001|Overall Study|Death|1|||
48568717|NCT00326716|156275471|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
48568718|NCT00326716|156275472|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
48568719|NCT00326716|156275473|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
48568720|NCT00326716|156275474|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
48568721|NCT03806933|156275477|FG000|Main Period|Physician Decision|0|||
48568722|NCT03806933|156275478|FG001|Main Period|Physician Decision|0|||
48568723|NCT03806933|156275479|FG002|Main Period|Physician Decision|0|||
48568724|NCT03806933|156275480|FG003|Main Period|Physician Decision|1|||
48568725|NCT03806933|156275477|FG000|Main Period|Pregnancy|0|||
48568726|NCT03806933|156275478|FG001|Main Period|Pregnancy|0|||
48568727|NCT03806933|156275479|FG002|Main Period|Pregnancy|1|||
48568728|NCT03806933|156275480|FG003|Main Period|Pregnancy|0|||
48568729|NCT03806933|156275477|FG000|Main Period|Withdrawal by Subject|2|||
48568730|NCT03806933|156275478|FG001|Main Period|Withdrawal by Subject|1|||
48568731|NCT03806933|156275479|FG002|Main Period|Withdrawal by Subject|1|||
48568732|NCT03806933|156275480|FG003|Main Period|Withdrawal by Subject|2|||
48568733|NCT03806933|156275477|FG000|Main Period|Lost to Follow-up|2|||
48568734|NCT03806933|156275478|FG001|Main Period|Lost to Follow-up|2|||
48568735|NCT03806933|156275479|FG002|Main Period|Lost to Follow-up|0|||
48568736|NCT03806933|156275480|FG003|Main Period|Lost to Follow-up|0|||
48568737|NCT03806933|156275477|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
48568738|NCT03806933|156275478|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
48568739|NCT03806933|156275479|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
48568740|NCT03806933|156275480|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
48568741|NCT00684411|156275484|FG000|Overall Study|New Primary Cancer|1|||
48568742|NCT00684411|156275484|FG000|Overall Study|Disease Progression|10|||
48568743|NCT00684411|156275484|FG000|Overall Study|Adverse Event|1|||
48568744|NCT02549859|156275485|FG000|Long-term 60 Hz DBS|Study Closed|1|||
48568745|NCT00734162|156275486|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
48568746|NCT00734162|156275487|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
48568747|NCT00734162|156275488|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
48568748|NCT00734162|156275489|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
48568749|NCT00734162|156275486|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
48568750|NCT00734162|156275487|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
48568751|NCT00734162|156275488|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
48568752|NCT00734162|156275489|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
48568753|NCT00734162|156275486|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
48568754|NCT00734162|156275487|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
48568755|NCT00734162|156275488|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
48568756|NCT00734162|156275489|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
48568757|NCT00734162|156275486|FG000|Open-Label Phase|Withdrew Consent|1|||
48568758|NCT00734162|156275487|FG001|Open-Label Phase|Withdrew Consent|0|||
48568759|NCT00734162|156275488|FG002|Open-Label Phase|Withdrew Consent|1|||
48568760|NCT00734162|156275489|FG003|Open-Label Phase|Withdrew Consent|1|||
48568761|NCT00734162|156275486|FG000|Open-Label Phase|Lost to Follow-up|1|||
48568762|NCT00734162|156275487|FG001|Open-Label Phase|Lost to Follow-up|2|||
48568763|NCT00734162|156275488|FG002|Open-Label Phase|Lost to Follow-up|0|||
48568764|NCT00734162|156275489|FG003|Open-Label Phase|Lost to Follow-up|1|||
48568765|NCT00734162|156275486|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
48568766|NCT00734162|156275487|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
48568767|NCT00734162|156275488|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
48735657|NCT02215096|156883706|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
48568768|NCT00734162|156275489|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
48568769|NCT05486091|156275490|FG000|Overall Study|Withdrawal by Subject|1|||
48568770|NCT05486091|156275490|FG000|Overall Study|Lost to Follow-up|2|||
48568771|NCT00728468|156275496|FG000|Overall Study|Enrolled but not treated|1|||
48568772|NCT00728468|156275496|FG000|Overall Study|Death|1|||
48568773|NCT00728468|156275496|FG000|Overall Study|Protocol Violation|4|||
48568774|NCT00728468|156275496|FG000|Overall Study|Objective progression or relapse|9|||
48568775|NCT00728468|156275496|FG000|Overall Study|Study terminated by sponsor|1|||
48568776|NCT01568034|156275497|FG000|Overall Study|Withdrawal by Subject|1|||
48568777|NCT01568034|156275498|FG001|Overall Study|Withdrawal by Subject|0|||
48568778|NCT01568034|156275499|FG002|Overall Study|Withdrawal by Subject|0|||
48568779|NCT01568034|156275500|FG003|Overall Study|Withdrawal by Subject|0|||
48568780|NCT02028767|156275504|FG000|Treatment Period 2|Non compliant with protocol|1|||
48568781|NCT02028767|156275505|FG001|Treatment Period 2|Non compliant with protocol|0|||
48568782|NCT02028767|156275504|FG000|Treatment Period 2|Reason other than those specified above|1|||
48568783|NCT02028767|156275505|FG001|Treatment Period 2|Reason other than those specified above|0|||
48568784|NCT00561392|156275506|FG000|Overall Study|Adverse Event|38|||
48568785|NCT00561392|156275506|FG000|Overall Study|Lack of Efficacy|2|||
48568786|NCT00561392|156275506|FG000|Overall Study|Protocol Violation|1|||
48568787|NCT00561392|156275506|FG000|Overall Study|Withdrawal by Subject|8|||
48568788|NCT00561392|156275506|FG000|Overall Study|Administrative problems|4|||
48568789|NCT01532518|156275507|FG000|Overall Study|Withdrawal by Subject|0|||
48568790|NCT01532518|156275508|FG001|Overall Study|Withdrawal by Subject|0|||
48568791|NCT01532518|156275509|FG002|Overall Study|Withdrawal by Subject|1|||
48568792|NCT03656692|156275519|FG000|Overall Study|Worsening of disease activity|2|||
48568793|NCT03656692|156275519|FG000|Overall Study|Physician Decision|1|||
48568794|NCT02498444|156275520|FG000|Overall Study|Withdrawal by Subject|3|||
48568795|NCT02498444|156275521|FG001|Overall Study|Withdrawal by Subject|0|||
48568796|NCT02498444|156275520|FG000|Overall Study|Physician Decision|1|||
48568797|NCT02498444|156275521|FG001|Overall Study|Physician Decision|0|||
48568798|NCT02968173|156275524|FG000|Overall Study|Withdrawal by Subject|1|||
48568799|NCT00356148|156275525|FG000|Overall Study|Reoperation within 30 days|2|||
48568800|NCT00356148|156275526|FG001|Overall Study|Reoperation within 30 days|1|||
48568801|NCT00179660|156275549|FG000|Overall Study|Adverse Event|7|||
48568802|NCT00179660|156275549|FG000|Overall Study|Lack of therapeutic effect|28|||
48568803|NCT00179660|156275549|FG000|Overall Study|Withdrawal by Subject|2|||
48568804|NCT00179660|156275549|FG000|Overall Study|Lost to Follow-up|1|||
48568805|NCT00179660|156275549|FG000|Overall Study|Death|3|||
48568806|NCT00179660|156275549|FG000|Overall Study|Other - Unspecified|9|||
48568807|NCT02282813|156275557|FG000|Overall Study|Withdrawal by Subject|4|||
48568808|NCT02282813|156275558|FG001|Overall Study|Withdrawal by Subject|5|||
48568809|NCT02282813|156275559|FG002|Overall Study|Withdrawal by Subject|0|||
48568810|NCT02282813|156275557|FG000|Overall Study|Adverse Event|3|||
48568811|NCT02282813|156275558|FG001|Overall Study|Adverse Event|10|||
48568812|NCT02282813|156275559|FG002|Overall Study|Adverse Event|1|||
48568813|NCT02282813|156275557|FG000|Overall Study|Subject non-compliance|1|||
48568814|NCT02282813|156275558|FG001|Overall Study|Subject non-compliance|4|||
48568815|NCT02282813|156275559|FG002|Overall Study|Subject non-compliance|0|||
48568816|NCT02282813|156275557|FG000|Overall Study|Physician Decision|0|||
48568817|NCT02282813|156275558|FG001|Overall Study|Physician Decision|3|||
48568818|NCT02282813|156275559|FG002|Overall Study|Physician Decision|1|||
48568819|NCT02282813|156275557|FG000|Overall Study|Lost to Follow-up|2|||
48568820|NCT02282813|156275558|FG001|Overall Study|Lost to Follow-up|0|||
48735658|NCT02215096|156883707|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
48735659|NCT02215096|156883708|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
48568821|NCT02282813|156275559|FG002|Overall Study|Lost to Follow-up|1|||
48568822|NCT02282813|156275557|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
48568823|NCT02282813|156275558|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
48735660|NCT02215096|156883709|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
48568824|NCT02282813|156275559|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
48568825|NCT02282813|156275557|FG000|Overall Study|Lack of Efficacy|1|||
48568826|NCT02282813|156275558|FG001|Overall Study|Lack of Efficacy|0|||
48568827|NCT02282813|156275559|FG002|Overall Study|Lack of Efficacy|0|||
48568828|NCT02282813|156275557|FG000|Overall Study|Administrative reasons|0|||
48735661|NCT02215096|156883705|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
48568829|NCT02282813|156275558|FG001|Overall Study|Administrative reasons|1|||
48568830|NCT02282813|156275559|FG002|Overall Study|Administrative reasons|0|||
48568831|NCT00402688|156275562|FG000|Overall Study|Adverse Event|12|||
48568832|NCT00402688|156275563|FG001|Overall Study|Adverse Event|9|||
48568833|NCT00402688|156275564|FG002|Overall Study|Adverse Event|3|||
48568834|NCT00402688|156275562|FG000|Overall Study|Withdrawal by Subject|3|||
48568835|NCT00402688|156275563|FG001|Overall Study|Withdrawal by Subject|1|||
48568836|NCT00402688|156275564|FG002|Overall Study|Withdrawal by Subject|1|||
48568837|NCT00402688|156275562|FG000|Overall Study|Physician Decision|0|||
48568838|NCT00402688|156275563|FG001|Overall Study|Physician Decision|0|||
48568839|NCT00402688|156275564|FG002|Overall Study|Physician Decision|1|||
48568840|NCT00402688|156275562|FG000|Overall Study|Lack of Efficacy|4|||
48568841|NCT00402688|156275563|FG001|Overall Study|Lack of Efficacy|4|||
48568842|NCT00402688|156275564|FG002|Overall Study|Lack of Efficacy|5|||
48568843|NCT00402688|156275562|FG000|Overall Study|Protocol Violation|1|||
48568844|NCT00402688|156275563|FG001|Overall Study|Protocol Violation|1|||
48568845|NCT00402688|156275564|FG002|Overall Study|Protocol Violation|1|||
48568846|NCT00402688|156275562|FG000|Overall Study|Lost to Follow-up|1|||
48568847|NCT00402688|156275563|FG001|Overall Study|Lost to Follow-up|0|||
48568848|NCT00402688|156275564|FG002|Overall Study|Lost to Follow-up|2|||
48568849|NCT00402688|156275562|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
48568850|NCT00402688|156275563|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
48568851|NCT00402688|156275564|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
48568852|NCT00402688|156275562|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
48568853|NCT00402688|156275563|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
48568854|NCT00402688|156275564|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
48568855|NCT00402688|156275562|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
48568856|NCT00402688|156275563|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
48568857|NCT00402688|156275564|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
48568858|NCT00178685|156275565|FG000|Overall Study|Death|3|||
48568859|NCT00178685|156275566|FG001|Overall Study|Death|3|||
48568860|NCT00178685|156275567|FG002|Overall Study|Death|6|||
48568861|NCT00178685|156275565|FG000|Overall Study|Lost to Follow-up|100|||
48568862|NCT00178685|156275566|FG001|Overall Study|Lost to Follow-up|187|||
48568863|NCT00178685|156275567|FG002|Overall Study|Lost to Follow-up|183|||
48568864|NCT00178685|156275565|FG000|Overall Study|Withdrawal by Subject|8|||
48568865|NCT00178685|156275566|FG001|Overall Study|Withdrawal by Subject|14|||
48568866|NCT00178685|156275567|FG002|Overall Study|Withdrawal by Subject|7|||
48568867|NCT00492648|156275568|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
48568868|NCT00492648|156275569|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
48568869|NCT03668119|156275570|FG000|Pre-treatment|Disease Progression|1|||
48568870|NCT03668119|156275571|FG001|Pre-treatment|Disease Progression|0|||
48568871|NCT03668119|156275570|FG000|Treatment|Disease Progression|76|||
48568872|NCT03668119|156275571|FG001|Treatment|Disease Progression|57|||
48568873|NCT03668119|156275570|FG000|Treatment|Study drug toxicity|19|||
48568874|NCT03668119|156275571|FG001|Treatment|Study drug toxicity|1|||
48568875|NCT03668119|156275570|FG000|Treatment|Death|3|||
48568876|NCT03668119|156275571|FG001|Treatment|Death|0|||
48568877|NCT03668119|156275570|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
48568878|NCT03668119|156275571|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
48568879|NCT03668119|156275570|FG000|Treatment|Withdrawal by Subject|1|||
48568880|NCT03668119|156275571|FG001|Treatment|Withdrawal by Subject|1|||
48568881|NCT03668119|156275570|FG000|Treatment|Participant request to discontinue study treatment|3|||
48568882|NCT03668119|156275571|FG001|Treatment|Participant request to discontinue study treatment|1|||
48568883|NCT03668119|156275570|FG000|Treatment|Maximum Clinical Benefit|0|||
48568884|NCT03668119|156275571|FG001|Treatment|Maximum Clinical Benefit|1|||
48568885|NCT03668119|156275570|FG000|Treatment|Participants completed treatment|27|||
48568886|NCT03668119|156275571|FG001|Treatment|Participants completed treatment|11|||
48568887|NCT03668119|156275570|FG000|Treatment|Other reasons|2|||
48568888|NCT03668119|156275571|FG001|Treatment|Other reasons|1|||
48568889|NCT04468347|156275574|FG000|Overall Study|Withdrawal by Subject|0|||
48568890|NCT04468347|156275575|FG001|Overall Study|Withdrawal by Subject|1|||
48568891|NCT04468347|156275576|FG002|Overall Study|Withdrawal by Subject|3|||
48568892|NCT04468347|156275577|FG003|Overall Study|Withdrawal by Subject|3|||
48568893|NCT04468347|156275574|FG000|Overall Study|Lost to Follow-up|0|||
48568894|NCT04468347|156275575|FG001|Overall Study|Lost to Follow-up|0|||
48568895|NCT04468347|156275576|FG002|Overall Study|Lost to Follow-up|1|||
48568896|NCT04468347|156275577|FG003|Overall Study|Lost to Follow-up|1|||
48568897|NCT04468347|156275574|FG000|Overall Study|Physician Decision|1|||
48568898|NCT04468347|156275575|FG001|Overall Study|Physician Decision|0|||
48568899|NCT04468347|156275576|FG002|Overall Study|Physician Decision|2|||
48568900|NCT04468347|156275577|FG003|Overall Study|Physician Decision|0|||
48568901|NCT04468347|156275574|FG000|Overall Study|Protocol Violation|1|||
48568902|NCT04468347|156275575|FG001|Overall Study|Protocol Violation|0|||
48568903|NCT04468347|156275576|FG002|Overall Study|Protocol Violation|0|||
48568904|NCT04468347|156275577|FG003|Overall Study|Protocol Violation|0|||
48568905|NCT01732458|156275578|FG000|Overall Study|Lost to Follow-up|0|||
48568906|NCT01732458|156275579|FG001|Overall Study|Lost to Follow-up|2|||
48568907|NCT01732458|156275580|FG002|Overall Study|Lost to Follow-up|0|||
48568908|NCT01732458|156275581|FG003|Overall Study|Lost to Follow-up|0|||
48568909|NCT01732458|156275578|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48568910|NCT01732458|156275579|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48568911|NCT01732458|156275580|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48568912|NCT01732458|156275581|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48568913|NCT01732458|156275578|FG000|Overall Study|Physician Decision|1|||
48568914|NCT01732458|156275579|FG001|Overall Study|Physician Decision|2|||
48568915|NCT01732458|156275580|FG002|Overall Study|Physician Decision|2|||
48568916|NCT01732458|156275581|FG003|Overall Study|Physician Decision|0|||
48568917|NCT01732458|156275578|FG000|Overall Study|Protocol Violation|2|||
48568918|NCT01732458|156275579|FG001|Overall Study|Protocol Violation|0|||
48568919|NCT01732458|156275580|FG002|Overall Study|Protocol Violation|0|||
48568920|NCT01732458|156275581|FG003|Overall Study|Protocol Violation|2|||
48568921|NCT01732458|156275578|FG000|Overall Study|Screen Failure|0|||
48568922|NCT01732458|156275579|FG001|Overall Study|Screen Failure|1|||
48568923|NCT01732458|156275580|FG002|Overall Study|Screen Failure|0|||
48568924|NCT01732458|156275581|FG003|Overall Study|Screen Failure|0|||
48568925|NCT03474731|156275586|FG000|Overall Study|Withdrawal by Subject|36|||
48568926|NCT03474731|156275587|FG001|Overall Study|Withdrawal by Subject|29|||
48568927|NCT03474731|156275588|FG002|Overall Study|Withdrawal by Subject|11|||
48568928|NCT03474731|156275589|FG003|Overall Study|Withdrawal by Subject|27|||
48568929|NCT03474731|156275586|FG000|Overall Study|COVID|0|||
48568930|NCT03474731|156275587|FG001|Overall Study|COVID|23|||
48568931|NCT03474731|156275588|FG002|Overall Study|COVID|0|||
48568932|NCT03474731|156275589|FG003|Overall Study|COVID|0|||
48568933|NCT03474731|156275586|FG000|Overall Study|Participant moved from area|1|||
48568934|NCT03474731|156275587|FG001|Overall Study|Participant moved from area|0|||
48568935|NCT03474731|156275588|FG002|Overall Study|Participant moved from area|0|||
48568936|NCT03474731|156275589|FG003|Overall Study|Participant moved from area|0|||
48568937|NCT03474731|156275586|FG000|Overall Study|Lost to Follow-up|11|||
48568938|NCT03474731|156275587|FG001|Overall Study|Lost to Follow-up|3|||
48568939|NCT03474731|156275588|FG002|Overall Study|Lost to Follow-up|18|||
48568940|NCT03474731|156275589|FG003|Overall Study|Lost to Follow-up|17|||
48568941|NCT03474731|156275586|FG000|Overall Study|Death|0|||
48568942|NCT03474731|156275587|FG001|Overall Study|Death|1|||
48568943|NCT03474731|156275588|FG002|Overall Study|Death|0|||
48568944|NCT03474731|156275589|FG003|Overall Study|Death|0|||
48568945|NCT03474731|156275586|FG000|Overall Study|Participant Removed|0|||
48568946|NCT03474731|156275587|FG001|Overall Study|Participant Removed|0|||
48568947|NCT03474731|156275588|FG002|Overall Study|Participant Removed|0|||
48568948|NCT03474731|156275589|FG003|Overall Study|Participant Removed|1|||
48568949|NCT00813150|156275592|FG000|Treatment Period|Adverse Event|16|||
48568950|NCT00813150|156275593|FG001|Treatment Period|Adverse Event|15|||
48568951|NCT00813150|156275592|FG000|Treatment Period|Death|2|||
48568952|NCT00813150|156275593|FG001|Treatment Period|Death|0|||
48568953|NCT00813150|156275592|FG000|Treatment Period|Progressive disease|1|||
48568954|NCT00813150|156275593|FG001|Treatment Period|Progressive disease|0|||
48735662|NCT02215096|156883706|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
48735663|NCT02215096|156883707|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
48735664|NCT02215096|156883708|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
48568955|NCT00813150|156275592|FG000|Treatment Period|Complete response|0|||
48568956|NCT00813150|156275593|FG001|Treatment Period|Complete response|1|||
48568957|NCT00813150|156275592|FG000|Treatment Period|Stable disease|1|||
48568958|NCT00813150|156275593|FG001|Treatment Period|Stable disease|2|||
48568959|NCT00813150|156275592|FG000|Treatment Period|Protocol Violation|3|||
48568960|NCT00813150|156275593|FG001|Treatment Period|Protocol Violation|4|||
48568961|NCT00813150|156275592|FG000|Treatment Period|Withdrawal by Subject|5|||
48568962|NCT00813150|156275593|FG001|Treatment Period|Withdrawal by Subject|3|||
48568963|NCT00813150|156275592|FG000|Treatment Period|Non compliance|0|||
48568964|NCT00813150|156275593|FG001|Treatment Period|Non compliance|1|||
48568965|NCT00813150|156275592|FG000|Treatment Period|Reason not specified|3|||
48568966|NCT00813150|156275593|FG001|Treatment Period|Reason not specified|4|||
48568967|NCT00813150|156275592|FG000|Treatment Period|Data not available|1|||
48568968|NCT00813150|156275593|FG001|Treatment Period|Data not available|2|||
48568969|NCT00813150|156275592|FG000|Long Term Follow-up|Death|0|||
48568970|NCT00813150|156275593|FG001|Long Term Follow-up|Death|4|||
48568971|NCT00813150|156275592|FG000|Long Term Follow-up|Other|0|||
48568972|NCT00813150|156275593|FG001|Long Term Follow-up|Other|3|||
48568973|NCT00813150|156275592|FG000|Long Term Follow-up|Lost to Follow-up|2|||
48568974|NCT00813150|156275593|FG001|Long Term Follow-up|Lost to Follow-up|0|||
48568975|NCT00813150|156275592|FG000|Long Term Follow-up|Progression/Relapse|22|||
48568976|NCT00813150|156275593|FG001|Long Term Follow-up|Progression/Relapse|24|||
48568977|NCT00554515|156275594|FG000|Overall Study|Withdrawal by Subject|3|||
48568978|NCT00554515|156275594|FG000|Overall Study|Disease progression|52|||
48568979|NCT00554515|156275594|FG000|Overall Study|Physician Decision|18|||
48568980|NCT00554515|156275594|FG000|Overall Study|Withdrawal by Subject|11|||
48568981|NCT00554515|156275594|FG000|Overall Study|Adverse Event|9|||
48568982|NCT00554515|156275594|FG000|Overall Study|Death|2|||
48568983|NCT00554515|156275594|FG000|Overall Study|Achieved Stable Disease|7|||
48568984|NCT00554515|156275594|FG000|Overall Study|Other|1|||
48568985|NCT00554515|156275594|FG000|Overall Study|Misc|15|||
48568986|NCT00994461|156275595|FG000|Overall Study|Adverse Event|2|||
48568987|NCT00994461|156275596|FG001|Overall Study|Adverse Event|1|||
48568988|NCT00994461|156275597|FG002|Overall Study|Adverse Event|0|||
48568989|NCT00952068|156275601|FG000|Overall Study|Adverse Event|3|||
48568990|NCT00952068|156275601|FG000|Overall Study|Withdrawal by Subject|4|||
48568991|NCT00766636|156275602|FG000|Overall Study|Withdrawal by Subject|1|||
48568992|NCT00766636|156275603|FG001|Overall Study|Withdrawal by Subject|1|||
48568993|NCT00766636|156275602|FG000|Overall Study|Incomplete Treatment|0|||
48568994|NCT00766636|156275603|FG001|Overall Study|Incomplete Treatment|1|||
48735665|NCT02215096|156883709|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
48735666|NCT02840721|156883710|FG000|Treatment Period|Adverse Event|1|||
48617398|NCT04491994|156456229|FG000|Overall Study|Withdrawal by Subject|10|||
48617399|NCT04491994|156456230|FG001|Overall Study|Withdrawal by Subject|5|||
48617400|NCT04491994|156456229|FG000|Overall Study|developed fever > 3 days|4|||
48617401|NCT04491994|156456230|FG001|Overall Study|developed fever > 3 days|1|||
48617402|NCT04491994|156456229|FG000|Overall Study|Protocol Violation|11|||
48617403|NCT04491994|156456230|FG001|Overall Study|Protocol Violation|2|||
48617404|NCT04491994|156456229|FG000|Overall Study|Lost to Follow-up|4|||
48617405|NCT04491994|156456230|FG001|Overall Study|Lost to Follow-up|3|||
48617406|NCT02448043|156456239|FG000|Overall Study|Withdrawal by Subject|2|||
48617407|NCT02448043|156456240|FG001|Overall Study|Withdrawal by Subject|2|||
48617408|NCT02448043|156456239|FG000|Overall Study|Protocol Violation|1|||
48617409|NCT02448043|156456240|FG001|Overall Study|Protocol Violation|2|||
48617410|NCT01138046|156456241|FG000|Overall Study|Withdrawal due to death|6|||
48617411|NCT00827242|156456242|FG000|Overall Study|Withdrawal by Subject|2|||
48617412|NCT00827242|156456243|FG001|Overall Study|Withdrawal by Subject|4|||
48568995|NCT00766636|156275602|FG000|Overall Study|Adverse Event|1|||
48568996|NCT00766636|156275603|FG001|Overall Study|Adverse Event|0|||
48568997|NCT00766636|156275602|FG000|Overall Study|Disease Progression|1|||
48568998|NCT00766636|156275603|FG001|Overall Study|Disease Progression|0|||
48568999|NCT03515811|156275604|FG000|Overall Study|Lost to Follow-up|2|||
48569000|NCT03515811|156275605|FG001|Overall Study|Lost to Follow-up|1|||
48569001|NCT03515811|156275604|FG000|Overall Study|Protocol Violation|1|||
48569002|NCT03515811|156275605|FG001|Overall Study|Protocol Violation|1|||
48569003|NCT03515811|156275604|FG000|Overall Study|Death|1|||
48569004|NCT03515811|156275605|FG001|Overall Study|Death|1|||
48569005|NCT03515811|156275604|FG000|Overall Study|Withdrawal by Subject|0|||
48569006|NCT03515811|156275605|FG001|Overall Study|Withdrawal by Subject|2|||
48569007|NCT03515811|156275604|FG000|Overall Study|Technical Problems|1|||
48569008|NCT03515811|156275605|FG001|Overall Study|Technical Problems|0|||
48569009|NCT03515811|156275604|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
48569010|NCT03515811|156275605|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
48569011|NCT03515811|156275604|FG000|Overall Study|COVID-19|0|||
48569012|NCT03515811|156275605|FG001|Overall Study|COVID-19|1|||
48569013|NCT01870973|156275614|FG000|Overall Study|Lost to Follow-up|10|||
48569014|NCT01870973|156275615|FG001|Overall Study|Lost to Follow-up|3|||
48569015|NCT01483027|156275616|FG000|Overall Study|Administrative Reasons|2|||
48569016|NCT01483027|156275617|FG001|Overall Study|Administrative Reasons|1|||
48569017|NCT01483027|156275616|FG000|Overall Study|Withdrawal by Subject|21|||
48569018|NCT01483027|156275617|FG001|Overall Study|Withdrawal by Subject|32|||
48569019|NCT01483027|156275616|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
48569020|NCT01483027|156275617|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
48569021|NCT01483027|156275616|FG000|Overall Study|Lost to Follow-up|1|||
48569022|NCT01483027|156275617|FG001|Overall Study|Lost to Follow-up|1|||
48569023|NCT01483027|156275616|FG000|Overall Study|Adverse Event|0|||
48569024|NCT01483027|156275617|FG001|Overall Study|Adverse Event|1|||
48569025|NCT01483027|156275616|FG000|Overall Study|Withdrawal by Subject|0|||
48569026|NCT01483027|156275617|FG001|Overall Study|Withdrawal by Subject|1|||
48569027|NCT01668173|156275618|FG000|Overall Study|Adverse Event|3|||
48569028|NCT01668173|156275618|FG000|Overall Study|Trial suspension|4|||
48569029|NCT01295827|156275619|FG000|Overall Study|Adverse Event|1|||
48569030|NCT01295827|156275620|FG001|Overall Study|Adverse Event|2|||
48569031|NCT01295827|156275621|FG002|Overall Study|Adverse Event|2|||
48569032|NCT01295827|156275622|FG003|Overall Study|Adverse Event|1|||
48569033|NCT01295827|156275623|FG004|Overall Study|Adverse Event|1|||
48569034|NCT01295827|156275624|FG005|Overall Study|Adverse Event|4|||
48569035|NCT01295827|156275625|FG006|Overall Study|Adverse Event|15|||
48569036|NCT01295827|156275626|FG007|Overall Study|Adverse Event|49|||
48569037|NCT01295827|156275627|FG008|Overall Study|Adverse Event|22|||
48569038|NCT01295827|156275628|FG009|Overall Study|Adverse Event|7|||
48569039|NCT01295827|156275629|FG010|Overall Study|Adverse Event|50|||
48569040|NCT01295827|156275630|FG011|Overall Study|Adverse Event|21|||
48569041|NCT01295827|156275631|FG012|Overall Study|Adverse Event|0|||
48569042|NCT01295827|156275632|FG013|Overall Study|Adverse Event|0|||
48569043|NCT01295827|156275633|FG014|Overall Study|Adverse Event|0|||
48569044|NCT01295827|156275619|FG000|Overall Study|Lost to Follow-up|0|||
48569045|NCT01295827|156275620|FG001|Overall Study|Lost to Follow-up|0|||
48569046|NCT01295827|156275621|FG002|Overall Study|Lost to Follow-up|3|||
48569047|NCT01295827|156275622|FG003|Overall Study|Lost to Follow-up|0|||
48569048|NCT01295827|156275623|FG004|Overall Study|Lost to Follow-up|1|||
48569049|NCT01295827|156275624|FG005|Overall Study|Lost to Follow-up|0|||
48569050|NCT01295827|156275625|FG006|Overall Study|Lost to Follow-up|4|||
48569051|NCT01295827|156275626|FG007|Overall Study|Lost to Follow-up|8|||
48569052|NCT01295827|156275627|FG008|Overall Study|Lost to Follow-up|7|||
48569053|NCT01295827|156275628|FG009|Overall Study|Lost to Follow-up|4|||
48617413|NCT00827242|156456242|FG000|Overall Study|Protocol Violation|1|||
48569054|NCT01295827|156275629|FG010|Overall Study|Lost to Follow-up|7|||
48569055|NCT01295827|156275630|FG011|Overall Study|Lost to Follow-up|3|||
48569056|NCT01295827|156275631|FG012|Overall Study|Lost to Follow-up|0|||
48569057|NCT01295827|156275632|FG013|Overall Study|Lost to Follow-up|0|||
48569058|NCT01295827|156275633|FG014|Overall Study|Lost to Follow-up|0|||
48569059|NCT01295827|156275619|FG000|Overall Study|Not Reported|0|||
48569060|NCT01295827|156275620|FG001|Overall Study|Not Reported|0|||
48569061|NCT01295827|156275621|FG002|Overall Study|Not Reported|0|||
48569062|NCT01295827|156275622|FG003|Overall Study|Not Reported|1|||
48617414|NCT00827242|156456243|FG001|Overall Study|Protocol Violation|3|||
48569063|NCT01295827|156275623|FG004|Overall Study|Not Reported|0|||
48569064|NCT01295827|156275624|FG005|Overall Study|Not Reported|0|||
48569065|NCT01295827|156275625|FG006|Overall Study|Not Reported|24|||
48569066|NCT01295827|156275626|FG007|Overall Study|Not Reported|58|||
48569067|NCT01295827|156275627|FG008|Overall Study|Not Reported|41|||
48569068|NCT01295827|156275628|FG009|Overall Study|Not Reported|2|||
48569069|NCT01295827|156275629|FG010|Overall Study|Not Reported|23|||
48569070|NCT01295827|156275630|FG011|Overall Study|Not Reported|13|||
48569071|NCT01295827|156275631|FG012|Overall Study|Not Reported|0|||
48569072|NCT01295827|156275632|FG013|Overall Study|Not Reported|0|||
48569073|NCT01295827|156275633|FG014|Overall Study|Not Reported|0|||
48569074|NCT01295827|156275619|FG000|Overall Study|Progressive Disease|2|||
48569075|NCT01295827|156275620|FG001|Overall Study|Progressive Disease|1|||
48569076|NCT01295827|156275621|FG002|Overall Study|Progressive Disease|5|||
48569077|NCT01295827|156275622|FG003|Overall Study|Progressive Disease|2|||
48569078|NCT01295827|156275623|FG004|Overall Study|Progressive Disease|0|||
48569079|NCT01295827|156275624|FG005|Overall Study|Progressive Disease|1|||
48569080|NCT01295827|156275625|FG006|Overall Study|Progressive Disease|87|||
48569081|NCT01295827|156275626|FG007|Overall Study|Progressive Disease|144|||
48569082|NCT01295827|156275627|FG008|Overall Study|Progressive Disease|85|||
48569083|NCT01295827|156275628|FG009|Overall Study|Progressive Disease|40|||
48569084|NCT01295827|156275629|FG010|Overall Study|Progressive Disease|175|||
48569085|NCT01295827|156275630|FG011|Overall Study|Progressive Disease|136|||
48569086|NCT01295827|156275631|FG012|Overall Study|Progressive Disease|0|||
48569087|NCT01295827|156275632|FG013|Overall Study|Progressive Disease|0|||
48569088|NCT01295827|156275633|FG014|Overall Study|Progressive Disease|0|||
48569089|NCT01295827|156275619|FG000|Overall Study|Screen Failure|0|||
48569090|NCT01295827|156275620|FG001|Overall Study|Screen Failure|0|||
48569091|NCT01295827|156275621|FG002|Overall Study|Screen Failure|0|||
48569092|NCT01295827|156275622|FG003|Overall Study|Screen Failure|0|||
48569093|NCT01295827|156275623|FG004|Overall Study|Screen Failure|0|||
48569094|NCT01295827|156275624|FG005|Overall Study|Screen Failure|0|||
48569095|NCT01295827|156275625|FG006|Overall Study|Screen Failure|2|||
48569096|NCT01295827|156275626|FG007|Overall Study|Screen Failure|2|||
48569097|NCT01295827|156275627|FG008|Overall Study|Screen Failure|2|||
48569098|NCT01295827|156275628|FG009|Overall Study|Screen Failure|0|||
48569099|NCT01295827|156275629|FG010|Overall Study|Screen Failure|1|||
48569100|NCT01295827|156275630|FG011|Overall Study|Screen Failure|0|||
48569101|NCT01295827|156275631|FG012|Overall Study|Screen Failure|0|||
48569102|NCT01295827|156275632|FG013|Overall Study|Screen Failure|0|||
48569103|NCT01295827|156275633|FG014|Overall Study|Screen Failure|0|||
48569104|NCT01295827|156275619|FG000|Overall Study|Withdrawal by Subject|1|||
48569105|NCT01295827|156275620|FG001|Overall Study|Withdrawal by Subject|0|||
48569106|NCT01295827|156275621|FG002|Overall Study|Withdrawal by Subject|2|||
48569107|NCT01295827|156275622|FG003|Overall Study|Withdrawal by Subject|0|||
48617415|NCT00827242|156456242|FG000|Overall Study|Lost to Follow-up|0|||
48617416|NCT00827242|156456243|FG001|Overall Study|Lost to Follow-up|3|||
48617417|NCT00827242|156456242|FG000|Overall Study|Adverse Event Excluding Death|2|||
48617418|NCT00827242|156456243|FG001|Overall Study|Adverse Event Excluding Death|1|||
48617419|NCT00827242|156456242|FG000|Overall Study|Entry Criteria Not Met|4|||
48617420|NCT00827242|156456243|FG001|Overall Study|Entry Criteria Not Met|1|||
48617421|NCT00827242|156456242|FG000|Overall Study|Physician Decision|2|||
48569108|NCT01295827|156275623|FG004|Overall Study|Withdrawal by Subject|0|||
48569109|NCT01295827|156275624|FG005|Overall Study|Withdrawal by Subject|1|||
48569110|NCT01295827|156275625|FG006|Overall Study|Withdrawal by Subject|13|||
48617422|NCT00827242|156456243|FG001|Overall Study|Physician Decision|0|||
48617423|NCT00827242|156456242|FG000|Overall Study|Death|1|||
48617424|NCT00827242|156456243|FG001|Overall Study|Death|0|||
48617425|NCT00827242|156456242|FG000|Overall Study|Lack of Efficacy|1|||
48617426|NCT00827242|156456243|FG001|Overall Study|Lack of Efficacy|0|||
48617427|NCT04790201|156456244|FG000|Overall Study|Lost to Follow-up|0|||
48617428|NCT04790201|156456245|FG001|Overall Study|Lost to Follow-up|0|||
48617429|NCT04790201|156456246|FG002|Overall Study|Lost to Follow-up|2|||
48617430|NCT04790201|156456244|FG000|Overall Study|Death|0|||
48617431|NCT04790201|156456245|FG001|Overall Study|Death|1|||
48617432|NCT04790201|156456246|FG002|Overall Study|Death|0|||
48617433|NCT04790201|156456244|FG000|Overall Study|Protocol Violation|1|||
48617434|NCT04790201|156456245|FG001|Overall Study|Protocol Violation|0|||
48617435|NCT04790201|156456246|FG002|Overall Study|Protocol Violation|1|||
48617436|NCT03670628|156456247|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
48617437|NCT03670628|156456248|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
48617438|NCT03670628|156456247|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
48617439|NCT03670628|156456248|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
48569111|NCT01295827|156275626|FG007|Overall Study|Withdrawal by Subject|35|||
48569112|NCT01295827|156275627|FG008|Overall Study|Withdrawal by Subject|11|||
48569113|NCT01295827|156275628|FG009|Overall Study|Withdrawal by Subject|2|||
48569114|NCT01295827|156275629|FG010|Overall Study|Withdrawal by Subject|18|||
48569115|NCT01295827|156275630|FG011|Overall Study|Withdrawal by Subject|13|||
48569116|NCT01295827|156275631|FG012|Overall Study|Withdrawal by Subject|0|||
48569117|NCT01295827|156275632|FG013|Overall Study|Withdrawal by Subject|0|||
48569118|NCT01295827|156275633|FG014|Overall Study|Withdrawal by Subject|0|||
48569119|NCT01295827|156275619|FG000|Overall Study|Other|0|||
48569120|NCT01295827|156275620|FG001|Overall Study|Other|0|||
48569121|NCT01295827|156275621|FG002|Overall Study|Other|0|||
48569122|NCT01295827|156275622|FG003|Overall Study|Other|0|||
48569123|NCT01295827|156275623|FG004|Overall Study|Other|0|||
48569124|NCT01295827|156275624|FG005|Overall Study|Other|0|||
48569125|NCT01295827|156275625|FG006|Overall Study|Other|1|||
48569126|NCT01295827|156275626|FG007|Overall Study|Other|1|||
48569127|NCT01295827|156275627|FG008|Overall Study|Other|1|||
48569128|NCT01295827|156275628|FG009|Overall Study|Other|0|||
48569129|NCT01295827|156275629|FG010|Overall Study|Other|2|||
48569130|NCT01295827|156275630|FG011|Overall Study|Other|0|||
48569131|NCT01295827|156275631|FG012|Overall Study|Other|0|||
48569132|NCT01295827|156275632|FG013|Overall Study|Other|0|||
48569133|NCT01295827|156275633|FG014|Overall Study|Other|0|||
48569134|NCT04463251|156275636|FG000|Overall Study|Death|1|||
48569135|NCT04463251|156275637|FG001|Overall Study|Death|0|||
48569136|NCT04463251|156275638|FG002|Overall Study|Death|1|||
48569137|NCT04463251|156275636|FG000|Overall Study|Adverse Event|0|||
48569138|NCT04463251|156275637|FG001|Overall Study|Adverse Event|1|||
48569139|NCT04463251|156275638|FG002|Overall Study|Adverse Event|0|||
48569140|NCT04463251|156275636|FG000|Overall Study|Lost to Follow-up|0|||
48569141|NCT04463251|156275637|FG001|Overall Study|Lost to Follow-up|1|||
48569142|NCT04463251|156275638|FG002|Overall Study|Lost to Follow-up|0|||
48569143|NCT04463251|156275636|FG000|Overall Study|Withdrawal by Subject|0|||
48569144|NCT04463251|156275637|FG001|Overall Study|Withdrawal by Subject|2|||
48617440|NCT01479530|156456249|FG000|Overall Study|Adverse Event|5|||
48617441|NCT01479530|156456250|FG001|Overall Study|Adverse Event|6|||
48617442|NCT01479530|156456249|FG000|Overall Study|Lack of Efficacy|0|||
48569145|NCT04463251|156275638|FG002|Overall Study|Withdrawal by Subject|2|||
48569146|NCT02504827|156275639|FG000|Overall Study|Could not produce sputum|1|||
48569147|NCT03386994|156275640|FG000|Overall Study|Lung transplant|1|||
48569148|NCT03386994|156275640|FG000|Overall Study|Adverse Event|14|||
48569149|NCT03386994|156275640|FG000|Overall Study|Lost to Follow-up|4|||
48569150|NCT03386994|156275640|FG000|Overall Study|Withdrawal by Subject|3|||
48569151|NCT03386994|156275640|FG000|Overall Study|Death|16|||
48569152|NCT01743560|156275641|FG000|Overall Study|Disease progression|26|||
48569153|NCT01743560|156275641|FG000|Overall Study|Adverse Event|8|||
48569154|NCT01743560|156275641|FG000|Overall Study|Death|3|||
48569155|NCT01743560|156275641|FG000|Overall Study|Withdrawal by Subject|2|||
48569156|NCT01743560|156275641|FG000|Overall Study|Protocol Violation|1|||
48569157|NCT01743560|156275641|FG000|Overall Study|>1 dose of study drug|3|||
48569158|NCT01379768|156277251|FG000|Overall Study|Adverse Event|1|||
48569159|NCT01379768|156277252|FG001|Overall Study|Adverse Event|1|||
48569160|NCT01379768|156277253|FG002|Overall Study|Adverse Event|0|||
48569161|NCT01379768|156277251|FG000|Overall Study|Lost to Follow-up|2|||
48569162|NCT01379768|156277252|FG001|Overall Study|Lost to Follow-up|0|||
48569163|NCT01379768|156277253|FG002|Overall Study|Lost to Follow-up|0|||
48569164|NCT00078767|156277254|FG000|Overall Study|Withdrawal by Subject|1|||
48569165|NCT00078767|156277255|FG001|Overall Study|Withdrawal by Subject|1|||
48569166|NCT05253573|156277256|FG000|Overall Study|Death|1|||
48569167|NCT05253573|156277257|FG001|Overall Study|Death|0|||
48569168|NCT01344824|156277260|FG000|Overall Study|Adverse Event|15|||
48569169|NCT01344824|156277260|FG000|Overall Study|Withdrawal by Subject|6|||
48569170|NCT01344824|156277260|FG000|Overall Study|Other complicating disease|1|||
48569171|NCT01344824|156277260|FG000|Overall Study|Progression|15|||
48569172|NCT00566020|156277261|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
48569173|NCT00566020|156277262|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
48569174|NCT00566020|156277261|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
48569175|NCT00566020|156277262|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
48569176|NCT00566020|156277261|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
48569177|NCT00566020|156277262|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
48569178|NCT00566020|156277261|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
48569179|NCT00566020|156277262|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
48569180|NCT00566020|156277261|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
48569181|NCT00566020|156277262|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
48569182|NCT00566020|156277261|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
48569183|NCT00566020|156277262|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
48569184|NCT02393950|156277263|FG000|Overall Study|Adverse Event|1|||
48569185|NCT02393950|156277264|FG001|Overall Study|Adverse Event|0|||
48569186|NCT02393950|156277263|FG000|Overall Study|Withdrawal by Subject|0|||
48569187|NCT02393950|156277264|FG001|Overall Study|Withdrawal by Subject|1|||
48569188|NCT00596687|156277265|FG000|Overall Study|< 24 hours of insulin treatment|8|||
48569189|NCT00596687|156277266|FG001|Overall Study|< 24 hours of insulin treatment|6|||
48569190|NCT00596687|156277265|FG000|Overall Study|continuous insulin infusion during TPN|2|||
48569191|NCT00596687|156277266|FG001|Overall Study|continuous insulin infusion during TPN|1|||
48569192|NCT00596687|156277265|FG000|Overall Study|Withdrawal by Subject|3|||
48569193|NCT00596687|156277266|FG001|Overall Study|Withdrawal by Subject|1|||
48569194|NCT00596687|156277265|FG000|Overall Study|cancelled surgery|1|||
48569195|NCT00596687|156277266|FG001|Overall Study|cancelled surgery|1|||
48569196|NCT00932373|156277269|FG000|Overall Study|Progressive disease|3|||
48569197|NCT00932373|156277270|FG001|Overall Study|Progressive disease|1|||
48569198|NCT00932373|156277271|FG002|Overall Study|Progressive disease|0|||
48569199|NCT00932373|156277272|FG003|Overall Study|Progressive disease|0|||
48569200|NCT00932373|156277273|FG004|Overall Study|Progressive disease|10|||
48569201|NCT00932373|156277274|FG005|Overall Study|Progressive disease|1|||
48569202|NCT00932373|156277275|FG006|Overall Study|Progressive disease|0|||
48569203|NCT00932373|156277276|FG007|Overall Study|Progressive disease|2|||
48569204|NCT00932373|156277277|FG008|Overall Study|Progressive disease|1|||
48569205|NCT00932373|156277278|FG009|Overall Study|Progressive disease|9|||
48569206|NCT00932373|156277279|FG010|Overall Study|Progressive disease|2|||
48569207|NCT00932373|156277269|FG000|Overall Study|Adverse Event|0|||
48569208|NCT00932373|156277270|FG001|Overall Study|Adverse Event|0|||
48569209|NCT00932373|156277271|FG002|Overall Study|Adverse Event|0|||
48569210|NCT00932373|156277272|FG003|Overall Study|Adverse Event|0|||
48569211|NCT00932373|156277273|FG004|Overall Study|Adverse Event|2|||
48569212|NCT00932373|156277274|FG005|Overall Study|Adverse Event|1|||
48569213|NCT00932373|156277275|FG006|Overall Study|Adverse Event|0|||
48569214|NCT00932373|156277276|FG007|Overall Study|Adverse Event|1|||
48569215|NCT00932373|156277277|FG008|Overall Study|Adverse Event|0|||
48569216|NCT00932373|156277278|FG009|Overall Study|Adverse Event|2|||
48569217|NCT00932373|156277279|FG010|Overall Study|Adverse Event|1|||
48569218|NCT00932373|156277269|FG000|Overall Study|Physician Decision|0|||
48569219|NCT00932373|156277270|FG001|Overall Study|Physician Decision|0|||
48569220|NCT00932373|156277271|FG002|Overall Study|Physician Decision|1|||
48569221|NCT00932373|156277272|FG003|Overall Study|Physician Decision|0|||
48569222|NCT00932373|156277273|FG004|Overall Study|Physician Decision|2|||
48569223|NCT00932373|156277274|FG005|Overall Study|Physician Decision|0|||
48569224|NCT00932373|156277275|FG006|Overall Study|Physician Decision|0|||
48569225|NCT00932373|156277276|FG007|Overall Study|Physician Decision|0|||
48569226|NCT00932373|156277277|FG008|Overall Study|Physician Decision|0|||
48569227|NCT00932373|156277278|FG009|Overall Study|Physician Decision|1|||
48569228|NCT00932373|156277279|FG010|Overall Study|Physician Decision|0|||
48569229|NCT00932373|156277269|FG000|Overall Study|Dose limiting toxicity|0|||
48569230|NCT00932373|156277270|FG001|Overall Study|Dose limiting toxicity|0|||
48569231|NCT00932373|156277271|FG002|Overall Study|Dose limiting toxicity|0|||
48569232|NCT00932373|156277272|FG003|Overall Study|Dose limiting toxicity|0|||
48569233|NCT00932373|156277273|FG004|Overall Study|Dose limiting toxicity|0|||
48569234|NCT00932373|156277274|FG005|Overall Study|Dose limiting toxicity|1|||
48569235|NCT00932373|156277275|FG006|Overall Study|Dose limiting toxicity|0|||
48617443|NCT01479530|156456250|FG001|Overall Study|Lack of Efficacy|1|||
48617444|NCT01479530|156456249|FG000|Overall Study|Protocol Violation|2|||
48617445|NCT01479530|156456250|FG001|Overall Study|Protocol Violation|3|||
48617446|NCT01479530|156456249|FG000|Overall Study|Withdrawal of Consent|3|||
48617447|NCT01479530|156456250|FG001|Overall Study|Withdrawal of Consent|2|||
48617448|NCT04795323|156456251|FG000|Overall Study|Did not interact with TARA|1|||
48617449|NCT04795323|156456252|FG001|Overall Study|Did not interact with TARA|0|||
48617450|NCT00514917|156456260|FG000|Overall Study|Death|4|||
48617451|NCT00514917|156456261|FG001|Overall Study|Death|10|||
48617452|NCT00514917|156456260|FG000|Overall Study|Protocol Violation|1|||
48617453|NCT00514917|156456261|FG001|Overall Study|Protocol Violation|0|||
48617454|NCT00514917|156456260|FG000|Overall Study|Lost to Follow-up|4|||
48617455|NCT00514917|156456261|FG001|Overall Study|Lost to Follow-up|3|||
48617456|NCT00514917|156456260|FG000|Overall Study|Withdrawal by Subject|18|||
48617457|NCT00514917|156456261|FG001|Overall Study|Withdrawal by Subject|16|||
48617458|NCT00514917|156456260|FG000|Overall Study|Discontinued due to study closure|88|||
48617459|NCT00514917|156456261|FG001|Overall Study|Discontinued due to study closure|81|||
48617460|NCT00514917|156456260|FG000|Overall Study|Undefined|11|||
48617461|NCT00514917|156456261|FG001|Overall Study|Undefined|5|||
48617462|NCT01132755|156456262|FG000|Overall Study|Procedure not done due to medical reason|23|||
48617463|NCT01132755|156456262|FG000|Overall Study|Protocol Violation|15|||
48617464|NCT01132755|156456262|FG000|Overall Study|Withdrawal by Subject|4|||
48617465|NCT02697422|156456263|FG000|Overall Study|Declined exit survey|9|||
48617466|NCT02697422|156456264|FG001|Overall Study|Declined exit survey|2|||
48617467|NCT02697422|156456263|FG000|Overall Study|Lost to Follow-up|13|||
48617468|NCT02697422|156456264|FG001|Overall Study|Lost to Follow-up|8|||
48617469|NCT02697422|156456263|FG000|Overall Study|Death|2|||
48617470|NCT02697422|156456264|FG001|Overall Study|Death|1|||
48617471|NCT02697422|156456263|FG000|Overall Study|Withdrawal by Subject|0|||
48617472|NCT02697422|156456264|FG001|Overall Study|Withdrawal by Subject|1|||
48617473|NCT02697422|156456263|FG000|Overall Study|Physician Decision|1|||
48617474|NCT02697422|156456264|FG001|Overall Study|Physician Decision|1|||
48617475|NCT02697422|156456263|FG000|Overall Study|Exit survey data lost|1|||
48617476|NCT02697422|156456264|FG001|Overall Study|Exit survey data lost|0|||
48617477|NCT00407030|156456265|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
48617478|NCT00407030|156456266|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
48617479|NCT00407030|156456267|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
48617480|NCT00407030|156456265|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
48617481|NCT00407030|156456266|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
48617482|NCT00407030|156456267|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
48617483|NCT00407030|156456265|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
48617484|NCT00407030|156456266|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
48617485|NCT00407030|156456267|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
48617486|NCT00407030|156456265|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
48617487|NCT00407030|156456266|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
48617488|NCT00407030|156456267|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
48617489|NCT00407030|156456265|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
48617490|NCT00407030|156456266|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
48617491|NCT00407030|156456267|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
48617492|NCT00407030|156456265|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
48617493|NCT00407030|156456266|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
48617494|NCT00407030|156456267|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
48617495|NCT00407030|156456265|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
48617496|NCT00407030|156456266|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
48617497|NCT00407030|156456267|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
48617498|NCT00407030|156456265|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
48617499|NCT00407030|156456266|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
48617500|NCT00407030|156456267|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
48617501|NCT00407030|156456265|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
48617502|NCT00407030|156456266|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
48617503|NCT00407030|156456267|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
48617504|NCT00407030|156456265|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
48617505|NCT00407030|156456266|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
48617506|NCT00407030|156456267|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
48617507|NCT00407030|156456265|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
48617508|NCT00407030|156456266|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
48617509|NCT00407030|156456267|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
48617510|NCT00407030|156456265|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
48617511|NCT00407030|156456266|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
48617512|NCT00407030|156456267|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
48617513|NCT00407030|156456265|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
48617514|NCT00407030|156456266|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
48617515|NCT00407030|156456267|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
48617516|NCT04243837|156456268|FG000|Overall Study|Adverse Event|2|||
48617517|NCT04243837|156456269|FG001|Overall Study|Adverse Event|1|||
48617518|NCT04243837|156456268|FG000|Overall Study|Withdrawal by Subject|4|||
48617519|NCT04243837|156456269|FG001|Overall Study|Withdrawal by Subject|2|||
48617520|NCT04243837|156456268|FG000|Overall Study|Covid-19 lock down|1|||
48617521|NCT04243837|156456269|FG001|Overall Study|Covid-19 lock down|0|||
48617522|NCT04243837|156456268|FG000|Overall Study|Study Terminated by Sponsor|11|||
48617523|NCT04243837|156456269|FG001|Overall Study|Study Terminated by Sponsor|12|||
48617524|NCT02337946|156456272|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
48617525|NCT02337946|156456273|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
48617526|NCT02337946|156456274|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
48617527|NCT02337946|156456272|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
48617528|NCT02337946|156456273|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
48617529|NCT02337946|156456274|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
48617530|NCT02337946|156456272|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
48617531|NCT02337946|156456273|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
48617532|NCT02337946|156456274|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
48617533|NCT02337946|156456272|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
48617534|NCT02337946|156456273|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
48617535|NCT02337946|156456274|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
48617536|NCT02337946|156456272|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
48617537|NCT02337946|156456273|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
48617538|NCT02337946|156456274|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
48617539|NCT02337946|156456272|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
48617540|NCT02337946|156456273|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
48617541|NCT02337946|156456274|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
48617542|NCT02337946|156456272|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
48617543|NCT02337946|156456273|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
48617544|NCT02337946|156456274|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
48617545|NCT02337946|156456272|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
48617546|NCT02337946|156456273|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
48617547|NCT02337946|156456274|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
48617548|NCT02337946|156456272|FG000|In-between Period|Without Informed Consent|1|||
48617549|NCT02337946|156456273|FG001|In-between Period|Without Informed Consent|0|||
48617550|NCT02337946|156456274|FG002|In-between Period|Without Informed Consent|0|||
48617551|NCT02337946|156456272|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
48617552|NCT02337946|156456273|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
48617553|NCT02337946|156456274|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
48617554|NCT02337946|156456272|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
48617555|NCT02337946|156456273|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
48617556|NCT02337946|156456274|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
48617557|NCT02337946|156456272|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
48617558|NCT02337946|156456273|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
48617559|NCT02337946|156456274|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
48617560|NCT02337946|156456272|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
48617561|NCT02337946|156456273|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
48617562|NCT02337946|156456274|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
48617563|NCT02337946|156456272|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
48617564|NCT02337946|156456273|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
48617565|NCT02337946|156456274|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
48617566|NCT02337946|156456272|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
48617567|NCT02337946|156456273|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
48617568|NCT02337946|156456274|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
48617569|NCT02280499|156456275|FG000|Overall Study|Death|14|||
48617570|NCT02280499|156456275|FG000|Overall Study|Lost to Follow-up|42|||
48617571|NCT02280499|156456275|FG000|Overall Study|Adverse Event|5|||
48617572|NCT01873833|156456280|FG000|Overall Study|Withdrawal by Subject|1|||
48617573|NCT01968785|156456281|FG000|Overall Study|Withdrawal by Subject|1|||
48617574|NCT01968785|156456282|FG001|Overall Study|Withdrawal by Subject|0|||
48617575|NCT01663987|156456284|FG000|Overall Study|Adverse Event|7|||
48617576|NCT01663987|156456285|FG001|Overall Study|Adverse Event|2|||
48617577|NCT01663987|156456284|FG000|Overall Study|Lost to Follow-up|1|||
48617578|NCT01663987|156456285|FG001|Overall Study|Lost to Follow-up|1|||
48617579|NCT01663987|156456284|FG000|Overall Study|Withdrawal by Subject|2|||
48617580|NCT01663987|156456285|FG001|Overall Study|Withdrawal by Subject|3|||
48617581|NCT01663987|156456284|FG000|Overall Study|Other reason not defined above|3|||
48617582|NCT01663987|156456285|FG001|Overall Study|Other reason not defined above|0|||
48617583|NCT04000724|156456286|FG000|Overall Study|Withdrawal by Subject|5|||
48617584|NCT04000724|156456287|FG001|Overall Study|Withdrawal by Subject|3|||
48617585|NCT04000724|156456288|FG002|Overall Study|Withdrawal by Subject|4|||
48617586|NCT04000724|156456286|FG000|Overall Study|Lost to Follow-up|11|||
48617587|NCT04000724|156456287|FG001|Overall Study|Lost to Follow-up|7|||
48617588|NCT04000724|156456288|FG002|Overall Study|Lost to Follow-up|13|||
48617589|NCT00455455|156456289|FG000|Washout|Withdrawal by Subject|0|||
48617590|NCT00455455|156456290|FG001|Washout|Withdrawal by Subject|1|||
48617591|NCT00455455|156456289|FG000|Washout|Withdrawal by Subject|1|||
48617592|NCT00455455|156456290|FG001|Washout|Withdrawal by Subject|0|||
48617593|NCT02006654|156456291|FG000|Overall Study|Withdrawal before treatment|4|||
48617594|NCT02006654|156456292|FG001|Overall Study|Withdrawal before treatment|2|||
48617595|NCT02006654|156456291|FG000|Overall Study|Adverse Event|16|||
48617596|NCT02006654|156456292|FG001|Overall Study|Adverse Event|17|||
48617597|NCT02006654|156456291|FG000|Overall Study|Death|1|||
48617598|NCT02006654|156456292|FG001|Overall Study|Death|0|||
48617599|NCT02006654|156456291|FG000|Overall Study|Withdrawal by Subject|14|||
48617600|NCT02006654|156456292|FG001|Overall Study|Withdrawal by Subject|12|||
48617601|NCT02006654|156456291|FG000|Overall Study|Protocol Violation|5|||
48617602|NCT02006654|156456292|FG001|Overall Study|Protocol Violation|8|||
48617603|NCT02006654|156456291|FG000|Overall Study|Lost to Follow-up|1|||
48617604|NCT02006654|156456292|FG001|Overall Study|Lost to Follow-up|0|||
48617605|NCT02006654|156456291|FG000|Overall Study|patient's will|2|||
48617606|NCT02006654|156456292|FG001|Overall Study|patient's will|1|||
48617607|NCT02006654|156456291|FG000|Overall Study|insufficient compliance|1|||
48617608|NCT02006654|156456292|FG001|Overall Study|insufficient compliance|0|||
48617609|NCT02006654|156456291|FG000|Overall Study|worsening cognitive condition|0|||
48617610|NCT02006654|156456292|FG001|Overall Study|worsening cognitive condition|1|||
48617611|NCT02006654|156456291|FG000|Overall Study|faecal incontinence|0|||
48617612|NCT02006654|156456292|FG001|Overall Study|faecal incontinence|1|||
48617613|NCT02006654|156456291|FG000|Overall Study|mood disorder|0|||
48569236|NCT00932373|156277276|FG007|Overall Study|Dose limiting toxicity|0|||
48569237|NCT00932373|156277277|FG008|Overall Study|Dose limiting toxicity|0|||
48569238|NCT00932373|156277278|FG009|Overall Study|Dose limiting toxicity|0|||
48569239|NCT00932373|156277279|FG010|Overall Study|Dose limiting toxicity|0|||
48569240|NCT00932373|156277269|FG000|Overall Study|Withdrawal by Subject|0|||
48569241|NCT00932373|156277270|FG001|Overall Study|Withdrawal by Subject|0|||
48569242|NCT00932373|156277271|FG002|Overall Study|Withdrawal by Subject|0|||
48569243|NCT00932373|156277272|FG003|Overall Study|Withdrawal by Subject|0|||
48569244|NCT00932373|156277273|FG004|Overall Study|Withdrawal by Subject|0|||
48569245|NCT00932373|156277274|FG005|Overall Study|Withdrawal by Subject|0|||
48569246|NCT00932373|156277275|FG006|Overall Study|Withdrawal by Subject|0|||
48569247|NCT00932373|156277276|FG007|Overall Study|Withdrawal by Subject|0|||
48569248|NCT00932373|156277277|FG008|Overall Study|Withdrawal by Subject|1|||
48569249|NCT00932373|156277278|FG009|Overall Study|Withdrawal by Subject|0|||
48569250|NCT00932373|156277279|FG010|Overall Study|Withdrawal by Subject|0|||
48569251|NCT00932373|156277269|FG000|Overall Study|Clinical progression|0|||
48569252|NCT00932373|156277270|FG001|Overall Study|Clinical progression|0|||
48569253|NCT00932373|156277271|FG002|Overall Study|Clinical progression|0|||
48569254|NCT00932373|156277272|FG003|Overall Study|Clinical progression|0|||
48569255|NCT00932373|156277273|FG004|Overall Study|Clinical progression|0|||
48569256|NCT00932373|156277274|FG005|Overall Study|Clinical progression|0|||
48569257|NCT00932373|156277275|FG006|Overall Study|Clinical progression|1|||
48617614|NCT02006654|156456292|FG001|Overall Study|mood disorder|1|||
48617615|NCT02006654|156456291|FG000|Overall Study|disallowed medication|1|||
48617616|NCT02006654|156456292|FG001|Overall Study|disallowed medication|0|||
48617617|NCT02006654|156456291|FG000|Overall Study|moving out of state|0|||
48617618|NCT02006654|156456292|FG001|Overall Study|moving out of state|1|||
48617619|NCT01370538|156456297|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
48617620|NCT01370538|156456298|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
48617621|NCT01370538|156456297|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48617622|NCT01370538|156456298|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48617623|NCT01370538|156456297|FG000|Overall Study|Adverse Event|1|||
48617624|NCT01370538|156456298|FG001|Overall Study|Adverse Event|0|||
48617625|NCT01370538|156456297|FG000|Overall Study|Protocol Violation|8|||
48617626|NCT01370538|156456298|FG001|Overall Study|Protocol Violation|5|||
48617627|NCT01370538|156456297|FG000|Overall Study|Development of study specific withdrawal|1|||
48617628|NCT01370538|156456298|FG001|Overall Study|Development of study specific withdrawal|1|||
48617629|NCT01370538|156456297|FG000|Overall Study|Lost to follow up|6|||
48617630|NCT01370538|156456298|FG001|Overall Study|Lost to follow up|10|||
48617631|NCT01757847|156456304|FG000|Overall Study|Withdrawal by Subject|3|||
48617632|NCT01757847|156456305|FG001|Overall Study|Withdrawal by Subject|4|||
48617633|NCT03520387|156456306|FG000|Pre-Randomization|Withdrawal by Subject|1|||
48617634|NCT03520387|156456307|FG001|Pre-Randomization|Withdrawal by Subject|0|||
48617635|NCT03520387|156456308|FG002|Pre-Randomization|Withdrawal by Subject|0|||
48617636|NCT03520387|156456309|FG003|Pre-Randomization|Withdrawal by Subject|0|||
48617637|NCT03520387|156456310|FG004|Pre-Randomization|Withdrawal by Subject|0|||
48569258|NCT00932373|156277276|FG007|Overall Study|Clinical progression|0|||
48569259|NCT00932373|156277277|FG008|Overall Study|Clinical progression|0|||
48569260|NCT00932373|156277278|FG009|Overall Study|Clinical progression|0|||
48617638|NCT03520387|156456306|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
48569261|NCT00932373|156277279|FG010|Overall Study|Clinical progression|0|||
48569262|NCT00932373|156277269|FG000|Overall Study|Lack of Efficacy|0|||
48617639|NCT03520387|156456307|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
48569263|NCT00932373|156277270|FG001|Overall Study|Lack of Efficacy|0|||
48617640|NCT03520387|156456308|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
48617641|NCT03520387|156456309|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
48617642|NCT03520387|156456310|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
48617643|NCT03336866|156456311|FG000|Overall Study|Lost to Follow-up|2|||
48617644|NCT03336866|156456312|FG001|Overall Study|Lost to Follow-up|0|||
48617645|NCT03336866|156456313|FG002|Overall Study|Lost to Follow-up|3|||
48617646|NCT03336866|156456311|FG000|Overall Study|Withdrawal by Subject|1|||
48617647|NCT03336866|156456312|FG001|Overall Study|Withdrawal by Subject|1|||
48617648|NCT03336866|156456313|FG002|Overall Study|Withdrawal by Subject|0|||
48617649|NCT03336866|156456311|FG000|Overall Study|Noncompliance with clinic house rules|0|||
48617650|NCT03336866|156456312|FG001|Overall Study|Noncompliance with clinic house rules|0|||
48617651|NCT03336866|156456313|FG002|Overall Study|Noncompliance with clinic house rules|1|||
48617652|NCT00250718|156456315|FG000|Overall Study|Death|1|||
48617653|NCT00250718|156456315|FG000|Overall Study|Adverse Event|1|||
48617654|NCT00250718|156456315|FG000|Overall Study|Withdrawal by Subject|1|||
48617655|NCT00985790|156456316|FG000|Overall Study|Withdrawal by Subject|1|||
48617656|NCT00985790|156456317|FG001|Overall Study|Withdrawal by Subject|1|||
48617657|NCT00985790|156456316|FG000|Overall Study|Lost to Follow-up|6|||
48617658|NCT00985790|156456317|FG001|Overall Study|Lost to Follow-up|7|||
48617659|NCT04518410|156456322|FG000|Overall Study|Lost to Follow-up|1|||
48617660|NCT04518410|156456323|FG001|Overall Study|Lost to Follow-up|1|||
48617661|NCT04518410|156456324|FG002|Overall Study|Lost to Follow-up|8|||
48617662|NCT04518410|156456325|FG003|Overall Study|Lost to Follow-up|5|||
48617663|NCT04518410|156456326|FG004|Overall Study|Lost to Follow-up|92|||
48617664|NCT04518410|156456327|FG005|Overall Study|Lost to Follow-up|25|||
48617665|NCT04518410|156456328|FG006|Overall Study|Lost to Follow-up|25|||
48617666|NCT04518410|156456329|FG007|Overall Study|Lost to Follow-up|3|||
48617667|NCT04518410|156456330|FG008|Overall Study|Lost to Follow-up|2|||
48617668|NCT04518410|156456331|FG009|Overall Study|Lost to Follow-up|13|||
48617669|NCT04518410|156456332|FG010|Overall Study|Lost to Follow-up|9|||
48617670|NCT04518410|156456333|FG011|Overall Study|Lost to Follow-up|13|||
48617671|NCT04518410|156456334|FG012|Overall Study|Lost to Follow-up|9|||
48617672|NCT04518410|156456335|FG013|Overall Study|Lost to Follow-up|13|||
48617673|NCT04518410|156456336|FG014|Overall Study|Lost to Follow-up|8|||
48617674|NCT04518410|156456337|FG015|Overall Study|Lost to Follow-up|10|||
48617675|NCT04518410|156456338|FG016|Overall Study|Lost to Follow-up|6|||
48617676|NCT04518410|156456339|FG017|Overall Study|Lost to Follow-up|13|||
48617677|NCT04518410|156456340|FG018|Overall Study|Lost to Follow-up|21|||
48617678|NCT04518410|156456341|FG019|Overall Study|Lost to Follow-up|6|||
48617679|NCT04518410|156456342|FG020|Overall Study|Lost to Follow-up|7|||
48617680|NCT04518410|156456343|FG021|Overall Study|Lost to Follow-up|21|||
48617681|NCT04518410|156456344|FG022|Overall Study|Lost to Follow-up|1|||
48617682|NCT04518410|156456345|FG023|Overall Study|Lost to Follow-up|7|||
48617683|NCT04518410|156456346|FG024|Overall Study|Lost to Follow-up|6|||
48617684|NCT04518410|156456322|FG000|Overall Study|Withdrawal by Subject|1|||
48617685|NCT04518410|156456323|FG001|Overall Study|Withdrawal by Subject|2|||
48617686|NCT04518410|156456324|FG002|Overall Study|Withdrawal by Subject|2|||
48617687|NCT04518410|156456325|FG003|Overall Study|Withdrawal by Subject|3|||
48617688|NCT04518410|156456326|FG004|Overall Study|Withdrawal by Subject|20|||
48617689|NCT04518410|156456327|FG005|Overall Study|Withdrawal by Subject|20|||
48617690|NCT04518410|156456328|FG006|Overall Study|Withdrawal by Subject|25|||
48617691|NCT04518410|156456329|FG007|Overall Study|Withdrawal by Subject|6|||
48617692|NCT04518410|156456330|FG008|Overall Study|Withdrawal by Subject|1|||
48617693|NCT04518410|156456331|FG009|Overall Study|Withdrawal by Subject|12|||
48617694|NCT04518410|156456332|FG010|Overall Study|Withdrawal by Subject|5|||
48617695|NCT04518410|156456333|FG011|Overall Study|Withdrawal by Subject|7|||
48617696|NCT04518410|156456334|FG012|Overall Study|Withdrawal by Subject|2|||
48617697|NCT04518410|156456335|FG013|Overall Study|Withdrawal by Subject|13|||
48617698|NCT04518410|156456336|FG014|Overall Study|Withdrawal by Subject|4|||
48617699|NCT04518410|156456337|FG015|Overall Study|Withdrawal by Subject|9|||
48617700|NCT04518410|156456338|FG016|Overall Study|Withdrawal by Subject|0|||
48617701|NCT04518410|156456339|FG017|Overall Study|Withdrawal by Subject|15|||
48617702|NCT04518410|156456340|FG018|Overall Study|Withdrawal by Subject|12|||
48617703|NCT04518410|156456341|FG019|Overall Study|Withdrawal by Subject|9|||
48617704|NCT04518410|156456342|FG020|Overall Study|Withdrawal by Subject|14|||
48617705|NCT04518410|156456343|FG021|Overall Study|Withdrawal by Subject|3|||
48617706|NCT04518410|156456344|FG022|Overall Study|Withdrawal by Subject|2|||
48617707|NCT04518410|156456345|FG023|Overall Study|Withdrawal by Subject|9|||
48617708|NCT04518410|156456346|FG024|Overall Study|Withdrawal by Subject|8|||
48617709|NCT04518410|156456322|FG000|Overall Study|Other|1|||
48617710|NCT04518410|156456323|FG001|Overall Study|Other|0|||
48617711|NCT04518410|156456324|FG002|Overall Study|Other|0|||
48617712|NCT04518410|156456325|FG003|Overall Study|Other|1|||
48617713|NCT04518410|156456326|FG004|Overall Study|Other|6|||
48617714|NCT04518410|156456327|FG005|Overall Study|Other|6|||
48617715|NCT04518410|156456328|FG006|Overall Study|Other|5|||
48617716|NCT04518410|156456329|FG007|Overall Study|Other|2|||
48617717|NCT04518410|156456330|FG008|Overall Study|Other|0|||
48617718|NCT04518410|156456331|FG009|Overall Study|Other|1|||
48617719|NCT04518410|156456332|FG010|Overall Study|Other|0|||
48617720|NCT04518410|156456333|FG011|Overall Study|Other|2|||
48617721|NCT04518410|156456334|FG012|Overall Study|Other|0|||
48617722|NCT04518410|156456335|FG013|Overall Study|Other|0|||
48617723|NCT04518410|156456336|FG014|Overall Study|Other|0|||
48569264|NCT00932373|156277271|FG002|Overall Study|Lack of Efficacy|0|||
48569265|NCT00932373|156277272|FG003|Overall Study|Lack of Efficacy|0|||
48569266|NCT00932373|156277273|FG004|Overall Study|Lack of Efficacy|0|||
48569267|NCT00932373|156277274|FG005|Overall Study|Lack of Efficacy|0|||
48569268|NCT00932373|156277275|FG006|Overall Study|Lack of Efficacy|0|||
48569269|NCT00932373|156277276|FG007|Overall Study|Lack of Efficacy|0|||
48569270|NCT00932373|156277277|FG008|Overall Study|Lack of Efficacy|0|||
48569271|NCT00932373|156277278|FG009|Overall Study|Lack of Efficacy|1|||
48569272|NCT00932373|156277279|FG010|Overall Study|Lack of Efficacy|0|||
48617724|NCT04518410|156456337|FG015|Overall Study|Other|3|||
48617725|NCT04518410|156456338|FG016|Overall Study|Other|1|||
48617726|NCT04518410|156456339|FG017|Overall Study|Other|1|||
48617727|NCT04518410|156456340|FG018|Overall Study|Other|1|||
48617728|NCT04518410|156456341|FG019|Overall Study|Other|0|||
48617729|NCT04518410|156456342|FG020|Overall Study|Other|1|||
48617730|NCT04518410|156456343|FG021|Overall Study|Other|0|||
48617731|NCT04518410|156456344|FG022|Overall Study|Other|1|||
48617732|NCT04518410|156456345|FG023|Overall Study|Other|2|||
48617733|NCT04518410|156456346|FG024|Overall Study|Other|2|||
48569273|NCT06098339|156277282|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
48569274|NCT06098339|156277283|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
48569275|NCT06098339|156277282|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
48569276|NCT06098339|156277283|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
48569277|NCT01436370|156277284|FG000|Overall Study|Lost to Follow-up|0|||
48569278|NCT01436370|156277285|FG001|Overall Study|Lost to Follow-up|0|||
48569279|NCT01436370|156277286|FG002|Overall Study|Lost to Follow-up|0|||
48569280|NCT01436370|156277287|FG003|Overall Study|Lost to Follow-up|0|||
48569281|NCT01436370|156277288|FG004|Overall Study|Lost to Follow-up|1|||
48569282|NCT01436370|156277289|FG005|Overall Study|Lost to Follow-up|0|||
48569283|NCT01436370|156277290|FG006|Overall Study|Lost to Follow-up|0|||
48569284|NCT01436370|156277291|FG007|Overall Study|Lost to Follow-up|0|||
48569285|NCT03831113|156277292|FG000|Overall Study|Withdrawal by Subject|0|||
48569286|NCT03831113|156277293|FG001|Overall Study|Withdrawal by Subject|2|||
48569287|NCT03831113|156277292|FG000|Overall Study|Protocol Violation|0|||
48569288|NCT03831113|156277293|FG001|Overall Study|Protocol Violation|9|||
48569289|NCT03491462|156277294|FG000|Overall Study|Lost to Follow-up|2|||
48569290|NCT03491462|156277295|FG001|Overall Study|Lost to Follow-up|0|||
48569291|NCT03491462|156277294|FG000|Overall Study|Adverse Event|11|||
48569292|NCT03491462|156277295|FG001|Overall Study|Adverse Event|1|||
48569293|NCT03491462|156277294|FG000|Overall Study|Physician Decision|3|||
48569294|NCT03491462|156277295|FG001|Overall Study|Physician Decision|0|||
48569295|NCT03491462|156277294|FG000|Overall Study|Withdrawal by Subject|22|||
48569296|NCT03491462|156277295|FG001|Overall Study|Withdrawal by Subject|15|||
48569297|NCT01019694|156277298|FG000|Overall Study|Adverse Event|12|||
48569298|NCT01019694|156277299|FG001|Overall Study|Adverse Event|16|||
48569299|NCT01019694|156277300|FG002|Overall Study|Adverse Event|19|||
48569300|NCT01019694|156277298|FG000|Overall Study|Protocol Violation|2|||
48569301|NCT01019694|156277299|FG001|Overall Study|Protocol Violation|6|||
48569302|NCT01019694|156277300|FG002|Overall Study|Protocol Violation|4|||
48569303|NCT01019694|156277298|FG000|Overall Study|Lost to Follow-up|5|||
48617734|NCT04518410|156456322|FG000|Overall Study|Protocol Violation|0|||
48617735|NCT04518410|156456323|FG001|Overall Study|Protocol Violation|0|||
48617736|NCT04518410|156456324|FG002|Overall Study|Protocol Violation|0|||
48617737|NCT04518410|156456325|FG003|Overall Study|Protocol Violation|2|||
48617738|NCT04518410|156456326|FG004|Overall Study|Protocol Violation|17|||
48617739|NCT04518410|156456327|FG005|Overall Study|Protocol Violation|1|||
48617740|NCT04518410|156456328|FG006|Overall Study|Protocol Violation|2|||
48617741|NCT04518410|156456329|FG007|Overall Study|Protocol Violation|1|||
48617742|NCT04518410|156456330|FG008|Overall Study|Protocol Violation|0|||
48617743|NCT04518410|156456331|FG009|Overall Study|Protocol Violation|0|||
48617744|NCT04518410|156456332|FG010|Overall Study|Protocol Violation|0|||
48617745|NCT04518410|156456333|FG011|Overall Study|Protocol Violation|0|||
48617746|NCT04518410|156456334|FG012|Overall Study|Protocol Violation|0|||
48617747|NCT04518410|156456335|FG013|Overall Study|Protocol Violation|0|||
48617748|NCT04518410|156456336|FG014|Overall Study|Protocol Violation|0|||
48617749|NCT04518410|156456337|FG015|Overall Study|Protocol Violation|0|||
48617750|NCT04518410|156456338|FG016|Overall Study|Protocol Violation|1|||
48617751|NCT04518410|156456339|FG017|Overall Study|Protocol Violation|1|||
48617752|NCT04518410|156456340|FG018|Overall Study|Protocol Violation|0|||
48617753|NCT04518410|156456341|FG019|Overall Study|Protocol Violation|0|||
48617754|NCT04518410|156456342|FG020|Overall Study|Protocol Violation|1|||
48617755|NCT04518410|156456343|FG021|Overall Study|Protocol Violation|2|||
48617756|NCT04518410|156456344|FG022|Overall Study|Protocol Violation|0|||
48617757|NCT04518410|156456345|FG023|Overall Study|Protocol Violation|3|||
48617758|NCT04518410|156456346|FG024|Overall Study|Protocol Violation|0|||
48617759|NCT04518410|156456322|FG000|Overall Study|Death|0|||
48617760|NCT04518410|156456323|FG001|Overall Study|Death|0|||
48617761|NCT04518410|156456324|FG002|Overall Study|Death|0|||
48617762|NCT04518410|156456325|FG003|Overall Study|Death|0|||
48617763|NCT04518410|156456326|FG004|Overall Study|Death|12|||
48617764|NCT04518410|156456327|FG005|Overall Study|Death|2|||
48617765|NCT04518410|156456328|FG006|Overall Study|Death|11|||
48617766|NCT04518410|156456329|FG007|Overall Study|Death|0|||
48617767|NCT04518410|156456330|FG008|Overall Study|Death|1|||
48617768|NCT04518410|156456331|FG009|Overall Study|Death|0|||
48617769|NCT04518410|156456332|FG010|Overall Study|Death|0|||
48617770|NCT04518410|156456333|FG011|Overall Study|Death|0|||
48617771|NCT04518410|156456334|FG012|Overall Study|Death|0|||
48569304|NCT01019694|156277299|FG001|Overall Study|Lost to Follow-up|3|||
48569305|NCT01019694|156277300|FG002|Overall Study|Lost to Follow-up|3|||
48569306|NCT01019694|156277298|FG000|Overall Study|Withdrawal by Subject|4|||
48569307|NCT01019694|156277299|FG001|Overall Study|Withdrawal by Subject|6|||
48569308|NCT01019694|156277300|FG002|Overall Study|Withdrawal by Subject|12|||
48569309|NCT01019694|156277298|FG000|Overall Study|Not treated|0|||
48569310|NCT01019694|156277299|FG001|Overall Study|Not treated|2|||
48569311|NCT01019694|156277300|FG002|Overall Study|Not treated|3|||
48569312|NCT01019694|156277298|FG000|Overall Study|Other reason (not specified)|1|||
48569313|NCT01019694|156277299|FG001|Overall Study|Other reason (not specified)|5|||
48569314|NCT01019694|156277300|FG002|Overall Study|Other reason (not specified)|6|||
48569315|NCT00441129|156277301|FG000|Overall Study|Withdrawal by Subject|6|||
48569316|NCT00441129|156277302|FG001|Overall Study|Withdrawal by Subject|14|||
48569317|NCT04747886|156277303|FG000|Overall Study|Withdrawal by Subject|1|||
48569318|NCT04747886|156277304|FG001|Overall Study|Withdrawal by Subject|4|||
48569319|NCT01996254|156277306|FG000|Overall Study|Change in Eligibility|0|||
48617772|NCT04518410|156456335|FG013|Overall Study|Death|1|||
48617773|NCT04518410|156456336|FG014|Overall Study|Death|1|||
48617774|NCT04518410|156456337|FG015|Overall Study|Death|0|||
48617775|NCT04518410|156456338|FG016|Overall Study|Death|0|||
48617776|NCT04518410|156456339|FG017|Overall Study|Death|1|||
48617777|NCT04518410|156456340|FG018|Overall Study|Death|4|||
48617778|NCT04518410|156456341|FG019|Overall Study|Death|4|||
48617779|NCT04518410|156456342|FG020|Overall Study|Death|1|||
48617780|NCT04518410|156456343|FG021|Overall Study|Death|0|||
48617781|NCT04518410|156456344|FG022|Overall Study|Death|0|||
48569320|NCT01996254|156277307|FG001|Overall Study|Change in Eligibility|2|||
48569321|NCT01996254|156277308|FG002|Overall Study|Change in Eligibility|0|||
48569322|NCT01996254|156277306|FG000|Overall Study|Withdrawal by Subject|0|||
48569323|NCT01996254|156277307|FG001|Overall Study|Withdrawal by Subject|3|||
48569324|NCT01996254|156277308|FG002|Overall Study|Withdrawal by Subject|4|||
48569325|NCT01996254|156277306|FG000|Overall Study|Lost to Follow-up|1|||
48569326|NCT01996254|156277307|FG001|Overall Study|Lost to Follow-up|0|||
48569327|NCT01996254|156277308|FG002|Overall Study|Lost to Follow-up|4|||
48569328|NCT01741688|156277309|FG000|Overall Study|Lack of insurance coverage|2|||
48569329|NCT01741688|156277309|FG000|Overall Study|Withdrawal by Subject|1|||
48569330|NCT01377922|156277313|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
48569331|NCT01377922|156277314|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
48569332|NCT03850496|156277315|FG000|Overall Study|Withdrawal by Subject|1|||
48569333|NCT03850496|156277316|FG001|Overall Study|Withdrawal by Subject|0|||
48569334|NCT03850496|156277317|FG002|Overall Study|Withdrawal by Subject|0|||
48569335|NCT03850496|156277315|FG000|Overall Study|Lost to Follow-up|0|||
48569336|NCT03850496|156277316|FG001|Overall Study|Lost to Follow-up|1|||
48569337|NCT03850496|156277317|FG002|Overall Study|Lost to Follow-up|4|||
48569338|NCT03777436|156277319|FG000|Placebo-controlled Phase|Adverse Event|8|||
48569339|NCT03777436|156277320|FG001|Placebo-controlled Phase|Adverse Event|10|||
48569340|NCT03777436|156277321|FG002|Placebo-controlled Phase|Adverse Event|0|||
48569341|NCT03777436|156277319|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
48569342|NCT03777436|156277320|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
48569343|NCT03777436|156277321|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
48569344|NCT03777436|156277319|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
48569345|NCT03777436|156277320|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
48569346|NCT03777436|156277321|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
48569347|NCT03777436|156277319|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
48569348|NCT03777436|156277320|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
48569349|NCT03777436|156277321|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
48569350|NCT03777436|156277319|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
48569351|NCT03777436|156277320|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
48569352|NCT03777436|156277321|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
48569353|NCT03777436|156277319|FG000|Placebo-controlled Phase|Physician Decision|0|||
48569354|NCT03777436|156277320|FG001|Placebo-controlled Phase|Physician Decision|1|||
48569355|NCT03777436|156277321|FG002|Placebo-controlled Phase|Physician Decision|0|||
48569356|NCT03777436|156277319|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
48569357|NCT03777436|156277320|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
48569358|NCT03777436|156277321|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
48569359|NCT03777436|156277319|FG000|Apremilast Extension Phase|Adverse Event|0|||
48569360|NCT03777436|156277320|FG001|Apremilast Extension Phase|Adverse Event|0|||
48569361|NCT03777436|156277321|FG002|Apremilast Extension Phase|Adverse Event|6|||
48569362|NCT03777436|156277319|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
48569363|NCT03777436|156277320|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
48569364|NCT03777436|156277321|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
48569365|NCT03777436|156277319|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
48569366|NCT03777436|156277320|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
48569367|NCT03777436|156277321|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
48569368|NCT03777436|156277319|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
48569369|NCT03777436|156277320|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
48569370|NCT03777436|156277321|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
48569371|NCT03777436|156277319|FG000|Apremilast Extension Phase|Miscellaneous|0|||
48569372|NCT03777436|156277320|FG001|Apremilast Extension Phase|Miscellaneous|0|||
48569373|NCT03777436|156277321|FG002|Apremilast Extension Phase|Miscellaneous|1|||
48569374|NCT02035202|156277325|FG000|Overall Study|Lost to Follow-up|8|||
48569375|NCT02035202|156277326|FG001|Overall Study|Lost to Follow-up|16|||
48569376|NCT02035202|156277327|FG002|Overall Study|Lost to Follow-up|2|||
48569377|NCT02737930|156277335|FG000|Overall Study|Withdrawal by Subject|0|||
48569378|NCT02737930|156277336|FG001|Overall Study|Withdrawal by Subject|1|||
48569379|NCT01326104|156277339|FG000|Overall Study|progressed prior to vaccine|0|||
48569380|NCT01326104|156277340|FG001|Overall Study|progressed prior to vaccine|2|||
48569381|NCT01326104|156277339|FG000|Overall Study|unable to make vaccine|0|||
48569382|NCT01326104|156277340|FG001|Overall Study|unable to make vaccine|2|||
48569383|NCT00644917|156277341|FG000|Overall Study|Withdrawal by Subject|2|||
48569384|NCT00758485|156277342|FG000|Overall Study|Lost to Follow-up|0|||
48569385|NCT00758485|156277343|FG001|Overall Study|Lost to Follow-up|1|||
48569386|NCT00758485|156277342|FG000|Overall Study|Not Treated|1|||
48569387|NCT00758485|156277343|FG001|Overall Study|Not Treated|2|||
48569388|NCT01136356|156277344|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
48569389|NCT01136356|156277345|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
48569390|NCT01136356|156277344|FG000|First 18-day Withdrawal|Physician Decision|1|||
48569391|NCT01136356|156277345|FG001|First 18-day Withdrawal|Physician Decision|0|||
48569392|NCT01136356|156277344|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
48569393|NCT01136356|156277345|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
48569394|NCT02875613|156277346|FG000|Overall Study|Withdrawal by Subject|1|||
48569395|NCT02875613|156277346|FG000|Overall Study|Screen Failure|1|||
48569396|NCT00237458|156277353|FG000|Overall Study|Lack of Efficacy|1|||
48569397|NCT00237458|156277353|FG000|Overall Study|Adverse Event|1|||
48569398|NCT00237458|156277353|FG000|Overall Study|Withdrawal by Subject|1|||
48569399|NCT01266291|156277371|FG000|Overall Study|Adverse Event|1|||
48569400|NCT05020665|156277372|FG000|Overall Study|Study terminated by Sponsor|5|||
48569401|NCT05020665|156277373|FG001|Overall Study|Study terminated by Sponsor|4|||
48569402|NCT05020665|156277372|FG000|Overall Study|Death|2|||
48569403|NCT05020665|156277373|FG001|Overall Study|Death|1|||
48569404|NCT05020665|156277372|FG000|Overall Study|Physician Decision|0|||
48569405|NCT05020665|156277373|FG001|Overall Study|Physician Decision|1|||
48569406|NCT05020665|156277372|FG000|Overall Study|Withdrawal by Subject|0|||
48569407|NCT05020665|156277373|FG001|Overall Study|Withdrawal by Subject|1|||
48569408|NCT05020665|156277372|FG000|Overall Study|Reason not specified|1|||
48569409|NCT05020665|156277373|FG001|Overall Study|Reason not specified|0|||
48569410|NCT03291431|156277374|FG000|Overall Study|Protocol Violation|2|||
48569411|NCT03291431|156277375|FG001|Overall Study|Protocol Violation|1|||
48569412|NCT03291431|156277374|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
48569413|NCT03291431|156277375|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
48569414|NCT03291431|156277374|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
48569415|NCT03291431|156277375|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
48569416|NCT03423173|156277376|FG000|Overall Study|Randomized but not vaccinated|1|||
48569417|NCT03423173|156277377|FG001|Overall Study|Randomized but not vaccinated|0|||
48569418|NCT03423173|156277378|FG002|Overall Study|Randomized but not vaccinated|2|||
48569419|NCT03423173|156277379|FG003|Overall Study|Randomized but not vaccinated|1|||
48569420|NCT03423173|156277376|FG000|Overall Study|Adverse Event|1|||
48569421|NCT03423173|156277377|FG001|Overall Study|Adverse Event|1|||
48569422|NCT03423173|156277378|FG002|Overall Study|Adverse Event|1|||
48569423|NCT03423173|156277379|FG003|Overall Study|Adverse Event|1|||
48569424|NCT03423173|156277376|FG000|Overall Study|Lost to Follow-up|10|||
48569425|NCT03423173|156277377|FG001|Overall Study|Lost to Follow-up|19|||
48569426|NCT03423173|156277378|FG002|Overall Study|Lost to Follow-up|17|||
48569427|NCT03423173|156277379|FG003|Overall Study|Lost to Follow-up|22|||
48569428|NCT03423173|156277376|FG000|Overall Study|Withdrawal of consent|4|||
48569429|NCT03423173|156277377|FG001|Overall Study|Withdrawal of consent|10|||
48569430|NCT03423173|156277378|FG002|Overall Study|Withdrawal of consent|4|||
48569431|NCT03423173|156277379|FG003|Overall Study|Withdrawal of consent|5|||
48569432|NCT03423173|156277376|FG000|Overall Study|Death|1|||
48569433|NCT03423173|156277377|FG001|Overall Study|Death|0|||
48569434|NCT03423173|156277378|FG002|Overall Study|Death|0|||
48569435|NCT03423173|156277379|FG003|Overall Study|Death|0|||
48569436|NCT03423173|156277376|FG000|Overall Study|Reason not Specified|2|||
48569437|NCT03423173|156277377|FG001|Overall Study|Reason not Specified|5|||
48569438|NCT03423173|156277378|FG002|Overall Study|Reason not Specified|3|||
48569439|NCT03423173|156277379|FG003|Overall Study|Reason not Specified|1|||
48569440|NCT00101166|156277380|FG000|Overall Study|progressive disease|10|||
48569441|NCT00072280|156277384|FG000|Treatment|Found ineligible|1|||
48569442|NCT00072280|156277385|FG001|Treatment|Found ineligible|2|||
48569443|NCT00072280|156277384|FG000|Follow-up|Early termination of study|2|||
48569444|NCT00072280|156277385|FG001|Follow-up|Early termination of study|2|||
48569445|NCT01868022|156277390|FG000|Overall Study|Withdrawal by Subject|0|||
48569446|NCT01868022|156277391|FG001|Overall Study|Withdrawal by Subject|0|||
48569447|NCT01868022|156277392|FG002|Overall Study|Withdrawal by Subject|1|||
48569448|NCT01868022|156277393|FG003|Overall Study|Withdrawal by Subject|1|||
48569449|NCT01868022|156277394|FG004|Overall Study|Withdrawal by Subject|0|||
48569450|NCT01868022|156277395|FG005|Overall Study|Withdrawal by Subject|0|||
48569451|NCT01868022|156277396|FG006|Overall Study|Withdrawal by Subject|0|||
48569452|NCT01868022|156277397|FG007|Overall Study|Withdrawal by Subject|1|||
48569453|NCT01868022|156277398|FG008|Overall Study|Withdrawal by Subject|0|||
48569454|NCT01868022|156277390|FG000|Overall Study|Adverse Event|0|||
48569455|NCT01868022|156277391|FG001|Overall Study|Adverse Event|0|||
48569456|NCT01868022|156277392|FG002|Overall Study|Adverse Event|0|||
48569457|NCT01868022|156277393|FG003|Overall Study|Adverse Event|0|||
48569458|NCT01868022|156277394|FG004|Overall Study|Adverse Event|2|||
48569459|NCT01868022|156277395|FG005|Overall Study|Adverse Event|0|||
48569460|NCT01868022|156277396|FG006|Overall Study|Adverse Event|0|||
48569461|NCT01868022|156277397|FG007|Overall Study|Adverse Event|2|||
48569462|NCT01868022|156277398|FG008|Overall Study|Adverse Event|2|||
48569463|NCT01868022|156277390|FG000|Overall Study|Physician Decision|0|||
48569464|NCT01868022|156277391|FG001|Overall Study|Physician Decision|0|||
48569465|NCT01868022|156277392|FG002|Overall Study|Physician Decision|0|||
48569466|NCT01868022|156277393|FG003|Overall Study|Physician Decision|0|||
48569467|NCT01868022|156277394|FG004|Overall Study|Physician Decision|0|||
48569468|NCT01868022|156277395|FG005|Overall Study|Physician Decision|1|||
48569469|NCT01868022|156277396|FG006|Overall Study|Physician Decision|0|||
48569470|NCT01868022|156277397|FG007|Overall Study|Physician Decision|2|||
48569471|NCT01868022|156277398|FG008|Overall Study|Physician Decision|0|||
48569472|NCT01868022|156277390|FG000|Overall Study|Study closed/terminated|0|||
48569473|NCT01868022|156277391|FG001|Overall Study|Study closed/terminated|0|||
48569474|NCT01868022|156277392|FG002|Overall Study|Study closed/terminated|0|||
48569475|NCT01868022|156277393|FG003|Overall Study|Study closed/terminated|0|||
48569476|NCT01868022|156277394|FG004|Overall Study|Study closed/terminated|0|||
48569477|NCT01868022|156277395|FG005|Overall Study|Study closed/terminated|0|||
48569478|NCT01868022|156277396|FG006|Overall Study|Study closed/terminated|0|||
48569479|NCT01868022|156277397|FG007|Overall Study|Study closed/terminated|1|||
48569480|NCT01868022|156277398|FG008|Overall Study|Study closed/terminated|0|||
48569481|NCT01868022|156277390|FG000|Overall Study|Ongoing|0|||
48569482|NCT01868022|156277391|FG001|Overall Study|Ongoing|0|||
48569483|NCT01868022|156277392|FG002|Overall Study|Ongoing|0|||
48569484|NCT01868022|156277393|FG003|Overall Study|Ongoing|0|||
48569485|NCT01868022|156277394|FG004|Overall Study|Ongoing|0|||
48569486|NCT01868022|156277395|FG005|Overall Study|Ongoing|0|||
48569487|NCT01868022|156277396|FG006|Overall Study|Ongoing|0|||
48569488|NCT01868022|156277397|FG007|Overall Study|Ongoing|3|||
48569489|NCT01868022|156277398|FG008|Overall Study|Ongoing|0|||
48569490|NCT00746564|156277399|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
48569491|NCT00550745|156277400|FG000|Overall Study|Death|20|||
48569492|NCT00550745|156277401|FG001|Overall Study|Death|16|||
48569493|NCT00550745|156277400|FG000|Overall Study|Lost to Follow-up|45|||
48569494|NCT00550745|156277401|FG001|Overall Study|Lost to Follow-up|30|||
48569495|NCT00550745|156277400|FG000|Overall Study|Physician Decision|0|||
48569496|NCT00550745|156277401|FG001|Overall Study|Physician Decision|2|||
48569497|NCT00550745|156277400|FG000|Overall Study|Protocol Violation|4|||
48569498|NCT00550745|156277401|FG001|Overall Study|Protocol Violation|2|||
48569499|NCT00550745|156277400|FG000|Overall Study|Withdrawal by Subject|17|||
48617782|NCT04518410|156456345|FG023|Overall Study|Death|0|||
48569500|NCT00550745|156277401|FG001|Overall Study|Withdrawal by Subject|10|||
48569501|NCT00550745|156277400|FG000|Overall Study|Screen failure|1|||
48569502|NCT00550745|156277401|FG001|Overall Study|Screen failure|0|||
48569503|NCT00022698|156277406|FG000|Overall Study|Adverse Event|5|||
48569504|NCT00022698|156277407|FG001|Overall Study|Adverse Event|9|||
48569505|NCT00022698|156277406|FG000|Overall Study|Death|0|||
48569506|NCT00022698|156277407|FG001|Overall Study|Death|2|||
48569507|NCT00022698|156277406|FG000|Overall Study|Failure to return|0|||
48569508|NCT00022698|156277407|FG001|Overall Study|Failure to return|1|||
48569509|NCT00022698|156277406|FG000|Overall Study|Refused treatment|0|||
48569510|NCT00022698|156277407|FG001|Overall Study|Refused treatment|2|||
48569511|NCT00022698|156277406|FG000|Overall Study|Insufficient therapeutic response|2|||
48569512|NCT00022698|156277407|FG001|Overall Study|Insufficient therapeutic response|14|||
48569513|NCT00022698|156277406|FG000|Overall Study|Administrative /other|1|||
48569514|NCT00022698|156277407|FG001|Overall Study|Administrative /other|7|||
48569515|NCT00570687|156278644|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569516|NCT00570687|156278645|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569517|NCT00570687|156278646|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569518|NCT00570687|156278647|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569519|NCT00570687|156278648|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
48569520|NCT00570687|156278649|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
48617783|NCT04518410|156456346|FG024|Overall Study|Death|0|||
48617784|NCT04518410|156456322|FG000|Overall Study|Requirement to start alternative therapy|0|||
48617785|NCT04518410|156456323|FG001|Overall Study|Requirement to start alternative therapy|0|||
48617786|NCT04518410|156456324|FG002|Overall Study|Requirement to start alternative therapy|1|||
48617787|NCT04518410|156456325|FG003|Overall Study|Requirement to start alternative therapy|0|||
48617788|NCT04518410|156456326|FG004|Overall Study|Requirement to start alternative therapy|0|||
48617789|NCT04518410|156456327|FG005|Overall Study|Requirement to start alternative therapy|0|||
48617790|NCT04518410|156456328|FG006|Overall Study|Requirement to start alternative therapy|0|||
48617791|NCT04518410|156456329|FG007|Overall Study|Requirement to start alternative therapy|0|||
48617792|NCT04518410|156456330|FG008|Overall Study|Requirement to start alternative therapy|0|||
48617793|NCT04518410|156456331|FG009|Overall Study|Requirement to start alternative therapy|0|||
48617794|NCT04518410|156456332|FG010|Overall Study|Requirement to start alternative therapy|0|||
48617795|NCT04518410|156456333|FG011|Overall Study|Requirement to start alternative therapy|0|||
48617796|NCT04518410|156456334|FG012|Overall Study|Requirement to start alternative therapy|0|||
48617797|NCT04518410|156456335|FG013|Overall Study|Requirement to start alternative therapy|0|||
48617798|NCT04518410|156456336|FG014|Overall Study|Requirement to start alternative therapy|0|||
48617799|NCT04518410|156456337|FG015|Overall Study|Requirement to start alternative therapy|0|||
48617800|NCT04518410|156456338|FG016|Overall Study|Requirement to start alternative therapy|0|||
48617801|NCT04518410|156456339|FG017|Overall Study|Requirement to start alternative therapy|0|||
48569521|NCT00570687|156278650|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
48569522|NCT00570687|156278651|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
48569523|NCT00570687|156278652|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
48569524|NCT00570687|156278653|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
48569525|NCT00570687|156278644|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569526|NCT00570687|156278645|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569527|NCT00570687|156278646|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48617802|NCT04518410|156456340|FG018|Overall Study|Requirement to start alternative therapy|0|||
48617803|NCT04518410|156456341|FG019|Overall Study|Requirement to start alternative therapy|0|||
48617804|NCT04518410|156456342|FG020|Overall Study|Requirement to start alternative therapy|0|||
48569528|NCT00570687|156278647|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569529|NCT00570687|156278648|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569530|NCT00570687|156278649|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569531|NCT00570687|156278650|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569532|NCT00570687|156278651|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569533|NCT00570687|156278652|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
48569534|NCT00570687|156278653|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569535|NCT00570687|156278644|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569536|NCT00570687|156278645|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569537|NCT00570687|156278646|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569538|NCT00570687|156278647|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569539|NCT00570687|156278648|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569540|NCT00570687|156278649|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569541|NCT00570687|156278650|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
48569542|NCT00570687|156278651|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569543|NCT00570687|156278652|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569544|NCT00570687|156278653|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
48569545|NCT00485732|156278654|FG000|Overall Study|Protocol Violation|1|||
48569546|NCT00485732|156278655|FG001|Overall Study|Protocol Violation|3|||
48569547|NCT00485732|156278654|FG000|Overall Study|Withdrawal by Subject|5|||
48569548|NCT00485732|156278655|FG001|Overall Study|Withdrawal by Subject|4|||
48569549|NCT00485732|156278654|FG000|Overall Study|Lost to Follow-up|2|||
48569550|NCT00485732|156278655|FG001|Overall Study|Lost to Follow-up|2|||
48569551|NCT02920008|156278667|FG000|Overall Study|Death|117|||
48569552|NCT02920008|156278668|FG001|Overall Study|Death|127|||
48569553|NCT02920008|156278667|FG000|Overall Study|Withdrawal by Subject|3|||
48569554|NCT02920008|156278668|FG001|Overall Study|Withdrawal by Subject|6|||
48569555|NCT02920008|156278667|FG000|Overall Study|Lost to Follow-up|0|||
48569556|NCT02920008|156278668|FG001|Overall Study|Lost to Follow-up|1|||
48569557|NCT00529308|156278669|FG000|Overall Study|Withdrawal by Subject|1|||
48569558|NCT00529308|156278670|FG001|Overall Study|Withdrawal by Subject|1|||
48569559|NCT00582608|156278671|FG000|Overall Study|Not Treated|7|||
48569560|NCT00582608|156278671|FG000|Overall Study|Patient Ineligible|1|||
48569561|NCT00582608|156278671|FG000|Overall Study|Lack of accrual|4|||
48569562|NCT01464164|156278673|FG000|Overall Study|Screen failure|0|||
48569563|NCT01464164|156278674|FG001|Overall Study|Screen failure|1|||
48569564|NCT01464164|156278675|FG002|Overall Study|Screen failure|2|||
48569565|NCT01464164|156278676|FG003|Overall Study|Screen failure|0|||
48569566|NCT01464164|156278677|FG004|Overall Study|Screen failure|0|||
48569567|NCT01464164|156278678|FG005|Overall Study|Screen failure|0|||
48569568|NCT01464164|156278679|FG006|Overall Study|Screen failure|0|||
48569569|NCT01464164|156278673|FG000|Overall Study|Physician Decision|0|||
48569570|NCT01464164|156278674|FG001|Overall Study|Physician Decision|1|||
48569571|NCT01464164|156278675|FG002|Overall Study|Physician Decision|0|||
48569572|NCT01464164|156278676|FG003|Overall Study|Physician Decision|0|||
48569573|NCT01464164|156278677|FG004|Overall Study|Physician Decision|0|||
48569574|NCT01464164|156278678|FG005|Overall Study|Physician Decision|0|||
48569575|NCT01464164|156278679|FG006|Overall Study|Physician Decision|2|||
48617805|NCT04518410|156456343|FG021|Overall Study|Requirement to start alternative therapy|0|||
48569576|NCT00083759|156278680|FG000|Overall Study|Adverse Event|5|||
48569577|NCT00083759|156278681|FG001|Overall Study|Adverse Event|3|||
48569578|NCT00083759|156278680|FG000|Overall Study|Lost to Follow-up|1|||
48569579|NCT00083759|156278681|FG001|Overall Study|Lost to Follow-up|0|||
48569580|NCT00083759|156278680|FG000|Overall Study|Death|1|||
48569581|NCT00083759|156278681|FG001|Overall Study|Death|1|||
48569582|NCT00083759|156278680|FG000|Overall Study|Inadequate Therapeutic Response|32|||
48569583|NCT00083759|156278681|FG001|Overall Study|Inadequate Therapeutic Response|35|||
48569584|NCT00083759|156278680|FG000|Overall Study|Subject Withdrew Consent|2|||
48569585|NCT00083759|156278681|FG001|Overall Study|Subject Withdrew Consent|2|||
48569586|NCT00083759|156278680|FG000|Overall Study|Non-Compliance|1|||
48569587|NCT00083759|156278681|FG001|Overall Study|Non-Compliance|0|||
48569588|NCT00083759|156278680|FG000|Overall Study|Sponsor's Discretion|28|||
48569589|NCT00083759|156278681|FG001|Overall Study|Sponsor's Discretion|29|||
48569590|NCT00083759|156278680|FG000|Overall Study|Other|14|||
48569591|NCT00083759|156278681|FG001|Overall Study|Other|13|||
48569592|NCT00685399|156278682|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48569593|NCT00685399|156278683|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48569594|NCT00685399|156278684|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48569595|NCT00685399|156278685|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48569596|NCT00685399|156278686|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48569597|NCT00685399|156278687|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48569598|NCT00685399|156278688|FG006|Treatment Period 1|Withdrawal by Subject|0|||
48569599|NCT00685399|156278689|FG007|Treatment Period 1|Withdrawal by Subject|0|||
48569600|NCT00685399|156278682|FG000|Treatment Period 1|Protocol Violation|1|||
48569601|NCT00685399|156278683|FG001|Treatment Period 1|Protocol Violation|0|||
48569602|NCT00685399|156278684|FG002|Treatment Period 1|Protocol Violation|0|||
48569603|NCT00685399|156278685|FG003|Treatment Period 1|Protocol Violation|0|||
48569604|NCT00685399|156278686|FG004|Treatment Period 1|Protocol Violation|0|||
48569605|NCT00685399|156278687|FG005|Treatment Period 1|Protocol Violation|0|||
48569606|NCT00685399|156278688|FG006|Treatment Period 1|Protocol Violation|0|||
48569607|NCT00685399|156278689|FG007|Treatment Period 1|Protocol Violation|0|||
48569608|NCT00685399|156278682|FG000|Treatment Period 1|Administrative|2|||
48569609|NCT00685399|156278683|FG001|Treatment Period 1|Administrative|0|||
48569610|NCT00685399|156278684|FG002|Treatment Period 1|Administrative|0|||
48569611|NCT00685399|156278685|FG003|Treatment Period 1|Administrative|0|||
48569612|NCT00685399|156278686|FG004|Treatment Period 1|Administrative|0|||
48569613|NCT00685399|156278687|FG005|Treatment Period 1|Administrative|0|||
48569614|NCT00685399|156278688|FG006|Treatment Period 1|Administrative|0|||
48569615|NCT00685399|156278689|FG007|Treatment Period 1|Administrative|0|||
48569616|NCT00685399|156278682|FG000|Treatment Period 1|Lack of Efficacy|1|||
48569617|NCT00685399|156278683|FG001|Treatment Period 1|Lack of Efficacy|0|||
48569618|NCT00685399|156278684|FG002|Treatment Period 1|Lack of Efficacy|0|||
48569619|NCT00685399|156278685|FG003|Treatment Period 1|Lack of Efficacy|0|||
48569620|NCT00685399|156278686|FG004|Treatment Period 1|Lack of Efficacy|0|||
48569621|NCT00685399|156278687|FG005|Treatment Period 1|Lack of Efficacy|0|||
48569622|NCT00685399|156278688|FG006|Treatment Period 1|Lack of Efficacy|0|||
48569623|NCT00685399|156278689|FG007|Treatment Period 1|Lack of Efficacy|0|||
48569624|NCT00685399|156278682|FG000|Treatment Period 2|Administrative Problems|0|||
48569625|NCT00685399|156278683|FG001|Treatment Period 2|Administrative Problems|2|||
48569626|NCT00685399|156278684|FG002|Treatment Period 2|Administrative Problems|1|||
48569627|NCT00685399|156278685|FG003|Treatment Period 2|Administrative Problems|0|||
48569628|NCT00685399|156278686|FG004|Treatment Period 2|Administrative Problems|0|||
48569629|NCT00685399|156278687|FG005|Treatment Period 2|Administrative Problems|0|||
48569630|NCT00685399|156278688|FG006|Treatment Period 2|Administrative Problems|0|||
48569631|NCT00685399|156278689|FG007|Treatment Period 2|Administrative Problems|0|||
48569632|NCT00685399|156278682|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48569633|NCT00685399|156278683|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48569634|NCT00685399|156278684|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48569635|NCT00685399|156278685|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48569636|NCT00685399|156278686|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48569637|NCT00685399|156278687|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48569638|NCT00685399|156278688|FG006|Treatment Period 2|Withdrawal by Subject|0|||
48569639|NCT00685399|156278689|FG007|Treatment Period 2|Withdrawal by Subject|2|||
48569640|NCT00685399|156278682|FG000|Treatment Period 2|Adverse Event|0|||
48569641|NCT00685399|156278683|FG001|Treatment Period 2|Adverse Event|0|||
48569642|NCT00685399|156278684|FG002|Treatment Period 2|Adverse Event|0|||
48617806|NCT04518410|156456344|FG022|Overall Study|Requirement to start alternative therapy|0|||
48617807|NCT04518410|156456345|FG023|Overall Study|Requirement to start alternative therapy|0|||
48617808|NCT04518410|156456346|FG024|Overall Study|Requirement to start alternative therapy|0|||
48617809|NCT04518410|156456322|FG000|Overall Study|Randomized but not treated|0|||
48617810|NCT04518410|156456323|FG001|Overall Study|Randomized but not treated|0|||
48617811|NCT04518410|156456324|FG002|Overall Study|Randomized but not treated|0|||
48617812|NCT04518410|156456325|FG003|Overall Study|Randomized but not treated|2|||
48617813|NCT04518410|156456326|FG004|Overall Study|Randomized but not treated|6|||
48617814|NCT04518410|156456327|FG005|Overall Study|Randomized but not treated|4|||
48617815|NCT04518410|156456328|FG006|Overall Study|Randomized but not treated|3|||
48569643|NCT00685399|156278685|FG003|Treatment Period 2|Adverse Event|0|||
48569644|NCT00685399|156278686|FG004|Treatment Period 2|Adverse Event|0|||
48569645|NCT00685399|156278687|FG005|Treatment Period 2|Adverse Event|1|||
48569646|NCT00685399|156278688|FG006|Treatment Period 2|Adverse Event|0|||
48569647|NCT00685399|156278689|FG007|Treatment Period 2|Adverse Event|0|||
48569648|NCT00685399|156278682|FG000|Treatment Period 2|Lack of Efficacy|0|||
48569649|NCT00685399|156278683|FG001|Treatment Period 2|Lack of Efficacy|10|||
48569650|NCT00685399|156278684|FG002|Treatment Period 2|Lack of Efficacy|2|||
48569651|NCT00685399|156278685|FG003|Treatment Period 2|Lack of Efficacy|0|||
48569652|NCT00685399|156278686|FG004|Treatment Period 2|Lack of Efficacy|0|||
48569653|NCT00685399|156278687|FG005|Treatment Period 2|Lack of Efficacy|1|||
48569654|NCT00685399|156278688|FG006|Treatment Period 2|Lack of Efficacy|0|||
48569655|NCT00685399|156278689|FG007|Treatment Period 2|Lack of Efficacy|0|||
48569656|NCT00685399|156278682|FG000|Extension|Administrative Issues|0|||
48569657|NCT00685399|156278683|FG001|Extension|Administrative Issues|0|||
48569658|NCT00685399|156278684|FG002|Extension|Administrative Issues|0|||
48569659|NCT00685399|156278685|FG003|Extension|Administrative Issues|1|||
48569660|NCT00685399|156278686|FG004|Extension|Administrative Issues|0|||
48569661|NCT00685399|156278687|FG005|Extension|Administrative Issues|0|||
48569662|NCT00685399|156278688|FG006|Extension|Administrative Issues|0|||
48569663|NCT00685399|156278689|FG007|Extension|Administrative Issues|0|||
48569664|NCT00685399|156278682|FG000|Extension|Withdrawal by Subject|0|||
48569665|NCT00685399|156278683|FG001|Extension|Withdrawal by Subject|0|||
48569666|NCT00685399|156278684|FG002|Extension|Withdrawal by Subject|0|||
48569667|NCT00685399|156278685|FG003|Extension|Withdrawal by Subject|1|||
48569668|NCT00685399|156278686|FG004|Extension|Withdrawal by Subject|0|||
48569669|NCT00685399|156278687|FG005|Extension|Withdrawal by Subject|0|||
48569670|NCT00685399|156278688|FG006|Extension|Withdrawal by Subject|0|||
48569671|NCT00685399|156278689|FG007|Extension|Withdrawal by Subject|0|||
48569672|NCT00685399|156278682|FG000|Extension|Protocol Violation|0|||
48569673|NCT00685399|156278683|FG001|Extension|Protocol Violation|0|||
48569674|NCT00685399|156278684|FG002|Extension|Protocol Violation|0|||
48569675|NCT00685399|156278685|FG003|Extension|Protocol Violation|1|||
48569676|NCT00685399|156278686|FG004|Extension|Protocol Violation|0|||
48617816|NCT04518410|156456329|FG007|Overall Study|Randomized but not treated|3|||
48617817|NCT04518410|156456330|FG008|Overall Study|Randomized but not treated|0|||
48617818|NCT04518410|156456331|FG009|Overall Study|Randomized but not treated|4|||
48617819|NCT04518410|156456332|FG010|Overall Study|Randomized but not treated|0|||
48617820|NCT04518410|156456333|FG011|Overall Study|Randomized but not treated|0|||
48569677|NCT00685399|156278687|FG005|Extension|Protocol Violation|0|||
48569678|NCT00685399|156278688|FG006|Extension|Protocol Violation|0|||
48569679|NCT00685399|156278689|FG007|Extension|Protocol Violation|0|||
48569680|NCT00685399|156278682|FG000|Extension|Lack of Efficacy|0|||
48569681|NCT00685399|156278683|FG001|Extension|Lack of Efficacy|0|||
48569682|NCT00685399|156278684|FG002|Extension|Lack of Efficacy|0|||
48569683|NCT00685399|156278685|FG003|Extension|Lack of Efficacy|2|||
48569684|NCT00685399|156278686|FG004|Extension|Lack of Efficacy|0|||
48569685|NCT00685399|156278687|FG005|Extension|Lack of Efficacy|0|||
48569686|NCT00685399|156278688|FG006|Extension|Lack of Efficacy|0|||
48617821|NCT04518410|156456334|FG012|Overall Study|Randomized but not treated|1|||
48617822|NCT04518410|156456335|FG013|Overall Study|Randomized but not treated|3|||
48617823|NCT04518410|156456336|FG014|Overall Study|Randomized but not treated|3|||
48569687|NCT00685399|156278689|FG007|Extension|Lack of Efficacy|0|||
48569688|NCT00685399|156278682|FG000|Extension|Adverse Event|0|||
48569689|NCT00685399|156278683|FG001|Extension|Adverse Event|0|||
48569690|NCT00685399|156278684|FG002|Extension|Adverse Event|0|||
48569691|NCT00685399|156278685|FG003|Extension|Adverse Event|2|||
48617824|NCT04518410|156456337|FG015|Overall Study|Randomized but not treated|3|||
48617825|NCT04518410|156456338|FG016|Overall Study|Randomized but not treated|4|||
48569692|NCT00685399|156278686|FG004|Extension|Adverse Event|0|||
48617826|NCT04518410|156456339|FG017|Overall Study|Randomized but not treated|5|||
48617827|NCT04518410|156456340|FG018|Overall Study|Randomized but not treated|4|||
48617828|NCT04518410|156456341|FG019|Overall Study|Randomized but not treated|0|||
48617829|NCT04518410|156456342|FG020|Overall Study|Randomized but not treated|0|||
48617830|NCT04518410|156456343|FG021|Overall Study|Randomized but not treated|5|||
48617831|NCT04518410|156456344|FG022|Overall Study|Randomized but not treated|0|||
48617832|NCT04518410|156456345|FG023|Overall Study|Randomized but not treated|3|||
48617833|NCT04518410|156456346|FG024|Overall Study|Randomized but not treated|1|||
48617834|NCT04518410|156456322|FG000|Overall Study|Screen Fail but Randomized|0|||
48617835|NCT04518410|156456323|FG001|Overall Study|Screen Fail but Randomized|0|||
48569693|NCT00685399|156278687|FG005|Extension|Adverse Event|0|||
48569694|NCT00685399|156278688|FG006|Extension|Adverse Event|0|||
48569695|NCT00685399|156278689|FG007|Extension|Adverse Event|0|||
48569696|NCT00869999|156278690|FG000|Overall Study|Withdrawal by Subject|1|||
48569697|NCT00869999|156278690|FG000|Overall Study|removed prior to starting therapy|1|||
48569698|NCT04478695|156278694|FG000|Overall Study|Death|1|||
48569699|NCT04478695|156278695|FG001|Overall Study|Death|0|||
48569700|NCT02347774|156278699|FG000|Study Participation|Lost to Follow-up|3|||
48569701|NCT02347774|156278700|FG001|Study Participation|Lost to Follow-up|6|||
48569702|NCT02347774|156278701|FG002|Study Participation|Lost to Follow-up|2|||
48569703|NCT02347774|156278699|FG000|Study Participation|Withdrawal by Subject|8|||
48569704|NCT02347774|156278700|FG001|Study Participation|Withdrawal by Subject|9|||
48569705|NCT02347774|156278701|FG002|Study Participation|Withdrawal by Subject|15|||
48569706|NCT02347774|156278699|FG000|Study Participation|Adverse Event|1|||
48569707|NCT02347774|156278700|FG001|Study Participation|Adverse Event|4|||
48569708|NCT02347774|156278701|FG002|Study Participation|Adverse Event|6|||
48569709|NCT02347774|156278699|FG000|Study Participation|withdrew consent|1|||
48569710|NCT02347774|156278700|FG001|Study Participation|withdrew consent|1|||
48617836|NCT04518410|156456324|FG002|Overall Study|Screen Fail but Randomized|0|||
48569711|NCT02347774|156278701|FG002|Study Participation|withdrew consent|1|||
48569712|NCT02347774|156278699|FG000|Study Participation|Met Prolonged QT criteria|1|||
48569713|NCT02347774|156278700|FG001|Study Participation|Met Prolonged QT criteria|0|||
48569714|NCT02347774|156278701|FG002|Study Participation|Met Prolonged QT criteria|0|||
48569715|NCT02347774|156278699|FG000|Study Participation|non-compliance with study drug|0|||
48569716|NCT02347774|156278700|FG001|Study Participation|non-compliance with study drug|1|||
48569717|NCT02347774|156278701|FG002|Study Participation|non-compliance with study drug|0|||
48569718|NCT02347774|156278699|FG000|Study Participation|incarceration|1|||
48569719|NCT02347774|156278700|FG001|Study Participation|incarceration|0|||
48569720|NCT02347774|156278701|FG002|Study Participation|incarceration|0|||
48569721|NCT02347774|156278699|FG000|Study Participation|randomized in error|0|||
48569722|NCT02347774|156278700|FG001|Study Participation|randomized in error|0|||
48569723|NCT02347774|156278701|FG002|Study Participation|randomized in error|1|||
48569724|NCT02347774|156278699|FG000|On Study Treatment|Adverse Event|9|||
48569725|NCT02347774|156278700|FG001|On Study Treatment|Adverse Event|15|||
48569726|NCT02347774|156278701|FG002|On Study Treatment|Adverse Event|19|||
48569727|NCT02347774|156278699|FG000|On Study Treatment|Lack of Efficacy|3|||
48569728|NCT02347774|156278700|FG001|On Study Treatment|Lack of Efficacy|0|||
48569729|NCT02347774|156278701|FG002|On Study Treatment|Lack of Efficacy|2|||
48617837|NCT04518410|156456325|FG003|Overall Study|Screen Fail but Randomized|0|||
48617838|NCT04518410|156456326|FG004|Overall Study|Screen Fail but Randomized|2|||
48617839|NCT04518410|156456327|FG005|Overall Study|Screen Fail but Randomized|0|||
48617840|NCT04518410|156456328|FG006|Overall Study|Screen Fail but Randomized|0|||
48617841|NCT04518410|156456329|FG007|Overall Study|Screen Fail but Randomized|0|||
48617842|NCT04518410|156456330|FG008|Overall Study|Screen Fail but Randomized|0|||
48617843|NCT04518410|156456331|FG009|Overall Study|Screen Fail but Randomized|0|||
48617844|NCT04518410|156456332|FG010|Overall Study|Screen Fail but Randomized|0|||
48617845|NCT04518410|156456333|FG011|Overall Study|Screen Fail but Randomized|0|||
48617846|NCT04518410|156456334|FG012|Overall Study|Screen Fail but Randomized|0|||
48617847|NCT04518410|156456335|FG013|Overall Study|Screen Fail but Randomized|0|||
48617848|NCT04518410|156456336|FG014|Overall Study|Screen Fail but Randomized|0|||
48617849|NCT04518410|156456337|FG015|Overall Study|Screen Fail but Randomized|0|||
48569730|NCT02347774|156278699|FG000|On Study Treatment|non-complicance with study medication|0|||
48569731|NCT02347774|156278700|FG001|On Study Treatment|non-complicance with study medication|2|||
48569732|NCT02347774|156278701|FG002|On Study Treatment|non-complicance with study medication|0|||
48569733|NCT02347774|156278699|FG000|On Study Treatment|Protocol Violation|0|||
48569734|NCT02347774|156278700|FG001|On Study Treatment|Protocol Violation|0|||
48569735|NCT02347774|156278701|FG002|On Study Treatment|Protocol Violation|1|||
48569736|NCT02347774|156278699|FG000|On Study Treatment|withdrew consent|9|||
48569737|NCT02347774|156278700|FG001|On Study Treatment|withdrew consent|8|||
48569738|NCT02347774|156278701|FG002|On Study Treatment|withdrew consent|12|||
48569739|NCT02347774|156278699|FG000|On Study Treatment|Lost to Follow-up|2|||
48569740|NCT02347774|156278700|FG001|On Study Treatment|Lost to Follow-up|6|||
48569741|NCT02347774|156278701|FG002|On Study Treatment|Lost to Follow-up|1|||
48569742|NCT02347774|156278699|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
48569743|NCT02347774|156278700|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
48569744|NCT02347774|156278701|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
48569745|NCT02347774|156278699|FG000|On Study Treatment|ranomized in error|0|||
48569746|NCT02347774|156278700|FG001|On Study Treatment|ranomized in error|0|||
48569747|NCT02347774|156278701|FG002|On Study Treatment|ranomized in error|1|||
48569748|NCT00927862|156278702|FG000|Overall Study|Missing data needed for endpt analyses|27|||
48569749|NCT00927862|156278703|FG001|Overall Study|Missing data needed for endpt analyses|45|||
48569750|NCT04112043|156278713|FG000|Overall Study|Withdrawal by Subject|1|||
48569751|NCT04112043|156278714|FG001|Overall Study|Withdrawal by Subject|1|||
48569752|NCT04112043|156278715|FG002|Overall Study|Withdrawal by Subject|1|||
48569753|NCT04112043|156278713|FG000|Overall Study|Taking NR supplement|1|||
48569754|NCT04112043|156278714|FG001|Overall Study|Taking NR supplement|0|||
48569755|NCT04112043|156278715|FG002|Overall Study|Taking NR supplement|0|||
48569756|NCT04112043|156278713|FG000|Overall Study|Adverse Event|0|||
48569757|NCT04112043|156278714|FG001|Overall Study|Adverse Event|1|||
48569758|NCT04112043|156278715|FG002|Overall Study|Adverse Event|0|||
48569759|NCT03259425|156278716|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
48569760|NCT03055338|156278717|FG000|Overall Study|Lost to Follow-up|9|||
48569761|NCT03055338|156278718|FG001|Overall Study|Lost to Follow-up|2|||
48569762|NCT03055338|156278719|FG002|Overall Study|Lost to Follow-up|3|||
48569763|NCT03055338|156278717|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
48569764|NCT03055338|156278718|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
48569765|NCT03055338|156278719|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
48569766|NCT03055338|156278717|FG000|Overall Study|Physician Decision|0|||
48569767|NCT03055338|156278718|FG001|Overall Study|Physician Decision|0|||
48569768|NCT03055338|156278719|FG002|Overall Study|Physician Decision|2|||
48569769|NCT03055338|156278717|FG000|Overall Study|Withdrawal by Subject|9|||
48617850|NCT04518410|156456338|FG016|Overall Study|Screen Fail but Randomized|0|||
48617851|NCT04518410|156456339|FG017|Overall Study|Screen Fail but Randomized|0|||
48617852|NCT04518410|156456340|FG018|Overall Study|Screen Fail but Randomized|0|||
48617853|NCT04518410|156456341|FG019|Overall Study|Screen Fail but Randomized|0|||
48617854|NCT04518410|156456342|FG020|Overall Study|Screen Fail but Randomized|0|||
48617855|NCT04518410|156456343|FG021|Overall Study|Screen Fail but Randomized|0|||
48617856|NCT04518410|156456344|FG022|Overall Study|Screen Fail but Randomized|0|||
48569770|NCT03055338|156278718|FG001|Overall Study|Withdrawal by Subject|8|||
48569771|NCT03055338|156278719|FG002|Overall Study|Withdrawal by Subject|7|||
48569772|NCT02237196|156278720|FG000|Overall Study|Adverse Event|0|||
48569773|NCT02237196|156278721|FG001|Overall Study|Adverse Event|1|||
48617857|NCT04518410|156456345|FG023|Overall Study|Screen Fail but Randomized|0|||
48569774|NCT02237196|156278722|FG002|Overall Study|Adverse Event|1|||
48569775|NCT02237196|156278723|FG003|Overall Study|Adverse Event|0|||
48569776|NCT02237196|156278720|FG000|Overall Study|Lost to Follow-up|4|||
48617858|NCT04518410|156456346|FG024|Overall Study|Screen Fail but Randomized|0|||
48617859|NCT04518410|156456322|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
48617860|NCT04518410|156456323|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
48617861|NCT04518410|156456324|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
48617862|NCT04518410|156456325|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
48617863|NCT04518410|156456326|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
48617864|NCT04518410|156456327|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
48617865|NCT04518410|156456328|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
48617866|NCT04518410|156456329|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
48617867|NCT04518410|156456330|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
48617868|NCT04518410|156456331|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
48617869|NCT04518410|156456332|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
48617870|NCT04518410|156456333|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
48617871|NCT04518410|156456334|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
48617872|NCT04518410|156456335|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
48617873|NCT04518410|156456336|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
48617874|NCT04518410|156456337|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
48617875|NCT04518410|156456338|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
48617876|NCT04518410|156456339|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
48617877|NCT04518410|156456340|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
48617878|NCT04518410|156456341|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
48617879|NCT04518410|156456342|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
48617880|NCT04518410|156456343|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
48617881|NCT04518410|156456344|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
48617882|NCT04518410|156456345|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
48617883|NCT04518410|156456346|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
48617884|NCT04518410|156456322|FG000|Overall Study|Dual Enrolled Subject|0|||
48617885|NCT04518410|156456323|FG001|Overall Study|Dual Enrolled Subject|0|||
48617886|NCT04518410|156456324|FG002|Overall Study|Dual Enrolled Subject|0|||
48617887|NCT04518410|156456325|FG003|Overall Study|Dual Enrolled Subject|0|||
48617888|NCT04518410|156456326|FG004|Overall Study|Dual Enrolled Subject|0|||
48617889|NCT04518410|156456327|FG005|Overall Study|Dual Enrolled Subject|0|||
48617890|NCT04518410|156456328|FG006|Overall Study|Dual Enrolled Subject|0|||
48617891|NCT04518410|156456329|FG007|Overall Study|Dual Enrolled Subject|0|||
48617892|NCT04518410|156456330|FG008|Overall Study|Dual Enrolled Subject|0|||
48617893|NCT04518410|156456331|FG009|Overall Study|Dual Enrolled Subject|0|||
48617894|NCT04518410|156456332|FG010|Overall Study|Dual Enrolled Subject|0|||
48617895|NCT04518410|156456333|FG011|Overall Study|Dual Enrolled Subject|0|||
48617896|NCT04518410|156456334|FG012|Overall Study|Dual Enrolled Subject|0|||
48617897|NCT04518410|156456335|FG013|Overall Study|Dual Enrolled Subject|0|||
48617898|NCT04518410|156456336|FG014|Overall Study|Dual Enrolled Subject|0|||
48617899|NCT04518410|156456337|FG015|Overall Study|Dual Enrolled Subject|0|||
48617900|NCT04518410|156456338|FG016|Overall Study|Dual Enrolled Subject|0|||
48617901|NCT04518410|156456339|FG017|Overall Study|Dual Enrolled Subject|1|||
48617902|NCT04518410|156456340|FG018|Overall Study|Dual Enrolled Subject|0|||
48617903|NCT04518410|156456341|FG019|Overall Study|Dual Enrolled Subject|0|||
48617904|NCT04518410|156456342|FG020|Overall Study|Dual Enrolled Subject|0|||
48617905|NCT04518410|156456343|FG021|Overall Study|Dual Enrolled Subject|0|||
48617906|NCT04518410|156456344|FG022|Overall Study|Dual Enrolled Subject|0|||
48617907|NCT04518410|156456345|FG023|Overall Study|Dual Enrolled Subject|0|||
48617908|NCT04518410|156456346|FG024|Overall Study|Dual Enrolled Subject|0|||
48617909|NCT00002874|156456347|FG000|Overall Study|Withdrawal by Subject|1|||
48617910|NCT00002874|156456348|FG001|Overall Study|Withdrawal by Subject|1|||
48617911|NCT00002874|156456347|FG000|Overall Study|Protocol Violation|44|||
48617912|NCT00002874|156456348|FG001|Overall Study|Protocol Violation|34|||
48617948|NCT03018938|156456354|FG000|Overall Study|Death|0|||
48617949|NCT03018938|156456355|FG001|Overall Study|Death|1|||
48617950|NCT03018938|156456354|FG000|Overall Study|Lost to Follow-up|21|||
48617951|NCT03018938|156456355|FG001|Overall Study|Lost to Follow-up|32|||
48617952|NCT03018938|156456354|FG000|Overall Study|Withdrawal by Subject|38|||
48617953|NCT03018938|156456355|FG001|Overall Study|Withdrawal by Subject|45|||
48617954|NCT03018938|156456354|FG000|Overall Study|Physician Decision|3|||
48617955|NCT03018938|156456355|FG001|Overall Study|Physician Decision|2|||
48617956|NCT03018938|156456354|FG000|Overall Study|Sponsor Decision|0|||
48617957|NCT03018938|156456355|FG001|Overall Study|Sponsor Decision|1|||
48617958|NCT03018938|156456354|FG000|Overall Study|Screen failure-After randomization|4|||
48617959|NCT03018938|156456355|FG001|Overall Study|Screen failure-After randomization|2|||
48617960|NCT03018938|156456354|FG000|Overall Study|Not recorded|0|||
48617961|NCT03018938|156456355|FG001|Overall Study|Not recorded|2|||
48617962|NCT03828383|156456368|FG000|Overall Study|Lost to Follow-up|3|||
48617963|NCT03828383|156456369|FG001|Overall Study|Lost to Follow-up|2|||
48617964|NCT03828383|156456368|FG000|Overall Study|Withdrawal by Subject|4|||
48617965|NCT03828383|156456369|FG001|Overall Study|Withdrawal by Subject|5|||
48617966|NCT00504309|156456370|FG000|Overall Study|Death|0|||
48617967|NCT00504309|156456371|FG001|Overall Study|Death|0|||
48617968|NCT00504309|156456372|FG002|Overall Study|Death|0|||
48617969|NCT00504309|156456373|FG003|Overall Study|Death|0|||
48617970|NCT00504309|156456374|FG004|Overall Study|Death|1|||
48617971|NCT00504309|156456375|FG005|Overall Study|Death|0|||
48617972|NCT00504309|156456370|FG000|Overall Study|Withdrawal by Subject|0|||
48617973|NCT00504309|156456371|FG001|Overall Study|Withdrawal by Subject|0|||
48617974|NCT00504309|156456372|FG002|Overall Study|Withdrawal by Subject|1|||
48617975|NCT00504309|156456373|FG003|Overall Study|Withdrawal by Subject|0|||
48617976|NCT00504309|156456374|FG004|Overall Study|Withdrawal by Subject|0|||
48617977|NCT00504309|156456375|FG005|Overall Study|Withdrawal by Subject|0|||
48617978|NCT00086307|156456376|FG000|Overall Study|Lack of Efficacy|1|||
48617979|NCT00086307|156456377|FG001|Overall Study|Lack of Efficacy|1|||
48617980|NCT00086307|156456378|FG002|Overall Study|Lack of Efficacy|2|||
48617981|NCT00086307|156456376|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
48617982|NCT00086307|156456377|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
48617983|NCT00086307|156456378|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
48617984|NCT00086307|156456376|FG000|Overall Study|Nausea and headaches|0|||
48617985|NCT00086307|156456377|FG001|Overall Study|Nausea and headaches|0|||
48617986|NCT00086307|156456378|FG002|Overall Study|Nausea and headaches|1|||
48617987|NCT00086307|156456376|FG000|Overall Study|Constipation and sleepiness|0|||
48617988|NCT00086307|156456377|FG001|Overall Study|Constipation and sleepiness|0|||
48617989|NCT00086307|156456378|FG002|Overall Study|Constipation and sleepiness|1|||
48617990|NCT00086307|156456376|FG000|Overall Study|Suicidal ideation|0|||
48617991|NCT00086307|156456377|FG001|Overall Study|Suicidal ideation|0|||
48617992|NCT00086307|156456378|FG002|Overall Study|Suicidal ideation|1|||
48617993|NCT00086307|156456376|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
48617994|NCT00086307|156456377|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
48617995|NCT00086307|156456378|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
48617996|NCT00086307|156456376|FG000|Overall Study|Withdrawal by Subject|0|||
48617997|NCT00086307|156456377|FG001|Overall Study|Withdrawal by Subject|0|||
48617998|NCT00086307|156456378|FG002|Overall Study|Withdrawal by Subject|2|||
48617999|NCT00683384|156456379|FG000|Overall Study|Death|1|||
48618000|NCT00683384|156456379|FG000|Overall Study|Adverse Event|1|||
48618001|NCT00120874|156456380|FG000|Overall Study|Death|0|||
48618002|NCT00120874|156456381|FG001|Overall Study|Death|1|||
48618003|NCT00441896|156456384|FG000|Overall Study|Withdrawal by Subject|0|||
48618004|NCT00441896|156456385|FG001|Overall Study|Withdrawal by Subject|0|||
48618005|NCT00441896|156456386|FG002|Overall Study|Withdrawal by Subject|0|||
48618006|NCT00441896|156456387|FG003|Overall Study|Withdrawal by Subject|1|||
48618007|NCT00441896|156456388|FG004|Overall Study|Withdrawal by Subject|0|||
48618008|NCT00441896|156456389|FG005|Overall Study|Withdrawal by Subject|0|||
48618009|NCT00441896|156456390|FG006|Overall Study|Withdrawal by Subject|0|||
48618010|NCT00441896|156456391|FG007|Overall Study|Withdrawal by Subject|0|||
48618011|NCT00441896|156456392|FG008|Overall Study|Withdrawal by Subject|0|||
48618012|NCT00441896|156456393|FG009|Overall Study|Withdrawal by Subject|0|||
48618013|NCT00441896|156456384|FG000|Overall Study|Other|0|||
48618014|NCT00441896|156456385|FG001|Overall Study|Other|0|||
48618015|NCT00441896|156456386|FG002|Overall Study|Other|0|||
48618016|NCT00441896|156456387|FG003|Overall Study|Other|0|||
48618017|NCT00441896|156456388|FG004|Overall Study|Other|1|||
48618018|NCT00441896|156456389|FG005|Overall Study|Other|0|||
48618019|NCT00441896|156456390|FG006|Overall Study|Other|0|||
48618020|NCT00441896|156456391|FG007|Overall Study|Other|0|||
48618021|NCT00441896|156456392|FG008|Overall Study|Other|0|||
48618022|NCT00441896|156456393|FG009|Overall Study|Other|0|||
48618023|NCT01301092|156456394|FG000|Overall Study|Lost to Follow-up|0|||
48618024|NCT01301092|156456395|FG001|Overall Study|Lost to Follow-up|0|||
48618025|NCT01301092|156456396|FG002|Overall Study|Lost to Follow-up|1|||
48618026|NCT01363076|156457821|FG000|Overall Study|Withdrawal by Subject|0|||
48618027|NCT01363076|156457822|FG001|Overall Study|Withdrawal by Subject|1|||
48618028|NCT01373229|156457823|FG000|Overall Study|Death|3|||
48618029|NCT01373229|156457823|FG000|Overall Study|Physician Decision|3|||
48618030|NCT02724644|156457824|FG000|Overall Study|Adverse Event|7|||
48618031|NCT02724644|156457825|FG001|Overall Study|Adverse Event|1|||
48618032|NCT02724644|156457824|FG000|Overall Study|Lost to Follow-up|6|||
48618033|NCT02724644|156457825|FG001|Overall Study|Lost to Follow-up|2|||
48618034|NCT02724644|156457824|FG000|Overall Study|Withdrawal by Subject|7|||
48618035|NCT02724644|156457825|FG001|Overall Study|Withdrawal by Subject|1|||
48618036|NCT02724644|156457824|FG000|Overall Study|Administrative|1|||
48618037|NCT02724644|156457825|FG001|Overall Study|Administrative|0|||
48618038|NCT01500096|156457826|FG000|Overall Study|Lost to Follow-up|1|||
48618039|NCT01500096|156457827|FG001|Overall Study|Lost to Follow-up|0|||
48618040|NCT01500096|156457828|FG002|Overall Study|Lost to Follow-up|0|||
48618041|NCT01500096|156457829|FG003|Overall Study|Lost to Follow-up|2|||
48618042|NCT00382070|156457832|FG000|Overall Study|No follow up data mapped to Other|17|||
48618043|NCT00382070|156457833|FG001|Overall Study|No follow up data mapped to Other|19|||
48618044|NCT00382070|156457832|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
48618045|NCT00382070|156457833|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
48618046|NCT00382070|156457832|FG000|Overall Study|No clinical assessment|9|||
48618047|NCT00382070|156457833|FG001|Overall Study|No clinical assessment|11|||
48618048|NCT03033901|156457834|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
48618049|NCT03033901|156457834|FG000|Overall Study|Refused PSG|23|||
48618050|NCT03033901|156457834|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
48569777|NCT02237196|156278721|FG001|Overall Study|Lost to Follow-up|2|||
48569778|NCT02237196|156278722|FG002|Overall Study|Lost to Follow-up|4|||
48569779|NCT02237196|156278723|FG003|Overall Study|Lost to Follow-up|6|||
48569780|NCT02237196|156278720|FG000|Overall Study|Physician Decision|2|||
48569781|NCT02237196|156278721|FG001|Overall Study|Physician Decision|0|||
48569782|NCT02237196|156278722|FG002|Overall Study|Physician Decision|0|||
48569783|NCT02237196|156278723|FG003|Overall Study|Physician Decision|1|||
48569784|NCT02237196|156278720|FG000|Overall Study|Pregnancy|0|||
48569785|NCT02237196|156278721|FG001|Overall Study|Pregnancy|0|||
48569786|NCT02237196|156278722|FG002|Overall Study|Pregnancy|1|||
48569787|NCT02237196|156278723|FG003|Overall Study|Pregnancy|1|||
48569788|NCT02237196|156278720|FG000|Overall Study|Withdrawal by Subject|1|||
48569789|NCT02237196|156278721|FG001|Overall Study|Withdrawal by Subject|1|||
48569790|NCT02237196|156278722|FG002|Overall Study|Withdrawal by Subject|4|||
48618051|NCT03033901|156457834|FG000|Overall Study|Missing Oximetry Data|3|||
48618052|NCT01567085|156457835|FG000|Overall Study|Death|6|||
48618053|NCT01567085|156457835|FG000|Overall Study|Adverse Event|6|||
48618054|NCT01567085|156457835|FG000|Overall Study|Lost to Follow-up|3|||
48618055|NCT01567085|156457835|FG000|Overall Study|Graft loss|2|||
48618056|NCT01567085|156457835|FG000|Overall Study|Renal transplantectomy|1|||
48618057|NCT01567085|156457835|FG000|Overall Study|Returned to chronic dialysis|1|||
48618058|NCT01567085|156457835|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
48618059|NCT03298061|156457840|FG000|Overall Study|Adverse Event|3|||
48618060|NCT03298061|156457840|FG000|Overall Study|Lack of Efficacy|6|||
48618061|NCT03298061|156457840|FG000|Overall Study|Protocol Violation|1|||
48618062|NCT03298061|156457840|FG000|Overall Study|Physician Decision|7|||
48618063|NCT03298061|156457840|FG000|Overall Study|Withdrawal by Subject|10|||
48618064|NCT02827708|156457843|FG000|Overall Study|Lost to Follow-up|3|||
48618065|NCT02827708|156457844|FG001|Overall Study|Lost to Follow-up|1|||
48618066|NCT02827708|156457843|FG000|Overall Study|Withdrawal by Subject|1|||
48618067|NCT02827708|156457844|FG001|Overall Study|Withdrawal by Subject|2|||
48569791|NCT02237196|156278723|FG003|Overall Study|Withdrawal by Subject|1|||
48569792|NCT02237196|156278720|FG000|Overall Study|Site Error|1|||
48569793|NCT02237196|156278721|FG001|Overall Study|Site Error|2|||
48618068|NCT02827708|156457843|FG000|Overall Study|Death|1|||
48618069|NCT02827708|156457844|FG001|Overall Study|Death|2|||
48618070|NCT02082483|156457847|FG000|Overall Study|Lost to Follow-up|1|||
48618071|NCT02082483|156457848|FG001|Overall Study|Lost to Follow-up|1|||
48618072|NCT02082483|156457847|FG000|Overall Study|Withdrawal by Subject|2|||
48618073|NCT02082483|156457848|FG001|Overall Study|Withdrawal by Subject|1|||
48618074|NCT02082483|156457847|FG000|Overall Study|Physician Decision|1|||
48618075|NCT02082483|156457848|FG001|Overall Study|Physician Decision|1|||
48618076|NCT02082483|156457847|FG000|Overall Study|Death|2|||
48618077|NCT02082483|156457848|FG001|Overall Study|Death|3|||
48618078|NCT03055195|156457850|FG000|Overall Study|Lack of Efficacy|1|||
48618079|NCT03055195|156457851|FG001|Overall Study|Lack of Efficacy|0|||
48618080|NCT03055195|156457850|FG000|Overall Study|Withdrawal by Subject|6|||
48618081|NCT03055195|156457851|FG001|Overall Study|Withdrawal by Subject|7|||
48618082|NCT03055195|156457850|FG000|Overall Study|Study Terminated by Sponsor|2|||
48618083|NCT03055195|156457851|FG001|Overall Study|Study Terminated by Sponsor|6|||
48618084|NCT03055195|156457850|FG000|Overall Study|Protocol Violation|2|||
48618085|NCT03055195|156457851|FG001|Overall Study|Protocol Violation|1|||
48618086|NCT03055195|156457850|FG000|Overall Study|Physician Decision|1|||
48618087|NCT03055195|156457851|FG001|Overall Study|Physician Decision|0|||
48618088|NCT00875667|156457859|FG000|Overall Study|Adverse Event|29|||
48618089|NCT00875667|156457860|FG001|Overall Study|Adverse Event|10|||
48618090|NCT00875667|156457859|FG000|Overall Study|Withdrawal by Subject|17|||
48618091|NCT00875667|156457860|FG001|Overall Study|Withdrawal by Subject|5|||
48618092|NCT00875667|156457859|FG000|Overall Study|Death|7|||
48618093|NCT00875667|156457860|FG001|Overall Study|Death|2|||
48618094|NCT00875667|156457859|FG000|Overall Study|Protocol Violation|2|||
48618095|NCT00875667|156457860|FG001|Overall Study|Protocol Violation|0|||
48618096|NCT00875667|156457859|FG000|Overall Study|Disease Progression|100|||
48618097|NCT00875667|156457860|FG001|Overall Study|Disease Progression|49|||
48618098|NCT00875667|156457859|FG000|Overall Study|Miscellaneous|12|||
48618099|NCT00875667|156457860|FG001|Overall Study|Miscellaneous|6|||
48618100|NCT00875667|156457859|FG000|Overall Study|Randomized but no Study Drug Given|3|||
48618101|NCT00875667|156457860|FG001|Overall Study|Randomized but no Study Drug Given|1|||
48618102|NCT00549328|156457863|FG000|Overall Study|Adverse Event|2|||
48618103|NCT00549328|156457863|FG000|Overall Study|Disease Progression|10|||
48618104|NCT00549328|156457863|FG000|Overall Study|Death|1|||
48618105|NCT00549328|156457863|FG000|Overall Study|Use of Prohibited Medication|1|||
48618106|NCT00770484|156457864|FG000|Overall Study|Withdrawal by Subject|1|||
48618107|NCT00770484|156457865|FG001|Overall Study|Withdrawal by Subject|0|||
48618108|NCT00894647|156457866|FG000|Overall Study|Adverse Event|5|||
48618109|NCT00894647|156457867|FG001|Overall Study|Adverse Event|4|||
48618110|NCT00894647|156457866|FG000|Overall Study|Withdrawal by Subject|4|||
48618111|NCT00894647|156457867|FG001|Overall Study|Withdrawal by Subject|4|||
48618112|NCT00894647|156457866|FG000|Overall Study|Lost to Follow-up|0|||
48618113|NCT00894647|156457867|FG001|Overall Study|Lost to Follow-up|2|||
48735667|NCT02840721|156883710|FG000|Follow-Up|Lack of Efficacy|1|||
48618114|NCT00894647|156457866|FG000|Overall Study|Non-compliance with study procedures|0|||
48618115|NCT00894647|156457867|FG001|Overall Study|Non-compliance with study procedures|2|||
48618116|NCT00894647|156457866|FG000|Overall Study|Other, not due to AE|1|||
48618117|NCT00894647|156457867|FG001|Overall Study|Other, not due to AE|2|||
48618118|NCT01967277|156457868|FG000|Overall Study|Lost to Follow-up|1|||
48618119|NCT01967277|156457869|FG001|Overall Study|Lost to Follow-up|2|||
48618120|NCT01967277|156457868|FG000|Overall Study|Unrelated illness|0|||
48618121|NCT01967277|156457869|FG001|Overall Study|Unrelated illness|1|||
48618122|NCT01281306|156457870|FG000|Overall Study|Lack of Efficacy|0|||
48618123|NCT01281306|156457871|FG001|Overall Study|Lack of Efficacy|1|||
48618124|NCT01281306|156457872|FG002|Overall Study|Lack of Efficacy|3|||
48618125|NCT01281306|156457873|FG003|Overall Study|Lack of Efficacy|0|||
48618126|NCT01281306|156457874|FG004|Overall Study|Lack of Efficacy|2|||
48618127|NCT01281306|156457875|FG005|Overall Study|Lack of Efficacy|0|||
48618128|NCT01281306|156457876|FG006|Overall Study|Lack of Efficacy|1|||
48618129|NCT01281306|156457870|FG000|Overall Study|Withdrawal by Subject|1|||
48618130|NCT01281306|156457871|FG001|Overall Study|Withdrawal by Subject|0|||
48618131|NCT01281306|156457872|FG002|Overall Study|Withdrawal by Subject|2|||
48618132|NCT01281306|156457873|FG003|Overall Study|Withdrawal by Subject|4|||
48618133|NCT01281306|156457874|FG004|Overall Study|Withdrawal by Subject|1|||
48618134|NCT01281306|156457875|FG005|Overall Study|Withdrawal by Subject|3|||
48618135|NCT01281306|156457876|FG006|Overall Study|Withdrawal by Subject|1|||
48618136|NCT01281306|156457870|FG000|Overall Study|Protocol deviation|0|||
48618137|NCT01281306|156457871|FG001|Overall Study|Protocol deviation|1|||
48618138|NCT01281306|156457872|FG002|Overall Study|Protocol deviation|1|||
48618139|NCT01281306|156457873|FG003|Overall Study|Protocol deviation|1|||
48618140|NCT01281306|156457874|FG004|Overall Study|Protocol deviation|1|||
48618141|NCT01281306|156457875|FG005|Overall Study|Protocol deviation|0|||
48618142|NCT01281306|156457876|FG006|Overall Study|Protocol deviation|0|||
48618143|NCT01281306|156457870|FG000|Overall Study|Condition no longer requires study drug|1|||
48618144|NCT01281306|156457871|FG001|Overall Study|Condition no longer requires study drug|0|||
48618145|NCT01281306|156457872|FG002|Overall Study|Condition no longer requires study drug|0|||
48618146|NCT01281306|156457873|FG003|Overall Study|Condition no longer requires study drug|0|||
48618147|NCT01281306|156457874|FG004|Overall Study|Condition no longer requires study drug|0|||
48618148|NCT01281306|156457875|FG005|Overall Study|Condition no longer requires study drug|1|||
48618149|NCT01281306|156457876|FG006|Overall Study|Condition no longer requires study drug|1|||
48618150|NCT01281306|156457870|FG000|Overall Study|Lost to Follow-up|1|||
48618151|NCT01281306|156457871|FG001|Overall Study|Lost to Follow-up|0|||
48618152|NCT01281306|156457872|FG002|Overall Study|Lost to Follow-up|0|||
48618153|NCT01281306|156457873|FG003|Overall Study|Lost to Follow-up|2|||
48618154|NCT01281306|156457874|FG004|Overall Study|Lost to Follow-up|0|||
48618155|NCT01281306|156457875|FG005|Overall Study|Lost to Follow-up|0|||
48618156|NCT01281306|156457876|FG006|Overall Study|Lost to Follow-up|1|||
48618157|NCT01281306|156457870|FG000|Overall Study|Death|1|||
48618158|NCT01281306|156457871|FG001|Overall Study|Death|0|||
48618159|NCT01281306|156457872|FG002|Overall Study|Death|0|||
48618160|NCT01281306|156457873|FG003|Overall Study|Death|0|||
48618161|NCT01281306|156457874|FG004|Overall Study|Death|0|||
48618162|NCT01281306|156457875|FG005|Overall Study|Death|0|||
48618163|NCT01281306|156457876|FG006|Overall Study|Death|0|||
48618164|NCT01281306|156457870|FG000|Overall Study|Adverse Event|3|||
48618165|NCT01281306|156457871|FG001|Overall Study|Adverse Event|2|||
48618166|NCT01281306|156457872|FG002|Overall Study|Adverse Event|2|||
48618167|NCT01281306|156457873|FG003|Overall Study|Adverse Event|3|||
48569794|NCT02237196|156278722|FG002|Overall Study|Site Error|0|||
48569795|NCT02237196|156278723|FG003|Overall Study|Site Error|2|||
48569796|NCT04157296|156278724|FG000|Overall Study|Withdrawal by Subject|0|||
48569797|NCT04157296|156278725|FG001|Overall Study|Withdrawal by Subject|1|||
48569798|NCT04157296|156278724|FG000|Overall Study|Did not obtain second fMRI.|0|||
48569799|NCT04157296|156278725|FG001|Overall Study|Did not obtain second fMRI.|1|||
48569800|NCT04157296|156278724|FG000|Overall Study|MRI failed/no second fMRI|0|||
48569801|NCT04157296|156278725|FG001|Overall Study|MRI failed/no second fMRI|1|||
48569802|NCT01387516|156278734|FG000|Overall Study|Lost to Follow-up|4|||
48569803|NCT01387516|156278735|FG001|Overall Study|Lost to Follow-up|4|||
48569804|NCT01387516|156278736|FG002|Overall Study|Lost to Follow-up|2|||
48569805|NCT01387516|156278737|FG003|Overall Study|Lost to Follow-up|3|||
48569806|NCT01387516|156278734|FG000|Overall Study|Withdrawal by Subject|1|||
48569807|NCT01387516|156278735|FG001|Overall Study|Withdrawal by Subject|1|||
48569808|NCT01387516|156278736|FG002|Overall Study|Withdrawal by Subject|2|||
48569809|NCT01387516|156278737|FG003|Overall Study|Withdrawal by Subject|0|||
48569810|NCT01387516|156278734|FG000|Overall Study|Death|0|||
48569811|NCT01387516|156278735|FG001|Overall Study|Death|0|||
48569812|NCT01387516|156278736|FG002|Overall Study|Death|0|||
48569813|NCT01387516|156278737|FG003|Overall Study|Death|1|||
48569814|NCT02564900|156278740|FG000|Dose Escalation|Progressive disease per RECIST|2|||
48569815|NCT02564900|156278741|FG001|Dose Escalation|Progressive disease per RECIST|3|||
48569816|NCT02564900|156278742|FG002|Dose Escalation|Progressive disease per RECIST|3|||
48569817|NCT02564900|156278743|FG003|Dose Escalation|Progressive disease per RECIST|3|||
48569818|NCT02564900|156278744|FG004|Dose Escalation|Progressive disease per RECIST|3|||
48569819|NCT02564900|156278745|FG005|Dose Escalation|Progressive disease per RECIST|1|||
48569820|NCT02564900|156278746|FG006|Dose Escalation|Progressive disease per RECIST|0|||
48569821|NCT02564900|156278747|FG007|Dose Escalation|Progressive disease per RECIST|0|||
48569822|NCT02564900|156278748|FG008|Dose Escalation|Progressive disease per RECIST|0|||
48569823|NCT02564900|156278749|FG009|Dose Escalation|Progressive disease per RECIST|0|||
48569824|NCT02564900|156278750|FG010|Dose Escalation|Progressive disease per RECIST|0|||
48618168|NCT01281306|156457874|FG004|Overall Study|Adverse Event|5|||
48569825|NCT02564900|156278751|FG011|Dose Escalation|Progressive disease per RECIST|0|||
48618169|NCT01281306|156457875|FG005|Overall Study|Adverse Event|3|||
48618170|NCT01281306|156457876|FG006|Overall Study|Adverse Event|3|||
48618171|NCT01281306|156457870|FG000|Overall Study|Randomized in error|1|||
48618172|NCT01281306|156457871|FG001|Overall Study|Randomized in error|0|||
48618173|NCT01281306|156457872|FG002|Overall Study|Randomized in error|0|||
48569826|NCT02564900|156278752|FG012|Dose Escalation|Progressive disease per RECIST|0|||
48569827|NCT02564900|156278753|FG013|Dose Escalation|Progressive disease per RECIST|0|||
48569828|NCT02564900|156278754|FG014|Dose Escalation|Progressive disease per RECIST|0|||
48569829|NCT02564900|156278740|FG000|Dose Escalation|Ongoing|1|||
48569830|NCT02564900|156278741|FG001|Dose Escalation|Ongoing|0|||
48569831|NCT02564900|156278742|FG002|Dose Escalation|Ongoing|0|||
48569832|NCT02564900|156278743|FG003|Dose Escalation|Ongoing|2|||
48569833|NCT02564900|156278744|FG004|Dose Escalation|Ongoing|2|||
48618174|NCT01281306|156457873|FG003|Overall Study|Randomized in error|1|||
48618175|NCT01281306|156457874|FG004|Overall Study|Randomized in error|0|||
48618176|NCT01281306|156457875|FG005|Overall Study|Randomized in error|0|||
48569834|NCT02564900|156278745|FG005|Dose Escalation|Ongoing|2|||
48569835|NCT02564900|156278746|FG006|Dose Escalation|Ongoing|0|||
48569836|NCT02564900|156278747|FG007|Dose Escalation|Ongoing|0|||
48569837|NCT02564900|156278748|FG008|Dose Escalation|Ongoing|0|||
48569838|NCT02564900|156278749|FG009|Dose Escalation|Ongoing|0|||
48569839|NCT02564900|156278750|FG010|Dose Escalation|Ongoing|0|||
48569840|NCT02564900|156278751|FG011|Dose Escalation|Ongoing|0|||
48569841|NCT02564900|156278752|FG012|Dose Escalation|Ongoing|0|||
48569842|NCT02564900|156278753|FG013|Dose Escalation|Ongoing|0|||
48569843|NCT02564900|156278754|FG014|Dose Escalation|Ongoing|0|||
48569844|NCT02564900|156278740|FG000|Dose Escalation|Adverse Event|0|||
48569845|NCT02564900|156278741|FG001|Dose Escalation|Adverse Event|0|||
48569846|NCT02564900|156278742|FG002|Dose Escalation|Adverse Event|0|||
48569847|NCT02564900|156278743|FG003|Dose Escalation|Adverse Event|1|||
48569848|NCT02564900|156278744|FG004|Dose Escalation|Adverse Event|1|||
48569849|NCT02564900|156278745|FG005|Dose Escalation|Adverse Event|3|||
48569850|NCT02564900|156278746|FG006|Dose Escalation|Adverse Event|0|||
48569851|NCT02564900|156278747|FG007|Dose Escalation|Adverse Event|0|||
48569852|NCT02564900|156278748|FG008|Dose Escalation|Adverse Event|0|||
48569853|NCT02564900|156278749|FG009|Dose Escalation|Adverse Event|0|||
48569854|NCT02564900|156278750|FG010|Dose Escalation|Adverse Event|0|||
48569855|NCT02564900|156278751|FG011|Dose Escalation|Adverse Event|0|||
48569856|NCT02564900|156278752|FG012|Dose Escalation|Adverse Event|0|||
48569857|NCT02564900|156278753|FG013|Dose Escalation|Adverse Event|0|||
48569858|NCT02564900|156278754|FG014|Dose Escalation|Adverse Event|0|||
48569859|NCT02564900|156278740|FG000|Dose Expansion|Progressive disease per RECIST|0|||
48569860|NCT02564900|156278741|FG001|Dose Expansion|Progressive disease per RECIST|0|||
48569861|NCT02564900|156278742|FG002|Dose Expansion|Progressive disease per RECIST|0|||
48569862|NCT02564900|156278743|FG003|Dose Expansion|Progressive disease per RECIST|0|||
48569863|NCT02564900|156278744|FG004|Dose Expansion|Progressive disease per RECIST|0|||
48569864|NCT02564900|156278745|FG005|Dose Expansion|Progressive disease per RECIST|0|||
48569865|NCT02564900|156278746|FG006|Dose Expansion|Progressive disease per RECIST|19|||
48569866|NCT02564900|156278747|FG007|Dose Expansion|Progressive disease per RECIST|17|||
48569867|NCT02564900|156278748|FG008|Dose Expansion|Progressive disease per RECIST|8|||
48569868|NCT02564900|156278749|FG009|Dose Expansion|Progressive disease per RECIST|16|||
48569869|NCT02564900|156278750|FG010|Dose Expansion|Progressive disease per RECIST|13|||
48569870|NCT02564900|156278751|FG011|Dose Expansion|Progressive disease per RECIST|19|||
48569871|NCT02564900|156278752|FG012|Dose Expansion|Progressive disease per RECIST|10|||
48569872|NCT02564900|156278753|FG013|Dose Expansion|Progressive disease per RECIST|13|||
48569873|NCT02564900|156278754|FG014|Dose Expansion|Progressive disease per RECIST|11|||
48569874|NCT02564900|156278740|FG000|Dose Expansion|Clinical progression|0|||
48569875|NCT02564900|156278741|FG001|Dose Expansion|Clinical progression|0|||
48569876|NCT02564900|156278742|FG002|Dose Expansion|Clinical progression|0|||
48569877|NCT02564900|156278743|FG003|Dose Expansion|Clinical progression|0|||
48569878|NCT02564900|156278744|FG004|Dose Expansion|Clinical progression|0|||
48569879|NCT02564900|156278745|FG005|Dose Expansion|Clinical progression|0|||
48569880|NCT02564900|156278746|FG006|Dose Expansion|Clinical progression|5|||
48569881|NCT02564900|156278747|FG007|Dose Expansion|Clinical progression|12|||
48569882|NCT02564900|156278748|FG008|Dose Expansion|Clinical progression|0|||
48569883|NCT02564900|156278749|FG009|Dose Expansion|Clinical progression|3|||
48569884|NCT02564900|156278750|FG010|Dose Expansion|Clinical progression|2|||
48569885|NCT02564900|156278751|FG011|Dose Expansion|Clinical progression|0|||
48569886|NCT02564900|156278752|FG012|Dose Expansion|Clinical progression|1|||
48569887|NCT02564900|156278753|FG013|Dose Expansion|Clinical progression|3|||
48569888|NCT02564900|156278754|FG014|Dose Expansion|Clinical progression|1|||
48569889|NCT02564900|156278740|FG000|Dose Expansion|Adverse Event|0|||
48569890|NCT02564900|156278741|FG001|Dose Expansion|Adverse Event|0|||
48569891|NCT02564900|156278742|FG002|Dose Expansion|Adverse Event|0|||
48569892|NCT02564900|156278743|FG003|Dose Expansion|Adverse Event|0|||
48569893|NCT02564900|156278744|FG004|Dose Expansion|Adverse Event|0|||
48569894|NCT02564900|156278745|FG005|Dose Expansion|Adverse Event|0|||
48569895|NCT02564900|156278746|FG006|Dose Expansion|Adverse Event|9|||
48569896|NCT02564900|156278747|FG007|Dose Expansion|Adverse Event|22|||
48569897|NCT02564900|156278748|FG008|Dose Expansion|Adverse Event|0|||
48569898|NCT02564900|156278749|FG009|Dose Expansion|Adverse Event|11|||
48569899|NCT02564900|156278750|FG010|Dose Expansion|Adverse Event|0|||
48618177|NCT01281306|156457876|FG006|Overall Study|Randomized in error|0|||
48618178|NCT01946802|156457881|FG000|Overall Study|Death|1|||
48618179|NCT01946802|156457881|FG000|Overall Study|Withdrawal by Subject|2|||
48618180|NCT01946802|156457881|FG000|Overall Study|Combined septic shock|1|||
48618181|NCT01946802|156457881|FG000|Overall Study|Protocol Violation|1|||
48618182|NCT00923702|156457882|FG000|Overall Study|Ongoing enrollment|0|||
48618183|NCT00923702|156457883|FG001|Overall Study|Ongoing enrollment|0|||
48618184|NCT00923702|156457884|FG002|Overall Study|Ongoing enrollment|0|||
48618185|NCT00923702|156457885|FG003|Overall Study|Ongoing enrollment|0|||
48618186|NCT00923702|156457886|FG004|Overall Study|Ongoing enrollment|354|||
48618187|NCT02755090|156457887|FG000|Overall Study|equipment malfunction|1|||
48618188|NCT02755090|156457888|FG001|Overall Study|equipment malfunction|0|||
48618189|NCT01186419|156457891|FG000|Overall Study|Withdrawal by Subject|5|||
48618190|NCT01186419|156457892|FG001|Overall Study|Withdrawal by Subject|3|||
48618191|NCT01186419|156457891|FG000|Overall Study|Adverse Event|1|||
48618192|NCT01186419|156457892|FG001|Overall Study|Adverse Event|2|||
48618193|NCT01186419|156457891|FG000|Overall Study|Physician Decision|0|||
48618194|NCT01186419|156457892|FG001|Overall Study|Physician Decision|3|||
48618195|NCT01186419|156457891|FG000|Overall Study|Other|1|||
48618196|NCT01186419|156457892|FG001|Overall Study|Other|1|||
48618197|NCT01078545|156457893|FG000|Overall Study|Lost to Follow-up|13|||
48618198|NCT01078545|156457893|FG000|Overall Study|Physician Decision|6|||
48618199|NCT01078545|156457893|FG000|Overall Study|Withdrawal by Subject|3|||
48618200|NCT01078545|156457893|FG000|Overall Study|Death|3|||
48618201|NCT01078545|156457893|FG000|Overall Study|Participant moved to another physician|1|||
48618202|NCT04401293|156457894|FG000|Overall Study|Withdrawal by Subject|1|||
48618203|NCT04401293|156457895|FG001|Overall Study|Withdrawal by Subject|3|||
48618204|NCT03679884|156457896|FG000|Overall Study|Other|12|||
48618205|NCT03679884|156457897|FG001|Overall Study|Other|12|||
48618206|NCT03679884|156457898|FG002|Overall Study|Other|12|||
48618207|NCT03679884|156457899|FG003|Overall Study|Other|7|||
48618208|NCT03679884|156457900|FG004|Overall Study|Other|8|||
48618209|NCT03679884|156457896|FG000|Overall Study|Lack of Efficacy|15|||
48618210|NCT03679884|156457897|FG001|Overall Study|Lack of Efficacy|29|||
48618211|NCT03679884|156457898|FG002|Overall Study|Lack of Efficacy|13|||
48618212|NCT03679884|156457899|FG003|Overall Study|Lack of Efficacy|29|||
48618213|NCT03679884|156457900|FG004|Overall Study|Lack of Efficacy|10|||
48618214|NCT03679884|156457896|FG000|Overall Study|Death|1|||
48618215|NCT03679884|156457897|FG001|Overall Study|Death|0|||
48618216|NCT03679884|156457898|FG002|Overall Study|Death|0|||
48618217|NCT03679884|156457899|FG003|Overall Study|Death|0|||
48618218|NCT03679884|156457900|FG004|Overall Study|Death|0|||
48618219|NCT03679884|156457896|FG000|Overall Study|Adverse Event|2|||
48618220|NCT03679884|156457897|FG001|Overall Study|Adverse Event|10|||
48618221|NCT03679884|156457898|FG002|Overall Study|Adverse Event|9|||
48618222|NCT03679884|156457899|FG003|Overall Study|Adverse Event|6|||
48618223|NCT03679884|156457900|FG004|Overall Study|Adverse Event|6|||
48618224|NCT03679884|156457896|FG000|Overall Study|Withdrawal by Subject|12|||
48618225|NCT03679884|156457897|FG001|Overall Study|Withdrawal by Subject|23|||
48618226|NCT03679884|156457898|FG002|Overall Study|Withdrawal by Subject|8|||
48618227|NCT03679884|156457899|FG003|Overall Study|Withdrawal by Subject|8|||
48618228|NCT03679884|156457900|FG004|Overall Study|Withdrawal by Subject|9|||
48618229|NCT03679884|156457896|FG000|Overall Study|Lost to Follow-up|1|||
48618230|NCT03679884|156457897|FG001|Overall Study|Lost to Follow-up|4|||
48618231|NCT03679884|156457898|FG002|Overall Study|Lost to Follow-up|2|||
48618232|NCT03679884|156457899|FG003|Overall Study|Lost to Follow-up|0|||
48569900|NCT02564900|156278751|FG011|Dose Expansion|Adverse Event|5|||
48569901|NCT02564900|156278752|FG012|Dose Expansion|Adverse Event|2|||
48569902|NCT02564900|156278753|FG013|Dose Expansion|Adverse Event|2|||
48569903|NCT02564900|156278754|FG014|Dose Expansion|Adverse Event|1|||
48569904|NCT02564900|156278740|FG000|Dose Expansion|Ongoing|0|||
48569905|NCT02564900|156278741|FG001|Dose Expansion|Ongoing|0|||
48569906|NCT02564900|156278742|FG002|Dose Expansion|Ongoing|0|||
48569907|NCT02564900|156278743|FG003|Dose Expansion|Ongoing|0|||
48569908|NCT02564900|156278744|FG004|Dose Expansion|Ongoing|0|||
48569909|NCT02564900|156278745|FG005|Dose Expansion|Ongoing|0|||
48569910|NCT02564900|156278746|FG006|Dose Expansion|Ongoing|9|||
48569911|NCT02564900|156278747|FG007|Dose Expansion|Ongoing|10|||
48569912|NCT02564900|156278748|FG008|Dose Expansion|Ongoing|11|||
48569913|NCT02564900|156278749|FG009|Dose Expansion|Ongoing|3|||
48569914|NCT02564900|156278750|FG010|Dose Expansion|Ongoing|0|||
48569915|NCT02564900|156278751|FG011|Dose Expansion|Ongoing|0|||
48569916|NCT02564900|156278752|FG012|Dose Expansion|Ongoing|4|||
48569917|NCT02564900|156278753|FG013|Dose Expansion|Ongoing|0|||
48569918|NCT02564900|156278754|FG014|Dose Expansion|Ongoing|6|||
48569919|NCT02564900|156278740|FG000|Dose Expansion|Death|0|||
48569920|NCT02564900|156278741|FG001|Dose Expansion|Death|0|||
48569921|NCT02564900|156278742|FG002|Dose Expansion|Death|0|||
48569922|NCT02564900|156278743|FG003|Dose Expansion|Death|0|||
48569923|NCT02564900|156278744|FG004|Dose Expansion|Death|0|||
48618233|NCT03679884|156457900|FG004|Overall Study|Lost to Follow-up|3|||
48618234|NCT00694161|156457901|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
48618235|NCT00694161|156457901|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
48569924|NCT02564900|156278745|FG005|Dose Expansion|Death|0|||
48569925|NCT02564900|156278746|FG006|Dose Expansion|Death|1|||
48569926|NCT02564900|156278747|FG007|Dose Expansion|Death|0|||
48569927|NCT02564900|156278748|FG008|Dose Expansion|Death|0|||
48569928|NCT02564900|156278749|FG009|Dose Expansion|Death|0|||
48569929|NCT02564900|156278750|FG010|Dose Expansion|Death|1|||
48569930|NCT02564900|156278751|FG011|Dose Expansion|Death|0|||
48569931|NCT02564900|156278752|FG012|Dose Expansion|Death|1|||
48569932|NCT02564900|156278753|FG013|Dose Expansion|Death|1|||
48569933|NCT02564900|156278754|FG014|Dose Expansion|Death|0|||
48569934|NCT02564900|156278740|FG000|Dose Expansion|Withdrawal by Subject|0|||
48569935|NCT02564900|156278741|FG001|Dose Expansion|Withdrawal by Subject|0|||
48569936|NCT02564900|156278742|FG002|Dose Expansion|Withdrawal by Subject|0|||
48569937|NCT02564900|156278743|FG003|Dose Expansion|Withdrawal by Subject|0|||
48569938|NCT02564900|156278744|FG004|Dose Expansion|Withdrawal by Subject|0|||
48569939|NCT02564900|156278745|FG005|Dose Expansion|Withdrawal by Subject|0|||
48569940|NCT02564900|156278746|FG006|Dose Expansion|Withdrawal by Subject|4|||
48569941|NCT02564900|156278747|FG007|Dose Expansion|Withdrawal by Subject|0|||
48569942|NCT02564900|156278748|FG008|Dose Expansion|Withdrawal by Subject|0|||
48569943|NCT02564900|156278749|FG009|Dose Expansion|Withdrawal by Subject|0|||
48569944|NCT02564900|156278750|FG010|Dose Expansion|Withdrawal by Subject|1|||
48569945|NCT02564900|156278751|FG011|Dose Expansion|Withdrawal by Subject|0|||
48569946|NCT02564900|156278752|FG012|Dose Expansion|Withdrawal by Subject|0|||
48569947|NCT02564900|156278753|FG013|Dose Expansion|Withdrawal by Subject|1|||
48569948|NCT02564900|156278754|FG014|Dose Expansion|Withdrawal by Subject|1|||
48569949|NCT02564900|156278740|FG000|Dose Expansion|Other|0|||
48569950|NCT02564900|156278741|FG001|Dose Expansion|Other|0|||
48569951|NCT02564900|156278742|FG002|Dose Expansion|Other|0|||
48569952|NCT02564900|156278743|FG003|Dose Expansion|Other|0|||
48569953|NCT02564900|156278744|FG004|Dose Expansion|Other|0|||
48569954|NCT02564900|156278745|FG005|Dose Expansion|Other|0|||
48569955|NCT02564900|156278746|FG006|Dose Expansion|Other|1|||
48569956|NCT02564900|156278747|FG007|Dose Expansion|Other|0|||
48569957|NCT02564900|156278748|FG008|Dose Expansion|Other|1|||
48569958|NCT02564900|156278749|FG009|Dose Expansion|Other|0|||
48569959|NCT02564900|156278750|FG010|Dose Expansion|Other|0|||
48569960|NCT02564900|156278751|FG011|Dose Expansion|Other|0|||
48569961|NCT02564900|156278752|FG012|Dose Expansion|Other|0|||
48569962|NCT02564900|156278753|FG013|Dose Expansion|Other|0|||
48569963|NCT02564900|156278754|FG014|Dose Expansion|Other|1|||
48569964|NCT02564900|156278740|FG000|Dose Expansion|Did not receive treatment|0|||
48569965|NCT02564900|156278741|FG001|Dose Expansion|Did not receive treatment|0|||
48569966|NCT02564900|156278742|FG002|Dose Expansion|Did not receive treatment|0|||
48569967|NCT02564900|156278743|FG003|Dose Expansion|Did not receive treatment|0|||
48569968|NCT02564900|156278744|FG004|Dose Expansion|Did not receive treatment|0|||
48569969|NCT02564900|156278745|FG005|Dose Expansion|Did not receive treatment|0|||
48569970|NCT02564900|156278746|FG006|Dose Expansion|Did not receive treatment|1|||
48569971|NCT02564900|156278747|FG007|Dose Expansion|Did not receive treatment|1|||
48569972|NCT02564900|156278748|FG008|Dose Expansion|Did not receive treatment|0|||
48569973|NCT02564900|156278749|FG009|Dose Expansion|Did not receive treatment|0|||
48569974|NCT02564900|156278750|FG010|Dose Expansion|Did not receive treatment|0|||
48569975|NCT02564900|156278751|FG011|Dose Expansion|Did not receive treatment|0|||
48569976|NCT02564900|156278752|FG012|Dose Expansion|Did not receive treatment|0|||
48569977|NCT02564900|156278753|FG013|Dose Expansion|Did not receive treatment|0|||
48569978|NCT02564900|156278754|FG014|Dose Expansion|Did not receive treatment|1|||
48569979|NCT02088905|156278755|FG000|Overall Study|Withdrawal by Subject|5|||
48569980|NCT02088905|156278756|FG001|Overall Study|Withdrawal by Subject|1|||
48569981|NCT00892151|156278757|FG000|Overall Study|Protocol Violation|1|||
48569982|NCT00463047|156278758|FG000|Titration Period 1|Adverse Event|10|||
48569983|NCT00463047|156278759|FG001|Titration Period 1|Adverse Event|8|||
48569984|NCT00463047|156278758|FG000|Titration Period 1|Lack of Efficacy|10|||
48569985|NCT00463047|156278759|FG001|Titration Period 1|Lack of Efficacy|4|||
48569986|NCT00463047|156278758|FG000|Titration Period 1|Lost to Follow-up|2|||
48569987|NCT00463047|156278759|FG001|Titration Period 1|Lost to Follow-up|0|||
48569988|NCT00463047|156278758|FG000|Titration Period 1|Non-compliance with study medication|3|||
48569989|NCT00463047|156278759|FG001|Titration Period 1|Non-compliance with study medication|5|||
48569990|NCT00463047|156278758|FG000|Titration Period 1|Protocol Violation|5|||
48569991|NCT00463047|156278759|FG001|Titration Period 1|Protocol Violation|5|||
48569992|NCT00463047|156278758|FG000|Titration Period 1|Withdrawal by Subject|3|||
48569993|NCT00463047|156278759|FG001|Titration Period 1|Withdrawal by Subject|5|||
48569994|NCT00463047|156278758|FG000|Titration Period 1|Non-compliance procedures|4|||
48569995|NCT00463047|156278759|FG001|Titration Period 1|Non-compliance procedures|10|||
48569996|NCT00463047|156278758|FG000|Titration Period 1|Other|0|||
48569997|NCT00463047|156278759|FG001|Titration Period 1|Other|2|||
48569998|NCT00463047|156278758|FG000|Titration Period 2|Adverse Event|9|||
48569999|NCT00463047|156278759|FG001|Titration Period 2|Adverse Event|9|||
48570000|NCT00463047|156278758|FG000|Titration Period 2|Lack of Efficacy|6|||
48570001|NCT00463047|156278759|FG001|Titration Period 2|Lack of Efficacy|4|||
48570002|NCT00463047|156278758|FG000|Titration Period 2|Withdrawal by Subject|1|||
48570003|NCT00463047|156278759|FG001|Titration Period 2|Withdrawal by Subject|0|||
48570004|NCT00463047|156278758|FG000|Titration Period 2|Protocol Violation|2|||
48570005|NCT00463047|156278759|FG001|Titration Period 2|Protocol Violation|3|||
48570006|NCT00463047|156278758|FG000|Titration Period 2|Lost to Follow-up|1|||
48570007|NCT00463047|156278759|FG001|Titration Period 2|Lost to Follow-up|2|||
48570008|NCT00463047|156278758|FG000|Titration Period 2|Non-compliance study medication|4|||
48570009|NCT00463047|156278759|FG001|Titration Period 2|Non-compliance study medication|2|||
48570010|NCT00463047|156278758|FG000|Titration Period 2|Non-compliance procedures|4|||
48570011|NCT00463047|156278759|FG001|Titration Period 2|Non-compliance procedures|1|||
48570012|NCT00463047|156278758|FG000|Titration Period 2|Other|3|||
48570013|NCT00463047|156278759|FG001|Titration Period 2|Other|2|||
48570014|NCT00463047|156278758|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
48570015|NCT00463047|156278759|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
48570016|NCT00463047|156278758|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
48570017|NCT00463047|156278759|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
48570018|NCT00463047|156278758|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
48570019|NCT00463047|156278759|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
48570020|NCT00463047|156278758|FG000|Double-Blind Treatment Period 1|Other|1|||
48570021|NCT00463047|156278759|FG001|Double-Blind Treatment Period 1|Other|0|||
48570022|NCT00463047|156278758|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
48570023|NCT00463047|156278759|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
48570024|NCT00463047|156278758|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
48570025|NCT00463047|156278759|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
48570026|NCT00463047|156278758|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
48570027|NCT00463047|156278759|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
48570028|NCT02693002|156278760|FG000|Overall Study|Withdrawal by Subject|1|||
48570029|NCT02693002|156278761|FG001|Overall Study|Withdrawal by Subject|0|||
48570030|NCT01355575|156278762|FG000|Overall Study|Withdrawal by Subject|2|||
48570031|NCT01046903|156278763|FG000|Overall Study|Lost to Follow-up|16|||
48570032|NCT01046903|156278763|FG000|Overall Study|Adverse Event|4|||
48570033|NCT01046903|156278763|FG000|Overall Study|Withdrawal by Subject|3|||
48570034|NCT01046903|156278763|FG000|Overall Study|Other|5|||
48570035|NCT01628198|156278765|FG000|Overall Study|Lost to Follow-up|7|||
48570036|NCT01628198|156278765|FG000|Overall Study|Withdrawal by Subject|10|||
48570037|NCT01628198|156278765|FG000|Overall Study|Screen failure|1|||
48570038|NCT00686829|156278768|FG000|Overall Study|Adverse Event|5|||
48570039|NCT00686829|156278768|FG000|Overall Study|Lack of Efficacy|6|||
48570040|NCT00686829|156278768|FG000|Overall Study|Lost to Follow-up|4|||
48570041|NCT00686829|156278768|FG000|Overall Study|Withdrawal by Subject|14|||
48570042|NCT00686829|156278768|FG000|Overall Study|Protocol Violation|3|||
48570043|NCT00686829|156278768|FG000|Overall Study|Sponsor discontinued VCV|47|||
48570044|NCT03226769|156278772|FG000|Overall Study|Withdrawal by Subject|0|||
48570045|NCT03226769|156278773|FG001|Overall Study|Withdrawal by Subject|1|||
48570046|NCT01827267|156278775|FG000|Overall Study|Did not receive study drug|1|||
48570047|NCT01827267|156278776|FG001|Overall Study|Did not receive study drug|1|||
48570048|NCT01827267|156278775|FG000|Overall Study|Physician Decision|1|||
48570049|NCT01827267|156278776|FG001|Overall Study|Physician Decision|0|||
48570050|NCT01827267|156278775|FG000|Overall Study|Disease Progression|1|||
48570051|NCT01827267|156278776|FG001|Overall Study|Disease Progression|1|||
48570052|NCT01827267|156278775|FG000|Overall Study|Sponsor Discontinued Study|2|||
48570053|NCT01827267|156278776|FG001|Overall Study|Sponsor Discontinued Study|8|||
48570054|NCT01827267|156278775|FG000|Overall Study|Still on study|0|||
48570055|NCT01827267|156278776|FG001|Overall Study|Still on study|2|||
48570056|NCT01732640|156278778|FG000|Overall Study|Adverse Event|0|||
48570057|NCT01732640|156278779|FG001|Overall Study|Adverse Event|1|||
48570058|NCT01732640|156278778|FG000|Overall Study|Death|0|||
48570059|NCT01732640|156278779|FG001|Overall Study|Death|1|||
48570060|NCT00877487|156278784|FG000|Open-label Treatment Phase|Adverse Event|1|||
48570061|NCT00877487|156278785|FG001|Open-label Treatment Phase|Adverse Event|0|||
48570062|NCT00877487|156278784|FG000|Open-label Treatment Phase|Protocol Violation|3|||
48570063|NCT00877487|156278785|FG001|Open-label Treatment Phase|Protocol Violation|0|||
48570064|NCT00877487|156278784|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
48570065|NCT00877487|156278785|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
48570066|NCT00877487|156278784|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
48570067|NCT00877487|156278785|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
48570068|NCT00877487|156278784|FG000|Open-label Treatment Phase|Out of country for business|1|||
48570069|NCT00877487|156278785|FG001|Open-label Treatment Phase|Out of country for business|0|||
48570070|NCT00877487|156278784|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
48570071|NCT00877487|156278785|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
48570072|NCT00877487|156278784|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
48570073|NCT00877487|156278785|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
48570074|NCT00877487|156278784|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
48570075|NCT00877487|156278785|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
48570076|NCT00877487|156278784|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
48570077|NCT00877487|156278785|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
48570078|NCT02640677|156278786|FG000|Overall Study|Lost to Follow-up|1|||
48570079|NCT02640677|156278786|FG000|Overall Study|Withdrawal by Subject|1|||
48570080|NCT01323387|156280263|FG000|Overall Study|Withdrawal by Subject|41|||
48570081|NCT01323387|156280263|FG000|Overall Study|Radiographic Data Unavailable|1|||
48570082|NCT01323387|156280263|FG000|Overall Study|Revision|14|||
48570083|NCT01323387|156280263|FG000|Overall Study|Protocol Violation|12|||
48570084|NCT01323387|156280263|FG000|Overall Study|Randomized but Never Treated|16|||
48570085|NCT01262287|156280264|FG000|Overall Study|Lost to Follow-up|2|||
48570086|NCT01262287|156280265|FG001|Overall Study|Lost to Follow-up|1|||
48570087|NCT01209949|156280266|FG000|Overall Study|Lost to Follow-up|3|||
48570088|NCT00940823|156280278|FG000|Overall Study|Death|8|||
48570089|NCT00940823|156280279|FG001|Overall Study|Death|12|||
48570090|NCT00940823|156280278|FG000|Overall Study|Lost to Follow-up|27|||
48570091|NCT00940823|156280279|FG001|Overall Study|Lost to Follow-up|20|||
48570092|NCT01295671|156280283|FG000|Overall Study|Lost to Follow-up|4|||
48570093|NCT01295671|156280284|FG001|Overall Study|Lost to Follow-up|6|||
48570094|NCT01295671|156280285|FG002|Overall Study|Lost to Follow-up|3|||
48570095|NCT01295671|156280283|FG000|Overall Study|Withdrawal by Subject|3|||
48570096|NCT01295671|156280284|FG001|Overall Study|Withdrawal by Subject|1|||
48570097|NCT01295671|156280285|FG002|Overall Study|Withdrawal by Subject|0|||
48570098|NCT02395848|156280288|FG000|Overall Study|Lost to Follow-up|2|||
48570099|NCT02860130|156280289|FG000|Overall Study|Adverse Event|2|||
48570100|NCT02860130|156280290|FG001|Overall Study|Adverse Event|3|||
48570101|NCT02860130|156280289|FG000|Overall Study|Protocol Violation|1|||
48570102|NCT02860130|156280290|FG001|Overall Study|Protocol Violation|1|||
48570103|NCT02860130|156280289|FG000|Overall Study|Withdrawal by Subject|0|||
48570104|NCT02860130|156280290|FG001|Overall Study|Withdrawal by Subject|2|||
48570105|NCT02860130|156280289|FG000|Overall Study|Physician Decision|2|||
48570106|NCT02860130|156280290|FG001|Overall Study|Physician Decision|2|||
48570107|NCT02860130|156280289|FG000|Overall Study|Other|2|||
48570108|NCT02860130|156280290|FG001|Overall Study|Other|1|||
48570109|NCT03625466|156280291|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
48570110|NCT03625466|156280292|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
48570111|NCT03625466|156280293|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
48570112|NCT03625466|156280291|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
48570113|NCT03625466|156280292|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
48570114|NCT03625466|156280293|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
48570115|NCT03625466|156280291|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
48570116|NCT03625466|156280292|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
48570117|NCT03625466|156280293|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
48570118|NCT00729612|156280294|FG000|Overall Study|Non evaluable for response|10|||
48618236|NCT00694161|156457901|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
48618237|NCT03601052|156457902|FG000|Overall Study|Lost to Follow-up|2|||
48618238|NCT01483651|156457903|FG000|Overall Study|Withdrawal by Subject|0|||
48618239|NCT01483651|156457904|FG001|Overall Study|Withdrawal by Subject|1|||
48618240|NCT01483651|156457905|FG002|Overall Study|Withdrawal by Subject|1|||
48618241|NCT01483651|156457906|FG003|Overall Study|Withdrawal by Subject|0|||
48618242|NCT01483651|156457907|FG004|Overall Study|Withdrawal by Subject|0|||
48618243|NCT01483651|156457908|FG005|Overall Study|Withdrawal by Subject|1|||
48618244|NCT00837330|156457909|FG000|Overall Study|Lost to Follow-up|1|||
48618245|NCT00837330|156457910|FG001|Overall Study|Lost to Follow-up|3|||
48618246|NCT01227395|156457911|FG000|Overall Study|Protocol Violation|0|||
48618247|NCT01227395|156457912|FG001|Overall Study|Protocol Violation|1|||
48618248|NCT00694122|156457916|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
48618249|NCT00694122|156457917|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
48618250|NCT00694122|156457916|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
48618251|NCT00694122|156457917|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
48618252|NCT00694122|156457916|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
48618253|NCT00694122|156457917|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
48618254|NCT00308685|156457918|FG000|Overall Study|Lost to Follow-up|1|||
48618255|NCT00308685|156457919|FG001|Overall Study|Lost to Follow-up|0|||
48618256|NCT00308685|156457918|FG000|Overall Study|Need to administer prohibited medication|1|||
48570119|NCT04134767|156280295|FG000|Overall Study|Death|0|||
48570120|NCT04134767|156280296|FG001|Overall Study|Death|1|||
48570121|NCT04134767|156280295|FG000|Overall Study|Removed for harassing staff|0|||
48570122|NCT04134767|156280296|FG001|Overall Study|Removed for harassing staff|1|||
48618257|NCT00308685|156457919|FG001|Overall Study|Need to administer prohibited medication|2|||
48618258|NCT00308685|156457918|FG000|Overall Study|Other than specified|1|||
48618259|NCT00308685|156457919|FG001|Overall Study|Other than specified|3|||
48618260|NCT01018953|156457920|FG000|Overall Study|Adverse Event|2|||
48618261|NCT01018953|156457920|FG000|Overall Study|Withdrawal by Subject|1|||
48618262|NCT01018953|156457920|FG000|Overall Study|Study termination by sponsor|5|||
48618263|NCT02665455|156457921|FG000|Overall Study|Withdrawal by Subject|6|||
48618264|NCT02665455|156457921|FG000|Overall Study|Lost to Follow-up|1|||
48618265|NCT02665455|156457921|FG000|Overall Study|Adverse Event|1|||
48618266|NCT02665455|156457921|FG000|Overall Study|Protocol Violation|1|||
48618267|NCT02830087|156457922|FG000|Overall Study|No study staff to follow-up patients|4|||
48618268|NCT02830087|156457923|FG001|Overall Study|No study staff to follow-up patients|4|||
48618269|NCT02830087|156457924|FG002|Overall Study|No study staff to follow-up patients|4|||
48618270|NCT02830087|156457925|FG003|Overall Study|No study staff to follow-up patients|3|||
48618271|NCT02830087|156457926|FG004|Overall Study|No study staff to follow-up patients|3|||
48618272|NCT02830087|156457927|FG005|Overall Study|No study staff to follow-up patients|3|||
48618273|NCT00724503|156457928|FG000|Overall Study|Lost to Follow-up|4|||
48618274|NCT00724503|156457929|FG001|Overall Study|Lost to Follow-up|8|||
48570123|NCT04134767|156280295|FG000|Overall Study|Lost to Follow-up|44|||
48570124|NCT04134767|156280296|FG001|Overall Study|Lost to Follow-up|40|||
48570125|NCT02276560|156280297|FG000|Overall Study|Adverse Event|1|||
48570126|NCT02276560|156280298|FG001|Overall Study|Adverse Event|0|||
48570127|NCT02276560|156280299|FG002|Overall Study|Adverse Event|0|||
48570128|NCT01754129|156280300|FG000|Overall Study|Death|13|||
48570129|NCT01754129|156280300|FG000|Overall Study|Duodopa discontinuation|9|||
48570130|NCT01754129|156280300|FG000|Overall Study|Lost to Follow-up|7|||
48570131|NCT01754129|156280300|FG000|Overall Study|Withdrew consent|1|||
48570132|NCT01754129|156280300|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
48570133|NCT01637922|156280301|FG000|Overall Study|Adverse Event|0|||
48570134|NCT01637922|156280302|FG001|Overall Study|Adverse Event|1|||
48570135|NCT01637922|156280301|FG000|Overall Study|Protocol Violation|0|||
48618275|NCT00724503|156457928|FG000|Overall Study|Withdrawal by Subject|11|||
48618276|NCT00724503|156457929|FG001|Overall Study|Withdrawal by Subject|23|||
48570136|NCT01637922|156280302|FG001|Overall Study|Protocol Violation|1|||
48570137|NCT01637922|156280301|FG000|Overall Study|Withdrawal by Subject|0|||
48570138|NCT01637922|156280302|FG001|Overall Study|Withdrawal by Subject|3|||
48570139|NCT01637922|156280301|FG000|Overall Study|Lost to Follow-up|2|||
48570140|NCT01637922|156280302|FG001|Overall Study|Lost to Follow-up|0|||
48570141|NCT01750697|156280303|FG000|Overall Study|Transferred Back to Local Hospital|1|||
48570142|NCT01750697|156280303|FG000|Overall Study|Physician and Family Decision|1|||
48570143|NCT01750697|156280303|FG000|Overall Study|Transferred to Adult Services|5|||
48570144|NCT01750697|156280303|FG000|Overall Study|Physician Decision|1|||
48570145|NCT01750697|156280303|FG000|Overall Study|Withdrawal by Subject|1|||
48570146|NCT02589626|156280304|FG000|Overall Study|Other than the reason specified|1|||
48570147|NCT02589626|156280305|FG001|Overall Study|Other than the reason specified|0|||
48570148|NCT02589626|156280304|FG000|Overall Study|Withdrawal by Subject|1|||
48618277|NCT00724503|156457928|FG000|Overall Study|Death|190|||
48618278|NCT00724503|156457929|FG001|Overall Study|Death|182|||
48570149|NCT02589626|156280305|FG001|Overall Study|Withdrawal by Subject|1|||
48570150|NCT02589626|156280304|FG000|Overall Study|Adverse Event|1|||
48570151|NCT02589626|156280305|FG001|Overall Study|Adverse Event|1|||
48570152|NCT03645395|156280306|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
48570153|NCT03645395|156280307|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
48570154|NCT03645395|156280308|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
48570155|NCT03645395|156280309|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
48570156|NCT03645395|156280306|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
48570157|NCT03645395|156280307|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
48618279|NCT00724503|156457928|FG000|Overall Study|Adverse Event|1|||
48570158|NCT03645395|156280308|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
48570159|NCT03645395|156280309|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
48570160|NCT03645395|156280306|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
48570161|NCT03645395|156280307|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
48570162|NCT03645395|156280308|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
48618280|NCT00724503|156457929|FG001|Overall Study|Adverse Event|0|||
48570163|NCT03645395|156280309|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
48570164|NCT03645395|156280306|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
48570165|NCT03645395|156280307|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
48570166|NCT03645395|156280308|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
48570167|NCT03645395|156280309|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
48570168|NCT01057810|156280310|FG000|Overall Study|Disease progression|156|||
48570169|NCT01057810|156280311|FG001|Overall Study|Disease progression|197|||
48570170|NCT01057810|156280310|FG000|Overall Study|Study drug toxicity|5|||
48570171|NCT01057810|156280311|FG001|Overall Study|Study drug toxicity|114|||
48570172|NCT01057810|156280310|FG000|Overall Study|Adverse event unrelated to study drug|13|||
48570173|NCT01057810|156280311|FG001|Overall Study|Adverse event unrelated to study drug|29|||
48570174|NCT01057810|156280310|FG000|Overall Study|Withdrawal by Subject|10|||
48570175|NCT01057810|156280311|FG001|Overall Study|Withdrawal by Subject|25|||
48570176|NCT01057810|156280310|FG000|Overall Study|Death|2|||
48570177|NCT01057810|156280311|FG001|Overall Study|Death|12|||
48570178|NCT01057810|156280310|FG000|Overall Study|Maximum clinical benefit|5|||
48570179|NCT01057810|156280311|FG001|Overall Study|Maximum clinical benefit|5|||
48570180|NCT01057810|156280310|FG000|Overall Study|Poor/non-compliance|0|||
48570181|NCT01057810|156280311|FG001|Overall Study|Poor/non-compliance|1|||
48570182|NCT01057810|156280310|FG000|Overall Study|No longer met study criteria|0|||
48570183|NCT01057810|156280311|FG001|Overall Study|No longer met study criteria|1|||
48570184|NCT01057810|156280310|FG000|Overall Study|Other|7|||
48570185|NCT01057810|156280311|FG001|Overall Study|Other|14|||
48570186|NCT04075682|156280316|FG000|Overall Study|Lost to Follow-up|5|||
48570187|NCT04075682|156280317|FG001|Overall Study|Lost to Follow-up|5|||
48618281|NCT00724503|156457928|FG000|Overall Study|Not otherwise specified|4|||
48618282|NCT00724503|156457929|FG001|Overall Study|Not otherwise specified|7|||
48618283|NCT01198548|156457936|FG000|Overall Study|Disease Progression|9|||
48618284|NCT01198548|156457936|FG000|Overall Study|Administrative Decision|1|||
48570188|NCT04075682|156280318|FG002|Overall Study|Lost to Follow-up|2|||
48570189|NCT04075682|156280319|FG003|Overall Study|Lost to Follow-up|2|||
48570190|NCT04075682|156280316|FG000|Overall Study|Withdrawal by Subject|1|||
48570191|NCT04075682|156280317|FG001|Overall Study|Withdrawal by Subject|0|||
48618285|NCT01049828|156457937|FG000|Overall Study|Claustrophibia and Frustration|2|||
48570192|NCT04075682|156280318|FG002|Overall Study|Withdrawal by Subject|1|||
48618286|NCT01245062|156457939|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
48618287|NCT01245062|156457940|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
48618288|NCT01245062|156457941|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
48570193|NCT04075682|156280319|FG003|Overall Study|Withdrawal by Subject|0|||
48570194|NCT04075682|156280316|FG000|Overall Study|Protocol Violation|0|||
48570195|NCT04075682|156280317|FG001|Overall Study|Protocol Violation|1|||
48570196|NCT04075682|156280318|FG002|Overall Study|Protocol Violation|1|||
48570197|NCT04075682|156280319|FG003|Overall Study|Protocol Violation|0|||
48570198|NCT04075682|156280316|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
48570199|NCT04075682|156280317|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
48570200|NCT04075682|156280318|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
48570201|NCT04075682|156280319|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
48618289|NCT01245062|156457939|FG000|Randomization and Crossover Phase|Physician Decision|2|||
48570202|NCT04075682|156280316|FG000|Overall Study|Lost study phone the first day of study participation|0|||
48570203|NCT04075682|156280317|FG001|Overall Study|Lost study phone the first day of study participation|1|||
48570204|NCT04075682|156280318|FG002|Overall Study|Lost study phone the first day of study participation|0|||
48570205|NCT04075682|156280319|FG003|Overall Study|Lost study phone the first day of study participation|0|||
48570206|NCT00862823|156280321|FG000|First Intervention|Withdrawal by Subject|1|||
48570207|NCT00862823|156280322|FG001|First Intervention|Withdrawal by Subject|1|||
48570208|NCT00887315|156280325|FG000|Overall Study|Study termination|7|||
48570209|NCT00887315|156280326|FG001|Overall Study|Study termination|4|||
48570210|NCT00619892|156280327|FG000|Overall Study|Adverse Event|3|||
48570211|NCT00619892|156280328|FG001|Overall Study|Adverse Event|0|||
48570212|NCT00619892|156280327|FG000|Overall Study|Lost to Follow-up|0|||
48570213|NCT00619892|156280328|FG001|Overall Study|Lost to Follow-up|1|||
48570214|NCT00619892|156280327|FG000|Overall Study|Intercurrent illness|0|||
48570215|NCT00619892|156280328|FG001|Overall Study|Intercurrent illness|1|||
48570216|NCT03363776|156280329|FG000|Overall Study|Progressive disease|2|||
48570217|NCT03363776|156280330|FG001|Overall Study|Progressive disease|3|||
48570218|NCT03363776|156280331|FG002|Overall Study|Progressive disease|1|||
48570219|NCT03363776|156280329|FG000|Overall Study|Study drug toxicity|0|||
48570220|NCT03363776|156280330|FG001|Overall Study|Study drug toxicity|0|||
48570221|NCT03363776|156280331|FG002|Overall Study|Study drug toxicity|1|||
48570222|NCT03363776|156280329|FG000|Overall Study|Death|1|||
48570223|NCT03363776|156280330|FG001|Overall Study|Death|0|||
48570224|NCT03363776|156280331|FG002|Overall Study|Death|0|||
48570225|NCT00379080|156280335|FG000|Overall Study|Withdrawal by Subject|0|||
48570226|NCT00379080|156280336|FG001|Overall Study|Withdrawal by Subject|4|||
48570227|NCT00379080|156280337|FG002|Overall Study|Withdrawal by Subject|0|||
48570228|NCT01562782|156280338|FG000|Overall Study|Withdrawal by Subject|3|||
48570229|NCT01562782|156280339|FG001|Overall Study|Withdrawal by Subject|3|||
48570230|NCT01562782|156280338|FG000|Overall Study|screen failure|1|||
48570231|NCT01562782|156280339|FG001|Overall Study|screen failure|2|||
48570232|NCT00857896|156280350|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
48570233|NCT01028014|156280351|FG000|Overall Study|Lost to Follow-up|1|||
48570234|NCT01028014|156280352|FG001|Overall Study|Lost to Follow-up|2|||
48570235|NCT01028014|156280353|FG002|Overall Study|Lost to Follow-up|0|||
48570236|NCT01028014|156280354|FG003|Overall Study|Lost to Follow-up|1|||
48570237|NCT01028014|156280355|FG004|Overall Study|Lost to Follow-up|1|||
48570238|NCT01028014|156280356|FG005|Overall Study|Lost to Follow-up|2|||
48570239|NCT02780713|156280359|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
48570240|NCT02780713|156280360|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
48570241|NCT02780713|156280361|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
48570242|NCT02780713|156280362|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
48570243|NCT02780713|156280363|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
48570244|NCT03617770|156280365|FG000|Overall Study|Lost to Follow-up|1|||
48570245|NCT03617770|156280366|FG001|Overall Study|Lost to Follow-up|0|||
48570246|NCT01540487|156280369|FG000|Overall Study|Protocol Violation|1|||
48570247|NCT01540487|156280370|FG001|Overall Study|Protocol Violation|0|||
48570248|NCT01931475|156280371|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
48570249|NCT01931475|156280372|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
48570250|NCT01931475|156280371|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
48570251|NCT01931475|156280372|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
48570252|NCT01931475|156280371|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
48570253|NCT01931475|156280372|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
48618290|NCT01245062|156457940|FG001|Randomization and Crossover Phase|Physician Decision|4|||
48618291|NCT01245062|156457941|FG002|Randomization and Crossover Phase|Physician Decision|0|||
48570254|NCT01931475|156280371|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
48570255|NCT01931475|156280372|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
48570256|NCT01931475|156280371|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
48570257|NCT01931475|156280372|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
48570258|NCT01931475|156280371|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
48570259|NCT01931475|156280372|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
48570260|NCT01931475|156280371|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
48570261|NCT01931475|156280372|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
48570262|NCT01931475|156280371|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
48570263|NCT01931475|156280372|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
48570264|NCT01931475|156280371|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
48570265|NCT01931475|156280372|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
48570266|NCT01931475|156280371|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
48570267|NCT01931475|156280372|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
48570268|NCT01931475|156280371|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
48570269|NCT01931475|156280372|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
48570270|NCT03991299|156280373|FG000|Overall Study|Study closed, sponsor decision|3|||
48570271|NCT03991299|156280373|FG000|Overall Study|Withdrawal by Subject|1|||
48570272|NCT01091662|156280374|FG000|Overall Study|Adverse Event|1|||
48570273|NCT01091662|156280375|FG001|Overall Study|Adverse Event|9|||
48570274|NCT01091662|156280374|FG000|Overall Study|Physician Decision|1|||
48570275|NCT01091662|156280375|FG001|Overall Study|Physician Decision|1|||
48570276|NCT01091662|156280374|FG000|Overall Study|Withdrawal by Subject|7|||
48570277|NCT01091662|156280375|FG001|Overall Study|Withdrawal by Subject|6|||
48570278|NCT01091662|156280374|FG000|Overall Study|met exit criteria|7|||
48570279|NCT01091662|156280375|FG001|Overall Study|met exit criteria|13|||
48570280|NCT01091662|156280374|FG000|Overall Study|met exclusion criteria|1|||
48570281|NCT01091662|156280375|FG001|Overall Study|met exclusion criteria|0|||
48570282|NCT01091662|156280374|FG000|Overall Study|Lost to Follow-up|0|||
48618292|NCT01245062|156457939|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
48570283|NCT01091662|156280375|FG001|Overall Study|Lost to Follow-up|1|||
48570284|NCT01091662|156280374|FG000|Overall Study|Pregnancy|0|||
48570285|NCT01091662|156280375|FG001|Overall Study|Pregnancy|1|||
48570286|NCT01091662|156280374|FG000|Overall Study|Protocol Violation|0|||
48570287|NCT01091662|156280375|FG001|Overall Study|Protocol Violation|2|||
48570288|NCT01091662|156280374|FG000|Overall Study|unable to swallow capsule|0|||
48570289|NCT01091662|156280375|FG001|Overall Study|unable to swallow capsule|1|||
48570290|NCT02417064|156280381|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
48570291|NCT02417064|156280382|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
48570292|NCT02417064|156280383|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
48570293|NCT02417064|156280381|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
48570294|NCT02417064|156280382|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
48570295|NCT02417064|156280383|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
48570296|NCT02417064|156280381|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
48570297|NCT02417064|156280382|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
48570298|NCT02417064|156280383|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
48570299|NCT02417064|156280381|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
48570300|NCT02417064|156280382|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
48570301|NCT02417064|156280383|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
48570302|NCT02417064|156280381|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
48570303|NCT02417064|156280382|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
48570304|NCT02417064|156280383|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
48570305|NCT02417064|156280381|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
48570306|NCT02417064|156280382|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
48570307|NCT02417064|156280383|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
48570308|NCT02417064|156280381|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
48570309|NCT02417064|156280382|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
48570310|NCT02417064|156280383|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
48570311|NCT02417064|156280381|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
48618293|NCT01245062|156457940|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
48618294|NCT01245062|156457941|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
48618295|NCT01245062|156457939|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
48618296|NCT01245062|156457940|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
48618297|NCT01245062|156457941|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
48618298|NCT01245062|156457939|FG000|Cross-over Phase|Lost to Follow-up|0|||
48618299|NCT01245062|156457940|FG001|Cross-over Phase|Lost to Follow-up|0|||
48618300|NCT01245062|156457941|FG002|Cross-over Phase|Lost to Follow-up|1|||
48618301|NCT01245062|156457939|FG000|Cross-over Phase|Physician Decision|0|||
48618302|NCT01245062|156457940|FG001|Cross-over Phase|Physician Decision|0|||
48618303|NCT01245062|156457941|FG002|Cross-over Phase|Physician Decision|1|||
48618304|NCT01245062|156457939|FG000|Cross-over Phase|Withdrew Consent|0|||
48618305|NCT01245062|156457940|FG001|Cross-over Phase|Withdrew Consent|0|||
48618306|NCT01245062|156457941|FG002|Cross-over Phase|Withdrew Consent|4|||
48618307|NCT01245062|156457939|FG000|Cross-over Phase|Study closed/ terminated|0|||
48618308|NCT01245062|156457940|FG001|Cross-over Phase|Study closed/ terminated|0|||
48618309|NCT01245062|156457941|FG002|Cross-over Phase|Study closed/ terminated|11|||
48618310|NCT03723070|156457943|FG000|Overall Study|Lost to Follow-up|2|||
48618311|NCT03723070|156457943|FG000|Overall Study|Physician Decision|1|||
48618312|NCT03723070|156457943|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
48618313|NCT02487199|156457944|FG000|Overall Study|Withdrew Consent|0|||
48618314|NCT02487199|156457945|FG001|Overall Study|Withdrew Consent|1|||
48618315|NCT00286455|156457946|FG000|Overall Study|Hyperglycemia rescue|19|||
48618316|NCT00286455|156457947|FG001|Overall Study|Hyperglycemia rescue|13|||
48618317|NCT00286455|156457948|FG002|Overall Study|Hyperglycemia rescue|10|||
48618318|NCT00286455|156457946|FG000|Overall Study|Adverse Event|1|||
48618319|NCT00286455|156457947|FG001|Overall Study|Adverse Event|3|||
48618320|NCT00286455|156457948|FG002|Overall Study|Adverse Event|2|||
48570312|NCT02417064|156280382|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
48570313|NCT02417064|156280383|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
48570314|NCT02417064|156280381|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
48570315|NCT02417064|156280382|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
48570316|NCT02417064|156280383|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
48570317|NCT02417064|156280381|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
48618321|NCT00286455|156457946|FG000|Overall Study|Lost to Follow-up|0|||
48618322|NCT00286455|156457947|FG001|Overall Study|Lost to Follow-up|3|||
48618323|NCT00286455|156457948|FG002|Overall Study|Lost to Follow-up|3|||
48618324|NCT00286455|156457946|FG000|Overall Study|Physician Decision|3|||
48618325|NCT00286455|156457947|FG001|Overall Study|Physician Decision|0|||
48618326|NCT00286455|156457948|FG002|Overall Study|Physician Decision|2|||
48618327|NCT00286455|156457946|FG000|Overall Study|Protocol Violation|1|||
48570318|NCT02417064|156280382|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
48570319|NCT02417064|156280383|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
48570320|NCT02417064|156280381|FG000|Follow-up Phase (24 Weeks)|Other|2|||
48570321|NCT02417064|156280382|FG001|Follow-up Phase (24 Weeks)|Other|2|||
48570322|NCT02417064|156280383|FG002|Follow-up Phase (24 Weeks)|Other|3|||
48570323|NCT02477332|156280384|FG000|Overall Study|Adverse Event|0|||
48570324|NCT02477332|156280385|FG001|Overall Study|Adverse Event|1|||
48570325|NCT02477332|156280386|FG002|Overall Study|Adverse Event|1|||
48570326|NCT02477332|156280387|FG003|Overall Study|Adverse Event|2|||
48570327|NCT02477332|156280388|FG004|Overall Study|Adverse Event|1|||
48570328|NCT02477332|156280389|FG005|Overall Study|Adverse Event|2|||
48570329|NCT02477332|156280384|FG000|Overall Study|Lack of Efficacy|1|||
48570330|NCT02477332|156280385|FG001|Overall Study|Lack of Efficacy|2|||
48570331|NCT02477332|156280386|FG002|Overall Study|Lack of Efficacy|1|||
48570332|NCT02477332|156280387|FG003|Overall Study|Lack of Efficacy|2|||
48570333|NCT02477332|156280388|FG004|Overall Study|Lack of Efficacy|1|||
48570334|NCT02477332|156280389|FG005|Overall Study|Lack of Efficacy|1|||
48570335|NCT02477332|156280384|FG000|Overall Study|Non-compliance with study treatment|0|||
48570336|NCT02477332|156280385|FG001|Overall Study|Non-compliance with study treatment|1|||
48570337|NCT02477332|156280386|FG002|Overall Study|Non-compliance with study treatment|2|||
48570338|NCT02477332|156280387|FG003|Overall Study|Non-compliance with study treatment|0|||
48570339|NCT02477332|156280388|FG004|Overall Study|Non-compliance with study treatment|0|||
48570340|NCT02477332|156280389|FG005|Overall Study|Non-compliance with study treatment|0|||
48570341|NCT02477332|156280384|FG000|Overall Study|Pregnancy|0|||
48570342|NCT02477332|156280385|FG001|Overall Study|Pregnancy|0|||
48570343|NCT02477332|156280386|FG002|Overall Study|Pregnancy|0|||
48570344|NCT02477332|156280387|FG003|Overall Study|Pregnancy|1|||
48570345|NCT02477332|156280388|FG004|Overall Study|Pregnancy|0|||
48570346|NCT02477332|156280389|FG005|Overall Study|Pregnancy|0|||
48570347|NCT02477332|156280384|FG000|Overall Study|Protocol Violation|2|||
48570348|NCT02477332|156280385|FG001|Overall Study|Protocol Violation|0|||
48570349|NCT02477332|156280386|FG002|Overall Study|Protocol Violation|3|||
48570350|NCT02477332|156280387|FG003|Overall Study|Protocol Violation|3|||
48570351|NCT02477332|156280388|FG004|Overall Study|Protocol Violation|1|||
48570352|NCT02477332|156280389|FG005|Overall Study|Protocol Violation|1|||
48570353|NCT02477332|156280384|FG000|Overall Study|Technical problems|0|||
48570354|NCT02477332|156280385|FG001|Overall Study|Technical problems|0|||
48570355|NCT02477332|156280386|FG002|Overall Study|Technical problems|1|||
48570356|NCT02477332|156280387|FG003|Overall Study|Technical problems|0|||
48618328|NCT00286455|156457947|FG001|Overall Study|Protocol Violation|1|||
48570357|NCT02477332|156280388|FG004|Overall Study|Technical problems|0|||
48570358|NCT02477332|156280389|FG005|Overall Study|Technical problems|0|||
48570359|NCT02477332|156280384|FG000|Overall Study|Lost to Follow-up|0|||
48570360|NCT02477332|156280385|FG001|Overall Study|Lost to Follow-up|0|||
48570361|NCT02477332|156280386|FG002|Overall Study|Lost to Follow-up|2|||
48570362|NCT02477332|156280387|FG003|Overall Study|Lost to Follow-up|0|||
48570363|NCT02477332|156280388|FG004|Overall Study|Lost to Follow-up|0|||
48570364|NCT02477332|156280389|FG005|Overall Study|Lost to Follow-up|0|||
48570365|NCT02477332|156280384|FG000|Overall Study|Physician Decision|0|||
48570366|NCT02477332|156280385|FG001|Overall Study|Physician Decision|0|||
48570367|NCT02477332|156280386|FG002|Overall Study|Physician Decision|1|||
48570368|NCT02477332|156280387|FG003|Overall Study|Physician Decision|3|||
48570369|NCT02477332|156280388|FG004|Overall Study|Physician Decision|0|||
48570370|NCT02477332|156280389|FG005|Overall Study|Physician Decision|1|||
48570371|NCT02477332|156280384|FG000|Overall Study|Withdrawal by Subject|0|||
48570372|NCT02477332|156280385|FG001|Overall Study|Withdrawal by Subject|3|||
48570373|NCT02477332|156280386|FG002|Overall Study|Withdrawal by Subject|1|||
48570374|NCT02477332|156280387|FG003|Overall Study|Withdrawal by Subject|2|||
48570375|NCT02477332|156280388|FG004|Overall Study|Withdrawal by Subject|1|||
48570376|NCT02477332|156280389|FG005|Overall Study|Withdrawal by Subject|0|||
48570377|NCT03793842|156280390|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
48570378|NCT03793842|156280391|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
48570379|NCT03793842|156280390|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
48570380|NCT03793842|156280391|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
48570381|NCT02549287|156280392|FG000|Overall Study|Lost to Follow-up|65|||
48570382|NCT02549287|156280393|FG001|Overall Study|Lost to Follow-up|26|||
48570383|NCT02549287|156280392|FG000|Overall Study|Withdrawal by Subject|15|||
48570384|NCT02549287|156280393|FG001|Overall Study|Withdrawal by Subject|6|||
48570385|NCT04657198|156280394|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
48570386|NCT04657198|156280395|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
48570387|NCT04657198|156280396|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
48570388|NCT04087720|156280397|FG000|Overall Study|Withdrawal by Subject|2|||
48570389|NCT04087720|156280397|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
48570390|NCT02418585|156280405|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
48618329|NCT00286455|156457948|FG002|Overall Study|Protocol Violation|0|||
48570391|NCT02418585|156280406|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
48570392|NCT02418585|156280405|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
48570393|NCT02418585|156280406|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
48570394|NCT02418585|156280405|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
48570395|NCT02418585|156280406|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
48570396|NCT02418585|156280405|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
48570397|NCT02418585|156280406|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
48570398|NCT02418585|156280405|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
48570399|NCT02418585|156280406|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
48570400|NCT02418585|156280405|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
48570401|NCT02418585|156280406|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
48570402|NCT02418585|156280405|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
48570403|NCT02418585|156280406|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
48570404|NCT02418585|156280405|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
48570405|NCT02418585|156280406|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
48570406|NCT02418585|156280405|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
48570407|NCT02418585|156280406|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
48570408|NCT02418585|156280405|FG000|Follow-up Phase (24 Weeks)|Other|3|||
48570409|NCT02418585|156280406|FG001|Follow-up Phase (24 Weeks)|Other|2|||
48570410|NCT02841280|156280409|FG000|Overall Study|Adverse Event|2|||
48570411|NCT02841280|156280410|FG001|Overall Study|Adverse Event|1|||
48570412|NCT02841280|156280409|FG000|Overall Study|Death|1|||
48570413|NCT02841280|156280410|FG001|Overall Study|Death|0|||
48570414|NCT02841280|156280409|FG000|Overall Study|Lost to Follow-up|2|||
48570415|NCT02841280|156280410|FG001|Overall Study|Lost to Follow-up|2|||
48570416|NCT02841280|156280409|FG000|Overall Study|Withdrawal by Subject|7|||
48570417|NCT02841280|156280410|FG001|Overall Study|Withdrawal by Subject|3|||
48570418|NCT02841280|156280409|FG000|Overall Study|Stop Point: BP above threshold|2|||
48570419|NCT02841280|156280410|FG001|Overall Study|Stop Point: BP above threshold|0|||
48570420|NCT03070002|156280411|FG000|Follow up for 2 Years|Death|1|||
48735668|NCT02840721|156883710|FG000|Follow-Up|Withdrawal by Subject|4|||
48570421|NCT04999163|156280414|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
48570422|NCT04999163|156280415|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
48570423|NCT04999163|156280414|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
48570424|NCT04999163|156280415|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
48570425|NCT04999163|156280414|FG000|Overall Study|Withdrawal by Subject|1|||
48570426|NCT04999163|156280415|FG001|Overall Study|Withdrawal by Subject|0|||
48570427|NCT01294696|156280416|FG000|Overall Study|Screening failures|7|||
48570428|NCT01294696|156280416|FG000|Overall Study|Protocol Violation|8|||
48570429|NCT01294696|156280416|FG000|Overall Study|Missing BPI Response|7|||
48570430|NCT01294696|156280416|FG000|Overall Study|Site closure|52|||
48570431|NCT00708552|156282186|FG000|Overall Study|Adverse Event|10|||
48570432|NCT00708552|156282187|FG001|Overall Study|Adverse Event|3|||
48570433|NCT00708552|156282188|FG002|Overall Study|Adverse Event|4|||
48570434|NCT00708552|156282189|FG003|Overall Study|Adverse Event|6|||
48570435|NCT00708552|156282186|FG000|Overall Study|Lack of Efficacy|0|||
48570436|NCT00708552|156282187|FG001|Overall Study|Lack of Efficacy|4|||
48570437|NCT00708552|156282188|FG002|Overall Study|Lack of Efficacy|1|||
48570438|NCT00708552|156282189|FG003|Overall Study|Lack of Efficacy|0|||
48570439|NCT00708552|156282186|FG000|Overall Study|Protocol Violation|0|||
48570440|NCT00708552|156282187|FG001|Overall Study|Protocol Violation|0|||
48570441|NCT00708552|156282188|FG002|Overall Study|Protocol Violation|2|||
48570442|NCT00708552|156282189|FG003|Overall Study|Protocol Violation|4|||
48570443|NCT00708552|156282186|FG000|Overall Study|Lost to Follow-up|4|||
48570444|NCT00708552|156282187|FG001|Overall Study|Lost to Follow-up|2|||
48570445|NCT00708552|156282188|FG002|Overall Study|Lost to Follow-up|0|||
48570446|NCT00708552|156282189|FG003|Overall Study|Lost to Follow-up|1|||
48570447|NCT00708552|156282186|FG000|Overall Study|Physician Decision|1|||
48570448|NCT00708552|156282187|FG001|Overall Study|Physician Decision|2|||
48570449|NCT00708552|156282188|FG002|Overall Study|Physician Decision|0|||
48570450|NCT00708552|156282189|FG003|Overall Study|Physician Decision|0|||
48570451|NCT00708552|156282186|FG000|Overall Study|Withdrawal by Subject|12|||
48570452|NCT00708552|156282187|FG001|Overall Study|Withdrawal by Subject|7|||
48570453|NCT00708552|156282188|FG002|Overall Study|Withdrawal by Subject|8|||
48570454|NCT00708552|156282189|FG003|Overall Study|Withdrawal by Subject|10|||
48570455|NCT02582242|156282190|FG000|Overall Study|Adverse Event|4|||
48570456|NCT02582242|156282191|FG001|Overall Study|Adverse Event|3|||
48570457|NCT02582242|156282190|FG000|Overall Study|Protocol Violation|3|||
48570458|NCT02582242|156282191|FG001|Overall Study|Protocol Violation|1|||
48570459|NCT02582242|156282190|FG000|Overall Study|Lost to Follow-up|0|||
48570460|NCT02582242|156282191|FG001|Overall Study|Lost to Follow-up|1|||
48570461|NCT02582242|156282190|FG000|Overall Study|Withdrawal by Subject|11|||
48570462|NCT02582242|156282191|FG001|Overall Study|Withdrawal by Subject|11|||
48570463|NCT02582242|156282190|FG000|Overall Study|Unclassified|2|||
48570464|NCT02582242|156282191|FG001|Overall Study|Unclassified|1|||
48570465|NCT00300885|156282192|FG000|Treatment|Adverse Event|134|||
48570466|NCT00300885|156282193|FG001|Treatment|Adverse Event|82|||
48570467|NCT00300885|156282192|FG000|Treatment|Death|20|||
48570468|NCT00300885|156282193|FG001|Treatment|Death|7|||
48570469|NCT00300885|156282192|FG000|Treatment|Lack of Efficacy|1|||
48570470|NCT00300885|156282193|FG001|Treatment|Lack of Efficacy|1|||
48570471|NCT00300885|156282192|FG000|Treatment|Lost to Follow-up|3|||
48570472|NCT00300885|156282193|FG001|Treatment|Lost to Follow-up|2|||
48570473|NCT00300885|156282192|FG000|Treatment|Physician Decision|4|||
48570474|NCT00300885|156282193|FG001|Treatment|Physician Decision|5|||
48570475|NCT00300885|156282192|FG000|Treatment|Protocol Violation|11|||
48570476|NCT00300885|156282193|FG001|Treatment|Protocol Violation|11|||
48570477|NCT00300885|156282192|FG000|Treatment|Withdrawal by Subject|26|||
48570478|NCT00300885|156282193|FG001|Treatment|Withdrawal by Subject|23|||
48618330|NCT00286455|156457946|FG000|Overall Study|Participant Non-compliance|1|||
48618331|NCT00286455|156457947|FG001|Overall Study|Participant Non-compliance|0|||
48570479|NCT00300885|156282192|FG000|Treatment|Disease progression|171|||
48570480|NCT00300885|156282193|FG001|Treatment|Disease progression|238|||
48570481|NCT00300885|156282192|FG000|Treatment|Random code broken (subject died)|0|||
48570482|NCT00300885|156282193|FG001|Treatment|Random code broken (subject died)|1|||
48570483|NCT00300885|156282192|FG000|Treatment|Non-compliant with study medication|3|||
48570484|NCT00300885|156282193|FG001|Treatment|Non-compliant with study medication|4|||
48570485|NCT00300885|156282192|FG000|Follow-up|Death|141|||
48570486|NCT00300885|156282193|FG001|Follow-up|Death|163|||
48618332|NCT00286455|156457948|FG002|Overall Study|Participant Non-compliance|0|||
48570487|NCT00300885|156282192|FG000|Follow-up|Lost to Follow-up|11|||
48570488|NCT00300885|156282193|FG001|Follow-up|Lost to Follow-up|7|||
48570489|NCT00300885|156282192|FG000|Follow-up|Withdrawal by Subject|26|||
48570490|NCT00300885|156282193|FG001|Follow-up|Withdrawal by Subject|25|||
48570491|NCT02058537|156282194|FG000|Overall Study|Withdrawal by Subject|1|||
48570492|NCT00638404|156282195|FG000|Overall Study|Physician Decision|8|||
48570493|NCT00638404|156282196|FG001|Overall Study|Physician Decision|0|||
48570494|NCT04072575|156282197|FG000|Overall Study|Physician Decision|1|||
48570495|NCT04072575|156282197|FG000|Overall Study|Adverse Event|7|||
48570496|NCT04072575|156282197|FG000|Overall Study|Withdrawal by Subject|14|||
48570497|NCT04072575|156282197|FG000|Overall Study|Other|2|||
48570498|NCT00803790|156282199|FG000|Period 1|Adverse Event|0|||
48570499|NCT00803790|156282200|FG001|Period 1|Adverse Event|1|||
48570500|NCT00803790|156282201|FG002|Period 1|Adverse Event|0|||
48570501|NCT00803790|156282202|FG003|Period 1|Adverse Event|0|||
48570502|NCT00803790|156282199|FG000|Period 1|Lost to Follow-up|1|||
48570503|NCT00803790|156282200|FG001|Period 1|Lost to Follow-up|2|||
48570504|NCT00803790|156282201|FG002|Period 1|Lost to Follow-up|0|||
48570505|NCT00803790|156282202|FG003|Period 1|Lost to Follow-up|0|||
48570506|NCT00803790|156282199|FG000|Period 1|Withdrawal by Subject|8|||
48570507|NCT00803790|156282200|FG001|Period 1|Withdrawal by Subject|6|||
48570508|NCT00803790|156282201|FG002|Period 1|Withdrawal by Subject|0|||
48570509|NCT00803790|156282202|FG003|Period 1|Withdrawal by Subject|0|||
48570510|NCT00803790|156282199|FG000|Period 1|positive drug screen or personal reasons|0|||
48570511|NCT00803790|156282200|FG001|Period 1|positive drug screen or personal reasons|3|||
48570512|NCT00803790|156282201|FG002|Period 1|positive drug screen or personal reasons|0|||
48570513|NCT00803790|156282202|FG003|Period 1|positive drug screen or personal reasons|4|||
48570514|NCT00803790|156282199|FG000|Period 1|Protocol Violation|0|||
48570515|NCT00803790|156282200|FG001|Period 1|Protocol Violation|0|||
48570516|NCT00803790|156282201|FG002|Period 1|Protocol Violation|1|||
48570517|NCT00803790|156282202|FG003|Period 1|Protocol Violation|0|||
48570518|NCT00803790|156282199|FG000|Period 2|Adverse Event|0|||
48570519|NCT00803790|156282200|FG001|Period 2|Adverse Event|0|||
48570520|NCT00803790|156282201|FG002|Period 2|Adverse Event|1|||
48570521|NCT00803790|156282202|FG003|Period 2|Adverse Event|1|||
48570522|NCT00803790|156282199|FG000|Period 2|Withdrawal by Subject|1|||
48570523|NCT00803790|156282200|FG001|Period 2|Withdrawal by Subject|0|||
48570524|NCT00803790|156282201|FG002|Period 2|Withdrawal by Subject|0|||
48570525|NCT00803790|156282202|FG003|Period 2|Withdrawal by Subject|0|||
48570526|NCT00803790|156282199|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
48570527|NCT00803790|156282200|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
48570528|NCT00803790|156282201|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
48570529|NCT00803790|156282202|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
48570530|NCT00820248|156282203|FG000|Overall Study|No treated|4|||
48570531|NCT00820248|156282204|FG001|Overall Study|No treated|1|||
48570532|NCT00921557|156282206|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
48570533|NCT00921557|156282207|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
48570534|NCT00921557|156282208|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
48570535|NCT00921557|156282206|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
48570536|NCT00921557|156282207|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
48570537|NCT00921557|156282208|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
48570538|NCT00921557|156282206|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
48570539|NCT00921557|156282207|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
48570540|NCT00921557|156282208|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
48570541|NCT00921557|156282206|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
48570542|NCT00921557|156282207|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
48570543|NCT00921557|156282208|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
48570544|NCT00921557|156282206|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
48570545|NCT00921557|156282207|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
48570546|NCT00921557|156282208|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
48570547|NCT00656292|156282209|FG000|Overall Study|Withdrawal by Subject|2|||
48570548|NCT00656292|156282210|FG001|Overall Study|Withdrawal by Subject|3|||
48570549|NCT00656292|156282209|FG000|Overall Study|Screen failure|1|||
48570550|NCT00656292|156282210|FG001|Overall Study|Screen failure|2|||
48570551|NCT00267969|156282211|FG000|Controlled Period|Adverse Event|6|||
48570552|NCT00267969|156282212|FG001|Controlled Period|Adverse Event|0|||
48570553|NCT00267969|156282213|FG002|Controlled Period|Adverse Event|2|||
48570554|NCT00267969|156282214|FG003|Controlled Period|Adverse Event|0|||
48570555|NCT00267969|156282215|FG004|Controlled Period|Adverse Event|0|||
48570556|NCT00267969|156282216|FG005|Controlled Period|Adverse Event|0|||
48618333|NCT00286455|156457946|FG000|Overall Study|Withdrawal by Subject|0|||
48570557|NCT00267969|156282217|FG006|Controlled Period|Adverse Event|0|||
48570558|NCT00267969|156282211|FG000|Controlled Period|Lack of Efficacy|3|||
48570559|NCT00267969|156282212|FG001|Controlled Period|Lack of Efficacy|0|||
48570560|NCT00267969|156282213|FG002|Controlled Period|Lack of Efficacy|1|||
48570561|NCT00267969|156282214|FG003|Controlled Period|Lack of Efficacy|0|||
48570562|NCT00267969|156282215|FG004|Controlled Period|Lack of Efficacy|0|||
48570563|NCT00267969|156282216|FG005|Controlled Period|Lack of Efficacy|0|||
48570564|NCT00267969|156282217|FG006|Controlled Period|Lack of Efficacy|0|||
48570565|NCT00267969|156282211|FG000|Controlled Period|Lost to Follow-up|1|||
48570566|NCT00267969|156282212|FG001|Controlled Period|Lost to Follow-up|0|||
48570567|NCT00267969|156282213|FG002|Controlled Period|Lost to Follow-up|1|||
48570568|NCT00267969|156282214|FG003|Controlled Period|Lost to Follow-up|0|||
48570569|NCT00267969|156282215|FG004|Controlled Period|Lost to Follow-up|0|||
48570570|NCT00267969|156282216|FG005|Controlled Period|Lost to Follow-up|0|||
48570571|NCT00267969|156282217|FG006|Controlled Period|Lost to Follow-up|0|||
48570572|NCT00267969|156282211|FG000|Controlled Period|Randomized but not treated|0|||
48570573|NCT00267969|156282212|FG001|Controlled Period|Randomized but not treated|0|||
48570574|NCT00267969|156282213|FG002|Controlled Period|Randomized but not treated|1|||
48570575|NCT00267969|156282214|FG003|Controlled Period|Randomized but not treated|0|||
48570576|NCT00267969|156282215|FG004|Controlled Period|Randomized but not treated|0|||
48570577|NCT00267969|156282216|FG005|Controlled Period|Randomized but not treated|0|||
48570578|NCT00267969|156282217|FG006|Controlled Period|Randomized but not treated|0|||
48570579|NCT00267969|156282211|FG000|Controlled Period|Other|2|||
48570580|NCT00267969|156282212|FG001|Controlled Period|Other|1|||
48570581|NCT00267969|156282213|FG002|Controlled Period|Other|6|||
48570582|NCT00267969|156282214|FG003|Controlled Period|Other|0|||
48570583|NCT00267969|156282215|FG004|Controlled Period|Other|0|||
48570584|NCT00267969|156282216|FG005|Controlled Period|Other|0|||
48570585|NCT00267969|156282217|FG006|Controlled Period|Other|0|||
48570586|NCT00267969|156282211|FG000|After Controlled Period|Adverse Event|0|||
48570587|NCT00267969|156282212|FG001|After Controlled Period|Adverse Event|0|||
48570588|NCT00267969|156282213|FG002|After Controlled Period|Adverse Event|0|||
48570589|NCT00267969|156282214|FG003|After Controlled Period|Adverse Event|7|||
48570590|NCT00267969|156282215|FG004|After Controlled Period|Adverse Event|8|||
48570591|NCT00267969|156282216|FG005|After Controlled Period|Adverse Event|23|||
48570592|NCT00267969|156282217|FG006|After Controlled Period|Adverse Event|21|||
48570593|NCT00267969|156282211|FG000|After Controlled Period|Death|0|||
48570594|NCT00267969|156282212|FG001|After Controlled Period|Death|0|||
48570595|NCT00267969|156282213|FG002|After Controlled Period|Death|0|||
48570596|NCT00267969|156282214|FG003|After Controlled Period|Death|1|||
48570597|NCT00267969|156282215|FG004|After Controlled Period|Death|2|||
48570598|NCT00267969|156282216|FG005|After Controlled Period|Death|0|||
48570599|NCT00267969|156282217|FG006|After Controlled Period|Death|1|||
48570600|NCT00267969|156282211|FG000|After Controlled Period|Lack of Efficacy|0|||
48570601|NCT00267969|156282212|FG001|After Controlled Period|Lack of Efficacy|0|||
48570602|NCT00267969|156282213|FG002|After Controlled Period|Lack of Efficacy|0|||
48570603|NCT00267969|156282214|FG003|After Controlled Period|Lack of Efficacy|10|||
48570604|NCT00267969|156282215|FG004|After Controlled Period|Lack of Efficacy|6|||
48570605|NCT00267969|156282216|FG005|After Controlled Period|Lack of Efficacy|28|||
48570606|NCT00267969|156282217|FG006|After Controlled Period|Lack of Efficacy|15|||
48570607|NCT00267969|156282211|FG000|After Controlled Period|Lost to Follow-up|0|||
48570608|NCT00267969|156282212|FG001|After Controlled Period|Lost to Follow-up|0|||
48570609|NCT00267969|156282213|FG002|After Controlled Period|Lost to Follow-up|0|||
48570610|NCT00267969|156282214|FG003|After Controlled Period|Lost to Follow-up|5|||
48570611|NCT00267969|156282215|FG004|After Controlled Period|Lost to Follow-up|8|||
48570612|NCT00267969|156282216|FG005|After Controlled Period|Lost to Follow-up|9|||
48570613|NCT00267969|156282217|FG006|After Controlled Period|Lost to Follow-up|10|||
48570614|NCT00267969|156282211|FG000|After Controlled Period|Other|0|||
48570615|NCT00267969|156282212|FG001|After Controlled Period|Other|0|||
48570616|NCT00267969|156282213|FG002|After Controlled Period|Other|0|||
48570617|NCT00267969|156282214|FG003|After Controlled Period|Other|13|||
48570618|NCT00267969|156282215|FG004|After Controlled Period|Other|11|||
48570619|NCT00267969|156282216|FG005|After Controlled Period|Other|22|||
48570620|NCT00267969|156282217|FG006|After Controlled Period|Other|25|||
48570621|NCT02993146|156282220|FG000|Overall Study|Withdrawal by Subject|0|||
48570622|NCT02993146|156282221|FG001|Overall Study|Withdrawal by Subject|0|||
48570623|NCT02993146|156282222|FG002|Overall Study|Withdrawal by Subject|1|||
48570624|NCT02993146|156282223|FG003|Overall Study|Withdrawal by Subject|1|||
48570625|NCT01289639|156282230|FG000|Overall Study|Lost to Follow-up|1|||
48570626|NCT01289639|156282231|FG001|Overall Study|Lost to Follow-up|0|||
48570627|NCT01289639|156282232|FG002|Overall Study|Lost to Follow-up|0|||
48570628|NCT02016105|156282233|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
48570629|NCT02016105|156282234|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
48570630|NCT02016105|156282235|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
48570631|NCT02016105|156282236|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
48570632|NCT02016105|156282237|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
48570633|NCT02016105|156282238|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
48570634|NCT02016105|156282233|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
48570635|NCT02016105|156282234|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
48570636|NCT02016105|156282235|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
48570637|NCT02016105|156282236|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
48570638|NCT02016105|156282237|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
48570639|NCT02016105|156282238|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
48570640|NCT02016105|156282233|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
48570641|NCT02016105|156282234|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
48570642|NCT02016105|156282235|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
48570643|NCT02016105|156282236|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
48570644|NCT02016105|156282237|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
48570645|NCT02016105|156282238|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
48570646|NCT02016105|156282233|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
48570647|NCT02016105|156282234|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
48570648|NCT02016105|156282235|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
48570649|NCT02016105|156282236|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
48570650|NCT02016105|156282237|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
48570651|NCT02016105|156282238|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
48570652|NCT02016105|156282233|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
48570653|NCT02016105|156282234|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
48570654|NCT02016105|156282235|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
48570655|NCT02016105|156282236|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
48570656|NCT02016105|156282237|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
48570657|NCT02016105|156282238|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
48618334|NCT00286455|156457947|FG001|Overall Study|Withdrawal by Subject|8|||
48618335|NCT00286455|156457948|FG002|Overall Study|Withdrawal by Subject|7|||
48570658|NCT02016105|156282233|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
48570659|NCT02016105|156282234|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
48570660|NCT02016105|156282235|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
48570661|NCT02016105|156282236|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
48570662|NCT02016105|156282237|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
48570663|NCT02016105|156282238|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
48570664|NCT02016105|156282233|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
48570665|NCT02016105|156282234|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
48570666|NCT02016105|156282235|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
48570667|NCT02016105|156282236|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
48570668|NCT02016105|156282237|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
48570669|NCT02016105|156282238|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
48570670|NCT02016105|156282233|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
48570671|NCT02016105|156282234|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
48618336|NCT04706403|156459298|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
48618337|NCT04706403|156459299|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
48618338|NCT04706403|156459300|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
48618339|NCT04706403|156459301|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
48618340|NCT04706403|156459302|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
48618341|NCT01797185|156459303|FG000|Overall Study|Adverse Event|5|||
48618342|NCT01797185|156459304|FG001|Overall Study|Adverse Event|15|||
48618343|NCT01797185|156459305|FG002|Overall Study|Adverse Event|6|||
48618344|NCT01797185|156459303|FG000|Overall Study|Withdrawal by Subject|6|||
48618345|NCT01797185|156459304|FG001|Overall Study|Withdrawal by Subject|9|||
48618346|NCT01797185|156459305|FG002|Overall Study|Withdrawal by Subject|5|||
48618347|NCT01797185|156459303|FG000|Overall Study|Site terminated|8|||
48618348|NCT01797185|156459304|FG001|Overall Study|Site terminated|4|||
48618349|NCT01797185|156459305|FG002|Overall Study|Site terminated|0|||
48618350|NCT01797185|156459303|FG000|Overall Study|Lost to Follow-up|2|||
48618351|NCT01797185|156459304|FG001|Overall Study|Lost to Follow-up|6|||
48618352|NCT01797185|156459305|FG002|Overall Study|Lost to Follow-up|1|||
48618353|NCT01797185|156459303|FG000|Overall Study|Withdrawn per sponsor|5|||
48618354|NCT01797185|156459304|FG001|Overall Study|Withdrawn per sponsor|0|||
48618355|NCT01797185|156459305|FG002|Overall Study|Withdrawn per sponsor|0|||
48618356|NCT01797185|156459303|FG000|Overall Study|Physician Decision|1|||
48570672|NCT02016105|156282235|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
48570673|NCT02016105|156282236|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
48570674|NCT02016105|156282237|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
48570675|NCT02016105|156282238|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
48570676|NCT02016105|156282233|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
48570677|NCT02016105|156282234|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
48570678|NCT02016105|156282235|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
48570679|NCT02016105|156282236|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
48570680|NCT02016105|156282237|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
48570681|NCT02016105|156282238|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
48618357|NCT01797185|156459304|FG001|Overall Study|Physician Decision|3|||
48618358|NCT01797185|156459305|FG002|Overall Study|Physician Decision|0|||
48618359|NCT01797185|156459303|FG000|Overall Study|Protocol Violation|1|||
48618360|NCT01797185|156459304|FG001|Overall Study|Protocol Violation|1|||
48618361|NCT01797185|156459305|FG002|Overall Study|Protocol Violation|0|||
48618362|NCT00992836|156459307|FG000|Overall Study|Lost to Follow-up|1|||
48570682|NCT02016105|156282233|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
48570683|NCT02016105|156282234|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
48570684|NCT02016105|156282235|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
48570685|NCT02016105|156282236|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
48570686|NCT02016105|156282237|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
48570687|NCT02016105|156282238|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
48570688|NCT02016105|156282233|FG000|TREATMENT PERIOD 2|Death|0|||
48570689|NCT02016105|156282234|FG001|TREATMENT PERIOD 2|Death|0|||
48570690|NCT02016105|156282235|FG002|TREATMENT PERIOD 2|Death|0|||
48570691|NCT02016105|156282236|FG003|TREATMENT PERIOD 2|Death|0|||
48570692|NCT02016105|156282237|FG004|TREATMENT PERIOD 2|Death|0|||
48570693|NCT02016105|156282238|FG005|TREATMENT PERIOD 2|Death|1|||
48570694|NCT02016105|156282233|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
48570695|NCT02016105|156282234|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
48570696|NCT02016105|156282235|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
48570697|NCT02016105|156282236|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
48570698|NCT02016105|156282237|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
48570699|NCT02016105|156282238|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
48570700|NCT02016105|156282233|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
48570701|NCT02016105|156282234|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
48570702|NCT02016105|156282235|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
48570703|NCT02016105|156282236|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
48570704|NCT02016105|156282237|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
48570705|NCT02016105|156282238|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
48570706|NCT02016105|156282233|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
48570707|NCT02016105|156282234|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
48570708|NCT02016105|156282235|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
48570709|NCT02016105|156282236|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
48570710|NCT02016105|156282237|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
48570711|NCT02016105|156282238|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
48570712|NCT02016105|156282233|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
48570713|NCT02016105|156282234|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
48570714|NCT02016105|156282235|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
48570715|NCT02016105|156282236|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
48570716|NCT02016105|156282237|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
48570717|NCT02016105|156282238|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
48570718|NCT02016105|156282233|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
48570719|NCT02016105|156282234|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
48570720|NCT02016105|156282235|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
48570721|NCT02016105|156282236|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
48570722|NCT02016105|156282237|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
48570723|NCT02016105|156282238|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
48570724|NCT02016105|156282233|FG000|EXTENSION PERIOD|Adverse Event|0|||
48570725|NCT02016105|156282234|FG001|EXTENSION PERIOD|Adverse Event|0|||
48570726|NCT02016105|156282235|FG002|EXTENSION PERIOD|Adverse Event|2|||
48570727|NCT02016105|156282236|FG003|EXTENSION PERIOD|Adverse Event|0|||
48570728|NCT02016105|156282237|FG004|EXTENSION PERIOD|Adverse Event|1|||
48570729|NCT02016105|156282238|FG005|EXTENSION PERIOD|Adverse Event|0|||
48570730|NCT02016105|156282233|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
48570731|NCT02016105|156282234|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
48570732|NCT02016105|156282235|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
48570733|NCT02016105|156282236|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
48570734|NCT02016105|156282237|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
48570735|NCT02016105|156282238|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
48570736|NCT02016105|156282233|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
48570737|NCT02016105|156282234|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
48570738|NCT02016105|156282235|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
48570739|NCT02016105|156282236|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
48570740|NCT02016105|156282237|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
48570741|NCT02016105|156282238|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
48570742|NCT02016105|156282233|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
48570743|NCT02016105|156282234|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
48570744|NCT02016105|156282235|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
48570745|NCT02016105|156282236|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
48570746|NCT02016105|156282237|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
48570747|NCT02016105|156282238|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
48570748|NCT01127451|156282239|FG000|Overall Study|Other|2|||
48570749|NCT01127451|156282240|FG001|Overall Study|Other|1|||
48570750|NCT01127451|156282239|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
48570751|NCT01127451|156282240|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
48570752|NCT01127451|156282239|FG000|Overall Study|Death|22|||
48570753|NCT01127451|156282240|FG001|Overall Study|Death|17|||
48570754|NCT01127451|156282239|FG000|Overall Study|Lost to Follow-up|3|||
48570755|NCT01127451|156282240|FG001|Overall Study|Lost to Follow-up|0|||
48570756|NCT01127451|156282239|FG000|Overall Study|Administrative Reason by Sponsor|2|||
48570757|NCT01127451|156282240|FG001|Overall Study|Administrative Reason by Sponsor|2|||
48570758|NCT02308540|156282242|FG000|Overall Study|Lost to Follow-up|0|||
48570759|NCT02308540|156282243|FG001|Overall Study|Lost to Follow-up|0|||
48570760|NCT02308540|156282244|FG002|Overall Study|Lost to Follow-up|0|||
48570761|NCT02308540|156282245|FG003|Overall Study|Lost to Follow-up|0|||
48570762|NCT02308540|156282246|FG004|Overall Study|Lost to Follow-up|0|||
48570763|NCT02308540|156282247|FG005|Overall Study|Lost to Follow-up|1|||
48570764|NCT04109391|156282248|FG000|Overall Study|Adverse Event|2|||
48570765|NCT04109391|156282249|FG001|Overall Study|Adverse Event|2|||
48570766|NCT04109391|156282250|FG002|Overall Study|Adverse Event|0|||
48570767|NCT04109391|156282248|FG000|Overall Study|Withdrawal by Subject|2|||
48618363|NCT00992836|156459307|FG000|Overall Study|Withdrawal by Subject|2|||
48618364|NCT00992836|156459307|FG000|Overall Study|Protocol Violation|2|||
48618365|NCT01121926|156459308|FG000|First Intervention Period|Adverse Event|1|||
48618366|NCT01121926|156459309|FG001|First Intervention Period|Adverse Event|0|||
48618367|NCT01121926|156459308|FG000|Washout Period|Adverse Event|0|||
48618368|NCT01121926|156459309|FG001|Washout Period|Adverse Event|1|||
48618369|NCT01121926|156459308|FG000|Washout Period|Positive pregnancy test|0|||
48618370|NCT01121926|156459309|FG001|Washout Period|Positive pregnancy test|1|||
48618371|NCT04137887|156459310|FG000|Overall Study|Death|102|||
48618372|NCT04137887|156459311|FG001|Overall Study|Death|92|||
48315770|NCT01111526|155355647|FG000|Overall Study|GVHD Disease Progression|0|||
48315771|NCT01111526|155355648|FG001|Overall Study|GVHD Disease Progression|1|||
48315772|NCT01111526|155355649|FG002|Overall Study|GVHD Disease Progression|2|||
48315773|NCT04424641|155355650|FG000|Overall Study|Death|1|||
48315774|NCT04424641|155355651|FG001|Overall Study|Death|2|||
48315775|NCT04424641|155355652|FG002|Overall Study|Death|3|||
48315776|NCT04424641|155355653|FG003|Overall Study|Death|0|||
48315777|NCT04424641|155355654|FG004|Overall Study|Death|3|||
48315778|NCT04424641|155355655|FG005|Overall Study|Death|0|||
48315779|NCT04424641|155355656|FG006|Overall Study|Death|1|||
48315780|NCT04424641|155355657|FG007|Overall Study|Death|2|||
48315781|NCT04424641|155355650|FG000|Overall Study|Sponsor decision|0|||
48315782|NCT04424641|155355651|FG001|Overall Study|Sponsor decision|2|||
48315783|NCT04424641|155355652|FG002|Overall Study|Sponsor decision|3|||
48315784|NCT04424641|155355653|FG003|Overall Study|Sponsor decision|7|||
48315785|NCT04424641|155355654|FG004|Overall Study|Sponsor decision|2|||
48315786|NCT04424641|155355655|FG005|Overall Study|Sponsor decision|2|||
48315787|NCT04424641|155355656|FG006|Overall Study|Sponsor decision|3|||
48315788|NCT04424641|155355657|FG007|Overall Study|Sponsor decision|4|||
48315789|NCT04424641|155355650|FG000|Overall Study|Withdrawal by Subject|0|||
48315790|NCT04424641|155355651|FG001|Overall Study|Withdrawal by Subject|0|||
48315791|NCT04424641|155355652|FG002|Overall Study|Withdrawal by Subject|0|||
48315792|NCT04424641|155355653|FG003|Overall Study|Withdrawal by Subject|0|||
48315793|NCT04424641|155355654|FG004|Overall Study|Withdrawal by Subject|1|||
48315794|NCT04424641|155355655|FG005|Overall Study|Withdrawal by Subject|0|||
48315795|NCT04424641|155355656|FG006|Overall Study|Withdrawal by Subject|0|||
48315796|NCT04424641|155355657|FG007|Overall Study|Withdrawal by Subject|0|||
48315797|NCT04424641|155355650|FG000|Overall Study|Other|0|||
48315798|NCT04424641|155355651|FG001|Overall Study|Other|0|||
48315799|NCT04424641|155355652|FG002|Overall Study|Other|1|||
48315800|NCT04424641|155355653|FG003|Overall Study|Other|0|||
48315801|NCT04424641|155355654|FG004|Overall Study|Other|0|||
48315802|NCT04424641|155355655|FG005|Overall Study|Other|0|||
48315803|NCT04424641|155355656|FG006|Overall Study|Other|0|||
48315804|NCT04424641|155355657|FG007|Overall Study|Other|0|||
48315811|NCT00186186|155355662|FG000|Overall Study|Lack of Efficacy|3|||
48315812|NCT00186186|155355662|FG000|Overall Study|Withdrawal by Subject|3|||
48315813|NCT00186186|155355662|FG000|Overall Study|Not reported as to reason|2|||
48618373|NCT04137887|156459310|FG000|Overall Study|Withdrawal by Subject|2|||
48618374|NCT04137887|156459311|FG001|Overall Study|Withdrawal by Subject|3|||
48618375|NCT04137887|156459310|FG000|Overall Study|Randomized but not treated|0|||
48315858|NCT01068743|155355682|FG000|Period 3|Adverse Event|0|||
48315859|NCT01068743|155355683|FG001|Period 3|Adverse Event|1|||
48315860|NCT01068743|155355684|FG002|Period 3|Adverse Event|0|||
48315861|NCT01068743|155355685|FG003|Period 3|Adverse Event|0|||
48315862|NCT00364013|155355686|FG000|Overall Study|Ineligibility determined|4|||
48315863|NCT00364013|155355687|FG001|Overall Study|Ineligibility determined|2|||
48315864|NCT00364013|155355686|FG000|Overall Study|Adverse Event|4|||
48315865|NCT00364013|155355687|FG001|Overall Study|Adverse Event|3|||
48315866|NCT00364013|155355686|FG000|Overall Study|Withdrawal by Subject|13|||
48315867|NCT00364013|155355687|FG001|Overall Study|Withdrawal by Subject|18|||
48315868|NCT00364013|155355686|FG000|Overall Study|Physician Decision|3|||
48315869|NCT00364013|155355687|FG001|Overall Study|Physician Decision|3|||
48315870|NCT00364013|155355686|FG000|Overall Study|Lost to Follow-up|10|||
48315871|NCT00364013|155355687|FG001|Overall Study|Lost to Follow-up|3|||
48315872|NCT00364013|155355686|FG000|Overall Study|Protocol-specified criteria|6|||
48315873|NCT00364013|155355687|FG001|Overall Study|Protocol-specified criteria|6|||
48315874|NCT00364013|155355686|FG000|Overall Study|Other|41|||
48315875|NCT00364013|155355687|FG001|Overall Study|Other|47|||
48315876|NCT00364013|155355686|FG000|Overall Study|Ongoing|20|||
48315877|NCT00364013|155355687|FG001|Overall Study|Ongoing|13|||
48315878|NCT02512965|155355688|FG000|Overall Study|Withdrawal by Subject|0|||
48315879|NCT02512965|155355689|FG001|Overall Study|Withdrawal by Subject|4|||
48315880|NCT00835770|155355690|FG000|Overall Study|MS Relapse|17|||
48315881|NCT00835770|155355691|FG001|Overall Study|MS Relapse|23|||
48315882|NCT00835770|155355690|FG000|Overall Study|MS Progression|14|||
48315883|NCT00835770|155355691|FG001|Overall Study|MS Progression|9|||
48315884|NCT00835770|155355690|FG000|Overall Study|Adverse Event|113|||
48315885|NCT00835770|155355691|FG001|Overall Study|Adverse Event|124|||
48315886|NCT00835770|155355690|FG000|Overall Study|Lost to Follow-up|22|||
48315887|NCT00835770|155355691|FG001|Overall Study|Lost to Follow-up|19|||
48315888|NCT00835770|155355690|FG000|Overall Study|Consent Withdrawn|144|||
48315889|NCT00835770|155355691|FG001|Overall Study|Consent Withdrawn|156|||
48315890|NCT00835770|155355690|FG000|Overall Study|Investigator Decision|42|||
48315891|NCT00835770|155355691|FG001|Overall Study|Investigator Decision|42|||
48315892|NCT00835770|155355690|FG000|Overall Study|Participant Non-Compliance|11|||
48315893|NCT00835770|155355691|FG001|Overall Study|Participant Non-Compliance|9|||
48315894|NCT00835770|155355690|FG000|Overall Study|Death|4|||
48315895|NCT00835770|155355691|FG001|Overall Study|Death|6|||
48315896|NCT00835770|155355690|FG000|Overall Study|Other|115|||
48315897|NCT00835770|155355691|FG001|Overall Study|Other|104|||
48315898|NCT00835770|155355690|FG000|Overall Study|Other|2|||
48315899|NCT00835770|155355691|FG001|Overall Study|Other|1|||
48315900|NCT02507752|155355694|FG000|Overall Study|Adverse Event|1|||
48315901|NCT02507752|155355694|FG000|Overall Study|Protocol Violation|6|||
48315902|NCT02507752|155355694|FG000|Overall Study|Lost to Follow-up|7|||
48315903|NCT02507752|155355694|FG000|Overall Study|Infusion reaction at first infusion|1|||
48315904|NCT02507752|155355694|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
48315905|NCT02507752|155355694|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
48315906|NCT00463788|155355699|FG000|Overall Study|Progressive Disease|86|||
48315907|NCT00463788|155355700|FG001|Overall Study|Progressive Disease|42|||
48315908|NCT00463788|155355699|FG000|Overall Study|Adverse Event|6|||
48315909|NCT00463788|155355700|FG001|Overall Study|Adverse Event|2|||
48315910|NCT00463788|155355699|FG000|Overall Study|Withdrawal by Subject|6|||
48315911|NCT00463788|155355700|FG001|Overall Study|Withdrawal by Subject|2|||
48315912|NCT00463788|155355699|FG000|Overall Study|Death|4|||
48315913|NCT00463788|155355700|FG001|Overall Study|Death|3|||
48315914|NCT00463788|155355699|FG000|Overall Study|Symptomatic Deterioration|2|||
48315915|NCT00463788|155355700|FG001|Overall Study|Symptomatic Deterioration|3|||
48315916|NCT00463788|155355699|FG000|Overall Study|Lost to Follow-up|1|||
48315917|NCT00463788|155355700|FG001|Overall Study|Lost to Follow-up|0|||
48315918|NCT00463788|155355699|FG000|Overall Study|Protocol Violation|0|||
48315919|NCT00463788|155355700|FG001|Overall Study|Protocol Violation|1|||
48315920|NCT00463788|155355699|FG000|Overall Study|Other|3|||
48315921|NCT00463788|155355700|FG001|Overall Study|Other|0|||
48315922|NCT00463788|155355699|FG000|Overall Study|Randomized but not treated|1|||
48315923|NCT00463788|155355700|FG001|Overall Study|Randomized but not treated|1|||
48315924|NCT00360698|155355701|FG000|Run-In|Physician Decision|0|||
48315925|NCT00360698|155355702|FG001|Run-In|Physician Decision|1|||
48315926|NCT00360698|155355701|FG000|Run-In|Withdrawal by Subject|0|||
48315927|NCT00360698|155355702|FG001|Run-In|Withdrawal by Subject|2|||
48315928|NCT00360698|155355701|FG000|Run-In|Non compliance with treatment procedure|0|||
48315929|NCT00360698|155355702|FG001|Run-In|Non compliance with treatment procedure|1|||
48315930|NCT00360698|155355701|FG000|Run-In|Sponsor request|0|||
48315931|NCT00360698|155355702|FG001|Run-In|Sponsor request|2|||
48315932|NCT00360698|155355701|FG000|Run-In|Patient did not meet inclusion criteria|0|||
48315933|NCT00360698|155355702|FG001|Run-In|Patient did not meet inclusion criteria|1|||
48315934|NCT00360698|155355701|FG000|Run-In|Patient personal reasons|0|||
48315935|NCT00360698|155355702|FG001|Run-In|Patient personal reasons|2|||
48315936|NCT00360698|155355701|FG000|Run-In|Need of insulin with meals|0|||
48315937|NCT00360698|155355702|FG001|Run-In|Need of insulin with meals|1|||
48315938|NCT00360698|155355701|FG000|Treatment Period|Non compliance with treatment procedure|1|||
48315939|NCT00360698|155355702|FG001|Treatment Period|Non compliance with treatment procedure|0|||
48315940|NCT00360698|155355701|FG000|Treatment Period|Early termination by error|0|||
48315941|NCT00360698|155355702|FG001|Treatment Period|Early termination by error|1|||
48315942|NCT02988817|155355703|FG000|Overall Study|Withdrawal by Subject|1|||
48315943|NCT02988817|155355704|FG001|Overall Study|Withdrawal by Subject|0|||
48315944|NCT02988817|155355705|FG002|Overall Study|Withdrawal by Subject|0|||
48315945|NCT02988817|155355706|FG003|Overall Study|Withdrawal by Subject|1|||
48315946|NCT02988817|155355707|FG004|Overall Study|Withdrawal by Subject|3|||
48315947|NCT02988817|155355708|FG005|Overall Study|Withdrawal by Subject|1|||
48315948|NCT02988817|155355709|FG006|Overall Study|Withdrawal by Subject|2|||
48315949|NCT02988817|155355710|FG007|Overall Study|Withdrawal by Subject|1|||
48315950|NCT02988817|155355711|FG008|Overall Study|Withdrawal by Subject|1|||
48315951|NCT02988817|155355712|FG009|Overall Study|Withdrawal by Subject|1|||
48315952|NCT02988817|155355713|FG010|Overall Study|Withdrawal by Subject|1|||
48315953|NCT02988817|155355714|FG011|Overall Study|Withdrawal by Subject|12|||
48315954|NCT02988817|155355715|FG012|Overall Study|Withdrawal by Subject|6|||
48315955|NCT02988817|155355716|FG013|Overall Study|Withdrawal by Subject|6|||
48315956|NCT02988817|155355717|FG014|Overall Study|Withdrawal by Subject|4|||
48315957|NCT02988817|155355718|FG015|Overall Study|Withdrawal by Subject|5|||
48315958|NCT02988817|155355719|FG016|Overall Study|Withdrawal by Subject|4|||
48315959|NCT02988817|155355720|FG017|Overall Study|Withdrawal by Subject|11|||
48315960|NCT02988817|155355721|FG018|Overall Study|Withdrawal by Subject|4|||
48315961|NCT02988817|155355722|FG019|Overall Study|Withdrawal by Subject|2|||
48315962|NCT02988817|155355703|FG000|Overall Study|Death|0|||
48315963|NCT02988817|155355704|FG001|Overall Study|Death|1|||
48315964|NCT02988817|155355705|FG002|Overall Study|Death|3|||
48315965|NCT02988817|155355706|FG003|Overall Study|Death|1|||
48315966|NCT02988817|155355707|FG004|Overall Study|Death|6|||
48315967|NCT02988817|155355708|FG005|Overall Study|Death|10|||
48315968|NCT02988817|155355709|FG006|Overall Study|Death|1|||
48315969|NCT02988817|155355710|FG007|Overall Study|Death|2|||
48315970|NCT02988817|155355711|FG008|Overall Study|Death|1|||
48315971|NCT02988817|155355712|FG009|Overall Study|Death|5|||
48315972|NCT02988817|155355713|FG010|Overall Study|Death|1|||
48315973|NCT02988817|155355714|FG011|Overall Study|Death|8|||
48315974|NCT02988817|155355715|FG012|Overall Study|Death|9|||
48315975|NCT02988817|155355716|FG013|Overall Study|Death|17|||
48315976|NCT02988817|155355717|FG014|Overall Study|Death|18|||
48315977|NCT02988817|155355718|FG015|Overall Study|Death|30|||
48315978|NCT02988817|155355719|FG016|Overall Study|Death|17|||
48315979|NCT02988817|155355720|FG017|Overall Study|Death|38|||
48315980|NCT02988817|155355721|FG018|Overall Study|Death|14|||
48315981|NCT02988817|155355722|FG019|Overall Study|Death|16|||
48315982|NCT02988817|155355703|FG000|Overall Study|Other|0|||
48315983|NCT02988817|155355704|FG001|Overall Study|Other|0|||
48315984|NCT02988817|155355705|FG002|Overall Study|Other|0|||
48315985|NCT02988817|155355706|FG003|Overall Study|Other|1|||
48315986|NCT02988817|155355707|FG004|Overall Study|Other|1|||
48315987|NCT02988817|155355708|FG005|Overall Study|Other|0|||
48315988|NCT02988817|155355709|FG006|Overall Study|Other|0|||
48315989|NCT02988817|155355710|FG007|Overall Study|Other|0|||
48315990|NCT02988817|155355711|FG008|Overall Study|Other|0|||
48315991|NCT02988817|155355712|FG009|Overall Study|Other|0|||
48315992|NCT02988817|155355713|FG010|Overall Study|Other|0|||
48315993|NCT02988817|155355714|FG011|Overall Study|Other|0|||
48315994|NCT02988817|155355715|FG012|Overall Study|Other|0|||
48618376|NCT04137887|156459311|FG001|Overall Study|Randomized but not treated|1|||
48618377|NCT00416949|156459312|FG000|Overall Study|Patients refused to participate|5|||
48618378|NCT01158404|156459319|FG000|Overall Study|Withdrawal by Subject|0|||
48618379|NCT01158404|156459320|FG001|Overall Study|Withdrawal by Subject|1|||
48315995|NCT02988817|155355716|FG013|Overall Study|Other|0|||
48315996|NCT02988817|155355717|FG014|Overall Study|Other|0|||
48315997|NCT02988817|155355718|FG015|Overall Study|Other|1|||
48315998|NCT02988817|155355719|FG016|Overall Study|Other|0|||
48315999|NCT02988817|155355720|FG017|Overall Study|Other|0|||
48316000|NCT02988817|155355721|FG018|Overall Study|Other|0|||
48316001|NCT02988817|155355722|FG019|Overall Study|Other|0|||
48316002|NCT02988817|155355703|FG000|Overall Study|Lost to Follow-up|0|||
48316003|NCT02988817|155355704|FG001|Overall Study|Lost to Follow-up|0|||
48316004|NCT02988817|155355705|FG002|Overall Study|Lost to Follow-up|0|||
48316005|NCT02988817|155355706|FG003|Overall Study|Lost to Follow-up|0|||
48316006|NCT02988817|155355707|FG004|Overall Study|Lost to Follow-up|0|||
48316007|NCT02988817|155355708|FG005|Overall Study|Lost to Follow-up|0|||
48316008|NCT02988817|155355709|FG006|Overall Study|Lost to Follow-up|0|||
48316009|NCT02988817|155355710|FG007|Overall Study|Lost to Follow-up|0|||
48316010|NCT02988817|155355711|FG008|Overall Study|Lost to Follow-up|1|||
48316011|NCT02988817|155355712|FG009|Overall Study|Lost to Follow-up|0|||
48316012|NCT02988817|155355713|FG010|Overall Study|Lost to Follow-up|1|||
48316013|NCT02988817|155355714|FG011|Overall Study|Lost to Follow-up|1|||
48618380|NCT01158404|156459321|FG002|Overall Study|Withdrawal by Subject|0|||
48618381|NCT01158404|156459322|FG003|Overall Study|Withdrawal by Subject|0|||
48316014|NCT02988817|155355715|FG012|Overall Study|Lost to Follow-up|0|||
48316015|NCT02988817|155355716|FG013|Overall Study|Lost to Follow-up|0|||
48316016|NCT02988817|155355717|FG014|Overall Study|Lost to Follow-up|1|||
48316017|NCT02988817|155355718|FG015|Overall Study|Lost to Follow-up|1|||
48316018|NCT02988817|155355719|FG016|Overall Study|Lost to Follow-up|2|||
48316019|NCT02988817|155355720|FG017|Overall Study|Lost to Follow-up|3|||
48316020|NCT02988817|155355721|FG018|Overall Study|Lost to Follow-up|0|||
48316021|NCT02988817|155355722|FG019|Overall Study|Lost to Follow-up|0|||
48316022|NCT02988817|155355703|FG000|Overall Study|Sponsor decision|0|||
48316023|NCT02988817|155355704|FG001|Overall Study|Sponsor decision|0|||
48316024|NCT02988817|155355705|FG002|Overall Study|Sponsor decision|0|||
48316025|NCT02988817|155355706|FG003|Overall Study|Sponsor decision|0|||
48316026|NCT02988817|155355707|FG004|Overall Study|Sponsor decision|0|||
48316027|NCT02988817|155355708|FG005|Overall Study|Sponsor decision|0|||
48316028|NCT02988817|155355709|FG006|Overall Study|Sponsor decision|0|||
48316029|NCT02988817|155355710|FG007|Overall Study|Sponsor decision|0|||
48316030|NCT02988817|155355711|FG008|Overall Study|Sponsor decision|0|||
48316031|NCT02988817|155355712|FG009|Overall Study|Sponsor decision|0|||
48316032|NCT02988817|155355713|FG010|Overall Study|Sponsor decision|0|||
48316033|NCT02988817|155355714|FG011|Overall Study|Sponsor decision|1|||
48316034|NCT02988817|155355715|FG012|Overall Study|Sponsor decision|1|||
48316035|NCT02988817|155355716|FG013|Overall Study|Sponsor decision|2|||
48316036|NCT02988817|155355717|FG014|Overall Study|Sponsor decision|2|||
48316037|NCT02988817|155355718|FG015|Overall Study|Sponsor decision|6|||
48316038|NCT02988817|155355719|FG016|Overall Study|Sponsor decision|2|||
48735669|NCT02840721|156883710|FG000|Follow-Up|Withdrawal of Consent|2|||
48735670|NCT00722800|156883718|FG000|Overall Study|Withdrawal by Subject|1|||
48735671|NCT00722800|156883719|FG001|Overall Study|Withdrawal by Subject|0|||
48735672|NCT00722800|156883718|FG000|Overall Study|Physician Decision|1|||
48735673|NCT00722800|156883719|FG001|Overall Study|Physician Decision|0|||
48735674|NCT00347360|156883720|FG000|Overall Study|Adverse Event|1|||
48735675|NCT00347360|156883721|FG001|Overall Study|Adverse Event|2|||
48735676|NCT00347360|156883722|FG002|Overall Study|Adverse Event|0|||
48735677|NCT00347360|156883723|FG003|Overall Study|Adverse Event|4|||
48735678|NCT00347360|156883724|FG004|Overall Study|Adverse Event|1|||
48735679|NCT00347360|156883725|FG005|Overall Study|Adverse Event|2|||
48735680|NCT00347360|156883726|FG006|Overall Study|Adverse Event|2|||
48735681|NCT00347360|156883727|FG007|Overall Study|Adverse Event|0|||
48735682|NCT00347360|156883728|FG008|Overall Study|Adverse Event|2|||
48735683|NCT00347360|156883729|FG009|Overall Study|Adverse Event|3|||
48735684|NCT00347360|156883730|FG010|Overall Study|Adverse Event|3|||
48735685|NCT00347360|156883731|FG011|Overall Study|Adverse Event|1|||
48735686|NCT00347360|156883732|FG012|Overall Study|Adverse Event|3|||
48735687|NCT00347360|156883733|FG013|Overall Study|Adverse Event|2|||
48735688|NCT00347360|156883734|FG014|Overall Study|Adverse Event|2|||
48735689|NCT00347360|156883720|FG000|Overall Study|Lost to Follow-up|0|||
48735690|NCT00347360|156883721|FG001|Overall Study|Lost to Follow-up|0|||
48735691|NCT00347360|156883722|FG002|Overall Study|Lost to Follow-up|0|||
48735692|NCT00347360|156883723|FG003|Overall Study|Lost to Follow-up|2|||
48735693|NCT00347360|156883724|FG004|Overall Study|Lost to Follow-up|1|||
48735694|NCT00347360|156883725|FG005|Overall Study|Lost to Follow-up|1|||
48735695|NCT00347360|156883726|FG006|Overall Study|Lost to Follow-up|0|||
48735696|NCT00347360|156883727|FG007|Overall Study|Lost to Follow-up|1|||
48735697|NCT00347360|156883728|FG008|Overall Study|Lost to Follow-up|1|||
48735698|NCT00347360|156883729|FG009|Overall Study|Lost to Follow-up|2|||
48735699|NCT00347360|156883730|FG010|Overall Study|Lost to Follow-up|0|||
48735700|NCT00347360|156883731|FG011|Overall Study|Lost to Follow-up|0|||
48735701|NCT00347360|156883732|FG012|Overall Study|Lost to Follow-up|1|||
48735702|NCT00347360|156883733|FG013|Overall Study|Lost to Follow-up|0|||
48735703|NCT00347360|156883734|FG014|Overall Study|Lost to Follow-up|0|||
48735704|NCT00347360|156883720|FG000|Overall Study|Protocol Violation|2|||
48735705|NCT00347360|156883721|FG001|Overall Study|Protocol Violation|3|||
48735706|NCT00347360|156883722|FG002|Overall Study|Protocol Violation|1|||
48735707|NCT00347360|156883723|FG003|Overall Study|Protocol Violation|2|||
48735708|NCT00347360|156883724|FG004|Overall Study|Protocol Violation|1|||
48735709|NCT00347360|156883725|FG005|Overall Study|Protocol Violation|2|||
48735710|NCT00347360|156883726|FG006|Overall Study|Protocol Violation|0|||
48735711|NCT00347360|156883727|FG007|Overall Study|Protocol Violation|0|||
48735712|NCT00347360|156883728|FG008|Overall Study|Protocol Violation|1|||
48735713|NCT00347360|156883729|FG009|Overall Study|Protocol Violation|2|||
48735714|NCT00347360|156883730|FG010|Overall Study|Protocol Violation|0|||
48735715|NCT00347360|156883731|FG011|Overall Study|Protocol Violation|0|||
48735716|NCT00347360|156883732|FG012|Overall Study|Protocol Violation|0|||
48735717|NCT00347360|156883733|FG013|Overall Study|Protocol Violation|1|||
48735718|NCT00347360|156883734|FG014|Overall Study|Protocol Violation|0|||
48735719|NCT00347360|156883720|FG000|Overall Study|Withdrawal by Subject|0|||
48735720|NCT00347360|156883721|FG001|Overall Study|Withdrawal by Subject|1|||
48735721|NCT00347360|156883722|FG002|Overall Study|Withdrawal by Subject|2|||
48735722|NCT00347360|156883723|FG003|Overall Study|Withdrawal by Subject|4|||
48735723|NCT00347360|156883724|FG004|Overall Study|Withdrawal by Subject|1|||
48735724|NCT00347360|156883725|FG005|Overall Study|Withdrawal by Subject|2|||
48735725|NCT00347360|156883726|FG006|Overall Study|Withdrawal by Subject|1|||
48735726|NCT00347360|156883727|FG007|Overall Study|Withdrawal by Subject|1|||
48735727|NCT00347360|156883728|FG008|Overall Study|Withdrawal by Subject|1|||
48735728|NCT00347360|156883729|FG009|Overall Study|Withdrawal by Subject|1|||
48735729|NCT00347360|156883730|FG010|Overall Study|Withdrawal by Subject|0|||
48735730|NCT00347360|156883731|FG011|Overall Study|Withdrawal by Subject|3|||
48735731|NCT00347360|156883732|FG012|Overall Study|Withdrawal by Subject|4|||
48735732|NCT00347360|156883733|FG013|Overall Study|Withdrawal by Subject|2|||
48735733|NCT00347360|156883734|FG014|Overall Study|Withdrawal by Subject|1|||
48316039|NCT02988817|155355720|FG017|Overall Study|Sponsor decision|3|||
48316040|NCT02988817|155355721|FG018|Overall Study|Sponsor decision|2|||
48618382|NCT01158404|156459323|FG004|Overall Study|Withdrawal by Subject|3|||
48735734|NCT00347360|156883720|FG000|Overall Study|Lack of Efficacy|1|||
48735735|NCT00347360|156883721|FG001|Overall Study|Lack of Efficacy|1|||
48735736|NCT00347360|156883722|FG002|Overall Study|Lack of Efficacy|3|||
48735737|NCT00347360|156883723|FG003|Overall Study|Lack of Efficacy|1|||
48735738|NCT00347360|156883724|FG004|Overall Study|Lack of Efficacy|0|||
48735739|NCT00347360|156883725|FG005|Overall Study|Lack of Efficacy|1|||
48618383|NCT01158404|156459324|FG005|Overall Study|Withdrawal by Subject|1|||
48618384|NCT01158404|156459325|FG006|Overall Study|Withdrawal by Subject|0|||
48618385|NCT01158404|156459326|FG007|Overall Study|Withdrawal by Subject|1|||
48618386|NCT01158404|156459319|FG000|Overall Study|Physician Decision|0|||
48618387|NCT01158404|156459320|FG001|Overall Study|Physician Decision|0|||
48618388|NCT01158404|156459321|FG002|Overall Study|Physician Decision|0|||
48618389|NCT01158404|156459322|FG003|Overall Study|Physician Decision|0|||
48618390|NCT01158404|156459323|FG004|Overall Study|Physician Decision|0|||
48618391|NCT01158404|156459324|FG005|Overall Study|Physician Decision|0|||
48618392|NCT01158404|156459325|FG006|Overall Study|Physician Decision|0|||
48618393|NCT01158404|156459326|FG007|Overall Study|Physician Decision|1|||
48618394|NCT01158404|156459319|FG000|Overall Study|Progressive Disease|0|||
48618395|NCT01158404|156459320|FG001|Overall Study|Progressive Disease|0|||
48618396|NCT01158404|156459321|FG002|Overall Study|Progressive Disease|0|||
48618397|NCT01158404|156459322|FG003|Overall Study|Progressive Disease|0|||
48618398|NCT01158404|156459323|FG004|Overall Study|Progressive Disease|0|||
48618399|NCT01158404|156459324|FG005|Overall Study|Progressive Disease|0|||
48618400|NCT01158404|156459325|FG006|Overall Study|Progressive Disease|1|||
48618401|NCT01158404|156459326|FG007|Overall Study|Progressive Disease|0|||
48618402|NCT02384460|156459327|FG000|Overall Study|Protocol Violation|0|||
48618403|NCT02384460|156459328|FG001|Overall Study|Protocol Violation|1|||
48618404|NCT02384460|156459327|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
48618405|NCT02384460|156459328|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
48618406|NCT02384460|156459327|FG000|Overall Study|Adverse Event|5|||
48618407|NCT02384460|156459328|FG001|Overall Study|Adverse Event|2|||
48618408|NCT02384460|156459327|FG000|Overall Study|Withdrawal by Subject|0|||
48618409|NCT02384460|156459328|FG001|Overall Study|Withdrawal by Subject|3|||
48618410|NCT02384460|156459327|FG000|Overall Study|Elective medical treatment|1|||
48618411|NCT02384460|156459328|FG001|Overall Study|Elective medical treatment|0|||
48618412|NCT02384460|156459327|FG000|Overall Study|Non-compliance|1|||
48618413|NCT02384460|156459328|FG001|Overall Study|Non-compliance|0|||
48618414|NCT02400580|156459329|FG000|Overall Study|Withdrawal by Subject|1|||
48618415|NCT02400580|156459330|FG001|Overall Study|Withdrawal by Subject|1|||
48618416|NCT02400580|156459329|FG000|Overall Study|Adverse Event|1|||
48618417|NCT02400580|156459330|FG001|Overall Study|Adverse Event|0|||
48618418|NCT01441414|156459331|FG000|Overall Study|Participant died|9|||
48618419|NCT01441414|156459331|FG000|Overall Study|Other reasons|3|||
48618420|NCT01441414|156459331|FG000|Overall Study|Study terminated by sponsor|2|||
48618421|NCT01441414|156459331|FG000|Overall Study|Subject refused further follow-up|1|||
48618422|NCT03822416|156459334|FG000|Overall Study|Lost to Follow-up|1|||
48618423|NCT03822416|156459335|FG001|Overall Study|Lost to Follow-up|0|||
48618424|NCT03822416|156459334|FG000|Overall Study|Withdrawal by Subject|0|||
48618425|NCT03822416|156459335|FG001|Overall Study|Withdrawal by Subject|1|||
48618426|NCT04339972|156459336|FG000|Overall Study|Scheduling Issues|3|||
48618427|NCT04339972|156459337|FG001|Overall Study|Scheduling Issues|3|||
48618428|NCT04339972|156459336|FG000|Overall Study|dropout|1|||
48618429|NCT04339972|156459337|FG001|Overall Study|dropout|1|||
48618430|NCT04339972|156459336|FG000|Overall Study|Technical issues|1|||
48618431|NCT04339972|156459337|FG001|Overall Study|Technical issues|0|||
48618432|NCT04339972|156459336|FG000|Overall Study|Claustraphobia|0|||
48618433|NCT04339972|156459337|FG001|Overall Study|Claustraphobia|1|||
48618434|NCT01011283|156459346|FG000|Overall Study|Adverse Event|4|||
48618435|NCT01011283|156459347|FG001|Overall Study|Adverse Event|2|||
48618436|NCT01011283|156459346|FG000|Overall Study|Progressive Disease|0|||
48618437|NCT01011283|156459347|FG001|Overall Study|Progressive Disease|2|||
48618438|NCT01011283|156459346|FG000|Overall Study|Terminated by Sponsor|5|||
48618439|NCT01011283|156459347|FG001|Overall Study|Terminated by Sponsor|5|||
48618440|NCT01011283|156459346|FG000|Overall Study|Other|2|||
48618441|NCT01011283|156459347|FG001|Overall Study|Other|2|||
48618442|NCT01717859|156459348|FG000|Overall Study|Adverse Event|5|||
48618443|NCT01717859|156459348|FG000|Overall Study|Moved out of state|1|||
48618444|NCT01717859|156459348|FG000|Overall Study|Patient concerned about mental health|1|||
48618445|NCT01717859|156459348|FG000|Overall Study|Lost to Follow-up|1|||
48618446|NCT01717859|156459348|FG000|Overall Study|Withdrawal by Subject|2|||
48618447|NCT04964388|156459349|FG000|Overall Study|Lost to Follow-up|3|||
48618448|NCT04964388|156459350|FG001|Overall Study|Lost to Follow-up|2|||
48618449|NCT01755637|156459351|FG000|Period 1|Adverse Event|0|||
48618450|NCT01755637|156459352|FG001|Period 1|Adverse Event|1|||
48618451|NCT03142750|156459353|FG000|Overall Study|Lost to Follow-up|4|||
48618452|NCT03142750|156459354|FG001|Overall Study|Lost to Follow-up|1|||
48618453|NCT00474968|156459355|FG000|Overall Study|Withdrawal by Subject|8|||
48618454|NCT00474968|156459356|FG001|Overall Study|Withdrawal by Subject|7|||
48618455|NCT00474968|156459355|FG000|Overall Study|Protocol Violation|9|||
48618456|NCT00474968|156459356|FG001|Overall Study|Protocol Violation|8|||
48618457|NCT00474968|156459355|FG000|Overall Study|Sample not collected|1|||
48618458|NCT00474968|156459356|FG001|Overall Study|Sample not collected|1|||
48618459|NCT01111292|156459357|FG000|Treatment|Physician Decision|1|||
48618460|NCT01111292|156459358|FG001|Treatment|Physician Decision|1|||
48618461|NCT04914000|156459359|FG000|Overall Study|Lost to Follow-up|8|||
48618462|NCT04914000|156459359|FG000|Overall Study|Withdrawal by Subject|1|||
48618463|NCT00471107|156459360|FG000|Overall Study|Technical problems/data loss|3|||
48618464|NCT00471107|156459361|FG001|Overall Study|Technical problems/data loss|1|||
48618465|NCT00471107|156459362|FG002|Overall Study|Technical problems/data loss|3|||
48618466|NCT01769443|156459366|FG000|Overall Study|Study closure|1|||
48618467|NCT01769443|156459367|FG001|Overall Study|Study closure|0|||
48618468|NCT02346370|156459368|FG000|Overall Study|Not treated|1|||
48618469|NCT02346370|156459369|FG001|Overall Study|Not treated|0|||
48618470|NCT02346370|156459370|FG002|Overall Study|Not treated|0|||
48618471|NCT02346370|156459368|FG000|Overall Study|Withdrawal of consent|1|||
48618472|NCT02346370|156459369|FG001|Overall Study|Withdrawal of consent|0|||
48618473|NCT02346370|156459370|FG002|Overall Study|Withdrawal of consent|0|||
48618474|NCT02346370|156459368|FG000|Overall Study|Death|1|||
48618475|NCT02346370|156459369|FG001|Overall Study|Death|3|||
48618476|NCT02346370|156459370|FG002|Overall Study|Death|1|||
48618477|NCT02346370|156459368|FG000|Overall Study|Sponsor discontinued study|5|||
48618478|NCT02346370|156459369|FG001|Overall Study|Sponsor discontinued study|0|||
48618479|NCT02346370|156459370|FG002|Overall Study|Sponsor discontinued study|2|||
48618480|NCT02346370|156459368|FG000|Overall Study|Radiologic progression|0|||
48618481|NCT02346370|156459369|FG001|Overall Study|Radiologic progression|0|||
48618482|NCT02346370|156459370|FG002|Overall Study|Radiologic progression|1|||
48618483|NCT02346370|156459368|FG000|Overall Study|Physician Decision|0|||
48618484|NCT02346370|156459369|FG001|Overall Study|Physician Decision|1|||
48618485|NCT02346370|156459370|FG002|Overall Study|Physician Decision|0|||
48618486|NCT01668537|156459371|FG000|Overall Study|Request to Discontinue Prematurely|1|||
48618487|NCT01668537|156459372|FG001|Overall Study|Request to Discontinue Prematurely|1|||
48618488|NCT01668537|156459371|FG000|Overall Study|Subject unwilling/unable to comply|5|||
48618489|NCT01668537|156459372|FG001|Overall Study|Subject unwilling/unable to comply|0|||
48618490|NCT01668537|156459371|FG000|Overall Study|Reason Precludes Participation|1|||
48618491|NCT01668537|156459372|FG001|Overall Study|Reason Precludes Participation|0|||
48618492|NCT01668537|156459371|FG000|Overall Study|Lost to Follow-up|13|||
48618493|NCT01668537|156459372|FG001|Overall Study|Lost to Follow-up|6|||
48618494|NCT01668537|156459371|FG000|Overall Study|Other|2|||
48618495|NCT01668537|156459372|FG001|Overall Study|Other|3|||
48618496|NCT00114777|156459373|FG000|Randomization to Month 36|Death|10|||
48618497|NCT00114777|156459374|FG001|Randomization to Month 36|Death|4|||
48618498|NCT00114777|156459375|FG002|Randomization to Month 36|Death|3|||
48618499|NCT00114777|156459373|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
48618500|NCT00114777|156459374|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
48618501|NCT00114777|156459375|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
48618502|NCT00114777|156459373|FG000|Randomization to Month 36|Lack of Efficacy|19|||
48618503|NCT00114777|156459374|FG001|Randomization to Month 36|Lack of Efficacy|15|||
48618504|NCT00114777|156459375|FG002|Randomization to Month 36|Lack of Efficacy|17|||
48618505|NCT00114777|156459373|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
48618506|NCT00114777|156459374|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
48618507|NCT00114777|156459375|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
48618508|NCT00114777|156459373|FG000|Randomization to Month 36|Adverse Event|34|||
48618509|NCT00114777|156459374|FG001|Randomization to Month 36|Adverse Event|35|||
48618510|NCT00114777|156459375|FG002|Randomization to Month 36|Adverse Event|44|||
48618511|NCT00114777|156459373|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
48618512|NCT00114777|156459374|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
48618513|NCT00114777|156459375|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
48618514|NCT00114777|156459373|FG000|Randomization to Month 36|Other|9|||
48618515|NCT00114777|156459374|FG001|Randomization to Month 36|Other|3|||
48618516|NCT00114777|156459375|FG002|Randomization to Month 36|Other|12|||
48618517|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|Death|8|||
48618518|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|Death|13|||
48618519|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|Death|7|||
48618520|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
48618521|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
48618522|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
48618523|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
48618524|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
48618525|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
48618526|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
48618527|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
48618528|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
48618529|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
48618530|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
48618531|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
48618532|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
48618533|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
48618534|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
48735740|NCT00347360|156883726|FG006|Overall Study|Lack of Efficacy|0|||
48735741|NCT00347360|156883727|FG007|Overall Study|Lack of Efficacy|1|||
48735742|NCT00347360|156883728|FG008|Overall Study|Lack of Efficacy|1|||
48735743|NCT00347360|156883729|FG009|Overall Study|Lack of Efficacy|0|||
48735744|NCT00347360|156883730|FG010|Overall Study|Lack of Efficacy|0|||
48735745|NCT00347360|156883731|FG011|Overall Study|Lack of Efficacy|0|||
48735746|NCT00347360|156883732|FG012|Overall Study|Lack of Efficacy|0|||
48735747|NCT00347360|156883733|FG013|Overall Study|Lack of Efficacy|0|||
48735748|NCT00347360|156883734|FG014|Overall Study|Lack of Efficacy|0|||
48735749|NCT00347360|156883720|FG000|Overall Study|Reason not listed/blank|1|||
48618535|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
48618536|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
48735750|NCT00347360|156883721|FG001|Overall Study|Reason not listed/blank|0|||
48735751|NCT00347360|156883722|FG002|Overall Study|Reason not listed/blank|0|||
48735752|NCT00347360|156883723|FG003|Overall Study|Reason not listed/blank|0|||
48735753|NCT00347360|156883724|FG004|Overall Study|Reason not listed/blank|0|||
48735754|NCT00347360|156883725|FG005|Overall Study|Reason not listed/blank|0|||
48735755|NCT00347360|156883726|FG006|Overall Study|Reason not listed/blank|1|||
48735756|NCT00347360|156883727|FG007|Overall Study|Reason not listed/blank|0|||
48735757|NCT00347360|156883728|FG008|Overall Study|Reason not listed/blank|0|||
48735758|NCT00347360|156883729|FG009|Overall Study|Reason not listed/blank|0|||
48735759|NCT00347360|156883730|FG010|Overall Study|Reason not listed/blank|0|||
48735760|NCT00347360|156883731|FG011|Overall Study|Reason not listed/blank|0|||
48735761|NCT00347360|156883732|FG012|Overall Study|Reason not listed/blank|0|||
48735762|NCT00347360|156883733|FG013|Overall Study|Reason not listed/blank|1|||
48735763|NCT00347360|156883734|FG014|Overall Study|Reason not listed/blank|0|||
48735764|NCT00347360|156883720|FG000|Overall Study|Per sponsors instruction|0|||
48735765|NCT00347360|156883721|FG001|Overall Study|Per sponsors instruction|1|||
48735766|NCT00347360|156883722|FG002|Overall Study|Per sponsors instruction|0|||
48735767|NCT00347360|156883723|FG003|Overall Study|Per sponsors instruction|0|||
48735768|NCT00347360|156883724|FG004|Overall Study|Per sponsors instruction|0|||
48735769|NCT00347360|156883725|FG005|Overall Study|Per sponsors instruction|0|||
48735770|NCT00347360|156883726|FG006|Overall Study|Per sponsors instruction|0|||
48735771|NCT00347360|156883727|FG007|Overall Study|Per sponsors instruction|0|||
48735772|NCT00347360|156883728|FG008|Overall Study|Per sponsors instruction|0|||
48735773|NCT00347360|156883729|FG009|Overall Study|Per sponsors instruction|0|||
48735774|NCT00347360|156883730|FG010|Overall Study|Per sponsors instruction|0|||
48735775|NCT00347360|156883731|FG011|Overall Study|Per sponsors instruction|0|||
48735776|NCT00347360|156883732|FG012|Overall Study|Per sponsors instruction|0|||
48735777|NCT00347360|156883733|FG013|Overall Study|Per sponsors instruction|0|||
48735778|NCT00347360|156883734|FG014|Overall Study|Per sponsors instruction|0|||
48735779|NCT00347360|156883720|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
48735780|NCT00347360|156883721|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
48735781|NCT00347360|156883722|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
48618537|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
48618538|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
48618539|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
48735782|NCT00347360|156883723|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
48735783|NCT00347360|156883724|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
48735784|NCT00347360|156883725|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
48735785|NCT00347360|156883726|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
48735786|NCT00347360|156883727|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
48735787|NCT00347360|156883728|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
48735788|NCT00347360|156883729|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
48735789|NCT00347360|156883730|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
48735790|NCT00347360|156883731|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
48735791|NCT00347360|156883732|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
48735792|NCT00347360|156883733|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
48735793|NCT00347360|156883734|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
48735794|NCT00347360|156883720|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
48735795|NCT00347360|156883721|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
48735796|NCT00347360|156883722|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
48735797|NCT00347360|156883723|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
48735798|NCT00347360|156883724|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
48735799|NCT00347360|156883725|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
48735800|NCT00347360|156883726|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
48735801|NCT00347360|156883727|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
48735802|NCT00347360|156883728|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
48618540|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
48735803|NCT00347360|156883729|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
48735804|NCT00347360|156883730|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
48735805|NCT00347360|156883731|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
48618541|NCT00114777|156459373|FG000|Long-Term Extension to Month 84|Other|2|||
48618542|NCT00114777|156459374|FG001|Long-Term Extension to Month 84|Other|0|||
48618543|NCT00114777|156459375|FG002|Long-Term Extension to Month 84|Other|2|||
48618544|NCT05064800|156459376|FG000|Period 3|Withdrawal by Subject|0|||
48618545|NCT05064800|156459377|FG001|Period 3|Withdrawal by Subject|0|||
48618546|NCT05064800|156459378|FG002|Period 3|Withdrawal by Subject|0|||
48618547|NCT05064800|156459379|FG003|Period 3|Withdrawal by Subject|0|||
48618548|NCT05064800|156459380|FG004|Period 3|Withdrawal by Subject|1|||
48618549|NCT05064800|156459381|FG005|Period 3|Withdrawal by Subject|0|||
48618550|NCT00629239|156459382|FG000|Overall Study|Adverse Event|7|||
48618551|NCT00629239|156459383|FG001|Overall Study|Adverse Event|4|||
48735806|NCT00347360|156883732|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
48735807|NCT00347360|156883733|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
48735808|NCT00347360|156883734|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
48735809|NCT00347360|156883720|FG000|Overall Study|Abnormal lab values|0|||
48735810|NCT00347360|156883721|FG001|Overall Study|Abnormal lab values|0|||
48735811|NCT00347360|156883722|FG002|Overall Study|Abnormal lab values|0|||
48618552|NCT00629239|156459382|FG000|Overall Study|Physician Decision|1|||
48735812|NCT00347360|156883723|FG003|Overall Study|Abnormal lab values|0|||
48735813|NCT00347360|156883724|FG004|Overall Study|Abnormal lab values|0|||
48735814|NCT00347360|156883725|FG005|Overall Study|Abnormal lab values|0|||
48735815|NCT00347360|156883726|FG006|Overall Study|Abnormal lab values|1|||
48735816|NCT00347360|156883727|FG007|Overall Study|Abnormal lab values|0|||
48735817|NCT00347360|156883728|FG008|Overall Study|Abnormal lab values|0|||
48735818|NCT00347360|156883729|FG009|Overall Study|Abnormal lab values|0|||
48735819|NCT00347360|156883730|FG010|Overall Study|Abnormal lab values|0|||
48735820|NCT00347360|156883731|FG011|Overall Study|Abnormal lab values|0|||
48735821|NCT00347360|156883732|FG012|Overall Study|Abnormal lab values|0|||
48735822|NCT00347360|156883733|FG013|Overall Study|Abnormal lab values|0|||
48735823|NCT00347360|156883734|FG014|Overall Study|Abnormal lab values|0|||
48735824|NCT00347360|156883720|FG000|Overall Study|PI recommended early withdrawal|0|||
48735825|NCT00347360|156883721|FG001|Overall Study|PI recommended early withdrawal|0|||
48735826|NCT00347360|156883722|FG002|Overall Study|PI recommended early withdrawal|0|||
48735827|NCT00347360|156883723|FG003|Overall Study|PI recommended early withdrawal|0|||
48735828|NCT00347360|156883724|FG004|Overall Study|PI recommended early withdrawal|0|||
48735829|NCT00347360|156883725|FG005|Overall Study|PI recommended early withdrawal|0|||
48735830|NCT00347360|156883726|FG006|Overall Study|PI recommended early withdrawal|0|||
48735831|NCT00347360|156883727|FG007|Overall Study|PI recommended early withdrawal|0|||
48735832|NCT00347360|156883728|FG008|Overall Study|PI recommended early withdrawal|0|||
48735833|NCT00347360|156883729|FG009|Overall Study|PI recommended early withdrawal|1|||
48735834|NCT00347360|156883730|FG010|Overall Study|PI recommended early withdrawal|0|||
48735835|NCT00347360|156883731|FG011|Overall Study|PI recommended early withdrawal|0|||
48735836|NCT00347360|156883732|FG012|Overall Study|PI recommended early withdrawal|0|||
48735837|NCT00347360|156883733|FG013|Overall Study|PI recommended early withdrawal|0|||
48735838|NCT00347360|156883734|FG014|Overall Study|PI recommended early withdrawal|0|||
48735839|NCT00347360|156883720|FG000|Overall Study|Did not meet criteria before ABPM|0|||
48735840|NCT00347360|156883721|FG001|Overall Study|Did not meet criteria before ABPM|0|||
48735841|NCT00347360|156883722|FG002|Overall Study|Did not meet criteria before ABPM|0|||
48735842|NCT00347360|156883723|FG003|Overall Study|Did not meet criteria before ABPM|0|||
48735843|NCT00347360|156883724|FG004|Overall Study|Did not meet criteria before ABPM|0|||
48735844|NCT00347360|156883725|FG005|Overall Study|Did not meet criteria before ABPM|0|||
48735845|NCT00347360|156883726|FG006|Overall Study|Did not meet criteria before ABPM|0|||
48735846|NCT00347360|156883727|FG007|Overall Study|Did not meet criteria before ABPM|0|||
48735847|NCT00347360|156883728|FG008|Overall Study|Did not meet criteria before ABPM|0|||
48735848|NCT00347360|156883729|FG009|Overall Study|Did not meet criteria before ABPM|0|||
48735849|NCT00347360|156883730|FG010|Overall Study|Did not meet criteria before ABPM|1|||
48735850|NCT00347360|156883731|FG011|Overall Study|Did not meet criteria before ABPM|0|||
48735851|NCT00347360|156883732|FG012|Overall Study|Did not meet criteria before ABPM|0|||
48735852|NCT00347360|156883733|FG013|Overall Study|Did not meet criteria before ABPM|0|||
48735853|NCT00347360|156883734|FG014|Overall Study|Did not meet criteria before ABPM|0|||
48735854|NCT00347360|156883720|FG000|Overall Study|Randomized in error|0|||
48735855|NCT00347360|156883721|FG001|Overall Study|Randomized in error|0|||
48735856|NCT00347360|156883722|FG002|Overall Study|Randomized in error|0|||
48735857|NCT00347360|156883723|FG003|Overall Study|Randomized in error|0|||
48735858|NCT00347360|156883724|FG004|Overall Study|Randomized in error|0|||
48735859|NCT00347360|156883725|FG005|Overall Study|Randomized in error|0|||
48735860|NCT00347360|156883726|FG006|Overall Study|Randomized in error|0|||
48618553|NCT00629239|156459383|FG001|Overall Study|Physician Decision|0|||
48735861|NCT00347360|156883727|FG007|Overall Study|Randomized in error|0|||
48735862|NCT00347360|156883728|FG008|Overall Study|Randomized in error|0|||
48735863|NCT00347360|156883729|FG009|Overall Study|Randomized in error|0|||
48735864|NCT00347360|156883730|FG010|Overall Study|Randomized in error|0|||
48618554|NCT01851369|156459388|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618555|NCT01851369|156459389|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618556|NCT01851369|156459390|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618557|NCT01851369|156459391|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618558|NCT01851369|156459392|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618559|NCT01851369|156459393|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
48618560|NCT01851369|156459394|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618561|NCT01851369|156459395|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618562|NCT01851369|156459396|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618563|NCT01851369|156459397|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618564|NCT01851369|156459398|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618565|NCT01851369|156459399|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618566|NCT01851369|156459400|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
48618567|NCT01691482|156459402|FG000|Treatment Period 2|Adverse Event|0|||
48618568|NCT01691482|156459403|FG001|Treatment Period 2|Adverse Event|1|||
48618569|NCT01691482|156459402|FG000|Treatment Period 2|Protocol Violation|1|||
48618570|NCT01691482|156459403|FG001|Treatment Period 2|Protocol Violation|1|||
48618571|NCT02460380|156459404|FG000|Overall Study|Withdrawal by Subject|10|||
48618572|NCT02460380|156459405|FG001|Overall Study|Withdrawal by Subject|5|||
48618573|NCT05436288|156459410|FG000|Overall Study|Lost to Follow-up|1|||
48618574|NCT05436288|156459410|FG000|Overall Study|Adverse Event|1|||
48618575|NCT03501277|156459417|FG000|Intervention Period 1 (4 Days)|Other|0|||
48618576|NCT03501277|156459418|FG001|Intervention Period 1 (4 Days)|Other|0|||
48618577|NCT03501277|156459419|FG002|Intervention Period 1 (4 Days)|Other|1|||
48618578|NCT03501277|156459420|FG003|Intervention Period 1 (4 Days)|Other|0|||
48618579|NCT03501277|156459417|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
48618580|NCT03501277|156459418|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
48735865|NCT00347360|156883731|FG011|Overall Study|Randomized in error|1|||
48735866|NCT00347360|156883732|FG012|Overall Study|Randomized in error|0|||
48735867|NCT00347360|156883733|FG013|Overall Study|Randomized in error|0|||
48735868|NCT00347360|156883734|FG014|Overall Study|Randomized in error|0|||
48735869|NCT00347360|156883720|FG000|Overall Study|Failed inclusion criteria #4|0|||
48735870|NCT00347360|156883721|FG001|Overall Study|Failed inclusion criteria #4|0|||
48735871|NCT00347360|156883722|FG002|Overall Study|Failed inclusion criteria #4|0|||
48735872|NCT00347360|156883723|FG003|Overall Study|Failed inclusion criteria #4|0|||
48735873|NCT00347360|156883724|FG004|Overall Study|Failed inclusion criteria #4|0|||
48735874|NCT00347360|156883725|FG005|Overall Study|Failed inclusion criteria #4|0|||
48735875|NCT00347360|156883726|FG006|Overall Study|Failed inclusion criteria #4|0|||
48735876|NCT00347360|156883727|FG007|Overall Study|Failed inclusion criteria #4|0|||
48735877|NCT00347360|156883728|FG008|Overall Study|Failed inclusion criteria #4|0|||
48735878|NCT00347360|156883729|FG009|Overall Study|Failed inclusion criteria #4|0|||
48735879|NCT00347360|156883730|FG010|Overall Study|Failed inclusion criteria #4|0|||
48735880|NCT00347360|156883731|FG011|Overall Study|Failed inclusion criteria #4|1|||
48735881|NCT00347360|156883732|FG012|Overall Study|Failed inclusion criteria #4|0|||
48735882|NCT00347360|156883733|FG013|Overall Study|Failed inclusion criteria #4|0|||
48735883|NCT00347360|156883734|FG014|Overall Study|Failed inclusion criteria #4|0|||
48735884|NCT00347360|156883720|FG000|Overall Study|Prolonged duration between visits|0|||
48735885|NCT00347360|156883721|FG001|Overall Study|Prolonged duration between visits|0|||
48735886|NCT00347360|156883722|FG002|Overall Study|Prolonged duration between visits|0|||
48735887|NCT00347360|156883723|FG003|Overall Study|Prolonged duration between visits|0|||
48735888|NCT00347360|156883724|FG004|Overall Study|Prolonged duration between visits|0|||
48735889|NCT00347360|156883725|FG005|Overall Study|Prolonged duration between visits|0|||
48735890|NCT00347360|156883726|FG006|Overall Study|Prolonged duration between visits|0|||
48735891|NCT00347360|156883727|FG007|Overall Study|Prolonged duration between visits|0|||
48735892|NCT00347360|156883728|FG008|Overall Study|Prolonged duration between visits|0|||
48735893|NCT00347360|156883729|FG009|Overall Study|Prolonged duration between visits|0|||
48735894|NCT00347360|156883730|FG010|Overall Study|Prolonged duration between visits|0|||
48735895|NCT00347360|156883731|FG011|Overall Study|Prolonged duration between visits|0|||
48735896|NCT00347360|156883732|FG012|Overall Study|Prolonged duration between visits|1|||
48735897|NCT00347360|156883733|FG013|Overall Study|Prolonged duration between visits|0|||
48735898|NCT00347360|156883734|FG014|Overall Study|Prolonged duration between visits|0|||
48735899|NCT00347360|156883720|FG000|Overall Study|Subject left town, ran out of study drug|0|||
48735900|NCT00347360|156883721|FG001|Overall Study|Subject left town, ran out of study drug|0|||
48735901|NCT00347360|156883722|FG002|Overall Study|Subject left town, ran out of study drug|0|||
48735902|NCT00347360|156883723|FG003|Overall Study|Subject left town, ran out of study drug|0|||
48735903|NCT00347360|156883724|FG004|Overall Study|Subject left town, ran out of study drug|0|||
48735904|NCT00347360|156883725|FG005|Overall Study|Subject left town, ran out of study drug|0|||
48735905|NCT00347360|156883726|FG006|Overall Study|Subject left town, ran out of study drug|0|||
48735906|NCT00347360|156883727|FG007|Overall Study|Subject left town, ran out of study drug|0|||
48735907|NCT00347360|156883728|FG008|Overall Study|Subject left town, ran out of study drug|0|||
48735908|NCT00347360|156883729|FG009|Overall Study|Subject left town, ran out of study drug|0|||
48735909|NCT00347360|156883730|FG010|Overall Study|Subject left town, ran out of study drug|0|||
48735910|NCT00347360|156883731|FG011|Overall Study|Subject left town, ran out of study drug|0|||
48735911|NCT00347360|156883732|FG012|Overall Study|Subject left town, ran out of study drug|0|||
48735912|NCT00347360|156883733|FG013|Overall Study|Subject left town, ran out of study drug|1|||
48735913|NCT00347360|156883734|FG014|Overall Study|Subject left town, ran out of study drug|0|||
48735914|NCT00347360|156883720|FG000|Overall Study|Subject refuse to sign updated consent|0|||
48735915|NCT00347360|156883721|FG001|Overall Study|Subject refuse to sign updated consent|0|||
48735916|NCT00347360|156883722|FG002|Overall Study|Subject refuse to sign updated consent|0|||
48735917|NCT00347360|156883723|FG003|Overall Study|Subject refuse to sign updated consent|0|||
48735918|NCT00347360|156883724|FG004|Overall Study|Subject refuse to sign updated consent|0|||
48735919|NCT00347360|156883725|FG005|Overall Study|Subject refuse to sign updated consent|0|||
48735920|NCT00347360|156883726|FG006|Overall Study|Subject refuse to sign updated consent|0|||
48735921|NCT00347360|156883727|FG007|Overall Study|Subject refuse to sign updated consent|0|||
48735922|NCT00347360|156883728|FG008|Overall Study|Subject refuse to sign updated consent|0|||
48735923|NCT00347360|156883729|FG009|Overall Study|Subject refuse to sign updated consent|0|||
48735924|NCT00347360|156883730|FG010|Overall Study|Subject refuse to sign updated consent|0|||
48735925|NCT00347360|156883731|FG011|Overall Study|Subject refuse to sign updated consent|0|||
48735926|NCT00347360|156883732|FG012|Overall Study|Subject refuse to sign updated consent|0|||
48735927|NCT00347360|156883733|FG013|Overall Study|Subject refuse to sign updated consent|0|||
48735928|NCT00347360|156883734|FG014|Overall Study|Subject refuse to sign updated consent|1|||
48735929|NCT00347360|156883720|FG000|Overall Study|Visits conflicted with new job|0|||
48735930|NCT00347360|156883721|FG001|Overall Study|Visits conflicted with new job|0|||
48735931|NCT00347360|156883722|FG002|Overall Study|Visits conflicted with new job|0|||
48735932|NCT00347360|156883723|FG003|Overall Study|Visits conflicted with new job|0|||
48735933|NCT00347360|156883724|FG004|Overall Study|Visits conflicted with new job|0|||
48735934|NCT00347360|156883725|FG005|Overall Study|Visits conflicted with new job|0|||
48735935|NCT00347360|156883726|FG006|Overall Study|Visits conflicted with new job|1|||
48735936|NCT00347360|156883727|FG007|Overall Study|Visits conflicted with new job|0|||
48735937|NCT00347360|156883728|FG008|Overall Study|Visits conflicted with new job|0|||
48735938|NCT00347360|156883729|FG009|Overall Study|Visits conflicted with new job|0|||
48735939|NCT00347360|156883730|FG010|Overall Study|Visits conflicted with new job|0|||
48735940|NCT00347360|156883731|FG011|Overall Study|Visits conflicted with new job|0|||
48735941|NCT00347360|156883732|FG012|Overall Study|Visits conflicted with new job|0|||
48735942|NCT00347360|156883733|FG013|Overall Study|Visits conflicted with new job|0|||
48735943|NCT00347360|156883734|FG014|Overall Study|Visits conflicted with new job|0|||
48735944|NCT00508755|156883735|FG000|Overall Study|Withdrawal by Subject|1|||
48735945|NCT04478266|156883736|FG000|Overall Study|Adverse Event|20|||
48735946|NCT04478266|156883737|FG001|Overall Study|Adverse Event|21|||
48735947|NCT04478266|156883736|FG000|Overall Study|Progressive disease|146|||
48735948|NCT04478266|156883737|FG001|Overall Study|Progressive disease|168|||
48735949|NCT04478266|156883736|FG000|Overall Study|Poor compliance to protocol|1|||
48735950|NCT04478266|156883737|FG001|Overall Study|Poor compliance to protocol|0|||
48735951|NCT04478266|156883736|FG000|Overall Study|Withdrawal by Subject|19|||
48735952|NCT04478266|156883737|FG001|Overall Study|Withdrawal by Subject|16|||
48618581|NCT03501277|156459419|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
48618582|NCT03501277|156459420|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
48618583|NCT03501277|156459417|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
48618584|NCT03501277|156459418|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
48618585|NCT03501277|156459419|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
48618586|NCT03501277|156459420|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
48618587|NCT03501277|156459417|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
48618588|NCT03501277|156459418|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
48618589|NCT03501277|156459419|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
48618590|NCT03501277|156459420|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
48618591|NCT00066170|156459421|FG000|Overall Study|Adverse Event|2|||
48618592|NCT00066170|156459422|FG001|Overall Study|Adverse Event|4|||
48618593|NCT00066170|156459423|FG002|Overall Study|Adverse Event|1|||
48618594|NCT00066170|156459424|FG003|Overall Study|Adverse Event|7|||
48618595|NCT00066170|156459421|FG000|Overall Study|Serious Adverse Event|0|||
48618596|NCT00066170|156459422|FG001|Overall Study|Serious Adverse Event|0|||
48618597|NCT00066170|156459423|FG002|Overall Study|Serious Adverse Event|1|||
48618598|NCT00066170|156459424|FG003|Overall Study|Serious Adverse Event|1|||
48618599|NCT00066170|156459421|FG000|Overall Study|Lost to Follow-up|0|||
48618600|NCT00066170|156459422|FG001|Overall Study|Lost to Follow-up|1|||
48618601|NCT00066170|156459423|FG002|Overall Study|Lost to Follow-up|0|||
48618602|NCT00066170|156459424|FG003|Overall Study|Lost to Follow-up|0|||
48618603|NCT00066170|156459421|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
48618604|NCT00066170|156459422|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
48618605|NCT00066170|156459423|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
48618606|NCT00066170|156459424|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
48618607|NCT00066170|156459421|FG000|Overall Study|Protocol Violation|3|||
48618608|NCT00066170|156459422|FG001|Overall Study|Protocol Violation|0|||
48618609|NCT00066170|156459423|FG002|Overall Study|Protocol Violation|0|||
48618610|NCT00066170|156459424|FG003|Overall Study|Protocol Violation|0|||
48618611|NCT00066170|156459421|FG000|Overall Study|Other|1|||
48618612|NCT00066170|156459422|FG001|Overall Study|Other|5|||
48618613|NCT00066170|156459423|FG002|Overall Study|Other|2|||
48618614|NCT00066170|156459424|FG003|Overall Study|Other|0|||
48618615|NCT00812097|156459425|FG000|Overall Study|Death|3|||
48618616|NCT00812097|156459426|FG001|Overall Study|Death|10|||
48618617|NCT00812097|156459427|FG002|Overall Study|Death|3|||
48618618|NCT00812097|156459428|FG003|Overall Study|Death|3|||
48618619|NCT00812097|156459425|FG000|Overall Study|Withdrawal by Subject|14|||
48618620|NCT00812097|156459426|FG001|Overall Study|Withdrawal by Subject|12|||
48618621|NCT00812097|156459427|FG002|Overall Study|Withdrawal by Subject|8|||
48618622|NCT00812097|156459428|FG003|Overall Study|Withdrawal by Subject|2|||
48618623|NCT00812097|156459425|FG000|Overall Study|Lost to Follow-up|90|||
48618624|NCT00812097|156459426|FG001|Overall Study|Lost to Follow-up|14|||
48618625|NCT00812097|156459427|FG002|Overall Study|Lost to Follow-up|17|||
48618626|NCT00812097|156459428|FG003|Overall Study|Lost to Follow-up|5|||
48618627|NCT00812097|156459425|FG000|Overall Study|Explantation of study device(s)|27|||
48618628|NCT00812097|156459426|FG001|Overall Study|Explantation of study device(s)|29|||
48618629|NCT00812097|156459427|FG002|Overall Study|Explantation of study device(s)|14|||
48618630|NCT00812097|156459428|FG003|Overall Study|Explantation of study device(s)|20|||
48618631|NCT00812097|156459425|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
48618632|NCT00812097|156459426|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
48618633|NCT00812097|156459427|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
48618634|NCT00812097|156459428|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
48618635|NCT04069520|156459430|FG000|Overall Study|Lost to Follow-up|0|||
48618636|NCT04069520|156459431|FG001|Overall Study|Lost to Follow-up|2|||
48618637|NCT04069520|156459430|FG000|Overall Study|Withdrawal by Subject|0|||
48618638|NCT04069520|156459431|FG001|Overall Study|Withdrawal by Subject|1|||
48618639|NCT04069520|156459430|FG000|Overall Study|Prior Injury|1|||
48618640|NCT04069520|156459431|FG001|Overall Study|Prior Injury|0|||
48618641|NCT04069520|156459430|FG000|Overall Study|Orthodontia|1|||
48618642|NCT04069520|156459431|FG001|Overall Study|Orthodontia|0|||
48618643|NCT04069520|156459430|FG000|Overall Study|Cut from team|0|||
48618644|NCT04069520|156459431|FG001|Overall Study|Cut from team|2|||
48618645|NCT01068912|156459432|FG000|Overall Study|Adverse Event|2|||
48618646|NCT01068912|156459433|FG001|Overall Study|Adverse Event|3|||
48618647|NCT01068912|156459434|FG002|Overall Study|Adverse Event|2|||
48618648|NCT01068912|156459432|FG000|Overall Study|Withdrawal by Subject|5|||
48618649|NCT01068912|156459433|FG001|Overall Study|Withdrawal by Subject|6|||
48618650|NCT01068912|156459434|FG002|Overall Study|Withdrawal by Subject|6|||
48618651|NCT01068912|156459432|FG000|Overall Study|Lost to Follow-up|3|||
48618652|NCT01068912|156459433|FG001|Overall Study|Lost to Follow-up|7|||
48618653|NCT01068912|156459434|FG002|Overall Study|Lost to Follow-up|3|||
48618654|NCT01068912|156459432|FG000|Overall Study|Protocol Violation|0|||
48618655|NCT01068912|156459433|FG001|Overall Study|Protocol Violation|2|||
48618656|NCT01068912|156459434|FG002|Overall Study|Protocol Violation|0|||
48618657|NCT01068912|156459432|FG000|Overall Study|aggravation influenza|1|||
48618658|NCT01068912|156459433|FG001|Overall Study|aggravation influenza|1|||
48618659|NCT01068912|156459434|FG002|Overall Study|aggravation influenza|1|||
48618660|NCT01068912|156459432|FG000|Overall Study|other underlying illness|0|||
48618661|NCT01068912|156459433|FG001|Overall Study|other underlying illness|3|||
48618662|NCT01068912|156459434|FG002|Overall Study|other underlying illness|3|||
48618663|NCT03528577|156459441|FG000|Sequence 1|Failed Spirometry|1|||
48618664|NCT03528577|156459441|FG000|Sequence 1|Restricted medication|1|||
48316041|NCT02988817|155355722|FG019|Overall Study|Sponsor decision|7|||
48316042|NCT02988817|155355703|FG000|Overall Study|Physician Decision|0|||
48316043|NCT02988817|155355704|FG001|Overall Study|Physician Decision|0|||
48316044|NCT02988817|155355705|FG002|Overall Study|Physician Decision|0|||
48316045|NCT02988817|155355706|FG003|Overall Study|Physician Decision|0|||
48316046|NCT02988817|155355707|FG004|Overall Study|Physician Decision|0|||
48316047|NCT02988817|155355708|FG005|Overall Study|Physician Decision|0|||
48316048|NCT02988817|155355709|FG006|Overall Study|Physician Decision|0|||
48316049|NCT02988817|155355710|FG007|Overall Study|Physician Decision|0|||
48316050|NCT02988817|155355711|FG008|Overall Study|Physician Decision|0|||
48316051|NCT02988817|155355712|FG009|Overall Study|Physician Decision|0|||
48316052|NCT02988817|155355713|FG010|Overall Study|Physician Decision|0|||
48316053|NCT02988817|155355714|FG011|Overall Study|Physician Decision|0|||
48316054|NCT02988817|155355715|FG012|Overall Study|Physician Decision|0|||
48316055|NCT02988817|155355716|FG013|Overall Study|Physician Decision|0|||
48316056|NCT02988817|155355717|FG014|Overall Study|Physician Decision|0|||
48316057|NCT02988817|155355718|FG015|Overall Study|Physician Decision|1|||
48316058|NCT02988817|155355719|FG016|Overall Study|Physician Decision|0|||
48316059|NCT02988817|155355720|FG017|Overall Study|Physician Decision|0|||
48316060|NCT02988817|155355721|FG018|Overall Study|Physician Decision|1|||
48316061|NCT02988817|155355722|FG019|Overall Study|Physician Decision|1|||
48316066|NCT03036813|155355724|FG000|Overall Study|Adverse Event|6|||
48316067|NCT03036813|155355725|FG001|Overall Study|Adverse Event|11|||
48316068|NCT03036813|155355726|FG002|Overall Study|Adverse Event|6|||
48316069|NCT03036813|155355724|FG000|Overall Study|Withdrawal by Subject|12|||
48316070|NCT03036813|155355725|FG001|Overall Study|Withdrawal by Subject|6|||
48316071|NCT03036813|155355726|FG002|Overall Study|Withdrawal by Subject|10|||
48316072|NCT03036813|155355724|FG000|Overall Study|Lost to Follow-up|1|||
48316073|NCT03036813|155355725|FG001|Overall Study|Lost to Follow-up|1|||
48316074|NCT03036813|155355726|FG002|Overall Study|Lost to Follow-up|0|||
48316075|NCT03036813|155355724|FG000|Overall Study|Physician Decision|2|||
48316076|NCT03036813|155355725|FG001|Overall Study|Physician Decision|1|||
48316077|NCT03036813|155355726|FG002|Overall Study|Physician Decision|1|||
48316078|NCT03036813|155355724|FG000|Overall Study|Non-Compliance|1|||
48316079|NCT03036813|155355725|FG001|Overall Study|Non-Compliance|5|||
48316080|NCT03036813|155355726|FG002|Overall Study|Non-Compliance|3|||
48316081|NCT03036813|155355724|FG000|Overall Study|Pregnancy|0|||
48316082|NCT03036813|155355725|FG001|Overall Study|Pregnancy|0|||
48316083|NCT03036813|155355726|FG002|Overall Study|Pregnancy|1|||
48316084|NCT03036813|155355724|FG000|Overall Study|Other|0|||
48316085|NCT03036813|155355725|FG001|Overall Study|Other|3|||
48316086|NCT03036813|155355726|FG002|Overall Study|Other|5|||
48316101|NCT02928224|155355729|FG000|Overall Study|Lost to Follow-up|1|||
48316102|NCT02928224|155355730|FG001|Overall Study|Lost to Follow-up|1|||
48316103|NCT02928224|155355731|FG002|Overall Study|Lost to Follow-up|3|||
48316104|NCT02928224|155355732|FG003|Overall Study|Lost to Follow-up|0|||
48316105|NCT02928224|155355729|FG000|Overall Study|Death|30|||
48316106|NCT02928224|155355730|FG001|Overall Study|Death|209|||
48316107|NCT02928224|155355731|FG002|Overall Study|Death|193|||
48316108|NCT02928224|155355732|FG003|Overall Study|Death|198|||
48316109|NCT02928224|155355729|FG000|Overall Study|Withdrawal by Subject|0|||
48316110|NCT02928224|155355730|FG001|Overall Study|Withdrawal by Subject|3|||
48316111|NCT02928224|155355731|FG002|Overall Study|Withdrawal by Subject|7|||
48316112|NCT02928224|155355732|FG003|Overall Study|Withdrawal by Subject|20|||
48316113|NCT02928224|155355729|FG000|Overall Study|Study participation terminated by sponsor|3|||
48316114|NCT02928224|155355730|FG001|Overall Study|Study participation terminated by sponsor|8|||
48316115|NCT02928224|155355731|FG002|Overall Study|Study participation terminated by sponsor|12|||
48316116|NCT02928224|155355732|FG003|Overall Study|Study participation terminated by sponsor|3|||
48316117|NCT02928224|155355729|FG000|Overall Study|Other|3|||
48316118|NCT02928224|155355730|FG001|Overall Study|Other|3|||
48316119|NCT02928224|155355731|FG002|Overall Study|Other|5|||
48316120|NCT02928224|155355732|FG003|Overall Study|Other|0|||
48316121|NCT01179334|155355733|FG000|Treatment Period|Adverse Event|1|||
48316122|NCT01179334|155355734|FG001|Treatment Period|Adverse Event|0|||
48316123|NCT01179334|155355733|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
48316124|NCT01179334|155355734|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
48316125|NCT01179334|155355733|FG000|Long-term Extension (LTE) Period|Death|3|||
48316126|NCT01179334|155355734|FG001|Long-term Extension (LTE) Period|Death|0|||
48316127|NCT01179334|155355733|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
48316128|NCT01179334|155355734|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
48316129|NCT02158091|155355735|FG000|Overall Study|DLT|2|||
48316130|NCT02158091|155355736|FG001|Overall Study|DLT|1|||
48316131|NCT02158091|155355737|FG002|Overall Study|DLT|0|||
48316132|NCT00396084|155355738|FG000|Overall Study|Adverse Event|0|||
48316133|NCT00396084|155355739|FG001|Overall Study|Adverse Event|0|||
48316134|NCT00396084|155355740|FG002|Overall Study|Adverse Event|0|||
48316135|NCT00396084|155355741|FG003|Overall Study|Adverse Event|0|||
48316136|NCT00396084|155355742|FG004|Overall Study|Adverse Event|1|||
48316137|NCT00396084|155355743|FG005|Overall Study|Adverse Event|2|||
48316138|NCT00396084|155355738|FG000|Overall Study|Withdrawal by Subject|0|||
48316139|NCT00396084|155355739|FG001|Overall Study|Withdrawal by Subject|0|||
48316140|NCT00396084|155355740|FG002|Overall Study|Withdrawal by Subject|0|||
48316141|NCT00396084|155355741|FG003|Overall Study|Withdrawal by Subject|1|||
48316142|NCT00396084|155355742|FG004|Overall Study|Withdrawal by Subject|0|||
48316143|NCT00396084|155355743|FG005|Overall Study|Withdrawal by Subject|0|||
48316144|NCT00510887|155355744|FG000|Overall Study|Lost to Follow-up|1|||
48316244|NCT00001277|155355769|FG000|Overall Study|Adverse Event|0|||
48316245|NCT00001277|155355770|FG001|Overall Study|Adverse Event|0|||
48316246|NCT00001277|155355771|FG002|Overall Study|Adverse Event|1|||
48316247|NCT00001277|155355769|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
48316248|NCT00001277|155355770|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
48316249|NCT00001277|155355771|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
48316279|NCT02974634|155357692|FG000|Overall Study|Advanced disease|12|||
48316280|NCT02974634|155357693|FG001|Overall Study|Advanced disease|3|||
48316281|NCT02974634|155357692|FG000|Overall Study|Noncompliance|3|||
48316282|NCT02974634|155357693|FG001|Overall Study|Noncompliance|7|||
48316283|NCT02974634|155357692|FG000|Overall Study|intervention technology related issues|5|||
48316284|NCT02974634|155357693|FG001|Overall Study|intervention technology related issues|0|||
48316285|NCT02974634|155357692|FG000|Overall Study|Death|8|||
48316286|NCT02974634|155357693|FG001|Overall Study|Death|11|||
48316287|NCT00774852|155357694|FG000|Overall Study|Adverse Event|9|||
48316288|NCT00774852|155357695|FG001|Overall Study|Adverse Event|6|||
48316289|NCT00774852|155357694|FG000|Overall Study|Death|2|||
48316290|NCT00774852|155357695|FG001|Overall Study|Death|1|||
48316291|NCT00774852|155357694|FG000|Overall Study|Lack of Efficacy|3|||
48316292|NCT00774852|155357695|FG001|Overall Study|Lack of Efficacy|7|||
48316293|NCT00774852|155357694|FG000|Overall Study|Lost to Follow-up|9|||
48316294|NCT00774852|155357695|FG001|Overall Study|Lost to Follow-up|5|||
48316295|NCT00774852|155357694|FG000|Overall Study|Physician Decision|2|||
48316296|NCT00774852|155357695|FG001|Overall Study|Physician Decision|6|||
48316297|NCT00774852|155357694|FG000|Overall Study|Pregnancy|1|||
48316298|NCT00774852|155357695|FG001|Overall Study|Pregnancy|2|||
48316299|NCT00774852|155357694|FG000|Overall Study|Withdrawal by Subject|2|||
48316300|NCT00774852|155357695|FG001|Overall Study|Withdrawal by Subject|2|||
48316301|NCT00774852|155357694|FG000|Overall Study|Non-responder|15|||
48316302|NCT00774852|155357695|FG001|Overall Study|Non-responder|11|||
48316303|NCT00774852|155357694|FG000|Overall Study|Subject non-compliance|0|||
48316304|NCT00774852|155357695|FG001|Overall Study|Subject non-compliance|1|||
48316305|NCT00774852|155357694|FG000|Overall Study|Protocol Violation|1|||
48316306|NCT00774852|155357695|FG001|Overall Study|Protocol Violation|0|||
48316307|NCT00774852|155357694|FG000|Overall Study|Subject received prohibited medication|1|||
48316308|NCT00774852|155357695|FG001|Overall Study|Subject received prohibited medication|0|||
48316309|NCT04867902|155357696|FG000|Overall Study|Lost to Follow-up|1|||
48316310|NCT04867902|155357696|FG000|Overall Study|Withdrawal by Subject|2|||
48316311|NCT04867902|155357696|FG000|Overall Study|Protocol Violation|1|||
48316312|NCT01662336|155357697|FG000|Overall Study|Adverse Event|1|||
48316313|NCT01662336|155357697|FG000|Overall Study|No longer on LPV/r|30|||
48316314|NCT01662336|155357697|FG000|Overall Study|Other|29|||
48316315|NCT01662336|155357697|FG000|Overall Study|Withdrawal by Subject|6|||
48316316|NCT03762668|155357699|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
48316317|NCT03762668|155357700|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
48316318|NCT00465816|155357702|FG000|Overall Study|Lost to Follow-up|0|||
48316319|NCT00465816|155357703|FG001|Overall Study|Lost to Follow-up|0|||
48316320|NCT00465816|155357704|FG002|Overall Study|Lost to Follow-up|2|||
48316321|NCT04425629|155357709|FG000|Overall Study|Adverse Event|0|||
48316322|NCT04425629|155357710|FG001|Overall Study|Adverse Event|0|||
48316323|NCT04425629|155357711|FG002|Overall Study|Adverse Event|0|||
48316324|NCT04425629|155357712|FG003|Overall Study|Adverse Event|0|||
48316325|NCT04425629|155357713|FG004|Overall Study|Adverse Event|1|||
48316326|NCT04425629|155357714|FG005|Overall Study|Adverse Event|0|||
48316327|NCT04425629|155357715|FG006|Overall Study|Adverse Event|0|||
48316328|NCT04425629|155357716|FG007|Overall Study|Adverse Event|0|||
48316329|NCT04425629|155357717|FG008|Overall Study|Adverse Event|0|||
48316330|NCT04425629|155357718|FG009|Overall Study|Adverse Event|3|||
48316331|NCT04425629|155357719|FG010|Overall Study|Adverse Event|2|||
48316332|NCT04425629|155357720|FG011|Overall Study|Adverse Event|1|||
48316333|NCT04425629|155357721|FG012|Overall Study|Adverse Event|1|||
48316334|NCT04425629|155357722|FG013|Overall Study|Adverse Event|0|||
48316335|NCT04425629|155357723|FG014|Overall Study|Adverse Event|0|||
48618665|NCT03528577|156459441|FG000|Sequence 2|Adverse Event|1|||
48618666|NCT03528577|156459441|FG000|Sequence 2|Withdrawal by Subject|1|||
48618667|NCT03528577|156459441|FG000|Sequence 2|Failed Spirometry|1|||
48316336|NCT04425629|155357724|FG015|Overall Study|Adverse Event|0|||
48316337|NCT04425629|155357725|FG016|Overall Study|Adverse Event|0|||
48316338|NCT04425629|155357726|FG017|Overall Study|Adverse Event|0|||
48316339|NCT04425629|155357727|FG018|Overall Study|Adverse Event|0|||
48316340|NCT04425629|155357709|FG000|Overall Study|Lost to Follow-up|1|||
48316341|NCT04425629|155357710|FG001|Overall Study|Lost to Follow-up|3|||
48316342|NCT04425629|155357711|FG002|Overall Study|Lost to Follow-up|1|||
48316343|NCT04425629|155357712|FG003|Overall Study|Lost to Follow-up|7|||
48316344|NCT04425629|155357713|FG004|Overall Study|Lost to Follow-up|1|||
48316345|NCT04425629|155357714|FG005|Overall Study|Lost to Follow-up|2|||
48316346|NCT04425629|155357715|FG006|Overall Study|Lost to Follow-up|1|||
48316347|NCT04425629|155357716|FG007|Overall Study|Lost to Follow-up|0|||
48316348|NCT04425629|155357717|FG008|Overall Study|Lost to Follow-up|1|||
48316349|NCT04425629|155357718|FG009|Overall Study|Lost to Follow-up|64|||
48316350|NCT04425629|155357719|FG010|Overall Study|Lost to Follow-up|70|||
48316351|NCT04425629|155357720|FG011|Overall Study|Lost to Follow-up|98|||
48316352|NCT04425629|155357721|FG012|Overall Study|Lost to Follow-up|30|||
48316353|NCT04425629|155357722|FG013|Overall Study|Lost to Follow-up|0|||
48316354|NCT04425629|155357723|FG014|Overall Study|Lost to Follow-up|5|||
48316355|NCT04425629|155357724|FG015|Overall Study|Lost to Follow-up|4|||
48618668|NCT03528577|156459441|FG000|Sequence 3|Failed Spirometry|1|||
48618669|NCT03528577|156459441|FG000|Sequence 4|Failed Spirometry|2|||
48618670|NCT03528577|156459441|FG000|Sequence 4|Adverse Event|1|||
48618671|NCT02939781|156459442|FG000|Overall Study|Protocol Violation|8|||
48316356|NCT04425629|155357725|FG016|Overall Study|Lost to Follow-up|0|||
48316357|NCT04425629|155357726|FG017|Overall Study|Lost to Follow-up|3|||
48316358|NCT04425629|155357727|FG018|Overall Study|Lost to Follow-up|1|||
48316359|NCT04425629|155357709|FG000|Overall Study|Subject Decision|0|||
48316360|NCT04425629|155357710|FG001|Overall Study|Subject Decision|2|||
48316361|NCT04425629|155357711|FG002|Overall Study|Subject Decision|1|||
48316362|NCT04425629|155357712|FG003|Overall Study|Subject Decision|3|||
48316363|NCT04425629|155357713|FG004|Overall Study|Subject Decision|6|||
48316364|NCT04425629|155357714|FG005|Overall Study|Subject Decision|6|||
48316365|NCT04425629|155357715|FG006|Overall Study|Subject Decision|3|||
48316366|NCT04425629|155357716|FG007|Overall Study|Subject Decision|3|||
48316367|NCT04425629|155357717|FG008|Overall Study|Subject Decision|1|||
48316368|NCT04425629|155357718|FG009|Overall Study|Subject Decision|70|||
48316369|NCT04425629|155357719|FG010|Overall Study|Subject Decision|95|||
48316370|NCT04425629|155357720|FG011|Overall Study|Subject Decision|124|||
48316371|NCT04425629|155357721|FG012|Overall Study|Subject Decision|25|||
48316372|NCT04425629|155357722|FG013|Overall Study|Subject Decision|0|||
48316373|NCT04425629|155357723|FG014|Overall Study|Subject Decision|1|||
48316374|NCT04425629|155357724|FG015|Overall Study|Subject Decision|4|||
48316375|NCT04425629|155357725|FG016|Overall Study|Subject Decision|1|||
48316376|NCT04425629|155357726|FG017|Overall Study|Subject Decision|0|||
48316377|NCT04425629|155357727|FG018|Overall Study|Subject Decision|2|||
48316378|NCT04425629|155357709|FG000|Overall Study|Death|0|||
48316379|NCT04425629|155357710|FG001|Overall Study|Death|0|||
48316380|NCT04425629|155357711|FG002|Overall Study|Death|0|||
48316381|NCT04425629|155357712|FG003|Overall Study|Death|0|||
48316382|NCT04425629|155357713|FG004|Overall Study|Death|0|||
48316383|NCT04425629|155357714|FG005|Overall Study|Death|0|||
48316384|NCT04425629|155357715|FG006|Overall Study|Death|0|||
48316385|NCT04425629|155357716|FG007|Overall Study|Death|0|||
48316386|NCT04425629|155357717|FG008|Overall Study|Death|0|||
48316387|NCT04425629|155357718|FG009|Overall Study|Death|11|||
48316388|NCT04425629|155357719|FG010|Overall Study|Death|2|||
48316389|NCT04425629|155357720|FG011|Overall Study|Death|4|||
48316390|NCT04425629|155357721|FG012|Overall Study|Death|0|||
48316391|NCT04425629|155357722|FG013|Overall Study|Death|0|||
48316392|NCT04425629|155357723|FG014|Overall Study|Death|0|||
48316393|NCT04425629|155357724|FG015|Overall Study|Death|0|||
48316394|NCT04425629|155357725|FG016|Overall Study|Death|0|||
48316395|NCT04425629|155357726|FG017|Overall Study|Death|0|||
48316396|NCT04425629|155357727|FG018|Overall Study|Death|0|||
48316397|NCT04425629|155357709|FG000|Overall Study|Sponsor Request|0|||
48316398|NCT04425629|155357710|FG001|Overall Study|Sponsor Request|0|||
48316399|NCT04425629|155357711|FG002|Overall Study|Sponsor Request|0|||
48316400|NCT04425629|155357712|FG003|Overall Study|Sponsor Request|2|||
48316401|NCT04425629|155357713|FG004|Overall Study|Sponsor Request|2|||
48316402|NCT04425629|155357714|FG005|Overall Study|Sponsor Request|2|||
48316403|NCT04425629|155357715|FG006|Overall Study|Sponsor Request|1|||
48316404|NCT04425629|155357716|FG007|Overall Study|Sponsor Request|0|||
48316405|NCT04425629|155357717|FG008|Overall Study|Sponsor Request|0|||
48316406|NCT04425629|155357718|FG009|Overall Study|Sponsor Request|9|||
48316407|NCT04425629|155357719|FG010|Overall Study|Sponsor Request|9|||
48316408|NCT04425629|155357720|FG011|Overall Study|Sponsor Request|10|||
48316409|NCT04425629|155357721|FG012|Overall Study|Sponsor Request|8|||
48316410|NCT04425629|155357722|FG013|Overall Study|Sponsor Request|0|||
48316411|NCT04425629|155357723|FG014|Overall Study|Sponsor Request|0|||
48316412|NCT04425629|155357724|FG015|Overall Study|Sponsor Request|1|||
48316413|NCT04425629|155357725|FG016|Overall Study|Sponsor Request|0|||
48316414|NCT04425629|155357726|FG017|Overall Study|Sponsor Request|0|||
48316415|NCT04425629|155357727|FG018|Overall Study|Sponsor Request|0|||
48316416|NCT04425629|155357709|FG000|Overall Study|Physician Decision|0|||
48316417|NCT04425629|155357710|FG001|Overall Study|Physician Decision|0|||
48316418|NCT04425629|155357711|FG002|Overall Study|Physician Decision|0|||
48316419|NCT04425629|155357712|FG003|Overall Study|Physician Decision|0|||
48316420|NCT04425629|155357713|FG004|Overall Study|Physician Decision|0|||
48316421|NCT04425629|155357714|FG005|Overall Study|Physician Decision|0|||
48316422|NCT04425629|155357715|FG006|Overall Study|Physician Decision|0|||
48316423|NCT04425629|155357716|FG007|Overall Study|Physician Decision|0|||
48316424|NCT04425629|155357717|FG008|Overall Study|Physician Decision|0|||
48316425|NCT04425629|155357718|FG009|Overall Study|Physician Decision|4|||
48316426|NCT04425629|155357719|FG010|Overall Study|Physician Decision|3|||
48316427|NCT04425629|155357720|FG011|Overall Study|Physician Decision|5|||
48618672|NCT02939781|156459442|FG000|Overall Study|Withdrawal by Subject|1|||
48316428|NCT04425629|155357721|FG012|Overall Study|Physician Decision|1|||
48316429|NCT04425629|155357722|FG013|Overall Study|Physician Decision|0|||
48316430|NCT04425629|155357723|FG014|Overall Study|Physician Decision|0|||
48316431|NCT04425629|155357724|FG015|Overall Study|Physician Decision|1|||
48618673|NCT00541775|156459443|FG000|Overall Study|Adverse Event|3|||
48618674|NCT00541775|156459444|FG001|Overall Study|Adverse Event|2|||
48618675|NCT00541775|156459445|FG002|Overall Study|Adverse Event|1|||
48618676|NCT00541775|156459443|FG000|Overall Study|Lack of Efficacy|0|||
48618677|NCT00541775|156459444|FG001|Overall Study|Lack of Efficacy|0|||
48618678|NCT00541775|156459445|FG002|Overall Study|Lack of Efficacy|3|||
48316432|NCT04425629|155357725|FG016|Overall Study|Physician Decision|0|||
48316433|NCT04425629|155357726|FG017|Overall Study|Physician Decision|0|||
48316434|NCT04425629|155357727|FG018|Overall Study|Physician Decision|0|||
48316435|NCT04425629|155357709|FG000|Overall Study|Lack of Efficacy|0|||
48316436|NCT04425629|155357710|FG001|Overall Study|Lack of Efficacy|0|||
48316437|NCT04425629|155357711|FG002|Overall Study|Lack of Efficacy|0|||
48316438|NCT04425629|155357712|FG003|Overall Study|Lack of Efficacy|0|||
48316439|NCT04425629|155357713|FG004|Overall Study|Lack of Efficacy|0|||
48618679|NCT00541775|156459443|FG000|Overall Study|Lost to Follow-up|0|||
48618680|NCT00541775|156459444|FG001|Overall Study|Lost to Follow-up|0|||
48618681|NCT00541775|156459445|FG002|Overall Study|Lost to Follow-up|2|||
48618682|NCT00541775|156459443|FG000|Overall Study|Protocol Violation|1|||
48618683|NCT00541775|156459444|FG001|Overall Study|Protocol Violation|0|||
48618684|NCT00541775|156459445|FG002|Overall Study|Protocol Violation|0|||
48618685|NCT00541775|156459443|FG000|Overall Study|Withdrawal by Subject and Other|5|||
48618686|NCT00541775|156459444|FG001|Overall Study|Withdrawal by Subject and Other|0|||
48618687|NCT00541775|156459445|FG002|Overall Study|Withdrawal by Subject and Other|2|||
48618688|NCT03753542|156459446|FG000|Overall Study|Lost to Follow-up|9|||
48618689|NCT03753542|156459447|FG001|Overall Study|Lost to Follow-up|14|||
48618690|NCT00032487|156459448|FG000|Overall Study|Withdrawal by Subject|67|||
48618691|NCT00032487|156459449|FG001|Overall Study|Withdrawal by Subject|43|||
48618692|NCT00032487|156459448|FG000|Overall Study|Adverse Event|3|||
48618693|NCT00032487|156459449|FG001|Overall Study|Adverse Event|7|||
48618694|NCT00032487|156459448|FG000|Overall Study|Lost to Follow-up|57|||
48618695|NCT00032487|156459449|FG001|Overall Study|Lost to Follow-up|58|||
48618696|NCT00032487|156459448|FG000|Overall Study|Had other reason|12|||
48316440|NCT04425629|155357714|FG005|Overall Study|Lack of Efficacy|0|||
48316441|NCT04425629|155357715|FG006|Overall Study|Lack of Efficacy|0|||
48316442|NCT04425629|155357716|FG007|Overall Study|Lack of Efficacy|0|||
48316443|NCT04425629|155357717|FG008|Overall Study|Lack of Efficacy|0|||
48316444|NCT04425629|155357718|FG009|Overall Study|Lack of Efficacy|0|||
48316445|NCT04425629|155357719|FG010|Overall Study|Lack of Efficacy|1|||
48316446|NCT04425629|155357720|FG011|Overall Study|Lack of Efficacy|0|||
48316447|NCT04425629|155357721|FG012|Overall Study|Lack of Efficacy|0|||
48316448|NCT04425629|155357722|FG013|Overall Study|Lack of Efficacy|0|||
48316449|NCT04425629|155357723|FG014|Overall Study|Lack of Efficacy|0|||
48316450|NCT04425629|155357724|FG015|Overall Study|Lack of Efficacy|0|||
48316451|NCT04425629|155357725|FG016|Overall Study|Lack of Efficacy|0|||
48316452|NCT04425629|155357726|FG017|Overall Study|Lack of Efficacy|0|||
48316453|NCT04425629|155357727|FG018|Overall Study|Lack of Efficacy|0|||
48316454|NCT00002842|155357728|FG000|Overall Study|ineligible for surgical resection|27|||
48316455|NCT00414544|155357733|FG000|Overall Study|Lost to Follow-up|14|||
48316456|NCT03452189|155357734|FG000|First Intervention (3 Months)|Adverse Event|1|||
48316457|NCT03452189|155357735|FG001|First Intervention (3 Months)|Adverse Event|0|||
48316458|NCT03452189|155357734|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
48316459|NCT03452189|155357735|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
48316460|NCT02271854|155357736|FG000|Overall Study|Withdrawal by Subject|2|||
48316461|NCT02271854|155357736|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
48316462|NCT02271854|155357736|FG000|Overall Study|Lost to Follow-up|1|||
48316463|NCT00807144|155357737|FG000|Overall Study|Lost to Follow-up|0|||
48316464|NCT00807144|155357738|FG001|Overall Study|Lost to Follow-up|1|||
48316465|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
48316466|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
48316467|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
48316468|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
48316469|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
48316470|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
48316471|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
48316472|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
48316473|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
48316474|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
48316475|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
48316476|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
48316477|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
48618697|NCT00032487|156459449|FG001|Overall Study|Had other reason|12|||
48618698|NCT01028391|156459450|FG000|Overall Study|Adverse Event|4|||
48316478|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
48316479|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
48316480|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
48316481|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
48316482|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
48316483|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
48316484|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
48618699|NCT01028391|156459451|FG001|Overall Study|Adverse Event|0|||
48316485|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
48316486|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
48316487|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
48316488|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
48316489|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
48316490|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
48316491|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
48316492|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
48316493|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
48316494|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
48316495|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
48316496|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
48316497|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
48618700|NCT01028391|156459450|FG000|Overall Study|Lack of Efficacy|0|||
48316498|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
48316499|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
48316500|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
48316501|NCT03593213|155357742|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
48316502|NCT03593213|155357743|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
48316503|NCT03593213|155357744|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
48316504|NCT03593213|155357745|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
48316505|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
48316506|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
48316507|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
48316508|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
48316509|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
48316510|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
48316511|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
48316512|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
48316513|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
48316514|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
48316515|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
48316516|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
48316517|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
48316518|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
48316519|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
48316520|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
48316521|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
48316522|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
48316523|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
48316524|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
48316525|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
48316526|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
48316527|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
48316528|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
48316529|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
48316530|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
48316531|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
48316532|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
48316533|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
48316534|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
48316535|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
48316536|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
48316537|NCT03593213|155357742|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
48316538|NCT03593213|155357743|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
48316539|NCT03593213|155357744|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
48316540|NCT03593213|155357745|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
48316541|NCT01135511|155357747|FG000|Overall Study|Adverse Event|0|||
48316542|NCT01135511|155357748|FG001|Overall Study|Adverse Event|1|||
48316543|NCT01135511|155357749|FG002|Overall Study|Adverse Event|2|||
48316544|NCT01135511|155357750|FG003|Overall Study|Adverse Event|0|||
48316545|NCT01135511|155357751|FG004|Overall Study|Adverse Event|0|||
48316546|NCT01135511|155357752|FG005|Overall Study|Adverse Event|1|||
48316547|NCT01135511|155357753|FG006|Overall Study|Adverse Event|0|||
48316548|NCT01135511|155357754|FG007|Overall Study|Adverse Event|1|||
48316549|NCT01135511|155357755|FG008|Overall Study|Adverse Event|0|||
48316550|NCT01135511|155357747|FG000|Overall Study|Lack of Efficacy|0|||
48316551|NCT01135511|155357748|FG001|Overall Study|Lack of Efficacy|1|||
48316552|NCT01135511|155357749|FG002|Overall Study|Lack of Efficacy|1|||
48316553|NCT01135511|155357750|FG003|Overall Study|Lack of Efficacy|2|||
48316554|NCT01135511|155357751|FG004|Overall Study|Lack of Efficacy|0|||
48316555|NCT01135511|155357752|FG005|Overall Study|Lack of Efficacy|0|||
48316556|NCT01135511|155357753|FG006|Overall Study|Lack of Efficacy|0|||
48316557|NCT01135511|155357754|FG007|Overall Study|Lack of Efficacy|0|||
48316558|NCT01135511|155357755|FG008|Overall Study|Lack of Efficacy|0|||
48316559|NCT01135511|155357747|FG000|Overall Study|Protocol Violation|0|||
48316560|NCT01135511|155357748|FG001|Overall Study|Protocol Violation|0|||
48316561|NCT01135511|155357749|FG002|Overall Study|Protocol Violation|3|||
48316562|NCT01135511|155357750|FG003|Overall Study|Protocol Violation|0|||
48316563|NCT01135511|155357751|FG004|Overall Study|Protocol Violation|0|||
48316564|NCT01135511|155357752|FG005|Overall Study|Protocol Violation|0|||
48316565|NCT01135511|155357753|FG006|Overall Study|Protocol Violation|0|||
48316566|NCT01135511|155357754|FG007|Overall Study|Protocol Violation|0|||
48316567|NCT01135511|155357755|FG008|Overall Study|Protocol Violation|0|||
48316568|NCT01135511|155357747|FG000|Overall Study|Pregnancy|0|||
48316569|NCT01135511|155357748|FG001|Overall Study|Pregnancy|0|||
48316570|NCT01135511|155357749|FG002|Overall Study|Pregnancy|0|||
48316571|NCT01135511|155357750|FG003|Overall Study|Pregnancy|1|||
48316572|NCT01135511|155357751|FG004|Overall Study|Pregnancy|0|||
48316573|NCT01135511|155357752|FG005|Overall Study|Pregnancy|0|||
48316574|NCT01135511|155357753|FG006|Overall Study|Pregnancy|0|||
48316575|NCT01135511|155357754|FG007|Overall Study|Pregnancy|0|||
48316576|NCT01135511|155357755|FG008|Overall Study|Pregnancy|0|||
48316577|NCT01135511|155357747|FG000|Overall Study|could not visit the clinic|0|||
48316578|NCT01135511|155357748|FG001|Overall Study|could not visit the clinic|1|||
48316579|NCT01135511|155357749|FG002|Overall Study|could not visit the clinic|2|||
48316580|NCT01135511|155357750|FG003|Overall Study|could not visit the clinic|0|||
48316581|NCT01135511|155357751|FG004|Overall Study|could not visit the clinic|0|||
48316582|NCT01135511|155357752|FG005|Overall Study|could not visit the clinic|0|||
48316583|NCT01135511|155357753|FG006|Overall Study|could not visit the clinic|0|||
48316584|NCT01135511|155357754|FG007|Overall Study|could not visit the clinic|0|||
48316585|NCT01135511|155357755|FG008|Overall Study|could not visit the clinic|0|||
48618701|NCT01028391|156459451|FG001|Overall Study|Lack of Efficacy|2|||
48618702|NCT01028391|156459450|FG000|Overall Study|Lost to Follow-up|3|||
48618703|NCT01028391|156459451|FG001|Overall Study|Lost to Follow-up|4|||
48316586|NCT01135511|155357747|FG000|Overall Study|noncompliance with study drug taken|0|||
48316587|NCT01135511|155357748|FG001|Overall Study|noncompliance with study drug taken|0|||
48316588|NCT01135511|155357749|FG002|Overall Study|noncompliance with study drug taken|0|||
48316589|NCT01135511|155357750|FG003|Overall Study|noncompliance with study drug taken|0|||
48316590|NCT01135511|155357751|FG004|Overall Study|noncompliance with study drug taken|1|||
48316591|NCT01135511|155357752|FG005|Overall Study|noncompliance with study drug taken|0|||
48316592|NCT01135511|155357753|FG006|Overall Study|noncompliance with study drug taken|0|||
48316593|NCT01135511|155357754|FG007|Overall Study|noncompliance with study drug taken|0|||
48316594|NCT01135511|155357755|FG008|Overall Study|noncompliance with study drug taken|0|||
48316595|NCT01135511|155357747|FG000|Overall Study|Withdrawal by Subject|0|||
48316596|NCT01135511|155357748|FG001|Overall Study|Withdrawal by Subject|0|||
48316597|NCT01135511|155357749|FG002|Overall Study|Withdrawal by Subject|0|||
48316598|NCT01135511|155357750|FG003|Overall Study|Withdrawal by Subject|0|||
48316599|NCT01135511|155357751|FG004|Overall Study|Withdrawal by Subject|0|||
48316600|NCT01135511|155357752|FG005|Overall Study|Withdrawal by Subject|0|||
48618704|NCT01028391|156459450|FG000|Overall Study|Physician Decision|0|||
48316601|NCT01135511|155357753|FG006|Overall Study|Withdrawal by Subject|1|||
48316602|NCT01135511|155357754|FG007|Overall Study|Withdrawal by Subject|0|||
48316603|NCT01135511|155357755|FG008|Overall Study|Withdrawal by Subject|1|||
48316604|NCT00585533|155357757|FG000|Overall Study|objective or symptomatic progression|9|||
48316605|NCT03740009|155357758|FG000|Overall Study|Physician Decision|9|||
48316606|NCT03740009|155357758|FG000|Overall Study|Lost to Follow-up|1|||
48316607|NCT01254188|155357759|FG000|Overall Study|Disease Progression|6|||
48316608|NCT01254188|155357759|FG000|Overall Study|Protocol Violation|6|||
48316609|NCT01254188|155357759|FG000|Overall Study|Pregnancy|2|||
48316610|NCT01254188|155357759|FG000|Overall Study|Death|4|||
48316611|NCT01254188|155357759|FG000|Overall Study|Lost to Follow-up|5|||
48316612|NCT01254188|155357759|FG000|Overall Study|Withdrawal by Subject|7|||
48316613|NCT01254188|155357759|FG000|Overall Study|Adverse Event|43|||
48316614|NCT01254188|155357759|FG000|Overall Study|per investigator discretion|20|||
48316615|NCT02202499|155357760|FG000|Overall Study|Cancer diagnosis|0|||
48316616|NCT02202499|155357761|FG001|Overall Study|Cancer diagnosis|0|||
48316617|NCT02202499|155357762|FG002|Overall Study|Cancer diagnosis|1|||
48316618|NCT02202499|155357760|FG000|Overall Study|Moved from area|0|||
48316619|NCT02202499|155357761|FG001|Overall Study|Moved from area|0|||
48316620|NCT02202499|155357762|FG002|Overall Study|Moved from area|1|||
48316621|NCT02202499|155357760|FG000|Overall Study|Declined before randomization|1|||
48316622|NCT02202499|155357761|FG001|Overall Study|Declined before randomization|0|||
48316623|NCT02202499|155357762|FG002|Overall Study|Declined before randomization|0|||
48316624|NCT02202499|155357760|FG000|Overall Study|Auto accident|1|||
48316625|NCT02202499|155357761|FG001|Overall Study|Auto accident|0|||
48316626|NCT02202499|155357762|FG002|Overall Study|Auto accident|0|||
48316627|NCT03830866|155357766|FG000|Overall Study|Death|90|||
48316628|NCT03830866|155357767|FG001|Overall Study|Death|111|||
48316629|NCT03830866|155357766|FG000|Overall Study|Lost to Follow-up|7|||
48316630|NCT03830866|155357767|FG001|Overall Study|Lost to Follow-up|7|||
48316631|NCT03830866|155357766|FG000|Overall Study|Withdrawal by Subject|19|||
48316632|NCT03830866|155357767|FG001|Overall Study|Withdrawal by Subject|16|||
48316633|NCT03830866|155357766|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
48316634|NCT03830866|155357767|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
48316635|NCT03830866|155357766|FG000|Overall Study|Other|1|||
48316636|NCT03830866|155357767|FG001|Overall Study|Other|1|||
48316637|NCT03811574|155357773|FG000|Overall Study|Withdrawal by Subject|2|||
48316638|NCT03811574|155357774|FG001|Overall Study|Withdrawal by Subject|4|||
48316639|NCT03811574|155357775|FG002|Overall Study|Withdrawal by Subject|0|||
48316640|NCT03380390|155357776|FG000|Overall Study|Adverse Event|3|||
48316641|NCT01832480|155357777|FG000|Overall Study|Lost to Follow-up|33|||
48316642|NCT01832480|155357778|FG001|Overall Study|Lost to Follow-up|30|||
48316643|NCT01832480|155357777|FG000|Overall Study|Withdrawal by Subject|0|||
48316644|NCT01832480|155357778|FG001|Overall Study|Withdrawal by Subject|2|||
48316645|NCT01832480|155357777|FG000|Overall Study|post randomization ineligible|8|||
48316646|NCT01832480|155357778|FG001|Overall Study|post randomization ineligible|10|||
48316647|NCT02886286|155357780|FG000|Overall Study|pump motor stall|0|||
48316648|NCT02886286|155357781|FG001|Overall Study|pump motor stall|1|||
48316649|NCT00390299|155357783|FG000|Overall Study|Cancellation|1|||
48316650|NCT00390299|155357784|FG001|Overall Study|Cancellation|0|||
48316651|NCT00390299|155357785|FG002|Overall Study|Cancellation|0|||
48316652|NCT00390299|155357786|FG003|Overall Study|Cancellation|0|||
48316653|NCT00390299|155357787|FG004|Overall Study|Cancellation|0|||
48316654|NCT01198028|155357790|FG000|Overall Study|Adverse Event|5|||
48316655|NCT01198028|155357790|FG000|Overall Study|Death|3|||
48316656|NCT01198028|155357790|FG000|Overall Study|Physician Decision|2|||
48316657|NCT00970359|155357793|FG000|Overall Study|Not Treated|4|||
48316658|NCT01565148|155357794|FG000|Overall Study|Withdrawal by Subject|1|||
48316659|NCT01565148|155357795|FG001|Overall Study|Withdrawal by Subject|1|||
48316660|NCT01565148|155357796|FG002|Overall Study|Withdrawal by Subject|1|||
48316661|NCT01565148|155357797|FG003|Overall Study|Withdrawal by Subject|2|||
48316662|NCT01565148|155357794|FG000|Overall Study|Lost to Follow-up|4|||
48316663|NCT01565148|155357795|FG001|Overall Study|Lost to Follow-up|4|||
48316664|NCT01565148|155357796|FG002|Overall Study|Lost to Follow-up|0|||
48316665|NCT01565148|155357797|FG003|Overall Study|Lost to Follow-up|3|||
48316666|NCT01565148|155357794|FG000|Overall Study|Rescue Therapy|8|||
48316667|NCT01565148|155357795|FG001|Overall Study|Rescue Therapy|5|||
48316668|NCT01565148|155357796|FG002|Overall Study|Rescue Therapy|5|||
48316669|NCT01565148|155357797|FG003|Overall Study|Rescue Therapy|8|||
48316670|NCT01565148|155357794|FG000|Overall Study|Death|0|||
48316671|NCT01565148|155357795|FG001|Overall Study|Death|0|||
48316672|NCT01565148|155357796|FG002|Overall Study|Death|1|||
48316673|NCT01565148|155357797|FG003|Overall Study|Death|0|||
48316674|NCT01565148|155357794|FG000|Overall Study|Physician Decision|2|||
48316675|NCT01565148|155357795|FG001|Overall Study|Physician Decision|5|||
48316676|NCT01565148|155357796|FG002|Overall Study|Physician Decision|0|||
48316677|NCT01565148|155357797|FG003|Overall Study|Physician Decision|0|||
48316678|NCT01759771|155357801|FG000|Overall Study|Withdrawal by Subject|1|||
48316679|NCT01759771|155357802|FG001|Overall Study|Withdrawal by Subject|1|||
48316680|NCT00357097|155357803|FG000|Overall Study|Did not meet inclusion criteria|5|||
48316681|NCT00357097|155357804|FG001|Overall Study|Did not meet inclusion criteria|3|||
48316682|NCT00357097|155357803|FG000|Overall Study|Adverse Event|34|||
48316683|NCT00357097|155357804|FG001|Overall Study|Adverse Event|6|||
48316684|NCT00357097|155357803|FG000|Overall Study|Withdrawal by Subject|8|||
48316685|NCT00357097|155357804|FG001|Overall Study|Withdrawal by Subject|7|||
48316686|NCT00357097|155357803|FG000|Overall Study|Non-compliance|1|||
48316687|NCT00357097|155357804|FG001|Overall Study|Non-compliance|2|||
48316688|NCT00357097|155357803|FG000|Overall Study|Lack of Efficacy|2|||
48316689|NCT00357097|155357804|FG001|Overall Study|Lack of Efficacy|8|||
48316690|NCT00357097|155357803|FG000|Overall Study|Met Exclusion Criteria|3|||
48316691|NCT00357097|155357804|FG001|Overall Study|Met Exclusion Criteria|1|||
48316692|NCT00357097|155357803|FG000|Overall Study|Other|1|||
48316693|NCT00357097|155357804|FG001|Overall Study|Other|1|||
48316694|NCT00357097|155357803|FG000|Overall Study|Increase of RLS Symptoms|0|||
48316695|NCT00357097|155357804|FG001|Overall Study|Increase of RLS Symptoms|1|||
48316696|NCT02528188|155357805|FG000|Overall Study|Adverse Event|23|||
48316697|NCT02528188|155357806|FG001|Overall Study|Adverse Event|22|||
48316698|NCT02528188|155357807|FG002|Overall Study|Adverse Event|8|||
48316699|NCT02528188|155357805|FG000|Overall Study|Protocol Violation|4|||
48316700|NCT02528188|155357806|FG001|Overall Study|Protocol Violation|6|||
48316701|NCT02528188|155357807|FG002|Overall Study|Protocol Violation|4|||
48316702|NCT02528188|155357805|FG000|Overall Study|Lack of Efficacy|19|||
48316703|NCT02528188|155357806|FG001|Overall Study|Lack of Efficacy|21|||
48316704|NCT02528188|155357807|FG002|Overall Study|Lack of Efficacy|22|||
48316705|NCT02528188|155357805|FG000|Overall Study|Withdrawal by Subject|97|||
48316706|NCT02528188|155357806|FG001|Overall Study|Withdrawal by Subject|104|||
48316707|NCT02528188|155357807|FG002|Overall Study|Withdrawal by Subject|100|||
48316708|NCT02528188|155357805|FG000|Overall Study|Lost to Follow-up|25|||
48316709|NCT02528188|155357806|FG001|Overall Study|Lost to Follow-up|21|||
48316710|NCT02528188|155357807|FG002|Overall Study|Lost to Follow-up|31|||
48316711|NCT02528188|155357805|FG000|Overall Study|Death|4|||
48316712|NCT02528188|155357806|FG001|Overall Study|Death|4|||
48316713|NCT02528188|155357807|FG002|Overall Study|Death|0|||
48316714|NCT02528188|155357805|FG000|Overall Study|Other|89|||
48316715|NCT02528188|155357806|FG001|Overall Study|Other|91|||
48316716|NCT02528188|155357807|FG002|Overall Study|Other|74|||
48316717|NCT02528188|155357805|FG000|Overall Study|Randomized but not treated|6|||
48316718|NCT02528188|155357806|FG001|Overall Study|Randomized but not treated|7|||
48618705|NCT01028391|156459451|FG001|Overall Study|Physician Decision|1|||
48316719|NCT02528188|155357807|FG002|Overall Study|Randomized but not treated|12|||
48316720|NCT00529659|155357810|FG000|Overall Study|Adverse Event|8|||
48316721|NCT00529659|155357811|FG001|Overall Study|Adverse Event|7|||
48316722|NCT00529659|155357810|FG000|Overall Study|Lost to Follow-up|0|||
48316723|NCT00529659|155357811|FG001|Overall Study|Lost to Follow-up|2|||
48316724|NCT00529659|155357810|FG000|Overall Study|Physician Decision|0|||
48316725|NCT00529659|155357811|FG001|Overall Study|Physician Decision|2|||
48316726|NCT00529659|155357810|FG000|Overall Study|Protocol Violation|2|||
48316727|NCT00529659|155357811|FG001|Overall Study|Protocol Violation|6|||
48316728|NCT00529659|155357810|FG000|Overall Study|Withdrawal by Subject|1|||
48316729|NCT00529659|155357811|FG001|Overall Study|Withdrawal by Subject|6|||
48316730|NCT03062358|155357812|FG000|Overall Study|Death|220|||
48316731|NCT03062358|155357813|FG001|Overall Study|Death|127|||
48316732|NCT03062358|155357812|FG000|Overall Study|Withdrawal by Subject|2|||
48316733|NCT03062358|155357813|FG001|Overall Study|Withdrawal by Subject|1|||
48316734|NCT03062358|155357812|FG000|Overall Study|Ongoing in Trial|78|||
48316735|NCT03062358|155357813|FG001|Overall Study|Ongoing in Trial|25|||
48316736|NCT01616459|155357818|FG000|Overall Study|Adverse Event|1|||
48316737|NCT01616459|155357819|FG001|Overall Study|Adverse Event|1|||
48316738|NCT01616459|155357820|FG002|Overall Study|Adverse Event|2|||
48316739|NCT01616459|155357821|FG003|Overall Study|Adverse Event|0|||
48316740|NCT01616459|155357818|FG000|Overall Study|Lost to Follow-up|1|||
48316741|NCT01616459|155357819|FG001|Overall Study|Lost to Follow-up|11|||
48316742|NCT01616459|155357820|FG002|Overall Study|Lost to Follow-up|3|||
48316743|NCT01616459|155357821|FG003|Overall Study|Lost to Follow-up|2|||
48316744|NCT01616459|155357818|FG000|Overall Study|Protocol Violation|0|||
48316745|NCT01616459|155357819|FG001|Overall Study|Protocol Violation|0|||
48316746|NCT01616459|155357820|FG002|Overall Study|Protocol Violation|0|||
48316747|NCT01616459|155357821|FG003|Overall Study|Protocol Violation|2|||
48316748|NCT01616459|155357818|FG000|Overall Study|Withdrawal by Subject|2|||
48316749|NCT01616459|155357819|FG001|Overall Study|Withdrawal by Subject|4|||
48316750|NCT01616459|155357820|FG002|Overall Study|Withdrawal by Subject|4|||
48316751|NCT01616459|155357821|FG003|Overall Study|Withdrawal by Subject|4|||
48316752|NCT01616459|155357818|FG000|Overall Study|Other reason|0|||
48316753|NCT01616459|155357819|FG001|Overall Study|Other reason|1|||
48316754|NCT01616459|155357820|FG002|Overall Study|Other reason|1|||
48316755|NCT01616459|155357821|FG003|Overall Study|Other reason|0|||
48316756|NCT02531113|155357822|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
48316757|NCT02531113|155357822|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
48316758|NCT02531113|155357822|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
48316759|NCT02531113|155357822|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
48316760|NCT02531113|155357822|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
48316761|NCT02531113|155357822|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
48316762|NCT02531113|155357822|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
48316763|NCT02531113|155357822|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
48316764|NCT01875250|155359011|FG000|Overall Study|Adverse Event|2|||
48316765|NCT01875250|155359012|FG001|Overall Study|Adverse Event|0|||
48316766|NCT02466516|155359013|FG000|Overall Study|Adverse Event|1|||
48316767|NCT02466516|155359014|FG001|Overall Study|Adverse Event|1|||
48316768|NCT02466516|155359015|FG002|Overall Study|Adverse Event|0|||
48316769|NCT02466516|155359016|FG003|Overall Study|Adverse Event|0|||
48316770|NCT02466516|155359017|FG004|Overall Study|Adverse Event|0|||
48316771|NCT02466516|155359013|FG000|Overall Study|Withdrew Consent|1|||
48316772|NCT02466516|155359014|FG001|Overall Study|Withdrew Consent|0|||
48316773|NCT02466516|155359015|FG002|Overall Study|Withdrew Consent|0|||
48316774|NCT02466516|155359016|FG003|Overall Study|Withdrew Consent|0|||
48316775|NCT02466516|155359017|FG004|Overall Study|Withdrew Consent|0|||
48316776|NCT02466516|155359013|FG000|Overall Study|Lost to Follow-up|2|||
48316777|NCT02466516|155359014|FG001|Overall Study|Lost to Follow-up|0|||
48316778|NCT02466516|155359015|FG002|Overall Study|Lost to Follow-up|1|||
48316779|NCT02466516|155359016|FG003|Overall Study|Lost to Follow-up|0|||
48316780|NCT02466516|155359017|FG004|Overall Study|Lost to Follow-up|0|||
48316781|NCT00482729|155359018|FG000|Overall Study|Adverse Event|29|||
48316782|NCT00482729|155359019|FG001|Overall Study|Adverse Event|33|||
48316783|NCT00482729|155359018|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
48316784|NCT00482729|155359019|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
48316785|NCT00482729|155359018|FG000|Overall Study|Hyperglycemia Criteria|7|||
48618706|NCT01028391|156459450|FG000|Overall Study|Withdrawal by Subject|6|||
48618707|NCT01028391|156459451|FG001|Overall Study|Withdrawal by Subject|3|||
48618708|NCT01028391|156459450|FG000|Overall Study|Needed excluded medication|1|||
48618709|NCT01028391|156459451|FG001|Overall Study|Needed excluded medication|1|||
48618710|NCT03259308|156459452|FG000|Overall Study|Adverse Event|5|||
48316786|NCT00482729|155359019|FG001|Overall Study|Hyperglycemia Criteria|5|||
48316787|NCT00482729|155359018|FG000|Overall Study|Lack of Efficacy|4|||
48316788|NCT00482729|155359019|FG001|Overall Study|Lack of Efficacy|16|||
48316789|NCT00482729|155359018|FG000|Overall Study|Lost to Follow-up|86|||
48316790|NCT00482729|155359019|FG001|Overall Study|Lost to Follow-up|66|||
48316791|NCT00482729|155359018|FG000|Overall Study|Physician Decision|10|||
48316792|NCT00482729|155359019|FG001|Overall Study|Physician Decision|7|||
48316793|NCT00482729|155359018|FG000|Overall Study|Pregnancy|4|||
48316794|NCT00482729|155359019|FG001|Overall Study|Pregnancy|2|||
48316795|NCT00482729|155359018|FG000|Overall Study|Protocol Violation|10|||
48316796|NCT00482729|155359019|FG001|Overall Study|Protocol Violation|18|||
48316797|NCT00482729|155359018|FG000|Overall Study|Withdrawal by Subject|67|||
48316798|NCT00482729|155359019|FG001|Overall Study|Withdrawal by Subject|69|||
48316799|NCT02396316|155359022|FG000|Overall Study|Physician Decision|1|||
48316800|NCT02396316|155359023|FG001|Overall Study|Physician Decision|0|||
48316801|NCT02396316|155359022|FG000|Overall Study|Progressive disease|6|||
48316802|NCT02396316|155359023|FG001|Overall Study|Progressive disease|3|||
48316803|NCT02396316|155359022|FG000|Overall Study|Protocol Violation|0|||
48316804|NCT02396316|155359023|FG001|Overall Study|Protocol Violation|1|||
48316805|NCT02396316|155359022|FG000|Overall Study|Treatment unblinded|0|||
48316806|NCT02396316|155359023|FG001|Overall Study|Treatment unblinded|1|||
48316807|NCT01875848|155359025|FG000|Overall Study|Withdrawal by Subject|2|||
48316808|NCT01875848|155359026|FG001|Overall Study|Withdrawal by Subject|0|||
48316809|NCT00925587|155359027|FG000|Overall Study|Protocol Specified Criteria|6|||
48316810|NCT00925587|155359028|FG001|Overall Study|Protocol Specified Criteria|6|||
48316811|NCT00925587|155359027|FG000|Overall Study|Physician Decision|4|||
48316812|NCT00925587|155359028|FG001|Overall Study|Physician Decision|1|||
48316813|NCT00925587|155359027|FG000|Overall Study|Protocol Violation|6|||
48618711|NCT03259308|156459453|FG001|Overall Study|Adverse Event|4|||
48316814|NCT00925587|155359028|FG001|Overall Study|Protocol Violation|4|||
48316815|NCT00925587|155359027|FG000|Overall Study|Withdrawal by Subject|9|||
48316816|NCT00925587|155359028|FG001|Overall Study|Withdrawal by Subject|6|||
48316817|NCT00925587|155359027|FG000|Overall Study|Death|5|||
48618712|NCT03259308|156459454|FG002|Overall Study|Adverse Event|1|||
48618713|NCT03259308|156459452|FG000|Overall Study|Withdrawal by Subject|2|||
48618714|NCT03259308|156459453|FG001|Overall Study|Withdrawal by Subject|1|||
48618715|NCT03259308|156459454|FG002|Overall Study|Withdrawal by Subject|3|||
48316818|NCT00925587|155359028|FG001|Overall Study|Death|5|||
48316819|NCT00925587|155359027|FG000|Overall Study|Adverse Event|6|||
48316820|NCT00925587|155359028|FG001|Overall Study|Adverse Event|2|||
48316821|NCT00925587|155359027|FG000|Overall Study|Lost to Follow-up|0|||
48316822|NCT00925587|155359028|FG001|Overall Study|Lost to Follow-up|1|||
48316823|NCT01198275|155359029|FG000|Overall Study|Adverse Event|2|||
48316824|NCT01198275|155359030|FG001|Overall Study|Adverse Event|3|||
48316825|NCT01198275|155359029|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
48316826|NCT01198275|155359030|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
48316827|NCT00941655|155359031|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
48316828|NCT00941655|155359032|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
48316829|NCT00941655|155359031|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
48618716|NCT03259308|156459452|FG000|Overall Study|Lost to Follow-up|0|||
48618717|NCT03259308|156459453|FG001|Overall Study|Lost to Follow-up|0|||
48618718|NCT03259308|156459454|FG002|Overall Study|Lost to Follow-up|1|||
48618719|NCT03259308|156459452|FG000|Overall Study|Pregnancy|0|||
48618720|NCT03259308|156459453|FG001|Overall Study|Pregnancy|0|||
48618721|NCT03259308|156459454|FG002|Overall Study|Pregnancy|1|||
48618722|NCT03259308|156459452|FG000|Overall Study|Protocol Deviation|0|||
48618723|NCT03259308|156459453|FG001|Overall Study|Protocol Deviation|3|||
48316830|NCT00941655|155359032|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
48316831|NCT00941655|155359031|FG000|Overall Study|progressed while on chemo|0|||
48316832|NCT00941655|155359032|FG001|Overall Study|progressed while on chemo|2|||
48316833|NCT00941655|155359031|FG000|Overall Study|refused further treatment|0|||
48316834|NCT00941655|155359032|FG001|Overall Study|refused further treatment|1|||
48316835|NCT00941655|155359031|FG000|Overall Study|withdrew consent|0|||
48316836|NCT00941655|155359032|FG001|Overall Study|withdrew consent|1|||
48316837|NCT00941655|155359031|FG000|Overall Study|non-compliant|0|||
48316838|NCT00941655|155359032|FG001|Overall Study|non-compliant|1|||
48316839|NCT00446550|155359034|FG000|Overall Study|Adverse Event|1|||
48316840|NCT00446550|155359035|FG001|Overall Study|Adverse Event|0|||
48316841|NCT01759264|155359036|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
48316842|NCT01759264|155359036|FG000|Overall Study|Adverse Event|1|||
48316843|NCT01759264|155359036|FG000|Overall Study|Other|2|||
48316844|NCT01759264|155359036|FG000|Overall Study|Lost to Follow-up|2|||
48316845|NCT01759264|155359036|FG000|Overall Study|Withdrawal by Subject|3|||
48316846|NCT01759264|155359036|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
48316847|NCT00516321|155359037|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
48316848|NCT00516321|155359038|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
48316849|NCT00516321|155359039|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
48316850|NCT00516321|155359037|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
48316851|NCT00516321|155359038|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
48316852|NCT00516321|155359039|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
48316853|NCT00516321|155359037|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
48316854|NCT00516321|155359038|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
48316855|NCT00516321|155359039|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
48316856|NCT00516321|155359037|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
48316857|NCT00516321|155359038|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
48316858|NCT00516321|155359039|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
48316859|NCT00516321|155359037|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
48316860|NCT00516321|155359038|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
48316861|NCT00516321|155359039|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
48316862|NCT00516321|155359037|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
48316863|NCT00516321|155359038|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
48316864|NCT00516321|155359039|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
48316865|NCT00516321|155359037|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
48316866|NCT00516321|155359038|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
48316867|NCT00516321|155359039|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
48316868|NCT00516321|155359037|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
48316869|NCT00516321|155359038|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
48316870|NCT00516321|155359039|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
48316871|NCT00516321|155359037|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
48316872|NCT00516321|155359038|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
48316873|NCT00516321|155359039|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
48316874|NCT00516321|155359037|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
48618724|NCT03259308|156459454|FG002|Overall Study|Protocol Deviation|0|||
48618725|NCT03259308|156459452|FG000|Overall Study|Lack of Efficacy|0|||
48618726|NCT03259308|156459453|FG001|Overall Study|Lack of Efficacy|0|||
48316875|NCT00516321|155359038|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
48316876|NCT00516321|155359039|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
48316877|NCT00516321|155359037|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
48316878|NCT00516321|155359038|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
48316879|NCT00516321|155359039|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
48316880|NCT04218110|155359042|FG000|Overall Study|Withdrawal by Subject|0|||
48316881|NCT04218110|155359043|FG001|Overall Study|Withdrawal by Subject|0|||
48316882|NCT04218110|155359044|FG002|Overall Study|Withdrawal by Subject|0|||
48316883|NCT04218110|155359045|FG003|Overall Study|Withdrawal by Subject|1|||
48316884|NCT01066923|155359048|FG000|Overall Study|Withdrawal by Subject|3|||
48316885|NCT01066923|155359049|FG001|Overall Study|Withdrawal by Subject|3|||
48316886|NCT01066923|155359050|FG002|Overall Study|Withdrawal by Subject|8|||
48316887|NCT01066923|155359051|FG003|Overall Study|Withdrawal by Subject|8|||
48316888|NCT01171625|155359053|FG000|Overall Study|On-Protocol|67|||
48316889|NCT01171625|155359053|FG000|Overall Study|Death|38|||
48316890|NCT01171625|155359053|FG000|Overall Study|Withdrawal by Subject|31|||
48316891|NCT01171625|155359053|FG000|Overall Study|Explanted|10|||
48316892|NCT01171625|155359053|FG000|Overall Study|Lost to Follow-up|5|||
48316893|NCT01171625|155359053|FG000|Overall Study|Patient received valve-in-valve|3|||
48316894|NCT01171625|155359053|FG000|Overall Study|Other|1|||
48316895|NCT01171625|155359053|FG000|Overall Study|Consented but did not receive device|25|||
48316896|NCT03557008|155359055|FG000|Overall Study|Withdrawal by Subject|2|||
48316897|NCT03557008|155359056|FG001|Overall Study|Withdrawal by Subject|2|||
48316898|NCT03557008|155359055|FG000|Overall Study|Early termination from study|3|||
48316899|NCT03557008|155359056|FG001|Overall Study|Early termination from study|1|||
48316900|NCT01318382|155359057|FG000|Overall Study|Physician Decision|2|||
48316901|NCT01318382|155359057|FG000|Overall Study|Device Malfunction|10|||
48316902|NCT01318382|155359057|FG000|Overall Study|Protocol Violation|1|||
48316903|NCT00743444|155359060|FG000|First Intervention|Catheter placement problems|0|||
48316904|NCT00743444|155359061|FG001|First Intervention|Catheter placement problems|1|||
48316905|NCT00743444|155359060|FG000|Washout Period|Adverse Event|0|||
48316906|NCT00743444|155359061|FG001|Washout Period|Adverse Event|1|||
48316907|NCT01337635|155359068|FG000|Overall Study|Lost to Follow-up|0|||
48316908|NCT01337635|155359069|FG001|Overall Study|Lost to Follow-up|1|||
48316909|NCT00979992|155359076|FG000|Overall Study|Ineligible - inadequate pathology|1|||
48316910|NCT00979992|155359076|FG000|Overall Study|Ineligible - wrong cell type|2|||
48316911|NCT00979992|155359076|FG000|Overall Study|Refused - Never Treated|2|||
48316912|NCT00309907|155359079|FG000|Overall Study|Death|4|||
48316913|NCT00309907|155359079|FG000|Overall Study|Physician Decision|1|||
48316914|NCT00309907|155359079|FG000|Overall Study|Ineligible|11|||
48316915|NCT00309907|155359079|FG000|Overall Study|Major infectious event|4|||
48316916|NCT02969863|155359080|FG000|Overall Study|Physician Decision|1|||
48316917|NCT02969863|155359081|FG001|Overall Study|Physician Decision|0|||
48316918|NCT02969863|155359082|FG002|Overall Study|Physician Decision|0|||
48316919|NCT02969863|155359083|FG003|Overall Study|Physician Decision|0|||
48316920|NCT02969863|155359084|FG004|Overall Study|Physician Decision|0|||
48316921|NCT02969863|155359085|FG005|Overall Study|Physician Decision|0|||
48316922|NCT00293293|155359086|FG000|Overall Study|Withdrawal by Subject|1|||
48316923|NCT00293293|155359087|FG001|Overall Study|Withdrawal by Subject|1|||
48316924|NCT00293293|155359086|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
48316925|NCT00293293|155359087|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
48316926|NCT00293293|155359086|FG000|Overall Study|Patient discontinued chemotherapy|0|||
48316927|NCT00293293|155359087|FG001|Overall Study|Patient discontinued chemotherapy|1|||
48316928|NCT00638963|155359088|FG000|Overall Study|Withdrawal by Subject|1|||
48316929|NCT00638963|155359089|FG001|Overall Study|Withdrawal by Subject|0|||
48316930|NCT01185782|155359092|FG000|Overall Study|Adverse Event|0|||
48316931|NCT01185782|155359093|FG001|Overall Study|Adverse Event|1|||
48316932|NCT01185782|155359092|FG000|Overall Study|Protocol Violation|1|||
48316933|NCT01185782|155359093|FG001|Overall Study|Protocol Violation|0|||
48316934|NCT01185782|155359092|FG000|Overall Study|Poor Response to Treatment|3|||
48316935|NCT01185782|155359093|FG001|Overall Study|Poor Response to Treatment|1|||
48316936|NCT01185782|155359092|FG000|Overall Study|Other|2|||
48316937|NCT01185782|155359093|FG001|Overall Study|Other|5|||
48316938|NCT01185782|155359092|FG000|Overall Study|Randomized but not treated|0|||
48316939|NCT01185782|155359093|FG001|Overall Study|Randomized but not treated|4|||
48316940|NCT05082935|155359097|FG000|Overall Study|Lost to Follow-up|549|||
48316941|NCT05082935|155359098|FG001|Overall Study|Lost to Follow-up|631|||
48316942|NCT05082935|155359097|FG000|Overall Study|Withdrawal by Subject|27|||
48316943|NCT05082935|155359098|FG001|Overall Study|Withdrawal by Subject|58|||
48316944|NCT05382104|155359099|FG000|Period 2 (2 Days)|Adverse Event|0|||
48316945|NCT05382104|155359100|FG001|Period 2 (2 Days)|Adverse Event|1|||
48316946|NCT05382104|155359101|FG002|Period 2 (2 Days)|Adverse Event|0|||
48316947|NCT05382104|155359102|FG003|Period 2 (2 Days)|Adverse Event|0|||
48316948|NCT05382104|155359103|FG004|Period 2 (2 Days)|Adverse Event|0|||
48316949|NCT05382104|155359104|FG005|Period 2 (2 Days)|Adverse Event|0|||
48316950|NCT02957136|155359105|FG000|Overall Study|Withdrawal by Subject|2|||
48316951|NCT02957136|155359106|FG001|Overall Study|Withdrawal by Subject|1|||
48316952|NCT00439569|155359110|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
48316953|NCT00439569|155359110|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
48316954|NCT00439569|155359110|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
48316955|NCT02423291|155359112|FG000|Overall Study|Lack of Efficacy|14|||
48316956|NCT02423291|155359112|FG000|Overall Study|Adverse Event|1|||
48316957|NCT01264679|155359118|FG000|Overall Study|Participation in Another Clinical Trial|1|||
48316958|NCT01264679|155359118|FG000|Overall Study|Physician Decision|1|||
48316959|NCT01264679|155359118|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
48316960|NCT01264679|155359118|FG000|Overall Study|Withdrawal by Subject|1|||
48316961|NCT03475316|155359119|FG000|6 Month Intervention|Adverse Event|2|||
48316962|NCT03475316|155359120|FG001|6 Month Intervention|Adverse Event|1|||
48316963|NCT03475316|155359119|FG000|6 Month Intervention|Withdrawal by Subject|2|||
48316964|NCT03475316|155359120|FG001|6 Month Intervention|Withdrawal by Subject|0|||
48316965|NCT03475316|155359119|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
48316966|NCT03475316|155359120|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
48316967|NCT03475316|155359119|FG000|9 Months|Study stopped due to COVID pandemic|3|||
48316968|NCT03475316|155359120|FG001|9 Months|Study stopped due to COVID pandemic|4|||
48316969|NCT02115139|155359128|FG000|Overall Study|Protocol Violation|1|||
48316970|NCT02115139|155359128|FG000|Overall Study|treatment discontinuation|6|||
48316971|NCT03403413|155359129|FG000|Overall Study|Lack of Efficacy|2|||
48316972|NCT03684044|155359132|FG000|Overall Study|Adverse Event|3|||
48316973|NCT03684044|155359133|FG001|Overall Study|Adverse Event|0|||
48316974|NCT03684044|155359132|FG000|Overall Study|Death|4|||
48316975|NCT03684044|155359133|FG001|Overall Study|Death|7|||
48316976|NCT03684044|155359132|FG000|Overall Study|Lost to Follow-up|3|||
48316977|NCT03684044|155359133|FG001|Overall Study|Lost to Follow-up|2|||
48316978|NCT03684044|155359132|FG000|Overall Study|Patient Not Available|0|||
48316979|NCT03684044|155359133|FG001|Overall Study|Patient Not Available|2|||
48316980|NCT03684044|155359132|FG000|Overall Study|Physician Decision|1|||
48316981|NCT03684044|155359133|FG001|Overall Study|Physician Decision|0|||
48316982|NCT03684044|155359132|FG000|Overall Study|Withdrawal by Subject|11|||
48316983|NCT03684044|155359133|FG001|Overall Study|Withdrawal by Subject|9|||
48316984|NCT03233633|155359134|FG000|Overall Study|Adverse Event|2|||
48316985|NCT03233633|155359134|FG000|Overall Study|Less Than 3 Days of Data|6|||
48316986|NCT04740164|155359135|FG000|Overall Study|Lack of Efficacy|4|||
48316987|NCT04740164|155359136|FG001|Overall Study|Lack of Efficacy|0|||
48316988|NCT04740164|155359135|FG000|Overall Study|Physician Decision|3|||
48316989|NCT04740164|155359136|FG001|Overall Study|Physician Decision|3|||
48316990|NCT01144468|155360466|FG000|Overall Study|Lost to Follow-up|4|||
48316991|NCT01144468|155360467|FG001|Overall Study|Lost to Follow-up|7|||
48316992|NCT01144468|155360466|FG000|Overall Study|Adverse Event|3|||
48316993|NCT01144468|155360467|FG001|Overall Study|Adverse Event|2|||
48316994|NCT01144468|155360466|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
48316995|NCT01144468|155360467|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
48316996|NCT04722003|155360470|FG000|Overall Study|Lost to Follow-up|2|||
48316997|NCT04722003|155360471|FG001|Overall Study|Lost to Follow-up|0|||
48316998|NCT04722003|155360470|FG000|Overall Study|Physician Decision|1|||
48316999|NCT04722003|155360471|FG001|Overall Study|Physician Decision|0|||
48317000|NCT01811706|155360476|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
48317001|NCT01811706|155360477|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
48317002|NCT01867216|155360479|FG000|Overall Study|Withdrawal by Subject|2|||
48317003|NCT01867216|155360480|FG001|Overall Study|Withdrawal by Subject|0|||
48317004|NCT01867216|155360481|FG002|Overall Study|Withdrawal by Subject|0|||
48317005|NCT01867216|155360482|FG003|Overall Study|Withdrawal by Subject|0|||
48317006|NCT01867216|155360483|FG004|Overall Study|Withdrawal by Subject|1|||
48317007|NCT01867216|155360484|FG005|Overall Study|Withdrawal by Subject|0|||
48317008|NCT01867216|155360485|FG006|Overall Study|Withdrawal by Subject|1|||
48317009|NCT01867216|155360479|FG000|Overall Study|Physician Decision|1|||
48317010|NCT01867216|155360480|FG001|Overall Study|Physician Decision|0|||
48317011|NCT01867216|155360481|FG002|Overall Study|Physician Decision|0|||
48317012|NCT01867216|155360482|FG003|Overall Study|Physician Decision|0|||
48317013|NCT01867216|155360483|FG004|Overall Study|Physician Decision|0|||
48317014|NCT01867216|155360484|FG005|Overall Study|Physician Decision|0|||
48317015|NCT01867216|155360485|FG006|Overall Study|Physician Decision|0|||
48317016|NCT01867216|155360479|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
48317017|NCT01867216|155360480|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48317018|NCT01867216|155360481|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48317019|NCT01867216|155360482|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48317020|NCT01867216|155360483|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48317021|NCT01867216|155360484|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48317022|NCT01867216|155360485|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
48317023|NCT03454529|155360486|FG000|Overall Study|Did not receive treatment|6|||
48317024|NCT03454529|155360486|FG000|Overall Study|Received < 80% doses|1|||
48317025|NCT02918279|155360494|FG000|Overall Study|Lost to Follow-up|3|||
48618727|NCT03259308|156459454|FG002|Overall Study|Lack of Efficacy|1|||
48618728|NCT01108055|156459455|FG000|Overall Study|Ineligible|11|||
48618729|NCT01108055|156459455|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
48618730|NCT03339453|156459458|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
48618731|NCT03339453|156459459|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
48618732|NCT03158311|156459462|FG000|Overall Study|Subject/Guardian Decision|10|||
48618733|NCT03158311|156459463|FG001|Overall Study|Subject/Guardian Decision|6|||
48618734|NCT03158311|156459464|FG002|Overall Study|Subject/Guardian Decision|11|||
48618735|NCT03158311|156459462|FG000|Overall Study|Adverse Event|5|||
48618736|NCT03158311|156459463|FG001|Overall Study|Adverse Event|3|||
48618737|NCT03158311|156459464|FG002|Overall Study|Adverse Event|3|||
48618738|NCT03158311|156459462|FG000|Overall Study|Techinical Problems|3|||
48618739|NCT03158311|156459463|FG001|Overall Study|Techinical Problems|1|||
48618740|NCT03158311|156459464|FG002|Overall Study|Techinical Problems|5|||
48618741|NCT03158311|156459462|FG000|Overall Study|Physician Decision|2|||
48618742|NCT03158311|156459463|FG001|Overall Study|Physician Decision|3|||
48618743|NCT03158311|156459464|FG002|Overall Study|Physician Decision|7|||
48618744|NCT03158311|156459462|FG000|Overall Study|Lost to Follow-up|1|||
48618745|NCT03158311|156459463|FG001|Overall Study|Lost to Follow-up|1|||
48618746|NCT03158311|156459464|FG002|Overall Study|Lost to Follow-up|1|||
48618747|NCT03158311|156459462|FG000|Overall Study|Sponsor decision|1|||
48618748|NCT03158311|156459463|FG001|Overall Study|Sponsor decision|0|||
48618749|NCT03158311|156459464|FG002|Overall Study|Sponsor decision|0|||
48618750|NCT03158311|156459462|FG000|Overall Study|Pregnancy|0|||
48618751|NCT03158311|156459463|FG001|Overall Study|Pregnancy|2|||
48618752|NCT03158311|156459464|FG002|Overall Study|Pregnancy|0|||
48317026|NCT02918279|155360495|FG001|Overall Study|Lost to Follow-up|6|||
48317027|NCT02918279|155360494|FG000|Overall Study|Withdrawal by Subject|5|||
48317028|NCT02918279|155360495|FG001|Overall Study|Withdrawal by Subject|15|||
48317029|NCT02918279|155360494|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48317030|NCT02918279|155360495|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48317031|NCT02918279|155360494|FG000|Overall Study|Other|3|||
48317032|NCT02918279|155360495|FG001|Overall Study|Other|1|||
48317033|NCT01190007|155360496|FG000|Overall Study|Withdrawal by Subject|4|||
48317034|NCT01190007|155360496|FG000|Overall Study|Adverse Event|8|||
48317035|NCT01190007|155360496|FG000|Overall Study|Difficulty of visit for complications|1|||
48317036|NCT01190007|155360496|FG000|Overall Study|Participant was arrested|1|||
48317037|NCT00869258|155360499|FG000|Overall Study|Physician Decision|1|||
48317038|NCT00636207|155360500|FG000|Overall Study|Adverse Event|1|||
48317039|NCT00636207|155360501|FG001|Overall Study|Adverse Event|0|||
48317040|NCT00636207|155360502|FG002|Overall Study|Adverse Event|0|||
48317041|NCT00636207|155360503|FG003|Overall Study|Adverse Event|0|||
48317042|NCT00636207|155360504|FG004|Overall Study|Adverse Event|0|||
48317043|NCT00636207|155360505|FG005|Overall Study|Adverse Event|0|||
48317044|NCT00636207|155360506|FG006|Overall Study|Adverse Event|0|||
48317045|NCT00636207|155360500|FG000|Overall Study|Withdrawal by Subject|0|||
48317046|NCT00636207|155360501|FG001|Overall Study|Withdrawal by Subject|1|||
48317047|NCT00636207|155360502|FG002|Overall Study|Withdrawal by Subject|0|||
48317048|NCT00636207|155360503|FG003|Overall Study|Withdrawal by Subject|0|||
48317049|NCT00636207|155360504|FG004|Overall Study|Withdrawal by Subject|1|||
48317050|NCT00636207|155360505|FG005|Overall Study|Withdrawal by Subject|0|||
48317051|NCT00636207|155360506|FG006|Overall Study|Withdrawal by Subject|0|||
48317052|NCT00666276|155360510|FG000|Overall Study|Protocol Violation|34|||
48317053|NCT02529995|155360511|FG000|Part A|Ongoing Study at Data Cut-off|14|||
48317054|NCT02529995|155360512|FG001|Part A|Ongoing Study at Data Cut-off|16|||
48317055|NCT02529995|155360511|FG000|Part A|Discontinued Study|1|||
48317056|NCT02529995|155360512|FG001|Part A|Discontinued Study|0|||
48317057|NCT02529995|155360511|FG000|Part B|Ongoing Study at Data Cut-off|0|||
48317058|NCT02529995|155360512|FG001|Part B|Ongoing Study at Data Cut-off|7|||
48317059|NCT02529995|155360511|FG000|Part B|Discontinued Study|6|||
48317060|NCT02529995|155360512|FG001|Part B|Discontinued Study|5|||
48317061|NCT03844269|155360515|FG000|Overall Study|Withdrawal pre-intervention|1|||
48317062|NCT03844269|155360515|FG000|Overall Study|Did not complete the intervention|2|||
48317063|NCT00665444|155360518|FG000|Overall Study|Physician Decision|1|||
48317064|NCT00665444|155360518|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
48317065|NCT00101010|155360519|FG000|Overall Study|Physician Decision|1|||
48317066|NCT02706717|155360521|FG000|Overall Study|Withdrawal by Subject|1|||
48317067|NCT02706717|155360522|FG001|Overall Study|Withdrawal by Subject|8|||
48317068|NCT02706717|155360521|FG000|Overall Study|Lost to Follow-up|0|||
48317069|NCT02706717|155360522|FG001|Overall Study|Lost to Follow-up|1|||
48317070|NCT02706717|155360521|FG000|Overall Study|Physician Decision|0|||
48317071|NCT02706717|155360522|FG001|Overall Study|Physician Decision|1|||
48317072|NCT02706717|155360521|FG000|Overall Study|Death|0|||
48317073|NCT02706717|155360522|FG001|Overall Study|Death|1|||
48317074|NCT00444600|155360524|FG000|Overall Study|Death|7|||
48317075|NCT00444600|155360525|FG001|Overall Study|Death|5|||
48317076|NCT00444600|155360526|FG002|Overall Study|Death|3|||
48317077|NCT00444600|155360527|FG003|Overall Study|Death|2|||
48317078|NCT00444600|155360524|FG000|Overall Study|Dropped|11|||
48317079|NCT00444600|155360525|FG001|Overall Study|Dropped|11|||
48317080|NCT00444600|155360526|FG002|Overall Study|Dropped|7|||
48317081|NCT00444600|155360527|FG003|Overall Study|Dropped|7|||
48317082|NCT00444600|155360524|FG000|Overall Study|Missed visit|1|||
48317083|NCT00444600|155360525|FG001|Overall Study|Missed visit|0|||
48317084|NCT00444600|155360526|FG002|Overall Study|Missed visit|0|||
48317085|NCT00444600|155360527|FG003|Overall Study|Missed visit|1|||
48317086|NCT05132478|155360528|FG000|Overall Study|did not complete survey after consent|1|||
48317087|NCT05132478|155360529|FG001|Overall Study|did not complete survey after consent|1|||
48317088|NCT05132478|155360528|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
48317089|NCT05132478|155360529|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
48317090|NCT00457743|155360530|FG000|Overall Study|Adverse Event|0|||
48317091|NCT00457743|155360531|FG001|Overall Study|Adverse Event|4|||
48317092|NCT00457743|155360532|FG002|Overall Study|Adverse Event|0|||
48317093|NCT00457743|155360530|FG000|Overall Study|Lack of Efficacy|3|||
48317094|NCT00457743|155360531|FG001|Overall Study|Lack of Efficacy|23|||
48317095|NCT00457743|155360532|FG002|Overall Study|Lack of Efficacy|3|||
48317096|NCT01943916|155360537|FG000|Overall Study|Technically invalid images|10|||
48317097|NCT01943916|155360537|FG000|Overall Study|Enrollment Failure|23|||
48317098|NCT01943916|155360537|FG000|Overall Study|Pilot Phase exclusion|100|||
48317099|NCT01943916|155360537|FG000|Overall Study|Quality Assurance Reader Fail|130|||
48317100|NCT01943916|155360537|FG000|Overall Study|Technical Failure|39|||
48317101|NCT01943916|155360537|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
48317102|NCT01943916|155360537|FG000|Overall Study|No Truth Panel Review|38|||
48317103|NCT01943916|155360537|FG000|Overall Study|Protocol Deviation|1|||
48317104|NCT00373529|155360539|FG000|Overall Study|Physician Decision|19|||
48317105|NCT00373529|155360539|FG000|Overall Study|Withdrawal by Subject|7|||
48317106|NCT00373529|155360539|FG000|Overall Study|Adverse Event|7|||
48317107|NCT00373529|155360539|FG000|Overall Study|Treatment failure|36|||
48317108|NCT00373529|155360539|FG000|Overall Study|Disease recurrence|10|||
48317109|NCT00373529|155360539|FG000|Overall Study|Death|16|||
48317110|NCT00373529|155360539|FG000|Overall Study|Need for treatment prohibited by study|1|||
48317111|NCT00373529|155360539|FG000|Overall Study|Other|8|||
48317112|NCT00373529|155360539|FG000|Overall Study|Failed independent confirmation of AML|3|||
48317113|NCT00373529|155360539|FG000|Overall Study|Consent violation|1|||
48317114|NCT02708108|155360540|FG000|Overall Study|Death|1|||
48317115|NCT02708108|155360541|FG001|Overall Study|Death|2|||
48317116|NCT02708108|155360540|FG000|Overall Study|Regimen change|1|||
48317117|NCT02708108|155360541|FG001|Overall Study|Regimen change|0|||
48317118|NCT02708108|155360540|FG000|Overall Study|No MRD and no imaging available|0|||
48317119|NCT02708108|155360541|FG001|Overall Study|No MRD and no imaging available|1|||
48317120|NCT01736215|155360542|FG000|Overall Study|Early termination of erythropoietin use|1|||
48317121|NCT01736215|155360542|FG000|Overall Study|Adverse Event|4|||
48317122|NCT01736215|155360542|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
48317123|NCT01736215|155360542|FG000|Overall Study|Insufficient data to perform analysis|8|||
48317124|NCT00440011|155360543|FG000|Overall Study|Adverse Event|2|||
48317125|NCT00440011|155360544|FG001|Overall Study|Adverse Event|0|||
48317126|NCT00440011|155360543|FG000|Overall Study|Lost to Follow-up|0|||
48317127|NCT00440011|155360544|FG001|Overall Study|Lost to Follow-up|2|||
48317128|NCT00440011|155360543|FG000|Overall Study|Protocol Violation|1|||
48317129|NCT00440011|155360544|FG001|Overall Study|Protocol Violation|1|||
48317130|NCT00440011|155360543|FG000|Overall Study|Withdrawal by Subject|1|||
48317131|NCT00440011|155360544|FG001|Overall Study|Withdrawal by Subject|0|||
48317132|NCT04200365|155360548|FG000|Overall Study|Adverse Event|2|||
48317133|NCT04200365|155360548|FG000|Overall Study|Progressive Disease|4|||
48317134|NCT04200365|155360548|FG000|Overall Study|Lack of Efficacy|1|||
48317135|NCT04200365|155360548|FG000|Overall Study|Study Closure|4|||
48317136|NCT02412748|155360552|FG000|Overall Study|Lost to Follow-up|38|||
48317137|NCT02412748|155360553|FG001|Overall Study|Lost to Follow-up|39|||
48317138|NCT02692417|155360556|FG000|Overall Study|Withdrawal by Subject|5|||
48317139|NCT02692417|155360557|FG001|Overall Study|Withdrawal by Subject|1|||
48317140|NCT02692417|155360556|FG000|Overall Study|Adverse Event|1|||
48317141|NCT02692417|155360557|FG001|Overall Study|Adverse Event|0|||
48317142|NCT01199575|155360562|FG000|Overall Study|Withdrawal by Subject|5|||
48317143|NCT00704184|155360564|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
48317144|NCT00704184|155360565|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
48317145|NCT00704184|155360566|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
48317146|NCT00704184|155360567|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
48317147|NCT00704184|155360568|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
48317148|NCT00704184|155360564|FG000|Open-Label Treatment|Adverse Event|0|||
48317149|NCT00704184|155360565|FG001|Open-Label Treatment|Adverse Event|0|||
48317150|NCT00704184|155360566|FG002|Open-Label Treatment|Adverse Event|2|||
48317151|NCT00704184|155360567|FG003|Open-Label Treatment|Adverse Event|0|||
48317152|NCT00704184|155360568|FG004|Open-Label Treatment|Adverse Event|1|||
48317153|NCT00704184|155360564|FG000|Open-Label Treatment|Lack of Efficacy|0|||
48317154|NCT00704184|155360565|FG001|Open-Label Treatment|Lack of Efficacy|2|||
48317155|NCT00704184|155360566|FG002|Open-Label Treatment|Lack of Efficacy|2|||
48317156|NCT00704184|155360567|FG003|Open-Label Treatment|Lack of Efficacy|2|||
48317157|NCT00704184|155360568|FG004|Open-Label Treatment|Lack of Efficacy|1|||
48317158|NCT00704184|155360564|FG000|Open-Label Treatment|Physician Decision|0|||
48317159|NCT00704184|155360565|FG001|Open-Label Treatment|Physician Decision|0|||
48317160|NCT00704184|155360566|FG002|Open-Label Treatment|Physician Decision|0|||
48317161|NCT00704184|155360567|FG003|Open-Label Treatment|Physician Decision|0|||
48317162|NCT00704184|155360568|FG004|Open-Label Treatment|Physician Decision|1|||
48317163|NCT00704184|155360564|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
48317164|NCT00704184|155360565|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
48317165|NCT00704184|155360566|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
48317166|NCT00704184|155360567|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
48317167|NCT00704184|155360568|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
48317168|NCT04732338|155360569|FG000|Overall Study|Lost to Follow-up|3|||
48317169|NCT04732338|155360570|FG001|Overall Study|Lost to Follow-up|3|||
48317170|NCT01976312|155360581|FG000|Overall Study|Pregnancy|0|||
48317171|NCT01976312|155360582|FG001|Overall Study|Pregnancy|1|||
48317172|NCT01976312|155360581|FG000|Overall Study|Lost to Follow-up|2|||
48317173|NCT01976312|155360582|FG001|Overall Study|Lost to Follow-up|0|||
48317174|NCT01976312|155360581|FG000|Overall Study|Withdrawal by Subject|7|||
48317175|NCT01976312|155360582|FG001|Overall Study|Withdrawal by Subject|2|||
48317176|NCT01976312|155360581|FG000|Overall Study|Adverse Event|6|||
48317177|NCT01976312|155360582|FG001|Overall Study|Adverse Event|6|||
48317178|NCT01976312|155360581|FG000|Overall Study|Protocol Violation|2|||
48317179|NCT01976312|155360582|FG001|Overall Study|Protocol Violation|0|||
48317180|NCT00411216|155360583|FG000|Overall Study|Ten participants were entered into the c|0|||
48317181|NCT00411216|155360584|FG001|Overall Study|Ten participants were entered into the c|2|||
48317182|NCT02556138|155360585|FG000|Overall Study|Withdrawal by Subject|1|||
48317183|NCT02079844|155360586|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
48317184|NCT02079844|155360587|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
48317185|NCT02079844|155360588|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
48317186|NCT02079844|155360586|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
48317187|NCT02079844|155360587|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
48317188|NCT02079844|155360588|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
48317189|NCT00203411|155360589|FG000|Follow-up|Progressive Disease|4|||
48317190|NCT03482635|155360590|FG000|Overall Study|Lack of Efficacy|0|||
48317191|NCT03482635|155360591|FG001|Overall Study|Lack of Efficacy|0|||
48317192|NCT03482635|155360592|FG002|Overall Study|Lack of Efficacy|1|||
48317193|NCT03482635|155360593|FG003|Overall Study|Lack of Efficacy|3|||
48317194|NCT03482635|155360590|FG000|Overall Study|Adverse Event|2|||
48317195|NCT03482635|155360591|FG001|Overall Study|Adverse Event|2|||
48317196|NCT03482635|155360592|FG002|Overall Study|Adverse Event|0|||
48317197|NCT03482635|155360593|FG003|Overall Study|Adverse Event|3|||
48317198|NCT03482635|155360590|FG000|Overall Study|Withdrawal by Subject|2|||
48317199|NCT03482635|155360591|FG001|Overall Study|Withdrawal by Subject|1|||
48317200|NCT03482635|155360592|FG002|Overall Study|Withdrawal by Subject|0|||
48317201|NCT03482635|155360593|FG003|Overall Study|Withdrawal by Subject|1|||
48317202|NCT03482635|155360590|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
48317203|NCT03482635|155360591|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
48317204|NCT03482635|155360592|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
48317205|NCT03482635|155360593|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
48317206|NCT03482635|155360590|FG000|Overall Study|Not treated|0|||
48317207|NCT03482635|155360591|FG001|Overall Study|Not treated|0|||
48317208|NCT03482635|155360592|FG002|Overall Study|Not treated|0|||
48317209|NCT03482635|155360593|FG003|Overall Study|Not treated|1|||
48317210|NCT02769858|155360594|FG000|Overall Study|Withdrawal by Subject|2|||
48317213|NCT01049503|155361976|FG000|Overall Study|Lost to Follow-up|11|||
48317214|NCT01049503|155361977|FG001|Overall Study|Lost to Follow-up|12|||
48317215|NCT01049503|155361978|FG002|Overall Study|Lost to Follow-up|24|||
48317216|NCT01049503|155361979|FG003|Overall Study|Lost to Follow-up|26|||
48317217|NCT01049503|155361980|FG004|Overall Study|Lost to Follow-up|27|||
48317218|NCT01049503|155361981|FG005|Overall Study|Lost to Follow-up|8|||
48317219|NCT00726596|155361982|FG000|Overall Study|Adverse Event|2|||
48317220|NCT00726596|155361983|FG001|Overall Study|Adverse Event|1|||
48317221|NCT00726596|155361982|FG000|Overall Study|Withdrawal by Subject|3|||
48317222|NCT00726596|155361983|FG001|Overall Study|Withdrawal by Subject|3|||
48317223|NCT00683696|155361984|FG000|Overall Study|Withdrawn due to study closure|337|||
48317224|NCT00683696|155361985|FG001|Overall Study|Withdrawn due to study closure|338|||
48317225|NCT00683696|155361984|FG000|Overall Study|Withdrawn prior to study closure|13|||
48317226|NCT00683696|155361985|FG001|Overall Study|Withdrawn prior to study closure|28|||
48317227|NCT00683696|155361984|FG000|Overall Study|Lost to Follow-up|5|||
48317228|NCT00683696|155361985|FG001|Overall Study|Lost to Follow-up|6|||
48317229|NCT00683696|155361984|FG000|Overall Study|Vital status follow-up only|3|||
48317230|NCT00683696|155361985|FG001|Overall Study|Vital status follow-up only|3|||
48317231|NCT00683696|155361984|FG000|Overall Study|Death|46|||
48317232|NCT00683696|155361985|FG001|Overall Study|Death|30|||
48317233|NCT03648762|155361988|FG000|Overall Study|Lost to Follow-up|1|||
48317234|NCT03648762|155361989|FG001|Overall Study|Lost to Follow-up|2|||
48317235|NCT03648762|155361990|FG002|Overall Study|Lost to Follow-up|0|||
48317236|NCT03648762|155361988|FG000|Overall Study|Withdrawal by Subject|5|||
48317237|NCT03648762|155361989|FG001|Overall Study|Withdrawal by Subject|2|||
48317238|NCT03648762|155361990|FG002|Overall Study|Withdrawal by Subject|1|||
48317239|NCT03169244|155361994|FG000|Overall Study|Lost to Follow-up|1|||
48317240|NCT03169244|155361995|FG001|Overall Study|Lost to Follow-up|2|||
48317241|NCT03169244|155361994|FG000|Overall Study|Adverse Event|1|||
48317242|NCT03169244|155361995|FG001|Overall Study|Adverse Event|0|||
48317243|NCT03169244|155361994|FG000|Overall Study|Withdrawal by Subject|2|||
48317244|NCT03169244|155361995|FG001|Overall Study|Withdrawal by Subject|2|||
48317245|NCT03169244|155361994|FG000|Overall Study|Physician Decision|1|||
48317246|NCT03169244|155361995|FG001|Overall Study|Physician Decision|0|||
48317247|NCT02544152|155361996|FG000|Overall Study|Adverse Event|0|||
48317248|NCT02544152|155361997|FG001|Overall Study|Adverse Event|4|||
48317249|NCT02544152|155361996|FG000|Overall Study|Withdrawal by Subject|0|||
48317250|NCT02544152|155361997|FG001|Overall Study|Withdrawal by Subject|3|||
48317251|NCT02544152|155361996|FG000|Overall Study|Other|1|||
48317252|NCT02544152|155361997|FG001|Overall Study|Other|0|||
48317253|NCT02731755|155362001|FG000|First Intervention|Withdrawal by Subject|0|||
48317254|NCT02731755|155362002|FG001|First Intervention|Withdrawal by Subject|2|||
48317255|NCT00955825|155362003|FG000|Overall Study|Adverse Event|15|||
48317256|NCT00955825|155362004|FG001|Overall Study|Adverse Event|2|||
48317257|NCT00955825|155362003|FG000|Overall Study|Withdrawal by Subject|4|||
48317258|NCT00955825|155362004|FG001|Overall Study|Withdrawal by Subject|6|||
48317259|NCT00955825|155362003|FG000|Overall Study|Any other reason not above-mentioned|7|||
48317260|NCT00955825|155362004|FG001|Overall Study|Any other reason not above-mentioned|9|||
48317261|NCT02751580|155362005|FG000|Overall Study|Lost to Follow-up|4|||
48317262|NCT02751580|155362005|FG000|Overall Study|Death|2|||
48317263|NCT00391846|155362006|FG000|Overall Study|Adverse Event|4|||
48317264|NCT00391846|155362007|FG001|Overall Study|Adverse Event|1|||
48317265|NCT00391846|155362006|FG000|Overall Study|Did not meet the required elig. crit|2|||
48317266|NCT00391846|155362007|FG001|Overall Study|Did not meet the required elig. crit|2|||
48317267|NCT00391846|155362006|FG000|Overall Study|Withdrawal by Subject|2|||
48317268|NCT00391846|155362007|FG001|Overall Study|Withdrawal by Subject|3|||
48317269|NCT00391846|155362006|FG000|Overall Study|Developed study specific DC criteria|0|||
48317270|NCT00391846|155362007|FG001|Overall Study|Developed study specific DC criteria|1|||
48317271|NCT01227278|155362008|FG000|Overall Study|Withdrawal by Subject|4|||
48317272|NCT01227278|155362009|FG001|Overall Study|Withdrawal by Subject|4|||
48317273|NCT01227278|155362008|FG000|Overall Study|Death|0|||
48317274|NCT01227278|155362009|FG001|Overall Study|Death|2|||
48317275|NCT01227278|155362008|FG000|Overall Study|Other|1|||
48317276|NCT01227278|155362009|FG001|Overall Study|Other|2|||
48317277|NCT00423098|155362010|FG000|Overall Study|Adverse Event|1|||
48317278|NCT00423098|155362011|FG001|Overall Study|Adverse Event|2|||
48317279|NCT00423098|155362010|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48317280|NCT00423098|155362011|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48317281|NCT00423098|155362010|FG000|Overall Study|Administrative problems|0|||
48317282|NCT00423098|155362011|FG001|Overall Study|Administrative problems|1|||
48317283|NCT00423098|155362010|FG000|Overall Study|Death|2|||
48317284|NCT00423098|155362011|FG001|Overall Study|Death|0|||
48317285|NCT01460446|155362015|FG000|Overall Study|Non-compliance|2|||
48317286|NCT01460446|155362016|FG001|Overall Study|Non-compliance|9|||
48317287|NCT01460446|155362015|FG000|Overall Study|Consent Withdrawn|0|||
48317288|NCT01460446|155362016|FG001|Overall Study|Consent Withdrawn|4|||
48317289|NCT01460446|155362015|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
48317290|NCT01460446|155362016|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
48317291|NCT01460446|155362015|FG000|Overall Study|Surgery/Illness|1|||
48317292|NCT01460446|155362016|FG001|Overall Study|Surgery/Illness|1|||
48317293|NCT01460446|155362015|FG000|Overall Study|Pregnancy|1|||
48317294|NCT01460446|155362016|FG001|Overall Study|Pregnancy|0|||
48317295|NCT01460446|155362015|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
48317296|NCT01460446|155362016|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
48317297|NCT01426269|155362019|FG000|Period 1: 12 Weeks|Adverse Event|5|||
48317298|NCT01426269|155362020|FG001|Period 1: 12 Weeks|Adverse Event|0|||
48317299|NCT01426269|155362021|FG002|Period 1: 12 Weeks|Adverse Event|0|||
48317300|NCT01426269|155362019|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
48317301|NCT01426269|155362020|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
48317302|NCT01426269|155362021|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
48317303|NCT01426269|155362019|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
48317304|NCT01426269|155362020|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
48317305|NCT01426269|155362021|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
48317306|NCT01426269|155362019|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
48317307|NCT01426269|155362020|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
48317308|NCT01426269|155362021|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
48317309|NCT01426269|155362019|FG000|Period 1: 12 Weeks|Pregnancy|1|||
48317310|NCT01426269|155362020|FG001|Period 1: 12 Weeks|Pregnancy|0|||
48317311|NCT01426269|155362021|FG002|Period 1: 12 Weeks|Pregnancy|0|||
48317312|NCT01426269|155362019|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
48317313|NCT01426269|155362020|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
48317314|NCT01426269|155362021|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
48317315|NCT01426269|155362019|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
48317316|NCT01426269|155362020|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
48317317|NCT01426269|155362021|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
48317318|NCT01426269|155362019|FG000|Period 2: 40 Weeks|Adverse Event|0|||
48317319|NCT01426269|155362020|FG001|Period 2: 40 Weeks|Adverse Event|1|||
48317320|NCT01426269|155362021|FG002|Period 2: 40 Weeks|Adverse Event|2|||
48317321|NCT01426269|155362019|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
48317322|NCT01426269|155362020|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
48317323|NCT01426269|155362021|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
48317324|NCT01426269|155362019|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
48317325|NCT01426269|155362020|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
48317326|NCT01426269|155362021|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
48317327|NCT01426269|155362019|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
48317328|NCT01426269|155362020|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
48317329|NCT01426269|155362021|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
48317330|NCT01426269|155362019|FG000|Period 2: 40 Weeks|Site closed|0|||
48317331|NCT01426269|155362020|FG001|Period 2: 40 Weeks|Site closed|6|||
48317332|NCT01426269|155362021|FG002|Period 2: 40 Weeks|Site closed|5|||
48317333|NCT01426269|155362019|FG000|Period 2: 40 Weeks|Relapsed|0|||
48317334|NCT01426269|155362020|FG001|Period 2: 40 Weeks|Relapsed|9|||
48317335|NCT01426269|155362021|FG002|Period 2: 40 Weeks|Relapsed|18|||
48317336|NCT00818454|155362022|FG000|Treatment Period 1|Adverse Event|0|||
48317337|NCT00818454|155362023|FG001|Treatment Period 1|Adverse Event|1|||
48317338|NCT00818454|155362024|FG002|Treatment Period 1|Adverse Event|0|||
48317339|NCT00818454|155362025|FG003|Treatment Period 1|Adverse Event|0|||
48317340|NCT00818454|155362022|FG000|Treatment Period 1|Other|3|||
48317341|NCT00818454|155362023|FG001|Treatment Period 1|Other|0|||
48317342|NCT00818454|155362024|FG002|Treatment Period 1|Other|0|||
48317343|NCT00818454|155362025|FG003|Treatment Period 1|Other|0|||
48317344|NCT00818454|155362022|FG000|Washout Period of 1 Week|Adverse Event|1|||
48317345|NCT00818454|155362023|FG001|Washout Period of 1 Week|Adverse Event|1|||
48317346|NCT00818454|155362024|FG002|Washout Period of 1 Week|Adverse Event|0|||
48317347|NCT00818454|155362025|FG003|Washout Period of 1 Week|Adverse Event|0|||
48317348|NCT00818454|155362022|FG000|Washout Period of 1 Week|Protocol Violation|2|||
48317349|NCT00818454|155362023|FG001|Washout Period of 1 Week|Protocol Violation|0|||
48317350|NCT00818454|155362024|FG002|Washout Period of 1 Week|Protocol Violation|0|||
48317351|NCT00818454|155362025|FG003|Washout Period of 1 Week|Protocol Violation|0|||
48317352|NCT00818454|155362022|FG000|Washout Period of 1 Week|Other|1|||
48317353|NCT00818454|155362023|FG001|Washout Period of 1 Week|Other|2|||
48317354|NCT00818454|155362024|FG002|Washout Period of 1 Week|Other|0|||
48317355|NCT00818454|155362025|FG003|Washout Period of 1 Week|Other|0|||
48317356|NCT00818454|155362022|FG000|Treatment Period 2|Other|2|||
48317357|NCT00818454|155362023|FG001|Treatment Period 2|Other|1|||
48317358|NCT00818454|155362024|FG002|Treatment Period 2|Other|0|||
48317359|NCT00818454|155362025|FG003|Treatment Period 2|Other|0|||
48317360|NCT00818454|155362022|FG000|Treatment Period 3|Adverse Event|0|||
48317361|NCT00818454|155362023|FG001|Treatment Period 3|Adverse Event|0|||
48317362|NCT00818454|155362024|FG002|Treatment Period 3|Adverse Event|0|||
48317363|NCT00818454|155362025|FG003|Treatment Period 3|Adverse Event|1|||
48317364|NCT00549848|155362026|FG000|Overall Study|Death|1|||
48317365|NCT00549848|155362027|FG001|Overall Study|Death|4|||
48317366|NCT00549848|155362028|FG002|Overall Study|Death|13|||
48317367|NCT00549848|155362026|FG000|Overall Study|Physician Decision|0|||
48317368|NCT00549848|155362027|FG001|Overall Study|Physician Decision|0|||
48317369|NCT00549848|155362028|FG002|Overall Study|Physician Decision|4|||
48317370|NCT00549848|155362026|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
48317371|NCT00549848|155362027|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
48317372|NCT00549848|155362028|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
48317373|NCT00549848|155362026|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
48317374|NCT00549848|155362027|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
48317375|NCT00549848|155362028|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
48317376|NCT00549848|155362026|FG000|Overall Study|Participant/Family Withdraw|2|||
48317377|NCT00549848|155362027|FG001|Overall Study|Participant/Family Withdraw|3|||
48317378|NCT00549848|155362028|FG002|Overall Study|Participant/Family Withdraw|5|||
48317379|NCT00549848|155362026|FG000|Overall Study|Second Malignancy|1|||
48317380|NCT00549848|155362027|FG001|Overall Study|Second Malignancy|0|||
48317381|NCT00549848|155362028|FG002|Overall Study|Second Malignancy|0|||
48317382|NCT00549848|155362026|FG000|Overall Study|Transplant|3|||
48317383|NCT00549848|155362027|FG001|Overall Study|Transplant|3|||
48317384|NCT00549848|155362028|FG002|Overall Study|Transplant|18|||
48317385|NCT00549848|155362026|FG000|Overall Study|Unacceptable Toxicity|1|||
48317386|NCT00549848|155362027|FG001|Overall Study|Unacceptable Toxicity|6|||
48317387|NCT00549848|155362028|FG002|Overall Study|Unacceptable Toxicity|6|||
48317388|NCT03262935|155362029|FG000|Overall Study|Withdrawal by Subject|6|||
48317389|NCT03262935|155362030|FG001|Overall Study|Withdrawal by Subject|7|||
48317390|NCT03262935|155362029|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
48317391|NCT03262935|155362030|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
48317392|NCT03262935|155362029|FG000|Overall Study|Death|181|||
48317393|NCT03262935|155362030|FG001|Overall Study|Death|94|||
48317394|NCT03262935|155362029|FG000|Overall Study|Lost to Follow-up|9|||
48317395|NCT03262935|155362030|FG001|Overall Study|Lost to Follow-up|4|||
48317396|NCT03262935|155362029|FG000|Overall Study|Other reason|5|||
48317397|NCT03262935|155362030|FG001|Overall Study|Other reason|0|||
48317398|NCT02224924|155362031|FG000|Overall Study|Withdrawal by Subject|7|||
48317399|NCT02224924|155362032|FG001|Overall Study|Withdrawal by Subject|6|||
48317400|NCT02224924|155362031|FG000|Overall Study|Biopsy cancelled|20|||
48317401|NCT02224924|155362032|FG001|Overall Study|Biopsy cancelled|14|||
48317402|NCT02224924|155362031|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
48317403|NCT02224924|155362032|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
48317404|NCT02224924|155362031|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
48317405|NCT02224924|155362032|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
48317406|NCT01443845|155362035|FG000|Overall Study|Protocol Violation|43|||
48317407|NCT01443845|155362036|FG001|Overall Study|Protocol Violation|45|||
48317408|NCT01443845|155362035|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
48317409|NCT01443845|155362036|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
48317410|NCT01443845|155362035|FG000|Overall Study|Deterioration in pulmonary function|1|||
48317411|NCT01443845|155362036|FG001|Overall Study|Deterioration in pulmonary function|4|||
48317412|NCT01443845|155362035|FG000|Overall Study|Lack of Efficacy|10|||
48317413|NCT01443845|155362036|FG001|Overall Study|Lack of Efficacy|5|||
48317414|NCT01443845|155362035|FG000|Overall Study|Adverse Event|64|||
48317415|NCT01443845|155362036|FG001|Overall Study|Adverse Event|138|||
48317416|NCT01443845|155362035|FG000|Overall Study|Withdrawal by Subject|63|||
48570768|NCT04109391|156282249|FG001|Overall Study|Withdrawal by Subject|0|||
48570769|NCT04109391|156282250|FG002|Overall Study|Withdrawal by Subject|0|||
48570770|NCT04109391|156282248|FG000|Overall Study|Pregnancy|1|||
48570771|NCT04109391|156282249|FG001|Overall Study|Pregnancy|0|||
48570772|NCT04109391|156282250|FG002|Overall Study|Pregnancy|0|||
48570773|NCT04109391|156282248|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
48570774|NCT04109391|156282249|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
48570775|NCT04109391|156282250|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
48570776|NCT04109391|156282248|FG000|Overall Study|Lost to Follow-up|0|||
48317417|NCT01443845|155362036|FG001|Overall Study|Withdrawal by Subject|67|||
48317418|NCT01443845|155362035|FG000|Overall Study|Military Conflict - Site Terminated|20|||
48317419|NCT01443845|155362036|FG001|Overall Study|Military Conflict - Site Terminated|21|||
48317420|NCT01443845|155362035|FG000|Overall Study|Lost to Follow-up|9|||
48317421|NCT01443845|155362036|FG001|Overall Study|Lost to Follow-up|13|||
48317422|NCT00542789|155362038|FG000|Overall Study|Adverse Event|18|||
48317423|NCT00542789|155362039|FG001|Overall Study|Adverse Event|17|||
48317424|NCT00542789|155362038|FG000|Overall Study|Withdrawal by Subject|7|||
48317425|NCT00542789|155362039|FG001|Overall Study|Withdrawal by Subject|3|||
48570777|NCT04109391|156282249|FG001|Overall Study|Lost to Follow-up|0|||
48570778|NCT04109391|156282250|FG002|Overall Study|Lost to Follow-up|1|||
48570779|NCT04109391|156282248|FG000|Overall Study|Lack of Efficacy|2|||
48317426|NCT00542789|155362038|FG000|Overall Study|Protocol Violation|8|||
48317427|NCT00542789|155362039|FG001|Overall Study|Protocol Violation|1|||
48317428|NCT00542789|155362038|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
48317429|NCT00542789|155362039|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
48317430|NCT01571596|155362040|FG000|Overall Study|Adverse Event|2|||
48317431|NCT01571596|155362041|FG001|Overall Study|Adverse Event|0|||
48317432|NCT01571596|155362042|FG002|Overall Study|Adverse Event|0|||
48317433|NCT01571596|155362040|FG000|Overall Study|Study Terminated by the Sponsor|0|||
48317434|NCT01571596|155362041|FG001|Overall Study|Study Terminated by the Sponsor|1|||
48317435|NCT01571596|155362042|FG002|Overall Study|Study Terminated by the Sponsor|1|||
48317436|NCT01765543|155362051|FG000|Overall Study|Death|1|||
48317437|NCT01765543|155362051|FG000|Overall Study|Withdrawal by Subject|2|||
48317438|NCT04723394|155362055|FG000|Overall Study|Adverse Event|0|||
48317439|NCT04723394|155362056|FG001|Overall Study|Adverse Event|3|||
48317440|NCT04723394|155362055|FG000|Overall Study|Death|8|||
48317441|NCT04723394|155362056|FG001|Overall Study|Death|8|||
48317442|NCT04723394|155362055|FG000|Overall Study|Lost to Follow-up|20|||
48317443|NCT04723394|155362056|FG001|Overall Study|Lost to Follow-up|17|||
48317444|NCT04723394|155362055|FG000|Overall Study|Physician Decision|1|||
48317445|NCT04723394|155362056|FG001|Overall Study|Physician Decision|0|||
48317446|NCT04723394|155362055|FG000|Overall Study|Withdrawal by Subject|20|||
48317447|NCT04723394|155362056|FG001|Overall Study|Withdrawal by Subject|34|||
48317448|NCT04723394|155362055|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
48317449|NCT04723394|155362056|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
48317450|NCT00446459|155362057|FG000|8 Months|Protocol Violation|12|||
48317451|NCT00446459|155362057|FG000|12 Months|Protocol Violation|4|||
48317452|NCT00446459|155362057|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
48317453|NCT00508924|155362058|FG000|Overall Study|Protocol Violation|0|||
48317454|NCT00508924|155362059|FG001|Overall Study|Protocol Violation|0|||
48317455|NCT00508924|155362060|FG002|Overall Study|Protocol Violation|1|||
48317456|NCT00508924|155362061|FG003|Overall Study|Protocol Violation|1|||
48570780|NCT04109391|156282249|FG001|Overall Study|Lack of Efficacy|2|||
48570781|NCT04109391|156282250|FG002|Overall Study|Lack of Efficacy|3|||
48570782|NCT01186692|156282251|FG000|Overall Study|Not Catheterized|11|||
48570783|NCT01186692|156282251|FG000|Overall Study|Futher testing contraindicated implant|19|||
48317457|NCT01444417|155362067|FG000|Overall Study|Ineligibility Determined|0|||
48317458|NCT01444417|155362068|FG001|Overall Study|Ineligibility Determined|1|||
48317459|NCT01444417|155362067|FG000|Overall Study|Withdrawal by Subject|2|||
48317460|NCT01444417|155362068|FG001|Overall Study|Withdrawal by Subject|0|||
48317461|NCT02200770|155362069|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
48317462|NCT02200770|155362070|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
48570784|NCT01186692|156282251|FG000|Overall Study|Adverse Event|2|||
48570785|NCT00596817|156282252|FG000|Open-label Period|Adverse Event|0|||
48570786|NCT00596817|156282253|FG001|Open-label Period|Adverse Event|49|||
48570787|NCT00596817|156282252|FG000|Open-label Period|Lack of Efficacy|0|||
48570788|NCT00596817|156282253|FG001|Open-label Period|Lack of Efficacy|33|||
48570789|NCT00596817|156282252|FG000|Open-label Period|Other Reasons|0|||
48570790|NCT00596817|156282253|FG001|Open-label Period|Other Reasons|65|||
48570791|NCT00596817|156282252|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
48570792|NCT00596817|156282253|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
48570793|NCT00596817|156282252|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
48570794|NCT00596817|156282253|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
48570795|NCT00596817|156282252|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
48570796|NCT00596817|156282253|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
48570797|NCT00596817|156282252|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
48570798|NCT00596817|156282253|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
48570799|NCT00596817|156282252|FG000|Double-blind Period|Adverse Event|5|||
48570800|NCT00596817|156282253|FG001|Double-blind Period|Adverse Event|16|||
48570801|NCT00596817|156282252|FG000|Double-blind Period|Lack of Efficacy|52|||
48570802|NCT00596817|156282253|FG001|Double-blind Period|Lack of Efficacy|28|||
48570803|NCT00596817|156282252|FG000|Double-blind Period|Non-compliance With Study Product|3|||
48570804|NCT00596817|156282253|FG001|Double-blind Period|Non-compliance With Study Product|4|||
48570805|NCT00596817|156282252|FG000|Double-blind Period|Protocol Violation|11|||
48570806|NCT00596817|156282253|FG001|Double-blind Period|Protocol Violation|8|||
48570807|NCT00596817|156282252|FG000|Double-blind Period|Withdrawal of Consent|7|||
48570808|NCT00596817|156282253|FG001|Double-blind Period|Withdrawal of Consent|3|||
48570809|NCT00596817|156282252|FG000|Double-blind Period|Lost to Follow-up|0|||
48570810|NCT00596817|156282253|FG001|Double-blind Period|Lost to Follow-up|2|||
48570811|NCT00596817|156282252|FG000|Double-blind Period|Other Reasons|10|||
48570812|NCT00596817|156282253|FG001|Double-blind Period|Other Reasons|18|||
48570813|NCT00667823|156282256|FG000|Overall Study|Lost to Follow-up|5|||
48570814|NCT00667823|156282256|FG000|Overall Study|Adverse Event|7|||
48570815|NCT00667823|156282256|FG000|Overall Study|Death|182|||
48570816|NCT00667823|156282256|FG000|Overall Study|Withdrawal by Subject|12|||
48570817|NCT00667823|156282256|FG000|Overall Study|Other|8|||
48570818|NCT00667823|156282256|FG000|Overall Study|Missing (completion page missing)|2|||
48570819|NCT02142959|156282257|FG000|Overall Study|Adverse Event|1|||
48570820|NCT02142959|156282258|FG001|Overall Study|Adverse Event|0|||
48570821|NCT02142959|156282259|FG002|Overall Study|Adverse Event|0|||
48570822|NCT02142959|156282257|FG000|Overall Study|Death|0|||
48570823|NCT02142959|156282258|FG001|Overall Study|Death|1|||
48570824|NCT02142959|156282259|FG002|Overall Study|Death|0|||
48570825|NCT02142959|156282257|FG000|Overall Study|Withdrawal by Subject|3|||
48570826|NCT02142959|156282258|FG001|Overall Study|Withdrawal by Subject|1|||
48570827|NCT02142959|156282259|FG002|Overall Study|Withdrawal by Subject|3|||
48570828|NCT02142959|156282257|FG000|Overall Study|Administrative Reasons|1|||
48570829|NCT02142959|156282258|FG001|Overall Study|Administrative Reasons|0|||
48570830|NCT02142959|156282259|FG002|Overall Study|Administrative Reasons|1|||
48570831|NCT02142959|156282257|FG000|Overall Study|Missing|0|||
48570832|NCT02142959|156282258|FG001|Overall Study|Missing|1|||
48570833|NCT02142959|156282259|FG002|Overall Study|Missing|0|||
48570834|NCT02142959|156282257|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
48618753|NCT03158311|156459462|FG000|Overall Study|Randomized in error|0|||
48570835|NCT02142959|156282258|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
48570836|NCT02142959|156282259|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
48570837|NCT02142959|156282257|FG000|Overall Study|Patient didn't complete end of study visit|0|||
48570838|NCT02142959|156282258|FG001|Overall Study|Patient didn't complete end of study visit|0|||
48570839|NCT02142959|156282259|FG002|Overall Study|Patient didn't complete end of study visit|1|||
48570840|NCT03509467|156282274|FG000|Overall Study|Withdrawal by Subject|5|||
48570841|NCT03509467|156282275|FG001|Overall Study|Withdrawal by Subject|1|||
48317463|NCT02200770|155362069|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
48317464|NCT02200770|155362070|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
48317465|NCT02200770|155362069|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
48570842|NCT03509467|156282276|FG002|Overall Study|Withdrawal by Subject|6|||
48570843|NCT03509467|156282277|FG003|Overall Study|Withdrawal by Subject|7|||
48570844|NCT03509467|156282278|FG004|Overall Study|Withdrawal by Subject|10|||
48570845|NCT03509467|156282279|FG005|Overall Study|Withdrawal by Subject|10|||
48570846|NCT03509467|156282280|FG006|Overall Study|Withdrawal by Subject|10|||
48570847|NCT03509467|156282281|FG007|Overall Study|Withdrawal by Subject|10|||
48570848|NCT03509467|156282274|FG000|Overall Study|Death|0|||
48618754|NCT03158311|156459463|FG001|Overall Study|Randomized in error|0|||
48618755|NCT03158311|156459464|FG002|Overall Study|Randomized in error|1|||
48618756|NCT01800058|156459469|FG000|Overall Study|Lost to Follow-up|1|||
48618757|NCT00290238|156459470|FG000|Overall Study|Study terminated|27|||
48570849|NCT03509467|156282275|FG001|Overall Study|Death|0|||
48570850|NCT03509467|156282276|FG002|Overall Study|Death|2|||
48570851|NCT03509467|156282277|FG003|Overall Study|Death|2|||
48570852|NCT03509467|156282278|FG004|Overall Study|Death|1|||
48570853|NCT03509467|156282279|FG005|Overall Study|Death|0|||
48570854|NCT03509467|156282280|FG006|Overall Study|Death|1|||
48570855|NCT03509467|156282281|FG007|Overall Study|Death|0|||
48570856|NCT03509467|156282274|FG000|Overall Study|Proxy Withdrawal|0|||
48570857|NCT03509467|156282275|FG001|Overall Study|Proxy Withdrawal|0|||
48570858|NCT03509467|156282276|FG002|Overall Study|Proxy Withdrawal|0|||
48570859|NCT03509467|156282277|FG003|Overall Study|Proxy Withdrawal|0|||
48570860|NCT03509467|156282278|FG004|Overall Study|Proxy Withdrawal|0|||
48570861|NCT03509467|156282279|FG005|Overall Study|Proxy Withdrawal|0|||
48317466|NCT02200770|155362070|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
48317467|NCT02200770|155362069|FG000|Randomized-controlled Period (RCP)|Other|1|||
48317468|NCT02200770|155362070|FG001|Randomized-controlled Period (RCP)|Other|2|||
48317469|NCT02200770|155362069|FG000|Open-label Period (OLP)|Adverse Event|1|||
48317470|NCT02200770|155362070|FG001|Open-label Period (OLP)|Adverse Event|2|||
48317471|NCT02200770|155362069|FG000|Open-label Period (OLP)|Death|1|||
48317472|NCT02200770|155362070|FG001|Open-label Period (OLP)|Death|2|||
48317473|NCT02200770|155362069|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
48317474|NCT02200770|155362070|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
48317475|NCT02200770|155362069|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
48317476|NCT02200770|155362070|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
48317477|NCT02200770|155362069|FG000|Open-label Period (OLP)|Other|6|||
48317478|NCT02200770|155362070|FG001|Open-label Period (OLP)|Other|15|||
48317479|NCT01414738|155362071|FG000|Overall Study|Death|26|||
48317480|NCT01414738|155362071|FG000|Overall Study|Refused testing|5|||
48317481|NCT01414738|155362071|FG000|Overall Study|Lost to Follow-up|2|||
48317482|NCT01414738|155362071|FG000|Overall Study|Refused, disease progression|8|||
48317483|NCT01414738|155362071|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
48570862|NCT03509467|156282280|FG006|Overall Study|Proxy Withdrawal|0|||
48618758|NCT00290238|156459471|FG001|Overall Study|Study terminated|27|||
48618759|NCT00290238|156459470|FG000|Overall Study|Lost to Follow-up|0|||
48618760|NCT00290238|156459471|FG001|Overall Study|Lost to Follow-up|1|||
48618761|NCT00290238|156459470|FG000|Overall Study|Withdrawal by Subject|15|||
48618762|NCT00290238|156459471|FG001|Overall Study|Withdrawal by Subject|13|||
48317484|NCT03950622|155362072|FG000|Overall Study|Withdrawal by Subject|1|||
48317485|NCT03950622|155362073|FG001|Overall Study|Withdrawal by Subject|0|||
48618763|NCT01671059|156459472|FG000|Overall Study|Adverse Event|4|||
48618764|NCT01671059|156459472|FG000|Overall Study|Lack of Efficacy|1|||
48317486|NCT03950622|155362072|FG000|Overall Study|Protocol Deviation|0|||
48570863|NCT03509467|156282281|FG007|Overall Study|Proxy Withdrawal|1|||
48618765|NCT00954538|156459478|FG000|Part III|Withdrawal by Subject|0|||
48618766|NCT00954538|156459479|FG001|Part III|Withdrawal by Subject|0|||
48317487|NCT03950622|155362073|FG001|Overall Study|Protocol Deviation|1|||
48317488|NCT03950622|155362072|FG000|Overall Study|Physician Decision|1|||
48570864|NCT03227224|156282282|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
48570865|NCT03227224|156282283|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
48618767|NCT00954538|156459480|FG002|Part III|Withdrawal by Subject|0|||
48570866|NCT03227224|156282284|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
48570867|NCT03227224|156282285|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
48570868|NCT03227224|156282282|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
48570869|NCT03227224|156282283|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
48570870|NCT03227224|156282284|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
48570871|NCT03227224|156282285|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
48317489|NCT03950622|155362073|FG001|Overall Study|Physician Decision|0|||
48317490|NCT03950622|155362072|FG000|Overall Study|Lost to Follow-up|5|||
48317491|NCT03950622|155362073|FG001|Overall Study|Lost to Follow-up|5|||
48317492|NCT03950622|155362072|FG000|Overall Study|Death|1|||
48317493|NCT03950622|155362073|FG001|Overall Study|Death|1|||
48317494|NCT02423798|155362074|FG000|Overall Study|Withdrawal by Subject|3|||
48317495|NCT01198145|155362080|FG000|Overall Study|Withdrawal by Subject|1|||
48317496|NCT01198145|155362081|FG001|Overall Study|Withdrawal by Subject|1|||
48317497|NCT01248936|155362086|FG000|Overall Study|Sponsor Decision|259|||
48317498|NCT01248936|155362086|FG000|Overall Study|Progression of Disease|50|||
48317499|NCT01248936|155362086|FG000|Overall Study|Death|26|||
48317500|NCT01248936|155362086|FG000|Overall Study|Withdrawal of Consent|20|||
48317501|NCT01248936|155362086|FG000|Overall Study|Adverse Event|8|||
48317502|NCT01248936|155362086|FG000|Overall Study|Lost to Follow-up|7|||
48570872|NCT03227224|156282282|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
48317503|NCT01248936|155362086|FG000|Overall Study|Refused Treatment|1|||
48570873|NCT03227224|156282283|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
48570874|NCT03227224|156282284|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
48570875|NCT03227224|156282285|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
48570876|NCT03227224|156282282|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
48570877|NCT03227224|156282283|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48570878|NCT03227224|156282284|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48570879|NCT03227224|156282285|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48570880|NCT03227224|156282282|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
48570881|NCT03227224|156282283|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
48570882|NCT03227224|156282284|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
48570883|NCT03227224|156282285|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
48570884|NCT03227224|156282282|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
48570885|NCT03227224|156282283|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
48570886|NCT03227224|156282284|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
48317504|NCT01248936|155362086|FG000|Overall Study|Other reason|3|||
48317505|NCT00068601|155362087|FG000|Overall Study|Ineligible|11|||
48317506|NCT00068601|155362088|FG001|Overall Study|Ineligible|13|||
48317507|NCT00068601|155362087|FG000|Overall Study|Not evaluable: withdrew consent|5|||
48317508|NCT00068601|155362088|FG001|Overall Study|Not evaluable: withdrew consent|4|||
48317509|NCT00068601|155362087|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
48317510|NCT00068601|155362088|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
48317511|NCT00068601|155362087|FG000|Overall Study|Death|11|||
48317512|NCT00068601|155362088|FG001|Overall Study|Death|3|||
48317513|NCT00068601|155362087|FG000|Overall Study|Lost to Follow-up|3|||
48317514|NCT00068601|155362088|FG001|Overall Study|Lost to Follow-up|2|||
48317515|NCT00068601|155362087|FG000|Overall Study|Missing primary outcome data|30|||
48317516|NCT00068601|155362088|FG001|Overall Study|Missing primary outcome data|34|||
48317517|NCT03565315|155362093|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
48317518|NCT03565315|155362094|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
48317519|NCT03565315|155362095|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
48317520|NCT03565315|155362096|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
48317521|NCT01017146|155362097|FG000|Overall Study|Adverse Event|11|||
48570887|NCT03227224|156282285|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
48570888|NCT03227224|156282282|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
48570889|NCT03227224|156282283|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
48570890|NCT03227224|156282284|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
48570891|NCT03227224|156282285|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
48570892|NCT03227224|156282282|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
48570893|NCT03227224|156282283|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
48317522|NCT01017146|155362098|FG001|Overall Study|Adverse Event|1|||
48317523|NCT01017146|155362097|FG000|Overall Study|Lost to Follow-up|14|||
48317524|NCT01017146|155362098|FG001|Overall Study|Lost to Follow-up|14|||
48317525|NCT01017146|155362097|FG000|Overall Study|Noncompliance with Study Product|1|||
48317526|NCT01017146|155362098|FG001|Overall Study|Noncompliance with Study Product|1|||
48317527|NCT01017146|155362097|FG000|Overall Study|Withdrawal by Subject|32|||
48317528|NCT01017146|155362098|FG001|Overall Study|Withdrawal by Subject|16|||
48317529|NCT01017146|155362097|FG000|Overall Study|Relocation|0|||
48317530|NCT01017146|155362098|FG001|Overall Study|Relocation|4|||
48570894|NCT03227224|156282284|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
48317531|NCT01017146|155362097|FG000|Overall Study|Pregnancy|2|||
48317532|NCT01017146|155362098|FG001|Overall Study|Pregnancy|1|||
48317533|NCT01017146|155362097|FG000|Overall Study|Protocol Violation|2|||
48317534|NCT01017146|155362098|FG001|Overall Study|Protocol Violation|0|||
48570895|NCT03227224|156282285|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
48570896|NCT03227224|156282282|FG000|Follow-up Phase (2 Weeks)|Other|4|||
48570897|NCT03227224|156282283|FG001|Follow-up Phase (2 Weeks)|Other|4|||
48570898|NCT03227224|156282284|FG002|Follow-up Phase (2 Weeks)|Other|6|||
48570899|NCT03227224|156282285|FG003|Follow-up Phase (2 Weeks)|Other|3|||
48570900|NCT01106911|156282286|FG000|Overall Study|Physician Decision|2|||
48570901|NCT01106911|156282286|FG000|Overall Study|deemed ineligible after screening|3|||
48570902|NCT01282372|156282287|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
48570903|NCT01282372|156282287|FG000|Overall Study|Lost to Follow-up|23|||
48570904|NCT01282372|156282287|FG000|Overall Study|Withdrawal by Subject|11|||
48570905|NCT01282372|156282287|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
48570906|NCT01282372|156282287|FG000|Overall Study|Death|1|||
48570907|NCT01282372|156282287|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
48570908|NCT01282372|156282287|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
48570909|NCT01282372|156282287|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
48570910|NCT01282372|156282287|FG000|Overall Study|Adverse Event|12|||
48570911|NCT04804540|156282290|FG000|Overall Study|Adverse Event|26|||
48570912|NCT04804540|156282291|FG001|Overall Study|Adverse Event|13|||
48570913|NCT03963232|156282294|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48570914|NCT03963232|156282295|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
48570915|NCT03963232|156282294|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
48570916|NCT03963232|156282295|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
48570917|NCT03963232|156282294|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
48570918|NCT03963232|156282295|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
48570919|NCT03963232|156282294|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
48570920|NCT03963232|156282295|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
48570921|NCT03963232|156282294|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
48570922|NCT03963232|156282295|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
48618768|NCT00954538|156459481|FG003|Part III|Withdrawal by Subject|0|||
48618769|NCT00954538|156459482|FG004|Part III|Withdrawal by Subject|1|||
48618770|NCT00954538|156459483|FG005|Part III|Withdrawal by Subject|0|||
48618771|NCT02400736|156461359|FG000|Overall Study|Lost to Follow-up|6|||
48317535|NCT01017146|155362097|FG000|Overall Study|Took Excluded Medication|2|||
48317536|NCT01017146|155362098|FG001|Overall Study|Took Excluded Medication|0|||
48570923|NCT03963232|156282294|FG000|Open-Label Treatment Phase|Adverse Event|1|||
48317537|NCT01017146|155362097|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
48317538|NCT01017146|155362098|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
48317539|NCT01017146|155362097|FG000|Overall Study|Change in Work Situation|1|||
48317540|NCT01017146|155362098|FG001|Overall Study|Change in Work Situation|0|||
48317541|NCT04128319|155362099|FG000|Overall Study|Death|3|||
48317542|NCT01109524|155362112|FG000|Overall Study|Disease Progression|29|||
48317543|NCT01109524|155362112|FG000|Overall Study|Study Drug toxicity|6|||
48317544|NCT01109524|155362112|FG000|Overall Study|Adverse Event|4|||
48317545|NCT01109524|155362112|FG000|Overall Study|Withdrawal by Subject|2|||
48317546|NCT01109524|155362112|FG000|Overall Study|Maximum clinical benefit|3|||
48570924|NCT03963232|156282295|FG001|Open-Label Treatment Phase|Adverse Event|2|||
48570925|NCT03963232|156282294|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
48570926|NCT03963232|156282295|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
48570927|NCT03963232|156282294|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
48570928|NCT03963232|156282295|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
48570929|NCT03963232|156282294|FG000|Open-Label Treatment Phase|Pregnancy|1|||
48570930|NCT03963232|156282295|FG001|Open-Label Treatment Phase|Pregnancy|0|||
48570931|NCT03963232|156282294|FG000|Follow-up Phase|Withdrawal by Subject|7|||
48570932|NCT03963232|156282295|FG001|Follow-up Phase|Withdrawal by Subject|5|||
48570933|NCT03963232|156282294|FG000|Follow-up Phase|Protocol Violation|0|||
48317547|NCT01109524|155362112|FG000|Overall Study|Death|2|||
48317548|NCT01109524|155362112|FG000|Overall Study|No longer meets criteria|2|||
48570934|NCT03963232|156282295|FG001|Follow-up Phase|Protocol Violation|2|||
48618772|NCT02400736|156461360|FG001|Overall Study|Lost to Follow-up|6|||
48618773|NCT02400736|156461359|FG000|Overall Study|Withdrawal by Subject|2|||
48570935|NCT03963232|156282294|FG000|Follow-up Phase|Adverse Event|0|||
48618774|NCT02400736|156461360|FG001|Overall Study|Withdrawal by Subject|1|||
48317549|NCT01109524|155362112|FG000|Overall Study|Participant requested to end treatment|4|||
48317550|NCT01109524|155362112|FG000|Overall Study|Other|5|||
48317551|NCT02759016|155362113|FG000|Overall Study|Not treated with BI 836826|1|||
48317552|NCT02759016|155362114|FG001|Overall Study|Not treated with BI 836826|0|||
48317553|NCT02759016|155362113|FG000|Overall Study|Progressive disease|1|||
48317554|NCT02759016|155362114|FG001|Overall Study|Progressive disease|0|||
48317555|NCT02759016|155362113|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
48317556|NCT02759016|155362114|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
48570936|NCT03963232|156282295|FG001|Follow-up Phase|Adverse Event|1|||
48570937|NCT03963232|156282294|FG000|Follow-up Phase|Lost to Follow-up|0|||
48570938|NCT03963232|156282295|FG001|Follow-up Phase|Lost to Follow-up|1|||
48570939|NCT04520997|156282296|FG000|Overall Study|Lost to Follow-up|1|||
48317557|NCT02759016|155362113|FG000|Overall Study|Other not defined above|2|||
48317558|NCT02759016|155362114|FG001|Overall Study|Other not defined above|1|||
48317559|NCT02318134|155362115|FG000|Overall Study|Withdrawal by Subject|2|||
48317560|NCT02318134|155362116|FG001|Overall Study|Withdrawal by Subject|1|||
48317561|NCT03892564|155362121|FG000|Overall Study|Withdrawal by Subject|2|||
48317562|NCT01149369|155364141|FG000|Overall Study|Adverse Event|6|||
48317563|NCT01149369|155364142|FG001|Overall Study|Adverse Event|3|||
48317564|NCT02034916|155364148|FG000|Overall Study|Death|39|||
48317565|NCT02034916|155364149|FG001|Overall Study|Death|28|||
48317566|NCT02034916|155364148|FG000|Overall Study|Withdrawal by Subject|2|||
48317567|NCT02034916|155364149|FG001|Overall Study|Withdrawal by Subject|1|||
48317568|NCT02034916|155364148|FG000|Overall Study|Lost to Follow-up|4|||
48317569|NCT02034916|155364149|FG001|Overall Study|Lost to Follow-up|1|||
48317570|NCT02034916|155364148|FG000|Overall Study|Study terminated by sponsor|4|||
48317571|NCT02034916|155364149|FG001|Overall Study|Study terminated by sponsor|5|||
48317572|NCT02015520|155364150|FG000|Overall Study|Lack of Efficacy|1|||
48317573|NCT02015520|155364151|FG001|Overall Study|Lack of Efficacy|0|||
48317574|NCT02015520|155364152|FG002|Overall Study|Lack of Efficacy|3|||
48317575|NCT02015520|155364153|FG003|Overall Study|Lack of Efficacy|2|||
48317576|NCT02015520|155364150|FG000|Overall Study|Adverse Event|0|||
48317577|NCT02015520|155364151|FG001|Overall Study|Adverse Event|0|||
48317578|NCT02015520|155364152|FG002|Overall Study|Adverse Event|0|||
48317579|NCT02015520|155364153|FG003|Overall Study|Adverse Event|1|||
48317580|NCT02015520|155364150|FG000|Overall Study|Withdrawal by Subject|2|||
48317581|NCT02015520|155364151|FG001|Overall Study|Withdrawal by Subject|2|||
48317582|NCT02015520|155364152|FG002|Overall Study|Withdrawal by Subject|1|||
48317583|NCT02015520|155364153|FG003|Overall Study|Withdrawal by Subject|0|||
48570940|NCT04520997|156282297|FG001|Overall Study|Lost to Follow-up|1|||
48570941|NCT04520997|156282296|FG000|Overall Study|Withdrawal by Subject|1|||
48570942|NCT04520997|156282297|FG001|Overall Study|Withdrawal by Subject|0|||
48570943|NCT04520997|156282296|FG000|Overall Study|Not Treated|0|||
48570944|NCT04520997|156282297|FG001|Overall Study|Not Treated|1|||
48570945|NCT02729051|156282306|FG000|Overall Study|Adverse Event|21|||
48317584|NCT02015520|155364150|FG000|Overall Study|Death|1|||
48317585|NCT02015520|155364151|FG001|Overall Study|Death|0|||
48317586|NCT02015520|155364152|FG002|Overall Study|Death|0|||
48317587|NCT02015520|155364153|FG003|Overall Study|Death|0|||
48317588|NCT02015520|155364150|FG000|Overall Study|Lost to Follow-up|0|||
48317589|NCT02015520|155364151|FG001|Overall Study|Lost to Follow-up|0|||
48317590|NCT02015520|155364152|FG002|Overall Study|Lost to Follow-up|1|||
48317591|NCT02015520|155364153|FG003|Overall Study|Lost to Follow-up|0|||
48317592|NCT02015520|155364150|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
48317593|NCT02015520|155364151|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
48317594|NCT02015520|155364152|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
48317595|NCT02015520|155364153|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
48317596|NCT02015520|155364150|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
48570946|NCT02729051|156282307|FG001|Overall Study|Adverse Event|11|||
48570947|NCT02729051|156282306|FG000|Overall Study|Lack of Efficacy|1|||
48570948|NCT02729051|156282307|FG001|Overall Study|Lack of Efficacy|1|||
48317597|NCT02015520|155364151|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
48570949|NCT02729051|156282306|FG000|Overall Study|Lost to Follow-up|1|||
48570950|NCT02729051|156282307|FG001|Overall Study|Lost to Follow-up|2|||
48570951|NCT02729051|156282306|FG000|Overall Study|Physician Decision|1|||
48570952|NCT02729051|156282307|FG001|Overall Study|Physician Decision|1|||
48317598|NCT02015520|155364152|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
48317599|NCT02015520|155364153|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
48317600|NCT02616900|155364154|FG000|Overall Study|Lack of Efficacy|7|||
48317601|NCT02616900|155364154|FG000|Overall Study|Lost to Follow-up|2|||
48317602|NCT02616900|155364154|FG000|Overall Study|Protocol Violation|5|||
48317603|NCT02616900|155364154|FG000|Overall Study|Withdrawal by Subject|3|||
48317604|NCT02616900|155364154|FG000|Overall Study|Incomplete data|6|||
48317605|NCT01087762|155364155|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
48317606|NCT01087762|155364156|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
48317607|NCT01087762|155364157|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
48317608|NCT01087762|155364158|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
48317609|NCT01087762|155364159|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
48317610|NCT01087762|155364155|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
48317611|NCT01087762|155364156|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
48317612|NCT01087762|155364157|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
48317613|NCT01087762|155364158|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
48317614|NCT01087762|155364159|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
48317615|NCT01087762|155364155|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
48317616|NCT01087762|155364156|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
48317617|NCT01087762|155364157|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
48317618|NCT01087762|155364158|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
48317619|NCT01087762|155364159|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
48317620|NCT01087762|155364155|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
48317621|NCT01087762|155364156|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
48317622|NCT01087762|155364157|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
48317623|NCT01087762|155364158|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
48618775|NCT02400736|156461359|FG000|Overall Study|Moved from the area|3|||
48317624|NCT01087762|155364159|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
48317625|NCT01087762|155364155|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
48317626|NCT01087762|155364156|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
48570953|NCT02729051|156282306|FG000|Overall Study|Withdrawal by Subject|6|||
48570954|NCT02729051|156282307|FG001|Overall Study|Withdrawal by Subject|17|||
48570955|NCT02702388|156282308|FG000|Overall Study|Disease Progression|18|||
48570956|NCT02702388|156282309|FG001|Overall Study|Disease Progression|25|||
48570957|NCT02702388|156282308|FG000|Overall Study|Withdrawal by Subject|9|||
48570958|NCT02702388|156282309|FG001|Overall Study|Withdrawal by Subject|7|||
48570959|NCT02702388|156282308|FG000|Overall Study|Adverse Event|11|||
48570960|NCT02702388|156282309|FG001|Overall Study|Adverse Event|15|||
48570961|NCT02702388|156282308|FG000|Overall Study|Other|2|||
48570962|NCT02702388|156282309|FG001|Overall Study|Other|4|||
48570963|NCT02406027|156282310|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
48570964|NCT02406027|156282311|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
48570965|NCT02406027|156282312|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
48570966|NCT02406027|156282313|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
48570967|NCT02406027|156282314|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
48570968|NCT02406027|156282315|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
48570969|NCT02406027|156282316|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
48570970|NCT02406027|156282310|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
48570971|NCT02406027|156282311|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
48570972|NCT02406027|156282312|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
48570973|NCT02406027|156282313|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
48570974|NCT02406027|156282314|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
48570975|NCT02406027|156282315|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
48570976|NCT02406027|156282316|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
48570977|NCT02406027|156282310|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
48570978|NCT02406027|156282311|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
48570979|NCT02406027|156282312|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
48570980|NCT02406027|156282313|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
48570981|NCT02406027|156282314|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
48570982|NCT02406027|156282315|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
48570983|NCT02406027|156282316|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
48570984|NCT02406027|156282310|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
48570985|NCT02406027|156282311|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
48570986|NCT02406027|156282312|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
48570987|NCT02406027|156282313|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
48570988|NCT02406027|156282314|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
48570989|NCT02406027|156282315|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
48570990|NCT02406027|156282316|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
48317627|NCT01087762|155364157|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
48317628|NCT01087762|155364158|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
48317629|NCT01087762|155364159|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
48570991|NCT02406027|156282310|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
48570992|NCT02406027|156282311|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
48618776|NCT02400736|156461360|FG001|Overall Study|Moved from the area|1|||
48317630|NCT01087762|155364155|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
48570993|NCT02406027|156282312|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
48570994|NCT02406027|156282313|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
48570995|NCT02406027|156282314|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
48570996|NCT02406027|156282315|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
48618777|NCT02370394|156461361|FG000|Overall Study|Lost to Follow-up|2|||
48317631|NCT01087762|155364156|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
48317632|NCT01087762|155364157|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
48317633|NCT01087762|155364158|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
48317634|NCT01087762|155364159|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
48317635|NCT01087762|155364155|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
48317636|NCT01087762|155364156|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
48317637|NCT01087762|155364157|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
48317638|NCT01087762|155364158|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
48317639|NCT01087762|155364159|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
48317640|NCT01087762|155364155|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
48317641|NCT01087762|155364156|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
48317642|NCT01087762|155364157|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
48317643|NCT01087762|155364158|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
48317644|NCT01087762|155364159|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
48317645|NCT01087762|155364155|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
48317646|NCT01087762|155364156|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
48317647|NCT01087762|155364157|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
48317648|NCT01087762|155364158|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
48317649|NCT01087762|155364159|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
48317650|NCT01087762|155364155|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
48317651|NCT01087762|155364156|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
48317652|NCT01087762|155364157|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
48317653|NCT01087762|155364158|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
48317654|NCT01087762|155364159|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
48317655|NCT01087762|155364155|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
48317656|NCT01087762|155364156|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
48317657|NCT01087762|155364157|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
48317658|NCT01087762|155364158|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
48317659|NCT01087762|155364159|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
48317660|NCT01087762|155364155|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
48317661|NCT01087762|155364156|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
48317662|NCT01087762|155364157|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
48317663|NCT01087762|155364158|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
48317664|NCT01087762|155364159|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
48317665|NCT01087762|155364155|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
48317666|NCT01087762|155364156|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
48317667|NCT01087762|155364157|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
48317668|NCT01087762|155364158|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
48317669|NCT01087762|155364159|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
48317670|NCT01641198|155364164|FG000|After 12 Months of Function|Lost to Follow-up|3|||
48317671|NCT01641198|155364165|FG001|After 12 Months of Function|Lost to Follow-up|2|||
48317672|NCT01641198|155364166|FG002|After 12 Months of Function|Lost to Follow-up|2|||
48317673|NCT01641198|155364164|FG000|After 12 Months of Function|Protocol Violation|1|||
48317674|NCT01641198|155364165|FG001|After 12 Months of Function|Protocol Violation|0|||
48317675|NCT01641198|155364166|FG002|After 12 Months of Function|Protocol Violation|0|||
48570997|NCT02406027|156282316|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
48317676|NCT01641198|155364164|FG000|After 12 Months of Function|Adverse Event|0|||
48570998|NCT02406027|156282310|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
48570999|NCT02406027|156282311|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
48571000|NCT02406027|156282312|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
48571001|NCT02406027|156282313|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
48571002|NCT02406027|156282314|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
48571003|NCT02406027|156282315|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
48571004|NCT02406027|156282316|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
48571005|NCT02406027|156282310|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
48571006|NCT02406027|156282311|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
48618778|NCT02370394|156461362|FG001|Overall Study|Lost to Follow-up|1|||
48317677|NCT01641198|155364165|FG001|After 12 Months of Function|Adverse Event|1|||
48317678|NCT01641198|155364166|FG002|After 12 Months of Function|Adverse Event|0|||
48317679|NCT01641198|155364164|FG000|After 24 Months of Function|Lost to Follow-up|4|||
48317680|NCT01641198|155364165|FG001|After 24 Months of Function|Lost to Follow-up|9|||
48317681|NCT01641198|155364166|FG002|After 24 Months of Function|Lost to Follow-up|6|||
48571007|NCT02406027|156282312|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
48618779|NCT02370394|156461361|FG000|Overall Study|Withdrawal by Subject|0|||
48618780|NCT02370394|156461362|FG001|Overall Study|Withdrawal by Subject|1|||
48618781|NCT01105130|156461363|FG000|Overall Study|Withdrawal by Subject|4|||
48618782|NCT01105130|156461364|FG001|Overall Study|Withdrawal by Subject|6|||
48618783|NCT01105130|156461365|FG002|Overall Study|Withdrawal by Subject|2|||
48618784|NCT01105130|156461363|FG000|Overall Study|Never Started|2|||
48618785|NCT01105130|156461364|FG001|Overall Study|Never Started|2|||
48618786|NCT01105130|156461365|FG002|Overall Study|Never Started|4|||
48618787|NCT01105130|156461363|FG000|Overall Study|Toxicity|1|||
48618788|NCT01105130|156461364|FG001|Overall Study|Toxicity|3|||
48618789|NCT01105130|156461365|FG002|Overall Study|Toxicity|2|||
48618790|NCT01105130|156461363|FG000|Overall Study|Multiple Reasons|3|||
48618791|NCT01105130|156461364|FG001|Overall Study|Multiple Reasons|0|||
48618792|NCT01105130|156461365|FG002|Overall Study|Multiple Reasons|2|||
48618793|NCT02927145|156461370|FG000|Initial Recruitment|Withdrawal by Subject|0|||
48618794|NCT02927145|156461371|FG001|Initial Recruitment|Withdrawal by Subject|1|||
48618795|NCT02927145|156461372|FG002|Initial Recruitment|Withdrawal by Subject|1|||
48618796|NCT02927145|156461373|FG003|Initial Recruitment|Withdrawal by Subject|4|||
48618797|NCT02927145|156461374|FG004|Initial Recruitment|Withdrawal by Subject|1|||
48618798|NCT02927145|156461375|FG005|Initial Recruitment|Withdrawal by Subject|1|||
48618799|NCT02927145|156461376|FG006|Initial Recruitment|Withdrawal by Subject|0|||
48618800|NCT02927145|156461377|FG007|Initial Recruitment|Withdrawal by Subject|0|||
48618801|NCT02927145|156461378|FG008|Initial Recruitment|Withdrawal by Subject|2|||
48618802|NCT02927145|156461370|FG000|Initial Recruitment|Adverse Event|0|||
48618803|NCT02927145|156461371|FG001|Initial Recruitment|Adverse Event|0|||
48618804|NCT02927145|156461372|FG002|Initial Recruitment|Adverse Event|0|||
48735953|NCT04478266|156883736|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
48735954|NCT04478266|156883737|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
48735955|NCT04478266|156883736|FG000|Overall Study|Study terminated by sponsor|33|||
48735956|NCT04478266|156883737|FG001|Overall Study|Study terminated by sponsor|35|||
48735957|NCT04478266|156883736|FG000|Overall Study|Other: unspecified|5|||
48735958|NCT04478266|156883737|FG001|Overall Study|Other: unspecified|7|||
48735959|NCT04478266|156883736|FG000|Overall Study|Randomized but not treated|1|||
48735960|NCT04478266|156883737|FG001|Overall Study|Randomized but not treated|1|||
48735961|NCT02699593|156883745|FG000|Period 1|Unsatisfactory Visual Response|0|||
48735962|NCT02699593|156883746|FG001|Period 1|Unsatisfactory Visual Response|1|||
48735963|NCT02699593|156883745|FG000|Period 1|Torn Contact Len|4|||
48735964|NCT02699593|156883746|FG001|Period 1|Torn Contact Len|3|||
48735965|NCT02699593|156883745|FG000|Period 1|Protocol Violation|0|||
48735966|NCT02699593|156883746|FG001|Period 1|Protocol Violation|1|||
48735967|NCT02699593|156883745|FG000|Period 1|Withdrawal by Subject|0|||
48735968|NCT02699593|156883746|FG001|Period 1|Withdrawal by Subject|1|||
48735969|NCT02699593|156883745|FG000|Period 1|Adverse Event|1|||
48735970|NCT02699593|156883746|FG001|Period 1|Adverse Event|1|||
48735971|NCT02699593|156883745|FG000|Period 2|Adverse Event|1|||
48735972|NCT02699593|156883746|FG001|Period 2|Adverse Event|1|||
48735973|NCT02699593|156883745|FG000|Period 2|Lost Contact Lens|0|||
48735974|NCT02699593|156883746|FG001|Period 2|Lost Contact Lens|1|||
48735975|NCT02699593|156883745|FG000|Period 2|Torn Contact Lens|1|||
48735976|NCT02699593|156883746|FG001|Period 2|Torn Contact Lens|0|||
48735977|NCT02935842|156883747|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
48735978|NCT02935842|156883748|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
48735979|NCT02935842|156883749|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
48735980|NCT02935842|156883750|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
48735981|NCT02935842|156883747|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
48735982|NCT02935842|156883748|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
48735983|NCT02935842|156883749|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
48571008|NCT02406027|156282313|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
48571009|NCT02406027|156282314|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
48571010|NCT02406027|156282315|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
48571011|NCT02406027|156282316|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
48571012|NCT02406027|156282310|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
48571013|NCT02406027|156282311|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
48571014|NCT02406027|156282312|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
48571015|NCT02406027|156282313|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
48735984|NCT02935842|156883750|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
48571016|NCT02406027|156282314|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
48735985|NCT02935842|156883747|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
48735986|NCT02935842|156883748|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
48571017|NCT02406027|156282315|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
48571018|NCT02406027|156282316|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
48571019|NCT02406027|156282310|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
48618805|NCT02927145|156461373|FG003|Initial Recruitment|Adverse Event|0|||
48618806|NCT02927145|156461374|FG004|Initial Recruitment|Adverse Event|2|||
48618807|NCT02927145|156461375|FG005|Initial Recruitment|Adverse Event|0|||
48618808|NCT02927145|156461376|FG006|Initial Recruitment|Adverse Event|0|||
48618809|NCT02927145|156461377|FG007|Initial Recruitment|Adverse Event|0|||
48618810|NCT02927145|156461378|FG008|Initial Recruitment|Adverse Event|0|||
48618811|NCT02927145|156461370|FG000|Invitation for Additional Challenge|Pregnancy|0|||
48618812|NCT02927145|156461371|FG001|Invitation for Additional Challenge|Pregnancy|0|||
48618813|NCT02927145|156461372|FG002|Invitation for Additional Challenge|Pregnancy|0|||
48618814|NCT02927145|156461373|FG003|Invitation for Additional Challenge|Pregnancy|0|||
48618815|NCT02927145|156461374|FG004|Invitation for Additional Challenge|Pregnancy|0|||
48618816|NCT02927145|156461375|FG005|Invitation for Additional Challenge|Pregnancy|0|||
48618817|NCT02927145|156461376|FG006|Invitation for Additional Challenge|Pregnancy|1|||
48618818|NCT02927145|156461377|FG007|Invitation for Additional Challenge|Pregnancy|0|||
48618819|NCT02927145|156461378|FG008|Invitation for Additional Challenge|Pregnancy|0|||
48618820|NCT00599313|156461382|FG000|Overall Study|Adverse Event|19|||
48618821|NCT00599313|156461382|FG000|Overall Study|Disease Progression|12|||
48618822|NCT00599313|156461382|FG000|Overall Study|Patient Request|4|||
48618823|NCT00599313|156461382|FG000|Overall Study|Ineligible|1|||
48618824|NCT00456612|156461387|FG000|Overall Study|Withdrawal by Subject|3|||
48618825|NCT00356590|156461392|FG000|Overall Study|Adverse Event|54|||
48618826|NCT00356590|156461392|FG000|Overall Study|Death|10|||
48618827|NCT00356590|156461392|FG000|Overall Study|Lost to Follow-up|35|||
48618828|NCT00356590|156461392|FG000|Overall Study|Physician Decision|46|||
48618829|NCT00356590|156461392|FG000|Overall Study|Withdrawal by Subject|41|||
48618830|NCT00356590|156461392|FG000|Overall Study|Completed month 12 only|2|||
48618831|NCT00356590|156461392|FG000|Overall Study|Protocol issues|6|||
48618832|NCT00356590|156461392|FG000|Overall Study|Response status|28|||
48618833|NCT00356590|156461392|FG000|Overall Study|Other|52|||
48618834|NCT03422718|156461395|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
48618835|NCT03422718|156461396|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
48618836|NCT03422718|156461397|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
48618837|NCT03422718|156461398|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
48618838|NCT03422718|156461399|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
48618839|NCT03422718|156461400|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
48618840|NCT03422718|156461401|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
48618841|NCT03422718|156461402|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
48618842|NCT03422718|156461395|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
48618843|NCT03422718|156461396|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
48618844|NCT03422718|156461397|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
48618845|NCT03422718|156461398|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
48618846|NCT03422718|156461399|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
48618847|NCT03422718|156461400|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
48618848|NCT03422718|156461401|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
48317682|NCT01641198|155364164|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
48317683|NCT01641198|155364165|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
48317684|NCT01641198|155364166|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
48317685|NCT01641198|155364164|FG000|At 15-20 Years of Function|Death|1|||
48317686|NCT01641198|155364165|FG001|At 15-20 Years of Function|Death|0|||
48317687|NCT01641198|155364166|FG002|At 15-20 Years of Function|Death|1|||
48317688|NCT03737240|155364167|FG000|Overall Study|Lost to Follow-up|16|||
48317689|NCT03737240|155364168|FG001|Overall Study|Lost to Follow-up|15|||
48317690|NCT01061151|155364170|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
48618849|NCT03422718|156461402|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
48317691|NCT01061151|155364171|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
48317692|NCT01061151|155364172|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
48317693|NCT01061151|155364173|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
48571020|NCT02406027|156282311|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
48571021|NCT02406027|156282312|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
48571022|NCT02406027|156282313|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
48571023|NCT02406027|156282314|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
48571024|NCT02406027|156282315|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
48571025|NCT02406027|156282316|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
48571026|NCT02406027|156282310|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
48618850|NCT03422718|156461395|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
48317694|NCT01061151|155364170|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
48317695|NCT01061151|155364171|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
48317696|NCT01061151|155364172|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
48571027|NCT02406027|156282311|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
48571028|NCT02406027|156282312|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
48618851|NCT03422718|156461396|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
48618852|NCT03422718|156461397|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
48618853|NCT03422718|156461398|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
48571029|NCT02406027|156282313|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
48571030|NCT02406027|156282314|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
48618854|NCT03422718|156461399|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
48618855|NCT03422718|156461400|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
48618856|NCT03422718|156461401|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
48618857|NCT03422718|156461402|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
48618858|NCT03422718|156461395|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
48618859|NCT03422718|156461396|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
48618860|NCT03422718|156461397|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
48618861|NCT03422718|156461398|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
48618862|NCT03422718|156461399|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
48618863|NCT03422718|156461400|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
48618864|NCT03422718|156461401|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
48618865|NCT03422718|156461402|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
48618866|NCT03422718|156461395|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
48618867|NCT03422718|156461396|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
48618868|NCT03422718|156461397|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
48618869|NCT03422718|156461398|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
48618870|NCT03422718|156461399|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
48618871|NCT03422718|156461400|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
48618872|NCT03422718|156461401|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
48618873|NCT03422718|156461402|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
48618874|NCT03422718|156461395|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
48618875|NCT03422718|156461396|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
48618876|NCT03422718|156461397|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
48618877|NCT03422718|156461398|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
48618878|NCT03422718|156461399|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
48618879|NCT03422718|156461400|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
48618880|NCT03422718|156461401|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
48618881|NCT03422718|156461402|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
48618882|NCT04602000|156461405|FG000|Overall Study|Withdrawal by Subject|3|||
48618883|NCT04602000|156461406|FG001|Overall Study|Withdrawal by Subject|6|||
48618884|NCT04602000|156461407|FG002|Overall Study|Withdrawal by Subject|3|||
48618885|NCT04602000|156461408|FG003|Overall Study|Withdrawal by Subject|27|||
48317697|NCT01061151|155364173|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
48618886|NCT04602000|156461409|FG004|Overall Study|Withdrawal by Subject|39|||
48618887|NCT04602000|156461405|FG000|Overall Study|Physician Decision|1|||
48618888|NCT04602000|156461406|FG001|Overall Study|Physician Decision|0|||
48618889|NCT04602000|156461407|FG002|Overall Study|Physician Decision|0|||
48317698|NCT01061151|155364170|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
48317699|NCT01061151|155364171|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
48317700|NCT01061151|155364172|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
48317701|NCT01061151|155364173|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
48317702|NCT01061151|155364170|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
48571031|NCT02406027|156282315|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
48571032|NCT02406027|156282316|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
48571033|NCT04075266|156282326|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
48571034|NCT04075266|156282327|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
48571035|NCT04075266|156282326|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
48571036|NCT04075266|156282327|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
48317703|NCT01061151|155364171|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
48317704|NCT01061151|155364172|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
48317705|NCT01061151|155364173|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
48317706|NCT01061151|155364170|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
48317707|NCT01061151|155364171|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
48317708|NCT01061151|155364172|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
48317709|NCT01061151|155364173|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
48317710|NCT01061151|155364170|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
48571037|NCT00617890|156282328|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
48618890|NCT04602000|156461408|FG003|Overall Study|Physician Decision|2|||
48618891|NCT04602000|156461409|FG004|Overall Study|Physician Decision|2|||
48618892|NCT04602000|156461405|FG000|Overall Study|Death|0|||
48618893|NCT04602000|156461406|FG001|Overall Study|Death|1|||
48618894|NCT04602000|156461407|FG002|Overall Study|Death|0|||
48618895|NCT04602000|156461408|FG003|Overall Study|Death|1|||
48618896|NCT04602000|156461409|FG004|Overall Study|Death|2|||
48571038|NCT00617890|156282329|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
48571039|NCT00617890|156282330|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
48571040|NCT00617890|156282331|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
48571041|NCT00617890|156282328|FG000|Overall Study|Lack of Efficacy|23|||
48571042|NCT00617890|156282329|FG001|Overall Study|Lack of Efficacy|26|||
48571043|NCT00617890|156282330|FG002|Overall Study|Lack of Efficacy|30|||
48571044|NCT00617890|156282331|FG003|Overall Study|Lack of Efficacy|97|||
48571045|NCT00617890|156282328|FG000|Overall Study|Lost to Follow-up|0|||
48571046|NCT00617890|156282329|FG001|Overall Study|Lost to Follow-up|0|||
48571047|NCT00617890|156282330|FG002|Overall Study|Lost to Follow-up|1|||
48571048|NCT00617890|156282331|FG003|Overall Study|Lost to Follow-up|2|||
48571049|NCT00617890|156282328|FG000|Overall Study|Withdrawal by Subject|4|||
48571050|NCT00617890|156282329|FG001|Overall Study|Withdrawal by Subject|1|||
48571051|NCT00617890|156282330|FG002|Overall Study|Withdrawal by Subject|0|||
48571052|NCT00617890|156282331|FG003|Overall Study|Withdrawal by Subject|2|||
48571053|NCT00617890|156282328|FG000|Overall Study|Protocol Violation|2|||
48571054|NCT00617890|156282329|FG001|Overall Study|Protocol Violation|1|||
48571055|NCT00617890|156282330|FG002|Overall Study|Protocol Violation|0|||
48571056|NCT00617890|156282331|FG003|Overall Study|Protocol Violation|0|||
48571057|NCT00617890|156282328|FG000|Overall Study|Adverse Event|1|||
48317711|NCT01061151|155364171|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
48317712|NCT01061151|155364172|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
48317713|NCT01061151|155364173|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
48317714|NCT01061151|155364170|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
48317715|NCT01061151|155364171|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
48571058|NCT00617890|156282329|FG001|Overall Study|Adverse Event|0|||
48571059|NCT00617890|156282330|FG002|Overall Study|Adverse Event|3|||
48571060|NCT00617890|156282331|FG003|Overall Study|Adverse Event|8|||
48571061|NCT00617890|156282328|FG000|Overall Study|Not treated|1|||
48571062|NCT00617890|156282329|FG001|Overall Study|Not treated|0|||
48571063|NCT00617890|156282330|FG002|Overall Study|Not treated|1|||
48571064|NCT00617890|156282331|FG003|Overall Study|Not treated|1|||
48571065|NCT00961571|156283759|FG000|Overall Study|Physician Decision|39|||
48571066|NCT00975611|156283760|FG000|Overall Study|Screen Fail|16|||
48571067|NCT00975611|156283760|FG000|Overall Study|Physician Decision|1|||
48571068|NCT03058705|156283761|FG000|Overall Study|Withdrawal by Subject|2|||
48571069|NCT03058705|156283761|FG000|Overall Study|Physician Decision|2|||
48571070|NCT01068730|156283762|FG000|Period 3|Personal reason|1|||
48571071|NCT01068730|156283763|FG001|Period 3|Personal reason|0|||
48618897|NCT04602000|156461405|FG000|Overall Study|Lost to Follow-up|0|||
48618898|NCT04602000|156461406|FG001|Overall Study|Lost to Follow-up|0|||
48618899|NCT04602000|156461407|FG002|Overall Study|Lost to Follow-up|0|||
48618900|NCT04602000|156461408|FG003|Overall Study|Lost to Follow-up|3|||
48618901|NCT04602000|156461409|FG004|Overall Study|Lost to Follow-up|4|||
48618902|NCT04602000|156461405|FG000|Overall Study|Other|4|||
48618903|NCT04602000|156461406|FG001|Overall Study|Other|1|||
48618904|NCT04602000|156461407|FG002|Overall Study|Other|2|||
48618905|NCT04602000|156461408|FG003|Overall Study|Other|5|||
48317716|NCT01061151|155364172|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
48317717|NCT01061151|155364173|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
48317718|NCT01061151|155364170|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
48317719|NCT01061151|155364171|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
48571072|NCT01068730|156283764|FG002|Period 3|Personal reason|0|||
48571073|NCT01068730|156283765|FG003|Period 3|Personal reason|0|||
48571074|NCT01068730|156283762|FG000|Period 4|Family emergency|0|||
48571075|NCT01068730|156283763|FG001|Period 4|Family emergency|1|||
48571076|NCT01068730|156283764|FG002|Period 4|Family emergency|0|||
48317720|NCT01061151|155364172|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
48317721|NCT01061151|155364173|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
48317722|NCT01061151|155364170|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
48317723|NCT01061151|155364171|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
48571077|NCT01068730|156283765|FG003|Period 4|Family emergency|0|||
48571078|NCT03508726|156283766|FG000|Overall Study|Withdrawal by Subject|0|||
48571079|NCT03508726|156283767|FG001|Overall Study|Withdrawal by Subject|1|||
48571080|NCT06232590|156283771|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
48571081|NCT06232590|156283772|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
48571082|NCT02492984|156283776|FG000|Overall Study|Adverse Event|1|||
48571083|NCT02492984|156283777|FG001|Overall Study|Adverse Event|0|||
48571084|NCT02492984|156283776|FG000|Overall Study|Protocol Violation|1|||
48571085|NCT02492984|156283777|FG001|Overall Study|Protocol Violation|0|||
48571086|NCT02492984|156283776|FG000|Overall Study|Withdrawal by Subject|1|||
48571087|NCT02492984|156283777|FG001|Overall Study|Withdrawal by Subject|0|||
48571088|NCT02126579|156283778|FG000|Overall Study|disease progression|0|||
48618906|NCT04602000|156461409|FG004|Overall Study|Other|4|||
48618907|NCT04602000|156461405|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
48618908|NCT04602000|156461406|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
48317724|NCT01061151|155364172|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
48317725|NCT01061151|155364173|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
48571089|NCT02126579|156283779|FG001|Overall Study|disease progression|0|||
48571090|NCT02126579|156283780|FG002|Overall Study|disease progression|0|||
48571091|NCT02126579|156283781|FG003|Overall Study|disease progression|1|||
48571092|NCT02126579|156283782|FG004|Overall Study|disease progression|0|||
48571093|NCT02126579|156283783|FG005|Overall Study|disease progression|0|||
48571094|NCT02126579|156283784|FG006|Overall Study|disease progression|1|||
48571095|NCT04105218|156283785|FG000|Overall Study|Withdrawal by Subject|3|||
48571096|NCT04105218|156283786|FG001|Overall Study|Withdrawal by Subject|2|||
48571097|NCT04105218|156283785|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
48571098|NCT04105218|156283786|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
48571099|NCT04105218|156283785|FG000|Overall Study|Failed screening tests|2|||
48571100|NCT04105218|156283786|FG001|Overall Study|Failed screening tests|1|||
48571101|NCT03047213|156283789|FG000|Overall Study|Withdrawal by Subject|2|||
48571102|NCT03047213|156283790|FG001|Overall Study|Withdrawal by Subject|0|||
48571103|NCT03047213|156283789|FG000|Overall Study|Adverse Event|2|||
48571104|NCT03047213|156283790|FG001|Overall Study|Adverse Event|0|||
48571105|NCT02101736|156283791|FG000|Overall Study|Protocol Violation|3|||
48571106|NCT02101736|156283792|FG001|Overall Study|Protocol Violation|0|||
48571107|NCT02101736|156283791|FG000|Overall Study|Withdrawal by Subject|1|||
48571108|NCT02101736|156283792|FG001|Overall Study|Withdrawal by Subject|1|||
48571109|NCT03674112|156283794|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
48571110|NCT03674112|156283795|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
48571111|NCT03674112|156283794|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
48571112|NCT03674112|156283795|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
48571113|NCT03674112|156283794|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
48571114|NCT03674112|156283795|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
48571115|NCT03674112|156283794|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
48571116|NCT03674112|156283795|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
48571117|NCT03674112|156283794|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
48618909|NCT04602000|156461407|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
48618910|NCT04602000|156461408|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
48618911|NCT04602000|156461409|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
48618912|NCT03055221|156461411|FG000|Overall Study|Adverse Event|2|||
48618913|NCT03055221|156461411|FG000|Overall Study|Withdrawal by Subject|4|||
48618914|NCT03055221|156461411|FG000|Overall Study|Death|6|||
48618915|NCT03055221|156461411|FG000|Overall Study|Physician Decision|1|||
48618916|NCT03055221|156461411|FG000|Overall Study|Study terminated by Sponsor|3|||
48618917|NCT03055221|156461411|FG000|Overall Study|Lost to Follow-up|4|||
48618918|NCT01243424|156461412|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
48618919|NCT01243424|156461413|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
48618920|NCT01243424|156461412|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
48618921|NCT01243424|156461413|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
48618922|NCT01243424|156461412|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
48618923|NCT01243424|156461413|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
48735987|NCT02935842|156883749|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
48618924|NCT01243424|156461412|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
48618925|NCT01243424|156461413|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
48618926|NCT01243424|156461412|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
48618927|NCT01243424|156461413|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
48618928|NCT01243424|156461412|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
48317726|NCT01061151|155364170|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
48571118|NCT03674112|156283795|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
48571119|NCT03674112|156283794|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
48571120|NCT03674112|156283795|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
48571121|NCT03674112|156283794|FG000|Follow-Up Period (≥3 Years)|Death|2|||
48571122|NCT03674112|156283795|FG001|Follow-Up Period (≥3 Years)|Death|0|||
48571123|NCT03674112|156283794|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
48571124|NCT03674112|156283795|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
48571125|NCT01222520|156283800|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
48571126|NCT01222520|156283801|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
48571127|NCT01222520|156283800|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
48571128|NCT01222520|156283801|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
48571129|NCT01222520|156283800|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
48571130|NCT01222520|156283801|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
48571131|NCT01222520|156283800|FG000|Double-blind Period|Adverse Event|0|||
48571132|NCT01222520|156283801|FG001|Double-blind Period|Adverse Event|1|||
48571133|NCT01222520|156283800|FG000|Double-blind Period|Lack of Efficacy|0|||
48571134|NCT01222520|156283801|FG001|Double-blind Period|Lack of Efficacy|1|||
48571135|NCT01222520|156283800|FG000|Double-blind Period|Study medication stolen|1|||
48571136|NCT01222520|156283801|FG001|Double-blind Period|Study medication stolen|0|||
48571137|NCT02285166|156283802|FG000|Overall Study|Case Report Forms Uncollected|564|||
48571138|NCT02285166|156283802|FG000|Overall Study|Protocol Deviation|402|||
48571139|NCT02964208|156283805|FG000|Overall Study|Death|103|||
48571140|NCT02964208|156283805|FG000|Overall Study|Withdrawal by Subject|6|||
48571141|NCT02964208|156283805|FG000|Overall Study|Lost to Follow-up|6|||
48571142|NCT02964208|156283805|FG000|Overall Study|Unsuccessful Procedure|5|||
48571143|NCT02964208|156283805|FG000|Overall Study|Device Explant|1|||
48571144|NCT02964208|156283805|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
48571145|NCT00384839|156283810|FG000|Overall Study|Adverse Event|4|||
48571146|NCT00384839|156283810|FG000|Overall Study|Investigator Request|1|||
48571147|NCT00384839|156283810|FG000|Overall Study|Patient Request|1|||
48571148|NCT00384839|156283810|FG000|Overall Study|Ineligible|2|||
48571149|NCT00443079|156283813|FG000|Overall Study|Lost to Follow-up|0|||
48571150|NCT00443079|156283814|FG001|Overall Study|Lost to Follow-up|1|||
48571151|NCT04292912|156283815|FG000|Overall Study|Physician Decision|1|||
48571152|NCT04292912|156283815|FG000|Overall Study|Protocol Violation|6|||
48571153|NCT02649439|156283816|FG000|Overall Study|Switched to alternative treatment|6|||
48571154|NCT02649439|156283817|FG001|Overall Study|Switched to alternative treatment|4|||
48571155|NCT02649439|156283816|FG000|Overall Study|Patient decision|1|||
48571156|NCT02649439|156283817|FG001|Overall Study|Patient decision|0|||
48571157|NCT02649439|156283816|FG000|Overall Study|Patient going out of country|1|||
48571158|NCT02649439|156283817|FG001|Overall Study|Patient going out of country|0|||
48571159|NCT02649439|156283816|FG000|Overall Study|To start finasteride|1|||
48571160|NCT02649439|156283817|FG001|Overall Study|To start finasteride|0|||
48571161|NCT02649439|156283816|FG000|Overall Study|Physician Decision|1|||
48571162|NCT02649439|156283817|FG001|Overall Study|Physician Decision|0|||
48571163|NCT02649439|156283816|FG000|Overall Study|Disease progression on study|12|||
48571164|NCT02649439|156283817|FG001|Overall Study|Disease progression on study|13|||
48571165|NCT02649439|156283816|FG000|Overall Study|Refused further treatment|1|||
48571166|NCT02649439|156283817|FG001|Overall Study|Refused further treatment|0|||
48571167|NCT02649439|156283816|FG000|Overall Study|Refused further follow up|2|||
48571168|NCT02649439|156283817|FG001|Overall Study|Refused further follow up|7|||
48571169|NCT02649439|156283816|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
48571170|NCT02649439|156283817|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
48571171|NCT02649439|156283816|FG000|Overall Study|No treatment, per protocol|1|||
48571172|NCT02649439|156283817|FG001|Overall Study|No treatment, per protocol|0|||
48571173|NCT02649439|156283816|FG000|Overall Study|PSA DT makes ineligible|0|||
48571174|NCT02649439|156283817|FG001|Overall Study|PSA DT makes ineligible|1|||
48571175|NCT02649439|156283816|FG000|Overall Study|Rising PSA No Mets|0|||
48571176|NCT02649439|156283817|FG001|Overall Study|Rising PSA No Mets|1|||
48571177|NCT02649439|156283816|FG000|Overall Study|Rising PSA|0|||
48571178|NCT02649439|156283817|FG001|Overall Study|Rising PSA|1|||
48571179|NCT02649439|156283816|FG000|Overall Study|Signed follow up protocol|0|||
48571180|NCT02649439|156283817|FG001|Overall Study|Signed follow up protocol|1|||
48571181|NCT02136134|156283818|FG000|Overall Study|Death|170|||
48618929|NCT01243424|156461413|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
48571182|NCT02136134|156283819|FG001|Overall Study|Death|148|||
48571183|NCT02136134|156283818|FG000|Overall Study|Withdrawal by Subject|19|||
48571184|NCT02136134|156283819|FG001|Overall Study|Withdrawal by Subject|10|||
48571185|NCT02136134|156283818|FG000|Overall Study|Lost to Follow-up|3|||
48571186|NCT02136134|156283819|FG001|Overall Study|Lost to Follow-up|3|||
48571187|NCT02136134|156283818|FG000|Overall Study|Uspecified|55|||
48571188|NCT02136134|156283819|FG001|Overall Study|Uspecified|90|||
48571189|NCT02049814|156283826|FG000|Overall Study|Reason not Specified|4|||
48571190|NCT02049814|156283827|FG001|Overall Study|Reason not Specified|3|||
48571191|NCT02049814|156283826|FG000|Overall Study|Pregnancy|1|||
48571192|NCT02049814|156283827|FG001|Overall Study|Pregnancy|0|||
48571193|NCT02049814|156283826|FG000|Overall Study|Lost to Follow-up|2|||
48571194|NCT02049814|156283827|FG001|Overall Study|Lost to Follow-up|3|||
48571195|NCT02049814|156283826|FG000|Overall Study|Serious Protocol Violation|5|||
48571196|NCT02049814|156283827|FG001|Overall Study|Serious Protocol Violation|7|||
48571197|NCT02049814|156283826|FG000|Overall Study|Study Termination|0|||
48571198|NCT02049814|156283827|FG001|Overall Study|Study Termination|1|||
48571199|NCT02049814|156283826|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
48571200|NCT02049814|156283827|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
48571201|NCT02049814|156283826|FG000|Overall Study|Voluntary withdrawal|9|||
48571202|NCT02049814|156283827|FG001|Overall Study|Voluntary withdrawal|8|||
48571203|NCT02097238|156283828|FG000|Overall Study|Death|1|||
48571204|NCT02097238|156283828|FG000|Overall Study|Physician Decision|1|||
48571205|NCT02097238|156283828|FG000|Overall Study|Progressive Disease|17|||
48571206|NCT03476343|156283829|FG000|Overall Study|Clinical exam moved to another scanner|7|||
48571207|NCT03476343|156283829|FG000|Overall Study|Clinical order cancelled|4|||
48571208|NCT03476343|156283829|FG000|Overall Study|Neonate did not settle down for the scan|1|||
48571209|NCT03088878|156283830|FG000|Overall Study|Adverse Event|0|||
48571210|NCT03088878|156283831|FG001|Overall Study|Adverse Event|0|||
48571211|NCT03088878|156283832|FG002|Overall Study|Adverse Event|0|||
48571212|NCT03088878|156283833|FG003|Overall Study|Adverse Event|0|||
48571213|NCT03088878|156283834|FG004|Overall Study|Adverse Event|4|||
48571214|NCT03088878|156283835|FG005|Overall Study|Adverse Event|2|||
48571215|NCT03088878|156283836|FG006|Overall Study|Adverse Event|1|||
48571216|NCT03088878|156283837|FG007|Overall Study|Adverse Event|0|||
48571217|NCT03088878|156283838|FG008|Overall Study|Adverse Event|0|||
48571218|NCT03088878|156283839|FG009|Overall Study|Adverse Event|0|||
48571219|NCT03088878|156283840|FG010|Overall Study|Adverse Event|0|||
48571220|NCT03088878|156283841|FG011|Overall Study|Adverse Event|0|||
48571221|NCT03088878|156283842|FG012|Overall Study|Adverse Event|5|||
48571222|NCT03088878|156283843|FG013|Overall Study|Adverse Event|3|||
48571223|NCT03088878|156283830|FG000|Overall Study|Clinical Progression|0|||
48571224|NCT03088878|156283831|FG001|Overall Study|Clinical Progression|0|||
48571225|NCT03088878|156283832|FG002|Overall Study|Clinical Progression|0|||
48571226|NCT03088878|156283833|FG003|Overall Study|Clinical Progression|0|||
48571227|NCT03088878|156283834|FG004|Overall Study|Clinical Progression|2|||
48571228|NCT03088878|156283835|FG005|Overall Study|Clinical Progression|0|||
48571229|NCT03088878|156283836|FG006|Overall Study|Clinical Progression|0|||
48571230|NCT03088878|156283837|FG007|Overall Study|Clinical Progression|0|||
48571231|NCT03088878|156283838|FG008|Overall Study|Clinical Progression|0|||
48571232|NCT03088878|156283839|FG009|Overall Study|Clinical Progression|0|||
48571233|NCT03088878|156283840|FG010|Overall Study|Clinical Progression|0|||
48571234|NCT03088878|156283841|FG011|Overall Study|Clinical Progression|0|||
48571235|NCT03088878|156283842|FG012|Overall Study|Clinical Progression|0|||
48571236|NCT03088878|156283843|FG013|Overall Study|Clinical Progression|0|||
48571237|NCT03088878|156283830|FG000|Overall Study|Death|0|||
48571238|NCT03088878|156283831|FG001|Overall Study|Death|0|||
48317727|NCT01061151|155364171|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
48317728|NCT01061151|155364172|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
48317729|NCT01061151|155364173|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
48317730|NCT01061151|155364170|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
48571239|NCT03088878|156283832|FG002|Overall Study|Death|0|||
48571240|NCT03088878|156283833|FG003|Overall Study|Death|0|||
48571241|NCT03088878|156283834|FG004|Overall Study|Death|2|||
48571242|NCT03088878|156283835|FG005|Overall Study|Death|0|||
48571243|NCT03088878|156283836|FG006|Overall Study|Death|0|||
48571244|NCT03088878|156283837|FG007|Overall Study|Death|0|||
48571245|NCT03088878|156283838|FG008|Overall Study|Death|0|||
48571246|NCT03088878|156283839|FG009|Overall Study|Death|0|||
48571247|NCT03088878|156283840|FG010|Overall Study|Death|0|||
48571248|NCT03088878|156283841|FG011|Overall Study|Death|1|||
48571249|NCT03088878|156283842|FG012|Overall Study|Death|0|||
48317731|NCT01061151|155364171|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
48571250|NCT03088878|156283843|FG013|Overall Study|Death|0|||
48571251|NCT03088878|156283830|FG000|Overall Study|Disease Progression|1|||
48571252|NCT03088878|156283831|FG001|Overall Study|Disease Progression|2|||
48571253|NCT03088878|156283832|FG002|Overall Study|Disease Progression|3|||
48571254|NCT03088878|156283833|FG003|Overall Study|Disease Progression|0|||
48571255|NCT03088878|156283834|FG004|Overall Study|Disease Progression|3|||
48618930|NCT01243424|156461412|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
48618931|NCT01243424|156461413|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
48618932|NCT01243424|156461412|FG000|Discontinuation From Treatment|Not treated|5|||
48618933|NCT01243424|156461413|FG001|Discontinuation From Treatment|Not treated|4|||
48618934|NCT01243424|156461412|FG000|Discontinuation From Treatment|Adverse Event|457|||
48618935|NCT01243424|156461413|FG001|Discontinuation From Treatment|Adverse Event|523|||
48618936|NCT01243424|156461412|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
48618937|NCT01243424|156461413|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
48618938|NCT01243424|156461412|FG000|Discontinuation From Treatment|Protocol Violation|46|||
48618939|NCT01243424|156461413|FG001|Discontinuation From Treatment|Protocol Violation|47|||
48618940|NCT01243424|156461412|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
48618941|NCT01243424|156461413|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
48618942|NCT01243424|156461412|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
48618943|NCT01243424|156461413|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
48618944|NCT01243424|156461412|FG000|Discontinuation From Treatment|Other than listed above|230|||
48618945|NCT01243424|156461413|FG001|Discontinuation From Treatment|Other than listed above|211|||
48618946|NCT01960842|156461420|FG000|Overall Study|Adverse Event|1|||
48618947|NCT01960842|156461420|FG000|Overall Study|Withdrawal by Subject|2|||
48618948|NCT01160744|156461434|FG000|Overall Study|Withdrawal by Subject|11|||
48618949|NCT01160744|156461435|FG001|Overall Study|Withdrawal by Subject|5|||
48618950|NCT01160744|156461436|FG002|Overall Study|Withdrawal by Subject|6|||
48618951|NCT01160744|156461437|FG003|Overall Study|Withdrawal by Subject|4|||
48618952|NCT01160744|156461434|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
48618953|NCT01160744|156461435|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
48618954|NCT01160744|156461436|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
48618955|NCT01160744|156461437|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
48618956|NCT00195429|156461438|FG000|Overall Study|Adverse Event|2|||
48618957|NCT00195429|156461439|FG001|Overall Study|Adverse Event|4|||
48618958|NCT00195429|156461438|FG000|Overall Study|Lack of Efficacy|2|||
48618959|NCT00195429|156461439|FG001|Overall Study|Lack of Efficacy|1|||
48618960|NCT00195429|156461438|FG000|Overall Study|Lost to Follow-up|1|||
48571256|NCT03088878|156283835|FG005|Overall Study|Disease Progression|0|||
48571257|NCT03088878|156283836|FG006|Overall Study|Disease Progression|0|||
48571258|NCT03088878|156283837|FG007|Overall Study|Disease Progression|0|||
48571259|NCT03088878|156283838|FG008|Overall Study|Disease Progression|0|||
48571260|NCT03088878|156283839|FG009|Overall Study|Disease Progression|0|||
48571261|NCT03088878|156283840|FG010|Overall Study|Disease Progression|0|||
48571262|NCT03088878|156283841|FG011|Overall Study|Disease Progression|0|||
48571263|NCT03088878|156283842|FG012|Overall Study|Disease Progression|1|||
48571264|NCT03088878|156283843|FG013|Overall Study|Disease Progression|1|||
48571265|NCT03088878|156283830|FG000|Overall Study|Initiation of Alternative Treatment|0|||
48571266|NCT03088878|156283831|FG001|Overall Study|Initiation of Alternative Treatment|0|||
48571267|NCT03088878|156283832|FG002|Overall Study|Initiation of Alternative Treatment|0|||
48571268|NCT03088878|156283833|FG003|Overall Study|Initiation of Alternative Treatment|1|||
48571269|NCT03088878|156283834|FG004|Overall Study|Initiation of Alternative Treatment|0|||
48571270|NCT03088878|156283835|FG005|Overall Study|Initiation of Alternative Treatment|0|||
48571271|NCT03088878|156283836|FG006|Overall Study|Initiation of Alternative Treatment|0|||
48571272|NCT03088878|156283837|FG007|Overall Study|Initiation of Alternative Treatment|1|||
48571273|NCT03088878|156283838|FG008|Overall Study|Initiation of Alternative Treatment|1|||
48571274|NCT03088878|156283839|FG009|Overall Study|Initiation of Alternative Treatment|0|||
48571275|NCT03088878|156283840|FG010|Overall Study|Initiation of Alternative Treatment|0|||
48571276|NCT03088878|156283841|FG011|Overall Study|Initiation of Alternative Treatment|0|||
48571277|NCT03088878|156283842|FG012|Overall Study|Initiation of Alternative Treatment|0|||
48571278|NCT03088878|156283843|FG013|Overall Study|Initiation of Alternative Treatment|0|||
48571279|NCT03088878|156283830|FG000|Overall Study|Withdrawal by Subject|0|||
48571280|NCT03088878|156283831|FG001|Overall Study|Withdrawal by Subject|0|||
48571281|NCT03088878|156283832|FG002|Overall Study|Withdrawal by Subject|0|||
48571282|NCT03088878|156283833|FG003|Overall Study|Withdrawal by Subject|1|||
48618961|NCT00195429|156461439|FG001|Overall Study|Lost to Follow-up|0|||
48618962|NCT04233580|156461442|FG000|Overall Study|Adverse Event|3|||
48618963|NCT04233580|156461443|FG001|Overall Study|Adverse Event|3|||
48571283|NCT03088878|156283834|FG004|Overall Study|Withdrawal by Subject|4|||
48618964|NCT04233580|156461442|FG000|Overall Study|Withdrawal by Subject|2|||
48618965|NCT04233580|156461443|FG001|Overall Study|Withdrawal by Subject|1|||
48618966|NCT02070991|156461446|FG000|Overall Study|Death|2|||
48618967|NCT02070991|156461447|FG001|Overall Study|Death|0|||
48571284|NCT03088878|156283835|FG005|Overall Study|Withdrawal by Subject|1|||
48571285|NCT03088878|156283836|FG006|Overall Study|Withdrawal by Subject|1|||
48571286|NCT03088878|156283837|FG007|Overall Study|Withdrawal by Subject|0|||
48571287|NCT03088878|156283838|FG008|Overall Study|Withdrawal by Subject|1|||
48571288|NCT03088878|156283839|FG009|Overall Study|Withdrawal by Subject|2|||
48571289|NCT03088878|156283840|FG010|Overall Study|Withdrawal by Subject|0|||
48571290|NCT03088878|156283841|FG011|Overall Study|Withdrawal by Subject|2|||
48571291|NCT03088878|156283842|FG012|Overall Study|Withdrawal by Subject|1|||
48571292|NCT03088878|156283843|FG013|Overall Study|Withdrawal by Subject|0|||
48571293|NCT03088878|156283830|FG000|Overall Study|Terminated by Sponsor|2|||
48571294|NCT03088878|156283831|FG001|Overall Study|Terminated by Sponsor|1|||
48571295|NCT03088878|156283832|FG002|Overall Study|Terminated by Sponsor|0|||
48571296|NCT03088878|156283833|FG003|Overall Study|Terminated by Sponsor|1|||
48571297|NCT03088878|156283834|FG004|Overall Study|Terminated by Sponsor|6|||
48571298|NCT03088878|156283835|FG005|Overall Study|Terminated by Sponsor|0|||
48571299|NCT03088878|156283836|FG006|Overall Study|Terminated by Sponsor|0|||
48571300|NCT03088878|156283837|FG007|Overall Study|Terminated by Sponsor|0|||
48571301|NCT03088878|156283838|FG008|Overall Study|Terminated by Sponsor|0|||
48571302|NCT03088878|156283839|FG009|Overall Study|Terminated by Sponsor|0|||
48571303|NCT03088878|156283840|FG010|Overall Study|Terminated by Sponsor|3|||
48571304|NCT03088878|156283841|FG011|Overall Study|Terminated by Sponsor|13|||
48571305|NCT03088878|156283842|FG012|Overall Study|Terminated by Sponsor|2|||
48571306|NCT03088878|156283843|FG013|Overall Study|Terminated by Sponsor|1|||
48571307|NCT03088878|156283830|FG000|Overall Study|Completed 2 years of Treatment|0|||
48571308|NCT03088878|156283831|FG001|Overall Study|Completed 2 years of Treatment|0|||
48571309|NCT03088878|156283832|FG002|Overall Study|Completed 2 years of Treatment|0|||
48571310|NCT03088878|156283833|FG003|Overall Study|Completed 2 years of Treatment|0|||
48571311|NCT03088878|156283834|FG004|Overall Study|Completed 2 years of Treatment|0|||
48571312|NCT03088878|156283835|FG005|Overall Study|Completed 2 years of Treatment|0|||
48571313|NCT03088878|156283836|FG006|Overall Study|Completed 2 years of Treatment|1|||
48571314|NCT03088878|156283837|FG007|Overall Study|Completed 2 years of Treatment|0|||
48571315|NCT03088878|156283838|FG008|Overall Study|Completed 2 years of Treatment|0|||
48571316|NCT03088878|156283839|FG009|Overall Study|Completed 2 years of Treatment|1|||
48571317|NCT03088878|156283840|FG010|Overall Study|Completed 2 years of Treatment|0|||
48571318|NCT03088878|156283841|FG011|Overall Study|Completed 2 years of Treatment|0|||
48571319|NCT03088878|156283842|FG012|Overall Study|Completed 2 years of Treatment|8|||
48571320|NCT03088878|156283843|FG013|Overall Study|Completed 2 years of Treatment|3|||
48571321|NCT03088878|156283830|FG000|Overall Study|Physician Decision|0|||
48571322|NCT03088878|156283831|FG001|Overall Study|Physician Decision|0|||
48571323|NCT03088878|156283832|FG002|Overall Study|Physician Decision|0|||
48571324|NCT03088878|156283833|FG003|Overall Study|Physician Decision|0|||
48571325|NCT03088878|156283834|FG004|Overall Study|Physician Decision|0|||
48571326|NCT03088878|156283835|FG005|Overall Study|Physician Decision|0|||
48571327|NCT03088878|156283836|FG006|Overall Study|Physician Decision|0|||
48571328|NCT03088878|156283837|FG007|Overall Study|Physician Decision|2|||
48571329|NCT03088878|156283838|FG008|Overall Study|Physician Decision|1|||
48571330|NCT03088878|156283839|FG009|Overall Study|Physician Decision|0|||
48571331|NCT03088878|156283840|FG010|Overall Study|Physician Decision|0|||
48571332|NCT03088878|156283841|FG011|Overall Study|Physician Decision|0|||
48571333|NCT03088878|156283842|FG012|Overall Study|Physician Decision|0|||
48571334|NCT03088878|156283843|FG013|Overall Study|Physician Decision|1|||
48571335|NCT03088878|156283830|FG000|Overall Study|COVID Related noncompliance|0|||
48571336|NCT03088878|156283831|FG001|Overall Study|COVID Related noncompliance|0|||
48571337|NCT03088878|156283832|FG002|Overall Study|COVID Related noncompliance|0|||
48571338|NCT03088878|156283833|FG003|Overall Study|COVID Related noncompliance|0|||
48571339|NCT03088878|156283834|FG004|Overall Study|COVID Related noncompliance|0|||
48571340|NCT03088878|156283835|FG005|Overall Study|COVID Related noncompliance|0|||
48571341|NCT03088878|156283836|FG006|Overall Study|COVID Related noncompliance|0|||
48571342|NCT03088878|156283837|FG007|Overall Study|COVID Related noncompliance|0|||
48571343|NCT03088878|156283838|FG008|Overall Study|COVID Related noncompliance|0|||
48571344|NCT03088878|156283839|FG009|Overall Study|COVID Related noncompliance|0|||
48571345|NCT03088878|156283840|FG010|Overall Study|COVID Related noncompliance|0|||
48571346|NCT03088878|156283841|FG011|Overall Study|COVID Related noncompliance|0|||
48571347|NCT03088878|156283842|FG012|Overall Study|COVID Related noncompliance|0|||
48571348|NCT03088878|156283843|FG013|Overall Study|COVID Related noncompliance|1|||
48571349|NCT03088878|156283830|FG000|Overall Study|Drug or Study Noncompliance|0|||
48571350|NCT03088878|156283831|FG001|Overall Study|Drug or Study Noncompliance|0|||
48571351|NCT03088878|156283832|FG002|Overall Study|Drug or Study Noncompliance|0|||
48571352|NCT03088878|156283833|FG003|Overall Study|Drug or Study Noncompliance|0|||
48571353|NCT03088878|156283834|FG004|Overall Study|Drug or Study Noncompliance|0|||
48571354|NCT03088878|156283835|FG005|Overall Study|Drug or Study Noncompliance|0|||
48571355|NCT03088878|156283836|FG006|Overall Study|Drug or Study Noncompliance|0|||
48571356|NCT03088878|156283837|FG007|Overall Study|Drug or Study Noncompliance|0|||
48571357|NCT03088878|156283838|FG008|Overall Study|Drug or Study Noncompliance|0|||
48571358|NCT03088878|156283839|FG009|Overall Study|Drug or Study Noncompliance|0|||
48571359|NCT03088878|156283840|FG010|Overall Study|Drug or Study Noncompliance|0|||
48571360|NCT03088878|156283841|FG011|Overall Study|Drug or Study Noncompliance|0|||
48571361|NCT03088878|156283842|FG012|Overall Study|Drug or Study Noncompliance|1|||
48571362|NCT03088878|156283843|FG013|Overall Study|Drug or Study Noncompliance|0|||
48571363|NCT04300309|156283846|FG000|Overall Study|Lost to Follow-up|1|||
48571364|NCT04300309|156283847|FG001|Overall Study|Lost to Follow-up|0|||
48571365|NCT02918318|156283859|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
48571366|NCT02918318|156283860|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
48571367|NCT02918318|156283861|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
48571368|NCT02918318|156283862|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
48571369|NCT02918318|156283863|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
48571370|NCT02918318|156283859|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
48571371|NCT02918318|156283860|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
48571372|NCT02918318|156283861|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
48571373|NCT02918318|156283862|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
48571374|NCT02918318|156283863|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
48571375|NCT02918318|156283859|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
48571376|NCT02918318|156283860|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
48571377|NCT02918318|156283861|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
48571378|NCT02918318|156283862|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
48571379|NCT02918318|156283863|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
48571380|NCT02918318|156283859|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
48571381|NCT02918318|156283860|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
48571382|NCT02918318|156283861|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
48571383|NCT02918318|156283862|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
48571384|NCT02918318|156283863|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
48571385|NCT02918318|156283859|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
48571386|NCT02918318|156283860|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
48571387|NCT02918318|156283861|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
48571388|NCT02918318|156283862|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
48571389|NCT02918318|156283863|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
48571390|NCT02918318|156283859|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
48571391|NCT02918318|156283860|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
48571392|NCT02918318|156283861|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
48571393|NCT02918318|156283862|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
48571394|NCT02918318|156283863|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
48571395|NCT02918318|156283859|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
48571396|NCT02918318|156283860|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
48571397|NCT02918318|156283861|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
48571398|NCT02918318|156283862|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
48571399|NCT02918318|156283863|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
48571400|NCT02918318|156283859|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
48571401|NCT02918318|156283860|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
48571402|NCT02918318|156283861|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
48571403|NCT02918318|156283862|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
48571404|NCT02918318|156283863|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
48571405|NCT02918318|156283859|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
48571406|NCT02918318|156283860|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
48571407|NCT02918318|156283861|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
48571408|NCT02918318|156283862|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
48571409|NCT02918318|156283863|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
48571410|NCT02918318|156283859|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
48571411|NCT02918318|156283860|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
48571412|NCT02918318|156283861|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
48317732|NCT01061151|155364172|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
48317733|NCT01061151|155364173|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
48317734|NCT01061151|155364170|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
48317735|NCT01061151|155364171|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
48317736|NCT01061151|155364172|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
48317737|NCT01061151|155364173|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
48317738|NCT01061151|155364170|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
48317739|NCT01061151|155364171|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
48317740|NCT01061151|155364172|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
48317741|NCT01061151|155364173|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
48317742|NCT01061151|155364170|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
48317743|NCT01061151|155364171|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
48317744|NCT01061151|155364172|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
48317745|NCT01061151|155364173|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
48317746|NCT01061151|155364170|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
48317747|NCT01061151|155364171|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
48317748|NCT01061151|155364172|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
48317749|NCT01061151|155364173|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
48317750|NCT00535145|155364176|FG000|Phase I|Adverse Event|3|||
48317751|NCT00535145|155364176|FG000|Phase I|Lost to Follow-up|7|||
48317752|NCT00535145|155364176|FG000|Phase I|Withdrawal by Subject|6|||
48317753|NCT00535145|155364176|FG000|Phase I|(eligibility)|8|||
48317754|NCT00535145|155364176|FG000|Phase I|(protocol violation)|1|||
48317755|NCT00535145|155364176|FG000|Phase I|(PI decision)|1|||
48571413|NCT02918318|156283862|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
48571414|NCT02918318|156283863|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
48571415|NCT02918318|156283859|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
48571416|NCT02918318|156283860|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
48571417|NCT02918318|156283861|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
48571418|NCT02918318|156283862|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
48571419|NCT02918318|156283863|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
48571420|NCT02918318|156283859|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
48571421|NCT02918318|156283860|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
48571422|NCT02918318|156283861|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
48571423|NCT02918318|156283862|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
48571424|NCT02918318|156283863|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
48571425|NCT01094301|156283866|FG000|Trial Stage|Withdrawal by Subject|1|||
48571426|NCT01094301|156283866|FG000|Implant Stage|Adverse Event|1|||
48571427|NCT01094301|156283866|FG000|Implant Stage|Protocol Violation|1|||
48571428|NCT01094301|156283866|FG000|Implant Stage|Withdrawal by Subject|2|||
48571429|NCT01094301|156283866|FG000|Implant Stage|No return of pain|4|||
48571430|NCT02977572|156283867|FG000|Overall Study|Exclusion criterion|2|||
48571431|NCT02977572|156283868|FG001|Overall Study|Exclusion criterion|2|||
48571432|NCT04080752|156283869|FG000|Overall Study|Adverse Event|2|||
48317756|NCT00535145|155364176|FG000|Phase I|(diagnosis)|3|||
48317757|NCT00535145|155364176|FG000|Phase II|Adverse Event|2|||
48317758|NCT00535145|155364176|FG000|Phase II|Lack of Efficacy|1|||
48317759|NCT00535145|155364176|FG000|Phase II|Lost to Follow-up|5|||
48317760|NCT00535145|155364176|FG000|Phase II|Withdrawal by Subject|5|||
48317761|NCT00535145|155364176|FG000|Phase II|Subject non-compliance|2|||
48317762|NCT01236001|155364177|FG000|Overall Study|Adverse Event|5|||
48317763|NCT01236001|155364178|FG001|Overall Study|Adverse Event|14|||
48317764|NCT01236001|155364177|FG000|Overall Study|Lack of Efficacy|6|||
48317765|NCT01236001|155364178|FG001|Overall Study|Lack of Efficacy|6|||
48317766|NCT01236001|155364177|FG000|Overall Study|Lost to Follow-up|6|||
48317767|NCT01236001|155364178|FG001|Overall Study|Lost to Follow-up|1|||
48571433|NCT04080752|156283870|FG001|Overall Study|Adverse Event|3|||
48571434|NCT04080752|156283869|FG000|Overall Study|Lack of Efficacy|1|||
48571435|NCT04080752|156283870|FG001|Overall Study|Lack of Efficacy|0|||
48317768|NCT01236001|155364177|FG000|Overall Study|Incompliance|1|||
48317769|NCT01236001|155364178|FG001|Overall Study|Incompliance|0|||
48317770|NCT01236001|155364177|FG000|Overall Study|Planned Visit After End of Study|0|||
48317771|NCT01236001|155364178|FG001|Overall Study|Planned Visit After End of Study|1|||
48317772|NCT02214160|155364182|FG000|Overall Study|Withdrawal by Subject|1|||
48317773|NCT02214160|155364183|FG001|Overall Study|Withdrawal by Subject|0|||
48317774|NCT02214160|155364184|FG002|Overall Study|Withdrawal by Subject|6|||
48317775|NCT02214160|155364182|FG000|Overall Study|Death|2|||
48618968|NCT02070991|156461446|FG000|Overall Study|Withdrawal by Subject|1|||
48317776|NCT02214160|155364183|FG001|Overall Study|Death|2|||
48317777|NCT02214160|155364184|FG002|Overall Study|Death|1|||
48317778|NCT02214160|155364182|FG000|Overall Study|Subject Non-Compliance|0|||
48317779|NCT02214160|155364183|FG001|Overall Study|Subject Non-Compliance|3|||
48317780|NCT02214160|155364184|FG002|Overall Study|Subject Non-Compliance|1|||
48317781|NCT02214160|155364182|FG000|Overall Study|Adverse Event|0|||
48317782|NCT02214160|155364183|FG001|Overall Study|Adverse Event|1|||
48317783|NCT02214160|155364184|FG002|Overall Study|Adverse Event|1|||
48317784|NCT02214160|155364182|FG000|Overall Study|Sponsor Decision|0|||
48317785|NCT02214160|155364183|FG001|Overall Study|Sponsor Decision|2|||
48317786|NCT02214160|155364184|FG002|Overall Study|Sponsor Decision|0|||
48317787|NCT02214160|155364182|FG000|Overall Study|Protocol Violation|1|||
48317788|NCT02214160|155364183|FG001|Overall Study|Protocol Violation|0|||
48317789|NCT02214160|155364184|FG002|Overall Study|Protocol Violation|0|||
48317790|NCT02214160|155364182|FG000|Overall Study|Physician Decision|0|||
48317791|NCT02214160|155364183|FG001|Overall Study|Physician Decision|0|||
48317792|NCT02214160|155364184|FG002|Overall Study|Physician Decision|1|||
48317793|NCT03051165|155364185|FG000|Overall Study|Withdrawal by Subject|1|||
48317794|NCT03051165|155364185|FG000|Overall Study|Early termination of study|12|||
48317795|NCT00761605|155364186|FG000|Overall Study|Adverse Event|26|||
48571436|NCT04080752|156283869|FG000|Overall Study|Lost to Follow-up|1|||
48571437|NCT04080752|156283870|FG001|Overall Study|Lost to Follow-up|0|||
48571438|NCT04080752|156283869|FG000|Overall Study|Pregnancy|0|||
48571439|NCT04080752|156283870|FG001|Overall Study|Pregnancy|1|||
48571440|NCT04080752|156283869|FG000|Overall Study|Withdrawal by Subject|7|||
48571441|NCT04080752|156283870|FG001|Overall Study|Withdrawal by Subject|0|||
48571442|NCT04080752|156283869|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48571443|NCT04080752|156283870|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48571444|NCT04080752|156283869|FG000|Overall Study|Other|2|||
48571445|NCT04080752|156283870|FG001|Overall Study|Other|1|||
48571446|NCT01684943|156283878|FG000|Overall Study|Inadequate Venous Access|3|||
48571447|NCT01684943|156283879|FG001|Overall Study|Inadequate Venous Access|0|||
48571448|NCT01684943|156283880|FG002|Overall Study|Inadequate Venous Access|0|||
48571449|NCT01684943|156283878|FG000|Overall Study|Principal Investigator Determination|1|||
48571450|NCT01684943|156283879|FG001|Overall Study|Principal Investigator Determination|0|||
48571451|NCT01684943|156283880|FG002|Overall Study|Principal Investigator Determination|0|||
48571452|NCT01684943|156283878|FG000|Overall Study|Excluded from Analysis|1|||
48571453|NCT01684943|156283879|FG001|Overall Study|Excluded from Analysis|1|||
48571454|NCT01684943|156283880|FG002|Overall Study|Excluded from Analysis|1|||
48571455|NCT01684943|156283878|FG000|Overall Study|Lost to Follow-up|3|||
48571456|NCT01684943|156283879|FG001|Overall Study|Lost to Follow-up|0|||
48571457|NCT01684943|156283880|FG002|Overall Study|Lost to Follow-up|0|||
48571458|NCT01684943|156283878|FG000|Overall Study|Planning Pregnancy|1|||
48571459|NCT01684943|156283879|FG001|Overall Study|Planning Pregnancy|0|||
48571460|NCT01684943|156283880|FG002|Overall Study|Planning Pregnancy|0|||
48571461|NCT00712543|156283881|FG000|Day 8-14|Lost to Follow-up|0|||
48571462|NCT00712543|156283882|FG001|Day 8-14|Lost to Follow-up|2|||
48571463|NCT01516008|156283883|FG000|Overall Study|Adverse Event|0|||
48571464|NCT01516008|156283884|FG001|Overall Study|Adverse Event|2|||
48571465|NCT01516008|156283885|FG002|Overall Study|Adverse Event|7|||
48571466|NCT01516008|156283883|FG000|Overall Study|Lack of Efficacy|44|||
48571467|NCT01516008|156283884|FG001|Overall Study|Lack of Efficacy|14|||
48618969|NCT02070991|156461447|FG001|Overall Study|Withdrawal by Subject|0|||
48618970|NCT00933933|156461451|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
48317796|NCT00761605|155364186|FG000|Overall Study|Death|2|||
48317797|NCT00761605|155364186|FG000|Overall Study|Lack of Efficacy|26|||
48571468|NCT01516008|156283885|FG002|Overall Study|Lack of Efficacy|10|||
48571469|NCT01516008|156283883|FG000|Overall Study|Protocol Violation|1|||
48571470|NCT01516008|156283884|FG001|Overall Study|Protocol Violation|0|||
48571471|NCT01516008|156283885|FG002|Overall Study|Protocol Violation|0|||
48571472|NCT01516008|156283883|FG000|Overall Study|Reason not specified|0|||
48618971|NCT00933933|156461452|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
48618972|NCT00933933|156461453|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
48571473|NCT01516008|156283884|FG001|Overall Study|Reason not specified|0|||
48317798|NCT00761605|155364186|FG000|Overall Study|Lost to Follow-up|29|||
48317799|NCT00761605|155364186|FG000|Overall Study|Withdrawal by Subject|37|||
48317800|NCT00761605|155364186|FG000|Overall Study|Other|21|||
48317801|NCT03074331|155364187|FG000|Overall Study|Enrolled but Not Treated|1|||
48317802|NCT03074331|155364187|FG000|Overall Study|Lost to Follow-up|5|||
48317803|NCT03074331|155364187|FG000|Overall Study|Withdrew Consent|1|||
48317804|NCT01000480|155364188|FG000|Induction Phase|Adverse Event|2|||
48317805|NCT01000480|155364188|FG000|Induction Phase|Lost to Follow-up|1|||
48317806|NCT01000480|155364188|FG000|Induction Phase|Physician Decision|1|||
48317807|NCT01000480|155364188|FG000|Induction Phase|Entry Criteria Not Met|3|||
48317808|NCT01000480|155364188|FG000|Concurrent Therapy Phase|Adverse Event|4|||
48317809|NCT01000480|155364188|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
48317810|NCT01000480|155364188|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
48317811|NCT01000480|155364188|FG000|Concurrent Therapy Phase|Physician Decision|1|||
48317812|NCT00520546|155364189|FG000|Overall Study|Withdrawal by Subject|1|||
48317813|NCT00520546|155364189|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
48317814|NCT04600752|155364190|FG000|Overall Study|Physician Decision|0|||
48317815|NCT04600752|155364191|FG001|Overall Study|Physician Decision|0|||
48317816|NCT04600752|155364192|FG002|Overall Study|Physician Decision|1|||
48317817|NCT04600752|155364190|FG000|Overall Study|Adverse Event|0|||
48317818|NCT04600752|155364191|FG001|Overall Study|Adverse Event|1|||
48317819|NCT04600752|155364192|FG002|Overall Study|Adverse Event|0|||
48317820|NCT04600752|155364190|FG000|Overall Study|Withdrawal by Subject|2|||
48317821|NCT04600752|155364191|FG001|Overall Study|Withdrawal by Subject|1|||
48317822|NCT04600752|155364192|FG002|Overall Study|Withdrawal by Subject|0|||
48317823|NCT04600752|155364190|FG000|Overall Study|Lack of Efficacy|1|||
48571474|NCT01516008|156283885|FG002|Overall Study|Reason not specified|1|||
48571475|NCT02027545|156283886|FG000|Overall Study|Failed to sign HIPAA|0|||
48571476|NCT02027545|156283887|FG001|Overall Study|Failed to sign HIPAA|2|||
48571477|NCT02027545|156283886|FG000|Overall Study|Failed to attend study visit|2|||
48571478|NCT02027545|156283887|FG001|Overall Study|Failed to attend study visit|0|||
48571479|NCT02027545|156283886|FG000|Overall Study|Protocol Violation|1|||
48571480|NCT02027545|156283887|FG001|Overall Study|Protocol Violation|0|||
48571481|NCT04553471|156283888|FG000|Overall Study|Did not start treatment on protocol|3|||
48571482|NCT04553471|156283888|FG000|Overall Study|Death|1|||
48571483|NCT02777593|156283891|FG000|Overall Study|Still in study|1|||
48571484|NCT02777593|156283892|FG001|Overall Study|Still in study|32|||
48571485|NCT02777593|156283893|FG002|Overall Study|Still in study|3|||
48571486|NCT02777593|156283894|FG003|Overall Study|Still in study|6|||
48571487|NCT02777593|156283895|FG004|Overall Study|Still in study|5|||
48571488|NCT02777593|156283891|FG000|Overall Study|Death|21|||
48571489|NCT02777593|156283892|FG001|Overall Study|Death|28|||
48571490|NCT02777593|156283893|FG002|Overall Study|Death|0|||
48571491|NCT02777593|156283894|FG003|Overall Study|Death|5|||
48571492|NCT02777593|156283895|FG004|Overall Study|Death|0|||
48571493|NCT02777593|156283891|FG000|Overall Study|Withdrawal by Subject|8|||
48571494|NCT02777593|156283892|FG001|Overall Study|Withdrawal by Subject|4|||
48571495|NCT02777593|156283893|FG002|Overall Study|Withdrawal by Subject|1|||
48571496|NCT02777593|156283894|FG003|Overall Study|Withdrawal by Subject|1|||
48571497|NCT02777593|156283895|FG004|Overall Study|Withdrawal by Subject|0|||
48571498|NCT02777593|156283891|FG000|Overall Study|Lost to Follow-up|8|||
48571499|NCT02777593|156283892|FG001|Overall Study|Lost to Follow-up|16|||
48571500|NCT02777593|156283893|FG002|Overall Study|Lost to Follow-up|5|||
48571501|NCT02777593|156283894|FG003|Overall Study|Lost to Follow-up|0|||
48571502|NCT02777593|156283895|FG004|Overall Study|Lost to Follow-up|1|||
48317824|NCT04600752|155364191|FG001|Overall Study|Lack of Efficacy|0|||
48571503|NCT02777593|156283891|FG000|Overall Study|Physician Decision|2|||
48571504|NCT02777593|156283892|FG001|Overall Study|Physician Decision|2|||
48571505|NCT02777593|156283893|FG002|Overall Study|Physician Decision|0|||
48571506|NCT02777593|156283894|FG003|Overall Study|Physician Decision|0|||
48571507|NCT02777593|156283895|FG004|Overall Study|Physician Decision|0|||
48571508|NCT02777593|156283891|FG000|Overall Study|Discontinued due to Other|1|||
48571509|NCT02777593|156283892|FG001|Overall Study|Discontinued due to Other|0|||
48571510|NCT02777593|156283893|FG002|Overall Study|Discontinued due to Other|0|||
48571511|NCT02777593|156283894|FG003|Overall Study|Discontinued due to Other|0|||
48571512|NCT02777593|156283895|FG004|Overall Study|Discontinued due to Other|0|||
48571513|NCT02497287|156283896|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
48571514|NCT02497287|156283896|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
48571515|NCT02497287|156283896|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
48571516|NCT02497287|156283896|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
48571517|NCT02497287|156283896|FG000|Induction Phase (4 Weeks)|Other|13|||
48571518|NCT02497287|156283896|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
48571519|NCT02497287|156283896|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
48571520|NCT02497287|156283896|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
48571521|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
48618973|NCT00933933|156461451|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
48317825|NCT04600752|155364192|FG002|Overall Study|Lack of Efficacy|0|||
48317826|NCT03988023|155364193|FG000|Overall Study|Non-compliance|3|||
48317827|NCT03988023|155364194|FG001|Overall Study|Non-compliance|0|||
48317828|NCT03988023|155364193|FG000|Overall Study|Withdrawal by Subject|39|||
48317829|NCT03988023|155364194|FG001|Overall Study|Withdrawal by Subject|37|||
48317830|NCT03988023|155364193|FG000|Overall Study|Adverse Event|0|||
48317831|NCT03988023|155364194|FG001|Overall Study|Adverse Event|2|||
48317832|NCT03988023|155364193|FG000|Overall Study|Physician Decision|0|||
48317833|NCT03988023|155364194|FG001|Overall Study|Physician Decision|1|||
48317834|NCT03988023|155364193|FG000|Overall Study|Lost to Follow-up|5|||
48317835|NCT03988023|155364194|FG001|Overall Study|Lost to Follow-up|8|||
48317836|NCT03988023|155364193|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
48317837|NCT03988023|155364194|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
48317838|NCT03988023|155364193|FG000|Overall Study|Lack of Efficacy|3|||
48317839|NCT03988023|155364194|FG001|Overall Study|Lack of Efficacy|1|||
48317840|NCT03988023|155364193|FG000|Overall Study|COVID-19 pandemic|225|||
48571522|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
48571523|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
48571524|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
48571525|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
48571526|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
48571527|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
48571528|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
48571529|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
48571530|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
48571531|NCT02497287|156283896|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
48571532|NCT02497287|156283896|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
48571533|NCT02497287|156283896|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
48571534|NCT02497287|156283896|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
48571535|NCT02497287|156283896|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
48571536|NCT02497287|156283896|FG000|Follow-up Phase (4 Week)|Other|1|||
48571537|NCT00125242|156283897|FG000|Overall Study|did not qualify|7|||
48571538|NCT00125242|156283898|FG001|Overall Study|did not qualify|2|||
48571539|NCT03921554|156283903|FG000|Overall Study|Adverse Event|2|||
48571540|NCT03921554|156283903|FG000|Overall Study|Withdrawal by Subject|1|||
48571541|NCT03921554|156283903|FG000|Overall Study|Death|3|||
48571542|NCT02659098|156283906|FG000|Overall Study|Withdrawal by Subject|7|||
48571543|NCT02431702|156285785|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
48571544|NCT02431702|156285786|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
48571545|NCT02431702|156285787|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
48571546|NCT02431702|156285788|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
48571547|NCT02431702|156285789|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
48571548|NCT02431702|156285790|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
48571549|NCT02431702|156285791|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
48571550|NCT02431702|156285785|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
48571551|NCT02431702|156285786|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
48571552|NCT02431702|156285787|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
48571553|NCT02431702|156285788|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
48571554|NCT02431702|156285789|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
48571555|NCT02431702|156285790|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
48571556|NCT02431702|156285791|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
48571557|NCT02431702|156285785|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
48571558|NCT02431702|156285786|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
48571559|NCT02431702|156285787|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
48571560|NCT02431702|156285788|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
48571561|NCT02431702|156285789|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
48571562|NCT02431702|156285790|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
48571563|NCT02431702|156285791|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
48571564|NCT02431702|156285785|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
48571565|NCT02431702|156285786|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
48571566|NCT02431702|156285787|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
48571567|NCT02431702|156285788|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
48571568|NCT02431702|156285789|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
48571569|NCT02431702|156285790|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
48571570|NCT02431702|156285791|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
48571571|NCT02431702|156285785|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
48317841|NCT03988023|155364194|FG001|Overall Study|COVID-19 pandemic|227|||
48317842|NCT00174382|155364197|FG000|Overall Study|Death|2|||
48571572|NCT02431702|156285786|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
48571573|NCT02431702|156285787|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
48571574|NCT02431702|156285788|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
48618974|NCT00933933|156461452|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
48571575|NCT02431702|156285789|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
48317843|NCT00174382|155364197|FG000|Overall Study|Adverse Event|19|||
48317844|NCT00174382|155364197|FG000|Overall Study|Withdrawal by Subject|6|||
48618975|NCT00933933|156461453|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
48618976|NCT01145222|156461461|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
48618977|NCT01145222|156461462|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
48618978|NCT01145222|156461463|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
48618979|NCT01145222|156461464|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
48618980|NCT01145222|156461461|FG000|Overall Study|Poor bowel preparation|0|||
48618981|NCT01145222|156461462|FG001|Overall Study|Poor bowel preparation|0|||
48618982|NCT01145222|156461463|FG002|Overall Study|Poor bowel preparation|0|||
48618983|NCT01145222|156461464|FG003|Overall Study|Poor bowel preparation|1|||
48618984|NCT01623752|156461469|FG000|Phase 1 (78 Weeks)|No Data|249|||
48618985|NCT01623752|156461470|FG001|Phase 1 (78 Weeks)|No Data|66|||
48618986|NCT01623752|156461471|FG002|Phase 1 (78 Weeks)|No Data|2|||
48618987|NCT01623752|156461469|FG000|Phase 1 (78 Weeks)|Other|33|||
48618988|NCT01623752|156461470|FG001|Phase 1 (78 Weeks)|Other|20|||
48618989|NCT01623752|156461471|FG002|Phase 1 (78 Weeks)|Other|0|||
48618990|NCT01623752|156461469|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
48618991|NCT01623752|156461470|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
48618992|NCT01623752|156461471|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
48618993|NCT01623752|156461469|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
48618994|NCT01623752|156461470|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
48618995|NCT01623752|156461471|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
48618996|NCT01623752|156461469|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
48618997|NCT01623752|156461470|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
48618998|NCT01623752|156461471|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
48618999|NCT01623752|156461469|FG000|Phase 2 (78 Weeks)|Other|5|||
48619000|NCT01623752|156461470|FG001|Phase 2 (78 Weeks)|Other|1|||
48619001|NCT01623752|156461471|FG002|Phase 2 (78 Weeks)|Other|0|||
48619002|NCT01623752|156461469|FG000|Phase 2 (78 Weeks)|No Data|43|||
48619003|NCT01623752|156461470|FG001|Phase 2 (78 Weeks)|No Data|11|||
48619004|NCT01623752|156461471|FG002|Phase 2 (78 Weeks)|No Data|0|||
48619005|NCT01623752|156461469|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
48619006|NCT01623752|156461470|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
48619007|NCT01623752|156461471|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
48619008|NCT01814332|156461472|FG000|Overall Study|Adverse Event|8|||
48619009|NCT01814332|156461473|FG001|Overall Study|Adverse Event|3|||
48619010|NCT01814332|156461472|FG000|Overall Study|Withdrawal by Subject|3|||
48619011|NCT01814332|156461473|FG001|Overall Study|Withdrawal by Subject|8|||
48619012|NCT01814332|156461472|FG000|Overall Study|Protocol Violation|0|||
48619013|NCT01814332|156461473|FG001|Overall Study|Protocol Violation|4|||
48619014|NCT01814332|156461472|FG000|Overall Study|Lost to Follow-up|5|||
48619015|NCT01814332|156461473|FG001|Overall Study|Lost to Follow-up|1|||
48619016|NCT02942407|156461475|FG000|Overall Study|Lost to Follow-up|3|||
48619017|NCT02942407|156461476|FG001|Overall Study|Lost to Follow-up|2|||
48317845|NCT00174382|155364197|FG000|Overall Study|Protocol Violation|3|||
48317846|NCT00174382|155364197|FG000|Overall Study|Arrived early for last visit in error|1|||
48619018|NCT02942407|156461475|FG000|Overall Study|Withdrawal by Subject|7|||
48619019|NCT02942407|156461476|FG001|Overall Study|Withdrawal by Subject|9|||
48619020|NCT02942407|156461475|FG000|Overall Study|Death|16|||
48619021|NCT02942407|156461476|FG001|Overall Study|Death|13|||
48619022|NCT02061592|156461477|FG000|Period 1|Withdrawal by Subject|1|||
48619023|NCT02061592|156461478|FG001|Period 1|Withdrawal by Subject|0|||
48619024|NCT02061592|156461477|FG000|Period 1|Protocol Violation|1|||
48619025|NCT02061592|156461478|FG001|Period 1|Protocol Violation|0|||
48619026|NCT02061592|156461477|FG000|Period 2|Lost to Follow-up|0|||
48619027|NCT02061592|156461478|FG001|Period 2|Lost to Follow-up|1|||
48619028|NCT03338023|156461479|FG000|Overall Study|Withdrawal by Subject|3|||
48619029|NCT03338023|156461480|FG001|Overall Study|Withdrawal by Subject|4|||
48619030|NCT03338023|156461479|FG000|Overall Study|Protocol Violation|3|||
48619031|NCT03338023|156461480|FG001|Overall Study|Protocol Violation|3|||
48619032|NCT03338023|156461479|FG000|Overall Study|Lost to Follow-up|2|||
48619033|NCT03338023|156461480|FG001|Overall Study|Lost to Follow-up|1|||
48619034|NCT03338023|156461479|FG000|Overall Study|Physician Decision|1|||
48619035|NCT03338023|156461480|FG001|Overall Study|Physician Decision|2|||
48317847|NCT00174382|155364197|FG000|Overall Study|Subject felt pill not effective enough|1|||
48317848|NCT00174382|155364197|FG000|Overall Study|Lost to Follow-up|1|||
48317849|NCT01493778|155364202|FG000|Overall Study|Withdrawal by Subject|8|||
48317850|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
48317851|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
48619036|NCT01716156|156461481|FG000|Overall Study|Protocol Violation|1|||
48619037|NCT01716156|156461482|FG001|Overall Study|Protocol Violation|0|||
48619038|NCT01716156|156461483|FG002|Overall Study|Protocol Violation|0|||
48619039|NCT01716156|156461481|FG000|Overall Study|Withdrawal by Subject|0|||
48317852|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
48619040|NCT01716156|156461482|FG001|Overall Study|Withdrawal by Subject|1|||
48619041|NCT01716156|156461483|FG002|Overall Study|Withdrawal by Subject|2|||
48619042|NCT01716156|156461481|FG000|Overall Study|Lost to Follow-up|1|||
48619043|NCT01716156|156461482|FG001|Overall Study|Lost to Follow-up|0|||
48619044|NCT01716156|156461483|FG002|Overall Study|Lost to Follow-up|0|||
48317853|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
48317854|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
48317855|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
48317856|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
48317857|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
48317858|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48317859|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48317860|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48317861|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48317862|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
48317863|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
48317864|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48317865|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
48317866|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48571576|NCT02431702|156285790|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
48571577|NCT02431702|156285791|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
48571578|NCT02431702|156285785|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
48571579|NCT02431702|156285786|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
48571580|NCT02431702|156285787|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
48571581|NCT02431702|156285788|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
48571582|NCT02431702|156285789|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
48317867|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48317868|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48317869|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48571583|NCT02431702|156285790|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
48571584|NCT02431702|156285791|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
48571585|NCT02431702|156285785|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
48571586|NCT02431702|156285786|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
48571587|NCT02431702|156285787|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
48571588|NCT02431702|156285788|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
48571589|NCT02431702|156285789|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
48571590|NCT02431702|156285790|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
48571591|NCT02431702|156285791|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
48571592|NCT02431702|156285785|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
48571593|NCT02431702|156285786|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
48571594|NCT02431702|156285787|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
48317870|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48317871|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
48317872|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
48317873|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
48317874|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
48317875|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
48317876|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
48317877|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
48571595|NCT02431702|156285788|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
48571596|NCT02431702|156285789|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
48571597|NCT02431702|156285790|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
48571598|NCT02431702|156285791|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
48571599|NCT02431702|156285785|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
48571600|NCT02431702|156285786|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
48571601|NCT02431702|156285787|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
48571602|NCT02431702|156285788|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
48571603|NCT02431702|156285789|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
48571604|NCT02431702|156285790|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
48571605|NCT02431702|156285791|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
48571606|NCT02431702|156285785|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
48571607|NCT02431702|156285786|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
48571608|NCT02431702|156285787|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
48571609|NCT02431702|156285788|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
48571610|NCT02431702|156285789|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
48571611|NCT02431702|156285790|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
48317878|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
48317879|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
48317880|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
48317881|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
48317882|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
48619045|NCT03467945|156461484|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48619046|NCT03467945|156461485|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48619047|NCT03467945|156461486|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48619048|NCT03467945|156461487|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48619049|NCT03467945|156461484|FG000|Treatment Period 3|Withdrawal by Subject|1|||
48619050|NCT03467945|156461485|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48619051|NCT03467945|156461486|FG002|Treatment Period 3|Withdrawal by Subject|2|||
48619052|NCT03467945|156461487|FG003|Treatment Period 3|Withdrawal by Subject|1|||
48619053|NCT02318277|156461490|FG000|Overall Study|Physician Decision|0|||
48619054|NCT02318277|156461491|FG001|Overall Study|Physician Decision|0|||
48619055|NCT02318277|156461492|FG002|Overall Study|Physician Decision|0|||
48619056|NCT02318277|156461493|FG003|Overall Study|Physician Decision|0|||
48619057|NCT02318277|156461494|FG004|Overall Study|Physician Decision|0|||
48317883|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
48317884|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
48571612|NCT02431702|156285791|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
48571613|NCT02431702|156285785|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
48571614|NCT02431702|156285786|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
48571615|NCT02431702|156285787|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
48571616|NCT02431702|156285788|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
48571617|NCT02431702|156285789|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
48571618|NCT02431702|156285790|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
48571619|NCT02431702|156285791|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
48571620|NCT02431702|156285785|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
48619058|NCT02318277|156461495|FG005|Overall Study|Physician Decision|0|||
48619059|NCT02318277|156461496|FG006|Overall Study|Physician Decision|0|||
48619060|NCT02318277|156461497|FG007|Overall Study|Physician Decision|1|||
48619061|NCT02318277|156461490|FG000|Overall Study|Other|0|||
48619062|NCT02318277|156461491|FG001|Overall Study|Other|0|||
48619063|NCT02318277|156461492|FG002|Overall Study|Other|0|||
48619064|NCT02318277|156461493|FG003|Overall Study|Other|0|||
48619065|NCT02318277|156461494|FG004|Overall Study|Other|0|||
48619066|NCT02318277|156461495|FG005|Overall Study|Other|0|||
48619067|NCT02318277|156461496|FG006|Overall Study|Other|1|||
48619068|NCT02318277|156461497|FG007|Overall Study|Other|0|||
48619069|NCT02318277|156461490|FG000|Overall Study|Withdrawal by Subject|0|||
48619070|NCT02318277|156461491|FG001|Overall Study|Withdrawal by Subject|0|||
48619071|NCT02318277|156461492|FG002|Overall Study|Withdrawal by Subject|1|||
48619072|NCT02318277|156461493|FG003|Overall Study|Withdrawal by Subject|0|||
48619073|NCT02318277|156461494|FG004|Overall Study|Withdrawal by Subject|1|||
48619074|NCT02318277|156461495|FG005|Overall Study|Withdrawal by Subject|1|||
48619075|NCT02318277|156461496|FG006|Overall Study|Withdrawal by Subject|6|||
48619076|NCT02318277|156461497|FG007|Overall Study|Withdrawal by Subject|14|||
48571621|NCT02431702|156285786|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
48571622|NCT02431702|156285787|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
48571623|NCT02431702|156285788|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
48571624|NCT02431702|156285789|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
48571625|NCT02431702|156285790|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
48571626|NCT02431702|156285791|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
48571627|NCT02431702|156285785|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
48571628|NCT02431702|156285786|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
48571629|NCT02431702|156285787|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
48571630|NCT02431702|156285788|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
48619077|NCT02318277|156461490|FG000|Overall Study|Participant trial terminated by sponsor|0|||
48619078|NCT02318277|156461491|FG001|Overall Study|Participant trial terminated by sponsor|0|||
48619079|NCT02318277|156461492|FG002|Overall Study|Participant trial terminated by sponsor|1|||
48619080|NCT02318277|156461493|FG003|Overall Study|Participant trial terminated by sponsor|0|||
48619081|NCT02318277|156461494|FG004|Overall Study|Participant trial terminated by sponsor|1|||
48619082|NCT02318277|156461495|FG005|Overall Study|Participant trial terminated by sponsor|2|||
48619083|NCT02318277|156461496|FG006|Overall Study|Participant trial terminated by sponsor|5|||
48619084|NCT02318277|156461497|FG007|Overall Study|Participant trial terminated by sponsor|16|||
48619085|NCT02318277|156461490|FG000|Overall Study|Lost to Follow-up|1|||
48619086|NCT02318277|156461491|FG001|Overall Study|Lost to Follow-up|0|||
48619087|NCT02318277|156461492|FG002|Overall Study|Lost to Follow-up|1|||
48317885|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
48317886|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
48571631|NCT02431702|156285789|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
48571632|NCT02431702|156285790|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
48571633|NCT02431702|156285791|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
48571634|NCT02431702|156285785|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
48571635|NCT02431702|156285786|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
48571636|NCT02431702|156285787|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
48571637|NCT02431702|156285788|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
48571638|NCT02431702|156285789|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
48571639|NCT02431702|156285790|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
48571640|NCT02431702|156285791|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
48571641|NCT02431702|156285785|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
48571642|NCT02431702|156285786|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
48571643|NCT02431702|156285787|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
48571644|NCT02431702|156285788|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
48571645|NCT02431702|156285789|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
48571646|NCT02431702|156285790|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
48571647|NCT02431702|156285791|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
48571648|NCT02282631|156285797|FG000|Overall Study|Lost to Follow-up|2|||
48571649|NCT02282631|156285798|FG001|Overall Study|Lost to Follow-up|0|||
48571650|NCT02498392|156285799|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
48571651|NCT02498392|156285800|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
48571652|NCT02498392|156285799|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
48571653|NCT02498392|156285800|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
48571654|NCT02498392|156285799|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
48571655|NCT02498392|156285800|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
48571656|NCT02498392|156285799|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
48571657|NCT02498392|156285800|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
48571658|NCT02498392|156285799|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
48571659|NCT02498392|156285800|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
48571660|NCT02498392|156285799|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
48571661|NCT02498392|156285800|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
48571662|NCT05784129|156285803|FG000|Overall Study|Study terminated by sponsor|2|||
48571663|NCT05784129|156285804|FG001|Overall Study|Study terminated by sponsor|2|||
48317887|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
48317888|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
48317889|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
48317890|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48317891|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48317892|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48571664|NCT02473289|156285805|FG000|Overall Study|Adverse Event|2|||
48571665|NCT02473289|156285806|FG001|Overall Study|Adverse Event|3|||
48571666|NCT02473289|156285805|FG000|Overall Study|Lost to Follow-up|1|||
48571667|NCT02473289|156285806|FG001|Overall Study|Lost to Follow-up|1|||
48571668|NCT02473289|156285805|FG000|Overall Study|Protocol Violation|0|||
48571669|NCT02473289|156285806|FG001|Overall Study|Protocol Violation|1|||
48571670|NCT02473289|156285805|FG000|Overall Study|Withdrawal of consent|6|||
48571671|NCT02473289|156285806|FG001|Overall Study|Withdrawal of consent|7|||
48571672|NCT02473289|156285805|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
48571673|NCT02473289|156285806|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
48571674|NCT02473289|156285805|FG000|Overall Study|Other|2|||
48571675|NCT02473289|156285806|FG001|Overall Study|Other|0|||
48317893|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
48317894|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48317895|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48317896|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48317897|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
48317898|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
48317899|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
48317900|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
48571676|NCT01780038|156285810|FG000|Overall Study|Lost to Follow-up|4|||
48571677|NCT01780038|156285811|FG001|Overall Study|Lost to Follow-up|1|||
48317901|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
48571678|NCT00459290|156285812|FG000|Overall Study|Adverse Event|3|||
48571679|NCT00459290|156285812|FG000|Overall Study|Ineligible|2|||
48619088|NCT02318277|156461493|FG003|Overall Study|Lost to Follow-up|0|||
48619089|NCT02318277|156461494|FG004|Overall Study|Lost to Follow-up|0|||
48619090|NCT02318277|156461495|FG005|Overall Study|Lost to Follow-up|0|||
48619091|NCT02318277|156461496|FG006|Overall Study|Lost to Follow-up|3|||
48619092|NCT02318277|156461497|FG007|Overall Study|Lost to Follow-up|4|||
48619093|NCT02318277|156461490|FG000|Overall Study|Death|5|||
48619094|NCT02318277|156461491|FG001|Overall Study|Death|3|||
48619095|NCT02318277|156461492|FG002|Overall Study|Death|1|||
48619096|NCT02318277|156461493|FG003|Overall Study|Death|4|||
48619097|NCT02318277|156461494|FG004|Overall Study|Death|6|||
48619098|NCT02318277|156461495|FG005|Overall Study|Death|5|||
48619099|NCT02318277|156461496|FG006|Overall Study|Death|34|||
48619100|NCT02318277|156461497|FG007|Overall Study|Death|58|||
48619101|NCT02318277|156461490|FG000|Overall Study|Transitioned to Hospice|0|||
48619102|NCT02318277|156461491|FG001|Overall Study|Transitioned to Hospice|0|||
48619103|NCT02318277|156461492|FG002|Overall Study|Transitioned to Hospice|0|||
48619104|NCT02318277|156461493|FG003|Overall Study|Transitioned to Hospice|0|||
48619105|NCT02318277|156461494|FG004|Overall Study|Transitioned to Hospice|0|||
48619106|NCT02318277|156461495|FG005|Overall Study|Transitioned to Hospice|1|||
48619107|NCT02318277|156461496|FG006|Overall Study|Transitioned to Hospice|0|||
48619108|NCT02318277|156461497|FG007|Overall Study|Transitioned to Hospice|0|||
48619109|NCT02503865|156461498|FG000|Overall Study|Moved out of area|1|||
48619110|NCT02503865|156461499|FG001|Overall Study|Moved out of area|8|||
48619111|NCT02503865|156461500|FG002|Overall Study|Moved out of area|0|||
48571680|NCT01085630|156285813|FG000|Overall Study|Insufficient data|1|||
48571681|NCT01085630|156285814|FG001|Overall Study|Insufficient data|0|||
48571682|NCT01085630|156285813|FG000|Overall Study|Ineligible|3|||
48571683|NCT01085630|156285814|FG001|Overall Study|Ineligible|0|||
48619112|NCT02503865|156461498|FG000|Overall Study|Refused treatment|4|||
48619113|NCT02503865|156461499|FG001|Overall Study|Refused treatment|39|||
48619114|NCT02503865|156461500|FG002|Overall Study|Refused treatment|2|||
48619115|NCT01210443|156461501|FG000|Overall Study|Study terminated by sponsor|2|||
48619116|NCT04584554|156461502|FG000|Overall Study|Withdrawal by Subject|2|||
48619117|NCT04584554|156461503|FG001|Overall Study|Withdrawal by Subject|2|||
48571684|NCT01089608|156285820|FG000|Overall Study|Adverse Event|0|||
48571685|NCT01089608|156285821|FG001|Overall Study|Adverse Event|4|||
48571686|NCT01089608|156285820|FG000|Overall Study|Lost to Follow-up|0|||
48571687|NCT01089608|156285821|FG001|Overall Study|Lost to Follow-up|2|||
48571688|NCT01421225|156285822|FG000|Overall Study|Withdrawal by Subject|0|||
48571689|NCT01421225|156285823|FG001|Overall Study|Withdrawal by Subject|1|||
48571690|NCT00280397|156285828|FG000|Overall Study|Adverse Event|1|||
48571691|NCT02724969|156285829|FG000|Overall Study|Lost to Follow-up|12|||
48571692|NCT02724969|156285830|FG001|Overall Study|Lost to Follow-up|6|||
48571693|NCT02724969|156285829|FG000|Overall Study|Withdrawal by Subject|3|||
48571694|NCT02724969|156285830|FG001|Overall Study|Withdrawal by Subject|3|||
48571695|NCT02724969|156285829|FG000|Overall Study|Infant demise|0|||
48571696|NCT02724969|156285830|FG001|Overall Study|Infant demise|2|||
48571697|NCT05089357|156285831|FG000|Overall Study|Withdrawal by Subject|23|||
48571698|NCT05089357|156285831|FG000|Overall Study|Lost to Follow-up|6|||
48571699|NCT05089357|156285831|FG000|Overall Study|Medical reason|1|||
48571700|NCT05089357|156285831|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
48571701|NCT05089357|156285831|FG000|Overall Study|Pregnancy|2|||
48571702|NCT01346540|156285839|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
48571703|NCT01346540|156285840|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
48571704|NCT01346540|156285839|FG000|Overall Study|Adverse Event|0|||
48571705|NCT01346540|156285840|FG001|Overall Study|Adverse Event|4|||
48317902|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
48317903|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
48317904|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
48619118|NCT02497755|156461504|FG000|Overall Study|Protocol Violation|1|||
48619119|NCT02497755|156461505|FG001|Overall Study|Protocol Violation|0|||
48317905|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
48317906|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
48317907|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48317908|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48317909|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48317910|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48571706|NCT03170648|156285846|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
48735988|NCT02935842|156883750|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
48571707|NCT03170648|156285846|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
48571708|NCT00135512|156285847|FG000|Overall Study|Adverse Event|56|||
48571709|NCT00135512|156285847|FG000|Overall Study|Lack of Efficacy|25|||
48571710|NCT00135512|156285847|FG000|Overall Study|Other|42|||
48571711|NCT04882072|156285848|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
48571712|NCT04882072|156285849|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
48619120|NCT01774370|156461506|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
48619121|NCT01774370|156461506|FG000|Overall Study|Administered prior to the contract date|4|||
48619122|NCT01774370|156461506|FG000|Overall Study|Subjects of contraindications|34|||
48619123|NCT01774370|156461506|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
48619124|NCT01774370|156461506|FG000|Overall Study|Follow-up failure|34|||
48619125|NCT00501085|156461514|FG000|Overall Study|Lost to Follow-up|195|||
48571713|NCT04882072|156285848|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
48571714|NCT04882072|156285849|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
48571715|NCT04882072|156285848|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
48571716|NCT04882072|156285849|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
48571717|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
48571718|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
48571719|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Death|0|||
48571720|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Death|4|||
48571721|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
48571722|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
48571723|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
48571724|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
48571725|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
48571726|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
48571727|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
48571728|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
48571729|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
48571730|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
48571731|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Other|4|||
48571732|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Other|3|||
48571733|NCT03517722|156285850|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
48571734|NCT03517722|156285851|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
48571735|NCT03517722|156285850|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
48571736|NCT03517722|156285851|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
48571737|NCT03517722|156285850|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
48571738|NCT03517722|156285851|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
48571739|NCT03517722|156285850|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
48571740|NCT03517722|156285851|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
48571741|NCT03517722|156285850|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
48571742|NCT03517722|156285851|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
48571743|NCT01844986|156285852|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
48571744|NCT01844986|156285853|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
48571745|NCT01844986|156285852|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
48571746|NCT01844986|156285853|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
48571747|NCT01844986|156285852|FG000|Overall Study (Global Cohort)|Death|55|||
48571748|NCT01844986|156285853|FG001|Overall Study (Global Cohort)|Death|26|||
48571749|NCT01844986|156285852|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
48571750|NCT01844986|156285853|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
48571751|NCT01844986|156285852|FG000|Overall Study (China Cohort)|Death|10|||
48571752|NCT01844986|156285853|FG001|Overall Study (China Cohort)|Death|6|||
48571753|NCT02422186|156285855|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
48571754|NCT02422186|156285856|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
48571755|NCT02422186|156285855|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
48571756|NCT02422186|156285856|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
48571757|NCT02422186|156285855|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
48571758|NCT02422186|156285856|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
48571759|NCT02422186|156285855|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
48571760|NCT02422186|156285856|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
48571761|NCT02422186|156285855|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
48571762|NCT02422186|156285856|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
48571763|NCT02422186|156285855|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
48571764|NCT02422186|156285856|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
48571765|NCT02422186|156285855|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
48571766|NCT02422186|156285856|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
48571767|NCT02422186|156285855|FG000|Follow-up Phase (2 Weeks)|Other|3|||
48571768|NCT02422186|156285856|FG001|Follow-up Phase (2 Weeks)|Other|0|||
48571769|NCT01814696|156285857|FG000|Overall Study|Withdrawal by Subject|1|||
48571770|NCT01814696|156285858|FG001|Overall Study|Withdrawal by Subject|0|||
48571771|NCT01814696|156285857|FG000|Overall Study|Randomized to wrong group|1|||
48735989|NCT02935842|156883747|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
48571772|NCT01814696|156285858|FG001|Overall Study|Randomized to wrong group|0|||
48571773|NCT02432703|156285859|FG000|Overall Study|Adverse Event|1|||
48619126|NCT00501085|156461514|FG000|Overall Study|Withdrawal by Subject|34|||
48619127|NCT00501085|156461514|FG000|Overall Study|Subject Decision|1|||
48619128|NCT00501085|156461514|FG000|Overall Study|Revision Surgery|7|||
48619129|NCT00501085|156461514|FG000|Overall Study|Explantation Surgery|26|||
48619130|NCT00501085|156461514|FG000|Overall Study|Adverse Event|4|||
48619131|NCT00501085|156461514|FG000|Overall Study|Non-Compliance|24|||
48619132|NCT00501085|156461514|FG000|Overall Study|Study closed by sponsor|109|||
48619133|NCT00501085|156461514|FG000|Overall Study|Other loss to follow-up|32|||
48619134|NCT02958527|156461519|FG000|Overall Study|Not collected CRFs|12|||
48619135|NCT02366130|156461520|FG000|Overall Study|Withdrawal by Subject|3|||
48619136|NCT02366130|156461520|FG000|Overall Study|Ineligible|6|||
48619137|NCT01666314|156461521|FG000|Overall Study|Adverse Event|3|||
48619138|NCT01666314|156461522|FG001|Overall Study|Adverse Event|13|||
48619139|NCT01666314|156461523|FG002|Overall Study|Adverse Event|7|||
48619140|NCT01666314|156461524|FG003|Overall Study|Adverse Event|7|||
48619141|NCT01666314|156461521|FG000|Overall Study|Progressive Disease|11|||
48619142|NCT01666314|156461522|FG001|Overall Study|Progressive Disease|9|||
48619143|NCT01666314|156461523|FG002|Overall Study|Progressive Disease|19|||
48619144|NCT01666314|156461524|FG003|Overall Study|Progressive Disease|20|||
48619145|NCT01666314|156461521|FG000|Overall Study|Symptomatic Deterioration|1|||
48619146|NCT01666314|156461522|FG001|Overall Study|Symptomatic Deterioration|0|||
48619147|NCT01666314|156461523|FG002|Overall Study|Symptomatic Deterioration|2|||
48619148|NCT01666314|156461524|FG003|Overall Study|Symptomatic Deterioration|0|||
48619149|NCT01666314|156461521|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
48619150|NCT01666314|156461522|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
48619151|NCT01666314|156461523|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
48619152|NCT01666314|156461524|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
48619153|NCT01666314|156461521|FG000|Overall Study|Withdrawal by Subject|1|||
48619154|NCT01666314|156461522|FG001|Overall Study|Withdrawal by Subject|1|||
48619155|NCT01666314|156461523|FG002|Overall Study|Withdrawal by Subject|2|||
48619156|NCT01666314|156461524|FG003|Overall Study|Withdrawal by Subject|3|||
48619157|NCT01666314|156461521|FG000|Overall Study|Reason not Specified|10|||
48619158|NCT01666314|156461522|FG001|Overall Study|Reason not Specified|7|||
48619159|NCT01666314|156461523|FG002|Overall Study|Reason not Specified|5|||
48619160|NCT01666314|156461524|FG003|Overall Study|Reason not Specified|5|||
48619161|NCT01945242|156461525|FG000|Overall Study|Physician Decision|3|||
48619162|NCT01945242|156461526|FG001|Overall Study|Physician Decision|3|||
48619163|NCT02405962|156461528|FG000|Overall Study|Lost to Follow-up|1|||
48619164|NCT02405962|156461529|FG001|Overall Study|Lost to Follow-up|4|||
48619165|NCT02405962|156461528|FG000|Overall Study|A participant has moved to another place|0|||
48619166|NCT02405962|156461529|FG001|Overall Study|A participant has moved to another place|1|||
48619167|NCT00962650|156461530|FG000|Overall Study|Transgastric DP was not completed|2|||
48619168|NCT00105508|156461532|FG000|Overall Study|Prephase Dropout|1|||
48619169|NCT00105508|156461533|FG001|Overall Study|Prephase Dropout|0|||
48619170|NCT00105508|156461532|FG000|Overall Study|Adverse Event|16|||
48619171|NCT00105508|156461533|FG001|Overall Study|Adverse Event|19|||
48619172|NCT00105508|156461532|FG000|Overall Study|Insufficient Efficacy|1|||
48619173|NCT00105508|156461533|FG001|Overall Study|Insufficient Efficacy|0|||
48619174|NCT00105508|156461532|FG000|Overall Study|Withdrawal by Subject|10|||
48619175|NCT00105508|156461533|FG001|Overall Study|Withdrawal by Subject|6|||
48619176|NCT00105508|156461532|FG000|Overall Study|Lost to Follow-up|3|||
48619177|NCT00105508|156461533|FG001|Overall Study|Lost to Follow-up|0|||
48619178|NCT00105508|156461532|FG000|Overall Study|Protocol Violation|1|||
48619179|NCT00105508|156461533|FG001|Overall Study|Protocol Violation|2|||
48619180|NCT00105508|156461532|FG000|Overall Study|Other|8|||
48619181|NCT00105508|156461533|FG001|Overall Study|Other|9|||
48619182|NCT03684057|156463465|FG000|Overall Study|Withdrawal by Subject|4|||
48619183|NCT03684057|156463466|FG001|Overall Study|Withdrawal by Subject|5|||
48619184|NCT00368849|156463474|FG000|Overall Study|Withdrawal by Subject|0|||
48619185|NCT00368849|156463475|FG001|Overall Study|Withdrawal by Subject|1|||
48619186|NCT00368849|156463474|FG000|Overall Study|Physician Decision|0|||
48619187|NCT00368849|156463475|FG001|Overall Study|Physician Decision|1|||
48619188|NCT01155323|156463476|FG000|First Intervention|exclusion criteria|1|||
48619189|NCT01155323|156463477|FG001|First Intervention|exclusion criteria|1|||
48619190|NCT01155323|156463476|FG000|Second Intervention|Lost to Follow-up|1|||
48619191|NCT01155323|156463477|FG001|Second Intervention|Lost to Follow-up|1|||
48619192|NCT01410604|156463478|FG000|Overall Study|Adverse Event|2|||
48619193|NCT01410604|156463479|FG001|Overall Study|Adverse Event|1|||
48619194|NCT01410604|156463478|FG000|Overall Study|Lost to Follow-up|1|||
48619195|NCT01410604|156463479|FG001|Overall Study|Lost to Follow-up|0|||
48619196|NCT01410604|156463478|FG000|Overall Study|Physician Decision|0|||
48619197|NCT01410604|156463479|FG001|Overall Study|Physician Decision|1|||
48619198|NCT01521364|156463481|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
48619199|NCT01521364|156463481|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
48619200|NCT02175758|156463482|FG000|Treatment Phase|Lost to Follow-up|0|||
48619201|NCT02175758|156463483|FG001|Treatment Phase|Lost to Follow-up|1|||
48619202|NCT02175758|156463484|FG002|Treatment Phase|Lost to Follow-up|0|||
48619203|NCT02175758|156463485|FG003|Treatment Phase|Lost to Follow-up|0|||
48619204|NCT02175758|156463486|FG004|Treatment Phase|Lost to Follow-up|0|||
48619205|NCT02175758|156463487|FG005|Treatment Phase|Lost to Follow-up|0|||
48619206|NCT02175758|156463482|FG000|Treatment Phase|Adverse Event|0|||
48619207|NCT02175758|156463483|FG001|Treatment Phase|Adverse Event|0|||
48619208|NCT02175758|156463484|FG002|Treatment Phase|Adverse Event|0|||
48619209|NCT02175758|156463485|FG003|Treatment Phase|Adverse Event|0|||
48619210|NCT02175758|156463486|FG004|Treatment Phase|Adverse Event|1|||
48619211|NCT02175758|156463487|FG005|Treatment Phase|Adverse Event|0|||
48619212|NCT02636283|156463490|FG000|Overall Study|Adverse Event|2|||
48571774|NCT02432703|156285860|FG001|Overall Study|Adverse Event|4|||
48571775|NCT02432703|156285859|FG000|Overall Study|Lack of Efficacy|1|||
48571776|NCT02432703|156285860|FG001|Overall Study|Lack of Efficacy|0|||
48571777|NCT02432703|156285859|FG000|Overall Study|Lost to Follow-up|5|||
48571778|NCT02432703|156285860|FG001|Overall Study|Lost to Follow-up|3|||
48571779|NCT02432703|156285859|FG000|Overall Study|Withdrawal by Subject|9|||
48571780|NCT02432703|156285860|FG001|Overall Study|Withdrawal by Subject|6|||
48571781|NCT02432703|156285859|FG000|Overall Study|Other|6|||
48571782|NCT02432703|156285860|FG001|Overall Study|Other|5|||
48619213|NCT02636283|156463491|FG001|Overall Study|Adverse Event|0|||
48449814|NCT01827319|155835500|FG000|Overall Study|Lost to Follow-up|3|||
48571783|NCT02993250|156285861|FG000|Overall Study|Lost to Follow-up|0|||
48571784|NCT02993250|156285862|FG001|Overall Study|Lost to Follow-up|1|||
48571785|NCT02829918|156285863|FG000|Overall Study|Death|2|||
48571786|NCT02829918|156285863|FG000|Overall Study|Withdrawal by Subject|4|||
48571787|NCT02829918|156285863|FG000|Overall Study|Adverse Event|1|||
48571788|NCT02829918|156285863|FG000|Overall Study|Progression|1|||
48571789|NCT04538664|156285864|FG000|Overall Study|Withdrawal by Subject|5|||
48571790|NCT04538664|156285865|FG001|Overall Study|Withdrawal by Subject|9|||
48571791|NCT04538664|156285864|FG000|Overall Study|Lost to Follow-up|2|||
48571792|NCT04538664|156285865|FG001|Overall Study|Lost to Follow-up|1|||
48571793|NCT04538664|156285864|FG000|Overall Study|Ongoing|106|||
48571794|NCT04538664|156285865|FG001|Overall Study|Ongoing|115|||
48571795|NCT05216406|156285866|FG000|Overall Study|Lost to Follow-up|8|||
48571796|NCT05216406|156285867|FG001|Overall Study|Lost to Follow-up|9|||
48571797|NCT02437162|156285868|FG000|Overall Study|Protocol Violation|0|||
48571798|NCT02437162|156285869|FG001|Overall Study|Protocol Violation|1|||
48571799|NCT02437162|156285870|FG002|Overall Study|Protocol Violation|0|||
48571800|NCT02437162|156285868|FG000|Overall Study|Randomized but not treated|0|||
48571801|NCT02437162|156285869|FG001|Overall Study|Randomized but not treated|0|||
48571802|NCT02437162|156285870|FG002|Overall Study|Randomized but not treated|1|||
48571803|NCT02437162|156285868|FG000|Overall Study|Study discontinued by Sponsor|93|||
48571804|NCT02437162|156285869|FG001|Overall Study|Study discontinued by Sponsor|98|||
48571805|NCT02437162|156285870|FG002|Overall Study|Study discontinued by Sponsor|97|||
48571806|NCT02437162|156285868|FG000|Overall Study|Withdrawal by Subject|13|||
48619214|NCT02636283|156463490|FG000|Overall Study|Trial Terminated Prematurely|0|||
48571807|NCT02437162|156285869|FG001|Overall Study|Withdrawal by Subject|7|||
48571808|NCT02437162|156285870|FG002|Overall Study|Withdrawal by Subject|9|||
48571809|NCT02437162|156285868|FG000|Overall Study|Adverse Event|0|||
48571810|NCT02437162|156285869|FG001|Overall Study|Adverse Event|1|||
48619215|NCT02636283|156463491|FG001|Overall Study|Trial Terminated Prematurely|3|||
48619216|NCT03309605|156463492|FG000|Overall Study|Adverse Event|0|||
48619217|NCT03309605|156463493|FG001|Overall Study|Adverse Event|0|||
48317911|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
48317912|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48449815|NCT03862495|155835501|FG000|Overall Study|Lost to Follow-up|37|||
48571811|NCT02437162|156285870|FG002|Overall Study|Adverse Event|0|||
48571812|NCT02437162|156285868|FG000|Overall Study|Lost to Follow-up|1|||
48571813|NCT02437162|156285869|FG001|Overall Study|Lost to Follow-up|0|||
48571814|NCT02437162|156285870|FG002|Overall Study|Lost to Follow-up|1|||
48571815|NCT02437162|156285868|FG000|Overall Study|Death|0|||
48571816|NCT02437162|156285869|FG001|Overall Study|Death|1|||
48571817|NCT02437162|156285870|FG002|Overall Study|Death|0|||
48571818|NCT02437162|156285868|FG000|Overall Study|Other|0|||
48571819|NCT02437162|156285869|FG001|Overall Study|Other|0|||
48571820|NCT02437162|156285870|FG002|Overall Study|Other|1|||
48571821|NCT03981744|156285871|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
48571822|NCT03981744|156285872|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
48571823|NCT03981744|156285873|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
48571824|NCT03981744|156285874|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
48571825|NCT03981744|156285871|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
48571826|NCT03981744|156285872|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
48571827|NCT03981744|156285873|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
48571828|NCT03981744|156285874|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
48571829|NCT03981744|156285871|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
48571830|NCT03981744|156285872|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
48571831|NCT03981744|156285873|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
48571832|NCT03981744|156285874|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
48571833|NCT03711474|156285875|FG000|Overall Study|Physician Decision|2|||
48571834|NCT03711474|156285876|FG001|Overall Study|Physician Decision|0|||
48571835|NCT03321526|156285877|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
48571836|NCT03321526|156285878|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
48571837|NCT03321526|156285877|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
48571838|NCT03321526|156285878|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
48571839|NCT03321526|156285877|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
48571840|NCT03321526|156285878|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
48571841|NCT03321526|156285877|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
48571842|NCT03321526|156285878|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
48571843|NCT03321526|156285877|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
48571844|NCT03321526|156285878|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
48571845|NCT03321526|156285877|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
48571846|NCT03321526|156285878|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
48571847|NCT03321526|156285877|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
48571848|NCT03321526|156285878|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
48571849|NCT03321526|156285877|FG000|Follow-up Phase (2 Weeks)|Other|24|||
48571850|NCT03321526|156285878|FG001|Follow-up Phase (2 Weeks)|Other|24|||
48571851|NCT05974501|156285879|FG000|Overall Study|Physician Decision|0|||
48571852|NCT05974501|156285880|FG001|Overall Study|Physician Decision|1|||
48571853|NCT02782104|156285881|FG000|Overall Study|Other|215|||
48571854|NCT02782104|156285881|FG000|Overall Study|Induction Day 28 Non Responder|9|||
48571855|NCT02782104|156285881|FG000|Overall Study|Non-Compliance with Study Drug|2|||
48571856|NCT02782104|156285881|FG000|Overall Study|Death|8|||
48571857|NCT02782104|156285881|FG000|Overall Study|Pregnancy|6|||
48571858|NCT02782104|156285881|FG000|Overall Study|Withdrawal by Subject|63|||
48571859|NCT02782104|156285881|FG000|Overall Study|Protocol Violation|7|||
48571860|NCT02782104|156285881|FG000|Overall Study|Lack of Efficacy|61|||
48571861|NCT02782104|156285881|FG000|Overall Study|Lost to Follow-up|23|||
48571862|NCT02782104|156285881|FG000|Overall Study|Adverse Event|74|||
48571863|NCT02714595|156285883|FG000|Overall Study|Lost to Follow-up|1|||
48571864|NCT02714595|156285884|FG001|Overall Study|Lost to Follow-up|0|||
48571865|NCT02714595|156285883|FG000|Overall Study|Withdrawal by Subject|1|||
48571866|NCT02714595|156285884|FG001|Overall Study|Withdrawal by Subject|2|||
48571867|NCT02714595|156285883|FG000|Overall Study|Lack of Efficacy|0|||
48571868|NCT02714595|156285884|FG001|Overall Study|Lack of Efficacy|1|||
48619218|NCT03309605|156463494|FG002|Overall Study|Adverse Event|0|||
48619219|NCT03309605|156463495|FG003|Overall Study|Adverse Event|1|||
48619220|NCT03309605|156463496|FG004|Overall Study|Adverse Event|0|||
48619221|NCT03309605|156463497|FG005|Overall Study|Adverse Event|0|||
48619222|NCT03309605|156463498|FG006|Overall Study|Adverse Event|2|||
48619223|NCT03309605|156463499|FG007|Overall Study|Adverse Event|1|||
48619224|NCT03309605|156463492|FG000|Overall Study|Withdrawal by Subject|0|||
48619225|NCT03309605|156463493|FG001|Overall Study|Withdrawal by Subject|0|||
48619226|NCT03309605|156463494|FG002|Overall Study|Withdrawal by Subject|0|||
48619227|NCT03309605|156463495|FG003|Overall Study|Withdrawal by Subject|0|||
48619228|NCT03309605|156463496|FG004|Overall Study|Withdrawal by Subject|1|||
48619229|NCT03309605|156463497|FG005|Overall Study|Withdrawal by Subject|0|||
48317913|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
48317914|NCT03903822|155364203|FG000|Treatment Phase (6 Weeks)|Other|2|||
48317915|NCT03903822|155364204|FG001|Treatment Phase (6 Weeks)|Other|1|||
48317916|NCT03903822|155364205|FG002|Treatment Phase (6 Weeks)|Other|0|||
48317917|NCT03903822|155364206|FG003|Treatment Phase (6 Weeks)|Other|0|||
48317918|NCT03903822|155364207|FG004|Treatment Phase (6 Weeks)|Other|1|||
48317919|NCT03903822|155364208|FG005|Treatment Phase (6 Weeks)|Other|1|||
48317920|NCT03903822|155364209|FG006|Treatment Phase (6 Weeks)|Other|0|||
48317921|NCT03903822|155364210|FG007|Treatment Phase (6 Weeks)|Other|0|||
48317922|NCT03903822|155364203|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
48317923|NCT03903822|155364204|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
48317924|NCT03903822|155364205|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
48317925|NCT03903822|155364206|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
48317926|NCT03903822|155364207|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
48317927|NCT03903822|155364208|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
48317928|NCT03903822|155364209|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
48317929|NCT03903822|155364210|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
48317930|NCT03903822|155364203|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48317931|NCT03903822|155364204|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48317932|NCT03903822|155364205|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48317933|NCT03903822|155364206|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48317934|NCT03903822|155364207|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
48317935|NCT03903822|155364208|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48317936|NCT03903822|155364209|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48317937|NCT03903822|155364210|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
48317938|NCT03903822|155364203|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
48317939|NCT03903822|155364204|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48317940|NCT03903822|155364205|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48317941|NCT03903822|155364206|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48317942|NCT03903822|155364207|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48317943|NCT03903822|155364208|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
48317944|NCT03903822|155364209|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
48317945|NCT03903822|155364210|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
48317946|NCT03903822|155364203|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
48317947|NCT03903822|155364204|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
48317948|NCT03903822|155364205|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
48317949|NCT03903822|155364206|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
48317950|NCT03903822|155364207|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
48317951|NCT03903822|155364208|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
48317952|NCT03903822|155364209|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
48317953|NCT03903822|155364210|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
48317954|NCT03903822|155364203|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
48317955|NCT03903822|155364204|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
48317956|NCT03903822|155364205|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
48317957|NCT03903822|155364206|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
48317958|NCT03903822|155364207|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
48317959|NCT03903822|155364208|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
48619230|NCT03309605|156463498|FG006|Overall Study|Withdrawal by Subject|1|||
48619231|NCT03309605|156463499|FG007|Overall Study|Withdrawal by Subject|1|||
48619232|NCT01178411|156463500|FG000|Overall Study|Adverse Event|5|||
48619233|NCT01178411|156463500|FG000|Overall Study|Withdrawal by Subject|4|||
48619234|NCT01178411|156463500|FG000|Overall Study|Protocol Violation|1|||
48619235|NCT01178411|156463500|FG000|Overall Study|Progressive disease per RECIST|32|||
48317960|NCT03903822|155364209|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
48619236|NCT01178411|156463500|FG000|Overall Study|Progressive disease per clinician|9|||
48619237|NCT01178411|156463500|FG000|Overall Study|Physician Decision|6|||
48619238|NCT01178411|156463500|FG000|Overall Study|Death|1|||
48619239|NCT01178411|156463500|FG000|Overall Study|No reason provided|1|||
48317961|NCT03903822|155364210|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
48317962|NCT03903822|155364203|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48317963|NCT03903822|155364204|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48317964|NCT03903822|155364205|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48571869|NCT02714595|156285883|FG000|Overall Study|Death|30|||
48571870|NCT02714595|156285884|FG001|Overall Study|Death|9|||
48571871|NCT02714595|156285883|FG000|Overall Study|Other-Miscellaneous|0|||
48571872|NCT02714595|156285884|FG001|Overall Study|Other-Miscellaneous|1|||
48571873|NCT03706690|156285885|FG000|Overall Study|Withdrawal by Subject|8|||
48571874|NCT03706690|156285886|FG001|Overall Study|Withdrawal by Subject|8|||
48571875|NCT03706690|156285885|FG000|Overall Study|Death|143|||
48571876|NCT03706690|156285886|FG001|Overall Study|Death|75|||
48571877|NCT03706690|156285885|FG000|Overall Study|Ongoing at DCO|121|||
48571878|NCT03706690|156285886|FG001|Overall Study|Ongoing at DCO|52|||
48571879|NCT00713258|156285887|FG000|Overall Study|Adverse Event|2|||
48571880|NCT00713258|156285888|FG001|Overall Study|Adverse Event|4|||
48571881|NCT00713258|156285887|FG000|Overall Study|Non-Compliance|2|||
48571882|NCT00713258|156285888|FG001|Overall Study|Non-Compliance|1|||
48571883|NCT00713258|156285887|FG000|Overall Study|Other|1|||
48571884|NCT00713258|156285888|FG001|Overall Study|Other|1|||
48571885|NCT03464136|156285889|FG000|Overall Study|Lost to Follow-up|5|||
48571886|NCT03464136|156285890|FG001|Overall Study|Lost to Follow-up|8|||
48571887|NCT03464136|156285889|FG000|Overall Study|Withdrawal by Subject|16|||
48571888|NCT03464136|156285890|FG001|Overall Study|Withdrawal by Subject|13|||
48571889|NCT03464136|156285889|FG000|Overall Study|Death|1|||
48571890|NCT03464136|156285890|FG001|Overall Study|Death|0|||
48571891|NCT03464136|156285889|FG000|Overall Study|Other|8|||
48571892|NCT03464136|156285890|FG001|Overall Study|Other|4|||
48571893|NCT03185819|156285891|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
48571894|NCT03185819|156285892|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
48571895|NCT03185819|156285893|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
48571896|NCT03185819|156285894|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
48571897|NCT03185819|156285891|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
48571898|NCT03185819|156285892|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
48571899|NCT03185819|156285893|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
48571900|NCT03185819|156285894|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
48571901|NCT03185819|156285891|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
48571902|NCT03185819|156285892|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
48571903|NCT03185819|156285893|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
48571904|NCT03185819|156285894|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
48571905|NCT03185819|156285891|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
48571906|NCT03185819|156285892|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
48571907|NCT03185819|156285893|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
48571908|NCT03185819|156285894|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
48571909|NCT03185819|156285891|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
48571910|NCT03185819|156285892|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
48571911|NCT03185819|156285893|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
48571912|NCT03185819|156285894|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
48571913|NCT03185819|156285891|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
48571914|NCT03185819|156285892|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
48571915|NCT03185819|156285893|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
48571916|NCT03185819|156285894|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
48571917|NCT03185819|156285891|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
48571918|NCT03185819|156285892|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
48571919|NCT03185819|156285893|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
48571920|NCT03185819|156285894|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
48571921|NCT03185819|156285891|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
48571922|NCT03185819|156285892|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
48571923|NCT03185819|156285893|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
48571924|NCT03185819|156285894|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
48571925|NCT03185819|156285891|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
48571926|NCT03185819|156285892|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
48619240|NCT01178411|156463500|FG000|Overall Study|Drug manufacturing ended|1|||
48619241|NCT00394472|156463504|FG000|Overall Study|Protocol Violation|1|||
48317965|NCT03903822|155364206|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48449816|NCT03862495|155835502|FG001|Overall Study|Lost to Follow-up|35|||
48571927|NCT03185819|156285893|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
48571928|NCT03185819|156285894|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
48571929|NCT03185819|156285891|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
48619242|NCT00394472|156463505|FG001|Overall Study|Protocol Violation|3|||
48619243|NCT00394472|156463504|FG000|Overall Study|incorrect enrolment|4|||
48619244|NCT00394472|156463505|FG001|Overall Study|incorrect enrolment|2|||
48619245|NCT00394472|156463504|FG000|Overall Study|Adverse Event|4|||
48619246|NCT00394472|156463505|FG001|Overall Study|Adverse Event|2|||
48619247|NCT00394472|156463504|FG000|Overall Study|Withdrawal by Subject|0|||
48619248|NCT00394472|156463505|FG001|Overall Study|Withdrawal by Subject|2|||
48571930|NCT03185819|156285892|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
48571931|NCT03185819|156285893|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
48571932|NCT03185819|156285894|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
48571933|NCT03185819|156285891|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
48619249|NCT00394472|156463504|FG000|Overall Study|Physician Decision|0|||
48619250|NCT00394472|156463505|FG001|Overall Study|Physician Decision|1|||
48619251|NCT00394472|156463504|FG000|Overall Study|Lost to Follow-up|0|||
48619252|NCT00394472|156463505|FG001|Overall Study|Lost to Follow-up|1|||
48619253|NCT01879852|156463506|FG000|Overall Study|Withdrawal by Subject|2|||
48619254|NCT01879852|156463507|FG001|Overall Study|Withdrawal by Subject|0|||
48619255|NCT00145327|156463513|FG000|Overall Study|Withdrawal by Subject|77|||
48619256|NCT00145327|156463514|FG001|Overall Study|Withdrawal by Subject|72|||
48619257|NCT00145327|156463515|FG002|Overall Study|Withdrawal by Subject|164|||
48619258|NCT00145327|156463513|FG000|Overall Study|Death|26|||
48619259|NCT00145327|156463514|FG001|Overall Study|Death|18|||
48619260|NCT00145327|156463515|FG002|Overall Study|Death|30|||
48619261|NCT00145327|156463513|FG000|Overall Study|Adverse Event|14|||
48619262|NCT00145327|156463514|FG001|Overall Study|Adverse Event|11|||
48619263|NCT00145327|156463515|FG002|Overall Study|Adverse Event|22|||
48619264|NCT00145327|156463513|FG000|Overall Study|Lost to Follow-up|9|||
48619265|NCT00145327|156463514|FG001|Overall Study|Lost to Follow-up|14|||
48619266|NCT00145327|156463515|FG002|Overall Study|Lost to Follow-up|14|||
48619267|NCT00145327|156463513|FG000|Overall Study|Administrative problems|12|||
48619268|NCT00145327|156463514|FG001|Overall Study|Administrative problems|9|||
48619269|NCT00145327|156463515|FG002|Overall Study|Administrative problems|13|||
48619270|NCT00145327|156463513|FG000|Overall Study|Protocol Violation|2|||
48619271|NCT00145327|156463514|FG001|Overall Study|Protocol Violation|0|||
48619272|NCT00145327|156463515|FG002|Overall Study|Protocol Violation|2|||
48619273|NCT00145327|156463513|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48619274|NCT00145327|156463514|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48619275|NCT00145327|156463515|FG002|Overall Study|Abnormal laboratory value(s)|2|||
48619276|NCT00145327|156463513|FG000|Overall Study|Missing - not stated|1|||
48619277|NCT00145327|156463514|FG001|Overall Study|Missing - not stated|0|||
48619278|NCT00145327|156463515|FG002|Overall Study|Missing - not stated|1|||
48619279|NCT01137812|156463518|FG000|Overall Study|Adverse Event|21|||
48619280|NCT01137812|156463519|FG001|Overall Study|Adverse Event|14|||
48619281|NCT01137812|156463518|FG000|Overall Study|Lost to Follow-up|6|||
48619282|NCT01137812|156463519|FG001|Overall Study|Lost to Follow-up|8|||
48619283|NCT01137812|156463518|FG000|Overall Study|Physician Decision|25|||
48619284|NCT01137812|156463519|FG001|Overall Study|Physician Decision|17|||
48619285|NCT01137812|156463518|FG000|Overall Study|Protocol Violation|5|||
48619286|NCT01137812|156463519|FG001|Overall Study|Protocol Violation|4|||
48619287|NCT01137812|156463518|FG000|Overall Study|Withdrawal by Subject|5|||
48619288|NCT01137812|156463519|FG001|Overall Study|Withdrawal by Subject|13|||
48619289|NCT01137812|156463518|FG000|Overall Study|Death|2|||
48619290|NCT01137812|156463519|FG001|Overall Study|Death|0|||
48619291|NCT01137812|156463518|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
48619292|NCT01137812|156463519|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
48619293|NCT01137812|156463518|FG000|Overall Study|Other|19|||
48619294|NCT01137812|156463519|FG001|Overall Study|Other|27|||
48619295|NCT01283386|156463520|FG000|Overall Study|Death|2|||
48619296|NCT01283386|156463521|FG001|Overall Study|Death|0|||
48619297|NCT01283386|156463520|FG000|Overall Study|Withdrawal by Subject|2|||
48619298|NCT01283386|156463521|FG001|Overall Study|Withdrawal by Subject|1|||
48619299|NCT01283386|156463520|FG000|Overall Study|Relapse of underlying disease|1|||
48619300|NCT01283386|156463521|FG001|Overall Study|Relapse of underlying disease|3|||
48619301|NCT01283386|156463520|FG000|Overall Study|Progression of underlying disease|2|||
48619302|NCT01283386|156463521|FG001|Overall Study|Progression of underlying disease|7|||
48619303|NCT01283386|156463520|FG000|Overall Study|Reason not specified|1|||
48619304|NCT01283386|156463521|FG001|Overall Study|Reason not specified|0|||
48619305|NCT01283386|156463520|FG000|Overall Study|Protocol Violation|0|||
48619306|NCT01283386|156463521|FG001|Overall Study|Protocol Violation|1|||
48619307|NCT04027946|156463522|FG000|Overall Study|Screen failures|3|||
48619308|NCT01028053|156463526|FG000|Overall Study|Screen Failure|113|||
48619309|NCT01028053|156463526|FG000|Overall Study|Patient Request|11|||
48619310|NCT01028053|156463526|FG000|Overall Study|Protocol Violation|1|||
48619311|NCT01028053|156463526|FG000|Overall Study|Physician Decision|2|||
48619312|NCT01028053|156463526|FG000|Overall Study|Technical Problem|1|||
48619313|NCT01028053|156463526|FG000|Overall Study|Terminated by Sponsor|1|||
48619314|NCT01028053|156463526|FG000|Overall Study|Various reasons|4|||
48619315|NCT03315689|156463527|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
48619316|NCT03315689|156463528|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
48571934|NCT03185819|156285892|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
48571935|NCT03185819|156285893|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
48571936|NCT03185819|156285894|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
48571937|NCT03185819|156285891|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
48571938|NCT03185819|156285892|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
48571939|NCT03185819|156285893|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
48571940|NCT03185819|156285894|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
48317966|NCT03903822|155364207|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48317967|NCT03903822|155364208|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
48317968|NCT03903822|155364209|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48317969|NCT03903822|155364210|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
48317970|NCT03903822|155364203|FG000|Follow up Phase (4 Weeks)|Other|1|||
48317971|NCT03903822|155364204|FG001|Follow up Phase (4 Weeks)|Other|1|||
48317972|NCT03903822|155364205|FG002|Follow up Phase (4 Weeks)|Other|0|||
48317973|NCT03903822|155364206|FG003|Follow up Phase (4 Weeks)|Other|0|||
48619317|NCT03315689|156463527|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
48619318|NCT03315689|156463528|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
48317974|NCT03903822|155364207|FG004|Follow up Phase (4 Weeks)|Other|0|||
48317975|NCT03903822|155364208|FG005|Follow up Phase (4 Weeks)|Other|0|||
48571941|NCT03185819|156285891|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
48571942|NCT03185819|156285892|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
48619319|NCT03315689|156463527|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
48619320|NCT03315689|156463528|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
48619321|NCT01297244|156463533|FG000|Overall Study|Progressive disease|22|||
48317976|NCT03903822|155364209|FG006|Follow up Phase (4 Weeks)|Other|0|||
48571943|NCT03185819|156285893|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
48619322|NCT01297244|156463534|FG001|Overall Study|Progressive disease|3|||
48619323|NCT01297244|156463533|FG000|Overall Study|Adverse Event|9|||
48619324|NCT01297244|156463534|FG001|Overall Study|Adverse Event|1|||
48619325|NCT01297244|156463533|FG000|Overall Study|Death|1|||
48619326|NCT01297244|156463534|FG001|Overall Study|Death|1|||
48619327|NCT01297244|156463533|FG000|Overall Study|Clinical progression|1|||
48619328|NCT01297244|156463534|FG001|Overall Study|Clinical progression|1|||
48619329|NCT01297244|156463533|FG000|Overall Study|Withdrawal by Subject|2|||
48619330|NCT01297244|156463534|FG001|Overall Study|Withdrawal by Subject|0|||
48619331|NCT00263562|156463536|FG000|Overall Study|Protocol Violation|3|||
48619332|NCT00263562|156463537|FG001|Overall Study|Protocol Violation|0|||
48619333|NCT03387046|156463539|FG000|Overall Study|Adverse Event|1|||
48619334|NCT03387046|156463540|FG001|Overall Study|Adverse Event|1|||
48571944|NCT03185819|156285894|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
48571945|NCT01322490|156285895|FG000|Treatment Period|Adverse Event|12|||
48571946|NCT01322490|156285896|FG001|Treatment Period|Adverse Event|18|||
48571947|NCT01322490|156285897|FG002|Treatment Period|Adverse Event|15|||
48571948|NCT01322490|156285895|FG000|Treatment Period|Death|5|||
48571949|NCT01322490|156285896|FG001|Treatment Period|Death|7|||
48619335|NCT00986232|156463541|FG000|Overall Study|Adverse Event|1|||
48619336|NCT00986232|156463542|FG001|Overall Study|Adverse Event|2|||
48619337|NCT00986232|156463543|FG002|Overall Study|Adverse Event|3|||
48619338|NCT00986232|156463544|FG003|Overall Study|Adverse Event|0|||
48619339|NCT00986232|156463541|FG000|Overall Study|Lost to Follow-up|19|||
48619340|NCT00986232|156463542|FG001|Overall Study|Lost to Follow-up|12|||
48619341|NCT00986232|156463543|FG002|Overall Study|Lost to Follow-up|12|||
48619342|NCT00986232|156463544|FG003|Overall Study|Lost to Follow-up|7|||
48619343|NCT00986232|156463541|FG000|Overall Study|Protocol Violation|2|||
48619344|NCT00986232|156463542|FG001|Overall Study|Protocol Violation|3|||
48619345|NCT00986232|156463543|FG002|Overall Study|Protocol Violation|0|||
48619346|NCT00986232|156463544|FG003|Overall Study|Protocol Violation|1|||
48619347|NCT00986232|156463541|FG000|Overall Study|Withdrawal by Subject|13|||
48619348|NCT00986232|156463542|FG001|Overall Study|Withdrawal by Subject|16|||
48619349|NCT00986232|156463543|FG002|Overall Study|Withdrawal by Subject|12|||
48619350|NCT00986232|156463544|FG003|Overall Study|Withdrawal by Subject|3|||
48619351|NCT00986232|156463541|FG000|Overall Study|Missed one or more bleeds|13|||
48619352|NCT00986232|156463542|FG001|Overall Study|Missed one or more bleeds|10|||
48619353|NCT00986232|156463543|FG002|Overall Study|Missed one or more bleeds|6|||
48619354|NCT00986232|156463544|FG003|Overall Study|Missed one or more bleeds|7|||
48619355|NCT00986232|156463541|FG000|Overall Study|Incomplete safety follow-up|3|||
48619356|NCT00986232|156463542|FG001|Overall Study|Incomplete safety follow-up|7|||
48619357|NCT00986232|156463543|FG002|Overall Study|Incomplete safety follow-up|2|||
48619358|NCT00986232|156463544|FG003|Overall Study|Incomplete safety follow-up|2|||
48619359|NCT01027416|156463545|FG000|Overall Study|Withdrawal by Subject|0|||
48619360|NCT01027416|156463546|FG001|Overall Study|Withdrawal by Subject|1|||
48619361|NCT01027416|156463545|FG000|Overall Study|Physician Decision|1|||
48619362|NCT01027416|156463546|FG001|Overall Study|Physician Decision|4|||
48619363|NCT00676052|156463547|FG000|Overall Study|Adverse Event|0|||
48619364|NCT00676052|156463548|FG001|Overall Study|Adverse Event|1|||
48619365|NCT00676052|156463549|FG002|Overall Study|Adverse Event|1|||
48619366|NCT00676052|156463550|FG003|Overall Study|Adverse Event|2|||
48619367|NCT00676052|156463551|FG004|Overall Study|Adverse Event|2|||
48619368|NCT00676052|156463552|FG005|Overall Study|Adverse Event|2|||
48619369|NCT00676052|156463547|FG000|Overall Study|Lack of Efficacy|2|||
48619370|NCT00676052|156463548|FG001|Overall Study|Lack of Efficacy|2|||
48619371|NCT00676052|156463549|FG002|Overall Study|Lack of Efficacy|1|||
48619372|NCT00676052|156463550|FG003|Overall Study|Lack of Efficacy|1|||
48619373|NCT00676052|156463551|FG004|Overall Study|Lack of Efficacy|2|||
48619374|NCT00676052|156463552|FG005|Overall Study|Lack of Efficacy|1|||
48619375|NCT00676052|156463547|FG000|Overall Study|Protocol Violation|5|||
48619376|NCT00676052|156463548|FG001|Overall Study|Protocol Violation|3|||
48619377|NCT00676052|156463549|FG002|Overall Study|Protocol Violation|2|||
48619378|NCT00676052|156463550|FG003|Overall Study|Protocol Violation|2|||
48619379|NCT00676052|156463551|FG004|Overall Study|Protocol Violation|1|||
48619380|NCT00676052|156463552|FG005|Overall Study|Protocol Violation|2|||
48619381|NCT00676052|156463547|FG000|Overall Study|Lost to Follow-up|0|||
48619382|NCT00676052|156463548|FG001|Overall Study|Lost to Follow-up|0|||
48619383|NCT00676052|156463549|FG002|Overall Study|Lost to Follow-up|0|||
48619384|NCT00676052|156463550|FG003|Overall Study|Lost to Follow-up|0|||
48619385|NCT00676052|156463551|FG004|Overall Study|Lost to Follow-up|1|||
48619386|NCT00676052|156463552|FG005|Overall Study|Lost to Follow-up|0|||
48619387|NCT00676052|156463547|FG000|Overall Study|Physician Decision|1|||
48619388|NCT00676052|156463548|FG001|Overall Study|Physician Decision|1|||
48571950|NCT01322490|156285897|FG002|Treatment Period|Death|3|||
48571951|NCT01322490|156285895|FG000|Treatment Period|Lack of Efficacy|89|||
48619389|NCT00676052|156463549|FG002|Overall Study|Physician Decision|1|||
48619390|NCT00676052|156463550|FG003|Overall Study|Physician Decision|0|||
48619391|NCT00676052|156463551|FG004|Overall Study|Physician Decision|0|||
48619392|NCT00676052|156463552|FG005|Overall Study|Physician Decision|1|||
48619393|NCT00676052|156463547|FG000|Overall Study|Withdrawal by Subject|1|||
48619394|NCT00676052|156463548|FG001|Overall Study|Withdrawal by Subject|0|||
48619395|NCT00676052|156463549|FG002|Overall Study|Withdrawal by Subject|1|||
48619396|NCT00676052|156463550|FG003|Overall Study|Withdrawal by Subject|0|||
48619397|NCT00676052|156463551|FG004|Overall Study|Withdrawal by Subject|0|||
48619398|NCT00676052|156463552|FG005|Overall Study|Withdrawal by Subject|0|||
48619399|NCT01913470|156463553|FG000|Overall Study|Lost to Follow-up|0|||
48571952|NCT01322490|156285896|FG001|Treatment Period|Lack of Efficacy|100|||
48619400|NCT01913470|156463554|FG001|Overall Study|Lost to Follow-up|1|||
48619401|NCT01913470|156463553|FG000|Overall Study|Physician Decision|0|||
48619402|NCT01913470|156463554|FG001|Overall Study|Physician Decision|1|||
48619403|NCT01913470|156463553|FG000|Overall Study|Withdrawal by Subject|0|||
48619404|NCT01913470|156463554|FG001|Overall Study|Withdrawal by Subject|1|||
48571953|NCT01322490|156285897|FG002|Treatment Period|Lack of Efficacy|112|||
48619405|NCT02573467|156463555|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
48619406|NCT02573467|156463556|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
48619407|NCT02573467|156463557|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
48619408|NCT02573467|156463558|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
48619409|NCT02573467|156463555|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
48619410|NCT02573467|156463556|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
48571954|NCT01322490|156285895|FG000|Treatment Period|Physician Decision|0|||
48571955|NCT01322490|156285896|FG001|Treatment Period|Physician Decision|2|||
48571956|NCT01322490|156285897|FG002|Treatment Period|Physician Decision|1|||
48571957|NCT01322490|156285895|FG000|Treatment Period|Protocol Violation|7|||
48571958|NCT01322490|156285896|FG001|Treatment Period|Protocol Violation|5|||
48571959|NCT01322490|156285897|FG002|Treatment Period|Protocol Violation|4|||
48571960|NCT01322490|156285895|FG000|Treatment Period|Withdrawal by Subject|14|||
48571961|NCT01322490|156285896|FG001|Treatment Period|Withdrawal by Subject|16|||
48571962|NCT01322490|156285897|FG002|Treatment Period|Withdrawal by Subject|11|||
48571963|NCT01322490|156285895|FG000|Treatment Period|Non-compliance with study drug|0|||
48571964|NCT01322490|156285896|FG001|Treatment Period|Non-compliance with study drug|0|||
48571965|NCT01322490|156285897|FG002|Treatment Period|Non-compliance with study drug|1|||
48571966|NCT01322490|156285895|FG000|Treatment Period|Other per report|2|||
48571967|NCT01322490|156285896|FG001|Treatment Period|Other per report|2|||
48571968|NCT01322490|156285897|FG002|Treatment Period|Other per report|1|||
48317977|NCT03903822|155364210|FG007|Follow up Phase (4 Weeks)|Other|0|||
48317978|NCT01278394|155364211|FG000|Overall Study|Lost to Follow-up|1|||
48317979|NCT00785512|155364212|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
48317980|NCT00785512|155364213|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
48317981|NCT00785512|155364212|FG000|Overall Study|Adverse Event|0|||
48317982|NCT00785512|155364213|FG001|Overall Study|Adverse Event|0|||
48317983|NCT00785512|155364212|FG000|Overall Study|Lack of Efficacy|0|||
48317984|NCT00785512|155364213|FG001|Overall Study|Lack of Efficacy|2|||
48317985|NCT00785512|155364212|FG000|Overall Study|Withdrawal by Subject|0|||
48317986|NCT00785512|155364213|FG001|Overall Study|Withdrawal by Subject|1|||
48317987|NCT00785512|155364212|FG000|Overall Study|Lost to Follow-up|3|||
48317988|NCT00785512|155364213|FG001|Overall Study|Lost to Follow-up|0|||
48317989|NCT00785512|155364212|FG000|Overall Study|Precedure Refused|0|||
48317990|NCT00785512|155364213|FG001|Overall Study|Precedure Refused|0|||
48317991|NCT00785512|155364212|FG000|Overall Study|IVRS Programing Error|0|||
48317992|NCT00785512|155364213|FG001|Overall Study|IVRS Programing Error|0|||
48317993|NCT00785512|155364212|FG000|Overall Study|Physician Decision|0|||
48317994|NCT00785512|155364213|FG001|Overall Study|Physician Decision|0|||
48317995|NCT00785512|155364212|FG000|Overall Study|Lack of compliance|0|||
48317996|NCT00785512|155364213|FG001|Overall Study|Lack of compliance|1|||
48317997|NCT00857649|155364214|FG000|Overall Study|Adverse Event|15|||
48317998|NCT00857649|155364215|FG001|Overall Study|Adverse Event|10|||
48317999|NCT00857649|155364214|FG000|Overall Study|Non-compliance|1|||
48318000|NCT00857649|155364215|FG001|Overall Study|Non-compliance|1|||
48318001|NCT00857649|155364214|FG000|Overall Study|Protocol Violation|2|||
48318002|NCT00857649|155364215|FG001|Overall Study|Protocol Violation|2|||
48318003|NCT00857649|155364214|FG000|Overall Study|Withdrawal of Consent|10|||
48318004|NCT00857649|155364215|FG001|Overall Study|Withdrawal of Consent|7|||
48318005|NCT00857649|155364214|FG000|Overall Study|Nursing Home Placement|2|||
48318006|NCT00857649|155364215|FG001|Overall Study|Nursing Home Placement|9|||
48318007|NCT00857649|155364214|FG000|Overall Study|Other Reasons|1|||
48318008|NCT00857649|155364215|FG001|Overall Study|Other Reasons|3|||
48318009|NCT02374307|155364216|FG000|3-months Follow-up|Lost to Follow-up|1|||
48318010|NCT02374307|155364217|FG001|3-months Follow-up|Lost to Follow-up|2|||
48318011|NCT02374307|155364216|FG000|3-months Follow-up|Withdrawal by Subject|1|||
48318012|NCT02374307|155364217|FG001|3-months Follow-up|Withdrawal by Subject|4|||
48318013|NCT02374307|155364216|FG000|3-months Follow-up|Death|1|||
48318014|NCT02374307|155364217|FG001|3-months Follow-up|Death|2|||
48318015|NCT02374307|155364216|FG000|3-months Follow-up|Missed first follow-up|5|||
48619411|NCT02573467|156463557|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
48619412|NCT02573467|156463558|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
48318016|NCT02374307|155364217|FG001|3-months Follow-up|Missed first follow-up|1|||
48571969|NCT01322490|156285895|FG000|Treatment Period|Randomized but Not Treated|3|||
48571970|NCT01322490|156285896|FG001|Treatment Period|Randomized but Not Treated|3|||
48571971|NCT01322490|156285897|FG002|Treatment Period|Randomized but Not Treated|5|||
48619413|NCT02573467|156463555|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
48318017|NCT02374307|155364216|FG000|6-months Follow-up|Lost to Follow-up|1|||
48318018|NCT02374307|155364217|FG001|6-months Follow-up|Lost to Follow-up|2|||
48318019|NCT02374307|155364216|FG000|6-months Follow-up|Death|2|||
48318020|NCT02374307|155364217|FG001|6-months Follow-up|Death|1|||
48318021|NCT02374307|155364216|FG000|6-months Follow-up|Withdrawal by Subject|0|||
48571972|NCT01322490|156285895|FG000|Long Term Follow-up Period|Death|235|||
48571973|NCT01322490|156285896|FG001|Long Term Follow-up Period|Death|239|||
48318022|NCT02374307|155364217|FG001|6-months Follow-up|Withdrawal by Subject|3|||
48318023|NCT03703336|155364218|FG000|Overall Study|Parent withdrew consent|29|||
48619414|NCT02573467|156463556|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
48619415|NCT02573467|156463557|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
48619416|NCT02573467|156463558|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
48619417|NCT02573467|156463555|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
48619418|NCT02573467|156463556|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
48619419|NCT02573467|156463557|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
48619420|NCT02573467|156463558|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
48619421|NCT02573467|156463555|FG000|Post-treatment Follow up Epoch|Death|1|||
48619422|NCT02573467|156463556|FG001|Post-treatment Follow up Epoch|Death|1|||
48619423|NCT02573467|156463557|FG002|Post-treatment Follow up Epoch|Death|0|||
48619424|NCT02573467|156463558|FG003|Post-treatment Follow up Epoch|Death|1|||
48619425|NCT02573467|156463555|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
48619426|NCT02573467|156463556|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
48619427|NCT02573467|156463557|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
48619428|NCT02573467|156463558|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
48619429|NCT02573467|156463555|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
48619430|NCT02573467|156463556|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
48318024|NCT03703336|155364219|FG001|Overall Study|Parent withdrew consent|8|||
48318025|NCT03703336|155364218|FG000|Overall Study|Migration|3|||
48318026|NCT03703336|155364219|FG001|Overall Study|Migration|3|||
48318027|NCT03703336|155364218|FG000|Overall Study|Protocol Violation|3|||
48318028|NCT03703336|155364219|FG001|Overall Study|Protocol Violation|1|||
48318029|NCT03703336|155364218|FG000|Overall Study|Physician Decision|2|||
48318030|NCT03703336|155364219|FG001|Overall Study|Physician Decision|0|||
48318031|NCT03703336|155364218|FG000|Overall Study|Adverse Event|0|||
48318032|NCT03703336|155364219|FG001|Overall Study|Adverse Event|2|||
48318033|NCT03703336|155364218|FG000|Overall Study|Lost to Follow-up|1|||
48318034|NCT03703336|155364219|FG001|Overall Study|Lost to Follow-up|0|||
48318035|NCT00595413|155364226|FG000|Overall Study|Adverse Event|0|||
48318036|NCT00595413|155364227|FG001|Overall Study|Adverse Event|2|||
48318037|NCT00595413|155364228|FG002|Overall Study|Adverse Event|1|||
48318038|NCT00595413|155364229|FG003|Overall Study|Adverse Event|1|||
48318039|NCT00595413|155364226|FG000|Overall Study|Lost to Follow-up|2|||
48318040|NCT00595413|155364227|FG001|Overall Study|Lost to Follow-up|2|||
48318041|NCT00595413|155364228|FG002|Overall Study|Lost to Follow-up|1|||
48318042|NCT00595413|155364229|FG003|Overall Study|Lost to Follow-up|3|||
48318043|NCT00595413|155364226|FG000|Overall Study|Death|0|||
48318044|NCT00595413|155364227|FG001|Overall Study|Death|0|||
48571974|NCT01322490|156285897|FG002|Long Term Follow-up Period|Death|236|||
48571975|NCT01322490|156285895|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
48571976|NCT01322490|156285896|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
48571977|NCT01322490|156285897|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
48571978|NCT01322490|156285895|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
48571979|NCT01322490|156285896|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
48571980|NCT01322490|156285897|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
48571981|NCT01322490|156285895|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
48571982|NCT01322490|156285896|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
48571983|NCT01322490|156285897|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
48571984|NCT01322490|156285895|FG000|Long Term Follow-up Period|Other per report|3|||
48571985|NCT01322490|156285896|FG001|Long Term Follow-up Period|Other per report|2|||
48619431|NCT02573467|156463557|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
48619432|NCT02573467|156463558|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
48619433|NCT01331005|156463561|FG000|Overall Study|Lost to Follow-up|2|||
48571986|NCT01322490|156285897|FG002|Long Term Follow-up Period|Other per report|2|||
48619434|NCT01331005|156463562|FG001|Overall Study|Lost to Follow-up|1|||
48619435|NCT01331005|156463561|FG000|Overall Study|Withdrawal by Subject|2|||
48318045|NCT00595413|155364228|FG002|Overall Study|Death|1|||
48318046|NCT00595413|155364229|FG003|Overall Study|Death|0|||
48318047|NCT00595413|155364226|FG000|Overall Study|Other|5|||
48318048|NCT00595413|155364227|FG001|Overall Study|Other|1|||
48619436|NCT01331005|156463562|FG001|Overall Study|Withdrawal by Subject|3|||
48318049|NCT00595413|155364228|FG002|Overall Study|Other|5|||
48318050|NCT00595413|155364229|FG003|Overall Study|Other|0|||
48318051|NCT04149002|155364234|FG000|Overall Study|Lost to Follow-up|1|||
48318052|NCT04149002|155364235|FG001|Overall Study|Lost to Follow-up|0|||
48318053|NCT04149002|155364234|FG000|Overall Study|Withdrawal by Subject|1|||
48318054|NCT04149002|155364235|FG001|Overall Study|Withdrawal by Subject|0|||
48318055|NCT00807937|155364238|FG000|Overall Study|Adverse Event|12|||
48318056|NCT00807937|155364239|FG001|Overall Study|Adverse Event|12|||
48318057|NCT00807937|155364240|FG002|Overall Study|Adverse Event|5|||
48318058|NCT00807937|155364241|FG003|Overall Study|Adverse Event|4|||
48318059|NCT00807937|155364238|FG000|Overall Study|Protocol Violation|4|||
48318060|NCT00807937|155364239|FG001|Overall Study|Protocol Violation|5|||
48318061|NCT00807937|155364240|FG002|Overall Study|Protocol Violation|3|||
48318062|NCT00807937|155364241|FG003|Overall Study|Protocol Violation|3|||
48318063|NCT00807937|155364238|FG000|Overall Study|Withdrawal by Subject|5|||
48318064|NCT00807937|155364239|FG001|Overall Study|Withdrawal by Subject|4|||
48318065|NCT00807937|155364240|FG002|Overall Study|Withdrawal by Subject|1|||
48318066|NCT00807937|155364241|FG003|Overall Study|Withdrawal by Subject|4|||
48318067|NCT00807937|155364238|FG000|Overall Study|Lost to Follow-up|4|||
48318068|NCT00807937|155364239|FG001|Overall Study|Lost to Follow-up|0|||
48318069|NCT00807937|155364240|FG002|Overall Study|Lost to Follow-up|2|||
48318070|NCT00807937|155364241|FG003|Overall Study|Lost to Follow-up|1|||
48318071|NCT00807937|155364238|FG000|Overall Study|Lack of Efficacy|0|||
48318072|NCT00807937|155364239|FG001|Overall Study|Lack of Efficacy|0|||
48318073|NCT00807937|155364240|FG002|Overall Study|Lack of Efficacy|1|||
48318074|NCT00807937|155364241|FG003|Overall Study|Lack of Efficacy|2|||
48318075|NCT00807937|155364238|FG000|Overall Study|Intake of prohibited medicine|0|||
48318076|NCT00807937|155364239|FG001|Overall Study|Intake of prohibited medicine|0|||
48318077|NCT00807937|155364240|FG002|Overall Study|Intake of prohibited medicine|2|||
48318078|NCT00807937|155364241|FG003|Overall Study|Intake of prohibited medicine|0|||
48318079|NCT00807937|155364238|FG000|Overall Study|All other reasons (not provided)|2|||
48318080|NCT00807937|155364239|FG001|Overall Study|All other reasons (not provided)|4|||
48571987|NCT01322490|156285895|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
48571988|NCT01322490|156285896|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
48571989|NCT01322490|156285897|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
48571990|NCT03412565|156285898|FG000|Overall Study|Lost to Follow-up|0|||
48571991|NCT03412565|156285899|FG001|Overall Study|Lost to Follow-up|0|||
48571992|NCT03412565|156285900|FG002|Overall Study|Lost to Follow-up|1|||
48571993|NCT03412565|156285901|FG003|Overall Study|Lost to Follow-up|0|||
48571994|NCT03412565|156285898|FG000|Overall Study|Physician Decision|0|||
48571995|NCT03412565|156285899|FG001|Overall Study|Physician Decision|0|||
48571996|NCT03412565|156285900|FG002|Overall Study|Physician Decision|0|||
48571997|NCT03412565|156285901|FG003|Overall Study|Physician Decision|1|||
48571998|NCT03412565|156285898|FG000|Overall Study|Withdrawal by Subject|0|||
48571999|NCT03412565|156285899|FG001|Overall Study|Withdrawal by Subject|4|||
48572000|NCT03412565|156285900|FG002|Overall Study|Withdrawal by Subject|5|||
48572001|NCT03412565|156285901|FG003|Overall Study|Withdrawal by Subject|5|||
48572002|NCT03412565|156285898|FG000|Overall Study|Death|1|||
48572003|NCT03412565|156285899|FG001|Overall Study|Death|3|||
48572004|NCT03412565|156285900|FG002|Overall Study|Death|4|||
48572005|NCT03412565|156285901|FG003|Overall Study|Death|5|||
48572006|NCT03412565|156285898|FG000|Overall Study|Data collection ended|0|||
48572007|NCT03412565|156285899|FG001|Overall Study|Data collection ended|41|||
48318081|NCT00807937|155364240|FG002|Overall Study|All other reasons (not provided)|0|||
48318082|NCT00807937|155364241|FG003|Overall Study|All other reasons (not provided)|1|||
48318083|NCT05512962|155364242|FG000|Overall Study|Withdrawal by Subject|1|||
48318084|NCT05512962|155364243|FG001|Overall Study|Withdrawal by Subject|0|||
48318085|NCT01697969|155364266|FG000|Overall Study|Did not meet inc/exc criteria|3|||
48318086|NCT01127373|155364267|FG000|Overall Study|Not Treated|3|||
48318087|NCT01127373|155364267|FG000|Overall Study|Lost to Follow-up|7|||
48318088|NCT01127373|155364267|FG000|Overall Study|Withdrawal by Subject|1|||
48318089|NCT01127373|155364267|FG000|Overall Study|Disease progression|1|||
48318090|NCT03764475|155364284|FG000|Overall Study|Adverse Event|11|||
48318091|NCT03764475|155364285|FG001|Overall Study|Adverse Event|2|||
48318092|NCT03764475|155364284|FG000|Overall Study|Lost to Follow-up|24|||
48572008|NCT03412565|156285900|FG002|Overall Study|Data collection ended|41|||
48572009|NCT03412565|156285901|FG003|Overall Study|Data collection ended|40|||
48619437|NCT02639559|156463568|FG000|Overall Study|Mobilization failure|0|||
48318093|NCT03764475|155364285|FG001|Overall Study|Lost to Follow-up|10|||
48318094|NCT03764475|155364284|FG000|Overall Study|Withdrawal by Subject|26|||
48318095|NCT03764475|155364285|FG001|Overall Study|Withdrawal by Subject|10|||
48318096|NCT03764475|155364284|FG000|Overall Study|Lack of Efficacy|3|||
48318097|NCT03764475|155364285|FG001|Overall Study|Lack of Efficacy|0|||
48318098|NCT03764475|155364284|FG000|Overall Study|COVID-19 Disruption|2|||
48318099|NCT03764475|155364285|FG001|Overall Study|COVID-19 Disruption|0|||
48318100|NCT02238483|155364286|FG000|Overall Study|Withdrawal by Subject|2|||
48572010|NCT00282113|156285905|FG000|Overall Study|Removed at parents request|1|||
48572011|NCT00282113|156285906|FG001|Overall Study|Removed at parents request|0|||
48318101|NCT02238483|155364287|FG001|Overall Study|Withdrawal by Subject|7|||
48318102|NCT02238483|155364286|FG000|Overall Study|Lost to Follow-up|1|||
48318103|NCT02238483|155364287|FG001|Overall Study|Lost to Follow-up|1|||
48318104|NCT02238483|155364286|FG000|Overall Study|Protocol Violation|1|||
48318105|NCT02238483|155364287|FG001|Overall Study|Protocol Violation|2|||
48318106|NCT02238483|155364286|FG000|Overall Study|Death|1|||
48318107|NCT02238483|155364287|FG001|Overall Study|Death|0|||
48318108|NCT02238483|155364286|FG000|Overall Study|Adverse Event|7|||
48318109|NCT02238483|155364287|FG001|Overall Study|Adverse Event|3|||
48318110|NCT02238483|155364286|FG000|Overall Study|Withdrawn due to physician decision|1|||
48318111|NCT02238483|155364287|FG001|Overall Study|Withdrawn due to physician decision|0|||
48318112|NCT02238483|155364286|FG000|Overall Study|Completion status not recorded|1|||
48318113|NCT02238483|155364287|FG001|Overall Study|Completion status not recorded|1|||
48318114|NCT02238483|155364286|FG000|Overall Study|Illness in family member|1|||
48318115|NCT02238483|155364287|FG001|Overall Study|Illness in family member|0|||
48318116|NCT01771731|155364288|FG000|Overall Study|Physician Decision|1|||
48318117|NCT01771731|155364289|FG001|Overall Study|Physician Decision|0|||
48318118|NCT01771731|155364288|FG000|Overall Study|Protocol Violation|0|||
48318119|NCT01771731|155364289|FG001|Overall Study|Protocol Violation|1|||
48318120|NCT01771731|155364288|FG000|Overall Study|Adverse event: Pain Crisis|1|||
48318121|NCT01771731|155364289|FG001|Overall Study|Adverse event: Pain Crisis|1|||
48318122|NCT01499199|155364297|FG000|Overall Study|Adverse Event|1|||
48318123|NCT01499199|155364297|FG000|Overall Study|Lack of Efficacy|1|||
48318124|NCT03069313|155364298|FG000|Overall Study|Adverse Event|5|||
48318125|NCT00716859|155364299|FG000|Overall Study|Adverse Event|4|||
48318126|NCT00716859|155364300|FG001|Overall Study|Adverse Event|1|||
48318127|NCT00716859|155364299|FG000|Overall Study|Lack of Efficacy|3|||
48318128|NCT00716859|155364300|FG001|Overall Study|Lack of Efficacy|0|||
48318129|NCT00716859|155364299|FG000|Overall Study|Withdrawal by Subject|1|||
48318130|NCT00716859|155364300|FG001|Overall Study|Withdrawal by Subject|3|||
48318131|NCT00716859|155364299|FG000|Overall Study|Not treated|1|||
48318132|NCT00716859|155364300|FG001|Overall Study|Not treated|1|||
48318133|NCT01037985|155364301|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
48318134|NCT01037985|155364302|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
48318135|NCT01037985|155364301|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
48318136|NCT01037985|155364302|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
48318137|NCT01037985|155364301|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
48318138|NCT01037985|155364302|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
48318139|NCT01037985|155364301|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
48318140|NCT01037985|155364302|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
48318141|NCT03664960|155364303|FG000|Overall Study|Adverse Event|0|||
48318142|NCT03664960|155364304|FG001|Overall Study|Adverse Event|3|||
48318143|NCT03664960|155364303|FG000|Overall Study|Lost to Follow-up|3|||
48318144|NCT03664960|155364304|FG001|Overall Study|Lost to Follow-up|2|||
48318145|NCT03664960|155364303|FG000|Overall Study|Physician Decision|1|||
48318146|NCT03664960|155364304|FG001|Overall Study|Physician Decision|0|||
48572012|NCT00282113|156285907|FG002|Overall Study|Removed at parents request|0|||
48572013|NCT04075396|156285908|FG000|Overall Study|Death|11|||
48572014|NCT04075396|156285909|FG001|Overall Study|Death|9|||
48572015|NCT04075396|156285908|FG000|Overall Study|Withdrawal by Subject|1|||
48572016|NCT04075396|156285909|FG001|Overall Study|Withdrawal by Subject|2|||
48572017|NCT04075396|156285908|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
48572018|NCT04075396|156285909|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
48572019|NCT04075396|156285908|FG000|Overall Study|Enrolled but not-treated|0|||
48572020|NCT04075396|156285909|FG001|Overall Study|Enrolled but not-treated|1|||
48572021|NCT00427921|156285910|FG000|Overall Study|Adverse Event|26|||
48572022|NCT00427921|156285910|FG000|Overall Study|Withdrawal by Subject|4|||
48572023|NCT00427921|156285910|FG000|Overall Study|Lost to Follow-up|2|||
48572024|NCT00427921|156285910|FG000|Overall Study|Other reason not specified|10|||
48572025|NCT00427921|156285910|FG000|Overall Study|Adverse Event + Hospitalization|1|||
48572026|NCT00427921|156285910|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
48572027|NCT00427921|156285910|FG000|Overall Study|Adverse Event + No Response|1|||
48572028|NCT00427921|156285910|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
48572029|NCT00427921|156285910|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
48572030|NCT00427921|156285910|FG000|Overall Study|Adverse Event + Lost Response|1|||
48572031|NCT00427921|156285910|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
48572032|NCT00427921|156285910|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
48318147|NCT03664960|155364303|FG000|Overall Study|Withdrawal by Subject|3|||
48318148|NCT03664960|155364304|FG001|Overall Study|Withdrawal by Subject|14|||
48318149|NCT03664960|155364303|FG000|Overall Study|Sponsor Decision|1|||
48318150|NCT03664960|155364304|FG001|Overall Study|Sponsor Decision|1|||
48318151|NCT03664960|155364303|FG000|Overall Study|Other|1|||
48318152|NCT03664960|155364304|FG001|Overall Study|Other|2|||
48318153|NCT01636687|155365522|FG000|Induction Period|Withdrawal by Subject|1|||
48318154|NCT01636687|155365523|FG001|Induction Period|Withdrawal by Subject|0|||
48318155|NCT01636687|155365524|FG002|Induction Period|Withdrawal by Subject|0|||
48318156|NCT01636687|155365525|FG003|Induction Period|Withdrawal by Subject|0|||
48318157|NCT01636687|155365526|FG004|Induction Period|Withdrawal by Subject|0|||
48318158|NCT01636687|155365522|FG000|Induction Period|Adverse Event|1|||
48318159|NCT01636687|155365523|FG001|Induction Period|Adverse Event|0|||
48318160|NCT01636687|155365524|FG002|Induction Period|Adverse Event|0|||
48318161|NCT01636687|155365525|FG003|Induction Period|Adverse Event|0|||
48318162|NCT01636687|155365526|FG004|Induction Period|Adverse Event|1|||
48318163|NCT01636687|155365522|FG000|Induction Period|Lack of Efficacy|0|||
48318164|NCT01636687|155365523|FG001|Induction Period|Lack of Efficacy|0|||
48318165|NCT01636687|155365524|FG002|Induction Period|Lack of Efficacy|0|||
48318166|NCT01636687|155365525|FG003|Induction Period|Lack of Efficacy|0|||
48318167|NCT01636687|155365526|FG004|Induction Period|Lack of Efficacy|1|||
48318168|NCT01636687|155365522|FG000|Induction Period|Physician Decision|1|||
48318169|NCT01636687|155365523|FG001|Induction Period|Physician Decision|0|||
48318170|NCT01636687|155365524|FG002|Induction Period|Physician Decision|0|||
48318171|NCT01636687|155365525|FG003|Induction Period|Physician Decision|0|||
48572033|NCT03434041|156285911|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
48572034|NCT03434041|156285912|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
48572035|NCT03434041|156285911|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
48572036|NCT03434041|156285912|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
48572037|NCT03434041|156285911|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
48572038|NCT03434041|156285912|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
48572039|NCT03434041|156285911|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
48572040|NCT03434041|156285912|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
48572041|NCT03434041|156285911|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
48572042|NCT03434041|156285912|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
48572043|NCT03434041|156285911|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
48572044|NCT03434041|156285912|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
48619438|NCT02639559|156463569|FG001|Overall Study|Mobilization failure|3|||
48318172|NCT01636687|155365526|FG004|Induction Period|Physician Decision|0|||
48318173|NCT01636687|155365522|FG000|Maintenance Period|Withdrawal by Subject|2|||
48318174|NCT01636687|155365523|FG001|Maintenance Period|Withdrawal by Subject|0|||
48318175|NCT01636687|155365524|FG002|Maintenance Period|Withdrawal by Subject|2|||
48318176|NCT01636687|155365525|FG003|Maintenance Period|Withdrawal by Subject|0|||
48318177|NCT01636687|155365526|FG004|Maintenance Period|Withdrawal by Subject|0|||
48318178|NCT01636687|155365522|FG000|Maintenance Period|Adverse Event|1|||
48318179|NCT01636687|155365523|FG001|Maintenance Period|Adverse Event|0|||
48318180|NCT01636687|155365524|FG002|Maintenance Period|Adverse Event|0|||
48318181|NCT01636687|155365525|FG003|Maintenance Period|Adverse Event|0|||
48318182|NCT01636687|155365526|FG004|Maintenance Period|Adverse Event|0|||
48318183|NCT01636687|155365522|FG000|Maintenance Period|Lack of Efficacy|4|||
48318184|NCT01636687|155365523|FG001|Maintenance Period|Lack of Efficacy|1|||
48318185|NCT01636687|155365524|FG002|Maintenance Period|Lack of Efficacy|0|||
48318186|NCT01636687|155365525|FG003|Maintenance Period|Lack of Efficacy|0|||
48318187|NCT01636687|155365526|FG004|Maintenance Period|Lack of Efficacy|0|||
48318188|NCT01636687|155365522|FG000|Maintenance Period|Lost to Follow-up|1|||
48318189|NCT01636687|155365523|FG001|Maintenance Period|Lost to Follow-up|1|||
48318190|NCT01636687|155365524|FG002|Maintenance Period|Lost to Follow-up|0|||
48318191|NCT01636687|155365525|FG003|Maintenance Period|Lost to Follow-up|0|||
48318192|NCT01636687|155365526|FG004|Maintenance Period|Lost to Follow-up|1|||
48318193|NCT01636687|155365522|FG000|Maintenance Period|Physician Decision|0|||
48318194|NCT01636687|155365523|FG001|Maintenance Period|Physician Decision|0|||
48318195|NCT01636687|155365524|FG002|Maintenance Period|Physician Decision|0|||
48572045|NCT03434041|156285911|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
48572046|NCT03434041|156285912|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
48572047|NCT03434041|156285911|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
48572048|NCT03434041|156285912|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
48572049|NCT03434041|156285911|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
48572050|NCT03434041|156285912|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
48572051|NCT03434041|156285911|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
48572052|NCT03434041|156285912|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
48572053|NCT03434041|156285911|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
48572054|NCT03434041|156285912|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
48572055|NCT00844415|156285913|FG000|Overall Study|Withdrawal by Subject|1|||
48572056|NCT02569398|156285914|FG000|Overall Study|Adverse Event|0|||
48572057|NCT02569398|156285915|FG001|Overall Study|Adverse Event|1|||
48572058|NCT02569398|156285916|FG002|Overall Study|Adverse Event|6|||
48572059|NCT02569398|156285914|FG000|Overall Study|Withdrawal by Subject|43|||
48572060|NCT02569398|156285915|FG001|Overall Study|Withdrawal by Subject|43|||
48572061|NCT02569398|156285916|FG002|Overall Study|Withdrawal by Subject|30|||
48572062|NCT02569398|156285914|FG000|Overall Study|Study terminated by sponsor|130|||
48572063|NCT02569398|156285915|FG001|Overall Study|Study terminated by sponsor|131|||
48572064|NCT02569398|156285916|FG002|Overall Study|Study terminated by sponsor|134|||
48572065|NCT02569398|156285914|FG000|Overall Study|Other|12|||
48572066|NCT02569398|156285915|FG001|Overall Study|Other|14|||
48572067|NCT02569398|156285916|FG002|Overall Study|Other|13|||
48572068|NCT03039192|156285919|FG000|Overall Study|Lost to Follow-up|4|||
48572069|NCT03039192|156285920|FG001|Overall Study|Lost to Follow-up|4|||
48572070|NCT03039192|156285919|FG000|Overall Study|Adverse event, serious fatal|0|||
48572071|NCT03039192|156285920|FG001|Overall Study|Adverse event, serious fatal|1|||
48572072|NCT03039192|156285919|FG000|Overall Study|Adverse event, non-fatal|0|||
48572073|NCT03039192|156285920|FG001|Overall Study|Adverse event, non-fatal|2|||
48572074|NCT03039192|156285919|FG000|Overall Study|Withdrawal by Subject|6|||
48572075|NCT03039192|156285920|FG001|Overall Study|Withdrawal by Subject|9|||
48572076|NCT03039192|156285919|FG000|Overall Study|Discontinued from treatment phase|19|||
48572077|NCT03039192|156285920|FG001|Overall Study|Discontinued from treatment phase|12|||
48572078|NCT03039192|156285919|FG000|Overall Study|Other|3|||
48572079|NCT03039192|156285920|FG001|Overall Study|Other|2|||
48572080|NCT03425396|156285921|FG000|Overall Study|Lost to Follow-up|2|||
48572081|NCT03425396|156285922|FG001|Overall Study|Lost to Follow-up|5|||
48572082|NCT03425396|156285923|FG002|Overall Study|Lost to Follow-up|2|||
48572083|NCT03425396|156285924|FG003|Overall Study|Lost to Follow-up|0|||
48572084|NCT03425396|156285925|FG004|Overall Study|Lost to Follow-up|0|||
48572085|NCT03425396|156285921|FG000|Overall Study|Withdrawal by Subject|0|||
48572086|NCT03425396|156285922|FG001|Overall Study|Withdrawal by Subject|1|||
48572087|NCT03425396|156285923|FG002|Overall Study|Withdrawal by Subject|0|||
48572088|NCT03425396|156285924|FG003|Overall Study|Withdrawal by Subject|1|||
48572089|NCT03425396|156285925|FG004|Overall Study|Withdrawal by Subject|0|||
48572090|NCT03425396|156285921|FG000|Overall Study|Other|0|||
48572091|NCT03425396|156285922|FG001|Overall Study|Other|1|||
48572092|NCT03425396|156285923|FG002|Overall Study|Other|1|||
48572093|NCT03425396|156285924|FG003|Overall Study|Other|0|||
48572094|NCT03425396|156285925|FG004|Overall Study|Other|1|||
48572095|NCT03345342|156287394|FG000|Open-Label Phase|Adverse Event|30|||
48572096|NCT03345342|156287395|FG001|Open-Label Phase|Adverse Event|0|||
48572097|NCT03345342|156287396|FG002|Open-Label Phase|Adverse Event|0|||
48318196|NCT01636687|155365525|FG003|Maintenance Period|Physician Decision|0|||
48318197|NCT01636687|155365526|FG004|Maintenance Period|Physician Decision|1|||
48318198|NCT01636687|155365522|FG000|Extension Period|technical problems|0|||
48318199|NCT01636687|155365523|FG001|Extension Period|technical problems|1|||
48318200|NCT01636687|155365524|FG002|Extension Period|technical problems|2|||
48449817|NCT01156532|155835507|FG000|Overall Study|Family Reasons|1|||
48572098|NCT03345342|156287397|FG003|Open-Label Phase|Adverse Event|0|||
48572099|NCT03345342|156287398|FG004|Open-Label Phase|Adverse Event|0|||
48572100|NCT03345342|156287394|FG000|Open-Label Phase|Death|1|||
48572101|NCT03345342|156287395|FG001|Open-Label Phase|Death|0|||
48572102|NCT03345342|156287396|FG002|Open-Label Phase|Death|0|||
48572103|NCT03345342|156287397|FG003|Open-Label Phase|Death|0|||
48572104|NCT03345342|156287398|FG004|Open-Label Phase|Death|0|||
48572105|NCT03345342|156287394|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
48572106|NCT03345342|156287395|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
48572107|NCT03345342|156287396|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
48572108|NCT03345342|156287397|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
48572109|NCT03345342|156287398|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
48572110|NCT03345342|156287394|FG000|Open-Label Phase|Lack of Efficacy|6|||
48572111|NCT03345342|156287395|FG001|Open-Label Phase|Lack of Efficacy|0|||
48572112|NCT03345342|156287396|FG002|Open-Label Phase|Lack of Efficacy|0|||
48572113|NCT03345342|156287397|FG003|Open-Label Phase|Lack of Efficacy|0|||
48572114|NCT03345342|156287398|FG004|Open-Label Phase|Lack of Efficacy|0|||
48572115|NCT03345342|156287394|FG000|Open-Label Phase|Lost to Follow-up|9|||
48572116|NCT03345342|156287395|FG001|Open-Label Phase|Lost to Follow-up|0|||
48572117|NCT03345342|156287396|FG002|Open-Label Phase|Lost to Follow-up|0|||
48572118|NCT03345342|156287397|FG003|Open-Label Phase|Lost to Follow-up|0|||
48572119|NCT03345342|156287398|FG004|Open-Label Phase|Lost to Follow-up|0|||
48572120|NCT03345342|156287394|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
48572121|NCT03345342|156287395|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
48572122|NCT03345342|156287396|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
48572123|NCT03345342|156287397|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
48572124|NCT03345342|156287398|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
48572125|NCT03345342|156287394|FG000|Open-Label Phase|Physician Decision|4|||
48572126|NCT03345342|156287395|FG001|Open-Label Phase|Physician Decision|0|||
48572127|NCT03345342|156287396|FG002|Open-Label Phase|Physician Decision|0|||
48572128|NCT03345342|156287397|FG003|Open-Label Phase|Physician Decision|0|||
48572129|NCT03345342|156287398|FG004|Open-Label Phase|Physician Decision|0|||
48572130|NCT03345342|156287394|FG000|Open-Label Phase|Protocol Violation|8|||
48572131|NCT03345342|156287395|FG001|Open-Label Phase|Protocol Violation|0|||
48572132|NCT03345342|156287396|FG002|Open-Label Phase|Protocol Violation|0|||
48572133|NCT03345342|156287397|FG003|Open-Label Phase|Protocol Violation|0|||
48572134|NCT03345342|156287398|FG004|Open-Label Phase|Protocol Violation|0|||
48572135|NCT03345342|156287394|FG000|Open-Label Phase|Withdrawal by Subject|57|||
48572136|NCT03345342|156287395|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48572137|NCT03345342|156287396|FG002|Open-Label Phase|Withdrawal by Subject|0|||
48572138|NCT03345342|156287397|FG003|Open-Label Phase|Withdrawal by Subject|0|||
48572139|NCT03345342|156287398|FG004|Open-Label Phase|Withdrawal by Subject|0|||
48572140|NCT03345342|156287394|FG000|Open-Label Phase|Other|15|||
48572141|NCT03345342|156287395|FG001|Open-Label Phase|Other|0|||
48572142|NCT03345342|156287396|FG002|Open-Label Phase|Other|0|||
48572143|NCT03345342|156287397|FG003|Open-Label Phase|Other|0|||
48572144|NCT03345342|156287398|FG004|Open-Label Phase|Other|0|||
48572145|NCT03345342|156287394|FG000|Double-Blind Phase|Adverse Event|0|||
48572146|NCT03345342|156287395|FG001|Double-Blind Phase|Adverse Event|1|||
48572147|NCT03345342|156287396|FG002|Double-Blind Phase|Adverse Event|6|||
48572148|NCT03345342|156287397|FG003|Double-Blind Phase|Adverse Event|0|||
48572149|NCT03345342|156287398|FG004|Double-Blind Phase|Adverse Event|0|||
48572150|NCT03345342|156287394|FG000|Double-Blind Phase|Death|0|||
48572151|NCT03345342|156287395|FG001|Double-Blind Phase|Death|2|||
48572152|NCT03345342|156287396|FG002|Double-Blind Phase|Death|1|||
48572153|NCT03345342|156287397|FG003|Double-Blind Phase|Death|0|||
48572154|NCT03345342|156287398|FG004|Double-Blind Phase|Death|0|||
48572155|NCT03345342|156287394|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
48572156|NCT03345342|156287395|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
48572157|NCT03345342|156287396|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
48572158|NCT03345342|156287397|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
48572159|NCT03345342|156287398|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
48572160|NCT03345342|156287394|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48572161|NCT03345342|156287395|FG001|Double-Blind Phase|Lost to Follow-up|1|||
48449818|NCT01156532|155835507|FG000|Overall Study|Lost to Follow-up|1|||
48572162|NCT03345342|156287396|FG002|Double-Blind Phase|Lost to Follow-up|7|||
48572163|NCT03345342|156287397|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48572164|NCT03345342|156287398|FG004|Double-Blind Phase|Lost to Follow-up|0|||
48572165|NCT03345342|156287394|FG000|Double-Blind Phase|Physician Decision|0|||
48572166|NCT03345342|156287395|FG001|Double-Blind Phase|Physician Decision|1|||
48572167|NCT03345342|156287396|FG002|Double-Blind Phase|Physician Decision|4|||
48572168|NCT03345342|156287397|FG003|Double-Blind Phase|Physician Decision|0|||
48572169|NCT03345342|156287398|FG004|Double-Blind Phase|Physician Decision|0|||
48572170|NCT03345342|156287394|FG000|Double-Blind Phase|Protocol Violation|0|||
48572171|NCT03345342|156287395|FG001|Double-Blind Phase|Protocol Violation|0|||
48572172|NCT03345342|156287396|FG002|Double-Blind Phase|Protocol Violation|1|||
48572173|NCT03345342|156287397|FG003|Double-Blind Phase|Protocol Violation|0|||
48572174|NCT03345342|156287398|FG004|Double-Blind Phase|Protocol Violation|0|||
48572175|NCT03345342|156287394|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
48572176|NCT03345342|156287395|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
48572177|NCT03345342|156287396|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
48572178|NCT03345342|156287397|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48572179|NCT03345342|156287398|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
48572180|NCT03345342|156287394|FG000|Double-Blind Phase|Other|0|||
48572181|NCT03345342|156287395|FG001|Double-Blind Phase|Other|1|||
48572182|NCT03345342|156287396|FG002|Double-Blind Phase|Other|3|||
48572183|NCT03345342|156287397|FG003|Double-Blind Phase|Other|0|||
48572184|NCT03345342|156287398|FG004|Double-Blind Phase|Other|0|||
48572185|NCT03345342|156287394|FG000|Follow-Up Phase|Adverse Event|0|||
48572186|NCT03345342|156287395|FG001|Follow-Up Phase|Adverse Event|0|||
48572187|NCT03345342|156287396|FG002|Follow-Up Phase|Adverse Event|0|||
48572188|NCT03345342|156287397|FG003|Follow-Up Phase|Adverse Event|0|||
48572189|NCT03345342|156287398|FG004|Follow-Up Phase|Adverse Event|4|||
48572190|NCT03345342|156287394|FG000|Follow-Up Phase|Lost to Follow-up|0|||
48572191|NCT03345342|156287395|FG001|Follow-Up Phase|Lost to Follow-up|0|||
48572192|NCT03345342|156287396|FG002|Follow-Up Phase|Lost to Follow-up|0|||
48572193|NCT03345342|156287397|FG003|Follow-Up Phase|Lost to Follow-up|0|||
48572194|NCT03345342|156287398|FG004|Follow-Up Phase|Lost to Follow-up|6|||
48572195|NCT03345342|156287394|FG000|Follow-Up Phase|Physician Decision|0|||
48572196|NCT03345342|156287395|FG001|Follow-Up Phase|Physician Decision|0|||
48572197|NCT03345342|156287396|FG002|Follow-Up Phase|Physician Decision|0|||
48572198|NCT03345342|156287397|FG003|Follow-Up Phase|Physician Decision|0|||
48572199|NCT03345342|156287398|FG004|Follow-Up Phase|Physician Decision|5|||
48572200|NCT03345342|156287394|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
48572201|NCT03345342|156287395|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
48572202|NCT03345342|156287396|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
48572203|NCT03345342|156287397|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
48572204|NCT03345342|156287398|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
48572205|NCT03345342|156287394|FG000|Follow-Up Phase|Other|0|||
48572206|NCT03345342|156287395|FG001|Follow-Up Phase|Other|0|||
48572207|NCT03345342|156287396|FG002|Follow-Up Phase|Other|0|||
48572208|NCT03345342|156287397|FG003|Follow-Up Phase|Other|3|||
48572209|NCT03345342|156287398|FG004|Follow-Up Phase|Other|1|||
48572210|NCT02877134|156287403|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572211|NCT02877134|156287404|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
48572212|NCT02877134|156287405|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572213|NCT02877134|156287406|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572214|NCT02877134|156287407|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572215|NCT02877134|156287408|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
48572216|NCT02877134|156287409|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572217|NCT02877134|156287410|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572218|NCT02877134|156287411|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572219|NCT02877134|156287412|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572220|NCT02877134|156287413|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572221|NCT02877134|156287414|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
48572222|NCT02877134|156287403|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48572223|NCT02877134|156287404|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
48572224|NCT02877134|156287405|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48572225|NCT02877134|156287406|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
48572226|NCT02877134|156287407|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48572227|NCT02877134|156287408|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48572228|NCT02877134|156287409|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
48572229|NCT02877134|156287410|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48572230|NCT02877134|156287411|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48572231|NCT02877134|156287412|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48572232|NCT02877134|156287413|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48318201|NCT01636687|155365525|FG003|Extension Period|technical problems|1|||
48572233|NCT02877134|156287414|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
48318202|NCT01636687|155365526|FG004|Extension Period|technical problems|0|||
48572234|NCT02877134|156287403|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
48572235|NCT02877134|156287404|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
48572236|NCT02877134|156287405|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
48572237|NCT02877134|156287406|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
48572238|NCT02877134|156287407|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
48572239|NCT02877134|156287408|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
48572240|NCT02877134|156287409|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
48572241|NCT02877134|156287410|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
48318203|NCT01636687|155365522|FG000|Extension Period|Adverse Event|4|||
48318204|NCT01636687|155365523|FG001|Extension Period|Adverse Event|3|||
48572242|NCT02877134|156287411|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
48318205|NCT01636687|155365524|FG002|Extension Period|Adverse Event|2|||
48572243|NCT02877134|156287412|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
48572244|NCT02877134|156287413|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
48318206|NCT01636687|155365525|FG003|Extension Period|Adverse Event|1|||
48318207|NCT01636687|155365526|FG004|Extension Period|Adverse Event|0|||
48318208|NCT01636687|155365522|FG000|Extension Period|Lack of Efficacy|7|||
48318209|NCT01636687|155365523|FG001|Extension Period|Lack of Efficacy|0|||
48318210|NCT01636687|155365524|FG002|Extension Period|Lack of Efficacy|2|||
48318211|NCT01636687|155365525|FG003|Extension Period|Lack of Efficacy|1|||
48318212|NCT01636687|155365526|FG004|Extension Period|Lack of Efficacy|0|||
48572245|NCT02877134|156287414|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
48572246|NCT02877134|156287403|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
48572247|NCT02877134|156287404|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
48572248|NCT02877134|156287405|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
48572249|NCT02877134|156287406|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
48572250|NCT02877134|156287407|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
48572251|NCT02877134|156287408|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
48318213|NCT01636687|155365522|FG000|Extension Period|Lost to Follow-up|1|||
48572252|NCT02877134|156287409|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
48572253|NCT02877134|156287410|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
48572254|NCT02877134|156287411|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
48572255|NCT02877134|156287412|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
48572256|NCT02877134|156287413|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
48572257|NCT02877134|156287414|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
48572258|NCT02877134|156287403|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572259|NCT02877134|156287404|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572260|NCT02877134|156287405|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572261|NCT02877134|156287406|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572262|NCT02877134|156287407|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572263|NCT02877134|156287408|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572264|NCT02877134|156287409|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572265|NCT02877134|156287410|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572266|NCT02877134|156287411|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
48572267|NCT02877134|156287412|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572268|NCT02877134|156287413|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572269|NCT02877134|156287414|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
48572270|NCT02877134|156287403|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
48572271|NCT02877134|156287404|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
48572272|NCT02877134|156287405|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
48572273|NCT02877134|156287406|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
48572274|NCT02877134|156287407|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
48572275|NCT02877134|156287408|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
48572276|NCT02877134|156287409|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
48572277|NCT02877134|156287410|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
48572278|NCT02877134|156287411|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
48572279|NCT02877134|156287412|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
48572280|NCT02877134|156287413|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
48572281|NCT02877134|156287414|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
48572282|NCT02877134|156287403|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572283|NCT02877134|156287404|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572284|NCT02877134|156287405|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572285|NCT02877134|156287406|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572286|NCT02877134|156287407|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572287|NCT02877134|156287408|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572288|NCT02877134|156287409|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572289|NCT02877134|156287410|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
48572290|NCT02877134|156287411|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
48572291|NCT02877134|156287412|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
48572292|NCT02877134|156287413|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572293|NCT02877134|156287414|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
48572294|NCT02877134|156287403|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
48572295|NCT02877134|156287404|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
48572296|NCT02877134|156287405|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
48572297|NCT02877134|156287406|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
48572298|NCT02877134|156287407|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
48318214|NCT01636687|155365523|FG001|Extension Period|Lost to Follow-up|0|||
48318215|NCT01636687|155365524|FG002|Extension Period|Lost to Follow-up|1|||
48572299|NCT02877134|156287408|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
48619439|NCT02639559|156463568|FG000|Overall Study|Issues with vascular acess|1|||
48619440|NCT02639559|156463569|FG001|Overall Study|Issues with vascular acess|0|||
48619441|NCT01058005|156463575|FG000|Overall Study|Adverse Event|0|||
48619442|NCT01058005|156463576|FG001|Overall Study|Adverse Event|2|||
48619443|NCT01058005|156463577|FG002|Overall Study|Adverse Event|1|||
48572300|NCT02877134|156287409|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
48572301|NCT02877134|156287410|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
48572302|NCT02877134|156287411|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
48619444|NCT01058005|156463575|FG000|Overall Study|Physician Decision|2|||
48619445|NCT01058005|156463576|FG001|Overall Study|Physician Decision|2|||
48619446|NCT01058005|156463577|FG002|Overall Study|Physician Decision|0|||
48619447|NCT01058005|156463575|FG000|Overall Study|Withdrawal by Subject|4|||
48619448|NCT01058005|156463576|FG001|Overall Study|Withdrawal by Subject|5|||
48619449|NCT01058005|156463577|FG002|Overall Study|Withdrawal by Subject|11|||
48619450|NCT01058005|156463575|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
48619451|NCT01058005|156463576|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
48619452|NCT01058005|156463577|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
48619453|NCT01058005|156463575|FG000|Overall Study|Reason Missing|5|||
48619454|NCT01058005|156463576|FG001|Overall Study|Reason Missing|3|||
48619455|NCT01058005|156463577|FG002|Overall Study|Reason Missing|1|||
48619456|NCT01896986|156463581|FG000|Overall Study|samples lost|14|||
48619457|NCT01896986|156463582|FG001|Overall Study|samples lost|23|||
48619458|NCT01750281|156463583|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
48619459|NCT01750281|156463584|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
48619460|NCT01750281|156463585|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
48619461|NCT01750281|156463583|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
48619462|NCT01750281|156463584|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
48619463|NCT01750281|156463585|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
48619464|NCT01750281|156463583|FG000|Overall Study|Did not receive treatment|0|||
48619465|NCT01750281|156463584|FG001|Overall Study|Did not receive treatment|1|||
48619466|NCT01750281|156463585|FG002|Overall Study|Did not receive treatment|0|||
48619467|NCT01421134|156463586|FG000|Overall Study|Adverse Event|3|||
48619468|NCT01421134|156463587|FG001|Overall Study|Adverse Event|5|||
48619469|NCT01421134|156463586|FG000|Overall Study|Lack of Efficacy|2|||
48619470|NCT01421134|156463587|FG001|Overall Study|Lack of Efficacy|4|||
48619471|NCT01421134|156463586|FG000|Overall Study|Protocol Violation|0|||
48318216|NCT01636687|155365525|FG003|Extension Period|Lost to Follow-up|0|||
48318217|NCT01636687|155365526|FG004|Extension Period|Lost to Follow-up|0|||
48572303|NCT02877134|156287412|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
48572304|NCT02877134|156287413|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
48572305|NCT02877134|156287414|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
48572306|NCT02527434|156287416|FG000|Overall Study|Lost to Follow-up|2|||
48572307|NCT02527434|156287417|FG001|Overall Study|Lost to Follow-up|2|||
48572308|NCT02527434|156287418|FG002|Overall Study|Lost to Follow-up|0|||
48572309|NCT02527434|156287416|FG000|Overall Study|Death|19|||
48572310|NCT02527434|156287417|FG001|Overall Study|Death|6|||
48572311|NCT02527434|156287418|FG002|Overall Study|Death|17|||
48572312|NCT02527434|156287416|FG000|Overall Study|Withdrawal by Subject|5|||
48572313|NCT02527434|156287417|FG001|Overall Study|Withdrawal by Subject|3|||
48572314|NCT02527434|156287418|FG002|Overall Study|Withdrawal by Subject|3|||
48572315|NCT02527434|156287416|FG000|Overall Study|Reason Not Specified|1|||
48572316|NCT02527434|156287417|FG001|Overall Study|Reason Not Specified|0|||
48572317|NCT02527434|156287418|FG002|Overall Study|Reason Not Specified|0|||
48619472|NCT01421134|156463587|FG001|Overall Study|Protocol Violation|3|||
48619473|NCT01421134|156463586|FG000|Overall Study|Withdrawal by Subject|1|||
48318218|NCT01636687|155365522|FG000|Extension Period|Physician Decision|1|||
48318219|NCT01636687|155365523|FG001|Extension Period|Physician Decision|0|||
48318220|NCT01636687|155365524|FG002|Extension Period|Physician Decision|0|||
48318221|NCT01636687|155365525|FG003|Extension Period|Physician Decision|1|||
48318222|NCT01636687|155365526|FG004|Extension Period|Physician Decision|0|||
48318223|NCT01636687|155365522|FG000|Extension Period|study terminated by sponsor|33|||
48572318|NCT02527434|156287416|FG000|Overall Study|Site closure|1|||
48572319|NCT02527434|156287417|FG001|Overall Study|Site closure|0|||
48619474|NCT01421134|156463587|FG001|Overall Study|Withdrawal by Subject|1|||
48318224|NCT01636687|155365523|FG001|Extension Period|study terminated by sponsor|50|||
48619475|NCT01421134|156463586|FG000|Overall Study|Administrative|0|||
48619476|NCT01421134|156463587|FG001|Overall Study|Administrative|1|||
48619477|NCT01421134|156463586|FG000|Overall Study|Lost to Follow-up|1|||
48619478|NCT01421134|156463587|FG001|Overall Study|Lost to Follow-up|1|||
48619479|NCT02959892|156463588|FG000|Overall Study|PET tracer synthesis failure|1|||
48619480|NCT02959892|156463589|FG001|Overall Study|PET tracer synthesis failure|0|||
48572320|NCT02527434|156287418|FG002|Overall Study|Site closure|0|||
48572321|NCT04338321|156287419|FG000|Overall Study|Adverse Event|4|||
48572322|NCT04338321|156287420|FG001|Overall Study|Adverse Event|10|||
48572323|NCT04338321|156287419|FG000|Overall Study|Death|1|||
48572324|NCT04338321|156287420|FG001|Overall Study|Death|1|||
48619481|NCT02959892|156463588|FG000|Overall Study|Study termination|0|||
48619482|NCT02959892|156463589|FG001|Overall Study|Study termination|1|||
48619483|NCT00281580|156463590|FG000|Overall Study|Adverse Event|2|||
48619484|NCT00281580|156463591|FG001|Overall Study|Adverse Event|0|||
48619485|NCT00281580|156463592|FG002|Overall Study|Adverse Event|2|||
48619486|NCT00281580|156463593|FG003|Overall Study|Adverse Event|4|||
48619487|NCT00281580|156463594|FG004|Overall Study|Adverse Event|1|||
48619488|NCT00281580|156463595|FG005|Overall Study|Adverse Event|0|||
48619489|NCT00281580|156463596|FG006|Overall Study|Adverse Event|1|||
48619490|NCT00281580|156463597|FG007|Overall Study|Adverse Event|0|||
48619491|NCT00281580|156463598|FG008|Overall Study|Adverse Event|1|||
48619492|NCT00281580|156463599|FG009|Overall Study|Adverse Event|6|||
48619493|NCT00281580|156463600|FG010|Overall Study|Adverse Event|0|||
48619494|NCT00281580|156463601|FG011|Overall Study|Adverse Event|5|||
48619495|NCT00281580|156463602|FG012|Overall Study|Adverse Event|8|||
48619496|NCT00281580|156463603|FG013|Overall Study|Adverse Event|2|||
48619497|NCT00281580|156463604|FG014|Overall Study|Adverse Event|3|||
48619498|NCT00281580|156463605|FG015|Overall Study|Adverse Event|3|||
48619499|NCT00281580|156463590|FG000|Overall Study|Protocol Violation|0|||
48619500|NCT00281580|156463591|FG001|Overall Study|Protocol Violation|0|||
48619501|NCT00281580|156463592|FG002|Overall Study|Protocol Violation|1|||
48619502|NCT00281580|156463593|FG003|Overall Study|Protocol Violation|1|||
48619503|NCT00281580|156463594|FG004|Overall Study|Protocol Violation|0|||
48619504|NCT00281580|156463595|FG005|Overall Study|Protocol Violation|0|||
48619505|NCT00281580|156463596|FG006|Overall Study|Protocol Violation|1|||
48619506|NCT00281580|156463597|FG007|Overall Study|Protocol Violation|0|||
48619507|NCT00281580|156463598|FG008|Overall Study|Protocol Violation|2|||
48619508|NCT00281580|156463599|FG009|Overall Study|Protocol Violation|0|||
48619509|NCT00281580|156463600|FG010|Overall Study|Protocol Violation|1|||
48619510|NCT00281580|156463601|FG011|Overall Study|Protocol Violation|2|||
48619511|NCT00281580|156463602|FG012|Overall Study|Protocol Violation|0|||
48619512|NCT00281580|156463603|FG013|Overall Study|Protocol Violation|1|||
48619513|NCT00281580|156463604|FG014|Overall Study|Protocol Violation|1|||
48619514|NCT00281580|156463605|FG015|Overall Study|Protocol Violation|3|||
48619515|NCT00281580|156463590|FG000|Overall Study|Withdrawal by Subject|3|||
48619516|NCT00281580|156463591|FG001|Overall Study|Withdrawal by Subject|0|||
48619517|NCT00281580|156463592|FG002|Overall Study|Withdrawal by Subject|1|||
48619518|NCT00281580|156463593|FG003|Overall Study|Withdrawal by Subject|1|||
48619519|NCT00281580|156463594|FG004|Overall Study|Withdrawal by Subject|1|||
48619520|NCT00281580|156463595|FG005|Overall Study|Withdrawal by Subject|2|||
48619521|NCT00281580|156463596|FG006|Overall Study|Withdrawal by Subject|2|||
48619522|NCT00281580|156463597|FG007|Overall Study|Withdrawal by Subject|0|||
48619523|NCT00281580|156463598|FG008|Overall Study|Withdrawal by Subject|1|||
48619524|NCT00281580|156463599|FG009|Overall Study|Withdrawal by Subject|4|||
48619525|NCT00281580|156463600|FG010|Overall Study|Withdrawal by Subject|1|||
48572325|NCT04338321|156287419|FG000|Overall Study|Lost to Follow-up|4|||
48572326|NCT04338321|156287420|FG001|Overall Study|Lost to Follow-up|9|||
48572327|NCT04338321|156287419|FG000|Overall Study|Withdrawal by Subject|45|||
48572328|NCT04338321|156287420|FG001|Overall Study|Withdrawal by Subject|69|||
48572329|NCT04338321|156287419|FG000|Overall Study|Physician Decision|5|||
48572330|NCT04338321|156287420|FG001|Overall Study|Physician Decision|9|||
48572331|NCT04338321|156287419|FG000|Overall Study|Other|3|||
48572332|NCT04338321|156287420|FG001|Overall Study|Other|10|||
48572333|NCT04270942|156287421|FG000|Overall Study|Death|1|||
48572334|NCT02438787|156287422|FG000|Overall Study|Adverse Event|1|||
48572335|NCT02438787|156287423|FG001|Overall Study|Adverse Event|0|||
48619526|NCT00281580|156463601|FG011|Overall Study|Withdrawal by Subject|1|||
48619527|NCT00281580|156463602|FG012|Overall Study|Withdrawal by Subject|2|||
48619528|NCT00281580|156463603|FG013|Overall Study|Withdrawal by Subject|2|||
48619529|NCT00281580|156463604|FG014|Overall Study|Withdrawal by Subject|1|||
48619530|NCT00281580|156463605|FG015|Overall Study|Withdrawal by Subject|5|||
48619531|NCT00281580|156463590|FG000|Overall Study|Lack of Efficacy|2|||
48619532|NCT00281580|156463591|FG001|Overall Study|Lack of Efficacy|1|||
48619533|NCT00281580|156463592|FG002|Overall Study|Lack of Efficacy|1|||
48619534|NCT00281580|156463593|FG003|Overall Study|Lack of Efficacy|6|||
48619535|NCT00281580|156463594|FG004|Overall Study|Lack of Efficacy|2|||
48619536|NCT00281580|156463595|FG005|Overall Study|Lack of Efficacy|0|||
48619537|NCT00281580|156463596|FG006|Overall Study|Lack of Efficacy|0|||
48619538|NCT00281580|156463597|FG007|Overall Study|Lack of Efficacy|0|||
48619539|NCT00281580|156463598|FG008|Overall Study|Lack of Efficacy|0|||
48619540|NCT00281580|156463599|FG009|Overall Study|Lack of Efficacy|0|||
48572336|NCT02438787|156287424|FG002|Overall Study|Adverse Event|2|||
48572337|NCT02438787|156287422|FG000|Overall Study|Lack of Efficacy|1|||
48619541|NCT00281580|156463600|FG010|Overall Study|Lack of Efficacy|0|||
48619542|NCT00281580|156463601|FG011|Overall Study|Lack of Efficacy|1|||
48572338|NCT02438787|156287423|FG001|Overall Study|Lack of Efficacy|2|||
48572339|NCT02438787|156287424|FG002|Overall Study|Lack of Efficacy|0|||
48572340|NCT02438787|156287422|FG000|Overall Study|Lost to Follow-up|0|||
48572341|NCT02438787|156287423|FG001|Overall Study|Lost to Follow-up|1|||
48572342|NCT02438787|156287424|FG002|Overall Study|Lost to Follow-up|0|||
48572343|NCT02438787|156287422|FG000|Overall Study|Protocol Violation|0|||
48572344|NCT02438787|156287423|FG001|Overall Study|Protocol Violation|0|||
48572345|NCT02438787|156287424|FG002|Overall Study|Protocol Violation|1|||
48572346|NCT02438787|156287422|FG000|Overall Study|Withdrawal by Subject|15|||
48572347|NCT02438787|156287423|FG001|Overall Study|Withdrawal by Subject|7|||
48572348|NCT02438787|156287424|FG002|Overall Study|Withdrawal by Subject|10|||
48572349|NCT02438787|156287422|FG000|Overall Study|Study discontinued by sponsor|64|||
48572350|NCT02438787|156287423|FG001|Overall Study|Study discontinued by sponsor|72|||
48572351|NCT02438787|156287424|FG002|Overall Study|Study discontinued by sponsor|69|||
48619543|NCT00281580|156463602|FG012|Overall Study|Lack of Efficacy|0|||
48619544|NCT00281580|156463603|FG013|Overall Study|Lack of Efficacy|2|||
48619545|NCT00281580|156463604|FG014|Overall Study|Lack of Efficacy|1|||
48619546|NCT00281580|156463605|FG015|Overall Study|Lack of Efficacy|0|||
48619547|NCT00281580|156463590|FG000|Overall Study|Lost to Follow-up|0|||
48619548|NCT00281580|156463591|FG001|Overall Study|Lost to Follow-up|0|||
48318225|NCT01636687|155365524|FG002|Extension Period|study terminated by sponsor|17|||
48318226|NCT01636687|155365525|FG003|Extension Period|study terminated by sponsor|23|||
48318227|NCT01636687|155365526|FG004|Extension Period|study terminated by sponsor|0|||
48318228|NCT01636687|155365522|FG000|Extension Period|Withdrawal by Subject|1|||
48619549|NCT00281580|156463592|FG002|Overall Study|Lost to Follow-up|0|||
48619550|NCT00281580|156463593|FG003|Overall Study|Lost to Follow-up|3|||
48619551|NCT00281580|156463594|FG004|Overall Study|Lost to Follow-up|0|||
48619552|NCT00281580|156463595|FG005|Overall Study|Lost to Follow-up|1|||
48619553|NCT00281580|156463596|FG006|Overall Study|Lost to Follow-up|0|||
48619554|NCT00281580|156463597|FG007|Overall Study|Lost to Follow-up|1|||
48318229|NCT01636687|155365523|FG001|Extension Period|Withdrawal by Subject|0|||
48318230|NCT01636687|155365524|FG002|Extension Period|Withdrawal by Subject|1|||
48318231|NCT01636687|155365525|FG003|Extension Period|Withdrawal by Subject|1|||
48318232|NCT01636687|155365526|FG004|Extension Period|Withdrawal by Subject|0|||
48318233|NCT01636687|155365522|FG000|Follow-up Period|Withdrawal by Subject|1|||
48318234|NCT01636687|155365523|FG001|Follow-up Period|Withdrawal by Subject|0|||
48318235|NCT01636687|155365524|FG002|Follow-up Period|Withdrawal by Subject|0|||
48318236|NCT01636687|155365525|FG003|Follow-up Period|Withdrawal by Subject|0|||
48318237|NCT01636687|155365526|FG004|Follow-up Period|Withdrawal by Subject|1|||
48318238|NCT01188655|155365527|FG000|Overall Study|Lack of Efficacy|1|||
48318239|NCT01188655|155365527|FG000|Overall Study|Lost to Follow-up|1|||
48318240|NCT01188655|155365527|FG000|Overall Study|Other|11|||
48318241|NCT00493649|155365528|FG000|Overall Study|Adverse Event|44|||
48318242|NCT00493649|155365528|FG000|Overall Study|Patient Request|21|||
48318243|NCT00493649|155365528|FG000|Overall Study|Investigator Request|2|||
48318244|NCT00493649|155365528|FG000|Overall Study|Disease Progression|1|||
48318245|NCT00493649|155365528|FG000|Overall Study|Lost to Follow-up|1|||
48318246|NCT00493649|155365528|FG000|Overall Study|Other|13|||
48318247|NCT00925899|155365531|FG000|Part 1|Death|1|||
48318248|NCT00925899|155365532|FG001|Part 1|Death|2|||
48318249|NCT00925899|155365531|FG000|Part 1|Withdrawal by Subject|10|||
48318250|NCT00925899|155365532|FG001|Part 1|Withdrawal by Subject|9|||
48318251|NCT00566735|155365537|FG000|Overall Study|Withdrawal by Subject|0|||
48318252|NCT00566735|155365538|FG001|Overall Study|Withdrawal by Subject|1|||
48318253|NCT00566735|155365537|FG000|Overall Study|Refused neuropsychological testing|2|||
48318254|NCT00566735|155365538|FG001|Overall Study|Refused neuropsychological testing|5|||
48318255|NCT00566735|155365537|FG000|Overall Study|Switched into a manic episode|0|||
48572352|NCT02438787|156287422|FG000|Overall Study|Other|0|||
48572353|NCT02438787|156287423|FG001|Overall Study|Other|1|||
48572354|NCT02438787|156287424|FG002|Overall Study|Other|0|||
48572355|NCT02438787|156287422|FG000|Overall Study|Site terminated by sponsor|0|||
48572356|NCT02438787|156287423|FG001|Overall Study|Site terminated by sponsor|0|||
48572357|NCT02438787|156287424|FG002|Overall Study|Site terminated by sponsor|1|||
48572358|NCT02257489|156287426|FG000|Overall Study|Withdrawal by Subject|0|||
48572359|NCT02257489|156287427|FG001|Overall Study|Withdrawal by Subject|0|||
48572360|NCT02257489|156287428|FG002|Overall Study|Withdrawal by Subject|0|||
48572361|NCT02257489|156287429|FG003|Overall Study|Withdrawal by Subject|1|||
48572362|NCT02257489|156287430|FG004|Overall Study|Withdrawal by Subject|0|||
48572363|NCT02257489|156287431|FG005|Overall Study|Withdrawal by Subject|0|||
48572364|NCT02257489|156287432|FG006|Overall Study|Withdrawal by Subject|0|||
48572365|NCT02257489|156287433|FG007|Overall Study|Withdrawal by Subject|0|||
48572366|NCT02257489|156287434|FG008|Overall Study|Withdrawal by Subject|0|||
48572367|NCT04606394|156287435|FG000|Overall Study|Withdrawal by Subject|3|||
48572368|NCT04606394|156287435|FG000|Overall Study|Exclusion criteria screen failure|12|||
48619555|NCT00281580|156463598|FG008|Overall Study|Lost to Follow-up|2|||
48619556|NCT00281580|156463599|FG009|Overall Study|Lost to Follow-up|1|||
48318256|NCT00566735|155365538|FG001|Overall Study|Switched into a manic episode|1|||
48318257|NCT01599104|155365544|FG000|Overall Study|Withdrawal by Subject|1|||
48572369|NCT03672916|156287436|FG000|Overall Study|Death|6|||
48572370|NCT03672916|156287436|FG000|Overall Study|Lost to Follow-up|29|||
48572371|NCT03672916|156287436|FG000|Overall Study|Adverse Event|6|||
48572372|NCT03672916|156287436|FG000|Overall Study|Withdrawal by Subject|11|||
48619557|NCT00281580|156463600|FG010|Overall Study|Lost to Follow-up|1|||
48619558|NCT00281580|156463601|FG011|Overall Study|Lost to Follow-up|0|||
48619559|NCT00281580|156463602|FG012|Overall Study|Lost to Follow-up|1|||
48619560|NCT00281580|156463603|FG013|Overall Study|Lost to Follow-up|0|||
48318258|NCT01599104|155365545|FG001|Overall Study|Withdrawal by Subject|1|||
48318259|NCT01599104|155365546|FG002|Overall Study|Withdrawal by Subject|2|||
48572373|NCT03375203|156287442|FG000|Overall Study|Protocol Violation|0|||
48572374|NCT03375203|156287443|FG001|Overall Study|Protocol Violation|0|||
48572375|NCT03375203|156287444|FG002|Overall Study|Protocol Violation|1|||
48572376|NCT03375203|156287445|FG003|Overall Study|Protocol Violation|0|||
48318260|NCT01599104|155365544|FG000|Overall Study|Technical Problems|1|||
48318261|NCT01599104|155365545|FG001|Overall Study|Technical Problems|0|||
48318262|NCT01599104|155365546|FG002|Overall Study|Technical Problems|0|||
48318263|NCT01599104|155365544|FG000|Overall Study|Physician Decision|3|||
48318264|NCT01599104|155365545|FG001|Overall Study|Physician Decision|2|||
48318265|NCT01599104|155365546|FG002|Overall Study|Physician Decision|2|||
48318266|NCT01599104|155365544|FG000|Overall Study|Non-compliance with study treatment|0|||
48318267|NCT01599104|155365545|FG001|Overall Study|Non-compliance with study treatment|1|||
48318268|NCT01599104|155365546|FG002|Overall Study|Non-compliance with study treatment|0|||
48318269|NCT01599104|155365544|FG000|Overall Study|Lack of Efficacy|4|||
48318270|NCT01599104|155365545|FG001|Overall Study|Lack of Efficacy|4|||
48318271|NCT01599104|155365546|FG002|Overall Study|Lack of Efficacy|10|||
48318272|NCT01599104|155365544|FG000|Overall Study|Adverse Event|7|||
48318273|NCT01599104|155365545|FG001|Overall Study|Adverse Event|6|||
48318274|NCT01599104|155365546|FG002|Overall Study|Adverse Event|12|||
48318275|NCT02567656|155365550|FG000|Overall Study|Premature discontinuation due to PD|1|||
48318276|NCT02567656|155365551|FG001|Overall Study|Premature discontinuation due to PD|1|||
48318277|NCT02567656|155365552|FG002|Overall Study|Premature discontinuation due to PD|2|||
48318278|NCT02567656|155365553|FG003|Overall Study|Premature discontinuation due to PD|0|||
48572377|NCT03375203|156287446|FG004|Overall Study|Protocol Violation|0|||
48572378|NCT03375203|156287442|FG000|Overall Study|Adverse Event|2|||
48572379|NCT03375203|156287443|FG001|Overall Study|Adverse Event|3|||
48572380|NCT03375203|156287444|FG002|Overall Study|Adverse Event|0|||
48572381|NCT03375203|156287445|FG003|Overall Study|Adverse Event|2|||
48572382|NCT03375203|156287446|FG004|Overall Study|Adverse Event|2|||
48318279|NCT02567656|155365554|FG004|Overall Study|Premature discontinuation due to PD|0|||
48318280|NCT02567656|155365555|FG005|Overall Study|Premature discontinuation due to PD|0|||
48318281|NCT01424397|155365558|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318282|NCT01424397|155365559|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318283|NCT01424397|155365560|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
48318284|NCT01424397|155365561|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
48572383|NCT03375203|156287442|FG000|Overall Study|Withdrawal by Subject|3|||
48318285|NCT01424397|155365562|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318286|NCT01424397|155365563|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318287|NCT01424397|155365564|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318288|NCT01424397|155365565|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318289|NCT01424397|155365566|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318290|NCT01424397|155365567|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318291|NCT01424397|155365568|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318292|NCT01424397|155365569|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
48318293|NCT01808339|155365570|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48318294|NCT01808339|155365571|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48318295|NCT01808339|155365572|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48318296|NCT01808339|155365573|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
48318297|NCT01808339|155365574|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
48318298|NCT01808339|155365575|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
48318299|NCT01808339|155365570|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48318300|NCT01808339|155365571|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48318301|NCT01808339|155365572|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48318302|NCT01808339|155365573|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48318303|NCT01808339|155365574|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48318304|NCT01808339|155365575|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48318305|NCT01808339|155365570|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48318306|NCT01808339|155365571|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48318307|NCT01808339|155365572|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
48318308|NCT01808339|155365573|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48318309|NCT01808339|155365574|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48318310|NCT01808339|155365575|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
48318311|NCT03593876|155365582|FG000|Overall Study|Withdrawal by Subject|1|||
48318312|NCT03593876|155365582|FG000|Overall Study|Discharged home before intervention completion|2|||
48572384|NCT03375203|156287443|FG001|Overall Study|Withdrawal by Subject|0|||
48572385|NCT03375203|156287444|FG002|Overall Study|Withdrawal by Subject|1|||
48572386|NCT03375203|156287445|FG003|Overall Study|Withdrawal by Subject|0|||
48318313|NCT01040689|155365583|FG000|Overall Study|Adverse Event|0|||
48318314|NCT01040689|155365584|FG001|Overall Study|Adverse Event|0|||
48318315|NCT01040689|155365585|FG002|Overall Study|Adverse Event|2|||
48318316|NCT01040689|155365586|FG003|Overall Study|Adverse Event|4|||
48318317|NCT01040689|155365583|FG000|Overall Study|Lack of Efficacy|0|||
48318318|NCT01040689|155365584|FG001|Overall Study|Lack of Efficacy|0|||
48572387|NCT03375203|156287446|FG004|Overall Study|Withdrawal by Subject|2|||
48572388|NCT03375203|156287442|FG000|Overall Study|Non-compliance with study drug|1|||
48619561|NCT00281580|156463604|FG014|Overall Study|Lost to Follow-up|0|||
48318319|NCT01040689|155365585|FG002|Overall Study|Lack of Efficacy|1|||
48318320|NCT01040689|155365586|FG003|Overall Study|Lack of Efficacy|0|||
48318321|NCT01040689|155365583|FG000|Overall Study|Lost to Follow-up|1|||
48318322|NCT01040689|155365584|FG001|Overall Study|Lost to Follow-up|0|||
48318323|NCT01040689|155365585|FG002|Overall Study|Lost to Follow-up|0|||
48318324|NCT01040689|155365586|FG003|Overall Study|Lost to Follow-up|0|||
48318325|NCT01040689|155365583|FG000|Overall Study|Withdrawal by Subject|2|||
48318326|NCT01040689|155365584|FG001|Overall Study|Withdrawal by Subject|1|||
48318327|NCT01040689|155365585|FG002|Overall Study|Withdrawal by Subject|1|||
48318328|NCT01040689|155365586|FG003|Overall Study|Withdrawal by Subject|0|||
48318329|NCT01040689|155365583|FG000|Overall Study|Other reasons not listed above|0|||
48318330|NCT01040689|155365584|FG001|Overall Study|Other reasons not listed above|1|||
48318331|NCT01040689|155365585|FG002|Overall Study|Other reasons not listed above|0|||
48318332|NCT01040689|155365586|FG003|Overall Study|Other reasons not listed above|0|||
48572389|NCT03375203|156287443|FG001|Overall Study|Non-compliance with study drug|0|||
48572390|NCT03375203|156287444|FG002|Overall Study|Non-compliance with study drug|0|||
48572391|NCT03375203|156287445|FG003|Overall Study|Non-compliance with study drug|0|||
48572392|NCT03375203|156287446|FG004|Overall Study|Non-compliance with study drug|0|||
48572393|NCT03375203|156287442|FG000|Overall Study|Randomized, not treated.|0|||
48572394|NCT03375203|156287443|FG001|Overall Study|Randomized, not treated.|1|||
48572395|NCT03375203|156287444|FG002|Overall Study|Randomized, not treated.|0|||
48318333|NCT03287622|155365589|FG000|Overall Study|Withdrawal by Subject|1|||
48318334|NCT03287622|155365590|FG001|Overall Study|Withdrawal by Subject|0|||
48318335|NCT03287622|155365589|FG000|Overall Study|Lost to Follow-up|27|||
48318336|NCT03287622|155365590|FG001|Overall Study|Lost to Follow-up|15|||
48318337|NCT03287622|155365589|FG000|Overall Study|No prescripion after surgery|28|||
48318338|NCT03287622|155365590|FG001|Overall Study|No prescripion after surgery|31|||
48318339|NCT03287622|155365589|FG000|Overall Study|prolonged Length of stay|2|||
48318340|NCT03287622|155365590|FG001|Overall Study|prolonged Length of stay|0|||
48318341|NCT03287622|155365589|FG000|Overall Study|surgery related|0|||
48318342|NCT03287622|155365590|FG001|Overall Study|surgery related|2|||
48318343|NCT01078116|155365593|FG000|Overall Study|Lost to Follow-up|17|||
48318344|NCT01078116|155365593|FG000|Overall Study|Adverse Event|5|||
48318345|NCT01078116|155365593|FG000|Overall Study|Withdrawal by Subject|8|||
48318346|NCT01078116|155365593|FG000|Overall Study|Lack of effectiveness|15|||
48318347|NCT01078116|155365593|FG000|Overall Study|Case report form not completed|3|||
48318348|NCT00585052|155365594|FG000|Overall Study|Withdrawal by Subject|1|||
48318349|NCT00371787|155365597|FG000|Overall Study|Withdrawal by Subject|3|||
48318350|NCT00371787|155365598|FG001|Overall Study|Withdrawal by Subject|1|||
48318351|NCT02242487|155365600|FG000|Overall Study|Adverse Event|13|||
48318352|NCT02242487|155365601|FG001|Overall Study|Adverse Event|15|||
48318353|NCT02242487|155365600|FG000|Overall Study|Lack of Efficacy|4|||
48318354|NCT02242487|155365601|FG001|Overall Study|Lack of Efficacy|6|||
48318355|NCT02242487|155365600|FG000|Overall Study|Protocol Violation|2|||
48318356|NCT02242487|155365601|FG001|Overall Study|Protocol Violation|0|||
48318357|NCT02242487|155365600|FG000|Overall Study|Lost to Follow-up|2|||
48318358|NCT02242487|155365601|FG001|Overall Study|Lost to Follow-up|1|||
48318359|NCT02242487|155365600|FG000|Overall Study|Other - Miscellaneous|4|||
48318360|NCT02242487|155365601|FG001|Overall Study|Other - Miscellaneous|6|||
48318361|NCT02242487|155365600|FG000|Overall Study|Withdrawal by Subject|37|||
48318362|NCT02242487|155365601|FG001|Overall Study|Withdrawal by Subject|19|||
48318363|NCT03644849|155365604|FG000|Overall Study|Lost to Follow-up|1|||
48318364|NCT03644849|155365605|FG001|Overall Study|Lost to Follow-up|3|||
48318365|NCT02932579|155365606|FG000|Overall Study|Withdrawal by Subject|4|||
48318366|NCT02932579|155365607|FG001|Overall Study|Withdrawal by Subject|1|||
48318367|NCT01972724|155365610|FG000|Double-Blind|Rescue Criteria Met|1|||
48318368|NCT01972724|155365611|FG001|Double-Blind|Rescue Criteria Met|0|||
48318369|NCT01972724|155365612|FG002|Double-Blind|Rescue Criteria Met|0|||
48318370|NCT01972724|155365610|FG000|Double-Blind|Adverse Event|1|||
48318371|NCT01972724|155365611|FG001|Double-Blind|Adverse Event|0|||
48318372|NCT01972724|155365612|FG002|Double-Blind|Adverse Event|0|||
48318373|NCT01972724|155365610|FG000|Double-Blind|Withdrawal of Consent|2|||
48318374|NCT01972724|155365611|FG001|Double-Blind|Withdrawal of Consent|1|||
48318375|NCT01972724|155365612|FG002|Double-Blind|Withdrawal of Consent|0|||
48318376|NCT01972724|155365610|FG000|Double-Blind|Significant Protocol Deviation|5|||
48318377|NCT01972724|155365611|FG001|Double-Blind|Significant Protocol Deviation|8|||
48318378|NCT01972724|155365612|FG002|Double-Blind|Significant Protocol Deviation|0|||
48318379|NCT01972724|155365610|FG000|Open-Label|Withdrew Consent|0|||
48318380|NCT01972724|155365611|FG001|Open-Label|Withdrew Consent|0|||
48318381|NCT01972724|155365612|FG002|Open-Label|Withdrew Consent|3|||
48572396|NCT03375203|156287445|FG003|Overall Study|Randomized, not treated.|0|||
48572397|NCT03375203|156287446|FG004|Overall Study|Randomized, not treated.|0|||
48572398|NCT03097133|156287457|FG000|Overall Study|Lost to Follow-up|3|||
48572399|NCT03097133|156287458|FG001|Overall Study|Lost to Follow-up|2|||
48572400|NCT03097133|156287457|FG000|Overall Study|Withdrawal by Subject|2|||
48572401|NCT03097133|156287458|FG001|Overall Study|Withdrawal by Subject|5|||
48572402|NCT03097133|156287457|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
48572403|NCT03097133|156287458|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
48572404|NCT03097133|156287457|FG000|Overall Study|Other|3|||
48572405|NCT03097133|156287458|FG001|Overall Study|Other|2|||
48572406|NCT03097133|156287457|FG000|Overall Study|Adverse Event|1|||
48619562|NCT00281580|156463605|FG015|Overall Study|Lost to Follow-up|0|||
48619563|NCT00281580|156463590|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
48619564|NCT00281580|156463591|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
48318382|NCT01972724|155365610|FG000|Open-Label|Significant Protocol Deviation|0|||
48318383|NCT01972724|155365611|FG001|Open-Label|Significant Protocol Deviation|0|||
48318384|NCT01972724|155365612|FG002|Open-Label|Significant Protocol Deviation|2|||
48318385|NCT01369498|155365616|FG000|Overall Study|Lack of Efficacy|9|||
48318386|NCT01369498|155365617|FG001|Overall Study|Lack of Efficacy|9|||
48318387|NCT01369498|155365618|FG002|Overall Study|Lack of Efficacy|1|||
48318388|NCT01369498|155365619|FG003|Overall Study|Lack of Efficacy|3|||
48318389|NCT01369498|155365616|FG000|Overall Study|Adverse Event|1|||
48318390|NCT01369498|155365617|FG001|Overall Study|Adverse Event|2|||
48318391|NCT01369498|155365618|FG002|Overall Study|Adverse Event|0|||
48318392|NCT01369498|155365619|FG003|Overall Study|Adverse Event|1|||
48572407|NCT03097133|156287458|FG001|Overall Study|Adverse Event|0|||
48572408|NCT03107793|156287459|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
48572409|NCT03107793|156287460|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
48572410|NCT03107793|156287461|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
48572411|NCT03107793|156287462|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
48572412|NCT03107793|156287463|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
48572413|NCT03107793|156287459|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
48572414|NCT03107793|156287460|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
48572415|NCT03107793|156287461|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
48572416|NCT03107793|156287462|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
48572417|NCT03107793|156287463|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
48572418|NCT03107793|156287459|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
48572419|NCT03107793|156287460|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
48572420|NCT03107793|156287461|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
48572421|NCT03107793|156287462|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
48572422|NCT03107793|156287463|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
48572423|NCT03107793|156287459|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
48572424|NCT03107793|156287460|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48572425|NCT03107793|156287461|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48572426|NCT03107793|156287462|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48572427|NCT03107793|156287463|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48572428|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48572429|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
48572430|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
48572431|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48572432|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48572433|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
48572434|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
48572435|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
48572436|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
48572437|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
48572438|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
48572439|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
48572440|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
48572441|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
48572442|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
48572443|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48572444|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
48572445|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
48572446|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48572447|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48572448|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
48572449|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
48572450|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
48572451|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
48572452|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
48572453|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
48572454|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
48572455|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
48572456|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
48572457|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
48572458|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48572459|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
48572460|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48572461|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48572462|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48572463|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
48572464|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
48572465|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
48572466|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
48572467|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
48572468|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
48572469|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
48572470|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
48572471|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
48572472|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
48572473|NCT03107793|156287459|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
48572474|NCT03107793|156287460|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
48572475|NCT03107793|156287461|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
48572476|NCT03107793|156287462|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
48572477|NCT03107793|156287463|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
48572478|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
48572479|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
48572480|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
48572481|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
48572482|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
48572483|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
48572484|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
48572485|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
48572486|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
48572487|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
48572488|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
48572489|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
48572490|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
48572491|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
48572492|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
48572493|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Death|0|||
48572494|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Death|0|||
48572495|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Death|0|||
48572496|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Death|0|||
48318393|NCT01369498|155365616|FG000|Overall Study|Withdrawal of Consent|0|||
48318394|NCT01369498|155365617|FG001|Overall Study|Withdrawal of Consent|1|||
48318395|NCT01369498|155365618|FG002|Overall Study|Withdrawal of Consent|1|||
48572497|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Death|1|||
48572498|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
48572499|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
48572500|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
48572501|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
48572502|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
48572503|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
48572504|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
48572505|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
48318396|NCT01369498|155365619|FG003|Overall Study|Withdrawal of Consent|1|||
48318397|NCT01369498|155365616|FG000|Overall Study|Death|0|||
48318398|NCT01369498|155365617|FG001|Overall Study|Death|0|||
48318399|NCT01369498|155365618|FG002|Overall Study|Death|1|||
48318400|NCT01369498|155365619|FG003|Overall Study|Death|0|||
48572506|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
48572507|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
48572508|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
48572509|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
48572510|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
48572511|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
48572512|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
48572513|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
48572514|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
48572515|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
48572516|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
48572517|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
48572518|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
48572519|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
48572520|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
48572521|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
48572522|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
48572523|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Other|0|||
48572524|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Other|0|||
48572525|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Other|0|||
48572526|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Other|1|||
48572527|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Other|3|||
48572528|NCT03107793|156287459|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
48572529|NCT03107793|156287460|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
48572530|NCT03107793|156287461|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
48572531|NCT03107793|156287462|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
48572532|NCT03107793|156287463|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
48572533|NCT02201251|156287466|FG000|Overall Study|Adverse Event|1|||
48572534|NCT02201251|156287467|FG001|Overall Study|Adverse Event|1|||
48572535|NCT02201251|156287466|FG000|Overall Study|Protocol Violation|1|||
48572536|NCT02201251|156287467|FG001|Overall Study|Protocol Violation|0|||
48572537|NCT02201251|156287466|FG000|Overall Study|Noncompliance with Study Drug|0|||
48572538|NCT02201251|156287467|FG001|Overall Study|Noncompliance with Study Drug|1|||
48572539|NCT02201251|156287466|FG000|Overall Study|Withdrawal by Subject|2|||
48572540|NCT02201251|156287467|FG001|Overall Study|Withdrawal by Subject|1|||
48572541|NCT02411396|156287468|FG000|Overall Study|Lost to Follow-up|31|||
48572542|NCT02411396|156287468|FG000|Overall Study|Death|10|||
48572543|NCT01250873|156287471|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
48572544|NCT01250873|156287471|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
48572545|NCT03575793|156287473|FG000|Overall Study|Withdrawal by Subject|0|||
48572546|NCT03575793|156287474|FG001|Overall Study|Withdrawal by Subject|1|||
48572547|NCT03575793|156287473|FG000|Overall Study|Never Treated|0|||
48572548|NCT03575793|156287474|FG001|Overall Study|Never Treated|2|||
48572549|NCT02125786|156287475|FG000|Overall Study|Still in Follow-up|3|||
48572550|NCT02125786|156287475|FG000|Overall Study|Screen Failure|2|||
48318401|NCT01369498|155365616|FG000|Overall Study|Investigator's Discretion|1|||
48318402|NCT01369498|155365617|FG001|Overall Study|Investigator's Discretion|0|||
48318403|NCT01369498|155365618|FG002|Overall Study|Investigator's Discretion|1|||
48318404|NCT01369498|155365619|FG003|Overall Study|Investigator's Discretion|3|||
48318405|NCT01369498|155365616|FG000|Overall Study|Unknown Reason|1|||
48572551|NCT02125786|156287475|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
48572552|NCT02125786|156287475|FG000|Overall Study|Progressive Disease|44|||
48572553|NCT02125786|156287475|FG000|Overall Study|Death|8|||
48318406|NCT01369498|155365617|FG001|Overall Study|Unknown Reason|0|||
48318407|NCT01369498|155365618|FG002|Overall Study|Unknown Reason|11|||
48318408|NCT01369498|155365619|FG003|Overall Study|Unknown Reason|6|||
48735990|NCT02935842|156883748|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
48318409|NCT01369498|155365616|FG000|Overall Study|Disease Progression|0|||
48318410|NCT01369498|155365617|FG001|Overall Study|Disease Progression|0|||
48318411|NCT01369498|155365618|FG002|Overall Study|Disease Progression|0|||
48318412|NCT01369498|155365619|FG003|Overall Study|Disease Progression|1|||
48318413|NCT03260140|155365620|FG000|Overall Study|Death|4|||
48318414|NCT03260140|155365621|FG001|Overall Study|Death|1|||
48318415|NCT03260140|155365620|FG000|Overall Study|Withdrawal by Subject|1|||
48318416|NCT03260140|155365621|FG001|Overall Study|Withdrawal by Subject|4|||
48318417|NCT04530747|155365629|FG000|Overall Study|Withdrawal by Subject|1|||
48318418|NCT04530747|155365630|FG001|Overall Study|Withdrawal by Subject|0|||
48318419|NCT00421889|155365631|FG000|Overall Study|Adverse Event|1|||
48318420|NCT00421889|155365632|FG001|Overall Study|Adverse Event|0|||
48318421|NCT00421889|155365633|FG002|Overall Study|Adverse Event|1|||
48318422|NCT00421889|155365634|FG003|Overall Study|Adverse Event|1|||
48318423|NCT00421889|155365635|FG004|Overall Study|Adverse Event|1|||
48318424|NCT00421889|155365636|FG005|Overall Study|Adverse Event|4|||
48318425|NCT00421889|155365637|FG006|Overall Study|Adverse Event|1|||
48318426|NCT00421889|155365638|FG007|Overall Study|Adverse Event|0|||
48318427|NCT00421889|155365639|FG008|Overall Study|Adverse Event|2|||
48318428|NCT00421889|155365631|FG000|Overall Study|Withdrawal by Subject|1|||
48318429|NCT00421889|155365632|FG001|Overall Study|Withdrawal by Subject|3|||
48318430|NCT00421889|155365633|FG002|Overall Study|Withdrawal by Subject|0|||
48318431|NCT00421889|155365634|FG003|Overall Study|Withdrawal by Subject|0|||
48318432|NCT00421889|155365635|FG004|Overall Study|Withdrawal by Subject|2|||
48318433|NCT00421889|155365636|FG005|Overall Study|Withdrawal by Subject|0|||
48318434|NCT00421889|155365637|FG006|Overall Study|Withdrawal by Subject|0|||
48318435|NCT00421889|155365638|FG007|Overall Study|Withdrawal by Subject|0|||
48318436|NCT00421889|155365639|FG008|Overall Study|Withdrawal by Subject|0|||
48318437|NCT00421889|155365631|FG000|Overall Study|Death|0|||
48318438|NCT00421889|155365632|FG001|Overall Study|Death|0|||
48318439|NCT00421889|155365633|FG002|Overall Study|Death|0|||
48318440|NCT00421889|155365634|FG003|Overall Study|Death|0|||
48318441|NCT00421889|155365635|FG004|Overall Study|Death|1|||
48318442|NCT00421889|155365636|FG005|Overall Study|Death|1|||
48318443|NCT00421889|155365637|FG006|Overall Study|Death|0|||
48318444|NCT00421889|155365638|FG007|Overall Study|Death|0|||
48318445|NCT00421889|155365639|FG008|Overall Study|Death|0|||
48318446|NCT00421889|155365631|FG000|Overall Study|Progressive disease|3|||
48318447|NCT00421889|155365632|FG001|Overall Study|Progressive disease|2|||
48318448|NCT00421889|155365633|FG002|Overall Study|Progressive disease|2|||
48318449|NCT00421889|155365634|FG003|Overall Study|Progressive disease|3|||
48318450|NCT00421889|155365635|FG004|Overall Study|Progressive disease|2|||
48318451|NCT00421889|155365636|FG005|Overall Study|Progressive disease|21|||
48318452|NCT00421889|155365637|FG006|Overall Study|Progressive disease|3|||
48318453|NCT00421889|155365638|FG007|Overall Study|Progressive disease|1|||
48318454|NCT00421889|155365639|FG008|Overall Study|Progressive disease|5|||
48318455|NCT00421889|155365631|FG000|Overall Study|Patient/Investigator request|0|||
48318456|NCT00421889|155365632|FG001|Overall Study|Patient/Investigator request|0|||
48318457|NCT00421889|155365633|FG002|Overall Study|Patient/Investigator request|0|||
48318458|NCT00421889|155365634|FG003|Overall Study|Patient/Investigator request|0|||
48318459|NCT00421889|155365635|FG004|Overall Study|Patient/Investigator request|0|||
48318460|NCT00421889|155365636|FG005|Overall Study|Patient/Investigator request|9|||
48318461|NCT00421889|155365637|FG006|Overall Study|Patient/Investigator request|0|||
48318462|NCT00421889|155365638|FG007|Overall Study|Patient/Investigator request|1|||
48318463|NCT00421889|155365639|FG008|Overall Study|Patient/Investigator request|3|||
48318464|NCT00421889|155365631|FG000|Overall Study|Lost to Follow-up|0|||
48318465|NCT00421889|155365632|FG001|Overall Study|Lost to Follow-up|0|||
48318466|NCT00421889|155365633|FG002|Overall Study|Lost to Follow-up|0|||
48318467|NCT00421889|155365634|FG003|Overall Study|Lost to Follow-up|0|||
48318468|NCT00421889|155365635|FG004|Overall Study|Lost to Follow-up|0|||
48318469|NCT00421889|155365636|FG005|Overall Study|Lost to Follow-up|0|||
48318470|NCT00421889|155365637|FG006|Overall Study|Lost to Follow-up|0|||
48572554|NCT01194999|156287476|FG000|Overall Study|Lost to Follow-up|17|||
48572555|NCT03382834|156287477|FG000|Step 1|Lost to Follow-up|0|||
48572556|NCT03382834|156287478|FG001|Step 1|Lost to Follow-up|1|||
48572557|NCT03382834|156287477|FG000|Step 2|Death|1|||
48572558|NCT03382834|156287478|FG001|Step 2|Death|0|||
48572559|NCT03382834|156287477|FG000|Step 2|Lost to Follow-up|2|||
48572560|NCT03382834|156287478|FG001|Step 2|Lost to Follow-up|2|||
48572561|NCT03382834|156287477|FG000|Step 2|Site Terminated by Sponsor|1|||
48572562|NCT03382834|156287478|FG001|Step 2|Site Terminated by Sponsor|0|||
48572563|NCT03706430|156287479|FG000|Overall Study|No A-Line placed|5|||
48572564|NCT03706430|156287479|FG000|Overall Study|Subject had gel nail polish|1|||
48572565|NCT03706430|156287479|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
48572566|NCT03706430|156287479|FG000|Overall Study|Cancelled Case|6|||
48572567|NCT03706430|156287479|FG000|Overall Study|Physician Decision|2|||
48318471|NCT00421889|155365638|FG007|Overall Study|Lost to Follow-up|0|||
48318472|NCT00421889|155365639|FG008|Overall Study|Lost to Follow-up|1|||
48318473|NCT01063972|155365643|FG000|Overall Study|Death|12|||
48318474|NCT01063972|155365644|FG001|Overall Study|Death|11|||
48572568|NCT01217476|156287480|FG000|Overall Study|Adverse Event|6|||
48572569|NCT01217476|156287481|FG001|Overall Study|Adverse Event|1|||
48572570|NCT01217476|156287480|FG000|Overall Study|Physician Decision|0|||
48572571|NCT01217476|156287481|FG001|Overall Study|Physician Decision|1|||
48572572|NCT01217476|156287480|FG000|Overall Study|Withdrawal by Subject|3|||
48572573|NCT01217476|156287481|FG001|Overall Study|Withdrawal by Subject|3|||
48572574|NCT01217476|156287480|FG000|Overall Study|Surgery on the Target Limb|0|||
48572575|NCT01217476|156287481|FG001|Overall Study|Surgery on the Target Limb|2|||
48572576|NCT01217476|156287480|FG000|Overall Study|Protocol Deviation|1|||
48572577|NCT01217476|156287481|FG001|Overall Study|Protocol Deviation|0|||
48572578|NCT01217476|156287480|FG000|Overall Study|Other|2|||
48572579|NCT01217476|156287481|FG001|Overall Study|Other|0|||
48572580|NCT03782376|156287482|FG000|Overall Study|Lost to Follow-up|2|||
48572581|NCT03782376|156287483|FG001|Overall Study|Lost to Follow-up|2|||
48572582|NCT03782376|156287482|FG000|Overall Study|Withdrawal by Subject|7|||
48572583|NCT03782376|156287483|FG001|Overall Study|Withdrawal by Subject|11|||
48572584|NCT03782376|156287482|FG000|Overall Study|Death|1|||
48572585|NCT03782376|156287483|FG001|Overall Study|Death|0|||
48572586|NCT03782376|156287482|FG000|Overall Study|Other|16|||
48572587|NCT03782376|156287483|FG001|Overall Study|Other|17|||
48572588|NCT04487080|156287484|FG000|Overall Study|Withdrawal by Subject|19|||
48572589|NCT04487080|156287485|FG001|Overall Study|Withdrawal by Subject|18|||
48572590|NCT04487080|156287486|FG002|Overall Study|Withdrawal by Subject|13|||
48572591|NCT04487080|156287484|FG000|Overall Study|Lost to Follow-up|3|||
48572592|NCT04487080|156287485|FG001|Overall Study|Lost to Follow-up|1|||
48572593|NCT04487080|156287486|FG002|Overall Study|Lost to Follow-up|0|||
48572594|NCT04487080|156287484|FG000|Overall Study|Ongoing|313|||
48572595|NCT04487080|156287485|FG001|Overall Study|Ongoing|297|||
48572596|NCT04487080|156287486|FG002|Overall Study|Ongoing|149|||
48572597|NCT03559192|156287487|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
48572598|NCT03559192|156287488|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
48572599|NCT03559192|156287489|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
48572600|NCT03559192|156287487|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
48572601|NCT03559192|156287488|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
48572602|NCT03559192|156287489|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
48572603|NCT03559192|156287487|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
48572604|NCT03559192|156287488|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
48572605|NCT03559192|156287489|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
48572606|NCT03559192|156287487|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
48572607|NCT03559192|156287488|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
48572608|NCT03559192|156287489|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
48572609|NCT03559192|156287487|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
48572610|NCT03559192|156287488|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
48572611|NCT03559192|156287489|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
48572612|NCT03559192|156287487|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
48572613|NCT03559192|156287488|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
48572614|NCT03559192|156287489|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
48572615|NCT03559192|156287487|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
48572616|NCT03559192|156287488|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
48572617|NCT03559192|156287489|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
48572618|NCT03559192|156287487|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
48572619|NCT03559192|156287488|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
48572620|NCT03559192|156287489|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
48572621|NCT03559192|156287487|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
48572622|NCT03559192|156287488|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
48572623|NCT03559192|156287489|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
48572624|NCT02493868|156287490|FG000|Induction Phase: DE Participants|Adverse Event|22|||
48572625|NCT02493868|156287491|FG001|Induction Phase: DE Participants|Adverse Event|0|||
48572626|NCT02493868|156287490|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
48572627|NCT02493868|156287491|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
48619565|NCT00281580|156463592|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
48619566|NCT00281580|156463593|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
48318475|NCT01063972|155365643|FG000|Overall Study|Incarcerated|2|||
48318476|NCT01063972|155365644|FG001|Overall Study|Incarcerated|1|||
48318477|NCT01610297|155365645|FG000|Overall Study|Lost to Follow-up|1|||
48572628|NCT02493868|156287490|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
48572629|NCT02493868|156287491|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
48572630|NCT02493868|156287490|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
48572631|NCT02493868|156287491|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
48572632|NCT02493868|156287490|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
48572633|NCT02493868|156287491|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
48572634|NCT02493868|156287490|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
48572635|NCT02493868|156287491|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
48572636|NCT02493868|156287490|FG000|Induction Phase: DE Participants|Other|8|||
48572637|NCT02493868|156287491|FG001|Induction Phase: DE Participants|Other|0|||
48572638|NCT02493868|156287490|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
48572639|NCT02493868|156287491|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
48572640|NCT02493868|156287490|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
48572641|NCT02493868|156287491|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
48572642|NCT02493868|156287490|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
48572643|NCT02493868|156287491|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
48572644|NCT02493868|156287490|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
48572645|NCT02493868|156287491|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
48572646|NCT02493868|156287490|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
48572647|NCT02493868|156287491|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
48572648|NCT02493868|156287490|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
48572649|NCT02493868|156287491|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
48572650|NCT02493868|156287490|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
48572651|NCT02493868|156287491|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
48572652|NCT02493868|156287490|FG000|Optimization Phase: DE+TE Participants|Other|10|||
48572653|NCT02493868|156287491|FG001|Optimization Phase: DE+TE Participants|Other|2|||
48572654|NCT02493868|156287490|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
48572655|NCT02493868|156287491|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
48572656|NCT02493868|156287490|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
48572657|NCT02493868|156287491|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
48572658|NCT02493868|156287490|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
48572659|NCT02493868|156287491|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
48572660|NCT02493868|156287490|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
48572661|NCT02493868|156287491|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
48572662|NCT02493868|156287490|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
48572663|NCT02493868|156287491|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
48572664|NCT02493868|156287490|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
48572665|NCT02493868|156287491|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
48572666|NCT02493868|156287490|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
48572667|NCT02493868|156287491|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
48572668|NCT02493868|156287490|FG000|Follow-up Phase|Lost to Follow-up|1|||
48572669|NCT02493868|156287491|FG001|Follow-up Phase|Lost to Follow-up|0|||
48572670|NCT02493868|156287490|FG000|Follow-up Phase|Withdrawal by Subject|3|||
48572671|NCT02493868|156287491|FG001|Follow-up Phase|Withdrawal by Subject|0|||
48572672|NCT02493868|156287490|FG000|Follow-up Phase|Investigator Decision|5|||
48572673|NCT02493868|156287491|FG001|Follow-up Phase|Investigator Decision|1|||
48572674|NCT02493868|156287490|FG000|Follow-up Phase|Other|2|||
48572675|NCT02493868|156287491|FG001|Follow-up Phase|Other|1|||
48572676|NCT04439214|156287492|FG000|Overall Study|Adverse Event|13|||
48572677|NCT04439214|156287492|FG000|Overall Study|Disease progression|16|||
48572678|NCT04439214|156287492|FG000|Overall Study|Death|1|||
48572679|NCT04439214|156287492|FG000|Overall Study|Withdrawal by Subject|2|||
48572680|NCT04439214|156287492|FG000|Overall Study|Declining health|1|||
48572681|NCT04439214|156287492|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
48572682|NCT04439214|156287492|FG000|Overall Study|Ineligible|5|||
48572683|NCT02147158|156287493|FG000|Treatment Course 1|Adverse Event|1|||
48572684|NCT02147158|156287494|FG001|Treatment Course 1|Adverse Event|4|||
48572685|NCT02147158|156287495|FG002|Treatment Course 1|Adverse Event|3|||
48572686|NCT02147158|156287496|FG003|Treatment Course 1|Adverse Event|4|||
48572687|NCT02147158|156287497|FG004|Treatment Course 1|Adverse Event|1|||
48572688|NCT02147158|156287498|FG005|Treatment Course 1|Adverse Event|2|||
48572689|NCT02147158|156287493|FG000|Treatment Course 1|Lost to Follow-up|2|||
48572690|NCT02147158|156287494|FG001|Treatment Course 1|Lost to Follow-up|4|||
48572691|NCT02147158|156287495|FG002|Treatment Course 1|Lost to Follow-up|3|||
48572692|NCT02147158|156287496|FG003|Treatment Course 1|Lost to Follow-up|3|||
48572693|NCT02147158|156287497|FG004|Treatment Course 1|Lost to Follow-up|2|||
48572694|NCT02147158|156287498|FG005|Treatment Course 1|Lost to Follow-up|4|||
48318478|NCT02092116|155365648|FG000|Overall Study|Withdrawal by Subject|0|||
48318479|NCT02092116|155365649|FG001|Overall Study|Withdrawal by Subject|3|||
48318480|NCT02092116|155365648|FG000|Overall Study|Adverse Event|0|||
48318481|NCT02092116|155365649|FG001|Overall Study|Adverse Event|1|||
48318482|NCT03482011|155365651|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
48318483|NCT03482011|155365652|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
48318484|NCT03482011|155365653|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
48318485|NCT03482011|155365654|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
48318486|NCT03482011|155365655|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
48318487|NCT03482011|155365656|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
48572695|NCT02147158|156287493|FG000|Treatment Course 1|Protocol Violation|0|||
48572696|NCT02147158|156287494|FG001|Treatment Course 1|Protocol Violation|0|||
48318488|NCT03482011|155365657|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
48318489|NCT03482011|155365658|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
48318490|NCT03482011|155365651|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
48318491|NCT03482011|155365652|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
48572697|NCT02147158|156287495|FG002|Treatment Course 1|Protocol Violation|1|||
48572698|NCT02147158|156287496|FG003|Treatment Course 1|Protocol Violation|1|||
48572699|NCT02147158|156287497|FG004|Treatment Course 1|Protocol Violation|0|||
48572700|NCT02147158|156287498|FG005|Treatment Course 1|Protocol Violation|0|||
48572701|NCT02147158|156287493|FG000|Treatment Course 1|Withdrawal of Consent|1|||
48572702|NCT02147158|156287494|FG001|Treatment Course 1|Withdrawal of Consent|1|||
48572703|NCT02147158|156287495|FG002|Treatment Course 1|Withdrawal of Consent|1|||
48572704|NCT02147158|156287496|FG003|Treatment Course 1|Withdrawal of Consent|5|||
48572705|NCT02147158|156287497|FG004|Treatment Course 1|Withdrawal of Consent|3|||
48572706|NCT02147158|156287498|FG005|Treatment Course 1|Withdrawal of Consent|2|||
48572707|NCT02147158|156287493|FG000|Off-Treatment Interval 1|Adverse Event|1|||
48572708|NCT02147158|156287494|FG001|Off-Treatment Interval 1|Adverse Event|0|||
48572709|NCT02147158|156287495|FG002|Off-Treatment Interval 1|Adverse Event|0|||
48572710|NCT02147158|156287496|FG003|Off-Treatment Interval 1|Adverse Event|1|||
48572711|NCT02147158|156287497|FG004|Off-Treatment Interval 1|Adverse Event|0|||
48572712|NCT02147158|156287498|FG005|Off-Treatment Interval 1|Adverse Event|0|||
48572713|NCT02147158|156287493|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
48572714|NCT02147158|156287494|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
48572715|NCT02147158|156287495|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
48572716|NCT02147158|156287496|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
48572717|NCT02147158|156287497|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
48572718|NCT02147158|156287498|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
48572719|NCT02147158|156287493|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
48572720|NCT02147158|156287494|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
48572721|NCT02147158|156287495|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
48572722|NCT02147158|156287496|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
48572723|NCT02147158|156287497|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
48572724|NCT02147158|156287498|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
48572725|NCT02147158|156287493|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
48572726|NCT02147158|156287494|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
48572727|NCT02147158|156287495|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
48572728|NCT02147158|156287496|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
48572729|NCT02147158|156287497|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
48572730|NCT02147158|156287498|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
48572731|NCT02147158|156287493|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
48572732|NCT02147158|156287494|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
48572733|NCT02147158|156287495|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
48572734|NCT02147158|156287496|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
48572735|NCT02147158|156287497|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
48572736|NCT02147158|156287498|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
48572737|NCT02147158|156287493|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
48572738|NCT02147158|156287494|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
48572739|NCT02147158|156287495|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
48572740|NCT02147158|156287496|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
48572741|NCT02147158|156287497|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
48572742|NCT02147158|156287498|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
48572743|NCT02147158|156287493|FG000|Treatment Course 2|Adverse Event|0|||
48572744|NCT02147158|156287494|FG001|Treatment Course 2|Adverse Event|4|||
48572745|NCT02147158|156287495|FG002|Treatment Course 2|Adverse Event|2|||
48572746|NCT02147158|156287496|FG003|Treatment Course 2|Adverse Event|1|||
48572747|NCT02147158|156287497|FG004|Treatment Course 2|Adverse Event|0|||
48572748|NCT02147158|156287498|FG005|Treatment Course 2|Adverse Event|1|||
48572749|NCT02147158|156287493|FG000|Treatment Course 2|Withdrawal of Consent|0|||
48572750|NCT02147158|156287494|FG001|Treatment Course 2|Withdrawal of Consent|1|||
48572751|NCT02147158|156287495|FG002|Treatment Course 2|Withdrawal of Consent|2|||
48572752|NCT02147158|156287496|FG003|Treatment Course 2|Withdrawal of Consent|3|||
48572753|NCT02147158|156287497|FG004|Treatment Course 2|Withdrawal of Consent|0|||
48318492|NCT03482011|155365653|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48572754|NCT02147158|156287498|FG005|Treatment Course 2|Withdrawal of Consent|0|||
48572755|NCT02147158|156287493|FG000|Treatment Course 2|Lost to Follow-up|1|||
48572756|NCT02147158|156287494|FG001|Treatment Course 2|Lost to Follow-up|0|||
48572757|NCT02147158|156287495|FG002|Treatment Course 2|Lost to Follow-up|1|||
48572758|NCT02147158|156287496|FG003|Treatment Course 2|Lost to Follow-up|1|||
48572759|NCT02147158|156287497|FG004|Treatment Course 2|Lost to Follow-up|0|||
48318493|NCT03482011|155365654|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48318494|NCT03482011|155365655|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48318495|NCT03482011|155365656|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48619567|NCT00281580|156463594|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
48619568|NCT00281580|156463595|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
48619569|NCT00281580|156463596|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
48619570|NCT00281580|156463597|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
48572760|NCT02147158|156287498|FG005|Treatment Course 2|Lost to Follow-up|1|||
48572761|NCT02147158|156287493|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
48572762|NCT02147158|156287494|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
48572763|NCT02147158|156287495|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
48572764|NCT02147158|156287496|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
48572765|NCT02147158|156287497|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
48619571|NCT00281580|156463598|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
48619572|NCT00281580|156463599|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
48619573|NCT00281580|156463600|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
48619574|NCT00281580|156463601|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
48619575|NCT00281580|156463602|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
48619576|NCT00281580|156463603|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
48619577|NCT00281580|156463604|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
48619578|NCT00281580|156463605|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
48619579|NCT00776997|156463606|FG000|Overall Study|Adverse Event|2|||
48619580|NCT00225758|156463607|FG000|Overall Study|Adverse Event|4|||
48619581|NCT01259024|156463608|FG000|Overall Study|Physician Decision|1|||
48619582|NCT00933166|156463609|FG000|Overall Study|Lost to Follow-up|4|||
48619583|NCT00933166|156463609|FG000|Overall Study|Lack of Efficacy|9|||
48619584|NCT00933166|156463609|FG000|Overall Study|Unavailable|4|||
48619585|NCT00933166|156463609|FG000|Overall Study|Withdrawal by Subject|1|||
48619586|NCT05029362|156463610|FG000|Overall Study|Lost to Follow-up|9|||
48619587|NCT01290731|156463612|FG000|Overall Study|Withdrawal by Subject|1|||
48619588|NCT00601107|156463613|FG000|Overall Study|Adverse Event|0|||
48318496|NCT03482011|155365657|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48572766|NCT02147158|156287498|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
48572767|NCT02147158|156287493|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
48572768|NCT02147158|156287494|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
48572769|NCT02147158|156287495|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
48572770|NCT02147158|156287496|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
48572771|NCT02147158|156287497|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
48619589|NCT00601107|156463614|FG001|Overall Study|Adverse Event|1|||
48619590|NCT00601107|156463615|FG002|Overall Study|Adverse Event|3|||
48619591|NCT00601107|156463616|FG003|Overall Study|Adverse Event|0|||
48318497|NCT03482011|155365658|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48572772|NCT02147158|156287498|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
48619592|NCT00601107|156463613|FG000|Overall Study|Withdrawal by Subject|5|||
48619593|NCT00601107|156463614|FG001|Overall Study|Withdrawal by Subject|4|||
48619594|NCT00601107|156463615|FG002|Overall Study|Withdrawal by Subject|7|||
48619595|NCT00601107|156463616|FG003|Overall Study|Withdrawal by Subject|4|||
48619596|NCT00601107|156463613|FG000|Overall Study|Lost to Follow-up|3|||
48619597|NCT00601107|156463614|FG001|Overall Study|Lost to Follow-up|3|||
48619598|NCT00601107|156463615|FG002|Overall Study|Lost to Follow-up|0|||
48318498|NCT03482011|155365651|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48318499|NCT03482011|155365652|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
48318500|NCT03482011|155365653|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48318501|NCT03482011|155365654|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48318502|NCT03482011|155365655|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48318503|NCT03482011|155365656|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48318504|NCT03482011|155365657|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48318505|NCT03482011|155365658|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
48318506|NCT03482011|155365651|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
48318507|NCT03482011|155365652|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
48318508|NCT03482011|155365653|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
48318509|NCT03482011|155365654|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
48572773|NCT02147158|156287493|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
48572774|NCT02147158|156287494|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
48318510|NCT03482011|155365655|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
48318511|NCT03482011|155365656|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
48318512|NCT03482011|155365657|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
48318513|NCT03482011|155365658|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
48318514|NCT03482011|155365651|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
48318515|NCT03482011|155365652|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
48318516|NCT03482011|155365653|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48318517|NCT03482011|155365654|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48318518|NCT03482011|155365655|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48318519|NCT03482011|155365656|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48318520|NCT03482011|155365657|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48318521|NCT03482011|155365658|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48318522|NCT03482011|155365651|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
48318523|NCT03482011|155365652|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
48318524|NCT03482011|155365653|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
48318525|NCT03482011|155365654|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
48619599|NCT00601107|156463616|FG003|Overall Study|Lost to Follow-up|3|||
48619600|NCT00601107|156463613|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
48318526|NCT03482011|155365655|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
48318527|NCT03482011|155365656|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
48318528|NCT03482011|155365657|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
48318529|NCT03482011|155365658|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
48318530|NCT03482011|155365651|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
48318531|NCT03482011|155365652|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
48318532|NCT03482011|155365653|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
48318533|NCT03482011|155365654|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
48318534|NCT03482011|155365655|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
48318535|NCT03482011|155365656|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
48318536|NCT03482011|155365657|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
48318537|NCT03482011|155365658|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
48318538|NCT03482011|155365651|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48572775|NCT02147158|156287495|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
48318539|NCT03482011|155365652|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48572776|NCT02147158|156287496|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
48572777|NCT02147158|156287497|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
48572778|NCT02147158|156287498|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
48572779|NCT02147158|156287493|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
48572780|NCT02147158|156287494|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
48572781|NCT02147158|156287495|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
48572782|NCT02147158|156287496|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
48572783|NCT02147158|156287497|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
48572784|NCT02147158|156287498|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
48572785|NCT02147158|156287493|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
48619601|NCT00601107|156463614|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
48619602|NCT00601107|156463615|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
48318540|NCT03482011|155365653|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48450047|NCT01831804|155835550|FG004|Overall Study|Withdrew Consent|0|||
48572786|NCT02147158|156287494|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
48572787|NCT02147158|156287495|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
48318541|NCT03482011|155365654|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48318542|NCT03482011|155365655|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
48318543|NCT03482011|155365656|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48318544|NCT03482011|155365657|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48318545|NCT03482011|155365658|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
48572788|NCT02147158|156287496|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
48572789|NCT02147158|156287497|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
48572790|NCT02147158|156287498|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
48572791|NCT03514017|156287502|FG000|Overall Study|Death|1|||
48572792|NCT03514017|156287502|FG000|Overall Study|Adverse Event|1|||
48572793|NCT03033602|156287503|FG000|Overall Study|Withdrawal by Subject|11|||
48572794|NCT03033602|156287504|FG001|Overall Study|Withdrawal by Subject|21|||
48572795|NCT03033602|156287503|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
48572796|NCT03033602|156287504|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
48572797|NCT02407236|156287505|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
48572798|NCT02407236|156287506|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
48572799|NCT02407236|156287507|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
48572800|NCT02407236|156287508|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
48572801|NCT02407236|156287509|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
48619603|NCT00601107|156463616|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
48619604|NCT00601107|156463613|FG000|Overall Study|Worsening of Psoriasis|4|||
48619605|NCT00601107|156463614|FG001|Overall Study|Worsening of Psoriasis|1|||
48619606|NCT00601107|156463615|FG002|Overall Study|Worsening of Psoriasis|1|||
48619607|NCT00601107|156463616|FG003|Overall Study|Worsening of Psoriasis|4|||
48619608|NCT00601107|156463613|FG000|Overall Study|Undefined|1|||
48619609|NCT00601107|156463614|FG001|Overall Study|Undefined|0|||
48619610|NCT00601107|156463615|FG002|Overall Study|Undefined|1|||
48619611|NCT00601107|156463616|FG003|Overall Study|Undefined|0|||
48619612|NCT02181738|156463619|FG000|Overall Study|Participant Withdrew Consent|2|||
48619613|NCT02181738|156463620|FG001|Overall Study|Participant Withdrew Consent|1|||
48619614|NCT02181738|156463621|FG002|Overall Study|Participant Withdrew Consent|1|||
48619615|NCT02181738|156463622|FG003|Overall Study|Participant Withdrew Consent|1|||
48619616|NCT02181738|156463619|FG000|Overall Study|Lost to Follow-up|1|||
48619617|NCT02181738|156463620|FG001|Overall Study|Lost to Follow-up|2|||
48619618|NCT02181738|156463621|FG002|Overall Study|Lost to Follow-up|1|||
48619619|NCT02181738|156463622|FG003|Overall Study|Lost to Follow-up|1|||
48619620|NCT02181738|156463619|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
48572802|NCT02407236|156287510|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
48572803|NCT02407236|156287511|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
48572804|NCT02407236|156287512|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
48572805|NCT02407236|156287513|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
48572806|NCT02407236|156287514|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
48572807|NCT02407236|156287515|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
48572808|NCT02407236|156287516|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
48572809|NCT02407236|156287517|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
48572810|NCT02407236|156287505|FG000|Induction Study (8 Weeks)|Death|0|||
48572811|NCT02407236|156287506|FG001|Induction Study (8 Weeks)|Death|0|||
48619621|NCT02181738|156463620|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
48619622|NCT02181738|156463621|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
48572812|NCT02407236|156287507|FG002|Induction Study (8 Weeks)|Death|1|||
48619623|NCT02181738|156463622|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
48619624|NCT02181738|156463619|FG000|Overall Study|Poor/Non-Compliance|1|||
48619625|NCT02181738|156463620|FG001|Overall Study|Poor/Non-Compliance|0|||
48450048|NCT01831804|155835551|FG005|Overall Study|Withdrew Consent|0|||
48619626|NCT02181738|156463621|FG002|Overall Study|Poor/Non-Compliance|2|||
48619627|NCT02181738|156463622|FG003|Overall Study|Poor/Non-Compliance|1|||
48572813|NCT02407236|156287508|FG003|Induction Study (8 Weeks)|Death|0|||
48318546|NCT03482011|155365651|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
48318547|NCT03482011|155365652|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
48318548|NCT03482011|155365653|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
48318549|NCT03482011|155365654|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
48318550|NCT03482011|155365655|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
48318551|NCT03482011|155365656|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
48318552|NCT03482011|155365657|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
48318553|NCT03482011|155365658|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
48318554|NCT03482011|155365651|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48318555|NCT03482011|155365652|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48318556|NCT03482011|155365653|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48318557|NCT03482011|155365654|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
48318558|NCT03482011|155365655|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
48318559|NCT03482011|155365656|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
48318560|NCT03482011|155365657|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
48318561|NCT03482011|155365658|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
48318562|NCT03482011|155365651|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48318563|NCT03482011|155365652|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48318564|NCT03482011|155365653|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48318565|NCT03482011|155365654|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
48318566|NCT03482011|155365655|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48318567|NCT03482011|155365656|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
48318568|NCT03482011|155365657|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
48318569|NCT03482011|155365658|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
48318570|NCT03482011|155365651|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
48318571|NCT03482011|155365652|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
48318572|NCT03482011|155365653|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
48318573|NCT03482011|155365654|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
48318574|NCT03482011|155365655|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
48318575|NCT03482011|155365656|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
48318576|NCT03482011|155365657|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
48318577|NCT03482011|155365658|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
48318578|NCT03482011|155365651|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48318579|NCT03482011|155365652|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48318580|NCT03482011|155365653|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
48318581|NCT03482011|155365654|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
48318582|NCT03482011|155365655|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48318583|NCT03482011|155365656|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48318584|NCT03482011|155365657|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
48318585|NCT03482011|155365658|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
48318586|NCT03482011|155365651|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
48318587|NCT03482011|155365652|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
48318588|NCT03482011|155365653|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
48318589|NCT03482011|155365654|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
48318590|NCT03482011|155365655|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
48318591|NCT03482011|155365656|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
48318592|NCT03482011|155365657|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
48318593|NCT03482011|155365658|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
48318594|NCT03482011|155365651|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48318595|NCT03482011|155365652|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48318596|NCT03482011|155365653|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48318597|NCT03482011|155365654|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48318598|NCT03482011|155365655|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48318599|NCT03482011|155365656|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48318600|NCT03482011|155365657|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48318601|NCT03482011|155365658|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
48318602|NCT00424645|155365661|FG000|Overall Study|Death|1|||
48318603|NCT00424645|155365662|FG001|Overall Study|Death|0|||
48318604|NCT02555215|155365664|FG000|Overall Study|Other|1|||
48318605|NCT02555215|155365664|FG000|Overall Study|Investigator Decision|2|||
48318606|NCT01561989|155365670|FG000|Overall Study|accural target not met.|5|||
48572814|NCT02407236|156287509|FG004|Induction Study (8 Weeks)|Death|0|||
48318607|NCT01561989|155365671|FG001|Overall Study|accural target not met.|6|||
48572815|NCT02407236|156287510|FG005|Induction Study (8 Weeks)|Death|0|||
48318608|NCT00522951|155365676|FG000|Period 1|body motion|0|||
48318609|NCT00522951|155365677|FG001|Period 1|body motion|1|||
48318610|NCT00522951|155365676|FG000|Washout Period|Adverse Event|0|||
48318611|NCT00522951|155365677|FG001|Washout Period|Adverse Event|1|||
48318612|NCT00522951|155365676|FG000|Washout Period|Death|0|||
48572816|NCT02407236|156287511|FG006|Induction Study (8 Weeks)|Death|0|||
48572817|NCT02407236|156287512|FG007|Induction Study (8 Weeks)|Death|0|||
48318613|NCT00522951|155365677|FG001|Washout Period|Death|1|||
48318614|NCT00522951|155365676|FG000|Period 2|Withdrawal by Subject|1|||
48318615|NCT00522951|155365677|FG001|Period 2|Withdrawal by Subject|0|||
48318616|NCT00522951|155365676|FG000|Period 2|residual contrast medium|1|||
48318617|NCT00522951|155365677|FG001|Period 2|residual contrast medium|1|||
48318618|NCT03447249|155365678|FG000|Overall Study|Adverse Event|1|||
48318619|NCT03447249|155365679|FG001|Overall Study|Adverse Event|0|||
48318620|NCT03447249|155365678|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
48318621|NCT03447249|155365679|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
48318622|NCT03447249|155365678|FG000|Overall Study|Other|3|||
48318623|NCT03447249|155365679|FG001|Overall Study|Other|0|||
48318624|NCT00089544|155368052|FG000|Overall Study|Ineligible|1|||
48318625|NCT00089544|155368053|FG001|Overall Study|Ineligible|0|||
48318626|NCT02189252|155368054|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
48318627|NCT02189252|155368055|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
48318628|NCT02189252|155368056|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
48318629|NCT02189252|155368057|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
48318630|NCT02189252|155368054|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
48318631|NCT02189252|155368055|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
48318632|NCT02189252|155368056|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
48318633|NCT02189252|155368057|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
48318634|NCT03990649|155368062|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
48318635|NCT03990649|155368063|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
48318636|NCT03990649|155368064|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
48318637|NCT03990649|155368062|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
48318638|NCT03990649|155368063|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
48318639|NCT03990649|155368064|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
48572818|NCT02407236|156287513|FG008|Induction Study (8 Weeks)|Death|0|||
48572819|NCT02407236|156287514|FG009|Induction Study (8 Weeks)|Death|0|||
48572820|NCT02407236|156287515|FG010|Induction Study (8 Weeks)|Death|0|||
48572821|NCT02407236|156287516|FG011|Induction Study (8 Weeks)|Death|0|||
48572822|NCT02407236|156287517|FG012|Induction Study (8 Weeks)|Death|0|||
48572823|NCT02407236|156287505|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
48572824|NCT02407236|156287506|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
48572825|NCT02407236|156287507|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
48572826|NCT02407236|156287508|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572827|NCT02407236|156287509|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572828|NCT02407236|156287510|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572829|NCT02407236|156287511|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572830|NCT02407236|156287512|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572831|NCT02407236|156287513|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572832|NCT02407236|156287514|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572833|NCT02407236|156287515|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572834|NCT02407236|156287516|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572835|NCT02407236|156287517|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
48572836|NCT02407236|156287505|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572837|NCT02407236|156287506|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572838|NCT02407236|156287507|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
48572839|NCT02407236|156287508|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48318640|NCT03990649|155368062|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
48318641|NCT03990649|155368063|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
48318642|NCT03990649|155368064|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
48572840|NCT02407236|156287509|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572841|NCT02407236|156287510|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572842|NCT02407236|156287511|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572843|NCT02407236|156287512|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572844|NCT02407236|156287513|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572845|NCT02407236|156287514|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572846|NCT02407236|156287515|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572847|NCT02407236|156287516|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572848|NCT02407236|156287517|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
48572849|NCT02407236|156287505|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
48318643|NCT03990649|155368062|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
48318644|NCT03990649|155368063|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
48572850|NCT02407236|156287506|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
48318645|NCT03990649|155368064|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
48318646|NCT03990649|155368062|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
48450049|NCT01831804|155835552|FG006|Overall Study|Withdrew Consent|0|||
48572851|NCT02407236|156287507|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
48572852|NCT02407236|156287508|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
48619628|NCT02181738|156463619|FG000|Overall Study|Disease Progression|28|||
48619629|NCT02181738|156463620|FG001|Overall Study|Disease Progression|35|||
48318647|NCT03990649|155368063|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
48318648|NCT03990649|155368064|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
48318649|NCT03990649|155368062|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
48318650|NCT03990649|155368063|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
48318651|NCT03990649|155368064|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
48318652|NCT03990649|155368062|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
48318653|NCT03990649|155368063|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
48318654|NCT03990649|155368064|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
48318655|NCT02383472|155368065|FG000|Overall Study|Withdrawal by Subject|1|||
48318656|NCT02383472|155368066|FG001|Overall Study|Withdrawal by Subject|1|||
48318657|NCT01613716|155368067|FG000|Overall Study|screen failures|3|||
48318658|NCT01613716|155368067|FG000|Overall Study|Lost to Follow-up|4|||
48318659|NCT01376089|155368068|FG000|Overall Study|Patient received no contrast media|3|||
48318660|NCT01376089|155368069|FG001|Overall Study|Patient received no contrast media|4|||
48572853|NCT02407236|156287509|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
48572854|NCT02407236|156287510|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
48572855|NCT02407236|156287511|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
48572856|NCT02407236|156287512|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
48572857|NCT02407236|156287513|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
48572858|NCT02407236|156287514|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
48572859|NCT02407236|156287515|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
48572860|NCT02407236|156287516|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
48572861|NCT02407236|156287517|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
48572862|NCT02407236|156287505|FG000|Induction Study (8 Weeks)|Other|2|||
48572863|NCT02407236|156287506|FG001|Induction Study (8 Weeks)|Other|1|||
48572864|NCT02407236|156287507|FG002|Induction Study (8 Weeks)|Other|5|||
48318661|NCT01303445|155368070|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
48318662|NCT01303445|155368071|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
48318663|NCT01303445|155368070|FG000|Second Intervention (7 Days)|Adverse Event|0|||
48318664|NCT01303445|155368071|FG001|Second Intervention (7 Days)|Adverse Event|2|||
48318665|NCT01303445|155368070|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
48572865|NCT02407236|156287508|FG003|Induction Study (8 Weeks)|Other|0|||
48572866|NCT02407236|156287509|FG004|Induction Study (8 Weeks)|Other|0|||
48572867|NCT02407236|156287510|FG005|Induction Study (8 Weeks)|Other|0|||
48572868|NCT02407236|156287511|FG006|Induction Study (8 Weeks)|Other|0|||
48572869|NCT02407236|156287512|FG007|Induction Study (8 Weeks)|Other|0|||
48572870|NCT02407236|156287513|FG008|Induction Study (8 Weeks)|Other|0|||
48572871|NCT02407236|156287514|FG009|Induction Study (8 Weeks)|Other|0|||
48572872|NCT02407236|156287515|FG010|Induction Study (8 Weeks)|Other|0|||
48572873|NCT02407236|156287516|FG011|Induction Study (8 Weeks)|Other|0|||
48572874|NCT02407236|156287517|FG012|Induction Study (8 Weeks)|Other|0|||
48572875|NCT02407236|156287505|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
48572876|NCT02407236|156287506|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
48572877|NCT02407236|156287507|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
48572878|NCT02407236|156287508|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
48572879|NCT02407236|156287509|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
48572880|NCT02407236|156287510|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
48572881|NCT02407236|156287511|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
48572882|NCT02407236|156287512|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
48572883|NCT02407236|156287513|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
48572884|NCT02407236|156287514|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
48572885|NCT02407236|156287515|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
48572886|NCT02407236|156287516|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
48572887|NCT02407236|156287517|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
48572888|NCT02407236|156287505|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
48572889|NCT02407236|156287506|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
48572890|NCT02407236|156287507|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
48572891|NCT02407236|156287508|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
48572892|NCT02407236|156287509|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
48572893|NCT02407236|156287510|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
48572894|NCT02407236|156287511|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
48572895|NCT02407236|156287512|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
48572896|NCT02407236|156287513|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
48572897|NCT02407236|156287514|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
48572898|NCT02407236|156287515|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
48572899|NCT02407236|156287516|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
48572900|NCT02407236|156287517|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
48572901|NCT02407236|156287505|FG000|Maintenance Study (44 Weeks)|Other|0|||
48572902|NCT02407236|156287506|FG001|Maintenance Study (44 Weeks)|Other|0|||
48572903|NCT02407236|156287507|FG002|Maintenance Study (44 Weeks)|Other|0|||
48735991|NCT02935842|156883749|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
48735992|NCT02935842|156883750|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
48318666|NCT01303445|155368071|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
48318667|NCT01303445|155368070|FG000|Washout (14 Days)|Protocol Violation|1|||
48318668|NCT01303445|155368071|FG001|Washout (14 Days)|Protocol Violation|0|||
48318669|NCT01303445|155368070|FG000|Washout (14 Days)|Lost to Follow-up|0|||
48318670|NCT01303445|155368071|FG001|Washout (14 Days)|Lost to Follow-up|2|||
48318671|NCT01303445|155368070|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
48318672|NCT01303445|155368071|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
48318673|NCT01303445|155368070|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
48318674|NCT01303445|155368071|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
48318675|NCT01582100|155368078|FG000|Overall Study|Adverse Event|1|||
48318676|NCT01582100|155368078|FG000|Overall Study|Withdrawal by Subject|1|||
48318677|NCT01307267|155368079|FG000|Overall Study|Death|4|||
48318678|NCT01307267|155368080|FG001|Overall Study|Death|3|||
48318679|NCT01307267|155368081|FG002|Overall Study|Death|5|||
48318680|NCT01307267|155368082|FG003|Overall Study|Death|3|||
48318681|NCT01307267|155368083|FG004|Overall Study|Death|1|||
48318682|NCT01307267|155368084|FG005|Overall Study|Death|26|||
48318683|NCT01307267|155368085|FG006|Overall Study|Death|2|||
48318684|NCT01307267|155368086|FG007|Overall Study|Death|2|||
48318685|NCT01307267|155368087|FG008|Overall Study|Death|21|||
48572904|NCT02407236|156287508|FG003|Maintenance Study (44 Weeks)|Other|5|||
48572905|NCT02407236|156287509|FG004|Maintenance Study (44 Weeks)|Other|7|||
48572906|NCT02407236|156287510|FG005|Maintenance Study (44 Weeks)|Other|8|||
48572907|NCT02407236|156287511|FG006|Maintenance Study (44 Weeks)|Other|4|||
48572908|NCT02407236|156287512|FG007|Maintenance Study (44 Weeks)|Other|6|||
48572909|NCT02407236|156287513|FG008|Maintenance Study (44 Weeks)|Other|0|||
48572910|NCT02407236|156287514|FG009|Maintenance Study (44 Weeks)|Other|0|||
48572911|NCT02407236|156287515|FG010|Maintenance Study (44 Weeks)|Other|0|||
48572912|NCT02407236|156287516|FG011|Maintenance Study (44 Weeks)|Other|0|||
48572913|NCT02407236|156287517|FG012|Maintenance Study (44 Weeks)|Other|0|||
48572914|NCT02407236|156287505|FG000|Maintenance Study (44 Weeks)|Death|0|||
48572915|NCT02407236|156287506|FG001|Maintenance Study (44 Weeks)|Death|0|||
48572916|NCT02407236|156287507|FG002|Maintenance Study (44 Weeks)|Death|0|||
48572917|NCT02407236|156287508|FG003|Maintenance Study (44 Weeks)|Death|0|||
48572918|NCT02407236|156287509|FG004|Maintenance Study (44 Weeks)|Death|0|||
48572919|NCT02407236|156287510|FG005|Maintenance Study (44 Weeks)|Death|0|||
48572920|NCT02407236|156287511|FG006|Maintenance Study (44 Weeks)|Death|0|||
48572921|NCT02407236|156287512|FG007|Maintenance Study (44 Weeks)|Death|1|||
48572922|NCT02407236|156287513|FG008|Maintenance Study (44 Weeks)|Death|0|||
48572923|NCT02407236|156287514|FG009|Maintenance Study (44 Weeks)|Death|0|||
48572924|NCT02407236|156287515|FG010|Maintenance Study (44 Weeks)|Death|0|||
48572925|NCT02407236|156287516|FG011|Maintenance Study (44 Weeks)|Death|0|||
48572926|NCT02407236|156287517|FG012|Maintenance Study (44 Weeks)|Death|0|||
48572927|NCT02407236|156287505|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
48572928|NCT02407236|156287506|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
48572929|NCT02407236|156287507|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
48572930|NCT02407236|156287508|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
48572931|NCT02407236|156287509|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
48572932|NCT02407236|156287510|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
48572933|NCT02407236|156287511|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
48572934|NCT02407236|156287512|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
48572935|NCT02407236|156287513|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
48572936|NCT02407236|156287514|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
48572937|NCT02407236|156287515|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
48572938|NCT02407236|156287516|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
48572939|NCT02407236|156287517|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
48572940|NCT02407236|156287505|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572941|NCT02407236|156287506|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572942|NCT02407236|156287507|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572943|NCT02407236|156287508|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572944|NCT02407236|156287509|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572945|NCT02407236|156287510|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572946|NCT02407236|156287511|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572947|NCT02407236|156287512|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572948|NCT02407236|156287513|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572949|NCT02407236|156287514|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572950|NCT02407236|156287515|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
48572951|NCT02407236|156287516|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48318686|NCT01307267|155368088|FG009|Overall Study|Death|2|||
48318687|NCT01307267|155368089|FG010|Overall Study|Death|3|||
48318688|NCT01307267|155368090|FG011|Overall Study|Death|9|||
48619630|NCT02181738|156463621|FG002|Overall Study|Disease Progression|40|||
48619631|NCT02181738|156463622|FG003|Overall Study|Disease Progression|0|||
48619632|NCT02181738|156463619|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
48619633|NCT02181738|156463620|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
48619634|NCT02181738|156463621|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
48619635|NCT02181738|156463622|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
48619636|NCT02181738|156463619|FG000|Overall Study|Study Drug Toxicity|6|||
48619637|NCT02181738|156463620|FG001|Overall Study|Study Drug Toxicity|11|||
48619638|NCT02181738|156463621|FG002|Overall Study|Study Drug Toxicity|8|||
48619639|NCT02181738|156463622|FG003|Overall Study|Study Drug Toxicity|1|||
48619640|NCT02181738|156463619|FG000|Overall Study|Other Reasons|14|||
48619641|NCT02181738|156463620|FG001|Overall Study|Other Reasons|16|||
48619642|NCT02181738|156463621|FG002|Overall Study|Other Reasons|28|||
48619643|NCT02181738|156463622|FG003|Overall Study|Other Reasons|0|||
48619644|NCT02181738|156463619|FG000|Overall Study|Maximum Clinical Benefit|3|||
48619645|NCT02181738|156463620|FG001|Overall Study|Maximum Clinical Benefit|0|||
48619646|NCT02181738|156463621|FG002|Overall Study|Maximum Clinical Benefit|1|||
48619647|NCT02181738|156463622|FG003|Overall Study|Maximum Clinical Benefit|0|||
48619648|NCT02181738|156463619|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
48619649|NCT02181738|156463620|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
48619650|NCT02181738|156463621|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
48619651|NCT02181738|156463622|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48619652|NCT00888849|156463623|FG000|Overall Study|Death|4|||
48619653|NCT00888849|156463624|FG001|Overall Study|Death|7|||
48619654|NCT00888849|156463623|FG000|Overall Study|Lost to Follow-up|1|||
48619655|NCT00888849|156463624|FG001|Overall Study|Lost to Follow-up|2|||
48619656|NCT01181128|156463625|FG000|Overall Study|Withdrawal by Subject|2|||
48619657|NCT01181128|156463626|FG001|Overall Study|Withdrawal by Subject|2|||
48619658|NCT01181128|156463627|FG002|Overall Study|Withdrawal by Subject|0|||
48619659|NCT01181128|156463625|FG000|Overall Study|Death|1|||
48619660|NCT01181128|156463626|FG001|Overall Study|Death|0|||
48619661|NCT01181128|156463627|FG002|Overall Study|Death|0|||
48619662|NCT01181128|156463625|FG000|Overall Study|Physician Decision|2|||
48619663|NCT01181128|156463626|FG001|Overall Study|Physician Decision|0|||
48619664|NCT01181128|156463627|FG002|Overall Study|Physician Decision|0|||
48619665|NCT01181128|156463625|FG000|Overall Study|Adverse Event|0|||
48619666|NCT01181128|156463626|FG001|Overall Study|Adverse Event|2|||
48619667|NCT01181128|156463627|FG002|Overall Study|Adverse Event|0|||
48619668|NCT01181128|156463625|FG000|Overall Study|Other|1|||
48619669|NCT01181128|156463626|FG001|Overall Study|Other|1|||
48619670|NCT01181128|156463627|FG002|Overall Study|Other|1|||
48619671|NCT01827943|156463628|FG000|Overall Study|Protocol Violation|8|||
48619672|NCT01827943|156463628|FG000|Overall Study|Never treated because of an rapid progression|1|||
48619673|NCT01653262|156465222|FG000|Overall Study|Lack of Efficacy|1|||
48619674|NCT01653262|156465222|FG000|Overall Study|SAE, non-fatal|1|||
48619675|NCT01653262|156465222|FG000|Overall Study|AE, non-serious non-fatal|1|||
48619676|NCT01778985|156465224|FG000|Overall Study|Lost to Follow-up|1|||
48619677|NCT01778985|156465225|FG001|Overall Study|Lost to Follow-up|0|||
48619678|NCT01778985|156465224|FG000|Overall Study|Physician Decision|2|||
48619679|NCT01778985|156465225|FG001|Overall Study|Physician Decision|2|||
48619680|NCT01778985|156465224|FG000|Overall Study|Protocol Violation|4|||
48619681|NCT01778985|156465225|FG001|Overall Study|Protocol Violation|1|||
48619682|NCT00723944|156465226|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
48619683|NCT00723944|156465227|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
48619684|NCT00723944|156465226|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
48619685|NCT00723944|156465227|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
48619686|NCT00723944|156465226|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
48619687|NCT00723944|156465227|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
48619688|NCT00530075|156465229|FG000|Overall Study|Adverse Event|1|||
48619689|NCT00530075|156465229|FG000|Overall Study|Death|1|||
48619690|NCT00530075|156465229|FG000|Overall Study|Lack of Efficacy|3|||
48619691|NCT00530075|156465229|FG000|Overall Study|Protocol Violation|1|||
48619692|NCT00530075|156465229|FG000|Overall Study|Withdrawal by Subject|1|||
48619693|NCT00552058|156465232|FG000|Overall Study|Adverse Event|8|||
48619694|NCT00552058|156465233|FG001|Overall Study|Adverse Event|7|||
48619695|NCT00552058|156465232|FG000|Overall Study|Lack of Efficacy|1|||
48619696|NCT00552058|156465233|FG001|Overall Study|Lack of Efficacy|5|||
48619697|NCT00552058|156465232|FG000|Overall Study|Lost to Follow-up|1|||
48619698|NCT00552058|156465233|FG001|Overall Study|Lost to Follow-up|0|||
48619699|NCT00552058|156465232|FG000|Overall Study|Withdrawal by Subject|4|||
48619700|NCT00552058|156465233|FG001|Overall Study|Withdrawal by Subject|4|||
48619701|NCT00552058|156465232|FG000|Overall Study|Other: Protocol Violation|0|||
48619702|NCT00552058|156465233|FG001|Overall Study|Other: Protocol Violation|1|||
48619703|NCT00552058|156465232|FG000|Overall Study|Other: Non Compliance|1|||
48619704|NCT00552058|156465233|FG001|Overall Study|Other: Non Compliance|2|||
48619705|NCT00552058|156465232|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
48619706|NCT00552058|156465233|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
48619707|NCT00552058|156465232|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
48619708|NCT00552058|156465233|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
48572952|NCT02407236|156287517|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
48572953|NCT02407236|156287505|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
48572954|NCT02407236|156287506|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
48318689|NCT01307267|155368091|FG012|Overall Study|Death|0|||
48318690|NCT01307267|155368092|FG013|Overall Study|Death|0|||
48318691|NCT01307267|155368093|FG014|Overall Study|Death|0|||
48318692|NCT01307267|155368094|FG015|Overall Study|Death|0|||
48318693|NCT01307267|155368095|FG016|Overall Study|Death|1|||
48318694|NCT01307267|155368096|FG017|Overall Study|Death|1|||
48318695|NCT01307267|155368097|FG018|Overall Study|Death|2|||
48318696|NCT01307267|155368098|FG019|Overall Study|Death|8|||
48318697|NCT01307267|155368099|FG020|Overall Study|Death|1|||
48318698|NCT01307267|155368100|FG021|Overall Study|Death|2|||
48318699|NCT01307267|155368101|FG022|Overall Study|Death|2|||
48318700|NCT01307267|155368079|FG000|Overall Study|Lost to Follow-up|0|||
48318701|NCT01307267|155368080|FG001|Overall Study|Lost to Follow-up|0|||
48318702|NCT01307267|155368081|FG002|Overall Study|Lost to Follow-up|0|||
48318703|NCT01307267|155368082|FG003|Overall Study|Lost to Follow-up|0|||
48318704|NCT01307267|155368083|FG004|Overall Study|Lost to Follow-up|0|||
48318705|NCT01307267|155368084|FG005|Overall Study|Lost to Follow-up|7|||
48572955|NCT02407236|156287507|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
48572956|NCT02407236|156287508|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
48572957|NCT02407236|156287509|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
48572958|NCT02407236|156287510|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
48572959|NCT02407236|156287511|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
48572960|NCT02407236|156287512|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
48572961|NCT02407236|156287513|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
48572962|NCT02407236|156287514|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
48572963|NCT02407236|156287515|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
48572964|NCT02407236|156287516|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
48572965|NCT02407236|156287517|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
48572966|NCT02407236|156287505|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
48572967|NCT02407236|156287506|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
48572968|NCT02407236|156287507|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
48572969|NCT02407236|156287508|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
48572970|NCT02407236|156287509|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
48572971|NCT02407236|156287510|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
48572972|NCT02407236|156287511|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
48572973|NCT02407236|156287512|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
48572974|NCT02407236|156287513|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
48572975|NCT02407236|156287514|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
48572976|NCT02407236|156287515|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
48572977|NCT02407236|156287516|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
48572978|NCT02407236|156287517|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
48572979|NCT01515865|156288777|FG000|Part A (Open-label)|Other|3|||
48572980|NCT01515865|156288778|FG001|Part A (Open-label)|Other|0|||
48572981|NCT01515865|156288779|FG002|Part A (Open-label)|Other|0|||
48572982|NCT01515865|156288777|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
48572983|NCT01515865|156288778|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
48572984|NCT01515865|156288779|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
48572985|NCT01515865|156288777|FG000|Part B (Open-label)|Other|1|||
48572986|NCT01515865|156288778|FG001|Part B (Open-label)|Other|0|||
48572987|NCT01515865|156288779|FG002|Part B (Open-label)|Other|0|||
48572988|NCT03693612|156288780|FG000|Overall Study|Lost to Follow-up|0|||
48572989|NCT03693612|156288781|FG001|Overall Study|Lost to Follow-up|0|||
48572990|NCT03693612|156288782|FG002|Overall Study|Lost to Follow-up|0|||
48572991|NCT03693612|156288783|FG003|Overall Study|Lost to Follow-up|0|||
48572992|NCT03693612|156288784|FG004|Overall Study|Lost to Follow-up|1|||
48572993|NCT03693612|156288785|FG005|Overall Study|Lost to Follow-up|0|||
48572994|NCT03693612|156288786|FG006|Overall Study|Lost to Follow-up|0|||
48572995|NCT03693612|156288780|FG000|Overall Study|Withdrawal by Subject|0|||
48572996|NCT03693612|156288781|FG001|Overall Study|Withdrawal by Subject|0|||
48572997|NCT03693612|156288782|FG002|Overall Study|Withdrawal by Subject|1|||
48619709|NCT00552058|156465232|FG000|Overall Study|Other: Positive Stool Result|0|||
48572998|NCT03693612|156288783|FG003|Overall Study|Withdrawal by Subject|0|||
48572999|NCT03693612|156288784|FG004|Overall Study|Withdrawal by Subject|2|||
48573000|NCT03693612|156288785|FG005|Overall Study|Withdrawal by Subject|0|||
48318706|NCT01307267|155368085|FG006|Overall Study|Lost to Follow-up|0|||
48318707|NCT01307267|155368086|FG007|Overall Study|Lost to Follow-up|0|||
48318708|NCT01307267|155368087|FG008|Overall Study|Lost to Follow-up|1|||
48318709|NCT01307267|155368088|FG009|Overall Study|Lost to Follow-up|2|||
48318710|NCT01307267|155368089|FG010|Overall Study|Lost to Follow-up|1|||
48318711|NCT01307267|155368090|FG011|Overall Study|Lost to Follow-up|0|||
48573001|NCT03693612|156288786|FG006|Overall Study|Withdrawal by Subject|0|||
48573002|NCT03693612|156288780|FG000|Overall Study|Study Terminated by Sponsor|0|||
48573003|NCT03693612|156288781|FG001|Overall Study|Study Terminated by Sponsor|1|||
48573004|NCT03693612|156288782|FG002|Overall Study|Study Terminated by Sponsor|0|||
48573005|NCT03693612|156288783|FG003|Overall Study|Study Terminated by Sponsor|0|||
48573006|NCT03693612|156288784|FG004|Overall Study|Study Terminated by Sponsor|3|||
48573007|NCT03693612|156288785|FG005|Overall Study|Study Terminated by Sponsor|0|||
48573008|NCT03693612|156288786|FG006|Overall Study|Study Terminated by Sponsor|0|||
48573009|NCT02366637|156288787|FG000|First Intervention Period|Adverse Event|0|||
48573010|NCT02366637|156288788|FG001|First Intervention Period|Adverse Event|1|||
48573011|NCT02366637|156288787|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
48573012|NCT02366637|156288788|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
48573013|NCT02366637|156288787|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
48573014|NCT02366637|156288788|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
48573015|NCT04871711|156288794|FG000|Overall Study|Withdrawal by Subject|11|||
48573016|NCT04871711|156288795|FG001|Overall Study|Withdrawal by Subject|5|||
48573017|NCT04871711|156288794|FG000|Overall Study|Lack of Efficacy|5|||
48573018|NCT04871711|156288795|FG001|Overall Study|Lack of Efficacy|7|||
48573019|NCT04871711|156288794|FG000|Overall Study|Adverse Event|2|||
48573020|NCT04871711|156288795|FG001|Overall Study|Adverse Event|6|||
48573021|NCT04871711|156288794|FG000|Overall Study|Various reasons|2|||
48573022|NCT04871711|156288795|FG001|Overall Study|Various reasons|1|||
48573023|NCT04871711|156288794|FG000|Overall Study|Lost to Follow-up|0|||
48573024|NCT04871711|156288795|FG001|Overall Study|Lost to Follow-up|2|||
48573025|NCT03503370|156288796|FG000|Overall Study|Death|3|||
48573026|NCT03503370|156288797|FG001|Overall Study|Death|1|||
48573027|NCT00568061|156288802|FG000|Overall Study|Inclusion / exclusion criteria|5|||
48573028|NCT00568061|156288803|FG001|Overall Study|Inclusion / exclusion criteria|1|||
48573029|NCT00568061|156288802|FG000|Overall Study|Adverse Event|0|||
48573030|NCT00568061|156288803|FG001|Overall Study|Adverse Event|1|||
48318712|NCT01307267|155368091|FG012|Overall Study|Lost to Follow-up|0|||
48318713|NCT01307267|155368092|FG013|Overall Study|Lost to Follow-up|0|||
48318714|NCT01307267|155368093|FG014|Overall Study|Lost to Follow-up|0|||
48318715|NCT01307267|155368094|FG015|Overall Study|Lost to Follow-up|0|||
48318716|NCT01307267|155368095|FG016|Overall Study|Lost to Follow-up|0|||
48318717|NCT01307267|155368096|FG017|Overall Study|Lost to Follow-up|0|||
48318718|NCT01307267|155368097|FG018|Overall Study|Lost to Follow-up|0|||
48318719|NCT01307267|155368098|FG019|Overall Study|Lost to Follow-up|2|||
48318720|NCT01307267|155368099|FG020|Overall Study|Lost to Follow-up|0|||
48318721|NCT01307267|155368100|FG021|Overall Study|Lost to Follow-up|0|||
48318722|NCT01307267|155368101|FG022|Overall Study|Lost to Follow-up|0|||
48318723|NCT01307267|155368079|FG000|Overall Study|Withdrawal by Subject|0|||
48318724|NCT01307267|155368080|FG001|Overall Study|Withdrawal by Subject|0|||
48318725|NCT01307267|155368081|FG002|Overall Study|Withdrawal by Subject|0|||
48318726|NCT01307267|155368082|FG003|Overall Study|Withdrawal by Subject|0|||
48318727|NCT01307267|155368083|FG004|Overall Study|Withdrawal by Subject|0|||
48318728|NCT01307267|155368084|FG005|Overall Study|Withdrawal by Subject|1|||
48318729|NCT01307267|155368085|FG006|Overall Study|Withdrawal by Subject|0|||
48318730|NCT01307267|155368086|FG007|Overall Study|Withdrawal by Subject|1|||
48318731|NCT01307267|155368087|FG008|Overall Study|Withdrawal by Subject|5|||
48318732|NCT01307267|155368088|FG009|Overall Study|Withdrawal by Subject|1|||
48573031|NCT00955955|156288804|FG000|Overall Study|Lost to Follow-up|2|||
48573032|NCT00955955|156288805|FG001|Overall Study|Lost to Follow-up|0|||
48573033|NCT00955955|156288806|FG002|Overall Study|Lost to Follow-up|0|||
48573034|NCT01972438|156288807|FG000|Baseline-Month 3 Crossover Period|Death|1|||
48573035|NCT01972438|156288808|FG001|Baseline-Month 3 Crossover Period|Death|0|||
48573036|NCT01972438|156288807|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
48573037|NCT01972438|156288808|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
48573038|NCT01972438|156288807|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
48573039|NCT01972438|156288808|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
48318733|NCT01307267|155368089|FG010|Overall Study|Withdrawal by Subject|1|||
48318734|NCT01307267|155368090|FG011|Overall Study|Withdrawal by Subject|1|||
48318735|NCT01307267|155368091|FG012|Overall Study|Withdrawal by Subject|0|||
48318736|NCT01307267|155368092|FG013|Overall Study|Withdrawal by Subject|0|||
48318737|NCT01307267|155368093|FG014|Overall Study|Withdrawal by Subject|0|||
48318738|NCT01307267|155368094|FG015|Overall Study|Withdrawal by Subject|0|||
48573040|NCT01972438|156288807|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
48573041|NCT01972438|156288808|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
48573042|NCT01972438|156288807|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
48573043|NCT01972438|156288808|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
48573044|NCT01972438|156288807|FG000|Months 6-12 Study Period|Death|1|||
48573045|NCT01972438|156288808|FG001|Months 6-12 Study Period|Death|0|||
48573046|NCT01972438|156288807|FG000|Months 6-12 Study Period|Early Study Closure|2|||
48318739|NCT01307267|155368095|FG016|Overall Study|Withdrawal by Subject|0|||
48318740|NCT01307267|155368096|FG017|Overall Study|Withdrawal by Subject|0|||
48318741|NCT01307267|155368097|FG018|Overall Study|Withdrawal by Subject|0|||
48318742|NCT01307267|155368098|FG019|Overall Study|Withdrawal by Subject|3|||
48573047|NCT01972438|156288808|FG001|Months 6-12 Study Period|Early Study Closure|2|||
48573048|NCT01972438|156288807|FG000|Post Month 12 Study Period|Early Study Closure|3|||
48573049|NCT01972438|156288808|FG001|Post Month 12 Study Period|Early Study Closure|4|||
48573050|NCT03277105|156288809|FG000|Overall Study|Death|129|||
48573051|NCT03277105|156288810|FG001|Overall Study|Death|124|||
48573052|NCT03277105|156288809|FG000|Overall Study|Lost to Follow-up|2|||
48573053|NCT03277105|156288810|FG001|Overall Study|Lost to Follow-up|4|||
48573054|NCT03277105|156288809|FG000|Overall Study|Withdrawal by Subject|10|||
48573055|NCT03277105|156288810|FG001|Overall Study|Withdrawal by Subject|10|||
48573056|NCT03277105|156288809|FG000|Overall Study|Other|118|||
48573057|NCT03277105|156288810|FG001|Overall Study|Other|125|||
48573058|NCT03348930|156288811|FG000|Washout (1 Week)|Lost to Follow-up|1|||
48573059|NCT03348930|156288812|FG001|Washout (1 Week)|Lost to Follow-up|1|||
48573060|NCT01053663|156288813|FG000|Overall Study|Death|2|||
48573061|NCT01053663|156288813|FG000|Overall Study|Lost to Follow-up|1|||
48573062|NCT01053663|156288813|FG000|Overall Study|Poor IV Access|1|||
48573063|NCT01053663|156288813|FG000|Overall Study|Transferred to Another Hospital|1|||
48573064|NCT01053663|156288813|FG000|Overall Study|Negative Influenza Diagnosis|1|||
48573065|NCT00708214|156288814|FG000|Overall Study|Other Adverse Event|3|||
48573066|NCT00708214|156288815|FG001|Overall Study|Other Adverse Event|6|||
48573067|NCT00708214|156288816|FG002|Overall Study|Other Adverse Event|2|||
48573068|NCT00708214|156288814|FG000|Overall Study|Other|0|||
48573069|NCT00708214|156288815|FG001|Overall Study|Other|1|||
48573070|NCT00708214|156288816|FG002|Overall Study|Other|1|||
48573071|NCT00708214|156288814|FG000|Overall Study|Progressive Disease|4|||
48573072|NCT00708214|156288815|FG001|Overall Study|Progressive Disease|6|||
48573073|NCT00708214|156288816|FG002|Overall Study|Progressive Disease|5|||
48573074|NCT00812981|156288817|FG000|Overall Study|Other|0|||
48573075|NCT00812981|156288818|FG001|Overall Study|Other|1|||
48573076|NCT03533114|156288819|FG000|Overall|Adverse Event|16|||
48573077|NCT03533114|156288820|FG001|Overall|Adverse Event|11|||
48573078|NCT03533114|156288819|FG000|Overall|Consent Withdrawal by Participant|7|||
48573079|NCT03533114|156288820|FG001|Overall|Consent Withdrawal by Participant|6|||
48573080|NCT03533114|156288819|FG000|Overall|Lack of Efficacy|5|||
48573081|NCT03533114|156288820|FG001|Overall|Lack of Efficacy|3|||
48573082|NCT03533114|156288819|FG000|Overall|Lost to Follow-up|1|||
48573083|NCT03533114|156288820|FG001|Overall|Lost to Follow-up|1|||
48573084|NCT03533114|156288819|FG000|Overall|Physician Decision|0|||
48573085|NCT03533114|156288820|FG001|Overall|Physician Decision|2|||
48573086|NCT03533114|156288819|FG000|Overall|Protocol deviation|1|||
48573087|NCT03533114|156288820|FG001|Overall|Protocol deviation|1|||
48573088|NCT03533114|156288819|FG000|Overall|Failure to meet randomization criteria|1|||
48573089|NCT03533114|156288820|FG001|Overall|Failure to meet randomization criteria|2|||
48573090|NCT03533114|156288819|FG000|Overall|Non-Compliance with study drug|0|||
48573091|NCT03533114|156288820|FG001|Overall|Non-Compliance with study drug|1|||
48573092|NCT03533114|156288819|FG000|Overall|Other|0|||
48573093|NCT03533114|156288820|FG001|Overall|Other|1|||
48573094|NCT03533114|156288819|FG000|Open Label Titration and Optimization|Adverse Event|11|||
48573095|NCT03533114|156288820|FG001|Open Label Titration and Optimization|Adverse Event|8|||
48619710|NCT00552058|156465233|FG001|Overall Study|Other: Positive Stool Result|1|||
48318743|NCT01307267|155368099|FG020|Overall Study|Withdrawal by Subject|0|||
48318744|NCT01307267|155368100|FG021|Overall Study|Withdrawal by Subject|0|||
48318745|NCT01307267|155368101|FG022|Overall Study|Withdrawal by Subject|0|||
48318746|NCT01307267|155368079|FG000|Overall Study|Other|0|||
48573096|NCT03533114|156288819|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
48573097|NCT03533114|156288820|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
48573098|NCT03533114|156288819|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
48573099|NCT03533114|156288820|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
48573100|NCT03533114|156288819|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
48573101|NCT03533114|156288820|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
48573102|NCT03533114|156288819|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
48573103|NCT03533114|156288820|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
48573104|NCT03533114|156288819|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
48619711|NCT00552058|156465232|FG000|Overall Study|Other: Randomized in error|0|||
48318747|NCT01307267|155368080|FG001|Overall Study|Other|0|||
48573105|NCT03533114|156288820|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
48573106|NCT03533114|156288819|FG000|Stable Dose|Adverse Event|0|||
48573107|NCT03533114|156288820|FG001|Stable Dose|Adverse Event|2|||
48573108|NCT03533114|156288819|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
48573109|NCT03533114|156288820|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
48573110|NCT03533114|156288819|FG000|Stable Dose|Lack of Efficacy|1|||
48573111|NCT03533114|156288820|FG001|Stable Dose|Lack of Efficacy|0|||
48573112|NCT03533114|156288819|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
48573113|NCT03533114|156288820|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
48619712|NCT00552058|156465233|FG001|Overall Study|Other: Randomized in error|1|||
48619713|NCT00552058|156465232|FG000|Overall Study|Other: Sponsors Decision|0|||
48619714|NCT00552058|156465233|FG001|Overall Study|Other: Sponsors Decision|1|||
48619715|NCT00552058|156465232|FG000|Overall Study|Other: Early Roll Over|1|||
48619716|NCT00552058|156465233|FG001|Overall Study|Other: Early Roll Over|0|||
48619717|NCT03439514|156465234|FG000|Double-Blind Treatment Period|Other|4|||
48619718|NCT03439514|156465235|FG001|Double-Blind Treatment Period|Other|1|||
48619719|NCT03439514|156465234|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
48619720|NCT03439514|156465235|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48619721|NCT03439514|156465234|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
48619722|NCT03439514|156465235|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
48619723|NCT03439514|156465234|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
48619724|NCT03439514|156465235|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
48619725|NCT03439514|156465234|FG000|Double-Blind Treatment Period|Death|1|||
48619726|NCT03439514|156465235|FG001|Double-Blind Treatment Period|Death|2|||
48619727|NCT03520569|156465239|FG000|Overall Study|Withdrawal by Subject|1|||
48619728|NCT02489773|156465240|FG000|Overall Study|Lost to Follow-up|4|||
48619729|NCT02489773|156465241|FG001|Overall Study|Lost to Follow-up|1|||
48619730|NCT02489773|156465240|FG000|Overall Study|Physician Decision|1|||
48619731|NCT02489773|156465241|FG001|Overall Study|Physician Decision|0|||
48619732|NCT02489773|156465240|FG000|Overall Study|Withdrawal by Subject|1|||
48619733|NCT02489773|156465241|FG001|Overall Study|Withdrawal by Subject|0|||
48619734|NCT02489773|156465240|FG000|Overall Study|Leave the country or the state|1|||
48619735|NCT02489773|156465241|FG001|Overall Study|Leave the country or the state|1|||
48619736|NCT02383173|156465244|FG000|Overall Study|Palliative Care Team withdrew|0|||
48619737|NCT02383173|156465245|FG001|Overall Study|Palliative Care Team withdrew|2|||
48619738|NCT03073109|156465246|FG000|Overall Study|Adverse Event|0|||
48619739|NCT03073109|156465247|FG001|Overall Study|Adverse Event|1|||
48619740|NCT03073109|156465246|FG000|Overall Study|Other|2|||
48619741|NCT03073109|156465247|FG001|Overall Study|Other|0|||
48619742|NCT03073109|156465246|FG000|Overall Study|Lost to Follow-up|8|||
48619743|NCT03073109|156465247|FG001|Overall Study|Lost to Follow-up|1|||
48619744|NCT04621760|156465248|FG000|Overall Study|Lost to Follow-up|2|||
48619745|NCT04621760|156465249|FG001|Overall Study|Lost to Follow-up|4|||
48619746|NCT04621760|156465248|FG000|Overall Study|Withdrawal by Subject|1|||
48619747|NCT04621760|156465249|FG001|Overall Study|Withdrawal by Subject|0|||
48619748|NCT00669331|156465250|FG000|Randomisation to First Dose|Adverse Event|1|||
48619749|NCT00669331|156465251|FG001|Randomisation to First Dose|Adverse Event|0|||
48619750|NCT00669331|156465250|FG000|Randomisation to First Dose|Protocol Violation|1|||
48619751|NCT00669331|156465251|FG001|Randomisation to First Dose|Protocol Violation|0|||
48619752|NCT00669331|156465250|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
48619753|NCT00669331|156465251|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
48619754|NCT00669331|156465250|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
48619755|NCT00669331|156465251|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
48619756|NCT00669331|156465250|FG000|Randomisation to First Dose|Death|1|||
48619757|NCT00669331|156465251|FG001|Randomisation to First Dose|Death|0|||
48619758|NCT00669331|156465250|FG000|Randomisation to First Dose|Sponsor decision|0|||
48619759|NCT00669331|156465251|FG001|Randomisation to First Dose|Sponsor decision|1|||
48619760|NCT00669331|156465250|FG000|Randomisation to First Dose|Randomised in error|3|||
48619761|NCT00669331|156465251|FG001|Randomisation to First Dose|Randomised in error|10|||
48619762|NCT00669331|156465250|FG000|Blinded Treatment Period|Adverse Event|16|||
48619763|NCT00669331|156465251|FG001|Blinded Treatment Period|Adverse Event|10|||
48619764|NCT00669331|156465250|FG000|Blinded Treatment Period|Protocol Violation|1|||
48619765|NCT00669331|156465251|FG001|Blinded Treatment Period|Protocol Violation|1|||
48619766|NCT00669331|156465250|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
48619767|NCT00669331|156465251|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
48573114|NCT03533114|156288819|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
48573115|NCT03533114|156288820|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
48573116|NCT03533114|156288819|FG000|Open-Label Safety Extension|Adverse Event|3|||
48573117|NCT03533114|156288820|FG001|Open-Label Safety Extension|Adverse Event|0|||
48573118|NCT03533114|156288819|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
48573119|NCT03533114|156288820|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
48573120|NCT03533114|156288819|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
48573121|NCT03533114|156288820|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
48573122|NCT03533114|156288819|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
48573123|NCT03533114|156288820|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
48573124|NCT03533114|156288819|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
48573125|NCT03533114|156288820|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
48573126|NCT03852264|156288821|FG000|Third Research Visit|Lost to Follow-up|1|||
48573127|NCT03852264|156288822|FG001|Third Research Visit|Lost to Follow-up|0|||
48619768|NCT00669331|156465250|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
48619769|NCT00669331|156465251|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
48619770|NCT00669331|156465250|FG000|Blinded Treatment Period|Death|0|||
48619771|NCT00669331|156465251|FG001|Blinded Treatment Period|Death|2|||
48619772|NCT00669331|156465250|FG000|Blinded Treatment Period|Physician Decision|3|||
48619773|NCT00669331|156465251|FG001|Blinded Treatment Period|Physician Decision|3|||
48619774|NCT00669331|156465250|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
48619775|NCT00669331|156465251|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
48619776|NCT01531153|156465252|FG000|Overall Study|Withdrawal by Subject|10|||
48619777|NCT01531153|156465253|FG001|Overall Study|Withdrawal by Subject|9|||
48619778|NCT01531153|156465254|FG002|Overall Study|Withdrawal by Subject|15|||
48619779|NCT01239745|156465257|FG000|Overall Study|Study terminated by sponsor|45|||
48318748|NCT01307267|155368081|FG002|Overall Study|Other|0|||
48318749|NCT01307267|155368082|FG003|Overall Study|Other|0|||
48619780|NCT01239745|156465257|FG000|Overall Study|Adverse Event|1|||
48619781|NCT03600428|156465258|FG000|Overall Study|Not eligible|0|||
48619782|NCT03600428|156465259|FG001|Overall Study|Not eligible|1|||
48619783|NCT03600428|156465258|FG000|Overall Study|Lost to Follow-up|5|||
48619784|NCT03600428|156465259|FG001|Overall Study|Lost to Follow-up|4|||
48619785|NCT00363467|156465260|FG000|Overall Study|Physician Decision|1|||
48619786|NCT00245570|156465261|FG000|Washout Between Periods III and IV|Adverse Event|0|||
48619787|NCT00245570|156465262|FG001|Washout Between Periods III and IV|Adverse Event|1|||
48619788|NCT00245570|156465263|FG002|Washout Between Periods III and IV|Adverse Event|0|||
48619789|NCT00245570|156465264|FG003|Washout Between Periods III and IV|Adverse Event|0|||
48619790|NCT00245570|156465265|FG004|Washout Between Periods III and IV|Adverse Event|0|||
48619791|NCT00245570|156465266|FG005|Washout Between Periods III and IV|Adverse Event|0|||
48619792|NCT00397930|156465287|FG000|Overall Study|Personal reasons|14|||
48619793|NCT00397930|156465288|FG001|Overall Study|Personal reasons|8|||
48619794|NCT00397930|156465287|FG000|Overall Study|Other medical|9|||
48619795|NCT00397930|156465288|FG001|Overall Study|Other medical|4|||
48619796|NCT00397930|156465287|FG000|Overall Study|Unknown reasons|9|||
48619797|NCT00397930|156465288|FG001|Overall Study|Unknown reasons|14|||
48619798|NCT00397930|156465287|FG000|Overall Study|Noncompliant|3|||
48619799|NCT00397930|156465288|FG001|Overall Study|Noncompliant|2|||
48619800|NCT00397930|156465287|FG000|Overall Study|Too time-consuming|2|||
48619801|NCT00397930|156465288|FG001|Overall Study|Too time-consuming|9|||
48619802|NCT00397930|156465287|FG000|Overall Study|Started own yoga program|1|||
48619803|NCT00397930|156465288|FG001|Overall Study|Started own yoga program|1|||
48619804|NCT00397930|156465287|FG000|Overall Study|Did not want to be in control group|0|||
48619805|NCT00397930|156465288|FG001|Overall Study|Did not want to be in control group|1|||
48619806|NCT00397930|156465287|FG000|Overall Study|Withdrawal by Subject|0|||
48619807|NCT00397930|156465288|FG001|Overall Study|Withdrawal by Subject|8|||
48619808|NCT00397930|156465287|FG000|Overall Study|Missing data|0|||
48619809|NCT00397930|156465288|FG001|Overall Study|Missing data|4|||
48619810|NCT00710554|156465296|FG000|Overall Study|Adverse Event|24|||
48619811|NCT00710554|156465297|FG001|Overall Study|Adverse Event|7|||
48619812|NCT00710554|156465296|FG000|Overall Study|Withdrawal by Subject|7|||
48619813|NCT00710554|156465297|FG001|Overall Study|Withdrawal by Subject|3|||
48619814|NCT00710554|156465296|FG000|Overall Study|Lost to Follow-up|7|||
48619815|NCT00710554|156465297|FG001|Overall Study|Lost to Follow-up|1|||
48619816|NCT00710554|156465296|FG000|Overall Study|Lack of Efficacy|11|||
48619817|NCT00710554|156465297|FG001|Overall Study|Lack of Efficacy|12|||
48619818|NCT00710554|156465296|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
48318750|NCT01307267|155368083|FG004|Overall Study|Other|0|||
48619819|NCT00710554|156465297|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
48619820|NCT02056288|156465298|FG000|In-Hospital Data|Surgery cancelled|1|||
48619821|NCT02056288|156465299|FG001|In-Hospital Data|Surgery cancelled|0|||
48619822|NCT02056288|156465298|FG000|In-Hospital Data|Protocol Violation|3|||
48619823|NCT02056288|156465299|FG001|In-Hospital Data|Protocol Violation|0|||
48619824|NCT02056288|156465298|FG000|In-Hospital Data|Physician Decision|1|||
48619825|NCT02056288|156465299|FG001|In-Hospital Data|Physician Decision|0|||
48619826|NCT02056288|156465298|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
48619827|NCT02056288|156465299|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
48318751|NCT01307267|155368084|FG005|Overall Study|Other|7|||
48619828|NCT01060111|156465302|FG000|Overall Study|Adverse Event|9|||
48619829|NCT01060111|156465303|FG001|Overall Study|Adverse Event|5|||
48619830|NCT01060111|156465304|FG002|Overall Study|Adverse Event|18|||
48619831|NCT01060111|156465302|FG000|Overall Study|Lack of Efficacy|2|||
48619832|NCT01060111|156465303|FG001|Overall Study|Lack of Efficacy|1|||
48573128|NCT03169881|156288823|FG000|Overall Study|Incomplete Follow-up|10|||
48573129|NCT03169881|156288824|FG001|Overall Study|Incomplete Follow-up|15|||
48573130|NCT03169881|156288823|FG000|Overall Study|Lost to Follow-up|18|||
48573131|NCT03169881|156288824|FG001|Overall Study|Lost to Follow-up|20|||
48573132|NCT03169881|156288823|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
48573133|NCT03169881|156288824|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
48573134|NCT02199795|156288825|FG000|Overall Study|no longer met inclusion criteria|1|||
48573135|NCT02199795|156288826|FG001|Overall Study|no longer met inclusion criteria|0|||
48573136|NCT02199795|156288825|FG000|Overall Study|withdrew due to shoulder pain|1|||
48573137|NCT02199795|156288826|FG001|Overall Study|withdrew due to shoulder pain|0|||
48573138|NCT01862250|156288827|FG000|Overall Study|Adverse Event|4|||
48573139|NCT06303167|156288831|FG000|Overall Study|Ineligible|1|||
48573140|NCT06303167|156288831|FG000|Overall Study|Never start protocol therapy|2|||
48573141|NCT06303167|156288831|FG000|Overall Study|Disease progression|16|||
48573142|NCT01482065|156288832|FG000|Overall Study|Withdrawal by Subject|0|||
48573143|NCT01482065|156288833|FG001|Overall Study|Withdrawal by Subject|1|||
48573144|NCT01942486|156288834|FG000|Overall Study|Lost to Follow-up|27|||
48573145|NCT02278939|156288835|FG000|Overall Study|lack of time|1|||
48573146|NCT02278939|156288836|FG001|Overall Study|lack of time|0|||
48573147|NCT02278939|156288835|FG000|Overall Study|Lost to Follow-up|1|||
48573148|NCT02278939|156288836|FG001|Overall Study|Lost to Follow-up|1|||
48573149|NCT02278939|156288835|FG000|Overall Study|death in family|1|||
48573150|NCT02278939|156288836|FG001|Overall Study|death in family|0|||
48573151|NCT02278939|156288835|FG000|Overall Study|family emergency unable to commit|2|||
48573152|NCT02278939|156288836|FG001|Overall Study|family emergency unable to commit|0|||
48573153|NCT02387957|156288839|FG000|Overall Study|The study was discontinued|21|||
48573154|NCT02387957|156288840|FG001|Overall Study|The study was discontinued|21|||
48573155|NCT02387957|156288841|FG002|Overall Study|The study was discontinued|20|||
48573156|NCT02887248|156288842|FG000|Overall Study|Withdrawal by Subject|1|||
48573157|NCT02887248|156288842|FG000|Overall Study|Adverse Event|1|||
48573158|NCT02887248|156288842|FG000|Overall Study|Progressive Disease|1|||
48573159|NCT01508130|156288843|FG000|Overall Study|Adverse Event|81|||
48573160|NCT01508130|156288844|FG001|Overall Study|Adverse Event|28|||
48573161|NCT01508130|156288843|FG000|Overall Study|Death|3|||
48573162|NCT01508130|156288844|FG001|Overall Study|Death|1|||
48318752|NCT01307267|155368085|FG006|Overall Study|Other|0|||
48318753|NCT01307267|155368086|FG007|Overall Study|Other|1|||
48318754|NCT01307267|155368087|FG008|Overall Study|Other|3|||
48318755|NCT01307267|155368088|FG009|Overall Study|Other|0|||
48573163|NCT01508130|156288843|FG000|Overall Study|Protocol Violation|2|||
48573164|NCT01508130|156288844|FG001|Overall Study|Protocol Violation|0|||
48573165|NCT01508130|156288843|FG000|Overall Study|Lost to Follow-up|25|||
48573166|NCT01508130|156288844|FG001|Overall Study|Lost to Follow-up|2|||
48573167|NCT01508130|156288843|FG000|Overall Study|Withdrawal by Subject|3|||
48573168|NCT01508130|156288844|FG001|Overall Study|Withdrawal by Subject|3|||
48573169|NCT01508130|156288843|FG000|Overall Study|Subject's substantial non-compliance|25|||
48573170|NCT01508130|156288844|FG001|Overall Study|Subject's substantial non-compliance|9|||
48573171|NCT01508130|156288843|FG000|Overall Study|Insufficient therapeutic response|74|||
48573172|NCT01508130|156288844|FG001|Overall Study|Insufficient therapeutic response|23|||
48573173|NCT01508130|156288843|FG000|Overall Study|Administrative|14|||
48619833|NCT01060111|156465304|FG002|Overall Study|Lack of Efficacy|0|||
48619834|NCT01060111|156465302|FG000|Overall Study|Inappropriate participant|5|||
48573174|NCT01508130|156288844|FG001|Overall Study|Administrative|3|||
48318756|NCT01307267|155368089|FG010|Overall Study|Other|1|||
48573175|NCT02294396|156288847|FG000|Overall Study|Adverse Event|26|||
48573176|NCT02294396|156288848|FG001|Overall Study|Adverse Event|25|||
48573177|NCT02294396|156288849|FG002|Overall Study|Adverse Event|21|||
48573178|NCT02294396|156288850|FG003|Overall Study|Adverse Event|24|||
48573179|NCT02294396|156288847|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
48573180|NCT02294396|156288848|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
48573181|NCT02294396|156288849|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
48573182|NCT02294396|156288850|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
48619835|NCT01060111|156465303|FG001|Overall Study|Inappropriate participant|4|||
48619836|NCT01060111|156465304|FG002|Overall Study|Inappropriate participant|5|||
48619837|NCT01060111|156465302|FG000|Overall Study|Participants' evasion for hospital visit|0|||
48619838|NCT01060111|156465303|FG001|Overall Study|Participants' evasion for hospital visit|3|||
48619839|NCT01060111|156465304|FG002|Overall Study|Participants' evasion for hospital visit|2|||
48619840|NCT01060111|156465302|FG000|Overall Study|Participants' non-cooperation|8|||
48318757|NCT01307267|155368090|FG011|Overall Study|Other|1|||
48318758|NCT01307267|155368091|FG012|Overall Study|Other|1|||
48619841|NCT01060111|156465303|FG001|Overall Study|Participants' non-cooperation|6|||
48619842|NCT01060111|156465304|FG002|Overall Study|Participants' non-cooperation|6|||
48619843|NCT01060111|156465302|FG000|Overall Study|Adverse event and insufficient effect|0|||
48619844|NCT01060111|156465303|FG001|Overall Study|Adverse event and insufficient effect|1|||
48619845|NCT01060111|156465304|FG002|Overall Study|Adverse event and insufficient effect|0|||
48619846|NCT01060111|156465302|FG000|Overall Study|Participants' non-cooperation|1|||
48318759|NCT01307267|155368092|FG013|Overall Study|Other|0|||
48318760|NCT01307267|155368093|FG014|Overall Study|Other|2|||
48318761|NCT01307267|155368094|FG015|Overall Study|Other|1|||
48318762|NCT01307267|155368095|FG016|Overall Study|Other|0|||
48318763|NCT01307267|155368096|FG017|Overall Study|Other|0|||
48318764|NCT01307267|155368097|FG018|Overall Study|Other|0|||
48318765|NCT01307267|155368098|FG019|Overall Study|Other|19|||
48318766|NCT01307267|155368099|FG020|Overall Study|Other|2|||
48318767|NCT01307267|155368100|FG021|Overall Study|Other|3|||
48318768|NCT01307267|155368101|FG022|Overall Study|Other|2|||
48318769|NCT00350792|155368102|FG000|Overall Study|Adverse Event|11|||
48318770|NCT00350792|155368102|FG000|Overall Study|Death from Study Disease|1|||
48318771|NCT00350792|155368102|FG000|Overall Study|Death from Study Drug Toxicity|1|||
48318772|NCT00350792|155368102|FG000|Overall Study|Death Not Study Drug Related|2|||
48318773|NCT00350792|155368102|FG000|Overall Study|Protocol Violation|1|||
48318774|NCT00350792|155368102|FG000|Overall Study|Withdrawal by Subject|4|||
48318775|NCT00350792|155368102|FG000|Overall Study|Physician Decision|2|||
48318776|NCT00350792|155368102|FG000|Overall Study|Lack of Efficacy|11|||
48318777|NCT01595061|155368107|FG000|Overall Study|Never Treated|3|||
48318778|NCT01595061|155368107|FG000|Overall Study|Inadequate Pathology|1|||
48318779|NCT02740231|155368110|FG000|Overall Study|Withdrawal by Subject|1|||
48318780|NCT02740231|155368111|FG001|Overall Study|Withdrawal by Subject|1|||
48318781|NCT02740231|155368112|FG002|Overall Study|Withdrawal by Subject|1|||
48318782|NCT02740231|155368113|FG003|Overall Study|Withdrawal by Subject|0|||
48318783|NCT02740231|155368110|FG000|Overall Study|Lack of Efficacy|0|||
48318784|NCT02740231|155368111|FG001|Overall Study|Lack of Efficacy|1|||
48318785|NCT02740231|155368112|FG002|Overall Study|Lack of Efficacy|0|||
48318786|NCT02740231|155368113|FG003|Overall Study|Lack of Efficacy|4|||
48573183|NCT02294396|156288847|FG000|Overall Study|Withdrawal by Subject|8|||
48619847|NCT01060111|156465303|FG001|Overall Study|Participants' non-cooperation|0|||
48619848|NCT01060111|156465304|FG002|Overall Study|Participants' non-cooperation|0|||
48318787|NCT02740231|155368110|FG000|Overall Study|Lost to Follow-up|1|||
48318788|NCT02740231|155368111|FG001|Overall Study|Lost to Follow-up|3|||
48573184|NCT02294396|156288848|FG001|Overall Study|Withdrawal by Subject|6|||
48573185|NCT02294396|156288849|FG002|Overall Study|Withdrawal by Subject|6|||
48573186|NCT02294396|156288850|FG003|Overall Study|Withdrawal by Subject|8|||
48573187|NCT02294396|156288847|FG000|Overall Study|Lost to Follow-up|0|||
48573188|NCT02294396|156288848|FG001|Overall Study|Lost to Follow-up|0|||
48573189|NCT02294396|156288849|FG002|Overall Study|Lost to Follow-up|1|||
48573190|NCT02294396|156288850|FG003|Overall Study|Lost to Follow-up|1|||
48573191|NCT02294396|156288847|FG000|Overall Study|Protocol Deviation|3|||
48573192|NCT02294396|156288848|FG001|Overall Study|Protocol Deviation|2|||
48573193|NCT02294396|156288849|FG002|Overall Study|Protocol Deviation|2|||
48573194|NCT02294396|156288850|FG003|Overall Study|Protocol Deviation|1|||
48573195|NCT02294396|156288847|FG000|Overall Study|Miscellaneous|2|||
48573196|NCT02294396|156288848|FG001|Overall Study|Miscellaneous|0|||
48573197|NCT02294396|156288849|FG002|Overall Study|Miscellaneous|5|||
48619849|NCT01060111|156465302|FG000|Overall Study|Other|2|||
48619850|NCT01060111|156465303|FG001|Overall Study|Other|3|||
48318789|NCT02740231|155368112|FG002|Overall Study|Lost to Follow-up|0|||
48318790|NCT02740231|155368113|FG003|Overall Study|Lost to Follow-up|3|||
48318791|NCT02740231|155368110|FG000|Overall Study|Adverse Event|0|||
48318792|NCT02740231|155368111|FG001|Overall Study|Adverse Event|1|||
48318793|NCT02740231|155368112|FG002|Overall Study|Adverse Event|0|||
48318794|NCT02740231|155368113|FG003|Overall Study|Adverse Event|1|||
48318795|NCT00243503|155368114|FG000|Overall Study|Adverse Event|11|||
48318796|NCT00243503|155368114|FG000|Overall Study|Withdrawal by Subject|1|||
48573198|NCT02294396|156288850|FG003|Overall Study|Miscellaneous|2|||
48573199|NCT00679029|156288851|FG000|Overall Study|Adverse Event|3|||
48573200|NCT00679029|156288851|FG000|Overall Study|Withdrawal by Subject|1|||
48573201|NCT00679029|156288851|FG000|Overall Study|Lost to Follow-up|1|||
48318797|NCT00243503|155368114|FG000|Overall Study|Lack of Efficacy|44|||
48573202|NCT02949843|156288852|FG000|Overall Study|Withdrawal by Subject|0|||
48573203|NCT02949843|156288853|FG001|Overall Study|Withdrawal by Subject|1|||
48573204|NCT02949843|156288854|FG002|Overall Study|Withdrawal by Subject|1|||
48573205|NCT02880865|156288855|FG000|Overall Study|Adverse Event|1|||
48573206|NCT02880865|156288856|FG001|Overall Study|Adverse Event|0|||
48573207|NCT02880865|156288855|FG000|Overall Study|Withdrawal by Subject|0|||
48573208|NCT02880865|156288856|FG001|Overall Study|Withdrawal by Subject|2|||
48573209|NCT02880865|156288855|FG000|Overall Study|Physician Decision|0|||
48573210|NCT02880865|156288856|FG001|Overall Study|Physician Decision|1|||
48573211|NCT03728426|156288857|FG000|Overall Study|Death|3|||
48573212|NCT04740827|156288858|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
48573213|NCT04740827|156288859|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
48573214|NCT04740827|156288858|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
48573215|NCT04740827|156288859|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
48318798|NCT00243503|155368114|FG000|Overall Study|Death|1|||
48318799|NCT00243503|155368114|FG000|Overall Study|Other|1|||
48318800|NCT00939510|155368115|FG000|Overall Study|Withdrawal by Subject|1|||
48318801|NCT00093015|155368116|FG000|Overall Study|Withdrawal by Subject|194|||
48318802|NCT00093015|155368117|FG001|Overall Study|Withdrawal by Subject|171|||
48318803|NCT00093015|155368116|FG000|Overall Study|Lost to Follow-up|96|||
48573216|NCT04740827|156288858|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
48573217|NCT04740827|156288859|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
48573218|NCT04740827|156288858|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
48573219|NCT04740827|156288859|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
48573220|NCT04740827|156288858|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
48573221|NCT04740827|156288859|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
48573222|NCT04740827|156288858|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
48573223|NCT04740827|156288859|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
48573224|NCT02727777|156288867|FG000|Overall Study|Screen Failure|2|||
48573225|NCT02727777|156288868|FG001|Overall Study|Screen Failure|0|||
48573226|NCT02727777|156288869|FG002|Overall Study|Screen Failure|0|||
48573227|NCT02727777|156288867|FG000|Overall Study|Progressive disease|2|||
48573228|NCT02727777|156288868|FG001|Overall Study|Progressive disease|0|||
48573229|NCT02727777|156288869|FG002|Overall Study|Progressive disease|0|||
48573230|NCT03003494|156288875|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
48573231|NCT02609607|156290241|FG000|Overall Study|Lost to Follow-up|0|||
48573232|NCT02609607|156290242|FG001|Overall Study|Lost to Follow-up|1|||
48573233|NCT03691207|156290243|FG000|Overall Study|Death|41|||
48573234|NCT03691207|156290244|FG001|Overall Study|Death|26|||
48573235|NCT03691207|156290243|FG000|Overall Study|Lost to Follow-up|1|||
48573236|NCT03691207|156290244|FG001|Overall Study|Lost to Follow-up|1|||
48619851|NCT01060111|156465304|FG002|Overall Study|Other|4|||
48619852|NCT02441114|156465305|FG000|Washout2|Withdrawal by Subject|4|||
48619853|NCT00625378|156465308|FG000|Overall Study|Adverse Event|22|||
48619854|NCT00625378|156465309|FG001|Overall Study|Adverse Event|0|||
48619855|NCT00625378|156465308|FG000|Overall Study|Withdrawal by Subject|16|||
48619856|NCT00625378|156465309|FG001|Overall Study|Withdrawal by Subject|0|||
48573237|NCT03691207|156290243|FG000|Overall Study|Withdrawal by Subject|2|||
48573238|NCT03691207|156290244|FG001|Overall Study|Withdrawal by Subject|8|||
48619857|NCT00625378|156465308|FG000|Overall Study|Death|38|||
48619858|NCT00625378|156465309|FG001|Overall Study|Death|0|||
48619859|NCT00625378|156465308|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
48619860|NCT00625378|156465309|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
48619861|NCT00625378|156465308|FG000|Overall Study|Lost to Follow-up|17|||
48619862|NCT00625378|156465309|FG001|Overall Study|Lost to Follow-up|0|||
48619863|NCT00625378|156465308|FG000|Overall Study|Non-compliant with study medication|3|||
48619864|NCT00625378|156465309|FG001|Overall Study|Non-compliant with study medication|0|||
48318804|NCT00093015|155368117|FG001|Overall Study|Lost to Follow-up|108|||
48318805|NCT00093015|155368116|FG000|Overall Study|Death|375|||
48318806|NCT00093015|155368117|FG001|Overall Study|Death|385|||
48318807|NCT02538107|155368122|FG000|Overall Study|Did not receive any Mircera dose|11|||
48318808|NCT02538107|155368122|FG000|Overall Study|Missing|5|||
48318809|NCT02538107|155368122|FG000|Overall Study|Necessity of dialysis|20|||
48318810|NCT02538107|155368122|FG000|Overall Study|Administration of other ESA|11|||
48318811|NCT02538107|155368122|FG000|Overall Study|No further treatment necessary|18|||
48318812|NCT02538107|155368122|FG000|Overall Study|Withdrawal by Subject|17|||
48318813|NCT02538107|155368122|FG000|Overall Study|Death|4|||
48318814|NCT02538107|155368122|FG000|Overall Study|Administrative reason|5|||
48318815|NCT02538107|155368122|FG000|Overall Study|Adverse Event|4|||
48318816|NCT02538107|155368122|FG000|Overall Study|Surgery|1|||
48318817|NCT02538107|155368122|FG000|Overall Study|Other|7|||
48318818|NCT02538107|155368122|FG000|Overall Study|Not recorded|7|||
48318819|NCT00546754|155368123|FG000|Overall Study|Serious Adverse Event|1|||
48573239|NCT03691207|156290243|FG000|Overall Study|Sponsor decision|1|||
48573240|NCT03691207|156290244|FG001|Overall Study|Sponsor decision|7|||
48573241|NCT00809471|156290251|FG000|Overall Study|Protocol non-compliance|15|||
48619865|NCT00625378|156465308|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
48318820|NCT00546754|155368124|FG001|Overall Study|Serious Adverse Event|1|||
48619866|NCT00625378|156465309|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
48619867|NCT00625378|156465308|FG000|Overall Study|Medical decision|1|||
48619868|NCT00625378|156465309|FG001|Overall Study|Medical decision|0|||
48619869|NCT00625378|156465308|FG000|Overall Study|Multiple toxicities|1|||
48619870|NCT00625378|156465309|FG001|Overall Study|Multiple toxicities|0|||
48619871|NCT00625378|156465308|FG000|Overall Study|New cancer|1|||
48619872|NCT00625378|156465309|FG001|Overall Study|New cancer|0|||
48619873|NCT00625378|156465308|FG000|Overall Study|PTA program|2|||
48619874|NCT00625378|156465309|FG001|Overall Study|PTA program|0|||
48619875|NCT00625378|156465308|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
48619876|NCT00625378|156465309|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
48619877|NCT00625378|156465308|FG000|Overall Study|Sponsor decision|1|||
48619878|NCT00625378|156465309|FG001|Overall Study|Sponsor decision|0|||
48619879|NCT00625378|156465308|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
48619880|NCT00625378|156465309|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
48619881|NCT00625378|156465308|FG000|Overall Study|Switch to commercial drug|6|||
48619882|NCT00625378|156465309|FG001|Overall Study|Switch to commercial drug|1|||
48619883|NCT00625378|156465308|FG000|Overall Study|Missing|2|||
48619884|NCT00625378|156465309|FG001|Overall Study|Missing|0|||
48619885|NCT00625378|156465308|FG000|Overall Study|End of treatment not available|2|||
48619886|NCT00625378|156465309|FG001|Overall Study|End of treatment not available|0|||
48619887|NCT00625378|156465308|FG000|Overall Study|Never treated|2|||
48619888|NCT00625378|156465309|FG001|Overall Study|Never treated|0|||
48619889|NCT00122187|156465318|FG000|Overall Study|Withdrew because of resource limitations|2|||
48619890|NCT00122187|156465319|FG001|Overall Study|Withdrew because of resource limitations|2|||
48619891|NCT00564070|156465320|FG000|Overall Study|Lost to Follow-up|9|||
48619892|NCT00564070|156465321|FG001|Overall Study|Lost to Follow-up|7|||
48619893|NCT00564070|156465320|FG000|Overall Study|Worsening depression, referred to care|3|||
48619894|NCT00564070|156465321|FG001|Overall Study|Worsening depression, referred to care|0|||
48619895|NCT00567112|156465322|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
48619896|NCT00567112|156465323|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
48619897|NCT00567112|156465324|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
48619898|NCT00567112|156465322|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
48619899|NCT00567112|156465323|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
48619900|NCT00567112|156465324|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
48619901|NCT00567112|156465322|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
48619902|NCT00567112|156465323|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
48619903|NCT00567112|156465324|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
48619904|NCT02945046|156465325|FG000|Overall Study|Adverse Event|1|||
48619905|NCT02945046|156465326|FG001|Overall Study|Adverse Event|0|||
48619906|NCT02945046|156465327|FG002|Overall Study|Adverse Event|2|||
48619907|NCT02945046|156465325|FG000|Overall Study|Withdrawal by Subject|3|||
48619908|NCT02945046|156465326|FG001|Overall Study|Withdrawal by Subject|3|||
48619909|NCT02945046|156465327|FG002|Overall Study|Withdrawal by Subject|3|||
48619910|NCT02945046|156465325|FG000|Overall Study|Protocol Violation|2|||
48619911|NCT02945046|156465326|FG001|Overall Study|Protocol Violation|3|||
48619912|NCT02945046|156465327|FG002|Overall Study|Protocol Violation|2|||
48619913|NCT02945046|156465325|FG000|Overall Study|Lost to Follow-up|1|||
48619914|NCT02945046|156465326|FG001|Overall Study|Lost to Follow-up|1|||
48619915|NCT02945046|156465327|FG002|Overall Study|Lost to Follow-up|0|||
48619916|NCT02945046|156465325|FG000|Overall Study|Lack of Efficacy|1|||
48619917|NCT02945046|156465326|FG001|Overall Study|Lack of Efficacy|2|||
48619918|NCT02945046|156465327|FG002|Overall Study|Lack of Efficacy|1|||
48619919|NCT02945046|156465325|FG000|Overall Study|Other than specified|5|||
48619920|NCT02945046|156465326|FG001|Overall Study|Other than specified|4|||
48619921|NCT02945046|156465327|FG002|Overall Study|Other than specified|7|||
48318821|NCT00546754|155368123|FG000|Overall Study|Adverse Event|11|||
48318822|NCT00546754|155368124|FG001|Overall Study|Adverse Event|16|||
48318823|NCT00546754|155368123|FG000|Overall Study|Lack of Efficacy|1|||
48318824|NCT00546754|155368124|FG001|Overall Study|Lack of Efficacy|1|||
48318825|NCT00546754|155368123|FG000|Overall Study|Lost to Follow-up|9|||
48619922|NCT03111732|156465330|FG000|Overall Study|Enrolled in different study|1|||
48619923|NCT03111732|156465330|FG000|Overall Study|Progressive disease|3|||
48619924|NCT03111732|156465330|FG000|Overall Study|Withdrawal by Subject|1|||
48619925|NCT03072875|156465331|FG000|Overall Study|Lost to Follow-up|1|||
48318826|NCT00546754|155368124|FG001|Overall Study|Lost to Follow-up|15|||
48318827|NCT00546754|155368123|FG000|Overall Study|Protocol Violation|3|||
48619926|NCT03478787|156465332|FG000|Overall Study|Adverse Event|5|||
48318828|NCT00546754|155368124|FG001|Overall Study|Protocol Violation|0|||
48450050|NCT01831804|155835553|FG007|Overall Study|Withdrew Consent|2|||
48619927|NCT03478787|156465333|FG001|Overall Study|Adverse Event|1|||
48619928|NCT03478787|156465332|FG000|Overall Study|Protocol Violation|3|||
48619929|NCT03478787|156465333|FG001|Overall Study|Protocol Violation|0|||
48619930|NCT03478787|156465332|FG000|Overall Study|Lack of Efficacy|7|||
48619931|NCT03478787|156465333|FG001|Overall Study|Lack of Efficacy|1|||
48619932|NCT03478787|156465332|FG000|Overall Study|Lost to Follow-up|9|||
48619933|NCT03478787|156465333|FG001|Overall Study|Lost to Follow-up|5|||
48619934|NCT03478787|156465332|FG000|Overall Study|Withdrawal by Subject|2|||
48619935|NCT03478787|156465333|FG001|Overall Study|Withdrawal by Subject|6|||
48619936|NCT03478787|156465332|FG000|Overall Study|Other, Not Specified|3|||
48619937|NCT03478787|156465333|FG001|Overall Study|Other, Not Specified|0|||
48619938|NCT00452400|156465336|FG000|Overall Study|Adverse Event|1|||
48619939|NCT00452400|156465337|FG001|Overall Study|Adverse Event|1|||
48619940|NCT00452400|156465338|FG002|Overall Study|Adverse Event|5|||
48619941|NCT00452400|156465339|FG003|Overall Study|Adverse Event|0|||
48619942|NCT00452400|156465340|FG004|Overall Study|Adverse Event|2|||
48619943|NCT00452400|156465336|FG000|Overall Study|Protocol Violation|0|||
48619944|NCT00452400|156465337|FG001|Overall Study|Protocol Violation|0|||
48619945|NCT00452400|156465338|FG002|Overall Study|Protocol Violation|1|||
48619946|NCT00452400|156465339|FG003|Overall Study|Protocol Violation|0|||
48619947|NCT00452400|156465340|FG004|Overall Study|Protocol Violation|0|||
48619948|NCT00452400|156465336|FG000|Overall Study|Lost to Follow-up|1|||
48619949|NCT00452400|156465337|FG001|Overall Study|Lost to Follow-up|0|||
48619950|NCT00452400|156465338|FG002|Overall Study|Lost to Follow-up|0|||
48619951|NCT00452400|156465339|FG003|Overall Study|Lost to Follow-up|0|||
48573242|NCT00809471|156290252|FG001|Overall Study|Protocol non-compliance|15|||
48573243|NCT00809471|156290253|FG002|Overall Study|Protocol non-compliance|6|||
48573244|NCT00809471|156290251|FG000|Overall Study|Lost to Follow-up|4|||
48573245|NCT00809471|156290252|FG001|Overall Study|Lost to Follow-up|2|||
48573246|NCT00809471|156290253|FG002|Overall Study|Lost to Follow-up|9|||
48573247|NCT00809471|156290251|FG000|Overall Study|Adverse Event|0|||
48573248|NCT00809471|156290252|FG001|Overall Study|Adverse Event|2|||
48573249|NCT00809471|156290253|FG002|Overall Study|Adverse Event|2|||
48573250|NCT00809471|156290251|FG000|Overall Study|Requirement for restricted medication|1|||
48619952|NCT00452400|156465340|FG004|Overall Study|Lost to Follow-up|0|||
48619953|NCT00452400|156465336|FG000|Overall Study|Withdrawal by Subject|1|||
48619954|NCT00452400|156465337|FG001|Overall Study|Withdrawal by Subject|0|||
48619955|NCT00452400|156465338|FG002|Overall Study|Withdrawal by Subject|1|||
48619956|NCT00452400|156465339|FG003|Overall Study|Withdrawal by Subject|0|||
48619957|NCT00452400|156465340|FG004|Overall Study|Withdrawal by Subject|0|||
48619958|NCT00452400|156465336|FG000|Overall Study|Lack of Efficacy|2|||
48619959|NCT00452400|156465337|FG001|Overall Study|Lack of Efficacy|0|||
48619960|NCT00452400|156465338|FG002|Overall Study|Lack of Efficacy|0|||
48619961|NCT00452400|156465339|FG003|Overall Study|Lack of Efficacy|0|||
48619962|NCT00452400|156465340|FG004|Overall Study|Lack of Efficacy|0|||
48619963|NCT00452400|156465336|FG000|Overall Study|Other reasons not listed above|0|||
48619964|NCT00452400|156465337|FG001|Overall Study|Other reasons not listed above|0|||
48619965|NCT00452400|156465338|FG002|Overall Study|Other reasons not listed above|0|||
48619966|NCT00452400|156465339|FG003|Overall Study|Other reasons not listed above|1|||
48619967|NCT00452400|156465340|FG004|Overall Study|Other reasons not listed above|1|||
48619968|NCT01121575|156465341|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
48619969|NCT01121575|156465342|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
48619970|NCT01121575|156465343|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
48619971|NCT01121575|156465344|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
48619972|NCT01121575|156465345|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
48619973|NCT01121575|156465346|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
48619974|NCT01121575|156465341|FG000|Overall Study|Unspecified Reasons|8|||
48619975|NCT01121575|156465342|FG001|Overall Study|Unspecified Reasons|6|||
48619976|NCT01121575|156465343|FG002|Overall Study|Unspecified Reasons|7|||
48619977|NCT01121575|156465344|FG003|Overall Study|Unspecified Reasons|5|||
48619978|NCT01121575|156465345|FG004|Overall Study|Unspecified Reasons|13|||
48619979|NCT01121575|156465346|FG005|Overall Study|Unspecified Reasons|10|||
48619980|NCT01121575|156465341|FG000|Overall Study|Death|6|||
48573251|NCT00809471|156290252|FG001|Overall Study|Requirement for restricted medication|1|||
48619981|NCT01121575|156465342|FG001|Overall Study|Death|0|||
48619982|NCT01121575|156465343|FG002|Overall Study|Death|0|||
48619983|NCT01121575|156465344|FG003|Overall Study|Death|1|||
48619984|NCT01121575|156465345|FG004|Overall Study|Death|7|||
48619985|NCT01121575|156465346|FG005|Overall Study|Death|1|||
48619986|NCT00003474|156465348|FG000|Overall Study|Not Evaluable|14|||
48619987|NCT01712074|156465349|FG000|Placebo Run-in Period|Adverse Event|2|||
48619988|NCT01712074|156465350|FG001|Placebo Run-in Period|Adverse Event|0|||
48619989|NCT01712074|156465351|FG002|Placebo Run-in Period|Adverse Event|0|||
48573252|NCT00809471|156290253|FG002|Overall Study|Requirement for restricted medication|0|||
48619990|NCT01712074|156465349|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
48318829|NCT00546754|155368123|FG000|Overall Study|Withdrawal by Subject|6|||
48318830|NCT00546754|155368124|FG001|Overall Study|Withdrawal by Subject|7|||
48318831|NCT00546754|155368123|FG000|Overall Study|Dyspnea|1|||
48318832|NCT00546754|155368124|FG001|Overall Study|Dyspnea|0|||
48573253|NCT00831311|156290254|FG000|Overall Study|Definitive Contraindication|3|||
48619991|NCT01712074|156465350|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
48619992|NCT01712074|156465351|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
48619993|NCT01712074|156465349|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
48619994|NCT01712074|156465350|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
48619995|NCT01712074|156465351|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
48619996|NCT01712074|156465349|FG000|Placebo Run-in Period|Other|1|||
48619997|NCT01712074|156465350|FG001|Placebo Run-in Period|Other|0|||
48619998|NCT01712074|156465351|FG002|Placebo Run-in Period|Other|0|||
48619999|NCT01712074|156465349|FG000|Placebo Run-in Period|No longer willing to participate|1|||
48620000|NCT01712074|156465350|FG001|Placebo Run-in Period|No longer willing to participate|0|||
48620001|NCT01712074|156465351|FG002|Placebo Run-in Period|No longer willing to participate|0|||
48620002|NCT01712074|156465349|FG000|Double Blind Period|Adverse Event|0|||
48620003|NCT01712074|156465350|FG001|Double Blind Period|Adverse Event|2|||
48620004|NCT01712074|156465351|FG002|Double Blind Period|Adverse Event|1|||
48620005|NCT01712074|156465349|FG000|Double Blind Period|No longer willing to participate|0|||
48620006|NCT01712074|156465350|FG001|Double Blind Period|No longer willing to participate|2|||
48620007|NCT01712074|156465351|FG002|Double Blind Period|No longer willing to participate|4|||
48620008|NCT01712074|156465349|FG000|Double Blind Period|Death|0|||
48620009|NCT01712074|156465350|FG001|Double Blind Period|Death|1|||
48620010|NCT01712074|156465351|FG002|Double Blind Period|Death|0|||
48620011|NCT01712074|156465349|FG000|Double Blind Period|Lost to Follow-up|0|||
48318833|NCT00546754|155368123|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
48318834|NCT00546754|155368124|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
48318835|NCT00546754|155368123|FG000|Overall Study|Hip Replacement|1|||
48318836|NCT00546754|155368124|FG001|Overall Study|Hip Replacement|0|||
48318837|NCT00546754|155368123|FG000|Overall Study|Suicide|1|||
48318838|NCT00546754|155368124|FG001|Overall Study|Suicide|0|||
48318839|NCT00546754|155368123|FG000|Overall Study|Missing Cooperation|1|||
48318840|NCT00546754|155368124|FG001|Overall Study|Missing Cooperation|0|||
48318841|NCT00546754|155368123|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
48318842|NCT00546754|155368124|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
48318843|NCT00546754|155368123|FG000|Overall Study|Patient's Decision|0|||
48318844|NCT00546754|155368124|FG001|Overall Study|Patient's Decision|1|||
48318845|NCT00546754|155368123|FG000|Overall Study|Missing|14|||
48573254|NCT00831311|156290255|FG001|Overall Study|Definitive Contraindication|3|||
48573255|NCT00831311|156290254|FG000|Overall Study|Lost to Follow-up|3|||
48573256|NCT00831311|156290255|FG001|Overall Study|Lost to Follow-up|0|||
48573257|NCT00831311|156290254|FG000|Overall Study|Physician Decision|0|||
48573258|NCT00831311|156290255|FG001|Overall Study|Physician Decision|1|||
48573259|NCT00831311|156290254|FG000|Overall Study|Withdrawal by Subject|6|||
48573260|NCT00831311|156290255|FG001|Overall Study|Withdrawal by Subject|4|||
48573261|NCT02309411|156290256|FG000|Overall Study|Physician Decision|1|||
48573262|NCT02309411|156290257|FG001|Overall Study|Physician Decision|0|||
48573263|NCT02309411|156290258|FG002|Overall Study|Physician Decision|0|||
48573264|NCT02309411|156290256|FG000|Overall Study|Withdrawal by Subject|1|||
48573265|NCT02309411|156290257|FG001|Overall Study|Withdrawal by Subject|1|||
48573266|NCT02309411|156290258|FG002|Overall Study|Withdrawal by Subject|0|||
48573267|NCT05338502|156290261|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
48573268|NCT05338502|156290262|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
48573269|NCT05338502|156290263|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
48573270|NCT05338502|156290261|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
48573271|NCT05338502|156290262|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
48573272|NCT05338502|156290263|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
48573273|NCT02423343|156290273|FG000|Overall Study|Withdrawal by Subject|0|||
48573274|NCT02423343|156290274|FG001|Overall Study|Withdrawal by Subject|1|||
48573275|NCT02423343|156290275|FG002|Overall Study|Withdrawal by Subject|0|||
48573276|NCT02423343|156290276|FG003|Overall Study|Withdrawal by Subject|0|||
48573277|NCT02423343|156290277|FG004|Overall Study|Withdrawal by Subject|0|||
48620012|NCT01712074|156465350|FG001|Double Blind Period|Lost to Follow-up|2|||
48620013|NCT01712074|156465351|FG002|Double Blind Period|Lost to Follow-up|1|||
48318846|NCT00546754|155368124|FG001|Overall Study|Missing|7|||
48318847|NCT03485950|155368127|FG000|Overall Study|Adverse Event|1|||
48318848|NCT03485950|155368128|FG001|Overall Study|Adverse Event|0|||
48318849|NCT03485950|155368127|FG000|Overall Study|Death|3|||
48573278|NCT02423343|156290278|FG005|Overall Study|Withdrawal by Subject|0|||
48573279|NCT02423343|156290273|FG000|Overall Study|Progressive Disease|0|||
48573280|NCT02423343|156290274|FG001|Overall Study|Progressive Disease|0|||
48573281|NCT02423343|156290275|FG002|Overall Study|Progressive Disease|0|||
48573282|NCT02423343|156290276|FG003|Overall Study|Progressive Disease|0|||
48573283|NCT02423343|156290277|FG004|Overall Study|Progressive Disease|2|||
48573284|NCT02423343|156290278|FG005|Overall Study|Progressive Disease|0|||
48620014|NCT01712074|156465349|FG000|Double Blind Period|Other|0|||
48620015|NCT01712074|156465350|FG001|Double Blind Period|Other|4|||
48620016|NCT01712074|156465351|FG002|Double Blind Period|Other|1|||
48620017|NCT01712074|156465349|FG000|Double Blind Period|Protocol Violation|0|||
48620018|NCT01712074|156465350|FG001|Double Blind Period|Protocol Violation|0|||
48620019|NCT01712074|156465351|FG002|Double Blind Period|Protocol Violation|1|||
48620020|NCT01712074|156465349|FG000|Double Blind Period|No longer met eligibility criteria|0|||
48620021|NCT01712074|156465350|FG001|Double Blind Period|No longer met eligibility criteria|3|||
48620022|NCT01712074|156465351|FG002|Double Blind Period|No longer met eligibility criteria|0|||
48620023|NCT02413346|156465356|FG000|Overall Study|Adverse Event|6|||
48318850|NCT03485950|155368128|FG001|Overall Study|Death|2|||
48318851|NCT03485950|155368127|FG000|Overall Study|Withdrawal by Subject|3|||
48318852|NCT03485950|155368128|FG001|Overall Study|Withdrawal by Subject|0|||
48318853|NCT00988858|155368130|FG000|Overall Study|Adverse Event|7|||
48318854|NCT00988858|155368130|FG000|Overall Study|Death|1|||
48318855|NCT00988858|155368130|FG000|Overall Study|Physician Decision|1|||
48318856|NCT00988858|155368130|FG000|Overall Study|Sponsor Decision|1|||
48318857|NCT02574455|155368131|FG000|Overall Study|Death|197|||
48318858|NCT02574455|155368132|FG001|Overall Study|Death|210|||
48318859|NCT02574455|155368131|FG000|Overall Study|Withdrawal of Consent|11|||
48318860|NCT02574455|155368132|FG001|Overall Study|Withdrawal of Consent|28|||
48318861|NCT02574455|155368131|FG000|Overall Study|Lost to Follow-up|4|||
48318862|NCT02574455|155368132|FG001|Overall Study|Lost to Follow-up|4|||
48318863|NCT02574455|155368131|FG000|Overall Study|Sponsor's Decision|55|||
48318864|NCT02574455|155368132|FG001|Overall Study|Sponsor's Decision|20|||
48318865|NCT00539734|155368134|FG000|Overall Study|Protocol Violation|1|||
48318866|NCT01061671|155368136|FG000|Overall Study|Withdrawal by Subject|16|||
48318867|NCT01061671|155368137|FG001|Overall Study|Withdrawal by Subject|20|||
48318868|NCT01061671|155368136|FG000|Overall Study|Lost to Follow-up|3|||
48318869|NCT01061671|155368137|FG001|Overall Study|Lost to Follow-up|5|||
48318870|NCT01061671|155368136|FG000|Overall Study|Death|28|||
48318871|NCT01061671|155368137|FG001|Overall Study|Death|30|||
48318872|NCT01747486|155368143|FG000|Stage 1|Physician Decision|3|||
48318873|NCT01747486|155368144|FG001|Stage 1|Physician Decision|0|||
48318874|NCT01747486|155368143|FG000|Stage 1|Withdrawal by Subject|4|||
48620024|NCT02413346|156465357|FG001|Overall Study|Adverse Event|6|||
48620025|NCT02413346|156465356|FG000|Overall Study|Withdrawal by Subject|30|||
48620026|NCT02413346|156465357|FG001|Overall Study|Withdrawal by Subject|40|||
48620027|NCT02413346|156465356|FG000|Overall Study|Lost to Follow-up|17|||
48620028|NCT02413346|156465357|FG001|Overall Study|Lost to Follow-up|21|||
48620029|NCT02413346|156465356|FG000|Overall Study|Protocol Violation|2|||
48620030|NCT02413346|156465357|FG001|Overall Study|Protocol Violation|0|||
48620031|NCT02413346|156465356|FG000|Overall Study|Other Miscellaneous Reasons|4|||
48620032|NCT02413346|156465357|FG001|Overall Study|Other Miscellaneous Reasons|3|||
48620033|NCT01472835|156465358|FG000|Overall Study|Lost to Follow-up|2|||
48620034|NCT01472835|156465359|FG001|Overall Study|Lost to Follow-up|0|||
48620035|NCT02205359|156465362|FG000|Overall Study|Death|293|||
48620036|NCT02205359|156465363|FG001|Overall Study|Death|327|||
48620037|NCT02205359|156465362|FG000|Overall Study|Lost to Follow-up|182|||
48620038|NCT02205359|156465363|FG001|Overall Study|Lost to Follow-up|162|||
48620039|NCT02205359|156465362|FG000|Overall Study|Physician Decision|51|||
48620040|NCT02205359|156465363|FG001|Overall Study|Physician Decision|53|||
48620041|NCT02205359|156465362|FG000|Overall Study|Withdrawal by Subject|167|||
48620042|NCT02205359|156465363|FG001|Overall Study|Withdrawal by Subject|169|||
48620043|NCT01316900|156465364|FG000|Overall Study|Adverse Event|10|||
48620044|NCT01316900|156465365|FG001|Overall Study|Adverse Event|10|||
48620045|NCT01316900|156465366|FG002|Overall Study|Adverse Event|15|||
48620046|NCT01316900|156465367|FG003|Overall Study|Adverse Event|9|||
48620047|NCT01316900|156465364|FG000|Overall Study|Lack of Efficacy|17|||
48620048|NCT01316900|156465365|FG001|Overall Study|Lack of Efficacy|9|||
48620049|NCT01316900|156465366|FG002|Overall Study|Lack of Efficacy|5|||
48318875|NCT01747486|155368144|FG001|Stage 1|Withdrawal by Subject|3|||
48620050|NCT01316900|156465367|FG003|Overall Study|Lack of Efficacy|7|||
48318876|NCT01747486|155368143|FG000|Stage 1|Disease progression|4|||
48318877|NCT01747486|155368144|FG001|Stage 1|Disease progression|9|||
48620051|NCT01316900|156465364|FG000|Overall Study|Protocol Violation|7|||
48620052|NCT01316900|156465365|FG001|Overall Study|Protocol Violation|1|||
48620053|NCT01316900|156465366|FG002|Overall Study|Protocol Violation|4|||
48620054|NCT01316900|156465367|FG003|Overall Study|Protocol Violation|0|||
48620055|NCT01316900|156465364|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
48620056|NCT01316900|156465365|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
48620057|NCT01316900|156465366|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
48620058|NCT01316900|156465367|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
48318878|NCT01747486|155368143|FG000|Stage 1|Death|1|||
48318879|NCT01747486|155368144|FG001|Stage 1|Death|1|||
48318880|NCT01747486|155368143|FG000|Stage 2|Physician Decision|2|||
48318881|NCT01747486|155368144|FG001|Stage 2|Physician Decision|0|||
48318882|NCT01747486|155368143|FG000|Stage 2|Withdrawal by Subject|1|||
48620059|NCT01316900|156465364|FG000|Overall Study|Lost to Follow-up|1|||
48620060|NCT01316900|156465365|FG001|Overall Study|Lost to Follow-up|0|||
48620061|NCT01316900|156465366|FG002|Overall Study|Lost to Follow-up|1|||
48620062|NCT01316900|156465367|FG003|Overall Study|Lost to Follow-up|1|||
48620063|NCT01316900|156465364|FG000|Overall Study|Withdrawal by Subject|7|||
48620064|NCT01316900|156465365|FG001|Overall Study|Withdrawal by Subject|8|||
48620065|NCT01316900|156465366|FG002|Overall Study|Withdrawal by Subject|6|||
48620066|NCT01316900|156465367|FG003|Overall Study|Withdrawal by Subject|9|||
48620067|NCT01905683|156465370|FG000|Overall Study|Protocol Violation|1|||
48620068|NCT01905683|156465370|FG000|Overall Study|Re-injection criteria not met; others|13|||
48620069|NCT01905683|156465370|FG000|Overall Study|Physician Decision|1|||
48620070|NCT01905683|156465370|FG000|Overall Study|Lack of Efficacy|8|||
48620071|NCT01905683|156465370|FG000|Overall Study|Withdrawal by Subject|20|||
48620072|NCT01905683|156465370|FG000|Overall Study|Adverse Event|4|||
48620073|NCT01905683|156465370|FG000|Overall Study|Lost to Follow-up|4|||
48620074|NCT02151604|156465371|FG000|Overall Study|Lost to Follow-up|3|||
48620075|NCT02151604|156465371|FG000|Overall Study|Withdrawal by Subject|2|||
48620076|NCT02151604|156465371|FG000|Overall Study|Physician Decision|3|||
48620077|NCT02151604|156465371|FG000|Overall Study|Death|1|||
48620078|NCT00182637|156466977|FG000|Overall Study|Adverse Event|2|||
48620079|NCT00182637|156466977|FG000|Overall Study|Disease Progression|1|||
48620080|NCT04289298|156466980|FG000|Overall Study|Lost to Follow-up|5|||
48620081|NCT04289298|156466981|FG001|Overall Study|Lost to Follow-up|0|||
48620082|NCT04289298|156466980|FG000|Overall Study|Withdrawal by Subject|2|||
48620083|NCT04289298|156466981|FG001|Overall Study|Withdrawal by Subject|0|||
48620084|NCT03418675|156466982|FG000|Overall Study|Lost to Follow-up|13|||
48620085|NCT03418675|156466983|FG001|Overall Study|Lost to Follow-up|10|||
48620086|NCT03418675|156466982|FG000|Overall Study|Adverse Event|2|||
48620087|NCT03418675|156466983|FG001|Overall Study|Adverse Event|0|||
48620088|NCT03197935|156466984|FG000|Overall Study|Death due to any cause|26|||
48620089|NCT03197935|156466985|FG001|Overall Study|Death due to any cause|15|||
48620090|NCT03197935|156466984|FG000|Overall Study|Lost to Follow-up|3|||
48620091|NCT03197935|156466985|FG001|Overall Study|Lost to Follow-up|5|||
48620092|NCT03197935|156466984|FG000|Overall Study|Physician Decision|2|||
48620093|NCT03197935|156466985|FG001|Overall Study|Physician Decision|1|||
48620094|NCT03197935|156466984|FG000|Overall Study|Withdrawal by Subject|16|||
48620095|NCT03197935|156466985|FG001|Overall Study|Withdrawal by Subject|8|||
48620096|NCT05059080|156466986|FG000|Overall Study|Withdrawal by Subject|3|||
48620097|NCT05059080|156466986|FG000|Overall Study|Study Terminated by Sponsor|64|||
48620098|NCT02255279|156466987|FG000|Overall Study|Lost to Follow-up|2|||
48620099|NCT02255279|156466988|FG001|Overall Study|Lost to Follow-up|2|||
48318883|NCT01747486|155368144|FG001|Stage 2|Withdrawal by Subject|0|||
48318884|NCT01747486|155368143|FG000|Stage 2|New Cancer Therapy|3|||
48318885|NCT01747486|155368144|FG001|Stage 2|New Cancer Therapy|0|||
48620100|NCT02255279|156466987|FG000|Overall Study|Protocol Violation|0|||
48620101|NCT02255279|156466988|FG001|Overall Study|Protocol Violation|1|||
48620102|NCT02255279|156466987|FG000|Overall Study|Withdrawal by Subject|3|||
48620103|NCT02255279|156466988|FG001|Overall Study|Withdrawal by Subject|6|||
48620104|NCT00509600|156466989|FG000|Overall Study|Adverse Event|1|||
48620105|NCT01829165|156466992|FG000|Overall Study|Did not complete intervention|2|||
48620106|NCT01829165|156466993|FG001|Overall Study|Did not complete intervention|0|||
48620107|NCT00090402|156466994|FG000|Overall Study|Death|1|||
48620108|NCT00090402|156466995|FG001|Overall Study|Death|1|||
48620109|NCT00090402|156466996|FG002|Overall Study|Death|0|||
48620110|NCT00090402|156466994|FG000|Overall Study|subject moved|0|||
48620111|NCT00090402|156466995|FG001|Overall Study|subject moved|1|||
48620112|NCT00090402|156466996|FG002|Overall Study|subject moved|0|||
48620113|NCT00090402|156466994|FG000|Overall Study|stopped taking study medication|1|||
48620114|NCT00090402|156466995|FG001|Overall Study|stopped taking study medication|0|||
48620115|NCT00090402|156466996|FG002|Overall Study|stopped taking study medication|1|||
48620116|NCT00965094|156466998|FG000|Overall Study|Adverse Event|5|||
48620117|NCT00965094|156466999|FG001|Overall Study|Adverse Event|0|||
48620118|NCT00965094|156466998|FG000|Overall Study|Lost to Follow-up|0|||
48735993|NCT02935842|156883747|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
48318886|NCT01747486|155368143|FG000|Stage 2|Disease Progression|3|||
48318887|NCT01747486|155368144|FG001|Stage 2|Disease Progression|0|||
48620119|NCT00965094|156466999|FG001|Overall Study|Lost to Follow-up|1|||
48620120|NCT00927186|156467000|FG000|12 Months Primary Study|Adverse Event|5|||
48620121|NCT00927186|156467001|FG001|12 Months Primary Study|Adverse Event|2|||
48620122|NCT00927186|156467000|FG000|12 Months Primary Study|Lost to Follow-up|1|||
48620123|NCT00927186|156467001|FG001|12 Months Primary Study|Lost to Follow-up|0|||
48620124|NCT00927186|156467000|FG000|12 Months Primary Study|Protocol Violation|0|||
48620125|NCT00927186|156467001|FG001|12 Months Primary Study|Protocol Violation|1|||
48620126|NCT00927186|156467000|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
48620127|NCT00927186|156467001|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
48318888|NCT01084707|155368145|FG000|Overall Study|Withdrawal by Subject|6|||
48620128|NCT01658735|156467006|FG000|Overall Study|Lack of Efficacy|1|||
48620129|NCT01658735|156467007|FG001|Overall Study|Lack of Efficacy|0|||
48620130|NCT01658735|156467008|FG002|Overall Study|Lack of Efficacy|1|||
48620131|NCT01658735|156467006|FG000|Overall Study|Lost to Follow-up|1|||
48318889|NCT00901901|155368146|FG000|Treatment Period|Adverse Event|120|||
48318890|NCT00901901|155368147|FG001|Treatment Period|Adverse Event|128|||
48318891|NCT00901901|155368146|FG000|Treatment Period|Withdrawal by Subject|26|||
48573285|NCT02423343|156290273|FG000|Overall Study|Adverse Event|0|||
48573286|NCT02423343|156290274|FG001|Overall Study|Adverse Event|0|||
48573287|NCT02423343|156290275|FG002|Overall Study|Adverse Event|0|||
48573288|NCT02423343|156290276|FG003|Overall Study|Adverse Event|0|||
48573289|NCT02423343|156290277|FG004|Overall Study|Adverse Event|2|||
48573290|NCT02423343|156290278|FG005|Overall Study|Adverse Event|0|||
48573291|NCT02423343|156290273|FG000|Overall Study|Death|0|||
48573292|NCT02423343|156290274|FG001|Overall Study|Death|0|||
48573293|NCT02423343|156290275|FG002|Overall Study|Death|0|||
48573294|NCT02423343|156290276|FG003|Overall Study|Death|0|||
48573295|NCT02423343|156290277|FG004|Overall Study|Death|1|||
48573296|NCT02423343|156290278|FG005|Overall Study|Death|0|||
48573297|NCT01894100|156290279|FG000|Overall Study|Lost to Follow-up|0|||
48573298|NCT01894100|156290280|FG001|Overall Study|Lost to Follow-up|1|||
48573299|NCT01894100|156290279|FG000|Overall Study|Withdrawal by Subject|3|||
48573300|NCT01894100|156290280|FG001|Overall Study|Withdrawal by Subject|0|||
48573301|NCT00930774|156290284|FG000|Overall Study|Withdrawal by Subject|1|||
48573302|NCT00930774|156290285|FG001|Overall Study|Withdrawal by Subject|9|||
48573303|NCT00930774|156290286|FG002|Overall Study|Withdrawal by Subject|2|||
48573304|NCT00930774|156290287|FG003|Overall Study|Withdrawal by Subject|0|||
48573305|NCT01102257|156290288|FG000|Overall Study|Adverse Event|1|||
48573306|NCT01102257|156290289|FG001|Overall Study|Adverse Event|0|||
48573307|NCT01102257|156290288|FG000|Overall Study|Adverse Event|1|||
48573308|NCT01102257|156290289|FG001|Overall Study|Adverse Event|0|||
48573309|NCT02048826|156290290|FG000|Overall Study|Withdrawal by Subject|1|||
48573310|NCT02048826|156290291|FG001|Overall Study|Withdrawal by Subject|0|||
48573311|NCT04470544|156290292|FG000|Overall Study|Withdrawal by Subject|4|||
48573312|NCT04470544|156290293|FG001|Overall Study|Withdrawal by Subject|6|||
48573313|NCT04666259|156290299|FG000|Overall Study|ongoing at data cut-off|6|||
48573314|NCT04666259|156290300|FG001|Overall Study|ongoing at data cut-off|14|||
48573315|NCT04666259|156290301|FG002|Overall Study|ongoing at data cut-off|0|||
48573316|NCT04666259|156290299|FG000|Overall Study|Progressive Disease|0|||
48573317|NCT04666259|156290300|FG001|Overall Study|Progressive Disease|1|||
48573318|NCT04666259|156290301|FG002|Overall Study|Progressive Disease|0|||
48573319|NCT04666259|156290299|FG000|Overall Study|Physician Decision|9|||
48573320|NCT04666259|156290300|FG001|Overall Study|Physician Decision|3|||
48573321|NCT04666259|156290301|FG002|Overall Study|Physician Decision|3|||
48573322|NCT04666259|156290299|FG000|Overall Study|Adverse Event|3|||
48573323|NCT04666259|156290300|FG001|Overall Study|Adverse Event|1|||
48573324|NCT04666259|156290301|FG002|Overall Study|Adverse Event|0|||
48573325|NCT04666259|156290299|FG000|Overall Study|Withdrawal by Subject|1|||
48573326|NCT04666259|156290300|FG001|Overall Study|Withdrawal by Subject|2|||
48573327|NCT04666259|156290301|FG002|Overall Study|Withdrawal by Subject|0|||
48573328|NCT04666259|156290299|FG000|Overall Study|Enrolled but not treated and discontinued|1|||
48573329|NCT04666259|156290300|FG001|Overall Study|Enrolled but not treated and discontinued|0|||
48573330|NCT04666259|156290301|FG002|Overall Study|Enrolled but not treated and discontinued|0|||
48573331|NCT00090493|156290302|FG000|Overall Study|Physician Decision|2|||
48573332|NCT01680861|156290303|FG000|Early Post-transplant Period|Protocol Violation|1|||
48573333|NCT01680861|156290304|FG001|Early Post-transplant Period|Protocol Violation|1|||
48573334|NCT02111577|156290309|FG000|Overall Study|Protocol Violation|2|||
48573335|NCT02111577|156290310|FG001|Overall Study|Protocol Violation|0|||
48573336|NCT02111577|156290309|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
48573337|NCT02111577|156290310|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
48573338|NCT02111577|156290309|FG000|Overall Study|Failure to produce study treatment|6|||
48573339|NCT02111577|156290310|FG001|Overall Study|Failure to produce study treatment|0|||
48573340|NCT02111577|156290309|FG000|Overall Study|Death|518|||
48573341|NCT02111577|156290310|FG001|Overall Study|Death|254|||
48573342|NCT02111577|156290309|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
48573343|NCT02111577|156290310|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
48573344|NCT02111577|156290309|FG000|Overall Study|Adverse Event|1|||
48573345|NCT02111577|156290310|FG001|Overall Study|Adverse Event|1|||
48573346|NCT02111577|156290309|FG000|Overall Study|Withdrawal by Subject|51|||
48573347|NCT02111577|156290310|FG001|Overall Study|Withdrawal by Subject|23|||
48573348|NCT02111577|156290309|FG000|Overall Study|Disease progression|0|||
48573349|NCT02111577|156290310|FG001|Overall Study|Disease progression|1|||
48573350|NCT02111577|156290309|FG000|Overall Study|Lost to Follow-up|19|||
48573351|NCT02111577|156290310|FG001|Overall Study|Lost to Follow-up|10|||
48573352|NCT02235077|156290311|FG000|Overall Study|Death|5|||
48573353|NCT02235077|156290312|FG001|Overall Study|Death|7|||
48573354|NCT02235077|156290311|FG000|Overall Study|Lost to Follow-up|5|||
48573355|NCT02235077|156290312|FG001|Overall Study|Lost to Follow-up|6|||
48573356|NCT02235077|156290311|FG000|Overall Study|Withdrawal by Subject|8|||
48573357|NCT02235077|156290312|FG001|Overall Study|Withdrawal by Subject|5|||
48573358|NCT02235077|156290311|FG000|Overall Study|Physician Decision|0|||
48573359|NCT02235077|156290312|FG001|Overall Study|Physician Decision|1|||
48620132|NCT01658735|156467007|FG001|Overall Study|Lost to Follow-up|1|||
48620133|NCT01658735|156467008|FG002|Overall Study|Lost to Follow-up|0|||
48620134|NCT01658735|156467006|FG000|Overall Study|Protocol Violation|0|||
48573360|NCT01908829|156290316|FG000|Overall Study|Adverse Event|13|||
48573361|NCT01908829|156290317|FG001|Overall Study|Adverse Event|11|||
48573362|NCT01908829|156290318|FG002|Overall Study|Adverse Event|13|||
48573363|NCT01908829|156290316|FG000|Overall Study|Lost to Follow-up|4|||
48573364|NCT01908829|156290317|FG001|Overall Study|Lost to Follow-up|2|||
48573365|NCT01908829|156290318|FG002|Overall Study|Lost to Follow-up|1|||
48573366|NCT01908829|156290316|FG000|Overall Study|Randomized no double-blind drug received|1|||
48573367|NCT01908829|156290317|FG001|Overall Study|Randomized no double-blind drug received|0|||
48573368|NCT01908829|156290318|FG002|Overall Study|Randomized no double-blind drug received|1|||
48573369|NCT01908829|156290316|FG000|Overall Study|Discontinued (no EoT page)|2|||
48573370|NCT01908829|156290317|FG001|Overall Study|Discontinued (no EoT page)|0|||
48573371|NCT01908829|156290318|FG002|Overall Study|Discontinued (no EoT page)|0|||
48573372|NCT01908829|156290316|FG000|Overall Study|Miscellaneous|0|||
48573373|NCT01908829|156290317|FG001|Overall Study|Miscellaneous|2|||
48573374|NCT01908829|156290318|FG002|Overall Study|Miscellaneous|0|||
48573375|NCT01908829|156290316|FG000|Overall Study|Protocol Violation|2|||
48573376|NCT01908829|156290317|FG001|Overall Study|Protocol Violation|2|||
48573377|NCT01908829|156290318|FG002|Overall Study|Protocol Violation|0|||
48573378|NCT01908829|156290316|FG000|Overall Study|Lack of Efficacy|1|||
48573379|NCT01908829|156290317|FG001|Overall Study|Lack of Efficacy|3|||
48573380|NCT01908829|156290318|FG002|Overall Study|Lack of Efficacy|2|||
48573381|NCT01908829|156290316|FG000|Overall Study|Withdrawal by Subject|26|||
48573382|NCT01908829|156290317|FG001|Overall Study|Withdrawal by Subject|29|||
48573383|NCT01908829|156290318|FG002|Overall Study|Withdrawal by Subject|22|||
48573384|NCT02005692|156290319|FG000|Overall Study|Protocol Violation|1|||
48573385|NCT02005692|156290319|FG000|Overall Study|Withdrawal by Subject|1|||
48573386|NCT02005692|156290319|FG000|Overall Study|Discharged earlier than anticipated|5|||
48573387|NCT02865499|156290322|FG000|Baseline|Adverse Event|1|||
48573388|NCT02865499|156290322|FG000|Baseline|Withdrawal by Subject|1|||
48573389|NCT01895270|156290323|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
48573390|NCT01895270|156290324|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
48573391|NCT01895270|156290323|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
48573392|NCT01895270|156290324|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
48573393|NCT01895270|156290323|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
48573394|NCT01895270|156290324|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
48573395|NCT01895270|156290323|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
48573396|NCT01895270|156290324|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
48573397|NCT01895270|156290323|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
48573398|NCT01895270|156290324|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
48573399|NCT01895270|156290323|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
48573400|NCT01895270|156290324|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
48573401|NCT01895270|156290323|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
48573402|NCT01895270|156290324|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
48573403|NCT02320058|156290330|FG000|Overall Study|Death|25|||
48573404|NCT02320058|156290331|FG001|Overall Study|Death|10|||
48573405|NCT02320058|156290330|FG000|Overall Study|Lost to Follow-up|4|||
48573406|NCT02320058|156290331|FG001|Overall Study|Lost to Follow-up|0|||
48573407|NCT02320058|156290330|FG000|Overall Study|Other reasons|4|||
48573408|NCT02320058|156290331|FG001|Overall Study|Other reasons|1|||
48573409|NCT02320058|156290330|FG000|Overall Study|Withdrawal by Subject|8|||
48573410|NCT02320058|156290331|FG001|Overall Study|Withdrawal by Subject|2|||
48573411|NCT02320058|156290330|FG000|Overall Study|Not reported|1|||
48573412|NCT02320058|156290331|FG001|Overall Study|Not reported|0|||
48573413|NCT05835011|156290334|FG000|Overall Study|Study Terminated by the Sponsor|1|||
48573414|NCT05835011|156290334|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
48573415|NCT00886743|156290339|FG000|Overall Study|Adverse Event|3|||
48573416|NCT00886743|156290339|FG000|Overall Study|Other|1|||
48573417|NCT01940887|156290343|FG000|Year 1|Protocol Violation|0|||
48573418|NCT01940887|156290344|FG001|Year 1|Protocol Violation|1|||
48573419|NCT01940887|156290343|FG000|Year 1|Physician Decision|7|||
48573420|NCT01940887|156290344|FG001|Year 1|Physician Decision|3|||
48573421|NCT01940887|156290343|FG000|Year 1|Death|5|||
48573422|NCT01940887|156290344|FG001|Year 1|Death|3|||
48573423|NCT01940887|156290343|FG000|Year 1|Adverse Event|7|||
48573424|NCT01940887|156290344|FG001|Year 1|Adverse Event|6|||
48573425|NCT01940887|156290343|FG000|Year 1|Withdrawal by Subject|18|||
48620135|NCT01658735|156467007|FG001|Overall Study|Protocol Violation|1|||
48620136|NCT01658735|156467008|FG002|Overall Study|Protocol Violation|0|||
48573426|NCT01940887|156290344|FG001|Year 1|Withdrawal by Subject|9|||
48573427|NCT01940887|156290343|FG000|Year 1|Lost to Follow-up|2|||
48573428|NCT01940887|156290344|FG001|Year 1|Lost to Follow-up|1|||
48573429|NCT01940887|156290343|FG000|Year 2|Physician Decision|8|||
48573430|NCT01940887|156290344|FG001|Year 2|Physician Decision|1|||
48573431|NCT01940887|156290343|FG000|Year 2|Death|0|||
48620137|NCT01658735|156467006|FG000|Overall Study|Withdrawal by Subject|3|||
48573432|NCT01940887|156290344|FG001|Year 2|Death|2|||
48573433|NCT01940887|156290343|FG000|Year 2|Sponsor Decision, early termination|192|||
48573434|NCT01940887|156290344|FG001|Year 2|Sponsor Decision, early termination|203|||
48573435|NCT01940887|156290343|FG000|Year 2|Adverse Event|8|||
48573436|NCT01940887|156290344|FG001|Year 2|Adverse Event|2|||
48573437|NCT01940887|156290343|FG000|Year 2|Withdrawal by Subject|8|||
48573438|NCT01940887|156290344|FG001|Year 2|Withdrawal by Subject|8|||
48573439|NCT01940887|156290343|FG000|Year 2|Lost to Follow-up|1|||
48573440|NCT01940887|156290344|FG001|Year 2|Lost to Follow-up|6|||
48573441|NCT04720911|156290348|FG000|Overall Study|Withdrawal by Subject|0|||
48573442|NCT04720911|156290349|FG001|Overall Study|Withdrawal by Subject|1|||
48573443|NCT04720911|156290350|FG002|Overall Study|Withdrawal by Subject|0|||
48573444|NCT00941863|156290352|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
48573445|NCT00941863|156290353|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
48573446|NCT00941863|156290354|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
48573447|NCT00941863|156290355|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
48573448|NCT00941863|156290356|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
48573449|NCT00941863|156290352|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
48573450|NCT00941863|156290353|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
48573451|NCT00941863|156290354|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
48573452|NCT00941863|156290355|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
48573453|NCT00941863|156290356|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
48573454|NCT00941863|156290352|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
48318892|NCT00901901|155368147|FG001|Treatment Period|Withdrawal by Subject|24|||
48318893|NCT00901901|155368146|FG000|Treatment Period|Physician Decision|2|||
48318894|NCT00901901|155368147|FG001|Treatment Period|Physician Decision|2|||
48318895|NCT00901901|155368146|FG000|Treatment Period|Lost to Follow-up|3|||
48573455|NCT00941863|156290353|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
48573456|NCT00941863|156290354|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
48573457|NCT00941863|156290355|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
48573458|NCT00941863|156290356|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
48573459|NCT00941863|156290352|FG000|Until Primary Completion Date (PCD)|Death|0|||
48573460|NCT00941863|156290353|FG001|Until Primary Completion Date (PCD)|Death|0|||
48573461|NCT00941863|156290354|FG002|Until Primary Completion Date (PCD)|Death|1|||
48573462|NCT00941863|156290355|FG003|Until Primary Completion Date (PCD)|Death|2|||
48573463|NCT00941863|156290356|FG004|Until Primary Completion Date (PCD)|Death|7|||
48573464|NCT00941863|156290352|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
48573465|NCT00941863|156290353|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
48573466|NCT00941863|156290354|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
48573467|NCT00941863|156290355|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
48573468|NCT00941863|156290356|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
48573469|NCT00941863|156290352|FG000|Continued After PCD|Withdrawal by Subject|0|||
48573470|NCT00941863|156290353|FG001|Continued After PCD|Withdrawal by Subject|0|||
48573471|NCT00941863|156290354|FG002|Continued After PCD|Withdrawal by Subject|0|||
48573472|NCT00941863|156290355|FG003|Continued After PCD|Withdrawal by Subject|0|||
48573473|NCT00941863|156290356|FG004|Continued After PCD|Withdrawal by Subject|1|||
48573474|NCT00941863|156290352|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
48573475|NCT00941863|156290353|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
48573476|NCT00941863|156290354|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
48573477|NCT00941863|156290355|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
48573478|NCT00941863|156290356|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
48573479|NCT02651155|156290357|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48573480|NCT02651155|156290358|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
48573481|NCT02651155|156290357|FG000|Overall Study|Voluntary Withdrawal|5|||
48573482|NCT02651155|156290358|FG001|Overall Study|Voluntary Withdrawal|0|||
48573483|NCT04533412|156290362|FG000|Overall Study|Withdrawal by Subject|1|||
48318896|NCT00901901|155368147|FG001|Treatment Period|Lost to Follow-up|5|||
48318897|NCT00901901|155368146|FG000|Treatment Period|Noncompliance with study medication|4|||
48318898|NCT00901901|155368147|FG001|Treatment Period|Noncompliance with study medication|1|||
48318899|NCT00901901|155368146|FG000|Treatment Period|Missing|1|||
48573484|NCT04533412|156290363|FG001|Overall Study|Withdrawal by Subject|1|||
48573485|NCT04533412|156290362|FG000|Overall Study|Lost to Follow-up|1|||
48573486|NCT04533412|156290363|FG001|Overall Study|Lost to Follow-up|4|||
48573487|NCT05107492|156290365|FG000|Overall Study|Lost to Follow-up|1|||
48573488|NCT05107492|156290366|FG001|Overall Study|Lost to Follow-up|0|||
48620138|NCT01658735|156467007|FG001|Overall Study|Withdrawal by Subject|5|||
48318900|NCT00901901|155368147|FG001|Treatment Period|Missing|0|||
48573489|NCT02040857|156290368|FG000|Overall Study|Adverse Event|14|||
48573490|NCT02040857|156290368|FG000|Overall Study|Physician Decision|5|||
48573491|NCT02040857|156290368|FG000|Overall Study|Withdrawal by Subject|31|||
48573492|NCT02040857|156290368|FG000|Overall Study|patient non-compliance|3|||
48573493|NCT02040857|156290368|FG000|Overall Study|Lost to Follow-up|2|||
48318901|NCT00901901|155368146|FG000|Treatment Period|Never treated|0|||
48573494|NCT02040857|156290368|FG000|Overall Study|recurrence|4|||
48318902|NCT00901901|155368147|FG001|Treatment Period|Never treated|3|||
48318903|NCT00901901|155368146|FG000|Treatment Period|Protocol driven decision point|0|||
48318904|NCT00901901|155368147|FG001|Treatment Period|Protocol driven decision point|2|||
48318905|NCT00901901|155368146|FG000|Treatment Period|Study terminated by sponsor|2|||
48318906|NCT00901901|155368147|FG001|Treatment Period|Study terminated by sponsor|0|||
48318907|NCT00901901|155368146|FG000|Treatment Period|Protocol Violation|5|||
48318908|NCT00901901|155368147|FG001|Treatment Period|Protocol Violation|9|||
48318909|NCT00901901|155368146|FG000|Treatment Period|Switch to commercial drug|1|||
48318910|NCT00901901|155368147|FG001|Treatment Period|Switch to commercial drug|1|||
48318911|NCT00901901|155368146|FG000|Treatment Period|Transfer to treatment continuation study|5|||
48318912|NCT00901901|155368147|FG001|Treatment Period|Transfer to treatment continuation study|2|||
48318913|NCT00901901|155368146|FG000|Follow-up Period|Death|181|||
48573495|NCT02040857|156290368|FG000|Overall Study|ineligible|1|||
48318914|NCT00901901|155368147|FG001|Follow-up Period|Death|208|||
48573496|NCT00900159|156290373|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
48573497|NCT00900159|156290374|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
48573498|NCT01680159|156290375|FG000|Screening Period|Not meet criteria for dose-up period|7|||
48573499|NCT01680159|156290375|FG000|Increased Dose Period|Adverse Event|6|||
48573500|NCT01680159|156290375|FG000|Increased Dose Period|Withdrawal by Subject|2|||
48573501|NCT02120833|156290376|FG000|Overall Study|Adverse Event|1|||
48573502|NCT02120833|156290377|FG001|Overall Study|Adverse Event|0|||
48573503|NCT02120833|156290376|FG000|Overall Study|Withdrawal by Subject|2|||
48573504|NCT02120833|156290377|FG001|Overall Study|Withdrawal by Subject|0|||
48573505|NCT02120833|156290376|FG000|Overall Study|Lost to Follow-up|1|||
48573506|NCT02120833|156290377|FG001|Overall Study|Lost to Follow-up|1|||
48573507|NCT00520533|156290378|FG000|Overall Study|Death|1|||
48573508|NCT00520533|156290378|FG000|Overall Study|Suspension of the study for safety reasons|1|||
48573509|NCT00520533|156290378|FG000|Overall Study|Withdrawal by Subject|1|||
48573510|NCT00520533|156290378|FG000|Overall Study|Physician Decision|1|||
48573511|NCT03483961|156290379|FG000|Overall Study|Lost to Follow-up|7|||
48573512|NCT03483961|156290380|FG001|Overall Study|Lost to Follow-up|6|||
48573513|NCT03483961|156290381|FG002|Overall Study|Lost to Follow-up|6|||
48573514|NCT03483961|156290382|FG003|Overall Study|Lost to Follow-up|6|||
48573515|NCT03483961|156290383|FG004|Overall Study|Lost to Follow-up|6|||
48573516|NCT03483961|156290384|FG005|Overall Study|Lost to Follow-up|4|||
48573517|NCT03483961|156290385|FG006|Overall Study|Lost to Follow-up|4|||
48573518|NCT03483961|156290386|FG007|Overall Study|Lost to Follow-up|11|||
48573519|NCT03483961|156290387|FG008|Overall Study|Lost to Follow-up|1|||
48573520|NCT03483961|156290388|FG009|Overall Study|Lost to Follow-up|0|||
48573521|NCT03483961|156290379|FG000|Overall Study|Withdrawal by Subject|3|||
48573522|NCT03483961|156290380|FG001|Overall Study|Withdrawal by Subject|4|||
48573523|NCT03483961|156290381|FG002|Overall Study|Withdrawal by Subject|5|||
48573524|NCT03483961|156290382|FG003|Overall Study|Withdrawal by Subject|3|||
48573525|NCT03483961|156290383|FG004|Overall Study|Withdrawal by Subject|4|||
48573526|NCT03483961|156290384|FG005|Overall Study|Withdrawal by Subject|2|||
48573527|NCT03483961|156290385|FG006|Overall Study|Withdrawal by Subject|1|||
48573528|NCT03483961|156290386|FG007|Overall Study|Withdrawal by Subject|2|||
48573529|NCT03483961|156290387|FG008|Overall Study|Withdrawal by Subject|1|||
48573530|NCT03483961|156290388|FG009|Overall Study|Withdrawal by Subject|0|||
48573531|NCT03483961|156290379|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
48573532|NCT03483961|156290380|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48573533|NCT03483961|156290381|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48573534|NCT03483961|156290382|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48573535|NCT03483961|156290383|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48318915|NCT00901901|155368146|FG000|Follow-up Period|Protocol driven decision point|47|||
48318916|NCT00901901|155368147|FG001|Follow-up Period|Protocol driven decision point|36|||
48318917|NCT00901901|155368146|FG000|Follow-up Period|Withdrawal by Subject|6|||
48573536|NCT03483961|156290384|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48573537|NCT03483961|156290385|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48585124|NCT01094782|156333787|FG004|Overall Study|Withdrawal by Subject|5|||
48585125|NCT01094782|156333788|FG005|Overall Study|Withdrawal by Subject|0|||
48585126|NCT01094782|156333783|FG000|Overall Study|Lost to Follow-up|1|||
48585127|NCT01094782|156333784|FG001|Overall Study|Lost to Follow-up|0|||
48585128|NCT01094782|156333785|FG002|Overall Study|Lost to Follow-up|0|||
48585129|NCT01094782|156333786|FG003|Overall Study|Lost to Follow-up|2|||
48585130|NCT01094782|156333787|FG004|Overall Study|Lost to Follow-up|1|||
48585131|NCT01094782|156333788|FG005|Overall Study|Lost to Follow-up|4|||
48585132|NCT01094782|156333783|FG000|Overall Study|Positive Drug Screen|2|||
48585133|NCT01094782|156333784|FG001|Overall Study|Positive Drug Screen|2|||
48620139|NCT01658735|156467008|FG002|Overall Study|Withdrawal by Subject|3|||
48620140|NCT05463705|156467012|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
48620141|NCT05463705|156467013|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
48620142|NCT05463705|156467014|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
48620143|NCT05463705|156467015|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
48620144|NCT05463705|156467016|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
48620145|NCT05463705|156467017|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
48620146|NCT00311168|156467018|FG000|First Intervention|Withdrawal by Subject|2|||
48620147|NCT00311168|156467019|FG001|First Intervention|Withdrawal by Subject|2|||
48620148|NCT00311168|156467018|FG000|First Intervention|Lost to Follow-up|1|||
48620149|NCT00311168|156467019|FG001|First Intervention|Lost to Follow-up|1|||
48620150|NCT00311168|156467018|FG000|First Intervention|Protocol Violation|1|||
48620151|NCT00311168|156467019|FG001|First Intervention|Protocol Violation|1|||
48620152|NCT00311168|156467018|FG000|First Intervention|Adverse Event|1|||
48620153|NCT00311168|156467019|FG001|First Intervention|Adverse Event|0|||
48620154|NCT00311168|156467018|FG000|First Intervention|Other|2|||
48620155|NCT00311168|156467019|FG001|First Intervention|Other|2|||
48620156|NCT00311168|156467018|FG000|Second Intervention|Lost to Follow-up|9|||
48620157|NCT00311168|156467019|FG001|Second Intervention|Lost to Follow-up|2|||
48620158|NCT00311168|156467018|FG000|Second Intervention|Withdrawal by Subject|0|||
48620159|NCT00311168|156467019|FG001|Second Intervention|Withdrawal by Subject|1|||
48620160|NCT00311168|156467018|FG000|Second Intervention|Other|1|||
48620161|NCT00311168|156467019|FG001|Second Intervention|Other|1|||
48620162|NCT01666652|156467022|FG000|Overall Study|Serious Adverse Event|0|||
48620163|NCT01666652|156467023|FG001|Overall Study|Serious Adverse Event|0|||
48620164|NCT01666652|156467024|FG002|Overall Study|Serious Adverse Event|0|||
48620165|NCT01666652|156467025|FG003|Overall Study|Serious Adverse Event|1|||
48620166|NCT01666652|156467026|FG004|Overall Study|Serious Adverse Event|0|||
48620167|NCT01666652|156467022|FG000|Overall Study|Withdrawal by Subject|0|||
48620168|NCT01666652|156467023|FG001|Overall Study|Withdrawal by Subject|0|||
48620169|NCT01666652|156467024|FG002|Overall Study|Withdrawal by Subject|0|||
48620170|NCT01666652|156467025|FG003|Overall Study|Withdrawal by Subject|0|||
48620171|NCT01666652|156467026|FG004|Overall Study|Withdrawal by Subject|1|||
48620172|NCT01666652|156467022|FG000|Overall Study|Moved from study area|1|||
48620173|NCT01666652|156467023|FG001|Overall Study|Moved from study area|0|||
48620174|NCT01666652|156467024|FG002|Overall Study|Moved from study area|0|||
48620175|NCT01666652|156467025|FG003|Overall Study|Moved from study area|2|||
48620176|NCT01666652|156467026|FG004|Overall Study|Moved from study area|0|||
48620177|NCT01666652|156467022|FG000|Overall Study|Lost to Follow-up|1|||
48620178|NCT01666652|156467023|FG001|Overall Study|Lost to Follow-up|1|||
48620179|NCT01666652|156467024|FG002|Overall Study|Lost to Follow-up|1|||
48620180|NCT01666652|156467025|FG003|Overall Study|Lost to Follow-up|1|||
48620181|NCT01666652|156467026|FG004|Overall Study|Lost to Follow-up|0|||
48573538|NCT03483961|156290386|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48573539|NCT03483961|156290387|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48573540|NCT03483961|156290388|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
48573541|NCT03483961|156290379|FG000|Overall Study|Adverse Event|0|||
48620182|NCT00609973|156467027|FG000|Overall Study|Adverse Event|2|||
48573542|NCT03483961|156290380|FG001|Overall Study|Adverse Event|0|||
48573543|NCT03483961|156290381|FG002|Overall Study|Adverse Event|1|||
48573544|NCT03483961|156290382|FG003|Overall Study|Adverse Event|0|||
48573545|NCT03483961|156290383|FG004|Overall Study|Adverse Event|0|||
48573546|NCT03483961|156290384|FG005|Overall Study|Adverse Event|0|||
48573547|NCT03483961|156290385|FG006|Overall Study|Adverse Event|0|||
48573548|NCT03483961|156290386|FG007|Overall Study|Adverse Event|0|||
48573549|NCT03483961|156290387|FG008|Overall Study|Adverse Event|0|||
48620183|NCT00609973|156467028|FG001|Overall Study|Adverse Event|1|||
48620184|NCT00609973|156467027|FG000|Overall Study|Protocol Violation|4|||
48620185|NCT00609973|156467028|FG001|Overall Study|Protocol Violation|3|||
48620186|NCT00609973|156467027|FG000|Overall Study|Lost to Follow-up|2|||
48620187|NCT00609973|156467028|FG001|Overall Study|Lost to Follow-up|1|||
48620188|NCT00609973|156467027|FG000|Overall Study|Withdrawal by Subject|0|||
48620189|NCT00609973|156467028|FG001|Overall Study|Withdrawal by Subject|1|||
48620190|NCT02453191|156467031|FG000|Overall Study|Withdrawal by Subject|1|||
48620191|NCT03412890|156467032|FG000|Overall Study|Adverse Event|5|||
48573550|NCT03483961|156290388|FG009|Overall Study|Adverse Event|0|||
48573551|NCT00977314|156290390|FG000|Overall Study|Withdrawal by Subject|1|||
48573552|NCT00977314|156290391|FG001|Overall Study|Withdrawal by Subject|0|||
48573553|NCT00977314|156290390|FG000|Overall Study|Physician Decision|1|||
48573554|NCT00977314|156290391|FG001|Overall Study|Physician Decision|0|||
48573555|NCT02107859|156290394|FG000|Overall Study|Withdrawal by Subject|14|||
48573556|NCT02107859|156290394|FG000|Overall Study|Adverse Event|3|||
48573557|NCT02107859|156290394|FG000|Overall Study|Study closure|41|||
48573558|NCT02107859|156290394|FG000|Overall Study|Other than specified|3|||
48573559|NCT02981082|156290397|FG000|Overall Study|Withdrawal by Subject|2|||
48573560|NCT02981082|156290398|FG001|Overall Study|Withdrawal by Subject|0|||
48573561|NCT02981082|156290397|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
48573562|NCT02981082|156290398|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
48573563|NCT02981082|156290397|FG000|Overall Study|Adverse Event|0|||
48573564|NCT02981082|156290398|FG001|Overall Study|Adverse Event|1|||
48573565|NCT02537431|156290399|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
48573566|NCT01736397|156292326|FG000|Overall Study|Lack of Efficacy|1|||
48573567|NCT01736397|156292327|FG001|Overall Study|Lack of Efficacy|11|||
48573568|NCT01736397|156292326|FG000|Overall Study|Withdrawal by Subject|6|||
48573569|NCT01736397|156292327|FG001|Overall Study|Withdrawal by Subject|5|||
48573570|NCT01736397|156292326|FG000|Overall Study|Lost to Follow-up|0|||
48573571|NCT01736397|156292327|FG001|Overall Study|Lost to Follow-up|1|||
48573572|NCT01736397|156292326|FG000|Overall Study|Adverse Event|6|||
48573573|NCT01736397|156292327|FG001|Overall Study|Adverse Event|3|||
48573574|NCT01736397|156292326|FG000|Overall Study|Not stated|1|||
48573575|NCT01736397|156292327|FG001|Overall Study|Not stated|4|||
48573576|NCT05088603|156292332|FG000|Overall Study|Protocol Violation|6|||
48573577|NCT05088603|156292333|FG001|Overall Study|Protocol Violation|1|||
48573578|NCT01672710|156292334|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
48573579|NCT01672710|156292335|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
48573580|NCT01672710|156292334|FG000|3 Month Follow up|Lost to Follow-up|2|||
48573581|NCT01672710|156292335|FG001|3 Month Follow up|Lost to Follow-up|3|||
48573582|NCT01672710|156292334|FG000|3 Month Follow up|follow up due after termination date|4|||
48573583|NCT01672710|156292335|FG001|3 Month Follow up|follow up due after termination date|1|||
48573584|NCT01167881|156292336|FG000|Overall Study|Adverse Event|47|||
48573585|NCT01167881|156292337|FG001|Overall Study|Adverse Event|51|||
48573586|NCT01167881|156292336|FG000|Overall Study|Lack of Efficacy|4|||
48573587|NCT01167881|156292337|FG001|Overall Study|Lack of Efficacy|7|||
48573588|NCT01167881|156292336|FG000|Overall Study|Non compliant with protocol|9|||
48573589|NCT01167881|156292337|FG001|Overall Study|Non compliant with protocol|18|||
48573590|NCT01167881|156292336|FG000|Overall Study|Lost to Follow-up|19|||
48573591|NCT01167881|156292337|FG001|Overall Study|Lost to Follow-up|20|||
48573592|NCT01167881|156292336|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
48573593|NCT01167881|156292337|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
48573594|NCT01167881|156292336|FG000|Overall Study|Not treated|4|||
48573595|NCT01167881|156292337|FG001|Overall Study|Not treated|0|||
48573596|NCT01167881|156292336|FG000|Overall Study|Other not defined above|31|||
48573597|NCT01167881|156292337|FG001|Overall Study|Other not defined above|55|||
48573598|NCT03436693|156292339|FG000|Overall Study|Adverse Event|22|||
48573599|NCT03436693|156292340|FG001|Overall Study|Adverse Event|10|||
48573600|NCT03436693|156292339|FG000|Overall Study|Physician Decision|3|||
48573601|NCT03436693|156292340|FG001|Overall Study|Physician Decision|3|||
48573602|NCT03436693|156292339|FG000|Overall Study|Withdrawal by Subject|4|||
48573603|NCT03436693|156292340|FG001|Overall Study|Withdrawal by Subject|13|||
48573604|NCT03436693|156292339|FG000|Overall Study|Progressive Disease|1|||
48573605|NCT03436693|156292340|FG001|Overall Study|Progressive Disease|1|||
48573606|NCT01014988|156292341|FG000|Overall Study|Adverse Event|20|||
48573607|NCT01014988|156292342|FG001|Overall Study|Adverse Event|0|||
48573608|NCT01014988|156292343|FG002|Overall Study|Adverse Event|1|||
48573609|NCT01014988|156292344|FG003|Overall Study|Adverse Event|0|||
48573610|NCT01014988|156292345|FG004|Overall Study|Adverse Event|1|||
48573611|NCT01014988|156292346|FG005|Overall Study|Adverse Event|3|||
48573612|NCT01014988|156292341|FG000|Overall Study|Lost to Follow-up|1|||
48573613|NCT01014988|156292342|FG001|Overall Study|Lost to Follow-up|0|||
48573614|NCT01014988|156292343|FG002|Overall Study|Lost to Follow-up|1|||
48573615|NCT01014988|156292344|FG003|Overall Study|Lost to Follow-up|0|||
48573616|NCT01014988|156292345|FG004|Overall Study|Lost to Follow-up|0|||
48573617|NCT01014988|156292346|FG005|Overall Study|Lost to Follow-up|0|||
48573618|NCT01014988|156292341|FG000|Overall Study|Physician Decision|1|||
48573619|NCT01014988|156292342|FG001|Overall Study|Physician Decision|0|||
48573620|NCT01014988|156292343|FG002|Overall Study|Physician Decision|0|||
48573621|NCT01014988|156292344|FG003|Overall Study|Physician Decision|0|||
48573622|NCT01014988|156292345|FG004|Overall Study|Physician Decision|0|||
48573623|NCT01014988|156292346|FG005|Overall Study|Physician Decision|0|||
48573624|NCT01014988|156292341|FG000|Overall Study|Withdrawal by Subject|1|||
48573625|NCT01014988|156292342|FG001|Overall Study|Withdrawal by Subject|0|||
48573626|NCT01014988|156292343|FG002|Overall Study|Withdrawal by Subject|0|||
48620192|NCT03412890|156467033|FG001|Overall Study|Adverse Event|5|||
48620193|NCT03412890|156467034|FG002|Overall Study|Adverse Event|9|||
48620194|NCT03412890|156467032|FG000|Overall Study|Protocol deviation|2|||
48620195|NCT03412890|156467033|FG001|Overall Study|Protocol deviation|1|||
48620196|NCT03412890|156467034|FG002|Overall Study|Protocol deviation|2|||
48620197|NCT03412890|156467032|FG000|Overall Study|Lost to Follow-up|7|||
48620198|NCT03412890|156467033|FG001|Overall Study|Lost to Follow-up|10|||
48620199|NCT03412890|156467034|FG002|Overall Study|Lost to Follow-up|10|||
48620200|NCT03412890|156467032|FG000|Overall Study|Withdrawal by Subject|9|||
48620201|NCT03412890|156467033|FG001|Overall Study|Withdrawal by Subject|12|||
48620202|NCT03412890|156467034|FG002|Overall Study|Withdrawal by Subject|11|||
48620203|NCT03412890|156467032|FG000|Overall Study|Lack of Efficacy|2|||
48620204|NCT03412890|156467033|FG001|Overall Study|Lack of Efficacy|7|||
48620205|NCT03412890|156467034|FG002|Overall Study|Lack of Efficacy|5|||
48620206|NCT03412890|156467032|FG000|Overall Study|Other|5|||
48620207|NCT03412890|156467033|FG001|Overall Study|Other|6|||
48620208|NCT03412890|156467034|FG002|Overall Study|Other|5|||
48620209|NCT03412890|156467032|FG000|Overall Study|Participants who did not receive any study drug|0|||
48620210|NCT03412890|156467033|FG001|Overall Study|Participants who did not receive any study drug|1|||
48620211|NCT03412890|156467034|FG002|Overall Study|Participants who did not receive any study drug|0|||
48620212|NCT01696214|156467040|FG000|Overall Study|Lost to Follow-up|1|||
48620213|NCT01696214|156467041|FG001|Overall Study|Lost to Follow-up|0|||
48573627|NCT01014988|156292344|FG003|Overall Study|Withdrawal by Subject|0|||
48620214|NCT01696214|156467042|FG002|Overall Study|Lost to Follow-up|0|||
48620215|NCT01696214|156467043|FG003|Overall Study|Lost to Follow-up|0|||
48620216|NCT02965976|156467044|FG000|Overall Study|Withdrawal by Subject|2|||
48620217|NCT02965976|156467045|FG001|Overall Study|Withdrawal by Subject|0|||
48620218|NCT02134028|156467046|FG000|Overall Study|Lack of Efficacy|1|||
48620219|NCT02134028|156467047|FG001|Overall Study|Lack of Efficacy|0|||
48620220|NCT02134028|156467048|FG002|Overall Study|Lack of Efficacy|3|||
48620221|NCT02134028|156467049|FG003|Overall Study|Lack of Efficacy|2|||
48620222|NCT02134028|156467050|FG004|Overall Study|Lack of Efficacy|1|||
48620223|NCT02134028|156467051|FG005|Overall Study|Lack of Efficacy|2|||
48620224|NCT02134028|156467052|FG006|Overall Study|Lack of Efficacy|1|||
48620225|NCT02134028|156467053|FG007|Overall Study|Lack of Efficacy|0|||
48573628|NCT01014988|156292345|FG004|Overall Study|Withdrawal by Subject|0|||
48573629|NCT01014988|156292346|FG005|Overall Study|Withdrawal by Subject|0|||
48573630|NCT05217641|156292351|FG000|Overall Study|Lost to Follow-up|1|||
48573631|NCT05217641|156292352|FG001|Overall Study|Lost to Follow-up|1|||
48573632|NCT05217641|156292353|FG002|Overall Study|Lost to Follow-up|0|||
48573633|NCT05217641|156292354|FG003|Overall Study|Lost to Follow-up|1|||
48573634|NCT05217641|156292355|FG004|Overall Study|Lost to Follow-up|1|||
48573635|NCT05217641|156292356|FG005|Overall Study|Lost to Follow-up|0|||
48573636|NCT05217641|156292351|FG000|Overall Study|Withdrawal by Subject|0|||
48573637|NCT05217641|156292352|FG001|Overall Study|Withdrawal by Subject|0|||
48573638|NCT05217641|156292353|FG002|Overall Study|Withdrawal by Subject|0|||
48573639|NCT05217641|156292354|FG003|Overall Study|Withdrawal by Subject|3|||
48573640|NCT05217641|156292355|FG004|Overall Study|Withdrawal by Subject|1|||
48573641|NCT05217641|156292356|FG005|Overall Study|Withdrawal by Subject|0|||
48573642|NCT05217641|156292351|FG000|Overall Study|Other: participant did not specify reason|0|||
48573643|NCT05217641|156292352|FG001|Overall Study|Other: participant did not specify reason|0|||
48573644|NCT05217641|156292353|FG002|Overall Study|Other: participant did not specify reason|0|||
48573645|NCT05217641|156292354|FG003|Overall Study|Other: participant did not specify reason|0|||
48573646|NCT05217641|156292355|FG004|Overall Study|Other: participant did not specify reason|1|||
48573647|NCT05217641|156292356|FG005|Overall Study|Other: participant did not specify reason|0|||
48573648|NCT05217641|156292351|FG000|Overall Study|Extended Follow up|1|||
48620226|NCT02134028|156467046|FG000|Overall Study|Poor compliance to protocol|1|||
48620227|NCT02134028|156467047|FG001|Overall Study|Poor compliance to protocol|1|||
48620228|NCT02134028|156467048|FG002|Overall Study|Poor compliance to protocol|3|||
48620229|NCT02134028|156467049|FG003|Overall Study|Poor compliance to protocol|7|||
48620230|NCT02134028|156467050|FG004|Overall Study|Poor compliance to protocol|1|||
48620231|NCT02134028|156467051|FG005|Overall Study|Poor compliance to protocol|1|||
48620232|NCT02134028|156467052|FG006|Overall Study|Poor compliance to protocol|0|||
48573649|NCT05217641|156292352|FG001|Overall Study|Extended Follow up|1|||
48573650|NCT05217641|156292353|FG002|Overall Study|Extended Follow up|0|||
48573651|NCT05217641|156292354|FG003|Overall Study|Extended Follow up|0|||
48573652|NCT05217641|156292355|FG004|Overall Study|Extended Follow up|1|||
48573653|NCT05217641|156292356|FG005|Overall Study|Extended Follow up|0|||
48573654|NCT02137850|156292357|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
48573655|NCT02137850|156292358|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
48573656|NCT02137850|156292359|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
48573657|NCT02137850|156292357|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
48573658|NCT02137850|156292358|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
48573659|NCT02137850|156292359|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
48573660|NCT02137850|156292357|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
48573661|NCT02137850|156292358|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
48573662|NCT02137850|156292359|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
48573663|NCT02137850|156292357|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
48573664|NCT02137850|156292358|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
48573665|NCT02137850|156292359|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
48573666|NCT02137850|156292357|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
48573667|NCT02137850|156292358|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
48573668|NCT02137850|156292359|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
48573669|NCT02137850|156292357|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
48573670|NCT02137850|156292358|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
48573671|NCT02137850|156292359|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
48573672|NCT02137850|156292357|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
48573673|NCT02137850|156292358|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
48573674|NCT02137850|156292359|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
48573675|NCT02137850|156292357|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
48573676|NCT02137850|156292358|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
48573677|NCT02137850|156292359|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
48573678|NCT02137850|156292357|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
48620233|NCT02134028|156467053|FG007|Overall Study|Poor compliance to protocol|0|||
48620234|NCT02134028|156467046|FG000|Overall Study|Other unspecified|4|||
48620235|NCT02134028|156467047|FG001|Overall Study|Other unspecified|22|||
48620236|NCT02134028|156467048|FG002|Overall Study|Other unspecified|33|||
48620237|NCT02134028|156467049|FG003|Overall Study|Other unspecified|64|||
48620238|NCT02134028|156467050|FG004|Overall Study|Other unspecified|8|||
48620239|NCT02134028|156467051|FG005|Overall Study|Other unspecified|6|||
48620240|NCT02134028|156467052|FG006|Overall Study|Other unspecified|2|||
48620241|NCT02134028|156467053|FG007|Overall Study|Other unspecified|1|||
48620242|NCT02134028|156467046|FG000|Overall Study|Adverse Event|3|||
48620243|NCT02134028|156467047|FG001|Overall Study|Adverse Event|19|||
48620244|NCT02134028|156467048|FG002|Overall Study|Adverse Event|13|||
48620245|NCT02134028|156467049|FG003|Overall Study|Adverse Event|32|||
48620246|NCT02134028|156467050|FG004|Overall Study|Adverse Event|4|||
48620247|NCT02134028|156467051|FG005|Overall Study|Adverse Event|5|||
48620248|NCT02134028|156467052|FG006|Overall Study|Adverse Event|1|||
48620249|NCT02134028|156467053|FG007|Overall Study|Adverse Event|2|||
48620250|NCT00806026|156467054|FG000|Overall Study|Death|0|||
48620251|NCT00806026|156467055|FG001|Overall Study|Death|0|||
48620252|NCT00806026|156467056|FG002|Overall Study|Death|0|||
48620253|NCT00806026|156467057|FG003|Overall Study|Death|1|||
48620254|NCT00806026|156467058|FG004|Overall Study|Death|0|||
48620255|NCT00806026|156467059|FG005|Overall Study|Death|0|||
48620256|NCT00806026|156467054|FG000|Overall Study|Did not meet entrance criteria|4|||
48620257|NCT00806026|156467055|FG001|Overall Study|Did not meet entrance criteria|1|||
48620258|NCT00806026|156467056|FG002|Overall Study|Did not meet entrance criteria|2|||
48620259|NCT00806026|156467057|FG003|Overall Study|Did not meet entrance criteria|1|||
48620260|NCT00806026|156467058|FG004|Overall Study|Did not meet entrance criteria|0|||
48620261|NCT00806026|156467059|FG005|Overall Study|Did not meet entrance criteria|0|||
48620262|NCT00806026|156467054|FG000|Overall Study|Lack of Efficacy|5|||
48620263|NCT00806026|156467055|FG001|Overall Study|Lack of Efficacy|18|||
48620264|NCT00806026|156467056|FG002|Overall Study|Lack of Efficacy|13|||
48620265|NCT00806026|156467057|FG003|Overall Study|Lack of Efficacy|4|||
48620266|NCT00806026|156467058|FG004|Overall Study|Lack of Efficacy|8|||
48620267|NCT00806026|156467059|FG005|Overall Study|Lack of Efficacy|7|||
48620268|NCT00806026|156467054|FG000|Overall Study|Lost to Follow-up|8|||
48620269|NCT00806026|156467055|FG001|Overall Study|Lost to Follow-up|15|||
48620270|NCT00806026|156467056|FG002|Overall Study|Lost to Follow-up|8|||
48620271|NCT00806026|156467057|FG003|Overall Study|Lost to Follow-up|2|||
48620272|NCT00806026|156467058|FG004|Overall Study|Lost to Follow-up|6|||
48620273|NCT00806026|156467059|FG005|Overall Study|Lost to Follow-up|6|||
48620274|NCT00806026|156467054|FG000|Overall Study|Withdrawal by Subject|14|||
48620275|NCT00806026|156467055|FG001|Overall Study|Withdrawal by Subject|17|||
48620276|NCT00806026|156467056|FG002|Overall Study|Withdrawal by Subject|9|||
48620277|NCT00806026|156467057|FG003|Overall Study|Withdrawal by Subject|2|||
48620278|NCT00806026|156467058|FG004|Overall Study|Withdrawal by Subject|5|||
48620279|NCT00806026|156467059|FG005|Overall Study|Withdrawal by Subject|3|||
48620280|NCT00806026|156467054|FG000|Overall Study|Other|3|||
48573679|NCT02137850|156292358|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
48620281|NCT00806026|156467055|FG001|Overall Study|Other|6|||
48620282|NCT00806026|156467056|FG002|Overall Study|Other|8|||
48318918|NCT00901901|155368147|FG001|Follow-up Period|Withdrawal by Subject|9|||
48318919|NCT00901901|155368146|FG000|Follow-up Period|Lost to Follow-up|12|||
48318920|NCT00901901|155368147|FG001|Follow-up Period|Lost to Follow-up|8|||
48318921|NCT00901901|155368146|FG000|Follow-up Period|Missing|94|||
48573680|NCT02137850|156292359|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
48573681|NCT02137850|156292357|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
48573682|NCT02137850|156292358|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
48573683|NCT02137850|156292359|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
48573684|NCT02137850|156292357|FG000|Main Phase: Prophylaxis|Other|0|||
48573685|NCT02137850|156292358|FG001|Main Phase: Prophylaxis|Other|1|||
48573686|NCT02137850|156292359|FG002|Main Phase: Prophylaxis|Other|0|||
48573687|NCT02137850|156292357|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
48573688|NCT02137850|156292358|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
48573689|NCT02137850|156292359|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
48573690|NCT02137850|156292357|FG000|Main Phase: Prophylaxis|Early site closure|0|||
48573691|NCT02137850|156292358|FG001|Main Phase: Prophylaxis|Early site closure|2|||
48573692|NCT02137850|156292359|FG002|Main Phase: Prophylaxis|Early site closure|0|||
48573693|NCT02137850|156292357|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
48573694|NCT02137850|156292358|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
48573695|NCT02137850|156292359|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
48573696|NCT02137850|156292357|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
48573697|NCT02137850|156292358|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
48573698|NCT02137850|156292359|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
48573699|NCT02137850|156292357|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
48573700|NCT02137850|156292358|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
48620283|NCT00806026|156467057|FG003|Overall Study|Other|2|||
48620284|NCT00806026|156467058|FG004|Overall Study|Other|0|||
48318922|NCT00901901|155368147|FG001|Follow-up Period|Missing|80|||
48620285|NCT00806026|156467059|FG005|Overall Study|Other|4|||
48620286|NCT00806026|156467054|FG000|Overall Study|Protocol Violation|6|||
48620287|NCT00806026|156467055|FG001|Overall Study|Protocol Violation|9|||
48620288|NCT00806026|156467056|FG002|Overall Study|Protocol Violation|9|||
48620289|NCT00806026|156467057|FG003|Overall Study|Protocol Violation|0|||
48620290|NCT00806026|156467058|FG004|Overall Study|Protocol Violation|2|||
48620291|NCT00806026|156467059|FG005|Overall Study|Protocol Violation|3|||
48620292|NCT00806026|156467054|FG000|Overall Study|Adverse Event|52|||
48620293|NCT00806026|156467055|FG001|Overall Study|Adverse Event|35|||
48620294|NCT00806026|156467056|FG002|Overall Study|Adverse Event|44|||
48620295|NCT00806026|156467057|FG003|Overall Study|Adverse Event|17|||
48620296|NCT00806026|156467058|FG004|Overall Study|Adverse Event|9|||
48620297|NCT00806026|156467059|FG005|Overall Study|Adverse Event|9|||
48620298|NCT00819832|156467062|FG000|Overall Study|Sponsor Termination of Study|3|||
48620299|NCT00819832|156467063|FG001|Overall Study|Sponsor Termination of Study|0|||
48620300|NCT00819832|156467064|FG002|Overall Study|Sponsor Termination of Study|0|||
48620301|NCT00819832|156467065|FG003|Overall Study|Sponsor Termination of Study|0|||
48620302|NCT00819832|156467066|FG004|Overall Study|Sponsor Termination of Study|0|||
48620303|NCT00819832|156467067|FG005|Overall Study|Sponsor Termination of Study|0|||
48620304|NCT02583477|156467070|FG000|Overall Study|Adverse Event|0|||
48620305|NCT02583477|156467071|FG001|Overall Study|Adverse Event|2|||
48620306|NCT02583477|156467070|FG000|Overall Study|Death|1|||
48620307|NCT02583477|156467071|FG001|Overall Study|Death|16|||
48620308|NCT02583477|156467070|FG000|Overall Study|Study terminated|2|||
48735994|NCT02935842|156883748|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
48318923|NCT02272816|155368148|FG000|Overall Study|Adverse Event|1|||
48573701|NCT02137850|156292359|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
48620309|NCT02583477|156467071|FG001|Overall Study|Study terminated|2|||
48318924|NCT00331136|155368149|FG000|Overall Study|Adverse Event|3|||
48318925|NCT00331136|155368150|FG001|Overall Study|Adverse Event|5|||
48318926|NCT00331136|155368151|FG002|Overall Study|Adverse Event|0|||
48318927|NCT00331136|155368152|FG003|Overall Study|Adverse Event|1|||
48318928|NCT00331136|155368149|FG000|Overall Study|Withdrawal by Subject|0|||
48318929|NCT00331136|155368150|FG001|Overall Study|Withdrawal by Subject|1|||
48318930|NCT00331136|155368151|FG002|Overall Study|Withdrawal by Subject|0|||
48318931|NCT00331136|155368152|FG003|Overall Study|Withdrawal by Subject|0|||
48318932|NCT00331136|155368149|FG000|Overall Study|Lost to Follow-up|0|||
48318933|NCT00331136|155368150|FG001|Overall Study|Lost to Follow-up|1|||
48318934|NCT00331136|155368151|FG002|Overall Study|Lost to Follow-up|0|||
48318935|NCT00331136|155368152|FG003|Overall Study|Lost to Follow-up|0|||
48318936|NCT00331136|155368149|FG000|Overall Study|Protocol Violation|1|||
48318937|NCT00331136|155368150|FG001|Overall Study|Protocol Violation|0|||
48318938|NCT00331136|155368151|FG002|Overall Study|Protocol Violation|0|||
48318939|NCT00331136|155368152|FG003|Overall Study|Protocol Violation|0|||
48318940|NCT00331136|155368149|FG000|Overall Study|Not treated|1|||
48318941|NCT00331136|155368150|FG001|Overall Study|Not treated|0|||
48318942|NCT00331136|155368151|FG002|Overall Study|Not treated|0|||
48318943|NCT00331136|155368152|FG003|Overall Study|Not treated|0|||
48318944|NCT00632749|155368153|FG000|Overall Study|Progressive disease|3|||
48573702|NCT02137850|156292357|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
48573703|NCT02137850|156292358|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
48573704|NCT02137850|156292359|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
48573705|NCT02137850|156292357|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
48318945|NCT00632749|155368154|FG001|Overall Study|Progressive disease|2|||
48318946|NCT00632749|155368155|FG002|Overall Study|Progressive disease|2|||
48318947|NCT00632749|155368156|FG003|Overall Study|Progressive disease|2|||
48318948|NCT00632749|155368157|FG004|Overall Study|Progressive disease|4|||
48318949|NCT00632749|155368158|FG005|Overall Study|Progressive disease|4|||
48318950|NCT00632749|155368159|FG006|Overall Study|Progressive disease|3|||
48318951|NCT00632749|155368160|FG007|Overall Study|Progressive disease|2|||
48318952|NCT00632749|155368161|FG008|Overall Study|Progressive disease|3|||
48318953|NCT00632749|155368162|FG009|Overall Study|Progressive disease|2|||
48318954|NCT00632749|155368163|FG010|Overall Study|Progressive disease|4|||
48318955|NCT00632749|155368164|FG011|Overall Study|Progressive disease|3|||
48318956|NCT00632749|155368165|FG012|Overall Study|Progressive disease|2|||
48318957|NCT00632749|155368166|FG013|Overall Study|Progressive disease|4|||
48318958|NCT00632749|155368153|FG000|Overall Study|Other Adverse event|1|||
48318959|NCT00632749|155368154|FG001|Overall Study|Other Adverse event|1|||
48318960|NCT00632749|155368155|FG002|Overall Study|Other Adverse event|1|||
48318961|NCT00632749|155368156|FG003|Overall Study|Other Adverse event|1|||
48318962|NCT00632749|155368157|FG004|Overall Study|Other Adverse event|2|||
48573706|NCT02137850|156292358|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
48573707|NCT02137850|156292359|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
48573708|NCT02137850|156292357|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
48573709|NCT02137850|156292358|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
48573710|NCT02137850|156292359|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
48573711|NCT02137850|156292357|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
48573712|NCT02137850|156292358|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
48573713|NCT02137850|156292359|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
48573714|NCT02137850|156292357|FG000|Extension Phase: Prophylaxis|Other|0|||
48573715|NCT02137850|156292358|FG001|Extension Phase: Prophylaxis|Other|1|||
48573716|NCT02137850|156292359|FG002|Extension Phase: Prophylaxis|Other|0|||
48573717|NCT02137850|156292357|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
48573718|NCT02137850|156292358|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
48573719|NCT02137850|156292359|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
48573720|NCT01867710|156292363|FG000|Overall Study|Death|25|||
48573721|NCT01867710|156292364|FG001|Overall Study|Death|15|||
48573722|NCT01867710|156292365|FG002|Overall Study|Death|27|||
48573723|NCT01867710|156292366|FG003|Overall Study|Death|20|||
48573724|NCT01867710|156292363|FG000|Overall Study|Lost to Follow-up|3|||
48573725|NCT01867710|156292364|FG001|Overall Study|Lost to Follow-up|4|||
48573726|NCT01867710|156292365|FG002|Overall Study|Lost to Follow-up|3|||
48573727|NCT01867710|156292366|FG003|Overall Study|Lost to Follow-up|2|||
48573728|NCT01867710|156292363|FG000|Overall Study|Withdrawal of consent|2|||
48573729|NCT01867710|156292364|FG001|Overall Study|Withdrawal of consent|5|||
48573730|NCT01867710|156292365|FG002|Overall Study|Withdrawal of consent|1|||
48573731|NCT01867710|156292366|FG003|Overall Study|Withdrawal of consent|2|||
48573732|NCT01867710|156292363|FG000|Overall Study|Study Terminated by Sponsor|9|||
48573733|NCT01867710|156292364|FG001|Overall Study|Study Terminated by Sponsor|13|||
48573734|NCT01867710|156292365|FG002|Overall Study|Study Terminated by Sponsor|8|||
48318963|NCT00632749|155368158|FG005|Overall Study|Other Adverse event|4|||
48573735|NCT01867710|156292366|FG003|Overall Study|Study Terminated by Sponsor|16|||
48573736|NCT01867710|156292363|FG000|Overall Study|Biochemical progression|0|||
48318964|NCT00632749|155368159|FG006|Overall Study|Other Adverse event|1|||
48318965|NCT00632749|155368160|FG007|Overall Study|Other Adverse event|2|||
48573737|NCT01867710|156292364|FG001|Overall Study|Biochemical progression|1|||
48573738|NCT01867710|156292365|FG002|Overall Study|Biochemical progression|0|||
48573739|NCT01867710|156292366|FG003|Overall Study|Biochemical progression|0|||
48573740|NCT01867710|156292363|FG000|Overall Study|Clinical progression|0|||
48573741|NCT01867710|156292364|FG001|Overall Study|Clinical progression|0|||
48573742|NCT01867710|156292365|FG002|Overall Study|Clinical progression|1|||
48573743|NCT01867710|156292366|FG003|Overall Study|Clinical progression|0|||
48573744|NCT01867710|156292363|FG000|Overall Study|Disease progression|1|||
48573745|NCT01867710|156292364|FG001|Overall Study|Disease progression|0|||
48573746|NCT01867710|156292365|FG002|Overall Study|Disease progression|0|||
48573747|NCT01867710|156292366|FG003|Overall Study|Disease progression|0|||
48573748|NCT01867710|156292363|FG000|Overall Study|Patient decision|0|||
48573749|NCT01867710|156292364|FG001|Overall Study|Patient decision|0|||
48573750|NCT01867710|156292365|FG002|Overall Study|Patient decision|0|||
48573751|NCT01867710|156292366|FG003|Overall Study|Patient decision|1|||
48573752|NCT01867710|156292363|FG000|Overall Study|Patient to follow subsequent treatment|0|||
48573753|NCT01867710|156292364|FG001|Overall Study|Patient to follow subsequent treatment|1|||
48573754|NCT01867710|156292365|FG002|Overall Study|Patient to follow subsequent treatment|0|||
48573755|NCT01867710|156292366|FG003|Overall Study|Patient to follow subsequent treatment|0|||
48573756|NCT01867710|156292363|FG000|Overall Study|Progressive disease|1|||
48573757|NCT01867710|156292364|FG001|Overall Study|Progressive disease|0|||
48573758|NCT01867710|156292365|FG002|Overall Study|Progressive disease|0|||
48573759|NCT01867710|156292366|FG003|Overall Study|Progressive disease|0|||
48573760|NCT01867710|156292363|FG000|Overall Study|Protocol Violation|0|||
48573761|NCT01867710|156292364|FG001|Overall Study|Protocol Violation|0|||
48573762|NCT01867710|156292365|FG002|Overall Study|Protocol Violation|0|||
48573763|NCT01867710|156292366|FG003|Overall Study|Protocol Violation|1|||
48573764|NCT01867710|156292363|FG000|Overall Study|PSA-progression|0|||
48573765|NCT01867710|156292364|FG001|Overall Study|PSA-progression|1|||
48573766|NCT01867710|156292365|FG002|Overall Study|PSA-progression|0|||
48573767|NCT01867710|156292366|FG003|Overall Study|PSA-progression|0|||
48573768|NCT01867710|156292363|FG000|Overall Study|Study medication no longer effective|0|||
48573769|NCT01867710|156292364|FG001|Overall Study|Study medication no longer effective|1|||
48573770|NCT01867710|156292365|FG002|Overall Study|Study medication no longer effective|0|||
48573771|NCT01867710|156292366|FG003|Overall Study|Study medication no longer effective|0|||
48573772|NCT03689374|156292373|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
48573773|NCT03689374|156292374|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
48573774|NCT03689374|156292375|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
48573775|NCT03689374|156292373|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
48573776|NCT03689374|156292374|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
48573777|NCT03689374|156292375|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
48573778|NCT03689374|156292373|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
48573779|NCT03689374|156292374|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
48573780|NCT03689374|156292375|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
48573781|NCT03689374|156292373|FG000|Treatment Period (Week 0 to 52)|Death|0|||
48573782|NCT03689374|156292374|FG001|Treatment Period (Week 0 to 52)|Death|11|||
48573783|NCT03689374|156292375|FG002|Treatment Period (Week 0 to 52)|Death|1|||
48573784|NCT05367973|156292376|FG000|Overall Study|Adverse Event|0|||
48573785|NCT05367973|156292377|FG001|Overall Study|Adverse Event|2|||
48573786|NCT00957268|156292378|FG000|Overall Study|Voluntary Withdrawal|0|||
48573787|NCT00957268|156292379|FG001|Overall Study|Voluntary Withdrawal|0|||
48573788|NCT00957268|156292380|FG002|Overall Study|Voluntary Withdrawal|1|||
48573789|NCT00957268|156292381|FG003|Overall Study|Voluntary Withdrawal|0|||
48573790|NCT00957268|156292382|FG004|Overall Study|Voluntary Withdrawal|0|||
48573791|NCT04432831|156292383|FG000|Overall Study|Withdrawal by Subject|24|||
48573792|NCT04432831|156292384|FG001|Overall Study|Withdrawal by Subject|28|||
48573793|NCT04432831|156292385|FG002|Overall Study|Withdrawal by Subject|21|||
48573794|NCT04432831|156292383|FG000|Overall Study|Death|23|||
48573795|NCT04432831|156292384|FG001|Overall Study|Death|23|||
48573796|NCT04432831|156292385|FG002|Overall Study|Death|17|||
48573797|NCT04432831|156292383|FG000|Overall Study|Lost to Follow-up|15|||
48573798|NCT04432831|156292384|FG001|Overall Study|Lost to Follow-up|15|||
48573799|NCT04432831|156292385|FG002|Overall Study|Lost to Follow-up|12|||
48573800|NCT04432831|156292383|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
48573801|NCT04432831|156292384|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
48573802|NCT04432831|156292385|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
48573803|NCT04432831|156292383|FG000|Overall Study|Reason Not Specified|7|||
48573804|NCT04432831|156292384|FG001|Overall Study|Reason Not Specified|11|||
48573805|NCT04432831|156292385|FG002|Overall Study|Reason Not Specified|9|||
48573806|NCT04432831|156292383|FG000|Overall Study|Adverse Event|7|||
48573807|NCT04432831|156292384|FG001|Overall Study|Adverse Event|7|||
48735995|NCT02935842|156883749|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
48573808|NCT04432831|156292385|FG002|Overall Study|Adverse Event|7|||
48573809|NCT04432831|156292383|FG000|Overall Study|Physician Decision|1|||
48573810|NCT04432831|156292384|FG001|Overall Study|Physician Decision|3|||
48573811|NCT04432831|156292385|FG002|Overall Study|Physician Decision|6|||
48573812|NCT04432831|156292383|FG000|Overall Study|Protocol Violation|1|||
48573813|NCT04432831|156292384|FG001|Overall Study|Protocol Violation|0|||
48573814|NCT04432831|156292385|FG002|Overall Study|Protocol Violation|2|||
48573815|NCT04432831|156292383|FG000|Overall Study|Pregnancy|0|||
48573816|NCT04432831|156292384|FG001|Overall Study|Pregnancy|1|||
48573817|NCT04432831|156292385|FG002|Overall Study|Pregnancy|0|||
48573818|NCT04432831|156292383|FG000|Overall Study|Lack of Efficacy|0|||
48573819|NCT04432831|156292384|FG001|Overall Study|Lack of Efficacy|0|||
48573820|NCT04432831|156292385|FG002|Overall Study|Lack of Efficacy|2|||
48573821|NCT01738503|156292391|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
48573822|NCT01738503|156292392|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
48573823|NCT01738503|156292393|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
48573824|NCT01738503|156292394|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
48573825|NCT01738503|156292395|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
48573826|NCT01738503|156292396|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
48573827|NCT01738503|156292397|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
48573828|NCT01738503|156292391|FG000|Treatment Period|Adverse Event|0|||
48573829|NCT01738503|156292392|FG001|Treatment Period|Adverse Event|1|||
48573830|NCT01738503|156292393|FG002|Treatment Period|Adverse Event|0|||
48573831|NCT01738503|156292394|FG003|Treatment Period|Adverse Event|1|||
48573832|NCT01738503|156292395|FG004|Treatment Period|Adverse Event|2|||
48573833|NCT01738503|156292396|FG005|Treatment Period|Adverse Event|2|||
48573834|NCT01738503|156292397|FG006|Treatment Period|Adverse Event|2|||
48573835|NCT01738503|156292391|FG000|Treatment Period|Lost to Follow-up|0|||
48573836|NCT01738503|156292392|FG001|Treatment Period|Lost to Follow-up|0|||
48573837|NCT01738503|156292393|FG002|Treatment Period|Lost to Follow-up|3|||
48573838|NCT01738503|156292394|FG003|Treatment Period|Lost to Follow-up|4|||
48573839|NCT01738503|156292395|FG004|Treatment Period|Lost to Follow-up|1|||
48573840|NCT01738503|156292396|FG005|Treatment Period|Lost to Follow-up|1|||
48573841|NCT01738503|156292397|FG006|Treatment Period|Lost to Follow-up|5|||
48573842|NCT01738503|156292391|FG000|Treatment Period|Withdrawal by Subject|0|||
48573843|NCT01738503|156292392|FG001|Treatment Period|Withdrawal by Subject|1|||
48573844|NCT01738503|156292393|FG002|Treatment Period|Withdrawal by Subject|0|||
48573845|NCT01738503|156292394|FG003|Treatment Period|Withdrawal by Subject|1|||
48573846|NCT01738503|156292395|FG004|Treatment Period|Withdrawal by Subject|1|||
48573847|NCT01738503|156292396|FG005|Treatment Period|Withdrawal by Subject|1|||
48573848|NCT01738503|156292397|FG006|Treatment Period|Withdrawal by Subject|1|||
48573849|NCT01738503|156292391|FG000|Treatment Period|Protocol Violation|0|||
48573850|NCT01738503|156292392|FG001|Treatment Period|Protocol Violation|3|||
48573851|NCT01738503|156292393|FG002|Treatment Period|Protocol Violation|1|||
48573852|NCT01738503|156292394|FG003|Treatment Period|Protocol Violation|0|||
48573853|NCT01738503|156292395|FG004|Treatment Period|Protocol Violation|4|||
48573854|NCT01738503|156292396|FG005|Treatment Period|Protocol Violation|2|||
48573855|NCT01738503|156292397|FG006|Treatment Period|Protocol Violation|0|||
48573856|NCT01738503|156292391|FG000|Treatment Period|Other|0|||
48573857|NCT01738503|156292392|FG001|Treatment Period|Other|0|||
48573858|NCT01738503|156292393|FG002|Treatment Period|Other|1|||
48573859|NCT01738503|156292394|FG003|Treatment Period|Other|0|||
48573860|NCT01738503|156292395|FG004|Treatment Period|Other|0|||
48573861|NCT01738503|156292396|FG005|Treatment Period|Other|0|||
48573862|NCT01738503|156292397|FG006|Treatment Period|Other|0|||
48573863|NCT01738503|156292391|FG000|PET Imaging Sub-study|Adverse Event|0|||
48573864|NCT01738503|156292392|FG001|PET Imaging Sub-study|Adverse Event|0|||
48573865|NCT01738503|156292393|FG002|PET Imaging Sub-study|Adverse Event|0|||
48573866|NCT01738503|156292394|FG003|PET Imaging Sub-study|Adverse Event|0|||
48573867|NCT01738503|156292395|FG004|PET Imaging Sub-study|Adverse Event|0|||
48573868|NCT01738503|156292396|FG005|PET Imaging Sub-study|Adverse Event|1|||
48573869|NCT01738503|156292397|FG006|PET Imaging Sub-study|Adverse Event|0|||
48573870|NCT01738503|156292391|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
48573871|NCT01738503|156292392|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
48573872|NCT01738503|156292393|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
48573873|NCT01738503|156292394|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
48573874|NCT01738503|156292395|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
48573875|NCT01738503|156292396|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
48573876|NCT01738503|156292397|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
48620310|NCT03767894|156467073|FG000|Overall Study|Withdrawal by Subject|1|||
48620311|NCT01452789|156467074|FG000|Overall Study|Withdrawal by Subject|3|||
48573877|NCT00794040|156292398|FG000|Overall Study|Withdrawal by Subject|3|||
48573878|NCT00794040|156292399|FG001|Overall Study|Withdrawal by Subject|4|||
48573879|NCT00794040|156292398|FG000|Overall Study|Physician Decision|0|||
48573880|NCT00794040|156292399|FG001|Overall Study|Physician Decision|1|||
48573881|NCT00813813|156292402|FG000|Overall Study|Withdrawal by Subject|1|||
48573882|NCT00813813|156292403|FG001|Overall Study|Withdrawal by Subject|1|||
48620312|NCT01452789|156467075|FG001|Overall Study|Withdrawal by Subject|2|||
48620313|NCT01436500|156467076|FG000|Overall Study|Death|1|||
48620314|NCT01436500|156467077|FG001|Overall Study|Death|0|||
48620315|NCT01436500|156467078|FG002|Overall Study|Death|0|||
48620316|NCT01436500|156467079|FG003|Overall Study|Death|0|||
48620317|NCT01436500|156467080|FG004|Overall Study|Death|0|||
48620318|NCT01436500|156467076|FG000|Overall Study|Adverse Event|0|||
48620319|NCT01436500|156467077|FG001|Overall Study|Adverse Event|2|||
48620320|NCT01436500|156467078|FG002|Overall Study|Adverse Event|2|||
48620321|NCT01436500|156467079|FG003|Overall Study|Adverse Event|0|||
48620322|NCT01436500|156467080|FG004|Overall Study|Adverse Event|1|||
48620323|NCT01436500|156467076|FG000|Overall Study|Withdrawal by Subject|0|||
48620324|NCT01436500|156467077|FG001|Overall Study|Withdrawal by Subject|0|||
48620325|NCT01436500|156467078|FG002|Overall Study|Withdrawal by Subject|2|||
48620326|NCT01436500|156467079|FG003|Overall Study|Withdrawal by Subject|0|||
48620327|NCT01436500|156467080|FG004|Overall Study|Withdrawal by Subject|2|||
48620328|NCT01436500|156467076|FG000|Overall Study|Physician Decision|0|||
48620329|NCT01436500|156467077|FG001|Overall Study|Physician Decision|0|||
48620330|NCT01436500|156467078|FG002|Overall Study|Physician Decision|1|||
48620331|NCT01436500|156467079|FG003|Overall Study|Physician Decision|0|||
48620332|NCT01436500|156467080|FG004|Overall Study|Physician Decision|0|||
48620333|NCT01436500|156467076|FG000|Overall Study|liver transplant|1|||
48620334|NCT01436500|156467077|FG001|Overall Study|liver transplant|0|||
48620335|NCT01436500|156467078|FG002|Overall Study|liver transplant|0|||
48620336|NCT01436500|156467079|FG003|Overall Study|liver transplant|0|||
48620337|NCT01436500|156467080|FG004|Overall Study|liver transplant|0|||
48620338|NCT01436500|156467076|FG000|Overall Study|initiation of dialysis|0|||
48620339|NCT01436500|156467077|FG001|Overall Study|initiation of dialysis|0|||
48620340|NCT01436500|156467078|FG002|Overall Study|initiation of dialysis|0|||
48620341|NCT01436500|156467079|FG003|Overall Study|initiation of dialysis|0|||
48620342|NCT01436500|156467080|FG004|Overall Study|initiation of dialysis|1|||
48620343|NCT01436500|156467076|FG000|Overall Study|discontinued study drug|1|||
48620344|NCT01436500|156467077|FG001|Overall Study|discontinued study drug|0|||
48620345|NCT01436500|156467078|FG002|Overall Study|discontinued study drug|0|||
48620346|NCT01436500|156467079|FG003|Overall Study|discontinued study drug|0|||
48620347|NCT01436500|156467080|FG004|Overall Study|discontinued study drug|0|||
48620348|NCT01436500|156467076|FG000|Overall Study|Other|0|||
48620349|NCT01436500|156467077|FG001|Overall Study|Other|1|||
48620350|NCT01436500|156467078|FG002|Overall Study|Other|0|||
48620351|NCT01436500|156467079|FG003|Overall Study|Other|1|||
48620352|NCT01436500|156467080|FG004|Overall Study|Other|0|||
48620353|NCT01489358|156467081|FG000|Overall Study|Lost to Follow-up|0|||
48573883|NCT00813813|156292402|FG000|Overall Study|Lost to Follow-up|2|||
48573884|NCT00813813|156292403|FG001|Overall Study|Lost to Follow-up|7|||
48573885|NCT00813813|156292402|FG000|Overall Study|Other|0|||
48573886|NCT00813813|156292403|FG001|Overall Study|Other|1|||
48573887|NCT00986921|156292404|FG000|Overall Study|Physician Decision|1|||
48573888|NCT00986921|156292405|FG001|Overall Study|Physician Decision|0|||
48573889|NCT04696354|156292408|FG000|Overall Study|Study termination|6|||
48573890|NCT04696354|156292409|FG001|Overall Study|Study termination|6|||
48573891|NCT03005327|156292410|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
48573892|NCT03005327|156292411|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
48573893|NCT03005327|156292412|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
48573894|NCT03005327|156292413|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
48573895|NCT03005327|156292410|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48573896|NCT03005327|156292411|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
48573897|NCT03005327|156292412|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48573898|NCT03005327|156292413|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48573899|NCT01758731|156292414|FG000|Overall Study|Physician Decision|1|||
48573900|NCT01340027|156292415|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
48573901|NCT01340027|156292416|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
48573902|NCT01340027|156292417|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
48573903|NCT01340027|156292418|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
48573904|NCT01340027|156292419|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
48620354|NCT01489358|156467082|FG001|Overall Study|Lost to Follow-up|0|||
48620355|NCT01489358|156467083|FG002|Overall Study|Lost to Follow-up|2|||
48620356|NCT01131585|156467084|FG000|Overall Study|Adverse Event|0|||
48620357|NCT01131585|156467085|FG001|Overall Study|Adverse Event|2|||
48620358|NCT01131585|156467084|FG000|Overall Study|Abnormal laboratory value|1|||
48620359|NCT01131585|156467085|FG001|Overall Study|Abnormal laboratory value|0|||
48620360|NCT01131585|156467084|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48573905|NCT01340027|156292420|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
48573906|NCT01340027|156292421|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
48573907|NCT01340027|156292422|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
48573908|NCT01340027|156292423|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
48620361|NCT01131585|156467085|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48620362|NCT01131585|156467084|FG000|Overall Study|Protocol Violation|2|||
48620363|NCT01131585|156467085|FG001|Overall Study|Protocol Violation|1|||
48573909|NCT01340027|156292424|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
48573910|NCT01340027|156292425|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
48573911|NCT01340027|156292426|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
48573912|NCT01340027|156292415|FG000|Overall Study|Adverse Event|0|||
48573913|NCT01340027|156292416|FG001|Overall Study|Adverse Event|1|||
48573914|NCT01340027|156292417|FG002|Overall Study|Adverse Event|2|||
48573915|NCT01340027|156292418|FG003|Overall Study|Adverse Event|0|||
48573916|NCT01340027|156292419|FG004|Overall Study|Adverse Event|1|||
48573917|NCT01340027|156292420|FG005|Overall Study|Adverse Event|2|||
48573918|NCT01340027|156292421|FG006|Overall Study|Adverse Event|2|||
48573919|NCT01340027|156292422|FG007|Overall Study|Adverse Event|1|||
48573920|NCT01340027|156292423|FG008|Overall Study|Adverse Event|4|||
48573921|NCT01340027|156292424|FG009|Overall Study|Adverse Event|1|||
48573922|NCT01340027|156292425|FG010|Overall Study|Adverse Event|1|||
48573923|NCT01340027|156292426|FG011|Overall Study|Adverse Event|3|||
48573924|NCT01340027|156292415|FG000|Overall Study|Lack of Efficacy|0|||
48573925|NCT01340027|156292416|FG001|Overall Study|Lack of Efficacy|0|||
48573926|NCT01340027|156292417|FG002|Overall Study|Lack of Efficacy|0|||
48573927|NCT01340027|156292418|FG003|Overall Study|Lack of Efficacy|0|||
48318966|NCT00632749|155368161|FG008|Overall Study|Other Adverse event|2|||
48573928|NCT01340027|156292419|FG004|Overall Study|Lack of Efficacy|0|||
48573929|NCT01340027|156292420|FG005|Overall Study|Lack of Efficacy|0|||
48573930|NCT01340027|156292421|FG006|Overall Study|Lack of Efficacy|1|||
48573931|NCT01340027|156292422|FG007|Overall Study|Lack of Efficacy|1|||
48573932|NCT01340027|156292423|FG008|Overall Study|Lack of Efficacy|1|||
48573933|NCT01340027|156292424|FG009|Overall Study|Lack of Efficacy|0|||
48573934|NCT01340027|156292425|FG010|Overall Study|Lack of Efficacy|0|||
48573935|NCT01340027|156292426|FG011|Overall Study|Lack of Efficacy|0|||
48573936|NCT01340027|156292415|FG000|Overall Study|Lost to Follow-up|0|||
48573937|NCT01340027|156292416|FG001|Overall Study|Lost to Follow-up|1|||
48573938|NCT01340027|156292417|FG002|Overall Study|Lost to Follow-up|0|||
48573939|NCT01340027|156292418|FG003|Overall Study|Lost to Follow-up|0|||
48573940|NCT01340027|156292419|FG004|Overall Study|Lost to Follow-up|0|||
48573941|NCT01340027|156292420|FG005|Overall Study|Lost to Follow-up|0|||
48573942|NCT01340027|156292421|FG006|Overall Study|Lost to Follow-up|1|||
48573943|NCT01340027|156292422|FG007|Overall Study|Lost to Follow-up|0|||
48573944|NCT01340027|156292423|FG008|Overall Study|Lost to Follow-up|0|||
48573945|NCT01340027|156292424|FG009|Overall Study|Lost to Follow-up|1|||
48573946|NCT01340027|156292425|FG010|Overall Study|Lost to Follow-up|0|||
48573947|NCT01340027|156292426|FG011|Overall Study|Lost to Follow-up|0|||
48573948|NCT01340027|156292415|FG000|Overall Study|Protocol Violation|1|||
48573949|NCT01340027|156292416|FG001|Overall Study|Protocol Violation|2|||
48573950|NCT01340027|156292417|FG002|Overall Study|Protocol Violation|0|||
48573951|NCT01340027|156292418|FG003|Overall Study|Protocol Violation|0|||
48573952|NCT01340027|156292419|FG004|Overall Study|Protocol Violation|6|||
48573953|NCT01340027|156292420|FG005|Overall Study|Protocol Violation|0|||
48573954|NCT01340027|156292421|FG006|Overall Study|Protocol Violation|0|||
48573955|NCT01340027|156292422|FG007|Overall Study|Protocol Violation|1|||
48573956|NCT01340027|156292423|FG008|Overall Study|Protocol Violation|2|||
48573957|NCT01340027|156292424|FG009|Overall Study|Protocol Violation|2|||
48573958|NCT01340027|156292425|FG010|Overall Study|Protocol Violation|0|||
48573959|NCT01340027|156292426|FG011|Overall Study|Protocol Violation|0|||
48573960|NCT01340027|156292415|FG000|Overall Study|Withdrawal by Subject|4|||
48573961|NCT01340027|156292416|FG001|Overall Study|Withdrawal by Subject|3|||
48573962|NCT01340027|156292417|FG002|Overall Study|Withdrawal by Subject|1|||
48573963|NCT01340027|156292418|FG003|Overall Study|Withdrawal by Subject|3|||
48573964|NCT01340027|156292419|FG004|Overall Study|Withdrawal by Subject|3|||
48573965|NCT01340027|156292420|FG005|Overall Study|Withdrawal by Subject|2|||
48573966|NCT01340027|156292421|FG006|Overall Study|Withdrawal by Subject|3|||
48573967|NCT01340027|156292422|FG007|Overall Study|Withdrawal by Subject|4|||
48573968|NCT01340027|156292423|FG008|Overall Study|Withdrawal by Subject|1|||
48573969|NCT01340027|156292424|FG009|Overall Study|Withdrawal by Subject|2|||
48573970|NCT01340027|156292425|FG010|Overall Study|Withdrawal by Subject|0|||
48573971|NCT01340027|156292426|FG011|Overall Study|Withdrawal by Subject|1|||
48573972|NCT01340027|156292415|FG000|Overall Study|Miscellaneous|0|||
48573973|NCT01340027|156292416|FG001|Overall Study|Miscellaneous|0|||
48573974|NCT01340027|156292417|FG002|Overall Study|Miscellaneous|0|||
48573975|NCT01340027|156292418|FG003|Overall Study|Miscellaneous|1|||
48573976|NCT01340027|156292419|FG004|Overall Study|Miscellaneous|0|||
48573977|NCT01340027|156292420|FG005|Overall Study|Miscellaneous|0|||
48573978|NCT01340027|156292421|FG006|Overall Study|Miscellaneous|0|||
48573979|NCT01340027|156292422|FG007|Overall Study|Miscellaneous|0|||
48573980|NCT01340027|156292423|FG008|Overall Study|Miscellaneous|0|||
48573981|NCT01340027|156292424|FG009|Overall Study|Miscellaneous|0|||
48573982|NCT01340027|156292425|FG010|Overall Study|Miscellaneous|1|||
48573983|NCT01340027|156292426|FG011|Overall Study|Miscellaneous|0|||
48573984|NCT02572076|156292427|FG000|Overall Study|Protocol Violation|1|||
48573985|NCT05238025|156292433|FG000|Overall Study|Adverse Event|2|||
48573986|NCT05238025|156292434|FG001|Overall Study|Adverse Event|2|||
48573987|NCT05238025|156292433|FG000|Overall Study|Lost to Follow-up|334|||
48573988|NCT05238025|156292434|FG001|Overall Study|Lost to Follow-up|339|||
48573989|NCT05238025|156292433|FG000|Overall Study|Withdrawal by Subject|203|||
48573990|NCT05238025|156292434|FG001|Overall Study|Withdrawal by Subject|222|||
48573991|NCT05238025|156292433|FG000|Overall Study|Physician Decision|20|||
48573992|NCT05238025|156292434|FG001|Overall Study|Physician Decision|8|||
48573993|NCT05238025|156292433|FG000|Overall Study|Protocol Violation|6|||
48573994|NCT05238025|156292434|FG001|Overall Study|Protocol Violation|2|||
48573995|NCT05238025|156292433|FG000|Overall Study|Death|38|||
48573996|NCT05238025|156292434|FG001|Overall Study|Death|32|||
48573997|NCT05238025|156292433|FG000|Overall Study|Study terminated by Sponsor|6358|||
48573998|NCT05238025|156292434|FG001|Overall Study|Study terminated by Sponsor|6358|||
48573999|NCT05238025|156292433|FG000|Overall Study|Other Reason|669|||
48574000|NCT05238025|156292434|FG001|Overall Study|Other Reason|690|||
48574001|NCT04687072|156292436|FG000|Overall Study|Adverse Event|2|||
48620364|NCT01131585|156467084|FG000|Overall Study|Withdrawal by Subject|3|||
48620365|NCT01131585|156467085|FG001|Overall Study|Withdrawal by Subject|3|||
48620366|NCT01131585|156467084|FG000|Overall Study|Lost to Follow-up|0|||
48574002|NCT04687072|156292437|FG001|Overall Study|Adverse Event|0|||
48574003|NCT04687072|156292436|FG000|Overall Study|Death|1|||
48620367|NCT01131585|156467085|FG001|Overall Study|Lost to Follow-up|1|||
48620368|NCT01131585|156467084|FG000|Overall Study|Administrative problems|1|||
48620369|NCT01131585|156467085|FG001|Overall Study|Administrative problems|1|||
48620370|NCT01131585|156467084|FG000|Overall Study|Study termination|78|||
48620371|NCT01131585|156467085|FG001|Overall Study|Study termination|32|||
48735996|NCT02935842|156883750|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
48574004|NCT04687072|156292437|FG001|Overall Study|Death|0|||
48574005|NCT04687072|156292436|FG000|Overall Study|Lack of Efficacy|2|||
48574006|NCT04687072|156292437|FG001|Overall Study|Lack of Efficacy|1|||
48574007|NCT04687072|156292436|FG000|Overall Study|Physician Decision|1|||
48574008|NCT04687072|156292437|FG001|Overall Study|Physician Decision|0|||
48574009|NCT04687072|156292436|FG000|Overall Study|Pregnancy|1|||
48574010|NCT04687072|156292437|FG001|Overall Study|Pregnancy|0|||
48620372|NCT01370642|156467086|FG000|Overall Study|Adverse Event|2|||
48574011|NCT04687072|156292436|FG000|Overall Study|Requires Prohibited Medication|2|||
48318967|NCT00632749|155368162|FG009|Overall Study|Other Adverse event|0|||
48574012|NCT04687072|156292437|FG001|Overall Study|Requires Prohibited Medication|0|||
48574013|NCT04687072|156292436|FG000|Overall Study|Withdrawal of Consent|11|||
48574014|NCT04687072|156292437|FG001|Overall Study|Withdrawal of Consent|6|||
48574015|NCT04687072|156292436|FG000|Overall Study|Miscellaneous|4|||
48574016|NCT04687072|156292437|FG001|Overall Study|Miscellaneous|1|||
48574017|NCT00833482|156292441|FG000|Days 11-20|Adverse Event|0|||
48574018|NCT00833482|156292442|FG001|Days 11-20|Adverse Event|2|||
48574019|NCT00833482|156292443|FG002|Days 11-20|Adverse Event|0|||
48574020|NCT00833482|156292444|FG003|Days 11-20|Adverse Event|0|||
48574021|NCT00833482|156292445|FG004|Days 11-20|Adverse Event|0|||
48574022|NCT00833482|156292446|FG005|Days 11-20|Adverse Event|0|||
48574023|NCT00833482|156292441|FG000|Days 11-20|Withdrawal by Subject|0|||
48574024|NCT00833482|156292442|FG001|Days 11-20|Withdrawal by Subject|1|||
48574025|NCT00833482|156292443|FG002|Days 11-20|Withdrawal by Subject|0|||
48574026|NCT00833482|156292444|FG003|Days 11-20|Withdrawal by Subject|0|||
48574027|NCT00833482|156292445|FG004|Days 11-20|Withdrawal by Subject|0|||
48318968|NCT00632749|155368163|FG010|Overall Study|Other Adverse event|1|||
48318969|NCT00632749|155368164|FG011|Overall Study|Other Adverse event|0|||
48318970|NCT00632749|155368165|FG012|Overall Study|Other Adverse event|1|||
48318971|NCT00632749|155368166|FG013|Overall Study|Other Adverse event|0|||
48318972|NCT00632749|155368153|FG000|Overall Study|Refuse to continue medication|0|||
48574028|NCT00833482|156292446|FG005|Days 11-20|Withdrawal by Subject|0|||
48574029|NCT00833482|156292441|FG000|Days 21-30|Adverse Event|0|||
48574030|NCT00833482|156292442|FG001|Days 21-30|Adverse Event|0|||
48574031|NCT00833482|156292443|FG002|Days 21-30|Adverse Event|1|||
48318973|NCT00632749|155368154|FG001|Overall Study|Refuse to continue medication|0|||
48318974|NCT00632749|155368155|FG002|Overall Study|Refuse to continue medication|0|||
48318975|NCT00632749|155368156|FG003|Overall Study|Refuse to continue medication|1|||
48318976|NCT00632749|155368157|FG004|Overall Study|Refuse to continue medication|0|||
48318977|NCT00632749|155368158|FG005|Overall Study|Refuse to continue medication|0|||
48318978|NCT00632749|155368159|FG006|Overall Study|Refuse to continue medication|0|||
48318979|NCT00632749|155368160|FG007|Overall Study|Refuse to continue medication|0|||
48318980|NCT00632749|155368161|FG008|Overall Study|Refuse to continue medication|0|||
48318981|NCT00632749|155368162|FG009|Overall Study|Refuse to continue medication|1|||
48318982|NCT00632749|155368163|FG010|Overall Study|Refuse to continue medication|0|||
48318983|NCT00632749|155368164|FG011|Overall Study|Refuse to continue medication|0|||
48318984|NCT00632749|155368165|FG012|Overall Study|Refuse to continue medication|0|||
48318985|NCT00632749|155368166|FG013|Overall Study|Refuse to continue medication|0|||
48318986|NCT00632749|155368153|FG000|Overall Study|Reason other than those specified above|0|||
48318987|NCT00632749|155368154|FG001|Overall Study|Reason other than those specified above|2|||
48318988|NCT00632749|155368155|FG002|Overall Study|Reason other than those specified above|0|||
48318989|NCT00632749|155368156|FG003|Overall Study|Reason other than those specified above|0|||
48318990|NCT00632749|155368157|FG004|Overall Study|Reason other than those specified above|1|||
48318991|NCT00632749|155368158|FG005|Overall Study|Reason other than those specified above|0|||
48318992|NCT00632749|155368159|FG006|Overall Study|Reason other than those specified above|1|||
48318993|NCT00632749|155368160|FG007|Overall Study|Reason other than those specified above|0|||
48318994|NCT00632749|155368161|FG008|Overall Study|Reason other than those specified above|0|||
48318995|NCT00632749|155368162|FG009|Overall Study|Reason other than those specified above|0|||
48318996|NCT00632749|155368163|FG010|Overall Study|Reason other than those specified above|2|||
48318997|NCT00632749|155368164|FG011|Overall Study|Reason other than those specified above|1|||
48318998|NCT00632749|155368165|FG012|Overall Study|Reason other than those specified above|0|||
48318999|NCT00632749|155368166|FG013|Overall Study|Reason other than those specified above|2|||
48319000|NCT00951379|155368167|FG000|Overall Study|Adverse Event|4|||
48319001|NCT00951379|155368168|FG001|Overall Study|Adverse Event|1|||
48319002|NCT00951379|155368167|FG000|Overall Study|Withdrawal by Subject|1|||
48319003|NCT00951379|155368168|FG001|Overall Study|Withdrawal by Subject|0|||
48319004|NCT00951379|155368167|FG000|Overall Study|Noncompliance|1|||
48319005|NCT00951379|155368168|FG001|Overall Study|Noncompliance|0|||
48319006|NCT00951379|155368167|FG000|Overall Study|Disease Progression|0|||
48319007|NCT00951379|155368168|FG001|Overall Study|Disease Progression|1|||
48319008|NCT00976937|155368169|FG000|Overall Study|Adverse Event|4|||
48574032|NCT00833482|156292444|FG003|Days 21-30|Adverse Event|0|||
48574033|NCT00833482|156292445|FG004|Days 21-30|Adverse Event|0|||
48574034|NCT00833482|156292446|FG005|Days 21-30|Adverse Event|0|||
48574035|NCT00833482|156292441|FG000|Days 21-30|Withdrawal by Subject|0|||
48574036|NCT00833482|156292442|FG001|Days 21-30|Withdrawal by Subject|0|||
48574037|NCT00833482|156292443|FG002|Days 21-30|Withdrawal by Subject|0|||
48574038|NCT00833482|156292444|FG003|Days 21-30|Withdrawal by Subject|0|||
48574039|NCT00833482|156292445|FG004|Days 21-30|Withdrawal by Subject|1|||
48319009|NCT00976937|155368170|FG001|Overall Study|Adverse Event|5|||
48319010|NCT00976937|155368169|FG000|Overall Study|Lost to Follow-up|2|||
48319011|NCT00976937|155368170|FG001|Overall Study|Lost to Follow-up|1|||
48574040|NCT00833482|156292446|FG005|Days 21-30|Withdrawal by Subject|0|||
48574041|NCT01263782|156292447|FG000|Overall Study|Death|0|||
48574042|NCT01263782|156292448|FG001|Overall Study|Death|0|||
48574043|NCT01263782|156292449|FG002|Overall Study|Death|1|||
48574044|NCT01263782|156292450|FG003|Overall Study|Death|0|||
48574045|NCT01263782|156292447|FG000|Overall Study|Progressive disease|0|||
48574046|NCT01263782|156292448|FG001|Overall Study|Progressive disease|0|||
48574047|NCT01263782|156292449|FG002|Overall Study|Progressive disease|0|||
48620373|NCT01370642|156467087|FG001|Overall Study|Adverse Event|1|||
48620374|NCT01370642|156467088|FG002|Overall Study|Adverse Event|1|||
48620375|NCT01370642|156467086|FG000|Overall Study|Detectable HCV RNA|0|||
48620376|NCT01370642|156467087|FG001|Overall Study|Detectable HCV RNA|0|||
48620377|NCT01370642|156467088|FG002|Overall Study|Detectable HCV RNA|22|||
48620378|NCT01370642|156467086|FG000|Overall Study|Lost to Follow-up|0|||
48620379|NCT01370642|156467087|FG001|Overall Study|Lost to Follow-up|0|||
48620380|NCT01370642|156467088|FG002|Overall Study|Lost to Follow-up|1|||
48620381|NCT01370642|156467086|FG000|Overall Study|Physician Decision|4|||
48620382|NCT01370642|156467087|FG001|Overall Study|Physician Decision|1|||
48620383|NCT01370642|156467088|FG002|Overall Study|Physician Decision|2|||
48620384|NCT01370642|156467086|FG000|Overall Study|Withdrawal by Subject|2|||
48620385|NCT01370642|156467087|FG001|Overall Study|Withdrawal by Subject|4|||
48620386|NCT01370642|156467088|FG002|Overall Study|Withdrawal by Subject|3|||
48574048|NCT01263782|156292450|FG003|Overall Study|Progressive disease|1|||
48574049|NCT01263782|156292447|FG000|Overall Study|Too early|0|||
48574050|NCT01263782|156292448|FG001|Overall Study|Too early|0|||
48574051|NCT01263782|156292449|FG002|Overall Study|Too early|1|||
48574052|NCT01263782|156292450|FG003|Overall Study|Too early|0|||
48574053|NCT01263782|156292447|FG000|Overall Study|Inevaluable|0|||
48574054|NCT01263782|156292448|FG001|Overall Study|Inevaluable|0|||
48574055|NCT01263782|156292449|FG002|Overall Study|Inevaluable|1|||
48574056|NCT01263782|156292450|FG003|Overall Study|Inevaluable|0|||
48574057|NCT02805660|156292451|FG000|Overall Study|Death|5|||
48574058|NCT02805660|156292452|FG001|Overall Study|Death|2|||
48574059|NCT02805660|156292453|FG002|Overall Study|Death|9|||
48574060|NCT02805660|156292454|FG003|Overall Study|Death|5|||
48574061|NCT02805660|156292455|FG004|Overall Study|Death|0|||
48574062|NCT02805660|156292456|FG005|Overall Study|Death|14|||
48574063|NCT02805660|156292457|FG006|Overall Study|Death|12|||
48574064|NCT02805660|156292451|FG000|Overall Study|Lost to Follow-up|0|||
48574065|NCT02805660|156292452|FG001|Overall Study|Lost to Follow-up|1|||
48574066|NCT02805660|156292453|FG002|Overall Study|Lost to Follow-up|1|||
48574067|NCT02805660|156292454|FG003|Overall Study|Lost to Follow-up|2|||
48574068|NCT02805660|156292455|FG004|Overall Study|Lost to Follow-up|0|||
48620387|NCT00728182|156467093|FG000|Overall Study|Adverse Event|1|||
48620388|NCT00728182|156467094|FG001|Overall Study|Adverse Event|0|||
48620389|NCT00728182|156467093|FG000|Overall Study|Lost to Follow-up|2|||
48620390|NCT00728182|156467094|FG001|Overall Study|Lost to Follow-up|0|||
48620391|NCT00728182|156467093|FG000|Overall Study|Death|0|||
48620392|NCT00728182|156467094|FG001|Overall Study|Death|2|||
48620393|NCT00728182|156467093|FG000|Overall Study|Protocol Noncompliance|0|||
48574069|NCT02805660|156292456|FG005|Overall Study|Lost to Follow-up|0|||
48574070|NCT02805660|156292457|FG006|Overall Study|Lost to Follow-up|0|||
48574071|NCT02805660|156292451|FG000|Overall Study|Withdrawal by Subject|0|||
48574072|NCT02805660|156292452|FG001|Overall Study|Withdrawal by Subject|0|||
48574073|NCT02805660|156292453|FG002|Overall Study|Withdrawal by Subject|0|||
48574074|NCT02805660|156292454|FG003|Overall Study|Withdrawal by Subject|3|||
48574075|NCT02805660|156292455|FG004|Overall Study|Withdrawal by Subject|1|||
48574076|NCT02805660|156292456|FG005|Overall Study|Withdrawal by Subject|0|||
48574077|NCT02805660|156292457|FG006|Overall Study|Withdrawal by Subject|2|||
48574078|NCT02805660|156292451|FG000|Overall Study|Study terminated by Sponsor|0|||
48574079|NCT02805660|156292452|FG001|Overall Study|Study terminated by Sponsor|0|||
48574080|NCT02805660|156292453|FG002|Overall Study|Study terminated by Sponsor|1|||
48574081|NCT02805660|156292454|FG003|Overall Study|Study terminated by Sponsor|4|||
48620394|NCT00728182|156467094|FG001|Overall Study|Protocol Noncompliance|1|||
48574082|NCT02805660|156292455|FG004|Overall Study|Study terminated by Sponsor|2|||
48574083|NCT02805660|156292456|FG005|Overall Study|Study terminated by Sponsor|3|||
48574084|NCT02805660|156292457|FG006|Overall Study|Study terminated by Sponsor|1|||
48574085|NCT02805660|156292451|FG000|Overall Study|Miscellaneous|0|||
48574086|NCT02805660|156292452|FG001|Overall Study|Miscellaneous|1|||
48574087|NCT02805660|156292453|FG002|Overall Study|Miscellaneous|0|||
48574088|NCT02805660|156292454|FG003|Overall Study|Miscellaneous|4|||
48574089|NCT02805660|156292455|FG004|Overall Study|Miscellaneous|0|||
48574090|NCT02805660|156292456|FG005|Overall Study|Miscellaneous|6|||
48574091|NCT02805660|156292457|FG006|Overall Study|Miscellaneous|4|||
48574092|NCT00915876|156292458|FG000|Overall Study|Adverse Event|0|||
48574093|NCT00915876|156292459|FG001|Overall Study|Adverse Event|1|||
48574094|NCT00150800|156294333|FG000|Overall Study|Adverse Event|89|||
48574095|NCT00150800|156294333|FG000|Overall Study|Death|18|||
48574096|NCT00150800|156294333|FG000|Overall Study|Lack of Efficacy|166|||
48574097|NCT00150800|156294333|FG000|Overall Study|Lost to Follow-up|58|||
48574098|NCT00150800|156294333|FG000|Overall Study|Subject's choice|90|||
48574099|NCT00150800|156294333|FG000|Overall Study|No compliance|18|||
48574100|NCT00150800|156294333|FG000|Overall Study|IP misshandling|1|||
48574101|NCT00150800|156294333|FG000|Overall Study|Site closure|24|||
48574102|NCT00150800|156294333|FG000|Overall Study|Protocol non-adherence|2|||
48574103|NCT00150800|156294333|FG000|Overall Study|Nobody to accompany patient|1|||
48574104|NCT00150800|156294333|FG000|Overall Study|Distance too long for patient|1|||
48574105|NCT00150800|156294333|FG000|Overall Study|Neurosurgery|2|||
48574106|NCT00150800|156294333|FG000|Overall Study|BRV monotherapy|1|||
48574107|NCT00150800|156294333|FG000|Overall Study|Visit refusal|3|||
48574108|NCT00150800|156294333|FG000|Overall Study|Sponsor's request|2|||
48574109|NCT00150800|156294333|FG000|Overall Study|Generalized Epilepsy|1|||
48574110|NCT00150800|156294333|FG000|Overall Study|Moved from area/country|8|||
48574111|NCT00150800|156294333|FG000|Overall Study|PI retiring|2|||
48574112|NCT00150800|156294333|FG000|Overall Study|PI leaving site|2|||
48574113|NCT00150800|156294333|FG000|Overall Study|Patient insurance|1|||
48574114|NCT00150800|156294333|FG000|Overall Study|Surgical intervention|4|||
48574115|NCT00150800|156294333|FG000|Overall Study|Pregnancy planned|1|||
48574116|NCT00150800|156294333|FG000|Overall Study|PI discontinuation request|1|||
48574117|NCT00594100|156294334|FG000|Procedure|Technical Failure|9|||
48574118|NCT00594100|156294334|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
48574119|NCT00594100|156294334|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
48574120|NCT00594100|156294334|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
48620395|NCT01618708|156467097|FG000|Overall Study|Adverse Event|10|||
48620396|NCT01618708|156467098|FG001|Overall Study|Adverse Event|10|||
48620397|NCT01618708|156467097|FG000|Overall Study|Lost to Follow-up|3|||
48574121|NCT01270464|156294336|FG000|Overall Study|Protocol Violation|4|||
48574122|NCT01270464|156294337|FG001|Overall Study|Protocol Violation|3|||
48574123|NCT01270464|156294338|FG002|Overall Study|Protocol Violation|2|||
48574124|NCT01270464|156294336|FG000|Overall Study|Lack of Efficacy|2|||
48574125|NCT01270464|156294337|FG001|Overall Study|Lack of Efficacy|3|||
48574126|NCT01270464|156294338|FG002|Overall Study|Lack of Efficacy|1|||
48574127|NCT01270464|156294336|FG000|Overall Study|Adverse Event|9|||
48574128|NCT01270464|156294337|FG001|Overall Study|Adverse Event|1|||
48574129|NCT01270464|156294338|FG002|Overall Study|Adverse Event|7|||
48574130|NCT01270464|156294336|FG000|Overall Study|Withdrawal by Subject|2|||
48574131|NCT01270464|156294337|FG001|Overall Study|Withdrawal by Subject|1|||
48574132|NCT01270464|156294338|FG002|Overall Study|Withdrawal by Subject|4|||
48574133|NCT01270464|156294336|FG000|Overall Study|Lost to Follow-up|2|||
48574134|NCT01270464|156294337|FG001|Overall Study|Lost to Follow-up|3|||
48574135|NCT01270464|156294338|FG002|Overall Study|Lost to Follow-up|1|||
48574136|NCT01270464|156294336|FG000|Overall Study|Other|1|||
48620398|NCT01618708|156467098|FG001|Overall Study|Lost to Follow-up|3|||
48620399|NCT01618708|156467097|FG000|Overall Study|Withdrawal by Subject|17|||
48620400|NCT01618708|156467098|FG001|Overall Study|Withdrawal by Subject|22|||
48620401|NCT01618708|156467097|FG000|Overall Study|Lack of Efficacy|8|||
48620402|NCT01618708|156467098|FG001|Overall Study|Lack of Efficacy|8|||
48620403|NCT01618708|156467097|FG000|Overall Study|Technical problems|2|||
48620404|NCT01618708|156467098|FG001|Overall Study|Technical problems|0|||
48620405|NCT01618708|156467097|FG000|Overall Study|Other than specified above|1|||
48620406|NCT01618708|156467098|FG001|Overall Study|Other than specified above|1|||
48620407|NCT01618708|156467097|FG000|Overall Study|Randomized but not treated|3|||
48620408|NCT01618708|156467098|FG001|Overall Study|Randomized but not treated|2|||
48620409|NCT00356421|156467099|FG000|Overall Study|Lack of Efficacy|3|||
48620410|NCT00356421|156467100|FG001|Overall Study|Lack of Efficacy|0|||
48620411|NCT00356421|156467099|FG000|Overall Study|Withdrawal by Subject|9|||
48620412|NCT00356421|156467100|FG001|Overall Study|Withdrawal by Subject|2|||
48620413|NCT00356421|156467099|FG000|Overall Study|Related to study drug|15|||
48620414|NCT00356421|156467100|FG001|Overall Study|Related to study drug|12|||
48620415|NCT00356421|156467099|FG000|Overall Study|Not related to study drug|5|||
48620416|NCT00356421|156467100|FG001|Overall Study|Not related to study drug|3|||
48620417|NCT00663351|156467101|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
48620418|NCT00663351|156467102|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
48620419|NCT00663351|156467101|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
48620420|NCT00663351|156467102|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
48620421|NCT00663351|156467101|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
48574137|NCT01270464|156294337|FG001|Overall Study|Other|1|||
48574138|NCT01270464|156294338|FG002|Overall Study|Other|3|||
48574139|NCT02453334|156294339|FG000|Overall Study|Death|15|||
48574140|NCT02453334|156294340|FG001|Overall Study|Death|13|||
48574141|NCT02453334|156294339|FG000|Overall Study|Adverse Event|2|||
48574142|NCT02453334|156294340|FG001|Overall Study|Adverse Event|1|||
48574143|NCT02453334|156294339|FG000|Overall Study|Lost to Follow-up|5|||
48574144|NCT02453334|156294340|FG001|Overall Study|Lost to Follow-up|9|||
48574145|NCT02453334|156294339|FG000|Overall Study|Physician Decision|1|||
48574146|NCT02453334|156294340|FG001|Overall Study|Physician Decision|0|||
48574147|NCT02453334|156294339|FG000|Overall Study|Withdrawal by Subject|17|||
48574148|NCT02453334|156294340|FG001|Overall Study|Withdrawal by Subject|13|||
48574149|NCT02453334|156294339|FG000|Overall Study|Other reason|1|||
48620422|NCT00663351|156467102|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
48620423|NCT00663351|156467101|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
48620424|NCT00663351|156467102|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
48574150|NCT02453334|156294340|FG001|Overall Study|Other reason|4|||
48574151|NCT01841762|156294341|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
48574152|NCT01841762|156294341|FG000|Treatment Period|Adverse Event|16|||
48620425|NCT00663351|156467101|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
48620426|NCT00663351|156467102|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
48620427|NCT00663351|156467101|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
48620428|NCT00663351|156467102|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
48620429|NCT03211832|156467103|FG000|Overall Study|No longer with agency|32|||
48620430|NCT03211832|156467104|FG001|Overall Study|No longer with agency|49|||
48620431|NCT03211832|156467105|FG002|Overall Study|No longer with agency|30|||
48620432|NCT03211832|156467103|FG000|Overall Study|Declined survey|3|||
48620433|NCT03211832|156467104|FG001|Overall Study|Declined survey|3|||
48620434|NCT03211832|156467105|FG002|Overall Study|Declined survey|2|||
48620435|NCT03211832|156467103|FG000|Overall Study|Not available during data collection|1|||
48735997|NCT01686828|156883752|FG000|Overall Study|Physician Decision|1|||
48574153|NCT01841762|156294341|FG000|Treatment Period|Death|1|||
48574154|NCT01841762|156294341|FG000|Treatment Period|Withdrawal by Subject|7|||
48574155|NCT01841762|156294341|FG000|Treatment Period|Lost to Follow-up|1|||
48574156|NCT01841762|156294341|FG000|Treatment Period|Physician Decision|2|||
48574157|NCT01841762|156294341|FG000|Treatment Period|Other, including non-compliance|5|||
48574158|NCT01841762|156294341|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
48574159|NCT01841762|156294341|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
48574160|NCT01841762|156294341|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
48574161|NCT01841762|156294341|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
48574162|NCT01868438|156294342|FG000|First Intervention|Withdrawal by Subject|5|||
48574163|NCT01868438|156294343|FG001|First Intervention|Withdrawal by Subject|1|||
48574164|NCT01868438|156294342|FG000|First Intervention|Lost to Follow-up|2|||
48574165|NCT01868438|156294343|FG001|First Intervention|Lost to Follow-up|3|||
48574166|NCT01868438|156294342|FG000|First Intervention|Meeting the non-redosing criteria|0|||
48574167|NCT01868438|156294343|FG001|First Intervention|Meeting the non-redosing criteria|1|||
48574168|NCT01868438|156294342|FG000|Second Intervention|Adverse Event|3|||
48574169|NCT01868438|156294343|FG001|Second Intervention|Adverse Event|3|||
48574170|NCT03260244|156294347|FG000|Overall Study|Death|19|||
48574171|NCT03260244|156294347|FG000|Overall Study|Lost to Follow-up|60|||
48574172|NCT03260244|156294347|FG000|Overall Study|Withdrawal by Subject|48|||
48574173|NCT03260244|156294347|FG000|Overall Study|Procedure Not Performed|21|||
48574174|NCT03260244|156294347|FG000|Overall Study|Enrollment Criteria Not Met|31|||
48574175|NCT03260244|156294347|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
48574176|NCT03260244|156294347|FG000|Overall Study|Subject Noncompliance|6|||
48574177|NCT03260244|156294347|FG000|Overall Study|No inducible Arrhythmia|2|||
48574178|NCT03260244|156294347|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
48574179|NCT03260244|156294347|FG000|Overall Study|Screen Failure|2|||
48574180|NCT03260244|156294347|FG000|Overall Study|Treated Off Label|69|||
48574181|NCT03260244|156294347|FG000|Overall Study|No Radiofrequency Ablation|14|||
48574182|NCT04967885|156294352|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
48574183|NCT04967885|156294353|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
48574184|NCT04967885|156294352|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
48574185|NCT04967885|156294353|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
48574186|NCT04967885|156294352|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
48574187|NCT04967885|156294353|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
48574188|NCT04967885|156294352|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
48574189|NCT04967885|156294353|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
48574190|NCT04967885|156294352|FG000|EMI-II Intervention|Lost to Follow-up|14|||
48574191|NCT04967885|156294353|FG001|EMI-II Intervention|Lost to Follow-up|10|||
48574192|NCT01011465|156294354|FG000|Overall Study|Withdrawal by Subject|2|||
48574193|NCT01011465|156294355|FG001|Overall Study|Withdrawal by Subject|1|||
48574194|NCT01011465|156294356|FG002|Overall Study|Withdrawal by Subject|0|||
48574195|NCT01011465|156294357|FG003|Overall Study|Withdrawal by Subject|0|||
48574196|NCT01011465|156294358|FG004|Overall Study|Withdrawal by Subject|1|||
48574197|NCT01011465|156294359|FG005|Overall Study|Withdrawal by Subject|0|||
48574198|NCT01011465|156294360|FG006|Overall Study|Withdrawal by Subject|1|||
48574199|NCT01011465|156294361|FG007|Overall Study|Withdrawal by Subject|0|||
48574200|NCT01682226|156294363|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
48574201|NCT01682226|156294363|FG000|Overall Study|Participants did not receive treatment|2|||
48620436|NCT03211832|156467104|FG001|Overall Study|Not available during data collection|0|||
48620437|NCT03211832|156467105|FG002|Overall Study|Not available during data collection|2|||
48620438|NCT03721965|156467106|FG000|Overall Study|Death|1|||
48620439|NCT03721965|156467106|FG000|Overall Study|Study Terminated by Sponsor|1|||
48620440|NCT02657551|156467110|FG000|Overall Study|Adverse Event|2|||
48620441|NCT02657551|156467110|FG000|Overall Study|Withdrawal by Subject|1|||
48620442|NCT02657551|156467110|FG000|Overall Study|Non-Compliance|1|||
48620443|NCT02657551|156467110|FG000|Overall Study|Progression / Relapse|4|||
48620444|NCT00025233|156467111|FG000|Overall Study|Ineligible: wrong cell type|1|||
48620445|NCT00025233|156467111|FG000|Overall Study|Ineligible: wrong primary|1|||
48620446|NCT00025233|156467111|FG000|Overall Study|Ineligible: improper prior treatment|1|||
48620447|NCT00025233|156467111|FG000|Overall Study|Never treated|1|||
48620448|NCT01184118|156467112|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
48620449|NCT01184118|156467112|FG000|Overall Study|No physiologic confirmation of asthma|8|||
48620450|NCT01184118|156467112|FG000|Overall Study|FEV1 <60% predicted|2|||
48620451|NCT01184118|156467112|FG000|Overall Study|Exclusionary medical condition|2|||
48620452|NCT01184118|156467112|FG000|Overall Study|Withdrawal by Subject|5|||
48620453|NCT00682435|156467117|FG000|Overall Study|Insufficient data|5|||
48620454|NCT00682435|156467117|FG000|Overall Study|Erroneously enrolled twice|2|||
48620455|NCT02916433|156467118|FG000|Overall Study|Withdrawal by Subject|1|||
48620456|NCT02916433|156467119|FG001|Overall Study|Withdrawal by Subject|0|||
48620457|NCT02916433|156467118|FG000|Overall Study|Physician Decision|1|||
48620458|NCT02916433|156467119|FG001|Overall Study|Physician Decision|0|||
48620459|NCT00800384|156467120|FG000|Overall Study|Withdrawal by Subject|24|||
48620460|NCT00800384|156467121|FG001|Overall Study|Withdrawal by Subject|17|||
48620461|NCT00800384|156467120|FG000|Overall Study|Lost to Follow-up|17|||
48620462|NCT00800384|156467121|FG001|Overall Study|Lost to Follow-up|26|||
48620463|NCT00853047|156467122|FG000|Core Phase|Participant Request|0|||
48620464|NCT00853047|156467123|FG001|Core Phase|Participant Request|0|||
48620465|NCT00853047|156467124|FG002|Core Phase|Participant Request|0|||
48620466|NCT00853047|156467125|FG003|Core Phase|Participant Request|1|||
48620467|NCT00853047|156467126|FG004|Core Phase|Participant Request|0|||
48620468|NCT00853047|156467127|FG005|Core Phase|Participant Request|0|||
48620469|NCT00853047|156467122|FG000|Open-Label Extension Phase|Participant Request|0|||
48620470|NCT00853047|156467123|FG001|Open-Label Extension Phase|Participant Request|0|||
48620471|NCT00853047|156467124|FG002|Open-Label Extension Phase|Participant Request|0|||
48620472|NCT00853047|156467125|FG003|Open-Label Extension Phase|Participant Request|0|||
48620473|NCT00853047|156467126|FG004|Open-Label Extension Phase|Participant Request|0|||
48620474|NCT00853047|156467127|FG005|Open-Label Extension Phase|Participant Request|7|||
48620475|NCT00853047|156467122|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
48620476|NCT00853047|156467123|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
48620477|NCT00853047|156467124|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
48620478|NCT00853047|156467125|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
48620479|NCT00853047|156467126|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
48620480|NCT00853047|156467127|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
48620481|NCT00853047|156467122|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
48620482|NCT00853047|156467123|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
48620483|NCT00853047|156467124|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
48620484|NCT00853047|156467125|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
48319012|NCT00976937|155368169|FG000|Overall Study|Withdrawal by Subject|5|||
48319013|NCT00976937|155368170|FG001|Overall Study|Withdrawal by Subject|3|||
48319014|NCT00976937|155368169|FG000|Overall Study|Poor compliance to protocol|3|||
48319015|NCT00976937|155368170|FG001|Overall Study|Poor compliance to protocol|0|||
48574202|NCT01682226|156294363|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
48574203|NCT02792192|156294366|FG000|Overall Study|Death|1|||
48620485|NCT00853047|156467126|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
48620486|NCT00853047|156467127|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
48620487|NCT00853047|156467122|FG000|Open-Label Extension Phase|Investigator Decision|0|||
48620488|NCT00853047|156467123|FG001|Open-Label Extension Phase|Investigator Decision|0|||
48620489|NCT00853047|156467124|FG002|Open-Label Extension Phase|Investigator Decision|0|||
48620490|NCT00853047|156467125|FG003|Open-Label Extension Phase|Investigator Decision|0|||
48620491|NCT00853047|156467126|FG004|Open-Label Extension Phase|Investigator Decision|0|||
48620492|NCT00853047|156467127|FG005|Open-Label Extension Phase|Investigator Decision|1|||
48620493|NCT00853047|156467122|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
48620494|NCT00853047|156467123|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
48620495|NCT00853047|156467124|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
48574204|NCT02792192|156294367|FG001|Overall Study|Death|0|||
48620496|NCT00853047|156467125|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
48620497|NCT00853047|156467126|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
48620498|NCT00853047|156467127|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
48620499|NCT00450749|156467131|FG000|Overall Study|Withdrawal by Subject|0|||
48620500|NCT00450749|156467132|FG001|Overall Study|Withdrawal by Subject|0|||
48319016|NCT00976937|155368169|FG000|Overall Study|Personal and Familial Reason|2|||
48574205|NCT02792192|156294368|FG002|Overall Study|Death|0|||
48574206|NCT02792192|156294369|FG003|Overall Study|Death|0|||
48574207|NCT02792192|156294366|FG000|Overall Study|Informed Consent Withdrawn|4|||
48574208|NCT02792192|156294367|FG001|Overall Study|Informed Consent Withdrawn|0|||
48574209|NCT02792192|156294368|FG002|Overall Study|Informed Consent Withdrawn|0|||
48574210|NCT02792192|156294369|FG003|Overall Study|Informed Consent Withdrawn|0|||
48574211|NCT02792192|156294366|FG000|Overall Study|Physician Decision|1|||
48574212|NCT02792192|156294367|FG001|Overall Study|Physician Decision|0|||
48574213|NCT02792192|156294368|FG002|Overall Study|Physician Decision|0|||
48574214|NCT02792192|156294369|FG003|Overall Study|Physician Decision|0|||
48574215|NCT02792192|156294366|FG000|Overall Study|Progressive Disease|0|||
48574216|NCT02792192|156294367|FG001|Overall Study|Progressive Disease|1|||
48574217|NCT02792192|156294368|FG002|Overall Study|Progressive Disease|0|||
48574218|NCT02792192|156294369|FG003|Overall Study|Progressive Disease|0|||
48574219|NCT02792192|156294366|FG000|Overall Study|Study Terminated By Sponsor|6|||
48574220|NCT02792192|156294367|FG001|Overall Study|Study Terminated By Sponsor|10|||
48574221|NCT02792192|156294368|FG002|Overall Study|Study Terminated By Sponsor|0|||
48574222|NCT02792192|156294369|FG003|Overall Study|Study Terminated By Sponsor|0|||
48574223|NCT02247440|156294370|FG000|Overall Study|Withdrawal by Subject|1|||
48574224|NCT02247440|156294370|FG000|Overall Study|Lack of Efficacy|3|||
48574225|NCT02682823|156294372|FG000|Overall Study|Withdrawal by Subject|0|||
48574226|NCT02682823|156294373|FG001|Overall Study|Withdrawal by Subject|0|||
48574227|NCT02682823|156294374|FG002|Overall Study|Withdrawal by Subject|1|||
48574228|NCT02682823|156294375|FG003|Overall Study|Withdrawal by Subject|0|||
48574229|NCT02682823|156294376|FG004|Overall Study|Withdrawal by Subject|1|||
48574230|NCT02682823|156294372|FG000|Overall Study|Protocol Deviation|0|||
48574231|NCT02682823|156294373|FG001|Overall Study|Protocol Deviation|1|||
48574232|NCT02682823|156294374|FG002|Overall Study|Protocol Deviation|0|||
48574233|NCT02682823|156294375|FG003|Overall Study|Protocol Deviation|0|||
48574234|NCT02682823|156294376|FG004|Overall Study|Protocol Deviation|0|||
48574235|NCT02682823|156294372|FG000|Overall Study|Adverse Event|0|||
48574236|NCT02682823|156294373|FG001|Overall Study|Adverse Event|0|||
48574237|NCT02682823|156294374|FG002|Overall Study|Adverse Event|0|||
48574238|NCT02682823|156294375|FG003|Overall Study|Adverse Event|1|||
48574239|NCT02682823|156294376|FG004|Overall Study|Adverse Event|0|||
48574240|NCT02042950|156294377|FG000|Overall Study|Progressive Disease|4|||
48574241|NCT00723008|156294378|FG000|Enrollment|Lost to Follow-up|1|||
48574242|NCT00723008|156294379|FG001|Enrollment|Lost to Follow-up|0|||
48574243|NCT00723008|156294378|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
48574244|NCT00723008|156294379|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
48574245|NCT00723008|156294378|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
48574246|NCT00723008|156294379|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
48574247|NCT00723008|156294378|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
48735998|NCT01686828|156883753|FG001|Overall Study|Physician Decision|0|||
48319017|NCT00976937|155368170|FG001|Overall Study|Personal and Familial Reason|2|||
48319018|NCT02372253|155368179|FG000|Overall Study|Non Compliance|2|||
48319019|NCT02372253|155368180|FG001|Overall Study|Non Compliance|0|||
48319020|NCT04484935|155368181|FG000|Overall Study|Other|0|||
48319021|NCT04484935|155368182|FG001|Overall Study|Other|1|||
48319022|NCT04484935|155368181|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48319023|NCT04484935|155368182|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48319024|NCT04484935|155368181|FG000|Overall Study|Lost to Follow-up|1|||
48319025|NCT04484935|155368182|FG001|Overall Study|Lost to Follow-up|0|||
48319026|NCT04484935|155368181|FG000|Overall Study|Death|2|||
48319027|NCT04484935|155368182|FG001|Overall Study|Death|1|||
48319028|NCT02742519|155368183|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
48319029|NCT02742519|155368184|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
48319030|NCT02742519|155368185|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
48319031|NCT02742519|155368183|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
48574248|NCT00723008|156294379|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
48574249|NCT00723008|156294378|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
48574250|NCT00723008|156294379|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
48574251|NCT00723008|156294378|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
48574252|NCT00723008|156294379|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
48574253|NCT01339923|156294383|FG000|Overall Study|Adverse Event|1|||
48574254|NCT01339923|156294384|FG001|Overall Study|Adverse Event|1|||
48574255|NCT01339923|156294385|FG002|Overall Study|Adverse Event|1|||
48574256|NCT01339923|156294386|FG003|Overall Study|Adverse Event|0|||
48574257|NCT01339923|156294387|FG004|Overall Study|Adverse Event|0|||
48574258|NCT01339923|156294388|FG005|Overall Study|Adverse Event|0|||
48574259|NCT01339923|156294389|FG006|Overall Study|Adverse Event|1|||
48574260|NCT01339923|156294383|FG000|Overall Study|Inappropriate Enrollment|1|||
48574261|NCT01339923|156294384|FG001|Overall Study|Inappropriate Enrollment|0|||
48574262|NCT01339923|156294385|FG002|Overall Study|Inappropriate Enrollment|0|||
48574263|NCT01339923|156294386|FG003|Overall Study|Inappropriate Enrollment|0|||
48574264|NCT01339923|156294387|FG004|Overall Study|Inappropriate Enrollment|0|||
48574265|NCT01339923|156294388|FG005|Overall Study|Inappropriate Enrollment|1|||
48574266|NCT01339923|156294389|FG006|Overall Study|Inappropriate Enrollment|0|||
48574267|NCT01339923|156294383|FG000|Overall Study|Lost to Follow-up|4|||
48574268|NCT01339923|156294384|FG001|Overall Study|Lost to Follow-up|4|||
48574269|NCT01339923|156294385|FG002|Overall Study|Lost to Follow-up|0|||
48574270|NCT01339923|156294386|FG003|Overall Study|Lost to Follow-up|3|||
48574271|NCT01339923|156294387|FG004|Overall Study|Lost to Follow-up|1|||
48574272|NCT01339923|156294388|FG005|Overall Study|Lost to Follow-up|1|||
48574273|NCT01339923|156294389|FG006|Overall Study|Lost to Follow-up|5|||
48574274|NCT01339923|156294383|FG000|Overall Study|Protocol Violation|0|||
48574275|NCT01339923|156294384|FG001|Overall Study|Protocol Violation|0|||
48574276|NCT01339923|156294385|FG002|Overall Study|Protocol Violation|0|||
48574277|NCT01339923|156294386|FG003|Overall Study|Protocol Violation|0|||
48574278|NCT01339923|156294387|FG004|Overall Study|Protocol Violation|0|||
48574279|NCT01339923|156294388|FG005|Overall Study|Protocol Violation|3|||
48574280|NCT01339923|156294389|FG006|Overall Study|Protocol Violation|1|||
48574281|NCT01339923|156294383|FG000|Overall Study|Unable to Classify|1|||
48574282|NCT01339923|156294384|FG001|Overall Study|Unable to Classify|0|||
48574283|NCT01339923|156294385|FG002|Overall Study|Unable to Classify|1|||
48574284|NCT01339923|156294386|FG003|Overall Study|Unable to Classify|0|||
48574285|NCT01339923|156294387|FG004|Overall Study|Unable to Classify|0|||
48574286|NCT01339923|156294388|FG005|Overall Study|Unable to Classify|1|||
48574287|NCT01339923|156294389|FG006|Overall Study|Unable to Classify|5|||
48574288|NCT01339923|156294383|FG000|Overall Study|Withdrawal by Subject|7|||
48574289|NCT01339923|156294384|FG001|Overall Study|Withdrawal by Subject|11|||
48574290|NCT01339923|156294385|FG002|Overall Study|Withdrawal by Subject|6|||
48574291|NCT01339923|156294386|FG003|Overall Study|Withdrawal by Subject|1|||
48574292|NCT01339923|156294387|FG004|Overall Study|Withdrawal by Subject|4|||
48574293|NCT01339923|156294388|FG005|Overall Study|Withdrawal by Subject|3|||
48574294|NCT01339923|156294389|FG006|Overall Study|Withdrawal by Subject|2|||
48574295|NCT00729157|156294390|FG000|Overall Study|Withdrawal by Subject|1|||
48574296|NCT01683266|156294391|FG000|Overall Study|Adverse Event|5|||
48574297|NCT01683266|156294392|FG001|Overall Study|Adverse Event|4|||
48574298|NCT01683266|156294391|FG000|Overall Study|Lack of Efficacy|5|||
48574299|NCT01683266|156294392|FG001|Overall Study|Lack of Efficacy|2|||
48574300|NCT01683266|156294391|FG000|Overall Study|Protocol Violation|13|||
48574301|NCT01683266|156294392|FG001|Overall Study|Protocol Violation|6|||
48574302|NCT01683266|156294391|FG000|Overall Study|Personal Reason|17|||
48574303|NCT01683266|156294392|FG001|Overall Study|Personal Reason|25|||
48574304|NCT01683266|156294391|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
48574305|NCT01683266|156294392|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
48574306|NCT01683266|156294391|FG000|Overall Study|Lost to Follow-up|5|||
48574307|NCT01683266|156294392|FG001|Overall Study|Lost to Follow-up|0|||
48574308|NCT01683266|156294391|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
48620501|NCT00450749|156467133|FG002|Overall Study|Withdrawal by Subject|2|||
48620502|NCT00450749|156467131|FG000|Overall Study|Noncompliant|0|||
48620503|NCT00450749|156467132|FG001|Overall Study|Noncompliant|1|||
48620504|NCT00450749|156467133|FG002|Overall Study|Noncompliant|0|||
48620505|NCT00537082|156467134|FG000|Overall Study|Adverse Event|6|||
48620506|NCT00537082|156467135|FG001|Overall Study|Adverse Event|6|||
48620507|NCT00537082|156467136|FG002|Overall Study|Adverse Event|3|||
48620508|NCT00537082|156467134|FG000|Overall Study|Protocol Violation|0|||
48620509|NCT00537082|156467135|FG001|Overall Study|Protocol Violation|2|||
48620510|NCT00537082|156467136|FG002|Overall Study|Protocol Violation|1|||
48620511|NCT00537082|156467134|FG000|Overall Study|Lack of Efficacy|0|||
48620512|NCT00537082|156467135|FG001|Overall Study|Lack of Efficacy|0|||
48620513|NCT00537082|156467136|FG002|Overall Study|Lack of Efficacy|2|||
48620514|NCT00537082|156467134|FG000|Overall Study|Withdrawal by Subject|0|||
48620515|NCT00537082|156467135|FG001|Overall Study|Withdrawal by Subject|1|||
48620516|NCT00537082|156467136|FG002|Overall Study|Withdrawal by Subject|0|||
48620517|NCT00537082|156467134|FG000|Overall Study|Discontinued before initiating treatment|3|||
48620518|NCT00537082|156467135|FG001|Overall Study|Discontinued before initiating treatment|0|||
48620519|NCT00537082|156467136|FG002|Overall Study|Discontinued before initiating treatment|0|||
48620520|NCT01691092|156467137|FG000|Overall Study|Lost to Follow-up|10|||
48620521|NCT01691092|156467137|FG000|Overall Study|Physician Decision|4|||
48620522|NCT01691092|156467137|FG000|Overall Study|Withdrawal by Subject|3|||
48620523|NCT01691092|156467137|FG000|Overall Study|non-compliance|3|||
48620524|NCT01691092|156467137|FG000|Overall Study|used for different study|2|||
48620525|NCT01691092|156467137|FG000|Overall Study|screen fail|19|||
48620526|NCT00655746|156467138|FG000|Overall Study|Withdrawal by Subject|1|||
48620527|NCT02931539|156467139|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
48620528|NCT02931539|156467140|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
48620529|NCT02931539|156467141|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
48620530|NCT02931539|156467139|FG000|Period 1: Treatment Phase|Adverse Event|5|||
48620531|NCT02931539|156467140|FG001|Period 1: Treatment Phase|Adverse Event|1|||
48574309|NCT01683266|156294392|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
48574310|NCT01683266|156294391|FG000|Overall Study|Nonserious Hypoglycemia|0|||
48574311|NCT01683266|156294392|FG001|Overall Study|Nonserious Hypoglycemia|3|||
48574312|NCT01683266|156294391|FG000|Overall Study|Perceived Lack of Efficacy|1|||
48574313|NCT01683266|156294392|FG001|Overall Study|Perceived Lack of Efficacy|1|||
48574314|NCT01683266|156294391|FG000|Overall Study|Possibly Hypoglycemia|1|||
48574315|NCT01683266|156294392|FG001|Overall Study|Possibly Hypoglycemia|0|||
48574316|NCT01683266|156294391|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
48574317|NCT01683266|156294392|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
48574318|NCT02217410|156294393|FG000|Overall Study|Graft Loss|0|||
48574319|NCT02217410|156294394|FG001|Overall Study|Graft Loss|0|||
48574320|NCT02217410|156294395|FG002|Overall Study|Graft Loss|2|||
48574321|NCT02217410|156294393|FG000|Overall Study|Withdrawal by Subject|0|||
48574322|NCT02217410|156294394|FG001|Overall Study|Withdrawal by Subject|0|||
48574323|NCT02217410|156294395|FG002|Overall Study|Withdrawal by Subject|2|||
48574324|NCT02217410|156294393|FG000|Overall Study|Lost to Follow-up|0|||
48574325|NCT02217410|156294394|FG001|Overall Study|Lost to Follow-up|0|||
48574326|NCT02217410|156294395|FG002|Overall Study|Lost to Follow-up|1|||
48574327|NCT02217410|156294393|FG000|Overall Study|Lack of Efficacy|0|||
48574328|NCT02217410|156294394|FG001|Overall Study|Lack of Efficacy|1|||
48574329|NCT02217410|156294395|FG002|Overall Study|Lack of Efficacy|0|||
48574330|NCT02217410|156294393|FG000|Overall Study|Physician Decision|1|||
48574331|NCT02217410|156294394|FG001|Overall Study|Physician Decision|3|||
48574332|NCT02217410|156294395|FG002|Overall Study|Physician Decision|0|||
48574333|NCT00626821|156294402|FG000|Overall Study|Adverse Event|44|||
48574334|NCT00626821|156294402|FG000|Overall Study|Protocol Violation|33|||
48574335|NCT00626821|156294402|FG000|Overall Study|Withdrawal by Subject|10|||
48574336|NCT00626821|156294402|FG000|Overall Study|Physician Decision|9|||
48574337|NCT00626821|156294402|FG000|Overall Study|Product dysfunction|21|||
48574338|NCT00626821|156294402|FG000|Overall Study|other/unknown reason|104|||
48574339|NCT05139303|156294403|FG000|Overall Study|Lost to Follow-up|3|||
48574340|NCT05139303|156294404|FG001|Overall Study|Lost to Follow-up|0|||
48574341|NCT05139303|156294403|FG000|Overall Study|Adverse Event|1|||
48620532|NCT02931539|156467141|FG002|Period 1: Treatment Phase|Adverse Event|0|||
48620533|NCT02931539|156467139|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
48574342|NCT05139303|156294404|FG001|Overall Study|Adverse Event|0|||
48574343|NCT02448537|156294405|FG000|Overall Study|Withdrawal by Subject|1|||
48574344|NCT02448537|156294406|FG001|Overall Study|Withdrawal by Subject|1|||
48574345|NCT02448537|156294407|FG002|Overall Study|Withdrawal by Subject|1|||
48574346|NCT02632409|156294410|FG000|Randomized|AE unrelated to study Drug|0|||
48574347|NCT02632409|156294411|FG001|Randomized|AE unrelated to study Drug|1|||
48574348|NCT02632409|156294410|FG000|Randomized|Participant withdrew consent|2|||
48574349|NCT02632409|156294411|FG001|Randomized|Participant withdrew consent|1|||
48620534|NCT02931539|156467140|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
48620535|NCT02931539|156467141|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
48620536|NCT02931539|156467139|FG000|Period 1: Treatment Phase|Death|8|||
48620537|NCT02931539|156467140|FG001|Period 1: Treatment Phase|Death|24|||
48620538|NCT02931539|156467141|FG002|Period 1: Treatment Phase|Death|0|||
48620539|NCT02931539|156467139|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
48620540|NCT02931539|156467140|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
48620541|NCT02931539|156467141|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
48620542|NCT02931539|156467139|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
48620543|NCT02931539|156467140|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
48620544|NCT02931539|156467141|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
48319032|NCT02742519|155368184|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
48319033|NCT02742519|155368185|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
48319034|NCT02742519|155368183|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
48319035|NCT02742519|155368184|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
48319036|NCT02742519|155368185|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
48319037|NCT02178098|155368187|FG000|Overall Study|Withdrawal by Subject|0|||
48319038|NCT02178098|155368188|FG001|Overall Study|Withdrawal by Subject|6|||
48319039|NCT02178098|155368187|FG000|Overall Study|Adverse Event|1|||
48319040|NCT02178098|155368188|FG001|Overall Study|Adverse Event|2|||
48319041|NCT02178098|155368187|FG000|Overall Study|Protocol Violation|1|||
48319042|NCT02178098|155368188|FG001|Overall Study|Protocol Violation|1|||
48319043|NCT02178098|155368187|FG000|Overall Study|Lost to Follow-up|0|||
48319044|NCT02178098|155368188|FG001|Overall Study|Lost to Follow-up|1|||
48319045|NCT02178098|155368187|FG000|Overall Study|Sponsor Request|1|||
48319046|NCT02178098|155368188|FG001|Overall Study|Sponsor Request|0|||
48319047|NCT02178098|155368187|FG000|Overall Study|Other|2|||
48319048|NCT02178098|155368188|FG001|Overall Study|Other|2|||
48319049|NCT01044303|155368189|FG000|Overall Study|Lost to Follow-up|2|||
48319050|NCT00761189|155368192|FG000|Overall Study|Adverse Event|42|||
48319051|NCT00761189|155368192|FG000|Overall Study|Lack of Efficacy|45|||
48319052|NCT00761189|155368192|FG000|Overall Study|Lost to Follow-up|36|||
48319053|NCT00761189|155368192|FG000|Overall Study|Withdrawal by Subject|49|||
48319054|NCT00761189|155368192|FG000|Overall Study|Other|13|||
48319055|NCT03101371|155368205|FG000|Overall Study|Physician Decision|0|||
48319056|NCT03101371|155368206|FG001|Overall Study|Physician Decision|1|||
48319057|NCT03101371|155368205|FG000|Overall Study|Lost to Follow-up|1|||
48319058|NCT03101371|155368206|FG001|Overall Study|Lost to Follow-up|4|||
48319059|NCT03101371|155368205|FG000|Overall Study|Did not meet eligibility criteria|2|||
48319060|NCT03101371|155368206|FG001|Overall Study|Did not meet eligibility criteria|1|||
48319061|NCT01494922|155368207|FG000|Overall Study|Adverse Event|1|||
48319062|NCT00031694|155368208|FG000|Overall Study|Adverse Event|12|||
48319063|NCT00031694|155368208|FG000|Overall Study|Death|2|||
48319064|NCT00031694|155368208|FG000|Overall Study|Withdrawal by Subject|5|||
48319065|NCT01925339|155368209|FG000|Overall Study|Adverse Event|2|||
48319066|NCT01925339|155368210|FG001|Overall Study|Adverse Event|0|||
48319067|NCT03527160|155368217|FG000|Overall Study|No urine collected|13|||
48319068|NCT03527160|155368217|FG000|Overall Study|No clinical serum creatinine collected|6|||
48319069|NCT03527160|155368217|FG000|Overall Study|Did not meet inclusion|2|||
48319070|NCT04048382|155368220|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
48319071|NCT04048382|155368221|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
48319072|NCT04048382|155368220|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
48319073|NCT04048382|155368221|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
48319074|NCT04048382|155368220|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
48319075|NCT04048382|155368221|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
48319076|NCT01255670|155368227|FG000|Overall Study|Adverse Event|10|||
48319077|NCT01255670|155368228|FG001|Overall Study|Adverse Event|10|||
48319078|NCT01255670|155368227|FG000|Overall Study|Lost to Follow-up|16|||
48319079|NCT01255670|155368228|FG001|Overall Study|Lost to Follow-up|10|||
48319080|NCT00632424|155368233|FG000|Overall Study|Disease Progression|17|||
48319081|NCT00632424|155368233|FG000|Overall Study|Study Drug Toxicity|1|||
48319082|NCT00589667|155369390|FG000|Overall Study|Adverse Event|2|||
48319083|NCT00589667|155369390|FG000|Overall Study|Withdrawal by Subject|1|||
48319084|NCT03050814|155369402|FG000|Overall Study|Screen failures|0|||
48319085|NCT03050814|155369403|FG001|Overall Study|Screen failures|0|||
48620545|NCT02931539|156467139|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
48620546|NCT02931539|156467140|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
48735999|NCT01686828|156883754|FG002|Overall Study|Physician Decision|0|||
48319086|NCT03050814|155369404|FG002|Overall Study|Screen failures|4|||
48319087|NCT00304031|155369405|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
48319088|NCT00304031|155369406|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
48319089|NCT00304031|155369407|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
48319090|NCT00304031|155369405|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
48319091|NCT00304031|155369406|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
48319092|NCT00304031|155369407|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
48319093|NCT00304031|155369405|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
48450051|NCT01831804|155835554|FG008|Overall Study|Withdrew Consent|0|||
48319094|NCT00304031|155369406|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
48319095|NCT00304031|155369407|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
48319096|NCT00304031|155369405|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
48319097|NCT00304031|155369406|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
48319098|NCT00304031|155369407|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
48319099|NCT00304031|155369405|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
48319100|NCT00304031|155369406|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
48319101|NCT00304031|155369407|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
48319102|NCT00304031|155369405|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
48319103|NCT00304031|155369406|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
48319104|NCT00304031|155369407|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
48319105|NCT00304031|155369405|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
48319106|NCT00304031|155369406|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
48319107|NCT00304031|155369407|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
48319108|NCT00304031|155369405|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
48319109|NCT00304031|155369406|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
48319110|NCT00304031|155369407|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
48319111|NCT00304031|155369405|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
48319112|NCT00304031|155369406|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
48319113|NCT00304031|155369407|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
48319114|NCT02584829|155369409|FG000|Overall Study|Physician Decision|1|||
48574350|NCT02632409|156294410|FG000|Randomized|No Longer meets study criteria|5|||
48574351|NCT02632409|156294411|FG001|Randomized|No Longer meets study criteria|0|||
48574352|NCT02632409|156294410|FG000|Randomized|other reasons|1|||
48574353|NCT02632409|156294411|FG001|Randomized|other reasons|0|||
48574354|NCT02632409|156294410|FG000|Treatment Period|Ongoing Treatment|20|||
48574355|NCT02632409|156294411|FG001|Treatment Period|Ongoing Treatment|21|||
48574356|NCT02632409|156294410|FG000|Treatment Period|Disease Recurrence|147|||
48574357|NCT02632409|156294411|FG001|Treatment Period|Disease Recurrence|90|||
48574358|NCT02632409|156294410|FG000|Treatment Period|Study Drug Toxicity|8|||
48574359|NCT02632409|156294411|FG001|Treatment Period|Study Drug Toxicity|49|||
48574360|NCT02632409|156294410|FG000|Treatment Period|Death|1|||
48574361|NCT02632409|156294411|FG001|Treatment Period|Death|0|||
48574362|NCT02632409|156294410|FG000|Treatment Period|AE unrelated to study drug|15|||
48574363|NCT02632409|156294411|FG001|Treatment Period|AE unrelated to study drug|16|||
48574364|NCT02632409|156294410|FG000|Treatment Period|Request to discontinue treatment|4|||
48574365|NCT02632409|156294411|FG001|Treatment Period|Request to discontinue treatment|19|||
48574366|NCT02632409|156294410|FG000|Treatment Period|Participant withdrew consent|7|||
48574367|NCT02632409|156294411|FG001|Treatment Period|Participant withdrew consent|5|||
48574368|NCT02632409|156294410|FG000|Treatment Period|Lost to Follow-up|0|||
48574369|NCT02632409|156294411|FG001|Treatment Period|Lost to Follow-up|1|||
48574370|NCT02632409|156294410|FG000|Treatment Period|Maximum clinical benefit|1|||
48574371|NCT02632409|156294411|FG001|Treatment Period|Maximum clinical benefit|0|||
48574372|NCT02632409|156294410|FG000|Treatment Period|No longer meets study criteria|3|||
48574373|NCT02632409|156294411|FG001|Treatment Period|No longer meets study criteria|0|||
48574374|NCT02632409|156294410|FG000|Treatment Period|Administrative Reason by sponsor|0|||
48574375|NCT02632409|156294411|FG001|Treatment Period|Administrative Reason by sponsor|1|||
48574376|NCT02632409|156294410|FG000|Treatment Period|Other Reasons|10|||
48574377|NCT02632409|156294411|FG001|Treatment Period|Other Reasons|6|||
48574378|NCT02222545|156294412|FG000|Overall Study|Adverse Event|1|||
48574379|NCT02222545|156294413|FG001|Overall Study|Adverse Event|0|||
48574380|NCT02222545|156294414|FG002|Overall Study|Adverse Event|2|||
48319115|NCT02584829|155369410|FG001|Overall Study|Physician Decision|0|||
48319116|NCT02584829|155369409|FG000|Overall Study|Withdrawal by Subject|0|||
48574381|NCT02222545|156294412|FG000|Overall Study|Death|0|||
48574382|NCT02222545|156294413|FG001|Overall Study|Death|0|||
48574383|NCT02222545|156294414|FG002|Overall Study|Death|9|||
48574384|NCT02222545|156294412|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
48574385|NCT02222545|156294413|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
48574386|NCT02222545|156294414|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
48574387|NCT02222545|156294412|FG000|Overall Study|Withdrawal by Subject|0|||
48620547|NCT02931539|156467141|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
48574388|NCT02222545|156294413|FG001|Overall Study|Withdrawal by Subject|0|||
48574389|NCT02222545|156294414|FG002|Overall Study|Withdrawal by Subject|3|||
48574390|NCT02222545|156294412|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
48574391|NCT02222545|156294413|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
48574392|NCT02222545|156294414|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
48574393|NCT00761280|156294416|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
48574394|NCT00761280|156294417|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
48574395|NCT00761280|156294416|FG000|Randomization to First Dose|Sponsor decision|1|||
48574396|NCT00761280|156294417|FG001|Randomization to First Dose|Sponsor decision|0|||
48574397|NCT00761280|156294416|FG000|Randomization to First Dose|Other|1|||
48574398|NCT00761280|156294417|FG001|Randomization to First Dose|Other|0|||
48574399|NCT00761280|156294416|FG000|First Dose to End of Study|End of trial|5|||
48574400|NCT00761280|156294417|FG001|First Dose to End of Study|End of trial|5|||
48574401|NCT00761280|156294416|FG000|First Dose to End of Study|Progressive disease|5|||
48574402|NCT00761280|156294417|FG001|First Dose to End of Study|Progressive disease|3|||
48574403|NCT00761280|156294416|FG000|First Dose to End of Study|Sponsor decision|1|||
48574404|NCT00761280|156294417|FG001|First Dose to End of Study|Sponsor decision|2|||
48574405|NCT00761280|156294416|FG000|First Dose to End of Study|Death|1|||
48574406|NCT00761280|156294417|FG001|First Dose to End of Study|Death|0|||
48574407|NCT00761280|156294416|FG000|First Dose to End of Study|Lost to Follow-up|0|||
48574408|NCT00761280|156294417|FG001|First Dose to End of Study|Lost to Follow-up|1|||
48574409|NCT01938430|156294418|FG000|Overall Study|Randomized but Not Treated|0|||
48574410|NCT01938430|156294419|FG001|Overall Study|Randomized but Not Treated|0|||
48574411|NCT01938430|156294420|FG002|Overall Study|Randomized but Not Treated|0|||
48574412|NCT01938430|156294421|FG003|Overall Study|Randomized but Not Treated|0|||
48574413|NCT01938430|156294422|FG004|Overall Study|Randomized but Not Treated|0|||
48574414|NCT01938430|156294423|FG005|Overall Study|Randomized but Not Treated|0|||
48574415|NCT01938430|156294424|FG006|Overall Study|Randomized but Not Treated|0|||
48574416|NCT01938430|156294425|FG007|Overall Study|Randomized but Not Treated|0|||
48574417|NCT01938430|156294426|FG008|Overall Study|Randomized but Not Treated|0|||
48574418|NCT01938430|156294427|FG009|Overall Study|Randomized but Not Treated|0|||
48574419|NCT01938430|156294428|FG010|Overall Study|Randomized but Not Treated|1|||
48620548|NCT02931539|156467139|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
48620549|NCT02931539|156467140|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
48620550|NCT02931539|156467141|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
48620551|NCT00003456|156469115|FG000|Overall Study|Not evaluable|8|||
48620552|NCT00284934|156469116|FG000|Overall Study|Adverse Event|1|||
48620553|NCT00284934|156469117|FG001|Overall Study|Adverse Event|2|||
48620554|NCT00284934|156469116|FG000|Overall Study|Other reasons|3|||
48620555|NCT00284934|156469117|FG001|Overall Study|Other reasons|1|||
48620556|NCT01108796|156469118|FG000|Overall Study|Adverse Event|0|||
48620557|NCT01108796|156469119|FG001|Overall Study|Adverse Event|1|||
48319117|NCT02584829|155369410|FG001|Overall Study|Withdrawal by Subject|1|||
48574420|NCT01938430|156294429|FG011|Overall Study|Randomized but Not Treated|0|||
48574421|NCT01938430|156294430|FG012|Overall Study|Randomized but Not Treated|0|||
48574422|NCT01938430|156294431|FG013|Overall Study|Randomized but Not Treated|1|||
48574423|NCT01938430|156294418|FG000|Overall Study|Adverse Event|0|||
48574424|NCT01938430|156294419|FG001|Overall Study|Adverse Event|0|||
48574425|NCT01938430|156294420|FG002|Overall Study|Adverse Event|0|||
48574426|NCT01938430|156294421|FG003|Overall Study|Adverse Event|0|||
48574427|NCT01938430|156294422|FG004|Overall Study|Adverse Event|0|||
48574428|NCT01938430|156294423|FG005|Overall Study|Adverse Event|0|||
48574429|NCT01938430|156294424|FG006|Overall Study|Adverse Event|1|||
48574430|NCT01938430|156294425|FG007|Overall Study|Adverse Event|0|||
48620558|NCT01108796|156469118|FG000|Overall Study|Lost to Follow-up|7|||
48620559|NCT01108796|156469119|FG001|Overall Study|Lost to Follow-up|6|||
48574431|NCT01938430|156294426|FG008|Overall Study|Adverse Event|0|||
48574432|NCT01938430|156294427|FG009|Overall Study|Adverse Event|0|||
48620560|NCT01208051|156469120|FG000|Total Enrollment|Withdrawal by Subject|0|||
48620561|NCT01208051|156469121|FG001|Total Enrollment|Withdrawal by Subject|1|||
48574433|NCT01938430|156294428|FG010|Overall Study|Adverse Event|0|||
48574434|NCT01938430|156294429|FG011|Overall Study|Adverse Event|0|||
48574435|NCT01938430|156294430|FG012|Overall Study|Adverse Event|0|||
48574436|NCT01938430|156294431|FG013|Overall Study|Adverse Event|0|||
48574437|NCT01938430|156294418|FG000|Overall Study|Death|1|||
48574438|NCT01938430|156294419|FG001|Overall Study|Death|2|||
48574439|NCT01938430|156294420|FG002|Overall Study|Death|2|||
48574440|NCT01938430|156294421|FG003|Overall Study|Death|1|||
48574441|NCT01938430|156294422|FG004|Overall Study|Death|0|||
48574442|NCT01938430|156294423|FG005|Overall Study|Death|0|||
48574443|NCT01938430|156294424|FG006|Overall Study|Death|1|||
48574444|NCT01938430|156294425|FG007|Overall Study|Death|1|||
48574445|NCT01938430|156294426|FG008|Overall Study|Death|2|||
48574446|NCT01938430|156294427|FG009|Overall Study|Death|3|||
48574447|NCT01938430|156294428|FG010|Overall Study|Death|0|||
48574448|NCT01938430|156294429|FG011|Overall Study|Death|0|||
48574449|NCT01938430|156294430|FG012|Overall Study|Death|0|||
48574450|NCT01938430|156294431|FG013|Overall Study|Death|0|||
48574451|NCT01938430|156294418|FG000|Overall Study|Investigator's Discretion|0|||
48574452|NCT01938430|156294419|FG001|Overall Study|Investigator's Discretion|0|||
48574453|NCT01938430|156294420|FG002|Overall Study|Investigator's Discretion|1|||
48574454|NCT01938430|156294421|FG003|Overall Study|Investigator's Discretion|0|||
48574455|NCT01938430|156294422|FG004|Overall Study|Investigator's Discretion|0|||
48574456|NCT01938430|156294423|FG005|Overall Study|Investigator's Discretion|0|||
48574457|NCT01938430|156294424|FG006|Overall Study|Investigator's Discretion|0|||
48574458|NCT01938430|156294425|FG007|Overall Study|Investigator's Discretion|0|||
48574459|NCT01938430|156294426|FG008|Overall Study|Investigator's Discretion|0|||
48574460|NCT01938430|156294427|FG009|Overall Study|Investigator's Discretion|0|||
48574461|NCT01938430|156294428|FG010|Overall Study|Investigator's Discretion|0|||
48574462|NCT01938430|156294429|FG011|Overall Study|Investigator's Discretion|0|||
48574463|NCT01938430|156294430|FG012|Overall Study|Investigator's Discretion|0|||
48574464|NCT01938430|156294431|FG013|Overall Study|Investigator's Discretion|0|||
48574465|NCT01938430|156294418|FG000|Overall Study|Lack of Efficacy|3|||
48574466|NCT01938430|156294419|FG001|Overall Study|Lack of Efficacy|1|||
48574467|NCT01938430|156294420|FG002|Overall Study|Lack of Efficacy|1|||
48574468|NCT01938430|156294421|FG003|Overall Study|Lack of Efficacy|1|||
48574469|NCT01938430|156294422|FG004|Overall Study|Lack of Efficacy|0|||
48574470|NCT01938430|156294423|FG005|Overall Study|Lack of Efficacy|0|||
48574471|NCT01938430|156294424|FG006|Overall Study|Lack of Efficacy|0|||
48574472|NCT01938430|156294425|FG007|Overall Study|Lack of Efficacy|0|||
48574473|NCT01938430|156294426|FG008|Overall Study|Lack of Efficacy|1|||
48574474|NCT01938430|156294427|FG009|Overall Study|Lack of Efficacy|0|||
48574475|NCT01938430|156294428|FG010|Overall Study|Lack of Efficacy|2|||
48574476|NCT01938430|156294429|FG011|Overall Study|Lack of Efficacy|1|||
48574477|NCT01938430|156294430|FG012|Overall Study|Lack of Efficacy|0|||
48574478|NCT01938430|156294431|FG013|Overall Study|Lack of Efficacy|0|||
48574479|NCT01938430|156294418|FG000|Overall Study|Lost to Follow-up|0|||
48574480|NCT01938430|156294419|FG001|Overall Study|Lost to Follow-up|0|||
48574481|NCT01938430|156294420|FG002|Overall Study|Lost to Follow-up|1|||
48574482|NCT01938430|156294421|FG003|Overall Study|Lost to Follow-up|0|||
48574483|NCT01938430|156294422|FG004|Overall Study|Lost to Follow-up|0|||
48574484|NCT01938430|156294423|FG005|Overall Study|Lost to Follow-up|1|||
48574485|NCT01938430|156294424|FG006|Overall Study|Lost to Follow-up|0|||
48574486|NCT01938430|156294425|FG007|Overall Study|Lost to Follow-up|0|||
48574487|NCT01938430|156294426|FG008|Overall Study|Lost to Follow-up|0|||
48574488|NCT01938430|156294427|FG009|Overall Study|Lost to Follow-up|0|||
48574489|NCT01938430|156294428|FG010|Overall Study|Lost to Follow-up|0|||
48574490|NCT01938430|156294429|FG011|Overall Study|Lost to Follow-up|0|||
48574491|NCT01938430|156294430|FG012|Overall Study|Lost to Follow-up|0|||
48574492|NCT01938430|156294431|FG013|Overall Study|Lost to Follow-up|0|||
48574493|NCT01938430|156294418|FG000|Overall Study|Withdrew Consent|0|||
48574494|NCT01938430|156294419|FG001|Overall Study|Withdrew Consent|0|||
48574495|NCT01938430|156294420|FG002|Overall Study|Withdrew Consent|0|||
48574496|NCT01938430|156294421|FG003|Overall Study|Withdrew Consent|0|||
48574497|NCT01938430|156294422|FG004|Overall Study|Withdrew Consent|0|||
48574498|NCT01938430|156294423|FG005|Overall Study|Withdrew Consent|0|||
48574499|NCT01938430|156294424|FG006|Overall Study|Withdrew Consent|0|||
48574500|NCT01938430|156294425|FG007|Overall Study|Withdrew Consent|0|||
48574501|NCT01938430|156294426|FG008|Overall Study|Withdrew Consent|1|||
48574502|NCT01938430|156294427|FG009|Overall Study|Withdrew Consent|0|||
48574503|NCT01938430|156294428|FG010|Overall Study|Withdrew Consent|0|||
48574504|NCT01938430|156294429|FG011|Overall Study|Withdrew Consent|0|||
48574505|NCT01938430|156294430|FG012|Overall Study|Withdrew Consent|0|||
48574506|NCT01938430|156294431|FG013|Overall Study|Withdrew Consent|0|||
48574507|NCT00090220|156294435|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
48620562|NCT01208051|156469122|FG002|Total Enrollment|Withdrawal by Subject|0|||
48736000|NCT01686828|156883755|FG003|Overall Study|Physician Decision|0|||
48736001|NCT01686828|156883752|FG000|Overall Study|New Job|0|||
48736002|NCT01686828|156883753|FG001|Overall Study|New Job|1|||
48736003|NCT01686828|156883754|FG002|Overall Study|New Job|0|||
48736004|NCT01686828|156883755|FG003|Overall Study|New Job|0|||
48736005|NCT01686828|156883752|FG000|Overall Study|Weight Loss|0|||
48736006|NCT01686828|156883753|FG001|Overall Study|Weight Loss|0|||
48736007|NCT01686828|156883754|FG002|Overall Study|Weight Loss|1|||
48736008|NCT01686828|156883755|FG003|Overall Study|Weight Loss|0|||
48736009|NCT01790932|156883757|FG000|Overall Study|Disease Progression|41|||
48574508|NCT00090220|156294436|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
48574509|NCT00090220|156294437|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
48736010|NCT01790932|156883757|FG000|Overall Study|Adverse Event|7|||
48736011|NCT01790932|156883757|FG000|Overall Study|Physician Decision|1|||
48736012|NCT01790932|156883757|FG000|Overall Study|Withdrawal by Subject|1|||
48574510|NCT00090220|156294438|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
48574511|NCT00090220|156294439|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
48574512|NCT00090220|156294440|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
48574513|NCT00090220|156294435|FG000|Base Study Vaccination Period|Adverse Event|6|||
48574514|NCT00090220|156294436|FG001|Base Study Vaccination Period|Adverse Event|1|||
48574515|NCT00090220|156294437|FG002|Base Study Vaccination Period|Adverse Event|0|||
48574516|NCT00090220|156294438|FG003|Base Study Vaccination Period|Adverse Event|0|||
48574517|NCT00090220|156294439|FG004|Base Study Vaccination Period|Adverse Event|0|||
48574518|NCT00090220|156294440|FG005|Base Study Vaccination Period|Adverse Event|0|||
48574519|NCT00090220|156294435|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
48574520|NCT00090220|156294436|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
48574521|NCT00090220|156294437|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
48574522|NCT00090220|156294438|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
48574523|NCT00090220|156294439|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
48574524|NCT00090220|156294440|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
48574525|NCT00090220|156294435|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
48574526|NCT00090220|156294436|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
48736013|NCT00257608|156885621|FG000|Chemotherapy Phase|Adverse Event|138|||
48736014|NCT00257608|156885622|FG001|Chemotherapy Phase|Adverse Event|0|||
48736015|NCT00257608|156885623|FG002|Chemotherapy Phase|Adverse Event|0|||
48736016|NCT00257608|156885621|FG000|Chemotherapy Phase|Disease progression|139|||
48736017|NCT00257608|156885622|FG001|Chemotherapy Phase|Disease progression|0|||
48736018|NCT00257608|156885623|FG002|Chemotherapy Phase|Disease progression|0|||
48574527|NCT00090220|156294437|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
48574528|NCT00090220|156294438|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
48574529|NCT00090220|156294439|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
48574530|NCT00090220|156294440|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
48574531|NCT00090220|156294435|FG000|Base Study Vaccination Period|Patient Moved|6|||
48574532|NCT00090220|156294436|FG001|Base Study Vaccination Period|Patient Moved|2|||
48574533|NCT00090220|156294437|FG002|Base Study Vaccination Period|Patient Moved|0|||
48574534|NCT00090220|156294438|FG003|Base Study Vaccination Period|Patient Moved|0|||
48574535|NCT00090220|156294439|FG004|Base Study Vaccination Period|Patient Moved|0|||
48574536|NCT00090220|156294440|FG005|Base Study Vaccination Period|Patient Moved|0|||
48574537|NCT00090220|156294435|FG000|Base Study Vaccination Period|Other|4|||
48574538|NCT00090220|156294436|FG001|Base Study Vaccination Period|Other|4|||
48574539|NCT00090220|156294437|FG002|Base Study Vaccination Period|Other|0|||
48574540|NCT00090220|156294438|FG003|Base Study Vaccination Period|Other|0|||
48574541|NCT00090220|156294439|FG004|Base Study Vaccination Period|Other|0|||
48574542|NCT00090220|156294440|FG005|Base Study Vaccination Period|Other|0|||
48574543|NCT00090220|156294435|FG000|Base Study Follow-up Period|Adverse Event|6|||
48574544|NCT00090220|156294436|FG001|Base Study Follow-up Period|Adverse Event|1|||
48574545|NCT00090220|156294437|FG002|Base Study Follow-up Period|Adverse Event|0|||
48574546|NCT00090220|156294438|FG003|Base Study Follow-up Period|Adverse Event|0|||
48574547|NCT00090220|156294439|FG004|Base Study Follow-up Period|Adverse Event|0|||
48574548|NCT00090220|156294440|FG005|Base Study Follow-up Period|Adverse Event|0|||
48574549|NCT00090220|156294435|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
48574550|NCT00090220|156294436|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
48574551|NCT00090220|156294437|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
48574552|NCT00090220|156294438|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
48574553|NCT00090220|156294439|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
48574554|NCT00090220|156294440|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
48736019|NCT00257608|156885621|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
48736020|NCT00257608|156885622|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
48736021|NCT00257608|156885623|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
48736022|NCT00257608|156885621|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
48574555|NCT00090220|156294435|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
48574556|NCT00090220|156294436|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
48620563|NCT01208051|156469123|FG003|Total Enrollment|Withdrawal by Subject|0|||
48620564|NCT01208051|156469124|FG004|Total Enrollment|Withdrawal by Subject|2|||
48620565|NCT01208051|156469120|FG000|Total Enrollment|Brain metastases|0|||
48620566|NCT01208051|156469121|FG001|Total Enrollment|Brain metastases|0|||
48620567|NCT01208051|156469122|FG002|Total Enrollment|Brain metastases|1|||
48620568|NCT01208051|156469123|FG003|Total Enrollment|Brain metastases|0|||
48620569|NCT01208051|156469124|FG004|Total Enrollment|Brain metastases|0|||
48620570|NCT00326495|156469125|FG000|Overall Study|Switched to alternative treatment|1|||
48620571|NCT00326495|156469125|FG000|Overall Study|Disease progression before treatment|1|||
48620572|NCT00326495|156469125|FG000|Overall Study|Refused further treatment|2|||
48620573|NCT00326495|156469125|FG000|Overall Study|Subject off study before assessment|1|||
48620574|NCT00864513|156469129|FG000|Overall Study|Withdrawal by Subject|3|||
48574557|NCT00090220|156294437|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
48574558|NCT00090220|156294438|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
48574559|NCT00090220|156294439|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
48574560|NCT00090220|156294440|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
48574561|NCT00090220|156294435|FG000|Base Study Follow-up Period|Patient Moved|20|||
48574562|NCT00090220|156294436|FG001|Base Study Follow-up Period|Patient Moved|28|||
48574563|NCT00090220|156294437|FG002|Base Study Follow-up Period|Patient Moved|0|||
48574564|NCT00090220|156294438|FG003|Base Study Follow-up Period|Patient Moved|0|||
48574565|NCT00090220|156294439|FG004|Base Study Follow-up Period|Patient Moved|0|||
48574566|NCT00090220|156294440|FG005|Base Study Follow-up Period|Patient Moved|0|||
48574567|NCT00090220|156294435|FG000|Base Study Follow-up Period|Other|19|||
48574568|NCT00090220|156294436|FG001|Base Study Follow-up Period|Other|21|||
48574569|NCT00090220|156294437|FG002|Base Study Follow-up Period|Other|0|||
48574570|NCT00090220|156294438|FG003|Base Study Follow-up Period|Other|0|||
48574571|NCT00090220|156294439|FG004|Base Study Follow-up Period|Other|0|||
48574572|NCT00090220|156294440|FG005|Base Study Follow-up Period|Other|0|||
48574573|NCT00090220|156294435|FG000|Extension 1 (EXT1)|Adverse Event|0|||
48574574|NCT00090220|156294436|FG001|Extension 1 (EXT1)|Adverse Event|0|||
48574575|NCT00090220|156294437|FG002|Extension 1 (EXT1)|Adverse Event|4|||
48574576|NCT00090220|156294438|FG003|Extension 1 (EXT1)|Adverse Event|0|||
48574577|NCT00090220|156294439|FG004|Extension 1 (EXT1)|Adverse Event|0|||
48574578|NCT00090220|156294440|FG005|Extension 1 (EXT1)|Adverse Event|0|||
48574579|NCT00090220|156294435|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
48574580|NCT00090220|156294436|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
48574581|NCT00090220|156294437|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
48574582|NCT00090220|156294438|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
48574583|NCT00090220|156294439|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
48574584|NCT00090220|156294440|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
48574585|NCT00090220|156294435|FG000|Extension 1 (EXT1)|Moved|0|||
48620575|NCT03548415|156469130|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
48620576|NCT03548415|156469131|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
48620577|NCT03548415|156469132|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
48620578|NCT03548415|156469133|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
48620579|NCT03548415|156469134|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
48620580|NCT00621322|156469135|FG000|Overall Study|Lost to Follow-up|0|||
48620581|NCT00621322|156469136|FG001|Overall Study|Lost to Follow-up|0|||
48620582|NCT00621322|156469137|FG002|Overall Study|Lost to Follow-up|0|||
48620583|NCT00621322|156469138|FG003|Overall Study|Lost to Follow-up|0|||
48620584|NCT00621322|156469139|FG004|Overall Study|Lost to Follow-up|1|||
48620585|NCT00621322|156469140|FG005|Overall Study|Lost to Follow-up|0|||
48574586|NCT00090220|156294436|FG001|Extension 1 (EXT1)|Moved|0|||
48574587|NCT00090220|156294437|FG002|Extension 1 (EXT1)|Moved|2|||
48620586|NCT00621322|156469135|FG000|Overall Study|Physician Decision|0|||
48574588|NCT00090220|156294438|FG003|Extension 1 (EXT1)|Moved|1|||
48574589|NCT00090220|156294439|FG004|Extension 1 (EXT1)|Moved|0|||
48574590|NCT00090220|156294440|FG005|Extension 1 (EXT1)|Moved|0|||
48574591|NCT00090220|156294435|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
48620587|NCT00621322|156469136|FG001|Overall Study|Physician Decision|0|||
48736023|NCT00257608|156885622|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
48574592|NCT00090220|156294436|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
48574593|NCT00090220|156294437|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
48574594|NCT00090220|156294438|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
48574595|NCT00090220|156294439|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
48574596|NCT00090220|156294440|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
48574597|NCT00090220|156294435|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
48574598|NCT00090220|156294436|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
48574599|NCT00090220|156294437|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
48574600|NCT00090220|156294438|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
48574601|NCT00090220|156294439|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
48620588|NCT00621322|156469137|FG002|Overall Study|Physician Decision|1|||
48620589|NCT00621322|156469138|FG003|Overall Study|Physician Decision|1|||
48620590|NCT00621322|156469139|FG004|Overall Study|Physician Decision|0|||
48319118|NCT02584829|155369409|FG000|Overall Study|Progressive Disease|0|||
48319119|NCT02584829|155369410|FG001|Overall Study|Progressive Disease|3|||
48319120|NCT00802464|155369411|FG000|Month 0 - Month 8|Adverse Event|0|||
48319121|NCT00802464|155369412|FG001|Month 0 - Month 8|Adverse Event|1|||
48574602|NCT00090220|156294440|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
48574603|NCT00090220|156294435|FG000|Extension 1 (EXT1)|Other reason|0|||
48574604|NCT00090220|156294436|FG001|Extension 1 (EXT1)|Other reason|0|||
48574605|NCT00090220|156294437|FG002|Extension 1 (EXT1)|Other reason|2|||
48574606|NCT00090220|156294438|FG003|Extension 1 (EXT1)|Other reason|0|||
48574607|NCT00090220|156294439|FG004|Extension 1 (EXT1)|Other reason|0|||
48574608|NCT00090220|156294440|FG005|Extension 1 (EXT1)|Other reason|0|||
48574609|NCT00090220|156294435|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48574610|NCT00090220|156294436|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48574611|NCT00090220|156294437|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48574612|NCT00090220|156294438|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48574613|NCT00090220|156294439|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
48574614|NCT00090220|156294440|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
48574615|NCT00090220|156294435|FG000|Long-term Follow-up (EXT2)|Death|0|||
48574616|NCT00090220|156294436|FG001|Long-term Follow-up (EXT2)|Death|0|||
48574617|NCT00090220|156294437|FG002|Long-term Follow-up (EXT2)|Death|0|||
48574618|NCT00090220|156294438|FG003|Long-term Follow-up (EXT2)|Death|0|||
48574619|NCT00090220|156294439|FG004|Long-term Follow-up (EXT2)|Death|1|||
48574620|NCT00090220|156294440|FG005|Long-term Follow-up (EXT2)|Death|1|||
48574621|NCT00090220|156294435|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48574622|NCT00090220|156294436|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48574623|NCT00090220|156294437|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48574624|NCT00090220|156294438|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48574625|NCT00090220|156294439|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
48574626|NCT00090220|156294440|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
48574627|NCT00090220|156294435|FG000|Long-term Follow-up (EXT2)|Other|0|||
48574628|NCT00090220|156294436|FG001|Long-term Follow-up (EXT2)|Other|0|||
48574629|NCT00090220|156294437|FG002|Long-term Follow-up (EXT2)|Other|0|||
48574630|NCT00090220|156294438|FG003|Long-term Follow-up (EXT2)|Other|0|||
48574631|NCT00090220|156294439|FG004|Long-term Follow-up (EXT2)|Other|1|||
48574632|NCT00090220|156294440|FG005|Long-term Follow-up (EXT2)|Other|0|||
48574633|NCT03875482|156294445|FG000|Overall Study|Adverse Event|0|||
48574634|NCT03875482|156294446|FG001|Overall Study|Adverse Event|1|||
48574635|NCT03875482|156294445|FG000|Overall Study|Withdrew consent|5|||
48574636|NCT03875482|156294446|FG001|Overall Study|Withdrew consent|6|||
48319122|NCT00802464|155369413|FG002|Month 0 - Month 8|Adverse Event|1|||
48319123|NCT00802464|155369414|FG003|Month 0 - Month 8|Adverse Event|2|||
48574637|NCT03875482|156294445|FG000|Overall Study|Lost to Follow-up|8|||
48574638|NCT03875482|156294446|FG001|Overall Study|Lost to Follow-up|2|||
48574639|NCT03875482|156294445|FG000|Overall Study|Lack of Efficacy|0|||
48574640|NCT03875482|156294446|FG001|Overall Study|Lack of Efficacy|11|||
48574641|NCT02424630|156294447|FG000|Overall Study|No rotator cuff tear|1|||
48574642|NCT02424630|156294448|FG001|Overall Study|No rotator cuff tear|2|||
48574643|NCT02424630|156294447|FG000|Overall Study|Open procedure|0|||
48574644|NCT02424630|156294448|FG001|Overall Study|Open procedure|1|||
48574645|NCT00537316|156294449|FG000|Part 1|Adverse Event|7|||
48574646|NCT00537316|156294450|FG001|Part 1|Adverse Event|11|||
48574647|NCT00537316|156294451|FG002|Part 1|Adverse Event|8|||
48574648|NCT00537316|156294452|FG003|Part 1|Adverse Event|0|||
48574649|NCT00537316|156294453|FG004|Part 1|Adverse Event|0|||
48574650|NCT00537316|156294454|FG005|Part 1|Adverse Event|0|||
48574651|NCT00537316|156294455|FG006|Part 1|Adverse Event|0|||
48574652|NCT00537316|156294449|FG000|Part 1|Protocol defined clinical event|1|||
48574653|NCT00537316|156294450|FG001|Part 1|Protocol defined clinical event|0|||
48574654|NCT00537316|156294451|FG002|Part 1|Protocol defined clinical event|0|||
48319124|NCT00802464|155369411|FG000|Month 0 - Month 8|Protocol Violation|0|||
48319125|NCT00802464|155369412|FG001|Month 0 - Month 8|Protocol Violation|0|||
48319126|NCT00802464|155369413|FG002|Month 0 - Month 8|Protocol Violation|1|||
48574655|NCT00537316|156294452|FG003|Part 1|Protocol defined clinical event|0|||
48574656|NCT00537316|156294453|FG004|Part 1|Protocol defined clinical event|0|||
48574657|NCT00537316|156294454|FG005|Part 1|Protocol defined clinical event|0|||
48574658|NCT00537316|156294455|FG006|Part 1|Protocol defined clinical event|0|||
48574659|NCT00537316|156294449|FG000|Part 1|Lost to Follow-up|1|||
48574660|NCT00537316|156294450|FG001|Part 1|Lost to Follow-up|0|||
48574661|NCT00537316|156294451|FG002|Part 1|Lost to Follow-up|0|||
48620591|NCT00621322|156469140|FG005|Overall Study|Physician Decision|0|||
48620592|NCT00621322|156469135|FG000|Overall Study|Withdrawal by Subject|0|||
48620593|NCT00621322|156469136|FG001|Overall Study|Withdrawal by Subject|0|||
48620594|NCT00621322|156469137|FG002|Overall Study|Withdrawal by Subject|0|||
48620595|NCT00621322|156469138|FG003|Overall Study|Withdrawal by Subject|1|||
48620596|NCT00621322|156469139|FG004|Overall Study|Withdrawal by Subject|0|||
48620597|NCT00621322|156469140|FG005|Overall Study|Withdrawal by Subject|2|||
48620598|NCT00621322|156469135|FG000|Overall Study|Migrated/moved from study area|1|||
48620599|NCT00621322|156469136|FG001|Overall Study|Migrated/moved from study area|0|||
48620600|NCT00621322|156469137|FG002|Overall Study|Migrated/moved from study area|1|||
48620601|NCT00621322|156469138|FG003|Overall Study|Migrated/moved from study area|1|||
48620602|NCT00621322|156469139|FG004|Overall Study|Migrated/moved from study area|0|||
48620603|NCT00621322|156469140|FG005|Overall Study|Migrated/moved from study area|2|||
48620604|NCT00756444|156469141|FG000|Overall Study|Adverse Event|1|||
48620605|NCT00756444|156469142|FG001|Overall Study|Adverse Event|1|||
48620606|NCT00756444|156469141|FG000|Overall Study|Withdrawal by Subject|6|||
48620607|NCT00756444|156469142|FG001|Overall Study|Withdrawal by Subject|8|||
48620608|NCT00756444|156469141|FG000|Overall Study|Lost to Follow-up|0|||
48620609|NCT00756444|156469142|FG001|Overall Study|Lost to Follow-up|1|||
48620610|NCT00756444|156469141|FG000|Overall Study|Death|5|||
48620611|NCT00756444|156469142|FG001|Overall Study|Death|4|||
48620612|NCT00756444|156469141|FG000|Overall Study|Disease Progression|2|||
48620613|NCT00756444|156469142|FG001|Overall Study|Disease Progression|7|||
48574662|NCT00537316|156294452|FG003|Part 1|Lost to Follow-up|0|||
48574663|NCT00537316|156294453|FG004|Part 1|Lost to Follow-up|0|||
48574664|NCT00537316|156294454|FG005|Part 1|Lost to Follow-up|0|||
48574665|NCT00537316|156294455|FG006|Part 1|Lost to Follow-up|0|||
48574666|NCT00537316|156294449|FG000|Part 1|Withdrawal by Subject|3|||
48620614|NCT00756444|156469141|FG000|Overall Study|Ineligibility Determined|1|||
48620615|NCT00756444|156469142|FG001|Overall Study|Ineligibility Determined|0|||
48620616|NCT04882215|156469146|FG000|Overall Study|Withdrawal by Subject|5|||
48620617|NCT04882215|156469147|FG001|Overall Study|Withdrawal by Subject|0|||
48620618|NCT01399099|156469148|FG000|Overall Study|Lost to Follow-up|14|||
48620619|NCT01399099|156469148|FG000|Overall Study|Physician Decision|1|||
48620620|NCT01399099|156469148|FG000|Overall Study|Protocol Violation|1|||
48620621|NCT01399099|156469148|FG000|Overall Study|Skin Irritation|13|||
48620622|NCT01399099|156469148|FG000|Overall Study|Infection|1|||
48620623|NCT01399099|156469148|FG000|Overall Study|Miscellaneous|4|||
48620624|NCT01362270|156469149|FG000|Overall Study|Withdrawal by Subject|1|||
48620625|NCT01362270|156469150|FG001|Overall Study|Withdrawal by Subject|0|||
48620626|NCT01362270|156469149|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
48620627|NCT01362270|156469150|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
48620628|NCT01362270|156469149|FG000|Overall Study|Met excl. criteria before 1st session|1|||
48620629|NCT01362270|156469150|FG001|Overall Study|Met excl. criteria before 1st session|1|||
48620630|NCT04341662|156469153|FG000|Overall Study|Did not have source-verified blood loss data|423|||
48620631|NCT04341662|156469154|FG001|Overall Study|Did not have source-verified blood loss data|514|||
48620632|NCT02571244|156469156|FG000|Overall Study|Lost to Follow-up|0|||
48620633|NCT02571244|156469157|FG001|Overall Study|Lost to Follow-up|1|||
48620634|NCT02571244|156469156|FG000|Overall Study|Unable to reach out post discharge|3|||
48620635|NCT02571244|156469157|FG001|Overall Study|Unable to reach out post discharge|0|||
48620636|NCT01543503|156469158|FG000|Overall Study|Lost to Follow-up|32|||
48620637|NCT01543503|156469159|FG001|Overall Study|Lost to Follow-up|36|||
48620638|NCT01543503|156469158|FG000|Overall Study|Adverse Event|9|||
48620639|NCT01543503|156469159|FG001|Overall Study|Adverse Event|13|||
48620640|NCT01543503|156469158|FG000|Overall Study|Lack of Efficacy|4|||
48574667|NCT00537316|156294450|FG001|Part 1|Withdrawal by Subject|8|||
48574668|NCT00537316|156294451|FG002|Part 1|Withdrawal by Subject|4|||
48574669|NCT00537316|156294452|FG003|Part 1|Withdrawal by Subject|0|||
48574670|NCT00537316|156294453|FG004|Part 1|Withdrawal by Subject|0|||
48574671|NCT00537316|156294454|FG005|Part 1|Withdrawal by Subject|0|||
48574672|NCT00537316|156294455|FG006|Part 1|Withdrawal by Subject|0|||
48574673|NCT00537316|156294449|FG000|Part 1|Protocol Violation|1|||
48620641|NCT01543503|156469159|FG001|Overall Study|Lack of Efficacy|16|||
48620642|NCT01543503|156469158|FG000|Overall Study|Participant withdrew informed consent|8|||
48620643|NCT01543503|156469159|FG001|Overall Study|Participant withdrew informed consent|10|||
48574674|NCT00537316|156294450|FG001|Part 1|Protocol Violation|5|||
48620644|NCT01543503|156469158|FG000|Overall Study|Change of jobs|0|||
48620645|NCT01543503|156469159|FG001|Overall Study|Change of jobs|1|||
48620646|NCT01543503|156469158|FG000|Overall Study|Intolerance to the biologic treatment|0|||
48620647|NCT01543503|156469159|FG001|Overall Study|Intolerance to the biologic treatment|1|||
48620648|NCT01543503|156469158|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
48620649|NCT01543503|156469159|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
48620650|NCT01543503|156469158|FG000|Overall Study|Participant did not complete last visit|0|||
48620651|NCT01543503|156469159|FG001|Overall Study|Participant did not complete last visit|2|||
48620652|NCT01543503|156469158|FG000|Overall Study|Refused to continue treatment|7|||
48574675|NCT00537316|156294451|FG002|Part 1|Protocol Violation|1|||
48620653|NCT01543503|156469159|FG001|Overall Study|Refused to continue treatment|0|||
48620654|NCT01543503|156469158|FG000|Overall Study|Incorrect medication received|1|||
48620655|NCT01543503|156469159|FG001|Overall Study|Incorrect medication received|0|||
48620656|NCT01543503|156469158|FG000|Overall Study|Participant moved to another city|2|||
48620657|NCT01543503|156469159|FG001|Overall Study|Participant moved to another city|0|||
48620658|NCT01543503|156469158|FG000|Overall Study|Participant will not return for visits|0|||
48620659|NCT01543503|156469159|FG001|Overall Study|Participant will not return for visits|2|||
48620660|NCT01543503|156469158|FG000|Overall Study|Participant transferred to another city|1|||
48620661|NCT01543503|156469159|FG001|Overall Study|Participant transferred to another city|0|||
48620662|NCT01543503|156469158|FG000|Overall Study|Participant moved to Scotland|1|||
48620663|NCT01543503|156469159|FG001|Overall Study|Participant moved to Scotland|0|||
48620664|NCT01543503|156469158|FG000|Overall Study|Participant decision to stop treatment|1|||
48620665|NCT01543503|156469159|FG001|Overall Study|Participant decision to stop treatment|0|||
48620666|NCT01543503|156469158|FG000|Overall Study|Investigator did not wish to participate|1|||
48620667|NCT01543503|156469159|FG001|Overall Study|Investigator did not wish to participate|1|||
48620668|NCT01543503|156469158|FG000|Overall Study|Participant recruited after closing date|0|||
48620669|NCT01543503|156469159|FG001|Overall Study|Participant recruited after closing date|1|||
48620670|NCT01543503|156469158|FG000|Overall Study|Site stopped participation|5|||
48620671|NCT01543503|156469159|FG001|Overall Study|Site stopped participation|1|||
48620672|NCT01543503|156469158|FG000|Overall Study|Participant did not attend a visit|1|||
48620673|NCT01543503|156469159|FG001|Overall Study|Participant did not attend a visit|0|||
48620674|NCT01543503|156469158|FG000|Overall Study|Moved to other rheumatologic site|0|||
48620675|NCT01543503|156469159|FG001|Overall Study|Moved to other rheumatologic site|1|||
48620676|NCT01543503|156469158|FG000|Overall Study|Participant consented to another study|0|||
48620677|NCT01543503|156469159|FG001|Overall Study|Participant consented to another study|2|||
48620678|NCT01543503|156469158|FG000|Overall Study|Participant went to United States|1|||
48574676|NCT00537316|156294452|FG003|Part 1|Protocol Violation|0|||
48574677|NCT00537316|156294453|FG004|Part 1|Protocol Violation|0|||
48574678|NCT00537316|156294454|FG005|Part 1|Protocol Violation|0|||
48620679|NCT01543503|156469159|FG001|Overall Study|Participant went to United States|0|||
48620680|NCT01543503|156469158|FG000|Overall Study|Screen failure|1|||
48620681|NCT01543503|156469159|FG001|Overall Study|Screen failure|0|||
48620682|NCT00052715|156469168|FG000|Overall Study|wrong histology|1|||
48620683|NCT01936974|156469169|FG000|Overall Study|Physician Decision|2|||
48620684|NCT01936974|156469170|FG001|Overall Study|Physician Decision|5|||
48620685|NCT01646216|156469173|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
48620686|NCT01646216|156469174|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
48620687|NCT01646216|156469173|FG000|Overall Study|Did not complete training|0|||
48574679|NCT00537316|156294455|FG006|Part 1|Protocol Violation|0|||
48574680|NCT00537316|156294449|FG000|Part 1|Did not meet protocol eligibility|1|||
48574681|NCT00537316|156294450|FG001|Part 1|Did not meet protocol eligibility|3|||
48574682|NCT00537316|156294451|FG002|Part 1|Did not meet protocol eligibility|2|||
48574683|NCT00537316|156294452|FG003|Part 1|Did not meet protocol eligibility|0|||
48574684|NCT00537316|156294453|FG004|Part 1|Did not meet protocol eligibility|0|||
48574685|NCT00537316|156294454|FG005|Part 1|Did not meet protocol eligibility|0|||
48574686|NCT00537316|156294455|FG006|Part 1|Did not meet protocol eligibility|0|||
48620688|NCT01646216|156469174|FG001|Overall Study|Did not complete training|2|||
48620689|NCT01646216|156469173|FG000|Overall Study|Investigator decision|1|||
48620690|NCT01646216|156469174|FG001|Overall Study|Investigator decision|1|||
48736024|NCT00257608|156885623|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
48736025|NCT00257608|156885621|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
48736026|NCT00257608|156885622|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
48736027|NCT00257608|156885623|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
48736028|NCT00257608|156885621|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
48736029|NCT00257608|156885622|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
48736030|NCT00257608|156885623|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
48736031|NCT00257608|156885621|FG000|Chemotherapy Phase|Physician Decision|28|||
48736032|NCT00257608|156885622|FG001|Chemotherapy Phase|Physician Decision|0|||
48736033|NCT00257608|156885623|FG002|Chemotherapy Phase|Physician Decision|0|||
48736034|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Adverse Event|0|||
48736035|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Adverse Event|34|||
48736036|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Adverse Event|38|||
48736037|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Disease progression|0|||
48450052|NCT01614795|155835557|FG000|Overall Study|Adverse Event|0|||
48574687|NCT00537316|156294449|FG000|Part 1|Administrative|0|||
48574688|NCT00537316|156294450|FG001|Part 1|Administrative|0|||
48620691|NCT03722030|156469175|FG000|Overall Study|Withdrawal by Subject|1|||
48620692|NCT03722030|156469176|FG001|Overall Study|Withdrawal by Subject|0|||
48620693|NCT00736476|156469184|FG000|Overall Study|Adverse Event|1|||
48620694|NCT00736476|156469185|FG001|Overall Study|Adverse Event|0|||
48736038|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Disease progression|204|||
48736039|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Disease progression|168|||
48574689|NCT00537316|156294451|FG002|Part 1|Administrative|2|||
48574690|NCT00537316|156294452|FG003|Part 1|Administrative|0|||
48574691|NCT00537316|156294453|FG004|Part 1|Administrative|0|||
48574692|NCT00537316|156294454|FG005|Part 1|Administrative|0|||
48574693|NCT00537316|156294455|FG006|Part 1|Administrative|0|||
48574694|NCT00537316|156294449|FG000|Part 2|Never entered follow-up|0|||
48574695|NCT00537316|156294450|FG001|Part 2|Never entered follow-up|0|||
48574696|NCT00537316|156294451|FG002|Part 2|Never entered follow-up|0|||
48574697|NCT00537316|156294452|FG003|Part 2|Never entered follow-up|0|||
48574698|NCT00537316|156294453|FG004|Part 2|Never entered follow-up|0|||
48574699|NCT00537316|156294454|FG005|Part 2|Never entered follow-up|0|||
48620695|NCT02547987|156469188|FG000|Overall Study|Withdrawal by Subject|1|||
48620696|NCT02547987|156469188|FG000|Overall Study|Adverse Event|2|||
48620697|NCT00147537|156469198|FG000|Phase 1b|Death|0|||
48574700|NCT00537316|156294455|FG006|Part 2|Never entered follow-up|1|||
48574701|NCT00537316|156294449|FG000|Part 2|Adverse Event|4|||
48574702|NCT00537316|156294450|FG001|Part 2|Adverse Event|0|||
48574703|NCT00537316|156294451|FG002|Part 2|Adverse Event|2|||
48574704|NCT00537316|156294452|FG003|Part 2|Adverse Event|0|||
48574705|NCT00537316|156294453|FG004|Part 2|Adverse Event|0|||
48574706|NCT00537316|156294454|FG005|Part 2|Adverse Event|0|||
48574707|NCT00537316|156294455|FG006|Part 2|Adverse Event|0|||
48574708|NCT00537316|156294449|FG000|Part 2|Lost to Follow-up|1|||
48574709|NCT00537316|156294450|FG001|Part 2|Lost to Follow-up|0|||
48574710|NCT00537316|156294451|FG002|Part 2|Lost to Follow-up|2|||
48574711|NCT00537316|156294452|FG003|Part 2|Lost to Follow-up|0|||
48574712|NCT00537316|156294453|FG004|Part 2|Lost to Follow-up|0|||
48574713|NCT00537316|156294454|FG005|Part 2|Lost to Follow-up|0|||
48574714|NCT00537316|156294455|FG006|Part 2|Lost to Follow-up|0|||
48574715|NCT00537316|156294449|FG000|Part 2|Withdrawal by Subject|5|||
48574716|NCT00537316|156294450|FG001|Part 2|Withdrawal by Subject|1|||
48574717|NCT00537316|156294451|FG002|Part 2|Withdrawal by Subject|4|||
48620698|NCT00147537|156469199|FG001|Phase 1b|Death|1|||
48620699|NCT00147537|156469200|FG002|Phase 1b|Death|2|||
48620700|NCT00147537|156469201|FG003|Phase 1b|Death|1|||
48620701|NCT00147537|156469202|FG004|Phase 1b|Death|2|||
48620702|NCT00147537|156469203|FG005|Phase 1b|Death|2|||
48620703|NCT00147537|156469204|FG006|Phase 1b|Death|1|||
48620704|NCT00147537|156469205|FG007|Phase 1b|Death|3|||
48620705|NCT00147537|156469206|FG008|Phase 1b|Death|9|||
48620706|NCT00147537|156469207|FG009|Phase 1b|Death|0|||
48620707|NCT00147537|156469208|FG010|Phase 1b|Death|0|||
48620708|NCT00147537|156469198|FG000|Phase 1b|Lost to Follow-up|2|||
48620709|NCT00147537|156469199|FG001|Phase 1b|Lost to Follow-up|1|||
48620710|NCT00147537|156469200|FG002|Phase 1b|Lost to Follow-up|0|||
48620711|NCT00147537|156469201|FG003|Phase 1b|Lost to Follow-up|0|||
48620712|NCT00147537|156469202|FG004|Phase 1b|Lost to Follow-up|0|||
48620713|NCT00147537|156469203|FG005|Phase 1b|Lost to Follow-up|0|||
48620714|NCT00147537|156469204|FG006|Phase 1b|Lost to Follow-up|2|||
48620715|NCT00147537|156469205|FG007|Phase 1b|Lost to Follow-up|0|||
48620716|NCT00147537|156469206|FG008|Phase 1b|Lost to Follow-up|1|||
48574718|NCT00537316|156294452|FG003|Part 2|Withdrawal by Subject|0|||
48574719|NCT00537316|156294453|FG004|Part 2|Withdrawal by Subject|0|||
48620717|NCT00147537|156469207|FG009|Phase 1b|Lost to Follow-up|0|||
48620718|NCT00147537|156469208|FG010|Phase 1b|Lost to Follow-up|0|||
48620719|NCT00147537|156469198|FG000|Phase 1b|Other|0|||
48620720|NCT00147537|156469199|FG001|Phase 1b|Other|0|||
48620721|NCT00147537|156469200|FG002|Phase 1b|Other|2|||
48620722|NCT00147537|156469201|FG003|Phase 1b|Other|1|||
48574720|NCT00537316|156294454|FG005|Part 2|Withdrawal by Subject|0|||
48574721|NCT00537316|156294455|FG006|Part 2|Withdrawal by Subject|0|||
48574722|NCT00537316|156294449|FG000|Part 2|Administrative|16|||
48574723|NCT00537316|156294450|FG001|Part 2|Administrative|8|||
48574724|NCT00537316|156294451|FG002|Part 2|Administrative|24|||
48574725|NCT00537316|156294452|FG003|Part 2|Administrative|3|||
48620723|NCT00147537|156469202|FG004|Phase 1b|Other|1|||
48620724|NCT00147537|156469203|FG005|Phase 1b|Other|1|||
48620725|NCT00147537|156469204|FG006|Phase 1b|Other|14|||
48620726|NCT00147537|156469205|FG007|Phase 1b|Other|4|||
48620727|NCT00147537|156469206|FG008|Phase 1b|Other|4|||
48620728|NCT00147537|156469207|FG009|Phase 1b|Other|0|||
48620729|NCT00147537|156469208|FG010|Phase 1b|Other|0|||
48620730|NCT00147537|156469198|FG000|Phase 1b|Withdrawal by Subject|0|||
48620731|NCT00147537|156469199|FG001|Phase 1b|Withdrawal by Subject|0|||
48620732|NCT00147537|156469200|FG002|Phase 1b|Withdrawal by Subject|0|||
48319127|NCT00802464|155369414|FG003|Month 0 - Month 8|Protocol Violation|0|||
48319128|NCT00802464|155369411|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
48319129|NCT00802464|155369412|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
48319130|NCT00802464|155369413|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
48319131|NCT00802464|155369414|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
48319132|NCT00802464|155369411|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
48319133|NCT00802464|155369412|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
48319134|NCT00802464|155369413|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
48319135|NCT00802464|155369414|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
48319136|NCT00802464|155369411|FG000|Month 0 - Month 8|Other|0|||
48319137|NCT00802464|155369412|FG001|Month 0 - Month 8|Other|0|||
48319138|NCT00802464|155369413|FG002|Month 0 - Month 8|Other|1|||
48319139|NCT00802464|155369414|FG003|Month 0 - Month 8|Other|0|||
48319140|NCT00802464|155369411|FG000|Month 8 - Month 14|Adverse Event|0|||
48319141|NCT00802464|155369412|FG001|Month 8 - Month 14|Adverse Event|1|||
48319142|NCT00802464|155369413|FG002|Month 8 - Month 14|Adverse Event|0|||
48574726|NCT00537316|156294453|FG004|Part 2|Administrative|1|||
48574727|NCT00537316|156294454|FG005|Part 2|Administrative|4|||
48574728|NCT00537316|156294455|FG006|Part 2|Administrative|1|||
48574729|NCT01062113|156294456|FG000|Overall Study|Adverse Event|1|||
48574730|NCT01062113|156294457|FG001|Overall Study|Adverse Event|0|||
48574731|NCT01062113|156294458|FG002|Overall Study|Adverse Event|0|||
48574732|NCT01062113|156294456|FG000|Overall Study|Lack of Efficacy|38|||
48574733|NCT01062113|156294457|FG001|Overall Study|Lack of Efficacy|22|||
48574734|NCT01062113|156294458|FG002|Overall Study|Lack of Efficacy|31|||
48574735|NCT01062113|156294456|FG000|Overall Study|Withdrawal by Subject|1|||
48574736|NCT01062113|156294457|FG001|Overall Study|Withdrawal by Subject|0|||
48574737|NCT01062113|156294458|FG002|Overall Study|Withdrawal by Subject|0|||
48574738|NCT00661609|156294461|FG000|Overall Study|Adverse Event|4|||
48574739|NCT00661609|156294461|FG000|Overall Study|Death|20|||
48574740|NCT00661609|156294461|FG000|Overall Study|Withdrawal by Subject|2|||
48574741|NCT00661609|156294461|FG000|Overall Study|PI Decision|1|||
48574742|NCT00661609|156294461|FG000|Overall Study|Survival follow up stage discontinued|11|||
48574743|NCT00661609|156294461|FG000|Overall Study|Disease progression|3|||
48574744|NCT00526669|156294462|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
48574745|NCT00526669|156294463|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
48574746|NCT00526669|156294462|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
48574747|NCT00526669|156294463|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
48574748|NCT00526669|156294462|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
48574749|NCT00526669|156294463|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
48574750|NCT00526669|156294462|FG000|Combined Treatment Phase|Death|0|||
48574751|NCT00526669|156294463|FG001|Combined Treatment Phase|Death|2|||
48574752|NCT00680901|156294464|FG000|Overall Study|Lost to Follow-up|8|||
48574753|NCT00680901|156294465|FG001|Overall Study|Lost to Follow-up|8|||
48574754|NCT00680901|156294464|FG000|Overall Study|Withdrawal by Subject|4|||
48574755|NCT00680901|156294465|FG001|Overall Study|Withdrawal by Subject|13|||
48574756|NCT00680901|156294464|FG000|Overall Study|Physician Decision|0|||
48574757|NCT00680901|156294465|FG001|Overall Study|Physician Decision|1|||
48574758|NCT00680901|156294464|FG000|Overall Study|Ongoing: On Study Treatment|16|||
48574759|NCT00680901|156294465|FG001|Overall Study|Ongoing: On Study Treatment|13|||
48574760|NCT00680901|156294464|FG000|Overall Study|Ongoing: In Follow Up|45|||
48574761|NCT00680901|156294465|FG001|Overall Study|Ongoing: In Follow Up|41|||
48574762|NCT01108341|156294470|FG000|Overall Study|Death|2|||
48574763|NCT01108341|156294470|FG000|Overall Study|Withdrawal by Subject|1|||
48574764|NCT01108341|156294470|FG000|Overall Study|Lost to Follow-up|1|||
48574765|NCT01108341|156294470|FG000|Overall Study|Other|1|||
48574766|NCT03499899|156294471|FG000|Overall Study|Adverse Event|2|||
48574767|NCT03499899|156294472|FG001|Overall Study|Adverse Event|3|||
48574768|NCT03499899|156294473|FG002|Overall Study|Adverse Event|3|||
48319143|NCT00802464|155369414|FG003|Month 8 - Month 14|Adverse Event|0|||
48319144|NCT00802464|155369411|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
48574769|NCT03499899|156294471|FG000|Overall Study|Death|0|||
48574770|NCT03499899|156294472|FG001|Overall Study|Death|0|||
48319145|NCT00802464|155369412|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
48574771|NCT03499899|156294473|FG002|Overall Study|Death|1|||
48574772|NCT03499899|156294471|FG000|Overall Study|Physician Decision|3|||
48620733|NCT00147537|156469201|FG003|Phase 1b|Withdrawal by Subject|0|||
48319146|NCT00802464|155369413|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
48319147|NCT00802464|155369414|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
48574773|NCT03499899|156294472|FG001|Overall Study|Physician Decision|6|||
48574774|NCT03499899|156294473|FG002|Overall Study|Physician Decision|6|||
48574775|NCT03499899|156294471|FG000|Overall Study|Progressive disease|15|||
48574776|NCT03499899|156294472|FG001|Overall Study|Progressive disease|23|||
48574777|NCT03499899|156294473|FG002|Overall Study|Progressive disease|23|||
48574778|NCT03499899|156294471|FG000|Overall Study|Patient decision|0|||
48574779|NCT03499899|156294472|FG001|Overall Study|Patient decision|1|||
48620734|NCT00147537|156469202|FG004|Phase 1b|Withdrawal by Subject|0|||
48620735|NCT00147537|156469203|FG005|Phase 1b|Withdrawal by Subject|0|||
48620736|NCT00147537|156469204|FG006|Phase 1b|Withdrawal by Subject|0|||
48620737|NCT00147537|156469205|FG007|Phase 1b|Withdrawal by Subject|0|||
48620738|NCT00147537|156469206|FG008|Phase 1b|Withdrawal by Subject|2|||
48620739|NCT00147537|156469207|FG009|Phase 1b|Withdrawal by Subject|0|||
48620740|NCT00147537|156469208|FG010|Phase 1b|Withdrawal by Subject|0|||
48620741|NCT00147537|156469198|FG000|Phase 1b|Randomized but not treated|0|||
48620742|NCT00147537|156469199|FG001|Phase 1b|Randomized but not treated|0|||
48620743|NCT00147537|156469200|FG002|Phase 1b|Randomized but not treated|0|||
48620744|NCT00147537|156469201|FG003|Phase 1b|Randomized but not treated|0|||
48620745|NCT00147537|156469202|FG004|Phase 1b|Randomized but not treated|0|||
48620746|NCT00147537|156469203|FG005|Phase 1b|Randomized but not treated|0|||
48620747|NCT00147537|156469204|FG006|Phase 1b|Randomized but not treated|1|||
48574780|NCT03499899|156294473|FG002|Overall Study|Patient decision|1|||
48574781|NCT03499899|156294471|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
48574782|NCT03499899|156294472|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
48574783|NCT03499899|156294473|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
48574784|NCT01489254|156294474|FG000|Double-blind Part|Adverse Event|7|||
48574785|NCT01489254|156294475|FG001|Double-blind Part|Adverse Event|2|||
48574786|NCT01489254|156294476|FG002|Double-blind Part|Adverse Event|2|||
48620748|NCT00147537|156469205|FG007|Phase 1b|Randomized but not treated|0|||
48620749|NCT00147537|156469206|FG008|Phase 1b|Randomized but not treated|1|||
48620750|NCT00147537|156469207|FG009|Phase 1b|Randomized but not treated|0|||
48620751|NCT00147537|156469208|FG010|Phase 1b|Randomized but not treated|0|||
48574787|NCT01489254|156294477|FG003|Double-blind Part|Adverse Event|0|||
48620752|NCT00147537|156469198|FG000|Phase 2|Death|0|||
48620753|NCT00147537|156469199|FG001|Phase 2|Death|0|||
48620754|NCT00147537|156469200|FG002|Phase 2|Death|0|||
48620755|NCT00147537|156469201|FG003|Phase 2|Death|0|||
48620756|NCT00147537|156469202|FG004|Phase 2|Death|0|||
48620757|NCT00147537|156469203|FG005|Phase 2|Death|0|||
48620758|NCT00147537|156469204|FG006|Phase 2|Death|0|||
48620759|NCT00147537|156469205|FG007|Phase 2|Death|0|||
48620760|NCT00147537|156469206|FG008|Phase 2|Death|0|||
48620761|NCT00147537|156469207|FG009|Phase 2|Death|85|||
48620762|NCT00147537|156469208|FG010|Phase 2|Death|31|||
48620763|NCT00147537|156469198|FG000|Phase 2|Lost to Follow-up|0|||
48620764|NCT00147537|156469199|FG001|Phase 2|Lost to Follow-up|0|||
48574788|NCT01489254|156294474|FG000|Double-blind Part|Pregnancy|1|||
48574789|NCT01489254|156294475|FG001|Double-blind Part|Pregnancy|3|||
48574790|NCT01489254|156294476|FG002|Double-blind Part|Pregnancy|0|||
48574791|NCT01489254|156294477|FG003|Double-blind Part|Pregnancy|0|||
48574792|NCT01489254|156294474|FG000|Double-blind Part|Withdrawal by Subject|12|||
48574793|NCT01489254|156294475|FG001|Double-blind Part|Withdrawal by Subject|20|||
48574794|NCT01489254|156294476|FG002|Double-blind Part|Withdrawal by Subject|1|||
48574795|NCT01489254|156294477|FG003|Double-blind Part|Withdrawal by Subject|0|||
48574796|NCT01489254|156294474|FG000|Double-blind Part|Lost to Follow-up|1|||
48574797|NCT01489254|156294475|FG001|Double-blind Part|Lost to Follow-up|2|||
48574798|NCT01489254|156294476|FG002|Double-blind Part|Lost to Follow-up|0|||
48574799|NCT01489254|156294477|FG003|Double-blind Part|Lost to Follow-up|0|||
48574800|NCT01489254|156294474|FG000|Double-blind Part|Other reasons for not completing study|4|||
48574801|NCT01489254|156294475|FG001|Double-blind Part|Other reasons for not completing study|6|||
48574802|NCT01489254|156294476|FG002|Double-blind Part|Other reasons for not completing study|0|||
48574803|NCT01489254|156294477|FG003|Double-blind Part|Other reasons for not completing study|0|||
48574804|NCT01489254|156294474|FG000|Open-label Extension Part|Adverse Event|0|||
48574805|NCT01489254|156294475|FG001|Open-label Extension Part|Adverse Event|0|||
48574806|NCT01489254|156294476|FG002|Open-label Extension Part|Adverse Event|0|||
48574807|NCT01489254|156294477|FG003|Open-label Extension Part|Adverse Event|10|||
48574808|NCT01489254|156294474|FG000|Open-label Extension Part|Pregnancy|0|||
48574809|NCT01489254|156294475|FG001|Open-label Extension Part|Pregnancy|0|||
48574810|NCT01489254|156294476|FG002|Open-label Extension Part|Pregnancy|0|||
48574811|NCT01489254|156294477|FG003|Open-label Extension Part|Pregnancy|3|||
48620765|NCT00147537|156469200|FG002|Phase 2|Lost to Follow-up|0|||
48620766|NCT00147537|156469201|FG003|Phase 2|Lost to Follow-up|0|||
48620767|NCT00147537|156469202|FG004|Phase 2|Lost to Follow-up|0|||
48620768|NCT00147537|156469203|FG005|Phase 2|Lost to Follow-up|0|||
48620769|NCT00147537|156469204|FG006|Phase 2|Lost to Follow-up|0|||
48620770|NCT00147537|156469205|FG007|Phase 2|Lost to Follow-up|0|||
48620771|NCT00147537|156469206|FG008|Phase 2|Lost to Follow-up|0|||
48620772|NCT00147537|156469207|FG009|Phase 2|Lost to Follow-up|12|||
48620773|NCT00147537|156469208|FG010|Phase 2|Lost to Follow-up|4|||
48620774|NCT00147537|156469198|FG000|Phase 2|Other|0|||
48319148|NCT00802464|155369411|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
48319149|NCT00802464|155369412|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
48319150|NCT00802464|155369413|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
48319151|NCT00802464|155369414|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
48319152|NCT01113931|155369417|FG000|Overall Study|Adverse Event|2|||
48319153|NCT01113931|155369418|FG001|Overall Study|Adverse Event|2|||
48574812|NCT01489254|156294474|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
48574813|NCT01489254|156294475|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
48574814|NCT01489254|156294476|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
48574815|NCT01489254|156294477|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
48574816|NCT01489254|156294474|FG000|Open-label Extension Part|Protocol Violation|0|||
48574817|NCT01489254|156294475|FG001|Open-label Extension Part|Protocol Violation|0|||
48574818|NCT01489254|156294476|FG002|Open-label Extension Part|Protocol Violation|0|||
48574819|NCT01489254|156294477|FG003|Open-label Extension Part|Protocol Violation|1|||
48574820|NCT01489254|156294474|FG000|Open-label Extension Part|Lost to Follow-up|0|||
48574821|NCT01489254|156294475|FG001|Open-label Extension Part|Lost to Follow-up|0|||
48574822|NCT01489254|156294476|FG002|Open-label Extension Part|Lost to Follow-up|0|||
48574823|NCT01489254|156294477|FG003|Open-label Extension Part|Lost to Follow-up|9|||
48574824|NCT01489254|156294474|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
48574825|NCT01489254|156294475|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
48574826|NCT01489254|156294476|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
48574827|NCT01489254|156294477|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
48574828|NCT01981954|156294478|FG000|Titration Period|Protocol Deviation|1|||
48574829|NCT01981954|156294478|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
48574830|NCT03655470|156294481|FG000|Overall Study|Lost to Follow-up|6|||
48574831|NCT03655470|156294482|FG001|Overall Study|Lost to Follow-up|7|||
48574832|NCT00507819|156294485|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
48574833|NCT00507819|156294486|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
48574834|NCT01475851|156294487|FG000|Overall Study|Protocol defined stopping criteria|1|||
48574835|NCT01475851|156294488|FG001|Overall Study|Protocol defined stopping criteria|0|||
48574836|NCT01082211|156294491|FG000|Overall Study|Protocol Violation|4|||
48574837|NCT01082211|156294491|FG000|Overall Study|No protocol treatment received|3|||
48574838|NCT01166438|156294492|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
48574839|NCT01166438|156294493|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
48574840|NCT01166438|156294492|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
48574841|NCT01166438|156294493|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
48574842|NCT01166438|156294492|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
48574843|NCT01166438|156294493|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
48574844|NCT01166438|156294492|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
48574845|NCT01166438|156294493|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
48574846|NCT01166438|156294492|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
48574847|NCT01166438|156294493|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
48574848|NCT01166438|156294492|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
48574849|NCT01166438|156294493|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
48574850|NCT02438826|156294495|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
48574851|NCT02438826|156294496|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
48574852|NCT02438826|156294497|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
48574853|NCT02438826|156294498|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
48574854|NCT02438826|156294495|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
48574855|NCT02438826|156294496|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48574856|NCT02438826|156294497|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48574857|NCT02438826|156294498|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48574858|NCT02438826|156294495|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
48574859|NCT02438826|156294496|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
48574860|NCT02438826|156294497|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48574861|NCT02438826|156294498|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48574862|NCT02438826|156294495|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
48574863|NCT02438826|156294496|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
48574864|NCT02438826|156294497|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
48574865|NCT02438826|156294498|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
48574866|NCT02438826|156294495|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
48574867|NCT02438826|156294496|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
48574868|NCT02438826|156294497|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
48574869|NCT02438826|156294498|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
48574870|NCT02438826|156294495|FG000|Open-Label Treatment Phase|Adverse Event|11|||
48574871|NCT02438826|156294496|FG001|Open-Label Treatment Phase|Adverse Event|6|||
48574872|NCT02438826|156294497|FG002|Open-Label Treatment Phase|Adverse Event|0|||
48574873|NCT02438826|156294498|FG003|Open-Label Treatment Phase|Adverse Event|0|||
48574874|NCT02438826|156294495|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
48574875|NCT02438826|156294496|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
48620775|NCT00147537|156469199|FG001|Phase 2|Other|0|||
48620776|NCT00147537|156469200|FG002|Phase 2|Other|0|||
48620777|NCT00147537|156469201|FG003|Phase 2|Other|0|||
48620778|NCT00147537|156469202|FG004|Phase 2|Other|0|||
48620779|NCT00147537|156469203|FG005|Phase 2|Other|0|||
48620780|NCT00147537|156469204|FG006|Phase 2|Other|0|||
48620781|NCT00147537|156469205|FG007|Phase 2|Other|0|||
48620782|NCT00147537|156469206|FG008|Phase 2|Other|0|||
48620783|NCT00147537|156469207|FG009|Phase 2|Other|47|||
48620784|NCT00147537|156469208|FG010|Phase 2|Other|12|||
48620785|NCT00147537|156469198|FG000|Phase 2|Withdrawal by Subject|0|||
48620786|NCT00147537|156469199|FG001|Phase 2|Withdrawal by Subject|0|||
48620787|NCT00147537|156469200|FG002|Phase 2|Withdrawal by Subject|0|||
48620788|NCT00147537|156469201|FG003|Phase 2|Withdrawal by Subject|0|||
48620789|NCT00147537|156469202|FG004|Phase 2|Withdrawal by Subject|0|||
48620790|NCT00147537|156469203|FG005|Phase 2|Withdrawal by Subject|0|||
48620791|NCT00147537|156469204|FG006|Phase 2|Withdrawal by Subject|0|||
48620792|NCT00147537|156469205|FG007|Phase 2|Withdrawal by Subject|0|||
48620793|NCT00147537|156469206|FG008|Phase 2|Withdrawal by Subject|0|||
48620794|NCT00147537|156469207|FG009|Phase 2|Withdrawal by Subject|16|||
48620795|NCT00147537|156469208|FG010|Phase 2|Withdrawal by Subject|4|||
48620796|NCT00147537|156469198|FG000|Phase 2|Randomized but not treated|0|||
48620797|NCT00147537|156469199|FG001|Phase 2|Randomized but not treated|0|||
48620798|NCT00147537|156469200|FG002|Phase 2|Randomized but not treated|0|||
48620799|NCT00147537|156469201|FG003|Phase 2|Randomized but not treated|0|||
48620800|NCT00147537|156469202|FG004|Phase 2|Randomized but not treated|0|||
48620801|NCT00147537|156469203|FG005|Phase 2|Randomized but not treated|0|||
48620802|NCT00147537|156469204|FG006|Phase 2|Randomized but not treated|0|||
48620803|NCT00147537|156469205|FG007|Phase 2|Randomized but not treated|0|||
48620804|NCT00147537|156469206|FG008|Phase 2|Randomized but not treated|0|||
48620805|NCT00147537|156469207|FG009|Phase 2|Randomized but not treated|1|||
48319154|NCT01113931|155369417|FG000|Overall Study|Physician Decision|0|||
48620806|NCT00147537|156469208|FG010|Phase 2|Randomized but not treated|1|||
48620807|NCT01089543|156469209|FG000|Overall Study|Withdrawal by Subject|2|||
48620808|NCT01089543|156469210|FG001|Overall Study|Withdrawal by Subject|3|||
48620809|NCT01089543|156469211|FG002|Overall Study|Withdrawal by Subject|3|||
48620810|NCT01089543|156469212|FG003|Overall Study|Withdrawal by Subject|1|||
48620811|NCT01089543|156469209|FG000|Overall Study|Physician Decision|1|||
48620812|NCT01089543|156469210|FG001|Overall Study|Physician Decision|0|||
48319155|NCT01113931|155369418|FG001|Overall Study|Physician Decision|2|||
48319156|NCT01113931|155369417|FG000|Overall Study|Lost to Follow-up|12|||
48319157|NCT01113931|155369418|FG001|Overall Study|Lost to Follow-up|9|||
48319158|NCT01113931|155369417|FG000|Overall Study|Various|2|||
48319159|NCT01113931|155369418|FG001|Overall Study|Various|4|||
48319160|NCT01113931|155369417|FG000|Overall Study|Withdrawal by Subject|3|||
48319161|NCT01113931|155369418|FG001|Overall Study|Withdrawal by Subject|0|||
48319162|NCT02374463|155369419|FG000|Overall Study|Withdrawal by Subject|3|||
48319163|NCT02374463|155369420|FG001|Overall Study|Withdrawal by Subject|3|||
48620813|NCT01089543|156469211|FG002|Overall Study|Physician Decision|0|||
48620814|NCT01089543|156469212|FG003|Overall Study|Physician Decision|1|||
48620815|NCT01089543|156469209|FG000|Overall Study|Adverse Event|0|||
48620816|NCT01089543|156469210|FG001|Overall Study|Adverse Event|1|||
48620817|NCT01089543|156469211|FG002|Overall Study|Adverse Event|0|||
48620818|NCT01089543|156469212|FG003|Overall Study|Adverse Event|0|||
48620819|NCT04146909|156469213|FG000|Overall Study|Withdrawal by Subject|3|||
48620820|NCT04146909|156469213|FG000|Overall Study|Did not qualify after consented|1|||
48620821|NCT00472641|156469217|FG000|Overall Study|Lack of Efficacy|3|||
48620822|NCT00472641|156469217|FG000|Overall Study|Adverse Event|3|||
48620823|NCT00472641|156469217|FG000|Overall Study|Lost to Follow-up|1|||
48620824|NCT00478140|156469218|FG000|Overall Study|Clinical Disease Progression|1|||
48620825|NCT04193527|156469219|FG000|Overall Study|Other|1|||
48319164|NCT02767765|155369422|FG000|Overall Study|Adverse Event|4|||
48319165|NCT02767765|155369422|FG000|Overall Study|Death|1|||
48319166|NCT02767765|155369422|FG000|Overall Study|Insufficient response|1|||
48319167|NCT02767765|155369422|FG000|Overall Study|Lost to Follow-up|2|||
48319168|NCT02767765|155369422|FG000|Overall Study|Investigator decision|1|||
48319169|NCT02767765|155369422|FG000|Overall Study|Non-Compliance|1|||
48319170|NCT02767765|155369422|FG000|Overall Study|Withdrawal by Subject|1|||
48450053|NCT01614795|155835558|FG001|Overall Study|Adverse Event|0|||
48620826|NCT04193527|156469220|FG001|Overall Study|Other|1|||
48620827|NCT04193527|156469221|FG002|Overall Study|Other|0|||
48620828|NCT03808909|156469223|FG000|Overall Study|Lost to Follow-up|3|||
48620829|NCT03808909|156469224|FG001|Overall Study|Lost to Follow-up|0|||
48620830|NCT01898091|156469225|FG000|Overall Study|Lost to Follow-up|1|||
48620831|NCT01898091|156469226|FG001|Overall Study|Lost to Follow-up|1|||
48620832|NCT01898091|156469225|FG000|Overall Study|Withdrawal by Subject|1|||
48620833|NCT01898091|156469226|FG001|Overall Study|Withdrawal by Subject|5|||
48620834|NCT00560404|156469229|FG000|Overall Study|Adverse Event|2|||
48620835|NCT00560404|156469230|FG001|Overall Study|Adverse Event|3|||
48620836|NCT00560404|156469229|FG000|Overall Study|Death|3|||
48620837|NCT00560404|156469230|FG001|Overall Study|Death|3|||
48620838|NCT00560404|156469229|FG000|Overall Study|Protocol Violation|12|||
48620839|NCT00560404|156469230|FG001|Overall Study|Protocol Violation|7|||
48620840|NCT00560404|156469229|FG000|Overall Study|Administrative Reasons|1|||
48620841|NCT00560404|156469230|FG001|Overall Study|Administrative Reasons|1|||
48620842|NCT00560404|156469229|FG000|Overall Study|Withdrew Consent|4|||
48620843|NCT00560404|156469230|FG001|Overall Study|Withdrew Consent|0|||
48620844|NCT00560404|156469229|FG000|Overall Study|Failure to return|1|||
48620845|NCT00560404|156469230|FG001|Overall Study|Failure to return|2|||
48620846|NCT00560404|156469229|FG000|Overall Study|Other withdrawal reason|13|||
48620847|NCT00560404|156469230|FG001|Overall Study|Other withdrawal reason|5|||
48620848|NCT00676689|156469231|FG000|Overall Study|Screen Failure|2|||
48620849|NCT00676689|156469231|FG000|Overall Study|Death|2|||
48620850|NCT00676689|156469231|FG000|Overall Study|Lost to Follow-up|4|||
48620851|NCT00676689|156469231|FG000|Overall Study|Physician Decision|1|||
48620852|NCT00676689|156469231|FG000|Overall Study|Withdrawal by Subject|3|||
48574876|NCT02438826|156294497|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
48620853|NCT00676689|156469231|FG000|Overall Study|Continuing FU|49|||
48620854|NCT00309244|156469232|FG000|Overall Study|Adverse Event|29|||
48620855|NCT00309244|156469233|FG001|Overall Study|Adverse Event|12|||
48620856|NCT00309244|156469232|FG000|Overall Study|Lost to Follow-up|6|||
48620857|NCT00309244|156469233|FG001|Overall Study|Lost to Follow-up|22|||
48620858|NCT00309244|156469232|FG000|Overall Study|Physician Decision|5|||
48620859|NCT00309244|156469233|FG001|Overall Study|Physician Decision|8|||
48620860|NCT00309244|156469232|FG000|Overall Study|Protocol Violation|6|||
48620861|NCT00309244|156469233|FG001|Overall Study|Protocol Violation|3|||
48620862|NCT00309244|156469232|FG000|Overall Study|Withdrawal by Subject|50|||
48620863|NCT00309244|156469233|FG001|Overall Study|Withdrawal by Subject|32|||
48620864|NCT00309244|156469232|FG000|Overall Study|Various|7|||
48620865|NCT00309244|156469233|FG001|Overall Study|Various|7|||
48620866|NCT00309244|156469232|FG000|Overall Study|Randomized but not dosed|11|||
48620867|NCT00309244|156469233|FG001|Overall Study|Randomized but not dosed|12|||
48620868|NCT00309244|156469232|FG000|Overall Study|Death|4|||
48620869|NCT00309244|156469233|FG001|Overall Study|Death|1|||
48620870|NCT01263028|156469234|FG000|Overall Study|Withdrawal by Subject|1|||
48620871|NCT01263028|156469234|FG000|Overall Study|Adverse Event|1|||
48620872|NCT01263028|156469234|FG000|Overall Study|Study terminated due to low enrollment.|4|||
48620873|NCT03888482|156469235|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
48620874|NCT03888482|156469236|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
48620875|NCT03888482|156469235|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
48620876|NCT03888482|156469236|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
48620877|NCT00825175|156469237|FG000|Overall Study|Withdrawal by Subject|0|||
48574877|NCT02438826|156294498|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
48574878|NCT02438826|156294495|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
48574879|NCT02438826|156294496|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
48574880|NCT02438826|156294497|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
48574881|NCT02438826|156294498|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
48574882|NCT02438826|156294495|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
48574883|NCT02438826|156294496|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
48574884|NCT02438826|156294497|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
48574885|NCT02438826|156294498|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
48574886|NCT02438826|156294495|FG000|Post-Treatment Phase|Adverse Event|3|||
48574887|NCT02438826|156294496|FG001|Post-Treatment Phase|Adverse Event|0|||
48574888|NCT02438826|156294497|FG002|Post-Treatment Phase|Adverse Event|0|||
48574889|NCT02438826|156294498|FG003|Post-Treatment Phase|Adverse Event|0|||
48574890|NCT02438826|156294495|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
48574891|NCT02438826|156294496|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
48574892|NCT02438826|156294497|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
48574893|NCT02438826|156294498|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
48620878|NCT00825175|156469238|FG001|Overall Study|Withdrawal by Subject|5|||
48620879|NCT03019588|156469239|FG000|Overall Study|Death|44|||
48620880|NCT03019588|156469240|FG001|Overall Study|Death|46|||
48450054|NCT01614795|155835559|FG002|Overall Study|Adverse Event|1|||
48620881|NCT03019588|156469239|FG000|Overall Study|Study terminated by Sponsor|3|||
48620882|NCT03019588|156469240|FG001|Overall Study|Study terminated by Sponsor|1|||
48620883|NCT02369159|156469241|FG000|Overall Study|Adverse Event|0|||
48620884|NCT02369159|156469242|FG001|Overall Study|Adverse Event|1|||
48620885|NCT02369159|156469241|FG000|Overall Study|Lost to Follow-up|1|||
48620886|NCT02369159|156469242|FG001|Overall Study|Lost to Follow-up|1|||
48620887|NCT02369159|156469241|FG000|Overall Study|Withdrawal by Subject|7|||
48620888|NCT02369159|156469242|FG001|Overall Study|Withdrawal by Subject|0|||
48620889|NCT00887588|156469243|FG000|Core Period|Death|1|||
48620890|NCT00887588|156469244|FG001|Core Period|Death|1|||
48620891|NCT00887588|156469243|FG000|Core Period|Lost to Follow-up|3|||
48620892|NCT00887588|156469244|FG001|Core Period|Lost to Follow-up|1|||
48620893|NCT00887588|156469243|FG000|Core Period|Withdrawal by Subject|6|||
48620894|NCT00887588|156469244|FG001|Core Period|Withdrawal by Subject|8|||
48620895|NCT00887588|156469243|FG000|Core Period|Adverse Event|9|||
48620896|NCT00887588|156469244|FG001|Core Period|Adverse Event|11|||
48620897|NCT00887588|156469243|FG000|Extension Period|Adverse Event|4|||
48620898|NCT00887588|156469244|FG001|Extension Period|Adverse Event|4|||
48620899|NCT00887588|156469243|FG000|Extension Period|Death|0|||
48620900|NCT00887588|156469244|FG001|Extension Period|Death|1|||
48620901|NCT00887588|156469243|FG000|Extension Period|Protocol deviation|1|||
48620902|NCT00887588|156469244|FG001|Extension Period|Protocol deviation|0|||
48620903|NCT00887588|156469243|FG000|Extension Period|Lost to Follow-up|1|||
48620904|NCT00887588|156469244|FG001|Extension Period|Lost to Follow-up|0|||
48620905|NCT03335566|156469245|FG000|Overall Study|Adverse Event|0|||
48574894|NCT02438826|156294495|FG000|Post-Treatment Phase|Physician Decision|1|||
48574895|NCT02438826|156294496|FG001|Post-Treatment Phase|Physician Decision|0|||
48574896|NCT02438826|156294497|FG002|Post-Treatment Phase|Physician Decision|0|||
48574897|NCT02438826|156294498|FG003|Post-Treatment Phase|Physician Decision|0|||
48574898|NCT02438826|156294495|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
48620906|NCT03335566|156469246|FG001|Overall Study|Adverse Event|1|||
48620907|NCT03335566|156469245|FG000|Overall Study|Lost to Follow-up|1|||
48450055|NCT01614795|155835560|FG003|Overall Study|Adverse Event|1|||
48574899|NCT02438826|156294496|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
48574900|NCT02438826|156294497|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
48574901|NCT02438826|156294498|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
48574902|NCT02640950|156294501|FG000|Overall Study|Adverse Event|1|||
48620908|NCT03335566|156469246|FG001|Overall Study|Lost to Follow-up|0|||
48620909|NCT03335566|156469245|FG000|Overall Study|Technical Problems|1|||
48620910|NCT03335566|156469246|FG001|Overall Study|Technical Problems|0|||
48620911|NCT03335566|156469245|FG000|Overall Study|Protocol Violation|1|||
48620912|NCT03335566|156469246|FG001|Overall Study|Protocol Violation|0|||
48620913|NCT03335566|156469245|FG000|Overall Study|Other than specified above|1|||
48620914|NCT03335566|156469246|FG001|Overall Study|Other than specified above|2|||
48620915|NCT00366535|156469247|FG000|First Phase: 12 Weeks|Adverse Event|1|||
48620916|NCT00366535|156469248|FG001|First Phase: 12 Weeks|Adverse Event|3|||
48620917|NCT00366535|156469247|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
48620918|NCT00366535|156469248|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
48620919|NCT00366535|156469247|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
48620920|NCT00366535|156469248|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
48620921|NCT00366535|156469247|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
48620922|NCT00366535|156469248|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
48620923|NCT00425854|156469249|FG000|Overall Study|Progressive Disease|19|||
48620924|NCT00425854|156469250|FG001|Overall Study|Progressive Disease|12|||
48620925|NCT00425854|156469249|FG000|Overall Study|Dose reduction toxicity AE|8|||
48620926|NCT00425854|156469250|FG001|Overall Study|Dose reduction toxicity AE|7|||
48620927|NCT00425854|156469249|FG000|Overall Study|Other Adverse Event|2|||
48620928|NCT00425854|156469250|FG001|Overall Study|Other Adverse Event|2|||
48620929|NCT00834587|156469251|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
48620930|NCT00834587|156469252|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
48620931|NCT01016015|156469253|FG000|Overall Study|Not Treated|3|||
48319171|NCT00894543|155369423|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
48319172|NCT00894543|155369424|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
48319173|NCT00894543|155369423|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
48319174|NCT00894543|155369424|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
48319175|NCT00858117|155369427|FG000|Treatment on Study|Adverse Event|2|||
48574903|NCT02640950|156294501|FG000|Overall Study|Withdrawal by Subject|1|||
48574904|NCT01075256|156294503|FG000|Overall Study|Withdrawal by Subject|1|||
48319176|NCT00858117|155369427|FG000|Follow up for 5 Years|Death|4|||
48319177|NCT00858117|155369427|FG000|Follow up for 5 Years|No further data collected for study|9|||
48319178|NCT00077675|155369428|FG000|Overall Study|Adverse Event|1|||
48620932|NCT01016015|156469253|FG000|Overall Study|Withdrawal by Subject|1|||
48620933|NCT01016015|156469253|FG000|Overall Study|Adverse Event|15|||
48319179|NCT00077675|155369429|FG001|Overall Study|Adverse Event|2|||
48319180|NCT00077675|155369428|FG000|Overall Study|Lost to Follow-up|6|||
48319181|NCT00077675|155369429|FG001|Overall Study|Lost to Follow-up|3|||
48319182|NCT00077675|155369428|FG000|Overall Study|Withdrawal by Subject|1|||
48319183|NCT00077675|155369429|FG001|Overall Study|Withdrawal by Subject|0|||
48574905|NCT01075256|156294504|FG001|Overall Study|Withdrawal by Subject|0|||
48574906|NCT01075256|156294505|FG002|Overall Study|Withdrawal by Subject|0|||
48620934|NCT00968968|156469257|FG000|Overall Study|Study closed/terminated|10|||
48620935|NCT00968968|156469258|FG001|Overall Study|Study closed/terminated|10|||
48620936|NCT00968968|156469257|FG000|Overall Study|Protocol defined stopping criteria|3|||
48620937|NCT00968968|156469258|FG001|Overall Study|Protocol defined stopping criteria|1|||
48620938|NCT00968968|156469257|FG000|Overall Study|Withdrawal by Subject|2|||
48620939|NCT00968968|156469258|FG001|Overall Study|Withdrawal by Subject|0|||
48620940|NCT00968968|156469257|FG000|Overall Study|Physician Decision|1|||
48620941|NCT00968968|156469258|FG001|Overall Study|Physician Decision|2|||
48620942|NCT00968968|156469257|FG000|Overall Study|Lost to Follow-up|0|||
48736040|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
48319184|NCT00077675|155369428|FG000|Overall Study|Other|0|||
48574907|NCT04445714|156294512|FG000|Overall Study|Discontinuation of the study|14|||
48574908|NCT04445714|156294512|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
48574909|NCT04445714|156294512|FG000|Overall Study|Withdrawal of Informed Consent|8|||
48574910|NCT03233529|156296139|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
48574911|NCT03233529|156296139|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
48574912|NCT05318092|156296142|FG000|Overall Study|Lost to Follow-up|3|||
48574913|NCT05318092|156296142|FG000|Overall Study|Withdrawal by Subject|1|||
48574914|NCT01177293|156296143|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
48574915|NCT01177293|156296144|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
48574916|NCT05113979|156296147|FG000|Overall Study|Death|2|||
48574917|NCT05113979|156296147|FG000|Overall Study|Lost to Follow-up|1|||
48574918|NCT02429778|156296148|FG000|Overall Study|Lost to Follow-up|2|||
48574919|NCT02429778|156296149|FG001|Overall Study|Lost to Follow-up|0|||
48574920|NCT02429778|156296148|FG000|Overall Study|Withdrawal by Subject|5|||
48574921|NCT02429778|156296149|FG001|Overall Study|Withdrawal by Subject|0|||
48574922|NCT03681678|156296150|FG000|Overall Study|Lost to Follow-up|20|||
48574923|NCT03521115|156296152|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
48574924|NCT03521115|156296153|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
48574925|NCT03521115|156296152|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
48574926|NCT03521115|156296153|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
48574927|NCT01471340|156296154|FG000|Overall Study|Death|5|||
48620943|NCT00968968|156469258|FG001|Overall Study|Lost to Follow-up|1|||
48620944|NCT03624036|156469259|FG000|Overall Study|Death|2|||
48620945|NCT03624036|156469260|FG001|Overall Study|Death|3|||
48620946|NCT03624036|156469261|FG002|Overall Study|Death|0|||
48620947|NCT03624036|156469262|FG003|Overall Study|Death|1|||
48620948|NCT03624036|156469259|FG000|Overall Study|Withdrawal by Subject|1|||
48620949|NCT03624036|156469260|FG001|Overall Study|Withdrawal by Subject|0|||
48620950|NCT03624036|156469261|FG002|Overall Study|Withdrawal by Subject|1|||
48620951|NCT03624036|156469262|FG003|Overall Study|Withdrawal by Subject|0|||
48620952|NCT03624036|156469259|FG000|Overall Study|Enrolled but Never Treated|1|||
48620953|NCT03624036|156469260|FG001|Overall Study|Enrolled but Never Treated|0|||
48620954|NCT03624036|156469261|FG002|Overall Study|Enrolled but Never Treated|0|||
48319185|NCT00077675|155369429|FG001|Overall Study|Other|1|||
48319186|NCT00077675|155369428|FG000|Overall Study|Never received study treatment|3|||
48319187|NCT00077675|155369429|FG001|Overall Study|Never received study treatment|3|||
48319188|NCT02919449|155369431|FG000|Overall Study|Withdrawal by Subject|1|||
48620955|NCT03624036|156469262|FG003|Overall Study|Enrolled but Never Treated|0|||
48319189|NCT02919449|155369431|FG000|Overall Study|Investigator decision|1|||
48319190|NCT02594735|155369432|FG000|Overall Study|Adverse Event|1|||
48319191|NCT03292913|155369434|FG000|Overall Study|Death|9|||
48319192|NCT03292913|155369435|FG001|Overall Study|Death|3|||
48319193|NCT03292913|155369434|FG000|Overall Study|Lost to Follow-up|49|||
48319194|NCT03292913|155369435|FG001|Overall Study|Lost to Follow-up|49|||
48319195|NCT03292913|155369434|FG000|Overall Study|Withdrawal by Subject|2|||
48319196|NCT03292913|155369435|FG001|Overall Study|Withdrawal by Subject|0|||
48319197|NCT03292913|155369434|FG000|Overall Study|Clinic closed due to COVID|22|||
48319198|NCT03292913|155369435|FG001|Overall Study|Clinic closed due to COVID|36|||
48319199|NCT04056624|155369436|FG000|Overall Study|Withdrawal by Subject|0|||
48319200|NCT04056624|155369437|FG001|Overall Study|Withdrawal by Subject|0|||
48319201|NCT04056624|155369438|FG002|Overall Study|Withdrawal by Subject|1|||
48319202|NCT04056624|155369436|FG000|Overall Study|Protocol Violation|1|||
48319203|NCT04056624|155369437|FG001|Overall Study|Protocol Violation|2|||
48319204|NCT04056624|155369438|FG002|Overall Study|Protocol Violation|0|||
48319205|NCT00998881|155369440|FG000|Overall Study|Adverse Event|2|||
48319206|NCT00998881|155369441|FG001|Overall Study|Adverse Event|2|||
48319207|NCT00998881|155369440|FG000|Overall Study|Lack of Efficacy|1|||
48319208|NCT00998881|155369441|FG001|Overall Study|Lack of Efficacy|0|||
48319209|NCT00998881|155369440|FG000|Overall Study|Physician Decision|3|||
48319210|NCT00998881|155369441|FG001|Overall Study|Physician Decision|0|||
48319211|NCT00998881|155369440|FG000|Overall Study|Withdrawal by Subject|1|||
48319212|NCT00998881|155369441|FG001|Overall Study|Withdrawal by Subject|0|||
48574928|NCT01471340|156296155|FG001|Overall Study|Death|4|||
48574929|NCT01471340|156296154|FG000|Overall Study|Lost to Follow-up|0|||
48574930|NCT01471340|156296155|FG001|Overall Study|Lost to Follow-up|1|||
48574931|NCT01471340|156296154|FG000|Overall Study|Investigational site closure|0|||
48574932|NCT01471340|156296155|FG001|Overall Study|Investigational site closure|1|||
48574933|NCT01471340|156296154|FG000|Overall Study|Invalid informed consent|1|||
48574934|NCT01471340|156296155|FG001|Overall Study|Invalid informed consent|0|||
48620956|NCT03624036|156469259|FG000|Overall Study|Reason not Specified|3|||
48620957|NCT03624036|156469260|FG001|Overall Study|Reason not Specified|0|||
48319213|NCT00998881|155369440|FG000|Overall Study|Personal matter|1|||
48574935|NCT02475265|156296156|FG000|Overall Study|Physician Decision|1|||
48574936|NCT02475265|156296156|FG000|Overall Study|Withdrawal by Subject|2|||
48574937|NCT00976820|156296157|FG000|Overall Study|Lost to Follow-up|5|||
48574938|NCT00976820|156296158|FG001|Overall Study|Lost to Follow-up|16|||
48574939|NCT00976820|156296159|FG002|Overall Study|Lost to Follow-up|2|||
48574940|NCT00976820|156296160|FG003|Overall Study|Lost to Follow-up|3|||
48574941|NCT00976820|156296157|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
48574942|NCT00976820|156296158|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
48574943|NCT00976820|156296159|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
48574944|NCT00976820|156296160|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
48574945|NCT00976820|156296157|FG000|Overall Study|Withdrawal by Subject|2|||
48574946|NCT00976820|156296158|FG001|Overall Study|Withdrawal by Subject|4|||
48574947|NCT00976820|156296159|FG002|Overall Study|Withdrawal by Subject|1|||
48574948|NCT00976820|156296160|FG003|Overall Study|Withdrawal by Subject|4|||
48574949|NCT00968981|156296163|FG000|Overall Study|Adverse Event|2|||
48574950|NCT00968981|156296164|FG001|Overall Study|Adverse Event|0|||
48574951|NCT00968981|156296165|FG002|Overall Study|Adverse Event|0|||
48574952|NCT00968981|156296163|FG000|Overall Study|Disease Progression|14|||
48574953|NCT00968981|156296164|FG001|Overall Study|Disease Progression|16|||
48574954|NCT00968981|156296165|FG002|Overall Study|Disease Progression|13|||
48574955|NCT00968981|156296163|FG000|Overall Study|Lost to Follow-up|0|||
48574956|NCT00968981|156296164|FG001|Overall Study|Lost to Follow-up|0|||
48574957|NCT00968981|156296165|FG002|Overall Study|Lost to Follow-up|1|||
48574958|NCT00968981|156296163|FG000|Overall Study|Physician Decision|5|||
48319214|NCT00998881|155369441|FG001|Overall Study|Personal matter|0|||
48319215|NCT03531840|155369445|FG000|Overall Study|Death on study|3|||
48319216|NCT03531840|155369446|FG001|Overall Study|Death on study|2|||
48319217|NCT03531840|155369447|FG002|Overall Study|Death on study|1|||
48319218|NCT03531840|155369448|FG003|Overall Study|Death on study|2|||
48574959|NCT00968981|156296164|FG001|Overall Study|Physician Decision|3|||
48620958|NCT03624036|156469261|FG002|Overall Study|Reason not Specified|2|||
48620959|NCT03624036|156469262|FG003|Overall Study|Reason not Specified|2|||
48574960|NCT00968981|156296165|FG002|Overall Study|Physician Decision|5|||
48574961|NCT00968981|156296163|FG000|Overall Study|Withdrawal by Subject|1|||
48574962|NCT00968981|156296164|FG001|Overall Study|Withdrawal by Subject|3|||
48574963|NCT00968981|156296165|FG002|Overall Study|Withdrawal by Subject|3|||
48574964|NCT01430403|156296174|FG000|Overall Study|Lost to Follow-up|5|||
48574965|NCT01430403|156296175|FG001|Overall Study|Lost to Follow-up|5|||
48574966|NCT01430403|156296176|FG002|Overall Study|Lost to Follow-up|3|||
48574967|NCT01430403|156296174|FG000|Overall Study|Physician Decision|1|||
48574968|NCT01430403|156296175|FG001|Overall Study|Physician Decision|0|||
48574969|NCT01430403|156296176|FG002|Overall Study|Physician Decision|0|||
48574970|NCT01430403|156296174|FG000|Overall Study|Protocol Violation|2|||
48574971|NCT01430403|156296175|FG001|Overall Study|Protocol Violation|3|||
48574972|NCT01430403|156296176|FG002|Overall Study|Protocol Violation|2|||
48574973|NCT01430403|156296174|FG000|Overall Study|Withdrawal by Subject|9|||
48574974|NCT01430403|156296175|FG001|Overall Study|Withdrawal by Subject|1|||
48574975|NCT01430403|156296176|FG002|Overall Study|Withdrawal by Subject|3|||
48574976|NCT03063086|156296187|FG000|Overall Study|technical problems|1|||
48574977|NCT03063086|156296188|FG001|Overall Study|technical problems|0|||
48574978|NCT03063086|156296189|FG002|Overall Study|technical problems|0|||
48574979|NCT03063086|156296190|FG003|Overall Study|technical problems|0|||
48574980|NCT03063086|156296191|FG004|Overall Study|technical problems|0|||
48574981|NCT03063086|156296192|FG005|Overall Study|technical problems|0|||
48574982|NCT03063086|156296187|FG000|Overall Study|Adverse Event|1|||
48574983|NCT03063086|156296188|FG001|Overall Study|Adverse Event|1|||
48574984|NCT03063086|156296189|FG002|Overall Study|Adverse Event|1|||
48574985|NCT03063086|156296190|FG003|Overall Study|Adverse Event|1|||
48574986|NCT03063086|156296191|FG004|Overall Study|Adverse Event|0|||
48574987|NCT03063086|156296192|FG005|Overall Study|Adverse Event|0|||
48574988|NCT03063086|156296187|FG000|Overall Study|subject/guardian decision|1|||
48574989|NCT03063086|156296188|FG001|Overall Study|subject/guardian decision|0|||
48574990|NCT03063086|156296189|FG002|Overall Study|subject/guardian decision|0|||
48574991|NCT03063086|156296190|FG003|Overall Study|subject/guardian decision|0|||
48574992|NCT03063086|156296191|FG004|Overall Study|subject/guardian decision|0|||
48574993|NCT03063086|156296192|FG005|Overall Study|subject/guardian decision|0|||
48574994|NCT03063086|156296187|FG000|Overall Study|Non-compliance with study treatment|0|||
48574995|NCT03063086|156296188|FG001|Overall Study|Non-compliance with study treatment|0|||
48574996|NCT03063086|156296189|FG002|Overall Study|Non-compliance with study treatment|0|||
48574997|NCT03063086|156296190|FG003|Overall Study|Non-compliance with study treatment|1|||
48574998|NCT03063086|156296191|FG004|Overall Study|Non-compliance with study treatment|0|||
48574999|NCT03063086|156296192|FG005|Overall Study|Non-compliance with study treatment|1|||
48575000|NCT03063086|156296187|FG000|Overall Study|Physician Decision|0|||
48575001|NCT03063086|156296188|FG001|Overall Study|Physician Decision|0|||
48575002|NCT03063086|156296189|FG002|Overall Study|Physician Decision|0|||
48575003|NCT03063086|156296190|FG003|Overall Study|Physician Decision|1|||
48575004|NCT03063086|156296191|FG004|Overall Study|Physician Decision|0|||
48575005|NCT03063086|156296192|FG005|Overall Study|Physician Decision|0|||
48575006|NCT04590586|156296194|FG000|Overall Study|Death|7|||
48575007|NCT04590586|156296195|FG001|Overall Study|Death|1|||
48575008|NCT04590586|156296196|FG002|Overall Study|Death|37|||
48620960|NCT02774278|156469273|FG000|Overall Study|Lack of Efficacy|199|||
48575009|NCT04590586|156296197|FG003|Overall Study|Death|34|||
48575010|NCT04590586|156296198|FG004|Overall Study|Death|19|||
48575011|NCT04590586|156296199|FG005|Overall Study|Death|3|||
48575012|NCT04590586|156296194|FG000|Overall Study|Lost to Follow-up|3|||
48575013|NCT04590586|156296195|FG001|Overall Study|Lost to Follow-up|0|||
48575014|NCT04590586|156296196|FG002|Overall Study|Lost to Follow-up|11|||
48575015|NCT04590586|156296197|FG003|Overall Study|Lost to Follow-up|11|||
48620961|NCT02774278|156469273|FG000|Overall Study|Death|29|||
48620962|NCT02774278|156469273|FG000|Overall Study|Adverse event/intercurrent illness|16|||
48620963|NCT02774278|156469273|FG000|Overall Study|Refused treatment/did not cooperate|9|||
48620964|NCT02774278|156469273|FG000|Overall Study|Administrative reasons|6|||
48620965|NCT02774278|156469273|FG000|Overall Study|Withdrawal by Subject|3|||
48620966|NCT02774278|156469273|FG000|Overall Study|Protocol Violation|2|||
48620967|NCT00127933|156469276|FG000|Overall Study|Randomized but not dosed|1|||
48620968|NCT00127933|156469277|FG001|Overall Study|Randomized but not dosed|0|||
48620969|NCT01783938|156469279|FG000|Overall Study|Disease Progression|18|||
48620970|NCT01783938|156469280|FG001|Overall Study|Disease Progression|41|||
48620971|NCT01783938|156469279|FG000|Overall Study|Study Drug Toxicity|27|||
48620972|NCT01783938|156469280|FG001|Overall Study|Study Drug Toxicity|14|||
48620973|NCT01783938|156469279|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
48620974|NCT01783938|156469280|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
48620975|NCT01783938|156469279|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
48620976|NCT01783938|156469280|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
48620977|NCT01783938|156469279|FG000|Overall Study|Participant Withdrew Consent|2|||
48620978|NCT01783938|156469280|FG001|Overall Study|Participant Withdrew Consent|0|||
48620979|NCT01783938|156469279|FG000|Overall Study|Maximum Clinical Benefit|1|||
48620980|NCT01783938|156469280|FG001|Overall Study|Maximum Clinical Benefit|0|||
48620981|NCT01783938|156469279|FG000|Overall Study|Other Reasons|3|||
48620982|NCT01783938|156469280|FG001|Overall Study|Other Reasons|1|||
48575016|NCT04590586|156296198|FG004|Overall Study|Lost to Follow-up|6|||
48620983|NCT00498485|156469281|FG000|Overall Study|Adverse Event|1|||
48620984|NCT00498485|156469282|FG001|Overall Study|Adverse Event|5|||
48620985|NCT03061214|156469290|FG000|Overall Study|Withdrawal by Subject|21|||
48620986|NCT03061214|156469291|FG001|Overall Study|Withdrawal by Subject|26|||
48620987|NCT03061214|156469292|FG002|Overall Study|Withdrawal by Subject|9|||
48620988|NCT03061214|156469290|FG000|Overall Study|Lost to Follow-up|3|||
48620989|NCT03061214|156469291|FG001|Overall Study|Lost to Follow-up|1|||
48620990|NCT03061214|156469292|FG002|Overall Study|Lost to Follow-up|1|||
48620991|NCT03061214|156469290|FG000|Overall Study|Death|1|||
48620992|NCT03061214|156469291|FG001|Overall Study|Death|1|||
48620993|NCT03061214|156469292|FG002|Overall Study|Death|0|||
48620994|NCT01684033|156469295|FG000|Period 1, First 30 Days|Adverse Event|1|||
48620995|NCT01684033|156469296|FG001|Period 1, First 30 Days|Adverse Event|1|||
48620996|NCT01684033|156469295|FG000|Period 1, First 30 Days|Noncompliance|1|||
48620997|NCT01684033|156469296|FG001|Period 1, First 30 Days|Noncompliance|0|||
48620998|NCT01684033|156469295|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
48620999|NCT01684033|156469296|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
48621000|NCT01684033|156469295|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
48621001|NCT01684033|156469296|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
48621002|NCT01684033|156469295|FG000|Period 2, Second 30 Days|Adverse Event|1|||
48621003|NCT01684033|156469296|FG001|Period 2, Second 30 Days|Adverse Event|0|||
48621004|NCT01348490|156469297|FG000|Overall Study|Death|1|||
48621005|NCT01348490|156469297|FG000|Overall Study|Adverse Event|3|||
48575017|NCT04590586|156296199|FG005|Overall Study|Lost to Follow-up|0|||
48575018|NCT04590586|156296194|FG000|Overall Study|Withdrawal by Subject|0|||
48575019|NCT04590586|156296195|FG001|Overall Study|Withdrawal by Subject|0|||
48575020|NCT04590586|156296196|FG002|Overall Study|Withdrawal by Subject|6|||
48575021|NCT04590586|156296197|FG003|Overall Study|Withdrawal by Subject|0|||
48575022|NCT04590586|156296198|FG004|Overall Study|Withdrawal by Subject|3|||
48575023|NCT04590586|156296199|FG005|Overall Study|Withdrawal by Subject|0|||
48575024|NCT04590586|156296194|FG000|Overall Study|Other|3|||
48575025|NCT04590586|156296195|FG001|Overall Study|Other|0|||
48575026|NCT04590586|156296196|FG002|Overall Study|Other|1|||
48575027|NCT04590586|156296197|FG003|Overall Study|Other|1|||
48621006|NCT01348490|156469297|FG000|Overall Study|Consent withdrawn|7|||
48621007|NCT01348490|156469297|FG000|Overall Study|Disease progression|3|||
48621008|NCT01348490|156469297|FG000|Overall Study|Lost to Follow-up|1|||
48621009|NCT01348490|156469297|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
48621010|NCT01348490|156469297|FG000|Overall Study|Other Unspecified|8|||
48621011|NCT01623154|156469298|FG000|Overall Study|Did not drink Pranactin Citric|4|||
48621012|NCT01412983|156469299|FG000|1st Period|Ineligible|0|||
48621013|NCT01412983|156469300|FG001|1st Period|Ineligible|1|||
48621014|NCT01412983|156469299|FG000|1st Period|Positive slit lamp finding|0|||
48621015|NCT01412983|156469300|FG001|1st Period|Positive slit lamp finding|1|||
48621016|NCT01412983|156469299|FG000|1st Period|Unacceptable lens movement|0|||
48621017|NCT01412983|156469300|FG001|1st Period|Unacceptable lens movement|1|||
48621018|NCT01412983|156469299|FG000|1st Period|Inability to maintain wear|0|||
48621019|NCT01412983|156469300|FG001|1st Period|Inability to maintain wear|1|||
48621020|NCT03921541|156471545|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
48621021|NCT03921541|156471546|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
48319219|NCT03531840|155369445|FG000|Overall Study|Death during follow up|2|||
48319220|NCT03531840|155369446|FG001|Overall Study|Death during follow up|3|||
48319221|NCT03531840|155369447|FG002|Overall Study|Death during follow up|4|||
48319222|NCT03531840|155369448|FG003|Overall Study|Death during follow up|1|||
48319223|NCT01510717|155369449|FG000|Overall Study|Adverse Event|1|||
48319224|NCT01510717|155369450|FG001|Overall Study|Adverse Event|2|||
48319225|NCT01510717|155369449|FG000|Overall Study|Death|1|||
48319226|NCT01510717|155369450|FG001|Overall Study|Death|0|||
48319227|NCT01510717|155369449|FG000|Overall Study|Lost to Follow-up|0|||
48319228|NCT01510717|155369450|FG001|Overall Study|Lost to Follow-up|1|||
48319229|NCT01510717|155369449|FG000|Overall Study|Withdrawal by Subject|0|||
48319230|NCT01510717|155369450|FG001|Overall Study|Withdrawal by Subject|2|||
48319231|NCT02121002|155369451|FG000|Overall Study|Physician Decision|2|||
48319232|NCT02121002|155369452|FG001|Overall Study|Physician Decision|0|||
48319233|NCT02121002|155369453|FG002|Overall Study|Physician Decision|0|||
48319234|NCT02121002|155369451|FG000|Overall Study|Withdrawal by Subject|3|||
48319235|NCT02121002|155369452|FG001|Overall Study|Withdrawal by Subject|1|||
48319236|NCT02121002|155369453|FG002|Overall Study|Withdrawal by Subject|4|||
48319237|NCT02121002|155369451|FG000|Overall Study|Protocol Violation|1|||
48319238|NCT02121002|155369452|FG001|Overall Study|Protocol Violation|2|||
48319239|NCT02121002|155369453|FG002|Overall Study|Protocol Violation|4|||
48319240|NCT02121002|155369451|FG000|Overall Study|Concomitant therapy|0|||
48319241|NCT02121002|155369452|FG001|Overall Study|Concomitant therapy|1|||
48319242|NCT02121002|155369453|FG002|Overall Study|Concomitant therapy|1|||
48319243|NCT02121002|155369451|FG000|Overall Study|Others|1|||
48319244|NCT02121002|155369452|FG001|Overall Study|Others|0|||
48575028|NCT04590586|156296198|FG004|Overall Study|Other|2|||
48575029|NCT04590586|156296199|FG005|Overall Study|Other|1|||
48575030|NCT01609543|156296200|FG000|Overall Study|Disease Progression|28|||
48575031|NCT01609543|156296200|FG000|Overall Study|Adverse Event|5|||
48575032|NCT01609543|156296200|FG000|Overall Study|Withdrawal by Subject|1|||
48575033|NCT01609543|156296200|FG000|Overall Study|Protocol Violation|1|||
48575034|NCT01609543|156296200|FG000|Overall Study|Death|7|||
48575035|NCT01893281|156296201|FG000|Overall Study|Adverse Event|1|||
48575036|NCT01893281|156296201|FG000|Overall Study|Protocol Violation|1|||
48575037|NCT01893281|156296201|FG000|Overall Study|Withdrawal by Subject|1|||
48575038|NCT02218736|156296205|FG000|Overall Study|Withdrawal by Subject|10|||
48575039|NCT02218736|156296206|FG001|Overall Study|Withdrawal by Subject|9|||
48575040|NCT02218736|156296205|FG000|Overall Study|Protocol Violation|2|||
48575041|NCT02218736|156296206|FG001|Overall Study|Protocol Violation|0|||
48575042|NCT03452488|156296209|FG000|Overall Study|Adverse Event|4|||
48575043|NCT03452488|156296210|FG001|Overall Study|Adverse Event|6|||
48575044|NCT03452488|156296211|FG002|Overall Study|Adverse Event|1|||
48575045|NCT03452488|156296209|FG000|Overall Study|Death|0|||
48575046|NCT03452488|156296210|FG001|Overall Study|Death|0|||
48621022|NCT00212355|156471547|FG000|Overall Study|Adverse Event|1|||
48319245|NCT02121002|155369453|FG002|Overall Study|Others|1|||
48319246|NCT03578536|155369459|FG000|Overall Study|Lost to Follow-up|1|||
48319247|NCT00468052|155369460|FG000|Overall Study|Protocol Violation|7|||
48319248|NCT00468052|155369461|FG001|Overall Study|Protocol Violation|8|||
48319249|NCT04788641|155369462|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
48575047|NCT03452488|156296211|FG002|Overall Study|Death|1|||
48575048|NCT03452488|156296209|FG000|Overall Study|Lost to Follow-up|1|||
48575049|NCT03452488|156296210|FG001|Overall Study|Lost to Follow-up|2|||
48575050|NCT03452488|156296211|FG002|Overall Study|Lost to Follow-up|0|||
48575051|NCT03452488|156296209|FG000|Overall Study|PI Decision|1|||
48575052|NCT03452488|156296210|FG001|Overall Study|PI Decision|0|||
48575053|NCT03452488|156296211|FG002|Overall Study|PI Decision|0|||
48575054|NCT03452488|156296209|FG000|Overall Study|Withdrew consent|4|||
48575055|NCT03452488|156296210|FG001|Overall Study|Withdrew consent|2|||
48575056|NCT03452488|156296211|FG002|Overall Study|Withdrew consent|2|||
48575057|NCT03452488|156296209|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
48575058|NCT03452488|156296210|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
48575059|NCT03452488|156296211|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
48575060|NCT03452488|156296209|FG000|Overall Study|Other|0|||
48575061|NCT03452488|156296210|FG001|Overall Study|Other|2|||
48575062|NCT03452488|156296211|FG002|Overall Study|Other|2|||
48575063|NCT01290679|156296212|FG000|Overall Study|Adverse Event|2|||
48575064|NCT01290679|156296213|FG001|Overall Study|Adverse Event|0|||
48319250|NCT04788641|155369463|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
48319251|NCT04788641|155369464|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
48319252|NCT04788641|155369465|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
48319253|NCT04788641|155369462|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
48450056|NCT01614795|155835557|FG000|Overall Study|Lack of Efficacy|10|||
48575065|NCT01290679|156296212|FG000|Overall Study|Lost to Follow-up|8|||
48575066|NCT01290679|156296213|FG001|Overall Study|Lost to Follow-up|10|||
48575067|NCT01290679|156296212|FG000|Overall Study|Protocol Violation|0|||
48575068|NCT01290679|156296213|FG001|Overall Study|Protocol Violation|1|||
48575069|NCT01290679|156296212|FG000|Overall Study|Withdrawal by Subject|6|||
48319254|NCT04788641|155369463|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
48319255|NCT04788641|155369464|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
48319256|NCT04788641|155369465|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
48319257|NCT04788641|155369462|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
48319258|NCT04788641|155369463|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
48319259|NCT04788641|155369464|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
48319260|NCT04788641|155369465|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
48319261|NCT00529789|155369466|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
48319262|NCT00529789|155369466|FG000|Study Period II/III|Adverse Event|3|||
48319263|NCT00529789|155369466|FG000|Study Period II/III|Lack of Efficacy|2|||
48319264|NCT00529789|155369466|FG000|Study Period II/III|Withdrawal by Subject|1|||
48319265|NCT00529789|155369466|FG000|Study Period II/III|Protocol Violation|3|||
48575070|NCT01290679|156296213|FG001|Overall Study|Withdrawal by Subject|5|||
48621023|NCT00212355|156471547|FG000|Overall Study|Withdrawal by Subject|1|||
48621024|NCT00212355|156471547|FG000|Overall Study|A change of address|1|||
48621025|NCT01112267|156471548|FG000|Overall Study|Adverse Event|24|||
48621026|NCT01112267|156471549|FG001|Overall Study|Adverse Event|6|||
48621027|NCT01112267|156471548|FG000|Overall Study|Withdrawal by Subject|3|||
48621028|NCT01112267|156471549|FG001|Overall Study|Withdrawal by Subject|5|||
48621029|NCT01112267|156471548|FG000|Overall Study|Protocol Violation|5|||
48621030|NCT01112267|156471549|FG001|Overall Study|Protocol Violation|3|||
48621031|NCT01112267|156471548|FG000|Overall Study|Participants not compliant|1|||
48621032|NCT01112267|156471549|FG001|Overall Study|Participants not compliant|2|||
48621033|NCT01112267|156471548|FG000|Overall Study|Participants not receive any study drug|1|||
48621034|NCT01112267|156471549|FG001|Overall Study|Participants not receive any study drug|2|||
48621035|NCT00160615|156471550|FG000|Overall Study|Adverse Event|5|||
48621036|NCT00160615|156471551|FG001|Overall Study|Adverse Event|12|||
48621037|NCT00160615|156471550|FG000|Overall Study|Withdrawal by Subject|0|||
48621038|NCT00160615|156471551|FG001|Overall Study|Withdrawal by Subject|2|||
48621039|NCT00160615|156471550|FG000|Overall Study|Lack of Efficacy|11|||
48621040|NCT00160615|156471551|FG001|Overall Study|Lack of Efficacy|23|||
48621041|NCT00160615|156471550|FG000|Overall Study|Patient decision|1|||
48621042|NCT00160615|156471551|FG001|Overall Study|Patient decision|2|||
48621043|NCT00160615|156471550|FG000|Overall Study|Investigator decision|1|||
48621044|NCT00160615|156471551|FG001|Overall Study|Investigator decision|1|||
48621045|NCT00160615|156471550|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
48575071|NCT01290679|156296212|FG000|Overall Study|Subject Entered Another Trial|0|||
48575072|NCT01290679|156296213|FG001|Overall Study|Subject Entered Another Trial|5|||
48575073|NCT01855243|156296214|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
48575074|NCT01855243|156296215|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
48575075|NCT01855243|156296216|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
48621046|NCT00160615|156471551|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
48621047|NCT00160615|156471550|FG000|Overall Study|Switch to surgical treatment|0|||
48621048|NCT00160615|156471551|FG001|Overall Study|Switch to surgical treatment|2|||
48621049|NCT00160615|156471550|FG000|Overall Study|Non-compliance was suspected|0|||
48621050|NCT00160615|156471551|FG001|Overall Study|Non-compliance was suspected|1|||
48621051|NCT00160615|156471550|FG000|Overall Study|Poor compliance|0|||
48621052|NCT00160615|156471551|FG001|Overall Study|Poor compliance|1|||
48621053|NCT03166631|156471552|FG000|Overall Study|Progressive disease|2|||
48621054|NCT03166631|156471553|FG001|Overall Study|Progressive disease|1|||
48621055|NCT03166631|156471554|FG002|Overall Study|Progressive disease|3|||
48319266|NCT00529789|155369466|FG000|Study Period II/III|Physician Decision|3|||
48319267|NCT00529789|155369466|FG000|Study Period II/III|Lost to Follow-up|3|||
48575076|NCT01435018|156296219|FG000|Overall Study|Death|37|||
48575077|NCT01435018|156296220|FG001|Overall Study|Death|18|||
48621056|NCT03166631|156471555|FG003|Overall Study|Progressive disease|4|||
48621057|NCT03166631|156471556|FG004|Overall Study|Progressive disease|2|||
48621058|NCT03166631|156471557|FG005|Overall Study|Progressive disease|2|||
48621059|NCT03166631|156471558|FG006|Overall Study|Progressive disease|5|||
48621060|NCT03166631|156471559|FG007|Overall Study|Progressive disease|6|||
48621061|NCT03166631|156471560|FG008|Overall Study|Progressive disease|11|||
48621062|NCT03166631|156471561|FG009|Overall Study|Progressive disease|5|||
48621063|NCT03166631|156471562|FG010|Overall Study|Progressive disease|7|||
48621064|NCT03166631|156471552|FG000|Overall Study|Physician Decision|0|||
48621065|NCT03166631|156471553|FG001|Overall Study|Physician Decision|0|||
48621066|NCT03166631|156471554|FG002|Overall Study|Physician Decision|0|||
48621067|NCT03166631|156471555|FG003|Overall Study|Physician Decision|0|||
48621068|NCT03166631|156471556|FG004|Overall Study|Physician Decision|0|||
48621069|NCT03166631|156471557|FG005|Overall Study|Physician Decision|0|||
48621070|NCT03166631|156471558|FG006|Overall Study|Physician Decision|1|||
48621071|NCT03166631|156471559|FG007|Overall Study|Physician Decision|0|||
48621072|NCT03166631|156471560|FG008|Overall Study|Physician Decision|1|||
48621073|NCT03166631|156471561|FG009|Overall Study|Physician Decision|0|||
48621074|NCT03166631|156471562|FG010|Overall Study|Physician Decision|1|||
48621075|NCT03166631|156471552|FG000|Overall Study|Death|0|||
48621076|NCT03166631|156471553|FG001|Overall Study|Death|0|||
48621077|NCT03166631|156471554|FG002|Overall Study|Death|0|||
48621078|NCT03166631|156471555|FG003|Overall Study|Death|0|||
48621079|NCT03166631|156471556|FG004|Overall Study|Death|1|||
48621080|NCT03166631|156471557|FG005|Overall Study|Death|0|||
48621081|NCT03166631|156471558|FG006|Overall Study|Death|1|||
48621082|NCT03166631|156471559|FG007|Overall Study|Death|0|||
48621083|NCT03166631|156471560|FG008|Overall Study|Death|0|||
48621084|NCT03166631|156471561|FG009|Overall Study|Death|0|||
48621085|NCT03166631|156471562|FG010|Overall Study|Death|0|||
48621086|NCT03166631|156471552|FG000|Overall Study|Adverse Event|1|||
48621087|NCT03166631|156471553|FG001|Overall Study|Adverse Event|0|||
48621088|NCT03166631|156471554|FG002|Overall Study|Adverse Event|0|||
48621089|NCT03166631|156471555|FG003|Overall Study|Adverse Event|0|||
48621090|NCT03166631|156471556|FG004|Overall Study|Adverse Event|0|||
48621091|NCT03166631|156471557|FG005|Overall Study|Adverse Event|1|||
48621092|NCT03166631|156471558|FG006|Overall Study|Adverse Event|1|||
48621093|NCT03166631|156471559|FG007|Overall Study|Adverse Event|0|||
48621094|NCT03166631|156471560|FG008|Overall Study|Adverse Event|1|||
48621095|NCT03166631|156471561|FG009|Overall Study|Adverse Event|2|||
48621096|NCT03166631|156471562|FG010|Overall Study|Adverse Event|1|||
48621097|NCT03166631|156471552|FG000|Overall Study|Withdrawal by Subject|0|||
48621098|NCT03166631|156471553|FG001|Overall Study|Withdrawal by Subject|0|||
48736041|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
48319268|NCT00529789|155369466|FG000|Study Period IV|Parent/Caregiver Decision|1|||
48319269|NCT00529789|155369466|FG000|Study Period IV|Adverse Event|1|||
48319270|NCT00529789|155369466|FG000|Study Period IV|Lack of Efficacy|1|||
48319271|NCT00529789|155369466|FG000|Study Period IV|Lost to Follow-up|3|||
48319272|NCT02204982|155369467|FG000|Overall Study|Patient ineligible-medical monitor|1|||
48319273|NCT02204982|155369468|FG001|Overall Study|Patient ineligible-medical monitor|0|||
48319274|NCT02204982|155369467|FG000|Overall Study|Withdrawal by Subject|1|||
48319275|NCT02204982|155369468|FG001|Overall Study|Withdrawal by Subject|0|||
48319276|NCT02204982|155369467|FG000|Overall Study|Adverse Event|1|||
48319277|NCT02204982|155369468|FG001|Overall Study|Adverse Event|0|||
48319278|NCT02204982|155369467|FG000|Overall Study|Adverse Event and Investigator decision|1|||
48319279|NCT02204982|155369468|FG001|Overall Study|Adverse Event and Investigator decision|0|||
48319280|NCT02204982|155369467|FG000|Overall Study|Physician Decision|0|||
48319281|NCT02204982|155369468|FG001|Overall Study|Physician Decision|2|||
48621099|NCT03166631|156471554|FG002|Overall Study|Withdrawal by Subject|0|||
48621100|NCT03166631|156471555|FG003|Overall Study|Withdrawal by Subject|0|||
48621101|NCT03166631|156471556|FG004|Overall Study|Withdrawal by Subject|0|||
48621102|NCT03166631|156471557|FG005|Overall Study|Withdrawal by Subject|0|||
48621103|NCT03166631|156471558|FG006|Overall Study|Withdrawal by Subject|0|||
48621104|NCT03166631|156471559|FG007|Overall Study|Withdrawal by Subject|0|||
48621105|NCT03166631|156471560|FG008|Overall Study|Withdrawal by Subject|1|||
48621106|NCT03166631|156471561|FG009|Overall Study|Withdrawal by Subject|1|||
48621107|NCT03166631|156471562|FG010|Overall Study|Withdrawal by Subject|0|||
48736042|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
48319282|NCT02204982|155369467|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
48319283|NCT02204982|155369468|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
48319284|NCT02204982|155369467|FG000|Overall Study|Termination of Study bySponsor|0|||
48621108|NCT03506633|156471565|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
48621109|NCT03506633|156471566|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
48621110|NCT01565694|156471567|FG000|Dose-Titration Period|Adverse Event|4|||
48621111|NCT01565694|156471567|FG000|Dose-Titration Period|Protocol Violation|10|||
48621112|NCT01565694|156471567|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
48621113|NCT01166945|156471568|FG000|Randomized|diagnosed with Group A strep|4|||
48621114|NCT01166945|156471569|FG001|Randomized|diagnosed with Group A strep|4|||
48621115|NCT01166945|156471568|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
48621116|NCT01166945|156471569|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
48621117|NCT01166945|156471568|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
48621118|NCT01166945|156471569|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
48319285|NCT02204982|155369468|FG001|Overall Study|Termination of Study bySponsor|1|||
48319286|NCT01546753|155369469|FG000|Overall Study|anxiety|1|||
48319287|NCT01546753|155369470|FG001|Overall Study|anxiety|1|||
48319288|NCT01546753|155369469|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
48319289|NCT01546753|155369470|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
48319290|NCT01837966|155369471|FG000|Overall Study|Withdrawal by Subject|2|||
48319291|NCT01837966|155369472|FG001|Overall Study|Withdrawal by Subject|1|||
48319292|NCT01102231|155369473|FG000|Overall Study|Protocol Violation|3|||
48575078|NCT01435018|156296221|FG002|Overall Study|Death|25|||
48575079|NCT01435018|156296219|FG000|Overall Study|Site is closing|4|||
48575080|NCT01435018|156296220|FG001|Overall Study|Site is closing|9|||
48575081|NCT01435018|156296221|FG002|Overall Study|Site is closing|7|||
48575082|NCT01435018|156296219|FG000|Overall Study|Withdrew consent|0|||
48575083|NCT01435018|156296220|FG001|Overall Study|Withdrew consent|3|||
48575084|NCT01435018|156296221|FG002|Overall Study|Withdrew consent|1|||
48575085|NCT01435018|156296219|FG000|Overall Study|Not willing to adhere to requirements|0|||
48575086|NCT01435018|156296220|FG001|Overall Study|Not willing to adhere to requirements|2|||
48575087|NCT01435018|156296221|FG002|Overall Study|Not willing to adhere to requirements|3|||
48575088|NCT01435018|156296219|FG000|Overall Study|Not able to get to clinic|2|||
48575089|NCT01435018|156296220|FG001|Overall Study|Not able to get to clinic|0|||
48575090|NCT01435018|156296221|FG002|Overall Study|Not able to get to clinic|2|||
48575091|NCT01435018|156296219|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48575092|NCT01435018|156296220|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48575093|NCT01435018|156296221|FG002|Overall Study|Severe debilitation, unable to continue|1|||
48575094|NCT01435018|156296219|FG000|Overall Study|Unable to contact participant/parent|1|||
48575095|NCT01435018|156296220|FG001|Overall Study|Unable to contact participant/parent|1|||
48575096|NCT01435018|156296221|FG002|Overall Study|Unable to contact participant/parent|1|||
48575097|NCT01435018|156296219|FG000|Overall Study|Enrollment Violation|0|||
48575098|NCT01435018|156296220|FG001|Overall Study|Enrollment Violation|1|||
48575099|NCT01435018|156296221|FG002|Overall Study|Enrollment Violation|0|||
48575100|NCT01435018|156296219|FG000|Overall Study|Never started chemotherapy|3|||
48575101|NCT01435018|156296220|FG001|Overall Study|Never started chemotherapy|0|||
48575102|NCT01435018|156296221|FG002|Overall Study|Never started chemotherapy|1|||
48575103|NCT03613649|156296222|FG000|Second Treatment|Lost to Follow-up|0|||
48575104|NCT03613649|156296223|FG001|Second Treatment|Lost to Follow-up|0|||
48575105|NCT03613649|156296224|FG002|Second Treatment|Lost to Follow-up|1|||
48575106|NCT03613649|156296225|FG003|Second Treatment|Lost to Follow-up|0|||
48575107|NCT03613649|156296226|FG004|Second Treatment|Lost to Follow-up|0|||
48575108|NCT03613649|156296227|FG005|Second Treatment|Lost to Follow-up|0|||
48575109|NCT03613649|156296228|FG006|Second Treatment|Lost to Follow-up|0|||
48575110|NCT03613649|156296229|FG007|Second Treatment|Lost to Follow-up|0|||
48575111|NCT03613649|156296230|FG008|Second Treatment|Lost to Follow-up|0|||
48575112|NCT03613649|156296231|FG009|Second Treatment|Lost to Follow-up|0|||
48575113|NCT03613649|156296232|FG010|Second Treatment|Lost to Follow-up|0|||
48575114|NCT03613649|156296233|FG011|Second Treatment|Lost to Follow-up|0|||
48575115|NCT03613649|156296222|FG000|Second Treatment|Withdrawal by Subject|0|||
48575116|NCT03613649|156296223|FG001|Second Treatment|Withdrawal by Subject|0|||
48575117|NCT03613649|156296224|FG002|Second Treatment|Withdrawal by Subject|0|||
48575118|NCT03613649|156296225|FG003|Second Treatment|Withdrawal by Subject|0|||
48575119|NCT03613649|156296226|FG004|Second Treatment|Withdrawal by Subject|1|||
48575120|NCT03613649|156296227|FG005|Second Treatment|Withdrawal by Subject|0|||
48575121|NCT03613649|156296228|FG006|Second Treatment|Withdrawal by Subject|0|||
48575122|NCT03613649|156296229|FG007|Second Treatment|Withdrawal by Subject|0|||
48575123|NCT03613649|156296230|FG008|Second Treatment|Withdrawal by Subject|0|||
48575124|NCT03613649|156296231|FG009|Second Treatment|Withdrawal by Subject|0|||
48575125|NCT03613649|156296232|FG010|Second Treatment|Withdrawal by Subject|0|||
48575126|NCT03613649|156296233|FG011|Second Treatment|Withdrawal by Subject|0|||
48575127|NCT03613649|156296222|FG000|Third Treatment|Lost to Follow-up|0|||
48575128|NCT03613649|156296223|FG001|Third Treatment|Lost to Follow-up|0|||
48575129|NCT03613649|156296224|FG002|Third Treatment|Lost to Follow-up|0|||
48575130|NCT03613649|156296225|FG003|Third Treatment|Lost to Follow-up|0|||
48575131|NCT03613649|156296226|FG004|Third Treatment|Lost to Follow-up|1|||
48575132|NCT03613649|156296227|FG005|Third Treatment|Lost to Follow-up|0|||
48575133|NCT03613649|156296228|FG006|Third Treatment|Lost to Follow-up|0|||
48575134|NCT03613649|156296229|FG007|Third Treatment|Lost to Follow-up|0|||
48575135|NCT03613649|156296230|FG008|Third Treatment|Lost to Follow-up|0|||
48575136|NCT03613649|156296231|FG009|Third Treatment|Lost to Follow-up|0|||
48575137|NCT03613649|156296232|FG010|Third Treatment|Lost to Follow-up|0|||
48575138|NCT03613649|156296233|FG011|Third Treatment|Lost to Follow-up|1|||
48575139|NCT03613649|156296222|FG000|Third Treatment|Protocol Violation|0|||
48575140|NCT03613649|156296223|FG001|Third Treatment|Protocol Violation|0|||
48575141|NCT03613649|156296224|FG002|Third Treatment|Protocol Violation|0|||
48575142|NCT03613649|156296225|FG003|Third Treatment|Protocol Violation|0|||
48575143|NCT03613649|156296226|FG004|Third Treatment|Protocol Violation|0|||
48575144|NCT03613649|156296227|FG005|Third Treatment|Protocol Violation|0|||
48621119|NCT01166945|156471568|FG000|Day 30|Lost to Follow-up|4|||
48575145|NCT03613649|156296228|FG006|Third Treatment|Protocol Violation|1|||
48621120|NCT01166945|156471569|FG001|Day 30|Lost to Follow-up|3|||
48621121|NCT00454142|156471570|FG000|Overall Study|Withdrawal by Subject|1|||
48621122|NCT01699685|156471573|FG000|Period 1|Adverse Event|1|||
48621123|NCT01699685|156471574|FG001|Period 1|Adverse Event|1|||
48621124|NCT01699685|156471573|FG000|Period 1|Medical or ethical, noncompliance|2|||
48621125|NCT01699685|156471574|FG001|Period 1|Medical or ethical, noncompliance|0|||
48319293|NCT01102231|155369473|FG000|Overall Study|Lack of Efficacy|2|||
48575146|NCT03613649|156296229|FG007|Third Treatment|Protocol Violation|0|||
48575147|NCT03613649|156296230|FG008|Third Treatment|Protocol Violation|0|||
48575148|NCT03613649|156296231|FG009|Third Treatment|Protocol Violation|0|||
48575149|NCT03613649|156296232|FG010|Third Treatment|Protocol Violation|0|||
48575150|NCT03613649|156296233|FG011|Third Treatment|Protocol Violation|1|||
48575151|NCT03613649|156296222|FG000|Fourth Treatment|Protocol Violation|1|||
48575152|NCT03613649|156296223|FG001|Fourth Treatment|Protocol Violation|0|||
48319294|NCT01102231|155369473|FG000|Overall Study|Death|2|||
48319295|NCT01102231|155369473|FG000|Overall Study|Adverse Event|3|||
48319296|NCT01102231|155369473|FG000|Overall Study|Withdrawal by Subject|1|||
48319297|NCT01102231|155369473|FG000|Overall Study|Did not received the treatment|4|||
48621126|NCT01699685|156471573|FG000|Period 1|Other|0|||
48621127|NCT01699685|156471574|FG001|Period 1|Other|1|||
48621128|NCT01699685|156471573|FG000|Period 1|Patient request|0|||
48621129|NCT01699685|156471574|FG001|Period 1|Patient request|1|||
48621130|NCT01699685|156471573|FG000|Period 2|Lost to Follow-up|1|||
48621131|NCT01699685|156471574|FG001|Period 2|Lost to Follow-up|0|||
48319298|NCT00609336|155369482|FG000|Overall Study|Protocol Violation|3|||
48319299|NCT00609336|155369482|FG000|Overall Study|Death|1|||
48319300|NCT00609336|155369482|FG000|Overall Study|LA or Met at Surgery|9|||
48319301|NCT02477605|155369483|FG000|Overall Study|Discontinued prior to treatment|1|||
48319302|NCT02477605|155369484|FG001|Overall Study|Discontinued prior to treatment|0|||
48319303|NCT02477605|155369483|FG000|Overall Study|Lost to Follow-up|0|||
48319304|NCT02477605|155369484|FG001|Overall Study|Lost to Follow-up|2|||
48319305|NCT02477605|155369483|FG000|Overall Study|Withdrawal by Subject|0|||
48319306|NCT02477605|155369484|FG001|Overall Study|Withdrawal by Subject|1|||
48319307|NCT02477605|155369483|FG000|Overall Study|Administered gas during surgery|0|||
48319308|NCT02477605|155369484|FG001|Overall Study|Administered gas during surgery|1|||
48319309|NCT02965846|155369486|FG000|Overall Study|Lost to Follow-up|1|||
48319310|NCT02965846|155369487|FG001|Overall Study|Lost to Follow-up|0|||
48319311|NCT02965846|155369488|FG002|Overall Study|Lost to Follow-up|0|||
48319312|NCT02965846|155369486|FG000|Overall Study|Withdrawal by Subject|0|||
48319313|NCT02965846|155369487|FG001|Overall Study|Withdrawal by Subject|1|||
48319314|NCT02965846|155369488|FG002|Overall Study|Withdrawal by Subject|0|||
48319315|NCT02965846|155369486|FG000|Overall Study|Study Terminated By Sponsor|4|||
48319316|NCT02965846|155369487|FG001|Overall Study|Study Terminated By Sponsor|4|||
48319317|NCT02965846|155369488|FG002|Overall Study|Study Terminated By Sponsor|0|||
48319318|NCT02965846|155369486|FG000|Overall Study|Participants not randomized|0|||
48575153|NCT03613649|156296224|FG002|Fourth Treatment|Protocol Violation|0|||
48575154|NCT03613649|156296225|FG003|Fourth Treatment|Protocol Violation|0|||
48575155|NCT03613649|156296226|FG004|Fourth Treatment|Protocol Violation|1|||
48575156|NCT03613649|156296227|FG005|Fourth Treatment|Protocol Violation|0|||
48575157|NCT03613649|156296228|FG006|Fourth Treatment|Protocol Violation|0|||
48575158|NCT03613649|156296229|FG007|Fourth Treatment|Protocol Violation|0|||
48575159|NCT03613649|156296230|FG008|Fourth Treatment|Protocol Violation|0|||
48575160|NCT03613649|156296231|FG009|Fourth Treatment|Protocol Violation|0|||
48575161|NCT03613649|156296232|FG010|Fourth Treatment|Protocol Violation|0|||
48575162|NCT03613649|156296233|FG011|Fourth Treatment|Protocol Violation|0|||
48575163|NCT03613649|156296222|FG000|Fourth Treatment|Physician Decision|0|||
48575164|NCT03613649|156296223|FG001|Fourth Treatment|Physician Decision|0|||
48575165|NCT03613649|156296224|FG002|Fourth Treatment|Physician Decision|0|||
48575166|NCT03613649|156296225|FG003|Fourth Treatment|Physician Decision|0|||
48575167|NCT03613649|156296226|FG004|Fourth Treatment|Physician Decision|0|||
48575168|NCT03613649|156296227|FG005|Fourth Treatment|Physician Decision|0|||
48621132|NCT02545127|156471577|FG000|Overall Study|Lost to Follow-up|1|||
48621133|NCT02545127|156471578|FG001|Overall Study|Lost to Follow-up|0|||
48319319|NCT02965846|155369487|FG001|Overall Study|Participants not randomized|0|||
48319320|NCT02965846|155369488|FG002|Overall Study|Participants not randomized|33|||
48319321|NCT01388361|155369489|FG000|Overall Study|Adverse Event|0|||
48319322|NCT01388361|155369490|FG001|Overall Study|Adverse Event|5|||
48319323|NCT01388361|155369491|FG002|Overall Study|Adverse Event|1|||
48319324|NCT01388361|155369489|FG000|Overall Study|Protocol Violation|0|||
48319325|NCT01388361|155369490|FG001|Overall Study|Protocol Violation|0|||
48319326|NCT01388361|155369491|FG002|Overall Study|Protocol Violation|2|||
48575169|NCT03613649|156296228|FG006|Fourth Treatment|Physician Decision|1|||
48575170|NCT03613649|156296229|FG007|Fourth Treatment|Physician Decision|0|||
48575171|NCT03613649|156296230|FG008|Fourth Treatment|Physician Decision|0|||
48621134|NCT01129284|156471579|FG000|Overall Study|Adverse Event|2|||
48621135|NCT01129284|156471580|FG001|Overall Study|Adverse Event|0|||
48621136|NCT01129284|156471581|FG002|Overall Study|Adverse Event|1|||
48575172|NCT03613649|156296231|FG009|Fourth Treatment|Physician Decision|0|||
48575173|NCT03613649|156296232|FG010|Fourth Treatment|Physician Decision|0|||
48575174|NCT03613649|156296233|FG011|Fourth Treatment|Physician Decision|0|||
48575175|NCT03502070|156296238|FG000|Overall Study|Withdrawal by Subject|1|||
48575176|NCT03502070|156296238|FG000|Overall Study|Screen Failure|1|||
48575177|NCT00652626|156296239|FG000|Initial Treatment Phase|Adverse Event|0|||
48575178|NCT00652626|156296240|FG001|Initial Treatment Phase|Adverse Event|0|||
48575179|NCT00652626|156296241|FG002|Initial Treatment Phase|Adverse Event|0|||
48319327|NCT01388361|155369489|FG000|Overall Study|Withdrawal criteria|12|||
48319328|NCT01388361|155369490|FG001|Overall Study|Withdrawal criteria|7|||
48319329|NCT01388361|155369491|FG002|Overall Study|Withdrawal criteria|10|||
48319330|NCT01388361|155369489|FG000|Overall Study|Unclassified|0|||
48319331|NCT01388361|155369490|FG001|Overall Study|Unclassified|0|||
48319332|NCT01388361|155369491|FG002|Overall Study|Unclassified|1|||
48621137|NCT00784927|156471582|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
48575180|NCT00652626|156296242|FG003|Initial Treatment Phase|Adverse Event|0|||
48575181|NCT00652626|156296243|FG004|Initial Treatment Phase|Adverse Event|1|||
48575182|NCT00652626|156296244|FG005|Initial Treatment Phase|Adverse Event|0|||
48575183|NCT00652626|156296245|FG006|Initial Treatment Phase|Adverse Event|0|||
48575184|NCT00652626|156296239|FG000|Initial Treatment Phase|Protocol Violation|0|||
48575185|NCT00652626|156296240|FG001|Initial Treatment Phase|Protocol Violation|0|||
48575186|NCT00652626|156296241|FG002|Initial Treatment Phase|Protocol Violation|0|||
48575187|NCT00652626|156296242|FG003|Initial Treatment Phase|Protocol Violation|1|||
48575188|NCT00652626|156296243|FG004|Initial Treatment Phase|Protocol Violation|0|||
48575189|NCT00652626|156296244|FG005|Initial Treatment Phase|Protocol Violation|0|||
48575190|NCT00652626|156296245|FG006|Initial Treatment Phase|Protocol Violation|0|||
48575191|NCT00652626|156296239|FG000|Initial Treatment Phase|Physician Decision|0|||
48621138|NCT00784927|156471582|FG000|Overall Study|Protocol Violation|1|||
48621139|NCT00784927|156471582|FG000|Overall Study|Ineligible|1|||
48621140|NCT00422461|156471583|FG000|Overall Study|Adverse Event|1|||
48319333|NCT01070069|155369492|FG000|Overall Study|Death|1|||
48319334|NCT01070069|155369493|FG001|Overall Study|Death|0|||
48319335|NCT01070069|155369494|FG002|Overall Study|Death|2|||
48575192|NCT00652626|156296240|FG001|Initial Treatment Phase|Physician Decision|0|||
48575193|NCT00652626|156296241|FG002|Initial Treatment Phase|Physician Decision|0|||
48575194|NCT00652626|156296242|FG003|Initial Treatment Phase|Physician Decision|0|||
48575195|NCT00652626|156296243|FG004|Initial Treatment Phase|Physician Decision|1|||
48575196|NCT00652626|156296244|FG005|Initial Treatment Phase|Physician Decision|0|||
48575197|NCT00652626|156296245|FG006|Initial Treatment Phase|Physician Decision|0|||
48575198|NCT00652626|156296239|FG000|Initial Treatment Phase|Sponsor Request|0|||
48621141|NCT00422461|156471584|FG001|Overall Study|Adverse Event|2|||
48621142|NCT00422461|156471585|FG002|Overall Study|Adverse Event|1|||
48621143|NCT00422461|156471586|FG003|Overall Study|Adverse Event|1|||
48621144|NCT00422461|156471583|FG000|Overall Study|Other|0|||
48621145|NCT00422461|156471584|FG001|Overall Study|Other|0|||
48621146|NCT00422461|156471585|FG002|Overall Study|Other|0|||
48621147|NCT00422461|156471586|FG003|Overall Study|Other|2|||
48621148|NCT00422461|156471583|FG000|Overall Study|Participants no longer willing to participate in study|1|||
48621149|NCT00422461|156471584|FG001|Overall Study|Participants no longer willing to participate in study|0|||
48621150|NCT00422461|156471585|FG002|Overall Study|Participants no longer willing to participate in study|0|||
48621151|NCT00422461|156471586|FG003|Overall Study|Participants no longer willing to participate in study|0|||
48621152|NCT00422461|156471583|FG000|Overall Study|Randomized but not treated|1|||
48621153|NCT00422461|156471584|FG001|Overall Study|Randomized but not treated|1|||
48621154|NCT00422461|156471585|FG002|Overall Study|Randomized but not treated|0|||
48621155|NCT00422461|156471586|FG003|Overall Study|Randomized but not treated|0|||
48621156|NCT02493855|156471587|FG000|Overall Study|Non-compliance|1|||
48621157|NCT02493855|156471588|FG001|Overall Study|Non-compliance|0|||
48621158|NCT02493855|156471589|FG002|Overall Study|Non-compliance|0|||
48621159|NCT02493855|156471587|FG000|Overall Study|Adverse Event|0|||
48621160|NCT02493855|156471588|FG001|Overall Study|Adverse Event|1|||
48621161|NCT02493855|156471589|FG002|Overall Study|Adverse Event|0|||
48621162|NCT02493855|156471587|FG000|Overall Study|Withdrawal by Subject|1|||
48621163|NCT02493855|156471588|FG001|Overall Study|Withdrawal by Subject|0|||
48621164|NCT02493855|156471589|FG002|Overall Study|Withdrawal by Subject|0|||
48319336|NCT01070069|155369495|FG003|Overall Study|Death|0|||
48319337|NCT01070069|155369496|FG004|Overall Study|Death|1|||
48319338|NCT01070069|155369492|FG000|Overall Study|Withdrawal by Subject|1|||
48319339|NCT01070069|155369493|FG001|Overall Study|Withdrawal by Subject|1|||
48319340|NCT01070069|155369494|FG002|Overall Study|Withdrawal by Subject|4|||
48319341|NCT01070069|155369495|FG003|Overall Study|Withdrawal by Subject|0|||
48621165|NCT01471574|156471590|FG000|Treatment Period|Lack of Efficacy|12|||
48319342|NCT01070069|155369496|FG004|Overall Study|Withdrawal by Subject|0|||
48319343|NCT01070069|155369492|FG000|Overall Study|Lost to Follow-up|4|||
48575199|NCT00652626|156296240|FG001|Initial Treatment Phase|Sponsor Request|0|||
48621166|NCT01471574|156471591|FG001|Treatment Period|Lack of Efficacy|4|||
48621167|NCT01471574|156471592|FG002|Treatment Period|Lack of Efficacy|14|||
48621168|NCT01471574|156471593|FG003|Treatment Period|Lack of Efficacy|1|||
48621169|NCT01471574|156471590|FG000|Treatment Period|Adverse Event|7|||
48621170|NCT01471574|156471591|FG001|Treatment Period|Adverse Event|3|||
48621171|NCT01471574|156471592|FG002|Treatment Period|Adverse Event|6|||
48621172|NCT01471574|156471593|FG003|Treatment Period|Adverse Event|1|||
48621173|NCT01471574|156471590|FG000|Treatment Period|Withdrawal by Subject|5|||
48621174|NCT01471574|156471591|FG001|Treatment Period|Withdrawal by Subject|1|||
48621175|NCT01471574|156471592|FG002|Treatment Period|Withdrawal by Subject|1|||
48621176|NCT01471574|156471593|FG003|Treatment Period|Withdrawal by Subject|0|||
48621177|NCT01471574|156471590|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
48621178|NCT01471574|156471591|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
48621179|NCT01471574|156471592|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
48319344|NCT01070069|155369493|FG001|Overall Study|Lost to Follow-up|1|||
48319345|NCT01070069|155369494|FG002|Overall Study|Lost to Follow-up|0|||
48319346|NCT01070069|155369495|FG003|Overall Study|Lost to Follow-up|0|||
48319347|NCT01070069|155369496|FG004|Overall Study|Lost to Follow-up|3|||
48319348|NCT05368831|155369497|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
48319349|NCT00262301|155369498|FG000|Double-blind Phase|Lost to Follow-up|1|||
48319350|NCT00262301|155369499|FG001|Double-blind Phase|Lost to Follow-up|0|||
48319351|NCT00262301|155369500|FG002|Double-blind Phase|Lost to Follow-up|0|||
48319352|NCT00262301|155369498|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
48319353|NCT00262301|155369499|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
48319354|NCT00262301|155369500|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
48319355|NCT03101930|155369501|FG000|Overall Study|Withdrawal by Subject|2|||
48319356|NCT03101930|155369502|FG001|Overall Study|Withdrawal by Subject|1|||
48319357|NCT03101930|155369503|FG002|Overall Study|Withdrawal by Subject|2|||
48319358|NCT00593489|155369505|FG000|Allocation|did not attend workshop; allocation not|2|||
48319359|NCT00593489|155369506|FG001|Allocation|did not attend workshop; allocation not|1|||
48319360|NCT00087139|155369507|FG000|Overall Study|Adverse Event|18|||
48319361|NCT00087139|155369508|FG001|Overall Study|Adverse Event|17|||
48319362|NCT00087139|155369509|FG002|Overall Study|Adverse Event|13|||
48319363|NCT00087139|155369507|FG000|Overall Study|Death|2|||
48319364|NCT00087139|155369508|FG001|Overall Study|Death|1|||
48319365|NCT00087139|155369509|FG002|Overall Study|Death|0|||
48319366|NCT00087139|155369507|FG000|Overall Study|Withdrawal by Subject|3|||
48319367|NCT00087139|155369508|FG001|Overall Study|Withdrawal by Subject|2|||
48319368|NCT00087139|155369509|FG002|Overall Study|Withdrawal by Subject|2|||
48319369|NCT00087139|155369507|FG000|Overall Study|Physician Decision|1|||
48319370|NCT00087139|155369508|FG001|Overall Study|Physician Decision|1|||
48319371|NCT00087139|155369509|FG002|Overall Study|Physician Decision|1|||
48575200|NCT00652626|156296241|FG002|Initial Treatment Phase|Sponsor Request|1|||
48575201|NCT00652626|156296242|FG003|Initial Treatment Phase|Sponsor Request|0|||
48575202|NCT00652626|156296243|FG004|Initial Treatment Phase|Sponsor Request|0|||
48575203|NCT00652626|156296244|FG005|Initial Treatment Phase|Sponsor Request|0|||
48575204|NCT00652626|156296245|FG006|Initial Treatment Phase|Sponsor Request|0|||
48575205|NCT00652626|156296239|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
48575206|NCT00652626|156296240|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
48575207|NCT00652626|156296241|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
48575208|NCT00652626|156296242|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
48575209|NCT00652626|156296243|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
48575210|NCT00652626|156296244|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
48575211|NCT00652626|156296245|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
48575212|NCT00652626|156296239|FG000|Extension Phase|Withdrawal by Subject|0|||
48575213|NCT00652626|156296240|FG001|Extension Phase|Withdrawal by Subject|0|||
48621180|NCT01471574|156471593|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
48621181|NCT01471574|156471590|FG000|Treatment Period|Lost to Follow-up|1|||
48621182|NCT01471574|156471591|FG001|Treatment Period|Lost to Follow-up|2|||
48621183|NCT01471574|156471592|FG002|Treatment Period|Lost to Follow-up|2|||
48319372|NCT00087139|155369507|FG000|Overall Study|Disease progression|9|||
48319373|NCT00087139|155369508|FG001|Overall Study|Disease progression|19|||
48319374|NCT00087139|155369509|FG002|Overall Study|Disease progression|12|||
48319375|NCT00087139|155369507|FG000|Overall Study|Ineligible|4|||
48319376|NCT00087139|155369508|FG001|Overall Study|Ineligible|7|||
48319377|NCT00087139|155369509|FG002|Overall Study|Ineligible|4|||
48319378|NCT00087139|155369507|FG000|Overall Study|Symptomatic deterioration|1|||
48319379|NCT00087139|155369508|FG001|Overall Study|Symptomatic deterioration|1|||
48319380|NCT00087139|155369509|FG002|Overall Study|Symptomatic deterioration|3|||
48319381|NCT00087139|155369507|FG000|Overall Study|Use of coumadin|1|||
48319382|NCT00087139|155369508|FG001|Overall Study|Use of coumadin|0|||
48319383|NCT00087139|155369509|FG002|Overall Study|Use of coumadin|0|||
48575214|NCT00652626|156296241|FG002|Extension Phase|Withdrawal by Subject|0|||
48621184|NCT01471574|156471593|FG003|Treatment Period|Lost to Follow-up|0|||
48319384|NCT00087139|155369507|FG000|Overall Study|Response achieved|0|||
48319385|NCT00087139|155369508|FG001|Overall Study|Response achieved|1|||
48319386|NCT00087139|155369509|FG002|Overall Study|Response achieved|0|||
48319387|NCT00087139|155369507|FG000|Overall Study|Extradural disease|0|||
48319388|NCT00087139|155369508|FG001|Overall Study|Extradural disease|0|||
48319389|NCT00087139|155369509|FG002|Overall Study|Extradural disease|1|||
48319390|NCT00976495|155369510|FG000|Overall Study|Withdrawal by Subject|0|||
48319391|NCT00976495|155369511|FG001|Overall Study|Withdrawal by Subject|1|||
48319392|NCT00976495|155369512|FG002|Overall Study|Withdrawal by Subject|0|||
48319393|NCT00419341|155369515|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
48319394|NCT00419341|155369515|FG000|Wash in/Wash Out Period|Adverse Event|2|||
48319395|NCT00419341|155369515|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
48319396|NCT00419341|155369515|FG000|Efficacy Period|Withdrawal by Subject|6|||
48319397|NCT00419341|155369515|FG000|Efficacy Period|Protocol Violation|1|||
48319398|NCT00419341|155369515|FG000|Efficacy Period|Lost to Follow-up|1|||
48319399|NCT00419341|155369515|FG000|Efficacy Period|Non-compliance|1|||
48319400|NCT00419341|155369515|FG000|Efficacy Period|Termination of study site|1|||
48319401|NCT02730871|155369519|FG000|Overall Study|Adverse Event|6|||
48319402|NCT02730871|155369520|FG001|Overall Study|Adverse Event|0|||
48319403|NCT03582722|155369525|FG000|Overall Study|Lost to Follow-up|1|||
48319404|NCT03582722|155369526|FG001|Overall Study|Lost to Follow-up|4|||
48319405|NCT03582722|155369525|FG000|Overall Study|Withdrawal by Subject|3|||
48319406|NCT03582722|155369526|FG001|Overall Study|Withdrawal by Subject|3|||
48319407|NCT03086369|155370974|FG000|Overall Study|Lost to Follow-up|1|||
48319408|NCT03086369|155370975|FG001|Overall Study|Lost to Follow-up|0|||
48319409|NCT03086369|155370976|FG002|Overall Study|Lost to Follow-up|0|||
48319410|NCT03086369|155370977|FG003|Overall Study|Lost to Follow-up|2|||
48319411|NCT03086369|155370978|FG004|Overall Study|Lost to Follow-up|1|||
48319412|NCT03086369|155370974|FG000|Overall Study|Physician Decision|0|||
48319413|NCT03086369|155370975|FG001|Overall Study|Physician Decision|0|||
48319414|NCT03086369|155370976|FG002|Overall Study|Physician Decision|0|||
48319415|NCT03086369|155370977|FG003|Overall Study|Physician Decision|1|||
48319416|NCT03086369|155370978|FG004|Overall Study|Physician Decision|2|||
48319417|NCT03086369|155370974|FG000|Overall Study|Withdrawal by Subject|0|||
48319418|NCT03086369|155370975|FG001|Overall Study|Withdrawal by Subject|0|||
48319419|NCT03086369|155370976|FG002|Overall Study|Withdrawal by Subject|0|||
48319420|NCT03086369|155370977|FG003|Overall Study|Withdrawal by Subject|5|||
48319421|NCT03086369|155370978|FG004|Overall Study|Withdrawal by Subject|3|||
48319422|NCT03086369|155370974|FG000|Overall Study|Progressive Disease|0|||
48319423|NCT03086369|155370975|FG001|Overall Study|Progressive Disease|0|||
48319424|NCT03086369|155370976|FG002|Overall Study|Progressive Disease|0|||
48319425|NCT03086369|155370977|FG003|Overall Study|Progressive Disease|1|||
48319426|NCT03086369|155370978|FG004|Overall Study|Progressive Disease|1|||
48319427|NCT01823536|155370979|FG000|Overall Study|Lost to Follow-up|1|||
48319428|NCT01823536|155370980|FG001|Overall Study|Lost to Follow-up|0|||
48319429|NCT01823536|155370981|FG002|Overall Study|Lost to Follow-up|0|||
48319430|NCT01823536|155370982|FG003|Overall Study|Lost to Follow-up|1|||
48319431|NCT01823536|155370983|FG004|Overall Study|Lost to Follow-up|1|||
48319432|NCT01823536|155370984|FG005|Overall Study|Lost to Follow-up|0|||
48319433|NCT01823536|155370979|FG000|Overall Study|Protocol Violation|0|||
48319434|NCT01823536|155370980|FG001|Overall Study|Protocol Violation|1|||
48319435|NCT01823536|155370981|FG002|Overall Study|Protocol Violation|0|||
48319436|NCT01823536|155370982|FG003|Overall Study|Protocol Violation|0|||
48319437|NCT01823536|155370983|FG004|Overall Study|Protocol Violation|0|||
48319438|NCT01823536|155370984|FG005|Overall Study|Protocol Violation|0|||
48319439|NCT01823536|155370979|FG000|Overall Study|Withdrawal by Subject|1|||
48319440|NCT01823536|155370980|FG001|Overall Study|Withdrawal by Subject|1|||
48319441|NCT01823536|155370981|FG002|Overall Study|Withdrawal by Subject|0|||
48575215|NCT00652626|156296242|FG003|Extension Phase|Withdrawal by Subject|0|||
48319442|NCT01823536|155370982|FG003|Overall Study|Withdrawal by Subject|0|||
48319443|NCT01823536|155370983|FG004|Overall Study|Withdrawal by Subject|0|||
48319444|NCT01823536|155370984|FG005|Overall Study|Withdrawal by Subject|0|||
48319445|NCT01823536|155370979|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48319446|NCT01823536|155370980|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48319447|NCT01823536|155370981|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
48319448|NCT01823536|155370982|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48575216|NCT00652626|156296243|FG004|Extension Phase|Withdrawal by Subject|0|||
48575217|NCT00652626|156296244|FG005|Extension Phase|Withdrawal by Subject|2|||
48575218|NCT00652626|156296245|FG006|Extension Phase|Withdrawal by Subject|0|||
48575219|NCT00652626|156296239|FG000|Extension Phase|Adverse Event|0|||
48575220|NCT00652626|156296240|FG001|Extension Phase|Adverse Event|0|||
48575221|NCT00652626|156296241|FG002|Extension Phase|Adverse Event|0|||
48575222|NCT00652626|156296242|FG003|Extension Phase|Adverse Event|0|||
48575223|NCT00652626|156296243|FG004|Extension Phase|Adverse Event|0|||
48575224|NCT00652626|156296244|FG005|Extension Phase|Adverse Event|2|||
48575225|NCT00652626|156296245|FG006|Extension Phase|Adverse Event|1|||
48575226|NCT00652626|156296239|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
48319449|NCT01823536|155370983|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48319450|NCT01823536|155370984|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
48319451|NCT01823536|155370979|FG000|Overall Study|Met exclusion criterion No 6|0|||
48319452|NCT01823536|155370980|FG001|Overall Study|Met exclusion criterion No 6|0|||
48450057|NCT01614795|155835558|FG001|Overall Study|Lack of Efficacy|10|||
48319453|NCT01823536|155370981|FG002|Overall Study|Met exclusion criterion No 6|0|||
48575227|NCT00652626|156296240|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
48575228|NCT00652626|156296241|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
48575229|NCT00652626|156296242|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
48575230|NCT00652626|156296243|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
48575231|NCT00652626|156296244|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
48575232|NCT00652626|156296245|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
48575233|NCT00652626|156296239|FG000|Extension Phase|Physician Decision|0|||
48575234|NCT00652626|156296240|FG001|Extension Phase|Physician Decision|0|||
48575235|NCT00652626|156296241|FG002|Extension Phase|Physician Decision|0|||
48575236|NCT00652626|156296242|FG003|Extension Phase|Physician Decision|0|||
48575237|NCT00652626|156296243|FG004|Extension Phase|Physician Decision|0|||
48575238|NCT00652626|156296244|FG005|Extension Phase|Physician Decision|1|||
48575239|NCT00652626|156296245|FG006|Extension Phase|Physician Decision|1|||
48575240|NCT00652626|156296239|FG000|Extension Phase|Death|0|||
48575241|NCT00652626|156296240|FG001|Extension Phase|Death|0|||
48575242|NCT00652626|156296241|FG002|Extension Phase|Death|0|||
48575243|NCT00652626|156296242|FG003|Extension Phase|Death|0|||
48575244|NCT00652626|156296243|FG004|Extension Phase|Death|0|||
48575245|NCT00652626|156296244|FG005|Extension Phase|Death|1|||
48575246|NCT00652626|156296245|FG006|Extension Phase|Death|1|||
48575247|NCT00068393|156296257|FG000|Overall Study|Adverse Event|2|||
48575248|NCT00068393|156296257|FG000|Overall Study|Death|3|||
48575249|NCT00068393|156296257|FG000|Overall Study|Withdrawal by Subject|3|||
48575250|NCT00068393|156296257|FG000|Overall Study|Alternative treatment|1|||
48575251|NCT00068393|156296257|FG000|Overall Study|Quality of life worsening|1|||
48575252|NCT03379753|156296260|FG000|Overall Study|Withdrawal by Subject|2|||
48575253|NCT03379753|156296261|FG001|Overall Study|Withdrawal by Subject|1|||
48575254|NCT03379753|156296260|FG000|Overall Study|not having correct procedure|1|||
48575255|NCT03379753|156296261|FG001|Overall Study|not having correct procedure|2|||
48575256|NCT03379753|156296260|FG000|Overall Study|No primary outcome|12|||
48575257|NCT03379753|156296261|FG001|Overall Study|No primary outcome|22|||
48575258|NCT00601172|156297788|FG000|Overall Study|Adverse Event|43|||
48575259|NCT00601172|156297789|FG001|Overall Study|Adverse Event|32|||
48575260|NCT00601172|156297788|FG000|Overall Study|Lack of Efficacy|11|||
48575261|NCT00601172|156297789|FG001|Overall Study|Lack of Efficacy|12|||
48575262|NCT00601172|156297788|FG000|Overall Study|Protocol Violation|2|||
48575263|NCT00601172|156297789|FG001|Overall Study|Protocol Violation|5|||
48319454|NCT01823536|155370982|FG003|Overall Study|Met exclusion criterion No 6|1|||
48319455|NCT01823536|155370983|FG004|Overall Study|Met exclusion criterion No 6|0|||
48319456|NCT01823536|155370984|FG005|Overall Study|Met exclusion criterion No 6|0|||
48319457|NCT01823536|155370979|FG000|Overall Study|Subject moved out of the state|0|||
48319458|NCT01823536|155370980|FG001|Overall Study|Subject moved out of the state|0|||
48319459|NCT01823536|155370981|FG002|Overall Study|Subject moved out of the state|0|||
48319460|NCT01823536|155370982|FG003|Overall Study|Subject moved out of the state|0|||
48319461|NCT01823536|155370983|FG004|Overall Study|Subject moved out of the state|1|||
48319462|NCT01823536|155370984|FG005|Overall Study|Subject moved out of the state|0|||
48319463|NCT03175172|155370986|FG000|Overall Study|Death|3|||
48319464|NCT03175172|155370986|FG000|Overall Study|Withdrawal by Subject|3|||
48319465|NCT03175172|155370986|FG000|Overall Study|Lost to Follow-up|1|||
48319466|NCT03175172|155370986|FG000|Overall Study|Study Terminated by Sponsor|3|||
48319467|NCT02411084|155370987|FG000|Overall Study|Lack of Efficacy|6|||
48319468|NCT02411084|155370988|FG001|Overall Study|Lack of Efficacy|3|||
48319469|NCT02411084|155370987|FG000|Overall Study|Death|5|||
48319470|NCT02411084|155370988|FG001|Overall Study|Death|4|||
48319471|NCT02411084|155370987|FG000|Overall Study|Adverse Event|2|||
48319472|NCT02411084|155370988|FG001|Overall Study|Adverse Event|1|||
48319473|NCT02411084|155370987|FG000|Overall Study|Other reasons|0|||
48319474|NCT02411084|155370988|FG001|Overall Study|Other reasons|5|||
48319475|NCT00686855|155370991|FG000|Overall Study|Lost to Follow-up|1|||
48575264|NCT00601172|156297788|FG000|Overall Study|Lost to Follow-up|4|||
48575265|NCT00601172|156297789|FG001|Overall Study|Lost to Follow-up|3|||
48319476|NCT00686855|155370992|FG001|Overall Study|Lost to Follow-up|0|||
48319477|NCT00686855|155370991|FG000|Overall Study|Progressive GVHD|0|||
48319478|NCT00686855|155370992|FG001|Overall Study|Progressive GVHD|1|||
48575266|NCT00601172|156297788|FG000|Overall Study|Physician Decision|27|||
48319479|NCT00610649|155370998|FG000|Overall Study|Adverse Event|1|||
48319480|NCT00610649|155370999|FG001|Overall Study|Adverse Event|0|||
48319481|NCT00610649|155371000|FG002|Overall Study|Adverse Event|0|||
48575267|NCT00601172|156297789|FG001|Overall Study|Physician Decision|28|||
48319482|NCT00610649|155371001|FG003|Overall Study|Adverse Event|0|||
48319483|NCT00610649|155371002|FG004|Overall Study|Adverse Event|0|||
48319484|NCT00610649|155371003|FG005|Overall Study|Adverse Event|0|||
48575268|NCT00601172|156297788|FG000|Overall Study|Withdrawal by Subject|35|||
48575269|NCT00601172|156297789|FG001|Overall Study|Withdrawal by Subject|27|||
48575270|NCT00601172|156297788|FG000|Overall Study|Did not meet continuation criteria|19|||
48575271|NCT00601172|156297789|FG001|Overall Study|Did not meet continuation criteria|20|||
48621185|NCT01471574|156471590|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
48575272|NCT00956592|156297794|FG000|Overall Study|Protocol Violation|1|||
48575273|NCT00956592|156297795|FG001|Overall Study|Protocol Violation|3|||
48575274|NCT01190410|156297796|FG000|Overall Study|Adverse Event|0|||
48575275|NCT01190410|156297797|FG001|Overall Study|Adverse Event|3|||
48575276|NCT01190410|156297796|FG000|Overall Study|Lack of Efficacy|0|||
48575277|NCT01190410|156297797|FG001|Overall Study|Lack of Efficacy|2|||
48575278|NCT01190410|156297796|FG000|Overall Study|Withdrawal by Subject|0|||
48575279|NCT01190410|156297797|FG001|Overall Study|Withdrawal by Subject|2|||
48575280|NCT01190410|156297796|FG000|Overall Study|Administrative decision|1|||
48575281|NCT01190410|156297797|FG001|Overall Study|Administrative decision|0|||
48575282|NCT01190410|156297796|FG000|Overall Study|PI discretion|0|||
48575283|NCT01190410|156297797|FG001|Overall Study|PI discretion|2|||
48575284|NCT00231114|156297798|FG000|Randomized|Withdrawal by Subject|6|||
48575285|NCT00231114|156297799|FG001|Randomized|Withdrawal by Subject|3|||
48575286|NCT00231114|156297798|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
48621186|NCT01471574|156471591|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
48621187|NCT01471574|156471592|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
48621188|NCT01471574|156471593|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
48621189|NCT01471574|156471590|FG000|Treatment Period|Other|1|||
48621190|NCT01471574|156471591|FG001|Treatment Period|Other|0|||
48621191|NCT01471574|156471592|FG002|Treatment Period|Other|0|||
48621192|NCT01471574|156471593|FG003|Treatment Period|Other|0|||
48621193|NCT01471574|156471590|FG000|Follow-up Period|Withdrawal by Subject|3|||
48621194|NCT01471574|156471591|FG001|Follow-up Period|Withdrawal by Subject|0|||
48621195|NCT01471574|156471592|FG002|Follow-up Period|Withdrawal by Subject|3|||
48621196|NCT01471574|156471593|FG003|Follow-up Period|Withdrawal by Subject|1|||
48621197|NCT01471574|156471590|FG000|Follow-up Period|Lost to Follow-up|4|||
48621198|NCT01471574|156471591|FG001|Follow-up Period|Lost to Follow-up|1|||
48621199|NCT01471574|156471592|FG002|Follow-up Period|Lost to Follow-up|3|||
48621200|NCT01471574|156471593|FG003|Follow-up Period|Lost to Follow-up|2|||
48621201|NCT01471574|156471590|FG000|Follow-up Period|Death|0|||
48621202|NCT01471574|156471591|FG001|Follow-up Period|Death|0|||
48621203|NCT01471574|156471592|FG002|Follow-up Period|Death|1|||
48621204|NCT01471574|156471593|FG003|Follow-up Period|Death|0|||
48621205|NCT01471574|156471590|FG000|Follow-up Period|Follow-up no longer required|0|||
48621206|NCT01471574|156471591|FG001|Follow-up Period|Follow-up no longer required|1|||
48621207|NCT01471574|156471592|FG002|Follow-up Period|Follow-up no longer required|0|||
48621208|NCT01471574|156471593|FG003|Follow-up Period|Follow-up no longer required|0|||
48621209|NCT01795937|156471594|FG000|Overall Study|Withdrawal by Subject|1|||
48621210|NCT01795937|156471595|FG001|Overall Study|Withdrawal by Subject|0|||
48621211|NCT01795937|156471596|FG002|Overall Study|Withdrawal by Subject|0|||
48621212|NCT01795937|156471594|FG000|Overall Study|Physician Decision|0|||
48621213|NCT01795937|156471595|FG001|Overall Study|Physician Decision|1|||
48621214|NCT01795937|156471596|FG002|Overall Study|Physician Decision|0|||
48621215|NCT01783015|156471600|FG000|Blinded Treatment|Adverse Event|0|||
48621216|NCT01783015|156471601|FG001|Blinded Treatment|Adverse Event|1|||
48621217|NCT01783015|156471602|FG002|Blinded Treatment|Adverse Event|0|||
48621218|NCT01783015|156471600|FG000|Blinded Treatment|Protocol Violation|0|||
48621219|NCT01783015|156471601|FG001|Blinded Treatment|Protocol Violation|1|||
48621220|NCT01783015|156471602|FG002|Blinded Treatment|Protocol Violation|0|||
48621221|NCT01783015|156471600|FG000|Blinded Treatment|Withdrawal by Subject|0|||
48621222|NCT01783015|156471601|FG001|Blinded Treatment|Withdrawal by Subject|1|||
48621223|NCT01783015|156471602|FG002|Blinded Treatment|Withdrawal by Subject|0|||
48621224|NCT01783015|156471600|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
48621225|NCT01783015|156471601|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
48621226|NCT01783015|156471602|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
48621227|NCT01783015|156471600|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
48621228|NCT01783015|156471601|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
48621229|NCT01783015|156471602|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
48621230|NCT03558672|156471605|FG000|Overall Study|Study Early Termination|10|||
48621231|NCT01529112|156471606|FG000|Overall Study|Adverse Event|2|||
48621232|NCT01529112|156471607|FG001|Overall Study|Adverse Event|0|||
48621233|NCT01529112|156471606|FG000|Overall Study|Death|59|||
48621234|NCT01529112|156471607|FG001|Overall Study|Death|38|||
48575287|NCT00231114|156297799|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
48621235|NCT01529112|156471606|FG000|Overall Study|Protocol Violation|1|||
48621236|NCT01529112|156471607|FG001|Overall Study|Protocol Violation|0|||
48621237|NCT01529112|156471606|FG000|Overall Study|Withdrawal by Subject|7|||
48575288|NCT00231114|156297798|FG000|Post-Treatment Period|Lost to Follow-up|6|||
48575289|NCT00231114|156297799|FG001|Post-Treatment Period|Lost to Follow-up|1|||
48575290|NCT00231114|156297798|FG000|Post-Treatment Period|Physician Decision|1|||
48621238|NCT01529112|156471607|FG001|Overall Study|Withdrawal by Subject|3|||
48621239|NCT03607695|156471608|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
48621240|NCT03607695|156471608|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
48621241|NCT00574951|156471613|FG000|Overall Study|Ineligible - improper prior treatment|1|||
48621242|NCT00585585|156471614|FG000|Overall Study|Adverse Event|1|||
48621243|NCT01530256|156471615|FG000|Overall Study|Death|2|||
48621244|NCT00153920|156471616|FG000|Overall Study|Adverse Event|9|||
48621245|NCT00153920|156471616|FG000|Overall Study|Progressive Disease|9|||
48621246|NCT00153920|156471616|FG000|Overall Study|Physician Decision|3|||
48621247|NCT00153920|156471616|FG000|Overall Study|Lack of Response|3|||
48319485|NCT00610649|155371004|FG006|Overall Study|Adverse Event|0|||
48575291|NCT00231114|156297799|FG001|Post-Treatment Period|Physician Decision|0|||
48621248|NCT00153920|156471616|FG000|Overall Study|Death|2|||
48621249|NCT00153920|156471616|FG000|Overall Study|Withdrawal by Subject|1|||
48575292|NCT00231114|156297798|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
48575293|NCT00231114|156297799|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
48575294|NCT04429555|156297800|FG000|Overall Study|Death|0|||
48575295|NCT04429555|156297801|FG001|Overall Study|Death|2|||
48575296|NCT04429555|156297800|FG000|Overall Study|Other|2|||
48575297|NCT04429555|156297801|FG001|Overall Study|Other|0|||
48575298|NCT02693106|156297805|FG000|Overall Study|No time|3|||
48575299|NCT03981900|156297806|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
48575300|NCT03981900|156297806|FG000|Overall Study|Adverse Event|5|||
48575301|NCT03981900|156297806|FG000|Overall Study|Protocol Violation|1|||
48575302|NCT03981900|156297806|FG000|Overall Study|Withdrawal by Subject|7|||
48575303|NCT03981900|156297806|FG000|Overall Study|Lost to Follow-up|46|||
48575304|NCT03981900|156297806|FG000|Overall Study|Decision of the researcher|3|||
48575305|NCT03981900|156297806|FG000|Overall Study|Death|3|||
48575306|NCT03981900|156297806|FG000|Overall Study|Other|5|||
48575307|NCT05481125|156297808|FG000|Overall Study|Adverse Event|1|||
48575308|NCT05481125|156297809|FG001|Overall Study|Adverse Event|0|||
48575309|NCT05481125|156297808|FG000|Overall Study|Lost to Follow-up|0|||
48575310|NCT05481125|156297809|FG001|Overall Study|Lost to Follow-up|1|||
48575311|NCT05481125|156297808|FG000|Overall Study|Withdrawal by Subject|0|||
48575312|NCT05481125|156297809|FG001|Overall Study|Withdrawal by Subject|1|||
48575313|NCT02244463|156297812|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
48575314|NCT02244463|156297813|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
48575315|NCT02244463|156297814|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
48575316|NCT02244463|156297815|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
48575317|NCT02244463|156297816|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
48575318|NCT02244463|156297817|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
48575319|NCT02244463|156297812|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
48575320|NCT02244463|156297813|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
48575321|NCT02244463|156297814|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
48575322|NCT02244463|156297815|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
48575323|NCT02244463|156297816|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
48575324|NCT02244463|156297817|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
48575325|NCT02244463|156297812|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
48575326|NCT02244463|156297813|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
48575327|NCT02244463|156297814|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
48575328|NCT02244463|156297815|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
48575329|NCT02244463|156297816|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
48575330|NCT02244463|156297817|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
48575331|NCT02244463|156297812|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
48575332|NCT02244463|156297813|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
48575333|NCT02244463|156297814|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
48575334|NCT02244463|156297815|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
48575335|NCT02244463|156297816|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
48575336|NCT02244463|156297817|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
48575337|NCT02244463|156297812|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
48575338|NCT02244463|156297813|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
48575339|NCT02244463|156297814|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
48575340|NCT02244463|156297815|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
48575341|NCT02244463|156297816|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
48575342|NCT02244463|156297817|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
48575343|NCT02244463|156297812|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
48575344|NCT02244463|156297813|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
48575345|NCT02244463|156297814|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
48575346|NCT02244463|156297815|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
48575347|NCT02244463|156297816|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
48575348|NCT02244463|156297817|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
48575349|NCT02244463|156297812|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
48575350|NCT02244463|156297813|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
48621250|NCT00153920|156471616|FG000|Overall Study|Non-Protocol Therapy|1|||
48621251|NCT00153920|156471616|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
48575351|NCT02244463|156297814|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
48575352|NCT02244463|156297815|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
48575353|NCT02244463|156297816|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
48575354|NCT02244463|156297817|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
48575355|NCT02244463|156297812|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
48575356|NCT02244463|156297813|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
48575357|NCT02244463|156297814|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
48575358|NCT02244463|156297815|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
48575359|NCT02244463|156297816|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
48575360|NCT02244463|156297817|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
48575361|NCT02244463|156297812|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
48575362|NCT02244463|156297813|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
48575363|NCT02244463|156297814|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
48575364|NCT02244463|156297815|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
48575365|NCT02244463|156297816|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
48575366|NCT02244463|156297817|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
48575367|NCT02244463|156297812|FG000|Period 5: Phase II|Disease Progression|0|||
48575368|NCT02244463|156297813|FG001|Period 5: Phase II|Disease Progression|0|||
48575369|NCT02244463|156297814|FG002|Period 5: Phase II|Disease Progression|0|||
48575370|NCT02244463|156297815|FG003|Period 5: Phase II|Disease Progression|0|||
48575371|NCT02244463|156297816|FG004|Period 5: Phase II|Disease Progression|10|||
48575372|NCT02244463|156297817|FG005|Period 5: Phase II|Disease Progression|11|||
48575373|NCT02244463|156297812|FG000|Period 5: Phase II|Physician Decision|0|||
48575374|NCT02244463|156297813|FG001|Period 5: Phase II|Physician Decision|0|||
48575375|NCT02244463|156297814|FG002|Period 5: Phase II|Physician Decision|0|||
48575376|NCT02244463|156297815|FG003|Period 5: Phase II|Physician Decision|0|||
48575377|NCT02244463|156297816|FG004|Period 5: Phase II|Physician Decision|3|||
48575378|NCT02244463|156297817|FG005|Period 5: Phase II|Physician Decision|2|||
48575379|NCT02244463|156297812|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
48575380|NCT02244463|156297813|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
48575381|NCT02244463|156297814|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
48575382|NCT02244463|156297815|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
48575383|NCT02244463|156297816|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
48575384|NCT02244463|156297817|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
48575385|NCT02244463|156297812|FG000|Period 5: Phase II|Intercurrent Illness|0|||
48621252|NCT00153920|156471616|FG000|Overall Study|Progressive Disease before Trt|1|||
48621253|NCT00500110|156471620|FG000|Overall Study|Withdrawal by Subject|3|||
48621254|NCT03446573|156471621|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
48621255|NCT03446573|156471622|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
48621256|NCT03446573|156471621|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
48621257|NCT03446573|156471622|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
48621258|NCT03446573|156471621|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
48621259|NCT03446573|156471622|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
48621260|NCT03446573|156471621|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
48621261|NCT03446573|156471622|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
48621262|NCT03446573|156471621|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
48621263|NCT03446573|156471622|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
48621264|NCT03446573|156471621|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
48621265|NCT03446573|156471622|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
48621266|NCT03446573|156471621|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
48621267|NCT03446573|156471622|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
48621268|NCT03446573|156471621|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
48621269|NCT03446573|156471622|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
48621270|NCT03446573|156471621|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
48621271|NCT03446573|156471622|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
48621272|NCT03446573|156471621|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
48621273|NCT03446573|156471622|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
48621274|NCT03446573|156471621|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
48621275|NCT03446573|156471622|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
48621276|NCT03446573|156471621|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
48621277|NCT03446573|156471622|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
48736043|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
48736044|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
48736045|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
48736046|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
48575386|NCT02244463|156297813|FG001|Period 5: Phase II|Intercurrent Illness|0|||
48575387|NCT02244463|156297814|FG002|Period 5: Phase II|Intercurrent Illness|0|||
48575388|NCT02244463|156297815|FG003|Period 5: Phase II|Intercurrent Illness|0|||
48575389|NCT02244463|156297816|FG004|Period 5: Phase II|Intercurrent Illness|2|||
48575390|NCT02244463|156297817|FG005|Period 5: Phase II|Intercurrent Illness|0|||
48575391|NCT02244463|156297812|FG000|Period 5: Phase II|Adverse Event|0|||
48575392|NCT02244463|156297813|FG001|Period 5: Phase II|Adverse Event|0|||
48575393|NCT02244463|156297814|FG002|Period 5: Phase II|Adverse Event|0|||
48575394|NCT02244463|156297815|FG003|Period 5: Phase II|Adverse Event|0|||
48575395|NCT02244463|156297816|FG004|Period 5: Phase II|Adverse Event|0|||
48575396|NCT02244463|156297817|FG005|Period 5: Phase II|Adverse Event|2|||
48575397|NCT02244463|156297812|FG000|Period 5: Phase II|Still On treatment|0|||
48575398|NCT02244463|156297813|FG001|Period 5: Phase II|Still On treatment|0|||
48575399|NCT02244463|156297814|FG002|Period 5: Phase II|Still On treatment|0|||
48575400|NCT02244463|156297815|FG003|Period 5: Phase II|Still On treatment|0|||
48575401|NCT02244463|156297816|FG004|Period 5: Phase II|Still On treatment|0|||
48575402|NCT02244463|156297817|FG005|Period 5: Phase II|Still On treatment|3|||
48575403|NCT03702010|156297818|FG000|Follow-up (30days)|Lack of Efficacy|2|||
48575404|NCT03702010|156297819|FG001|Follow-up (30days)|Lack of Efficacy|2|||
48575405|NCT03843541|156297820|FG000|Overall Study|Adverse Event|4|||
48575406|NCT03843541|156297821|FG001|Overall Study|Adverse Event|2|||
48319486|NCT00610649|155371005|FG007|Overall Study|Adverse Event|0|||
48319487|NCT00610649|155371006|FG008|Overall Study|Adverse Event|0|||
48319488|NCT00610649|155371007|FG009|Overall Study|Adverse Event|0|||
48319489|NCT00610649|155371008|FG010|Overall Study|Adverse Event|1|||
48319490|NCT00610649|155370998|FG000|Overall Study|Family Emergency|0|||
48319491|NCT00610649|155370999|FG001|Overall Study|Family Emergency|1|||
48319492|NCT00610649|155371000|FG002|Overall Study|Family Emergency|0|||
48319493|NCT00610649|155371001|FG003|Overall Study|Family Emergency|0|||
48319494|NCT00610649|155371002|FG004|Overall Study|Family Emergency|0|||
48319495|NCT00610649|155371003|FG005|Overall Study|Family Emergency|0|||
48319496|NCT00610649|155371004|FG006|Overall Study|Family Emergency|0|||
48319497|NCT00610649|155371005|FG007|Overall Study|Family Emergency|0|||
48319498|NCT00610649|155371006|FG008|Overall Study|Family Emergency|0|||
48319499|NCT00610649|155371007|FG009|Overall Study|Family Emergency|0|||
48319500|NCT00610649|155371008|FG010|Overall Study|Family Emergency|0|||
48319501|NCT00610649|155370998|FG000|Overall Study|Withdrawal by Subject|0|||
48319502|NCT00610649|155370999|FG001|Overall Study|Withdrawal by Subject|0|||
48319503|NCT00610649|155371000|FG002|Overall Study|Withdrawal by Subject|0|||
48319504|NCT00610649|155371001|FG003|Overall Study|Withdrawal by Subject|0|||
48319505|NCT00610649|155371002|FG004|Overall Study|Withdrawal by Subject|0|||
48319506|NCT00610649|155371003|FG005|Overall Study|Withdrawal by Subject|0|||
48319507|NCT00610649|155371004|FG006|Overall Study|Withdrawal by Subject|0|||
48319508|NCT00610649|155371005|FG007|Overall Study|Withdrawal by Subject|0|||
48319509|NCT00610649|155371006|FG008|Overall Study|Withdrawal by Subject|0|||
48319510|NCT00610649|155371007|FG009|Overall Study|Withdrawal by Subject|1|||
48319511|NCT00610649|155371008|FG010|Overall Study|Withdrawal by Subject|0|||
48319512|NCT04252586|155371011|FG000|Overall Study|Withdrawal by parent/guardian|3|||
48575407|NCT03843541|156297822|FG002|Overall Study|Adverse Event|3|||
48575408|NCT03843541|156297820|FG000|Overall Study|Death|1|||
48575409|NCT03843541|156297821|FG001|Overall Study|Death|0|||
48575410|NCT03843541|156297822|FG002|Overall Study|Death|0|||
48319513|NCT04252586|155371011|FG000|Overall Study|Adverse Event|1|||
48575411|NCT03843541|156297820|FG000|Overall Study|Lack of adherence to study medication|0|||
48575412|NCT03843541|156297821|FG001|Overall Study|Lack of adherence to study medication|0|||
48575413|NCT03843541|156297822|FG002|Overall Study|Lack of adherence to study medication|1|||
48575414|NCT03843541|156297820|FG000|Overall Study|Physician Decision|1|||
48575415|NCT03843541|156297821|FG001|Overall Study|Physician Decision|2|||
48575416|NCT03843541|156297822|FG002|Overall Study|Physician Decision|2|||
48575417|NCT03843541|156297820|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
48575418|NCT03843541|156297821|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
48575419|NCT03843541|156297822|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
48319514|NCT04252586|155371011|FG000|Overall Study|Death|2|||
48319515|NCT04252586|155371011|FG000|Overall Study|Study terminated by sponsor|4|||
48319516|NCT04252586|155371011|FG000|Overall Study|Sponsor request|10|||
48450058|NCT01614795|155835559|FG002|Overall Study|Lack of Efficacy|9|||
48319517|NCT04252586|155371011|FG000|Overall Study|Did not complete treatment period|1|||
48319518|NCT00232180|155371012|FG000|Double-blind (DB) Phase|Death|186|||
48575420|NCT03843541|156297820|FG000|Overall Study|Withdrawal by Subject|6|||
48575421|NCT03843541|156297821|FG001|Overall Study|Withdrawal by Subject|9|||
48575422|NCT03843541|156297822|FG002|Overall Study|Withdrawal by Subject|7|||
48575423|NCT03843541|156297820|FG000|Overall Study|Administration of rescue mucolytic|0|||
48575424|NCT03843541|156297821|FG001|Overall Study|Administration of rescue mucolytic|0|||
48575425|NCT03843541|156297822|FG002|Overall Study|Administration of rescue mucolytic|1|||
48575426|NCT03843541|156297820|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
48575427|NCT03843541|156297821|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
48575428|NCT03843541|156297822|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
48575429|NCT00637000|156297836|FG000|Overall Study|Withdrawal by Subject|4|||
48575430|NCT00637000|156297837|FG001|Overall Study|Withdrawal by Subject|3|||
48575431|NCT02295020|156297847|FG000|Overall Study|Adverse Event|0|||
48575432|NCT02295020|156297848|FG001|Overall Study|Adverse Event|1|||
48575433|NCT02295020|156297847|FG000|Overall Study|Withdrawal by Subject|3|||
48575434|NCT02295020|156297848|FG001|Overall Study|Withdrawal by Subject|2|||
48575435|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
48575436|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
48575437|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
48575438|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
48575439|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
48575440|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
48575441|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
48575442|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
48575443|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
48575444|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
48575445|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
48575446|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
48575447|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
48575448|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
48575449|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
48575450|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
48575451|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
48575452|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
48575453|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
48575454|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
48575455|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
48575456|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
48575457|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
48575458|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
48575459|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
48575460|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
48575461|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
48575462|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
48575463|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
48575464|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
48575465|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
48575466|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
48575467|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
48621278|NCT03446573|156471621|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
48621279|NCT03446573|156471622|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
48621280|NCT00378560|156471623|FG000|Overall Study|Adverse Event|1|||
48621281|NCT00378560|156471624|FG001|Overall Study|Adverse Event|0|||
48621282|NCT00378560|156471623|FG000|Overall Study|Lost to Follow-up|24|||
48621283|NCT00378560|156471624|FG001|Overall Study|Lost to Follow-up|29|||
48621284|NCT00378560|156471623|FG000|Overall Study|Protocol Violation|2|||
48621285|NCT00378560|156471624|FG001|Overall Study|Protocol Violation|0|||
48621286|NCT00378560|156471623|FG000|Overall Study|Withdrawal by Subject|17|||
48621287|NCT00378560|156471624|FG001|Overall Study|Withdrawal by Subject|21|||
48621288|NCT00378560|156471623|FG000|Overall Study|Moved|4|||
48621289|NCT00378560|156471624|FG001|Overall Study|Moved|3|||
48621290|NCT00378560|156471623|FG000|Overall Study|Pregnancy|7|||
48621291|NCT00378560|156471624|FG001|Overall Study|Pregnancy|5|||
48621292|NCT00378560|156471623|FG000|Overall Study|Laboratory test values abnormal|1|||
48575468|NCT00839527|156297849|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
48621293|NCT00378560|156471624|FG001|Overall Study|Laboratory test values abnormal|0|||
48621294|NCT00976391|156471625|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
48621295|NCT00976391|156471626|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
48575469|NCT00839527|156297850|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
48575470|NCT00839527|156297851|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
48575471|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
48575472|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
48575473|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
48319519|NCT00232180|155371013|FG001|Double-blind (DB) Phase|Death|222|||
48319520|NCT00232180|155371014|FG002|Double-blind (DB) Phase|Death|0|||
48319521|NCT00232180|155371012|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
48319522|NCT00232180|155371013|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
48319523|NCT00232180|155371014|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
48319524|NCT00232180|155371012|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
48575474|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
48575475|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
48575476|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
48575477|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
48575478|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
48575479|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
48575480|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
48575481|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
48575482|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
48575483|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
48575484|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
48575485|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
48575486|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
48575487|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
48575488|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
48575489|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
48575490|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
48575491|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
48575492|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
48575493|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
48575494|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
48575495|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
48575496|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
48575497|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
48575498|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
48575499|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
48575500|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
48575501|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
48575502|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
48575503|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
48621296|NCT00976391|156471625|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
48621297|NCT00976391|156471626|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
48621298|NCT00976391|156471625|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
48621299|NCT00976391|156471626|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
48621300|NCT00976391|156471625|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
48621301|NCT00976391|156471626|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
48621302|NCT00976391|156471625|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
48621303|NCT00976391|156471626|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
48621304|NCT00976391|156471625|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
48621305|NCT00976391|156471626|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
48319525|NCT00232180|155371013|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
48319526|NCT00232180|155371014|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
48319527|NCT00232180|155371012|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
48575504|NCT00839527|156297849|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
48575505|NCT00839527|156297850|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
48575506|NCT00839527|156297851|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
48575507|NCT04481789|156297853|FG000|Period 1|Withdrawal by Subject|1|||
48575508|NCT04481789|156297854|FG001|Period 1|Withdrawal by Subject|0|||
48575509|NCT04481789|156297855|FG002|Period 1|Withdrawal by Subject|0|||
48575510|NCT04481789|156297856|FG003|Period 1|Withdrawal by Subject|0|||
48575511|NCT04481789|156297857|FG004|Period 1|Withdrawal by Subject|0|||
48575512|NCT04481789|156297858|FG005|Period 1|Withdrawal by Subject|0|||
48575513|NCT02291601|156297859|FG000|Abdomen|Did not qualify|333|||
48575514|NCT02291601|156297860|FG001|Abdomen|Did not qualify|54|||
48575515|NCT02291601|156297861|FG002|Abdomen|Did not qualify|339|||
48575516|NCT02291601|156297859|FG000|Groin|Did not qualify|183|||
48575517|NCT02291601|156297860|FG001|Groin|Did not qualify|30|||
48575518|NCT02291601|156297861|FG002|Groin|Did not qualify|177|||
48575519|NCT03261674|156297862|FG000|Overall Study|Lost to Follow-up|6|||
48575520|NCT03261674|156297863|FG001|Overall Study|Lost to Follow-up|7|||
48575521|NCT03261674|156297862|FG000|Overall Study|Protocol Violation|1|||
48575522|NCT03261674|156297863|FG001|Overall Study|Protocol Violation|4|||
48575523|NCT03261674|156297862|FG000|Overall Study|Withdrawal by Subject|1|||
48575524|NCT03261674|156297863|FG001|Overall Study|Withdrawal by Subject|4|||
48575525|NCT03261674|156297862|FG000|Overall Study|Physician Decision|1|||
48575526|NCT03261674|156297863|FG001|Overall Study|Physician Decision|0|||
48575527|NCT02751450|156297864|FG000|Overall Study|Adverse Event|1|||
48575528|NCT02751450|156297865|FG001|Overall Study|Adverse Event|0|||
48575529|NCT01137110|156297866|FG000|Overall Study|Protocol Violation|1|||
48575530|NCT01137110|156297867|FG001|Overall Study|Protocol Violation|0|||
48575531|NCT00562302|156297868|FG000|Overall Study|Lost to Follow-up|3|||
48575532|NCT00562302|156297869|FG001|Overall Study|Lost to Follow-up|3|||
48575533|NCT00562302|156297868|FG000|Overall Study|Adverse Event|0|||
48575534|NCT00562302|156297869|FG001|Overall Study|Adverse Event|6|||
48575535|NCT00562302|156297868|FG000|Overall Study|Non-compliance|1|||
48575536|NCT00562302|156297869|FG001|Overall Study|Non-compliance|2|||
48575537|NCT00562302|156297868|FG000|Overall Study|Withdrawal by Subject|7|||
48575538|NCT00562302|156297869|FG001|Overall Study|Withdrawal by Subject|8|||
48575539|NCT00562302|156297868|FG000|Overall Study|Death|1|||
48575540|NCT00562302|156297869|FG001|Overall Study|Death|2|||
48575541|NCT00562302|156297868|FG000|Overall Study|Lung resection prior to study completion|7|||
48575542|NCT00562302|156297869|FG001|Overall Study|Lung resection prior to study completion|7|||
48575543|NCT00562302|156297868|FG000|Overall Study|Not stated|1|||
48575544|NCT00562302|156297869|FG001|Overall Study|Not stated|4|||
48575545|NCT01598090|156297870|FG000|Treatment Period|Poor/non-compliance|0|||
48575546|NCT01598090|156297871|FG001|Treatment Period|Poor/non-compliance|2|||
48575547|NCT01598090|156297872|FG002|Treatment Period|Poor/non-compliance|0|||
48575548|NCT01598090|156297870|FG000|Treatment Period|No longer meet study criteria|0|||
48575549|NCT01598090|156297871|FG001|Treatment Period|No longer meet study criteria|1|||
48575550|NCT01598090|156297872|FG002|Treatment Period|No longer meet study criteria|0|||
48575551|NCT01598090|156297870|FG000|Treatment Period|Lack of Efficacy|5|||
48575552|NCT01598090|156297871|FG001|Treatment Period|Lack of Efficacy|14|||
48575553|NCT01598090|156297872|FG002|Treatment Period|Lack of Efficacy|6|||
48575554|NCT01598090|156297870|FG000|Treatment Period|Adverse Event|2|||
48319528|NCT00232180|155371013|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
48575555|NCT01598090|156297871|FG001|Treatment Period|Adverse Event|33|||
48575556|NCT01598090|156297872|FG002|Treatment Period|Adverse Event|17|||
48575557|NCT01598090|156297870|FG000|Treatment Period|Other reasons|0|||
48575558|NCT01598090|156297871|FG001|Treatment Period|Other reasons|4|||
48575559|NCT01598090|156297872|FG002|Treatment Period|Other reasons|1|||
48575560|NCT01598090|156297870|FG000|Treatment Period|Withdrawal by Subject|3|||
48575561|NCT01598090|156297871|FG001|Treatment Period|Withdrawal by Subject|13|||
48575562|NCT01598090|156297872|FG002|Treatment Period|Withdrawal by Subject|10|||
48575563|NCT01598090|156297870|FG000|Treatment Period|Lost to Follow-up|1|||
48575564|NCT01598090|156297871|FG001|Treatment Period|Lost to Follow-up|5|||
48575565|NCT01598090|156297872|FG002|Treatment Period|Lost to Follow-up|1|||
48575566|NCT01598090|156297870|FG000|Follow-up Period|Death|0|||
48575567|NCT01598090|156297871|FG001|Follow-up Period|Death|1|||
48575568|NCT01598090|156297872|FG002|Follow-up Period|Death|0|||
48575569|NCT01598090|156297870|FG000|Follow-up Period|No longer required per protocol|1|||
48575570|NCT01598090|156297871|FG001|Follow-up Period|No longer required per protocol|3|||
48575571|NCT01598090|156297872|FG002|Follow-up Period|No longer required per protocol|2|||
48575572|NCT01598090|156297870|FG000|Follow-up Period|Not reported|0|||
48575573|NCT01598090|156297871|FG001|Follow-up Period|Not reported|10|||
48575574|NCT01598090|156297872|FG002|Follow-up Period|Not reported|4|||
48319529|NCT00232180|155371014|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
48621306|NCT00976391|156471625|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
48621307|NCT00976391|156471626|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
48621308|NCT00976391|156471625|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
48621309|NCT00976391|156471626|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
48621310|NCT00976391|156471625|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
48319530|NCT00232180|155371012|FG000|Double-blind (DB) Phase|Adverse Event|83|||
48319531|NCT00232180|155371013|FG001|Double-blind (DB) Phase|Adverse Event|100|||
48319532|NCT00232180|155371014|FG002|Double-blind (DB) Phase|Adverse Event|0|||
48319533|NCT00232180|155371012|FG000|Double-blind (DB) Phase|Other|70|||
48319534|NCT00232180|155371013|FG001|Double-blind (DB) Phase|Other|75|||
48319535|NCT00232180|155371014|FG002|Double-blind (DB) Phase|Other|0|||
48319536|NCT00232180|155371012|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
48621311|NCT00976391|156471626|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
48621312|NCT00976391|156471625|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
48621313|NCT00976391|156471626|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
48621314|NCT00976391|156471625|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
48621315|NCT00976391|156471626|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
48621316|NCT00976391|156471625|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
48621317|NCT00976391|156471626|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
48621318|NCT00976391|156471625|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
48621319|NCT00976391|156471626|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
48621320|NCT00976391|156471625|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
48621321|NCT00976391|156471626|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
48621322|NCT02852434|156471627|FG000|Overall Study|Withdrawal by Subject|0|||
48621323|NCT02852434|156471628|FG001|Overall Study|Withdrawal by Subject|1|||
48621324|NCT02852434|156471627|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
48621325|NCT02852434|156471628|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
48621326|NCT03188705|156471629|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
48621327|NCT03188705|156471629|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
48621328|NCT02018887|156471630|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
48319537|NCT00232180|155371013|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
48319538|NCT00232180|155371014|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
48575575|NCT01598090|156297870|FG000|Follow-up Period|Withdrawal by Subject|0|||
48575576|NCT01598090|156297871|FG001|Follow-up Period|Withdrawal by Subject|3|||
48575577|NCT01598090|156297872|FG002|Follow-up Period|Withdrawal by Subject|2|||
48575578|NCT01598090|156297870|FG000|Follow-up Period|Other reasons|2|||
48575579|NCT01598090|156297871|FG001|Follow-up Period|Other reasons|8|||
48621329|NCT02018887|156471631|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48319539|NCT00232180|155371012|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
48575580|NCT01598090|156297872|FG002|Follow-up Period|Other reasons|8|||
48575581|NCT01598090|156297870|FG000|Follow-up Period|Lost to Follow-up|2|||
48575582|NCT01598090|156297871|FG001|Follow-up Period|Lost to Follow-up|10|||
48575583|NCT01598090|156297872|FG002|Follow-up Period|Lost to Follow-up|12|||
48575584|NCT02587598|156297873|FG000|Overall Study|Death|4|||
48575585|NCT02587598|156297874|FG001|Overall Study|Death|8|||
48621330|NCT02018887|156471632|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621331|NCT02018887|156471633|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621332|NCT02018887|156471634|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621333|NCT02018887|156471635|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621334|NCT02018887|156471636|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621335|NCT02018887|156471637|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621336|NCT02018887|156471638|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621337|NCT02018887|156471639|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621338|NCT02018887|156471640|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
48621339|NCT02018887|156471630|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
48621340|NCT02018887|156471631|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
48621341|NCT02018887|156471632|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
48621342|NCT02018887|156471633|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
48621343|NCT02018887|156471634|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
48621344|NCT02018887|156471635|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
48621345|NCT02018887|156471636|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
48621346|NCT02018887|156471637|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
48621347|NCT02018887|156471638|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
48621348|NCT02018887|156471639|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
48621349|NCT02018887|156471640|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
48621350|NCT02018887|156471630|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
48621351|NCT02018887|156471631|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
48621352|NCT02018887|156471632|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
48621353|NCT02018887|156471633|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
48621354|NCT02018887|156471634|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
48621355|NCT02018887|156471635|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
48621356|NCT02018887|156471636|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
48621357|NCT02018887|156471637|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
48621358|NCT02018887|156471638|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
48575586|NCT02587598|156297875|FG002|Overall Study|Death|4|||
48575587|NCT02587598|156297876|FG003|Overall Study|Death|16|||
48575588|NCT02587598|156297877|FG004|Overall Study|Death|9|||
48575589|NCT02587598|156297878|FG005|Overall Study|Death|4|||
48575590|NCT02587598|156297879|FG006|Overall Study|Death|6|||
48575591|NCT02587598|156297880|FG007|Overall Study|Death|7|||
48575592|NCT02587598|156297881|FG008|Overall Study|Death|9|||
48575593|NCT02587598|156297882|FG009|Overall Study|Death|1|||
48575594|NCT02587598|156297883|FG010|Overall Study|Death|3|||
48319540|NCT00232180|155371013|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
48319541|NCT00232180|155371014|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
48319542|NCT00232180|155371012|FG000|Open Label Phase|Death|0|||
48319543|NCT00232180|155371013|FG001|Open Label Phase|Death|0|||
48319544|NCT00232180|155371014|FG002|Open Label Phase|Death|48|||
48575595|NCT02587598|156297873|FG000|Overall Study|Study Terminated by the Sponsor|0|||
48575596|NCT02587598|156297874|FG001|Overall Study|Study Terminated by the Sponsor|1|||
48575597|NCT02587598|156297875|FG002|Overall Study|Study Terminated by the Sponsor|0|||
48575598|NCT02587598|156297876|FG003|Overall Study|Study Terminated by the Sponsor|3|||
48575599|NCT02587598|156297877|FG004|Overall Study|Study Terminated by the Sponsor|0|||
48575600|NCT02587598|156297878|FG005|Overall Study|Study Terminated by the Sponsor|1|||
48319545|NCT00232180|155371012|FG000|Open Label Phase|Lost to Follow-up|0|||
48575601|NCT02587598|156297879|FG006|Overall Study|Study Terminated by the Sponsor|0|||
48575602|NCT02587598|156297880|FG007|Overall Study|Study Terminated by the Sponsor|0|||
48575603|NCT02587598|156297881|FG008|Overall Study|Study Terminated by the Sponsor|0|||
48575604|NCT02587598|156297882|FG009|Overall Study|Study Terminated by the Sponsor|1|||
48575605|NCT02587598|156297883|FG010|Overall Study|Study Terminated by the Sponsor|6|||
48575606|NCT02587598|156297873|FG000|Overall Study|Reason for study withdrawal not specified|0|||
48575607|NCT02587598|156297874|FG001|Overall Study|Reason for study withdrawal not specified|1|||
48575608|NCT02587598|156297875|FG002|Overall Study|Reason for study withdrawal not specified|0|||
48575609|NCT02587598|156297876|FG003|Overall Study|Reason for study withdrawal not specified|0|||
48575610|NCT02587598|156297877|FG004|Overall Study|Reason for study withdrawal not specified|0|||
48575611|NCT02587598|156297878|FG005|Overall Study|Reason for study withdrawal not specified|0|||
48575612|NCT02587598|156297879|FG006|Overall Study|Reason for study withdrawal not specified|0|||
48575613|NCT02587598|156297880|FG007|Overall Study|Reason for study withdrawal not specified|0|||
48575614|NCT02587598|156297881|FG008|Overall Study|Reason for study withdrawal not specified|0|||
48575615|NCT02587598|156297882|FG009|Overall Study|Reason for study withdrawal not specified|0|||
48575616|NCT02587598|156297883|FG010|Overall Study|Reason for study withdrawal not specified|0|||
48575617|NCT02587598|156297873|FG000|Overall Study|Withdrawal by Subject|0|||
48319546|NCT00232180|155371013|FG001|Open Label Phase|Lost to Follow-up|0|||
48319547|NCT00232180|155371014|FG002|Open Label Phase|Lost to Follow-up|5|||
48319548|NCT00232180|155371012|FG000|Open Label Phase|Protocol Violation|0|||
48319549|NCT00232180|155371013|FG001|Open Label Phase|Protocol Violation|0|||
48575618|NCT02587598|156297874|FG001|Overall Study|Withdrawal by Subject|1|||
48575619|NCT02587598|156297875|FG002|Overall Study|Withdrawal by Subject|0|||
48575620|NCT02587598|156297876|FG003|Overall Study|Withdrawal by Subject|2|||
48575621|NCT02587598|156297877|FG004|Overall Study|Withdrawal by Subject|3|||
48575622|NCT02587598|156297878|FG005|Overall Study|Withdrawal by Subject|1|||
48575623|NCT02587598|156297879|FG006|Overall Study|Withdrawal by Subject|0|||
48319550|NCT00232180|155371014|FG002|Open Label Phase|Protocol Violation|3|||
48575624|NCT02587598|156297880|FG007|Overall Study|Withdrawal by Subject|0|||
48575625|NCT02587598|156297881|FG008|Overall Study|Withdrawal by Subject|0|||
48575626|NCT02587598|156297882|FG009|Overall Study|Withdrawal by Subject|1|||
48575627|NCT02587598|156297883|FG010|Overall Study|Withdrawal by Subject|2|||
48575628|NCT02587598|156297873|FG000|Overall Study|Physician Decision|0|||
48575629|NCT02587598|156297874|FG001|Overall Study|Physician Decision|0|||
48575630|NCT02587598|156297875|FG002|Overall Study|Physician Decision|0|||
48319551|NCT00232180|155371012|FG000|Open Label Phase|Study terminated by sponsor|0|||
48319552|NCT00232180|155371013|FG001|Open Label Phase|Study terminated by sponsor|0|||
48319553|NCT00232180|155371014|FG002|Open Label Phase|Study terminated by sponsor|3|||
48575631|NCT02587598|156297876|FG003|Overall Study|Physician Decision|0|||
48575632|NCT02587598|156297877|FG004|Overall Study|Physician Decision|0|||
48575633|NCT02587598|156297878|FG005|Overall Study|Physician Decision|0|||
48575634|NCT02587598|156297879|FG006|Overall Study|Physician Decision|0|||
48575635|NCT02587598|156297880|FG007|Overall Study|Physician Decision|0|||
48575636|NCT02587598|156297881|FG008|Overall Study|Physician Decision|0|||
48575637|NCT02587598|156297882|FG009|Overall Study|Physician Decision|0|||
48575638|NCT02587598|156297883|FG010|Overall Study|Physician Decision|3|||
48575639|NCT03589326|156297886|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
48575640|NCT03589326|156297887|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
48575641|NCT03589326|156297886|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
48575642|NCT03589326|156297887|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
48575643|NCT03589326|156297886|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
48575644|NCT03589326|156297887|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
48575645|NCT03589326|156297886|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
48575646|NCT03589326|156297887|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
48575647|NCT03589326|156297886|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
48575648|NCT03589326|156297887|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
48575649|NCT02783729|156297888|FG000|Overall Study|Lack of Efficacy|1|||
48575650|NCT02783729|156297889|FG001|Overall Study|Lack of Efficacy|0|||
48575651|NCT02783729|156297890|FG002|Overall Study|Lack of Efficacy|0|||
48575652|NCT02783729|156297891|FG003|Overall Study|Lack of Efficacy|0|||
48575653|NCT02783729|156297888|FG000|Overall Study|Adverse Event|2|||
48575654|NCT02783729|156297889|FG001|Overall Study|Adverse Event|6|||
48575655|NCT02783729|156297890|FG002|Overall Study|Adverse Event|2|||
48575656|NCT02783729|156297891|FG003|Overall Study|Adverse Event|3|||
48575657|NCT02783729|156297888|FG000|Overall Study|Other|1|||
48575658|NCT02783729|156297889|FG001|Overall Study|Other|6|||
48575659|NCT02783729|156297890|FG002|Overall Study|Other|2|||
48575660|NCT02783729|156297891|FG003|Overall Study|Other|3|||
48575661|NCT02783729|156297888|FG000|Overall Study|Withdrawal by Subject|2|||
48575662|NCT02783729|156297889|FG001|Overall Study|Withdrawal by Subject|3|||
48575663|NCT02783729|156297890|FG002|Overall Study|Withdrawal by Subject|1|||
48575664|NCT02783729|156297891|FG003|Overall Study|Withdrawal by Subject|2|||
48575665|NCT02783729|156297888|FG000|Overall Study|Participant's choice|2|||
48575666|NCT02783729|156297889|FG001|Overall Study|Participant's choice|1|||
48575667|NCT02783729|156297890|FG002|Overall Study|Participant's choice|2|||
48575668|NCT02783729|156297891|FG003|Overall Study|Participant's choice|1|||
48575669|NCT02783729|156297888|FG000|Overall Study|Lost to Follow-up|2|||
48575670|NCT02783729|156297889|FG001|Overall Study|Lost to Follow-up|1|||
48575671|NCT02783729|156297890|FG002|Overall Study|Lost to Follow-up|1|||
48575672|NCT02783729|156297891|FG003|Overall Study|Lost to Follow-up|0|||
48575673|NCT02693171|156297892|FG000|Overall Study|Adverse Event|1|||
48575674|NCT02693171|156297892|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
48575675|NCT00675428|156297893|FG000|Overall Study|Disease Progression|2|||
48575676|NCT00675428|156297894|FG001|Overall Study|Disease Progression|2|||
48575677|NCT00675428|156297893|FG000|Overall Study|No Disease Response After Cycle 6|0|||
48575678|NCT00675428|156297894|FG001|Overall Study|No Disease Response After Cycle 6|1|||
48575679|NCT00675428|156297893|FG000|Overall Study|Physician Decision|1|||
48621359|NCT02018887|156471639|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
48621360|NCT02018887|156471640|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
48621361|NCT02018887|156471630|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
48621362|NCT02018887|156471631|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
48621363|NCT02018887|156471632|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
48621364|NCT02018887|156471633|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
48621365|NCT02018887|156471634|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
48621366|NCT02018887|156471635|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
48621367|NCT02018887|156471636|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
48621368|NCT02018887|156471637|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
48621369|NCT02018887|156471638|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
48621370|NCT02018887|156471639|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
48621371|NCT02018887|156471640|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
48621372|NCT01174459|156471641|FG000|Overall Study|case report form (CRF) not collected|5|||
48575680|NCT00675428|156297894|FG001|Overall Study|Physician Decision|0|||
48575681|NCT00435487|156297895|FG000|Overall Study|Death|3|||
48575682|NCT00435487|156297896|FG001|Overall Study|Death|4|||
48575683|NCT00435487|156297895|FG000|Overall Study|Adverse Event|0|||
48575684|NCT00435487|156297896|FG001|Overall Study|Adverse Event|3|||
48575685|NCT00435487|156297895|FG000|Overall Study|Lost to Follow-up|2|||
48575686|NCT00435487|156297896|FG001|Overall Study|Lost to Follow-up|2|||
48621373|NCT03123588|156471642|FG000|Overall Study|Study Terminated by Sponsor|2|||
48575687|NCT00435487|156297895|FG000|Overall Study|Other|5|||
48575688|NCT00435487|156297896|FG001|Overall Study|Other|2|||
48575689|NCT00435487|156297895|FG000|Overall Study|Withdrawal by Subject|2|||
48575690|NCT00435487|156297896|FG001|Overall Study|Withdrawal by Subject|1|||
48575691|NCT00435487|156297895|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
48575692|NCT00435487|156297896|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
48575693|NCT00435487|156297895|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
48575694|NCT00435487|156297896|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
48575695|NCT04484142|156297897|FG000|Overall Study|Adverse Event|13|||
48575696|NCT04484142|156297897|FG000|Overall Study|Progressive Disease|87|||
48575697|NCT04484142|156297897|FG000|Overall Study|Clinical Progression|10|||
48575698|NCT04484142|156297897|FG000|Overall Study|Withdrawal by Subject|6|||
48575699|NCT04484142|156297897|FG000|Overall Study|Physician Decision|1|||
48575700|NCT01116648|156297898|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
48575701|NCT01116648|156297899|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
48575702|NCT01116648|156297900|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
48575703|NCT01116648|156297901|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
48575704|NCT01116648|156297902|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
48575705|NCT01116648|156297903|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
48575706|NCT01116648|156297904|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
48575707|NCT01116648|156297905|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
48575708|NCT01116648|156297906|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
48575709|NCT01116648|156297907|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
48575710|NCT01116648|156297908|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
48575711|NCT01116648|156297909|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
48575712|NCT01116648|156297910|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
48575713|NCT01116648|156297911|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
48575714|NCT01116648|156297912|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
48575715|NCT01399047|156297913|FG000|Overall Study|Withdrawal by Subject|0|||
48575716|NCT01399047|156297914|FG001|Overall Study|Withdrawal by Subject|1|||
48575717|NCT00319592|156297915|FG000|Overall Study|Protocol Violation|1|||
48575718|NCT00319592|156297916|FG001|Overall Study|Protocol Violation|0|||
48575719|NCT00319592|156297915|FG000|Overall Study|Physician Decision|0|||
48575720|NCT00319592|156297916|FG001|Overall Study|Physician Decision|1|||
48575721|NCT00378508|156297917|FG000|Overall Study|Withdrawal by Subject|1|||
48575722|NCT00378508|156297918|FG001|Overall Study|Withdrawal by Subject|3|||
48575723|NCT00378508|156297917|FG000|Overall Study|Lost to Follow-up|1|||
48575724|NCT00378508|156297918|FG001|Overall Study|Lost to Follow-up|0|||
48575725|NCT01597375|156297929|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
48575726|NCT01597375|156297930|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
48575727|NCT01597375|156297929|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
48575728|NCT01597375|156297930|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
48575729|NCT01597375|156297929|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
48575730|NCT01597375|156297930|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
48575731|NCT01597375|156297929|FG000|Washout (2 Weeks)|Adverse Event|1|||
48575732|NCT01597375|156297930|FG001|Washout (2 Weeks)|Adverse Event|0|||
48575733|NCT01597375|156297929|FG000|Second Intervention|Failed to react at both Aspirin|1|||
48575734|NCT01597375|156297930|FG001|Second Intervention|Failed to react at both Aspirin|1|||
48575735|NCT04545567|156297931|FG000|Overall Study|tested positive for SARS-co-V2|1|||
48575736|NCT04545567|156297932|FG001|Overall Study|tested positive for SARS-co-V2|1|||
48575737|NCT04545567|156297931|FG000|Overall Study|Withdrawal by Subject|0|||
48575738|NCT04545567|156297932|FG001|Overall Study|Withdrawal by Subject|1|||
48575739|NCT02640404|156297933|FG000|Overall Study|Protocol Violation|1|||
48575740|NCT02640404|156297934|FG001|Overall Study|Protocol Violation|0|||
48575741|NCT02640404|156297933|FG000|Overall Study|Withdrawal by Subject|1|||
48575742|NCT02640404|156297934|FG001|Overall Study|Withdrawal by Subject|0|||
48575743|NCT02778074|156297937|FG000|Overall Study|Lost to Follow-up|7|||
48575744|NCT02778074|156297938|FG001|Overall Study|Lost to Follow-up|10|||
48575745|NCT02496091|156297939|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48575746|NCT05483686|156299344|FG000|Overall Study|Lost to Follow-up|5|||
48575747|NCT05483686|156299345|FG001|Overall Study|Lost to Follow-up|7|||
48575748|NCT03528369|156299350|FG000|Overall Study|Withdrawal by Subject|2|||
48575749|NCT03528369|156299351|FG001|Overall Study|Withdrawal by Subject|0|||
48575750|NCT03528369|156299352|FG002|Overall Study|Withdrawal by Subject|0|||
48575751|NCT03528369|156299350|FG000|Overall Study|Lost to Follow-up|1|||
48575752|NCT03528369|156299351|FG001|Overall Study|Lost to Follow-up|0|||
48575753|NCT03528369|156299352|FG002|Overall Study|Lost to Follow-up|0|||
48575754|NCT03528369|156299350|FG000|Overall Study|Adverse Event|0|||
48575755|NCT03528369|156299351|FG001|Overall Study|Adverse Event|1|||
48575756|NCT03528369|156299352|FG002|Overall Study|Adverse Event|0|||
48575757|NCT02162719|156299363|FG000|Overall Study|Death|41|||
48575758|NCT02162719|156299364|FG001|Overall Study|Death|46|||
48575759|NCT02162719|156299363|FG000|Overall Study|Lost to Follow-up|1|||
48575760|NCT02162719|156299364|FG001|Overall Study|Lost to Follow-up|3|||
48575761|NCT02162719|156299363|FG000|Overall Study|Disease Progression|2|||
48319554|NCT00232180|155371012|FG000|Open Label Phase|Withdrawal by Subject|0|||
48319555|NCT00232180|155371013|FG001|Open Label Phase|Withdrawal by Subject|0|||
48319556|NCT00232180|155371014|FG002|Open Label Phase|Withdrawal by Subject|37|||
48319557|NCT00232180|155371012|FG000|Open Label Phase|Other|0|||
48319558|NCT00232180|155371013|FG001|Open Label Phase|Other|0|||
48319559|NCT00232180|155371014|FG002|Open Label Phase|Other|16|||
48319560|NCT00232180|155371012|FG000|Open Label Phase|Adverse Event|0|||
48319561|NCT00232180|155371013|FG001|Open Label Phase|Adverse Event|0|||
48319562|NCT00232180|155371014|FG002|Open Label Phase|Adverse Event|25|||
48319563|NCT00232180|155371012|FG000|Open Label Phase|Laboratory abnormality|0|||
48319564|NCT00232180|155371013|FG001|Open Label Phase|Laboratory abnormality|0|||
48319565|NCT00232180|155371014|FG002|Open Label Phase|Laboratory abnormality|10|||
48319566|NCT00232180|155371012|FG000|Open Label Phase|Randomized but not treated|0|||
48319567|NCT00232180|155371013|FG001|Open Label Phase|Randomized but not treated|0|||
48319568|NCT00232180|155371014|FG002|Open Label Phase|Randomized but not treated|1|||
48319569|NCT02748317|155371015|FG000|Overall Study|Withdrawal by Subject|14|||
48319570|NCT02748317|155371015|FG000|Overall Study|Lost to Follow-up|8|||
48319571|NCT02748317|155371015|FG000|Overall Study|Death|1|||
48319572|NCT00505934|155371016|FG000|Overall Study|Adverse Event|1|||
48575762|NCT02162719|156299364|FG001|Overall Study|Disease Progression|1|||
48575763|NCT02162719|156299363|FG000|Overall Study|Withdrawal by Subject|8|||
48575764|NCT02162719|156299364|FG001|Overall Study|Withdrawal by Subject|2|||
48575765|NCT02162719|156299363|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
48575766|NCT02162719|156299364|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
48575767|NCT00160706|156299365|FG000|Overall Study|Adverse Event|53|||
48575768|NCT00160706|156299365|FG000|Overall Study|Adverse Event and Other Reason|105|||
48575769|NCT00160706|156299365|FG000|Overall Study|Protocol Violation|3|||
48575770|NCT00160706|156299365|FG000|Overall Study|Withdrawal by Subject|41|||
48575771|NCT00160706|156299365|FG000|Overall Study|Withdrawal by Subject and Other|12|||
48575772|NCT00160706|156299365|FG000|Overall Study|Physician Decision|10|||
48575773|NCT00160706|156299365|FG000|Overall Study|Physician Decision and Other|3|||
48575774|NCT00160706|156299365|FG000|Overall Study|Lost to Follow-up|4|||
48736047|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
48736048|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
48736049|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
48736050|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
48736051|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
48736052|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
48736053|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
48736054|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
48736055|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Physician Decision|0|||
48736056|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Physician Decision|8|||
48736057|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Physician Decision|11|||
48736058|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
48736059|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
48736060|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
48736061|NCT00257608|156885621|FG000|Post Chemotherapy Phase|Not treated|0|||
48736062|NCT00257608|156885622|FG001|Post Chemotherapy Phase|Not treated|4|||
48736063|NCT00257608|156885623|FG002|Post Chemotherapy Phase|Not treated|7|||
48736064|NCT00866788|156885625|FG000|Overall Study|Adverse Event|0|||
48736065|NCT00866788|156885626|FG001|Overall Study|Adverse Event|2|||
48736066|NCT00866788|156885627|FG002|Overall Study|Adverse Event|0|||
48736067|NCT00866788|156885628|FG003|Overall Study|Adverse Event|1|||
48736068|NCT00866788|156885625|FG000|Overall Study|Lost to Follow-up|1|||
48736069|NCT00866788|156885626|FG001|Overall Study|Lost to Follow-up|1|||
48736070|NCT00866788|156885627|FG002|Overall Study|Lost to Follow-up|0|||
48736071|NCT00866788|156885628|FG003|Overall Study|Lost to Follow-up|2|||
48736072|NCT00866788|156885625|FG000|Overall Study|Withdrawal by Subject|2|||
48736073|NCT00866788|156885626|FG001|Overall Study|Withdrawal by Subject|1|||
48736074|NCT00866788|156885627|FG002|Overall Study|Withdrawal by Subject|0|||
48736075|NCT00866788|156885628|FG003|Overall Study|Withdrawal by Subject|1|||
48736076|NCT00866788|156885625|FG000|Overall Study|Pregnancy|0|||
48319573|NCT00505934|155371016|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
48319574|NCT00505934|155371016|FG000|Overall Study|Other: IV dose needed to be changed|1|||
48319575|NCT00799396|155371017|FG000|Clopidogrel Treatment|Adverse Event|6|||
48575775|NCT00160706|156299365|FG000|Overall Study|Lost to Follow-up and Other|1|||
48575776|NCT00160706|156299365|FG000|Overall Study|Lack of Efficacy|42|||
48319576|NCT00799396|155371017|FG000|Clopidogrel Treatment|Physician Decision|5|||
48319577|NCT00799396|155371017|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
48319578|NCT00799396|155371017|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
48319579|NCT00799396|155371017|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
48319580|NCT00332241|155371025|FG000|Overall Study|Lack of Efficacy|6|||
48319581|NCT00332241|155371026|FG001|Overall Study|Lack of Efficacy|1|||
48319582|NCT00332241|155371025|FG000|Overall Study|Adverse Event|3|||
48319583|NCT00332241|155371026|FG001|Overall Study|Adverse Event|5|||
48575777|NCT00160706|156299365|FG000|Overall Study|Lack of Efficacy and Other|1|||
48575778|NCT00160706|156299365|FG000|Overall Study|Other Reason|11|||
48575779|NCT03214380|156299366|FG000|Lead-in|Adverse Event|3|||
48575780|NCT03214380|156299367|FG001|Lead-in|Adverse Event|0|||
48575781|NCT03214380|156299368|FG002|Lead-in|Adverse Event|0|||
48575782|NCT03214380|156299369|FG003|Lead-in|Adverse Event|1|||
48575783|NCT03214380|156299370|FG004|Lead-in|Adverse Event|0|||
48575784|NCT03214380|156299371|FG005|Lead-in|Adverse Event|0|||
48575785|NCT03214380|156299366|FG000|Lead-in|Lost to Follow-up|4|||
48575786|NCT03214380|156299367|FG001|Lead-in|Lost to Follow-up|0|||
48575787|NCT03214380|156299368|FG002|Lead-in|Lost to Follow-up|0|||
48575788|NCT03214380|156299369|FG003|Lead-in|Lost to Follow-up|1|||
48575789|NCT03214380|156299370|FG004|Lead-in|Lost to Follow-up|0|||
48575790|NCT03214380|156299371|FG005|Lead-in|Lost to Follow-up|0|||
48575791|NCT03214380|156299366|FG000|Lead-in|Eligibility Criteria|3|||
48575792|NCT03214380|156299367|FG001|Lead-in|Eligibility Criteria|0|||
48575793|NCT03214380|156299368|FG002|Lead-in|Eligibility Criteria|0|||
48575794|NCT03214380|156299369|FG003|Lead-in|Eligibility Criteria|0|||
48575795|NCT03214380|156299370|FG004|Lead-in|Eligibility Criteria|0|||
48575796|NCT03214380|156299371|FG005|Lead-in|Eligibility Criteria|0|||
48575797|NCT03214380|156299366|FG000|Lead-in|Physician Decision|6|||
48575798|NCT03214380|156299367|FG001|Lead-in|Physician Decision|0|||
48575799|NCT03214380|156299368|FG002|Lead-in|Physician Decision|0|||
48575800|NCT03214380|156299369|FG003|Lead-in|Physician Decision|0|||
48575801|NCT03214380|156299370|FG004|Lead-in|Physician Decision|0|||
48575802|NCT03214380|156299371|FG005|Lead-in|Physician Decision|0|||
48575803|NCT03214380|156299366|FG000|Lead-in|Protocol Deviation|7|||
48575804|NCT03214380|156299367|FG001|Lead-in|Protocol Deviation|0|||
48575805|NCT03214380|156299368|FG002|Lead-in|Protocol Deviation|0|||
48575806|NCT03214380|156299369|FG003|Lead-in|Protocol Deviation|3|||
48575807|NCT03214380|156299370|FG004|Lead-in|Protocol Deviation|0|||
48575808|NCT03214380|156299371|FG005|Lead-in|Protocol Deviation|0|||
48575809|NCT03214380|156299366|FG000|Lead-in|Withdrawal by Subject|41|||
48575810|NCT03214380|156299367|FG001|Lead-in|Withdrawal by Subject|0|||
48575811|NCT03214380|156299368|FG002|Lead-in|Withdrawal by Subject|0|||
48575812|NCT03214380|156299369|FG003|Lead-in|Withdrawal by Subject|14|||
48575813|NCT03214380|156299370|FG004|Lead-in|Withdrawal by Subject|0|||
48319584|NCT00332241|155371025|FG000|Overall Study|Withdrawal by Subject|2|||
48319585|NCT00332241|155371026|FG001|Overall Study|Withdrawal by Subject|1|||
48319586|NCT00332241|155371025|FG000|Overall Study|Lost to Follow-up|4|||
48575814|NCT03214380|156299371|FG005|Lead-in|Withdrawal by Subject|0|||
48575815|NCT03214380|156299366|FG000|Lead-in|Family Emergency|1|||
48319587|NCT00332241|155371026|FG001|Overall Study|Lost to Follow-up|1|||
48575816|NCT03214380|156299367|FG001|Lead-in|Family Emergency|0|||
48575817|NCT03214380|156299368|FG002|Lead-in|Family Emergency|0|||
48621374|NCT03123588|156471643|FG001|Overall Study|Study Terminated by Sponsor|5|||
48575818|NCT03214380|156299369|FG003|Lead-in|Family Emergency|0|||
48575819|NCT03214380|156299370|FG004|Lead-in|Family Emergency|0|||
48575820|NCT03214380|156299371|FG005|Lead-in|Family Emergency|0|||
48575821|NCT03214380|156299366|FG000|Lead-in|Natural Disaster|9|||
48575822|NCT03214380|156299367|FG001|Lead-in|Natural Disaster|0|||
48575823|NCT03214380|156299368|FG002|Lead-in|Natural Disaster|0|||
48575824|NCT03214380|156299369|FG003|Lead-in|Natural Disaster|0|||
48575825|NCT03214380|156299370|FG004|Lead-in|Natural Disaster|0|||
48575826|NCT03214380|156299371|FG005|Lead-in|Natural Disaster|0|||
48575827|NCT03214380|156299366|FG000|Lead-in|Non Compliance|1|||
48575828|NCT03214380|156299367|FG001|Lead-in|Non Compliance|0|||
48575829|NCT03214380|156299368|FG002|Lead-in|Non Compliance|0|||
48575830|NCT03214380|156299369|FG003|Lead-in|Non Compliance|0|||
48575831|NCT03214380|156299370|FG004|Lead-in|Non Compliance|0|||
48575832|NCT03214380|156299371|FG005|Lead-in|Non Compliance|0|||
48575833|NCT03214380|156299366|FG000|Lead-in|Participant Schedule|2|||
48575834|NCT03214380|156299367|FG001|Lead-in|Participant Schedule|0|||
48575835|NCT03214380|156299368|FG002|Lead-in|Participant Schedule|0|||
48575836|NCT03214380|156299369|FG003|Lead-in|Participant Schedule|0|||
48575837|NCT03214380|156299370|FG004|Lead-in|Participant Schedule|0|||
48575838|NCT03214380|156299371|FG005|Lead-in|Participant Schedule|0|||
48575839|NCT03214380|156299366|FG000|Treatment Period|Adverse Event|0|||
48575840|NCT03214380|156299367|FG001|Treatment Period|Adverse Event|1|||
48575841|NCT03214380|156299368|FG002|Treatment Period|Adverse Event|1|||
48575842|NCT03214380|156299369|FG003|Treatment Period|Adverse Event|0|||
48575843|NCT03214380|156299370|FG004|Treatment Period|Adverse Event|1|||
48575844|NCT03214380|156299371|FG005|Treatment Period|Adverse Event|0|||
48575845|NCT03214380|156299366|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
48575846|NCT03214380|156299367|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
48575847|NCT03214380|156299368|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
48575848|NCT03214380|156299369|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
48575849|NCT03214380|156299370|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
48575850|NCT03214380|156299371|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
48575851|NCT03214380|156299366|FG000|Treatment Period|Withdrawal by Subject|0|||
48575852|NCT03214380|156299367|FG001|Treatment Period|Withdrawal by Subject|10|||
48575853|NCT03214380|156299368|FG002|Treatment Period|Withdrawal by Subject|8|||
48575854|NCT03214380|156299369|FG003|Treatment Period|Withdrawal by Subject|0|||
48575855|NCT03214380|156299370|FG004|Treatment Period|Withdrawal by Subject|7|||
48575856|NCT03214380|156299371|FG005|Treatment Period|Withdrawal by Subject|11|||
48575857|NCT03214380|156299366|FG000|Treatment Period|Death|0|||
48575858|NCT03214380|156299367|FG001|Treatment Period|Death|1|||
48575859|NCT03214380|156299368|FG002|Treatment Period|Death|2|||
48575860|NCT03214380|156299369|FG003|Treatment Period|Death|0|||
48575861|NCT03214380|156299370|FG004|Treatment Period|Death|0|||
48575862|NCT03214380|156299371|FG005|Treatment Period|Death|0|||
48575863|NCT03214380|156299366|FG000|Treatment Period|Lost to Follow-up|0|||
48575864|NCT03214380|156299367|FG001|Treatment Period|Lost to Follow-up|6|||
48575865|NCT03214380|156299368|FG002|Treatment Period|Lost to Follow-up|3|||
48575866|NCT03214380|156299369|FG003|Treatment Period|Lost to Follow-up|0|||
48575867|NCT03214380|156299370|FG004|Treatment Period|Lost to Follow-up|0|||
48575868|NCT03214380|156299371|FG005|Treatment Period|Lost to Follow-up|0|||
48575869|NCT03214380|156299366|FG000|Treatment Period|Participant schedule|0|||
48575870|NCT03214380|156299367|FG001|Treatment Period|Participant schedule|0|||
48575871|NCT03214380|156299368|FG002|Treatment Period|Participant schedule|1|||
48575872|NCT03214380|156299369|FG003|Treatment Period|Participant schedule|0|||
48621375|NCT03123588|156471642|FG000|Overall Study|Withdrawal by Subject|1|||
48621376|NCT03123588|156471643|FG001|Overall Study|Withdrawal by Subject|0|||
48621377|NCT03123588|156471642|FG000|Overall Study|Adverse Event|1|||
48621378|NCT03123588|156471643|FG001|Overall Study|Adverse Event|0|||
48621379|NCT03123588|156471642|FG000|Overall Study|Physician Decision|2|||
48621380|NCT03123588|156471643|FG001|Overall Study|Physician Decision|1|||
48621381|NCT01698008|156471644|FG000|Overall Study|Withdrawal by Subject|1|||
48621382|NCT01698008|156471645|FG001|Overall Study|Withdrawal by Subject|2|||
48621383|NCT00290758|156471648|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
48319588|NCT02724592|155371029|FG000|Overall Study|Lost to Follow-up|4|||
48575873|NCT03214380|156299370|FG004|Treatment Period|Participant schedule|0|||
48575874|NCT03214380|156299371|FG005|Treatment Period|Participant schedule|0|||
48575875|NCT03214380|156299366|FG000|Treatment Period|Treatment Interruption|0|||
48575876|NCT03214380|156299367|FG001|Treatment Period|Treatment Interruption|0|||
48575877|NCT03214380|156299368|FG002|Treatment Period|Treatment Interruption|1|||
48575878|NCT03214380|156299369|FG003|Treatment Period|Treatment Interruption|0|||
48575879|NCT03214380|156299370|FG004|Treatment Period|Treatment Interruption|0|||
48575880|NCT03214380|156299371|FG005|Treatment Period|Treatment Interruption|0|||
48575881|NCT04434469|156299372|FG000|Overall Study|Death|2|||
48575882|NCT04434469|156299373|FG001|Overall Study|Death|3|||
48575883|NCT04434469|156299374|FG002|Overall Study|Death|2|||
48575884|NCT04434469|156299375|FG003|Overall Study|Death|2|||
48575885|NCT04434469|156299376|FG004|Overall Study|Death|2|||
48575886|NCT04434469|156299377|FG005|Overall Study|Death|0|||
48575887|NCT04434469|156299372|FG000|Overall Study|Lost to Follow-up|0|||
48575888|NCT04434469|156299373|FG001|Overall Study|Lost to Follow-up|0|||
48575889|NCT04434469|156299374|FG002|Overall Study|Lost to Follow-up|0|||
48575890|NCT04434469|156299375|FG003|Overall Study|Lost to Follow-up|1|||
48575891|NCT04434469|156299376|FG004|Overall Study|Lost to Follow-up|1|||
48575892|NCT04434469|156299377|FG005|Overall Study|Lost to Follow-up|0|||
48575893|NCT04434469|156299372|FG000|Overall Study|Study terminated by sponsor|1|||
48575894|NCT04434469|156299373|FG001|Overall Study|Study terminated by sponsor|1|||
48575895|NCT04434469|156299374|FG002|Overall Study|Study terminated by sponsor|1|||
48575896|NCT04434469|156299375|FG003|Overall Study|Study terminated by sponsor|2|||
48575897|NCT04434469|156299376|FG004|Overall Study|Study terminated by sponsor|3|||
48575898|NCT04434469|156299377|FG005|Overall Study|Study terminated by sponsor|3|||
48575899|NCT04434469|156299372|FG000|Overall Study|Withdrawal by Subject|0|||
48575900|NCT04434469|156299373|FG001|Overall Study|Withdrawal by Subject|0|||
48575901|NCT04434469|156299374|FG002|Overall Study|Withdrawal by Subject|1|||
48575902|NCT04434469|156299375|FG003|Overall Study|Withdrawal by Subject|0|||
48575903|NCT04434469|156299376|FG004|Overall Study|Withdrawal by Subject|0|||
48575904|NCT04434469|156299377|FG005|Overall Study|Withdrawal by Subject|0|||
48575905|NCT01669174|156299380|FG000|Overall Study|Subject withdrew consent|2|||
48575906|NCT01669174|156299381|FG001|Overall Study|Subject withdrew consent|2|||
48575907|NCT01669174|156299380|FG000|Overall Study|Lost to Follow-up|1|||
48575908|NCT01669174|156299381|FG001|Overall Study|Lost to Follow-up|0|||
48319589|NCT02724592|155371030|FG001|Overall Study|Lost to Follow-up|1|||
48319590|NCT00434304|155371031|FG000|Overall Study|Adverse Event|14|||
48319591|NCT00434304|155371031|FG000|Overall Study|Lack of Efficacy|2|||
48575909|NCT01669174|156299380|FG000|Overall Study|Adverse Event|2|||
48575910|NCT01669174|156299381|FG001|Overall Study|Adverse Event|2|||
48575911|NCT01669174|156299380|FG000|Overall Study|Administrative problems|1|||
48575912|NCT01669174|156299381|FG001|Overall Study|Administrative problems|2|||
48319592|NCT00434304|155371031|FG000|Overall Study|Withdrawal by Subject|4|||
48319593|NCT02601820|155371035|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
48319594|NCT02601820|155371035|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
48319595|NCT02601820|155371035|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
48319596|NCT02601820|155371035|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
48319597|NCT01599793|155371036|FG000|Overall Study|Adverse Event|2|||
48319598|NCT04588298|155371037|FG000|Overall Study|Adverse Event|0|||
48319599|NCT04588298|155371038|FG001|Overall Study|Adverse Event|0|||
48319600|NCT04588298|155371039|FG002|Overall Study|Adverse Event|1|||
48319601|NCT04588298|155371040|FG003|Overall Study|Adverse Event|0|||
48319602|NCT04588298|155371041|FG004|Overall Study|Adverse Event|2|||
48319603|NCT04588298|155371037|FG000|Overall Study|Withdrawal by Subject|1|||
48319604|NCT04588298|155371038|FG001|Overall Study|Withdrawal by Subject|0|||
48575913|NCT01769508|156299394|FG000|Overall Study|Death|3|||
48575914|NCT01769508|156299394|FG000|Overall Study|Withdrawal by Subject|1|||
48575915|NCT01769508|156299394|FG000|Overall Study|Adverse Event|1|||
48575916|NCT01769508|156299394|FG000|Overall Study|Lost to Follow-up|1|||
48575917|NCT01254318|156299395|FG000|Overall Study|Lost to Follow-up|5|||
48575918|NCT01254318|156299395|FG000|Overall Study|Death|47|||
48575919|NCT04016779|156299396|FG000|Overall Study|Adverse Event|9|||
48575920|NCT04016779|156299397|FG001|Overall Study|Adverse Event|17|||
48575921|NCT04016779|156299396|FG000|Overall Study|Lack of Efficacy|4|||
48575922|NCT04016779|156299397|FG001|Overall Study|Lack of Efficacy|1|||
48575923|NCT04016779|156299396|FG000|Overall Study|Lost to Follow-up|5|||
48575924|NCT04016779|156299397|FG001|Overall Study|Lost to Follow-up|14|||
48575925|NCT04016779|156299396|FG000|Overall Study|Physician Decision|1|||
48575926|NCT04016779|156299397|FG001|Overall Study|Physician Decision|3|||
48575927|NCT04016779|156299396|FG000|Overall Study|Withdrawal by Subject|6|||
48575928|NCT04016779|156299397|FG001|Overall Study|Withdrawal by Subject|8|||
48575929|NCT04016779|156299396|FG000|Overall Study|Non-compliance with Study Drug|2|||
48575930|NCT04016779|156299397|FG001|Overall Study|Non-compliance with Study Drug|3|||
48575931|NCT04016779|156299396|FG000|Overall Study|Other, Multiple categories|17|||
48319605|NCT04588298|155371039|FG002|Overall Study|Withdrawal by Subject|0|||
48575932|NCT04016779|156299397|FG001|Overall Study|Other, Multiple categories|17|||
48575933|NCT03615144|156299402|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
48575934|NCT03615144|156299403|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
48575935|NCT04791319|156299413|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
48575936|NCT04791319|156299414|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
48319606|NCT04588298|155371040|FG003|Overall Study|Withdrawal by Subject|1|||
48319607|NCT04588298|155371041|FG004|Overall Study|Withdrawal by Subject|0|||
48319608|NCT01376700|155371042|FG000|Overall Study|Sponsor terminated study early|8|||
48621384|NCT00290758|156471649|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
48319609|NCT01376700|155371042|FG000|Overall Study|Low or high titer inhibitor|8|||
48575937|NCT04791319|156299415|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
48575938|NCT04791319|156299416|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
48575939|NCT04791319|156299417|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
48575940|NCT04791319|156299418|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
48575941|NCT04791319|156299419|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
48575942|NCT04791319|156299420|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
48575943|NCT04791319|156299421|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
48575944|NCT04791319|156299422|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
48575945|NCT04791319|156299423|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
48575946|NCT04791319|156299413|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
48575947|NCT04791319|156299414|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
48621385|NCT00290758|156471648|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
48621386|NCT00290758|156471649|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
48621387|NCT00290758|156471648|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
48621388|NCT00290758|156471649|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
48621389|NCT00290758|156471648|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
48621390|NCT00290758|156471649|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
48621391|NCT00290758|156471648|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
48621392|NCT00290758|156471649|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
48621393|NCT00290758|156471648|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
48621394|NCT00290758|156471649|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
48621395|NCT00290758|156471648|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
48621396|NCT00290758|156471649|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
48621397|NCT00290758|156471648|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
48621398|NCT00290758|156471649|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
48621399|NCT03436420|156471650|FG000|Overall Study|Lack of Efficacy|3|||
48621400|NCT04389671|156471651|FG000|Overall Study|Death|7|||
48621401|NCT03994120|156471652|FG000|Overall Study|Lost to Follow-up|3|||
48621402|NCT03994120|156471653|FG001|Overall Study|Lost to Follow-up|1|||
48621403|NCT00215553|156471654|FG000|Overall Study|Adverse Event|0|||
48621404|NCT00215553|156471655|FG001|Overall Study|Adverse Event|1|||
48621405|NCT00215553|156471656|FG002|Overall Study|Adverse Event|2|||
48621406|NCT00215553|156471657|FG003|Overall Study|Adverse Event|1|||
48621407|NCT00215553|156471658|FG004|Overall Study|Adverse Event|2|||
48621408|NCT00215553|156471659|FG005|Overall Study|Adverse Event|6|||
48621409|NCT00215553|156471660|FG006|Overall Study|Adverse Event|0|||
48621410|NCT03178942|156471661|FG000|Overall Study|Withdrawal by Subject|2|||
48621411|NCT03178942|156471662|FG001|Overall Study|Withdrawal by Subject|0|||
48621412|NCT03178942|156471661|FG000|Overall Study|Lost to Follow-up|1|||
48621413|NCT03178942|156471662|FG001|Overall Study|Lost to Follow-up|2|||
48621414|NCT01429623|156471663|FG000|Overall Study|Death|1|||
48621415|NCT01429623|156471664|FG001|Overall Study|Death|0|||
48621416|NCT01429623|156471663|FG000|Overall Study|Adverse Event|7|||
48621417|NCT01429623|156471664|FG001|Overall Study|Adverse Event|14|||
48621418|NCT01429623|156471663|FG000|Overall Study|Withdrawal by Subject|19|||
48621419|NCT01429623|156471664|FG001|Overall Study|Withdrawal by Subject|13|||
48621420|NCT01429623|156471663|FG000|Overall Study|Physician Decision|2|||
48621421|NCT01429623|156471664|FG001|Overall Study|Physician Decision|3|||
48319610|NCT02564744|155371043|FG000|Overall Study|Investigator decision|0|||
48319611|NCT02564744|155371044|FG001|Overall Study|Investigator decision|0|||
48621422|NCT01429623|156471663|FG000|Overall Study|Protocol Violation|3|||
48621423|NCT01429623|156471664|FG001|Overall Study|Protocol Violation|2|||
48621424|NCT01429623|156471663|FG000|Overall Study|Assorted|1|||
48621425|NCT01429623|156471664|FG001|Overall Study|Assorted|2|||
48621426|NCT01429623|156471663|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
48319612|NCT02564744|155371045|FG002|Overall Study|Investigator decision|0|||
48575948|NCT04791319|156299415|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
48575949|NCT04791319|156299416|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
48575950|NCT04791319|156299417|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
48575951|NCT04791319|156299418|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
48575952|NCT04791319|156299419|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
48575953|NCT04791319|156299420|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
48575954|NCT04791319|156299421|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
48575955|NCT04791319|156299422|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
48575956|NCT04791319|156299423|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
48575957|NCT04791319|156299413|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
48575958|NCT04791319|156299414|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
48575959|NCT04791319|156299415|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
48575960|NCT04791319|156299416|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
48575961|NCT04791319|156299417|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
48575962|NCT04791319|156299418|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
48575963|NCT04791319|156299419|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
48575964|NCT04791319|156299420|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
48575965|NCT04791319|156299421|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
48575966|NCT04791319|156299422|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
48575967|NCT04791319|156299423|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
48575968|NCT04791319|156299413|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
48575969|NCT04791319|156299414|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
48575970|NCT04791319|156299415|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
48575971|NCT04791319|156299416|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
48575972|NCT04791319|156299417|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
48575973|NCT04791319|156299418|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
48575974|NCT04791319|156299419|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
48575975|NCT04791319|156299420|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
48575976|NCT04791319|156299421|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
48575977|NCT04791319|156299422|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
48575978|NCT04791319|156299423|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
48575979|NCT04791319|156299413|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575980|NCT04791319|156299414|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575981|NCT04791319|156299415|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575982|NCT04791319|156299416|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
48575983|NCT04791319|156299417|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575984|NCT04791319|156299418|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575985|NCT04791319|156299419|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575986|NCT04791319|156299420|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575987|NCT04791319|156299421|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575988|NCT04791319|156299422|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575989|NCT04791319|156299423|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
48575990|NCT04791319|156299413|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
48575991|NCT04791319|156299414|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
48575992|NCT04791319|156299415|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
48575993|NCT04791319|156299416|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
48575994|NCT04791319|156299417|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
48575995|NCT04791319|156299418|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
48575996|NCT04791319|156299419|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
48575997|NCT04791319|156299420|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
48575998|NCT04791319|156299421|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
48575999|NCT04791319|156299422|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
48576000|NCT04791319|156299423|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
48576001|NCT04791319|156299413|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576002|NCT04791319|156299414|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576003|NCT04791319|156299415|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576004|NCT04791319|156299416|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576005|NCT04791319|156299417|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576006|NCT04791319|156299418|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576007|NCT04791319|156299419|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576008|NCT04791319|156299420|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576009|NCT04791319|156299421|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48576010|NCT04791319|156299422|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
48576011|NCT04791319|156299423|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
48450059|NCT01614795|155835560|FG003|Overall Study|Lack of Efficacy|8|||
48576012|NCT04791319|156299413|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
48576013|NCT04791319|156299414|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
48576014|NCT04791319|156299415|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
48576015|NCT04791319|156299416|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
48576016|NCT04791319|156299417|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
48576017|NCT04791319|156299418|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
48576018|NCT04791319|156299419|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
48576019|NCT04791319|156299420|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
48576020|NCT04791319|156299421|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
48576021|NCT04791319|156299422|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
48576022|NCT04791319|156299423|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
48576023|NCT04791319|156299413|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
48576024|NCT04791319|156299414|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
48576025|NCT04791319|156299415|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
48576026|NCT04791319|156299416|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
48576027|NCT04791319|156299417|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
48576028|NCT04791319|156299418|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
48576029|NCT04791319|156299419|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
48576030|NCT04791319|156299420|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
48576031|NCT04791319|156299421|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
48319613|NCT02564744|155371046|FG003|Overall Study|Investigator decision|0|||
48319614|NCT02564744|155371047|FG004|Overall Study|Investigator decision|1|||
48319615|NCT02564744|155371043|FG000|Overall Study|Death|10|||
48319616|NCT02564744|155371044|FG001|Overall Study|Death|5|||
48319617|NCT02564744|155371045|FG002|Overall Study|Death|4|||
48319618|NCT02564744|155371046|FG003|Overall Study|Death|16|||
48576032|NCT04791319|156299422|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
48576033|NCT04791319|156299423|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
48576034|NCT03124407|156299430|FG000|Overall Study|Lost to Follow-up|1|||
48576035|NCT03124407|156299431|FG001|Overall Study|Lost to Follow-up|0|||
48576036|NCT03124407|156299432|FG002|Overall Study|Lost to Follow-up|0|||
48576037|NCT03124407|156299433|FG003|Overall Study|Lost to Follow-up|0|||
48576038|NCT03124407|156299430|FG000|Overall Study|Adverse Event|0|||
48576039|NCT03124407|156299431|FG001|Overall Study|Adverse Event|0|||
48576040|NCT03124407|156299432|FG002|Overall Study|Adverse Event|1|||
48576041|NCT03124407|156299433|FG003|Overall Study|Adverse Event|0|||
48576042|NCT02045862|156299434|FG000|Overall Study|Death|0|||
48576043|NCT02045862|156299435|FG001|Overall Study|Death|0|||
48576044|NCT02045862|156299436|FG002|Overall Study|Death|1|||
48576045|NCT02045862|156299434|FG000|Overall Study|Miscellaneous|5|||
48576046|NCT02045862|156299435|FG001|Overall Study|Miscellaneous|0|||
48576047|NCT02045862|156299436|FG002|Overall Study|Miscellaneous|8|||
48576048|NCT02045862|156299434|FG000|Overall Study|Withdrawal by Patient|18|||
48576049|NCT02045862|156299435|FG001|Overall Study|Withdrawal by Patient|27|||
48576050|NCT02045862|156299436|FG002|Overall Study|Withdrawal by Patient|57|||
48576051|NCT02045862|156299434|FG000|Overall Study|Protocol Violation|0|||
48576052|NCT02045862|156299435|FG001|Overall Study|Protocol Violation|0|||
48576053|NCT02045862|156299436|FG002|Overall Study|Protocol Violation|6|||
48576054|NCT02045862|156299434|FG000|Overall Study|Lack of Efficacy|8|||
48576055|NCT02045862|156299435|FG001|Overall Study|Lack of Efficacy|4|||
48576056|NCT02045862|156299436|FG002|Overall Study|Lack of Efficacy|13|||
48576057|NCT02045862|156299434|FG000|Overall Study|Randomized but not Received Study Drug|0|||
48576058|NCT02045862|156299435|FG001|Overall Study|Randomized but not Received Study Drug|2|||
48576059|NCT02045862|156299436|FG002|Overall Study|Randomized but not Received Study Drug|8|||
48576060|NCT02045862|156299434|FG000|Overall Study|Adverse Event|7|||
48576061|NCT02045862|156299435|FG001|Overall Study|Adverse Event|5|||
48576062|NCT02045862|156299436|FG002|Overall Study|Adverse Event|27|||
48621427|NCT01429623|156471664|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
48319619|NCT02564744|155371047|FG004|Overall Study|Death|16|||
48319620|NCT02564744|155371043|FG000|Overall Study|End of study Page Missing|0|||
48576063|NCT02045862|156299434|FG000|Overall Study|Lost to Follow-up|1|||
48576064|NCT02045862|156299435|FG001|Overall Study|Lost to Follow-up|2|||
48576065|NCT02045862|156299436|FG002|Overall Study|Lost to Follow-up|6|||
48319621|NCT02564744|155371044|FG001|Overall Study|End of study Page Missing|0|||
48576066|NCT00623935|156299439|FG000|Overall Study|Death|1|||
48576067|NCT00623935|156299439|FG000|Overall Study|Patient Declined Transplant|1|||
48576068|NCT00355147|156299444|FG000|Overall Study|Lost to Follow-up|10|||
48576069|NCT00355147|156299445|FG001|Overall Study|Lost to Follow-up|8|||
48621428|NCT01429623|156471663|FG000|Overall Study|No post baseline data|4|||
48621429|NCT01429623|156471664|FG001|Overall Study|No post baseline data|4|||
48319622|NCT02564744|155371045|FG002|Overall Study|End of study Page Missing|3|||
48576070|NCT00355147|156299444|FG000|Overall Study|Withdrawal by Subject|8|||
48576071|NCT00355147|156299445|FG001|Overall Study|Withdrawal by Subject|12|||
48576072|NCT01704651|156299448|FG000|Overall Study|Pre-op withdrawal by subject|1|||
48576073|NCT01704651|156299449|FG001|Overall Study|Pre-op withdrawal by subject|1|||
48576074|NCT01704651|156299448|FG000|Overall Study|Pre-op change in treatment plan|1|||
48576075|NCT01704651|156299449|FG001|Overall Study|Pre-op change in treatment plan|4|||
48576076|NCT01704651|156299448|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
48576077|NCT01704651|156299449|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
48576078|NCT01704651|156299448|FG000|Overall Study|Post-op did not have laparotomy|2|||
48576079|NCT01704651|156299449|FG001|Overall Study|Post-op did not have laparotomy|1|||
48576080|NCT03164564|156299454|FG000|Overall Study|Death|3|||
48576081|NCT03164564|156299455|FG001|Overall Study|Death|0|||
48576082|NCT03164564|156299454|FG000|Overall Study|Withdrawal by Subject|20|||
48576083|NCT03164564|156299455|FG001|Overall Study|Withdrawal by Subject|15|||
48576084|NCT03164564|156299454|FG000|Overall Study|Lost to Follow-up|2|||
48576085|NCT03164564|156299455|FG001|Overall Study|Lost to Follow-up|0|||
48576086|NCT03164564|156299454|FG000|Overall Study|Physician Decision|0|||
48576087|NCT03164564|156299455|FG001|Overall Study|Physician Decision|1|||
48576088|NCT03164564|156299454|FG000|Overall Study|Adverse Event|0|||
48576089|NCT03164564|156299455|FG001|Overall Study|Adverse Event|1|||
48576090|NCT03164564|156299454|FG000|Overall Study|Ongoing|1586|||
48576091|NCT03164564|156299455|FG001|Overall Study|Ongoing|1586|||
48621430|NCT00981175|156471665|FG000|Primary Dose Vaccination|Adverse Event|1|||
48621431|NCT00981175|156471666|FG001|Primary Dose Vaccination|Adverse Event|0|||
48621432|NCT00981175|156471665|FG000|Primary Dose Vaccination|Protocol Violation|0|||
48621433|NCT00981175|156471666|FG001|Primary Dose Vaccination|Protocol Violation|1|||
48621434|NCT00981175|156471665|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
48621435|NCT00981175|156471666|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
48621436|NCT00981175|156471665|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
48621437|NCT00981175|156471666|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
48621438|NCT01096186|156471668|FG000|Overall Study|Adverse Event|16|||
48621439|NCT01096186|156471668|FG000|Overall Study|Death|4|||
48621440|NCT01096186|156471668|FG000|Overall Study|Lack of Efficacy|4|||
48621441|NCT01096186|156471668|FG000|Overall Study|Lost to Follow-up|2|||
48621442|NCT01096186|156471668|FG000|Overall Study|Withdrawal by Subject|22|||
48621443|NCT01096186|156471668|FG000|Overall Study|Physician Decision|1|||
48621444|NCT01096186|156471668|FG000|Overall Study|Noncompliance with study drug|1|||
48621445|NCT01061710|156471669|FG000|Overall Study|Protocol Violation|14|||
48621446|NCT03473301|156471670|FG000|Overall Study|Protocol Violation|4|||
48621447|NCT03473301|156471671|FG001|Overall Study|Protocol Violation|0|||
48621448|NCT03473301|156471672|FG002|Overall Study|Protocol Violation|0|||
48621449|NCT03473301|156471670|FG000|Overall Study|Withdrawal by Subject|0|||
48621450|NCT03473301|156471671|FG001|Overall Study|Withdrawal by Subject|1|||
48621451|NCT03473301|156471672|FG002|Overall Study|Withdrawal by Subject|0|||
48621452|NCT03473301|156471670|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
48621453|NCT03473301|156471671|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
48621454|NCT03473301|156471672|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
48621455|NCT04913675|156471673|FG000|Main Study (Up to Week 36)|Death|0|||
48621456|NCT04913675|156471674|FG001|Main Study (Up to Week 36)|Death|2|||
48621457|NCT04913675|156471675|FG002|Main Study (Up to Week 36)|Death|2|||
48621458|NCT04913675|156471676|FG003|Main Study (Up to Week 36)|Death|0|||
48621459|NCT04913675|156471673|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
48621460|NCT04913675|156471674|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
48621461|NCT04913675|156471675|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
48621462|NCT04913675|156471676|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
48621463|NCT04913675|156471673|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
48621464|NCT04913675|156471674|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
48621465|NCT04913675|156471675|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
48576092|NCT01252563|156299462|FG000|Overall Study|Contract Deviation|41|||
48621466|NCT04913675|156471676|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
48621467|NCT04913675|156471673|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
48450060|NCT01614795|155835557|FG000|Overall Study|Physician Decision|1|||
48621468|NCT04913675|156471674|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
48621469|NCT04913675|156471675|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
48621470|NCT04913675|156471676|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
48621471|NCT04913675|156471673|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
48621472|NCT04913675|156471674|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
48736077|NCT00866788|156885626|FG001|Overall Study|Pregnancy|1|||
48450061|NCT01614795|155835558|FG001|Overall Study|Physician Decision|0|||
48576093|NCT01252563|156299462|FG000|Overall Study|Centralized Registration Deviation|30|||
48319623|NCT02564744|155371046|FG003|Overall Study|End of study Page Missing|3|||
48576094|NCT01252563|156299462|FG000|Overall Study|Lost to Follow-up|161|||
48576095|NCT01252563|156299462|FG000|Overall Study|No visit after first day of treatment|194|||
48576096|NCT01252563|156299462|FG000|Overall Study|No drug administration|6|||
48576097|NCT01866657|156299463|FG000|Overall Study|Surgery canceled|2|||
48576098|NCT01866657|156299464|FG001|Overall Study|Surgery canceled|0|||
48576099|NCT01880086|156299465|FG000|Overall Study|Lost to Follow-up|1|||
48576100|NCT01880086|156299466|FG001|Overall Study|Lost to Follow-up|1|||
48576101|NCT03919695|156299469|FG000|3-month Follow-up|Death|1|||
48576102|NCT03919695|156299470|FG001|3-month Follow-up|Death|1|||
48576103|NCT03919695|156299469|FG000|3-month Follow-up|unable to contact|0|||
48576104|NCT03919695|156299470|FG001|3-month Follow-up|unable to contact|3|||
48576105|NCT03919695|156299469|FG000|3-month Follow-up|in prison|0|||
48576106|NCT03919695|156299470|FG001|3-month Follow-up|in prison|1|||
48576107|NCT03919695|156299469|FG000|6-month Follow-up|Death|0|||
48576108|NCT03919695|156299470|FG001|6-month Follow-up|Death|1|||
48576109|NCT03919695|156299469|FG000|6-month Follow-up|Lost to Follow-up|1|||
48576110|NCT03919695|156299470|FG001|6-month Follow-up|Lost to Follow-up|2|||
48576111|NCT03919695|156299469|FG000|6-month Follow-up|in prison|0|||
48576112|NCT03919695|156299470|FG001|6-month Follow-up|in prison|2|||
48576113|NCT03919695|156299469|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
48576114|NCT03919695|156299470|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
48576115|NCT03919695|156299469|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
48576116|NCT03919695|156299470|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
48576117|NCT01032239|156299471|FG000|Overall Study|Lost to Follow-up|3|||
48576118|NCT01032239|156299472|FG001|Overall Study|Lost to Follow-up|2|||
48576119|NCT01032239|156299471|FG000|Overall Study|Withdrawal by Subject|2|||
48576120|NCT01032239|156299472|FG001|Overall Study|Withdrawal by Subject|3|||
48576121|NCT01032239|156299471|FG000|Overall Study|Death|1|||
48576122|NCT01032239|156299472|FG001|Overall Study|Death|0|||
48576123|NCT01032239|156299471|FG000|Overall Study|Protocol Violation|1|||
48576124|NCT01032239|156299472|FG001|Overall Study|Protocol Violation|0|||
48576125|NCT02272842|156299474|FG000|Overall Study|Lost to Follow-up|8|||
48576126|NCT02272842|156299475|FG001|Overall Study|Lost to Follow-up|8|||
48576127|NCT02272842|156299474|FG000|Overall Study|Withdrawal by Subject|8|||
48576128|NCT02272842|156299475|FG001|Overall Study|Withdrawal by Subject|2|||
48576129|NCT02752165|156301870|FG000|Overall Study|Withdrawal by Subject|6|||
48576130|NCT02752165|156301871|FG001|Overall Study|Withdrawal by Subject|6|||
48576131|NCT02752165|156301870|FG000|Overall Study|Protocol Violation|6|||
48576132|NCT02752165|156301871|FG001|Overall Study|Protocol Violation|5|||
48576133|NCT02752165|156301870|FG000|Overall Study|Lost to Follow-up|33|||
48576134|NCT02752165|156301871|FG001|Overall Study|Lost to Follow-up|38|||
48576135|NCT03555565|156301877|FG000|Overall Study|Case Report Forms Uncollected|2|||
48576136|NCT03555565|156301877|FG000|Overall Study|Protocol Deviation|13|||
48576137|NCT03557931|156301882|FG000|Overall Study|Adverse Event|4|||
48576138|NCT03557931|156301883|FG001|Overall Study|Adverse Event|6|||
48576139|NCT03557931|156301884|FG002|Overall Study|Adverse Event|1|||
48576140|NCT03557931|156301882|FG000|Overall Study|Lost to Follow-up|4|||
48576141|NCT03557931|156301883|FG001|Overall Study|Lost to Follow-up|4|||
48576142|NCT03557931|156301884|FG002|Overall Study|Lost to Follow-up|1|||
48576143|NCT03557931|156301882|FG000|Overall Study|Protocol Violation|1|||
48576144|NCT03557931|156301883|FG001|Overall Study|Protocol Violation|4|||
48576145|NCT03557931|156301884|FG002|Overall Study|Protocol Violation|1|||
48576146|NCT03557931|156301882|FG000|Overall Study|Withdrawal by Subject|14|||
48576147|NCT03557931|156301883|FG001|Overall Study|Withdrawal by Subject|0|||
48576148|NCT03557931|156301884|FG002|Overall Study|Withdrawal by Subject|7|||
48576149|NCT03557931|156301882|FG000|Overall Study|Miscellaneous|8|||
48576150|NCT03557931|156301883|FG001|Overall Study|Miscellaneous|5|||
48576151|NCT03557931|156301884|FG002|Overall Study|Miscellaneous|3|||
48319624|NCT02564744|155371047|FG004|Overall Study|End of study Page Missing|0|||
48319625|NCT02564744|155371043|FG000|Overall Study|Subject Withdrew Consent|1|||
48319626|NCT02564744|155371044|FG001|Overall Study|Subject Withdrew Consent|1|||
48319627|NCT02564744|155371045|FG002|Overall Study|Subject Withdrew Consent|1|||
48319628|NCT02564744|155371046|FG003|Overall Study|Subject Withdrew Consent|0|||
48319629|NCT02564744|155371047|FG004|Overall Study|Subject Withdrew Consent|2|||
48621473|NCT04913675|156471675|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
48621474|NCT04913675|156471676|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
48621475|NCT04648241|156471677|FG000|Overall Study|Lost to Follow-up|1|||
48621476|NCT04648241|156471678|FG001|Overall Study|Lost to Follow-up|0|||
48621477|NCT02569242|156471679|FG000|Overall Study|Death|1|||
48621478|NCT02569242|156471680|FG001|Overall Study|Death|0|||
48621479|NCT02569242|156471679|FG000|Overall Study|Withdrawal by Subject|0|||
48621480|NCT02569242|156471680|FG001|Overall Study|Withdrawal by Subject|1|||
48621481|NCT02218268|156471681|FG000|24 Hour Washout|Physician Decision|11|||
48621482|NCT02218268|156471682|FG001|24 Hour Washout|Physician Decision|9|||
48621483|NCT00689052|156471683|FG000|Overall Study|Adverse Event|4|||
48621484|NCT00689052|156471684|FG001|Overall Study|Adverse Event|6|||
48621485|NCT00689052|156471683|FG000|Overall Study|Protocol Violation|1|||
48621486|NCT00689052|156471684|FG001|Overall Study|Protocol Violation|0|||
48621487|NCT00689052|156471683|FG000|Overall Study|Lost to Follow-up|2|||
48621488|NCT00689052|156471684|FG001|Overall Study|Lost to Follow-up|0|||
48621489|NCT00689052|156471683|FG000|Overall Study|Withdrawal by Subject|2|||
48621490|NCT00689052|156471684|FG001|Overall Study|Withdrawal by Subject|0|||
48621491|NCT00689052|156471683|FG000|Overall Study|Early termination of the trial|22|||
48621492|NCT00689052|156471684|FG001|Overall Study|Early termination of the trial|24|||
48621493|NCT01117350|156471687|FG000|Comparative Period|Not Treated|5|||
48621494|NCT01117350|156471688|FG001|Comparative Period|Not Treated|8|||
48621495|NCT01117350|156471687|FG000|Comparative Period|Adverse Event|6|||
48621496|NCT01117350|156471688|FG001|Comparative Period|Adverse Event|33|||
48621497|NCT01117350|156471687|FG000|Comparative Period|Lost to Follow-up|11|||
48621498|NCT01117350|156471688|FG001|Comparative Period|Lost to Follow-up|7|||
48621499|NCT01117350|156471687|FG000|Comparative Period|Withdrawal by Subject|9|||
48621500|NCT01117350|156471688|FG001|Comparative Period|Withdrawal by Subject|13|||
48621501|NCT01117350|156471687|FG000|Comparative Period|Protocol Violation|8|||
48621502|NCT01117350|156471688|FG001|Comparative Period|Protocol Violation|12|||
48621503|NCT01117350|156471687|FG000|Comparative Period|Lack of Efficacy|1|||
48621504|NCT01117350|156471688|FG001|Comparative Period|Lack of Efficacy|0|||
48621505|NCT01117350|156471687|FG000|Comparative Period|Physician Decision|0|||
48621506|NCT01117350|156471688|FG001|Comparative Period|Physician Decision|1|||
48621507|NCT01117350|156471687|FG000|Comparative Period|Move to another city/country|2|||
48621508|NCT01117350|156471688|FG001|Comparative Period|Move to another city/country|1|||
48621509|NCT01117350|156471687|FG000|Extension Period|Not included in extension, not treated|0|||
48621510|NCT01117350|156471688|FG001|Extension Period|Not included in extension, not treated|50|||
48621511|NCT01117350|156471687|FG000|Extension Period|Adverse Event|0|||
48621512|NCT01117350|156471688|FG001|Extension Period|Adverse Event|2|||
48621513|NCT01117350|156471687|FG000|Extension Period|Protocol Violation|0|||
48621514|NCT01117350|156471688|FG001|Extension Period|Protocol Violation|2|||
48621515|NCT01117350|156471687|FG000|Extension Period|Lost to Follow-up|0|||
48621516|NCT01117350|156471688|FG001|Extension Period|Lost to Follow-up|2|||
48576152|NCT01860040|156301887|FG000|Overall Study|Withdrawal by Subject|1|||
48319630|NCT02564744|155371043|FG000|Overall Study|Lost to Follow-up|0|||
48319631|NCT02564744|155371044|FG001|Overall Study|Lost to Follow-up|1|||
48319632|NCT02564744|155371045|FG002|Overall Study|Lost to Follow-up|0|||
48319633|NCT02564744|155371046|FG003|Overall Study|Lost to Follow-up|0|||
48319634|NCT02564744|155371047|FG004|Overall Study|Lost to Follow-up|1|||
48319635|NCT02564744|155371043|FG000|Overall Study|Reason not specified|1|||
48319636|NCT02564744|155371044|FG001|Overall Study|Reason not specified|0|||
48319637|NCT02564744|155371045|FG002|Overall Study|Reason not specified|0|||
48319638|NCT02564744|155371046|FG003|Overall Study|Reason not specified|0|||
48319639|NCT02564744|155371047|FG004|Overall Study|Reason not specified|0|||
48319640|NCT02765100|155371054|FG000|Overall Study|subject found ineligible after baseline|1|||
48319641|NCT02765100|155371055|FG001|Overall Study|subject found ineligible after baseline|1|||
48319642|NCT02765100|155371054|FG000|Overall Study|Lost to Follow-up|0|||
48319643|NCT02765100|155371055|FG001|Overall Study|Lost to Follow-up|1|||
48319644|NCT02675244|155371063|FG000|Overall Study|Death|9|||
48319645|NCT02675244|155371064|FG001|Overall Study|Death|6|||
48319646|NCT02675244|155371063|FG000|Overall Study|Withdrawal by Subject|3|||
48319647|NCT02675244|155371064|FG001|Overall Study|Withdrawal by Subject|6|||
48319648|NCT02675244|155371063|FG000|Overall Study|Lost to Follow-up|1|||
48319649|NCT02675244|155371064|FG001|Overall Study|Lost to Follow-up|1|||
48319650|NCT02675244|155371063|FG000|Overall Study|Ongoing at 2 Years|190|||
48319651|NCT02675244|155371064|FG001|Overall Study|Ongoing at 2 Years|185|||
48319652|NCT00071799|155371065|FG000|Overall Study|Adverse Event|19|||
48319653|NCT00071799|155371066|FG001|Overall Study|Adverse Event|10|||
48319654|NCT00071799|155371065|FG000|Overall Study|Protocol Violation|1|||
48319655|NCT00071799|155371066|FG001|Overall Study|Protocol Violation|7|||
48319656|NCT00071799|155371065|FG000|Overall Study|Lost to Follow-up|1|||
48319657|NCT00071799|155371066|FG001|Overall Study|Lost to Follow-up|1|||
48576153|NCT01860040|156301888|FG001|Overall Study|Withdrawal by Subject|0|||
48576154|NCT02394340|156301889|FG000|Overall Study|Failed drug screen test|1|||
48576155|NCT02394340|156301889|FG000|Overall Study|Adverse Event|1|||
48576156|NCT03315286|156301890|FG000|Overall Study|Lost to Follow-up|0|||
48576157|NCT03315286|156301891|FG001|Overall Study|Lost to Follow-up|3|||
48576158|NCT03315286|156301890|FG000|Overall Study|Withdrawal by Subject|1|||
48576159|NCT03315286|156301891|FG001|Overall Study|Withdrawal by Subject|0|||
48576160|NCT03315286|156301890|FG000|Overall Study|Protocol Violation|0|||
48576161|NCT03315286|156301891|FG001|Overall Study|Protocol Violation|1|||
48319658|NCT00071799|155371065|FG000|Overall Study|Withdrawal by Subject|15|||
48319659|NCT00071799|155371066|FG001|Overall Study|Withdrawal by Subject|37|||
48319660|NCT00071799|155371065|FG000|Overall Study|Physician Decision|0|||
48319661|NCT00071799|155371066|FG001|Overall Study|Physician Decision|2|||
48319662|NCT00071799|155371065|FG000|Overall Study|Lack of Efficacy|11|||
48576162|NCT02828124|156301892|FG000|Overall Study|Disease Progression|1|||
48576163|NCT02828124|156301893|FG001|Overall Study|Disease Progression|2|||
48576164|NCT02828124|156301894|FG002|Overall Study|Disease Progression|1|||
48576165|NCT02828124|156301895|FG003|Overall Study|Disease Progression|4|||
48576166|NCT02828124|156301892|FG000|Overall Study|AE Unrelated to Study Drug|0|||
48576167|NCT02828124|156301893|FG001|Overall Study|AE Unrelated to Study Drug|0|||
48576168|NCT02828124|156301894|FG002|Overall Study|AE Unrelated to Study Drug|0|||
48576169|NCT02828124|156301895|FG003|Overall Study|AE Unrelated to Study Drug|1|||
48576170|NCT02828124|156301892|FG000|Overall Study|Subject Withdrew Consent|0|||
48576171|NCT02828124|156301893|FG001|Overall Study|Subject Withdrew Consent|0|||
48576172|NCT02828124|156301894|FG002|Overall Study|Subject Withdrew Consent|0|||
48576173|NCT02828124|156301895|FG003|Overall Study|Subject Withdrew Consent|1|||
48621517|NCT01117350|156471687|FG000|Extension Period|Withdrawal by Subject|0|||
48319663|NCT00071799|155371066|FG001|Overall Study|Lack of Efficacy|18|||
48319664|NCT00071799|155371065|FG000|Overall Study|Disease Progression|23|||
48319665|NCT00071799|155371066|FG001|Overall Study|Disease Progression|20|||
48576174|NCT00747474|156301896|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48621518|NCT01117350|156471688|FG001|Extension Period|Withdrawal by Subject|3|||
48621519|NCT01117350|156471687|FG000|Extension Period|Lack of Efficacy|0|||
48621520|NCT01117350|156471688|FG001|Extension Period|Lack of Efficacy|2|||
48621521|NCT01117350|156471687|FG000|Extension Period|Inclusion criteria not respected|0|||
48621522|NCT01117350|156471688|FG001|Extension Period|Inclusion criteria not respected|1|||
48621523|NCT01117350|156471687|FG000|Extension Period|Prohibited medication|0|||
48621524|NCT01117350|156471688|FG001|Extension Period|Prohibited medication|1|||
48621525|NCT02975700|156471695|FG000|Overall Study|Adverse Event|1|||
48621526|NCT02975700|156471695|FG000|Overall Study|Progressive disease|3|||
48621527|NCT02975700|156471695|FG000|Overall Study|Failed screening criteria|2|||
48621528|NCT03511209|156471696|FG000|Overall Study|Withdrawal by Subject|2|||
48621529|NCT03511209|156471697|FG001|Overall Study|Withdrawal by Subject|4|||
48621530|NCT03511209|156471696|FG000|Overall Study|Death|1|||
48621531|NCT03511209|156471697|FG001|Overall Study|Death|0|||
48621532|NCT03511209|156471696|FG000|Overall Study|Lost to Follow-up|0|||
48621533|NCT03511209|156471697|FG001|Overall Study|Lost to Follow-up|2|||
48621534|NCT03462563|156471701|FG000|Overall Study|Death|1|||
48621535|NCT03462563|156471702|FG001|Overall Study|Death|1|||
48621536|NCT03462563|156471701|FG000|Overall Study|Termination of study|2|||
48621537|NCT03462563|156471702|FG001|Overall Study|Termination of study|1|||
48621538|NCT03462563|156471701|FG000|Overall Study|Adverse Event|1|||
48621539|NCT03462563|156471702|FG001|Overall Study|Adverse Event|3|||
48621540|NCT03462563|156471701|FG000|Overall Study|Unspecified reason|10|||
48319666|NCT00071799|155371065|FG000|Overall Study|Different Central+Local Pathology Review|0|||
48319667|NCT00071799|155371066|FG001|Overall Study|Different Central+Local Pathology Review|1|||
48319668|NCT00071799|155371065|FG000|Overall Study|Not Documented|0|||
48576175|NCT00747474|156301897|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576176|NCT00747474|156301898|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576177|NCT00747474|156301899|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576178|NCT00747474|156301900|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48621541|NCT03462563|156471702|FG001|Overall Study|Unspecified reason|12|||
48621542|NCT03462563|156471701|FG000|Overall Study|Physician Decision|1|||
48319669|NCT00071799|155371066|FG001|Overall Study|Not Documented|2|||
48319670|NCT00391898|155371067|FG000|Overall Study|Adverse Event|3|||
48319671|NCT00391898|155371068|FG001|Overall Study|Adverse Event|0|||
48319672|NCT00391898|155371067|FG000|Overall Study|Other|8|||
48319673|NCT00391898|155371068|FG001|Overall Study|Other|10|||
48576179|NCT00747474|156301901|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576180|NCT00747474|156301902|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576181|NCT00747474|156301903|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
48621543|NCT03462563|156471702|FG001|Overall Study|Physician Decision|0|||
48576182|NCT00747474|156301904|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576183|NCT00747474|156301905|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576184|NCT00747474|156301906|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576185|NCT00747474|156301907|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
48576186|NCT01931995|156301916|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
48576187|NCT01931995|156301917|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
48576188|NCT01931995|156301916|FG000|First Intervention (1 Day)|Physician Decision|1|||
48576189|NCT01931995|156301917|FG001|First Intervention (1 Day)|Physician Decision|1|||
48576190|NCT01931995|156301916|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
48576191|NCT01931995|156301917|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
48576192|NCT02829723|156301918|FG000|Overall Study|Adverse Event|0|||
48576193|NCT02829723|156301919|FG001|Overall Study|Adverse Event|0|||
48576194|NCT02829723|156301920|FG002|Overall Study|Adverse Event|1|||
48576195|NCT02829723|156301921|FG003|Overall Study|Adverse Event|1|||
48576196|NCT02829723|156301922|FG004|Overall Study|Adverse Event|0|||
48576197|NCT02829723|156301923|FG005|Overall Study|Adverse Event|0|||
48576198|NCT02829723|156301924|FG006|Overall Study|Adverse Event|0|||
48576199|NCT02829723|156301925|FG007|Overall Study|Adverse Event|1|||
48576200|NCT02829723|156301926|FG008|Overall Study|Adverse Event|0|||
48576201|NCT02829723|156301927|FG009|Overall Study|Adverse Event|0|||
48576202|NCT02829723|156301928|FG010|Overall Study|Adverse Event|0|||
48576203|NCT02829723|156301929|FG011|Overall Study|Adverse Event|0|||
48576204|NCT02829723|156301930|FG012|Overall Study|Adverse Event|0|||
48576205|NCT02829723|156301931|FG013|Overall Study|Adverse Event|0|||
48576206|NCT02829723|156301932|FG014|Overall Study|Adverse Event|1|||
48576207|NCT02829723|156301933|FG015|Overall Study|Adverse Event|1|||
48576208|NCT02829723|156301934|FG016|Overall Study|Adverse Event|1|||
48576209|NCT02829723|156301935|FG017|Overall Study|Adverse Event|2|||
48576210|NCT02829723|156301936|FG018|Overall Study|Adverse Event|1|||
48576211|NCT02829723|156301937|FG019|Overall Study|Adverse Event|1|||
48576212|NCT02829723|156301938|FG020|Overall Study|Adverse Event|3|||
48576213|NCT02829723|156301939|FG021|Overall Study|Adverse Event|0|||
48576214|NCT02829723|156301940|FG022|Overall Study|Adverse Event|0|||
48576215|NCT02829723|156301941|FG023|Overall Study|Adverse Event|1|||
48576216|NCT02829723|156301942|FG024|Overall Study|Adverse Event|1|||
48576217|NCT02829723|156301943|FG025|Overall Study|Adverse Event|3|||
48576218|NCT02829723|156301944|FG026|Overall Study|Adverse Event|5|||
48576219|NCT02829723|156301918|FG000|Overall Study|Death|1|||
48576220|NCT02829723|156301919|FG001|Overall Study|Death|0|||
48576221|NCT02829723|156301920|FG002|Overall Study|Death|1|||
48576222|NCT02829723|156301921|FG003|Overall Study|Death|1|||
48576223|NCT02829723|156301922|FG004|Overall Study|Death|0|||
48576224|NCT02829723|156301923|FG005|Overall Study|Death|0|||
48576225|NCT02829723|156301924|FG006|Overall Study|Death|2|||
48576226|NCT02829723|156301925|FG007|Overall Study|Death|0|||
48576227|NCT02829723|156301926|FG008|Overall Study|Death|1|||
48576228|NCT02829723|156301927|FG009|Overall Study|Death|0|||
48576229|NCT02829723|156301928|FG010|Overall Study|Death|0|||
48576230|NCT02829723|156301929|FG011|Overall Study|Death|0|||
48576231|NCT02829723|156301930|FG012|Overall Study|Death|2|||
48576232|NCT02829723|156301931|FG013|Overall Study|Death|1|||
48576233|NCT02829723|156301932|FG014|Overall Study|Death|0|||
48576234|NCT02829723|156301933|FG015|Overall Study|Death|0|||
48576235|NCT02829723|156301934|FG016|Overall Study|Death|0|||
48576236|NCT02829723|156301935|FG017|Overall Study|Death|0|||
48576237|NCT02829723|156301936|FG018|Overall Study|Death|0|||
48576238|NCT02829723|156301937|FG019|Overall Study|Death|0|||
48576239|NCT02829723|156301938|FG020|Overall Study|Death|0|||
48576240|NCT02829723|156301939|FG021|Overall Study|Death|2|||
48576241|NCT02829723|156301940|FG022|Overall Study|Death|0|||
48576242|NCT02829723|156301941|FG023|Overall Study|Death|0|||
48576243|NCT02829723|156301942|FG024|Overall Study|Death|0|||
48576244|NCT02829723|156301943|FG025|Overall Study|Death|1|||
48576245|NCT02829723|156301944|FG026|Overall Study|Death|2|||
48576246|NCT02829723|156301918|FG000|Overall Study|Physician Decision|0|||
48576247|NCT02829723|156301919|FG001|Overall Study|Physician Decision|0|||
48576248|NCT02829723|156301920|FG002|Overall Study|Physician Decision|0|||
48576249|NCT02829723|156301921|FG003|Overall Study|Physician Decision|0|||
48576250|NCT02829723|156301922|FG004|Overall Study|Physician Decision|0|||
48576251|NCT02829723|156301923|FG005|Overall Study|Physician Decision|0|||
48576252|NCT02829723|156301924|FG006|Overall Study|Physician Decision|0|||
48576253|NCT02829723|156301925|FG007|Overall Study|Physician Decision|0|||
48576254|NCT02829723|156301926|FG008|Overall Study|Physician Decision|0|||
48576255|NCT02829723|156301927|FG009|Overall Study|Physician Decision|1|||
48576256|NCT02829723|156301928|FG010|Overall Study|Physician Decision|1|||
48576257|NCT02829723|156301929|FG011|Overall Study|Physician Decision|0|||
48576258|NCT02829723|156301930|FG012|Overall Study|Physician Decision|0|||
48576259|NCT02829723|156301931|FG013|Overall Study|Physician Decision|1|||
48576260|NCT02829723|156301932|FG014|Overall Study|Physician Decision|0|||
48576261|NCT02829723|156301933|FG015|Overall Study|Physician Decision|0|||
48576262|NCT02829723|156301934|FG016|Overall Study|Physician Decision|2|||
48576263|NCT02829723|156301935|FG017|Overall Study|Physician Decision|0|||
48576264|NCT02829723|156301936|FG018|Overall Study|Physician Decision|0|||
48576265|NCT02829723|156301937|FG019|Overall Study|Physician Decision|0|||
48576266|NCT02829723|156301938|FG020|Overall Study|Physician Decision|0|||
48576267|NCT02829723|156301939|FG021|Overall Study|Physician Decision|0|||
48576268|NCT02829723|156301940|FG022|Overall Study|Physician Decision|1|||
48576269|NCT02829723|156301941|FG023|Overall Study|Physician Decision|1|||
48576270|NCT02829723|156301942|FG024|Overall Study|Physician Decision|1|||
48576271|NCT02829723|156301943|FG025|Overall Study|Physician Decision|1|||
48576272|NCT02829723|156301944|FG026|Overall Study|Physician Decision|3|||
48576273|NCT02829723|156301918|FG000|Overall Study|Progressive disease|4|||
48576274|NCT02829723|156301919|FG001|Overall Study|Progressive disease|6|||
48576275|NCT02829723|156301920|FG002|Overall Study|Progressive disease|3|||
48576276|NCT02829723|156301921|FG003|Overall Study|Progressive disease|3|||
48576277|NCT02829723|156301922|FG004|Overall Study|Progressive disease|3|||
48576278|NCT02829723|156301923|FG005|Overall Study|Progressive disease|5|||
48576279|NCT02829723|156301924|FG006|Overall Study|Progressive disease|4|||
48576280|NCT02829723|156301925|FG007|Overall Study|Progressive disease|6|||
48576281|NCT02829723|156301926|FG008|Overall Study|Progressive disease|8|||
48576282|NCT02829723|156301927|FG009|Overall Study|Progressive disease|4|||
48576283|NCT02829723|156301928|FG010|Overall Study|Progressive disease|9|||
48576284|NCT02829723|156301929|FG011|Overall Study|Progressive disease|0|||
48576285|NCT02829723|156301930|FG012|Overall Study|Progressive disease|3|||
48576286|NCT02829723|156301931|FG013|Overall Study|Progressive disease|4|||
48576287|NCT02829723|156301932|FG014|Overall Study|Progressive disease|2|||
48576288|NCT02829723|156301933|FG015|Overall Study|Progressive disease|4|||
48576289|NCT02829723|156301934|FG016|Overall Study|Progressive disease|5|||
48576290|NCT02829723|156301935|FG017|Overall Study|Progressive disease|3|||
48576291|NCT02829723|156301936|FG018|Overall Study|Progressive disease|4|||
48576292|NCT02829723|156301937|FG019|Overall Study|Progressive disease|4|||
48576293|NCT02829723|156301938|FG020|Overall Study|Progressive disease|7|||
48576294|NCT02829723|156301939|FG021|Overall Study|Progressive disease|6|||
48576295|NCT02829723|156301940|FG022|Overall Study|Progressive disease|3|||
48576296|NCT02829723|156301941|FG023|Overall Study|Progressive disease|3|||
48576297|NCT02829723|156301942|FG024|Overall Study|Progressive disease|3|||
48576298|NCT02829723|156301943|FG025|Overall Study|Progressive disease|16|||
48576299|NCT02829723|156301944|FG026|Overall Study|Progressive disease|10|||
48576300|NCT02829723|156301918|FG000|Overall Study|Subject/guardian decision|0|||
48576301|NCT02829723|156301919|FG001|Overall Study|Subject/guardian decision|1|||
48576302|NCT02829723|156301920|FG002|Overall Study|Subject/guardian decision|0|||
48576303|NCT02829723|156301921|FG003|Overall Study|Subject/guardian decision|1|||
48576304|NCT02829723|156301922|FG004|Overall Study|Subject/guardian decision|0|||
48576305|NCT02829723|156301923|FG005|Overall Study|Subject/guardian decision|0|||
48576306|NCT02829723|156301924|FG006|Overall Study|Subject/guardian decision|0|||
48576307|NCT02829723|156301925|FG007|Overall Study|Subject/guardian decision|1|||
48576308|NCT02829723|156301926|FG008|Overall Study|Subject/guardian decision|0|||
48576309|NCT02829723|156301927|FG009|Overall Study|Subject/guardian decision|0|||
48576310|NCT02829723|156301928|FG010|Overall Study|Subject/guardian decision|0|||
48576311|NCT02829723|156301929|FG011|Overall Study|Subject/guardian decision|0|||
48576312|NCT02829723|156301930|FG012|Overall Study|Subject/guardian decision|0|||
48576313|NCT02829723|156301931|FG013|Overall Study|Subject/guardian decision|0|||
48576314|NCT02829723|156301932|FG014|Overall Study|Subject/guardian decision|1|||
48576315|NCT02829723|156301933|FG015|Overall Study|Subject/guardian decision|0|||
48576316|NCT02829723|156301934|FG016|Overall Study|Subject/guardian decision|1|||
48576317|NCT02829723|156301935|FG017|Overall Study|Subject/guardian decision|0|||
48576318|NCT02829723|156301936|FG018|Overall Study|Subject/guardian decision|1|||
48576319|NCT02829723|156301937|FG019|Overall Study|Subject/guardian decision|0|||
48576320|NCT02829723|156301938|FG020|Overall Study|Subject/guardian decision|1|||
48576321|NCT02829723|156301939|FG021|Overall Study|Subject/guardian decision|0|||
48576322|NCT02829723|156301940|FG022|Overall Study|Subject/guardian decision|0|||
48621544|NCT02021318|156471703|FG000|Overall Study|Adverse Event|2|||
48621545|NCT02021318|156471704|FG001|Overall Study|Adverse Event|1|||
48621546|NCT02021318|156471703|FG000|Overall Study|Death|33|||
48621547|NCT02021318|156471704|FG001|Overall Study|Death|34|||
48621548|NCT02021318|156471703|FG000|Overall Study|Lost to Follow-up|3|||
48621549|NCT02021318|156471704|FG001|Overall Study|Lost to Follow-up|3|||
48621550|NCT02021318|156471703|FG000|Overall Study|Progressive Disease|0|||
48621551|NCT02021318|156471704|FG001|Overall Study|Progressive Disease|1|||
48576323|NCT02829723|156301941|FG023|Overall Study|Subject/guardian decision|1|||
48621552|NCT02021318|156471703|FG000|Overall Study|Withdrawal by Subject|30|||
48621553|NCT02021318|156471704|FG001|Overall Study|Withdrawal by Subject|18|||
48576324|NCT02829723|156301942|FG024|Overall Study|Subject/guardian decision|0|||
48576325|NCT02829723|156301943|FG025|Overall Study|Subject/guardian decision|1|||
48576326|NCT02829723|156301944|FG026|Overall Study|Subject/guardian decision|1|||
48576327|NCT02829723|156301918|FG000|Overall Study|Study terminated by sponsor|0|||
48576328|NCT02829723|156301919|FG001|Overall Study|Study terminated by sponsor|0|||
48621554|NCT02021318|156471703|FG000|Overall Study|Physician Decision|3|||
48621555|NCT02021318|156471704|FG001|Overall Study|Physician Decision|3|||
48621556|NCT02021318|156471703|FG000|Overall Study|Miscellaneous|2|||
48621557|NCT02021318|156471704|FG001|Overall Study|Miscellaneous|3|||
48621558|NCT01602666|156471705|FG000|Induction Chemotherapy|Death|2|||
48621559|NCT01602666|156471706|FG001|Induction Chemotherapy|Death|1|||
48576329|NCT02829723|156301920|FG002|Overall Study|Study terminated by sponsor|0|||
48576330|NCT02829723|156301921|FG003|Overall Study|Study terminated by sponsor|0|||
48319690|NCT02755116|155371075|FG000|Overall Study|surgery converted to open, pt admitted|3|||
48319691|NCT02755116|155371076|FG001|Overall Study|surgery converted to open, pt admitted|1|||
48319692|NCT01266122|155371077|FG000|Overall Study|Lost to Follow-up|6|||
48319693|NCT01266122|155371078|FG001|Overall Study|Lost to Follow-up|6|||
48319694|NCT03756571|155371079|FG000|Overall Study|Lost to Follow-up|1|||
48319695|NCT03756571|155371080|FG001|Overall Study|Lost to Follow-up|1|||
48319696|NCT00978042|155371081|FG000|Initial Treatment Period|Treated in Error|0|||
48319697|NCT00978042|155371082|FG001|Initial Treatment Period|Treated in Error|3|||
48576331|NCT02829723|156301922|FG004|Overall Study|Study terminated by sponsor|0|||
48621560|NCT01602666|156471705|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
48621561|NCT01602666|156471706|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
48576332|NCT02829723|156301923|FG005|Overall Study|Study terminated by sponsor|0|||
48576333|NCT02829723|156301924|FG006|Overall Study|Study terminated by sponsor|0|||
48576334|NCT02829723|156301925|FG007|Overall Study|Study terminated by sponsor|0|||
48576335|NCT02829723|156301926|FG008|Overall Study|Study terminated by sponsor|0|||
48576336|NCT02829723|156301927|FG009|Overall Study|Study terminated by sponsor|0|||
48576337|NCT02829723|156301928|FG010|Overall Study|Study terminated by sponsor|0|||
48576338|NCT02829723|156301929|FG011|Overall Study|Study terminated by sponsor|0|||
48576339|NCT02829723|156301930|FG012|Overall Study|Study terminated by sponsor|0|||
48576340|NCT02829723|156301931|FG013|Overall Study|Study terminated by sponsor|0|||
48319698|NCT00978042|155371081|FG000|Initial Treatment Period|Ineligibility|1|||
48319699|NCT00978042|155371082|FG001|Initial Treatment Period|Ineligibility|0|||
48576341|NCT02829723|156301932|FG014|Overall Study|Study terminated by sponsor|0|||
48576342|NCT02829723|156301933|FG015|Overall Study|Study terminated by sponsor|0|||
48576343|NCT02829723|156301934|FG016|Overall Study|Study terminated by sponsor|0|||
48576344|NCT02829723|156301935|FG017|Overall Study|Study terminated by sponsor|0|||
48576345|NCT02829723|156301936|FG018|Overall Study|Study terminated by sponsor|0|||
48576346|NCT02829723|156301937|FG019|Overall Study|Study terminated by sponsor|0|||
48576347|NCT02829723|156301938|FG020|Overall Study|Study terminated by sponsor|0|||
48576348|NCT02829723|156301939|FG021|Overall Study|Study terminated by sponsor|1|||
48621562|NCT01602666|156471705|FG000|Induction Chemotherapy|Physician Decision|12|||
48621563|NCT01602666|156471706|FG001|Induction Chemotherapy|Physician Decision|5|||
48621564|NCT01602666|156471705|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
48621565|NCT01602666|156471706|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
48576349|NCT02829723|156301940|FG022|Overall Study|Study terminated by sponsor|0|||
48576350|NCT02829723|156301941|FG023|Overall Study|Study terminated by sponsor|0|||
48576351|NCT02829723|156301942|FG024|Overall Study|Study terminated by sponsor|0|||
48576352|NCT02829723|156301943|FG025|Overall Study|Study terminated by sponsor|0|||
48576353|NCT02829723|156301944|FG026|Overall Study|Study terminated by sponsor|0|||
48576354|NCT00256854|156301945|FG000|Overall Study|Withdrawal by Subject|2|||
48576355|NCT00256854|156301946|FG001|Overall Study|Withdrawal by Subject|3|||
48576356|NCT00256854|156301947|FG002|Overall Study|Withdrawal by Subject|0|||
48576357|NCT00256854|156301948|FG003|Overall Study|Withdrawal by Subject|0|||
48576358|NCT00256854|156301949|FG004|Overall Study|Withdrawal by Subject|0|||
48621566|NCT01602666|156471705|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
48319700|NCT00978042|155371081|FG000|Initial Treatment Period|Lost to Follow-up|21|||
48576359|NCT00256854|156301950|FG005|Overall Study|Withdrawal by Subject|0|||
48576360|NCT00256854|156301945|FG000|Overall Study|Lack of Efficacy|1|||
48576361|NCT00256854|156301946|FG001|Overall Study|Lack of Efficacy|0|||
48576362|NCT00256854|156301947|FG002|Overall Study|Lack of Efficacy|0|||
48576363|NCT00256854|156301948|FG003|Overall Study|Lack of Efficacy|0|||
48576364|NCT00256854|156301949|FG004|Overall Study|Lack of Efficacy|0|||
48576365|NCT00256854|156301950|FG005|Overall Study|Lack of Efficacy|0|||
48576366|NCT00256854|156301945|FG000|Overall Study|Protocol Violation|0|||
48576367|NCT00256854|156301946|FG001|Overall Study|Protocol Violation|1|||
48576368|NCT00256854|156301947|FG002|Overall Study|Protocol Violation|1|||
48576369|NCT00256854|156301948|FG003|Overall Study|Protocol Violation|1|||
48576370|NCT00256854|156301949|FG004|Overall Study|Protocol Violation|0|||
48576371|NCT00256854|156301950|FG005|Overall Study|Protocol Violation|0|||
48576372|NCT00256854|156301945|FG000|Overall Study|Adverse Event|0|||
48576373|NCT00256854|156301946|FG001|Overall Study|Adverse Event|0|||
48576374|NCT00256854|156301947|FG002|Overall Study|Adverse Event|2|||
48576375|NCT00256854|156301948|FG003|Overall Study|Adverse Event|2|||
48576376|NCT00256854|156301949|FG004|Overall Study|Adverse Event|0|||
48576377|NCT00256854|156301950|FG005|Overall Study|Adverse Event|1|||
48576378|NCT00256854|156301945|FG000|Overall Study|Not compliant with the study drug|0|||
48576379|NCT00256854|156301946|FG001|Overall Study|Not compliant with the study drug|0|||
48576380|NCT00256854|156301947|FG002|Overall Study|Not compliant with the study drug|0|||
48576381|NCT00256854|156301948|FG003|Overall Study|Not compliant with the study drug|0|||
48576382|NCT00256854|156301949|FG004|Overall Study|Not compliant with the study drug|1|||
48576383|NCT00256854|156301950|FG005|Overall Study|Not compliant with the study drug|0|||
48576384|NCT02353442|156301951|FG000|Overall Study|Withdrawal by Subject|3|||
48576385|NCT02353442|156301952|FG001|Overall Study|Withdrawal by Subject|4|||
48576386|NCT06586788|156301953|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
48576387|NCT03990571|156301954|FG000|Overall Study|Withdrawal by Subject|1|||
48576388|NCT03990571|156301954|FG000|Overall Study|Insurance Issues|3|||
48576389|NCT03990571|156301954|FG000|Overall Study|Covid Restrictions|2|||
48576390|NCT03514485|156301955|FG000|Overall Study|Lost to Follow-up|5|||
48576391|NCT03514485|156301956|FG001|Overall Study|Lost to Follow-up|3|||
48576392|NCT03514485|156301957|FG002|Overall Study|Lost to Follow-up|2|||
48576393|NCT03514485|156301958|FG003|Overall Study|Lost to Follow-up|0|||
48576394|NCT03514485|156301959|FG004|Overall Study|Lost to Follow-up|1|||
48576395|NCT03514485|156301960|FG005|Overall Study|Lost to Follow-up|4|||
48576396|NCT03514485|156301955|FG000|Overall Study|Withdrawal by Subject|0|||
48576397|NCT03514485|156301956|FG001|Overall Study|Withdrawal by Subject|1|||
48576398|NCT03514485|156301957|FG002|Overall Study|Withdrawal by Subject|3|||
48576399|NCT03514485|156301958|FG003|Overall Study|Withdrawal by Subject|1|||
48576400|NCT03514485|156301959|FG004|Overall Study|Withdrawal by Subject|2|||
48576401|NCT03514485|156301960|FG005|Overall Study|Withdrawal by Subject|1|||
48576402|NCT02553499|156301962|FG000|Overall Study|Adverse Event|0|||
48576403|NCT02553499|156301963|FG001|Overall Study|Adverse Event|0|||
48576404|NCT02553499|156301964|FG002|Overall Study|Adverse Event|0|||
48576405|NCT02553499|156301965|FG003|Overall Study|Adverse Event|0|||
48576406|NCT02553499|156301966|FG004|Overall Study|Adverse Event|0|||
48576407|NCT02553499|156301967|FG005|Overall Study|Adverse Event|0|||
48576408|NCT02553499|156301968|FG006|Overall Study|Adverse Event|1|||
48576409|NCT02553499|156301969|FG007|Overall Study|Adverse Event|1|||
48576410|NCT02553499|156301970|FG008|Overall Study|Adverse Event|0|||
48576411|NCT02553499|156301971|FG009|Overall Study|Adverse Event|0|||
48576412|NCT02553499|156301972|FG010|Overall Study|Adverse Event|0|||
48576413|NCT02553499|156301973|FG011|Overall Study|Adverse Event|0|||
48576414|NCT02553499|156301974|FG012|Overall Study|Adverse Event|0|||
48576415|NCT02553499|156301975|FG013|Overall Study|Adverse Event|1|||
48576416|NCT02553499|156301962|FG000|Overall Study|Death|0|||
48576417|NCT02553499|156301963|FG001|Overall Study|Death|1|||
48576418|NCT02553499|156301964|FG002|Overall Study|Death|1|||
48621567|NCT01602666|156471706|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
48576419|NCT02553499|156301965|FG003|Overall Study|Death|0|||
48576420|NCT02553499|156301966|FG004|Overall Study|Death|1|||
48736078|NCT00866788|156885627|FG002|Overall Study|Pregnancy|0|||
48576421|NCT02553499|156301967|FG005|Overall Study|Death|2|||
48576422|NCT02553499|156301968|FG006|Overall Study|Death|0|||
48576423|NCT02553499|156301969|FG007|Overall Study|Death|0|||
48576424|NCT02553499|156301970|FG008|Overall Study|Death|0|||
48576425|NCT02553499|156301971|FG009|Overall Study|Death|0|||
48576426|NCT02553499|156301972|FG010|Overall Study|Death|1|||
48576427|NCT02553499|156301973|FG011|Overall Study|Death|0|||
48576428|NCT02553499|156301974|FG012|Overall Study|Death|0|||
48576429|NCT02553499|156301975|FG013|Overall Study|Death|0|||
48576430|NCT02553499|156301962|FG000|Overall Study|Lost to Follow-up|0|||
48576431|NCT02553499|156301963|FG001|Overall Study|Lost to Follow-up|0|||
48576432|NCT02553499|156301964|FG002|Overall Study|Lost to Follow-up|0|||
48576433|NCT02553499|156301965|FG003|Overall Study|Lost to Follow-up|0|||
48576434|NCT02553499|156301966|FG004|Overall Study|Lost to Follow-up|0|||
48576435|NCT02553499|156301967|FG005|Overall Study|Lost to Follow-up|0|||
48576436|NCT02553499|156301968|FG006|Overall Study|Lost to Follow-up|1|||
48621568|NCT01602666|156471705|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
48621569|NCT01602666|156471706|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
48621570|NCT01602666|156471705|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
48621571|NCT01602666|156471706|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
48621572|NCT01602666|156471705|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
48621573|NCT01602666|156471706|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
48621574|NCT01602666|156471705|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
48621575|NCT01602666|156471706|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
48621576|NCT01602666|156471705|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
48621577|NCT01602666|156471706|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
48621578|NCT01602666|156471705|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
48621579|NCT01602666|156471706|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
48621580|NCT02614066|156471707|FG000|Overall Study|Death|6|||
48621581|NCT02614066|156471708|FG001|Overall Study|Death|14|||
48621582|NCT02614066|156471709|FG002|Overall Study|Death|11|||
48621583|NCT02614066|156471710|FG003|Overall Study|Death|29|||
48621584|NCT02614066|156471707|FG000|Overall Study|Full consent withdrawn|0|||
48621585|NCT02614066|156471708|FG001|Overall Study|Full consent withdrawn|1|||
48621586|NCT02614066|156471709|FG002|Overall Study|Full consent withdrawn|0|||
48621587|NCT02614066|156471710|FG003|Overall Study|Full consent withdrawn|8|||
48621588|NCT02614066|156471707|FG000|Overall Study|Lost to Follow-up|0|||
48621589|NCT02614066|156471708|FG001|Overall Study|Lost to Follow-up|2|||
48621590|NCT02614066|156471709|FG002|Overall Study|Lost to Follow-up|2|||
48621591|NCT02614066|156471710|FG003|Overall Study|Lost to Follow-up|2|||
48621592|NCT02614066|156471707|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
48621593|NCT02614066|156471708|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
48621594|NCT02614066|156471709|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
48621595|NCT02614066|156471710|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
48621596|NCT02614066|156471707|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
48621597|NCT02614066|156471708|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
48621598|NCT02614066|156471709|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
48621599|NCT02614066|156471710|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
48621600|NCT02614066|156471707|FG000|Overall Study|Reason not specified|0|||
48621601|NCT02614066|156471708|FG001|Overall Study|Reason not specified|2|||
48621602|NCT02614066|156471709|FG002|Overall Study|Reason not specified|1|||
48621603|NCT02614066|156471710|FG003|Overall Study|Reason not specified|1|||
48621604|NCT01185366|156471711|FG000|First Line Therapy|Insurance Coverage Denied|1|||
48621605|NCT01185366|156471712|FG001|First Line Therapy|Insurance Coverage Denied|1|||
48621606|NCT01185366|156471711|FG000|First Line Therapy|Withdrawal by Subject|1|||
48621607|NCT01185366|156471712|FG001|First Line Therapy|Withdrawal by Subject|0|||
48621608|NCT01185366|156471711|FG000|First Line Therapy|Lack of Metastatic Site|1|||
48621609|NCT01185366|156471712|FG001|First Line Therapy|Lack of Metastatic Site|0|||
48621610|NCT01185366|156471711|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
48621611|NCT01185366|156471712|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
48621612|NCT01185366|156471711|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
48621613|NCT01185366|156471712|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
48621614|NCT01185366|156471711|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
48621615|NCT01185366|156471712|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
48621616|NCT01185366|156471711|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
48621617|NCT01185366|156471712|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
48621618|NCT00930176|156471713|FG000|Overall Study|Death|1|||
48621619|NCT00300495|156471714|FG000|Overall Study|Protocol Violation|4|||
48621620|NCT00300495|156471715|FG001|Overall Study|Protocol Violation|1|||
48621621|NCT03632720|156471718|FG000|Overall Study|Adverse Event|2|||
48621622|NCT03632720|156471719|FG001|Overall Study|Adverse Event|0|||
48621623|NCT03632720|156471720|FG002|Overall Study|Adverse Event|0|||
48621624|NCT03632720|156471718|FG000|Overall Study|Lost to Follow-up|0|||
48621625|NCT03632720|156471719|FG001|Overall Study|Lost to Follow-up|1|||
48621626|NCT03632720|156471720|FG002|Overall Study|Lost to Follow-up|0|||
48621627|NCT03632720|156471718|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
48621628|NCT03632720|156471719|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
48621629|NCT03632720|156471720|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
48621630|NCT03632720|156471718|FG000|Overall Study|Screen failure|0|||
48621631|NCT03632720|156471719|FG001|Overall Study|Screen failure|1|||
48621632|NCT03632720|156471720|FG002|Overall Study|Screen failure|0|||
48621633|NCT00553475|156471723|FG000|Overall Study|Adverse Event|7|||
48621634|NCT00553475|156471724|FG001|Overall Study|Adverse Event|17|||
48319701|NCT00978042|155371082|FG001|Initial Treatment Period|Lost to Follow-up|3|||
48319702|NCT00978042|155371081|FG000|Initial Treatment Period|Adverse Event|2|||
48319703|NCT00978042|155371082|FG001|Initial Treatment Period|Adverse Event|0|||
48621635|NCT00553475|156471725|FG002|Overall Study|Adverse Event|13|||
48621636|NCT00553475|156471723|FG000|Overall Study|Lack of Efficacy|7|||
48621637|NCT00553475|156471724|FG001|Overall Study|Lack of Efficacy|1|||
48621638|NCT00553475|156471725|FG002|Overall Study|Lack of Efficacy|0|||
48621639|NCT00553475|156471723|FG000|Overall Study|Withdrawal by Subject|1|||
48621640|NCT00553475|156471724|FG001|Overall Study|Withdrawal by Subject|1|||
48621641|NCT00553475|156471725|FG002|Overall Study|Withdrawal by Subject|0|||
48576437|NCT02553499|156301969|FG007|Overall Study|Lost to Follow-up|0|||
48576438|NCT02553499|156301970|FG008|Overall Study|Lost to Follow-up|0|||
48621642|NCT00553475|156471723|FG000|Overall Study|Physician Decision|1|||
48621643|NCT00553475|156471724|FG001|Overall Study|Physician Decision|0|||
48621644|NCT00553475|156471725|FG002|Overall Study|Physician Decision|0|||
48621645|NCT00553475|156471723|FG000|Overall Study|Due to moving|0|||
48621646|NCT00553475|156471724|FG001|Overall Study|Due to moving|1|||
48621647|NCT00553475|156471725|FG002|Overall Study|Due to moving|0|||
48621648|NCT00289900|156471729|FG000|Overall Study|Adverse Event|28|||
48621649|NCT00289900|156471730|FG001|Overall Study|Adverse Event|40|||
48621650|NCT00289900|156471731|FG002|Overall Study|Adverse Event|13|||
48621651|NCT00289900|156471732|FG003|Overall Study|Adverse Event|19|||
48621652|NCT00289900|156471733|FG004|Overall Study|Adverse Event|20|||
48621653|NCT00289900|156471734|FG005|Overall Study|Adverse Event|33|||
48621654|NCT00289900|156471729|FG000|Overall Study|Lost to Follow-up|7|||
48621655|NCT00289900|156471730|FG001|Overall Study|Lost to Follow-up|7|||
48621656|NCT00289900|156471731|FG002|Overall Study|Lost to Follow-up|8|||
48621657|NCT00289900|156471732|FG003|Overall Study|Lost to Follow-up|8|||
48621658|NCT00289900|156471733|FG004|Overall Study|Lost to Follow-up|4|||
48621659|NCT00289900|156471734|FG005|Overall Study|Lost to Follow-up|8|||
48621660|NCT00289900|156471729|FG000|Overall Study|Participant had flushing|18|||
48621661|NCT00289900|156471730|FG001|Overall Study|Participant had flushing|42|||
48621662|NCT00289900|156471731|FG002|Overall Study|Participant had flushing|1|||
48621663|NCT00289900|156471732|FG003|Overall Study|Participant had flushing|2|||
48621664|NCT00289900|156471733|FG004|Overall Study|Participant had flushing|0|||
48621665|NCT00289900|156471734|FG005|Overall Study|Participant had flushing|4|||
48621666|NCT00289900|156471729|FG000|Overall Study|Other|0|||
48621667|NCT00289900|156471730|FG001|Overall Study|Other|0|||
48621668|NCT00289900|156471731|FG002|Overall Study|Other|0|||
48621669|NCT00289900|156471732|FG003|Overall Study|Other|5|||
48621670|NCT00289900|156471733|FG004|Overall Study|Other|1|||
48621671|NCT00289900|156471734|FG005|Overall Study|Other|0|||
48621672|NCT00289900|156471729|FG000|Overall Study|Participant moved|1|||
48621673|NCT00289900|156471730|FG001|Overall Study|Participant moved|0|||
48621674|NCT00289900|156471731|FG002|Overall Study|Participant moved|0|||
48621675|NCT00289900|156471732|FG003|Overall Study|Participant moved|1|||
48621676|NCT00289900|156471733|FG004|Overall Study|Participant moved|1|||
48621677|NCT00289900|156471734|FG005|Overall Study|Participant moved|1|||
48621678|NCT00289900|156471729|FG000|Overall Study|Withdrawal by Subject|10|||
48621679|NCT00289900|156471730|FG001|Overall Study|Withdrawal by Subject|21|||
48621680|NCT00289900|156471731|FG002|Overall Study|Withdrawal by Subject|8|||
48621681|NCT00289900|156471732|FG003|Overall Study|Withdrawal by Subject|18|||
48621682|NCT00289900|156471733|FG004|Overall Study|Withdrawal by Subject|12|||
48621683|NCT00289900|156471734|FG005|Overall Study|Withdrawal by Subject|11|||
48621684|NCT00289900|156471729|FG000|Overall Study|Protocol Violation|3|||
48621685|NCT00289900|156471730|FG001|Overall Study|Protocol Violation|9|||
48621686|NCT00289900|156471731|FG002|Overall Study|Protocol Violation|2|||
48621687|NCT00289900|156471732|FG003|Overall Study|Protocol Violation|6|||
48576439|NCT02553499|156301971|FG009|Overall Study|Lost to Follow-up|0|||
48576440|NCT02553499|156301972|FG010|Overall Study|Lost to Follow-up|0|||
48576441|NCT02553499|156301973|FG011|Overall Study|Lost to Follow-up|0|||
48576442|NCT02553499|156301974|FG012|Overall Study|Lost to Follow-up|0|||
48576443|NCT02553499|156301975|FG013|Overall Study|Lost to Follow-up|0|||
48576444|NCT02553499|156301962|FG000|Overall Study|Physician Decision|0|||
48621688|NCT00289900|156471733|FG004|Overall Study|Protocol Violation|7|||
48319704|NCT00978042|155371081|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
48450062|NCT01614795|155835559|FG002|Overall Study|Physician Decision|1|||
48576445|NCT02553499|156301963|FG001|Overall Study|Physician Decision|1|||
48576446|NCT02553499|156301964|FG002|Overall Study|Physician Decision|1|||
48576447|NCT02553499|156301965|FG003|Overall Study|Physician Decision|0|||
48576448|NCT02553499|156301966|FG004|Overall Study|Physician Decision|1|||
48576449|NCT02553499|156301967|FG005|Overall Study|Physician Decision|0|||
48576450|NCT02553499|156301968|FG006|Overall Study|Physician Decision|0|||
48576451|NCT02553499|156301969|FG007|Overall Study|Physician Decision|1|||
48621689|NCT00289900|156471734|FG005|Overall Study|Protocol Violation|4|||
48621690|NCT00289900|156471729|FG000|Overall Study|site terminated|1|||
48621691|NCT00289900|156471730|FG001|Overall Study|site terminated|0|||
48621692|NCT00289900|156471731|FG002|Overall Study|site terminated|1|||
48621693|NCT00289900|156471732|FG003|Overall Study|site terminated|0|||
48621694|NCT00289900|156471733|FG004|Overall Study|site terminated|0|||
48621695|NCT00289900|156471734|FG005|Overall Study|site terminated|0|||
48621696|NCT00289900|156471729|FG000|Overall Study|Not treated|0|||
48621697|NCT00289900|156471730|FG001|Overall Study|Not treated|1|||
48621698|NCT00289900|156471731|FG002|Overall Study|Not treated|0|||
48621699|NCT00289900|156471732|FG003|Overall Study|Not treated|0|||
48621700|NCT00289900|156471733|FG004|Overall Study|Not treated|0|||
48621701|NCT00289900|156471734|FG005|Overall Study|Not treated|0|||
48621702|NCT02186171|156471735|FG000|Overall Study|Withdrawal by Subject|1|||
48621703|NCT02186171|156471736|FG001|Overall Study|Withdrawal by Subject|9|||
48621704|NCT02186171|156471735|FG000|Overall Study|Lost to Follow-up|2|||
48621705|NCT02186171|156471736|FG001|Overall Study|Lost to Follow-up|2|||
48621706|NCT02186171|156471735|FG000|Overall Study|Death|1|||
48621707|NCT02186171|156471736|FG001|Overall Study|Death|2|||
48621708|NCT02186171|156471735|FG000|Overall Study|Protocol-specified Criteria|0|||
48621709|NCT02186171|156471736|FG001|Overall Study|Protocol-specified Criteria|2|||
48621710|NCT01703221|156471737|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
48576452|NCT02553499|156301970|FG008|Overall Study|Physician Decision|1|||
48576453|NCT02553499|156301971|FG009|Overall Study|Physician Decision|2|||
48576454|NCT02553499|156301972|FG010|Overall Study|Physician Decision|1|||
48576455|NCT02553499|156301973|FG011|Overall Study|Physician Decision|3|||
48621711|NCT01703221|156471738|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
48621712|NCT01703221|156471739|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48621713|NCT01703221|156471737|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
48621714|NCT01703221|156471738|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
48621715|NCT01703221|156471739|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
48621716|NCT01703221|156471737|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
48621717|NCT01703221|156471738|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48621718|NCT01703221|156471739|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48621719|NCT01703221|156471737|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
48621720|NCT01703221|156471738|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48621721|NCT01703221|156471739|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48621722|NCT01703221|156471737|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48621723|NCT01703221|156471738|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48621724|NCT01703221|156471739|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
48621725|NCT01703221|156471737|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
48621726|NCT01703221|156471738|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
48621727|NCT01703221|156471739|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
48621728|NCT01703221|156471737|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
48621729|NCT01703221|156471738|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
48621730|NCT01703221|156471739|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
48621731|NCT01703221|156471737|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
48621732|NCT01703221|156471738|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
48621733|NCT01703221|156471739|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
48621734|NCT00504231|156473119|FG000|Overall Study|Discrepant chart documentation re route|0|||
48621735|NCT00504231|156473120|FG001|Overall Study|Discrepant chart documentation re route|0|||
48621736|NCT00504231|156473121|FG002|Overall Study|Discrepant chart documentation re route|1|||
48621737|NCT00504231|156473122|FG003|Overall Study|Discrepant chart documentation re route|0|||
48621738|NCT01902303|156473123|FG000|Overall Study|Adverse Event|0|||
48621739|NCT01902303|156473124|FG001|Overall Study|Adverse Event|1|||
48621740|NCT01902303|156473123|FG000|Overall Study|Lost to Follow-up|0|||
48621741|NCT01902303|156473124|FG001|Overall Study|Lost to Follow-up|1|||
48621742|NCT01902303|156473123|FG000|Overall Study|Protocol Violation|2|||
48621743|NCT01902303|156473124|FG001|Overall Study|Protocol Violation|2|||
48621744|NCT01902303|156473123|FG000|Overall Study|subject lost investigational product|0|||
48621745|NCT01902303|156473124|FG001|Overall Study|subject lost investigational product|1|||
48576456|NCT02553499|156301974|FG012|Overall Study|Physician Decision|1|||
48576457|NCT02553499|156301975|FG013|Overall Study|Physician Decision|0|||
48576458|NCT02553499|156301962|FG000|Overall Study|Progressive Disease|0|||
48621746|NCT01902303|156473123|FG000|Overall Study|Did not develop a cold sore|21|||
48621747|NCT01902303|156473124|FG001|Overall Study|Did not develop a cold sore|19|||
48621748|NCT05938010|156473128|FG000|Overall Study|Lost to Follow-up|2|||
48576459|NCT02553499|156301963|FG001|Overall Study|Progressive Disease|0|||
48621749|NCT04076579|156473129|FG000|Overall Study|Adverse Event|2|||
48621750|NCT04076579|156473130|FG001|Overall Study|Adverse Event|0|||
48621751|NCT04076579|156473129|FG000|Overall Study|discontinued due to toxicity|1|||
48621752|NCT04076579|156473130|FG001|Overall Study|discontinued due to toxicity|0|||
48621753|NCT04076579|156473129|FG000|Overall Study|Physician Decision|1|||
48621754|NCT04076579|156473130|FG001|Overall Study|Physician Decision|0|||
48621755|NCT04076579|156473129|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
48621756|NCT04076579|156473130|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
48576460|NCT02553499|156301964|FG002|Overall Study|Progressive Disease|0|||
48576461|NCT02553499|156301965|FG003|Overall Study|Progressive Disease|2|||
48576462|NCT02553499|156301966|FG004|Overall Study|Progressive Disease|1|||
48576463|NCT02553499|156301967|FG005|Overall Study|Progressive Disease|1|||
48621757|NCT04076579|156473129|FG000|Overall Study|Noncompliance|0|||
48621758|NCT04076579|156473130|FG001|Overall Study|Noncompliance|1|||
48621759|NCT04076579|156473129|FG000|Overall Study|Withdrawal by Subject|0|||
48621760|NCT04076579|156473130|FG001|Overall Study|Withdrawal by Subject|2|||
48621761|NCT00983957|156473131|FG000|Overall Study|Adverse Event|1|||
48621762|NCT00983957|156473131|FG000|Overall Study|Personal Reasons|1|||
48621763|NCT00421733|156473132|FG000|Overall Study|Adverse Event|4|||
48621764|NCT00421733|156473133|FG001|Overall Study|Adverse Event|9|||
48621765|NCT00421733|156473134|FG002|Overall Study|Adverse Event|2|||
48621766|NCT00421733|156473132|FG000|Overall Study|Lost to Follow-up|1|||
48621767|NCT00421733|156473133|FG001|Overall Study|Lost to Follow-up|2|||
48621768|NCT00421733|156473134|FG002|Overall Study|Lost to Follow-up|4|||
48621769|NCT00421733|156473132|FG000|Overall Study|Withdrawal by Subject|1|||
48621770|NCT00421733|156473133|FG001|Overall Study|Withdrawal by Subject|2|||
48621771|NCT00421733|156473134|FG002|Overall Study|Withdrawal by Subject|7|||
48621772|NCT00421733|156473132|FG000|Overall Study|Death|0|||
48621773|NCT00421733|156473133|FG001|Overall Study|Death|3|||
48621774|NCT00421733|156473134|FG002|Overall Study|Death|0|||
48621775|NCT00421733|156473132|FG000|Overall Study|Required dialysis|1|||
48621776|NCT00421733|156473133|FG001|Overall Study|Required dialysis|0|||
48576464|NCT02553499|156301968|FG006|Overall Study|Progressive Disease|1|||
48576465|NCT02553499|156301969|FG007|Overall Study|Progressive Disease|0|||
48621777|NCT00421733|156473134|FG002|Overall Study|Required dialysis|0|||
48621778|NCT00421733|156473132|FG000|Overall Study|Administrative|2|||
48621779|NCT00421733|156473133|FG001|Overall Study|Administrative|0|||
48621780|NCT00421733|156473134|FG002|Overall Study|Administrative|0|||
48621781|NCT00421733|156473132|FG000|Overall Study|Did not satisfy entry criteria|1|||
48621782|NCT00421733|156473133|FG001|Overall Study|Did not satisfy entry criteria|3|||
48621783|NCT00421733|156473134|FG002|Overall Study|Did not satisfy entry criteria|2|||
48621784|NCT00421733|156473132|FG000|Overall Study|Sponsor request|1|||
48621785|NCT00421733|156473133|FG001|Overall Study|Sponsor request|0|||
48576466|NCT02553499|156301970|FG008|Overall Study|Progressive Disease|0|||
48576467|NCT02553499|156301971|FG009|Overall Study|Progressive Disease|1|||
48576468|NCT02553499|156301972|FG010|Overall Study|Progressive Disease|0|||
48576469|NCT02553499|156301973|FG011|Overall Study|Progressive Disease|0|||
48576470|NCT02553499|156301974|FG012|Overall Study|Progressive Disease|2|||
48576471|NCT02553499|156301975|FG013|Overall Study|Progressive Disease|1|||
48576472|NCT02553499|156301962|FG000|Overall Study|Study Terminated by Sponsor|0|||
48576473|NCT02553499|156301963|FG001|Overall Study|Study Terminated by Sponsor|0|||
48576474|NCT02553499|156301964|FG002|Overall Study|Study Terminated by Sponsor|0|||
48576475|NCT02553499|156301965|FG003|Overall Study|Study Terminated by Sponsor|0|||
48576476|NCT02553499|156301966|FG004|Overall Study|Study Terminated by Sponsor|0|||
48576477|NCT02553499|156301967|FG005|Overall Study|Study Terminated by Sponsor|0|||
48576478|NCT02553499|156301968|FG006|Overall Study|Study Terminated by Sponsor|0|||
48576479|NCT02553499|156301969|FG007|Overall Study|Study Terminated by Sponsor|0|||
48576480|NCT02553499|156301970|FG008|Overall Study|Study Terminated by Sponsor|1|||
48576481|NCT02553499|156301971|FG009|Overall Study|Study Terminated by Sponsor|0|||
48621786|NCT00421733|156473134|FG002|Overall Study|Sponsor request|3|||
48621787|NCT00421733|156473132|FG000|Overall Study|Protocol deviation|4|||
48576482|NCT02553499|156301972|FG010|Overall Study|Study Terminated by Sponsor|0|||
48576483|NCT02553499|156301973|FG011|Overall Study|Study Terminated by Sponsor|0|||
48576484|NCT02553499|156301974|FG012|Overall Study|Study Terminated by Sponsor|0|||
48576485|NCT02553499|156301975|FG013|Overall Study|Study Terminated by Sponsor|0|||
48576486|NCT02553499|156301962|FG000|Overall Study|Withdrawal by Subject|2|||
48621788|NCT00421733|156473133|FG001|Overall Study|Protocol deviation|7|||
48621789|NCT00421733|156473134|FG002|Overall Study|Protocol deviation|2|||
48576487|NCT02553499|156301963|FG001|Overall Study|Withdrawal by Subject|0|||
48621790|NCT01524705|156473135|FG000|Overall Study|Adverse Event|2|||
48621791|NCT01524705|156473136|FG001|Overall Study|Adverse Event|0|||
48576488|NCT02553499|156301964|FG002|Overall Study|Withdrawal by Subject|0|||
48576489|NCT02553499|156301965|FG003|Overall Study|Withdrawal by Subject|0|||
48576490|NCT02553499|156301966|FG004|Overall Study|Withdrawal by Subject|0|||
48576491|NCT02553499|156301967|FG005|Overall Study|Withdrawal by Subject|0|||
48576492|NCT02553499|156301968|FG006|Overall Study|Withdrawal by Subject|0|||
48621792|NCT01524705|156473135|FG000|Overall Study|Death|1|||
48621793|NCT01524705|156473136|FG001|Overall Study|Death|0|||
48621794|NCT01524705|156473135|FG000|Overall Study|Lost to Follow-up|0|||
48621795|NCT01524705|156473136|FG001|Overall Study|Lost to Follow-up|1|||
48621796|NCT01524705|156473135|FG000|Overall Study|Withdrawal by Subject|0|||
48621797|NCT01524705|156473136|FG001|Overall Study|Withdrawal by Subject|1|||
48621798|NCT01524705|156473135|FG000|Overall Study|Pancreatic Cancer|0|||
48621799|NCT01524705|156473136|FG001|Overall Study|Pancreatic Cancer|1|||
48621800|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
48621801|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
48621802|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
48621803|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
48621804|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
48621805|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
48621806|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
48621807|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
48621808|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
48621809|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
48621810|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
48621811|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
48621812|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
48621813|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
48621814|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
48621815|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
48621816|NCT01755156|156473137|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
48621817|NCT01755156|156473138|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
48621818|NCT01755156|156473137|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
48621819|NCT01755156|156473138|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
48621820|NCT01755156|156473137|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
48621821|NCT01755156|156473138|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
48621822|NCT03142451|156473139|FG000|Overall Study|Adverse Event|5|||
48621823|NCT03142451|156473140|FG001|Overall Study|Adverse Event|2|||
48621824|NCT03142451|156473139|FG000|Overall Study|Lost to Follow-up|25|||
48621825|NCT03142451|156473140|FG001|Overall Study|Lost to Follow-up|8|||
48621826|NCT03142451|156473139|FG000|Overall Study|Participant request|24|||
48621827|NCT03142451|156473140|FG001|Overall Study|Participant request|12|||
48621828|NCT03142451|156473139|FG000|Overall Study|Protocol Violation|3|||
48621829|NCT03142451|156473140|FG001|Overall Study|Protocol Violation|1|||
48621830|NCT03142451|156473139|FG000|Overall Study|Other|1|||
48621831|NCT03142451|156473140|FG001|Overall Study|Other|1|||
48621832|NCT00585169|156473141|FG000|Overall Study|Withdrawal by Subject|1|||
48621833|NCT00710970|156473144|FG000|Overall Study|Never took drug|3|||
48621834|NCT02391584|156473147|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
48621835|NCT02391584|156473148|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
48621836|NCT02391584|156473147|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
48621837|NCT02391584|156473148|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
48621838|NCT02391584|156473147|FG000|3 Month|Lost to Follow-up|1|||
48621839|NCT02391584|156473148|FG001|3 Month|Lost to Follow-up|0|||
48621840|NCT02391584|156473147|FG000|6 Month|Withdrawal by Subject|1|||
48621841|NCT02391584|156473148|FG001|6 Month|Withdrawal by Subject|0|||
48621842|NCT02391584|156473147|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
48621843|NCT02391584|156473148|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
48621844|NCT04621786|156473153|FG000|Overall Study|Lost to Follow-up|9|||
48621845|NCT04621786|156473153|FG000|Overall Study|Protocol Violation|3|||
48621846|NCT01093885|156473154|FG000|Overall Study|Adverse Event|4|||
48621847|NCT01093885|156473154|FG000|Overall Study|Lost to Follow-up|1|||
48621848|NCT01301001|156473155|FG000|First Intervention|Lost to Follow-up|4|||
48621849|NCT01301001|156473156|FG001|First Intervention|Lost to Follow-up|4|||
48621850|NCT01301001|156473155|FG000|First Intervention|Withdrawal by Subject|1|||
48621851|NCT01301001|156473156|FG001|First Intervention|Withdrawal by Subject|4|||
48621852|NCT01301001|156473155|FG000|First Intervention|Adverse Event|5|||
48621853|NCT01301001|156473156|FG001|First Intervention|Adverse Event|0|||
48621854|NCT01301001|156473155|FG000|First Intervention|Protocol Violation|0|||
48621855|NCT01301001|156473156|FG001|First Intervention|Protocol Violation|1|||
48621856|NCT01301001|156473155|FG000|Second Intervention|Adverse Event|2|||
48621857|NCT01301001|156473156|FG001|Second Intervention|Adverse Event|0|||
48621858|NCT01301001|156473155|FG000|Second Intervention|Withdrawal by Subject|2|||
48621859|NCT01301001|156473156|FG001|Second Intervention|Withdrawal by Subject|0|||
48621860|NCT01346709|156473157|FG000|Overall Study|Protocol Violation|35|||
48319705|NCT00978042|155371082|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
48621861|NCT01346709|156473157|FG000|Overall Study|Lost to Follow-up|31|||
48319706|NCT00978042|155371081|FG000|Initial Treatment Period|Consent withdrawn|22|||
48319707|NCT00978042|155371082|FG001|Initial Treatment Period|Consent withdrawn|9|||
48319708|NCT00978042|155371081|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
48319709|NCT00978042|155371082|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
48621862|NCT01346709|156473157|FG000|Overall Study|Missing data in candidate risk factor|285|||
48621863|NCT01292473|156473162|FG000|Overall Study|Adverse Event|1|||
48621864|NCT01292473|156473163|FG001|Overall Study|Adverse Event|0|||
48621865|NCT01292473|156473164|FG002|Overall Study|Adverse Event|1|||
48621866|NCT01292473|156473165|FG003|Overall Study|Adverse Event|1|||
48621867|NCT01292473|156473162|FG000|Overall Study|Lost to Follow-up|1|||
48621868|NCT01292473|156473163|FG001|Overall Study|Lost to Follow-up|1|||
48621869|NCT01292473|156473164|FG002|Overall Study|Lost to Follow-up|2|||
48576493|NCT02553499|156301969|FG007|Overall Study|Withdrawal by Subject|1|||
48576494|NCT02553499|156301970|FG008|Overall Study|Withdrawal by Subject|1|||
48576495|NCT02553499|156301971|FG009|Overall Study|Withdrawal by Subject|0|||
48576496|NCT02553499|156301972|FG010|Overall Study|Withdrawal by Subject|1|||
48576497|NCT02553499|156301973|FG011|Overall Study|Withdrawal by Subject|0|||
48576498|NCT02553499|156301974|FG012|Overall Study|Withdrawal by Subject|0|||
48576499|NCT02553499|156301975|FG013|Overall Study|Withdrawal by Subject|0|||
48576500|NCT00890084|156301976|FG000|Overall Study|Adverse Event|16|||
48576501|NCT00890084|156301976|FG000|Overall Study|Lost to Follow-up|126|||
48576502|NCT01438294|156301977|FG000|Overall Study|Lost to Follow-up|3|||
48576503|NCT01438294|156301978|FG001|Overall Study|Lost to Follow-up|7|||
48576504|NCT03301844|156301983|FG000|Overall Study|suspected colon cancer|1|||
48576505|NCT03301844|156301984|FG001|Overall Study|suspected colon cancer|1|||
48576506|NCT03429244|156301985|FG000|Overall Study|Withdrawal by Subject|2|||
48576507|NCT03429244|156301986|FG001|Overall Study|Withdrawal by Subject|1|||
48576508|NCT03429244|156301987|FG002|Overall Study|Withdrawal by Subject|1|||
48576509|NCT02288091|156301989|FG000|Overall Study|Lost to Follow-up|1|||
48576510|NCT02288091|156301989|FG000|Overall Study|Screen fail|7|||
48576511|NCT04021121|156301993|FG000|Overall Study|Death|3|||
48576512|NCT04021121|156301994|FG001|Overall Study|Death|3|||
48576513|NCT04021121|156301995|FG002|Overall Study|Death|5|||
48576514|NCT04021121|156301996|FG003|Overall Study|Death|4|||
48576515|NCT00656851|156302001|FG000|Overall Study|Withdrawal by Subject|0|||
48576516|NCT00656851|156302002|FG001|Overall Study|Withdrawal by Subject|4|||
48576517|NCT01343277|156302004|FG000|Overall Study|Other|3|||
48576518|NCT01343277|156302005|FG001|Overall Study|Other|3|||
48576519|NCT01343277|156302004|FG000|Overall Study|Withdrawal by Subject|18|||
48576520|NCT01343277|156302005|FG001|Overall Study|Withdrawal by Subject|13|||
48576521|NCT01343277|156302004|FG000|Overall Study|Physician Decision|1|||
48576522|NCT01343277|156302005|FG001|Overall Study|Physician Decision|2|||
48576523|NCT01343277|156302004|FG000|Overall Study|Death|10|||
48576524|NCT01343277|156302005|FG001|Overall Study|Death|1|||
48576525|NCT01343277|156302004|FG000|Overall Study|Adverse Event|67|||
48576526|NCT01343277|156302005|FG001|Overall Study|Adverse Event|13|||
48576527|NCT01343277|156302004|FG000|Overall Study|Disease progression|270|||
48576528|NCT01343277|156302005|FG001|Overall Study|Disease progression|138|||
48576529|NCT01343277|156302004|FG000|Overall Study|Randomized not treated|6|||
48576530|NCT01343277|156302005|FG001|Overall Study|Randomized not treated|21|||
48576531|NCT01343277|156302004|FG000|Overall Study|Treatment ongoing|8|||
48576532|NCT01343277|156302005|FG001|Overall Study|Treatment ongoing|2|||
48576533|NCT01343277|156302004|FG000|Overall Study|Subsequent anticancer therapy|1|||
48576534|NCT01343277|156302005|FG001|Overall Study|Subsequent anticancer therapy|0|||
48576535|NCT05033262|156302012|FG000|Overall Study|Lost to Follow-up|1|||
48576536|NCT05033262|156302013|FG001|Overall Study|Lost to Follow-up|0|||
48576537|NCT05033262|156302014|FG002|Overall Study|Lost to Follow-up|0|||
48576538|NCT05033262|156302015|FG003|Overall Study|Lost to Follow-up|1|||
48576539|NCT01273623|156302017|FG000|Overall Study|did not meet IVUS criteria|29|||
48576540|NCT01493284|156302019|FG000|Overall Study|Death|29|||
48576541|NCT01493284|156302019|FG000|Overall Study|Withdrawal by Subject|32|||
48576542|NCT00325156|156302022|FG000|Overall Study|Protocol Violation|8|||
48576543|NCT00325156|156302022|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
48576544|NCT00325156|156302022|FG000|Overall Study|Migrated/moved from study area|12|||
48576545|NCT00325156|156302022|FG000|Overall Study|Adverse event, non-fatal|3|||
48576546|NCT00325156|156302022|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
48576547|NCT00325156|156302022|FG000|Overall Study|Other|1|||
48576548|NCT00325156|156302022|FG000|Overall Study|Withdrawal by Subject|31|||
48576549|NCT03489707|156302023|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
48450063|NCT01614795|155835560|FG003|Overall Study|Physician Decision|1|||
48585134|NCT01094782|156333785|FG002|Overall Study|Positive Drug Screen|1|||
48585135|NCT01094782|156333786|FG003|Overall Study|Positive Drug Screen|1|||
48585136|NCT01094782|156333787|FG004|Overall Study|Positive Drug Screen|3|||
48585137|NCT01094782|156333788|FG005|Overall Study|Positive Drug Screen|2|||
48585138|NCT01094782|156333783|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
48585139|NCT01094782|156333784|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
48585140|NCT01094782|156333785|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
48585141|NCT01094782|156333786|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
48585142|NCT01094782|156333787|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
48585143|NCT01094782|156333788|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
48585144|NCT01094782|156333783|FG000|Overall Study|Unable to Complete Questionnaires|0|||
48585145|NCT01094782|156333784|FG001|Overall Study|Unable to Complete Questionnaires|1|||
48585146|NCT01094782|156333785|FG002|Overall Study|Unable to Complete Questionnaires|0|||
48585147|NCT01094782|156333786|FG003|Overall Study|Unable to Complete Questionnaires|0|||
48585148|NCT01094782|156333787|FG004|Overall Study|Unable to Complete Questionnaires|0|||
48585149|NCT01094782|156333788|FG005|Overall Study|Unable to Complete Questionnaires|0|||
48585150|NCT01094782|156333783|FG000|Overall Study|Healthy Subject Had Pain|0|||
48585151|NCT01094782|156333784|FG001|Overall Study|Healthy Subject Had Pain|1|||
48576550|NCT03489707|156302024|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
48576551|NCT03489707|156302023|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
48576552|NCT03489707|156302024|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
48576553|NCT01931956|156302029|FG000|Overall Study|Death|42|||
48576554|NCT01931956|156302030|FG001|Overall Study|Death|7|||
48621870|NCT01292473|156473165|FG003|Overall Study|Lost to Follow-up|2|||
48621871|NCT01292473|156473162|FG000|Overall Study|Withdrawal by Subject|3|||
48621872|NCT01292473|156473163|FG001|Overall Study|Withdrawal by Subject|4|||
48621873|NCT01292473|156473164|FG002|Overall Study|Withdrawal by Subject|3|||
48621874|NCT01292473|156473165|FG003|Overall Study|Withdrawal by Subject|3|||
48621875|NCT01292473|156473162|FG000|Overall Study|Physician Decision|0|||
48576555|NCT01931956|156302031|FG002|Overall Study|Death|379|||
48576556|NCT01931956|156302032|FG003|Overall Study|Death|96|||
48576557|NCT01931956|156302029|FG000|Overall Study|Withdrawal by Subject|5|||
48576558|NCT01931956|156302030|FG001|Overall Study|Withdrawal by Subject|0|||
48576559|NCT01931956|156302031|FG002|Overall Study|Withdrawal by Subject|70|||
48576560|NCT01931956|156302032|FG003|Overall Study|Withdrawal by Subject|30|||
48576561|NCT01931956|156302029|FG000|Overall Study|Lost to Follow-up|2|||
48576562|NCT01931956|156302030|FG001|Overall Study|Lost to Follow-up|0|||
48576563|NCT01931956|156302031|FG002|Overall Study|Lost to Follow-up|11|||
48576564|NCT01931956|156302032|FG003|Overall Study|Lost to Follow-up|7|||
48576565|NCT01931956|156302029|FG000|Overall Study|Expected|2|||
48576566|NCT01931956|156302030|FG001|Overall Study|Expected|0|||
48576567|NCT01931956|156302031|FG002|Overall Study|Expected|6|||
48576568|NCT01931956|156302032|FG003|Overall Study|Expected|0|||
48576569|NCT01931956|156302029|FG000|Overall Study|Not due|0|||
48576570|NCT01931956|156302030|FG001|Overall Study|Not due|0|||
48576571|NCT01931956|156302031|FG002|Overall Study|Not due|21|||
48576572|NCT01931956|156302032|FG003|Overall Study|Not due|0|||
48576573|NCT00519428|156302033|FG000|Overall Study|Adverse Event|5|||
48576574|NCT00519428|156302034|FG001|Overall Study|Adverse Event|2|||
48576575|NCT00519428|156302035|FG002|Overall Study|Adverse Event|10|||
48576576|NCT00519428|156302033|FG000|Overall Study|Lost to Follow-up|7|||
48576577|NCT00519428|156302034|FG001|Overall Study|Lost to Follow-up|7|||
48621876|NCT01292473|156473163|FG001|Overall Study|Physician Decision|1|||
48621877|NCT01292473|156473164|FG002|Overall Study|Physician Decision|0|||
48621878|NCT01292473|156473165|FG003|Overall Study|Physician Decision|0|||
48621879|NCT01292473|156473162|FG000|Overall Study|Disease Progression|0|||
48621880|NCT01292473|156473163|FG001|Overall Study|Disease Progression|1|||
48621881|NCT01292473|156473164|FG002|Overall Study|Disease Progression|3|||
48621882|NCT01292473|156473165|FG003|Overall Study|Disease Progression|6|||
48621883|NCT01133977|156473179|FG000|Overall Study|Adverse Event|0|||
48621884|NCT01133977|156473180|FG001|Overall Study|Adverse Event|0|||
48621885|NCT01133977|156473181|FG002|Overall Study|Adverse Event|1|||
48621886|NCT01133977|156473182|FG003|Overall Study|Adverse Event|0|||
48621887|NCT01133977|156473183|FG004|Overall Study|Adverse Event|0|||
48621888|NCT01133977|156473179|FG000|Overall Study|Death|1|||
48621889|NCT01133977|156473180|FG001|Overall Study|Death|1|||
48621890|NCT01133977|156473181|FG002|Overall Study|Death|1|||
48621891|NCT01133977|156473182|FG003|Overall Study|Death|7|||
48621892|NCT01133977|156473183|FG004|Overall Study|Death|3|||
48621893|NCT01133977|156473179|FG000|Overall Study|Started a New Line of Therapy|2|||
48621894|NCT01133977|156473180|FG001|Overall Study|Started a New Line of Therapy|6|||
48621895|NCT01133977|156473181|FG002|Overall Study|Started a New Line of Therapy|4|||
48621896|NCT01133977|156473182|FG003|Overall Study|Started a New Line of Therapy|25|||
48621897|NCT01133977|156473183|FG004|Overall Study|Started a New Line of Therapy|33|||
48736079|NCT00866788|156885628|FG003|Overall Study|Pregnancy|0|||
48736080|NCT00866788|156885625|FG000|Overall Study|Disease progression|3|||
48736081|NCT00866788|156885626|FG001|Overall Study|Disease progression|1|||
48576578|NCT00519428|156302035|FG002|Overall Study|Lost to Follow-up|6|||
48576579|NCT00519428|156302033|FG000|Overall Study|Withdrawal by Subject|8|||
48576580|NCT00519428|156302034|FG001|Overall Study|Withdrawal by Subject|3|||
48576581|NCT00519428|156302035|FG002|Overall Study|Withdrawal by Subject|7|||
48736082|NCT00866788|156885627|FG002|Overall Study|Disease progression|1|||
48736083|NCT00866788|156885628|FG003|Overall Study|Disease progression|0|||
48736084|NCT00866788|156885625|FG000|Overall Study|Physician Decision|0|||
48576582|NCT00519428|156302033|FG000|Overall Study|unstated|1|||
48576583|NCT00519428|156302034|FG001|Overall Study|unstated|3|||
48576584|NCT00519428|156302035|FG002|Overall Study|unstated|2|||
48576585|NCT04064411|156302036|FG000|Overall Study|Adverse Event|29|||
48576586|NCT04064411|156302037|FG001|Overall Study|Adverse Event|19|||
48621898|NCT01133977|156473179|FG000|Overall Study|Lost to Follow-up|0|||
48621899|NCT01133977|156473180|FG001|Overall Study|Lost to Follow-up|0|||
48621900|NCT01133977|156473181|FG002|Overall Study|Lost to Follow-up|0|||
48621901|NCT01133977|156473182|FG003|Overall Study|Lost to Follow-up|2|||
48621902|NCT01133977|156473183|FG004|Overall Study|Lost to Follow-up|1|||
48621903|NCT01133977|156473179|FG000|Overall Study|Withdrawal by Subject|0|||
48621904|NCT01133977|156473180|FG001|Overall Study|Withdrawal by Subject|0|||
48621905|NCT01133977|156473181|FG002|Overall Study|Withdrawal by Subject|0|||
48621906|NCT01133977|156473182|FG003|Overall Study|Withdrawal by Subject|5|||
48621907|NCT01133977|156473183|FG004|Overall Study|Withdrawal by Subject|1|||
48621908|NCT01371565|156473184|FG000|Overall Study|Withdrawal by Subject|1|||
48621909|NCT01371565|156473184|FG000|Overall Study|Death|1|||
48621910|NCT01371565|156473184|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
48621911|NCT02609633|156473185|FG000|Overall Study|Consent Withdrawn|0|||
48621912|NCT02609633|156473186|FG001|Overall Study|Consent Withdrawn|1|||
48621913|NCT02609633|156473185|FG000|Overall Study|Protocol Deviation|1|||
48621914|NCT02609633|156473186|FG001|Overall Study|Protocol Deviation|0|||
48621915|NCT02609633|156473185|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
48621916|NCT02609633|156473186|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
48621917|NCT02609633|156473185|FG000|Overall Study|Reason not Specified|2|||
48621918|NCT02609633|156473186|FG001|Overall Study|Reason not Specified|1|||
48621919|NCT00337194|156473187|FG000|Overall Study|Adverse Event|5|||
48576587|NCT04064411|156302036|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
48576588|NCT04064411|156302037|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
48576589|NCT04064411|156302036|FG000|Overall Study|Protocol Deviation|0|||
48576590|NCT04064411|156302037|FG001|Overall Study|Protocol Deviation|2|||
48576591|NCT04064411|156302036|FG000|Overall Study|Withdrawal by Subject|25|||
48576592|NCT04064411|156302037|FG001|Overall Study|Withdrawal by Subject|29|||
48576593|NCT04064411|156302036|FG000|Overall Study|Lost to Follow-up|5|||
48576594|NCT04064411|156302037|FG001|Overall Study|Lost to Follow-up|2|||
48576595|NCT04064411|156302036|FG000|Overall Study|Other than Specified|4|||
48576596|NCT04064411|156302037|FG001|Overall Study|Other than Specified|1|||
48576597|NCT04064411|156302036|FG000|Overall Study|Death|1|||
48576598|NCT04064411|156302037|FG001|Overall Study|Death|0|||
48576599|NCT03814720|156302038|FG000|Overall Study|Lost to Follow-up|0|||
48621920|NCT00337194|156473188|FG001|Overall Study|Adverse Event|1|||
48621921|NCT00337194|156473187|FG000|Overall Study|Death|2|||
48576600|NCT03814720|156302039|FG001|Overall Study|Lost to Follow-up|1|||
48576601|NCT03814720|156302040|FG002|Overall Study|Lost to Follow-up|0|||
48576602|NCT03814720|156302041|FG003|Overall Study|Lost to Follow-up|0|||
48576603|NCT03814720|156302042|FG004|Overall Study|Lost to Follow-up|0|||
48576604|NCT03626363|156302044|FG000|Overall Study|Protocol Violation|4|||
48576605|NCT03626363|156302045|FG001|Overall Study|Protocol Violation|0|||
48576606|NCT03626363|156302044|FG000|Overall Study|Lost to Follow-up|5|||
48576607|NCT03626363|156302045|FG001|Overall Study|Lost to Follow-up|7|||
48576608|NCT02091986|156302046|FG000|Overall Study|7 rand in error 1 patient decision|2|||
48576609|NCT02091986|156302047|FG001|Overall Study|7 rand in error 1 patient decision|3|||
48576610|NCT02091986|156302048|FG002|Overall Study|7 rand in error 1 patient decision|3|||
48576611|NCT02091986|156302046|FG000|Overall Study|Lost to Follow-up|1|||
48576612|NCT02091986|156302047|FG001|Overall Study|Lost to Follow-up|0|||
48576613|NCT02091986|156302048|FG002|Overall Study|Lost to Follow-up|0|||
48576614|NCT02091986|156302046|FG000|Overall Study|Withdrawal by Subject|4|||
48576615|NCT02091986|156302047|FG001|Overall Study|Withdrawal by Subject|8|||
48576616|NCT02091986|156302048|FG002|Overall Study|Withdrawal by Subject|3|||
48576617|NCT02091986|156302046|FG000|Overall Study|Adverse Event|0|||
48576618|NCT02091986|156302047|FG001|Overall Study|Adverse Event|0|||
48576619|NCT02091986|156302048|FG002|Overall Study|Adverse Event|2|||
48576620|NCT02419612|156302049|FG000|Short-term Treatment Period|Adverse Event|1|||
48576621|NCT02419612|156302050|FG001|Short-term Treatment Period|Adverse Event|1|||
48576622|NCT02419612|156302049|FG000|Short-term Treatment Period|Death|0|||
48576623|NCT02419612|156302050|FG001|Short-term Treatment Period|Death|2|||
48576624|NCT02419612|156302049|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
48576625|NCT02419612|156302050|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
48576626|NCT02419612|156302049|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
48621922|NCT00337194|156473188|FG001|Overall Study|Death|0|||
48621923|NCT00337194|156473187|FG000|Overall Study|Withdrawal by Subject|1|||
48576627|NCT02419612|156302050|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
48576628|NCT02419612|156302049|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
48576629|NCT02419612|156302050|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
48576630|NCT02419612|156302049|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
48576631|NCT02419612|156302050|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
48576632|NCT02419612|156302049|FG000|Short-term Treatment Period|Worsening of liver function|0|||
48576633|NCT02419612|156302050|FG001|Short-term Treatment Period|Worsening of liver function|1|||
48576634|NCT02419612|156302049|FG000|Short-term Treatment Period|Subject moved out of state|0|||
48621924|NCT00337194|156473188|FG001|Overall Study|Withdrawal by Subject|0|||
48621925|NCT00337194|156473187|FG000|Overall Study|Disease progression|1|||
48621926|NCT00337194|156473188|FG001|Overall Study|Disease progression|2|||
48621927|NCT00337194|156473187|FG000|Overall Study|Subsequent non-protocol therapy|3|||
48621928|NCT00337194|156473188|FG001|Overall Study|Subsequent non-protocol therapy|1|||
48621929|NCT01657500|156473196|FG000|Overall Study|set impropperly matched|3|||
48621930|NCT01657500|156473197|FG001|Overall Study|set impropperly matched|3|||
48621931|NCT01657500|156473196|FG000|Overall Study|Lost to Follow-up|2|||
48621932|NCT01657500|156473197|FG001|Overall Study|Lost to Follow-up|2|||
48621933|NCT03225989|156473198|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
48621934|NCT03225989|156473199|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
48621935|NCT03225989|156473200|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
48621936|NCT03225989|156473198|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
48621937|NCT03225989|156473199|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
48621938|NCT03225989|156473200|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
48621939|NCT03225989|156473198|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
48621940|NCT03225989|156473199|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
48576635|NCT02419612|156302050|FG001|Short-term Treatment Period|Subject moved out of state|1|||
48621941|NCT03225989|156473200|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
48621942|NCT03225989|156473198|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
48621943|NCT03225989|156473199|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
48621944|NCT03225989|156473200|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
48621945|NCT03225989|156473198|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
48621946|NCT03225989|156473199|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
48621947|NCT03225989|156473200|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
48621948|NCT03225989|156473198|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
48576636|NCT02419612|156302049|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
48576637|NCT02419612|156302050|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
48621949|NCT03225989|156473199|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
48621950|NCT03225989|156473200|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
48621951|NCT03225989|156473198|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
48621952|NCT03225989|156473199|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
48621953|NCT03225989|156473200|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
48621954|NCT03225989|156473198|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
48621955|NCT03225989|156473199|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
48621956|NCT03225989|156473200|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
48621957|NCT03225989|156473198|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
48621958|NCT03225989|156473199|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
48621959|NCT03225989|156473200|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
48621960|NCT03225989|156473198|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
48621961|NCT03225989|156473199|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
48621962|NCT03225989|156473200|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
48621963|NCT03225989|156473198|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
48621964|NCT03225989|156473199|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
48621965|NCT03225989|156473200|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
48621966|NCT03225989|156473198|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
48621967|NCT03225989|156473199|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
48621968|NCT03225989|156473200|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
48621969|NCT00098293|156473201|FG000|Double-blind (DB) Phase|Adverse Event|14|||
48621970|NCT00098293|156473202|FG001|Double-blind (DB) Phase|Adverse Event|27|||
48576638|NCT02419612|156302049|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
48576639|NCT02419612|156302050|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
48576640|NCT02419612|156302049|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
48576641|NCT02419612|156302050|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
48576642|NCT02419612|156302049|FG000|Long-term Treatment Period|Death|0|||
48576643|NCT02419612|156302050|FG001|Long-term Treatment Period|Death|1|||
48576644|NCT02419612|156302049|FG000|Long-term Treatment Period|Adverse Event|0|||
48576645|NCT02419612|156302050|FG001|Long-term Treatment Period|Adverse Event|5|||
48576646|NCT02419612|156302049|FG000|Long-term Treatment Period|Other|4|||
48576647|NCT02419612|156302050|FG001|Long-term Treatment Period|Other|4|||
48576648|NCT02419612|156302049|FG000|Long-term Treatment Period|Subject Decision|2|||
48576649|NCT02419612|156302050|FG001|Long-term Treatment Period|Subject Decision|4|||
48576650|NCT02419612|156302049|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
48576651|NCT02419612|156302050|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
48576652|NCT01744184|156302051|FG000|Overall Study|Adverse Event|1|||
48576653|NCT01744184|156302052|FG001|Overall Study|Adverse Event|0|||
48576654|NCT01744184|156302051|FG000|Overall Study|Withdrawal by Subject|0|||
48576655|NCT01744184|156302052|FG001|Overall Study|Withdrawal by Subject|1|||
48576656|NCT00533702|156302055|FG000|Overall Study|Withdrawal by Subject|3|||
48576657|NCT00533702|156302056|FG001|Overall Study|Withdrawal by Subject|1|||
48621971|NCT00098293|156473203|FG002|Double-blind (DB) Phase|Adverse Event|60|||
48621972|NCT00098293|156473204|FG003|Double-blind (DB) Phase|Adverse Event|0|||
48621973|NCT00098293|156473205|FG004|Double-blind (DB) Phase|Adverse Event|0|||
48621974|NCT00098293|156473201|FG000|Double-blind (DB) Phase|Pregnancy|0|||
48621975|NCT00098293|156473202|FG001|Double-blind (DB) Phase|Pregnancy|7|||
48621976|NCT00098293|156473203|FG002|Double-blind (DB) Phase|Pregnancy|9|||
48621977|NCT00098293|156473204|FG003|Double-blind (DB) Phase|Pregnancy|0|||
48621978|NCT00098293|156473205|FG004|Double-blind (DB) Phase|Pregnancy|0|||
48621979|NCT00098293|156473201|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
48621980|NCT00098293|156473202|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
48621981|NCT00098293|156473203|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
48576658|NCT00533702|156302055|FG000|Overall Study|Found ineligible after randomization|2|||
48576659|NCT00533702|156302056|FG001|Overall Study|Found ineligible after randomization|1|||
48621982|NCT00098293|156473204|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
48621983|NCT00098293|156473205|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
48621984|NCT00098293|156473201|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
48621985|NCT00098293|156473202|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
48621986|NCT00098293|156473203|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
48621987|NCT00098293|156473204|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
48621988|NCT00098293|156473205|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
48621989|NCT00098293|156473201|FG000|Double-blind (DB) Phase|Death|1|||
48621990|NCT00098293|156473202|FG001|Double-blind (DB) Phase|Death|2|||
48621991|NCT00098293|156473203|FG002|Double-blind (DB) Phase|Death|2|||
48621992|NCT00098293|156473204|FG003|Double-blind (DB) Phase|Death|0|||
48621993|NCT00098293|156473205|FG004|Double-blind (DB) Phase|Death|0|||
48576660|NCT02009397|156302059|FG000|Overall Study|Protocol Violation|6|||
48576661|NCT02009397|156302059|FG000|Overall Study|Death|8|||
48576662|NCT02009397|156302059|FG000|Overall Study|Lost to Follow-up|6|||
48576663|NCT01953601|156303884|FG000|Part 1 (Base Study)|Adverse Event|24|||
48576664|NCT01953601|156303885|FG001|Part 1 (Base Study)|Adverse Event|37|||
48576665|NCT01953601|156303886|FG002|Part 1 (Base Study)|Adverse Event|15|||
48621994|NCT00098293|156473201|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
48621995|NCT00098293|156473202|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
48621996|NCT00098293|156473203|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
48621997|NCT00098293|156473204|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
48621998|NCT00098293|156473205|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
48621999|NCT00098293|156473201|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
48622000|NCT00098293|156473202|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
48622001|NCT00098293|156473203|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
48622002|NCT00098293|156473204|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
48622003|NCT00098293|156473205|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
48622004|NCT00098293|156473201|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
48622005|NCT00098293|156473202|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
48622006|NCT00098293|156473203|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
48622007|NCT00098293|156473204|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
48622008|NCT00098293|156473205|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
48622009|NCT00098293|156473201|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
48622010|NCT00098293|156473202|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
48622011|NCT00098293|156473203|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
48622012|NCT00098293|156473204|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
48622013|NCT00098293|156473205|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
48622014|NCT00098293|156473201|FG000|Open-label (OL) Phase|Adverse Event|0|||
48622015|NCT00098293|156473202|FG001|Open-label (OL) Phase|Adverse Event|3|||
48576666|NCT01953601|156303884|FG000|Part 1 (Base Study)|Death|2|||
48576667|NCT01953601|156303885|FG001|Part 1 (Base Study)|Death|0|||
48576668|NCT01953601|156303886|FG002|Part 1 (Base Study)|Death|3|||
48576669|NCT01953601|156303884|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
48576670|NCT01953601|156303885|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
48576671|NCT01953601|156303886|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
48576672|NCT01953601|156303884|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
48622016|NCT00098293|156473203|FG002|Open-label (OL) Phase|Adverse Event|7|||
48622017|NCT00098293|156473204|FG003|Open-label (OL) Phase|Adverse Event|6|||
48622018|NCT00098293|156473205|FG004|Open-label (OL) Phase|Adverse Event|0|||
48622019|NCT00098293|156473201|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
48622020|NCT00098293|156473202|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
48622021|NCT00098293|156473203|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
48576673|NCT01953601|156303885|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
48622022|NCT00098293|156473204|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
48622023|NCT00098293|156473205|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
48622024|NCT00098293|156473201|FG000|Open-label (OL) Phase|Pregnancy|0|||
48622025|NCT00098293|156473202|FG001|Open-label (OL) Phase|Pregnancy|1|||
48576674|NCT01953601|156303886|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
48622026|NCT00098293|156473203|FG002|Open-label (OL) Phase|Pregnancy|0|||
48622027|NCT00098293|156473204|FG003|Open-label (OL) Phase|Pregnancy|3|||
48576675|NCT01953601|156303884|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
48450143|NCT01814826|155835605|FG001|Overall Study|Death|24|||
48622028|NCT00098293|156473205|FG004|Open-label (OL) Phase|Pregnancy|0|||
48622029|NCT00098293|156473201|FG000|Open-label (OL) Phase|Protocol Violation|0|||
48576676|NCT01953601|156303885|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
48576677|NCT01953601|156303886|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
48576678|NCT01953601|156303884|FG000|Part 1 (Base Study)|Physician Decision|3|||
48576679|NCT01953601|156303885|FG001|Part 1 (Base Study)|Physician Decision|7|||
48576680|NCT01953601|156303886|FG002|Part 1 (Base Study)|Physician Decision|4|||
48576681|NCT01953601|156303884|FG000|Part 1 (Base Study)|Screen failure|1|||
48576682|NCT01953601|156303885|FG001|Part 1 (Base Study)|Screen failure|0|||
48576683|NCT01953601|156303886|FG002|Part 1 (Base Study)|Screen failure|1|||
48576684|NCT01953601|156303884|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
48576685|NCT01953601|156303885|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
48576686|NCT01953601|156303886|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
48576687|NCT01953601|156303884|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
48576688|NCT01953601|156303885|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
48576689|NCT01953601|156303886|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
48576690|NCT01953601|156303884|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
48576691|NCT01953601|156303885|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
48576692|NCT01953601|156303886|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
48576693|NCT01953601|156303884|FG000|Part 1 (Base Study)|Subject moved|2|||
48576694|NCT01953601|156303885|FG001|Part 1 (Base Study)|Subject moved|2|||
48576695|NCT01953601|156303886|FG002|Part 1 (Base Study)|Subject moved|1|||
48576696|NCT01953601|156303884|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
48576697|NCT01953601|156303885|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
48576698|NCT01953601|156303886|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
48576699|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Adverse Event|1|||
48576700|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Adverse Event|1|||
48622030|NCT00098293|156473202|FG001|Open-label (OL) Phase|Protocol Violation|6|||
48622031|NCT00098293|156473203|FG002|Open-label (OL) Phase|Protocol Violation|13|||
48622032|NCT00098293|156473204|FG003|Open-label (OL) Phase|Protocol Violation|16|||
48622033|NCT00098293|156473205|FG004|Open-label (OL) Phase|Protocol Violation|0|||
48622034|NCT00098293|156473201|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
48622035|NCT00098293|156473202|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
48622036|NCT00098293|156473203|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
48622037|NCT00098293|156473204|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
48622038|NCT00098293|156473205|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
48622039|NCT00098293|156473201|FG000|Open-label (OL) Phase|Death|0|||
48576701|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Adverse Event|10|||
48576702|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Death|0|||
48576703|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Death|3|||
48576704|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Death|0|||
48576705|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
48576706|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
48576707|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
48576708|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
48576709|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
48576710|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
48576711|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Physician Decision|2|||
48576712|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Physician Decision|0|||
48576713|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Physician Decision|2|||
48576714|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
48576715|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
48576716|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
48576717|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
48576718|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
48622040|NCT00098293|156473202|FG001|Open-label (OL) Phase|Death|2|||
48622041|NCT00098293|156473203|FG002|Open-label (OL) Phase|Death|3|||
48622042|NCT00098293|156473204|FG003|Open-label (OL) Phase|Death|0|||
48576719|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
48576720|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
48622043|NCT00098293|156473205|FG004|Open-label (OL) Phase|Death|0|||
48622044|NCT00098293|156473201|FG000|Supplemental Phase (SP)|Death|0|||
48622045|NCT00098293|156473202|FG001|Supplemental Phase (SP)|Death|0|||
48576721|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
48576722|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
48576723|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Subject moved|0|||
48576724|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Subject moved|0|||
48576725|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Subject moved|1|||
48576726|NCT01953601|156303884|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
48576727|NCT01953601|156303885|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
48622046|NCT00098293|156473203|FG002|Supplemental Phase (SP)|Death|0|||
48622047|NCT00098293|156473204|FG003|Supplemental Phase (SP)|Death|0|||
48622048|NCT00098293|156473205|FG004|Supplemental Phase (SP)|Death|1|||
48622049|NCT00098293|156473201|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
48576728|NCT01953601|156303886|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
48576729|NCT01154296|156303887|FG000|Randomization and Intervention|Decided to decline|1|||
48576730|NCT01154296|156303888|FG001|Randomization and Intervention|Decided to decline|1|||
48576731|NCT01154296|156303887|FG000|Randomization and Intervention|Declined by staff|1|||
48576732|NCT01154296|156303888|FG001|Randomization and Intervention|Declined by staff|0|||
48576733|NCT01154296|156303887|FG000|Randomization and Intervention|Did not return|1|||
48576734|NCT01154296|156303888|FG001|Randomization and Intervention|Did not return|0|||
48576735|NCT01154296|156303887|FG000|Randomization and Intervention|Left before test|0|||
48576736|NCT01154296|156303888|FG001|Randomization and Intervention|Left before test|1|||
48576737|NCT01154296|156303887|FG000|Randomization and Intervention|Left clinic early|2|||
48576738|NCT01154296|156303888|FG001|Randomization and Intervention|Left clinic early|0|||
48576739|NCT01154296|156303887|FG000|6-month Follow-up|Lost contact|269|||
48576740|NCT01154296|156303888|FG001|6-month Follow-up|Lost contact|275|||
48576741|NCT01154296|156303887|FG000|6-month Follow-up|Incarcerated|37|||
48576742|NCT01154296|156303888|FG001|6-month Follow-up|Incarcerated|32|||
48576743|NCT01154296|156303887|FG000|6-month Follow-up|Withdrew consent|14|||
48576744|NCT01154296|156303888|FG001|6-month Follow-up|Withdrew consent|15|||
48576745|NCT01154296|156303887|FG000|6-month Follow-up|Death|3|||
48576746|NCT01154296|156303888|FG001|6-month Follow-up|Death|2|||
48576747|NCT01154296|156303887|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
48576748|NCT01154296|156303888|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
48576749|NCT01905553|156303892|FG000|Period 2|Adverse Event|1|||
48576750|NCT01905553|156303893|FG001|Period 2|Adverse Event|0|||
48576751|NCT04310397|156303894|FG000|Overall Study|Lack of Efficacy|3|||
48576752|NCT04310397|156303894|FG000|Overall Study|Withdrawal by Subject|1|||
48576753|NCT02989649|156303896|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
48622050|NCT00098293|156473202|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
48622051|NCT00098293|156473203|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
48622052|NCT00098293|156473204|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
48622053|NCT00098293|156473205|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
48576754|NCT02989649|156303896|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
48576755|NCT02989649|156303896|FG000|Overall Study|Lost For Observation During Study|3|||
48576756|NCT02989649|156303896|FG000|Overall Study|Reason Not Specified|13|||
48622054|NCT00098293|156473201|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
48622055|NCT00098293|156473202|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
48622056|NCT00098293|156473203|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
48622057|NCT00098293|156473204|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
48622058|NCT00098293|156473205|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
48622059|NCT00098293|156473201|FG000|Supplemental Phase (SP)|Other|0|||
48622060|NCT00098293|156473202|FG001|Supplemental Phase (SP)|Other|0|||
48622061|NCT00098293|156473203|FG002|Supplemental Phase (SP)|Other|0|||
48622062|NCT00098293|156473204|FG003|Supplemental Phase (SP)|Other|0|||
48622063|NCT00098293|156473205|FG004|Supplemental Phase (SP)|Other|22|||
48576757|NCT00330343|156303897|FG000|Overall Study|Lost to Follow-up|5|||
48576758|NCT02111785|156303898|FG000|Overall Study|Death|0|||
48576759|NCT02111785|156303899|FG001|Overall Study|Death|1|||
48576760|NCT02111785|156303900|FG002|Overall Study|Death|0|||
48576761|NCT02111785|156303901|FG003|Overall Study|Death|0|||
48576762|NCT04507256|156303902|FG000|Overall Study|Withdrawal by Subject|1|||
48576763|NCT04507256|156303903|FG001|Overall Study|Withdrawal by Subject|0|||
48576764|NCT04507256|156303904|FG002|Overall Study|Withdrawal by Subject|0|||
48576765|NCT04507256|156303905|FG003|Overall Study|Withdrawal by Subject|1|||
48576766|NCT04507256|156303906|FG004|Overall Study|Withdrawal by Subject|0|||
48576767|NCT04507256|156303907|FG005|Overall Study|Withdrawal by Subject|0|||
48576768|NCT00631410|156303908|FG000|Overall Study|Adverse Event|1|||
48576769|NCT00631410|156303909|FG001|Overall Study|Adverse Event|3|||
48622064|NCT03518203|156473206|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
48622065|NCT03518203|156473206|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
48622066|NCT02829957|156473207|FG000|Overall Study|Lost to Follow-up|2|||
48622067|NCT02829957|156473208|FG001|Overall Study|Lost to Follow-up|1|||
48622068|NCT03511066|156473209|FG000|Overall Study|Withdrawal by Subject|1|||
48576770|NCT00631410|156303908|FG000|Overall Study|Objective Progression or Relapse|4|||
48576771|NCT00631410|156303909|FG001|Overall Study|Objective Progression or Relapse|3|||
48576772|NCT00631410|156303908|FG000|Overall Study|Surgery|1|||
48576773|NCT00631410|156303909|FG001|Overall Study|Surgery|0|||
48576774|NCT00782184|156303922|FG000|Overall Study|Adverse Event|1|||
48576775|NCT00782184|156303923|FG001|Overall Study|Adverse Event|2|||
48622069|NCT03511066|156473210|FG001|Overall Study|Withdrawal by Subject|2|||
48576776|NCT00782184|156303922|FG000|Overall Study|Protocol Violation|0|||
48622070|NCT03511066|156473211|FG002|Overall Study|Withdrawal by Subject|3|||
48576777|NCT00782184|156303923|FG001|Overall Study|Protocol Violation|1|||
48576778|NCT00782184|156303922|FG000|Overall Study|Withdrawal by Subject|3|||
48576779|NCT00782184|156303923|FG001|Overall Study|Withdrawal by Subject|2|||
48576780|NCT03973918|156303928|FG000|Overall Study|Adverse Event|0|||
48576781|NCT03973918|156303929|FG001|Overall Study|Adverse Event|0|||
48622071|NCT03511066|156473209|FG000|Overall Study|Lost to Follow-up|2|||
48622072|NCT03511066|156473210|FG001|Overall Study|Lost to Follow-up|3|||
48622073|NCT03511066|156473211|FG002|Overall Study|Lost to Follow-up|0|||
48622074|NCT01189227|156473212|FG000|Overall Study|Study terminated due to low accrual|6|||
48622075|NCT01189227|156473213|FG001|Overall Study|Study terminated due to low accrual|3|||
48622076|NCT04595370|156473214|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
48622077|NCT04595370|156473215|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
48622078|NCT04595370|156473216|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
48622079|NCT04595370|156473217|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
48622080|NCT04595370|156473218|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
48576782|NCT03973918|156303930|FG002|Overall Study|Adverse Event|0|||
48576783|NCT03973918|156303931|FG003|Overall Study|Adverse Event|1|||
48576784|NCT03973918|156303928|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
48576785|NCT03973918|156303929|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
48576786|NCT03973918|156303930|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
48576787|NCT03973918|156303931|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
48622081|NCT04595370|156473219|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
48622082|NCT04595370|156473214|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
48622083|NCT04595370|156473215|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
48622084|NCT04595370|156473216|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
48622085|NCT04595370|156473217|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
48622086|NCT04595370|156473218|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
48622087|NCT04595370|156473219|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
48622088|NCT04595370|156473214|FG000|Overall Study|Adverse Event|0|||
48622089|NCT04595370|156473215|FG001|Overall Study|Adverse Event|4|||
48622090|NCT04595370|156473216|FG002|Overall Study|Adverse Event|3|||
48622091|NCT04595370|156473217|FG003|Overall Study|Adverse Event|1|||
48622092|NCT04595370|156473218|FG004|Overall Study|Adverse Event|1|||
48622093|NCT04595370|156473219|FG005|Overall Study|Adverse Event|1|||
48622094|NCT04595370|156473214|FG000|Overall Study|Withdrawal of Consent|1|||
48622095|NCT04595370|156473215|FG001|Overall Study|Withdrawal of Consent|1|||
48622096|NCT04595370|156473216|FG002|Overall Study|Withdrawal of Consent|1|||
48622097|NCT04595370|156473217|FG003|Overall Study|Withdrawal of Consent|0|||
48622098|NCT04595370|156473218|FG004|Overall Study|Withdrawal of Consent|0|||
48622099|NCT04595370|156473219|FG005|Overall Study|Withdrawal of Consent|0|||
48622100|NCT04595370|156473214|FG000|Overall Study|Death|0|||
48622101|NCT04595370|156473215|FG001|Overall Study|Death|1|||
48622102|NCT04595370|156473216|FG002|Overall Study|Death|0|||
48576788|NCT00978250|156303932|FG000|Overall Study|Late determination of ineligibility|0|||
48576789|NCT00978250|156303933|FG001|Overall Study|Late determination of ineligibility|1|||
48576790|NCT00978250|156303934|FG002|Overall Study|Late determination of ineligibility|0|||
48576791|NCT00978250|156303935|FG003|Overall Study|Late determination of ineligibility|1|||
48576792|NCT01992653|156303941|FG000|Overall Study|Death|0|||
48576793|NCT01992653|156303942|FG001|Overall Study|Death|0|||
48576794|NCT01992653|156303943|FG002|Overall Study|Death|1|||
48736085|NCT00866788|156885626|FG001|Overall Study|Physician Decision|0|||
48319710|NCT03752151|155371083|FG000|Overall Study|Withdrawal by Subject|1|||
48319711|NCT03752151|155371083|FG000|Overall Study|Protocol Violation|1|||
48576795|NCT01992653|156303944|FG003|Overall Study|Death|0|||
48576796|NCT01992653|156303945|FG004|Overall Study|Death|1|||
48622103|NCT04595370|156473217|FG003|Overall Study|Death|0|||
48622104|NCT04595370|156473218|FG004|Overall Study|Death|1|||
48622105|NCT04595370|156473219|FG005|Overall Study|Death|0|||
48622106|NCT04595370|156473214|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48576797|NCT01992653|156303946|FG005|Overall Study|Death|0|||
48576798|NCT01992653|156303947|FG006|Overall Study|Death|4|||
48576799|NCT01992653|156303948|FG007|Overall Study|Death|2|||
48576800|NCT01992653|156303941|FG000|Overall Study|Lost to Follow-up|0|||
48576801|NCT01992653|156303942|FG001|Overall Study|Lost to Follow-up|0|||
48576802|NCT01992653|156303943|FG002|Overall Study|Lost to Follow-up|0|||
48576803|NCT01992653|156303944|FG003|Overall Study|Lost to Follow-up|0|||
48576804|NCT01992653|156303945|FG004|Overall Study|Lost to Follow-up|0|||
48576805|NCT01992653|156303946|FG005|Overall Study|Lost to Follow-up|0|||
48576806|NCT01992653|156303947|FG006|Overall Study|Lost to Follow-up|0|||
48576807|NCT01992653|156303948|FG007|Overall Study|Lost to Follow-up|1|||
48576808|NCT01992653|156303941|FG000|Overall Study|Study Completed|0|||
48576809|NCT01992653|156303942|FG001|Overall Study|Study Completed|0|||
48576810|NCT01992653|156303943|FG002|Overall Study|Study Completed|0|||
48576811|NCT01992653|156303944|FG003|Overall Study|Study Completed|0|||
48576812|NCT01992653|156303945|FG004|Overall Study|Study Completed|0|||
48576813|NCT01992653|156303946|FG005|Overall Study|Study Completed|0|||
48576814|NCT01992653|156303947|FG006|Overall Study|Study Completed|0|||
48576815|NCT01992653|156303948|FG007|Overall Study|Study Completed|1|||
48576816|NCT01992653|156303941|FG000|Overall Study|Disease Progression|0|||
48576817|NCT01992653|156303942|FG001|Overall Study|Disease Progression|0|||
48576818|NCT01992653|156303943|FG002|Overall Study|Disease Progression|0|||
48576819|NCT01992653|156303944|FG003|Overall Study|Disease Progression|0|||
48576820|NCT01992653|156303945|FG004|Overall Study|Disease Progression|0|||
48576821|NCT01992653|156303946|FG005|Overall Study|Disease Progression|0|||
48576822|NCT01992653|156303947|FG006|Overall Study|Disease Progression|4|||
48576823|NCT01992653|156303948|FG007|Overall Study|Disease Progression|0|||
48576824|NCT02396420|156303955|FG000|Overall Study|Death|1|||
48576825|NCT03395184|156303956|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
48576826|NCT03395184|156303957|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
48576827|NCT03395184|156303958|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
48576828|NCT03395184|156303959|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
48576829|NCT03395184|156303960|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
48576830|NCT03395184|156303961|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
48576831|NCT03395184|156303962|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
48576832|NCT03395184|156303956|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
48576833|NCT03395184|156303957|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
48576834|NCT03395184|156303958|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
48576835|NCT03395184|156303959|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
48576836|NCT03395184|156303960|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
48576837|NCT03395184|156303961|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
48576838|NCT03395184|156303962|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
48576839|NCT03395184|156303956|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
48576840|NCT03395184|156303957|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
48576841|NCT03395184|156303958|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
48576842|NCT03395184|156303959|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
48576843|NCT03395184|156303960|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
48576844|NCT03395184|156303961|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
48576845|NCT03395184|156303962|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
48576846|NCT03395184|156303956|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
48576847|NCT03395184|156303957|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
48576848|NCT03395184|156303958|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
48576849|NCT03395184|156303959|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
48576850|NCT03395184|156303960|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
48576851|NCT03395184|156303961|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
48576852|NCT03395184|156303962|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
48576853|NCT03395184|156303956|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
48576854|NCT03395184|156303957|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48576855|NCT03395184|156303958|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
48576856|NCT03395184|156303959|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48576857|NCT03395184|156303960|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48576858|NCT03395184|156303961|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48576859|NCT03395184|156303962|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48576860|NCT03395184|156303956|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
48576861|NCT03395184|156303957|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
48576862|NCT03395184|156303958|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
48576863|NCT03395184|156303959|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
48576864|NCT03395184|156303960|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
48576865|NCT03395184|156303961|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
48622107|NCT04595370|156473215|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48622108|NCT04595370|156473216|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
48622109|NCT04595370|156473217|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48622110|NCT04595370|156473218|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48622111|NCT04595370|156473219|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48622112|NCT04595370|156473214|FG000|Overall Study|Withdrawal by Subject|0|||
48622113|NCT04595370|156473215|FG001|Overall Study|Withdrawal by Subject|0|||
48622114|NCT04595370|156473216|FG002|Overall Study|Withdrawal by Subject|1|||
48622115|NCT04595370|156473217|FG003|Overall Study|Withdrawal by Subject|0|||
48622116|NCT04595370|156473218|FG004|Overall Study|Withdrawal by Subject|2|||
48622117|NCT04595370|156473219|FG005|Overall Study|Withdrawal by Subject|0|||
48622118|NCT04595370|156473214|FG000|Overall Study|Lost to Follow-up|0|||
48622119|NCT04595370|156473215|FG001|Overall Study|Lost to Follow-up|0|||
48622120|NCT04595370|156473216|FG002|Overall Study|Lost to Follow-up|0|||
48622121|NCT04595370|156473217|FG003|Overall Study|Lost to Follow-up|0|||
48622122|NCT04595370|156473218|FG004|Overall Study|Lost to Follow-up|1|||
48622123|NCT04595370|156473219|FG005|Overall Study|Lost to Follow-up|0|||
48622124|NCT04595370|156473214|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
48622125|NCT04595370|156473215|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
48319712|NCT00529516|155371084|FG000|Overall Study|Adverse Event|2|||
48576866|NCT03395184|156303962|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
48576867|NCT03395184|156303956|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
48319713|NCT00529516|155371085|FG001|Overall Study|Adverse Event|1|||
48319714|NCT00529516|155371086|FG002|Overall Study|Adverse Event|0|||
48576868|NCT03395184|156303957|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
48576869|NCT03395184|156303958|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
48576870|NCT03395184|156303959|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
48576871|NCT03395184|156303960|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
48576872|NCT03395184|156303961|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
48576873|NCT03395184|156303962|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
48576874|NCT03395184|156303956|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
48576875|NCT03395184|156303957|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
48576876|NCT03395184|156303958|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
48576877|NCT03395184|156303959|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
48576878|NCT03395184|156303960|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
48576879|NCT03395184|156303961|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
48576880|NCT03395184|156303962|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
48576881|NCT03395184|156303956|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
48576882|NCT03395184|156303957|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
48576883|NCT03395184|156303958|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
48576884|NCT03395184|156303959|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
48576885|NCT03395184|156303960|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
48576886|NCT03395184|156303961|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
48576887|NCT03395184|156303962|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
48576888|NCT03395184|156303956|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
48576889|NCT03395184|156303957|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
48576890|NCT03395184|156303958|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
48576891|NCT03395184|156303959|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
48576892|NCT03395184|156303960|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
48622126|NCT04595370|156473216|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
48622127|NCT04595370|156473217|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
48622128|NCT04595370|156473218|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
48622129|NCT04595370|156473219|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
48622130|NCT02520154|156473221|FG000|Overall Study|Death|1|||
48622131|NCT02520154|156473221|FG000|Overall Study|Withdrawal by Subject|2|||
48622132|NCT02520154|156473221|FG000|Overall Study|Physician Decision|2|||
48622133|NCT01740427|156473225|FG000|Overall Study|Objective Progression or Relapse|286|||
48622134|NCT01740427|156473226|FG001|Overall Study|Objective Progression or Relapse|172|||
48622135|NCT01740427|156473225|FG000|Overall Study|Adverse Event|32|||
48622136|NCT01740427|156473226|FG001|Overall Study|Adverse Event|9|||
48622137|NCT01740427|156473225|FG000|Overall Study|Global Deterioration of Health Status|28|||
48622138|NCT01740427|156473226|FG001|Overall Study|Global Deterioration of Health Status|12|||
48622139|NCT01740427|156473225|FG000|Overall Study|Participant Refused Continued Treatment|27|||
48622140|NCT01740427|156473226|FG001|Overall Study|Participant Refused Continued Treatment|15|||
48622141|NCT01740427|156473225|FG000|Overall Study|Unspecified reasons|52|||
48622142|NCT01740427|156473226|FG001|Overall Study|Unspecified reasons|8|||
48622143|NCT01740427|156473225|FG000|Overall Study|Death|10|||
48622144|NCT01740427|156473226|FG001|Overall Study|Death|3|||
48622145|NCT01740427|156473225|FG000|Overall Study|Protocol Violation|5|||
48622146|NCT01740427|156473226|FG001|Overall Study|Protocol Violation|3|||
48622147|NCT01740427|156473225|FG000|Overall Study|Lost to Follow-up|3|||
48622148|NCT01740427|156473226|FG001|Overall Study|Lost to Follow-up|0|||
48622149|NCT01740427|156473225|FG000|Overall Study|Site Terminated by Sponsor|1|||
48622150|NCT01740427|156473226|FG001|Overall Study|Site Terminated by Sponsor|0|||
48622151|NCT01390584|156473231|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
48622152|NCT01390584|156473232|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
48622153|NCT01390584|156473233|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
48622154|NCT00362609|156473236|FG000|Overall Study|Withdrawal by Subject|0|||
48622155|NCT00362609|156473237|FG001|Overall Study|Withdrawal by Subject|1|||
48622156|NCT00362609|156473236|FG000|Overall Study|Protocol Violation|0|||
48622157|NCT00362609|156473237|FG001|Overall Study|Protocol Violation|1|||
48622158|NCT02539394|156473238|FG000|Overall Study|Protocol Violation|1|||
48622159|NCT02539394|156473239|FG001|Overall Study|Protocol Violation|3|||
48622160|NCT02539394|156473238|FG000|Overall Study|Lost to Follow-up|1|||
48622161|NCT02539394|156473239|FG001|Overall Study|Lost to Follow-up|2|||
48622162|NCT02539394|156473238|FG000|Overall Study|Incomplete dataset|6|||
48622163|NCT02539394|156473239|FG001|Overall Study|Incomplete dataset|6|||
48622164|NCT03020888|156473242|FG000|Overall Study|Physician Decision|4|||
48622165|NCT03020888|156473242|FG000|Overall Study|Withdrawal by Subject|6|||
48622166|NCT03020888|156473242|FG000|Overall Study|Insurance coverage|2|||
48622167|NCT03020888|156473242|FG000|Overall Study|Lost to Follow-up|1|||
48622168|NCT00992394|156473247|FG000|Overall Study|Lack of Efficacy|6|||
48622169|NCT00992394|156473248|FG001|Overall Study|Lack of Efficacy|3|||
48622170|NCT00992394|156473247|FG000|Overall Study|Adverse Event|4|||
48576893|NCT03395184|156303961|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
48576894|NCT03395184|156303962|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
48576895|NCT03395184|156303956|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
48576896|NCT03395184|156303957|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
48576897|NCT03395184|156303958|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
48622171|NCT00992394|156473248|FG001|Overall Study|Adverse Event|5|||
48622172|NCT00992394|156473247|FG000|Overall Study|Withdrawal by Subject|8|||
48622173|NCT00992394|156473248|FG001|Overall Study|Withdrawal by Subject|2|||
48622174|NCT00992394|156473247|FG000|Overall Study|Physician Decision|1|||
48622175|NCT00992394|156473248|FG001|Overall Study|Physician Decision|0|||
48622176|NCT00992394|156473247|FG000|Overall Study|Protocol Violation|2|||
48622177|NCT00992394|156473248|FG001|Overall Study|Protocol Violation|4|||
48622178|NCT00992394|156473247|FG000|Overall Study|Lost to Follow-up|2|||
48576898|NCT03395184|156303959|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
48576899|NCT03395184|156303960|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
48576900|NCT03395184|156303961|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
48576901|NCT03395184|156303962|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
48622179|NCT00992394|156473248|FG001|Overall Study|Lost to Follow-up|0|||
48622180|NCT00992394|156473247|FG000|Overall Study|Other event|1|||
48622181|NCT00992394|156473248|FG001|Overall Study|Other event|0|||
48622182|NCT02568254|156473249|FG000|Period 2|Adverse Event|0|||
48622183|NCT02568254|156473250|FG001|Period 2|Adverse Event|0|||
48576902|NCT03395184|156303956|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
48622184|NCT02568254|156473251|FG002|Period 2|Adverse Event|1|||
48622185|NCT02568254|156473252|FG003|Period 2|Adverse Event|0|||
48622186|NCT02568254|156473253|FG004|Period 2|Adverse Event|0|||
48622187|NCT02568254|156473254|FG005|Period 2|Adverse Event|0|||
48622188|NCT02568254|156473249|FG000|Period 3|Unstatisfactory Lens fitting|0|||
48622189|NCT02568254|156473250|FG001|Period 3|Unstatisfactory Lens fitting|0|||
48622190|NCT02568254|156473251|FG002|Period 3|Unstatisfactory Lens fitting|0|||
48622191|NCT02568254|156473252|FG003|Period 3|Unstatisfactory Lens fitting|0|||
48622192|NCT02568254|156473253|FG004|Period 3|Unstatisfactory Lens fitting|1|||
48622193|NCT02568254|156473254|FG005|Period 3|Unstatisfactory Lens fitting|0|||
48622194|NCT04495478|156473257|FG000|Overall Study|Withdrawal by Subject|0|||
48622195|NCT04495478|156473258|FG001|Overall Study|Withdrawal by Subject|0|||
48622196|NCT04495478|156473259|FG002|Overall Study|Withdrawal by Subject|0|||
48622197|NCT04495478|156473260|FG003|Overall Study|Withdrawal by Subject|1|||
48622198|NCT04495478|156473261|FG004|Overall Study|Withdrawal by Subject|0|||
48622199|NCT04495478|156473262|FG005|Overall Study|Withdrawal by Subject|0|||
48622200|NCT04495478|156473263|FG006|Overall Study|Withdrawal by Subject|0|||
48622201|NCT04495478|156473257|FG000|Overall Study|Physician Decision|0|||
48622202|NCT04495478|156473258|FG001|Overall Study|Physician Decision|1|||
48622203|NCT04495478|156473259|FG002|Overall Study|Physician Decision|0|||
48622204|NCT04495478|156473260|FG003|Overall Study|Physician Decision|0|||
48622205|NCT04495478|156473261|FG004|Overall Study|Physician Decision|1|||
48622206|NCT04495478|156473262|FG005|Overall Study|Physician Decision|0|||
48622207|NCT04495478|156473263|FG006|Overall Study|Physician Decision|0|||
48622208|NCT03882801|156475075|FG000|Period 1|Adverse Event|0|||
48622209|NCT03882801|156475076|FG001|Period 1|Adverse Event|1|||
48622210|NCT03882801|156475075|FG000|Period 1|Non-compliance with study drug|1|||
48622211|NCT03882801|156475076|FG001|Period 1|Non-compliance with study drug|1|||
48622212|NCT03882801|156475075|FG000|Period 1|Never treated with study drug|1|||
48622213|NCT03882801|156475076|FG001|Period 1|Never treated with study drug|0|||
48622214|NCT03882801|156475075|FG000|Washout Period|Physician Decision|0|||
48622215|NCT03882801|156475076|FG001|Washout Period|Physician Decision|1|||
48622216|NCT03882801|156475075|FG000|Period 2|Non-compliance with study drug|0|||
48622217|NCT03882801|156475076|FG001|Period 2|Non-compliance with study drug|1|||
48622218|NCT02642679|156475077|FG000|Overall Study|Withdrawal by Subject|1|||
48622219|NCT02642679|156475077|FG000|Overall Study|Physician Decision|1|||
48622220|NCT02642679|156475077|FG000|Overall Study|Physician Decision|1|||
48622221|NCT03735498|156475078|FG000|Overall Study|Withdrawal by Subject|3|||
48622222|NCT03735498|156475078|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
48622223|NCT00420407|156475079|FG000|Overall Study|Lost to Follow-up|0|||
48622224|NCT00420407|156475080|FG001|Overall Study|Lost to Follow-up|3|||
48622225|NCT00420407|156475079|FG000|Overall Study|Physician Decision|2|||
48622226|NCT00420407|156475080|FG001|Overall Study|Physician Decision|1|||
48622227|NCT00420407|156475079|FG000|Overall Study|subject identified as detainee|1|||
48622228|NCT00420407|156475080|FG001|Overall Study|subject identified as detainee|0|||
48622229|NCT00420407|156475079|FG000|Overall Study|subject identified as Jehovah's witness|1|||
48622230|NCT00420407|156475080|FG001|Overall Study|subject identified as Jehovah's witness|0|||
48622231|NCT00420407|156475079|FG000|Overall Study|Withdrawal by Subject|0|||
48622232|NCT00420407|156475080|FG001|Overall Study|Withdrawal by Subject|2|||
48622233|NCT02562040|156475086|FG000|Overall Study|Lost to Follow-up|20|||
48622234|NCT02562040|156475087|FG001|Overall Study|Lost to Follow-up|28|||
48622235|NCT02562040|156475086|FG000|Overall Study|Withdrawal by Subject|8|||
48622236|NCT02562040|156475087|FG001|Overall Study|Withdrawal by Subject|7|||
48622237|NCT02562040|156475086|FG000|Overall Study|Adverse Event|1|||
48622238|NCT02562040|156475087|FG001|Overall Study|Adverse Event|0|||
48622239|NCT02821000|156475088|FG000|Overall Study|Death|89|||
48622240|NCT02821000|156475088|FG000|Overall Study|Sponsor Decision|12|||
48622241|NCT02821000|156475088|FG000|Overall Study|Withdrawal by Subject|2|||
48622242|NCT03437733|156475092|FG000|Overall Study|Eligibility criteria not met|0|||
48622243|NCT03437733|156475093|FG001|Overall Study|Eligibility criteria not met|3|||
48622244|NCT02143778|156475096|FG000|Overall Study|Withdrawal by Subject|2|||
48622245|NCT02143778|156475096|FG000|Overall Study|Device malfunction|1|||
48622246|NCT02565186|156475100|FG000|Overall Study|Adverse Event|113|||
48622247|NCT02565186|156475101|FG001|Overall Study|Adverse Event|148|||
48622248|NCT02565186|156475100|FG000|Overall Study|Lost to Follow-up|102|||
48622249|NCT02565186|156475101|FG001|Overall Study|Lost to Follow-up|93|||
48576903|NCT03395184|156303957|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
48576904|NCT03395184|156303958|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
48576905|NCT03395184|156303959|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
48576906|NCT03395184|156303960|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
48576907|NCT03395184|156303961|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
48576908|NCT03395184|156303962|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
48576909|NCT00474045|156303963|FG000|Overall Study|Adverse Event|18|||
48576910|NCT00474045|156303964|FG001|Overall Study|Adverse Event|8|||
48622250|NCT02565186|156475100|FG000|Overall Study|Non-Compliance|57|||
48622251|NCT02565186|156475101|FG001|Overall Study|Non-Compliance|55|||
48622252|NCT02565186|156475100|FG000|Overall Study|Withdrawal by Subject|229|||
48622253|NCT02565186|156475101|FG001|Overall Study|Withdrawal by Subject|214|||
48576911|NCT00474045|156303963|FG000|Overall Study|Unclassified|1|||
48622254|NCT02565186|156475100|FG000|Overall Study|Physician Decision|18|||
48622255|NCT02565186|156475101|FG001|Overall Study|Physician Decision|16|||
48622256|NCT02565186|156475100|FG000|Overall Study|Sponsor Request|5|||
48622257|NCT02565186|156475101|FG001|Overall Study|Sponsor Request|9|||
48622258|NCT02565186|156475100|FG000|Overall Study|Missing|1|||
48622259|NCT02565186|156475101|FG001|Overall Study|Missing|0|||
48622260|NCT02565186|156475100|FG000|Overall Study|Did Not Receive Study Drug|55|||
48622261|NCT02565186|156475101|FG001|Overall Study|Did Not Receive Study Drug|86|||
48622262|NCT01975285|156475112|FG000|Overall Study|Failed Block and follow up|2|||
48622263|NCT01975285|156475113|FG001|Overall Study|Failed Block and follow up|2|||
48622264|NCT06074523|156475114|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
48622265|NCT06074523|156475114|FG000|Overall Study|Withdrawal by Subject|1|||
48622266|NCT02619812|156475115|FG000|Overall Study|Withdrawal by Subject|0|||
48622267|NCT02619812|156475116|FG001|Overall Study|Withdrawal by Subject|0|||
48622268|NCT02619812|156475117|FG002|Overall Study|Withdrawal by Subject|1|||
48622269|NCT02619812|156475118|FG003|Overall Study|Withdrawal by Subject|2|||
48622270|NCT04189588|156475123|FG000|Overall Study|Death|0|||
48622271|NCT04189588|156475124|FG001|Overall Study|Death|1|||
48622272|NCT04189588|156475123|FG000|Overall Study|Lost to Follow-up|0|||
48622273|NCT04189588|156475124|FG001|Overall Study|Lost to Follow-up|1|||
48622274|NCT02872142|156475132|FG000|Overall Study|Adverse Event|2|||
48622275|NCT02872142|156475132|FG000|Overall Study|Death|1|||
48622276|NCT02872142|156475132|FG000|Overall Study|Participant Decision|3|||
48622277|NCT03156621|156475135|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
48576912|NCT00474045|156303964|FG001|Overall Study|Unclassified|3|||
48576913|NCT00474045|156303963|FG000|Overall Study|Lack of Efficacy|0|||
48576914|NCT00474045|156303964|FG001|Overall Study|Lack of Efficacy|9|||
48576915|NCT00474045|156303963|FG000|Overall Study|Lost to Follow-up|1|||
48576916|NCT00474045|156303964|FG001|Overall Study|Lost to Follow-up|1|||
48576917|NCT00474045|156303963|FG000|Overall Study|Protocol Violation|10|||
48576918|NCT00474045|156303964|FG001|Overall Study|Protocol Violation|12|||
48576919|NCT00474045|156303963|FG000|Overall Study|Withdrawal by Subject|16|||
48576920|NCT00474045|156303964|FG001|Overall Study|Withdrawal by Subject|18|||
48576921|NCT00474045|156303963|FG000|Overall Study|Withdrawal criteria|60|||
48576922|NCT00474045|156303964|FG001|Overall Study|Withdrawal criteria|50|||
48576923|NCT01095978|156303968|FG000|Overall Study|Did not take Klacid SR|2|||
48576924|NCT01095978|156303968|FG000|Overall Study|Adverse Event|1|||
48576925|NCT02135107|156303969|FG000|Treatment Period|Withdrawal by Subject|11|||
48576926|NCT02135107|156303970|FG001|Treatment Period|Withdrawal by Subject|0|||
48576927|NCT02135107|156303971|FG002|Treatment Period|Withdrawal by Subject|0|||
48576928|NCT02135107|156303972|FG003|Treatment Period|Withdrawal by Subject|0|||
48576929|NCT02135107|156303969|FG000|Treatment Period|Adverse Event|5|||
48576930|NCT02135107|156303970|FG001|Treatment Period|Adverse Event|2|||
48576931|NCT02135107|156303971|FG002|Treatment Period|Adverse Event|0|||
48622278|NCT03156621|156475136|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
48622279|NCT03156621|156475135|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
48622280|NCT03156621|156475136|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
48622281|NCT03016403|156475141|FG000|Baseline|Death|5|||
48576932|NCT02135107|156303972|FG003|Treatment Period|Adverse Event|0|||
48576933|NCT02135107|156303969|FG000|Treatment Period|Pregnancy|1|||
48576934|NCT02135107|156303970|FG001|Treatment Period|Pregnancy|0|||
48576935|NCT02135107|156303971|FG002|Treatment Period|Pregnancy|0|||
48576936|NCT02135107|156303972|FG003|Treatment Period|Pregnancy|0|||
48622282|NCT03016403|156475142|FG001|Baseline|Death|8|||
48622283|NCT03016403|156475143|FG002|Baseline|Death|1|||
48622284|NCT03016403|156475144|FG003|Baseline|Death|0|||
48622285|NCT03016403|156475141|FG000|Baseline|Withdrawal by Subject|2|||
48622286|NCT03016403|156475142|FG001|Baseline|Withdrawal by Subject|8|||
48622287|NCT03016403|156475143|FG002|Baseline|Withdrawal by Subject|4|||
48622288|NCT03016403|156475144|FG003|Baseline|Withdrawal by Subject|10|||
48622289|NCT03016403|156475141|FG000|Baseline|Lost to Follow-up|9|||
48622290|NCT03016403|156475142|FG001|Baseline|Lost to Follow-up|11|||
48622291|NCT03016403|156475143|FG002|Baseline|Lost to Follow-up|6|||
48622292|NCT03016403|156475144|FG003|Baseline|Lost to Follow-up|24|||
48576937|NCT02135107|156303969|FG000|Treatment Period|Other|115|||
48576938|NCT02135107|156303970|FG001|Treatment Period|Other|24|||
48576939|NCT02135107|156303971|FG002|Treatment Period|Other|0|||
48576940|NCT02135107|156303972|FG003|Treatment Period|Other|0|||
48576941|NCT02135107|156303969|FG000|Maintenance Therapy Period|Adverse Event|0|||
48576942|NCT02135107|156303970|FG001|Maintenance Therapy Period|Adverse Event|0|||
48576943|NCT02135107|156303971|FG002|Maintenance Therapy Period|Adverse Event|3|||
48622293|NCT03016403|156475141|FG000|6-week Follow-up|Death|1|||
48576944|NCT02135107|156303972|FG003|Maintenance Therapy Period|Adverse Event|7|||
48576945|NCT02135107|156303969|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
48576946|NCT02135107|156303970|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
48576947|NCT02135107|156303971|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
48576948|NCT02135107|156303972|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
48576949|NCT02135107|156303969|FG000|Maintenance Therapy Period|Pregnancy|0|||
48576950|NCT02135107|156303970|FG001|Maintenance Therapy Period|Pregnancy|0|||
48576951|NCT02135107|156303971|FG002|Maintenance Therapy Period|Pregnancy|0|||
48576952|NCT02135107|156303972|FG003|Maintenance Therapy Period|Pregnancy|1|||
48622294|NCT03016403|156475142|FG001|6-week Follow-up|Death|4|||
48622295|NCT03016403|156475143|FG002|6-week Follow-up|Death|0|||
48622296|NCT03016403|156475144|FG003|6-week Follow-up|Death|0|||
48622297|NCT03016403|156475141|FG000|6-week Follow-up|Lost to Follow-up|2|||
48622298|NCT03016403|156475142|FG001|6-week Follow-up|Lost to Follow-up|7|||
48622299|NCT03016403|156475143|FG002|6-week Follow-up|Lost to Follow-up|4|||
48622300|NCT03016403|156475144|FG003|6-week Follow-up|Lost to Follow-up|8|||
48622301|NCT03016403|156475141|FG000|6-week Follow-up|Withdrawal by Subject|0|||
48622302|NCT03016403|156475142|FG001|6-week Follow-up|Withdrawal by Subject|2|||
48622303|NCT03016403|156475143|FG002|6-week Follow-up|Withdrawal by Subject|0|||
48622304|NCT03016403|156475144|FG003|6-week Follow-up|Withdrawal by Subject|1|||
48622305|NCT03016403|156475141|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
48622306|NCT03016403|156475142|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
48622307|NCT03016403|156475143|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
48622308|NCT03016403|156475144|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
48622309|NCT03016403|156475141|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
48622310|NCT03016403|156475142|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
48622311|NCT03016403|156475143|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
48576953|NCT02135107|156303969|FG000|Maintenance Therapy Period|Other|0|||
48576954|NCT02135107|156303970|FG001|Maintenance Therapy Period|Other|0|||
48576955|NCT02135107|156303971|FG002|Maintenance Therapy Period|Other|7|||
48576956|NCT02135107|156303972|FG003|Maintenance Therapy Period|Other|8|||
48576957|NCT02278120|156303985|FG000|Treatment Period|Progressive disease|234|||
48576958|NCT02278120|156303986|FG001|Treatment Period|Progressive disease|260|||
48576959|NCT02278120|156303985|FG000|Treatment Period|Subject/guardian decision|23|||
48576960|NCT02278120|156303986|FG001|Treatment Period|Subject/guardian decision|20|||
48576961|NCT02278120|156303985|FG000|Treatment Period|Adverse Event|16|||
48576962|NCT02278120|156303986|FG001|Treatment Period|Adverse Event|14|||
48576963|NCT02278120|156303985|FG000|Treatment Period|Physician Decision|14|||
48576964|NCT02278120|156303986|FG001|Treatment Period|Physician Decision|27|||
48576965|NCT02278120|156303985|FG000|Treatment Period|Death|3|||
48576966|NCT02278120|156303986|FG001|Treatment Period|Death|3|||
48576967|NCT02278120|156303985|FG000|Treatment Period|Lost to Follow-up|2|||
48576968|NCT02278120|156303986|FG001|Treatment Period|Lost to Follow-up|0|||
48576969|NCT02278120|156303985|FG000|Treatment Period|Protocol deviation|0|||
48576970|NCT02278120|156303986|FG001|Treatment Period|Protocol deviation|2|||
48576971|NCT02278120|156303985|FG000|Treatment Period|Study terminated as per protocol|43|||
48576972|NCT02278120|156303986|FG001|Treatment Period|Study terminated as per protocol|11|||
48576973|NCT02278120|156303985|FG000|Post-treatment Efficacy Follow-up|Death|0|||
48576974|NCT02278120|156303986|FG001|Post-treatment Efficacy Follow-up|Death|1|||
48576975|NCT02278120|156303985|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
48576976|NCT02278120|156303986|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
48576977|NCT02278120|156303985|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
48576978|NCT02278120|156303986|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
48576979|NCT02278120|156303985|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
48576980|NCT02278120|156303986|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
48576981|NCT02278120|156303985|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48576982|NCT02278120|156303986|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48576983|NCT01817582|156303992|FG000|Overall Study|Withdrawal by Subject|0|||
48576984|NCT01817582|156303993|FG001|Overall Study|Withdrawal by Subject|1|||
48576985|NCT01817582|156303994|FG002|Overall Study|Withdrawal by Subject|0|||
48576986|NCT01817582|156303992|FG000|Overall Study|Participant revealed masked treatment|1|||
48576987|NCT01817582|156303993|FG001|Overall Study|Participant revealed masked treatment|0|||
48576988|NCT01817582|156303994|FG002|Overall Study|Participant revealed masked treatment|0|||
48576989|NCT01817582|156303992|FG000|Overall Study|Randomized but exclusion criteria met|1|||
48576990|NCT01817582|156303993|FG001|Overall Study|Randomized but exclusion criteria met|0|||
48576991|NCT01817582|156303994|FG002|Overall Study|Randomized but exclusion criteria met|0|||
48576992|NCT02847494|156303995|FG000|Overall Study|Lost to Follow-up|8|||
48576993|NCT02847494|156303996|FG001|Overall Study|Lost to Follow-up|5|||
48576994|NCT02703272|156303997|FG000|Overall Study|Death|4|||
48576995|NCT02703272|156303998|FG001|Overall Study|Death|9|||
48576996|NCT02703272|156303999|FG002|Overall Study|Death|19|||
48576997|NCT02703272|156304000|FG003|Overall Study|Death|10|||
48576998|NCT02703272|156303997|FG000|Overall Study|Withdrawal by Subject|0|||
48576999|NCT02703272|156303998|FG001|Overall Study|Withdrawal by Subject|0|||
48577000|NCT02703272|156303999|FG002|Overall Study|Withdrawal by Subject|4|||
48577001|NCT02703272|156304000|FG003|Overall Study|Withdrawal by Subject|2|||
48577002|NCT02703272|156303997|FG000|Overall Study|Study Terminated by Sponsor|6|||
48577003|NCT02703272|156303998|FG001|Overall Study|Study Terminated by Sponsor|1|||
48577004|NCT02703272|156303999|FG002|Overall Study|Study Terminated by Sponsor|12|||
48577005|NCT02703272|156304000|FG003|Overall Study|Study Terminated by Sponsor|4|||
48622312|NCT03016403|156475144|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
48622313|NCT03016403|156475141|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
48622314|NCT03016403|156475142|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
48622315|NCT03016403|156475143|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
48622316|NCT03016403|156475144|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
48622317|NCT00799864|156475145|FG000|Overall Study|Participant reached a virologic endpoint|9|||
48622318|NCT00799864|156475146|FG001|Overall Study|Participant reached a virologic endpoint|2|||
48622319|NCT00799864|156475147|FG002|Overall Study|Participant reached a virologic endpoint|2|||
48622320|NCT00799864|156475148|FG003|Overall Study|Participant reached a virologic endpoint|0|||
48622321|NCT00799864|156475149|FG004|Overall Study|Participant reached a virologic endpoint|0|||
48622322|NCT00799864|156475145|FG000|Overall Study|Other|2|||
48622323|NCT00799864|156475146|FG001|Overall Study|Other|1|||
48622324|NCT00799864|156475147|FG002|Overall Study|Other|0|||
48622325|NCT00799864|156475148|FG003|Overall Study|Other|0|||
48622326|NCT00799864|156475149|FG004|Overall Study|Other|0|||
48622327|NCT05529173|156475155|FG000|Overall Study|Physician Decision|3|||
48622328|NCT05529173|156475156|FG001|Overall Study|Physician Decision|6|||
48622329|NCT05529173|156475155|FG000|Overall Study|Sample shipment delay more than one day|4|||
48622330|NCT05529173|156475156|FG001|Overall Study|Sample shipment delay more than one day|0|||
48622331|NCT04865978|156475157|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
48622332|NCT04865978|156475158|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
48622333|NCT00986102|156475159|FG000|Overall Study|Lost to Follow-up|0|||
48622334|NCT00986102|156475160|FG001|Overall Study|Lost to Follow-up|1|||
48622335|NCT00986102|156475161|FG002|Overall Study|Lost to Follow-up|0|||
48622336|NCT00986102|156475162|FG003|Overall Study|Lost to Follow-up|1|||
48622337|NCT00986102|156475159|FG000|Overall Study|Withdrawal by Subject|1|||
48622338|NCT00986102|156475160|FG001|Overall Study|Withdrawal by Subject|1|||
48622339|NCT00986102|156475161|FG002|Overall Study|Withdrawal by Subject|0|||
48622340|NCT00986102|156475162|FG003|Overall Study|Withdrawal by Subject|0|||
48622341|NCT06083493|156475163|FG000|Overall Study|Technical issues with the interventional device|2|||
48622342|NCT06083493|156475164|FG001|Overall Study|Technical issues with the interventional device|2|||
48622343|NCT06083493|156475163|FG000|Overall Study|Performed incorrect visual task|1|||
48622344|NCT06083493|156475164|FG001|Overall Study|Performed incorrect visual task|0|||
48622345|NCT06083493|156475163|FG000|Overall Study|Insufficient baseline performance|0|||
48622346|NCT06083493|156475164|FG001|Overall Study|Insufficient baseline performance|1|||
48622347|NCT02048813|156475165|FG000|Overall Study|Still on treatment|279|||
48622348|NCT02048813|156475166|FG001|Overall Study|Still on treatment|0|||
48622349|NCT02048813|156475165|FG000|Overall Study|Adverse Event|40|||
48622350|NCT02048813|156475166|FG001|Overall Study|Adverse Event|38|||
48622351|NCT02048813|156475165|FG000|Overall Study|Disease progression|13|||
48577006|NCT02703272|156303997|FG000|Overall Study|Other|1|||
48577007|NCT02703272|156303998|FG001|Overall Study|Other|0|||
48577008|NCT02703272|156303999|FG002|Overall Study|Other|0|||
48577009|NCT02703272|156304000|FG003|Overall Study|Other|0|||
48577010|NCT01966068|156304004|FG000|Overall Study|Withdrawal by Subject|57|||
48577011|NCT01966068|156304004|FG000|Overall Study|Lost to Follow-up|81|||
48577012|NCT02600845|156304007|FG000|Overall Study|Reason Not Specified|3|||
48577013|NCT02600845|156304007|FG000|Overall Study|Non-compliance with Study Procedures|10|||
48577014|NCT02600845|156304007|FG000|Overall Study|Consent Withdrawal|5|||
48577015|NCT03852628|156304011|FG000|Overall Study|Lost to Follow-up|7|||
48577016|NCT03852628|156304012|FG001|Overall Study|Lost to Follow-up|6|||
48577017|NCT03852628|156304011|FG000|Overall Study|Lack of Efficacy|6|||
48577018|NCT03852628|156304012|FG001|Overall Study|Lack of Efficacy|6|||
48577019|NCT01077739|156304013|FG000|Overall Study|Premature withdrawal|1|||
48577020|NCT01077739|156304014|FG001|Overall Study|Premature withdrawal|3|||
48577021|NCT01077739|156304013|FG000|Overall Study|Withdrawal by Subject|1|||
48577022|NCT01077739|156304014|FG001|Overall Study|Withdrawal by Subject|0|||
48577023|NCT01077739|156304013|FG000|Overall Study|Death|0|||
48577024|NCT01077739|156304014|FG001|Overall Study|Death|3|||
48577025|NCT01077739|156304013|FG000|Overall Study|Unacceptable toxicity|1|||
48577026|NCT01077739|156304014|FG001|Overall Study|Unacceptable toxicity|2|||
48577027|NCT01077739|156304013|FG000|Overall Study|Other|2|||
48577028|NCT01077739|156304014|FG001|Overall Study|Other|2|||
48577029|NCT00960986|156304015|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
48577030|NCT00960986|156304016|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
48577031|NCT00960986|156304017|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
48450144|NCT01814826|155835606|FG002|Overall Study|Death|3|||
48577032|NCT00960986|156304018|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
48577033|NCT00960986|156304015|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
48577034|NCT00960986|156304016|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
48577035|NCT00960986|156304017|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
48577036|NCT00960986|156304018|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
48577037|NCT00960986|156304015|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
48622352|NCT02048813|156475166|FG001|Overall Study|Disease progression|3|||
48622353|NCT02048813|156475165|FG000|Overall Study|Withdrawal by Subject|7|||
48622354|NCT02048813|156475166|FG001|Overall Study|Withdrawal by Subject|8|||
48622355|NCT02048813|156475165|FG000|Overall Study|Death|2|||
48622356|NCT02048813|156475166|FG001|Overall Study|Death|1|||
48622357|NCT02048813|156475165|FG000|Overall Study|Complication|2|||
48622358|NCT02048813|156475166|FG001|Overall Study|Complication|2|||
48622359|NCT02048813|156475165|FG000|Overall Study|Non-protocol therapy|0|||
48622360|NCT02048813|156475166|FG001|Overall Study|Non-protocol therapy|1|||
48622361|NCT02048813|156475165|FG000|Overall Study|Second primary cancer|2|||
48622362|NCT02048813|156475166|FG001|Overall Study|Second primary cancer|0|||
48622363|NCT02048813|156475165|FG000|Overall Study|Insurance|2|||
48622364|NCT02048813|156475166|FG001|Overall Study|Insurance|0|||
48577038|NCT00960986|156304016|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
48577039|NCT00960986|156304017|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
48577040|NCT00960986|156304018|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
48577041|NCT00960986|156304015|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
48577042|NCT00960986|156304016|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
48577043|NCT00960986|156304017|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
48577044|NCT00960986|156304018|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
48577045|NCT00960986|156304015|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
48577046|NCT00960986|156304016|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
48577047|NCT00960986|156304017|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
48577048|NCT00960986|156304018|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
48577049|NCT00960986|156304015|FG000|Period 3 (7-week Therapy Period)|Death|0|||
48577050|NCT00960986|156304016|FG001|Period 3 (7-week Therapy Period)|Death|0|||
48577051|NCT00960986|156304017|FG002|Period 3 (7-week Therapy Period)|Death|1|||
48577052|NCT00960986|156304018|FG003|Period 3 (7-week Therapy Period)|Death|0|||
48577053|NCT00960986|156304015|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
48577054|NCT00960986|156304016|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
48577055|NCT00960986|156304017|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
48577056|NCT00960986|156304018|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
48577057|NCT00960986|156304015|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
48577058|NCT00960986|156304016|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
48577059|NCT00960986|156304017|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
48577060|NCT00960986|156304018|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
48577061|NCT00960986|156304015|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
48577062|NCT00960986|156304016|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
48577063|NCT00960986|156304017|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
48577064|NCT00960986|156304018|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
48577065|NCT00960986|156304015|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
48577066|NCT00960986|156304016|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
48577067|NCT00960986|156304017|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
48577068|NCT00960986|156304018|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
48577069|NCT04413552|156304022|FG000|Overall Study|Adverse Event|0|||
48577070|NCT04413552|156304023|FG001|Overall Study|Adverse Event|0|||
48577071|NCT04413552|156304024|FG002|Overall Study|Adverse Event|0|||
48577072|NCT04413552|156304025|FG003|Overall Study|Adverse Event|0|||
48577073|NCT04413552|156304026|FG004|Overall Study|Adverse Event|0|||
48622365|NCT02048813|156475165|FG000|Overall Study|Wound infection/healing|2|||
48622366|NCT02048813|156475166|FG001|Overall Study|Wound infection/healing|0|||
48622367|NCT02048813|156475165|FG000|Overall Study|Missed appointment|3|||
48622368|NCT02048813|156475166|FG001|Overall Study|Missed appointment|0|||
48622369|NCT02048813|156475165|FG000|Overall Study|Never started treatment|2|||
48622370|NCT02048813|156475166|FG001|Overall Study|Never started treatment|17|||
48622371|NCT00507507|156475171|FG000|Treatment Period|Lost to Follow-up|0|||
48622372|NCT00507507|156475172|FG001|Treatment Period|Lost to Follow-up|2|||
48622373|NCT00507507|156475171|FG000|Treatment Period|Physician Decision|4|||
48622374|NCT00507507|156475172|FG001|Treatment Period|Physician Decision|1|||
48622375|NCT00507507|156475171|FG000|Treatment Period|Protocol Violation|1|||
48622376|NCT00507507|156475172|FG001|Treatment Period|Protocol Violation|2|||
48622377|NCT00507507|156475171|FG000|Treatment Period|Adverse Event|1|||
48622378|NCT00507507|156475172|FG001|Treatment Period|Adverse Event|1|||
48622379|NCT00507507|156475171|FG000|Treatment Period|Withdrawal by Subject|46|||
48622380|NCT00507507|156475172|FG001|Treatment Period|Withdrawal by Subject|47|||
48622381|NCT00507507|156475171|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
48622382|NCT00507507|156475172|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
48622383|NCT00507507|156475171|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
48622384|NCT00507507|156475172|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
48622385|NCT00507507|156475171|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
48622386|NCT00507507|156475172|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
48622387|NCT00183391|156475173|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
48622388|NCT00183391|156475174|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
48622389|NCT00183391|156475173|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
48622390|NCT00183391|156475174|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
48622391|NCT00395512|156475175|FG000|Overall Study|Adverse Event|3|||
48622392|NCT00395512|156475176|FG001|Overall Study|Adverse Event|8|||
48622393|NCT00395512|156475177|FG002|Overall Study|Adverse Event|6|||
48622394|NCT00395512|156475178|FG003|Overall Study|Adverse Event|6|||
48622395|NCT00395512|156475175|FG000|Overall Study|Protocol Violation|2|||
48622396|NCT00395512|156475176|FG001|Overall Study|Protocol Violation|3|||
48622397|NCT00395512|156475177|FG002|Overall Study|Protocol Violation|6|||
48622398|NCT00395512|156475178|FG003|Overall Study|Protocol Violation|7|||
48622399|NCT00395512|156475175|FG000|Overall Study|Lost to Follow-up|2|||
48622400|NCT00395512|156475176|FG001|Overall Study|Lost to Follow-up|6|||
48622401|NCT00395512|156475177|FG002|Overall Study|Lost to Follow-up|5|||
48622402|NCT00395512|156475178|FG003|Overall Study|Lost to Follow-up|5|||
48622403|NCT00395512|156475175|FG000|Overall Study|Withdrawal by Subject|6|||
48622404|NCT00395512|156475176|FG001|Overall Study|Withdrawal by Subject|5|||
48622405|NCT00395512|156475177|FG002|Overall Study|Withdrawal by Subject|5|||
48622406|NCT00395512|156475178|FG003|Overall Study|Withdrawal by Subject|12|||
48622407|NCT00395512|156475175|FG000|Overall Study|Physician Decision|6|||
48622408|NCT00395512|156475176|FG001|Overall Study|Physician Decision|4|||
48622409|NCT00395512|156475177|FG002|Overall Study|Physician Decision|2|||
48622410|NCT00395512|156475178|FG003|Overall Study|Physician Decision|2|||
48622411|NCT00395512|156475175|FG000|Overall Study|Other|1|||
48622412|NCT00395512|156475176|FG001|Overall Study|Other|1|||
48622413|NCT00395512|156475177|FG002|Overall Study|Other|0|||
48622414|NCT00395512|156475178|FG003|Overall Study|Other|0|||
48622415|NCT00395512|156475175|FG000|Overall Study|Hyperglycemic Rescue|18|||
48622416|NCT00395512|156475176|FG001|Overall Study|Hyperglycemic Rescue|10|||
48622417|NCT00395512|156475177|FG002|Overall Study|Hyperglycemic Rescue|4|||
48622418|NCT00395512|156475178|FG003|Overall Study|Hyperglycemic Rescue|6|||
48622419|NCT03180138|156475180|FG000|Overall Study|Mobile-phone could not be verified|2|||
48622420|NCT03180138|156475181|FG001|Overall Study|Mobile-phone could not be verified|13|||
48622421|NCT03180138|156475182|FG002|Overall Study|Mobile-phone could not be verified|15|||
48622422|NCT03180138|156475180|FG000|Overall Study|No prior immunization records|17|||
48622423|NCT03180138|156475181|FG001|Overall Study|No prior immunization records|0|||
48622424|NCT03180138|156475182|FG002|Overall Study|No prior immunization records|6|||
48622425|NCT03180138|156475180|FG000|Overall Study|Found to be >24 mon after randomization|3|||
48622426|NCT03180138|156475181|FG001|Overall Study|Found to be >24 mon after randomization|0|||
48622427|NCT03180138|156475182|FG002|Overall Study|Found to be >24 mon after randomization|3|||
48622428|NCT04576949|156475183|FG000|Overall Study|Adverse Event|1|||
48622429|NCT04576949|156475184|FG001|Overall Study|Adverse Event|3|||
48622430|NCT04576949|156475185|FG002|Overall Study|Adverse Event|2|||
48622431|NCT04576949|156475183|FG000|Overall Study|Withdrawal by Subject|41|||
48622432|NCT04576949|156475184|FG001|Overall Study|Withdrawal by Subject|26|||
48622433|NCT04576949|156475185|FG002|Overall Study|Withdrawal by Subject|18|||
48622434|NCT04576949|156475183|FG000|Overall Study|Physician Decision|3|||
48622435|NCT04576949|156475184|FG001|Overall Study|Physician Decision|0|||
48622436|NCT04576949|156475185|FG002|Overall Study|Physician Decision|0|||
48622437|NCT04576949|156475183|FG000|Overall Study|Death|0|||
48622438|NCT04576949|156475184|FG001|Overall Study|Death|1|||
48622439|NCT04576949|156475185|FG002|Overall Study|Death|0|||
48622440|NCT04576949|156475183|FG000|Overall Study|Lost to Follow-up|29|||
48622441|NCT04576949|156475184|FG001|Overall Study|Lost to Follow-up|37|||
48622442|NCT04576949|156475185|FG002|Overall Study|Lost to Follow-up|24|||
48622443|NCT04576949|156475183|FG000|Overall Study|Other, Not Specified|2|||
48622444|NCT04576949|156475184|FG001|Overall Study|Other, Not Specified|3|||
48577074|NCT04413552|156304027|FG005|Overall Study|Adverse Event|0|||
48577075|NCT04413552|156304028|FG006|Overall Study|Adverse Event|1|||
48577076|NCT04413552|156304029|FG007|Overall Study|Adverse Event|0|||
48577077|NCT04413552|156304030|FG008|Overall Study|Adverse Event|0|||
48577078|NCT04413552|156304031|FG009|Overall Study|Adverse Event|0|||
48577079|NCT00877071|156304032|FG000|Overall Study|disease progression|2|||
48577080|NCT01790828|156304033|FG000|Overall Study|Other|34|||
48577081|NCT03200704|156305600|FG000|Overall Study|Withdrawal by Subject|1|||
48577082|NCT00723255|156305603|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
48577083|NCT00723255|156305603|FG000|Overall Study|Ineligible: Second primary|1|||
48577084|NCT00723255|156305603|FG000|Overall Study|Ineligible: Wrong Primary|2|||
48577085|NCT00614523|156305604|FG000|Overall Study|Adverse Event|4|||
48577086|NCT00614523|156305605|FG001|Overall Study|Adverse Event|20|||
48577087|NCT00614523|156305604|FG000|Overall Study|Death|5|||
48577088|NCT00614523|156305605|FG001|Overall Study|Death|8|||
48577089|NCT00614523|156305604|FG000|Overall Study|Lack of Efficacy|9|||
48577090|NCT00614523|156305605|FG001|Overall Study|Lack of Efficacy|11|||
48577091|NCT00614523|156305604|FG000|Overall Study|Lost to Follow-up|0|||
48577092|NCT00614523|156305605|FG001|Overall Study|Lost to Follow-up|1|||
48577093|NCT00614523|156305604|FG000|Overall Study|Protocol Violation|3|||
48577094|NCT00614523|156305605|FG001|Overall Study|Protocol Violation|2|||
48577095|NCT00614523|156305604|FG000|Overall Study|Withdrawal by Subject|12|||
48577096|NCT00614523|156305605|FG001|Overall Study|Withdrawal by Subject|22|||
48577097|NCT00614523|156305604|FG000|Overall Study|Other|6|||
48577098|NCT00614523|156305605|FG001|Overall Study|Other|11|||
48577099|NCT00614523|156305604|FG000|Overall Study|Ineligibility Determined|1|||
48577100|NCT00614523|156305605|FG001|Overall Study|Ineligibility Determined|2|||
48577101|NCT00614523|156305604|FG000|Overall Study|Disease Progression|0|||
48577102|NCT00614523|156305605|FG001|Overall Study|Disease Progression|8|||
48577103|NCT00614523|156305604|FG000|Overall Study|Administrative Decision|23|||
48577104|NCT00614523|156305605|FG001|Overall Study|Administrative Decision|46|||
48577105|NCT02759055|156305606|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
48622445|NCT04576949|156475185|FG002|Overall Study|Other, Not Specified|1|||
48622446|NCT04576949|156475183|FG000|Overall Study|Other|1|||
48622447|NCT04576949|156475184|FG001|Overall Study|Other|0|||
48622448|NCT04576949|156475185|FG002|Overall Study|Other|0|||
48622449|NCT03438656|156475194|FG000|Overall Study|Lost to Follow-up|2|||
48622450|NCT01065766|156475195|FG000|Overall Study|Assessed before the contracted date|1|||
48622451|NCT01065766|156475195|FG000|Overall Study|Contraindication to administration|6|||
48622452|NCT01065766|156475195|FG000|Overall Study|Violated dosage/administration|25|||
48622453|NCT02362412|156475199|FG000|Treatment Period III|Lost to Follow-up|0|||
48622454|NCT02362412|156475200|FG001|Treatment Period III|Lost to Follow-up|1|||
48622455|NCT01725308|156475201|FG000|Treatment Period I|Did Not Receive Drug|1|||
48622456|NCT01725308|156475202|FG001|Treatment Period I|Did Not Receive Drug|0|||
48622457|NCT01725308|156475203|FG002|Treatment Period I|Did Not Receive Drug|0|||
48577106|NCT02759055|156305607|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
48577107|NCT04934189|156305608|FG000|Overall Study|Lost to Follow-up|4|||
48577108|NCT04934189|156305608|FG000|Overall Study|Withdrawal by Subject|17|||
48577109|NCT03962790|156305609|FG000|Period 1|Adverse Event|0|||
48577110|NCT03962790|156305610|FG001|Period 1|Adverse Event|1|||
48622458|NCT01725308|156475201|FG000|Treatment Period I|Adverse Event|5|||
48622459|NCT01725308|156475202|FG001|Treatment Period I|Adverse Event|4|||
48622460|NCT01725308|156475203|FG002|Treatment Period I|Adverse Event|21|||
48577111|NCT03962790|156305609|FG000|Period 1|Failed to meet all eligibility criteria|1|||
48577112|NCT03962790|156305610|FG001|Period 1|Failed to meet all eligibility criteria|1|||
48577113|NCT03962790|156305609|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
48577114|NCT03962790|156305610|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
48577115|NCT03962790|156305609|FG000|Period 1|Withdrawal by Subject|1|||
48577116|NCT03962790|156305610|FG001|Period 1|Withdrawal by Subject|0|||
48577117|NCT02589522|156305617|FG000|Overall Study|Physician Decision|1|||
48577118|NCT02589522|156305618|FG001|Overall Study|Physician Decision|2|||
48577119|NCT02589522|156305619|FG002|Overall Study|Physician Decision|0|||
48577120|NCT02589522|156305617|FG000|Overall Study|Did not start treatment|1|||
48577121|NCT02589522|156305618|FG001|Overall Study|Did not start treatment|0|||
48577122|NCT02589522|156305619|FG002|Overall Study|Did not start treatment|0|||
48319715|NCT00529516|155371084|FG000|Overall Study|Withdrawal by Subject|1|||
48577123|NCT02691013|156305625|FG000|Overall Study|Withdrawal by Subject|3|||
48577124|NCT02691013|156305626|FG001|Overall Study|Withdrawal by Subject|0|||
48577125|NCT00281632|156305627|FG000|Overall Study|Adverse Event|7|||
48577126|NCT00281632|156305627|FG000|Overall Study|Withdrawal by Subject|2|||
48577127|NCT00281632|156305627|FG000|Overall Study|Disease Progression|22|||
48577128|NCT00281632|156305627|FG000|Overall Study|Death|1|||
48577129|NCT00281632|156305627|FG000|Overall Study|Physician Decision|1|||
48319716|NCT00529516|155371085|FG001|Overall Study|Withdrawal by Subject|1|||
48577130|NCT00281632|156305627|FG000|Overall Study|Ongoing|3|||
48577131|NCT02738879|156305635|FG000|Overall Study|Adverse Event|1|||
48577132|NCT02738879|156305636|FG001|Overall Study|Adverse Event|1|||
48577133|NCT02738879|156305635|FG000|Overall Study|Death|0|||
48577134|NCT02738879|156305636|FG001|Overall Study|Death|2|||
48577135|NCT02738879|156305635|FG000|Overall Study|Lost to Follow-up|1|||
48577136|NCT02738879|156305636|FG001|Overall Study|Lost to Follow-up|5|||
48577137|NCT02738879|156305635|FG000|Overall Study|Protocol Violation|1|||
48577138|NCT02738879|156305636|FG001|Overall Study|Protocol Violation|3|||
48577139|NCT02738879|156305635|FG000|Overall Study|Physician Decision|3|||
48577140|NCT02738879|156305636|FG001|Overall Study|Physician Decision|4|||
48577141|NCT02738879|156305635|FG000|Overall Study|Pregnancy|0|||
48577142|NCT02738879|156305636|FG001|Overall Study|Pregnancy|1|||
48577143|NCT02738879|156305635|FG000|Overall Study|Screen Failure|1|||
48622461|NCT01725308|156475201|FG000|Treatment Period I|Insufficient Response|7|||
48622462|NCT01725308|156475202|FG001|Treatment Period I|Insufficient Response|0|||
48622463|NCT01725308|156475203|FG002|Treatment Period I|Insufficient Response|5|||
48622464|NCT01725308|156475201|FG000|Treatment Period I|Worsening of the Target Disease|8|||
48622465|NCT01725308|156475202|FG001|Treatment Period I|Worsening of the Target Disease|0|||
48622466|NCT01725308|156475203|FG002|Treatment Period I|Worsening of the Target Disease|2|||
48622467|NCT01725308|156475201|FG000|Treatment Period I|Changes in the Episodes|3|||
48622468|NCT01725308|156475202|FG001|Treatment Period I|Changes in the Episodes|0|||
48622469|NCT01725308|156475203|FG002|Treatment Period I|Changes in the Episodes|2|||
48622470|NCT01725308|156475201|FG000|Treatment Period I|Withdrawal of Consent|12|||
48622471|NCT01725308|156475202|FG001|Treatment Period I|Withdrawal of Consent|7|||
48622472|NCT01725308|156475203|FG002|Treatment Period I|Withdrawal of Consent|5|||
48622473|NCT01725308|156475201|FG000|Treatment Period I|Lost to Follow-up|3|||
48622474|NCT01725308|156475202|FG001|Treatment Period I|Lost to Follow-up|2|||
48622475|NCT01725308|156475203|FG002|Treatment Period I|Lost to Follow-up|2|||
48622476|NCT01725308|156475201|FG000|Treatment Period I|Protocol Deviations|3|||
48622477|NCT01725308|156475202|FG001|Treatment Period I|Protocol Deviations|1|||
48622478|NCT01725308|156475203|FG002|Treatment Period I|Protocol Deviations|1|||
48622479|NCT01725308|156475201|FG000|Treatment Period I|Miscellaneous|2|||
48622480|NCT01725308|156475202|FG001|Treatment Period I|Miscellaneous|0|||
48622481|NCT01725308|156475203|FG002|Treatment Period I|Miscellaneous|3|||
48622482|NCT01725308|156475201|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
48622483|NCT01725308|156475202|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
48622484|NCT01725308|156475203|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
48622485|NCT01725308|156475201|FG000|Treatment Period II|Did Not Receive Drug|4|||
48622486|NCT01725308|156475202|FG001|Treatment Period II|Did Not Receive Drug|0|||
48622487|NCT01725308|156475203|FG002|Treatment Period II|Did Not Receive Drug|0|||
48622488|NCT01725308|156475201|FG000|Treatment Period II|Adverse Event|13|||
48622489|NCT01725308|156475202|FG001|Treatment Period II|Adverse Event|8|||
48622490|NCT01725308|156475203|FG002|Treatment Period II|Adverse Event|20|||
48622491|NCT01725308|156475201|FG000|Treatment Period II|Insufficient Response|2|||
48622492|NCT01725308|156475202|FG001|Treatment Period II|Insufficient Response|4|||
48622493|NCT01725308|156475203|FG002|Treatment Period II|Insufficient Response|6|||
48622494|NCT01725308|156475201|FG000|Treatment Period II|Worsening of the Target Disease|1|||
48622495|NCT01725308|156475202|FG001|Treatment Period II|Worsening of the Target Disease|4|||
48622496|NCT01725308|156475203|FG002|Treatment Period II|Worsening of the Target Disease|2|||
48622497|NCT01725308|156475201|FG000|Treatment Period II|Changes in the Episodes|1|||
48622498|NCT01725308|156475202|FG001|Treatment Period II|Changes in the Episodes|0|||
48622499|NCT01725308|156475203|FG002|Treatment Period II|Changes in the Episodes|5|||
48736086|NCT00866788|156885627|FG002|Overall Study|Physician Decision|1|||
48736087|NCT00866788|156885628|FG003|Overall Study|Physician Decision|1|||
48736088|NCT00108433|156885629|FG000|Overall Study|Lack of Efficacy|1|||
48736089|NCT00108433|156885630|FG001|Overall Study|Lack of Efficacy|2|||
48736090|NCT00108433|156885629|FG000|Overall Study|Death|3|||
48736091|NCT00108433|156885630|FG001|Overall Study|Death|0|||
48736092|NCT00108433|156885629|FG000|Overall Study|Adverse Event|3|||
48736093|NCT00108433|156885630|FG001|Overall Study|Adverse Event|1|||
48736094|NCT00108433|156885629|FG000|Overall Study|Other|14|||
48736095|NCT00108433|156885630|FG001|Overall Study|Other|14|||
48736096|NCT02202837|156885631|FG000|Overall Study|Enbrel treatment discontinued|36|||
48736097|NCT02202837|156885632|FG001|Overall Study|Enbrel treatment discontinued|4|||
48736098|NCT02202837|156885631|FG000|Overall Study|Other|10|||
48736099|NCT02202837|156885632|FG001|Overall Study|Other|0|||
48577144|NCT02738879|156305636|FG001|Overall Study|Screen Failure|2|||
48577145|NCT02738879|156305635|FG000|Overall Study|Site Discontinued Study Participation|1|||
48622500|NCT01725308|156475201|FG000|Treatment Period II|Withdrawal of Consent|28|||
48622501|NCT01725308|156475202|FG001|Treatment Period II|Withdrawal of Consent|2|||
48622502|NCT01725308|156475203|FG002|Treatment Period II|Withdrawal of Consent|16|||
48736100|NCT02202837|156885631|FG000|Overall Study|Lost to Follow-up|7|||
48577146|NCT02738879|156305636|FG001|Overall Study|Site Discontinued Study Participation|0|||
48577147|NCT02738879|156305635|FG000|Overall Study|Withdrawal by Subject|5|||
48577148|NCT02738879|156305636|FG001|Overall Study|Withdrawal by Subject|7|||
48577149|NCT01676896|156305637|FG000|Overall Study|Withdrawal by Subject|12|||
48577150|NCT01676896|156305638|FG001|Overall Study|Withdrawal by Subject|7|||
48577151|NCT01676896|156305639|FG002|Overall Study|Withdrawal by Subject|19|||
48577152|NCT01647516|156305640|FG000|Induction Period (IP)|Physician Decision|2|||
48577153|NCT01647516|156305641|FG001|Induction Period (IP)|Physician Decision|0|||
48577154|NCT01647516|156305642|FG002|Induction Period (IP)|Physician Decision|0|||
48577155|NCT01647516|156305643|FG003|Induction Period (IP)|Physician Decision|0|||
48736101|NCT02202837|156885632|FG001|Overall Study|Lost to Follow-up|1|||
48736102|NCT00231842|156885639|FG000|Overall Study|Withdrawal by Subject|3|||
48577156|NCT01647516|156305644|FG004|Induction Period (IP)|Physician Decision|0|||
48577157|NCT01647516|156305645|FG005|Induction Period (IP)|Physician Decision|0|||
48577158|NCT01647516|156305640|FG000|Induction Period (IP)|Adverse Event|1|||
48577159|NCT01647516|156305641|FG001|Induction Period (IP)|Adverse Event|2|||
48736103|NCT00231842|156885639|FG000|Overall Study|Did not complete the last 3 cycle|8|||
48736104|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
48736105|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
48736106|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
48736107|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
48736108|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
48736109|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
48736110|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
48736111|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
48736112|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
48736113|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
48736114|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
48736115|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
48736116|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
48736117|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
48736118|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
48736119|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
48736120|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
48736121|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
48736122|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
48736123|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
48736124|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
48736125|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
48736126|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
48736127|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
48736128|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
48736129|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
48736130|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
48736131|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
48736132|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
48577160|NCT01647516|156305642|FG002|Induction Period (IP)|Adverse Event|0|||
48736133|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
48736134|NCT00313300|156885640|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
48736135|NCT00313300|156885641|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
48736136|NCT00313300|156885642|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
48736137|NCT00313300|156885643|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
48736138|NCT00313300|156885644|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
48736139|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
48736140|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
48736141|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
48736142|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
48736143|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
48736144|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
48736145|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
48736146|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
48736147|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
48736148|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
48736149|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
48736150|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
48736151|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
48736152|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
48736153|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
48736154|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
48736155|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
48736156|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
48736157|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
48736158|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
48736159|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
48736160|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
48736161|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
48736162|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
48736163|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
48736164|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
48736165|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
48736166|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
48736167|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
48577161|NCT01647516|156305643|FG003|Induction Period (IP)|Adverse Event|0|||
48577162|NCT01647516|156305644|FG004|Induction Period (IP)|Adverse Event|0|||
48736168|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
48577163|NCT01647516|156305645|FG005|Induction Period (IP)|Adverse Event|0|||
48577164|NCT01647516|156305640|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
48577165|NCT01647516|156305641|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
48577166|NCT01647516|156305642|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
48577167|NCT01647516|156305643|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
48577168|NCT01647516|156305644|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
48577169|NCT01647516|156305645|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
48577170|NCT01647516|156305640|FG000|Induction Period (IP)|Participant Choice|0|||
48577171|NCT01647516|156305641|FG001|Induction Period (IP)|Participant Choice|0|||
48577172|NCT01647516|156305642|FG002|Induction Period (IP)|Participant Choice|1|||
48577173|NCT01647516|156305643|FG003|Induction Period (IP)|Participant Choice|0|||
48577174|NCT01647516|156305644|FG004|Induction Period (IP)|Participant Choice|0|||
48577175|NCT01647516|156305645|FG005|Induction Period (IP)|Participant Choice|0|||
48577176|NCT01647516|156305640|FG000|Induction Period (IP)|Lack of Efficacy|1|||
48577177|NCT01647516|156305641|FG001|Induction Period (IP)|Lack of Efficacy|0|||
48577178|NCT01647516|156305642|FG002|Induction Period (IP)|Lack of Efficacy|0|||
48736169|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
48736170|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
48622503|NCT01725308|156475201|FG000|Treatment Period II|Lost to Follow-up|1|||
48622504|NCT01725308|156475202|FG001|Treatment Period II|Lost to Follow-up|5|||
48622505|NCT01725308|156475203|FG002|Treatment Period II|Lost to Follow-up|3|||
48622506|NCT01725308|156475201|FG000|Treatment Period II|Protocol Deviations|0|||
48622507|NCT01725308|156475202|FG001|Treatment Period II|Protocol Deviations|0|||
48622508|NCT01725308|156475203|FG002|Treatment Period II|Protocol Deviations|1|||
48622509|NCT01725308|156475201|FG000|Treatment Period II|Miscellaneous|5|||
48622510|NCT01725308|156475202|FG001|Treatment Period II|Miscellaneous|3|||
48622511|NCT01725308|156475203|FG002|Treatment Period II|Miscellaneous|7|||
48622512|NCT04128228|156475205|FG000|Overall Study|Withdrawal by Subject|3|||
48622513|NCT04128228|156475206|FG001|Overall Study|Withdrawal by Subject|3|||
48622514|NCT04128228|156475207|FG002|Overall Study|Withdrawal by Subject|0|||
48622515|NCT04128228|156475208|FG003|Overall Study|Withdrawal by Subject|0|||
48622516|NCT04128228|156475205|FG000|Overall Study|noncompliance|2|||
48622517|NCT04128228|156475206|FG001|Overall Study|noncompliance|2|||
48622518|NCT04128228|156475207|FG002|Overall Study|noncompliance|0|||
48736171|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
48736172|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
48736173|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
48736174|NCT00313300|156885640|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
48736175|NCT00313300|156885641|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
48736176|NCT00313300|156885642|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
48736177|NCT00313300|156885643|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
48736178|NCT00313300|156885644|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
48736179|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
48736180|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
48622519|NCT04128228|156475208|FG003|Overall Study|noncompliance|0|||
48622520|NCT05652140|156475209|FG000|Overall Study|Lost to Follow-up|7|||
48622521|NCT05652140|156475210|FG001|Overall Study|Lost to Follow-up|16|||
48622522|NCT05652140|156475211|FG002|Overall Study|Lost to Follow-up|22|||
48622523|NCT05652140|156475212|FG003|Overall Study|Lost to Follow-up|31|||
48622524|NCT01245049|156475213|FG000|Overall Study|Migrated/moved from study area|0|||
48622525|NCT01245049|156475214|FG001|Overall Study|Migrated/moved from study area|1|||
48622526|NCT01245049|156475213|FG000|Overall Study|Withdrawal by Subject|0|||
48622527|NCT01245049|156475214|FG001|Overall Study|Withdrawal by Subject|1|||
48736181|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
48736182|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
48736183|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
48736184|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
48736185|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
48736186|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
48736187|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
48736188|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
48736189|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
48622528|NCT01245049|156475213|FG000|Overall Study|Lost to Follow-up|1|||
48622529|NCT01245049|156475214|FG001|Overall Study|Lost to Follow-up|2|||
48622530|NCT00974233|156475218|FG000|Induction Chemoimmunotherapy|Death|2|||
48577179|NCT01647516|156305643|FG003|Induction Period (IP)|Lack of Efficacy|0|||
48577180|NCT01647516|156305644|FG004|Induction Period (IP)|Lack of Efficacy|0|||
48577181|NCT01647516|156305645|FG005|Induction Period (IP)|Lack of Efficacy|0|||
48577182|NCT01647516|156305640|FG000|Induction Period (IP)|No study drug received|1|||
48577183|NCT01647516|156305641|FG001|Induction Period (IP)|No study drug received|1|||
48577184|NCT01647516|156305642|FG002|Induction Period (IP)|No study drug received|0|||
48577185|NCT01647516|156305643|FG003|Induction Period (IP)|No study drug received|0|||
48577186|NCT01647516|156305644|FG004|Induction Period (IP)|No study drug received|0|||
48577187|NCT01647516|156305645|FG005|Induction Period (IP)|No study drug received|0|||
48577188|NCT01647516|156305640|FG000|Maintenance Period (MP)|Adverse Event|2|||
48577189|NCT01647516|156305641|FG001|Maintenance Period (MP)|Adverse Event|1|||
48577190|NCT01647516|156305642|FG002|Maintenance Period (MP)|Adverse Event|0|||
48577191|NCT01647516|156305643|FG003|Maintenance Period (MP)|Adverse Event|0|||
48577192|NCT01647516|156305644|FG004|Maintenance Period (MP)|Adverse Event|0|||
48577193|NCT01647516|156305645|FG005|Maintenance Period (MP)|Adverse Event|0|||
48577194|NCT01647516|156305640|FG000|Maintenance Period (MP)|Non-compliance|1|||
48577195|NCT01647516|156305641|FG001|Maintenance Period (MP)|Non-compliance|0|||
48577196|NCT01647516|156305642|FG002|Maintenance Period (MP)|Non-compliance|0|||
48577197|NCT01647516|156305643|FG003|Maintenance Period (MP)|Non-compliance|0|||
48577198|NCT01647516|156305644|FG004|Maintenance Period (MP)|Non-compliance|0|||
48577199|NCT01647516|156305645|FG005|Maintenance Period (MP)|Non-compliance|0|||
48577200|NCT01647516|156305640|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
48577201|NCT01647516|156305641|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
48577202|NCT01647516|156305642|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
48577203|NCT01647516|156305643|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
48577204|NCT01647516|156305644|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
48577205|NCT01647516|156305645|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
48577206|NCT01647516|156305640|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
48577207|NCT01647516|156305641|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
48577208|NCT01647516|156305642|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
48577209|NCT01647516|156305643|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
48577210|NCT01647516|156305644|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
48577211|NCT01647516|156305645|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
48577212|NCT01647516|156305640|FG000|Open-Label Period|Adverse Event|0|||
48577213|NCT01647516|156305641|FG001|Open-Label Period|Adverse Event|0|||
48577214|NCT01647516|156305642|FG002|Open-Label Period|Adverse Event|0|||
48577215|NCT01647516|156305643|FG003|Open-Label Period|Adverse Event|5|||
48577216|NCT01647516|156305644|FG004|Open-Label Period|Adverse Event|6|||
48577217|NCT01647516|156305645|FG005|Open-Label Period|Adverse Event|3|||
48577218|NCT01647516|156305640|FG000|Open-Label Period|Pregnancy|0|||
48577219|NCT01647516|156305641|FG001|Open-Label Period|Pregnancy|0|||
48577220|NCT01647516|156305642|FG002|Open-Label Period|Pregnancy|0|||
48577221|NCT01647516|156305643|FG003|Open-Label Period|Pregnancy|0|||
48577222|NCT01647516|156305644|FG004|Open-Label Period|Pregnancy|0|||
48577223|NCT01647516|156305645|FG005|Open-Label Period|Pregnancy|1|||
48577224|NCT01647516|156305640|FG000|Open-Label Period|Non-compliance|0|||
48577225|NCT01647516|156305641|FG001|Open-Label Period|Non-compliance|0|||
48577226|NCT01647516|156305642|FG002|Open-Label Period|Non-compliance|0|||
48577227|NCT01647516|156305643|FG003|Open-Label Period|Non-compliance|1|||
48577228|NCT01647516|156305644|FG004|Open-Label Period|Non-compliance|0|||
48577229|NCT01647516|156305645|FG005|Open-Label Period|Non-compliance|1|||
48577230|NCT01647516|156305640|FG000|Open-Label Period|Physician Decision|0|||
48736190|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
48736191|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
48736192|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
48736193|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
48736194|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
48736195|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
48736196|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
48736197|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
48736198|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
48736199|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
48736200|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
48736201|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
48736202|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
48736203|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
48736204|NCT00313300|156885640|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
48736205|NCT00313300|156885641|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
48736206|NCT00313300|156885642|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
48577231|NCT01647516|156305641|FG001|Open-Label Period|Physician Decision|0|||
48577232|NCT01647516|156305642|FG002|Open-Label Period|Physician Decision|0|||
48622531|NCT00974233|156475218|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
48577233|NCT01647516|156305643|FG003|Open-Label Period|Physician Decision|1|||
48577234|NCT01647516|156305644|FG004|Open-Label Period|Physician Decision|1|||
48577235|NCT01647516|156305645|FG005|Open-Label Period|Physician Decision|0|||
48577236|NCT01647516|156305640|FG000|Open-Label Period|Withdrawal by Subject|0|||
48577237|NCT01647516|156305641|FG001|Open-Label Period|Withdrawal by Subject|0|||
48577238|NCT01647516|156305642|FG002|Open-Label Period|Withdrawal by Subject|0|||
48577239|NCT01647516|156305643|FG003|Open-Label Period|Withdrawal by Subject|9|||
48577240|NCT01647516|156305644|FG004|Open-Label Period|Withdrawal by Subject|11|||
48577241|NCT01647516|156305645|FG005|Open-Label Period|Withdrawal by Subject|6|||
48577242|NCT01647516|156305640|FG000|Open-Label Period|Lost to Follow-up|0|||
48577243|NCT01647516|156305641|FG001|Open-Label Period|Lost to Follow-up|0|||
48577244|NCT01647516|156305642|FG002|Open-Label Period|Lost to Follow-up|0|||
48577245|NCT01647516|156305643|FG003|Open-Label Period|Lost to Follow-up|1|||
48577246|NCT01647516|156305644|FG004|Open-Label Period|Lost to Follow-up|0|||
48736207|NCT00313300|156885643|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
48736208|NCT00313300|156885644|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
48736209|NCT02436304|156885645|FG000|Overall Study|Lost to Follow-up|0|||
48736210|NCT02436304|156885646|FG001|Overall Study|Lost to Follow-up|1|||
48736211|NCT02436304|156885647|FG002|Overall Study|Lost to Follow-up|0|||
48736212|NCT02436304|156885645|FG000|Overall Study|Withdrawal by Subject|0|||
48736213|NCT02436304|156885646|FG001|Overall Study|Withdrawal by Subject|1|||
48736214|NCT02436304|156885647|FG002|Overall Study|Withdrawal by Subject|0|||
48736215|NCT02436304|156885645|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
48577247|NCT01647516|156305645|FG005|Open-Label Period|Lost to Follow-up|1|||
48577248|NCT01647516|156305640|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
48577249|NCT01647516|156305641|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
48577250|NCT01647516|156305642|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
48577251|NCT01647516|156305643|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
48577252|NCT01647516|156305644|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
48577253|NCT01647516|156305645|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
48577254|NCT01647516|156305640|FG000|Open-Label Period|Lack of Efficacy|0|||
48577255|NCT01647516|156305641|FG001|Open-Label Period|Lack of Efficacy|0|||
48577256|NCT01647516|156305642|FG002|Open-Label Period|Lack of Efficacy|0|||
48577257|NCT01647516|156305643|FG003|Open-Label Period|Lack of Efficacy|7|||
48577258|NCT01647516|156305644|FG004|Open-Label Period|Lack of Efficacy|9|||
48736216|NCT02436304|156885646|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
48736217|NCT02436304|156885647|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
48736218|NCT02764333|156885648|FG000|Overall Study|Ineligible|1|||
48736219|NCT00864721|156885651|FG000|Overall Study|Patient request|11|||
48736220|NCT00864721|156885651|FG000|Overall Study|Hospitalized|1|||
48736221|NCT00864721|156885651|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
48736222|NCT00864721|156885651|FG000|Overall Study|Adverse Event|21|||
48736223|NCT00615108|156885652|FG000|Overall Study|Adverse Event|122|||
48736224|NCT00615108|156885652|FG000|Overall Study|Other|370|||
48577259|NCT01647516|156305645|FG005|Open-Label Period|Lack of Efficacy|10|||
48577260|NCT01647516|156305640|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
48736225|NCT00615108|156885652|FG000|Overall Study|Lost to Follow-up|15|||
48577261|NCT01647516|156305641|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
48577262|NCT01647516|156305642|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
48577263|NCT01647516|156305643|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
48577264|NCT01647516|156305644|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
48577265|NCT01647516|156305645|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
48577266|NCT01647516|156305640|FG000|Open-Label Period|No completion / discontinuation visit|0|||
48577267|NCT01647516|156305641|FG001|Open-Label Period|No completion / discontinuation visit|0|||
48577268|NCT01647516|156305642|FG002|Open-Label Period|No completion / discontinuation visit|0|||
48577269|NCT01647516|156305643|FG003|Open-Label Period|No completion / discontinuation visit|0|||
48577270|NCT01647516|156305644|FG004|Open-Label Period|No completion / discontinuation visit|2|||
48577271|NCT01647516|156305645|FG005|Open-Label Period|No completion / discontinuation visit|1|||
48577272|NCT02980341|156305646|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
48577273|NCT02980341|156305647|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
48577274|NCT02980341|156305648|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
48577275|NCT02980341|156305649|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
48577276|NCT02980341|156305650|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
48577277|NCT02980341|156305651|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
48577278|NCT02980341|156305652|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
48577279|NCT02980341|156305653|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
48577280|NCT02980341|156305654|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
48622532|NCT00974233|156475218|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
48622533|NCT00974233|156475218|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
48622534|NCT00974233|156475218|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
48622535|NCT00974233|156475218|FG000|Maintenance Lenalidomide|Adverse Event|8|||
48622536|NCT00620035|156476533|FG000|Overall Study|Adverse Event|106|||
48622537|NCT00620035|156476533|FG000|Overall Study|Withdrawal of Informed Consent|1|||
48577281|NCT02980341|156305655|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
48577282|NCT02980341|156305656|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
48577283|NCT02980341|156305646|FG000|Dose Escalation|Clinical progression|0|||
48577284|NCT02980341|156305647|FG001|Dose Escalation|Clinical progression|0|||
48577285|NCT02980341|156305648|FG002|Dose Escalation|Clinical progression|2|||
48577286|NCT02980341|156305649|FG003|Dose Escalation|Clinical progression|1|||
48577287|NCT02980341|156305650|FG004|Dose Escalation|Clinical progression|0|||
48577288|NCT02980341|156305651|FG005|Dose Escalation|Clinical progression|0|||
48577289|NCT02980341|156305652|FG006|Dose Escalation|Clinical progression|0|||
48577290|NCT02980341|156305653|FG007|Dose Escalation|Clinical progression|0|||
48577291|NCT02980341|156305654|FG008|Dose Escalation|Clinical progression|0|||
48577292|NCT02980341|156305655|FG009|Dose Escalation|Clinical progression|0|||
48577293|NCT02980341|156305656|FG010|Dose Escalation|Clinical progression|0|||
48577294|NCT02980341|156305646|FG000|Dose Escalation|Adverse Event|0|||
48577295|NCT02980341|156305647|FG001|Dose Escalation|Adverse Event|0|||
48577296|NCT02980341|156305648|FG002|Dose Escalation|Adverse Event|1|||
48577297|NCT02980341|156305649|FG003|Dose Escalation|Adverse Event|2|||
48577298|NCT02980341|156305650|FG004|Dose Escalation|Adverse Event|2|||
48577299|NCT02980341|156305651|FG005|Dose Escalation|Adverse Event|0|||
48622538|NCT00620035|156476533|FG000|Overall Study|Other Reason|38|||
48622539|NCT03928704|156476534|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
48622540|NCT03928704|156476535|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
48622541|NCT03928704|156476536|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
48622542|NCT03928704|156476537|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
48622543|NCT03928704|156476538|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
48622544|NCT03928704|156476539|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
48622545|NCT03928704|156476534|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
48622546|NCT03928704|156476535|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
48622547|NCT03928704|156476536|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
48622548|NCT03928704|156476537|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
48622549|NCT03928704|156476538|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
48622550|NCT03928704|156476539|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
48622551|NCT03928704|156476534|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
48622552|NCT03928704|156476535|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
48622553|NCT03928704|156476536|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
48622554|NCT03928704|156476537|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
48622555|NCT03928704|156476538|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
48622556|NCT03928704|156476539|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
48622557|NCT03928704|156476534|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
48622558|NCT03928704|156476535|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
48622559|NCT03928704|156476536|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
48622560|NCT03928704|156476537|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
48577300|NCT02980341|156305652|FG006|Dose Escalation|Adverse Event|0|||
48577301|NCT02980341|156305653|FG007|Dose Escalation|Adverse Event|0|||
48577302|NCT02980341|156305654|FG008|Dose Escalation|Adverse Event|0|||
48577303|NCT02980341|156305655|FG009|Dose Escalation|Adverse Event|0|||
48577304|NCT02980341|156305656|FG010|Dose Escalation|Adverse Event|0|||
48577305|NCT02980341|156305646|FG000|Dose Escalation|Withdrawal by Subject|0|||
48577306|NCT02980341|156305647|FG001|Dose Escalation|Withdrawal by Subject|0|||
48577307|NCT02980341|156305648|FG002|Dose Escalation|Withdrawal by Subject|1|||
48577308|NCT02980341|156305649|FG003|Dose Escalation|Withdrawal by Subject|0|||
48577309|NCT02980341|156305650|FG004|Dose Escalation|Withdrawal by Subject|0|||
48577310|NCT02980341|156305651|FG005|Dose Escalation|Withdrawal by Subject|0|||
48577311|NCT02980341|156305652|FG006|Dose Escalation|Withdrawal by Subject|0|||
48577312|NCT02980341|156305653|FG007|Dose Escalation|Withdrawal by Subject|0|||
48577313|NCT02980341|156305654|FG008|Dose Escalation|Withdrawal by Subject|0|||
48577314|NCT02980341|156305655|FG009|Dose Escalation|Withdrawal by Subject|0|||
48577315|NCT02980341|156305656|FG010|Dose Escalation|Withdrawal by Subject|0|||
48577316|NCT02980341|156305646|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577317|NCT02980341|156305647|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577318|NCT02980341|156305648|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577319|NCT02980341|156305649|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
48577320|NCT02980341|156305650|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577321|NCT02980341|156305651|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577322|NCT02980341|156305652|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577323|NCT02980341|156305653|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577324|NCT02980341|156305654|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577325|NCT02980341|156305655|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577326|NCT02980341|156305656|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
48577327|NCT02980341|156305646|FG000|Dose Escalation|Due to investigator's decision|0|||
48577328|NCT02980341|156305647|FG001|Dose Escalation|Due to investigator's decision|0|||
48577329|NCT02980341|156305648|FG002|Dose Escalation|Due to investigator's decision|0|||
48577330|NCT02980341|156305649|FG003|Dose Escalation|Due to investigator's decision|0|||
48577331|NCT02980341|156305650|FG004|Dose Escalation|Due to investigator's decision|1|||
48577332|NCT02980341|156305651|FG005|Dose Escalation|Due to investigator's decision|0|||
48577333|NCT02980341|156305652|FG006|Dose Escalation|Due to investigator's decision|0|||
48577334|NCT02980341|156305653|FG007|Dose Escalation|Due to investigator's decision|0|||
48577335|NCT02980341|156305654|FG008|Dose Escalation|Due to investigator's decision|0|||
48577336|NCT02980341|156305655|FG009|Dose Escalation|Due to investigator's decision|0|||
48577337|NCT02980341|156305656|FG010|Dose Escalation|Due to investigator's decision|0|||
48577338|NCT02980341|156305646|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577339|NCT02980341|156305647|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577340|NCT02980341|156305648|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577341|NCT02980341|156305649|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577342|NCT02980341|156305650|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577343|NCT02980341|156305651|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
48577344|NCT02980341|156305652|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
48577345|NCT02980341|156305653|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577346|NCT02980341|156305654|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577347|NCT02980341|156305655|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577348|NCT02980341|156305656|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
48577349|NCT02980341|156305646|FG000|Dose Finding|Adverse Event|0|||
48577350|NCT02980341|156305647|FG001|Dose Finding|Adverse Event|0|||
48577351|NCT02980341|156305648|FG002|Dose Finding|Adverse Event|0|||
48577352|NCT02980341|156305649|FG003|Dose Finding|Adverse Event|0|||
48577353|NCT02980341|156305650|FG004|Dose Finding|Adverse Event|0|||
48577354|NCT02980341|156305651|FG005|Dose Finding|Adverse Event|3|||
48577355|NCT02980341|156305652|FG006|Dose Finding|Adverse Event|0|||
48577356|NCT02980341|156305653|FG007|Dose Finding|Adverse Event|0|||
48622561|NCT03928704|156476538|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
48577357|NCT02980341|156305654|FG008|Dose Finding|Adverse Event|0|||
48577358|NCT02980341|156305655|FG009|Dose Finding|Adverse Event|0|||
48622562|NCT03928704|156476539|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
48622563|NCT03928704|156476534|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
48622564|NCT03928704|156476535|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
48577359|NCT02980341|156305656|FG010|Dose Finding|Adverse Event|0|||
48577360|NCT02980341|156305646|FG000|Dose Finding|Withdrawal by Subject|0|||
48577361|NCT02980341|156305647|FG001|Dose Finding|Withdrawal by Subject|0|||
48577362|NCT02980341|156305648|FG002|Dose Finding|Withdrawal by Subject|0|||
48577363|NCT02980341|156305649|FG003|Dose Finding|Withdrawal by Subject|0|||
48577364|NCT02980341|156305650|FG004|Dose Finding|Withdrawal by Subject|0|||
48622565|NCT03928704|156476536|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
48622566|NCT03928704|156476537|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
48577365|NCT02980341|156305651|FG005|Dose Finding|Withdrawal by Subject|1|||
48577366|NCT02980341|156305652|FG006|Dose Finding|Withdrawal by Subject|1|||
48577367|NCT02980341|156305653|FG007|Dose Finding|Withdrawal by Subject|0|||
48577368|NCT02980341|156305654|FG008|Dose Finding|Withdrawal by Subject|0|||
48577369|NCT02980341|156305655|FG009|Dose Finding|Withdrawal by Subject|0|||
48577370|NCT02980341|156305656|FG010|Dose Finding|Withdrawal by Subject|0|||
48577371|NCT02980341|156305646|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
48577372|NCT02980341|156305647|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
48736226|NCT01868503|156885653|FG000|Overall Study|Withdrawal by Subject|1|||
48577373|NCT02980341|156305648|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
48577374|NCT02980341|156305649|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
48577375|NCT02980341|156305650|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
48577376|NCT02980341|156305651|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
48736227|NCT01868503|156885653|FG000|Overall Study|Protocol Violation|1|||
48736228|NCT02651467|156885654|FG000|Overall Study|Withdrawal by Subject|0|||
48577377|NCT02980341|156305652|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
48577378|NCT02980341|156305653|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
48577379|NCT02980341|156305654|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
48577380|NCT02980341|156305655|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
48577381|NCT02980341|156305656|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
48577382|NCT02980341|156305646|FG000|Dose Expansion|Clinical progression|0|||
48577383|NCT02980341|156305647|FG001|Dose Expansion|Clinical progression|0|||
48577384|NCT02980341|156305648|FG002|Dose Expansion|Clinical progression|0|||
48577385|NCT02980341|156305649|FG003|Dose Expansion|Clinical progression|0|||
48577386|NCT02980341|156305650|FG004|Dose Expansion|Clinical progression|0|||
48577387|NCT02980341|156305651|FG005|Dose Expansion|Clinical progression|0|||
48736229|NCT02651467|156885655|FG001|Overall Study|Withdrawal by Subject|0|||
48736230|NCT02651467|156885656|FG002|Overall Study|Withdrawal by Subject|2|||
48736231|NCT02651467|156885654|FG000|Overall Study|Other (Not specified)|1|||
48736232|NCT02651467|156885655|FG001|Overall Study|Other (Not specified)|0|||
48736233|NCT02651467|156885656|FG002|Overall Study|Other (Not specified)|2|||
48736234|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
48736235|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
48736236|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
48736237|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
48736238|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
48736239|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
48736240|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
48736241|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
48736242|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
48736243|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
48736244|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
48736245|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
48736246|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
48736247|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
48577388|NCT02980341|156305652|FG006|Dose Expansion|Clinical progression|0|||
48577389|NCT02980341|156305653|FG007|Dose Expansion|Clinical progression|4|||
48577390|NCT02980341|156305654|FG008|Dose Expansion|Clinical progression|3|||
48577391|NCT02980341|156305655|FG009|Dose Expansion|Clinical progression|1|||
48577392|NCT02980341|156305656|FG010|Dose Expansion|Clinical progression|4|||
48577393|NCT02980341|156305646|FG000|Dose Expansion|Adverse Event|0|||
48577394|NCT02980341|156305647|FG001|Dose Expansion|Adverse Event|0|||
48577395|NCT02980341|156305648|FG002|Dose Expansion|Adverse Event|0|||
48577396|NCT02980341|156305649|FG003|Dose Expansion|Adverse Event|0|||
48577397|NCT02980341|156305650|FG004|Dose Expansion|Adverse Event|0|||
48736248|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
48577398|NCT02980341|156305651|FG005|Dose Expansion|Adverse Event|0|||
48577399|NCT02980341|156305652|FG006|Dose Expansion|Adverse Event|0|||
48577400|NCT02980341|156305653|FG007|Dose Expansion|Adverse Event|3|||
48577401|NCT02980341|156305654|FG008|Dose Expansion|Adverse Event|0|||
48577402|NCT02980341|156305655|FG009|Dose Expansion|Adverse Event|1|||
48577403|NCT02980341|156305656|FG010|Dose Expansion|Adverse Event|3|||
48577404|NCT02980341|156305646|FG000|Dose Expansion|Death|0|||
48577405|NCT02980341|156305647|FG001|Dose Expansion|Death|0|||
48577406|NCT02980341|156305648|FG002|Dose Expansion|Death|0|||
48577407|NCT02980341|156305649|FG003|Dose Expansion|Death|0|||
48577408|NCT02980341|156305650|FG004|Dose Expansion|Death|0|||
48577409|NCT02980341|156305651|FG005|Dose Expansion|Death|0|||
48577410|NCT02980341|156305652|FG006|Dose Expansion|Death|0|||
48577411|NCT02980341|156305653|FG007|Dose Expansion|Death|0|||
48577412|NCT02980341|156305654|FG008|Dose Expansion|Death|2|||
48577413|NCT02980341|156305655|FG009|Dose Expansion|Death|1|||
48577414|NCT02980341|156305656|FG010|Dose Expansion|Death|0|||
48577415|NCT02980341|156305646|FG000|Dose Expansion|Withdrawal by Subject|0|||
48577416|NCT02980341|156305647|FG001|Dose Expansion|Withdrawal by Subject|0|||
48577417|NCT02980341|156305648|FG002|Dose Expansion|Withdrawal by Subject|0|||
48577418|NCT02980341|156305649|FG003|Dose Expansion|Withdrawal by Subject|0|||
48577419|NCT02980341|156305650|FG004|Dose Expansion|Withdrawal by Subject|0|||
48736249|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
48736250|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
48736251|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
48736252|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
48736253|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
48577420|NCT02980341|156305651|FG005|Dose Expansion|Withdrawal by Subject|0|||
48577421|NCT02980341|156305652|FG006|Dose Expansion|Withdrawal by Subject|0|||
48736254|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
48736255|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
48736256|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
48736257|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
48736258|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Death|2|||
48736259|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Death|1|||
48736260|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Death|0|||
48736261|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Death|0|||
48736262|NCT02607930|156885661|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
48736263|NCT02607930|156885662|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
48736264|NCT02607930|156885663|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
48319717|NCT00529516|155371086|FG002|Overall Study|Withdrawal by Subject|0|||
48319718|NCT00529516|155371084|FG000|Overall Study|Lost to Follow-up|0|||
48319719|NCT00529516|155371085|FG001|Overall Study|Lost to Follow-up|0|||
48577422|NCT02980341|156305653|FG007|Dose Expansion|Withdrawal by Subject|2|||
48736265|NCT02607930|156885664|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
48736266|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
48736267|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
48736268|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
48736269|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
48736270|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
48577423|NCT02980341|156305654|FG008|Dose Expansion|Withdrawal by Subject|0|||
48736271|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
48736272|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
48736273|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
48736274|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
48736275|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
48736276|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
48736277|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
48736278|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
48577424|NCT02980341|156305655|FG009|Dose Expansion|Withdrawal by Subject|1|||
48577425|NCT02980341|156305656|FG010|Dose Expansion|Withdrawal by Subject|0|||
48577426|NCT02980341|156305646|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577427|NCT02980341|156305647|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577428|NCT02980341|156305648|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577429|NCT02980341|156305649|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577430|NCT02980341|156305650|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577431|NCT02980341|156305651|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577432|NCT02980341|156305652|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577433|NCT02980341|156305653|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
48577434|NCT02980341|156305654|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577435|NCT02980341|156305655|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577436|NCT02980341|156305656|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
48577437|NCT02980341|156305646|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577438|NCT02980341|156305647|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577439|NCT02980341|156305648|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577440|NCT02980341|156305649|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577441|NCT02980341|156305650|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577442|NCT02980341|156305651|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48736279|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
48736280|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
48736281|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
48319720|NCT00529516|155371086|FG002|Overall Study|Lost to Follow-up|1|||
48577443|NCT02980341|156305652|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577444|NCT02980341|156305653|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577445|NCT02980341|156305654|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
48577446|NCT02980341|156305655|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577447|NCT02980341|156305656|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
48577448|NCT02980341|156305646|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577449|NCT02980341|156305647|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577450|NCT02980341|156305648|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577451|NCT02980341|156305649|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577452|NCT02980341|156305650|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577453|NCT02980341|156305651|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577454|NCT02980341|156305652|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577455|NCT02980341|156305653|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577456|NCT02980341|156305654|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
48577457|NCT02980341|156305655|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577458|NCT02980341|156305656|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
48577459|NCT02980341|156305646|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48736282|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
48736283|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
48577460|NCT02980341|156305647|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577461|NCT02980341|156305648|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577462|NCT02980341|156305649|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577463|NCT02980341|156305650|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577464|NCT02980341|156305651|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577465|NCT02980341|156305652|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577466|NCT02980341|156305653|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577467|NCT02980341|156305654|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577468|NCT02980341|156305655|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
48577469|NCT02980341|156305656|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
48577470|NCT02256982|156305657|FG000|Overall Study|Disease Progression|0|||
48577471|NCT02256982|156305658|FG001|Overall Study|Disease Progression|1|||
48577472|NCT03075891|156305659|FG000|Overall Study|Withdrawal by Subject|3|||
48577473|NCT03075891|156305660|FG001|Overall Study|Withdrawal by Subject|6|||
48577474|NCT03075891|156305659|FG000|Overall Study|Lost to Follow-up|1|||
48577475|NCT03075891|156305660|FG001|Overall Study|Lost to Follow-up|0|||
48577476|NCT03075891|156305659|FG000|Overall Study|Pregnancy|3|||
48577477|NCT03075891|156305660|FG001|Overall Study|Pregnancy|1|||
48577478|NCT03075891|156305659|FG000|Overall Study|visits not performed (no time)|1|||
48577479|NCT03075891|156305660|FG001|Overall Study|visits not performed (no time)|0|||
48577480|NCT03075891|156305659|FG000|Overall Study|Drug abuse relapse issue|0|||
48577481|NCT03075891|156305660|FG001|Overall Study|Drug abuse relapse issue|1|||
48736284|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
48736285|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
48736286|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
48736287|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
48736288|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
48736289|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
48736290|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
48736291|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
48736292|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
48736293|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
48736294|NCT02607930|156885661|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
48736295|NCT02607930|156885662|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
48736296|NCT02607930|156885663|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
48736297|NCT02607930|156885664|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
48736298|NCT02833350|156885669|FG000|Overall Study|Adverse Event|0|||
48736299|NCT02833350|156885670|FG001|Overall Study|Adverse Event|3|||
48736300|NCT02833350|156885671|FG002|Overall Study|Adverse Event|4|||
48736301|NCT02833350|156885672|FG003|Overall Study|Adverse Event|4|||
48736302|NCT02833350|156885673|FG004|Overall Study|Adverse Event|1|||
48736303|NCT02833350|156885674|FG005|Overall Study|Adverse Event|0|||
48736304|NCT02833350|156885675|FG006|Overall Study|Adverse Event|1|||
48319721|NCT00111813|155371087|FG000|Overall Study|Adverse Event|1|||
48319722|NCT00111813|155371088|FG001|Overall Study|Adverse Event|2|||
48577482|NCT03075891|156305659|FG000|Overall Study|Participant requiring study withdrawal|0|||
48577483|NCT03075891|156305660|FG001|Overall Study|Participant requiring study withdrawal|1|||
48577484|NCT03075891|156305659|FG000|Overall Study|Adverse event, non-fatal|1|||
48577485|NCT03075891|156305660|FG001|Overall Study|Adverse event, non-fatal|4|||
48577486|NCT03614078|156305661|FG000|Overall Study|Withdrawal by Subject|2|||
48577487|NCT03614078|156305662|FG001|Overall Study|Withdrawal by Subject|2|||
48577488|NCT03614078|156305663|FG002|Overall Study|Withdrawal by Subject|3|||
48577489|NCT03614078|156305661|FG000|Overall Study|Participant Did Not Return for Visit|0|||
48577490|NCT03614078|156305662|FG001|Overall Study|Participant Did Not Return for Visit|1|||
48577491|NCT03614078|156305663|FG002|Overall Study|Participant Did Not Return for Visit|0|||
48577492|NCT03614078|156305661|FG000|Overall Study|High Neutrophils|0|||
48577493|NCT03614078|156305662|FG001|Overall Study|High Neutrophils|0|||
48577494|NCT03614078|156305663|FG002|Overall Study|High Neutrophils|2|||
48577495|NCT03614078|156305661|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
48577496|NCT03614078|156305662|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
48736305|NCT02833350|156885669|FG000|Overall Study|Death|0|||
48736306|NCT02833350|156885670|FG001|Overall Study|Death|0|||
48736307|NCT02833350|156885671|FG002|Overall Study|Death|1|||
48736308|NCT02833350|156885672|FG003|Overall Study|Death|0|||
48577497|NCT03614078|156305663|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
48577498|NCT03614078|156305661|FG000|Overall Study|Exacerbation of Psoriasis|0|||
48577499|NCT03614078|156305662|FG001|Overall Study|Exacerbation of Psoriasis|1|||
48577500|NCT03614078|156305663|FG002|Overall Study|Exacerbation of Psoriasis|0|||
48577501|NCT03614078|156305661|FG000|Overall Study|Adverse Event|0|||
48577502|NCT03614078|156305662|FG001|Overall Study|Adverse Event|2|||
48577503|NCT03614078|156305663|FG002|Overall Study|Adverse Event|0|||
48577504|NCT03614078|156305661|FG000|Overall Study|Dizziness and Rash|0|||
48577505|NCT03614078|156305662|FG001|Overall Study|Dizziness and Rash|1|||
48577506|NCT03614078|156305663|FG002|Overall Study|Dizziness and Rash|0|||
48577507|NCT02951533|156305667|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
48577508|NCT02951533|156305668|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
48577509|NCT02951533|156305669|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
48577510|NCT02951533|156305667|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
48577511|NCT02951533|156305668|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
48577512|NCT02951533|156305669|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
48577513|NCT02951533|156305667|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
48577514|NCT02951533|156305668|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
48577515|NCT02951533|156305669|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
48577516|NCT02951533|156305667|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
48577517|NCT02951533|156305668|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
48577518|NCT02951533|156305669|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
48577519|NCT02951533|156305667|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
48577520|NCT02951533|156305668|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
48577521|NCT02951533|156305669|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
48577522|NCT02951533|156305667|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
48577523|NCT02951533|156305668|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
48577524|NCT02951533|156305669|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
48577525|NCT02951533|156305667|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
48577526|NCT02951533|156305668|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
48577527|NCT02951533|156305669|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
48577528|NCT02951533|156305667|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
48577529|NCT02951533|156305668|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
48577530|NCT02951533|156305669|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
48577531|NCT02951533|156305667|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
48577532|NCT02951533|156305668|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
48577533|NCT02951533|156305669|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
48577534|NCT02951533|156305667|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
48577535|NCT02951533|156305668|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
48736309|NCT02833350|156885673|FG004|Overall Study|Death|0|||
48736310|NCT02833350|156885674|FG005|Overall Study|Death|0|||
48736311|NCT02833350|156885675|FG006|Overall Study|Death|0|||
48736312|NCT02833350|156885669|FG000|Overall Study|Lack of Efficacy|0|||
48736313|NCT02833350|156885670|FG001|Overall Study|Lack of Efficacy|2|||
48736314|NCT02833350|156885671|FG002|Overall Study|Lack of Efficacy|1|||
48736315|NCT02833350|156885672|FG003|Overall Study|Lack of Efficacy|4|||
48736316|NCT02833350|156885673|FG004|Overall Study|Lack of Efficacy|0|||
48736317|NCT02833350|156885674|FG005|Overall Study|Lack of Efficacy|1|||
48577536|NCT02951533|156305669|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
48577537|NCT02951533|156305667|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
48577538|NCT02951533|156305668|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
48736318|NCT02833350|156885675|FG006|Overall Study|Lack of Efficacy|1|||
48736319|NCT02833350|156885669|FG000|Overall Study|Lost to Follow-up|0|||
48577539|NCT02951533|156305669|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
48577540|NCT05174949|156305670|FG000|Overall Study|Physician Decision|1|||
48577541|NCT05174949|156305671|FG001|Overall Study|Physician Decision|2|||
48577542|NCT05174949|156305672|FG002|Overall Study|Physician Decision|0|||
48577543|NCT05174949|156305673|FG003|Overall Study|Physician Decision|1|||
48577544|NCT05174949|156305674|FG004|Overall Study|Physician Decision|0|||
48577545|NCT05174949|156305675|FG005|Overall Study|Physician Decision|0|||
48577546|NCT05174949|156305670|FG000|Overall Study|Withdrawal by Subject|0|||
48577547|NCT05174949|156305671|FG001|Overall Study|Withdrawal by Subject|1|||
48577548|NCT05174949|156305672|FG002|Overall Study|Withdrawal by Subject|0|||
48577549|NCT05174949|156305673|FG003|Overall Study|Withdrawal by Subject|0|||
48577550|NCT05174949|156305674|FG004|Overall Study|Withdrawal by Subject|0|||
48577551|NCT05174949|156305675|FG005|Overall Study|Withdrawal by Subject|0|||
48736320|NCT02833350|156885670|FG001|Overall Study|Lost to Follow-up|1|||
48736321|NCT02833350|156885671|FG002|Overall Study|Lost to Follow-up|0|||
48577552|NCT05174949|156305670|FG000|Overall Study|Lost to Follow-up|0|||
48577553|NCT05174949|156305671|FG001|Overall Study|Lost to Follow-up|0|||
48736322|NCT02833350|156885672|FG003|Overall Study|Lost to Follow-up|0|||
48736323|NCT02833350|156885673|FG004|Overall Study|Lost to Follow-up|0|||
48736324|NCT02833350|156885674|FG005|Overall Study|Lost to Follow-up|0|||
48736325|NCT02833350|156885675|FG006|Overall Study|Lost to Follow-up|1|||
48736326|NCT02833350|156885669|FG000|Overall Study|Withdrawal by Subject|3|||
48736327|NCT02833350|156885670|FG001|Overall Study|Withdrawal by Subject|3|||
48736328|NCT02833350|156885671|FG002|Overall Study|Withdrawal by Subject|2|||
48736329|NCT02833350|156885672|FG003|Overall Study|Withdrawal by Subject|0|||
48736330|NCT02833350|156885673|FG004|Overall Study|Withdrawal by Subject|2|||
48736331|NCT02833350|156885674|FG005|Overall Study|Withdrawal by Subject|0|||
48577554|NCT05174949|156305672|FG002|Overall Study|Lost to Follow-up|0|||
48577555|NCT05174949|156305673|FG003|Overall Study|Lost to Follow-up|1|||
48577556|NCT05174949|156305674|FG004|Overall Study|Lost to Follow-up|0|||
48577557|NCT05174949|156305675|FG005|Overall Study|Lost to Follow-up|0|||
48577558|NCT01500187|156305676|FG000|Overall Study|Lost to Follow-up|6|||
48577559|NCT01500187|156305677|FG001|Overall Study|Lost to Follow-up|0|||
48577560|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
48577561|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
48736332|NCT02833350|156885675|FG006|Overall Study|Withdrawal by Subject|2|||
48736333|NCT00570765|156885676|FG000|DB Phase|Withdrawal by Subject|1|||
48736334|NCT00570765|156885677|FG001|DB Phase|Withdrawal by Subject|0|||
48736335|NCT00570765|156885678|FG002|DB Phase|Withdrawal by Subject|0|||
48736336|NCT00570765|156885679|FG003|DB Phase|Withdrawal by Subject|0|||
48736337|NCT00570765|156885676|FG000|DB Phase|Protocol Violation|0|||
48736338|NCT00570765|156885677|FG001|DB Phase|Protocol Violation|1|||
48736339|NCT00570765|156885678|FG002|DB Phase|Protocol Violation|0|||
48736340|NCT00570765|156885679|FG003|DB Phase|Protocol Violation|0|||
48736341|NCT00570765|156885676|FG000|DB Phase|Adverse Event|3|||
48736342|NCT00570765|156885677|FG001|DB Phase|Adverse Event|6|||
48736343|NCT00570765|156885678|FG002|DB Phase|Adverse Event|0|||
48736344|NCT00570765|156885679|FG003|DB Phase|Adverse Event|0|||
48736345|NCT00570765|156885676|FG000|DB Phase|Did Not Receive Study Drug|0|||
48736346|NCT00570765|156885677|FG001|DB Phase|Did Not Receive Study Drug|0|||
48736347|NCT00570765|156885678|FG002|DB Phase|Did Not Receive Study Drug|1|||
48736348|NCT00570765|156885679|FG003|DB Phase|Did Not Receive Study Drug|0|||
48736349|NCT00570765|156885676|FG000|LTSE Phase|Withdrawal by Subject|0|||
48736350|NCT00570765|156885677|FG001|LTSE Phase|Withdrawal by Subject|0|||
48736351|NCT00570765|156885678|FG002|LTSE Phase|Withdrawal by Subject|0|||
48736352|NCT00570765|156885679|FG003|LTSE Phase|Withdrawal by Subject|1|||
48736353|NCT00570765|156885676|FG000|LTSE Phase|Adverse Event|0|||
48577562|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
48577563|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
48577564|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Death|0|||
48736354|NCT00570765|156885677|FG001|LTSE Phase|Adverse Event|0|||
48736355|NCT00570765|156885678|FG002|LTSE Phase|Adverse Event|0|||
48736356|NCT00570765|156885679|FG003|LTSE Phase|Adverse Event|7|||
48736357|NCT00570765|156885676|FG000|LTSE Phase|Physician Decision|0|||
48736358|NCT00570765|156885677|FG001|LTSE Phase|Physician Decision|0|||
48736359|NCT00570765|156885678|FG002|LTSE Phase|Physician Decision|0|||
48736360|NCT00570765|156885679|FG003|LTSE Phase|Physician Decision|4|||
48577565|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Death|0|||
48577566|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Death|1|||
48577567|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Death|0|||
48577568|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
48577569|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
48577570|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
48736361|NCT01500031|156885680|FG000|Overall Study|Death|1|||
48736362|NCT01500031|156885680|FG000|Overall Study|Withdrawal by Subject|4|||
48736363|NCT01739309|156885682|FG000|Overall Study|Adverse Event|1|||
48736364|NCT01739309|156885682|FG000|Overall Study|Withdrawal by Subject|1|||
48736365|NCT00875979|156885686|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
48736366|NCT00875979|156885687|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
48577571|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
48577572|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
48577573|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
48577574|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
48577575|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
48577576|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
48577577|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
48577578|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
48577579|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
48577580|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
48577581|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
48577582|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
48577583|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
48577584|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
48577585|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
48577586|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
48577587|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
48577588|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
48577589|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
48577590|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
48577591|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
48577592|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
48577593|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
48577594|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48577595|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48577596|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
48577597|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
48577598|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
48577599|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
48577600|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
48577601|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
48577602|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
48577603|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
48577604|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Other|8|||
48577605|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Other|14|||
48577606|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Other|8|||
48577607|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Other|23|||
48736367|NCT00875979|156885686|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
48736368|NCT00875979|156885687|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
48577608|NCT01106677|156305678|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
48577609|NCT01106677|156305679|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
48577610|NCT01106677|156305680|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
48577611|NCT01106677|156305681|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
48577612|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
48577613|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
48577614|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
48577615|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
48577616|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Death|0|||
48577617|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Death|0|||
48577618|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Death|0|||
48577619|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Death|1|||
48577620|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
48577621|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
48577622|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
48577623|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
48577624|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
48577625|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
48577626|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
48577627|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
48736369|NCT00875979|156885686|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
48577628|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
48577629|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
48577630|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
48577631|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
48736370|NCT00875979|156885687|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
48736371|NCT00875979|156885686|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
48736372|NCT00875979|156885687|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
48736373|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
48736374|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
48736375|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
48736376|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
48736377|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
48736378|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
48577632|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
48577633|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48577634|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48577635|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48577636|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48736379|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
48736380|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
48736381|NCT00875979|156885686|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
48736382|NCT00875979|156885687|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
48736383|NCT01254292|156885688|FG000|Comparative Phase|Adverse Event|25|||
48736384|NCT01254292|156885689|FG001|Comparative Phase|Adverse Event|25|||
48736385|NCT01254292|156885688|FG000|Comparative Phase|Lost to Follow-up|3|||
48736386|NCT01254292|156885689|FG001|Comparative Phase|Lost to Follow-up|21|||
48736387|NCT01254292|156885688|FG000|Comparative Phase|Pregnancy|2|||
48736388|NCT01254292|156885689|FG001|Comparative Phase|Pregnancy|6|||
48736389|NCT01254292|156885688|FG000|Comparative Phase|Withdrawal by Subject|20|||
48736390|NCT01254292|156885689|FG001|Comparative Phase|Withdrawal by Subject|21|||
48736391|NCT01254292|156885688|FG000|Comparative Phase|Protocol Violation|1|||
48736392|NCT01254292|156885689|FG001|Comparative Phase|Protocol Violation|2|||
48736393|NCT01254292|156885688|FG000|Comparative Phase|Wish for pregnancy|4|||
48736394|NCT01254292|156885689|FG001|Comparative Phase|Wish for pregnancy|6|||
48736395|NCT01254292|156885688|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
48736396|NCT01254292|156885689|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
48736397|NCT01254292|156885688|FG000|LCS12 Extension Phase|Adverse Event|9|||
48736398|NCT01254292|156885689|FG001|LCS12 Extension Phase|Adverse Event|0|||
48736399|NCT01254292|156885688|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
48736400|NCT01254292|156885689|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
48736401|NCT01254292|156885688|FG000|LCS12 Extension Phase|Other unknown|4|||
48736402|NCT01254292|156885689|FG001|LCS12 Extension Phase|Other unknown|0|||
48736403|NCT01254292|156885688|FG000|LCS12 Extension Phase|Pregnancy|2|||
48736404|NCT01254292|156885689|FG001|LCS12 Extension Phase|Pregnancy|0|||
48577637|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
48577638|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
48577639|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48577640|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
48577641|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
48577642|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
48577643|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
48577644|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
48577645|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
48577646|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
48585152|NCT01094782|156333785|FG002|Overall Study|Healthy Subject Had Pain|0|||
48585153|NCT01094782|156333786|FG003|Overall Study|Healthy Subject Had Pain|0|||
48585154|NCT01094782|156333787|FG004|Overall Study|Healthy Subject Had Pain|0|||
48585155|NCT01094782|156333788|FG005|Overall Study|Healthy Subject Had Pain|0|||
48585156|NCT01094782|156333783|FG000|Overall Study|Hypertension|0|||
48585157|NCT01094782|156333784|FG001|Overall Study|Hypertension|0|||
48585158|NCT01094782|156333785|FG002|Overall Study|Hypertension|1|||
48585159|NCT01094782|156333786|FG003|Overall Study|Hypertension|0|||
48585160|NCT01094782|156333787|FG004|Overall Study|Hypertension|0|||
48585161|NCT01094782|156333788|FG005|Overall Study|Hypertension|0|||
48585162|NCT01094782|156333783|FG000|Overall Study|Wrong Pain Condition|0|||
48585163|NCT01094782|156333784|FG001|Overall Study|Wrong Pain Condition|0|||
48585164|NCT01094782|156333785|FG002|Overall Study|Wrong Pain Condition|0|||
48585165|NCT01094782|156333786|FG003|Overall Study|Wrong Pain Condition|2|||
48585166|NCT01094782|156333787|FG004|Overall Study|Wrong Pain Condition|1|||
48577647|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
48577648|NCT01106677|156305678|FG000|Extension Period: Week 26 to Week 52|Other|6|||
48577649|NCT01106677|156305679|FG001|Extension Period: Week 26 to Week 52|Other|5|||
48577650|NCT01106677|156305680|FG002|Extension Period: Week 26 to Week 52|Other|8|||
48577651|NCT01106677|156305681|FG003|Extension Period: Week 26 to Week 52|Other|5|||
48577652|NCT02029989|156305682|FG000|Overall Study|Withdrawal by Subject|1|||
48577653|NCT02029989|156305683|FG001|Overall Study|Withdrawal by Subject|0|||
48577654|NCT02029989|156305682|FG000|Overall Study|Withdrawal: Fear of needles|1|||
48577655|NCT02029989|156305683|FG001|Overall Study|Withdrawal: Fear of needles|0|||
48577656|NCT02029989|156305682|FG000|Overall Study|Change of location|2|||
48577657|NCT02029989|156305683|FG001|Overall Study|Change of location|3|||
48577658|NCT02029989|156305682|FG000|Overall Study|Physician Decision|2|||
48577659|NCT02029989|156305683|FG001|Overall Study|Physician Decision|0|||
48577660|NCT02029989|156305682|FG000|Overall Study|Lost to Follow-up|9|||
48577661|NCT02029989|156305683|FG001|Overall Study|Lost to Follow-up|7|||
48622567|NCT03928704|156476538|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
48622568|NCT03928704|156476539|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
48622569|NCT03928704|156476534|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
48622570|NCT03928704|156476535|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
48622571|NCT03928704|156476536|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
48622572|NCT03928704|156476537|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
48622573|NCT03928704|156476538|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
48622574|NCT03928704|156476539|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
48622575|NCT03928704|156476534|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
48622576|NCT03928704|156476535|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
48622577|NCT03928704|156476536|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
48622578|NCT03928704|156476537|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
48622579|NCT03928704|156476538|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
48622580|NCT03928704|156476539|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
48622581|NCT03928704|156476534|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
48622582|NCT03928704|156476535|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
48622583|NCT03928704|156476536|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
48622584|NCT03928704|156476537|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
48622585|NCT03928704|156476538|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
48622586|NCT03928704|156476539|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
48622587|NCT03928704|156476534|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
48577662|NCT02029989|156305682|FG000|Overall Study|Death|0|||
48577663|NCT02029989|156305683|FG001|Overall Study|Death|1|||
48577664|NCT02029989|156305682|FG000|Overall Study|Protocol Violation|1|||
48622588|NCT03928704|156476535|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
48622589|NCT03928704|156476536|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
48622590|NCT03928704|156476537|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
48622591|NCT03928704|156476538|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
48622592|NCT03928704|156476539|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
48622593|NCT03928704|156476534|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
48622594|NCT03928704|156476535|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
48622595|NCT03928704|156476536|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
48622596|NCT03928704|156476537|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
48622597|NCT03928704|156476538|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
48622598|NCT03928704|156476539|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
48622599|NCT01454063|156476546|FG000|Randomized|Adverse Event|1|||
48622600|NCT01454063|156476547|FG001|Randomized|Adverse Event|1|||
48622601|NCT01454063|156476546|FG000|Randomized|Protocol Violation|0|||
48622602|NCT01454063|156476547|FG001|Randomized|Protocol Violation|1|||
48622603|NCT02741193|156476554|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
48622604|NCT02741193|156476554|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
48736405|NCT01254292|156885688|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
48736406|NCT01254292|156885689|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
48736407|NCT01328431|156885690|FG000|Baseline|Protocol Violation|0|||
48736408|NCT01328431|156885691|FG001|Baseline|Protocol Violation|2|||
48736409|NCT01328431|156885690|FG000|1 Month (1M)|Lost to Follow-up|55|||
48736410|NCT01328431|156885691|FG001|1 Month (1M)|Lost to Follow-up|58|||
48736411|NCT01328431|156885690|FG000|3 Month (3M)|Death|2|||
48319723|NCT00111813|155371089|FG002|Overall Study|Adverse Event|4|||
48319724|NCT00111813|155371090|FG003|Overall Study|Adverse Event|2|||
48736412|NCT01328431|156885691|FG001|3 Month (3M)|Death|2|||
48736413|NCT01328431|156885690|FG000|3 Month (3M)|Lost to Follow-up|75|||
48736414|NCT01328431|156885691|FG001|3 Month (3M)|Lost to Follow-up|70|||
48736415|NCT01328431|156885690|FG000|12 Month (12M)|Death|2|||
48736416|NCT01328431|156885691|FG001|12 Month (12M)|Death|6|||
48736417|NCT01328431|156885690|FG000|12 Month (12M)|Lost to Follow-up|82|||
48736418|NCT01328431|156885691|FG001|12 Month (12M)|Lost to Follow-up|91|||
48736419|NCT00199875|156885693|FG000|Overall Study|Withdrawal by Subject|0|||
48736420|NCT00199875|156885694|FG001|Overall Study|Withdrawal by Subject|0|||
48736421|NCT00199875|156885695|FG002|Overall Study|Withdrawal by Subject|0|||
48736422|NCT00199875|156885696|FG003|Overall Study|Withdrawal by Subject|0|||
48736423|NCT00199875|156885697|FG004|Overall Study|Withdrawal by Subject|1|||
48736424|NCT02589405|156885698|FG000|Overall Study|Adverse Event|3|||
48736425|NCT02589405|156885698|FG000|Overall Study|Withdrawal by Subject|1|||
48736426|NCT02905149|156885699|FG000|Overall Study|Lost to Follow-up|2|||
48736427|NCT02905149|156885700|FG001|Overall Study|Lost to Follow-up|0|||
48736428|NCT03330288|156885702|FG000|Overall Study|Other reason|1|||
48736429|NCT03330288|156885703|FG001|Overall Study|Other reason|1|||
48736430|NCT03330288|156885702|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
48736431|NCT03330288|156885703|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
48736432|NCT03330288|156885702|FG000|Overall Study|Adverse Event|1|||
48736433|NCT03330288|156885703|FG001|Overall Study|Adverse Event|0|||
48736434|NCT03330288|156885702|FG000|Overall Study|Withdrawal by Subject|1|||
48736435|NCT03330288|156885703|FG001|Overall Study|Withdrawal by Subject|0|||
48736436|NCT03330288|156885702|FG000|Overall Study|Lost to Follow-up|26|||
48736437|NCT03330288|156885703|FG001|Overall Study|Lost to Follow-up|7|||
48736438|NCT01042678|156885704|FG000|Overall Study|Physician Decision|1|||
48736439|NCT01042678|156885705|FG001|Overall Study|Physician Decision|0|||
48736440|NCT01042678|156885706|FG002|Overall Study|Physician Decision|0|||
48736441|NCT01042678|156885707|FG003|Overall Study|Physician Decision|0|||
48577665|NCT02029989|156305683|FG001|Overall Study|Protocol Violation|0|||
48736442|NCT01042678|156885708|FG004|Overall Study|Physician Decision|0|||
48736443|NCT01042678|156885709|FG005|Overall Study|Physician Decision|0|||
48736444|NCT04889222|156885714|FG000|Overall Study|Did not meet eligibility criteria|8|||
48736445|NCT04889222|156885714|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
48736446|NCT04889222|156885714|FG000|Overall Study|Did not proceed due to time constraints|5|||
48319725|NCT00111813|155371091|FG004|Overall Study|Adverse Event|2|||
48319726|NCT00111813|155371092|FG005|Overall Study|Adverse Event|2|||
48577666|NCT03843632|156305684|FG000|Overall Study|Withdrawal by Subject|1|||
48577667|NCT03843632|156305685|FG001|Overall Study|Withdrawal by Subject|0|||
48577668|NCT03843632|156305686|FG002|Overall Study|Withdrawal by Subject|0|||
48577669|NCT03843632|156305687|FG003|Overall Study|Withdrawal by Subject|0|||
48577670|NCT04351373|156305693|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
48577671|NCT03403751|156305695|FG000|Overall Study|Death|5|||
48577672|NCT03403751|156305696|FG001|Overall Study|Death|6|||
48319727|NCT00111813|155371087|FG000|Overall Study|Progressive disease|2|||
48319728|NCT00111813|155371088|FG001|Overall Study|Progressive disease|1|||
48319729|NCT00111813|155371089|FG002|Overall Study|Progressive disease|5|||
48319730|NCT00111813|155371090|FG003|Overall Study|Progressive disease|3|||
48577673|NCT03403751|156305695|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
48577674|NCT03403751|156305696|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
48577675|NCT00381043|156305699|FG000|Overall Study|Lost to Follow-up|8|||
48577676|NCT00381043|156305700|FG001|Overall Study|Lost to Follow-up|6|||
48577677|NCT00381043|156305699|FG000|Overall Study|Withdrawal by Subject|3|||
48577678|NCT00381043|156305700|FG001|Overall Study|Withdrawal by Subject|1|||
48577679|NCT00381043|156305699|FG000|Overall Study|wanted more care|0|||
48577680|NCT00381043|156305700|FG001|Overall Study|wanted more care|1|||
48577681|NCT00381043|156305699|FG000|Overall Study|incarcerated|1|||
48736447|NCT01609231|156885715|FG000|Overall Study|Adverse Event|1|||
48736448|NCT01609231|156885716|FG001|Overall Study|Adverse Event|3|||
48736449|NCT01609231|156885715|FG000|Overall Study|Physician Decision|1|||
48736450|NCT01609231|156885716|FG001|Overall Study|Physician Decision|0|||
48319731|NCT00111813|155371091|FG004|Overall Study|Progressive disease|4|||
48319732|NCT00111813|155371092|FG005|Overall Study|Progressive disease|3|||
48577682|NCT00381043|156305700|FG001|Overall Study|incarcerated|0|||
48577683|NCT01123941|156305703|FG000|Overall Study|Lost to Follow-up|2|||
48736451|NCT01609231|156885715|FG000|Overall Study|Withdrawal by Subject|1|||
48736452|NCT01609231|156885716|FG001|Overall Study|Withdrawal by Subject|0|||
48736453|NCT01180647|156885717|FG000|Overall Study|Lost to Follow-up|5|||
48736454|NCT01180647|156885718|FG001|Overall Study|Lost to Follow-up|6|||
48736455|NCT02761733|156885721|FG000|Overall Study|Death|3|||
48736456|NCT02761733|156885722|FG001|Overall Study|Death|5|||
48736457|NCT02761733|156885723|FG002|Overall Study|Death|1|||
48736458|NCT02761733|156885724|FG003|Overall Study|Death|1|||
48736459|NCT02761733|156885721|FG000|Overall Study|Lost to Follow-up|6|||
48736460|NCT02761733|156885722|FG001|Overall Study|Lost to Follow-up|7|||
48736461|NCT02761733|156885723|FG002|Overall Study|Lost to Follow-up|0|||
48736462|NCT02761733|156885724|FG003|Overall Study|Lost to Follow-up|3|||
48736463|NCT02761733|156885721|FG000|Overall Study|Physician Decision|4|||
48736464|NCT02761733|156885722|FG001|Overall Study|Physician Decision|0|||
48736465|NCT02761733|156885723|FG002|Overall Study|Physician Decision|0|||
48736466|NCT02761733|156885724|FG003|Overall Study|Physician Decision|0|||
48736467|NCT02761733|156885721|FG000|Overall Study|Withdrawal by Subject|2|||
48736468|NCT02761733|156885722|FG001|Overall Study|Withdrawal by Subject|0|||
48736469|NCT02761733|156885723|FG002|Overall Study|Withdrawal by Subject|0|||
48736470|NCT02761733|156885724|FG003|Overall Study|Withdrawal by Subject|0|||
48736471|NCT02761733|156885721|FG000|Overall Study|Discharged from Study Site|10|||
48736472|NCT02761733|156885722|FG001|Overall Study|Discharged from Study Site|9|||
48736473|NCT02761733|156885723|FG002|Overall Study|Discharged from Study Site|25|||
48736474|NCT02761733|156885724|FG003|Overall Study|Discharged from Study Site|11|||
48736475|NCT02761733|156885721|FG000|Overall Study|Cognitive Impairment|5|||
48736476|NCT02761733|156885722|FG001|Overall Study|Cognitive Impairment|0|||
48736477|NCT02761733|156885723|FG002|Overall Study|Cognitive Impairment|1|||
48736478|NCT02761733|156885724|FG003|Overall Study|Cognitive Impairment|0|||
48736479|NCT00936611|156885726|FG000|Overall Study|Progressive Disease|3|||
48736480|NCT00936611|156885726|FG000|Overall Study|New Systemic Therapy|22|||
48736481|NCT00936611|156885726|FG000|Overall Study|Lost to Follow-up|1|||
48736482|NCT00936611|156885726|FG000|Overall Study|Withdrawal by Subject|2|||
48736483|NCT00936611|156885726|FG000|Overall Study|Still on Follow-up|1|||
48736484|NCT00936611|156885726|FG000|Overall Study|Still on Active Therapy|7|||
48736485|NCT00936611|156885726|FG000|Overall Study|Ineligible for Study Drug|3|||
48736486|NCT02979197|156885727|FG000|Overall Study|Adverse Event|4|||
48736487|NCT02979197|156885728|FG001|Overall Study|Adverse Event|2|||
48736488|NCT02979197|156885729|FG002|Overall Study|Adverse Event|0|||
48736489|NCT02979197|156885727|FG000|Overall Study|Protocol Violation|0|||
48736490|NCT02979197|156885728|FG001|Overall Study|Protocol Violation|1|||
48736491|NCT02979197|156885729|FG002|Overall Study|Protocol Violation|0|||
48736492|NCT02979197|156885727|FG000|Overall Study|Subject unable to commit to study dates|0|||
48736493|NCT02979197|156885728|FG001|Overall Study|Subject unable to commit to study dates|1|||
48736494|NCT02979197|156885729|FG002|Overall Study|Subject unable to commit to study dates|0|||
48736495|NCT00066729|156885735|FG000|Overall Study|Lost to Follow-up|1|||
48577684|NCT01123941|156305704|FG001|Overall Study|Lost to Follow-up|1|||
48577685|NCT00595517|156305705|FG000|Overall Study|Adverse Event|6|||
48577686|NCT00595517|156305705|FG000|Overall Study|Withdrawal by Subject|4|||
48577687|NCT00595517|156305705|FG000|Overall Study|Protocol Violation|2|||
48577688|NCT00595517|156305705|FG000|Overall Study|Recurrence of ulcer|5|||
48577689|NCT00595517|156305705|FG000|Overall Study|usage of prohibited treatment|1|||
48577690|NCT00595517|156305705|FG000|Overall Study|No intention to attend regularly|1|||
48577691|NCT00471718|156305706|FG000|Overall Study|Adverse Event|3|||
48577692|NCT00471718|156305706|FG000|Overall Study|other complicating disease|1|||
48736496|NCT00066729|156885735|FG000|Overall Study|Disease progression|1|||
48577693|NCT00471718|156305706|FG000|Overall Study|disease progression|22|||
48736497|NCT03841448|156885736|FG000|Double-blind Treatment (DBT) Period|Death|1|||
48736498|NCT03841448|156885737|FG001|Double-blind Treatment (DBT) Period|Death|1|||
48736499|NCT03841448|156885738|FG002|Double-blind Treatment (DBT) Period|Death|0|||
48736500|NCT03841448|156885739|FG003|Double-blind Treatment (DBT) Period|Death|0|||
48736501|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
48577694|NCT00471718|156305706|FG000|Overall Study|Withdrawal by Subject|1|||
48577695|NCT04050124|156305707|FG000|Overall Study|Death|1|||
48577696|NCT04050124|156305708|FG001|Overall Study|Death|0|||
48577697|NCT01940900|156305711|FG000|Overall Study|Physician Decision|4|||
48577698|NCT01940900|156305712|FG001|Overall Study|Physician Decision|0|||
48577699|NCT01940900|156305711|FG000|Overall Study|Adverse Event|10|||
48577700|NCT01940900|156305712|FG001|Overall Study|Adverse Event|15|||
48736502|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
48736503|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
48736504|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
48577701|NCT01940900|156305711|FG000|Overall Study|Withdrawal by Subject|11|||
48577702|NCT01940900|156305712|FG001|Overall Study|Withdrawal by Subject|15|||
48577703|NCT01940900|156305711|FG000|Overall Study|Lost to Follow-up|1|||
48577704|NCT01940900|156305712|FG001|Overall Study|Lost to Follow-up|0|||
48577705|NCT01940900|156305711|FG000|Overall Study|Sponsor Decision|1|||
48577706|NCT01940900|156305712|FG001|Overall Study|Sponsor Decision|0|||
48577707|NCT01940900|156305711|FG000|Overall Study|subject non-compliance|1|||
48577708|NCT01940900|156305712|FG001|Overall Study|subject non-compliance|1|||
48577709|NCT01940900|156305711|FG000|Overall Study|other|1|||
48577710|NCT01940900|156305712|FG001|Overall Study|other|0|||
48577711|NCT02234596|156305717|FG000|Overall Study|Participant not treated|2|||
48736505|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Death|0|||
48736506|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Death|0|||
48736507|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Death|0|||
48736508|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Death|1|||
48736509|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
48736510|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
48736511|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
48736512|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
48736513|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
48736514|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
48736515|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
48736516|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
48319733|NCT00111813|155371087|FG000|Overall Study|Lack of Efficacy|0|||
48319734|NCT00111813|155371088|FG001|Overall Study|Lack of Efficacy|0|||
48319735|NCT00111813|155371089|FG002|Overall Study|Lack of Efficacy|0|||
48319736|NCT00111813|155371090|FG003|Overall Study|Lack of Efficacy|0|||
48319737|NCT00111813|155371091|FG004|Overall Study|Lack of Efficacy|0|||
48577712|NCT00808639|156305718|FG000|Overall Study|Disease progression before surgery.|1|||
48736517|NCT03841448|156885736|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
48736518|NCT03841448|156885737|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
48736519|NCT03841448|156885738|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
48736520|NCT03841448|156885739|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
48736521|NCT01811225|156885740|FG000|Treatment Period 1|Adverse Event|2|||
48736522|NCT01811225|156885741|FG001|Treatment Period 1|Adverse Event|3|||
48736523|NCT01811225|156885740|FG000|Treatment Period 1|Lost to Follow-up|12|||
48736524|NCT01811225|156885741|FG001|Treatment Period 1|Lost to Follow-up|8|||
48736525|NCT01811225|156885740|FG000|Treatment Period 1|transporation|1|||
48736526|NCT01811225|156885741|FG001|Treatment Period 1|transporation|0|||
48736527|NCT01811225|156885740|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
48736528|NCT01811225|156885741|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
48736529|NCT01811225|156885740|FG000|Treatment Period 2|Lost to Follow-up|1|||
48319738|NCT00111813|155371092|FG005|Overall Study|Lack of Efficacy|1|||
48319739|NCT00111813|155371087|FG000|Overall Study|Other|0|||
48736530|NCT01811225|156885741|FG001|Treatment Period 2|Lost to Follow-up|2|||
48736531|NCT01811225|156885740|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
48736532|NCT01811225|156885741|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
48736533|NCT00492531|156885743|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
48319740|NCT00111813|155371088|FG001|Overall Study|Other|0|||
48319741|NCT00111813|155371089|FG002|Overall Study|Other|1|||
48319742|NCT00111813|155371090|FG003|Overall Study|Other|0|||
48319743|NCT00111813|155371091|FG004|Overall Study|Other|0|||
48319744|NCT00111813|155371092|FG005|Overall Study|Other|0|||
48319745|NCT00703820|155371093|FG000|Overall Study|Adverse Event|12|||
48577713|NCT03197324|156305722|FG000|Overall Study|Adverse Event|0|||
48577714|NCT03197324|156305723|FG001|Overall Study|Adverse Event|1|||
48319746|NCT00703820|155371094|FG001|Overall Study|Adverse Event|17|||
48319747|NCT00703820|155371093|FG000|Overall Study|Death|5|||
48319748|NCT00703820|155371094|FG001|Overall Study|Death|0|||
48319749|NCT00703820|155371093|FG000|Overall Study|Lack of Efficacy|11|||
48319750|NCT00703820|155371094|FG001|Overall Study|Lack of Efficacy|11|||
48319751|NCT00703820|155371093|FG000|Overall Study|Received non-protocol therapy|1|||
48577715|NCT02655016|156305724|FG000|Overall Study|Disease progression|6|||
48577716|NCT02655016|156305725|FG001|Overall Study|Disease progression|4|||
48577717|NCT02655016|156305724|FG000|Overall Study|Site closed|0|||
48577718|NCT02655016|156305725|FG001|Overall Study|Site closed|1|||
48577719|NCT02655016|156305724|FG000|Overall Study|Death|30|||
48577720|NCT02655016|156305725|FG001|Overall Study|Death|48|||
48577721|NCT02655016|156305724|FG000|Overall Study|Lost to Follow-up|1|||
48577722|NCT02655016|156305725|FG001|Overall Study|Lost to Follow-up|1|||
48577723|NCT02655016|156305724|FG000|Overall Study|Withdrawal by Subject|18|||
48577724|NCT02655016|156305725|FG001|Overall Study|Withdrawal by Subject|36|||
48577725|NCT03053063|156305726|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
48577726|NCT03053063|156305727|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
48577727|NCT03053063|156305728|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
48577728|NCT03053063|156305729|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
48577729|NCT03053063|156305726|FG000|Randomized Phase|Withdrew consent|8|||
48577730|NCT03053063|156305727|FG001|Randomized Phase|Withdrew consent|11|||
48577731|NCT03053063|156305728|FG002|Randomized Phase|Withdrew consent|5|||
48577732|NCT03053063|156305729|FG003|Randomized Phase|Withdrew consent|0|||
48577733|NCT03053063|156305726|FG000|Randomized Phase|Investigator's Discretion|8|||
48577734|NCT03053063|156305727|FG001|Randomized Phase|Investigator's Discretion|6|||
48577735|NCT03053063|156305728|FG002|Randomized Phase|Investigator's Discretion|2|||
48577736|NCT03053063|156305729|FG003|Randomized Phase|Investigator's Discretion|0|||
48577737|NCT03053063|156305726|FG000|Randomized Phase|Lost to Follow-up|3|||
48577738|NCT03053063|156305727|FG001|Randomized Phase|Lost to Follow-up|5|||
48577739|NCT03053063|156305728|FG002|Randomized Phase|Lost to Follow-up|1|||
48577740|NCT03053063|156305729|FG003|Randomized Phase|Lost to Follow-up|0|||
48577741|NCT03053063|156305726|FG000|Randomized Phase|Adverse Event|0|||
48577742|NCT03053063|156305727|FG001|Randomized Phase|Adverse Event|1|||
48577743|NCT03053063|156305728|FG002|Randomized Phase|Adverse Event|0|||
48577744|NCT03053063|156305729|FG003|Randomized Phase|Adverse Event|0|||
48577745|NCT03053063|156305726|FG000|Randomized Phase|Randomized but Never Treated|1|||
48577746|NCT03053063|156305727|FG001|Randomized Phase|Randomized but Never Treated|3|||
48577747|NCT03053063|156305728|FG002|Randomized Phase|Randomized but Never Treated|2|||
48577748|NCT03053063|156305729|FG003|Randomized Phase|Randomized but Never Treated|0|||
48577749|NCT03053063|156305726|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
48577750|NCT03053063|156305727|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
48577751|NCT03053063|156305728|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
48577752|NCT03053063|156305729|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
48577753|NCT03053063|156305726|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
48577754|NCT03053063|156305727|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
48577755|NCT03053063|156305728|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
48577756|NCT03053063|156305729|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
48577757|NCT03053063|156305726|FG000|Open-Label Phase|Death|0|||
48577758|NCT03053063|156305727|FG001|Open-Label Phase|Death|0|||
48577759|NCT03053063|156305728|FG002|Open-Label Phase|Death|0|||
48577760|NCT03053063|156305729|FG003|Open-Label Phase|Death|2|||
48577761|NCT03053063|156305726|FG000|Open-Label Phase|Investigator's discretion|0|||
48577762|NCT03053063|156305727|FG001|Open-Label Phase|Investigator's discretion|0|||
48577763|NCT03053063|156305728|FG002|Open-Label Phase|Investigator's discretion|0|||
48577764|NCT03053063|156305729|FG003|Open-Label Phase|Investigator's discretion|2|||
48577765|NCT00191282|156305732|FG000|Overall Study|Adverse Event|5|||
48577766|NCT00191282|156305733|FG001|Overall Study|Adverse Event|6|||
48577767|NCT00191282|156305732|FG000|Overall Study|Death|51|||
48577768|NCT00191282|156305733|FG001|Overall Study|Death|51|||
48577769|NCT00191282|156305732|FG000|Overall Study|Lack of Efficacy|11|||
48577770|NCT00191282|156305733|FG001|Overall Study|Lack of Efficacy|6|||
48577771|NCT00191282|156305732|FG000|Overall Study|Noncompliance|14|||
48577772|NCT00191282|156305733|FG001|Overall Study|Noncompliance|17|||
48577773|NCT00191282|156305732|FG000|Overall Study|Patient moved|11|||
48577774|NCT00191282|156305733|FG001|Overall Study|Patient moved|14|||
48577775|NCT00191282|156305732|FG000|Overall Study|Withdrawal by Subject|59|||
48577776|NCT00191282|156305733|FG001|Overall Study|Withdrawal by Subject|44|||
48577777|NCT00191282|156305732|FG000|Overall Study|Physician Decision|18|||
48577778|NCT00191282|156305733|FG001|Overall Study|Physician Decision|15|||
48577779|NCT00191282|156305732|FG000|Overall Study|Protocol entry criteria not met|14|||
48577780|NCT00191282|156305733|FG001|Overall Study|Protocol entry criteria not met|9|||
48577781|NCT00191282|156305732|FG000|Overall Study|Protocol Violation|9|||
48577782|NCT00191282|156305733|FG001|Overall Study|Protocol Violation|12|||
48577783|NCT00191282|156305732|FG000|Overall Study|Severity of outcome|2|||
48577784|NCT00191282|156305733|FG001|Overall Study|Severity of outcome|5|||
48736534|NCT00492531|156885744|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
48736535|NCT00810355|156885745|FG000|Overall Study|Lost to Follow-up|13|||
48736536|NCT00810355|156885746|FG001|Overall Study|Lost to Follow-up|17|||
48736537|NCT00810355|156885747|FG002|Overall Study|Lost to Follow-up|11|||
48736538|NCT00810355|156885745|FG000|Overall Study|Withdrawal by Subject|1|||
48736539|NCT00810355|156885746|FG001|Overall Study|Withdrawal by Subject|0|||
48736540|NCT00810355|156885747|FG002|Overall Study|Withdrawal by Subject|0|||
48736541|NCT00397215|156885748|FG000|Month 0 (Day 0)|Adverse Event|0|||
48736542|NCT00397215|156885749|FG001|Month 0 (Day 0)|Adverse Event|1|||
48736543|NCT00397215|156885750|FG002|Month 0 (Day 0)|Adverse Event|0|||
48736544|NCT00397215|156885751|FG003|Month 0 (Day 0)|Adverse Event|0|||
48736545|NCT00397215|156885748|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
48736546|NCT00397215|156885749|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
48736547|NCT00397215|156885750|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
48736548|NCT00397215|156885751|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
48736549|NCT00397215|156885748|FG000|Month 0 (Day 0)|Other|4|||
48736550|NCT00397215|156885749|FG001|Month 0 (Day 0)|Other|1|||
48736551|NCT00397215|156885750|FG002|Month 0 (Day 0)|Other|3|||
48736552|NCT00397215|156885751|FG003|Month 0 (Day 0)|Other|3|||
48736553|NCT00397215|156885748|FG000|Month 6 (Day 180)|Adverse Event|0|||
48736554|NCT00397215|156885749|FG001|Month 6 (Day 180)|Adverse Event|3|||
48577785|NCT00191282|156305732|FG000|Overall Study|Sponsor's decision|2|||
48577786|NCT00191282|156305733|FG001|Overall Study|Sponsor's decision|2|||
48319752|NCT00703820|155371094|FG001|Overall Study|Received non-protocol therapy|0|||
48577787|NCT00191282|156305732|FG000|Overall Study|Lost to Follow-up|24|||
48577788|NCT00191282|156305733|FG001|Overall Study|Lost to Follow-up|31|||
48577789|NCT00102531|156305736|FG000|Overall Study|Adverse Event|0|||
48577790|NCT00102531|156305737|FG001|Overall Study|Adverse Event|1|||
48577791|NCT00102531|156305736|FG000|Overall Study|Disease Progression|5|||
48577792|NCT00102531|156305737|FG001|Overall Study|Disease Progression|9|||
48577793|NCT00102531|156305736|FG000|Overall Study|Physician Decision|0|||
48577794|NCT00102531|156305737|FG001|Overall Study|Physician Decision|1|||
48577795|NCT00954512|156305739|FG000|Overall Study|Withdrawal by Subject|0|||
48577796|NCT00954512|156305740|FG001|Overall Study|Withdrawal by Subject|0|||
48577797|NCT00954512|156305741|FG002|Overall Study|Withdrawal by Subject|0|||
48577798|NCT00954512|156305742|FG003|Overall Study|Withdrawal by Subject|0|||
48577799|NCT00954512|156305743|FG004|Overall Study|Withdrawal by Subject|0|||
48577800|NCT00954512|156305744|FG005|Overall Study|Withdrawal by Subject|1|||
48577801|NCT00954512|156305739|FG000|Overall Study|Adverse Event|0|||
48577802|NCT00954512|156305740|FG001|Overall Study|Adverse Event|0|||
48577803|NCT00954512|156305741|FG002|Overall Study|Adverse Event|0|||
48577804|NCT00954512|156305742|FG003|Overall Study|Adverse Event|0|||
48577805|NCT00954512|156305743|FG004|Overall Study|Adverse Event|1|||
48577806|NCT00954512|156305744|FG005|Overall Study|Adverse Event|2|||
48577807|NCT00954512|156305739|FG000|Overall Study|Physician Decision|0|||
48577808|NCT00954512|156305740|FG001|Overall Study|Physician Decision|1|||
48577809|NCT00954512|156305741|FG002|Overall Study|Physician Decision|0|||
48577810|NCT00954512|156305742|FG003|Overall Study|Physician Decision|1|||
48577811|NCT00954512|156305743|FG004|Overall Study|Physician Decision|0|||
48577812|NCT00954512|156305744|FG005|Overall Study|Physician Decision|0|||
48577813|NCT00954512|156305739|FG000|Overall Study|Symptomatic Deterioration|0|||
48577814|NCT00954512|156305740|FG001|Overall Study|Symptomatic Deterioration|1|||
48577815|NCT00954512|156305741|FG002|Overall Study|Symptomatic Deterioration|0|||
48577816|NCT00954512|156305742|FG003|Overall Study|Symptomatic Deterioration|0|||
48577817|NCT00954512|156305743|FG004|Overall Study|Symptomatic Deterioration|2|||
48577818|NCT00954512|156305744|FG005|Overall Study|Symptomatic Deterioration|0|||
48577819|NCT00954512|156305739|FG000|Overall Study|Progression of Disease|2|||
48577820|NCT00954512|156305740|FG001|Overall Study|Progression of Disease|1|||
48577821|NCT00954512|156305741|FG002|Overall Study|Progression of Disease|0|||
48577822|NCT00954512|156305742|FG003|Overall Study|Progression of Disease|1|||
48577823|NCT00954512|156305743|FG004|Overall Study|Progression of Disease|1|||
48736555|NCT00397215|156885750|FG002|Month 6 (Day 180)|Adverse Event|2|||
48577824|NCT00954512|156305744|FG005|Overall Study|Progression of Disease|1|||
48736556|NCT00397215|156885751|FG003|Month 6 (Day 180)|Adverse Event|0|||
48319753|NCT00703820|155371093|FG000|Overall Study|Physician Decision|4|||
48577825|NCT00965341|156305746|FG000|Overall Study|Withdrew consent|1|||
48577826|NCT00965341|156305747|FG001|Overall Study|Withdrew consent|5|||
48577827|NCT00965341|156305746|FG000|Overall Study|Lost to Follow-up|1|||
48577828|NCT00965341|156305747|FG001|Overall Study|Lost to Follow-up|0|||
48577829|NCT00965341|156305746|FG000|Overall Study|Transportation issues|4|||
48577830|NCT00965341|156305747|FG001|Overall Study|Transportation issues|3|||
48577831|NCT01970475|156305753|FG000|Overall Study|Withdrawal by Subject|11|||
48736557|NCT00397215|156885748|FG000|Month 6 (Day 180)|Other|2|||
48736558|NCT00397215|156885749|FG001|Month 6 (Day 180)|Other|0|||
48736559|NCT00397215|156885750|FG002|Month 6 (Day 180)|Other|3|||
48736560|NCT00397215|156885751|FG003|Month 6 (Day 180)|Other|0|||
48736561|NCT01893203|156885753|FG000|Overall Study|Withdrawal by Subject|1|||
48736562|NCT00306189|156885756|FG000|Overall Study|Physician Decision|0|||
48736563|NCT00306189|156885757|FG001|Overall Study|Physician Decision|0|||
48736564|NCT00306189|156885758|FG002|Overall Study|Physician Decision|0|||
48736565|NCT00306189|156885759|FG003|Overall Study|Physician Decision|1|||
48736566|NCT00306189|156885756|FG000|Overall Study|Adverse Event|3|||
48736567|NCT00306189|156885757|FG001|Overall Study|Adverse Event|3|||
48577832|NCT01970475|156305754|FG001|Overall Study|Withdrawal by Subject|6|||
48577833|NCT01970475|156305753|FG000|Overall Study|Adverse Event|7|||
48577834|NCT01970475|156305754|FG001|Overall Study|Adverse Event|3|||
48577835|NCT01970475|156305753|FG000|Overall Study|Lost to Follow-up|2|||
48577836|NCT01970475|156305754|FG001|Overall Study|Lost to Follow-up|2|||
48577837|NCT01970475|156305753|FG000|Overall Study|Protocol Violation|1|||
48577838|NCT01970475|156305754|FG001|Overall Study|Protocol Violation|0|||
48577839|NCT00073983|156305755|FG000|Overall Study|not evaluable|1|||
48577840|NCT04756154|156305756|FG000|Overall Study|Did not meet treatment day baseline|30|||
48577841|NCT04756154|156305757|FG001|Overall Study|Did not meet treatment day baseline|28|||
48577842|NCT04756154|156305758|FG002|Overall Study|Did not meet treatment day baseline|7|||
48577843|NCT04756154|156305756|FG000|Overall Study|Did not return for final sample collection|1|||
48577844|NCT04756154|156305757|FG001|Overall Study|Did not return for final sample collection|1|||
48577845|NCT04756154|156305758|FG002|Overall Study|Did not return for final sample collection|0|||
48577846|NCT03057054|156305759|FG000|Overall Study|Death|4|||
48577847|NCT03057054|156305760|FG001|Overall Study|Death|4|||
48577848|NCT03057054|156305759|FG000|Overall Study|Withdrawal by Subject|6|||
48577849|NCT03057054|156305760|FG001|Overall Study|Withdrawal by Subject|3|||
48577850|NCT03057054|156305759|FG000|Overall Study|Ineligible|1|||
48577851|NCT03057054|156305760|FG001|Overall Study|Ineligible|1|||
48577852|NCT03854370|156307140|FG000|Overall Study|samples not collected|1|||
48577853|NCT03854370|156307141|FG001|Overall Study|samples not collected|1|||
48577854|NCT03854370|156307142|FG002|Overall Study|samples not collected|1|||
48577855|NCT03854370|156307143|FG003|Overall Study|samples not collected|1|||
48577856|NCT00076752|156307146|FG000|Overall Study|Death|2|||
48577857|NCT00076752|156307146|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
48577858|NCT00452673|156307148|FG000|Dose Escalation Period|Disease Progression|6|||
48577859|NCT00452673|156307149|FG001|Dose Escalation Period|Disease Progression|6|||
48577860|NCT00452673|156307150|FG002|Dose Escalation Period|Disease Progression|2|||
48577861|NCT00452673|156307151|FG003|Dose Escalation Period|Disease Progression|6|||
48577862|NCT00452673|156307152|FG004|Dose Escalation Period|Disease Progression|0|||
48577863|NCT00452673|156307148|FG000|Dose Escalation Period|study drug toxicity|1|||
48577864|NCT00452673|156307149|FG001|Dose Escalation Period|study drug toxicity|3|||
48577865|NCT00452673|156307150|FG002|Dose Escalation Period|study drug toxicity|3|||
48577866|NCT00452673|156307151|FG003|Dose Escalation Period|study drug toxicity|1|||
48577867|NCT00452673|156307152|FG004|Dose Escalation Period|study drug toxicity|0|||
48577868|NCT00452673|156307148|FG000|Dose Escalation Period|Other|0|||
48577869|NCT00452673|156307149|FG001|Dose Escalation Period|Other|0|||
48577870|NCT00452673|156307150|FG002|Dose Escalation Period|Other|1|||
48577871|NCT00452673|156307151|FG003|Dose Escalation Period|Other|0|||
48736568|NCT00306189|156885758|FG002|Overall Study|Adverse Event|2|||
48736569|NCT00306189|156885759|FG003|Overall Study|Adverse Event|2|||
48736570|NCT00306189|156885756|FG000|Overall Study|Withdrawal by Subject|4|||
48736571|NCT00306189|156885757|FG001|Overall Study|Withdrawal by Subject|2|||
48736572|NCT00306189|156885758|FG002|Overall Study|Withdrawal by Subject|8|||
48577872|NCT00452673|156307152|FG004|Dose Escalation Period|Other|0|||
48577873|NCT00452673|156307148|FG000|Dose Escalation Period|Adverse Event|0|||
48577874|NCT00452673|156307149|FG001|Dose Escalation Period|Adverse Event|0|||
48577875|NCT00452673|156307150|FG002|Dose Escalation Period|Adverse Event|0|||
48577876|NCT00452673|156307151|FG003|Dose Escalation Period|Adverse Event|1|||
48577877|NCT00452673|156307152|FG004|Dose Escalation Period|Adverse Event|0|||
48577878|NCT00452673|156307148|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
48577879|NCT00452673|156307149|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
48736573|NCT00306189|156885759|FG003|Overall Study|Withdrawal by Subject|1|||
48736574|NCT00306189|156885756|FG000|Overall Study|Ineligibility determined|1|||
48736575|NCT00306189|156885757|FG001|Overall Study|Ineligibility determined|1|||
48736576|NCT00306189|156885758|FG002|Overall Study|Ineligibility determined|1|||
48577880|NCT00452673|156307150|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
48577881|NCT00452673|156307151|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
48577882|NCT00452673|156307152|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
48577883|NCT00452673|156307148|FG000|Dose Expansion Period|Disease Progression|0|||
48577884|NCT00452673|156307149|FG001|Dose Expansion Period|Disease Progression|0|||
48577885|NCT00452673|156307150|FG002|Dose Expansion Period|Disease Progression|0|||
48577886|NCT00452673|156307151|FG003|Dose Expansion Period|Disease Progression|0|||
48577887|NCT00452673|156307152|FG004|Dose Expansion Period|Disease Progression|19|||
48577888|NCT00452673|156307148|FG000|Dose Expansion Period|Other|0|||
48577889|NCT00452673|156307149|FG001|Dose Expansion Period|Other|0|||
48577890|NCT00452673|156307150|FG002|Dose Expansion Period|Other|0|||
48577891|NCT00452673|156307151|FG003|Dose Expansion Period|Other|0|||
48577892|NCT00452673|156307152|FG004|Dose Expansion Period|Other|2|||
48577893|NCT03030989|156307157|FG000|Overall Study|Fever|2|||
48577894|NCT03030989|156307158|FG001|Overall Study|Fever|2|||
48577895|NCT03030989|156307157|FG000|Overall Study|Rash|2|||
48577896|NCT03030989|156307158|FG001|Overall Study|Rash|1|||
48577897|NCT03030989|156307157|FG000|Overall Study|Fatigue/Overwhelmed|1|||
48577898|NCT03030989|156307158|FG001|Overall Study|Fatigue/Overwhelmed|5|||
48577899|NCT03030989|156307157|FG000|Overall Study|Positive Blood Cultures|2|||
48577900|NCT03030989|156307158|FG001|Overall Study|Positive Blood Cultures|1|||
48319754|NCT00703820|155371094|FG001|Overall Study|Physician Decision|5|||
48319755|NCT00703820|155371093|FG000|Overall Study|Withdrawal by Subject|2|||
48319756|NCT00703820|155371094|FG001|Overall Study|Withdrawal by Subject|1|||
48319757|NCT00818246|155371095|FG000|Overall Study|Impossible to match pictures|5|||
48319758|NCT02267824|155371096|FG000|Overall Study|Pregnancy|1|||
48319759|NCT02267824|155371097|FG001|Overall Study|Pregnancy|1|||
48319760|NCT02267824|155371096|FG000|Overall Study|Lost to Follow-up|4|||
48319761|NCT02267824|155371097|FG001|Overall Study|Lost to Follow-up|0|||
48319762|NCT02267824|155371096|FG000|Overall Study|Protocol Violation|3|||
48319763|NCT02267824|155371097|FG001|Overall Study|Protocol Violation|0|||
48319764|NCT02267824|155371096|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
48319765|NCT02267824|155371097|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
48319766|NCT01007396|155371098|FG000|Overall Study|Lost to Follow-up|47|||
48319767|NCT03283371|155371102|FG000|Placebo-controlled|Adverse Event|1|||
48319768|NCT03283371|155371103|FG001|Placebo-controlled|Adverse Event|1|||
48319769|NCT03283371|155371104|FG002|Placebo-controlled|Adverse Event|0|||
48577901|NCT03030989|156307157|FG000|Overall Study|Line Removed|0|||
48577902|NCT03030989|156307158|FG001|Overall Study|Line Removed|2|||
48577903|NCT03030989|156307157|FG000|Overall Study|No longer interested|5|||
48577904|NCT03030989|156307158|FG001|Overall Study|No longer interested|3|||
48577905|NCT01346189|156307160|FG000|Overall Study|Withdrawal by Subject|7|||
48577906|NCT01346189|156307161|FG001|Overall Study|Withdrawal by Subject|5|||
48577907|NCT01346189|156307162|FG002|Overall Study|Withdrawal by Subject|3|||
48577908|NCT01346189|156307163|FG003|Overall Study|Withdrawal by Subject|5|||
48577909|NCT01346189|156307160|FG000|Overall Study|Physician Decision|4|||
48577910|NCT01346189|156307161|FG001|Overall Study|Physician Decision|0|||
48319770|NCT03283371|155371105|FG003|Placebo-controlled|Adverse Event|0|||
48319771|NCT03283371|155371102|FG000|Placebo-controlled|Lack of Efficacy|1|||
48319772|NCT03283371|155371103|FG001|Placebo-controlled|Lack of Efficacy|0|||
48319773|NCT03283371|155371104|FG002|Placebo-controlled|Lack of Efficacy|0|||
48319774|NCT03283371|155371105|FG003|Placebo-controlled|Lack of Efficacy|0|||
48319775|NCT03283371|155371102|FG000|Placebo-controlled|Withdrawal by Subject|1|||
48319776|NCT03283371|155371103|FG001|Placebo-controlled|Withdrawal by Subject|1|||
48319777|NCT03283371|155371104|FG002|Placebo-controlled|Withdrawal by Subject|0|||
48319778|NCT03283371|155371105|FG003|Placebo-controlled|Withdrawal by Subject|0|||
48319779|NCT03283371|155371102|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
48319780|NCT03283371|155371103|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
48319781|NCT03283371|155371104|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
48319782|NCT03283371|155371105|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
48319783|NCT03283371|155371102|FG000|Open-label Phase|Adverse Event|0|||
48319784|NCT03283371|155371103|FG001|Open-label Phase|Adverse Event|0|||
48577911|NCT01346189|156307162|FG002|Overall Study|Physician Decision|0|||
48577912|NCT01346189|156307163|FG003|Overall Study|Physician Decision|0|||
48577913|NCT01346189|156307160|FG000|Overall Study|Moved|3|||
48577914|NCT01346189|156307161|FG001|Overall Study|Moved|0|||
48577915|NCT01346189|156307162|FG002|Overall Study|Moved|4|||
48577916|NCT01346189|156307163|FG003|Overall Study|Moved|0|||
48577917|NCT01346189|156307160|FG000|Overall Study|Other|2|||
48319785|NCT03283371|155371104|FG002|Open-label Phase|Adverse Event|2|||
48319786|NCT03283371|155371105|FG003|Open-label Phase|Adverse Event|0|||
48319787|NCT03283371|155371102|FG000|Open-label Phase|Withdrawal by Subject|0|||
48319788|NCT03283371|155371103|FG001|Open-label Phase|Withdrawal by Subject|0|||
48319789|NCT03283371|155371104|FG002|Open-label Phase|Withdrawal by Subject|1|||
48319790|NCT03283371|155371105|FG003|Open-label Phase|Withdrawal by Subject|0|||
48319791|NCT03283371|155371102|FG000|Open-label Phase|Other|0|||
48319792|NCT03283371|155371103|FG001|Open-label Phase|Other|0|||
48319793|NCT03283371|155371104|FG002|Open-label Phase|Other|1|||
48577918|NCT01346189|156307161|FG001|Overall Study|Other|4|||
48577919|NCT01346189|156307162|FG002|Overall Study|Other|7|||
48577920|NCT01346189|156307163|FG003|Overall Study|Other|3|||
48577921|NCT01346189|156307160|FG000|Overall Study|Death|0|||
48577922|NCT01346189|156307161|FG001|Overall Study|Death|3|||
48577923|NCT01346189|156307162|FG002|Overall Study|Death|0|||
48577924|NCT01346189|156307163|FG003|Overall Study|Death|0|||
48577925|NCT01346189|156307160|FG000|Overall Study|Non-health system primary care physician|0|||
48577926|NCT01346189|156307161|FG001|Overall Study|Non-health system primary care physician|5|||
48577927|NCT01346189|156307162|FG002|Overall Study|Non-health system primary care physician|0|||
48577928|NCT01346189|156307163|FG003|Overall Study|Non-health system primary care physician|0|||
48577929|NCT01346189|156307160|FG000|Overall Study|Travel|0|||
48577930|NCT01346189|156307161|FG001|Overall Study|Travel|0|||
48577931|NCT01346189|156307162|FG002|Overall Study|Travel|0|||
48577932|NCT01346189|156307163|FG003|Overall Study|Travel|3|||
48577933|NCT01075646|156307171|FG000|Overall Study|Lost to Follow-up|4|||
48577934|NCT01075646|156307172|FG001|Overall Study|Lost to Follow-up|3|||
48577935|NCT01075646|156307173|FG002|Overall Study|Lost to Follow-up|1|||
48577936|NCT01075646|156307174|FG003|Overall Study|Lost to Follow-up|2|||
48577937|NCT01730534|156307179|FG000|Overall Study|Withdrawal by Subject|97|||
48577938|NCT01730534|156307180|FG001|Overall Study|Withdrawal by Subject|127|||
48577939|NCT01730534|156307179|FG000|Overall Study|Lost to Follow-up|12|||
48577940|NCT01730534|156307180|FG001|Overall Study|Lost to Follow-up|18|||
48577941|NCT00791661|156307188|FG000|7 Day Wash-out|Adverse Event|0|||
48577942|NCT00791661|156307189|FG001|7 Day Wash-out|Adverse Event|0|||
48577943|NCT00791661|156307190|FG002|7 Day Wash-out|Adverse Event|1|||
48577944|NCT00791661|156307188|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
48577945|NCT00791661|156307189|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
48577946|NCT00791661|156307190|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
48577947|NCT02004886|156307191|FG000|Overall Study|Adverse Event|0|||
48577948|NCT02004886|156307192|FG001|Overall Study|Adverse Event|1|||
48577949|NCT02004886|156307193|FG002|Overall Study|Adverse Event|0|||
48577950|NCT02004886|156307194|FG003|Overall Study|Adverse Event|0|||
48577951|NCT02004886|156307191|FG000|Overall Study|Unable to attend future visits|1|||
48577952|NCT02004886|156307192|FG001|Overall Study|Unable to attend future visits|0|||
48577953|NCT02004886|156307193|FG002|Overall Study|Unable to attend future visits|0|||
48577954|NCT02004886|156307194|FG003|Overall Study|Unable to attend future visits|0|||
48577955|NCT03193801|156307197|FG000|Overall Study|Physician Decision|2|||
48577956|NCT03193801|156307197|FG000|Overall Study|Withdrawal by Subject|1|||
48577957|NCT04964544|156307200|FG000|Overall Study|Screen failure or other uncategorised|10|||
48577958|NCT04964544|156307200|FG000|Overall Study|Physician Decision|4|||
48577959|NCT04964544|156307200|FG000|Overall Study|Lost to Follow-up|9|||
48577960|NCT04964544|156307200|FG000|Overall Study|Withdrawal by Subject|18|||
48577961|NCT04964544|156307200|FG000|Overall Study|Death|1|||
48577962|NCT03467217|156307201|FG000|Overall Study|Trial stopped early|5|||
48577963|NCT03467217|156307202|FG001|Overall Study|Trial stopped early|2|||
48577964|NCT03467217|156307201|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
48577965|NCT03467217|156307202|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
48577966|NCT03467217|156307201|FG000|Overall Study|Lost to Follow-up|0|||
48577967|NCT03467217|156307202|FG001|Overall Study|Lost to Follow-up|2|||
48577968|NCT01613222|156307203|FG000|Overall Study|Physician Decision|1|||
48577969|NCT01613222|156307203|FG000|Overall Study|Unable to place arterial line|1|||
48577970|NCT01613222|156307203|FG000|Overall Study|Reused disposable sensors|10|||
48577971|NCT00712881|156307204|FG000|Overall Study|Adverse Event|3|||
48577972|NCT00712881|156307205|FG001|Overall Study|Adverse Event|3|||
48577973|NCT00712881|156307204|FG000|Overall Study|Withdrawal by Subject|1|||
48577974|NCT00712881|156307205|FG001|Overall Study|Withdrawal by Subject|1|||
48577975|NCT00712881|156307204|FG000|Overall Study|Disease Progression|2|||
48577976|NCT00712881|156307205|FG001|Overall Study|Disease Progression|1|||
48577977|NCT00712881|156307204|FG000|Overall Study|Lost to Follow-up|1|||
48577978|NCT00712881|156307205|FG001|Overall Study|Lost to Follow-up|1|||
48577979|NCT00712881|156307204|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
48577980|NCT00712881|156307205|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
48577981|NCT00712881|156307204|FG000|Overall Study|Protocol Violation|1|||
48577982|NCT00712881|156307205|FG001|Overall Study|Protocol Violation|1|||
48577983|NCT00712881|156307204|FG000|Overall Study|Randomized but not treated|1|||
48577984|NCT00712881|156307205|FG001|Overall Study|Randomized but not treated|0|||
48577985|NCT02659514|156307206|FG000|Overall Study|Adverse Event|3|||
48577986|NCT02659514|156307207|FG001|Overall Study|Adverse Event|12|||
48577987|NCT02659514|156307206|FG000|Overall Study|Disease Progression|23|||
48577988|NCT02659514|156307207|FG001|Overall Study|Disease Progression|13|||
48577989|NCT02659514|156307206|FG000|Overall Study|Withdrawal by Subject|0|||
48577990|NCT02659514|156307207|FG001|Overall Study|Withdrawal by Subject|4|||
48736577|NCT00306189|156885759|FG003|Overall Study|Ineligibility determined|1|||
48736578|NCT00306189|156885756|FG000|Overall Study|Other|1|||
48577991|NCT02659514|156307206|FG000|Overall Study|Lost to Follow-up|0|||
48577992|NCT02659514|156307207|FG001|Overall Study|Lost to Follow-up|1|||
48577993|NCT02659514|156307206|FG000|Overall Study|Death|6|||
48577994|NCT02659514|156307207|FG001|Overall Study|Death|1|||
48577995|NCT02659514|156307206|FG000|Overall Study|Reason Unspecified|0|||
48577996|NCT02659514|156307207|FG001|Overall Study|Reason Unspecified|3|||
48577997|NCT01895608|156307210|FG000|Overall Study|change in health status|0|||
48577998|NCT01895608|156307211|FG001|Overall Study|change in health status|1|||
48577999|NCT01895608|156307212|FG002|Overall Study|change in health status|1|||
48578000|NCT01895608|156307213|FG003|Overall Study|change in health status|0|||
48578001|NCT01895608|156307210|FG000|Overall Study|Withdrawal by Subject|0|||
48578002|NCT01895608|156307211|FG001|Overall Study|Withdrawal by Subject|0|||
48578003|NCT01895608|156307212|FG002|Overall Study|Withdrawal by Subject|2|||
48578004|NCT01895608|156307213|FG003|Overall Study|Withdrawal by Subject|0|||
48578005|NCT01283334|156307214|FG000|Overall Study|Withdrawal by Subject|1|||
48578006|NCT01283334|156307214|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
48578007|NCT01283334|156307214|FG000|Overall Study|Adverse Event|4|||
48578008|NCT01283334|156307214|FG000|Overall Study|Physician Decision|1|||
48578009|NCT02691936|156307221|FG000|Overall Study|Withdrawal by Subject|2|||
48578010|NCT02691936|156307222|FG001|Overall Study|Withdrawal by Subject|5|||
48578011|NCT03937908|156307223|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
48578012|NCT03937908|156307224|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
48578013|NCT01878084|156307225|FG000|Overall Study|Physician Decision|2|||
48578014|NCT04143594|156307228|FG000|Overall Study|Withdrew consent|3|||
48578015|NCT04143594|156307229|FG001|Overall Study|Withdrew consent|10|||
48578016|NCT04143594|156307230|FG002|Overall Study|Withdrew consent|3|||
48578017|NCT04143594|156307231|FG003|Overall Study|Withdrew consent|1|||
48578018|NCT04143594|156307228|FG000|Overall Study|Lost to Follow-up|3|||
48578019|NCT04143594|156307229|FG001|Overall Study|Lost to Follow-up|5|||
48578020|NCT04143594|156307230|FG002|Overall Study|Lost to Follow-up|11|||
48578021|NCT04143594|156307231|FG003|Overall Study|Lost to Follow-up|0|||
48578022|NCT04143594|156307228|FG000|Overall Study|Investigator's discretion|2|||
48578023|NCT04143594|156307229|FG001|Overall Study|Investigator's discretion|2|||
48578024|NCT04143594|156307230|FG002|Overall Study|Investigator's discretion|0|||
48578025|NCT04143594|156307231|FG003|Overall Study|Investigator's discretion|0|||
48578026|NCT04143594|156307228|FG000|Overall Study|Randomized but never treated|0|||
48578027|NCT04143594|156307229|FG001|Overall Study|Randomized but never treated|0|||
48578028|NCT04143594|156307230|FG002|Overall Study|Randomized but never treated|0|||
48578029|NCT04143594|156307231|FG003|Overall Study|Randomized but never treated|1|||
48578030|NCT04143594|156307228|FG000|Overall Study|Death|1|||
48578031|NCT04143594|156307229|FG001|Overall Study|Death|0|||
48578032|NCT04143594|156307230|FG002|Overall Study|Death|1|||
48578033|NCT04143594|156307231|FG003|Overall Study|Death|0|||
48578034|NCT04143594|156307228|FG000|Overall Study|Adverse Event|1|||
48736579|NCT00306189|156885757|FG001|Overall Study|Other|0|||
48736580|NCT00306189|156885758|FG002|Overall Study|Other|0|||
48736581|NCT00306189|156885759|FG003|Overall Study|Other|0|||
48736582|NCT00191269|156885762|FG000|Overall Study|Protocol Violation|0|||
48736583|NCT00191269|156885763|FG001|Overall Study|Protocol Violation|2|||
48736584|NCT00191269|156885762|FG000|Overall Study|Adverse Event|1|||
48736585|NCT00191269|156885763|FG001|Overall Study|Adverse Event|4|||
48578035|NCT04143594|156307229|FG001|Overall Study|Adverse Event|0|||
48578036|NCT04143594|156307230|FG002|Overall Study|Adverse Event|0|||
48578037|NCT04143594|156307231|FG003|Overall Study|Adverse Event|0|||
48578038|NCT04143594|156307228|FG000|Overall Study|Pregnancy|0|||
48578039|NCT04143594|156307229|FG001|Overall Study|Pregnancy|0|||
48578040|NCT04143594|156307230|FG002|Overall Study|Pregnancy|1|||
48578041|NCT04143594|156307231|FG003|Overall Study|Pregnancy|0|||
48736586|NCT00191269|156885762|FG000|Overall Study|Progression of Disease|4|||
48736587|NCT00191269|156885763|FG001|Overall Study|Progression of Disease|42|||
48736588|NCT00191269|156885762|FG000|Overall Study|Lack of Efficacy|1|||
48578042|NCT04143594|156307228|FG000|Overall Study|Lack of Efficacy|1|||
48578043|NCT04143594|156307229|FG001|Overall Study|Lack of Efficacy|1|||
48578044|NCT04143594|156307230|FG002|Overall Study|Lack of Efficacy|0|||
48578045|NCT04143594|156307231|FG003|Overall Study|Lack of Efficacy|0|||
48578046|NCT02855359|156307234|FG000|Overall Study|Death|2|||
48578047|NCT02855359|156307235|FG001|Overall Study|Death|2|||
48736589|NCT00191269|156885763|FG001|Overall Study|Lack of Efficacy|5|||
48578048|NCT02855359|156307236|FG002|Overall Study|Death|0|||
48578049|NCT02855359|156307237|FG003|Overall Study|Death|0|||
48578050|NCT02855359|156307234|FG000|Overall Study|Study Termination by Sponsor|9|||
48578051|NCT02855359|156307235|FG001|Overall Study|Study Termination by Sponsor|11|||
48578052|NCT02855359|156307236|FG002|Overall Study|Study Termination by Sponsor|0|||
48578053|NCT02855359|156307237|FG003|Overall Study|Study Termination by Sponsor|0|||
48578054|NCT01023256|156307238|FG000|Overall Study|Protocol Violation|2|||
48578055|NCT01023256|156307239|FG001|Overall Study|Protocol Violation|3|||
48578056|NCT01023256|156307240|FG002|Overall Study|Protocol Violation|0|||
48578057|NCT01023256|156307241|FG003|Overall Study|Protocol Violation|0|||
48578058|NCT01023256|156307238|FG000|Overall Study|Randomized but not treated|1|||
48578059|NCT01023256|156307239|FG001|Overall Study|Randomized but not treated|0|||
48578060|NCT01023256|156307240|FG002|Overall Study|Randomized but not treated|1|||
48578061|NCT01023256|156307241|FG003|Overall Study|Randomized but not treated|0|||
48578062|NCT01023256|156307238|FG000|Overall Study|Other|1|||
48578063|NCT01023256|156307239|FG001|Overall Study|Other|0|||
48578064|NCT01023256|156307240|FG002|Overall Study|Other|0|||
48578065|NCT01023256|156307241|FG003|Overall Study|Other|2|||
48578066|NCT01023256|156307238|FG000|Overall Study|Adverse Event|0|||
48578067|NCT01023256|156307239|FG001|Overall Study|Adverse Event|0|||
48578068|NCT01023256|156307240|FG002|Overall Study|Adverse Event|0|||
48578069|NCT01023256|156307241|FG003|Overall Study|Adverse Event|1|||
48578070|NCT01023256|156307238|FG000|Overall Study|Withdrawal by Subject|0|||
48736590|NCT00191269|156885762|FG000|Overall Study|Withdrawal by Subject|0|||
48736591|NCT00191269|156885763|FG001|Overall Study|Withdrawal by Subject|1|||
48736592|NCT00191269|156885762|FG000|Overall Study|Pathologic Aggrevation|0|||
48736593|NCT00191269|156885763|FG001|Overall Study|Pathologic Aggrevation|1|||
48736594|NCT00191269|156885762|FG000|Overall Study|Physician Decision|0|||
48736595|NCT00191269|156885763|FG001|Overall Study|Physician Decision|3|||
48736596|NCT01201785|156885764|FG000|Overall Study|Lost to Follow-up|16|||
48736597|NCT01696071|156885772|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
48736598|NCT01696071|156885773|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
48736599|NCT04223973|156885775|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
48736600|NCT04223973|156885776|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
48736601|NCT04223973|156885775|FG000|Overall Study|Adverse Event|4|||
48736602|NCT04223973|156885776|FG001|Overall Study|Adverse Event|0|||
48736603|NCT04223973|156885775|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
48736604|NCT04223973|156885776|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
48736605|NCT04223973|156885775|FG000|Overall Study|Physician Decision|1|||
48736606|NCT04223973|156885776|FG001|Overall Study|Physician Decision|1|||
48736607|NCT04223973|156885775|FG000|Overall Study|Withdrawal by Subject|0|||
48736608|NCT04223973|156885776|FG001|Overall Study|Withdrawal by Subject|1|||
48736609|NCT00293033|156885777|FG000|Open-label Titration Period|Adverse Event|10|||
48736610|NCT00293033|156885777|FG000|Open-label Titration Period|Death|3|||
48736611|NCT00293033|156885777|FG000|Open-label Titration Period|Lack of Efficacy|5|||
48578071|NCT01023256|156307239|FG001|Overall Study|Withdrawal by Subject|0|||
48578072|NCT01023256|156307240|FG002|Overall Study|Withdrawal by Subject|0|||
48578073|NCT01023256|156307241|FG003|Overall Study|Withdrawal by Subject|2|||
48578074|NCT03089697|156307242|FG000|Overall Study|Adverse Event|1|||
48578075|NCT03089697|156307243|FG001|Overall Study|Adverse Event|2|||
48578076|NCT03089697|156307242|FG000|Overall Study|Withdrawal by Subject|1|||
48578077|NCT03089697|156307243|FG001|Overall Study|Withdrawal by Subject|0|||
48578078|NCT01899742|156307244|FG000|Overall Study|Adverse Event|5|||
48578079|NCT01899742|156307245|FG001|Overall Study|Adverse Event|4|||
48578080|NCT01899742|156307244|FG000|Overall Study|Lack of Efficacy|1|||
48578081|NCT01899742|156307245|FG001|Overall Study|Lack of Efficacy|5|||
48578082|NCT01899742|156307244|FG000|Overall Study|Protocol Violation|2|||
48736612|NCT00293033|156885777|FG000|Open-label Titration Period|Protocol Violation|2|||
48736613|NCT00293033|156885777|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
48736614|NCT00293033|156885777|FG000|Open-label Titration Period|Noncompliance and other|27|||
48736615|NCT00293033|156885777|FG000|Double-blind Treatment Period|Adverse Event|3|||
48736616|NCT00293033|156885777|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
48319794|NCT03283371|155371105|FG003|Open-label Phase|Other|1|||
48319795|NCT01985334|155371106|FG000|Overall Study|Administrative problems|1|||
48319796|NCT01985334|155371107|FG001|Overall Study|Administrative problems|1|||
48319797|NCT01985334|155371108|FG002|Overall Study|Administrative problems|0|||
48319798|NCT01985334|155371109|FG003|Overall Study|Administrative problems|2|||
48319799|NCT01985334|155371110|FG004|Overall Study|Administrative problems|0|||
48319800|NCT01985334|155371111|FG005|Overall Study|Administrative problems|1|||
48319801|NCT01985334|155371112|FG006|Overall Study|Administrative problems|1|||
48578083|NCT01899742|156307245|FG001|Overall Study|Protocol Violation|2|||
48578084|NCT01899742|156307244|FG000|Overall Study|Withdrawal by Subject|9|||
48578085|NCT01899742|156307245|FG001|Overall Study|Withdrawal by Subject|5|||
48578086|NCT05087966|156307250|FG000|Overall Study|Lost to Follow-up|1|||
48578087|NCT05087966|156307250|FG000|Overall Study|Withdrawal by Subject|5|||
48578088|NCT00750139|156307251|FG000|Overall Study|Adverse Event|1|||
48578089|NCT00750139|156307252|FG001|Overall Study|Adverse Event|2|||
48578090|NCT00750139|156307253|FG002|Overall Study|Adverse Event|0|||
48578091|NCT00750139|156307254|FG003|Overall Study|Adverse Event|1|||
48578092|NCT00750139|156307251|FG000|Overall Study|Lost to Follow-up|17|||
48578093|NCT00750139|156307252|FG001|Overall Study|Lost to Follow-up|12|||
48578094|NCT00750139|156307253|FG002|Overall Study|Lost to Follow-up|15|||
48578095|NCT00750139|156307254|FG003|Overall Study|Lost to Follow-up|6|||
48578096|NCT00750139|156307251|FG000|Overall Study|Withdrawal by Subject|3|||
48578097|NCT00750139|156307252|FG001|Overall Study|Withdrawal by Subject|2|||
48578098|NCT00750139|156307253|FG002|Overall Study|Withdrawal by Subject|6|||
48578099|NCT00750139|156307254|FG003|Overall Study|Withdrawal by Subject|2|||
48578100|NCT00750139|156307251|FG000|Overall Study|Physician Decision|1|||
48578101|NCT00750139|156307252|FG001|Overall Study|Physician Decision|1|||
48578102|NCT00750139|156307253|FG002|Overall Study|Physician Decision|0|||
48578103|NCT00750139|156307254|FG003|Overall Study|Physician Decision|0|||
48578104|NCT00750139|156307251|FG000|Overall Study|Non-compliance|1|||
48578105|NCT00750139|156307252|FG001|Overall Study|Non-compliance|0|||
48578106|NCT00750139|156307253|FG002|Overall Study|Non-compliance|1|||
48578107|NCT00750139|156307254|FG003|Overall Study|Non-compliance|3|||
48578108|NCT00750139|156307251|FG000|Overall Study|Termination by sponsor|4|||
48578109|NCT00750139|156307252|FG001|Overall Study|Termination by sponsor|0|||
48578110|NCT00750139|156307253|FG002|Overall Study|Termination by sponsor|0|||
48578111|NCT00750139|156307254|FG003|Overall Study|Termination by sponsor|1|||
48578112|NCT00750139|156307251|FG000|Overall Study|Non-specific|62|||
48578113|NCT00750139|156307252|FG001|Overall Study|Non-specific|42|||
48578114|NCT00750139|156307253|FG002|Overall Study|Non-specific|79|||
48578115|NCT00750139|156307254|FG003|Overall Study|Non-specific|33|||
48578116|NCT01820572|156307255|FG000|Randomization|Not Treated|2|||
48578117|NCT01820572|156307256|FG001|Randomization|Not Treated|1|||
48578118|NCT01820572|156307255|FG000|Treatment Period|Adverse Event|12|||
48578119|NCT01820572|156307256|FG001|Treatment Period|Adverse Event|7|||
48578120|NCT01820572|156307255|FG000|Treatment Period|Death|3|||
48578121|NCT01820572|156307256|FG001|Treatment Period|Death|3|||
48578122|NCT01820572|156307255|FG000|Treatment Period|Lack of Efficacy|1|||
48578123|NCT01820572|156307256|FG001|Treatment Period|Lack of Efficacy|0|||
48578124|NCT01820572|156307255|FG000|Treatment Period|poor/non compliance|0|||
48578125|NCT01820572|156307256|FG001|Treatment Period|poor/non compliance|3|||
48578126|NCT01820572|156307255|FG000|Treatment Period|request to discontinue|6|||
48578127|NCT01820572|156307256|FG001|Treatment Period|request to discontinue|11|||
48736617|NCT00293033|156885777|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
48319802|NCT01985334|155371113|FG007|Overall Study|Administrative problems|3|||
48319803|NCT01985334|155371106|FG000|Overall Study|Death|1|||
48319804|NCT01985334|155371107|FG001|Overall Study|Death|0|||
48319805|NCT01985334|155371108|FG002|Overall Study|Death|0|||
48319806|NCT01985334|155371109|FG003|Overall Study|Death|3|||
48319807|NCT01985334|155371110|FG004|Overall Study|Death|0|||
48578128|NCT01820572|156307255|FG000|Treatment Period|No longer meets study criteria|3|||
48578129|NCT01820572|156307256|FG001|Treatment Period|No longer meets study criteria|10|||
48578130|NCT01820572|156307255|FG000|Treatment Period|withdrew consent|1|||
48578131|NCT01820572|156307256|FG001|Treatment Period|withdrew consent|2|||
48319808|NCT01985334|155371111|FG005|Overall Study|Death|0|||
48319809|NCT01985334|155371112|FG006|Overall Study|Death|1|||
48578132|NCT02253316|156307257|FG000|Consolidation|Progression|4|||
48578133|NCT02253316|156307258|FG001|Consolidation|Progression|0|||
48578134|NCT02253316|156307259|FG002|Consolidation|Progression|0|||
48578135|NCT02253316|156307257|FG000|Consolidation|Non-Compliance|1|||
48736618|NCT00293033|156885777|FG000|Double-blind Treatment Period|Noncompliance|4|||
48319810|NCT01985334|155371113|FG007|Overall Study|Death|2|||
48319811|NCT01985334|155371106|FG000|Overall Study|Worsening of disease|0|||
48319812|NCT01985334|155371107|FG001|Overall Study|Worsening of disease|0|||
48578136|NCT02253316|156307258|FG001|Consolidation|Non-Compliance|0|||
48578137|NCT02253316|156307259|FG002|Consolidation|Non-Compliance|0|||
48578138|NCT02253316|156307257|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
48578139|NCT02253316|156307258|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
48578140|NCT02253316|156307259|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
48319813|NCT01985334|155371108|FG002|Overall Study|Worsening of disease|0|||
48319814|NCT01985334|155371109|FG003|Overall Study|Worsening of disease|1|||
48319815|NCT01985334|155371110|FG004|Overall Study|Worsening of disease|0|||
48319816|NCT01985334|155371111|FG005|Overall Study|Worsening of disease|3|||
48319817|NCT01985334|155371112|FG006|Overall Study|Worsening of disease|0|||
48319818|NCT01985334|155371113|FG007|Overall Study|Worsening of disease|1|||
48319819|NCT01985334|155371106|FG000|Overall Study|Other|2|||
48319820|NCT01985334|155371107|FG001|Overall Study|Other|9|||
48578141|NCT02253316|156307257|FG000|Consolidation|Secondary Malignancy|2|||
48578142|NCT02253316|156307258|FG001|Consolidation|Secondary Malignancy|0|||
48578143|NCT02253316|156307259|FG002|Consolidation|Secondary Malignancy|0|||
48578144|NCT02253316|156307257|FG000|Consolidation|Adverse Event|7|||
48578145|NCT02253316|156307258|FG001|Consolidation|Adverse Event|0|||
48578146|NCT02253316|156307259|FG002|Consolidation|Adverse Event|0|||
48578147|NCT02253316|156307257|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
48578148|NCT02253316|156307258|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
48578149|NCT02253316|156307259|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
48578150|NCT02253316|156307257|FG000|Maintenance|Physician Decision|0|||
48578151|NCT02253316|156307258|FG001|Maintenance|Physician Decision|7|||
48578152|NCT02253316|156307259|FG002|Maintenance|Physician Decision|16|||
48578153|NCT02253316|156307257|FG000|Maintenance|Non-Compliance|0|||
48578154|NCT02253316|156307258|FG001|Maintenance|Non-Compliance|1|||
48578155|NCT02253316|156307259|FG002|Maintenance|Non-Compliance|1|||
48578156|NCT02253316|156307257|FG000|Maintenance|Secondary Malignancy|0|||
48736619|NCT03583697|156885778|FG000|Overall Study|Withdrawal by Subject|0|||
48736620|NCT03583697|156885779|FG001|Overall Study|Withdrawal by Subject|0|||
48736621|NCT03583697|156885780|FG002|Overall Study|Withdrawal by Subject|1|||
48736622|NCT03583697|156885778|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
48736623|NCT03583697|156885779|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
48736624|NCT03583697|156885780|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
48736625|NCT04444895|156887918|FG000|Overall Study|Adverse Event|2|||
48736626|NCT04444895|156887918|FG000|Overall Study|Lost to Follow-up|2|||
48736627|NCT04444895|156887918|FG000|Overall Study|Withdrawal by Subject|5|||
48736628|NCT01313858|156887921|FG000|Overall Study|Premature Treatment Termination|251|||
48736629|NCT01313858|156887922|FG001|Overall Study|Premature Treatment Termination|219|||
48736630|NCT01313858|156887923|FG002|Overall Study|Premature Treatment Termination|191|||
48736631|NCT01313858|156887921|FG000|Overall Study|Lost to Follow-up|35|||
48736632|NCT01313858|156887922|FG001|Overall Study|Lost to Follow-up|51|||
48736633|NCT01313858|156887923|FG002|Overall Study|Lost to Follow-up|47|||
48736634|NCT01890746|156887924|FG000|Overall Study|Death|39|||
48736635|NCT01890746|156887925|FG001|Overall Study|Death|30|||
48736636|NCT01890746|156887924|FG000|Overall Study|Adverse Event|1|||
48736637|NCT01890746|156887925|FG001|Overall Study|Adverse Event|0|||
48736638|NCT01890746|156887924|FG000|Overall Study|Lost to Follow-up|4|||
48736639|NCT01890746|156887925|FG001|Overall Study|Lost to Follow-up|1|||
48736640|NCT01890746|156887924|FG000|Overall Study|Physician Decision|3|||
48736641|NCT01890746|156887925|FG001|Overall Study|Physician Decision|2|||
48736642|NCT01890746|156887924|FG000|Overall Study|Withdrawal by Subject|5|||
48736643|NCT01890746|156887925|FG001|Overall Study|Withdrawal by Subject|8|||
48736644|NCT03917459|156887926|FG000|Overall Study|Adverse Event|1|||
48319821|NCT01985334|155371108|FG002|Overall Study|Other|7|||
48319822|NCT01985334|155371109|FG003|Overall Study|Other|17|||
48319823|NCT01985334|155371110|FG004|Overall Study|Other|4|||
48578157|NCT02253316|156307258|FG001|Maintenance|Secondary Malignancy|2|||
48578158|NCT02253316|156307259|FG002|Maintenance|Secondary Malignancy|6|||
48578159|NCT02253316|156307257|FG000|Maintenance|Adverse Event|0|||
48578160|NCT02253316|156307258|FG001|Maintenance|Adverse Event|8|||
48736645|NCT03917459|156887927|FG001|Overall Study|Adverse Event|0|||
48736646|NCT03917459|156887926|FG000|Overall Study|Withdrawal by Subject|0|||
48736647|NCT03917459|156887927|FG001|Overall Study|Withdrawal by Subject|1|||
48319824|NCT01985334|155371111|FG005|Overall Study|Other|8|||
48736648|NCT00491764|156887929|FG000|Overall Study|Adverse Event|1|||
48736649|NCT00491764|156887930|FG001|Overall Study|Adverse Event|2|||
48736650|NCT00491764|156887931|FG002|Overall Study|Adverse Event|4|||
48736651|NCT00491764|156887932|FG003|Overall Study|Adverse Event|4|||
48578161|NCT02253316|156307259|FG002|Maintenance|Adverse Event|12|||
48736652|NCT00491764|156887933|FG004|Overall Study|Adverse Event|0|||
48319825|NCT01985334|155371112|FG006|Overall Study|Other|4|||
48319826|NCT01985334|155371113|FG007|Overall Study|Other|7|||
48578162|NCT02253316|156307257|FG000|Maintenance|Still receiving active treatment|0|||
48736653|NCT00491764|156887934|FG005|Overall Study|Adverse Event|1|||
48736654|NCT00491764|156887929|FG000|Overall Study|Lost to Follow-up|0|||
48736655|NCT00491764|156887930|FG001|Overall Study|Lost to Follow-up|1|||
48736656|NCT00491764|156887931|FG002|Overall Study|Lost to Follow-up|0|||
48736657|NCT00491764|156887932|FG003|Overall Study|Lost to Follow-up|1|||
48736658|NCT00491764|156887933|FG004|Overall Study|Lost to Follow-up|0|||
48736659|NCT00491764|156887934|FG005|Overall Study|Lost to Follow-up|3|||
48736660|NCT00491764|156887929|FG000|Overall Study|Withdrawal by Subject|2|||
48578163|NCT02253316|156307258|FG001|Maintenance|Still receiving active treatment|5|||
48736661|NCT00491764|156887930|FG001|Overall Study|Withdrawal by Subject|3|||
48736662|NCT00491764|156887931|FG002|Overall Study|Withdrawal by Subject|1|||
48578164|NCT02253316|156307259|FG002|Maintenance|Still receiving active treatment|0|||
48578165|NCT02637895|156307265|FG000|Overall Study|Lost to Follow-up|4|||
48578166|NCT02637895|156307266|FG001|Overall Study|Lost to Follow-up|0|||
48578167|NCT02637895|156307265|FG000|Overall Study|Protocol Violation|0|||
48578168|NCT02637895|156307266|FG001|Overall Study|Protocol Violation|1|||
48578169|NCT02637895|156307265|FG000|Overall Study|Lack of Efficacy|1|||
48736663|NCT00491764|156887932|FG003|Overall Study|Withdrawal by Subject|2|||
48736664|NCT00491764|156887933|FG004|Overall Study|Withdrawal by Subject|2|||
48736665|NCT00491764|156887934|FG005|Overall Study|Withdrawal by Subject|4|||
48736666|NCT00491764|156887929|FG000|Overall Study|Non Compliance with the Protocol|1|||
48736667|NCT00491764|156887930|FG001|Overall Study|Non Compliance with the Protocol|0|||
48736668|NCT00491764|156887931|FG002|Overall Study|Non Compliance with the Protocol|0|||
48736669|NCT00491764|156887932|FG003|Overall Study|Non Compliance with the Protocol|0|||
48736670|NCT00491764|156887933|FG004|Overall Study|Non Compliance with the Protocol|0|||
48736671|NCT00491764|156887934|FG005|Overall Study|Non Compliance with the Protocol|0|||
48736672|NCT00491764|156887929|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
48736673|NCT00491764|156887930|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
48736674|NCT00491764|156887931|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
48736675|NCT00491764|156887932|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
48736676|NCT00491764|156887933|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
48736677|NCT00491764|156887934|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
48736678|NCT00491764|156887929|FG000|Overall Study|Administrative|1|||
48736679|NCT00491764|156887930|FG001|Overall Study|Administrative|0|||
48736680|NCT00491764|156887931|FG002|Overall Study|Administrative|2|||
48736681|NCT00491764|156887932|FG003|Overall Study|Administrative|1|||
48736682|NCT00491764|156887933|FG004|Overall Study|Administrative|0|||
48736683|NCT00491764|156887934|FG005|Overall Study|Administrative|0|||
48578170|NCT02637895|156307266|FG001|Overall Study|Lack of Efficacy|0|||
48578171|NCT02637895|156307265|FG000|Overall Study|Withdrawal by Subject|1|||
48736684|NCT01426438|156887935|FG000|Overall Study|Lost to Follow-up|1|||
48736685|NCT01426438|156887936|FG001|Overall Study|Lost to Follow-up|3|||
48736686|NCT01426438|156887935|FG000|Overall Study|Off study Treatment|9|||
48736687|NCT01426438|156887936|FG001|Overall Study|Off study Treatment|3|||
48736688|NCT01426438|156887935|FG000|Overall Study|Poor scan quality|3|||
48736689|NCT01426438|156887936|FG001|Overall Study|Poor scan quality|2|||
48736690|NCT01426438|156887935|FG000|Overall Study|Missed Scan|2|||
48578172|NCT02637895|156307266|FG001|Overall Study|Withdrawal by Subject|1|||
48578173|NCT02637895|156307265|FG000|Overall Study|Abnormal baseline lab|0|||
48578174|NCT02637895|156307266|FG001|Overall Study|Abnormal baseline lab|1|||
48578175|NCT02225366|156307272|FG000|Overall Study|Lack of Efficacy|1|||
48578176|NCT02225366|156307273|FG001|Overall Study|Lack of Efficacy|0|||
48578177|NCT04713592|156307274|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
48578178|NCT04713592|156307275|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
48578179|NCT04713592|156307276|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
48578180|NCT04713592|156307277|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
48578181|NCT04713592|156307274|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
48578182|NCT04713592|156307275|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
48578183|NCT04713592|156307276|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
48578184|NCT04713592|156307277|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
48578185|NCT04713592|156307274|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
48578186|NCT04713592|156307275|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
48578187|NCT04713592|156307276|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
48578188|NCT04713592|156307277|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
48319827|NCT01985334|155371106|FG000|Overall Study|Protocol deviation|6|||
48578189|NCT04713592|156307274|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48578190|NCT04713592|156307275|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
48319828|NCT01985334|155371107|FG001|Overall Study|Protocol deviation|31|||
48319829|NCT01985334|155371108|FG002|Overall Study|Protocol deviation|25|||
48319830|NCT01985334|155371109|FG003|Overall Study|Protocol deviation|84|||
48319831|NCT01985334|155371110|FG004|Overall Study|Protocol deviation|17|||
48319832|NCT01985334|155371111|FG005|Overall Study|Protocol deviation|47|||
48319833|NCT01985334|155371112|FG006|Overall Study|Protocol deviation|15|||
48578191|NCT04713592|156307276|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
48578192|NCT04713592|156307277|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
48578193|NCT04713592|156307274|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
48578194|NCT04713592|156307275|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
48578195|NCT04713592|156307276|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
48578196|NCT04713592|156307277|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
48578197|NCT04713592|156307274|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48578198|NCT04713592|156307275|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
48578199|NCT04713592|156307276|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
48578200|NCT04713592|156307277|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
48578201|NCT04713592|156307274|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
48578202|NCT04713592|156307275|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
48578203|NCT04713592|156307276|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
48578204|NCT04713592|156307277|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
48578205|NCT00688701|156308566|FG000|Overall Study|Adverse Event|1|||
48578206|NCT00688701|156308567|FG001|Overall Study|Adverse Event|0|||
48319834|NCT01985334|155371113|FG007|Overall Study|Protocol deviation|42|||
48319835|NCT01985334|155371106|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
48319836|NCT01985334|155371107|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
48319837|NCT01985334|155371108|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
48578207|NCT00688701|156308568|FG002|Overall Study|Adverse Event|5|||
48578208|NCT00688701|156308569|FG003|Overall Study|Adverse Event|3|||
48578209|NCT00688701|156308566|FG000|Overall Study|Lack of Efficacy|0|||
48319838|NCT01985334|155371109|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
48319839|NCT01985334|155371110|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
48319840|NCT01985334|155371111|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
48319841|NCT01985334|155371112|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
48319842|NCT01985334|155371113|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
48578210|NCT00688701|156308567|FG001|Overall Study|Lack of Efficacy|1|||
48578211|NCT00688701|156308568|FG002|Overall Study|Lack of Efficacy|0|||
48578212|NCT00688701|156308569|FG003|Overall Study|Lack of Efficacy|0|||
48578213|NCT00688701|156308566|FG000|Overall Study|Withdrawal by Subject|3|||
48578214|NCT00688701|156308567|FG001|Overall Study|Withdrawal by Subject|3|||
48578215|NCT00688701|156308568|FG002|Overall Study|Withdrawal by Subject|4|||
48578216|NCT00688701|156308569|FG003|Overall Study|Withdrawal by Subject|8|||
48578217|NCT00688701|156308566|FG000|Overall Study|Poor compliance to protocol|0|||
48578218|NCT00688701|156308567|FG001|Overall Study|Poor compliance to protocol|1|||
48578219|NCT00688701|156308568|FG002|Overall Study|Poor compliance to protocol|1|||
48578220|NCT00688701|156308569|FG003|Overall Study|Poor compliance to protocol|0|||
48578221|NCT00769067|156308570|FG000|Overall Study|Death|89|||
48578222|NCT00769067|156308571|FG001|Overall Study|Death|86|||
48578223|NCT00769067|156308570|FG000|Overall Study|Lost to Follow-up|3|||
48578224|NCT00769067|156308571|FG001|Overall Study|Lost to Follow-up|1|||
48578225|NCT00769067|156308570|FG000|Overall Study|Study terminated by sponsor|1|||
48578226|NCT00769067|156308571|FG001|Overall Study|Study terminated by sponsor|3|||
48578227|NCT00769067|156308570|FG000|Overall Study|Other|1|||
48578228|NCT00769067|156308571|FG001|Overall Study|Other|3|||
48578229|NCT00769067|156308570|FG000|Overall Study|Withdrawal by Subject|0|||
48578230|NCT00769067|156308571|FG001|Overall Study|Withdrawal by Subject|1|||
48578231|NCT05413369|156308574|FG000|Overall Study|Adverse Event|1|||
48578232|NCT05413369|156308575|FG001|Overall Study|Adverse Event|1|||
48578233|NCT05413369|156308574|FG000|Overall Study|Withdrawal by Subject|13|||
48578234|NCT05413369|156308575|FG001|Overall Study|Withdrawal by Subject|4|||
48578235|NCT05413369|156308574|FG000|Overall Study|Non-compliance with study schedule|2|||
48578236|NCT05413369|156308575|FG001|Overall Study|Non-compliance with study schedule|1|||
48578237|NCT05413369|156308574|FG000|Overall Study|Other|1|||
48578238|NCT05413369|156308575|FG001|Overall Study|Other|1|||
48578239|NCT05500274|156308576|FG000|Overall Study|Not able to complete the session and follow-up visits.|2|||
48578240|NCT05500274|156308577|FG001|Overall Study|Not able to complete the session and follow-up visits.|0|||
48578241|NCT05500274|156308576|FG000|Overall Study|Lost to Follow-up|86|||
48578242|NCT05500274|156308577|FG001|Overall Study|Lost to Follow-up|93|||
48578243|NCT02836236|156308585|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
48578244|NCT02836236|156308586|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
48578245|NCT02836236|156308587|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
48578246|NCT02836236|156308588|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
48578247|NCT02836236|156308585|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
48578248|NCT02836236|156308586|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
48578249|NCT02836236|156308587|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
48578250|NCT02836236|156308588|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
48578251|NCT02836236|156308585|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48578252|NCT02836236|156308586|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
48578253|NCT02836236|156308587|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
48578254|NCT02836236|156308588|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
48578255|NCT02836236|156308585|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
48578256|NCT02836236|156308586|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
48578257|NCT02836236|156308587|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
48578258|NCT02836236|156308588|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
48578259|NCT02836236|156308585|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
48736691|NCT01426438|156887936|FG001|Overall Study|Missed Scan|2|||
48736692|NCT00412542|156887937|FG000|Overall Study|Withdrawal by Subject|0|||
48736693|NCT00412542|156887938|FG001|Overall Study|Withdrawal by Subject|2|||
48736694|NCT00412542|156887937|FG000|Overall Study|Not Eligible|0|||
48736695|NCT00412542|156887938|FG001|Overall Study|Not Eligible|1|||
48736696|NCT01393301|156887941|FG000|Overall Study|Lost to Follow-up|5|||
48578260|NCT02836236|156308586|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
48578261|NCT02836236|156308587|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
48578262|NCT02836236|156308588|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
48578263|NCT02836236|156308585|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
48578264|NCT02836236|156308586|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
48578265|NCT02836236|156308587|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
48578266|NCT02836236|156308588|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
48578267|NCT02836236|156308585|FG000|Open-Label TAF Treatment Phase|Death|0|||
48578268|NCT02836236|156308586|FG001|Open-Label TAF Treatment Phase|Death|0|||
48578269|NCT02836236|156308587|FG002|Open-Label TAF Treatment Phase|Death|1|||
48736697|NCT01393301|156887942|FG001|Overall Study|Lost to Follow-up|3|||
48578270|NCT02836236|156308588|FG003|Open-Label TAF Treatment Phase|Death|1|||
48578271|NCT02836236|156308585|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
48736698|NCT01393301|156887941|FG000|Overall Study|Withdrawal by Subject|2|||
48736699|NCT01393301|156887942|FG001|Overall Study|Withdrawal by Subject|0|||
48736700|NCT01393301|156887941|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
48736701|NCT01393301|156887942|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
48736702|NCT00464269|156887947|FG000|Overall Study|Lack of Efficacy|1|||
48736703|NCT00464269|156887948|FG001|Overall Study|Lack of Efficacy|0|||
48736704|NCT00464269|156887949|FG002|Overall Study|Lack of Efficacy|0|||
48736705|NCT00464269|156887950|FG003|Overall Study|Lack of Efficacy|0|||
48736706|NCT00464269|156887947|FG000|Overall Study|Lost to Follow-up|0|||
48736707|NCT00464269|156887948|FG001|Overall Study|Lost to Follow-up|4|||
48736708|NCT00464269|156887949|FG002|Overall Study|Lost to Follow-up|0|||
48736709|NCT00464269|156887950|FG003|Overall Study|Lost to Follow-up|1|||
48736710|NCT00464269|156887947|FG000|Overall Study|Withdrawal by Subject|0|||
48736711|NCT00464269|156887948|FG001|Overall Study|Withdrawal by Subject|2|||
48736712|NCT00464269|156887949|FG002|Overall Study|Withdrawal by Subject|1|||
48736713|NCT00464269|156887950|FG003|Overall Study|Withdrawal by Subject|1|||
48736714|NCT00464269|156887947|FG000|Overall Study|Other reason|3|||
48736715|NCT00464269|156887948|FG001|Overall Study|Other reason|3|||
48736716|NCT00464269|156887949|FG002|Overall Study|Other reason|1|||
48736717|NCT00464269|156887950|FG003|Overall Study|Other reason|1|||
48736718|NCT00464269|156887947|FG000|Overall Study|AE, serious fatal|0|||
48736719|NCT00464269|156887948|FG001|Overall Study|AE, serious fatal|0|||
48736720|NCT00464269|156887949|FG002|Overall Study|AE, serious fatal|1|||
48736721|NCT00464269|156887950|FG003|Overall Study|AE, serious fatal|1|||
48736722|NCT00464269|156887947|FG000|Overall Study|SAE, non-fatal|0|||
48736723|NCT00464269|156887948|FG001|Overall Study|SAE, non-fatal|0|||
48736724|NCT00464269|156887949|FG002|Overall Study|SAE, non-fatal|0|||
48736725|NCT00464269|156887950|FG003|Overall Study|SAE, non-fatal|1|||
48736726|NCT00464269|156887947|FG000|Overall Study|AE, non-serious non-fatal|2|||
48736727|NCT00464269|156887948|FG001|Overall Study|AE, non-serious non-fatal|8|||
48736728|NCT00464269|156887949|FG002|Overall Study|AE, non-serious non-fatal|3|||
48736729|NCT00464269|156887950|FG003|Overall Study|AE, non-serious non-fatal|4|||
48736730|NCT00464269|156887947|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48578272|NCT02836236|156308586|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
48578273|NCT02836236|156308587|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
48578274|NCT02836236|156308588|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
48578275|NCT01806961|156308591|FG000|Overall Study|sponsor decision|16|||
48736731|NCT00464269|156887948|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48736732|NCT00464269|156887949|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
48736733|NCT00464269|156887950|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48578276|NCT02656290|156308597|FG000|Overall Study|Lost to Follow-up|1|||
48578277|NCT02656290|156308597|FG000|Overall Study|Reintervention|3|||
48578278|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
48578279|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
48578280|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
48578281|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
48578282|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
48736734|NCT02913612|156887953|FG000|Overall Study|Lost to Follow-up|6|||
48736735|NCT02913612|156887954|FG001|Overall Study|Lost to Follow-up|5|||
48736736|NCT02913612|156887955|FG002|Overall Study|Lost to Follow-up|2|||
48736737|NCT02913612|156887956|FG003|Overall Study|Lost to Follow-up|0|||
48736738|NCT02913612|156887953|FG000|Overall Study|Physician Decision|1|||
48736739|NCT02913612|156887954|FG001|Overall Study|Physician Decision|4|||
48736740|NCT02913612|156887955|FG002|Overall Study|Physician Decision|1|||
48736741|NCT02913612|156887956|FG003|Overall Study|Physician Decision|0|||
48736742|NCT02913612|156887953|FG000|Overall Study|Withdrawal by Subject|2|||
48736743|NCT02913612|156887954|FG001|Overall Study|Withdrawal by Subject|4|||
48736744|NCT02913612|156887955|FG002|Overall Study|Withdrawal by Subject|0|||
48736745|NCT02913612|156887956|FG003|Overall Study|Withdrawal by Subject|0|||
48578283|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
48578284|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
48578285|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
48578286|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Death|0|||
48578287|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Death|1|||
48578288|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
48578289|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
48578290|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
48578291|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
48578292|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
48736746|NCT02913612|156887953|FG000|Overall Study|Hemangioma resolved|1|||
48736747|NCT02913612|156887954|FG001|Overall Study|Hemangioma resolved|0|||
48736748|NCT02913612|156887955|FG002|Overall Study|Hemangioma resolved|0|||
48736749|NCT02913612|156887956|FG003|Overall Study|Hemangioma resolved|0|||
48736750|NCT02913612|156887953|FG000|Overall Study|Local IRB decision|1|||
48736751|NCT02913612|156887954|FG001|Overall Study|Local IRB decision|0|||
48736752|NCT02913612|156887955|FG002|Overall Study|Local IRB decision|0|||
48736753|NCT02913612|156887956|FG003|Overall Study|Local IRB decision|0|||
48736754|NCT02913612|156887953|FG000|Overall Study|Study drug non-compliance|1|||
48736755|NCT02913612|156887954|FG001|Overall Study|Study drug non-compliance|1|||
48736756|NCT02913612|156887955|FG002|Overall Study|Study drug non-compliance|0|||
48450301|NCT03365947|155835680|FG010|Overall Study|Lost to Follow-up|0|||
48587290|NCT03003000|156343170|FG001|Overall Study|Adverse Event|2|||
48736757|NCT02913612|156887956|FG003|Overall Study|Study drug non-compliance|0|||
48319843|NCT01985334|155371106|FG000|Overall Study|Subject withdrawal of consent|3|||
48319844|NCT01985334|155371107|FG001|Overall Study|Subject withdrawal of consent|6|||
48736758|NCT02913612|156887953|FG000|Overall Study|Insurance issues|0|||
48736759|NCT02913612|156887954|FG001|Overall Study|Insurance issues|1|||
48736760|NCT02913612|156887955|FG002|Overall Study|Insurance issues|0|||
48736761|NCT02913612|156887956|FG003|Overall Study|Insurance issues|0|||
48736762|NCT02913612|156887953|FG000|Overall Study|Needed to treat second hemangioma|0|||
48319845|NCT01985334|155371108|FG002|Overall Study|Subject withdrawal of consent|2|||
48736763|NCT02913612|156887954|FG001|Overall Study|Needed to treat second hemangioma|1|||
48736764|NCT02913612|156887955|FG002|Overall Study|Needed to treat second hemangioma|0|||
48736765|NCT02913612|156887956|FG003|Overall Study|Needed to treat second hemangioma|0|||
48319846|NCT01985334|155371109|FG003|Overall Study|Subject withdrawal of consent|28|||
48319847|NCT01985334|155371110|FG004|Overall Study|Subject withdrawal of consent|4|||
48319848|NCT01985334|155371111|FG005|Overall Study|Subject withdrawal of consent|19|||
48578293|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
48736766|NCT02913612|156887953|FG000|Overall Study|Study completion criteria not met|0|||
48578294|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
48578295|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
48578296|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
48578297|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
48578298|NCT00394836|156308600|FG000|Teatment or Follow-up Phase|Non compliance|0|||
48578299|NCT00394836|156308601|FG001|Teatment or Follow-up Phase|Non compliance|1|||
48578300|NCT00394836|156308600|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
48578301|NCT00394836|156308601|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
48578302|NCT00394836|156308600|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
48578303|NCT00394836|156308601|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
48578304|NCT00394836|156308600|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
48578305|NCT00394836|156308601|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
48578306|NCT00394836|156308600|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
48578307|NCT00394836|156308601|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
48578308|NCT01608087|156308602|FG000|Overall Study|Lost to Follow-up|0|||
48578309|NCT01608087|156308603|FG001|Overall Study|Lost to Follow-up|1|||
48578310|NCT01608087|156308604|FG002|Overall Study|Lost to Follow-up|0|||
48578311|NCT01608087|156308602|FG000|Overall Study|Other Reason|0|||
48578312|NCT01608087|156308603|FG001|Overall Study|Other Reason|1|||
48578313|NCT01608087|156308604|FG002|Overall Study|Other Reason|0|||
48578314|NCT04725812|156308605|FG000|Overall Study|Withdrawal by Subject|1|||
48578315|NCT00749684|156308612|FG000|Overall Study|Death|1|||
48736767|NCT02913612|156887954|FG001|Overall Study|Study completion criteria not met|1|||
48578316|NCT00749684|156308612|FG000|Overall Study|Adverse Event|27|||
48578317|NCT00749684|156308612|FG000|Overall Study|Participant's Wish|10|||
48578318|NCT00749684|156308612|FG000|Overall Study|Not Documented|1|||
48736768|NCT02913612|156887955|FG002|Overall Study|Study completion criteria not met|0|||
48578319|NCT00749684|156308612|FG000|Overall Study|Progressive Desease|31|||
48578320|NCT00749684|156308612|FG000|Overall Study|Therapy according to protocol + AE|2|||
48578321|NCT00749684|156308612|FG000|Overall Study|AE+discontinuation on participants wish|1|||
48736769|NCT02913612|156887956|FG003|Overall Study|Study completion criteria not met|0|||
48736770|NCT02913612|156887953|FG000|Overall Study|Ineligible|0|||
48578322|NCT00749684|156308612|FG000|Overall Study|Missing|9|||
48578323|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
48578324|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
48578325|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
48578326|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
48578327|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
48578328|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
48578329|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
48578330|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
48578331|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
48578332|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
48578333|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Death|1|||
48578334|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Death|0|||
48578335|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
48578336|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
48578337|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
48578338|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
48578339|NCT01876784|156308613|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
48578340|NCT01876784|156308614|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
48578341|NCT01876784|156308613|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
48578342|NCT01876784|156308614|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
48578343|NCT01876784|156308613|FG000|Open-label Period (31 Months)|Adverse Event|2|||
48578344|NCT01876784|156308614|FG001|Open-label Period (31 Months)|Adverse Event|6|||
48736771|NCT02913612|156887954|FG001|Overall Study|Ineligible|1|||
48736772|NCT02913612|156887955|FG002|Overall Study|Ineligible|0|||
48736773|NCT02913612|156887956|FG003|Overall Study|Ineligible|0|||
48736774|NCT03082261|156887959|FG000|Overall Study|Death|4|||
48736775|NCT03082261|156887959|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
48736776|NCT03082261|156887959|FG000|Overall Study|Insurance denial|1|||
48736777|NCT03082261|156887959|FG000|Overall Study|Peripheral lead added|1|||
48736778|NCT03082261|156887959|FG000|Overall Study|Withdrawal by Subject|40|||
48736779|NCT03082261|156887959|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
48736780|NCT03082261|156887959|FG000|Overall Study|Subject implanted with device other than study device|1|||
48736781|NCT03082261|156887959|FG000|Overall Study|Lost to Follow-up|14|||
48736782|NCT03082261|156887959|FG000|Overall Study|Subject moved to a different state|1|||
48736783|NCT03082261|156887959|FG000|Overall Study|Subject non-compliance|2|||
48736784|NCT03082261|156887959|FG000|Overall Study|Subject participation terminated by investigator|9|||
48736785|NCT03082261|156887959|FG000|Overall Study|Subject participation terminated by sponsor|4|||
48736786|NCT03082261|156887959|FG000|Overall Study|System explant|19|||
48578345|NCT01876784|156308613|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
48578346|NCT01876784|156308614|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
48578347|NCT01876784|156308613|FG000|Open-label Period (31 Months)|Progressive disease|4|||
48578348|NCT01876784|156308614|FG001|Open-label Period (31 Months)|Progressive disease|35|||
48587291|NCT03003000|156343171|FG002|Overall Study|Adverse Event|3|||
48587292|NCT03003000|156343169|FG000|Overall Study|Lack of Efficacy|1|||
48736787|NCT03082261|156887959|FG000|Overall Study|Unable to place lead(s)|2|||
48578349|NCT01876784|156308613|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
48578350|NCT01876784|156308614|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
48578351|NCT01876784|156308613|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
48578352|NCT01876784|156308614|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
48578353|NCT01876784|156308613|FG000|Open-label Period (31 Months)|Death|0|||
48578354|NCT01876784|156308614|FG001|Open-label Period (31 Months)|Death|1|||
48578355|NCT01876784|156308613|FG000|Open-label Period (31 Months)|Other than specified above|9|||
48578356|NCT01876784|156308614|FG001|Open-label Period (31 Months)|Other than specified above|18|||
48578357|NCT03696108|156308615|FG000|Overall Study|Physician Decision|1|||
48578358|NCT03696108|156308616|FG001|Overall Study|Physician Decision|0|||
48578359|NCT03696108|156308615|FG000|Overall Study|Withdrawal by Subject|3|||
48578360|NCT03696108|156308616|FG001|Overall Study|Withdrawal by Subject|6|||
48578361|NCT03505593|156308618|FG000|Overall Study|Withdrawal by Subject|1|||
48736788|NCT03082261|156887959|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
48736789|NCT01032174|156887960|FG000|Overall Study|Adverse Event|0|||
48736790|NCT01032174|156887961|FG001|Overall Study|Adverse Event|1|||
48578362|NCT03505593|156308618|FG000|Overall Study|Died before procedure|1|||
48578363|NCT03505593|156308618|FG000|Overall Study|Anatomical abnormality|1|||
48578364|NCT03505593|156308618|FG000|Overall Study|Unable to pass through esophagus|1|||
48578365|NCT03505593|156308618|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
48578366|NCT03605862|156308619|FG000|Overall Study|Withdrawal by Subject|12|||
48578367|NCT03605862|156308620|FG001|Overall Study|Withdrawal by Subject|9|||
48578368|NCT03605862|156308619|FG000|Overall Study|Adverse Event|2|||
48578369|NCT03605862|156308620|FG001|Overall Study|Adverse Event|1|||
48578370|NCT03605862|156308619|FG000|Overall Study|Physician Decision|3|||
48578371|NCT03605862|156308620|FG001|Overall Study|Physician Decision|1|||
48578372|NCT03605862|156308619|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
48578373|NCT03605862|156308620|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
48578374|NCT01194531|156308621|FG000|Overall Study|Withdrawal by Subject|1|||
48578375|NCT01194531|156308622|FG001|Overall Study|Withdrawal by Subject|0|||
48578376|NCT01194531|156308621|FG000|Overall Study|Protocol Violation|4|||
48578377|NCT01194531|156308622|FG001|Overall Study|Protocol Violation|1|||
48578378|NCT01194531|156308621|FG000|Overall Study|Physician Decision|0|||
48578379|NCT01194531|156308622|FG001|Overall Study|Physician Decision|2|||
48578380|NCT02822573|156308623|FG000|Overall Study|Lost to Follow-up|5|||
48578381|NCT02822573|156308624|FG001|Overall Study|Lost to Follow-up|3|||
48578382|NCT02822573|156308623|FG000|Overall Study|Physician Decision|1|||
48578383|NCT02822573|156308624|FG001|Overall Study|Physician Decision|1|||
48578384|NCT02822573|156308623|FG000|Overall Study|Withdrawal by Subject|9|||
48578385|NCT02822573|156308624|FG001|Overall Study|Withdrawal by Subject|5|||
48578386|NCT02822573|156308623|FG000|Overall Study|Protocol Violation|6|||
48578387|NCT02822573|156308624|FG001|Overall Study|Protocol Violation|4|||
48578388|NCT02822573|156308623|FG000|Overall Study|Too sick or ill|2|||
48578389|NCT02822573|156308624|FG001|Overall Study|Too sick or ill|1|||
48578390|NCT02822573|156308623|FG000|Overall Study|Disease Progression|1|||
48578391|NCT02822573|156308624|FG001|Overall Study|Disease Progression|1|||
48578392|NCT02822573|156308623|FG000|Overall Study|No reason given|6|||
48578393|NCT02822573|156308624|FG001|Overall Study|No reason given|4|||
48578394|NCT03891862|156308626|FG000|Open-label Period|Adverse Event|2|||
48578395|NCT03891862|156308627|FG001|Open-label Period|Adverse Event|0|||
48578396|NCT03891862|156308628|FG002|Open-label Period|Adverse Event|0|||
48578397|NCT03891862|156308626|FG000|Open-label Period|Protocol Violation|5|||
48578398|NCT03891862|156308627|FG001|Open-label Period|Protocol Violation|0|||
48578399|NCT03891862|156308628|FG002|Open-label Period|Protocol Violation|0|||
48578400|NCT03891862|156308626|FG000|Open-label Period|Withdrawal by Subject|6|||
48578401|NCT03891862|156308627|FG001|Open-label Period|Withdrawal by Subject|0|||
48578402|NCT03891862|156308628|FG002|Open-label Period|Withdrawal by Subject|0|||
48622605|NCT00120250|156476556|FG000|Overall Study|Lost to Follow-up|1|||
48736791|NCT00113087|156887962|FG000|Overall Study|Death or Transplant|14|||
48736792|NCT00113087|156887963|FG001|Overall Study|Death or Transplant|16|||
48736793|NCT00113087|156887962|FG000|Overall Study|Family or MD withdrew subject|10|||
48578403|NCT03891862|156308626|FG000|Open-label Period|Death|1|||
48578404|NCT03891862|156308627|FG001|Open-label Period|Death|0|||
48578405|NCT03891862|156308628|FG002|Open-label Period|Death|0|||
48578406|NCT03891862|156308626|FG000|Open-label Period|Lost to Follow-up|2|||
48578407|NCT03891862|156308627|FG001|Open-label Period|Lost to Follow-up|0|||
48578408|NCT03891862|156308628|FG002|Open-label Period|Lost to Follow-up|0|||
48578409|NCT03891862|156308626|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
48578410|NCT03891862|156308627|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
48578411|NCT03891862|156308628|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
48578412|NCT03891862|156308626|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
48578413|NCT03891862|156308627|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
48578414|NCT03891862|156308628|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
48622606|NCT00120250|156476557|FG001|Overall Study|Lost to Follow-up|1|||
48578415|NCT03891862|156308626|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
48578416|NCT03891862|156308627|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
48578417|NCT03891862|156308628|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
48578418|NCT03891862|156308626|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
48578419|NCT03891862|156308627|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
48578420|NCT03891862|156308628|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
48578421|NCT05239494|156308629|FG000|Overall Study|Lost to Follow-up|1|||
48578422|NCT00174967|156308630|FG000|Overall Study|Adverse Event|1|||
48578423|NCT00174967|156308631|FG001|Overall Study|Adverse Event|2|||
48578424|NCT00174967|156308632|FG002|Overall Study|Adverse Event|2|||
48578425|NCT00174967|156308633|FG003|Overall Study|Adverse Event|1|||
48578426|NCT00174967|156308630|FG000|Overall Study|Gout Flare|0|||
48578427|NCT00174967|156308631|FG001|Overall Study|Gout Flare|0|||
48578428|NCT00174967|156308632|FG002|Overall Study|Gout Flare|0|||
48578429|NCT00174967|156308633|FG003|Overall Study|Gout Flare|1|||
48578430|NCT00174967|156308630|FG000|Overall Study|Other|0|||
48578431|NCT00174967|156308631|FG001|Overall Study|Other|1|||
48578432|NCT00174967|156308632|FG002|Overall Study|Other|0|||
48578433|NCT00174967|156308633|FG003|Overall Study|Other|0|||
48578434|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Adverse Event|6|||
48578435|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Adverse Event|14|||
48578436|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Death|3|||
48578437|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Death|1|||
48578438|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
48578439|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
48578440|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
48578441|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
48578442|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
48578443|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
48578444|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
48578445|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
48578446|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
48578447|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
48578448|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Physician Decision|2|||
48578449|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Physician Decision|4|||
48578450|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Pregnancy|2|||
48578451|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Pregnancy|1|||
48578452|NCT02275780|156308634|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
48578453|NCT02275780|156308635|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
48578454|NCT02275780|156308634|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
48578455|NCT02275780|156308635|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
48578456|NCT02275780|156308634|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
48578457|NCT02275780|156308635|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
48578458|NCT02275780|156308634|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
48578459|NCT02275780|156308635|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
48736794|NCT00113087|156887963|FG001|Overall Study|Family or MD withdrew subject|5|||
48578460|NCT02275780|156308634|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
48578461|NCT02275780|156308635|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
48578462|NCT02275780|156308634|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
48578463|NCT02275780|156308635|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
48578464|NCT02275780|156308634|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
48578465|NCT02275780|156308635|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
48578466|NCT02275780|156308634|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
48578467|NCT02275780|156308635|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
48578468|NCT02275780|156308634|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
48578469|NCT02275780|156308635|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
48578470|NCT02275780|156308634|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
48578471|NCT02275780|156308635|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
48578472|NCT02275780|156308634|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
48578473|NCT02275780|156308635|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
48578474|NCT02275780|156308634|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
48736795|NCT04402060|156887964|FG000|Overall Study|Death|1|||
48736796|NCT04402060|156887965|FG001|Overall Study|Death|12|||
48736797|NCT04402060|156887966|FG002|Overall Study|Death|7|||
48578475|NCT02275780|156308635|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
48578476|NCT02275780|156308634|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
48578477|NCT02275780|156308635|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
48578478|NCT02275780|156308634|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
48578479|NCT02275780|156308635|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
48578480|NCT02275780|156308634|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
48578481|NCT02275780|156308635|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
48578482|NCT02275780|156308634|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
48578483|NCT02275780|156308635|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
48578484|NCT02275780|156308634|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
48578485|NCT02275780|156308635|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
48578486|NCT02275780|156308634|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
48578487|NCT02275780|156308635|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
48736798|NCT04402060|156887964|FG000|Overall Study|Adverse Event|0|||
48736799|NCT04402060|156887965|FG001|Overall Study|Adverse Event|0|||
48578488|NCT02275780|156308634|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
48578489|NCT02275780|156308635|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
48578490|NCT02275780|156308634|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
48578491|NCT02275780|156308635|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
48578492|NCT02275780|156308634|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
48578493|NCT02275780|156308635|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
48578494|NCT02275780|156308634|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
48578495|NCT02275780|156308635|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
48578496|NCT00679289|156308636|FG000|Overall Study|Progressive disease|4|||
48578497|NCT00679289|156308637|FG001|Overall Study|Progressive disease|5|||
48578498|NCT00679289|156308638|FG002|Overall Study|Progressive disease|18|||
48578499|NCT00679289|156308636|FG000|Overall Study|Withdrawal by Subject|0|||
48578500|NCT00679289|156308637|FG001|Overall Study|Withdrawal by Subject|1|||
48578501|NCT00679289|156308638|FG002|Overall Study|Withdrawal by Subject|1|||
48578502|NCT00679289|156308636|FG000|Overall Study|Adverse Event|0|||
48578503|NCT00679289|156308637|FG001|Overall Study|Adverse Event|0|||
48578504|NCT00679289|156308638|FG002|Overall Study|Adverse Event|3|||
48578505|NCT00679289|156308636|FG000|Overall Study|Physician Decision|1|||
48578506|NCT00679289|156308637|FG001|Overall Study|Physician Decision|0|||
48578507|NCT00679289|156308638|FG002|Overall Study|Physician Decision|1|||
48578508|NCT01053962|156308641|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
48578509|NCT01053962|156308642|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
48578510|NCT01053962|156308643|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
48578511|NCT01053962|156308644|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
48578512|NCT01053962|156308645|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
48578513|NCT01053962|156308641|FG000|Pretreatment Period|Venipuncture Failure|0|||
48578514|NCT01053962|156308642|FG001|Pretreatment Period|Venipuncture Failure|0|||
48578515|NCT01053962|156308643|FG002|Pretreatment Period|Venipuncture Failure|1|||
48578516|NCT01053962|156308644|FG003|Pretreatment Period|Venipuncture Failure|0|||
48736800|NCT04402060|156887966|FG002|Overall Study|Adverse Event|1|||
48736801|NCT04402060|156887964|FG000|Overall Study|Withdrawal by Subject|0|||
48736802|NCT04402060|156887965|FG001|Overall Study|Withdrawal by Subject|1|||
48736803|NCT04402060|156887966|FG002|Overall Study|Withdrawal by Subject|2|||
48736804|NCT04402060|156887964|FG000|Overall Study|Sponsor Request|0|||
48736805|NCT04402060|156887965|FG001|Overall Study|Sponsor Request|2|||
48736806|NCT04402060|156887966|FG002|Overall Study|Sponsor Request|0|||
48736807|NCT04402060|156887964|FG000|Overall Study|Physician Decision|0|||
48319849|NCT01985334|155371112|FG006|Overall Study|Subject withdrawal of consent|0|||
48319850|NCT01985334|155371113|FG007|Overall Study|Subject withdrawal of consent|20|||
48319851|NCT01985334|155371106|FG000|Overall Study|Adverse Event|0|||
48319852|NCT01985334|155371107|FG001|Overall Study|Adverse Event|8|||
48319853|NCT01985334|155371108|FG002|Overall Study|Adverse Event|2|||
48319854|NCT01985334|155371109|FG003|Overall Study|Adverse Event|26|||
48578517|NCT01053962|156308645|FG004|Pretreatment Period|Venipuncture Failure|0|||
48578518|NCT01053962|156308641|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
48578519|NCT01053962|156308642|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
48578520|NCT01053962|156308643|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
48578521|NCT01053962|156308644|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
48578522|NCT01053962|156308645|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
48578523|NCT01053962|156308641|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
48578524|NCT01053962|156308642|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
48578525|NCT01053962|156308643|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
48578526|NCT01053962|156308644|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
48578527|NCT01053962|156308645|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
48578528|NCT01053962|156308641|FG000|Treatment Period|Lack of Efficacy|0|||
48578529|NCT01053962|156308642|FG001|Treatment Period|Lack of Efficacy|0|||
48578530|NCT01053962|156308643|FG002|Treatment Period|Lack of Efficacy|0|||
48319855|NCT01985334|155371110|FG004|Overall Study|Adverse Event|3|||
48736808|NCT04402060|156887965|FG001|Overall Study|Physician Decision|0|||
48736809|NCT04402060|156887966|FG002|Overall Study|Physician Decision|1|||
48736810|NCT04402060|156887964|FG000|Overall Study|Other|0|||
48319856|NCT01985334|155371111|FG005|Overall Study|Adverse Event|18|||
48319857|NCT01985334|155371112|FG006|Overall Study|Adverse Event|3|||
48736811|NCT04402060|156887965|FG001|Overall Study|Other|1|||
48736812|NCT04402060|156887966|FG002|Overall Study|Other|0|||
48736813|NCT02158975|156887969|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
48736814|NCT01967173|156887972|FG000|Overall Study|Lost to Follow-up|5|||
48736815|NCT01967173|156887973|FG001|Overall Study|Lost to Follow-up|3|||
48578531|NCT01053962|156308644|FG003|Treatment Period|Lack of Efficacy|0|||
48578532|NCT01053962|156308645|FG004|Treatment Period|Lack of Efficacy|1|||
48578533|NCT01053962|156308641|FG000|Treatment Period|Adverse Event|0|||
48578534|NCT01053962|156308642|FG001|Treatment Period|Adverse Event|0|||
48578535|NCT01053962|156308643|FG002|Treatment Period|Adverse Event|0|||
48578536|NCT01053962|156308644|FG003|Treatment Period|Adverse Event|0|||
48736816|NCT01967173|156887974|FG002|Overall Study|Lost to Follow-up|2|||
48736817|NCT01967173|156887975|FG003|Overall Study|Lost to Follow-up|4|||
48736818|NCT01967173|156887976|FG004|Overall Study|Lost to Follow-up|8|||
48736819|NCT01967173|156887977|FG005|Overall Study|Lost to Follow-up|12|||
48736820|NCT01967173|156887978|FG006|Overall Study|Lost to Follow-up|6|||
48736821|NCT01967173|156887979|FG007|Overall Study|Lost to Follow-up|8|||
48736822|NCT01967173|156887972|FG000|Overall Study|Physician Decision|2|||
48736823|NCT01967173|156887973|FG001|Overall Study|Physician Decision|0|||
48736824|NCT01967173|156887974|FG002|Overall Study|Physician Decision|2|||
48578537|NCT01053962|156308645|FG004|Treatment Period|Adverse Event|1|||
48578538|NCT01053962|156308641|FG000|Treatment Period|Withdrawal by Subject|0|||
48578539|NCT01053962|156308642|FG001|Treatment Period|Withdrawal by Subject|0|||
48578540|NCT01053962|156308643|FG002|Treatment Period|Withdrawal by Subject|0|||
48578541|NCT01053962|156308644|FG003|Treatment Period|Withdrawal by Subject|0|||
48578542|NCT01053962|156308645|FG004|Treatment Period|Withdrawal by Subject|1|||
48578543|NCT01053962|156308641|FG000|Treatment Period|Noncompliance with protocol|1|||
48578544|NCT01053962|156308642|FG001|Treatment Period|Noncompliance with protocol|0|||
48578545|NCT01053962|156308643|FG002|Treatment Period|Noncompliance with protocol|0|||
48578546|NCT01053962|156308644|FG003|Treatment Period|Noncompliance with protocol|0|||
48578547|NCT01053962|156308645|FG004|Treatment Period|Noncompliance with protocol|0|||
48578548|NCT02892422|156308646|FG000|Overall Study|Enrolled not treated|4|||
48578549|NCT02892422|156308646|FG000|Overall Study|Adverse Event|38|||
48578550|NCT02892422|156308646|FG000|Overall Study|Lack of Efficacy|32|||
48578551|NCT02892422|156308646|FG000|Overall Study|Non-compliance with study drug|11|||
48578552|NCT02892422|156308646|FG000|Overall Study|Protocol Violation|4|||
48578553|NCT02892422|156308646|FG000|Overall Study|Withdrawal by Subject|56|||
48578554|NCT02892422|156308646|FG000|Overall Study|Lost to Follow-up|5|||
48578555|NCT02892422|156308646|FG000|Overall Study|sponsor information 16159A results|21|||
48578556|NCT02892422|156308646|FG000|Overall Study|withdrawal of consent|13|||
48578557|NCT02892422|156308646|FG000|Overall Study|exclusion criteria met|3|||
48578558|NCT02892422|156308646|FG000|Overall Study|moving elsewhere|4|||
48578559|NCT02892422|156308646|FG000|Overall Study|non-compliance|10|||
48319858|NCT01985334|155371113|FG007|Overall Study|Adverse Event|15|||
48319859|NCT01985334|155371106|FG000|Overall Study|Other|4|||
48578560|NCT02892422|156308646|FG000|Overall Study|patient legally incapable|1|||
48578561|NCT02892422|156308646|FG000|Overall Study|patient decision|7|||
48578562|NCT02892422|156308646|FG000|Overall Study|Investigator decision|1|||
48578563|NCT00638443|156308647|FG000|First Intervention|Adverse Event|2|||
48578564|NCT00638443|156308648|FG001|First Intervention|Adverse Event|1|||
48736825|NCT01967173|156887975|FG003|Overall Study|Physician Decision|1|||
48736826|NCT01967173|156887976|FG004|Overall Study|Physician Decision|1|||
48736827|NCT01967173|156887977|FG005|Overall Study|Physician Decision|1|||
48736828|NCT01967173|156887978|FG006|Overall Study|Physician Decision|1|||
48578565|NCT01054300|156308649|FG000|Period 1|Adverse Event|1|||
48319860|NCT01985334|155371107|FG001|Overall Study|Other|2|||
48319861|NCT01985334|155371108|FG002|Overall Study|Other|3|||
48319862|NCT01985334|155371109|FG003|Overall Study|Other|10|||
48319863|NCT01985334|155371110|FG004|Overall Study|Other|1|||
48319864|NCT01985334|155371111|FG005|Overall Study|Other|6|||
48578566|NCT01054300|156308650|FG001|Period 1|Adverse Event|0|||
48578567|NCT01054300|156308651|FG002|Period 1|Adverse Event|0|||
48578568|NCT01054300|156308652|FG003|Period 1|Adverse Event|0|||
48578569|NCT01054300|156308649|FG000|Period 2|Withdrawal by Subject|0|||
48578570|NCT01054300|156308650|FG001|Period 2|Withdrawal by Subject|0|||
48578571|NCT01054300|156308651|FG002|Period 2|Withdrawal by Subject|1|||
48578572|NCT01054300|156308652|FG003|Period 2|Withdrawal by Subject|0|||
48578573|NCT00308087|156308657|FG000|Overall Study|Progressive Disease|19|||
48578574|NCT00308087|156308658|FG001|Overall Study|Progressive Disease|21|||
48736829|NCT01967173|156887979|FG007|Overall Study|Physician Decision|0|||
48736830|NCT01967173|156887972|FG000|Overall Study|Lack of Efficacy|2|||
48736831|NCT01967173|156887973|FG001|Overall Study|Lack of Efficacy|0|||
48736832|NCT01967173|156887974|FG002|Overall Study|Lack of Efficacy|2|||
48736833|NCT01967173|156887975|FG003|Overall Study|Lack of Efficacy|2|||
48736834|NCT01967173|156887976|FG004|Overall Study|Lack of Efficacy|0|||
48736835|NCT01967173|156887977|FG005|Overall Study|Lack of Efficacy|1|||
48736836|NCT01967173|156887978|FG006|Overall Study|Lack of Efficacy|0|||
48736837|NCT01967173|156887979|FG007|Overall Study|Lack of Efficacy|2|||
48736838|NCT01967173|156887972|FG000|Overall Study|Pregnancy|0|||
48736839|NCT01967173|156887973|FG001|Overall Study|Pregnancy|0|||
48736840|NCT01967173|156887974|FG002|Overall Study|Pregnancy|0|||
48736841|NCT01967173|156887975|FG003|Overall Study|Pregnancy|0|||
48736842|NCT01967173|156887976|FG004|Overall Study|Pregnancy|0|||
48736843|NCT01967173|156887977|FG005|Overall Study|Pregnancy|0|||
48736844|NCT01967173|156887978|FG006|Overall Study|Pregnancy|1|||
48736845|NCT01967173|156887979|FG007|Overall Study|Pregnancy|1|||
48736846|NCT01967173|156887972|FG000|Overall Study|Adverse Event|0|||
48736847|NCT01967173|156887973|FG001|Overall Study|Adverse Event|0|||
48736848|NCT01967173|156887974|FG002|Overall Study|Adverse Event|0|||
48736849|NCT01967173|156887975|FG003|Overall Study|Adverse Event|0|||
48622607|NCT00120250|156476556|FG000|Overall Study|Protocol Violation|0|||
48736850|NCT01967173|156887976|FG004|Overall Study|Adverse Event|0|||
48736851|NCT01967173|156887977|FG005|Overall Study|Adverse Event|0|||
48736852|NCT01967173|156887978|FG006|Overall Study|Adverse Event|0|||
48736853|NCT01967173|156887979|FG007|Overall Study|Adverse Event|1|||
48736854|NCT01967173|156887972|FG000|Overall Study|Withdrawal by Subject|15|||
48736855|NCT01967173|156887973|FG001|Overall Study|Withdrawal by Subject|14|||
48319865|NCT01985334|155371112|FG006|Overall Study|Other|2|||
48319866|NCT01985334|155371113|FG007|Overall Study|Other|2|||
48578575|NCT00308087|156308657|FG000|Overall Study|Study Closure|11|||
48736856|NCT01967173|156887974|FG002|Overall Study|Withdrawal by Subject|10|||
48736857|NCT01967173|156887975|FG003|Overall Study|Withdrawal by Subject|7|||
48736858|NCT01967173|156887976|FG004|Overall Study|Withdrawal by Subject|8|||
48736859|NCT01967173|156887977|FG005|Overall Study|Withdrawal by Subject|9|||
48319867|NCT01985334|155371106|FG000|Overall Study|Medication non-compliance|0|||
48319868|NCT01985334|155371107|FG001|Overall Study|Medication non-compliance|4|||
48578576|NCT00308087|156308658|FG001|Overall Study|Study Closure|12|||
48578577|NCT00308087|156308657|FG000|Overall Study|Withdrawal by Subject|2|||
48578578|NCT00308087|156308658|FG001|Overall Study|Withdrawal by Subject|1|||
48578579|NCT00308087|156308657|FG000|Overall Study|Other|4|||
48578580|NCT00308087|156308658|FG001|Overall Study|Other|3|||
48578581|NCT05036668|156308659|FG000|Overall Study|lost to follow Up|0|||
48578582|NCT05036668|156308660|FG001|Overall Study|lost to follow Up|0|||
48578583|NCT05036668|156308661|FG002|Overall Study|lost to follow Up|1|||
48578584|NCT00658775|156308662|FG000|Overall Study|Adverse Event|4|||
48578585|NCT00658775|156308663|FG001|Overall Study|Adverse Event|6|||
48578586|NCT00658775|156308662|FG000|Overall Study|Lost to Follow-up|17|||
48578587|NCT00658775|156308663|FG001|Overall Study|Lost to Follow-up|18|||
48578588|NCT00658775|156308662|FG000|Overall Study|Withdrawal by Subject|6|||
48578589|NCT00658775|156308663|FG001|Overall Study|Withdrawal by Subject|4|||
48578590|NCT00658775|156308662|FG000|Overall Study|Withdrawal of consent|8|||
48578591|NCT00658775|156308663|FG001|Overall Study|Withdrawal of consent|7|||
48578592|NCT00658775|156308662|FG000|Overall Study|Other|7|||
48578593|NCT00658775|156308663|FG001|Overall Study|Other|8|||
48578594|NCT01190267|156308666|FG000|Overall Study|Adverse Event|10|||
48578595|NCT01190267|156308667|FG001|Overall Study|Adverse Event|0|||
48578596|NCT01190267|156308666|FG000|Overall Study|Treatment Failure|8|||
48578597|NCT01190267|156308667|FG001|Overall Study|Treatment Failure|2|||
48578598|NCT01190267|156308666|FG000|Overall Study|Lost to Follow-up|2|||
48578599|NCT01190267|156308667|FG001|Overall Study|Lost to Follow-up|0|||
48578600|NCT01190267|156308666|FG000|Overall Study|Withdrawal by Subject|13|||
48578601|NCT01190267|156308667|FG001|Overall Study|Withdrawal by Subject|1|||
48578602|NCT01190267|156308666|FG000|Overall Study|Protocol Violation|8|||
48578603|NCT01190267|156308667|FG001|Overall Study|Protocol Violation|1|||
48578604|NCT03782298|156308670|FG000|Overall Study|Protocol Deviation|4|||
48578605|NCT01901653|156308683|FG000|Overall Study|Death|2|||
48736860|NCT01967173|156887978|FG006|Overall Study|Withdrawal by Subject|10|||
48736861|NCT01967173|156887979|FG007|Overall Study|Withdrawal by Subject|12|||
48736862|NCT03307785|156887980|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
48736863|NCT03307785|156887981|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
48736864|NCT03307785|156887982|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
48736865|NCT03307785|156887983|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
48736866|NCT03307785|156887984|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
48736867|NCT03307785|156887985|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
48736868|NCT03307785|156887986|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
48736869|NCT03307785|156887987|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
48736870|NCT03307785|156887988|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
48736871|NCT03307785|156887989|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
48736872|NCT03307785|156887990|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
48736873|NCT03307785|156887980|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
48736874|NCT03307785|156887981|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
48736875|NCT03307785|156887982|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736876|NCT03307785|156887983|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736877|NCT03307785|156887984|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736878|NCT03307785|156887985|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736879|NCT03307785|156887986|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736880|NCT03307785|156887987|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48319869|NCT01985334|155371108|FG002|Overall Study|Medication non-compliance|1|||
48578606|NCT01901653|156308684|FG001|Overall Study|Death|1|||
48578607|NCT01901653|156308685|FG002|Overall Study|Death|8|||
48578608|NCT01901653|156308686|FG003|Overall Study|Death|3|||
48578609|NCT01901653|156308687|FG004|Overall Study|Death|2|||
48578610|NCT01901653|156308688|FG005|Overall Study|Death|2|||
48578611|NCT01901653|156308689|FG006|Overall Study|Death|6|||
48578612|NCT01901653|156308690|FG007|Overall Study|Death|9|||
48578613|NCT01901653|156308691|FG008|Overall Study|Death|1|||
48736881|NCT03307785|156887988|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736882|NCT03307785|156887989|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736883|NCT03307785|156887990|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
48736884|NCT03307785|156887980|FG000|Part A: Up to 28.5 Months|Death|4|||
48578614|NCT01901653|156308692|FG009|Overall Study|Death|16|||
48578615|NCT01901653|156308693|FG010|Overall Study|Death|2|||
48578616|NCT01901653|156308694|FG011|Overall Study|Death|15|||
48736885|NCT03307785|156887981|FG001|Part A: Up to 28.5 Months|Death|4|||
48736886|NCT03307785|156887982|FG002|Part A: Up to 28.5 Months|Death|0|||
48736887|NCT03307785|156887983|FG003|Part A: Up to 28.5 Months|Death|0|||
48736888|NCT03307785|156887984|FG004|Part A: Up to 28.5 Months|Death|0|||
48736889|NCT03307785|156887985|FG005|Part A: Up to 28.5 Months|Death|0|||
48736890|NCT03307785|156887986|FG006|Part A: Up to 28.5 Months|Death|0|||
48736891|NCT03307785|156887987|FG007|Part A: Up to 28.5 Months|Death|0|||
48736892|NCT03307785|156887988|FG008|Part A: Up to 28.5 Months|Death|0|||
48578617|NCT01901653|156308695|FG012|Overall Study|Death|4|||
48578618|NCT01901653|156308683|FG000|Overall Study|Lost to Follow-up|1|||
48578619|NCT01901653|156308684|FG001|Overall Study|Lost to Follow-up|0|||
48578620|NCT01901653|156308685|FG002|Overall Study|Lost to Follow-up|2|||
48578621|NCT01901653|156308686|FG003|Overall Study|Lost to Follow-up|0|||
48578622|NCT01901653|156308687|FG004|Overall Study|Lost to Follow-up|0|||
48578623|NCT01901653|156308688|FG005|Overall Study|Lost to Follow-up|1|||
48578624|NCT01901653|156308689|FG006|Overall Study|Lost to Follow-up|0|||
48736893|NCT03307785|156887989|FG009|Part A: Up to 28.5 Months|Death|0|||
48736894|NCT03307785|156887990|FG010|Part A: Up to 28.5 Months|Death|0|||
48736895|NCT03307785|156887980|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
48736896|NCT03307785|156887981|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
48736897|NCT03307785|156887982|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
48736898|NCT03307785|156887983|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
48736899|NCT03307785|156887984|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
48736900|NCT03307785|156887985|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
48736901|NCT03307785|156887986|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
48736902|NCT03307785|156887987|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
48736903|NCT03307785|156887988|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
48736904|NCT03307785|156887989|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
48736905|NCT03307785|156887990|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
48736906|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
48578625|NCT01901653|156308690|FG007|Overall Study|Lost to Follow-up|1|||
48578626|NCT01901653|156308691|FG008|Overall Study|Lost to Follow-up|0|||
48578627|NCT01901653|156308692|FG009|Overall Study|Lost to Follow-up|0|||
48578628|NCT01901653|156308693|FG010|Overall Study|Lost to Follow-up|0|||
48578629|NCT01901653|156308694|FG011|Overall Study|Lost to Follow-up|0|||
48578630|NCT01901653|156308695|FG012|Overall Study|Lost to Follow-up|0|||
48578631|NCT01901653|156308683|FG000|Overall Study|Withdrawal by Subject|0|||
48578632|NCT01901653|156308684|FG001|Overall Study|Withdrawal by Subject|0|||
48578633|NCT01901653|156308685|FG002|Overall Study|Withdrawal by Subject|0|||
48578634|NCT01901653|156308686|FG003|Overall Study|Withdrawal by Subject|0|||
48578635|NCT01901653|156308687|FG004|Overall Study|Withdrawal by Subject|0|||
48578636|NCT01901653|156308688|FG005|Overall Study|Withdrawal by Subject|0|||
48578637|NCT01901653|156308689|FG006|Overall Study|Withdrawal by Subject|1|||
48578638|NCT01901653|156308690|FG007|Overall Study|Withdrawal by Subject|0|||
48578639|NCT01901653|156308691|FG008|Overall Study|Withdrawal by Subject|0|||
48578640|NCT01901653|156308692|FG009|Overall Study|Withdrawal by Subject|0|||
48578641|NCT01901653|156308693|FG010|Overall Study|Withdrawal by Subject|0|||
48319870|NCT01985334|155371109|FG003|Overall Study|Medication non-compliance|6|||
48578642|NCT01901653|156308694|FG011|Overall Study|Withdrawal by Subject|0|||
48578643|NCT01901653|156308695|FG012|Overall Study|Withdrawal by Subject|0|||
48578644|NCT01901653|156308683|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
48578645|NCT01901653|156308684|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
48578646|NCT01901653|156308685|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
48578647|NCT01901653|156308686|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
48736907|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736908|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
48736909|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736910|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736911|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736912|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736913|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736914|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736915|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736916|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
48736917|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Death|0|||
48736918|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Death|0|||
48736919|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Death|7|||
48736920|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Death|0|||
48736921|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Death|0|||
48736922|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Death|0|||
48736923|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Death|0|||
48736924|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Death|0|||
48736925|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Death|0|||
48736926|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Death|0|||
48736927|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Death|0|||
48736928|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736929|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736930|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
48736931|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736932|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736933|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736934|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736935|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736936|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736937|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736938|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
48736939|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736940|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736941|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
48736942|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48578648|NCT01901653|156308687|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
48578649|NCT01901653|156308688|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
48578650|NCT01901653|156308689|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
48578651|NCT01901653|156308690|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
48578652|NCT01901653|156308691|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
48578653|NCT01901653|156308692|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
48578654|NCT01901653|156308693|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
48578655|NCT01901653|156308694|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
48578656|NCT01901653|156308695|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
48578657|NCT02548351|156308696|FG000|Overall Study|Withdrawal by Subject|149|||
48578658|NCT02548351|156308697|FG001|Overall Study|Withdrawal by Subject|154|||
48578659|NCT02548351|156308698|FG002|Overall Study|Withdrawal by Subject|152|||
48578660|NCT02548351|156308696|FG000|Overall Study|Death|11|||
48578661|NCT02548351|156308697|FG001|Overall Study|Death|15|||
48578662|NCT02548351|156308698|FG002|Overall Study|Death|12|||
48578663|NCT02548351|156308696|FG000|Overall Study|Adverse Event|22|||
48578664|NCT02548351|156308697|FG001|Overall Study|Adverse Event|56|||
48578665|NCT02548351|156308698|FG002|Overall Study|Adverse Event|36|||
48578666|NCT02548351|156308696|FG000|Overall Study|Study Terminated by Sponsor|549|||
48578667|NCT02548351|156308697|FG001|Overall Study|Study Terminated by Sponsor|509|||
48578668|NCT02548351|156308698|FG002|Overall Study|Study Terminated by Sponsor|528|||
48736943|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736944|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736945|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736946|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736947|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48319871|NCT01985334|155371110|FG004|Overall Study|Medication non-compliance|2|||
48319872|NCT01985334|155371111|FG005|Overall Study|Medication non-compliance|3|||
48319873|NCT01985334|155371112|FG006|Overall Study|Medication non-compliance|1|||
48319874|NCT01985334|155371113|FG007|Overall Study|Medication non-compliance|3|||
48319875|NCT01985334|155371106|FG000|Overall Study|Use of prohibited treatment|1|||
48319876|NCT01985334|155371107|FG001|Overall Study|Use of prohibited treatment|4|||
48319877|NCT01985334|155371108|FG002|Overall Study|Use of prohibited treatment|1|||
48319878|NCT01985334|155371109|FG003|Overall Study|Use of prohibited treatment|2|||
48319879|NCT01985334|155371110|FG004|Overall Study|Use of prohibited treatment|1|||
48319880|NCT01985334|155371111|FG005|Overall Study|Use of prohibited treatment|6|||
48319881|NCT01985334|155371112|FG006|Overall Study|Use of prohibited treatment|2|||
48319882|NCT01985334|155371113|FG007|Overall Study|Use of prohibited treatment|0|||
48319883|NCT01985334|155371106|FG000|Overall Study|Investigator decision|0|||
48319884|NCT01985334|155371107|FG001|Overall Study|Investigator decision|3|||
48319885|NCT01985334|155371108|FG002|Overall Study|Investigator decision|0|||
48319886|NCT01985334|155371109|FG003|Overall Study|Investigator decision|7|||
48319887|NCT01985334|155371110|FG004|Overall Study|Investigator decision|1|||
48319888|NCT01985334|155371111|FG005|Overall Study|Investigator decision|1|||
48319889|NCT01985334|155371112|FG006|Overall Study|Investigator decision|0|||
48319890|NCT01985334|155371113|FG007|Overall Study|Investigator decision|4|||
48319891|NCT01985334|155371106|FG000|Overall Study|Lost to Follow-up|0|||
48319892|NCT01985334|155371107|FG001|Overall Study|Lost to Follow-up|2|||
48578669|NCT02548351|156308696|FG000|Overall Study|Site Closure|14|||
48578670|NCT02548351|156308697|FG001|Overall Study|Site Closure|5|||
48578671|NCT02548351|156308698|FG002|Overall Study|Site Closure|7|||
48578672|NCT02548351|156308696|FG000|Overall Study|Non-compliance with Study Drug|4|||
48736948|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48736949|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
48578673|NCT02548351|156308697|FG001|Overall Study|Non-compliance with Study Drug|2|||
48578674|NCT02548351|156308698|FG002|Overall Study|Non-compliance with Study Drug|0|||
48578675|NCT02548351|156308696|FG000|Overall Study|Protocol Violation|2|||
48578676|NCT02548351|156308697|FG001|Overall Study|Protocol Violation|1|||
48578677|NCT02548351|156308698|FG002|Overall Study|Protocol Violation|2|||
48578678|NCT02548351|156308696|FG000|Overall Study|Physician Decision|11|||
48578679|NCT02548351|156308697|FG001|Overall Study|Physician Decision|18|||
48578680|NCT02548351|156308698|FG002|Overall Study|Physician Decision|11|||
48578681|NCT02548351|156308696|FG000|Overall Study|Lost to Follow-up|43|||
48578682|NCT02548351|156308697|FG001|Overall Study|Lost to Follow-up|50|||
48578683|NCT02548351|156308698|FG002|Overall Study|Lost to Follow-up|57|||
48578684|NCT02548351|156308696|FG000|Overall Study|Other|19|||
48578685|NCT02548351|156308697|FG001|Overall Study|Other|16|||
48578686|NCT02548351|156308698|FG002|Overall Study|Other|20|||
48578687|NCT02548351|156308696|FG000|Overall Study|Missing|1|||
48578688|NCT02548351|156308697|FG001|Overall Study|Missing|1|||
48578689|NCT02548351|156308698|FG002|Overall Study|Missing|0|||
48578690|NCT00824382|156308699|FG000|Overall Study|Adverse Event|4|||
48578691|NCT00824382|156308700|FG001|Overall Study|Adverse Event|1|||
48578692|NCT00824382|156308701|FG002|Overall Study|Adverse Event|1|||
48578693|NCT00824382|156308702|FG003|Overall Study|Adverse Event|4|||
48578694|NCT00824382|156308699|FG000|Overall Study|Protocol Violation|1|||
48578695|NCT00824382|156308700|FG001|Overall Study|Protocol Violation|0|||
48319893|NCT01985334|155371108|FG002|Overall Study|Lost to Follow-up|0|||
48319894|NCT01985334|155371109|FG003|Overall Study|Lost to Follow-up|3|||
48319895|NCT01985334|155371110|FG004|Overall Study|Lost to Follow-up|1|||
48319896|NCT01985334|155371111|FG005|Overall Study|Lost to Follow-up|4|||
48319897|NCT01985334|155371112|FG006|Overall Study|Lost to Follow-up|0|||
48578696|NCT00824382|156308701|FG002|Overall Study|Protocol Violation|0|||
48578697|NCT00824382|156308702|FG003|Overall Study|Protocol Violation|1|||
48319898|NCT01985334|155371113|FG007|Overall Study|Lost to Follow-up|3|||
48319899|NCT00296036|155371114|FG000|Overall Study|Withdrawal by Subject|1|||
48319900|NCT00296036|155371115|FG001|Overall Study|Withdrawal by Subject|0|||
48319901|NCT00296036|155371116|FG002|Overall Study|Withdrawal by Subject|2|||
48319902|NCT00296036|155371117|FG003|Overall Study|Withdrawal by Subject|1|||
48319903|NCT00296036|155371118|FG004|Overall Study|Withdrawal by Subject|2|||
48319904|NCT00296036|155371119|FG005|Overall Study|Withdrawal by Subject|1|||
48319905|NCT00296036|155371114|FG000|Overall Study|Protocol Violation|0|||
48319906|NCT00296036|155371115|FG001|Overall Study|Protocol Violation|0|||
48319907|NCT00296036|155371116|FG002|Overall Study|Protocol Violation|0|||
48319908|NCT00296036|155371117|FG003|Overall Study|Protocol Violation|0|||
48319909|NCT00296036|155371118|FG004|Overall Study|Protocol Violation|0|||
48319910|NCT00296036|155371119|FG005|Overall Study|Protocol Violation|3|||
48319911|NCT01236560|155371122|FG000|Overall Study|Adverse Event|0|||
48319912|NCT01236560|155371123|FG001|Overall Study|Adverse Event|2|||
48319913|NCT01236560|155371124|FG002|Overall Study|Adverse Event|1|||
48319914|NCT01236560|155371125|FG003|Overall Study|Adverse Event|3|||
48319915|NCT01236560|155371126|FG004|Overall Study|Adverse Event|0|||
48319916|NCT01236560|155371127|FG005|Overall Study|Adverse Event|0|||
48319917|NCT01236560|155371122|FG000|Overall Study|Death|0|||
48319918|NCT01236560|155371123|FG001|Overall Study|Death|1|||
48319919|NCT01236560|155371124|FG002|Overall Study|Death|0|||
48319920|NCT01236560|155371125|FG003|Overall Study|Death|1|||
48319921|NCT01236560|155371126|FG004|Overall Study|Death|0|||
48319922|NCT01236560|155371127|FG005|Overall Study|Death|0|||
48319923|NCT01236560|155371122|FG000|Overall Study|Lost to Follow-up|0|||
48319924|NCT01236560|155371123|FG001|Overall Study|Lost to Follow-up|1|||
48319925|NCT01236560|155371124|FG002|Overall Study|Lost to Follow-up|1|||
48319926|NCT01236560|155371125|FG003|Overall Study|Lost to Follow-up|0|||
48319927|NCT01236560|155371126|FG004|Overall Study|Lost to Follow-up|0|||
48319928|NCT01236560|155371127|FG005|Overall Study|Lost to Follow-up|0|||
48319929|NCT01236560|155371122|FG000|Overall Study|Physician Decision|0|||
48319930|NCT01236560|155371123|FG001|Overall Study|Physician Decision|1|||
48319931|NCT01236560|155371124|FG002|Overall Study|Physician Decision|8|||
48319932|NCT01236560|155371125|FG003|Overall Study|Physician Decision|0|||
48319933|NCT01236560|155371126|FG004|Overall Study|Physician Decision|0|||
48319934|NCT01236560|155371127|FG005|Overall Study|Physician Decision|0|||
48319935|NCT01236560|155371122|FG000|Overall Study|Withdrawal by Subject|0|||
48319936|NCT01236560|155371123|FG001|Overall Study|Withdrawal by Subject|0|||
48319937|NCT01236560|155371124|FG002|Overall Study|Withdrawal by Subject|1|||
48319938|NCT01236560|155371125|FG003|Overall Study|Withdrawal by Subject|2|||
48319939|NCT01236560|155371126|FG004|Overall Study|Withdrawal by Subject|0|||
48319940|NCT01236560|155371127|FG005|Overall Study|Withdrawal by Subject|0|||
48319941|NCT01236560|155371122|FG000|Overall Study|Progressive disease|5|||
48319942|NCT01236560|155371123|FG001|Overall Study|Progressive disease|19|||
48319943|NCT01236560|155371124|FG002|Overall Study|Progressive disease|9|||
48319944|NCT01236560|155371125|FG003|Overall Study|Progressive disease|16|||
48319945|NCT01236560|155371126|FG004|Overall Study|Progressive disease|0|||
48319946|NCT01236560|155371127|FG005|Overall Study|Progressive disease|0|||
48319947|NCT00088413|155371130|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
48319948|NCT00088413|155371131|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
48319949|NCT00088413|155371132|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
48319950|NCT00088413|155371133|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
48319951|NCT00088413|155371130|FG000|Overall Study|Adverse Events/Side Effects|0|||
48319952|NCT00088413|155371131|FG001|Overall Study|Adverse Events/Side Effects|1|||
48319953|NCT00088413|155371132|FG002|Overall Study|Adverse Events/Side Effects|1|||
48319954|NCT00088413|155371133|FG003|Overall Study|Adverse Events/Side Effects|0|||
48319955|NCT00088413|155371130|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
48319956|NCT00088413|155371131|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
48319957|NCT00088413|155371132|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
48319958|NCT00088413|155371133|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
48319959|NCT00088413|155371130|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
48319960|NCT00088413|155371131|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
48319961|NCT00088413|155371132|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
48736950|NCT03307785|156887980|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736951|NCT03307785|156887981|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736952|NCT03307785|156887982|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
48736953|NCT03307785|156887983|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736954|NCT03307785|156887984|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48319962|NCT00088413|155371133|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
48319963|NCT00088413|155371130|FG000|Overall Study|Death|0|||
48319964|NCT00088413|155371131|FG001|Overall Study|Death|1|||
48319965|NCT00088413|155371132|FG002|Overall Study|Death|0|||
48319966|NCT00088413|155371133|FG003|Overall Study|Death|0|||
48319967|NCT00088413|155371130|FG000|Overall Study|Progressive disease|9|||
48319968|NCT00088413|155371131|FG001|Overall Study|Progressive disease|11|||
48736955|NCT03307785|156887985|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736956|NCT03307785|156887986|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736957|NCT03307785|156887987|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736958|NCT03307785|156887988|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736959|NCT03307785|156887989|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736960|NCT03307785|156887990|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
48736961|NCT03307785|156887980|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736962|NCT03307785|156887981|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736963|NCT03307785|156887982|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736964|NCT03307785|156887983|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
48736965|NCT03307785|156887984|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
48736966|NCT03307785|156887985|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736967|NCT03307785|156887986|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736968|NCT03307785|156887987|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736969|NCT03307785|156887988|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736970|NCT03307785|156887989|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736971|NCT03307785|156887990|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
48736972|NCT03307785|156887980|FG000|Part C: Up to Approx. 60 Months|Death|0|||
48736973|NCT03307785|156887981|FG001|Part C: Up to Approx. 60 Months|Death|0|||
48736974|NCT03307785|156887982|FG002|Part C: Up to Approx. 60 Months|Death|0|||
48736975|NCT03307785|156887983|FG003|Part C: Up to Approx. 60 Months|Death|2|||
48736976|NCT03307785|156887984|FG004|Part C: Up to Approx. 60 Months|Death|5|||
48736977|NCT03307785|156887985|FG005|Part C: Up to Approx. 60 Months|Death|0|||
48736978|NCT03307785|156887986|FG006|Part C: Up to Approx. 60 Months|Death|0|||
48736979|NCT03307785|156887987|FG007|Part C: Up to Approx. 60 Months|Death|0|||
48736980|NCT03307785|156887988|FG008|Part C: Up to Approx. 60 Months|Death|0|||
48578698|NCT00824382|156308699|FG000|Overall Study|Investigator's decision|0|||
48578699|NCT00824382|156308700|FG001|Overall Study|Investigator's decision|1|||
48578700|NCT00824382|156308701|FG002|Overall Study|Investigator's decision|2|||
48578701|NCT00824382|156308702|FG003|Overall Study|Investigator's decision|0|||
48578702|NCT01984892|156308703|FG000|Overall Study|Progressive disease|7|||
48578703|NCT00721279|156308704|FG000|Overall Study|Lack of Efficacy|6|||
48578704|NCT00721279|156308705|FG001|Overall Study|Lack of Efficacy|3|||
48578705|NCT00721279|156308704|FG000|Overall Study|Tolerability insufficient|5|||
48578706|NCT00721279|156308705|FG001|Overall Study|Tolerability insufficient|2|||
48578707|NCT00721279|156308704|FG000|Overall Study|Withdrawal by Subject|13|||
48578708|NCT00721279|156308705|FG001|Overall Study|Withdrawal by Subject|3|||
48319969|NCT00088413|155371132|FG002|Overall Study|Progressive disease|8|||
48578709|NCT00721279|156308704|FG000|Overall Study|Other|12|||
48578710|NCT00721279|156308705|FG001|Overall Study|Other|16|||
48578711|NCT04852679|156308708|FG000|Main Intervention Period|Withdrawal by Subject|3|||
48578712|NCT04852679|156308708|FG000|Main Intervention Period|Adverse Event|1|||
48578713|NCT04852679|156308708|FG000|Main Intervention Period|Progressive Disease|16|||
48578714|NCT04852679|156308708|FG000|Main Intervention Period|Refused study visit|1|||
48736981|NCT03307785|156887989|FG009|Part C: Up to Approx. 60 Months|Death|0|||
48736982|NCT03307785|156887990|FG010|Part C: Up to Approx. 60 Months|Death|0|||
48736983|NCT03307785|156887980|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736984|NCT03307785|156887981|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736985|NCT03307785|156887982|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48578715|NCT04852679|156308708|FG000|Independent Injection Period|Missed study visit|1|||
48578716|NCT03155178|156309829|FG000|Overall Study|Did not meet treatment day baseline|7|||
48578717|NCT03155178|156309830|FG001|Overall Study|Did not meet treatment day baseline|7|||
48319970|NCT00088413|155371133|FG003|Overall Study|Progressive disease|14|||
48319971|NCT00088413|155371130|FG000|Overall Study|Other|0|||
48319972|NCT00088413|155371131|FG001|Overall Study|Other|1|||
48319973|NCT00088413|155371132|FG002|Overall Study|Other|0|||
48319974|NCT00088413|155371133|FG003|Overall Study|Other|0|||
48319975|NCT00088413|155371130|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
48319976|NCT00088413|155371131|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
48319977|NCT00088413|155371132|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
48319978|NCT00088413|155371133|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
48319979|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
48319980|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
48319981|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
48319982|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
48319983|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
48319984|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
48319985|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
48319986|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
48319987|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
48578718|NCT03155178|156309831|FG002|Overall Study|Did not meet treatment day baseline|7|||
48578719|NCT03155178|156309832|FG003|Overall Study|Did not meet treatment day baseline|7|||
48578720|NCT02833844|156309833|FG000|Double-Blind Period|Withdrawal by Subject|2|||
48578721|NCT02833844|156309834|FG001|Double-Blind Period|Withdrawal by Subject|3|||
48578722|NCT02833844|156309833|FG000|Double-Blind Period|Protocol Violation|0|||
48319988|NCT03939312|155371134|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
48319989|NCT03939312|155371134|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
48578723|NCT02833844|156309834|FG001|Double-Blind Period|Protocol Violation|4|||
48578724|NCT02833844|156309833|FG000|Open-Label Period|Death|0|||
48578725|NCT02833844|156309834|FG001|Open-Label Period|Death|2|||
48578726|NCT02833844|156309833|FG000|Open-Label Period|Lost to Follow-up|1|||
48578727|NCT02833844|156309834|FG001|Open-Label Period|Lost to Follow-up|0|||
48578728|NCT02833844|156309833|FG000|Open-Label Period|Withdrawal by Subject|1|||
48578729|NCT02833844|156309834|FG001|Open-Label Period|Withdrawal by Subject|0|||
48578730|NCT00937040|156309835|FG000|Overall Study|Adverse Event|5|||
48578731|NCT00937040|156309836|FG001|Overall Study|Adverse Event|8|||
48578732|NCT00937040|156309835|FG000|Overall Study|Lost to Follow-up|12|||
48578733|NCT00937040|156309836|FG001|Overall Study|Lost to Follow-up|12|||
48578734|NCT00937040|156309835|FG000|Overall Study|Protocol Violation|3|||
48578735|NCT00937040|156309836|FG001|Overall Study|Protocol Violation|0|||
48578736|NCT00937040|156309835|FG000|Overall Study|Withdrawal by Subject|13|||
48578737|NCT00937040|156309836|FG001|Overall Study|Withdrawal by Subject|7|||
48578738|NCT00937040|156309835|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
48578739|NCT00937040|156309836|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
48578740|NCT00937040|156309835|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
48578741|NCT00937040|156309836|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
48578742|NCT00348790|156309843|FG000|Completed Treatment|Withdrawal by Subject|4|||
48319990|NCT03939312|155371134|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
48578743|NCT00348790|156309843|FG000|Completed Treatment|Disease progression|14|||
48578744|NCT00348790|156309843|FG000|Completed Treatment|Adverse Event|4|||
48578745|NCT00348790|156309843|FG000|Completed Treatment|Required surgery|2|||
48578746|NCT00348790|156309843|FG000|Completed Treatment|Unable to travel to study site|1|||
48578747|NCT01044290|156309844|FG000|Follow-up 1|Death|3|||
48578748|NCT01044290|156309845|FG001|Follow-up 1|Death|3|||
48578749|NCT01044290|156309846|FG002|Follow-up 1|Death|1|||
48578750|NCT01044290|156309844|FG000|Follow-up 1|Withdrawal by Subject|2|||
48578751|NCT01044290|156309845|FG001|Follow-up 1|Withdrawal by Subject|2|||
48578752|NCT01044290|156309846|FG002|Follow-up 1|Withdrawal by Subject|0|||
48578753|NCT01044290|156309844|FG000|Follow-Up 2|Death|0|||
48578754|NCT01044290|156309845|FG001|Follow-Up 2|Death|1|||
48578755|NCT01044290|156309846|FG002|Follow-Up 2|Death|1|||
48578756|NCT01044290|156309844|FG000|Follow-Up 2|Withdrawal by Subject|0|||
48578757|NCT01044290|156309845|FG001|Follow-Up 2|Withdrawal by Subject|1|||
48578758|NCT01044290|156309846|FG002|Follow-Up 2|Withdrawal by Subject|1|||
48578759|NCT02662764|156309847|FG000|Overall Study|Adverse Event|6|||
48578760|NCT02662764|156309847|FG000|Overall Study|Lack of Efficacy|8|||
48578761|NCT02662764|156309847|FG000|Overall Study|Protocol Violation|1|||
48578762|NCT02662764|156309847|FG000|Overall Study|Withdrawal by Subject|5|||
48578763|NCT02662764|156309847|FG000|Overall Study|Device failure|4|||
48578764|NCT02662764|156309847|FG000|Overall Study|Patient changed treatment|1|||
48578765|NCT02662764|156309847|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
48578766|NCT04186806|156309848|FG000|Period 1: 7 Days|Adverse Event|1|||
48578767|NCT04186806|156309849|FG001|Period 1: 7 Days|Adverse Event|0|||
48578768|NCT00759785|156309855|FG000|Overall Study|Participant sample not evaluable|11|||
48578769|NCT00759785|156309856|FG001|Overall Study|Participant sample not evaluable|2|||
48320001|NCT05613205|155372500|FG000|Overall Study|Lost to Follow-up|0|||
48578770|NCT00759785|156309855|FG000|Overall Study|Participant sample lost|0|||
48578771|NCT00759785|156309856|FG001|Overall Study|Participant sample lost|1|||
48578772|NCT00759785|156309855|FG000|Overall Study|Protocol Violation|1|||
48578773|NCT00759785|156309856|FG001|Overall Study|Protocol Violation|0|||
48578774|NCT00759785|156309855|FG000|Overall Study|Physician Decision|0|||
48578775|NCT00759785|156309856|FG001|Overall Study|Physician Decision|1|||
48578776|NCT00759785|156309855|FG000|Overall Study|Withdrawal by Subject|0|||
48578777|NCT00759785|156309856|FG001|Overall Study|Withdrawal by Subject|1|||
48578778|NCT00089778|156309857|FG000|Overall Study|Protocol Violation|0|||
48578779|NCT00089778|156309858|FG001|Overall Study|Protocol Violation|0|||
48578780|NCT00089778|156309859|FG002|Overall Study|Protocol Violation|1|||
48736986|NCT03307785|156887983|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
48736987|NCT03307785|156887984|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736988|NCT03307785|156887985|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736989|NCT03307785|156887986|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736990|NCT03307785|156887987|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736991|NCT03307785|156887988|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736992|NCT03307785|156887989|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736993|NCT03307785|156887990|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
48736994|NCT03307785|156887980|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48736995|NCT03307785|156887981|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48736996|NCT03307785|156887982|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48736997|NCT03307785|156887983|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48736998|NCT03307785|156887984|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
48736999|NCT03307785|156887985|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737000|NCT03307785|156887986|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737001|NCT03307785|156887987|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737002|NCT03307785|156887988|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48578781|NCT02733185|156309860|FG000|Overall Study|Withdrawal by Subject|12|||
48578782|NCT02733185|156309861|FG001|Overall Study|Withdrawal by Subject|10|||
48578783|NCT02733185|156309862|FG002|Overall Study|Withdrawal by Subject|17|||
48578784|NCT02733185|156309863|FG003|Overall Study|Withdrawal by Subject|21|||
48578785|NCT02733185|156309860|FG000|Overall Study|Death|46|||
48578786|NCT02733185|156309861|FG001|Overall Study|Death|34|||
48578787|NCT02733185|156309862|FG002|Overall Study|Death|35|||
48578788|NCT02733185|156309863|FG003|Overall Study|Death|43|||
48578789|NCT02733185|156309860|FG000|Overall Study|Lost to Follow-up|17|||
48578790|NCT02733185|156309861|FG001|Overall Study|Lost to Follow-up|18|||
48578791|NCT02733185|156309862|FG002|Overall Study|Lost to Follow-up|16|||
48578792|NCT02733185|156309863|FG003|Overall Study|Lost to Follow-up|11|||
48578793|NCT00177307|156309864|FG000|Overall Study|Withdrawal by Subject|1|||
48578794|NCT04712019|156309868|FG000|Overall Study|Withdrawal by Subject|2|||
48578795|NCT04712019|156309869|FG001|Overall Study|Withdrawal by Subject|2|||
48578796|NCT04712019|156309868|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
48578797|NCT04712019|156309869|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
48578798|NCT01664949|156309876|FG000|Overall Study|Adverse Event|11|||
48578799|NCT01664949|156309877|FG001|Overall Study|Adverse Event|12|||
48737003|NCT03307785|156887989|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48737004|NCT03307785|156887990|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
48578800|NCT01664949|156309876|FG000|Overall Study|Lack of Efficacy|1|||
48578801|NCT01664949|156309877|FG001|Overall Study|Lack of Efficacy|1|||
48578802|NCT01664949|156309876|FG000|Overall Study|Lost to Follow-up|1|||
48578803|NCT01664949|156309877|FG001|Overall Study|Lost to Follow-up|2|||
48578804|NCT01664949|156309876|FG000|Overall Study|Personal Reasons|3|||
48578805|NCT01664949|156309877|FG001|Overall Study|Personal Reasons|4|||
48578806|NCT01664949|156309876|FG000|Overall Study|Protocol Violation|5|||
48578807|NCT01664949|156309877|FG001|Overall Study|Protocol Violation|5|||
48578808|NCT01664949|156309876|FG000|Overall Study|Other Miscellaneous Reasons|3|||
48737005|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737006|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48320002|NCT05613205|155372501|FG001|Overall Study|Lost to Follow-up|0|||
48737007|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737008|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48320003|NCT05613205|155372502|FG002|Overall Study|Lost to Follow-up|1|||
48320004|NCT05613205|155372503|FG003|Overall Study|Lost to Follow-up|1|||
48320005|NCT05613205|155372504|FG004|Overall Study|Lost to Follow-up|0|||
48320006|NCT05613205|155372500|FG000|Overall Study|Withdrawal by Subject|0|||
48320007|NCT05613205|155372501|FG001|Overall Study|Withdrawal by Subject|0|||
48578809|NCT01664949|156309877|FG001|Overall Study|Other Miscellaneous Reasons|1|||
48578810|NCT02777970|156309878|FG000|Overall Study|Lost to Follow-up|0|||
48320008|NCT05613205|155372502|FG002|Overall Study|Withdrawal by Subject|1|||
48578811|NCT02777970|156309879|FG001|Overall Study|Lost to Follow-up|1|||
48578812|NCT02777970|156309880|FG002|Overall Study|Lost to Follow-up|0|||
48450302|NCT03365947|155835681|FG011|Overall Study|Lost to Follow-up|0|||
48578813|NCT02777970|156309878|FG000|Overall Study|Protocol Violation|1|||
48320009|NCT05613205|155372503|FG003|Overall Study|Withdrawal by Subject|1|||
48320010|NCT05613205|155372504|FG004|Overall Study|Withdrawal by Subject|0|||
48320011|NCT02566902|155372508|FG000|Overall Study|Protocol Violation|2|||
48320012|NCT02566902|155372509|FG001|Overall Study|Protocol Violation|1|||
48320013|NCT00411151|155372510|FG000|Overall Study|Death|38|||
48578814|NCT02777970|156309879|FG001|Overall Study|Protocol Violation|0|||
48578815|NCT02777970|156309880|FG002|Overall Study|Protocol Violation|0|||
48578816|NCT01967706|156309881|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
48578817|NCT01967706|156309882|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
48578818|NCT01967706|156309883|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
48578819|NCT01967706|156309884|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
48578820|NCT02541669|156309890|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
48578821|NCT02541669|156309891|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
48578822|NCT02541669|156309892|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
48578823|NCT02541669|156309893|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
48578824|NCT02541669|156309894|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
48578825|NCT03535740|156309895|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
48578826|NCT03535740|156309895|FG000|Overall Study|Death|34|||
48578827|NCT03535740|156309895|FG000|Overall Study|Lost to Follow-up|1|||
48578828|NCT03535740|156309895|FG000|Overall Study|Withdrawal by Subject|13|||
48578829|NCT00834639|156309898|FG000|Second Intervention|Physician Decision|0|||
48578830|NCT00834639|156309899|FG001|Second Intervention|Physician Decision|2|||
48578831|NCT04739722|156309900|FG000|Overall Study|Lost to Follow-up|5301|||
48578832|NCT04739722|156309900|FG000|Overall Study|Withdrawal by Subject|42|||
48578833|NCT04739722|156309900|FG000|Overall Study|Non Average-risk|1157|||
48578834|NCT00725608|156309904|FG000|Overall Study|Lost to Follow-up|60|||
48578835|NCT00725608|156309904|FG000|Overall Study|Adverse Event|14|||
48578836|NCT00725608|156309904|FG000|Overall Study|Individual reasons|86|||
48578837|NCT00725608|156309904|FG000|Overall Study|Other|7|||
48578838|NCT00199797|156309908|FG000|Overall Study|Progressive Disease|1|||
48578839|NCT00199797|156309908|FG000|Overall Study|Adverse Event|1|||
48578840|NCT00199797|156309908|FG000|Overall Study|Physician Decision|1|||
48578841|NCT00614120|156309913|FG000|Overall Study|Adverse Event|9|||
48578842|NCT00614120|156309914|FG001|Overall Study|Adverse Event|22|||
48578843|NCT00614120|156309915|FG002|Overall Study|Adverse Event|30|||
48578844|NCT00614120|156309916|FG003|Overall Study|Adverse Event|3|||
48578845|NCT00614120|156309913|FG000|Overall Study|Lack of Efficacy|3|||
48578846|NCT00614120|156309914|FG001|Overall Study|Lack of Efficacy|3|||
48578847|NCT00614120|156309915|FG002|Overall Study|Lack of Efficacy|2|||
48578848|NCT00614120|156309916|FG003|Overall Study|Lack of Efficacy|2|||
48578849|NCT00614120|156309913|FG000|Overall Study|Protocol Violation|2|||
48578850|NCT00614120|156309914|FG001|Overall Study|Protocol Violation|5|||
48578851|NCT00614120|156309915|FG002|Overall Study|Protocol Violation|3|||
48578852|NCT00614120|156309916|FG003|Overall Study|Protocol Violation|1|||
48578853|NCT00614120|156309913|FG000|Overall Study|Withdrawal criteria|1|||
48578854|NCT00614120|156309914|FG001|Overall Study|Withdrawal criteria|0|||
48578855|NCT00614120|156309915|FG002|Overall Study|Withdrawal criteria|0|||
48578856|NCT00614120|156309916|FG003|Overall Study|Withdrawal criteria|0|||
48578857|NCT00614120|156309913|FG000|Overall Study|Withdrawal by Subject|9|||
48578858|NCT00614120|156309914|FG001|Overall Study|Withdrawal by Subject|10|||
48578859|NCT00614120|156309915|FG002|Overall Study|Withdrawal by Subject|16|||
48578860|NCT00614120|156309916|FG003|Overall Study|Withdrawal by Subject|3|||
48578861|NCT00614120|156309913|FG000|Overall Study|Did not meet trial criteria|0|||
48578862|NCT00614120|156309914|FG001|Overall Study|Did not meet trial criteria|1|||
48578863|NCT00614120|156309915|FG002|Overall Study|Did not meet trial criteria|1|||
48578864|NCT00614120|156309916|FG003|Overall Study|Did not meet trial criteria|1|||
48578865|NCT00614120|156309913|FG000|Overall Study|hCG positive (not pregnant)|0|||
48578866|NCT00614120|156309914|FG001|Overall Study|hCG positive (not pregnant)|0|||
48578867|NCT00614120|156309915|FG002|Overall Study|hCG positive (not pregnant)|1|||
48578868|NCT00614120|156309916|FG003|Overall Study|hCG positive (not pregnant)|0|||
48578869|NCT00614120|156309913|FG000|Overall Study|Hypoglycaemia|0|||
48578870|NCT00614120|156309914|FG001|Overall Study|Hypoglycaemia|0|||
48320014|NCT00411151|155372510|FG000|Overall Study|Withdrawal by Subject|2|||
48578871|NCT00614120|156309915|FG002|Overall Study|Hypoglycaemia|0|||
48578872|NCT00614120|156309916|FG003|Overall Study|Hypoglycaemia|1|||
48578873|NCT00614120|156309913|FG000|Overall Study|Lack of trial product|3|||
48578874|NCT00614120|156309914|FG001|Overall Study|Lack of trial product|3|||
48578875|NCT00614120|156309915|FG002|Overall Study|Lack of trial product|2|||
48578876|NCT00614120|156309916|FG003|Overall Study|Lack of trial product|0|||
48578877|NCT00614120|156309913|FG000|Overall Study|Late syphilis, latent|1|||
48578878|NCT00614120|156309914|FG001|Overall Study|Late syphilis, latent|0|||
48578879|NCT00614120|156309915|FG002|Overall Study|Late syphilis, latent|0|||
48578880|NCT00614120|156309916|FG003|Overall Study|Late syphilis, latent|0|||
48578881|NCT00614120|156309913|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
48578882|NCT00614120|156309914|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
48578883|NCT00614120|156309915|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
48578884|NCT00614120|156309916|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
48578885|NCT00614120|156309913|FG000|Overall Study|Lost to Follow-up|1|||
48578886|NCT00614120|156309914|FG001|Overall Study|Lost to Follow-up|2|||
48578887|NCT00614120|156309915|FG002|Overall Study|Lost to Follow-up|3|||
48578888|NCT00614120|156309916|FG003|Overall Study|Lost to Follow-up|4|||
48578889|NCT03047720|156309917|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
48578890|NCT03047720|156309918|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
48578891|NCT00784238|156309919|FG000|Overall Study|Adverse Event|14|||
48578892|NCT00784238|156309919|FG000|Overall Study|Death|2|||
48578893|NCT00784238|156309919|FG000|Overall Study|Lack of Efficacy|33|||
48578894|NCT00784238|156309919|FG000|Overall Study|Lost to Follow-up|29|||
48578895|NCT00784238|156309919|FG000|Overall Study|Pregnancy|1|||
48578896|NCT00784238|156309919|FG000|Overall Study|Withdrawal by Subject|26|||
48578897|NCT00784238|156309919|FG000|Overall Study|Other|14|||
48578898|NCT01698879|156309920|FG000|Overall Study|Withdrawal by Subject|1|||
48578899|NCT01698879|156309921|FG001|Overall Study|Withdrawal by Subject|0|||
48578900|NCT01698879|156309922|FG002|Overall Study|Withdrawal by Subject|0|||
48578901|NCT04972968|156309925|FG000|Overall Study|Adverse Event|3|||
48578902|NCT04972968|156309926|FG001|Overall Study|Adverse Event|1|||
48578903|NCT04972968|156309927|FG002|Overall Study|Adverse Event|1|||
48578904|NCT04972968|156309928|FG003|Overall Study|Adverse Event|7|||
48578905|NCT04972968|156309925|FG000|Overall Study|Lack of Efficacy|2|||
48578906|NCT04972968|156309926|FG001|Overall Study|Lack of Efficacy|1|||
48578907|NCT04972968|156309927|FG002|Overall Study|Lack of Efficacy|0|||
48578908|NCT04972968|156309928|FG003|Overall Study|Lack of Efficacy|0|||
48578909|NCT04972968|156309925|FG000|Overall Study|Withdrawal by Subject|7|||
48578910|NCT04972968|156309926|FG001|Overall Study|Withdrawal by Subject|4|||
48578911|NCT04972968|156309927|FG002|Overall Study|Withdrawal by Subject|3|||
48578912|NCT04972968|156309928|FG003|Overall Study|Withdrawal by Subject|2|||
48578913|NCT04972968|156309925|FG000|Overall Study|Study Terminated by Sponsor|25|||
48578914|NCT04972968|156309926|FG001|Overall Study|Study Terminated by Sponsor|28|||
48578915|NCT04972968|156309927|FG002|Overall Study|Study Terminated by Sponsor|32|||
48578916|NCT04972968|156309928|FG003|Overall Study|Study Terminated by Sponsor|27|||
48578917|NCT04972968|156309925|FG000|Overall Study|Other|1|||
48578918|NCT04972968|156309926|FG001|Overall Study|Other|0|||
48578919|NCT04972968|156309927|FG002|Overall Study|Other|1|||
48578920|NCT04972968|156309928|FG003|Overall Study|Other|1|||
48578921|NCT03589976|156309933|FG000|Overall Study|Death|5|||
48578922|NCT03589976|156309934|FG001|Overall Study|Death|1|||
48578923|NCT03589976|156309933|FG000|Overall Study|Adverse Event|5|||
48578924|NCT03589976|156309934|FG001|Overall Study|Adverse Event|1|||
48578925|NCT03589976|156309933|FG000|Overall Study|Withdrawal by Subject|4|||
48578926|NCT03589976|156309934|FG001|Overall Study|Withdrawal by Subject|1|||
48578927|NCT03589976|156309933|FG000|Overall Study|Lost to Follow-up|1|||
48578928|NCT03589976|156309934|FG001|Overall Study|Lost to Follow-up|0|||
48578929|NCT03589976|156309933|FG000|Overall Study|Other|4|||
48578930|NCT03589976|156309934|FG001|Overall Study|Other|3|||
48578931|NCT00710684|156309941|FG000|Overall Study|Adverse Event|11|||
48578932|NCT00710684|156309942|FG001|Overall Study|Adverse Event|19|||
48578933|NCT00710684|156309943|FG002|Overall Study|Adverse Event|16|||
48578934|NCT00710684|156309941|FG000|Overall Study|Lack of Efficacy|4|||
48578935|NCT00710684|156309942|FG001|Overall Study|Lack of Efficacy|3|||
48578936|NCT00710684|156309943|FG002|Overall Study|Lack of Efficacy|5|||
48578937|NCT00710684|156309941|FG000|Overall Study|Protocol Violation|5|||
48578938|NCT00710684|156309942|FG001|Overall Study|Protocol Violation|5|||
48578939|NCT00710684|156309943|FG002|Overall Study|Protocol Violation|5|||
48578940|NCT00710684|156309941|FG000|Overall Study|Lost to Follow-up|4|||
48578941|NCT00710684|156309942|FG001|Overall Study|Lost to Follow-up|6|||
48578942|NCT00710684|156309943|FG002|Overall Study|Lost to Follow-up|7|||
48578943|NCT00710684|156309941|FG000|Overall Study|Physician Decision|0|||
48578944|NCT00710684|156309942|FG001|Overall Study|Physician Decision|2|||
48578945|NCT00710684|156309943|FG002|Overall Study|Physician Decision|4|||
48578946|NCT00710684|156309941|FG000|Overall Study|Withdrawal by Subject|24|||
48320015|NCT00411151|155372510|FG000|Overall Study|Lost to Follow-up|2|||
48578947|NCT00710684|156309942|FG001|Overall Study|Withdrawal by Subject|18|||
48578948|NCT00710684|156309943|FG002|Overall Study|Withdrawal by Subject|11|||
48578949|NCT00710684|156309941|FG000|Overall Study|Missing|1|||
48320016|NCT00411151|155372510|FG000|Overall Study|Protocol Violation|1|||
48578950|NCT00710684|156309942|FG001|Overall Study|Missing|0|||
48578951|NCT00710684|156309943|FG002|Overall Study|Missing|0|||
48578952|NCT00710684|156309941|FG000|Overall Study|Did not continue after week 24|25|||
48578953|NCT00710684|156309942|FG001|Overall Study|Did not continue after week 24|21|||
48578954|NCT00710684|156309943|FG002|Overall Study|Did not continue after week 24|16|||
48578955|NCT02276053|156312492|FG000|Overall Study|Death|2|||
48320017|NCT00411151|155372510|FG000|Overall Study|Trial prematurely closed|4|||
48578956|NCT02276053|156312492|FG000|Overall Study|Adverse Event|5|||
48578957|NCT02276053|156312492|FG000|Overall Study|Lack of Efficacy|2|||
48578958|NCT02276053|156312492|FG000|Overall Study|Withdrawal by Subject|1|||
48578959|NCT02276053|156312492|FG000|Overall Study|Patient does not meet selection criteria|3|||
48737009|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737010|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
48737011|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737012|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737013|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737014|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48737015|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
48578960|NCT02276053|156312492|FG000|Overall Study|Patient needs to increase baseline AED|1|||
48578961|NCT02730377|156312493|FG000|Overall Study|Other|5|||
48578962|NCT02730377|156312494|FG001|Overall Study|Other|4|||
48578963|NCT02730377|156312493|FG000|Overall Study|Death|1|||
48578964|NCT02730377|156312494|FG001|Overall Study|Death|8|||
48578965|NCT02730377|156312493|FG000|Overall Study|Inadequate glycaemic control|368|||
48578966|NCT02730377|156312494|FG001|Overall Study|Inadequate glycaemic control|473|||
48578967|NCT02730377|156312493|FG000|Overall Study|Adverse Event|79|||
48578968|NCT02730377|156312494|FG001|Overall Study|Adverse Event|41|||
48578969|NCT02730377|156312493|FG000|Overall Study|Protocol Violation|23|||
48578970|NCT02730377|156312494|FG001|Overall Study|Protocol Violation|30|||
48578971|NCT02730377|156312493|FG000|Overall Study|Lack of Efficacy|4|||
48737016|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
48737017|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
48737018|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
48737019|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
48737020|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
48737021|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
48737022|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
48737023|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
48737024|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
48320018|NCT03345901|155372516|FG000|Overall Study|The study was terminated|18|||
48320019|NCT01622868|155372522|FG000|Overall Study|Protocol Violation|7|||
48320020|NCT01622868|155372523|FG001|Overall Study|Protocol Violation|0|||
48320021|NCT00714714|155372527|FG000|Overall Study|Adverse Event|1|||
48320022|NCT01184326|155372528|FG000|Overall Study|Adverse Event|1|||
48578972|NCT02730377|156312494|FG001|Overall Study|Lack of Efficacy|13|||
48578973|NCT02730377|156312493|FG000|Overall Study|Pregnancy|0|||
48578974|NCT02730377|156312494|FG001|Overall Study|Pregnancy|1|||
48578975|NCT02730377|156312493|FG000|Overall Study|Withdrawal by Subject|45|||
48578976|NCT02730377|156312494|FG001|Overall Study|Withdrawal by Subject|42|||
48578977|NCT02730377|156312493|FG000|Overall Study|Lost to Follow-up|25|||
48578978|NCT02730377|156312494|FG001|Overall Study|Lost to Follow-up|21|||
48578979|NCT03339726|156312495|FG000|Overall Study|Withdrawal by Subject|1|||
48578980|NCT03339726|156312496|FG001|Overall Study|Withdrawal by Subject|0|||
48578981|NCT03339726|156312497|FG002|Overall Study|Withdrawal by Subject|0|||
48578982|NCT03339726|156312495|FG000|Overall Study|Lost to Follow-up|0|||
48578983|NCT03339726|156312496|FG001|Overall Study|Lost to Follow-up|1|||
48578984|NCT03339726|156312497|FG002|Overall Study|Lost to Follow-up|0|||
48578985|NCT01275755|156312500|FG000|Double-blind Treatment Period|Adverse Event|0|||
48578986|NCT01275755|156312501|FG001|Double-blind Treatment Period|Adverse Event|2|||
48578987|NCT01275755|156312500|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
48578988|NCT01275755|156312501|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
48578989|NCT01275755|156312500|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
48578990|NCT01275755|156312501|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
48578991|NCT01275755|156312500|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
48578992|NCT01275755|156312501|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
48578993|NCT00504725|156312502|FG000|Overall Study|Protocol Violation|1|||
48578994|NCT00504725|156312503|FG001|Overall Study|Protocol Violation|0|||
48578995|NCT03692325|156312515|FG000|Overall Study|Adverse Event|2|||
48578996|NCT03692325|156312515|FG000|Overall Study|Progression/Recurrence|2|||
48578997|NCT02908672|156312516|FG000|Overall Study|Death|112|||
48578998|NCT02908672|156312517|FG001|Overall Study|Death|93|||
48578999|NCT02908672|156312516|FG000|Overall Study|Lost to Follow-up|3|||
48737025|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
48737026|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
48737027|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737028|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737029|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737030|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737031|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737032|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
48320023|NCT01184326|155372529|FG001|Overall Study|Adverse Event|2|||
48579000|NCT02908672|156312517|FG001|Overall Study|Lost to Follow-up|3|||
48579001|NCT02908672|156312516|FG000|Overall Study|Other|2|||
48579002|NCT02908672|156312517|FG001|Overall Study|Other|0|||
48579003|NCT02908672|156312516|FG000|Overall Study|Protocol Violation|1|||
48579004|NCT02908672|156312517|FG001|Overall Study|Protocol Violation|1|||
48320024|NCT01184326|155372530|FG002|Overall Study|Adverse Event|0|||
48320025|NCT01184326|155372528|FG000|Overall Study|Death|0|||
48320026|NCT01184326|155372529|FG001|Overall Study|Death|0|||
48320027|NCT01184326|155372530|FG002|Overall Study|Death|1|||
48320028|NCT01184326|155372528|FG000|Overall Study|Withdrawal by Subject|0|||
48320029|NCT01184326|155372529|FG001|Overall Study|Withdrawal by Subject|0|||
48320030|NCT01184326|155372530|FG002|Overall Study|Withdrawal by Subject|1|||
48320031|NCT01184326|155372528|FG000|Overall Study|Physician Decision|1|||
48320032|NCT01184326|155372529|FG001|Overall Study|Physician Decision|1|||
48320033|NCT01184326|155372530|FG002|Overall Study|Physician Decision|0|||
48320034|NCT01184326|155372528|FG000|Overall Study|Disease Progression|1|||
48320035|NCT01184326|155372529|FG001|Overall Study|Disease Progression|3|||
48320036|NCT01184326|155372530|FG002|Overall Study|Disease Progression|12|||
48320037|NCT01534494|155372533|FG000|Overall Study|Withdrawal by Subject|1|||
48320038|NCT00431834|155372534|FG000|Overall Study|Withdrawal by Subject|7|||
48320039|NCT00431834|155372534|FG000|Overall Study|Death|3|||
48320040|NCT00431834|155372534|FG000|Overall Study|Missed Endpoint Visit|2|||
48320041|NCT00431834|155372534|FG000|Overall Study|Lost to Follow-up|1|||
48320042|NCT01471691|155372535|FG000|Overall Study|Lack of Efficacy|0|||
48320043|NCT01471691|155372536|FG001|Overall Study|Lack of Efficacy|1|||
48320044|NCT02622568|155372544|FG000|Overall Study|Lost to Follow-up|5|||
48320045|NCT02622568|155372545|FG001|Overall Study|Lost to Follow-up|5|||
48320046|NCT01185561|155372546|FG000|Overall Study|Lost to Follow-up|0|||
48320047|NCT01185561|155372547|FG001|Overall Study|Lost to Follow-up|4|||
48320048|NCT01185561|155372546|FG000|Overall Study|Withdrawal by Subject|2|||
48320049|NCT01185561|155372547|FG001|Overall Study|Withdrawal by Subject|8|||
48320050|NCT02461628|155372548|FG000|Overall Study|Refused to complete survey|4|||
48320051|NCT02461628|155372549|FG001|Overall Study|Refused to complete survey|7|||
48320052|NCT02058108|155372551|FG000|Overall Study|Abnormal Laboratory Values|0|||
48320053|NCT02058108|155372552|FG001|Overall Study|Abnormal Laboratory Values|1|||
48579005|NCT02908672|156312516|FG000|Overall Study|Withdrawal by Subject|13|||
48579006|NCT02908672|156312517|FG001|Overall Study|Withdrawal by Subject|18|||
48579007|NCT02908672|156312516|FG000|Overall Study|Study is ongoing|124|||
48579008|NCT02908672|156312517|FG001|Overall Study|Study is ongoing|141|||
48579009|NCT02908672|156312516|FG000|Overall Study|Discontinued the study during run-in|3|||
48579010|NCT02908672|156312517|FG001|Overall Study|Discontinued the study during run-in|0|||
48737033|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737034|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737035|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737036|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737037|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
48737038|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737039|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737040|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737041|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737042|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737043|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
48737044|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737045|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737046|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737047|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737048|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
48737049|NCT03307785|156887980|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737050|NCT03307785|156887981|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737051|NCT03307785|156887982|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737052|NCT03307785|156887983|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737053|NCT03307785|156887984|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737054|NCT03307785|156887985|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
48737055|NCT03307785|156887986|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737056|NCT03307785|156887987|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737057|NCT03307785|156887988|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737058|NCT03307785|156887989|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48320054|NCT02058108|155372551|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
48320055|NCT02058108|155372552|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48320056|NCT02058108|155372551|FG000|Overall Study|No longer requires study drug|0|||
48320057|NCT02058108|155372552|FG001|Overall Study|No longer requires study drug|1|||
48320058|NCT02058108|155372551|FG000|Overall Study|Withdrawal by Subject|1|||
48320059|NCT02058108|155372552|FG001|Overall Study|Withdrawal by Subject|0|||
48579011|NCT01300338|156312520|FG000|Overall Study|Lost to Follow-up|5|||
48737059|NCT03307785|156887990|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
48737060|NCT03307785|156887980|FG000|Part E: Up to 4.4 Months|Death|0|||
48737061|NCT03307785|156887981|FG001|Part E: Up to 4.4 Months|Death|0|||
48737062|NCT03307785|156887982|FG002|Part E: Up to 4.4 Months|Death|0|||
48737063|NCT03307785|156887983|FG003|Part E: Up to 4.4 Months|Death|0|||
48737064|NCT03307785|156887984|FG004|Part E: Up to 4.4 Months|Death|0|||
48320060|NCT02058108|155372551|FG000|Overall Study|Administrative problems|3|||
48320061|NCT02058108|155372552|FG001|Overall Study|Administrative problems|3|||
48320062|NCT02058108|155372551|FG000|Overall Study|Protocol Violation|0|||
48320063|NCT02058108|155372552|FG001|Overall Study|Protocol Violation|1|||
48579012|NCT01300338|156312521|FG001|Overall Study|Lost to Follow-up|0|||
48579013|NCT02461524|156312528|FG000|Overall Study|Death|16|||
48579014|NCT02461524|156312528|FG000|Overall Study|Withdrawal by Subject|4|||
48579015|NCT02461524|156312528|FG000|Overall Study|Device Explanted|5|||
48579016|NCT02461524|156312528|FG000|Overall Study|Missed Visit|6|||
48579017|NCT01936181|156312534|FG000|Randomised, Double-blind|Adverse Event|27|||
48579018|NCT01936181|156312535|FG001|Randomised, Double-blind|Adverse Event|21|||
48579019|NCT01936181|156312536|FG002|Randomised, Double-blind|Adverse Event|0|||
48737065|NCT03307785|156887985|FG005|Part E: Up to 4.4 Months|Death|0|||
48320064|NCT02252042|155372557|FG000|Overall Study|Adverse Event|9|||
48320065|NCT02252042|155372558|FG001|Overall Study|Adverse Event|6|||
48320066|NCT02252042|155372557|FG000|Overall Study|Death|209|||
48320067|NCT02252042|155372558|FG001|Overall Study|Death|217|||
48320068|NCT02252042|155372557|FG000|Overall Study|Physician Decision|0|||
48320069|NCT02252042|155372558|FG001|Overall Study|Physician Decision|2|||
48320070|NCT02252042|155372557|FG000|Overall Study|Transferred to Extension Study|7|||
48320071|NCT02252042|155372558|FG001|Overall Study|Transferred to Extension Study|1|||
48320072|NCT02252042|155372557|FG000|Overall Study|Did Not Continue on Extension Study|7|||
48320073|NCT02252042|155372558|FG001|Overall Study|Did Not Continue on Extension Study|2|||
48320074|NCT02252042|155372557|FG000|Overall Study|Withdrawal by Subject|15|||
48320075|NCT02252042|155372558|FG001|Overall Study|Withdrawal by Subject|20|||
48320076|NCT00106080|155372564|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
48320077|NCT00106080|155372565|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
48320078|NCT02590432|155372569|FG000|Open-label Treatment Period|Adverse Event|97|||
48320079|NCT02590432|155372570|FG001|Open-label Treatment Period|Adverse Event|79|||
48737066|NCT03307785|156887986|FG006|Part E: Up to 4.4 Months|Death|1|||
48737067|NCT03307785|156887987|FG007|Part E: Up to 4.4 Months|Death|0|||
48737068|NCT03307785|156887988|FG008|Part E: Up to 4.4 Months|Death|0|||
48320080|NCT02590432|155372571|FG002|Open-label Treatment Period|Adverse Event|0|||
48320081|NCT02590432|155372572|FG003|Open-label Treatment Period|Adverse Event|0|||
48579020|NCT01936181|156312537|FG003|Randomised, Double-blind|Adverse Event|0|||
48579021|NCT01936181|156312534|FG000|Randomised, Double-blind|Protocol Violation|1|||
48579022|NCT01936181|156312535|FG001|Randomised, Double-blind|Protocol Violation|5|||
48579023|NCT01936181|156312536|FG002|Randomised, Double-blind|Protocol Violation|0|||
48579024|NCT01936181|156312537|FG003|Randomised, Double-blind|Protocol Violation|0|||
48579025|NCT01936181|156312534|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
48579026|NCT01936181|156312535|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
48579027|NCT01936181|156312536|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
48579028|NCT01936181|156312537|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
48579029|NCT01936181|156312534|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
48579030|NCT01936181|156312535|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
48579031|NCT01936181|156312536|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
48579032|NCT01936181|156312537|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
48579033|NCT01936181|156312534|FG000|Randomised, Double-blind|Pregnancy|0|||
48579034|NCT01936181|156312535|FG001|Randomised, Double-blind|Pregnancy|1|||
48579035|NCT01936181|156312536|FG002|Randomised, Double-blind|Pregnancy|0|||
48579036|NCT01936181|156312537|FG003|Randomised, Double-blind|Pregnancy|0|||
48579037|NCT01936181|156312534|FG000|Randomised, Double-blind|Physician Decision|4|||
48579038|NCT01936181|156312535|FG001|Randomised, Double-blind|Physician Decision|4|||
48579039|NCT01936181|156312536|FG002|Randomised, Double-blind|Physician Decision|0|||
48579040|NCT01936181|156312537|FG003|Randomised, Double-blind|Physician Decision|0|||
48579041|NCT01936181|156312534|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
48579042|NCT01936181|156312535|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
48579043|NCT01936181|156312536|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
48579044|NCT01936181|156312537|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
48579045|NCT01936181|156312534|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
48579046|NCT01936181|156312535|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
48579047|NCT01936181|156312536|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
48579048|NCT01936181|156312537|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
48579049|NCT01936181|156312534|FG000|Transition-extension|Adverse Event|3|||
48579050|NCT01936181|156312535|FG001|Transition-extension|Adverse Event|0|||
48579051|NCT01936181|156312536|FG002|Transition-extension|Adverse Event|3|||
48579052|NCT01936181|156312537|FG003|Transition-extension|Adverse Event|1|||
48579053|NCT01936181|156312534|FG000|Transition-extension|Lost to Follow-up|3|||
48579054|NCT01936181|156312535|FG001|Transition-extension|Lost to Follow-up|0|||
48579055|NCT01936181|156312536|FG002|Transition-extension|Lost to Follow-up|1|||
48579056|NCT01936181|156312537|FG003|Transition-extension|Lost to Follow-up|2|||
48579057|NCT01936181|156312534|FG000|Transition-extension|Physician Decision|2|||
48579058|NCT01936181|156312535|FG001|Transition-extension|Physician Decision|0|||
48579059|NCT01936181|156312536|FG002|Transition-extension|Physician Decision|0|||
48579060|NCT01936181|156312537|FG003|Transition-extension|Physician Decision|1|||
48579061|NCT01936181|156312534|FG000|Transition-extension|Withdrawal by Subject|7|||
48579062|NCT01936181|156312535|FG001|Transition-extension|Withdrawal by Subject|0|||
48579063|NCT01936181|156312536|FG002|Transition-extension|Withdrawal by Subject|2|||
48579064|NCT01936181|156312537|FG003|Transition-extension|Withdrawal by Subject|1|||
48579065|NCT00970632|156312538|FG000|Overall Study|Adverse Event|2|||
48579066|NCT00970632|156312539|FG001|Overall Study|Adverse Event|2|||
48579067|NCT00970632|156312540|FG002|Overall Study|Adverse Event|1|||
48579068|NCT00970632|156312538|FG000|Overall Study|Lack of Efficacy|3|||
48579069|NCT00970632|156312539|FG001|Overall Study|Lack of Efficacy|0|||
48579070|NCT00970632|156312540|FG002|Overall Study|Lack of Efficacy|0|||
48579071|NCT00970632|156312538|FG000|Overall Study|Lost to Follow-up|3|||
48579072|NCT00970632|156312539|FG001|Overall Study|Lost to Follow-up|0|||
48579073|NCT00970632|156312540|FG002|Overall Study|Lost to Follow-up|2|||
48579074|NCT00970632|156312538|FG000|Overall Study|Protocol Violation|8|||
48579075|NCT00970632|156312539|FG001|Overall Study|Protocol Violation|5|||
48579076|NCT00970632|156312540|FG002|Overall Study|Protocol Violation|8|||
48579077|NCT00970632|156312538|FG000|Overall Study|Withdrawal by Subject|7|||
48579078|NCT00970632|156312539|FG001|Overall Study|Withdrawal by Subject|6|||
48579079|NCT00970632|156312540|FG002|Overall Study|Withdrawal by Subject|4|||
48579080|NCT00970632|156312538|FG000|Overall Study|Entry criteria not met|0|||
48579081|NCT00970632|156312539|FG001|Overall Study|Entry criteria not met|2|||
48579082|NCT00970632|156312540|FG002|Overall Study|Entry criteria not met|2|||
48579083|NCT00970632|156312538|FG000|Overall Study|Sponsor decision|1|||
48579084|NCT00970632|156312539|FG001|Overall Study|Sponsor decision|0|||
48579085|NCT00970632|156312540|FG002|Overall Study|Sponsor decision|1|||
48579086|NCT00664859|156312541|FG000|Overall Study|Adverse Event|2|||
48737069|NCT03307785|156887989|FG009|Part E: Up to 4.4 Months|Death|0|||
48737070|NCT03307785|156887990|FG010|Part E: Up to 4.4 Months|Death|0|||
48737071|NCT03307785|156887980|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
48737072|NCT03307785|156887981|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
48737073|NCT03307785|156887982|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
48737074|NCT03307785|156887983|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
48737075|NCT03307785|156887984|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
48737076|NCT03307785|156887985|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
48737077|NCT03307785|156887986|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
48737078|NCT03307785|156887987|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
48737079|NCT03307785|156887988|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
48737080|NCT03307785|156887989|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
48737081|NCT03307785|156887990|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
48579087|NCT00664859|156312542|FG001|Overall Study|Adverse Event|1|||
48579088|NCT00664859|156312543|FG002|Overall Study|Adverse Event|3|||
48579089|NCT00664859|156312541|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
48579090|NCT00664859|156312542|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
48579091|NCT00664859|156312543|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
48579092|NCT00664859|156312541|FG000|Overall Study|Noncompliance with protocol|1|||
48579093|NCT00664859|156312542|FG001|Overall Study|Noncompliance with protocol|0|||
48579094|NCT00664859|156312543|FG002|Overall Study|Noncompliance with protocol|4|||
48579095|NCT00664859|156312541|FG000|Overall Study|Laboratory abnormality|2|||
48579096|NCT00664859|156312542|FG001|Overall Study|Laboratory abnormality|1|||
48579097|NCT00664859|156312543|FG002|Overall Study|Laboratory abnormality|4|||
48579098|NCT00664859|156312541|FG000|Overall Study|Withdrawal by Subject|4|||
48579099|NCT00664859|156312542|FG001|Overall Study|Withdrawal by Subject|1|||
48579100|NCT00664859|156312543|FG002|Overall Study|Withdrawal by Subject|3|||
48579101|NCT00664859|156312541|FG000|Overall Study|Lost to Follow-up|2|||
48579102|NCT00664859|156312542|FG001|Overall Study|Lost to Follow-up|2|||
48579103|NCT00664859|156312543|FG002|Overall Study|Lost to Follow-up|1|||
48579104|NCT00664859|156312541|FG000|Overall Study|Other|0|||
48579105|NCT00664859|156312542|FG001|Overall Study|Other|1|||
48579106|NCT00664859|156312543|FG002|Overall Study|Other|2|||
48579107|NCT01943851|156312544|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579108|NCT01943851|156312545|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579109|NCT01943851|156312546|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48737082|NCT03307785|156887980|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
48737083|NCT03307785|156887981|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
48737084|NCT03307785|156887982|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
48737085|NCT03307785|156887983|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
48737086|NCT03307785|156887984|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
48737087|NCT03307785|156887985|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
48737088|NCT03307785|156887986|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
48737089|NCT03307785|156887987|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
48737090|NCT03307785|156887988|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
48737091|NCT03307785|156887989|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
48737092|NCT03307785|156887990|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
48737093|NCT00566111|156887991|FG000|Overall Study|Adverse Event|0|||
48737094|NCT00566111|156887992|FG001|Overall Study|Adverse Event|2|||
48737095|NCT03666624|156887993|FG000|Overall Study|participant grieving over recent death of parent|1|||
48737096|NCT03666624|156887994|FG001|Overall Study|participant grieving over recent death of parent|0|||
48737097|NCT01612858|156887999|FG000|Overall Study|Withdrawal by Subject|5|||
48737098|NCT01612858|156888000|FG001|Overall Study|Withdrawal by Subject|1|||
48737099|NCT02128932|156888001|FG000|Overall Study|Withdrawal by Subject|11|||
48737100|NCT02128932|156888002|FG001|Overall Study|Withdrawal by Subject|7|||
48737101|NCT02128932|156888003|FG002|Overall Study|Withdrawal by Subject|8|||
48737102|NCT02128932|156888001|FG000|Overall Study|Death|2|||
48737103|NCT02128932|156888002|FG001|Overall Study|Death|0|||
48737104|NCT02128932|156888003|FG002|Overall Study|Death|2|||
48320082|NCT02590432|155372573|FG004|Open-label Treatment Period|Adverse Event|0|||
48320083|NCT02590432|155372574|FG005|Open-label Treatment Period|Adverse Event|0|||
48320084|NCT02590432|155372575|FG006|Open-label Treatment Period|Adverse Event|0|||
48320085|NCT02590432|155372576|FG007|Open-label Treatment Period|Adverse Event|0|||
48320086|NCT02590432|155372577|FG008|Open-label Treatment Period|Adverse Event|0|||
48320087|NCT02590432|155372569|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
48320088|NCT02590432|155372570|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
48320089|NCT02590432|155372571|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
48320090|NCT02590432|155372572|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
48320091|NCT02590432|155372573|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
48320092|NCT02590432|155372574|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
48320093|NCT02590432|155372575|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
48320094|NCT02590432|155372576|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
48320095|NCT02590432|155372577|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
48320096|NCT02590432|155372569|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
48320097|NCT02590432|155372570|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
48320098|NCT02590432|155372571|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
48320099|NCT02590432|155372572|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
48320100|NCT02590432|155372573|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
48320101|NCT02590432|155372574|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
48320102|NCT02590432|155372575|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
48320103|NCT02590432|155372576|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
48320104|NCT02590432|155372577|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
48320105|NCT02590432|155372569|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
48320106|NCT02590432|155372570|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
48320107|NCT02590432|155372571|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
48320108|NCT02590432|155372572|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
48320109|NCT02590432|155372573|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
48320110|NCT02590432|155372574|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
48320111|NCT02590432|155372575|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
48737105|NCT02128932|156888001|FG000|Overall Study|Lost to Follow-up|2|||
48320112|NCT02590432|155372576|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
48320113|NCT02590432|155372577|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
48320114|NCT02590432|155372569|FG000|Open-label Treatment Period|Protocol Violation|10|||
48320115|NCT02590432|155372570|FG001|Open-label Treatment Period|Protocol Violation|4|||
48320116|NCT02590432|155372571|FG002|Open-label Treatment Period|Protocol Violation|0|||
48320117|NCT02590432|155372572|FG003|Open-label Treatment Period|Protocol Violation|0|||
48320118|NCT02590432|155372573|FG004|Open-label Treatment Period|Protocol Violation|0|||
48320119|NCT02590432|155372574|FG005|Open-label Treatment Period|Protocol Violation|0|||
48320120|NCT02590432|155372575|FG006|Open-label Treatment Period|Protocol Violation|0|||
48320121|NCT02590432|155372576|FG007|Open-label Treatment Period|Protocol Violation|0|||
48320122|NCT02590432|155372577|FG008|Open-label Treatment Period|Protocol Violation|0|||
48320123|NCT02590432|155372569|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
48320124|NCT02590432|155372570|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
48320125|NCT02590432|155372571|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48320126|NCT02590432|155372572|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48320127|NCT02590432|155372573|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48320128|NCT02590432|155372574|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48320129|NCT02590432|155372575|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48320130|NCT02590432|155372576|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48320131|NCT02590432|155372577|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
48320132|NCT02590432|155372569|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
48320133|NCT02590432|155372570|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
48320134|NCT02590432|155372571|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48737106|NCT02128932|156888002|FG001|Overall Study|Lost to Follow-up|1|||
48737107|NCT02128932|156888003|FG002|Overall Study|Lost to Follow-up|1|||
48737108|NCT02128932|156888001|FG000|Overall Study|No reason for withdrawal|12|||
48737109|NCT02128932|156888002|FG001|Overall Study|No reason for withdrawal|11|||
48737110|NCT02128932|156888003|FG002|Overall Study|No reason for withdrawal|7|||
48737111|NCT01361568|156888004|FG000|Overall Study|Adverse Event|0|||
48737112|NCT01361568|156888005|FG001|Overall Study|Adverse Event|0|||
48737113|NCT01361568|156888006|FG002|Overall Study|Adverse Event|0|||
48737114|NCT01361568|156888007|FG003|Overall Study|Adverse Event|0|||
48737115|NCT01361568|156888008|FG004|Overall Study|Adverse Event|1|||
48737116|NCT01361568|156888009|FG005|Overall Study|Adverse Event|0|||
48320135|NCT02590432|155372572|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48320136|NCT02590432|155372573|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48320137|NCT02590432|155372574|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48320138|NCT02590432|155372575|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48737117|NCT01361568|156888004|FG000|Overall Study|Physician Decision|0|||
48737118|NCT01361568|156888005|FG001|Overall Study|Physician Decision|0|||
48737119|NCT01361568|156888006|FG002|Overall Study|Physician Decision|0|||
48737120|NCT01361568|156888007|FG003|Overall Study|Physician Decision|0|||
48737121|NCT01361568|156888008|FG004|Overall Study|Physician Decision|0|||
48737122|NCT01361568|156888009|FG005|Overall Study|Physician Decision|1|||
48737123|NCT01361568|156888004|FG000|Overall Study|Withdrawal by Subject|2|||
48737124|NCT01361568|156888005|FG001|Overall Study|Withdrawal by Subject|1|||
48737125|NCT01361568|156888006|FG002|Overall Study|Withdrawal by Subject|0|||
48737126|NCT01361568|156888007|FG003|Overall Study|Withdrawal by Subject|0|||
48737127|NCT01361568|156888008|FG004|Overall Study|Withdrawal by Subject|0|||
48737128|NCT01361568|156888009|FG005|Overall Study|Withdrawal by Subject|1|||
48737129|NCT04154930|156888012|FG000|Overall Study|Withdrawal by Subject|15|||
48737130|NCT04154930|156888013|FG001|Overall Study|Withdrawal by Subject|6|||
48737131|NCT04154930|156888012|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
48737132|NCT04154930|156888013|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
48737133|NCT04154930|156888012|FG000|Overall Study|Lost to Follow-up|14|||
48737134|NCT04154930|156888013|FG001|Overall Study|Lost to Follow-up|6|||
48737135|NCT04154930|156888012|FG000|Overall Study|Other|6|||
48737136|NCT04154930|156888013|FG001|Overall Study|Other|0|||
48737137|NCT02106975|156888014|FG000|Overall Study|Death|25|||
48737138|NCT02106975|156888015|FG001|Overall Study|Death|39|||
48737139|NCT01254630|156888016|FG000|Overall Study|Adverse Event|36|||
48737140|NCT01254630|156888017|FG001|Overall Study|Adverse Event|15|||
48737141|NCT01254630|156888018|FG002|Overall Study|Adverse Event|40|||
48737142|NCT01254630|156888019|FG003|Overall Study|Adverse Event|8|||
48737143|NCT01254630|156888016|FG000|Overall Study|Death|461|||
48737144|NCT01254630|156888017|FG001|Overall Study|Death|151|||
48737145|NCT01254630|156888018|FG002|Overall Study|Death|478|||
48737146|NCT01254630|156888019|FG003|Overall Study|Death|139|||
48737147|NCT01254630|156888016|FG000|Overall Study|Lost to Follow-up|80|||
48737148|NCT01254630|156888017|FG001|Overall Study|Lost to Follow-up|26|||
48737149|NCT01254630|156888018|FG002|Overall Study|Lost to Follow-up|89|||
48737150|NCT01254630|156888019|FG003|Overall Study|Lost to Follow-up|32|||
48737151|NCT01254630|156888016|FG000|Overall Study|Physician Decision|24|||
48737152|NCT01254630|156888017|FG001|Overall Study|Physician Decision|8|||
48737153|NCT01254630|156888018|FG002|Overall Study|Physician Decision|16|||
48737154|NCT01254630|156888019|FG003|Overall Study|Physician Decision|7|||
48737155|NCT01254630|156888016|FG000|Overall Study|Withdrawal by Subject|201|||
48737156|NCT01254630|156888017|FG001|Overall Study|Withdrawal by Subject|94|||
48737157|NCT01254630|156888018|FG002|Overall Study|Withdrawal by Subject|188|||
48737158|NCT01254630|156888019|FG003|Overall Study|Withdrawal by Subject|89|||
48737159|NCT01254630|156888016|FG000|Overall Study|Study terminated by sponsor|0|||
48737160|NCT01254630|156888017|FG001|Overall Study|Study terminated by sponsor|994|||
48737161|NCT01254630|156888018|FG002|Overall Study|Study terminated by sponsor|0|||
48737162|NCT01254630|156888019|FG003|Overall Study|Study terminated by sponsor|1010|||
48737163|NCT01254630|156888016|FG000|Overall Study|Status not recorded|0|||
48737164|NCT01254630|156888017|FG001|Overall Study|Status not recorded|0|||
48737165|NCT01254630|156888018|FG002|Overall Study|Status not recorded|1|||
48737166|NCT01254630|156888019|FG003|Overall Study|Status not recorded|0|||
48737167|NCT00241358|156888022|FG000|Overall Study|Determined to be not ineligible|0|||
48737168|NCT00241358|156888023|FG001|Overall Study|Determined to be not ineligible|1|||
48737169|NCT00241358|156888024|FG002|Overall Study|Determined to be not ineligible|1|||
48737170|NCT01758523|156888029|FG000|Overall Study|Adverse Event|2|||
48737171|NCT01758523|156888030|FG001|Overall Study|Adverse Event|1|||
48737172|NCT01758523|156888029|FG000|Overall Study|Lack of Efficacy|4|||
48737173|NCT01758523|156888030|FG001|Overall Study|Lack of Efficacy|2|||
48737174|NCT01758523|156888029|FG000|Overall Study|Lost to Follow-up|3|||
48737175|NCT01758523|156888030|FG001|Overall Study|Lost to Follow-up|4|||
48737176|NCT01758523|156888029|FG000|Overall Study|Withdrawal by Subject|12|||
48737177|NCT01758523|156888030|FG001|Overall Study|Withdrawal by Subject|7|||
48737178|NCT04729621|156888031|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
48737179|NCT04729621|156888032|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
48737180|NCT04729621|156888033|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
48737181|NCT04729621|156888034|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
48737182|NCT04729621|156888035|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
48737183|NCT04729621|156888031|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
48737184|NCT04729621|156888032|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
48737185|NCT04729621|156888033|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
48320139|NCT02590432|155372576|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48450303|NCT03365947|155835682|FG012|Overall Study|Lost to Follow-up|0|||
48737186|NCT04729621|156888034|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
48737187|NCT04729621|156888035|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
48737188|NCT04729621|156888031|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
48737189|NCT04729621|156888032|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
48737190|NCT04729621|156888033|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
48737191|NCT04729621|156888034|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
48737192|NCT04729621|156888035|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
48737193|NCT04729621|156888031|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48737194|NCT04729621|156888032|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48737195|NCT04729621|156888033|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
48737196|NCT04729621|156888034|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
48737197|NCT04729621|156888035|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
48737198|NCT04729621|156888031|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
48737199|NCT04729621|156888032|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
48737200|NCT04729621|156888033|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
48737201|NCT04729621|156888034|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
48737202|NCT04729621|156888035|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
48737203|NCT04729621|156888031|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
48737204|NCT04729621|156888032|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
48737205|NCT04729621|156888033|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
48737206|NCT04729621|156888034|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
48737207|NCT04729621|156888035|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
48737208|NCT02925117|156888036|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
48737209|NCT02925117|156888037|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
48737210|NCT02925117|156888038|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
48737211|NCT02925117|156888039|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
48737212|NCT02925117|156888040|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737213|NCT02925117|156888041|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737214|NCT02925117|156888042|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737215|NCT02925117|156888043|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737216|NCT02925117|156888044|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737217|NCT02925117|156888045|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737218|NCT02925117|156888046|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737219|NCT02925117|156888047|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
48737220|NCT02925117|156888036|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
48737221|NCT02925117|156888037|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
48737222|NCT02925117|156888038|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
48737223|NCT02925117|156888039|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737224|NCT02925117|156888040|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737225|NCT02925117|156888041|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737226|NCT02925117|156888042|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737227|NCT02925117|156888043|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737228|NCT02925117|156888044|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737229|NCT02925117|156888045|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737230|NCT02925117|156888046|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737231|NCT02925117|156888047|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
48737232|NCT02925117|156888036|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
48737233|NCT02925117|156888037|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
48737234|NCT02925117|156888038|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737235|NCT02925117|156888039|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737236|NCT02925117|156888040|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737237|NCT02925117|156888041|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737238|NCT02925117|156888042|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737239|NCT02925117|156888043|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737240|NCT02925117|156888044|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737241|NCT02925117|156888045|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737242|NCT02925117|156888046|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737243|NCT02925117|156888047|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
48737244|NCT02925117|156888036|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
48737245|NCT02925117|156888037|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
48737246|NCT02925117|156888038|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
48737247|NCT02925117|156888039|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
48737248|NCT02925117|156888040|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
48737249|NCT02925117|156888041|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
48737250|NCT02925117|156888042|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
48737251|NCT02925117|156888043|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
48737252|NCT02925117|156888044|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
48579110|NCT01943851|156312547|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
48579111|NCT01943851|156312548|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579112|NCT01943851|156312549|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579113|NCT01943851|156312550|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
48579114|NCT01943851|156312551|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
48579115|NCT01943851|156312552|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
48579116|NCT01943851|156312553|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579117|NCT01943851|156312554|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579118|NCT01943851|156312555|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48320140|NCT02590432|155372577|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
48320141|NCT02590432|155372569|FG000|Double-blind Treatment Period|Adverse Event|0|||
48320142|NCT02590432|155372570|FG001|Double-blind Treatment Period|Adverse Event|0|||
48320143|NCT02590432|155372571|FG002|Double-blind Treatment Period|Adverse Event|14|||
48320144|NCT02590432|155372572|FG003|Double-blind Treatment Period|Adverse Event|12|||
48320145|NCT02590432|155372573|FG004|Double-blind Treatment Period|Adverse Event|6|||
48320146|NCT02590432|155372574|FG005|Double-blind Treatment Period|Adverse Event|22|||
48320147|NCT02590432|155372575|FG006|Double-blind Treatment Period|Adverse Event|20|||
48320148|NCT02590432|155372576|FG007|Double-blind Treatment Period|Adverse Event|0|||
48320149|NCT02590432|155372577|FG008|Double-blind Treatment Period|Adverse Event|0|||
48320150|NCT02590432|155372569|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
48320151|NCT02590432|155372570|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
48320152|NCT02590432|155372571|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
48320153|NCT02590432|155372572|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
48320154|NCT02590432|155372573|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
48320155|NCT02590432|155372574|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
48320156|NCT02590432|155372575|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
48320157|NCT02590432|155372576|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
48320158|NCT02590432|155372577|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
48579119|NCT01943851|156312556|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579120|NCT01943851|156312557|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579121|NCT01943851|156312558|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579122|NCT01943851|156312559|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579123|NCT01943851|156312560|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579124|NCT01943851|156312561|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
48579125|NCT01943851|156312544|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579126|NCT01943851|156312545|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579127|NCT01943851|156312546|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579128|NCT01943851|156312547|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579129|NCT01943851|156312548|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
48579130|NCT01943851|156312549|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579131|NCT01943851|156312550|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48737253|NCT02925117|156888045|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
48737254|NCT02925117|156888046|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
48320159|NCT02590432|155372569|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
48579132|NCT01943851|156312551|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
48579133|NCT01943851|156312552|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579134|NCT01943851|156312553|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579135|NCT01943851|156312554|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579136|NCT01943851|156312555|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579137|NCT01943851|156312556|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579138|NCT01943851|156312557|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579139|NCT01943851|156312558|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579140|NCT01943851|156312559|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579141|NCT01943851|156312560|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579142|NCT01943851|156312561|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
48579143|NCT01943851|156312544|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579144|NCT01943851|156312545|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579145|NCT01943851|156312546|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579146|NCT01943851|156312547|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579147|NCT01943851|156312548|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579148|NCT01943851|156312549|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579149|NCT01943851|156312550|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579150|NCT01943851|156312551|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579151|NCT01943851|156312552|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579152|NCT01943851|156312553|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579153|NCT01943851|156312554|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579154|NCT01943851|156312555|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579155|NCT01943851|156312556|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579156|NCT01943851|156312557|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
48579157|NCT01943851|156312558|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579158|NCT01943851|156312559|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579159|NCT01943851|156312560|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579160|NCT01943851|156312561|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
48579161|NCT01943851|156312544|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48320160|NCT02590432|155372570|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
48579162|NCT01943851|156312545|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579163|NCT01943851|156312546|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579164|NCT01943851|156312547|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579165|NCT01943851|156312548|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48737255|NCT02925117|156888047|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
48737256|NCT02925117|156888036|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737257|NCT02925117|156888037|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737258|NCT02925117|156888038|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48579166|NCT01943851|156312549|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579167|NCT01943851|156312550|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579168|NCT01943851|156312551|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579169|NCT01943851|156312552|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579170|NCT01943851|156312553|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579171|NCT01943851|156312554|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579172|NCT01943851|156312555|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579173|NCT01943851|156312556|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579174|NCT01943851|156312557|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579175|NCT01943851|156312558|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48737259|NCT02925117|156888039|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737260|NCT02925117|156888040|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737261|NCT02925117|156888041|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
48737262|NCT02925117|156888042|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737263|NCT02925117|156888043|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48579176|NCT01943851|156312559|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
48579177|NCT01943851|156312560|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579178|NCT01943851|156312561|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
48579179|NCT01943851|156312544|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579180|NCT01943851|156312545|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579181|NCT01943851|156312546|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579182|NCT01943851|156312547|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579183|NCT01943851|156312548|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579184|NCT01943851|156312549|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579185|NCT01943851|156312550|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579186|NCT01943851|156312551|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579187|NCT01943851|156312552|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579188|NCT01943851|156312553|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579189|NCT01943851|156312554|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579190|NCT01943851|156312555|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579191|NCT01943851|156312556|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579192|NCT01943851|156312557|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579193|NCT01943851|156312558|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
48579194|NCT01943851|156312559|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
48579195|NCT01943851|156312560|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
48579196|NCT01943851|156312561|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
48579197|NCT00738881|156312562|FG000|Overall Study|Withdrawal by Subject|0|||
48579198|NCT00738881|156312563|FG001|Overall Study|Withdrawal by Subject|2|||
48579199|NCT04323306|156312564|FG000|Overall Study|Physician Decision|1|||
48579200|NCT04323306|156312565|FG001|Overall Study|Physician Decision|0|||
48579201|NCT04323306|156312566|FG002|Overall Study|Physician Decision|0|||
48579202|NCT04323306|156312567|FG003|Overall Study|Physician Decision|0|||
48579203|NCT04323306|156312568|FG004|Overall Study|Physician Decision|0|||
48579204|NCT04323306|156312569|FG005|Overall Study|Physician Decision|0|||
48579205|NCT04323306|156312570|FG006|Overall Study|Physician Decision|0|||
48579206|NCT04323306|156312571|FG007|Overall Study|Physician Decision|0|||
48579207|NCT04323306|156312572|FG008|Overall Study|Physician Decision|0|||
48737264|NCT02925117|156888044|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737265|NCT02925117|156888045|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
48737266|NCT02925117|156888046|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
48737267|NCT02925117|156888047|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
48737268|NCT02925117|156888036|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737269|NCT02925117|156888037|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737270|NCT02925117|156888038|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737271|NCT02925117|156888039|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737272|NCT02925117|156888040|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
48737273|NCT02925117|156888041|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
48737274|NCT02925117|156888042|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
48579208|NCT04323306|156312564|FG000|Overall Study|Withdrawal by Subject|0|||
48579209|NCT04323306|156312565|FG001|Overall Study|Withdrawal by Subject|0|||
48579210|NCT04323306|156312566|FG002|Overall Study|Withdrawal by Subject|0|||
48579211|NCT04323306|156312567|FG003|Overall Study|Withdrawal by Subject|0|||
48579212|NCT04323306|156312568|FG004|Overall Study|Withdrawal by Subject|0|||
48579213|NCT04323306|156312569|FG005|Overall Study|Withdrawal by Subject|1|||
48579214|NCT04323306|156312570|FG006|Overall Study|Withdrawal by Subject|3|||
48579215|NCT04323306|156312571|FG007|Overall Study|Withdrawal by Subject|0|||
48579216|NCT04323306|156312572|FG008|Overall Study|Withdrawal by Subject|1|||
48579217|NCT02677038|156312576|FG000|Overall Study|Physician Decision|1|||
48579218|NCT02677038|156312576|FG000|Overall Study|Withdrawal by Subject|1|||
48579219|NCT01646021|156312577|FG000|Overall Study|Death|77|||
48579220|NCT01646021|156312578|FG001|Overall Study|Death|83|||
48579221|NCT01646021|156312577|FG000|Overall Study|Study Terminated by Sponsor|50|||
48579222|NCT01646021|156312578|FG001|Overall Study|Study Terminated by Sponsor|41|||
48579223|NCT01646021|156312577|FG000|Overall Study|Lost to Follow-up|2|||
48579224|NCT01646021|156312578|FG001|Overall Study|Lost to Follow-up|2|||
48579225|NCT01646021|156312577|FG000|Overall Study|Withdrawal by Subject|10|||
48579226|NCT01646021|156312578|FG001|Overall Study|Withdrawal by Subject|15|||
48579227|NCT03671564|156312579|FG000|Overall Study|Progressive Disease|3|||
48579228|NCT03671564|156312580|FG001|Overall Study|Progressive Disease|5|||
48579229|NCT03671564|156312581|FG002|Overall Study|Progressive Disease|3|||
48579230|NCT03671564|156312579|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
48579231|NCT03671564|156312580|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
48579232|NCT03671564|156312581|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
48579233|NCT03671564|156312579|FG000|Overall Study|Withdrawal by Subject|1|||
48579234|NCT03671564|156312580|FG001|Overall Study|Withdrawal by Subject|1|||
48579235|NCT03671564|156312581|FG002|Overall Study|Withdrawal by Subject|0|||
48579236|NCT04521621|156312582|FG000|Overall Study|Death|17|||
48579237|NCT04521621|156312583|FG001|Overall Study|Death|8|||
48579238|NCT04521621|156312584|FG002|Overall Study|Death|8|||
48737275|NCT02925117|156888043|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
48737276|NCT02925117|156888044|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
48737277|NCT02925117|156888045|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
48579239|NCT04521621|156312585|FG003|Overall Study|Death|5|||
48579240|NCT04521621|156312586|FG004|Overall Study|Death|2|||
48737278|NCT02925117|156888046|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
48737279|NCT02925117|156888047|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
48737280|NCT02925117|156888036|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737281|NCT02925117|156888037|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737282|NCT02925117|156888038|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737283|NCT02925117|156888039|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737284|NCT02925117|156888040|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737285|NCT02925117|156888041|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
48737286|NCT02925117|156888042|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737287|NCT02925117|156888043|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737288|NCT02925117|156888044|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737289|NCT02925117|156888045|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737290|NCT02925117|156888046|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
48737291|NCT02925117|156888047|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
48737292|NCT02925117|156888036|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
48737293|NCT02925117|156888037|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
48737294|NCT02925117|156888038|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
48737295|NCT02925117|156888039|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
48737296|NCT02925117|156888040|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
48737297|NCT02925117|156888041|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
48737298|NCT02925117|156888042|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
48737299|NCT02925117|156888043|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
48737300|NCT02925117|156888044|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
48737301|NCT02925117|156888045|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
48737302|NCT02925117|156888046|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
48737303|NCT02925117|156888047|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
48737304|NCT04032652|156888048|FG000|Overall Study|The study was terminated and the PI has|1|||
48737305|NCT04032652|156888049|FG001|Overall Study|The study was terminated and the PI has|1|||
48737306|NCT02663908|156888050|FG000|Overall Study|Withdrawal by Subject|8|||
48737307|NCT02663908|156888051|FG001|Overall Study|Withdrawal by Subject|5|||
48737308|NCT02663908|156888050|FG000|Overall Study|Lost to Follow-up|1|||
48737309|NCT02663908|156888051|FG001|Overall Study|Lost to Follow-up|5|||
48737310|NCT02663908|156888050|FG000|Overall Study|Adverse Event|13|||
48737311|NCT02663908|156888051|FG001|Overall Study|Adverse Event|11|||
48737312|NCT02663908|156888050|FG000|Overall Study|Protocol Violation|1|||
48737313|NCT02663908|156888051|FG001|Overall Study|Protocol Violation|2|||
48737314|NCT02663908|156888050|FG000|Overall Study|Lack of therapeutic response|2|||
48737315|NCT02663908|156888051|FG001|Overall Study|Lack of therapeutic response|0|||
48737316|NCT02663908|156888050|FG000|Overall Study|COVID-19|1|||
48737317|NCT02663908|156888051|FG001|Overall Study|COVID-19|0|||
48579241|NCT04521621|156312587|FG005|Overall Study|Death|7|||
48579242|NCT04521621|156312588|FG006|Overall Study|Death|0|||
48579243|NCT04521621|156312589|FG007|Overall Study|Death|0|||
48579244|NCT04521621|156312582|FG000|Overall Study|Study Terminated by Sponsor|4|||
48579245|NCT04521621|156312583|FG001|Overall Study|Study Terminated by Sponsor|6|||
48579246|NCT04521621|156312584|FG002|Overall Study|Study Terminated by Sponsor|8|||
48579247|NCT04521621|156312585|FG003|Overall Study|Study Terminated by Sponsor|0|||
48579248|NCT04521621|156312586|FG004|Overall Study|Study Terminated by Sponsor|1|||
48579249|NCT04521621|156312587|FG005|Overall Study|Study Terminated by Sponsor|7|||
48579250|NCT04521621|156312588|FG006|Overall Study|Study Terminated by Sponsor|0|||
48579251|NCT04521621|156312589|FG007|Overall Study|Study Terminated by Sponsor|0|||
48579252|NCT04521621|156312582|FG000|Overall Study|Withdrawal by Subject|0|||
48579253|NCT04521621|156312583|FG001|Overall Study|Withdrawal by Subject|0|||
48579254|NCT04521621|156312584|FG002|Overall Study|Withdrawal by Subject|1|||
48737318|NCT02663908|156888050|FG000|Overall Study|Site closed|1|||
48737319|NCT02663908|156888051|FG001|Overall Study|Site closed|0|||
48737320|NCT02663908|156888050|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
48737321|NCT02663908|156888051|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
48737322|NCT02663908|156888050|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
48579255|NCT04521621|156312585|FG003|Overall Study|Withdrawal by Subject|1|||
48737323|NCT02663908|156888051|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
48737324|NCT02663908|156888050|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
48737325|NCT02663908|156888051|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
48737326|NCT02663908|156888050|FG000|Overall Study|Death|1|||
48737327|NCT02663908|156888051|FG001|Overall Study|Death|0|||
48737328|NCT02663908|156888050|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
48737329|NCT02663908|156888051|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
48737330|NCT02663908|156888050|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
48737331|NCT02663908|156888051|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
48737332|NCT02906332|156888053|FG000|Overall Study|Withdrawal by Subject|1|||
48737333|NCT00913380|156888054|FG000|Clinical Outcomes|Lost to Follow-up|6|||
48737334|NCT00913380|156888055|FG001|Clinical Outcomes|Lost to Follow-up|6|||
48737335|NCT00181155|156888056|FG000|Overall Study|Physician Decision|1|||
48737336|NCT00181155|156888057|FG001|Overall Study|Physician Decision|0|||
48737337|NCT00181155|156888056|FG000|Overall Study|Withdrawal by Subject|1|||
48737338|NCT00181155|156888057|FG001|Overall Study|Withdrawal by Subject|0|||
48737339|NCT01788228|156888058|FG000|Overall Study|Migrated/moved from study area|1|||
48737340|NCT01788228|156888059|FG001|Overall Study|Migrated/moved from study area|0|||
48737341|NCT00370071|156888060|FG000|Overall Study|Withdrawal by Subject|2|||
48737342|NCT01548287|156888061|FG000|Screening|No reason provided|0|||
48737343|NCT01548287|156888062|FG001|Screening|No reason provided|0|||
48737344|NCT01548287|156888063|FG002|Screening|No reason provided|0|||
48737345|NCT01548287|156888064|FG003|Screening|No reason provided|0|||
48737346|NCT01548287|156888065|FG004|Screening|No reason provided|9|||
48737347|NCT01548287|156888061|FG000|Screening|Did not meet eligibility criteria|0|||
48737348|NCT01548287|156888062|FG001|Screening|Did not meet eligibility criteria|0|||
48737349|NCT01548287|156888063|FG002|Screening|Did not meet eligibility criteria|0|||
48737350|NCT01548287|156888064|FG003|Screening|Did not meet eligibility criteria|0|||
48737351|NCT01548287|156888065|FG004|Screening|Did not meet eligibility criteria|74|||
48737352|NCT01548287|156888061|FG000|Randomized Period|Did not meet inclusion criteria|0|||
48737353|NCT01548287|156888062|FG001|Randomized Period|Did not meet inclusion criteria|0|||
48737354|NCT01548287|156888063|FG002|Randomized Period|Did not meet inclusion criteria|2|||
48737355|NCT01548287|156888064|FG003|Randomized Period|Did not meet inclusion criteria|0|||
48737356|NCT01548287|156888065|FG004|Randomized Period|Did not meet inclusion criteria|0|||
48737357|NCT01548287|156888061|FG000|Randomized Period|Adverse Event|0|||
48737358|NCT01548287|156888062|FG001|Randomized Period|Adverse Event|2|||
48737359|NCT01548287|156888063|FG002|Randomized Period|Adverse Event|5|||
48737360|NCT01548287|156888064|FG003|Randomized Period|Adverse Event|0|||
48737361|NCT01548287|156888065|FG004|Randomized Period|Adverse Event|0|||
48737362|NCT02762578|156888066|FG000|Overall Study|Adverse Event|1|||
48737363|NCT02762578|156888067|FG001|Overall Study|Adverse Event|6|||
48737364|NCT02762578|156888066|FG000|Overall Study|Protocol Violation|4|||
48737365|NCT02762578|156888067|FG001|Overall Study|Protocol Violation|2|||
48737366|NCT02762578|156888066|FG000|Overall Study|Withdrawal by Subject|4|||
48737367|NCT02762578|156888067|FG001|Overall Study|Withdrawal by Subject|2|||
48737368|NCT02762578|156888066|FG000|Overall Study|Unclassified|6|||
48737369|NCT02762578|156888067|FG001|Overall Study|Unclassified|0|||
48737370|NCT02083965|156888068|FG000|Treatment Period|Other|1|||
48737371|NCT02083965|156888069|FG001|Treatment Period|Other|0|||
48737372|NCT01128842|156888072|FG000|Overall Study|Adverse Event|1|||
48737373|NCT01128842|156888072|FG000|Overall Study|Disease Progression|6|||
48737374|NCT02405780|156888073|FG000|Period I|Adverse Event|8|||
48737375|NCT02405780|156888074|FG001|Period I|Adverse Event|0|||
48737376|NCT02405780|156888075|FG002|Period I|Adverse Event|3|||
48737377|NCT02405780|156888076|FG003|Period I|Adverse Event|7|||
48737378|NCT02405780|156888073|FG000|Period I|Medical reasons|1|||
48737379|NCT02405780|156888074|FG001|Period I|Medical reasons|1|||
48737380|NCT02405780|156888075|FG002|Period I|Medical reasons|0|||
48320161|NCT02590432|155372571|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
48579256|NCT04521621|156312586|FG004|Overall Study|Withdrawal by Subject|0|||
48579257|NCT04521621|156312587|FG005|Overall Study|Withdrawal by Subject|0|||
48579258|NCT04521621|156312588|FG006|Overall Study|Withdrawal by Subject|0|||
48579259|NCT04521621|156312589|FG007|Overall Study|Withdrawal by Subject|0|||
48579260|NCT04521621|156312582|FG000|Overall Study|Allocated in error without study intervention|1|||
48579261|NCT04521621|156312583|FG001|Overall Study|Allocated in error without study intervention|0|||
48579262|NCT04521621|156312584|FG002|Overall Study|Allocated in error without study intervention|0|||
48737381|NCT02405780|156888076|FG003|Period I|Medical reasons|1|||
48737382|NCT02405780|156888073|FG000|Period I|Screening Failure|1|||
48737383|NCT02405780|156888074|FG001|Period I|Screening Failure|0|||
48737384|NCT02405780|156888075|FG002|Period I|Screening Failure|1|||
48737385|NCT02405780|156888076|FG003|Period I|Screening Failure|0|||
48737386|NCT02405780|156888073|FG000|Period I|Withdrawal by Subject|9|||
48737387|NCT02405780|156888074|FG001|Period I|Withdrawal by Subject|1|||
48737388|NCT02405780|156888075|FG002|Period I|Withdrawal by Subject|3|||
48737389|NCT02405780|156888076|FG003|Period I|Withdrawal by Subject|4|||
48737390|NCT02405780|156888073|FG000|Period I|Non-compliance with study procedures|8|||
48737391|NCT02405780|156888074|FG001|Period I|Non-compliance with study procedures|6|||
48737392|NCT02405780|156888075|FG002|Period I|Non-compliance with study procedures|8|||
48737393|NCT02405780|156888076|FG003|Period I|Non-compliance with study procedures|11|||
48737394|NCT02405780|156888073|FG000|Period II|Adverse Event|3|||
48737395|NCT02405780|156888074|FG001|Period II|Adverse Event|5|||
48737396|NCT02405780|156888075|FG002|Period II|Adverse Event|4|||
48737397|NCT02405780|156888076|FG003|Period II|Adverse Event|11|||
48579263|NCT04521621|156312585|FG003|Overall Study|Allocated in error without study intervention|0|||
48579264|NCT04521621|156312586|FG004|Overall Study|Allocated in error without study intervention|0|||
48579265|NCT04521621|156312587|FG005|Overall Study|Allocated in error without study intervention|0|||
48579266|NCT04521621|156312588|FG006|Overall Study|Allocated in error without study intervention|0|||
48737398|NCT02405780|156888073|FG000|Period II|Medical reason|0|||
48320162|NCT02590432|155372572|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
48320163|NCT02590432|155372573|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
48320164|NCT02590432|155372574|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
48320165|NCT02590432|155372575|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
48320166|NCT02590432|155372576|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
48320167|NCT02590432|155372577|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
48320168|NCT02590432|155372569|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48320169|NCT02590432|155372570|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
48320170|NCT02590432|155372571|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
48320171|NCT02590432|155372572|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
48320172|NCT02590432|155372573|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
48320173|NCT02590432|155372574|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
48320174|NCT02590432|155372575|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
48320175|NCT02590432|155372576|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
48320176|NCT02590432|155372577|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
48320177|NCT02590432|155372569|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48320178|NCT02590432|155372570|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48320179|NCT02590432|155372571|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48320180|NCT02590432|155372572|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48320181|NCT02590432|155372573|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48320182|NCT02590432|155372574|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
48320183|NCT02590432|155372575|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48320184|NCT02590432|155372576|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48320185|NCT02590432|155372577|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
48320186|NCT02590432|155372569|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48320187|NCT02590432|155372570|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48320188|NCT02590432|155372571|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48320189|NCT02590432|155372572|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48320190|NCT02590432|155372573|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48320191|NCT02590432|155372574|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48320192|NCT02590432|155372575|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
48320193|NCT02590432|155372576|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
48320194|NCT02590432|155372577|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
48320195|NCT02590432|155372569|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48320196|NCT02590432|155372570|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48320197|NCT02590432|155372571|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48320198|NCT02590432|155372572|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48320199|NCT02590432|155372573|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48320200|NCT02590432|155372574|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48320201|NCT02590432|155372575|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48320202|NCT02590432|155372576|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
48320203|NCT02590432|155372577|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
48320204|NCT02590432|155372569|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48320205|NCT02590432|155372570|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48320206|NCT02590432|155372571|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48320207|NCT02590432|155372572|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48320208|NCT02590432|155372573|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48320209|NCT02590432|155372574|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48320210|NCT02590432|155372575|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
48320211|NCT02590432|155372576|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
48320212|NCT02590432|155372577|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
48320213|NCT02590432|155372569|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48320214|NCT02590432|155372570|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48737399|NCT02405780|156888074|FG001|Period II|Medical reason|1|||
48737400|NCT02405780|156888075|FG002|Period II|Medical reason|0|||
48737401|NCT02405780|156888076|FG003|Period II|Medical reason|0|||
48737402|NCT02405780|156888073|FG000|Period II|Pregnancy|0|||
48737403|NCT02405780|156888074|FG001|Period II|Pregnancy|0|||
48320215|NCT02590432|155372571|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48737404|NCT02405780|156888075|FG002|Period II|Pregnancy|1|||
48737405|NCT02405780|156888076|FG003|Period II|Pregnancy|0|||
48737406|NCT02405780|156888073|FG000|Period II|Withdrawal by Subject|7|||
48320216|NCT02590432|155372572|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48320217|NCT02590432|155372573|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48579267|NCT04521621|156312589|FG007|Overall Study|Allocated in error without study intervention|0|||
48579268|NCT01282164|156312595|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
48579269|NCT01282164|156312596|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
48579270|NCT02100670|156312601|FG000|Overall Study|Adverse Event|10|||
48579271|NCT02100670|156312602|FG001|Overall Study|Adverse Event|3|||
48579272|NCT02100670|156312603|FG002|Overall Study|Adverse Event|3|||
48579273|NCT02100670|156312604|FG003|Overall Study|Adverse Event|0|||
48579274|NCT02100670|156312601|FG000|Overall Study|Lost to Follow-up|1|||
48320218|NCT02590432|155372574|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48320219|NCT02590432|155372575|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48320220|NCT02590432|155372576|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
48320221|NCT02590432|155372577|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
48320222|NCT02590432|155372569|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48320223|NCT02590432|155372570|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48320224|NCT02590432|155372571|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48320225|NCT02590432|155372572|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48320226|NCT02590432|155372573|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48320227|NCT02590432|155372574|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48320228|NCT02590432|155372575|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48320229|NCT02590432|155372576|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
48320230|NCT02590432|155372577|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
48320231|NCT02590432|155372569|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48320232|NCT02590432|155372570|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48320233|NCT02590432|155372571|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48320234|NCT02590432|155372572|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48320235|NCT02590432|155372573|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48320236|NCT02590432|155372574|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48320237|NCT02590432|155372575|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48320238|NCT02590432|155372576|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
48320239|NCT02590432|155372577|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
48320240|NCT02590432|155372569|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48320241|NCT02590432|155372570|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48320242|NCT02590432|155372571|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48320243|NCT02590432|155372572|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48320244|NCT02590432|155372573|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48320245|NCT02590432|155372574|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48320246|NCT02590432|155372575|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48320247|NCT02590432|155372576|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
48320248|NCT02590432|155372577|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
48320249|NCT03451721|155372579|FG000|Overall Study|Death|1|||
48320250|NCT02538900|155372582|FG000|Overall Study|Death|2|||
48320251|NCT02538900|155372583|FG001|Overall Study|Death|2|||
48320252|NCT02538900|155372584|FG002|Overall Study|Death|2|||
48320253|NCT02538900|155372582|FG000|Overall Study|Withdrawal by Subject|18|||
48320254|NCT02538900|155372583|FG001|Overall Study|Withdrawal by Subject|16|||
48320255|NCT02538900|155372584|FG002|Overall Study|Withdrawal by Subject|15|||
48320256|NCT04110054|155372585|FG000|Overall Study|COVID-19 reason other than AE|0|||
48320257|NCT04110054|155372586|FG001|Overall Study|COVID-19 reason other than AE|0|||
48320258|NCT04110054|155372587|FG002|Overall Study|COVID-19 reason other than AE|2|||
48320259|NCT04110054|155372588|FG003|Overall Study|COVID-19 reason other than AE|0|||
48320260|NCT04110054|155372585|FG000|Overall Study|Withdrawal by Subject|0|||
48320261|NCT04110054|155372586|FG001|Overall Study|Withdrawal by Subject|3|||
48320262|NCT04110054|155372587|FG002|Overall Study|Withdrawal by Subject|2|||
48320263|NCT04110054|155372588|FG003|Overall Study|Withdrawal by Subject|0|||
48320264|NCT04110054|155372585|FG000|Overall Study|Adverse Event|1|||
48320265|NCT04110054|155372586|FG001|Overall Study|Adverse Event|1|||
48320266|NCT04110054|155372587|FG002|Overall Study|Adverse Event|4|||
48320267|NCT04110054|155372588|FG003|Overall Study|Adverse Event|3|||
48320268|NCT00480077|155372591|FG000|Overall Study|Death|19|||
48320269|NCT00480077|155372592|FG001|Overall Study|Death|15|||
48320270|NCT00480077|155372591|FG000|Overall Study|early exit|12|||
48320271|NCT00480077|155372592|FG001|Overall Study|early exit|11|||
48320272|NCT02101281|155372593|FG000|Overall Study|Adverse Event|0|||
48320273|NCT02101281|155372594|FG001|Overall Study|Adverse Event|1|||
48579275|NCT02100670|156312602|FG001|Overall Study|Lost to Follow-up|0|||
48579276|NCT02100670|156312603|FG002|Overall Study|Lost to Follow-up|0|||
48579277|NCT02100670|156312604|FG003|Overall Study|Lost to Follow-up|0|||
48579278|NCT02100670|156312601|FG000|Overall Study|Protocol Violation|0|||
48579279|NCT02100670|156312602|FG001|Overall Study|Protocol Violation|1|||
48579280|NCT02100670|156312603|FG002|Overall Study|Protocol Violation|0|||
48579281|NCT02100670|156312604|FG003|Overall Study|Protocol Violation|1|||
48579282|NCT02100670|156312601|FG000|Overall Study|Withdrawal of Consent|0|||
48579283|NCT02100670|156312602|FG001|Overall Study|Withdrawal of Consent|1|||
48579284|NCT02100670|156312603|FG002|Overall Study|Withdrawal of Consent|1|||
48579285|NCT02100670|156312604|FG003|Overall Study|Withdrawal of Consent|0|||
48579286|NCT02100670|156312601|FG000|Overall Study|No swelling no pain|1|||
48579287|NCT02100670|156312602|FG001|Overall Study|No swelling no pain|0|||
48579288|NCT02100670|156312603|FG002|Overall Study|No swelling no pain|0|||
48579289|NCT02100670|156312604|FG003|Overall Study|No swelling no pain|0|||
48579290|NCT02100670|156312601|FG000|Overall Study|Poor Efficacy|0|||
48579291|NCT02100670|156312602|FG001|Overall Study|Poor Efficacy|1|||
48579292|NCT02100670|156312603|FG002|Overall Study|Poor Efficacy|0|||
48579293|NCT02100670|156312604|FG003|Overall Study|Poor Efficacy|0|||
48579294|NCT02100670|156312601|FG000|Overall Study|Physician Decision|0|||
48579295|NCT02100670|156312602|FG001|Overall Study|Physician Decision|1|||
48579296|NCT02100670|156312603|FG002|Overall Study|Physician Decision|0|||
48579297|NCT02100670|156312604|FG003|Overall Study|Physician Decision|0|||
48579298|NCT02100670|156312601|FG000|Overall Study|Withdrawal by Subject|1|||
48579299|NCT02100670|156312602|FG001|Overall Study|Withdrawal by Subject|0|||
48579300|NCT02100670|156312603|FG002|Overall Study|Withdrawal by Subject|0|||
48579301|NCT02100670|156312604|FG003|Overall Study|Withdrawal by Subject|0|||
48579302|NCT05845567|156312605|FG000|Overall Study|Withdrawal by Subject|1|||
48579303|NCT00567489|156312606|FG000|Overall Study|Adverse Event|6|||
48579304|NCT00567489|156312607|FG001|Overall Study|Adverse Event|14|||
48579305|NCT00567489|156312606|FG000|Overall Study|Physician Decision|0|||
48579306|NCT00567489|156312607|FG001|Overall Study|Physician Decision|4|||
48579307|NCT00567489|156312606|FG000|Overall Study|Withdrawal by Subject|0|||
48579308|NCT00567489|156312607|FG001|Overall Study|Withdrawal by Subject|2|||
48579309|NCT00567489|156312606|FG000|Overall Study|Renal Transplantation|0|||
48579310|NCT00567489|156312607|FG001|Overall Study|Renal Transplantation|3|||
48579311|NCT00567489|156312606|FG000|Overall Study|Other|1|||
48579312|NCT00567489|156312607|FG001|Overall Study|Other|0|||
48579313|NCT02347891|156312608|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
48579314|NCT02347891|156312609|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
48579315|NCT02347891|156312608|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
48579316|NCT02347891|156312609|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
48579317|NCT03409107|156312615|FG000|Overall Study|Withdrawal by Subject|4|||
48579318|NCT03409107|156312616|FG001|Overall Study|Withdrawal by Subject|2|||
48579319|NCT03409107|156312615|FG000|Overall Study|Physician Decision|1|||
48579320|NCT03409107|156312616|FG001|Overall Study|Physician Decision|0|||
48579321|NCT03409107|156312615|FG000|Overall Study|Lost to Follow-up|7|||
48579322|NCT03409107|156312616|FG001|Overall Study|Lost to Follow-up|2|||
48579323|NCT03409107|156312615|FG000|Overall Study|Adverse Event|5|||
48579324|NCT03409107|156312616|FG001|Overall Study|Adverse Event|3|||
48579325|NCT01154088|156312620|FG000|Overall Study|Lost to Follow-up|4|||
48579326|NCT01154088|156312621|FG001|Overall Study|Lost to Follow-up|6|||
48579327|NCT01154088|156312622|FG002|Overall Study|Lost to Follow-up|7|||
48579328|NCT00425061|156312623|FG000|Overall Study|Adverse Event|1|||
48579329|NCT00425061|156312624|FG001|Overall Study|Adverse Event|0|||
48579330|NCT00425061|156312625|FG002|Overall Study|Adverse Event|0|||
48579331|NCT00425061|156312626|FG003|Overall Study|Adverse Event|2|||
48579332|NCT00425061|156312627|FG004|Overall Study|Adverse Event|2|||
48579333|NCT00425061|156312628|FG005|Overall Study|Adverse Event|0|||
48579334|NCT00425061|156312629|FG006|Overall Study|Adverse Event|0|||
48579335|NCT00425061|156312623|FG000|Overall Study|Lost to Follow-up|0|||
48579336|NCT00425061|156312624|FG001|Overall Study|Lost to Follow-up|1|||
48579337|NCT00425061|156312625|FG002|Overall Study|Lost to Follow-up|0|||
48579338|NCT00425061|156312626|FG003|Overall Study|Lost to Follow-up|0|||
48579339|NCT00425061|156312627|FG004|Overall Study|Lost to Follow-up|0|||
48737407|NCT02405780|156888074|FG001|Period II|Withdrawal by Subject|4|||
48737408|NCT02405780|156888075|FG002|Period II|Withdrawal by Subject|0|||
48579340|NCT00425061|156312628|FG005|Overall Study|Lost to Follow-up|0|||
48579341|NCT00425061|156312629|FG006|Overall Study|Lost to Follow-up|0|||
48579342|NCT00425061|156312623|FG000|Overall Study|Protocol Violation|1|||
48579343|NCT00425061|156312624|FG001|Overall Study|Protocol Violation|0|||
48579344|NCT00425061|156312625|FG002|Overall Study|Protocol Violation|0|||
48737409|NCT02405780|156888076|FG003|Period II|Withdrawal by Subject|3|||
48579345|NCT00425061|156312626|FG003|Overall Study|Protocol Violation|0|||
48579346|NCT00425061|156312627|FG004|Overall Study|Protocol Violation|0|||
48579347|NCT00425061|156312628|FG005|Overall Study|Protocol Violation|0|||
48579348|NCT00425061|156312629|FG006|Overall Study|Protocol Violation|0|||
48579349|NCT00425061|156312623|FG000|Overall Study|Withdrawal by Subject|0|||
48579350|NCT00425061|156312624|FG001|Overall Study|Withdrawal by Subject|1|||
48579351|NCT00425061|156312625|FG002|Overall Study|Withdrawal by Subject|0|||
48579352|NCT00425061|156312626|FG003|Overall Study|Withdrawal by Subject|0|||
48320274|NCT01095796|155372595|FG000|Overall Study|Randomized but Not Treated|5|||
48320275|NCT01095796|155372596|FG001|Overall Study|Randomized but Not Treated|2|||
48320276|NCT01095796|155372595|FG000|Overall Study|Adverse Event|9|||
48320277|NCT01095796|155372596|FG001|Overall Study|Adverse Event|19|||
48320278|NCT01095796|155372595|FG000|Overall Study|Death|3|||
48320279|NCT01095796|155372596|FG001|Overall Study|Death|2|||
48320280|NCT01095796|155372595|FG000|Overall Study|Pregnancy|2|||
48320281|NCT01095796|155372596|FG001|Overall Study|Pregnancy|0|||
48320282|NCT01095796|155372595|FG000|Overall Study|Lack of Efficacy|5|||
48320283|NCT01095796|155372596|FG001|Overall Study|Lack of Efficacy|3|||
48320284|NCT01095796|155372595|FG000|Overall Study|Investigator's Discretion|7|||
48320285|NCT01095796|155372596|FG001|Overall Study|Investigator's Discretion|2|||
48320286|NCT01095796|155372595|FG000|Overall Study|Withdrew Consent|16|||
48320287|NCT01095796|155372596|FG001|Overall Study|Withdrew Consent|22|||
48320288|NCT01095796|155372595|FG000|Overall Study|Lost to Follow-up|27|||
48320289|NCT01095796|155372596|FG001|Overall Study|Lost to Follow-up|29|||
48320290|NCT01095796|155372595|FG000|Overall Study|Participant Noncompliance|5|||
48320291|NCT01095796|155372596|FG001|Overall Study|Participant Noncompliance|10|||
48320292|NCT01095796|155372595|FG000|Overall Study|Protocol Violation|1|||
48320293|NCT01095796|155372596|FG001|Overall Study|Protocol Violation|0|||
48320294|NCT01095796|155372595|FG000|Overall Study|Participant Transferred to Another Study|215|||
48320295|NCT01095796|155372596|FG001|Overall Study|Participant Transferred to Another Study|200|||
48320296|NCT03655262|155372603|FG000|Overall Study|Withdrawal by Subject|0|||
48320297|NCT03655262|155372604|FG001|Overall Study|Withdrawal by Subject|0|||
48320298|NCT03655262|155372605|FG002|Overall Study|Withdrawal by Subject|1|||
48320299|NCT00632203|155372608|FG000|Overall Study|Did not start study treatment|1|||
48320300|NCT00632203|155372609|FG001|Overall Study|Did not start study treatment|0|||
48320301|NCT00529100|155372610|FG000|Overall Study|Adverse Event|0|||
48579353|NCT00425061|156312627|FG004|Overall Study|Withdrawal by Subject|1|||
48320302|NCT00529100|155372611|FG001|Overall Study|Adverse Event|5|||
48320303|NCT00529100|155372610|FG000|Overall Study|Protocol Violation|0|||
48320304|NCT00529100|155372611|FG001|Overall Study|Protocol Violation|1|||
48320305|NCT00529100|155372610|FG000|Overall Study|Progressive Disease|0|||
48320306|NCT00529100|155372611|FG001|Overall Study|Progressive Disease|1|||
48320307|NCT00529100|155372610|FG000|Overall Study|Withdrawal by Subject|0|||
48320308|NCT00529100|155372611|FG001|Overall Study|Withdrawal by Subject|1|||
48320309|NCT00529100|155372610|FG000|Overall Study|Participant Ineligibility|0|||
48320310|NCT00529100|155372611|FG001|Overall Study|Participant Ineligibility|1|||
48320311|NCT00999167|155372612|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
48579354|NCT00425061|156312628|FG005|Overall Study|Withdrawal by Subject|0|||
48579355|NCT00425061|156312629|FG006|Overall Study|Withdrawal by Subject|3|||
48579356|NCT00425061|156312623|FG000|Overall Study|Sponsor's request|0|||
48579357|NCT00425061|156312624|FG001|Overall Study|Sponsor's request|0|||
48579358|NCT00425061|156312625|FG002|Overall Study|Sponsor's request|0|||
48579359|NCT00425061|156312626|FG003|Overall Study|Sponsor's request|0|||
48579360|NCT00425061|156312627|FG004|Overall Study|Sponsor's request|19|||
48579361|NCT00425061|156312628|FG005|Overall Study|Sponsor's request|4|||
48579362|NCT00425061|156312629|FG006|Overall Study|Sponsor's request|15|||
48579363|NCT00425061|156312623|FG000|Overall Study|Physician Decision|0|||
48579364|NCT00425061|156312624|FG001|Overall Study|Physician Decision|0|||
48579365|NCT00425061|156312625|FG002|Overall Study|Physician Decision|0|||
48579366|NCT00425061|156312626|FG003|Overall Study|Physician Decision|0|||
48579367|NCT00425061|156312627|FG004|Overall Study|Physician Decision|1|||
48579368|NCT00425061|156312628|FG005|Overall Study|Physician Decision|0|||
48579369|NCT00425061|156312629|FG006|Overall Study|Physician Decision|0|||
48579370|NCT00425061|156312623|FG000|Overall Study|Other|0|||
48579371|NCT00425061|156312624|FG001|Overall Study|Other|0|||
48579372|NCT00425061|156312625|FG002|Overall Study|Other|0|||
48579373|NCT00425061|156312626|FG003|Overall Study|Other|0|||
48579374|NCT00425061|156312627|FG004|Overall Study|Other|3|||
48579375|NCT00425061|156312628|FG005|Overall Study|Other|0|||
48579376|NCT00425061|156312629|FG006|Overall Study|Other|1|||
48737410|NCT02405780|156888073|FG000|Period II|Non-compliance with study procedures|5|||
48737411|NCT02405780|156888074|FG001|Period II|Non-compliance with study procedures|2|||
48737412|NCT02405780|156888075|FG002|Period II|Non-compliance with study procedures|7|||
48737413|NCT02405780|156888076|FG003|Period II|Non-compliance with study procedures|4|||
48320312|NCT00999167|155372613|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
48320313|NCT00999167|155372614|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
48320314|NCT00999167|155372612|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
48320315|NCT00999167|155372613|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
48320316|NCT00999167|155372614|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
48320317|NCT00999167|155372612|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
48320318|NCT00999167|155372613|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
48320319|NCT00999167|155372614|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
48579377|NCT01968707|156312632|FG000|Overall Study|Did not meet treatment day baseline|49|||
48579378|NCT01968707|156312633|FG001|Overall Study|Did not meet treatment day baseline|12|||
48320320|NCT00999167|155372612|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
48320321|NCT00999167|155372613|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
48320322|NCT00999167|155372614|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
48320323|NCT00999167|155372612|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
48320324|NCT00999167|155372613|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
48320325|NCT00999167|155372614|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
48320326|NCT00999167|155372612|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
48320327|NCT00999167|155372613|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
48320328|NCT00999167|155372614|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
48320329|NCT00999167|155372612|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
48320330|NCT00999167|155372613|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
48320331|NCT00999167|155372614|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
48320332|NCT00999167|155372612|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
48320333|NCT00999167|155372613|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
48320334|NCT00999167|155372614|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
48320335|NCT03733119|155372615|FG000|Overall Study|Physician Decision|2|||
48320336|NCT03733119|155372616|FG001|Overall Study|Physician Decision|1|||
48320337|NCT03733119|155372615|FG000|Overall Study|ineligible to treat per protocol|0|||
48320338|NCT03733119|155372616|FG001|Overall Study|ineligible to treat per protocol|1|||
48320339|NCT02789020|155372623|FG000|Overall Study|Withdrawal by Subject|6|||
48320340|NCT02789020|155372624|FG001|Overall Study|Withdrawal by Subject|5|||
48320341|NCT03338816|155372625|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
48320342|NCT03338816|155372626|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
48320343|NCT03338816|155372627|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
48320344|NCT03338816|155372628|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
48320345|NCT03338816|155372625|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
48320346|NCT03338816|155372626|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
48320347|NCT03338816|155372627|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
48320348|NCT03338816|155372628|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
48320349|NCT03338816|155372625|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
48320350|NCT03338816|155372626|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
48320351|NCT03338816|155372627|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
48320352|NCT03338816|155372628|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
48320353|NCT03338816|155372625|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
48579379|NCT01968707|156312634|FG002|Overall Study|Did not meet treatment day baseline|41|||
48579380|NCT01968707|156312635|FG003|Overall Study|Did not meet treatment day baseline|44|||
48579381|NCT01968707|156312636|FG004|Overall Study|Did not meet treatment day baseline|36|||
48579382|NCT01968707|156312637|FG005|Overall Study|Did not meet treatment day baseline|11|||
48579383|NCT01968707|156312638|FG006|Overall Study|Did not meet treatment day baseline|34|||
48579384|NCT01968707|156312639|FG007|Overall Study|Did not meet treatment day baseline|35|||
48579385|NCT03917472|156312640|FG000|Overall Study|Physician Decision|4|||
48579386|NCT03917472|156312641|FG001|Overall Study|Physician Decision|0|||
48579387|NCT03917472|156312640|FG000|Overall Study|Adverse Event|3|||
48579388|NCT03917472|156312641|FG001|Overall Study|Adverse Event|1|||
48579389|NCT03917472|156312640|FG000|Overall Study|Death|7|||
48579390|NCT03917472|156312641|FG001|Overall Study|Death|5|||
48579391|NCT03917472|156312640|FG000|Overall Study|Withdrawal by Subject|11|||
48579392|NCT03917472|156312641|FG001|Overall Study|Withdrawal by Subject|4|||
48579393|NCT03917472|156312640|FG000|Overall Study|Lost to Follow-up|10|||
48579394|NCT03917472|156312641|FG001|Overall Study|Lost to Follow-up|5|||
48579395|NCT00742508|156312642|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
48579396|NCT00742508|156312643|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
48579397|NCT00742508|156312642|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
48579398|NCT00742508|156312643|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
48579399|NCT00742508|156312642|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
48579400|NCT00742508|156312643|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
48579401|NCT00742508|156312642|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
48579402|NCT00742508|156312643|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
48579403|NCT00742508|156312642|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
48579404|NCT00742508|156312643|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
48579405|NCT02484651|156312644|FG000|Overall Study|Patients' data files were corrupted.|1|||
48737414|NCT00302107|156888079|FG000|Overall Study|Lost to Follow-up|6|||
48579406|NCT02484651|156312645|FG001|Overall Study|Patients' data files were corrupted.|1|||
48579407|NCT02484651|156312644|FG000|Overall Study|BIS monitoring failed.|1|||
48320354|NCT03338816|155372626|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
48320355|NCT03338816|155372627|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
48320356|NCT03338816|155372628|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
48320357|NCT03338816|155372625|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
48320358|NCT03338816|155372626|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
48320359|NCT03338816|155372627|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
48320360|NCT03338816|155372628|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
48320361|NCT03338816|155372625|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
48320362|NCT03338816|155372626|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
48320363|NCT03338816|155372627|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
48320364|NCT03338816|155372628|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
48320365|NCT03338816|155372625|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
48320366|NCT03338816|155372626|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
48320367|NCT03338816|155372627|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
48320368|NCT03338816|155372628|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
48320369|NCT06103188|155372631|FG000|Overall Study|Lost to Follow-up|1|||
48320370|NCT06103188|155372632|FG001|Overall Study|Lost to Follow-up|6|||
48320371|NCT06103188|155372633|FG002|Overall Study|Lost to Follow-up|4|||
48320372|NCT05246670|155372634|FG000|Overall Study|Withdrawal by Subject|2|||
48320373|NCT05246670|155372635|FG001|Overall Study|Withdrawal by Subject|3|||
48579408|NCT02484651|156312645|FG001|Overall Study|BIS monitoring failed.|1|||
48579409|NCT02484651|156312644|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
48579410|NCT02484651|156312645|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
48579411|NCT02089334|156312649|FG000|Overall Study|Withdrawal by Subject|0|||
48579412|NCT02089334|156312650|FG001|Overall Study|Withdrawal by Subject|0|||
48579413|NCT02089334|156312651|FG002|Overall Study|Withdrawal by Subject|0|||
48579414|NCT02089334|156312652|FG003|Overall Study|Withdrawal by Subject|2|||
48579415|NCT02089334|156312649|FG000|Overall Study|Adverse Event|0|||
48579416|NCT02089334|156312650|FG001|Overall Study|Adverse Event|0|||
48579417|NCT02089334|156312651|FG002|Overall Study|Adverse Event|0|||
48579418|NCT02089334|156312652|FG003|Overall Study|Adverse Event|2|||
48579419|NCT02089334|156312649|FG000|Overall Study|Progressive disease|0|||
48579420|NCT02089334|156312650|FG001|Overall Study|Progressive disease|0|||
48579421|NCT02089334|156312651|FG002|Overall Study|Progressive disease|0|||
48579422|NCT02089334|156312652|FG003|Overall Study|Progressive disease|2|||
48579423|NCT02089334|156312649|FG000|Overall Study|Physician Decision|0|||
48579424|NCT02089334|156312650|FG001|Overall Study|Physician Decision|0|||
48579425|NCT02089334|156312651|FG002|Overall Study|Physician Decision|1|||
48579426|NCT02089334|156312652|FG003|Overall Study|Physician Decision|1|||
48579427|NCT02680834|156312653|FG000|Overall Study|Physician Decision|5|||
48579428|NCT02680834|156312654|FG001|Overall Study|Physician Decision|2|||
48579429|NCT02680834|156312653|FG000|Overall Study|Withdrawal by Subject|6|||
48579430|NCT02680834|156312654|FG001|Overall Study|Withdrawal by Subject|0|||
48579431|NCT02680834|156312653|FG000|Overall Study|Lost to Follow-up|0|||
48579432|NCT02680834|156312654|FG001|Overall Study|Lost to Follow-up|1|||
48579433|NCT02520427|156312656|FG000|Overall Study|Decision by sponsor|0|||
48579434|NCT02520427|156312657|FG001|Overall Study|Decision by sponsor|0|||
48579435|NCT02520427|156312658|FG002|Overall Study|Decision by sponsor|0|||
48579436|NCT02520427|156312659|FG003|Overall Study|Decision by sponsor|0|||
48579437|NCT02520427|156312660|FG004|Overall Study|Decision by sponsor|0|||
48579438|NCT02520427|156312661|FG005|Overall Study|Decision by sponsor|0|||
48579439|NCT02520427|156312662|FG006|Overall Study|Decision by sponsor|0|||
48579440|NCT02520427|156312663|FG007|Overall Study|Decision by sponsor|0|||
48579441|NCT02520427|156312664|FG008|Overall Study|Decision by sponsor|1|||
48579442|NCT02520427|156312665|FG009|Overall Study|Decision by sponsor|1|||
48579443|NCT02520427|156312666|FG010|Overall Study|Decision by sponsor|0|||
48579444|NCT02520427|156312667|FG011|Overall Study|Decision by sponsor|0|||
48579445|NCT02520427|156312668|FG012|Overall Study|Decision by sponsor|0|||
48579446|NCT02520427|156312669|FG013|Overall Study|Decision by sponsor|0|||
48579447|NCT02520427|156312670|FG014|Overall Study|Decision by sponsor|0|||
48579448|NCT02520427|156312671|FG015|Overall Study|Decision by sponsor|0|||
48579449|NCT02520427|156312672|FG016|Overall Study|Decision by sponsor|0|||
48579450|NCT02520427|156312673|FG017|Overall Study|Decision by sponsor|0|||
48579451|NCT02520427|156312674|FG018|Overall Study|Decision by sponsor|0|||
48579452|NCT02520427|156312675|FG019|Overall Study|Decision by sponsor|0|||
48579453|NCT02520427|156312676|FG020|Overall Study|Decision by sponsor|0|||
48579454|NCT02520427|156312677|FG021|Overall Study|Decision by sponsor|0|||
48579455|NCT02520427|156312678|FG022|Overall Study|Decision by sponsor|0|||
48579456|NCT02520427|156312679|FG023|Overall Study|Decision by sponsor|0|||
48579457|NCT02520427|156312680|FG024|Overall Study|Decision by sponsor|0|||
48579458|NCT02520427|156312681|FG025|Overall Study|Decision by sponsor|0|||
48579459|NCT02520427|156312656|FG000|Overall Study|Withdrawal by Subject|0|||
48579460|NCT02520427|156312657|FG001|Overall Study|Withdrawal by Subject|0|||
48320374|NCT05246670|155372636|FG002|Overall Study|Withdrawal by Subject|0|||
48320375|NCT05246670|155372637|FG003|Overall Study|Withdrawal by Subject|1|||
48579461|NCT02520427|156312658|FG002|Overall Study|Withdrawal by Subject|1|||
48579462|NCT02520427|156312659|FG003|Overall Study|Withdrawal by Subject|0|||
48579463|NCT02520427|156312660|FG004|Overall Study|Withdrawal by Subject|0|||
48579464|NCT02520427|156312661|FG005|Overall Study|Withdrawal by Subject|0|||
48579465|NCT02520427|156312662|FG006|Overall Study|Withdrawal by Subject|0|||
48320376|NCT05246670|155372634|FG000|Overall Study|Adverse Event|0|||
48320377|NCT05246670|155372635|FG001|Overall Study|Adverse Event|0|||
48320378|NCT05246670|155372636|FG002|Overall Study|Adverse Event|1|||
48320379|NCT05246670|155372637|FG003|Overall Study|Adverse Event|0|||
48320380|NCT05246670|155372634|FG000|Overall Study|Physician Decision|1|||
48320381|NCT05246670|155372635|FG001|Overall Study|Physician Decision|0|||
48320382|NCT05246670|155372636|FG002|Overall Study|Physician Decision|0|||
48579466|NCT02520427|156312663|FG007|Overall Study|Withdrawal by Subject|0|||
48579467|NCT02520427|156312664|FG008|Overall Study|Withdrawal by Subject|0|||
48579468|NCT02520427|156312665|FG009|Overall Study|Withdrawal by Subject|0|||
48579469|NCT02520427|156312666|FG010|Overall Study|Withdrawal by Subject|0|||
48579470|NCT02520427|156312667|FG011|Overall Study|Withdrawal by Subject|0|||
48320383|NCT05246670|155372637|FG003|Overall Study|Physician Decision|0|||
48320384|NCT05246670|155372634|FG000|Overall Study|Protocol Violation|1|||
48320385|NCT05246670|155372635|FG001|Overall Study|Protocol Violation|0|||
48579471|NCT02520427|156312668|FG012|Overall Study|Withdrawal by Subject|1|||
48579472|NCT02520427|156312669|FG013|Overall Study|Withdrawal by Subject|1|||
48579473|NCT02520427|156312670|FG014|Overall Study|Withdrawal by Subject|1|||
48579474|NCT02520427|156312671|FG015|Overall Study|Withdrawal by Subject|0|||
48320386|NCT05246670|155372636|FG002|Overall Study|Protocol Violation|0|||
48320387|NCT05246670|155372637|FG003|Overall Study|Protocol Violation|0|||
48320388|NCT04093752|155372638|FG000|Overall Study|Adverse Event|7|||
48320389|NCT04093752|155372639|FG001|Overall Study|Adverse Event|19|||
48579475|NCT02520427|156312672|FG016|Overall Study|Withdrawal by Subject|1|||
48579476|NCT02520427|156312673|FG017|Overall Study|Withdrawal by Subject|0|||
48320390|NCT04093752|155372640|FG002|Overall Study|Adverse Event|18|||
48320391|NCT04093752|155372641|FG003|Overall Study|Adverse Event|4|||
48320392|NCT04093752|155372638|FG000|Overall Study|Withdrawal by Subject|6|||
48320393|NCT04093752|155372639|FG001|Overall Study|Withdrawal by Subject|6|||
48320394|NCT04093752|155372640|FG002|Overall Study|Withdrawal by Subject|8|||
48320395|NCT04093752|155372641|FG003|Overall Study|Withdrawal by Subject|20|||
48320396|NCT04093752|155372638|FG000|Overall Study|Lost to Follow-up|2|||
48320397|NCT04093752|155372639|FG001|Overall Study|Lost to Follow-up|1|||
48320398|NCT04093752|155372640|FG002|Overall Study|Lost to Follow-up|1|||
48579477|NCT02520427|156312674|FG018|Overall Study|Withdrawal by Subject|0|||
48579478|NCT02520427|156312675|FG019|Overall Study|Withdrawal by Subject|3|||
48320399|NCT04093752|155372641|FG003|Overall Study|Lost to Follow-up|1|||
48320400|NCT04093752|155372638|FG000|Overall Study|Death|0|||
48320401|NCT04093752|155372639|FG001|Overall Study|Death|0|||
48320402|NCT04093752|155372640|FG002|Overall Study|Death|1|||
48320403|NCT04093752|155372641|FG003|Overall Study|Death|2|||
48320404|NCT04093752|155372638|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
48320405|NCT04093752|155372639|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
48320406|NCT04093752|155372640|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
48320407|NCT04093752|155372641|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
48320408|NCT04093752|155372638|FG000|Overall Study|Covid 19|0|||
48320409|NCT04093752|155372639|FG001|Overall Study|Covid 19|0|||
48320410|NCT04093752|155372640|FG002|Overall Study|Covid 19|0|||
48320411|NCT04093752|155372641|FG003|Overall Study|Covid 19|1|||
48320412|NCT04093752|155372638|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
48320413|NCT04093752|155372639|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
48320414|NCT04093752|155372640|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
48320415|NCT04093752|155372641|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
48320416|NCT04093752|155372638|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
48320417|NCT04093752|155372639|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
48320418|NCT04093752|155372640|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
48320419|NCT04093752|155372641|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
48320420|NCT04093752|155372638|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
48320421|NCT04093752|155372639|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
48320422|NCT04093752|155372640|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
48320423|NCT04093752|155372641|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
48579479|NCT02520427|156312676|FG020|Overall Study|Withdrawal by Subject|2|||
48320424|NCT02140645|155372644|FG000|Overall Study|Not linked|5489|||
48320425|NCT02140645|155372645|FG001|Overall Study|Not linked|61654|||
48320426|NCT02140645|155372646|FG002|Overall Study|Not linked|4236|||
48320427|NCT02140645|155372647|FG003|Overall Study|Not linked|13833|||
48320428|NCT02140645|155372648|FG004|Overall Study|Not linked|3286|||
48320429|NCT02140645|155372649|FG005|Overall Study|Not linked|70896|||
48320430|NCT03014453|155372651|FG000|Overall Study|Lost to Follow-up|12|||
48320431|NCT03014453|155372651|FG000|Overall Study|Discontinued GER|3|||
48320432|NCT03014453|155372651|FG000|Overall Study|Excluded|19|||
48320433|NCT03014453|155372651|FG000|Overall Study|Refused to take part in|37|||
48320434|NCT02814838|155372652|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
48320435|NCT02814838|155372653|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
48320436|NCT02814838|155372652|FG000|Overall Study|Consent withdrawal|1|||
48579480|NCT02520427|156312677|FG021|Overall Study|Withdrawal by Subject|0|||
48579481|NCT02520427|156312678|FG022|Overall Study|Withdrawal by Subject|0|||
48579482|NCT02520427|156312679|FG023|Overall Study|Withdrawal by Subject|0|||
48579483|NCT02520427|156312680|FG024|Overall Study|Withdrawal by Subject|0|||
48579484|NCT02520427|156312681|FG025|Overall Study|Withdrawal by Subject|0|||
48579485|NCT02520427|156312656|FG000|Overall Study|Death|1|||
48579486|NCT02520427|156312657|FG001|Overall Study|Death|0|||
48579487|NCT02520427|156312658|FG002|Overall Study|Death|0|||
48579488|NCT02520427|156312659|FG003|Overall Study|Death|0|||
48579489|NCT02520427|156312660|FG004|Overall Study|Death|0|||
48579490|NCT02520427|156312661|FG005|Overall Study|Death|0|||
48579491|NCT02520427|156312662|FG006|Overall Study|Death|0|||
48579492|NCT02520427|156312663|FG007|Overall Study|Death|0|||
48579493|NCT02520427|156312664|FG008|Overall Study|Death|0|||
48320437|NCT02814838|155372653|FG001|Overall Study|Consent withdrawal|1|||
48320438|NCT03432858|155372654|FG000|Overall Study|Protocol Violation|2|||
48320439|NCT03432858|155372655|FG001|Overall Study|Protocol Violation|1|||
48579494|NCT02520427|156312665|FG009|Overall Study|Death|0|||
48579495|NCT02520427|156312666|FG010|Overall Study|Death|0|||
48579496|NCT02520427|156312667|FG011|Overall Study|Death|0|||
48579497|NCT02520427|156312668|FG012|Overall Study|Death|0|||
48320440|NCT03432858|155372656|FG002|Overall Study|Protocol Violation|9|||
48320441|NCT03432858|155372654|FG000|Overall Study|Withdrawal by Subject|0|||
48320442|NCT03432858|155372655|FG001|Overall Study|Withdrawal by Subject|1|||
48579498|NCT02520427|156312669|FG013|Overall Study|Death|0|||
48737415|NCT00302107|156888080|FG001|Overall Study|Lost to Follow-up|5|||
48579499|NCT02520427|156312670|FG014|Overall Study|Death|0|||
48320443|NCT03432858|155372656|FG002|Overall Study|Withdrawal by Subject|1|||
48320444|NCT03432858|155372654|FG000|Overall Study|Procedure canceled/rescheduled|0|||
48320445|NCT03432858|155372655|FG001|Overall Study|Procedure canceled/rescheduled|9|||
48320446|NCT03432858|155372656|FG002|Overall Study|Procedure canceled/rescheduled|6|||
48320447|NCT03432858|155372654|FG000|Overall Study|Required postop mobilization with splinting|0|||
48320448|NCT03432858|155372655|FG001|Overall Study|Required postop mobilization with splinting|0|||
48320449|NCT03432858|155372656|FG002|Overall Study|Required postop mobilization with splinting|1|||
48320450|NCT03544515|155375215|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
48320451|NCT03544515|155375216|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
48320452|NCT03544515|155375215|FG000|Overall Study|Lost to Follow-up|2|||
48320453|NCT03544515|155375216|FG001|Overall Study|Lost to Follow-up|0|||
48579500|NCT02520427|156312671|FG015|Overall Study|Death|0|||
48579501|NCT02520427|156312672|FG016|Overall Study|Death|2|||
48579502|NCT02520427|156312673|FG017|Overall Study|Death|1|||
48579503|NCT02520427|156312674|FG018|Overall Study|Death|3|||
48579504|NCT02520427|156312675|FG019|Overall Study|Death|2|||
48579505|NCT02520427|156312676|FG020|Overall Study|Death|0|||
48579506|NCT02520427|156312677|FG021|Overall Study|Death|0|||
48579507|NCT02520427|156312678|FG022|Overall Study|Death|1|||
48579508|NCT02520427|156312679|FG023|Overall Study|Death|0|||
48579509|NCT02520427|156312680|FG024|Overall Study|Death|1|||
48579510|NCT02520427|156312681|FG025|Overall Study|Death|0|||
48579511|NCT04778059|156312685|FG000|Overall Study|Death|2|||
48579512|NCT04778059|156312686|FG001|Overall Study|Death|2|||
48579513|NCT04778059|156312687|FG002|Overall Study|Death|1|||
48737416|NCT00302107|156888079|FG000|Overall Study|Protocol Violation|1|||
48579514|NCT04778059|156312688|FG003|Overall Study|Death|1|||
48579515|NCT04778059|156312689|FG004|Overall Study|Death|1|||
48579516|NCT04778059|156312685|FG000|Overall Study|Lost to Follow-up|0|||
48579517|NCT04778059|156312686|FG001|Overall Study|Lost to Follow-up|0|||
48579518|NCT04778059|156312687|FG002|Overall Study|Lost to Follow-up|0|||
48579519|NCT04778059|156312688|FG003|Overall Study|Lost to Follow-up|0|||
48579520|NCT04778059|156312689|FG004|Overall Study|Lost to Follow-up|1|||
48579521|NCT04778059|156312685|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
48579522|NCT04778059|156312686|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
48579523|NCT04778059|156312687|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
48579524|NCT04778059|156312688|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
48579525|NCT04778059|156312689|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
48579526|NCT03875092|156314568|FG000|Overall Study|Adverse Event|2|||
48579527|NCT03875092|156314569|FG001|Overall Study|Adverse Event|5|||
48320482|NCT00722046|155375219|FG000|Overall Study|Adverse Event|0|||
48320483|NCT00722046|155375220|FG001|Overall Study|Adverse Event|1|||
48320484|NCT00722046|155375221|FG002|Overall Study|Adverse Event|2|||
48320485|NCT00722046|155375222|FG003|Overall Study|Adverse Event|1|||
48320486|NCT00722046|155375223|FG004|Overall Study|Adverse Event|2|||
48320487|NCT00722046|155375224|FG005|Overall Study|Adverse Event|1|||
48320488|NCT00722046|155375225|FG006|Overall Study|Adverse Event|0|||
48320489|NCT00722046|155375219|FG000|Overall Study|Death|0|||
48320490|NCT00722046|155375220|FG001|Overall Study|Death|1|||
48320491|NCT00722046|155375221|FG002|Overall Study|Death|0|||
48320492|NCT00722046|155375222|FG003|Overall Study|Death|0|||
48320493|NCT00722046|155375223|FG004|Overall Study|Death|0|||
48320494|NCT00722046|155375224|FG005|Overall Study|Death|0|||
48320495|NCT00722046|155375225|FG006|Overall Study|Death|2|||
48579528|NCT03875092|156314568|FG000|Overall Study|Death|44|||
48579529|NCT03875092|156314569|FG001|Overall Study|Death|51|||
48579530|NCT03875092|156314568|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
48579531|NCT03875092|156314569|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
48579532|NCT03205761|156314570|FG000|Overall Study|Withdrawal by Subject|1|||
48737417|NCT00302107|156888080|FG001|Overall Study|Protocol Violation|0|||
48737418|NCT00302107|156888079|FG000|Overall Study|Relocation|0|||
48737419|NCT00302107|156888080|FG001|Overall Study|Relocation|1|||
48320496|NCT00722046|155375219|FG000|Overall Study|Protocol Violation|1|||
48320497|NCT00722046|155375220|FG001|Overall Study|Protocol Violation|0|||
48320498|NCT00722046|155375221|FG002|Overall Study|Protocol Violation|0|||
48320499|NCT00722046|155375222|FG003|Overall Study|Protocol Violation|0|||
48320500|NCT00722046|155375223|FG004|Overall Study|Protocol Violation|0|||
48579533|NCT03205761|156314570|FG000|Overall Study|Progressive Disease|10|||
48579534|NCT00636194|156314574|FG000|Overall Study|Study related symptoms and complaints|1|||
48579535|NCT00636194|156314575|FG001|Overall Study|Study related symptoms and complaints|0|||
48320501|NCT00722046|155375224|FG005|Overall Study|Protocol Violation|1|||
48320502|NCT00722046|155375225|FG006|Overall Study|Protocol Violation|0|||
48320503|NCT00722046|155375219|FG000|Overall Study|Withdrawal by Subject|3|||
48320504|NCT00722046|155375220|FG001|Overall Study|Withdrawal by Subject|3|||
48320505|NCT00722046|155375221|FG002|Overall Study|Withdrawal by Subject|4|||
48579536|NCT00636194|156314574|FG000|Overall Study|Protocol Violation|2|||
48320506|NCT00722046|155375222|FG003|Overall Study|Withdrawal by Subject|4|||
48579537|NCT00636194|156314575|FG001|Overall Study|Protocol Violation|0|||
48579538|NCT02706886|156314576|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
48579539|NCT02706886|156314577|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
48579540|NCT02706886|156314578|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
48320507|NCT00722046|155375223|FG004|Overall Study|Withdrawal by Subject|4|||
48320508|NCT00722046|155375224|FG005|Overall Study|Withdrawal by Subject|7|||
48320509|NCT00722046|155375225|FG006|Overall Study|Withdrawal by Subject|3|||
48320510|NCT00722046|155375219|FG000|Overall Study|Randomized, but not treated|1|||
48320511|NCT00722046|155375220|FG001|Overall Study|Randomized, but not treated|1|||
48320512|NCT00722046|155375221|FG002|Overall Study|Randomized, but not treated|0|||
48320513|NCT00722046|155375222|FG003|Overall Study|Randomized, but not treated|2|||
48579541|NCT02706886|156314579|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
48579542|NCT02706886|156314580|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
48579543|NCT02706886|156314581|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
48579544|NCT02706886|156314582|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
48579545|NCT02706886|156314583|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
48579546|NCT02706886|156314584|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
48579547|NCT04420585|156314586|FG000|Overall Study|Adverse Event|1|||
48579548|NCT04420585|156314586|FG000|Overall Study|Never initiated medication|2|||
48579549|NCT02817516|156314587|FG000|Overall Study|Other|0|||
48579550|NCT02817516|156314588|FG001|Overall Study|Other|0|||
48579551|NCT02817516|156314589|FG002|Overall Study|Other|1|||
48320514|NCT00722046|155375223|FG004|Overall Study|Randomized, but not treated|0|||
48320515|NCT00722046|155375224|FG005|Overall Study|Randomized, but not treated|0|||
48320516|NCT00722046|155375225|FG006|Overall Study|Randomized, but not treated|0|||
48320517|NCT00722046|155375219|FG000|Overall Study|Other|0|||
48320518|NCT00722046|155375220|FG001|Overall Study|Other|0|||
48320519|NCT00722046|155375221|FG002|Overall Study|Other|1|||
48320520|NCT00722046|155375222|FG003|Overall Study|Other|1|||
48320521|NCT00722046|155375223|FG004|Overall Study|Other|3|||
48320522|NCT00722046|155375224|FG005|Overall Study|Other|2|||
48320523|NCT00722046|155375225|FG006|Overall Study|Other|1|||
48320524|NCT02107703|155375226|FG000|Overall Study|Withdrawal by Subject|46|||
48579552|NCT02817516|156314590|FG003|Overall Study|Other|0|||
48320525|NCT02107703|155375227|FG001|Overall Study|Withdrawal by Subject|21|||
48320526|NCT02107703|155375226|FG000|Overall Study|Lost to Follow-up|20|||
48320527|NCT02107703|155375227|FG001|Overall Study|Lost to Follow-up|9|||
48320528|NCT02107703|155375226|FG000|Overall Study|On study treatment/follow up|48|||
48320529|NCT02107703|155375227|FG001|Overall Study|On study treatment/follow up|5|||
48320530|NCT02499159|155375230|FG000|Randomization|Protocol Violation|1|||
48320531|NCT02499159|155375231|FG001|Randomization|Protocol Violation|1|||
48320532|NCT02499159|155375230|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
48320533|NCT02499159|155375231|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
48579553|NCT00348595|156314591|FG000|Overall Study|Adverse Event|5|||
48579554|NCT00348595|156314592|FG001|Overall Study|Adverse Event|8|||
48579555|NCT01846221|156314593|FG000|Overall Study|Catheter Failure|2|||
48320534|NCT02499159|155375230|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
48320535|NCT02499159|155375231|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
48320536|NCT02499159|155375230|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
48320537|NCT02499159|155375231|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
48579556|NCT01846221|156314594|FG001|Overall Study|Catheter Failure|0|||
48579557|NCT01846221|156314593|FG000|Overall Study|Age Exclusion|1|||
48579558|NCT01846221|156314594|FG001|Overall Study|Age Exclusion|0|||
48579559|NCT00748189|156314597|FG000|Overall Study|Death|99|||
48320538|NCT02499159|155375230|FG000|30-Day Follow-Up Phone Call|Other|1|||
48320539|NCT02499159|155375231|FG001|30-Day Follow-Up Phone Call|Other|0|||
48320540|NCT01696994|155375232|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
48320541|NCT01696994|155375233|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
48320542|NCT01696994|155375232|FG000|Overall Study|Died Before Randomization|1|||
48320543|NCT01696994|155375233|FG001|Overall Study|Died Before Randomization|2|||
48320544|NCT01696994|155375232|FG000|Overall Study|Died Before ASU (Control)|73|||
48737420|NCT00302107|156888079|FG000|Overall Study|Withdrawal by Subject|0|||
48579560|NCT00748189|156314598|FG001|Overall Study|Death|84|||
48579561|NCT00748189|156314597|FG000|Overall Study|Withdrawal by Subject|23|||
48579562|NCT00748189|156314598|FG001|Overall Study|Withdrawal by Subject|29|||
48579563|NCT00748189|156314597|FG000|Overall Study|Physician Decision|16|||
48737421|NCT00302107|156888080|FG001|Overall Study|Withdrawal by Subject|3|||
48320545|NCT01696994|155375233|FG001|Overall Study|Died Before ASU (Control)|0|||
48320546|NCT01696994|155375232|FG000|Overall Study|No Ovaries at Baseline|4807|||
48320547|NCT01696994|155375233|FG001|Overall Study|No Ovaries at Baseline|4851|||
48320548|NCT01696994|155375232|FG000|Overall Study|Refused ASU (Control)|311|||
48579564|NCT00748189|156314598|FG001|Overall Study|Physician Decision|5|||
48579565|NCT00748189|156314597|FG000|Overall Study|Lost to Follow-up|8|||
48579566|NCT00748189|156314598|FG001|Overall Study|Lost to Follow-up|15|||
48579567|NCT00748189|156314597|FG000|Overall Study|Study terminated by Sponsor|70|||
48579568|NCT00748189|156314598|FG001|Overall Study|Study terminated by Sponsor|79|||
48579569|NCT01661933|156314599|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
48579570|NCT01661933|156314599|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
48579571|NCT00916344|156314601|FG000|Overall Study|Death|2|||
48579572|NCT00916344|156314601|FG000|Overall Study|ICD upgrade|1|||
48579573|NCT00916344|156314601|FG000|Overall Study|Drop-out|5|||
48579574|NCT05129137|156314602|FG000|Second Period|Adverse Event|1|||
48579575|NCT05129137|156314603|FG001|Second Period|Adverse Event|0|||
48579576|NCT05129137|156314604|FG002|Second Period|Adverse Event|0|||
48579577|NCT05129137|156314605|FG003|Second Period|Adverse Event|0|||
48579578|NCT05129137|156314602|FG000|Second Period|Protocol Violation|0|||
48579579|NCT05129137|156314603|FG001|Second Period|Protocol Violation|0|||
48579580|NCT05129137|156314604|FG002|Second Period|Protocol Violation|0|||
48579581|NCT05129137|156314605|FG003|Second Period|Protocol Violation|1|||
48579582|NCT05129137|156314602|FG000|Third Period|Protocol Violation|0|||
48579583|NCT05129137|156314603|FG001|Third Period|Protocol Violation|0|||
48579584|NCT05129137|156314604|FG002|Third Period|Protocol Violation|0|||
48579585|NCT05129137|156314605|FG003|Third Period|Protocol Violation|1|||
48737422|NCT00302107|156888079|FG000|Overall Study|Adverse Event|1|||
48737423|NCT00302107|156888080|FG001|Overall Study|Adverse Event|0|||
48320549|NCT01696994|155375233|FG001|Overall Study|Refused ASU (Control)|0|||
48320550|NCT01696994|155375232|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
48320551|NCT01696994|155375233|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
48320552|NCT02500758|155375236|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
48320553|NCT02500758|155375237|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
48737424|NCT02777333|156888081|FG000|Overall Study|Withdrawal by Subject|0|||
48579586|NCT05129137|156314602|FG000|Forth Period|Protocol Violation|0|||
48579587|NCT05129137|156314603|FG001|Forth Period|Protocol Violation|1|||
48579588|NCT05129137|156314604|FG002|Forth Period|Protocol Violation|0|||
48579589|NCT05129137|156314605|FG003|Forth Period|Protocol Violation|0|||
48579590|NCT05129137|156314602|FG000|Forth Period|Withdrawal by Subject|0|||
48579591|NCT05129137|156314603|FG001|Forth Period|Withdrawal by Subject|0|||
48579592|NCT05129137|156314604|FG002|Forth Period|Withdrawal by Subject|1|||
48579593|NCT05129137|156314605|FG003|Forth Period|Withdrawal by Subject|0|||
48737425|NCT02777333|156888082|FG001|Overall Study|Withdrawal by Subject|1|||
48737426|NCT02777333|156888081|FG000|Overall Study|Lost to Follow-up|0|||
48320554|NCT02500758|155375236|FG000|Washout (1 Week)|Lost to Follow-up|2|||
48320555|NCT02500758|155375237|FG001|Washout (1 Week)|Lost to Follow-up|2|||
48320556|NCT02500758|155375236|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
48320557|NCT02500758|155375237|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
48320558|NCT02500758|155375236|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
48579594|NCT01185509|156314606|FG000|Overall Study|Progression/Relapse|9|||
48579595|NCT01185509|156314607|FG001|Overall Study|Progression/Relapse|15|||
48579596|NCT01185509|156314606|FG000|Overall Study|Physician Decision|2|||
48579597|NCT01185509|156314607|FG001|Overall Study|Physician Decision|2|||
48579598|NCT01185509|156314606|FG000|Overall Study|Withdrawal by Subject|0|||
48579599|NCT01185509|156314607|FG001|Overall Study|Withdrawal by Subject|1|||
48579600|NCT01185509|156314606|FG000|Overall Study|Death|0|||
48579601|NCT01185509|156314607|FG001|Overall Study|Death|1|||
48579602|NCT01185509|156314606|FG000|Overall Study|Intercurrent Illness|0|||
48579603|NCT01185509|156314607|FG001|Overall Study|Intercurrent Illness|1|||
48579604|NCT03385304|156314612|FG000|Overall Study|Death|19|||
48579605|NCT03385304|156314613|FG001|Overall Study|Death|7|||
48737427|NCT02777333|156888082|FG001|Overall Study|Lost to Follow-up|1|||
48737428|NCT00518687|156890084|FG000|Overall Study|Adverse Event|201|||
48737429|NCT00518687|156890085|FG001|Overall Study|Adverse Event|177|||
48737430|NCT00518687|156890084|FG000|Overall Study|Lost to Follow-up|144|||
48737431|NCT00518687|156890085|FG001|Overall Study|Lost to Follow-up|155|||
48737432|NCT00518687|156890084|FG000|Overall Study|Physician Decision|42|||
48737433|NCT00518687|156890085|FG001|Overall Study|Physician Decision|48|||
48737434|NCT00518687|156890084|FG000|Overall Study|Progressive disease|2|||
48737435|NCT00518687|156890085|FG001|Overall Study|Progressive disease|2|||
48737436|NCT00518687|156890084|FG000|Overall Study|Protocol Violation|8|||
48737437|NCT00518687|156890085|FG001|Overall Study|Protocol Violation|10|||
48737438|NCT00518687|156890084|FG000|Overall Study|Study terminated by sponsor|930|||
48737439|NCT00518687|156890085|FG001|Overall Study|Study terminated by sponsor|918|||
48737440|NCT00518687|156890084|FG000|Overall Study|Withdrawal by Subject|110|||
48737441|NCT00518687|156890085|FG001|Overall Study|Withdrawal by Subject|110|||
48737442|NCT02360995|156890088|FG000|Overall Study|Lost to Follow-up|2|||
48737443|NCT02360995|156890089|FG001|Overall Study|Lost to Follow-up|0|||
48737444|NCT02360995|156890090|FG002|Overall Study|Lost to Follow-up|2|||
48737445|NCT02360995|156890088|FG000|Overall Study|Withdrawal by Subject|0|||
48737446|NCT02360995|156890089|FG001|Overall Study|Withdrawal by Subject|1|||
48579606|NCT03385304|156314612|FG000|Overall Study|Lost to Follow-up|17|||
48579607|NCT03385304|156314613|FG001|Overall Study|Lost to Follow-up|14|||
48579608|NCT03385304|156314612|FG000|Overall Study|Withdrawal by Subject|3|||
48737447|NCT02360995|156890090|FG002|Overall Study|Withdrawal by Subject|0|||
48737448|NCT00428792|156890093|FG000|Overall Study|Lack of Efficacy|1|||
48737449|NCT00428792|156890094|FG001|Overall Study|Lack of Efficacy|3|||
48737450|NCT00428792|156890093|FG000|Overall Study|Lost to Follow-up|0|||
48737451|NCT00428792|156890094|FG001|Overall Study|Lost to Follow-up|1|||
48737452|NCT00809354|156890096|FG000|Overall Study|Adverse Event|32|||
48737453|NCT00809354|156890097|FG001|Overall Study|Adverse Event|45|||
48579609|NCT03385304|156314613|FG001|Overall Study|Withdrawal by Subject|2|||
48579610|NCT03385304|156314612|FG000|Overall Study|Incarceration|2|||
48579611|NCT03385304|156314613|FG001|Overall Study|Incarceration|3|||
48579612|NCT02031640|156314614|FG000|Screening Period|Adverse Event|1|||
48579613|NCT02031640|156314615|FG001|Screening Period|Adverse Event|0|||
48579614|NCT02031640|156314616|FG002|Screening Period|Adverse Event|0|||
48579615|NCT02031640|156314617|FG003|Screening Period|Adverse Event|0|||
48579616|NCT02031640|156314618|FG004|Screening Period|Adverse Event|0|||
48579617|NCT02031640|156314619|FG005|Screening Period|Adverse Event|0|||
48579618|NCT02031640|156314614|FG000|Screening Period|Withdrawal by Subject|29|||
48579619|NCT02031640|156314615|FG001|Screening Period|Withdrawal by Subject|0|||
48579620|NCT02031640|156314616|FG002|Screening Period|Withdrawal by Subject|0|||
48579621|NCT02031640|156314617|FG003|Screening Period|Withdrawal by Subject|0|||
48579622|NCT02031640|156314618|FG004|Screening Period|Withdrawal by Subject|0|||
48737454|NCT00809354|156890098|FG002|Overall Study|Adverse Event|37|||
48737455|NCT00809354|156890099|FG003|Overall Study|Adverse Event|53|||
48737456|NCT00809354|156890100|FG004|Overall Study|Adverse Event|26|||
48737457|NCT00809354|156890101|FG005|Overall Study|Adverse Event|33|||
48737458|NCT00809354|156890102|FG006|Overall Study|Adverse Event|44|||
48737459|NCT00809354|156890103|FG007|Overall Study|Adverse Event|40|||
48320559|NCT02500758|155375237|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
48320560|NCT02500758|155375236|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
48320561|NCT02500758|155375237|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
48320562|NCT00220740|155375238|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
48320563|NCT00220740|155375239|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
48320564|NCT00220740|155375238|FG000|Efficacy Period|Adverse Event|1|||
48320565|NCT00220740|155375239|FG001|Efficacy Period|Adverse Event|1|||
48320566|NCT00220740|155375238|FG000|Efficacy Period|Withdrawal by Subject|1|||
48579623|NCT02031640|156314619|FG005|Screening Period|Withdrawal by Subject|0|||
48579624|NCT02031640|156314614|FG000|Screening Period|Inclusion criteria not met|312|||
48737460|NCT00809354|156890104|FG008|Overall Study|Adverse Event|46|||
48737461|NCT00809354|156890105|FG009|Overall Study|Adverse Event|26|||
48737462|NCT00809354|156890096|FG000|Overall Study|Lack of Efficacy|23|||
48579625|NCT02031640|156314615|FG001|Screening Period|Inclusion criteria not met|0|||
48579626|NCT02031640|156314616|FG002|Screening Period|Inclusion criteria not met|0|||
48579627|NCT02031640|156314617|FG003|Screening Period|Inclusion criteria not met|0|||
48579628|NCT02031640|156314618|FG004|Screening Period|Inclusion criteria not met|0|||
48320567|NCT00220740|155375239|FG001|Efficacy Period|Withdrawal by Subject|0|||
48320568|NCT00220740|155375238|FG000|Efficacy Period|Protocol Violation|1|||
48579629|NCT02031640|156314619|FG005|Screening Period|Inclusion criteria not met|0|||
48737463|NCT00809354|156890097|FG001|Overall Study|Lack of Efficacy|23|||
48737464|NCT00809354|156890098|FG002|Overall Study|Lack of Efficacy|22|||
48320569|NCT00220740|155375239|FG001|Efficacy Period|Protocol Violation|0|||
48320570|NCT00220740|155375238|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
48579630|NCT02031640|156314614|FG000|Screening Period|Exclusion criteria met|30|||
48579631|NCT02031640|156314615|FG001|Screening Period|Exclusion criteria met|0|||
48579632|NCT02031640|156314616|FG002|Screening Period|Exclusion criteria met|0|||
48579633|NCT02031640|156314617|FG003|Screening Period|Exclusion criteria met|0|||
48579634|NCT02031640|156314618|FG004|Screening Period|Exclusion criteria met|0|||
48579635|NCT02031640|156314619|FG005|Screening Period|Exclusion criteria met|0|||
48579636|NCT02031640|156314614|FG000|Screening Period|Lost to Follow-up|14|||
48579637|NCT02031640|156314615|FG001|Screening Period|Lost to Follow-up|0|||
48579638|NCT02031640|156314616|FG002|Screening Period|Lost to Follow-up|0|||
48737465|NCT00809354|156890099|FG003|Overall Study|Lack of Efficacy|15|||
48737466|NCT00809354|156890100|FG004|Overall Study|Lack of Efficacy|40|||
48737467|NCT00809354|156890101|FG005|Overall Study|Lack of Efficacy|19|||
48737468|NCT00809354|156890102|FG006|Overall Study|Lack of Efficacy|21|||
48737469|NCT00809354|156890103|FG007|Overall Study|Lack of Efficacy|15|||
48737470|NCT00809354|156890104|FG008|Overall Study|Lack of Efficacy|18|||
48737471|NCT00809354|156890105|FG009|Overall Study|Lack of Efficacy|38|||
48737472|NCT00809354|156890096|FG000|Overall Study|Lost to Follow-up|10|||
48737473|NCT00809354|156890097|FG001|Overall Study|Lost to Follow-up|11|||
48737474|NCT00809354|156890098|FG002|Overall Study|Lost to Follow-up|8|||
48737475|NCT00809354|156890099|FG003|Overall Study|Lost to Follow-up|13|||
48737476|NCT00809354|156890100|FG004|Overall Study|Lost to Follow-up|6|||
48737477|NCT00809354|156890101|FG005|Overall Study|Lost to Follow-up|2|||
48737478|NCT00809354|156890102|FG006|Overall Study|Lost to Follow-up|0|||
48737479|NCT00809354|156890103|FG007|Overall Study|Lost to Follow-up|5|||
48737480|NCT00809354|156890104|FG008|Overall Study|Lost to Follow-up|4|||
48737481|NCT00809354|156890105|FG009|Overall Study|Lost to Follow-up|0|||
48737482|NCT00809354|156890096|FG000|Overall Study|Protocol Violation|7|||
48737483|NCT00809354|156890097|FG001|Overall Study|Protocol Violation|14|||
48737484|NCT00809354|156890098|FG002|Overall Study|Protocol Violation|14|||
48320571|NCT00220740|155375239|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
48320572|NCT02006758|155375242|FG000|Overall Study|Protocol Violation|1|||
48320573|NCT02006758|155375242|FG000|Overall Study|Death|1|||
48320574|NCT02006758|155375242|FG000|Overall Study|Lost to Follow-up|4|||
48320575|NCT02006758|155375242|FG000|Overall Study|Withdrawal by Subject|4|||
48320576|NCT02006758|155375242|FG000|Overall Study|Procedurally excluded|1|||
48320577|NCT02006758|155375242|FG000|Overall Study|Other|2|||
48320578|NCT01619410|155375243|FG000|Overall Study|Lost to Follow-up|7|||
48320579|NCT01619410|155375244|FG001|Overall Study|Lost to Follow-up|4|||
48320580|NCT01250769|155375245|FG000|Overall Study|Withdrawal by Subject|0|||
48320581|NCT01250769|155375246|FG001|Overall Study|Withdrawal by Subject|1|||
48320582|NCT01250769|155375247|FG002|Overall Study|Withdrawal by Subject|1|||
48320583|NCT01250769|155375248|FG003|Overall Study|Withdrawal by Subject|0|||
48320584|NCT01250769|155375245|FG000|Overall Study|Adverse Event|0|||
48320585|NCT01250769|155375246|FG001|Overall Study|Adverse Event|0|||
48320586|NCT01250769|155375247|FG002|Overall Study|Adverse Event|1|||
48320587|NCT01250769|155375248|FG003|Overall Study|Adverse Event|0|||
48320588|NCT02462759|155375249|FG000|Part 1: Double Blind|Death|1|||
48320589|NCT02462759|155375250|FG001|Part 1: Double Blind|Death|0|||
48320590|NCT02462759|155375251|FG002|Part 1: Double Blind|Death|0|||
48320591|NCT00914589|155375252|FG000|Overall Study|Adverse Event|1|||
48320592|NCT00914589|155375253|FG001|Overall Study|Adverse Event|0|||
48320593|NCT00914589|155375254|FG002|Overall Study|Adverse Event|1|||
48320594|NCT00914589|155375252|FG000|Overall Study|Protocol Violation|8|||
48320595|NCT00914589|155375253|FG001|Overall Study|Protocol Violation|6|||
48320596|NCT00914589|155375254|FG002|Overall Study|Protocol Violation|3|||
48320597|NCT00914589|155375252|FG000|Overall Study|unclassified|16|||
48320598|NCT00914589|155375253|FG001|Overall Study|unclassified|9|||
48320599|NCT00914589|155375254|FG002|Overall Study|unclassified|7|||
48320600|NCT00914589|155375252|FG000|Overall Study|Death|0|||
48579639|NCT02031640|156314617|FG003|Screening Period|Lost to Follow-up|0|||
48579640|NCT02031640|156314618|FG004|Screening Period|Lost to Follow-up|0|||
48737485|NCT00809354|156890099|FG003|Overall Study|Protocol Violation|12|||
48320601|NCT00914589|155375253|FG001|Overall Study|Death|1|||
48320602|NCT00914589|155375254|FG002|Overall Study|Death|1|||
48587293|NCT03003000|156343170|FG001|Overall Study|Lack of Efficacy|0|||
48737486|NCT00809354|156890100|FG004|Overall Study|Protocol Violation|14|||
48737487|NCT00809354|156890101|FG005|Overall Study|Protocol Violation|6|||
48737488|NCT00809354|156890102|FG006|Overall Study|Protocol Violation|4|||
48737489|NCT00809354|156890103|FG007|Overall Study|Protocol Violation|6|||
48320603|NCT01998958|155375256|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320604|NCT01998958|155375257|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
48320605|NCT01998958|155375258|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320606|NCT01998958|155375259|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320607|NCT01998958|155375260|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320608|NCT01998958|155375261|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320609|NCT01998958|155375262|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48737490|NCT00809354|156890104|FG008|Overall Study|Protocol Violation|9|||
48320610|NCT01998958|155375263|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320611|NCT01998958|155375264|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320612|NCT01998958|155375265|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320613|NCT01998958|155375266|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320614|NCT01998958|155375267|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320615|NCT01998958|155375268|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320616|NCT01998958|155375269|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320617|NCT01998958|155375270|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320618|NCT01998958|155375271|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320619|NCT01998958|155375272|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320620|NCT01998958|155375273|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48579641|NCT02031640|156314619|FG005|Screening Period|Lost to Follow-up|0|||
48737491|NCT00809354|156890105|FG009|Overall Study|Protocol Violation|3|||
48737492|NCT00809354|156890096|FG000|Overall Study|Withdrawal by Subject|32|||
48737493|NCT00809354|156890097|FG001|Overall Study|Withdrawal by Subject|27|||
48737494|NCT00809354|156890098|FG002|Overall Study|Withdrawal by Subject|31|||
48737495|NCT00809354|156890099|FG003|Overall Study|Withdrawal by Subject|33|||
48737496|NCT00809354|156890100|FG004|Overall Study|Withdrawal by Subject|34|||
48737497|NCT00809354|156890101|FG005|Overall Study|Withdrawal by Subject|29|||
48737498|NCT00809354|156890102|FG006|Overall Study|Withdrawal by Subject|27|||
48737499|NCT00809354|156890103|FG007|Overall Study|Withdrawal by Subject|19|||
48737500|NCT00809354|156890104|FG008|Overall Study|Withdrawal by Subject|18|||
48737501|NCT00809354|156890105|FG009|Overall Study|Withdrawal by Subject|20|||
48737502|NCT00809354|156890096|FG000|Overall Study|Other|10|||
48737503|NCT00809354|156890097|FG001|Overall Study|Other|2|||
48737504|NCT00809354|156890098|FG002|Overall Study|Other|7|||
48737505|NCT00809354|156890099|FG003|Overall Study|Other|10|||
48737506|NCT00809354|156890100|FG004|Overall Study|Other|5|||
48737507|NCT00809354|156890101|FG005|Overall Study|Other|3|||
48737508|NCT00809354|156890102|FG006|Overall Study|Other|2|||
48737509|NCT00809354|156890103|FG007|Overall Study|Other|3|||
48737510|NCT00809354|156890104|FG008|Overall Study|Other|4|||
48320621|NCT01998958|155375274|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320622|NCT01998958|155375275|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320623|NCT01998958|155375276|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48737511|NCT00809354|156890105|FG009|Overall Study|Other|3|||
48320624|NCT01998958|155375277|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320625|NCT01998958|155375278|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320626|NCT01998958|155375279|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320627|NCT01998958|155375280|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320628|NCT01998958|155375281|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320629|NCT01998958|155375282|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320630|NCT01998958|155375283|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320631|NCT01998958|155375284|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320632|NCT01998958|155375285|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320633|NCT01998958|155375286|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320634|NCT01998958|155375287|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
48320635|NCT01998958|155375256|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320636|NCT01998958|155375257|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
48320637|NCT01998958|155375258|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320638|NCT01998958|155375259|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320639|NCT01998958|155375260|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320640|NCT01998958|155375261|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48579642|NCT02031640|156314614|FG000|Screening Period|Enrollment closed|26|||
48320641|NCT01998958|155375262|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48737512|NCT00809354|156890096|FG000|Overall Study|Study terminated by sponsor|138|||
48737513|NCT00809354|156890097|FG001|Overall Study|Study terminated by sponsor|134|||
48320642|NCT01998958|155375263|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48737514|NCT00809354|156890098|FG002|Overall Study|Study terminated by sponsor|129|||
48737515|NCT00809354|156890099|FG003|Overall Study|Study terminated by sponsor|120|||
48320643|NCT01998958|155375264|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48737516|NCT00809354|156890100|FG004|Overall Study|Study terminated by sponsor|126|||
48737517|NCT00809354|156890101|FG005|Overall Study|Study terminated by sponsor|133|||
48737518|NCT00809354|156890102|FG006|Overall Study|Study terminated by sponsor|124|||
48737519|NCT00809354|156890103|FG007|Overall Study|Study terminated by sponsor|148|||
48737520|NCT00809354|156890104|FG008|Overall Study|Study terminated by sponsor|127|||
48737521|NCT00809354|156890105|FG009|Overall Study|Study terminated by sponsor|135|||
48737522|NCT00809354|156890096|FG000|Overall Study|Withdrawn due to pregnancy|0|||
48737523|NCT00809354|156890097|FG001|Overall Study|Withdrawn due to pregnancy|1|||
48737524|NCT00809354|156890098|FG002|Overall Study|Withdrawn due to pregnancy|0|||
48320644|NCT01998958|155375265|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320645|NCT01998958|155375266|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320646|NCT01998958|155375267|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320647|NCT01998958|155375268|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320648|NCT01998958|155375269|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320649|NCT01998958|155375270|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320650|NCT01998958|155375271|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320651|NCT01998958|155375272|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320652|NCT01998958|155375273|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320653|NCT01998958|155375274|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320654|NCT01998958|155375275|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320655|NCT01998958|155375276|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320656|NCT01998958|155375277|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320657|NCT01998958|155375278|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320658|NCT01998958|155375279|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320659|NCT01998958|155375280|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48737525|NCT00809354|156890099|FG003|Overall Study|Withdrawn due to pregnancy|0|||
48737526|NCT00809354|156890100|FG004|Overall Study|Withdrawn due to pregnancy|0|||
48737527|NCT00809354|156890101|FG005|Overall Study|Withdrawn due to pregnancy|0|||
48737528|NCT00809354|156890102|FG006|Overall Study|Withdrawn due to pregnancy|0|||
48737529|NCT00809354|156890103|FG007|Overall Study|Withdrawn due to pregnancy|0|||
48737530|NCT00809354|156890104|FG008|Overall Study|Withdrawn due to pregnancy|0|||
48737531|NCT00809354|156890105|FG009|Overall Study|Withdrawn due to pregnancy|0|||
48737532|NCT00809354|156890096|FG000|Overall Study|Randomized but not Treated|3|||
48737533|NCT00809354|156890097|FG001|Overall Study|Randomized but not Treated|1|||
48737534|NCT00809354|156890098|FG002|Overall Study|Randomized but not Treated|6|||
48737535|NCT00809354|156890099|FG003|Overall Study|Randomized but not Treated|0|||
48737536|NCT00809354|156890100|FG004|Overall Study|Randomized but not Treated|5|||
48737537|NCT00809354|156890101|FG005|Overall Study|Randomized but not Treated|0|||
48737538|NCT00809354|156890102|FG006|Overall Study|Randomized but not Treated|1|||
48320660|NCT01998958|155375281|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48737539|NCT00809354|156890103|FG007|Overall Study|Randomized but not Treated|1|||
48737540|NCT00809354|156890104|FG008|Overall Study|Randomized but not Treated|2|||
48320661|NCT01998958|155375282|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320662|NCT01998958|155375283|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320663|NCT01998958|155375284|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320664|NCT01998958|155375285|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320665|NCT01998958|155375286|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48737541|NCT00809354|156890105|FG009|Overall Study|Randomized but not Treated|1|||
48737542|NCT00809354|156890096|FG000|Overall Study|Death|0|||
48320666|NCT01998958|155375287|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
48320667|NCT01998958|155375256|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
48320668|NCT01998958|155375257|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
48320669|NCT01998958|155375258|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
48320670|NCT01998958|155375259|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
48320671|NCT01998958|155375260|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
48320672|NCT01998958|155375261|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
48320673|NCT01998958|155375262|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
48320674|NCT01998958|155375263|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
48320675|NCT01998958|155375264|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
48320676|NCT01998958|155375265|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
48320677|NCT01998958|155375266|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
48320678|NCT01998958|155375267|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
48320679|NCT01998958|155375268|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
48320680|NCT01998958|155375269|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
48579643|NCT02031640|156314615|FG001|Screening Period|Enrollment closed|0|||
48320681|NCT01998958|155375270|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
48320682|NCT01998958|155375271|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
48579644|NCT02031640|156314616|FG002|Screening Period|Enrollment closed|0|||
48737543|NCT00809354|156890097|FG001|Overall Study|Death|0|||
48320683|NCT01998958|155375272|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
48320684|NCT01998958|155375273|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
48320685|NCT01998958|155375274|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
48320686|NCT01998958|155375275|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
48320687|NCT01998958|155375276|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
48320688|NCT01998958|155375277|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
48579645|NCT02031640|156314617|FG003|Screening Period|Enrollment closed|0|||
48737544|NCT00809354|156890098|FG002|Overall Study|Death|0|||
48737545|NCT00809354|156890099|FG003|Overall Study|Death|0|||
48737546|NCT00809354|156890100|FG004|Overall Study|Death|0|||
48737547|NCT00809354|156890101|FG005|Overall Study|Death|0|||
48737548|NCT00809354|156890102|FG006|Overall Study|Death|0|||
48737549|NCT00809354|156890103|FG007|Overall Study|Death|1|||
48737550|NCT00809354|156890104|FG008|Overall Study|Death|0|||
48737551|NCT00809354|156890105|FG009|Overall Study|Death|0|||
48737552|NCT01823146|156890106|FG000|Overall Study|Withdrawal by Subject|0|||
48737553|NCT01823146|156890107|FG001|Overall Study|Withdrawal by Subject|1|||
48737554|NCT01823146|156890106|FG000|Overall Study|Lost to Follow-up|2|||
48737555|NCT01823146|156890107|FG001|Overall Study|Lost to Follow-up|1|||
48737556|NCT02122458|156890111|FG000|Overall Study|Withdrawal by Subject|0|||
48579646|NCT02031640|156314618|FG004|Screening Period|Enrollment closed|0|||
48579647|NCT02031640|156314619|FG005|Screening Period|Enrollment closed|0|||
48579648|NCT02031640|156314614|FG000|Run-In Period|Adverse Event|4|||
48579649|NCT02031640|156314615|FG001|Run-In Period|Adverse Event|0|||
48579650|NCT02031640|156314616|FG002|Run-In Period|Adverse Event|0|||
48579651|NCT02031640|156314617|FG003|Run-In Period|Adverse Event|0|||
48579652|NCT02031640|156314618|FG004|Run-In Period|Adverse Event|0|||
48579653|NCT02031640|156314619|FG005|Run-In Period|Adverse Event|0|||
48579654|NCT02031640|156314614|FG000|Run-In Period|Withdrawal by Subject|17|||
48579655|NCT02031640|156314615|FG001|Run-In Period|Withdrawal by Subject|0|||
48737557|NCT02122458|156890112|FG001|Overall Study|Withdrawal by Subject|0|||
48737558|NCT02122458|156890113|FG002|Overall Study|Withdrawal by Subject|0|||
48737559|NCT02122458|156890114|FG003|Overall Study|Withdrawal by Subject|4|||
48737560|NCT02122458|156890115|FG004|Overall Study|Withdrawal by Subject|4|||
48737561|NCT02122458|156890116|FG005|Overall Study|Withdrawal by Subject|4|||
48737562|NCT02122458|156890117|FG006|Overall Study|Withdrawal by Subject|0|||
48737563|NCT02122458|156890111|FG000|Overall Study|Lost to Follow-up|1|||
48737564|NCT02122458|156890112|FG001|Overall Study|Lost to Follow-up|3|||
48737565|NCT02122458|156890113|FG002|Overall Study|Lost to Follow-up|0|||
48737566|NCT02122458|156890114|FG003|Overall Study|Lost to Follow-up|7|||
48737567|NCT02122458|156890115|FG004|Overall Study|Lost to Follow-up|5|||
48737568|NCT02122458|156890116|FG005|Overall Study|Lost to Follow-up|15|||
48737569|NCT02122458|156890117|FG006|Overall Study|Lost to Follow-up|1|||
48737570|NCT02122458|156890111|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
48737571|NCT02122458|156890112|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737572|NCT02122458|156890113|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737573|NCT02122458|156890114|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737574|NCT02122458|156890115|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737575|NCT02122458|156890116|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737576|NCT02122458|156890117|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
48737577|NCT02122458|156890111|FG000|Overall Study|Adverse Event|1|||
48737578|NCT02122458|156890112|FG001|Overall Study|Adverse Event|0|||
48737579|NCT02122458|156890113|FG002|Overall Study|Adverse Event|0|||
48737580|NCT02122458|156890114|FG003|Overall Study|Adverse Event|0|||
48737581|NCT02122458|156890115|FG004|Overall Study|Adverse Event|0|||
48737582|NCT02122458|156890116|FG005|Overall Study|Adverse Event|0|||
48737583|NCT02122458|156890117|FG006|Overall Study|Adverse Event|0|||
48737584|NCT02122458|156890111|FG000|Overall Study|Experimental Error|0|||
48737585|NCT02122458|156890112|FG001|Overall Study|Experimental Error|0|||
48737586|NCT02122458|156890113|FG002|Overall Study|Experimental Error|0|||
48737587|NCT02122458|156890114|FG003|Overall Study|Experimental Error|0|||
48737588|NCT02122458|156890115|FG004|Overall Study|Experimental Error|3|||
48737589|NCT02122458|156890116|FG005|Overall Study|Experimental Error|0|||
48737590|NCT02122458|156890117|FG006|Overall Study|Experimental Error|0|||
48737591|NCT02122458|156890111|FG000|Overall Study|Deployed or Moved|0|||
48737592|NCT02122458|156890112|FG001|Overall Study|Deployed or Moved|0|||
48737593|NCT02122458|156890113|FG002|Overall Study|Deployed or Moved|0|||
48737594|NCT02122458|156890114|FG003|Overall Study|Deployed or Moved|0|||
48737595|NCT02122458|156890115|FG004|Overall Study|Deployed or Moved|1|||
48737596|NCT02122458|156890116|FG005|Overall Study|Deployed or Moved|0|||
48737597|NCT02122458|156890117|FG006|Overall Study|Deployed or Moved|0|||
48737598|NCT02122458|156890111|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
48737599|NCT02122458|156890112|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
48737600|NCT02122458|156890113|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
48320689|NCT01998958|155375278|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
48320690|NCT01998958|155375279|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
48320691|NCT01998958|155375280|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
48737601|NCT02122458|156890114|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
48737602|NCT02122458|156890115|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
48737603|NCT02122458|156890116|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
48737604|NCT02122458|156890117|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
48737605|NCT02122458|156890111|FG000|Overall Study|Noncompliance|0|||
48737606|NCT02122458|156890112|FG001|Overall Study|Noncompliance|1|||
48737607|NCT02122458|156890113|FG002|Overall Study|Noncompliance|0|||
48737608|NCT02122458|156890114|FG003|Overall Study|Noncompliance|0|||
48737609|NCT02122458|156890115|FG004|Overall Study|Noncompliance|0|||
48737610|NCT02122458|156890116|FG005|Overall Study|Noncompliance|0|||
48737611|NCT02122458|156890117|FG006|Overall Study|Noncompliance|0|||
48737612|NCT00075218|156890118|FG000|Double-Blind Treatment|Adverse Event|23|||
48737613|NCT00075218|156890119|FG001|Double-Blind Treatment|Adverse Event|4|||
48737614|NCT00075218|156890120|FG002|Double-Blind Treatment|Adverse Event|0|||
48737615|NCT00075218|156890118|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
48737616|NCT00075218|156890119|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
48737617|NCT00075218|156890120|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
48737618|NCT00075218|156890118|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
48737619|NCT00075218|156890119|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
48320692|NCT01998958|155375281|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
48320693|NCT01998958|155375282|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
48320694|NCT01998958|155375283|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
48320695|NCT01998958|155375284|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
48320696|NCT01998958|155375285|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
48320697|NCT01998958|155375286|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
48320698|NCT01998958|155375287|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
48320699|NCT01998958|155375256|FG000|Period 1 (Panel A and B)|Other|1|||
48320700|NCT01998958|155375257|FG001|Period 1 (Panel A and B)|Other|0|||
48320701|NCT01998958|155375258|FG002|Period 1 (Panel A and B)|Other|0|||
48737620|NCT00075218|156890120|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
48737621|NCT00075218|156890118|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
48737622|NCT00075218|156890119|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
48737623|NCT00075218|156890120|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
48737624|NCT00075218|156890118|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
48737625|NCT00075218|156890119|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
48737626|NCT00075218|156890120|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
48737627|NCT00075218|156890118|FG000|Double-Blind Treatment|No study medication taken|2|||
48737628|NCT00075218|156890119|FG001|Double-Blind Treatment|No study medication taken|0|||
48737629|NCT00075218|156890120|FG002|Double-Blind Treatment|No study medication taken|0|||
48320702|NCT01998958|155375259|FG003|Period 1 (Panel A and B)|Other|0|||
48320703|NCT01998958|155375260|FG004|Period 1 (Panel A and B)|Other|0|||
48579656|NCT02031640|156314616|FG002|Run-In Period|Withdrawal by Subject|0|||
48737630|NCT00075218|156890118|FG000|Open-Label Treatment|Lack of Efficacy|0|||
48737631|NCT00075218|156890119|FG001|Open-Label Treatment|Lack of Efficacy|0|||
48320704|NCT01998958|155375261|FG005|Period 1 (Panel A and B)|Other|0|||
48320705|NCT01998958|155375262|FG006|Period 1 (Panel A and B)|Other|0|||
48579657|NCT02031640|156314617|FG003|Run-In Period|Withdrawal by Subject|0|||
48737632|NCT00075218|156890120|FG002|Open-Label Treatment|Lack of Efficacy|174|||
48737633|NCT00075218|156890118|FG000|Open-Label Treatment|Adverse Event|0|||
48737634|NCT00075218|156890119|FG001|Open-Label Treatment|Adverse Event|0|||
48737635|NCT00075218|156890120|FG002|Open-Label Treatment|Adverse Event|51|||
48737636|NCT00075218|156890118|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
48737637|NCT00075218|156890119|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
48737638|NCT00075218|156890120|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
48737639|NCT00075218|156890118|FG000|Open-Label Treatment|Decision of Sponsor|0|||
48737640|NCT00075218|156890119|FG001|Open-Label Treatment|Decision of Sponsor|0|||
48737641|NCT00075218|156890120|FG002|Open-Label Treatment|Decision of Sponsor|8|||
48737642|NCT00075218|156890118|FG000|Open-Label Treatment|Protocol Violation|0|||
48737643|NCT00075218|156890119|FG001|Open-Label Treatment|Protocol Violation|0|||
48737644|NCT00075218|156890120|FG002|Open-Label Treatment|Protocol Violation|1|||
48737645|NCT00075218|156890118|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
48737646|NCT00075218|156890119|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
48737647|NCT00075218|156890120|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
48737648|NCT05095454|156890121|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
48737649|NCT05095454|156890122|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
48737650|NCT03840174|156890123|FG000|Overall Study|Withdrawal by Subject|1|||
48737651|NCT03840174|156890124|FG001|Overall Study|Withdrawal by Subject|0|||
48737652|NCT03840174|156890125|FG002|Overall Study|Withdrawal by Subject|0|||
48737653|NCT03840174|156890126|FG003|Overall Study|Withdrawal by Subject|0|||
48737654|NCT00722423|156890129|FG000|Overall Study|Protocol Violation|0|||
48737655|NCT00722423|156890130|FG001|Overall Study|Protocol Violation|1|||
48737656|NCT00131508|156890131|FG000|Overall Study|Disease progression|0|||
48737657|NCT00131508|156890132|FG001|Overall Study|Disease progression|2|||
48737658|NCT00131508|156890131|FG000|Overall Study|Non-Compliance|2|||
48737659|NCT00131508|156890132|FG001|Overall Study|Non-Compliance|4|||
48737660|NCT00131508|156890131|FG000|Overall Study|Withdrawal by Subject|1|||
48737661|NCT00131508|156890132|FG001|Overall Study|Withdrawal by Subject|2|||
48737662|NCT03643575|156890133|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
48737663|NCT03643575|156890134|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
48737664|NCT03643575|156890135|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
48737665|NCT03643575|156890136|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
48737666|NCT03643575|156890137|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
48737667|NCT03643575|156890138|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
48737668|NCT03643575|156890133|FG000|Washout: 7 Days|Adverse Event|1|||
48737669|NCT03643575|156890134|FG001|Washout: 7 Days|Adverse Event|0|||
48737670|NCT03643575|156890135|FG002|Washout: 7 Days|Adverse Event|0|||
48737671|NCT03643575|156890136|FG003|Washout: 7 Days|Adverse Event|0|||
48737672|NCT03643575|156890137|FG004|Washout: 7 Days|Adverse Event|0|||
48737673|NCT03643575|156890138|FG005|Washout: 7 Days|Adverse Event|0|||
48737674|NCT03643575|156890133|FG000|Washout: 7 Days|Non compliance check in|0|||
48320706|NCT01998958|155375263|FG007|Period 1 (Panel A and B)|Other|0|||
48320707|NCT01998958|155375264|FG008|Period 1 (Panel A and B)|Other|0|||
48320708|NCT01998958|155375265|FG009|Period 1 (Panel A and B)|Other|0|||
48320709|NCT01998958|155375266|FG010|Period 1 (Panel A and B)|Other|0|||
48320710|NCT01998958|155375267|FG011|Period 1 (Panel A and B)|Other|0|||
48320711|NCT01998958|155375268|FG012|Period 1 (Panel A and B)|Other|0|||
48579658|NCT02031640|156314618|FG004|Run-In Period|Withdrawal by Subject|0|||
48579659|NCT02031640|156314619|FG005|Run-In Period|Withdrawal by Subject|0|||
48579660|NCT02031640|156314614|FG000|Run-In Period|Inclusion criteria not met|38|||
48579661|NCT02031640|156314615|FG001|Run-In Period|Inclusion criteria not met|0|||
48579662|NCT02031640|156314616|FG002|Run-In Period|Inclusion criteria not met|0|||
48579663|NCT02031640|156314617|FG003|Run-In Period|Inclusion criteria not met|0|||
48579664|NCT02031640|156314618|FG004|Run-In Period|Inclusion criteria not met|0|||
48579665|NCT02031640|156314619|FG005|Run-In Period|Inclusion criteria not met|0|||
48579666|NCT02031640|156314614|FG000|Run-In Period|Exclusion criteria met|8|||
48579667|NCT02031640|156314615|FG001|Run-In Period|Exclusion criteria met|0|||
48579668|NCT02031640|156314616|FG002|Run-In Period|Exclusion criteria met|0|||
48579669|NCT02031640|156314617|FG003|Run-In Period|Exclusion criteria met|0|||
48579670|NCT02031640|156314618|FG004|Run-In Period|Exclusion criteria met|0|||
48579671|NCT02031640|156314619|FG005|Run-In Period|Exclusion criteria met|0|||
48579672|NCT02031640|156314614|FG000|Run-In Period|Randomization criteria not met|85|||
48579673|NCT02031640|156314615|FG001|Run-In Period|Randomization criteria not met|0|||
48579674|NCT02031640|156314616|FG002|Run-In Period|Randomization criteria not met|0|||
48737675|NCT03643575|156890134|FG001|Washout: 7 Days|Non compliance check in|1|||
48737676|NCT03643575|156890135|FG002|Washout: 7 Days|Non compliance check in|0|||
48737677|NCT03643575|156890136|FG003|Washout: 7 Days|Non compliance check in|0|||
48320712|NCT01998958|155375269|FG013|Period 1 (Panel A and B)|Other|0|||
48579675|NCT02031640|156314617|FG003|Run-In Period|Randomization criteria not met|0|||
48579676|NCT02031640|156314618|FG004|Run-In Period|Randomization criteria not met|0|||
48579677|NCT02031640|156314619|FG005|Run-In Period|Randomization criteria not met|0|||
48579678|NCT02031640|156314614|FG000|Run-In Period|Various administrative reasons|17|||
48579679|NCT02031640|156314615|FG001|Run-In Period|Various administrative reasons|0|||
48737678|NCT03643575|156890137|FG004|Washout: 7 Days|Non compliance check in|0|||
48737679|NCT03643575|156890138|FG005|Washout: 7 Days|Non compliance check in|0|||
48320713|NCT01998958|155375270|FG014|Period 1 (Panel A and B)|Other|0|||
48579680|NCT02031640|156314616|FG002|Run-In Period|Various administrative reasons|0|||
48579681|NCT02031640|156314617|FG003|Run-In Period|Various administrative reasons|0|||
48579682|NCT02031640|156314618|FG004|Run-In Period|Various administrative reasons|0|||
48579683|NCT02031640|156314619|FG005|Run-In Period|Various administrative reasons|0|||
48579684|NCT02031640|156314614|FG000|Double-blind Treatment Period|Protocol deviation|0|||
48737680|NCT01950169|156890139|FG000|Overall Study|Withdrawal by Subject|2|||
48737681|NCT01950169|156890140|FG001|Overall Study|Withdrawal by Subject|8|||
48737682|NCT01950169|156890141|FG002|Overall Study|Withdrawal by Subject|1|||
48737683|NCT01950169|156890139|FG000|Overall Study|Death|1|||
48320714|NCT01998958|155375271|FG015|Period 1 (Panel A and B)|Other|0|||
48320715|NCT01998958|155375272|FG016|Period 1 (Panel A and B)|Other|0|||
48320716|NCT01998958|155375273|FG017|Period 1 (Panel A and B)|Other|0|||
48320717|NCT01998958|155375274|FG018|Period 1 (Panel A and B)|Other|0|||
48579685|NCT02031640|156314615|FG001|Double-blind Treatment Period|Protocol deviation|2|||
48579686|NCT02031640|156314616|FG002|Double-blind Treatment Period|Protocol deviation|0|||
48579687|NCT02031640|156314617|FG003|Double-blind Treatment Period|Protocol deviation|1|||
48579688|NCT02031640|156314618|FG004|Double-blind Treatment Period|Protocol deviation|3|||
48579689|NCT02031640|156314619|FG005|Double-blind Treatment Period|Protocol deviation|1|||
48579690|NCT02031640|156314614|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
48579691|NCT02031640|156314615|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
48579692|NCT02031640|156314616|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
48320718|NCT01998958|155375275|FG019|Period 1 (Panel A and B)|Other|0|||
48320719|NCT01998958|155375276|FG020|Period 1 (Panel A and B)|Other|0|||
48320720|NCT01998958|155375277|FG021|Period 1 (Panel A and B)|Other|0|||
48579693|NCT02031640|156314617|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
48579694|NCT02031640|156314618|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
48579695|NCT02031640|156314619|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
48579696|NCT02031640|156314614|FG000|Double-blind Treatment Period|Non-compliance|0|||
48579697|NCT02031640|156314615|FG001|Double-blind Treatment Period|Non-compliance|1|||
48320721|NCT01998958|155375278|FG022|Period 1 (Panel A and B)|Other|0|||
48579698|NCT02031640|156314616|FG002|Double-blind Treatment Period|Non-compliance|0|||
48579699|NCT02031640|156314617|FG003|Double-blind Treatment Period|Non-compliance|1|||
48579700|NCT02031640|156314618|FG004|Double-blind Treatment Period|Non-compliance|1|||
48579701|NCT02031640|156314619|FG005|Double-blind Treatment Period|Non-compliance|0|||
48579702|NCT02031640|156314614|FG000|Double-blind Treatment Period|Adverse Event|0|||
48579703|NCT02031640|156314615|FG001|Double-blind Treatment Period|Adverse Event|0|||
48579704|NCT02031640|156314616|FG002|Double-blind Treatment Period|Adverse Event|0|||
48579705|NCT02031640|156314617|FG003|Double-blind Treatment Period|Adverse Event|2|||
48579706|NCT02031640|156314618|FG004|Double-blind Treatment Period|Adverse Event|0|||
48579707|NCT02031640|156314619|FG005|Double-blind Treatment Period|Adverse Event|0|||
48579708|NCT02031640|156314614|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
48579709|NCT02031640|156314615|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
48579710|NCT02031640|156314616|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
48579711|NCT02031640|156314617|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
48579712|NCT02031640|156314618|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
48579713|NCT02031640|156314619|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
48579714|NCT02031640|156314614|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48579715|NCT02031640|156314615|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
48579716|NCT02031640|156314616|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
48579717|NCT02031640|156314617|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
48579718|NCT02031640|156314618|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
48579719|NCT02031640|156314619|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
48579720|NCT01084668|156314620|FG000|Overall Study|Lack of Efficacy|5|||
48579721|NCT01084668|156314620|FG000|Overall Study|Withdrawal by Subject|2|||
48579722|NCT01084668|156314620|FG000|Overall Study|Pregnancy|1|||
48579723|NCT01084668|156314620|FG000|Overall Study|Non-compliance|1|||
48579724|NCT03687372|156314621|FG000|Overall Study|Lost to Follow-up|12|||
48579725|NCT03687372|156314622|FG001|Overall Study|Lost to Follow-up|21|||
48579726|NCT03687372|156314621|FG000|Overall Study|Withdrawal by Subject|4|||
48579727|NCT03687372|156314622|FG001|Overall Study|Withdrawal by Subject|17|||
48579728|NCT03687372|156314621|FG000|Overall Study|Investigator Decision|1|||
48579729|NCT03687372|156314622|FG001|Overall Study|Investigator Decision|1|||
48579730|NCT01565668|156314623|FG000|Overall Study|Death|2|||
48579731|NCT01565668|156314624|FG001|Overall Study|Death|1|||
48579732|NCT01565668|156314623|FG000|Overall Study|Lack of Efficacy|4|||
48579733|NCT01565668|156314624|FG001|Overall Study|Lack of Efficacy|2|||
48579734|NCT01565668|156314623|FG000|Overall Study|Participant went on Hospice Care|1|||
48579735|NCT01565668|156314624|FG001|Overall Study|Participant went on Hospice Care|0|||
48579736|NCT01565668|156314623|FG000|Overall Study|Adverse Event|6|||
48579737|NCT01565668|156314624|FG001|Overall Study|Adverse Event|1|||
48737684|NCT01950169|156890140|FG001|Overall Study|Death|0|||
48737685|NCT01950169|156890141|FG002|Overall Study|Death|0|||
48320722|NCT01998958|155375279|FG023|Period 1 (Panel A and B)|Other|0|||
48320723|NCT01998958|155375280|FG024|Period 1 (Panel A and B)|Other|0|||
48320724|NCT01998958|155375281|FG025|Period 1 (Panel A and B)|Other|0|||
48320725|NCT01998958|155375282|FG026|Period 1 (Panel A and B)|Other|0|||
48320726|NCT01998958|155375283|FG027|Period 1 (Panel A and B)|Other|0|||
48320727|NCT01998958|155375284|FG028|Period 1 (Panel A and B)|Other|0|||
48320728|NCT01998958|155375285|FG029|Period 1 (Panel A and B)|Other|0|||
48320729|NCT01998958|155375286|FG030|Period 1 (Panel A and B)|Other|0|||
48320730|NCT01998958|155375287|FG031|Period 1 (Panel A and B)|Other|0|||
48320731|NCT01998958|155375256|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
48320732|NCT01998958|155375257|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
48320733|NCT01998958|155375258|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
48579738|NCT01565668|156314623|FG000|Overall Study|Randomized, but never received drug|0|||
48579739|NCT01565668|156314624|FG001|Overall Study|Randomized, but never received drug|2|||
48579740|NCT01565668|156314623|FG000|Overall Study|Progressive disease|13|||
48579741|NCT01565668|156314624|FG001|Overall Study|Progressive disease|14|||
48579742|NCT01565668|156314623|FG000|Overall Study|Withdrawal by Subject|1|||
48579743|NCT01565668|156314624|FG001|Overall Study|Withdrawal by Subject|3|||
48579744|NCT01565668|156314623|FG000|Overall Study|HSCT Transplant|11|||
48579745|NCT01565668|156314624|FG001|Overall Study|HSCT Transplant|15|||
48579746|NCT01104246|156314625|FG000|Overall Study|Withdrawal by Subject|1|||
48579747|NCT01104246|156314625|FG000|Overall Study|did not meet inclusion criteria|4|||
48579748|NCT05178641|156314638|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
48579749|NCT05178641|156314639|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
48579750|NCT05178641|156314638|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
48579751|NCT05178641|156314639|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
48579752|NCT02375555|156314640|FG000|Induction Period|Adverse Event|7|||
48579753|NCT02375555|156314640|FG000|Induction Period|Withdrawal by Subject|2|||
48579754|NCT02375555|156314640|FG000|Induction Period|Other|1|||
48579755|NCT02375555|156314640|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
48579756|NCT02375555|156314640|FG000|Maintenance Period|Adverse Event|2|||
48579757|NCT02375555|156314640|FG000|Maintenance Period|Withdrawal by Subject|4|||
48579758|NCT02375555|156314640|FG000|Maintenance Period|Death|1|||
48579759|NCT02375555|156314640|FG000|Maintenance Period|Disease Progression|5|||
48579760|NCT02375555|156314640|FG000|Maintenance Period|Patient Non-compliance|1|||
48579761|NCT02375555|156314640|FG000|Maintenance Period|Still on maintenance|16|||
48579762|NCT05148234|156314642|FG000|Phase I|Ineligible|0|||
48579763|NCT05148234|156314643|FG001|Phase I|Ineligible|0|||
48579764|NCT05148234|156314644|FG002|Phase I|Ineligible|0|||
48579765|NCT05148234|156314645|FG003|Phase I|Ineligible|0|||
48579766|NCT05148234|156314646|FG004|Phase I|Ineligible|0|||
48579767|NCT05148234|156314647|FG005|Phase I|Ineligible|0|||
48579768|NCT05148234|156314648|FG006|Phase I|Ineligible|0|||
48579769|NCT05148234|156314649|FG007|Phase I|Ineligible|1|||
48579770|NCT05148234|156314642|FG000|Phase I|Company closed the trial.|0|||
48579771|NCT05148234|156314643|FG001|Phase I|Company closed the trial.|1|||
48579772|NCT05148234|156314644|FG002|Phase I|Company closed the trial.|0|||
48579773|NCT05148234|156314645|FG003|Phase I|Company closed the trial.|0|||
48579774|NCT05148234|156314646|FG004|Phase I|Company closed the trial.|0|||
48579775|NCT05148234|156314647|FG005|Phase I|Company closed the trial.|0|||
48579776|NCT05148234|156314648|FG006|Phase I|Company closed the trial.|0|||
48579777|NCT05148234|156314649|FG007|Phase I|Company closed the trial.|0|||
48579778|NCT01869699|156314650|FG000|Overall Study|Withdrawal by Subject|1|||
48579779|NCT01869699|156314651|FG001|Overall Study|Withdrawal by Subject|0|||
48579780|NCT03602391|156314652|FG000|Overall Study|COVID-19|7|||
48579781|NCT03602391|156314653|FG001|Overall Study|COVID-19|6|||
48579782|NCT01083186|156314659|FG000|Overall Study|Lost to Follow-up|48|||
48579783|NCT01083186|156314659|FG000|Overall Study|Consent Withdrawal|7|||
48579784|NCT01083186|156314659|FG000|Overall Study|Death|3|||
48579785|NCT01083186|156314659|FG000|Overall Study|Adverse Event|3|||
48579786|NCT01083186|156314659|FG000|Overall Study|Lack of Efficacy|2|||
48579787|NCT01083186|156314659|FG000|Overall Study|Hemodialysis Initiation|28|||
48579788|NCT01083186|156314659|FG000|Overall Study|Administrative Reasons|2|||
48579789|NCT01083186|156314659|FG000|Overall Study|Non-compliance to Study Treatment|1|||
48320734|NCT01998958|155375259|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
48320735|NCT01998958|155375260|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
48579790|NCT00108485|156314666|FG000|Overall Study|Withdrawal by Subject|3|||
48579791|NCT00108485|156314667|FG001|Overall Study|Withdrawal by Subject|0|||
48579792|NCT00108485|156314666|FG000|Overall Study|Lost to Follow-up|0|||
48579793|NCT00108485|156314667|FG001|Overall Study|Lost to Follow-up|2|||
48579794|NCT01582178|156314670|FG000|Overall Study|Physician Decision|6|||
48579795|NCT01582178|156314671|FG001|Overall Study|Physician Decision|5|||
48579796|NCT01097421|156314675|FG000|Overall Study|Adverse Event|8|||
48579797|NCT01097421|156314675|FG000|Overall Study|Protocol Violation|2|||
48579798|NCT01097421|156314675|FG000|Overall Study|Lost to Follow-up|1|||
48579799|NCT01097421|156314675|FG000|Overall Study|Withdrawal by Subject|3|||
48579800|NCT03627416|156314676|FG000|Overall Study|Adverse Event|0|||
48579801|NCT03627416|156314677|FG001|Overall Study|Adverse Event|1|||
48587294|NCT03003000|156343171|FG002|Overall Study|Lack of Efficacy|0|||
48320736|NCT01998958|155375261|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
48320737|NCT01998958|155375262|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
48579802|NCT04464720|156314678|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
48579803|NCT00793624|156314681|FG000|Overall Study|Adverse Event|18|||
48579804|NCT00793624|156314682|FG001|Overall Study|Adverse Event|16|||
48579805|NCT00793624|156314683|FG002|Overall Study|Adverse Event|15|||
48579806|NCT00793624|156314684|FG003|Overall Study|Adverse Event|20|||
48579807|NCT00793624|156314681|FG000|Overall Study|Lost to Follow-up|2|||
48579808|NCT00793624|156314682|FG001|Overall Study|Lost to Follow-up|2|||
48579809|NCT00793624|156314683|FG002|Overall Study|Lost to Follow-up|4|||
48579810|NCT00793624|156314684|FG003|Overall Study|Lost to Follow-up|0|||
48579811|NCT00793624|156314681|FG000|Overall Study|Withdrawal by Subject|20|||
48579812|NCT00793624|156314682|FG001|Overall Study|Withdrawal by Subject|9|||
48579813|NCT00793624|156314683|FG002|Overall Study|Withdrawal by Subject|11|||
48579814|NCT00793624|156314684|FG003|Overall Study|Withdrawal by Subject|14|||
48579815|NCT00793624|156314681|FG000|Overall Study|Lack of Efficacy|9|||
48579816|NCT00793624|156314682|FG001|Overall Study|Lack of Efficacy|2|||
48579817|NCT00793624|156314683|FG002|Overall Study|Lack of Efficacy|1|||
48579818|NCT00793624|156314684|FG003|Overall Study|Lack of Efficacy|3|||
48579819|NCT00793624|156314681|FG000|Overall Study|Non compliance with protocol|2|||
48579820|NCT00793624|156314682|FG001|Overall Study|Non compliance with protocol|3|||
48579821|NCT00793624|156314683|FG002|Overall Study|Non compliance with protocol|2|||
48579822|NCT00793624|156314684|FG003|Overall Study|Non compliance with protocol|3|||
48579823|NCT00793624|156314681|FG000|Overall Study|Other reason not described above|6|||
48579824|NCT00793624|156314682|FG001|Overall Study|Other reason not described above|4|||
48579825|NCT00793624|156314683|FG002|Overall Study|Other reason not described above|6|||
48579826|NCT00793624|156314684|FG003|Overall Study|Other reason not described above|3|||
48579827|NCT02071706|156314687|FG000|Overall Study|Adverse Event|1|||
48579828|NCT02071706|156314687|FG000|Overall Study|Withdrawal by Subject|2|||
48579829|NCT02832375|156314688|FG000|Overall Study|Lost to Follow-up|1|||
48579830|NCT02832375|156314689|FG001|Overall Study|Lost to Follow-up|0|||
48579831|NCT02832375|156314688|FG000|Overall Study|Withdrawal of Consent|1|||
48579832|NCT02832375|156314689|FG001|Overall Study|Withdrawal of Consent|0|||
48579833|NCT05723328|156314695|FG000|Overall Study|Investigator's Decision|5|||
48579834|NCT05723328|156314696|FG001|Overall Study|Investigator's Decision|2|||
48579835|NCT00336024|156314700|FG000|Overall Study|Death|2|||
48579836|NCT00336024|156314701|FG001|Overall Study|Death|1|||
48579837|NCT00336024|156314700|FG000|Overall Study|Physician Decision|4|||
48579838|NCT00336024|156314701|FG001|Overall Study|Physician Decision|1|||
48579839|NCT00336024|156314700|FG000|Overall Study|Protocol Violation|1|||
48579840|NCT00336024|156314701|FG001|Overall Study|Protocol Violation|0|||
48579841|NCT00336024|156314700|FG000|Overall Study|Withdrawal by Subject|1|||
48579842|NCT00336024|156314701|FG001|Overall Study|Withdrawal by Subject|2|||
48579843|NCT00336024|156314700|FG000|Overall Study|Failure to fulfill consolidation|1|||
48579844|NCT00336024|156314701|FG001|Overall Study|Failure to fulfill consolidation|1|||
48579845|NCT00336024|156314700|FG000|Overall Study|Progressive Disease|4|||
48579846|NCT00336024|156314701|FG001|Overall Study|Progressive Disease|7|||
48579847|NCT00336024|156314700|FG000|Overall Study|Ineligible|7|||
48579848|NCT00336024|156314701|FG001|Overall Study|Ineligible|7|||
48579849|NCT00084318|156314709|FG000|Overall Study|Withdrawal by Subject|5|||
48579850|NCT00084318|156314710|FG001|Overall Study|Withdrawal by Subject|2|||
48579851|NCT00084318|156314709|FG000|Overall Study|Protocol Violation|15|||
48320738|NCT01998958|155375263|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
48320739|NCT01998958|155375264|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
48320740|NCT01998958|155375265|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
48320741|NCT01998958|155375266|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
48320742|NCT01998958|155375267|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
48320743|NCT01998958|155375268|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
48320744|NCT01998958|155375269|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
48320745|NCT01998958|155375270|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
48320746|NCT01998958|155375271|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
48320747|NCT01998958|155375272|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
48320748|NCT01998958|155375273|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
48579852|NCT00084318|156314710|FG001|Overall Study|Protocol Violation|11|||
48579853|NCT00084318|156314709|FG000|Overall Study|No protocol treatment|2|||
48579854|NCT00084318|156314710|FG001|Overall Study|No protocol treatment|0|||
48579855|NCT03430895|156314711|FG000|Overall Study|Not Treated|2|||
48579856|NCT00157820|156314716|FG000|Randomized|Physician Decision|4|||
48737686|NCT01146912|156890144|FG000|Overall Study|Already received influenza vaccination|817|||
48320749|NCT01998958|155375274|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
48579857|NCT00157820|156314717|FG001|Randomized|Physician Decision|2|||
48579858|NCT00157820|156314718|FG002|Randomized|Physician Decision|3|||
48579859|NCT00157820|156314716|FG000|Randomized|Withdrawal by Subject|1|||
48579860|NCT00157820|156314717|FG001|Randomized|Withdrawal by Subject|2|||
48579861|NCT00157820|156314718|FG002|Randomized|Withdrawal by Subject|3|||
48579862|NCT00157820|156314716|FG000|Randomized|Protocol Violation|2|||
48320750|NCT01998958|155375275|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
48320751|NCT01998958|155375276|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
48320752|NCT01998958|155375277|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
48320753|NCT01998958|155375278|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
48320754|NCT01998958|155375279|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
48579863|NCT00157820|156314717|FG001|Randomized|Protocol Violation|1|||
48579864|NCT00157820|156314718|FG002|Randomized|Protocol Violation|2|||
48320755|NCT01998958|155375280|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
48320756|NCT01998958|155375281|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
48320757|NCT01998958|155375282|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
48320758|NCT01998958|155375283|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
48320759|NCT01998958|155375284|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
48320760|NCT01998958|155375285|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
48320761|NCT01998958|155375286|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
48320762|NCT01998958|155375287|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
48320763|NCT01998958|155375256|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48579865|NCT00157820|156314716|FG000|1st 8 Month|Death|7|||
48579866|NCT00157820|156314717|FG001|1st 8 Month|Death|8|||
48579867|NCT00157820|156314718|FG002|1st 8 Month|Death|3|||
48579868|NCT00157820|156314716|FG000|1st 8 Month|Lost to Follow-up|1|||
48579869|NCT00157820|156314717|FG001|1st 8 Month|Lost to Follow-up|2|||
48579870|NCT00157820|156314718|FG002|1st 8 Month|Lost to Follow-up|1|||
48579871|NCT00157820|156314716|FG000|1st 8 Month|Premature cross-over|0|||
48579872|NCT00157820|156314717|FG001|1st 8 Month|Premature cross-over|2|||
48579873|NCT00157820|156314718|FG002|1st 8 Month|Premature cross-over|2|||
48579874|NCT00157820|156314716|FG000|2nd 8 Months|Death|3|||
48579875|NCT00157820|156314717|FG001|2nd 8 Months|Death|1|||
48579876|NCT00157820|156314718|FG002|2nd 8 Months|Death|3|||
48579877|NCT00157820|156314716|FG000|2nd 8 Months|Lost to Follow-up|1|||
48579878|NCT00157820|156314717|FG001|2nd 8 Months|Lost to Follow-up|5|||
48579879|NCT00157820|156314718|FG002|2nd 8 Months|Lost to Follow-up|2|||
48579880|NCT00157820|156314716|FG000|2nd 8 Months|Premature cross-over|1|||
48579881|NCT00157820|156314717|FG001|2nd 8 Months|Premature cross-over|7|||
48579882|NCT00157820|156314718|FG002|2nd 8 Months|Premature cross-over|9|||
48579883|NCT01645891|156314720|FG000|Overall Study|Adverse Event|6|||
48579884|NCT01645891|156314721|FG001|Overall Study|Adverse Event|10|||
48579885|NCT01645891|156314720|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
48579886|NCT01645891|156314721|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
48579887|NCT01645891|156314720|FG000|Overall Study|Withdrawal by Subject|3|||
48579888|NCT01645891|156314721|FG001|Overall Study|Withdrawal by Subject|3|||
48579889|NCT01645891|156314720|FG000|Overall Study|Protocol Violation|4|||
48579890|NCT01645891|156314721|FG001|Overall Study|Protocol Violation|0|||
48579891|NCT01645891|156314720|FG000|Overall Study|Lost to Follow-up|4|||
48579892|NCT01645891|156314721|FG001|Overall Study|Lost to Follow-up|1|||
48579893|NCT01645891|156314720|FG000|Overall Study|Death|0|||
48579894|NCT01645891|156314721|FG001|Overall Study|Death|2|||
48579895|NCT00138073|156314722|FG000|Overall Study|lack of resources|55|||
48579896|NCT03026530|156314723|FG000|Overall Study|Lost to Follow-up|19|||
48579897|NCT03026530|156314724|FG001|Overall Study|Lost to Follow-up|24|||
48579898|NCT03026530|156314723|FG000|Overall Study|Protocol Violation|2|||
48579899|NCT03026530|156314724|FG001|Overall Study|Protocol Violation|5|||
48579900|NCT03301740|156314726|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
48579901|NCT03301740|156314727|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
48579902|NCT03301740|156314726|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
48579903|NCT03301740|156314727|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
48579904|NCT00819780|156314729|FG000|Overall Study|Did not receive study drug|3|||
48579905|NCT00819780|156314730|FG001|Overall Study|Did not receive study drug|4|||
48579906|NCT00819780|156314729|FG000|Overall Study|Still in treatment|25|||
48579907|NCT00819780|156314730|FG001|Overall Study|Still in treatment|17|||
48579908|NCT04776018|156314734|FG000|Overall Study|Death|0|||
48579909|NCT04776018|156314735|FG001|Overall Study|Death|1|||
48579910|NCT04776018|156314736|FG002|Overall Study|Death|4|||
48579911|NCT04776018|156314737|FG003|Overall Study|Death|1|||
48579912|NCT04776018|156314738|FG004|Overall Study|Death|4|||
48579913|NCT04776018|156314739|FG005|Overall Study|Death|0|||
48737687|NCT01146912|156890145|FG001|Overall Study|Already received influenza vaccination|822|||
48579914|NCT04776018|156314740|FG006|Overall Study|Death|0|||
48579915|NCT04776018|156314734|FG000|Overall Study|Study terminated by sponsor|2|||
48579916|NCT04776018|156314735|FG001|Overall Study|Study terminated by sponsor|1|||
48579917|NCT04776018|156314736|FG002|Overall Study|Study terminated by sponsor|4|||
48579918|NCT04776018|156314737|FG003|Overall Study|Study terminated by sponsor|0|||
48579919|NCT04776018|156314738|FG004|Overall Study|Study terminated by sponsor|3|||
48579920|NCT04776018|156314739|FG005|Overall Study|Study terminated by sponsor|0|||
48737688|NCT01146912|156890146|FG002|Overall Study|Already received influenza vaccination|13|||
48320764|NCT01998958|155375257|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320765|NCT01998958|155375258|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48450304|NCT03365947|155835683|FG013|Overall Study|Lost to Follow-up|0|||
48579921|NCT04776018|156314740|FG006|Overall Study|Study terminated by sponsor|0|||
48579922|NCT04776018|156314734|FG000|Overall Study|Withdrawal by Subject|1|||
48579923|NCT04776018|156314735|FG001|Overall Study|Withdrawal by Subject|0|||
48579924|NCT04776018|156314736|FG002|Overall Study|Withdrawal by Subject|0|||
48579925|NCT04776018|156314737|FG003|Overall Study|Withdrawal by Subject|2|||
48579926|NCT04776018|156314738|FG004|Overall Study|Withdrawal by Subject|1|||
48579927|NCT04776018|156314739|FG005|Overall Study|Withdrawal by Subject|0|||
48579928|NCT04776018|156314740|FG006|Overall Study|Withdrawal by Subject|0|||
48579929|NCT04776018|156314734|FG000|Overall Study|Other|0|||
48579930|NCT04776018|156314735|FG001|Overall Study|Other|1|||
48579931|NCT04776018|156314736|FG002|Overall Study|Other|1|||
48579932|NCT04776018|156314737|FG003|Overall Study|Other|0|||
48579933|NCT04776018|156314738|FG004|Overall Study|Other|0|||
48579934|NCT04776018|156314739|FG005|Overall Study|Other|0|||
48579935|NCT04776018|156314740|FG006|Overall Study|Other|0|||
48579936|NCT04776018|156314734|FG000|Overall Study|Lost to Follow-up|0|||
48579937|NCT04776018|156314735|FG001|Overall Study|Lost to Follow-up|0|||
48579938|NCT04776018|156314736|FG002|Overall Study|Lost to Follow-up|1|||
48579939|NCT04776018|156314737|FG003|Overall Study|Lost to Follow-up|0|||
48579940|NCT04776018|156314738|FG004|Overall Study|Lost to Follow-up|0|||
48579941|NCT04776018|156314739|FG005|Overall Study|Lost to Follow-up|0|||
48579942|NCT04776018|156314740|FG006|Overall Study|Lost to Follow-up|0|||
48579943|NCT00972816|156316382|FG000|Overall Study|Adverse Event|0|||
48579944|NCT00972816|156316383|FG001|Overall Study|Adverse Event|0|||
48579945|NCT00972816|156316384|FG002|Overall Study|Adverse Event|1|||
48579946|NCT00972816|156316385|FG003|Overall Study|Adverse Event|0|||
48579947|NCT00972816|156316386|FG004|Overall Study|Adverse Event|0|||
48579948|NCT00972816|156316387|FG005|Overall Study|Adverse Event|0|||
48579949|NCT00972816|156316388|FG006|Overall Study|Adverse Event|0|||
48579950|NCT00972816|156316389|FG007|Overall Study|Adverse Event|0|||
48579951|NCT00972816|156316382|FG000|Overall Study|Withdrawal by Subject|4|||
48579952|NCT00972816|156316383|FG001|Overall Study|Withdrawal by Subject|2|||
48579953|NCT00972816|156316384|FG002|Overall Study|Withdrawal by Subject|1|||
48579954|NCT00972816|156316385|FG003|Overall Study|Withdrawal by Subject|3|||
48579955|NCT00972816|156316386|FG004|Overall Study|Withdrawal by Subject|0|||
48579956|NCT00972816|156316387|FG005|Overall Study|Withdrawal by Subject|1|||
48579957|NCT00972816|156316388|FG006|Overall Study|Withdrawal by Subject|1|||
48579958|NCT00972816|156316389|FG007|Overall Study|Withdrawal by Subject|2|||
48579959|NCT00972816|156316382|FG000|Overall Study|Lost to Follow-up|11|||
48579960|NCT00972816|156316383|FG001|Overall Study|Lost to Follow-up|9|||
48579961|NCT00972816|156316384|FG002|Overall Study|Lost to Follow-up|7|||
48579962|NCT00972816|156316385|FG003|Overall Study|Lost to Follow-up|5|||
48579963|NCT00972816|156316386|FG004|Overall Study|Lost to Follow-up|11|||
48579964|NCT00972816|156316387|FG005|Overall Study|Lost to Follow-up|10|||
48579965|NCT00972816|156316388|FG006|Overall Study|Lost to Follow-up|7|||
48579966|NCT00972816|156316389|FG007|Overall Study|Lost to Follow-up|7|||
48579967|NCT00972816|156316382|FG000|Overall Study|Inappropriate enrolment|0|||
48579968|NCT00972816|156316383|FG001|Overall Study|Inappropriate enrolment|0|||
48579969|NCT00972816|156316384|FG002|Overall Study|Inappropriate enrolment|0|||
48579970|NCT00972816|156316385|FG003|Overall Study|Inappropriate enrolment|0|||
48579971|NCT00972816|156316386|FG004|Overall Study|Inappropriate enrolment|0|||
48579972|NCT00972816|156316387|FG005|Overall Study|Inappropriate enrolment|0|||
48579973|NCT00972816|156316388|FG006|Overall Study|Inappropriate enrolment|2|||
48579974|NCT00972816|156316389|FG007|Overall Study|Inappropriate enrolment|0|||
48579975|NCT00972816|156316382|FG000|Overall Study|Unable to classify|2|||
48579976|NCT00972816|156316383|FG001|Overall Study|Unable to classify|0|||
48579977|NCT00972816|156316384|FG002|Overall Study|Unable to classify|0|||
48579978|NCT00972816|156316385|FG003|Overall Study|Unable to classify|0|||
48579979|NCT00972816|156316386|FG004|Overall Study|Unable to classify|1|||
48579980|NCT00972816|156316387|FG005|Overall Study|Unable to classify|0|||
48579981|NCT00972816|156316388|FG006|Overall Study|Unable to classify|0|||
48579982|NCT00972816|156316389|FG007|Overall Study|Unable to classify|0|||
48579983|NCT03104400|156316390|FG000|Overall Study|Adverse Event|5|||
48579984|NCT03104400|156316391|FG001|Overall Study|Adverse Event|7|||
48579985|NCT03104400|156316392|FG002|Overall Study|Adverse Event|11|||
48579986|NCT03104400|156316393|FG003|Overall Study|Adverse Event|9|||
48579987|NCT03104400|156316394|FG004|Overall Study|Adverse Event|21|||
48579988|NCT03104400|156316390|FG000|Overall Study|Withdrawal by Subject|17|||
48579989|NCT03104400|156316391|FG001|Overall Study|Withdrawal by Subject|19|||
48579990|NCT03104400|156316392|FG002|Overall Study|Withdrawal by Subject|29|||
48579991|NCT03104400|156316393|FG003|Overall Study|Withdrawal by Subject|25|||
48579992|NCT03104400|156316394|FG004|Overall Study|Withdrawal by Subject|24|||
48579993|NCT03104400|156316390|FG000|Overall Study|Lost to Follow-up|4|||
48579994|NCT03104400|156316391|FG001|Overall Study|Lost to Follow-up|1|||
48579995|NCT03104400|156316392|FG002|Overall Study|Lost to Follow-up|4|||
48579996|NCT03104400|156316393|FG003|Overall Study|Lost to Follow-up|8|||
48579997|NCT03104400|156316394|FG004|Overall Study|Lost to Follow-up|7|||
48579998|NCT03104400|156316390|FG000|Overall Study|Lack of Efficacy|6|||
48579999|NCT03104400|156316391|FG001|Overall Study|Lack of Efficacy|3|||
48580000|NCT03104400|156316392|FG002|Overall Study|Lack of Efficacy|8|||
48580001|NCT03104400|156316393|FG003|Overall Study|Lack of Efficacy|2|||
48580002|NCT03104400|156316394|FG004|Overall Study|Lack of Efficacy|1|||
48580003|NCT03104400|156316390|FG000|Overall Study|COVID Logistical Restrictions|0|||
48580004|NCT03104400|156316391|FG001|Overall Study|COVID Logistical Restrictions|0|||
48580005|NCT03104400|156316392|FG002|Overall Study|COVID Logistical Restrictions|0|||
48580006|NCT03104400|156316393|FG003|Overall Study|COVID Logistical Restrictions|1|||
48580007|NCT03104400|156316394|FG004|Overall Study|COVID Logistical Restrictions|0|||
48580008|NCT03104400|156316390|FG000|Overall Study|Other|2|||
48580009|NCT03104400|156316391|FG001|Overall Study|Other|3|||
48580010|NCT03104400|156316392|FG002|Overall Study|Other|7|||
48580011|NCT03104400|156316393|FG003|Overall Study|Other|6|||
48580012|NCT03104400|156316394|FG004|Overall Study|Other|4|||
48580013|NCT03104400|156316390|FG000|Overall Study|Other|0|||
48580014|NCT03104400|156316391|FG001|Overall Study|Other|1|||
48580015|NCT03104400|156316392|FG002|Overall Study|Other|0|||
48580016|NCT03104400|156316393|FG003|Overall Study|Other|0|||
48580017|NCT03104400|156316394|FG004|Overall Study|Other|0|||
48580018|NCT02163226|156316396|FG000|Overall Study|Death|2|||
48580019|NCT02163226|156316397|FG001|Overall Study|Death|1|||
48580020|NCT02163226|156316396|FG000|Overall Study|Withdrawal by Subject|5|||
48580021|NCT02163226|156316397|FG001|Overall Study|Withdrawal by Subject|2|||
48580022|NCT02163226|156316396|FG000|Overall Study|Returned home, local radiotherapy|3|||
48580023|NCT02163226|156316397|FG001|Overall Study|Returned home, local radiotherapy|0|||
48580024|NCT02163226|156316396|FG000|Overall Study|Repeat imaging showed no disease|2|||
48580025|NCT02163226|156316397|FG001|Overall Study|Repeat imaging showed no disease|0|||
48580026|NCT02163226|156316396|FG000|Overall Study|Incomplete radiotherapy|3|||
48320766|NCT01998958|155375259|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320767|NCT01998958|155375260|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320768|NCT01998958|155375261|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320769|NCT01998958|155375262|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320770|NCT01998958|155375263|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320771|NCT01998958|155375264|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320772|NCT01998958|155375265|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320773|NCT01998958|155375266|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320774|NCT01998958|155375267|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320775|NCT01998958|155375268|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320776|NCT01998958|155375269|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320777|NCT01998958|155375270|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
48320778|NCT01998958|155375271|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320779|NCT01998958|155375272|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48580027|NCT02163226|156316397|FG001|Overall Study|Incomplete radiotherapy|0|||
48580028|NCT02163226|156316396|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
48580029|NCT02163226|156316397|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
48580030|NCT02163226|156316396|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
48580031|NCT02163226|156316397|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
48580032|NCT02163226|156316396|FG000|Overall Study|ineligible|0|||
48580033|NCT02163226|156316397|FG001|Overall Study|ineligible|3|||
48580034|NCT04114357|156316400|FG000|Baseline-Randomization|Adverse Event|2|||
48580035|NCT04114357|156316401|FG001|Baseline-Randomization|Adverse Event|1|||
48580036|NCT04114357|156316400|FG000|Baseline-Randomization|Lost to Follow-up|1|||
48580037|NCT04114357|156316401|FG001|Baseline-Randomization|Lost to Follow-up|1|||
48320780|NCT01998958|155375273|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320781|NCT01998958|155375274|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
48320782|NCT01998958|155375275|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320783|NCT01998958|155375276|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320784|NCT01998958|155375277|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48580038|NCT04114357|156316400|FG000|Cross-over|Adverse Event|0|||
48580039|NCT04114357|156316401|FG001|Cross-over|Adverse Event|1|||
48580040|NCT00477750|156316402|FG000|Overall Study|Currently Receiving Treatment|11|||
48580041|NCT00900757|156316404|FG000|Overall Study|screen failure|19|||
48580042|NCT03320850|156316405|FG000|Overall Study|Lost to Follow-up|0|||
48580043|NCT03320850|156316406|FG001|Overall Study|Lost to Follow-up|0|||
48580044|NCT03320850|156316407|FG002|Overall Study|Lost to Follow-up|0|||
48580045|NCT03320850|156316408|FG003|Overall Study|Lost to Follow-up|0|||
48580046|NCT03320850|156316409|FG004|Overall Study|Lost to Follow-up|1|||
48737689|NCT01146912|156890147|FG003|Overall Study|Already received influenza vaccination|15|||
48737690|NCT01146912|156890148|FG004|Overall Study|Already received influenza vaccination|41|||
48737691|NCT01146912|156890149|FG005|Overall Study|Already received influenza vaccination|61|||
48737692|NCT01146912|156890150|FG006|Overall Study|Already received influenza vaccination|56|||
48320785|NCT01998958|155375278|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320786|NCT01998958|155375279|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320787|NCT01998958|155375280|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320788|NCT01998958|155375281|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320789|NCT01998958|155375282|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320790|NCT01998958|155375283|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320791|NCT01998958|155375284|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320792|NCT01998958|155375285|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320793|NCT01998958|155375286|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320794|NCT01998958|155375287|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
48320795|NCT01998958|155375256|FG000|Open Label Phase (Optional)|Adverse Event|0|||
48320796|NCT01998958|155375257|FG001|Open Label Phase (Optional)|Adverse Event|0|||
48320797|NCT01998958|155375258|FG002|Open Label Phase (Optional)|Adverse Event|0|||
48320798|NCT01998958|155375259|FG003|Open Label Phase (Optional)|Adverse Event|0|||
48320799|NCT01998958|155375260|FG004|Open Label Phase (Optional)|Adverse Event|0|||
48320800|NCT01998958|155375261|FG005|Open Label Phase (Optional)|Adverse Event|0|||
48320801|NCT01998958|155375262|FG006|Open Label Phase (Optional)|Adverse Event|0|||
48320802|NCT01998958|155375263|FG007|Open Label Phase (Optional)|Adverse Event|0|||
48320803|NCT01998958|155375264|FG008|Open Label Phase (Optional)|Adverse Event|0|||
48320804|NCT01998958|155375265|FG009|Open Label Phase (Optional)|Adverse Event|0|||
48320805|NCT01998958|155375266|FG010|Open Label Phase (Optional)|Adverse Event|0|||
48320806|NCT01998958|155375267|FG011|Open Label Phase (Optional)|Adverse Event|0|||
48320807|NCT01998958|155375268|FG012|Open Label Phase (Optional)|Adverse Event|0|||
48320808|NCT01998958|155375269|FG013|Open Label Phase (Optional)|Adverse Event|0|||
48320809|NCT01998958|155375270|FG014|Open Label Phase (Optional)|Adverse Event|0|||
48320810|NCT01998958|155375271|FG015|Open Label Phase (Optional)|Adverse Event|0|||
48320811|NCT01998958|155375272|FG016|Open Label Phase (Optional)|Adverse Event|0|||
48320812|NCT01998958|155375273|FG017|Open Label Phase (Optional)|Adverse Event|0|||
48320813|NCT01998958|155375274|FG018|Open Label Phase (Optional)|Adverse Event|0|||
48320814|NCT01998958|155375275|FG019|Open Label Phase (Optional)|Adverse Event|0|||
48320815|NCT01998958|155375276|FG020|Open Label Phase (Optional)|Adverse Event|0|||
48320816|NCT01998958|155375277|FG021|Open Label Phase (Optional)|Adverse Event|0|||
48320817|NCT01998958|155375278|FG022|Open Label Phase (Optional)|Adverse Event|0|||
48320818|NCT01998958|155375279|FG023|Open Label Phase (Optional)|Adverse Event|1|||
48320819|NCT01998958|155375280|FG024|Open Label Phase (Optional)|Adverse Event|0|||
48737693|NCT01146912|156890151|FG007|Overall Study|Already received influenza vaccination|0|||
48737694|NCT01146912|156890144|FG000|Overall Study|< 14 weeks gestational age|0|||
48737695|NCT01146912|156890145|FG001|Overall Study|< 14 weeks gestational age|0|||
48737696|NCT01146912|156890146|FG002|Overall Study|< 14 weeks gestational age|3|||
48737697|NCT01146912|156890147|FG003|Overall Study|< 14 weeks gestational age|2|||
48737698|NCT01146912|156890148|FG004|Overall Study|< 14 weeks gestational age|0|||
48737699|NCT01146912|156890149|FG005|Overall Study|< 14 weeks gestational age|0|||
48737700|NCT01146912|156890150|FG006|Overall Study|< 14 weeks gestational age|0|||
48737701|NCT01146912|156890151|FG007|Overall Study|< 14 weeks gestational age|0|||
48737702|NCT01146912|156890144|FG000|Overall Study|Duplicate patient|0|||
48737703|NCT01146912|156890145|FG001|Overall Study|Duplicate patient|0|||
48737704|NCT01146912|156890146|FG002|Overall Study|Duplicate patient|1|||
48737705|NCT01146912|156890147|FG003|Overall Study|Duplicate patient|0|||
48737706|NCT01146912|156890148|FG004|Overall Study|Duplicate patient|0|||
48737707|NCT01146912|156890149|FG005|Overall Study|Duplicate patient|0|||
48737708|NCT01146912|156890150|FG006|Overall Study|Duplicate patient|0|||
48737709|NCT01146912|156890151|FG007|Overall Study|Duplicate patient|0|||
48737710|NCT00333840|156890152|FG000|First-line Treatment Period|Adverse Event|38|||
48737711|NCT00333840|156890153|FG001|First-line Treatment Period|Adverse Event|37|||
48737712|NCT00333840|156890154|FG002|First-line Treatment Period|Adverse Event|0|||
48737713|NCT00333840|156890155|FG003|First-line Treatment Period|Adverse Event|0|||
48737714|NCT00333840|156890152|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
48737715|NCT00333840|156890153|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
48320820|NCT01998958|155375281|FG025|Open Label Phase (Optional)|Adverse Event|0|||
48320821|NCT01998958|155375282|FG026|Open Label Phase (Optional)|Adverse Event|0|||
48737716|NCT00333840|156890154|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
48580047|NCT03320850|156316410|FG005|Overall Study|Lost to Follow-up|2|||
48737717|NCT00333840|156890155|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
48737718|NCT00333840|156890152|FG000|First-line Treatment Period|Abnormal procedure|2|||
48737719|NCT00333840|156890153|FG001|First-line Treatment Period|Abnormal procedure|0|||
48320822|NCT01998958|155375283|FG027|Open Label Phase (Optional)|Adverse Event|0|||
48320823|NCT01998958|155375284|FG028|Open Label Phase (Optional)|Adverse Event|0|||
48737720|NCT00333840|156890154|FG002|First-line Treatment Period|Abnormal procedure|0|||
48737721|NCT00333840|156890155|FG003|First-line Treatment Period|Abnormal procedure|0|||
48737722|NCT00333840|156890152|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
48737723|NCT00333840|156890153|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
48737724|NCT00333840|156890154|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
48737725|NCT00333840|156890155|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
48737726|NCT00333840|156890152|FG000|First-line Treatment Period|No longer required study drug|21|||
48737727|NCT00333840|156890153|FG001|First-line Treatment Period|No longer required study drug|8|||
48737728|NCT00333840|156890154|FG002|First-line Treatment Period|No longer required study drug|0|||
48737729|NCT00333840|156890155|FG003|First-line Treatment Period|No longer required study drug|0|||
48737730|NCT00333840|156890152|FG000|First-line Treatment Period|Protocol Violation|17|||
48737731|NCT00333840|156890153|FG001|First-line Treatment Period|Protocol Violation|17|||
48737732|NCT00333840|156890154|FG002|First-line Treatment Period|Protocol Violation|0|||
48737733|NCT00333840|156890155|FG003|First-line Treatment Period|Protocol Violation|0|||
48737734|NCT00333840|156890152|FG000|First-line Treatment Period|Subject withdrew consent|57|||
48737735|NCT00333840|156890153|FG001|First-line Treatment Period|Subject withdrew consent|77|||
48737736|NCT00333840|156890154|FG002|First-line Treatment Period|Subject withdrew consent|0|||
48737737|NCT00333840|156890155|FG003|First-line Treatment Period|Subject withdrew consent|0|||
48737738|NCT00333840|156890152|FG000|First-line Treatment Period|Lost to Follow-up|15|||
48737739|NCT00333840|156890153|FG001|First-line Treatment Period|Lost to Follow-up|6|||
48737740|NCT00333840|156890154|FG002|First-line Treatment Period|Lost to Follow-up|0|||
48737741|NCT00333840|156890155|FG003|First-line Treatment Period|Lost to Follow-up|0|||
48737742|NCT00333840|156890152|FG000|First-line Treatment Period|Administrative problems|12|||
48737743|NCT00333840|156890153|FG001|First-line Treatment Period|Administrative problems|6|||
48737744|NCT00333840|156890154|FG002|First-line Treatment Period|Administrative problems|0|||
48737745|NCT00333840|156890155|FG003|First-line Treatment Period|Administrative problems|0|||
48737746|NCT00333840|156890152|FG000|First-line Treatment Period|Death|19|||
48737747|NCT00333840|156890153|FG001|First-line Treatment Period|Death|2|||
48320824|NCT01998958|155375285|FG029|Open Label Phase (Optional)|Adverse Event|0|||
48320825|NCT01998958|155375286|FG030|Open Label Phase (Optional)|Adverse Event|0|||
48320826|NCT01998958|155375287|FG031|Open Label Phase (Optional)|Adverse Event|0|||
48320827|NCT01998958|155375256|FG000|Open Label Phase (Optional)|Other|0|||
48320828|NCT01998958|155375257|FG001|Open Label Phase (Optional)|Other|0|||
48580048|NCT03320850|156316411|FG006|Overall Study|Lost to Follow-up|2|||
48580049|NCT03320850|156316412|FG007|Overall Study|Lost to Follow-up|0|||
48580050|NCT03320850|156316413|FG008|Overall Study|Lost to Follow-up|6|||
48580051|NCT03320850|156316414|FG009|Overall Study|Lost to Follow-up|4|||
48580052|NCT03320850|156316405|FG000|Overall Study|Withdrawal by Subject|0|||
48580053|NCT03320850|156316406|FG001|Overall Study|Withdrawal by Subject|0|||
48580054|NCT03320850|156316407|FG002|Overall Study|Withdrawal by Subject|0|||
48580055|NCT03320850|156316408|FG003|Overall Study|Withdrawal by Subject|0|||
48580056|NCT03320850|156316409|FG004|Overall Study|Withdrawal by Subject|1|||
48580057|NCT03320850|156316410|FG005|Overall Study|Withdrawal by Subject|2|||
48580058|NCT03320850|156316411|FG006|Overall Study|Withdrawal by Subject|4|||
48580059|NCT03320850|156316412|FG007|Overall Study|Withdrawal by Subject|5|||
48580060|NCT03320850|156316413|FG008|Overall Study|Withdrawal by Subject|2|||
48580061|NCT03320850|156316414|FG009|Overall Study|Withdrawal by Subject|1|||
48580062|NCT03320850|156316405|FG000|Overall Study|Lack of Efficacy|0|||
48580063|NCT03320850|156316406|FG001|Overall Study|Lack of Efficacy|0|||
48580064|NCT03320850|156316407|FG002|Overall Study|Lack of Efficacy|0|||
48580065|NCT03320850|156316408|FG003|Overall Study|Lack of Efficacy|1|||
48580066|NCT03320850|156316409|FG004|Overall Study|Lack of Efficacy|0|||
48580067|NCT03320850|156316410|FG005|Overall Study|Lack of Efficacy|1|||
48580068|NCT03320850|156316411|FG006|Overall Study|Lack of Efficacy|0|||
48580069|NCT03320850|156316412|FG007|Overall Study|Lack of Efficacy|2|||
48580070|NCT03320850|156316413|FG008|Overall Study|Lack of Efficacy|0|||
48580071|NCT03320850|156316414|FG009|Overall Study|Lack of Efficacy|3|||
48580072|NCT03320850|156316405|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
48737748|NCT00333840|156890154|FG002|First-line Treatment Period|Death|0|||
48737749|NCT00333840|156890155|FG003|First-line Treatment Period|Death|0|||
48737750|NCT00333840|156890152|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
48580073|NCT03320850|156316406|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
48580074|NCT03320850|156316407|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
48580075|NCT03320850|156316408|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
48580076|NCT03320850|156316409|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
48580077|NCT03320850|156316410|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
48580078|NCT03320850|156316411|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
48580079|NCT03320850|156316412|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
48737751|NCT00333840|156890153|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
48320829|NCT01998958|155375258|FG002|Open Label Phase (Optional)|Other|0|||
48320830|NCT01998958|155375259|FG003|Open Label Phase (Optional)|Other|0|||
48320831|NCT01998958|155375260|FG004|Open Label Phase (Optional)|Other|0|||
48320832|NCT01998958|155375261|FG005|Open Label Phase (Optional)|Other|0|||
48320833|NCT01998958|155375262|FG006|Open Label Phase (Optional)|Other|0|||
48320834|NCT01998958|155375263|FG007|Open Label Phase (Optional)|Other|0|||
48320835|NCT01998958|155375264|FG008|Open Label Phase (Optional)|Other|0|||
48580080|NCT03320850|156316413|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
48580081|NCT03320850|156316414|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
48580082|NCT03320850|156316405|FG000|Overall Study|Adverse Event|0|||
48580083|NCT03320850|156316406|FG001|Overall Study|Adverse Event|0|||
48580084|NCT03320850|156316407|FG002|Overall Study|Adverse Event|0|||
48580085|NCT03320850|156316408|FG003|Overall Study|Adverse Event|0|||
48580086|NCT03320850|156316409|FG004|Overall Study|Adverse Event|0|||
48580087|NCT03320850|156316410|FG005|Overall Study|Adverse Event|2|||
48580088|NCT03320850|156316411|FG006|Overall Study|Adverse Event|1|||
48580089|NCT03320850|156316412|FG007|Overall Study|Adverse Event|0|||
48580090|NCT03320850|156316413|FG008|Overall Study|Adverse Event|2|||
48580091|NCT03320850|156316414|FG009|Overall Study|Adverse Event|0|||
48580092|NCT03320850|156316405|FG000|Overall Study|Reason Not Specified|0|||
48580093|NCT03320850|156316406|FG001|Overall Study|Reason Not Specified|0|||
48580094|NCT03320850|156316407|FG002|Overall Study|Reason Not Specified|0|||
48580095|NCT03320850|156316408|FG003|Overall Study|Reason Not Specified|0|||
48580096|NCT03320850|156316409|FG004|Overall Study|Reason Not Specified|0|||
48580097|NCT03320850|156316410|FG005|Overall Study|Reason Not Specified|1|||
48580098|NCT03320850|156316411|FG006|Overall Study|Reason Not Specified|0|||
48580099|NCT03320850|156316412|FG007|Overall Study|Reason Not Specified|0|||
48580100|NCT03320850|156316413|FG008|Overall Study|Reason Not Specified|0|||
48580101|NCT03320850|156316414|FG009|Overall Study|Reason Not Specified|1|||
48580102|NCT00347919|156316417|FG000|Overall Study|Lost to Follow-up|11|||
48580103|NCT00347919|156316418|FG001|Overall Study|Lost to Follow-up|13|||
48580104|NCT00347919|156316419|FG002|Overall Study|Lost to Follow-up|0|||
48580105|NCT00347919|156316417|FG000|Overall Study|Withdrawal by Subject|6|||
48580106|NCT00347919|156316418|FG001|Overall Study|Withdrawal by Subject|8|||
48580107|NCT00347919|156316419|FG002|Overall Study|Withdrawal by Subject|0|||
48580108|NCT00347919|156316417|FG000|Overall Study|Physician Decision|1|||
48580109|NCT00347919|156316418|FG001|Overall Study|Physician Decision|1|||
48580110|NCT00347919|156316419|FG002|Overall Study|Physician Decision|0|||
48580111|NCT00347919|156316417|FG000|Overall Study|Sponsor terminated study|15|||
48580112|NCT00347919|156316418|FG001|Overall Study|Sponsor terminated study|10|||
48580113|NCT00347919|156316419|FG002|Overall Study|Sponsor terminated study|16|||
48580114|NCT00347919|156316417|FG000|Overall Study|Death|35|||
48580115|NCT00347919|156316418|FG001|Overall Study|Death|42|||
48580116|NCT00347919|156316419|FG002|Overall Study|Death|19|||
48580117|NCT00347919|156316417|FG000|Overall Study|Par. Started Other Treatment|1|||
48580118|NCT00347919|156316418|FG001|Overall Study|Par. Started Other Treatment|1|||
48580119|NCT00347919|156316419|FG002|Overall Study|Par. Started Other Treatment|1|||
48580120|NCT00347919|156316417|FG000|Overall Study|Missing|2|||
48580121|NCT00347919|156316418|FG001|Overall Study|Missing|1|||
48580122|NCT00347919|156316419|FG002|Overall Study|Missing|2|||
48580123|NCT02344290|156316420|FG000|Overall Study|Withdrawal by Subject|315|||
48580124|NCT02344290|156316421|FG001|Overall Study|Withdrawal by Subject|324|||
48580125|NCT02344290|156316420|FG000|Overall Study|Lost to Follow-up|258|||
48580126|NCT02344290|156316421|FG001|Overall Study|Lost to Follow-up|249|||
48580127|NCT02344290|156316420|FG000|Overall Study|Unable to get to clinic|69|||
48580128|NCT02344290|156316421|FG001|Overall Study|Unable to get to clinic|60|||
48580129|NCT02344290|156316420|FG000|Overall Study|Physician Decision|25|||
48580130|NCT02344290|156316421|FG001|Overall Study|Physician Decision|25|||
48580131|NCT02344290|156316420|FG000|Overall Study|Site Closure|15|||
48580132|NCT02344290|156316421|FG001|Overall Study|Site Closure|19|||
48737752|NCT00333840|156890154|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
48737753|NCT00333840|156890155|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
48737754|NCT00333840|156890152|FG000|Second-line Treatment Period|Adverse Event|0|||
48737755|NCT00333840|156890153|FG001|Second-line Treatment Period|Adverse Event|0|||
48737756|NCT00333840|156890154|FG002|Second-line Treatment Period|Adverse Event|3|||
48737757|NCT00333840|156890155|FG003|Second-line Treatment Period|Adverse Event|34|||
48580133|NCT02344290|156316420|FG000|Overall Study|Other|5|||
48580134|NCT02344290|156316421|FG001|Overall Study|Other|3|||
48580135|NCT05343364|156316422|FG000|Overall Study|Miscellaneous|0|||
48580136|NCT05343364|156316423|FG001|Overall Study|Miscellaneous|1|||
48580137|NCT03729570|156316432|FG000|Overall Study|Lost to Follow-up|16|||
48580138|NCT03729570|156316433|FG001|Overall Study|Lost to Follow-up|20|||
48580139|NCT03729570|156316432|FG000|Overall Study|Seroconversion|5|||
48580140|NCT03729570|156316433|FG001|Overall Study|Seroconversion|0|||
48580141|NCT03729570|156316432|FG000|Overall Study|Moved out of the city|1|||
48580142|NCT03729570|156316433|FG001|Overall Study|Moved out of the city|0|||
48737758|NCT00333840|156890152|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
48320836|NCT01998958|155375265|FG009|Open Label Phase (Optional)|Other|0|||
48320837|NCT01998958|155375266|FG010|Open Label Phase (Optional)|Other|0|||
48737759|NCT00333840|156890153|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
48737760|NCT00333840|156890154|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
48737761|NCT00333840|156890155|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
48737762|NCT00333840|156890152|FG000|Second-line Treatment Period|Abnormal procedure|0|||
48737763|NCT00333840|156890153|FG001|Second-line Treatment Period|Abnormal procedure|0|||
48737764|NCT00333840|156890154|FG002|Second-line Treatment Period|Abnormal procedure|0|||
48737765|NCT00333840|156890155|FG003|Second-line Treatment Period|Abnormal procedure|1|||
48737766|NCT00333840|156890152|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
48737767|NCT00333840|156890153|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
48737768|NCT00333840|156890154|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
48737769|NCT00333840|156890155|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
48737770|NCT00333840|156890152|FG000|Second-line Treatment Period|No longer required study drug|0|||
48737771|NCT00333840|156890153|FG001|Second-line Treatment Period|No longer required study drug|0|||
48737772|NCT00333840|156890154|FG002|Second-line Treatment Period|No longer required study drug|1|||
48737773|NCT00333840|156890155|FG003|Second-line Treatment Period|No longer required study drug|14|||
48737774|NCT00333840|156890152|FG000|Second-line Treatment Period|Protocol Violation|0|||
48737775|NCT00333840|156890153|FG001|Second-line Treatment Period|Protocol Violation|0|||
48737776|NCT00333840|156890154|FG002|Second-line Treatment Period|Protocol Violation|1|||
48737777|NCT00333840|156890155|FG003|Second-line Treatment Period|Protocol Violation|10|||
48737778|NCT00333840|156890152|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
48580143|NCT03729570|156316432|FG000|Overall Study|Time Conflict|1|||
48580144|NCT03729570|156316433|FG001|Overall Study|Time Conflict|0|||
48580145|NCT03729570|156316432|FG000|Overall Study|Time Commitment|2|||
48580146|NCT03729570|156316433|FG001|Overall Study|Time Commitment|0|||
48580147|NCT03729570|156316432|FG000|Overall Study|Bad Experience|0|||
48580148|NCT03729570|156316433|FG001|Overall Study|Bad Experience|1|||
48580149|NCT03729570|156316432|FG000|Overall Study|No reason provided|2|||
48580150|NCT03729570|156316433|FG001|Overall Study|No reason provided|1|||
48580151|NCT03729570|156316432|FG000|Overall Study|Family Conflict|0|||
48580152|NCT03729570|156316433|FG001|Overall Study|Family Conflict|1|||
48580153|NCT03729570|156316432|FG000|Overall Study|Did not want to continue taking medications|0|||
48580154|NCT03729570|156316433|FG001|Overall Study|Did not want to continue taking medications|1|||
48580155|NCT03729570|156316432|FG000|Overall Study|Found another PrEP provider|1|||
48580156|NCT03729570|156316433|FG001|Overall Study|Found another PrEP provider|0|||
48580157|NCT03729570|156316432|FG000|Overall Study|Did not enjoy being in the control group|0|||
48580158|NCT03729570|156316433|FG001|Overall Study|Did not enjoy being in the control group|1|||
48580159|NCT00655733|156316436|FG000|Overall Study|Lost to Follow-up|2|||
48580160|NCT00655733|156316437|FG001|Overall Study|Lost to Follow-up|2|||
48580161|NCT00655733|156316436|FG000|Overall Study|Adverse Event|2|||
48580162|NCT00655733|156316437|FG001|Overall Study|Adverse Event|2|||
48580163|NCT00655733|156316436|FG000|Overall Study|Withdrawal by Subject|3|||
48580164|NCT00655733|156316437|FG001|Overall Study|Withdrawal by Subject|3|||
48580165|NCT00655733|156316436|FG000|Overall Study|Physician Decision|0|||
48580166|NCT00655733|156316437|FG001|Overall Study|Physician Decision|1|||
48580167|NCT01701193|156316441|FG000|Overall Study|Withdrawal by Subject|2|||
48580168|NCT01701193|156316442|FG001|Overall Study|Withdrawal by Subject|2|||
48580169|NCT01701193|156316443|FG002|Overall Study|Withdrawal by Subject|1|||
48580170|NCT01701193|156316444|FG003|Overall Study|Withdrawal by Subject|2|||
48580171|NCT01701193|156316441|FG000|Overall Study|Adverse Event|1|||
48580172|NCT01701193|156316442|FG001|Overall Study|Adverse Event|0|||
48580173|NCT01701193|156316443|FG002|Overall Study|Adverse Event|0|||
48580174|NCT01701193|156316444|FG003|Overall Study|Adverse Event|0|||
48580175|NCT01867294|156316447|FG000|Overall Study|Withdrawal by Subject|1|||
48580176|NCT01867294|156316448|FG001|Overall Study|Withdrawal by Subject|1|||
48737779|NCT00333840|156890153|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
48580177|NCT01867294|156316449|FG002|Overall Study|Withdrawal by Subject|0|||
48580178|NCT01867294|156316450|FG003|Overall Study|Withdrawal by Subject|0|||
48580179|NCT02720744|156316451|FG000|Overall Study|Protocol Violation|0|||
48580180|NCT02720744|156316452|FG001|Overall Study|Protocol Violation|2|||
48580181|NCT02720744|156316451|FG000|Overall Study|Pregnancy|2|||
48580182|NCT02720744|156316452|FG001|Overall Study|Pregnancy|0|||
48580183|NCT02720744|156316451|FG000|Overall Study|Lack of Efficacy|2|||
48580184|NCT02720744|156316452|FG001|Overall Study|Lack of Efficacy|8|||
48580185|NCT02720744|156316451|FG000|Overall Study|Adverse Event|21|||
48580186|NCT02720744|156316452|FG001|Overall Study|Adverse Event|3|||
48580187|NCT02720744|156316451|FG000|Overall Study|Withdrawal by Subject|11|||
48580188|NCT02720744|156316452|FG001|Overall Study|Withdrawal by Subject|11|||
48580189|NCT02720744|156316451|FG000|Overall Study|Lost to follow up|2|||
48580190|NCT02720744|156316452|FG001|Overall Study|Lost to follow up|0|||
48580191|NCT02720744|156316451|FG000|Overall Study|Non Compliance with Investigational Product|0|||
48580192|NCT02720744|156316452|FG001|Overall Study|Non Compliance with Investigational Product|1|||
48580193|NCT02720744|156316451|FG000|Overall Study|Excluded Concomitant Medication|0|||
48580194|NCT02720744|156316452|FG001|Overall Study|Excluded Concomitant Medication|1|||
48580195|NCT02062944|156316453|FG000|Overall Study|Lost to Follow-up|1|||
48737780|NCT00333840|156890154|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
48580196|NCT02062944|156316453|FG000|Overall Study|New hemotological disorder identified|1|||
48580197|NCT02062944|156316453|FG000|Overall Study|Uncontrolled Hypertension|1|||
48580198|NCT02062944|156316453|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
48580199|NCT01482962|156316455|FG000|Overall Study|Progressive Disease|65|||
48737781|NCT00333840|156890155|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
48737782|NCT00333840|156890152|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
48737783|NCT00333840|156890153|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
48737784|NCT00333840|156890154|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
48737785|NCT00333840|156890155|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
48737786|NCT00333840|156890152|FG000|Second-line Treatment Period|Administrative problems|0|||
48737787|NCT00333840|156890153|FG001|Second-line Treatment Period|Administrative problems|0|||
48737788|NCT00333840|156890154|FG002|Second-line Treatment Period|Administrative problems|0|||
48737789|NCT00333840|156890155|FG003|Second-line Treatment Period|Administrative problems|7|||
48737790|NCT00333840|156890152|FG000|Second-line Treatment Period|Death|0|||
48737791|NCT00333840|156890153|FG001|Second-line Treatment Period|Death|0|||
48737792|NCT00333840|156890154|FG002|Second-line Treatment Period|Death|0|||
48737793|NCT00333840|156890155|FG003|Second-line Treatment Period|Death|9|||
48737794|NCT01453725|156890156|FG000|Overall Study|Adverse Event|3|||
48737795|NCT01453725|156890157|FG001|Overall Study|Adverse Event|3|||
48737796|NCT01453725|156890156|FG000|Overall Study|Lost to Follow-up|4|||
48737797|NCT01453725|156890157|FG001|Overall Study|Lost to Follow-up|0|||
48737798|NCT01453725|156890156|FG000|Overall Study|Non-compliance With Protocol|1|||
48580200|NCT01482962|156316456|FG001|Overall Study|Progressive Disease|53|||
48580201|NCT01482962|156316455|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
48580202|NCT01482962|156316456|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
48580203|NCT01482962|156316455|FG000|Overall Study|Adverse Event|18|||
48580204|NCT01482962|156316456|FG001|Overall Study|Adverse Event|22|||
48580205|NCT01482962|156316455|FG000|Overall Study|Withdrawal by Participant|8|||
48737799|NCT01453725|156890157|FG001|Overall Study|Non-compliance With Protocol|2|||
48737800|NCT01453725|156890156|FG000|Overall Study|Protocol Violation|1|||
48320838|NCT01998958|155375267|FG011|Open Label Phase (Optional)|Other|0|||
48320839|NCT01998958|155375268|FG012|Open Label Phase (Optional)|Other|0|||
48580206|NCT01482962|156316456|FG001|Overall Study|Withdrawal by Participant|13|||
48580207|NCT01482962|156316455|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
48580208|NCT01482962|156316456|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
48580209|NCT01482962|156316455|FG000|Overall Study|Other Reason|1|||
48580210|NCT01482962|156316456|FG001|Overall Study|Other Reason|5|||
48580211|NCT01482962|156316455|FG000|Overall Study|Study Terminated by Sponsor|5|||
48580212|NCT01482962|156316456|FG001|Overall Study|Study Terminated by Sponsor|2|||
48580213|NCT01482962|156316455|FG000|Overall Study|Did not Receive Study Drug|1|||
48580214|NCT01482962|156316456|FG001|Overall Study|Did not Receive Study Drug|6|||
48580215|NCT02407457|156316458|FG000|1 Month|Death|3|||
48580216|NCT02407457|156316459|FG001|1 Month|Death|0|||
48580217|NCT02407457|156316458|FG000|1 Month|Lost to Follow-up|1|||
48580218|NCT02407457|156316459|FG001|1 Month|Lost to Follow-up|1|||
48580219|NCT02407457|156316458|FG000|1 Month|missed visit|2|||
48580220|NCT02407457|156316459|FG001|1 Month|missed visit|5|||
48580221|NCT02407457|156316458|FG000|6-Month|Death|2|||
48580222|NCT02407457|156316459|FG001|6-Month|Death|8|||
48580223|NCT02407457|156316458|FG000|6-Month|Lost to Follow-up|2|||
48580224|NCT02407457|156316459|FG001|6-Month|Lost to Follow-up|2|||
48580225|NCT02407457|156316458|FG000|6-Month|missed visit|16|||
48580226|NCT02407457|156316459|FG001|6-Month|missed visit|14|||
48580227|NCT02407457|156316458|FG000|6-Month|Open Repair|0|||
48320840|NCT01998958|155375269|FG013|Open Label Phase (Optional)|Other|0|||
48320841|NCT01998958|155375270|FG014|Open Label Phase (Optional)|Other|0|||
48320842|NCT01998958|155375271|FG015|Open Label Phase (Optional)|Other|0|||
48580228|NCT02407457|156316459|FG001|6-Month|Open Repair|1|||
48580229|NCT02407457|156316458|FG000|1 Year|Death|6|||
48580230|NCT02407457|156316459|FG001|1 Year|Death|11|||
48737801|NCT01453725|156890157|FG001|Overall Study|Protocol Violation|0|||
48737802|NCT01453725|156890156|FG000|Overall Study|Withdrawal by Subject|2|||
48737803|NCT01453725|156890157|FG001|Overall Study|Withdrawal by Subject|3|||
48737804|NCT01453725|156890156|FG000|Overall Study|Pregnancy Wish|0|||
48320843|NCT01998958|155375272|FG016|Open Label Phase (Optional)|Other|0|||
48320844|NCT01998958|155375273|FG017|Open Label Phase (Optional)|Other|0|||
48580231|NCT02407457|156316458|FG000|1 Year|Lost to Follow-up|3|||
48580232|NCT02407457|156316459|FG001|1 Year|Lost to Follow-up|2|||
48580233|NCT02407457|156316458|FG000|1 Year|Missed Visit|24|||
48580234|NCT02407457|156316459|FG001|1 Year|Missed Visit|14|||
48320845|NCT01998958|155375274|FG018|Open Label Phase (Optional)|Other|0|||
48320846|NCT01998958|155375275|FG019|Open Label Phase (Optional)|Other|0|||
48580235|NCT02407457|156316458|FG000|1 Year|Open Repair|0|||
48580236|NCT02407457|156316459|FG001|1 Year|Open Repair|1|||
48580237|NCT02407457|156316458|FG000|2-year|Death|14|||
48580238|NCT02407457|156316459|FG001|2-year|Death|8|||
48580239|NCT02407457|156316458|FG000|2-year|Lost to Follow-up|7|||
48737805|NCT01453725|156890157|FG001|Overall Study|Pregnancy Wish|2|||
48737806|NCT01453725|156890156|FG000|Overall Study|Pregnancy|1|||
48737807|NCT01453725|156890157|FG001|Overall Study|Pregnancy|0|||
48737808|NCT01453725|156890156|FG000|Overall Study|Physician Decision|1|||
48737809|NCT01453725|156890157|FG001|Overall Study|Physician Decision|1|||
48737810|NCT00074984|156890158|FG000|Overall Study|Death|1|||
48737811|NCT00074984|156890159|FG001|Overall Study|Death|2|||
48320847|NCT01998958|155375276|FG020|Open Label Phase (Optional)|Other|0|||
48320848|NCT01998958|155375277|FG021|Open Label Phase (Optional)|Other|0|||
48737812|NCT00074984|156890158|FG000|Overall Study|Withdrawal by Subject|2|||
48737813|NCT00074984|156890159|FG001|Overall Study|Withdrawal by Subject|3|||
48737814|NCT00074984|156890158|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
48737815|NCT00074984|156890159|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
48737816|NCT01436396|156890168|FG000|Overall Study|Protocol Violation|7|||
48737817|NCT01436396|156890169|FG001|Overall Study|Protocol Violation|5|||
48737818|NCT01436396|156890168|FG000|Overall Study|Adverse Event|1|||
48737819|NCT01436396|156890169|FG001|Overall Study|Adverse Event|2|||
48737820|NCT01436396|156890168|FG000|Overall Study|Withdrawal by Subject|19|||
48737821|NCT01436396|156890169|FG001|Overall Study|Withdrawal by Subject|29|||
48737822|NCT01436396|156890168|FG000|Overall Study|Serious adverse event|2|||
48737823|NCT01436396|156890169|FG001|Overall Study|Serious adverse event|3|||
48320849|NCT01998958|155375278|FG022|Open Label Phase (Optional)|Other|5|||
48320850|NCT01998958|155375279|FG023|Open Label Phase (Optional)|Other|1|||
48320851|NCT01998958|155375280|FG024|Open Label Phase (Optional)|Other|0|||
48320852|NCT01998958|155375281|FG025|Open Label Phase (Optional)|Other|0|||
48320853|NCT01998958|155375282|FG026|Open Label Phase (Optional)|Other|0|||
48320854|NCT01998958|155375283|FG027|Open Label Phase (Optional)|Other|0|||
48320855|NCT01998958|155375284|FG028|Open Label Phase (Optional)|Other|0|||
48320856|NCT01998958|155375285|FG029|Open Label Phase (Optional)|Other|0|||
48737824|NCT01436396|156890168|FG000|Overall Study|Lost to Follow-up|3|||
48737825|NCT01436396|156890169|FG001|Overall Study|Lost to Follow-up|3|||
48737826|NCT00216476|156890170|FG000|Overall Study|Withdrawal by Subject|59|||
48737827|NCT00216476|156890171|FG001|Overall Study|Withdrawal by Subject|72|||
48737828|NCT00216476|156890172|FG002|Overall Study|Withdrawal by Subject|9|||
48737829|NCT00216476|156890170|FG000|Overall Study|Lost to Follow-up|10|||
48737830|NCT00216476|156890171|FG001|Overall Study|Lost to Follow-up|9|||
48320857|NCT01998958|155375286|FG030|Open Label Phase (Optional)|Other|0|||
48320858|NCT01998958|155375287|FG031|Open Label Phase (Optional)|Other|0|||
48320859|NCT01998958|155375256|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320860|NCT01998958|155375257|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320861|NCT01998958|155375258|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320862|NCT01998958|155375259|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
48737831|NCT00216476|156890172|FG002|Overall Study|Lost to Follow-up|1|||
48737832|NCT00216476|156890170|FG000|Overall Study|Adverse Event|6|||
48320863|NCT01998958|155375260|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
48580240|NCT02407457|156316459|FG001|2-year|Lost to Follow-up|10|||
48580241|NCT02407457|156316458|FG000|2-year|Missed Visit|13|||
48580242|NCT02407457|156316459|FG001|2-year|Missed Visit|15|||
48580243|NCT02407457|156316458|FG000|2-year|Open Repair|0|||
48580244|NCT02407457|156316459|FG001|2-year|Open Repair|2|||
48580245|NCT02407457|156316458|FG000|3-year|Death|11|||
48580246|NCT02407457|156316459|FG001|3-year|Death|10|||
48580247|NCT02407457|156316458|FG000|3-year|Lost to Follow-up|9|||
48580248|NCT02407457|156316459|FG001|3-year|Lost to Follow-up|10|||
48580249|NCT02407457|156316458|FG000|3-year|Missed Visit|19|||
48580250|NCT02407457|156316459|FG001|3-year|Missed Visit|16|||
48580251|NCT02407457|156316458|FG000|4-year|Death|18|||
48580252|NCT02407457|156316459|FG001|4-year|Death|10|||
48580253|NCT02407457|156316458|FG000|4-year|Lost to Follow-up|10|||
48580254|NCT02407457|156316459|FG001|4-year|Lost to Follow-up|12|||
48580255|NCT02407457|156316458|FG000|4-year|Missed Visit|18|||
48580256|NCT02407457|156316459|FG001|4-year|Missed Visit|16|||
48580257|NCT02407457|156316458|FG000|5-year|Death|10|||
48737833|NCT00216476|156890171|FG001|Overall Study|Adverse Event|10|||
48737834|NCT00216476|156890172|FG002|Overall Study|Adverse Event|1|||
48737835|NCT00216476|156890170|FG000|Overall Study|Lack of Efficacy|4|||
48320864|NCT01998958|155375261|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320865|NCT01998958|155375262|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
48737836|NCT00216476|156890171|FG001|Overall Study|Lack of Efficacy|3|||
48737837|NCT00216476|156890172|FG002|Overall Study|Lack of Efficacy|0|||
48320866|NCT01998958|155375263|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320867|NCT01998958|155375264|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
48737838|NCT00216476|156890170|FG000|Overall Study|Death|2|||
48737839|NCT00216476|156890171|FG001|Overall Study|Death|0|||
48580258|NCT02407457|156316459|FG001|5-year|Death|3|||
48580259|NCT02407457|156316458|FG000|5-year|Lost to Follow-up|22|||
48580260|NCT02407457|156316459|FG001|5-year|Lost to Follow-up|13|||
48580261|NCT02407457|156316458|FG000|5-year|Missed Visit|9|||
48580262|NCT02407457|156316459|FG001|5-year|Missed Visit|1|||
48737840|NCT00216476|156890172|FG002|Overall Study|Death|0|||
48737841|NCT00216476|156890170|FG000|Overall Study|Pregnancy|0|||
48737842|NCT00216476|156890171|FG001|Overall Study|Pregnancy|1|||
48580263|NCT05397171|156316461|FG000|Overall Study|Death|2|||
48580264|NCT05397171|156316462|FG001|Overall Study|Death|3|||
48580265|NCT05397171|156316463|FG002|Overall Study|Death|3|||
48580266|NCT05397171|156316461|FG000|Overall Study|Study Terminated By Sponsor|1|||
48320868|NCT01998958|155375265|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320869|NCT01998958|155375266|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320870|NCT01998958|155375267|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320871|NCT01998958|155375268|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320872|NCT01998958|155375269|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320873|NCT01998958|155375270|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320874|NCT01998958|155375271|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320875|NCT01998958|155375272|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320876|NCT01998958|155375273|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320877|NCT01998958|155375274|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320878|NCT01998958|155375275|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320879|NCT01998958|155375276|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320880|NCT01998958|155375277|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320881|NCT01998958|155375278|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
48320882|NCT01998958|155375279|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
48580267|NCT05397171|156316462|FG001|Overall Study|Study Terminated By Sponsor|2|||
48580268|NCT05397171|156316463|FG002|Overall Study|Study Terminated By Sponsor|3|||
48580269|NCT05397171|156316461|FG000|Overall Study|Withdrawal by Subject|0|||
48580270|NCT05397171|156316462|FG001|Overall Study|Withdrawal by Subject|1|||
48580271|NCT05397171|156316463|FG002|Overall Study|Withdrawal by Subject|1|||
48580272|NCT01447446|156316469|FG000|Overall Study|Death|6|||
48580273|NCT01447446|156316470|FG001|Overall Study|Death|3|||
48580274|NCT01447446|156316471|FG002|Overall Study|Death|2|||
48580275|NCT01447446|156316472|FG003|Overall Study|Death|1|||
48580276|NCT01447446|156316473|FG004|Overall Study|Death|7|||
48580277|NCT01447446|156316474|FG005|Overall Study|Death|0|||
48580278|NCT01447446|156316469|FG000|Overall Study|Adverse Event|3|||
48580279|NCT01447446|156316470|FG001|Overall Study|Adverse Event|0|||
48580280|NCT01447446|156316471|FG002|Overall Study|Adverse Event|1|||
48580281|NCT01447446|156316472|FG003|Overall Study|Adverse Event|0|||
48580282|NCT01447446|156316473|FG004|Overall Study|Adverse Event|2|||
48580283|NCT01447446|156316474|FG005|Overall Study|Adverse Event|0|||
48580284|NCT01447446|156316469|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
48580285|NCT01447446|156316470|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
48580286|NCT01447446|156316471|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
48580287|NCT01447446|156316472|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
48580288|NCT01447446|156316473|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
48580289|NCT01447446|156316474|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
48580290|NCT01447446|156316469|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
48580291|NCT01447446|156316470|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
48580292|NCT01447446|156316471|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
48580293|NCT01447446|156316472|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
48580294|NCT01447446|156316473|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
48580295|NCT01447446|156316474|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
48580296|NCT01447446|156316469|FG000|Overall Study|Administrative/Other|34|||
48580297|NCT01447446|156316470|FG001|Overall Study|Administrative/Other|9|||
48580298|NCT01447446|156316471|FG002|Overall Study|Administrative/Other|10|||
48580299|NCT01447446|156316472|FG003|Overall Study|Administrative/Other|2|||
48580300|NCT01447446|156316473|FG004|Overall Study|Administrative/Other|33|||
48580301|NCT01447446|156316474|FG005|Overall Study|Administrative/Other|4|||
48580302|NCT01447446|156316469|FG000|Overall Study|SVR12 Assessment|13|||
48580303|NCT01447446|156316470|FG001|Overall Study|SVR12 Assessment|1|||
48580304|NCT01447446|156316471|FG002|Overall Study|SVR12 Assessment|2|||
48580305|NCT01447446|156316472|FG003|Overall Study|SVR12 Assessment|1|||
48580306|NCT01447446|156316473|FG004|Overall Study|SVR12 Assessment|5|||
48580307|NCT01447446|156316474|FG005|Overall Study|SVR12 Assessment|5|||
48320883|NCT01998958|155375280|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
48580308|NCT01447446|156316469|FG000|Overall Study|New Treatment Started|8|||
48580309|NCT01447446|156316470|FG001|Overall Study|New Treatment Started|2|||
48580310|NCT01447446|156316471|FG002|Overall Study|New Treatment Started|1|||
48580311|NCT01447446|156316472|FG003|Overall Study|New Treatment Started|0|||
48580312|NCT01447446|156316473|FG004|Overall Study|New Treatment Started|2|||
48580313|NCT01447446|156316474|FG005|Overall Study|New Treatment Started|0|||
48580314|NCT01447446|156316469|FG000|Overall Study|Reason not Specified|1|||
48580315|NCT01447446|156316470|FG001|Overall Study|Reason not Specified|1|||
48580316|NCT01447446|156316471|FG002|Overall Study|Reason not Specified|1|||
48580317|NCT01447446|156316472|FG003|Overall Study|Reason not Specified|1|||
48580318|NCT01447446|156316473|FG004|Overall Study|Reason not Specified|1|||
48580319|NCT01447446|156316474|FG005|Overall Study|Reason not Specified|0|||
48320884|NCT01998958|155375281|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
48580320|NCT02499146|156316475|FG000|Overall Study|Lost to Follow-up|1|||
48320885|NCT01998958|155375282|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320886|NCT01998958|155375283|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
48737843|NCT00216476|156890172|FG002|Overall Study|Pregnancy|1|||
48737844|NCT00216476|156890170|FG000|Overall Study|Other|0|||
48737845|NCT00216476|156890171|FG001|Overall Study|Other|0|||
48737846|NCT00216476|156890172|FG002|Overall Study|Other|1|||
48737847|NCT00216476|156890170|FG000|Overall Study|Refuses Injection|11|||
48737848|NCT00216476|156890171|FG001|Overall Study|Refuses Injection|0|||
48320887|NCT01998958|155375284|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320888|NCT01998958|155375285|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320889|NCT01998958|155375286|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
48320890|NCT01998958|155375287|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
48737849|NCT00216476|156890172|FG002|Overall Study|Refuses Injection|0|||
48737850|NCT00216476|156890170|FG000|Overall Study|No Further Need for Treatment|3|||
48737851|NCT00216476|156890171|FG001|Overall Study|No Further Need for Treatment|4|||
48737852|NCT00216476|156890172|FG002|Overall Study|No Further Need for Treatment|1|||
48737853|NCT00216476|156890170|FG000|Overall Study|Non-compliance|0|||
48737854|NCT00216476|156890171|FG001|Overall Study|Non-compliance|4|||
48320891|NCT01998958|155375256|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320892|NCT01998958|155375257|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320893|NCT01998958|155375258|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320894|NCT01998958|155375259|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580321|NCT02499146|156316475|FG000|Overall Study|Withdrawal by Subject|1|||
48737855|NCT00216476|156890172|FG002|Overall Study|Non-compliance|1|||
48737856|NCT00216476|156890170|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
48737857|NCT00216476|156890171|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
48737858|NCT00216476|156890172|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
48737859|NCT00216476|156890170|FG000|Overall Study|Administrative Reasons|1|||
48737860|NCT00216476|156890171|FG001|Overall Study|Administrative Reasons|1|||
48737861|NCT00216476|156890172|FG002|Overall Study|Administrative Reasons|0|||
48737862|NCT00216476|156890170|FG000|Overall Study|Protocol Deviation|5|||
48737863|NCT00216476|156890171|FG001|Overall Study|Protocol Deviation|1|||
48737864|NCT00216476|156890172|FG002|Overall Study|Protocol Deviation|0|||
48737865|NCT00216476|156890170|FG000|Overall Study|Patient Moved|2|||
48737866|NCT00216476|156890171|FG001|Overall Study|Patient Moved|2|||
48737867|NCT00216476|156890172|FG002|Overall Study|Patient Moved|0|||
48737868|NCT01952145|156890175|FG000|Overall Study|Protocol Violation|2|||
48737869|NCT01952145|156890176|FG001|Overall Study|Protocol Violation|1|||
48737870|NCT01952145|156890175|FG000|Overall Study|Death|0|||
48737871|NCT01952145|156890176|FG001|Overall Study|Death|1|||
48737872|NCT01952145|156890175|FG000|Overall Study|Adverse Event|9|||
48737873|NCT01952145|156890176|FG001|Overall Study|Adverse Event|0|||
48580322|NCT02499146|156316475|FG000|Overall Study|Other|2|||
48580323|NCT02499146|156316475|FG000|Overall Study|Ongoing at date of cut-off|9|||
48580324|NCT02499146|156316475|FG000|Overall Study|Began other treatment/therapy|13|||
48580325|NCT00581542|156316483|FG000|Overall Study|they met an exclusion criteria|2|||
48580326|NCT00581542|156316484|FG001|Overall Study|they met an exclusion criteria|2|||
48580327|NCT00581542|156316483|FG000|Overall Study|Lost to Follow-up|9|||
48580328|NCT00581542|156316484|FG001|Overall Study|Lost to Follow-up|21|||
48320895|NCT01998958|155375260|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580329|NCT01217385|156316492|FG000|Overall Study|Withdrawal by Subject|3|||
48580330|NCT01217385|156316492|FG000|Overall Study|DOSI not performed/not eval|12|||
48580331|NCT01217385|156316492|FG000|Overall Study|Central Path not Available|1|||
48580332|NCT01217385|156316492|FG000|Overall Study|Normal Breast TOI not available|10|||
48580333|NCT00090987|156316493|FG000|Overall Study|Adverse Event|5|||
48580334|NCT00090987|156316493|FG000|Overall Study|Lack of Efficacy|7|||
48580335|NCT00090987|156316493|FG000|Overall Study|Withdrawal by Subject|3|||
48580336|NCT00090987|156316493|FG000|Overall Study|alternative therapy|1|||
48580337|NCT00090987|156316493|FG000|Overall Study|Non-compliance|4|||
48580338|NCT00090987|156316493|FG000|Overall Study|Incarcerated|1|||
48580339|NCT04017832|156316494|FG000|Overall Study|Withdrawal by Subject|13|||
48580340|NCT04017832|156316495|FG001|Overall Study|Withdrawal by Subject|12|||
48580341|NCT04017832|156316496|FG002|Overall Study|Withdrawal by Subject|21|||
48580342|NCT04017832|156316497|FG003|Overall Study|Withdrawal by Subject|7|||
48580343|NCT04017832|156316494|FG000|Overall Study|Lost to Follow-up|0|||
48580344|NCT04017832|156316495|FG001|Overall Study|Lost to Follow-up|3|||
48580345|NCT04017832|156316496|FG002|Overall Study|Lost to Follow-up|3|||
48580346|NCT04017832|156316497|FG003|Overall Study|Lost to Follow-up|1|||
48580347|NCT04017832|156316494|FG000|Overall Study|Physician Decision|1|||
48737874|NCT01952145|156890175|FG000|Overall Study|Withdrawal Criteria|16|||
48580348|NCT04017832|156316495|FG001|Overall Study|Physician Decision|1|||
48737875|NCT01952145|156890176|FG001|Overall Study|Withdrawal Criteria|11|||
48737876|NCT01952145|156890175|FG000|Overall Study|Unclassified|1|||
48737877|NCT01952145|156890176|FG001|Overall Study|Unclassified|1|||
48737878|NCT00178633|156890177|FG000|Overall Study|Lost to Follow-up|6|||
48737879|NCT03570697|156890178|FG000|Overall Study|Lost to Follow-up|0|||
48737880|NCT03570697|156890179|FG001|Overall Study|Lost to Follow-up|1|||
48580349|NCT04017832|156316496|FG002|Overall Study|Physician Decision|1|||
48737881|NCT03570697|156890178|FG000|Overall Study|Death|2|||
48580350|NCT04017832|156316497|FG003|Overall Study|Physician Decision|1|||
48580351|NCT04017832|156316494|FG000|Overall Study|Death|2|||
48580352|NCT04017832|156316495|FG001|Overall Study|Death|2|||
48580353|NCT04017832|156316496|FG002|Overall Study|Death|1|||
48580354|NCT04017832|156316497|FG003|Overall Study|Death|0|||
48580355|NCT01294371|156316498|FG000|Overall Study|Adverse Event|1|||
48737882|NCT03570697|156890179|FG001|Overall Study|Death|0|||
48580356|NCT01294371|156316498|FG000|Overall Study|Withdrawal by Subject|12|||
48737883|NCT03570697|156890178|FG000|Overall Study|Withdrawal by Subject|4|||
48737884|NCT03570697|156890179|FG001|Overall Study|Withdrawal by Subject|2|||
48737885|NCT03469934|156890180|FG000|Overall Study|Withdrawal by Subject|0|||
48737886|NCT03469934|156890181|FG001|Overall Study|Withdrawal by Subject|1|||
48737887|NCT02693119|156890182|FG000|Open-Label Period|Withdrawal by Subject|0|||
48737888|NCT02693119|156890183|FG001|Open-Label Period|Withdrawal by Subject|1|||
48737889|NCT01719783|156890186|FG000|Dose 2|Physician Decision|1|||
48580357|NCT01294371|156316498|FG000|Overall Study|Lost to Follow-up|6|||
48580358|NCT01294371|156316498|FG000|Overall Study|Administrative Reason|1|||
48580359|NCT01294371|156316498|FG000|Overall Study|Other|14|||
48580360|NCT00514904|156316499|FG000|Overall Study|Withdrawal by Subject|3|||
48580361|NCT00514904|156316500|FG001|Overall Study|Withdrawal by Subject|2|||
48580362|NCT00514904|156316499|FG000|Overall Study|Lost to Follow-up|21|||
48580363|NCT00514904|156316500|FG001|Overall Study|Lost to Follow-up|3|||
48580364|NCT00477607|156316502|FG000|Overall Study|Lost to Follow-up|7|||
48580365|NCT00477607|156316503|FG001|Overall Study|Lost to Follow-up|7|||
48580366|NCT01317797|156316505|FG000|Overall Study|Other|0|||
48580367|NCT01317797|156316506|FG001|Overall Study|Other|1|||
48580368|NCT01317797|156316507|FG002|Overall Study|Other|0|||
48580369|NCT01317797|156316505|FG000|Overall Study|Withdrawal of Patient|0|||
48580370|NCT01317797|156316506|FG001|Overall Study|Withdrawal of Patient|0|||
48580371|NCT01317797|156316507|FG002|Overall Study|Withdrawal of Patient|1|||
48580372|NCT04506905|156316508|FG000|Overall Study|Lost to Follow-up|1|||
48580373|NCT04506905|156316509|FG001|Overall Study|Lost to Follow-up|0|||
48580374|NCT04506905|156316510|FG002|Overall Study|Lost to Follow-up|0|||
48580375|NCT04506905|156316511|FG003|Overall Study|Lost to Follow-up|1|||
48580376|NCT04506905|156316512|FG004|Overall Study|Lost to Follow-up|0|||
48580377|NCT04506905|156316513|FG005|Overall Study|Lost to Follow-up|0|||
48580378|NCT04506905|156316514|FG006|Overall Study|Lost to Follow-up|0|||
48580379|NCT04506905|156316515|FG007|Overall Study|Lost to Follow-up|0|||
48580380|NCT04506905|156316516|FG008|Overall Study|Lost to Follow-up|0|||
48580381|NCT04506905|156316508|FG000|Overall Study|Withdrawal by Subject|0|||
48580382|NCT04506905|156316509|FG001|Overall Study|Withdrawal by Subject|0|||
48580383|NCT04506905|156316510|FG002|Overall Study|Withdrawal by Subject|0|||
48580384|NCT04506905|156316511|FG003|Overall Study|Withdrawal by Subject|2|||
48580385|NCT04506905|156316512|FG004|Overall Study|Withdrawal by Subject|0|||
48580386|NCT04506905|156316513|FG005|Overall Study|Withdrawal by Subject|0|||
48580387|NCT04506905|156316514|FG006|Overall Study|Withdrawal by Subject|0|||
48580388|NCT04506905|156316515|FG007|Overall Study|Withdrawal by Subject|0|||
48580389|NCT04506905|156316516|FG008|Overall Study|Withdrawal by Subject|0|||
48580390|NCT03558152|156317731|FG000|Overall Study|Adverse Event|0|||
48580391|NCT03558152|156317732|FG001|Overall Study|Adverse Event|0|||
48580392|NCT03558152|156317733|FG002|Overall Study|Adverse Event|1|||
48580393|NCT03558152|156317734|FG003|Overall Study|Adverse Event|1|||
48580394|NCT03558152|156317735|FG004|Overall Study|Adverse Event|2|||
48580395|NCT03558152|156317736|FG005|Overall Study|Adverse Event|1|||
48580396|NCT03558152|156317737|FG006|Overall Study|Adverse Event|1|||
48580397|NCT03558152|156317738|FG007|Overall Study|Adverse Event|0|||
48580398|NCT03558152|156317731|FG000|Overall Study|Death|0|||
48580399|NCT03558152|156317732|FG001|Overall Study|Death|0|||
48580400|NCT03558152|156317733|FG002|Overall Study|Death|0|||
48580401|NCT03558152|156317734|FG003|Overall Study|Death|0|||
48320896|NCT01998958|155375261|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320897|NCT01998958|155375262|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580402|NCT03558152|156317735|FG004|Overall Study|Death|1|||
48580403|NCT03558152|156317736|FG005|Overall Study|Death|0|||
48580404|NCT03558152|156317737|FG006|Overall Study|Death|0|||
48737890|NCT01719783|156890187|FG001|Dose 2|Physician Decision|0|||
48737891|NCT00494299|156890188|FG000|Overall Study|Adverse Event|93|||
48580405|NCT03558152|156317738|FG007|Overall Study|Death|0|||
48580406|NCT03558152|156317731|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
48737892|NCT00494299|156890189|FG001|Overall Study|Adverse Event|13|||
48737893|NCT00494299|156890188|FG000|Overall Study|Lost to Follow-up|1|||
48580407|NCT03558152|156317732|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
48580408|NCT03558152|156317733|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
48580409|NCT03558152|156317734|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
48580410|NCT03558152|156317735|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
48580411|NCT03558152|156317736|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
48737894|NCT00494299|156890189|FG001|Overall Study|Lost to Follow-up|0|||
48737895|NCT00494299|156890188|FG000|Overall Study|Physician Decision|0|||
48737896|NCT00494299|156890189|FG001|Overall Study|Physician Decision|2|||
48737897|NCT00494299|156890188|FG000|Overall Study|Protocol Violation|1|||
48737898|NCT00494299|156890189|FG001|Overall Study|Protocol Violation|2|||
48737899|NCT00494299|156890188|FG000|Overall Study|Withdrawal by Subject|8|||
48737900|NCT00494299|156890189|FG001|Overall Study|Withdrawal by Subject|3|||
48737901|NCT00494299|156890188|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
48737902|NCT00494299|156890189|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
48737903|NCT00494299|156890188|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
48737904|NCT00494299|156890189|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
48737905|NCT00494299|156890188|FG000|Overall Study|Site Closed by Sponsor|6|||
48580412|NCT03558152|156317737|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
48737906|NCT00494299|156890189|FG001|Overall Study|Site Closed by Sponsor|0|||
48737907|NCT00494299|156890188|FG000|Overall Study|Protocol Driven Decision Point|11|||
48737908|NCT00494299|156890189|FG001|Overall Study|Protocol Driven Decision Point|22|||
48737909|NCT03780543|156890194|FG000|Overall Study|Adverse Event|1|||
48737910|NCT03780543|156890195|FG001|Overall Study|Adverse Event|0|||
48737911|NCT03780543|156890196|FG002|Overall Study|Adverse Event|2|||
48737912|NCT03780543|156890194|FG000|Overall Study|Lost to Follow-up|2|||
48737913|NCT03780543|156890195|FG001|Overall Study|Lost to Follow-up|0|||
48737914|NCT03780543|156890196|FG002|Overall Study|Lost to Follow-up|1|||
48737915|NCT03780543|156890194|FG000|Overall Study|Study terminated by Sponsor|8|||
48737916|NCT03780543|156890195|FG001|Overall Study|Study terminated by Sponsor|7|||
48737917|NCT03780543|156890196|FG002|Overall Study|Study terminated by Sponsor|13|||
48737918|NCT03780543|156890194|FG000|Overall Study|Withdrawal by Subject|1|||
48320898|NCT01998958|155375263|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580413|NCT03558152|156317738|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
48580414|NCT03558152|156317731|FG000|Overall Study|Miscalculation in mmcs|0|||
48580415|NCT03558152|156317732|FG001|Overall Study|Miscalculation in mmcs|0|||
48580416|NCT03558152|156317733|FG002|Overall Study|Miscalculation in mmcs|0|||
48580417|NCT03558152|156317734|FG003|Overall Study|Miscalculation in mmcs|0|||
48580418|NCT03558152|156317735|FG004|Overall Study|Miscalculation in mmcs|0|||
48580419|NCT03558152|156317736|FG005|Overall Study|Miscalculation in mmcs|0|||
48580420|NCT03558152|156317737|FG006|Overall Study|Miscalculation in mmcs|1|||
48580421|NCT03558152|156317738|FG007|Overall Study|Miscalculation in mmcs|0|||
48580422|NCT03558152|156317731|FG000|Overall Study|Mistake in calculation|0|||
48580423|NCT03558152|156317732|FG001|Overall Study|Mistake in calculation|0|||
48580424|NCT03558152|156317733|FG002|Overall Study|Mistake in calculation|0|||
48580425|NCT03558152|156317734|FG003|Overall Study|Mistake in calculation|1|||
48580426|NCT03558152|156317735|FG004|Overall Study|Mistake in calculation|0|||
48580427|NCT03558152|156317736|FG005|Overall Study|Mistake in calculation|0|||
48580428|NCT03558152|156317737|FG006|Overall Study|Mistake in calculation|0|||
48580429|NCT03558152|156317738|FG007|Overall Study|Mistake in calculation|0|||
48580430|NCT03558152|156317731|FG000|Overall Study|Mistake in evaluation of disease status|0|||
48737919|NCT03780543|156890195|FG001|Overall Study|Withdrawal by Subject|8|||
48320899|NCT01998958|155375264|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580431|NCT03558152|156317732|FG001|Overall Study|Mistake in evaluation of disease status|0|||
48580432|NCT03558152|156317733|FG002|Overall Study|Mistake in evaluation of disease status|0|||
48580433|NCT03558152|156317734|FG003|Overall Study|Mistake in evaluation of disease status|0|||
48580434|NCT03558152|156317735|FG004|Overall Study|Mistake in evaluation of disease status|0|||
48580435|NCT03558152|156317736|FG005|Overall Study|Mistake in evaluation of disease status|0|||
48580436|NCT03558152|156317737|FG006|Overall Study|Mistake in evaluation of disease status|0|||
48580437|NCT03558152|156317738|FG007|Overall Study|Mistake in evaluation of disease status|1|||
48737920|NCT03780543|156890196|FG002|Overall Study|Withdrawal by Subject|1|||
48737921|NCT03780543|156890194|FG000|Overall Study|Noncompliance with study drug|1|||
48737922|NCT03780543|156890195|FG001|Overall Study|Noncompliance with study drug|0|||
48737923|NCT03780543|156890196|FG002|Overall Study|Noncompliance with study drug|0|||
48737924|NCT01254331|156890203|FG000|Initial Phase|Adverse Event|3|||
48737925|NCT01254331|156890203|FG000|Initial Phase|Withdrawal by Subject|1|||
48450305|NCT03365947|155835684|FG014|Overall Study|Lost to Follow-up|0|||
48450306|NCT03365947|155835685|FG015|Overall Study|Lost to Follow-up|0|||
48580438|NCT03558152|156317731|FG000|Overall Study|Physician Decision|0|||
48580439|NCT03558152|156317732|FG001|Overall Study|Physician Decision|0|||
48580440|NCT03558152|156317733|FG002|Overall Study|Physician Decision|0|||
48580441|NCT03558152|156317734|FG003|Overall Study|Physician Decision|0|||
48580442|NCT03558152|156317735|FG004|Overall Study|Physician Decision|0|||
48580443|NCT03558152|156317736|FG005|Overall Study|Physician Decision|0|||
48580444|NCT03558152|156317737|FG006|Overall Study|Physician Decision|1|||
48580445|NCT03558152|156317738|FG007|Overall Study|Physician Decision|0|||
48580446|NCT03558152|156317731|FG000|Overall Study|Withdrawal by Subject|2|||
48580447|NCT03558152|156317732|FG001|Overall Study|Withdrawal by Subject|3|||
48580448|NCT03558152|156317733|FG002|Overall Study|Withdrawal by Subject|2|||
48580449|NCT03558152|156317734|FG003|Overall Study|Withdrawal by Subject|1|||
48580450|NCT03558152|156317735|FG004|Overall Study|Withdrawal by Subject|1|||
48580451|NCT03558152|156317736|FG005|Overall Study|Withdrawal by Subject|1|||
48580452|NCT03558152|156317737|FG006|Overall Study|Withdrawal by Subject|3|||
48580453|NCT03558152|156317738|FG007|Overall Study|Withdrawal by Subject|2|||
48580454|NCT03558152|156317731|FG000|Overall Study|Lack of Efficacy|11|||
48580455|NCT03558152|156317732|FG001|Overall Study|Lack of Efficacy|11|||
48580456|NCT03558152|156317733|FG002|Overall Study|Lack of Efficacy|10|||
48580457|NCT03558152|156317734|FG003|Overall Study|Lack of Efficacy|11|||
48580458|NCT03558152|156317735|FG004|Overall Study|Lack of Efficacy|14|||
48580459|NCT03558152|156317736|FG005|Overall Study|Lack of Efficacy|12|||
48580460|NCT03558152|156317737|FG006|Overall Study|Lack of Efficacy|14|||
48580461|NCT03558152|156317738|FG007|Overall Study|Lack of Efficacy|13|||
48580462|NCT03558152|156317731|FG000|Overall Study|Protocol Violation|1|||
48580463|NCT03558152|156317732|FG001|Overall Study|Protocol Violation|1|||
48580464|NCT03558152|156317733|FG002|Overall Study|Protocol Violation|0|||
48580465|NCT03558152|156317734|FG003|Overall Study|Protocol Violation|1|||
48580466|NCT03558152|156317735|FG004|Overall Study|Protocol Violation|1|||
48580467|NCT03558152|156317736|FG005|Overall Study|Protocol Violation|0|||
48580468|NCT03558152|156317737|FG006|Overall Study|Protocol Violation|2|||
48580469|NCT03558152|156317738|FG007|Overall Study|Protocol Violation|0|||
48580470|NCT01668966|156317739|FG000|Overall Study|Withdrawal by Subject|1|||
48580471|NCT01668966|156317739|FG000|Overall Study|Death|1|||
48580472|NCT01668966|156317739|FG000|Overall Study|Not treated|2|||
48580473|NCT04045132|156317748|FG000|Overall Study|Lost to Follow-up|3|||
48580474|NCT04045132|156317749|FG001|Overall Study|Lost to Follow-up|6|||
48580475|NCT04481191|156317750|FG000|Overall Study|Withdrawn by parent/guardian|15|||
48580476|NCT04481191|156317751|FG001|Overall Study|Withdrawn by parent/guardian|10|||
48580477|NCT03361865|156317754|FG000|Overall Study|Death|17|||
48580478|NCT03361865|156317755|FG001|Overall Study|Death|18|||
48580479|NCT03361865|156317754|FG000|Overall Study|Physician Decision|1|||
48580480|NCT03361865|156317755|FG001|Overall Study|Physician Decision|9|||
48580481|NCT03361865|156317754|FG000|Overall Study|Withdrawal by Subject|1|||
48580482|NCT03361865|156317755|FG001|Overall Study|Withdrawal by Subject|0|||
48580483|NCT02294175|156317756|FG000|Overall Study|Withdrawal by Subject|1|||
48580484|NCT02294175|156317757|FG001|Overall Study|Withdrawal by Subject|2|||
48580485|NCT02294175|156317756|FG000|Overall Study|pt taking excluded medication|3|||
48580486|NCT02294175|156317757|FG001|Overall Study|pt taking excluded medication|1|||
48580487|NCT02294175|156317756|FG000|Overall Study|Protocol Violation|1|||
48580488|NCT02294175|156317757|FG001|Overall Study|Protocol Violation|0|||
48580489|NCT02294175|156317756|FG000|Overall Study|Lost to Follow-up|0|||
48737926|NCT01254331|156890203|FG000|Initial Phase|Pregnancy|1|||
48737927|NCT01254331|156890203|FG000|Extension Phase|Lack of Efficacy|1|||
48580490|NCT02294175|156317757|FG001|Overall Study|Lost to Follow-up|1|||
48580491|NCT02294175|156317756|FG000|Overall Study|wound healed|0|||
48580492|NCT02294175|156317757|FG001|Overall Study|wound healed|2|||
48580493|NCT00878969|156317760|FG000|Overall Study|Physician Decision|5|||
48580494|NCT00878969|156317761|FG001|Overall Study|Physician Decision|3|||
48580495|NCT00878969|156317762|FG002|Overall Study|Physician Decision|2|||
48580496|NCT00878969|156317760|FG000|Overall Study|Withdrawal by Subject|1|||
48580497|NCT00878969|156317761|FG001|Overall Study|Withdrawal by Subject|6|||
48580498|NCT00878969|156317762|FG002|Overall Study|Withdrawal by Subject|3|||
48580499|NCT00878969|156317760|FG000|Overall Study|kidney transplant|2|||
48580500|NCT00878969|156317761|FG001|Overall Study|kidney transplant|3|||
48737928|NCT01254331|156890203|FG000|Extension Phase|Lost to Follow-up|3|||
48737929|NCT00516074|156890206|FG000|Overall Study|Adverse Event|0|||
48580501|NCT00878969|156317762|FG002|Overall Study|kidney transplant|2|||
48580502|NCT00878969|156317760|FG000|Overall Study|Adverse Event|3|||
48580503|NCT00878969|156317761|FG001|Overall Study|Adverse Event|1|||
48580504|NCT00878969|156317762|FG002|Overall Study|Adverse Event|2|||
48580505|NCT00878969|156317760|FG000|Overall Study|Lost to Follow-up|2|||
48580506|NCT00878969|156317761|FG001|Overall Study|Lost to Follow-up|1|||
48580507|NCT00878969|156317762|FG002|Overall Study|Lost to Follow-up|0|||
48580508|NCT00878969|156317760|FG000|Overall Study|Protocol Violation|2|||
48580509|NCT00878969|156317761|FG001|Overall Study|Protocol Violation|0|||
48580510|NCT00878969|156317762|FG002|Overall Study|Protocol Violation|0|||
48580511|NCT00878969|156317760|FG000|Overall Study|Death|0|||
48580512|NCT00878969|156317761|FG001|Overall Study|Death|0|||
48580513|NCT00878969|156317762|FG002|Overall Study|Death|2|||
48580514|NCT00878969|156317760|FG000|Overall Study|Pregnancy|0|||
48580515|NCT00878969|156317761|FG001|Overall Study|Pregnancy|1|||
48320900|NCT01998958|155375265|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320901|NCT01998958|155375266|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320902|NCT01998958|155375267|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320903|NCT01998958|155375268|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320904|NCT01998958|155375269|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320905|NCT01998958|155375270|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320906|NCT01998958|155375271|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320907|NCT01998958|155375272|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580516|NCT00878969|156317762|FG002|Overall Study|Pregnancy|0|||
48580517|NCT02284568|156317763|FG000|Overall Study|Adverse Event|2|||
48580518|NCT02284568|156317764|FG001|Overall Study|Adverse Event|9|||
48580519|NCT02284568|156317765|FG002|Overall Study|Adverse Event|4|||
48580520|NCT02284568|156317763|FG000|Overall Study|Withdrawal by Subject|22|||
48580521|NCT02284568|156317764|FG001|Overall Study|Withdrawal by Subject|21|||
48580522|NCT02284568|156317765|FG002|Overall Study|Withdrawal by Subject|1|||
48580523|NCT02284568|156317763|FG000|Overall Study|Noncompliance with study drug admin|1|||
48580524|NCT02284568|156317764|FG001|Overall Study|Noncompliance with study drug admin|2|||
48580525|NCT02284568|156317765|FG002|Overall Study|Noncompliance with study drug admin|0|||
48580526|NCT02284568|156317763|FG000|Overall Study|Noncompliance|1|||
48580527|NCT02284568|156317764|FG001|Overall Study|Noncompliance|0|||
48580528|NCT02284568|156317765|FG002|Overall Study|Noncompliance|0|||
48580529|NCT02284568|156317763|FG000|Overall Study|Protocol Violation|0|||
48580530|NCT02284568|156317764|FG001|Overall Study|Protocol Violation|1|||
48580531|NCT02284568|156317765|FG002|Overall Study|Protocol Violation|0|||
48580532|NCT02284568|156317763|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
48580533|NCT02284568|156317764|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
48580534|NCT02284568|156317765|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
48580535|NCT02284568|156317763|FG000|Overall Study|Lost to Follow-up|0|||
48580536|NCT02284568|156317764|FG001|Overall Study|Lost to Follow-up|3|||
48580537|NCT02284568|156317765|FG002|Overall Study|Lost to Follow-up|0|||
48580538|NCT02284568|156317763|FG000|Overall Study|Lack of Efficacy|4|||
48580539|NCT02284568|156317764|FG001|Overall Study|Lack of Efficacy|7|||
48580540|NCT02284568|156317765|FG002|Overall Study|Lack of Efficacy|0|||
48580541|NCT02284568|156317763|FG000|Overall Study|Other|1|||
48580542|NCT02284568|156317764|FG001|Overall Study|Other|2|||
48580543|NCT02284568|156317765|FG002|Overall Study|Other|0|||
48580544|NCT02284568|156317763|FG000|Overall Study|Withdrew before taking study drug|0|||
48580545|NCT02284568|156317764|FG001|Overall Study|Withdrew before taking study drug|1|||
48580546|NCT02284568|156317765|FG002|Overall Study|Withdrew before taking study drug|0|||
48580547|NCT04258254|156317766|FG000|Overall Study|Withdrawal by Subject|0|||
48580548|NCT04258254|156317767|FG001|Overall Study|Withdrawal by Subject|1|||
48580549|NCT04258254|156317768|FG002|Overall Study|Withdrawal by Subject|0|||
48580550|NCT03045276|156317769|FG000|Intervention Phase|Withdrawal by Subject|7|||
48580551|NCT03045276|156317770|FG001|Intervention Phase|Withdrawal by Subject|2|||
48580552|NCT03045276|156317771|FG002|Intervention Phase|Withdrawal by Subject|3|||
48580553|NCT03045276|156317772|FG003|Intervention Phase|Withdrawal by Subject|7|||
48580554|NCT03045276|156317769|FG000|Intervention Phase|Developed exclusionary criteria|3|||
48580555|NCT03045276|156317770|FG001|Intervention Phase|Developed exclusionary criteria|3|||
48580556|NCT03045276|156317771|FG002|Intervention Phase|Developed exclusionary criteria|0|||
48580557|NCT03045276|156317772|FG003|Intervention Phase|Developed exclusionary criteria|0|||
48580558|NCT03045276|156317769|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
48580559|NCT03045276|156317770|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
48580560|NCT03045276|156317771|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
48580561|NCT03045276|156317772|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
48580562|NCT03045276|156317769|FG000|Follow-Up Phase|Lost to Follow-up|0|||
48580563|NCT03045276|156317770|FG001|Follow-Up Phase|Lost to Follow-up|1|||
48580564|NCT03045276|156317771|FG002|Follow-Up Phase|Lost to Follow-up|0|||
48580565|NCT03045276|156317772|FG003|Follow-Up Phase|Lost to Follow-up|1|||
48580566|NCT03045276|156317769|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
48580567|NCT03045276|156317770|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
48580568|NCT03045276|156317771|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
48580569|NCT03045276|156317772|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
48580570|NCT00278148|156317773|FG000|Phase II - Expansion Phase|Disease progression|0|||
48580571|NCT00278148|156317774|FG001|Phase II - Expansion Phase|Disease progression|0|||
48580572|NCT00278148|156317775|FG002|Phase II - Expansion Phase|Disease progression|4|||
48580573|NCT00278148|156317773|FG000|Phase II - Expansion Phase|Adverse Event|0|||
48580574|NCT00278148|156317774|FG001|Phase II - Expansion Phase|Adverse Event|0|||
48580575|NCT00278148|156317775|FG002|Phase II - Expansion Phase|Adverse Event|2|||
48580576|NCT02035748|156317779|FG000|Overall Study|Adverse Event|5|||
48580577|NCT02035748|156317779|FG000|Overall Study|Death|3|||
48580578|NCT02035748|156317779|FG000|Overall Study|Lost to Follow-up|2|||
48580579|NCT02035748|156317779|FG000|Overall Study|Physician Decision|3|||
48580580|NCT02035748|156317779|FG000|Overall Study|Withdrawal by Subject|6|||
48580581|NCT02035748|156317779|FG000|Overall Study|Progressive Disease|1|||
48320908|NCT01998958|155375273|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580582|NCT01088243|156317781|FG000|Overall Study|Adverse Event|1|||
48580583|NCT01088243|156317782|FG001|Overall Study|Adverse Event|0|||
48580584|NCT02255552|156317785|FG000|Overall Study|Participants enrolled into another study|0|||
48580585|NCT02255552|156317786|FG001|Overall Study|Participants enrolled into another study|11|||
48580586|NCT02255552|156317785|FG000|Overall Study|Withdrawal by Subject|1|||
48580587|NCT02255552|156317786|FG001|Overall Study|Withdrawal by Subject|4|||
48580588|NCT02122770|156317787|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
48580589|NCT02122770|156317788|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
48580590|NCT02122770|156317789|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
48580591|NCT02122770|156317790|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
48580592|NCT02122770|156317791|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
48580593|NCT02122770|156317792|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
48580594|NCT02122770|156317787|FG000|Part A: Drug-drug Interaction 2|Other|0|||
48580595|NCT02122770|156317788|FG001|Part A: Drug-drug Interaction 2|Other|0|||
48580596|NCT02122770|156317789|FG002|Part A: Drug-drug Interaction 2|Other|1|||
48580597|NCT02122770|156317790|FG003|Part A: Drug-drug Interaction 2|Other|0|||
48580598|NCT02122770|156317791|FG004|Part A: Drug-drug Interaction 2|Other|0|||
48580599|NCT02122770|156317792|FG005|Part A: Drug-drug Interaction 2|Other|0|||
48580600|NCT02122770|156317787|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
48580601|NCT02122770|156317788|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
48580602|NCT02122770|156317789|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
48580603|NCT02122770|156317790|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
48580604|NCT02122770|156317791|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
48580605|NCT02122770|156317792|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
48580606|NCT02122770|156317787|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
48580607|NCT02122770|156317788|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
48580608|NCT02122770|156317789|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
48580609|NCT02122770|156317790|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
48580610|NCT02122770|156317791|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
48580611|NCT02122770|156317792|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
48580612|NCT02122770|156317787|FG000|Part B: Standard of Care|Adverse Event|0|||
48580613|NCT02122770|156317788|FG001|Part B: Standard of Care|Adverse Event|0|||
48580614|NCT02122770|156317789|FG002|Part B: Standard of Care|Adverse Event|0|||
48580615|NCT02122770|156317790|FG003|Part B: Standard of Care|Adverse Event|0|||
48580616|NCT02122770|156317791|FG004|Part B: Standard of Care|Adverse Event|4|||
48580617|NCT02122770|156317792|FG005|Part B: Standard of Care|Adverse Event|1|||
48580618|NCT02122770|156317787|FG000|Part B: Standard of Care|Other|0|||
48580619|NCT02122770|156317788|FG001|Part B: Standard of Care|Other|0|||
48580620|NCT02122770|156317789|FG002|Part B: Standard of Care|Other|0|||
48580621|NCT02122770|156317790|FG003|Part B: Standard of Care|Other|0|||
48580622|NCT02122770|156317791|FG004|Part B: Standard of Care|Other|0|||
48580623|NCT02122770|156317792|FG005|Part B: Standard of Care|Other|2|||
48580624|NCT02122770|156317787|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
48580625|NCT02122770|156317788|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
48580626|NCT02122770|156317789|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
48580627|NCT02122770|156317790|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
48580628|NCT02122770|156317791|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
48580629|NCT02122770|156317792|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
48580630|NCT02122770|156317787|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
48580631|NCT02122770|156317788|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
48580632|NCT02122770|156317789|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
48580633|NCT02122770|156317790|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
48580634|NCT02122770|156317791|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
48580635|NCT02122770|156317792|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
48580636|NCT02122770|156317787|FG000|Part B: Standard of Care|Progressive Disease|0|||
48580637|NCT02122770|156317788|FG001|Part B: Standard of Care|Progressive Disease|0|||
48580638|NCT02122770|156317789|FG002|Part B: Standard of Care|Progressive Disease|0|||
48580639|NCT02122770|156317790|FG003|Part B: Standard of Care|Progressive Disease|0|||
48580640|NCT02122770|156317791|FG004|Part B: Standard of Care|Progressive Disease|10|||
48580641|NCT02122770|156317792|FG005|Part B: Standard of Care|Progressive Disease|8|||
48580642|NCT04450407|156317793|FG000|Overall Study|Withdrawal by Subject|10|||
48580643|NCT04450407|156317794|FG001|Overall Study|Withdrawal by Subject|1|||
48580644|NCT04450407|156317795|FG002|Overall Study|Withdrawal by Subject|4|||
48580645|NCT04450407|156317793|FG000|Overall Study|Adverse Event|0|||
48580646|NCT04450407|156317794|FG001|Overall Study|Adverse Event|0|||
48580647|NCT04450407|156317795|FG002|Overall Study|Adverse Event|1|||
48580648|NCT04450407|156317793|FG000|Overall Study|Lost to Follow-up|1|||
48580649|NCT04450407|156317794|FG001|Overall Study|Lost to Follow-up|0|||
48580650|NCT04450407|156317795|FG002|Overall Study|Lost to Follow-up|0|||
48580651|NCT04450407|156317793|FG000|Overall Study|Physician Decision|0|||
48580652|NCT04450407|156317794|FG001|Overall Study|Physician Decision|0|||
48737930|NCT00516074|156890207|FG001|Overall Study|Adverse Event|1|||
48737931|NCT00516074|156890206|FG000|Overall Study|Subject Decision|4|||
48737932|NCT00516074|156890207|FG001|Overall Study|Subject Decision|2|||
48737933|NCT00516074|156890206|FG000|Overall Study|Loss of Glucose Control|2|||
48737934|NCT00516074|156890207|FG001|Overall Study|Loss of Glucose Control|0|||
48737935|NCT01903031|156890209|FG000|Overall Study|Not Able to Attend Clinic|1|||
48580653|NCT04450407|156317795|FG002|Overall Study|Physician Decision|1|||
48580654|NCT04450407|156317793|FG000|Overall Study|Pregnancy|1|||
48580655|NCT04450407|156317794|FG001|Overall Study|Pregnancy|0|||
48580656|NCT04450407|156317795|FG002|Overall Study|Pregnancy|0|||
48580657|NCT04450407|156317793|FG000|Overall Study|Protocol Violation|2|||
48580658|NCT04450407|156317794|FG001|Overall Study|Protocol Violation|0|||
48580659|NCT04450407|156317795|FG002|Overall Study|Protocol Violation|0|||
48580660|NCT04450407|156317793|FG000|Overall Study|Investigational site terminated by sponsor|3|||
48737936|NCT01903031|156890210|FG001|Overall Study|Not Able to Attend Clinic|1|||
48737937|NCT01903031|156890211|FG002|Overall Study|Not Able to Attend Clinic|0|||
48737938|NCT01903031|156890209|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
48737939|NCT01903031|156890210|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
48737940|NCT01903031|156890211|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
48320909|NCT01998958|155375274|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320910|NCT01998958|155375275|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320911|NCT01998958|155375276|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580661|NCT04450407|156317794|FG001|Overall Study|Investigational site terminated by sponsor|0|||
48580662|NCT04450407|156317795|FG002|Overall Study|Investigational site terminated by sponsor|2|||
48580663|NCT03419598|156317796|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
48580664|NCT02474589|156317797|FG000|Overall Study|Adverse Event|6|||
48580665|NCT02474589|156317798|FG001|Overall Study|Adverse Event|2|||
48580666|NCT02474589|156317797|FG000|Overall Study|Lost to Follow-up|6|||
48580667|NCT02474589|156317798|FG001|Overall Study|Lost to Follow-up|1|||
48580668|NCT02474589|156317797|FG000|Overall Study|Protocol Violation|4|||
48580669|NCT02474589|156317798|FG001|Overall Study|Protocol Violation|1|||
48580670|NCT02474589|156317797|FG000|Overall Study|Withdrawal by Subject|4|||
48320912|NCT01998958|155375277|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
48320913|NCT01998958|155375278|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
48580671|NCT02474589|156317798|FG001|Overall Study|Withdrawal by Subject|0|||
48580672|NCT02474589|156317797|FG000|Overall Study|Inability to complete study procedures|5|||
48580673|NCT02474589|156317798|FG001|Overall Study|Inability to complete study procedures|1|||
48580674|NCT01740128|156317799|FG000|Overall Study|Pregnancy|0|||
48580675|NCT01740128|156317800|FG001|Overall Study|Pregnancy|1|||
48580676|NCT01740128|156317799|FG000|Overall Study|Protocol Violation|1|||
48580677|NCT01740128|156317800|FG001|Overall Study|Protocol Violation|2|||
48580678|NCT01740128|156317799|FG000|Overall Study|Lost to Follow-up|2|||
48580679|NCT01740128|156317800|FG001|Overall Study|Lost to Follow-up|2|||
48320914|NCT01998958|155375279|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320915|NCT01998958|155375280|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320916|NCT01998958|155375281|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320917|NCT01998958|155375282|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580680|NCT01740128|156317799|FG000|Overall Study|Withdrawal by Subject|1|||
48580681|NCT01740128|156317800|FG001|Overall Study|Withdrawal by Subject|0|||
48580682|NCT01740128|156317799|FG000|Overall Study|Insufficient protocol compliance|2|||
48580683|NCT01740128|156317800|FG001|Overall Study|Insufficient protocol compliance|2|||
48580684|NCT01041976|156317801|FG000|Overall Study|Withdrawal by Subject|3|||
48580685|NCT01041976|156317802|FG001|Overall Study|Withdrawal by Subject|0|||
48580686|NCT01041976|156317801|FG000|Overall Study|Incarceration|2|||
48580687|NCT01041976|156317802|FG001|Overall Study|Incarceration|0|||
48580688|NCT01041976|156317801|FG000|Overall Study|Death|0|||
48580689|NCT01041976|156317802|FG001|Overall Study|Death|4|||
48580690|NCT00380081|156317805|FG000|Overall Study|Withdrawal by Subject|0|||
48580691|NCT00380081|156317806|FG001|Overall Study|Withdrawal by Subject|0|||
48320918|NCT01998958|155375283|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320919|NCT01998958|155375284|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320920|NCT01998958|155375285|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320921|NCT01998958|155375286|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
48580692|NCT00380081|156317807|FG002|Overall Study|Withdrawal by Subject|0|||
48580693|NCT00380081|156317808|FG003|Overall Study|Withdrawal by Subject|0|||
48737941|NCT01903031|156890209|FG000|Overall Study|Adverse Event|0|||
48580694|NCT00380081|156317809|FG004|Overall Study|Withdrawal by Subject|1|||
48580695|NCT00380081|156317810|FG005|Overall Study|Withdrawal by Subject|0|||
48737942|NCT01903031|156890210|FG001|Overall Study|Adverse Event|1|||
48580696|NCT00380081|156317805|FG000|Overall Study|Family Emergency|0|||
48580697|NCT00380081|156317806|FG001|Overall Study|Family Emergency|0|||
48580698|NCT00380081|156317807|FG002|Overall Study|Family Emergency|0|||
48580699|NCT00380081|156317808|FG003|Overall Study|Family Emergency|0|||
48320922|NCT01998958|155375287|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
48320923|NCT01998958|155375256|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320924|NCT01998958|155375257|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320925|NCT01998958|155375258|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320926|NCT01998958|155375259|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320927|NCT01998958|155375260|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320928|NCT01998958|155375261|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320929|NCT01998958|155375262|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580700|NCT00380081|156317809|FG004|Overall Study|Family Emergency|0|||
48580701|NCT00380081|156317810|FG005|Overall Study|Family Emergency|1|||
48580702|NCT02658734|156317811|FG000|Overall Study|Adverse Event|2|||
48580703|NCT02658734|156317811|FG000|Overall Study|Death|4|||
48580704|NCT02658734|156317811|FG000|Overall Study|Lost to Follow-up|7|||
48580705|NCT02658734|156317811|FG000|Overall Study|Withdrawal of Consent|16|||
48580706|NCT02658734|156317811|FG000|Overall Study|Disease Progression|28|||
48580707|NCT02231879|156317815|FG000|Overall Study|Adverse Event|2|||
48580708|NCT02231879|156317816|FG001|Overall Study|Adverse Event|1|||
48580709|NCT02231879|156317815|FG000|Overall Study|Lack of Efficacy|0|||
48580710|NCT02231879|156317816|FG001|Overall Study|Lack of Efficacy|1|||
48580711|NCT00176644|156317817|FG000|Overall Study|Withdrawal by Subject|1|||
48580712|NCT02017912|156317818|FG000|Overall Study|Withdrawal by Subject|2|||
48580713|NCT02017912|156317819|FG001|Overall Study|Withdrawal by Subject|1|||
48580714|NCT02017912|156317818|FG000|Overall Study|miscellaneous|1|||
48580715|NCT02017912|156317819|FG001|Overall Study|miscellaneous|1|||
48580716|NCT03640481|156317820|FG000|Overall Study|Death|14|||
48580717|NCT03640481|156317821|FG001|Overall Study|Death|14|||
48580718|NCT03640481|156317822|FG002|Overall Study|Death|0|||
48580719|NCT03640481|156317823|FG003|Overall Study|Death|0|||
48580720|NCT03640481|156317820|FG000|Overall Study|Lost to Follow-up|2|||
48580721|NCT03640481|156317821|FG001|Overall Study|Lost to Follow-up|0|||
48580722|NCT03640481|156317822|FG002|Overall Study|Lost to Follow-up|0|||
48580723|NCT03640481|156317823|FG003|Overall Study|Lost to Follow-up|0|||
48580724|NCT03640481|156317820|FG000|Overall Study|Site terminated by sponsor|1|||
48580725|NCT03640481|156317821|FG001|Overall Study|Site terminated by sponsor|3|||
48580726|NCT03640481|156317822|FG002|Overall Study|Site terminated by sponsor|0|||
48580727|NCT03640481|156317823|FG003|Overall Study|Site terminated by sponsor|0|||
48580728|NCT03640481|156317820|FG000|Overall Study|Study terminated by sponsor|29|||
48580729|NCT03640481|156317821|FG001|Overall Study|Study terminated by sponsor|42|||
48580730|NCT03640481|156317822|FG002|Overall Study|Study terminated by sponsor|1|||
48580731|NCT03640481|156317823|FG003|Overall Study|Study terminated by sponsor|0|||
48580732|NCT03640481|156317820|FG000|Overall Study|Withdrawal by Subject|5|||
48580733|NCT03640481|156317821|FG001|Overall Study|Withdrawal by Subject|4|||
48580734|NCT03640481|156317822|FG002|Overall Study|Withdrawal by Subject|0|||
48580735|NCT03640481|156317823|FG003|Overall Study|Withdrawal by Subject|1|||
48580736|NCT03640481|156317820|FG000|Overall Study|Other|26|||
48580737|NCT03640481|156317821|FG001|Overall Study|Other|12|||
48580738|NCT03640481|156317822|FG002|Overall Study|Other|1|||
48580739|NCT03640481|156317823|FG003|Overall Study|Other|0|||
48580740|NCT03640481|156317820|FG000|Overall Study|Randomized, but not treated|1|||
48580741|NCT03640481|156317821|FG001|Overall Study|Randomized, but not treated|3|||
48320930|NCT01998958|155375263|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580742|NCT03640481|156317822|FG002|Overall Study|Randomized, but not treated|0|||
48580743|NCT03640481|156317823|FG003|Overall Study|Randomized, but not treated|0|||
48580744|NCT04601103|156317826|FG000|Overall Study|Needed crown & cleaning|0|||
48580745|NCT04601103|156317827|FG001|Overall Study|Needed crown & cleaning|0|||
48580746|NCT04601103|156317828|FG002|Overall Study|Needed crown & cleaning|1|||
48580747|NCT04601103|156317826|FG000|Overall Study|study was terminated|18|||
48580748|NCT04601103|156317827|FG001|Overall Study|study was terminated|18|||
48580749|NCT04601103|156317828|FG002|Overall Study|study was terminated|16|||
48580750|NCT02968433|156317830|FG000|Overall Study|Withdrawal by Subject|1|||
48580751|NCT05619536|156317831|FG000|Overall Study|Withdrawal by Subject|0|||
48580752|NCT05619536|156317832|FG001|Overall Study|Withdrawal by Subject|1|||
48580753|NCT05619536|156317833|FG002|Overall Study|Withdrawal by Subject|0|||
48580754|NCT05619536|156317834|FG003|Overall Study|Withdrawal by Subject|1|||
48320931|NCT01998958|155375264|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320932|NCT01998958|155375265|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580755|NCT05619536|156317831|FG000|Overall Study|Lost to Follow-up|0|||
48580756|NCT05619536|156317832|FG001|Overall Study|Lost to Follow-up|1|||
48580757|NCT05619536|156317833|FG002|Overall Study|Lost to Follow-up|1|||
48580758|NCT05619536|156317834|FG003|Overall Study|Lost to Follow-up|0|||
48580759|NCT03673345|156317837|FG000|Overall Study|Lost to Follow-up|1|||
48580760|NCT03673345|156317838|FG001|Overall Study|Lost to Follow-up|0|||
48580761|NCT03673345|156317839|FG002|Overall Study|Lost to Follow-up|3|||
48580762|NCT03673345|156317840|FG003|Overall Study|Lost to Follow-up|3|||
48580763|NCT03673345|156317841|FG004|Overall Study|Lost to Follow-up|2|||
48580764|NCT03673345|156317842|FG005|Overall Study|Lost to Follow-up|1|||
48580765|NCT03673345|156317843|FG006|Overall Study|Lost to Follow-up|0|||
48580766|NCT03673345|156317844|FG007|Overall Study|Lost to Follow-up|0|||
48737943|NCT01903031|156890211|FG002|Overall Study|Adverse Event|0|||
48737944|NCT01903031|156890209|FG000|Overall Study|Withdrawal by Subject|0|||
48737945|NCT01903031|156890210|FG001|Overall Study|Withdrawal by Subject|1|||
48737946|NCT01903031|156890211|FG002|Overall Study|Withdrawal by Subject|1|||
48737947|NCT01903031|156890209|FG000|Overall Study|Protocol Violation|0|||
48737948|NCT01903031|156890210|FG001|Overall Study|Protocol Violation|0|||
48737949|NCT01903031|156890211|FG002|Overall Study|Protocol Violation|2|||
48737950|NCT01903031|156890209|FG000|Overall Study|Lost to Follow-up|0|||
48737951|NCT01903031|156890210|FG001|Overall Study|Lost to Follow-up|0|||
48737952|NCT01903031|156890211|FG002|Overall Study|Lost to Follow-up|1|||
48737953|NCT01903031|156890209|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
48737954|NCT01903031|156890210|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
48737955|NCT01903031|156890211|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
48737956|NCT03896165|156890212|FG000|Overall Study|Withdrawal by Subject|2|||
48737957|NCT00415168|156890216|FG000|Overall Study|Death|26|||
48737958|NCT00415168|156890216|FG000|Overall Study|Lost to Follow-up|3|||
48737959|NCT00415168|156890216|FG000|Overall Study|Physician Decision|13|||
48320933|NCT01998958|155375266|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320934|NCT01998958|155375267|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320935|NCT01998958|155375268|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320936|NCT01998958|155375269|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580767|NCT03673345|156317837|FG000|Overall Study|Withdrawal by Subject|1|||
48737960|NCT00415168|156890216|FG000|Overall Study|Sponsor Decision|4|||
48737961|NCT00415168|156890216|FG000|Overall Study|Withdrawal by Subject|6|||
48737962|NCT00400764|156890220|FG000|Phase Ib|Adverse Event|1|||
48737963|NCT00400764|156890221|FG001|Phase Ib|Adverse Event|0|||
48320937|NCT01998958|155375270|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320938|NCT01998958|155375271|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320939|NCT01998958|155375272|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580768|NCT03673345|156317838|FG001|Overall Study|Withdrawal by Subject|0|||
48580769|NCT03673345|156317839|FG002|Overall Study|Withdrawal by Subject|4|||
48580770|NCT03673345|156317840|FG003|Overall Study|Withdrawal by Subject|2|||
48580771|NCT03673345|156317841|FG004|Overall Study|Withdrawal by Subject|0|||
48580772|NCT03673345|156317842|FG005|Overall Study|Withdrawal by Subject|0|||
48580773|NCT03673345|156317843|FG006|Overall Study|Withdrawal by Subject|0|||
48580774|NCT03673345|156317844|FG007|Overall Study|Withdrawal by Subject|0|||
48580775|NCT03673345|156317837|FG000|Overall Study|Physician Decision|0|||
48580776|NCT03673345|156317838|FG001|Overall Study|Physician Decision|0|||
48580777|NCT03673345|156317839|FG002|Overall Study|Physician Decision|2|||
48580778|NCT03673345|156317840|FG003|Overall Study|Physician Decision|0|||
48580779|NCT03673345|156317841|FG004|Overall Study|Physician Decision|0|||
48580780|NCT03673345|156317842|FG005|Overall Study|Physician Decision|0|||
48580781|NCT03673345|156317843|FG006|Overall Study|Physician Decision|0|||
48580782|NCT03673345|156317844|FG007|Overall Study|Physician Decision|0|||
48580783|NCT01037127|156317845|FG000|Overall Study|Lost to Follow-up|2|||
48580784|NCT01037127|156317846|FG001|Overall Study|Lost to Follow-up|4|||
48580785|NCT01037127|156317845|FG000|Overall Study|Physician Decision|1|||
48580786|NCT01037127|156317846|FG001|Overall Study|Physician Decision|0|||
48580787|NCT01037127|156317845|FG000|Overall Study|Study Closed Terminated|2|||
48580788|NCT01037127|156317846|FG001|Overall Study|Study Closed Terminated|17|||
48580789|NCT01362244|156317847|FG000|Overall Study|Adverse Event|3|||
48580790|NCT01362244|156317848|FG001|Overall Study|Adverse Event|5|||
48580791|NCT01362244|156317847|FG000|Overall Study|Lack of Efficacy|5|||
48580792|NCT01362244|156317848|FG001|Overall Study|Lack of Efficacy|11|||
48580793|NCT01362244|156317847|FG000|Overall Study|Lost to Follow-up|0|||
48580794|NCT01362244|156317848|FG001|Overall Study|Lost to Follow-up|2|||
48580795|NCT01362244|156317847|FG000|Overall Study|Protocol Violation|5|||
48580796|NCT01362244|156317848|FG001|Overall Study|Protocol Violation|1|||
48580797|NCT01362244|156317847|FG000|Overall Study|Withdrawal by Subject|2|||
48737964|NCT00400764|156890222|FG002|Phase Ib|Adverse Event|0|||
48737965|NCT00400764|156890223|FG003|Phase Ib|Adverse Event|0|||
48320940|NCT01998958|155375273|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580798|NCT01362244|156317848|FG001|Overall Study|Withdrawal by Subject|1|||
48580799|NCT01362244|156317847|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
48580800|NCT01362244|156317848|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
48580801|NCT01362244|156317847|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
48580802|NCT01362244|156317848|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
48580803|NCT03652636|156317849|FG000|Overall Study|Withdrawal by Subject|7|||
48580804|NCT02847182|156317856|FG000|Overall Study|Withdrawal by Subject|0|||
48737966|NCT00400764|156890224|FG004|Phase Ib|Adverse Event|0|||
48737967|NCT00400764|156890220|FG000|Phase Ib|Death|1|||
48737968|NCT00400764|156890221|FG001|Phase Ib|Death|0|||
48320941|NCT01998958|155375274|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48737969|NCT00400764|156890222|FG002|Phase Ib|Death|0|||
48580805|NCT02847182|156317857|FG001|Overall Study|Withdrawal by Subject|1|||
48580806|NCT00546117|156319554|FG000|Overall Study|Withdrawal by Subject|3|||
48737970|NCT00400764|156890223|FG003|Phase Ib|Death|0|||
48737971|NCT00400764|156890224|FG004|Phase Ib|Death|0|||
48320942|NCT01998958|155375275|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580807|NCT00546117|156319555|FG001|Overall Study|Withdrawal by Subject|0|||
48580808|NCT00546117|156319554|FG000|Overall Study|Inability to schedule follow-up visit|1|||
48580809|NCT00546117|156319555|FG001|Overall Study|Inability to schedule follow-up visit|0|||
48580810|NCT01286168|156319556|FG000|Overall Study|Withdrawal by Subject|1|||
48580811|NCT01286168|156319556|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
48580812|NCT01424514|156319557|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
48580813|NCT01424514|156319558|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
48580814|NCT01424514|156319557|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
48580815|NCT01424514|156319558|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
48580816|NCT00654875|156319559|FG000|Overall Study|Adverse Event|5|||
48580817|NCT00654875|156319560|FG001|Overall Study|Adverse Event|5|||
48580818|NCT00654875|156319559|FG000|Overall Study|Withdrawal by Subject|4|||
48580819|NCT00654875|156319560|FG001|Overall Study|Withdrawal by Subject|4|||
48580820|NCT00654875|156319559|FG000|Overall Study|Protocol Violation|3|||
48580821|NCT00654875|156319560|FG001|Overall Study|Protocol Violation|3|||
48580822|NCT00654875|156319559|FG000|Overall Study|Lack of Efficacy|2|||
48580823|NCT00654875|156319560|FG001|Overall Study|Lack of Efficacy|2|||
48580824|NCT00654875|156319559|FG000|Overall Study|Lost to Follow-up|1|||
48580825|NCT00654875|156319560|FG001|Overall Study|Lost to Follow-up|3|||
48580826|NCT00654875|156319559|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
48580827|NCT00654875|156319560|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
48580828|NCT00654875|156319559|FG000|Overall Study|Administrative Problems|1|||
48580829|NCT00654875|156319560|FG001|Overall Study|Administrative Problems|0|||
48580830|NCT02091375|156319561|FG000|Overall Study|Adverse Event|8|||
48580831|NCT02091375|156319562|FG001|Overall Study|Adverse Event|1|||
48580832|NCT02091375|156319561|FG000|Overall Study|Lost to Follow-up|0|||
48580833|NCT02091375|156319562|FG001|Overall Study|Lost to Follow-up|1|||
48580834|NCT02091375|156319561|FG000|Overall Study|Withdrawal by Subject|0|||
48580835|NCT02091375|156319562|FG001|Overall Study|Withdrawal by Subject|1|||
48580836|NCT02091375|156319561|FG000|Overall Study|Withdrawn by the investigator|1|||
48580837|NCT02091375|156319562|FG001|Overall Study|Withdrawn by the investigator|0|||
48580838|NCT04599933|156319565|FG000|Overall Study|Adverse Event|4|||
48580839|NCT04599933|156319566|FG001|Overall Study|Adverse Event|1|||
48580840|NCT04599933|156319565|FG000|Overall Study|Withdrawal by Subject|4|||
48580841|NCT04599933|156319566|FG001|Overall Study|Withdrawal by Subject|2|||
48580842|NCT04599933|156319565|FG000|Overall Study|Lost to Follow-up|0|||
48580843|NCT04599933|156319566|FG001|Overall Study|Lost to Follow-up|1|||
48580844|NCT04599933|156319565|FG000|Overall Study|Physician Decision|0|||
48580845|NCT04599933|156319566|FG001|Overall Study|Physician Decision|1|||
48580846|NCT04599933|156319565|FG000|Overall Study|Screen Failure|1|||
48580847|NCT04599933|156319566|FG001|Overall Study|Screen Failure|2|||
48580848|NCT02487771|156319567|FG000|Overall Study|Lost to Follow-up|2|||
48580849|NCT02487771|156319568|FG001|Overall Study|Lost to Follow-up|3|||
48580850|NCT02487771|156319567|FG000|Overall Study|Moved out of area|5|||
48580851|NCT02487771|156319568|FG001|Overall Study|Moved out of area|6|||
48580852|NCT02487771|156319567|FG000|Overall Study|Withdrawal by Subject|3|||
48580853|NCT02487771|156319568|FG001|Overall Study|Withdrawal by Subject|5|||
48737972|NCT00400764|156890220|FG000|Phase Ib|Disease Progression|4|||
48737973|NCT00400764|156890221|FG001|Phase Ib|Disease Progression|4|||
48737974|NCT00400764|156890222|FG002|Phase Ib|Disease Progression|0|||
48737975|NCT00400764|156890223|FG003|Phase Ib|Disease Progression|0|||
48737976|NCT00400764|156890224|FG004|Phase Ib|Disease Progression|0|||
48737977|NCT00400764|156890220|FG000|Phase II|Death|0|||
48737978|NCT00400764|156890221|FG001|Phase II|Death|0|||
48737979|NCT00400764|156890222|FG002|Phase II|Death|1|||
48737980|NCT00400764|156890223|FG003|Phase II|Death|2|||
48737981|NCT00400764|156890224|FG004|Phase II|Death|0|||
48737982|NCT00400764|156890220|FG000|Phase II|Lost to Follow-up|0|||
48737983|NCT00400764|156890221|FG001|Phase II|Lost to Follow-up|0|||
48737984|NCT00400764|156890222|FG002|Phase II|Lost to Follow-up|1|||
48737985|NCT00400764|156890223|FG003|Phase II|Lost to Follow-up|0|||
48737986|NCT00400764|156890224|FG004|Phase II|Lost to Follow-up|0|||
48737987|NCT00400764|156890220|FG000|Phase II|Physician Decision|0|||
48737988|NCT00400764|156890221|FG001|Phase II|Physician Decision|0|||
48737989|NCT00400764|156890222|FG002|Phase II|Physician Decision|1|||
48737990|NCT00400764|156890223|FG003|Phase II|Physician Decision|1|||
48320943|NCT01998958|155375276|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580854|NCT02653170|156319571|FG000|Overall Study|Withdrawal by Subject|3|||
48580855|NCT02653170|156319572|FG001|Overall Study|Withdrawal by Subject|8|||
48580856|NCT02653170|156319573|FG002|Overall Study|Withdrawal by Subject|3|||
48580857|NCT02653170|156319571|FG000|Overall Study|withdrawn by study team|2|||
48587371|NCT05268016|156343198|FG001|Overall Study|Other|0|||
48737991|NCT00400764|156890224|FG004|Phase II|Physician Decision|0|||
48737992|NCT00400764|156890220|FG000|Phase II|Sponsor's decision to terminate|0|||
48737993|NCT00400764|156890221|FG001|Phase II|Sponsor's decision to terminate|0|||
48737994|NCT00400764|156890222|FG002|Phase II|Sponsor's decision to terminate|18|||
48737995|NCT00400764|156890223|FG003|Phase II|Sponsor's decision to terminate|22|||
48580858|NCT02653170|156319572|FG001|Overall Study|withdrawn by study team|4|||
48580859|NCT02653170|156319573|FG002|Overall Study|withdrawn by study team|5|||
48580860|NCT02653170|156319571|FG000|Overall Study|Lost to Follow-up|12|||
48580861|NCT02653170|156319572|FG001|Overall Study|Lost to Follow-up|4|||
48580862|NCT02653170|156319573|FG002|Overall Study|Lost to Follow-up|10|||
48580863|NCT02002533|156319574|FG000|Overall Study|Withdrawal by Subject|6|||
48580864|NCT02002533|156319575|FG001|Overall Study|Withdrawal by Subject|13|||
48580865|NCT02002533|156319574|FG000|Overall Study|Protocol Violation|0|||
48580866|NCT02002533|156319575|FG001|Overall Study|Protocol Violation|1|||
48580867|NCT02002533|156319574|FG000|Overall Study|Adverse Event|0|||
48580868|NCT02002533|156319575|FG001|Overall Study|Adverse Event|3|||
48580869|NCT02002533|156319574|FG000|Overall Study|Lost to Follow-up|0|||
48737996|NCT00400764|156890224|FG004|Phase II|Sponsor's decision to terminate|11|||
48737997|NCT00400764|156890220|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
48580870|NCT02002533|156319575|FG001|Overall Study|Lost to Follow-up|1|||
48580871|NCT04598451|156319578|FG000|Overall Study|Adverse Event|3|||
48580872|NCT04598451|156319579|FG001|Overall Study|Adverse Event|2|||
48580873|NCT04598451|156319578|FG000|Overall Study|Withdrawal by Subject|3|||
48580874|NCT04598451|156319579|FG001|Overall Study|Withdrawal by Subject|7|||
48737998|NCT00400764|156890221|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
48737999|NCT00400764|156890222|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
48738000|NCT00400764|156890223|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
48738001|NCT00400764|156890224|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
48738002|NCT00400764|156890220|FG000|Phase II|Withdrawal by Subject|0|||
48738003|NCT00400764|156890221|FG001|Phase II|Withdrawal by Subject|0|||
48738004|NCT00400764|156890222|FG002|Phase II|Withdrawal by Subject|1|||
48738005|NCT00400764|156890223|FG003|Phase II|Withdrawal by Subject|1|||
48738006|NCT00400764|156890224|FG004|Phase II|Withdrawal by Subject|0|||
48580875|NCT04598451|156319578|FG000|Overall Study|Lost to Follow-up|2|||
48580876|NCT04598451|156319579|FG001|Overall Study|Lost to Follow-up|0|||
48580877|NCT04598451|156319578|FG000|Overall Study|Physician Decision|4|||
48580878|NCT04598451|156319579|FG001|Overall Study|Physician Decision|1|||
48580879|NCT04598451|156319578|FG000|Overall Study|Requires Prohibited Medication|1|||
48580880|NCT04598451|156319579|FG001|Overall Study|Requires Prohibited Medication|0|||
48580881|NCT04598451|156319578|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
48580882|NCT04598451|156319579|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
48580883|NCT02083185|156319588|FG000|Overall Study|Lost to Follow-up|0|||
48580884|NCT02083185|156319589|FG001|Overall Study|Lost to Follow-up|3|||
48580885|NCT02083185|156319590|FG002|Overall Study|Lost to Follow-up|0|||
48580886|NCT02083185|156319588|FG000|Overall Study|Withdrawal by Subject|9|||
48580887|NCT02083185|156319589|FG001|Overall Study|Withdrawal by Subject|15|||
48580888|NCT02083185|156319590|FG002|Overall Study|Withdrawal by Subject|1|||
48580889|NCT02083185|156319588|FG000|Overall Study|Death|2|||
48580890|NCT02083185|156319589|FG001|Overall Study|Death|2|||
48580891|NCT02083185|156319590|FG002|Overall Study|Death|1|||
48580892|NCT02083185|156319588|FG000|Overall Study|Reason not Specified|9|||
48580893|NCT02083185|156319589|FG001|Overall Study|Reason not Specified|6|||
48580894|NCT02083185|156319590|FG002|Overall Study|Reason not Specified|5|||
48580895|NCT02083185|156319588|FG000|Overall Study|Study Terminated by Sponsor|0|||
48580896|NCT02083185|156319589|FG001|Overall Study|Study Terminated by Sponsor|1|||
48580897|NCT02083185|156319590|FG002|Overall Study|Study Terminated by Sponsor|0|||
48580898|NCT02083185|156319588|FG000|Overall Study|Did not Receive Study Drug|0|||
48580899|NCT02083185|156319589|FG001|Overall Study|Did not Receive Study Drug|2|||
48580900|NCT02083185|156319590|FG002|Overall Study|Did not Receive Study Drug|0|||
48580901|NCT00189306|156319591|FG000|Treatment Period|Withdrawal by Subject|2|||
48580902|NCT00189306|156319591|FG000|Treatment Period|Adverse Event|2|||
48580903|NCT00189306|156319591|FG000|Treatment Period|Protocol Violation|1|||
48580904|NCT00189306|156319591|FG000|Posttreatment Period|Death|1|||
48580905|NCT00189306|156319591|FG000|Posttreatment Period|Withdrawal by Subject|2|||
48580906|NCT00189306|156319591|FG000|Posttreatment Period|Noncompliance|1|||
48580907|NCT00189306|156319591|FG000|Posttreatment Period|Target lesion excised|1|||
48580908|NCT00189306|156319591|FG000|Posttreatment Period|Protocol Violation|1|||
48738007|NCT02058693|156890225|FG000|Phase 1|Withdrawal by Subject|3|||
48738008|NCT02058693|156890226|FG001|Phase 1|Withdrawal by Subject|2|||
48738009|NCT02058693|156890225|FG000|Phase 1|Adverse Event|0|||
48738010|NCT02058693|156890226|FG001|Phase 1|Adverse Event|1|||
48738011|NCT02058693|156890225|FG000|Phase 1|Lack of Efficacy|1|||
48320944|NCT01998958|155375277|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
48320945|NCT01998958|155375278|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
48580909|NCT00189306|156319591|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
48580910|NCT00189306|156319591|FG000|Posttreatment Period|Local skin reaction/sign|1|||
48580911|NCT00189306|156319591|FG000|Long-Term Follow-up|Adverse Event|2|||
48580912|NCT00189306|156319591|FG000|Long-Term Follow-up|Death|4|||
48580913|NCT00189306|156319591|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
48580914|NCT00189306|156319591|FG000|Long-Term Follow-up|Intercurrent disease|2|||
48738012|NCT02058693|156890226|FG001|Phase 1|Lack of Efficacy|0|||
48738013|NCT02058693|156890225|FG000|Phase 1|Physician Decision|1|||
48738014|NCT02058693|156890226|FG001|Phase 1|Physician Decision|1|||
48738015|NCT02058693|156890225|FG000|Phase 2|Withdrawal by Subject|0|||
48738016|NCT02058693|156890226|FG001|Phase 2|Withdrawal by Subject|2|||
48738017|NCT00450255|156890230|FG000|Overall Study|Prior RFA ablation of liver|1|||
48738018|NCT02465515|156890232|FG000|Overall Study|Investigator site closed|4|||
48738019|NCT02465515|156890233|FG001|Overall Study|Investigator site closed|5|||
48580915|NCT00189306|156319591|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
48580916|NCT00189306|156319591|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
48580917|NCT00459706|156319592|FG000|Overall Study|Adverse Event|19|||
48580918|NCT00459706|156319593|FG001|Overall Study|Adverse Event|13|||
48580919|NCT00459706|156319592|FG000|Overall Study|Withdrawal by Subject|1|||
48738020|NCT02465515|156890232|FG000|Overall Study|Withdrawal by Subject|74|||
48738021|NCT02465515|156890233|FG001|Overall Study|Withdrawal by Subject|43|||
48738022|NCT02465515|156890232|FG000|Overall Study|Physician Decision|8|||
48738023|NCT02465515|156890233|FG001|Overall Study|Physician Decision|12|||
48738024|NCT02465515|156890232|FG000|Overall Study|Lost to Follow-up|68|||
48738025|NCT02465515|156890233|FG001|Overall Study|Lost to Follow-up|51|||
48738026|NCT01897714|156892448|FG000|Phase I (Dose Escalation)|Disease progression|3|||
48738027|NCT01897714|156892449|FG001|Phase I (Dose Escalation)|Disease progression|5|||
48738028|NCT01897714|156892450|FG002|Phase I (Dose Escalation)|Disease progression|1|||
48738029|NCT01897714|156892451|FG003|Phase I (Dose Escalation)|Disease progression|3|||
48738030|NCT01897714|156892452|FG004|Phase I (Dose Escalation)|Disease progression|0|||
48738031|NCT01897714|156892453|FG005|Phase I (Dose Escalation)|Disease progression|0|||
48738032|NCT01897714|156892448|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
48738033|NCT01897714|156892449|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
48738034|NCT01897714|156892450|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
48738035|NCT01897714|156892451|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
48738036|NCT01897714|156892452|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
48738037|NCT01897714|156892453|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
48738038|NCT01897714|156892448|FG000|Phase I (Dose Escalation)|Other|0|||
48738039|NCT01897714|156892449|FG001|Phase I (Dose Escalation)|Other|1|||
48738040|NCT01897714|156892450|FG002|Phase I (Dose Escalation)|Other|0|||
48738041|NCT01897714|156892451|FG003|Phase I (Dose Escalation)|Other|0|||
48738042|NCT01897714|156892452|FG004|Phase I (Dose Escalation)|Other|0|||
48738043|NCT01897714|156892453|FG005|Phase I (Dose Escalation)|Other|0|||
48738044|NCT01897714|156892448|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
48738045|NCT01897714|156892449|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
48738046|NCT01897714|156892450|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
48738047|NCT01897714|156892451|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
48738048|NCT01897714|156892452|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
48738049|NCT01897714|156892453|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
48738050|NCT01897714|156892448|FG000|Phase II (MTD)|Lost to Follow-up|0|||
48738051|NCT01897714|156892449|FG001|Phase II (MTD)|Lost to Follow-up|0|||
48738052|NCT01897714|156892450|FG002|Phase II (MTD)|Lost to Follow-up|0|||
48738053|NCT01897714|156892451|FG003|Phase II (MTD)|Lost to Follow-up|0|||
48738054|NCT01897714|156892452|FG004|Phase II (MTD)|Lost to Follow-up|1|||
48738055|NCT01897714|156892453|FG005|Phase II (MTD)|Lost to Follow-up|0|||
48738056|NCT01897714|156892448|FG000|Phase II (MTD)|Death|0|||
48738057|NCT01897714|156892449|FG001|Phase II (MTD)|Death|0|||
48738058|NCT01897714|156892450|FG002|Phase II (MTD)|Death|0|||
48738059|NCT01897714|156892451|FG003|Phase II (MTD)|Death|0|||
48738060|NCT01897714|156892452|FG004|Phase II (MTD)|Death|25|||
48738061|NCT01897714|156892453|FG005|Phase II (MTD)|Death|10|||
48738062|NCT01897714|156892448|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
48738063|NCT01897714|156892449|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
48738064|NCT01897714|156892450|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
48738065|NCT01897714|156892451|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
48738066|NCT01897714|156892452|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
48738067|NCT01897714|156892453|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
48738068|NCT01897714|156892448|FG000|Phase II (MTD)|Other|0|||
48738069|NCT01897714|156892449|FG001|Phase II (MTD)|Other|0|||
48738070|NCT01897714|156892450|FG002|Phase II (MTD)|Other|0|||
48738071|NCT01897714|156892451|FG003|Phase II (MTD)|Other|0|||
48738072|NCT01897714|156892452|FG004|Phase II (MTD)|Other|3|||
48738073|NCT01897714|156892453|FG005|Phase II (MTD)|Other|0|||
48738074|NCT00423722|156892454|FG000|Overall Study|Death|4|||
48738075|NCT00423722|156892455|FG001|Overall Study|Death|4|||
48738076|NCT00423722|156892454|FG000|Overall Study|Declined to participate|2|||
48580920|NCT00459706|156319593|FG001|Overall Study|Withdrawal by Subject|6|||
48580921|NCT00459706|156319592|FG000|Overall Study|Physician Decision|2|||
48580922|NCT00459706|156319593|FG001|Overall Study|Physician Decision|0|||
48580923|NCT00459706|156319592|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
48580924|NCT00459706|156319593|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48580925|NCT00459706|156319592|FG000|Overall Study|Protocol Violation|2|||
48580926|NCT00459706|156319593|FG001|Overall Study|Protocol Violation|1|||
48580927|NCT00459706|156319592|FG000|Overall Study|Failed to Return|1|||
48580928|NCT00459706|156319593|FG001|Overall Study|Failed to Return|0|||
48580929|NCT00459706|156319592|FG000|Overall Study|Other|0|||
48580930|NCT00459706|156319593|FG001|Overall Study|Other|1|||
48738077|NCT00423722|156892455|FG001|Overall Study|Declined to participate|3|||
48738078|NCT00423722|156892454|FG000|Overall Study|Unable to complete questionnaires|4|||
48738079|NCT00423722|156892455|FG001|Overall Study|Unable to complete questionnaires|4|||
48738080|NCT00423722|156892454|FG000|Overall Study|Withdrawal by Subject|4|||
48738081|NCT00423722|156892455|FG001|Overall Study|Withdrawal by Subject|2|||
48738082|NCT02171065|156892458|FG000|Overall Study|Withdrawal by Subject|1|||
48738083|NCT02171065|156892459|FG001|Overall Study|Withdrawal by Subject|0|||
48738084|NCT02171065|156892460|FG002|Overall Study|Withdrawal by Subject|0|||
48738085|NCT02171065|156892458|FG000|Overall Study|Lost to Follow-up|0|||
48738086|NCT02171065|156892459|FG001|Overall Study|Lost to Follow-up|0|||
48738087|NCT02171065|156892460|FG002|Overall Study|Lost to Follow-up|1|||
48738088|NCT01896050|156892462|FG000|Overall Study|Adverse Event|37|||
48738089|NCT01896050|156892463|FG001|Overall Study|Adverse Event|2|||
48738090|NCT01896050|156892462|FG000|Overall Study|Death|1|||
48738091|NCT01896050|156892463|FG001|Overall Study|Death|0|||
48738092|NCT02598960|156892464|FG000|Treatment Period|Disease Progression|4|||
48738093|NCT02598960|156892465|FG001|Treatment Period|Disease Progression|4|||
48738094|NCT02598960|156892466|FG002|Treatment Period|Disease Progression|4|||
48738095|NCT02598960|156892467|FG003|Treatment Period|Disease Progression|6|||
48738096|NCT02598960|156892468|FG004|Treatment Period|Disease Progression|8|||
48738097|NCT02598960|156892469|FG005|Treatment Period|Disease Progression|2|||
48738098|NCT02598960|156892470|FG006|Treatment Period|Disease Progression|2|||
48738099|NCT02598960|156892471|FG007|Treatment Period|Disease Progression|3|||
48738100|NCT02598960|156892472|FG008|Treatment Period|Disease Progression|7|||
48738101|NCT02598960|156892473|FG009|Treatment Period|Disease Progression|9|||
48738102|NCT02598960|156892474|FG010|Treatment Period|Disease Progression|7|||
48738103|NCT02598960|156892475|FG011|Treatment Period|Disease Progression|143|||
48738104|NCT02598960|156892476|FG012|Treatment Period|Disease Progression|23|||
48738105|NCT02598960|156892464|FG000|Treatment Period|Study drug toxicity|0|||
48738106|NCT02598960|156892465|FG001|Treatment Period|Study drug toxicity|0|||
48580931|NCT02447497|156319594|FG000|Overall Study|Did not meet treatment day baseline.|6|||
48738107|NCT02598960|156892466|FG002|Treatment Period|Study drug toxicity|0|||
48738108|NCT02598960|156892467|FG003|Treatment Period|Study drug toxicity|0|||
48738109|NCT02598960|156892468|FG004|Treatment Period|Study drug toxicity|0|||
48738110|NCT02598960|156892469|FG005|Treatment Period|Study drug toxicity|0|||
48738111|NCT02598960|156892470|FG006|Treatment Period|Study drug toxicity|0|||
48738112|NCT02598960|156892471|FG007|Treatment Period|Study drug toxicity|0|||
48450307|NCT03365947|155835686|FG016|Overall Study|Lost to Follow-up|0|||
48580932|NCT02447497|156319595|FG001|Overall Study|Did not meet treatment day baseline.|5|||
48587372|NCT05268016|156343199|FG002|Overall Study|Other|1|||
48738113|NCT02598960|156892472|FG008|Treatment Period|Study drug toxicity|0|||
48738114|NCT02598960|156892473|FG009|Treatment Period|Study drug toxicity|1|||
48738115|NCT02598960|156892474|FG010|Treatment Period|Study drug toxicity|0|||
48738116|NCT02598960|156892475|FG011|Treatment Period|Study drug toxicity|3|||
48738117|NCT02598960|156892476|FG012|Treatment Period|Study drug toxicity|0|||
48320946|NCT01998958|155375279|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
48320947|NCT01998958|155375280|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320948|NCT01998958|155375281|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48580933|NCT02447497|156319596|FG002|Overall Study|Did not meet treatment day baseline.|2|||
48580934|NCT02447497|156319597|FG003|Overall Study|Did not meet treatment day baseline.|2|||
48580935|NCT02447497|156319594|FG000|Overall Study|Dressing was compromised|0|||
48580936|NCT02447497|156319595|FG001|Overall Study|Dressing was compromised|1|||
48580937|NCT02447497|156319596|FG002|Overall Study|Dressing was compromised|0|||
48580938|NCT02447497|156319597|FG003|Overall Study|Dressing was compromised|0|||
48580939|NCT01801280|156319598|FG000|Period 1|Withdrawal by Subject|0|||
48580940|NCT01801280|156319599|FG001|Period 1|Withdrawal by Subject|1|||
48580941|NCT01801280|156319600|FG002|Period 1|Withdrawal by Subject|0|||
48580942|NCT01801280|156319601|FG003|Period 1|Withdrawal by Subject|0|||
48580943|NCT01801280|156319598|FG000|Period 2|Withdrawal by Subject|1|||
48738118|NCT02598960|156892464|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
48738119|NCT02598960|156892465|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
48738120|NCT02598960|156892466|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
48738121|NCT02598960|156892467|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
48738122|NCT02598960|156892468|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
48738123|NCT02598960|156892469|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
48738124|NCT02598960|156892470|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
48738125|NCT02598960|156892471|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
48738126|NCT02598960|156892472|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
48738127|NCT02598960|156892473|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
48580944|NCT01801280|156319599|FG001|Period 2|Withdrawal by Subject|0|||
48580945|NCT01801280|156319600|FG002|Period 2|Withdrawal by Subject|0|||
48580946|NCT01801280|156319601|FG003|Period 2|Withdrawal by Subject|0|||
48580947|NCT01801280|156319598|FG000|Period 4|Protocol Violation|0|||
48580948|NCT01801280|156319599|FG001|Period 4|Protocol Violation|0|||
48580949|NCT01801280|156319600|FG002|Period 4|Protocol Violation|1|||
48580950|NCT01801280|156319601|FG003|Period 4|Protocol Violation|0|||
48580951|NCT01322035|156319602|FG000|Overall Study|Lost to Follow-up|8|||
48580952|NCT01322035|156319603|FG001|Overall Study|Lost to Follow-up|3|||
48580953|NCT00535847|156319606|FG000|Overall Study|Adverse Event|5|||
48580954|NCT00535847|156319607|FG001|Overall Study|Adverse Event|3|||
48580955|NCT00535847|156319608|FG002|Overall Study|Adverse Event|2|||
48580956|NCT00535847|156319606|FG000|Overall Study|Non compliance|1|||
48580957|NCT00535847|156319607|FG001|Overall Study|Non compliance|1|||
48580958|NCT00535847|156319608|FG002|Overall Study|Non compliance|0|||
48580959|NCT00535847|156319606|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
48580960|NCT00535847|156319607|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
48580961|NCT00535847|156319608|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
48580962|NCT04743804|156319609|FG000|Overall Study|Other|1|||
48580963|NCT04743804|156319610|FG001|Overall Study|Other|0|||
48580964|NCT04743804|156319609|FG000|Overall Study|Withdrawal by Subject|0|||
48580965|NCT04743804|156319610|FG001|Overall Study|Withdrawal by Subject|1|||
48580966|NCT04743804|156319609|FG000|Overall Study|Study Terminated by Sponsor|1|||
48580967|NCT04743804|156319610|FG001|Overall Study|Study Terminated by Sponsor|4|||
48580968|NCT04743804|156319609|FG000|Overall Study|Physician Decision|0|||
48580969|NCT04743804|156319610|FG001|Overall Study|Physician Decision|1|||
48580970|NCT04743804|156319609|FG000|Overall Study|Death|3|||
48580971|NCT04743804|156319610|FG001|Overall Study|Death|0|||
48580972|NCT01632904|156319611|FG000|Overall Study|Adverse Event|4|||
48580973|NCT01632904|156319612|FG001|Overall Study|Adverse Event|1|||
48580974|NCT01632904|156319611|FG000|Overall Study|Physician Decision|0|||
48580975|NCT01632904|156319612|FG001|Overall Study|Physician Decision|1|||
48580976|NCT01632904|156319611|FG000|Overall Study|Subject decision|3|||
48580977|NCT01632904|156319612|FG001|Overall Study|Subject decision|2|||
48580978|NCT01632904|156319611|FG000|Overall Study|Disease Progression|0|||
48580979|NCT01632904|156319612|FG001|Overall Study|Disease Progression|1|||
48580980|NCT01632904|156319611|FG000|Overall Study|Reason for discontinuation not available|0|||
48580981|NCT01632904|156319612|FG001|Overall Study|Reason for discontinuation not available|1|||
48580982|NCT04569968|156319613|FG000|Overall Study|Lost to Follow-up|2|||
48580983|NCT04569968|156319614|FG001|Overall Study|Lost to Follow-up|5|||
48580984|NCT04569968|156319613|FG000|Overall Study|Story of head and/or neck surgery|2|||
48580985|NCT04569968|156319614|FG001|Overall Study|Story of head and/or neck surgery|2|||
48580986|NCT04569968|156319613|FG000|Overall Study|Time of stroke onset|8|||
48580987|NCT04569968|156319614|FG001|Overall Study|Time of stroke onset|7|||
48580988|NCT04569968|156319613|FG000|Overall Study|Type of strokr|12|||
48580989|NCT04569968|156319614|FG001|Overall Study|Type of strokr|8|||
48580990|NCT04569968|156319613|FG000|Overall Study|Cooperation|8|||
48580991|NCT04569968|156319614|FG001|Overall Study|Cooperation|8|||
48580992|NCT04569968|156319613|FG000|Overall Study|Age interval|17|||
48580993|NCT04569968|156319614|FG001|Overall Study|Age interval|6|||
48580994|NCT04569968|156319613|FG000|Overall Study|Denial of participation to the study|0|||
48580995|NCT04569968|156319614|FG001|Overall Study|Denial of participation to the study|3|||
48580996|NCT04569968|156319613|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
48580997|NCT04569968|156319614|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
48580998|NCT04569968|156319613|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
48580999|NCT04569968|156319614|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
48581000|NCT04569968|156319613|FG000|Overall Study|Quarantine|1|||
48581001|NCT04569968|156319614|FG001|Overall Study|Quarantine|0|||
48581002|NCT04569968|156319613|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
48581003|NCT04569968|156319614|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
48581004|NCT04569968|156319613|FG000|Overall Study|Repetitive stroke|8|||
48581005|NCT04569968|156319614|FG001|Overall Study|Repetitive stroke|0|||
48581006|NCT04569968|156319613|FG000|Overall Study|Insufficient mastication|1|||
48738128|NCT02598960|156892474|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
48738129|NCT02598960|156892475|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
48738130|NCT02598960|156892476|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
48738131|NCT02598960|156892464|FG000|Treatment Period|participant request to discontinue|0|||
48738132|NCT02598960|156892465|FG001|Treatment Period|participant request to discontinue|1|||
48581007|NCT04569968|156319614|FG001|Overall Study|Insufficient mastication|0|||
48581008|NCT04569968|156319613|FG000|Overall Study|Infection|1|||
48581009|NCT04569968|156319614|FG001|Overall Study|Infection|0|||
48581010|NCT00727844|156319615|FG000|Initial Randomization|Physician Decision|2|||
48581011|NCT00727844|156319616|FG001|Initial Randomization|Physician Decision|0|||
48581012|NCT00727844|156319617|FG002|Initial Randomization|Physician Decision|0|||
48581013|NCT00727844|156319618|FG003|Initial Randomization|Physician Decision|0|||
48581014|NCT00732758|156319619|FG000|Overall Study|Lost to Follow-up|8|||
48581015|NCT00732758|156319620|FG001|Overall Study|Lost to Follow-up|16|||
48581016|NCT00373958|156319621|FG000|Infant Series|Withdrawal by Subject|13|||
48581017|NCT00373958|156319622|FG001|Infant Series|Withdrawal by Subject|15|||
48320949|NCT01998958|155375282|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48581018|NCT00373958|156319621|FG000|Infant Series|Failed to return|8|||
48581019|NCT00373958|156319622|FG001|Infant Series|Failed to return|13|||
48581020|NCT00373958|156319621|FG000|Infant Series|Lost to Follow-up|6|||
48581021|NCT00373958|156319622|FG001|Infant Series|Lost to Follow-up|5|||
48450308|NCT03365947|155835687|FG017|Overall Study|Lost to Follow-up|0|||
48581022|NCT00373958|156319621|FG000|Infant Series|Protocol Violation|3|||
48581023|NCT00373958|156319622|FG001|Infant Series|Protocol Violation|7|||
48581024|NCT00373958|156319621|FG000|Infant Series|Lost Kaiser coverage|4|||
48581025|NCT00373958|156319622|FG001|Infant Series|Lost Kaiser coverage|0|||
48581026|NCT00373958|156319621|FG000|Infant Series|Child relocated|1|||
48581027|NCT00373958|156319622|FG001|Infant Series|Child relocated|0|||
48581028|NCT00373958|156319621|FG000|Infant Series|Consent was not received|1|||
48581029|NCT00373958|156319622|FG001|Infant Series|Consent was not received|0|||
48581030|NCT00373958|156319621|FG000|Infant Series|Adverse Event|3|||
48581031|NCT00373958|156319622|FG001|Infant Series|Adverse Event|1|||
48581032|NCT00373958|156319621|FG000|Infant Series|Physician Decision|1|||
48581033|NCT00373958|156319622|FG001|Infant Series|Physician Decision|1|||
48581034|NCT00373958|156319621|FG000|Toddler Dose|Lost to Follow-up|5|||
48581035|NCT00373958|156319622|FG001|Toddler Dose|Lost to Follow-up|8|||
48581036|NCT00373958|156319621|FG000|Toddler Dose|Withdrawal by Subject|2|||
48581037|NCT00373958|156319622|FG001|Toddler Dose|Withdrawal by Subject|2|||
48581038|NCT00373958|156319621|FG000|Toddler Dose|Failed to return|1|||
48581039|NCT00373958|156319622|FG001|Toddler Dose|Failed to return|2|||
48581040|NCT00373958|156319621|FG000|Toddler Dose|Protocol Violation|0|||
48581041|NCT00373958|156319622|FG001|Toddler Dose|Protocol Violation|1|||
48581042|NCT00373958|156319621|FG000|Toddler Dose|Withdrawn after infant series|22|||
48581043|NCT00373958|156319622|FG001|Toddler Dose|Withdrawn after infant series|25|||
48581044|NCT05007041|156319629|FG000|Overall Study|Missing Diary Entries|0|||
48581045|NCT05007041|156319630|FG001|Overall Study|Missing Diary Entries|1|||
48581046|NCT05177354|156319631|FG000|Implant to 30-day Visit|Physician Decision|1|||
48581047|NCT05177354|156319631|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
48581048|NCT05177354|156319631|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
48581049|NCT05177354|156319631|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
48581050|NCT04495816|156319632|FG000|Overall Study|Lost to Follow-up|10|||
48581051|NCT04495816|156319633|FG001|Overall Study|Lost to Follow-up|4|||
48581052|NCT04495816|156319632|FG000|Overall Study|Withdrawal by Subject|3|||
48581053|NCT04495816|156319633|FG001|Overall Study|Withdrawal by Subject|5|||
48581054|NCT01552915|156319634|FG000|Overall Study|Adverse Event|3|||
48581055|NCT01552915|156319635|FG001|Overall Study|Adverse Event|14|||
48581056|NCT01552915|156319636|FG002|Overall Study|Adverse Event|3|||
48581057|NCT01552915|156319634|FG000|Overall Study|Lost to Follow-up|4|||
48581058|NCT01552915|156319635|FG001|Overall Study|Lost to Follow-up|6|||
48581059|NCT01552915|156319636|FG002|Overall Study|Lost to Follow-up|5|||
48581060|NCT01552915|156319634|FG000|Overall Study|Withdrawal by Subject|6|||
48581061|NCT01552915|156319635|FG001|Overall Study|Withdrawal by Subject|4|||
48581062|NCT01552915|156319636|FG002|Overall Study|Withdrawal by Subject|5|||
48581063|NCT01552915|156319634|FG000|Overall Study|Protocol Violation|0|||
48581064|NCT01552915|156319635|FG001|Overall Study|Protocol Violation|4|||
48581065|NCT01552915|156319636|FG002|Overall Study|Protocol Violation|4|||
48581066|NCT01552915|156319634|FG000|Overall Study|Lack of Efficacy|8|||
48581067|NCT01552915|156319635|FG001|Overall Study|Lack of Efficacy|1|||
48581068|NCT01552915|156319636|FG002|Overall Study|Lack of Efficacy|4|||
48581069|NCT01552915|156319634|FG000|Overall Study|Other|2|||
48581070|NCT01552915|156319635|FG001|Overall Study|Other|0|||
48581071|NCT01552915|156319636|FG002|Overall Study|Other|6|||
48581072|NCT01546168|156319637|FG000|Overall Study|Lost to Follow-up|1|||
48581073|NCT01546168|156319638|FG001|Overall Study|Lost to Follow-up|0|||
48581074|NCT01546168|156319637|FG000|Overall Study|Withdrawal by Subject|1|||
48581075|NCT01546168|156319638|FG001|Overall Study|Withdrawal by Subject|0|||
48581076|NCT01546168|156319637|FG000|Overall Study|ineligible after signing consent|2|||
48581077|NCT01546168|156319638|FG001|Overall Study|ineligible after signing consent|0|||
48581078|NCT00232596|156319641|FG000|6-Week Titration Phase|Adverse Event|6|||
48581079|NCT00232596|156319642|FG001|6-Week Titration Phase|Adverse Event|19|||
48581080|NCT00232596|156319641|FG000|6-Week Titration Phase|Failed to Return|2|||
48581081|NCT00232596|156319642|FG001|6-Week Titration Phase|Failed to Return|1|||
48581082|NCT00232596|156319641|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
48581083|NCT00232596|156319642|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
48450309|NCT03365947|155835688|FG018|Overall Study|Lost to Follow-up|0|||
48738133|NCT02598960|156892466|FG002|Treatment Period|participant request to discontinue|0|||
48738134|NCT02598960|156892467|FG003|Treatment Period|participant request to discontinue|0|||
48738135|NCT02598960|156892468|FG004|Treatment Period|participant request to discontinue|1|||
48738136|NCT02598960|156892469|FG005|Treatment Period|participant request to discontinue|0|||
48738137|NCT02598960|156892470|FG006|Treatment Period|participant request to discontinue|0|||
48738138|NCT02598960|156892471|FG007|Treatment Period|participant request to discontinue|0|||
48738139|NCT02598960|156892472|FG008|Treatment Period|participant request to discontinue|0|||
48738140|NCT02598960|156892473|FG009|Treatment Period|participant request to discontinue|0|||
48738141|NCT02598960|156892474|FG010|Treatment Period|participant request to discontinue|1|||
48738142|NCT02598960|156892475|FG011|Treatment Period|participant request to discontinue|4|||
48738143|NCT02598960|156892476|FG012|Treatment Period|participant request to discontinue|0|||
48738144|NCT02598960|156892464|FG000|Treatment Period|participant withdrew consent|0|||
48738145|NCT02598960|156892465|FG001|Treatment Period|participant withdrew consent|0|||
48738146|NCT02598960|156892466|FG002|Treatment Period|participant withdrew consent|0|||
48738147|NCT02598960|156892467|FG003|Treatment Period|participant withdrew consent|0|||
48738148|NCT02598960|156892468|FG004|Treatment Period|participant withdrew consent|0|||
48738149|NCT02598960|156892469|FG005|Treatment Period|participant withdrew consent|0|||
48738150|NCT02598960|156892470|FG006|Treatment Period|participant withdrew consent|0|||
48738151|NCT02598960|156892471|FG007|Treatment Period|participant withdrew consent|0|||
48738152|NCT02598960|156892472|FG008|Treatment Period|participant withdrew consent|0|||
48738153|NCT02598960|156892473|FG009|Treatment Period|participant withdrew consent|0|||
48738154|NCT02598960|156892474|FG010|Treatment Period|participant withdrew consent|0|||
48738155|NCT02598960|156892475|FG011|Treatment Period|participant withdrew consent|3|||
48738156|NCT02598960|156892476|FG012|Treatment Period|participant withdrew consent|0|||
48738157|NCT02598960|156892464|FG000|Treatment Period|No longer meets study criteria|0|||
48738158|NCT02598960|156892465|FG001|Treatment Period|No longer meets study criteria|0|||
48738159|NCT02598960|156892466|FG002|Treatment Period|No longer meets study criteria|0|||
48738160|NCT02598960|156892467|FG003|Treatment Period|No longer meets study criteria|0|||
48738161|NCT02598960|156892468|FG004|Treatment Period|No longer meets study criteria|0|||
48738162|NCT02598960|156892469|FG005|Treatment Period|No longer meets study criteria|0|||
48738163|NCT02598960|156892470|FG006|Treatment Period|No longer meets study criteria|0|||
48738164|NCT02598960|156892471|FG007|Treatment Period|No longer meets study criteria|0|||
48738165|NCT02598960|156892472|FG008|Treatment Period|No longer meets study criteria|0|||
48738166|NCT02598960|156892473|FG009|Treatment Period|No longer meets study criteria|0|||
48738167|NCT02598960|156892474|FG010|Treatment Period|No longer meets study criteria|0|||
48738168|NCT02598960|156892475|FG011|Treatment Period|No longer meets study criteria|1|||
48738169|NCT02598960|156892476|FG012|Treatment Period|No longer meets study criteria|0|||
48738170|NCT02598960|156892464|FG000|Treatment Period|Other Reasons|0|||
48738171|NCT02598960|156892465|FG001|Treatment Period|Other Reasons|0|||
48738172|NCT02598960|156892466|FG002|Treatment Period|Other Reasons|0|||
48738173|NCT02598960|156892467|FG003|Treatment Period|Other Reasons|0|||
48738174|NCT02598960|156892468|FG004|Treatment Period|Other Reasons|0|||
48738175|NCT02598960|156892469|FG005|Treatment Period|Other Reasons|0|||
48738176|NCT02598960|156892470|FG006|Treatment Period|Other Reasons|0|||
48738177|NCT02598960|156892471|FG007|Treatment Period|Other Reasons|0|||
48738178|NCT02598960|156892472|FG008|Treatment Period|Other Reasons|0|||
48738179|NCT02598960|156892473|FG009|Treatment Period|Other Reasons|0|||
48738180|NCT02598960|156892474|FG010|Treatment Period|Other Reasons|0|||
48738181|NCT02598960|156892475|FG011|Treatment Period|Other Reasons|0|||
48738182|NCT02598960|156892476|FG012|Treatment Period|Other Reasons|1|||
48738183|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|Death|1|||
48738184|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|Death|0|||
48738185|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|Death|0|||
48738186|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|Death|0|||
48738187|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|Death|0|||
48320950|NCT01998958|155375283|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320951|NCT01998958|155375284|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320952|NCT01998958|155375285|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320953|NCT01998958|155375286|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320954|NCT01998958|155375287|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
48320955|NCT00002540|155375290|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
48320956|NCT00002540|155375291|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
48320957|NCT00002540|155375290|FG000|Overall Study|Died Before Randomization|2|||
48320958|NCT00002540|155375291|FG001|Overall Study|Died Before Randomization|6|||
48320959|NCT00002540|155375290|FG000|Overall Study|Died Before ASU (Control)|202|||
48320960|NCT00002540|155375291|FG001|Overall Study|Died Before ASU (Control)|0|||
48738188|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|Death|0|||
48738189|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|Death|0|||
48738190|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|Death|0|||
48320961|NCT00002540|155375290|FG000|Overall Study|Refused ASU (Control)|597|||
48320962|NCT00002540|155375291|FG001|Overall Study|Refused ASU (Control)|0|||
48581084|NCT00232596|156319641|FG000|6-Week Titration Phase|Protocol Violation|1|||
48581085|NCT00232596|156319642|FG001|6-Week Titration Phase|Protocol Violation|3|||
48581086|NCT00232596|156319641|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
48320963|NCT00002540|155375290|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
48320964|NCT00002540|155375291|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
48320965|NCT01989455|155375294|FG000|Overall Study|Adverse Event|0|||
48320966|NCT01989455|155375295|FG001|Overall Study|Adverse Event|1|||
48320967|NCT01989455|155375296|FG002|Overall Study|Adverse Event|0|||
48320968|NCT01989455|155375297|FG003|Overall Study|Adverse Event|0|||
48320969|NCT01989455|155375298|FG004|Overall Study|Adverse Event|0|||
48581087|NCT00232596|156319642|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
48581088|NCT00232596|156319641|FG000|6-Week Titration Phase|Other|3|||
48581089|NCT00232596|156319642|FG001|6-Week Titration Phase|Other|3|||
48581090|NCT00232596|156319641|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
48581091|NCT00232596|156319642|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
48581092|NCT00232596|156319641|FG000|12-Week Maintenance Phase|Adverse Event|7|||
48581093|NCT00232596|156319642|FG001|12-Week Maintenance Phase|Adverse Event|22|||
48581094|NCT00232596|156319641|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
48581095|NCT00232596|156319642|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
48320970|NCT01989455|155375294|FG000|Overall Study|Withdrawal by Subject|0|||
48320971|NCT01989455|155375295|FG001|Overall Study|Withdrawal by Subject|1|||
48320972|NCT01989455|155375296|FG002|Overall Study|Withdrawal by Subject|0|||
48320973|NCT01989455|155375297|FG003|Overall Study|Withdrawal by Subject|0|||
48320974|NCT01989455|155375298|FG004|Overall Study|Withdrawal by Subject|0|||
48581096|NCT00232596|156319641|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
48581097|NCT00232596|156319642|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
48581098|NCT00232596|156319641|FG000|12-Week Maintenance Phase|Other|1|||
48581099|NCT00232596|156319642|FG001|12-Week Maintenance Phase|Other|3|||
48581100|NCT00705718|156319643|FG000|Overall Study|Death|6|||
48581101|NCT00705718|156319644|FG001|Overall Study|Death|6|||
48581102|NCT00705718|156319643|FG000|Overall Study|Not due for Visit|0|||
48581103|NCT00705718|156319644|FG001|Overall Study|Not due for Visit|12|||
48581104|NCT00705718|156319643|FG000|Overall Study|Follow up not done|1|||
48581105|NCT00705718|156319644|FG001|Overall Study|Follow up not done|4|||
48581106|NCT01793688|156319648|FG000|Overall Study|Protocol Violation|2|||
48581107|NCT04331067|156319657|FG000|Overall Study|Adverse Event|1|||
48581108|NCT04331067|156319658|FG001|Overall Study|Adverse Event|3|||
48581109|NCT04331067|156319659|FG002|Overall Study|Adverse Event|1|||
48581110|NCT04331067|156319657|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
48581111|NCT04331067|156319658|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
48581112|NCT04331067|156319659|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
48581113|NCT01382225|156319663|FG000|Overall Study|Adverse Event|3|||
48581114|NCT01382225|156319664|FG001|Overall Study|Adverse Event|2|||
48581115|NCT01382225|156319663|FG000|Overall Study|Protocol Violation|2|||
48581116|NCT01382225|156319664|FG001|Overall Study|Protocol Violation|1|||
48581117|NCT01382225|156319663|FG000|Overall Study|Subject Withdrew Consent|5|||
48581118|NCT01382225|156319664|FG001|Overall Study|Subject Withdrew Consent|2|||
48581119|NCT01382225|156319663|FG000|Overall Study|Other|4|||
48581120|NCT01382225|156319664|FG001|Overall Study|Other|2|||
48581121|NCT00157248|156319667|FG000|Overall Study|Adverse Event|36|||
48581122|NCT00157248|156319668|FG001|Overall Study|Adverse Event|25|||
48581123|NCT00157248|156319669|FG002|Overall Study|Adverse Event|13|||
48581124|NCT00157248|156319670|FG003|Overall Study|Adverse Event|33|||
48581125|NCT00157248|156319667|FG000|Overall Study|Protocol Violation|4|||
48581126|NCT00157248|156319668|FG001|Overall Study|Protocol Violation|0|||
48581127|NCT00157248|156319669|FG002|Overall Study|Protocol Violation|2|||
48581128|NCT00157248|156319670|FG003|Overall Study|Protocol Violation|2|||
48581129|NCT00157248|156319667|FG000|Overall Study|Lost to Follow-up|0|||
48581130|NCT00157248|156319668|FG001|Overall Study|Lost to Follow-up|1|||
48581131|NCT00157248|156319669|FG002|Overall Study|Lost to Follow-up|0|||
48581132|NCT00157248|156319670|FG003|Overall Study|Lost to Follow-up|0|||
48581133|NCT00157248|156319667|FG000|Overall Study|Withdrawal by Subject|1|||
48581134|NCT00157248|156319668|FG001|Overall Study|Withdrawal by Subject|4|||
48320975|NCT01989455|155375294|FG000|Overall Study|Technical problems with infusion|0|||
48581135|NCT00157248|156319669|FG002|Overall Study|Withdrawal by Subject|3|||
48581136|NCT00157248|156319670|FG003|Overall Study|Withdrawal by Subject|3|||
48320976|NCT01989455|155375295|FG001|Overall Study|Technical problems with infusion|0|||
48320977|NCT01989455|155375296|FG002|Overall Study|Technical problems with infusion|1|||
48320978|NCT01989455|155375297|FG003|Overall Study|Technical problems with infusion|0|||
48450387|NCT00437203|155835720|FG009|Overall Study|Other|0|||
48581137|NCT00157248|156319667|FG000|Overall Study|site closures, subject moving|7|||
48581138|NCT00157248|156319668|FG001|Overall Study|site closures, subject moving|7|||
48581139|NCT00157248|156319669|FG002|Overall Study|site closures, subject moving|3|||
48581140|NCT00157248|156319670|FG003|Overall Study|site closures, subject moving|9|||
48581141|NCT00474786|156319671|FG000|Overall Study|Not Meeting Study Criteria|0|||
48581142|NCT00474786|156319672|FG001|Overall Study|Not Meeting Study Criteria|1|||
48738191|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|Death|0|||
48738192|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|Death|1|||
48581143|NCT00474786|156319671|FG000|Overall Study|Investigator Request|2|||
48738193|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|Death|0|||
48738194|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|Death|11|||
48738195|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|Death|2|||
48738196|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738197|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738198|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738199|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738200|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738201|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738202|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738203|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
48320979|NCT01989455|155375298|FG004|Overall Study|Technical problems with infusion|1|||
48581144|NCT00474786|156319672|FG001|Overall Study|Investigator Request|1|||
48581145|NCT00474786|156319671|FG000|Overall Study|Death|189|||
48581146|NCT00474786|156319672|FG001|Overall Study|Death|170|||
48581147|NCT00474786|156319671|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
48581148|NCT00474786|156319672|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
48581149|NCT00474786|156319671|FG000|Overall Study|Lost to Follow-up|4|||
48581150|NCT00474786|156319672|FG001|Overall Study|Lost to Follow-up|7|||
48581151|NCT00474786|156319671|FG000|Overall Study|Protocol Violation|2|||
48581152|NCT00474786|156319672|FG001|Overall Study|Protocol Violation|0|||
48581153|NCT00474786|156319671|FG000|Overall Study|Withdrawal by Subject|15|||
48581154|NCT00474786|156319672|FG001|Overall Study|Withdrawal by Subject|15|||
48581155|NCT00474786|156319671|FG000|Overall Study|Other|5|||
48581156|NCT00474786|156319672|FG001|Overall Study|Other|0|||
48581157|NCT01173055|156319674|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
48581158|NCT01173055|156319675|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
48581159|NCT01173055|156319674|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
48581160|NCT01173055|156319675|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
48581161|NCT03426436|156319676|FG000|Overall Study|Incorrect lead placement|12|||
48581162|NCT03426436|156319676|FG000|Overall Study|Withdrawal by Subject|2|||
48581163|NCT03426436|156319676|FG000|Overall Study|Consent issue|1|||
48581164|NCT03426436|156319676|FG000|Overall Study|ECGs not saved|4|||
48581165|NCT02267135|156319677|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
48581166|NCT02267135|156319678|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
48581167|NCT02267135|156319677|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
48581168|NCT02267135|156319678|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
48581169|NCT02267135|156319677|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
48581170|NCT02267135|156319678|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
48581171|NCT02267135|156319677|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
48581172|NCT02267135|156319678|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
48581173|NCT02267135|156319677|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
48581174|NCT02267135|156319678|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
48581175|NCT02892513|156319679|FG000|Overall Study|Withdrawal by Subject|0|||
48581176|NCT02892513|156319680|FG001|Overall Study|Withdrawal by Subject|1|||
48581177|NCT04325698|156319681|FG000|Overall Study|Study Terminated By Sponsor|1|||
48581178|NCT04325698|156319682|FG001|Overall Study|Study Terminated By Sponsor|1|||
48581179|NCT04325698|156319681|FG000|Overall Study|Withdrawal by Subject|0|||
48581180|NCT04325698|156319682|FG001|Overall Study|Withdrawal by Subject|2|||
48581181|NCT00962091|156319683|FG000|Overall Study|Withdrawal by Subject|1|||
48581182|NCT00962091|156319684|FG001|Overall Study|Withdrawal by Subject|2|||
48581183|NCT00962091|156319685|FG002|Overall Study|Withdrawal by Subject|1|||
48581184|NCT00962091|156319686|FG003|Overall Study|Withdrawal by Subject|1|||
48581185|NCT00962091|156319687|FG004|Overall Study|Withdrawal by Subject|0|||
48581186|NCT00962091|156319688|FG005|Overall Study|Withdrawal by Subject|1|||
48581187|NCT00962091|156319689|FG006|Overall Study|Withdrawal by Subject|0|||
48581188|NCT00962091|156319683|FG000|Overall Study|Adverse Event|0|||
48581189|NCT00962091|156319684|FG001|Overall Study|Adverse Event|0|||
48738204|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
48320980|NCT04452318|155375301|FG000|Overall Study|Physician Decision|1|||
48581190|NCT00962091|156319685|FG002|Overall Study|Adverse Event|0|||
48581191|NCT00962091|156319686|FG003|Overall Study|Adverse Event|0|||
48581192|NCT00962091|156319687|FG004|Overall Study|Adverse Event|0|||
48581193|NCT00962091|156319688|FG005|Overall Study|Adverse Event|0|||
48581194|NCT00962091|156319689|FG006|Overall Study|Adverse Event|1|||
48581195|NCT04216589|156319690|FG000|Overall Study|Withdrawal by Subject|2|||
48581196|NCT04216589|156319690|FG000|Overall Study|Protocol Violation|1|||
48581197|NCT04216589|156319690|FG000|Overall Study|Incarceration|1|||
48320981|NCT04452318|155375302|FG001|Overall Study|Physician Decision|2|||
48320982|NCT04452318|155375303|FG002|Overall Study|Physician Decision|0|||
48581198|NCT01877382|156319692|FG000|Dose Escalation|Progressive disease|2|||
48581199|NCT01877382|156319693|FG001|Dose Escalation|Progressive disease|0|||
48581200|NCT01877382|156319694|FG002|Dose Escalation|Progressive disease|1|||
48581201|NCT01877382|156319695|FG003|Dose Escalation|Progressive disease|6|||
48581202|NCT01877382|156319696|FG004|Dose Escalation|Progressive disease|1|||
48581203|NCT01877382|156319697|FG005|Dose Escalation|Progressive disease|0|||
48581204|NCT01877382|156319698|FG006|Dose Escalation|Progressive disease|3|||
48581205|NCT01877382|156319699|FG007|Dose Escalation|Progressive disease|10|||
48581206|NCT01877382|156319700|FG008|Dose Escalation|Progressive disease|4|||
48581207|NCT01877382|156319701|FG009|Dose Escalation|Progressive disease|2|||
48581208|NCT01877382|156319702|FG010|Dose Escalation|Progressive disease|3|||
48581209|NCT01877382|156319703|FG011|Dose Escalation|Progressive disease|3|||
48581210|NCT01877382|156319704|FG012|Dose Escalation|Progressive disease|13|||
48581211|NCT01877382|156319705|FG013|Dose Escalation|Progressive disease|1|||
48581212|NCT01877382|156319706|FG014|Dose Escalation|Progressive disease|0|||
48581213|NCT01877382|156319692|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
48581214|NCT01877382|156319693|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581215|NCT01877382|156319694|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581216|NCT01877382|156319695|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
48581217|NCT01877382|156319696|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581218|NCT01877382|156319697|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581219|NCT01877382|156319698|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
48581220|NCT01877382|156319699|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581221|NCT01877382|156319700|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581222|NCT01877382|156319701|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581223|NCT01877382|156319702|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581224|NCT01877382|156319703|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581225|NCT01877382|156319704|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581226|NCT01877382|156319705|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581227|NCT01877382|156319706|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581228|NCT01877382|156319692|FG000|Dose Escalation|Clinical progression|0|||
48581229|NCT01877382|156319693|FG001|Dose Escalation|Clinical progression|1|||
48581230|NCT01877382|156319694|FG002|Dose Escalation|Clinical progression|0|||
48581231|NCT01877382|156319695|FG003|Dose Escalation|Clinical progression|2|||
48581232|NCT01877382|156319696|FG004|Dose Escalation|Clinical progression|0|||
48581233|NCT01877382|156319697|FG005|Dose Escalation|Clinical progression|0|||
48581234|NCT01877382|156319698|FG006|Dose Escalation|Clinical progression|1|||
48581235|NCT01877382|156319699|FG007|Dose Escalation|Clinical progression|0|||
48581236|NCT01877382|156319700|FG008|Dose Escalation|Clinical progression|0|||
48581237|NCT01877382|156319701|FG009|Dose Escalation|Clinical progression|1|||
48581238|NCT01877382|156319702|FG010|Dose Escalation|Clinical progression|0|||
48581239|NCT01877382|156319703|FG011|Dose Escalation|Clinical progression|0|||
48581240|NCT01877382|156319704|FG012|Dose Escalation|Clinical progression|2|||
48581241|NCT01877382|156319705|FG013|Dose Escalation|Clinical progression|1|||
48581242|NCT01877382|156319706|FG014|Dose Escalation|Clinical progression|0|||
48581243|NCT01877382|156319692|FG000|Dose Escalation|Adverse Event|0|||
48581244|NCT01877382|156319693|FG001|Dose Escalation|Adverse Event|0|||
48738205|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
48581245|NCT01877382|156319694|FG002|Dose Escalation|Adverse Event|0|||
48581246|NCT01877382|156319695|FG003|Dose Escalation|Adverse Event|4|||
48581247|NCT01877382|156319696|FG004|Dose Escalation|Adverse Event|1|||
48581248|NCT01877382|156319697|FG005|Dose Escalation|Adverse Event|2|||
48581249|NCT01877382|156319698|FG006|Dose Escalation|Adverse Event|1|||
48581250|NCT01877382|156319699|FG007|Dose Escalation|Adverse Event|2|||
48581251|NCT01877382|156319700|FG008|Dose Escalation|Adverse Event|0|||
48581252|NCT01877382|156319701|FG009|Dose Escalation|Adverse Event|0|||
48581253|NCT01877382|156319702|FG010|Dose Escalation|Adverse Event|0|||
48581254|NCT01877382|156319703|FG011|Dose Escalation|Adverse Event|0|||
48581255|NCT01877382|156319704|FG012|Dose Escalation|Adverse Event|1|||
48581256|NCT01877382|156319705|FG013|Dose Escalation|Adverse Event|0|||
48581257|NCT01877382|156319706|FG014|Dose Escalation|Adverse Event|0|||
48581258|NCT01877382|156319692|FG000|Dose Escalation|Withdrawal by Subject|0|||
48581259|NCT01877382|156319693|FG001|Dose Escalation|Withdrawal by Subject|0|||
48581260|NCT01877382|156319694|FG002|Dose Escalation|Withdrawal by Subject|0|||
48581261|NCT01877382|156319695|FG003|Dose Escalation|Withdrawal by Subject|0|||
48581262|NCT01877382|156319696|FG004|Dose Escalation|Withdrawal by Subject|0|||
48581263|NCT01877382|156319697|FG005|Dose Escalation|Withdrawal by Subject|3|||
48581264|NCT01877382|156319698|FG006|Dose Escalation|Withdrawal by Subject|2|||
48581265|NCT01877382|156319699|FG007|Dose Escalation|Withdrawal by Subject|1|||
48581266|NCT01877382|156319700|FG008|Dose Escalation|Withdrawal by Subject|1|||
48581267|NCT01877382|156319701|FG009|Dose Escalation|Withdrawal by Subject|0|||
48581268|NCT01877382|156319702|FG010|Dose Escalation|Withdrawal by Subject|0|||
48581269|NCT01877382|156319703|FG011|Dose Escalation|Withdrawal by Subject|0|||
48581270|NCT01877382|156319704|FG012|Dose Escalation|Withdrawal by Subject|0|||
48581271|NCT01877382|156319705|FG013|Dose Escalation|Withdrawal by Subject|0|||
48581272|NCT01877382|156319706|FG014|Dose Escalation|Withdrawal by Subject|0|||
48581273|NCT01877382|156319692|FG000|Dose Escalation|Protocol Violation|0|||
48581274|NCT01877382|156319693|FG001|Dose Escalation|Protocol Violation|0|||
48581275|NCT01877382|156319694|FG002|Dose Escalation|Protocol Violation|0|||
48581276|NCT01877382|156319695|FG003|Dose Escalation|Protocol Violation|0|||
48581277|NCT01877382|156319696|FG004|Dose Escalation|Protocol Violation|0|||
48581278|NCT01877382|156319697|FG005|Dose Escalation|Protocol Violation|0|||
48581279|NCT01877382|156319698|FG006|Dose Escalation|Protocol Violation|1|||
48738206|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738207|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
48738208|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
48738209|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
48738210|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
48738211|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
48738212|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
48581280|NCT01877382|156319699|FG007|Dose Escalation|Protocol Violation|0|||
48581281|NCT01877382|156319700|FG008|Dose Escalation|Protocol Violation|0|||
48738213|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
48738214|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
48738215|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
48738216|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
48738217|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
48738218|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
48738219|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
48738220|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
48581282|NCT01877382|156319701|FG009|Dose Escalation|Protocol Violation|0|||
48581283|NCT01877382|156319702|FG010|Dose Escalation|Protocol Violation|0|||
48738221|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
48581284|NCT01877382|156319703|FG011|Dose Escalation|Protocol Violation|0|||
48581285|NCT01877382|156319704|FG012|Dose Escalation|Protocol Violation|0|||
48581286|NCT01877382|156319705|FG013|Dose Escalation|Protocol Violation|0|||
48581287|NCT01877382|156319706|FG014|Dose Escalation|Protocol Violation|0|||
48581288|NCT01877382|156319692|FG000|Dose Escalation|Study terminated by sponsor|0|||
48581289|NCT01877382|156319693|FG001|Dose Escalation|Study terminated by sponsor|0|||
48581290|NCT01877382|156319694|FG002|Dose Escalation|Study terminated by sponsor|0|||
48581291|NCT01877382|156319695|FG003|Dose Escalation|Study terminated by sponsor|0|||
48581292|NCT01877382|156319696|FG004|Dose Escalation|Study terminated by sponsor|0|||
48581293|NCT01877382|156319697|FG005|Dose Escalation|Study terminated by sponsor|0|||
48581294|NCT01877382|156319698|FG006|Dose Escalation|Study terminated by sponsor|0|||
48581295|NCT01877382|156319699|FG007|Dose Escalation|Study terminated by sponsor|1|||
48581296|NCT01877382|156319700|FG008|Dose Escalation|Study terminated by sponsor|1|||
48581297|NCT01877382|156319701|FG009|Dose Escalation|Study terminated by sponsor|0|||
48581298|NCT01877382|156319702|FG010|Dose Escalation|Study terminated by sponsor|0|||
48581299|NCT01877382|156319703|FG011|Dose Escalation|Study terminated by sponsor|0|||
48581300|NCT01877382|156319704|FG012|Dose Escalation|Study terminated by sponsor|3|||
48581301|NCT01877382|156319705|FG013|Dose Escalation|Study terminated by sponsor|0|||
48581302|NCT01877382|156319706|FG014|Dose Escalation|Study terminated by sponsor|0|||
48581303|NCT01877382|156319692|FG000|Dose Escalation|Death|0|||
48581304|NCT01877382|156319693|FG001|Dose Escalation|Death|0|||
48581305|NCT01877382|156319694|FG002|Dose Escalation|Death|0|||
48581306|NCT01877382|156319695|FG003|Dose Escalation|Death|0|||
48581307|NCT01877382|156319696|FG004|Dose Escalation|Death|0|||
48581308|NCT01877382|156319697|FG005|Dose Escalation|Death|0|||
48581309|NCT01877382|156319698|FG006|Dose Escalation|Death|0|||
48320983|NCT04452318|155375304|FG003|Overall Study|Physician Decision|2|||
48320984|NCT04452318|155375305|FG004|Overall Study|Physician Decision|0|||
48320985|NCT04452318|155375306|FG005|Overall Study|Physician Decision|2|||
48320986|NCT04452318|155375307|FG006|Overall Study|Physician Decision|5|||
48320987|NCT04452318|155375301|FG000|Overall Study|Death|2|||
48320988|NCT04452318|155375302|FG001|Overall Study|Death|3|||
48320989|NCT04452318|155375303|FG002|Overall Study|Death|0|||
48320990|NCT04452318|155375304|FG003|Overall Study|Death|0|||
48320991|NCT04452318|155375305|FG004|Overall Study|Death|0|||
48320992|NCT04452318|155375306|FG005|Overall Study|Death|0|||
48320993|NCT04452318|155375307|FG006|Overall Study|Death|0|||
48320994|NCT04452318|155375301|FG000|Overall Study|Lost to Follow-up|38|||
48320995|NCT04452318|155375302|FG001|Overall Study|Lost to Follow-up|28|||
48320996|NCT04452318|155375303|FG002|Overall Study|Lost to Follow-up|0|||
48320997|NCT04452318|155375304|FG003|Overall Study|Lost to Follow-up|3|||
48320998|NCT04452318|155375305|FG004|Overall Study|Lost to Follow-up|3|||
48320999|NCT04452318|155375306|FG005|Overall Study|Lost to Follow-up|2|||
48321000|NCT04452318|155375307|FG006|Overall Study|Lost to Follow-up|1|||
48321001|NCT04452318|155375301|FG000|Overall Study|Withdrawal by Subject|46|||
48321002|NCT04452318|155375302|FG001|Overall Study|Withdrawal by Subject|40|||
48321003|NCT04452318|155375303|FG002|Overall Study|Withdrawal by Subject|0|||
48321004|NCT04452318|155375304|FG003|Overall Study|Withdrawal by Subject|18|||
48321005|NCT04452318|155375305|FG004|Overall Study|Withdrawal by Subject|6|||
48321006|NCT04452318|155375306|FG005|Overall Study|Withdrawal by Subject|8|||
48321007|NCT04452318|155375307|FG006|Overall Study|Withdrawal by Subject|6|||
48321008|NCT02554786|155375308|FG000|Overall Study|Subject/guardian decision|29|||
48321009|NCT02554786|155375309|FG001|Overall Study|Subject/guardian decision|17|||
48321010|NCT02554786|155375310|FG002|Overall Study|Subject/guardian decision|18|||
48321011|NCT02554786|155375311|FG003|Overall Study|Subject/guardian decision|30|||
48321012|NCT02554786|155375312|FG004|Overall Study|Subject/guardian decision|20|||
48321013|NCT02554786|155375308|FG000|Overall Study|Lost to Follow-up|4|||
48321014|NCT02554786|155375309|FG001|Overall Study|Lost to Follow-up|3|||
48321015|NCT02554786|155375310|FG002|Overall Study|Lost to Follow-up|4|||
48321016|NCT02554786|155375311|FG003|Overall Study|Lost to Follow-up|2|||
48321017|NCT02554786|155375312|FG004|Overall Study|Lost to Follow-up|2|||
48321018|NCT02554786|155375308|FG000|Overall Study|Protocol deviation|1|||
48321019|NCT02554786|155375309|FG001|Overall Study|Protocol deviation|3|||
48321020|NCT02554786|155375310|FG002|Overall Study|Protocol deviation|3|||
48321021|NCT02554786|155375311|FG003|Overall Study|Protocol deviation|4|||
48321022|NCT02554786|155375312|FG004|Overall Study|Protocol deviation|2|||
48321023|NCT02554786|155375308|FG000|Overall Study|Technical problems|1|||
48321024|NCT02554786|155375309|FG001|Overall Study|Technical problems|1|||
48321025|NCT02554786|155375310|FG002|Overall Study|Technical problems|0|||
48321026|NCT02554786|155375311|FG003|Overall Study|Technical problems|2|||
48321027|NCT02554786|155375312|FG004|Overall Study|Technical problems|1|||
48321028|NCT02554786|155375308|FG000|Overall Study|Adverse Event|0|||
48321029|NCT02554786|155375309|FG001|Overall Study|Adverse Event|0|||
48321030|NCT02554786|155375310|FG002|Overall Study|Adverse Event|0|||
48321031|NCT02554786|155375311|FG003|Overall Study|Adverse Event|0|||
48321032|NCT02554786|155375312|FG004|Overall Study|Adverse Event|2|||
48321033|NCT02554786|155375308|FG000|Overall Study|Death|0|||
48321034|NCT02554786|155375309|FG001|Overall Study|Death|0|||
48581310|NCT01877382|156319699|FG007|Dose Escalation|Death|1|||
48581311|NCT01877382|156319700|FG008|Dose Escalation|Death|0|||
48581312|NCT01877382|156319701|FG009|Dose Escalation|Death|0|||
48581313|NCT01877382|156319702|FG010|Dose Escalation|Death|0|||
48581314|NCT01877382|156319703|FG011|Dose Escalation|Death|0|||
48581315|NCT01877382|156319704|FG012|Dose Escalation|Death|1|||
48581316|NCT01877382|156319705|FG013|Dose Escalation|Death|1|||
48581317|NCT01877382|156319706|FG014|Dose Escalation|Death|0|||
48581318|NCT01877382|156319692|FG000|Dose Expansion|Progressive disease|0|||
48581319|NCT01877382|156319693|FG001|Dose Expansion|Progressive disease|0|||
48581320|NCT01877382|156319694|FG002|Dose Expansion|Progressive disease|0|||
48738222|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48321035|NCT02554786|155375310|FG002|Overall Study|Death|0|||
48321036|NCT02554786|155375311|FG003|Overall Study|Death|1|||
48321037|NCT02554786|155375312|FG004|Overall Study|Death|0|||
48321038|NCT02554786|155375308|FG000|Overall Study|Non-compliance with study treatment|0|||
48321039|NCT02554786|155375309|FG001|Overall Study|Non-compliance with study treatment|1|||
48321040|NCT02554786|155375310|FG002|Overall Study|Non-compliance with study treatment|1|||
48321041|NCT02554786|155375311|FG003|Overall Study|Non-compliance with study treatment|0|||
48321042|NCT02554786|155375312|FG004|Overall Study|Non-compliance with study treatment|1|||
48321043|NCT02554786|155375308|FG000|Overall Study|Physician Decision|0|||
48321044|NCT02554786|155375309|FG001|Overall Study|Physician Decision|1|||
48321045|NCT02554786|155375310|FG002|Overall Study|Physician Decision|4|||
48321046|NCT02554786|155375311|FG003|Overall Study|Physician Decision|1|||
48581321|NCT01877382|156319695|FG003|Dose Expansion|Progressive disease|0|||
48581322|NCT01877382|156319696|FG004|Dose Expansion|Progressive disease|0|||
48581323|NCT01877382|156319697|FG005|Dose Expansion|Progressive disease|0|||
48321047|NCT02554786|155375312|FG004|Overall Study|Physician Decision|1|||
48321048|NCT02554786|155375308|FG000|Overall Study|Pregnancy|0|||
48321049|NCT02554786|155375309|FG001|Overall Study|Pregnancy|0|||
48321050|NCT02554786|155375310|FG002|Overall Study|Pregnancy|0|||
48321051|NCT02554786|155375311|FG003|Overall Study|Pregnancy|1|||
48321052|NCT02554786|155375312|FG004|Overall Study|Pregnancy|1|||
48321053|NCT00448669|155375315|FG000|Overall Study|Lost to Follow-up|52|||
48321054|NCT00448669|155375316|FG001|Overall Study|Lost to Follow-up|63|||
48321055|NCT00448669|155375315|FG000|Overall Study|Withdrawal by Subject|90|||
48321056|NCT00448669|155375316|FG001|Overall Study|Withdrawal by Subject|74|||
48321057|NCT00448669|155375315|FG000|Overall Study|Relocated|49|||
48321058|NCT00448669|155375316|FG001|Overall Study|Relocated|36|||
48321059|NCT00448669|155375315|FG000|Overall Study|Were withdrawn by investigator|10|||
48321060|NCT00448669|155375316|FG001|Overall Study|Were withdrawn by investigator|6|||
48321061|NCT00448669|155375315|FG000|Overall Study|Death|2|||
48321062|NCT00448669|155375316|FG001|Overall Study|Death|4|||
48321063|NCT00448669|155375315|FG000|Overall Study|Had other reasons|5|||
48321064|NCT00448669|155375316|FG001|Overall Study|Had other reasons|6|||
48321065|NCT00448669|155375315|FG000|Overall Study|HIV-infected at enrollment|1|||
48321066|NCT00448669|155375316|FG001|Overall Study|HIV-infected at enrollment|2|||
48581324|NCT01877382|156319698|FG006|Dose Expansion|Progressive disease|0|||
48581325|NCT01877382|156319699|FG007|Dose Expansion|Progressive disease|0|||
48581326|NCT01877382|156319700|FG008|Dose Expansion|Progressive disease|0|||
48738223|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738224|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738225|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738226|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738227|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738228|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48321067|NCT00448669|155375315|FG000|Overall Study|Never started drug|9|||
48321068|NCT00448669|155375316|FG001|Overall Study|Never started drug|7|||
48321069|NCT04287985|155375317|FG000|Overall Study|Adverse Event|1|||
48321070|NCT04287985|155375318|FG001|Overall Study|Adverse Event|0|||
48321071|NCT04287985|155375319|FG002|Overall Study|Adverse Event|0|||
48321072|NCT04287985|155375320|FG003|Overall Study|Adverse Event|0|||
48321073|NCT04287985|155375317|FG000|Overall Study|Protocol Violation|0|||
48321074|NCT04287985|155375318|FG001|Overall Study|Protocol Violation|1|||
48321075|NCT04287985|155375319|FG002|Overall Study|Protocol Violation|0|||
48321076|NCT04287985|155375320|FG003|Overall Study|Protocol Violation|0|||
48321077|NCT04287985|155375317|FG000|Overall Study|Physician Decision|0|||
48321078|NCT04287985|155375318|FG001|Overall Study|Physician Decision|0|||
48321079|NCT04287985|155375319|FG002|Overall Study|Physician Decision|0|||
48321080|NCT04287985|155375320|FG003|Overall Study|Physician Decision|1|||
48321081|NCT04287985|155375317|FG000|Overall Study|Withdrawal by Subject|2|||
48321082|NCT04287985|155375318|FG001|Overall Study|Withdrawal by Subject|1|||
48321083|NCT04287985|155375319|FG002|Overall Study|Withdrawal by Subject|1|||
48321084|NCT04287985|155375320|FG003|Overall Study|Withdrawal by Subject|2|||
48321085|NCT02638337|155375321|FG000|Overall Study|Adverse Event|6|||
48321086|NCT02638337|155375322|FG001|Overall Study|Adverse Event|10|||
48321087|NCT02638337|155375321|FG000|Overall Study|Protocol Violation|3|||
48321088|NCT02638337|155375322|FG001|Overall Study|Protocol Violation|0|||
48321089|NCT02638337|155375321|FG000|Overall Study|Withdrawal by Subject|13|||
48321090|NCT02638337|155375322|FG001|Overall Study|Withdrawal by Subject|16|||
48321091|NCT02638337|155375321|FG000|Overall Study|Lost to Follow-up|7|||
48321092|NCT02638337|155375322|FG001|Overall Study|Lost to Follow-up|7|||
48321093|NCT02638337|155375321|FG000|Overall Study|Other - Miscellaneous|4|||
48581327|NCT01877382|156319701|FG009|Dose Expansion|Progressive disease|0|||
48581328|NCT01877382|156319702|FG010|Dose Expansion|Progressive disease|0|||
48581329|NCT01877382|156319703|FG011|Dose Expansion|Progressive disease|0|||
48581330|NCT01877382|156319704|FG012|Dose Expansion|Progressive disease|0|||
48581331|NCT01877382|156319705|FG013|Dose Expansion|Progressive disease|0|||
48321094|NCT02638337|155375322|FG001|Overall Study|Other - Miscellaneous|3|||
48738229|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48321095|NCT03951805|155375323|FG000|Overall Study|Adverse Event|1|||
48321096|NCT03951805|155375324|FG001|Overall Study|Adverse Event|0|||
48321097|NCT03951805|155375325|FG002|Overall Study|Adverse Event|0|||
48321098|NCT03951805|155375326|FG003|Overall Study|Adverse Event|0|||
48321099|NCT01340066|155375328|FG000|Placebo Run in Period|Screen Failures|27|||
48321100|NCT01340066|155375329|FG001|Placebo Run in Period|Screen Failures|0|||
48321101|NCT01340066|155375330|FG002|Placebo Run in Period|Screen Failures|0|||
48321102|NCT01340066|155375328|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
48321103|NCT01340066|155375329|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
48321104|NCT01340066|155375330|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
48321105|NCT01340066|155375328|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
48321106|NCT01340066|155375329|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
48581332|NCT01877382|156319706|FG014|Dose Expansion|Progressive disease|11|||
48738230|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738231|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738232|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738233|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
48738234|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
48738235|NCT02598960|156892464|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
48738236|NCT02598960|156892465|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
48738237|NCT02598960|156892466|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
48738238|NCT02598960|156892467|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
48738239|NCT02598960|156892468|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
48738240|NCT02598960|156892469|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
48738241|NCT02598960|156892470|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
48738242|NCT02598960|156892471|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
48738243|NCT02598960|156892472|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
48738244|NCT02598960|156892473|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
48738245|NCT02598960|156892474|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
48738246|NCT02598960|156892475|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
48738247|NCT02598960|156892476|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
48738248|NCT00531934|156892477|FG000|Overall Study|Adverse Event|4|||
48738249|NCT00531934|156892478|FG001|Overall Study|Adverse Event|8|||
48738250|NCT00531934|156892477|FG000|Overall Study|Progression|52|||
48738251|NCT00531934|156892478|FG001|Overall Study|Progression|42|||
48738252|NCT00531934|156892477|FG000|Overall Study|Death|7|||
48321107|NCT01340066|155375330|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
48321108|NCT01340066|155375328|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
48321109|NCT01340066|155375329|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
48738253|NCT00531934|156892478|FG001|Overall Study|Death|10|||
48738254|NCT00531934|156892477|FG000|Overall Study|Withdrawal by Subject|1|||
48738255|NCT00531934|156892478|FG001|Overall Study|Withdrawal by Subject|1|||
48738256|NCT00531934|156892477|FG000|Overall Study|Other|2|||
48321110|NCT01340066|155375330|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
48321111|NCT03771352|155375335|FG000|Overall Study|Screen failure|2|||
48321112|NCT03771352|155375335|FG000|Overall Study|Withdrawal by Subject|2|||
48321113|NCT00274469|155375336|FG000|Overall Study|Death|63|||
48321114|NCT00274469|155375337|FG001|Overall Study|Death|74|||
48321115|NCT00274469|155375336|FG000|Overall Study|Did not consent to OS follow-up|16|||
48321116|NCT00274469|155375337|FG001|Overall Study|Did not consent to OS follow-up|19|||
48321117|NCT03092726|155375346|FG000|Overall Study|Adverse Event|3|||
48321118|NCT03092726|155375347|FG001|Overall Study|Adverse Event|10|||
48321119|NCT03092726|155375346|FG000|Overall Study|Lack of Efficacy|0|||
48321120|NCT03092726|155375347|FG001|Overall Study|Lack of Efficacy|1|||
48321121|NCT03092726|155375346|FG000|Overall Study|Lost to Follow-up|1|||
48321122|NCT03092726|155375347|FG001|Overall Study|Lost to Follow-up|0|||
48581333|NCT01877382|156319692|FG000|Dose Expansion|Clinical progression|0|||
48581334|NCT01877382|156319693|FG001|Dose Expansion|Clinical progression|0|||
48581335|NCT01877382|156319694|FG002|Dose Expansion|Clinical progression|0|||
48581336|NCT01877382|156319695|FG003|Dose Expansion|Clinical progression|0|||
48581337|NCT01877382|156319696|FG004|Dose Expansion|Clinical progression|0|||
48581338|NCT01877382|156319697|FG005|Dose Expansion|Clinical progression|0|||
48581339|NCT01877382|156319698|FG006|Dose Expansion|Clinical progression|0|||
48581340|NCT01877382|156319699|FG007|Dose Expansion|Clinical progression|0|||
48581341|NCT01877382|156319700|FG008|Dose Expansion|Clinical progression|0|||
48581342|NCT01877382|156319701|FG009|Dose Expansion|Clinical progression|0|||
48738257|NCT00531934|156892478|FG001|Overall Study|Other|2|||
48321123|NCT03092726|155375346|FG000|Overall Study|Withdrawal by Subject|5|||
48321124|NCT03092726|155375347|FG001|Overall Study|Withdrawal by Subject|3|||
48738258|NCT00851630|156892479|FG000|Overall Study|Death|2|||
48738259|NCT00851630|156892480|FG001|Overall Study|Death|1|||
48738260|NCT00851630|156892479|FG000|Overall Study|Clinical failure|0|||
48738261|NCT00851630|156892480|FG001|Overall Study|Clinical failure|1|||
48738262|NCT02339285|156892483|FG000|Overall Study|Withdrawal by Subject|0|||
48581343|NCT01877382|156319702|FG010|Dose Expansion|Clinical progression|0|||
48581344|NCT01877382|156319703|FG011|Dose Expansion|Clinical progression|0|||
48738263|NCT02339285|156892484|FG001|Overall Study|Withdrawal by Subject|1|||
48738264|NCT02339285|156892485|FG002|Overall Study|Withdrawal by Subject|1|||
48738265|NCT02339285|156892483|FG000|Overall Study|Lost to Follow-up|1|||
48738266|NCT02339285|156892484|FG001|Overall Study|Lost to Follow-up|1|||
48738267|NCT02339285|156892485|FG002|Overall Study|Lost to Follow-up|1|||
48738268|NCT02339285|156892483|FG000|Overall Study|Protocol Deviation|0|||
48738269|NCT02339285|156892484|FG001|Overall Study|Protocol Deviation|1|||
48738270|NCT02339285|156892485|FG002|Overall Study|Protocol Deviation|0|||
48738271|NCT01854658|156892488|FG000|Overall Study|Protocol Violation|6|||
48738272|NCT01854658|156892489|FG001|Overall Study|Protocol Violation|2|||
48738273|NCT01854658|156892490|FG002|Overall Study|Protocol Violation|2|||
48738274|NCT01854658|156892491|FG003|Overall Study|Protocol Violation|1|||
48738275|NCT01854658|156892488|FG000|Overall Study|Physician Decision|7|||
48738276|NCT01854658|156892489|FG001|Overall Study|Physician Decision|5|||
48738277|NCT01854658|156892490|FG002|Overall Study|Physician Decision|2|||
48738278|NCT01854658|156892491|FG003|Overall Study|Physician Decision|4|||
48738279|NCT01854658|156892488|FG000|Overall Study|Lost to Follow-up|8|||
48581345|NCT01877382|156319704|FG012|Dose Expansion|Clinical progression|0|||
48581346|NCT01877382|156319705|FG013|Dose Expansion|Clinical progression|0|||
48581347|NCT01877382|156319706|FG014|Dose Expansion|Clinical progression|6|||
48581348|NCT01877382|156319692|FG000|Dose Expansion|Adverse Event|0|||
48581349|NCT01877382|156319693|FG001|Dose Expansion|Adverse Event|0|||
48581350|NCT01877382|156319694|FG002|Dose Expansion|Adverse Event|0|||
48738280|NCT01854658|156892489|FG001|Overall Study|Lost to Follow-up|9|||
48738281|NCT01854658|156892490|FG002|Overall Study|Lost to Follow-up|8|||
48738282|NCT01854658|156892491|FG003|Overall Study|Lost to Follow-up|4|||
48738283|NCT01854658|156892488|FG000|Overall Study|Withdrawal by Subject|28|||
48738284|NCT01854658|156892489|FG001|Overall Study|Withdrawal by Subject|21|||
48738285|NCT01854658|156892490|FG002|Overall Study|Withdrawal by Subject|29|||
48581351|NCT01877382|156319695|FG003|Dose Expansion|Adverse Event|0|||
48581352|NCT01877382|156319696|FG004|Dose Expansion|Adverse Event|0|||
48738286|NCT01854658|156892491|FG003|Overall Study|Withdrawal by Subject|15|||
48738287|NCT01854658|156892488|FG000|Overall Study|Protocol-specified criteria|15|||
48738288|NCT01854658|156892489|FG001|Overall Study|Protocol-specified criteria|15|||
48738289|NCT01854658|156892490|FG002|Overall Study|Protocol-specified criteria|10|||
48738290|NCT01854658|156892491|FG003|Overall Study|Protocol-specified criteria|7|||
48738291|NCT01854658|156892488|FG000|Overall Study|Lack of Efficacy|3|||
48738292|NCT01854658|156892489|FG001|Overall Study|Lack of Efficacy|8|||
48321125|NCT04599062|155375348|FG000|Overall Study|Physician Decision|1|||
48321126|NCT04599062|155375349|FG001|Overall Study|Physician Decision|0|||
48581353|NCT01877382|156319697|FG005|Dose Expansion|Adverse Event|0|||
48581354|NCT01877382|156319698|FG006|Dose Expansion|Adverse Event|0|||
48581355|NCT01877382|156319699|FG007|Dose Expansion|Adverse Event|0|||
48581356|NCT01877382|156319700|FG008|Dose Expansion|Adverse Event|0|||
48581357|NCT01877382|156319701|FG009|Dose Expansion|Adverse Event|0|||
48321127|NCT02411448|155375350|FG000|Overall Study|Withdrawal by Subject|1|||
48321128|NCT02411448|155375351|FG001|Overall Study|Withdrawal by Subject|14|||
48321129|NCT02411448|155375352|FG002|Overall Study|Withdrawal by Subject|9|||
48321130|NCT02411448|155375350|FG000|Overall Study|Other|0|||
48321131|NCT02411448|155375351|FG001|Overall Study|Other|2|||
48321132|NCT02411448|155375352|FG002|Overall Study|Other|0|||
48321133|NCT02411448|155375350|FG000|Overall Study|Did not receive study treatment|0|||
48321134|NCT02411448|155375351|FG001|Overall Study|Did not receive study treatment|3|||
48321135|NCT02411448|155375352|FG002|Overall Study|Did not receive study treatment|0|||
48581358|NCT01877382|156319702|FG010|Dose Expansion|Adverse Event|0|||
48581359|NCT01877382|156319703|FG011|Dose Expansion|Adverse Event|0|||
48581360|NCT01877382|156319704|FG012|Dose Expansion|Adverse Event|0|||
48581361|NCT01877382|156319705|FG013|Dose Expansion|Adverse Event|0|||
48581362|NCT01877382|156319706|FG014|Dose Expansion|Adverse Event|1|||
48581363|NCT01877382|156319692|FG000|Dose Expansion|Death|0|||
48581364|NCT01877382|156319693|FG001|Dose Expansion|Death|0|||
48581365|NCT01877382|156319694|FG002|Dose Expansion|Death|0|||
48581366|NCT01877382|156319695|FG003|Dose Expansion|Death|0|||
48581367|NCT01877382|156319696|FG004|Dose Expansion|Death|0|||
48581368|NCT01877382|156319697|FG005|Dose Expansion|Death|0|||
48581369|NCT01877382|156319698|FG006|Dose Expansion|Death|0|||
48581370|NCT01877382|156319699|FG007|Dose Expansion|Death|0|||
48581371|NCT01877382|156319700|FG008|Dose Expansion|Death|0|||
48581372|NCT01877382|156319701|FG009|Dose Expansion|Death|0|||
48581373|NCT01877382|156319702|FG010|Dose Expansion|Death|0|||
48581374|NCT01877382|156319703|FG011|Dose Expansion|Death|0|||
48581375|NCT01877382|156319704|FG012|Dose Expansion|Death|0|||
48581376|NCT01877382|156319705|FG013|Dose Expansion|Death|0|||
48581377|NCT01877382|156319706|FG014|Dose Expansion|Death|1|||
48581378|NCT01877382|156319692|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581379|NCT01877382|156319693|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581380|NCT01877382|156319694|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48738293|NCT01854658|156892490|FG002|Overall Study|Lack of Efficacy|4|||
48738294|NCT01854658|156892491|FG003|Overall Study|Lack of Efficacy|7|||
48738295|NCT01854658|156892488|FG000|Overall Study|Adverse Event|21|||
48738296|NCT01854658|156892489|FG001|Overall Study|Adverse Event|14|||
48738297|NCT01854658|156892490|FG002|Overall Study|Adverse Event|23|||
48321136|NCT02411448|155375350|FG000|Overall Study|Alive on study treatment|3|||
48581381|NCT01877382|156319695|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581382|NCT01877382|156319696|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581383|NCT01877382|156319697|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581384|NCT01877382|156319698|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581385|NCT01877382|156319699|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581386|NCT01877382|156319700|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48738298|NCT01854658|156892491|FG003|Overall Study|Adverse Event|19|||
48738299|NCT01854658|156892488|FG000|Overall Study|Administrative reasons|5|||
48738300|NCT01854658|156892489|FG001|Overall Study|Administrative reasons|1|||
48738301|NCT01854658|156892490|FG002|Overall Study|Administrative reasons|2|||
48738302|NCT01854658|156892491|FG003|Overall Study|Administrative reasons|2|||
48738303|NCT04195906|156892494|FG000|Part 1|Adverse Event|3|||
48738304|NCT04195906|156892495|FG001|Part 1|Adverse Event|7|||
48738305|NCT04195906|156892494|FG000|Part 1|Withdrawal by Subject|0|||
48738306|NCT04195906|156892495|FG001|Part 1|Withdrawal by Subject|1|||
48738307|NCT04195906|156892494|FG000|Part 2|Adverse Event|1|||
48738308|NCT04195906|156892495|FG001|Part 2|Adverse Event|1|||
48738309|NCT04195906|156892494|FG000|Part 2|Withdrawal by Subject|0|||
48321137|NCT02411448|155375351|FG001|Overall Study|Alive on study treatment|64|||
48321138|NCT02411448|155375352|FG002|Overall Study|Alive on study treatment|43|||
48581387|NCT01877382|156319701|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581388|NCT01877382|156319702|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581389|NCT01877382|156319703|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48738310|NCT04195906|156892495|FG001|Part 2|Withdrawal by Subject|3|||
48738311|NCT04195906|156892494|FG000|Part 2|Other|1|||
48321139|NCT03155997|155375353|FG000|Overall Study|Withdrawal by Subject|119|||
48738312|NCT04195906|156892495|FG001|Part 2|Other|3|||
48321140|NCT03155997|155375354|FG001|Overall Study|Withdrawal by Subject|134|||
48738313|NCT02281773|156892499|FG000|Overall Study|Adverse Event|6|||
48738314|NCT02281773|156892500|FG001|Overall Study|Adverse Event|1|||
48738315|NCT02281773|156892501|FG002|Overall Study|Adverse Event|4|||
48321141|NCT03155997|155375353|FG000|Overall Study|Lost to Follow-up|12|||
48321142|NCT03155997|155375354|FG001|Overall Study|Lost to Follow-up|13|||
48321143|NCT03155997|155375353|FG000|Overall Study|Missing disposition data|0|||
48321144|NCT03155997|155375354|FG001|Overall Study|Missing disposition data|1|||
48321145|NCT03155997|155375353|FG000|Overall Study|On study treatment|2027|||
48321146|NCT03155997|155375354|FG001|Overall Study|On study treatment|2074|||
48321147|NCT04248725|155375355|FG000|Post-Treatment|Lost to Follow-up|6|||
48321148|NCT04248725|155375356|FG001|Post-Treatment|Lost to Follow-up|5|||
48321149|NCT04248725|155375355|FG000|6-Month Follow Up|Lost to Follow-up|9|||
48321150|NCT04248725|155375356|FG001|6-Month Follow Up|Lost to Follow-up|8|||
48321151|NCT01948661|155375357|FG000|Overall Study|Withdrawal by Subject|2|||
48321152|NCT01948661|155375358|FG001|Overall Study|Withdrawal by Subject|4|||
48321153|NCT04524442|155375361|FG000|Overall Study|Subject Decision|1|||
48321154|NCT04154384|155375364|FG000|Overall Study|Lost to Follow-up|24|||
48321155|NCT04154384|155375365|FG001|Overall Study|Lost to Follow-up|33|||
48321156|NCT04154384|155375366|FG002|Overall Study|Lost to Follow-up|0|||
48321157|NCT04154384|155375364|FG000|Overall Study|Withdrawal by Subject|7|||
48321158|NCT04154384|155375365|FG001|Overall Study|Withdrawal by Subject|18|||
48321159|NCT04154384|155375366|FG002|Overall Study|Withdrawal by Subject|0|||
48321160|NCT04154384|155375364|FG000|Overall Study|Missing outcome data|1|||
48321161|NCT04154384|155375365|FG001|Overall Study|Missing outcome data|0|||
48321162|NCT04154384|155375366|FG002|Overall Study|Missing outcome data|0|||
48321163|NCT01136876|155375367|FG000|Overall Study|Lost to Follow-up|0|||
48321164|NCT01136876|155375368|FG001|Overall Study|Lost to Follow-up|1|||
48321165|NCT01136876|155375367|FG000|Overall Study|Physician Decision|3|||
48321166|NCT01136876|155375368|FG001|Overall Study|Physician Decision|5|||
48321167|NCT01136876|155375367|FG000|Overall Study|Missing NGAL measurement|2|||
48321168|NCT01136876|155375368|FG001|Overall Study|Missing NGAL measurement|5|||
48321169|NCT04218266|155375369|FG000|Overall Study|Death|1|||
48321170|NCT04218266|155375370|FG001|Overall Study|Death|2|||
48581390|NCT01877382|156319704|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581391|NCT01877382|156319705|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
48581392|NCT01877382|156319706|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
48581393|NCT00900731|156319707|FG000|Overall Study|Adverse Event|31|||
48581394|NCT00900731|156319708|FG001|Overall Study|Adverse Event|27|||
48581395|NCT00900731|156319707|FG000|Overall Study|Withdrawal by Subject|8|||
48581396|NCT00900731|156319708|FG001|Overall Study|Withdrawal by Subject|7|||
48581397|NCT00900731|156319707|FG000|Overall Study|Protocol Deviation|8|||
48581398|NCT00900731|156319708|FG001|Overall Study|Protocol Deviation|11|||
48581399|NCT00900731|156319707|FG000|Overall Study|Administrative Problems|5|||
48581400|NCT00900731|156319708|FG001|Overall Study|Administrative Problems|4|||
48581401|NCT00900731|156319707|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
48581402|NCT00900731|156319708|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
48581403|NCT00900731|156319707|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
48581404|NCT00900731|156319708|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
48581405|NCT00900731|156319707|FG000|Overall Study|Lost to Follow-up|2|||
48581406|NCT00900731|156319708|FG001|Overall Study|Lost to Follow-up|3|||
48581407|NCT00900731|156319707|FG000|Overall Study|Lack of Efficacy|1|||
48581408|NCT00900731|156319708|FG001|Overall Study|Lack of Efficacy|3|||
48581409|NCT00900731|156319707|FG000|Overall Study|Death|0|||
48581410|NCT00900731|156319708|FG001|Overall Study|Death|2|||
48581411|NCT03800836|156319709|FG000|Overall Study|Other|2|||
48581412|NCT03800836|156319710|FG001|Overall Study|Other|1|||
48581413|NCT03800836|156319711|FG002|Overall Study|Other|0|||
48581414|NCT03800836|156319712|FG003|Overall Study|Other|2|||
48581415|NCT03800836|156319713|FG004|Overall Study|Other|0|||
48581416|NCT03800836|156319714|FG005|Overall Study|Other|1|||
48581417|NCT03800836|156319709|FG000|Overall Study|Lost to Follow-up|2|||
48581418|NCT03800836|156319710|FG001|Overall Study|Lost to Follow-up|0|||
48581419|NCT03800836|156319711|FG002|Overall Study|Lost to Follow-up|1|||
48738316|NCT02281773|156892502|FG003|Overall Study|Adverse Event|8|||
48738317|NCT02281773|156892503|FG004|Overall Study|Adverse Event|9|||
48738318|NCT02281773|156892499|FG000|Overall Study|Protocol Violation|1|||
48738319|NCT02281773|156892500|FG001|Overall Study|Protocol Violation|0|||
48738320|NCT02281773|156892501|FG002|Overall Study|Protocol Violation|0|||
48738321|NCT02281773|156892502|FG003|Overall Study|Protocol Violation|2|||
48738322|NCT02281773|156892503|FG004|Overall Study|Protocol Violation|2|||
48738323|NCT02281773|156892499|FG000|Overall Study|Lost to Follow-up|2|||
48738324|NCT02281773|156892500|FG001|Overall Study|Lost to Follow-up|2|||
48738325|NCT02281773|156892501|FG002|Overall Study|Lost to Follow-up|6|||
48321171|NCT04218266|155375371|FG002|Overall Study|Death|3|||
48321172|NCT04218266|155375369|FG000|Overall Study|Adverse Event|13|||
48321173|NCT04218266|155375370|FG001|Overall Study|Adverse Event|14|||
48321174|NCT04218266|155375371|FG002|Overall Study|Adverse Event|11|||
48321175|NCT04218266|155375369|FG000|Overall Study|Other|7|||
48321176|NCT04218266|155375370|FG001|Overall Study|Other|5|||
48321177|NCT04218266|155375371|FG002|Overall Study|Other|14|||
48738326|NCT02281773|156892502|FG003|Overall Study|Lost to Follow-up|2|||
48738327|NCT02281773|156892503|FG004|Overall Study|Lost to Follow-up|10|||
48321178|NCT04218266|155375369|FG000|Overall Study|Physician Decision|1|||
48321179|NCT04218266|155375370|FG001|Overall Study|Physician Decision|3|||
48738328|NCT02281773|156892499|FG000|Overall Study|Withdrawal by Subject|2|||
48738329|NCT02281773|156892500|FG001|Overall Study|Withdrawal by Subject|8|||
48738330|NCT02281773|156892501|FG002|Overall Study|Withdrawal by Subject|6|||
48738331|NCT02281773|156892502|FG003|Overall Study|Withdrawal by Subject|6|||
48738332|NCT02281773|156892503|FG004|Overall Study|Withdrawal by Subject|8|||
48738333|NCT02281773|156892499|FG000|Overall Study|Other Reason|0|||
48738334|NCT02281773|156892500|FG001|Overall Study|Other Reason|4|||
48738335|NCT02281773|156892501|FG002|Overall Study|Other Reason|2|||
48738336|NCT02281773|156892502|FG003|Overall Study|Other Reason|3|||
48738337|NCT02281773|156892503|FG004|Overall Study|Other Reason|1|||
48738338|NCT00085709|156892505|FG000|Overall Study|Adverse Event|8|||
48738339|NCT00085709|156892506|FG001|Overall Study|Adverse Event|0|||
48738340|NCT00085709|156892505|FG000|Overall Study|Death|8|||
48738341|NCT00085709|156892506|FG001|Overall Study|Death|2|||
48738342|NCT00085709|156892505|FG000|Overall Study|Refusal unrelated to adverse events|1|||
48738343|NCT00085709|156892506|FG001|Overall Study|Refusal unrelated to adverse events|2|||
48738344|NCT00085709|156892505|FG000|Overall Study|Progression|3|||
48738345|NCT00085709|156892506|FG001|Overall Study|Progression|4|||
48738346|NCT00085709|156892505|FG000|Overall Study|Not protocol specified|12|||
48738347|NCT00085709|156892506|FG001|Overall Study|Not protocol specified|22|||
48738348|NCT00085709|156892505|FG000|Overall Study|Not eligible|19|||
48738349|NCT00085709|156892506|FG001|Overall Study|Not eligible|19|||
48738350|NCT00085709|156892505|FG000|Overall Study|Withdrawal by Subject|2|||
48738351|NCT00085709|156892506|FG001|Overall Study|Withdrawal by Subject|1|||
48738352|NCT00734474|156892507|FG000|Overall Study|Entry Criteria Not Met|0|||
48738353|NCT00734474|156892508|FG001|Overall Study|Entry Criteria Not Met|0|||
48738354|NCT00734474|156892509|FG002|Overall Study|Entry Criteria Not Met|5|||
48738355|NCT00734474|156892510|FG003|Overall Study|Entry Criteria Not Met|0|||
48738356|NCT00734474|156892511|FG004|Overall Study|Entry Criteria Not Met|3|||
48738357|NCT00734474|156892512|FG005|Overall Study|Entry Criteria Not Met|1|||
48321180|NCT04218266|155375371|FG002|Overall Study|Physician Decision|2|||
48450903|NCT00646113|155837635|FG000|Overall Study|Lost to Follow-up|5|||
48450904|NCT00646113|155837635|FG000|Overall Study|Adverse Event|3|||
48450905|NCT03326869|155839172|FG000|Overall Study|Study data has been lost to natural disa|1|||
48450906|NCT03326869|155839173|FG001|Overall Study|Study data has been lost to natural disa|1|||
48450907|NCT03750240|155839175|FG000|Overall Study|Technical Difficulties|2|||
48450908|NCT01316939|155839178|FG000|Overall Study|Study closed/terminated|26|||
48450909|NCT01316939|155839179|FG001|Overall Study|Study closed/terminated|25|||
48450910|NCT01316939|155839180|FG002|Overall Study|Study closed/terminated|23|||
48450911|NCT01316939|155839178|FG000|Overall Study|Lack of Efficacy|24|||
48450912|NCT01316939|155839179|FG001|Overall Study|Lack of Efficacy|25|||
48450913|NCT01316939|155839180|FG002|Overall Study|Lack of Efficacy|25|||
48450914|NCT01316939|155839178|FG000|Overall Study|Adverse Event|9|||
48450915|NCT01316939|155839179|FG001|Overall Study|Adverse Event|12|||
48450916|NCT01316939|155839180|FG002|Overall Study|Adverse Event|11|||
48450917|NCT01316939|155839178|FG000|Overall Study|Withdrawal by Subject|1|||
48450918|NCT01316939|155839179|FG001|Overall Study|Withdrawal by Subject|3|||
48450919|NCT01316939|155839180|FG002|Overall Study|Withdrawal by Subject|6|||
48450920|NCT01316939|155839178|FG000|Overall Study|Physician Decision|2|||
48450921|NCT01316939|155839179|FG001|Overall Study|Physician Decision|2|||
48450922|NCT01316939|155839180|FG002|Overall Study|Physician Decision|1|||
48450923|NCT01316939|155839178|FG000|Overall Study|Lost to Follow-up|0|||
48450924|NCT01316939|155839179|FG001|Overall Study|Lost to Follow-up|0|||
48321181|NCT04218266|155375369|FG000|Overall Study|Non-compliance with study drug|0|||
48321182|NCT04218266|155375370|FG001|Overall Study|Non-compliance with study drug|0|||
48321183|NCT04218266|155375371|FG002|Overall Study|Non-compliance with study drug|1|||
48321184|NCT04218266|155375369|FG000|Overall Study|Withdrawal by Subject|1|||
48321185|NCT04218266|155375370|FG001|Overall Study|Withdrawal by Subject|3|||
48321186|NCT04218266|155375371|FG002|Overall Study|Withdrawal by Subject|1|||
48321187|NCT04218266|155375369|FG000|Overall Study|Study drug never administered|2|||
48321188|NCT04218266|155375370|FG001|Overall Study|Study drug never administered|0|||
48321189|NCT04218266|155375371|FG002|Overall Study|Study drug never administered|0|||
48321190|NCT01011946|155375375|FG000|Overall Study|Transferred to another hospital|2|||
48321191|NCT01011946|155375375|FG000|Overall Study|No pathological lab value|1|||
48321192|NCT01424670|155375377|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
48321193|NCT01424670|155375378|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
48321194|NCT01424670|155375377|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
48738358|NCT00734474|156892513|FG006|Overall Study|Entry Criteria Not Met|0|||
48738359|NCT00734474|156892514|FG007|Overall Study|Entry Criteria Not Met|1|||
48738360|NCT00734474|156892515|FG008|Overall Study|Entry Criteria Not Met|1|||
48738361|NCT00734474|156892507|FG000|Overall Study|Lost to Follow-up|1|||
48738362|NCT00734474|156892508|FG001|Overall Study|Lost to Follow-up|0|||
48738363|NCT00734474|156892509|FG002|Overall Study|Lost to Follow-up|13|||
48738364|NCT00734474|156892510|FG003|Overall Study|Lost to Follow-up|0|||
48738365|NCT00734474|156892511|FG004|Overall Study|Lost to Follow-up|11|||
48738366|NCT00734474|156892512|FG005|Overall Study|Lost to Follow-up|1|||
48738367|NCT00734474|156892513|FG006|Overall Study|Lost to Follow-up|0|||
48738368|NCT00734474|156892514|FG007|Overall Study|Lost to Follow-up|9|||
48738369|NCT00734474|156892515|FG008|Overall Study|Lost to Follow-up|4|||
48738370|NCT00734474|156892507|FG000|Overall Study|Withdrawal by Subject|2|||
48738371|NCT00734474|156892508|FG001|Overall Study|Withdrawal by Subject|1|||
48738372|NCT00734474|156892509|FG002|Overall Study|Withdrawal by Subject|18|||
48738373|NCT00734474|156892510|FG003|Overall Study|Withdrawal by Subject|0|||
48738374|NCT00734474|156892511|FG004|Overall Study|Withdrawal by Subject|24|||
48738375|NCT00734474|156892512|FG005|Overall Study|Withdrawal by Subject|2|||
48738376|NCT00734474|156892513|FG006|Overall Study|Withdrawal by Subject|0|||
48738377|NCT00734474|156892514|FG007|Overall Study|Withdrawal by Subject|36|||
48738378|NCT00734474|156892515|FG008|Overall Study|Withdrawal by Subject|21|||
48738379|NCT00734474|156892507|FG000|Overall Study|Physician Decision|0|||
48738380|NCT00734474|156892508|FG001|Overall Study|Physician Decision|0|||
48738381|NCT00734474|156892509|FG002|Overall Study|Physician Decision|4|||
48738382|NCT00734474|156892510|FG003|Overall Study|Physician Decision|1|||
48738383|NCT00734474|156892511|FG004|Overall Study|Physician Decision|11|||
48738384|NCT00734474|156892512|FG005|Overall Study|Physician Decision|0|||
48738385|NCT00734474|156892513|FG006|Overall Study|Physician Decision|0|||
48738386|NCT00734474|156892514|FG007|Overall Study|Physician Decision|9|||
48738387|NCT00734474|156892515|FG008|Overall Study|Physician Decision|9|||
48738388|NCT00734474|156892507|FG000|Overall Study|Adverse Event|4|||
48738389|NCT00734474|156892508|FG001|Overall Study|Adverse Event|4|||
48738390|NCT00734474|156892509|FG002|Overall Study|Adverse Event|63|||
48738391|NCT00734474|156892510|FG003|Overall Study|Adverse Event|1|||
48738392|NCT00734474|156892511|FG004|Overall Study|Adverse Event|64|||
48738393|NCT00734474|156892512|FG005|Overall Study|Adverse Event|0|||
48738394|NCT00734474|156892513|FG006|Overall Study|Adverse Event|1|||
48738395|NCT00734474|156892514|FG007|Overall Study|Adverse Event|65|||
48738396|NCT00734474|156892515|FG008|Overall Study|Adverse Event|39|||
48738397|NCT00734474|156892507|FG000|Overall Study|Protocol Violation|0|||
48738398|NCT00734474|156892508|FG001|Overall Study|Protocol Violation|0|||
48738399|NCT00734474|156892509|FG002|Overall Study|Protocol Violation|4|||
48738400|NCT00734474|156892510|FG003|Overall Study|Protocol Violation|0|||
48738401|NCT00734474|156892511|FG004|Overall Study|Protocol Violation|3|||
48738402|NCT00734474|156892512|FG005|Overall Study|Protocol Violation|0|||
48738403|NCT00734474|156892513|FG006|Overall Study|Protocol Violation|0|||
48738404|NCT00734474|156892514|FG007|Overall Study|Protocol Violation|3|||
48738405|NCT00734474|156892515|FG008|Overall Study|Protocol Violation|1|||
48738406|NCT00734474|156892507|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
48738407|NCT00734474|156892508|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
48738408|NCT00734474|156892509|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
48738409|NCT00734474|156892510|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
48321195|NCT01424670|155375378|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
48738410|NCT00734474|156892511|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
48738411|NCT00734474|156892512|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
48738412|NCT00734474|156892513|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
48738413|NCT00734474|156892514|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
48738414|NCT00734474|156892515|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
48738415|NCT00734474|156892507|FG000|Overall Study|Sponsor Decision|0|||
48738416|NCT00734474|156892508|FG001|Overall Study|Sponsor Decision|0|||
48738417|NCT00734474|156892509|FG002|Overall Study|Sponsor Decision|0|||
48738418|NCT00734474|156892510|FG003|Overall Study|Sponsor Decision|0|||
48738419|NCT00734474|156892511|FG004|Overall Study|Sponsor Decision|2|||
48738420|NCT00734474|156892512|FG005|Overall Study|Sponsor Decision|0|||
48738421|NCT00734474|156892513|FG006|Overall Study|Sponsor Decision|0|||
48321196|NCT01424670|155375377|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
48321197|NCT01424670|155375378|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
48581420|NCT03800836|156319712|FG003|Overall Study|Lost to Follow-up|1|||
48581421|NCT03800836|156319713|FG004|Overall Study|Lost to Follow-up|3|||
48581422|NCT03800836|156319714|FG005|Overall Study|Lost to Follow-up|0|||
48581423|NCT03800836|156319709|FG000|Overall Study|Withdrawal by Subject|1|||
48581424|NCT03800836|156319710|FG001|Overall Study|Withdrawal by Subject|0|||
48738422|NCT00734474|156892514|FG007|Overall Study|Sponsor Decision|0|||
48738423|NCT00734474|156892515|FG008|Overall Study|Sponsor Decision|0|||
48321198|NCT01424670|155375377|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
48321199|NCT01424670|155375378|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
48321200|NCT01424670|155375377|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
48321201|NCT01424670|155375378|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
48321202|NCT01424670|155375377|FG000|Continuation Period|Adverse Event|13|||
48321203|NCT01424670|155375378|FG001|Continuation Period|Adverse Event|5|||
48321204|NCT01424670|155375377|FG000|Continuation Period|Lost to Follow-up|2|||
48321205|NCT01424670|155375378|FG001|Continuation Period|Lost to Follow-up|0|||
48321206|NCT01424670|155375377|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
48321207|NCT01424670|155375378|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
48321208|NCT01424670|155375377|FG000|Continuation Period|Physician Decision|5|||
48321209|NCT01424670|155375378|FG001|Continuation Period|Physician Decision|4|||
48321210|NCT01424670|155375377|FG000|Continuation Period|Withdrawal by Subject|13|||
48321211|NCT01424670|155375378|FG001|Continuation Period|Withdrawal by Subject|4|||
48321212|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
48321213|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
48581425|NCT03800836|156319711|FG002|Overall Study|Withdrawal by Subject|0|||
48581426|NCT03800836|156319712|FG003|Overall Study|Withdrawal by Subject|0|||
48581427|NCT03800836|156319713|FG004|Overall Study|Withdrawal by Subject|0|||
48581428|NCT03800836|156319714|FG005|Overall Study|Withdrawal by Subject|0|||
48321214|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
48321215|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
48321216|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
48581429|NCT03800836|156319709|FG000|Overall Study|Physician Decision|31|||
48581430|NCT03800836|156319710|FG001|Overall Study|Physician Decision|3|||
48581431|NCT03800836|156319711|FG002|Overall Study|Physician Decision|6|||
48581432|NCT03800836|156319712|FG003|Overall Study|Physician Decision|4|||
48581433|NCT03800836|156319713|FG004|Overall Study|Physician Decision|4|||
48581434|NCT03800836|156319714|FG005|Overall Study|Physician Decision|5|||
48581435|NCT03800836|156319709|FG000|Overall Study|Death|34|||
48581436|NCT03800836|156319710|FG001|Overall Study|Death|16|||
48581437|NCT03800836|156319711|FG002|Overall Study|Death|5|||
48581438|NCT03800836|156319712|FG003|Overall Study|Death|5|||
48581439|NCT03800836|156319713|FG004|Overall Study|Death|10|||
48581440|NCT03800836|156319714|FG005|Overall Study|Death|0|||
48581441|NCT03800836|156319709|FG000|Overall Study|Symptomatic Deterioration|1|||
48581442|NCT03800836|156319710|FG001|Overall Study|Symptomatic Deterioration|0|||
48581443|NCT03800836|156319711|FG002|Overall Study|Symptomatic Deterioration|1|||
48581444|NCT03800836|156319712|FG003|Overall Study|Symptomatic Deterioration|0|||
48581445|NCT03800836|156319713|FG004|Overall Study|Symptomatic Deterioration|0|||
48581446|NCT03800836|156319714|FG005|Overall Study|Symptomatic Deterioration|0|||
48581447|NCT04852276|156319715|FG000|Overall Study|Death|2|||
48581448|NCT04852276|156319716|FG001|Overall Study|Death|0|||
48581449|NCT04852276|156319715|FG000|Overall Study|Lost to Follow-up|15|||
48581450|NCT04852276|156319716|FG001|Overall Study|Lost to Follow-up|9|||
48581451|NCT04852276|156319715|FG000|Overall Study|Withdrawal by Subject|26|||
48581452|NCT04852276|156319716|FG001|Overall Study|Withdrawal by Subject|6|||
48581453|NCT01397786|156321393|FG000|Phase A|Lost to Follow-up|0|||
48581454|NCT01397786|156321394|FG001|Phase A|Lost to Follow-up|0|||
48581455|NCT01397786|156321395|FG002|Phase A|Lost to Follow-up|6|||
48738424|NCT00734474|156892507|FG000|Overall Study|Death|0|||
48321217|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
48581456|NCT01397786|156321393|FG000|Phase A|Adverse Event|0|||
48581457|NCT01397786|156321394|FG001|Phase A|Adverse Event|0|||
48581458|NCT01397786|156321395|FG002|Phase A|Adverse Event|8|||
48581459|NCT01397786|156321393|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
48581460|NCT01397786|156321394|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
48738425|NCT00734474|156892508|FG001|Overall Study|Death|0|||
48581461|NCT01397786|156321395|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
48581462|NCT01397786|156321393|FG000|Phase A|Physician Decision|0|||
48581463|NCT01397786|156321394|FG001|Phase A|Physician Decision|0|||
48581464|NCT01397786|156321395|FG002|Phase A|Physician Decision|1|||
48581465|NCT01397786|156321393|FG000|Phase A|Withdrawal by Subject|0|||
48581466|NCT01397786|156321394|FG001|Phase A|Withdrawal by Subject|0|||
48738426|NCT00734474|156892509|FG002|Overall Study|Death|1|||
48738427|NCT00734474|156892510|FG003|Overall Study|Death|0|||
48738428|NCT00734474|156892511|FG004|Overall Study|Death|0|||
48738429|NCT00734474|156892512|FG005|Overall Study|Death|0|||
48738430|NCT00734474|156892513|FG006|Overall Study|Death|0|||
48738431|NCT00734474|156892514|FG007|Overall Study|Death|2|||
48738432|NCT00734474|156892515|FG008|Overall Study|Death|1|||
48738433|NCT00734474|156892507|FG000|Overall Study|Lack of Efficacy|0|||
48738434|NCT00734474|156892508|FG001|Overall Study|Lack of Efficacy|0|||
48581467|NCT01397786|156321395|FG002|Phase A|Withdrawal by Subject|5|||
48581468|NCT01397786|156321393|FG000|Phase A|Lack of Efficacy|0|||
48581469|NCT01397786|156321394|FG001|Phase A|Lack of Efficacy|0|||
48581470|NCT01397786|156321395|FG002|Phase A|Lack of Efficacy|1|||
48581471|NCT01397786|156321393|FG000|Phase B|Lost to Follow-up|22|||
48581472|NCT01397786|156321394|FG001|Phase B|Lost to Follow-up|12|||
48581473|NCT01397786|156321395|FG002|Phase B|Lost to Follow-up|22|||
48581474|NCT01397786|156321393|FG000|Phase B|Adverse Event|109|||
48581475|NCT01397786|156321394|FG001|Phase B|Adverse Event|23|||
48581476|NCT01397786|156321395|FG002|Phase B|Adverse Event|27|||
48581477|NCT01397786|156321393|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
48581478|NCT01397786|156321394|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
48581479|NCT01397786|156321395|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
48581480|NCT01397786|156321393|FG000|Phase B|Physician Decision|9|||
48581481|NCT01397786|156321394|FG001|Phase B|Physician Decision|1|||
48581482|NCT01397786|156321395|FG002|Phase B|Physician Decision|3|||
48581483|NCT01397786|156321393|FG000|Phase B|Withdrawal by Subject|102|||
48738435|NCT00734474|156892509|FG002|Overall Study|Lack of Efficacy|4|||
48738436|NCT00734474|156892510|FG003|Overall Study|Lack of Efficacy|0|||
48738437|NCT00734474|156892511|FG004|Overall Study|Lack of Efficacy|0|||
48738438|NCT00734474|156892512|FG005|Overall Study|Lack of Efficacy|0|||
48738439|NCT00734474|156892513|FG006|Overall Study|Lack of Efficacy|0|||
48738440|NCT00734474|156892514|FG007|Overall Study|Lack of Efficacy|4|||
48738441|NCT00734474|156892515|FG008|Overall Study|Lack of Efficacy|6|||
48738442|NCT00785928|156892516|FG000|Treatment Phase|Adverse Event|1|||
48738443|NCT00785928|156892517|FG001|Treatment Phase|Adverse Event|1|||
48738444|NCT00785928|156892518|FG002|Treatment Phase|Adverse Event|2|||
48738445|NCT00785928|156892519|FG003|Treatment Phase|Adverse Event|0|||
48321218|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
48321219|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
48321220|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
48321221|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
48321222|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
48321223|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
48321224|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
48321225|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
48321226|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
48321227|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
48321228|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
48321229|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
48321230|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
48321231|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
48321232|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
48321233|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
48321234|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
48321235|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
48321236|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
48321237|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
48321238|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
48321239|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
48321240|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
48321241|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
48321242|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
48321243|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
48581484|NCT01397786|156321394|FG001|Phase B|Withdrawal by Subject|45|||
48581485|NCT01397786|156321395|FG002|Phase B|Withdrawal by Subject|30|||
48581486|NCT01397786|156321393|FG000|Phase B|Protocol Deviation|1|||
48581487|NCT01397786|156321394|FG001|Phase B|Protocol Deviation|2|||
48738446|NCT00785928|156892520|FG004|Treatment Phase|Adverse Event|0|||
48738447|NCT00785928|156892521|FG005|Treatment Phase|Adverse Event|0|||
48738448|NCT00785928|156892522|FG006|Treatment Phase|Adverse Event|2|||
48581488|NCT01397786|156321395|FG002|Phase B|Protocol Deviation|4|||
48581489|NCT01397786|156321393|FG000|Phase B|Lack of Efficacy|22|||
48738449|NCT00785928|156892516|FG000|Treatment Phase|Inadequate Response|0|||
48738450|NCT00785928|156892517|FG001|Treatment Phase|Inadequate Response|1|||
48738451|NCT00785928|156892518|FG002|Treatment Phase|Inadequate Response|0|||
48738452|NCT00785928|156892519|FG003|Treatment Phase|Inadequate Response|0|||
48738453|NCT00785928|156892520|FG004|Treatment Phase|Inadequate Response|0|||
48738454|NCT00785928|156892521|FG005|Treatment Phase|Inadequate Response|0|||
48738455|NCT00785928|156892522|FG006|Treatment Phase|Inadequate Response|0|||
48581490|NCT01397786|156321394|FG001|Phase B|Lack of Efficacy|7|||
48581491|NCT01397786|156321395|FG002|Phase B|Lack of Efficacy|14|||
48581492|NCT03126019|156321396|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
48581493|NCT03126019|156321397|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
48581494|NCT03126019|156321396|FG000|Overall Study|Death|2|||
48581495|NCT03126019|156321397|FG001|Overall Study|Death|7|||
48738456|NCT00785928|156892516|FG000|Treatment Phase|Lack of Efficacy|0|||
48738457|NCT00785928|156892517|FG001|Treatment Phase|Lack of Efficacy|1|||
48738458|NCT00785928|156892518|FG002|Treatment Phase|Lack of Efficacy|1|||
48738459|NCT00785928|156892519|FG003|Treatment Phase|Lack of Efficacy|0|||
48738460|NCT00785928|156892520|FG004|Treatment Phase|Lack of Efficacy|0|||
48738461|NCT00785928|156892521|FG005|Treatment Phase|Lack of Efficacy|0|||
48738462|NCT00785928|156892522|FG006|Treatment Phase|Lack of Efficacy|0|||
48738463|NCT00785928|156892516|FG000|Treatment Phase|Physician Decision|0|||
48738464|NCT00785928|156892517|FG001|Treatment Phase|Physician Decision|0|||
48738465|NCT00785928|156892518|FG002|Treatment Phase|Physician Decision|0|||
48738466|NCT00785928|156892519|FG003|Treatment Phase|Physician Decision|0|||
48738467|NCT00785928|156892520|FG004|Treatment Phase|Physician Decision|1|||
48738468|NCT00785928|156892521|FG005|Treatment Phase|Physician Decision|0|||
48738469|NCT00785928|156892522|FG006|Treatment Phase|Physician Decision|0|||
48738470|NCT00785928|156892516|FG000|Treatment Phase|Sponsor Decision|1|||
48738471|NCT00785928|156892517|FG001|Treatment Phase|Sponsor Decision|0|||
48738472|NCT00785928|156892518|FG002|Treatment Phase|Sponsor Decision|0|||
48738473|NCT00785928|156892519|FG003|Treatment Phase|Sponsor Decision|0|||
48738474|NCT00785928|156892520|FG004|Treatment Phase|Sponsor Decision|0|||
48738475|NCT00785928|156892521|FG005|Treatment Phase|Sponsor Decision|0|||
48738476|NCT00785928|156892522|FG006|Treatment Phase|Sponsor Decision|1|||
48738477|NCT00785928|156892516|FG000|Treatment Phase|Withdrawal by Subject|1|||
48738478|NCT00785928|156892517|FG001|Treatment Phase|Withdrawal by Subject|2|||
48738479|NCT00785928|156892518|FG002|Treatment Phase|Withdrawal by Subject|0|||
48738480|NCT00785928|156892519|FG003|Treatment Phase|Withdrawal by Subject|0|||
48738481|NCT00785928|156892520|FG004|Treatment Phase|Withdrawal by Subject|1|||
48738482|NCT00785928|156892521|FG005|Treatment Phase|Withdrawal by Subject|0|||
48738483|NCT00785928|156892522|FG006|Treatment Phase|Withdrawal by Subject|0|||
48738484|NCT02104752|156892525|FG000|Overall Study|Withdrawal by Subject|1|||
48738485|NCT02104752|156892526|FG001|Overall Study|Withdrawal by Subject|0|||
48738486|NCT02104752|156892525|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
48738487|NCT02104752|156892526|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
48738488|NCT00573183|156892527|FG000|Overall Study|Lost to Follow-up|52|||
48738489|NCT00573183|156892528|FG001|Overall Study|Lost to Follow-up|50|||
48738490|NCT00573183|156892527|FG000|Overall Study|Withdrawal by Subject|8|||
48738491|NCT00573183|156892528|FG001|Overall Study|Withdrawal by Subject|2|||
48738492|NCT00573183|156892527|FG000|Overall Study|Death|0|||
48738493|NCT00573183|156892528|FG001|Overall Study|Death|1|||
48738494|NCT00573183|156892527|FG000|Overall Study|Adverse Event|2|||
48738495|NCT00573183|156892528|FG001|Overall Study|Adverse Event|0|||
48738496|NCT00573183|156892527|FG000|Overall Study|Incarceration|5|||
48738497|NCT00573183|156892528|FG001|Overall Study|Incarceration|8|||
48738498|NCT00573183|156892527|FG000|Overall Study|Other|5|||
48738499|NCT00573183|156892528|FG001|Overall Study|Other|2|||
48581496|NCT03126019|156321396|FG000|Overall Study|Lost to Follow-up|2|||
48738500|NCT02422303|156892529|FG000|Overall Study|Lost to Follow-up|1|||
48738501|NCT02422303|156892530|FG001|Overall Study|Lost to Follow-up|1|||
48738502|NCT01816074|156892531|FG000|Phase 1|Time commitment issues|0|||
48738503|NCT01816074|156892532|FG001|Phase 1|Time commitment issues|0|||
48738504|NCT01816074|156892533|FG002|Phase 1|Time commitment issues|1|||
48581497|NCT03126019|156321397|FG001|Overall Study|Lost to Follow-up|3|||
48581498|NCT03126019|156321396|FG000|Overall Study|Withdrawal by Participant|1|||
48738505|NCT01816074|156892534|FG003|Phase 1|Time commitment issues|0|||
48738506|NCT01816074|156892531|FG000|Phase 2|Time commitment Issues|0|||
48738507|NCT01816074|156892532|FG001|Phase 2|Time commitment Issues|2|||
48738508|NCT01816074|156892533|FG002|Phase 2|Time commitment Issues|0|||
48738509|NCT01816074|156892534|FG003|Phase 2|Time commitment Issues|0|||
48321244|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
48321245|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
48321246|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
48321247|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
48450925|NCT01316939|155839180|FG002|Overall Study|Lost to Follow-up|2|||
48581499|NCT03126019|156321397|FG001|Overall Study|Withdrawal by Participant|3|||
48581500|NCT03126019|156321396|FG000|Overall Study|Reason not Specified|1|||
48738510|NCT01816074|156892531|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
48738511|NCT01816074|156892532|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
48738512|NCT01816074|156892533|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
48738513|NCT01816074|156892534|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
48738514|NCT01816074|156892531|FG000|Phase 2|Physician Decision|0|||
48581501|NCT03126019|156321397|FG001|Overall Study|Reason not Specified|3|||
48581502|NCT02059434|156321401|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
48581503|NCT02059434|156321402|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
48581504|NCT02059434|156321403|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
48581505|NCT02059434|156321404|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
48581506|NCT02059434|156321405|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
48581507|NCT02059434|156321406|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
48581508|NCT02059434|156321407|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
48738515|NCT01816074|156892532|FG001|Phase 2|Physician Decision|0|||
48581509|NCT02059434|156321408|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
48738516|NCT01816074|156892533|FG002|Phase 2|Physician Decision|0|||
48738517|NCT01816074|156892534|FG003|Phase 2|Physician Decision|1|||
48738518|NCT01816074|156892531|FG000|Phase 2|Withdrawal by Subject|1|||
48738519|NCT01816074|156892532|FG001|Phase 2|Withdrawal by Subject|0|||
48738520|NCT01816074|156892533|FG002|Phase 2|Withdrawal by Subject|0|||
48738521|NCT01816074|156892534|FG003|Phase 2|Withdrawal by Subject|0|||
48738522|NCT00408629|156892537|FG000|Overall Study|Adverse Event|13|||
48581510|NCT02059434|156321409|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
48581511|NCT02059434|156321401|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
48581512|NCT02059434|156321402|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
48581513|NCT02059434|156321403|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
48581514|NCT02059434|156321404|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
48581515|NCT02059434|156321405|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
48581516|NCT02059434|156321406|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
48581517|NCT02059434|156321407|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
48581518|NCT02059434|156321408|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
48581519|NCT02059434|156321409|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
48581520|NCT02059434|156321401|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
48581521|NCT02059434|156321402|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
48738523|NCT00408629|156892538|FG001|Overall Study|Adverse Event|27|||
48738524|NCT00408629|156892537|FG000|Overall Study|Withdrawal by Subject|8|||
48321248|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
48321249|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
48321250|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
48321251|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
48321252|NCT02409667|155375381|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
48321253|NCT02409667|155375382|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
48321254|NCT02409667|155375383|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
48321255|NCT02409667|155375384|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
48321256|NCT02409667|155375385|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
48321257|NCT02409667|155375381|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
48321258|NCT02409667|155375382|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
48321259|NCT02409667|155375383|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
48321260|NCT02409667|155375384|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
48321261|NCT02409667|155375385|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
48581522|NCT02059434|156321403|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
48581523|NCT02059434|156321404|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
48738525|NCT00408629|156892538|FG001|Overall Study|Withdrawal by Subject|4|||
48321262|NCT02409667|155375381|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
48321263|NCT02409667|155375382|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
48321264|NCT02409667|155375383|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
48321265|NCT02409667|155375384|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
48321266|NCT02409667|155375385|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
48321267|NCT02409667|155375381|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
48321268|NCT02409667|155375382|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
48321269|NCT02409667|155375383|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
48321270|NCT02409667|155375384|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
48321271|NCT02409667|155375385|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
48321272|NCT02409667|155375381|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
48321273|NCT02409667|155375382|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
48321274|NCT02409667|155375383|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
48321275|NCT02409667|155375384|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
48321276|NCT02409667|155375385|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
48321277|NCT02409667|155375381|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
48581524|NCT02059434|156321405|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
48581525|NCT02059434|156321406|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
48581526|NCT02059434|156321407|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
48581527|NCT02059434|156321408|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
48581528|NCT02059434|156321409|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
48581529|NCT02059434|156321401|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
48581530|NCT02059434|156321402|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
48581531|NCT02059434|156321403|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
48581532|NCT02059434|156321404|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
48581533|NCT02059434|156321405|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
48581534|NCT02059434|156321406|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
48581535|NCT02059434|156321407|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
48581536|NCT02059434|156321408|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
48581537|NCT02059434|156321409|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
48581538|NCT02059434|156321401|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
48581539|NCT02059434|156321402|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
48581540|NCT02059434|156321403|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
48581541|NCT02059434|156321404|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
48581542|NCT02059434|156321405|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
48581543|NCT02059434|156321406|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
48581544|NCT02059434|156321407|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
48581545|NCT02059434|156321408|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
48581546|NCT02059434|156321409|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
48581547|NCT02203851|156321412|FG000|Overall Study|Lost to Follow-up|4|||
48581548|NCT02203851|156321412|FG000|Overall Study|Withdrawal by Subject|6|||
48581549|NCT02203851|156321412|FG000|Overall Study|Other|1|||
48581550|NCT01632150|156321420|FG000|Overall Study|Disease progression|27|||
48581551|NCT01632150|156321420|FG000|Overall Study|Study drug toxicity|1|||
48581552|NCT01632150|156321420|FG000|Overall Study|Unrelated adverse event|7|||
48581553|NCT01632150|156321420|FG000|Overall Study|Withdrawal by Subject|2|||
48581554|NCT01632150|156321420|FG000|Overall Study|Patient underwent autologous transplant|1|||
48581555|NCT01632150|156321420|FG000|Overall Study|Moved to compassionate program|2|||
48581556|NCT03085238|156321424|FG000|Overall Study|Adverse Event|2|||
48581557|NCT03085238|156321424|FG000|Overall Study|Death|2|||
48581558|NCT00381238|156321425|FG000|Overall Study|Adverse Event|3|||
48581559|NCT00381238|156321425|FG000|Overall Study|Protocol Violation|1|||
48581560|NCT00381238|156321425|FG000|Overall Study|Withdrawal by Subject|4|||
48581561|NCT00381238|156321425|FG000|Overall Study|Lack of Efficacy|2|||
48581562|NCT00381238|156321425|FG000|Overall Study|Withdrew by physician|1|||
48581563|NCT00381238|156321425|FG000|Overall Study|Disease progression|1|||
48581564|NCT02879994|156321437|FG000|Overall Study|off treatment early|7|||
48581565|NCT02879994|156321437|FG000|Overall Study|Adverse Event|2|||
48581566|NCT02879994|156321437|FG000|Overall Study|Death|2|||
48738526|NCT00408629|156892537|FG000|Overall Study|Lost to Follow-up|1|||
48738527|NCT00408629|156892538|FG001|Overall Study|Lost to Follow-up|1|||
48321278|NCT02409667|155375382|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
48581567|NCT04392167|156321438|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
48581568|NCT02143791|156321439|FG000|Enrolled|Withdrawal by Subject|4|||
48581569|NCT02143791|156321439|FG000|Trial Stimulation|Lack of Efficacy|21|||
48581570|NCT02143791|156321439|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
48581571|NCT02143791|156321439|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
48581572|NCT02143791|156321439|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
48451078|NCT01947894|155839261|FG002|Overall Study|Death|0|||
48581573|NCT02143791|156321439|FG000|Any Programming (3-6 Months)|Missing Data|1|||
48451079|NCT01947894|155839259|FG000|Overall Study|Physician Decision|2|||
48581574|NCT02143791|156321439|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
48581575|NCT02370667|156321444|FG000|Overall Study|Lost to Follow-up|0|||
48581576|NCT02370667|156321445|FG001|Overall Study|Lost to Follow-up|1|||
48581577|NCT02370667|156321446|FG002|Overall Study|Lost to Follow-up|0|||
48581578|NCT02850016|156321447|FG000|Overall Study|Withdrawal by Subject|1|||
48581579|NCT02850016|156321448|FG001|Overall Study|Withdrawal by Subject|2|||
48581580|NCT02052596|156321449|FG000|Active Phase|Adverse Event|3|||
48581581|NCT02052596|156321450|FG001|Active Phase|Adverse Event|2|||
48581582|NCT02052596|156321449|FG000|Active Phase|Lost to Follow-up|8|||
48581583|NCT02052596|156321450|FG001|Active Phase|Lost to Follow-up|11|||
48581584|NCT02052596|156321449|FG000|Active Phase|Protocol Violation|1|||
48581585|NCT02052596|156321450|FG001|Active Phase|Protocol Violation|2|||
48581586|NCT02052596|156321449|FG000|Active Phase|Withdrawal by Subject|3|||
48581587|NCT02052596|156321450|FG001|Active Phase|Withdrawal by Subject|4|||
48581588|NCT02052596|156321449|FG000|Active Phase|Enrolled in error|1|||
48581589|NCT02052596|156321450|FG001|Active Phase|Enrolled in error|0|||
48581590|NCT02052596|156321449|FG000|Active Phase|Lost due to Crohn's disease|0|||
48581591|NCT02052596|156321450|FG001|Active Phase|Lost due to Crohn's disease|1|||
48581592|NCT02052596|156321449|FG000|Safety Phase|Adverse Event|6|||
48581593|NCT02052596|156321450|FG001|Safety Phase|Adverse Event|3|||
48581594|NCT02052596|156321449|FG000|Safety Phase|Lost to Follow-up|11|||
48581595|NCT02052596|156321450|FG001|Safety Phase|Lost to Follow-up|18|||
48581596|NCT02052596|156321449|FG000|Safety Phase|Protocol Violation|1|||
48581597|NCT02052596|156321450|FG001|Safety Phase|Protocol Violation|2|||
48581598|NCT02052596|156321449|FG000|Safety Phase|Withdrawal by Subject|8|||
48581599|NCT02052596|156321450|FG001|Safety Phase|Withdrawal by Subject|11|||
48581600|NCT02052596|156321449|FG000|Safety Phase|Enrolled in error|1|||
48581601|NCT02052596|156321450|FG001|Safety Phase|Enrolled in error|0|||
48581602|NCT02052596|156321449|FG000|Safety Phase|Lost due to Crohn's disease|0|||
48581603|NCT02052596|156321450|FG001|Safety Phase|Lost due to Crohn's disease|1|||
48581604|NCT00558896|156321451|FG000|Overall Study|Adverse Event|1|||
48581605|NCT00558896|156321452|FG001|Overall Study|Adverse Event|1|||
48581606|NCT00558896|156321453|FG002|Overall Study|Adverse Event|1|||
48581607|NCT00558896|156321454|FG003|Overall Study|Adverse Event|3|||
48581608|NCT00558896|156321455|FG004|Overall Study|Adverse Event|4|||
48581609|NCT00558896|156321456|FG005|Overall Study|Adverse Event|10|||
48581610|NCT00558896|156321457|FG006|Overall Study|Adverse Event|3|||
48581611|NCT00558896|156321451|FG000|Overall Study|Death|3|||
48581612|NCT00558896|156321452|FG001|Overall Study|Death|0|||
48581613|NCT00558896|156321453|FG002|Overall Study|Death|2|||
48581614|NCT00558896|156321454|FG003|Overall Study|Death|3|||
48581615|NCT00558896|156321455|FG004|Overall Study|Death|2|||
48581616|NCT00558896|156321456|FG005|Overall Study|Death|2|||
48581617|NCT00558896|156321457|FG006|Overall Study|Death|6|||
48581618|NCT00558896|156321451|FG000|Overall Study|Withdrawal by Subject|2|||
48321279|NCT02409667|155375383|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
48321280|NCT02409667|155375384|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
48321281|NCT02409667|155375385|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
48451080|NCT01947894|155839260|FG001|Overall Study|Physician Decision|0|||
48581619|NCT00558896|156321452|FG001|Overall Study|Withdrawal by Subject|1|||
48581620|NCT00558896|156321453|FG002|Overall Study|Withdrawal by Subject|1|||
48581621|NCT00558896|156321454|FG003|Overall Study|Withdrawal by Subject|1|||
48581622|NCT00558896|156321455|FG004|Overall Study|Withdrawal by Subject|1|||
48581623|NCT00558896|156321456|FG005|Overall Study|Withdrawal by Subject|5|||
48581624|NCT00558896|156321457|FG006|Overall Study|Withdrawal by Subject|5|||
48581625|NCT00558896|156321451|FG000|Overall Study|Alternative Treatment|2|||
48581626|NCT00558896|156321452|FG001|Overall Study|Alternative Treatment|2|||
48581627|NCT00558896|156321453|FG002|Overall Study|Alternative Treatment|0|||
48581628|NCT00558896|156321454|FG003|Overall Study|Alternative Treatment|2|||
48581629|NCT00558896|156321455|FG004|Overall Study|Alternative Treatment|6|||
48581630|NCT00558896|156321456|FG005|Overall Study|Alternative Treatment|7|||
48581631|NCT00558896|156321457|FG006|Overall Study|Alternative Treatment|1|||
48581632|NCT00558896|156321451|FG000|Overall Study|Physician discretion|3|||
48581633|NCT00558896|156321452|FG001|Overall Study|Physician discretion|2|||
48581634|NCT00558896|156321453|FG002|Overall Study|Physician discretion|1|||
48581635|NCT00558896|156321454|FG003|Overall Study|Physician discretion|2|||
48581636|NCT00558896|156321455|FG004|Overall Study|Physician discretion|1|||
48581637|NCT00558896|156321456|FG005|Overall Study|Physician discretion|3|||
48581638|NCT00558896|156321457|FG006|Overall Study|Physician discretion|3|||
48581639|NCT00558896|156321451|FG000|Overall Study|Continues on treatment|10|||
48581640|NCT00558896|156321452|FG001|Overall Study|Continues on treatment|1|||
48581641|NCT00558896|156321453|FG002|Overall Study|Continues on treatment|0|||
48581642|NCT00558896|156321454|FG003|Overall Study|Continues on treatment|1|||
48581643|NCT00558896|156321455|FG004|Overall Study|Continues on treatment|9|||
48581644|NCT00558896|156321456|FG005|Overall Study|Continues on treatment|25|||
48581645|NCT00558896|156321457|FG006|Overall Study|Continues on treatment|6|||
48581646|NCT03536949|156321458|FG000|Overall Study|Adverse Event|4|||
48581647|NCT03536949|156321459|FG001|Overall Study|Adverse Event|0|||
48581648|NCT03536949|156321458|FG000|Overall Study|Lost to Follow-up|2|||
48581649|NCT03536949|156321459|FG001|Overall Study|Lost to Follow-up|1|||
48581650|NCT03536949|156321458|FG000|Overall Study|Withdrawal by Subject|6|||
48581651|NCT03536949|156321459|FG001|Overall Study|Withdrawal by Subject|0|||
48581652|NCT03536949|156321458|FG000|Overall Study|Non-compliance|2|||
48581653|NCT03536949|156321459|FG001|Overall Study|Non-compliance|1|||
48581654|NCT02457832|156321460|FG000|Training|Lost to Follow-up|10|||
48581655|NCT02457832|156321461|FG001|Training|Lost to Follow-up|6|||
48581656|NCT02457832|156321462|FG002|Training|Lost to Follow-up|3|||
48581657|NCT02457832|156321460|FG000|One Month Washout|Lost to Follow-up|0|||
48581658|NCT02457832|156321461|FG001|One Month Washout|Lost to Follow-up|1|||
48581659|NCT02457832|156321462|FG002|One Month Washout|Lost to Follow-up|1|||
48581660|NCT02954653|156321465|FG000|Overall Study|Death|3|||
48581661|NCT02954653|156321466|FG001|Overall Study|Death|1|||
48581662|NCT02954653|156321467|FG002|Overall Study|Death|0|||
48581663|NCT02954653|156321468|FG003|Overall Study|Death|0|||
48581664|NCT02954653|156321469|FG004|Overall Study|Death|0|||
48581665|NCT02954653|156321470|FG005|Overall Study|Death|0|||
48581666|NCT02954653|156321471|FG006|Overall Study|Death|0|||
48581667|NCT02954653|156321472|FG007|Overall Study|Death|0|||
48581668|NCT02954653|156321473|FG008|Overall Study|Death|0|||
48581669|NCT02954653|156321465|FG000|Overall Study|Randomized but did not receive treatment|1|||
48581670|NCT02954653|156321466|FG001|Overall Study|Randomized but did not receive treatment|0|||
48581671|NCT02954653|156321467|FG002|Overall Study|Randomized but did not receive treatment|0|||
48581672|NCT02954653|156321468|FG003|Overall Study|Randomized but did not receive treatment|0|||
48581673|NCT02954653|156321469|FG004|Overall Study|Randomized but did not receive treatment|0|||
48581674|NCT02954653|156321470|FG005|Overall Study|Randomized but did not receive treatment|0|||
48581675|NCT02954653|156321471|FG006|Overall Study|Randomized but did not receive treatment|0|||
48581676|NCT02954653|156321472|FG007|Overall Study|Randomized but did not receive treatment|0|||
48581677|NCT02954653|156321473|FG008|Overall Study|Randomized but did not receive treatment|0|||
48581678|NCT02954653|156321465|FG000|Overall Study|Started another anti-cancer therapy|0|||
48581679|NCT02954653|156321466|FG001|Overall Study|Started another anti-cancer therapy|1|||
48581680|NCT02954653|156321467|FG002|Overall Study|Started another anti-cancer therapy|0|||
48581681|NCT02954653|156321468|FG003|Overall Study|Started another anti-cancer therapy|0|||
48581682|NCT02954653|156321469|FG004|Overall Study|Started another anti-cancer therapy|0|||
48581683|NCT02954653|156321470|FG005|Overall Study|Started another anti-cancer therapy|0|||
48581684|NCT02954653|156321471|FG006|Overall Study|Started another anti-cancer therapy|0|||
48581685|NCT02954653|156321472|FG007|Overall Study|Started another anti-cancer therapy|0|||
48581686|NCT02954653|156321473|FG008|Overall Study|Started another anti-cancer therapy|0|||
48581687|NCT02954653|156321465|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
48581688|NCT02954653|156321466|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
48581689|NCT02954653|156321467|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
48581690|NCT02954653|156321468|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
48738528|NCT00408629|156892537|FG000|Overall Study|Lack of Efficacy|63|||
48738529|NCT00408629|156892538|FG001|Overall Study|Lack of Efficacy|73|||
48738530|NCT00408629|156892537|FG000|Overall Study|Protocol Violation|1|||
48738531|NCT00408629|156892538|FG001|Overall Study|Protocol Violation|5|||
48738532|NCT00408629|156892537|FG000|Overall Study|Miscellaneous|11|||
48738533|NCT00408629|156892538|FG001|Overall Study|Miscellaneous|15|||
48738534|NCT04638660|156892539|FG000|Overall Study|Withdrawal by Subject|2|||
48738535|NCT04638660|156892540|FG001|Overall Study|Withdrawal by Subject|0|||
48738536|NCT04638660|156892539|FG000|Overall Study|Lost to Follow-up|1|||
48738537|NCT04638660|156892540|FG001|Overall Study|Lost to Follow-up|0|||
48738538|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Adverse Event|3|||
48738539|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Adverse Event|0|||
48738540|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
48738541|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
48738542|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
48581691|NCT02954653|156321469|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
48581692|NCT02954653|156321470|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
48581693|NCT02954653|156321471|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
48581694|NCT02954653|156321472|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
48581695|NCT02954653|156321473|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
48581696|NCT00250458|156321475|FG000|Overall Study|Lost to Follow-up|4|||
48581697|NCT00250458|156321476|FG001|Overall Study|Lost to Follow-up|2|||
48581698|NCT00250458|156321475|FG000|Overall Study|Protocol Violation|0|||
48581699|NCT00250458|156321476|FG001|Overall Study|Protocol Violation|1|||
48581700|NCT00250458|156321475|FG000|Overall Study|Withdrawal by Subject|4|||
48581701|NCT00250458|156321476|FG001|Overall Study|Withdrawal by Subject|2|||
48581702|NCT00250458|156321475|FG000|Overall Study|Lack of Migraine Attack|20|||
48581703|NCT00250458|156321476|FG001|Overall Study|Lack of Migraine Attack|9|||
48581704|NCT00250458|156321475|FG000|Overall Study|Qualifying migraine but did not treat|3|||
48581705|NCT00250458|156321476|FG001|Overall Study|Qualifying migraine but did not treat|3|||
48581706|NCT00250458|156321475|FG000|Overall Study|Other|1|||
48581707|NCT00250458|156321476|FG001|Overall Study|Other|0|||
48581708|NCT06137703|156321477|FG000|Overall Study|Other|0|||
48581709|NCT06137703|156321478|FG001|Overall Study|Other|1|||
48581710|NCT06137703|156321479|FG002|Overall Study|Other|0|||
48581711|NCT06137703|156321480|FG003|Overall Study|Other|0|||
48581712|NCT06137703|156321477|FG000|Overall Study|Adverse Event|0|||
48581713|NCT06137703|156321478|FG001|Overall Study|Adverse Event|0|||
48581714|NCT06137703|156321479|FG002|Overall Study|Adverse Event|1|||
48581715|NCT06137703|156321480|FG003|Overall Study|Adverse Event|0|||
48581716|NCT03054064|156321481|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
48581717|NCT03054064|156321481|FG000|Overall Study|Investigator Decision|2|||
48581718|NCT03054064|156321481|FG000|Overall Study|Bladder Issue|1|||
48581719|NCT03054064|156321481|FG000|Overall Study|High Blood Pressure|1|||
48581720|NCT03054064|156321481|FG000|Overall Study|Change in Status|1|||
48581721|NCT00387010|156321497|FG000|Dose Titration Period|Adverse Event|12|||
48581722|NCT00387010|156321497|FG000|Dose Titration Period|Lack of Efficacy|5|||
48581723|NCT00387010|156321497|FG000|Dose Titration Period|Withdrawal by Subject|3|||
48581724|NCT00387010|156321497|FG000|Dose Titration Period|Protocol Violation|1|||
48581725|NCT00387010|156321497|FG000|Dose Titration Period|Lost to Follow-up|2|||
48581726|NCT00387010|156321497|FG000|Dose Titration Period|Noncompliance with study medication|8|||
48581727|NCT00387010|156321497|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
48581728|NCT00387010|156321497|FG000|Treatment Period|Adverse Event|4|||
48581729|NCT00387010|156321497|FG000|Treatment Period|Withdrawal by Subject|1|||
48581730|NCT00387010|156321497|FG000|Treatment Period|Noncompliance with study medication|2|||
48581731|NCT00387010|156321497|FG000|Treatment Period|Noncompliance with study procedures|3|||
48581732|NCT00387010|156321497|FG000|Treatment Period|Participant reported study drug stolen|1|||
48581733|NCT00520481|156321498|FG000|Overall Study|Adverse Event|4|||
48581734|NCT00520481|156321499|FG001|Overall Study|Adverse Event|1|||
48581735|NCT00520481|156321498|FG000|Overall Study|Withdrawal by Subject|3|||
48581736|NCT00520481|156321499|FG001|Overall Study|Withdrawal by Subject|0|||
48581737|NCT00990665|156321500|FG000|Overall Study|Unsuccessful Implant|8|||
48581738|NCT00990665|156321500|FG000|Overall Study|Death|29|||
48581739|NCT00990665|156321500|FG000|Overall Study|Heart Transplant|1|||
48581740|NCT00990665|156321500|FG000|Overall Study|Withdrawal by Subject|6|||
48581741|NCT00990665|156321500|FG000|Overall Study|Lost to Follow-up|1|||
48581742|NCT00990665|156321500|FG000|Overall Study|System Explant|3|||
48581743|NCT00835679|156321501|FG000|Overall Study|Withdrawal by Subject|1|||
48738543|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
48738544|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Physician Decision|0|||
48738545|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Physician Decision|2|||
48738546|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
48581744|NCT00835679|156321502|FG001|Overall Study|Withdrawal by Subject|0|||
48738547|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
48581745|NCT00835679|156321503|FG002|Overall Study|Withdrawal by Subject|0|||
48581746|NCT00835679|156321504|FG003|Overall Study|Withdrawal by Subject|0|||
48581747|NCT02079636|156321507|FG000|Overall Study|Death|2|||
48581748|NCT02079636|156321508|FG001|Overall Study|Death|1|||
48581749|NCT02079636|156321509|FG002|Overall Study|Death|0|||
48581750|NCT02079636|156321510|FG003|Overall Study|Death|5|||
48581751|NCT02079636|156321511|FG004|Overall Study|Death|1|||
48581752|NCT02079636|156321512|FG005|Overall Study|Death|2|||
48581753|NCT02079636|156321513|FG006|Overall Study|Death|1|||
48581754|NCT02079636|156321514|FG007|Overall Study|Death|0|||
48581755|NCT02079636|156321515|FG008|Overall Study|Death|0|||
48581756|NCT02079636|156321516|FG009|Overall Study|Death|0|||
48581757|NCT02079636|156321517|FG010|Overall Study|Death|0|||
48581758|NCT02079636|156321518|FG011|Overall Study|Death|1|||
48581759|NCT02079636|156321519|FG012|Overall Study|Death|1|||
48581760|NCT02079636|156321520|FG013|Overall Study|Death|0|||
48581761|NCT02079636|156321521|FG014|Overall Study|Death|2|||
48581762|NCT02079636|156321507|FG000|Overall Study|Adverse Event|1|||
48581763|NCT02079636|156321508|FG001|Overall Study|Adverse Event|1|||
48581764|NCT02079636|156321509|FG002|Overall Study|Adverse Event|0|||
48581765|NCT02079636|156321510|FG003|Overall Study|Adverse Event|1|||
48581766|NCT02079636|156321511|FG004|Overall Study|Adverse Event|1|||
48581767|NCT02079636|156321512|FG005|Overall Study|Adverse Event|2|||
48581768|NCT02079636|156321513|FG006|Overall Study|Adverse Event|0|||
48581769|NCT02079636|156321514|FG007|Overall Study|Adverse Event|0|||
48581770|NCT02079636|156321515|FG008|Overall Study|Adverse Event|0|||
48581771|NCT02079636|156321516|FG009|Overall Study|Adverse Event|0|||
48581772|NCT02079636|156321517|FG010|Overall Study|Adverse Event|0|||
48581773|NCT02079636|156321518|FG011|Overall Study|Adverse Event|0|||
48581774|NCT02079636|156321519|FG012|Overall Study|Adverse Event|0|||
48581775|NCT02079636|156321520|FG013|Overall Study|Adverse Event|0|||
48321282|NCT02409667|155375381|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
48321283|NCT02409667|155375382|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
48321284|NCT02409667|155375383|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
48321285|NCT02409667|155375384|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
48321286|NCT02409667|155375385|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
48321287|NCT02409667|155375381|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
48581776|NCT02079636|156321521|FG014|Overall Study|Adverse Event|0|||
48581777|NCT02079636|156321507|FG000|Overall Study|Progressive disease|0|||
48581778|NCT02079636|156321508|FG001|Overall Study|Progressive disease|0|||
48581779|NCT02079636|156321509|FG002|Overall Study|Progressive disease|0|||
48581780|NCT02079636|156321510|FG003|Overall Study|Progressive disease|2|||
48581781|NCT02079636|156321511|FG004|Overall Study|Progressive disease|0|||
48581782|NCT02079636|156321512|FG005|Overall Study|Progressive disease|0|||
48581783|NCT02079636|156321513|FG006|Overall Study|Progressive disease|0|||
48581784|NCT02079636|156321514|FG007|Overall Study|Progressive disease|0|||
48581785|NCT02079636|156321515|FG008|Overall Study|Progressive disease|0|||
48581786|NCT02079636|156321516|FG009|Overall Study|Progressive disease|0|||
48581787|NCT02079636|156321517|FG010|Overall Study|Progressive disease|0|||
48581788|NCT02079636|156321518|FG011|Overall Study|Progressive disease|0|||
48581789|NCT02079636|156321519|FG012|Overall Study|Progressive disease|1|||
48581790|NCT02079636|156321520|FG013|Overall Study|Progressive disease|0|||
48581791|NCT02079636|156321521|FG014|Overall Study|Progressive disease|0|||
48581792|NCT02079636|156321507|FG000|Overall Study|Withdrawal by Subject|0|||
48581793|NCT02079636|156321508|FG001|Overall Study|Withdrawal by Subject|0|||
48581794|NCT02079636|156321509|FG002|Overall Study|Withdrawal by Subject|0|||
48581795|NCT02079636|156321510|FG003|Overall Study|Withdrawal by Subject|4|||
48581796|NCT02079636|156321511|FG004|Overall Study|Withdrawal by Subject|0|||
48581797|NCT02079636|156321512|FG005|Overall Study|Withdrawal by Subject|1|||
48581798|NCT02079636|156321513|FG006|Overall Study|Withdrawal by Subject|0|||
48581799|NCT02079636|156321514|FG007|Overall Study|Withdrawal by Subject|0|||
48581800|NCT02079636|156321515|FG008|Overall Study|Withdrawal by Subject|0|||
48581801|NCT02079636|156321516|FG009|Overall Study|Withdrawal by Subject|2|||
48581802|NCT02079636|156321517|FG010|Overall Study|Withdrawal by Subject|1|||
48581803|NCT02079636|156321518|FG011|Overall Study|Withdrawal by Subject|1|||
48581804|NCT02079636|156321519|FG012|Overall Study|Withdrawal by Subject|1|||
48581805|NCT02079636|156321520|FG013|Overall Study|Withdrawal by Subject|0|||
48581806|NCT02079636|156321521|FG014|Overall Study|Withdrawal by Subject|2|||
48581807|NCT02079636|156321507|FG000|Overall Study|Physician Decision|0|||
48581808|NCT02079636|156321508|FG001|Overall Study|Physician Decision|0|||
48581809|NCT02079636|156321509|FG002|Overall Study|Physician Decision|0|||
48581810|NCT02079636|156321510|FG003|Overall Study|Physician Decision|0|||
48581811|NCT02079636|156321511|FG004|Overall Study|Physician Decision|0|||
48581812|NCT02079636|156321512|FG005|Overall Study|Physician Decision|1|||
48581813|NCT02079636|156321513|FG006|Overall Study|Physician Decision|0|||
48581814|NCT02079636|156321514|FG007|Overall Study|Physician Decision|0|||
48581815|NCT02079636|156321515|FG008|Overall Study|Physician Decision|0|||
48581816|NCT02079636|156321516|FG009|Overall Study|Physician Decision|1|||
48581817|NCT02079636|156321517|FG010|Overall Study|Physician Decision|1|||
48581818|NCT02079636|156321518|FG011|Overall Study|Physician Decision|0|||
48581819|NCT02079636|156321519|FG012|Overall Study|Physician Decision|0|||
48581820|NCT02079636|156321520|FG013|Overall Study|Physician Decision|0|||
48581821|NCT02079636|156321521|FG014|Overall Study|Physician Decision|1|||
48581822|NCT02079636|156321507|FG000|Overall Study|Lost to Follow-up|0|||
48581823|NCT02079636|156321508|FG001|Overall Study|Lost to Follow-up|0|||
48581824|NCT02079636|156321509|FG002|Overall Study|Lost to Follow-up|0|||
48581825|NCT02079636|156321510|FG003|Overall Study|Lost to Follow-up|0|||
48581826|NCT02079636|156321511|FG004|Overall Study|Lost to Follow-up|0|||
48581827|NCT02079636|156321512|FG005|Overall Study|Lost to Follow-up|0|||
48581828|NCT02079636|156321513|FG006|Overall Study|Lost to Follow-up|0|||
48581829|NCT02079636|156321514|FG007|Overall Study|Lost to Follow-up|1|||
48581830|NCT02079636|156321515|FG008|Overall Study|Lost to Follow-up|0|||
48581831|NCT02079636|156321516|FG009|Overall Study|Lost to Follow-up|0|||
48581832|NCT02079636|156321517|FG010|Overall Study|Lost to Follow-up|0|||
48581833|NCT02079636|156321518|FG011|Overall Study|Lost to Follow-up|0|||
48581834|NCT02079636|156321519|FG012|Overall Study|Lost to Follow-up|0|||
48581835|NCT02079636|156321520|FG013|Overall Study|Lost to Follow-up|0|||
48581836|NCT02079636|156321521|FG014|Overall Study|Lost to Follow-up|0|||
48581837|NCT01524783|156321522|FG000|Blinded Period|Adverse Event|64|||
48581838|NCT01524783|156321523|FG001|Blinded Period|Adverse Event|7|||
48581839|NCT01524783|156321524|FG002|Blinded Period|Adverse Event|0|||
48581840|NCT01524783|156321522|FG000|Blinded Period|Disease Progression|89|||
48581841|NCT01524783|156321523|FG001|Blinded Period|Disease Progression|75|||
48581842|NCT01524783|156321524|FG002|Blinded Period|Disease Progression|0|||
48581843|NCT01524783|156321522|FG000|Blinded Period|Withdrawal by Subject|19|||
48581844|NCT01524783|156321523|FG001|Blinded Period|Withdrawal by Subject|6|||
48581845|NCT01524783|156321524|FG002|Blinded Period|Withdrawal by Subject|0|||
48581846|NCT01524783|156321522|FG000|Blinded Period|Protocol deviation|2|||
48581847|NCT01524783|156321523|FG001|Blinded Period|Protocol deviation|1|||
48581848|NCT01524783|156321524|FG002|Blinded Period|Protocol deviation|0|||
48581849|NCT01524783|156321522|FG000|Blinded Period|Death|5|||
48581850|NCT01524783|156321523|FG001|Blinded Period|Death|2|||
48581851|NCT01524783|156321524|FG002|Blinded Period|Death|0|||
48581852|NCT01524783|156321522|FG000|Open-label Period|Disease progression|13|||
48581853|NCT01524783|156321523|FG001|Open-label Period|Disease progression|0|||
48581854|NCT01524783|156321524|FG002|Open-label Period|Disease progression|2|||
48581855|NCT01524783|156321522|FG000|Open-label Period|Administrative problems|5|||
48581856|NCT01524783|156321523|FG001|Open-label Period|Administrative problems|0|||
48581857|NCT01524783|156321524|FG002|Open-label Period|Administrative problems|2|||
48581858|NCT01524783|156321522|FG000|Open-label Period|Adverse Event|5|||
48581859|NCT01524783|156321523|FG001|Open-label Period|Adverse Event|0|||
48581860|NCT01524783|156321524|FG002|Open-label Period|Adverse Event|1|||
48581861|NCT01524783|156321522|FG000|Open-label Period|Withdrawal by Subject|2|||
48581862|NCT01524783|156321523|FG001|Open-label Period|Withdrawal by Subject|0|||
48581863|NCT01524783|156321524|FG002|Open-label Period|Withdrawal by Subject|1|||
48581864|NCT01524783|156321522|FG000|Open-label Period|Protocol deviation|1|||
48581865|NCT01524783|156321523|FG001|Open-label Period|Protocol deviation|0|||
48581866|NCT01524783|156321524|FG002|Open-label Period|Protocol deviation|0|||
48581867|NCT01797081|156321525|FG000|Overall Study|Adverse Event|1|||
48581868|NCT01797081|156321526|FG001|Overall Study|Adverse Event|0|||
48581869|NCT01797081|156321527|FG002|Overall Study|Adverse Event|1|||
48581870|NCT01797081|156321528|FG003|Overall Study|Adverse Event|0|||
48581871|NCT01797081|156321525|FG000|Overall Study|Pregnancy|1|||
48581872|NCT01797081|156321526|FG001|Overall Study|Pregnancy|0|||
48581873|NCT01797081|156321527|FG002|Overall Study|Pregnancy|0|||
48581874|NCT01797081|156321528|FG003|Overall Study|Pregnancy|0|||
48581875|NCT01797081|156321525|FG000|Overall Study|Personal Reasons|12|||
48581876|NCT01797081|156321526|FG001|Overall Study|Personal Reasons|4|||
48581877|NCT01797081|156321527|FG002|Overall Study|Personal Reasons|4|||
48738548|NCT02110238|156892541|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
48738549|NCT02110238|156892542|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
48738550|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
48738551|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
48738552|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
48738553|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
48738554|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
48581878|NCT01797081|156321528|FG003|Overall Study|Personal Reasons|8|||
48581879|NCT01797081|156321525|FG000|Overall Study|Protocol Violation|0|||
48581880|NCT01797081|156321526|FG001|Overall Study|Protocol Violation|0|||
48581881|NCT01797081|156321527|FG002|Overall Study|Protocol Violation|0|||
48581882|NCT01797081|156321528|FG003|Overall Study|Protocol Violation|1|||
48581883|NCT01253174|156321531|FG000|Period 1|Randomized but not treated|0|||
48581884|NCT01253174|156321532|FG001|Period 1|Randomized but not treated|1|||
48738555|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
48581885|NCT01253174|156321533|FG002|Period 1|Randomized but not treated|1|||
48581886|NCT01253174|156321534|FG003|Period 1|Randomized but not treated|0|||
48581887|NCT01253174|156321535|FG004|Period 1|Randomized but not treated|1|||
48581888|NCT01253174|156321536|FG005|Period 1|Randomized but not treated|0|||
48581889|NCT01253174|156321531|FG000|Period 2|Adverse Event|0|||
48581890|NCT01253174|156321532|FG001|Period 2|Adverse Event|0|||
48581891|NCT01253174|156321533|FG002|Period 2|Adverse Event|1|||
48581892|NCT01253174|156321534|FG003|Period 2|Adverse Event|0|||
48581893|NCT01253174|156321535|FG004|Period 2|Adverse Event|0|||
48581894|NCT01253174|156321536|FG005|Period 2|Adverse Event|0|||
48581895|NCT01253174|156321531|FG000|Period 3|Withdrawal by Subject|0|||
48581896|NCT01253174|156321532|FG001|Period 3|Withdrawal by Subject|1|||
48581897|NCT01253174|156321533|FG002|Period 3|Withdrawal by Subject|0|||
48581898|NCT01253174|156321534|FG003|Period 3|Withdrawal by Subject|0|||
48581899|NCT01253174|156321535|FG004|Period 3|Withdrawal by Subject|1|||
48581900|NCT01253174|156321536|FG005|Period 3|Withdrawal by Subject|0|||
48581901|NCT01253174|156321531|FG000|Period 3|Pregnancy|0|||
48581902|NCT01253174|156321532|FG001|Period 3|Pregnancy|0|||
48581903|NCT01253174|156321533|FG002|Period 3|Pregnancy|1|||
48581904|NCT01253174|156321534|FG003|Period 3|Pregnancy|0|||
48581905|NCT01253174|156321535|FG004|Period 3|Pregnancy|0|||
48581906|NCT01253174|156321536|FG005|Period 3|Pregnancy|0|||
48581907|NCT02345889|156321537|FG000|Overall Study|Inadequate Bowel Prep|17|||
48581908|NCT02345889|156321538|FG001|Overall Study|Inadequate Bowel Prep|16|||
48581909|NCT02345889|156321539|FG002|Overall Study|Inadequate Bowel Prep|18|||
48581910|NCT02345889|156321540|FG003|Overall Study|Inadequate Bowel Prep|14|||
48581911|NCT02345889|156321537|FG000|Overall Study|Polyposis identified during procedure|1|||
48581912|NCT02345889|156321538|FG001|Overall Study|Polyposis identified during procedure|1|||
48581913|NCT02345889|156321539|FG002|Overall Study|Polyposis identified during procedure|0|||
48581914|NCT02345889|156321540|FG003|Overall Study|Polyposis identified during procedure|1|||
48581915|NCT02345889|156321537|FG000|Overall Study|Recognized ineligible post-randomization|1|||
48581916|NCT02345889|156321538|FG001|Overall Study|Recognized ineligible post-randomization|0|||
48581917|NCT02345889|156321539|FG002|Overall Study|Recognized ineligible post-randomization|2|||
48581918|NCT02345889|156321540|FG003|Overall Study|Recognized ineligible post-randomization|1|||
48581919|NCT02345889|156321537|FG000|Overall Study|Ulcerative Colitis identified|1|||
48581920|NCT02345889|156321538|FG001|Overall Study|Ulcerative Colitis identified|0|||
48581921|NCT02345889|156321539|FG002|Overall Study|Ulcerative Colitis identified|0|||
48581922|NCT02345889|156321540|FG003|Overall Study|Ulcerative Colitis identified|0|||
48581923|NCT02345889|156321537|FG000|Overall Study|Cecum not intubated|1|||
48581924|NCT02345889|156321538|FG001|Overall Study|Cecum not intubated|0|||
48581925|NCT02345889|156321539|FG002|Overall Study|Cecum not intubated|0|||
48581926|NCT02345889|156321540|FG003|Overall Study|Cecum not intubated|0|||
48581927|NCT05153148|156321541|FG000|Overall Study|Adverse Event|1|||
48581928|NCT05153148|156321542|FG001|Overall Study|Adverse Event|0|||
48581929|NCT05153148|156321543|FG002|Overall Study|Adverse Event|3|||
48581930|NCT05153148|156321544|FG003|Overall Study|Adverse Event|5|||
48581931|NCT05153148|156321541|FG000|Overall Study|Lost to Follow-up|1|||
48581932|NCT05153148|156321542|FG001|Overall Study|Lost to Follow-up|1|||
48581933|NCT05153148|156321543|FG002|Overall Study|Lost to Follow-up|2|||
48581934|NCT05153148|156321544|FG003|Overall Study|Lost to Follow-up|0|||
48738556|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
48738557|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
48738558|NCT02110238|156892541|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
48738559|NCT02110238|156892542|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
48738560|NCT01604408|156892543|FG000|Treatment Period 1|Protocol Violation|0|||
48738561|NCT01604408|156892544|FG001|Treatment Period 1|Protocol Violation|1|||
48738562|NCT01604408|156892543|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48738563|NCT01604408|156892544|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48738564|NCT01604408|156892543|FG000|Treatment Period 2|Protocol Violation|1|||
48738565|NCT01604408|156892544|FG001|Treatment Period 2|Protocol Violation|0|||
48738566|NCT01604408|156892543|FG000|Treatment Period 2|Adverse Event|0|||
48738567|NCT01604408|156892544|FG001|Treatment Period 2|Adverse Event|1|||
48738568|NCT01604408|156892543|FG000|Treatment Period 3|Protocol Violation|1|||
48738569|NCT01604408|156892544|FG001|Treatment Period 3|Protocol Violation|1|||
48738570|NCT01604408|156892543|FG000|Treatment Period 3|Adverse Event|0|||
48738571|NCT01604408|156892544|FG001|Treatment Period 3|Adverse Event|3|||
48738572|NCT01604408|156892543|FG000|Treatment Period 3|Withdrawal by Subject|3|||
48738573|NCT01604408|156892544|FG001|Treatment Period 3|Withdrawal by Subject|1|||
48581935|NCT05153148|156321541|FG000|Overall Study|Withdrawal by Subject|6|||
48581936|NCT05153148|156321542|FG001|Overall Study|Withdrawal by Subject|8|||
48581937|NCT05153148|156321543|FG002|Overall Study|Withdrawal by Subject|6|||
48738574|NCT01604408|156892543|FG000|Treatment Period 3|Sponsor Decision|1|||
48738575|NCT01604408|156892544|FG001|Treatment Period 3|Sponsor Decision|0|||
48738576|NCT01604408|156892543|FG000|Treatment Period 4|Death|1|||
48321288|NCT02409667|155375382|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
48581938|NCT05153148|156321544|FG003|Overall Study|Withdrawal by Subject|8|||
48581939|NCT05153148|156321541|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
48581940|NCT05153148|156321542|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
48581941|NCT05153148|156321543|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
48581942|NCT05153148|156321544|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
48581943|NCT05153148|156321541|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
48581944|NCT05153148|156321542|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
48738577|NCT01604408|156892544|FG001|Treatment Period 4|Death|0|||
48738578|NCT01604408|156892543|FG000|Treatment Period 4|Withdrawal by Subject|2|||
48738579|NCT01604408|156892544|FG001|Treatment Period 4|Withdrawal by Subject|1|||
48738580|NCT01604408|156892543|FG000|Treatment Period 4|Adverse Event|0|||
48738581|NCT01604408|156892544|FG001|Treatment Period 4|Adverse Event|1|||
48738582|NCT01604408|156892543|FG000|Treatment Period 5|Adverse Event|4|||
48738583|NCT01604408|156892544|FG001|Treatment Period 5|Adverse Event|0|||
48738584|NCT01604408|156892543|FG000|Treatment Period 6|Lost to Follow-up|0|||
48738585|NCT01604408|156892544|FG001|Treatment Period 6|Lost to Follow-up|1|||
48738586|NCT01604408|156892543|FG000|Treatment Period 6|Adverse Event|2|||
48738587|NCT01604408|156892544|FG001|Treatment Period 6|Adverse Event|0|||
48738588|NCT01604408|156892543|FG000|Treatment Period 6|Sponsor decision|0|||
48738589|NCT01604408|156892544|FG001|Treatment Period 6|Sponsor decision|1|||
48738590|NCT01604408|156892543|FG000|Observation Period|Adverse Event|1|||
48738591|NCT01604408|156892544|FG001|Observation Period|Adverse Event|1|||
48738592|NCT01604408|156892543|FG000|Observation Period|Withdrawal by Subject|0|||
48738593|NCT01604408|156892544|FG001|Observation Period|Withdrawal by Subject|2|||
48738594|NCT00917501|156892545|FG000|Overall Study|Lost to Follow-up|4|||
48738595|NCT00917501|156892546|FG001|Overall Study|Lost to Follow-up|1|||
48738596|NCT00917501|156892545|FG000|Overall Study|Withdrawal by Subject|3|||
48738597|NCT00917501|156892546|FG001|Overall Study|Withdrawal by Subject|1|||
48738598|NCT00917501|156892545|FG000|Overall Study|Lack of Efficacy|1|||
48738599|NCT00917501|156892546|FG001|Overall Study|Lack of Efficacy|2|||
48738600|NCT00917501|156892545|FG000|Overall Study|trouble swollowing capsules|0|||
48738601|NCT00917501|156892546|FG001|Overall Study|trouble swollowing capsules|1|||
48738602|NCT02410551|156892552|FG000|Overall Study|Adverse Event|1|||
48738603|NCT02410551|156892552|FG000|Overall Study|Withdrawal by Subject|1|||
48738604|NCT02410551|156892552|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
48738605|NCT01419626|156892553|FG000|Overall Study|Protocol Violation|3|||
48738606|NCT01419626|156892554|FG001|Overall Study|Protocol Violation|2|||
48738607|NCT01419626|156892555|FG002|Overall Study|Protocol Violation|2|||
48738608|NCT01419626|156892553|FG000|Overall Study|Withdrawal by Subject|1|||
48738609|NCT01419626|156892554|FG001|Overall Study|Withdrawal by Subject|0|||
48738610|NCT01419626|156892555|FG002|Overall Study|Withdrawal by Subject|0|||
48738611|NCT01419626|156892553|FG000|Overall Study|Lost to Follow-up|0|||
48738612|NCT01419626|156892554|FG001|Overall Study|Lost to Follow-up|1|||
48738613|NCT01419626|156892555|FG002|Overall Study|Lost to Follow-up|1|||
48738614|NCT02609828|156892556|FG000|Overall Study|Adverse Event|8|||
48738615|NCT02609828|156892557|FG001|Overall Study|Adverse Event|1|||
48738616|NCT02609828|156892558|FG002|Overall Study|Adverse Event|0|||
48738617|NCT02609828|156892559|FG003|Overall Study|Adverse Event|6|||
48738618|NCT02609828|156892556|FG000|Overall Study|Death|15|||
48738619|NCT02609828|156892557|FG001|Overall Study|Death|1|||
48738620|NCT02609828|156892558|FG002|Overall Study|Death|1|||
48738621|NCT02609828|156892559|FG003|Overall Study|Death|19|||
48738622|NCT02609828|156892556|FG000|Overall Study|Insufficient clinical response|2|||
48738623|NCT02609828|156892557|FG001|Overall Study|Insufficient clinical response|1|||
48738624|NCT02609828|156892558|FG002|Overall Study|Insufficient clinical response|0|||
48738625|NCT02609828|156892559|FG003|Overall Study|Insufficient clinical response|0|||
48738626|NCT02609828|156892556|FG000|Overall Study|Lost to Follow-up|0|||
48581945|NCT05153148|156321543|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
48581946|NCT05153148|156321544|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
48587373|NCT05268016|156343200|FG003|Overall Study|Other|2|||
48738627|NCT02609828|156892557|FG001|Overall Study|Lost to Follow-up|0|||
48738628|NCT02609828|156892558|FG002|Overall Study|Lost to Follow-up|0|||
48738629|NCT02609828|156892559|FG003|Overall Study|Lost to Follow-up|1|||
48738630|NCT02609828|156892556|FG000|Overall Study|Protocol Violation|2|||
48738631|NCT02609828|156892557|FG001|Overall Study|Protocol Violation|0|||
48738632|NCT02609828|156892558|FG002|Overall Study|Protocol Violation|0|||
48738633|NCT02609828|156892559|FG003|Overall Study|Protocol Violation|1|||
48738634|NCT02609828|156892556|FG000|Overall Study|Withdrawal by Subject|12|||
48738635|NCT02609828|156892557|FG001|Overall Study|Withdrawal by Subject|1|||
48738636|NCT02609828|156892558|FG002|Overall Study|Withdrawal by Subject|0|||
48738637|NCT02609828|156892559|FG003|Overall Study|Withdrawal by Subject|10|||
48738638|NCT02609828|156892556|FG000|Overall Study|Other|3|||
48738639|NCT02609828|156892557|FG001|Overall Study|Other|0|||
48738640|NCT02609828|156892558|FG002|Overall Study|Other|0|||
48738641|NCT02609828|156892559|FG003|Overall Study|Other|6|||
48738642|NCT02609828|156892556|FG000|Overall Study|Randomized but not treated|1|||
48738643|NCT02609828|156892557|FG001|Overall Study|Randomized but not treated|0|||
48738644|NCT02609828|156892558|FG002|Overall Study|Randomized but not treated|0|||
48738645|NCT02609828|156892559|FG003|Overall Study|Randomized but not treated|0|||
48738646|NCT00747812|156892570|FG000|Overall Study|Research Site Staff Relocation|5|||
48738647|NCT00747812|156892571|FG001|Overall Study|Research Site Staff Relocation|3|||
48738648|NCT03208127|156892573|FG000|Overall Study|Death|1|||
48738649|NCT00660673|156892574|FG000|Overall Study|Adverse Event|84|||
48738650|NCT00660673|156892574|FG000|Overall Study|Lack of Efficacy|7|||
48738651|NCT00660673|156892574|FG000|Overall Study|Withdrawal by Subject|22|||
48738652|NCT00660673|156892574|FG000|Overall Study|Administrative|2|||
48738653|NCT00660673|156892574|FG000|Overall Study|Protocol Violation|2|||
48738654|NCT01786148|156892575|FG000|Overall Study|Lost to Follow-up|21|||
48738655|NCT01786148|156892576|FG001|Overall Study|Lost to Follow-up|13|||
48738656|NCT01786148|156892575|FG000|Overall Study|Death|0|||
48738657|NCT01786148|156892576|FG001|Overall Study|Death|1|||
48738658|NCT01786148|156892575|FG000|Overall Study|Withdrawal by Subject|0|||
48738659|NCT01786148|156892576|FG001|Overall Study|Withdrawal by Subject|7|||
48738660|NCT01786148|156892575|FG000|Overall Study|Incarceration|1|||
48738661|NCT01786148|156892576|FG001|Overall Study|Incarceration|1|||
48738662|NCT00239590|156892577|FG000|Randomized|Lost to Follow-up|0|||
48738663|NCT00239590|156892578|FG001|Randomized|Lost to Follow-up|1|||
48738664|NCT00239590|156892577|FG000|Randomized|Withdrawal by Subject|0|||
48738665|NCT00239590|156892578|FG001|Randomized|Withdrawal by Subject|1|||
48738666|NCT00239590|156892577|FG000|Completed Study Protocol|Adverse Event|1|||
48738667|NCT00239590|156892578|FG001|Completed Study Protocol|Adverse Event|1|||
48738668|NCT00239590|156892577|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
48738669|NCT00239590|156892578|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
48738670|NCT03000569|156892579|FG000|Overall Study|Withdrawal by Subject|1|||
48738671|NCT03000569|156892580|FG001|Overall Study|Withdrawal by Subject|0|||
48738672|NCT00968864|156892581|FG000|Overall Study|Protocol exception/ not evaluable|1|||
48738673|NCT00657358|156892584|FG000|Overall Study|Lack of Efficacy|6|||
48738674|NCT01752985|156892587|FG000|Treatment Period|Subject request to discontinue treatment|1|||
48738675|NCT01752985|156892588|FG001|Treatment Period|Subject request to discontinue treatment|0|||
48738676|NCT01752985|156892589|FG002|Treatment Period|Subject request to discontinue treatment|1|||
48738677|NCT01752985|156892587|FG000|Treatment Period|Subject no longer meets study criteria|0|||
48738678|NCT01752985|156892588|FG001|Treatment Period|Subject no longer meets study criteria|1|||
48738679|NCT01752985|156892589|FG002|Treatment Period|Subject no longer meets study criteria|1|||
48738680|NCT01752985|156892587|FG000|Treatment Period|Adverse Event|2|||
48738681|NCT01752985|156892588|FG001|Treatment Period|Adverse Event|1|||
48738682|NCT01752985|156892589|FG002|Treatment Period|Adverse Event|2|||
48738683|NCT01752985|156892587|FG000|Treatment Period|Withdrawal by Subject|1|||
48738684|NCT01752985|156892588|FG001|Treatment Period|Withdrawal by Subject|1|||
48738685|NCT01752985|156892589|FG002|Treatment Period|Withdrawal by Subject|0|||
48738686|NCT01752985|156892587|FG000|Treatment Period|Lost to Follow-up|0|||
48738687|NCT01752985|156892588|FG001|Treatment Period|Lost to Follow-up|0|||
48738688|NCT01752985|156892589|FG002|Treatment Period|Lost to Follow-up|1|||
48738689|NCT03546062|156892596|FG000|Overall Study|Adverse Event|6|||
48738690|NCT03546062|156892597|FG001|Overall Study|Adverse Event|5|||
48738691|NCT03546062|156892598|FG002|Overall Study|Adverse Event|8|||
48738692|NCT02130297|156892599|FG000|Overall Study|Lost to Follow-up|4|||
48738693|NCT03308786|156892600|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
48738694|NCT02949700|156892603|FG000|Phase I|Withdrawal by Subject|1|||
48738695|NCT02949700|156892604|FG001|Phase I|Withdrawal by Subject|1|||
48738696|NCT02949700|156892605|FG002|Phase I|Withdrawal by Subject|0|||
48738697|NCT02949700|156892606|FG003|Phase I|Withdrawal by Subject|0|||
48738698|NCT02949700|156892603|FG000|Phase I|Protocol Violation|1|||
48738699|NCT02949700|156892604|FG001|Phase I|Protocol Violation|0|||
48738700|NCT02949700|156892605|FG002|Phase I|Protocol Violation|0|||
48738701|NCT02949700|156892606|FG003|Phase I|Protocol Violation|0|||
48738702|NCT02949700|156892603|FG000|Phase II|Withdrawal by Subject|0|||
48738703|NCT02949700|156892604|FG001|Phase II|Withdrawal by Subject|0|||
48738704|NCT02949700|156892605|FG002|Phase II|Withdrawal by Subject|0|||
48738705|NCT02949700|156892606|FG003|Phase II|Withdrawal by Subject|2|||
48738706|NCT02949700|156892603|FG000|Phase II|Protocol Violation|0|||
48738707|NCT02949700|156892604|FG001|Phase II|Protocol Violation|0|||
48738708|NCT02949700|156892605|FG002|Phase II|Protocol Violation|1|||
48738709|NCT02949700|156892606|FG003|Phase II|Protocol Violation|3|||
48738710|NCT00806351|156892609|FG000|Overall Study|Death|5|||
48738711|NCT00806351|156892610|FG001|Overall Study|Death|4|||
48738712|NCT02187744|156892611|FG000|Study|Participant refused further follow-up|1|||
48738713|NCT02187744|156892612|FG001|Study|Participant refused further follow-up|0|||
48738714|NCT02187744|156892611|FG000|Study|Other|2|||
48738715|NCT02187744|156892612|FG001|Study|Other|1|||
48738716|NCT02187744|156892611|FG000|Study|Lost to Follow-up|0|||
48738717|NCT02187744|156892612|FG001|Study|Lost to Follow-up|2|||
48738718|NCT02187744|156892611|FG000|Study|Related adverse event, not serious|0|||
48738719|NCT02187744|156892612|FG001|Study|Related adverse event, not serious|2|||
48321289|NCT02409667|155375383|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
48321290|NCT02409667|155375384|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
48581947|NCT05153148|156321541|FG000|Overall Study|Reason not Specified|1|||
48581948|NCT05153148|156321542|FG001|Overall Study|Reason not Specified|1|||
48581949|NCT05153148|156321543|FG002|Overall Study|Reason not Specified|1|||
48581950|NCT05153148|156321544|FG003|Overall Study|Reason not Specified|1|||
48581951|NCT01854879|156321545|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
48581952|NCT01854879|156321545|FG000|Overall Study|screen fail|3|||
48581953|NCT01854879|156321545|FG000|Overall Study|incomplete data set|1|||
48581954|NCT00358956|156321546|FG000|Overall Study|Adverse Event|3|||
48581955|NCT00358956|156321546|FG000|Overall Study|condition under investigation worsened|4|||
48581956|NCT00358956|156321546|FG000|Overall Study|Withdrawal by Subject|1|||
48581957|NCT03813147|156321547|FG000|Overall Study|Lack of Efficacy|4|||
48581958|NCT03813147|156321548|FG001|Overall Study|Lack of Efficacy|4|||
48321291|NCT02409667|155375385|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
48321292|NCT01094184|155375386|FG000|Overall Study|Death|35|||
48321293|NCT01094184|155375387|FG001|Overall Study|Death|11|||
48321294|NCT03912831|155375388|FG000|Overall Study|Death|1|||
48321295|NCT03912831|155375389|FG001|Overall Study|Death|1|||
48738720|NCT02187744|156892611|FG000|Study|Death|1|||
48738721|NCT02187744|156892612|FG001|Study|Death|0|||
48738722|NCT02187744|156892611|FG000|Study|Related adverse event, serious non-fatal|0|||
48738723|NCT02187744|156892612|FG001|Study|Related adverse event, serious non-fatal|1|||
48738724|NCT02187744|156892611|FG000|Treatment|Death|1|||
48738725|NCT02187744|156892612|FG001|Treatment|Death|0|||
48738726|NCT02187744|156892611|FG000|Treatment|Related adverse event, serious non-fatal|0|||
48738727|NCT02187744|156892612|FG001|Treatment|Related adverse event, serious non-fatal|1|||
48738728|NCT02187744|156892611|FG000|Treatment|Related adverse event, not serious|0|||
48321296|NCT03912831|155375390|FG002|Overall Study|Death|1|||
48581959|NCT03813147|156321547|FG000|Overall Study|Physician Decision|2|||
48581960|NCT03813147|156321548|FG001|Overall Study|Physician Decision|1|||
48581961|NCT04253782|156321549|FG000|Overall Study|Death|2|||
48581962|NCT04253782|156321550|FG001|Overall Study|Death|0|||
48581963|NCT01306045|156321552|FG000|Met General Eligibility Criteria|Screen failures|193|||
48581964|NCT01306045|156321553|FG001|Met General Eligibility Criteria|Screen failures|11|||
48581965|NCT01306045|156321554|FG002|Met General Eligibility Criteria|Screen failures|8|||
48738729|NCT02187744|156892612|FG001|Treatment|Related adverse event, not serious|2|||
48321297|NCT03912831|155375391|FG003|Overall Study|Death|1|||
48581966|NCT04250350|156323172|FG000|Overall Study|Withdrawal by Subject|13|||
48581967|NCT04250350|156323172|FG000|Overall Study|Lost to Follow-up|8|||
48581968|NCT04250350|156323172|FG000|Overall Study|Adverse Event|5|||
48581969|NCT04250350|156323172|FG000|Overall Study|Lack of Efficacy|4|||
48581970|NCT04250350|156323172|FG000|Overall Study|Physician Decision|1|||
48581971|NCT04250350|156323172|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
48581972|NCT01279070|156323173|FG000|Overall Study|Withdrawal by Subject|2|||
48738730|NCT02187744|156892611|FG000|Treatment|Lost to Follow-up|0|||
48738731|NCT02187744|156892612|FG001|Treatment|Lost to Follow-up|1|||
48738732|NCT02187744|156892611|FG000|Treatment|Other|2|||
48738733|NCT02187744|156892612|FG001|Treatment|Other|0|||
48738734|NCT02187744|156892611|FG000|Treatment|Participant refused continued treatment|1|||
48738735|NCT02187744|156892612|FG001|Treatment|Participant refused continued treatment|1|||
48738736|NCT01972568|156892617|FG000|Overall Study|Other events|3|||
48738737|NCT01972568|156892618|FG001|Overall Study|Other events|0|||
48581973|NCT01279070|156323174|FG001|Overall Study|Withdrawal by Subject|3|||
48581974|NCT01279070|156323173|FG000|Overall Study|Acute exacerbation|3|||
48581975|NCT01279070|156323174|FG001|Overall Study|Acute exacerbation|1|||
48581976|NCT04161079|156323175|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
48581977|NCT02086448|156323179|FG000|Overall Study|Withdrawal by Subject|1|||
48581978|NCT02086448|156323180|FG001|Overall Study|Withdrawal by Subject|0|||
48581979|NCT02086448|156323181|FG002|Overall Study|Withdrawal by Subject|0|||
48581980|NCT02086448|156323182|FG003|Overall Study|Withdrawal by Subject|2|||
48581981|NCT01446237|156323184|FG000|Overall Study|Adverse Event|1|||
48581982|NCT01446237|156323184|FG000|Overall Study|Lost to Follow-up|2|||
48581983|NCT01446237|156323184|FG000|Overall Study|Withdrawal by Subject|7|||
48581984|NCT00843037|156323185|FG000|Overall Study|Lost to Follow-up|1|||
48581985|NCT04829331|156323186|FG000|Overall Study|Lost to Follow-up|1|||
48581986|NCT04829331|156323187|FG001|Overall Study|Lost to Follow-up|0|||
48581987|NCT04329091|156323188|FG000|Overall Study|Physician Decision|5|||
48738738|NCT01972568|156892619|FG002|Overall Study|Other events|0|||
48738739|NCT01972568|156892617|FG000|Overall Study|Lack of Efficacy|0|||
48738740|NCT01972568|156892618|FG001|Overall Study|Lack of Efficacy|1|||
48738741|NCT01972568|156892619|FG002|Overall Study|Lack of Efficacy|2|||
48738742|NCT01972568|156892617|FG000|Overall Study|Protocol Violation|1|||
48738743|NCT01972568|156892618|FG001|Overall Study|Protocol Violation|2|||
48738744|NCT01972568|156892619|FG002|Overall Study|Protocol Violation|2|||
48738745|NCT01972568|156892617|FG000|Overall Study|Withdrawal by Subject|6|||
48738746|NCT01972568|156892618|FG001|Overall Study|Withdrawal by Subject|3|||
48738747|NCT01972568|156892619|FG002|Overall Study|Withdrawal by Subject|7|||
48738748|NCT01972568|156892617|FG000|Overall Study|Lost to Follow-up|1|||
48738749|NCT01972568|156892618|FG001|Overall Study|Lost to Follow-up|0|||
48738750|NCT01972568|156892619|FG002|Overall Study|Lost to Follow-up|0|||
48738751|NCT01972568|156892617|FG000|Overall Study|Adverse Event|5|||
48581988|NCT01741792|156323189|FG000|Overall Study|Death|6|||
48581989|NCT01741792|156323190|FG001|Overall Study|Death|1|||
48581990|NCT01741792|156323191|FG002|Overall Study|Death|12|||
48581991|NCT00423189|156323192|FG000|Overall Study|Death|0|||
48581992|NCT00423189|156323193|FG001|Overall Study|Death|1|||
48581993|NCT00423189|156323194|FG002|Overall Study|Death|0|||
48581994|NCT00741091|156323197|FG000|Overall Study|Death|13|||
48581995|NCT00741091|156323197|FG000|Overall Study|Lost to Follow-up|16|||
48581996|NCT00741091|156323197|FG000|Overall Study|Withdrawal by Subject|6|||
48581997|NCT00741091|156323197|FG000|Overall Study|Missed Visit|22|||
48581998|NCT05323994|156323198|FG000|Overall Study|Protocol Violation|1|||
48738752|NCT01972568|156892618|FG001|Overall Study|Adverse Event|6|||
48738753|NCT01972568|156892619|FG002|Overall Study|Adverse Event|5|||
48738754|NCT03113071|156892620|FG000|Overall Study|Withdrawal by Subject|1|||
48738755|NCT03113071|156892621|FG001|Overall Study|Withdrawal by Subject|0|||
48738756|NCT01602120|156892622|FG000|Overall Study|Adverse Event|3|||
48738757|NCT01602120|156892623|FG001|Overall Study|Adverse Event|6|||
48738758|NCT01602120|156892624|FG002|Overall Study|Adverse Event|0|||
48738759|NCT01602120|156892625|FG003|Overall Study|Adverse Event|2|||
48738760|NCT01602120|156892622|FG000|Overall Study|Death|0|||
48738761|NCT01602120|156892623|FG001|Overall Study|Death|4|||
48738762|NCT01602120|156892624|FG002|Overall Study|Death|0|||
48738763|NCT01602120|156892625|FG003|Overall Study|Death|0|||
48738764|NCT01602120|156892622|FG000|Overall Study|Lost to Follow-up|0|||
48738765|NCT01602120|156892623|FG001|Overall Study|Lost to Follow-up|1|||
48738766|NCT01602120|156892624|FG002|Overall Study|Lost to Follow-up|0|||
48738767|NCT01602120|156892625|FG003|Overall Study|Lost to Follow-up|1|||
48738768|NCT01602120|156892622|FG000|Overall Study|Protocol Violation|1|||
48738769|NCT01602120|156892623|FG001|Overall Study|Protocol Violation|1|||
48738770|NCT01602120|156892624|FG002|Overall Study|Protocol Violation|0|||
48738771|NCT01602120|156892625|FG003|Overall Study|Protocol Violation|0|||
48738772|NCT01602120|156892622|FG000|Overall Study|Non-compliance|0|||
48738773|NCT01602120|156892623|FG001|Overall Study|Non-compliance|3|||
48738774|NCT01602120|156892624|FG002|Overall Study|Non-compliance|0|||
48581999|NCT00460265|156323201|FG000|Overall Study|Lost to Follow-up|14|||
48582000|NCT00460265|156323202|FG001|Overall Study|Lost to Follow-up|15|||
48582001|NCT00460265|156323201|FG000|Overall Study|Physician Decision|1|||
48582002|NCT00460265|156323202|FG001|Overall Study|Physician Decision|2|||
48582003|NCT00460265|156323201|FG000|Overall Study|Withdrawal by Subject|10|||
48582004|NCT00460265|156323202|FG001|Overall Study|Withdrawal by Subject|25|||
48582005|NCT00460265|156323201|FG000|Overall Study|Ongoing|60|||
48738775|NCT01602120|156892625|FG003|Overall Study|Non-compliance|1|||
48738776|NCT01602120|156892622|FG000|Overall Study|Withdrawal by Subject|8|||
48738777|NCT01602120|156892623|FG001|Overall Study|Withdrawal by Subject|17|||
48738778|NCT01602120|156892624|FG002|Overall Study|Withdrawal by Subject|0|||
48738779|NCT01602120|156892625|FG003|Overall Study|Withdrawal by Subject|3|||
48582006|NCT00460265|156323202|FG001|Overall Study|Ongoing|47|||
48582007|NCT01801358|156323206|FG000|Overall Study|Adverse Event|0|||
48582008|NCT01801358|156323207|FG001|Overall Study|Adverse Event|2|||
48321298|NCT03912831|155375392|FG004|Overall Study|Death|1|||
48321299|NCT03912831|155375393|FG005|Overall Study|Death|1|||
48582009|NCT01801358|156323208|FG002|Overall Study|Adverse Event|1|||
48321300|NCT03912831|155375388|FG000|Overall Study|Reason not Specified|0|||
48321301|NCT03912831|155375389|FG001|Overall Study|Reason not Specified|0|||
48321302|NCT03912831|155375390|FG002|Overall Study|Reason not Specified|0|||
48321303|NCT03912831|155375391|FG003|Overall Study|Reason not Specified|0|||
48321304|NCT03912831|155375392|FG004|Overall Study|Reason not Specified|1|||
48321305|NCT03912831|155375393|FG005|Overall Study|Reason not Specified|0|||
48321306|NCT03912831|155375388|FG000|Overall Study|Withdrawal by Participant|0|||
48321307|NCT03912831|155375389|FG001|Overall Study|Withdrawal by Participant|0|||
48321308|NCT03912831|155375390|FG002|Overall Study|Withdrawal by Participant|0|||
48321309|NCT03912831|155375391|FG003|Overall Study|Withdrawal by Participant|0|||
48321310|NCT03912831|155375392|FG004|Overall Study|Withdrawal by Participant|1|||
48321311|NCT03912831|155375393|FG005|Overall Study|Withdrawal by Participant|0|||
48321312|NCT03580369|155375394|FG000|Overall Study|No treatment due to mis-randomization|1|||
48321313|NCT03580369|155375395|FG001|Overall Study|No treatment due to mis-randomization|0|||
48321314|NCT03580369|155375396|FG002|Overall Study|No treatment due to mis-randomization|0|||
48321315|NCT03580369|155375397|FG003|Overall Study|No treatment due to mis-randomization|0|||
48321316|NCT03580369|155375398|FG004|Overall Study|No treatment due to mis-randomization|3|||
48321317|NCT03580369|155375399|FG005|Overall Study|No treatment due to mis-randomization|0|||
48321318|NCT03580369|155375400|FG006|Overall Study|No treatment due to mis-randomization|0|||
48321319|NCT03580369|155375401|FG007|Overall Study|No treatment due to mis-randomization|0|||
48321320|NCT03580369|155375394|FG000|Overall Study|Reason unknown|0|||
48321321|NCT03580369|155375395|FG001|Overall Study|Reason unknown|0|||
48321322|NCT03580369|155375396|FG002|Overall Study|Reason unknown|1|||
48321323|NCT03580369|155375397|FG003|Overall Study|Reason unknown|0|||
48321324|NCT03580369|155375398|FG004|Overall Study|Reason unknown|0|||
48321325|NCT03580369|155375399|FG005|Overall Study|Reason unknown|0|||
48321326|NCT03580369|155375400|FG006|Overall Study|Reason unknown|0|||
48321327|NCT03580369|155375401|FG007|Overall Study|Reason unknown|0|||
48321328|NCT03580369|155375394|FG000|Overall Study|Technical problems|0|||
48321329|NCT03580369|155375395|FG001|Overall Study|Technical problems|0|||
48321330|NCT03580369|155375396|FG002|Overall Study|Technical problems|0|||
48321331|NCT03580369|155375397|FG003|Overall Study|Technical problems|0|||
48321332|NCT03580369|155375398|FG004|Overall Study|Technical problems|1|||
48582010|NCT01801358|156323209|FG003|Overall Study|Adverse Event|0|||
48582011|NCT01801358|156323210|FG004|Overall Study|Adverse Event|0|||
48582012|NCT01801358|156323211|FG005|Overall Study|Adverse Event|1|||
48582013|NCT01801358|156323206|FG000|Overall Study|Physician Decision|0|||
48582014|NCT01801358|156323207|FG001|Overall Study|Physician Decision|0|||
48582015|NCT01801358|156323208|FG002|Overall Study|Physician Decision|1|||
48582016|NCT01801358|156323209|FG003|Overall Study|Physician Decision|0|||
48582017|NCT01801358|156323210|FG004|Overall Study|Physician Decision|0|||
48582018|NCT01801358|156323211|FG005|Overall Study|Physician Decision|0|||
48582019|NCT01801358|156323206|FG000|Overall Study|Progressive Disease|6|||
48582020|NCT01801358|156323207|FG001|Overall Study|Progressive Disease|4|||
48582021|NCT01801358|156323208|FG002|Overall Study|Progressive Disease|4|||
48582022|NCT01801358|156323209|FG003|Overall Study|Progressive Disease|5|||
48582023|NCT01801358|156323210|FG004|Overall Study|Progressive Disease|6|||
48582024|NCT01801358|156323211|FG005|Overall Study|Progressive Disease|5|||
48582025|NCT01801358|156323206|FG000|Overall Study|Withdrawal by Subject|0|||
48582026|NCT01801358|156323207|FG001|Overall Study|Withdrawal by Subject|0|||
48582027|NCT01801358|156323208|FG002|Overall Study|Withdrawal by Subject|0|||
48582028|NCT01801358|156323209|FG003|Overall Study|Withdrawal by Subject|1|||
48582029|NCT01801358|156323210|FG004|Overall Study|Withdrawal by Subject|0|||
48582030|NCT01801358|156323211|FG005|Overall Study|Withdrawal by Subject|2|||
48582031|NCT00622336|156323212|FG000|Treatment Phase|Progression of Disease|181|||
48321333|NCT03580369|155375399|FG005|Overall Study|Technical problems|0|||
48582032|NCT00622336|156323212|FG000|Treatment Phase|Adverse Event|46|||
48582033|NCT00622336|156323212|FG000|Treatment Phase|Other|40|||
48321334|NCT03580369|155375400|FG006|Overall Study|Technical problems|2|||
48321335|NCT03580369|155375401|FG007|Overall Study|Technical problems|0|||
48321336|NCT03580369|155375394|FG000|Overall Study|Pregnancy|2|||
48321337|NCT03580369|155375395|FG001|Overall Study|Pregnancy|0|||
48321338|NCT03580369|155375396|FG002|Overall Study|Pregnancy|3|||
48321339|NCT03580369|155375397|FG003|Overall Study|Pregnancy|0|||
48582034|NCT00622336|156323212|FG000|Treatment Phase|Death|14|||
48582035|NCT00622336|156323212|FG000|Treatment Phase|Lack of therapeutic effect|13|||
48321340|NCT03580369|155375398|FG004|Overall Study|Pregnancy|2|||
48321341|NCT03580369|155375399|FG005|Overall Study|Pregnancy|0|||
48321342|NCT03580369|155375400|FG006|Overall Study|Pregnancy|0|||
48321343|NCT03580369|155375401|FG007|Overall Study|Pregnancy|0|||
48582036|NCT00622336|156323212|FG000|Treatment Phase|Withdrawal by Subject|13|||
48582037|NCT00622336|156323212|FG000|Treatment Phase|Lost to Follow-up|2|||
48582038|NCT00622336|156323212|FG000|Extension Phase|Adverse Event|2|||
48738780|NCT01602120|156892622|FG000|Overall Study|Study Terminated by Sponsor|12|||
48738781|NCT01602120|156892623|FG001|Overall Study|Study Terminated by Sponsor|24|||
48738782|NCT01602120|156892624|FG002|Overall Study|Study Terminated by Sponsor|17|||
48738783|NCT01602120|156892625|FG003|Overall Study|Study Terminated by Sponsor|44|||
48738784|NCT01602120|156892622|FG000|Overall Study|Physician Decision|2|||
48738785|NCT01602120|156892623|FG001|Overall Study|Physician Decision|3|||
48738786|NCT01602120|156892624|FG002|Overall Study|Physician Decision|0|||
48738787|NCT01602120|156892625|FG003|Overall Study|Physician Decision|0|||
48738788|NCT01602120|156892622|FG000|Overall Study|Unspecified Reason|3|||
48738789|NCT01602120|156892623|FG001|Overall Study|Unspecified Reason|1|||
48738790|NCT01602120|156892624|FG002|Overall Study|Unspecified Reason|0|||
48738791|NCT01602120|156892625|FG003|Overall Study|Unspecified Reason|2|||
48738792|NCT01787331|156892626|FG000|Overall Study|Physician Decision|1|||
48738793|NCT01787331|156892626|FG000|Overall Study|Withdrawal by Subject|1|||
48738794|NCT00911547|156892627|FG000|Overall Study|Adverse Event|8|||
48738795|NCT00911547|156892628|FG001|Overall Study|Adverse Event|27|||
48582039|NCT00622336|156323212|FG000|Extension Phase|Progressive Disease|6|||
48582040|NCT00622336|156323212|FG000|Extension Phase|Lack of therapeutic effect|2|||
48582041|NCT00622336|156323212|FG000|Extension Phase|Withdrawal by Subject|1|||
48582042|NCT00622336|156323212|FG000|Extension Phase|Lost to Follow-up|1|||
48582043|NCT00622336|156323212|FG000|Extension Phase|Other|9|||
48582044|NCT03787303|156323213|FG000|Overall Study|Death|1|||
48582045|NCT03787303|156323213|FG000|Overall Study|Premature Termination of Study|1|||
48582046|NCT01527487|156323220|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
48582047|NCT01527487|156323221|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
48582048|NCT01527487|156323220|FG000|Overall Study|Disease Progression|4|||
48582049|NCT01527487|156323221|FG001|Overall Study|Disease Progression|1|||
48582050|NCT01527487|156323220|FG000|Overall Study|Adverse Event|1|||
48738796|NCT00911547|156892629|FG002|Overall Study|Adverse Event|11|||
48738797|NCT00911547|156892630|FG003|Overall Study|Adverse Event|6|||
48738798|NCT00911547|156892627|FG000|Overall Study|Lost to Follow-up|0|||
48738799|NCT00911547|156892628|FG001|Overall Study|Lost to Follow-up|0|||
48738800|NCT00911547|156892629|FG002|Overall Study|Lost to Follow-up|2|||
48738801|NCT00911547|156892630|FG003|Overall Study|Lost to Follow-up|1|||
48738802|NCT00911547|156892627|FG000|Overall Study|Protocol Violation|0|||
48738803|NCT00911547|156892628|FG001|Overall Study|Protocol Violation|5|||
48738804|NCT00911547|156892629|FG002|Overall Study|Protocol Violation|5|||
48738805|NCT00911547|156892630|FG003|Overall Study|Protocol Violation|1|||
48738806|NCT00911547|156892627|FG000|Overall Study|Withdrawal by Subject|3|||
48738807|NCT00911547|156892628|FG001|Overall Study|Withdrawal by Subject|10|||
48738808|NCT00911547|156892629|FG002|Overall Study|Withdrawal by Subject|4|||
48582051|NCT01527487|156323221|FG001|Overall Study|Adverse Event|1|||
48738809|NCT00911547|156892630|FG003|Overall Study|Withdrawal by Subject|8|||
48738810|NCT00319501|156892635|FG000|Double-blind Period|Withdrawal by Subject|0|||
48582052|NCT01527487|156323220|FG000|Overall Study|Death|0|||
48582053|NCT01527487|156323221|FG001|Overall Study|Death|1|||
48582054|NCT01210495|156323222|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
48582055|NCT01210495|156323223|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
48582056|NCT01210495|156323224|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
48582057|NCT01210495|156323225|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
48582058|NCT01210495|156323222|FG000|Overall Study|Death|14|||
48582059|NCT01210495|156323223|FG001|Overall Study|Death|7|||
48582060|NCT01210495|156323224|FG002|Overall Study|Death|112|||
48582061|NCT01210495|156323225|FG003|Overall Study|Death|54|||
48582062|NCT01210495|156323222|FG000|Overall Study|Study Terminated by Sponsor|0|||
48582063|NCT01210495|156323223|FG001|Overall Study|Study Terminated by Sponsor|0|||
48582064|NCT01210495|156323224|FG002|Overall Study|Study Terminated by Sponsor|4|||
48582065|NCT01210495|156323225|FG003|Overall Study|Study Terminated by Sponsor|11|||
48582066|NCT01210495|156323222|FG000|Overall Study|Lost to Follow-up|0|||
48582067|NCT01210495|156323223|FG001|Overall Study|Lost to Follow-up|0|||
48582068|NCT01210495|156323224|FG002|Overall Study|Lost to Follow-up|1|||
48582069|NCT01210495|156323225|FG003|Overall Study|Lost to Follow-up|1|||
48582070|NCT01210495|156323222|FG000|Overall Study|Other unspecified|0|||
48321344|NCT03580369|155375394|FG000|Overall Study|Lost to Follow-up|2|||
48582071|NCT01210495|156323223|FG001|Overall Study|Other unspecified|0|||
48738811|NCT00319501|156892636|FG001|Double-blind Period|Withdrawal by Subject|3|||
48582072|NCT01210495|156323224|FG002|Overall Study|Other unspecified|6|||
48321345|NCT03580369|155375395|FG001|Overall Study|Lost to Follow-up|0|||
48321346|NCT03580369|155375396|FG002|Overall Study|Lost to Follow-up|2|||
48321347|NCT03580369|155375397|FG003|Overall Study|Lost to Follow-up|0|||
48321348|NCT03580369|155375398|FG004|Overall Study|Lost to Follow-up|3|||
48321349|NCT03580369|155375399|FG005|Overall Study|Lost to Follow-up|0|||
48321350|NCT03580369|155375400|FG006|Overall Study|Lost to Follow-up|1|||
48321351|NCT03580369|155375401|FG007|Overall Study|Lost to Follow-up|0|||
48321352|NCT03580369|155375394|FG000|Overall Study|Physician Decision|4|||
48321353|NCT03580369|155375395|FG001|Overall Study|Physician Decision|0|||
48321354|NCT03580369|155375396|FG002|Overall Study|Physician Decision|4|||
48321355|NCT03580369|155375397|FG003|Overall Study|Physician Decision|1|||
48321356|NCT03580369|155375398|FG004|Overall Study|Physician Decision|1|||
48321357|NCT03580369|155375399|FG005|Overall Study|Physician Decision|0|||
48321358|NCT03580369|155375400|FG006|Overall Study|Physician Decision|0|||
48321359|NCT03580369|155375401|FG007|Overall Study|Physician Decision|0|||
48321360|NCT03580369|155375394|FG000|Overall Study|Lack of Efficacy|3|||
48321361|NCT03580369|155375395|FG001|Overall Study|Lack of Efficacy|0|||
48321362|NCT03580369|155375396|FG002|Overall Study|Lack of Efficacy|7|||
48321363|NCT03580369|155375397|FG003|Overall Study|Lack of Efficacy|0|||
48321364|NCT03580369|155375398|FG004|Overall Study|Lack of Efficacy|2|||
48321365|NCT03580369|155375399|FG005|Overall Study|Lack of Efficacy|0|||
48321366|NCT03580369|155375400|FG006|Overall Study|Lack of Efficacy|3|||
48321367|NCT03580369|155375401|FG007|Overall Study|Lack of Efficacy|0|||
48321368|NCT03580369|155375394|FG000|Overall Study|Protocol Violation|6|||
48321369|NCT03580369|155375395|FG001|Overall Study|Protocol Violation|0|||
48321370|NCT03580369|155375396|FG002|Overall Study|Protocol Violation|6|||
48582073|NCT01210495|156323225|FG003|Overall Study|Other unspecified|0|||
48582074|NCT01459718|156323228|FG000|Overall Study|Physician Decision|1|||
48582075|NCT01459718|156323228|FG000|Overall Study|Lost to Follow-up|1|||
48582076|NCT01459718|156323228|FG000|Overall Study|Adverse Event|1|||
48582077|NCT00723190|156323230|FG000|Overall Study|Withdrawal by Subject|45|||
48582078|NCT00723190|156323230|FG000|Overall Study|Lost to Follow-up|37|||
48582079|NCT00723190|156323230|FG000|Overall Study|Adverse Event|18|||
48582080|NCT00723190|156323230|FG000|Overall Study|Lack of Efficacy|16|||
48582081|NCT00723190|156323230|FG000|Overall Study|Protocol Violation|15|||
48582082|NCT00723190|156323230|FG000|Overall Study|Other-Premature Discontinuation|9|||
48582083|NCT00723190|156323230|FG000|Overall Study|Other-Not included in safety population|2|||
48582084|NCT01149421|156323233|FG000|Overall Study|Adverse Event|22|||
48582085|NCT01149421|156323234|FG001|Overall Study|Adverse Event|6|||
48582086|NCT01149421|156323235|FG002|Overall Study|Adverse Event|11|||
48582087|NCT01149421|156323233|FG000|Overall Study|Withdrawal by Subject|20|||
48582088|NCT01149421|156323234|FG001|Overall Study|Withdrawal by Subject|12|||
48582089|NCT01149421|156323235|FG002|Overall Study|Withdrawal by Subject|13|||
48582090|NCT01149421|156323233|FG000|Overall Study|Sponsor Decision|0|||
48582091|NCT01149421|156323234|FG001|Overall Study|Sponsor Decision|1|||
48582092|NCT01149421|156323235|FG002|Overall Study|Sponsor Decision|1|||
48582093|NCT01149421|156323233|FG000|Overall Study|Lost to Follow-up|2|||
48582094|NCT01149421|156323234|FG001|Overall Study|Lost to Follow-up|4|||
48582095|NCT01149421|156323235|FG002|Overall Study|Lost to Follow-up|5|||
48582096|NCT01149421|156323233|FG000|Overall Study|Physician Decision|5|||
48582097|NCT01149421|156323234|FG001|Overall Study|Physician Decision|3|||
48582098|NCT01149421|156323235|FG002|Overall Study|Physician Decision|6|||
48582099|NCT01149421|156323233|FG000|Overall Study|Entry Criteria Not Met|1|||
48582100|NCT01149421|156323234|FG001|Overall Study|Entry Criteria Not Met|1|||
48582101|NCT01149421|156323235|FG002|Overall Study|Entry Criteria Not Met|2|||
48582102|NCT01149421|156323233|FG000|Overall Study|Protocol Violation|2|||
48582103|NCT01149421|156323234|FG001|Overall Study|Protocol Violation|2|||
48582104|NCT01149421|156323235|FG002|Overall Study|Protocol Violation|6|||
48582105|NCT00197002|156323236|FG000|Overall Study|Adverse Event|0|||
48321371|NCT03580369|155375397|FG003|Overall Study|Protocol Violation|1|||
48582106|NCT00197002|156323237|FG001|Overall Study|Adverse Event|1|||
48582107|NCT00197002|156323238|FG002|Overall Study|Adverse Event|0|||
48582108|NCT00197002|156323236|FG000|Overall Study|Protocol Violation|1|||
48582109|NCT00197002|156323237|FG001|Overall Study|Protocol Violation|0|||
48582110|NCT00197002|156323238|FG002|Overall Study|Protocol Violation|2|||
48582111|NCT00197002|156323236|FG000|Overall Study|Withdrawal by Subject|9|||
48321372|NCT03580369|155375398|FG004|Overall Study|Protocol Violation|8|||
48321373|NCT03580369|155375399|FG005|Overall Study|Protocol Violation|2|||
48321374|NCT03580369|155375400|FG006|Overall Study|Protocol Violation|1|||
48321375|NCT03580369|155375401|FG007|Overall Study|Protocol Violation|0|||
48321376|NCT03580369|155375394|FG000|Overall Study|Adverse Event|7|||
48321377|NCT03580369|155375395|FG001|Overall Study|Adverse Event|0|||
48321378|NCT03580369|155375396|FG002|Overall Study|Adverse Event|14|||
48321379|NCT03580369|155375397|FG003|Overall Study|Adverse Event|1|||
48321380|NCT03580369|155375398|FG004|Overall Study|Adverse Event|6|||
48321381|NCT03580369|155375399|FG005|Overall Study|Adverse Event|0|||
48321382|NCT03580369|155375400|FG006|Overall Study|Adverse Event|1|||
48582112|NCT00197002|156323237|FG001|Overall Study|Withdrawal by Subject|5|||
48582113|NCT00197002|156323238|FG002|Overall Study|Withdrawal by Subject|7|||
48582114|NCT00197002|156323236|FG000|Overall Study|Migrated/moved from study area|3|||
48321383|NCT03580369|155375401|FG007|Overall Study|Adverse Event|0|||
48321384|NCT03580369|155375394|FG000|Overall Study|Withdrawal by Subject|19|||
48321385|NCT03580369|155375395|FG001|Overall Study|Withdrawal by Subject|0|||
48321386|NCT03580369|155375396|FG002|Overall Study|Withdrawal by Subject|17|||
48321387|NCT03580369|155375397|FG003|Overall Study|Withdrawal by Subject|0|||
48321388|NCT03580369|155375398|FG004|Overall Study|Withdrawal by Subject|16|||
48321389|NCT03580369|155375399|FG005|Overall Study|Withdrawal by Subject|1|||
48321390|NCT03580369|155375400|FG006|Overall Study|Withdrawal by Subject|7|||
48321391|NCT03580369|155375401|FG007|Overall Study|Withdrawal by Subject|0|||
48321392|NCT04766034|155375402|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
48582115|NCT00197002|156323237|FG001|Overall Study|Migrated/moved from study area|5|||
48582116|NCT00197002|156323238|FG002|Overall Study|Migrated/moved from study area|1|||
48582117|NCT00197002|156323236|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
48582118|NCT00197002|156323237|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
48582119|NCT00197002|156323238|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
48582120|NCT00197002|156323236|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
48582121|NCT00197002|156323237|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
48582122|NCT00197002|156323238|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
48582123|NCT00197002|156323236|FG000|Overall Study|Others|3|||
48582124|NCT00197002|156323237|FG001|Overall Study|Others|1|||
48582125|NCT00197002|156323238|FG002|Overall Study|Others|1|||
48582126|NCT00454818|156323239|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
48582127|NCT00454818|156323240|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
48582128|NCT00454818|156323241|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
48582129|NCT00454818|156323242|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
48582130|NCT00454818|156323243|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
48582131|NCT00454818|156323239|FG000|Phase I: Open-label Dose-escalation|Death|0|||
48582132|NCT00454818|156323240|FG001|Phase I: Open-label Dose-escalation|Death|1|||
48582133|NCT00454818|156323241|FG002|Phase I: Open-label Dose-escalation|Death|0|||
48582134|NCT00454818|156323242|FG003|Phase I: Open-label Dose-escalation|Death|0|||
48582135|NCT00454818|156323243|FG004|Phase I: Open-label Dose-escalation|Death|0|||
48582136|NCT00454818|156323239|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
48582137|NCT00454818|156323240|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
48582138|NCT00454818|156323241|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
48582139|NCT00454818|156323242|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
48582140|NCT00454818|156323243|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
48582141|NCT00454818|156323239|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
48582142|NCT00454818|156323240|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
48582143|NCT00454818|156323241|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
48582144|NCT00454818|156323242|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
48582145|NCT00454818|156323243|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
48582146|NCT00454818|156323239|FG000|Phase 2: Randomized Double-blind|Death|0|||
48582147|NCT00454818|156323240|FG001|Phase 2: Randomized Double-blind|Death|1|||
48582148|NCT00454818|156323241|FG002|Phase 2: Randomized Double-blind|Death|0|||
48582149|NCT00454818|156323242|FG003|Phase 2: Randomized Double-blind|Death|0|||
48582150|NCT00454818|156323243|FG004|Phase 2: Randomized Double-blind|Death|1|||
48582151|NCT00454818|156323239|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
48582152|NCT00454818|156323240|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
48582153|NCT00454818|156323241|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
48582154|NCT00454818|156323242|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
48582155|NCT00454818|156323243|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
48582156|NCT00454818|156323239|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
48582157|NCT00454818|156323240|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
48582158|NCT00454818|156323241|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
48582159|NCT00454818|156323242|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
48582160|NCT00454818|156323243|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
48582161|NCT01384019|156323249|FG000|Overall Study|Withdrawal by Subject|3|||
48582162|NCT01384019|156323250|FG001|Overall Study|Withdrawal by Subject|0|||
48582163|NCT01384019|156323249|FG000|Overall Study|Death|1|||
48582164|NCT01384019|156323250|FG001|Overall Study|Death|0|||
48582165|NCT01384019|156323249|FG000|Overall Study|MRI refusal|6|||
48321393|NCT04766034|155375403|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
48321394|NCT04766034|155375404|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
48321395|NCT04766034|155375405|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
48582166|NCT01384019|156323250|FG001|Overall Study|MRI refusal|6|||
48582167|NCT03181503|156323251|FG000|Overall Study|Adverse Event|2|||
48321396|NCT04766034|155375406|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
48321397|NCT04766034|155375402|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
48738812|NCT00319501|156892635|FG000|Double-blind Period|Sponsor Request|1|||
48738813|NCT00319501|156892636|FG001|Double-blind Period|Sponsor Request|0|||
48738814|NCT00319501|156892635|FG000|Double-blind Period|Did not receive treatment|42|||
48738815|NCT00319501|156892636|FG001|Double-blind Period|Did not receive treatment|29|||
48738816|NCT00319501|156892635|FG000|Open-label Period|Adverse Event|5|||
48738817|NCT00319501|156892636|FG001|Open-label Period|Adverse Event|0|||
48738818|NCT00319501|156892635|FG000|Open-label Period|Protocol Violation|6|||
48738819|NCT00319501|156892636|FG001|Open-label Period|Protocol Violation|0|||
48738820|NCT00319501|156892635|FG000|Open-label Period|Withdrawal by Subject|38|||
48738821|NCT00319501|156892636|FG001|Open-label Period|Withdrawal by Subject|0|||
48738822|NCT00319501|156892635|FG000|Open-label Period|Principal Investigator decision|6|||
48582168|NCT03181503|156323252|FG001|Overall Study|Adverse Event|2|||
48582169|NCT03181503|156323251|FG000|Overall Study|Protocol Violation|1|||
48582170|NCT03181503|156323252|FG001|Overall Study|Protocol Violation|0|||
48582171|NCT03181503|156323251|FG000|Overall Study|Withdrawal by Subject|3|||
48582172|NCT03181503|156323252|FG001|Overall Study|Withdrawal by Subject|0|||
48582173|NCT03181503|156323251|FG000|Overall Study|Lost to Follow-up|1|||
48582174|NCT03181503|156323252|FG001|Overall Study|Lost to Follow-up|1|||
48582175|NCT00767039|156323255|FG000|Overall Study|Death|5|||
48582176|NCT00767039|156323256|FG001|Overall Study|Death|2|||
48582177|NCT01537068|156323259|FG000|Overall Study|Lost to Follow-up|2|||
48582178|NCT01537068|156323260|FG001|Overall Study|Lost to Follow-up|1|||
48582179|NCT01537068|156323259|FG000|Overall Study|Adverse Event|0|||
48582180|NCT01537068|156323260|FG001|Overall Study|Adverse Event|1|||
48582181|NCT01537068|156323259|FG000|Overall Study|Withdrawal by Subject|1|||
48582182|NCT01537068|156323260|FG001|Overall Study|Withdrawal by Subject|1|||
48582183|NCT01537068|156323259|FG000|Overall Study|Lack of Efficacy|1|||
48582184|NCT01537068|156323260|FG001|Overall Study|Lack of Efficacy|0|||
48582185|NCT01267201|156323261|FG000|First Intervention Period|Withdrawal by Subject|1|||
48582186|NCT01267201|156323262|FG001|First Intervention Period|Withdrawal by Subject|0|||
48582187|NCT01267201|156323263|FG002|First Intervention Period|Withdrawal by Subject|0|||
48582188|NCT01267201|156323264|FG003|First Intervention Period|Withdrawal by Subject|0|||
48582189|NCT01267201|156323265|FG004|First Intervention Period|Withdrawal by Subject|0|||
48582190|NCT01267201|156323266|FG005|First Intervention Period|Withdrawal by Subject|0|||
48582191|NCT01267201|156323261|FG000|Second Intervention Period|Withdrawal by Subject|0|||
48582192|NCT01267201|156323262|FG001|Second Intervention Period|Withdrawal by Subject|1|||
48582193|NCT01267201|156323263|FG002|Second Intervention Period|Withdrawal by Subject|0|||
48582194|NCT01267201|156323264|FG003|Second Intervention Period|Withdrawal by Subject|0|||
48582195|NCT01267201|156323265|FG004|Second Intervention Period|Withdrawal by Subject|0|||
48582196|NCT01267201|156323266|FG005|Second Intervention Period|Withdrawal by Subject|0|||
48582197|NCT03806231|156323273|FG000|Overall Study|Physician Decision|1|||
48582198|NCT03806231|156323274|FG001|Overall Study|Physician Decision|0|||
48582199|NCT03806231|156323273|FG000|Overall Study|Withdrawal by Subject|1|||
48582200|NCT03806231|156323274|FG001|Overall Study|Withdrawal by Subject|0|||
48582201|NCT01328548|156323275|FG000|Overall Study|Death|3|||
48582202|NCT01328548|156323276|FG001|Overall Study|Death|0|||
48738823|NCT00319501|156892636|FG001|Open-label Period|Principal Investigator decision|0|||
48738824|NCT00319501|156892635|FG000|Open-label Period|Sponsor request|12|||
48321398|NCT04766034|155375403|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
48321399|NCT04766034|155375404|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
48321400|NCT04766034|155375405|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
48321401|NCT04766034|155375406|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
48321402|NCT04766034|155375402|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
48321403|NCT04766034|155375403|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
48321404|NCT04766034|155375404|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
48321405|NCT04766034|155375405|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
48321406|NCT04766034|155375406|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
48582203|NCT01328548|156323275|FG000|Overall Study|Protocol Violation|1|||
48582204|NCT01328548|156323276|FG001|Overall Study|Protocol Violation|0|||
48582205|NCT02919267|156323277|FG000|Overall Study|Protocol Violation|0|||
48582206|NCT02919267|156323278|FG001|Overall Study|Protocol Violation|3|||
48582207|NCT02919267|156323279|FG002|Overall Study|Protocol Violation|3|||
48582208|NCT02919267|156323280|FG003|Overall Study|Protocol Violation|4|||
48582209|NCT03721835|156323281|FG000|Overall Study|Participant not able to return|1|||
48582210|NCT03721835|156323281|FG000|Overall Study|Lost to Follow-up|1|||
48582211|NCT03721835|156323281|FG000|Overall Study|Revision of the components of the study device|2|||
48582212|NCT03721835|156323281|FG000|Overall Study|Sponsor terminated study|6|||
48738825|NCT00319501|156892636|FG001|Open-label Period|Sponsor request|0|||
48321407|NCT04766034|155375402|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
48321408|NCT04766034|155375403|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
48321409|NCT04766034|155375404|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
48321410|NCT04766034|155375405|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
48321411|NCT04766034|155375406|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
48321412|NCT01227265|155375407|FG000|Overall Study|Did Not Receive Treatment|1|||
48321413|NCT01227265|155375408|FG001|Overall Study|Did Not Receive Treatment|2|||
48321414|NCT01227265|155375409|FG002|Overall Study|Did Not Receive Treatment|0|||
48321415|NCT01227265|155375407|FG000|Overall Study|Administrative|1|||
48582213|NCT03721835|156323281|FG000|Overall Study|Death|1|||
48582214|NCT03721835|156323281|FG000|Overall Study|Sponsor decision|1|||
48582215|NCT03467763|156323282|FG000|Overall Study|Lost to Follow-up|1|||
48582216|NCT03467763|156323282|FG000|Overall Study|Protocol Violation|2|||
48582217|NCT02326298|156323289|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582218|NCT02326298|156323290|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582219|NCT02326298|156323291|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
48582220|NCT02326298|156323292|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582221|NCT02326298|156323293|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582222|NCT02326298|156323294|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582223|NCT02326298|156323295|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582224|NCT02326298|156323296|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582225|NCT02326298|156323297|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582226|NCT02326298|156323298|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582227|NCT02326298|156323299|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582228|NCT02326298|156323300|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582229|NCT02326298|156323301|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582230|NCT02326298|156323302|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48582231|NCT02326298|156323289|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
48582232|NCT02326298|156323290|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582233|NCT02326298|156323291|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582234|NCT02326298|156323292|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582235|NCT02326298|156323293|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582236|NCT02326298|156323294|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582237|NCT02326298|156323295|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582238|NCT02326298|156323296|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582239|NCT02326298|156323297|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582240|NCT02326298|156323298|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582241|NCT02326298|156323299|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582242|NCT02326298|156323300|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582243|NCT02326298|156323301|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582244|NCT02326298|156323302|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
48582245|NCT02326298|156323289|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
48582246|NCT02326298|156323290|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
48582247|NCT02326298|156323291|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582248|NCT02326298|156323292|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582249|NCT02326298|156323293|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582250|NCT02326298|156323294|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582251|NCT02326298|156323295|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582252|NCT02326298|156323296|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582253|NCT02326298|156323297|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582254|NCT02326298|156323298|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582255|NCT02326298|156323299|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582256|NCT02326298|156323300|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582257|NCT02326298|156323301|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582258|NCT02326298|156323302|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
48582259|NCT02326298|156323289|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
48582260|NCT02326298|156323290|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
48582261|NCT02326298|156323291|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582262|NCT02326298|156323292|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582263|NCT02326298|156323293|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582264|NCT02326298|156323294|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582265|NCT02326298|156323295|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582266|NCT02326298|156323296|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582267|NCT02326298|156323297|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582268|NCT02326298|156323298|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582269|NCT02326298|156323299|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48321416|NCT01227265|155375408|FG001|Overall Study|Administrative|0|||
48582270|NCT02326298|156323300|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582271|NCT02326298|156323301|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582272|NCT02326298|156323302|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48582273|NCT02326298|156323289|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582274|NCT02326298|156323290|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582275|NCT02326298|156323291|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
48582276|NCT02326298|156323292|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582277|NCT02326298|156323293|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582278|NCT02326298|156323294|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582279|NCT02326298|156323295|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582280|NCT02326298|156323296|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582281|NCT02326298|156323297|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582282|NCT02326298|156323298|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582283|NCT02326298|156323299|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582284|NCT02326298|156323300|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582285|NCT02326298|156323301|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582286|NCT02326298|156323302|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
48582287|NCT02326298|156323289|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582288|NCT02326298|156323290|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582289|NCT02326298|156323291|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582290|NCT02326298|156323292|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582291|NCT02326298|156323293|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582292|NCT02326298|156323294|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48582293|NCT02326298|156323295|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
48582294|NCT02326298|156323296|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48582295|NCT02326298|156323297|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48582296|NCT02326298|156323298|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48582297|NCT02326298|156323299|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582298|NCT02326298|156323300|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582299|NCT02326298|156323301|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582300|NCT02326298|156323302|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48582301|NCT02326298|156323289|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582302|NCT02326298|156323290|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582303|NCT02326298|156323291|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48321417|NCT01227265|155375409|FG002|Overall Study|Administrative|2|||
48321418|NCT01227265|155375407|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
48321419|NCT01227265|155375408|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
48321420|NCT01227265|155375409|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
48321421|NCT01227265|155375407|FG000|Overall Study|Protocol Violation|2|||
48582304|NCT02326298|156323292|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582305|NCT02326298|156323293|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582306|NCT02326298|156323294|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
48582307|NCT02326298|156323295|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
48582308|NCT02326298|156323296|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582309|NCT02326298|156323297|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
48582310|NCT02326298|156323298|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582311|NCT02326298|156323299|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582312|NCT02326298|156323300|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582313|NCT02326298|156323301|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582314|NCT02326298|156323302|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
48582315|NCT02326298|156323289|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48738826|NCT00319501|156892635|FG000|Open-label Period|Lost to Follow-up|5|||
48738827|NCT00319501|156892636|FG001|Open-label Period|Lost to Follow-up|0|||
48738828|NCT00319501|156892635|FG000|Open-label Period|Did not receive treatment|33|||
48738829|NCT00319501|156892636|FG001|Open-label Period|Did not receive treatment|0|||
48738830|NCT00319501|156892635|FG000|Open-label Period|Other|11|||
48321422|NCT01227265|155375408|FG001|Overall Study|Protocol Violation|1|||
48321423|NCT01227265|155375409|FG002|Overall Study|Protocol Violation|0|||
48321424|NCT01227265|155375407|FG000|Overall Study|Withdrawal by Subject|7|||
48321425|NCT01227265|155375408|FG001|Overall Study|Withdrawal by Subject|7|||
48321426|NCT01227265|155375409|FG002|Overall Study|Withdrawal by Subject|3|||
48321427|NCT01227265|155375407|FG000|Overall Study|Lost to Follow-up|2|||
48738831|NCT00319501|156892636|FG001|Open-label Period|Other|0|||
48738832|NCT00319501|156892635|FG000|Open-label Extension Period|Adverse Event|2|||
48738833|NCT00319501|156892636|FG001|Open-label Extension Period|Adverse Event|0|||
48738834|NCT00319501|156892635|FG000|Open-label Extension Period|Did not receive treatment|18|||
48738835|NCT00319501|156892636|FG001|Open-label Extension Period|Did not receive treatment|0|||
48738836|NCT00319501|156892635|FG000|Open-label Extension Period|Other|1|||
48738837|NCT00319501|156892636|FG001|Open-label Extension Period|Other|0|||
48321428|NCT01227265|155375408|FG001|Overall Study|Lost to Follow-up|0|||
48321429|NCT01227265|155375409|FG002|Overall Study|Lost to Follow-up|3|||
48321430|NCT01227265|155375407|FG000|Overall Study|Adverse Event|6|||
48321431|NCT01227265|155375408|FG001|Overall Study|Adverse Event|10|||
48321432|NCT01227265|155375409|FG002|Overall Study|Adverse Event|5|||
48321433|NCT03481816|155375411|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
48321434|NCT03481816|155375412|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
48321435|NCT03481816|155375411|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
48321436|NCT03481816|155375412|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
48321437|NCT03481816|155375411|FG000|Dose Expansion|Withdrawal by Subject|0|||
48321438|NCT03481816|155375412|FG001|Dose Expansion|Withdrawal by Subject|2|||
48321439|NCT03481816|155375411|FG000|Dose Expansion|Physician Decision|0|||
48321440|NCT03481816|155375412|FG001|Dose Expansion|Physician Decision|5|||
48321441|NCT00823472|155375413|FG000|Overall Study|Physician Decision|24|||
48321442|NCT00823472|155375414|FG001|Overall Study|Physician Decision|28|||
48321443|NCT01721291|155375416|FG000|Overall Study|Withdrawal by Subject|1|||
48321444|NCT01721291|155375417|FG001|Overall Study|Withdrawal by Subject|0|||
48321445|NCT01721291|155375416|FG000|Overall Study|did not like the treatment|1|||
48321446|NCT01721291|155375417|FG001|Overall Study|did not like the treatment|0|||
48321447|NCT00812461|155375420|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
48321448|NCT00812461|155375421|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
48321449|NCT00812461|155375420|FG000|All Treated Patients|Adverse Event|8|||
48321450|NCT00812461|155375421|FG001|All Treated Patients|Adverse Event|15|||
48738838|NCT00319501|156892635|FG000|Open-label Extension Period|Principal investigator decision|2|||
48738839|NCT00319501|156892636|FG001|Open-label Extension Period|Principal investigator decision|0|||
48738840|NCT00319501|156892635|FG000|Open-label Extension Period|Sponsor request|26|||
48738841|NCT00319501|156892636|FG001|Open-label Extension Period|Sponsor request|0|||
48582316|NCT02326298|156323290|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582317|NCT02326298|156323291|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582318|NCT02326298|156323292|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48738842|NCT00319501|156892635|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
48738843|NCT00319501|156892636|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
48738844|NCT02564796|156892640|FG000|Overall Study|Physician Decision|2|||
48738845|NCT02564796|156892641|FG001|Overall Study|Physician Decision|2|||
48738846|NCT01817530|156892642|FG000|Overall Study|Exclusionary Medication Received|0|||
48738847|NCT01817530|156892643|FG001|Overall Study|Exclusionary Medication Received|0|||
48738848|NCT01817530|156892644|FG002|Overall Study|Exclusionary Medication Received|0|||
48321451|NCT00812461|155375420|FG000|All Treated Patients|Lack of Efficacy|13|||
48321452|NCT00812461|155375421|FG001|All Treated Patients|Lack of Efficacy|7|||
48321453|NCT00812461|155375420|FG000|All Treated Patients|Non-compliance|6|||
48321454|NCT00812461|155375421|FG001|All Treated Patients|Non-compliance|9|||
48321455|NCT00812461|155375420|FG000|All Treated Patients|Protocol Violation|36|||
48321456|NCT00812461|155375421|FG001|All Treated Patients|Protocol Violation|27|||
48321457|NCT00812461|155375420|FG000|All Treated Patients|Withdrawal by Subject|45|||
48321458|NCT00812461|155375421|FG001|All Treated Patients|Withdrawal by Subject|54|||
48321459|NCT00812461|155375420|FG000|All Treated Patients|Lost to Follow-up|11|||
48321460|NCT00812461|155375421|FG001|All Treated Patients|Lost to Follow-up|14|||
48321461|NCT00812461|155375420|FG000|All Treated Patients|Other Reason|13|||
48321462|NCT00812461|155375421|FG001|All Treated Patients|Other Reason|21|||
48582319|NCT02326298|156323293|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582320|NCT02326298|156323294|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
48582321|NCT02326298|156323295|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582322|NCT02326298|156323296|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582323|NCT02326298|156323297|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582324|NCT02326298|156323298|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582325|NCT02326298|156323299|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582326|NCT02326298|156323300|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582327|NCT02326298|156323301|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582328|NCT02326298|156323302|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
48582329|NCT02326298|156323289|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48587374|NCT05268016|156343201|FG004|Overall Study|Other|0|||
48321463|NCT03613740|155376910|FG000|Overall Study|Lost to Follow-up|1|||
48321464|NCT03613740|155376911|FG001|Overall Study|Lost to Follow-up|1|||
48738849|NCT01817530|156892645|FG003|Overall Study|Exclusionary Medication Received|0|||
48738850|NCT01817530|156892646|FG004|Overall Study|Exclusionary Medication Received|1|||
48738851|NCT01817530|156892647|FG005|Overall Study|Exclusionary Medication Received|0|||
48738852|NCT01817530|156892648|FG006|Overall Study|Exclusionary Medication Received|0|||
48738853|NCT01817530|156892649|FG007|Overall Study|Exclusionary Medication Received|0|||
48738854|NCT01817530|156892642|FG000|Overall Study|Adverse Event|6|||
48738855|NCT01817530|156892643|FG001|Overall Study|Adverse Event|3|||
48582330|NCT02326298|156323290|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582331|NCT02326298|156323291|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582332|NCT02326298|156323292|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582333|NCT02326298|156323293|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582334|NCT02326298|156323294|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582335|NCT02326298|156323295|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
48582336|NCT02326298|156323296|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48321465|NCT03351075|155376912|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
48321466|NCT03351075|155376913|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
48321467|NCT03351075|155376912|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
48321468|NCT03351075|155376913|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
48321469|NCT03351075|155376912|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
48321470|NCT03351075|155376913|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
48321471|NCT03351075|155376912|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
48321472|NCT03351075|155376913|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
48582337|NCT02326298|156323297|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582338|NCT02326298|156323298|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582339|NCT02326298|156323299|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582340|NCT02326298|156323300|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582341|NCT02326298|156323301|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582342|NCT02326298|156323302|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
48582343|NCT02326298|156323289|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582344|NCT02326298|156323290|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582345|NCT02326298|156323291|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582346|NCT02326298|156323292|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582347|NCT02326298|156323293|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582348|NCT02326298|156323294|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582349|NCT02326298|156323295|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582350|NCT02326298|156323296|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
48582351|NCT02326298|156323297|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582352|NCT02326298|156323298|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582353|NCT02326298|156323299|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582354|NCT02326298|156323300|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582355|NCT02326298|156323301|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582356|NCT02326298|156323302|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
48582357|NCT02326298|156323289|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582358|NCT02326298|156323290|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582359|NCT02326298|156323291|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582360|NCT02326298|156323292|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582361|NCT02326298|156323293|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582362|NCT02326298|156323294|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582363|NCT02326298|156323295|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
48582364|NCT02326298|156323296|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
48582365|NCT02326298|156323297|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582366|NCT02326298|156323298|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582367|NCT02326298|156323299|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582368|NCT02326298|156323300|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582369|NCT02326298|156323301|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582370|NCT02326298|156323302|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48582371|NCT02326298|156323289|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582372|NCT02326298|156323290|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582373|NCT02326298|156323291|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48587375|NCT02273908|156343211|FG000|Overall Study|Adverse Event|16|||
48738856|NCT01817530|156892644|FG002|Overall Study|Adverse Event|2|||
48738857|NCT01817530|156892645|FG003|Overall Study|Adverse Event|5|||
48738858|NCT01817530|156892646|FG004|Overall Study|Adverse Event|0|||
48738859|NCT01817530|156892647|FG005|Overall Study|Adverse Event|10|||
48321473|NCT02407249|155376921|FG000|Overall Study|Did not complete 12-month follow-up|13|||
48321474|NCT02407249|155376921|FG000|Overall Study|Not treated|13|||
48321475|NCT00840177|155376922|FG000|Overall Study|Adverse Event|5|||
48321476|NCT00840177|155376923|FG001|Overall Study|Adverse Event|1|||
48321477|NCT00840177|155376924|FG002|Overall Study|Adverse Event|1|||
48321478|NCT00840177|155376922|FG000|Overall Study|Refusal unrelated to adverse events|1|||
48321479|NCT00840177|155376923|FG001|Overall Study|Refusal unrelated to adverse events|0|||
48321480|NCT00840177|155376924|FG002|Overall Study|Refusal unrelated to adverse events|1|||
48321481|NCT00840177|155376922|FG000|Overall Study|Progression/relapse|2|||
48321482|NCT00840177|155376923|FG001|Overall Study|Progression/relapse|0|||
48321483|NCT00840177|155376924|FG002|Overall Study|Progression/relapse|0|||
48582374|NCT02326298|156323292|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48738860|NCT01817530|156892648|FG006|Overall Study|Adverse Event|5|||
48738861|NCT01817530|156892649|FG007|Overall Study|Adverse Event|8|||
48738862|NCT01817530|156892642|FG000|Overall Study|Subject Noncompliant|3|||
48321484|NCT00840177|155376922|FG000|Overall Study|Death|4|||
48321485|NCT00840177|155376923|FG001|Overall Study|Death|5|||
48582375|NCT02326298|156323293|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582376|NCT02326298|156323294|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582377|NCT02326298|156323295|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582378|NCT02326298|156323296|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
48582379|NCT02326298|156323297|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582380|NCT02326298|156323298|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582381|NCT02326298|156323299|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582382|NCT02326298|156323300|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582383|NCT02326298|156323301|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582384|NCT02326298|156323302|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48582385|NCT02326298|156323289|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582386|NCT02326298|156323290|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582387|NCT02326298|156323291|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582388|NCT02326298|156323292|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582389|NCT02326298|156323293|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582390|NCT02326298|156323294|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
48738863|NCT01817530|156892643|FG001|Overall Study|Subject Noncompliant|1|||
48738864|NCT01817530|156892644|FG002|Overall Study|Subject Noncompliant|0|||
48738865|NCT01817530|156892645|FG003|Overall Study|Subject Noncompliant|4|||
48738866|NCT01817530|156892646|FG004|Overall Study|Subject Noncompliant|0|||
48738867|NCT01817530|156892647|FG005|Overall Study|Subject Noncompliant|1|||
48738868|NCT01817530|156892648|FG006|Overall Study|Subject Noncompliant|1|||
48738869|NCT01817530|156892649|FG007|Overall Study|Subject Noncompliant|1|||
48738870|NCT01817530|156892642|FG000|Overall Study|Lack of Efficacy|1|||
48738871|NCT01817530|156892643|FG001|Overall Study|Lack of Efficacy|0|||
48738872|NCT01817530|156892644|FG002|Overall Study|Lack of Efficacy|0|||
48738873|NCT01817530|156892645|FG003|Overall Study|Lack of Efficacy|0|||
48738874|NCT01817530|156892646|FG004|Overall Study|Lack of Efficacy|0|||
48738875|NCT01817530|156892647|FG005|Overall Study|Lack of Efficacy|1|||
48738876|NCT01817530|156892648|FG006|Overall Study|Lack of Efficacy|0|||
48738877|NCT01817530|156892649|FG007|Overall Study|Lack of Efficacy|1|||
48738878|NCT01817530|156892642|FG000|Overall Study|Pregnancy|0|||
48738879|NCT01817530|156892643|FG001|Overall Study|Pregnancy|0|||
48738880|NCT01817530|156892644|FG002|Overall Study|Pregnancy|0|||
48738881|NCT01817530|156892645|FG003|Overall Study|Pregnancy|0|||
48738882|NCT01817530|156892646|FG004|Overall Study|Pregnancy|0|||
48738883|NCT01817530|156892647|FG005|Overall Study|Pregnancy|1|||
48321486|NCT00840177|155376924|FG002|Overall Study|Death|5|||
48321487|NCT00840177|155376922|FG000|Overall Study|not protocol specified|6|||
48622608|NCT00120250|156476557|FG001|Overall Study|Protocol Violation|1|||
48738884|NCT01817530|156892648|FG006|Overall Study|Pregnancy|0|||
48738885|NCT01817530|156892649|FG007|Overall Study|Pregnancy|0|||
48738886|NCT01817530|156892642|FG000|Overall Study|Other|0|||
48321488|NCT00840177|155376923|FG001|Overall Study|not protocol specified|3|||
48321489|NCT00840177|155376924|FG002|Overall Study|not protocol specified|0|||
48738887|NCT01817530|156892643|FG001|Overall Study|Other|1|||
48321490|NCT00840177|155376922|FG000|Overall Study|Ineligible|0|||
48321491|NCT00840177|155376923|FG001|Overall Study|Ineligible|0|||
48321492|NCT00840177|155376924|FG002|Overall Study|Ineligible|3|||
48738888|NCT01817530|156892644|FG002|Overall Study|Other|0|||
48738889|NCT01817530|156892645|FG003|Overall Study|Other|0|||
48738890|NCT01817530|156892646|FG004|Overall Study|Other|1|||
48738891|NCT01817530|156892647|FG005|Overall Study|Other|0|||
48738892|NCT01817530|156892648|FG006|Overall Study|Other|5|||
48738893|NCT01817530|156892649|FG007|Overall Study|Other|0|||
48321493|NCT00840177|155376922|FG000|Overall Study|Did not start treatment|0|||
48321494|NCT00840177|155376923|FG001|Overall Study|Did not start treatment|0|||
48321495|NCT00840177|155376924|FG002|Overall Study|Did not start treatment|1|||
48582391|NCT02326298|156323295|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582392|NCT02326298|156323296|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582393|NCT02326298|156323297|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582394|NCT02326298|156323298|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582395|NCT02326298|156323299|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582396|NCT02326298|156323300|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582397|NCT02326298|156323301|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582398|NCT02326298|156323302|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
48582399|NCT02326298|156323289|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
48582400|NCT02326298|156323290|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
48582401|NCT02326298|156323291|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
48582402|NCT02326298|156323292|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
48582403|NCT02326298|156323293|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
48582404|NCT02326298|156323294|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
48582405|NCT02326298|156323295|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
48582406|NCT02326298|156323296|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
48582407|NCT02326298|156323297|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
48582408|NCT02326298|156323298|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
48582409|NCT02326298|156323299|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
48582410|NCT02326298|156323300|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
48582411|NCT02326298|156323301|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
48582412|NCT02326298|156323302|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
48582413|NCT02326298|156323289|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582414|NCT02326298|156323290|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582415|NCT02326298|156323291|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582416|NCT02326298|156323292|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582417|NCT02326298|156323293|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582418|NCT02326298|156323294|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582419|NCT02326298|156323295|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582420|NCT02326298|156323296|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582421|NCT02326298|156323297|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582422|NCT02326298|156323298|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582423|NCT02326298|156323299|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582424|NCT02326298|156323300|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
48582425|NCT02326298|156323301|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
48582426|NCT02326298|156323302|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
48582427|NCT02326298|156323289|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582428|NCT02326298|156323290|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582429|NCT02326298|156323291|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582430|NCT02326298|156323292|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582431|NCT02326298|156323293|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582432|NCT02326298|156323294|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582433|NCT02326298|156323295|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582434|NCT02326298|156323296|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582435|NCT02326298|156323297|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582436|NCT02326298|156323298|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582437|NCT02326298|156323299|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582438|NCT02326298|156323300|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
48582439|NCT02326298|156323301|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
48582440|NCT02326298|156323302|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48582441|NCT02326298|156323289|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582442|NCT02326298|156323290|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48738894|NCT01817530|156892642|FG000|Overall Study|Surgery or Invasive Intervention|1|||
48738895|NCT01817530|156892643|FG001|Overall Study|Surgery or Invasive Intervention|0|||
48321496|NCT03093428|155376925|FG000|Overall Study|Not eligible for treatment|2|||
48321497|NCT03093428|155376926|FG001|Overall Study|Not eligible for treatment|1|||
48321498|NCT03093428|155376925|FG000|Overall Study|Progression|14|||
48321499|NCT03093428|155376926|FG001|Overall Study|Progression|4|||
48321500|NCT03093428|155376925|FG000|Overall Study|Death|1|||
48321501|NCT03093428|155376926|FG001|Overall Study|Death|0|||
48321502|NCT03093428|155376925|FG000|Overall Study|Adverse Event|1|||
48321503|NCT03093428|155376926|FG001|Overall Study|Adverse Event|0|||
48321504|NCT03093428|155376925|FG000|Overall Study|Withdrawal by Subject|1|||
48321505|NCT03093428|155376926|FG001|Overall Study|Withdrawal by Subject|1|||
48321506|NCT00150813|155376927|FG000|Overall Study|Adverse Event|1|||
48321507|NCT00150813|155376927|FG000|Overall Study|Lack of Efficacy|1|||
48321508|NCT00150813|155376927|FG000|Overall Study|Lost to Follow-up|5|||
48321509|NCT00150813|155376927|FG000|Overall Study|Withdrawal by Subject|5|||
48321510|NCT00150813|155376927|FG000|Overall Study|Remission|3|||
48321511|NCT00150813|155376927|FG000|Overall Study|Planned pregancy|1|||
48321512|NCT00150813|155376927|FG000|Overall Study|Switch to commercially available LEV|2|||
48321513|NCT03624972|155376928|FG000|Overall Study|Lost to Follow-up|2|||
48321514|NCT03624972|155376929|FG001|Overall Study|Lost to Follow-up|0|||
48321515|NCT03624972|155376930|FG002|Overall Study|Lost to Follow-up|0|||
48321516|NCT03624972|155376928|FG000|Overall Study|Withdrawal by Subject|0|||
48321517|NCT03624972|155376929|FG001|Overall Study|Withdrawal by Subject|2|||
48321518|NCT03624972|155376930|FG002|Overall Study|Withdrawal by Subject|0|||
48321519|NCT01696968|155376931|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
48321520|NCT01696968|155376932|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
48321521|NCT01696968|155376931|FG000|Overall Study|Died Before Randomization|3|||
48321522|NCT01696968|155376932|FG001|Overall Study|Died Before Randomization|8|||
48321523|NCT01696968|155376931|FG000|Overall Study|Died Before ASU (Control)|278|||
48321524|NCT01696968|155376932|FG001|Overall Study|Died Before ASU (Control)|0|||
48321525|NCT01696968|155376931|FG000|Overall Study|Refused ASU (Control)|920|||
48321526|NCT01696968|155376932|FG001|Overall Study|Refused ASU (Control)|0|||
48321527|NCT01696968|155376931|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
48321528|NCT01696968|155376932|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
48321529|NCT02729311|155376933|FG000|Overall Study|Withdrawal by Subject|8|||
48321530|NCT02729311|155376934|FG001|Overall Study|Withdrawal by Subject|2|||
48582443|NCT02326298|156323291|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582444|NCT02326298|156323292|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582445|NCT02326298|156323293|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582446|NCT02326298|156323294|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582447|NCT02326298|156323295|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582448|NCT02326298|156323296|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582449|NCT02326298|156323297|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582450|NCT02326298|156323298|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582451|NCT02326298|156323299|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582452|NCT02326298|156323300|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582453|NCT02326298|156323301|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
48582454|NCT02326298|156323302|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
48582455|NCT02326298|156323289|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582456|NCT02326298|156323290|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582457|NCT02326298|156323291|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582458|NCT02326298|156323292|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582459|NCT02326298|156323293|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582460|NCT02326298|156323294|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582461|NCT02326298|156323295|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582462|NCT02326298|156323296|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582463|NCT02326298|156323297|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48321543|NCT01308567|155376940|FG000|Overall Study|Lost to Follow-up|2|||
48321544|NCT01308567|155376941|FG001|Overall Study|Lost to Follow-up|4|||
48321545|NCT01308567|155376942|FG002|Overall Study|Lost to Follow-up|4|||
48321546|NCT02724956|155376943|FG000|Overall Study|Physician Decision|1|||
48321547|NCT02724956|155376944|FG001|Overall Study|Physician Decision|0|||
48582464|NCT02326298|156323298|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582465|NCT02326298|156323299|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48582466|NCT02326298|156323300|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
48582467|NCT02326298|156323301|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
48582468|NCT02326298|156323302|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
48582469|NCT02326298|156323289|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582470|NCT02326298|156323290|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582471|NCT02326298|156323291|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582472|NCT02326298|156323292|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582473|NCT02326298|156323293|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582474|NCT02326298|156323294|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582475|NCT02326298|156323295|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582476|NCT02326298|156323296|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582477|NCT02326298|156323297|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582478|NCT02326298|156323298|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582479|NCT02326298|156323299|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
48582480|NCT02326298|156323300|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
48582481|NCT02326298|156323301|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
48582482|NCT02326298|156323302|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
48582483|NCT02326298|156323289|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582484|NCT02326298|156323290|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582485|NCT02326298|156323291|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582486|NCT02326298|156323292|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582487|NCT02326298|156323293|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48738896|NCT01817530|156892644|FG002|Overall Study|Surgery or Invasive Intervention|0|||
48738897|NCT01817530|156892645|FG003|Overall Study|Surgery or Invasive Intervention|0|||
48738898|NCT01817530|156892646|FG004|Overall Study|Surgery or Invasive Intervention|1|||
48738899|NCT01817530|156892647|FG005|Overall Study|Surgery or Invasive Intervention|1|||
48738900|NCT01817530|156892648|FG006|Overall Study|Surgery or Invasive Intervention|1|||
48738901|NCT01817530|156892649|FG007|Overall Study|Surgery or Invasive Intervention|0|||
48738902|NCT01817530|156892642|FG000|Overall Study|Consent Withdrawn by Subject|3|||
48738903|NCT01817530|156892643|FG001|Overall Study|Consent Withdrawn by Subject|4|||
48738904|NCT01817530|156892644|FG002|Overall Study|Consent Withdrawn by Subject|7|||
48738905|NCT01817530|156892645|FG003|Overall Study|Consent Withdrawn by Subject|3|||
48738906|NCT01817530|156892646|FG004|Overall Study|Consent Withdrawn by Subject|5|||
48738907|NCT01817530|156892647|FG005|Overall Study|Consent Withdrawn by Subject|3|||
48738908|NCT01817530|156892648|FG006|Overall Study|Consent Withdrawn by Subject|3|||
48738909|NCT01817530|156892649|FG007|Overall Study|Consent Withdrawn by Subject|10|||
48738910|NCT01817530|156892642|FG000|Overall Study|Lost to Follow-up|1|||
48738911|NCT01817530|156892643|FG001|Overall Study|Lost to Follow-up|4|||
48738912|NCT01817530|156892644|FG002|Overall Study|Lost to Follow-up|2|||
48738913|NCT01817530|156892645|FG003|Overall Study|Lost to Follow-up|1|||
48738914|NCT01817530|156892646|FG004|Overall Study|Lost to Follow-up|3|||
48738915|NCT01817530|156892647|FG005|Overall Study|Lost to Follow-up|2|||
48738916|NCT01817530|156892648|FG006|Overall Study|Lost to Follow-up|8|||
48738917|NCT01817530|156892649|FG007|Overall Study|Lost to Follow-up|4|||
48738918|NCT02008318|156894048|FG000|Overall Study|Adverse Event|4|||
48738919|NCT02008318|156894049|FG001|Overall Study|Adverse Event|0|||
48738920|NCT02008318|156894048|FG000|Overall Study|Physician Decision|2|||
48738921|NCT02008318|156894049|FG001|Overall Study|Physician Decision|0|||
48738922|NCT02008318|156894048|FG000|Overall Study|Progressive Disease|2|||
48738923|NCT02008318|156894049|FG001|Overall Study|Progressive Disease|0|||
48582488|NCT02326298|156323294|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582489|NCT02326298|156323295|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582490|NCT02326298|156323296|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582491|NCT02326298|156323297|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582492|NCT02326298|156323298|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582493|NCT02326298|156323299|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48582494|NCT02326298|156323300|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
48582495|NCT02326298|156323301|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
48582496|NCT02326298|156323302|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
48582497|NCT01001598|156323303|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
48582498|NCT01001598|156323303|FG000|Overall Study|Adverse Event|1|||
48582499|NCT02407054|156323309|FG000|Overall Study|Adverse Event|1|||
48582500|NCT02407054|156323310|FG001|Overall Study|Adverse Event|4|||
48582501|NCT02407054|156323311|FG002|Overall Study|Adverse Event|1|||
48582502|NCT02407054|156323309|FG000|Overall Study|Non-compliance with Study|0|||
48582503|NCT02407054|156323310|FG001|Overall Study|Non-compliance with Study|2|||
48582504|NCT02407054|156323311|FG002|Overall Study|Non-compliance with Study|1|||
48582505|NCT02407054|156323309|FG000|Overall Study|Physician Decision|1|||
48582506|NCT02407054|156323310|FG001|Overall Study|Physician Decision|3|||
48582507|NCT02407054|156323311|FG002|Overall Study|Physician Decision|3|||
48582508|NCT02407054|156323309|FG000|Overall Study|Withdrawal by Subject|5|||
48582509|NCT02407054|156323310|FG001|Overall Study|Withdrawal by Subject|9|||
48582510|NCT02407054|156323311|FG002|Overall Study|Withdrawal by Subject|2|||
48582511|NCT00932698|156323312|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
48582512|NCT00932698|156323313|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
48582513|NCT00932698|156323314|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
48582514|NCT00932698|156323315|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
48582515|NCT00932698|156323316|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
48582516|NCT00932698|156323317|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
48582517|NCT00932698|156323318|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
48582518|NCT00932698|156323319|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
48582519|NCT00932698|156323320|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
48582520|NCT00932698|156323321|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
48582521|NCT00932698|156323322|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
48582522|NCT00932698|156323312|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
48582523|NCT00932698|156323313|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
48582524|NCT00932698|156323314|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
48582525|NCT00932698|156323315|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
48582526|NCT00932698|156323316|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
48582527|NCT00932698|156323317|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
48582528|NCT00932698|156323318|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
48582529|NCT00932698|156323319|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
48582530|NCT00932698|156323320|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
48582531|NCT00932698|156323321|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
48582532|NCT00932698|156323322|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
48582533|NCT00932698|156323312|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
48582534|NCT00932698|156323313|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
48582535|NCT00932698|156323314|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
48582536|NCT00932698|156323315|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
48582537|NCT00932698|156323316|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
48582538|NCT00932698|156323317|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
48582539|NCT00932698|156323318|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
48582540|NCT00932698|156323319|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
48582541|NCT00932698|156323320|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
48582542|NCT00932698|156323321|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
48582543|NCT00932698|156323322|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
48582544|NCT00932698|156323312|FG000|Part 1 (Dose Escalation)|Other|0|||
48582545|NCT00932698|156323313|FG001|Part 1 (Dose Escalation)|Other|0|||
48582546|NCT00932698|156323314|FG002|Part 1 (Dose Escalation)|Other|1|||
48582547|NCT00932698|156323315|FG003|Part 1 (Dose Escalation)|Other|0|||
48582548|NCT00932698|156323316|FG004|Part 1 (Dose Escalation)|Other|0|||
48582549|NCT00932698|156323317|FG005|Part 1 (Dose Escalation)|Other|0|||
48582550|NCT00932698|156323318|FG006|Part 1 (Dose Escalation)|Other|1|||
48738924|NCT02008318|156894048|FG000|Overall Study|Protocol Violation|1|||
48582551|NCT00932698|156323319|FG007|Part 1 (Dose Escalation)|Other|0|||
48738925|NCT02008318|156894049|FG001|Overall Study|Protocol Violation|1|||
48738926|NCT02008318|156894048|FG000|Overall Study|Withdrawal by Subject|3|||
48738927|NCT02008318|156894049|FG001|Overall Study|Withdrawal by Subject|0|||
48738928|NCT00293215|156894055|FG000|Overall Study|Progressive disease|3|||
48738929|NCT00293215|156894056|FG001|Overall Study|Progressive disease|1|||
48738930|NCT00293215|156894055|FG000|Overall Study|Adverse Event|2|||
48738931|NCT00293215|156894056|FG001|Overall Study|Adverse Event|2|||
48738932|NCT00371826|156894057|FG000|Core Phase (12 Months)|Adverse Event|15|||
48738933|NCT00371826|156894058|FG001|Core Phase (12 Months)|Adverse Event|4|||
48738934|NCT00371826|156894059|FG002|Core Phase (12 Months)|Adverse Event|9|||
48738935|NCT00371826|156894057|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
48738936|NCT00371826|156894058|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
48738937|NCT00371826|156894059|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
48738938|NCT00371826|156894057|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
48738939|NCT00371826|156894058|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
48738940|NCT00371826|156894059|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
48738941|NCT00371826|156894057|FG000|Core Phase (12 Months)|Protocol Violation|1|||
48738942|NCT00371826|156894058|FG001|Core Phase (12 Months)|Protocol Violation|0|||
48738943|NCT00371826|156894059|FG002|Core Phase (12 Months)|Protocol Violation|1|||
48738944|NCT00371826|156894057|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
48738945|NCT00371826|156894058|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
48738946|NCT00371826|156894059|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
48738947|NCT00371826|156894057|FG000|Core Phase (12 Months)|Administrative problems|1|||
48738948|NCT00371826|156894058|FG001|Core Phase (12 Months)|Administrative problems|0|||
48738949|NCT00371826|156894059|FG002|Core Phase (12 Months)|Administrative problems|8|||
48738950|NCT00371826|156894057|FG000|Core Phase (12 Months)|Graft Loss|0|||
48738951|NCT00371826|156894058|FG001|Core Phase (12 Months)|Graft Loss|1|||
48738952|NCT00371826|156894059|FG002|Core Phase (12 Months)|Graft Loss|0|||
48738953|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Adverse Event|4|||
48738954|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Adverse Event|5|||
48738955|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Adverse Event|0|||
48738956|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
48738957|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
48738958|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
48738959|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
48738960|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
48738961|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
48738962|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
48738963|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
48738964|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
48738965|NCT00371826|156894057|FG000|Extension Phase (24 Months)|Administrative problems|0|||
48582552|NCT00932698|156323320|FG008|Part 1 (Dose Escalation)|Other|0|||
48582553|NCT00932698|156323321|FG009|Part 1 (Dose Escalation)|Other|0|||
48582554|NCT00932698|156323322|FG010|Part 1 (Dose Escalation)|Other|0|||
48582555|NCT00932698|156323312|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
48582556|NCT00932698|156323313|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
48582557|NCT00932698|156323314|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
48582558|NCT00932698|156323315|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
48582559|NCT00932698|156323316|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
48582560|NCT00932698|156323317|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
48582561|NCT00932698|156323318|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
48582562|NCT00932698|156323319|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
48582563|NCT00932698|156323320|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
48582564|NCT00932698|156323321|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
48582565|NCT00932698|156323322|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
48582566|NCT00932698|156323312|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
48582567|NCT00932698|156323313|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
48582568|NCT00932698|156323314|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
48582569|NCT00932698|156323315|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
48582570|NCT00932698|156323316|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
48738966|NCT00371826|156894058|FG001|Extension Phase (24 Months)|Administrative problems|0|||
48582571|NCT00932698|156323317|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
48582572|NCT00932698|156323318|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
48587376|NCT02273908|156343212|FG001|Overall Study|Adverse Event|0|||
48738967|NCT00371826|156894059|FG002|Extension Phase (24 Months)|Administrative problems|2|||
48738968|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
48738969|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
48738970|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
48738971|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
48738972|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
48738973|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
48738974|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
48738975|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
48738976|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
48582573|NCT00932698|156323319|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
48582574|NCT00932698|156323320|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
48582575|NCT00932698|156323321|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
48582576|NCT00932698|156323322|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
48582577|NCT00932698|156323312|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
48738977|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48738978|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48582578|NCT00932698|156323313|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
48582579|NCT00932698|156323314|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
48582580|NCT00932698|156323315|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
48582581|NCT00932698|156323316|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
48582582|NCT00932698|156323317|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
48582583|NCT00932698|156323318|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
48582584|NCT00932698|156323319|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
48582585|NCT00932698|156323320|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
48582586|NCT00932698|156323321|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
48582587|NCT00932698|156323322|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
48582588|NCT04608344|156323324|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
48582589|NCT04608344|156323325|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
48582590|NCT04608344|156323324|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
48738979|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48582591|NCT04608344|156323325|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
48582592|NCT00655681|156323326|FG000|Overall Study|Lost to Follow-up|1|||
48582593|NCT00655681|156323327|FG001|Overall Study|Lost to Follow-up|1|||
48582594|NCT00467961|156323329|FG000|Overall Study|Technical Failures|5|||
48582595|NCT00467961|156323329|FG000|Overall Study|Disease Progression|2|||
48582596|NCT01844505|156323330|FG000|Overall Study|Disease progression|170|||
48582597|NCT01844505|156323331|FG001|Overall Study|Disease progression|88|||
48582598|NCT01844505|156323332|FG002|Overall Study|Disease progression|224|||
48582599|NCT01844505|156323330|FG000|Overall Study|Study drug toxicity|40|||
48582600|NCT01844505|156323331|FG001|Overall Study|Study drug toxicity|131|||
48582601|NCT01844505|156323332|FG002|Overall Study|Study drug toxicity|50|||
48582602|NCT01844505|156323330|FG000|Overall Study|Death|1|||
48582603|NCT01844505|156323331|FG001|Overall Study|Death|3|||
48582604|NCT01844505|156323332|FG002|Overall Study|Death|1|||
48582605|NCT01844505|156323330|FG000|Overall Study|Adverse event unrelated to study drug|7|||
48582606|NCT01844505|156323331|FG001|Overall Study|Adverse event unrelated to study drug|15|||
48582607|NCT01844505|156323332|FG002|Overall Study|Adverse event unrelated to study drug|6|||
48738980|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48738981|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48738982|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48582608|NCT01844505|156323330|FG000|Overall Study|Subject request discontinue treatment|17|||
48582609|NCT01844505|156323331|FG001|Overall Study|Subject request discontinue treatment|14|||
48582610|NCT01844505|156323332|FG002|Overall Study|Subject request discontinue treatment|8|||
48738983|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
48321548|NCT02724956|155376943|FG000|Overall Study|Lack of Efficacy|0|||
48321549|NCT02724956|155376944|FG001|Overall Study|Lack of Efficacy|1|||
48321550|NCT02724956|155376943|FG000|Overall Study|Withdrawal by Subject|0|||
48321551|NCT02724956|155376944|FG001|Overall Study|Withdrawal by Subject|1|||
48582611|NCT01844505|156323330|FG000|Overall Study|Withdrawal by Subject|0|||
48582612|NCT01844505|156323331|FG001|Overall Study|Withdrawal by Subject|3|||
48582613|NCT01844505|156323332|FG002|Overall Study|Withdrawal by Subject|0|||
48582614|NCT01844505|156323330|FG000|Overall Study|Lost to Follow-up|1|||
48582615|NCT01844505|156323331|FG001|Overall Study|Lost to Follow-up|0|||
48582616|NCT01844505|156323332|FG002|Overall Study|Lost to Follow-up|0|||
48582617|NCT01844505|156323330|FG000|Overall Study|Maximum clinical benefit|8|||
48582618|NCT01844505|156323331|FG001|Overall Study|Maximum clinical benefit|11|||
48582619|NCT01844505|156323332|FG002|Overall Study|Maximum clinical benefit|2|||
48582620|NCT01844505|156323330|FG000|Overall Study|Poor/non-compliance|1|||
48321552|NCT05262738|155376946|FG000|Overall Study|Withdrawal by Subject|1|||
48321553|NCT05262738|155376947|FG001|Overall Study|Withdrawal by Subject|0|||
48321554|NCT01574716|155376954|FG000|Part 1|Death|3|||
48321555|NCT01574716|155376955|FG001|Part 1|Death|1|||
48321556|NCT01574716|155376956|FG002|Part 1|Death|8|||
48321557|NCT01574716|155376957|FG003|Part 1|Death|0|||
48321558|NCT01574716|155376958|FG004|Part 1|Death|0|||
48321559|NCT01574716|155376954|FG000|Part 1|Discontinuation of study by sponsor|0|||
48321560|NCT01574716|155376955|FG001|Part 1|Discontinuation of study by sponsor|0|||
48321561|NCT01574716|155376956|FG002|Part 1|Discontinuation of study by sponsor|1|||
48321562|NCT01574716|155376957|FG003|Part 1|Discontinuation of study by sponsor|0|||
48321563|NCT01574716|155376958|FG004|Part 1|Discontinuation of study by sponsor|0|||
48321564|NCT01574716|155376954|FG000|Part 1|Withdrawal by Subject|0|||
48321565|NCT01574716|155376955|FG001|Part 1|Withdrawal by Subject|2|||
48321566|NCT01574716|155376956|FG002|Part 1|Withdrawal by Subject|0|||
48321567|NCT01574716|155376957|FG003|Part 1|Withdrawal by Subject|0|||
48321568|NCT01574716|155376958|FG004|Part 1|Withdrawal by Subject|0|||
48321569|NCT01574716|155376954|FG000|Part 1|Lost to Follow-up|0|||
48321570|NCT01574716|155376955|FG001|Part 1|Lost to Follow-up|1|||
48321571|NCT01574716|155376956|FG002|Part 1|Lost to Follow-up|0|||
48321572|NCT01574716|155376957|FG003|Part 1|Lost to Follow-up|0|||
48321573|NCT01574716|155376958|FG004|Part 1|Lost to Follow-up|0|||
48321574|NCT01574716|155376954|FG000|Part 2|Progressive disease|0|||
48321575|NCT01574716|155376955|FG001|Part 2|Progressive disease|0|||
48321576|NCT01574716|155376956|FG002|Part 2|Progressive disease|0|||
48321577|NCT01574716|155376957|FG003|Part 2|Progressive disease|1|||
48321578|NCT01574716|155376958|FG004|Part 2|Progressive disease|0|||
48321579|NCT01574716|155376954|FG000|Part 2|Death|0|||
48321580|NCT01574716|155376955|FG001|Part 2|Death|0|||
48321581|NCT01574716|155376956|FG002|Part 2|Death|0|||
48321582|NCT01574716|155376957|FG003|Part 2|Death|76|||
48321583|NCT01574716|155376958|FG004|Part 2|Death|35|||
48321584|NCT01574716|155376954|FG000|Part 2|Discontinuation of study by sponsor|0|||
48321585|NCT01574716|155376955|FG001|Part 2|Discontinuation of study by sponsor|0|||
48321586|NCT01574716|155376956|FG002|Part 2|Discontinuation of study by sponsor|0|||
48321587|NCT01574716|155376957|FG003|Part 2|Discontinuation of study by sponsor|51|||
48321588|NCT01574716|155376958|FG004|Part 2|Discontinuation of study by sponsor|31|||
48321589|NCT01574716|155376954|FG000|Part 2|Withdrawal by Subject|0|||
48321590|NCT01574716|155376955|FG001|Part 2|Withdrawal by Subject|0|||
48321591|NCT01574716|155376956|FG002|Part 2|Withdrawal by Subject|0|||
48321592|NCT01574716|155376957|FG003|Part 2|Withdrawal by Subject|5|||
48321593|NCT01574716|155376958|FG004|Part 2|Withdrawal by Subject|4|||
48321594|NCT01574716|155376954|FG000|Part 2|Brain metastases|0|||
48321595|NCT01574716|155376955|FG001|Part 2|Brain metastases|0|||
48321596|NCT01574716|155376956|FG002|Part 2|Brain metastases|0|||
48321597|NCT01574716|155376957|FG003|Part 2|Brain metastases|1|||
48321598|NCT01574716|155376958|FG004|Part 2|Brain metastases|0|||
48321599|NCT01574716|155376954|FG000|Part 2|Lost to Follow-up|0|||
48321600|NCT01574716|155376955|FG001|Part 2|Lost to Follow-up|0|||
48321601|NCT01574716|155376956|FG002|Part 2|Lost to Follow-up|0|||
48321602|NCT01574716|155376957|FG003|Part 2|Lost to Follow-up|3|||
48321603|NCT01574716|155376958|FG004|Part 2|Lost to Follow-up|0|||
48321604|NCT04048681|155376959|FG000|Overall Study|family emergency|0|||
48321605|NCT04048681|155376960|FG001|Overall Study|family emergency|0|||
48321606|NCT04048681|155376961|FG002|Overall Study|family emergency|0|||
48321607|NCT04048681|155376962|FG003|Overall Study|family emergency|1|||
48321608|NCT04048681|155376963|FG004|Overall Study|family emergency|0|||
48321609|NCT00727909|155376964|FG000|Overall Study|Withdrawal by Subject|5|||
48321610|NCT00727909|155376965|FG001|Overall Study|Withdrawal by Subject|11|||
48321611|NCT00727909|155376966|FG002|Overall Study|Withdrawal by Subject|8|||
48321612|NCT00727909|155376967|FG003|Overall Study|Withdrawal by Subject|5|||
48321613|NCT00727909|155376964|FG000|Overall Study|Death|0|||
48321614|NCT00727909|155376965|FG001|Overall Study|Death|0|||
48321615|NCT00727909|155376966|FG002|Overall Study|Death|1|||
48582621|NCT01844505|156323331|FG001|Overall Study|Poor/non-compliance|1|||
48582622|NCT01844505|156323332|FG002|Overall Study|Poor/non-compliance|1|||
48321616|NCT00727909|155376967|FG003|Overall Study|Death|0|||
48321617|NCT04166773|155376969|FG000|Overall Study|Adverse Event|2|||
48321618|NCT04166773|155376970|FG001|Overall Study|Adverse Event|0|||
48321619|NCT04166773|155376971|FG002|Overall Study|Adverse Event|2|||
48321620|NCT04166773|155376972|FG003|Overall Study|Adverse Event|1|||
48321621|NCT04166773|155376969|FG000|Overall Study|Lost to Follow-up|4|||
48582623|NCT01844505|156323330|FG000|Overall Study|Subject no longer meets criteria|0|||
48582624|NCT01844505|156323331|FG001|Overall Study|Subject no longer meets criteria|1|||
48582625|NCT01844505|156323332|FG002|Overall Study|Subject no longer meets criteria|0|||
48738984|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
48738985|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738986|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738987|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48582626|NCT01844505|156323330|FG000|Overall Study|Other Reasons|4|||
48582627|NCT01844505|156323331|FG001|Overall Study|Other Reasons|2|||
48738988|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738989|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738990|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738991|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
48738992|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
48738993|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738994|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738995|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738996|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738997|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48582628|NCT01844505|156323332|FG002|Overall Study|Other Reasons|2|||
48582629|NCT01844505|156323330|FG000|Overall Study|Not Reported|0|||
48738998|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48738999|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
48739000|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
48739001|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739002|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739003|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739004|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739005|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739006|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739007|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
48739008|NCT00533897|156894062|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
48739009|NCT00533897|156894063|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739010|NCT00533897|156894064|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739011|NCT00533897|156894065|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739012|NCT00533897|156894066|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739013|NCT00533897|156894067|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739014|NCT00533897|156894068|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739015|NCT00533897|156894069|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
48739016|NCT00533897|156894062|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739017|NCT00533897|156894063|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
48739018|NCT00533897|156894064|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
48582630|NCT01844505|156323331|FG001|Overall Study|Not Reported|0|||
48582631|NCT01844505|156323332|FG002|Overall Study|Not Reported|1|||
48582632|NCT02186847|156323333|FG000|Overall Study|Protocol Violation|3|||
48582633|NCT02186847|156323334|FG001|Overall Study|Protocol Violation|0|||
48582634|NCT01211483|156323336|FG000|Phase 1b|Death|6|||
48582635|NCT01211483|156323337|FG001|Phase 1b|Death|0|||
48582636|NCT01211483|156323338|FG002|Phase 1b|Death|0|||
48582637|NCT01211483|156323339|FG003|Phase 1b|Death|0|||
48582638|NCT01211483|156323336|FG000|Phase 1b|Withdrawal by Subject|1|||
48582639|NCT01211483|156323337|FG001|Phase 1b|Withdrawal by Subject|0|||
48582640|NCT01211483|156323338|FG002|Phase 1b|Withdrawal by Subject|0|||
48582641|NCT01211483|156323339|FG003|Phase 1b|Withdrawal by Subject|0|||
48582642|NCT01211483|156323336|FG000|Phase 2|Lost to Follow-up|0|||
48582643|NCT01211483|156323337|FG001|Phase 2|Lost to Follow-up|1|||
48582644|NCT01211483|156323338|FG002|Phase 2|Lost to Follow-up|1|||
48582645|NCT01211483|156323339|FG003|Phase 2|Lost to Follow-up|2|||
48582646|NCT01211483|156323336|FG000|Phase 2|Death|0|||
48739019|NCT00533897|156894065|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739020|NCT00533897|156894066|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48582647|NCT01211483|156323337|FG001|Phase 2|Death|64|||
48321622|NCT04166773|155376970|FG001|Overall Study|Lost to Follow-up|2|||
48321623|NCT04166773|155376971|FG002|Overall Study|Lost to Follow-up|1|||
48582648|NCT01211483|156323338|FG002|Phase 2|Death|53|||
48582649|NCT01211483|156323339|FG003|Phase 2|Death|53|||
48582650|NCT01211483|156323336|FG000|Phase 2|Withdrawal by Subject|0|||
48582651|NCT01211483|156323337|FG001|Phase 2|Withdrawal by Subject|1|||
48582652|NCT01211483|156323338|FG002|Phase 2|Withdrawal by Subject|10|||
48321624|NCT04166773|155376972|FG003|Overall Study|Lost to Follow-up|3|||
48321625|NCT04166773|155376969|FG000|Overall Study|Physician Decision|0|||
48321626|NCT04166773|155376970|FG001|Overall Study|Physician Decision|0|||
48321627|NCT04166773|155376971|FG002|Overall Study|Physician Decision|0|||
48321628|NCT04166773|155376972|FG003|Overall Study|Physician Decision|1|||
48321629|NCT04166773|155376969|FG000|Overall Study|Withdrawal by Subject|1|||
48321630|NCT04166773|155376970|FG001|Overall Study|Withdrawal by Subject|1|||
48321631|NCT04166773|155376971|FG002|Overall Study|Withdrawal by Subject|2|||
48321632|NCT04166773|155376972|FG003|Overall Study|Withdrawal by Subject|5|||
48321633|NCT00112359|155376975|FG000|Overall Study|Unrelated adverse event|16|||
48321634|NCT00112359|155376976|FG001|Overall Study|Unrelated adverse event|8|||
48321635|NCT00112359|155376975|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
48321636|NCT00112359|155376976|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
48321637|NCT00112359|155376975|FG000|Overall Study|Related adverse event|5|||
48321638|NCT00112359|155376976|FG001|Overall Study|Related adverse event|3|||
48321639|NCT00112359|155376975|FG000|Overall Study|Lost to Follow-up|0|||
48321640|NCT00112359|155376976|FG001|Overall Study|Lost to Follow-up|1|||
48321641|NCT00112359|155376975|FG000|Overall Study|Personal/administrative|1|||
48321642|NCT00112359|155376976|FG001|Overall Study|Personal/administrative|1|||
48321643|NCT00112359|155376975|FG000|Overall Study|Other|3|||
48321644|NCT00112359|155376976|FG001|Overall Study|Other|0|||
48321645|NCT02763566|155376983|FG000|Overall Study|Lost to Follow-up|1|||
48321646|NCT02763566|155376984|FG001|Overall Study|Lost to Follow-up|4|||
48321647|NCT02763566|155376985|FG002|Overall Study|Lost to Follow-up|0|||
48321648|NCT02763566|155376986|FG003|Overall Study|Lost to Follow-up|1|||
48321649|NCT02763566|155376983|FG000|Overall Study|On study treatment at study conclusion|114|||
48321650|NCT02763566|155376984|FG001|Overall Study|On study treatment at study conclusion|34|||
48321651|NCT02763566|155376985|FG002|Overall Study|On study treatment at study conclusion|54|||
48321652|NCT02763566|155376986|FG003|Overall Study|On study treatment at study conclusion|13|||
48321653|NCT02763566|155376983|FG000|Overall Study|Withdrawal by Subject|3|||
48582653|NCT01211483|156323339|FG003|Phase 2|Withdrawal by Subject|5|||
48582654|NCT01211483|156323336|FG000|Phase 2|Study terminated by Sponsor|0|||
48582655|NCT01211483|156323337|FG001|Phase 2|Study terminated by Sponsor|6|||
48582656|NCT01211483|156323338|FG002|Phase 2|Study terminated by Sponsor|8|||
48582657|NCT01211483|156323339|FG003|Phase 2|Study terminated by Sponsor|11|||
48582658|NCT05249127|156323342|FG000|Overall Study|Protocol Violation|13|||
48739021|NCT00533897|156894067|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739022|NCT00533897|156894068|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739023|NCT00533897|156894069|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
48739024|NCT00533897|156894062|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739025|NCT00533897|156894063|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739026|NCT00533897|156894064|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
48739027|NCT00533897|156894065|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739028|NCT00533897|156894066|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739029|NCT00533897|156894067|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739030|NCT00533897|156894068|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48739031|NCT00533897|156894069|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
48582659|NCT05249127|156323342|FG000|Overall Study|Physician Decision|4|||
48582660|NCT05249127|156323342|FG000|Overall Study|Withdrawal by Subject|2|||
48582661|NCT05249127|156323342|FG000|Overall Study|Participant Non-compliance|1|||
48582662|NCT01794793|156323343|FG000|Treatment Period|Withdrawal by Subject|24|||
48582663|NCT01794793|156323343|FG000|Treatment Period|Lack of Efficacy|22|||
48582664|NCT01794793|156323343|FG000|Treatment Period|Adverse Event|17|||
48582665|NCT01794793|156323343|FG000|Treatment Period|Physician Decision|14|||
48582666|NCT01794793|156323343|FG000|Treatment Period|Lost to Follow-up|7|||
48582667|NCT01794793|156323343|FG000|Treatment Period|Death|6|||
48582668|NCT01794793|156323343|FG000|Treatment Period|Protocol Violation|5|||
48582669|NCT01794793|156323343|FG000|Treatment Period|administrative problem|3|||
48582670|NCT01794793|156323343|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
48582671|NCT01794793|156323343|FG000|Post-treatment Follow-up|Adverse Event|8|||
48739032|NCT00533897|156894062|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739033|NCT00533897|156894063|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48582672|NCT01794793|156323343|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
48582673|NCT01794793|156323343|FG000|Post-treatment Follow-up|administrative problem|5|||
48321654|NCT02763566|155376984|FG001|Overall Study|Withdrawal by Subject|1|||
48321655|NCT02763566|155376985|FG002|Overall Study|Withdrawal by Subject|0|||
48321656|NCT02763566|155376986|FG003|Overall Study|Withdrawal by Subject|0|||
48321657|NCT04088409|155376987|FG000|Part A|Withdrawal by Subject|2|||
48321658|NCT04088409|155376988|FG001|Part A|Withdrawal by Subject|1|||
48587377|NCT02273908|156343211|FG000|Overall Study|Lost to Follow-up|10|||
48321659|NCT04088409|155376987|FG000|Part A|Did Not Meet Randomization Criteria|2|||
48321660|NCT04088409|155376988|FG001|Part A|Did Not Meet Randomization Criteria|0|||
48321661|NCT04088409|155376987|FG000|Part A|Lack of Efficacy|9|||
48321662|NCT04088409|155376988|FG001|Part A|Lack of Efficacy|0|||
48321663|NCT04088409|155376987|FG000|Part A|Lost to Follow-up|1|||
48321664|NCT04088409|155376988|FG001|Part A|Lost to Follow-up|0|||
48321665|NCT04088409|155376987|FG000|Part A|Adverse Event|1|||
48321666|NCT04088409|155376988|FG001|Part A|Adverse Event|0|||
48321667|NCT04088409|155376987|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
48321668|NCT04088409|155376988|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
48321669|NCT04088409|155376987|FG000|Part B|Ongoing Treatment|10|||
48321670|NCT04088409|155376988|FG001|Part B|Ongoing Treatment|0|||
48582674|NCT01794793|156323343|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
48582675|NCT01794793|156323343|FG000|Post-treatment Follow-up|Protocol Violation|3|||
48582676|NCT02044874|156323344|FG000|Overall Study|Adverse Event|5|||
48582677|NCT02044874|156323345|FG001|Overall Study|Adverse Event|6|||
48582678|NCT02044874|156323346|FG002|Overall Study|Adverse Event|6|||
48582679|NCT02044874|156323344|FG000|Overall Study|Withdrawal by Subject|8|||
48582680|NCT02044874|156323345|FG001|Overall Study|Withdrawal by Subject|16|||
48739034|NCT00533897|156894064|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739035|NCT00533897|156894065|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739036|NCT00533897|156894066|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739037|NCT00533897|156894067|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
48739038|NCT00533897|156894068|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739039|NCT00533897|156894069|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
48739040|NCT00533897|156894062|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739041|NCT00533897|156894063|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739042|NCT00533897|156894064|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48321671|NCT02063724|155376989|FG000|Overall Study|Disease progression|1|||
48582681|NCT02044874|156323346|FG002|Overall Study|Withdrawal by Subject|23|||
48582682|NCT02044874|156323344|FG000|Overall Study|Physician Decision|0|||
48582683|NCT02044874|156323345|FG001|Overall Study|Physician Decision|2|||
48582684|NCT02044874|156323346|FG002|Overall Study|Physician Decision|1|||
48582685|NCT02044874|156323344|FG000|Overall Study|Lost to Follow-up|10|||
48582686|NCT02044874|156323345|FG001|Overall Study|Lost to Follow-up|27|||
48582687|NCT02044874|156323346|FG002|Overall Study|Lost to Follow-up|21|||
48582688|NCT02044874|156323344|FG000|Overall Study|Sponsor Decision|0|||
48582689|NCT02044874|156323345|FG001|Overall Study|Sponsor Decision|1|||
48582690|NCT02044874|156323346|FG002|Overall Study|Sponsor Decision|1|||
48582691|NCT02044874|156323344|FG000|Overall Study|Other|7|||
48582692|NCT02044874|156323345|FG001|Overall Study|Other|3|||
48582693|NCT02044874|156323346|FG002|Overall Study|Other|8|||
48582694|NCT01004406|156324909|FG000|Overall Study|Withdrawal by Subject|2|||
48582695|NCT01004406|156324910|FG001|Overall Study|Withdrawal by Subject|0|||
48582696|NCT01004406|156324909|FG000|Overall Study|Lost to Follow-up|1|||
48582697|NCT01004406|156324910|FG001|Overall Study|Lost to Follow-up|0|||
48582698|NCT02963558|156324911|FG000|Overall Study|Withdrawn by investigator|1|||
48582699|NCT02963558|156324912|FG001|Overall Study|Withdrawn by investigator|0|||
48582700|NCT02963558|156324911|FG000|Overall Study|Withdrawal by Subject|0|||
48582701|NCT02963558|156324912|FG001|Overall Study|Withdrawal by Subject|1|||
48582702|NCT03309696|156324915|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
48582703|NCT03309696|156324916|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
48582704|NCT03309696|156324917|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
48582705|NCT03309696|156324918|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
48582706|NCT00616603|156324919|FG000|Overall Study|Physician Decision|2|||
48582707|NCT00616603|156324920|FG001|Overall Study|Physician Decision|0|||
48582708|NCT00616603|156324921|FG002|Overall Study|Physician Decision|2|||
48582709|NCT01892085|156324928|FG000|Overall Study|Death|4|||
48582710|NCT01892085|156324929|FG001|Overall Study|Death|1|||
48582711|NCT01892085|156324930|FG002|Overall Study|Death|3|||
48582712|NCT01892085|156324928|FG000|Overall Study|Withdrawal by Subject|2|||
48582713|NCT01892085|156324929|FG001|Overall Study|Withdrawal by Subject|0|||
48582714|NCT01892085|156324930|FG002|Overall Study|Withdrawal by Subject|2|||
48582715|NCT01258075|156324933|FG000|Overall Study|Adverse Event|8|||
48582716|NCT01258075|156324934|FG001|Overall Study|Adverse Event|3|||
48582717|NCT01258075|156324933|FG000|Overall Study|Lost to Follow-up|11|||
48321672|NCT01696981|155376992|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
48582718|NCT01258075|156324934|FG001|Overall Study|Lost to Follow-up|6|||
48582719|NCT01258075|156324933|FG000|Overall Study|Withdrawal by Subject|10|||
48582720|NCT01258075|156324934|FG001|Overall Study|Withdrawal by Subject|7|||
48582721|NCT01258075|156324933|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
48321673|NCT01696981|155376993|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
48582722|NCT01258075|156324934|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
48582723|NCT01258075|156324933|FG000|Overall Study|Other|12|||
48582724|NCT01258075|156324934|FG001|Overall Study|Other|5|||
48582725|NCT03738800|156324939|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
48582726|NCT03738800|156324940|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
48582727|NCT03738800|156324941|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48582728|NCT03738800|156324939|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
48582729|NCT03738800|156324940|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
48582730|NCT03738800|156324941|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
48582731|NCT03738800|156324939|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
48582732|NCT03738800|156324940|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
48582733|NCT03738800|156324941|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
48582734|NCT04416737|156324942|FG000|Week 1 (First Injection)|Physician Decision|0|||
48582735|NCT04416737|156324943|FG001|Week 1 (First Injection)|Physician Decision|1|||
48582736|NCT02719353|156324944|FG000|First Intervention|Physician Decision|0|||
48582737|NCT02719353|156324945|FG001|First Intervention|Physician Decision|1|||
48582738|NCT01712334|156324946|FG000|Treatment Period 1|Randomized in Error|0|||
48582739|NCT01712334|156324947|FG001|Treatment Period 1|Randomized in Error|2|||
48582740|NCT01472757|156324948|FG000|Overall Study|Withdrawal by Subject|1|||
48739043|NCT00533897|156894065|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739044|NCT00533897|156894066|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739045|NCT00533897|156894067|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
48739046|NCT00533897|156894068|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739047|NCT00533897|156894069|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
48739048|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48739049|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48739050|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48582741|NCT01472757|156324949|FG001|Overall Study|Withdrawal by Subject|2|||
48582742|NCT01472757|156324950|FG002|Overall Study|Withdrawal by Subject|2|||
48582743|NCT01472757|156324951|FG003|Overall Study|Withdrawal by Subject|0|||
48582744|NCT01472757|156324948|FG000|Overall Study|Asthma exacerbation|4|||
48582745|NCT01472757|156324949|FG001|Overall Study|Asthma exacerbation|1|||
48582746|NCT01472757|156324950|FG002|Overall Study|Asthma exacerbation|2|||
48582747|NCT01472757|156324951|FG003|Overall Study|Asthma exacerbation|1|||
48582748|NCT01472757|156324948|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
48582749|NCT01472757|156324949|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
48582750|NCT01472757|156324950|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
48582751|NCT01472757|156324951|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
48582752|NCT01472757|156324948|FG000|Overall Study|Protocol Violation|3|||
48582753|NCT01472757|156324949|FG001|Overall Study|Protocol Violation|2|||
48582754|NCT01472757|156324950|FG002|Overall Study|Protocol Violation|4|||
48582755|NCT01472757|156324951|FG003|Overall Study|Protocol Violation|4|||
48582756|NCT01472757|156324948|FG000|Overall Study|Other reasons|1|||
48582757|NCT01472757|156324949|FG001|Overall Study|Other reasons|0|||
48582758|NCT01472757|156324950|FG002|Overall Study|Other reasons|2|||
48582759|NCT01472757|156324951|FG003|Overall Study|Other reasons|2|||
48582760|NCT00948506|156324952|FG000|Overall Study|Withdrawal by Subject|3|||
48582761|NCT00948506|156324953|FG001|Overall Study|Withdrawal by Subject|1|||
48582762|NCT00943670|156324957|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
48582763|NCT00943670|156324957|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
48582764|NCT00943670|156324957|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
48582765|NCT00943670|156324957|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
48582766|NCT00943670|156324957|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
48582767|NCT00943670|156324957|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
48582768|NCT00943670|156324957|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
48582769|NCT00943670|156324957|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
48582770|NCT00943670|156324957|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
48739051|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48582771|NCT00943670|156324957|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
48582772|NCT00501059|156324960|FG000|Overall Study|Protocol Violation|80|||
48582773|NCT00501059|156324961|FG001|Overall Study|Protocol Violation|69|||
48582774|NCT00501059|156324960|FG000|Overall Study|Death|140|||
48582775|NCT00501059|156324961|FG001|Overall Study|Death|137|||
48582776|NCT00501059|156324960|FG000|Overall Study|Other|236|||
48582777|NCT00501059|156324961|FG001|Overall Study|Other|239|||
48582778|NCT00501059|156324960|FG000|Overall Study|Missing end-of-study page|91|||
48739052|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48582779|NCT00501059|156324961|FG001|Overall Study|Missing end-of-study page|92|||
48739053|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
48582780|NCT00501059|156324960|FG000|Overall Study|Clinical endpoint reached|110|||
48582781|NCT00501059|156324961|FG001|Overall Study|Clinical endpoint reached|123|||
48582782|NCT00501059|156324960|FG000|Overall Study|Insufficient therapeutic effect|4|||
48582783|NCT00501059|156324961|FG001|Overall Study|Insufficient therapeutic effect|5|||
48582784|NCT00501059|156324960|FG000|Overall Study|Consent withdrawn by subject|817|||
48582785|NCT00501059|156324961|FG001|Overall Study|Consent withdrawn by subject|873|||
48582786|NCT00501059|156324960|FG000|Overall Study|Non-compliant with study treatment|23|||
48582787|NCT00501059|156324961|FG001|Overall Study|Non-compliant with study treatment|16|||
48582788|NCT00501059|156324960|FG000|Overall Study|Reason not given|3|||
48582789|NCT00501059|156324961|FG001|Overall Study|Reason not given|1|||
48582790|NCT00501059|156324960|FG000|Overall Study|Adverse Event|129|||
48582791|NCT00501059|156324961|FG001|Overall Study|Adverse Event|122|||
48582792|NCT00501059|156324960|FG000|Overall Study|Lost to Follow-up|210|||
48582793|NCT00501059|156324961|FG001|Overall Study|Lost to Follow-up|198|||
48582794|NCT00501059|156324960|FG000|Overall Study|Not treated|25|||
48582795|NCT00501059|156324961|FG001|Overall Study|Not treated|17|||
48582796|NCT02603562|156324962|FG000|Overall Study|Lost to Follow-up|1|||
48582797|NCT00270231|156324963|FG000|First Intervention|Lost to Follow-up|1|||
48582798|NCT00270231|156324964|FG001|First Intervention|Lost to Follow-up|1|||
48582799|NCT00270231|156324963|FG000|Washout Period|Lost to Follow-up|1|||
48582800|NCT00270231|156324964|FG001|Washout Period|Lost to Follow-up|0|||
48582801|NCT00270231|156324963|FG000|Second Intervention|Lost to Follow-up|0|||
48582802|NCT00270231|156324964|FG001|Second Intervention|Lost to Follow-up|1|||
48582803|NCT03672461|156324965|FG000|Overall Study|COVID Related|4|||
48582804|NCT03672461|156324966|FG001|Overall Study|COVID Related|2|||
48582805|NCT03672461|156324965|FG000|Overall Study|Adverse Event|2|||
48582806|NCT03672461|156324966|FG001|Overall Study|Adverse Event|0|||
48582807|NCT03672461|156324965|FG000|Overall Study|Serious Adverse Event|0|||
48582808|NCT03672461|156324966|FG001|Overall Study|Serious Adverse Event|1|||
48582809|NCT03672461|156324965|FG000|Overall Study|Too Busy|3|||
48582810|NCT03672461|156324966|FG001|Overall Study|Too Busy|1|||
48582811|NCT03672461|156324965|FG000|Overall Study|Lost to Follow-up|1|||
48582812|NCT03672461|156324966|FG001|Overall Study|Lost to Follow-up|2|||
48582813|NCT03672461|156324965|FG000|Overall Study|Family|2|||
48739054|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
48739055|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
48739056|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Death|0|||
48582814|NCT03672461|156324966|FG001|Overall Study|Family|2|||
48582815|NCT03672461|156324965|FG000|Overall Study|No remote technology access|0|||
48582816|NCT03672461|156324966|FG001|Overall Study|No remote technology access|1|||
48582817|NCT03672461|156324965|FG000|Overall Study|Withdrawal by Subject|1|||
48582818|NCT03672461|156324966|FG001|Overall Study|Withdrawal by Subject|0|||
48582819|NCT03672461|156324965|FG000|Overall Study|Cannot tolerate intervention|1|||
48582820|NCT03672461|156324966|FG001|Overall Study|Cannot tolerate intervention|0|||
48582821|NCT03672461|156324965|FG000|Overall Study|Incomplete outcome data|6|||
48582822|NCT03672461|156324966|FG001|Overall Study|Incomplete outcome data|1|||
48582823|NCT06011161|156324969|FG000|Overall Study|Withdrawal by Subject|2|||
48582824|NCT06011161|156324969|FG000|Overall Study|Lost to Follow-up|5|||
48582825|NCT00860249|156324975|FG000|Overall Study|trial was terminated prior to completion|21|||
48582826|NCT00860249|156324976|FG001|Overall Study|trial was terminated prior to completion|18|||
48582827|NCT00860249|156324977|FG002|Overall Study|trial was terminated prior to completion|21|||
48582828|NCT02928770|156324978|FG000|Overall Study|Withdrawal by Subject|2|||
48582829|NCT00875433|156324979|FG000|Overall Study|Progressive disease|41|||
48582830|NCT00875433|156324979|FG000|Overall Study|Other Adverse Event|14|||
48582831|NCT00875433|156324979|FG000|Overall Study|Withdrawal by Subject|2|||
48582832|NCT00875433|156324979|FG000|Overall Study|Other|3|||
48739057|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Death|0|||
48739058|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Death|0|||
48739059|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Death|0|||
48739060|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Death|0|||
48739061|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Death|0|||
48739062|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Death|1|||
48739063|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Death|3|||
48739064|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
48582833|NCT01995175|156324980|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
48582834|NCT01995175|156324980|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
48582835|NCT01995175|156324980|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
48582836|NCT01995175|156324980|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
48739065|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739066|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
48582837|NCT01995175|156324980|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
48582838|NCT01995175|156324980|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
48582839|NCT01995175|156324980|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
48582840|NCT01995175|156324980|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
48582841|NCT01995175|156324980|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
48582842|NCT00432276|156324984|FG000|Overall Study|Hyperglycemic Rescue|44|||
48582843|NCT00432276|156324985|FG001|Overall Study|Hyperglycemic Rescue|87|||
48582844|NCT00432276|156324984|FG000|Overall Study|Adverse Event|13|||
48582845|NCT00432276|156324985|FG001|Overall Study|Adverse Event|16|||
48582846|NCT00432276|156324984|FG000|Overall Study|Protocol Violation|25|||
48582847|NCT00432276|156324985|FG001|Overall Study|Protocol Violation|20|||
48582848|NCT00432276|156324984|FG000|Overall Study|Lost to Follow-up|6|||
48582849|NCT00432276|156324985|FG001|Overall Study|Lost to Follow-up|2|||
48582850|NCT00432276|156324984|FG000|Overall Study|Withdrawal by Subject|25|||
48582851|NCT00432276|156324985|FG001|Overall Study|Withdrawal by Subject|20|||
48582852|NCT00432276|156324984|FG000|Overall Study|Physician Decision|6|||
48739067|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739068|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739069|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
48739070|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
48739071|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
48582853|NCT00432276|156324985|FG001|Overall Study|Physician Decision|8|||
48582854|NCT00432276|156324984|FG000|Overall Study|Other|2|||
48739072|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48582855|NCT00432276|156324985|FG001|Overall Study|Other|3|||
48582856|NCT00131365|156324986|FG000|Overall Study|Withdrawal by Subject|1|||
48582857|NCT00131365|156324986|FG000|Overall Study|Alternative treatment|3|||
48582858|NCT03191864|156324987|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
48582859|NCT03191864|156324988|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
48582860|NCT03191864|156324989|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
48582861|NCT03191864|156324990|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
48582862|NCT03191864|156324991|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
48739073|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739074|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739075|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739076|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739077|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739078|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
48582863|NCT03191864|156324992|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
48582864|NCT03191864|156324987|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
48582865|NCT03191864|156324988|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
48582866|NCT03191864|156324989|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
48739079|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
48739080|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Adverse Event|0|||
48739081|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Adverse Event|0|||
48739082|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Adverse Event|0|||
48739083|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Adverse Event|0|||
48739084|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Adverse Event|0|||
48582867|NCT03191864|156324990|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
48582868|NCT03191864|156324991|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
48582869|NCT03191864|156324992|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
48582870|NCT03191864|156324987|FG000|Baseline Symptom Assessment|Adverse Event|0|||
48582871|NCT03191864|156324988|FG001|Baseline Symptom Assessment|Adverse Event|0|||
48582872|NCT03191864|156324989|FG002|Baseline Symptom Assessment|Adverse Event|0|||
48582873|NCT03191864|156324990|FG003|Baseline Symptom Assessment|Adverse Event|0|||
48582874|NCT03191864|156324991|FG004|Baseline Symptom Assessment|Adverse Event|0|||
48582875|NCT03191864|156324992|FG005|Baseline Symptom Assessment|Adverse Event|2|||
48582876|NCT03191864|156324987|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
48582877|NCT03191864|156324988|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
48582878|NCT03191864|156324989|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
48582879|NCT03191864|156324990|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
48582880|NCT03191864|156324991|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
48582881|NCT03191864|156324992|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
48582882|NCT03191864|156324987|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
48582883|NCT03191864|156324988|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
48582884|NCT03191864|156324989|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
48582885|NCT03191864|156324990|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
48582886|NCT03191864|156324991|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
48582887|NCT03191864|156324992|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
48582888|NCT03191864|156324987|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
48582889|NCT03191864|156324988|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
48582890|NCT03191864|156324989|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
48582891|NCT03191864|156324990|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
48582892|NCT03191864|156324991|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
48582893|NCT03191864|156324992|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
48582894|NCT03191864|156324987|FG000|Part 1 - Induction|Adverse Event|0|||
48582895|NCT03191864|156324988|FG001|Part 1 - Induction|Adverse Event|2|||
48582896|NCT03191864|156324989|FG002|Part 1 - Induction|Adverse Event|0|||
48582897|NCT03191864|156324990|FG003|Part 1 - Induction|Adverse Event|1|||
48582898|NCT03191864|156324991|FG004|Part 1 - Induction|Adverse Event|0|||
48582899|NCT03191864|156324992|FG005|Part 1 - Induction|Adverse Event|2|||
48582900|NCT03191864|156324987|FG000|Part 1 - Induction|Randomized but never dosed|0|||
48582901|NCT03191864|156324988|FG001|Part 1 - Induction|Randomized but never dosed|0|||
48582902|NCT03191864|156324989|FG002|Part 1 - Induction|Randomized but never dosed|1|||
48582903|NCT03191864|156324990|FG003|Part 1 - Induction|Randomized but never dosed|0|||
48582904|NCT03191864|156324991|FG004|Part 1 - Induction|Randomized but never dosed|0|||
48582905|NCT03191864|156324992|FG005|Part 1 - Induction|Randomized but never dosed|0|||
48582906|NCT03191864|156324987|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
48582907|NCT03191864|156324988|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
48582908|NCT03191864|156324989|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
48582909|NCT03191864|156324990|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
48582910|NCT03191864|156324991|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
48582911|NCT03191864|156324992|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
48739085|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Adverse Event|0|||
48739086|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Adverse Event|2|||
48739087|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Adverse Event|5|||
48739088|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Pregnancy|0|||
48739089|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Pregnancy|0|||
48739090|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Pregnancy|0|||
48739091|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Pregnancy|0|||
48739092|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Pregnancy|0|||
48739093|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Pregnancy|0|||
48739094|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Pregnancy|0|||
48739095|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Pregnancy|2|||
48739096|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739097|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739098|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739099|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739100|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739101|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
48739102|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
48739103|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
48739104|NCT00533897|156894062|FG000|Long Term Extension (LTE)|Other|0|||
48739105|NCT00533897|156894063|FG001|Long Term Extension (LTE)|Other|0|||
48739106|NCT00533897|156894064|FG002|Long Term Extension (LTE)|Other|0|||
48739107|NCT00533897|156894065|FG003|Long Term Extension (LTE)|Other|0|||
48739108|NCT00533897|156894066|FG004|Long Term Extension (LTE)|Other|0|||
48739109|NCT00533897|156894067|FG005|Long Term Extension (LTE)|Other|0|||
48739110|NCT00533897|156894068|FG006|Long Term Extension (LTE)|Other|1|||
48739111|NCT00533897|156894069|FG007|Long Term Extension (LTE)|Other|6|||
48739112|NCT00246753|156894071|FG000|Overall Study|Withdrawal by Subject|2|||
48739113|NCT00246753|156894071|FG000|Overall Study|Physician Decision|2|||
48739114|NCT00246753|156894071|FG000|Overall Study|Adverse Event|2|||
48739115|NCT00246753|156894071|FG000|Overall Study|Unacceptable toxicity|2|||
48739116|NCT00434954|156894076|FG000|Overall Study|Adverse Event|17|||
48739117|NCT00434954|156894077|FG001|Overall Study|Adverse Event|2|||
48739118|NCT00434954|156894076|FG000|Overall Study|Entry criteria not met|14|||
48739119|NCT00434954|156894077|FG001|Overall Study|Entry criteria not met|16|||
48739120|NCT00434954|156894076|FG000|Overall Study|Lost to Follow-up|0|||
48321674|NCT01696981|155376992|FG000|Overall Study|Died Before Randomization|3|||
48321675|NCT01696981|155376993|FG001|Overall Study|Died Before Randomization|8|||
48321676|NCT01696981|155376992|FG000|Overall Study|Died Before ASU (Control)|278|||
48321677|NCT01696981|155376993|FG001|Overall Study|Died Before ASU (Control)|0|||
48321678|NCT01696981|155376992|FG000|Overall Study|Refused ASU (Control)|920|||
48582912|NCT03191864|156324987|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
48582913|NCT03191864|156324988|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
48582914|NCT03191864|156324989|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
48582915|NCT03191864|156324990|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
48582916|NCT03191864|156324991|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
48582917|NCT03191864|156324992|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
48582918|NCT03191864|156324987|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
48582919|NCT03191864|156324988|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
48739121|NCT00434954|156894077|FG001|Overall Study|Lost to Follow-up|1|||
48321679|NCT01696981|155376993|FG001|Overall Study|Refused ASU (Control)|0|||
48321680|NCT01696981|155376992|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
48582920|NCT03191864|156324989|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
48739122|NCT00434954|156894076|FG000|Overall Study|Physician Decision|6|||
48739123|NCT00434954|156894077|FG001|Overall Study|Physician Decision|3|||
48739124|NCT00434954|156894076|FG000|Overall Study|Protocol Violation|36|||
48739125|NCT00434954|156894077|FG001|Overall Study|Protocol Violation|27|||
48321681|NCT01696981|155376993|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
48739126|NCT00434954|156894076|FG000|Overall Study|Sponsor decision|1|||
48739127|NCT00434954|156894077|FG001|Overall Study|Sponsor decision|0|||
48739128|NCT00434954|156894076|FG000|Overall Study|Subject decision|8|||
48739129|NCT00434954|156894077|FG001|Overall Study|Subject decision|22|||
48739130|NCT00002651|156894078|FG000|Induction|Adverse Event|44|||
48739131|NCT00002651|156894079|FG001|Induction|Adverse Event|0|||
48739132|NCT00002651|156894080|FG002|Induction|Adverse Event|0|||
48739133|NCT00002651|156894078|FG000|Induction|Refusal unrelated to adverse event|50|||
48739134|NCT00002651|156894079|FG001|Induction|Refusal unrelated to adverse event|0|||
48739135|NCT00002651|156894080|FG002|Induction|Refusal unrelated to adverse event|0|||
48739136|NCT00002651|156894078|FG000|Induction|Progression/relapse|274|||
48739137|NCT00002651|156894079|FG001|Induction|Progression/relapse|0|||
48739138|NCT00002651|156894080|FG002|Induction|Progression/relapse|0|||
48739139|NCT00002651|156894078|FG000|Induction|Death|62|||
48739140|NCT00002651|156894079|FG001|Induction|Death|0|||
48739141|NCT00002651|156894080|FG002|Induction|Death|0|||
48739142|NCT00002651|156894078|FG000|Induction|Other|823|||
48739143|NCT00002651|156894079|FG001|Induction|Other|0|||
48739144|NCT00002651|156894080|FG002|Induction|Other|0|||
48739145|NCT00002651|156894078|FG000|Induction|not eligible|90|||
48321682|NCT03735121|155376994|FG000|Overall Study|Death|3|||
48321683|NCT03735121|155376995|FG001|Overall Study|Death|6|||
48321684|NCT03735121|155376996|FG002|Overall Study|Death|8|||
48321685|NCT03735121|155376997|FG003|Overall Study|Death|37|||
48582921|NCT03191864|156324990|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
48582922|NCT03191864|156324991|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
48582923|NCT03191864|156324992|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
48582924|NCT03191864|156324987|FG000|Part 2 - Maintenance|Physician Decision|1|||
48582925|NCT03191864|156324988|FG001|Part 2 - Maintenance|Physician Decision|0|||
48582926|NCT03191864|156324989|FG002|Part 2 - Maintenance|Physician Decision|0|||
48582927|NCT03191864|156324990|FG003|Part 2 - Maintenance|Physician Decision|0|||
48582928|NCT03191864|156324991|FG004|Part 2 - Maintenance|Physician Decision|0|||
48582929|NCT03191864|156324992|FG005|Part 2 - Maintenance|Physician Decision|0|||
48582930|NCT03191864|156324987|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
48582931|NCT03191864|156324988|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
48739146|NCT00002651|156894079|FG001|Induction|not eligible|0|||
48321686|NCT03735121|155376998|FG004|Overall Study|Death|86|||
48321687|NCT03735121|155376994|FG000|Overall Study|Withdrawal by Subject|1|||
48321688|NCT03735121|155376995|FG001|Overall Study|Withdrawal by Subject|1|||
48321689|NCT03735121|155376996|FG002|Overall Study|Withdrawal by Subject|3|||
48739147|NCT00002651|156894080|FG002|Induction|not eligible|0|||
48582932|NCT03191864|156324989|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
48582933|NCT03191864|156324990|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
48582934|NCT03191864|156324991|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
48582935|NCT03191864|156324992|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
48321690|NCT03735121|155376997|FG003|Overall Study|Withdrawal by Subject|4|||
48582936|NCT03191864|156324987|FG000|Part 2 - Maintenance|Adverse Event|0|||
48582937|NCT03191864|156324988|FG001|Part 2 - Maintenance|Adverse Event|0|||
48582938|NCT03191864|156324989|FG002|Part 2 - Maintenance|Adverse Event|0|||
48582939|NCT03191864|156324990|FG003|Part 2 - Maintenance|Adverse Event|0|||
48582940|NCT03191864|156324991|FG004|Part 2 - Maintenance|Adverse Event|1|||
48582941|NCT03191864|156324992|FG005|Part 2 - Maintenance|Adverse Event|0|||
48582942|NCT03191864|156324987|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
48321691|NCT03735121|155376998|FG004|Overall Study|Withdrawal by Subject|2|||
48321692|NCT03735121|155376994|FG000|Overall Study|Progressive Disease|0|||
48321693|NCT03735121|155376995|FG001|Overall Study|Progressive Disease|0|||
48321694|NCT03735121|155376996|FG002|Overall Study|Progressive Disease|1|||
48321695|NCT03735121|155376997|FG003|Overall Study|Progressive Disease|0|||
48321696|NCT03735121|155376998|FG004|Overall Study|Progressive Disease|0|||
48321697|NCT03735121|155376994|FG000|Overall Study|Lost to Follow-up|0|||
48321698|NCT03735121|155376995|FG001|Overall Study|Lost to Follow-up|0|||
48321699|NCT03735121|155376996|FG002|Overall Study|Lost to Follow-up|0|||
48321700|NCT03735121|155376997|FG003|Overall Study|Lost to Follow-up|0|||
48321701|NCT03735121|155376998|FG004|Overall Study|Lost to Follow-up|1|||
48321702|NCT03735121|155376994|FG000|Overall Study|Ongoing|3|||
48321703|NCT03735121|155376995|FG001|Overall Study|Ongoing|3|||
48321704|NCT03735121|155376996|FG002|Overall Study|Ongoing|26|||
48321705|NCT03735121|155376997|FG003|Overall Study|Ongoing|83|||
48321706|NCT03735121|155376998|FG004|Overall Study|Ongoing|158|||
48321707|NCT03987022|155376999|FG000|Overall Study|Lost to Follow-up|2|||
48582943|NCT03191864|156324988|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
48582944|NCT03191864|156324989|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
48739148|NCT00002651|156894078|FG000|Consolidation and Randomization|Adverse Event|0|||
48739149|NCT00002651|156894079|FG001|Consolidation and Randomization|Adverse Event|36|||
48321708|NCT03987022|155377000|FG001|Overall Study|Lost to Follow-up|2|||
48739150|NCT00002651|156894080|FG002|Consolidation and Randomization|Adverse Event|14|||
48321709|NCT03987022|155376999|FG000|Overall Study|Withdrawal by Subject|1|||
48321710|NCT03987022|155377000|FG001|Overall Study|Withdrawal by Subject|0|||
48321711|NCT00603954|155377001|FG000|Overall Study|Protocol Violation|1|||
48321712|NCT00603954|155377002|FG001|Overall Study|Protocol Violation|2|||
48321713|NCT02376790|155377003|FG000|Overall Study|Withdrawal by Subject|43|||
48321714|NCT02376790|155377004|FG001|Overall Study|Withdrawal by Subject|36|||
48321715|NCT02376790|155377005|FG002|Overall Study|Withdrawal by Subject|37|||
48321716|NCT02376790|155377003|FG000|Overall Study|Decision by Sponsor|2|||
48582945|NCT03191864|156324990|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
48582946|NCT03191864|156324991|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
48582947|NCT03191864|156324992|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
48582948|NCT03191864|156324987|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
48321717|NCT02376790|155377004|FG001|Overall Study|Decision by Sponsor|1|||
48321718|NCT02376790|155377005|FG002|Overall Study|Decision by Sponsor|4|||
48321719|NCT02376790|155377003|FG000|Overall Study|Lost to Follow-up|15|||
48321720|NCT02376790|155377004|FG001|Overall Study|Lost to Follow-up|10|||
48321721|NCT02376790|155377005|FG002|Overall Study|Lost to Follow-up|12|||
48321722|NCT05147116|155377006|FG000|Overall Study|Withdrawal by Subject|0|||
48321723|NCT05147116|155377007|FG001|Overall Study|Withdrawal by Subject|1|||
48321724|NCT02827877|155377008|FG000|Overall Study|Withdrawal by Subject|1|||
48321725|NCT02974621|155377010|FG000|Overall Study|Didn't receive study treatment|1|||
48321726|NCT02974621|155377011|FG001|Overall Study|Didn't receive study treatment|10|||
48321727|NCT00073749|155377015|FG000|Overall Study|Disease Progression|2|||
48321728|NCT00073749|155377016|FG001|Overall Study|Disease Progression|0|||
48321729|NCT00073749|155377017|FG002|Overall Study|Disease Progression|3|||
48321730|NCT00073749|155377018|FG003|Overall Study|Disease Progression|2|||
48321731|NCT00073749|155377019|FG004|Overall Study|Disease Progression|3|||
48321732|NCT00073749|155377020|FG005|Overall Study|Disease Progression|1|||
48321733|NCT00073749|155377021|FG006|Overall Study|Disease Progression|3|||
48321734|NCT00073749|155377015|FG000|Overall Study|Death|0|||
48321735|NCT00073749|155377016|FG001|Overall Study|Death|1|||
48321736|NCT00073749|155377017|FG002|Overall Study|Death|1|||
48321737|NCT00073749|155377018|FG003|Overall Study|Death|0|||
48321738|NCT00073749|155377019|FG004|Overall Study|Death|0|||
48321739|NCT00073749|155377020|FG005|Overall Study|Death|0|||
48321740|NCT00073749|155377021|FG006|Overall Study|Death|29|||
48321741|NCT00073749|155377015|FG000|Overall Study|Adverse Event|0|||
48321742|NCT00073749|155377016|FG001|Overall Study|Adverse Event|3|||
48321743|NCT00073749|155377017|FG002|Overall Study|Adverse Event|6|||
48321744|NCT00073749|155377018|FG003|Overall Study|Adverse Event|4|||
48321745|NCT00073749|155377019|FG004|Overall Study|Adverse Event|2|||
48321746|NCT00073749|155377020|FG005|Overall Study|Adverse Event|1|||
48321747|NCT00073749|155377021|FG006|Overall Study|Adverse Event|0|||
48321748|NCT00073749|155377015|FG000|Overall Study|Physician Decision|0|||
48321749|NCT00073749|155377016|FG001|Overall Study|Physician Decision|0|||
48321750|NCT00073749|155377017|FG002|Overall Study|Physician Decision|1|||
48321751|NCT00073749|155377018|FG003|Overall Study|Physician Decision|0|||
48321752|NCT00073749|155377019|FG004|Overall Study|Physician Decision|0|||
48321753|NCT00073749|155377020|FG005|Overall Study|Physician Decision|2|||
48321754|NCT00073749|155377021|FG006|Overall Study|Physician Decision|0|||
48321755|NCT00073749|155377015|FG000|Overall Study|Withdrawal by Subject|0|||
48321756|NCT00073749|155377016|FG001|Overall Study|Withdrawal by Subject|1|||
48321757|NCT00073749|155377017|FG002|Overall Study|Withdrawal by Subject|0|||
48321758|NCT00073749|155377018|FG003|Overall Study|Withdrawal by Subject|0|||
48321759|NCT00073749|155377019|FG004|Overall Study|Withdrawal by Subject|1|||
48321760|NCT00073749|155377020|FG005|Overall Study|Withdrawal by Subject|0|||
48321761|NCT00073749|155377021|FG006|Overall Study|Withdrawal by Subject|2|||
48321762|NCT00073749|155377015|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
48321763|NCT00073749|155377016|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48321764|NCT00073749|155377017|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
48321765|NCT00073749|155377018|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
48321766|NCT00073749|155377019|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
48321767|NCT00073749|155377020|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
48321768|NCT00073749|155377021|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
48321769|NCT00073749|155377015|FG000|Overall Study|Lost to Follow-up|0|||
48582949|NCT03191864|156324988|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
48582950|NCT03191864|156324989|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
48582951|NCT03191864|156324990|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
48582952|NCT03191864|156324991|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
48582953|NCT03191864|156324992|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
48582954|NCT02889835|156324993|FG000|Overall Study|Lost to Follow-up|13|||
48582955|NCT02889835|156324994|FG001|Overall Study|Lost to Follow-up|13|||
48582956|NCT02889835|156324995|FG002|Overall Study|Lost to Follow-up|13|||
48582957|NCT02889835|156324993|FG000|Overall Study|Withdrawal by Subject|2|||
48582958|NCT02889835|156324994|FG001|Overall Study|Withdrawal by Subject|2|||
48582959|NCT02889835|156324995|FG002|Overall Study|Withdrawal by Subject|2|||
48582960|NCT02889835|156324993|FG000|Overall Study|Protocol Violation|1|||
48321770|NCT00073749|155377016|FG001|Overall Study|Lost to Follow-up|0|||
48321771|NCT00073749|155377017|FG002|Overall Study|Lost to Follow-up|0|||
48321772|NCT00073749|155377018|FG003|Overall Study|Lost to Follow-up|0|||
48321773|NCT00073749|155377019|FG004|Overall Study|Lost to Follow-up|0|||
48321774|NCT00073749|155377020|FG005|Overall Study|Lost to Follow-up|0|||
48582961|NCT02889835|156324994|FG001|Overall Study|Protocol Violation|1|||
48582962|NCT02889835|156324995|FG002|Overall Study|Protocol Violation|1|||
48582963|NCT02889835|156324993|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
48582964|NCT02889835|156324994|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
48582965|NCT02889835|156324995|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
48582966|NCT02889835|156324993|FG000|Overall Study|Death|1|||
48321775|NCT00073749|155377021|FG006|Overall Study|Lost to Follow-up|2|||
48321776|NCT00073749|155377015|FG000|Overall Study|Other|0|||
48321777|NCT00073749|155377016|FG001|Overall Study|Other|0|||
48321778|NCT00073749|155377017|FG002|Overall Study|Other|0|||
48321779|NCT00073749|155377018|FG003|Overall Study|Other|0|||
48321780|NCT00073749|155377019|FG004|Overall Study|Other|0|||
48321781|NCT00073749|155377020|FG005|Overall Study|Other|2|||
48321782|NCT00073749|155377021|FG006|Overall Study|Other|0|||
48321783|NCT02538341|155377022|FG000|Overall Study|Lost to Follow-up|51|||
48321784|NCT02538341|155377023|FG001|Overall Study|Lost to Follow-up|46|||
48321785|NCT02538341|155377022|FG000|Overall Study|Withdrawal by Subject|3|||
48321786|NCT02538341|155377023|FG001|Overall Study|Withdrawal by Subject|1|||
48321787|NCT02538341|155377022|FG000|Overall Study|Death|2|||
48321788|NCT02538341|155377023|FG001|Overall Study|Death|0|||
48321789|NCT02998528|155377024|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
48321790|NCT02998528|155377025|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
48321791|NCT02998528|155377026|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
48321792|NCT02998528|155377024|FG000|Randomization Period|Participant withdrew consent|0|||
48739151|NCT00002651|156894078|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
48321793|NCT02998528|155377025|FG001|Randomization Period|Participant withdrew consent|3|||
48321794|NCT02998528|155377026|FG002|Randomization Period|Participant withdrew consent|0|||
48321795|NCT02998528|155377024|FG000|Randomization Period|Participant no longer meets study criteria|1|||
48321796|NCT02998528|155377025|FG001|Randomization Period|Participant no longer meets study criteria|3|||
48321797|NCT02998528|155377026|FG002|Randomization Period|Participant no longer meets study criteria|2|||
48321798|NCT02998528|155377024|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
48321799|NCT02998528|155377025|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
48321800|NCT02998528|155377026|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
48321801|NCT02998528|155377024|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
48321802|NCT02998528|155377025|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
48739152|NCT00002651|156894079|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
48743074|NCT00968201|156910495|FG001|Extension Study - (Period III)|Adverse Event|5|||
48321803|NCT02998528|155377026|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
48582967|NCT02889835|156324994|FG001|Overall Study|Death|1|||
48582968|NCT02889835|156324995|FG002|Overall Study|Death|1|||
48582969|NCT05072964|156324998|FG000|Overall Study|Withdrawal by Subject|4|||
48582970|NCT05072964|156324998|FG000|Overall Study|Death|1|||
48582971|NCT02908074|156324999|FG000|Overall Study|sponsor/ICON decision|0|||
48582972|NCT02908074|156325000|FG001|Overall Study|sponsor/ICON decision|0|||
48582973|NCT02908074|156325001|FG002|Overall Study|sponsor/ICON decision|1|||
48582974|NCT02908074|156325002|FG003|Overall Study|sponsor/ICON decision|0|||
48582975|NCT02908074|156325003|FG004|Overall Study|sponsor/ICON decision|0|||
48582976|NCT02908074|156325004|FG005|Overall Study|sponsor/ICON decision|0|||
48582977|NCT02908074|156324999|FG000|Overall Study|Protocol Violation|0|||
48582978|NCT02908074|156325000|FG001|Overall Study|Protocol Violation|1|||
48582979|NCT02908074|156325001|FG002|Overall Study|Protocol Violation|0|||
48582980|NCT02908074|156325002|FG003|Overall Study|Protocol Violation|0|||
48582981|NCT02908074|156325003|FG004|Overall Study|Protocol Violation|0|||
48582982|NCT02908074|156325004|FG005|Overall Study|Protocol Violation|0|||
48582983|NCT02908074|156324999|FG000|Overall Study|Adverse Event|5|||
48582984|NCT02908074|156325000|FG001|Overall Study|Adverse Event|2|||
48582985|NCT02908074|156325001|FG002|Overall Study|Adverse Event|0|||
48582986|NCT02908074|156325002|FG003|Overall Study|Adverse Event|0|||
48582987|NCT02908074|156325003|FG004|Overall Study|Adverse Event|1|||
48582988|NCT02908074|156325004|FG005|Overall Study|Adverse Event|0|||
48582989|NCT02908074|156324999|FG000|Overall Study|AESI|1|||
48582990|NCT02908074|156325000|FG001|Overall Study|AESI|0|||
48582991|NCT02908074|156325001|FG002|Overall Study|AESI|1|||
48582992|NCT02908074|156325002|FG003|Overall Study|AESI|0|||
48321804|NCT02998528|155377024|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
48321805|NCT02998528|155377025|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
48451081|NCT01947894|155839261|FG002|Overall Study|Physician Decision|0|||
48582993|NCT02908074|156325003|FG004|Overall Study|AESI|1|||
48582994|NCT02908074|156325004|FG005|Overall Study|AESI|0|||
48582995|NCT02908074|156324999|FG000|Overall Study|Discontinuation criteria per protocol|0|||
48582996|NCT02908074|156325000|FG001|Overall Study|Discontinuation criteria per protocol|0|||
48582997|NCT02908074|156325001|FG002|Overall Study|Discontinuation criteria per protocol|1|||
48582998|NCT02908074|156325002|FG003|Overall Study|Discontinuation criteria per protocol|0|||
48582999|NCT02908074|156325003|FG004|Overall Study|Discontinuation criteria per protocol|0|||
48583000|NCT02908074|156325004|FG005|Overall Study|Discontinuation criteria per protocol|1|||
48583001|NCT02908074|156324999|FG000|Overall Study|Withdrawal by Subject|3|||
48583002|NCT02908074|156325000|FG001|Overall Study|Withdrawal by Subject|2|||
48583003|NCT02908074|156325001|FG002|Overall Study|Withdrawal by Subject|2|||
48583004|NCT02908074|156325002|FG003|Overall Study|Withdrawal by Subject|2|||
48583005|NCT02908074|156325003|FG004|Overall Study|Withdrawal by Subject|2|||
48583006|NCT02908074|156325004|FG005|Overall Study|Withdrawal by Subject|2|||
48583007|NCT02908074|156324999|FG000|Overall Study|Lost to Follow-up|0|||
48583008|NCT02908074|156325000|FG001|Overall Study|Lost to Follow-up|1|||
48583009|NCT02908074|156325001|FG002|Overall Study|Lost to Follow-up|1|||
48583010|NCT02908074|156325002|FG003|Overall Study|Lost to Follow-up|1|||
48583011|NCT02908074|156325003|FG004|Overall Study|Lost to Follow-up|0|||
48583012|NCT02908074|156325004|FG005|Overall Study|Lost to Follow-up|1|||
48583013|NCT02073565|156325005|FG000|Cohort A|Withdrawal by Subject|1|||
48583014|NCT02073565|156325006|FG001|Cohort A|Withdrawal by Subject|0|||
48583015|NCT02073565|156325005|FG000|Cohort B|Withdrawal by Subject|1|||
48583016|NCT02073565|156325006|FG001|Cohort B|Withdrawal by Subject|2|||
48583017|NCT02073565|156325005|FG000|Cohort C|Withdrawal by Subject|0|||
48583018|NCT02073565|156325006|FG001|Cohort C|Withdrawal by Subject|2|||
48583019|NCT02073565|156325005|FG000|Cohort C|Lost to Follow-up|0|||
48583020|NCT02073565|156325006|FG001|Cohort C|Lost to Follow-up|2|||
48583021|NCT00778102|156325010|FG000|Overall Study|Adverse Event|8|||
48583022|NCT00778102|156325011|FG001|Overall Study|Adverse Event|5|||
48583023|NCT00778102|156325010|FG000|Overall Study|Death|1|||
48583024|NCT00778102|156325011|FG001|Overall Study|Death|1|||
48583025|NCT00778102|156325010|FG000|Overall Study|Lost to Follow-up|1|||
48583026|NCT00778102|156325011|FG001|Overall Study|Lost to Follow-up|0|||
48583027|NCT00778102|156325010|FG000|Overall Study|Violation of Selection Criteria|1|||
48583028|NCT00778102|156325011|FG001|Overall Study|Violation of Selection Criteria|1|||
48583029|NCT00778102|156325010|FG000|Overall Study|Protocol Violation|0|||
48583030|NCT00778102|156325011|FG001|Overall Study|Protocol Violation|1|||
48583031|NCT00778102|156325010|FG000|Overall Study|Refused Treatment|2|||
48583032|NCT00778102|156325011|FG001|Overall Study|Refused Treatment|3|||
48583033|NCT00778102|156325010|FG000|Overall Study|Withdrawal by Subject|1|||
48583034|NCT00778102|156325011|FG001|Overall Study|Withdrawal by Subject|1|||
48583035|NCT00778102|156325010|FG000|Overall Study|Administrative Reason|7|||
48583036|NCT00778102|156325011|FG001|Overall Study|Administrative Reason|10|||
48583037|NCT00394433|156325012|FG000|Overall Study|Adverse Event|2|||
48583038|NCT00394433|156325012|FG000|Overall Study|Alternative Therapy|1|||
48321806|NCT02998528|155377026|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
48321807|NCT02998528|155377024|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
48321808|NCT02998528|155377025|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
48321809|NCT02998528|155377026|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
48321810|NCT02998528|155377024|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
48321811|NCT02998528|155377025|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
48321812|NCT02998528|155377026|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
48321813|NCT02998528|155377024|FG000|Neoadjuvant Treatment Period|Death|1|||
48321814|NCT02998528|155377025|FG001|Neoadjuvant Treatment Period|Death|0|||
48321815|NCT02998528|155377026|FG002|Neoadjuvant Treatment Period|Death|0|||
48321816|NCT02998528|155377024|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
48321817|NCT02998528|155377025|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
48583039|NCT00932451|156325013|FG000|Overall Study|Withdrawal by Subject|69|||
48583040|NCT00932451|156325013|FG000|Overall Study|Lost to Follow-up|22|||
48583041|NCT00932451|156325013|FG000|Overall Study|Death|726|||
48583042|NCT00932451|156325013|FG000|Overall Study|Other reasons|5|||
48583043|NCT03646305|156325018|FG000|Overall Study|Lost to Follow-up|4|||
48583044|NCT03646305|156325019|FG001|Overall Study|Lost to Follow-up|2|||
48583045|NCT03646305|156325020|FG002|Overall Study|Lost to Follow-up|2|||
48583046|NCT03646305|156325021|FG003|Overall Study|Lost to Follow-up|1|||
48583047|NCT03646305|156325018|FG000|Overall Study|Withdrawal by Subject|1|||
48583048|NCT03646305|156325019|FG001|Overall Study|Withdrawal by Subject|0|||
48583049|NCT03646305|156325020|FG002|Overall Study|Withdrawal by Subject|0|||
48583050|NCT03646305|156325021|FG003|Overall Study|Withdrawal by Subject|1|||
48583051|NCT00787917|156325022|FG000|Blinded Treatment|Adverse Event|1|||
48583052|NCT00787917|156325023|FG001|Blinded Treatment|Adverse Event|0|||
48583053|NCT00787917|156325022|FG000|Blinded Treatment|Lack of Efficacy|1|||
48583054|NCT00787917|156325023|FG001|Blinded Treatment|Lack of Efficacy|0|||
48583055|NCT00787917|156325022|FG000|Blinded Treatment|Administrative problems|3|||
48583056|NCT00787917|156325023|FG001|Blinded Treatment|Administrative problems|2|||
48583057|NCT00787917|156325022|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
48583058|NCT00787917|156325023|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
48583059|NCT00787917|156325022|FG000|Open Label|Administrative problems|3|||
48583060|NCT00787917|156325023|FG001|Open Label|Administrative problems|0|||
48583061|NCT01085136|156325024|FG000|Part A|Other Adverse event|223|||
48583062|NCT01085136|156325025|FG001|Part A|Other Adverse event|0|||
48583063|NCT01085136|156325026|FG002|Part A|Other Adverse event|0|||
48583064|NCT01085136|156325024|FG000|Part A|Protocol Violation|3|||
48583065|NCT01085136|156325025|FG001|Part A|Protocol Violation|0|||
48583066|NCT01085136|156325026|FG002|Part A|Protocol Violation|0|||
48583067|NCT01085136|156325024|FG000|Part A|Lost to Follow-up|3|||
48583068|NCT01085136|156325025|FG001|Part A|Lost to Follow-up|0|||
48583069|NCT01085136|156325026|FG002|Part A|Lost to Follow-up|0|||
48583070|NCT01085136|156325024|FG000|Part A|Refusal to continue trial medication|64|||
48583071|NCT01085136|156325025|FG001|Part A|Refusal to continue trial medication|0|||
48583072|NCT01085136|156325026|FG002|Part A|Refusal to continue trial medication|0|||
48583073|NCT01085136|156325024|FG000|Part A|Other reason not defined above|30|||
48583074|NCT01085136|156325025|FG001|Part A|Other reason not defined above|0|||
48583075|NCT01085136|156325026|FG002|Part A|Other reason not defined above|0|||
48583076|NCT01085136|156325024|FG000|Part B|Other AE|0|||
48583077|NCT01085136|156325025|FG001|Part B|Other AE|29|||
48583078|NCT01085136|156325026|FG002|Part B|Other AE|8|||
48583079|NCT01085136|156325024|FG000|Part B|Refusal to continue trial medication|0|||
48583080|NCT01085136|156325025|FG001|Part B|Refusal to continue trial medication|12|||
48583081|NCT01085136|156325026|FG002|Part B|Refusal to continue trial medication|7|||
48583082|NCT01085136|156325024|FG000|Part B|Not treated|0|||
48583083|NCT01085136|156325025|FG001|Part B|Not treated|4|||
48583084|NCT01085136|156325026|FG002|Part B|Not treated|8|||
48583085|NCT01085136|156325024|FG000|Part B|Other reason not defined above|0|||
48583086|NCT01085136|156325025|FG001|Part B|Other reason not defined above|6|||
48583087|NCT01085136|156325026|FG002|Part B|Other reason not defined above|3|||
48583088|NCT04683939|156325027|FG000|Overall Study|Study termination by the sponsor|0|||
48583089|NCT04683939|156325028|FG001|Overall Study|Study termination by the sponsor|1|||
48583090|NCT04683939|156325029|FG002|Overall Study|Study termination by the sponsor|2|||
48583091|NCT04683939|156325030|FG003|Overall Study|Study termination by the sponsor|2|||
48583092|NCT04683939|156325027|FG000|Overall Study|Death|1|||
48583093|NCT04683939|156325028|FG001|Overall Study|Death|1|||
48583094|NCT04683939|156325029|FG002|Overall Study|Death|2|||
48583095|NCT04683939|156325030|FG003|Overall Study|Death|1|||
48583096|NCT04683939|156325027|FG000|Overall Study|Withdrawal by Subject|1|||
48583097|NCT04683939|156325028|FG001|Overall Study|Withdrawal by Subject|0|||
48583098|NCT04683939|156325029|FG002|Overall Study|Withdrawal by Subject|0|||
48583099|NCT04683939|156325030|FG003|Overall Study|Withdrawal by Subject|0|||
48583100|NCT04683939|156325027|FG000|Overall Study|Physician Decision|1|||
48583101|NCT04683939|156325028|FG001|Overall Study|Physician Decision|0|||
48583102|NCT04683939|156325029|FG002|Overall Study|Physician Decision|0|||
48583103|NCT04683939|156325030|FG003|Overall Study|Physician Decision|0|||
48583104|NCT04683939|156325027|FG000|Overall Study|Lost to Follow-up|0|||
48583105|NCT04683939|156325028|FG001|Overall Study|Lost to Follow-up|1|||
48583106|NCT04683939|156325029|FG002|Overall Study|Lost to Follow-up|0|||
48583107|NCT04683939|156325030|FG003|Overall Study|Lost to Follow-up|0|||
48583108|NCT00401544|156326337|FG000|Overall Study|Adverse Event|5|||
48583109|NCT00401544|156326338|FG001|Overall Study|Adverse Event|1|||
48583110|NCT00401544|156326339|FG002|Overall Study|Adverse Event|1|||
48583111|NCT00401544|156326340|FG003|Overall Study|Adverse Event|1|||
48583112|NCT00401544|156326337|FG000|Overall Study|Death|3|||
48583113|NCT00401544|156326338|FG001|Overall Study|Death|6|||
48583114|NCT00401544|156326339|FG002|Overall Study|Death|2|||
48583115|NCT00401544|156326340|FG003|Overall Study|Death|5|||
48583116|NCT00401544|156326337|FG000|Overall Study|Lost to Follow-up|2|||
48583117|NCT00401544|156326338|FG001|Overall Study|Lost to Follow-up|0|||
48583118|NCT00401544|156326339|FG002|Overall Study|Lost to Follow-up|1|||
48583119|NCT00401544|156326340|FG003|Overall Study|Lost to Follow-up|1|||
48583120|NCT00401544|156326337|FG000|Overall Study|Withdrawal by Subject|7|||
48583121|NCT00401544|156326338|FG001|Overall Study|Withdrawal by Subject|6|||
48583122|NCT00401544|156326339|FG002|Overall Study|Withdrawal by Subject|6|||
48583123|NCT00401544|156326340|FG003|Overall Study|Withdrawal by Subject|5|||
48583124|NCT00401544|156326337|FG000|Overall Study|Physician Decision|1|||
48583125|NCT00401544|156326338|FG001|Overall Study|Physician Decision|3|||
48583126|NCT00401544|156326339|FG002|Overall Study|Physician Decision|0|||
48583127|NCT00401544|156326340|FG003|Overall Study|Physician Decision|0|||
48583128|NCT00401544|156326337|FG000|Overall Study|Ineligibility determined|0|||
48583129|NCT00401544|156326338|FG001|Overall Study|Ineligibility determined|1|||
48583130|NCT00401544|156326339|FG002|Overall Study|Ineligibility determined|0|||
48583131|NCT00401544|156326340|FG003|Overall Study|Ineligibility determined|2|||
48583132|NCT00401544|156326337|FG000|Overall Study|Disease progression|0|||
48583133|NCT00401544|156326338|FG001|Overall Study|Disease progression|1|||
48583134|NCT00401544|156326339|FG002|Overall Study|Disease progression|0|||
48583135|NCT00401544|156326340|FG003|Overall Study|Disease progression|0|||
48583136|NCT00401544|156326337|FG000|Overall Study|Other|0|||
48583137|NCT00401544|156326338|FG001|Overall Study|Other|0|||
48583138|NCT00401544|156326339|FG002|Overall Study|Other|2|||
48583139|NCT00401544|156326340|FG003|Overall Study|Other|2|||
48583140|NCT01826370|156326348|FG000|Overall Study|Protocol Violation|6|||
48583141|NCT01826370|156326348|FG000|Overall Study|Lost to Follow-up|12|||
48583142|NCT01826370|156326348|FG000|Overall Study|Other reason not defined above|2|||
48583143|NCT03570554|156326349|FG000|Overall Study|Non-compliance with study drug|0|||
48583144|NCT03570554|156326350|FG001|Overall Study|Non-compliance with study drug|0|||
48583145|NCT03570554|156326351|FG002|Overall Study|Non-compliance with study drug|1|||
48583146|NCT03570554|156326352|FG003|Overall Study|Non-compliance with study drug|0|||
48583147|NCT03570554|156326349|FG000|Overall Study|Adverse Event|0|||
48583148|NCT03570554|156326350|FG001|Overall Study|Adverse Event|0|||
48583149|NCT03570554|156326351|FG002|Overall Study|Adverse Event|0|||
48583150|NCT03570554|156326352|FG003|Overall Study|Adverse Event|1|||
48583151|NCT03332628|156326363|FG000|Overall Study|Physician Decision|2|||
48583152|NCT02134353|156326366|FG000|Overall Study|Adverse Event|10|||
48583153|NCT02134353|156326367|FG001|Overall Study|Adverse Event|6|||
48583154|NCT02134353|156326366|FG000|Overall Study|Lost to Follow-up|1|||
48583155|NCT02134353|156326367|FG001|Overall Study|Lost to Follow-up|1|||
48583156|NCT02134353|156326366|FG000|Overall Study|Lack of Efficacy|2|||
48583157|NCT02134353|156326367|FG001|Overall Study|Lack of Efficacy|1|||
48583158|NCT02134353|156326366|FG000|Overall Study|Withdrawal by Subject|12|||
48583159|NCT02134353|156326367|FG001|Overall Study|Withdrawal by Subject|13|||
48583160|NCT02134353|156326366|FG000|Overall Study|Death|0|||
48583161|NCT02134353|156326367|FG001|Overall Study|Death|1|||
48583162|NCT02134353|156326366|FG000|Overall Study|Pregnancy|0|||
48583163|NCT02134353|156326367|FG001|Overall Study|Pregnancy|1|||
48583164|NCT02134353|156326366|FG000|Overall Study|Relocation|1|||
48583165|NCT02134353|156326367|FG001|Overall Study|Relocation|0|||
48583166|NCT02134353|156326366|FG000|Overall Study|Other - Patient's Choice|0|||
48583167|NCT02134353|156326367|FG001|Overall Study|Other - Patient's Choice|1|||
48583168|NCT04696861|156326368|FG000|Overall Study|Death|1|||
48583169|NCT04696861|156326369|FG001|Overall Study|Death|0|||
48583170|NCT04696861|156326368|FG000|Overall Study|Lost to Follow-up|3|||
48583171|NCT04696861|156326369|FG001|Overall Study|Lost to Follow-up|0|||
48583172|NCT00766467|156326378|FG000|Overall Study|Withdrawal by Subject|7|||
48583173|NCT00766467|156326379|FG001|Overall Study|Withdrawal by Subject|2|||
48583174|NCT00766467|156326378|FG000|Overall Study|Adverse Event|1|||
48739153|NCT00002651|156894080|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
48739154|NCT00002651|156894078|FG000|Consolidation and Randomization|Progression/relapse|0|||
48739155|NCT00002651|156894079|FG001|Consolidation and Randomization|Progression/relapse|295|||
48739156|NCT00002651|156894080|FG002|Consolidation and Randomization|Progression/relapse|298|||
48321818|NCT02998528|155377026|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
48451082|NCT01947894|155839259|FG000|Overall Study|Adverse Event|5|||
48583175|NCT00766467|156326379|FG001|Overall Study|Adverse Event|1|||
48583176|NCT00766467|156326378|FG000|Overall Study|Protocol Violation|2|||
48583177|NCT00766467|156326379|FG001|Overall Study|Protocol Violation|4|||
48583178|NCT00766467|156326378|FG000|Overall Study|Tumor Progression on Study|0|||
48583179|NCT00766467|156326379|FG001|Overall Study|Tumor Progression on Study|1|||
48583180|NCT00766467|156326378|FG000|Overall Study|Physician Decision|1|||
48583181|NCT00766467|156326379|FG001|Overall Study|Physician Decision|0|||
48583182|NCT01917344|156326384|FG000|Overall Study|Withdrawal by Subject|1|||
48583183|NCT02956057|156326385|FG000|Overall Study|Discontinued intervention|14|||
48583184|NCT02956057|156326386|FG001|Overall Study|Discontinued intervention|10|||
48583185|NCT02956057|156326387|FG002|Overall Study|Discontinued intervention|7|||
48583186|NCT02956057|156326388|FG003|Overall Study|Discontinued intervention|14|||
48583187|NCT02956057|156326389|FG004|Overall Study|Discontinued intervention|4|||
48583188|NCT02956057|156326390|FG005|Overall Study|Discontinued intervention|17|||
48583189|NCT02956057|156326385|FG000|Overall Study|Lost to Follow-up|0|||
48583190|NCT02956057|156326386|FG001|Overall Study|Lost to Follow-up|2|||
48583191|NCT02956057|156326387|FG002|Overall Study|Lost to Follow-up|1|||
48739157|NCT00002651|156894078|FG000|Consolidation and Randomization|Death|0|||
48739158|NCT00002651|156894079|FG001|Consolidation and Randomization|Death|38|||
48739159|NCT00002651|156894080|FG002|Consolidation and Randomization|Death|48|||
48739160|NCT00002651|156894078|FG000|Consolidation and Randomization|Other|0|||
48739161|NCT00002651|156894079|FG001|Consolidation and Randomization|Other|314|||
48739162|NCT00002651|156894080|FG002|Consolidation and Randomization|Other|313|||
48739163|NCT00002651|156894078|FG000|Consolidation and Randomization|not eligible|0|||
48739164|NCT00002651|156894079|FG001|Consolidation and Randomization|not eligible|102|||
48739165|NCT00002651|156894080|FG002|Consolidation and Randomization|not eligible|112|||
48739166|NCT00004635|156894081|FG000|Period One|refused|2|||
48739167|NCT00004635|156894082|FG001|Period One|refused|1|||
48739168|NCT00004635|156894081|FG000|Period One|Withdrawal by Subject|1|||
48739169|NCT00004635|156894082|FG001|Period One|Withdrawal by Subject|1|||
48739170|NCT00004635|156894081|FG000|Period One|Protocol Violation|1|||
48321819|NCT02998528|155377024|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
48321820|NCT02998528|155377025|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
48739171|NCT00004635|156894082|FG001|Period One|Protocol Violation|0|||
48739172|NCT00004635|156894081|FG000|Period One|PSA did not go <5 ng/mL|1|||
48739173|NCT00004635|156894082|FG001|Period One|PSA did not go <5 ng/mL|0|||
48739174|NCT00004635|156894081|FG000|Period One|second malignancy|1|||
48739175|NCT00004635|156894082|FG001|Period One|second malignancy|0|||
48739176|NCT00004635|156894081|FG000|Period One|progressed|0|||
48739177|NCT00004635|156894082|FG001|Period One|progressed|2|||
48739178|NCT00004635|156894081|FG000|Period One|health problem|0|||
48739179|NCT00004635|156894082|FG001|Period One|health problem|1|||
48739180|NCT00004635|156894081|FG000|Period One|discrepancy in data entry|0|||
48739181|NCT00004635|156894082|FG001|Period One|discrepancy in data entry|1|||
48739182|NCT00004635|156894081|FG000|Period Two|progression|2|||
48739183|NCT00004635|156894082|FG001|Period Two|progression|3|||
48739184|NCT00004635|156894081|FG000|Period Two|Adverse Event|1|||
48739185|NCT00004635|156894082|FG001|Period Two|Adverse Event|0|||
48739186|NCT00004635|156894081|FG000|Period Two|refused|0|||
48739187|NCT00004635|156894082|FG001|Period Two|refused|2|||
48739188|NCT00004635|156894081|FG000|Period Two|health problem|1|||
48739189|NCT00004635|156894082|FG001|Period Two|health problem|1|||
48739190|NCT00004635|156894081|FG000|Period Two|travel issues|0|||
48739191|NCT00004635|156894082|FG001|Period Two|travel issues|1|||
48739192|NCT00004635|156894081|FG000|Period Two|secondary malignancy|1|||
48739193|NCT00004635|156894082|FG001|Period Two|secondary malignancy|1|||
48739194|NCT00004635|156894081|FG000|Period Two|Lost to Follow-up|1|||
48739195|NCT00004635|156894082|FG001|Period Two|Lost to Follow-up|0|||
48583192|NCT02956057|156326388|FG003|Overall Study|Lost to Follow-up|1|||
48739196|NCT00004635|156894081|FG000|Period Two|discrepancy in data entry|0|||
48739197|NCT00004635|156894082|FG001|Period Two|discrepancy in data entry|1|||
48739198|NCT00573937|156894083|FG000|Overall Study|Study Terminated|0|||
48739199|NCT00573937|156894084|FG001|Overall Study|Study Terminated|1|||
48583193|NCT02956057|156326389|FG004|Overall Study|Lost to Follow-up|1|||
48583194|NCT02956057|156326390|FG005|Overall Study|Lost to Follow-up|0|||
48583195|NCT02505334|156326401|FG000|Main Treatment Period|Adverse Event|3|||
48583196|NCT02505334|156326402|FG001|Main Treatment Period|Adverse Event|3|||
48583197|NCT02505334|156326401|FG000|Main Treatment Period|Lack of Efficacy|7|||
48583198|NCT02505334|156326402|FG001|Main Treatment Period|Lack of Efficacy|17|||
48583199|NCT02505334|156326401|FG000|Main Treatment Period|Protocol Violation|0|||
48583200|NCT02505334|156326402|FG001|Main Treatment Period|Protocol Violation|1|||
48583201|NCT02505334|156326401|FG000|Main Treatment Period|Withdrawal by Subject|1|||
48583202|NCT02505334|156326402|FG001|Main Treatment Period|Withdrawal by Subject|8|||
48583203|NCT02505334|156326401|FG000|Main Treatment Period|Unclassified|4|||
48583204|NCT02505334|156326402|FG001|Main Treatment Period|Unclassified|10|||
48583205|NCT02505334|156326401|FG000|Extension Treatment Period|Adverse Event|5|||
48583206|NCT02505334|156326402|FG001|Extension Treatment Period|Adverse Event|0|||
48583207|NCT02505334|156326401|FG000|Extension Treatment Period|Lack of Efficacy|4|||
48583208|NCT02505334|156326402|FG001|Extension Treatment Period|Lack of Efficacy|0|||
48583209|NCT02505334|156326401|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
48583210|NCT02505334|156326402|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
48583211|NCT02505334|156326401|FG000|Extension Treatment Period|Unclassified|3|||
48583212|NCT02505334|156326402|FG001|Extension Treatment Period|Unclassified|0|||
48583213|NCT03435224|156326405|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
48583214|NCT01549041|156326410|FG000|Overall Study|Lack of Efficacy|2|||
48739200|NCT00691301|156894085|FG000|Overall Study|Adverse Event|10|||
48583215|NCT01549041|156326411|FG001|Overall Study|Lack of Efficacy|4|||
48739201|NCT00691301|156894085|FG000|Overall Study|Death|2|||
48739202|NCT00691301|156894085|FG000|Overall Study|Lack of Efficacy|32|||
48739203|NCT00691301|156894085|FG000|Overall Study|Withdrawal by Subject|4|||
48739204|NCT00691301|156894085|FG000|Overall Study|Concurrent illness|2|||
48739205|NCT00691301|156894085|FG000|Overall Study|other reason|3|||
48583216|NCT01549041|156326410|FG000|Overall Study|Adverse Event|0|||
48583217|NCT01549041|156326411|FG001|Overall Study|Adverse Event|4|||
48739206|NCT00691301|156894085|FG000|Overall Study|Did not initiate study treatment|1|||
48583218|NCT00367484|156326412|FG000|Overall Study|Adverse Event|7|||
48583219|NCT00367484|156326412|FG000|Overall Study|Withdrew informed consent|5|||
48583220|NCT00367484|156326412|FG000|Overall Study|Travel to USA|1|||
48583221|NCT00367484|156326412|FG000|Overall Study|Lost to Follow-up|1|||
48583222|NCT00367484|156326412|FG000|Overall Study|Protocol Violation|1|||
48583223|NCT00367484|156326412|FG000|Overall Study|The choice of the patient|1|||
48583224|NCT00367484|156326412|FG000|Overall Study|Lack of Efficacy|1|||
48583225|NCT01420679|156326413|FG000|Overall Study|Disease Progression|3|||
48583226|NCT01420679|156326414|FG001|Overall Study|Disease Progression|2|||
48583227|NCT01420679|156326413|FG000|Overall Study|Adverse Event|4|||
48583228|NCT01420679|156326414|FG001|Overall Study|Adverse Event|0|||
48583229|NCT01420679|156326413|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
48583230|NCT01420679|156326414|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
48583231|NCT01420679|156326413|FG000|Overall Study|Patient Decision|1|||
48583232|NCT01420679|156326414|FG001|Overall Study|Patient Decision|0|||
48583233|NCT01420679|156326413|FG000|Overall Study|Investigator Decision|1|||
48583234|NCT01420679|156326414|FG001|Overall Study|Investigator Decision|2|||
48583235|NCT01420679|156326413|FG000|Overall Study|Sponsor Decision|3|||
48583236|NCT01420679|156326414|FG001|Overall Study|Sponsor Decision|3|||
48583237|NCT01420679|156326413|FG000|Overall Study|Other|1|||
48583238|NCT01420679|156326414|FG001|Overall Study|Other|0|||
48583239|NCT00597506|156326415|FG000|Overall Study|Subject is being followed for survival|1|||
48583240|NCT02543892|156326421|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
48583241|NCT02543892|156326422|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
48583242|NCT02543892|156326423|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
48583243|NCT02543892|156326424|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
48583244|NCT02543892|156326425|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
48583245|NCT02543892|156326426|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
48583246|NCT02543892|156326427|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
48583247|NCT02543892|156326428|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
48583248|NCT02543892|156326421|FG000|Received Vaccination 2|Physician Decision|0|||
48583249|NCT02543892|156326422|FG001|Received Vaccination 2|Physician Decision|0|||
48583250|NCT02543892|156326423|FG002|Received Vaccination 2|Physician Decision|0|||
48583251|NCT02543892|156326424|FG003|Received Vaccination 2|Physician Decision|0|||
48583252|NCT02543892|156326425|FG004|Received Vaccination 2|Physician Decision|0|||
48583253|NCT02543892|156326426|FG005|Received Vaccination 2|Physician Decision|1|||
48583254|NCT02543892|156326427|FG006|Received Vaccination 2|Physician Decision|0|||
48583255|NCT02543892|156326428|FG007|Received Vaccination 2|Physician Decision|0|||
48583256|NCT02543892|156326421|FG000|Received Vaccination 2|Adverse Event|0|||
48583257|NCT02543892|156326422|FG001|Received Vaccination 2|Adverse Event|1|||
48583258|NCT02543892|156326423|FG002|Received Vaccination 2|Adverse Event|0|||
48583259|NCT02543892|156326424|FG003|Received Vaccination 2|Adverse Event|0|||
48583260|NCT02543892|156326425|FG004|Received Vaccination 2|Adverse Event|0|||
48583261|NCT02543892|156326426|FG005|Received Vaccination 2|Adverse Event|0|||
48583262|NCT02543892|156326427|FG006|Received Vaccination 2|Adverse Event|0|||
48583263|NCT02543892|156326428|FG007|Received Vaccination 2|Adverse Event|0|||
48583264|NCT02543892|156326421|FG000|Had Immunology Data|Withdrawal by Subject|0|||
48583265|NCT02543892|156326422|FG001|Had Immunology Data|Withdrawal by Subject|0|||
48583266|NCT02543892|156326423|FG002|Had Immunology Data|Withdrawal by Subject|0|||
48583267|NCT02543892|156326424|FG003|Had Immunology Data|Withdrawal by Subject|0|||
48583268|NCT02543892|156326425|FG004|Had Immunology Data|Withdrawal by Subject|0|||
48583269|NCT02543892|156326426|FG005|Had Immunology Data|Withdrawal by Subject|0|||
48583270|NCT02543892|156326427|FG006|Had Immunology Data|Withdrawal by Subject|1|||
48583271|NCT02543892|156326428|FG007|Had Immunology Data|Withdrawal by Subject|0|||
48583272|NCT02386345|156326434|FG000|Overall Study|Not treated|14|||
48583273|NCT02386345|156326434|FG000|Overall Study|Lost to Follow-up|1|||
48583274|NCT02386345|156326434|FG000|Overall Study|Adverse Event|5|||
48583275|NCT02386345|156326434|FG000|Overall Study|Repeat Procedure|10|||
48583276|NCT02386345|156326434|FG000|Overall Study|Did not complete 12-month follow-up|72|||
48583277|NCT00379808|156326435|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
48583278|NCT00379808|156326436|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
48583279|NCT02279745|156326438|FG000|Overall Study|Adverse Event|7|||
48583280|NCT02279745|156326438|FG000|Overall Study|Death|6|||
48739207|NCT03342963|156894093|FG000|Overall Study|Adverse Event|1|||
48739208|NCT03342963|156894094|FG001|Overall Study|Adverse Event|2|||
48583281|NCT02279745|156326438|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
48583282|NCT02279745|156326438|FG000|Overall Study|Withdrawal by Subject|2|||
48583283|NCT02279745|156326438|FG000|Overall Study|Pregnancy|1|||
48583284|NCT02279745|156326438|FG000|Overall Study|Study Non-compliance|1|||
48583285|NCT02279745|156326438|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
48583286|NCT01987232|156326454|FG000|Overall Study|Ongoing in Study|0|||
48583287|NCT01987232|156326455|FG001|Overall Study|Ongoing in Study|0|||
48583288|NCT01987232|156326456|FG002|Overall Study|Ongoing in Study|0|||
48583289|NCT01987232|156326457|FG003|Overall Study|Ongoing in Study|1|||
48739209|NCT03342963|156894095|FG002|Overall Study|Adverse Event|0|||
48739210|NCT03342963|156894096|FG003|Overall Study|Adverse Event|0|||
48739211|NCT03342963|156894093|FG000|Overall Study|Withdrawal by Subject|1|||
48739212|NCT03342963|156894094|FG001|Overall Study|Withdrawal by Subject|0|||
48739213|NCT03342963|156894095|FG002|Overall Study|Withdrawal by Subject|0|||
48739214|NCT03342963|156894096|FG003|Overall Study|Withdrawal by Subject|0|||
48739215|NCT02527161|156894097|FG000|Overall Study|Failed MRI|52|||
48739216|NCT02527161|156894097|FG000|Overall Study|Withdrawal by Subject|19|||
48739217|NCT02527161|156894097|FG000|Overall Study|Delay in or unfit for surgery|16|||
48739218|NCT02527161|156894097|FG000|Overall Study|MRI contraindication|6|||
48739219|NCT02527161|156894097|FG000|Overall Study|Consent violation|4|||
48739220|NCT02527161|156894097|FG000|Overall Study|Only Recruited to Part A|27|||
48739221|NCT02527161|156894097|FG000|Overall Study|Physician Decision|1|||
48739222|NCT02527161|156894097|FG000|Overall Study|Adverse Event|1|||
48739223|NCT02527161|156894097|FG000|Overall Study|Lost to Follow-up|6|||
48739224|NCT01330030|156894098|FG000|Overall Study|Lost to Follow-up|16|||
48739225|NCT01330030|156894099|FG001|Overall Study|Lost to Follow-up|17|||
48739226|NCT02248701|156894100|FG000|Overall Study|Withdrawal by Subject|2|||
48739227|NCT02248701|156894101|FG001|Overall Study|Withdrawal by Subject|1|||
48739228|NCT02248701|156894100|FG000|Overall Study|Physician Decision|0|||
48739229|NCT02248701|156894101|FG001|Overall Study|Physician Decision|1|||
48739230|NCT02248701|156894100|FG000|Overall Study|Adverse Event|1|||
48739231|NCT02248701|156894101|FG001|Overall Study|Adverse Event|0|||
48739232|NCT02248701|156894100|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
48739233|NCT02248701|156894101|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
48739234|NCT00986830|156894102|FG000|Overall Study|Death|1|||
48739235|NCT00986830|156894102|FG000|Overall Study|Lost to Follow-up|1|||
48739236|NCT00986830|156894102|FG000|Overall Study|Lack of Efficacy|1|||
48739237|NCT00986830|156894102|FG000|Overall Study|Unable to access sinus with device|5|||
48739238|NCT05085730|156894103|FG000|Overall Study|Withdrawal by Subject|4|||
48739239|NCT05085730|156894103|FG000|Overall Study|Physician Decision|1|||
48739240|NCT04553679|156894104|FG000|Overall Study|Withdrawal by Subject|2|||
48583290|NCT01987232|156326458|FG004|Overall Study|Ongoing in Study|0|||
48583291|NCT01675154|156326464|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
48583292|NCT01675154|156326465|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
48587378|NCT02273908|156343212|FG001|Overall Study|Lost to Follow-up|1|||
48739241|NCT04553679|156894105|FG001|Overall Study|Withdrawal by Subject|0|||
48739242|NCT04553679|156894104|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
48739243|NCT04553679|156894105|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
48739244|NCT01145625|156894106|FG000|Overall Study|Lost to Follow-up|8|||
48739245|NCT01145625|156894107|FG001|Overall Study|Lost to Follow-up|9|||
48739246|NCT01145625|156894106|FG000|Overall Study|Adverse Event|6|||
48739247|NCT01145625|156894107|FG001|Overall Study|Adverse Event|4|||
48739248|NCT01145625|156894106|FG000|Overall Study|Protocol Violation|3|||
48739249|NCT01145625|156894107|FG001|Overall Study|Protocol Violation|1|||
48583293|NCT01675154|156326466|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
48583294|NCT01675154|156326467|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
48583295|NCT03634033|156326468|FG000|Overall Study|Did not have a post-assessment|384|||
48583296|NCT03634033|156326469|FG001|Overall Study|Did not have a post-assessment|291|||
48583297|NCT03634033|156326470|FG002|Overall Study|Did not have a post-assessment|114|||
48583298|NCT03634033|156326471|FG003|Overall Study|Did not have a post-assessment|161|||
48583299|NCT03634033|156326472|FG004|Overall Study|Did not have a post-assessment|5|||
48583300|NCT03634033|156326473|FG005|Overall Study|Did not have a post-assessment|0|||
48583301|NCT03634033|156326474|FG006|Overall Study|Did not have a post-assessment|0|||
48583302|NCT03634033|156326468|FG000|Overall Study|Death|0|||
48583303|NCT03634033|156326469|FG001|Overall Study|Death|0|||
48583304|NCT03634033|156326470|FG002|Overall Study|Death|0|||
48583305|NCT03634033|156326471|FG003|Overall Study|Death|0|||
48583306|NCT03634033|156326472|FG004|Overall Study|Death|0|||
48583307|NCT03634033|156326473|FG005|Overall Study|Death|7|||
48583308|NCT03634033|156326474|FG006|Overall Study|Death|7|||
48583309|NCT03634033|156326468|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
48583310|NCT03634033|156326469|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
48583311|NCT03634033|156326470|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
48583312|NCT03634033|156326471|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
48583313|NCT03634033|156326472|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
48583314|NCT03634033|156326473|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
48583315|NCT03634033|156326474|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
48583316|NCT03634033|156326468|FG000|Overall Study|Lost to Follow-up|0|||
48583317|NCT03634033|156326469|FG001|Overall Study|Lost to Follow-up|0|||
48583318|NCT03634033|156326470|FG002|Overall Study|Lost to Follow-up|0|||
48583319|NCT03634033|156326471|FG003|Overall Study|Lost to Follow-up|0|||
48583320|NCT03634033|156326472|FG004|Overall Study|Lost to Follow-up|0|||
48583321|NCT03634033|156326473|FG005|Overall Study|Lost to Follow-up|1|||
48739250|NCT01145625|156894106|FG000|Overall Study|Withdrawal by Subject|7|||
48739251|NCT01145625|156894107|FG001|Overall Study|Withdrawal by Subject|16|||
48739252|NCT01145625|156894106|FG000|Overall Study|Pregnancy|0|||
48739253|NCT01145625|156894107|FG001|Overall Study|Pregnancy|1|||
48739254|NCT03945214|156894108|FG000|Overall Study|Lost to Follow-up|3|||
48739255|NCT03945214|156894109|FG001|Overall Study|Lost to Follow-up|4|||
48583322|NCT03634033|156326474|FG006|Overall Study|Lost to Follow-up|2|||
48583323|NCT03634033|156326468|FG000|Overall Study|Withdrawal by Subject|0|||
48583324|NCT03634033|156326469|FG001|Overall Study|Withdrawal by Subject|0|||
48583325|NCT03634033|156326470|FG002|Overall Study|Withdrawal by Subject|0|||
48583326|NCT03634033|156326471|FG003|Overall Study|Withdrawal by Subject|0|||
48583327|NCT03634033|156326472|FG004|Overall Study|Withdrawal by Subject|0|||
48583328|NCT03634033|156326473|FG005|Overall Study|Withdrawal by Subject|0|||
48583329|NCT03634033|156326474|FG006|Overall Study|Withdrawal by Subject|1|||
48583330|NCT00415597|156326476|FG000|Enrollment|Withdrawal by Subject|1|||
48583331|NCT00415597|156326476|FG000|Enrollment|Protocol Violation|1|||
48583332|NCT00415597|156326476|FG000|Treatment|Adverse Event|110|||
48583333|NCT00415597|156326476|FG000|Treatment|Lack of Efficacy|39|||
48583334|NCT00415597|156326476|FG000|Treatment|Protocol Violation|67|||
48583335|NCT00415597|156326476|FG000|Treatment|Physician Decision|3|||
48583336|NCT00415597|156326476|FG000|Treatment|Withdrawal by Subject|51|||
48583337|NCT00415597|156326476|FG000|Treatment|Lost to Follow-up|28|||
48583338|NCT00415597|156326476|FG000|Treatment|Drug Screen|2|||
48583339|NCT00415597|156326476|FG000|Treatment|Administrative|3|||
48583340|NCT00415597|156326476|FG000|Treatment|Sponsor Decision|1|||
48739256|NCT03945214|156894110|FG002|Overall Study|Lost to Follow-up|7|||
48739257|NCT03945214|156894111|FG003|Overall Study|Lost to Follow-up|4|||
48451083|NCT01947894|155839260|FG001|Overall Study|Adverse Event|1|||
48583341|NCT00415597|156326476|FG000|Treatment|Multiple Reasons|1|||
48583342|NCT01447927|156326477|FG000|Overall Study|Adverse Event|4|||
48583343|NCT01447927|156326478|FG001|Overall Study|Adverse Event|3|||
48583344|NCT01447927|156326477|FG000|Overall Study|Withdrawal by Subject|1|||
48583345|NCT01447927|156326478|FG001|Overall Study|Withdrawal by Subject|0|||
48583346|NCT00784550|156326480|FG000|Overall Study|Adverse Event|12|||
48583347|NCT00784550|156326481|FG001|Overall Study|Adverse Event|10|||
48583348|NCT00784550|156326480|FG000|Overall Study|Lack of Efficacy|0|||
48583349|NCT00784550|156326481|FG001|Overall Study|Lack of Efficacy|1|||
48583350|NCT00784550|156326480|FG000|Overall Study|Protocol Violation|10|||
48583351|NCT00784550|156326481|FG001|Overall Study|Protocol Violation|10|||
48583352|NCT00784550|156326480|FG000|Overall Study|Lost to Follow-up|8|||
48583353|NCT00784550|156326481|FG001|Overall Study|Lost to Follow-up|5|||
48583354|NCT00784550|156326480|FG000|Overall Study|Physician Decision|2|||
48583355|NCT00784550|156326481|FG001|Overall Study|Physician Decision|3|||
48583356|NCT00784550|156326480|FG000|Overall Study|Withdrawal by Subject|4|||
48583357|NCT00784550|156326481|FG001|Overall Study|Withdrawal by Subject|13|||
48583358|NCT02342548|156326482|FG000|Overall Study|Adverse Event|12|||
48583359|NCT02342548|156326483|FG001|Overall Study|Adverse Event|17|||
48583360|NCT02342548|156326484|FG002|Overall Study|Adverse Event|13|||
48583361|NCT02342548|156326482|FG000|Overall Study|Lost to Follow-up|0|||
48583362|NCT02342548|156326483|FG001|Overall Study|Lost to Follow-up|1|||
48583363|NCT02342548|156326484|FG002|Overall Study|Lost to Follow-up|0|||
48583364|NCT02342548|156326482|FG000|Overall Study|Study terminated by sponsor|20|||
48583365|NCT02342548|156326483|FG001|Overall Study|Study terminated by sponsor|39|||
48583366|NCT02342548|156326484|FG002|Overall Study|Study terminated by sponsor|25|||
48583367|NCT02342548|156326482|FG000|Overall Study|Protocol Violation|0|||
48583368|NCT02342548|156326483|FG001|Overall Study|Protocol Violation|1|||
48583369|NCT02342548|156326484|FG002|Overall Study|Protocol Violation|0|||
48583370|NCT02342548|156326482|FG000|Overall Study|Withdrawal by Subject|1|||
48583371|NCT02342548|156326483|FG001|Overall Study|Withdrawal by Subject|3|||
48583372|NCT02342548|156326484|FG002|Overall Study|Withdrawal by Subject|4|||
48583373|NCT02342548|156326482|FG000|Overall Study|Other|1|||
48583374|NCT02342548|156326483|FG001|Overall Study|Other|1|||
48583375|NCT02342548|156326484|FG002|Overall Study|Other|1|||
48583376|NCT02987972|156326485|FG000|Overall Study|Adverse Event|1|||
48583377|NCT02987972|156326486|FG001|Overall Study|Adverse Event|1|||
48583378|NCT02987972|156326487|FG002|Overall Study|Adverse Event|0|||
48583379|NCT02987972|156326485|FG000|Overall Study|Death|1|||
48583380|NCT02987972|156326486|FG001|Overall Study|Death|0|||
48583381|NCT02987972|156326487|FG002|Overall Study|Death|0|||
48583382|NCT02987972|156326485|FG000|Overall Study|Lack of Efficacy|9|||
48583383|NCT02987972|156326486|FG001|Overall Study|Lack of Efficacy|12|||
48583384|NCT02987972|156326487|FG002|Overall Study|Lack of Efficacy|12|||
48583385|NCT02987972|156326485|FG000|Overall Study|Lost to Follow-up|7|||
48583386|NCT02987972|156326486|FG001|Overall Study|Lost to Follow-up|8|||
48583387|NCT02987972|156326487|FG002|Overall Study|Lost to Follow-up|4|||
48583388|NCT02987972|156326485|FG000|Overall Study|Physician Decision|1|||
48583389|NCT02987972|156326486|FG001|Overall Study|Physician Decision|6|||
48583390|NCT02987972|156326487|FG002|Overall Study|Physician Decision|0|||
48583391|NCT02987972|156326485|FG000|Overall Study|Protocol Violation|2|||
48583392|NCT02987972|156326486|FG001|Overall Study|Protocol Violation|1|||
48583393|NCT02987972|156326487|FG002|Overall Study|Protocol Violation|5|||
48583394|NCT02987972|156326485|FG000|Overall Study|Withdrawal by Subject|22|||
48321821|NCT02998528|155377026|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
48321822|NCT02998528|155377024|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
48321823|NCT02998528|155377025|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
48321824|NCT02998528|155377026|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
48321825|NCT02998528|155377024|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
48321826|NCT02998528|155377025|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
48321827|NCT02998528|155377026|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
48321828|NCT02998528|155377024|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
48321829|NCT02998528|155377025|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
48321830|NCT02998528|155377026|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
48321831|NCT02998528|155377024|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
48321832|NCT02998528|155377025|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
48321833|NCT02998528|155377026|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
48321834|NCT04820686|155377029|FG000|Overall Study|Withdrawal by Subject|5|||
48321835|NCT04820686|155377030|FG001|Overall Study|Withdrawal by Subject|2|||
48321836|NCT04820686|155377031|FG002|Overall Study|Withdrawal by Subject|3|||
48321837|NCT04820686|155377029|FG000|Overall Study|Study Termination|25|||
48321838|NCT04820686|155377030|FG001|Overall Study|Study Termination|13|||
48321839|NCT04820686|155377031|FG002|Overall Study|Study Termination|14|||
48321840|NCT04820686|155377029|FG000|Overall Study|Adverse Event|0|||
48321841|NCT04820686|155377030|FG001|Overall Study|Adverse Event|1|||
48321842|NCT04820686|155377031|FG002|Overall Study|Adverse Event|0|||
48321843|NCT01872078|155377033|FG000|Overall Study|Adverse Event|0|||
48321844|NCT01872078|155377034|FG001|Overall Study|Adverse Event|0|||
48321845|NCT01872078|155377035|FG002|Overall Study|Adverse Event|1|||
48583395|NCT02987972|156326486|FG001|Overall Study|Withdrawal by Subject|17|||
48583396|NCT02987972|156326487|FG002|Overall Study|Withdrawal by Subject|21|||
48583397|NCT03495154|156326488|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
48583398|NCT03495154|156326488|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
48583399|NCT03495154|156326488|FG000|Overall Study|Screen Failures During Surgery|6|||
48583400|NCT03495154|156326488|FG000|Overall Study|Death|2|||
48583401|NCT03495154|156326488|FG000|Overall Study|Lost to Follow-up|16|||
48583402|NCT03495154|156326488|FG000|Overall Study|Withdrawal by Subject|2|||
48583403|NCT03495154|156326488|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
48583404|NCT01764997|156326491|FG000|Run-in Period|Adverse Event|15|||
48583405|NCT01764997|156326492|FG001|Run-in Period|Adverse Event|0|||
48583406|NCT01764997|156326493|FG002|Run-in Period|Adverse Event|0|||
48583407|NCT01764997|156326494|FG003|Run-in Period|Adverse Event|0|||
48583408|NCT01764997|156326495|FG004|Run-in Period|Adverse Event|0|||
48583409|NCT01764997|156326491|FG000|Run-in Period|Lack of Efficacy|5|||
48583410|NCT01764997|156326492|FG001|Run-in Period|Lack of Efficacy|0|||
48583411|NCT01764997|156326493|FG002|Run-in Period|Lack of Efficacy|0|||
48583412|NCT01764997|156326494|FG003|Run-in Period|Lack of Efficacy|0|||
48583413|NCT01764997|156326495|FG004|Run-in Period|Lack of Efficacy|0|||
48583414|NCT01764997|156326491|FG000|Run-in Period|Poor compliance to protocol|1|||
48583415|NCT01764997|156326492|FG001|Run-in Period|Poor compliance to protocol|0|||
48583416|NCT01764997|156326493|FG002|Run-in Period|Poor compliance to protocol|0|||
48583417|NCT01764997|156326494|FG003|Run-in Period|Poor compliance to protocol|0|||
48583418|NCT01764997|156326495|FG004|Run-in Period|Poor compliance to protocol|0|||
48583419|NCT01764997|156326491|FG000|Run-in Period|Other than specified above|17|||
48583420|NCT01764997|156326492|FG001|Run-in Period|Other than specified above|0|||
48583421|NCT01764997|156326493|FG002|Run-in Period|Other than specified above|0|||
48583422|NCT01764997|156326494|FG003|Run-in Period|Other than specified above|0|||
48321846|NCT01872078|155377036|FG003|Overall Study|Adverse Event|0|||
48583423|NCT01764997|156326495|FG004|Run-in Period|Other than specified above|0|||
48583424|NCT01764997|156326491|FG000|Study Drug Treatment Period|Adverse Event|0|||
48583425|NCT01764997|156326492|FG001|Study Drug Treatment Period|Adverse Event|1|||
48583426|NCT01764997|156326493|FG002|Study Drug Treatment Period|Adverse Event|0|||
48587522|NCT01134263|156343246|FG000|Overall Study|Other adverse event|1|||
48583427|NCT01764997|156326494|FG003|Study Drug Treatment Period|Adverse Event|0|||
48583428|NCT01764997|156326495|FG004|Study Drug Treatment Period|Adverse Event|24|||
48321847|NCT01872078|155377033|FG000|Overall Study|Dose administration non-compliance|0|||
48583429|NCT01764997|156326491|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
48583430|NCT01764997|156326492|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
48583431|NCT01764997|156326493|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
48583432|NCT01764997|156326494|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
48583433|NCT01764997|156326495|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
48583434|NCT01764997|156326491|FG000|Study Drug Treatment Period|Other than specified above|0|||
48583435|NCT01764997|156326492|FG001|Study Drug Treatment Period|Other than specified above|0|||
48583436|NCT01764997|156326493|FG002|Study Drug Treatment Period|Other than specified above|0|||
48583437|NCT01764997|156326494|FG003|Study Drug Treatment Period|Other than specified above|0|||
48583438|NCT01764997|156326495|FG004|Study Drug Treatment Period|Other than specified above|10|||
48583439|NCT03168919|156326497|FG000|Overall Study|Withdrawal by Subject|2|||
48583440|NCT03521817|156326498|FG000|Overall Study|Protocol Violation|0|||
48583441|NCT03521817|156326499|FG001|Overall Study|Protocol Violation|1|||
48583442|NCT04015518|156326500|FG000|Overall Study|Adverse Event|6|||
48583443|NCT04015518|156326501|FG001|Overall Study|Adverse Event|1|||
48583444|NCT04015518|156326502|FG002|Overall Study|Adverse Event|1|||
48583445|NCT04015518|156326503|FG003|Overall Study|Adverse Event|3|||
48583446|NCT04015518|156326504|FG004|Overall Study|Adverse Event|3|||
48583447|NCT04015518|156326500|FG000|Overall Study|Lack of Efficacy|1|||
48583448|NCT04015518|156326501|FG001|Overall Study|Lack of Efficacy|0|||
48583449|NCT04015518|156326502|FG002|Overall Study|Lack of Efficacy|1|||
48583450|NCT04015518|156326503|FG003|Overall Study|Lack of Efficacy|0|||
48583451|NCT04015518|156326504|FG004|Overall Study|Lack of Efficacy|4|||
48583452|NCT04015518|156326500|FG000|Overall Study|Lost to Follow-up|0|||
48583453|NCT04015518|156326501|FG001|Overall Study|Lost to Follow-up|0|||
48583454|NCT04015518|156326502|FG002|Overall Study|Lost to Follow-up|0|||
48583455|NCT04015518|156326503|FG003|Overall Study|Lost to Follow-up|0|||
48583456|NCT04015518|156326504|FG004|Overall Study|Lost to Follow-up|1|||
48583457|NCT04015518|156326500|FG000|Overall Study|Withdrawal by Subject|0|||
48583458|NCT04015518|156326501|FG001|Overall Study|Withdrawal by Subject|1|||
48583459|NCT04015518|156326502|FG002|Overall Study|Withdrawal by Subject|0|||
48583460|NCT04015518|156326503|FG003|Overall Study|Withdrawal by Subject|1|||
48583461|NCT04015518|156326504|FG004|Overall Study|Withdrawal by Subject|1|||
48583462|NCT04015518|156326500|FG000|Overall Study|Patient did not come for consecutive visits|0|||
48583463|NCT04015518|156326501|FG001|Overall Study|Patient did not come for consecutive visits|1|||
48583464|NCT04015518|156326502|FG002|Overall Study|Patient did not come for consecutive visits|0|||
48583465|NCT04015518|156326503|FG003|Overall Study|Patient did not come for consecutive visits|0|||
48321848|NCT01872078|155377034|FG001|Overall Study|Dose administration non-compliance|0|||
48321849|NCT01872078|155377035|FG002|Overall Study|Dose administration non-compliance|0|||
48321850|NCT01872078|155377036|FG003|Overall Study|Dose administration non-compliance|1|||
48321851|NCT01872078|155377033|FG000|Overall Study|Protocol Violation|0|||
48321852|NCT01872078|155377034|FG001|Overall Study|Protocol Violation|0|||
48321853|NCT01872078|155377035|FG002|Overall Study|Protocol Violation|1|||
48321854|NCT01872078|155377036|FG003|Overall Study|Protocol Violation|0|||
48321855|NCT01872078|155377033|FG000|Overall Study|Withdrawal by Subject|0|||
48321856|NCT01872078|155377034|FG001|Overall Study|Withdrawal by Subject|0|||
48321857|NCT01872078|155377035|FG002|Overall Study|Withdrawal by Subject|1|||
48321858|NCT01872078|155377036|FG003|Overall Study|Withdrawal by Subject|0|||
48321859|NCT01872078|155377033|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
48321860|NCT01872078|155377034|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
48321861|NCT01872078|155377035|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
48583466|NCT04015518|156326504|FG004|Overall Study|Patient did not come for consecutive visits|0|||
48739258|NCT02980783|156894112|FG000|Overall Study|Lost to Follow-up|1|||
48739259|NCT00880542|156894113|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
48739260|NCT00880542|156894113|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
48739261|NCT00880542|156894113|FG000|REP: Surgical Resection|progressive disease|1|||
48739262|NCT01522248|156894116|FG000|Overall Study|Lost to Follow-up|1|||
48739263|NCT01522248|156894117|FG001|Overall Study|Lost to Follow-up|0|||
48739264|NCT03719586|156894118|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
48739265|NCT03719586|156894119|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
48321862|NCT01872078|155377036|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
48321863|NCT04377308|155377037|FG000|Overall Study|Withdrawal by Subject|0|||
48321864|NCT04377308|155377038|FG001|Overall Study|Withdrawal by Subject|1|||
48583467|NCT04015518|156326500|FG000|Overall Study|not willing to travel due to Covid-19|0|||
48583468|NCT04015518|156326501|FG001|Overall Study|not willing to travel due to Covid-19|0|||
48583469|NCT04015518|156326502|FG002|Overall Study|not willing to travel due to Covid-19|1|||
48583470|NCT04015518|156326503|FG003|Overall Study|not willing to travel due to Covid-19|0|||
48583471|NCT04015518|156326504|FG004|Overall Study|not willing to travel due to Covid-19|0|||
48583472|NCT04015518|156326500|FG000|Overall Study|Patient wants to discontinue treatment|0|||
48583473|NCT04015518|156326501|FG001|Overall Study|Patient wants to discontinue treatment|0|||
48321865|NCT03988842|155377039|FG000|Overall Study|Death|1|||
48321866|NCT02891915|155377040|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
48321867|NCT02891915|155377041|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
48321868|NCT02891915|155377040|FG000|Overall Study|Withdrawal by Subject|3|||
48321869|NCT02891915|155377041|FG001|Overall Study|Withdrawal by Subject|3|||
48321870|NCT02891915|155377040|FG000|Overall Study|Became Ineligible After Enrollment|2|||
48321871|NCT02891915|155377041|FG001|Overall Study|Became Ineligible After Enrollment|1|||
48321872|NCT02891915|155377040|FG000|Overall Study|Lost to Follow-up|1|||
48321873|NCT02891915|155377041|FG001|Overall Study|Lost to Follow-up|4|||
48321874|NCT02891915|155377040|FG000|Overall Study|Physician Decision|1|||
48321875|NCT02891915|155377041|FG001|Overall Study|Physician Decision|0|||
48321876|NCT01205048|155377042|FG000|Overall Study|Withdrawal by Subject|14|||
48321877|NCT01205048|155377042|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
48321878|NCT01205048|155377042|FG000|Overall Study|Lost to Follow-up|4|||
48321879|NCT01205048|155377042|FG000|Overall Study|Other|2|||
48321880|NCT03394885|155377043|FG000|Overall Study|Adverse Event|4|||
48321881|NCT03394885|155377043|FG000|Overall Study|Lack of Efficacy|1|||
48321882|NCT03394885|155377043|FG000|Overall Study|Physician Decision|1|||
48321883|NCT03394885|155377043|FG000|Overall Study|Withdrawal by Subject|8|||
48321884|NCT03394885|155377043|FG000|Overall Study|Alternative Therapy|1|||
48321885|NCT04019444|155377044|FG000|Overall Study|Withdrawal by Subject|0|||
48321886|NCT04019444|155377045|FG001|Overall Study|Withdrawal by Subject|1|||
48321887|NCT04019444|155377046|FG002|Overall Study|Withdrawal by Subject|0|||
48321888|NCT04019444|155377047|FG003|Overall Study|Withdrawal by Subject|1|||
48321889|NCT04019444|155377044|FG000|Overall Study|Solicited Event|0|||
48321890|NCT04019444|155377045|FG001|Overall Study|Solicited Event|0|||
48321891|NCT04019444|155377046|FG002|Overall Study|Solicited Event|2|||
48321892|NCT04019444|155377047|FG003|Overall Study|Solicited Event|0|||
48321893|NCT01091168|155377048|FG000|Overall Study|Progressive disease|250|||
48321894|NCT01091168|155377049|FG001|Overall Study|Progressive disease|234|||
48321895|NCT01091168|155377048|FG000|Overall Study|Adverse Event|21|||
48321896|NCT01091168|155377049|FG001|Overall Study|Adverse Event|24|||
48321897|NCT01091168|155377048|FG000|Overall Study|Lost to Follow-up|0|||
48321898|NCT01091168|155377049|FG001|Overall Study|Lost to Follow-up|1|||
48321899|NCT01091168|155377048|FG000|Overall Study|Physician, patient's decision, other|27|||
48321900|NCT01091168|155377049|FG001|Overall Study|Physician, patient's decision, other|37|||
48321901|NCT01609218|155377050|FG000|Period 1|Adverse Event|3|||
48583474|NCT04015518|156326502|FG002|Overall Study|Patient wants to discontinue treatment|0|||
48583475|NCT04015518|156326503|FG003|Overall Study|Patient wants to discontinue treatment|1|||
48583476|NCT04015518|156326504|FG004|Overall Study|Patient wants to discontinue treatment|0|||
48583477|NCT04015518|156326500|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
48583478|NCT04015518|156326501|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
48583479|NCT04015518|156326502|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
48583480|NCT04015518|156326503|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
48583481|NCT04015518|156326504|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
48583482|NCT04015518|156326500|FG000|Overall Study|Pregnancy|0|||
48583483|NCT04015518|156326501|FG001|Overall Study|Pregnancy|0|||
48583484|NCT04015518|156326502|FG002|Overall Study|Pregnancy|0|||
48583485|NCT04015518|156326503|FG003|Overall Study|Pregnancy|0|||
48583486|NCT04015518|156326504|FG004|Overall Study|Pregnancy|1|||
48583487|NCT04015518|156326500|FG000|Overall Study|Personal reasons|1|||
48583488|NCT04015518|156326501|FG001|Overall Study|Personal reasons|0|||
48583489|NCT04015518|156326502|FG002|Overall Study|Personal reasons|0|||
48583490|NCT04015518|156326503|FG003|Overall Study|Personal reasons|0|||
48583491|NCT04015518|156326504|FG004|Overall Study|Personal reasons|1|||
48583492|NCT04015518|156326500|FG000|Overall Study|Withdrew consent|1|||
48583493|NCT04015518|156326501|FG001|Overall Study|Withdrew consent|0|||
48321902|NCT01609218|155377051|FG001|Period 1|Adverse Event|5|||
48321903|NCT01609218|155377050|FG000|Period 1|Sponsor Decision|0|||
48321904|NCT01609218|155377051|FG001|Period 1|Sponsor Decision|1|||
48321905|NCT01609218|155377050|FG000|Period 2|Adverse Event|1|||
48583494|NCT04015518|156326502|FG002|Overall Study|Withdrew consent|0|||
48321906|NCT01609218|155377051|FG001|Period 2|Adverse Event|0|||
48583495|NCT04015518|156326503|FG003|Overall Study|Withdrew consent|0|||
48583496|NCT04015518|156326504|FG004|Overall Study|Withdrew consent|0|||
48583497|NCT04015518|156326500|FG000|Overall Study|Prostate carcinoma|1|||
48583498|NCT04015518|156326501|FG001|Overall Study|Prostate carcinoma|0|||
48583499|NCT04015518|156326502|FG002|Overall Study|Prostate carcinoma|0|||
48583500|NCT04015518|156326503|FG003|Overall Study|Prostate carcinoma|0|||
48583501|NCT04015518|156326504|FG004|Overall Study|Prostate carcinoma|0|||
48583502|NCT04015518|156326500|FG000|Overall Study|Could not keep appointments due to work|1|||
48583503|NCT04015518|156326501|FG001|Overall Study|Could not keep appointments due to work|0|||
48583504|NCT04015518|156326502|FG002|Overall Study|Could not keep appointments due to work|0|||
48583505|NCT04015518|156326503|FG003|Overall Study|Could not keep appointments due to work|0|||
48583506|NCT04015518|156326504|FG004|Overall Study|Could not keep appointments due to work|0|||
48583507|NCT02360475|156326505|FG000|Overall Study|Lost to Follow-up|4|||
48583508|NCT02360475|156326506|FG001|Overall Study|Lost to Follow-up|12|||
48583509|NCT02360475|156326507|FG002|Overall Study|Lost to Follow-up|6|||
48583510|NCT02360475|156326508|FG003|Overall Study|Lost to Follow-up|4|||
48583511|NCT02360475|156326505|FG000|Overall Study|Withdrawal by Subject|0|||
48583512|NCT02360475|156326506|FG001|Overall Study|Withdrawal by Subject|1|||
48583513|NCT02360475|156326507|FG002|Overall Study|Withdrawal by Subject|2|||
48321907|NCT03080883|155377052|FG000|Overall Study|Withdrawal by Subject|11|||
48321908|NCT03080883|155377053|FG001|Overall Study|Withdrawal by Subject|15|||
48583514|NCT02360475|156326508|FG003|Overall Study|Withdrawal by Subject|0|||
48583515|NCT02360475|156326505|FG000|Overall Study|Migrated/moved from study area|0|||
48583516|NCT02360475|156326506|FG001|Overall Study|Migrated/moved from study area|0|||
48583517|NCT02360475|156326507|FG002|Overall Study|Migrated/moved from study area|0|||
48583518|NCT02360475|156326508|FG003|Overall Study|Migrated/moved from study area|1|||
48583519|NCT01959698|156326509|FG000|Overall Study|Adverse Event|0|||
48321909|NCT03080883|155377052|FG000|Overall Study|Adverse Event|22|||
48321910|NCT03080883|155377053|FG001|Overall Study|Adverse Event|22|||
48321911|NCT03080883|155377052|FG000|Overall Study|Alternative Therapy|0|||
48321912|NCT03080883|155377053|FG001|Overall Study|Alternative Therapy|3|||
48321913|NCT03080883|155377052|FG000|Overall Study|Other Complicating Disease|9|||
48321914|NCT03080883|155377053|FG001|Overall Study|Other Complicating Disease|5|||
48321915|NCT03080883|155377052|FG000|Overall Study|Death|21|||
48321916|NCT03080883|155377053|FG001|Overall Study|Death|16|||
48321917|NCT03080883|155377052|FG000|Overall Study|Physician Decision|2|||
48321918|NCT03080883|155377053|FG001|Overall Study|Physician Decision|2|||
48321919|NCT03080883|155377052|FG000|Overall Study|Disease Progression|2|||
48321920|NCT03080883|155377053|FG001|Overall Study|Disease Progression|8|||
48321921|NCT03080883|155377052|FG000|Overall Study|Lost to Follow-up|1|||
48321922|NCT03080883|155377053|FG001|Overall Study|Lost to Follow-up|1|||
48321923|NCT03785782|155378135|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
48321924|NCT03785782|155378136|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
48321925|NCT03785782|155378135|FG000|Overall Study|Withdrawal by Subject|1|||
48321926|NCT03785782|155378136|FG001|Overall Study|Withdrawal by Subject|1|||
48321927|NCT03785782|155378135|FG000|Overall Study|insufficient image quality.|3|||
48321928|NCT03785782|155378136|FG001|Overall Study|insufficient image quality.|0|||
48321929|NCT05075408|155378139|FG000|Overall Study|Withdrawal by Subject|5|||
48321930|NCT05075408|155378140|FG001|Overall Study|Withdrawal by Subject|3|||
48321931|NCT05075408|155378141|FG002|Overall Study|Withdrawal by Subject|4|||
48321932|NCT05075408|155378139|FG000|Overall Study|Adverse Event|5|||
48321933|NCT05075408|155378140|FG001|Overall Study|Adverse Event|7|||
48321934|NCT05075408|155378141|FG002|Overall Study|Adverse Event|8|||
48321935|NCT05075408|155378139|FG000|Overall Study|Protocol Violation|0|||
48321936|NCT05075408|155378140|FG001|Overall Study|Protocol Violation|1|||
48321937|NCT05075408|155378141|FG002|Overall Study|Protocol Violation|0|||
48321938|NCT05075408|155378139|FG000|Overall Study|Lost to Follow-up|2|||
48321939|NCT05075408|155378140|FG001|Overall Study|Lost to Follow-up|1|||
48321940|NCT05075408|155378141|FG002|Overall Study|Lost to Follow-up|1|||
48321941|NCT05075408|155378139|FG000|Overall Study|Physician Decision|1|||
48321942|NCT05075408|155378140|FG001|Overall Study|Physician Decision|0|||
48321943|NCT05075408|155378141|FG002|Overall Study|Physician Decision|0|||
48321944|NCT05075408|155378139|FG000|Overall Study|Other-unspecified|3|||
48321945|NCT05075408|155378140|FG001|Overall Study|Other-unspecified|2|||
48321946|NCT05075408|155378141|FG002|Overall Study|Other-unspecified|0|||
48321947|NCT03940703|155378142|FG000|Overall Study|Still under treatment|31|||
48321948|NCT03940703|155378143|FG001|Overall Study|Still under treatment|0|||
48321949|NCT05608005|155378146|FG000|Overall Study|Adverse Event|2|||
48321950|NCT05608005|155378147|FG001|Overall Study|Adverse Event|1|||
48321951|NCT05608005|155378148|FG002|Overall Study|Adverse Event|3|||
48321952|NCT05608005|155378146|FG000|Overall Study|Protocol Violation|2|||
48321953|NCT05608005|155378147|FG001|Overall Study|Protocol Violation|3|||
48321954|NCT05608005|155378148|FG002|Overall Study|Protocol Violation|0|||
48321955|NCT05608005|155378146|FG000|Overall Study|Withdrawal by Subject|10|||
48321956|NCT05608005|155378147|FG001|Overall Study|Withdrawal by Subject|12|||
48583520|NCT01959698|156326510|FG001|Overall Study|Adverse Event|0|||
48583521|NCT01959698|156326511|FG002|Overall Study|Adverse Event|0|||
48583522|NCT01959698|156326512|FG003|Overall Study|Adverse Event|0|||
48583523|NCT01959698|156326513|FG004|Overall Study|Adverse Event|0|||
48583524|NCT01959698|156326514|FG005|Overall Study|Adverse Event|0|||
48583525|NCT01959698|156326515|FG006|Overall Study|Adverse Event|1|||
48583526|NCT01959698|156326509|FG000|Overall Study|Physician Decision|1|||
48583527|NCT01959698|156326510|FG001|Overall Study|Physician Decision|0|||
48583528|NCT01959698|156326511|FG002|Overall Study|Physician Decision|1|||
48321957|NCT05608005|155378148|FG002|Overall Study|Withdrawal by Subject|4|||
48583529|NCT01959698|156326512|FG003|Overall Study|Physician Decision|2|||
48583530|NCT01959698|156326513|FG004|Overall Study|Physician Decision|0|||
48583531|NCT01959698|156326514|FG005|Overall Study|Physician Decision|3|||
48583532|NCT01959698|156326515|FG006|Overall Study|Physician Decision|3|||
48583533|NCT01573767|156327675|FG000|Overall Study|Adverse Event|0|||
48583534|NCT01573767|156327676|FG001|Overall Study|Adverse Event|1|||
48583535|NCT01573767|156327677|FG002|Overall Study|Adverse Event|0|||
48583536|NCT01573767|156327678|FG003|Overall Study|Adverse Event|1|||
48583537|NCT01573767|156327675|FG000|Overall Study|Lack of Efficacy|18|||
48583538|NCT01573767|156327676|FG001|Overall Study|Lack of Efficacy|15|||
48321958|NCT05608005|155378146|FG000|Overall Study|Lost to Follow-up|25|||
48321959|NCT05608005|155378147|FG001|Overall Study|Lost to Follow-up|27|||
48321960|NCT05608005|155378148|FG002|Overall Study|Lost to Follow-up|15|||
48321961|NCT05608005|155378146|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
48321962|NCT05608005|155378147|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
48321963|NCT05608005|155378148|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
48321964|NCT04593472|155378149|FG000|Overall Study|Death|31|||
48321965|NCT04593472|155378150|FG001|Overall Study|Death|27|||
48321966|NCT04593472|155378149|FG000|Overall Study|Withdrawal by Subject|12|||
48321967|NCT04593472|155378150|FG001|Overall Study|Withdrawal by Subject|12|||
48321968|NCT04593472|155378149|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
48321969|NCT04593472|155378150|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
48321970|NCT04593472|155378149|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
48321971|NCT04593472|155378150|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
48321972|NCT04593472|155378149|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
48321973|NCT04593472|155378150|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
48321974|NCT04593472|155378149|FG000|Overall Study|Lost to Follow-up|0|||
48321975|NCT04593472|155378150|FG001|Overall Study|Lost to Follow-up|2|||
48321976|NCT04593472|155378149|FG000|Overall Study|Still collecting 24-month assessment|17|||
48321977|NCT04593472|155378150|FG001|Overall Study|Still collecting 24-month assessment|10|||
48321978|NCT03655132|155378151|FG000|Overall Study|Lost to Follow-up|2|||
48321979|NCT03655132|155378152|FG001|Overall Study|Lost to Follow-up|1|||
48321980|NCT03655132|155378151|FG000|Overall Study|Withdrawal by Subject|0|||
48321981|NCT03655132|155378152|FG001|Overall Study|Withdrawal by Subject|1|||
48321982|NCT03655132|155378151|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
48321983|NCT03655132|155378152|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
48321984|NCT02651324|155378153|FG000|Overall Study|drug not administered, due dispensing issue|1|||
48321985|NCT02651324|155378154|FG001|Overall Study|drug not administered, due dispensing issue|0|||
48583539|NCT01573767|156327677|FG002|Overall Study|Lack of Efficacy|12|||
48583540|NCT01573767|156327678|FG003|Overall Study|Lack of Efficacy|17|||
48583541|NCT01573767|156327675|FG000|Overall Study|Protocol Violation|3|||
48583542|NCT01573767|156327676|FG001|Overall Study|Protocol Violation|1|||
48583543|NCT01573767|156327677|FG002|Overall Study|Protocol Violation|1|||
48583544|NCT01573767|156327678|FG003|Overall Study|Protocol Violation|3|||
48583545|NCT01573767|156327675|FG000|Overall Study|Lost to Follow-up|0|||
48583546|NCT01573767|156327676|FG001|Overall Study|Lost to Follow-up|1|||
48583547|NCT01573767|156327677|FG002|Overall Study|Lost to Follow-up|1|||
48583548|NCT01573767|156327678|FG003|Overall Study|Lost to Follow-up|1|||
48583549|NCT01573767|156327675|FG000|Overall Study|Physician Decision|1|||
48583550|NCT01573767|156327676|FG001|Overall Study|Physician Decision|2|||
48583551|NCT01573767|156327677|FG002|Overall Study|Physician Decision|0|||
48583552|NCT01573767|156327678|FG003|Overall Study|Physician Decision|2|||
48583553|NCT01573767|156327675|FG000|Overall Study|Withdrawal by Subject|0|||
48583554|NCT01573767|156327676|FG001|Overall Study|Withdrawal by Subject|1|||
48583555|NCT01573767|156327677|FG002|Overall Study|Withdrawal by Subject|0|||
48583556|NCT01573767|156327678|FG003|Overall Study|Withdrawal by Subject|0|||
48583557|NCT02920177|156327681|FG000|Overall Study|Withdrawal by Subject|1|||
48583558|NCT02920177|156327682|FG001|Overall Study|Withdrawal by Subject|1|||
48583559|NCT02920177|156327681|FG000|Overall Study|Physician Decision|1|||
48583560|NCT02920177|156327682|FG001|Overall Study|Physician Decision|0|||
48583561|NCT02920177|156327681|FG000|Overall Study|Lost to Follow-up|0|||
48583562|NCT02920177|156327682|FG001|Overall Study|Lost to Follow-up|1|||
48583563|NCT01871402|156327683|FG000|Overall Study|Lost to Follow-up|1|||
48583564|NCT01871402|156327684|FG001|Overall Study|Lost to Follow-up|0|||
48583565|NCT01871402|156327683|FG000|Overall Study|Withdrawal by Subject|0|||
48583566|NCT01871402|156327684|FG001|Overall Study|Withdrawal by Subject|2|||
48583567|NCT01871402|156327683|FG000|Overall Study|Non-compliance|0|||
48583568|NCT01871402|156327684|FG001|Overall Study|Non-compliance|1|||
48583569|NCT04594941|156327687|FG000|Overall Study|Other|0|||
48583570|NCT04594941|156327688|FG001|Overall Study|Other|3|||
48583571|NCT04594941|156327689|FG002|Overall Study|Other|1|||
48583572|NCT04594941|156327690|FG003|Overall Study|Other|0|||
48583573|NCT02223819|156327695|FG000|Overall Study|Lost to Follow-up|2|||
48583574|NCT04489381|156327700|FG000|Overall Study|Lost to Follow-up|2|||
48583575|NCT04489381|156327701|FG001|Overall Study|Lost to Follow-up|3|||
48583576|NCT04489381|156327700|FG000|Overall Study|Withdrawal by Subject|1|||
48583577|NCT04489381|156327701|FG001|Overall Study|Withdrawal by Subject|0|||
48583578|NCT00070018|156327702|FG000|Overall Study|Adverse Event|2|||
48583579|NCT00070018|156327702|FG000|Overall Study|Lack of Efficacy|1|||
48583580|NCT00070018|156327702|FG000|Overall Study|Withdrawal by Subject|1|||
48583581|NCT03956615|156327707|FG000|Overall Study|No multiple myeloma confirmed|2|||
48583582|NCT03956615|156327707|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
48583583|NCT03956615|156327707|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
48583584|NCT03956615|156327707|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
48583585|NCT03199612|156327708|FG000|Overall Study|Adverse Event|1|||
48583586|NCT03199612|156327709|FG001|Overall Study|Adverse Event|0|||
48583587|NCT02604550|156327710|FG000|Overall Study|Lost to Follow-up|7|||
48583588|NCT02604550|156327711|FG001|Overall Study|Lost to Follow-up|6|||
48583589|NCT02604550|156327710|FG000|Overall Study|Withdrawal by Subject|0|||
48583590|NCT02604550|156327711|FG001|Overall Study|Withdrawal by Subject|1|||
48583591|NCT02604550|156327710|FG000|Overall Study|Incomplete data using paper journal|18|||
48583592|NCT02604550|156327711|FG001|Overall Study|Incomplete data using paper journal|19|||
48583593|NCT04472026|156327712|FG000|Overall Study|Lost to Follow-up|5|||
48583594|NCT02939716|156327715|FG000|Overall Study|scanner failure|0|||
48583595|NCT02939716|156327716|FG001|Overall Study|scanner failure|0|||
48583596|NCT02939716|156327717|FG002|Overall Study|scanner failure|0|||
48583597|NCT02939716|156327718|FG003|Overall Study|scanner failure|1|||
48583598|NCT02939716|156327719|FG004|Overall Study|scanner failure|1|||
48583599|NCT02939716|156327720|FG005|Overall Study|scanner failure|1|||
48583600|NCT02637713|156327721|FG000|Overall Study|Screen Failure|2|||
48583601|NCT01732471|156327722|FG000|Overall Study|Withdrawal by Subject|1|||
48583602|NCT02669082|156327725|FG000|Overall Study|Adverse Event|1|||
48583603|NCT01625689|156327726|FG000|Overall Study|Migration|2|||
48583604|NCT01625689|156327727|FG001|Overall Study|Migration|1|||
48583605|NCT01096589|156327728|FG000|Overall Study|Adverse Event|2|||
48583606|NCT01096589|156327729|FG001|Overall Study|Adverse Event|1|||
48583607|NCT01096589|156327730|FG002|Overall Study|Adverse Event|2|||
48583608|NCT01096589|156327731|FG003|Overall Study|Adverse Event|1|||
48583609|NCT01096589|156327728|FG000|Overall Study|Withdrawal by Subject|2|||
48583610|NCT01096589|156327729|FG001|Overall Study|Withdrawal by Subject|1|||
48583611|NCT01096589|156327730|FG002|Overall Study|Withdrawal by Subject|1|||
48583612|NCT01096589|156327731|FG003|Overall Study|Withdrawal by Subject|1|||
48583613|NCT01096589|156327728|FG000|Overall Study|Compliance with protocol|0|||
48583614|NCT01096589|156327729|FG001|Overall Study|Compliance with protocol|0|||
48583615|NCT01096589|156327730|FG002|Overall Study|Compliance with protocol|1|||
48583616|NCT01096589|156327731|FG003|Overall Study|Compliance with protocol|0|||
48583617|NCT01096589|156327728|FG000|Overall Study|found treatment exhausting|0|||
48583618|NCT01096589|156327729|FG001|Overall Study|found treatment exhausting|0|||
48583619|NCT01096589|156327730|FG002|Overall Study|found treatment exhausting|0|||
48583620|NCT01096589|156327731|FG003|Overall Study|found treatment exhausting|1|||
48583621|NCT03201874|156327733|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
48583622|NCT03201874|156327734|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
48583623|NCT03201874|156327733|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
48583624|NCT03201874|156327734|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
48583625|NCT04240457|156327737|FG000|Overall Study|Lost to Follow-up|5|||
48583626|NCT04240457|156327738|FG001|Overall Study|Lost to Follow-up|1|||
48583627|NCT00081731|156327739|FG000|Overall Study|scientific integrity issue|8|||
48583628|NCT00081731|156327740|FG001|Overall Study|scientific integrity issue|8|||
48583629|NCT03233204|156327741|FG000|Overall Study|Adverse Event|1|||
48583630|NCT03233204|156327741|FG000|Overall Study|Death|1|||
48583631|NCT03233204|156327741|FG000|Overall Study|Withdrawal by Subject|1|||
48583632|NCT03233204|156327741|FG000|Overall Study|Progressive Disease|3|||
48583633|NCT01404208|156327750|FG000|Overall Study|Discontinued|3|||
48583634|NCT01404208|156327751|FG001|Overall Study|Discontinued|0|||
48583635|NCT01629823|156327752|FG000|Trial Period|Missed visit|11|||
48583636|NCT01629823|156327753|FG001|Trial Period|Missed visit|9|||
48583637|NCT01629823|156327754|FG002|Trial Period|Missed visit|8|||
48583638|NCT01629823|156327752|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
48583639|NCT01629823|156327753|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
48587523|NCT01134263|156343247|FG001|Overall Study|Other adverse event|2|||
48583640|NCT01629823|156327754|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
48583641|NCT01629823|156327752|FG000|Trial Period|Pregnancy|1|||
48583642|NCT01629823|156327753|FG001|Trial Period|Pregnancy|0|||
48583643|NCT01629823|156327754|FG002|Trial Period|Pregnancy|0|||
48583644|NCT01629823|156327752|FG000|Trial Period|Adverse Event|0|||
48583645|NCT01629823|156327753|FG001|Trial Period|Adverse Event|1|||
48322052|NCT03047928|155378174|FG000|Overall Study|Adverse Event|0|||
48322053|NCT03047928|155378175|FG001|Overall Study|Adverse Event|2|||
48322054|NCT03047928|155378176|FG002|Overall Study|Adverse Event|0|||
48322055|NCT03047928|155378174|FG000|Overall Study|Protocol Violation|0|||
48322056|NCT03047928|155378175|FG001|Overall Study|Protocol Violation|1|||
48322057|NCT03047928|155378176|FG002|Overall Study|Protocol Violation|0|||
48322058|NCT03047928|155378174|FG000|Overall Study|included in another protocol|0|||
48322059|NCT03047928|155378175|FG001|Overall Study|included in another protocol|1|||
48322060|NCT03047928|155378176|FG002|Overall Study|included in another protocol|0|||
48322061|NCT00920621|155378177|FG000|Overall Study|Lost to Follow-up|16|||
48322062|NCT00920621|155378178|FG001|Overall Study|Lost to Follow-up|17|||
48322063|NCT00920621|155378179|FG002|Overall Study|Lost to Follow-up|19|||
48583646|NCT01629823|156327754|FG002|Trial Period|Adverse Event|0|||
48583647|NCT01629823|156327752|FG000|Trial Period|Out-of-window visit|0|||
48583648|NCT01629823|156327753|FG001|Trial Period|Out-of-window visit|2|||
48322064|NCT00920621|155378180|FG003|Overall Study|Lost to Follow-up|21|||
48322065|NCT00920621|155378177|FG000|Overall Study|Fetal/neonatal deaths|16|||
48322066|NCT00920621|155378178|FG001|Overall Study|Fetal/neonatal deaths|14|||
48322067|NCT00920621|155378179|FG002|Overall Study|Fetal/neonatal deaths|16|||
48583649|NCT01629823|156327754|FG002|Trial Period|Out-of-window visit|0|||
48583650|NCT01629823|156327752|FG000|Trial Period|Failed to hold medication|0|||
48583651|NCT01629823|156327753|FG001|Trial Period|Failed to hold medication|0|||
48583652|NCT01629823|156327754|FG002|Trial Period|Failed to hold medication|1|||
48583653|NCT01629823|156327752|FG000|Washout Period|Safety|2|||
48583654|NCT01629823|156327753|FG001|Washout Period|Safety|5|||
48583655|NCT01629823|156327754|FG002|Washout Period|Safety|0|||
48583656|NCT01629823|156327752|FG000|Washout Period|Pregnancy|1|||
48583657|NCT01629823|156327753|FG001|Washout Period|Pregnancy|0|||
48583658|NCT01629823|156327754|FG002|Washout Period|Pregnancy|0|||
48583659|NCT01629823|156327752|FG000|Washout Period|Protocol Violation|0|||
48583660|NCT01629823|156327753|FG001|Washout Period|Protocol Violation|1|||
48583661|NCT01629823|156327754|FG002|Washout Period|Protocol Violation|0|||
48583662|NCT01199822|156327755|FG000|Overall Study|Investigator discontinued therapy|0|||
48583663|NCT01199822|156327756|FG001|Overall Study|Investigator discontinued therapy|1|||
48583664|NCT01199822|156327757|FG002|Overall Study|Investigator discontinued therapy|0|||
48583665|NCT01777295|156327758|FG000|Overall Study|Withdrawal by Subject|2|||
48583666|NCT01777295|156327759|FG001|Overall Study|Withdrawal by Subject|2|||
48583667|NCT01777295|156327758|FG000|Overall Study|Pregnancy|0|||
48583668|NCT01777295|156327759|FG001|Overall Study|Pregnancy|1|||
48583669|NCT01777295|156327758|FG000|Overall Study|Personal problem|1|||
48583670|NCT01777295|156327759|FG001|Overall Study|Personal problem|0|||
48583671|NCT01777295|156327758|FG000|Overall Study|Investigator call for AEs check|1|||
48583672|NCT01777295|156327759|FG001|Overall Study|Investigator call for AEs check|0|||
48583673|NCT00412217|156327760|FG000|Overall Study|Insufficient Data Available|8|||
48583674|NCT00412217|156327761|FG001|Overall Study|Insufficient Data Available|3|||
48583675|NCT00412217|156327760|FG000|Overall Study|Death|5|||
48583676|NCT00412217|156327761|FG001|Overall Study|Death|4|||
48583677|NCT00412217|156327760|FG000|Overall Study|Disease Progression|2|||
48583678|NCT00412217|156327761|FG001|Overall Study|Disease Progression|3|||
48583679|NCT00412217|156327760|FG000|Overall Study|Investigator Decision|1|||
48322068|NCT00920621|155378180|FG003|Overall Study|Fetal/neonatal deaths|14|||
48322069|NCT00920621|155378177|FG000|Overall Study|Blood sample not collected|22|||
48322070|NCT00920621|155378178|FG001|Overall Study|Blood sample not collected|14|||
48322071|NCT00920621|155378179|FG002|Overall Study|Blood sample not collected|0|||
48322072|NCT00920621|155378180|FG003|Overall Study|Blood sample not collected|0|||
48322073|NCT05247489|155378182|FG000|Overall Study|Lost to Follow-up|5|||
48322074|NCT05247489|155378183|FG001|Overall Study|Lost to Follow-up|1|||
48322075|NCT05247489|155378182|FG000|Overall Study|Withdrawal by Subject|6|||
48583680|NCT00412217|156327761|FG001|Overall Study|Investigator Decision|0|||
48583681|NCT00412217|156327760|FG000|Overall Study|Withdrawal by Subject|2|||
48322076|NCT05247489|155378183|FG001|Overall Study|Withdrawal by Subject|7|||
48322077|NCT05247489|155378182|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
48322078|NCT05247489|155378183|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
48322079|NCT05247489|155378182|FG000|Overall Study|Left Country|1|||
48322080|NCT05247489|155378183|FG001|Overall Study|Left Country|0|||
48322081|NCT05247489|155378182|FG000|Overall Study|Noncompliance with Investigational Product|1|||
48583682|NCT00412217|156327761|FG001|Overall Study|Withdrawal by Subject|0|||
48583683|NCT00412217|156327760|FG000|Overall Study|Lost to Follow-up|1|||
48583684|NCT00412217|156327761|FG001|Overall Study|Lost to Follow-up|4|||
48583685|NCT00412217|156327760|FG000|Overall Study|Study Terminated by Sponsor|26|||
48583686|NCT00412217|156327761|FG001|Overall Study|Study Terminated by Sponsor|33|||
48583687|NCT00412217|156327760|FG000|Overall Study|Other|1|||
48583688|NCT00412217|156327761|FG001|Overall Study|Other|1|||
48322082|NCT05247489|155378183|FG001|Overall Study|Noncompliance with Investigational Product|0|||
48322083|NCT05247489|155378182|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
48322084|NCT05247489|155378183|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
48322085|NCT00650104|155378184|FG000|Overall Study|Adverse Event|17|||
48322086|NCT00650104|155378184|FG000|Overall Study|Death|2|||
48322087|NCT00650104|155378184|FG000|Overall Study|Withdrawal by Subject|11|||
48322088|NCT00650104|155378184|FG000|Overall Study|Physician Decision|7|||
48322089|NCT00650104|155378184|FG000|Overall Study|Lost to Follow-up|1|||
48322090|NCT00650104|155378184|FG000|Overall Study|Non-compliance|2|||
48322091|NCT00650104|155378184|FG000|Overall Study|Sponsor Terminated Dosing|1|||
48322092|NCT04512482|155378185|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
48322093|NCT04512482|155378186|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
48322094|NCT01939899|155378187|FG000|Lead-in Dose Finding Phase|Death|0|||
48322095|NCT01939899|155378188|FG001|Lead-in Dose Finding Phase|Death|3|||
48322096|NCT01939899|155378189|FG002|Lead-in Dose Finding Phase|Death|1|||
48322097|NCT01939899|155378190|FG003|Lead-in Dose Finding Phase|Death|0|||
48322098|NCT01939899|155378191|FG004|Lead-in Dose Finding Phase|Death|0|||
48322099|NCT01939899|155378187|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
48322100|NCT01939899|155378188|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
48322101|NCT01939899|155378189|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
48322102|NCT01939899|155378190|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
48322103|NCT01939899|155378191|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
48322104|NCT01939899|155378187|FG000|Lead-in Dose Finding Phase|Other|0|||
48322105|NCT01939899|155378188|FG001|Lead-in Dose Finding Phase|Other|0|||
48322106|NCT01939899|155378189|FG002|Lead-in Dose Finding Phase|Other|1|||
48322107|NCT01939899|155378190|FG003|Lead-in Dose Finding Phase|Other|0|||
48322108|NCT01939899|155378191|FG004|Lead-in Dose Finding Phase|Other|0|||
48322109|NCT01939899|155378187|FG000|Phase 2|Withdrawal by Subject|0|||
48322110|NCT01939899|155378188|FG001|Phase 2|Withdrawal by Subject|0|||
48322111|NCT01939899|155378189|FG002|Phase 2|Withdrawal by Subject|0|||
48322112|NCT01939899|155378190|FG003|Phase 2|Withdrawal by Subject|2|||
48322113|NCT01939899|155378191|FG004|Phase 2|Withdrawal by Subject|0|||
48322114|NCT01939899|155378187|FG000|Phase 2|Disease Progression|0|||
48322115|NCT01939899|155378188|FG001|Phase 2|Disease Progression|0|||
48322116|NCT01939899|155378189|FG002|Phase 2|Disease Progression|0|||
48322117|NCT01939899|155378190|FG003|Phase 2|Disease Progression|9|||
48322118|NCT01939899|155378191|FG004|Phase 2|Disease Progression|1|||
48322119|NCT00931710|155378194|FG000|Overall Study|Adverse Event|16|||
48322120|NCT00931710|155378195|FG001|Overall Study|Adverse Event|10|||
48322121|NCT00931710|155378194|FG000|Overall Study|Abnormal test procedure results|2|||
48322122|NCT00931710|155378195|FG001|Overall Study|Abnormal test procedure results|0|||
48322123|NCT00931710|155378194|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
48322124|NCT00931710|155378195|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
48322125|NCT00931710|155378194|FG000|Overall Study|Patient withdrew consent|4|||
48322126|NCT00931710|155378195|FG001|Overall Study|Patient withdrew consent|9|||
48322127|NCT00931710|155378194|FG000|Overall Study|Lost to Follow-up|6|||
48322128|NCT00931710|155378195|FG001|Overall Study|Lost to Follow-up|5|||
48322129|NCT00931710|155378194|FG000|Overall Study|Protocol deviation|1|||
48322130|NCT00931710|155378195|FG001|Overall Study|Protocol deviation|2|||
48322131|NCT02647905|155378202|FG000|Overall Study|Lost to Follow-up|1|||
48322132|NCT02647905|155378202|FG000|Overall Study|Withdrawal by Subject|2|||
48322133|NCT00439270|155378203|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
48322134|NCT00439270|155378204|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
48322135|NCT00439270|155378205|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
48322136|NCT00439270|155378206|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
48322137|NCT00439270|155378207|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
48583689|NCT01069419|156327762|FG000|Overall Study|Adverse Event|233|||
48583690|NCT01069419|156327762|FG000|Overall Study|Lack of Efficacy|332|||
48583691|NCT01069419|156327762|FG000|Overall Study|Lost to Follow-up|49|||
48583692|NCT01069419|156327762|FG000|Overall Study|Remission of disease|11|||
48322138|NCT00439270|155378203|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
48322139|NCT00439270|155378204|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
48322140|NCT00439270|155378205|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
48583693|NCT01069419|156327762|FG000|Overall Study|Withdrawal by Subject|34|||
48322141|NCT00439270|155378206|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
48322142|NCT00439270|155378207|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
48322143|NCT00439270|155378203|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
48583694|NCT01069419|156327762|FG000|Overall Study|Other Reason|43|||
48322144|NCT00439270|155378204|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
48322145|NCT00439270|155378205|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
48322146|NCT00439270|155378206|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
48322147|NCT00439270|155378207|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
48322148|NCT00439270|155378203|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
48322149|NCT00439270|155378204|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
48322150|NCT00439270|155378205|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
48583695|NCT01069419|156327762|FG000|Overall Study|Missing termination information|13|||
48322151|NCT00439270|155378206|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
48322152|NCT00439270|155378207|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
48322153|NCT00439270|155378203|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
48322154|NCT00439270|155378204|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
48322155|NCT00439270|155378205|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
48322156|NCT00439270|155378206|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
48322157|NCT00439270|155378207|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
48322158|NCT00439270|155378203|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
48322159|NCT00439270|155378204|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
48322160|NCT00439270|155378205|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
48322161|NCT00439270|155378206|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
48322162|NCT00439270|155378207|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
48322163|NCT00439270|155378203|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
48322164|NCT00439270|155378204|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
48322165|NCT00439270|155378205|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
48322166|NCT00439270|155378206|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
48322167|NCT00439270|155378207|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
48322168|NCT00439270|155378203|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
48322169|NCT00439270|155378204|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
48322170|NCT00439270|155378205|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
48322171|NCT00439270|155378206|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
48322172|NCT00439270|155378207|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
48322173|NCT00439270|155378203|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
48322174|NCT00439270|155378204|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
48322175|NCT00439270|155378205|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
48322176|NCT00439270|155378206|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
48322177|NCT00439270|155378207|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
48322178|NCT00439270|155378203|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
48322179|NCT00439270|155378204|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
48322180|NCT00439270|155378205|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
48322181|NCT00439270|155378206|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
48322182|NCT00439270|155378207|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
48322183|NCT01532388|155378208|FG000|3-month Follow-up|Lost to Follow-up|68|||
48322184|NCT01532388|155378209|FG001|3-month Follow-up|Lost to Follow-up|68|||
48322185|NCT01532388|155378208|FG000|6-month Follow-up|Lost to Follow-up|74|||
48322186|NCT01532388|155378209|FG001|6-month Follow-up|Lost to Follow-up|66|||
48322187|NCT01532388|155378208|FG000|12-month Follow-up|Lost to Follow-up|69|||
48322188|NCT01532388|155378209|FG001|12-month Follow-up|Lost to Follow-up|67|||
48322189|NCT00792636|155378210|FG000|Overall Study|Protocol Violation|17|||
48322190|NCT00792636|155378211|FG001|Overall Study|Protocol Violation|23|||
48322191|NCT00792636|155378212|FG002|Overall Study|Protocol Violation|20|||
48322192|NCT00792636|155378210|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
48739266|NCT03719586|156894120|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
48739267|NCT03719586|156894121|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
48583696|NCT01500213|156327763|FG000|Overall Study|Adverse Event|35|||
48583697|NCT01500213|156327764|FG001|Overall Study|Adverse Event|35|||
48583698|NCT01500213|156327763|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
48583699|NCT01500213|156327764|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
48739268|NCT02747875|156894122|FG000|Overall Study|Physician Decision|1|||
48739269|NCT02747875|156894123|FG001|Overall Study|Physician Decision|0|||
48322193|NCT00792636|155378211|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
48583700|NCT01500213|156327763|FG000|Overall Study|Withdrawal by Subject|28|||
48583701|NCT01500213|156327764|FG001|Overall Study|Withdrawal by Subject|37|||
48583702|NCT01500213|156327763|FG000|Overall Study|Death|7|||
48739270|NCT02747875|156894122|FG000|Overall Study|Adverse Event|0|||
48322194|NCT00792636|155378212|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
48322195|NCT00792636|155378210|FG000|Overall Study|Lost to Follow-up|13|||
48322196|NCT00792636|155378211|FG001|Overall Study|Lost to Follow-up|19|||
48583703|NCT01500213|156327764|FG001|Overall Study|Death|3|||
48583704|NCT01500213|156327763|FG000|Overall Study|Disease Progression|13|||
48583705|NCT01500213|156327764|FG001|Overall Study|Disease Progression|21|||
48583706|NCT01500213|156327763|FG000|Overall Study|Protocol Violation|19|||
48583707|NCT01500213|156327764|FG001|Overall Study|Protocol Violation|19|||
48322197|NCT00792636|155378212|FG002|Overall Study|Lost to Follow-up|14|||
48322198|NCT00792636|155378210|FG000|Overall Study|Withdrew Consent|10|||
48322199|NCT00792636|155378211|FG001|Overall Study|Withdrew Consent|13|||
48322200|NCT00792636|155378212|FG002|Overall Study|Withdrew Consent|9|||
48322201|NCT00792636|155378210|FG000|Overall Study|Lack of Efficacy|3|||
48322202|NCT00792636|155378211|FG001|Overall Study|Lack of Efficacy|4|||
48583708|NCT01500213|156327763|FG000|Overall Study|Physician Decision|12|||
48583709|NCT01500213|156327764|FG001|Overall Study|Physician Decision|10|||
48322203|NCT00792636|155378212|FG002|Overall Study|Lack of Efficacy|13|||
48322204|NCT00792636|155378210|FG000|Overall Study|Adverse Event|4|||
48322205|NCT00792636|155378211|FG001|Overall Study|Adverse Event|2|||
48322206|NCT00792636|155378212|FG002|Overall Study|Adverse Event|3|||
48322207|NCT00792636|155378210|FG000|Overall Study|Investigator Discretion|2|||
48322208|NCT00792636|155378211|FG001|Overall Study|Investigator Discretion|0|||
48322209|NCT00792636|155378212|FG002|Overall Study|Investigator Discretion|2|||
48322210|NCT04425863|155378213|FG000|Overall Study|Death|0|||
48322211|NCT04425863|155378214|FG001|Overall Study|Death|0|||
48322212|NCT04425863|155378215|FG002|Overall Study|Death|1|||
48322213|NCT01046136|155378216|FG000|Overall Study|Withdrawal by Subject|0|||
48322214|NCT01046136|155378217|FG001|Overall Study|Withdrawal by Subject|4|||
48322215|NCT01046136|155378216|FG000|Overall Study|Physician Decision|1|||
48322216|NCT01046136|155378217|FG001|Overall Study|Physician Decision|1|||
48322217|NCT01046136|155378216|FG000|Overall Study|Lost to Follow-up|3|||
48322218|NCT01046136|155378217|FG001|Overall Study|Lost to Follow-up|3|||
48322219|NCT03406871|155378218|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
48322220|NCT03406871|155378219|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
48322221|NCT03406871|155378220|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
48322222|NCT03406871|155378218|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
48322223|NCT03406871|155378219|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
48322224|NCT03406871|155378220|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
48322225|NCT03406871|155378218|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
48322226|NCT03406871|155378219|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
48322227|NCT03406871|155378220|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
48322228|NCT03406871|155378218|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
48322229|NCT03406871|155378219|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
48322230|NCT03406871|155378220|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
48322231|NCT03406871|155378218|FG000|Expansion Cohort(Final Analysis)|Death|0|||
48322232|NCT03406871|155378219|FG001|Expansion Cohort(Final Analysis)|Death|1|||
48322233|NCT03406871|155378220|FG002|Expansion Cohort(Final Analysis)|Death|0|||
48322234|NCT03406871|155378218|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
48322235|NCT03406871|155378219|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
48322236|NCT03406871|155378220|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
48322237|NCT00277355|155378221|FG000|Overall Study|Withdrawal by Subject|3|||
48322238|NCT00277355|155378222|FG001|Overall Study|Withdrawal by Subject|3|||
48322239|NCT00277355|155378221|FG000|Overall Study|Lost to Follow-up|2|||
48322240|NCT00277355|155378222|FG001|Overall Study|Lost to Follow-up|2|||
48322241|NCT00277355|155378221|FG000|Overall Study|Adverse Event|5|||
48322242|NCT00277355|155378222|FG001|Overall Study|Adverse Event|0|||
48322243|NCT00277355|155378221|FG000|Overall Study|Death|3|||
48322244|NCT00277355|155378222|FG001|Overall Study|Death|0|||
48322245|NCT00277355|155378221|FG000|Overall Study|Physician Decision|1|||
48322246|NCT00277355|155378222|FG001|Overall Study|Physician Decision|0|||
48322247|NCT00642850|155378223|FG000|Overall Study|Death|7|||
48322248|NCT00642850|155378223|FG000|Overall Study|Adverse Event|2|||
48322249|NCT00642850|155378223|FG000|Overall Study|Lack of Efficacy|1|||
48322250|NCT00642850|155378223|FG000|Overall Study|Protocol Violation|2|||
48322251|NCT00642850|155378223|FG000|Overall Study|Kidney transplantation|8|||
48322252|NCT00642850|155378223|FG000|Overall Study|Blood transfusion|6|||
48322253|NCT00642850|155378223|FG000|Overall Study|Other reasons|7|||
48322258|NCT01839331|155378226|FG000|Overall Study|Early Termination|3|||
48322259|NCT01839331|155378227|FG001|Overall Study|Early Termination|0|||
48322260|NCT01839331|155378228|FG002|Overall Study|Early Termination|1|||
48583710|NCT01500213|156327763|FG000|Overall Study|Lack of Efficacy|9|||
48583711|NCT01500213|156327764|FG001|Overall Study|Lack of Efficacy|7|||
48583712|NCT01500213|156327763|FG000|Overall Study|Lost to Follow-up|3|||
48322261|NCT01839331|155378229|FG003|Overall Study|Early Termination|2|||
48322262|NCT01839331|155378226|FG000|Overall Study|Protocol Violation|1|||
48583713|NCT01500213|156327764|FG001|Overall Study|Lost to Follow-up|6|||
48322263|NCT01839331|155378227|FG001|Overall Study|Protocol Violation|6|||
48322264|NCT01839331|155378228|FG002|Overall Study|Protocol Violation|4|||
48322265|NCT01839331|155378229|FG003|Overall Study|Protocol Violation|3|||
48322266|NCT01121991|155378231|FG000|Overall Study|Lack of Ovarian Response|2|||
48322267|NCT01121991|155378231|FG000|Overall Study|No Oocytes Retrieved|3|||
48322268|NCT01121991|155378231|FG000|Overall Study|No Fertilization|1|||
48322269|NCT00623194|155378235|FG000|Overall Study|Lack of Efficacy|1|||
48322270|NCT00623194|155378235|FG000|Overall Study|Protocol Violation|3|||
48322271|NCT00623194|155378235|FG000|Overall Study|Unclassified|1|||
48322272|NCT03785405|155378236|FG000|Overall Study|Adverse Event|16|||
48322273|NCT03785405|155378237|FG001|Overall Study|Adverse Event|1|||
48322274|NCT03785405|155378236|FG000|Overall Study|Death|6|||
48583714|NCT01500213|156327763|FG000|Overall Study|Other Reasons|7|||
48583715|NCT01500213|156327764|FG001|Overall Study|Other Reasons|5|||
48583716|NCT00785213|156327765|FG000|Quinine Sulfate Alone|Adverse Event|4|||
48583717|NCT00785213|156327765|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
48322275|NCT03785405|155378237|FG001|Overall Study|Death|4|||
48322276|NCT03785405|155378236|FG000|Overall Study|Guardian decision|4|||
48322277|NCT03785405|155378237|FG001|Overall Study|Guardian decision|1|||
48739271|NCT02747875|156894123|FG001|Overall Study|Adverse Event|1|||
48739272|NCT00696800|156894124|FG000|Overall Study|Adverse Event|16|||
48739273|NCT00696800|156894125|FG001|Overall Study|Adverse Event|3|||
48739274|NCT00696800|156894124|FG000|Overall Study|Insufficient compliance with medication|2|||
48739275|NCT00696800|156894125|FG001|Overall Study|Insufficient compliance with medication|1|||
48322278|NCT03785405|155378236|FG000|Overall Study|Lost to Follow-up|1|||
48322279|NCT03785405|155378237|FG001|Overall Study|Lost to Follow-up|0|||
48322280|NCT03785405|155378236|FG000|Overall Study|Physician Decision|8|||
48583718|NCT00525902|156327766|FG000|Overall Study|Lack of Efficacy|1|||
48583719|NCT01490697|156327767|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
48322281|NCT03785405|155378237|FG001|Overall Study|Physician Decision|5|||
48322282|NCT03785405|155378236|FG000|Overall Study|Participant decision|2|||
48322283|NCT03785405|155378237|FG001|Overall Study|Participant decision|0|||
48322284|NCT03785405|155378236|FG000|Overall Study|Other|1|||
48322285|NCT03785405|155378237|FG001|Overall Study|Other|0|||
48322286|NCT03785405|155378236|FG000|Overall Study|No treatment was received|0|||
48322287|NCT03785405|155378237|FG001|Overall Study|No treatment was received|1|||
48322288|NCT01290341|155378238|FG000|Overall Study|Protocol Violation|7|||
48322289|NCT01290341|155378239|FG001|Overall Study|Protocol Violation|3|||
48322290|NCT01290341|155378238|FG000|Overall Study|Adverse Event|1|||
48322291|NCT01290341|155378239|FG001|Overall Study|Adverse Event|0|||
48322292|NCT01290341|155378238|FG000|Overall Study|Lost to Follow-up|21|||
48322293|NCT01290341|155378239|FG001|Overall Study|Lost to Follow-up|10|||
48322294|NCT01290341|155378238|FG000|Overall Study|Withdrawal by Subject|19|||
48583720|NCT01490697|156327768|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
48583721|NCT01534208|156327769|FG000|Overall Study|Lost to Follow-up|19|||
48583722|NCT01534208|156327770|FG001|Overall Study|Lost to Follow-up|14|||
48583723|NCT01534208|156327769|FG000|Overall Study|Withdrawal by Subject|6|||
48583724|NCT01534208|156327770|FG001|Overall Study|Withdrawal by Subject|20|||
48583725|NCT01534208|156327769|FG000|Overall Study|Adverse Event|15|||
48583726|NCT01534208|156327770|FG001|Overall Study|Adverse Event|8|||
48583727|NCT01534208|156327769|FG000|Overall Study|Physician Decision|2|||
48583728|NCT01534208|156327770|FG001|Overall Study|Physician Decision|0|||
48583729|NCT01534208|156327769|FG000|Overall Study|Lack of Efficacy|0|||
48583730|NCT01534208|156327770|FG001|Overall Study|Lack of Efficacy|3|||
48583731|NCT01534208|156327769|FG000|Overall Study|Protocol Violation|2|||
48583732|NCT01534208|156327770|FG001|Overall Study|Protocol Violation|2|||
48322295|NCT01290341|155378239|FG001|Overall Study|Withdrawal by Subject|5|||
48322296|NCT01290341|155378238|FG000|Overall Study|Negative baseline culture and others|44|||
48322297|NCT01290341|155378239|FG001|Overall Study|Negative baseline culture and others|11|||
48583733|NCT01534208|156327769|FG000|Overall Study|Sponsor decision|4|||
48583734|NCT01534208|156327770|FG001|Overall Study|Sponsor decision|1|||
48583735|NCT01534208|156327769|FG000|Overall Study|Subject relocation|2|||
48583736|NCT01534208|156327770|FG001|Overall Study|Subject relocation|0|||
48583737|NCT01534208|156327769|FG000|Overall Study|Lab assessment|2|||
48583738|NCT01534208|156327770|FG001|Overall Study|Lab assessment|1|||
48583739|NCT01534208|156327769|FG000|Overall Study|Eligibility error|3|||
48583740|NCT01534208|156327770|FG001|Overall Study|Eligibility error|0|||
48583741|NCT01534208|156327769|FG000|Overall Study|PCP decision|1|||
48583742|NCT01534208|156327770|FG001|Overall Study|PCP decision|0|||
48583743|NCT01534208|156327769|FG000|Overall Study|Needed prohibited meds|1|||
48583744|NCT01534208|156327770|FG001|Overall Study|Needed prohibited meds|0|||
48322298|NCT00960141|155378240|FG000|Overall Study|Adverse Event|4|||
48322299|NCT00960141|155378241|FG001|Overall Study|Adverse Event|8|||
48322300|NCT00960141|155378242|FG002|Overall Study|Adverse Event|2|||
48322301|NCT00960141|155378240|FG000|Overall Study|Lack of Efficacy|3|||
48322302|NCT00960141|155378241|FG001|Overall Study|Lack of Efficacy|4|||
48583745|NCT00955968|156327771|FG000|Overall Study|Death|2|||
48583746|NCT00955968|156327772|FG001|Overall Study|Death|4|||
48583747|NCT00955968|156327771|FG000|Overall Study|Withdrawal by Subject|35|||
48583748|NCT00955968|156327772|FG001|Overall Study|Withdrawal by Subject|31|||
48322303|NCT00960141|155378242|FG002|Overall Study|Lack of Efficacy|2|||
48583749|NCT00955968|156327771|FG000|Overall Study|Lost to Follow-up|45|||
48583750|NCT00955968|156327772|FG001|Overall Study|Lost to Follow-up|39|||
48583751|NCT00955968|156327771|FG000|Overall Study|Site closed|55|||
48583752|NCT00955968|156327772|FG001|Overall Study|Site closed|52|||
48583753|NCT01877551|156327777|FG000|Overall Study|Physician Decision|0|||
48739276|NCT00696800|156894124|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
48739277|NCT00696800|156894125|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
48322304|NCT00960141|155378240|FG000|Overall Study|Lost to Follow-up|1|||
48322305|NCT00960141|155378241|FG001|Overall Study|Lost to Follow-up|0|||
48583754|NCT01877551|156327778|FG001|Overall Study|Physician Decision|1|||
48583755|NCT04102865|156327779|FG000|Overall Study|Adverse Event|4|||
48322306|NCT00960141|155378242|FG002|Overall Study|Lost to Follow-up|0|||
48583756|NCT04102865|156327780|FG001|Overall Study|Adverse Event|0|||
48583757|NCT04102865|156327779|FG000|Overall Study|Lost to Follow-up|1|||
48583758|NCT04102865|156327780|FG001|Overall Study|Lost to Follow-up|0|||
48583759|NCT04102865|156327779|FG000|Overall Study|Withdrawal by Subject|2|||
48583760|NCT04102865|156327780|FG001|Overall Study|Withdrawal by Subject|0|||
48583761|NCT02429310|156327781|FG000|Overall Study|Lost to Follow-up|1|||
48583762|NCT02429310|156327782|FG001|Overall Study|Lost to Follow-up|2|||
48583763|NCT02429310|156327781|FG000|Overall Study|Protocol Violation|1|||
48583764|NCT02429310|156327782|FG001|Overall Study|Protocol Violation|1|||
48583765|NCT01047332|156327783|FG000|Overall Study|SEMS Obstruction|11|||
48583766|NCT01047332|156327784|FG001|Overall Study|SEMS Obstruction|20|||
48583767|NCT01047332|156327783|FG000|Overall Study|Died Unobstructed|38|||
48583768|NCT01047332|156327784|FG001|Overall Study|Died Unobstructed|41|||
48583769|NCT01047332|156327783|FG000|Overall Study|Lost to Follow-up|8|||
48583770|NCT01047332|156327784|FG001|Overall Study|Lost to Follow-up|3|||
48583771|NCT03417024|156327787|FG000|Overall Study|Study Termination prior to follow-up|11|||
48583772|NCT03417024|156327787|FG000|Overall Study|Physician Decision|2|||
48583773|NCT01298141|156327788|FG000|Overall Study|Adverse Event|3|||
48583774|NCT01298141|156327788|FG000|Overall Study|Refusal of Required Study Procedures|1|||
48583775|NCT01298141|156327788|FG000|Overall Study|Withdrawal by Subject|6|||
48583776|NCT01298141|156327788|FG000|Overall Study|Termination of Study by the Investigator|5|||
48583777|NCT01298141|156327788|FG000|Overall Study|Other|5|||
48583778|NCT01298141|156327788|FG000|Overall Study|Lost to Follow-up|1|||
48583779|NCT01298141|156327788|FG000|Overall Study|Death|6|||
48583780|NCT01298141|156327788|FG000|Overall Study|Not treated|4|||
48583781|NCT00793546|156327789|FG000|Overall Study|Death|3|||
48322307|NCT00960141|155378240|FG000|Overall Study|Protocol Violation|1|||
48583782|NCT00793546|156327790|FG001|Overall Study|Death|0|||
48583783|NCT00793546|156327789|FG000|Overall Study|Lost to Follow-up|1|||
48739278|NCT00696800|156894124|FG000|Overall Study|Insufficient ovarian response|4|||
48583784|NCT00793546|156327790|FG001|Overall Study|Lost to Follow-up|0|||
48583785|NCT00793546|156327789|FG000|Overall Study|Withdrawal by Subject|1|||
48583786|NCT00793546|156327790|FG001|Overall Study|Withdrawal by Subject|1|||
48322308|NCT00960141|155378241|FG001|Overall Study|Protocol Violation|3|||
48322309|NCT00960141|155378242|FG002|Overall Study|Protocol Violation|2|||
48322310|NCT00960141|155378240|FG000|Overall Study|Withdrawal by Subject|1|||
48322311|NCT00960141|155378241|FG001|Overall Study|Withdrawal by Subject|2|||
48322312|NCT00960141|155378242|FG002|Overall Study|Withdrawal by Subject|1|||
48322313|NCT02874534|155378243|FG000|Overall Study|Withdrawal by Subject|5|||
48322314|NCT02874534|155378244|FG001|Overall Study|Withdrawal by Subject|8|||
48322315|NCT02874534|155378243|FG000|Overall Study|Lost to Follow-up|2|||
48322316|NCT02874534|155378244|FG001|Overall Study|Lost to Follow-up|2|||
48322317|NCT02874534|155378243|FG000|Overall Study|Ongoing in study|1|||
48583787|NCT00793546|156327789|FG000|Overall Study|Study Terminated by Sponsor|8|||
48583788|NCT00793546|156327790|FG001|Overall Study|Study Terminated by Sponsor|27|||
48583789|NCT00793546|156327789|FG000|Overall Study|Other|1|||
48583790|NCT00793546|156327790|FG001|Overall Study|Other|0|||
48583791|NCT04063657|156330142|FG000|Overall Study|Lost to Follow-up|1|||
48583792|NCT04063657|156330143|FG001|Overall Study|Lost to Follow-up|0|||
48583793|NCT03408444|156330144|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
48322318|NCT02874534|155378244|FG001|Overall Study|Ongoing in study|1|||
48322319|NCT02797184|155378247|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
48583794|NCT03408444|156330145|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
48583795|NCT03408444|156330146|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
48583796|NCT03408444|156330147|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
48583797|NCT03408444|156330144|FG000|Overall Study|Lens Discomfort|0|||
48583798|NCT03408444|156330145|FG001|Overall Study|Lens Discomfort|1|||
48583799|NCT03408444|156330146|FG002|Overall Study|Lens Discomfort|0|||
48583800|NCT03408444|156330147|FG003|Overall Study|Lens Discomfort|0|||
48583801|NCT03408444|156330144|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
48583802|NCT03408444|156330145|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
48583803|NCT03408444|156330146|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
48583804|NCT03408444|156330147|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
48583805|NCT03408444|156330144|FG000|Overall Study|Withdrawal by Subject|0|||
48583806|NCT03408444|156330145|FG001|Overall Study|Withdrawal by Subject|2|||
48583807|NCT03408444|156330146|FG002|Overall Study|Withdrawal by Subject|3|||
48583808|NCT03408444|156330147|FG003|Overall Study|Withdrawal by Subject|0|||
48583809|NCT03408444|156330144|FG000|Overall Study|Lost to Follow-up|0|||
48325508|NCT02502526|155389131|FG001|Overall Study|Withdrawal by Subject|1|||
48583810|NCT03408444|156330145|FG001|Overall Study|Lost to Follow-up|0|||
48583811|NCT03408444|156330146|FG002|Overall Study|Lost to Follow-up|1|||
48583812|NCT03408444|156330147|FG003|Overall Study|Lost to Follow-up|0|||
48583813|NCT03408444|156330144|FG000|Overall Study|Adverse Event|0|||
48739279|NCT00696800|156894125|FG001|Overall Study|Insufficient ovarian response|1|||
48739280|NCT00696800|156894124|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
48739281|NCT00696800|156894125|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
48739282|NCT00696800|156894124|FG000|Overall Study|Too high ovarian response|6|||
48739283|NCT00696800|156894125|FG001|Overall Study|Too high ovarian response|1|||
48739284|NCT00696800|156894124|FG000|Overall Study|No/too few/bad quality oocytes|4|||
48739285|NCT00696800|156894125|FG001|Overall Study|No/too few/bad quality oocytes|3|||
48322320|NCT02797184|155378248|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
48583814|NCT03408444|156330145|FG001|Overall Study|Adverse Event|0|||
48583815|NCT03408444|156330146|FG002|Overall Study|Adverse Event|0|||
48739286|NCT00696800|156894124|FG000|Overall Study|No/abnormal fertilization|11|||
48739287|NCT00696800|156894125|FG001|Overall Study|No/abnormal fertilization|13|||
48739288|NCT00696800|156894124|FG000|Overall Study|No/too few/bad quality embryos|24|||
48739289|NCT00696800|156894125|FG001|Overall Study|No/too few/bad quality embryos|18|||
48739290|NCT00696800|156894124|FG000|Overall Study|Other Reasons|5|||
48739291|NCT00696800|156894125|FG001|Overall Study|Other Reasons|3|||
48739292|NCT00696800|156894124|FG000|Overall Study|Not treated|1|||
48739293|NCT00696800|156894125|FG001|Overall Study|Not treated|2|||
48739294|NCT00762385|156894126|FG000|First Intervention|Lens Issue|1|||
48739295|NCT00762385|156894127|FG001|First Intervention|Lens Issue|1|||
48739296|NCT00762385|156894126|FG000|First Intervention|Lost to Follow-up|0|||
48739297|NCT00762385|156894127|FG001|First Intervention|Lost to Follow-up|2|||
48739298|NCT00762385|156894126|FG000|First Intervention|Ineligible|1|||
48739299|NCT00762385|156894127|FG001|First Intervention|Ineligible|0|||
48739300|NCT00762385|156894126|FG000|First Intervention|Protocol Violation|0|||
48739301|NCT00762385|156894127|FG001|First Intervention|Protocol Violation|1|||
48739302|NCT00762385|156894126|FG000|Second Intervention|Protocol Violation|3|||
48739303|NCT00762385|156894127|FG001|Second Intervention|Protocol Violation|3|||
48739304|NCT00538291|156894128|FG000|Overall Study|Adverse Event|2|||
48739305|NCT00538291|156894128|FG000|Overall Study|Withdrawal by Subject|1|||
48739306|NCT04515394|156894132|FG000|Overall Study|Participant did not receive treatment|1|||
48739307|NCT02404220|156894138|FG000|Overall Study|Adverse Event|0|||
48739308|NCT02404220|156894139|FG001|Overall Study|Adverse Event|0|||
48739309|NCT02404220|156894140|FG002|Overall Study|Adverse Event|1|||
48739310|NCT02404220|156894141|FG003|Overall Study|Adverse Event|0|||
48739311|NCT02404220|156894138|FG000|Overall Study|Death|5|||
48739312|NCT02404220|156894139|FG001|Overall Study|Death|5|||
48739313|NCT02404220|156894140|FG002|Overall Study|Death|3|||
48739314|NCT02404220|156894141|FG003|Overall Study|Death|8|||
48739315|NCT02404220|156894138|FG000|Overall Study|Progressive Disease|0|||
48739316|NCT02404220|156894139|FG001|Overall Study|Progressive Disease|0|||
48739317|NCT02404220|156894140|FG002|Overall Study|Progressive Disease|1|||
48739318|NCT02404220|156894141|FG003|Overall Study|Progressive Disease|1|||
48739319|NCT02404220|156894138|FG000|Overall Study|Study Terminated by Sponsor|0|||
48739320|NCT02404220|156894139|FG001|Overall Study|Study Terminated by Sponsor|0|||
48739321|NCT02404220|156894140|FG002|Overall Study|Study Terminated by Sponsor|2|||
48739322|NCT02404220|156894141|FG003|Overall Study|Study Terminated by Sponsor|1|||
48739323|NCT02404220|156894138|FG000|Overall Study|Withdrawal by Subject|0|||
48739324|NCT02404220|156894139|FG001|Overall Study|Withdrawal by Subject|1|||
48739325|NCT02404220|156894140|FG002|Overall Study|Withdrawal by Subject|0|||
48739326|NCT02404220|156894141|FG003|Overall Study|Withdrawal by Subject|0|||
48739327|NCT02404220|156894138|FG000|Overall Study|Enrolled but Never Treated|0|||
48739328|NCT02404220|156894139|FG001|Overall Study|Enrolled but Never Treated|2|||
48739329|NCT02404220|156894140|FG002|Overall Study|Enrolled but Never Treated|0|||
48739330|NCT02404220|156894141|FG003|Overall Study|Enrolled but Never Treated|0|||
48583816|NCT03408444|156330147|FG003|Overall Study|Adverse Event|1|||
48583817|NCT03408444|156330144|FG000|Overall Study|Lens Handling Difficulties|0|||
48322321|NCT00604669|155378249|FG000|Overall Study|lack of information in chart|7|||
48322322|NCT03756662|155378252|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
48322323|NCT02705820|155378253|FG000|Overall Study|Death|2|||
48322324|NCT02705820|155378253|FG000|Overall Study|Disease Progression|34|||
48322325|NCT02705820|155378253|FG000|Overall Study|Clinical Deterioration|3|||
48322326|NCT03496662|155378254|FG000|Overall Study|Adverse Event|1|||
48583818|NCT03408444|156330145|FG001|Overall Study|Lens Handling Difficulties|0|||
48583819|NCT03408444|156330146|FG002|Overall Study|Lens Handling Difficulties|1|||
48583820|NCT03408444|156330147|FG003|Overall Study|Lens Handling Difficulties|0|||
48583821|NCT03408444|156330144|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
48583822|NCT03408444|156330145|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
48739331|NCT02264639|156894150|FG000|Overall Study|Death (after completing single-dose phase)|1|||
48739332|NCT02264639|156894151|FG001|Overall Study|Death (after completing single-dose phase)|0|||
48739333|NCT02264639|156894152|FG002|Overall Study|Death (after completing single-dose phase)|0|||
48739334|NCT02264639|156894153|FG003|Overall Study|Death (after completing single-dose phase)|0|||
48739335|NCT02264639|156894154|FG004|Overall Study|Death (after completing single-dose phase)|0|||
48739336|NCT02264639|156894150|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
48583823|NCT03408444|156330146|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
48322327|NCT03496662|155378255|FG001|Overall Study|Adverse Event|0|||
48322328|NCT03496662|155378256|FG002|Overall Study|Adverse Event|1|||
48322329|NCT03496662|155378254|FG000|Overall Study|Physician Decision|1|||
48322330|NCT03496662|155378255|FG001|Overall Study|Physician Decision|0|||
48322331|NCT03496662|155378256|FG002|Overall Study|Physician Decision|3|||
48322332|NCT03496662|155378254|FG000|Overall Study|Withdrawal by Subject|0|||
48322333|NCT03496662|155378255|FG001|Overall Study|Withdrawal by Subject|0|||
48322334|NCT03496662|155378256|FG002|Overall Study|Withdrawal by Subject|2|||
48739337|NCT02264639|156894151|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
48739338|NCT02264639|156894152|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
48739339|NCT02264639|156894153|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
48739340|NCT02264639|156894154|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
48322335|NCT03496662|155378254|FG000|Overall Study|Death|0|||
48322336|NCT03496662|155378255|FG001|Overall Study|Death|0|||
48322337|NCT03496662|155378256|FG002|Overall Study|Death|2|||
48322338|NCT03496662|155378254|FG000|Overall Study|Noncompliance|0|||
48322339|NCT03496662|155378255|FG001|Overall Study|Noncompliance|0|||
48322340|NCT03496662|155378256|FG002|Overall Study|Noncompliance|1|||
48322341|NCT05371652|155379396|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
48322342|NCT05371652|155379396|FG000|Overall Study|Withdrawal by Subject|12|||
48322343|NCT05371652|155379396|FG000|Overall Study|Adverse Event|1|||
48322344|NCT05371652|155379396|FG000|Overall Study|Other|11|||
48322345|NCT05659537|155379400|FG000|Overall Study|Adverse Event|5|||
48322346|NCT05659537|155379400|FG000|Overall Study|Lost to Follow-up|4|||
48739341|NCT02264639|156894150|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
48739342|NCT02264639|156894151|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
48739343|NCT02264639|156894152|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
48322347|NCT05659537|155379400|FG000|Overall Study|Withdrawal by Subject|13|||
48322348|NCT05659537|155379400|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
48322349|NCT05659537|155379400|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
48322350|NCT05659537|155379400|FG000|Overall Study|Participant was suffering from anaemia|1|||
48322351|NCT04098068|155379401|FG000|Overall Study|Disease Progression|7|||
48322352|NCT04098068|155379401|FG000|Overall Study|Withdrawal by Subject|2|||
48322353|NCT04098068|155379401|FG000|Overall Study|New Cancer Diagnosis|1|||
48322354|NCT03748641|155379402|FG000|Overall Study|Ongoing|155|||
48322355|NCT03748641|155379403|FG001|Overall Study|Ongoing|148|||
48322356|NCT03748641|155379404|FG002|Overall Study|Ongoing|66|||
48322357|NCT03748641|155379405|FG003|Overall Study|Ongoing|79|||
48739344|NCT02264639|156894153|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
48739345|NCT02264639|156894154|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
48739346|NCT02264639|156894150|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
48739347|NCT02264639|156894151|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
48739348|NCT02264639|156894152|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
48739349|NCT02264639|156894153|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
48739350|NCT02264639|156894154|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
48739351|NCT00406354|156894159|FG000|All Randomized Patients|Protocol Violation|0|||
48739352|NCT00406354|156894160|FG001|All Randomized Patients|Protocol Violation|0|||
48739353|NCT00406354|156894161|FG002|All Randomized Patients|Protocol Violation|1|||
48739354|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
48739355|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
48739356|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
48739357|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Adverse Event|6|||
48739358|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Adverse Event|2|||
48739359|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Adverse Event|1|||
48739360|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
48739361|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
48739362|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
48739363|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
48739364|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
48739365|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
48739366|NCT00406354|156894159|FG000|All Randomized and Treated Patients|Physician Decision|0|||
48739367|NCT00406354|156894160|FG001|All Randomized and Treated Patients|Physician Decision|0|||
48739368|NCT00406354|156894161|FG002|All Randomized and Treated Patients|Physician Decision|1|||
48739369|NCT02639546|156894162|FG000|Overall Study|Death|2|||
48739370|NCT02639546|156894163|FG001|Overall Study|Death|2|||
48739371|NCT02639546|156894164|FG002|Overall Study|Death|1|||
48739372|NCT02639546|156894165|FG003|Overall Study|Death|2|||
48739373|NCT02639546|156894166|FG004|Overall Study|Death|2|||
48739374|NCT02639546|156894167|FG005|Overall Study|Death|2|||
48739375|NCT02639546|156894168|FG006|Overall Study|Death|0|||
48739376|NCT02639546|156894169|FG007|Overall Study|Death|0|||
48739377|NCT02639546|156894162|FG000|Overall Study|Lost to Follow-up|0|||
48739378|NCT02639546|156894163|FG001|Overall Study|Lost to Follow-up|0|||
48739379|NCT02639546|156894164|FG002|Overall Study|Lost to Follow-up|1|||
48739380|NCT02639546|156894165|FG003|Overall Study|Lost to Follow-up|0|||
48739381|NCT02639546|156894166|FG004|Overall Study|Lost to Follow-up|1|||
48739382|NCT02639546|156894167|FG005|Overall Study|Lost to Follow-up|1|||
48739383|NCT02639546|156894168|FG006|Overall Study|Lost to Follow-up|0|||
48739384|NCT02639546|156894169|FG007|Overall Study|Lost to Follow-up|1|||
48739385|NCT02639546|156894162|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
48739386|NCT02639546|156894163|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
48739387|NCT02639546|156894164|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
48739388|NCT02639546|156894165|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
48739389|NCT02639546|156894166|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
48739390|NCT02639546|156894167|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
48739391|NCT02639546|156894168|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
48739392|NCT02639546|156894169|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
48739393|NCT02639546|156894162|FG000|Overall Study|Study Terminated By Sponsor|0|||
48739394|NCT02639546|156894163|FG001|Overall Study|Study Terminated By Sponsor|2|||
48739395|NCT02639546|156894164|FG002|Overall Study|Study Terminated By Sponsor|3|||
48739396|NCT02639546|156894165|FG003|Overall Study|Study Terminated By Sponsor|4|||
48739397|NCT02639546|156894166|FG004|Overall Study|Study Terminated By Sponsor|4|||
48739398|NCT02639546|156894167|FG005|Overall Study|Study Terminated By Sponsor|3|||
48739399|NCT02639546|156894168|FG006|Overall Study|Study Terminated By Sponsor|3|||
48739400|NCT02639546|156894169|FG007|Overall Study|Study Terminated By Sponsor|9|||
48739401|NCT02639546|156894162|FG000|Overall Study|Withdrawal by Subject|2|||
48739402|NCT02639546|156894163|FG001|Overall Study|Withdrawal by Subject|2|||
48739403|NCT02639546|156894164|FG002|Overall Study|Withdrawal by Subject|1|||
48739404|NCT02639546|156894165|FG003|Overall Study|Withdrawal by Subject|0|||
48739405|NCT02639546|156894166|FG004|Overall Study|Withdrawal by Subject|0|||
48322358|NCT03748641|155379406|FG004|Overall Study|Ongoing|84|||
48322359|NCT03748641|155379402|FG000|Overall Study|Death|54|||
48322360|NCT03748641|155379403|FG001|Overall Study|Death|59|||
48322361|NCT03748641|155379404|FG002|Overall Study|Death|51|||
48322362|NCT03748641|155379405|FG003|Overall Study|Death|42|||
48322363|NCT03748641|155379406|FG004|Overall Study|Death|9|||
48322364|NCT03748641|155379402|FG000|Overall Study|Lost to Follow-up|0|||
48322365|NCT03748641|155379403|FG001|Overall Study|Lost to Follow-up|2|||
48322366|NCT03748641|155379404|FG002|Overall Study|Lost to Follow-up|1|||
48322367|NCT03748641|155379405|FG003|Overall Study|Lost to Follow-up|0|||
48322368|NCT03748641|155379406|FG004|Overall Study|Lost to Follow-up|0|||
48322369|NCT03748641|155379402|FG000|Overall Study|Withdrawal by Subject|3|||
48322370|NCT03748641|155379403|FG001|Overall Study|Withdrawal by Subject|2|||
48322371|NCT03748641|155379404|FG002|Overall Study|Withdrawal by Subject|5|||
48322372|NCT03748641|155379405|FG003|Overall Study|Withdrawal by Subject|3|||
48322373|NCT03748641|155379406|FG004|Overall Study|Withdrawal by Subject|2|||
48322374|NCT03656718|155379407|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
48322375|NCT03656718|155379408|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
48322376|NCT03656718|155379409|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
48322377|NCT03656718|155379410|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
48322378|NCT03656718|155379411|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
48322379|NCT03656718|155379412|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
48322380|NCT03656718|155379413|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
48322381|NCT03656718|155379407|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
48322382|NCT03656718|155379408|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
48322383|NCT03656718|155379409|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
48322384|NCT03656718|155379410|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
48322385|NCT03656718|155379411|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
48322386|NCT03656718|155379412|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
48322387|NCT03656718|155379413|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
48583824|NCT03408444|156330147|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
48583825|NCT02339155|156330148|FG000|Overall Study|Adverse Event|0|||
48583826|NCT02339155|156330149|FG001|Overall Study|Adverse Event|6|||
48583827|NCT02339155|156330148|FG000|Overall Study|Death|1|||
48583828|NCT02339155|156330149|FG001|Overall Study|Death|1|||
48739406|NCT02639546|156894167|FG005|Overall Study|Withdrawal by Subject|1|||
48739407|NCT02639546|156894168|FG006|Overall Study|Withdrawal by Subject|2|||
48739408|NCT02639546|156894169|FG007|Overall Study|Withdrawal by Subject|1|||
48739409|NCT02716805|156894172|FG000|Overall Study|Progressive disease|2|||
48322388|NCT03656718|155379407|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
48583829|NCT02339155|156330148|FG000|Overall Study|Lost to Follow-up|8|||
48583830|NCT02339155|156330149|FG001|Overall Study|Lost to Follow-up|9|||
48583831|NCT02339155|156330148|FG000|Overall Study|Physician Decision|2|||
48583832|NCT02339155|156330149|FG001|Overall Study|Physician Decision|1|||
48583833|NCT02339155|156330148|FG000|Overall Study|Withdrawal by Subject|4|||
48583834|NCT02339155|156330149|FG001|Overall Study|Withdrawal by Subject|4|||
48583835|NCT04984681|156330150|FG000|Overall Study|Lost to Follow-up|3|||
48583836|NCT04984681|156330151|FG001|Overall Study|Lost to Follow-up|1|||
48583837|NCT00908076|156330154|FG000|Overall Study|Lack of Efficacy|1|||
48583838|NCT00908076|156330155|FG001|Overall Study|Lack of Efficacy|1|||
48583839|NCT02382796|156330156|FG000|Overall Study|Global deterioration of health status|1|||
48583840|NCT02382796|156330156|FG000|Overall Study|Objective progression or relapse|3|||
48583841|NCT02382796|156330156|FG000|Overall Study|Commercial dacomitinib became available|3|||
48583842|NCT02609724|156330157|FG000|Overall Study|Death|2|||
48583843|NCT02609724|156330158|FG001|Overall Study|Death|0|||
48583844|NCT02609724|156330159|FG002|Overall Study|Death|1|||
48583845|NCT02609724|156330157|FG000|Overall Study|Withdrawal by Subject|1|||
48583846|NCT02609724|156330158|FG001|Overall Study|Withdrawal by Subject|2|||
48583847|NCT02609724|156330159|FG002|Overall Study|Withdrawal by Subject|3|||
48583848|NCT02609724|156330157|FG000|Overall Study|Illness|2|||
48583849|NCT02609724|156330158|FG001|Overall Study|Illness|1|||
48583850|NCT02609724|156330159|FG002|Overall Study|Illness|0|||
48583851|NCT02258334|156330160|FG000|Overall Study|Adverse Event|1|||
48583852|NCT02258334|156330161|FG001|Overall Study|Adverse Event|0|||
48583853|NCT02258334|156330162|FG002|Overall Study|Adverse Event|0|||
48583854|NCT02258334|156330163|FG003|Overall Study|Adverse Event|0|||
48583855|NCT03077659|156330164|FG000|Overall Study|Withdrawal by Subject|0|||
48583856|NCT03077659|156330165|FG001|Overall Study|Withdrawal by Subject|0|||
48583857|NCT03077659|156330166|FG002|Overall Study|Withdrawal by Subject|1|||
48322389|NCT03656718|155379408|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
48322390|NCT03656718|155379409|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
48322391|NCT03656718|155379410|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
48583858|NCT00985959|156330171|FG000|Overall Study|Adverse Event|0|||
48583859|NCT00985959|156330172|FG001|Overall Study|Adverse Event|0|||
48583860|NCT00985959|156330173|FG002|Overall Study|Adverse Event|19|||
48583861|NCT00985959|156330171|FG000|Overall Study|Withdrawal by Subject|0|||
48583862|NCT00985959|156330172|FG001|Overall Study|Withdrawal by Subject|0|||
48583863|NCT00985959|156330173|FG002|Overall Study|Withdrawal by Subject|8|||
48739410|NCT02716805|156894173|FG001|Overall Study|Progressive disease|0|||
48739411|NCT02716805|156894174|FG002|Overall Study|Progressive disease|0|||
48739412|NCT02716805|156894175|FG003|Overall Study|Progressive disease|0|||
48739413|NCT00939640|156894179|FG000|Overall Study|Physician Decision|1|||
48739414|NCT03817879|156895610|FG000|Overall Study|Drop out|5|||
48739415|NCT03817879|156895611|FG001|Overall Study|Drop out|12|||
48739416|NCT03817879|156895610|FG000|Overall Study|Withdrawal by Subject|0|||
48739417|NCT03817879|156895611|FG001|Overall Study|Withdrawal by Subject|1|||
48739418|NCT02925923|156895612|FG000|Overall Study|blood samples hemolyzed|0|||
48739419|NCT02925923|156895613|FG001|Overall Study|blood samples hemolyzed|2|||
48739420|NCT01846104|156895614|FG000|Overall Study|Withdrawal by Subject|1|||
48739421|NCT00282412|156895615|FG000|Overall Study|Death|2|||
48739422|NCT03055858|156895616|FG000|Overall Study|Death|9|||
48322392|NCT03656718|155379411|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
48322393|NCT03656718|155379412|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
48322394|NCT03656718|155379413|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
48322395|NCT03656718|155379407|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48322396|NCT03656718|155379408|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48322397|NCT03656718|155379409|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48322398|NCT03656718|155379410|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48322399|NCT03656718|155379411|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48322400|NCT03656718|155379412|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
48322401|NCT03656718|155379413|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
48322402|NCT03656718|155379407|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
48322403|NCT03656718|155379408|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48322404|NCT03656718|155379409|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48322405|NCT03656718|155379410|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48322406|NCT03656718|155379411|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48322407|NCT03656718|155379412|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
48322408|NCT03656718|155379413|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
48322409|NCT03656718|155379407|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48322410|NCT03656718|155379408|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48322411|NCT03656718|155379409|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48322412|NCT03656718|155379410|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48322413|NCT03656718|155379411|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
48322414|NCT03656718|155379412|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
48322415|NCT03656718|155379413|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
48583864|NCT00985959|156330171|FG000|Overall Study|Progressive disease|1|||
48583865|NCT00985959|156330172|FG001|Overall Study|Progressive disease|2|||
48739423|NCT03055858|156895616|FG000|Overall Study|Withdrawal by Subject|11|||
48739424|NCT03055858|156895616|FG000|Overall Study|Lost to Follow-up|6|||
48739425|NCT03055858|156895616|FG000|Overall Study|Missed Follow-Up Visits|18|||
48739426|NCT04218695|156895620|FG000|Overall Study|Adverse Event|1|||
48739427|NCT04218695|156895621|FG001|Overall Study|Adverse Event|0|||
48739428|NCT02899299|156895622|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
48739429|NCT02899299|156895623|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
48739430|NCT02899299|156895622|FG000|Pre-treatment|Participant withdrew consent|1|||
48739431|NCT02899299|156895623|FG001|Pre-treatment|Participant withdrew consent|11|||
48739432|NCT02899299|156895622|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
48739433|NCT02899299|156895623|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
48739434|NCT02899299|156895622|FG000|Pre-treatment|Not reported|0|||
48739435|NCT02899299|156895623|FG001|Pre-treatment|Not reported|1|||
48583866|NCT00985959|156330173|FG002|Overall Study|Progressive disease|8|||
48583867|NCT00985959|156330171|FG000|Overall Study|Unrecovered toxicity|0|||
48583868|NCT00985959|156330172|FG001|Overall Study|Unrecovered toxicity|0|||
48583869|NCT00985959|156330173|FG002|Overall Study|Unrecovered toxicity|7|||
48583870|NCT00985959|156330171|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
48583871|NCT00985959|156330172|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
48583872|NCT00985959|156330173|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
48583873|NCT00985959|156330171|FG000|Overall Study|Complete response observed over 2 cycles|0|||
48583874|NCT00985959|156330172|FG001|Overall Study|Complete response observed over 2 cycles|1|||
48583875|NCT00985959|156330173|FG002|Overall Study|Complete response observed over 2 cycles|4|||
48739436|NCT02899299|156895622|FG000|Treatment|Disease Progression|182|||
48739437|NCT02899299|156895623|FG001|Treatment|Disease Progression|43|||
48739438|NCT02899299|156895622|FG000|Treatment|Study Drug Toxicity|60|||
48739439|NCT02899299|156895623|FG001|Treatment|Study Drug Toxicity|24|||
48739440|NCT02899299|156895622|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
48739441|NCT02899299|156895623|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
48739442|NCT02899299|156895622|FG000|Treatment|Participant request to discontinue Study treatment|4|||
48739443|NCT02899299|156895623|FG001|Treatment|Participant request to discontinue Study treatment|10|||
48739444|NCT02899299|156895622|FG000|Treatment|Participant withdrew consent|6|||
48739445|NCT02899299|156895623|FG001|Treatment|Participant withdrew consent|3|||
48739446|NCT02899299|156895622|FG000|Treatment|Lost to Follow-up|0|||
48739447|NCT02899299|156895623|FG001|Treatment|Lost to Follow-up|2|||
48739448|NCT02899299|156895622|FG000|Treatment|Maximum Clinical Benefit|11|||
48739449|NCT02899299|156895623|FG001|Treatment|Maximum Clinical Benefit|2|||
48739450|NCT02899299|156895622|FG000|Treatment|Poor/Non-compliance|1|||
48739451|NCT02899299|156895623|FG001|Treatment|Poor/Non-compliance|0|||
48739452|NCT02899299|156895622|FG000|Treatment|Participant no longer meets Study criteria|4|||
48739453|NCT02899299|156895623|FG001|Treatment|Participant no longer meets Study criteria|0|||
48739454|NCT02899299|156895622|FG000|Treatment|Administrative reason by Sponsor|2|||
48739455|NCT02899299|156895623|FG001|Treatment|Administrative reason by Sponsor|0|||
48739456|NCT02899299|156895622|FG000|Treatment|Other reasons|12|||
48739457|NCT02899299|156895623|FG001|Treatment|Other reasons|2|||
48739458|NCT02899299|156895622|FG000|Treatment|Not reported|7|||
48622609|NCT02168439|156476563|FG000|Overall Study|Protocol Violation|0|||
48622610|NCT02168439|156476564|FG001|Overall Study|Protocol Violation|2|||
48622611|NCT02004275|156476565|FG000|Phase 1|Ineligible|0|||
48622612|NCT02004275|156476566|FG001|Phase 1|Ineligible|0|||
48739459|NCT02899299|156895623|FG001|Treatment|Not reported|0|||
48739460|NCT01392443|156895626|FG000|Overall Study|Disease progression|30|||
48739461|NCT01392443|156895626|FG000|Overall Study|Adverse Event|24|||
48739462|NCT01392443|156895626|FG000|Overall Study|Death|7|||
48739463|NCT01392443|156895626|FG000|Overall Study|Withdrawal by Subject|5|||
48739464|NCT01392443|156895626|FG000|Overall Study|Lost to Follow-up|1|||
48739465|NCT01392443|156895626|FG000|Overall Study|Protocol Violation|1|||
48739466|NCT00289133|156895629|FG000|Overall Study|Non-study device implanted|12|||
48739467|NCT00289133|156895630|FG001|Overall Study|Non-study device implanted|0|||
48739468|NCT00289133|156895629|FG000|Overall Study|Protocol Violation|32|||
48739469|NCT00289133|156895630|FG001|Overall Study|Protocol Violation|38|||
48739470|NCT00289133|156895629|FG000|Overall Study|Withdrawal by Subject|9|||
48739471|NCT00289133|156895630|FG001|Overall Study|Withdrawal by Subject|10|||
48739472|NCT00289133|156895629|FG000|Overall Study|Death|5|||
48739473|NCT00289133|156895630|FG001|Overall Study|Death|10|||
48739474|NCT00289133|156895629|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
48739475|NCT00289133|156895630|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
48739476|NCT00289133|156895629|FG000|Overall Study|Physician Decision|41|||
48739477|NCT00289133|156895630|FG001|Overall Study|Physician Decision|45|||
48583876|NCT00985959|156330171|FG000|Overall Study|Other|0|||
48583877|NCT00985959|156330172|FG001|Overall Study|Other|0|||
48583878|NCT00985959|156330173|FG002|Overall Study|Other|11|||
48583879|NCT02258542|156330176|FG000|Overall Study|eg. not made to the visit|7|||
48583880|NCT02258542|156330177|FG001|Overall Study|eg. not made to the visit|4|||
48583881|NCT02258542|156330178|FG002|Overall Study|eg. not made to the visit|0|||
48583882|NCT02258542|156330179|FG003|Overall Study|eg. not made to the visit|1|||
48583883|NCT02258542|156330176|FG000|Overall Study|study specific discount. criteria|1|||
48583884|NCT02258542|156330177|FG001|Overall Study|study specific discount. criteria|1|||
48583885|NCT02258542|156330178|FG002|Overall Study|study specific discount. criteria|0|||
48583886|NCT02258542|156330179|FG003|Overall Study|study specific discount. criteria|0|||
48583887|NCT02258542|156330176|FG000|Overall Study|Withdrawal by Subject|20|||
48583888|NCT02258542|156330177|FG001|Overall Study|Withdrawal by Subject|20|||
48583889|NCT02258542|156330178|FG002|Overall Study|Withdrawal by Subject|7|||
48583890|NCT02258542|156330179|FG003|Overall Study|Withdrawal by Subject|1|||
48583891|NCT02258542|156330176|FG000|Overall Study|Lost to Follow-up|5|||
48583892|NCT02258542|156330177|FG001|Overall Study|Lost to Follow-up|12|||
48583893|NCT02258542|156330178|FG002|Overall Study|Lost to Follow-up|1|||
48583894|NCT02258542|156330179|FG003|Overall Study|Lost to Follow-up|2|||
48583895|NCT02258542|156330176|FG000|Overall Study|Death|5|||
48622613|NCT02004275|156476567|FG002|Phase 1|Ineligible|0|||
48622614|NCT02004275|156476568|FG003|Phase 1|Ineligible|1|||
48622615|NCT02004275|156476569|FG004|Phase 1|Ineligible|1|||
48622616|NCT02004275|156476570|FG005|Phase 1|Ineligible|0|||
48622617|NCT02004275|156476565|FG000|Phase 1|Protocol Violation|0|||
48622618|NCT02004275|156476566|FG001|Phase 1|Protocol Violation|0|||
48622619|NCT02004275|156476567|FG002|Phase 1|Protocol Violation|0|||
48622620|NCT02004275|156476568|FG003|Phase 1|Protocol Violation|1|||
48622621|NCT02004275|156476569|FG004|Phase 1|Protocol Violation|0|||
48622622|NCT02004275|156476570|FG005|Phase 1|Protocol Violation|5|||
48622623|NCT02004275|156476565|FG000|Phase 2 Part 1|Ineligible|6|||
48622624|NCT02004275|156476566|FG001|Phase 2 Part 1|Ineligible|9|||
48622625|NCT02004275|156476567|FG002|Phase 2 Part 1|Ineligible|0|||
48622626|NCT02004275|156476568|FG003|Phase 2 Part 1|Ineligible|0|||
48622627|NCT02004275|156476569|FG004|Phase 2 Part 1|Ineligible|0|||
48622628|NCT02004275|156476570|FG005|Phase 2 Part 1|Ineligible|0|||
48622629|NCT02004275|156476565|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
48739478|NCT00289133|156895629|FG000|Overall Study|Revision|8|||
48739479|NCT00289133|156895630|FG001|Overall Study|Revision|6|||
48739480|NCT00289133|156895629|FG000|Overall Study|Lost to Follow-up|92|||
48739481|NCT00289133|156895630|FG001|Overall Study|Lost to Follow-up|115|||
48739482|NCT01364649|156895631|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
48739483|NCT01364649|156895632|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
48739484|NCT01364649|156895631|FG000|Overall Study|Lack of Efficacy|6|||
48739485|NCT01364649|156895632|FG001|Overall Study|Lack of Efficacy|0|||
48739486|NCT01364649|156895631|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
48739487|NCT01364649|156895632|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
48739488|NCT01364649|156895631|FG000|Overall Study|Protocol Deviations|4|||
48739489|NCT01364649|156895632|FG001|Overall Study|Protocol Deviations|8|||
48739490|NCT01364649|156895631|FG000|Overall Study|Withdrawal of Consent|9|||
48739491|NCT01364649|156895632|FG001|Overall Study|Withdrawal of Consent|7|||
48739492|NCT01364649|156895631|FG000|Overall Study|Lost to Follow-up|12|||
48739493|NCT01364649|156895632|FG001|Overall Study|Lost to Follow-up|13|||
48739494|NCT01364649|156895631|FG000|Overall Study|Other|4|||
48739495|NCT01364649|156895632|FG001|Overall Study|Other|1|||
48739496|NCT02097420|156895635|FG000|Overall Study|Death|6|||
48739497|NCT02097420|156895635|FG000|Overall Study|Valve explanted|13|||
48739498|NCT02097420|156895635|FG000|Overall Study|Other Reason|1|||
48739499|NCT04938492|156895639|FG000|Overall Study|Lost to Follow-up|17|||
48739500|NCT04938492|156895640|FG001|Overall Study|Lost to Follow-up|18|||
48739501|NCT01065597|156895647|FG000|Overall Study|Adverse Event|1|||
48739502|NCT01453361|156895648|FG000|Overall Study|Disease Progression|6|||
48739503|NCT01453361|156895648|FG000|Overall Study|Screen-Failures|10|||
48739504|NCT01708161|156895649|FG000|Overall Study|Adverse Event|1|||
48739505|NCT01708161|156895650|FG001|Overall Study|Adverse Event|3|||
48739506|NCT01708161|156895651|FG002|Overall Study|Adverse Event|4|||
48739507|NCT01708161|156895652|FG003|Overall Study|Adverse Event|2|||
48739508|NCT01708161|156895653|FG004|Overall Study|Adverse Event|3|||
48739509|NCT01708161|156895654|FG005|Overall Study|Adverse Event|0|||
48739510|NCT01708161|156895649|FG000|Overall Study|Death|0|||
48739511|NCT01708161|156895650|FG001|Overall Study|Death|0|||
48739512|NCT01708161|156895651|FG002|Overall Study|Death|0|||
48739513|NCT01708161|156895652|FG003|Overall Study|Death|1|||
48739514|NCT01708161|156895653|FG004|Overall Study|Death|0|||
48739515|NCT01708161|156895654|FG005|Overall Study|Death|1|||
48739516|NCT01708161|156895649|FG000|Overall Study|Withdrawal by Subject|0|||
48739517|NCT01708161|156895650|FG001|Overall Study|Withdrawal by Subject|1|||
48739518|NCT01708161|156895651|FG002|Overall Study|Withdrawal by Subject|1|||
48322416|NCT03656718|155379407|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48322417|NCT03656718|155379408|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48322418|NCT03656718|155379409|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48322419|NCT03656718|155379410|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48739519|NCT01708161|156895652|FG003|Overall Study|Withdrawal by Subject|0|||
48739520|NCT01708161|156895653|FG004|Overall Study|Withdrawal by Subject|0|||
48739521|NCT01708161|156895654|FG005|Overall Study|Withdrawal by Subject|0|||
48739522|NCT01708161|156895649|FG000|Overall Study|Administrative problems|0|||
48322420|NCT03656718|155379411|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48322421|NCT03656718|155379412|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
48583896|NCT02258542|156330177|FG001|Overall Study|Death|4|||
48583897|NCT02258542|156330178|FG002|Overall Study|Death|0|||
48583898|NCT02258542|156330179|FG003|Overall Study|Death|1|||
48583899|NCT02258542|156330176|FG000|Overall Study|Adverse Event|3|||
48583900|NCT02258542|156330177|FG001|Overall Study|Adverse Event|4|||
48583901|NCT02258542|156330178|FG002|Overall Study|Adverse Event|0|||
48583902|NCT02258542|156330179|FG003|Overall Study|Adverse Event|0|||
48583903|NCT02258542|156330176|FG000|Overall Study|Protocol Violation|1|||
48583904|NCT02258542|156330177|FG001|Overall Study|Protocol Violation|2|||
48583905|NCT02258542|156330178|FG002|Overall Study|Protocol Violation|0|||
48583906|NCT02258542|156330179|FG003|Overall Study|Protocol Violation|0|||
48583907|NCT02258542|156330176|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48583908|NCT02258542|156330177|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
48583909|NCT02258542|156330178|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
48583910|NCT02258542|156330179|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
48739523|NCT01708161|156895650|FG001|Overall Study|Administrative problems|1|||
48739524|NCT01708161|156895651|FG002|Overall Study|Administrative problems|0|||
48739525|NCT01708161|156895652|FG003|Overall Study|Administrative problems|0|||
48583911|NCT04007107|156330180|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
48583912|NCT04007107|156330181|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
48583913|NCT04007107|156330182|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
48583914|NCT04007107|156330183|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
48739526|NCT01708161|156895653|FG004|Overall Study|Administrative problems|0|||
48739527|NCT01708161|156895654|FG005|Overall Study|Administrative problems|0|||
48739528|NCT01708161|156895649|FG000|Overall Study|Disease progression|3|||
48739529|NCT01708161|156895650|FG001|Overall Study|Disease progression|5|||
48451084|NCT01947894|155839261|FG002|Overall Study|Adverse Event|0|||
48739530|NCT01708161|156895651|FG002|Overall Study|Disease progression|5|||
48739531|NCT01708161|156895652|FG003|Overall Study|Disease progression|13|||
48739532|NCT01708161|156895653|FG004|Overall Study|Disease progression|3|||
48583915|NCT00976209|156330186|FG000|Treatment Period 1|Protocol Violation|1|||
48583916|NCT00976209|156330187|FG001|Treatment Period 1|Protocol Violation|0|||
48583917|NCT00976209|156330186|FG000|Treatment Period 1|Lost to Follow-up|2|||
48583918|NCT00976209|156330187|FG001|Treatment Period 1|Lost to Follow-up|0|||
48583919|NCT00976209|156330186|FG000|Treatment Period 1|Other|0|||
48583920|NCT00976209|156330187|FG001|Treatment Period 1|Other|1|||
48583921|NCT00976209|156330186|FG000|Wash-out Period|Adverse Event|1|||
48583922|NCT00976209|156330187|FG001|Wash-out Period|Adverse Event|2|||
48583923|NCT00976209|156330186|FG000|Wash-out Period|Lost to Follow-up|1|||
48583924|NCT00976209|156330187|FG001|Wash-out Period|Lost to Follow-up|0|||
48583925|NCT00976209|156330186|FG000|Wash-out Period|Protocol Violation|1|||
48583926|NCT00976209|156330187|FG001|Wash-out Period|Protocol Violation|0|||
48583927|NCT00976209|156330186|FG000|Wash-out Period|Other|1|||
48583928|NCT00976209|156330187|FG001|Wash-out Period|Other|0|||
48583929|NCT00976209|156330186|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48583930|NCT00976209|156330187|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48583931|NCT00976209|156330186|FG000|Treatment Period 2|Lost to Follow-up|0|||
48583932|NCT00976209|156330187|FG001|Treatment Period 2|Lost to Follow-up|1|||
48583933|NCT02923245|156330188|FG000|Overall Study|ultrasound order was cancelled|2|||
48583934|NCT02923245|156330189|FG001|Overall Study|ultrasound order was cancelled|1|||
48583935|NCT03617861|156330190|FG000|Second Intervention (1 Day)|Adverse Event|0|||
48583936|NCT03617861|156330191|FG001|Second Intervention (1 Day)|Adverse Event|0|||
48583937|NCT03617861|156330192|FG002|Second Intervention (1 Day)|Adverse Event|1|||
48583938|NCT03617861|156330193|FG003|Second Intervention (1 Day)|Adverse Event|0|||
48583939|NCT00480493|156330194|FG000|Overall Study|moved|2|||
48583940|NCT00480493|156330195|FG001|Overall Study|moved|7|||
48583941|NCT04526574|156330200|FG000|Overall Study|Protocol Violation|3|||
48583942|NCT04526574|156330201|FG001|Overall Study|Protocol Violation|1|||
48583943|NCT04526574|156330200|FG000|Overall Study|Withdrawal by Subject|12|||
48583944|NCT04526574|156330201|FG001|Overall Study|Withdrawal by Subject|9|||
48583945|NCT04526574|156330200|FG000|Overall Study|Other|1|||
48583946|NCT04526574|156330201|FG001|Overall Study|Other|2|||
48583947|NCT04526574|156330200|FG000|Overall Study|Adverse Event|1|||
48583948|NCT04526574|156330201|FG001|Overall Study|Adverse Event|1|||
48583949|NCT04526574|156330200|FG000|Overall Study|Death|2|||
48583950|NCT04526574|156330201|FG001|Overall Study|Death|3|||
48583951|NCT04526574|156330200|FG000|Overall Study|Lost to Follow-up|9|||
48583952|NCT04526574|156330201|FG001|Overall Study|Lost to Follow-up|9|||
48583953|NCT04526574|156330200|FG000|Overall Study|No longer meets eligibility criteria|8|||
48583954|NCT04526574|156330201|FG001|Overall Study|No longer meets eligibility criteria|8|||
48583955|NCT04907227|156330202|FG000|Overall Study|Death|12|||
48583956|NCT04907227|156330203|FG001|Overall Study|Death|8|||
48583957|NCT04907227|156330202|FG000|Overall Study|Withdrawal by Subject|2|||
48583958|NCT04907227|156330203|FG001|Overall Study|Withdrawal by Subject|2|||
48583959|NCT04907227|156330202|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
48583960|NCT04907227|156330203|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
48583961|NCT04907227|156330202|FG000|Overall Study|Sponsor Decision|25|||
48583962|NCT04907227|156330203|FG001|Overall Study|Sponsor Decision|30|||
48583963|NCT04907227|156330202|FG000|Overall Study|Physician Decision|1|||
48583964|NCT04907227|156330203|FG001|Overall Study|Physician Decision|0|||
48583965|NCT03747302|156330204|FG000|Overall Study|Withdrawal by Subject|1|||
48583966|NCT03747302|156330205|FG001|Overall Study|Withdrawal by Subject|2|||
48583967|NCT04027075|156330208|FG000|Overall Study|Lost to Follow-up|41|||
48583968|NCT04027075|156330209|FG001|Overall Study|Lost to Follow-up|22|||
48583969|NCT01032070|156330210|FG000|Overall Study|Disease progression|13|||
48583970|NCT01032070|156330211|FG001|Overall Study|Disease progression|8|||
48583971|NCT01032070|156330210|FG000|Overall Study|Medical or ethical reasons|0|||
48583972|NCT01032070|156330211|FG001|Overall Study|Medical or ethical reasons|2|||
48583973|NCT01032070|156330210|FG000|Overall Study|Withdrawal by Subject|0|||
48583974|NCT01032070|156330211|FG001|Overall Study|Withdrawal by Subject|2|||
48583975|NCT03769675|156330212|FG000|Overall Study|Lost to Follow-up|1|||
48583976|NCT01378975|156330213|FG000|Overall Study|Death|77|||
48583977|NCT01378975|156330214|FG001|Overall Study|Death|46|||
48583978|NCT01378975|156330213|FG000|Overall Study|Investigator Request|1|||
48583979|NCT01378975|156330214|FG001|Overall Study|Investigator Request|0|||
48583980|NCT01378975|156330213|FG000|Overall Study|Lost to Follow-up|4|||
48583981|NCT01378975|156330214|FG001|Overall Study|Lost to Follow-up|1|||
48739533|NCT01708161|156895654|FG005|Overall Study|Disease progression|0|||
48739534|NCT01058655|156895655|FG000|Overall Study|Withdrawal by Subject|1|||
48739535|NCT01058655|156895656|FG001|Overall Study|Withdrawal by Subject|0|||
48583982|NCT01378975|156330213|FG000|Overall Study|Withdrew Consent|4|||
48583983|NCT01378975|156330214|FG001|Overall Study|Withdrew Consent|3|||
48583984|NCT01702532|156330219|FG000|Overall Study|Adverse Event|0|||
48583985|NCT01702532|156330220|FG001|Overall Study|Adverse Event|1|||
48583986|NCT02844907|156330226|FG000|With Dexamethasone|No IV access|1|||
48739536|NCT01058655|156895657|FG002|Overall Study|Withdrawal by Subject|3|||
48583987|NCT04068688|156330227|FG000|Overall Study|Lost to Follow-up|1|||
48583988|NCT04068688|156330228|FG001|Overall Study|Lost to Follow-up|1|||
48583989|NCT04068688|156330229|FG002|Overall Study|Lost to Follow-up|0|||
48583990|NCT04068688|156330230|FG003|Overall Study|Lost to Follow-up|0|||
48583991|NCT04068688|156330231|FG004|Overall Study|Lost to Follow-up|5|||
48583992|NCT04068688|156330232|FG005|Overall Study|Lost to Follow-up|5|||
48583993|NCT04068688|156330233|FG006|Overall Study|Lost to Follow-up|0|||
48583994|NCT04068688|156330234|FG007|Overall Study|Lost to Follow-up|0|||
48583995|NCT04068688|156330235|FG008|Overall Study|Lost to Follow-up|1|||
48583996|NCT04068688|156330236|FG009|Overall Study|Lost to Follow-up|0|||
48583997|NCT04068688|156330227|FG000|Overall Study|Withdrawal by Subject|1|||
48583998|NCT04068688|156330228|FG001|Overall Study|Withdrawal by Subject|1|||
48583999|NCT04068688|156330229|FG002|Overall Study|Withdrawal by Subject|0|||
48584000|NCT04068688|156330230|FG003|Overall Study|Withdrawal by Subject|0|||
48584001|NCT04068688|156330231|FG004|Overall Study|Withdrawal by Subject|0|||
48584002|NCT04068688|156330232|FG005|Overall Study|Withdrawal by Subject|0|||
48584003|NCT04068688|156330233|FG006|Overall Study|Withdrawal by Subject|0|||
48584004|NCT04068688|156330234|FG007|Overall Study|Withdrawal by Subject|0|||
48584005|NCT04068688|156330235|FG008|Overall Study|Withdrawal by Subject|0|||
48584006|NCT04068688|156330236|FG009|Overall Study|Withdrawal by Subject|0|||
48584007|NCT04068688|156330227|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
48584008|NCT04068688|156330228|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
48584009|NCT04068688|156330229|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
48584010|NCT04068688|156330230|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
48584011|NCT04068688|156330231|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
48584012|NCT04068688|156330232|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
48584013|NCT04068688|156330233|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
48584014|NCT04068688|156330234|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
48584015|NCT04068688|156330235|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
48584016|NCT04068688|156330236|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
48584017|NCT00551161|156330237|FG000|Overall Study|Withdrawal by Subject|1|||
48584018|NCT04679051|156330238|FG000|Overall Study|felt tired after restricted time in bed|3|||
48584019|NCT04679051|156330239|FG001|Overall Study|felt tired after restricted time in bed|0|||
48584020|NCT04679051|156330238|FG000|Overall Study|discomfort with blood pressure cuff|2|||
48584021|NCT04679051|156330239|FG001|Overall Study|discomfort with blood pressure cuff|0|||
48584022|NCT04679051|156330238|FG000|Overall Study|scheduling conflict|1|||
48584023|NCT04679051|156330239|FG001|Overall Study|scheduling conflict|1|||
48584024|NCT04679051|156330238|FG000|Overall Study|Protocol Violation|0|||
48584025|NCT04679051|156330239|FG001|Overall Study|Protocol Violation|4|||
48584026|NCT00426660|156330241|FG000|Overall Study|Death|14|||
48584027|NCT00426660|156330241|FG000|Overall Study|Adverse Event|23|||
48584028|NCT00426660|156330241|FG000|Overall Study|Insufficient Clinical Response|22|||
48584029|NCT00426660|156330241|FG000|Overall Study|Lost to Follow-up|15|||
48584030|NCT00426660|156330241|FG000|Overall Study|Other|23|||
48584031|NCT00426660|156330241|FG000|Overall Study|Withdrawal by Subject|18|||
48584032|NCT00426660|156330241|FG000|Overall Study|Protocol Violation|1|||
48739537|NCT01058655|156895658|FG003|Overall Study|Withdrawal by Subject|4|||
48739538|NCT01058655|156895655|FG000|Overall Study|Prolonged Treatment Delay|0|||
48584033|NCT00426660|156330241|FG000|Overall Study|Enrolled Not Treated|15|||
48584034|NCT02772276|156330242|FG000|Overall Study|Lost to Follow-up|0|||
48584035|NCT02772276|156330243|FG001|Overall Study|Lost to Follow-up|0|||
48584036|NCT02772276|156330244|FG002|Overall Study|Lost to Follow-up|0|||
48584037|NCT02772276|156330245|FG003|Overall Study|Lost to Follow-up|0|||
48584038|NCT02772276|156330246|FG004|Overall Study|Lost to Follow-up|0|||
48584039|NCT02772276|156330247|FG005|Overall Study|Lost to Follow-up|0|||
48584040|NCT02772276|156330248|FG006|Overall Study|Lost to Follow-up|1|||
48584041|NCT02772276|156330249|FG007|Overall Study|Lost to Follow-up|0|||
48584042|NCT02772276|156330250|FG008|Overall Study|Lost to Follow-up|0|||
48584043|NCT02772276|156330251|FG009|Overall Study|Lost to Follow-up|0|||
48584044|NCT02772276|156330252|FG010|Overall Study|Lost to Follow-up|0|||
48584045|NCT02772276|156330253|FG011|Overall Study|Lost to Follow-up|0|||
48584046|NCT02772276|156330254|FG012|Overall Study|Lost to Follow-up|0|||
48584047|NCT02772276|156330242|FG000|Overall Study|Withdrew consent|0|||
48739539|NCT01058655|156895656|FG001|Overall Study|Prolonged Treatment Delay|0|||
48739540|NCT01058655|156895657|FG002|Overall Study|Prolonged Treatment Delay|0|||
48584048|NCT02772276|156330243|FG001|Overall Study|Withdrew consent|0|||
48584049|NCT02772276|156330244|FG002|Overall Study|Withdrew consent|0|||
48584050|NCT02772276|156330245|FG003|Overall Study|Withdrew consent|0|||
48584051|NCT02772276|156330246|FG004|Overall Study|Withdrew consent|0|||
48584052|NCT02772276|156330247|FG005|Overall Study|Withdrew consent|0|||
48584053|NCT02772276|156330248|FG006|Overall Study|Withdrew consent|0|||
48739541|NCT01058655|156895658|FG003|Overall Study|Prolonged Treatment Delay|2|||
48739542|NCT01058655|156895655|FG000|Overall Study|Symptomatic Deterioration|0|||
48739543|NCT01058655|156895656|FG001|Overall Study|Symptomatic Deterioration|0|||
48739544|NCT01058655|156895657|FG002|Overall Study|Symptomatic Deterioration|0|||
48739545|NCT01058655|156895658|FG003|Overall Study|Symptomatic Deterioration|1|||
48739546|NCT01058655|156895655|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
48739547|NCT01058655|156895656|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
48739548|NCT01058655|156895657|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
48739549|NCT01058655|156895658|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
48739550|NCT01058655|156895655|FG000|Overall Study|Death|0|||
48739551|NCT01058655|156895656|FG001|Overall Study|Death|1|||
48739552|NCT01058655|156895657|FG002|Overall Study|Death|1|||
48584054|NCT02772276|156330249|FG007|Overall Study|Withdrew consent|1|||
48584055|NCT02772276|156330250|FG008|Overall Study|Withdrew consent|0|||
48584056|NCT02772276|156330251|FG009|Overall Study|Withdrew consent|0|||
48584057|NCT02772276|156330252|FG010|Overall Study|Withdrew consent|0|||
48584058|NCT02772276|156330253|FG011|Overall Study|Withdrew consent|0|||
48584059|NCT02772276|156330254|FG012|Overall Study|Withdrew consent|0|||
48584060|NCT00738062|156330255|FG000|Open Label Treatment|Lack of Efficacy|5|||
48584061|NCT00738062|156330256|FG001|Open Label Treatment|Lack of Efficacy|0|||
48584062|NCT00738062|156330257|FG002|Open Label Treatment|Lack of Efficacy|0|||
48584063|NCT00738062|156330255|FG000|Open Label Treatment|Adverse Event|11|||
48584064|NCT00738062|156330256|FG001|Open Label Treatment|Adverse Event|0|||
48584065|NCT00738062|156330257|FG002|Open Label Treatment|Adverse Event|0|||
48739553|NCT01058655|156895658|FG003|Overall Study|Death|0|||
48739554|NCT01058655|156895655|FG000|Overall Study|Disease Progression|1|||
48584066|NCT00738062|156330255|FG000|Open Label Treatment|Protocol Violation|2|||
48584067|NCT00738062|156330256|FG001|Open Label Treatment|Protocol Violation|0|||
48584068|NCT00738062|156330257|FG002|Open Label Treatment|Protocol Violation|0|||
48739555|NCT01058655|156895656|FG001|Overall Study|Disease Progression|2|||
48739556|NCT01058655|156895657|FG002|Overall Study|Disease Progression|4|||
48739557|NCT01058655|156895658|FG003|Overall Study|Disease Progression|24|||
48739558|NCT01058655|156895655|FG000|Overall Study|Other|0|||
48739559|NCT01058655|156895656|FG001|Overall Study|Other|0|||
48322422|NCT03656718|155379413|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
48322423|NCT03656718|155379407|FG000|Treatment Period Part C|Disease progression|0|||
48322424|NCT03656718|155379408|FG001|Treatment Period Part C|Disease progression|0|||
48584069|NCT00738062|156330255|FG000|Open Label Treatment|Withdrawal by Subject|9|||
48584070|NCT00738062|156330256|FG001|Open Label Treatment|Withdrawal by Subject|0|||
48584071|NCT00738062|156330257|FG002|Open Label Treatment|Withdrawal by Subject|0|||
48584072|NCT00738062|156330255|FG000|Open Label Treatment|Investigator Decision|1|||
48584073|NCT00738062|156330256|FG001|Open Label Treatment|Investigator Decision|0|||
48584074|NCT00738062|156330257|FG002|Open Label Treatment|Investigator Decision|0|||
48584075|NCT00738062|156330255|FG000|Open-Label Extension|Adverse Event|5|||
48584076|NCT00738062|156330256|FG001|Open-Label Extension|Adverse Event|0|||
48584077|NCT00738062|156330257|FG002|Open-Label Extension|Adverse Event|0|||
48584078|NCT00738062|156330255|FG000|Open-Label Extension|Physician Decision|1|||
48584079|NCT00738062|156330256|FG001|Open-Label Extension|Physician Decision|0|||
48584080|NCT00738062|156330257|FG002|Open-Label Extension|Physician Decision|0|||
48584081|NCT00738062|156330255|FG000|Open-Label Extension|Lack of Efficacy|2|||
48584082|NCT00738062|156330256|FG001|Open-Label Extension|Lack of Efficacy|0|||
48584083|NCT00738062|156330257|FG002|Open-Label Extension|Lack of Efficacy|0|||
48584084|NCT00738062|156330255|FG000|Open-Label Extension|Withdrawal by Subject|6|||
48584085|NCT00738062|156330256|FG001|Open-Label Extension|Withdrawal by Subject|0|||
48584086|NCT00738062|156330257|FG002|Open-Label Extension|Withdrawal by Subject|0|||
48584087|NCT00738062|156330255|FG000|Open-Label Extension|Protocol Violation|1|||
48584088|NCT00738062|156330256|FG001|Open-Label Extension|Protocol Violation|0|||
48584089|NCT00738062|156330257|FG002|Open-Label Extension|Protocol Violation|0|||
48584090|NCT00738062|156330255|FG000|Open-Label Extension|Study Terminated|2|||
48584091|NCT00738062|156330256|FG001|Open-Label Extension|Study Terminated|0|||
48584092|NCT00738062|156330257|FG002|Open-Label Extension|Study Terminated|0|||
48584093|NCT02858180|156330258|FG000|Overall Study|Lost to Follow-up|0|||
48584094|NCT02858180|156330259|FG001|Overall Study|Lost to Follow-up|2|||
48584095|NCT00550862|156330260|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
48584096|NCT00550862|156330261|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
48584097|NCT00550862|156330262|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
48584098|NCT00550862|156330263|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
48584099|NCT00550862|156330264|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
48584100|NCT00550862|156330260|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
48584101|NCT00550862|156330261|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
48584102|NCT00550862|156330262|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
48584103|NCT00550862|156330263|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
48584104|NCT00550862|156330264|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
48584105|NCT00550862|156330260|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
48584106|NCT00550862|156330261|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
48584107|NCT00550862|156330262|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
48584108|NCT00550862|156330263|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
48584109|NCT00550862|156330264|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
48584110|NCT00550862|156330260|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
48584111|NCT00550862|156330261|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
48584112|NCT00550862|156330262|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
48584113|NCT00550862|156330263|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
48584114|NCT00550862|156330264|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
48584115|NCT00550862|156330260|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
48584116|NCT00550862|156330261|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
48584117|NCT00550862|156330262|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
48584118|NCT00550862|156330263|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
48584119|NCT00550862|156330264|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
48739560|NCT01058655|156895657|FG002|Overall Study|Other|0|||
48739561|NCT01058655|156895658|FG003|Overall Study|Other|4|||
48739562|NCT03212690|156895659|FG000|Overall Study|Protocol Violation|1|||
48322425|NCT03656718|155379409|FG002|Treatment Period Part C|Disease progression|0|||
48451165|NCT01041404|155839300|FG000|Overall Study|Other|11|||
48739563|NCT01313312|156895660|FG000|Overall Study|Adverse Event|5|||
48739564|NCT01313312|156895660|FG000|Overall Study|Withdrawal by Subject|18|||
48739565|NCT01313312|156895660|FG000|Overall Study|Lack of Efficacy|3|||
48739566|NCT01313312|156895660|FG000|Overall Study|Investigator Decision|1|||
48739567|NCT01313312|156895660|FG000|Overall Study|Observational Phase|1|||
48739568|NCT01313312|156895660|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
48739569|NCT01313312|156895660|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
48739570|NCT00932126|156895666|FG000|Overall Study|Adverse Event|0|||
48739571|NCT00932126|156895667|FG001|Overall Study|Adverse Event|0|||
48739572|NCT00932126|156895668|FG002|Overall Study|Adverse Event|0|||
48739573|NCT00932126|156895669|FG003|Overall Study|Adverse Event|0|||
48739574|NCT00932126|156895670|FG004|Overall Study|Adverse Event|0|||
48739575|NCT00932126|156895671|FG005|Overall Study|Adverse Event|0|||
48739576|NCT00932126|156895672|FG006|Overall Study|Adverse Event|1|||
48584120|NCT00550862|156330260|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
48584121|NCT00550862|156330261|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
48584122|NCT00550862|156330262|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
48584123|NCT00550862|156330263|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
48584124|NCT00550862|156330264|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
48584125|NCT00550862|156330260|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
48584126|NCT00550862|156330261|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
48584127|NCT00550862|156330262|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
48584128|NCT00550862|156330263|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
48584129|NCT00550862|156330264|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
48584130|NCT00550862|156330260|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
48584131|NCT00550862|156330261|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
48584132|NCT00550862|156330262|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
48584133|NCT00550862|156330263|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
48584134|NCT00550862|156330264|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
48584135|NCT00550862|156330260|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
48584136|NCT00550862|156330261|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
48584137|NCT00550862|156330262|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
48584138|NCT00550862|156330263|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
48584139|NCT00550862|156330264|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
48584140|NCT00550862|156330260|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
48584141|NCT00550862|156330261|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
48584142|NCT00550862|156330262|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
48584143|NCT00550862|156330263|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
48584144|NCT00550862|156330264|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
48584145|NCT00574249|156330265|FG000|Overall Study|Adverse Event|6|||
48739577|NCT00932126|156895673|FG007|Overall Study|Adverse Event|2|||
48739578|NCT00932126|156895666|FG000|Overall Study|Protocol Violation|0|||
48739579|NCT00932126|156895667|FG001|Overall Study|Protocol Violation|0|||
48739580|NCT00932126|156895668|FG002|Overall Study|Protocol Violation|0|||
48739581|NCT00932126|156895669|FG003|Overall Study|Protocol Violation|0|||
48739582|NCT00932126|156895670|FG004|Overall Study|Protocol Violation|1|||
48739583|NCT00932126|156895671|FG005|Overall Study|Protocol Violation|0|||
48584146|NCT00574249|156330266|FG001|Overall Study|Adverse Event|18|||
48584147|NCT00574249|156330265|FG000|Overall Study|Lack of Efficacy|5|||
48584148|NCT00574249|156330266|FG001|Overall Study|Lack of Efficacy|3|||
48584149|NCT00574249|156330265|FG000|Overall Study|Lost to Follow-up|4|||
48584150|NCT00574249|156330266|FG001|Overall Study|Lost to Follow-up|3|||
48584151|NCT00574249|156330265|FG000|Overall Study|Protocol Violation|5|||
48322426|NCT03656718|155379410|FG003|Treatment Period Part C|Disease progression|0|||
48584152|NCT00574249|156330266|FG001|Overall Study|Protocol Violation|2|||
48584153|NCT00574249|156330265|FG000|Overall Study|History of carcinoma|1|||
48584154|NCT00574249|156330266|FG001|Overall Study|History of carcinoma|0|||
48584155|NCT00574249|156330265|FG000|Overall Study|Withdrawal by Subject|3|||
48584156|NCT00574249|156330266|FG001|Overall Study|Withdrawal by Subject|0|||
48584157|NCT00574249|156330265|FG000|Overall Study|Physician Decision|1|||
48584158|NCT00574249|156330266|FG001|Overall Study|Physician Decision|0|||
48584159|NCT00574249|156330265|FG000|Overall Study|Pregnancy|1|||
48584160|NCT00574249|156330266|FG001|Overall Study|Pregnancy|0|||
48584161|NCT00574249|156330265|FG000|Overall Study|Excluded by company|0|||
48584162|NCT00574249|156330266|FG001|Overall Study|Excluded by company|1|||
48584163|NCT00574249|156330265|FG000|Overall Study|PPD test taken twice|0|||
48584164|NCT00574249|156330266|FG001|Overall Study|PPD test taken twice|1|||
48584165|NCT03197870|156330272|FG000|Overall Study|Adverse Event|9|||
48584166|NCT03197870|156330273|FG001|Overall Study|Adverse Event|4|||
48584167|NCT03197870|156330274|FG002|Overall Study|Adverse Event|6|||
48584168|NCT03197870|156330272|FG000|Overall Study|Withdrawal by Subject|2|||
48584169|NCT03197870|156330273|FG001|Overall Study|Withdrawal by Subject|3|||
48584170|NCT03197870|156330274|FG002|Overall Study|Withdrawal by Subject|0|||
48584171|NCT03197870|156330272|FG000|Overall Study|Lost to Follow-up|2|||
48584172|NCT03197870|156330273|FG001|Overall Study|Lost to Follow-up|2|||
48584173|NCT03197870|156330274|FG002|Overall Study|Lost to Follow-up|0|||
48584174|NCT03197870|156330272|FG000|Overall Study|data not available|1|||
48584175|NCT03197870|156330273|FG001|Overall Study|data not available|1|||
48584176|NCT03197870|156330274|FG002|Overall Study|data not available|0|||
48584177|NCT02554318|156330275|FG000|Overall Study|Withdrawal by Subject|10|||
48584178|NCT02554318|156330276|FG001|Overall Study|Withdrawal by Subject|8|||
48584179|NCT02248974|156330277|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
48584180|NCT02248974|156330278|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
48584181|NCT02248974|156330277|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
48584182|NCT02248974|156330278|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
48584183|NCT02248974|156330277|FG000|1-Day Follow-Up|Enrolled in another study|1|||
48584184|NCT02248974|156330278|FG001|1-Day Follow-Up|Enrolled in another study|0|||
48622630|NCT02004275|156476566|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
48584185|NCT02248974|156330277|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
48584186|NCT02248974|156330278|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
48584187|NCT02248974|156330277|FG000|1-Week Follow-Up|Enrolled in another study|1|||
48584188|NCT02248974|156330278|FG001|1-Week Follow-Up|Enrolled in another study|1|||
48584189|NCT02248974|156330277|FG000|1-Week Follow-Up|Transferred to another facility|1|||
48584190|NCT02248974|156330278|FG001|1-Week Follow-Up|Transferred to another facility|0|||
48584191|NCT02248974|156330277|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
48584192|NCT02248974|156330278|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
48584193|NCT02248974|156330277|FG000|1-Week Follow-Up|Death|1|||
48322427|NCT03656718|155379411|FG004|Treatment Period Part C|Disease progression|12|||
48322428|NCT03656718|155379412|FG005|Treatment Period Part C|Disease progression|0|||
48322429|NCT03656718|155379413|FG006|Treatment Period Part C|Disease progression|0|||
48322430|NCT03656718|155379407|FG000|Treatment Period Part C|Death|0|||
48322431|NCT03656718|155379408|FG001|Treatment Period Part C|Death|0|||
48322432|NCT03656718|155379409|FG002|Treatment Period Part C|Death|0|||
48322433|NCT03656718|155379410|FG003|Treatment Period Part C|Death|0|||
48322434|NCT03656718|155379411|FG004|Treatment Period Part C|Death|1|||
48322435|NCT03656718|155379412|FG005|Treatment Period Part C|Death|0|||
48322436|NCT03656718|155379413|FG006|Treatment Period Part C|Death|0|||
48322437|NCT03656718|155379407|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48322438|NCT03656718|155379408|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48322439|NCT03656718|155379409|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48322440|NCT03656718|155379410|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48322441|NCT03656718|155379411|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
48322442|NCT03656718|155379412|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48322443|NCT03656718|155379413|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
48322444|NCT03656718|155379407|FG000|Treatment Period Part C|Other reasons|0|||
48322445|NCT03656718|155379408|FG001|Treatment Period Part C|Other reasons|0|||
48322446|NCT03656718|155379409|FG002|Treatment Period Part C|Other reasons|0|||
48322447|NCT03656718|155379410|FG003|Treatment Period Part C|Other reasons|0|||
48322448|NCT03656718|155379411|FG004|Treatment Period Part C|Other reasons|1|||
48584194|NCT02248974|156330278|FG001|1-Week Follow-Up|Death|1|||
48584195|NCT02248974|156330277|FG000|1-Week Follow-Up|Excluded because of age|0|||
48322449|NCT03656718|155379412|FG005|Treatment Period Part C|Other reasons|0|||
48322450|NCT03656718|155379413|FG006|Treatment Period Part C|Other reasons|0|||
48322451|NCT03656718|155379407|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
48322452|NCT03656718|155379408|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
48322453|NCT03656718|155379409|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
48322454|NCT03656718|155379410|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
48322455|NCT03656718|155379411|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
48322456|NCT03656718|155379412|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
48322457|NCT03656718|155379413|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
48322458|NCT04770532|155379415|FG000|Overall Study|Withdrawal by Subject|0|||
48322459|NCT04770532|155379416|FG001|Overall Study|Withdrawal by Subject|3|||
48322460|NCT04770532|155379415|FG000|Overall Study|Physician Decision|1|||
48322461|NCT04770532|155379416|FG001|Overall Study|Physician Decision|0|||
48322462|NCT04770532|155379415|FG000|Overall Study|Death|2|||
48322463|NCT04770532|155379416|FG001|Overall Study|Death|2|||
48322464|NCT04623671|155379418|FG000|Overall Study|Adverse Event|0|||
48322465|NCT04623671|155379419|FG001|Overall Study|Adverse Event|1|||
48322466|NCT04623671|155379418|FG000|Overall Study|Lost to Follow-up|2|||
48322467|NCT04623671|155379419|FG001|Overall Study|Lost to Follow-up|1|||
48322468|NCT04623671|155379418|FG000|Overall Study|Death|5|||
48322469|NCT04623671|155379419|FG001|Overall Study|Death|5|||
48322470|NCT02519348|155379420|FG000|Overall Study|Death|31|||
48322471|NCT02519348|155379421|FG001|Overall Study|Death|74|||
48322472|NCT02519348|155379422|FG002|Overall Study|Death|47|||
48322473|NCT02519348|155379423|FG003|Overall Study|Death|54|||
48322474|NCT02519348|155379424|FG004|Overall Study|Death|63|||
48322475|NCT02519348|155379425|FG005|Overall Study|Death|18|||
48322476|NCT02519348|155379426|FG006|Overall Study|Death|2|||
48322477|NCT02519348|155379427|FG007|Overall Study|Death|5|||
48584196|NCT02248974|156330278|FG001|1-Week Follow-Up|Excluded because of age|1|||
48322478|NCT02519348|155379428|FG008|Overall Study|Death|5|||
48322479|NCT02519348|155379420|FG000|Overall Study|Withdrawal by Subject|4|||
48322480|NCT02519348|155379421|FG001|Overall Study|Withdrawal by Subject|7|||
48322481|NCT02519348|155379422|FG002|Overall Study|Withdrawal by Subject|4|||
48322482|NCT02519348|155379423|FG003|Overall Study|Withdrawal by Subject|3|||
48322483|NCT02519348|155379424|FG004|Overall Study|Withdrawal by Subject|3|||
48322484|NCT02519348|155379425|FG005|Overall Study|Withdrawal by Subject|2|||
48322485|NCT02519348|155379426|FG006|Overall Study|Withdrawal by Subject|0|||
48322486|NCT02519348|155379427|FG007|Overall Study|Withdrawal by Subject|0|||
48322487|NCT02519348|155379428|FG008|Overall Study|Withdrawal by Subject|1|||
48322488|NCT02519348|155379420|FG000|Overall Study|Lost to Follow-up|0|||
48322489|NCT02519348|155379421|FG001|Overall Study|Lost to Follow-up|0|||
48322490|NCT02519348|155379422|FG002|Overall Study|Lost to Follow-up|1|||
48322491|NCT02519348|155379423|FG003|Overall Study|Lost to Follow-up|0|||
48322492|NCT02519348|155379424|FG004|Overall Study|Lost to Follow-up|2|||
48322493|NCT02519348|155379425|FG005|Overall Study|Lost to Follow-up|1|||
48322494|NCT02519348|155379426|FG006|Overall Study|Lost to Follow-up|1|||
48322495|NCT02519348|155379427|FG007|Overall Study|Lost to Follow-up|0|||
48322496|NCT02519348|155379428|FG008|Overall Study|Lost to Follow-up|0|||
48322497|NCT02519348|155379420|FG000|Overall Study|Other|0|||
48322498|NCT02519348|155379421|FG001|Overall Study|Other|3|||
48322499|NCT02519348|155379422|FG002|Overall Study|Other|0|||
48322500|NCT02519348|155379423|FG003|Overall Study|Other|0|||
48322501|NCT02519348|155379424|FG004|Overall Study|Other|1|||
48322502|NCT02519348|155379425|FG005|Overall Study|Other|0|||
48322503|NCT02519348|155379426|FG006|Overall Study|Other|0|||
48584197|NCT02248974|156330277|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
48584198|NCT02248974|156330278|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
48584199|NCT02248974|156330277|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
48584200|NCT02248974|156330278|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
48584201|NCT02248974|156330277|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
48584202|NCT02248974|156330278|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
48584203|NCT02248974|156330277|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
48584204|NCT02248974|156330278|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
48584205|NCT02248974|156330277|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
48584206|NCT02248974|156330278|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
48584207|NCT01904903|156330281|FG000|Overall Study|Withdrawal by Subject|1|||
48584208|NCT02117713|156330297|FG000|Week 48|Adverse Event|4|||
48584209|NCT02117713|156330297|FG000|Week 48|Withdrawal by caregiver|2|||
48584210|NCT02117713|156330297|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
48584211|NCT02117713|156330297|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
48584212|NCT02117713|156330297|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
48584213|NCT02117713|156330297|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
48584214|NCT03802565|156330298|FG000|Overall Study|Adverse Event|0|||
48584215|NCT03802565|156330299|FG001|Overall Study|Adverse Event|1|||
48584216|NCT03802565|156330300|FG002|Overall Study|Adverse Event|2|||
48584217|NCT03802565|156330301|FG003|Overall Study|Adverse Event|1|||
48584218|NCT03802565|156330302|FG004|Overall Study|Adverse Event|1|||
48584219|NCT03802565|156330298|FG000|Overall Study|Withdrawal by Subject|2|||
48584220|NCT03802565|156330299|FG001|Overall Study|Withdrawal by Subject|2|||
48584221|NCT03802565|156330300|FG002|Overall Study|Withdrawal by Subject|2|||
48584222|NCT03802565|156330301|FG003|Overall Study|Withdrawal by Subject|0|||
48584223|NCT03802565|156330302|FG004|Overall Study|Withdrawal by Subject|1|||
48584224|NCT03802565|156330298|FG000|Overall Study|Protocol Violation|2|||
48584225|NCT03802565|156330299|FG001|Overall Study|Protocol Violation|1|||
48322504|NCT02519348|155379427|FG007|Overall Study|Other|0|||
48322505|NCT02519348|155379428|FG008|Overall Study|Other|0|||
48584226|NCT03802565|156330300|FG002|Overall Study|Protocol Violation|4|||
48584227|NCT03802565|156330301|FG003|Overall Study|Protocol Violation|5|||
48584228|NCT03802565|156330302|FG004|Overall Study|Protocol Violation|1|||
48584229|NCT03802565|156330298|FG000|Overall Study|Lost to Follow-up|0|||
48584230|NCT03802565|156330299|FG001|Overall Study|Lost to Follow-up|0|||
48584231|NCT03802565|156330300|FG002|Overall Study|Lost to Follow-up|1|||
48584232|NCT03802565|156330301|FG003|Overall Study|Lost to Follow-up|0|||
48322506|NCT02519348|155379420|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
48322507|NCT02519348|155379421|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
48322508|NCT02519348|155379422|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
48322509|NCT02519348|155379423|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
48584233|NCT03802565|156330302|FG004|Overall Study|Lost to Follow-up|0|||
48584234|NCT03802565|156330298|FG000|Overall Study|Subjects Related to Each Other|1|||
48322510|NCT02519348|155379424|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
48322511|NCT02519348|155379425|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
48322512|NCT02519348|155379426|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
48322513|NCT02519348|155379427|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
48322514|NCT02519348|155379428|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
48322515|NCT00588770|155379429|FG000|Overall Study|Disease progression|85|||
48322516|NCT00588770|155379430|FG001|Overall Study|Disease progression|68|||
48322517|NCT00588770|155379429|FG000|Overall Study|Adverse Event|29|||
48322518|NCT00588770|155379430|FG001|Overall Study|Adverse Event|58|||
48322519|NCT00588770|155379429|FG000|Overall Study|Death|13|||
48322520|NCT00588770|155379430|FG001|Overall Study|Death|22|||
48322521|NCT00588770|155379429|FG000|Overall Study|Withdrawal by Subject|15|||
48322522|NCT00588770|155379430|FG001|Overall Study|Withdrawal by Subject|25|||
48322523|NCT00588770|155379429|FG000|Overall Study|Alternative therapy|2|||
48322524|NCT00588770|155379430|FG001|Overall Study|Alternative therapy|4|||
48322525|NCT00588770|155379429|FG000|Overall Study|Other complicating disease|3|||
48322526|NCT00588770|155379430|FG001|Overall Study|Other complicating disease|2|||
48322527|NCT00588770|155379429|FG000|Overall Study|Not start protocol therapy|0|||
48322528|NCT00588770|155379430|FG001|Overall Study|Not start protocol therapy|9|||
48322529|NCT00588770|155379429|FG000|Overall Study|Lack of Efficacy|8|||
48322530|NCT00588770|155379430|FG001|Overall Study|Lack of Efficacy|10|||
48322531|NCT00588770|155379429|FG000|Overall Study|Physician discretion|2|||
48322532|NCT00588770|155379430|FG001|Overall Study|Physician discretion|0|||
48322533|NCT00588770|155379429|FG000|Overall Study|Patient non-compliance|2|||
48322534|NCT00588770|155379430|FG001|Overall Study|Patient non-compliance|2|||
48322535|NCT03569891|155379431|FG000|Lead-in|Ineligible during lead-in|8|||
48322536|NCT03569891|155379431|FG000|Lead-in|Withdrawal by Subject|3|||
48322537|NCT03569891|155379431|FG000|Lead-in|Risks related to COVID-19|2|||
48322538|NCT03569891|155379431|FG000|AMT-061|Adverse Event|1|||
48322539|NCT04882241|155379432|FG000|Overall Study|Ongoing in study|46|||
48322540|NCT04882241|155379433|FG001|Overall Study|Ongoing in study|48|||
48322541|NCT04882241|155379434|FG002|Overall Study|Ongoing in study|0|||
48322542|NCT04882241|155379435|FG003|Overall Study|Ongoing in study|0|||
48322543|NCT04882241|155379432|FG000|Overall Study|Death|13|||
48584235|NCT03802565|156330299|FG001|Overall Study|Subjects Related to Each Other|0|||
48584236|NCT03802565|156330300|FG002|Overall Study|Subjects Related to Each Other|0|||
48322544|NCT04882241|155379433|FG001|Overall Study|Death|13|||
48322545|NCT04882241|155379434|FG002|Overall Study|Death|0|||
48322546|NCT04882241|155379435|FG003|Overall Study|Death|0|||
48322547|NCT05764525|155379436|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
48322548|NCT05764525|155379437|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
48322549|NCT05764525|155379436|FG000|Overall Study|Withdrawal by Subject|4|||
48322550|NCT05764525|155379437|FG001|Overall Study|Withdrawal by Subject|8|||
48322551|NCT05764525|155379436|FG000|Overall Study|Physician Decision|1|||
48322552|NCT05764525|155379437|FG001|Overall Study|Physician Decision|0|||
48322553|NCT04907357|155379438|FG000|Overall Study|Death|0|||
48322554|NCT04907357|155379439|FG001|Overall Study|Death|1|||
48584237|NCT03802565|156330301|FG003|Overall Study|Subjects Related to Each Other|2|||
48584238|NCT03802565|156330302|FG004|Overall Study|Subjects Related to Each Other|1|||
48584239|NCT03802565|156330298|FG000|Overall Study|Elevated Enzymes|0|||
48584240|NCT03802565|156330299|FG001|Overall Study|Elevated Enzymes|0|||
48584241|NCT03802565|156330300|FG002|Overall Study|Elevated Enzymes|0|||
48584242|NCT03802565|156330301|FG003|Overall Study|Elevated Enzymes|0|||
48584243|NCT03802565|156330302|FG004|Overall Study|Elevated Enzymes|2|||
48584244|NCT00574795|156330306|FG000|Infant Series|Withdrawal by Subject|2|||
48584245|NCT00574795|156330306|FG000|Infant Series|Protocol Violation|2|||
48584246|NCT00574795|156330306|FG000|Infant Series|Adverse Event|1|||
48584247|NCT00574795|156330306|FG000|After Infant Series|Withdrawal by Subject|1|||
48584248|NCT00574795|156330306|FG000|After Infant Series|Adverse Event|2|||
48584249|NCT00574795|156330306|FG000|Toddler Dose|Withdrawal by Subject|1|||
48584250|NCT03434249|156330307|FG000|Overall Study|Adverse Event|1|||
48584251|NCT03434249|156330308|FG001|Overall Study|Adverse Event|0|||
48584252|NCT03434249|156330307|FG000|Overall Study|Lost to Follow-up|0|||
48584253|NCT03434249|156330308|FG001|Overall Study|Lost to Follow-up|1|||
48322555|NCT04907357|155379438|FG000|Overall Study|Lost to Follow-up|9|||
48322556|NCT04907357|155379439|FG001|Overall Study|Lost to Follow-up|18|||
48584254|NCT03434249|156330307|FG000|Overall Study|Non-compliance of family|2|||
48584255|NCT03434249|156330308|FG001|Overall Study|Non-compliance of family|1|||
48584256|NCT03434249|156330307|FG000|Overall Study|Difficulties in completing daily diary|2|||
48584257|NCT03434249|156330308|FG001|Overall Study|Difficulties in completing daily diary|1|||
48584258|NCT00561470|156330309|FG000|Overall Study|Adverse Event|74|||
48322557|NCT04907357|155379438|FG000|Overall Study|Physician Decision|1|||
48322558|NCT04907357|155379439|FG001|Overall Study|Physician Decision|0|||
48322559|NCT04907357|155379438|FG000|Overall Study|Withdrawal by Subject|0|||
48322560|NCT04907357|155379439|FG001|Overall Study|Withdrawal by Subject|1|||
48584259|NCT00561470|156330310|FG001|Overall Study|Adverse Event|163|||
48584260|NCT00561470|156330309|FG000|Overall Study|Disease progression|437|||
48584261|NCT00561470|156330310|FG001|Overall Study|Disease progression|305|||
48584262|NCT00561470|156330309|FG000|Overall Study|poor compliance to protocol|4|||
48584263|NCT00561470|156330310|FG001|Overall Study|poor compliance to protocol|4|||
48584264|NCT00561470|156330309|FG000|Overall Study|Lost to Follow-up|2|||
48584265|NCT00561470|156330310|FG001|Overall Study|Lost to Follow-up|0|||
48584266|NCT00561470|156330309|FG000|Overall Study|Physician Decision|21|||
48584267|NCT00561470|156330310|FG001|Overall Study|Physician Decision|20|||
48584268|NCT00561470|156330309|FG000|Overall Study|Consent Withdrawn|2|||
48584269|NCT00561470|156330310|FG001|Overall Study|Consent Withdrawn|6|||
48584270|NCT00561470|156330309|FG000|Overall Study|Subject request|43|||
48584271|NCT00561470|156330310|FG001|Overall Study|Subject request|77|||
48584272|NCT00561470|156330309|FG000|Overall Study|Metastatic surgery|10|||
48584273|NCT00561470|156330310|FG001|Overall Study|Metastatic surgery|12|||
48584274|NCT00561470|156330309|FG000|Overall Study|Unauthorized procedure|3|||
48584275|NCT00561470|156330310|FG001|Overall Study|Unauthorized procedure|1|||
48584276|NCT00561470|156330309|FG000|Overall Study|Randomized but not treated|5|||
48584277|NCT00561470|156330310|FG001|Overall Study|Randomized but not treated|5|||
48584278|NCT00561470|156330309|FG000|Overall Study|Missed visit window|1|||
48584279|NCT00561470|156330310|FG001|Overall Study|Missed visit window|4|||
48584280|NCT00561470|156330309|FG000|Overall Study|Planning surgery|1|||
48584281|NCT00561470|156330310|FG001|Overall Study|Planning surgery|1|||
48584282|NCT00561470|156330309|FG000|Overall Study|Ongoing Treatment|11|||
48584283|NCT00561470|156330310|FG001|Overall Study|Ongoing Treatment|14|||
48739584|NCT00932126|156895672|FG006|Overall Study|Protocol Violation|0|||
48739585|NCT00932126|156895673|FG007|Overall Study|Protocol Violation|0|||
48739586|NCT00932126|156895666|FG000|Overall Study|Withdrawal by Subject|0|||
48739587|NCT00932126|156895667|FG001|Overall Study|Withdrawal by Subject|0|||
48739588|NCT00932126|156895668|FG002|Overall Study|Withdrawal by Subject|1|||
48739589|NCT00932126|156895669|FG003|Overall Study|Withdrawal by Subject|0|||
48739590|NCT00932126|156895670|FG004|Overall Study|Withdrawal by Subject|0|||
48739591|NCT00932126|156895671|FG005|Overall Study|Withdrawal by Subject|0|||
48739592|NCT00932126|156895672|FG006|Overall Study|Withdrawal by Subject|0|||
48739593|NCT00932126|156895673|FG007|Overall Study|Withdrawal by Subject|1|||
48739594|NCT00932126|156895666|FG000|Overall Study|Objective progression or relapse|3|||
48739595|NCT00932126|156895667|FG001|Overall Study|Objective progression or relapse|3|||
48739596|NCT00932126|156895668|FG002|Overall Study|Objective progression or relapse|2|||
48739597|NCT00932126|156895669|FG003|Overall Study|Objective progression or relapse|3|||
48739598|NCT00932126|156895670|FG004|Overall Study|Objective progression or relapse|3|||
48584284|NCT00637806|156330311|FG000|Double-blind Phase|Study Discontinued|2|||
48584285|NCT00637806|156330312|FG001|Double-blind Phase|Study Discontinued|0|||
48584286|NCT00637806|156330313|FG002|Double-blind Phase|Study Discontinued|1|||
48584287|NCT00637806|156330314|FG003|Double-blind Phase|Study Discontinued|0|||
48584288|NCT00637806|156330311|FG000|Extension Phase|Study Discontinued|0|||
48584289|NCT00637806|156330312|FG001|Extension Phase|Study Discontinued|0|||
48584290|NCT00637806|156330313|FG002|Extension Phase|Study Discontinued|0|||
48584291|NCT00637806|156330314|FG003|Extension Phase|Study Discontinued|1|||
48584292|NCT04272606|156330315|FG000|Overall Study|Protocol Violation|1|||
48584293|NCT04272606|156330316|FG001|Overall Study|Protocol Violation|1|||
48584294|NCT04272606|156330315|FG000|Overall Study|Physician Decision|0|||
48584295|NCT04272606|156330316|FG001|Overall Study|Physician Decision|1|||
48739599|NCT00932126|156895671|FG005|Overall Study|Objective progression or relapse|3|||
48584296|NCT00725101|156330317|FG000|Overall Study|Death|3|||
48739600|NCT00932126|156895672|FG006|Overall Study|Objective progression or relapse|3|||
48739601|NCT00932126|156895673|FG007|Overall Study|Objective progression or relapse|5|||
48739602|NCT00932126|156895666|FG000|Overall Study|Other|0|||
48739603|NCT00932126|156895667|FG001|Overall Study|Other|0|||
48322561|NCT04907357|155379438|FG000|Overall Study|Unable to attend visits|1|||
48584297|NCT00725101|156330317|FG000|Overall Study|Lost to Follow-up|353|||
48584298|NCT00725101|156330317|FG000|Overall Study|Protocol Violation|1|||
48584299|NCT00725101|156330317|FG000|Overall Study|Withdrawal by Subject|127|||
48584300|NCT00725101|156330317|FG000|Overall Study|not specified/no reason given|11|||
48584301|NCT02918552|156330318|FG000|Overall Study|Failed Pharmacokinetics|1|||
48584302|NCT02918552|156330319|FG001|Overall Study|Failed Pharmacokinetics|0|||
48584303|NCT02918552|156330318|FG000|Overall Study|Withdrawal by Subject|0|||
48584304|NCT02918552|156330319|FG001|Overall Study|Withdrawal by Subject|1|||
48584305|NCT02918552|156330318|FG000|Overall Study|Lost to Follow-up|0|||
48584306|NCT02918552|156330319|FG001|Overall Study|Lost to Follow-up|1|||
48584307|NCT01554176|156330320|FG000|Treatment Phase|Protocol Violation|1|||
48584308|NCT01554176|156330321|FG001|Treatment Phase|Protocol Violation|2|||
48584309|NCT01554176|156330322|FG002|Treatment Phase|Protocol Violation|0|||
48584310|NCT01554176|156330323|FG003|Treatment Phase|Protocol Violation|0|||
48584311|NCT01554176|156330324|FG004|Treatment Phase|Protocol Violation|0|||
48584312|NCT01554176|156330320|FG000|Treatment Phase|Physician Decision|1|||
48584313|NCT01554176|156330321|FG001|Treatment Phase|Physician Decision|1|||
48584314|NCT01554176|156330322|FG002|Treatment Phase|Physician Decision|0|||
48584315|NCT01554176|156330323|FG003|Treatment Phase|Physician Decision|0|||
48584316|NCT01554176|156330324|FG004|Treatment Phase|Physician Decision|0|||
48584317|NCT01554176|156330320|FG000|Treatment Phase|Lack of Efficacy|0|||
48584318|NCT01554176|156330321|FG001|Treatment Phase|Lack of Efficacy|1|||
48584319|NCT01554176|156330322|FG002|Treatment Phase|Lack of Efficacy|0|||
48584320|NCT01554176|156330323|FG003|Treatment Phase|Lack of Efficacy|0|||
48584321|NCT01554176|156330324|FG004|Treatment Phase|Lack of Efficacy|0|||
48584322|NCT01554176|156330320|FG000|Treatment Phase|Adverse event, non-fatal|1|||
48584323|NCT01554176|156330321|FG001|Treatment Phase|Adverse event, non-fatal|1|||
48584324|NCT01554176|156330322|FG002|Treatment Phase|Adverse event, non-fatal|0|||
48584325|NCT01554176|156330323|FG003|Treatment Phase|Adverse event, non-fatal|0|||
48584326|NCT01554176|156330324|FG004|Treatment Phase|Adverse event, non-fatal|0|||
48584327|NCT01554176|156330320|FG000|Treatment Phase|Non-compliance with study drug|1|||
48584328|NCT01554176|156330321|FG001|Treatment Phase|Non-compliance with study drug|0|||
48584329|NCT01554176|156330322|FG002|Treatment Phase|Non-compliance with study drug|0|||
48584330|NCT01554176|156330323|FG003|Treatment Phase|Non-compliance with study drug|0|||
48584331|NCT01554176|156330324|FG004|Treatment Phase|Non-compliance with study drug|0|||
48584332|NCT01554176|156330320|FG000|Treatment Phase|Withdrawal by Subject|1|||
48584333|NCT01554176|156330321|FG001|Treatment Phase|Withdrawal by Subject|0|||
48584334|NCT01554176|156330322|FG002|Treatment Phase|Withdrawal by Subject|0|||
48584335|NCT01554176|156330323|FG003|Treatment Phase|Withdrawal by Subject|0|||
48584336|NCT01554176|156330324|FG004|Treatment Phase|Withdrawal by Subject|0|||
48584337|NCT01554176|156330320|FG000|Treatment Phase|Lost to Follow-up|3|||
48584338|NCT01554176|156330321|FG001|Treatment Phase|Lost to Follow-up|0|||
48584339|NCT01554176|156330322|FG002|Treatment Phase|Lost to Follow-up|0|||
48584340|NCT01554176|156330323|FG003|Treatment Phase|Lost to Follow-up|0|||
48584341|NCT01554176|156330324|FG004|Treatment Phase|Lost to Follow-up|0|||
48584342|NCT01554176|156330320|FG000|Run-out Phase|Protocol Violation|0|||
48584343|NCT01554176|156330321|FG001|Run-out Phase|Protocol Violation|0|||
48584344|NCT01554176|156330322|FG002|Run-out Phase|Protocol Violation|0|||
48584345|NCT01554176|156330323|FG003|Run-out Phase|Protocol Violation|1|||
48584346|NCT01554176|156330324|FG004|Run-out Phase|Protocol Violation|0|||
48739604|NCT00932126|156895668|FG002|Overall Study|Other|0|||
48322562|NCT04907357|155379439|FG001|Overall Study|Unable to attend visits|0|||
48322563|NCT04907357|155379438|FG000|Overall Study|Incarcerated|1|||
48322564|NCT04907357|155379439|FG001|Overall Study|Incarcerated|1|||
48322565|NCT05975840|155379440|FG000|Overall Study|Other|1|||
48584347|NCT02240069|156330325|FG000|Overall Study|Withdrawal by Subject|5|||
48584348|NCT02240069|156330326|FG001|Overall Study|Withdrawal by Subject|5|||
48584349|NCT02240069|156330327|FG002|Overall Study|Withdrawal by Subject|2|||
48584350|NCT02195427|156330330|FG000|Overall Study|Did not consent to study extension|13|||
48584351|NCT02195427|156330331|FG001|Overall Study|Did not consent to study extension|9|||
48584352|NCT02195427|156330330|FG000|Overall Study|Withdrawal by Subject|4|||
48584353|NCT02195427|156330331|FG001|Overall Study|Withdrawal by Subject|2|||
48584354|NCT02195427|156330330|FG000|Overall Study|Lost to Follow-up|0|||
48584355|NCT02195427|156330331|FG001|Overall Study|Lost to Follow-up|1|||
48739605|NCT00932126|156895669|FG003|Overall Study|Other|0|||
48584356|NCT02195427|156330330|FG000|Overall Study|Protocol Violation|7|||
48584357|NCT02195427|156330331|FG001|Overall Study|Protocol Violation|14|||
48584358|NCT02195427|156330330|FG000|Overall Study|Conditional re-treatment at W52|2|||
48584359|NCT02195427|156330331|FG001|Overall Study|Conditional re-treatment at W52|1|||
48584360|NCT01210144|156330333|FG000|Overall Study|Lack of ovarian response|1|||
48584361|NCT01210144|156330334|FG001|Overall Study|Lack of ovarian response|0|||
48584362|NCT01210144|156330333|FG000|Overall Study|No fertilization|1|||
48584363|NCT01210144|156330334|FG001|Overall Study|No fertilization|0|||
48584364|NCT01210144|156330333|FG000|Overall Study|No transfer|1|||
48584365|NCT01210144|156330334|FG001|Overall Study|No transfer|0|||
48584366|NCT02655419|156330337|FG000|Overall Study|Enrolled but not treated|1|||
48584367|NCT02655419|156330338|FG001|Overall Study|Enrolled but not treated|5|||
48584368|NCT02655419|156330337|FG000|Overall Study|Withdrawal by Subject|4|||
48584369|NCT02655419|156330338|FG001|Overall Study|Withdrawal by Subject|1|||
48584370|NCT02655419|156330337|FG000|Overall Study|Other|0|||
48584371|NCT02655419|156330338|FG001|Overall Study|Other|1|||
48584372|NCT00094536|156330339|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
48584373|NCT00094536|156330339|FG000|Treatment and Follow-up|Adverse Event|4|||
48584374|NCT00094536|156330339|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
48584375|NCT00094536|156330339|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
48584376|NCT00094536|156330339|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
48584377|NCT00094536|156330339|FG000|Treatment and Follow-up|Subject non-compliance|9|||
48584378|NCT00094536|156330339|FG000|Treatment and Follow-up|Unable to attend visits|1|||
48584379|NCT02678000|156330342|FG000|PART 2|Adverse Event|0|||
48584380|NCT02678000|156330343|FG001|PART 2|Adverse Event|0|||
48584381|NCT02678000|156330344|FG002|PART 2|Adverse Event|2|||
48584382|NCT02678000|156330345|FG003|PART 2|Adverse Event|1|||
48584383|NCT02678000|156330346|FG004|PART 2|Adverse Event|0|||
48584384|NCT02678000|156330342|FG000|PART 2|Withdrawal by Subject|0|||
48584385|NCT02678000|156330343|FG001|PART 2|Withdrawal by Subject|0|||
48584386|NCT02678000|156330344|FG002|PART 2|Withdrawal by Subject|1|||
48584387|NCT02678000|156330345|FG003|PART 2|Withdrawal by Subject|0|||
48584388|NCT02678000|156330346|FG004|PART 2|Withdrawal by Subject|0|||
48584389|NCT02906033|156330347|FG000|Baseline|Protocol Violation|37|||
48584390|NCT02906033|156330348|FG001|Baseline|Protocol Violation|33|||
48584391|NCT02906033|156330347|FG000|Follow-up|Lost to Follow-up|46|||
48584392|NCT02906033|156330348|FG001|Follow-up|Lost to Follow-up|62|||
48584393|NCT02101359|156330351|FG000|Overall Study|Not included|23|||
48584394|NCT02101359|156330352|FG001|Overall Study|Not included|13|||
48584395|NCT02101359|156330351|FG000|Overall Study|Withdrawal by Subject|5|||
48584396|NCT02101359|156330352|FG001|Overall Study|Withdrawal by Subject|4|||
48584397|NCT02101359|156330351|FG000|Overall Study|Lost to Follow-up|1|||
48584398|NCT02101359|156330352|FG001|Overall Study|Lost to Follow-up|0|||
48584399|NCT02101359|156330351|FG000|Overall Study|Protocol Violation|0|||
48584400|NCT02101359|156330352|FG001|Overall Study|Protocol Violation|2|||
48584401|NCT00623597|156332175|FG000|Overall Study|Failed to return|1|||
48584402|NCT00623597|156332176|FG001|Overall Study|Failed to return|0|||
48584403|NCT02278367|156332177|FG000|Overall Study|Physician Decision|5|||
48584404|NCT02278367|156332178|FG001|Overall Study|Physician Decision|0|||
48584405|NCT02278367|156332177|FG000|Overall Study|Withdrawal by Subject|5|||
48584406|NCT02278367|156332178|FG001|Overall Study|Withdrawal by Subject|0|||
48584407|NCT00526331|156332180|FG000|Overall Study|Sponsor Termination|55|||
48584408|NCT00979420|156332181|FG000|Overall Study|Adverse Event|1|||
48584409|NCT00979420|156332182|FG001|Overall Study|Adverse Event|0|||
48584410|NCT00979420|156332183|FG002|Overall Study|Adverse Event|0|||
48584411|NCT00979420|156332184|FG003|Overall Study|Adverse Event|0|||
48584412|NCT00979420|156332181|FG000|Overall Study|Lack of Efficacy|3|||
48584413|NCT00979420|156332182|FG001|Overall Study|Lack of Efficacy|0|||
48584414|NCT00979420|156332183|FG002|Overall Study|Lack of Efficacy|1|||
48584415|NCT00979420|156332184|FG003|Overall Study|Lack of Efficacy|1|||
48584416|NCT00979420|156332181|FG000|Overall Study|Other reasons not related to Viramune|3|||
48584417|NCT00979420|156332182|FG001|Overall Study|Other reasons not related to Viramune|0|||
48584418|NCT00979420|156332183|FG002|Overall Study|Other reasons not related to Viramune|0|||
48584419|NCT00979420|156332184|FG003|Overall Study|Other reasons not related to Viramune|1|||
48584420|NCT03840148|156332185|FG000|Study Drug Disposition|Adverse Event|13|||
48584421|NCT03840148|156332186|FG001|Study Drug Disposition|Adverse Event|2|||
48584422|NCT03840148|156332185|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
48584423|NCT03840148|156332186|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
48584424|NCT03840148|156332185|FG000|Study Drug Disposition|Lack of Efficacy|3|||
48584425|NCT03840148|156332186|FG001|Study Drug Disposition|Lack of Efficacy|0|||
48584426|NCT03840148|156332185|FG000|Study Drug Disposition|Physician Decision|2|||
48584427|NCT03840148|156332186|FG001|Study Drug Disposition|Physician Decision|0|||
48584428|NCT03840148|156332185|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
48584429|NCT03840148|156332186|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
48584430|NCT03840148|156332185|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
48584431|NCT03840148|156332186|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
48584432|NCT03840148|156332185|FG000|Study Completion Disposition|Physician Decision|2|||
48584433|NCT03840148|156332186|FG001|Study Completion Disposition|Physician Decision|0|||
48584434|NCT03840148|156332185|FG000|Study Completion Disposition|Covid-19 related|2|||
48584435|NCT03840148|156332186|FG001|Study Completion Disposition|Covid-19 related|0|||
48584436|NCT03840148|156332185|FG000|Study Completion Disposition|Lost to Follow-up|1|||
48584437|NCT03840148|156332186|FG001|Study Completion Disposition|Lost to Follow-up|1|||
48584438|NCT03840148|156332185|FG000|Study Completion Disposition|Death|1|||
48622631|NCT02004275|156476567|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
48322566|NCT05975840|155379441|FG001|Overall Study|Other|0|||
48322567|NCT05975840|155379442|FG002|Overall Study|Other|0|||
48322568|NCT05975840|155379443|FG003|Overall Study|Other|0|||
48322569|NCT05975840|155379444|FG004|Overall Study|Other|1|||
48322570|NCT05975840|155379445|FG005|Overall Study|Other|0|||
48322571|NCT05975840|155379446|FG006|Overall Study|Other|0|||
48322572|NCT05975840|155379447|FG007|Overall Study|Other|0|||
48322573|NCT05975840|155379440|FG000|Overall Study|Lost to Follow-up|3|||
48322574|NCT05975840|155379441|FG001|Overall Study|Lost to Follow-up|6|||
48322575|NCT05975840|155379442|FG002|Overall Study|Lost to Follow-up|3|||
48584439|NCT03840148|156332186|FG001|Study Completion Disposition|Death|0|||
48584440|NCT03840148|156332185|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
48584441|NCT03840148|156332186|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
48584442|NCT03673501|156332187|FG000|Overall Study|Participants ongoing.|36|||
48584443|NCT03673501|156332188|FG001|Overall Study|Participants ongoing.|24|||
48584444|NCT03488225|156332190|FG000|Overall Study|Off Protocol Therapy|2|||
48584445|NCT03488225|156332190|FG000|Overall Study|Stem Cell Transplant|2|||
48584446|NCT03448939|156332191|FG000|Overall Study|Adverse Event|5|||
48584447|NCT03448939|156332192|FG001|Overall Study|Adverse Event|1|||
48584448|NCT03448939|156332191|FG000|Overall Study|Lost to Follow-up|6|||
48584449|NCT03448939|156332192|FG001|Overall Study|Lost to Follow-up|6|||
48584450|NCT03448939|156332191|FG000|Overall Study|Pregnancy|1|||
48584451|NCT03448939|156332192|FG001|Overall Study|Pregnancy|1|||
48584452|NCT03448939|156332191|FG000|Overall Study|Withdrawal by Subject|9|||
48584453|NCT03448939|156332192|FG001|Overall Study|Withdrawal by Subject|3|||
48584454|NCT02332239|156332193|FG000|Overall Study|Lost to Follow-up|4|||
48584455|NCT02332239|156332194|FG001|Overall Study|Lost to Follow-up|6|||
48584456|NCT00894790|156332196|FG000|Overall Study|Protocol Violation|0|||
48584457|NCT00894790|156332197|FG001|Overall Study|Protocol Violation|1|||
48584458|NCT00894790|156332196|FG000|Overall Study|Lost to Follow-up|0|||
48584459|NCT00894790|156332197|FG001|Overall Study|Lost to Follow-up|1|||
48584460|NCT00894790|156332196|FG000|Overall Study|Did not meet entrance criteria|1|||
48584461|NCT00894790|156332197|FG001|Overall Study|Did not meet entrance criteria|0|||
48584462|NCT04093492|156332198|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
48584463|NCT04093492|156332199|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
48584464|NCT04093492|156332200|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
48584465|NCT04093492|156332201|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
48584466|NCT04093492|156332198|FG000|25 Weeks Gestational Age (GA)|No response|5|||
48584467|NCT04093492|156332199|FG001|25 Weeks Gestational Age (GA)|No response|5|||
48584468|NCT04093492|156332200|FG002|25 Weeks Gestational Age (GA)|No response|5|||
48584469|NCT04093492|156332201|FG003|25 Weeks Gestational Age (GA)|No response|2|||
48584470|NCT04093492|156332198|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
48584471|NCT04093492|156332199|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
48584472|NCT04093492|156332200|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
48584473|NCT04093492|156332201|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
48584474|NCT04093492|156332198|FG000|30 Weeks GA|Delivered before assessment|1|||
48584475|NCT04093492|156332199|FG001|30 Weeks GA|Delivered before assessment|2|||
48584476|NCT04093492|156332200|FG002|30 Weeks GA|Delivered before assessment|0|||
48584477|NCT04093492|156332201|FG003|30 Weeks GA|Delivered before assessment|0|||
48584478|NCT04093492|156332198|FG000|30 Weeks GA|No response|7|||
48584479|NCT04093492|156332199|FG001|30 Weeks GA|No response|5|||
48584480|NCT04093492|156332200|FG002|30 Weeks GA|No response|5|||
48584481|NCT04093492|156332201|FG003|30 Weeks GA|No response|2|||
48584482|NCT04093492|156332198|FG000|30 Weeks GA|Lost to Follow-up|0|||
48584483|NCT04093492|156332199|FG001|30 Weeks GA|Lost to Follow-up|1|||
48584484|NCT04093492|156332200|FG002|30 Weeks GA|Lost to Follow-up|0|||
48584485|NCT04093492|156332201|FG003|30 Weeks GA|Lost to Follow-up|0|||
48584486|NCT04093492|156332198|FG000|34 Weeks GA|Delivered before assessment|6|||
48584487|NCT04093492|156332199|FG001|34 Weeks GA|Delivered before assessment|3|||
48584488|NCT04093492|156332200|FG002|34 Weeks GA|Delivered before assessment|0|||
48584489|NCT04093492|156332201|FG003|34 Weeks GA|Delivered before assessment|0|||
48584490|NCT04093492|156332198|FG000|34 Weeks GA|No response|0|||
48584491|NCT04093492|156332199|FG001|34 Weeks GA|No response|7|||
48584492|NCT04093492|156332200|FG002|34 Weeks GA|No response|5|||
48322576|NCT05975840|155379443|FG003|Overall Study|Lost to Follow-up|1|||
48584493|NCT04093492|156332201|FG003|34 Weeks GA|No response|3|||
48584494|NCT04093492|156332198|FG000|34 Weeks GA|Lost to Follow-up|0|||
48584495|NCT04093492|156332199|FG001|34 Weeks GA|Lost to Follow-up|1|||
48584496|NCT04093492|156332200|FG002|34 Weeks GA|Lost to Follow-up|0|||
48584497|NCT04093492|156332201|FG003|34 Weeks GA|Lost to Follow-up|0|||
48584498|NCT01259375|156332202|FG000|Overall Study|Adverse Event|1|||
48584499|NCT01432275|156332203|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
48584500|NCT01432275|156332204|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
48322577|NCT05975840|155379444|FG004|Overall Study|Lost to Follow-up|4|||
48322578|NCT05975840|155379445|FG005|Overall Study|Lost to Follow-up|1|||
48322579|NCT05975840|155379446|FG006|Overall Study|Lost to Follow-up|2|||
48584501|NCT01432275|156332203|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
48322580|NCT05975840|155379447|FG007|Overall Study|Lost to Follow-up|4|||
48584502|NCT01432275|156332204|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
48584503|NCT01432275|156332203|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
48584504|NCT01432275|156332204|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
48584505|NCT01432275|156332203|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
48584506|NCT01432275|156332204|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
48584507|NCT01432275|156332203|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
48584508|NCT01432275|156332204|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
48584509|NCT01432275|156332203|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
48584510|NCT01432275|156332204|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
48584511|NCT01432275|156332203|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
48584512|NCT01432275|156332204|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
48584513|NCT01432275|156332203|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
48584514|NCT01432275|156332204|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
48584515|NCT01432275|156332203|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
48622632|NCT02004275|156476568|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
48622633|NCT02004275|156476569|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
48622634|NCT02004275|156476570|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
48622635|NCT02533674|156476571|FG000|Dose Level I|Progressive disease|1|||
48622636|NCT02533674|156476572|FG001|Dose Level I|Progressive disease|0|||
48622637|NCT02533674|156476573|FG002|Dose Level I|Progressive disease|0|||
48622638|NCT02533674|156476574|FG003|Dose Level I|Progressive disease|0|||
48622639|NCT02533674|156476575|FG004|Dose Level I|Progressive disease|0|||
48622640|NCT02533674|156476576|FG005|Dose Level I|Progressive disease|0|||
48622641|NCT02533674|156476577|FG006|Dose Level I|Progressive disease|0|||
48622642|NCT02533674|156476578|FG007|Dose Level I|Progressive disease|0|||
48622643|NCT02533674|156476571|FG000|Dose Level I|Withdrawal by Subject|1|||
48622644|NCT02533674|156476572|FG001|Dose Level I|Withdrawal by Subject|0|||
48622645|NCT02533674|156476573|FG002|Dose Level I|Withdrawal by Subject|0|||
48622646|NCT02533674|156476574|FG003|Dose Level I|Withdrawal by Subject|0|||
48622647|NCT02533674|156476575|FG004|Dose Level I|Withdrawal by Subject|0|||
48622648|NCT02533674|156476576|FG005|Dose Level I|Withdrawal by Subject|0|||
48622649|NCT02533674|156476577|FG006|Dose Level I|Withdrawal by Subject|0|||
48622650|NCT02533674|156476578|FG007|Dose Level I|Withdrawal by Subject|0|||
48622651|NCT02533674|156476571|FG000|Dose Level I|Physician Decision|1|||
48622652|NCT02533674|156476572|FG001|Dose Level I|Physician Decision|0|||
48622653|NCT02533674|156476573|FG002|Dose Level I|Physician Decision|0|||
48622654|NCT02533674|156476574|FG003|Dose Level I|Physician Decision|0|||
48622655|NCT02533674|156476575|FG004|Dose Level I|Physician Decision|0|||
48622656|NCT02533674|156476576|FG005|Dose Level I|Physician Decision|0|||
48622657|NCT02533674|156476577|FG006|Dose Level I|Physician Decision|0|||
48622658|NCT02533674|156476578|FG007|Dose Level I|Physician Decision|0|||
48622659|NCT02533674|156476571|FG000|Dose Level I|Death|1|||
48622660|NCT02533674|156476572|FG001|Dose Level I|Death|0|||
48622661|NCT02533674|156476573|FG002|Dose Level I|Death|0|||
48622662|NCT02533674|156476574|FG003|Dose Level I|Death|0|||
48622663|NCT02533674|156476575|FG004|Dose Level I|Death|0|||
48622664|NCT02533674|156476576|FG005|Dose Level I|Death|0|||
48622665|NCT02533674|156476577|FG006|Dose Level I|Death|0|||
48622666|NCT02533674|156476578|FG007|Dose Level I|Death|0|||
48622667|NCT02533674|156476571|FG000|Dose Level I|Never Treated|1|||
48622668|NCT02533674|156476572|FG001|Dose Level I|Never Treated|0|||
48622669|NCT02533674|156476573|FG002|Dose Level I|Never Treated|0|||
48622670|NCT02533674|156476574|FG003|Dose Level I|Never Treated|0|||
48622671|NCT02533674|156476575|FG004|Dose Level I|Never Treated|0|||
48622672|NCT02533674|156476576|FG005|Dose Level I|Never Treated|0|||
48622673|NCT02533674|156476577|FG006|Dose Level I|Never Treated|0|||
48622674|NCT02533674|156476578|FG007|Dose Level I|Never Treated|0|||
48622675|NCT02533674|156476571|FG000|Dose Level II|Progressive disease|0|||
48622676|NCT02533674|156476572|FG001|Dose Level II|Progressive disease|3|||
48622677|NCT02533674|156476573|FG002|Dose Level II|Progressive disease|0|||
48622678|NCT02533674|156476574|FG003|Dose Level II|Progressive disease|0|||
48622679|NCT02533674|156476575|FG004|Dose Level II|Progressive disease|0|||
48622680|NCT02533674|156476576|FG005|Dose Level II|Progressive disease|0|||
48739606|NCT00932126|156895670|FG004|Overall Study|Other|1|||
48739607|NCT00932126|156895671|FG005|Overall Study|Other|0|||
48622681|NCT02533674|156476577|FG006|Dose Level II|Progressive disease|0|||
48622682|NCT02533674|156476578|FG007|Dose Level II|Progressive disease|0|||
48622683|NCT02533674|156476571|FG000|Dose Level II|Withdrawal by Subject|0|||
48739608|NCT00932126|156895672|FG006|Overall Study|Other|1|||
48622684|NCT02533674|156476572|FG001|Dose Level II|Withdrawal by Subject|1|||
48622685|NCT02533674|156476573|FG002|Dose Level II|Withdrawal by Subject|0|||
48622686|NCT02533674|156476574|FG003|Dose Level II|Withdrawal by Subject|0|||
48739609|NCT00932126|156895673|FG007|Overall Study|Other|2|||
48622687|NCT02533674|156476575|FG004|Dose Level II|Withdrawal by Subject|0|||
48622688|NCT02533674|156476576|FG005|Dose Level II|Withdrawal by Subject|0|||
48739610|NCT00066365|156895674|FG000|Overall Study|Adverse Event|1|||
48739611|NCT00066365|156895675|FG001|Overall Study|Adverse Event|0|||
48739612|NCT00066365|156895674|FG000|Overall Study|Lack of Efficacy|15|||
48739613|NCT00066365|156895675|FG001|Overall Study|Lack of Efficacy|12|||
48739614|NCT00066365|156895674|FG000|Overall Study|Physician Decision|1|||
48739615|NCT00066365|156895675|FG001|Overall Study|Physician Decision|0|||
48739616|NCT00066365|156895674|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
48739617|NCT00066365|156895675|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
48739618|NCT00066365|156895674|FG000|Overall Study|Ineligible|4|||
48739619|NCT00066365|156895675|FG001|Overall Study|Ineligible|2|||
48739620|NCT04203498|156895676|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
48739621|NCT04203498|156895677|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
48739622|NCT04203498|156895676|FG000|Overall Study|Withdrawal of patient consent|7|||
48739623|NCT04203498|156895677|FG001|Overall Study|Withdrawal of patient consent|2|||
48739624|NCT04203498|156895676|FG000|Overall Study|Adverse Event|4|||
48739625|NCT04203498|156895677|FG001|Overall Study|Adverse Event|1|||
48739626|NCT04203498|156895676|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
48739627|NCT04203498|156895677|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
48739628|NCT04203498|156895676|FG000|Overall Study|Did not receive IMP|2|||
48739629|NCT04203498|156895677|FG001|Overall Study|Did not receive IMP|0|||
48739630|NCT04203797|156895678|FG000|Overall Study|Adverse Event|1|||
48584516|NCT01432275|156332204|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
48584517|NCT01472965|156332205|FG000|Overall Study|Withdrawal by Subject|1|||
48584518|NCT01472965|156332206|FG001|Overall Study|Withdrawal by Subject|0|||
48584519|NCT00986986|156332207|FG000|Overall Study|Lost to Follow-up|0|||
48584520|NCT00986986|156332208|FG001|Overall Study|Lost to Follow-up|1|||
48622689|NCT02533674|156476577|FG006|Dose Level II|Withdrawal by Subject|0|||
48622690|NCT02533674|156476578|FG007|Dose Level II|Withdrawal by Subject|0|||
48622691|NCT02533674|156476571|FG000|Dose Level II|Treatment-related AE|0|||
48622692|NCT02533674|156476572|FG001|Dose Level II|Treatment-related AE|1|||
48622693|NCT02533674|156476573|FG002|Dose Level II|Treatment-related AE|0|||
48622694|NCT02533674|156476574|FG003|Dose Level II|Treatment-related AE|0|||
48622695|NCT02533674|156476575|FG004|Dose Level II|Treatment-related AE|0|||
48622696|NCT02533674|156476576|FG005|Dose Level II|Treatment-related AE|0|||
48622697|NCT02533674|156476577|FG006|Dose Level II|Treatment-related AE|0|||
48622698|NCT02533674|156476578|FG007|Dose Level II|Treatment-related AE|0|||
48622699|NCT02533674|156476571|FG000|Dose Level II|Physician Decision|0|||
48622700|NCT02533674|156476572|FG001|Dose Level II|Physician Decision|1|||
48622701|NCT02533674|156476573|FG002|Dose Level II|Physician Decision|0|||
48622702|NCT02533674|156476574|FG003|Dose Level II|Physician Decision|0|||
48622703|NCT02533674|156476575|FG004|Dose Level II|Physician Decision|0|||
48622704|NCT02533674|156476576|FG005|Dose Level II|Physician Decision|0|||
48622705|NCT02533674|156476577|FG006|Dose Level II|Physician Decision|0|||
48622706|NCT02533674|156476578|FG007|Dose Level II|Physician Decision|0|||
48739631|NCT04203797|156895679|FG001|Overall Study|Adverse Event|0|||
48584521|NCT01618019|156332210|FG000|Overall Study|Withdrawal by Subject|14|||
48584522|NCT01618019|156332211|FG001|Overall Study|Withdrawal by Subject|14|||
48584523|NCT03114657|156332214|FG000|Overall Study|Adverse Event|9|||
48584524|NCT03114657|156332215|FG001|Overall Study|Adverse Event|6|||
48584525|NCT03114657|156332214|FG000|Overall Study|Death|4|||
48584526|NCT03114657|156332215|FG001|Overall Study|Death|0|||
48584527|NCT03114657|156332214|FG000|Overall Study|Multiple Reasons|1|||
48584528|NCT03114657|156332215|FG001|Overall Study|Multiple Reasons|2|||
48584529|NCT03114657|156332214|FG000|Overall Study|Physician Decision|2|||
48584530|NCT03114657|156332215|FG001|Overall Study|Physician Decision|2|||
48584531|NCT03114657|156332214|FG000|Overall Study|Study Terminated By Sponsor|355|||
48584532|NCT03114657|156332215|FG001|Overall Study|Study Terminated By Sponsor|374|||
48584533|NCT03114657|156332214|FG000|Overall Study|Symptomatic Deterioration|0|||
48584534|NCT03114657|156332215|FG001|Overall Study|Symptomatic Deterioration|1|||
48584535|NCT03114657|156332214|FG000|Overall Study|Withdrawal by Subject|28|||
48584536|NCT03114657|156332215|FG001|Overall Study|Withdrawal by Subject|22|||
48584537|NCT00329641|156332216|FG000|Overall Study|Did not start treatment|1|||
48584538|NCT00329641|156332216|FG000|Overall Study|Not eligible|1|||
48584539|NCT00329641|156332216|FG000|Overall Study|Adverse Event|3|||
48584540|NCT00329641|156332216|FG000|Overall Study|Other reason, not protocol specified|1|||
48739632|NCT04203797|156895678|FG000|Overall Study|Did not complete End of Study follow-up|1|||
48322581|NCT05975840|155379440|FG000|Overall Study|Migrated/moved from the study area|1|||
48322582|NCT05975840|155379441|FG001|Overall Study|Migrated/moved from the study area|0|||
48584541|NCT00478699|156332217|FG000|Overall Study|Inclusion Error|1|||
48584542|NCT00478699|156332218|FG001|Overall Study|Inclusion Error|7|||
48584543|NCT00478699|156332217|FG000|Overall Study|Not receive study treatment|6|||
48584544|NCT00478699|156332218|FG001|Overall Study|Not receive study treatment|30|||
48584545|NCT00672841|156332219|FG000|Overall Study|Comfort care|1|||
48584546|NCT00672841|156332220|FG001|Overall Study|Comfort care|4|||
48584547|NCT00672841|156332219|FG000|Overall Study|icteric specimens|0|||
48584548|NCT00672841|156332220|FG001|Overall Study|icteric specimens|3|||
48584549|NCT00672841|156332219|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
48584550|NCT00672841|156332220|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
48739633|NCT04203797|156895679|FG001|Overall Study|Did not complete End of Study follow-up|0|||
48739634|NCT01611155|156895687|FG000|Overall Study|Adverse Event|1|||
48739635|NCT01611155|156895688|FG001|Overall Study|Adverse Event|1|||
48739636|NCT01611155|156895687|FG000|Overall Study|Refused further treatment|6|||
48739637|NCT01611155|156895688|FG001|Overall Study|Refused further treatment|4|||
48739638|NCT01611155|156895687|FG000|Overall Study|Disease progression|1|||
48739639|NCT01611155|156895688|FG001|Overall Study|Disease progression|0|||
48739640|NCT01611155|156895687|FG000|Overall Study|Withdrawal by Subject|1|||
48739641|NCT01611155|156895688|FG001|Overall Study|Withdrawal by Subject|0|||
48739642|NCT01611155|156895687|FG000|Overall Study|Alternative treatment|0|||
48739643|NCT01611155|156895688|FG001|Overall Study|Alternative treatment|1|||
48739644|NCT01611155|156895687|FG000|Overall Study|Ineligible patient|0|||
48739645|NCT01611155|156895688|FG001|Overall Study|Ineligible patient|1|||
48739646|NCT02021773|156895691|FG000|Overall Study|Adverse Event|1|||
48739647|NCT02021773|156895692|FG001|Overall Study|Adverse Event|4|||
48739648|NCT02021773|156895693|FG002|Overall Study|Adverse Event|3|||
48739649|NCT02021773|156895691|FG000|Overall Study|Lack of Efficacy|2|||
48739650|NCT02021773|156895692|FG001|Overall Study|Lack of Efficacy|2|||
48322583|NCT05975840|155379442|FG002|Overall Study|Migrated/moved from the study area|0|||
48322584|NCT05975840|155379443|FG003|Overall Study|Migrated/moved from the study area|0|||
48322585|NCT05975840|155379444|FG004|Overall Study|Migrated/moved from the study area|0|||
48322586|NCT05975840|155379445|FG005|Overall Study|Migrated/moved from the study area|0|||
48322587|NCT05975840|155379446|FG006|Overall Study|Migrated/moved from the study area|0|||
48322588|NCT05975840|155379447|FG007|Overall Study|Migrated/moved from the study area|0|||
48322589|NCT05975840|155379440|FG000|Overall Study|Withdrawal by Subject|0|||
48322590|NCT05975840|155379441|FG001|Overall Study|Withdrawal by Subject|5|||
48322591|NCT05975840|155379442|FG002|Overall Study|Withdrawal by Subject|2|||
48322592|NCT05975840|155379443|FG003|Overall Study|Withdrawal by Subject|2|||
48322593|NCT05975840|155379444|FG004|Overall Study|Withdrawal by Subject|0|||
48322594|NCT05975840|155379445|FG005|Overall Study|Withdrawal by Subject|2|||
48322595|NCT05975840|155379446|FG006|Overall Study|Withdrawal by Subject|2|||
48322596|NCT05975840|155379447|FG007|Overall Study|Withdrawal by Subject|1|||
48322597|NCT05975840|155379440|FG000|Overall Study|Protocol Violation|0|||
48322598|NCT05975840|155379441|FG001|Overall Study|Protocol Violation|1|||
48322599|NCT05975840|155379442|FG002|Overall Study|Protocol Violation|0|||
48322600|NCT05975840|155379443|FG003|Overall Study|Protocol Violation|0|||
48584551|NCT00672841|156332219|FG000|Overall Study|Adverse Event|0|||
48739651|NCT02021773|156895693|FG002|Overall Study|Lack of Efficacy|2|||
48739652|NCT02021773|156895691|FG000|Overall Study|Protocol Violation|2|||
48584552|NCT00672841|156332220|FG001|Overall Study|Adverse Event|3|||
48739653|NCT02021773|156895692|FG001|Overall Study|Protocol Violation|3|||
48739654|NCT02021773|156895693|FG002|Overall Study|Protocol Violation|1|||
48739655|NCT02021773|156895691|FG000|Overall Study|Withdrawal by Subject|3|||
48322601|NCT05975840|155379444|FG004|Overall Study|Protocol Violation|0|||
48322602|NCT05975840|155379445|FG005|Overall Study|Protocol Violation|0|||
48322603|NCT05975840|155379446|FG006|Overall Study|Protocol Violation|0|||
48322604|NCT05975840|155379447|FG007|Overall Study|Protocol Violation|0|||
48584553|NCT00672841|156332219|FG000|Overall Study|Pregnancy|0|||
48584554|NCT00672841|156332220|FG001|Overall Study|Pregnancy|1|||
48584555|NCT05020899|156332221|FG000|8 Week Follow-up|Lost to Follow-up|3|||
48584556|NCT05020899|156332222|FG001|8 Week Follow-up|Lost to Follow-up|6|||
48584557|NCT05020899|156332221|FG000|12 Week Follow-up|Lost to Follow-up|1|||
48584558|NCT05020899|156332222|FG001|12 Week Follow-up|Lost to Follow-up|0|||
48584559|NCT05020899|156332221|FG000|12 Week Follow-up|Death|0|||
48584560|NCT05020899|156332222|FG001|12 Week Follow-up|Death|1|||
48584561|NCT00430352|156332225|FG000|Overall Study|Disease progression|58|||
48584562|NCT00430352|156332225|FG000|Overall Study|Withdrawal by Subject|11|||
48322605|NCT05975840|155379440|FG000|Overall Study|Adverse Event|0|||
48322606|NCT05975840|155379441|FG001|Overall Study|Adverse Event|0|||
48322607|NCT05975840|155379442|FG002|Overall Study|Adverse Event|0|||
48322608|NCT05975840|155379443|FG003|Overall Study|Adverse Event|1|||
48322609|NCT05975840|155379444|FG004|Overall Study|Adverse Event|0|||
48322610|NCT05975840|155379445|FG005|Overall Study|Adverse Event|0|||
48322611|NCT05975840|155379446|FG006|Overall Study|Adverse Event|0|||
48322612|NCT05975840|155379447|FG007|Overall Study|Adverse Event|0|||
48584563|NCT00430352|156332225|FG000|Overall Study|Adverse Event|16|||
48584564|NCT00430352|156332225|FG000|Overall Study|Death|5|||
48584565|NCT00430352|156332225|FG000|Overall Study|Other|48|||
48322613|NCT05975840|155379440|FG000|Overall Study|Death|0|||
48322614|NCT05975840|155379441|FG001|Overall Study|Death|1|||
48322615|NCT05975840|155379442|FG002|Overall Study|Death|0|||
48584566|NCT01944670|156332228|FG000|Overall Study|Lost to Follow-up|2|||
48584567|NCT02638259|156332229|FG000|Treatment Period 1|Adverse Event|1|||
48584568|NCT02638259|156332230|FG001|Treatment Period 1|Adverse Event|5|||
48584569|NCT02638259|156332229|FG000|Treatment Period 1|Death|0|||
48584570|NCT02638259|156332230|FG001|Treatment Period 1|Death|1|||
48584571|NCT02638259|156332229|FG000|Treatment Period 1|Lack of Efficacy|0|||
48322616|NCT05975840|155379443|FG003|Overall Study|Death|0|||
48322617|NCT05975840|155379444|FG004|Overall Study|Death|0|||
48322618|NCT05975840|155379445|FG005|Overall Study|Death|0|||
48322619|NCT05975840|155379446|FG006|Overall Study|Death|0|||
48322620|NCT05975840|155379447|FG007|Overall Study|Death|1|||
48322621|NCT02056834|155379450|FG000|Overall Study|Lost to Follow-up|7|||
48322622|NCT05601102|155379451|FG000|Overall Study|Death|1|||
48322623|NCT05601102|155379452|FG001|Overall Study|Death|2|||
48322624|NCT05601102|155379451|FG000|Overall Study|Withdrawal by Subject|1|||
48322625|NCT05601102|155379452|FG001|Overall Study|Withdrawal by Subject|1|||
48322626|NCT05601102|155379451|FG000|Overall Study|Lost to Follow-up|0|||
48322627|NCT05601102|155379452|FG001|Overall Study|Lost to Follow-up|2|||
48322628|NCT01917084|155379462|FG000|Overall Study|Withdrawal by Subject|1|||
48322629|NCT04605159|155379463|FG000|Overall Study|Adverse Event|6|||
48322630|NCT04605159|155379464|FG001|Overall Study|Adverse Event|3|||
48322631|NCT04605159|155379465|FG002|Overall Study|Adverse Event|21|||
48322632|NCT04605159|155379466|FG003|Overall Study|Adverse Event|4|||
48322633|NCT04605159|155379463|FG000|Overall Study|Lost to Follow-up|74|||
48322634|NCT04605159|155379464|FG001|Overall Study|Lost to Follow-up|45|||
48322635|NCT04605159|155379465|FG002|Overall Study|Lost to Follow-up|119|||
48322636|NCT04605159|155379466|FG003|Overall Study|Lost to Follow-up|80|||
48322637|NCT04605159|155379463|FG000|Overall Study|Protocol Violation|4|||
48322638|NCT04605159|155379464|FG001|Overall Study|Protocol Violation|5|||
48322639|NCT04605159|155379465|FG002|Overall Study|Protocol Violation|2|||
48322640|NCT04605159|155379466|FG003|Overall Study|Protocol Violation|0|||
48322641|NCT04605159|155379463|FG000|Overall Study|Withdrawal by Subject|66|||
48322642|NCT04605159|155379464|FG001|Overall Study|Withdrawal by Subject|37|||
48322643|NCT04605159|155379465|FG002|Overall Study|Withdrawal by Subject|68|||
48322644|NCT04605159|155379466|FG003|Overall Study|Withdrawal by Subject|50|||
48322645|NCT04605159|155379463|FG000|Overall Study|Migrated / moved from the study area|32|||
48322646|NCT04605159|155379464|FG001|Overall Study|Migrated / moved from the study area|22|||
48322647|NCT04605159|155379465|FG002|Overall Study|Migrated / moved from the study area|41|||
48322648|NCT04605159|155379466|FG003|Overall Study|Migrated / moved from the study area|21|||
48322649|NCT04605159|155379463|FG000|Overall Study|Other|1|||
48322650|NCT04605159|155379464|FG001|Overall Study|Other|2|||
48322651|NCT04605159|155379465|FG002|Overall Study|Other|7|||
48322652|NCT04605159|155379466|FG003|Overall Study|Other|3|||
48322653|NCT03988621|155379468|FG000|Overall Study|Lost to Follow-up|16|||
48322654|NCT03988621|155379469|FG001|Overall Study|Lost to Follow-up|17|||
48322655|NCT03988621|155379468|FG000|Overall Study|Withdrawal by Subject|14|||
48322656|NCT03988621|155379469|FG001|Overall Study|Withdrawal by Subject|7|||
48322657|NCT03988621|155379468|FG000|Overall Study|Patient Lost to Follow Up|15|||
48322658|NCT03988621|155379469|FG001|Overall Study|Patient Lost to Follow Up|15|||
48322659|NCT03988621|155379468|FG000|Overall Study|Patient death|1|||
48322660|NCT03988621|155379469|FG001|Overall Study|Patient death|5|||
48322661|NCT01391832|155380209|FG000|Overall Study|Withdrawal by Subject|21|||
48322662|NCT01391832|155380210|FG001|Overall Study|Withdrawal by Subject|22|||
48322663|NCT01391832|155380209|FG000|Overall Study|Lost to Follow-up|0|||
48322664|NCT01391832|155380210|FG001|Overall Study|Lost to Follow-up|1|||
48322665|NCT02755805|155380213|FG000|Overall Study|Lost to Follow-up|1|||
48322666|NCT02755805|155380214|FG001|Overall Study|Lost to Follow-up|2|||
48322667|NCT02755805|155380213|FG000|Overall Study|Refused assessments|1|||
48322668|NCT02755805|155380214|FG001|Overall Study|Refused assessments|0|||
48322669|NCT02755805|155380213|FG000|Overall Study|Withdrawal by Subject|0|||
48322670|NCT02755805|155380214|FG001|Overall Study|Withdrawal by Subject|2|||
48322671|NCT02597920|155380215|FG000|Overall Study|Worsening of other pre-existing disease|0|||
48322672|NCT02597920|155380216|FG001|Overall Study|Worsening of other pre-existing disease|1|||
48322673|NCT02597920|155380217|FG002|Overall Study|Worsening of other pre-existing disease|0|||
48322674|NCT02597920|155380215|FG000|Overall Study|Other adverse event|20|||
48322675|NCT02597920|155380216|FG001|Overall Study|Other adverse event|30|||
48322676|NCT02597920|155380217|FG002|Overall Study|Other adverse event|0|||
48322677|NCT02597920|155380215|FG000|Overall Study|Lost to Follow-up|7|||
48322678|NCT02597920|155380216|FG001|Overall Study|Lost to Follow-up|9|||
48322679|NCT02597920|155380217|FG002|Overall Study|Lost to Follow-up|0|||
48322680|NCT02597920|155380215|FG000|Overall Study|Refuse to continue in the study|3|||
48322681|NCT02597920|155380216|FG001|Overall Study|Refuse to continue in the study|13|||
48322682|NCT02597920|155380217|FG002|Overall Study|Refuse to continue in the study|1|||
48322683|NCT02597920|155380215|FG000|Overall Study|Other than specified|10|||
48322684|NCT02597920|155380216|FG001|Overall Study|Other than specified|31|||
48322685|NCT02597920|155380217|FG002|Overall Study|Other than specified|5|||
48322686|NCT02597920|155380215|FG000|Overall Study|Other|1|||
48322687|NCT02597920|155380216|FG001|Overall Study|Other|0|||
48322688|NCT02597920|155380217|FG002|Overall Study|Other|0|||
48322689|NCT02652442|155380221|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
48322690|NCT02379819|155380222|FG000|Overall Study|Withdrawal by Subject|10|||
48322691|NCT02379819|155380222|FG000|Overall Study|Death|2|||
48322692|NCT02379819|155380222|FG000|Overall Study|Lack of Efficacy|1|||
48322693|NCT02379819|155380222|FG000|Overall Study|Lost to Follow-up|1|||
48322694|NCT02075554|155380223|FG000|Overall Study|Lost to Follow-up|7|||
48322695|NCT02075554|155380223|FG000|Overall Study|Withdrawal by Subject|5|||
48322696|NCT02075554|155380223|FG000|Overall Study|Physician Decision|3|||
48322697|NCT01057433|155380224|FG000|Overall Study|Adverse Event|1|||
48322698|NCT01074294|155380225|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
48322699|NCT01074294|155380226|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
48322700|NCT01074294|155380227|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
48322701|NCT01074294|155380228|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
48322702|NCT01074294|155380225|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
48322703|NCT01074294|155380226|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
48322704|NCT01074294|155380227|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
48322705|NCT01074294|155380228|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
48322706|NCT01074294|155380225|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
48322707|NCT01074294|155380226|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
48322708|NCT01074294|155380227|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
48322709|NCT01074294|155380228|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
48322710|NCT01074294|155380225|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
48322711|NCT01074294|155380226|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
48322712|NCT01074294|155380227|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
48322713|NCT01074294|155380228|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
48322714|NCT01074294|155380225|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
48322715|NCT01074294|155380226|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
48322716|NCT01074294|155380227|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
48322717|NCT01074294|155380228|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
48322718|NCT01074294|155380225|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
48322719|NCT01074294|155380226|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
48322720|NCT01074294|155380227|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
48322721|NCT01074294|155380228|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
48322722|NCT01074294|155380225|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
48322723|NCT01074294|155380226|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
48322724|NCT01074294|155380227|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
48322725|NCT01074294|155380228|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
48322726|NCT01074294|155380225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
48322727|NCT01074294|155380226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
48322728|NCT01074294|155380227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
48322729|NCT01074294|155380228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
48322730|NCT01074294|155380225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
48322731|NCT01074294|155380226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
48322732|NCT01074294|155380227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
48322733|NCT01074294|155380228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
48322734|NCT01074294|155380225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
48322735|NCT01074294|155380226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
48322736|NCT01074294|155380227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
48322737|NCT01074294|155380228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
48322738|NCT01074294|155380225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
48322739|NCT01074294|155380226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
48322740|NCT01074294|155380227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
48322741|NCT01074294|155380228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
48322742|NCT01074294|155380225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
48322743|NCT01074294|155380226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
48322744|NCT01074294|155380227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
48322745|NCT01074294|155380228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
48322746|NCT01074294|155380225|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
48322747|NCT01074294|155380226|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
48322748|NCT01074294|155380227|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
48322749|NCT01074294|155380228|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
48322750|NCT01952366|155380230|FG000|Overall Study|Death|22|||
48322751|NCT01952366|155380230|FG000|Overall Study|Withdrawal by Subject|9|||
48322752|NCT00312208|155380231|FG000|Overall Study|Adverse Event|97|||
48322753|NCT00312208|155380232|FG001|Overall Study|Adverse Event|61|||
48322754|NCT00312208|155380231|FG000|Overall Study|Protocol Violation|5|||
48584572|NCT02638259|156332230|FG001|Treatment Period 1|Lack of Efficacy|1|||
48584573|NCT02638259|156332229|FG000|Treatment Period 1|Protocol Violation|0|||
48584574|NCT02638259|156332230|FG001|Treatment Period 1|Protocol Violation|3|||
48584575|NCT02638259|156332229|FG000|Treatment Period 1|Withdrawal by Subject|4|||
48584576|NCT02638259|156332230|FG001|Treatment Period 1|Withdrawal by Subject|6|||
48739656|NCT02021773|156895692|FG001|Overall Study|Withdrawal by Subject|4|||
48739657|NCT02021773|156895693|FG002|Overall Study|Withdrawal by Subject|5|||
48584577|NCT02638259|156332229|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
48584578|NCT02638259|156332230|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
48584579|NCT02638259|156332229|FG000|Treatment Period 2|Adverse Event|5|||
48584580|NCT02638259|156332230|FG001|Treatment Period 2|Adverse Event|4|||
48739658|NCT02021773|156895691|FG000|Overall Study|Lost to Follow-up|1|||
48739659|NCT02021773|156895692|FG001|Overall Study|Lost to Follow-up|3|||
48739660|NCT02021773|156895693|FG002|Overall Study|Lost to Follow-up|0|||
48739661|NCT02021773|156895691|FG000|Overall Study|Reason not specified|3|||
48739662|NCT02021773|156895692|FG001|Overall Study|Reason not specified|0|||
48739663|NCT02021773|156895693|FG002|Overall Study|Reason not specified|0|||
48739664|NCT04545385|156895695|FG000|Overall Study|Withdrawal by Subject|2|||
48739665|NCT04545385|156895696|FG001|Overall Study|Withdrawal by Subject|0|||
48584581|NCT02638259|156332229|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48584582|NCT02638259|156332230|FG001|Treatment Period 2|Withdrawal by Subject|7|||
48739666|NCT04545385|156895695|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
48739667|NCT04545385|156895696|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
48739668|NCT04545385|156895695|FG000|Overall Study|Study termination|10|||
48739669|NCT04545385|156895696|FG001|Overall Study|Study termination|10|||
48739670|NCT04545385|156895695|FG000|Overall Study|Sponsor decision|2|||
48739671|NCT04545385|156895696|FG001|Overall Study|Sponsor decision|2|||
48584583|NCT02124759|156332231|FG000|Overall Study|Withdrawal by Subject|3|||
48584584|NCT02124759|156332232|FG001|Overall Study|Withdrawal by Subject|1|||
48739672|NCT04545385|156895695|FG000|Overall Study|Other than specified|1|||
48739673|NCT04545385|156895696|FG001|Overall Study|Other than specified|0|||
48739674|NCT00915278|156895697|FG000|Overall Study|Death|1|||
48739675|NCT00915278|156895698|FG001|Overall Study|Death|0|||
48739676|NCT00915278|156895699|FG002|Overall Study|Death|0|||
48322755|NCT00312208|155380232|FG001|Overall Study|Protocol Violation|3|||
48584585|NCT02124759|156332233|FG002|Overall Study|Withdrawal by Subject|1|||
48584586|NCT02124759|156332231|FG000|Overall Study|Screen Fail|2|||
48584587|NCT02124759|156332232|FG001|Overall Study|Screen Fail|2|||
48584588|NCT02124759|156332233|FG002|Overall Study|Screen Fail|3|||
48584589|NCT03099694|156332235|FG000|Overall Study|Withdrawal by Subject|11|||
48584590|NCT03099694|156332236|FG001|Overall Study|Withdrawal by Subject|13|||
48584591|NCT03099694|156332235|FG000|Overall Study|Lost to Follow-up|9|||
48584592|NCT03099694|156332236|FG001|Overall Study|Lost to Follow-up|5|||
48584593|NCT02912455|156332237|FG000|Overall Study|Withdrawal by Subject|0|||
48584594|NCT02912455|156332238|FG001|Overall Study|Withdrawal by Subject|1|||
48584595|NCT02912455|156332237|FG000|Overall Study|Lack of Efficacy|0|||
48584596|NCT02912455|156332238|FG001|Overall Study|Lack of Efficacy|1|||
48739677|NCT00915278|156895700|FG003|Overall Study|Death|0|||
48322756|NCT00312208|155380231|FG000|Overall Study|Death|2|||
48584597|NCT02912455|156332237|FG000|Overall Study|Lost to Follow-up|2|||
48584598|NCT02912455|156332238|FG001|Overall Study|Lost to Follow-up|1|||
48584599|NCT00985426|156332241|FG000|Overall Study|Adverse Event|0|||
48584600|NCT00985426|156332242|FG001|Overall Study|Adverse Event|1|||
48584601|NCT00985426|156332241|FG000|Overall Study|Subject Non-Compliance|3|||
48739678|NCT00915278|156895701|FG004|Overall Study|Death|0|||
48739679|NCT00915278|156895702|FG005|Overall Study|Death|0|||
48739680|NCT00915278|156895697|FG000|Overall Study|Lost to Follow-up|0|||
48322757|NCT00312208|155380232|FG001|Overall Study|Death|1|||
48322758|NCT00312208|155380231|FG000|Overall Study|Lack of Efficacy|7|||
48322759|NCT00312208|155380232|FG001|Overall Study|Lack of Efficacy|4|||
48584602|NCT00985426|156332242|FG001|Overall Study|Subject Non-Compliance|3|||
48584603|NCT00985426|156332241|FG000|Overall Study|Withdrawal by Subject|12|||
48584604|NCT00985426|156332242|FG001|Overall Study|Withdrawal by Subject|16|||
48584605|NCT00985426|156332241|FG000|Overall Study|Lost to Follow-up|8|||
48584606|NCT00985426|156332242|FG001|Overall Study|Lost to Follow-up|10|||
48584607|NCT00985426|156332241|FG000|Overall Study|Death|7|||
48584608|NCT00985426|156332242|FG001|Overall Study|Death|3|||
48584609|NCT00985426|156332241|FG000|Overall Study|Protocol Violation|2|||
48584610|NCT00985426|156332242|FG001|Overall Study|Protocol Violation|0|||
48584611|NCT00985426|156332241|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
48584612|NCT00985426|156332242|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
48584613|NCT01731470|156332243|FG000|Overall Study|Withdrawal by Subject|1|||
48584614|NCT01731470|156332243|FG000|Overall Study|Did not meet study criteria|1|||
48584615|NCT02450552|156332244|FG000|Overall Study|Withdrawal by Subject|4|||
48584616|NCT02450552|156332245|FG001|Overall Study|Withdrawal by Subject|0|||
48584617|NCT02450552|156332246|FG002|Overall Study|Withdrawal by Subject|4|||
48584618|NCT02450552|156332244|FG000|Overall Study|Physician Decision|1|||
48584619|NCT02450552|156332245|FG001|Overall Study|Physician Decision|0|||
48584620|NCT02450552|156332246|FG002|Overall Study|Physician Decision|1|||
48584621|NCT04395274|156332247|FG000|Overall Study|Lost to Follow-up|20|||
48584622|NCT04395274|156332248|FG001|Overall Study|Lost to Follow-up|11|||
48584623|NCT04395274|156332247|FG000|Overall Study|Withdrawal by Subject|13|||
48622707|NCT02533674|156476571|FG000|Dose Level II|Non-treatment-related AE|0|||
48584624|NCT04395274|156332248|FG001|Overall Study|Withdrawal by Subject|10|||
48584625|NCT04395274|156332247|FG000|Overall Study|Moved Abroad|0|||
48584626|NCT04395274|156332248|FG001|Overall Study|Moved Abroad|1|||
48584627|NCT03325894|156332249|FG000|Overall Study|Adverse Event|2|||
48584628|NCT03325894|156332250|FG001|Overall Study|Adverse Event|3|||
48584629|NCT03325894|156332249|FG000|Overall Study|Protocol Violation|1|||
48584630|NCT03325894|156332250|FG001|Overall Study|Protocol Violation|2|||
48584631|NCT03325894|156332249|FG000|Overall Study|Withdrawal by Subject|10|||
48584632|NCT03325894|156332250|FG001|Overall Study|Withdrawal by Subject|6|||
48584633|NCT03325894|156332249|FG000|Overall Study|Lost to Follow-up|4|||
48584634|NCT03325894|156332250|FG001|Overall Study|Lost to Follow-up|9|||
48322760|NCT00312208|155380231|FG000|Overall Study|Lost to Follow-up|3|||
48322761|NCT00312208|155380232|FG001|Overall Study|Lost to Follow-up|5|||
48322762|NCT00312208|155380231|FG000|Overall Study|Withdrawal by Subject|53|||
48322763|NCT00312208|155380232|FG001|Overall Study|Withdrawal by Subject|42|||
48322764|NCT00312208|155380231|FG000|Overall Study|Other|5|||
48322765|NCT00312208|155380232|FG001|Overall Study|Other|7|||
48322766|NCT03257410|155380233|FG000|Overall Study|Adverse Event|2|||
48322767|NCT03257410|155380234|FG001|Overall Study|Adverse Event|3|||
48322768|NCT03257410|155380233|FG000|Overall Study|Protocol Violation|1|||
48322769|NCT03257410|155380234|FG001|Overall Study|Protocol Violation|2|||
48322770|NCT03257410|155380233|FG000|Overall Study|Lost to Follow-up|1|||
48322771|NCT03257410|155380234|FG001|Overall Study|Lost to Follow-up|0|||
48322772|NCT03257410|155380233|FG000|Overall Study|Withdrawal by Subject|1|||
48584635|NCT03325894|156332249|FG000|Overall Study|Lack of Efficacy|8|||
48584636|NCT03325894|156332250|FG001|Overall Study|Lack of Efficacy|14|||
48584637|NCT03325894|156332249|FG000|Overall Study|Study Terminated by Sponsor|38|||
48584638|NCT03325894|156332250|FG001|Overall Study|Study Terminated by Sponsor|43|||
48322773|NCT03257410|155380234|FG001|Overall Study|Withdrawal by Subject|2|||
48322774|NCT03257410|155380233|FG000|Overall Study|Physician Decision|1|||
48322775|NCT03257410|155380234|FG001|Overall Study|Physician Decision|1|||
48322776|NCT03257410|155380233|FG000|Overall Study|Renal transplantation|2|||
48322777|NCT03257410|155380234|FG001|Overall Study|Renal transplantation|0|||
48739681|NCT00915278|156895698|FG001|Overall Study|Lost to Follow-up|1|||
48739682|NCT00915278|156895699|FG002|Overall Study|Lost to Follow-up|0|||
48739683|NCT00915278|156895700|FG003|Overall Study|Lost to Follow-up|0|||
48739684|NCT00915278|156895701|FG004|Overall Study|Lost to Follow-up|0|||
48739685|NCT00915278|156895702|FG005|Overall Study|Lost to Follow-up|0|||
48739686|NCT00915278|156895697|FG000|Overall Study|Withdrawal by Subject|0|||
48584639|NCT03325894|156332249|FG000|Overall Study|Other (Not received Treatment)|1|||
48584640|NCT03325894|156332250|FG001|Overall Study|Other (Not received Treatment)|0|||
48584641|NCT01592292|156332252|FG000|Overall Study|Follow-up loss|3|||
48739687|NCT00915278|156895698|FG001|Overall Study|Withdrawal by Subject|1|||
48739688|NCT00915278|156895699|FG002|Overall Study|Withdrawal by Subject|0|||
48739689|NCT00915278|156895700|FG003|Overall Study|Withdrawal by Subject|0|||
48739690|NCT00915278|156895701|FG004|Overall Study|Withdrawal by Subject|1|||
48739691|NCT00915278|156895702|FG005|Overall Study|Withdrawal by Subject|4|||
48739692|NCT00915278|156895697|FG000|Overall Study|Adverse Event|4|||
48739693|NCT00915278|156895698|FG001|Overall Study|Adverse Event|1|||
48739694|NCT00915278|156895699|FG002|Overall Study|Adverse Event|0|||
48739695|NCT00915278|156895700|FG003|Overall Study|Adverse Event|0|||
48739696|NCT00915278|156895701|FG004|Overall Study|Adverse Event|0|||
48739697|NCT00915278|156895702|FG005|Overall Study|Adverse Event|0|||
48739698|NCT00915278|156895697|FG000|Overall Study|Progressive disease/clinical progression|0|||
48739699|NCT00915278|156895698|FG001|Overall Study|Progressive disease/clinical progression|0|||
48739700|NCT00915278|156895699|FG002|Overall Study|Progressive disease/clinical progression|0|||
48739701|NCT00915278|156895700|FG003|Overall Study|Progressive disease/clinical progression|3|||
48739702|NCT00915278|156895701|FG004|Overall Study|Progressive disease/clinical progression|1|||
48739703|NCT00915278|156895702|FG005|Overall Study|Progressive disease/clinical progression|2|||
48739704|NCT00915278|156895697|FG000|Overall Study|Infusion related AEs|0|||
48739705|NCT00915278|156895698|FG001|Overall Study|Infusion related AEs|0|||
48739706|NCT00915278|156895699|FG002|Overall Study|Infusion related AEs|0|||
48739707|NCT00915278|156895700|FG003|Overall Study|Infusion related AEs|0|||
48739708|NCT00915278|156895701|FG004|Overall Study|Infusion related AEs|0|||
48739709|NCT00915278|156895702|FG005|Overall Study|Infusion related AEs|2|||
48739710|NCT00915278|156895697|FG000|Overall Study|Admission to hospice|0|||
48739711|NCT00915278|156895698|FG001|Overall Study|Admission to hospice|0|||
48739712|NCT00915278|156895699|FG002|Overall Study|Admission to hospice|1|||
48739713|NCT00915278|156895700|FG003|Overall Study|Admission to hospice|0|||
48739714|NCT00915278|156895701|FG004|Overall Study|Admission to hospice|0|||
48739715|NCT00915278|156895702|FG005|Overall Study|Admission to hospice|0|||
48739716|NCT00437983|156895705|FG000|Overall Study|Adverse Event|6|||
48739717|NCT00437983|156895706|FG001|Overall Study|Adverse Event|6|||
48739718|NCT00437983|156895705|FG000|Overall Study|Protocol Violation|2|||
48739719|NCT00437983|156895706|FG001|Overall Study|Protocol Violation|1|||
48739720|NCT00437983|156895705|FG000|Overall Study|Withdrawal by Subject|5|||
48739721|NCT00437983|156895706|FG001|Overall Study|Withdrawal by Subject|6|||
48739722|NCT03137537|156895707|FG000|Overall Study|Adverse Event|0|||
48739723|NCT03137537|156895708|FG001|Overall Study|Adverse Event|1|||
48739724|NCT02192359|156895709|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
48739725|NCT02192359|156895710|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
48739726|NCT02192359|156895711|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
48451166|NCT01041404|155839301|FG001|Overall Study|Other|23|||
48584642|NCT01592292|156332253|FG001|Overall Study|Follow-up loss|3|||
48584643|NCT01592292|156332254|FG002|Overall Study|Follow-up loss|1|||
48584644|NCT01592292|156332255|FG003|Overall Study|Follow-up loss|0|||
48584645|NCT01592292|156332252|FG000|Overall Study|Withdrew consent|2|||
48584646|NCT01592292|156332253|FG001|Overall Study|Withdrew consent|1|||
48584647|NCT01592292|156332254|FG002|Overall Study|Withdrew consent|0|||
48584648|NCT01592292|156332255|FG003|Overall Study|Withdrew consent|0|||
48584649|NCT01592292|156332252|FG000|Overall Study|Other|1|||
48584650|NCT01592292|156332253|FG001|Overall Study|Other|1|||
48584651|NCT01592292|156332254|FG002|Overall Study|Other|2|||
48584652|NCT01592292|156332255|FG003|Overall Study|Other|1|||
48584653|NCT00386425|156332258|FG000|Overall Study|Physician Decision|3|||
48584654|NCT00386425|156332259|FG001|Overall Study|Physician Decision|0|||
48739727|NCT02192359|156895712|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
48739728|NCT02192359|156895709|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
48739729|NCT02192359|156895710|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
48739730|NCT02192359|156895711|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
48584655|NCT00386425|156332260|FG002|Overall Study|Physician Decision|0|||
48739731|NCT02192359|156895712|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
48743075|NCT00968201|156910496|FG002|Extension Study - (Period III)|Adverse Event|22|||
48584656|NCT00386425|156332258|FG000|Overall Study|Withdrawal by Subject|0|||
48584657|NCT00386425|156332259|FG001|Overall Study|Withdrawal by Subject|1|||
48584658|NCT00386425|156332260|FG002|Overall Study|Withdrawal by Subject|0|||
48584659|NCT00435019|156332265|FG000|Overall Study|Adverse Event|1|||
48584660|NCT00435019|156332266|FG001|Overall Study|Adverse Event|0|||
48584661|NCT00435019|156332265|FG000|Overall Study|Lack of Efficacy|1|||
48584662|NCT00435019|156332266|FG001|Overall Study|Lack of Efficacy|2|||
48584663|NCT00435019|156332265|FG000|Overall Study|Protocol Violation|3|||
48584664|NCT00435019|156332266|FG001|Overall Study|Protocol Violation|1|||
48584665|NCT00435019|156332265|FG000|Overall Study|Personal reasons for withdrawal|8|||
48584666|NCT00435019|156332266|FG001|Overall Study|Personal reasons for withdrawal|7|||
48584667|NCT02620384|156332267|FG000|Overall Study|Adverse Event|2|||
48584668|NCT02620384|156332268|FG001|Overall Study|Adverse Event|1|||
48584669|NCT02620384|156332267|FG000|Overall Study|Discharged prior to 2nd dose|2|||
48584670|NCT02620384|156332268|FG001|Overall Study|Discharged prior to 2nd dose|5|||
48584671|NCT02620384|156332267|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
48584672|NCT02620384|156332268|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
48584673|NCT00204477|156332269|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
48584674|NCT00204477|156332270|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
48584675|NCT00204477|156332269|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
48584676|NCT00204477|156332270|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
48622708|NCT02533674|156476572|FG001|Dose Level II|Non-treatment-related AE|1|||
48622709|NCT02533674|156476573|FG002|Dose Level II|Non-treatment-related AE|0|||
48622710|NCT02533674|156476574|FG003|Dose Level II|Non-treatment-related AE|0|||
48622711|NCT02533674|156476575|FG004|Dose Level II|Non-treatment-related AE|0|||
48622712|NCT02533674|156476576|FG005|Dose Level II|Non-treatment-related AE|0|||
48622713|NCT02533674|156476577|FG006|Dose Level II|Non-treatment-related AE|0|||
48622714|NCT02533674|156476578|FG007|Dose Level II|Non-treatment-related AE|0|||
48622715|NCT02533674|156476571|FG000|Dose Level III|Progressive disease|0|||
48584677|NCT03053427|156332271|FG000|Overall Study|Adverse Event|4|||
48584678|NCT03053427|156332272|FG001|Overall Study|Adverse Event|4|||
48322778|NCT03257410|155380233|FG000|Overall Study|Switch to peritoneal dialysis|1|||
48322779|NCT03257410|155380234|FG001|Overall Study|Switch to peritoneal dialysis|0|||
48322780|NCT03257410|155380233|FG000|Overall Study|Death|3|||
48322781|NCT03257410|155380234|FG001|Overall Study|Death|2|||
48322782|NCT03257410|155380233|FG000|Overall Study|Change to another dialysis center|2|||
48322783|NCT03257410|155380234|FG001|Overall Study|Change to another dialysis center|2|||
48322784|NCT03257410|155380233|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
48322785|NCT03257410|155380234|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
48322786|NCT03257410|155380233|FG000|Overall Study|Miscellaneous|2|||
48322787|NCT03257410|155380234|FG001|Overall Study|Miscellaneous|2|||
48322788|NCT03257410|155380233|FG000|Overall Study|Other|0|||
48322789|NCT03257410|155380234|FG001|Overall Study|Other|1|||
48322790|NCT00943917|155380239|FG000|Stage I|Adverse Event|1|||
48584679|NCT03053427|156332271|FG000|Overall Study|Lack of Efficacy|1|||
48622716|NCT02533674|156476572|FG001|Dose Level III|Progressive disease|0|||
48622717|NCT02533674|156476573|FG002|Dose Level III|Progressive disease|2|||
48622718|NCT02533674|156476574|FG003|Dose Level III|Progressive disease|0|||
48322791|NCT00943917|155380240|FG001|Stage I|Adverse Event|2|||
48322792|NCT00943917|155380241|FG002|Stage I|Adverse Event|2|||
48622719|NCT02533674|156476575|FG004|Dose Level III|Progressive disease|0|||
48584680|NCT03053427|156332272|FG001|Overall Study|Lack of Efficacy|3|||
48584681|NCT03053427|156332271|FG000|Overall Study|Lost to Follow-up|2|||
48584682|NCT03053427|156332272|FG001|Overall Study|Lost to Follow-up|2|||
48584683|NCT03053427|156332271|FG000|Overall Study|Worsening of the target disease|0|||
48322793|NCT00943917|155380242|FG003|Stage I|Adverse Event|0|||
48322794|NCT00943917|155380243|FG004|Stage I|Adverse Event|0|||
48322795|NCT00943917|155380244|FG005|Stage I|Adverse Event|0|||
48322796|NCT00943917|155380245|FG006|Stage I|Adverse Event|0|||
48322797|NCT00943917|155380246|FG007|Stage I|Adverse Event|0|||
48322798|NCT00943917|155380247|FG008|Stage I|Adverse Event|0|||
48322799|NCT00943917|155380248|FG009|Stage I|Adverse Event|0|||
48322800|NCT00943917|155380249|FG010|Stage I|Adverse Event|0|||
48322801|NCT00943917|155380250|FG011|Stage I|Adverse Event|0|||
48322802|NCT00943917|155380251|FG012|Stage I|Adverse Event|0|||
48322803|NCT00943917|155380252|FG013|Stage I|Adverse Event|0|||
48322804|NCT00943917|155380253|FG014|Stage I|Adverse Event|0|||
48322805|NCT00943917|155380239|FG000|Stage I|Lost to Follow-up|0|||
48584684|NCT03053427|156332272|FG001|Overall Study|Worsening of the target disease|1|||
48584685|NCT03053427|156332271|FG000|Overall Study|Protocol Deviation|3|||
48584686|NCT03053427|156332272|FG001|Overall Study|Protocol Deviation|3|||
48584687|NCT03053427|156332271|FG000|Overall Study|Withdrawal by Subject|3|||
48584688|NCT03053427|156332272|FG001|Overall Study|Withdrawal by Subject|2|||
48322806|NCT00943917|155380240|FG001|Stage I|Lost to Follow-up|0|||
48322807|NCT00943917|155380241|FG002|Stage I|Lost to Follow-up|1|||
48322808|NCT00943917|155380242|FG003|Stage I|Lost to Follow-up|0|||
48322809|NCT00943917|155380243|FG004|Stage I|Lost to Follow-up|0|||
48322810|NCT00943917|155380244|FG005|Stage I|Lost to Follow-up|0|||
48584689|NCT03053427|156332271|FG000|Overall Study|Miscellaneous|0|||
48584690|NCT03053427|156332272|FG001|Overall Study|Miscellaneous|1|||
48322811|NCT00943917|155380245|FG006|Stage I|Lost to Follow-up|0|||
48322812|NCT00943917|155380246|FG007|Stage I|Lost to Follow-up|0|||
48584691|NCT02071082|156332273|FG000|Overall Study|Enrolled and Never Treated|1|||
48584692|NCT02071082|156332274|FG001|Overall Study|Enrolled and Never Treated|1|||
48584693|NCT02071082|156332273|FG000|Overall Study|Adverse Event|0|||
48584694|NCT02071082|156332274|FG001|Overall Study|Adverse Event|1|||
48584695|NCT02071082|156332273|FG000|Overall Study|Withdrew Consent|0|||
48584696|NCT02071082|156332274|FG001|Overall Study|Withdrew Consent|4|||
48584697|NCT02071082|156332273|FG000|Overall Study|Lost to Follow-up|1|||
48584698|NCT02071082|156332274|FG001|Overall Study|Lost to Follow-up|1|||
48584699|NCT02172040|156332283|FG000|Overall Study|Adverse Event|0|||
48584700|NCT02172040|156332284|FG001|Overall Study|Adverse Event|2|||
48584701|NCT02172040|156332285|FG002|Overall Study|Adverse Event|0|||
48584702|NCT02172040|156332286|FG003|Overall Study|Adverse Event|0|||
48584703|NCT02172040|156332283|FG000|Overall Study|Protocol Violation|0|||
48584704|NCT02172040|156332284|FG001|Overall Study|Protocol Violation|1|||
48584705|NCT02172040|156332285|FG002|Overall Study|Protocol Violation|0|||
48584706|NCT02172040|156332286|FG003|Overall Study|Protocol Violation|0|||
48584707|NCT02172040|156332283|FG000|Overall Study|Withdrawal by Subject|0|||
48584708|NCT02172040|156332284|FG001|Overall Study|Withdrawal by Subject|0|||
48584709|NCT02172040|156332285|FG002|Overall Study|Withdrawal by Subject|1|||
48584710|NCT02172040|156332286|FG003|Overall Study|Withdrawal by Subject|0|||
48584711|NCT02172040|156332283|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
48584712|NCT02172040|156332284|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
48584713|NCT02172040|156332285|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
48584714|NCT02172040|156332286|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
48584715|NCT02172040|156332283|FG000|Overall Study|Family emergency abroad|0|||
48584716|NCT02172040|156332284|FG001|Overall Study|Family emergency abroad|0|||
48584717|NCT02172040|156332285|FG002|Overall Study|Family emergency abroad|0|||
48584718|NCT02172040|156332286|FG003|Overall Study|Family emergency abroad|1|||
48584719|NCT02054910|156332287|FG000|Overall Study|Lost to Follow-up|4|||
48322813|NCT00943917|155380247|FG008|Stage I|Lost to Follow-up|0|||
48322814|NCT00943917|155380248|FG009|Stage I|Lost to Follow-up|0|||
48322815|NCT00943917|155380249|FG010|Stage I|Lost to Follow-up|0|||
48322816|NCT00943917|155380250|FG011|Stage I|Lost to Follow-up|0|||
48322817|NCT00943917|155380251|FG012|Stage I|Lost to Follow-up|0|||
48322818|NCT00943917|155380252|FG013|Stage I|Lost to Follow-up|0|||
48322819|NCT00943917|155380253|FG014|Stage I|Lost to Follow-up|0|||
48322820|NCT00943917|155380239|FG000|Stage I|hyperglycemia|0|||
48322821|NCT00943917|155380240|FG001|Stage I|hyperglycemia|0|||
48322822|NCT00943917|155380241|FG002|Stage I|hyperglycemia|1|||
48322823|NCT00943917|155380242|FG003|Stage I|hyperglycemia|0|||
48322824|NCT00943917|155380243|FG004|Stage I|hyperglycemia|0|||
48322825|NCT00943917|155380244|FG005|Stage I|hyperglycemia|0|||
48322826|NCT00943917|155380245|FG006|Stage I|hyperglycemia|0|||
48584720|NCT02054910|156332288|FG001|Overall Study|Lost to Follow-up|1|||
48584721|NCT01324570|156332293|FG000|Overall Study|Adverse Event|4|||
48584722|NCT01324570|156332294|FG001|Overall Study|Adverse Event|7|||
48584723|NCT01324570|156332293|FG000|Overall Study|Withdrawal by Subject|0|||
48584724|NCT01324570|156332294|FG001|Overall Study|Withdrawal by Subject|3|||
48584725|NCT01324570|156332293|FG000|Overall Study|Lack of Efficacy|0|||
48584726|NCT01324570|156332294|FG001|Overall Study|Lack of Efficacy|1|||
48584727|NCT01324570|156332293|FG000|Overall Study|Confirmed or suspected diversion|0|||
48584728|NCT01324570|156332294|FG001|Overall Study|Confirmed or suspected diversion|1|||
48584729|NCT01324570|156332293|FG000|Overall Study|Administrative|0|||
48584730|NCT01324570|156332294|FG001|Overall Study|Administrative|2|||
48584731|NCT02607306|156332295|FG000|Overall Study|Adverse Event|8|||
48584732|NCT02607306|156332296|FG001|Overall Study|Adverse Event|6|||
48584733|NCT02607306|156332297|FG002|Overall Study|Adverse Event|6|||
48584734|NCT02607306|156332295|FG000|Overall Study|Unclassified|1|||
48739732|NCT02192359|156895709|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
48322827|NCT00943917|155380246|FG007|Stage I|hyperglycemia|0|||
48322828|NCT00943917|155380247|FG008|Stage I|hyperglycemia|0|||
48322829|NCT00943917|155380248|FG009|Stage I|hyperglycemia|0|||
48322830|NCT00943917|155380249|FG010|Stage I|hyperglycemia|0|||
48322831|NCT00943917|155380250|FG011|Stage I|hyperglycemia|0|||
48322832|NCT00943917|155380251|FG012|Stage I|hyperglycemia|0|||
48322833|NCT00943917|155380252|FG013|Stage I|hyperglycemia|0|||
48322834|NCT00943917|155380253|FG014|Stage I|hyperglycemia|0|||
48322835|NCT00943917|155380239|FG000|Stage I|A1C elevation|1|||
48322836|NCT00943917|155380240|FG001|Stage I|A1C elevation|0|||
48322837|NCT00943917|155380241|FG002|Stage I|A1C elevation|0|||
48322838|NCT00943917|155380242|FG003|Stage I|A1C elevation|0|||
48584735|NCT02607306|156332296|FG001|Overall Study|Unclassified|4|||
48584736|NCT02607306|156332297|FG002|Overall Study|Unclassified|0|||
48322839|NCT00943917|155380243|FG004|Stage I|A1C elevation|0|||
48322840|NCT00943917|155380244|FG005|Stage I|A1C elevation|0|||
48322841|NCT00943917|155380245|FG006|Stage I|A1C elevation|0|||
48584737|NCT02607306|156332295|FG000|Overall Study|Withdrawal by Subject|8|||
48584738|NCT02607306|156332296|FG001|Overall Study|Withdrawal by Subject|10|||
48584739|NCT02607306|156332297|FG002|Overall Study|Withdrawal by Subject|2|||
48584740|NCT02607306|156332295|FG000|Overall Study|Lack of Efficacy|0|||
48584741|NCT02607306|156332296|FG001|Overall Study|Lack of Efficacy|1|||
48584742|NCT02607306|156332297|FG002|Overall Study|Lack of Efficacy|1|||
48584743|NCT02607306|156332295|FG000|Overall Study|Protocol Violation|4|||
48584744|NCT02607306|156332296|FG001|Overall Study|Protocol Violation|2|||
48584745|NCT02607306|156332297|FG002|Overall Study|Protocol Violation|1|||
48584746|NCT00207727|156332302|FG000|Overall Study|Withdrawal by Subject|0|||
48584747|NCT00207727|156332303|FG001|Overall Study|Withdrawal by Subject|0|||
48584748|NCT00207727|156332304|FG002|Overall Study|Withdrawal by Subject|0|||
48622720|NCT02533674|156476576|FG005|Dose Level III|Progressive disease|0|||
48622721|NCT02533674|156476577|FG006|Dose Level III|Progressive disease|0|||
48622722|NCT02533674|156476578|FG007|Dose Level III|Progressive disease|0|||
48622723|NCT02533674|156476571|FG000|Dose Level III|Withdrawal by Subject|0|||
48622724|NCT02533674|156476572|FG001|Dose Level III|Withdrawal by Subject|0|||
48622725|NCT02533674|156476573|FG002|Dose Level III|Withdrawal by Subject|1|||
48584749|NCT00207727|156332305|FG003|Overall Study|Withdrawal by Subject|0|||
48584750|NCT00207727|156332306|FG004|Overall Study|Withdrawal by Subject|1|||
48584751|NCT00207727|156332302|FG000|Overall Study|Lost to Follow-up|0|||
48584752|NCT00207727|156332303|FG001|Overall Study|Lost to Follow-up|1|||
48584753|NCT00207727|156332304|FG002|Overall Study|Lost to Follow-up|0|||
48584754|NCT00207727|156332305|FG003|Overall Study|Lost to Follow-up|0|||
48584755|NCT00207727|156332306|FG004|Overall Study|Lost to Follow-up|0|||
48584756|NCT00207727|156332302|FG000|Overall Study|Other|38|||
48584757|NCT00207727|156332303|FG001|Overall Study|Other|41|||
48584758|NCT00207727|156332304|FG002|Overall Study|Other|41|||
48584759|NCT00207727|156332305|FG003|Overall Study|Other|37|||
48584760|NCT00207727|156332306|FG004|Overall Study|Other|33|||
48584761|NCT01876979|156332311|FG000|Overall Study|Physician Decision|2|||
48584762|NCT01876979|156332312|FG001|Overall Study|Physician Decision|3|||
48584763|NCT04438499|156332313|FG000|Overall Study|Lack of Efficacy|3|||
48584764|NCT01214252|156333660|FG000|Overall Study|Not eligible per protocol|82|||
48584765|NCT03226678|156333668|FG000|Part A (Core Study Phase)|Adverse Event|0|||
48584766|NCT03226678|156333669|FG001|Part A (Core Study Phase)|Adverse Event|1|||
48584767|NCT03226678|156333670|FG002|Part A (Core Study Phase)|Adverse Event|0|||
48584768|NCT03226678|156333671|FG003|Part A (Core Study Phase)|Adverse Event|0|||
48584769|NCT03226678|156333672|FG004|Part A (Core Study Phase)|Adverse Event|0|||
48584770|NCT03226678|156333673|FG005|Part A (Core Study Phase)|Adverse Event|0|||
48584771|NCT03226678|156333668|FG000|Part A (Core Study Phase)|Death|0|||
48584772|NCT03226678|156333669|FG001|Part A (Core Study Phase)|Death|0|||
48622726|NCT02533674|156476574|FG003|Dose Level III|Withdrawal by Subject|0|||
48622727|NCT02533674|156476575|FG004|Dose Level III|Withdrawal by Subject|0|||
48622728|NCT02533674|156476576|FG005|Dose Level III|Withdrawal by Subject|0|||
48622729|NCT02533674|156476577|FG006|Dose Level III|Withdrawal by Subject|0|||
48622730|NCT02533674|156476578|FG007|Dose Level III|Withdrawal by Subject|0|||
48622731|NCT02533674|156476571|FG000|Dose Level III|Treatment-related AE|0|||
48622732|NCT02533674|156476572|FG001|Dose Level III|Treatment-related AE|0|||
48622733|NCT02533674|156476573|FG002|Dose Level III|Treatment-related AE|1|||
48622734|NCT02533674|156476574|FG003|Dose Level III|Treatment-related AE|0|||
48622735|NCT02533674|156476575|FG004|Dose Level III|Treatment-related AE|0|||
48622736|NCT02533674|156476576|FG005|Dose Level III|Treatment-related AE|0|||
48622737|NCT02533674|156476577|FG006|Dose Level III|Treatment-related AE|0|||
48622738|NCT02533674|156476578|FG007|Dose Level III|Treatment-related AE|0|||
48584773|NCT03226678|156333670|FG002|Part A (Core Study Phase)|Death|1|||
48622739|NCT02533674|156476571|FG000|Dose Level IV|Progressive disease|0|||
48622740|NCT02533674|156476572|FG001|Dose Level IV|Progressive disease|0|||
48622741|NCT02533674|156476573|FG002|Dose Level IV|Progressive disease|0|||
48622742|NCT02533674|156476574|FG003|Dose Level IV|Progressive disease|3|||
48622743|NCT02533674|156476575|FG004|Dose Level IV|Progressive disease|0|||
48622744|NCT02533674|156476576|FG005|Dose Level IV|Progressive disease|0|||
48622745|NCT02533674|156476577|FG006|Dose Level IV|Progressive disease|0|||
48622746|NCT02533674|156476578|FG007|Dose Level IV|Progressive disease|0|||
48622747|NCT02533674|156476571|FG000|Dose Level IV|Withdrawal by Subject|0|||
48622748|NCT02533674|156476572|FG001|Dose Level IV|Withdrawal by Subject|0|||
48622749|NCT02533674|156476573|FG002|Dose Level IV|Withdrawal by Subject|0|||
48584774|NCT03226678|156333671|FG003|Part A (Core Study Phase)|Death|0|||
48584775|NCT03226678|156333672|FG004|Part A (Core Study Phase)|Death|0|||
48584776|NCT03226678|156333673|FG005|Part A (Core Study Phase)|Death|0|||
48584777|NCT03226678|156333668|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
48584778|NCT03226678|156333669|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
48584779|NCT03226678|156333670|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
48584780|NCT03226678|156333671|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
48584781|NCT03226678|156333672|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
48584782|NCT03226678|156333673|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
48584783|NCT03226678|156333668|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
48584784|NCT03226678|156333669|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
48584785|NCT03226678|156333670|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
48584786|NCT03226678|156333671|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
48584787|NCT03226678|156333672|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
48584788|NCT03226678|156333673|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
48584789|NCT03226678|156333668|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
48584790|NCT03226678|156333669|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
48584791|NCT03226678|156333670|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
48584792|NCT03226678|156333671|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
48584793|NCT03226678|156333672|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
48584794|NCT03226678|156333673|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
48584795|NCT03226678|156333668|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
48584796|NCT03226678|156333669|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
48584797|NCT03226678|156333670|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
48584798|NCT03226678|156333671|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
48584799|NCT03226678|156333672|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
48584800|NCT03226678|156333673|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
48584801|NCT03226678|156333668|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
48584802|NCT03226678|156333669|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
48584803|NCT03226678|156333670|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
48584804|NCT03226678|156333671|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
48584805|NCT03226678|156333672|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
48584806|NCT03226678|156333673|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
48584807|NCT03226678|156333668|FG000|Part B (Long-Term Extension Phase)|Death|0|||
48622750|NCT02533674|156476574|FG003|Dose Level IV|Withdrawal by Subject|1|||
48739733|NCT02192359|156895710|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
48739734|NCT02192359|156895711|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
48322842|NCT00943917|155380246|FG007|Stage I|A1C elevation|0|||
48322843|NCT00943917|155380247|FG008|Stage I|A1C elevation|0|||
48322844|NCT00943917|155380248|FG009|Stage I|A1C elevation|0|||
48322845|NCT00943917|155380249|FG010|Stage I|A1C elevation|0|||
48322846|NCT00943917|155380250|FG011|Stage I|A1C elevation|0|||
48322847|NCT00943917|155380251|FG012|Stage I|A1C elevation|0|||
48322848|NCT00943917|155380252|FG013|Stage I|A1C elevation|0|||
48322849|NCT00943917|155380253|FG014|Stage I|A1C elevation|0|||
48322850|NCT00943917|155380239|FG000|Stage I|Withdrawal by Subject|2|||
48322851|NCT00943917|155380240|FG001|Stage I|Withdrawal by Subject|1|||
48322852|NCT00943917|155380241|FG002|Stage I|Withdrawal by Subject|2|||
48322853|NCT00943917|155380242|FG003|Stage I|Withdrawal by Subject|0|||
48322854|NCT00943917|155380243|FG004|Stage I|Withdrawal by Subject|0|||
48322855|NCT00943917|155380244|FG005|Stage I|Withdrawal by Subject|0|||
48322856|NCT00943917|155380245|FG006|Stage I|Withdrawal by Subject|0|||
48322857|NCT00943917|155380246|FG007|Stage I|Withdrawal by Subject|0|||
48322858|NCT00943917|155380247|FG008|Stage I|Withdrawal by Subject|0|||
48322859|NCT00943917|155380248|FG009|Stage I|Withdrawal by Subject|0|||
48622751|NCT02533674|156476575|FG004|Dose Level IV|Withdrawal by Subject|0|||
48739735|NCT02192359|156895712|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
48322860|NCT00943917|155380249|FG010|Stage I|Withdrawal by Subject|0|||
48322861|NCT00943917|155380250|FG011|Stage I|Withdrawal by Subject|0|||
48322862|NCT00943917|155380251|FG012|Stage I|Withdrawal by Subject|0|||
48322863|NCT00943917|155380252|FG013|Stage I|Withdrawal by Subject|0|||
48584808|NCT03226678|156333669|FG001|Part B (Long-Term Extension Phase)|Death|0|||
48584809|NCT03226678|156333670|FG002|Part B (Long-Term Extension Phase)|Death|0|||
48584810|NCT03226678|156333671|FG003|Part B (Long-Term Extension Phase)|Death|0|||
48584811|NCT03226678|156333672|FG004|Part B (Long-Term Extension Phase)|Death|0|||
48622752|NCT02533674|156476576|FG005|Dose Level IV|Withdrawal by Subject|0|||
48622753|NCT02533674|156476577|FG006|Dose Level IV|Withdrawal by Subject|0|||
48584812|NCT03226678|156333673|FG005|Part B (Long-Term Extension Phase)|Death|1|||
48584813|NCT03226678|156333668|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
48584814|NCT03226678|156333669|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
48584815|NCT03226678|156333670|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
48584816|NCT03226678|156333671|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
48584817|NCT03226678|156333672|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
48584818|NCT03226678|156333673|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
48584819|NCT03226678|156333668|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
48584820|NCT03226678|156333669|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
48584821|NCT03226678|156333670|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
48584822|NCT03226678|156333671|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
48584823|NCT03226678|156333672|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
48584824|NCT03226678|156333673|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
48322864|NCT00943917|155380253|FG014|Stage I|Withdrawal by Subject|0|||
48584825|NCT03226678|156333668|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
48584826|NCT03226678|156333669|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
48584827|NCT03226678|156333670|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
48584828|NCT03226678|156333671|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
48584829|NCT03226678|156333672|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
48584830|NCT03226678|156333673|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
48584831|NCT04327661|156333676|FG000|Overall Study|Withdrawal by Subject|1|||
48584832|NCT04327661|156333677|FG001|Overall Study|Withdrawal by Subject|0|||
48584833|NCT04327661|156333678|FG002|Overall Study|Withdrawal by Subject|0|||
48584834|NCT04984278|156333679|FG000|Period 1|Withdrawal by Subject|1|||
48584835|NCT04984278|156333680|FG001|Period 1|Withdrawal by Subject|0|||
48584836|NCT04984278|156333679|FG000|Period 1|Other|0|||
48584837|NCT04984278|156333680|FG001|Period 1|Other|1|||
48584838|NCT04984278|156333679|FG000|Period 2|Adverse Event|1|||
48584839|NCT04984278|156333680|FG001|Period 2|Adverse Event|0|||
48584840|NCT04984278|156333679|FG000|Period 2|Other|0|||
48584841|NCT04984278|156333680|FG001|Period 2|Other|1|||
48584842|NCT01371877|156333681|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
48584843|NCT01371877|156333682|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
48584844|NCT01143064|156333683|FG000|Overall Study|Death|109|||
48584845|NCT01143064|156333684|FG001|Overall Study|Death|91|||
48584846|NCT01143064|156333683|FG000|Overall Study|Adverse Event|0|||
48584847|NCT01143064|156333684|FG001|Overall Study|Adverse Event|1|||
48584848|NCT01143064|156333683|FG000|Overall Study|Withdrawal by Subject|7|||
48584849|NCT01143064|156333684|FG001|Overall Study|Withdrawal by Subject|5|||
48584850|NCT01143064|156333683|FG000|Overall Study|Lost to Follow-up|17|||
48584851|NCT01143064|156333684|FG001|Overall Study|Lost to Follow-up|14|||
48584852|NCT01143064|156333683|FG000|Overall Study|Physician Decision|0|||
48584853|NCT01143064|156333684|FG001|Overall Study|Physician Decision|4|||
48584854|NCT03781583|156333685|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
48584855|NCT03781583|156333686|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
48584856|NCT03781583|156333687|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
48584857|NCT03781583|156333688|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
48584858|NCT03781583|156333685|FG000|Overall Study|Technology did not work for that person in that environment|1|||
48584859|NCT03781583|156333686|FG001|Overall Study|Technology did not work for that person in that environment|0|||
48584860|NCT03781583|156333687|FG002|Overall Study|Technology did not work for that person in that environment|0|||
48584861|NCT03781583|156333688|FG003|Overall Study|Technology did not work for that person in that environment|0|||
48584862|NCT03781583|156333685|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
48584863|NCT03781583|156333686|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
48584864|NCT03781583|156333687|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
48584865|NCT03781583|156333688|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
48584866|NCT03781583|156333685|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
48584867|NCT03781583|156333686|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
48584868|NCT03781583|156333687|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
48584869|NCT03781583|156333688|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
48584870|NCT00984061|156333689|FG000|Clarithromycin Alone|Protocol Violation|1|||
48584871|NCT04643964|156333692|FG000|Overall Study|Lost to Follow-up|55|||
48622754|NCT02533674|156476578|FG007|Dose Level IV|Withdrawal by Subject|0|||
48622755|NCT02533674|156476571|FG000|Dose Level IV|Physician Decision|0|||
48322865|NCT00943917|155380239|FG000|Stage II|Adverse Event|0|||
48322866|NCT00943917|155380240|FG001|Stage II|Adverse Event|0|||
48739736|NCT00114530|156895714|FG000|Overall Study|Death|3|||
48739737|NCT00114530|156895715|FG001|Overall Study|Death|11|||
48739738|NCT00114530|156895714|FG000|Overall Study|Lost to Follow-up|1|||
48739739|NCT00114530|156895715|FG001|Overall Study|Lost to Follow-up|1|||
48739740|NCT00114530|156895714|FG000|Overall Study|Physician Decision|1|||
48322867|NCT00943917|155380241|FG002|Stage II|Adverse Event|0|||
48322868|NCT00943917|155380242|FG003|Stage II|Adverse Event|0|||
48322869|NCT00943917|155380243|FG004|Stage II|Adverse Event|0|||
48322870|NCT00943917|155380244|FG005|Stage II|Adverse Event|1|||
48322871|NCT00943917|155380245|FG006|Stage II|Adverse Event|3|||
48322872|NCT00943917|155380246|FG007|Stage II|Adverse Event|0|||
48322873|NCT00943917|155380247|FG008|Stage II|Adverse Event|1|||
48322874|NCT00943917|155380248|FG009|Stage II|Adverse Event|0|||
48322875|NCT00943917|155380249|FG010|Stage II|Adverse Event|0|||
48322876|NCT00943917|155380250|FG011|Stage II|Adverse Event|0|||
48322877|NCT00943917|155380251|FG012|Stage II|Adverse Event|0|||
48322878|NCT00943917|155380252|FG013|Stage II|Adverse Event|0|||
48322879|NCT00943917|155380253|FG014|Stage II|Adverse Event|0|||
48322880|NCT00943917|155380239|FG000|Stage II|Withdrawal by Subject|0|||
48322881|NCT00943917|155380240|FG001|Stage II|Withdrawal by Subject|0|||
48322882|NCT00943917|155380241|FG002|Stage II|Withdrawal by Subject|0|||
48322883|NCT00943917|155380242|FG003|Stage II|Withdrawal by Subject|0|||
48322884|NCT00943917|155380243|FG004|Stage II|Withdrawal by Subject|0|||
48322885|NCT00943917|155380244|FG005|Stage II|Withdrawal by Subject|1|||
48322886|NCT00943917|155380245|FG006|Stage II|Withdrawal by Subject|0|||
48322887|NCT00943917|155380246|FG007|Stage II|Withdrawal by Subject|0|||
48322888|NCT00943917|155380247|FG008|Stage II|Withdrawal by Subject|0|||
48322889|NCT00943917|155380248|FG009|Stage II|Withdrawal by Subject|0|||
48322890|NCT00943917|155380249|FG010|Stage II|Withdrawal by Subject|0|||
48322891|NCT00943917|155380250|FG011|Stage II|Withdrawal by Subject|0|||
48322892|NCT00943917|155380251|FG012|Stage II|Withdrawal by Subject|0|||
48322893|NCT00943917|155380252|FG013|Stage II|Withdrawal by Subject|0|||
48322894|NCT00943917|155380253|FG014|Stage II|Withdrawal by Subject|0|||
48322895|NCT00943917|155380239|FG000|Stage II|Pregnancy|0|||
48322896|NCT00943917|155380240|FG001|Stage II|Pregnancy|0|||
48322897|NCT00943917|155380241|FG002|Stage II|Pregnancy|0|||
48322898|NCT00943917|155380242|FG003|Stage II|Pregnancy|0|||
48322899|NCT00943917|155380243|FG004|Stage II|Pregnancy|0|||
48322900|NCT00943917|155380244|FG005|Stage II|Pregnancy|1|||
48739741|NCT00114530|156895715|FG001|Overall Study|Physician Decision|1|||
48739742|NCT00114530|156895714|FG000|Overall Study|Withdrawal by Subject|2|||
48739743|NCT00114530|156895715|FG001|Overall Study|Withdrawal by Subject|6|||
48739744|NCT00114530|156895714|FG000|Overall Study|Breast Cancer|1|||
48739745|NCT00114530|156895715|FG001|Overall Study|Breast Cancer|0|||
48739746|NCT00114530|156895714|FG000|Overall Study|Subject decision after endpoint failure|0|||
48739747|NCT00114530|156895715|FG001|Overall Study|Subject decision after endpoint failure|1|||
48739748|NCT00114530|156895714|FG000|Overall Study|Ineligible|1|||
48739749|NCT00114530|156895715|FG001|Overall Study|Ineligible|0|||
48739750|NCT03846804|156895724|FG000|Overall Study|Refused blood draw|1|||
48739751|NCT03846804|156895724|FG000|Overall Study|Protocol Violation|1|||
48739752|NCT02538029|156895725|FG000|Overall Study|unable to complete cognitive assessments|1|||
48739753|NCT02538029|156895726|FG001|Overall Study|unable to complete cognitive assessments|0|||
48739754|NCT02538029|156895727|FG002|Overall Study|unable to complete cognitive assessments|1|||
48322901|NCT00943917|155380245|FG006|Stage II|Pregnancy|0|||
48622756|NCT02533674|156476572|FG001|Dose Level IV|Physician Decision|0|||
48622757|NCT02533674|156476573|FG002|Dose Level IV|Physician Decision|0|||
48584872|NCT04643964|156333693|FG001|Overall Study|Lost to Follow-up|59|||
48584873|NCT04643964|156333694|FG002|Overall Study|Lost to Follow-up|54|||
48584874|NCT04643964|156333695|FG003|Overall Study|Lost to Follow-up|129|||
48584875|NCT04643964|156333696|FG004|Overall Study|Lost to Follow-up|48|||
48584876|NCT04643964|156333692|FG000|Overall Study|Failed attention check|1|||
48584877|NCT04643964|156333693|FG001|Overall Study|Failed attention check|8|||
48584878|NCT04643964|156333694|FG002|Overall Study|Failed attention check|2|||
48584879|NCT04643964|156333695|FG003|Overall Study|Failed attention check|14|||
48584880|NCT04643964|156333696|FG004|Overall Study|Failed attention check|11|||
48584881|NCT03427268|156333697|FG000|Overall Study|Progressive disease|25|||
48739755|NCT00566995|156895728|FG000|Overall Study|Toxicity|4|||
48322902|NCT00943917|155380246|FG007|Stage II|Pregnancy|0|||
48322903|NCT00943917|155380247|FG008|Stage II|Pregnancy|0|||
48322904|NCT00943917|155380248|FG009|Stage II|Pregnancy|0|||
48322905|NCT00943917|155380249|FG010|Stage II|Pregnancy|0|||
48584882|NCT03427268|156333697|FG000|Overall Study|Never treated|2|||
48584883|NCT03427268|156333697|FG000|Overall Study|Compassionate use|1|||
48322906|NCT00943917|155380250|FG011|Stage II|Pregnancy|0|||
48322907|NCT00943917|155380251|FG012|Stage II|Pregnancy|0|||
48322908|NCT00943917|155380252|FG013|Stage II|Pregnancy|0|||
48322909|NCT00943917|155380253|FG014|Stage II|Pregnancy|0|||
48322910|NCT00943917|155380239|FG000|Stage II Continuation|Adverse Event|0|||
48451238|NCT00355134|155841607|FG004|Core Phase|Withdrawal by Subject|0|||
48584884|NCT03427268|156333697|FG000|Overall Study|Withdrawal by Subject|1|||
48739756|NCT00566995|156895728|FG000|Overall Study|Withdrew consent|3|||
48739757|NCT00404235|156895729|FG000|Overall Study|Withdrawal by Subject|1|||
48739758|NCT00404235|156895730|FG001|Overall Study|Withdrawal by Subject|2|||
48739759|NCT05248867|156895731|FG000|Double-blind Period|Lost to Follow-up|0|||
48584885|NCT03427268|156333697|FG000|Overall Study|Adverse Event|3|||
48584886|NCT00844480|156333698|FG000|Overall Study|Withdrawal by Subject|2|||
48584887|NCT00844480|156333699|FG001|Overall Study|Withdrawal by Subject|3|||
48584888|NCT00980174|156333701|FG000|Overall Study|Withdrawal by Subject|1|||
48584889|NCT00980174|156333702|FG001|Overall Study|Withdrawal by Subject|4|||
48622758|NCT02533674|156476574|FG003|Dose Level IV|Physician Decision|1|||
48622759|NCT02533674|156476575|FG004|Dose Level IV|Physician Decision|0|||
48622760|NCT02533674|156476576|FG005|Dose Level IV|Physician Decision|0|||
48622761|NCT02533674|156476577|FG006|Dose Level IV|Physician Decision|0|||
48622762|NCT02533674|156476578|FG007|Dose Level IV|Physician Decision|0|||
48622763|NCT02533674|156476571|FG000|Dose Level V|Progressive disease|0|||
48739760|NCT05248867|156895732|FG001|Double-blind Period|Lost to Follow-up|3|||
48739761|NCT05248867|156895733|FG002|Double-blind Period|Lost to Follow-up|0|||
48739762|NCT05248867|156895734|FG003|Double-blind Period|Lost to Follow-up|0|||
48739763|NCT05248867|156895735|FG004|Double-blind Period|Lost to Follow-up|0|||
48584890|NCT00980174|156333701|FG000|Overall Study|Adverse Event|0|||
48584891|NCT00980174|156333702|FG001|Overall Study|Adverse Event|3|||
48584892|NCT00980174|156333701|FG000|Overall Study|Ineligibility determined|2|||
48584893|NCT00980174|156333702|FG001|Overall Study|Ineligibility determined|1|||
48584894|NCT00980174|156333701|FG000|Overall Study|Death|1|||
48584895|NCT00980174|156333702|FG001|Overall Study|Death|1|||
48622764|NCT02533674|156476572|FG001|Dose Level V|Progressive disease|0|||
48622765|NCT02533674|156476573|FG002|Dose Level V|Progressive disease|0|||
48622766|NCT02533674|156476574|FG003|Dose Level V|Progressive disease|0|||
48622767|NCT02533674|156476575|FG004|Dose Level V|Progressive disease|3|||
48622768|NCT02533674|156476576|FG005|Dose Level V|Progressive disease|0|||
48622769|NCT02533674|156476577|FG006|Dose Level V|Progressive disease|0|||
48622770|NCT02533674|156476578|FG007|Dose Level V|Progressive disease|0|||
48622771|NCT02533674|156476571|FG000|Dose Level V|Withdrawal by Subject|0|||
48622772|NCT02533674|156476572|FG001|Dose Level V|Withdrawal by Subject|0|||
48622773|NCT02533674|156476573|FG002|Dose Level V|Withdrawal by Subject|0|||
48622774|NCT02533674|156476574|FG003|Dose Level V|Withdrawal by Subject|0|||
48622775|NCT02533674|156476575|FG004|Dose Level V|Withdrawal by Subject|1|||
48622776|NCT02533674|156476576|FG005|Dose Level V|Withdrawal by Subject|0|||
48622777|NCT02533674|156476577|FG006|Dose Level V|Withdrawal by Subject|0|||
48622778|NCT02533674|156476578|FG007|Dose Level V|Withdrawal by Subject|0|||
48622779|NCT02533674|156476571|FG000|Dose Level V|Physician Decision|0|||
48622780|NCT02533674|156476572|FG001|Dose Level V|Physician Decision|0|||
48622781|NCT02533674|156476573|FG002|Dose Level V|Physician Decision|0|||
48622782|NCT02533674|156476574|FG003|Dose Level V|Physician Decision|0|||
48622783|NCT02533674|156476575|FG004|Dose Level V|Physician Decision|1|||
48622784|NCT02533674|156476576|FG005|Dose Level V|Physician Decision|0|||
48622785|NCT02533674|156476577|FG006|Dose Level V|Physician Decision|0|||
48622786|NCT02533674|156476578|FG007|Dose Level V|Physician Decision|0|||
48622787|NCT02533674|156476571|FG000|Dose Level VI|Progressive disease|0|||
48622788|NCT02533674|156476572|FG001|Dose Level VI|Progressive disease|0|||
48622789|NCT02533674|156476573|FG002|Dose Level VI|Progressive disease|0|||
48622790|NCT02533674|156476574|FG003|Dose Level VI|Progressive disease|0|||
48622791|NCT02533674|156476575|FG004|Dose Level VI|Progressive disease|0|||
48622792|NCT02533674|156476576|FG005|Dose Level VI|Progressive disease|7|||
48622793|NCT02533674|156476577|FG006|Dose Level VI|Progressive disease|0|||
48622794|NCT02533674|156476578|FG007|Dose Level VI|Progressive disease|0|||
48622795|NCT02533674|156476571|FG000|Dose Level VI|Withdrawal by Subject|0|||
48622796|NCT02533674|156476572|FG001|Dose Level VI|Withdrawal by Subject|0|||
48622797|NCT02533674|156476573|FG002|Dose Level VI|Withdrawal by Subject|0|||
48622798|NCT02533674|156476574|FG003|Dose Level VI|Withdrawal by Subject|0|||
48622799|NCT02533674|156476575|FG004|Dose Level VI|Withdrawal by Subject|0|||
48622800|NCT02533674|156476576|FG005|Dose Level VI|Withdrawal by Subject|1|||
48622801|NCT02533674|156476577|FG006|Dose Level VI|Withdrawal by Subject|0|||
48622802|NCT02533674|156476578|FG007|Dose Level VI|Withdrawal by Subject|0|||
48622803|NCT02533674|156476571|FG000|Dose Level VI|Treatment-related AE|0|||
48622804|NCT02533674|156476572|FG001|Dose Level VI|Treatment-related AE|0|||
48622805|NCT02533674|156476573|FG002|Dose Level VI|Treatment-related AE|0|||
48622806|NCT02533674|156476574|FG003|Dose Level VI|Treatment-related AE|0|||
48622807|NCT02533674|156476575|FG004|Dose Level VI|Treatment-related AE|0|||
48622808|NCT02533674|156476576|FG005|Dose Level VI|Treatment-related AE|1|||
48622809|NCT02533674|156476577|FG006|Dose Level VI|Treatment-related AE|0|||
48622810|NCT02533674|156476578|FG007|Dose Level VI|Treatment-related AE|0|||
48622811|NCT02533674|156476571|FG000|Dose Level VII|Progressive disease|0|||
48622812|NCT02533674|156476572|FG001|Dose Level VII|Progressive disease|0|||
48622813|NCT02533674|156476573|FG002|Dose Level VII|Progressive disease|0|||
48622814|NCT02533674|156476574|FG003|Dose Level VII|Progressive disease|0|||
48622815|NCT02533674|156476575|FG004|Dose Level VII|Progressive disease|0|||
48622816|NCT02533674|156476576|FG005|Dose Level VII|Progressive disease|0|||
48622817|NCT02533674|156476577|FG006|Dose Level VII|Progressive disease|10|||
48622818|NCT02533674|156476578|FG007|Dose Level VII|Progressive disease|0|||
48622819|NCT02533674|156476571|FG000|Dose Level VII|Withdrawal by Subject|0|||
48622820|NCT02533674|156476572|FG001|Dose Level VII|Withdrawal by Subject|0|||
48622821|NCT02533674|156476573|FG002|Dose Level VII|Withdrawal by Subject|0|||
48622822|NCT02533674|156476574|FG003|Dose Level VII|Withdrawal by Subject|0|||
48622823|NCT02533674|156476575|FG004|Dose Level VII|Withdrawal by Subject|0|||
48739764|NCT05248867|156895736|FG005|Double-blind Period|Lost to Follow-up|0|||
48739765|NCT05248867|156895731|FG000|Double-blind Period|Withdrawal by Subject|5|||
48739766|NCT05248867|156895732|FG001|Double-blind Period|Withdrawal by Subject|14|||
48739767|NCT05248867|156895733|FG002|Double-blind Period|Withdrawal by Subject|0|||
48739768|NCT05248867|156895734|FG003|Double-blind Period|Withdrawal by Subject|0|||
48739769|NCT05248867|156895735|FG004|Double-blind Period|Withdrawal by Subject|0|||
48739770|NCT05248867|156895736|FG005|Double-blind Period|Withdrawal by Subject|0|||
48739771|NCT05248867|156895731|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48622824|NCT02533674|156476576|FG005|Dose Level VII|Withdrawal by Subject|0|||
48622825|NCT02533674|156476577|FG006|Dose Level VII|Withdrawal by Subject|3|||
48622826|NCT02533674|156476578|FG007|Dose Level VII|Withdrawal by Subject|0|||
48622827|NCT02533674|156476571|FG000|Dose Level VII|Treatment-related AE|0|||
48622828|NCT02533674|156476572|FG001|Dose Level VII|Treatment-related AE|0|||
48622829|NCT02533674|156476573|FG002|Dose Level VII|Treatment-related AE|0|||
48622830|NCT02533674|156476574|FG003|Dose Level VII|Treatment-related AE|0|||
48622831|NCT02533674|156476575|FG004|Dose Level VII|Treatment-related AE|0|||
48622832|NCT02533674|156476576|FG005|Dose Level VII|Treatment-related AE|0|||
48622833|NCT02533674|156476577|FG006|Dose Level VII|Treatment-related AE|1|||
48622834|NCT02533674|156476578|FG007|Dose Level VII|Treatment-related AE|0|||
48622835|NCT02533674|156476571|FG000|Dose Level VII|Death|0|||
48622836|NCT02533674|156476572|FG001|Dose Level VII|Death|0|||
48622837|NCT02533674|156476573|FG002|Dose Level VII|Death|0|||
48622838|NCT02533674|156476574|FG003|Dose Level VII|Death|0|||
48622839|NCT02533674|156476575|FG004|Dose Level VII|Death|0|||
48622840|NCT02533674|156476576|FG005|Dose Level VII|Death|0|||
48622841|NCT02533674|156476577|FG006|Dose Level VII|Death|2|||
48622842|NCT02533674|156476578|FG007|Dose Level VII|Death|0|||
48622843|NCT02533674|156476571|FG000|Dose Level VIII|Progressive disease|0|||
48622844|NCT02533674|156476572|FG001|Dose Level VIII|Progressive disease|0|||
48622845|NCT02533674|156476573|FG002|Dose Level VIII|Progressive disease|0|||
48622846|NCT02533674|156476574|FG003|Dose Level VIII|Progressive disease|0|||
48622847|NCT02533674|156476575|FG004|Dose Level VIII|Progressive disease|0|||
48739772|NCT05248867|156895732|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
48739773|NCT05248867|156895733|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48322911|NCT00943917|155380240|FG001|Stage II Continuation|Adverse Event|0|||
48739774|NCT05248867|156895734|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48739775|NCT05248867|156895735|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48739776|NCT05248867|156895736|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
48739777|NCT05248867|156895731|FG000|Double-blind Period|Other, not specified|3|||
48739778|NCT05248867|156895732|FG001|Double-blind Period|Other, not specified|8|||
48739779|NCT05248867|156895733|FG002|Double-blind Period|Other, not specified|0|||
48322912|NCT00943917|155380241|FG002|Stage II Continuation|Adverse Event|0|||
48622848|NCT02533674|156476576|FG005|Dose Level VIII|Progressive disease|0|||
48622849|NCT02533674|156476577|FG006|Dose Level VIII|Progressive disease|0|||
48622850|NCT02533674|156476578|FG007|Dose Level VIII|Progressive disease|3|||
48622851|NCT02533674|156476571|FG000|Dose Level VIII|Withdrawal by Subject|0|||
48622852|NCT02533674|156476572|FG001|Dose Level VIII|Withdrawal by Subject|0|||
48622853|NCT02533674|156476573|FG002|Dose Level VIII|Withdrawal by Subject|0|||
48622854|NCT02533674|156476574|FG003|Dose Level VIII|Withdrawal by Subject|0|||
48622855|NCT02533674|156476575|FG004|Dose Level VIII|Withdrawal by Subject|0|||
48622856|NCT02533674|156476576|FG005|Dose Level VIII|Withdrawal by Subject|0|||
48622857|NCT02533674|156476577|FG006|Dose Level VIII|Withdrawal by Subject|0|||
48622858|NCT02533674|156476578|FG007|Dose Level VIII|Withdrawal by Subject|1|||
48622859|NCT02533674|156476571|FG000|Dose Level VIII|Treatment-related AE|0|||
48622860|NCT02533674|156476572|FG001|Dose Level VIII|Treatment-related AE|0|||
48622861|NCT02533674|156476573|FG002|Dose Level VIII|Treatment-related AE|0|||
48322913|NCT00943917|155380242|FG003|Stage II Continuation|Adverse Event|0|||
48622862|NCT02533674|156476574|FG003|Dose Level VIII|Treatment-related AE|0|||
48622863|NCT02533674|156476575|FG004|Dose Level VIII|Treatment-related AE|0|||
48622864|NCT02533674|156476576|FG005|Dose Level VIII|Treatment-related AE|0|||
48622865|NCT02533674|156476577|FG006|Dose Level VIII|Treatment-related AE|0|||
48622866|NCT02533674|156476578|FG007|Dose Level VIII|Treatment-related AE|1|||
48622867|NCT02533674|156476571|FG000|Dose Level VIII|Never treated|0|||
48622868|NCT02533674|156476572|FG001|Dose Level VIII|Never treated|0|||
48322914|NCT00943917|155380243|FG004|Stage II Continuation|Adverse Event|0|||
48622869|NCT02533674|156476573|FG002|Dose Level VIII|Never treated|0|||
48622870|NCT02533674|156476574|FG003|Dose Level VIII|Never treated|0|||
48622871|NCT02533674|156476575|FG004|Dose Level VIII|Never treated|0|||
48622872|NCT02533674|156476576|FG005|Dose Level VIII|Never treated|0|||
48622873|NCT02533674|156476577|FG006|Dose Level VIII|Never treated|0|||
48739780|NCT05248867|156895734|FG003|Double-blind Period|Other, not specified|0|||
48739781|NCT05248867|156895735|FG004|Double-blind Period|Other, not specified|0|||
48739782|NCT05248867|156895736|FG005|Double-blind Period|Other, not specified|0|||
48739783|NCT05248867|156895731|FG000|Open-label Period|Withdrawal by Subject|0|||
48739784|NCT05248867|156895732|FG001|Open-label Period|Withdrawal by Subject|0|||
48739785|NCT05248867|156895733|FG002|Open-label Period|Withdrawal by Subject|3|||
48739786|NCT05248867|156895734|FG003|Open-label Period|Withdrawal by Subject|1|||
48739787|NCT05248867|156895735|FG004|Open-label Period|Withdrawal by Subject|7|||
48739788|NCT05248867|156895736|FG005|Open-label Period|Withdrawal by Subject|9|||
48739789|NCT05248867|156895731|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739790|NCT05248867|156895732|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739791|NCT05248867|156895733|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739792|NCT05248867|156895734|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
48739793|NCT05248867|156895735|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739794|NCT05248867|156895736|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
48739795|NCT05248867|156895731|FG000|Open-label Period|Lost to Follow-up|0|||
48739796|NCT05248867|156895732|FG001|Open-label Period|Lost to Follow-up|0|||
48739797|NCT05248867|156895733|FG002|Open-label Period|Lost to Follow-up|0|||
48739798|NCT05248867|156895734|FG003|Open-label Period|Lost to Follow-up|0|||
48739799|NCT05248867|156895735|FG004|Open-label Period|Lost to Follow-up|5|||
48739800|NCT05248867|156895736|FG005|Open-label Period|Lost to Follow-up|2|||
48739801|NCT05248867|156895731|FG000|Open-label Period|COVID-19 Infection|0|||
48739802|NCT05248867|156895732|FG001|Open-label Period|COVID-19 Infection|0|||
48739803|NCT05248867|156895733|FG002|Open-label Period|COVID-19 Infection|0|||
48739804|NCT05248867|156895734|FG003|Open-label Period|COVID-19 Infection|0|||
48739805|NCT05248867|156895735|FG004|Open-label Period|COVID-19 Infection|1|||
48739806|NCT05248867|156895736|FG005|Open-label Period|COVID-19 Infection|0|||
48739807|NCT05248867|156895731|FG000|Open-label Period|Other, not specified|0|||
48739808|NCT05248867|156895732|FG001|Open-label Period|Other, not specified|0|||
48739809|NCT05248867|156895733|FG002|Open-label Period|Other, not specified|0|||
48739810|NCT05248867|156895734|FG003|Open-label Period|Other, not specified|0|||
48739811|NCT05248867|156895735|FG004|Open-label Period|Other, not specified|4|||
48322915|NCT00943917|155380244|FG005|Stage II Continuation|Adverse Event|0|||
48322916|NCT00943917|155380245|FG006|Stage II Continuation|Adverse Event|0|||
48322917|NCT00943917|155380246|FG007|Stage II Continuation|Adverse Event|0|||
48322918|NCT00943917|155380247|FG008|Stage II Continuation|Adverse Event|0|||
48322919|NCT00943917|155380248|FG009|Stage II Continuation|Adverse Event|0|||
48322920|NCT00943917|155380249|FG010|Stage II Continuation|Adverse Event|0|||
48322921|NCT00943917|155380250|FG011|Stage II Continuation|Adverse Event|1|||
48322922|NCT00943917|155380251|FG012|Stage II Continuation|Adverse Event|2|||
48322923|NCT00943917|155380252|FG013|Stage II Continuation|Adverse Event|1|||
48322924|NCT00943917|155380253|FG014|Stage II Continuation|Adverse Event|1|||
48739812|NCT05248867|156895736|FG005|Open-label Period|Other, not specified|0|||
48739813|NCT00001880|156895737|FG000|Overall Study|Death|14|||
48739814|NCT01441180|156895738|FG000|Overall Study|Lost to Follow-up|1|||
48739815|NCT01441180|156895739|FG001|Overall Study|Lost to Follow-up|1|||
48739816|NCT01441180|156895740|FG002|Overall Study|Lost to Follow-up|1|||
48739817|NCT01441180|156895738|FG000|Overall Study|Discontinued|0|||
48739818|NCT01441180|156895739|FG001|Overall Study|Discontinued|0|||
48739819|NCT01441180|156895740|FG002|Overall Study|Discontinued|2|||
48739820|NCT00824720|156895741|FG000|Overall Study|failed plug insertion|3|||
48739821|NCT00824720|156895742|FG001|Overall Study|failed plug insertion|1|||
48739822|NCT00824720|156895743|FG002|Overall Study|failed plug insertion|0|||
48322925|NCT00943917|155380239|FG000|Stage II Continuation|Withdrawal by Subject|0|||
48322926|NCT00943917|155380240|FG001|Stage II Continuation|Withdrawal by Subject|0|||
48322927|NCT00943917|155380241|FG002|Stage II Continuation|Withdrawal by Subject|0|||
48322928|NCT00943917|155380242|FG003|Stage II Continuation|Withdrawal by Subject|0|||
48322929|NCT00943917|155380243|FG004|Stage II Continuation|Withdrawal by Subject|0|||
48322930|NCT00943917|155380244|FG005|Stage II Continuation|Withdrawal by Subject|0|||
48322931|NCT00943917|155380245|FG006|Stage II Continuation|Withdrawal by Subject|0|||
48322932|NCT00943917|155380246|FG007|Stage II Continuation|Withdrawal by Subject|0|||
48739823|NCT00824720|156895741|FG000|Overall Study|Protocol Violation|0|||
48739824|NCT00824720|156895742|FG001|Overall Study|Protocol Violation|0|||
48739825|NCT00824720|156895743|FG002|Overall Study|Protocol Violation|1|||
48739826|NCT00142298|156895746|FG000|Overall Study|Adverse Event|10|||
48739827|NCT00142298|156895747|FG001|Overall Study|Adverse Event|10|||
48739828|NCT00142298|156895748|FG002|Overall Study|Adverse Event|1|||
48739829|NCT00142298|156895749|FG003|Overall Study|Adverse Event|5|||
48739830|NCT00142298|156895750|FG004|Overall Study|Adverse Event|2|||
48739831|NCT00142298|156895751|FG005|Overall Study|Adverse Event|2|||
48739832|NCT00142298|156895752|FG006|Overall Study|Adverse Event|0|||
48739833|NCT00142298|156895753|FG007|Overall Study|Adverse Event|0|||
48322933|NCT00943917|155380247|FG008|Stage II Continuation|Withdrawal by Subject|0|||
48739834|NCT00142298|156895754|FG008|Overall Study|Adverse Event|0|||
48739835|NCT00142298|156895755|FG009|Overall Study|Adverse Event|0|||
48739836|NCT00142298|156895746|FG000|Overall Study|Clinical disease progression|1|||
48739837|NCT00142298|156895747|FG001|Overall Study|Clinical disease progression|0|||
48739838|NCT00142298|156895748|FG002|Overall Study|Clinical disease progression|0|||
48739839|NCT00142298|156895749|FG003|Overall Study|Clinical disease progression|0|||
48739840|NCT00142298|156895750|FG004|Overall Study|Clinical disease progression|0|||
48739841|NCT00142298|156895751|FG005|Overall Study|Clinical disease progression|0|||
48739842|NCT00142298|156895752|FG006|Overall Study|Clinical disease progression|0|||
48739843|NCT00142298|156895753|FG007|Overall Study|Clinical disease progression|0|||
48739844|NCT00142298|156895754|FG008|Overall Study|Clinical disease progression|0|||
48739845|NCT00142298|156895755|FG009|Overall Study|Clinical disease progression|0|||
48739846|NCT00142298|156895746|FG000|Overall Study|Death|1|||
48739847|NCT00142298|156895747|FG001|Overall Study|Death|1|||
48739848|NCT00142298|156895748|FG002|Overall Study|Death|1|||
48739849|NCT00142298|156895749|FG003|Overall Study|Death|0|||
48739850|NCT00142298|156895750|FG004|Overall Study|Death|0|||
48739851|NCT00142298|156895751|FG005|Overall Study|Death|6|||
48739852|NCT00142298|156895752|FG006|Overall Study|Death|0|||
48739853|NCT00142298|156895753|FG007|Overall Study|Death|0|||
48739854|NCT00142298|156895754|FG008|Overall Study|Death|0|||
48739855|NCT00142298|156895755|FG009|Overall Study|Death|0|||
48739856|NCT00142298|156895746|FG000|Overall Study|Lack of Efficacy|44|||
48739857|NCT00142298|156895747|FG001|Overall Study|Lack of Efficacy|62|||
48739858|NCT00142298|156895748|FG002|Overall Study|Lack of Efficacy|9|||
48739859|NCT00142298|156895749|FG003|Overall Study|Lack of Efficacy|12|||
48739860|NCT00142298|156895750|FG004|Overall Study|Lack of Efficacy|1|||
48739861|NCT00142298|156895751|FG005|Overall Study|Lack of Efficacy|0|||
48739862|NCT00142298|156895752|FG006|Overall Study|Lack of Efficacy|0|||
48739863|NCT00142298|156895753|FG007|Overall Study|Lack of Efficacy|1|||
48739864|NCT00142298|156895754|FG008|Overall Study|Lack of Efficacy|0|||
48739865|NCT00142298|156895755|FG009|Overall Study|Lack of Efficacy|0|||
48739866|NCT00142298|156895746|FG000|Overall Study|Non-compliance|15|||
48739867|NCT00142298|156895747|FG001|Overall Study|Non-compliance|13|||
48739868|NCT00142298|156895748|FG002|Overall Study|Non-compliance|0|||
48739869|NCT00142298|156895749|FG003|Overall Study|Non-compliance|6|||
48739870|NCT00142298|156895750|FG004|Overall Study|Non-compliance|1|||
48739871|NCT00142298|156895751|FG005|Overall Study|Non-compliance|0|||
48739872|NCT00142298|156895752|FG006|Overall Study|Non-compliance|0|||
48739873|NCT00142298|156895753|FG007|Overall Study|Non-compliance|3|||
48739874|NCT00142298|156895754|FG008|Overall Study|Non-compliance|3|||
48739875|NCT00142298|156895755|FG009|Overall Study|Non-compliance|0|||
48739876|NCT00142298|156895746|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
48739877|NCT00142298|156895747|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
48739878|NCT00142298|156895748|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
48739879|NCT00142298|156895749|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
48622874|NCT02533674|156476578|FG007|Dose Level VIII|Never treated|1|||
48622875|NCT04432298|156476583|FG000|Overall Study|Other than specified|1|||
48739880|NCT00142298|156895750|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
48739881|NCT00142298|156895751|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
48739882|NCT00142298|156895752|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
48739883|NCT00142298|156895753|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
48739884|NCT00142298|156895754|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
48739885|NCT00142298|156895755|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
48739886|NCT00142298|156895746|FG000|Overall Study|Pregnancy|4|||
48739887|NCT00142298|156895747|FG001|Overall Study|Pregnancy|4|||
48739888|NCT00142298|156895748|FG002|Overall Study|Pregnancy|2|||
48739889|NCT00142298|156895749|FG003|Overall Study|Pregnancy|3|||
48739890|NCT00142298|156895750|FG004|Overall Study|Pregnancy|0|||
48322934|NCT00943917|155380248|FG009|Stage II Continuation|Withdrawal by Subject|0|||
48322935|NCT00943917|155380249|FG010|Stage II Continuation|Withdrawal by Subject|0|||
48322936|NCT00943917|155380250|FG011|Stage II Continuation|Withdrawal by Subject|0|||
48322937|NCT00943917|155380251|FG012|Stage II Continuation|Withdrawal by Subject|0|||
48322938|NCT00943917|155380252|FG013|Stage II Continuation|Withdrawal by Subject|1|||
48322939|NCT00943917|155380253|FG014|Stage II Continuation|Withdrawal by Subject|3|||
48322940|NCT00943917|155380239|FG000|Stage II Continuation|Protocol Violation|0|||
48322941|NCT00943917|155380240|FG001|Stage II Continuation|Protocol Violation|0|||
48322942|NCT00943917|155380241|FG002|Stage II Continuation|Protocol Violation|0|||
48622876|NCT04432298|156476584|FG001|Overall Study|Other than specified|0|||
48322943|NCT00943917|155380242|FG003|Stage II Continuation|Protocol Violation|0|||
48322944|NCT00943917|155380243|FG004|Stage II Continuation|Protocol Violation|0|||
48322945|NCT00943917|155380244|FG005|Stage II Continuation|Protocol Violation|0|||
48322946|NCT00943917|155380245|FG006|Stage II Continuation|Protocol Violation|0|||
48322947|NCT00943917|155380246|FG007|Stage II Continuation|Protocol Violation|0|||
48322948|NCT00943917|155380247|FG008|Stage II Continuation|Protocol Violation|0|||
48322949|NCT00943917|155380248|FG009|Stage II Continuation|Protocol Violation|1|||
48322950|NCT00943917|155380249|FG010|Stage II Continuation|Protocol Violation|0|||
48739891|NCT00142298|156895751|FG005|Overall Study|Pregnancy|0|||
48739892|NCT00142298|156895752|FG006|Overall Study|Pregnancy|0|||
48739893|NCT00142298|156895753|FG007|Overall Study|Pregnancy|0|||
48622877|NCT04432298|156476583|FG000|Overall Study|Lost to Follow-up|0|||
48739894|NCT00142298|156895754|FG008|Overall Study|Pregnancy|1|||
48739895|NCT00142298|156895755|FG009|Overall Study|Pregnancy|0|||
48739896|NCT00142298|156895746|FG000|Overall Study|Virologic breakthrough|19|||
48739897|NCT00142298|156895747|FG001|Overall Study|Virologic breakthrough|23|||
48739898|NCT00142298|156895748|FG002|Overall Study|Virologic breakthrough|9|||
48739899|NCT00142298|156895749|FG003|Overall Study|Virologic breakthrough|7|||
48739900|NCT00142298|156895750|FG004|Overall Study|Virologic breakthrough|2|||
48739901|NCT00142298|156895751|FG005|Overall Study|Virologic breakthrough|3|||
48739902|NCT00142298|156895752|FG006|Overall Study|Virologic breakthrough|3|||
48739903|NCT00142298|156895753|FG007|Overall Study|Virologic breakthrough|0|||
48739904|NCT00142298|156895754|FG008|Overall Study|Virologic breakthrough|0|||
48739905|NCT00142298|156895755|FG009|Overall Study|Virologic breakthrough|0|||
48739906|NCT00142298|156895746|FG000|Overall Study|Other- not specified|0|||
48739907|NCT00142298|156895747|FG001|Overall Study|Other- not specified|3|||
48739908|NCT00142298|156895748|FG002|Overall Study|Other- not specified|0|||
48622878|NCT04432298|156476584|FG001|Overall Study|Lost to Follow-up|1|||
48739909|NCT00142298|156895749|FG003|Overall Study|Other- not specified|1|||
48739910|NCT00142298|156895750|FG004|Overall Study|Other- not specified|0|||
48739911|NCT00142298|156895751|FG005|Overall Study|Other- not specified|0|||
48622879|NCT04432298|156476583|FG000|Overall Study|Death|3|||
48739912|NCT00142298|156895752|FG006|Overall Study|Other- not specified|0|||
48739913|NCT00142298|156895753|FG007|Overall Study|Other- not specified|0|||
48739914|NCT00142298|156895754|FG008|Overall Study|Other- not specified|0|||
48739915|NCT00142298|156895755|FG009|Overall Study|Other- not specified|0|||
48622880|NCT04432298|156476584|FG001|Overall Study|Death|2|||
48622881|NCT04432298|156476583|FG000|Overall Study|Withdrawal by Subject|2|||
48622882|NCT04432298|156476584|FG001|Overall Study|Withdrawal by Subject|0|||
48622883|NCT01336972|156476587|FG000|Overall Study|Adverse Event|1|||
48622884|NCT01336972|156476588|FG001|Overall Study|Adverse Event|1|||
48622885|NCT01336972|156476589|FG002|Overall Study|Adverse Event|0|||
48622886|NCT01716559|156476590|FG000|Overall Study|Adverse Event|11|||
48622887|NCT01716559|156476590|FG000|Overall Study|Death|21|||
48622888|NCT01716559|156476590|FG000|Overall Study|Withdrawal by Subject|4|||
48622889|NCT01716559|156476590|FG000|Overall Study|Other withdrawal reason|75|||
48622890|NCT00617903|156476601|FG000|Overall Study|Withdrawal by Subject|2|||
48622891|NCT00617903|156476602|FG001|Overall Study|Withdrawal by Subject|3|||
48622892|NCT00617903|156476601|FG000|Overall Study|Lost to Follow-up|1|||
48622893|NCT00617903|156476602|FG001|Overall Study|Lost to Follow-up|1|||
48622894|NCT00617903|156476601|FG000|Overall Study|Lack of Efficacy|0|||
48622895|NCT00617903|156476602|FG001|Overall Study|Lack of Efficacy|1|||
48622896|NCT00617903|156476601|FG000|Overall Study|Adverse Event|0|||
48622897|NCT00617903|156476602|FG001|Overall Study|Adverse Event|1|||
48622898|NCT00617903|156476601|FG000|Overall Study|noncompliance|0|||
48622899|NCT00617903|156476602|FG001|Overall Study|noncompliance|1|||
48622900|NCT00414609|156476603|FG000|Core Study|Adverse Event|9|||
48622901|NCT00414609|156476604|FG001|Core Study|Adverse Event|11|||
48622902|NCT00414609|156476605|FG002|Core Study|Adverse Event|0|||
48622903|NCT00414609|156476603|FG000|Core Study|Abnormal laboratory values|0|||
48622904|NCT00414609|156476604|FG001|Core Study|Abnormal laboratory values|1|||
48622905|NCT00414609|156476605|FG002|Core Study|Abnormal laboratory values|0|||
48622906|NCT00414609|156476603|FG000|Core Study|Abnormal test procedure results|1|||
48622907|NCT00414609|156476604|FG001|Core Study|Abnormal test procedure results|1|||
48622908|NCT00414609|156476605|FG002|Core Study|Abnormal test procedure results|0|||
48622909|NCT00414609|156476603|FG000|Core Study|Protocol deviation|0|||
48622910|NCT00414609|156476604|FG001|Core Study|Protocol deviation|1|||
48622911|NCT00414609|156476605|FG002|Core Study|Protocol deviation|0|||
48739916|NCT00142298|156895746|FG000|Overall Study|Lost to Follow-up|0|||
48739917|NCT00142298|156895747|FG001|Overall Study|Lost to Follow-up|0|||
48622912|NCT00414609|156476603|FG000|Core Study|Patient withdrew consent|10|||
48622913|NCT00414609|156476604|FG001|Core Study|Patient withdrew consent|11|||
48739918|NCT00142298|156895748|FG002|Overall Study|Lost to Follow-up|0|||
48739919|NCT00142298|156895749|FG003|Overall Study|Lost to Follow-up|0|||
48622914|NCT00414609|156476605|FG002|Core Study|Patient withdrew consent|0|||
48622915|NCT00414609|156476603|FG000|Core Study|Lost to Follow-up|7|||
48622916|NCT00414609|156476604|FG001|Core Study|Lost to Follow-up|4|||
48622917|NCT00414609|156476605|FG002|Core Study|Lost to Follow-up|0|||
48622918|NCT00414609|156476603|FG000|Core Study|Administrative problems|0|||
48622919|NCT00414609|156476604|FG001|Core Study|Administrative problems|2|||
48622920|NCT00414609|156476605|FG002|Core Study|Administrative problems|0|||
48622921|NCT00414609|156476603|FG000|Core Study|Death|7|||
48622922|NCT00414609|156476604|FG001|Core Study|Death|14|||
48622923|NCT00414609|156476605|FG002|Core Study|Death|0|||
48622924|NCT00414609|156476603|FG000|Extension Study|Adverse Event|0|||
48622925|NCT00414609|156476604|FG001|Extension Study|Adverse Event|0|||
48622926|NCT00414609|156476605|FG002|Extension Study|Adverse Event|14|||
48622927|NCT00414609|156476603|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
48622928|NCT00414609|156476604|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
48622929|NCT00414609|156476605|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
48622930|NCT00414609|156476603|FG000|Extension Study|Withdrawal by Subject|0|||
48622931|NCT00414609|156476604|FG001|Extension Study|Withdrawal by Subject|0|||
48622932|NCT00414609|156476605|FG002|Extension Study|Withdrawal by Subject|13|||
48622933|NCT00414609|156476603|FG000|Extension Study|Lost to Follow-up|0|||
48622934|NCT00414609|156476604|FG001|Extension Study|Lost to Follow-up|0|||
48622935|NCT00414609|156476605|FG002|Extension Study|Lost to Follow-up|10|||
48622936|NCT00414609|156476603|FG000|Extension Study|Administrative problems|0|||
48622937|NCT00414609|156476604|FG001|Extension Study|Administrative problems|0|||
48622938|NCT00414609|156476605|FG002|Extension Study|Administrative problems|1|||
48622939|NCT00414609|156476603|FG000|Extension Study|Death|0|||
48622940|NCT00414609|156476604|FG001|Extension Study|Death|0|||
48622941|NCT00414609|156476605|FG002|Extension Study|Death|17|||
48739920|NCT00142298|156895750|FG004|Overall Study|Lost to Follow-up|0|||
48739921|NCT00142298|156895751|FG005|Overall Study|Lost to Follow-up|0|||
48739922|NCT00142298|156895752|FG006|Overall Study|Lost to Follow-up|2|||
48739923|NCT00142298|156895753|FG007|Overall Study|Lost to Follow-up|0|||
48739924|NCT00142298|156895754|FG008|Overall Study|Lost to Follow-up|0|||
48739925|NCT00142298|156895755|FG009|Overall Study|Lost to Follow-up|0|||
48739926|NCT00142298|156895746|FG000|Overall Study|Treatment Failure|0|||
48739927|NCT00142298|156895747|FG001|Overall Study|Treatment Failure|0|||
48739928|NCT00142298|156895748|FG002|Overall Study|Treatment Failure|0|||
48739929|NCT00142298|156895749|FG003|Overall Study|Treatment Failure|0|||
48739930|NCT00142298|156895750|FG004|Overall Study|Treatment Failure|0|||
48739931|NCT00142298|156895751|FG005|Overall Study|Treatment Failure|2|||
48739932|NCT00142298|156895752|FG006|Overall Study|Treatment Failure|2|||
48739933|NCT00142298|156895753|FG007|Overall Study|Treatment Failure|0|||
48739934|NCT00142298|156895754|FG008|Overall Study|Treatment Failure|0|||
48739935|NCT00142298|156895755|FG009|Overall Study|Treatment Failure|0|||
48739936|NCT00242216|156895756|FG000|Overall Study|Lost to Follow-up|12|||
48739937|NCT00242216|156895757|FG001|Overall Study|Lost to Follow-up|17|||
48739938|NCT00242216|156895756|FG000|Overall Study|Death|4|||
48739939|NCT00242216|156895757|FG001|Overall Study|Death|2|||
48739940|NCT00242216|156895756|FG000|Overall Study|Lack of Efficacy|1|||
48739941|NCT00242216|156895757|FG001|Overall Study|Lack of Efficacy|2|||
48739942|NCT00242216|156895756|FG000|Overall Study|no medicaiton dispensed|1|||
48739943|NCT00242216|156895757|FG001|Overall Study|no medicaiton dispensed|1|||
48739944|NCT01980940|156895758|FG000|Overall Study|Protocol Violation|0|||
48739945|NCT01980940|156895759|FG001|Overall Study|Protocol Violation|0|||
48739946|NCT01980940|156895760|FG002|Overall Study|Protocol Violation|0|||
48622942|NCT00576407|156476606|FG000|Overall Study|Death|7|||
48739947|NCT01980940|156895761|FG003|Overall Study|Protocol Violation|0|||
48739948|NCT01980940|156895762|FG004|Overall Study|Protocol Violation|0|||
48739949|NCT01980940|156895763|FG005|Overall Study|Protocol Violation|2|||
48739950|NCT01980940|156895764|FG006|Overall Study|Protocol Violation|0|||
48739951|NCT01980940|156895765|FG007|Overall Study|Protocol Violation|0|||
48739952|NCT02079740|156897368|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
48739953|NCT02079740|156897369|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
48739954|NCT02079740|156897370|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
48622943|NCT00576407|156476606|FG000|Overall Study|Physician Decision|1|||
48622944|NCT04641975|156476607|FG000|Overall Study|Protocol Violation|1|||
48584896|NCT00980174|156333701|FG000|Overall Study|Other|0|||
48584897|NCT00980174|156333702|FG001|Overall Study|Other|1|||
48584898|NCT00455520|156333705|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
48584899|NCT00455520|156333706|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
48584900|NCT00455520|156333705|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
48584901|NCT00455520|156333706|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
48584902|NCT00455520|156333705|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
48584903|NCT00455520|156333706|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
48584904|NCT00455520|156333705|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
48584905|NCT00455520|156333706|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
48584906|NCT00455520|156333705|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
48584907|NCT00455520|156333706|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
48584908|NCT00455520|156333705|FG000|Open Label Tapentadol Extended Release|All other|33|||
48584909|NCT00455520|156333706|FG001|Open Label Tapentadol Extended Release|All other|0|||
48584910|NCT00455520|156333705|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
48584911|NCT00455520|156333706|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
48584912|NCT00455520|156333705|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
48584913|NCT00455520|156333706|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
48584914|NCT00455520|156333705|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
48584915|NCT00455520|156333706|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
48584916|NCT00455520|156333705|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
48584917|NCT00455520|156333706|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
48584918|NCT00455520|156333705|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
48584919|NCT00455520|156333706|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
48584920|NCT00455520|156333705|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
48584921|NCT00455520|156333706|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
48584922|NCT00628095|156333708|FG000|Overall Study|Adverse Event|5|||
48584923|NCT00628095|156333709|FG001|Overall Study|Adverse Event|3|||
48584924|NCT00628095|156333708|FG000|Overall Study|Lack of Efficacy|0|||
48584925|NCT00628095|156333709|FG001|Overall Study|Lack of Efficacy|3|||
48584926|NCT00628095|156333708|FG000|Overall Study|Withdrawal by Subject|2|||
48622945|NCT04641975|156476608|FG001|Overall Study|Protocol Violation|2|||
48622946|NCT04641975|156476609|FG002|Overall Study|Protocol Violation|0|||
48622947|NCT04641975|156476610|FG003|Overall Study|Protocol Violation|0|||
48622948|NCT04641975|156476607|FG000|Overall Study|Adverse Event|0|||
48622949|NCT04641975|156476608|FG001|Overall Study|Adverse Event|0|||
48622950|NCT04641975|156476609|FG002|Overall Study|Adverse Event|1|||
48622951|NCT04641975|156476610|FG003|Overall Study|Adverse Event|1|||
48622952|NCT04641975|156476607|FG000|Overall Study|Withdrawal by Subject|1|||
48622953|NCT04641975|156476608|FG001|Overall Study|Withdrawal by Subject|0|||
48622954|NCT04641975|156476609|FG002|Overall Study|Withdrawal by Subject|0|||
48622955|NCT04641975|156476610|FG003|Overall Study|Withdrawal by Subject|0|||
48622956|NCT03142334|156476614|FG000|Overall Study|Death|18|||
48622957|NCT03142334|156476615|FG001|Overall Study|Death|33|||
48622958|NCT03142334|156476614|FG000|Overall Study|Withdrawal by Subject|15|||
48622959|NCT03142334|156476615|FG001|Overall Study|Withdrawal by Subject|11|||
48622960|NCT03142334|156476614|FG000|Overall Study|Ongoing on trial follow up|463|||
48622961|NCT03142334|156476615|FG001|Overall Study|Ongoing on trial follow up|454|||
48622962|NCT00191152|156476621|FG000|Initial Treatment|Adverse Event|43|||
48622963|NCT00191152|156476622|FG001|Initial Treatment|Adverse Event|67|||
48622964|NCT00191152|156476621|FG000|Initial Treatment|Physician Decision|40|||
48622965|NCT00191152|156476622|FG001|Initial Treatment|Physician Decision|31|||
48622966|NCT00191152|156476621|FG000|Initial Treatment|Withdrawal by Subject|40|||
48622967|NCT00191152|156476622|FG001|Initial Treatment|Withdrawal by Subject|28|||
48622968|NCT00191152|156476621|FG000|Initial Treatment|Lost to Follow-up|0|||
48622969|NCT00191152|156476622|FG001|Initial Treatment|Lost to Follow-up|6|||
48622970|NCT00191152|156476621|FG000|Initial Treatment|Other|18|||
48622971|NCT00191152|156476622|FG001|Initial Treatment|Other|21|||
48622972|NCT00191152|156476621|FG000|Crossover Treatment|Adverse Event|8|||
48322951|NCT00943917|155380250|FG011|Stage II Continuation|Protocol Violation|1|||
48322952|NCT00943917|155380251|FG012|Stage II Continuation|Protocol Violation|0|||
48322953|NCT00943917|155380252|FG013|Stage II Continuation|Protocol Violation|0|||
48322954|NCT00943917|155380253|FG014|Stage II Continuation|Protocol Violation|0|||
48322955|NCT00943917|155380239|FG000|Stage II Continuation|hypoglycemia|0|||
48322956|NCT00943917|155380240|FG001|Stage II Continuation|hypoglycemia|0|||
48322957|NCT00943917|155380241|FG002|Stage II Continuation|hypoglycemia|0|||
48322958|NCT00943917|155380242|FG003|Stage II Continuation|hypoglycemia|0|||
48322959|NCT00943917|155380243|FG004|Stage II Continuation|hypoglycemia|0|||
48322960|NCT00943917|155380244|FG005|Stage II Continuation|hypoglycemia|0|||
48322961|NCT00943917|155380245|FG006|Stage II Continuation|hypoglycemia|0|||
48322962|NCT00943917|155380246|FG007|Stage II Continuation|hypoglycemia|0|||
48322963|NCT00943917|155380247|FG008|Stage II Continuation|hypoglycemia|0|||
48322964|NCT00943917|155380248|FG009|Stage II Continuation|hypoglycemia|0|||
48322965|NCT00943917|155380249|FG010|Stage II Continuation|hypoglycemia|0|||
48322966|NCT00943917|155380250|FG011|Stage II Continuation|hypoglycemia|0|||
48322967|NCT00943917|155380251|FG012|Stage II Continuation|hypoglycemia|1|||
48322968|NCT00943917|155380252|FG013|Stage II Continuation|hypoglycemia|0|||
48322969|NCT00943917|155380253|FG014|Stage II Continuation|hypoglycemia|0|||
48322970|NCT00943917|155380239|FG000|Stage II Continuation|A1C elevation|0|||
48322971|NCT00943917|155380240|FG001|Stage II Continuation|A1C elevation|0|||
48322972|NCT00943917|155380241|FG002|Stage II Continuation|A1C elevation|0|||
48322973|NCT00943917|155380242|FG003|Stage II Continuation|A1C elevation|0|||
48622973|NCT00191152|156476622|FG001|Crossover Treatment|Adverse Event|8|||
48622974|NCT00191152|156476621|FG000|Crossover Treatment|Physician Decision|7|||
48622975|NCT00191152|156476622|FG001|Crossover Treatment|Physician Decision|7|||
48622976|NCT00191152|156476621|FG000|Crossover Treatment|Withdrawal by Subject|6|||
48622977|NCT00191152|156476622|FG001|Crossover Treatment|Withdrawal by Subject|9|||
48322974|NCT00943917|155380243|FG004|Stage II Continuation|A1C elevation|0|||
48322975|NCT00943917|155380244|FG005|Stage II Continuation|A1C elevation|0|||
48322976|NCT00943917|155380245|FG006|Stage II Continuation|A1C elevation|0|||
48739955|NCT02079740|156897371|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
48739956|NCT02079740|156897372|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
48739957|NCT02079740|156897373|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
48739958|NCT02079740|156897374|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
48739959|NCT02079740|156897375|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
48739960|NCT02079740|156897376|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
48739961|NCT02079740|156897377|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
48739962|NCT02079740|156897378|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
48739963|NCT02079740|156897379|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
48739964|NCT02079740|156897380|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
48739965|NCT02079740|156897368|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
48739966|NCT02079740|156897369|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
48322977|NCT00943917|155380246|FG007|Stage II Continuation|A1C elevation|0|||
48622978|NCT00191152|156476621|FG000|Crossover Treatment|Lost to Follow-up|2|||
48622979|NCT00191152|156476622|FG001|Crossover Treatment|Lost to Follow-up|1|||
48622980|NCT00191152|156476621|FG000|Crossover Treatment|Other|4|||
48622981|NCT00191152|156476622|FG001|Crossover Treatment|Other|3|||
48622982|NCT02739828|156476623|FG000|Overall Study|Adverse Event|1|||
48622983|NCT02739828|156476623|FG000|Overall Study|Lost to Follow-up|4|||
48622984|NCT03364686|156476624|FG000|Overall Study|Physician Decision|2|||
48622985|NCT01953354|156476625|FG000|Overall Study|Withdrawal by Subject|0|||
48622986|NCT01953354|156476626|FG001|Overall Study|Withdrawal by Subject|1|||
48622987|NCT01953354|156476625|FG000|Overall Study|Decision of Sponsor|0|||
48622988|NCT01953354|156476626|FG001|Overall Study|Decision of Sponsor|1|||
48622989|NCT01953354|156476625|FG000|Overall Study|Disease Exacerbation|1|||
48622990|NCT01953354|156476626|FG001|Overall Study|Disease Exacerbation|0|||
48622991|NCT01392495|156476627|FG000|Overall Study|Death|3|||
48622992|NCT01392495|156476627|FG000|Overall Study|Administrative problems|8|||
48622993|NCT01392495|156476627|FG000|Overall Study|Withdrawal by Subject|2|||
48622994|NCT01392495|156476627|FG000|Overall Study|Adverse Event|3|||
48622995|NCT01986751|156476628|FG000|Overall Study|improperly consented|10|||
48622996|NCT01986751|156476629|FG001|Overall Study|improperly consented|2|||
48622997|NCT00063999|156476630|FG000|Overall Study|Withdrawal by Subject|1|||
48622998|NCT00063999|156476631|FG001|Overall Study|Withdrawal by Subject|0|||
48622999|NCT00063999|156476630|FG000|Overall Study|Ineligible|44|||
48322978|NCT00943917|155380247|FG008|Stage II Continuation|A1C elevation|0|||
48322979|NCT00943917|155380248|FG009|Stage II Continuation|A1C elevation|0|||
48322980|NCT00943917|155380249|FG010|Stage II Continuation|A1C elevation|0|||
48623000|NCT00063999|156476631|FG001|Overall Study|Ineligible|24|||
48623001|NCT01340170|156476633|FG000|Overall Study|Lost to Follow-up|2|||
48623002|NCT01340170|156476634|FG001|Overall Study|Lost to Follow-up|4|||
48623003|NCT01340170|156476635|FG002|Overall Study|Lost to Follow-up|0|||
48623004|NCT01340170|156476633|FG000|Overall Study|Implant failure|1|||
48739967|NCT02079740|156897370|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
48322981|NCT00943917|155380250|FG011|Stage II Continuation|A1C elevation|0|||
48623005|NCT01340170|156476634|FG001|Overall Study|Implant failure|3|||
48623006|NCT01340170|156476635|FG002|Overall Study|Implant failure|0|||
48623007|NCT02191397|156476636|FG000|Overall Study|Adverse Event|28|||
48739968|NCT02079740|156897371|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
48739969|NCT02079740|156897372|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
48739970|NCT02079740|156897373|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
48739971|NCT02079740|156897374|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
48739972|NCT02079740|156897375|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
48739973|NCT02079740|156897376|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
48739974|NCT02079740|156897377|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
48739975|NCT02079740|156897378|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
48739976|NCT02079740|156897379|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
48739977|NCT02079740|156897380|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
48739978|NCT02079740|156897368|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739979|NCT02079740|156897369|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739980|NCT02079740|156897370|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739981|NCT02079740|156897371|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
48623008|NCT02191397|156476637|FG001|Overall Study|Adverse Event|17|||
48623009|NCT02191397|156476636|FG000|Overall Study|Lack of Efficacy|10|||
48623010|NCT02191397|156476637|FG001|Overall Study|Lack of Efficacy|5|||
48623011|NCT02191397|156476636|FG000|Overall Study|Protocol Violation|0|||
48623012|NCT02191397|156476637|FG001|Overall Study|Protocol Violation|3|||
48739982|NCT02079740|156897372|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739983|NCT02079740|156897373|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739984|NCT02079740|156897374|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739985|NCT02079740|156897375|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
48739986|NCT02079740|156897376|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739987|NCT02079740|156897377|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739988|NCT02079740|156897378|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
48739989|NCT02079740|156897379|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
48322982|NCT00943917|155380251|FG012|Stage II Continuation|A1C elevation|0|||
48322983|NCT00943917|155380252|FG013|Stage II Continuation|A1C elevation|1|||
48322984|NCT00943917|155380253|FG014|Stage II Continuation|A1C elevation|0|||
48322985|NCT03631407|155380254|FG000|Overall Study|Withdrawal by Subject|3|||
48322986|NCT03631407|155380255|FG001|Overall Study|Withdrawal by Subject|2|||
48322987|NCT03631407|155380254|FG000|Overall Study|Sponsor Decision|0|||
48322988|NCT03631407|155380255|FG001|Overall Study|Sponsor Decision|2|||
48322989|NCT03631407|155380254|FG000|Overall Study|Death|16|||
48322990|NCT03631407|155380255|FG001|Overall Study|Death|16|||
48322991|NCT03631407|155380254|FG000|Overall Study|Randomized by mistake without study treatment|1|||
48322992|NCT03631407|155380255|FG001|Overall Study|Randomized by mistake without study treatment|0|||
48322993|NCT01695954|155380256|FG000|Overall Study|Withdrawal by Subject|4|||
48322994|NCT01695954|155380257|FG001|Overall Study|Withdrawal by Subject|0|||
48322995|NCT01695954|155380256|FG000|Overall Study|Adverse Event|0|||
48623013|NCT02191397|156476636|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
48623014|NCT02191397|156476637|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
48623015|NCT02191397|156476636|FG000|Overall Study|Lost to Follow-up|10|||
48623016|NCT02191397|156476637|FG001|Overall Study|Lost to Follow-up|11|||
48623017|NCT02191397|156476636|FG000|Overall Study|Physician Decision|8|||
48623018|NCT02191397|156476637|FG001|Overall Study|Physician Decision|3|||
48623019|NCT02191397|156476636|FG000|Overall Study|Withdrawal by Subject|22|||
48623020|NCT02191397|156476637|FG001|Overall Study|Withdrawal by Subject|27|||
48623021|NCT02852005|156476640|FG000|Overall Study|Lost to Follow-up|0|||
48623022|NCT02852005|156476641|FG001|Overall Study|Lost to Follow-up|0|||
48623023|NCT02852005|156476642|FG002|Overall Study|Lost to Follow-up|0|||
48623024|NCT02852005|156476643|FG003|Overall Study|Lost to Follow-up|0|||
48623025|NCT02852005|156476644|FG004|Overall Study|Lost to Follow-up|1|||
48623026|NCT02852005|156476640|FG000|Overall Study|Withdrawal by Subject|1|||
48623027|NCT02852005|156476641|FG001|Overall Study|Withdrawal by Subject|0|||
48623028|NCT02852005|156476642|FG002|Overall Study|Withdrawal by Subject|0|||
48623029|NCT02852005|156476643|FG003|Overall Study|Withdrawal by Subject|0|||
48623030|NCT02852005|156476644|FG004|Overall Study|Withdrawal by Subject|0|||
48623031|NCT00545948|156476645|FG000|Overall Study|Not Treated|1|||
48623032|NCT00545948|156476646|FG001|Overall Study|Not Treated|1|||
48623033|NCT00545948|156476647|FG002|Overall Study|Not Treated|7|||
48623034|NCT03976375|156476650|FG000|Overall Study|Death|147|||
48623035|NCT03976375|156476651|FG001|Overall Study|Death|150|||
48623036|NCT03976375|156476652|FG002|Overall Study|Death|38|||
48322996|NCT01695954|155380257|FG001|Overall Study|Adverse Event|2|||
48322997|NCT02269475|155380265|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
48322998|NCT02269475|155380266|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
48623037|NCT03976375|156476650|FG000|Overall Study|Lost to Follow-up|1|||
48322999|NCT02269475|155380265|FG000|Overall Study|Withdrawal by Subject|0|||
48323000|NCT02269475|155380266|FG001|Overall Study|Withdrawal by Subject|1|||
48623038|NCT03976375|156476651|FG001|Overall Study|Lost to Follow-up|1|||
48623039|NCT03976375|156476652|FG002|Overall Study|Lost to Follow-up|1|||
48323001|NCT03884101|155380269|FG000|Overall Study|Participant Ongoing in Study|202|||
48323002|NCT03884101|155380270|FG001|Overall Study|Participant Ongoing in Study|186|||
48323003|NCT03884101|155380269|FG000|Overall Study|Death|212|||
48323004|NCT03884101|155380270|FG001|Overall Study|Death|224|||
48323005|NCT03884101|155380269|FG000|Overall Study|Lost to Follow-up|0|||
48323006|NCT03884101|155380270|FG001|Overall Study|Lost to Follow-up|1|||
48323007|NCT03884101|155380269|FG000|Overall Study|Withdrawal by Subject|6|||
48323008|NCT03884101|155380270|FG001|Overall Study|Withdrawal by Subject|11|||
48323009|NCT05741294|155380271|FG000|Overall Study|Lost to Follow-up|3|||
48323010|NCT05741294|155380271|FG000|Overall Study|Protocol deviation|3|||
48323011|NCT05741294|155380271|FG000|Overall Study|Withdrawal by Subject|1|||
48323012|NCT04721977|155380272|FG000|Overall Study|Death|15|||
48323013|NCT04721977|155380272|FG000|Overall Study|Ongoing|51|||
48323014|NCT01778686|155380276|FG000|Overall Study|Adverse Event|0|||
48323015|NCT01778686|155380277|FG001|Overall Study|Adverse Event|0|||
48323016|NCT01778686|155380278|FG002|Overall Study|Adverse Event|1|||
48323017|NCT03221426|155380285|FG000|Overall Study|Ongoing in study|212|||
48323018|NCT03221426|155380286|FG001|Overall Study|Ongoing in study|193|||
48323019|NCT03221426|155380287|FG002|Overall Study|Ongoing in study|61|||
48323020|NCT03221426|155380288|FG003|Overall Study|Ongoing in study|55|||
48323021|NCT03221426|155380285|FG000|Overall Study|Withdrawal by Subject|12|||
48323022|NCT03221426|155380286|FG001|Overall Study|Withdrawal by Subject|4|||
48323023|NCT03221426|155380287|FG002|Overall Study|Withdrawal by Subject|2|||
48323024|NCT03221426|155380288|FG003|Overall Study|Withdrawal by Subject|3|||
48323025|NCT03221426|155380285|FG000|Overall Study|Lost to Follow-up|4|||
48323026|NCT03221426|155380286|FG001|Overall Study|Lost to Follow-up|1|||
48323027|NCT03221426|155380287|FG002|Overall Study|Lost to Follow-up|1|||
48323028|NCT03221426|155380288|FG003|Overall Study|Lost to Follow-up|0|||
48323029|NCT03221426|155380285|FG000|Overall Study|Death|174|||
48739990|NCT02079740|156897380|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
48323030|NCT03221426|155380286|FG001|Overall Study|Death|204|||
48323031|NCT03221426|155380287|FG002|Overall Study|Death|36|||
48323032|NCT03221426|155380288|FG003|Overall Study|Death|45|||
48323033|NCT05432986|155380289|FG000|Overall Study|Withdrawal by Subject|2|||
48323034|NCT05432986|155380289|FG000|Overall Study|incomplete measurement|7|||
48323035|NCT00670046|155381923|FG000|Overall Study|Lost to Follow-up|1|||
48323036|NCT00670046|155381924|FG001|Overall Study|Lost to Follow-up|1|||
48323037|NCT00670046|155381923|FG000|Overall Study|Withdrawal by Subject|0|||
48323038|NCT00670046|155381924|FG001|Overall Study|Withdrawal by Subject|1|||
48323039|NCT06571695|155381927|FG000|Overall Study|Lost to Follow-up|1|||
48739991|NCT02079740|156897368|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739992|NCT02079740|156897369|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739993|NCT02079740|156897370|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739994|NCT02079740|156897371|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739995|NCT02079740|156897372|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739996|NCT02079740|156897373|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739997|NCT02079740|156897374|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48739998|NCT02079740|156897375|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
48739999|NCT02079740|156897376|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740000|NCT02079740|156897377|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740001|NCT02079740|156897378|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740002|NCT02079740|156897379|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740003|NCT02079740|156897380|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
48740004|NCT02079740|156897368|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48323040|NCT06571695|155381928|FG001|Overall Study|Lost to Follow-up|6|||
48323041|NCT02962284|155381929|FG000|Overall Study|Death|2|||
48323042|NCT02962284|155381930|FG001|Overall Study|Death|0|||
48323043|NCT02962284|155381929|FG000|Overall Study|Progressive disease|2|||
48323044|NCT02962284|155381930|FG001|Overall Study|Progressive disease|3|||
48323045|NCT02962284|155381929|FG000|Overall Study|Withdrawal by Subject|1|||
48323046|NCT02962284|155381930|FG001|Overall Study|Withdrawal by Subject|0|||
48623040|NCT03976375|156476650|FG000|Overall Study|Withdrawal by Subject|4|||
48623041|NCT03976375|156476651|FG001|Overall Study|Withdrawal by Subject|9|||
48623042|NCT03976375|156476652|FG002|Overall Study|Withdrawal by Subject|4|||
48740005|NCT02079740|156897369|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48323047|NCT02422615|155381943|FG000|Treatment Period|Progressive disease|314|||
48323048|NCT02422615|155381944|FG001|Treatment Period|Progressive disease|200|||
48323049|NCT02422615|155381943|FG000|Treatment Period|Adverse Event|51|||
48323050|NCT02422615|155381944|FG001|Treatment Period|Adverse Event|9|||
48323051|NCT02422615|155381943|FG000|Treatment Period|Physician Decision|32|||
48323052|NCT02422615|155381944|FG001|Treatment Period|Physician Decision|8|||
48323053|NCT02422615|155381943|FG000|Treatment Period|Subject/guardian decision|38|||
48323054|NCT02422615|155381944|FG001|Treatment Period|Subject/guardian decision|8|||
48323055|NCT02422615|155381943|FG000|Treatment Period|Death|2|||
48323056|NCT02422615|155381944|FG001|Treatment Period|Death|1|||
48323057|NCT02422615|155381943|FG000|Treatment Period|Technical problems|0|||
48323058|NCT02422615|155381944|FG001|Treatment Period|Technical problems|1|||
48323059|NCT02422615|155381943|FG000|Treatment Period|Protocol deviation|1|||
48323060|NCT02422615|155381944|FG001|Treatment Period|Protocol deviation|1|||
48323061|NCT02422615|155381943|FG000|Treatment Period|Study terminated as per protocol|46|||
48323062|NCT02422615|155381944|FG001|Treatment Period|Study terminated as per protocol|14|||
48323063|NCT02422615|155381943|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
48323064|NCT02422615|155381944|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
48323065|NCT02422615|155381943|FG000|Post-treatment Efficacy Follow-up|Death|2|||
48323066|NCT02422615|155381944|FG001|Post-treatment Efficacy Follow-up|Death|1|||
48323067|NCT02422615|155381943|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48323068|NCT02422615|155381944|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48323069|NCT02422615|155381943|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
48323070|NCT02422615|155381944|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
48323071|NCT02422615|155381943|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
48323072|NCT02422615|155381944|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
48323073|NCT02422615|155381943|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
48323074|NCT02422615|155381944|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
48740006|NCT02079740|156897370|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48323075|NCT01036724|155381945|FG000|Overall Study|Adverse Event|1|||
48323076|NCT01036724|155381946|FG001|Overall Study|Adverse Event|2|||
48323077|NCT01036724|155381945|FG000|Overall Study|Lack of Efficacy|1|||
48323078|NCT01036724|155381946|FG001|Overall Study|Lack of Efficacy|1|||
48323079|NCT01036724|155381945|FG000|Overall Study|Protocol Violation|4|||
48323080|NCT01036724|155381946|FG001|Overall Study|Protocol Violation|5|||
48323081|NCT00402246|155381947|FG000|Overall Study|Death|62|||
48323082|NCT00402246|155381948|FG001|Overall Study|Death|58|||
48323083|NCT00402246|155381947|FG000|Overall Study|Lost to Follow-up|20|||
48323084|NCT00402246|155381948|FG001|Overall Study|Lost to Follow-up|28|||
48623043|NCT03976375|156476650|FG000|Overall Study|Ongoing|33|||
48623044|NCT03976375|156476651|FG001|Overall Study|Ongoing|29|||
48623045|NCT03976375|156476652|FG002|Overall Study|Ongoing|5|||
48623046|NCT00562861|156476653|FG000|Overall Study|Adverse Event|1|||
48623047|NCT00562861|156476654|FG001|Overall Study|Adverse Event|1|||
48623048|NCT00562861|156476653|FG000|Overall Study|Lack of Efficacy|5|||
48623049|NCT00562861|156476654|FG001|Overall Study|Lack of Efficacy|5|||
48623050|NCT00562861|156476653|FG000|Overall Study|noncompliance, moved|7|||
48323085|NCT00402246|155381947|FG000|Overall Study|Withdrawal by Subject|72|||
48323086|NCT00402246|155381948|FG001|Overall Study|Withdrawal by Subject|87|||
48323087|NCT00402246|155381947|FG000|Overall Study|Physician Decision|24|||
48740007|NCT02079740|156897371|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48740008|NCT02079740|156897372|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48740009|NCT02079740|156897373|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48323088|NCT00402246|155381948|FG001|Overall Study|Physician Decision|26|||
48323089|NCT00402246|155381947|FG000|Overall Study|Protocol Violation|25|||
48323090|NCT00402246|155381948|FG001|Overall Study|Protocol Violation|24|||
48323091|NCT00402246|155381947|FG000|Overall Study|Missed Final Visit|1|||
48323092|NCT00402246|155381948|FG001|Overall Study|Missed Final Visit|2|||
48323093|NCT00402246|155381947|FG000|Overall Study|Insurance Issues|2|||
48323094|NCT00402246|155381948|FG001|Overall Study|Insurance Issues|1|||
48323095|NCT00402246|155381947|FG000|Overall Study|Heart Transplant|0|||
48323096|NCT00402246|155381948|FG001|Overall Study|Heart Transplant|1|||
48323097|NCT00402246|155381947|FG000|Overall Study|Patient's device explanted|6|||
48623051|NCT00562861|156476654|FG001|Overall Study|noncompliance, moved|2|||
48623052|NCT00562861|156476653|FG000|Overall Study|Lost to Follow-up|7|||
48623053|NCT00562861|156476654|FG001|Overall Study|Lost to Follow-up|3|||
48740010|NCT02079740|156897374|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48740011|NCT02079740|156897375|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48323098|NCT00402246|155381948|FG001|Overall Study|Patient's device explanted|2|||
48323099|NCT00402246|155381947|FG000|Overall Study|Center Closure|5|||
48323100|NCT00402246|155381948|FG001|Overall Study|Center Closure|3|||
48323101|NCT00402246|155381947|FG000|Overall Study|Deterioriating Condition|3|||
48623054|NCT00655356|156476655|FG000|Overall Study|Withdrawal by Subject|3|||
48623055|NCT00655356|156476656|FG001|Overall Study|Withdrawal by Subject|4|||
48623056|NCT00655356|156476655|FG000|Overall Study|Sponsor Request|10|||
48740012|NCT02079740|156897376|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48323102|NCT00402246|155381948|FG001|Overall Study|Deterioriating Condition|2|||
48323103|NCT01288443|155381949|FG000|Overall Study|Adverse Event|0|||
48323104|NCT01288443|155381950|FG001|Overall Study|Adverse Event|0|||
48323105|NCT01288443|155381951|FG002|Overall Study|Adverse Event|1|||
48323106|NCT01288443|155381952|FG003|Overall Study|Adverse Event|1|||
48323107|NCT01288443|155381953|FG004|Overall Study|Adverse Event|3|||
48323108|NCT01288443|155381954|FG005|Overall Study|Adverse Event|1|||
48323109|NCT01288443|155381949|FG000|Overall Study|Poor compliance to protocol|0|||
48323110|NCT01288443|155381950|FG001|Overall Study|Poor compliance to protocol|0|||
48623057|NCT00655356|156476656|FG001|Overall Study|Sponsor Request|4|||
48623058|NCT00655356|156476655|FG000|Overall Study|Adverse Event|1|||
48623059|NCT00655356|156476656|FG001|Overall Study|Adverse Event|1|||
48740013|NCT02079740|156897377|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
48740014|NCT02079740|156897378|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
48740015|NCT02079740|156897379|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
48323111|NCT01288443|155381951|FG002|Overall Study|Poor compliance to protocol|0|||
48323112|NCT01288443|155381952|FG003|Overall Study|Poor compliance to protocol|0|||
48323113|NCT01288443|155381953|FG004|Overall Study|Poor compliance to protocol|0|||
48323114|NCT01288443|155381954|FG005|Overall Study|Poor compliance to protocol|1|||
48323115|NCT01288443|155381949|FG000|Overall Study|Participant Moved|0|||
48323116|NCT01288443|155381950|FG001|Overall Study|Participant Moved|0|||
48323117|NCT01288443|155381951|FG002|Overall Study|Participant Moved|0|||
48323118|NCT01288443|155381952|FG003|Overall Study|Participant Moved|1|||
48323119|NCT01288443|155381953|FG004|Overall Study|Participant Moved|2|||
48323120|NCT01288443|155381954|FG005|Overall Study|Participant Moved|1|||
48323121|NCT01288443|155381949|FG000|Overall Study|Consent withdrawn by Participant|0|||
48323122|NCT01288443|155381950|FG001|Overall Study|Consent withdrawn by Participant|0|||
48623060|NCT00655356|156476655|FG000|Overall Study|Protocol Violation|2|||
48323123|NCT01288443|155381951|FG002|Overall Study|Consent withdrawn by Participant|0|||
48323124|NCT01288443|155381952|FG003|Overall Study|Consent withdrawn by Participant|0|||
48323125|NCT01288443|155381953|FG004|Overall Study|Consent withdrawn by Participant|0|||
48323126|NCT01288443|155381954|FG005|Overall Study|Consent withdrawn by Participant|1|||
48323127|NCT01288443|155381949|FG000|Overall Study|Lost to Follow-up|0|||
48323128|NCT01288443|155381950|FG001|Overall Study|Lost to Follow-up|1|||
48323129|NCT01288443|155381951|FG002|Overall Study|Lost to Follow-up|0|||
48323130|NCT01288443|155381952|FG003|Overall Study|Lost to Follow-up|0|||
48323131|NCT01288443|155381953|FG004|Overall Study|Lost to Follow-up|0|||
48323132|NCT01288443|155381954|FG005|Overall Study|Lost to Follow-up|0|||
48323133|NCT01288443|155381949|FG000|Overall Study|Study drug auto-injector administration|0|||
48323134|NCT01288443|155381950|FG001|Overall Study|Study drug auto-injector administration|0|||
48323135|NCT01288443|155381951|FG002|Overall Study|Study drug auto-injector administration|0|||
48740016|NCT02079740|156897380|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
48740017|NCT05644444|156897381|FG000|Tolerance Phase|Adverse Event|0|||
48740018|NCT05644444|156897382|FG001|Tolerance Phase|Adverse Event|2|||
48740019|NCT05644444|156897381|FG000|Treatment Phase|Adverse Event|0|||
48740020|NCT05644444|156897382|FG001|Treatment Phase|Adverse Event|2|||
48740021|NCT01649271|156897390|FG000|Overall Study|Progressive disease|4|||
48740022|NCT01649271|156897391|FG001|Overall Study|Progressive disease|5|||
48740023|NCT01649271|156897390|FG000|Overall Study|Other Adverse Event|0|||
48740024|NCT01649271|156897391|FG001|Overall Study|Other Adverse Event|2|||
48740025|NCT01649271|156897390|FG000|Overall Study|Withdrawal by Subject|1|||
48740026|NCT01649271|156897391|FG001|Overall Study|Withdrawal by Subject|0|||
48740027|NCT01649271|156897390|FG000|Overall Study|Other than stated above|1|||
48740028|NCT01649271|156897391|FG001|Overall Study|Other than stated above|0|||
48740029|NCT00392015|156897392|FG000|Overall Study|Lost to Follow-up|2|||
48740030|NCT00392015|156897393|FG001|Overall Study|Lost to Follow-up|0|||
48323136|NCT01288443|155381952|FG003|Overall Study|Study drug auto-injector administration|0|||
48323137|NCT01288443|155381953|FG004|Overall Study|Study drug auto-injector administration|1|||
48323138|NCT01288443|155381954|FG005|Overall Study|Study drug auto-injector administration|1|||
48323139|NCT01288443|155381949|FG000|Overall Study|Other than above|0|||
48323140|NCT01288443|155381950|FG001|Overall Study|Other than above|0|||
48623061|NCT00655356|156476656|FG001|Overall Study|Protocol Violation|1|||
48623062|NCT00655356|156476655|FG000|Overall Study|Other Reason|1|||
48623063|NCT00655356|156476656|FG001|Overall Study|Other Reason|0|||
48623064|NCT01657942|156476657|FG000|Overall Study|Alternative Treatment|7|||
48623065|NCT01657942|156476657|FG000|Overall Study|Lost to Follow-up|1|||
48623068|NCT01734928|156477991|FG000|Randomization|Physician Decision|0|||
48623069|NCT01734928|156477992|FG001|Randomization|Physician Decision|1|||
48623070|NCT01734928|156477991|FG000|Randomization|clinical progression|0|||
48623071|NCT01734928|156477992|FG001|Randomization|clinical progression|1|||
48623072|NCT01734928|156477991|FG000|Randomization|progressive disease|0|||
48623073|NCT01734928|156477992|FG001|Randomization|progressive disease|2|||
48323141|NCT01288443|155381951|FG002|Overall Study|Other than above|0|||
48623074|NCT01734928|156477991|FG000|Randomization|Withdrew informed consent|0|||
48623075|NCT01734928|156477992|FG001|Randomization|Withdrew informed consent|4|||
48623076|NCT01734928|156477991|FG000|Randomization|Death|1|||
48740031|NCT00392015|156897394|FG002|Overall Study|Lost to Follow-up|2|||
48740032|NCT00392015|156897395|FG003|Overall Study|Lost to Follow-up|1|||
48740033|NCT00392015|156897396|FG004|Overall Study|Lost to Follow-up|1|||
48740034|NCT00392015|156897397|FG005|Overall Study|Lost to Follow-up|0|||
48323142|NCT01288443|155381952|FG003|Overall Study|Other than above|2|||
48323143|NCT01288443|155381953|FG004|Overall Study|Other than above|1|||
48323144|NCT01288443|155381954|FG005|Overall Study|Other than above|0|||
48323145|NCT00739908|155381955|FG000|Overall Study|Adverse Event|5|||
48323146|NCT00739908|155381956|FG001|Overall Study|Adverse Event|6|||
48323147|NCT00739908|155381955|FG000|Overall Study|Withdrawal by Subject|4|||
48323148|NCT00739908|155381956|FG001|Overall Study|Withdrawal by Subject|2|||
48323149|NCT00739908|155381955|FG000|Overall Study|Lost to Follow-up|14|||
48323150|NCT00739908|155381956|FG001|Overall Study|Lost to Follow-up|9|||
48323151|NCT00739908|155381955|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
48323152|NCT00739908|155381956|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
48323153|NCT00739908|155381955|FG000|Overall Study|Non-Compliance With Study Medication|0|||
48323154|NCT00739908|155381956|FG001|Overall Study|Non-Compliance With Study Medication|3|||
48323155|NCT00739908|155381955|FG000|Overall Study|Lack of Efficacy|0|||
48323156|NCT00739908|155381956|FG001|Overall Study|Lack of Efficacy|1|||
48323157|NCT00739908|155381955|FG000|Overall Study|Relocation|0|||
48323158|NCT00739908|155381956|FG001|Overall Study|Relocation|1|||
48323159|NCT01639131|155381957|FG000|Overall Study|Disease Progression|6|||
48323160|NCT00495677|155381958|FG000|Stage 1 (25 Days)|Adverse Event|0|||
48323161|NCT00495677|155381959|FG001|Stage 1 (25 Days)|Adverse Event|0|||
48323162|NCT00495677|155381960|FG002|Stage 1 (25 Days)|Adverse Event|1|||
48323163|NCT00495677|155381961|FG003|Stage 1 (25 Days)|Adverse Event|0|||
48323164|NCT00495677|155381962|FG004|Stage 1 (25 Days)|Adverse Event|0|||
48323165|NCT00495677|155381963|FG005|Stage 1 (25 Days)|Adverse Event|0|||
48323166|NCT00495677|155381964|FG006|Stage 1 (25 Days)|Adverse Event|0|||
48323167|NCT01964300|155381965|FG000|Overall Study|Ineligible after enrollment|0|||
48323168|NCT01964300|155381966|FG001|Overall Study|Ineligible after enrollment|1|||
48323169|NCT01964300|155381965|FG000|Overall Study|Adverse Event|1|||
48323170|NCT01964300|155381966|FG001|Overall Study|Adverse Event|1|||
48323171|NCT01964300|155381965|FG000|Overall Study|Lack of Efficacy|3|||
48323172|NCT01964300|155381966|FG001|Overall Study|Lack of Efficacy|5|||
48323173|NCT01964300|155381965|FG000|Overall Study|Withdrawal by Subject|0|||
48323174|NCT01964300|155381966|FG001|Overall Study|Withdrawal by Subject|1|||
48323175|NCT01964300|155381965|FG000|Overall Study|To receive alternative therapy|1|||
48323176|NCT01964300|155381966|FG001|Overall Study|To receive alternative therapy|2|||
48323177|NCT01964300|155381965|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
48623077|NCT01734928|156477992|FG001|Randomization|Death|0|||
48623078|NCT01734928|156477991|FG000|Randomization|Randomization error|1|||
48623079|NCT01734928|156477992|FG001|Randomization|Randomization error|0|||
48623080|NCT01734928|156477991|FG000|Randomization|Lost to Follow-up|1|||
48623081|NCT01734928|156477992|FG001|Randomization|Lost to Follow-up|0|||
48623082|NCT01734928|156477991|FG000|Treatment Period|Lost to Follow-up|0|||
48623083|NCT01734928|156477992|FG001|Treatment Period|Lost to Follow-up|2|||
48623084|NCT01734928|156477991|FG000|Treatment Period|Progressive Disease|167|||
48623085|NCT01734928|156477992|FG001|Treatment Period|Progressive Disease|165|||
48623086|NCT01734928|156477991|FG000|Treatment Period|Adverse Event|39|||
48623087|NCT01734928|156477992|FG001|Treatment Period|Adverse Event|52|||
48623088|NCT01734928|156477991|FG000|Treatment Period|Withdrawal of Consent|25|||
48623089|NCT01734928|156477992|FG001|Treatment Period|Withdrawal of Consent|22|||
48623090|NCT01734928|156477991|FG000|Treatment Period|Death|20|||
48623091|NCT01734928|156477992|FG001|Treatment Period|Death|9|||
48623092|NCT01734928|156477991|FG000|Treatment Period|Other Reasons|27|||
48623093|NCT01734928|156477992|FG001|Treatment Period|Other Reasons|19|||
48623094|NCT01734928|156477991|FG000|Treatment Period|Pregnancy|0|||
48623095|NCT01734928|156477992|FG001|Treatment Period|Pregnancy|1|||
48623096|NCT04359680|156477999|FG000|Overall Study|Withdrawal by Subject|29|||
48623097|NCT04359680|156478000|FG001|Overall Study|Withdrawal by Subject|24|||
48623098|NCT04359680|156477999|FG000|Overall Study|Adverse Event|6|||
48623099|NCT04359680|156478000|FG001|Overall Study|Adverse Event|2|||
48623100|NCT04359680|156477999|FG000|Overall Study|Lost to Follow-up|56|||
48740035|NCT00392015|156897392|FG000|Overall Study|Withdrawal by Subject|0|||
48323178|NCT01964300|155381966|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
48323179|NCT01964300|155381965|FG000|Overall Study|Weight criteria not met|0|||
48623101|NCT04359680|156478000|FG001|Overall Study|Lost to Follow-up|59|||
48623102|NCT04359680|156477999|FG000|Overall Study|Protocol Violation|3|||
48623103|NCT04359680|156478000|FG001|Overall Study|Protocol Violation|5|||
48623104|NCT04359680|156477999|FG000|Overall Study|Physician Decision|1|||
48623105|NCT04359680|156478000|FG001|Overall Study|Physician Decision|1|||
48623106|NCT04359680|156477999|FG000|Overall Study|Sponsor Decision|0|||
48623107|NCT04359680|156478000|FG001|Overall Study|Sponsor Decision|1|||
48623108|NCT02181621|156478001|FG000|Overall Study|Adverse Event|1|||
48623109|NCT02181621|156478002|FG001|Overall Study|Adverse Event|0|||
48623110|NCT02181621|156478001|FG000|Overall Study|Previously Enrolled|0|||
48623111|NCT02181621|156478002|FG001|Overall Study|Previously Enrolled|1|||
48623112|NCT02181621|156478001|FG000|Overall Study|Enrollment Hold|1|||
48623113|NCT02181621|156478002|FG001|Overall Study|Enrollment Hold|1|||
48623114|NCT02802865|156478003|FG000|Overall Study|Pregnancy|1|||
48623115|NCT02802865|156478004|FG001|Overall Study|Pregnancy|1|||
48623116|NCT02802865|156478003|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
48623117|NCT02802865|156478004|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
48623118|NCT01654250|156478005|FG000|Overall Study|Lost to Follow-up|1|||
48623119|NCT01654250|156478006|FG001|Overall Study|Lost to Follow-up|0|||
48623120|NCT01964560|156478007|FG000|Overall Study|Adverse Event|23|||
48623121|NCT01964560|156478007|FG000|Overall Study|Lack of Efficacy|46|||
48623122|NCT01964560|156478007|FG000|Overall Study|Protocol deviation|2|||
48623123|NCT01964560|156478007|FG000|Overall Study|Lost to Follow-up|4|||
48623124|NCT01964560|156478007|FG000|Overall Study|Withdrawal by Subject|64|||
48623125|NCT01964560|156478007|FG000|Overall Study|Surgery-hemispherotomy|1|||
48623126|NCT01964560|156478007|FG000|Overall Study|Surgery|1|||
48623127|NCT01964560|156478007|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
48623128|NCT01964560|156478007|FG000|Overall Study|Patient and Investigator choice|1|||
48623129|NCT01964560|156478007|FG000|Overall Study|Patient was prescribed CBD|1|||
48623130|NCT01964560|156478007|FG000|Overall Study|Participant moved to another country|1|||
48623131|NCT02301429|156478008|FG000|Overall Study|not acceptable vascular anatomy|3|||
48623132|NCT01502072|156478009|FG000|Overall Study|Withdrawal by Subject|1|||
48623133|NCT01502072|156478010|FG001|Overall Study|Withdrawal by Subject|0|||
48623134|NCT01502072|156478011|FG002|Overall Study|Withdrawal by Subject|0|||
48623135|NCT01502072|156478009|FG000|Overall Study|Death|0|||
48623136|NCT01502072|156478010|FG001|Overall Study|Death|1|||
48623137|NCT01502072|156478011|FG002|Overall Study|Death|0|||
48623138|NCT02123511|156478016|FG000|Overall Study|Cancelled treatment|1|||
48623139|NCT02123511|156478017|FG001|Overall Study|Cancelled treatment|0|||
48623140|NCT02123511|156478016|FG000|Overall Study|Incomplete data|1|||
48623141|NCT02123511|156478017|FG001|Overall Study|Incomplete data|3|||
48623142|NCT02123511|156478016|FG000|Overall Study|Ineligible|0|||
48623143|NCT02123511|156478017|FG001|Overall Study|Ineligible|1|||
48623144|NCT03954938|156478018|FG000|Overall Study|Withdrawal by Subject|2|||
48623145|NCT03954938|156478018|FG000|Overall Study|Adverse Event|1|||
48623146|NCT03671148|156478019|FG000|Overall Study|Adverse Event|3|||
48623147|NCT03671148|156478020|FG001|Overall Study|Adverse Event|2|||
48623148|NCT03671148|156478019|FG000|Overall Study|Withdrawal by Subject|8|||
48623149|NCT03671148|156478020|FG001|Overall Study|Withdrawal by Subject|2|||
48623150|NCT03671148|156478019|FG000|Overall Study|Lost to Follow-up|1|||
48623151|NCT03671148|156478020|FG001|Overall Study|Lost to Follow-up|2|||
48623152|NCT03671148|156478019|FG000|Overall Study|Lack of Efficacy|7|||
48623153|NCT03671148|156478020|FG001|Overall Study|Lack of Efficacy|2|||
48623154|NCT03671148|156478019|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
48623155|NCT03671148|156478020|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
48623156|NCT03671148|156478019|FG000|Overall Study|Other|1|||
48623157|NCT03671148|156478020|FG001|Overall Study|Other|0|||
48623158|NCT03671148|156478019|FG000|Overall Study|Incomplete Randomization Visit|1|||
48623159|NCT03671148|156478020|FG001|Overall Study|Incomplete Randomization Visit|0|||
48623160|NCT03892915|156478024|FG000|Overall Study|Lost to Follow-up|6|||
48623161|NCT03892915|156478025|FG001|Overall Study|Lost to Follow-up|12|||
48623162|NCT03892915|156478024|FG000|Overall Study|Death|0|||
48623163|NCT03892915|156478025|FG001|Overall Study|Death|2|||
48623164|NCT03892915|156478024|FG000|Overall Study|Withdrawal by Subject|1|||
48623165|NCT03892915|156478025|FG001|Overall Study|Withdrawal by Subject|1|||
48623166|NCT03892915|156478024|FG000|Overall Study|unsuccessful delivery|13|||
48623167|NCT03892915|156478025|FG001|Overall Study|unsuccessful delivery|18|||
48623168|NCT01520714|156478026|FG000|Overall Study|Protocol Violation|0|||
48623169|NCT01520714|156478027|FG001|Overall Study|Protocol Violation|3|||
48623170|NCT01520714|156478026|FG000|Overall Study|Adverse Event|0|||
48740036|NCT00392015|156897393|FG001|Overall Study|Withdrawal by Subject|0|||
48740037|NCT00392015|156897394|FG002|Overall Study|Withdrawal by Subject|2|||
48623171|NCT01520714|156478027|FG001|Overall Study|Adverse Event|2|||
48623172|NCT01520714|156478026|FG000|Overall Study|Lack of Efficacy|0|||
48623173|NCT01520714|156478027|FG001|Overall Study|Lack of Efficacy|1|||
48623174|NCT01570192|156478028|FG000|Overall Study|no qualifying organism|6|||
48623175|NCT01570192|156478029|FG001|Overall Study|no qualifying organism|12|||
48623176|NCT01570192|156478028|FG000|Overall Study|changed to palliative care|1|||
48623177|NCT01570192|156478029|FG001|Overall Study|changed to palliative care|0|||
48623178|NCT01570192|156478028|FG000|Overall Study|Physician Decision|0|||
48623179|NCT01570192|156478029|FG001|Overall Study|Physician Decision|1|||
48623180|NCT01478087|156478030|FG000|Overall Study|due to sponsor closing study|1|||
48623181|NCT04191733|156478036|FG000|Overall Study|Withdrawn due to study closure|13|||
48623182|NCT04191733|156478037|FG001|Overall Study|Withdrawn due to study closure|14|||
48623183|NCT04191733|156478036|FG000|Overall Study|Withdrawal by Subject|2|||
48740038|NCT00392015|156897395|FG003|Overall Study|Withdrawal by Subject|0|||
48740039|NCT00392015|156897396|FG004|Overall Study|Withdrawal by Subject|0|||
48740040|NCT00392015|156897397|FG005|Overall Study|Withdrawal by Subject|0|||
48740041|NCT00392015|156897392|FG000|Overall Study|Adverse Event|0|||
48740042|NCT00392015|156897393|FG001|Overall Study|Adverse Event|0|||
48623184|NCT04191733|156478037|FG001|Overall Study|Withdrawal by Subject|4|||
48623185|NCT04191733|156478036|FG000|Overall Study|Physician Decision|1|||
48623186|NCT04191733|156478037|FG001|Overall Study|Physician Decision|1|||
48623187|NCT04191733|156478036|FG000|Overall Study|Lost to Follow-up|5|||
48623188|NCT04191733|156478037|FG001|Overall Study|Lost to Follow-up|6|||
48623189|NCT04191733|156478036|FG000|Overall Study|Death|0|||
48623190|NCT04191733|156478037|FG001|Overall Study|Death|1|||
48623191|NCT01309100|156478040|FG000|Overall Study|Protocol Violation|1|||
48740043|NCT00392015|156897394|FG002|Overall Study|Adverse Event|0|||
48740044|NCT00392015|156897395|FG003|Overall Study|Adverse Event|0|||
48740045|NCT00392015|156897396|FG004|Overall Study|Adverse Event|1|||
48740046|NCT00392015|156897397|FG005|Overall Study|Adverse Event|0|||
48740047|NCT00392015|156897392|FG000|Overall Study|Previous trial recipient|0|||
48740048|NCT00392015|156897393|FG001|Overall Study|Previous trial recipient|0|||
48740049|NCT00392015|156897394|FG002|Overall Study|Previous trial recipient|0|||
48740050|NCT00392015|156897395|FG003|Overall Study|Previous trial recipient|0|||
48740051|NCT00392015|156897396|FG004|Overall Study|Previous trial recipient|1|||
48740052|NCT00392015|156897397|FG005|Overall Study|Previous trial recipient|0|||
48740053|NCT05369208|156897398|FG000|Core Phase|Prohibited Medication Required|2|||
48740054|NCT05369208|156897398|FG000|Core Phase|Adverse Event|1|||
48623192|NCT01309100|156478040|FG000|Overall Study|Positive Slit lamp finding|1|||
48623193|NCT02176525|156478041|FG000|Overall Study|Adverse Event|0|||
48623194|NCT02176525|156478042|FG001|Overall Study|Adverse Event|0|||
48623195|NCT02176525|156478043|FG002|Overall Study|Adverse Event|0|||
48623196|NCT02176525|156478044|FG003|Overall Study|Adverse Event|1|||
48623197|NCT02176525|156478045|FG004|Overall Study|Adverse Event|1|||
48623198|NCT02176525|156478046|FG005|Overall Study|Adverse Event|0|||
48623199|NCT02176525|156478047|FG006|Overall Study|Adverse Event|1|||
48623200|NCT02176525|156478048|FG007|Overall Study|Adverse Event|0|||
48623201|NCT02176525|156478041|FG000|Overall Study|not treated|1|||
48623202|NCT02176525|156478042|FG001|Overall Study|not treated|0|||
48623203|NCT02176525|156478043|FG002|Overall Study|not treated|0|||
48623204|NCT02176525|156478044|FG003|Overall Study|not treated|0|||
48623205|NCT02176525|156478045|FG004|Overall Study|not treated|0|||
48623206|NCT02176525|156478046|FG005|Overall Study|not treated|1|||
48623207|NCT02176525|156478047|FG006|Overall Study|not treated|0|||
48623208|NCT02176525|156478048|FG007|Overall Study|not treated|0|||
48623209|NCT03721107|156478051|FG000|Overall Study|Adverse Event|1|||
48623210|NCT03721107|156478052|FG001|Overall Study|Adverse Event|1|||
48623211|NCT03721107|156478053|FG002|Overall Study|Adverse Event|6|||
48623212|NCT03721107|156478054|FG003|Overall Study|Adverse Event|5|||
48623213|NCT03721107|156478051|FG000|Overall Study|Lost to Follow-up|2|||
48623214|NCT03721107|156478052|FG001|Overall Study|Lost to Follow-up|0|||
48623215|NCT03721107|156478053|FG002|Overall Study|Lost to Follow-up|3|||
48623216|NCT03721107|156478054|FG003|Overall Study|Lost to Follow-up|0|||
48623217|NCT03721107|156478051|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
48740055|NCT05369208|156897398|FG000|Core Phase|Lack of Efficacy|1|||
48740056|NCT03693300|156897399|FG000|Overall Study|Withdrawal by Subject|6|||
48623218|NCT03721107|156478052|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
48623219|NCT03721107|156478053|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
48623220|NCT03721107|156478054|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
48623221|NCT03721107|156478051|FG000|Overall Study|Physician Decision|0|||
48740057|NCT03693300|156897400|FG001|Overall Study|Withdrawal by Subject|0|||
48740058|NCT03693300|156897399|FG000|Overall Study|Death|50|||
48740059|NCT03693300|156897400|FG001|Overall Study|Death|2|||
48740060|NCT03693300|156897399|FG000|Overall Study|Lost to Follow-up|2|||
48623222|NCT03721107|156478052|FG001|Overall Study|Physician Decision|1|||
48623223|NCT03721107|156478053|FG002|Overall Study|Physician Decision|0|||
48623224|NCT03721107|156478054|FG003|Overall Study|Physician Decision|0|||
48623225|NCT03721107|156478051|FG000|Overall Study|Pregnancy|0|||
48623226|NCT03721107|156478052|FG001|Overall Study|Pregnancy|0|||
48623227|NCT03721107|156478053|FG002|Overall Study|Pregnancy|1|||
48623228|NCT03721107|156478054|FG003|Overall Study|Pregnancy|0|||
48623229|NCT03721107|156478051|FG000|Overall Study|Withdrawal by Subject|1|||
48623230|NCT03721107|156478052|FG001|Overall Study|Withdrawal by Subject|1|||
48623231|NCT03721107|156478053|FG002|Overall Study|Withdrawal by Subject|5|||
48740061|NCT03693300|156897400|FG001|Overall Study|Lost to Follow-up|0|||
48740062|NCT04855760|156897404|FG000|Overall Study|Adverse Event|21|||
48740063|NCT04855760|156897404|FG000|Overall Study|Withdrawal by Subject|116|||
48740064|NCT04855760|156897404|FG000|Overall Study|Lack of Efficacy|21|||
48623232|NCT03721107|156478054|FG003|Overall Study|Withdrawal by Subject|5|||
48623233|NCT03721107|156478051|FG000|Overall Study|Other|1|||
48623234|NCT03721107|156478052|FG001|Overall Study|Other|0|||
48623235|NCT03721107|156478053|FG002|Overall Study|Other|0|||
48623236|NCT03721107|156478054|FG003|Overall Study|Other|1|||
48623237|NCT02294019|156478055|FG000|Overall Study|Adverse Event|2|||
48623238|NCT02294019|156478055|FG000|Overall Study|Protocol Violation|68|||
48623239|NCT02294019|156478055|FG000|Overall Study|Lost to Follow-up|31|||
48623240|NCT02294019|156478055|FG000|Overall Study|Other|1|||
48623241|NCT02294019|156478055|FG000|Overall Study|Withdrawal by Subject|1|||
48623242|NCT02991859|156478056|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623243|NCT02991859|156478057|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
48623244|NCT02991859|156478058|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623245|NCT02991859|156478059|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623246|NCT02991859|156478060|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
48623247|NCT02991859|156478061|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623248|NCT02991859|156478062|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623249|NCT02991859|156478063|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623250|NCT02991859|156478064|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623251|NCT02991859|156478065|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623252|NCT02991859|156478066|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623253|NCT02991859|156478067|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623254|NCT02991859|156478068|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623255|NCT02991859|156478069|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623256|NCT02991859|156478070|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623257|NCT02991859|156478071|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623258|NCT02991859|156478072|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
48623259|NCT02991859|156478056|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623260|NCT02991859|156478057|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623261|NCT02991859|156478058|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623262|NCT02991859|156478059|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623263|NCT02991859|156478060|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623264|NCT02991859|156478061|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623265|NCT02991859|156478062|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623266|NCT02991859|156478063|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623267|NCT02991859|156478064|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623268|NCT02991859|156478065|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623269|NCT02991859|156478066|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623270|NCT02991859|156478067|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623271|NCT02991859|156478068|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
48623272|NCT02991859|156478069|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
48623273|NCT02991859|156478070|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623274|NCT02991859|156478071|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623275|NCT02991859|156478072|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
48623276|NCT02991859|156478056|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623277|NCT02991859|156478057|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623278|NCT02991859|156478058|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623279|NCT02991859|156478059|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623280|NCT02991859|156478060|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623281|NCT02991859|156478061|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
48623282|NCT02991859|156478062|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623283|NCT02991859|156478063|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623284|NCT02991859|156478064|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623285|NCT02991859|156478065|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623286|NCT02991859|156478066|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623287|NCT02991859|156478067|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623288|NCT02991859|156478068|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623289|NCT02991859|156478069|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623290|NCT02991859|156478070|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48623291|NCT02991859|156478071|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48740065|NCT04855760|156897404|FG000|Overall Study|Lost to Follow-up|49|||
48623292|NCT02991859|156478072|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
48740066|NCT04855760|156897404|FG000|Overall Study|Protocol Violation|2|||
48740067|NCT04855760|156897404|FG000|Overall Study|Physician Decision|5|||
48740068|NCT04855760|156897404|FG000|Overall Study|Pregnancy|1|||
48740069|NCT04855760|156897404|FG000|Overall Study|Non-Compliance with Study Drug|11|||
48740070|NCT04855760|156897404|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
48740071|NCT04855760|156897404|FG000|Overall Study|Study Completed by Sponsor|202|||
48740072|NCT04855760|156897404|FG000|Overall Study|Other|13|||
48740073|NCT01543958|156897417|FG000|Overall Study|Loss to follow-up|3|||
48740074|NCT01543958|156897417|FG000|Overall Study|ART initiation|1|||
48740075|NCT01020981|156897418|FG000|Overall Study|Did not return mailed survey|74|||
48740076|NCT01020981|156897419|FG001|Overall Study|Did not return mailed survey|58|||
48740077|NCT01020981|156897418|FG000|Overall Study|Survey returned undeliverable|8|||
48740078|NCT01020981|156897419|FG001|Overall Study|Survey returned undeliverable|32|||
48740079|NCT01020981|156897418|FG000|Overall Study|Participant declined to complete survey|2|||
48740080|NCT01020981|156897419|FG001|Overall Study|Participant declined to complete survey|0|||
48740081|NCT05439941|156897420|FG000|Overall Study|Lack of Efficacy|8|||
48740082|NCT05439941|156897421|FG001|Overall Study|Lack of Efficacy|5|||
48740083|NCT05439941|156897422|FG002|Overall Study|Lack of Efficacy|3|||
48740084|NCT05439941|156897420|FG000|Overall Study|Treatment Failure|0|||
48740085|NCT05439941|156897421|FG001|Overall Study|Treatment Failure|1|||
48740086|NCT05439941|156897422|FG002|Overall Study|Treatment Failure|0|||
48740087|NCT05439941|156897420|FG000|Overall Study|Adverse Event|1|||
48740088|NCT05439941|156897421|FG001|Overall Study|Adverse Event|3|||
48740089|NCT05439941|156897422|FG002|Overall Study|Adverse Event|0|||
48740090|NCT05439941|156897420|FG000|Overall Study|Adverse Event - Parent Study|1|||
48740091|NCT05439941|156897421|FG001|Overall Study|Adverse Event - Parent Study|0|||
48740092|NCT05439941|156897422|FG002|Overall Study|Adverse Event - Parent Study|0|||
48740093|NCT05439941|156897420|FG000|Overall Study|Pregnancy|1|||
48740094|NCT05439941|156897421|FG001|Overall Study|Pregnancy|0|||
48740095|NCT05439941|156897422|FG002|Overall Study|Pregnancy|0|||
48740096|NCT05439941|156897420|FG000|Overall Study|Withdrawal by Subject|9|||
48623293|NCT02991859|156478056|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623294|NCT02991859|156478057|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623295|NCT02991859|156478058|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623296|NCT02991859|156478059|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623297|NCT02991859|156478060|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623298|NCT02991859|156478061|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623299|NCT02991859|156478062|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623300|NCT02991859|156478063|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623301|NCT02991859|156478064|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623302|NCT02991859|156478065|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
48623303|NCT02991859|156478066|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623304|NCT02991859|156478067|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623305|NCT02991859|156478068|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623306|NCT02991859|156478069|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623307|NCT02991859|156478070|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48740097|NCT05439941|156897421|FG001|Overall Study|Withdrawal by Subject|6|||
48740098|NCT05439941|156897422|FG002|Overall Study|Withdrawal by Subject|10|||
48740099|NCT05439941|156897420|FG000|Overall Study|Non-Compliance|1|||
48740100|NCT05439941|156897421|FG001|Overall Study|Non-Compliance|1|||
48740101|NCT05439941|156897422|FG002|Overall Study|Non-Compliance|1|||
48623308|NCT02991859|156478071|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623309|NCT02991859|156478072|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
48623310|NCT02991859|156478056|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623311|NCT02991859|156478057|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623312|NCT02991859|156478058|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623313|NCT02991859|156478059|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623314|NCT02991859|156478060|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623315|NCT02991859|156478061|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623316|NCT02991859|156478062|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623317|NCT02991859|156478063|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623318|NCT02991859|156478064|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
48623319|NCT02991859|156478065|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623320|NCT02991859|156478066|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623321|NCT02991859|156478067|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48740102|NCT05439941|156897420|FG000|Overall Study|Lost to Follow-up|2|||
48740103|NCT05439941|156897421|FG001|Overall Study|Lost to Follow-up|2|||
48623322|NCT02991859|156478068|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623323|NCT02991859|156478069|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48740104|NCT05439941|156897422|FG002|Overall Study|Lost to Follow-up|0|||
48740105|NCT05439941|156897420|FG000|Overall Study|Physician Decision|1|||
48740106|NCT05439941|156897421|FG001|Overall Study|Physician Decision|0|||
48623324|NCT02991859|156478070|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623325|NCT02991859|156478071|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623326|NCT02991859|156478072|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
48623327|NCT01630811|156478073|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
48623328|NCT01630811|156478074|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
48623329|NCT02057666|156478077|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
48623330|NCT02057666|156478078|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
48623331|NCT02057666|156478077|FG000|Double Blind Treatment Period|Poor tolerability|7|||
48623332|NCT02057666|156478078|FG001|Double Blind Treatment Period|Poor tolerability|2|||
48623333|NCT02057666|156478077|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
48623334|NCT02057666|156478078|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
48623335|NCT02057666|156478077|FG000|Double Blind Treatment Period|Physician Decision|1|||
48623336|NCT02057666|156478078|FG001|Double Blind Treatment Period|Physician Decision|0|||
48623337|NCT02057666|156478077|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
48623338|NCT02057666|156478078|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
48623339|NCT02057666|156478077|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
48623340|NCT02057666|156478078|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
48623341|NCT02057666|156478077|FG000|Double Blind Treatment Period|Sponsor's request|70|||
48623342|NCT02057666|156478078|FG001|Double Blind Treatment Period|Sponsor's request|34|||
48623343|NCT02057666|156478077|FG000|Open-Label Treatment Period|Poor tolerability|0|||
48623344|NCT02057666|156478078|FG001|Open-Label Treatment Period|Poor tolerability|1|||
48623345|NCT02057666|156478077|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
48623346|NCT02057666|156478078|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
48623347|NCT02057666|156478077|FG000|Open-Label Treatment Period|Sponsor's request|0|||
48623348|NCT02057666|156478078|FG001|Open-Label Treatment Period|Sponsor's request|4|||
48623349|NCT05287685|156478080|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
48623350|NCT05287685|156478081|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
48623351|NCT05287685|156478080|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
48623352|NCT05287685|156478081|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
48623353|NCT06048705|156478084|FG000|Overall Study|Physician Decision|1|||
48623354|NCT06048705|156478085|FG001|Overall Study|Physician Decision|0|||
48623355|NCT06048705|156478086|FG002|Overall Study|Physician Decision|0|||
48623356|NCT06048705|156478084|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
48623357|NCT06048705|156478085|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
48623358|NCT06048705|156478086|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
48623359|NCT06048705|156478084|FG000|Overall Study|Death prior to lymphodepletion|0|||
48623360|NCT06048705|156478085|FG001|Overall Study|Death prior to lymphodepletion|0|||
48623361|NCT06048705|156478086|FG002|Overall Study|Death prior to lymphodepletion|1|||
48623362|NCT04042311|156478087|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
48623363|NCT04042311|156478087|FG000|Overall Study|Unable to tolerate|4|||
48623364|NCT04042311|156478087|FG000|Overall Study|Concurrent illness|2|||
48623365|NCT04042311|156478087|FG000|Overall Study|Adverse Event|2|||
48623366|NCT04042311|156478087|FG000|Overall Study|No longer meeting inclusion criteria|2|||
48623367|NCT04042311|156478087|FG000|Overall Study|No reason given|1|||
48623368|NCT04042311|156478087|FG000|Overall Study|Withdrawal by Subject|4|||
48623369|NCT01341990|156478088|FG000|Overall Study|Adverse Event|0|||
48623370|NCT01341990|156478089|FG001|Overall Study|Adverse Event|1|||
48623371|NCT01341990|156478088|FG000|Overall Study|Torn Study Lens|1|||
48623372|NCT01341990|156478089|FG001|Overall Study|Torn Study Lens|0|||
48623373|NCT01341990|156478088|FG000|Overall Study|Withdrawal by Subject|2|||
48623374|NCT01341990|156478089|FG001|Overall Study|Withdrawal by Subject|0|||
48623375|NCT01943825|156478090|FG000|Overall Study|Lost to Follow-up|9|||
48623376|NCT01943825|156478091|FG001|Overall Study|Lost to Follow-up|3|||
48623377|NCT01943825|156478092|FG002|Overall Study|Lost to Follow-up|12|||
48623378|NCT01943825|156478093|FG003|Overall Study|Lost to Follow-up|8|||
48623379|NCT01943825|156478090|FG000|Overall Study|Withdrawal by Subject|1|||
48623380|NCT01943825|156478091|FG001|Overall Study|Withdrawal by Subject|0|||
48623381|NCT01943825|156478092|FG002|Overall Study|Withdrawal by Subject|3|||
48623382|NCT01943825|156478093|FG003|Overall Study|Withdrawal by Subject|2|||
48623383|NCT01943825|156478090|FG000|Overall Study|Other than specified above|0|||
48623384|NCT01943825|156478091|FG001|Overall Study|Other than specified above|1|||
48623385|NCT01943825|156478092|FG002|Overall Study|Other than specified above|0|||
48623386|NCT01943825|156478093|FG003|Overall Study|Other than specified above|1|||
48623387|NCT02268851|156478095|FG000|Overall Study|Death|0|||
48623388|NCT02268851|156478096|FG001|Overall Study|Death|0|||
48623389|NCT02268851|156478097|FG002|Overall Study|Death|0|||
48623390|NCT02268851|156478098|FG003|Overall Study|Death|1|||
48623391|NCT02268851|156478099|FG004|Overall Study|Death|2|||
48623392|NCT02268851|156478100|FG005|Overall Study|Death|1|||
48623393|NCT02268851|156478095|FG000|Overall Study|Adverse Event|0|||
48623394|NCT02268851|156478096|FG001|Overall Study|Adverse Event|0|||
48623395|NCT02268851|156478097|FG002|Overall Study|Adverse Event|0|||
48623396|NCT02268851|156478098|FG003|Overall Study|Adverse Event|0|||
48740107|NCT05439941|156897422|FG002|Overall Study|Physician Decision|0|||
48740108|NCT05439941|156897420|FG000|Overall Study|Trial Termination by Sponsor|78|||
48740109|NCT05439941|156897421|FG001|Overall Study|Trial Termination by Sponsor|83|||
48740110|NCT05439941|156897422|FG002|Overall Study|Trial Termination by Sponsor|65|||
48740111|NCT05439941|156897420|FG000|Overall Study|Other than Reasons Listed|2|||
48740112|NCT05439941|156897421|FG001|Overall Study|Other than Reasons Listed|1|||
48740113|NCT05439941|156897422|FG002|Overall Study|Other than Reasons Listed|0|||
48740114|NCT03689530|156897423|FG000|Overall Study|Withdrawal by Subject|53|||
48740115|NCT03689530|156897424|FG001|Overall Study|Withdrawal by Subject|16|||
48740116|NCT01926015|156897425|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48740117|NCT01926015|156897426|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48740118|NCT01926015|156897425|FG000|Overall Study|Randomized not treated|2|||
48740119|NCT01926015|156897426|FG001|Overall Study|Randomized not treated|0|||
48740120|NCT03314987|156897427|FG000|Overall Study|Lost to Follow-up|13|||
48740121|NCT03314987|156897428|FG001|Overall Study|Lost to Follow-up|13|||
48740122|NCT03594110|156897430|FG000|Overall Study|Participant concerned about study treatment|23|||
48623397|NCT02268851|156478099|FG004|Overall Study|Adverse Event|2|||
48623398|NCT02268851|156478100|FG005|Overall Study|Adverse Event|2|||
48623399|NCT02268851|156478095|FG000|Overall Study|Withdrawal by Subject|0|||
48623400|NCT02268851|156478096|FG001|Overall Study|Withdrawal by Subject|0|||
48623401|NCT02268851|156478097|FG002|Overall Study|Withdrawal by Subject|0|||
48623402|NCT02268851|156478098|FG003|Overall Study|Withdrawal by Subject|2|||
48623403|NCT02268851|156478099|FG004|Overall Study|Withdrawal by Subject|0|||
48623404|NCT02268851|156478100|FG005|Overall Study|Withdrawal by Subject|1|||
48623405|NCT02268851|156478095|FG000|Overall Study|Progressive Disease|1|||
48623406|NCT02268851|156478096|FG001|Overall Study|Progressive Disease|3|||
48623407|NCT02268851|156478097|FG002|Overall Study|Progressive Disease|0|||
48623408|NCT02268851|156478098|FG003|Overall Study|Progressive Disease|0|||
48623409|NCT02268851|156478099|FG004|Overall Study|Progressive Disease|1|||
48623410|NCT02268851|156478100|FG005|Overall Study|Progressive Disease|4|||
48623411|NCT02268851|156478095|FG000|Overall Study|Physician Decision|0|||
48623412|NCT02268851|156478096|FG001|Overall Study|Physician Decision|0|||
48623413|NCT02268851|156478097|FG002|Overall Study|Physician Decision|1|||
48623414|NCT02268851|156478098|FG003|Overall Study|Physician Decision|0|||
48623415|NCT02268851|156478099|FG004|Overall Study|Physician Decision|0|||
48623416|NCT02268851|156478100|FG005|Overall Study|Physician Decision|1|||
48623417|NCT02268851|156478095|FG000|Overall Study|Patient Compliance|0|||
48623418|NCT02268851|156478096|FG001|Overall Study|Patient Compliance|0|||
48623419|NCT02268851|156478097|FG002|Overall Study|Patient Compliance|0|||
48623420|NCT02268851|156478098|FG003|Overall Study|Patient Compliance|0|||
48623421|NCT02268851|156478099|FG004|Overall Study|Patient Compliance|1|||
48623422|NCT02268851|156478100|FG005|Overall Study|Patient Compliance|1|||
48623423|NCT02268851|156478095|FG000|Overall Study|Co-Morbid Condition|0|||
48623424|NCT02268851|156478096|FG001|Overall Study|Co-Morbid Condition|0|||
48623425|NCT02268851|156478097|FG002|Overall Study|Co-Morbid Condition|0|||
48623426|NCT02268851|156478098|FG003|Overall Study|Co-Morbid Condition|0|||
48623427|NCT02268851|156478099|FG004|Overall Study|Co-Morbid Condition|1|||
48623428|NCT02268851|156478100|FG005|Overall Study|Co-Morbid Condition|1|||
48623429|NCT00176254|156478119|FG000|Overall Study|Lost to Follow-up|1|||
48623430|NCT01694771|156478120|FG000|Overall Study|Adverse Event|18|||
48623431|NCT01694771|156478121|FG001|Overall Study|Adverse Event|16|||
48623432|NCT01694771|156478120|FG000|Overall Study|Lack of Efficacy|1|||
48623433|NCT01694771|156478121|FG001|Overall Study|Lack of Efficacy|0|||
48623434|NCT01694771|156478120|FG000|Overall Study|Non compliance protocol|7|||
48623435|NCT01694771|156478121|FG001|Overall Study|Non compliance protocol|6|||
48623436|NCT01694771|156478120|FG000|Overall Study|Lost to Follow-up|2|||
48623437|NCT01694771|156478121|FG001|Overall Study|Lost to Follow-up|3|||
48623438|NCT01694771|156478120|FG000|Overall Study|Consent withdrawn|7|||
48623439|NCT01694771|156478121|FG001|Overall Study|Consent withdrawn|9|||
48623440|NCT01694771|156478120|FG000|Overall Study|Other reasons|5|||
48623441|NCT01694771|156478121|FG001|Overall Study|Other reasons|6|||
48623442|NCT00890097|156478122|FG000|Overall Study|Adverse Event|21|||
48623443|NCT00890097|156478123|FG001|Overall Study|Adverse Event|32|||
48623444|NCT00890097|156478124|FG002|Overall Study|Adverse Event|28|||
48623445|NCT00890097|156478122|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
48623446|NCT00890097|156478123|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
48623447|NCT00890097|156478124|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
48623448|NCT00890097|156478122|FG000|Overall Study|Withdrew Consent|9|||
48623449|NCT00890097|156478123|FG001|Overall Study|Withdrew Consent|6|||
48623450|NCT00890097|156478124|FG002|Overall Study|Withdrew Consent|9|||
48623451|NCT00890097|156478122|FG000|Overall Study|Lost to Follow-up|5|||
48740123|NCT03594110|156897431|FG001|Overall Study|Participant concerned about study treatment|28|||
48740124|NCT03594110|156897430|FG000|Overall Study|Doctor advice|38|||
48623452|NCT00890097|156478123|FG001|Overall Study|Lost to Follow-up|5|||
48623453|NCT00890097|156478124|FG002|Overall Study|Lost to Follow-up|5|||
48323180|NCT01964300|155381966|FG001|Overall Study|Weight criteria not met|1|||
48323181|NCT01951170|155381967|FG000|Overall Study|Investigator decision|1|||
48323182|NCT00557492|155381968|FG000|Overall Study|Change in health insurance|1|||
48323183|NCT02438137|155381972|FG000|Overall Study|Lost to Follow-up|3|||
48323184|NCT02438137|155381973|FG001|Overall Study|Lost to Follow-up|2|||
48323185|NCT02438137|155381972|FG000|Overall Study|Adverse Event|1|||
48323186|NCT02438137|155381973|FG001|Overall Study|Adverse Event|0|||
48323187|NCT02438137|155381972|FG000|Overall Study|Withdrawal by Subject|4|||
48323188|NCT02438137|155381973|FG001|Overall Study|Withdrawal by Subject|3|||
48323189|NCT02438137|155381972|FG000|Overall Study|Physician Decision|0|||
48323190|NCT02438137|155381973|FG001|Overall Study|Physician Decision|1|||
48323191|NCT03621735|155381974|FG000|Overall Study|Withdrawal by Subject|13|||
48323192|NCT03621735|155381975|FG001|Overall Study|Withdrawal by Subject|13|||
48323193|NCT01854385|155381976|FG000|Pre-Treatment|Withdrawal by Subject|4|||
48740125|NCT03594110|156897431|FG001|Overall Study|Doctor advice|40|||
48323194|NCT01854385|155381976|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
48740126|NCT03594110|156897430|FG000|Overall Study|Participants' wish|89|||
48740127|NCT03594110|156897431|FG001|Overall Study|Participants' wish|68|||
48740128|NCT03594110|156897430|FG000|Overall Study|Adverse event-non-fatal events|119|||
48740129|NCT03594110|156897431|FG001|Overall Study|Adverse event-non-fatal events|116|||
48740130|NCT03594110|156897430|FG000|Overall Study|Study drug stopped, reason missing|336|||
48740131|NCT03594110|156897431|FG001|Overall Study|Study drug stopped, reason missing|294|||
48323195|NCT01854385|155381976|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
48323196|NCT01854385|155381976|FG000|Pre-Treatment|Unable to come for study visits|1|||
48323197|NCT01854385|155381976|FG000|Treatment|Lost to Follow-up|1|||
48740132|NCT03594110|156897430|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
48323198|NCT04579250|155381979|FG000|Overall Study|Withdrawal by Subject|1|||
48323199|NCT04579250|155381980|FG001|Overall Study|Withdrawal by Subject|1|||
48323200|NCT04579250|155381981|FG002|Overall Study|Withdrawal by Subject|0|||
48623454|NCT00890097|156478122|FG000|Overall Study|Noncompliance|0|||
48740133|NCT03594110|156897431|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
48740134|NCT03594110|156897430|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
48740135|NCT03594110|156897431|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
48740136|NCT03594110|156897430|FG000|Overall Study|Contraindicated drug started|32|||
48623455|NCT00890097|156478123|FG001|Overall Study|Noncompliance|4|||
48623456|NCT00890097|156478124|FG002|Overall Study|Noncompliance|4|||
48623457|NCT00890097|156478122|FG000|Overall Study|Sponsor Decision|7|||
48623458|NCT00890097|156478123|FG001|Overall Study|Sponsor Decision|11|||
48623459|NCT00890097|156478124|FG002|Overall Study|Sponsor Decision|7|||
48623460|NCT00890097|156478122|FG000|Overall Study|Did not attend final visit|2|||
48623461|NCT00890097|156478123|FG001|Overall Study|Did not attend final visit|3|||
48623462|NCT00890097|156478124|FG002|Overall Study|Did not attend final visit|0|||
48623463|NCT00890097|156478122|FG000|Overall Study|Subject Decision|3|||
48623464|NCT00890097|156478123|FG001|Overall Study|Subject Decision|2|||
48623465|NCT00890097|156478124|FG002|Overall Study|Subject Decision|6|||
48623466|NCT00890097|156478122|FG000|Overall Study|Randomization Error|2|||
48623467|NCT00890097|156478123|FG001|Overall Study|Randomization Error|0|||
48623468|NCT00890097|156478124|FG002|Overall Study|Randomization Error|0|||
48623469|NCT00890097|156478122|FG000|Overall Study|Failed inclusion criteria|3|||
48623470|NCT00890097|156478123|FG001|Overall Study|Failed inclusion criteria|4|||
48623471|NCT00890097|156478124|FG002|Overall Study|Failed inclusion criteria|0|||
48623472|NCT00890097|156478122|FG000|Overall Study|Transportation|0|||
48623473|NCT00890097|156478123|FG001|Overall Study|Transportation|2|||
48623474|NCT00890097|156478124|FG002|Overall Study|Transportation|0|||
48623475|NCT00890097|156478122|FG000|Overall Study|Subject Moved|0|||
48623476|NCT00890097|156478123|FG001|Overall Study|Subject Moved|4|||
48623477|NCT00890097|156478124|FG002|Overall Study|Subject Moved|0|||
48623478|NCT00890097|156478122|FG000|Overall Study|Protocol Deviation|1|||
48623479|NCT00890097|156478123|FG001|Overall Study|Protocol Deviation|1|||
48623480|NCT00890097|156478124|FG002|Overall Study|Protocol Deviation|1|||
48623481|NCT02613507|156478127|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
48623482|NCT02613507|156478128|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
48623483|NCT02613507|156478127|FG000|Pre-Treamtent|Participant withdrew consent|0|||
48623484|NCT02613507|156478128|FG001|Pre-Treamtent|Participant withdrew consent|4|||
48623485|NCT02613507|156478127|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
48623486|NCT02613507|156478128|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
48740137|NCT03594110|156897431|FG001|Overall Study|Contraindicated drug started|18|||
48740138|NCT03594110|156897430|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
48740139|NCT03594110|156897431|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
48740140|NCT03594110|156897430|FG000|Overall Study|Adverse event-Serious fatal events|130|||
48740141|NCT03594110|156897431|FG001|Overall Study|Adverse event-Serious fatal events|121|||
48740142|NCT03436745|156897432|FG000|Overall Study|Ineligible|0|||
48740143|NCT03436745|156897433|FG001|Overall Study|Ineligible|0|||
48740144|NCT03436745|156897434|FG002|Overall Study|Ineligible|1|||
48740145|NCT02476201|156897435|FG000|Overall Study|Unable to program MPP|9|||
48740146|NCT02476201|156897435|FG000|Overall Study|Study echo not performed|5|||
48623487|NCT02613507|156478127|FG000|Treatment|Not reported|3|||
48623488|NCT02613507|156478128|FG001|Treatment|Not reported|0|||
48623489|NCT02613507|156478127|FG000|Treatment|Other reasons|8|||
48623490|NCT02613507|156478128|FG001|Treatment|Other reasons|0|||
48623491|NCT02613507|156478127|FG000|Treatment|Participant no longer meets criteria|3|||
48623492|NCT02613507|156478128|FG001|Treatment|Participant no longer meets criteria|0|||
48623493|NCT02613507|156478127|FG000|Treatment|Maximum clinical benefit|5|||
48623494|NCT02613507|156478128|FG001|Treatment|Maximum clinical benefit|10|||
48623495|NCT02613507|156478127|FG000|Treatment|Lost to Follow-up|1|||
48623496|NCT02613507|156478128|FG001|Treatment|Lost to Follow-up|0|||
48623497|NCT02613507|156478127|FG000|Treatment|Participant withdrew consent|0|||
48623498|NCT02613507|156478128|FG001|Treatment|Participant withdrew consent|2|||
48623499|NCT02613507|156478127|FG000|Treatment|Participant request to discontinue study treatment|13|||
48623500|NCT02613507|156478128|FG001|Treatment|Participant request to discontinue study treatment|17|||
48623501|NCT02613507|156478127|FG000|Treatment|Adverse event unrelated to study drug|20|||
48740147|NCT02476201|156897435|FG000|Overall Study|Adverse Event|4|||
48740148|NCT02476201|156897435|FG000|Overall Study|Death|2|||
48623502|NCT02613507|156478128|FG001|Treatment|Adverse event unrelated to study drug|3|||
48623503|NCT02613507|156478127|FG000|Treatment|Death|2|||
48623504|NCT02613507|156478128|FG001|Treatment|Death|0|||
48623505|NCT02613507|156478127|FG000|Treatment|Study drug toxicity|19|||
48623506|NCT02613507|156478128|FG001|Treatment|Study drug toxicity|14|||
48623507|NCT02613507|156478127|FG000|Treatment|Disease progression|263|||
48623508|NCT02613507|156478128|FG001|Treatment|Disease progression|110|||
48623509|NCT02536339|156478129|FG000|Overall Study|Death|20|||
48623510|NCT02536339|156478129|FG000|Overall Study|Withdrawal by Subject|3|||
48623511|NCT02536339|156478129|FG000|Overall Study|Lost to Follow-up|2|||
48623512|NCT02536339|156478129|FG000|Overall Study|Treatment discontinued|2|||
48623513|NCT02536339|156478129|FG000|Overall Study|Physician Decision|1|||
48623514|NCT05206604|156479169|FG000|Overall Study|Non-compliance with study drug|0|||
48623515|NCT05206604|156479170|FG001|Overall Study|Non-compliance with study drug|0|||
48623516|NCT05206604|156479171|FG002|Overall Study|Non-compliance with study drug|0|||
48623517|NCT05206604|156479172|FG003|Overall Study|Non-compliance with study drug|0|||
48623518|NCT05206604|156479173|FG004|Overall Study|Non-compliance with study drug|0|||
48623519|NCT05206604|156479174|FG005|Overall Study|Non-compliance with study drug|1|||
48623520|NCT05206604|156479175|FG006|Overall Study|Non-compliance with study drug|0|||
48623521|NCT05206604|156479176|FG007|Overall Study|Non-compliance with study drug|0|||
48623522|NCT04941898|156479177|FG000|Overall Study|Protocol Violation|1|||
48623523|NCT01862029|156479178|FG000|Overall Study|Physician Decision|1|||
48623524|NCT03931785|156479179|FG000|Overall Study|Lost to Follow-up|4|||
48623525|NCT03931785|156479180|FG001|Overall Study|Lost to Follow-up|1|||
48623526|NCT03931785|156479181|FG002|Overall Study|Lost to Follow-up|4|||
48623527|NCT03931785|156479182|FG003|Overall Study|Lost to Follow-up|3|||
48623528|NCT03931785|156479179|FG000|Overall Study|Adverse Event|1|||
48623529|NCT03931785|156479180|FG001|Overall Study|Adverse Event|0|||
48623530|NCT03931785|156479181|FG002|Overall Study|Adverse Event|3|||
48623531|NCT03931785|156479182|FG003|Overall Study|Adverse Event|4|||
48623532|NCT03931785|156479179|FG000|Overall Study|Protocol Violation|0|||
48623533|NCT03931785|156479180|FG001|Overall Study|Protocol Violation|1|||
48623534|NCT03931785|156479181|FG002|Overall Study|Protocol Violation|0|||
48623535|NCT03931785|156479182|FG003|Overall Study|Protocol Violation|0|||
48623536|NCT03931785|156479179|FG000|Overall Study|Noncompliance With Study drug|0|||
48623537|NCT03931785|156479180|FG001|Overall Study|Noncompliance With Study drug|1|||
48623538|NCT03931785|156479181|FG002|Overall Study|Noncompliance With Study drug|0|||
48623539|NCT03931785|156479182|FG003|Overall Study|Noncompliance With Study drug|0|||
48623540|NCT03931785|156479179|FG000|Overall Study|Other Not specified|0|||
48623541|NCT03931785|156479180|FG001|Overall Study|Other Not specified|2|||
48623542|NCT03931785|156479181|FG002|Overall Study|Other Not specified|2|||
48623543|NCT03931785|156479182|FG003|Overall Study|Other Not specified|2|||
48623544|NCT03931785|156479179|FG000|Overall Study|Withdrawal by Subject|0|||
48623545|NCT03931785|156479180|FG001|Overall Study|Withdrawal by Subject|2|||
48623546|NCT03931785|156479181|FG002|Overall Study|Withdrawal by Subject|4|||
48623547|NCT03931785|156479182|FG003|Overall Study|Withdrawal by Subject|1|||
48623548|NCT03931785|156479179|FG000|Overall Study|Pregnancy|0|||
48623549|NCT03931785|156479180|FG001|Overall Study|Pregnancy|0|||
48623550|NCT03931785|156479181|FG002|Overall Study|Pregnancy|0|||
48623551|NCT03931785|156479182|FG003|Overall Study|Pregnancy|1|||
48623552|NCT04605588|156479186|FG000|Overall Study|Withdrawal by Subject|1|||
48623553|NCT04605588|156479187|FG001|Overall Study|Withdrawal by Subject|0|||
48623554|NCT01230814|156479188|FG000|Overall Study|Lost to Follow-up|11|||
48623555|NCT01230814|156479189|FG001|Overall Study|Lost to Follow-up|3|||
48623556|NCT01230814|156479188|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
48623557|NCT01230814|156479189|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
48623558|NCT01803737|156479192|FG000|Overall Study|Lack of Time|1|||
48623559|NCT01803737|156479193|FG001|Overall Study|Lack of Time|0|||
48623560|NCT01803737|156479192|FG000|Overall Study|Medical Reason|0|||
48623561|NCT01803737|156479193|FG001|Overall Study|Medical Reason|1|||
48623562|NCT01803737|156479192|FG000|Overall Study|Lost to Follow-up|0|||
48623563|NCT01803737|156479193|FG001|Overall Study|Lost to Follow-up|2|||
48623564|NCT02502383|156479196|FG000|Overall Study|Lost to Follow-up|130|||
48623565|NCT02502383|156479197|FG001|Overall Study|Lost to Follow-up|131|||
48623566|NCT02502383|156479196|FG000|Overall Study|Withdrawal by Subject|31|||
48623567|NCT02502383|156479197|FG001|Overall Study|Withdrawal by Subject|24|||
48623568|NCT01052428|156479198|FG000|Overall Study|Death|1|||
48623569|NCT01052428|156479199|FG001|Overall Study|Death|0|||
48623570|NCT01052428|156479198|FG000|Overall Study|Withdrawal by Subject|0|||
48623571|NCT01052428|156479199|FG001|Overall Study|Withdrawal by Subject|1|||
48623572|NCT01034657|156479200|FG000|Core Phase|Withdrawal by Subject|1|||
48623573|NCT01034657|156479201|FG001|Core Phase|Withdrawal by Subject|0|||
48623574|NCT01034657|156479202|FG002|Core Phase|Withdrawal by Subject|0|||
48623575|NCT01034657|156479200|FG000|Core Phase|Lack of Efficacy|2|||
48623576|NCT01034657|156479201|FG001|Core Phase|Lack of Efficacy|0|||
48623577|NCT01034657|156479202|FG002|Core Phase|Lack of Efficacy|0|||
48623578|NCT01034657|156479200|FG000|Core Phase|Abnormal laboratory value|1|||
48623579|NCT01034657|156479201|FG001|Core Phase|Abnormal laboratory value|0|||
48623580|NCT01034657|156479202|FG002|Core Phase|Abnormal laboratory value|0|||
48623581|NCT01034657|156479200|FG000|Core Phase|Adverse Event|8|||
48623582|NCT01034657|156479201|FG001|Core Phase|Adverse Event|0|||
48623583|NCT01034657|156479202|FG002|Core Phase|Adverse Event|0|||
48623584|NCT01034657|156479200|FG000|Core Phase|Protocol Violation|2|||
48623585|NCT01034657|156479201|FG001|Core Phase|Protocol Violation|0|||
48623586|NCT01034657|156479202|FG002|Core Phase|Protocol Violation|0|||
48740149|NCT02476201|156897435|FG000|Overall Study|Lost to Follow-up|2|||
48740150|NCT02476201|156897435|FG000|Overall Study|MPP programmed to OFF|2|||
48740151|NCT02476201|156897435|FG000|Overall Study|Withdrawal by Subject|1|||
48740152|NCT02476201|156897435|FG000|Overall Study|Unsuccessful implant|1|||
48740153|NCT03650556|156897436|FG000|Overall Study|Death|2|||
48740154|NCT03650556|156897436|FG000|Overall Study|Withdrawal by Subject|20|||
48740155|NCT03650556|156897436|FG000|Overall Study|Physician Decision|2|||
48740156|NCT03650556|156897436|FG000|Overall Study|Lost to Follow-up|8|||
48740157|NCT03650556|156897436|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
48740158|NCT03650556|156897436|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
48740159|NCT01705730|156897439|FG000|Overall Study|Lack of Efficacy|1|||
48740160|NCT01705730|156897439|FG000|Overall Study|Adverse Event|3|||
48740161|NCT01705730|156897439|FG000|Overall Study|Lost to Follow-up|1|||
48740162|NCT01705730|156897439|FG000|Overall Study|Reason not Specified|4|||
48740163|NCT00142935|156897441|FG000|Overall Study|Other reason|1|||
48740164|NCT00142935|156897442|FG001|Overall Study|Other reason|1|||
48740165|NCT00142935|156897443|FG002|Overall Study|Other reason|1|||
48740166|NCT00142935|156897441|FG000|Overall Study|Lost to Follow-up|2|||
48740167|NCT00142935|156897442|FG001|Overall Study|Lost to Follow-up|5|||
48740168|NCT00142935|156897443|FG002|Overall Study|Lost to Follow-up|5|||
48740169|NCT00142935|156897441|FG000|Overall Study|Death|0|||
48740170|NCT00142935|156897442|FG001|Overall Study|Death|2|||
48740171|NCT00142935|156897443|FG002|Overall Study|Death|1|||
48740172|NCT03345914|156897448|FG000|Overall Study|Transition to another study at week 16|80|||
48740173|NCT03345914|156897449|FG001|Overall Study|Transition to another study at week 16|86|||
48740174|NCT03345914|156897450|FG002|Overall Study|Transition to another study at week 16|78|||
48740175|NCT03345914|156897448|FG000|Overall Study|Transition to OLE during follow-up|37|||
48323201|NCT04579250|155381979|FG000|Overall Study|Lost to Follow-up|1|||
48623587|NCT01034657|156479200|FG000|Randomized Phase|Withdrawal by Subject|0|||
48623588|NCT01034657|156479201|FG001|Randomized Phase|Withdrawal by Subject|2|||
48623589|NCT01034657|156479202|FG002|Randomized Phase|Withdrawal by Subject|0|||
48623590|NCT01034657|156479200|FG000|Randomized Phase|Lack of Efficacy|5|||
48623591|NCT01034657|156479201|FG001|Randomized Phase|Lack of Efficacy|1|||
48623592|NCT01034657|156479202|FG002|Randomized Phase|Lack of Efficacy|0|||
48623593|NCT01034657|156479200|FG000|Randomized Phase|Abnormal laboratory value|0|||
48623594|NCT01034657|156479201|FG001|Randomized Phase|Abnormal laboratory value|1|||
48740176|NCT03345914|156897449|FG001|Overall Study|Transition to OLE during follow-up|33|||
48740177|NCT03345914|156897450|FG002|Overall Study|Transition to OLE during follow-up|39|||
48740178|NCT03345914|156897448|FG000|Overall Study|Physician Decision|0|||
48323202|NCT04579250|155381980|FG001|Overall Study|Lost to Follow-up|1|||
48623595|NCT01034657|156479202|FG002|Randomized Phase|Abnormal laboratory value|0|||
48623596|NCT01034657|156479200|FG000|Randomized Phase|Adverse Event|0|||
48623597|NCT01034657|156479201|FG001|Randomized Phase|Adverse Event|2|||
48623598|NCT01034657|156479202|FG002|Randomized Phase|Adverse Event|1|||
48623599|NCT01682603|156479203|FG000|Overall Study|Lost to Follow-up|3|||
48623600|NCT01840163|156479204|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
48623601|NCT01840163|156479205|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
48623602|NCT01840163|156479204|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
48623603|NCT01840163|156479205|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
48623604|NCT01840163|156479204|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
48623605|NCT01840163|156479205|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
48623606|NCT03636269|156479206|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
48623607|NCT03636269|156479207|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
48623608|NCT03636269|156479208|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
48623609|NCT03636269|156479206|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
48623610|NCT03636269|156479207|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
48623611|NCT03636269|156479208|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
48623612|NCT03636269|156479206|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
48623613|NCT03636269|156479207|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
48623614|NCT03636269|156479208|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
48623615|NCT03636269|156479206|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
48623616|NCT03636269|156479207|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
48623617|NCT03636269|156479208|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
48623618|NCT03636269|156479206|FG000|Period 1: Double-blind Phase|Other|6|||
48623619|NCT03636269|156479207|FG001|Period 1: Double-blind Phase|Other|3|||
48623620|NCT03636269|156479208|FG002|Period 1: Double-blind Phase|Other|0|||
48623621|NCT03636269|156479206|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
48623622|NCT03636269|156479207|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
48623623|NCT03636269|156479208|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
48623624|NCT03636269|156479206|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
48623625|NCT03636269|156479207|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
48623626|NCT03636269|156479208|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
48623627|NCT03636269|156479206|FG000|Period 2: Open-label Phase|Adverse Event|0|||
48623628|NCT03636269|156479207|FG001|Period 2: Open-label Phase|Adverse Event|0|||
48623629|NCT03636269|156479208|FG002|Period 2: Open-label Phase|Adverse Event|21|||
48623630|NCT03636269|156479206|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
48623631|NCT03636269|156479207|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
48623632|NCT03636269|156479208|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
48623633|NCT03636269|156479206|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
48623634|NCT03636269|156479207|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
48623635|NCT03636269|156479208|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
48623636|NCT03636269|156479206|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
48623637|NCT03636269|156479207|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
48623638|NCT03636269|156479208|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
48623639|NCT03636269|156479206|FG000|Period 2: Open-label Phase|Administrative|0|||
48623640|NCT03636269|156479207|FG001|Period 2: Open-label Phase|Administrative|0|||
48623641|NCT03636269|156479208|FG002|Period 2: Open-label Phase|Administrative|36|||
48623642|NCT03636269|156479206|FG000|Period 2: Open-label Phase|Other|0|||
48623643|NCT03636269|156479207|FG001|Period 2: Open-label Phase|Other|0|||
48623644|NCT03636269|156479208|FG002|Period 2: Open-label Phase|Other|9|||
48623645|NCT03636269|156479206|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
48623646|NCT03636269|156479207|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
48623647|NCT03636269|156479208|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
48623648|NCT02217982|156479209|FG000|Overall Study|Trial discontinued|1|||
48623649|NCT02217982|156479210|FG001|Overall Study|Trial discontinued|0|||
48623650|NCT02217982|156479209|FG000|Overall Study|Adverse Event|0|||
48623651|NCT02217982|156479210|FG001|Overall Study|Adverse Event|1|||
48623652|NCT05156125|156479211|FG000|Overall Study|Lack of Efficacy|1|||
48623653|NCT05156125|156479212|FG001|Overall Study|Lack of Efficacy|1|||
48623654|NCT05156125|156479213|FG002|Overall Study|Lack of Efficacy|1|||
48623655|NCT05156125|156479211|FG000|Overall Study|Physician Decision|0|||
48623656|NCT05156125|156479212|FG001|Overall Study|Physician Decision|0|||
48623657|NCT05156125|156479213|FG002|Overall Study|Physician Decision|1|||
48623658|NCT05156125|156479211|FG000|Overall Study|Non-compliance|0|||
48623659|NCT05156125|156479212|FG001|Overall Study|Non-compliance|1|||
48623660|NCT05156125|156479213|FG002|Overall Study|Non-compliance|1|||
48623661|NCT05156125|156479211|FG000|Overall Study|Withdrawal by Subject|0|||
48623662|NCT05156125|156479212|FG001|Overall Study|Withdrawal by Subject|0|||
48623663|NCT05156125|156479213|FG002|Overall Study|Withdrawal by Subject|1|||
48623664|NCT05156125|156479211|FG000|Overall Study|Adverse Event|2|||
48623665|NCT05156125|156479212|FG001|Overall Study|Adverse Event|1|||
48740179|NCT03345914|156897449|FG001|Overall Study|Physician Decision|1|||
48740180|NCT03345914|156897450|FG002|Overall Study|Physician Decision|1|||
48740181|NCT03345914|156897448|FG000|Overall Study|Withdrawal by Subject|5|||
48740182|NCT03345914|156897449|FG001|Overall Study|Withdrawal by Subject|1|||
48740183|NCT03345914|156897450|FG002|Overall Study|Withdrawal by Subject|2|||
48740184|NCT03345914|156897448|FG000|Overall Study|Other|1|||
48740185|NCT03345914|156897449|FG001|Overall Study|Other|1|||
48740186|NCT03345914|156897450|FG002|Overall Study|Other|1|||
48623666|NCT05156125|156479213|FG002|Overall Study|Adverse Event|0|||
48623667|NCT03865706|156479228|FG000|Overall Study|Death|0|||
48623668|NCT03865706|156479229|FG001|Overall Study|Death|3|||
48623669|NCT03865706|156479230|FG002|Overall Study|Death|1|||
48623670|NCT04829214|156479231|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
48623671|NCT04829214|156479232|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
48623672|NCT04829214|156479231|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
48623673|NCT04829214|156479232|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
48740187|NCT03345914|156897448|FG000|Overall Study|Ongoing|0|||
48740188|NCT03345914|156897449|FG001|Overall Study|Ongoing|0|||
48740189|NCT03345914|156897450|FG002|Overall Study|Ongoing|1|||
48740190|NCT00675948|156897451|FG000|Overall Study|Adverse Event|23|||
48740191|NCT00675948|156897452|FG001|Overall Study|Adverse Event|1|||
48740192|NCT00675948|156897451|FG000|Overall Study|Lack of Efficacy|3|||
48740193|NCT00675948|156897452|FG001|Overall Study|Lack of Efficacy|0|||
48740194|NCT00675948|156897451|FG000|Overall Study|Withdrawal by Subject|7|||
48740195|NCT00675948|156897452|FG001|Overall Study|Withdrawal by Subject|0|||
48740196|NCT00675948|156897451|FG000|Overall Study|Lost to Follow-up|2|||
48740197|NCT00675948|156897452|FG001|Overall Study|Lost to Follow-up|0|||
48740198|NCT00675948|156897451|FG000|Overall Study|Protocol Violation|1|||
48623674|NCT01229111|156479233|FG000|Overall Study|Death|1|||
48623675|NCT03093870|156479236|FG000|Overall Study|Withdrawal by Subject|2|||
48623676|NCT03093870|156479237|FG001|Overall Study|Withdrawal by Subject|6|||
48623677|NCT03093870|156479238|FG002|Overall Study|Withdrawal by Subject|5|||
48623678|NCT03093870|156479236|FG000|Overall Study|Death|1|||
48623679|NCT03093870|156479237|FG001|Overall Study|Death|35|||
48623680|NCT03093870|156479238|FG002|Overall Study|Death|35|||
48623681|NCT03093870|156479236|FG000|Overall Study|Radiographic disease progression|10|||
48623682|NCT03093870|156479237|FG001|Overall Study|Radiographic disease progression|0|||
48623683|NCT03093870|156479238|FG002|Overall Study|Radiographic disease progression|0|||
48623684|NCT03093870|156479236|FG000|Overall Study|Clinical disease progression|1|||
48623685|NCT03093870|156479237|FG001|Overall Study|Clinical disease progression|0|||
48623686|NCT03093870|156479238|FG002|Overall Study|Clinical disease progression|0|||
48623687|NCT03093870|156479236|FG000|Overall Study|Physician Decision|2|||
48623688|NCT03093870|156479237|FG001|Overall Study|Physician Decision|0|||
48623689|NCT03093870|156479238|FG002|Overall Study|Physician Decision|0|||
48623690|NCT03093870|156479236|FG000|Overall Study|Adverse Event|7|||
48623691|NCT03093870|156479237|FG001|Overall Study|Adverse Event|0|||
48623692|NCT03093870|156479238|FG002|Overall Study|Adverse Event|0|||
48623693|NCT03093870|156479236|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
48623694|NCT03093870|156479237|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
48623695|NCT03093870|156479238|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
48623696|NCT03093870|156479236|FG000|Overall Study|Lost to Follow-up|0|||
48623697|NCT03093870|156479237|FG001|Overall Study|Lost to Follow-up|0|||
48623698|NCT03093870|156479238|FG002|Overall Study|Lost to Follow-up|1|||
48623699|NCT05261490|156479239|FG000|Overall Study|Other|1|||
48623700|NCT05261490|156479240|FG001|Overall Study|Other|0|||
48623701|NCT05261490|156479241|FG002|Overall Study|Other|0|||
48623702|NCT05261490|156479239|FG000|Overall Study|Study Terminated by Sponsor|1|||
48623703|NCT05261490|156479240|FG001|Overall Study|Study Terminated by Sponsor|1|||
48740199|NCT00675948|156897452|FG001|Overall Study|Protocol Violation|0|||
48623704|NCT05261490|156479241|FG002|Overall Study|Study Terminated by Sponsor|4|||
48623705|NCT05261490|156479239|FG000|Overall Study|Death|1|||
48740200|NCT00675948|156897451|FG000|Overall Study|Pain under control|1|||
48740201|NCT00675948|156897452|FG001|Overall Study|Pain under control|0|||
48740202|NCT00675948|156897451|FG000|Overall Study|Sponsor decision|0|||
48740203|NCT00675948|156897452|FG001|Overall Study|Sponsor decision|1|||
48623706|NCT05261490|156479240|FG001|Overall Study|Death|2|||
48740204|NCT00675948|156897451|FG000|Overall Study|Patient died|1|||
48623707|NCT05261490|156479241|FG002|Overall Study|Death|0|||
48740205|NCT00675948|156897452|FG001|Overall Study|Patient died|0|||
48740206|NCT00675948|156897451|FG000|Overall Study|Patient unable to comply with diaries|1|||
48740207|NCT00675948|156897452|FG001|Overall Study|Patient unable to comply with diaries|0|||
48740208|NCT00675948|156897451|FG000|Overall Study|Patient feels unable to take medication|0|||
48740209|NCT00675948|156897452|FG001|Overall Study|Patient feels unable to take medication|1|||
48740210|NCT00762229|156897455|FG000|Overall Study|Lost to Follow-up|1|||
48740211|NCT00762229|156897456|FG001|Overall Study|Lost to Follow-up|1|||
48740212|NCT00762229|156897455|FG000|Overall Study|did not recveive intervention|0|||
48740213|NCT00762229|156897456|FG001|Overall Study|did not recveive intervention|1|||
48740214|NCT02191137|156897458|FG000|Treatment|Death|4|||
48740215|NCT02191137|156897458|FG000|Treatment|Withdrawal by Subject|3|||
48740216|NCT02191137|156897458|FG000|Treatment|Adverse Event|2|||
48740217|NCT02191137|156897458|FG000|Treatment|Other|1|||
48740218|NCT02191137|156897458|FG000|Follow-up|Lost to Follow-up|2|||
48740219|NCT02191137|156897458|FG000|Follow-up|Ongoing/unknown|2|||
48740220|NCT02191137|156897458|FG000|Follow-up|Adverse Event|1|||
48740221|NCT01696695|156897459|FG000|Overall Study|Disease progression|373|||
48740222|NCT01696695|156897459|FG000|Overall Study|Death|29|||
48740223|NCT01696695|156897459|FG000|Overall Study|Adverse Event|74|||
48740224|NCT01696695|156897459|FG000|Overall Study|Withdrawal by Subject|92|||
48740225|NCT01696695|156897459|FG000|Overall Study|Lost to Follow-up|48|||
48740226|NCT01696695|156897459|FG000|Overall Study|Other|74|||
48740227|NCT01696695|156897459|FG000|Overall Study|Major Protocol Violation|192|||
48623708|NCT02314247|156479242|FG000|Overall Study|Adverse Event|2|||
48623709|NCT02314247|156479243|FG001|Overall Study|Adverse Event|1|||
48623710|NCT02314247|156479244|FG002|Overall Study|Adverse Event|0|||
48623711|NCT02314247|156479242|FG000|Overall Study|Withdrawal by Subject|1|||
48623712|NCT02314247|156479243|FG001|Overall Study|Withdrawal by Subject|3|||
48623713|NCT02314247|156479244|FG002|Overall Study|Withdrawal by Subject|1|||
48623714|NCT02314247|156479242|FG000|Overall Study|Progression of Disease|6|||
48623715|NCT02314247|156479243|FG001|Overall Study|Progression of Disease|2|||
48623716|NCT02314247|156479244|FG002|Overall Study|Progression of Disease|0|||
48623717|NCT05085405|156479245|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
48623718|NCT05085405|156479246|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
48623719|NCT05085405|156479247|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
48623720|NCT05085405|156479248|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
48623721|NCT05085405|156479249|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
48623722|NCT05085405|156479250|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
48623723|NCT05085405|156479245|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
48623724|NCT05085405|156479246|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
48623725|NCT05085405|156479247|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
48623726|NCT05085405|156479248|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
48623727|NCT05085405|156479249|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
48623728|NCT05085405|156479250|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
48623729|NCT01871727|156479251|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
48623730|NCT01871727|156479252|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
48623731|NCT01871727|156479253|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
48623732|NCT01871727|156479254|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
48623733|NCT01871727|156479255|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
48623734|NCT01871727|156479251|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
48623735|NCT01871727|156479252|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
48623736|NCT01871727|156479253|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
48623737|NCT01871727|156479254|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
48623738|NCT01871727|156479255|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
48623739|NCT01871727|156479251|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
48623740|NCT01871727|156479252|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
48623741|NCT01871727|156479253|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
48623742|NCT01871727|156479254|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
48623743|NCT01871727|156479255|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
48623744|NCT01871727|156479251|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
48623745|NCT01871727|156479252|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
48623746|NCT01871727|156479253|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
48623747|NCT01871727|156479254|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
48623748|NCT01871727|156479255|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
48623749|NCT01871727|156479251|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
48623750|NCT01871727|156479252|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
48623751|NCT01871727|156479253|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
48740228|NCT03948581|156897460|FG000|Overall Study|Lost to Follow-up|0|||
48740229|NCT03948581|156897461|FG001|Overall Study|Lost to Follow-up|1|||
48740230|NCT01593917|156897466|FG000|Overall Study|Death|67|||
48740231|NCT01593917|156897466|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
48740232|NCT01593917|156897466|FG000|Overall Study|Withdrawal by Subject|23|||
48740233|NCT01593917|156897466|FG000|Overall Study|Lost to Follow-up|12|||
48623752|NCT01871727|156479254|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
48623753|NCT01871727|156479255|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
48623754|NCT01871727|156479251|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
48623755|NCT01871727|156479252|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
48623756|NCT01871727|156479253|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
48623757|NCT01871727|156479254|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
48623758|NCT01871727|156479255|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
48623759|NCT01871727|156479251|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
48623760|NCT01871727|156479252|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
48623761|NCT01871727|156479253|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
48623762|NCT01871727|156479254|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
48623763|NCT01871727|156479255|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
48623764|NCT01905267|156479256|FG000|Overall Study|Physician Decision|2|||
48623765|NCT01905267|156479257|FG001|Overall Study|Physician Decision|2|||
48623766|NCT01084135|156479258|FG000|20 Week|Physician Decision|0|||
48623767|NCT01084135|156479259|FG001|20 Week|Physician Decision|1|||
48740234|NCT01593917|156897466|FG000|Overall Study|Protocol Violation|5|||
48740235|NCT01593917|156897466|FG000|Overall Study|Physician Decision|3|||
48740236|NCT05457647|156897467|FG000|Overall Study|Lost to Follow-up|3|||
48740237|NCT01802788|156897468|FG000|Overall Study|Withdrawal by Subject|102|||
48740238|NCT01802788|156897469|FG001|Overall Study|Withdrawal by Subject|5|||
48623768|NCT03769116|156479260|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
48623769|NCT03769116|156479261|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
48623770|NCT03769116|156479260|FG000|Part 3 - Open Label|Physician Decision|1|||
48623771|NCT03769116|156479261|FG001|Part 3 - Open Label|Physician Decision|0|||
48623772|NCT03769116|156479260|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
48623773|NCT03769116|156479261|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
48623774|NCT03688139|156479267|FG000|Overall Study|Lost to Follow-up|2|||
48623775|NCT03688139|156479268|FG001|Overall Study|Lost to Follow-up|0|||
48623776|NCT03688139|156479267|FG000|Overall Study|Physician Decision|0|||
48623777|NCT03688139|156479268|FG001|Overall Study|Physician Decision|1|||
48623778|NCT03688139|156479267|FG000|Overall Study|Withdrawal by Subject|2|||
48623779|NCT03688139|156479268|FG001|Overall Study|Withdrawal by Subject|3|||
48623780|NCT00231465|156479269|FG000|Overall Study|Completed only one cycle|1|||
48623781|NCT00231465|156479269|FG000|Overall Study|Did not have follow up CT scans|1|||
48623782|NCT04380753|156479270|FG000|Overall Study|Participants continuing study|4|||
48623783|NCT04380753|156479270|FG000|Overall Study|Death|2|||
48623784|NCT01720602|156479271|FG000|Overall Study|Adverse Event|3|||
48623785|NCT01720602|156479271|FG000|Overall Study|Progressive disease on therapy|2|||
48623786|NCT01539525|156479274|FG000|Overall Study|Lost to Follow-up|19|||
48623787|NCT01539525|156479275|FG001|Overall Study|Lost to Follow-up|12|||
48623788|NCT01539525|156479276|FG002|Overall Study|Lost to Follow-up|11|||
48623789|NCT01539525|156479274|FG000|Overall Study|Withdrawal by Subject|0|||
48623790|NCT01539525|156479275|FG001|Overall Study|Withdrawal by Subject|3|||
48623791|NCT01539525|156479276|FG002|Overall Study|Withdrawal by Subject|2|||
48623792|NCT01539525|156479274|FG000|Overall Study|Protocol Violation|1|||
48623793|NCT01539525|156479275|FG001|Overall Study|Protocol Violation|1|||
48623794|NCT01539525|156479276|FG002|Overall Study|Protocol Violation|4|||
48623795|NCT02528305|156479277|FG000|Overall Study|Withdrawal by Subject|1|||
48623796|NCT02528305|156479277|FG000|Overall Study|Adverse Event|1|||
48623797|NCT02528305|156479277|FG000|Overall Study|Physician Decision|1|||
48623798|NCT03425188|156479278|FG000|Overall Study|Withdrawal by Subject|1|||
48623799|NCT01835431|156479279|FG000|Overall Study|Adverse Event|1|||
48623800|NCT01835431|156479280|FG001|Overall Study|Adverse Event|0|||
48623801|NCT01835431|156479279|FG000|Overall Study|other|0|||
48623802|NCT01835431|156479280|FG001|Overall Study|other|2|||
48623803|NCT01835431|156479279|FG000|Overall Study|Withdrawal by Subject|6|||
48623804|NCT01835431|156479280|FG001|Overall Study|Withdrawal by Subject|10|||
48623805|NCT01835431|156479279|FG000|Overall Study|Protocol Violation|1|||
48623806|NCT01835431|156479280|FG001|Overall Study|Protocol Violation|0|||
48623807|NCT03878069|156479281|FG000|Overall Study|Death|0|||
48623808|NCT03878069|156479282|FG001|Overall Study|Death|1|||
48623809|NCT03878069|156479283|FG002|Overall Study|Death|0|||
48740239|NCT01802788|156897468|FG000|Overall Study|Death|382|||
48623810|NCT04579380|156480522|FG000|Overall Study|Death|9|||
48623811|NCT04579380|156480523|FG001|Overall Study|Death|22|||
48740240|NCT01802788|156897469|FG001|Overall Study|Death|18|||
48623812|NCT04579380|156480524|FG002|Overall Study|Death|22|||
48623813|NCT04579380|156480525|FG003|Overall Study|Death|17|||
48623814|NCT04579380|156480526|FG004|Overall Study|Death|6|||
48623815|NCT04579380|156480527|FG005|Overall Study|Death|21|||
48623816|NCT04579380|156480528|FG006|Overall Study|Death|10|||
48623817|NCT04579380|156480529|FG007|Overall Study|Death|11|||
48623818|NCT04579380|156480530|FG008|Overall Study|Death|25|||
48740241|NCT01802788|156897468|FG000|Overall Study|Lost to Follow-up|31|||
48623819|NCT04579380|156480522|FG000|Overall Study|Withdrawal by Subject|0|||
48740242|NCT01802788|156897469|FG001|Overall Study|Lost to Follow-up|2|||
48623820|NCT04579380|156480523|FG001|Overall Study|Withdrawal by Subject|3|||
48623821|NCT04579380|156480524|FG002|Overall Study|Withdrawal by Subject|4|||
48623822|NCT04579380|156480525|FG003|Overall Study|Withdrawal by Subject|0|||
48623823|NCT04579380|156480526|FG004|Overall Study|Withdrawal by Subject|1|||
48623824|NCT04579380|156480527|FG005|Overall Study|Withdrawal by Subject|2|||
48623825|NCT04579380|156480528|FG006|Overall Study|Withdrawal by Subject|0|||
48623826|NCT04579380|156480529|FG007|Overall Study|Withdrawal by Subject|1|||
48623827|NCT04579380|156480530|FG008|Overall Study|Withdrawal by Subject|2|||
48623828|NCT04579380|156480522|FG000|Overall Study|Ongoing|2|||
48623829|NCT04579380|156480523|FG001|Overall Study|Ongoing|6|||
48623830|NCT04579380|156480524|FG002|Overall Study|Ongoing|4|||
48623831|NCT04579380|156480525|FG003|Overall Study|Ongoing|8|||
48623832|NCT04579380|156480526|FG004|Overall Study|Ongoing|5|||
48623833|NCT04579380|156480527|FG005|Overall Study|Ongoing|8|||
48623834|NCT04579380|156480528|FG006|Overall Study|Ongoing|3|||
48623835|NCT04579380|156480529|FG007|Overall Study|Ongoing|19|||
48623836|NCT04579380|156480530|FG008|Overall Study|Ongoing|6|||
48623837|NCT04971837|156480531|FG000|Overall Study|Long Term Illness|1|||
48623838|NCT04971837|156480531|FG000|Overall Study|BMI too low|9|||
48623839|NCT04971837|156480531|FG000|Overall Study|geographic location|1|||
48623840|NCT04971837|156480531|FG000|Overall Study|Discontinued scheduling conflict|1|||
48623841|NCT01433978|156480532|FG000|Core Study|Adverse Event, Non-Fatal|0|||
48623842|NCT01433978|156480533|FG001|Core Study|Adverse Event, Non-Fatal|1|||
48623843|NCT01433978|156480534|FG002|Core Study|Adverse Event, Non-Fatal|0|||
48623844|NCT01433978|156480532|FG000|Core Study|Lack of Efficacy|5|||
48623845|NCT01433978|156480533|FG001|Core Study|Lack of Efficacy|1|||
48623846|NCT01433978|156480534|FG002|Core Study|Lack of Efficacy|0|||
48623847|NCT01433978|156480532|FG000|Core Study|Study Terminated by Sponsor|6|||
48623848|NCT01433978|156480533|FG001|Core Study|Study Terminated by Sponsor|9|||
48623849|NCT01433978|156480534|FG002|Core Study|Study Terminated by Sponsor|0|||
48623850|NCT01433978|156480532|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
48623851|NCT01433978|156480533|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
48623852|NCT01433978|156480534|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
48623853|NCT01433978|156480532|FG000|Extension Phase|Lack of Efficacy|0|||
48623854|NCT01433978|156480533|FG001|Extension Phase|Lack of Efficacy|0|||
48623855|NCT01433978|156480534|FG002|Extension Phase|Lack of Efficacy|1|||
48623856|NCT01433978|156480532|FG000|Extension Phase|Study Terminated by Sponsor|0|||
48623857|NCT01433978|156480533|FG001|Extension Phase|Study Terminated by Sponsor|0|||
48623858|NCT01433978|156480534|FG002|Extension Phase|Study Terminated by Sponsor|4|||
48623859|NCT01773889|156480535|FG000|Overall Study|lack of funding|2|||
48623860|NCT00866775|156480538|FG000|Overall Study|Adverse Event|5|||
48623861|NCT00866775|156480539|FG001|Overall Study|Adverse Event|19|||
48623862|NCT00866775|156480538|FG000|Overall Study|Death|1|||
48623863|NCT00866775|156480539|FG001|Overall Study|Death|0|||
48623864|NCT00866775|156480538|FG000|Overall Study|Lost to Follow-up|0|||
48623865|NCT00866775|156480539|FG001|Overall Study|Lost to Follow-up|4|||
48623866|NCT00866775|156480538|FG000|Overall Study|Physician Decision|0|||
48623867|NCT00866775|156480539|FG001|Overall Study|Physician Decision|3|||
48623868|NCT00866775|156480538|FG000|Overall Study|Protocol Violation|3|||
48623869|NCT00866775|156480539|FG001|Overall Study|Protocol Violation|4|||
48623870|NCT00866775|156480538|FG000|Overall Study|Withdrawal by Subject|4|||
48623871|NCT00866775|156480539|FG001|Overall Study|Withdrawal by Subject|4|||
48623872|NCT00866775|156480538|FG000|Overall Study|met exit criteria|23|||
48623873|NCT00866775|156480539|FG001|Overall Study|met exit criteria|17|||
48623874|NCT00866775|156480538|FG000|Overall Study|discontinued due to communication error|0|||
48623875|NCT00866775|156480539|FG001|Overall Study|discontinued due to communication error|1|||
48623876|NCT02773537|156480542|FG000|Overall Study|Lost to Follow-up|0|||
48623877|NCT02773537|156480543|FG001|Overall Study|Lost to Follow-up|1|||
48623878|NCT02773537|156480544|FG002|Overall Study|Lost to Follow-up|4|||
48623879|NCT02595879|156480546|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
48623880|NCT02595879|156480547|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
48623881|NCT00756314|156480551|FG000|Overall Study|Lost to Follow-up|2|||
48623882|NCT00756314|156480552|FG001|Overall Study|Lost to Follow-up|59|||
48623883|NCT05587998|156480553|FG000|Overall Study|Withdrawal by Subject|1|||
48623884|NCT05587998|156480554|FG001|Overall Study|Withdrawal by Subject|1|||
48623885|NCT05587998|156480553|FG000|Overall Study|Not treated|3|||
48623886|NCT05587998|156480554|FG001|Overall Study|Not treated|1|||
48623887|NCT05587998|156480553|FG000|Overall Study|Non-compliance with study procedures|0|||
48623888|NCT05587998|156480554|FG001|Overall Study|Non-compliance with study procedures|1|||
48623889|NCT01725282|156480555|FG000|Overall Study|Adverse Event|1|||
48623890|NCT01725282|156480556|FG001|Overall Study|Adverse Event|3|||
48623891|NCT01725282|156480557|FG002|Overall Study|Adverse Event|6|||
48623892|NCT01725282|156480558|FG003|Overall Study|Adverse Event|4|||
48623893|NCT01725282|156480555|FG000|Overall Study|Exacerbation of Target Disease|1|||
48623894|NCT01725282|156480556|FG001|Overall Study|Exacerbation of Target Disease|0|||
48623895|NCT01725282|156480557|FG002|Overall Study|Exacerbation of Target Disease|0|||
48623896|NCT01725282|156480558|FG003|Overall Study|Exacerbation of Target Disease|1|||
48623897|NCT01725282|156480555|FG000|Overall Study|Met Exclusion Criteria|0|||
48623898|NCT01725282|156480556|FG001|Overall Study|Met Exclusion Criteria|0|||
48623899|NCT01725282|156480557|FG002|Overall Study|Met Exclusion Criteria|1|||
48623900|NCT01725282|156480558|FG003|Overall Study|Met Exclusion Criteria|0|||
48623901|NCT01725282|156480555|FG000|Overall Study|Study Site Withdrawal|0|||
48623902|NCT01725282|156480556|FG001|Overall Study|Study Site Withdrawal|1|||
48623903|NCT01725282|156480557|FG002|Overall Study|Study Site Withdrawal|0|||
48623904|NCT01725282|156480558|FG003|Overall Study|Study Site Withdrawal|0|||
48623905|NCT01725282|156480555|FG000|Overall Study|Withdrawal by Subject|0|||
48623906|NCT01725282|156480556|FG001|Overall Study|Withdrawal by Subject|0|||
48623907|NCT01725282|156480557|FG002|Overall Study|Withdrawal by Subject|1|||
48623908|NCT01725282|156480558|FG003|Overall Study|Withdrawal by Subject|1|||
48623909|NCT01725282|156480555|FG000|Overall Study|Lack of Efficacy|0|||
48623910|NCT01725282|156480556|FG001|Overall Study|Lack of Efficacy|1|||
48623911|NCT01725282|156480557|FG002|Overall Study|Lack of Efficacy|0|||
48623912|NCT01725282|156480558|FG003|Overall Study|Lack of Efficacy|1|||
48623913|NCT01260311|156480559|FG000|Overall Study|Adverse Event|11|||
48623914|NCT01260311|156480559|FG000|Overall Study|Lack of Efficacy|4|||
48623915|NCT01260311|156480559|FG000|Overall Study|Lost to Follow-up|25|||
48623916|NCT01260311|156480559|FG000|Overall Study|Withdrawal by Subject|6|||
48623917|NCT01260311|156480559|FG000|Overall Study|Financial Constraints|77|||
48623918|NCT01260311|156480559|FG000|Overall Study|Gone to Province|2|||
48623919|NCT01260311|156480559|FG000|Overall Study|Medication Stopped|1|||
48623920|NCT01260311|156480559|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
48623921|NCT02965456|156480560|FG000|Overall Study|Lost to Follow-up|40|||
48623922|NCT02965456|156480561|FG001|Overall Study|Lost to Follow-up|18|||
48623923|NCT02965456|156480560|FG000|Overall Study|Subject Request|22|||
48623924|NCT02965456|156480561|FG001|Overall Study|Subject Request|13|||
48623925|NCT02965456|156480560|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
48623926|NCT02965456|156480561|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
48623927|NCT02965456|156480560|FG000|Overall Study|Adverse Event|3|||
48623928|NCT02965456|156480561|FG001|Overall Study|Adverse Event|0|||
48623929|NCT02965456|156480560|FG000|Overall Study|Noncompliance with Study Drug|1|||
48623930|NCT02965456|156480561|FG001|Overall Study|Noncompliance with Study Drug|1|||
48623931|NCT02965456|156480560|FG000|Overall Study|Worsening Condition|0|||
48623932|NCT02965456|156480561|FG001|Overall Study|Worsening Condition|2|||
48623933|NCT02965456|156480560|FG000|Overall Study|Lack of Efficacy|1|||
48623934|NCT02965456|156480561|FG001|Overall Study|Lack of Efficacy|0|||
48623935|NCT02965456|156480560|FG000|Overall Study|Physician Decision|0|||
48623936|NCT02965456|156480561|FG001|Overall Study|Physician Decision|1|||
48623937|NCT02965456|156480560|FG000|Overall Study|Pregnancy|1|||
48623938|NCT02965456|156480561|FG001|Overall Study|Pregnancy|0|||
48623939|NCT02965456|156480560|FG000|Overall Study|Protocol Violation|0|||
48623940|NCT02965456|156480561|FG001|Overall Study|Protocol Violation|1|||
48623941|NCT02965456|156480560|FG000|Overall Study|Participant ran out of study drug|0|||
48623942|NCT02965456|156480561|FG001|Overall Study|Participant ran out of study drug|1|||
48623943|NCT00452530|156480564|FG000|Overall Study|Death|1|||
48623944|NCT00452530|156480565|FG001|Overall Study|Death|0|||
48623945|NCT00452530|156480564|FG000|Overall Study|Adverse Event|40|||
48623946|NCT00452530|156480565|FG001|Overall Study|Adverse Event|44|||
48623947|NCT00452530|156480564|FG000|Overall Study|Withdrawal by Subject|68|||
48623948|NCT00452530|156480565|FG001|Overall Study|Withdrawal by Subject|57|||
48623949|NCT00452530|156480564|FG000|Overall Study|Lost to Follow-up|1|||
48623950|NCT00452530|156480565|FG001|Overall Study|Lost to Follow-up|0|||
48623951|NCT00452530|156480564|FG000|Overall Study|Poor compliance/noncompliance|1|||
48623952|NCT00452530|156480565|FG001|Overall Study|Poor compliance/noncompliance|2|||
48623953|NCT00452530|156480564|FG000|Overall Study|No longer met study criteria|18|||
48623954|NCT00452530|156480565|FG001|Overall Study|No longer met study criteria|22|||
48623955|NCT00452530|156480564|FG000|Overall Study|Other|7|||
48623956|NCT00452530|156480565|FG001|Overall Study|Other|11|||
48623957|NCT03760068|156480568|FG000|Overall Study|Withdrawal by Subject|7|||
48623958|NCT03760068|156480569|FG001|Overall Study|Withdrawal by Subject|8|||
48623959|NCT03760068|156480568|FG000|Overall Study|Adverse Event|1|||
48623960|NCT03760068|156480569|FG001|Overall Study|Adverse Event|2|||
48623961|NCT03760068|156480568|FG000|Overall Study|Administrative Decision by Sponsor|0|||
48623962|NCT03760068|156480569|FG001|Overall Study|Administrative Decision by Sponsor|2|||
48623963|NCT03760068|156480568|FG000|Overall Study|Physician Decision|1|||
48623964|NCT03760068|156480569|FG001|Overall Study|Physician Decision|2|||
48623965|NCT03760068|156480568|FG000|Overall Study|Lost to Follow-up|4|||
48623966|NCT03760068|156480569|FG001|Overall Study|Lost to Follow-up|9|||
48623967|NCT03760068|156480568|FG000|Overall Study|Subject Moved Out of State|1|||
48623968|NCT03760068|156480569|FG001|Overall Study|Subject Moved Out of State|0|||
48623969|NCT04003389|156480581|FG000|Overall Study|Adverse Event|27|||
48623970|NCT04003389|156480582|FG001|Overall Study|Adverse Event|34|||
48623971|NCT04003389|156480583|FG002|Overall Study|Adverse Event|28|||
48623972|NCT04003389|156480581|FG000|Overall Study|Lost to Follow-up|39|||
48623973|NCT04003389|156480582|FG001|Overall Study|Lost to Follow-up|30|||
48623974|NCT04003389|156480583|FG002|Overall Study|Lost to Follow-up|33|||
48623975|NCT04003389|156480581|FG000|Overall Study|Protocol Violation|1|||
48623976|NCT04003389|156480582|FG001|Overall Study|Protocol Violation|6|||
48623977|NCT04003389|156480583|FG002|Overall Study|Protocol Violation|5|||
48623978|NCT04003389|156480581|FG000|Overall Study|Withdrawal by Subject|119|||
48623979|NCT04003389|156480582|FG001|Overall Study|Withdrawal by Subject|79|||
48623980|NCT04003389|156480583|FG002|Overall Study|Withdrawal by Subject|85|||
48623981|NCT04003389|156480581|FG000|Overall Study|Miscellaneous|14|||
48623982|NCT04003389|156480582|FG001|Overall Study|Miscellaneous|11|||
48623983|NCT04003389|156480583|FG002|Overall Study|Miscellaneous|14|||
48623984|NCT04003389|156480581|FG000|Overall Study|Participant did not receive study drug|1|||
48623985|NCT04003389|156480582|FG001|Overall Study|Participant did not receive study drug|0|||
48623986|NCT04003389|156480583|FG002|Overall Study|Participant did not receive study drug|0|||
48623987|NCT04439903|156480584|FG000|Overall Study|Withdrawal by Subject|2|||
48623988|NCT04439903|156480584|FG000|Overall Study|Screen Failure|1|||
48623989|NCT03163264|156480586|FG000|Overall Study|Withdrawal by Subject|13|||
48623990|NCT03163264|156480587|FG001|Overall Study|Withdrawal by Subject|3|||
48623991|NCT03163264|156480588|FG002|Overall Study|Withdrawal by Subject|4|||
48623992|NCT03163264|156480589|FG003|Overall Study|Withdrawal by Subject|2|||
48623993|NCT03163264|156480586|FG000|Overall Study|Lost to Follow-up|17|||
48623994|NCT03163264|156480587|FG001|Overall Study|Lost to Follow-up|20|||
48623995|NCT03163264|156480588|FG002|Overall Study|Lost to Follow-up|0|||
48623996|NCT03163264|156480589|FG003|Overall Study|Lost to Follow-up|0|||
48623997|NCT03163264|156480586|FG000|Overall Study|Death|0|||
48623998|NCT03163264|156480587|FG001|Overall Study|Death|2|||
48623999|NCT03163264|156480588|FG002|Overall Study|Death|0|||
48624000|NCT03163264|156480589|FG003|Overall Study|Death|0|||
48624001|NCT00401830|156480596|FG000|Overall Study|Adverse Event|10|||
48624002|NCT00401830|156480597|FG001|Overall Study|Adverse Event|18|||
48624003|NCT00401830|156480596|FG000|Overall Study|Lack of Efficacy|11|||
48624004|NCT00401830|156480597|FG001|Overall Study|Lack of Efficacy|5|||
48624005|NCT00401830|156480596|FG000|Overall Study|Withdrawal by Subject|4|||
48624006|NCT00401830|156480597|FG001|Overall Study|Withdrawal by Subject|3|||
48624007|NCT00401830|156480596|FG000|Overall Study|Protocol Violation|3|||
48624008|NCT00401830|156480597|FG001|Overall Study|Protocol Violation|3|||
48624009|NCT00401830|156480596|FG000|Overall Study|Non-compliance with drug study|1|||
48624010|NCT00401830|156480597|FG001|Overall Study|Non-compliance with drug study|0|||
48624011|NCT00401830|156480596|FG000|Overall Study|Lost to Follow-up|1|||
48624012|NCT00401830|156480597|FG001|Overall Study|Lost to Follow-up|3|||
48624013|NCT00401830|156480596|FG000|Overall Study|Other: Personal / Family problems|1|||
48624014|NCT00401830|156480597|FG001|Overall Study|Other: Personal / Family problems|0|||
48624015|NCT04090749|156480598|FG000|Open Label Pilot|Lost to Follow-up|1|||
48624016|NCT04090749|156480599|FG001|Open Label Pilot|Lost to Follow-up|0|||
48624017|NCT04090749|156480600|FG002|Open Label Pilot|Lost to Follow-up|0|||
48624018|NCT04090749|156480598|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
48624019|NCT04090749|156480599|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
48624020|NCT04090749|156480600|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
48624021|NCT04090749|156480598|FG000|Pilot Trial|Lost to Follow-up|0|||
48624022|NCT04090749|156480599|FG001|Pilot Trial|Lost to Follow-up|1|||
48624023|NCT04090749|156480600|FG002|Pilot Trial|Lost to Follow-up|1|||
48624024|NCT04091438|156480601|FG000|Treatment Period 1 (1 Day)|Other|1|||
48624025|NCT04091438|156480602|FG001|Treatment Period 1 (1 Day)|Other|0|||
48624026|NCT04091438|156480601|FG000|Washout Period (1 Day)|Protocol deviation|0|||
48624027|NCT04091438|156480602|FG001|Washout Period (1 Day)|Protocol deviation|1|||
48624028|NCT04091438|156480601|FG000|Washout Period (1 Day)|Other|0|||
48624029|NCT04091438|156480602|FG001|Washout Period (1 Day)|Other|1|||
48624030|NCT04105725|156480603|FG000|Primary Intervention|Lost to Follow-up|0|||
48624031|NCT04105725|156480604|FG001|Primary Intervention|Lost to Follow-up|2|||
48624032|NCT04105725|156480603|FG000|Primary Intervention|Withdrawal by Subject|0|||
48624033|NCT04105725|156480604|FG001|Primary Intervention|Withdrawal by Subject|1|||
48740243|NCT01802788|156897468|FG000|Overall Study|Physician Decision|3|||
48740244|NCT01802788|156897469|FG001|Overall Study|Physician Decision|0|||
48624034|NCT00787800|156480605|FG000|Overall Study|Withdrawal by Subject|3|||
48740245|NCT01802788|156897468|FG000|Overall Study|Patient Non-Compliance|1|||
48624035|NCT00787800|156480606|FG001|Overall Study|Withdrawal by Subject|5|||
48624036|NCT00787800|156480605|FG000|Overall Study|Death|0|||
48624037|NCT00787800|156480606|FG001|Overall Study|Death|2|||
48624038|NCT04634331|156480607|FG000|Overall Study|Withdrawal by Subject|2|||
48624039|NCT04634331|156480608|FG001|Overall Study|Withdrawal by Subject|2|||
48624040|NCT05626686|156480610|FG000|Overall Study|Protocol Violation|3|||
48624041|NCT05626686|156480610|FG000|Overall Study|Withdrawal by Subject|3|||
48624042|NCT00089583|156480611|FG000|Overall Study|Adverse Event|0|||
48624043|NCT00089583|156480612|FG001|Overall Study|Adverse Event|3|||
48624044|NCT00089583|156480611|FG000|Overall Study|Insufficient Viral Load Response|5|||
48624045|NCT00089583|156480612|FG001|Overall Study|Insufficient Viral Load Response|5|||
48740246|NCT01802788|156897469|FG001|Overall Study|Patient Non-Compliance|0|||
48624046|NCT00089583|156480611|FG000|Overall Study|Withdrawal by Subject|0|||
48624047|NCT00089583|156480612|FG001|Overall Study|Withdrawal by Subject|4|||
48624048|NCT00089583|156480611|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
48624049|NCT00089583|156480612|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
48624050|NCT00089583|156480611|FG000|Overall Study|Participant Refused Study Medication|0|||
48624051|NCT00089583|156480612|FG001|Overall Study|Participant Refused Study Medication|2|||
48624052|NCT00089583|156480611|FG000|Overall Study|Non-Compliance|0|||
48624053|NCT00089583|156480612|FG001|Overall Study|Non-Compliance|4|||
48624054|NCT00089583|156480611|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
48624055|NCT00089583|156480612|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
48624056|NCT00089583|156480611|FG000|Overall Study|Participant Management Criteria Met|0|||
48624057|NCT00089583|156480612|FG001|Overall Study|Participant Management Criteria Met|1|||
48624058|NCT00089583|156480611|FG000|Overall Study|Reason Not Provided|0|||
48624059|NCT00089583|156480612|FG001|Overall Study|Reason Not Provided|1|||
48624060|NCT00089583|156480611|FG000|Overall Study|Protocol Violation|0|||
48624061|NCT00089583|156480612|FG001|Overall Study|Protocol Violation|3|||
48624062|NCT00089583|156480611|FG000|Overall Study|Principal Investigator Decision|0|||
48624063|NCT00089583|156480612|FG001|Overall Study|Principal Investigator Decision|10|||
48624064|NCT00089583|156480611|FG000|Overall Study|Start of Disallowed Medication|0|||
48624065|NCT00089583|156480612|FG001|Overall Study|Start of Disallowed Medication|1|||
48624066|NCT00089583|156480611|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
48624067|NCT00089583|156480612|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
48624068|NCT00089583|156480611|FG000|Overall Study|Participant Incarcerated|0|||
48624069|NCT00089583|156480612|FG001|Overall Study|Participant Incarcerated|1|||
48624070|NCT05569954|156480613|FG000|Overall Study|Lost to Follow-up|3|||
48624071|NCT05569954|156480614|FG001|Overall Study|Lost to Follow-up|4|||
48624072|NCT05569954|156480613|FG000|Overall Study|Protocol Violation|1|||
48624073|NCT05569954|156480614|FG001|Overall Study|Protocol Violation|2|||
48624074|NCT05569954|156480613|FG000|Overall Study|Withdrawal by Subject|4|||
48624075|NCT05569954|156480614|FG001|Overall Study|Withdrawal by Subject|2|||
48624076|NCT02656173|156480621|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
48624077|NCT02656173|156480622|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
48624078|NCT02656173|156480621|FG000|Overall Study|Adverse Event|7|||
48624079|NCT02656173|156480622|FG001|Overall Study|Adverse Event|5|||
48624080|NCT02656173|156480621|FG000|Overall Study|Withdrawal by Subject|1|||
48624081|NCT02656173|156480622|FG001|Overall Study|Withdrawal by Subject|3|||
48624082|NCT02656173|156480621|FG000|Overall Study|Protocol Violation|0|||
48624083|NCT02656173|156480622|FG001|Overall Study|Protocol Violation|1|||
48624084|NCT02656173|156480621|FG000|Overall Study|Miscellaneous|2|||
48624085|NCT02656173|156480622|FG001|Overall Study|Miscellaneous|0|||
48624086|NCT01064622|156480623|FG000|Randomized Phase II|Withdrawal by Subject|2|||
48624087|NCT01064622|156480624|FG001|Randomized Phase II|Withdrawal by Subject|2|||
48624088|NCT01064622|156480623|FG000|Randomized Phase II|Protocol Violation|0|||
48624089|NCT01064622|156480624|FG001|Randomized Phase II|Protocol Violation|1|||
48624090|NCT03927846|156480625|FG000|Overall Study|Lost to Follow-up|10|||
48624091|NCT03927846|156480626|FG001|Overall Study|Lost to Follow-up|11|||
48624092|NCT00964678|156480629|FG000|Overall Study|Physician Decision|4|||
48624093|NCT03164356|156480632|FG000|Overall Study|Lost to Follow-up|1|||
48624094|NCT03164356|156480633|FG001|Overall Study|Lost to Follow-up|1|||
48624095|NCT03164356|156480634|FG002|Overall Study|Lost to Follow-up|2|||
48624096|NCT03164356|156480635|FG003|Overall Study|Lost to Follow-up|1|||
48624097|NCT03164356|156480632|FG000|Overall Study|Physician Decision|0|||
48624098|NCT03164356|156480633|FG001|Overall Study|Physician Decision|0|||
48624099|NCT03164356|156480634|FG002|Overall Study|Physician Decision|3|||
48624100|NCT03164356|156480635|FG003|Overall Study|Physician Decision|0|||
48624101|NCT03164356|156480632|FG000|Overall Study|Protocol Violation|2|||
48624102|NCT03164356|156480633|FG001|Overall Study|Protocol Violation|1|||
48624103|NCT03164356|156480634|FG002|Overall Study|Protocol Violation|0|||
48624104|NCT03164356|156480635|FG003|Overall Study|Protocol Violation|0|||
48624105|NCT03164356|156480632|FG000|Overall Study|Withdrawal by Subject|1|||
48624106|NCT03164356|156480633|FG001|Overall Study|Withdrawal by Subject|0|||
48624107|NCT03164356|156480634|FG002|Overall Study|Withdrawal by Subject|0|||
48624108|NCT03164356|156480635|FG003|Overall Study|Withdrawal by Subject|0|||
48624109|NCT03164356|156480632|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
48624110|NCT03164356|156480633|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
48624111|NCT03164356|156480634|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
48624112|NCT03164356|156480635|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
48624113|NCT03164356|156480632|FG000|Overall Study|Subject Incarcerated|0|||
48624114|NCT03164356|156480633|FG001|Overall Study|Subject Incarcerated|1|||
48624115|NCT03164356|156480634|FG002|Overall Study|Subject Incarcerated|0|||
48624116|NCT03164356|156480635|FG003|Overall Study|Subject Incarcerated|0|||
48624117|NCT03164356|156480632|FG000|Overall Study|Prosthetist unable to participate|0|||
48624118|NCT03164356|156480633|FG001|Overall Study|Prosthetist unable to participate|2|||
48624119|NCT03164356|156480634|FG002|Overall Study|Prosthetist unable to participate|1|||
48624120|NCT03164356|156480635|FG003|Overall Study|Prosthetist unable to participate|0|||
48624121|NCT03787212|156482217|FG000|Period 1|Study Termination|2|||
48624122|NCT03787212|156482218|FG001|Period 1|Study Termination|2|||
48624123|NCT03004183|156482221|FG000|Overall Study|Adverse Event|7|||
48624124|NCT03004183|156482221|FG000|Overall Study|Lost to Follow-up|1|||
48624125|NCT03004183|156482221|FG000|Overall Study|Physician Decision|40|||
48624126|NCT03004183|156482221|FG000|Overall Study|Withdrawal by Subject|1|||
48624127|NCT03004183|156482221|FG000|Overall Study|COVID-19|1|||
48624128|NCT03681093|156482222|FG000|Overall Study|Subject decision|0|||
48624129|NCT03681093|156482223|FG001|Overall Study|Subject decision|2|||
48624130|NCT03681093|156482224|FG002|Overall Study|Subject decision|1|||
48624131|NCT02469961|156482225|FG000|Overall Study|Physician Decision|4|||
48624132|NCT02469961|156482226|FG001|Overall Study|Physician Decision|1|||
48624133|NCT00758043|156482227|FG000|Overall Study|Adverse Event|1|||
48624134|NCT00758043|156482228|FG001|Overall Study|Adverse Event|20|||
48624135|NCT00758043|156482229|FG002|Overall Study|Adverse Event|12|||
48624136|NCT00758043|156482230|FG003|Overall Study|Adverse Event|62|||
48624137|NCT00758043|156482227|FG000|Overall Study|Lack of Efficacy|0|||
48624138|NCT00758043|156482228|FG001|Overall Study|Lack of Efficacy|6|||
48624139|NCT00758043|156482229|FG002|Overall Study|Lack of Efficacy|18|||
48624140|NCT00758043|156482230|FG003|Overall Study|Lack of Efficacy|12|||
48624141|NCT00758043|156482227|FG000|Overall Study|Refused Further Treatment|0|||
48624142|NCT00758043|156482228|FG001|Overall Study|Refused Further Treatment|11|||
48624143|NCT00758043|156482229|FG002|Overall Study|Refused Further Treatment|5|||
48624144|NCT00758043|156482230|FG003|Overall Study|Refused Further Treatment|8|||
48624145|NCT00758043|156482227|FG000|Overall Study|Lost to Follow-up|0|||
48624146|NCT00758043|156482228|FG001|Overall Study|Lost to Follow-up|2|||
48624147|NCT00758043|156482229|FG002|Overall Study|Lost to Follow-up|2|||
48624148|NCT00758043|156482230|FG003|Overall Study|Lost to Follow-up|5|||
48624149|NCT00758043|156482227|FG000|Overall Study|Withdrawal by Subject|0|||
48624150|NCT00758043|156482228|FG001|Overall Study|Withdrawal by Subject|1|||
48624151|NCT00758043|156482229|FG002|Overall Study|Withdrawal by Subject|1|||
48624152|NCT00758043|156482230|FG003|Overall Study|Withdrawal by Subject|4|||
48624153|NCT00758043|156482227|FG000|Overall Study|Required Prohibited Medication|0|||
48624154|NCT00758043|156482228|FG001|Overall Study|Required Prohibited Medication|0|||
48624155|NCT00758043|156482229|FG002|Overall Study|Required Prohibited Medication|1|||
48624156|NCT00758043|156482230|FG003|Overall Study|Required Prohibited Medication|3|||
48624157|NCT00758043|156482227|FG000|Overall Study|Non-Compliant With study Drug|0|||
48624158|NCT00758043|156482228|FG001|Overall Study|Non-Compliant With study Drug|0|||
48624159|NCT00758043|156482229|FG002|Overall Study|Non-Compliant With study Drug|0|||
48624160|NCT00758043|156482230|FG003|Overall Study|Non-Compliant With study Drug|1|||
48624161|NCT00758043|156482227|FG000|Overall Study|Other Reasons|0|||
48624162|NCT00758043|156482228|FG001|Overall Study|Other Reasons|1|||
48624163|NCT00758043|156482229|FG002|Overall Study|Other Reasons|0|||
48624164|NCT00758043|156482230|FG003|Overall Study|Other Reasons|5|||
48624165|NCT00520572|156482231|FG000|Overall Study|Adverse Event|9|||
48624166|NCT00520572|156482232|FG001|Overall Study|Adverse Event|3|||
48624167|NCT00520572|156482233|FG002|Overall Study|Adverse Event|6|||
48624168|NCT00520572|156482234|FG003|Overall Study|Adverse Event|9|||
48624169|NCT00520572|156482235|FG004|Overall Study|Adverse Event|7|||
48624170|NCT00520572|156482236|FG005|Overall Study|Adverse Event|2|||
48624171|NCT00520572|156482231|FG000|Overall Study|Withdrawal by Subject|0|||
48624172|NCT00520572|156482232|FG001|Overall Study|Withdrawal by Subject|9|||
48624173|NCT00520572|156482233|FG002|Overall Study|Withdrawal by Subject|5|||
48624174|NCT00520572|156482234|FG003|Overall Study|Withdrawal by Subject|2|||
48624175|NCT00520572|156482235|FG004|Overall Study|Withdrawal by Subject|2|||
48624176|NCT00520572|156482236|FG005|Overall Study|Withdrawal by Subject|0|||
48624177|NCT00520572|156482231|FG000|Overall Study|Protocol Violation|0|||
48624178|NCT00520572|156482232|FG001|Overall Study|Protocol Violation|0|||
48624179|NCT00520572|156482233|FG002|Overall Study|Protocol Violation|1|||
48624180|NCT00520572|156482234|FG003|Overall Study|Protocol Violation|0|||
48624181|NCT00520572|156482235|FG004|Overall Study|Protocol Violation|0|||
48624182|NCT00520572|156482236|FG005|Overall Study|Protocol Violation|0|||
48624183|NCT00520572|156482231|FG000|Overall Study|Lack of Efficacy|1|||
48740247|NCT01802788|156897468|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
48740248|NCT01802788|156897469|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
48624184|NCT00520572|156482232|FG001|Overall Study|Lack of Efficacy|1|||
48624185|NCT00520572|156482233|FG002|Overall Study|Lack of Efficacy|1|||
48624186|NCT00520572|156482234|FG003|Overall Study|Lack of Efficacy|2|||
48624187|NCT00520572|156482235|FG004|Overall Study|Lack of Efficacy|1|||
48740249|NCT01802788|156897468|FG000|Overall Study|Other Reasons|19|||
48740250|NCT01802788|156897469|FG001|Overall Study|Other Reasons|0|||
48624188|NCT00520572|156482236|FG005|Overall Study|Lack of Efficacy|0|||
48624189|NCT00520572|156482231|FG000|Overall Study|Lost to Follow-up|0|||
48624190|NCT00520572|156482232|FG001|Overall Study|Lost to Follow-up|0|||
48624191|NCT00520572|156482233|FG002|Overall Study|Lost to Follow-up|0|||
48624192|NCT00520572|156482234|FG003|Overall Study|Lost to Follow-up|0|||
48624193|NCT00520572|156482235|FG004|Overall Study|Lost to Follow-up|1|||
48624194|NCT00520572|156482236|FG005|Overall Study|Lost to Follow-up|0|||
48624195|NCT00520572|156482231|FG000|Overall Study|Incorrect enrollment|1|||
48624196|NCT00520572|156482232|FG001|Overall Study|Incorrect enrollment|0|||
48624197|NCT00520572|156482233|FG002|Overall Study|Incorrect enrollment|1|||
48624198|NCT00520572|156482234|FG003|Overall Study|Incorrect enrollment|0|||
48624199|NCT00520572|156482235|FG004|Overall Study|Incorrect enrollment|1|||
48624200|NCT00520572|156482236|FG005|Overall Study|Incorrect enrollment|0|||
48624201|NCT00520572|156482231|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
48323203|NCT04579250|155381981|FG002|Overall Study|Lost to Follow-up|0|||
48323204|NCT04579250|155381979|FG000|Overall Study|Moved from area|0|||
48323205|NCT04579250|155381980|FG001|Overall Study|Moved from area|1|||
48323206|NCT04579250|155381981|FG002|Overall Study|Moved from area|2|||
48323207|NCT04759833|155381984|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
48323208|NCT04759833|155381985|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
48323209|NCT04759833|155381986|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
48323210|NCT04759833|155381987|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
48323211|NCT04759833|155381988|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
48624202|NCT00520572|156482232|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
48624203|NCT00520572|156482233|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
48624204|NCT00520572|156482234|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
48624205|NCT00520572|156482235|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
48624206|NCT00520572|156482236|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
48624207|NCT00520572|156482231|FG000|Overall Study|Long break in taking Medication|0|||
48624208|NCT00520572|156482232|FG001|Overall Study|Long break in taking Medication|0|||
48624209|NCT00520572|156482233|FG002|Overall Study|Long break in taking Medication|0|||
48624210|NCT00520572|156482234|FG003|Overall Study|Long break in taking Medication|1|||
48624211|NCT00520572|156482235|FG004|Overall Study|Long break in taking Medication|0|||
48624212|NCT00520572|156482236|FG005|Overall Study|Long break in taking Medication|0|||
48624213|NCT00520572|156482231|FG000|Overall Study|Did not receive Treatment|1|||
48624214|NCT00520572|156482232|FG001|Overall Study|Did not receive Treatment|0|||
48624215|NCT00520572|156482233|FG002|Overall Study|Did not receive Treatment|1|||
48624216|NCT00520572|156482234|FG003|Overall Study|Did not receive Treatment|0|||
48624217|NCT00520572|156482235|FG004|Overall Study|Did not receive Treatment|0|||
48624218|NCT00520572|156482236|FG005|Overall Study|Did not receive Treatment|0|||
48624219|NCT00960856|156482237|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
48624220|NCT00960856|156482238|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
48624221|NCT00960856|156482239|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
48624222|NCT00960856|156482240|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
48624223|NCT00960856|156482237|FG000|Washout Period of 7 Days|Adverse Event|0|||
48624224|NCT00960856|156482238|FG001|Washout Period of 7 Days|Adverse Event|0|||
48624225|NCT00960856|156482239|FG002|Washout Period of 7 Days|Adverse Event|1|||
48624226|NCT00960856|156482240|FG003|Washout Period of 7 Days|Adverse Event|0|||
48624227|NCT00985192|156482241|FG000|Overall Study|Withdrawal by Subject|1|||
48624228|NCT00985192|156482241|FG000|Overall Study|Disease Progression|1|||
48624229|NCT00985192|156482241|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
48624230|NCT03794544|156482242|FG000|Overall Study|Withdrawal by Subject|1|||
48624231|NCT03794544|156482243|FG001|Overall Study|Withdrawal by Subject|1|||
48624232|NCT03794544|156482244|FG002|Overall Study|Withdrawal by Subject|0|||
48624233|NCT03794544|156482245|FG003|Overall Study|Withdrawal by Subject|0|||
48624234|NCT03794544|156482242|FG000|Overall Study|Death|0|||
48624235|NCT03794544|156482243|FG001|Overall Study|Death|0|||
48624236|NCT03794544|156482244|FG002|Overall Study|Death|0|||
48624237|NCT03794544|156482245|FG003|Overall Study|Death|1|||
48624238|NCT03794544|156482242|FG000|Overall Study|Lost to Follow-up|0|||
48624239|NCT03794544|156482243|FG001|Overall Study|Lost to Follow-up|1|||
48624240|NCT03794544|156482244|FG002|Overall Study|Lost to Follow-up|1|||
48624241|NCT03794544|156482245|FG003|Overall Study|Lost to Follow-up|0|||
48624242|NCT03794544|156482242|FG000|Overall Study|Other|0|||
48624243|NCT03794544|156482243|FG001|Overall Study|Other|1|||
48624244|NCT03794544|156482244|FG002|Overall Study|Other|0|||
48624245|NCT03794544|156482245|FG003|Overall Study|Other|0|||
48624246|NCT01013870|156482246|FG000|Overall Study|Lost to Follow-up|1|||
48624247|NCT01013870|156482247|FG001|Overall Study|Lost to Follow-up|3|||
48624248|NCT00289978|156482249|FG000|Overall Study|Withdrawal by Subject|31|||
48624249|NCT00289978|156482250|FG001|Overall Study|Withdrawal by Subject|17|||
48624250|NCT00289978|156482251|FG002|Overall Study|Withdrawal by Subject|28|||
48323212|NCT04759833|155381984|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
48323213|NCT04759833|155381985|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
48323214|NCT04759833|155381986|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
48323215|NCT04759833|155381987|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
48323216|NCT04759833|155381988|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
48624251|NCT00289978|156482249|FG000|Overall Study|Adverse Event|22|||
48624252|NCT00289978|156482250|FG001|Overall Study|Adverse Event|13|||
48624253|NCT00289978|156482251|FG002|Overall Study|Adverse Event|18|||
48624254|NCT00289978|156482249|FG000|Overall Study|Lack of Efficacy|13|||
48624255|NCT00289978|156482250|FG001|Overall Study|Lack of Efficacy|6|||
48624256|NCT00289978|156482251|FG002|Overall Study|Lack of Efficacy|25|||
48624257|NCT00289978|156482249|FG000|Overall Study|Abnormal laboratory value(s)|20|||
48624258|NCT00289978|156482250|FG001|Overall Study|Abnormal laboratory value(s)|9|||
48624259|NCT00289978|156482251|FG002|Overall Study|Abnormal laboratory value(s)|1|||
48624260|NCT00289978|156482249|FG000|Overall Study|Lost to Follow-up|3|||
48624261|NCT00289978|156482250|FG001|Overall Study|Lost to Follow-up|5|||
48624262|NCT00289978|156482251|FG002|Overall Study|Lost to Follow-up|7|||
48624263|NCT00289978|156482249|FG000|Overall Study|Protocol Violation|5|||
48624264|NCT00289978|156482250|FG001|Overall Study|Protocol Violation|5|||
48624265|NCT00289978|156482251|FG002|Overall Study|Protocol Violation|4|||
48624266|NCT00289978|156482249|FG000|Overall Study|Abnormal test procedure result(s)|2|||
48624267|NCT00289978|156482250|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48624268|NCT00289978|156482251|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48624269|NCT00289978|156482249|FG000|Overall Study|Death|1|||
48624270|NCT00289978|156482250|FG001|Overall Study|Death|0|||
48624271|NCT00289978|156482251|FG002|Overall Study|Death|2|||
48624272|NCT00432991|156482252|FG000|Overall Study|Protocol Violation|7|||
48624273|NCT00432991|156482253|FG001|Overall Study|Protocol Violation|12|||
48624274|NCT00720083|156482254|FG000|Overall Study|Ineligible|1|||
48624275|NCT00720083|156482255|FG001|Overall Study|Ineligible|2|||
48624276|NCT00862277|156482265|FG000|Overall Study|Protocol Violation|1|||
48624277|NCT00862277|156482266|FG001|Overall Study|Protocol Violation|2|||
48624278|NCT00862277|156482267|FG002|Overall Study|Protocol Violation|5|||
48624279|NCT00871000|156482268|FG000|Overall Study|Withdrawal by Subject|1|||
48624280|NCT00871000|156482269|FG001|Overall Study|Withdrawal by Subject|0|||
48624281|NCT02715856|156482270|FG000|Overall Study|Software Issues|12|||
48624282|NCT02715856|156482271|FG001|Overall Study|Software Issues|7|||
48624283|NCT02715856|156482270|FG000|Overall Study|Death|6|||
48624284|NCT02715856|156482271|FG001|Overall Study|Death|5|||
48624285|NCT02715856|156482270|FG000|Overall Study|Non- Compliant|0|||
48624286|NCT02715856|156482271|FG001|Overall Study|Non- Compliant|40|||
48740251|NCT03270501|156897470|FG000|Overall Study|Screen failure|6|||
48740252|NCT03270501|156897470|FG000|Overall Study|Lost to Follow-up|2|||
48740253|NCT03270501|156897470|FG000|Overall Study|Adverse Event|1|||
48740254|NCT05661851|156897471|FG000|Overall Study|Protocol Violation|1|||
48624287|NCT01772693|156482276|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
48624288|NCT01772693|156482277|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
48624289|NCT01772693|156482276|FG000|Overall Study|Withdrawal by Subject|2|||
48624290|NCT01772693|156482277|FG001|Overall Study|Withdrawal by Subject|0|||
48624291|NCT01772693|156482276|FG000|Overall Study|Alternative Treatment|2|||
48624292|NCT01772693|156482277|FG001|Overall Study|Alternative Treatment|0|||
48624293|NCT01633112|156482278|FG000|Overall Study|Lack of Efficacy|1|||
48624294|NCT01633112|156482279|FG001|Overall Study|Lack of Efficacy|6|||
48740255|NCT05661851|156897472|FG001|Overall Study|Protocol Violation|1|||
48740256|NCT05661851|156897471|FG000|Overall Study|Covid-19 Related|3|||
48740257|NCT05661851|156897472|FG001|Overall Study|Covid-19 Related|4|||
48740258|NCT05661851|156897471|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
48740259|NCT05661851|156897472|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
48740260|NCT05661851|156897471|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
48624295|NCT01633112|156482280|FG002|Overall Study|Lack of Efficacy|13|||
48624296|NCT01633112|156482278|FG000|Overall Study|Abnormal laboratory value(s)|3|||
48624297|NCT01633112|156482279|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48624298|NCT01633112|156482280|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48624299|NCT01633112|156482278|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48624300|NCT01633112|156482279|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48624301|NCT01633112|156482280|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48624302|NCT01633112|156482278|FG000|Overall Study|Administrative problems|1|||
48624303|NCT01633112|156482279|FG001|Overall Study|Administrative problems|2|||
48624304|NCT01633112|156482280|FG002|Overall Study|Administrative problems|5|||
48624305|NCT01633112|156482278|FG000|Overall Study|Adverse Event|16|||
48624306|NCT01633112|156482279|FG001|Overall Study|Adverse Event|18|||
48624307|NCT01633112|156482280|FG002|Overall Study|Adverse Event|20|||
48624308|NCT01633112|156482278|FG000|Overall Study|Lost to Follow-up|7|||
48624309|NCT01633112|156482279|FG001|Overall Study|Lost to Follow-up|19|||
48624310|NCT01633112|156482280|FG002|Overall Study|Lost to Follow-up|6|||
48624311|NCT01633112|156482278|FG000|Overall Study|Protocol Violation|4|||
48624312|NCT01633112|156482279|FG001|Overall Study|Protocol Violation|0|||
48624313|NCT01633112|156482280|FG002|Overall Study|Protocol Violation|2|||
48624314|NCT01633112|156482278|FG000|Overall Study|Subject no longer requires study drug|0|||
48624315|NCT01633112|156482279|FG001|Overall Study|Subject no longer requires study drug|0|||
48624316|NCT01633112|156482280|FG002|Overall Study|Subject no longer requires study drug|1|||
48624317|NCT01633112|156482278|FG000|Overall Study|Withdrawal by Subject|20|||
48624318|NCT01633112|156482279|FG001|Overall Study|Withdrawal by Subject|12|||
48624319|NCT01633112|156482280|FG002|Overall Study|Withdrawal by Subject|41|||
48624320|NCT01633112|156482278|FG000|Overall Study|missing Study Completion CRF|1|||
48743076|NCT00968201|156910494|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
48624321|NCT01633112|156482279|FG001|Overall Study|missing Study Completion CRF|1|||
48624322|NCT01633112|156482280|FG002|Overall Study|missing Study Completion CRF|4|||
48624323|NCT03021005|156482281|FG000|Overall Study|Lost to Follow-up|39|||
48624324|NCT03021005|156482282|FG001|Overall Study|Lost to Follow-up|26|||
48624325|NCT00159874|156482289|FG000|Overall Study|Adverse Event|2|||
48624326|NCT00159874|156482290|FG001|Overall Study|Adverse Event|2|||
48624327|NCT00159874|156482291|FG002|Overall Study|Adverse Event|5|||
48624328|NCT00159874|156482292|FG003|Overall Study|Adverse Event|1|||
48624329|NCT00159874|156482293|FG004|Overall Study|Adverse Event|1|||
48624330|NCT00159874|156482294|FG005|Overall Study|Adverse Event|2|||
48624331|NCT00159874|156482295|FG006|Overall Study|Adverse Event|0|||
48624332|NCT00159874|156482289|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
48624333|NCT00159874|156482290|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
48624334|NCT00159874|156482291|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
48624335|NCT00159874|156482292|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
48624336|NCT00159874|156482293|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
48624337|NCT00159874|156482294|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
48624338|NCT00159874|156482295|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
48624339|NCT00159874|156482289|FG000|Overall Study|Lack of Efficacy|2|||
48624340|NCT00159874|156482290|FG001|Overall Study|Lack of Efficacy|0|||
48624341|NCT00159874|156482291|FG002|Overall Study|Lack of Efficacy|1|||
48624342|NCT00159874|156482292|FG003|Overall Study|Lack of Efficacy|1|||
48624343|NCT00159874|156482293|FG004|Overall Study|Lack of Efficacy|0|||
48624344|NCT00159874|156482294|FG005|Overall Study|Lack of Efficacy|3|||
48624345|NCT00159874|156482295|FG006|Overall Study|Lack of Efficacy|0|||
48624346|NCT00159874|156482289|FG000|Overall Study|Lost to Follow-up|1|||
48624347|NCT00159874|156482290|FG001|Overall Study|Lost to Follow-up|0|||
48624348|NCT00159874|156482291|FG002|Overall Study|Lost to Follow-up|3|||
48624349|NCT00159874|156482292|FG003|Overall Study|Lost to Follow-up|0|||
48624350|NCT00159874|156482293|FG004|Overall Study|Lost to Follow-up|1|||
48624351|NCT00159874|156482294|FG005|Overall Study|Lost to Follow-up|2|||
48624352|NCT00159874|156482295|FG006|Overall Study|Lost to Follow-up|1|||
48624353|NCT00159874|156482289|FG000|Overall Study|Other|8|||
48740261|NCT05661851|156897472|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
48740262|NCT00446251|156897475|FG000|Overall Study|On-study Transplants|2|||
48624354|NCT00159874|156482290|FG001|Overall Study|Other|8|||
48624355|NCT00159874|156482291|FG002|Overall Study|Other|8|||
48740263|NCT00446251|156897475|FG000|Overall Study|Rituximab Infusion Reaction|2|||
48740264|NCT00446251|156897475|FG000|Overall Study|Lost to Follow-up|1|||
48740265|NCT00474760|156897476|FG000|Overall Study|Death|0|||
48740266|NCT00474760|156897477|FG001|Overall Study|Death|0|||
48624356|NCT00159874|156482292|FG003|Overall Study|Other|0|||
48624357|NCT00159874|156482293|FG004|Overall Study|Other|2|||
48624358|NCT00159874|156482294|FG005|Overall Study|Other|1|||
48624359|NCT00159874|156482295|FG006|Overall Study|Other|3|||
48624360|NCT00159874|156482289|FG000|Overall Study|Protocol Violation|0|||
48624361|NCT00159874|156482290|FG001|Overall Study|Protocol Violation|5|||
48624362|NCT00159874|156482291|FG002|Overall Study|Protocol Violation|2|||
48624363|NCT00159874|156482292|FG003|Overall Study|Protocol Violation|0|||
48624364|NCT00159874|156482293|FG004|Overall Study|Protocol Violation|0|||
48624365|NCT00159874|156482294|FG005|Overall Study|Protocol Violation|0|||
48624366|NCT00159874|156482295|FG006|Overall Study|Protocol Violation|0|||
48624367|NCT00159874|156482289|FG000|Overall Study|Death|3|||
48740267|NCT00474760|156897478|FG002|Overall Study|Death|0|||
48740268|NCT00474760|156897479|FG003|Overall Study|Death|0|||
48740269|NCT00474760|156897480|FG004|Overall Study|Death|2|||
48740270|NCT00474760|156897481|FG005|Overall Study|Death|0|||
48624368|NCT00159874|156482290|FG001|Overall Study|Death|8|||
48624369|NCT00159874|156482291|FG002|Overall Study|Death|15|||
48624370|NCT00159874|156482292|FG003|Overall Study|Death|0|||
48740271|NCT00474760|156897482|FG006|Overall Study|Death|0|||
48740272|NCT00474760|156897476|FG000|Overall Study|Adverse Event|0|||
48740273|NCT00474760|156897477|FG001|Overall Study|Adverse Event|0|||
48624371|NCT00159874|156482293|FG004|Overall Study|Death|1|||
48624372|NCT00159874|156482294|FG005|Overall Study|Death|2|||
48624373|NCT00159874|156482295|FG006|Overall Study|Death|0|||
48624374|NCT00159874|156482289|FG000|Overall Study|Withdrawal by Subject|2|||
48624375|NCT00159874|156482290|FG001|Overall Study|Withdrawal by Subject|6|||
48624376|NCT00159874|156482291|FG002|Overall Study|Withdrawal by Subject|8|||
48624377|NCT00159874|156482292|FG003|Overall Study|Withdrawal by Subject|4|||
48624378|NCT00159874|156482293|FG004|Overall Study|Withdrawal by Subject|3|||
48624379|NCT00159874|156482294|FG005|Overall Study|Withdrawal by Subject|2|||
48624380|NCT00159874|156482295|FG006|Overall Study|Withdrawal by Subject|1|||
48740274|NCT00474760|156897478|FG002|Overall Study|Adverse Event|0|||
48740275|NCT00474760|156897479|FG003|Overall Study|Adverse Event|0|||
48740276|NCT00474760|156897480|FG004|Overall Study|Adverse Event|1|||
48740277|NCT00474760|156897481|FG005|Overall Study|Adverse Event|7|||
48323217|NCT04759833|155381984|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
48323218|NCT04759833|155381985|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
48323219|NCT04759833|155381986|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
48323220|NCT04759833|155381987|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
48323221|NCT04759833|155381988|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
48624381|NCT00159874|156482289|FG000|Overall Study|Pregnancy|1|||
48624382|NCT00159874|156482290|FG001|Overall Study|Pregnancy|1|||
48624383|NCT00159874|156482291|FG002|Overall Study|Pregnancy|0|||
48624384|NCT00159874|156482292|FG003|Overall Study|Pregnancy|0|||
48740278|NCT00474760|156897482|FG006|Overall Study|Adverse Event|0|||
48740279|NCT00474760|156897476|FG000|Overall Study|Laboratory abnormality|0|||
48740280|NCT00474760|156897477|FG001|Overall Study|Laboratory abnormality|0|||
48740281|NCT00474760|156897478|FG002|Overall Study|Laboratory abnormality|0|||
48740282|NCT00474760|156897479|FG003|Overall Study|Laboratory abnormality|0|||
48740283|NCT00474760|156897480|FG004|Overall Study|Laboratory abnormality|0|||
48740284|NCT00474760|156897481|FG005|Overall Study|Laboratory abnormality|1|||
48740285|NCT00474760|156897482|FG006|Overall Study|Laboratory abnormality|0|||
48740286|NCT00474760|156897476|FG000|Overall Study|Withdrawal by Subject|0|||
48740287|NCT00474760|156897477|FG001|Overall Study|Withdrawal by Subject|0|||
48624385|NCT00159874|156482293|FG004|Overall Study|Pregnancy|0|||
48624386|NCT00159874|156482294|FG005|Overall Study|Pregnancy|0|||
48624387|NCT00159874|156482295|FG006|Overall Study|Pregnancy|0|||
48624388|NCT03302936|156482296|FG000|Overall Study|Protocol Violation|3|||
48624389|NCT03302936|156482297|FG001|Overall Study|Protocol Violation|4|||
48624390|NCT01104870|156482298|FG000|Overall Study|Adverse Event|1|||
48624391|NCT01104870|156482299|FG001|Overall Study|Adverse Event|1|||
48624392|NCT01104870|156482300|FG002|Overall Study|Adverse Event|0|||
48624393|NCT01104870|156482298|FG000|Overall Study|Death|0|||
48624394|NCT01104870|156482299|FG001|Overall Study|Death|0|||
48624395|NCT01104870|156482300|FG002|Overall Study|Death|1|||
48624396|NCT01104870|156482298|FG000|Overall Study|Withdrawal by Subject|0|||
48624397|NCT01104870|156482299|FG001|Overall Study|Withdrawal by Subject|0|||
48624398|NCT01104870|156482300|FG002|Overall Study|Withdrawal by Subject|1|||
48624399|NCT01122680|156482301|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
48624400|NCT01122680|156482302|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
48624401|NCT01122680|156482303|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
48624402|NCT01122680|156482304|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
48624403|NCT01122680|156482301|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
48624404|NCT01122680|156482302|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
48624405|NCT01122680|156482303|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
48624406|NCT01122680|156482304|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
48624407|NCT01122680|156482301|FG000|Period 1 (4 Weeks)|Other|1|||
48624408|NCT01122680|156482302|FG001|Period 1 (4 Weeks)|Other|1|||
48624409|NCT01122680|156482303|FG002|Period 1 (4 Weeks)|Other|0|||
48624410|NCT01122680|156482304|FG003|Period 1 (4 Weeks)|Other|0|||
48624411|NCT01122680|156482301|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
48624412|NCT01122680|156482302|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
48624413|NCT01122680|156482303|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
48624414|NCT01122680|156482304|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
48624415|NCT01122680|156482301|FG000|Period 2 (4 Weeks)|Other|1|||
48624416|NCT01122680|156482302|FG001|Period 2 (4 Weeks)|Other|0|||
48624417|NCT01122680|156482303|FG002|Period 2 (4 Weeks)|Other|0|||
48740288|NCT00474760|156897478|FG002|Overall Study|Withdrawal by Subject|0|||
48740289|NCT00474760|156897479|FG003|Overall Study|Withdrawal by Subject|1|||
48740290|NCT00474760|156897480|FG004|Overall Study|Withdrawal by Subject|0|||
48740291|NCT00474760|156897481|FG005|Overall Study|Withdrawal by Subject|1|||
48740292|NCT00474760|156897482|FG006|Overall Study|Withdrawal by Subject|1|||
48740293|NCT00474760|156897476|FG000|Overall Study|Other|0|||
48624418|NCT01122680|156482304|FG003|Period 2 (4 Weeks)|Other|0|||
48624419|NCT01122680|156482301|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
48624420|NCT01122680|156482302|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
48624421|NCT01122680|156482303|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
48740294|NCT00474760|156897477|FG001|Overall Study|Other|1|||
48740295|NCT00474760|156897478|FG002|Overall Study|Other|0|||
48740296|NCT00474760|156897479|FG003|Overall Study|Other|0|||
48740297|NCT00474760|156897480|FG004|Overall Study|Other|1|||
48624422|NCT01122680|156482304|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
48624423|NCT01122680|156482301|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48624424|NCT01122680|156482302|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
48740298|NCT00474760|156897481|FG005|Overall Study|Other|0|||
48624425|NCT01122680|156482303|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48624426|NCT01122680|156482304|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48624427|NCT00692237|156482307|FG000|Overall Study|Withdrawal by Subject|1|||
48624428|NCT00692237|156482308|FG001|Overall Study|Withdrawal by Subject|3|||
48624429|NCT00692237|156482307|FG000|Overall Study|Adverse Event|0|||
48624430|NCT00692237|156482308|FG001|Overall Study|Adverse Event|1|||
48624431|NCT01530997|156482309|FG000|Overall Study|Physician Decision|1|||
48624432|NCT01530997|156482309|FG000|Overall Study|Withdrawal by Subject|1|||
48624433|NCT01063881|156482310|FG000|Overall Study|Adverse Event|12|||
48624434|NCT01063881|156482311|FG001|Overall Study|Adverse Event|2|||
48624435|NCT01063881|156482312|FG002|Overall Study|Adverse Event|0|||
48624436|NCT01063881|156482310|FG000|Overall Study|Lost to Follow-up|13|||
48624437|NCT01063881|156482311|FG001|Overall Study|Lost to Follow-up|7|||
48624438|NCT01063881|156482312|FG002|Overall Study|Lost to Follow-up|1|||
48624439|NCT01063881|156482310|FG000|Overall Study|Withdrawal by Subject|25|||
48624440|NCT01063881|156482311|FG001|Overall Study|Withdrawal by Subject|1|||
48624441|NCT01063881|156482312|FG002|Overall Study|Withdrawal by Subject|0|||
48624442|NCT01063881|156482310|FG000|Overall Study|Reason for not completed not specified|5|||
48624443|NCT01063881|156482311|FG001|Overall Study|Reason for not completed not specified|1|||
48624444|NCT01063881|156482312|FG002|Overall Study|Reason for not completed not specified|0|||
48624445|NCT01927861|156482315|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
48624446|NCT01927861|156482316|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
48624447|NCT01927861|156482315|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
48624448|NCT01927861|156482316|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
48624449|NCT00987935|156482317|FG000|Overall Study|Progressive disease|3|||
48624450|NCT00987935|156482318|FG001|Overall Study|Progressive disease|2|||
48624451|NCT00987935|156482319|FG002|Overall Study|Progressive disease|3|||
48624452|NCT00987935|156482320|FG003|Overall Study|Progressive disease|2|||
48624453|NCT00987935|156482321|FG004|Overall Study|Progressive disease|5|||
48624454|NCT00987935|156482322|FG005|Overall Study|Progressive disease|3|||
48624455|NCT00987935|156482323|FG006|Overall Study|Progressive disease|9|||
48624456|NCT00987935|156482324|FG007|Overall Study|Progressive disease|48|||
48624457|NCT00987935|156482325|FG008|Overall Study|Progressive disease|23|||
48624458|NCT00987935|156482317|FG000|Overall Study|Adverse Event|0|||
48624459|NCT00987935|156482318|FG001|Overall Study|Adverse Event|1|||
48624460|NCT00987935|156482319|FG002|Overall Study|Adverse Event|0|||
48624461|NCT00987935|156482320|FG003|Overall Study|Adverse Event|1|||
48624462|NCT00987935|156482321|FG004|Overall Study|Adverse Event|1|||
48624463|NCT00987935|156482322|FG005|Overall Study|Adverse Event|0|||
48624464|NCT00987935|156482323|FG006|Overall Study|Adverse Event|2|||
48624465|NCT00987935|156482324|FG007|Overall Study|Adverse Event|10|||
48624466|NCT00987935|156482325|FG008|Overall Study|Adverse Event|6|||
48624467|NCT00987935|156482317|FG000|Overall Study|Refused to continue taking trial med.|1|||
48624468|NCT00987935|156482318|FG001|Overall Study|Refused to continue taking trial med.|0|||
48624469|NCT00987935|156482319|FG002|Overall Study|Refused to continue taking trial med.|0|||
48624470|NCT00987935|156482320|FG003|Overall Study|Refused to continue taking trial med.|0|||
48624471|NCT00987935|156482321|FG004|Overall Study|Refused to continue taking trial med.|1|||
48624472|NCT00987935|156482322|FG005|Overall Study|Refused to continue taking trial med.|0|||
48624473|NCT00987935|156482323|FG006|Overall Study|Refused to continue taking trial med.|4|||
48624474|NCT00987935|156482324|FG007|Overall Study|Refused to continue taking trial med.|4|||
48624475|NCT00987935|156482325|FG008|Overall Study|Refused to continue taking trial med.|2|||
48624476|NCT00987935|156482317|FG000|Overall Study|Reason other than those specified above|0|||
48624477|NCT00987935|156482318|FG001|Overall Study|Reason other than those specified above|0|||
48624478|NCT00987935|156482319|FG002|Overall Study|Reason other than those specified above|0|||
48624479|NCT00987935|156482320|FG003|Overall Study|Reason other than those specified above|0|||
48624480|NCT00987935|156482321|FG004|Overall Study|Reason other than those specified above|0|||
48624481|NCT00987935|156482322|FG005|Overall Study|Reason other than those specified above|0|||
48624482|NCT00987935|156482323|FG006|Overall Study|Reason other than those specified above|0|||
48624483|NCT00987935|156482324|FG007|Overall Study|Reason other than those specified above|0|||
48624484|NCT00987935|156482325|FG008|Overall Study|Reason other than those specified above|1|||
48624485|NCT04560309|156482326|FG000|Overall Study|Meet drop out criteria|1|||
48624486|NCT04560309|156482327|FG001|Overall Study|Meet drop out criteria|1|||
48624487|NCT02100644|156482328|FG000|LTG Escalation Phase|Adverse Event|9|||
48624488|NCT02100644|156482329|FG001|LTG Escalation Phase|Adverse Event|0|||
48624489|NCT02100644|156482330|FG002|LTG Escalation Phase|Adverse Event|0|||
48624490|NCT02100644|156482328|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
48624491|NCT02100644|156482329|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
48624492|NCT02100644|156482330|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
48624493|NCT02100644|156482328|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
48624494|NCT02100644|156482329|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
48624495|NCT02100644|156482330|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
48624496|NCT02940223|156482331|FG000|Overall Study|Failed Requirement|2|||
48624497|NCT02940223|156482332|FG001|Overall Study|Failed Requirement|0|||
48624498|NCT01608308|156482333|FG000|Overall Study|pretreatment medical and billing reasons|0|||
48624499|NCT01608308|156482334|FG001|Overall Study|pretreatment medical and billing reasons|2|||
48624500|NCT03382873|156482339|FG000|Overall Study|Lost to Follow-up|9|||
48624501|NCT03382873|156482340|FG001|Overall Study|Lost to Follow-up|10|||
48624502|NCT03382873|156482339|FG000|Overall Study|Withdrawal by Subject|6|||
48624503|NCT03382873|156482340|FG001|Overall Study|Withdrawal by Subject|11|||
48624504|NCT03382873|156482339|FG000|Overall Study|Visit not completed due to pandemic|16|||
48624505|NCT03382873|156482340|FG001|Overall Study|Visit not completed due to pandemic|41|||
48624506|NCT03769467|156482342|FG000|Overall Study|Adverse Event|1|||
48624507|NCT03769467|156482343|FG001|Overall Study|Adverse Event|1|||
48624508|NCT03769467|156482344|FG002|Overall Study|Adverse Event|0|||
48323222|NCT04759833|155381984|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
48323223|NCT04759833|155381985|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
48740299|NCT00474760|156897482|FG006|Overall Study|Other|0|||
48740300|NCT00474760|156897476|FG000|Overall Study|Progressive disease|3|||
48740301|NCT00474760|156897477|FG001|Overall Study|Progressive disease|2|||
48740302|NCT00474760|156897478|FG002|Overall Study|Progressive disease|3|||
48624509|NCT03769467|156482342|FG000|Overall Study|Death|3|||
48624510|NCT03769467|156482343|FG001|Overall Study|Death|3|||
48740303|NCT00474760|156897479|FG003|Overall Study|Progressive disease|2|||
48740304|NCT00474760|156897480|FG004|Overall Study|Progressive disease|8|||
48740305|NCT00474760|156897481|FG005|Overall Study|Progressive disease|20|||
48740306|NCT00474760|156897482|FG006|Overall Study|Progressive disease|7|||
48740307|NCT00474760|156897476|FG000|Overall Study|Terminated by sponsor|0|||
48740308|NCT00474760|156897477|FG001|Overall Study|Terminated by sponsor|0|||
48740309|NCT00474760|156897478|FG002|Overall Study|Terminated by sponsor|0|||
48740310|NCT00474760|156897479|FG003|Overall Study|Terminated by sponsor|0|||
48624511|NCT03769467|156482344|FG002|Overall Study|Death|0|||
48624512|NCT03769467|156482342|FG000|Overall Study|Study Terminated By Sponsor|2|||
48624513|NCT03769467|156482343|FG001|Overall Study|Study Terminated By Sponsor|1|||
48624514|NCT03769467|156482344|FG002|Overall Study|Study Terminated By Sponsor|0|||
48624515|NCT03769467|156482342|FG000|Overall Study|Withdrawal by Subject|0|||
48624516|NCT03769467|156482343|FG001|Overall Study|Withdrawal by Subject|1|||
48624517|NCT03769467|156482344|FG002|Overall Study|Withdrawal by Subject|0|||
48624518|NCT00461812|156482347|FG000|Overall Study|study terminated|10|||
48624519|NCT03760666|156482348|FG000|Overall Study|Adverse Event|2|||
48624520|NCT03760666|156482349|FG001|Overall Study|Adverse Event|4|||
48624521|NCT03760666|156482350|FG002|Overall Study|Adverse Event|1|||
48740311|NCT00474760|156897480|FG004|Overall Study|Terminated by sponsor|0|||
48740312|NCT00474760|156897481|FG005|Overall Study|Terminated by sponsor|0|||
48740313|NCT00474760|156897482|FG006|Overall Study|Terminated by sponsor|2|||
48740314|NCT01206166|156897483|FG000|Overall Study|No evaluable data|2|||
48740315|NCT01206166|156897484|FG001|Overall Study|No evaluable data|3|||
48740316|NCT03338010|156897488|FG000|Overall Study|Withdrawal by Subject|14|||
48740317|NCT03338010|156897489|FG001|Overall Study|Withdrawal by Subject|8|||
48624522|NCT03760666|156482348|FG000|Overall Study|AML Disease Progression|3|||
48624523|NCT03760666|156482349|FG001|Overall Study|AML Disease Progression|3|||
48624524|NCT03760666|156482350|FG002|Overall Study|AML Disease Progression|0|||
48624525|NCT03760666|156482348|FG000|Overall Study|Physician Decision|0|||
48624526|NCT03760666|156482349|FG001|Overall Study|Physician Decision|3|||
48624527|NCT03760666|156482350|FG002|Overall Study|Physician Decision|0|||
48624528|NCT03760666|156482348|FG000|Overall Study|Withdrawal by Subject|0|||
48624529|NCT03760666|156482349|FG001|Overall Study|Withdrawal by Subject|1|||
48624530|NCT03760666|156482350|FG002|Overall Study|Withdrawal by Subject|0|||
48624531|NCT01152385|156482351|FG000|Overall Study|Withdrawal by Subject|3|||
48624532|NCT01152385|156482352|FG001|Overall Study|Withdrawal by Subject|1|||
48624533|NCT01152385|156482353|FG002|Overall Study|Withdrawal by Subject|1|||
48740318|NCT03338010|156897488|FG000|Overall Study|Lost to Follow-up|4|||
48740319|NCT03338010|156897489|FG001|Overall Study|Lost to Follow-up|2|||
48740320|NCT03338010|156897488|FG000|Overall Study|Adverse Event|3|||
48740321|NCT03338010|156897489|FG001|Overall Study|Adverse Event|2|||
48740322|NCT03338010|156897488|FG000|Overall Study|Physician Decision|2|||
48740323|NCT03338010|156897489|FG001|Overall Study|Physician Decision|2|||
48740324|NCT03338010|156897488|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48740325|NCT03338010|156897489|FG001|Overall Study|Non-Compliance with Study Drug|3|||
48740326|NCT03338010|156897488|FG000|Overall Study|Protocol Violation|0|||
48740327|NCT03338010|156897489|FG001|Overall Study|Protocol Violation|1|||
48740328|NCT00453063|156897490|FG000|Overall Study|Adverse Event|1|||
48740329|NCT00453063|156897491|FG001|Overall Study|Adverse Event|2|||
48740330|NCT00453063|156897490|FG000|Overall Study|Withdrawal by Subject|1|||
48740331|NCT00453063|156897491|FG001|Overall Study|Withdrawal by Subject|1|||
48740332|NCT00453063|156897490|FG000|Overall Study|Protocol Violation|1|||
48740333|NCT00453063|156897491|FG001|Overall Study|Protocol Violation|0|||
48740334|NCT04797195|156897494|FG000|Overall Study|Death|8|||
48740335|NCT04797195|156897495|FG001|Overall Study|Death|15|||
48740336|NCT04797195|156897494|FG000|Overall Study|Change from PD|15|||
48740337|NCT04797195|156897495|FG001|Overall Study|Change from PD|15|||
48740338|NCT04797195|156897494|FG000|Overall Study|Withdrawal by Subject|3|||
48740339|NCT04797195|156897495|FG001|Overall Study|Withdrawal by Subject|2|||
48323224|NCT04759833|155381986|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
48323225|NCT04759833|155381987|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
48323226|NCT04759833|155381988|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
48323227|NCT04759833|155381984|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
48323228|NCT04759833|155381985|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
48323229|NCT04759833|155381986|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
48323230|NCT04759833|155381987|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
48323231|NCT04759833|155381988|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
48323232|NCT04759833|155381984|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
48323233|NCT04759833|155381985|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
48323234|NCT04759833|155381986|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
48323235|NCT04759833|155381987|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
48323236|NCT04759833|155381988|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
48323237|NCT04759833|155381984|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
48323238|NCT04759833|155381985|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
48323239|NCT04759833|155381986|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
48740340|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
48740341|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
48740342|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
48740343|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
48740344|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
48740345|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
48740346|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
48323240|NCT04759833|155381987|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
48323241|NCT04759833|155381988|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
48323242|NCT04759833|155381984|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
48624534|NCT01152385|156482354|FG003|Overall Study|Withdrawal by Subject|1|||
48624535|NCT01152385|156482351|FG000|Overall Study|Protocol Violation|0|||
48624536|NCT01152385|156482352|FG001|Overall Study|Protocol Violation|0|||
48624537|NCT01152385|156482353|FG002|Overall Study|Protocol Violation|0|||
48624538|NCT01152385|156482354|FG003|Overall Study|Protocol Violation|1|||
48624539|NCT01152385|156482351|FG000|Overall Study|Adverse Event|1|||
48624540|NCT01152385|156482352|FG001|Overall Study|Adverse Event|1|||
48624541|NCT01152385|156482353|FG002|Overall Study|Adverse Event|0|||
48624542|NCT01152385|156482354|FG003|Overall Study|Adverse Event|0|||
48624543|NCT01152385|156482351|FG000|Overall Study|Study-specific withdrawal criteria|1|||
48624544|NCT01152385|156482352|FG001|Overall Study|Study-specific withdrawal criteria|1|||
48624545|NCT01152385|156482353|FG002|Overall Study|Study-specific withdrawal criteria|2|||
48624546|NCT01152385|156482354|FG003|Overall Study|Study-specific withdrawal criteria|0|||
48740347|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
48323243|NCT04759833|155381985|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
48323244|NCT04759833|155381986|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
48323245|NCT04759833|155381987|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
48323246|NCT04759833|155381988|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
48323247|NCT04759833|155381984|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
48323248|NCT04759833|155381985|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
48323249|NCT04759833|155381986|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
48323250|NCT04759833|155381987|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
48323251|NCT04759833|155381988|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
48624547|NCT01152385|156482351|FG000|Overall Study|Other|4|||
48624548|NCT01152385|156482352|FG001|Overall Study|Other|3|||
48624549|NCT01152385|156482353|FG002|Overall Study|Other|2|||
48624550|NCT01152385|156482354|FG003|Overall Study|Other|3|||
48624551|NCT03249558|156482355|FG000|Overall Study|Lost to Follow-up|2|||
48624552|NCT03249558|156482356|FG001|Overall Study|Lost to Follow-up|1|||
48624553|NCT03249558|156482357|FG002|Overall Study|Lost to Follow-up|4|||
48323252|NCT04759833|155381984|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
48323253|NCT04759833|155381985|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
48323254|NCT04759833|155381986|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
48323255|NCT04759833|155381987|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
48323256|NCT04759833|155381988|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
48624554|NCT03249558|156482355|FG000|Overall Study|Physician Decision|1|||
48624555|NCT03249558|156482356|FG001|Overall Study|Physician Decision|0|||
48624556|NCT03249558|156482357|FG002|Overall Study|Physician Decision|0|||
48624557|NCT03249558|156482355|FG000|Overall Study|Withdrawal by Subject|6|||
48624558|NCT03249558|156482356|FG001|Overall Study|Withdrawal by Subject|5|||
48624559|NCT03249558|156482357|FG002|Overall Study|Withdrawal by Subject|7|||
48624560|NCT03249558|156482355|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
48624561|NCT03249558|156482356|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
48624562|NCT03249558|156482357|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
48740348|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
48740349|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
48323257|NCT04759833|155381984|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
48323258|NCT04759833|155381985|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
48323259|NCT04759833|155381986|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
48323260|NCT04759833|155381987|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
48323261|NCT04759833|155381988|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
48323262|NCT04759833|155381984|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
48323263|NCT04759833|155381985|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
48323264|NCT04759833|155381986|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
48323265|NCT04759833|155381987|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
48323266|NCT04759833|155381988|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
48323267|NCT04759833|155381984|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
48323268|NCT04759833|155381985|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
48323269|NCT04759833|155381986|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
48323270|NCT04759833|155381987|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
48323271|NCT04759833|155381988|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
48323272|NCT00409838|155381989|FG000|Short-term Period|Adverse Event|0|||
48323273|NCT00409838|155381990|FG001|Short-term Period|Adverse Event|1|||
48323274|NCT00409838|155381989|FG000|Short-term Period|Lost to Follow-up|0|||
48323275|NCT00409838|155381990|FG001|Short-term Period|Lost to Follow-up|1|||
48323276|NCT00409838|155381989|FG000|Short-term Period|Withdrawal by Subject|2|||
48323277|NCT00409838|155381990|FG001|Short-term Period|Withdrawal by Subject|3|||
48323278|NCT00409838|155381989|FG000|Short-term Period|Never Treated|1|||
48323279|NCT00409838|155381990|FG001|Short-term Period|Never Treated|0|||
48624563|NCT03249558|156482355|FG000|Overall Study|Protocol Violation|1|||
48624564|NCT03249558|156482356|FG001|Overall Study|Protocol Violation|1|||
48740350|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
48740351|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
48740352|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
48323280|NCT00409838|155381989|FG000|Long-term Extension Period|Adverse Event|10|||
48323281|NCT00409838|155381990|FG001|Long-term Extension Period|Adverse Event|0|||
48323282|NCT00409838|155381989|FG000|Long-term Extension Period|Death|1|||
48323283|NCT00409838|155381990|FG001|Long-term Extension Period|Death|0|||
48624565|NCT03249558|156482357|FG002|Overall Study|Protocol Violation|2|||
48624566|NCT04398706|156482358|FG000|Overall Study|Adverse Event|0|||
48624567|NCT04398706|156482359|FG001|Overall Study|Adverse Event|0|||
48624568|NCT04398706|156482360|FG002|Overall Study|Adverse Event|0|||
48740353|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
48624569|NCT04398706|156482361|FG003|Overall Study|Adverse Event|0|||
48624570|NCT04398706|156482362|FG004|Overall Study|Adverse Event|0|||
48624571|NCT04398706|156482363|FG005|Overall Study|Adverse Event|1|||
48624572|NCT04398706|156482364|FG006|Overall Study|Adverse Event|1|||
48624573|NCT04398706|156482365|FG007|Overall Study|Adverse Event|0|||
48624574|NCT04398706|156482358|FG000|Overall Study|Lost to Follow-up|0|||
48624575|NCT04398706|156482359|FG001|Overall Study|Lost to Follow-up|1|||
48740354|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
48740355|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
48624576|NCT04398706|156482360|FG002|Overall Study|Lost to Follow-up|2|||
48624577|NCT04398706|156482361|FG003|Overall Study|Lost to Follow-up|1|||
48624578|NCT04398706|156482362|FG004|Overall Study|Lost to Follow-up|6|||
48624579|NCT04398706|156482363|FG005|Overall Study|Lost to Follow-up|3|||
48624580|NCT04398706|156482364|FG006|Overall Study|Lost to Follow-up|8|||
48624581|NCT04398706|156482365|FG007|Overall Study|Lost to Follow-up|2|||
48624582|NCT04398706|156482358|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48624583|NCT04398706|156482359|FG001|Overall Study|Withdrawal by parent/guardian|2|||
48624584|NCT04398706|156482360|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48624585|NCT04398706|156482361|FG003|Overall Study|Withdrawal by parent/guardian|2|||
48624586|NCT04398706|156482362|FG004|Overall Study|Withdrawal by parent/guardian|19|||
48624587|NCT04398706|156482363|FG005|Overall Study|Withdrawal by parent/guardian|23|||
48624588|NCT04398706|156482364|FG006|Overall Study|Withdrawal by parent/guardian|13|||
48624589|NCT04398706|156482365|FG007|Overall Study|Withdrawal by parent/guardian|11|||
48624590|NCT04398706|156482358|FG000|Overall Study|Protocol deviation|0|||
48624591|NCT04398706|156482359|FG001|Overall Study|Protocol deviation|1|||
48624592|NCT04398706|156482360|FG002|Overall Study|Protocol deviation|0|||
48740356|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
48740357|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
48740358|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
48740359|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
48740360|NCT05307692|156897496|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
48740361|NCT05307692|156897497|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
48740362|NCT05307692|156897498|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
48797776|NCT00483184|157097061|FG000|Overall Study|Protocol Violation|1|||
48323284|NCT00409838|155381989|FG000|Long-term Extension Period|Lack of Efficacy|2|||
48323285|NCT00409838|155381990|FG001|Long-term Extension Period|Lack of Efficacy|0|||
48323286|NCT00409838|155381989|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
48323287|NCT00409838|155381990|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
48323288|NCT00409838|155381989|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
48323289|NCT00409838|155381990|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
48323290|NCT00409838|155381989|FG000|Long-term Extension Period|Pregnancy|1|||
48323291|NCT00409838|155381990|FG001|Long-term Extension Period|Pregnancy|0|||
48323292|NCT01426412|155382000|FG000|Overall Study|Withdrawal by Subject|1|||
48323293|NCT01426412|155382001|FG001|Overall Study|Withdrawal by Subject|0|||
48323294|NCT01426412|155382002|FG002|Overall Study|Withdrawal by Subject|0|||
48323295|NCT01426412|155382003|FG003|Overall Study|Withdrawal by Subject|0|||
48323296|NCT01426412|155382004|FG004|Overall Study|Withdrawal by Subject|1|||
48323297|NCT01426412|155382005|FG005|Overall Study|Withdrawal by Subject|0|||
48323298|NCT01426412|155382006|FG006|Overall Study|Withdrawal by Subject|0|||
48323299|NCT01426412|155382007|FG007|Overall Study|Withdrawal by Subject|3|||
48323300|NCT01426412|155382008|FG008|Overall Study|Withdrawal by Subject|1|||
48323301|NCT00687219|155382010|FG000|Overall Study|Adverse Event|8|||
48323302|NCT00687219|155382010|FG000|Overall Study|Discontinuance criteria met|7|||
48323303|NCT00687219|155382010|FG000|Overall Study|HCV-RNA positive conversion|34|||
48323304|NCT00687219|155382010|FG000|Overall Study|Withdrawal by Subject|1|||
48323305|NCT00687219|155382010|FG000|Overall Study|Lack of Efficacy|1|||
48323306|NCT02008916|155382011|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
48323307|NCT02008916|155382012|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
48323308|NCT02008916|155382013|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
48323309|NCT02008916|155382011|FG000|Week 16 - 156|Adverse Event|4|||
48323310|NCT02008916|155382012|FG001|Week 16 - 156|Adverse Event|2|||
48323311|NCT02008916|155382013|FG002|Week 16 - 156|Adverse Event|3|||
48323312|NCT02008916|155382011|FG000|Week 16 - 156|Withdrawal by Subject|7|||
48323313|NCT02008916|155382012|FG001|Week 16 - 156|Withdrawal by Subject|3|||
48624593|NCT04398706|156482361|FG003|Overall Study|Protocol deviation|0|||
48624594|NCT04398706|156482362|FG004|Overall Study|Protocol deviation|6|||
48624595|NCT04398706|156482363|FG005|Overall Study|Protocol deviation|4|||
48323314|NCT02008916|155382013|FG002|Week 16 - 156|Withdrawal by Subject|5|||
48323315|NCT02008916|155382011|FG000|Week 16 - 156|No longer requires treatment|0|||
48323316|NCT02008916|155382012|FG001|Week 16 - 156|No longer requires treatment|1|||
48323317|NCT02008916|155382013|FG002|Week 16 - 156|No longer requires treatment|0|||
48323318|NCT02008916|155382011|FG000|Week 16 - 156|Lost to Follow-up|5|||
48624596|NCT04398706|156482364|FG006|Overall Study|Protocol deviation|6|||
48624597|NCT04398706|156482365|FG007|Overall Study|Protocol deviation|3|||
48323319|NCT02008916|155382012|FG001|Week 16 - 156|Lost to Follow-up|0|||
48323320|NCT02008916|155382013|FG002|Week 16 - 156|Lost to Follow-up|0|||
48323321|NCT02008916|155382011|FG000|Week 16 - 156|Lack of Efficacy|3|||
48323322|NCT02008916|155382012|FG001|Week 16 - 156|Lack of Efficacy|5|||
48323323|NCT02008916|155382013|FG002|Week 16 - 156|Lack of Efficacy|2|||
48323324|NCT02008916|155382011|FG000|Week 16 - 156|Pregnancy|0|||
48323325|NCT02008916|155382012|FG001|Week 16 - 156|Pregnancy|1|||
48323326|NCT02008916|155382013|FG002|Week 16 - 156|Pregnancy|0|||
48323327|NCT02008916|155382011|FG000|Week 16 - 156|Physician Decision|0|||
48323328|NCT02008916|155382012|FG001|Week 16 - 156|Physician Decision|1|||
48323329|NCT02008916|155382013|FG002|Week 16 - 156|Physician Decision|0|||
48323330|NCT01367236|155382014|FG000|Overall Study|Withdrawal by Subject|3|||
48323331|NCT01367236|155382015|FG001|Overall Study|Withdrawal by Subject|1|||
48323332|NCT05171777|155382016|FG000|Treatment Crossover Period|Adverse Event|9|||
48323333|NCT05171777|155382017|FG001|Treatment Crossover Period|Adverse Event|6|||
48323334|NCT05171777|155382018|FG002|Treatment Crossover Period|Adverse Event|0|||
48323335|NCT05171777|155382019|FG003|Treatment Crossover Period|Adverse Event|0|||
48323336|NCT05171777|155382016|FG000|Treatment Crossover Period|Death|5|||
48323337|NCT05171777|155382017|FG001|Treatment Crossover Period|Death|5|||
48323338|NCT05171777|155382018|FG002|Treatment Crossover Period|Death|0|||
48323339|NCT05171777|155382019|FG003|Treatment Crossover Period|Death|0|||
48624598|NCT02037984|156482366|FG000|Overall Study|Lack of Efficacy|0|||
48624599|NCT02037984|156482367|FG001|Overall Study|Lack of Efficacy|0|||
48624600|NCT02037984|156482368|FG002|Overall Study|Lack of Efficacy|3|||
48624601|NCT02037984|156482369|FG003|Overall Study|Lack of Efficacy|10|||
48624602|NCT02037984|156482370|FG004|Overall Study|Lack of Efficacy|2|||
48624603|NCT02037984|156482371|FG005|Overall Study|Lack of Efficacy|2|||
48323340|NCT05171777|155382016|FG000|Treatment Crossover Period|Disease Relapse|0|||
48323341|NCT05171777|155382017|FG001|Treatment Crossover Period|Disease Relapse|1|||
48323342|NCT05171777|155382018|FG002|Treatment Crossover Period|Disease Relapse|0|||
48323343|NCT05171777|155382019|FG003|Treatment Crossover Period|Disease Relapse|0|||
48323344|NCT05171777|155382016|FG000|Treatment Crossover Period|Reason not Specified|2|||
48323345|NCT05171777|155382017|FG001|Treatment Crossover Period|Reason not Specified|1|||
48323346|NCT05171777|155382018|FG002|Treatment Crossover Period|Reason not Specified|0|||
48323347|NCT05171777|155382019|FG003|Treatment Crossover Period|Reason not Specified|0|||
48323348|NCT05171777|155382016|FG000|Treatment Crossover Period|Physician Decision|0|||
48323349|NCT05171777|155382017|FG001|Treatment Crossover Period|Physician Decision|1|||
48323350|NCT05171777|155382018|FG002|Treatment Crossover Period|Physician Decision|0|||
48323351|NCT05171777|155382019|FG003|Treatment Crossover Period|Physician Decision|0|||
48624604|NCT02037984|156482372|FG006|Overall Study|Lack of Efficacy|4|||
48624605|NCT02037984|156482373|FG007|Overall Study|Lack of Efficacy|3|||
48624606|NCT02037984|156482366|FG000|Overall Study|Lost to Follow-up|1|||
48624607|NCT02037984|156482367|FG001|Overall Study|Lost to Follow-up|0|||
48624608|NCT02037984|156482368|FG002|Overall Study|Lost to Follow-up|3|||
48624609|NCT02037984|156482369|FG003|Overall Study|Lost to Follow-up|5|||
48624610|NCT02037984|156482370|FG004|Overall Study|Lost to Follow-up|2|||
48624611|NCT02037984|156482371|FG005|Overall Study|Lost to Follow-up|2|||
48624612|NCT02037984|156482372|FG006|Overall Study|Lost to Follow-up|2|||
48624613|NCT02037984|156482373|FG007|Overall Study|Lost to Follow-up|4|||
48624614|NCT02037984|156482366|FG000|Overall Study|Physician Decision|0|||
48624615|NCT02037984|156482367|FG001|Overall Study|Physician Decision|0|||
48624616|NCT02037984|156482368|FG002|Overall Study|Physician Decision|0|||
48624617|NCT02037984|156482369|FG003|Overall Study|Physician Decision|0|||
48624618|NCT02037984|156482370|FG004|Overall Study|Physician Decision|0|||
48624619|NCT02037984|156482371|FG005|Overall Study|Physician Decision|0|||
48323352|NCT05171777|155382016|FG000|Treatment Crossover Period|Progressive Disease|13|||
48323353|NCT05171777|155382017|FG001|Treatment Crossover Period|Progressive Disease|9|||
48323354|NCT05171777|155382018|FG002|Treatment Crossover Period|Progressive Disease|0|||
48323355|NCT05171777|155382019|FG003|Treatment Crossover Period|Progressive Disease|0|||
48323356|NCT05171777|155382016|FG000|Treatment Crossover Period|Protocol Violation|0|||
48323357|NCT05171777|155382017|FG001|Treatment Crossover Period|Protocol Violation|2|||
48323358|NCT05171777|155382018|FG002|Treatment Crossover Period|Protocol Violation|0|||
48323359|NCT05171777|155382019|FG003|Treatment Crossover Period|Protocol Violation|0|||
48323360|NCT05171777|155382016|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
48323361|NCT05171777|155382017|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
48323362|NCT05171777|155382018|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
48323363|NCT05171777|155382019|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
48323364|NCT05171777|155382016|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
48323365|NCT05171777|155382017|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
48323366|NCT05171777|155382018|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
48323367|NCT05171777|155382019|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
48323368|NCT05171777|155382016|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
48624620|NCT02037984|156482372|FG006|Overall Study|Physician Decision|1|||
48624621|NCT02037984|156482373|FG007|Overall Study|Physician Decision|0|||
48624622|NCT02037984|156482366|FG000|Overall Study|Protocol Violation|0|||
48624623|NCT02037984|156482367|FG001|Overall Study|Protocol Violation|0|||
48624624|NCT02037984|156482368|FG002|Overall Study|Protocol Violation|0|||
48624625|NCT02037984|156482369|FG003|Overall Study|Protocol Violation|0|||
48624626|NCT02037984|156482370|FG004|Overall Study|Protocol Violation|0|||
48624627|NCT02037984|156482371|FG005|Overall Study|Protocol Violation|1|||
48624628|NCT02037984|156482372|FG006|Overall Study|Protocol Violation|2|||
48624629|NCT02037984|156482373|FG007|Overall Study|Protocol Violation|0|||
48624630|NCT02037984|156482366|FG000|Overall Study|Technical Problems|0|||
48624631|NCT02037984|156482367|FG001|Overall Study|Technical Problems|0|||
48624632|NCT02037984|156482368|FG002|Overall Study|Technical Problems|3|||
48624633|NCT02037984|156482369|FG003|Overall Study|Technical Problems|3|||
48624634|NCT02037984|156482370|FG004|Overall Study|Technical Problems|2|||
48624635|NCT02037984|156482371|FG005|Overall Study|Technical Problems|3|||
48624636|NCT02037984|156482372|FG006|Overall Study|Technical Problems|4|||
48624637|NCT02037984|156482373|FG007|Overall Study|Technical Problems|2|||
48624638|NCT02037984|156482366|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48323369|NCT05171777|155382017|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
48323370|NCT05171777|155382018|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
48323371|NCT05171777|155382019|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
48323372|NCT05171777|155382016|FG000|Treatment Continuation Period|Death|0|||
48323373|NCT05171777|155382017|FG001|Treatment Continuation Period|Death|0|||
48323374|NCT05171777|155382018|FG002|Treatment Continuation Period|Death|1|||
48323375|NCT05171777|155382019|FG003|Treatment Continuation Period|Death|6|||
48323376|NCT05171777|155382016|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
48323377|NCT05171777|155382017|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
48323378|NCT05171777|155382018|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
48323379|NCT05171777|155382019|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
48323380|NCT01083316|155382020|FG000|Overall Study|Adverse Event|2|||
48323381|NCT01083316|155382020|FG000|Overall Study|Withdrawal by Subject|1|||
48323382|NCT00611559|155382023|FG000|Overall Study|Lost to Follow-up|0|||
48323383|NCT00611559|155382024|FG001|Overall Study|Lost to Follow-up|1|||
48323384|NCT00611559|155382025|FG002|Overall Study|Lost to Follow-up|0|||
48323385|NCT00611559|155382023|FG000|Overall Study|Protocol Violation|1|||
48323386|NCT00611559|155382024|FG001|Overall Study|Protocol Violation|0|||
48323387|NCT00611559|155382025|FG002|Overall Study|Protocol Violation|1|||
48323388|NCT00879333|155382026|FG000|Overall Study|Adverse Event|94|||
48323389|NCT00879333|155382027|FG001|Overall Study|Adverse Event|34|||
48323390|NCT00879333|155382026|FG000|Overall Study|Abnormal Laboratory Value|1|||
48323391|NCT00879333|155382027|FG001|Overall Study|Abnormal Laboratory Value|0|||
48323392|NCT00879333|155382026|FG000|Overall Study|Withdrawal by Subject|20|||
48323393|NCT00879333|155382027|FG001|Overall Study|Withdrawal by Subject|7|||
48624639|NCT02037984|156482367|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48624640|NCT02037984|156482368|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
48624641|NCT02037984|156482369|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
48624642|NCT02037984|156482370|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
48624643|NCT02037984|156482371|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
48624644|NCT02037984|156482372|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
48624645|NCT02037984|156482373|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
48624646|NCT02037984|156482366|FG000|Overall Study|Withdrawal by Subject|0|||
48624647|NCT02037984|156482367|FG001|Overall Study|Withdrawal by Subject|0|||
48624648|NCT02037984|156482368|FG002|Overall Study|Withdrawal by Subject|0|||
48624649|NCT02037984|156482369|FG003|Overall Study|Withdrawal by Subject|1|||
48624650|NCT02037984|156482370|FG004|Overall Study|Withdrawal by Subject|1|||
48624651|NCT02037984|156482371|FG005|Overall Study|Withdrawal by Subject|3|||
48624652|NCT02037984|156482372|FG006|Overall Study|Withdrawal by Subject|0|||
48624653|NCT02037984|156482373|FG007|Overall Study|Withdrawal by Subject|1|||
48624654|NCT00908141|156482376|FG000|Overall Study|Withdrawal by Subject|0|||
48624655|NCT00908141|156482377|FG001|Overall Study|Withdrawal by Subject|1|||
48624656|NCT05943990|156482378|FG000|Overall Study|Study Terminated by Sponsor|0|||
48323394|NCT00879333|155382026|FG000|Overall Study|Lost to Follow-up|2|||
48323395|NCT00879333|155382027|FG001|Overall Study|Lost to Follow-up|1|||
48323396|NCT00879333|155382026|FG000|Overall Study|Administrative Problems|2|||
48323397|NCT00879333|155382027|FG001|Overall Study|Administrative Problems|0|||
48624657|NCT05943990|156482379|FG001|Overall Study|Study Terminated by Sponsor|0|||
48624658|NCT05943990|156482380|FG002|Overall Study|Study Terminated by Sponsor|1|||
48624659|NCT01569763|156483434|FG000|Overall Study|Lack of Efficacy|2|||
48624660|NCT01569763|156483435|FG001|Overall Study|Lack of Efficacy|7|||
48624661|NCT01569763|156483434|FG000|Overall Study|Adverse Event|1|||
48624662|NCT01569763|156483435|FG001|Overall Study|Adverse Event|0|||
48624663|NCT00088881|156483438|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
48323398|NCT00879333|155382026|FG000|Overall Study|Death|16|||
48323399|NCT00879333|155382027|FG001|Overall Study|Death|5|||
48624664|NCT00088881|156483438|FG000|Step 1 - R-CHOP|Adverse Event|1|||
48624665|NCT00088881|156483438|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
48323400|NCT00879333|155382026|FG000|Overall Study|Disease Progression|292|||
48323401|NCT00879333|155382027|FG001|Overall Study|Disease Progression|169|||
48323402|NCT00879333|155382026|FG000|Overall Study|Protocol Violation|1|||
48624666|NCT00088881|156483438|FG000|Step 1 - R-CHOP|Physician Decision|1|||
48624667|NCT00088881|156483438|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
48624668|NCT00088881|156483438|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
48624669|NCT00088881|156483438|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
48624670|NCT03537729|156483444|FG000|Overall Study|Death|2|||
48624671|NCT03537729|156483445|FG001|Overall Study|Death|2|||
48624672|NCT03537729|156483446|FG002|Overall Study|Death|7|||
48624673|NCT03537729|156483444|FG000|Overall Study|Withdrawal by Subject|3|||
48624674|NCT03537729|156483445|FG001|Overall Study|Withdrawal by Subject|3|||
48624675|NCT03537729|156483446|FG002|Overall Study|Withdrawal by Subject|0|||
48624676|NCT03537729|156483444|FG000|Overall Study|Subject Moved|8|||
48624677|NCT03537729|156483445|FG001|Overall Study|Subject Moved|5|||
48624678|NCT03537729|156483446|FG002|Overall Study|Subject Moved|4|||
48624679|NCT03537729|156483444|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
48624680|NCT03537729|156483445|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
48624681|NCT03537729|156483446|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
48624682|NCT03537729|156483444|FG000|Overall Study|COVID-19 Site Restrictions|11|||
48624683|NCT03537729|156483445|FG001|Overall Study|COVID-19 Site Restrictions|15|||
48624684|NCT03537729|156483446|FG002|Overall Study|COVID-19 Site Restrictions|18|||
48624685|NCT03537729|156483444|FG000|Overall Study|Decline in Health|5|||
48624686|NCT03537729|156483445|FG001|Overall Study|Decline in Health|9|||
48624687|NCT03537729|156483446|FG002|Overall Study|Decline in Health|4|||
48624688|NCT03537729|156483444|FG000|Overall Study|Determined Ineligible|0|||
48624689|NCT03537729|156483445|FG001|Overall Study|Determined Ineligible|0|||
48624690|NCT03537729|156483446|FG002|Overall Study|Determined Ineligible|1|||
48624691|NCT01748552|156483450|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
48624692|NCT01748552|156483451|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
48624693|NCT01748552|156483452|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
48624694|NCT01748552|156483453|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
48624695|NCT01748552|156483454|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
48624696|NCT01748552|156483455|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
48624697|NCT01748552|156483456|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
48624698|NCT01748552|156483457|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
48624699|NCT01748552|156483458|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
48624700|NCT01748552|156483459|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
48624701|NCT01748552|156483460|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
48624702|NCT01748552|156483461|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
48624703|NCT01748552|156483450|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624704|NCT01748552|156483451|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624705|NCT01748552|156483452|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624706|NCT01748552|156483453|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624707|NCT01748552|156483454|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624708|NCT01748552|156483455|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624709|NCT01748552|156483456|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
48624710|NCT01748552|156483457|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
48624711|NCT01748552|156483458|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
48624712|NCT01748552|156483459|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624713|NCT01748552|156483460|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624714|NCT01748552|156483461|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
48624715|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
48624716|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
48624717|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
48624718|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
48624719|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
48624720|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
48624721|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
48624722|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
48624723|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
48624724|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
48624725|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
48624726|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
48624727|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
48624728|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
48624729|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
48323403|NCT00879333|155382027|FG001|Overall Study|Protocol Violation|1|||
48323404|NCT03500549|155382029|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
48323405|NCT03500549|155382030|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
48624730|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
48624731|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
48624732|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
48624733|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
48624734|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
48624735|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
48624736|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
48624737|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
48624738|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
48624739|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
48624740|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
48624741|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
48624742|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
48624743|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
48624744|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
48624745|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
48624746|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
48624747|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
48624748|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
48624749|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
48624750|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
48624751|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
48624752|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
48624753|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
48624754|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
48624755|NCT02596893|156483462|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
48624756|NCT02596893|156483463|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
48624757|NCT02596893|156483464|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
48624758|NCT02596893|156483465|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
48624759|NCT03280615|156483466|FG000|Overall Study|Lost to Follow-up|1|||
48624760|NCT03280615|156483467|FG001|Overall Study|Lost to Follow-up|2|||
48624761|NCT03280615|156483466|FG000|Overall Study|Adverse Event|1|||
48624762|NCT03280615|156483467|FG001|Overall Study|Adverse Event|1|||
48624763|NCT03280615|156483466|FG000|Overall Study|Withdrawal by Subject|2|||
48624764|NCT03280615|156483467|FG001|Overall Study|Withdrawal by Subject|2|||
48624765|NCT00185614|156483471|FG000|Inter-treatment Period|Physician Decision|1|||
48624766|NCT00185614|156483471|FG000|Inter-treatment Period|Relapse|2|||
48624767|NCT00185614|156483471|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
48624768|NCT02410200|156483472|FG000|Overall Study|Adverse Event|2|||
48624769|NCT00527748|156483474|FG000|Overall Study|Other|3|||
48624770|NCT00382863|156483475|FG000|Overall Study|Death|9|||
48624771|NCT00382863|156483476|FG001|Overall Study|Death|9|||
48624772|NCT00382863|156483475|FG000|Overall Study|Lost to Follow-up|1|||
48624773|NCT00382863|156483476|FG001|Overall Study|Lost to Follow-up|2|||
48624774|NCT00382863|156483475|FG000|Overall Study|Withdrawal by Subject|5|||
48624775|NCT00382863|156483476|FG001|Overall Study|Withdrawal by Subject|25|||
48624776|NCT00292370|156483477|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
48624777|NCT00292370|156483478|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
48624778|NCT00292370|156483479|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
48624779|NCT00292370|156483477|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
48624780|NCT00292370|156483478|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
48624781|NCT00292370|156483479|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
48624782|NCT00292370|156483477|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
48624783|NCT00292370|156483478|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
48624784|NCT00292370|156483479|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
48624785|NCT00292370|156483477|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
48624786|NCT00292370|156483478|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
48624787|NCT00292370|156483479|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
48624788|NCT00292370|156483477|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
48624789|NCT00292370|156483478|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
48624790|NCT00292370|156483479|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
48624791|NCT00292370|156483477|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
48797777|NCT00483184|157097062|FG001|Overall Study|Protocol Violation|0|||
48797778|NCT00483184|157097063|FG002|Overall Study|Protocol Violation|1|||
48797779|NCT02570126|157097064|FG000|Overall Study|Lost to Follow-up|2|||
48797780|NCT02570126|157097065|FG001|Overall Study|Lost to Follow-up|0|||
48797781|NCT02570126|157097064|FG000|Overall Study|Unable To Arrange Visit 3|1|||
48797782|NCT02570126|157097065|FG001|Overall Study|Unable To Arrange Visit 3|0|||
48323406|NCT03500549|155382029|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
48624792|NCT00292370|156483478|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
48624793|NCT00292370|156483479|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
48624794|NCT00458705|156483481|FG000|Overall Study|Adverse Event|4|||
48624795|NCT00458705|156483481|FG000|Overall Study|Not Treated|1|||
48624796|NCT02070380|156483484|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
48624797|NCT02070380|156483485|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
48624798|NCT02070380|156483486|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
48624799|NCT02070380|156483487|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
48624800|NCT02070380|156483484|FG000|Second Injection|Image sets missing or technically inadeq|0|||
48624801|NCT02070380|156483485|FG001|Second Injection|Image sets missing or technically inadeq|1|||
48624802|NCT02070380|156483486|FG002|Second Injection|Image sets missing or technically inadeq|0|||
48624803|NCT02070380|156483487|FG003|Second Injection|Image sets missing or technically inadeq|0|||
48624804|NCT02070380|156483484|FG000|Second Injection|Protocol Violation|0|||
48624805|NCT02070380|156483485|FG001|Second Injection|Protocol Violation|1|||
48624806|NCT02070380|156483486|FG002|Second Injection|Protocol Violation|1|||
48624807|NCT02070380|156483487|FG003|Second Injection|Protocol Violation|5|||
48624808|NCT01362530|156483490|FG000|Base Study (Cycle 1)|Adverse Event|2|||
48624809|NCT01362530|156483491|FG001|Base Study (Cycle 1)|Adverse Event|0|||
48624810|NCT01362530|156483490|FG000|Base Study (Cycle 1)|Physician Decision|0|||
48624811|NCT01362530|156483491|FG001|Base Study (Cycle 1)|Physician Decision|1|||
48624812|NCT01362530|156483490|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
48624813|NCT01362530|156483491|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
48624814|NCT01362530|156483490|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
48624815|NCT01362530|156483491|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
48624816|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
48624817|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
48624818|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
48624819|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
48624820|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
48624821|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
48624822|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
48624823|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
48624824|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
48624825|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
48624826|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
48624827|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
48624828|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
48624829|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
48624830|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
48624831|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
48624832|NCT01362530|156483490|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
48624833|NCT01362530|156483491|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
48624834|NCT02336555|156483494|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48624835|NCT02336555|156483495|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48624836|NCT02336555|156483494|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
48624837|NCT02336555|156483495|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
48624838|NCT02336555|156483494|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
48624839|NCT02336555|156483495|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
48624840|NCT00395447|156483497|FG000|Overall Study|Death|37|||
48624841|NCT00395447|156483498|FG001|Overall Study|Death|32|||
48624842|NCT00395447|156483497|FG000|Overall Study|Lost to Follow-up|52|||
48624843|NCT00395447|156483498|FG001|Overall Study|Lost to Follow-up|43|||
48624844|NCT00395447|156483497|FG000|Overall Study|Withdrawal by Subject|24|||
48624845|NCT00395447|156483498|FG001|Overall Study|Withdrawal by Subject|19|||
48624846|NCT00395447|156483497|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
48624847|NCT00395447|156483498|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
48624848|NCT00276380|156483499|FG000|Overall Study|Adverse Event|5|||
48624849|NCT00276380|156483500|FG001|Overall Study|Adverse Event|3|||
48624850|NCT00276380|156483499|FG000|Overall Study|Lost to Follow-up|1|||
48624851|NCT00276380|156483500|FG001|Overall Study|Lost to Follow-up|1|||
48624852|NCT00276380|156483499|FG000|Overall Study|Withdrawal by Subject|3|||
48740363|NCT05307692|156897499|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
48740364|NCT05307692|156897496|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
48740365|NCT05307692|156897497|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
48740366|NCT05307692|156897498|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
48624853|NCT00276380|156483500|FG001|Overall Study|Withdrawal by Subject|6|||
48740367|NCT05307692|156897499|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
48624854|NCT00276380|156483499|FG000|Overall Study|Death|5|||
48624855|NCT00276380|156483500|FG001|Overall Study|Death|3|||
48323407|NCT03500549|155382030|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
48323408|NCT02246621|155382031|FG000|Overall Study|Withdrawal by Subject|28|||
48323409|NCT02246621|155382032|FG001|Overall Study|Withdrawal by Subject|16|||
48323410|NCT02246621|155382031|FG000|Overall Study|Lost to Follow-up|1|||
48323411|NCT02246621|155382032|FG001|Overall Study|Lost to Follow-up|0|||
48323412|NCT02246621|155382031|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
48323413|NCT02246621|155382032|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
48323414|NCT03750968|155382033|FG000|Overall Study|Adverse Event|2|||
48323415|NCT03750968|155382034|FG001|Overall Study|Adverse Event|0|||
48323416|NCT03750968|155382033|FG000|Overall Study|Lost to Follow-up|1|||
48323417|NCT03750968|155382034|FG001|Overall Study|Lost to Follow-up|3|||
48740368|NCT05307692|156897496|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
48740369|NCT05307692|156897497|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
48740370|NCT05307692|156897498|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
48740371|NCT05307692|156897499|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
48740372|NCT03673046|156898854|FG000|Overall Study|Adverse Event|1|||
48740373|NCT03673046|156898855|FG001|Overall Study|Adverse Event|1|||
48740374|NCT03673046|156898854|FG000|Overall Study|Withdrawal by Subject|8|||
48740375|NCT03673046|156898855|FG001|Overall Study|Withdrawal by Subject|2|||
48323418|NCT00308997|155382035|FG000|Overall Study|Subject feigned clinical data|0|||
48323419|NCT00308997|155382036|FG001|Overall Study|Subject feigned clinical data|1|||
48323420|NCT00308997|155382035|FG000|Overall Study|Unable to tolerate intervention|1|||
48323421|NCT00308997|155382036|FG001|Overall Study|Unable to tolerate intervention|0|||
48323422|NCT02107261|155382039|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
48323423|NCT02107261|155382040|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
48323424|NCT02107261|155382039|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
48323425|NCT02107261|155382040|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
48323426|NCT00709098|155382041|FG000|Double-blind Period|Withdrawal of consent|3|||
48323427|NCT00709098|155382042|FG001|Double-blind Period|Withdrawal of consent|3|||
48323428|NCT00709098|155382043|FG002|Double-blind Period|Withdrawal of consent|0|||
48323429|NCT00709098|155382041|FG000|Double-blind Period|Administrative reason|1|||
48323430|NCT00709098|155382042|FG001|Double-blind Period|Administrative reason|3|||
48323431|NCT00709098|155382043|FG002|Double-blind Period|Administrative reason|0|||
48323432|NCT00709098|155382041|FG000|Double-blind Period|Death|1|||
48323433|NCT00709098|155382042|FG001|Double-blind Period|Death|1|||
48323434|NCT00709098|155382043|FG002|Double-blind Period|Death|0|||
48323435|NCT00709098|155382041|FG000|Double-blind Period|Lost to Follow-up|1|||
48323436|NCT00709098|155382042|FG001|Double-blind Period|Lost to Follow-up|1|||
48323437|NCT00709098|155382043|FG002|Double-blind Period|Lost to Follow-up|0|||
48624856|NCT00276380|156483499|FG000|Overall Study|Abnormal aPPT Levels|0|||
48624857|NCT00276380|156483500|FG001|Overall Study|Abnormal aPPT Levels|1|||
48624858|NCT03596983|156483501|FG000|Overall Study|Withdrawal by Subject|3|||
48624859|NCT01655069|156483502|FG000|Overall Study|Physician Decision|0|||
48624860|NCT01655069|156483503|FG001|Overall Study|Physician Decision|0|||
48624861|NCT01655069|156483504|FG002|Overall Study|Physician Decision|0|||
48624862|NCT01655069|156483505|FG003|Overall Study|Physician Decision|1|||
48624863|NCT01655069|156483502|FG000|Overall Study|Adverse Event|6|||
48624864|NCT01655069|156483503|FG001|Overall Study|Adverse Event|7|||
48624865|NCT01655069|156483504|FG002|Overall Study|Adverse Event|2|||
48624866|NCT01655069|156483505|FG003|Overall Study|Adverse Event|3|||
48624867|NCT01655069|156483502|FG000|Overall Study|Lack of Efficacy|0|||
48624868|NCT01655069|156483503|FG001|Overall Study|Lack of Efficacy|1|||
48624869|NCT01655069|156483504|FG002|Overall Study|Lack of Efficacy|0|||
48624870|NCT01655069|156483505|FG003|Overall Study|Lack of Efficacy|0|||
48624871|NCT01655069|156483502|FG000|Overall Study|No Treatment Needed|0|||
48624872|NCT01655069|156483503|FG001|Overall Study|No Treatment Needed|1|||
48740376|NCT00150709|156898856|FG000|Overall Study|Protocol Violation|7|||
48740377|NCT00150709|156898857|FG001|Overall Study|Protocol Violation|8|||
48323438|NCT00709098|155382041|FG000|Open-label Period|Withdrawal of consent|0|||
48624873|NCT01655069|156483504|FG002|Overall Study|No Treatment Needed|0|||
48624874|NCT01655069|156483505|FG003|Overall Study|No Treatment Needed|0|||
48624875|NCT01655069|156483502|FG000|Overall Study|Withdrawal by Subject|2|||
48624876|NCT01655069|156483503|FG001|Overall Study|Withdrawal by Subject|3|||
48624877|NCT01655069|156483504|FG002|Overall Study|Withdrawal by Subject|0|||
48624878|NCT01655069|156483505|FG003|Overall Study|Withdrawal by Subject|0|||
48624879|NCT06399471|156483506|FG000|Overall Study|Withdrawal by Subject|1|||
48624880|NCT03566550|156483512|FG000|Overall Study|Withdrawal by Subject|0|||
48624881|NCT03566550|156483513|FG001|Overall Study|Withdrawal by Subject|1|||
48624882|NCT03745313|156483522|FG000|At 30 Days Follow-up|Death|2|||
48624883|NCT03745313|156483522|FG000|At 6 Months Follow-up|Death|1|||
48624884|NCT03745313|156483522|FG000|At 6 Months Follow-up|Missed Visit|1|||
48624885|NCT03745313|156483522|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
48624886|NCT03745313|156483522|FG000|At 1 Year Follow-up|Death|2|||
48624887|NCT03745313|156483522|FG000|At 1 Year Follow-up|Missed Visit|2|||
48624888|NCT03745313|156483522|FG000|At 2 Year Follow-up|Missed Visit|1|||
48624889|NCT02181413|156483523|FG000|Overall Study|Withdrawal by Subject|45|||
48624890|NCT02181413|156483524|FG001|Overall Study|Withdrawal by Subject|61|||
48624891|NCT02181413|156483523|FG000|Overall Study|Reason Not Specified|2|||
48624892|NCT02181413|156483524|FG001|Overall Study|Reason Not Specified|5|||
48624893|NCT02181413|156483523|FG000|Overall Study|Lost to Follow-up|8|||
48624894|NCT02181413|156483524|FG001|Overall Study|Lost to Follow-up|7|||
48624895|NCT03973489|156483525|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
48624896|NCT03973489|156483526|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
48624897|NCT03973489|156483527|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
48624898|NCT03973489|156483528|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
48624899|NCT03973489|156483529|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
48624900|NCT03973489|156483530|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
48624901|NCT03973489|156483531|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
48624902|NCT03973489|156483532|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
48624903|NCT03973489|156483525|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
48624904|NCT03973489|156483526|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
48624905|NCT03973489|156483527|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
48624906|NCT03973489|156483528|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
48624907|NCT03973489|156483529|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
48624908|NCT03973489|156483530|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
48624909|NCT03973489|156483531|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
48624910|NCT03973489|156483532|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
48624911|NCT03973489|156483525|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
48624912|NCT03973489|156483526|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
48624913|NCT03973489|156483527|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
48624914|NCT03973489|156483528|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
48624915|NCT03973489|156483529|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
48624916|NCT03973489|156483530|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
48624917|NCT03973489|156483531|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
48624918|NCT03973489|156483532|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
48624919|NCT03973489|156483525|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
48624920|NCT03973489|156483526|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
48624921|NCT03973489|156483527|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
48624922|NCT03973489|156483528|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
48624923|NCT03973489|156483529|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
48624924|NCT03973489|156483530|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
48624925|NCT03973489|156483531|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
48624926|NCT03973489|156483532|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
48624927|NCT03973489|156483525|FG000|Second Intervention (1 Day)|Adverse Event|0|||
48624928|NCT03973489|156483526|FG001|Second Intervention (1 Day)|Adverse Event|0|||
48624929|NCT03973489|156483527|FG002|Second Intervention (1 Day)|Adverse Event|0|||
48624930|NCT03973489|156483528|FG003|Second Intervention (1 Day)|Adverse Event|1|||
48624931|NCT03973489|156483529|FG004|Second Intervention (1 Day)|Adverse Event|0|||
48624932|NCT03973489|156483530|FG005|Second Intervention (1 Day)|Adverse Event|0|||
48624933|NCT03973489|156483531|FG006|Second Intervention (1 Day)|Adverse Event|0|||
48624934|NCT03973489|156483532|FG007|Second Intervention (1 Day)|Adverse Event|0|||
48624935|NCT03247673|156483533|FG000|Overall Study|Withdrawal by Subject|1|||
48624936|NCT03247673|156483534|FG001|Overall Study|Withdrawal by Subject|0|||
48624937|NCT03247673|156483535|FG002|Overall Study|Withdrawal by Subject|3|||
48624938|NCT03247673|156483533|FG000|Overall Study|Lost to Follow-up|0|||
48624939|NCT03247673|156483534|FG001|Overall Study|Lost to Follow-up|0|||
48624940|NCT03247673|156483535|FG002|Overall Study|Lost to Follow-up|1|||
48624941|NCT00215657|156483536|FG000|Overall Study|Adverse Event|5|||
48624942|NCT00215657|156483537|FG001|Overall Study|Adverse Event|1|||
48624943|NCT00215657|156483538|FG002|Overall Study|Adverse Event|3|||
48624944|NCT00215657|156483539|FG003|Overall Study|Adverse Event|0|||
48624945|NCT00215657|156483540|FG004|Overall Study|Adverse Event|3|||
48624946|NCT00215657|156483541|FG005|Overall Study|Adverse Event|1|||
48624947|NCT00215657|156483542|FG006|Overall Study|Adverse Event|0|||
48624948|NCT00215657|156483543|FG007|Overall Study|Adverse Event|3|||
48740378|NCT00150709|156898858|FG002|Overall Study|Protocol Violation|3|||
48624949|NCT00215657|156483536|FG000|Overall Study|Withdrawal by Subject|6|||
48624950|NCT00215657|156483537|FG001|Overall Study|Withdrawal by Subject|3|||
48624951|NCT00215657|156483538|FG002|Overall Study|Withdrawal by Subject|3|||
48624952|NCT00215657|156483539|FG003|Overall Study|Withdrawal by Subject|1|||
48624953|NCT00215657|156483540|FG004|Overall Study|Withdrawal by Subject|6|||
48624954|NCT00215657|156483541|FG005|Overall Study|Withdrawal by Subject|1|||
48624955|NCT00215657|156483542|FG006|Overall Study|Withdrawal by Subject|10|||
48624956|NCT00215657|156483543|FG007|Overall Study|Withdrawal by Subject|3|||
48624957|NCT00215657|156483536|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
48624958|NCT00215657|156483537|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
48624959|NCT00215657|156483538|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
48624960|NCT00215657|156483539|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
48624961|NCT00215657|156483540|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
48624962|NCT00215657|156483541|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
48740379|NCT00150709|156898859|FG003|Overall Study|Protocol Violation|1|||
48740380|NCT00150709|156898856|FG000|Overall Study|Adverse Event|8|||
48740381|NCT00150709|156898857|FG001|Overall Study|Adverse Event|2|||
48740382|NCT00150709|156898858|FG002|Overall Study|Adverse Event|2|||
48740383|NCT00150709|156898859|FG003|Overall Study|Adverse Event|3|||
48740384|NCT00150709|156898856|FG000|Overall Study|Lack of Efficacy|6|||
48740385|NCT00150709|156898857|FG001|Overall Study|Lack of Efficacy|11|||
48740386|NCT00150709|156898858|FG002|Overall Study|Lack of Efficacy|9|||
48740387|NCT00150709|156898859|FG003|Overall Study|Lack of Efficacy|0|||
48740388|NCT00150709|156898856|FG000|Overall Study|Withdrawal by Subject|7|||
48740389|NCT00150709|156898857|FG001|Overall Study|Withdrawal by Subject|10|||
48740390|NCT00150709|156898858|FG002|Overall Study|Withdrawal by Subject|5|||
48740391|NCT00150709|156898859|FG003|Overall Study|Withdrawal by Subject|0|||
48740392|NCT00150709|156898856|FG000|Overall Study|Lost to Follow-up|3|||
48740393|NCT00150709|156898857|FG001|Overall Study|Lost to Follow-up|2|||
48740394|NCT00150709|156898858|FG002|Overall Study|Lost to Follow-up|0|||
48740395|NCT00150709|156898859|FG003|Overall Study|Lost to Follow-up|0|||
48740396|NCT00150709|156898856|FG000|Overall Study|Sponsor decision|0|||
48740397|NCT00150709|156898857|FG001|Overall Study|Sponsor decision|0|||
48740398|NCT00150709|156898858|FG002|Overall Study|Sponsor decision|0|||
48740399|NCT00150709|156898859|FG003|Overall Study|Sponsor decision|1|||
48740400|NCT00150709|156898856|FG000|Overall Study|Site/Investigator discontinued the study|5|||
48740401|NCT00150709|156898857|FG001|Overall Study|Site/Investigator discontinued the study|5|||
48740402|NCT00150709|156898858|FG002|Overall Study|Site/Investigator discontinued the study|2|||
48740403|NCT00150709|156898859|FG003|Overall Study|Site/Investigator discontinued the study|0|||
48740404|NCT00150709|156898856|FG000|Overall Study|Decision of parent(s)|1|||
48797938|NCT02291679|157097124|FG001|Overall Study|Withdrew Consent|10|||
48797939|NCT02291679|157097125|FG002|Overall Study|Withdrew Consent|15|||
48797940|NCT02291679|157097123|FG000|Overall Study|Lost to Follow-up|12|||
48797941|NCT02291679|157097124|FG001|Overall Study|Lost to Follow-up|10|||
48797942|NCT02291679|157097125|FG002|Overall Study|Lost to Follow-up|9|||
48797943|NCT02291679|157097123|FG000|Overall Study|Insufficient Therapeutic Response|5|||
48797944|NCT02291679|157097124|FG001|Overall Study|Insufficient Therapeutic Response|5|||
48797945|NCT02291679|157097125|FG002|Overall Study|Insufficient Therapeutic Response|7|||
48797946|NCT02291679|157097123|FG000|Overall Study|Other|2|||
48797947|NCT02291679|157097124|FG001|Overall Study|Other|4|||
48797948|NCT02291679|157097125|FG002|Overall Study|Other|2|||
48797949|NCT02048072|157097126|FG000|Overall Study|Adverse Event|3|||
48797950|NCT02048072|157097126|FG000|Overall Study|Lost to Follow-up|1|||
48797951|NCT02276222|157097127|FG000|Overall Study|Adverse Event|62|||
48797952|NCT02276222|157097128|FG001|Overall Study|Adverse Event|11|||
48797953|NCT02276222|157097127|FG000|Overall Study|Death|3|||
48797954|NCT02276222|157097128|FG001|Overall Study|Death|4|||
48797955|NCT02276222|157097127|FG000|Overall Study|Lack of Efficacy|13|||
48797956|NCT02276222|157097128|FG001|Overall Study|Lack of Efficacy|3|||
48797957|NCT02276222|157097127|FG000|Overall Study|Protocol Violation|3|||
48797958|NCT02276222|157097128|FG001|Overall Study|Protocol Violation|2|||
48797959|NCT02276222|157097127|FG000|Overall Study|Withdrawal by Subject|79|||
48797960|NCT02276222|157097128|FG001|Overall Study|Withdrawal by Subject|33|||
48797961|NCT02276222|157097127|FG000|Overall Study|non compliance with study medication|6|||
48797962|NCT02276222|157097128|FG001|Overall Study|non compliance with study medication|2|||
48797963|NCT02276222|157097127|FG000|Overall Study|sponsor decision|0|||
48797964|NCT02276222|157097128|FG001|Overall Study|sponsor decision|3|||
48797965|NCT02276222|157097127|FG000|Overall Study|Lost to Follow-up|15|||
48797966|NCT02276222|157097128|FG001|Overall Study|Lost to Follow-up|5|||
48797967|NCT02276222|157097127|FG000|Overall Study|Physician Decision|2|||
48797968|NCT02276222|157097128|FG001|Overall Study|Physician Decision|1|||
48797969|NCT02276222|157097127|FG000|Overall Study|sheduling conflict|1|||
48797970|NCT02276222|157097128|FG001|Overall Study|sheduling conflict|0|||
48797971|NCT02276222|157097127|FG000|Overall Study|subject withdrew after randomization|1|||
48797972|NCT02276222|157097128|FG001|Overall Study|subject withdrew after randomization|0|||
48624963|NCT00215657|156483542|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
48624964|NCT00215657|156483543|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
48624965|NCT00215657|156483536|FG000|Overall Study|Insufficient testosterone response|5|||
48624966|NCT00215657|156483537|FG001|Overall Study|Insufficient testosterone response|4|||
48624967|NCT00215657|156483538|FG002|Overall Study|Insufficient testosterone response|1|||
48624968|NCT00215657|156483539|FG003|Overall Study|Insufficient testosterone response|12|||
48624969|NCT00215657|156483540|FG004|Overall Study|Insufficient testosterone response|8|||
48624970|NCT00215657|156483541|FG005|Overall Study|Insufficient testosterone response|12|||
48624971|NCT00215657|156483542|FG006|Overall Study|Insufficient testosterone response|4|||
48624972|NCT00215657|156483543|FG007|Overall Study|Insufficient testosterone response|7|||
48624973|NCT00215657|156483536|FG000|Overall Study|Other|3|||
48624974|NCT00215657|156483537|FG001|Overall Study|Other|1|||
48624975|NCT00215657|156483538|FG002|Overall Study|Other|2|||
48624976|NCT00215657|156483539|FG003|Overall Study|Other|3|||
48624977|NCT00215657|156483540|FG004|Overall Study|Other|5|||
48624978|NCT00215657|156483541|FG005|Overall Study|Other|4|||
48624979|NCT00215657|156483542|FG006|Overall Study|Other|6|||
48624980|NCT00215657|156483543|FG007|Overall Study|Other|1|||
48624981|NCT01093573|156483544|FG000|Overall Study|Physician Decision|0|||
48624982|NCT01093573|156483545|FG001|Overall Study|Physician Decision|0|||
48624983|NCT01093573|156483546|FG002|Overall Study|Physician Decision|1|||
48624984|NCT01093573|156483544|FG000|Overall Study|Insurance Denied|0|||
48624985|NCT01093573|156483545|FG001|Overall Study|Insurance Denied|0|||
48624986|NCT01093573|156483546|FG002|Overall Study|Insurance Denied|1|||
48624987|NCT01385995|156483547|FG000|Period 1, 2 Months|Physician Decision|1|||
48624988|NCT01385995|156483548|FG001|Period 1, 2 Months|Physician Decision|0|||
48624989|NCT03359395|156483552|FG000|First Intervention A / B|Withdrawal by Subject|1|||
48624990|NCT03359395|156483553|FG001|First Intervention A / B|Withdrawal by Subject|0|||
48624991|NCT03359395|156483552|FG000|First Intervention A / B|Lost to Follow-up|2|||
48624992|NCT03359395|156483553|FG001|First Intervention A / B|Lost to Follow-up|3|||
48624993|NCT03359395|156483552|FG000|Second Intervention B/A|Exclusion criteria|0|||
48624994|NCT03359395|156483553|FG001|Second Intervention B/A|Exclusion criteria|1|||
48624995|NCT03359395|156483552|FG000|Second Intervention B/A|Lost to Follow-up|3|||
48624996|NCT03359395|156483553|FG001|Second Intervention B/A|Lost to Follow-up|2|||
48624997|NCT05788328|156484670|FG000|Treatment Period 4 (5 Days)|Other|1|||
48624998|NCT05788328|156484670|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
48624999|NCT01386645|156484673|FG000|Overall Study|Physician Decision|0|||
48625000|NCT01386645|156484674|FG001|Overall Study|Physician Decision|0|||
48740405|NCT00150709|156898857|FG001|Overall Study|Decision of parent(s)|2|||
48740406|NCT00150709|156898858|FG002|Overall Study|Decision of parent(s)|0|||
48740407|NCT00150709|156898859|FG003|Overall Study|Decision of parent(s)|0|||
48740408|NCT00150709|156898856|FG000|Overall Study|Decision of parent(s) and investigator|3|||
48740409|NCT00150709|156898857|FG001|Overall Study|Decision of parent(s) and investigator|0|||
48740410|NCT00150709|156898858|FG002|Overall Study|Decision of parent(s) and investigator|0|||
48740411|NCT00150709|156898859|FG003|Overall Study|Decision of parent(s) and investigator|0|||
48740412|NCT00150709|156898856|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
48740413|NCT00150709|156898857|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
48740414|NCT00150709|156898858|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
48740415|NCT00150709|156898859|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
48740416|NCT00150709|156898856|FG000|Overall Study|Investigator decision|1|||
48740417|NCT00150709|156898857|FG001|Overall Study|Investigator decision|0|||
48740418|NCT00150709|156898858|FG002|Overall Study|Investigator decision|0|||
48740419|NCT00150709|156898859|FG003|Overall Study|Investigator decision|1|||
48740420|NCT00150709|156898856|FG000|Overall Study|Subject relocated|2|||
48740421|NCT00150709|156898857|FG001|Overall Study|Subject relocated|2|||
48740422|NCT00150709|156898858|FG002|Overall Study|Subject relocated|1|||
48740423|NCT00150709|156898859|FG003|Overall Study|Subject relocated|0|||
48740424|NCT00150709|156898856|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
48740425|NCT00150709|156898857|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
48740426|NCT00150709|156898858|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
48740427|NCT00150709|156898859|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
48740428|NCT00150709|156898856|FG000|Overall Study|Convenience|0|||
48740429|NCT00150709|156898857|FG001|Overall Study|Convenience|1|||
48740430|NCT00150709|156898858|FG002|Overall Study|Convenience|0|||
48625001|NCT01386645|156484675|FG002|Overall Study|Physician Decision|1|||
48625002|NCT01386645|156484673|FG000|Overall Study|Withdrawal by Subject|0|||
48625003|NCT01386645|156484674|FG001|Overall Study|Withdrawal by Subject|1|||
48625004|NCT01386645|156484675|FG002|Overall Study|Withdrawal by Subject|1|||
48625005|NCT00101400|156484676|FG000|Survival Follow-Up|Alive|7|||
48625006|NCT03048019|156484677|FG000|Overall Study|Adverse Event|1|||
48740431|NCT00150709|156898859|FG003|Overall Study|Convenience|0|||
48740432|NCT00150709|156898856|FG000|Overall Study|Subject entered new drug study|0|||
48740433|NCT00150709|156898857|FG001|Overall Study|Subject entered new drug study|1|||
48740434|NCT00150709|156898858|FG002|Overall Study|Subject entered new drug study|0|||
48625007|NCT03048019|156484678|FG001|Overall Study|Adverse Event|0|||
48740435|NCT00150709|156898859|FG003|Overall Study|Subject entered new drug study|0|||
48625008|NCT02365064|156484681|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
48625009|NCT02365064|156484682|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
48625010|NCT02365064|156484681|FG000|Overall Study|Withdrawal by Subject|6|||
48625011|NCT02365064|156484682|FG001|Overall Study|Withdrawal by Subject|9|||
48625012|NCT02365064|156484681|FG000|Overall Study|Treatment intolerance|2|||
48625013|NCT02365064|156484682|FG001|Overall Study|Treatment intolerance|4|||
48625014|NCT02451007|156484683|FG000|Overall Study|Withdrawal by Subject|4|||
48625015|NCT02451007|156484683|FG000|Overall Study|Adverse Event|1|||
48625016|NCT02451007|156484683|FG000|Overall Study|Disease Progression|2|||
48625017|NCT00449787|156484684|FG000|Overall Study|Lost to Follow-up|10|||
48625018|NCT00449787|156484685|FG001|Overall Study|Lost to Follow-up|8|||
48625019|NCT00449787|156484684|FG000|Overall Study|Did not require medication|95|||
48625020|NCT00449787|156484685|FG001|Overall Study|Did not require medication|92|||
48625021|NCT00348374|156484686|FG000|Overall Study|Adverse Event|1|||
48625022|NCT00348374|156484687|FG001|Overall Study|Adverse Event|4|||
48625023|NCT00348374|156484686|FG000|Overall Study|Lost to Follow-up|1|||
48740436|NCT00150709|156898856|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
48740437|NCT00150709|156898857|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
48740438|NCT00150709|156898858|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
48740439|NCT00150709|156898859|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
48740440|NCT00150709|156898856|FG000|Overall Study|Lack of ease of swallowing|0|||
48740441|NCT00150709|156898857|FG001|Overall Study|Lack of ease of swallowing|1|||
48740442|NCT00150709|156898858|FG002|Overall Study|Lack of ease of swallowing|0|||
48740443|NCT00150709|156898859|FG003|Overall Study|Lack of ease of swallowing|0|||
48740444|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
48740445|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
48740446|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
48740447|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
48740448|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
48740449|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
48740450|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
48740451|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
48625024|NCT00348374|156484687|FG001|Overall Study|Lost to Follow-up|3|||
48625025|NCT00348374|156484686|FG000|Overall Study|Withdrawal by Subject|5|||
48625026|NCT00348374|156484687|FG001|Overall Study|Withdrawal by Subject|5|||
48625027|NCT00348374|156484686|FG000|Overall Study|Other|11|||
48625028|NCT00348374|156484687|FG001|Overall Study|Other|12|||
48625029|NCT00348374|156484686|FG000|Overall Study|ongoing at date of cutoff|1|||
48625030|NCT00348374|156484687|FG001|Overall Study|ongoing at date of cutoff|1|||
48625031|NCT00348374|156484686|FG000|Overall Study|randomized but did not receive treatment|0|||
48625032|NCT00348374|156484687|FG001|Overall Study|randomized but did not receive treatment|7|||
48625033|NCT00128492|156484691|FG000|Overall Study|AE unrelated to study|2|||
48625034|NCT00128492|156484692|FG001|Overall Study|AE unrelated to study|9|||
48625035|NCT00128492|156484691|FG000|Overall Study|Study drug intolerance (AE)|2|||
48625036|NCT00128492|156484692|FG001|Overall Study|Study drug intolerance (AE)|8|||
48740452|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
48740453|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
48740454|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
48740455|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
48740456|NCT02349061|156898860|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
48323439|NCT00709098|155382042|FG001|Open-label Period|Withdrawal of consent|0|||
48323440|NCT00709098|155382043|FG002|Open-label Period|Withdrawal of consent|7|||
48323441|NCT00709098|155382041|FG000|Open-label Period|Administrative reason|0|||
48323442|NCT00709098|155382042|FG001|Open-label Period|Administrative reason|0|||
48323443|NCT00709098|155382043|FG002|Open-label Period|Administrative reason|5|||
48323444|NCT00709098|155382041|FG000|Open-label Period|Death|0|||
48323445|NCT00709098|155382042|FG001|Open-label Period|Death|0|||
48323446|NCT00709098|155382043|FG002|Open-label Period|Death|1|||
48323447|NCT00709098|155382041|FG000|Open-label Period|Lost to Follow-up|0|||
48323448|NCT00709098|155382042|FG001|Open-label Period|Lost to Follow-up|0|||
48323449|NCT00709098|155382043|FG002|Open-label Period|Lost to Follow-up|1|||
48323450|NCT02119650|155382044|FG000|Overall Study|Adverse Event|3|||
48323451|NCT02119650|155382045|FG001|Overall Study|Adverse Event|4|||
48323452|NCT02119650|155382044|FG000|Overall Study|Subject decision|2|||
48625037|NCT00128492|156484691|FG000|Overall Study|AE related to study|1|||
48625038|NCT00128492|156484692|FG001|Overall Study|AE related to study|4|||
48625039|NCT00128492|156484691|FG000|Overall Study|Death|1|||
48625040|NCT00128492|156484692|FG001|Overall Study|Death|0|||
48625041|NCT00128492|156484691|FG000|Overall Study|Lost to Follow-up|1|||
48625042|NCT00128492|156484692|FG001|Overall Study|Lost to Follow-up|5|||
48625043|NCT00128492|156484691|FG000|Overall Study|Noncompliance|0|||
48625044|NCT00128492|156484692|FG001|Overall Study|Noncompliance|5|||
48323453|NCT02119650|155382045|FG001|Overall Study|Subject decision|3|||
48323454|NCT02119650|155382044|FG000|Overall Study|Disease progression|11|||
48625045|NCT00128492|156484691|FG000|Overall Study|Personal or administrative|10|||
48625046|NCT00128492|156484692|FG001|Overall Study|Personal or administrative|22|||
48625047|NCT00128492|156484691|FG000|Overall Study|Withdrawal by Subject|3|||
48625048|NCT00128492|156484692|FG001|Overall Study|Withdrawal by Subject|5|||
48625049|NCT00128492|156484691|FG000|Overall Study|Pregnancy|0|||
48625050|NCT00128492|156484692|FG001|Overall Study|Pregnancy|1|||
48625051|NCT02605967|156484693|FG000|Overall Study|subject / guardian decision|1|||
48625052|NCT02605967|156484694|FG001|Overall Study|subject / guardian decision|2|||
48625053|NCT02605967|156484693|FG000|Overall Study|Physician Decision|10|||
48740457|NCT02349061|156898861|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
48740458|NCT02349061|156898862|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
48740459|NCT02349061|156898860|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
48740460|NCT02349061|156898861|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
48740461|NCT02349061|156898862|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
48740462|NCT02349061|156898860|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
48740463|NCT02349061|156898861|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
48740464|NCT02349061|156898862|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
48740465|NCT02349061|156898860|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
48740466|NCT02349061|156898861|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
48740467|NCT02349061|156898862|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
48740468|NCT02349061|156898860|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
48740469|NCT02349061|156898861|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
48740470|NCT02349061|156898862|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
48740471|NCT02349061|156898860|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
48740472|NCT02349061|156898861|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
48740473|NCT02349061|156898862|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
48740474|NCT02349061|156898860|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
48740475|NCT02349061|156898861|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
48740476|NCT02349061|156898862|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
48740477|NCT02349061|156898860|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
48740478|NCT02349061|156898861|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
48740479|NCT02349061|156898862|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
48740480|NCT02349061|156898860|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
48740481|NCT02349061|156898861|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
48740482|NCT02349061|156898862|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
48323455|NCT02119650|155382045|FG001|Overall Study|Disease progression|14|||
48323456|NCT02119650|155382044|FG000|Overall Study|Death|5|||
48625054|NCT02605967|156484694|FG001|Overall Study|Physician Decision|1|||
48323457|NCT02119650|155382045|FG001|Overall Study|Death|1|||
48625055|NCT02605967|156484693|FG000|Overall Study|Death|4|||
48323458|NCT02119650|155382044|FG000|Overall Study|Noncompliance with study treatment|1|||
48323459|NCT02119650|155382045|FG001|Overall Study|Noncompliance with study treatment|1|||
48323460|NCT02119650|155382044|FG000|Overall Study|Study terminated by the sponsor|1|||
48323461|NCT02119650|155382045|FG001|Overall Study|Study terminated by the sponsor|0|||
48323462|NCT02119650|155382044|FG000|Overall Study|Physician Decision|0|||
48323463|NCT02119650|155382045|FG001|Overall Study|Physician Decision|2|||
48625056|NCT02605967|156484694|FG001|Overall Study|Death|2|||
48625057|NCT02605967|156484693|FG000|Overall Study|Adverse Event|1|||
48625058|NCT02605967|156484694|FG001|Overall Study|Adverse Event|0|||
48625059|NCT02605967|156484693|FG000|Overall Study|progressive disease|66|||
48625060|NCT02605967|156484694|FG001|Overall Study|progressive disease|35|||
48625061|NCT00079781|156484697|FG000|Pre-implant Period|Withdrawal by Subject|2|||
48625062|NCT00079781|156484698|FG001|Pre-implant Period|Withdrawal by Subject|0|||
48625063|NCT00079781|156484699|FG002|Pre-implant Period|Withdrawal by Subject|0|||
48625064|NCT00079781|156484697|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
48625065|NCT00079781|156484698|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
48625066|NCT00079781|156484699|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
48625067|NCT00079781|156484697|FG000|Follow-up Period|Withdrawal by Subject|3|||
48740483|NCT00316719|156898863|FG000|Overall Study|Adverse Event|0|||
48740484|NCT00316719|156898864|FG001|Overall Study|Adverse Event|6|||
48740485|NCT00316719|156898863|FG000|Overall Study|Consent withdrawn|2|||
48740486|NCT00316719|156898864|FG001|Overall Study|Consent withdrawn|0|||
48740487|NCT05215847|156898868|FG000|Overall Study|Lost to Follow-up|1|||
48740488|NCT01560403|156898869|FG000|Overall Study|Lost to Follow-up|0|||
48740489|NCT01560403|156898870|FG001|Overall Study|Lost to Follow-up|1|||
48740490|NCT05228470|156898877|FG000|Overall Study|Death|6|||
48740491|NCT05228470|156898878|FG001|Overall Study|Death|11|||
48740492|NCT05228470|156898877|FG000|Overall Study|Withdrawal by Subject|1|||
48740493|NCT05228470|156898878|FG001|Overall Study|Withdrawal by Subject|8|||
48740494|NCT05228470|156898877|FG000|Overall Study|Ongoing|1|||
48740495|NCT05228470|156898878|FG001|Overall Study|Ongoing|11|||
48740496|NCT02300298|156898879|FG000|Disposition for Nintedanib|Progressive disease|10|||
48740497|NCT02300298|156898880|FG001|Disposition for Nintedanib|Progressive disease|0|||
48740498|NCT02300298|156898879|FG000|Disposition for Docetaxel|Progressive disease|0|||
48740499|NCT02300298|156898880|FG001|Disposition for Docetaxel|Progressive disease|6|||
48740500|NCT02300298|156898879|FG000|Disposition for Docetaxel|other adverse event|0|||
48740501|NCT02300298|156898880|FG001|Disposition for Docetaxel|other adverse event|4|||
48740502|NCT03016169|156898881|FG000|Overall Study|Lost to Follow-up|4|||
48740503|NCT03016169|156898881|FG000|Overall Study|Death|54|||
48740504|NCT03016169|156898881|FG000|Overall Study|Device Explant|11|||
48740505|NCT03016169|156898881|FG000|Overall Study|Withdrawal by Subject|19|||
48740506|NCT03016169|156898881|FG000|Overall Study|Other Reasons|1|||
48740507|NCT04390048|156898882|FG000|Overall Study|Withdrawal by Subject|1|||
48740508|NCT04390048|156898883|FG001|Overall Study|Withdrawal by Subject|3|||
48740509|NCT04812535|156898886|FG000|Overall Study|Withdrawal by Subject|0|||
48740510|NCT04812535|156898887|FG001|Overall Study|Withdrawal by Subject|0|||
48740511|NCT04812535|156898888|FG002|Overall Study|Withdrawal by Subject|0|||
48740512|NCT04812535|156898889|FG003|Overall Study|Withdrawal by Subject|1|||
48740513|NCT04812535|156898886|FG000|Overall Study|Death|7|||
48740514|NCT04812535|156898887|FG001|Overall Study|Death|2|||
48740515|NCT04812535|156898888|FG002|Overall Study|Death|4|||
48740516|NCT04812535|156898889|FG003|Overall Study|Death|1|||
48740517|NCT04812535|156898886|FG000|Overall Study|Due to premature study termination by sponsor|2|||
48740518|NCT04812535|156898887|FG001|Overall Study|Due to premature study termination by sponsor|0|||
48740519|NCT04812535|156898888|FG002|Overall Study|Due to premature study termination by sponsor|1|||
48740520|NCT04812535|156898889|FG003|Overall Study|Due to premature study termination by sponsor|3|||
48740521|NCT01084876|156898891|FG000|Main Study Treatment Period|Adverse Event|12|||
48323464|NCT02119650|155382044|FG000|Overall Study|Multiple reasons for termination|2|||
48323465|NCT02119650|155382045|FG001|Overall Study|Multiple reasons for termination|1|||
48323466|NCT04337931|155382047|FG000|Overall Study|Death|4|||
48625068|NCT00079781|156484698|FG001|Follow-up Period|Withdrawal by Subject|0|||
48625069|NCT00079781|156484699|FG002|Follow-up Period|Withdrawal by Subject|1|||
48740522|NCT01084876|156898892|FG001|Main Study Treatment Period|Adverse Event|7|||
48740523|NCT01084876|156898891|FG000|Main Study Treatment Period|Disease Progression|41|||
48740524|NCT01084876|156898892|FG001|Main Study Treatment Period|Disease Progression|24|||
48797973|NCT01949311|157098516|FG000|Overall Study|Lost to Follow-up|73|||
48797974|NCT01949311|157098516|FG000|Overall Study|Terminated by Sponsor|708|||
48797975|NCT01949311|157098516|FG000|Overall Study|Withdrawal by Subject|375|||
48797976|NCT01949311|157098516|FG000|Overall Study|Lack of Efficacy|50|||
48797977|NCT01949311|157098516|FG000|Overall Study|Protocol Deviation|34|||
48797978|NCT01949311|157098516|FG000|Overall Study|Pregnancy|20|||
48797979|NCT01949311|157098516|FG000|Overall Study|Physician Decision|9|||
48797980|NCT01949311|157098516|FG000|Overall Study|Other|4|||
48797981|NCT01949311|157098516|FG000|Overall Study|Adverse Event|107|||
48797982|NCT00677833|157098520|FG000|Overall Study|Withdrawal by Subject|4|||
48797983|NCT00677833|157098521|FG001|Overall Study|Withdrawal by Subject|0|||
48625070|NCT00079781|156484697|FG000|Follow-up Period|Lost to Follow-up|1|||
48625071|NCT00079781|156484698|FG001|Follow-up Period|Lost to Follow-up|0|||
48625072|NCT00079781|156484699|FG002|Follow-up Period|Lost to Follow-up|0|||
48625073|NCT00079781|156484697|FG000|Follow-up Period|Death|0|||
48625074|NCT00079781|156484698|FG001|Follow-up Period|Death|0|||
48625075|NCT00079781|156484699|FG002|Follow-up Period|Death|1|||
48625076|NCT01217047|156484700|FG000|Overall Study|Lost to Follow-up|0|||
48625077|NCT01217047|156484701|FG001|Overall Study|Lost to Follow-up|1|||
48625078|NCT01217047|156484702|FG002|Overall Study|Lost to Follow-up|0|||
48625079|NCT03268499|156484703|FG000|Overall Study|Withdrawal by Subject|2|||
48625080|NCT03268499|156484704|FG001|Overall Study|Withdrawal by Subject|1|||
48625081|NCT02662582|156484707|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
48625082|NCT02662582|156484708|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
48625083|NCT02662582|156484707|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
48625084|NCT02662582|156484708|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
48625085|NCT02662582|156484707|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
48625086|NCT02662582|156484708|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
48625087|NCT02662582|156484707|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48625088|NCT02662582|156484708|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48625089|NCT04576481|156484709|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
48625090|NCT04576481|156484710|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
48740525|NCT01084876|156898891|FG000|Main Study Treatment Period|Physician Decision|2|||
48323467|NCT04337931|155382048|FG001|Overall Study|Death|1|||
48323468|NCT04337931|155382049|FG002|Overall Study|Death|7|||
48323469|NCT04337931|155382047|FG000|Overall Study|Withdrawal by Subject|0|||
48323470|NCT04337931|155382048|FG001|Overall Study|Withdrawal by Subject|1|||
48323471|NCT04337931|155382049|FG002|Overall Study|Withdrawal by Subject|0|||
48323472|NCT04337931|155382047|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
48323473|NCT04337931|155382048|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
48323474|NCT04337931|155382049|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
48323475|NCT04337931|155382047|FG000|Overall Study|Study terminated by sponsor|3|||
48323476|NCT04337931|155382048|FG001|Overall Study|Study terminated by sponsor|6|||
48323477|NCT04337931|155382049|FG002|Overall Study|Study terminated by sponsor|2|||
48323478|NCT04337931|155382047|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
48323479|NCT04337931|155382048|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
48323480|NCT04337931|155382049|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
48323481|NCT04337931|155382047|FG000|Overall Study|Colorectal cancer treatment|1|||
48323482|NCT04337931|155382048|FG001|Overall Study|Colorectal cancer treatment|0|||
48323483|NCT04337931|155382049|FG002|Overall Study|Colorectal cancer treatment|0|||
48323484|NCT04337931|155382047|FG000|Overall Study|Participant decision|0|||
48323485|NCT04337931|155382048|FG001|Overall Study|Participant decision|1|||
48323486|NCT04337931|155382049|FG002|Overall Study|Participant decision|0|||
48323487|NCT01738438|155382050|FG000|Overall Study|Disease Progression|32|||
48323488|NCT01738438|155382050|FG000|Overall Study|Adverse Event|3|||
48323489|NCT02910713|155382051|FG000|Overall Study|Protocol Violation|2|||
48323490|NCT02910713|155382051|FG000|Overall Study|Subject Choice|4|||
48323491|NCT02910713|155382051|FG000|Overall Study|Received One Application|10|||
48323492|NCT02910713|155382051|FG000|Overall Study|Received Neither Application|18|||
48323493|NCT02910713|155382051|FG000|Overall Study|Enrollment cap|7|||
48625091|NCT04576481|156484711|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
48625092|NCT04576481|156484712|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
48740526|NCT01084876|156898892|FG001|Main Study Treatment Period|Physician Decision|0|||
48740527|NCT01084876|156898891|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
48740528|NCT01084876|156898892|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
48740529|NCT01084876|156898891|FG000|Main Study Treatment Period|Other Reason|0|||
48740530|NCT01084876|156898892|FG001|Main Study Treatment Period|Other Reason|1|||
48740531|NCT01084876|156898891|FG000|Main Study Treatment Period|Other|0|||
48740532|NCT01084876|156898892|FG001|Main Study Treatment Period|Other|1|||
48740533|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
48740534|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
48740535|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
48740536|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
48740537|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
48740538|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
48740539|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
48740540|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
48740541|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
48740542|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
48740543|NCT01084876|156898891|FG000|Treatment Period Beyond Cycle 8|Other|6|||
48740544|NCT01084876|156898892|FG001|Treatment Period Beyond Cycle 8|Other|9|||
48740545|NCT02075840|156898893|FG000|Overall Study|Withdrawal by Subject|13|||
48740546|NCT02075840|156898894|FG001|Overall Study|Withdrawal by Subject|22|||
48323494|NCT02910713|155382051|FG000|Overall Study|Investigator Discretion|1|||
48323495|NCT01701401|155382054|FG000|Overall Study|Randomized But Not Treated|3|||
48323496|NCT01701401|155382055|FG001|Overall Study|Randomized But Not Treated|1|||
48323497|NCT01701401|155382056|FG002|Overall Study|Randomized But Not Treated|0|||
48740547|NCT02075840|156898893|FG000|Overall Study|Reason not specified|1|||
48323498|NCT01701401|155382057|FG003|Overall Study|Randomized But Not Treated|1|||
48323499|NCT01701401|155382054|FG000|Overall Study|Lost to Follow-up|5|||
48323500|NCT01701401|155382055|FG001|Overall Study|Lost to Follow-up|5|||
48323501|NCT01701401|155382056|FG002|Overall Study|Lost to Follow-up|1|||
48740548|NCT02075840|156898894|FG001|Overall Study|Reason not specified|0|||
48740549|NCT02075840|156898893|FG000|Overall Study|Adverse Event|0|||
48740550|NCT02075840|156898894|FG001|Overall Study|Adverse Event|2|||
48740551|NCT02075840|156898893|FG000|Overall Study|Death|35|||
48740552|NCT02075840|156898894|FG001|Overall Study|Death|40|||
48740553|NCT02075840|156898893|FG000|Overall Study|Lost to Follow-up|3|||
48740554|NCT02075840|156898894|FG001|Overall Study|Lost to Follow-up|2|||
48740555|NCT02075840|156898893|FG000|Overall Study|Physician Decision|1|||
48740556|NCT02075840|156898894|FG001|Overall Study|Physician Decision|3|||
48740557|NCT02075840|156898893|FG000|Overall Study|Ongoing at CCOD|99|||
48740558|NCT02075840|156898894|FG001|Overall Study|Ongoing at CCOD|82|||
48323502|NCT01701401|155382057|FG003|Overall Study|Lost to Follow-up|3|||
48323503|NCT01701401|155382054|FG000|Overall Study|Withdrew Consent|0|||
48323504|NCT01701401|155382055|FG001|Overall Study|Withdrew Consent|3|||
48323505|NCT01701401|155382056|FG002|Overall Study|Withdrew Consent|1|||
48323506|NCT01701401|155382057|FG003|Overall Study|Withdrew Consent|2|||
48323507|NCT01701401|155382054|FG000|Overall Study|Lack of Efficacy|1|||
48323508|NCT01701401|155382055|FG001|Overall Study|Lack of Efficacy|0|||
48323509|NCT01701401|155382056|FG002|Overall Study|Lack of Efficacy|2|||
48323510|NCT01701401|155382057|FG003|Overall Study|Lack of Efficacy|0|||
48323511|NCT01701401|155382054|FG000|Overall Study|Adverse Event|1|||
48625093|NCT05463952|156484716|FG000|Treatment|Progressive disease|4|||
48625094|NCT05463952|156484716|FG000|Treatment|Ongoing|2|||
48625095|NCT04135352|156484717|FG000|Overall Study|Not treated-randomization error|0|||
48625096|NCT04135352|156484718|FG001|Overall Study|Not treated-randomization error|0|||
48625097|NCT04135352|156484719|FG002|Overall Study|Not treated-randomization error|1|||
48740559|NCT05028634|156898895|FG000|Overall Study|Withdrawal by Subject|0|||
48740560|NCT05028634|156898896|FG001|Overall Study|Withdrawal by Subject|1|||
48740561|NCT02908477|156898897|FG000|Overall Study|Withdrawal by Subject|8|||
48323512|NCT01701401|155382055|FG001|Overall Study|Adverse Event|0|||
48323513|NCT01701401|155382056|FG002|Overall Study|Adverse Event|0|||
48323514|NCT01701401|155382057|FG003|Overall Study|Adverse Event|0|||
48323515|NCT01701401|155382054|FG000|Overall Study|Protocol Violation|0|||
48323516|NCT01701401|155382055|FG001|Overall Study|Protocol Violation|0|||
48323517|NCT01701401|155382056|FG002|Overall Study|Protocol Violation|1|||
48323518|NCT01701401|155382057|FG003|Overall Study|Protocol Violation|0|||
48323519|NCT00309166|155382060|FG000|Overall Study|Adverse event, non-fatal|1|||
48323520|NCT00309166|155382061|FG001|Overall Study|Adverse event, non-fatal|0|||
48323521|NCT00309166|155382060|FG000|Overall Study|Withdrawal by Subject|4|||
48323522|NCT00309166|155382061|FG001|Overall Study|Withdrawal by Subject|3|||
48625098|NCT04135352|156484720|FG003|Overall Study|Not treated-randomization error|0|||
48625099|NCT04135352|156484721|FG004|Overall Study|Not treated-randomization error|0|||
48625100|NCT04135352|156484722|FG005|Overall Study|Not treated-randomization error|0|||
48625101|NCT04135352|156484723|FG006|Overall Study|Not treated-randomization error|0|||
48740562|NCT02908477|156898898|FG001|Overall Study|Withdrawal by Subject|28|||
48740563|NCT01999114|156898907|FG000|Overall Study|Adverse Event|8|||
48740564|NCT01999114|156898908|FG001|Overall Study|Adverse Event|7|||
48740565|NCT01999114|156898909|FG002|Overall Study|Adverse Event|2|||
48740566|NCT01999114|156898910|FG003|Overall Study|Adverse Event|2|||
48625102|NCT04135352|156484724|FG007|Overall Study|Not treated-randomization error|0|||
48625103|NCT04135352|156484717|FG000|Overall Study|Withdrawal by Subject|0|||
48625104|NCT04135352|156484718|FG001|Overall Study|Withdrawal by Subject|0|||
48625105|NCT04135352|156484719|FG002|Overall Study|Withdrawal by Subject|2|||
48625106|NCT04135352|156484720|FG003|Overall Study|Withdrawal by Subject|0|||
48625107|NCT04135352|156484721|FG004|Overall Study|Withdrawal by Subject|0|||
48740567|NCT01999114|156898911|FG004|Overall Study|Adverse Event|1|||
48740568|NCT01999114|156898907|FG000|Overall Study|Withdrawal by Subject|0|||
48740569|NCT01999114|156898908|FG001|Overall Study|Withdrawal by Subject|0|||
48625108|NCT04135352|156484722|FG005|Overall Study|Withdrawal by Subject|0|||
48625109|NCT04135352|156484723|FG006|Overall Study|Withdrawal by Subject|0|||
48625110|NCT04135352|156484724|FG007|Overall Study|Withdrawal by Subject|0|||
48625111|NCT04135352|156484717|FG000|Overall Study|Sponsor Decision|0|||
48625112|NCT04135352|156484718|FG001|Overall Study|Sponsor Decision|0|||
48625113|NCT04135352|156484719|FG002|Overall Study|Sponsor Decision|2|||
48625114|NCT04135352|156484720|FG003|Overall Study|Sponsor Decision|5|||
48625115|NCT04135352|156484721|FG004|Overall Study|Sponsor Decision|1|||
48625116|NCT04135352|156484722|FG005|Overall Study|Sponsor Decision|4|||
48625117|NCT04135352|156484723|FG006|Overall Study|Sponsor Decision|0|||
48625118|NCT04135352|156484724|FG007|Overall Study|Sponsor Decision|0|||
48625119|NCT04135352|156484717|FG000|Overall Study|Physician Decision|0|||
48625120|NCT04135352|156484718|FG001|Overall Study|Physician Decision|0|||
48625121|NCT04135352|156484719|FG002|Overall Study|Physician Decision|1|||
48625122|NCT04135352|156484720|FG003|Overall Study|Physician Decision|0|||
48625123|NCT04135352|156484721|FG004|Overall Study|Physician Decision|1|||
48625124|NCT04135352|156484722|FG005|Overall Study|Physician Decision|0|||
48625125|NCT04135352|156484723|FG006|Overall Study|Physician Decision|0|||
48625126|NCT04135352|156484724|FG007|Overall Study|Physician Decision|0|||
48625127|NCT04135352|156484717|FG000|Overall Study|Death|3|||
48625128|NCT04135352|156484718|FG001|Overall Study|Death|4|||
48625129|NCT04135352|156484719|FG002|Overall Study|Death|7|||
48625130|NCT04135352|156484720|FG003|Overall Study|Death|0|||
48625131|NCT04135352|156484721|FG004|Overall Study|Death|3|||
48625132|NCT04135352|156484722|FG005|Overall Study|Death|1|||
48625133|NCT04135352|156484723|FG006|Overall Study|Death|0|||
48625134|NCT04135352|156484724|FG007|Overall Study|Death|0|||
48625135|NCT01682720|156484726|FG000|Overall Study|Randomized but Not Treated|0|||
48625136|NCT01682720|156484727|FG001|Overall Study|Randomized but Not Treated|1|||
48625137|NCT01682720|156484728|FG002|Overall Study|Randomized but Not Treated|1|||
48625138|NCT01682720|156484729|FG003|Overall Study|Randomized but Not Treated|0|||
48625139|NCT01682720|156484726|FG000|Overall Study|Terminated by Sponsor|83|||
48625140|NCT01682720|156484727|FG001|Overall Study|Terminated by Sponsor|0|||
48625141|NCT01682720|156484728|FG002|Overall Study|Terminated by Sponsor|0|||
48625142|NCT01682720|156484729|FG003|Overall Study|Terminated by Sponsor|0|||
48625143|NCT01682720|156484726|FG000|Overall Study|Efficacy Failure|0|||
48625144|NCT01682720|156484727|FG001|Overall Study|Efficacy Failure|3|||
48625145|NCT01682720|156484728|FG002|Overall Study|Efficacy Failure|3|||
48625146|NCT01682720|156484729|FG003|Overall Study|Efficacy Failure|30|||
48625147|NCT01682720|156484726|FG000|Overall Study|Lost to Follow-up|1|||
48740570|NCT01999114|156898909|FG002|Overall Study|Withdrawal by Subject|1|||
48740571|NCT01999114|156898910|FG003|Overall Study|Withdrawal by Subject|0|||
48625148|NCT01682720|156484727|FG001|Overall Study|Lost to Follow-up|1|||
48625149|NCT01682720|156484728|FG002|Overall Study|Lost to Follow-up|0|||
48740572|NCT01999114|156898911|FG004|Overall Study|Withdrawal by Subject|1|||
48625150|NCT01682720|156484729|FG003|Overall Study|Lost to Follow-up|6|||
48625151|NCT01682720|156484726|FG000|Overall Study|Subject Withdrew Consent|0|||
48625152|NCT01682720|156484727|FG001|Overall Study|Subject Withdrew Consent|0|||
48625153|NCT01682720|156484728|FG002|Overall Study|Subject Withdrew Consent|2|||
48625154|NCT01682720|156484729|FG003|Overall Study|Subject Withdrew Consent|2|||
48625155|NCT01682720|156484726|FG000|Overall Study|Adverse Event|1|||
48625156|NCT01682720|156484727|FG001|Overall Study|Adverse Event|0|||
48625157|NCT01682720|156484728|FG002|Overall Study|Adverse Event|1|||
48625158|NCT01682720|156484729|FG003|Overall Study|Adverse Event|1|||
48625159|NCT00069953|156484733|FG000|Overall Study|Protocol Violation|2|||
48625160|NCT01299961|156484738|FG000|Overall Study|Adverse Event|3|||
48625161|NCT01299961|156484738|FG000|Overall Study|Lack of Efficacy|2|||
48625162|NCT01299961|156484738|FG000|Overall Study|Lost to Follow-up|1|||
48625163|NCT04223687|156484741|FG000|Overall Study|Missing primary outcome|1|||
48625164|NCT04223687|156484742|FG001|Overall Study|Missing primary outcome|0|||
48625165|NCT01272219|156484756|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
48625166|NCT01272219|156484757|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
48625167|NCT01272219|156484758|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
48625168|NCT01272219|156484759|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
48625169|NCT01272219|156484760|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
48625170|NCT01272219|156484761|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
48625171|NCT01272219|156484756|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
48625172|NCT01272219|156484757|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
48625173|NCT01272219|156484758|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
48625174|NCT01272219|156484759|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
48625175|NCT01272219|156484760|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
48625176|NCT01272219|156484761|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
48625177|NCT01272219|156484756|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
48625178|NCT01272219|156484757|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
48625179|NCT01272219|156484758|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
48625180|NCT01272219|156484759|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
48625181|NCT01272219|156484760|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
48625182|NCT01272219|156484761|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
48625183|NCT01272219|156484756|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
48625184|NCT01272219|156484757|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
48625185|NCT01272219|156484758|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
48625186|NCT01272219|156484759|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
48625187|NCT01272219|156484760|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
48625188|NCT01272219|156484761|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
48625189|NCT01272219|156484756|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
48740573|NCT01999114|156898907|FG000|Overall Study|Lost to Follow-up|0|||
48740574|NCT01999114|156898908|FG001|Overall Study|Lost to Follow-up|0|||
48740575|NCT01999114|156898909|FG002|Overall Study|Lost to Follow-up|1|||
48740576|NCT01999114|156898910|FG003|Overall Study|Lost to Follow-up|0|||
48740577|NCT01999114|156898911|FG004|Overall Study|Lost to Follow-up|0|||
48740578|NCT01999114|156898907|FG000|Overall Study|Administrative|0|||
48740579|NCT01999114|156898908|FG001|Overall Study|Administrative|0|||
48740580|NCT01999114|156898909|FG002|Overall Study|Administrative|1|||
48740581|NCT01999114|156898910|FG003|Overall Study|Administrative|1|||
48740582|NCT01999114|156898911|FG004|Overall Study|Administrative|2|||
48740583|NCT05047770|156898915|FG000|Overall Study|Withdrawal by Subject|15|||
48740584|NCT05047770|156898916|FG001|Overall Study|Withdrawal by Subject|10|||
48740585|NCT05047770|156898917|FG002|Overall Study|Withdrawal by Subject|6|||
48740586|NCT05047770|156898918|FG003|Overall Study|Withdrawal by Subject|12|||
48625190|NCT01272219|156484757|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
48625191|NCT01272219|156484758|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
48625192|NCT01272219|156484759|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
48625193|NCT01272219|156484760|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
48740587|NCT05047770|156898915|FG000|Overall Study|Lost to Follow-up|7|||
48740588|NCT05047770|156898916|FG001|Overall Study|Lost to Follow-up|5|||
48740589|NCT05047770|156898917|FG002|Overall Study|Lost to Follow-up|12|||
48740590|NCT05047770|156898918|FG003|Overall Study|Lost to Follow-up|13|||
48740591|NCT05047770|156898915|FG000|Overall Study|Other|1|||
48740592|NCT05047770|156898916|FG001|Overall Study|Other|0|||
48740593|NCT05047770|156898917|FG002|Overall Study|Other|1|||
48625194|NCT01272219|156484761|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
48740594|NCT05047770|156898918|FG003|Overall Study|Other|0|||
48625195|NCT01272219|156484756|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
48740595|NCT04489771|156898919|FG000|Overall Study|Death|27|||
48740596|NCT04489771|156898920|FG001|Overall Study|Death|25|||
48740597|NCT04489771|156898919|FG000|Overall Study|Withdrawal by Subject|1|||
48740598|NCT04489771|156898920|FG001|Overall Study|Withdrawal by Subject|0|||
48740599|NCT04489771|156898919|FG000|Overall Study|Participants Ongoing in Study|50|||
48740600|NCT04489771|156898920|FG001|Overall Study|Participants Ongoing in Study|51|||
48740601|NCT03173313|156898921|FG000|Overall Study|Lost to Follow-up|2|||
48740602|NCT03173313|156898922|FG001|Overall Study|Lost to Follow-up|3|||
48740603|NCT03173313|156898921|FG000|Overall Study|Withdrawal by Subject|0|||
48740604|NCT03173313|156898922|FG001|Overall Study|Withdrawal by Subject|1|||
48740605|NCT03173313|156898921|FG000|Overall Study|Death|5|||
48740606|NCT03173313|156898922|FG001|Overall Study|Death|0|||
48740607|NCT03173313|156898921|FG000|Overall Study|Physician Decision|1|||
48740608|NCT03173313|156898922|FG001|Overall Study|Physician Decision|0|||
48740609|NCT03173313|156898921|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
48740610|NCT03173313|156898922|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
48740611|NCT03173313|156898921|FG000|Overall Study|Bone Fracture|1|||
48625196|NCT01272219|156484757|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
48625197|NCT01272219|156484758|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
48625198|NCT01272219|156484759|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
48625199|NCT01272219|156484760|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
48625200|NCT01272219|156484761|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
48625201|NCT01272219|156484756|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
48740612|NCT03173313|156898922|FG001|Overall Study|Bone Fracture|0|||
48740613|NCT02195479|156898923|FG000|Overall Study|Lost to Follow-up|3|||
48740614|NCT02195479|156898924|FG001|Overall Study|Lost to Follow-up|0|||
48740615|NCT02195479|156898923|FG000|Overall Study|Death|48|||
48740616|NCT02195479|156898924|FG001|Overall Study|Death|45|||
48740617|NCT02195479|156898923|FG000|Overall Study|Physician Decision|1|||
48740618|NCT02195479|156898924|FG001|Overall Study|Physician Decision|0|||
48740619|NCT02195479|156898923|FG000|Overall Study|Withdrawal by Subject|11|||
48740620|NCT02195479|156898924|FG001|Overall Study|Withdrawal by Subject|6|||
48740621|NCT02195479|156898923|FG000|Overall Study|Other|2|||
48740622|NCT02195479|156898924|FG001|Overall Study|Other|2|||
48740623|NCT02195479|156898923|FG000|Overall Study|Ongoing|291|||
48740624|NCT02195479|156898924|FG001|Overall Study|Ongoing|297|||
48740625|NCT04696055|156898928|FG000|Overall Study|Adverse Event|10|||
48740626|NCT04696055|156898929|FG001|Overall Study|Adverse Event|0|||
48740627|NCT04696055|156898928|FG000|Overall Study|Death|2|||
48740628|NCT04696055|156898929|FG001|Overall Study|Death|1|||
48740629|NCT04696055|156898928|FG000|Overall Study|Other|4|||
48740630|NCT04696055|156898929|FG001|Overall Study|Other|0|||
48740631|NCT04696055|156898928|FG000|Overall Study|Physician Decision|1|||
48740632|NCT04696055|156898929|FG001|Overall Study|Physician Decision|0|||
48740633|NCT04696055|156898928|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
48740634|NCT04696055|156898929|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
48740635|NCT04696055|156898928|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
48740636|NCT04696055|156898929|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
48740637|NCT04696055|156898928|FG000|Overall Study|Subject Decision|1|||
48740638|NCT04696055|156898929|FG001|Overall Study|Subject Decision|2|||
48740639|NCT04696055|156898928|FG000|Overall Study|Ongoing with study treatment|13|||
48740640|NCT04696055|156898929|FG001|Overall Study|Ongoing with study treatment|10|||
48625202|NCT01272219|156484757|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
48625203|NCT01272219|156484758|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
48625204|NCT01272219|156484759|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
48625205|NCT01272219|156484760|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
48740641|NCT00389597|156898934|FG000|Overall Study|Lost to Follow-up|8|||
48740642|NCT00389597|156898935|FG001|Overall Study|Lost to Follow-up|6|||
48740643|NCT00389597|156898936|FG002|Overall Study|Lost to Follow-up|4|||
48740644|NCT00389597|156898937|FG003|Overall Study|Lost to Follow-up|6|||
48740645|NCT03685123|156898938|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
48740646|NCT03685123|156898939|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
48740647|NCT03685123|156898940|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
48740648|NCT03685123|156898938|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
48740649|NCT03685123|156898939|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
48740650|NCT03685123|156898940|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
48740651|NCT03685123|156898938|FG000|Weight Loss Phase|Lost to Follow-up|1|||
48740652|NCT03685123|156898939|FG001|Weight Loss Phase|Lost to Follow-up|0|||
48740653|NCT03685123|156898940|FG002|Weight Loss Phase|Lost to Follow-up|0|||
48740654|NCT03685123|156898938|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
48625206|NCT01272219|156484761|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
48625207|NCT01272219|156484756|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
48625208|NCT01272219|156484757|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
48625209|NCT01272219|156484758|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
48625210|NCT01272219|156484759|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
48625211|NCT01272219|156484760|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
48625212|NCT01272219|156484761|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
48740655|NCT03685123|156898939|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
48740656|NCT03685123|156898940|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
48740657|NCT03685123|156898938|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
48740658|NCT03685123|156898939|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
48740659|NCT03685123|156898940|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
48740660|NCT03685123|156898938|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
48740661|NCT03685123|156898939|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
48740662|NCT03685123|156898940|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
48740663|NCT00586625|156898941|FG000|Overall Study|Adverse Event|6|||
48740664|NCT00586625|156898942|FG001|Overall Study|Adverse Event|6|||
48740665|NCT00586625|156898941|FG000|Overall Study|Protocol Violation|3|||
48740666|NCT00586625|156898942|FG001|Overall Study|Protocol Violation|0|||
48740667|NCT00586625|156898941|FG000|Overall Study|Withdrawal by Subject|32|||
48740668|NCT00586625|156898942|FG001|Overall Study|Withdrawal by Subject|10|||
48740669|NCT00586625|156898941|FG000|Overall Study|Subject non-compliance|0|||
48740670|NCT00586625|156898942|FG001|Overall Study|Subject non-compliance|1|||
48740671|NCT00586625|156898941|FG000|Overall Study|Subject unable to return for visit|2|||
48740672|NCT00586625|156898942|FG001|Overall Study|Subject unable to return for visit|0|||
48740673|NCT04528732|156898944|FG000|Overall Study|Death|1|||
48740674|NCT04528732|156898945|FG001|Overall Study|Death|0|||
48740675|NCT04528732|156898946|FG002|Overall Study|Death|1|||
48740676|NCT04528732|156898944|FG000|Overall Study|Lost to Follow-up|0|||
48740677|NCT04528732|156898945|FG001|Overall Study|Lost to Follow-up|1|||
48740678|NCT04528732|156898946|FG002|Overall Study|Lost to Follow-up|2|||
48625213|NCT01272219|156484756|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
48625214|NCT01272219|156484757|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
48625215|NCT01272219|156484758|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
48625216|NCT01272219|156484759|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
48625217|NCT01272219|156484760|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
48625218|NCT01272219|156484761|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
48625219|NCT01272219|156484756|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
48625220|NCT01272219|156484757|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
48625221|NCT01272219|156484758|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
48625222|NCT01272219|156484759|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
48625223|NCT01272219|156484760|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
48625224|NCT01272219|156484761|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
48625225|NCT01272219|156484756|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
48625226|NCT01272219|156484757|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
48625227|NCT01272219|156484758|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
48625228|NCT01272219|156484759|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
48625229|NCT01272219|156484760|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
48625230|NCT01272219|156484761|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
48625231|NCT01272219|156484756|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
48625232|NCT01272219|156484757|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
48740679|NCT02369016|156898949|FG000|Overall Study|AE associated with clinical disease progression|2|||
48740680|NCT02369016|156898950|FG001|Overall Study|AE associated with clinical disease progression|1|||
48740681|NCT02369016|156898949|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
48740682|NCT02369016|156898950|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
48740683|NCT02369016|156898949|FG000|Overall Study|Progressive disease - clinical progression|1|||
48740684|NCT02369016|156898950|FG001|Overall Study|Progressive disease - clinical progression|4|||
48740685|NCT02369016|156898949|FG000|Overall Study|withdrawal by patient|4|||
48740686|NCT02369016|156898950|FG001|Overall Study|withdrawal by patient|0|||
48625233|NCT01272219|156484758|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
48625234|NCT01272219|156484759|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
48625235|NCT01272219|156484760|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
48625236|NCT01272219|156484761|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
48740687|NCT02369016|156898949|FG000|Overall Study|Progressive disease - radiological progression|6|||
48740688|NCT02369016|156898950|FG001|Overall Study|Progressive disease - radiological progression|2|||
48740689|NCT00660699|156898953|FG000|Overall Study|Withdrawal by Subject|2|||
48740690|NCT01397162|156900160|FG000|Overall Study|Adverse Event|4|||
48740691|NCT01397162|156900161|FG001|Overall Study|Adverse Event|0|||
48451239|NCT00355134|155841603|FG000|Core Phase|Adverse Event|28|||
48625237|NCT01272219|156484756|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
48625238|NCT01272219|156484757|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
48625239|NCT01272219|156484758|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
48625240|NCT01272219|156484759|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
48625241|NCT01272219|156484760|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
48625242|NCT01272219|156484761|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
48625243|NCT01272219|156484756|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
48625244|NCT01272219|156484757|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
48625245|NCT01272219|156484758|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
48323568|NCT00701701|155382071|FG000|Overall Study|Withdrawal by Subject|0|||
48625246|NCT01272219|156484759|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
48625247|NCT01272219|156484760|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
48625248|NCT01272219|156484761|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
48625249|NCT01272219|156484756|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
48625250|NCT01272219|156484757|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
48740692|NCT01397162|156900162|FG002|Overall Study|Adverse Event|0|||
48740693|NCT01397162|156900163|FG003|Overall Study|Adverse Event|0|||
48740694|NCT01397162|156900164|FG004|Overall Study|Adverse Event|0|||
48740695|NCT01397162|156900160|FG000|Overall Study|Not yet defined|3|||
48740696|NCT01397162|156900161|FG001|Overall Study|Not yet defined|4|||
48740697|NCT01397162|156900162|FG002|Overall Study|Not yet defined|3|||
48740698|NCT01397162|156900163|FG003|Overall Study|Not yet defined|5|||
48740699|NCT01397162|156900164|FG004|Overall Study|Not yet defined|3|||
48740700|NCT00560105|156900165|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
48740701|NCT00560105|156900166|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
48740702|NCT01507298|156900167|FG000|Overall Study|Protocol Violation|0|||
48740703|NCT01507298|156900168|FG001|Overall Study|Protocol Violation|6|||
48740704|NCT01945281|156900169|FG000|Overall Study|Adverse Event|1|||
48740705|NCT01945281|156900170|FG001|Overall Study|Adverse Event|0|||
48740706|NCT01945281|156900169|FG000|Overall Study|Death|3|||
48740707|NCT01945281|156900170|FG001|Overall Study|Death|3|||
48740708|NCT01945281|156900169|FG000|Overall Study|Physician Decision|1|||
48740709|NCT01945281|156900170|FG001|Overall Study|Physician Decision|1|||
48740710|NCT01945281|156900169|FG000|Overall Study|Technical Problems|1|||
48740711|NCT01945281|156900170|FG001|Overall Study|Technical Problems|0|||
48740712|NCT00385762|156900171|FG000|Overall Study|Adverse Event|1|||
48740713|NCT00385762|156900171|FG000|Overall Study|Lost to Follow-up|1|||
48323569|NCT00701701|155382072|FG001|Overall Study|Withdrawal by Subject|1|||
48323570|NCT00701701|155382071|FG000|Overall Study|Adverse Event|0|||
48740714|NCT00894166|156900186|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
48740715|NCT00894166|156900187|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
48740716|NCT00894166|156900188|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
48740717|NCT00894166|156900189|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
48740718|NCT00894166|156900190|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
48625251|NCT01272219|156484758|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
48625252|NCT01272219|156484759|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
48625253|NCT01272219|156484760|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
48625254|NCT01272219|156484761|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
48625255|NCT01272219|156484756|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
48625256|NCT01272219|156484757|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
48625257|NCT01272219|156484758|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
48625258|NCT01272219|156484759|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
48625259|NCT01272219|156484760|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
48625260|NCT01272219|156484761|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
48625261|NCT04818086|156484762|FG000|Overall Study|Physician Decision|1|||
48625262|NCT04818086|156484763|FG001|Overall Study|Physician Decision|0|||
48625263|NCT04818086|156484762|FG000|Overall Study|Withdrawal by Subject|0|||
48625264|NCT04818086|156484763|FG001|Overall Study|Withdrawal by Subject|1|||
48625265|NCT01852214|156484766|FG000|Period 1|Adverse Event|1|||
48625266|NCT01852214|156484767|FG001|Period 1|Adverse Event|2|||
48625267|NCT01852214|156484766|FG000|Period 1|Withdrawal by Subject|0|||
48625268|NCT01852214|156484767|FG001|Period 1|Withdrawal by Subject|1|||
48625269|NCT01852214|156484766|FG000|Washout Period|Withdrawal by Subject|0|||
48625270|NCT01852214|156484767|FG001|Washout Period|Withdrawal by Subject|1|||
48625271|NCT02691494|156484768|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
48625272|NCT02691494|156484769|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
48625273|NCT02691494|156484770|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
48625274|NCT02691494|156484768|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48625275|NCT02691494|156484769|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
48625276|NCT02691494|156484770|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
48625277|NCT02691494|156484768|FG000|Post-Treatment Follow-Up Period|Other|2|||
48625278|NCT02691494|156484769|FG001|Post-Treatment Follow-Up Period|Other|1|||
48625279|NCT02691494|156484770|FG002|Post-Treatment Follow-Up Period|Other|1|||
48625280|NCT02691494|156484768|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
48625281|NCT02691494|156484769|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
48625282|NCT02691494|156484770|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
48625283|NCT02691494|156484768|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
48625284|NCT02691494|156484769|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
48625285|NCT02691494|156484770|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
48625286|NCT05346640|156484771|FG000|Overall Study|Lack of Efficacy|2|||
48625287|NCT05346640|156484771|FG000|Overall Study|Lost to Follow-up|14|||
48625288|NCT05346640|156484771|FG000|Overall Study|Protocol Violation|4|||
48625289|NCT05346640|156484771|FG000|Overall Study|Withdrawal by Subject|2|||
48625290|NCT05346640|156484771|FG000|Overall Study|Physiological Complications|3|||
48625291|NCT05346640|156484771|FG000|Overall Study|Other Reason|3|||
48625292|NCT03941093|156484778|FG000|Overall Study|Protocol Violation|0|||
48625293|NCT03941093|156484779|FG001|Overall Study|Protocol Violation|1|||
48625294|NCT03941093|156484778|FG000|Overall Study|Withdrawal by Subject|9|||
48625295|NCT03941093|156484779|FG001|Overall Study|Withdrawal by Subject|6|||
48625296|NCT01897896|156486819|FG000|Overall Study|Death|1|||
48625297|NCT01897896|156486820|FG001|Overall Study|Death|0|||
48740719|NCT00894166|156900191|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
48740720|NCT00894166|156900192|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
48740721|NCT00894166|156900193|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
48740722|NCT00894166|156900186|FG000|Overall Study|Death|0|||
48740723|NCT00894166|156900187|FG001|Overall Study|Death|0|||
48740724|NCT00894166|156900188|FG002|Overall Study|Death|0|||
48740725|NCT00894166|156900189|FG003|Overall Study|Death|1|||
48740726|NCT00894166|156900190|FG004|Overall Study|Death|0|||
48740727|NCT00894166|156900191|FG005|Overall Study|Death|0|||
48740728|NCT00894166|156900192|FG006|Overall Study|Death|0|||
48740729|NCT00894166|156900193|FG007|Overall Study|Death|0|||
48740730|NCT04898673|156900195|FG000|Overall Study|Screenfail|1|||
48740731|NCT04898673|156900196|FG001|Overall Study|Screenfail|0|||
48740732|NCT00369824|156900199|FG000|Overall Study|Adverse Event|0|||
48740733|NCT00369824|156900200|FG001|Overall Study|Adverse Event|2|||
48740734|NCT00369824|156900201|FG002|Overall Study|Adverse Event|0|||
48740735|NCT00369824|156900202|FG003|Overall Study|Adverse Event|0|||
48625298|NCT01897896|156486819|FG000|Overall Study|Adverse Event|11|||
48625299|NCT01897896|156486820|FG001|Overall Study|Adverse Event|1|||
48625300|NCT01897896|156486819|FG000|Overall Study|Lost to Follow-up|1|||
48625301|NCT01897896|156486820|FG001|Overall Study|Lost to Follow-up|0|||
48625302|NCT01897896|156486819|FG000|Overall Study|Non-compliance with study drug dosing|1|||
48740736|NCT00369824|156900203|FG004|Overall Study|Adverse Event|1|||
48740737|NCT00369824|156900204|FG005|Overall Study|Adverse Event|0|||
48740738|NCT00369824|156900199|FG000|Overall Study|Protocol Violation|0|||
48740739|NCT00369824|156900200|FG001|Overall Study|Protocol Violation|1|||
48740740|NCT00369824|156900201|FG002|Overall Study|Protocol Violation|0|||
48740741|NCT00369824|156900202|FG003|Overall Study|Protocol Violation|1|||
48740742|NCT00369824|156900203|FG004|Overall Study|Protocol Violation|1|||
48625303|NCT01897896|156486820|FG001|Overall Study|Non-compliance with study drug dosing|1|||
48625304|NCT01897896|156486819|FG000|Overall Study|Withdrawal by Subject|7|||
48625305|NCT01897896|156486820|FG001|Overall Study|Withdrawal by Subject|1|||
48625306|NCT01897896|156486819|FG000|Overall Study|Require drug that interfere with study|1|||
48625307|NCT01897896|156486820|FG001|Overall Study|Require drug that interfere with study|4|||
48625308|NCT01897896|156486819|FG000|Overall Study|Protocol Violation|1|||
48625309|NCT01897896|156486820|FG001|Overall Study|Protocol Violation|1|||
48625310|NCT01897896|156486819|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
48625311|NCT01897896|156486820|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
48625312|NCT01897896|156486819|FG000|Overall Study|Caregiver can no longer participate|0|||
48625313|NCT01897896|156486820|FG001|Overall Study|Caregiver can no longer participate|2|||
48625314|NCT01897896|156486819|FG000|Overall Study|Other than specified|2|||
48625315|NCT01897896|156486820|FG001|Overall Study|Other than specified|1|||
48625316|NCT04821245|156486823|FG000|Overall Study|Withdrawal by Subject|3|||
48625317|NCT04821245|156486823|FG000|Overall Study|Physician Decision|1|||
48625318|NCT04821245|156486823|FG000|Overall Study|Protocol Violation|5|||
48625319|NCT02105012|156486827|FG000|Overall Study|Withdrawal by Subject|11|||
48625320|NCT02105012|156486827|FG000|Overall Study|Protocol Specified Criteria|9|||
48625321|NCT02105012|156486827|FG000|Overall Study|Lost to Follow-up|4|||
48625322|NCT02105012|156486827|FG000|Overall Study|Protocol Violation|4|||
48625323|NCT02105012|156486827|FG000|Overall Study|Physician Decision|3|||
48740743|NCT00369824|156900204|FG005|Overall Study|Protocol Violation|0|||
48740744|NCT00369824|156900199|FG000|Overall Study|Withdrawal by Subject|9|||
48740745|NCT00369824|156900200|FG001|Overall Study|Withdrawal by Subject|5|||
48740746|NCT00369824|156900201|FG002|Overall Study|Withdrawal by Subject|5|||
48740747|NCT00369824|156900202|FG003|Overall Study|Withdrawal by Subject|4|||
48740748|NCT00369824|156900203|FG004|Overall Study|Withdrawal by Subject|6|||
48740749|NCT00369824|156900204|FG005|Overall Study|Withdrawal by Subject|2|||
48740750|NCT00369824|156900199|FG000|Overall Study|Lost to Follow-up|6|||
48740751|NCT00369824|156900200|FG001|Overall Study|Lost to Follow-up|11|||
48740752|NCT00369824|156900201|FG002|Overall Study|Lost to Follow-up|7|||
48740753|NCT00369824|156900202|FG003|Overall Study|Lost to Follow-up|8|||
48740754|NCT00369824|156900203|FG004|Overall Study|Lost to Follow-up|9|||
48740755|NCT00369824|156900204|FG005|Overall Study|Lost to Follow-up|6|||
48740756|NCT00369824|156900199|FG000|Overall Study|Other|0|||
48740757|NCT00369824|156900200|FG001|Overall Study|Other|0|||
48740758|NCT00369824|156900201|FG002|Overall Study|Other|0|||
48625324|NCT02105012|156486827|FG000|Overall Study|Adverse Event|1|||
48625325|NCT02105012|156486827|FG000|Overall Study|Lack of Efficacy|1|||
48625326|NCT05071027|156486828|FG000|Overall Study|Lost to Follow-up|1|||
48625327|NCT05071027|156486829|FG001|Overall Study|Lost to Follow-up|4|||
48740759|NCT00369824|156900202|FG003|Overall Study|Other|2|||
48740760|NCT00369824|156900203|FG004|Overall Study|Other|1|||
48625328|NCT05524948|156486834|FG000|Overall Study|Withdrawal by Subject|1|||
48625329|NCT05524948|156486835|FG001|Overall Study|Withdrawal by Subject|0|||
48625330|NCT05524948|156486834|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
48625331|NCT05524948|156486835|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
48625332|NCT01796470|156486836|FG000|Overall Study|Adverse Event|4|||
48625333|NCT01796470|156486837|FG001|Overall Study|Adverse Event|2|||
48625334|NCT01796470|156486838|FG002|Overall Study|Adverse Event|2|||
48625335|NCT01796470|156486839|FG003|Overall Study|Adverse Event|1|||
48625336|NCT01796470|156486840|FG004|Overall Study|Adverse Event|3|||
48625337|NCT01796470|156486836|FG000|Overall Study|Death|2|||
48625338|NCT01796470|156486837|FG001|Overall Study|Death|0|||
48625339|NCT01796470|156486838|FG002|Overall Study|Death|0|||
48625340|NCT01796470|156486839|FG003|Overall Study|Death|0|||
48625341|NCT01796470|156486840|FG004|Overall Study|Death|1|||
48625342|NCT01796470|156486836|FG000|Overall Study|Initiated New Therapy|9|||
48625343|NCT01796470|156486837|FG001|Overall Study|Initiated New Therapy|0|||
48625344|NCT01796470|156486838|FG002|Overall Study|Initiated New Therapy|0|||
48625345|NCT01796470|156486839|FG003|Overall Study|Initiated New Therapy|0|||
48625346|NCT01796470|156486840|FG004|Overall Study|Initiated New Therapy|2|||
48625347|NCT01796470|156486836|FG000|Overall Study|Lost to Follow-up|0|||
48625348|NCT01796470|156486837|FG001|Overall Study|Lost to Follow-up|1|||
48625349|NCT01796470|156486838|FG002|Overall Study|Lost to Follow-up|0|||
48625350|NCT01796470|156486839|FG003|Overall Study|Lost to Follow-up|0|||
48625351|NCT01796470|156486840|FG004|Overall Study|Lost to Follow-up|0|||
48625352|NCT01796470|156486836|FG000|Overall Study|Physician Decision|5|||
48625353|NCT01796470|156486837|FG001|Overall Study|Physician Decision|4|||
48625354|NCT01796470|156486838|FG002|Overall Study|Physician Decision|1|||
48625355|NCT01796470|156486839|FG003|Overall Study|Physician Decision|0|||
48625356|NCT01796470|156486840|FG004|Overall Study|Physician Decision|1|||
48625357|NCT01796470|156486836|FG000|Overall Study|Progressive Disease|7|||
48625358|NCT01796470|156486837|FG001|Overall Study|Progressive Disease|7|||
48625359|NCT01796470|156486838|FG002|Overall Study|Progressive Disease|3|||
48625360|NCT01796470|156486839|FG003|Overall Study|Progressive Disease|2|||
48625361|NCT01796470|156486840|FG004|Overall Study|Progressive Disease|0|||
48625362|NCT01796470|156486836|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
48625363|NCT01796470|156486837|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
48625364|NCT01796470|156486838|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
48625365|NCT01796470|156486839|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
48625366|NCT01796470|156486840|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
48625367|NCT01796470|156486836|FG000|Overall Study|Withdrawal by Subject|7|||
48625368|NCT01796470|156486837|FG001|Overall Study|Withdrawal by Subject|0|||
48625369|NCT01796470|156486838|FG002|Overall Study|Withdrawal by Subject|0|||
48625370|NCT01796470|156486839|FG003|Overall Study|Withdrawal by Subject|0|||
48625371|NCT01796470|156486840|FG004|Overall Study|Withdrawal by Subject|1|||
48625372|NCT02633527|156486841|FG000|Overall Study|Failed to meet eligibility|0|||
48625373|NCT02633527|156486842|FG001|Overall Study|Failed to meet eligibility|1|||
48625374|NCT02633527|156486843|FG002|Overall Study|Failed to meet eligibility|1|||
48625375|NCT02633527|156486844|FG003|Overall Study|Failed to meet eligibility|0|||
48625376|NCT02633527|156486845|FG004|Overall Study|Failed to meet eligibility|1|||
48625377|NCT02633527|156486841|FG000|Overall Study|Adverse Event|0|||
48625378|NCT02633527|156486842|FG001|Overall Study|Adverse Event|4|||
48625379|NCT02633527|156486843|FG002|Overall Study|Adverse Event|3|||
48625380|NCT02633527|156486844|FG003|Overall Study|Adverse Event|1|||
48625381|NCT02633527|156486845|FG004|Overall Study|Adverse Event|5|||
48625382|NCT02633527|156486841|FG000|Overall Study|Lost to Follow-up|1|||
48625383|NCT02633527|156486842|FG001|Overall Study|Lost to Follow-up|2|||
48625384|NCT02633527|156486843|FG002|Overall Study|Lost to Follow-up|5|||
48625385|NCT02633527|156486844|FG003|Overall Study|Lost to Follow-up|5|||
48625386|NCT02633527|156486845|FG004|Overall Study|Lost to Follow-up|4|||
48625387|NCT02633527|156486841|FG000|Overall Study|Withdrawal by Subject|0|||
48625388|NCT02633527|156486842|FG001|Overall Study|Withdrawal by Subject|3|||
48625389|NCT02633527|156486843|FG002|Overall Study|Withdrawal by Subject|5|||
48625390|NCT02633527|156486844|FG003|Overall Study|Withdrawal by Subject|4|||
48625391|NCT02633527|156486845|FG004|Overall Study|Withdrawal by Subject|4|||
48625392|NCT02633527|156486841|FG000|Overall Study|Protocol Violation|0|||
48625393|NCT02633527|156486842|FG001|Overall Study|Protocol Violation|1|||
48625394|NCT02633527|156486843|FG002|Overall Study|Protocol Violation|1|||
48625395|NCT02633527|156486844|FG003|Overall Study|Protocol Violation|1|||
48625396|NCT02633527|156486845|FG004|Overall Study|Protocol Violation|1|||
48625397|NCT02633527|156486841|FG000|Overall Study|Physician Decision|0|||
48625398|NCT02633527|156486842|FG001|Overall Study|Physician Decision|0|||
48625399|NCT02633527|156486843|FG002|Overall Study|Physician Decision|0|||
48625400|NCT02633527|156486844|FG003|Overall Study|Physician Decision|0|||
48625401|NCT02633527|156486845|FG004|Overall Study|Physician Decision|1|||
48625402|NCT02633527|156486841|FG000|Overall Study|Administrative reason|1|||
48625403|NCT02633527|156486842|FG001|Overall Study|Administrative reason|0|||
48625404|NCT02633527|156486843|FG002|Overall Study|Administrative reason|0|||
48625405|NCT02633527|156486844|FG003|Overall Study|Administrative reason|1|||
48625406|NCT02633527|156486845|FG004|Overall Study|Administrative reason|0|||
48625407|NCT02633527|156486841|FG000|Overall Study|Multiple reasons|1|||
48625408|NCT02633527|156486842|FG001|Overall Study|Multiple reasons|0|||
48625409|NCT02633527|156486843|FG002|Overall Study|Multiple reasons|2|||
48625410|NCT02633527|156486844|FG003|Overall Study|Multiple reasons|2|||
48625411|NCT02633527|156486845|FG004|Overall Study|Multiple reasons|1|||
48625412|NCT04439357|156486846|FG000|Overall Study|Disease Progression|4|||
48625413|NCT00754559|156486847|FG000|Overall Study|Adverse Event|15|||
48625414|NCT00754559|156486847|FG000|Overall Study|Protocol Violation|11|||
48625415|NCT00754559|156486847|FG000|Overall Study|Lack of Efficacy|10|||
48625416|NCT00754559|156486847|FG000|Overall Study|Lost to Follow-up|2|||
48625417|NCT00754559|156486847|FG000|Overall Study|Administrative reason|1|||
48625418|NCT00754559|156486847|FG000|Overall Study|Other|5|||
48625419|NCT00754559|156486847|FG000|Overall Study|Withdrawal by Subject|3|||
48625420|NCT03829683|156486848|FG000|Overall Study|Lost to Follow-up|1|||
48625421|NCT03829683|156486849|FG001|Overall Study|Lost to Follow-up|0|||
48625422|NCT03829683|156486848|FG000|Overall Study|Physician Decision|3|||
48625423|NCT03829683|156486849|FG001|Overall Study|Physician Decision|1|||
48625424|NCT03829683|156486848|FG000|Overall Study|Withdrawal by Subject|0|||
48625425|NCT03829683|156486849|FG001|Overall Study|Withdrawal by Subject|1|||
48625426|NCT03829683|156486848|FG000|Overall Study|Discharge from hospital|1|||
48625427|NCT03829683|156486849|FG001|Overall Study|Discharge from hospital|0|||
48625428|NCT01248468|156486850|FG000|Overall Study|Administrative problem|1|||
48625429|NCT01248468|156486851|FG001|Overall Study|Administrative problem|0|||
48625430|NCT01248468|156486852|FG002|Overall Study|Administrative problem|0|||
48625431|NCT01248468|156486850|FG000|Overall Study|Lost to Follow-up|9|||
48625432|NCT01248468|156486851|FG001|Overall Study|Lost to Follow-up|12|||
48625433|NCT01248468|156486852|FG002|Overall Study|Lost to Follow-up|4|||
48625434|NCT01248468|156486850|FG000|Overall Study|Pregnancy|1|||
48625435|NCT01248468|156486851|FG001|Overall Study|Pregnancy|0|||
48625436|NCT01248468|156486852|FG002|Overall Study|Pregnancy|0|||
48625437|NCT01248468|156486850|FG000|Overall Study|Withdrawal by Subject|4|||
48625438|NCT01248468|156486851|FG001|Overall Study|Withdrawal by Subject|2|||
48625439|NCT01248468|156486852|FG002|Overall Study|Withdrawal by Subject|0|||
48625440|NCT02226653|156486856|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
48625441|NCT02226653|156486857|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
48625442|NCT02226653|156486856|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
48625443|NCT02226653|156486857|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
48625444|NCT00635050|156486858|FG000|Overall Study|Withdrawal by Subject|1|||
48625445|NCT04525183|156486859|FG000|Overall Study|Withdrawal by Subject|0|||
48625446|NCT04525183|156486860|FG001|Overall Study|Withdrawal by Subject|0|||
48625447|NCT04525183|156486861|FG002|Overall Study|Withdrawal by Subject|3|||
48625448|NCT04525183|156486859|FG000|Overall Study|Study non-compliance|0|||
48625449|NCT04525183|156486860|FG001|Overall Study|Study non-compliance|0|||
48625450|NCT04525183|156486861|FG002|Overall Study|Study non-compliance|1|||
48625451|NCT04525183|156486859|FG000|Overall Study|Recurrent disease before starting on study|0|||
48625452|NCT04525183|156486860|FG001|Overall Study|Recurrent disease before starting on study|0|||
48625453|NCT04525183|156486861|FG002|Overall Study|Recurrent disease before starting on study|1|||
48625454|NCT04629521|156486862|FG000|Overall Study|Death|1|||
48625455|NCT04629521|156486862|FG000|Overall Study|Lost to Follow-up|3|||
48625456|NCT04629521|156486862|FG000|Overall Study|Subject withdrew consent|3|||
48625457|NCT04629521|156486862|FG000|Overall Study|Enrolled in error|1|||
48625458|NCT01916226|156486863|FG000|Overall Study|Adverse Event|1|||
48625459|NCT01916226|156486864|FG001|Overall Study|Adverse Event|0|||
48740761|NCT00369824|156900204|FG005|Overall Study|Other|3|||
48740762|NCT01390649|156900205|FG000|Overall Study|Physician Decision|1|||
48740763|NCT03822182|156900208|FG000|Overall Study|Protocol Violation|0|||
48740764|NCT03822182|156900209|FG001|Overall Study|Protocol Violation|1|||
48740765|NCT03822182|156900210|FG002|Overall Study|Protocol Violation|1|||
48740766|NCT01484275|156900211|FG000|Overall Study|Study terminated by sponsor|28|||
48740767|NCT01484275|156900212|FG001|Overall Study|Study terminated by sponsor|32|||
48740768|NCT01484275|156900211|FG000|Overall Study|Other|10|||
48740769|NCT01484275|156900212|FG001|Overall Study|Other|0|||
48740770|NCT01484275|156900211|FG000|Overall Study|Death|3|||
48740771|NCT01484275|156900212|FG001|Overall Study|Death|4|||
48740772|NCT01484275|156900211|FG000|Overall Study|Withdrawal by Subject|1|||
48740773|NCT01484275|156900212|FG001|Overall Study|Withdrawal by Subject|5|||
48740774|NCT01484275|156900211|FG000|Overall Study|Lost to Follow-up|1|||
48740775|NCT01484275|156900212|FG001|Overall Study|Lost to Follow-up|1|||
48323571|NCT00701701|155382072|FG001|Overall Study|Adverse Event|1|||
48625460|NCT01916226|156486865|FG002|Overall Study|Adverse Event|1|||
48625461|NCT01916226|156486866|FG003|Overall Study|Adverse Event|1|||
48740776|NCT00005044|156900213|FG000|Overall Study|Protocol Violation|37|||
48740777|NCT00005044|156900214|FG001|Overall Study|Protocol Violation|46|||
48625462|NCT01916226|156486863|FG000|Overall Study|Lack of Efficacy|0|||
48740778|NCT00005044|156900213|FG000|Overall Study|Withdrawal by Subject|1|||
48625463|NCT01916226|156486864|FG001|Overall Study|Lack of Efficacy|0|||
48625464|NCT01916226|156486865|FG002|Overall Study|Lack of Efficacy|2|||
48625465|NCT01916226|156486866|FG003|Overall Study|Lack of Efficacy|1|||
48625466|NCT01916226|156486863|FG000|Overall Study|Protocol Violation|0|||
48625467|NCT01916226|156486864|FG001|Overall Study|Protocol Violation|1|||
48625468|NCT01916226|156486865|FG002|Overall Study|Protocol Violation|0|||
48625469|NCT01916226|156486866|FG003|Overall Study|Protocol Violation|1|||
48625470|NCT01916226|156486863|FG000|Overall Study|Physician Decision|0|||
48625471|NCT01916226|156486864|FG001|Overall Study|Physician Decision|0|||
48625472|NCT01916226|156486865|FG002|Overall Study|Physician Decision|0|||
48625473|NCT01916226|156486866|FG003|Overall Study|Physician Decision|1|||
48625474|NCT02420314|156486867|FG000|Overall Study|Withdrawal by Subject|1|||
48625475|NCT02420314|156486867|FG000|Overall Study|Protocol Violation|1|||
48625476|NCT04875533|156486870|FG000|Overall Study|Adverse Event|6|||
48625477|NCT04875533|156486871|FG001|Overall Study|Adverse Event|4|||
48625478|NCT04875533|156486870|FG000|Overall Study|Protocol Violation|4|||
48625479|NCT04875533|156486871|FG001|Overall Study|Protocol Violation|0|||
48625480|NCT04875533|156486870|FG000|Overall Study|Withdrawal by Subject|8|||
48625481|NCT04875533|156486871|FG001|Overall Study|Withdrawal by Subject|5|||
48323572|NCT01079949|155382073|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
48740779|NCT00005044|156900214|FG001|Overall Study|Withdrawal by Subject|5|||
48740780|NCT00005044|156900213|FG000|Overall Study|No protocol treatment|0|||
48625482|NCT04875533|156486870|FG000|Overall Study|No longer meets eligibility criteria|1|||
48625483|NCT04875533|156486871|FG001|Overall Study|No longer meets eligibility criteria|0|||
48625484|NCT04875533|156486870|FG000|Overall Study|Other|0|||
48625485|NCT04875533|156486871|FG001|Overall Study|Other|2|||
48625486|NCT00680914|156486872|FG000|Overall Study|Consent withdrawal|6|||
48625487|NCT00680914|156486873|FG001|Overall Study|Consent withdrawal|3|||
48625488|NCT00680914|156486872|FG000|Overall Study|Lost to Follow-up|4|||
48625489|NCT00680914|156486873|FG001|Overall Study|Lost to Follow-up|0|||
48625490|NCT00680914|156486872|FG000|Overall Study|serious adverse event (SAE)|0|||
48625491|NCT00680914|156486873|FG001|Overall Study|serious adverse event (SAE)|1|||
48625492|NCT01487161|156486874|FG000|Overall Study|Adverse Event|1|||
48625493|NCT01487161|156486875|FG001|Overall Study|Adverse Event|0|||
48625494|NCT01487161|156486876|FG002|Overall Study|Adverse Event|0|||
48625495|NCT01487161|156486877|FG003|Overall Study|Adverse Event|0|||
48625496|NCT01487161|156486874|FG000|Overall Study|Withdrawal by Subject|1|||
48625497|NCT01487161|156486875|FG001|Overall Study|Withdrawal by Subject|1|||
48625498|NCT01487161|156486876|FG002|Overall Study|Withdrawal by Subject|1|||
48625499|NCT01487161|156486877|FG003|Overall Study|Withdrawal by Subject|2|||
48625500|NCT01487161|156486874|FG000|Overall Study|missing data|0|||
48625501|NCT01487161|156486875|FG001|Overall Study|missing data|1|||
48625502|NCT01487161|156486876|FG002|Overall Study|missing data|0|||
48625503|NCT01487161|156486877|FG003|Overall Study|missing data|0|||
48625504|NCT02554474|156486878|FG000|Overall Study|Protocol Violation|1|||
48625505|NCT02554474|156486879|FG001|Overall Study|Protocol Violation|1|||
48625506|NCT02554474|156486878|FG000|Overall Study|Health issue not related to the study|1|||
48625507|NCT02554474|156486879|FG001|Overall Study|Health issue not related to the study|0|||
48625508|NCT02554474|156486878|FG000|Overall Study|Withdrawal by Subject|1|||
48625509|NCT02554474|156486879|FG001|Overall Study|Withdrawal by Subject|1|||
48625510|NCT03186378|156486880|FG000|Overall Study|Lost to Follow-up|1|||
48625511|NCT03186378|156486881|FG001|Overall Study|Lost to Follow-up|0|||
48625512|NCT01848457|156486884|FG000|Overall Study|Death|1|||
48740781|NCT00005044|156900214|FG001|Overall Study|No protocol treatment|1|||
48740782|NCT00843856|156900215|FG000|Overall Study|Lost to Follow-up|1|||
48740783|NCT00843856|156900216|FG001|Overall Study|Lost to Follow-up|2|||
48740784|NCT02059408|156900235|FG000|Overall Study|Did not get tested|0|||
48323573|NCT01079949|155382074|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
48625513|NCT01848457|156486885|FG001|Overall Study|Death|0|||
48625514|NCT01848457|156486886|FG002|Overall Study|Death|0|||
48625515|NCT01848457|156486887|FG003|Overall Study|Death|0|||
48740785|NCT02059408|156900236|FG001|Overall Study|Did not get tested|330|||
48740786|NCT02059408|156900237|FG002|Overall Study|Did not get tested|358|||
48740787|NCT00259610|156900238|FG000|Overall Study|Withdrawal by Subject|33|||
48740788|NCT00259610|156900239|FG001|Overall Study|Withdrawal by Subject|25|||
48625516|NCT00489476|156486888|FG000|Overall Study|Lost to Follow-up|0|||
48625517|NCT00489476|156486889|FG001|Overall Study|Lost to Follow-up|1|||
48625518|NCT00489476|156486890|FG002|Overall Study|Lost to Follow-up|0|||
48625519|NCT00489476|156486891|FG003|Overall Study|Lost to Follow-up|0|||
48625520|NCT03460704|156486892|FG000|Overall Study|Withdrawal by Subject|11|||
48625521|NCT03460704|156486893|FG001|Overall Study|Withdrawal by Subject|14|||
48740789|NCT00259610|156900240|FG002|Overall Study|Withdrawal by Subject|29|||
48323574|NCT01079949|155382073|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
48323575|NCT01079949|155382074|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
48625522|NCT03460704|156486892|FG000|Overall Study|Study terminated by the Sponsor|29|||
48740790|NCT00259610|156900241|FG003|Overall Study|Withdrawal by Subject|19|||
48740791|NCT00259610|156900238|FG000|Overall Study|Lost to Follow-up|19|||
48740792|NCT00259610|156900239|FG001|Overall Study|Lost to Follow-up|8|||
48740793|NCT00259610|156900240|FG002|Overall Study|Lost to Follow-up|18|||
48740794|NCT00259610|156900241|FG003|Overall Study|Lost to Follow-up|15|||
48625523|NCT03460704|156486893|FG001|Overall Study|Study terminated by the Sponsor|19|||
48625524|NCT03460704|156486892|FG000|Overall Study|Adverse Event|10|||
48625525|NCT03460704|156486893|FG001|Overall Study|Adverse Event|5|||
48625526|NCT03460704|156486892|FG000|Overall Study|Death|3|||
48625527|NCT03460704|156486893|FG001|Overall Study|Death|2|||
48740795|NCT00259610|156900238|FG000|Overall Study|Physician Decision|6|||
48625528|NCT03460704|156486892|FG000|Overall Study|Non-Compliance with Study Drug|3|||
48625529|NCT03460704|156486893|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48625530|NCT03460704|156486892|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48625531|NCT03460704|156486893|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
48625532|NCT03460704|156486892|FG000|Overall Study|Other|2|||
48740796|NCT00259610|156900239|FG001|Overall Study|Physician Decision|4|||
48740797|NCT00259610|156900240|FG002|Overall Study|Physician Decision|7|||
48740798|NCT00259610|156900241|FG003|Overall Study|Physician Decision|2|||
48740799|NCT00259610|156900238|FG000|Overall Study|Death|1|||
48740800|NCT00259610|156900239|FG001|Overall Study|Death|1|||
48740801|NCT00259610|156900240|FG002|Overall Study|Death|2|||
48740802|NCT00259610|156900241|FG003|Overall Study|Death|0|||
48740803|NCT00259610|156900238|FG000|Overall Study|non medical reason|6|||
48625533|NCT03460704|156486893|FG001|Overall Study|Other|1|||
48740804|NCT00259610|156900239|FG001|Overall Study|non medical reason|2|||
48740805|NCT00259610|156900240|FG002|Overall Study|non medical reason|10|||
48740806|NCT00259610|156900241|FG003|Overall Study|non medical reason|3|||
48740807|NCT00259610|156900238|FG000|Overall Study|Adverse Event|3|||
48740808|NCT00259610|156900239|FG001|Overall Study|Adverse Event|4|||
48740809|NCT00259610|156900240|FG002|Overall Study|Adverse Event|5|||
48740810|NCT00259610|156900241|FG003|Overall Study|Adverse Event|2|||
48740811|NCT00259610|156900238|FG000|Overall Study|Serious Adverse Event|8|||
48740812|NCT00259610|156900239|FG001|Overall Study|Serious Adverse Event|2|||
48740813|NCT00259610|156900240|FG002|Overall Study|Serious Adverse Event|2|||
48740814|NCT00259610|156900241|FG003|Overall Study|Serious Adverse Event|2|||
48740815|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
48740816|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
48740817|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
48740818|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
48740819|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
48740820|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
48625534|NCT03620981|156486894|FG000|Overall Study|Adverse Event|14|||
48625535|NCT03620981|156486895|FG001|Overall Study|Adverse Event|38|||
48625536|NCT03620981|156486896|FG002|Overall Study|Adverse Event|25|||
48625537|NCT03620981|156486894|FG000|Overall Study|Lack of Efficacy|2|||
48625538|NCT03620981|156486895|FG001|Overall Study|Lack of Efficacy|1|||
48625539|NCT03620981|156486896|FG002|Overall Study|Lack of Efficacy|1|||
48625540|NCT03620981|156486894|FG000|Overall Study|Physician Decision|7|||
48625541|NCT03620981|156486895|FG001|Overall Study|Physician Decision|4|||
48625542|NCT03620981|156486896|FG002|Overall Study|Physician Decision|4|||
48625543|NCT03620981|156486894|FG000|Overall Study|Protocol Violation|1|||
48625544|NCT03620981|156486895|FG001|Overall Study|Protocol Violation|2|||
48625545|NCT03620981|156486896|FG002|Overall Study|Protocol Violation|1|||
48625546|NCT03620981|156486894|FG000|Overall Study|Withdrawal by Legal Representative|2|||
48625547|NCT03620981|156486895|FG001|Overall Study|Withdrawal by Legal Representative|1|||
48625548|NCT03620981|156486896|FG002|Overall Study|Withdrawal by Legal Representative|1|||
48625549|NCT03620981|156486894|FG000|Overall Study|Withdrawal by Care Giver|2|||
48625550|NCT03620981|156486895|FG001|Overall Study|Withdrawal by Care Giver|0|||
48625551|NCT03620981|156486896|FG002|Overall Study|Withdrawal by Care Giver|1|||
48625552|NCT03620981|156486894|FG000|Overall Study|Non-compliance with Study Drug|1|||
48625553|NCT03620981|156486895|FG001|Overall Study|Non-compliance with Study Drug|1|||
48625554|NCT03620981|156486896|FG002|Overall Study|Non-compliance with Study Drug|0|||
48625555|NCT02899754|156486897|FG000|Overall Study|Lost to Follow-up|7|||
48625556|NCT02899754|156486898|FG001|Overall Study|Lost to Follow-up|9|||
48625557|NCT02514746|156486899|FG000|Overall Study|Chronically Ill|1|||
48625558|NCT02514746|156486900|FG001|Overall Study|Chronically Ill|2|||
48625559|NCT02514746|156486899|FG000|Overall Study|Physician Decision|4|||
48625560|NCT02514746|156486900|FG001|Overall Study|Physician Decision|2|||
48625561|NCT02514746|156486899|FG000|Overall Study|Withdrawal by Subject|12|||
48625562|NCT02514746|156486900|FG001|Overall Study|Withdrawal by Subject|10|||
48625563|NCT02514746|156486899|FG000|Overall Study|Other|5|||
48625564|NCT02514746|156486900|FG001|Overall Study|Other|1|||
48625565|NCT03633058|156486907|FG000|Overall Study|Adverse Event|0|||
48625566|NCT03633058|156486908|FG001|Overall Study|Adverse Event|0|||
48625567|NCT03633058|156486909|FG002|Overall Study|Adverse Event|1|||
48625568|NCT03633058|156486910|FG003|Overall Study|Adverse Event|0|||
48740821|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
48740822|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
48740823|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740824|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
48740825|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48625569|NCT04551053|156486914|FG000|Overall Study|Death|9|||
48625570|NCT04551053|156486915|FG001|Overall Study|Death|9|||
48625571|NCT04551053|156486914|FG000|Overall Study|Lost to Follow-up|0|||
48625572|NCT04551053|156486915|FG001|Overall Study|Lost to Follow-up|2|||
48625573|NCT04551053|156486914|FG000|Overall Study|Study Terminated by Sponsor|53|||
48625574|NCT04551053|156486915|FG001|Overall Study|Study Terminated by Sponsor|63|||
48625575|NCT04551053|156486914|FG000|Overall Study|Withdrawal by Subject|12|||
48625576|NCT04551053|156486915|FG001|Overall Study|Withdrawal by Subject|5|||
48625577|NCT04551053|156486914|FG000|Overall Study|Adverse Event|1|||
48625578|NCT04551053|156486915|FG001|Overall Study|Adverse Event|0|||
48625579|NCT04551053|156486914|FG000|Overall Study|Lack of Efficacy|2|||
48625580|NCT04551053|156486915|FG001|Overall Study|Lack of Efficacy|0|||
48625581|NCT04551053|156486914|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
48625582|NCT04551053|156486915|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
48625583|NCT04551053|156486914|FG000|Overall Study|Splenapendectomi|1|||
48625584|NCT04551053|156486915|FG001|Overall Study|Splenapendectomi|0|||
48625585|NCT04551053|156486914|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
48625586|NCT04551053|156486915|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
48625587|NCT04551053|156486914|FG000|Overall Study|Medical Decision|0|||
48625588|NCT04551053|156486915|FG001|Overall Study|Medical Decision|1|||
48625589|NCT04551053|156486914|FG000|Overall Study|Ongoing|6|||
48625590|NCT04551053|156486915|FG001|Overall Study|Ongoing|4|||
48625591|NCT03301415|156486920|FG000|Overall Study|Lost to Follow-up|2|||
48625592|NCT03301415|156486920|FG000|Overall Study|Unable to comply with visit schedule|2|||
48625593|NCT02489045|156486923|FG000|Overall Study|unable to collect usable data|53|||
48625594|NCT02489045|156486923|FG000|Follow-up|Lost to Follow-up|10|||
48625595|NCT01887600|156486928|FG000|Overall Study|Death|39|||
48625596|NCT01887600|156486929|FG001|Overall Study|Death|16|||
48625597|NCT01887600|156486928|FG000|Overall Study|Lack of Efficacy|3|||
48625598|NCT01887600|156486929|FG001|Overall Study|Lack of Efficacy|26|||
48625599|NCT01887600|156486928|FG000|Overall Study|Lost to Follow-up|5|||
48625600|NCT01887600|156486929|FG001|Overall Study|Lost to Follow-up|1|||
48625601|NCT01887600|156486928|FG000|Overall Study|Physician Decision|7|||
48625602|NCT01887600|156486929|FG001|Overall Study|Physician Decision|8|||
48625603|NCT01887600|156486928|FG000|Overall Study|Protocol Deviation|3|||
48625604|NCT01887600|156486929|FG001|Overall Study|Protocol Deviation|0|||
48625605|NCT01887600|156486928|FG000|Overall Study|Withdrawal by Subject|58|||
48625606|NCT01887600|156486929|FG001|Overall Study|Withdrawal by Subject|52|||
48625607|NCT01887600|156486928|FG000|Overall Study|Adverse Event|21|||
48625608|NCT01887600|156486929|FG001|Overall Study|Adverse Event|9|||
48740826|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740827|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740828|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740829|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
48740830|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
48740831|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740832|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740833|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
48740834|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740835|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740836|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740837|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740838|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740839|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Other|0|||
48740840|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Other|0|||
48740841|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Other|1|||
48740842|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Other|1|||
48740843|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Other|2|||
48625609|NCT01887600|156486928|FG000|Overall Study|Non-compliance with study drug|3|||
48625610|NCT01887600|156486929|FG001|Overall Study|Non-compliance with study drug|0|||
48625611|NCT01887600|156486928|FG000|Overall Study|Miscellaneous|6|||
48625612|NCT01887600|156486929|FG001|Overall Study|Miscellaneous|2|||
48625613|NCT01887600|156486928|FG000|Overall Study|Progressive Disease|1|||
48625614|NCT01887600|156486929|FG001|Overall Study|Progressive Disease|0|||
48625615|NCT00420056|156486930|FG000|Overall Study|Objective progression or relapse|17|||
48625616|NCT02184442|156486936|FG000|Overall Study|Death|61|||
48625617|NCT02184442|156486937|FG001|Overall Study|Death|65|||
48740844|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Other|0|||
48740845|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Other|0|||
48625618|NCT02184442|156486936|FG000|Overall Study|Withdrawal by Subject|3|||
48625619|NCT02184442|156486937|FG001|Overall Study|Withdrawal by Subject|11|||
48625620|NCT00236197|156486940|FG000|Overall Study|Withdrawal by Subject|3|||
48625621|NCT00236197|156486941|FG001|Overall Study|Withdrawal by Subject|2|||
48740846|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Other|0|||
48798063|NCT00677352|157098541|FG001|Tapering Phase|Adverse Event|5|||
48625622|NCT00236197|156486940|FG000|Overall Study|Lost to Follow-up|1|||
48625623|NCT00236197|156486941|FG001|Overall Study|Lost to Follow-up|5|||
48625624|NCT00236197|156486940|FG000|Overall Study|Protocol Violation|0|||
48625625|NCT00236197|156486941|FG001|Overall Study|Protocol Violation|3|||
48740847|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
48740848|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
48740849|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
48740850|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
48740851|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
48740852|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
48625626|NCT00236197|156486940|FG000|Overall Study|Medication non-compliance|1|||
48625627|NCT00236197|156486941|FG001|Overall Study|Medication non-compliance|2|||
48625628|NCT00236197|156486940|FG000|Overall Study|Other|0|||
48625629|NCT00236197|156486941|FG001|Overall Study|Other|2|||
48625630|NCT04309500|156486942|FG000|Overall Study|Lost to Follow-up|1|||
48625631|NCT04309500|156486943|FG001|Overall Study|Lost to Follow-up|0|||
48625632|NCT04309500|156486944|FG002|Overall Study|Lost to Follow-up|0|||
48625633|NCT04309500|156486945|FG003|Overall Study|Lost to Follow-up|0|||
48625634|NCT00637156|156486946|FG000|Overall Study|Withdrawal by Subject|0|||
48625635|NCT00637156|156486947|FG001|Overall Study|Withdrawal by Subject|7|||
48323576|NCT01079949|155382073|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
48625636|NCT00637156|156486946|FG000|Overall Study|Death|0|||
48625637|NCT00637156|156486947|FG001|Overall Study|Death|1|||
48625638|NCT00637156|156486946|FG000|Overall Study|Lost to Follow-up|10|||
48625639|NCT00637156|156486947|FG001|Overall Study|Lost to Follow-up|16|||
48625640|NCT03193437|156486948|FG000|Overall Study|Adverse Event|4|||
48625641|NCT03193437|156486948|FG000|Overall Study|Withdrawal by Subject|2|||
48625642|NCT03193437|156486948|FG000|Overall Study|Disease Progression|2|||
48625643|NCT00561821|156486951|FG000|Overall Study|Not treated|0|||
48625644|NCT00561821|156486952|FG001|Overall Study|Not treated|0|||
48625645|NCT00561821|156486953|FG002|Overall Study|Not treated|1|||
48625646|NCT00561821|156486954|FG003|Overall Study|Not treated|0|||
48625647|NCT00561821|156486951|FG000|Overall Study|Withdrawal by Subject|0|||
48625648|NCT00561821|156486952|FG001|Overall Study|Withdrawal by Subject|1|||
48625649|NCT00561821|156486953|FG002|Overall Study|Withdrawal by Subject|0|||
48625650|NCT00561821|156486954|FG003|Overall Study|Withdrawal by Subject|2|||
48625651|NCT00561821|156486951|FG000|Overall Study|Reasons not related to trial|2|||
48625652|NCT00561821|156486952|FG001|Overall Study|Reasons not related to trial|1|||
48625653|NCT00561821|156486953|FG002|Overall Study|Reasons not related to trial|0|||
48625654|NCT00561821|156486954|FG003|Overall Study|Reasons not related to trial|0|||
48625655|NCT00561821|156486951|FG000|Overall Study|Other (reason not specified)|1|||
48625656|NCT00561821|156486952|FG001|Overall Study|Other (reason not specified)|1|||
48625657|NCT00561821|156486953|FG002|Overall Study|Other (reason not specified)|0|||
48625658|NCT00561821|156486954|FG003|Overall Study|Other (reason not specified)|0|||
48625659|NCT00561821|156486951|FG000|Overall Study|Adverse Event|2|||
48625660|NCT00561821|156486952|FG001|Overall Study|Adverse Event|3|||
48625661|NCT00561821|156486953|FG002|Overall Study|Adverse Event|1|||
48625662|NCT00561821|156486954|FG003|Overall Study|Adverse Event|1|||
48625663|NCT03648372|156486955|FG000|Overall Study|Withdrawal by Subject|2|||
48625664|NCT03648372|156486956|FG001|Overall Study|Withdrawal by Subject|0|||
48625665|NCT03648372|156486957|FG002|Overall Study|Withdrawal by Subject|0|||
48625666|NCT03648372|156486958|FG003|Overall Study|Withdrawal by Subject|0|||
48625667|NCT03648372|156486959|FG004|Overall Study|Withdrawal by Subject|0|||
48625668|NCT03648372|156486960|FG005|Overall Study|Withdrawal by Subject|1|||
48625669|NCT03648372|156486961|FG006|Overall Study|Withdrawal by Subject|2|||
48625670|NCT03648372|156486962|FG007|Overall Study|Withdrawal by Subject|0|||
48625671|NCT03648372|156486963|FG008|Overall Study|Withdrawal by Subject|0|||
48625672|NCT03648372|156486964|FG009|Overall Study|Withdrawal by Subject|0|||
48625673|NCT03648372|156486965|FG010|Overall Study|Withdrawal by Subject|2|||
48625674|NCT03648372|156486966|FG011|Overall Study|Withdrawal by Subject|0|||
48625675|NCT03648372|156486967|FG012|Overall Study|Withdrawal by Subject|2|||
48625676|NCT03648372|156486968|FG013|Overall Study|Withdrawal by Subject|0|||
48625677|NCT03648372|156486969|FG014|Overall Study|Withdrawal by Subject|0|||
48625678|NCT03648372|156486970|FG015|Overall Study|Withdrawal by Subject|0|||
48740853|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
48323577|NCT01079949|155382074|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
48625679|NCT03648372|156486971|FG016|Overall Study|Withdrawal by Subject|1|||
48625680|NCT03648372|156486972|FG017|Overall Study|Withdrawal by Subject|0|||
48625681|NCT03648372|156486973|FG018|Overall Study|Withdrawal by Subject|0|||
48625682|NCT03648372|156486974|FG019|Overall Study|Withdrawal by Subject|0|||
48625683|NCT03648372|156486975|FG020|Overall Study|Withdrawal by Subject|0|||
48625684|NCT03648372|156486955|FG000|Overall Study|Progressive Disease|2|||
48625685|NCT03648372|156486956|FG001|Overall Study|Progressive Disease|3|||
48625686|NCT03648372|156486957|FG002|Overall Study|Progressive Disease|4|||
48625687|NCT03648372|156486958|FG003|Overall Study|Progressive Disease|3|||
48625688|NCT03648372|156486959|FG004|Overall Study|Progressive Disease|2|||
48625689|NCT03648372|156486960|FG005|Overall Study|Progressive Disease|2|||
48625690|NCT03648372|156486961|FG006|Overall Study|Progressive Disease|3|||
48625691|NCT03648372|156486962|FG007|Overall Study|Progressive Disease|3|||
48740854|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
48625692|NCT03648372|156486963|FG008|Overall Study|Progressive Disease|5|||
48625693|NCT03648372|156486964|FG009|Overall Study|Progressive Disease|5|||
48625694|NCT03648372|156486965|FG010|Overall Study|Progressive Disease|2|||
48625695|NCT03648372|156486966|FG011|Overall Study|Progressive Disease|3|||
48625696|NCT03648372|156486967|FG012|Overall Study|Progressive Disease|3|||
48625697|NCT03648372|156486968|FG013|Overall Study|Progressive Disease|3|||
48323578|NCT01079949|155382073|FG000|Overall Study|Randomized but not treated|1|||
48323579|NCT01079949|155382074|FG001|Overall Study|Randomized but not treated|0|||
48323580|NCT05824559|155382077|FG000|Overall Study|Adverse Event|2|||
48323581|NCT05824559|155382077|FG000|Overall Study|Physician Decision|2|||
48323582|NCT05824559|155382077|FG000|Overall Study|Progressive Disease|16|||
48323583|NCT05824559|155382077|FG000|Overall Study|Study Terminated by Sponsor|1|||
48323584|NCT05824559|155382077|FG000|Overall Study|Withdrawal by Subject|2|||
48323585|NCT02409680|155382080|FG000|Overall Study|Lost to Follow-up|15|||
48323586|NCT02409680|155382081|FG001|Overall Study|Lost to Follow-up|30|||
48625698|NCT03648372|156486969|FG014|Overall Study|Progressive Disease|6|||
48625699|NCT03648372|156486970|FG015|Overall Study|Progressive Disease|0|||
48625700|NCT03648372|156486971|FG016|Overall Study|Progressive Disease|0|||
48625701|NCT03648372|156486972|FG017|Overall Study|Progressive Disease|0|||
48625702|NCT03648372|156486973|FG018|Overall Study|Progressive Disease|0|||
48625703|NCT03648372|156486974|FG019|Overall Study|Progressive Disease|0|||
48625704|NCT03648372|156486975|FG020|Overall Study|Progressive Disease|0|||
48625705|NCT03648372|156486955|FG000|Overall Study|Other|0|||
48625706|NCT03648372|156486956|FG001|Overall Study|Other|0|||
48625707|NCT03648372|156486957|FG002|Overall Study|Other|0|||
48625708|NCT03648372|156486958|FG003|Overall Study|Other|0|||
48625709|NCT03648372|156486959|FG004|Overall Study|Other|1|||
48625710|NCT03648372|156486960|FG005|Overall Study|Other|0|||
48625711|NCT03648372|156486961|FG006|Overall Study|Other|0|||
48625712|NCT03648372|156486962|FG007|Overall Study|Other|0|||
48625713|NCT03648372|156486963|FG008|Overall Study|Other|0|||
48625714|NCT03648372|156486964|FG009|Overall Study|Other|0|||
48625715|NCT03648372|156486965|FG010|Overall Study|Other|1|||
48625716|NCT03648372|156486966|FG011|Overall Study|Other|2|||
48625717|NCT03648372|156486967|FG012|Overall Study|Other|1|||
48625718|NCT03648372|156486968|FG013|Overall Study|Other|3|||
48625719|NCT03648372|156486969|FG014|Overall Study|Other|0|||
48625720|NCT03648372|156486970|FG015|Overall Study|Other|5|||
48625721|NCT03648372|156486971|FG016|Overall Study|Other|1|||
48625722|NCT03648372|156486972|FG017|Overall Study|Other|5|||
48625723|NCT03648372|156486973|FG018|Overall Study|Other|0|||
48625724|NCT03648372|156486974|FG019|Overall Study|Other|1|||
48625725|NCT03648372|156486975|FG020|Overall Study|Other|0|||
48625726|NCT03648372|156486955|FG000|Overall Study|Lost to Follow-up|0|||
48625727|NCT03648372|156486956|FG001|Overall Study|Lost to Follow-up|0|||
48625728|NCT03648372|156486957|FG002|Overall Study|Lost to Follow-up|0|||
48625729|NCT03648372|156486958|FG003|Overall Study|Lost to Follow-up|0|||
48625730|NCT03648372|156486959|FG004|Overall Study|Lost to Follow-up|0|||
48625731|NCT03648372|156486960|FG005|Overall Study|Lost to Follow-up|0|||
48625732|NCT03648372|156486961|FG006|Overall Study|Lost to Follow-up|0|||
48625733|NCT03648372|156486962|FG007|Overall Study|Lost to Follow-up|0|||
48625734|NCT03648372|156486963|FG008|Overall Study|Lost to Follow-up|0|||
48625735|NCT03648372|156486964|FG009|Overall Study|Lost to Follow-up|0|||
48625736|NCT03648372|156486965|FG010|Overall Study|Lost to Follow-up|0|||
48625737|NCT03648372|156486966|FG011|Overall Study|Lost to Follow-up|0|||
48625738|NCT03648372|156486967|FG012|Overall Study|Lost to Follow-up|0|||
48625739|NCT03648372|156486968|FG013|Overall Study|Lost to Follow-up|1|||
48625740|NCT03648372|156486969|FG014|Overall Study|Lost to Follow-up|0|||
48625741|NCT03648372|156486970|FG015|Overall Study|Lost to Follow-up|1|||
48625742|NCT03648372|156486971|FG016|Overall Study|Lost to Follow-up|0|||
48625743|NCT03648372|156486972|FG017|Overall Study|Lost to Follow-up|1|||
48625744|NCT03648372|156486973|FG018|Overall Study|Lost to Follow-up|0|||
48625745|NCT03648372|156486974|FG019|Overall Study|Lost to Follow-up|0|||
48625746|NCT03648372|156486975|FG020|Overall Study|Lost to Follow-up|0|||
48625747|NCT03648372|156486955|FG000|Overall Study|Start of a New Systemic Treatment|0|||
48625748|NCT03648372|156486956|FG001|Overall Study|Start of a New Systemic Treatment|0|||
48625749|NCT03648372|156486957|FG002|Overall Study|Start of a New Systemic Treatment|0|||
48625750|NCT03648372|156486958|FG003|Overall Study|Start of a New Systemic Treatment|0|||
48625751|NCT03648372|156486959|FG004|Overall Study|Start of a New Systemic Treatment|0|||
48625752|NCT03648372|156486960|FG005|Overall Study|Start of a New Systemic Treatment|0|||
48625753|NCT03648372|156486961|FG006|Overall Study|Start of a New Systemic Treatment|0|||
48625754|NCT03648372|156486962|FG007|Overall Study|Start of a New Systemic Treatment|2|||
48625755|NCT03648372|156486963|FG008|Overall Study|Start of a New Systemic Treatment|0|||
48625756|NCT03648372|156486964|FG009|Overall Study|Start of a New Systemic Treatment|0|||
48323587|NCT01371994|155382082|FG000|Overall Study|Adverse Event|3|||
48323588|NCT01371994|155382083|FG001|Overall Study|Adverse Event|6|||
48323589|NCT01371994|155382082|FG000|Overall Study|Lack of Efficacy|3|||
48625757|NCT03648372|156486965|FG010|Overall Study|Start of a New Systemic Treatment|1|||
48625758|NCT03648372|156486966|FG011|Overall Study|Start of a New Systemic Treatment|0|||
48625759|NCT03648372|156486967|FG012|Overall Study|Start of a New Systemic Treatment|0|||
48740855|NCT01090492|156900242|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
48740856|NCT01090492|156900243|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
48740857|NCT01090492|156900244|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
48740858|NCT01090492|156900245|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
48740859|NCT01090492|156900246|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
48740860|NCT01090492|156900247|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
48625760|NCT03648372|156486968|FG013|Overall Study|Start of a New Systemic Treatment|0|||
48625761|NCT03648372|156486969|FG014|Overall Study|Start of a New Systemic Treatment|0|||
48625762|NCT03648372|156486970|FG015|Overall Study|Start of a New Systemic Treatment|0|||
48625763|NCT03648372|156486971|FG016|Overall Study|Start of a New Systemic Treatment|0|||
48625764|NCT03648372|156486972|FG017|Overall Study|Start of a New Systemic Treatment|0|||
48625765|NCT03648372|156486973|FG018|Overall Study|Start of a New Systemic Treatment|0|||
48625766|NCT03648372|156486974|FG019|Overall Study|Start of a New Systemic Treatment|0|||
48625767|NCT03648372|156486975|FG020|Overall Study|Start of a New Systemic Treatment|0|||
48625768|NCT04744831|156488075|FG000|Overall Study|Progressive Disease|31|||
48625769|NCT04744831|156488076|FG001|Overall Study|Progressive Disease|27|||
48625770|NCT04744831|156488077|FG002|Overall Study|Progressive Disease|25|||
48740861|NCT01090492|156900248|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
48740862|NCT01090492|156900249|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
48740863|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
48740864|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
48740865|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
48740866|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
48740867|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
48740868|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
48740869|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
48740870|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
48740871|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740872|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
48740873|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740874|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740875|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740876|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740877|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740878|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
48740879|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Other|0|||
48740880|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Other|1|||
48740881|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Other|1|||
48740882|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Other|0|||
48740883|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Other|0|||
48740884|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Other|0|||
48740885|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Other|0|||
48740886|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Other|0|||
48740887|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
48740888|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
48625771|NCT04744831|156488075|FG000|Overall Study|Adverse Event|3|||
48625772|NCT04744831|156488076|FG001|Overall Study|Adverse Event|3|||
48625773|NCT04744831|156488077|FG002|Overall Study|Adverse Event|3|||
48625774|NCT04744831|156488075|FG000|Overall Study|Clinical Progression|3|||
48625775|NCT04744831|156488076|FG001|Overall Study|Clinical Progression|2|||
48625776|NCT04744831|156488077|FG002|Overall Study|Clinical Progression|5|||
48625777|NCT04744831|156488075|FG000|Overall Study|Other|0|||
48625778|NCT04744831|156488076|FG001|Overall Study|Other|2|||
48625779|NCT04744831|156488077|FG002|Overall Study|Other|1|||
48625780|NCT04744831|156488075|FG000|Overall Study|Death|0|||
48740889|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
48740890|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
48740891|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
48740892|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
48625781|NCT04744831|156488076|FG001|Overall Study|Death|2|||
48625782|NCT04744831|156488077|FG002|Overall Study|Death|1|||
48625783|NCT04101331|156488078|FG000|Overall Study|Adverse Event|9|||
48625784|NCT04101331|156488078|FG000|Overall Study|Disease progression|82|||
48740893|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
48740894|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
48740895|NCT01090492|156900242|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740896|NCT01090492|156900243|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740897|NCT01090492|156900244|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740898|NCT01090492|156900245|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740899|NCT01090492|156900246|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740900|NCT01090492|156900247|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740901|NCT01090492|156900248|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
48740902|NCT01090492|156900249|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
48740903|NCT00945893|156900250|FG000|Overall Study|Lost to Follow-up|2|||
48740904|NCT00945893|156900251|FG001|Overall Study|Lost to Follow-up|8|||
48740905|NCT00945893|156900250|FG000|Overall Study|Withdrawal of consent|1|||
48740906|NCT00945893|156900251|FG001|Overall Study|Withdrawal of consent|2|||
48740907|NCT01768286|156900252|FG000|Overall Study|Randomized But Not Treated|0|||
48740908|NCT01768286|156900253|FG001|Overall Study|Randomized But Not Treated|0|||
48740909|NCT01768286|156900254|FG002|Overall Study|Randomized But Not Treated|1|||
48740910|NCT01768286|156900255|FG003|Overall Study|Randomized But Not Treated|0|||
48740911|NCT01768286|156900252|FG000|Overall Study|Lack of Efficacy|7|||
48740912|NCT01768286|156900253|FG001|Overall Study|Lack of Efficacy|4|||
48740913|NCT01768286|156900254|FG002|Overall Study|Lack of Efficacy|0|||
48740914|NCT01768286|156900255|FG003|Overall Study|Lack of Efficacy|1|||
48740915|NCT01768286|156900252|FG000|Overall Study|Withdrew Consent|0|||
48740916|NCT01768286|156900253|FG001|Overall Study|Withdrew Consent|0|||
48740917|NCT01768286|156900254|FG002|Overall Study|Withdrew Consent|1|||
48740918|NCT01768286|156900255|FG003|Overall Study|Withdrew Consent|0|||
48740919|NCT02004522|156900258|FG000|Overall Study|Adverse Event|55|||
48625785|NCT04101331|156488078|FG000|Overall Study|Withdrawal by Subject|1|||
48625786|NCT04101331|156488078|FG000|Overall Study|Investigator decision|6|||
48625787|NCT04101331|156488078|FG000|Overall Study|Death|6|||
48625788|NCT04101331|156488078|FG000|Overall Study|Allogenic transplant|1|||
48625789|NCT04193176|156488080|FG000|Overall Study|Withdrawal by Subject|6|||
48625790|NCT04193176|156488081|FG001|Overall Study|Withdrawal by Subject|10|||
48625791|NCT01027754|156488082|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
48625792|NCT01027754|156488083|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
48625793|NCT01027754|156488082|FG000|Overall Study|Withdrawal by Subject|0|||
48625794|NCT01027754|156488083|FG001|Overall Study|Withdrawal by Subject|5|||
48625795|NCT02529488|156488084|FG000|Overall Study|Adverse Event|1|||
48625796|NCT02529488|156488084|FG000|Overall Study|Death|3|||
48625797|NCT00504556|156488098|FG000|Overall Study|Adverse Event|11|||
48625798|NCT00504556|156488099|FG001|Overall Study|Adverse Event|11|||
48625799|NCT00504556|156488100|FG002|Overall Study|Adverse Event|14|||
48625800|NCT00504556|156488101|FG003|Overall Study|Adverse Event|13|||
48625801|NCT00504556|156488102|FG004|Overall Study|Adverse Event|5|||
48625802|NCT00504556|156488098|FG000|Overall Study|Death|3|||
48625803|NCT00504556|156488099|FG001|Overall Study|Death|3|||
48625804|NCT00504556|156488100|FG002|Overall Study|Death|1|||
48625805|NCT00504556|156488101|FG003|Overall Study|Death|0|||
48625806|NCT00504556|156488102|FG004|Overall Study|Death|2|||
48625807|NCT00504556|156488098|FG000|Overall Study|Protocol Violation|1|||
48625808|NCT00504556|156488099|FG001|Overall Study|Protocol Violation|3|||
48625809|NCT00504556|156488100|FG002|Overall Study|Protocol Violation|2|||
48625810|NCT00504556|156488101|FG003|Overall Study|Protocol Violation|1|||
48625811|NCT00504556|156488102|FG004|Overall Study|Protocol Violation|2|||
48625812|NCT00504556|156488098|FG000|Overall Study|Lost to Follow-up|0|||
48625813|NCT00504556|156488099|FG001|Overall Study|Lost to Follow-up|0|||
48625814|NCT00504556|156488100|FG002|Overall Study|Lost to Follow-up|1|||
48625815|NCT00504556|156488101|FG003|Overall Study|Lost to Follow-up|1|||
48625816|NCT00504556|156488102|FG004|Overall Study|Lost to Follow-up|1|||
48625817|NCT00504556|156488098|FG000|Overall Study|Withdrawal by Subject|16|||
48625818|NCT00504556|156488099|FG001|Overall Study|Withdrawal by Subject|16|||
48625819|NCT00504556|156488100|FG002|Overall Study|Withdrawal by Subject|7|||
48625820|NCT00504556|156488101|FG003|Overall Study|Withdrawal by Subject|8|||
48740920|NCT02004522|156900259|FG001|Overall Study|Adverse Event|6|||
48740921|NCT02004522|156900258|FG000|Overall Study|Withdrawal by Subject|13|||
48740922|NCT02004522|156900259|FG001|Overall Study|Withdrawal by Subject|7|||
48740923|NCT02004522|156900258|FG000|Overall Study|Death|12|||
48740924|NCT02004522|156900259|FG001|Overall Study|Death|3|||
48740925|NCT02004522|156900258|FG000|Overall Study|Physician Decision|3|||
48740926|NCT02004522|156900259|FG001|Overall Study|Physician Decision|4|||
48625821|NCT00504556|156488102|FG004|Overall Study|Withdrawal by Subject|12|||
48625822|NCT00504556|156488098|FG000|Overall Study|administrative reasons|0|||
48625823|NCT00504556|156488099|FG001|Overall Study|administrative reasons|2|||
48625824|NCT00504556|156488100|FG002|Overall Study|administrative reasons|2|||
48625825|NCT00504556|156488101|FG003|Overall Study|administrative reasons|1|||
48625826|NCT00504556|156488102|FG004|Overall Study|administrative reasons|2|||
48625827|NCT00504556|156488098|FG000|Overall Study|did not meet entry criteria|2|||
48625828|NCT00504556|156488099|FG001|Overall Study|did not meet entry criteria|0|||
48625829|NCT00504556|156488100|FG002|Overall Study|did not meet entry criteria|1|||
48625830|NCT00504556|156488101|FG003|Overall Study|did not meet entry criteria|1|||
48625831|NCT00504556|156488102|FG004|Overall Study|did not meet entry criteria|0|||
48625832|NCT00504556|156488098|FG000|Overall Study|data monitor committee decision|0|||
48740927|NCT02004522|156900258|FG000|Overall Study|Protocol Violation|1|||
48740928|NCT02004522|156900259|FG001|Overall Study|Protocol Violation|0|||
48740929|NCT02004522|156900258|FG000|Overall Study|Other is reason listed by PI|4|||
48740930|NCT02004522|156900259|FG001|Overall Study|Other is reason listed by PI|1|||
48740931|NCT02004522|156900258|FG000|Overall Study|Never Dosed|2|||
48740932|NCT02004522|156900259|FG001|Overall Study|Never Dosed|4|||
48740933|NCT02004522|156900258|FG000|Overall Study|Disease Progression|35|||
48740934|NCT02004522|156900259|FG001|Overall Study|Disease Progression|31|||
48740935|NCT02004522|156900258|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
48740936|NCT02004522|156900259|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
48740937|NCT04502433|156900260|FG000|Overall Study|Death|2|||
48740938|NCT04502433|156900261|FG001|Overall Study|Death|4|||
48740939|NCT04502433|156900260|FG000|Overall Study|Lost to Follow-up|1|||
48740940|NCT04502433|156900261|FG001|Overall Study|Lost to Follow-up|0|||
48740941|NCT04502433|156900260|FG000|Overall Study|Physician Decision|0|||
48740942|NCT04502433|156900261|FG001|Overall Study|Physician Decision|1|||
48740943|NCT02252172|156900262|FG000|Overall Study|Lost to Follow-up|3|||
48740944|NCT02252172|156900263|FG001|Overall Study|Lost to Follow-up|1|||
48740945|NCT02252172|156900262|FG000|Overall Study|Ongoing|276|||
48740946|NCT02252172|156900263|FG001|Overall Study|Ongoing|298|||
48740947|NCT00674362|156900265|FG000|Double Blind|Adverse Event|6|||
48740948|NCT00674362|156900266|FG001|Double Blind|Adverse Event|6|||
48740949|NCT00674362|156900265|FG000|Double Blind|Lack of Efficacy|2|||
48740950|NCT00674362|156900266|FG001|Double Blind|Lack of Efficacy|6|||
48740951|NCT00674362|156900265|FG000|Double Blind|Loss of efficacy|0|||
48740952|NCT00674362|156900266|FG001|Double Blind|Loss of efficacy|1|||
48740953|NCT00674362|156900265|FG000|Double Blind|Withdrawal by Subject|4|||
48740954|NCT00674362|156900266|FG001|Double Blind|Withdrawal by Subject|3|||
48740955|NCT00674362|156900265|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
48740956|NCT00674362|156900266|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
48740957|NCT00674362|156900265|FG000|Double Blind|Other: Surgery|0|||
48740958|NCT00674362|156900266|FG001|Double Blind|Other: Surgery|1|||
48740959|NCT00674362|156900265|FG000|Open Label|Adverse Event|1|||
48740960|NCT00674362|156900266|FG001|Open Label|Adverse Event|0|||
48740961|NCT00674362|156900265|FG000|Open Label|Other: Subject moved to extension study|1|||
48740962|NCT00674362|156900266|FG001|Open Label|Other: Subject moved to extension study|0|||
48740963|NCT00594659|156900268|FG000|Overall Study|Lost to Follow-up|13|||
48740964|NCT00594659|156900269|FG001|Overall Study|Lost to Follow-up|9|||
48740965|NCT00594659|156900270|FG002|Overall Study|Lost to Follow-up|7|||
48740966|NCT04865289|156900271|FG000|Overall Study|Participant ongoing in study|47|||
48740967|NCT04865289|156900272|FG001|Overall Study|Participant ongoing in study|35|||
48740968|NCT04865289|156900271|FG000|Overall Study|Death|27|||
48740969|NCT04865289|156900272|FG001|Overall Study|Death|21|||
48740970|NCT02302807|156900273|FG000|Overall Study|Withdrawal by Subject|28|||
48740971|NCT02302807|156900274|FG001|Overall Study|Withdrawal by Subject|11|||
48740972|NCT02302807|156900273|FG000|Overall Study|Lost to Follow-up|4|||
48740973|NCT02302807|156900274|FG001|Overall Study|Lost to Follow-up|6|||
48740974|NCT02302807|156900273|FG000|Overall Study|Death|397|||
48740975|NCT02302807|156900274|FG001|Overall Study|Death|385|||
48740976|NCT02302807|156900273|FG000|Overall Study|Study Terminated By Sponsor|35|||
48740977|NCT02302807|156900274|FG001|Overall Study|Study Terminated By Sponsor|64|||
48740978|NCT02302807|156900273|FG000|Overall Study|Physician Decision|0|||
48740979|NCT02302807|156900274|FG001|Overall Study|Physician Decision|1|||
48740980|NCT03056573|156900275|FG000|Overall Study|Death|2|||
48740981|NCT03056573|156900276|FG001|Overall Study|Death|4|||
48740982|NCT03056573|156900275|FG000|Overall Study|Withdrawal by Subject|2|||
48740983|NCT03056573|156900276|FG001|Overall Study|Withdrawal by Subject|0|||
48740984|NCT03056573|156900275|FG000|Overall Study|Lost to Follow-up|1|||
48740985|NCT03056573|156900276|FG001|Overall Study|Lost to Follow-up|1|||
48740986|NCT05601544|156900277|FG000|Phase 2 Period 1|Adverse Event|0|||
48740987|NCT05601544|156900278|FG001|Phase 2 Period 1|Adverse Event|1|||
48740988|NCT05601544|156900279|FG002|Phase 2 Period 1|Adverse Event|0|||
48740989|NCT05601544|156900280|FG003|Phase 2 Period 1|Adverse Event|0|||
48740990|NCT05601544|156900281|FG004|Phase 2 Period 1|Adverse Event|0|||
48740991|NCT05601544|156900282|FG005|Phase 2 Period 1|Adverse Event|0|||
48740992|NCT01892722|156900283|FG000|Overall Study|Protocol deviation|0|||
48740993|NCT01892722|156900284|FG001|Overall Study|Protocol deviation|1|||
48625833|NCT00504556|156488099|FG001|Overall Study|data monitor committee decision|0|||
48625834|NCT00504556|156488100|FG002|Overall Study|data monitor committee decision|0|||
48625835|NCT00504556|156488101|FG003|Overall Study|data monitor committee decision|100|||
48625836|NCT00504556|156488102|FG004|Overall Study|data monitor committee decision|0|||
48625837|NCT00504556|156488098|FG000|Overall Study|Other|2|||
48625838|NCT00504556|156488099|FG001|Overall Study|Other|2|||
48625839|NCT00504556|156488100|FG002|Overall Study|Other|2|||
48625840|NCT00504556|156488101|FG003|Overall Study|Other|3|||
48625841|NCT00504556|156488102|FG004|Overall Study|Other|0|||
48625842|NCT00504556|156488098|FG000|Overall Study|not in safety analysis set|0|||
48625843|NCT00504556|156488099|FG001|Overall Study|not in safety analysis set|1|||
48625844|NCT00504556|156488100|FG002|Overall Study|not in safety analysis set|1|||
48625845|NCT00504556|156488101|FG003|Overall Study|not in safety analysis set|0|||
48625846|NCT00504556|156488102|FG004|Overall Study|not in safety analysis set|1|||
48625847|NCT03810365|156488103|FG000|Overall Study|Lost to Follow-up|2|||
48625848|NCT03810365|156488104|FG001|Overall Study|Lost to Follow-up|2|||
48625849|NCT03810365|156488103|FG000|Overall Study|Withdrawal by Subject|4|||
48625850|NCT03810365|156488104|FG001|Overall Study|Withdrawal by Subject|5|||
48625851|NCT03160573|156488111|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
48625852|NCT03160573|156488112|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
48625853|NCT03160573|156488113|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
48625854|NCT03160573|156488114|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
48625855|NCT00488293|156488118|FG000|Overall Study|Lost to Follow-up|28|||
48625856|NCT00488293|156488119|FG001|Overall Study|Lost to Follow-up|25|||
48625857|NCT00488293|156488118|FG000|Overall Study|Withdrawal by Subject|5|||
48625858|NCT00488293|156488119|FG001|Overall Study|Withdrawal by Subject|3|||
48625859|NCT00488293|156488118|FG000|Overall Study|Death|2|||
48625860|NCT00488293|156488119|FG001|Overall Study|Death|1|||
48625861|NCT00488293|156488118|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
48625862|NCT00488293|156488119|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
48625863|NCT01028560|156488120|FG000|Overall Study|Lack of Efficacy|3|||
48625864|NCT01028560|156488121|FG001|Overall Study|Lack of Efficacy|6|||
48625865|NCT01028560|156488120|FG000|Overall Study|Withdrawal by Subject|7|||
48625866|NCT01028560|156488121|FG001|Overall Study|Withdrawal by Subject|12|||
48625867|NCT03400787|156488122|FG000|Overall Study|Lost to Follow-up|1|||
48625868|NCT03400787|156488123|FG001|Overall Study|Lost to Follow-up|0|||
48625869|NCT03400787|156488122|FG000|Overall Study|Death|1|||
48625870|NCT03400787|156488123|FG001|Overall Study|Death|0|||
48625871|NCT03400787|156488122|FG000|Overall Study|Protocol Violation|0|||
48625872|NCT03400787|156488123|FG001|Overall Study|Protocol Violation|2|||
48625873|NCT03400787|156488122|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
48625874|NCT03400787|156488123|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
48625875|NCT00662038|156488130|FG000|Overall Study|Reason not specified|3|||
48625876|NCT00662038|156488130|FG000|Overall Study|Withdrawn consent|22|||
48625877|NCT00662038|156488130|FG000|Overall Study|Withdrawal by Subject|83|||
48625878|NCT00662038|156488130|FG000|Overall Study|Sponsor decision|1|||
48625879|NCT00662038|156488130|FG000|Overall Study|Physician Decision|19|||
48625880|NCT00662038|156488130|FG000|Overall Study|Lung transplantation|44|||
48625881|NCT00662038|156488130|FG000|Overall Study|Lost to Follow-up|1|||
48625882|NCT00662038|156488130|FG000|Overall Study|Death|95|||
48625883|NCT00662038|156488130|FG000|Overall Study|Adverse Event|358|||
48625884|NCT00662038|156488130|FG000|Overall Study|Continued treatment|5|||
48625885|NCT00397046|156488132|FG000|Overall Study|Disease Progression|3|||
48625886|NCT00397046|156488133|FG001|Overall Study|Disease Progression|3|||
48625887|NCT00397046|156488134|FG002|Overall Study|Disease Progression|10|||
48625888|NCT00397046|156488135|FG003|Overall Study|Disease Progression|5|||
48625889|NCT01791205|156488138|FG000|Phase II|Lack of Efficacy|6|||
48625890|NCT01791205|156488139|FG001|Phase II|Lack of Efficacy|0|||
48625891|NCT01791205|156488138|FG000|Phase II|Adverse Event|2|||
48625892|NCT01791205|156488139|FG001|Phase II|Adverse Event|0|||
48625893|NCT01791205|156488138|FG000|Phase II|Safety|1|||
48625894|NCT01791205|156488139|FG001|Phase II|Safety|0|||
48625895|NCT01791205|156488138|FG000|Phase II|Lost to Follow-up|1|||
48625896|NCT01791205|156488139|FG001|Phase II|Lost to Follow-up|0|||
48625897|NCT01791205|156488138|FG000|Phase II|Remission of disease|1|||
48625898|NCT01791205|156488139|FG001|Phase II|Remission of disease|0|||
48625899|NCT01791205|156488138|FG000|Phase II|Physician's decision|1|||
48625900|NCT01791205|156488139|FG001|Phase II|Physician's decision|0|||
48625901|NCT02242903|156488145|FG000|Overall Study|Withdrawal by Subject|1|||
48625902|NCT02242903|156488146|FG001|Overall Study|Withdrawal by Subject|0|||
48625903|NCT02242903|156488147|FG002|Overall Study|Withdrawal by Subject|0|||
48625904|NCT02242903|156488148|FG003|Overall Study|Withdrawal by Subject|0|||
48625905|NCT02242903|156488149|FG004|Overall Study|Withdrawal by Subject|0|||
48625906|NCT02242903|156488150|FG005|Overall Study|Withdrawal by Subject|0|||
48625907|NCT02242903|156488151|FG006|Overall Study|Withdrawal by Subject|0|||
48625908|NCT02094885|156488152|FG000|Overall Study|Death|1|||
48625909|NCT02094885|156488153|FG001|Overall Study|Death|5|||
48625910|NCT02094885|156488152|FG000|Overall Study|Withdrawn due to age|1|||
48625911|NCT02094885|156488153|FG001|Overall Study|Withdrawn due to age|0|||
48740994|NCT01892722|156900283|FG000|Overall Study|Administrative problems|0|||
48323590|NCT01371994|155382083|FG001|Overall Study|Lack of Efficacy|0|||
48323591|NCT01371994|155382082|FG000|Overall Study|Withdrawal by Subject|13|||
48740995|NCT01892722|156900284|FG001|Overall Study|Administrative problems|1|||
48323592|NCT01371994|155382083|FG001|Overall Study|Withdrawal by Subject|7|||
48323593|NCT01371994|155382082|FG000|Overall Study|Lost to Follow-up|1|||
48323594|NCT01371994|155382083|FG001|Overall Study|Lost to Follow-up|1|||
48323595|NCT01371994|155382082|FG000|Overall Study|Protocol Violation|24|||
48323596|NCT01371994|155382083|FG001|Overall Study|Protocol Violation|17|||
48625912|NCT02272985|156488154|FG000|Overall Study|Withdrawal by Subject|1|||
48625913|NCT02272985|156488154|FG000|Overall Study|hip fracture|1|||
48625914|NCT02272985|156488154|FG000|Overall Study|kidney transplantation|1|||
48625915|NCT03791060|156488155|FG000|Overall Study|Withdrawal by Subject|1|||
48625916|NCT01546987|156488156|FG000|Overall Study|Protocol Violation|3|||
48625917|NCT01546987|156488157|FG001|Overall Study|Protocol Violation|4|||
48625918|NCT02771145|156488160|FG000|Overall Study|Adverse Event|3|||
48625919|NCT02771145|156488160|FG000|Overall Study|Lost to Follow-up|1|||
48625920|NCT03533491|156488168|FG000|Overall Study|Lost to Follow-up|2|||
48625921|NCT04204902|156488171|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
48625922|NCT04204902|156488172|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
48625923|NCT01903733|156488173|FG000|Overall Study|Death|23|||
48625924|NCT01903733|156488174|FG001|Overall Study|Death|54|||
48625925|NCT01903733|156488175|FG002|Overall Study|Death|30|||
48625926|NCT01903733|156488176|FG003|Overall Study|Death|98|||
48625927|NCT01903733|156488173|FG000|Overall Study|Participant refused further follow-up|35|||
48625928|NCT01903733|156488174|FG001|Overall Study|Participant refused further follow-up|38|||
48625929|NCT01903733|156488175|FG002|Overall Study|Participant refused further follow-up|13|||
48625930|NCT01903733|156488176|FG003|Overall Study|Participant refused further follow-up|9|||
48625931|NCT01903733|156488173|FG000|Overall Study|Lost to Follow-up|18|||
48625932|NCT01903733|156488174|FG001|Overall Study|Lost to Follow-up|19|||
48625933|NCT01903733|156488175|FG002|Overall Study|Lost to Follow-up|6|||
48625934|NCT01903733|156488176|FG003|Overall Study|Lost to Follow-up|9|||
48625935|NCT01903733|156488173|FG000|Overall Study|Other|10|||
48625936|NCT01903733|156488174|FG001|Overall Study|Other|15|||
48625937|NCT01903733|156488175|FG002|Overall Study|Other|12|||
48625938|NCT01903733|156488176|FG003|Overall Study|Other|3|||
48625939|NCT01903733|156488173|FG000|Overall Study|Missing|2|||
48625940|NCT01903733|156488174|FG001|Overall Study|Missing|0|||
48625941|NCT01903733|156488175|FG002|Overall Study|Missing|0|||
48625942|NCT01903733|156488176|FG003|Overall Study|Missing|0|||
48625943|NCT01903733|156488173|FG000|Overall Study|Investigator request|18|||
48625944|NCT01903733|156488174|FG001|Overall Study|Investigator request|0|||
48625945|NCT01903733|156488175|FG002|Overall Study|Investigator request|0|||
48625946|NCT01903733|156488176|FG003|Overall Study|Investigator request|0|||
48625947|NCT04191616|156488177|FG000|Overall Study|Death|26|||
48625948|NCT04191616|156488177|FG000|Overall Study|Withdrawal by Subject|1|||
48625949|NCT04191616|156488177|FG000|Overall Study|Sponsor decision|2|||
48625950|NCT04191616|156488177|FG000|Overall Study|Continuing study|25|||
48625957|NCT00421408|156488189|FG000|Overall Study|Lost to Follow-up|30|||
48625958|NCT00421408|156488190|FG001|Overall Study|Lost to Follow-up|20|||
48625959|NCT00421408|156488189|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
48625960|NCT00421408|156488190|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
48740996|NCT01892722|156900283|FG000|Overall Study|Patient/guardian decision|0|||
48740997|NCT01892722|156900284|FG001|Overall Study|Patient/guardian decision|2|||
48740998|NCT01892722|156900283|FG000|Overall Study|Physician Decision|1|||
48625961|NCT02414841|156488191|FG000|Overall Study|Withdrawal by Subject|7|||
48323597|NCT01371994|155382082|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
48323598|NCT01371994|155382083|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
48625962|NCT02414841|156488192|FG001|Overall Study|Withdrawal by Subject|5|||
48625963|NCT02414841|156488191|FG000|Overall Study|Lost to Follow-up|13|||
48625964|NCT02414841|156488192|FG001|Overall Study|Lost to Follow-up|6|||
48625965|NCT02414841|156488191|FG000|Overall Study|Death|17|||
48625966|NCT02414841|156488192|FG001|Overall Study|Death|14|||
48625967|NCT02414841|156488191|FG000|Overall Study|Received a Kidney Transplant|13|||
48625968|NCT02414841|156488192|FG001|Overall Study|Received a Kidney Transplant|4|||
48625969|NCT02414841|156488191|FG000|Overall Study|Randomized But Not Treated|6|||
48740999|NCT01892722|156900284|FG001|Overall Study|Physician Decision|2|||
48741000|NCT01892722|156900283|FG000|Overall Study|Adverse Event|3|||
48741001|NCT01892722|156900284|FG001|Overall Study|Adverse Event|2|||
48625970|NCT02414841|156488192|FG001|Overall Study|Randomized But Not Treated|4|||
48625971|NCT05486065|156488196|FG000|Overall Study|Withdrawal by Subject|1|||
48625972|NCT05486065|156488197|FG001|Overall Study|Withdrawal by Subject|5|||
48741002|NCT01892722|156900283|FG000|Overall Study|Lack of Efficacy|0|||
48741003|NCT01892722|156900284|FG001|Overall Study|Lack of Efficacy|7|||
48741004|NCT01892722|156900283|FG000|Overall Study|Withdrawal by Subject|3|||
48741005|NCT01892722|156900284|FG001|Overall Study|Withdrawal by Subject|5|||
48741006|NCT01199133|156900285|FG000|Year 1|Adverse Event|16|||
48741007|NCT01199133|156900286|FG001|Year 1|Adverse Event|4|||
48741008|NCT01199133|156900285|FG000|Year 1|Withdrawal by Subject|8|||
48741009|NCT01199133|156900286|FG001|Year 1|Withdrawal by Subject|4|||
48625973|NCT05486065|156488198|FG002|Overall Study|Withdrawal by Subject|4|||
48625974|NCT05486065|156488199|FG003|Overall Study|Withdrawal by Subject|3|||
48625975|NCT05486065|156488196|FG000|Overall Study|Lost to Follow-up|4|||
48625976|NCT05486065|156488197|FG001|Overall Study|Lost to Follow-up|2|||
48625977|NCT05486065|156488198|FG002|Overall Study|Lost to Follow-up|2|||
48625978|NCT05486065|156488199|FG003|Overall Study|Lost to Follow-up|2|||
48625979|NCT05486065|156488196|FG000|Overall Study|Physician Decision|0|||
48625980|NCT05486065|156488197|FG001|Overall Study|Physician Decision|1|||
48625981|NCT05486065|156488198|FG002|Overall Study|Physician Decision|1|||
48625982|NCT05486065|156488199|FG003|Overall Study|Physician Decision|0|||
48625983|NCT05486065|156488196|FG000|Overall Study|Failure to meet randomization criteria|0|||
48625984|NCT05486065|156488197|FG001|Overall Study|Failure to meet randomization criteria|0|||
48741010|NCT01199133|156900285|FG000|Year 1|Any other reason not above-mentioned|6|||
48741011|NCT01199133|156900286|FG001|Year 1|Any other reason not above-mentioned|7|||
48741012|NCT01199133|156900285|FG000|Year 2|Adverse Event|1|||
48625985|NCT05486065|156488198|FG002|Overall Study|Failure to meet randomization criteria|0|||
48741013|NCT01199133|156900286|FG001|Year 2|Adverse Event|0|||
48741014|NCT01199133|156900285|FG000|Year 2|Withdrawal by Subject|1|||
48741015|NCT01199133|156900286|FG001|Year 2|Withdrawal by Subject|1|||
48741016|NCT01199133|156900285|FG000|Year 2|Any other reason not above-mentioned|1|||
48625986|NCT05486065|156488199|FG003|Overall Study|Failure to meet randomization criteria|1|||
48625987|NCT01197300|156489873|FG000|Overall Study|Lost to Follow-up|0|||
48625988|NCT01197300|156489874|FG001|Overall Study|Lost to Follow-up|1|||
48625989|NCT01197300|156489873|FG000|Overall Study|Protocol Violation|0|||
48625990|NCT01197300|156489874|FG001|Overall Study|Protocol Violation|1|||
48625991|NCT01832038|156489875|FG000|Overall Study|Death|5|||
48625992|NCT01832038|156489875|FG000|Overall Study|Adverse Event|50|||
48741017|NCT01199133|156900286|FG001|Year 2|Any other reason not above-mentioned|2|||
48741018|NCT03742258|156900287|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
48741019|NCT03742258|156900288|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
48741020|NCT03742258|156900289|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
48625993|NCT01832038|156489875|FG000|Overall Study|Lack of Efficacy|81|||
48625994|NCT01832038|156489875|FG000|Overall Study|Protocol Violation|7|||
48625995|NCT01832038|156489875|FG000|Overall Study|Lost to Follow-up|10|||
48625996|NCT01832038|156489875|FG000|Overall Study|Withdrawal by Subject|49|||
48625997|NCT01832038|156489875|FG000|Overall Study|Visit non-compliance|2|||
48625998|NCT01832038|156489875|FG000|Overall Study|Subject refused to return visit|2|||
48741021|NCT03742258|156900287|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
48741022|NCT03742258|156900288|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
48741023|NCT03742258|156900289|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
48741024|NCT03742258|156900287|FG000|Survival Follow-Up|Still in Follow-up|0|||
48625999|NCT01832038|156489875|FG000|Overall Study|Not convenient to come back to site|2|||
48626000|NCT01832038|156489875|FG000|Overall Study|Participant was asked to quit|5|||
48626001|NCT01832038|156489875|FG000|Overall Study|Back home|1|||
48626002|NCT01832038|156489875|FG000|Overall Study|Pregnancy|1|||
48626003|NCT01832038|156489875|FG000|Overall Study|Low compliance|3|||
48626004|NCT01832038|156489875|FG000|Overall Study|Prohibit procedure|2|||
48626005|NCT01832038|156489875|FG000|Overall Study|Not possible to visit the hospital|1|||
48626006|NCT01832038|156489875|FG000|Overall Study|Changes of implementation system|3|||
48626007|NCT01832038|156489875|FG000|Overall Study|Plan to pregnancy|7|||
48626008|NCT01832038|156489875|FG000|Overall Study|Bad mood and has suicidal thought|1|||
48626009|NCT01832038|156489875|FG000|Overall Study|Prohibited concomitant medication|1|||
48626010|NCT01832038|156489875|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
48626011|NCT01832038|156489875|FG000|Overall Study|Subject considered the efficacy was poor|1|||
48626012|NCT00004228|156489876|FG000|Overall Study|Adverse Event|0|||
48626013|NCT00004228|156489877|FG001|Overall Study|Adverse Event|1|||
48626014|NCT00004228|156489878|FG002|Overall Study|Adverse Event|0|||
48626015|NCT00004228|156489879|FG003|Overall Study|Adverse Event|0|||
48626016|NCT00004228|156489880|FG004|Overall Study|Adverse Event|1|||
48626017|NCT00004228|156489881|FG005|Overall Study|Adverse Event|0|||
48626018|NCT00004228|156489882|FG006|Overall Study|Adverse Event|0|||
48626019|NCT00004228|156489876|FG000|Overall Study|Death|0|||
48626020|NCT00004228|156489877|FG001|Overall Study|Death|1|||
48626021|NCT00004228|156489878|FG002|Overall Study|Death|2|||
48626022|NCT00004228|156489879|FG003|Overall Study|Death|0|||
48626023|NCT00004228|156489880|FG004|Overall Study|Death|1|||
48626024|NCT00004228|156489881|FG005|Overall Study|Death|0|||
48626025|NCT00004228|156489882|FG006|Overall Study|Death|0|||
48626026|NCT00004228|156489876|FG000|Overall Study|Lack of Efficacy|1|||
48626027|NCT00004228|156489877|FG001|Overall Study|Lack of Efficacy|6|||
48626028|NCT00004228|156489878|FG002|Overall Study|Lack of Efficacy|5|||
48626029|NCT00004228|156489879|FG003|Overall Study|Lack of Efficacy|3|||
48626030|NCT00004228|156489880|FG004|Overall Study|Lack of Efficacy|9|||
48626031|NCT00004228|156489881|FG005|Overall Study|Lack of Efficacy|8|||
48626032|NCT00004228|156489882|FG006|Overall Study|Lack of Efficacy|4|||
48626033|NCT00004228|156489876|FG000|Overall Study|Lost to Follow-up|0|||
48626034|NCT00004228|156489877|FG001|Overall Study|Lost to Follow-up|0|||
48626035|NCT00004228|156489878|FG002|Overall Study|Lost to Follow-up|1|||
48626036|NCT00004228|156489879|FG003|Overall Study|Lost to Follow-up|0|||
48626037|NCT00004228|156489880|FG004|Overall Study|Lost to Follow-up|0|||
48626038|NCT00004228|156489881|FG005|Overall Study|Lost to Follow-up|0|||
48626039|NCT00004228|156489882|FG006|Overall Study|Lost to Follow-up|0|||
48626040|NCT00004228|156489876|FG000|Overall Study|Physician Decision|1|||
48626041|NCT00004228|156489877|FG001|Overall Study|Physician Decision|0|||
48626042|NCT00004228|156489878|FG002|Overall Study|Physician Decision|3|||
48626043|NCT00004228|156489879|FG003|Overall Study|Physician Decision|2|||
48626044|NCT00004228|156489880|FG004|Overall Study|Physician Decision|1|||
48626045|NCT00004228|156489881|FG005|Overall Study|Physician Decision|1|||
48741025|NCT03742258|156900288|FG001|Survival Follow-Up|Still in Follow-up|0|||
48323599|NCT01371994|155382082|FG000|Overall Study|Physician Decision|1|||
48626046|NCT00004228|156489882|FG006|Overall Study|Physician Decision|1|||
48626047|NCT00004228|156489876|FG000|Overall Study|Protocol Violation|0|||
48626048|NCT00004228|156489877|FG001|Overall Study|Protocol Violation|5|||
48626049|NCT00004228|156489878|FG002|Overall Study|Protocol Violation|2|||
48626050|NCT00004228|156489879|FG003|Overall Study|Protocol Violation|1|||
48626051|NCT00004228|156489880|FG004|Overall Study|Protocol Violation|1|||
48626052|NCT00004228|156489881|FG005|Overall Study|Protocol Violation|2|||
48626053|NCT00004228|156489882|FG006|Overall Study|Protocol Violation|0|||
48323600|NCT01371994|155382083|FG001|Overall Study|Physician Decision|1|||
48323601|NCT01371994|155382082|FG000|Overall Study|Miscellaneous Reasons|6|||
48323602|NCT01371994|155382083|FG001|Overall Study|Miscellaneous Reasons|4|||
48323603|NCT00372775|155383633|FG000|Overall Study|Adverse Event|8|||
48323604|NCT00372775|155383633|FG000|Overall Study|Death|15|||
48323605|NCT00372775|155383633|FG000|Overall Study|Objective progression or relapse|30|||
48323606|NCT00372775|155383633|FG000|Overall Study|Global deterioration of health status|6|||
48323607|NCT00372775|155383633|FG000|Overall Study|Withdrawal by Subject|1|||
48626054|NCT00004228|156489876|FG000|Overall Study|Withdrawal by Subject|3|||
48626055|NCT00004228|156489877|FG001|Overall Study|Withdrawal by Subject|0|||
48323608|NCT00372775|155383633|FG000|Overall Study|Other|1|||
48323609|NCT00372775|155383633|FG000|Overall Study|Not Treated|2|||
48323610|NCT03875313|155383634|FG000|Overall Study|Withdrawal by Subject|1|||
48323611|NCT03875313|155383635|FG001|Overall Study|Withdrawal by Subject|3|||
48323612|NCT03875313|155383636|FG002|Overall Study|Withdrawal by Subject|0|||
48323613|NCT03875313|155383637|FG003|Overall Study|Withdrawal by Subject|0|||
48323614|NCT03875313|155383638|FG004|Overall Study|Withdrawal by Subject|0|||
48323615|NCT03875313|155383634|FG000|Overall Study|Death|0|||
48323616|NCT03875313|155383635|FG001|Overall Study|Death|0|||
48323617|NCT03875313|155383636|FG002|Overall Study|Death|0|||
48323618|NCT03875313|155383637|FG003|Overall Study|Death|0|||
48323619|NCT03875313|155383638|FG004|Overall Study|Death|1|||
48323620|NCT03875313|155383634|FG000|Overall Study|Lost to Follow-up|0|||
48323621|NCT03875313|155383635|FG001|Overall Study|Lost to Follow-up|0|||
48323622|NCT03875313|155383636|FG002|Overall Study|Lost to Follow-up|0|||
48323623|NCT03875313|155383637|FG003|Overall Study|Lost to Follow-up|0|||
48323624|NCT03875313|155383638|FG004|Overall Study|Lost to Follow-up|1|||
48323625|NCT03875313|155383634|FG000|Overall Study|Study Termination by Sponsor|0|||
48323626|NCT03875313|155383635|FG001|Overall Study|Study Termination by Sponsor|1|||
48323627|NCT03875313|155383636|FG002|Overall Study|Study Termination by Sponsor|1|||
48323628|NCT03875313|155383637|FG003|Overall Study|Study Termination by Sponsor|0|||
48323629|NCT03875313|155383638|FG004|Overall Study|Study Termination by Sponsor|1|||
48323630|NCT03875313|155383634|FG000|Overall Study|New Anticancer Treatment|0|||
48323631|NCT03875313|155383635|FG001|Overall Study|New Anticancer Treatment|1|||
48626056|NCT00004228|156489878|FG002|Overall Study|Withdrawal by Subject|1|||
48626057|NCT00004228|156489879|FG003|Overall Study|Withdrawal by Subject|0|||
48626058|NCT00004228|156489880|FG004|Overall Study|Withdrawal by Subject|2|||
48626059|NCT00004228|156489881|FG005|Overall Study|Withdrawal by Subject|1|||
48626060|NCT00004228|156489882|FG006|Overall Study|Withdrawal by Subject|2|||
48626061|NCT00004228|156489876|FG000|Overall Study|Other|0|||
48626062|NCT00004228|156489877|FG001|Overall Study|Other|0|||
48626063|NCT00004228|156489878|FG002|Overall Study|Other|1|||
48626064|NCT00004228|156489879|FG003|Overall Study|Other|0|||
48626065|NCT00004228|156489880|FG004|Overall Study|Other|0|||
48626066|NCT00004228|156489881|FG005|Overall Study|Other|0|||
48626067|NCT00004228|156489882|FG006|Overall Study|Other|0|||
48626068|NCT00004228|156489876|FG000|Overall Study|ineligible|4|||
48626069|NCT00004228|156489877|FG001|Overall Study|ineligible|2|||
48626070|NCT00004228|156489878|FG002|Overall Study|ineligible|4|||
48626071|NCT00004228|156489879|FG003|Overall Study|ineligible|1|||
48626072|NCT00004228|156489880|FG004|Overall Study|ineligible|1|||
48626073|NCT00004228|156489881|FG005|Overall Study|ineligible|2|||
48626074|NCT00004228|156489882|FG006|Overall Study|ineligible|5|||
48626075|NCT00903344|156489885|FG000|Overall Study|Pregnancy|2|||
48626076|NCT00903344|156489886|FG001|Overall Study|Pregnancy|3|||
48626077|NCT00903344|156489885|FG000|Overall Study|Lost to Follow-up|3|||
48626078|NCT00903344|156489886|FG001|Overall Study|Lost to Follow-up|0|||
48626079|NCT02595437|156489892|FG000|Triferic Via IV|Withdrawal by Subject|1|||
48626080|NCT01423084|156489893|FG000|Overall Study|Adverse Event|0|||
48626081|NCT01423084|156489894|FG001|Overall Study|Adverse Event|1|||
48323632|NCT03875313|155383636|FG002|Overall Study|New Anticancer Treatment|2|||
48323633|NCT03875313|155383637|FG003|Overall Study|New Anticancer Treatment|1|||
48323634|NCT03875313|155383638|FG004|Overall Study|New Anticancer Treatment|0|||
48323635|NCT03875313|155383634|FG000|Overall Study|Other, Not Specified|2|||
48323636|NCT03875313|155383635|FG001|Overall Study|Other, Not Specified|11|||
48323637|NCT03875313|155383636|FG002|Overall Study|Other, Not Specified|3|||
48323638|NCT03875313|155383637|FG003|Overall Study|Other, Not Specified|3|||
48323639|NCT03875313|155383638|FG004|Overall Study|Other, Not Specified|1|||
48323640|NCT04121546|155383640|FG000|Overall Study|Lost to Follow-up|1|||
48323641|NCT04121546|155383641|FG001|Overall Study|Lost to Follow-up|3|||
48323642|NCT00366249|155383642|FG000|Overall Study|Adverse Event|53|||
48626082|NCT01423084|156489893|FG000|Overall Study|Withdrawal by Subject|2|||
48626083|NCT01423084|156489894|FG001|Overall Study|Withdrawal by Subject|3|||
48626084|NCT03574389|156489895|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
48626085|NCT03574389|156489896|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
48323643|NCT00366249|155383643|FG001|Overall Study|Adverse Event|28|||
48323644|NCT00366249|155383642|FG000|Overall Study|Death|0|||
48626086|NCT03574389|156489897|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
48323645|NCT00366249|155383643|FG001|Overall Study|Death|1|||
48626087|NCT03574389|156489898|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
48626088|NCT03574389|156489899|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
48626089|NCT03574389|156489900|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
48626090|NCT03574389|156489901|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
48626091|NCT03574389|156489895|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
48626092|NCT03574389|156489896|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
48626093|NCT03574389|156489897|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
48626094|NCT03574389|156489898|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
48626095|NCT03574389|156489899|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
48626096|NCT03574389|156489900|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
48626097|NCT03574389|156489901|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
48626098|NCT03574389|156489895|FG000|Vaccination Period|Other|6|||
48626099|NCT03574389|156489896|FG001|Vaccination Period|Other|0|||
48626100|NCT03574389|156489897|FG002|Vaccination Period|Other|0|||
48626101|NCT03574389|156489898|FG003|Vaccination Period|Other|0|||
48626102|NCT03574389|156489899|FG004|Vaccination Period|Other|0|||
48626103|NCT03574389|156489900|FG005|Vaccination Period|Other|0|||
48626104|NCT03574389|156489901|FG006|Vaccination Period|Other|0|||
48626105|NCT03574389|156489895|FG000|Vaccination Period|Adverse Event|0|||
48626106|NCT03574389|156489896|FG001|Vaccination Period|Adverse Event|1|||
48626107|NCT03574389|156489897|FG002|Vaccination Period|Adverse Event|0|||
48626108|NCT03574389|156489898|FG003|Vaccination Period|Adverse Event|0|||
48626109|NCT03574389|156489899|FG004|Vaccination Period|Adverse Event|0|||
48626110|NCT03574389|156489900|FG005|Vaccination Period|Adverse Event|0|||
48626111|NCT03574389|156489901|FG006|Vaccination Period|Adverse Event|0|||
48626112|NCT03574389|156489895|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
48626113|NCT03574389|156489896|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
48626114|NCT03574389|156489897|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
48626115|NCT03574389|156489898|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
48626116|NCT03574389|156489899|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
48626117|NCT03574389|156489900|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
48626118|NCT03574389|156489901|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
48626119|NCT01517178|156489902|FG000|Period 1|Adverse Event|1|||
48626120|NCT01517178|156489903|FG001|Period 1|Adverse Event|2|||
48626121|NCT01517178|156489902|FG000|Period 1|Lack of Efficacy|0|||
48626122|NCT01517178|156489903|FG001|Period 1|Lack of Efficacy|1|||
48626123|NCT01517178|156489902|FG000|Period 1|E.g. study termination|3|||
48626124|NCT01517178|156489903|FG001|Period 1|E.g. study termination|1|||
48626125|NCT01517178|156489902|FG000|Period 1|Withdrawal by Subject|0|||
48626126|NCT01517178|156489903|FG001|Period 1|Withdrawal by Subject|1|||
48626127|NCT01517178|156489902|FG000|Period 2|Adverse Event|1|||
48626128|NCT01517178|156489903|FG001|Period 2|Adverse Event|0|||
48626129|NCT01517178|156489902|FG000|Period 2|Withdrawal by Subject|3|||
48626130|NCT01517178|156489903|FG001|Period 2|Withdrawal by Subject|0|||
48626131|NCT01517178|156489902|FG000|Period 2|E.g. study termination|2|||
48626132|NCT01517178|156489903|FG001|Period 2|E.g. study termination|2|||
48626133|NCT01908699|156489904|FG000|Overall Study|Adverse Event|8|||
48626134|NCT01908699|156489905|FG001|Overall Study|Adverse Event|12|||
48626135|NCT01908699|156489904|FG000|Overall Study|Lack of Efficacy|2|||
48626136|NCT01908699|156489905|FG001|Overall Study|Lack of Efficacy|2|||
48626137|NCT01908699|156489904|FG000|Overall Study|Lost to Follow-up|2|||
48626138|NCT01908699|156489905|FG001|Overall Study|Lost to Follow-up|4|||
48626139|NCT01908699|156489904|FG000|Overall Study|Physician Decision|8|||
48626140|NCT01908699|156489905|FG001|Overall Study|Physician Decision|8|||
48626141|NCT01908699|156489904|FG000|Overall Study|Withdrawal by Subject|15|||
48626142|NCT01908699|156489905|FG001|Overall Study|Withdrawal by Subject|10|||
48626143|NCT01908699|156489904|FG000|Overall Study|Pregnancy|0|||
48626144|NCT01908699|156489905|FG001|Overall Study|Pregnancy|1|||
48626145|NCT01908699|156489904|FG000|Overall Study|Randomized in Error|1|||
48626146|NCT01908699|156489905|FG001|Overall Study|Randomized in Error|0|||
48626147|NCT01908699|156489904|FG000|Overall Study|Death|9|||
48626148|NCT01908699|156489905|FG001|Overall Study|Death|12|||
48741026|NCT03742258|156900289|FG002|Survival Follow-Up|Still in Follow-up|2|||
48626149|NCT01908699|156489904|FG000|Overall Study|Progressive Disease|30|||
48626150|NCT01908699|156489905|FG001|Overall Study|Progressive Disease|29|||
48626151|NCT00493285|156489908|FG000|Overall Study|Lost to Follow-up|0|||
48626152|NCT00493285|156489909|FG001|Overall Study|Lost to Follow-up|0|||
48323646|NCT00366249|155383642|FG000|Overall Study|Physician Decision|5|||
48626153|NCT00493285|156489910|FG002|Overall Study|Lost to Follow-up|0|||
48626154|NCT00493285|156489911|FG003|Overall Study|Lost to Follow-up|0|||
48626155|NCT00493285|156489912|FG004|Overall Study|Lost to Follow-up|1|||
48626156|NCT00493285|156489913|FG005|Overall Study|Lost to Follow-up|0|||
48626157|NCT02003898|156489914|FG000|Overall Study|Death|3|||
48626158|NCT02003898|156489914|FG000|Overall Study|Lost to Follow-up|12|||
48626159|NCT02003898|156489914|FG000|Overall Study|Withdrawal by Subject|52|||
48626160|NCT04535362|156489915|FG000|Overall Study|Lost to Follow-up|3|||
48626161|NCT04535362|156489916|FG001|Overall Study|Lost to Follow-up|1|||
48626162|NCT01592747|156489923|FG000|Overall Study|Loss of Therapeutic Response|107|||
48741027|NCT04424316|156900292|FG000|Overall Study|Adverse Event|0|||
48626163|NCT01592747|156489924|FG001|Overall Study|Loss of Therapeutic Response|108|||
48626164|NCT01592747|156489925|FG002|Overall Study|Loss of Therapeutic Response|100|||
48626165|NCT01592747|156489923|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
48626166|NCT01592747|156489924|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
48741028|NCT04424316|156900293|FG001|Overall Study|Adverse Event|1|||
48741029|NCT04424316|156900294|FG002|Overall Study|Adverse Event|0|||
48741030|NCT04424316|156900295|FG003|Overall Study|Adverse Event|0|||
48741031|NCT04424316|156900292|FG000|Overall Study|Death|1|||
48741032|NCT04424316|156900293|FG001|Overall Study|Death|0|||
48741033|NCT04424316|156900294|FG002|Overall Study|Death|8|||
48741034|NCT04424316|156900295|FG003|Overall Study|Death|14|||
48741035|NCT04424316|156900292|FG000|Overall Study|Lost to Follow-up|93|||
48741036|NCT04424316|156900293|FG001|Overall Study|Lost to Follow-up|88|||
48741037|NCT04424316|156900294|FG002|Overall Study|Lost to Follow-up|224|||
48741038|NCT04424316|156900295|FG003|Overall Study|Lost to Follow-up|211|||
48741039|NCT04424316|156900292|FG000|Overall Study|No longer met eligibility criteria|1|||
48741040|NCT04424316|156900293|FG001|Overall Study|No longer met eligibility criteria|0|||
48741041|NCT04424316|156900294|FG002|Overall Study|No longer met eligibility criteria|0|||
48741042|NCT04424316|156900295|FG003|Overall Study|No longer met eligibility criteria|0|||
48741043|NCT04424316|156900292|FG000|Overall Study|Other|15|||
48626167|NCT01592747|156489925|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
48626168|NCT01592747|156489923|FG000|Overall Study|Adverse Event|1|||
48626169|NCT01592747|156489924|FG001|Overall Study|Adverse Event|0|||
48626170|NCT01592747|156489925|FG002|Overall Study|Adverse Event|0|||
48626171|NCT01592747|156489923|FG000|Overall Study|Protocol Violation|4|||
48626172|NCT01592747|156489924|FG001|Overall Study|Protocol Violation|0|||
48626173|NCT01592747|156489925|FG002|Overall Study|Protocol Violation|4|||
48626174|NCT01592747|156489923|FG000|Overall Study|Lack of Efficacy|0|||
48626175|NCT01592747|156489924|FG001|Overall Study|Lack of Efficacy|1|||
48626176|NCT01592747|156489925|FG002|Overall Study|Lack of Efficacy|0|||
48626177|NCT01592747|156489923|FG000|Overall Study|Withdrawal by Subject|2|||
48626178|NCT01592747|156489924|FG001|Overall Study|Withdrawal by Subject|0|||
48626179|NCT01592747|156489925|FG002|Overall Study|Withdrawal by Subject|2|||
48626180|NCT01592747|156489923|FG000|Overall Study|Lost to Follow-up|1|||
48626181|NCT01592747|156489924|FG001|Overall Study|Lost to Follow-up|0|||
48626182|NCT01592747|156489925|FG002|Overall Study|Lost to Follow-up|1|||
48626183|NCT01592747|156489923|FG000|Overall Study|Other Reasons|1|||
48626184|NCT01592747|156489924|FG001|Overall Study|Other Reasons|1|||
48626185|NCT01592747|156489925|FG002|Overall Study|Other Reasons|0|||
48626186|NCT00266032|156489926|FG000|Treatment|Adverse Event|42|||
48626187|NCT00266032|156489927|FG001|Treatment|Adverse Event|26|||
48626188|NCT00266032|156489928|FG002|Treatment|Adverse Event|10|||
48626189|NCT00266032|156489926|FG000|Treatment|Lost to Follow-up|19|||
48626190|NCT00266032|156489927|FG001|Treatment|Lost to Follow-up|4|||
48626191|NCT00266032|156489928|FG002|Treatment|Lost to Follow-up|2|||
48626192|NCT00266032|156489926|FG000|Treatment|Pregnancy|3|||
48626193|NCT00266032|156489927|FG001|Treatment|Pregnancy|2|||
48626194|NCT00266032|156489928|FG002|Treatment|Pregnancy|2|||
48626195|NCT00266032|156489926|FG000|Treatment|Protocol Violation|6|||
48626196|NCT00266032|156489927|FG001|Treatment|Protocol Violation|14|||
48626197|NCT00266032|156489928|FG002|Treatment|Protocol Violation|13|||
48626198|NCT00266032|156489926|FG000|Treatment|Withdrawal by Subject|28|||
48626199|NCT00266032|156489927|FG001|Treatment|Withdrawal by Subject|13|||
48741044|NCT04424316|156900293|FG001|Overall Study|Other|11|||
48626200|NCT00266032|156489928|FG002|Treatment|Withdrawal by Subject|12|||
48626201|NCT00266032|156489926|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
48626202|NCT00266032|156489927|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
48626203|NCT00266032|156489928|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
48626204|NCT00266032|156489926|FG000|Open-label Safety Extension|Adverse Event|5|||
48626205|NCT00266032|156489927|FG001|Open-label Safety Extension|Adverse Event|0|||
48626206|NCT00266032|156489928|FG002|Open-label Safety Extension|Adverse Event|4|||
48626207|NCT00266032|156489926|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
48626208|NCT00266032|156489927|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
48741045|NCT04424316|156900294|FG002|Overall Study|Other|34|||
48741046|NCT04424316|156900295|FG003|Overall Study|Other|45|||
48741047|NCT04424316|156900292|FG000|Overall Study|Physician Decision|1|||
48626209|NCT00266032|156489928|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
48626210|NCT00266032|156489926|FG000|Open-label Safety Extension|Pregnancy|4|||
48626211|NCT00266032|156489927|FG001|Open-label Safety Extension|Pregnancy|1|||
48626212|NCT00266032|156489928|FG002|Open-label Safety Extension|Pregnancy|2|||
48626213|NCT00266032|156489926|FG000|Open-label Safety Extension|Protocol Violation|1|||
48626214|NCT00266032|156489927|FG001|Open-label Safety Extension|Protocol Violation|3|||
48741048|NCT04424316|156900293|FG001|Overall Study|Physician Decision|0|||
48741049|NCT04424316|156900294|FG002|Overall Study|Physician Decision|1|||
48741050|NCT04424316|156900295|FG003|Overall Study|Physician Decision|1|||
48741051|NCT04424316|156900292|FG000|Overall Study|Protocol Violation|0|||
48741052|NCT04424316|156900293|FG001|Overall Study|Protocol Violation|1|||
48741053|NCT04424316|156900294|FG002|Overall Study|Protocol Violation|0|||
48741054|NCT04424316|156900295|FG003|Overall Study|Protocol Violation|0|||
48741055|NCT04424316|156900292|FG000|Overall Study|Withdrawal by Subject|71|||
48741056|NCT04424316|156900293|FG001|Overall Study|Withdrawal by Subject|77|||
48741057|NCT04424316|156900294|FG002|Overall Study|Withdrawal by Subject|0|||
48741058|NCT04424316|156900295|FG003|Overall Study|Withdrawal by Subject|0|||
48626215|NCT00266032|156489928|FG002|Open-label Safety Extension|Protocol Violation|2|||
48626216|NCT00266032|156489926|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
48626217|NCT00266032|156489927|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
48626218|NCT00266032|156489928|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
48626219|NCT00266032|156489926|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
48626220|NCT00266032|156489927|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
48626221|NCT00266032|156489928|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
48626222|NCT00124657|156489930|FG000|Overall Study|Toxicity|0|||
48626223|NCT00124657|156489931|FG001|Overall Study|Toxicity|0|||
48626224|NCT00124657|156489932|FG002|Overall Study|Toxicity|1|||
48626225|NCT00124657|156489930|FG000|Overall Study|Non-compliance|1|||
48626226|NCT00124657|156489931|FG001|Overall Study|Non-compliance|0|||
48626227|NCT00124657|156489932|FG002|Overall Study|Non-compliance|4|||
48626228|NCT00124657|156489930|FG000|Overall Study|Progressive disease|14|||
48626229|NCT00124657|156489931|FG001|Overall Study|Progressive disease|5|||
48626230|NCT00124657|156489932|FG002|Overall Study|Progressive disease|27|||
48626231|NCT00124657|156489930|FG000|Overall Study|Intercurrent illness|1|||
48626232|NCT00124657|156489931|FG001|Overall Study|Intercurrent illness|0|||
48626233|NCT00124657|156489932|FG002|Overall Study|Intercurrent illness|0|||
48626234|NCT04985682|156489935|FG000|Overall Study|Withdrawal by Subject|1|||
48626235|NCT05122143|156489936|FG000|Overall Study|Adverse Event|1|||
48626236|NCT05122143|156489937|FG001|Overall Study|Adverse Event|0|||
48626237|NCT05122143|156489938|FG002|Overall Study|Adverse Event|0|||
48626238|NCT05122143|156489939|FG003|Overall Study|Adverse Event|0|||
48626239|NCT05122143|156489940|FG004|Overall Study|Adverse Event|1|||
48626240|NCT05122143|156489941|FG005|Overall Study|Adverse Event|0|||
48626241|NCT05122143|156489936|FG000|Overall Study|Protocol non-compliance|0|||
48626242|NCT05122143|156489937|FG001|Overall Study|Protocol non-compliance|0|||
48626243|NCT05122143|156489938|FG002|Overall Study|Protocol non-compliance|1|||
48626244|NCT05122143|156489939|FG003|Overall Study|Protocol non-compliance|0|||
48626245|NCT05122143|156489940|FG004|Overall Study|Protocol non-compliance|0|||
48626246|NCT05122143|156489941|FG005|Overall Study|Protocol non-compliance|0|||
48626247|NCT05122143|156489936|FG000|Overall Study|Covid contact|0|||
48626248|NCT05122143|156489937|FG001|Overall Study|Covid contact|0|||
48626249|NCT05122143|156489938|FG002|Overall Study|Covid contact|0|||
48626250|NCT05122143|156489939|FG003|Overall Study|Covid contact|0|||
48626251|NCT05122143|156489940|FG004|Overall Study|Covid contact|1|||
48626252|NCT05122143|156489941|FG005|Overall Study|Covid contact|0|||
48626253|NCT01475825|156489947|FG000|Overall Study|Adverse Event|41|||
48626254|NCT01475825|156489948|FG001|Overall Study|Adverse Event|15|||
48626255|NCT01475825|156489949|FG002|Overall Study|Adverse Event|27|||
48626256|NCT01475825|156489950|FG003|Overall Study|Adverse Event|11|||
48741059|NCT04424316|156900292|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48741060|NCT04424316|156900293|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48741061|NCT04424316|156900294|FG002|Overall Study|Withdrawal by parent/guardian|74|||
48741062|NCT04424316|156900295|FG003|Overall Study|Withdrawal by parent/guardian|81|||
48323647|NCT00366249|155383643|FG001|Overall Study|Physician Decision|2|||
48626257|NCT01475825|156489947|FG000|Overall Study|Death|1|||
48626258|NCT01475825|156489948|FG001|Overall Study|Death|0|||
48626259|NCT01475825|156489949|FG002|Overall Study|Death|1|||
48626260|NCT01475825|156489950|FG003|Overall Study|Death|0|||
48626261|NCT01475825|156489947|FG000|Overall Study|Lack of Efficacy|0|||
48626262|NCT01475825|156489948|FG001|Overall Study|Lack of Efficacy|0|||
48626263|NCT01475825|156489949|FG002|Overall Study|Lack of Efficacy|1|||
48626264|NCT01475825|156489950|FG003|Overall Study|Lack of Efficacy|0|||
48626265|NCT01475825|156489947|FG000|Overall Study|Lost to Follow-up|0|||
48626266|NCT01475825|156489948|FG001|Overall Study|Lost to Follow-up|0|||
48626267|NCT01475825|156489949|FG002|Overall Study|Lost to Follow-up|3|||
48626268|NCT01475825|156489950|FG003|Overall Study|Lost to Follow-up|1|||
48626269|NCT01475825|156489947|FG000|Overall Study|Non-compliance with Study Drug|1|||
48626270|NCT01475825|156489948|FG001|Overall Study|Non-compliance with Study Drug|2|||
48323648|NCT00366249|155383642|FG000|Overall Study|Lost to Follow-up|2|||
48323649|NCT00366249|155383643|FG001|Overall Study|Lost to Follow-up|0|||
48323650|NCT00366249|155383642|FG000|Overall Study|Protocol Violation|1|||
48626271|NCT01475825|156489949|FG002|Overall Study|Non-compliance with Study Drug|4|||
48323651|NCT00366249|155383643|FG001|Overall Study|Protocol Violation|2|||
48323652|NCT00366249|155383642|FG000|Overall Study|Withdrawal by Subject|18|||
48323653|NCT00366249|155383643|FG001|Overall Study|Withdrawal by Subject|4|||
48323654|NCT00366249|155383642|FG000|Overall Study|Lack of Efficacy|21|||
48323655|NCT00366249|155383643|FG001|Overall Study|Lack of Efficacy|21|||
48323656|NCT00366249|155383642|FG000|Overall Study|Most due to osteomylitis status|31|||
48323657|NCT00366249|155383643|FG001|Overall Study|Most due to osteomylitis status|20|||
48323658|NCT00246805|155383644|FG000|Phase 1|Lost to Follow-up|1|||
48323659|NCT00246805|155383645|FG001|Phase 1|Lost to Follow-up|0|||
48323660|NCT01177670|155383648|FG000|Overall Study|Study Terminated|115|||
48323661|NCT01177670|155383648|FG000|Overall Study|Physician Decision|50|||
48323662|NCT01177670|155383648|FG000|Overall Study|Withdrawal by Subject|4|||
48323663|NCT01970007|155383650|FG000|Overall Study|Death|5|||
48323664|NCT01970007|155383650|FG000|Overall Study|Withdrawal by Subject|23|||
48323665|NCT01970007|155383650|FG000|Overall Study|Lost to Follow-up|24|||
48323666|NCT01970007|155383650|FG000|Overall Study|"Other endpoint"|3|||
48323667|NCT00754065|155383651|FG000|Overall Study|Never received treatment|12|||
48741063|NCT04424316|156900292|FG000|Overall Study|Randomized but not vaccinated|13|||
48741064|NCT04424316|156900293|FG001|Overall Study|Randomized but not vaccinated|21|||
48741065|NCT04424316|156900294|FG002|Overall Study|Randomized but not vaccinated|0|||
48741066|NCT04424316|156900295|FG003|Overall Study|Randomized but not vaccinated|0|||
48741067|NCT04424316|156900292|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
48741068|NCT04424316|156900293|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
48741069|NCT04424316|156900294|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
48741070|NCT04424316|156900295|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
48741071|NCT02277444|156900296|FG000|Overall Study|Adverse Event|10|||
48741072|NCT02277444|156900296|FG000|Overall Study|Withdrawal by Subject|3|||
48741073|NCT02277444|156900296|FG000|Overall Study|Other|1|||
48741074|NCT02277444|156900296|FG000|Overall Study|Enrolled and not Treated|3|||
48741075|NCT02277444|156900296|FG000|Overall Study|Ongoing|113|||
48741076|NCT03320057|156901718|FG000|Overall Study|Lost to Follow-up|4|||
48741077|NCT03320057|156901719|FG001|Overall Study|Lost to Follow-up|17|||
48323668|NCT00754065|155383652|FG001|Overall Study|Never received treatment|2|||
48323669|NCT00754065|155383651|FG000|Overall Study|Adverse Event|19|||
48323670|NCT00754065|155383652|FG001|Overall Study|Adverse Event|25|||
48323671|NCT00754065|155383651|FG000|Overall Study|Lost to Follow-up|7|||
48323672|NCT00754065|155383652|FG001|Overall Study|Lost to Follow-up|11|||
48323673|NCT00754065|155383651|FG000|Overall Study|Protocol Violation|12|||
48323674|NCT00754065|155383652|FG001|Overall Study|Protocol Violation|10|||
48323675|NCT00754065|155383651|FG000|Overall Study|Withdrawal by Subject|4|||
48323676|NCT00754065|155383652|FG001|Overall Study|Withdrawal by Subject|5|||
48323677|NCT00754065|155383651|FG000|Overall Study|Pregnancy|6|||
48323678|NCT00754065|155383652|FG001|Overall Study|Pregnancy|0|||
48323679|NCT00754065|155383651|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
48323680|NCT00754065|155383652|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
48323681|NCT02463448|155383660|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
48626272|NCT01475825|156489950|FG003|Overall Study|Non-compliance with Study Drug|0|||
48741078|NCT03320057|156901718|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
48741079|NCT03320057|156901719|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
48741080|NCT00717093|156901720|FG000|Overall Study|Adverse Event|19|||
48741081|NCT00717093|156901721|FG001|Overall Study|Adverse Event|9|||
48741082|NCT00717093|156901720|FG000|Overall Study|Lack of Efficacy|3|||
48741083|NCT00717093|156901721|FG001|Overall Study|Lack of Efficacy|13|||
48741084|NCT00717093|156901720|FG000|Overall Study|Lost to Follow-up|9|||
48741085|NCT00717093|156901721|FG001|Overall Study|Lost to Follow-up|6|||
48741086|NCT00717093|156901720|FG000|Overall Study|Withdrawal by Subject|12|||
48741087|NCT00717093|156901721|FG001|Overall Study|Withdrawal by Subject|19|||
48741088|NCT00717093|156901720|FG000|Overall Study|Other|0|||
48626273|NCT01475825|156489947|FG000|Overall Study|Other: Not available|0|||
48626274|NCT01475825|156489948|FG001|Overall Study|Other: Not available|0|||
48741089|NCT00717093|156901721|FG001|Overall Study|Other|1|||
48741090|NCT00717093|156901720|FG000|Overall Study|Randomized but not treated|1|||
48741091|NCT00717093|156901721|FG001|Overall Study|Randomized but not treated|0|||
48741092|NCT00825682|156901722|FG000|Overall Study|personal reasons/ inconvenience|13|||
48741093|NCT00825682|156901723|FG001|Overall Study|personal reasons/ inconvenience|5|||
48323682|NCT02463448|155383660|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
48323683|NCT02463448|155383660|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
48323684|NCT02463448|155383660|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
48323685|NCT00571649|155383661|FG000|Treatment Period|Adverse Event|438|||
48323686|NCT00571649|155383662|FG001|Treatment Period|Adverse Event|385|||
48626275|NCT01475825|156489949|FG002|Overall Study|Other: Not available|2|||
48626276|NCT01475825|156489950|FG003|Overall Study|Other: Not available|0|||
48626277|NCT01475825|156489947|FG000|Overall Study|Protocol Violation|1|||
48626278|NCT01475825|156489948|FG001|Overall Study|Protocol Violation|0|||
48626279|NCT01475825|156489949|FG002|Overall Study|Protocol Violation|0|||
48626280|NCT01475825|156489950|FG003|Overall Study|Protocol Violation|0|||
48626281|NCT01475825|156489947|FG000|Overall Study|Physician Decision|0|||
48626282|NCT01475825|156489948|FG001|Overall Study|Physician Decision|1|||
48626283|NCT01475825|156489949|FG002|Overall Study|Physician Decision|0|||
48626284|NCT01475825|156489950|FG003|Overall Study|Physician Decision|0|||
48626285|NCT01475825|156489947|FG000|Overall Study|Withdrawal by Subject|8|||
48626286|NCT01475825|156489948|FG001|Overall Study|Withdrawal by Subject|3|||
48626287|NCT01475825|156489949|FG002|Overall Study|Withdrawal by Subject|11|||
48626288|NCT01475825|156489950|FG003|Overall Study|Withdrawal by Subject|7|||
48626289|NCT01475825|156489947|FG000|Overall Study|Did not enter OLC|15|||
48626290|NCT01475825|156489948|FG001|Overall Study|Did not enter OLC|11|||
48626291|NCT01475825|156489949|FG002|Overall Study|Did not enter OLC|15|||
48626292|NCT01475825|156489950|FG003|Overall Study|Did not enter OLC|11|||
48626293|NCT04157738|156489951|FG000|Overall Study|Moved out of state|0|||
48626294|NCT04157738|156489952|FG001|Overall Study|Moved out of state|2|||
48626295|NCT04157738|156489951|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
48626296|NCT04157738|156489952|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
48626297|NCT00309946|156489953|FG000|Overall Study|Withdrawal by Subject|1|||
48626298|NCT02244957|156489957|FG000|Overall Study|Lack of Efficacy|1|||
48626299|NCT02244957|156489958|FG001|Overall Study|Lack of Efficacy|0|||
48626300|NCT01347086|156489960|FG000|Overall Study|failed screening visit|0|||
48626301|NCT01347086|156489961|FG001|Overall Study|failed screening visit|0|||
48626302|NCT01347086|156489962|FG002|Overall Study|failed screening visit|1|||
48626303|NCT01347086|156489963|FG003|Overall Study|failed screening visit|0|||
48626304|NCT01347086|156489964|FG004|Overall Study|failed screening visit|0|||
48626305|NCT01347086|156489965|FG005|Overall Study|failed screening visit|0|||
48626306|NCT01347086|156489966|FG006|Overall Study|failed screening visit|1|||
48626307|NCT01347086|156489967|FG007|Overall Study|failed screening visit|1|||
48626308|NCT01347086|156489968|FG008|Overall Study|failed screening visit|0|||
48626309|NCT01347086|156489969|FG009|Overall Study|failed screening visit|1|||
48626310|NCT03766906|156489971|FG000|Overall Study|Withdrawal by Subject|6|||
48626311|NCT02624687|156489972|FG000|Overall Study|Withdrawal by Subject|1|||
48626312|NCT02624687|156489973|FG001|Overall Study|Withdrawal by Subject|1|||
48626313|NCT02624687|156489972|FG000|Overall Study|medical leave from work|0|||
48626314|NCT02624687|156489973|FG001|Overall Study|medical leave from work|1|||
48626315|NCT03111108|156489974|FG000|Overall Study|Death|0|||
48626316|NCT03111108|156489975|FG001|Overall Study|Death|1|||
48626317|NCT03111108|156489974|FG000|Overall Study|Withdrawal by Subject|1|||
48323687|NCT00571649|155383661|FG000|Treatment Period|Clinical endpoint reached|50|||
48626318|NCT03111108|156489975|FG001|Overall Study|Withdrawal by Subject|0|||
48626319|NCT01689649|156489980|FG000|Overall Study|Lack of Efficacy|3|||
48626320|NCT01689649|156489980|FG000|Overall Study|Non-compliance|11|||
48626321|NCT01689649|156489980|FG000|Overall Study|Protocol Violation|3|||
48626322|NCT01689649|156489980|FG000|Overall Study|Lost to Follow-up|5|||
48626323|NCT03760081|156489981|FG000|Overall Study|Miscellaneous|0|||
48626324|NCT03760081|156489982|FG001|Overall Study|Miscellaneous|1|||
48741094|NCT00115739|156901727|FG000|Overall Study|Lost to Follow-up|3|||
48741095|NCT02742441|156901728|FG000|Overall Study|Lost to Follow-up|4|||
48741096|NCT02742441|156901729|FG001|Overall Study|Lost to Follow-up|4|||
48741097|NCT02742441|156901728|FG000|Overall Study|Withdrawal by Subject|2|||
48323688|NCT00571649|155383662|FG001|Treatment Period|Clinical endpoint reached|56|||
48323689|NCT00571649|155383661|FG000|Treatment Period|Withdrawal by Subject|285|||
48323690|NCT00571649|155383662|FG001|Treatment Period|Withdrawal by Subject|255|||
48323691|NCT00571649|155383661|FG000|Treatment Period|Death|76|||
48323692|NCT00571649|155383662|FG001|Treatment Period|Death|59|||
48323693|NCT00571649|155383661|FG000|Treatment Period|Physician Decision|8|||
48323694|NCT00571649|155383662|FG001|Treatment Period|Physician Decision|9|||
48323695|NCT00571649|155383661|FG000|Treatment Period|Lost to Follow-up|43|||
48323696|NCT00571649|155383662|FG001|Treatment Period|Lost to Follow-up|41|||
48323697|NCT00571649|155383661|FG000|Treatment Period|Non-compliant with study medication|88|||
48323698|NCT00571649|155383662|FG001|Treatment Period|Non-compliant with study medication|89|||
48323699|NCT00571649|155383661|FG000|Treatment Period|Patient convenience|11|||
48741098|NCT02742441|156901729|FG001|Overall Study|Withdrawal by Subject|2|||
48741099|NCT02742441|156901728|FG000|Overall Study|Adverse Event|0|||
48741100|NCT02742441|156901729|FG001|Overall Study|Adverse Event|2|||
48741101|NCT02468674|156901730|FG000|Overall Study|Adverse Event|0|||
48741102|NCT02468674|156901731|FG001|Overall Study|Adverse Event|0|||
48741103|NCT02468674|156901732|FG002|Overall Study|Adverse Event|0|||
48741104|NCT02468674|156901733|FG003|Overall Study|Adverse Event|1|||
48741105|NCT02468674|156901734|FG004|Overall Study|Adverse Event|0|||
48741106|NCT02468674|156901735|FG005|Overall Study|Adverse Event|1|||
48741107|NCT02468674|156901736|FG006|Overall Study|Adverse Event|0|||
48741108|NCT02468674|156901737|FG007|Overall Study|Adverse Event|0|||
48741109|NCT02468674|156901738|FG008|Overall Study|Adverse Event|0|||
48741110|NCT02468674|156901730|FG000|Overall Study|Lost to Follow-up|1|||
48323700|NCT00571649|155383662|FG001|Treatment Period|Patient convenience|13|||
48323701|NCT00571649|155383661|FG000|Treatment Period|Protocol Violation|90|||
48323702|NCT00571649|155383662|FG001|Treatment Period|Protocol Violation|92|||
48323703|NCT00571649|155383661|FG000|Treatment Period|Technical problems|3|||
48323704|NCT00571649|155383662|FG001|Treatment Period|Technical problems|5|||
48323705|NCT00571649|155383661|FG000|Follow-up Period|Adverse Event|46|||
48323706|NCT00571649|155383662|FG001|Follow-up Period|Adverse Event|40|||
48323707|NCT00571649|155383661|FG000|Follow-up Period|Clinical endpoint reached|5|||
48323708|NCT00571649|155383662|FG001|Follow-up Period|Clinical endpoint reached|2|||
48323709|NCT00571649|155383661|FG000|Follow-up Period|Withdrawal by Subject|119|||
48323710|NCT00571649|155383662|FG001|Follow-up Period|Withdrawal by Subject|115|||
48323711|NCT00571649|155383661|FG000|Follow-up Period|Death|132|||
48323712|NCT00571649|155383662|FG001|Follow-up Period|Death|133|||
48323713|NCT00571649|155383661|FG000|Follow-up Period|Physician Decision|7|||
48323714|NCT00571649|155383662|FG001|Follow-up Period|Physician Decision|13|||
48323715|NCT00571649|155383661|FG000|Follow-up Period|Lost to Follow-up|95|||
48323716|NCT00571649|155383662|FG001|Follow-up Period|Lost to Follow-up|92|||
48323717|NCT00571649|155383661|FG000|Follow-up Period|Patient convenience|136|||
48323718|NCT00571649|155383662|FG001|Follow-up Period|Patient convenience|121|||
48323719|NCT00571649|155383661|FG000|Follow-up Period|Protocol Violation|5|||
48323720|NCT00571649|155383662|FG001|Follow-up Period|Protocol Violation|12|||
48323721|NCT01421667|155383664|FG000|Overall Study|Withdrawal by Subject|0|||
48323722|NCT01421667|155383665|FG001|Overall Study|Withdrawal by Subject|1|||
48323723|NCT01421667|155383666|FG002|Overall Study|Withdrawal by Subject|2|||
48323724|NCT01421667|155383667|FG003|Overall Study|Withdrawal by Subject|1|||
48323725|NCT01421667|155383664|FG000|Overall Study|Lost to Follow-up|0|||
48323726|NCT01421667|155383665|FG001|Overall Study|Lost to Follow-up|1|||
48741111|NCT02468674|156901731|FG001|Overall Study|Lost to Follow-up|0|||
48741112|NCT02468674|156901732|FG002|Overall Study|Lost to Follow-up|0|||
48741113|NCT02468674|156901733|FG003|Overall Study|Lost to Follow-up|0|||
48741114|NCT02468674|156901734|FG004|Overall Study|Lost to Follow-up|0|||
48741115|NCT02468674|156901735|FG005|Overall Study|Lost to Follow-up|0|||
48741116|NCT02468674|156901736|FG006|Overall Study|Lost to Follow-up|0|||
48741117|NCT02468674|156901737|FG007|Overall Study|Lost to Follow-up|1|||
48741118|NCT02468674|156901738|FG008|Overall Study|Lost to Follow-up|1|||
48741119|NCT02468674|156901730|FG000|Overall Study|Physician Decision|0|||
48741120|NCT02468674|156901731|FG001|Overall Study|Physician Decision|0|||
48741121|NCT02468674|156901732|FG002|Overall Study|Physician Decision|0|||
48741122|NCT02468674|156901733|FG003|Overall Study|Physician Decision|0|||
48741123|NCT02468674|156901734|FG004|Overall Study|Physician Decision|0|||
48741124|NCT02468674|156901735|FG005|Overall Study|Physician Decision|0|||
48741125|NCT02468674|156901736|FG006|Overall Study|Physician Decision|1|||
48741126|NCT02468674|156901737|FG007|Overall Study|Physician Decision|0|||
48741127|NCT02468674|156901738|FG008|Overall Study|Physician Decision|0|||
48741128|NCT02468674|156901730|FG000|Overall Study|Patient/Guardian Decision|0|||
48741129|NCT02468674|156901731|FG001|Overall Study|Patient/Guardian Decision|0|||
48741130|NCT02468674|156901732|FG002|Overall Study|Patient/Guardian Decision|0|||
48741131|NCT02468674|156901733|FG003|Overall Study|Patient/Guardian Decision|0|||
48741132|NCT02468674|156901734|FG004|Overall Study|Patient/Guardian Decision|1|||
48741133|NCT02468674|156901735|FG005|Overall Study|Patient/Guardian Decision|0|||
48741134|NCT02468674|156901736|FG006|Overall Study|Patient/Guardian Decision|0|||
48741135|NCT02468674|156901737|FG007|Overall Study|Patient/Guardian Decision|2|||
48741136|NCT02468674|156901738|FG008|Overall Study|Patient/Guardian Decision|1|||
48741137|NCT02468674|156901730|FG000|Overall Study|Protocol Deviation|0|||
48741138|NCT02468674|156901731|FG001|Overall Study|Protocol Deviation|0|||
48741139|NCT02468674|156901732|FG002|Overall Study|Protocol Deviation|0|||
48741140|NCT02468674|156901733|FG003|Overall Study|Protocol Deviation|0|||
48741141|NCT02468674|156901734|FG004|Overall Study|Protocol Deviation|0|||
48741142|NCT02468674|156901735|FG005|Overall Study|Protocol Deviation|0|||
48741143|NCT02468674|156901736|FG006|Overall Study|Protocol Deviation|0|||
48741144|NCT02468674|156901737|FG007|Overall Study|Protocol Deviation|1|||
48741145|NCT02468674|156901738|FG008|Overall Study|Protocol Deviation|1|||
48741146|NCT00401531|156901739|FG000|Overall Study|Adverse Event|2|||
48741147|NCT00401531|156901740|FG001|Overall Study|Adverse Event|0|||
48741148|NCT00401531|156901739|FG000|Overall Study|Protocol Violation|3|||
48741149|NCT00401531|156901740|FG001|Overall Study|Protocol Violation|7|||
48741150|NCT00401531|156901739|FG000|Overall Study|Lost to Follow-up|1|||
48741151|NCT00401531|156901740|FG001|Overall Study|Lost to Follow-up|1|||
48741152|NCT00401531|156901739|FG000|Overall Study|Withdrawal by Subject|3|||
48741153|NCT00401531|156901740|FG001|Overall Study|Withdrawal by Subject|2|||
48741154|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Adverse Event|16|||
48741155|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Adverse Event|17|||
48323727|NCT01421667|155383666|FG002|Overall Study|Lost to Follow-up|0|||
48323728|NCT01421667|155383667|FG003|Overall Study|Lost to Follow-up|0|||
48323729|NCT01160354|155383669|FG000|Overall Study|Death|0|||
48323730|NCT01160354|155383670|FG001|Overall Study|Death|1|||
48323731|NCT01160354|155383671|FG002|Overall Study|Death|1|||
48323732|NCT00580866|155383676|FG000|Overall Study|Lost to Follow-up|2|||
48323733|NCT00580866|155383677|FG001|Overall Study|Lost to Follow-up|2|||
48323734|NCT02052440|155383681|FG000|Overall Study|Withdrawal by Subject|0|||
48323735|NCT02052440|155383682|FG001|Overall Study|Withdrawal by Subject|1|||
48323736|NCT05048186|155383683|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
48323737|NCT05048186|155383684|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
48323738|NCT05048186|155383683|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
48323739|NCT05048186|155383684|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
48323740|NCT02754596|155383687|FG000|Overall Study|Withdrawal by Subject|3|||
48626325|NCT03760081|156489981|FG000|Overall Study|Progressive Disease|5|||
48626326|NCT03760081|156489982|FG001|Overall Study|Progressive Disease|10|||
48626327|NCT03760081|156489981|FG000|Overall Study|Death|1|||
48626328|NCT03760081|156489982|FG001|Overall Study|Death|1|||
48626329|NCT03258593|156489985|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
48626330|NCT03258593|156489986|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
48626331|NCT03258593|156489987|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
48626332|NCT03258593|156489988|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
48626333|NCT03258593|156489985|FG000|Run-In Maintenance Phase|Disease progression|3|||
48626334|NCT03258593|156489986|FG001|Run-In Maintenance Phase|Disease progression|0|||
48626335|NCT03258593|156489987|FG002|Run-In Maintenance Phase|Disease progression|0|||
48626336|NCT03258593|156489988|FG003|Run-In Maintenance Phase|Disease progression|0|||
48626337|NCT03258593|156489985|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
48626338|NCT03258593|156489986|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
48626339|NCT03258593|156489987|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
48626340|NCT03258593|156489988|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
48626341|NCT03258593|156489985|FG000|Expansion Maintenance Phase|Physician Decision|0|||
48626342|NCT03258593|156489986|FG001|Expansion Maintenance Phase|Physician Decision|1|||
48626343|NCT03258593|156489987|FG002|Expansion Maintenance Phase|Physician Decision|0|||
48626344|NCT03258593|156489988|FG003|Expansion Maintenance Phase|Physician Decision|0|||
48626345|NCT03464461|156489989|FG000|Overall Study|exclusionary medication given ,|1|||
48626346|NCT03464461|156489990|FG001|Overall Study|exclusionary medication given ,|2|||
48741156|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Adverse Event|13|||
48741157|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Adverse Event|18|||
48741158|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Adverse Event|0|||
48741159|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Adverse Event|0|||
48741160|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Adverse Event|0|||
48741161|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Adverse Event|0|||
48741162|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
48741163|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
48626347|NCT03464461|156489991|FG002|Overall Study|exclusionary medication given ,|0|||
48626348|NCT03464461|156489989|FG000|Overall Study|Physician Decision|0|||
48626349|NCT03464461|156489990|FG001|Overall Study|Physician Decision|1|||
48626350|NCT03464461|156489991|FG002|Overall Study|Physician Decision|0|||
48741164|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
48626351|NCT00595075|156489992|FG000|Overall Study|Withdrawal by Subject|1|||
48626352|NCT00595075|156489993|FG001|Overall Study|Withdrawal by Subject|0|||
48626353|NCT04008069|156489994|FG000|Open-Label Period|Adverse Event|1|||
48626354|NCT04008069|156489995|FG001|Open-Label Period|Adverse Event|0|||
48626355|NCT04008069|156489996|FG002|Open-Label Period|Adverse Event|0|||
48626356|NCT04008069|156489994|FG000|Open-Label Period|Lack of Efficacy|4|||
48626357|NCT04008069|156489995|FG001|Open-Label Period|Lack of Efficacy|0|||
48626358|NCT04008069|156489996|FG002|Open-Label Period|Lack of Efficacy|0|||
48626359|NCT04008069|156489994|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
48626360|NCT04008069|156489995|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
48741165|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
48741166|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
48741167|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
48741168|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
48741169|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
48626361|NCT04008069|156489996|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
48626362|NCT04008069|156489994|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
48741170|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
48741171|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
48741172|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
48741173|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
48741174|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
48741175|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
48741176|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
48741177|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
48741178|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
48741179|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
48626363|NCT04008069|156489995|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
48626364|NCT04008069|156489996|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
48626365|NCT01674062|156489997|FG000|Overall Study|Insufficient Therapeutic Response|56|||
48626366|NCT01674062|156489998|FG001|Overall Study|Insufficient Therapeutic Response|26|||
48626367|NCT01674062|156489997|FG000|Overall Study|Other|8|||
48626368|NCT01674062|156489998|FG001|Overall Study|Other|1|||
48741180|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
48741181|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
48741182|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
48626369|NCT01674062|156489997|FG000|Overall Study|Adverse Event|1|||
48626370|NCT01674062|156489998|FG001|Overall Study|Adverse Event|1|||
48626371|NCT01674062|156489997|FG000|Overall Study|Death|0|||
48626372|NCT01674062|156489998|FG001|Overall Study|Death|1|||
48626373|NCT01674062|156489997|FG000|Overall Study|Programming Error|1|||
48626374|NCT01674062|156489998|FG001|Overall Study|Programming Error|0|||
48626375|NCT04620668|156489999|FG000|Overall Study|Withdrawal by Subject|2|||
48626376|NCT04620668|156490000|FG001|Overall Study|Withdrawal by Subject|0|||
48626377|NCT04620668|156489999|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
48626378|NCT04620668|156490000|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
48626379|NCT04620668|156489999|FG000|Overall Study|Removed before analysis: missing data|2|||
48626380|NCT04620668|156490000|FG001|Overall Study|Removed before analysis: missing data|0|||
48626381|NCT04620668|156489999|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
48626382|NCT04620668|156490000|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
48741183|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
48741184|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
48741185|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
48626383|NCT04620668|156489999|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
48741186|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
48741187|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48626384|NCT04620668|156490000|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
48626385|NCT00511199|156490001|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
48626386|NCT00511199|156490002|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
48741188|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
48741189|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
48741190|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48626387|NCT00511199|156490001|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
48626388|NCT00511199|156490002|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
48626389|NCT00511199|156490001|FG000|Overall Study|Withdrawal of Informed Consent|19|||
48626390|NCT00511199|156490002|FG001|Overall Study|Withdrawal of Informed Consent|4|||
48626391|NCT00511199|156490001|FG000|Overall Study|Pregnancy|6|||
48626392|NCT00511199|156490002|FG001|Overall Study|Pregnancy|3|||
48626393|NCT00511199|156490001|FG000|Overall Study|Pregnancy Wish|16|||
48626394|NCT00511199|156490002|FG001|Overall Study|Pregnancy Wish|8|||
48626395|NCT00511199|156490001|FG000|Overall Study|Lost to Follow-up|40|||
48626396|NCT00511199|156490002|FG001|Overall Study|Lost to Follow-up|17|||
48626397|NCT00511199|156490001|FG000|Overall Study|Other Reason|78|||
48626398|NCT00511199|156490002|FG001|Overall Study|Other Reason|37|||
48626399|NCT01687595|156490003|FG000|Overall Study|Withdrawal by Subject|8|||
48626400|NCT01687595|156490004|FG001|Overall Study|Withdrawal by Subject|0|||
48626401|NCT01687595|156490003|FG000|Overall Study|Lost to Follow-up|3|||
48626402|NCT01687595|156490004|FG001|Overall Study|Lost to Follow-up|1|||
48626403|NCT01687595|156490003|FG000|Overall Study|Investigator's decision|1|||
48626404|NCT01687595|156490004|FG001|Overall Study|Investigator's decision|0|||
48626405|NCT01687595|156490003|FG000|Overall Study|Sponsor's decision|1|||
48626406|NCT01687595|156490004|FG001|Overall Study|Sponsor's decision|0|||
48626407|NCT01687595|156490003|FG000|Overall Study|Noncompliance|1|||
48626408|NCT01687595|156490004|FG001|Overall Study|Noncompliance|2|||
48626409|NCT01687595|156490003|FG000|Overall Study|Other than specified|56|||
48626410|NCT01687595|156490004|FG001|Overall Study|Other than specified|7|||
48626411|NCT00489359|156490005|FG000|Overall Study|Death|0|||
48626412|NCT00489359|156490006|FG001|Overall Study|Death|2|||
48626413|NCT00489359|156490005|FG000|Overall Study|Progressive Disease|5|||
48626414|NCT00489359|156490006|FG001|Overall Study|Progressive Disease|6|||
48626415|NCT00489359|156490005|FG000|Overall Study|Lost to Follow-up|1|||
48626416|NCT00489359|156490006|FG001|Overall Study|Lost to Follow-up|0|||
48626417|NCT00489359|156490005|FG000|Overall Study|Withdrawal by Subject|1|||
48626418|NCT00489359|156490006|FG001|Overall Study|Withdrawal by Subject|5|||
48626419|NCT00489359|156490005|FG000|Overall Study|Adverse Event|0|||
48626420|NCT00489359|156490006|FG001|Overall Study|Adverse Event|16|||
48626421|NCT00456365|156490007|FG000|Overall Study|Lost to Follow-up|1|||
48626422|NCT00456365|156490008|FG001|Overall Study|Lost to Follow-up|3|||
48626423|NCT00456365|156490007|FG000|Overall Study|Withdrawal by Subject|4|||
48626424|NCT00456365|156490008|FG001|Overall Study|Withdrawal by Subject|7|||
48626425|NCT00456365|156490007|FG000|Overall Study|Pregnancy|1|||
48626426|NCT00456365|156490008|FG001|Overall Study|Pregnancy|1|||
48626427|NCT00456365|156490007|FG000|Overall Study|oncologic diagnosis|1|||
48626428|NCT00456365|156490008|FG001|Overall Study|oncologic diagnosis|1|||
48626429|NCT01714063|156490009|FG000|Overall Study|Equipment malfunction|2|||
48626430|NCT00345592|156490010|FG000|Overall Study|Death|14|||
48626431|NCT00345592|156490011|FG001|Overall Study|Death|16|||
48626432|NCT00345592|156490010|FG000|Overall Study|Withdrawal by Subject|11|||
48626433|NCT00345592|156490011|FG001|Overall Study|Withdrawal by Subject|8|||
48626434|NCT00468546|156490019|FG000|Week 24 Analysis|Lack of Efficacy|83|||
48626435|NCT00468546|156490020|FG001|Week 24 Analysis|Lack of Efficacy|37|||
48626436|NCT00468546|156490019|FG000|Week 24 Analysis|Refused treatment|5|||
48626437|NCT00468546|156490020|FG001|Week 24 Analysis|Refused treatment|5|||
48626438|NCT00468546|156490019|FG000|Week 24 Analysis|Adverse Event|1|||
48626439|NCT00468546|156490020|FG001|Week 24 Analysis|Adverse Event|8|||
48626440|NCT00468546|156490019|FG000|Week 24 Analysis|Failure to return|3|||
48626441|NCT00468546|156490020|FG001|Week 24 Analysis|Failure to return|4|||
48626442|NCT00468546|156490019|FG000|Week 24 Analysis|Rescue therapy|2|||
48626443|NCT00468546|156490020|FG001|Week 24 Analysis|Rescue therapy|0|||
48626444|NCT00468546|156490019|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
48626445|NCT00468546|156490020|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
48626446|NCT00468546|156490019|FG000|Week 24 Analysis|Due to clinical hold|1|||
48626447|NCT00468546|156490020|FG001|Week 24 Analysis|Due to clinical hold|0|||
48626448|NCT00468546|156490019|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
48626449|NCT00468546|156490020|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
48626450|NCT00468546|156490019|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
48626451|NCT00468546|156490020|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
48626452|NCT00468546|156490019|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
48626453|NCT00468546|156490020|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
48626454|NCT00468546|156490019|FG000|Week 24 to Week 104 Analysis|Death|1|||
48626455|NCT00468546|156490020|FG001|Week 24 to Week 104 Analysis|Death|0|||
48626456|NCT00468546|156490019|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
48626457|NCT00468546|156490020|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
48626458|NCT00468546|156490019|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
48626459|NCT00468546|156490020|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
48741191|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48741192|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48741193|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
48741194|NCT02975336|156901741|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
48741195|NCT02975336|156901742|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
48741196|NCT02975336|156901743|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
48741197|NCT02975336|156901744|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
48741198|NCT02975336|156901745|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
48626460|NCT00468546|156490019|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
48626461|NCT00468546|156490020|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
48626462|NCT00468546|156490019|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
48626463|NCT00468546|156490020|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
48626464|NCT00468546|156490019|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
48626465|NCT00468546|156490020|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
48626466|NCT00468546|156490019|FG000|Week 24 to Week 104 Analysis|Other|17|||
48626467|NCT00468546|156490020|FG001|Week 24 to Week 104 Analysis|Other|14|||
48626468|NCT01922895|156490021|FG000|Overall Study|Death|0|||
48626469|NCT01922895|156490022|FG001|Overall Study|Death|1|||
48626470|NCT01922895|156490021|FG000|Overall Study|Withdrawal by Subject|1|||
48626471|NCT01922895|156490022|FG001|Overall Study|Withdrawal by Subject|2|||
48626472|NCT01922895|156490021|FG000|Overall Study|Lost to Follow-up|5|||
48626473|NCT01922895|156490022|FG001|Overall Study|Lost to Follow-up|11|||
48626474|NCT04918771|156490023|FG000|Overall Study|Withdrawal by Subject|4|||
48626475|NCT04918771|156490024|FG001|Overall Study|Withdrawal by Subject|5|||
48626476|NCT04918771|156490023|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
48626477|NCT04918771|156490024|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
48626478|NCT00855166|156490025|FG000|Overall Study|Adverse Event|0|||
48626479|NCT00855166|156490026|FG001|Overall Study|Adverse Event|2|||
48626480|NCT00855166|156490025|FG000|Overall Study|Death|0|||
48626481|NCT00855166|156490026|FG001|Overall Study|Death|1|||
48626482|NCT00855166|156490025|FG000|Overall Study|Withdrawal by Subject|1|||
48626483|NCT00855166|156490026|FG001|Overall Study|Withdrawal by Subject|4|||
48626484|NCT00855166|156490025|FG000|Overall Study|Poor/non-compliance|2|||
48626485|NCT00855166|156490026|FG001|Overall Study|Poor/non-compliance|0|||
48626486|NCT00855166|156490025|FG000|Overall Study|Administrative reasons by sponsor|1|||
48626487|NCT00855166|156490026|FG001|Overall Study|Administrative reasons by sponsor|0|||
48626488|NCT00855166|156490025|FG000|Overall Study|Subject no longer meets study criteria|1|||
48626489|NCT00855166|156490026|FG001|Overall Study|Subject no longer meets study criteria|1|||
48626490|NCT03996395|156490028|FG000|Overall Study|Lost to Follow-up|4|||
48626491|NCT03996395|156490028|FG000|Overall Study|Withdrawal by Subject|1|||
48626492|NCT03996395|156490028|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
48626493|NCT02496156|156490029|FG000|Overall Study|Lost to Follow-up|5|||
48626494|NCT02496156|156490030|FG001|Overall Study|Lost to Follow-up|0|||
48626495|NCT02496156|156490029|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
48626496|NCT02496156|156490030|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
48626497|NCT04349098|156490031|FG000|Overall Study|Death|16|||
48626498|NCT04349098|156490032|FG001|Overall Study|Death|8|||
48626499|NCT04349098|156490031|FG000|Overall Study|Lost to Follow-up|11|||
48626500|NCT04349098|156490032|FG001|Overall Study|Lost to Follow-up|8|||
48626501|NCT04349098|156490031|FG000|Overall Study|Withdrawal by Subject|8|||
48626502|NCT04349098|156490032|FG001|Overall Study|Withdrawal by Subject|5|||
48626503|NCT04349098|156490031|FG000|Overall Study|Other|3|||
48626504|NCT04349098|156490032|FG001|Overall Study|Other|5|||
48626505|NCT00112385|156490034|FG000|Overall Study|Lost to Follow-up|1|||
48626506|NCT00112385|156490035|FG001|Overall Study|Lost to Follow-up|0|||
48626507|NCT00112385|156490034|FG000|Overall Study|Withdrawal by Subject|0|||
48626508|NCT00112385|156490035|FG001|Overall Study|Withdrawal by Subject|1|||
48626509|NCT03810495|156490039|FG000|Overall Study|Lost to Follow-up|2|||
48626510|NCT03810495|156490039|FG000|Overall Study|Withdrawal by Subject|1|||
48626511|NCT02014103|156491452|FG000|Overall Study|Protocol Violation|7|||
48626512|NCT02014103|156491453|FG001|Overall Study|Protocol Violation|7|||
48626513|NCT02014103|156491452|FG000|Overall Study|Adverse Event|1|||
48741199|NCT02975336|156901746|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
48741200|NCT02975336|156901747|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
48741201|NCT02975336|156901748|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
48741202|NCT02975336|156901741|FG000|LTE (104 Weeks)|Adverse Event|0|||
48741203|NCT02975336|156901742|FG001|LTE (104 Weeks)|Adverse Event|0|||
48741204|NCT02975336|156901743|FG002|LTE (104 Weeks)|Adverse Event|0|||
48741205|NCT02975336|156901744|FG003|LTE (104 Weeks)|Adverse Event|0|||
48626514|NCT02014103|156491453|FG001|Overall Study|Adverse Event|0|||
48626515|NCT02014103|156491452|FG000|Overall Study|Lost venous access|1|||
48626516|NCT02014103|156491453|FG001|Overall Study|Lost venous access|0|||
48626517|NCT02014103|156491452|FG000|Overall Study|Withdrawal by Subject|0|||
48626518|NCT02014103|156491453|FG001|Overall Study|Withdrawal by Subject|2|||
48626519|NCT01882829|156491454|FG000|Overall Study|Adverse Event|4|||
48626520|NCT01882829|156491454|FG000|Overall Study|Protocol Violation|1|||
48626521|NCT01882829|156491454|FG000|Overall Study|Withdrawal by Subject|1|||
48626522|NCT05130281|156491456|FG000|Overall Study|Withdrawal by Subject|0|||
48626523|NCT05130281|156491457|FG001|Overall Study|Withdrawal by Subject|0|||
48626524|NCT05130281|156491458|FG002|Overall Study|Withdrawal by Subject|1|||
48626525|NCT03523585|156491460|FG000|Overall Study|Progressive Disease|174|||
48626526|NCT03523585|156491461|FG001|Overall Study|Progressive Disease|64|||
48626527|NCT03523585|156491462|FG002|Overall Study|Progressive Disease|77|||
48626528|NCT03523585|156491460|FG000|Overall Study|Adverse Event|74|||
48626529|NCT03523585|156491461|FG001|Overall Study|Adverse Event|5|||
48626530|NCT03523585|156491462|FG002|Overall Study|Adverse Event|9|||
48741206|NCT02975336|156901745|FG004|LTE (104 Weeks)|Adverse Event|7|||
48741207|NCT02975336|156901746|FG005|LTE (104 Weeks)|Adverse Event|4|||
48741208|NCT02975336|156901747|FG006|LTE (104 Weeks)|Adverse Event|2|||
48626531|NCT03523585|156491460|FG000|Overall Study|Withdrawal by Subject|30|||
48626532|NCT03523585|156491461|FG001|Overall Study|Withdrawal by Subject|11|||
48626533|NCT03523585|156491462|FG002|Overall Study|Withdrawal by Subject|6|||
48626534|NCT03523585|156491460|FG000|Overall Study|Clinical Progression|23|||
48626535|NCT03523585|156491461|FG001|Overall Study|Clinical Progression|5|||
48626536|NCT03523585|156491462|FG002|Overall Study|Clinical Progression|10|||
48626537|NCT03523585|156491460|FG000|Overall Study|Death|4|||
48626538|NCT03523585|156491461|FG001|Overall Study|Death|0|||
48741209|NCT02975336|156901748|FG007|LTE (104 Weeks)|Adverse Event|0|||
48741210|NCT02975336|156901741|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
48741211|NCT02975336|156901742|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
48741212|NCT02975336|156901743|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
48626539|NCT03523585|156491462|FG002|Overall Study|Death|1|||
48626540|NCT03523585|156491460|FG000|Overall Study|Physician Decision|2|||
48626541|NCT03523585|156491461|FG001|Overall Study|Physician Decision|1|||
48626542|NCT03523585|156491462|FG002|Overall Study|Physician Decision|0|||
48626543|NCT03523585|156491460|FG000|Overall Study|Lost to Follow-up|1|||
48626544|NCT03523585|156491461|FG001|Overall Study|Lost to Follow-up|0|||
48626545|NCT03523585|156491462|FG002|Overall Study|Lost to Follow-up|0|||
48626546|NCT03523585|156491460|FG000|Overall Study|Miscellaneous|1|||
48626547|NCT03523585|156491461|FG001|Overall Study|Miscellaneous|0|||
48626548|NCT03523585|156491462|FG002|Overall Study|Miscellaneous|0|||
48626549|NCT03523585|156491460|FG000|Overall Study|Protocol Deviation|1|||
48626550|NCT03523585|156491461|FG001|Overall Study|Protocol Deviation|0|||
48626551|NCT03523585|156491462|FG002|Overall Study|Protocol Deviation|1|||
48626552|NCT03523585|156491460|FG000|Overall Study|Randomized But Not Treated|2|||
48626553|NCT03523585|156491461|FG001|Overall Study|Randomized But Not Treated|4|||
48626554|NCT03523585|156491462|FG002|Overall Study|Randomized But Not Treated|3|||
48626555|NCT01903720|156491463|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
48626556|NCT01903720|156491463|FG000|Overall Study|Adverse Event|1|||
48626557|NCT01903720|156491463|FG000|Overall Study|Rescinding of informed consent|2|||
48626558|NCT01903720|156491463|FG000|Overall Study|Lost to Follow-up|2|||
48626559|NCT01903720|156491463|FG000|Overall Study|Treatment with alternative drug|1|||
48626560|NCT01379937|156491464|FG000|Overall Study|Protocol Violation|0|||
48626561|NCT01379937|156491465|FG001|Overall Study|Protocol Violation|0|||
48626562|NCT01379937|156491466|FG002|Overall Study|Protocol Violation|0|||
48626563|NCT01379937|156491467|FG003|Overall Study|Protocol Violation|1|||
48626564|NCT01379937|156491464|FG000|Overall Study|Consent withdrawal|0|||
48626565|NCT01379937|156491465|FG001|Overall Study|Consent withdrawal|1|||
48626566|NCT01379937|156491466|FG002|Overall Study|Consent withdrawal|0|||
48626567|NCT01379937|156491467|FG003|Overall Study|Consent withdrawal|0|||
48741213|NCT02975336|156901744|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
48741214|NCT02975336|156901745|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
48741215|NCT02975336|156901746|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
48741216|NCT02975336|156901747|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
48626568|NCT01379937|156491464|FG000|Overall Study|Lost to Follow-up|1|||
48626569|NCT01379937|156491465|FG001|Overall Study|Lost to Follow-up|2|||
48741217|NCT02975336|156901748|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
48741218|NCT02975336|156901741|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
48626570|NCT01379937|156491466|FG002|Overall Study|Lost to Follow-up|2|||
48626571|NCT01379937|156491467|FG003|Overall Study|Lost to Follow-up|0|||
48626572|NCT02264821|156491469|FG000|Overall Study|Protocol Violation|1|||
48626573|NCT02264821|156491470|FG001|Overall Study|Protocol Violation|3|||
48626574|NCT02264821|156491471|FG002|Overall Study|Protocol Violation|6|||
48626575|NCT02067156|156491474|FG000|Overall Study|Lost to Follow-up|4|||
48626576|NCT03654326|156491478|FG000|Overall Study|Withdrawal by Subject|5|||
48626577|NCT03654326|156491479|FG001|Overall Study|Withdrawal by Subject|3|||
48626578|NCT03654326|156491478|FG000|Overall Study|Physician Decision|0|||
48741219|NCT02975336|156901742|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
48741220|NCT02975336|156901743|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
48741221|NCT02975336|156901744|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
48741222|NCT02975336|156901745|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
48323741|NCT02754596|155383688|FG001|Overall Study|Withdrawal by Subject|4|||
48323742|NCT02754596|155383689|FG002|Overall Study|Withdrawal by Subject|0|||
48323743|NCT02754596|155383687|FG000|Overall Study|Physician Decision|1|||
48323744|NCT02754596|155383688|FG001|Overall Study|Physician Decision|1|||
48323745|NCT02754596|155383689|FG002|Overall Study|Physician Decision|1|||
48323746|NCT02754596|155383687|FG000|Overall Study|Lost to Follow-up|1|||
48323747|NCT02754596|155383688|FG001|Overall Study|Lost to Follow-up|1|||
48323748|NCT02754596|155383689|FG002|Overall Study|Lost to Follow-up|2|||
48323749|NCT02754596|155383687|FG000|Overall Study|Death|0|||
48323750|NCT02754596|155383688|FG001|Overall Study|Death|2|||
48323751|NCT02754596|155383689|FG002|Overall Study|Death|0|||
48626579|NCT03654326|156491479|FG001|Overall Study|Physician Decision|1|||
48626580|NCT03654326|156491478|FG000|Overall Study|Unable to adhere to study schedule|0|||
48626581|NCT03654326|156491479|FG001|Overall Study|Unable to adhere to study schedule|1|||
48626582|NCT03654326|156491478|FG000|Overall Study|Lost to Follow-up|1|||
48626583|NCT03654326|156491479|FG001|Overall Study|Lost to Follow-up|1|||
48626584|NCT04725188|156491481|FG000|Overall Study|Death|44|||
48626585|NCT04725188|156491482|FG001|Overall Study|Death|46|||
48626586|NCT04725188|156491483|FG002|Overall Study|Death|48|||
48626587|NCT04725188|156491481|FG000|Overall Study|Lost to Follow-up|0|||
48626588|NCT04725188|156491482|FG001|Overall Study|Lost to Follow-up|0|||
48626589|NCT04725188|156491483|FG002|Overall Study|Lost to Follow-up|1|||
48626590|NCT04725188|156491481|FG000|Overall Study|Withdrawal by Subject|2|||
48626591|NCT04725188|156491482|FG001|Overall Study|Withdrawal by Subject|2|||
48626592|NCT04725188|156491483|FG002|Overall Study|Withdrawal by Subject|1|||
48626593|NCT04725188|156491481|FG000|Overall Study|Participants ongoing in the study|41|||
48626594|NCT04725188|156491482|FG001|Overall Study|Participants ongoing in the study|35|||
48626595|NCT04725188|156491483|FG002|Overall Study|Participants ongoing in the study|35|||
48626596|NCT02076009|156491484|FG000|Overall Study|Death|172|||
48626597|NCT02076009|156491485|FG001|Overall Study|Death|153|||
48741223|NCT02975336|156901746|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
48626598|NCT02076009|156491484|FG000|Overall Study|Withdrawal by Subject|16|||
48626599|NCT02076009|156491485|FG001|Overall Study|Withdrawal by Subject|12|||
48626600|NCT02076009|156491484|FG000|Overall Study|Lost to Follow-up|4|||
48626601|NCT02076009|156491485|FG001|Overall Study|Lost to Follow-up|2|||
48626602|NCT02076009|156491484|FG000|Overall Study|Progressive Disease|1|||
48626603|NCT02076009|156491485|FG001|Overall Study|Progressive Disease|0|||
48626604|NCT02076009|156491484|FG000|Overall Study|Physician Decision|0|||
48626605|NCT02076009|156491485|FG001|Overall Study|Physician Decision|1|||
48626606|NCT02076009|156491484|FG000|Overall Study|End of data collection|90|||
48626607|NCT02076009|156491485|FG001|Overall Study|End of data collection|118|||
48626608|NCT05418426|156491486|FG000|Overall Study|Adverse Event|0|||
48626609|NCT05418426|156491487|FG001|Overall Study|Adverse Event|1|||
48626610|NCT05418426|156491488|FG002|Overall Study|Adverse Event|0|||
48626611|NCT05418426|156491486|FG000|Overall Study|Withdrawal by Subject|0|||
48626612|NCT05418426|156491487|FG001|Overall Study|Withdrawal by Subject|1|||
48626613|NCT05418426|156491488|FG002|Overall Study|Withdrawal by Subject|0|||
48626614|NCT05418426|156491486|FG000|Overall Study|Protocol Violation|0|||
48626615|NCT05418426|156491487|FG001|Overall Study|Protocol Violation|0|||
48626616|NCT05418426|156491488|FG002|Overall Study|Protocol Violation|1|||
48626617|NCT01946880|156491489|FG000|Overall Study|Lost to Follow-up|1|||
48626618|NCT01946880|156491490|FG001|Overall Study|Lost to Follow-up|0|||
48626619|NCT01946880|156491489|FG000|Overall Study|Physician Decision|1|||
48626620|NCT01946880|156491490|FG001|Overall Study|Physician Decision|1|||
48626621|NCT01946880|156491489|FG000|Overall Study|Withdrawal by Subject|3|||
48626622|NCT01946880|156491490|FG001|Overall Study|Withdrawal by Subject|2|||
48626623|NCT01946880|156491489|FG000|Overall Study|Met Primary Endpoint|1|||
48626624|NCT01946880|156491490|FG001|Overall Study|Met Primary Endpoint|0|||
48626625|NCT01946880|156491489|FG000|Overall Study|Personal and Family Issues|1|||
48626626|NCT01946880|156491490|FG001|Overall Study|Personal and Family Issues|0|||
48626627|NCT02609503|156491496|FG000|Overall Study|Adverse Event|1|||
48626628|NCT02609503|156491496|FG000|Overall Study|Death|1|||
48626629|NCT02609503|156491496|FG000|Overall Study|Withdrawal by Subject|1|||
48626630|NCT02609503|156491496|FG000|Overall Study|Disease progression|1|||
48626631|NCT03715829|156491499|FG000|Dose Ranging Period|Adverse Event|2|||
48626632|NCT03715829|156491500|FG001|Dose Ranging Period|Adverse Event|4|||
48626633|NCT03715829|156491501|FG002|Dose Ranging Period|Adverse Event|5|||
48626634|NCT03715829|156491502|FG003|Dose Ranging Period|Adverse Event|2|||
48741224|NCT02975336|156901747|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
48323752|NCT02754596|155383687|FG000|Overall Study|Adverse Event|1|||
48323753|NCT02754596|155383688|FG001|Overall Study|Adverse Event|0|||
48626635|NCT03715829|156491503|FG004|Dose Ranging Period|Adverse Event|3|||
48626636|NCT03715829|156491504|FG005|Dose Ranging Period|Adverse Event|3|||
48626637|NCT03715829|156491505|FG006|Dose Ranging Period|Adverse Event|0|||
48626638|NCT03715829|156491506|FG007|Dose Ranging Period|Adverse Event|0|||
48626639|NCT03715829|156491507|FG008|Dose Ranging Period|Adverse Event|0|||
48626640|NCT03715829|156491508|FG009|Dose Ranging Period|Adverse Event|0|||
48626641|NCT03715829|156491509|FG010|Dose Ranging Period|Adverse Event|0|||
48741225|NCT02975336|156901748|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
48626642|NCT03715829|156491499|FG000|Dose Ranging Period|Lack of Efficacy|0|||
48741226|NCT02975336|156901741|FG000|LTE (104 Weeks)|Other|0|||
48741227|NCT02975336|156901742|FG001|LTE (104 Weeks)|Other|0|||
48741228|NCT02975336|156901743|FG002|LTE (104 Weeks)|Other|0|||
48741229|NCT02975336|156901744|FG003|LTE (104 Weeks)|Other|0|||
48741230|NCT02975336|156901745|FG004|LTE (104 Weeks)|Other|55|||
48741231|NCT02975336|156901746|FG005|LTE (104 Weeks)|Other|63|||
48626643|NCT03715829|156491500|FG001|Dose Ranging Period|Lack of Efficacy|1|||
48626644|NCT03715829|156491501|FG002|Dose Ranging Period|Lack of Efficacy|0|||
48626645|NCT03715829|156491502|FG003|Dose Ranging Period|Lack of Efficacy|1|||
48626646|NCT03715829|156491503|FG004|Dose Ranging Period|Lack of Efficacy|0|||
48626647|NCT03715829|156491504|FG005|Dose Ranging Period|Lack of Efficacy|0|||
48626648|NCT03715829|156491505|FG006|Dose Ranging Period|Lack of Efficacy|0|||
48626649|NCT03715829|156491506|FG007|Dose Ranging Period|Lack of Efficacy|0|||
48626650|NCT03715829|156491507|FG008|Dose Ranging Period|Lack of Efficacy|0|||
48626651|NCT03715829|156491508|FG009|Dose Ranging Period|Lack of Efficacy|0|||
48626652|NCT03715829|156491509|FG010|Dose Ranging Period|Lack of Efficacy|0|||
48626653|NCT03715829|156491499|FG000|Dose Ranging Period|Lost to Follow-up|2|||
48626654|NCT03715829|156491500|FG001|Dose Ranging Period|Lost to Follow-up|0|||
48626655|NCT03715829|156491501|FG002|Dose Ranging Period|Lost to Follow-up|1|||
48626656|NCT03715829|156491502|FG003|Dose Ranging Period|Lost to Follow-up|1|||
48626657|NCT03715829|156491503|FG004|Dose Ranging Period|Lost to Follow-up|1|||
48626658|NCT03715829|156491504|FG005|Dose Ranging Period|Lost to Follow-up|2|||
48626659|NCT03715829|156491505|FG006|Dose Ranging Period|Lost to Follow-up|0|||
48626660|NCT03715829|156491506|FG007|Dose Ranging Period|Lost to Follow-up|0|||
48626661|NCT03715829|156491507|FG008|Dose Ranging Period|Lost to Follow-up|0|||
48626662|NCT03715829|156491508|FG009|Dose Ranging Period|Lost to Follow-up|0|||
48626663|NCT03715829|156491509|FG010|Dose Ranging Period|Lost to Follow-up|0|||
48626664|NCT03715829|156491499|FG000|Dose Ranging Period|Protocol Violation|0|||
48626665|NCT03715829|156491500|FG001|Dose Ranging Period|Protocol Violation|0|||
48626666|NCT03715829|156491501|FG002|Dose Ranging Period|Protocol Violation|0|||
48626667|NCT03715829|156491502|FG003|Dose Ranging Period|Protocol Violation|1|||
48626668|NCT03715829|156491503|FG004|Dose Ranging Period|Protocol Violation|0|||
48626669|NCT03715829|156491504|FG005|Dose Ranging Period|Protocol Violation|0|||
48626670|NCT03715829|156491505|FG006|Dose Ranging Period|Protocol Violation|0|||
48626671|NCT03715829|156491506|FG007|Dose Ranging Period|Protocol Violation|0|||
48626672|NCT03715829|156491507|FG008|Dose Ranging Period|Protocol Violation|0|||
48626673|NCT03715829|156491508|FG009|Dose Ranging Period|Protocol Violation|0|||
48626674|NCT03715829|156491509|FG010|Dose Ranging Period|Protocol Violation|0|||
48626675|NCT03715829|156491499|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
48626676|NCT03715829|156491500|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
48626677|NCT03715829|156491501|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
48626678|NCT03715829|156491502|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
48626679|NCT03715829|156491503|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
48626680|NCT03715829|156491504|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
48626681|NCT03715829|156491505|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
48626682|NCT03715829|156491506|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
48626683|NCT03715829|156491507|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
48626684|NCT03715829|156491508|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
48626685|NCT03715829|156491509|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
48626686|NCT03715829|156491499|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48626687|NCT03715829|156491500|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48626688|NCT03715829|156491501|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
48626689|NCT03715829|156491502|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48626690|NCT03715829|156491503|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48626691|NCT03715829|156491504|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48626692|NCT03715829|156491505|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48741232|NCT02975336|156901747|FG006|LTE (104 Weeks)|Other|76|||
48741233|NCT02975336|156901748|FG007|LTE (104 Weeks)|Other|72|||
48741234|NCT03372096|156901753|FG000|Overall Study|Study Closed|8|||
48741235|NCT02468232|156901754|FG000|Core Part of Study|Adverse Event|0|||
48626693|NCT03715829|156491506|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48741236|NCT02468232|156901755|FG001|Core Part of Study|Adverse Event|1|||
48626694|NCT03715829|156491507|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48626695|NCT03715829|156491508|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48626696|NCT03715829|156491509|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
48626697|NCT03715829|156491499|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48741237|NCT02468232|156901756|FG002|Core Part of Study|Adverse Event|0|||
48741238|NCT02468232|156901757|FG003|Core Part of Study|Adverse Event|0|||
48741239|NCT02468232|156901754|FG000|Core Part of Study|Death|20|||
48626698|NCT03715829|156491500|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48626699|NCT03715829|156491501|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
48626700|NCT03715829|156491502|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48626701|NCT03715829|156491503|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
48626702|NCT03715829|156491504|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48626703|NCT03715829|156491505|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48626704|NCT03715829|156491506|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48626705|NCT03715829|156491507|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48626706|NCT03715829|156491508|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48626707|NCT03715829|156491509|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
48626708|NCT03715829|156491499|FG000|Dose Ranging Period|Other|0|||
48626709|NCT03715829|156491500|FG001|Dose Ranging Period|Other|0|||
48626710|NCT03715829|156491501|FG002|Dose Ranging Period|Other|2|||
48626711|NCT03715829|156491502|FG003|Dose Ranging Period|Other|0|||
48626712|NCT03715829|156491503|FG004|Dose Ranging Period|Other|0|||
48626713|NCT03715829|156491504|FG005|Dose Ranging Period|Other|3|||
48626714|NCT03715829|156491505|FG006|Dose Ranging Period|Other|0|||
48626715|NCT03715829|156491506|FG007|Dose Ranging Period|Other|0|||
48626716|NCT03715829|156491507|FG008|Dose Ranging Period|Other|0|||
48626717|NCT03715829|156491508|FG009|Dose Ranging Period|Other|0|||
48626718|NCT03715829|156491509|FG010|Dose Ranging Period|Other|0|||
48626719|NCT03715829|156491499|FG000|Extension Period|Adverse Event|0|||
48626720|NCT03715829|156491500|FG001|Extension Period|Adverse Event|0|||
48626721|NCT03715829|156491501|FG002|Extension Period|Adverse Event|0|||
48626722|NCT03715829|156491502|FG003|Extension Period|Adverse Event|0|||
48626723|NCT03715829|156491503|FG004|Extension Period|Adverse Event|0|||
48626724|NCT03715829|156491504|FG005|Extension Period|Adverse Event|0|||
48626725|NCT03715829|156491505|FG006|Extension Period|Adverse Event|3|||
48626726|NCT03715829|156491506|FG007|Extension Period|Adverse Event|1|||
48626727|NCT03715829|156491507|FG008|Extension Period|Adverse Event|6|||
48626728|NCT03715829|156491508|FG009|Extension Period|Adverse Event|0|||
48626729|NCT03715829|156491509|FG010|Extension Period|Adverse Event|0|||
48626730|NCT03715829|156491499|FG000|Extension Period|Lack of Efficacy|0|||
48626731|NCT03715829|156491500|FG001|Extension Period|Lack of Efficacy|0|||
48626732|NCT03715829|156491501|FG002|Extension Period|Lack of Efficacy|0|||
48626733|NCT03715829|156491502|FG003|Extension Period|Lack of Efficacy|0|||
48626734|NCT03715829|156491503|FG004|Extension Period|Lack of Efficacy|0|||
48626735|NCT03715829|156491504|FG005|Extension Period|Lack of Efficacy|0|||
48626736|NCT03715829|156491505|FG006|Extension Period|Lack of Efficacy|1|||
48626737|NCT03715829|156491506|FG007|Extension Period|Lack of Efficacy|9|||
48626738|NCT03715829|156491507|FG008|Extension Period|Lack of Efficacy|2|||
48626739|NCT03715829|156491508|FG009|Extension Period|Lack of Efficacy|0|||
48626740|NCT03715829|156491509|FG010|Extension Period|Lack of Efficacy|0|||
48626741|NCT03715829|156491499|FG000|Extension Period|Lost to Follow-up|0|||
48626742|NCT03715829|156491500|FG001|Extension Period|Lost to Follow-up|0|||
48626743|NCT03715829|156491501|FG002|Extension Period|Lost to Follow-up|0|||
48626744|NCT03715829|156491502|FG003|Extension Period|Lost to Follow-up|0|||
48626745|NCT03715829|156491503|FG004|Extension Period|Lost to Follow-up|0|||
48626746|NCT03715829|156491504|FG005|Extension Period|Lost to Follow-up|0|||
48626747|NCT03715829|156491505|FG006|Extension Period|Lost to Follow-up|0|||
48626748|NCT03715829|156491506|FG007|Extension Period|Lost to Follow-up|0|||
48626749|NCT03715829|156491507|FG008|Extension Period|Lost to Follow-up|2|||
48626750|NCT03715829|156491508|FG009|Extension Period|Lost to Follow-up|0|||
48626751|NCT03715829|156491509|FG010|Extension Period|Lost to Follow-up|0|||
48626752|NCT03715829|156491499|FG000|Extension Period|Protocol Violation|0|||
48626753|NCT03715829|156491500|FG001|Extension Period|Protocol Violation|0|||
48626754|NCT03715829|156491501|FG002|Extension Period|Protocol Violation|0|||
48626755|NCT03715829|156491502|FG003|Extension Period|Protocol Violation|0|||
48626756|NCT03715829|156491503|FG004|Extension Period|Protocol Violation|0|||
48626757|NCT03715829|156491504|FG005|Extension Period|Protocol Violation|0|||
48626758|NCT03715829|156491505|FG006|Extension Period|Protocol Violation|0|||
48626759|NCT03715829|156491506|FG007|Extension Period|Protocol Violation|0|||
48626760|NCT03715829|156491507|FG008|Extension Period|Protocol Violation|1|||
48626761|NCT03715829|156491508|FG009|Extension Period|Protocol Violation|0|||
48626762|NCT03715829|156491509|FG010|Extension Period|Protocol Violation|0|||
48626763|NCT03715829|156491499|FG000|Extension Period|Withdrawal by Subject|0|||
48626764|NCT03715829|156491500|FG001|Extension Period|Withdrawal by Subject|0|||
48626765|NCT03715829|156491501|FG002|Extension Period|Withdrawal by Subject|0|||
48626766|NCT03715829|156491502|FG003|Extension Period|Withdrawal by Subject|0|||
48626767|NCT03715829|156491503|FG004|Extension Period|Withdrawal by Subject|0|||
48626768|NCT03715829|156491504|FG005|Extension Period|Withdrawal by Subject|0|||
48626769|NCT03715829|156491505|FG006|Extension Period|Withdrawal by Subject|3|||
48626770|NCT03715829|156491506|FG007|Extension Period|Withdrawal by Subject|3|||
48626771|NCT03715829|156491507|FG008|Extension Period|Withdrawal by Subject|12|||
48626772|NCT03715829|156491508|FG009|Extension Period|Withdrawal by Subject|3|||
48626773|NCT03715829|156491509|FG010|Extension Period|Withdrawal by Subject|0|||
48626774|NCT03715829|156491499|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
48741240|NCT02468232|156901755|FG001|Core Part of Study|Death|17|||
48741241|NCT02468232|156901756|FG002|Core Part of Study|Death|0|||
48741242|NCT02468232|156901757|FG003|Core Part of Study|Death|0|||
48741243|NCT02468232|156901754|FG000|Core Part of Study|Technical Problems|1|||
48741244|NCT02468232|156901755|FG001|Core Part of Study|Technical Problems|1|||
48741245|NCT02468232|156901756|FG002|Core Part of Study|Technical Problems|0|||
48741246|NCT02468232|156901757|FG003|Core Part of Study|Technical Problems|0|||
48741247|NCT02468232|156901754|FG000|OLE Part of Study|Adverse Event|0|||
48741248|NCT02468232|156901755|FG001|OLE Part of Study|Adverse Event|0|||
48741249|NCT02468232|156901756|FG002|OLE Part of Study|Adverse Event|4|||
48741250|NCT02468232|156901757|FG003|OLE Part of Study|Adverse Event|5|||
48741251|NCT02468232|156901754|FG000|OLE Part of Study|Death|0|||
48741252|NCT02468232|156901755|FG001|OLE Part of Study|Death|0|||
48741253|NCT02468232|156901756|FG002|OLE Part of Study|Death|4|||
48741254|NCT02468232|156901757|FG003|OLE Part of Study|Death|2|||
48741255|NCT02468232|156901754|FG000|OLE Part of Study|Physician Decision|0|||
48741256|NCT02468232|156901755|FG001|OLE Part of Study|Physician Decision|0|||
48741257|NCT02468232|156901756|FG002|OLE Part of Study|Physician Decision|4|||
48741258|NCT02468232|156901757|FG003|OLE Part of Study|Physician Decision|0|||
48741259|NCT02468232|156901754|FG000|OLE Part of Study|Subject/Guardian decision|0|||
48741260|NCT02468232|156901755|FG001|OLE Part of Study|Subject/Guardian decision|0|||
48741261|NCT02468232|156901756|FG002|OLE Part of Study|Subject/Guardian decision|2|||
48741262|NCT02468232|156901757|FG003|OLE Part of Study|Subject/Guardian decision|5|||
48741263|NCT01773733|156901760|FG000|Overall Study|Adverse Event|3286|||
48741264|NCT01773733|156901761|FG001|Overall Study|Adverse Event|540|||
48741265|NCT01773733|156901760|FG000|Overall Study|Pregnancy|28|||
48741266|NCT01773733|156901761|FG001|Overall Study|Pregnancy|0|||
48741267|NCT01773733|156901760|FG000|Overall Study|Other different categories of not compl|55415|||
48741268|NCT01773733|156901761|FG001|Overall Study|Other different categories of not compl|7781|||
48741269|NCT02846324|156901767|FG000|Overall Study|Other|1|||
48741270|NCT02846324|156901768|FG001|Overall Study|Other|0|||
48741271|NCT02846324|156901769|FG002|Overall Study|Other|0|||
48741272|NCT02846324|156901770|FG003|Overall Study|Other|0|||
48741273|NCT02846324|156901767|FG000|Overall Study|Withdrawal by Subject|1|||
48741274|NCT02846324|156901768|FG001|Overall Study|Withdrawal by Subject|0|||
48626775|NCT03715829|156491500|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
48626776|NCT03715829|156491501|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
48626777|NCT03715829|156491502|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
48626778|NCT03715829|156491503|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
48626779|NCT03715829|156491504|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
48626780|NCT03715829|156491505|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
48626781|NCT03715829|156491506|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
48626782|NCT03715829|156491507|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
48626783|NCT03715829|156491508|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
48626784|NCT03715829|156491509|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
48626785|NCT03715829|156491499|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626786|NCT03715829|156491500|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626787|NCT03715829|156491501|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626788|NCT03715829|156491502|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626789|NCT03715829|156491503|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626790|NCT03715829|156491504|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626791|NCT03715829|156491505|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626792|NCT03715829|156491506|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626793|NCT03715829|156491507|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
48741275|NCT02846324|156901769|FG002|Overall Study|Withdrawal by Subject|4|||
48741276|NCT02846324|156901770|FG003|Overall Study|Withdrawal by Subject|0|||
48741277|NCT00892047|156901775|FG000|Overall Study|Adverse Event|2|||
48741278|NCT00892047|156901776|FG001|Overall Study|Adverse Event|2|||
48741279|NCT00892047|156901775|FG000|Overall Study|subject burden|2|||
48741280|NCT00892047|156901776|FG001|Overall Study|subject burden|3|||
48741281|NCT00892047|156901775|FG000|Overall Study|Lack of Efficacy|0|||
48626794|NCT03715829|156491508|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626795|NCT03715829|156491509|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
48626796|NCT03715829|156491499|FG000|Extension Period|Other|0|||
48626797|NCT03715829|156491500|FG001|Extension Period|Other|0|||
48626798|NCT03715829|156491501|FG002|Extension Period|Other|0|||
48626799|NCT03715829|156491502|FG003|Extension Period|Other|0|||
48626800|NCT03715829|156491503|FG004|Extension Period|Other|0|||
48626801|NCT03715829|156491504|FG005|Extension Period|Other|0|||
48626802|NCT03715829|156491505|FG006|Extension Period|Other|1|||
48626803|NCT03715829|156491506|FG007|Extension Period|Other|2|||
48626804|NCT03715829|156491507|FG008|Extension Period|Other|4|||
48626805|NCT03715829|156491508|FG009|Extension Period|Other|0|||
48626806|NCT03715829|156491509|FG010|Extension Period|Other|0|||
48626807|NCT01681849|156491513|FG000|Overall Study|Protocol Violation|2|||
48626808|NCT01681849|156491514|FG001|Overall Study|Protocol Violation|0|||
48626809|NCT01681849|156491515|FG002|Overall Study|Protocol Violation|0|||
48626810|NCT01681849|156491513|FG000|Overall Study|Withdrawal by Subject|3|||
48626811|NCT01681849|156491514|FG001|Overall Study|Withdrawal by Subject|5|||
48626812|NCT01681849|156491515|FG002|Overall Study|Withdrawal by Subject|33|||
48626813|NCT01681849|156491513|FG000|Overall Study|Lost to Follow-up|3|||
48626814|NCT01681849|156491514|FG001|Overall Study|Lost to Follow-up|2|||
48626815|NCT01681849|156491515|FG002|Overall Study|Lost to Follow-up|6|||
48626816|NCT02298946|156491526|FG000|Overall Study|Did not receive treatment|2|||
48626817|NCT02298946|156491527|FG001|Overall Study|Did not receive treatment|0|||
48626818|NCT02298946|156491526|FG000|Overall Study|Unevaluable|2|||
48626819|NCT02298946|156491527|FG001|Overall Study|Unevaluable|1|||
48626820|NCT00050011|156491530|FG000|Overall Study|Adverse Event|41|||
48626821|NCT00050011|156491531|FG001|Overall Study|Adverse Event|46|||
48626822|NCT00050011|156491530|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48626823|NCT00050011|156491531|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48626824|NCT00050011|156491530|FG000|Overall Study|Abnormal test procedure results|0|||
48626825|NCT00050011|156491531|FG001|Overall Study|Abnormal test procedure results|1|||
48626826|NCT00050011|156491530|FG000|Overall Study|Lack of Efficacy|16|||
48741282|NCT00892047|156901776|FG001|Overall Study|Lack of Efficacy|2|||
48741283|NCT01235689|156901778|FG000|Overall Study|Adverse Event|12|||
48741284|NCT01235689|156901779|FG001|Overall Study|Adverse Event|16|||
48741285|NCT01235689|156901778|FG000|Overall Study|Lack of Efficacy|12|||
48741286|NCT01235689|156901779|FG001|Overall Study|Lack of Efficacy|5|||
48741287|NCT01235689|156901778|FG000|Overall Study|Withdrawal by Subject|3|||
48741288|NCT01235689|156901779|FG001|Overall Study|Withdrawal by Subject|4|||
48741289|NCT01235689|156901778|FG000|Overall Study|Lost to Follow-up|1|||
48741290|NCT01235689|156901779|FG001|Overall Study|Lost to Follow-up|2|||
48741291|NCT01235689|156901778|FG000|Overall Study|Miscellaneous|1|||
48741292|NCT01235689|156901779|FG001|Overall Study|Miscellaneous|5|||
48741293|NCT02728596|156901780|FG000|Overall Study|Refusal unrelated to adverse event|3|||
48741294|NCT02728596|156901781|FG001|Overall Study|Refusal unrelated to adverse event|6|||
48741295|NCT02728596|156901782|FG002|Overall Study|Refusal unrelated to adverse event|7|||
48741296|NCT02728596|156901783|FG003|Overall Study|Refusal unrelated to adverse event|7|||
48741297|NCT02728596|156901780|FG000|Overall Study|Death|44|||
48741298|NCT02728596|156901781|FG001|Overall Study|Death|42|||
48741299|NCT02728596|156901782|FG002|Overall Study|Death|123|||
48741300|NCT02728596|156901783|FG003|Overall Study|Death|68|||
48741301|NCT01999868|156901788|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
48741302|NCT01999868|156901789|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
48741303|NCT01999868|156901790|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
48741304|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
48741305|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
48741306|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
48741307|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
48741308|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
48741309|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
48741310|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
48626827|NCT00050011|156491531|FG001|Overall Study|Lack of Efficacy|21|||
48626828|NCT00050011|156491530|FG000|Overall Study|Participant condition no longer required|1|||
48626829|NCT00050011|156491531|FG001|Overall Study|Participant condition no longer required|0|||
48626830|NCT00050011|156491530|FG000|Overall Study|Protocol Violation|4|||
48626831|NCT00050011|156491531|FG001|Overall Study|Protocol Violation|10|||
48626832|NCT00050011|156491530|FG000|Overall Study|Withdrawal by Subject|34|||
48741311|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
48741312|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
48741313|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
48741314|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
48626833|NCT00050011|156491531|FG001|Overall Study|Withdrawal by Subject|26|||
48626834|NCT00050011|156491530|FG000|Overall Study|Lost to Follow-up|7|||
48626835|NCT00050011|156491531|FG001|Overall Study|Lost to Follow-up|9|||
48626836|NCT00050011|156491530|FG000|Overall Study|Administrative problems|10|||
48626837|NCT00050011|156491531|FG001|Overall Study|Administrative problems|6|||
48626838|NCT00050011|156491530|FG000|Overall Study|Death|7|||
48626839|NCT00050011|156491531|FG001|Overall Study|Death|4|||
48626840|NCT00050011|156491530|FG000|Overall Study|Unknown - Reason is missing|0|||
48323754|NCT02754596|155383689|FG002|Overall Study|Adverse Event|1|||
48323755|NCT02754596|155383687|FG000|Overall Study|Other|1|||
48323756|NCT02754596|155383688|FG001|Overall Study|Other|0|||
48741315|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
48741316|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
48741317|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
48741318|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
48323757|NCT02754596|155383689|FG002|Overall Study|Other|0|||
48323758|NCT01400958|155383693|FG000|Overall Study|Physician Decision|0|||
48323759|NCT01400958|155383694|FG001|Overall Study|Physician Decision|1|||
48323760|NCT01400958|155383693|FG000|Overall Study|Withdrawal by Subject|0|||
48323761|NCT01400958|155383694|FG001|Overall Study|Withdrawal by Subject|1|||
48323762|NCT01400958|155383693|FG000|Overall Study|Adverse Event|1|||
48323763|NCT01400958|155383694|FG001|Overall Study|Adverse Event|0|||
48323764|NCT04436289|155383695|FG000|Overall Study|Death prior to hospital discharge|8|||
48323765|NCT04436289|155383696|FG001|Overall Study|Death prior to hospital discharge|5|||
48323766|NCT04436289|155383697|FG002|Overall Study|Death prior to hospital discharge|0|||
48323767|NCT04436289|155383698|FG003|Overall Study|Death prior to hospital discharge|1|||
48626841|NCT00050011|156491531|FG001|Overall Study|Unknown - Reason is missing|2|||
48626842|NCT05013905|156491532|FG000|Overall Study|Adverse Event|1|||
48626843|NCT05013905|156491532|FG000|Overall Study|Lack of Efficacy|1|||
48626844|NCT04003142|156491533|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
48741319|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
48741320|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
48741321|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
48741322|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
48741323|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
48741324|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
48741325|NCT01999868|156901788|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
48741326|NCT01999868|156901789|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
48741327|NCT01999868|156901790|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
48741328|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
48741329|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
48741330|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
48741331|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
48741332|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
48741333|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
48741334|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
48741335|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
48741336|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
48741337|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
48741338|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
48741339|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
48741340|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
48741341|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
48741342|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
48626845|NCT04003142|156491534|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
48741343|NCT01999868|156901788|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
48741344|NCT01999868|156901789|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
48741345|NCT01999868|156901790|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
48741346|NCT01681472|156901791|FG000|Overall Study|Adverse Event|0|||
48741347|NCT01681472|156901792|FG001|Overall Study|Adverse Event|1|||
48741348|NCT01681472|156901793|FG002|Overall Study|Adverse Event|0|||
48741349|NCT01681472|156901794|FG003|Overall Study|Adverse Event|0|||
48741350|NCT01217801|156901795|FG000|Period 1|Protocol Violation|1|||
48323768|NCT04436289|155383695|FG000|Overall Study|Withdrawal by Subject|0|||
48323769|NCT04436289|155383696|FG001|Overall Study|Withdrawal by Subject|1|||
48451240|NCT00355134|155841604|FG001|Core Phase|Adverse Event|22|||
48626846|NCT04003142|156491535|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
48741351|NCT01217801|156901796|FG001|Period 1|Protocol Violation|1|||
48741352|NCT01217801|156901795|FG000|Period 1|Withdrawal by Subject|0|||
48626847|NCT04003142|156491536|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
48626848|NCT04003142|156491537|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
48626849|NCT04003142|156491533|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
48626850|NCT04003142|156491534|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
48626851|NCT04003142|156491535|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
48626852|NCT04003142|156491536|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
48626853|NCT04003142|156491537|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
48626854|NCT04003142|156491533|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
48626855|NCT04003142|156491534|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
48626856|NCT04003142|156491535|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
48626857|NCT04003142|156491536|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
48626858|NCT04003142|156491537|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
48626859|NCT04003142|156491533|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
48626860|NCT04003142|156491534|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
48626861|NCT04003142|156491535|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
48626862|NCT04003142|156491536|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
48626863|NCT04003142|156491537|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
48626864|NCT04003142|156491533|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
48626865|NCT04003142|156491534|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
48626866|NCT04003142|156491535|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
48626867|NCT04003142|156491536|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
48626868|NCT04003142|156491537|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
48626869|NCT04003142|156491533|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
48626870|NCT04003142|156491534|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
48626871|NCT04003142|156491535|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
48626872|NCT04003142|156491536|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
48626873|NCT04003142|156491537|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
48626874|NCT04003142|156491533|FG000|Extension Period (40 Weeks)|Death|0|||
48626875|NCT04003142|156491534|FG001|Extension Period (40 Weeks)|Death|0|||
48626876|NCT04003142|156491535|FG002|Extension Period (40 Weeks)|Death|0|||
48626877|NCT04003142|156491536|FG003|Extension Period (40 Weeks)|Death|0|||
48626878|NCT04003142|156491537|FG004|Extension Period (40 Weeks)|Death|1|||
48626879|NCT04003142|156491533|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
48626880|NCT04003142|156491534|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
48626881|NCT04003142|156491535|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
48626882|NCT04003142|156491536|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
48626883|NCT04003142|156491537|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
48626884|NCT04003142|156491533|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
48626885|NCT04003142|156491534|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
48626886|NCT04003142|156491535|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
48626887|NCT04003142|156491536|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
48626888|NCT04003142|156491537|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
48626889|NCT04003142|156491533|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
48626890|NCT04003142|156491534|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
48626891|NCT04003142|156491535|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
48626892|NCT04003142|156491536|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
48626893|NCT04003142|156491537|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
48626894|NCT04003142|156491533|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
48626895|NCT04003142|156491534|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
48626896|NCT04003142|156491535|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
48626897|NCT04003142|156491536|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
48626898|NCT04003142|156491537|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
48626899|NCT03734536|156491542|FG000|Overall Study|Withdrew Consent|1|||
48626900|NCT03734536|156491543|FG001|Overall Study|Withdrew Consent|5|||
48626901|NCT03734536|156491542|FG000|Overall Study|Lost to Follow-up|10|||
48626902|NCT03734536|156491543|FG001|Overall Study|Lost to Follow-up|7|||
48626903|NCT02757963|156491544|FG000|Overall Study|Adverse Event|3|||
48626904|NCT02757963|156491544|FG000|Overall Study|Reached Stopping Criteria|1054|||
48626905|NCT02757963|156491544|FG000|Overall Study|Lost to Follow-up|5|||
48626906|NCT02757963|156491544|FG000|Overall Study|Physician Decision|1|||
48626907|NCT02757963|156491544|FG000|Overall Study|Withdrawal by Subject|34|||
48626908|NCT04755231|156491545|FG000|Overall Study|Lost to Follow-up|5|||
48626909|NCT04755231|156491545|FG000|Overall Study|Withdrawal by Subject|5|||
48626910|NCT00911157|156491546|FG000|Overall Study|Adverse Event|4|||
48626911|NCT00911157|156491547|FG001|Overall Study|Adverse Event|1|||
48626912|NCT00911157|156491546|FG000|Overall Study|Withdrawal by Subject|1|||
48626913|NCT00911157|156491547|FG001|Overall Study|Withdrawal by Subject|1|||
48626914|NCT00911157|156491546|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
48626915|NCT00911157|156491547|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
48626916|NCT00911157|156491546|FG000|Overall Study|Need to treat for lung cancer|1|||
48626917|NCT00911157|156491547|FG001|Overall Study|Need to treat for lung cancer|0|||
48626918|NCT02769481|156491550|FG000|Overall Study|Protocol Violation|1|||
48626919|NCT02769481|156491551|FG001|Overall Study|Protocol Violation|0|||
48626920|NCT02769481|156491550|FG000|Overall Study|Adverse Event|3|||
48626921|NCT02769481|156491551|FG001|Overall Study|Adverse Event|6|||
48626922|NCT02769481|156491550|FG000|Overall Study|Entry Criteria Not Met|1|||
48741353|NCT01217801|156901796|FG001|Period 1|Withdrawal by Subject|1|||
48626923|NCT02769481|156491551|FG001|Overall Study|Entry Criteria Not Met|2|||
48741354|NCT00191139|156901797|FG000|Overall Study|Adverse Event|2|||
48626924|NCT02769481|156491550|FG000|Overall Study|Withdrawal by Subject|14|||
48626925|NCT02769481|156491551|FG001|Overall Study|Withdrawal by Subject|16|||
48626926|NCT02769481|156491550|FG000|Overall Study|Lost to Follow-up|9|||
48626927|NCT02769481|156491551|FG001|Overall Study|Lost to Follow-up|9|||
48626928|NCT02769481|156491550|FG000|Overall Study|Physician Decision|0|||
48626929|NCT02769481|156491551|FG001|Overall Study|Physician Decision|1|||
48626930|NCT02769481|156491550|FG000|Overall Study|Terminated by Sponsor|1|||
48626931|NCT02769481|156491551|FG001|Overall Study|Terminated by Sponsor|0|||
48626932|NCT02769481|156491550|FG000|Overall Study|Death|0|||
48626933|NCT02769481|156491551|FG001|Overall Study|Death|1|||
48626934|NCT02769481|156491550|FG000|Overall Study|Undefined|4|||
48626935|NCT02769481|156491551|FG001|Overall Study|Undefined|1|||
48741355|NCT00191139|156901798|FG001|Overall Study|Adverse Event|6|||
48741356|NCT00191139|156901797|FG000|Overall Study|Death|2|||
48741357|NCT00191139|156901798|FG001|Overall Study|Death|0|||
48741358|NCT00191139|156901797|FG000|Overall Study|Withdrawal by Subject|0|||
48626936|NCT01346592|156491553|FG000|Overall Study|Lost to Follow-up|62|||
48626937|NCT01346592|156491554|FG001|Overall Study|Lost to Follow-up|29|||
48626938|NCT01346592|156491555|FG002|Overall Study|Lost to Follow-up|29|||
48626939|NCT01346592|156491553|FG000|Overall Study|Protocol Violation|2|||
48626940|NCT01346592|156491554|FG001|Overall Study|Protocol Violation|1|||
48626941|NCT01346592|156491555|FG002|Overall Study|Protocol Violation|0|||
48626942|NCT01346592|156491553|FG000|Overall Study|Death|1|||
48626943|NCT01346592|156491554|FG001|Overall Study|Death|3|||
48626944|NCT01346592|156491555|FG002|Overall Study|Death|4|||
48626945|NCT01346592|156491553|FG000|Overall Study|Adverse Event|0|||
48626946|NCT01346592|156491554|FG001|Overall Study|Adverse Event|1|||
48626947|NCT01346592|156491555|FG002|Overall Study|Adverse Event|0|||
48626948|NCT01346592|156491553|FG000|Overall Study|Withdrawal by Subject|77|||
48626949|NCT01346592|156491554|FG001|Overall Study|Withdrawal by Subject|51|||
48626950|NCT01346592|156491555|FG002|Overall Study|Withdrawal by Subject|38|||
48626951|NCT01346592|156491553|FG000|Overall Study|Inappropriate enrollment|3|||
48626952|NCT01346592|156491554|FG001|Overall Study|Inappropriate enrollment|1|||
48626953|NCT01346592|156491555|FG002|Overall Study|Inappropriate enrollment|1|||
48626954|NCT01346592|156491553|FG000|Overall Study|Administrative reason|1|||
48626955|NCT01346592|156491554|FG001|Overall Study|Administrative reason|0|||
48626956|NCT01346592|156491555|FG002|Overall Study|Administrative reason|0|||
48626957|NCT01346592|156491553|FG000|Overall Study|Unable to Classify|7|||
48626958|NCT01346592|156491554|FG001|Overall Study|Unable to Classify|3|||
48626959|NCT01346592|156491555|FG002|Overall Study|Unable to Classify|6|||
48626960|NCT04191135|156491558|FG000|Induction Treatment|Not Treated|2|||
48626961|NCT04191135|156491559|FG001|Induction Treatment|Not Treated|0|||
48626962|NCT04191135|156491560|FG002|Induction Treatment|Not Treated|0|||
48626963|NCT04191135|156491558|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
48626964|NCT04191135|156491559|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
48626965|NCT04191135|156491560|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
48626966|NCT04191135|156491558|FG000|Induction Treatment|Adverse Event|25|||
48626967|NCT04191135|156491559|FG001|Induction Treatment|Adverse Event|0|||
48626968|NCT04191135|156491560|FG002|Induction Treatment|Adverse Event|0|||
48626969|NCT04191135|156491558|FG000|Induction Treatment|Clinical Progression|8|||
48626970|NCT04191135|156491559|FG001|Induction Treatment|Clinical Progression|0|||
48626971|NCT04191135|156491560|FG002|Induction Treatment|Clinical Progression|0|||
48626972|NCT04191135|156491558|FG000|Induction Treatment|Excluded Medication|1|||
48626973|NCT04191135|156491559|FG001|Induction Treatment|Excluded Medication|0|||
48626974|NCT04191135|156491560|FG002|Induction Treatment|Excluded Medication|0|||
48626975|NCT04191135|156491558|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
48626976|NCT04191135|156491559|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
48741359|NCT00191139|156901798|FG001|Overall Study|Withdrawal by Subject|3|||
48626977|NCT04191135|156491560|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
48626978|NCT04191135|156491558|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
48626979|NCT04191135|156491559|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
48626980|NCT04191135|156491560|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
48626981|NCT04191135|156491558|FG000|Induction Treatment|Physician Decision|2|||
48626982|NCT04191135|156491559|FG001|Induction Treatment|Physician Decision|0|||
48626983|NCT04191135|156491560|FG002|Induction Treatment|Physician Decision|0|||
48741360|NCT00191139|156901797|FG000|Overall Study|Disease Progression|0|||
48626984|NCT04191135|156491558|FG000|Induction Treatment|Progressive Disease|135|||
48626985|NCT04191135|156491559|FG001|Induction Treatment|Progressive Disease|0|||
48626986|NCT04191135|156491560|FG002|Induction Treatment|Progressive Disease|0|||
48626987|NCT04191135|156491558|FG000|Induction Treatment|Protocol Violation|10|||
48626988|NCT04191135|156491559|FG001|Induction Treatment|Protocol Violation|0|||
48626989|NCT04191135|156491560|FG002|Induction Treatment|Protocol Violation|0|||
48626990|NCT04191135|156491558|FG000|Induction Treatment|Withdrawal by Subject|4|||
48626991|NCT04191135|156491559|FG001|Induction Treatment|Withdrawal by Subject|0|||
48626992|NCT04191135|156491560|FG002|Induction Treatment|Withdrawal by Subject|0|||
48626993|NCT04191135|156491558|FG000|Randomized Treatment|Death|0|||
48626994|NCT04191135|156491559|FG001|Randomized Treatment|Death|50|||
48626995|NCT04191135|156491560|FG002|Randomized Treatment|Death|54|||
48626996|NCT04191135|156491558|FG000|Randomized Treatment|Lost to Follow-up|0|||
48626997|NCT04191135|156491559|FG001|Randomized Treatment|Lost to Follow-up|0|||
48626998|NCT04191135|156491560|FG002|Randomized Treatment|Lost to Follow-up|1|||
48626999|NCT04191135|156491558|FG000|Randomized Treatment|Withdrawal by Subject|0|||
48627000|NCT04191135|156491559|FG001|Randomized Treatment|Withdrawal by Subject|2|||
48627001|NCT04191135|156491560|FG002|Randomized Treatment|Withdrawal by Subject|0|||
48627002|NCT04191135|156491558|FG000|Randomized Treatment|Ongoing in Trial|0|||
48627003|NCT04191135|156491559|FG001|Randomized Treatment|Ongoing in Trial|83|||
48627004|NCT04191135|156491560|FG002|Randomized Treatment|Ongoing in Trial|81|||
48741361|NCT00191139|156901798|FG001|Overall Study|Disease Progression|1|||
48741362|NCT00191139|156901797|FG000|Overall Study|Other|1|||
48741363|NCT00191139|156901798|FG001|Overall Study|Other|2|||
48741364|NCT01402011|156901803|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
48741365|NCT01402011|156901804|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
48741366|NCT01402011|156901805|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
48741367|NCT01402011|156901803|FG000|Active Treatment Period|Withdrawal by Subject|1|||
48741368|NCT01402011|156901804|FG001|Active Treatment Period|Withdrawal by Subject|3|||
48741369|NCT01402011|156901805|FG002|Active Treatment Period|Withdrawal by Subject|0|||
48741370|NCT01402011|156901803|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
48741371|NCT01402011|156901804|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
48741372|NCT01402011|156901805|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
48741373|NCT03607487|156901806|FG000|Overall Study|Withdrawal by Subject|2|||
48741374|NCT03607487|156901807|FG001|Overall Study|Withdrawal by Subject|0|||
48741375|NCT03607487|156901808|FG002|Overall Study|Withdrawal by Subject|0|||
48741376|NCT03607487|156901809|FG003|Overall Study|Withdrawal by Subject|1|||
48741377|NCT01273597|156901810|FG000|Overall Study|Adverse Event|5|||
48741378|NCT01273597|156901810|FG000|Overall Study|Underwent Kidney Transplantation|2|||
48741379|NCT01273597|156901810|FG000|Overall Study|Reason Not Reported|1|||
48741380|NCT00873912|156901811|FG000|Overall Study|Withdrawal by Subject|1|||
48741381|NCT00873912|156901812|FG001|Overall Study|Withdrawal by Subject|0|||
48741382|NCT00873912|156901811|FG000|Overall Study|Lost to Follow-up|2|||
48741383|NCT00873912|156901812|FG001|Overall Study|Lost to Follow-up|0|||
48741384|NCT01466153|156901814|FG000|Overall Study|Disease Progression|2|||
48741385|NCT01466153|156901815|FG001|Overall Study|Disease Progression|2|||
48741386|NCT01466153|156901816|FG002|Overall Study|Disease Progression|0|||
48741387|NCT01466153|156901814|FG000|Overall Study|Adverse Event|14|||
48741388|NCT01466153|156901815|FG001|Overall Study|Adverse Event|13|||
48741389|NCT01466153|156901816|FG002|Overall Study|Adverse Event|17|||
48741390|NCT01466153|156901814|FG000|Overall Study|Withdrawal of Consent|2|||
48741391|NCT01466153|156901815|FG001|Overall Study|Withdrawal of Consent|0|||
48741392|NCT01466153|156901816|FG002|Overall Study|Withdrawal of Consent|0|||
48741393|NCT01466153|156901814|FG000|Overall Study|Investigator Discretion|3|||
48741394|NCT01466153|156901815|FG001|Overall Study|Investigator Discretion|2|||
48627005|NCT04115293|156493085|FG000|Overall Study|Adverse Event|0|||
48627006|NCT04115293|156493086|FG001|Overall Study|Adverse Event|2|||
48627007|NCT04115293|156493085|FG000|Overall Study|Withdrawal by Subject|2|||
48627008|NCT04115293|156493086|FG001|Overall Study|Withdrawal by Subject|1|||
48741395|NCT01466153|156901816|FG002|Overall Study|Investigator Discretion|2|||
48741396|NCT01466153|156901814|FG000|Overall Study|Randomized-Not Treated|2|||
48741397|NCT01466153|156901815|FG001|Overall Study|Randomized-Not Treated|3|||
48741398|NCT01466153|156901816|FG002|Overall Study|Randomized-Not Treated|4|||
48741399|NCT01466153|156901814|FG000|Overall Study|Other-Unspecified|6|||
48741400|NCT01466153|156901815|FG001|Overall Study|Other-Unspecified|4|||
48741401|NCT01466153|156901816|FG002|Overall Study|Other-Unspecified|2|||
48741402|NCT01785069|156901817|FG000|Overall Study|Implanted with nonstudy device|1|||
48627009|NCT04115293|156493085|FG000|Overall Study|Physician Decision|1|||
48627010|NCT04115293|156493086|FG001|Overall Study|Physician Decision|0|||
48627011|NCT04115293|156493085|FG000|Overall Study|Death|1|||
48798206|NCT00441701|157098562|FG001|Overall Study|Lack of Efficacy|0|||
48798207|NCT00441701|157098563|FG002|Overall Study|Lack of Efficacy|2|||
48798208|NCT00441701|157098564|FG003|Overall Study|Lack of Efficacy|2|||
48798209|NCT00441701|157098565|FG004|Overall Study|Lack of Efficacy|0|||
48798210|NCT00441701|157098566|FG005|Overall Study|Lack of Efficacy|1|||
48798211|NCT00441701|157098567|FG006|Overall Study|Lack of Efficacy|0|||
48627012|NCT04115293|156493086|FG001|Overall Study|Death|1|||
48627013|NCT05543174|156493087|FG000|Overall Study|Ongoing|7|||
48627014|NCT02363283|156493088|FG000|Overall Study|Withdrawal by Subject|1|||
48627015|NCT02363283|156493088|FG000|Overall Study|Not eligible due to transaminitis|1|||
48627016|NCT02698787|156493089|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
48627017|NCT02698787|156493090|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
48627018|NCT03211858|156493092|FG000|Overall Study|Adverse Event|8|||
48627019|NCT03211858|156493093|FG001|Overall Study|Adverse Event|6|||
48627020|NCT03211858|156493092|FG000|Overall Study|Lack of Efficacy|0|||
48627021|NCT03211858|156493093|FG001|Overall Study|Lack of Efficacy|4|||
48627022|NCT03211858|156493092|FG000|Overall Study|Poor compliance to protocol|6|||
48627023|NCT03211858|156493093|FG001|Overall Study|Poor compliance to protocol|2|||
48627024|NCT03211858|156493092|FG000|Overall Study|Non-serious Hypoglycemia|1|||
48627025|NCT03211858|156493093|FG001|Overall Study|Non-serious Hypoglycemia|0|||
48741403|NCT01785069|156901818|FG001|Overall Study|Implanted with nonstudy device|2|||
48741404|NCT01785069|156901819|FG002|Overall Study|Implanted with nonstudy device|1|||
48741405|NCT01785069|156901820|FG003|Overall Study|Implanted with nonstudy device|0|||
48741406|NCT01785069|156901817|FG000|Overall Study|Death|0|||
48741407|NCT01785069|156901818|FG001|Overall Study|Death|0|||
48741408|NCT01785069|156901819|FG002|Overall Study|Death|2|||
48627026|NCT03211858|156493092|FG000|Overall Study|Other than specified above|22|||
48627027|NCT03211858|156493093|FG001|Overall Study|Other than specified above|21|||
48627028|NCT02904265|156493095|FG000|Overall Study|Physician Decision|1|||
48627029|NCT02904265|156493096|FG001|Overall Study|Physician Decision|2|||
48627030|NCT00107614|156493097|FG000|Overall Study|Physician Decision|10|||
48627031|NCT00107614|156493097|FG000|Overall Study|Death|2|||
48627032|NCT01428713|156493098|FG000|Overall Study|Non-compliance|2|||
48627033|NCT01428713|156493099|FG001|Overall Study|Non-compliance|2|||
48627034|NCT01428713|156493098|FG000|Overall Study|Withdrawal by Subject|1|||
48627035|NCT01428713|156493099|FG001|Overall Study|Withdrawal by Subject|1|||
48627036|NCT01428713|156493098|FG000|Overall Study|Adverse Event|0|||
48627037|NCT01428713|156493099|FG001|Overall Study|Adverse Event|2|||
48627038|NCT05333965|156493121|FG000|First Intervention|Adverse Event|0|||
48627039|NCT05333965|156493122|FG001|First Intervention|Adverse Event|1|||
48627040|NCT05333965|156493121|FG000|First Intervention|Withdrawal by Subject|0|||
48627041|NCT05333965|156493122|FG001|First Intervention|Withdrawal by Subject|1|||
48627042|NCT01730729|156493125|FG000|Overall Study|Adverse Event|1|||
48627043|NCT01730729|156493125|FG000|Overall Study|Death|1|||
48627044|NCT01730729|156493125|FG000|Overall Study|Progressive Disease|12|||
48627045|NCT02402907|156493126|FG000|Overall Study|Delivered vaginally|9|||
48627046|NCT02402907|156493127|FG001|Overall Study|Delivered vaginally|3|||
48627047|NCT02402907|156493126|FG000|Overall Study|Delivered outside of Sinai|1|||
48627048|NCT02402907|156493127|FG001|Overall Study|Delivered outside of Sinai|1|||
48627049|NCT02402907|156493126|FG000|Overall Study|Lost to follow up after C-Section|10|||
48627050|NCT02402907|156493127|FG001|Overall Study|Lost to follow up after C-Section|23|||
48627051|NCT02462057|156493130|FG000|Overall Study|Left Vitality|32|||
48627052|NCT02462057|156493131|FG001|Overall Study|Left Vitality|27|||
48627053|NCT02462057|156493132|FG002|Overall Study|Left Vitality|23|||
48627054|NCT02462057|156493133|FG003|Overall Study|Left Vitality|35|||
48627055|NCT02462057|156493134|FG004|Overall Study|Left Vitality|33|||
48627056|NCT02462057|156493130|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
48627057|NCT02462057|156493131|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
48741409|NCT01785069|156901820|FG003|Overall Study|Death|0|||
48741410|NCT01785069|156901817|FG000|Overall Study|Subject choice|2|||
48741411|NCT01785069|156901818|FG001|Overall Study|Subject choice|2|||
48741412|NCT01785069|156901819|FG002|Overall Study|Subject choice|0|||
48741413|NCT01785069|156901820|FG003|Overall Study|Subject choice|1|||
48741414|NCT01785069|156901817|FG000|Overall Study|Lost to Follow-up|1|||
48741415|NCT01785069|156901818|FG001|Overall Study|Lost to Follow-up|2|||
48741416|NCT01785069|156901819|FG002|Overall Study|Lost to Follow-up|4|||
48741417|NCT01785069|156901820|FG003|Overall Study|Lost to Follow-up|1|||
48741418|NCT01785069|156901817|FG000|Overall Study|Reason not Specified|1|||
48741419|NCT01785069|156901818|FG001|Overall Study|Reason not Specified|2|||
48741420|NCT01785069|156901819|FG002|Overall Study|Reason not Specified|1|||
48741421|NCT01785069|156901820|FG003|Overall Study|Reason not Specified|4|||
48323770|NCT04436289|155383697|FG002|Overall Study|Withdrawal by Subject|4|||
48323771|NCT04436289|155383698|FG003|Overall Study|Withdrawal by Subject|0|||
48627058|NCT02462057|156493132|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
48627059|NCT02462057|156493133|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
48627060|NCT02462057|156493134|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
48627061|NCT01697501|156493136|FG000|Overall Study|Protocol Violation|2|||
48741422|NCT01785069|156901817|FG000|Overall Study|Not evaluable|7|||
48741423|NCT01785069|156901818|FG001|Overall Study|Not evaluable|4|||
48741424|NCT01785069|156901819|FG002|Overall Study|Not evaluable|5|||
48741425|NCT01785069|156901820|FG003|Overall Study|Not evaluable|8|||
48741426|NCT03280030|156901827|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
48741427|NCT03280030|156901828|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
48741428|NCT03280030|156901829|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
48323772|NCT04436289|155383695|FG000|Overall Study|Extended hospital stay|0|||
48323773|NCT04436289|155383696|FG001|Overall Study|Extended hospital stay|1|||
48323774|NCT04436289|155383697|FG002|Overall Study|Extended hospital stay|0|||
48323775|NCT04436289|155383698|FG003|Overall Study|Extended hospital stay|0|||
48323776|NCT04436289|155383695|FG000|Overall Study|Lost to Follow-up|0|||
48323777|NCT04436289|155383696|FG001|Overall Study|Lost to Follow-up|4|||
48323778|NCT04436289|155383697|FG002|Overall Study|Lost to Follow-up|1|||
48323779|NCT04436289|155383698|FG003|Overall Study|Lost to Follow-up|3|||
48323780|NCT03102034|155383699|FG000|Overall Study|Withdrawal by Subject|1|||
48323781|NCT03102034|155383700|FG001|Overall Study|Withdrawal by Subject|0|||
48323782|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
48627062|NCT00836901|156493140|FG000|First Intervention|Withdrawal by Subject|1|||
48627063|NCT00836901|156493141|FG001|First Intervention|Withdrawal by Subject|0|||
48627064|NCT04893811|156493142|FG000|Vaccination Phase|Death|1|||
48627065|NCT04893811|156493143|FG001|Vaccination Phase|Death|0|||
48627066|NCT04893811|156493142|FG000|Vaccination Phase|Lost to Follow-up|1|||
48627067|NCT04893811|156493143|FG001|Vaccination Phase|Lost to Follow-up|1|||
48627068|NCT04893811|156493142|FG000|Vaccination Phase|Protocol Violation|2|||
48627069|NCT04893811|156493143|FG001|Vaccination Phase|Protocol Violation|0|||
48627070|NCT04893811|156493142|FG000|Vaccination Phase|Withdrawal by Subject|2|||
48627071|NCT04893811|156493143|FG001|Vaccination Phase|Withdrawal by Subject|1|||
48627072|NCT04893811|156493142|FG000|Vaccination Phase|Other|0|||
48627073|NCT04893811|156493143|FG001|Vaccination Phase|Other|1|||
48627074|NCT04893811|156493142|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
48627075|NCT04893811|156493143|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
48627076|NCT04893811|156493142|FG000|Follow-up Phase|Lost to Follow-up|0|||
48627077|NCT04893811|156493143|FG001|Follow-up Phase|Lost to Follow-up|1|||
48627078|NCT02951819|156493157|FG000|Overall Study|Death|9|||
48627079|NCT02951819|156493158|FG001|Overall Study|Death|7|||
48627080|NCT02951819|156493157|FG000|Overall Study|Withdrawal by Subject|3|||
48627081|NCT02951819|156493158|FG001|Overall Study|Withdrawal by Subject|0|||
48627082|NCT02951819|156493157|FG000|Overall Study|Adverse Event|1|||
48627083|NCT02951819|156493158|FG001|Overall Study|Adverse Event|0|||
48627084|NCT02951819|156493157|FG000|Overall Study|Lack of Efficacy|4|||
48627085|NCT02951819|156493158|FG001|Overall Study|Lack of Efficacy|0|||
48627086|NCT02951819|156493157|FG000|Overall Study|Lost to Follow-up|1|||
48627087|NCT02951819|156493158|FG001|Overall Study|Lost to Follow-up|0|||
48627088|NCT02951819|156493157|FG000|Overall Study|Progressive Disease|1|||
48627089|NCT02951819|156493158|FG001|Overall Study|Progressive Disease|0|||
48627090|NCT02951819|156493157|FG000|Overall Study|Other|9|||
48627091|NCT02951819|156493158|FG001|Overall Study|Other|0|||
48627092|NCT01443026|156493159|FG000|Overall Study|Physician Decision|1|||
48627093|NCT01443026|156493160|FG001|Overall Study|Physician Decision|0|||
48627094|NCT01443026|156493159|FG000|Overall Study|Death|0|||
48627095|NCT01443026|156493160|FG001|Overall Study|Death|1|||
48627096|NCT01443026|156493159|FG000|Overall Study|Withdrawal by Subject|0|||
48627097|NCT01443026|156493160|FG001|Overall Study|Withdrawal by Subject|3|||
48627098|NCT01443026|156493159|FG000|Overall Study|Lost to Follow-up|2|||
48627099|NCT01443026|156493160|FG001|Overall Study|Lost to Follow-up|1|||
48627100|NCT02202577|156493161|FG000|Overall Study|Lost to Follow-up|6|||
48627101|NCT02202577|156493162|FG001|Overall Study|Lost to Follow-up|16|||
48627102|NCT02202577|156493161|FG000|Overall Study|Protocol Violation|7|||
48627103|NCT02202577|156493162|FG001|Overall Study|Protocol Violation|3|||
48627104|NCT03878602|156493163|FG000|Overall Study|cord blood donation|7|||
48627105|NCT03878602|156493164|FG001|Overall Study|cord blood donation|1|||
48627106|NCT03878602|156493163|FG000|Overall Study|incomplete data collection|2|||
48627107|NCT03878602|156493164|FG001|Overall Study|incomplete data collection|0|||
48627108|NCT02395627|156493165|FG000|Overall Study|Withdrawal by Subject|0|||
48741429|NCT03280030|156901827|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
48741430|NCT03280030|156901828|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
48741431|NCT03280030|156901829|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
48741432|NCT03280030|156901827|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
48741433|NCT03280030|156901828|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
48741434|NCT03280030|156901829|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
48741435|NCT03280030|156901827|FG000|Part 2 - Efficacy|Adverse Event|0|||
48741436|NCT03280030|156901828|FG001|Part 2 - Efficacy|Adverse Event|4|||
48741437|NCT03280030|156901829|FG002|Part 2 - Efficacy|Adverse Event|6|||
48323783|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
48627109|NCT02395627|156493166|FG001|Overall Study|Withdrawal by Subject|2|||
48627110|NCT02395627|156493167|FG002|Overall Study|Withdrawal by Subject|0|||
48627111|NCT02395627|156493165|FG000|Overall Study|Did not receive pembrolizumab|3|||
48627112|NCT02395627|156493166|FG001|Overall Study|Did not receive pembrolizumab|1|||
48741438|NCT03280030|156901827|FG000|Part 2 - Efficacy|Death|0|||
48741439|NCT03280030|156901828|FG001|Part 2 - Efficacy|Death|3|||
48741440|NCT03280030|156901829|FG002|Part 2 - Efficacy|Death|0|||
48627113|NCT02395627|156493167|FG002|Overall Study|Did not receive pembrolizumab|0|||
48627114|NCT00721110|156493168|FG000|Overall Study|Ultram use|1|||
48627115|NCT00721110|156493169|FG001|Overall Study|Ultram use|0|||
48627116|NCT00721110|156493170|FG002|Overall Study|Ultram use|0|||
48627117|NCT00721110|156493171|FG003|Overall Study|Ultram use|0|||
48627118|NCT00721110|156493168|FG000|Overall Study|vertical incision|0|||
48627119|NCT00721110|156493169|FG001|Overall Study|vertical incision|0|||
48627120|NCT00721110|156493170|FG002|Overall Study|vertical incision|1|||
48627121|NCT00721110|156493171|FG003|Overall Study|vertical incision|0|||
48627122|NCT02799043|156493172|FG000|Overall Study|Adverse Event|0|||
48627123|NCT02799043|156493173|FG001|Overall Study|Adverse Event|1|||
48627124|NCT02799043|156493172|FG000|Overall Study|Death|1|||
48627125|NCT02799043|156493173|FG001|Overall Study|Death|1|||
48627126|NCT02799043|156493172|FG000|Overall Study|Lost to Follow-up|3|||
48627127|NCT02799043|156493173|FG001|Overall Study|Lost to Follow-up|6|||
48627128|NCT02799043|156493172|FG000|Overall Study|Withdrawal by Subject|4|||
48627129|NCT02799043|156493173|FG001|Overall Study|Withdrawal by Subject|4|||
48627130|NCT02799043|156493172|FG000|Overall Study|Moved to different country|0|||
48627131|NCT02799043|156493173|FG001|Overall Study|Moved to different country|1|||
48627132|NCT02799043|156493172|FG000|Overall Study|Trial Screen Failure|1|||
48627133|NCT02799043|156493173|FG001|Overall Study|Trial Screen Failure|0|||
48627134|NCT02799043|156493172|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
48627135|NCT02799043|156493173|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
48627136|NCT06351371|156493174|FG000|Overall Study|Mutation Status Not Confirmed|9|||
48627137|NCT06351371|156493174|FG000|Overall Study|Ineligible|1|||
48627138|NCT06351371|156493174|FG000|Overall Study|Adverse Event|4|||
48627139|NCT06351371|156493174|FG000|Overall Study|Death|1|||
48627140|NCT06351371|156493174|FG000|Overall Study|Disease progression|14|||
48627141|NCT06351371|156493174|FG000|Overall Study|Withdrawal by Subject|3|||
48627142|NCT06351371|156493174|FG000|Overall Study|Physician Decision|3|||
48627143|NCT04642079|156493180|FG000|Overall Study|Lost to Follow-up|2|||
48627144|NCT04642079|156493181|FG001|Overall Study|Lost to Follow-up|5|||
48627145|NCT04642079|156493182|FG002|Overall Study|Lost to Follow-up|2|||
48627146|NCT04642079|156493183|FG003|Overall Study|Lost to Follow-up|0|||
48627147|NCT04642079|156493180|FG000|Overall Study|Withdrawal by Subject|0|||
48627148|NCT04642079|156493181|FG001|Overall Study|Withdrawal by Subject|4|||
48627149|NCT04642079|156493182|FG002|Overall Study|Withdrawal by Subject|1|||
48627150|NCT04642079|156493183|FG003|Overall Study|Withdrawal by Subject|2|||
48627151|NCT04642079|156493180|FG000|Overall Study|Other|0|||
48627152|NCT04642079|156493181|FG001|Overall Study|Other|0|||
48627153|NCT04642079|156493182|FG002|Overall Study|Other|0|||
48741441|NCT03280030|156901827|FG000|Part 2 - Efficacy|Physician Decision|0|||
48741442|NCT03280030|156901828|FG001|Part 2 - Efficacy|Physician Decision|10|||
48741443|NCT03280030|156901829|FG002|Part 2 - Efficacy|Physician Decision|16|||
48741444|NCT03280030|156901827|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
48741445|NCT03280030|156901828|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
48741446|NCT03280030|156901829|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
48741447|NCT03280030|156901827|FG000|Part 2 - Efficacy|Progressive disease|0|||
48741448|NCT03280030|156901828|FG001|Part 2 - Efficacy|Progressive disease|7|||
48741449|NCT03280030|156901829|FG002|Part 2 - Efficacy|Progressive disease|5|||
48741450|NCT00748709|156901830|FG000|Overall Study|Progressive disease|15|||
48741451|NCT00748709|156901830|FG000|Overall Study|Drug reducing Toxity|2|||
48627154|NCT04642079|156493183|FG003|Overall Study|Other|1|||
48627155|NCT04642079|156493180|FG000|Overall Study|No longer met eligibility criteria|1|||
48627156|NCT04642079|156493181|FG001|Overall Study|No longer met eligibility criteria|0|||
48627157|NCT04642079|156493182|FG002|Overall Study|No longer met eligibility criteria|1|||
48627158|NCT04642079|156493183|FG003|Overall Study|No longer met eligibility criteria|1|||
48627159|NCT01335685|156493187|FG000|Overall Study|Study Terminated by Sponsor|2|||
48627160|NCT01335685|156493188|FG001|Overall Study|Study Terminated by Sponsor|1|||
48627161|NCT01335685|156493189|FG002|Overall Study|Study Terminated by Sponsor|1|||
48627162|NCT01335685|156493190|FG003|Overall Study|Study Terminated by Sponsor|10|||
48627163|NCT01335685|156493191|FG004|Overall Study|Study Terminated by Sponsor|0|||
48627164|NCT01335685|156493192|FG005|Overall Study|Study Terminated by Sponsor|4|||
48741452|NCT00748709|156901830|FG000|Overall Study|Other Adverse Event|1|||
48741453|NCT00748709|156901830|FG000|Overall Study|Withdrawal by Subject|1|||
48741454|NCT00748709|156901830|FG000|Overall Study|Other Reasons|1|||
48627165|NCT01335685|156493193|FG006|Overall Study|Study Terminated by Sponsor|2|||
48627166|NCT01335685|156493194|FG007|Overall Study|Study Terminated by Sponsor|3|||
48627167|NCT01335685|156493187|FG000|Overall Study|Withdrawal by Subject|1|||
48627168|NCT01335685|156493188|FG001|Overall Study|Withdrawal by Subject|0|||
48741455|NCT00647387|156901831|FG000|Overall Study|Lost to Follow-up|6|||
48323784|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
48323785|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
48323786|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
48323787|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
48323788|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
48323789|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
48323790|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
48323791|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
48323792|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
48323793|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
48323794|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
48323795|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
48323796|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
48323797|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
48323798|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
48323799|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
48627169|NCT01335685|156493189|FG002|Overall Study|Withdrawal by Subject|0|||
48627170|NCT01335685|156493190|FG003|Overall Study|Withdrawal by Subject|1|||
48627171|NCT01335685|156493191|FG004|Overall Study|Withdrawal by Subject|0|||
48627172|NCT01335685|156493192|FG005|Overall Study|Withdrawal by Subject|0|||
48627173|NCT01335685|156493193|FG006|Overall Study|Withdrawal by Subject|0|||
48627174|NCT01335685|156493194|FG007|Overall Study|Withdrawal by Subject|0|||
48627175|NCT01335685|156493187|FG000|Overall Study|Reason not Specified|0|||
48627176|NCT01335685|156493188|FG001|Overall Study|Reason not Specified|0|||
48627177|NCT01335685|156493189|FG002|Overall Study|Reason not Specified|1|||
48627178|NCT01335685|156493190|FG003|Overall Study|Reason not Specified|0|||
48627179|NCT01335685|156493191|FG004|Overall Study|Reason not Specified|0|||
48627180|NCT01335685|156493192|FG005|Overall Study|Reason not Specified|1|||
48627181|NCT01335685|156493193|FG006|Overall Study|Reason not Specified|0|||
48627182|NCT01335685|156493194|FG007|Overall Study|Reason not Specified|0|||
48627183|NCT00563316|156493199|FG000|Overall Study|Adverse Event|2|||
48627184|NCT00563316|156493199|FG000|Overall Study|Physician Decision|1|||
48627185|NCT00563316|156493199|FG000|Overall Study|Lost to Follow-up|2|||
48627186|NCT00563316|156493199|FG000|Overall Study|Death|1|||
48627187|NCT00563316|156493199|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
48627188|NCT00563316|156493199|FG000|Overall Study|Other|1|||
48627189|NCT02011542|156493202|FG000|Overall Study|Physician Decision|1|||
48627190|NCT02913326|156493203|FG000|Overall Study|Reason not listed|0|||
48627191|NCT02913326|156493204|FG001|Overall Study|Reason not listed|1|||
48627192|NCT02913326|156493203|FG000|Overall Study|Lost to Follow-up|0|||
48627193|NCT02913326|156493204|FG001|Overall Study|Lost to Follow-up|1|||
48627194|NCT02913326|156493203|FG000|Overall Study|Adverse Event|1|||
48627195|NCT02913326|156493204|FG001|Overall Study|Adverse Event|0|||
48627196|NCT01767857|156493205|FG000|Overall Study|Adverse Event|27|||
48627197|NCT01767857|156493206|FG001|Overall Study|Adverse Event|7|||
48627198|NCT01767857|156493205|FG000|Overall Study|Death|28|||
48627199|NCT01767857|156493206|FG001|Overall Study|Death|13|||
48627200|NCT01767857|156493205|FG000|Overall Study|Lack of Efficacy|299|||
48627201|NCT01767857|156493206|FG001|Overall Study|Lack of Efficacy|151|||
48627202|NCT01767857|156493205|FG000|Overall Study|Lost to Follow-up|1|||
48627203|NCT01767857|156493206|FG001|Overall Study|Lost to Follow-up|1|||
48627204|NCT01767857|156493205|FG000|Overall Study|Withdrawal by Subject|38|||
48627205|NCT01767857|156493206|FG001|Overall Study|Withdrawal by Subject|18|||
48627206|NCT01767857|156493205|FG000|Overall Study|Physician Decision|17|||
48627207|NCT01767857|156493206|FG001|Overall Study|Physician Decision|10|||
48627208|NCT01767857|156493205|FG000|Overall Study|Protocol Terminated|1|||
48627209|NCT01767857|156493206|FG001|Overall Study|Protocol Terminated|0|||
48627210|NCT01767857|156493205|FG000|Overall Study|Randomized But Never Treated|19|||
48627211|NCT01767857|156493206|FG001|Overall Study|Randomized But Never Treated|13|||
48323800|NCT02222493|155383701|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
48323801|NCT02222493|155383702|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
48323802|NCT02222493|155383701|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
48323803|NCT02222493|155383702|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
48627212|NCT01421459|156493207|FG000|Overall Study|Adverse Event|6|||
48627213|NCT01421459|156493208|FG001|Overall Study|Adverse Event|10|||
48627214|NCT01421459|156493207|FG000|Overall Study|Death|1|||
48627215|NCT01421459|156493208|FG001|Overall Study|Death|1|||
48627216|NCT01421459|156493207|FG000|Overall Study|Lack of Efficacy|1|||
48627217|NCT01421459|156493208|FG001|Overall Study|Lack of Efficacy|2|||
48627218|NCT01421459|156493207|FG000|Overall Study|Lost to Follow-up|8|||
48627219|NCT01421459|156493208|FG001|Overall Study|Lost to Follow-up|9|||
48741456|NCT00647387|156901831|FG000|Overall Study|Unsuccessful implant|5|||
48627220|NCT01421459|156493207|FG000|Overall Study|Physician Decision|9|||
48627221|NCT01421459|156493208|FG001|Overall Study|Physician Decision|9|||
48323804|NCT02222493|155383701|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
48323805|NCT02222493|155383702|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
48323806|NCT02222493|155383701|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
48323807|NCT02222493|155383702|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
48323808|NCT02222493|155383701|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
48323809|NCT02222493|155383702|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
48323810|NCT02222493|155383701|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
48323811|NCT02222493|155383702|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
48323812|NCT02222493|155383701|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
48323813|NCT02222493|155383702|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
48323814|NCT02222493|155383701|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
48627222|NCT01421459|156493207|FG000|Overall Study|Protocol Violation|8|||
48627223|NCT01421459|156493208|FG001|Overall Study|Protocol Violation|5|||
48741457|NCT00647387|156901831|FG000|Overall Study|Device explanted|3|||
48741458|NCT00647387|156901831|FG000|Overall Study|Other Reason|3|||
48741459|NCT00647387|156901831|FG000|Overall Study|Death|2|||
48741460|NCT01644565|156903093|FG000|Overall Study|Undisclosed Medical History|1|||
48741461|NCT01644565|156903094|FG001|Overall Study|Undisclosed Medical History|0|||
48741462|NCT01644565|156903095|FG002|Overall Study|Undisclosed Medical History|0|||
48741463|NCT01644565|156903096|FG003|Overall Study|Undisclosed Medical History|0|||
48741464|NCT01644565|156903097|FG004|Overall Study|Undisclosed Medical History|0|||
48741465|NCT01644565|156903098|FG005|Overall Study|Undisclosed Medical History|0|||
48741466|NCT01644565|156903099|FG006|Overall Study|Undisclosed Medical History|0|||
48741467|NCT01644565|156903100|FG007|Overall Study|Undisclosed Medical History|0|||
48741468|NCT01644565|156903101|FG008|Overall Study|Undisclosed Medical History|0|||
48741469|NCT01644565|156903093|FG000|Overall Study|Lost to Follow-up|0|||
48741470|NCT01644565|156903094|FG001|Overall Study|Lost to Follow-up|0|||
48741471|NCT01644565|156903095|FG002|Overall Study|Lost to Follow-up|0|||
48741472|NCT01644565|156903096|FG003|Overall Study|Lost to Follow-up|1|||
48741473|NCT01644565|156903097|FG004|Overall Study|Lost to Follow-up|0|||
48741474|NCT01644565|156903098|FG005|Overall Study|Lost to Follow-up|0|||
48741475|NCT01644565|156903099|FG006|Overall Study|Lost to Follow-up|0|||
48741476|NCT01644565|156903100|FG007|Overall Study|Lost to Follow-up|2|||
48741477|NCT01644565|156903101|FG008|Overall Study|Lost to Follow-up|0|||
48741478|NCT01644565|156903093|FG000|Overall Study|Family emergency|0|||
48741479|NCT01644565|156903094|FG001|Overall Study|Family emergency|0|||
48741480|NCT01644565|156903095|FG002|Overall Study|Family emergency|0|||
48741481|NCT01644565|156903096|FG003|Overall Study|Family emergency|0|||
48741482|NCT01644565|156903097|FG004|Overall Study|Family emergency|1|||
48741483|NCT01644565|156903098|FG005|Overall Study|Family emergency|0|||
48741484|NCT01644565|156903099|FG006|Overall Study|Family emergency|0|||
48741485|NCT01644565|156903100|FG007|Overall Study|Family emergency|0|||
48741486|NCT01644565|156903101|FG008|Overall Study|Family emergency|0|||
48741487|NCT01644565|156903093|FG000|Overall Study|Relocation|0|||
48741488|NCT01644565|156903094|FG001|Overall Study|Relocation|0|||
48741489|NCT01644565|156903095|FG002|Overall Study|Relocation|0|||
48741490|NCT01644565|156903096|FG003|Overall Study|Relocation|0|||
48741491|NCT01644565|156903097|FG004|Overall Study|Relocation|0|||
48741492|NCT01644565|156903098|FG005|Overall Study|Relocation|0|||
48741493|NCT01644565|156903099|FG006|Overall Study|Relocation|0|||
48741494|NCT01644565|156903100|FG007|Overall Study|Relocation|0|||
48741495|NCT01644565|156903101|FG008|Overall Study|Relocation|1|||
48741496|NCT01034631|156903102|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
48741497|NCT01034631|156903103|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
48741498|NCT01034631|156903104|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
48741499|NCT01034631|156903102|FG000|Phase II|Not Evaluable per protocol|0|||
48741500|NCT01034631|156903103|FG001|Phase II|Not Evaluable per protocol|0|||
48741501|NCT01034631|156903104|FG002|Phase II|Not Evaluable per protocol|2|||
48741502|NCT01034631|156903102|FG000|Phase II|Determined Ineligible per protocol|0|||
48741503|NCT01034631|156903103|FG001|Phase II|Determined Ineligible per protocol|1|||
48741504|NCT01034631|156903104|FG002|Phase II|Determined Ineligible per protocol|0|||
48741505|NCT01193530|156903106|FG000|Overall Study|Withdrawal by Subject|2|||
48741506|NCT01193530|156903107|FG001|Overall Study|Withdrawal by Subject|2|||
48741507|NCT01193530|156903106|FG000|Overall Study|Began Contraindicated Therapy|1|||
48741508|NCT01193530|156903107|FG001|Overall Study|Began Contraindicated Therapy|0|||
48741509|NCT01193530|156903106|FG000|Overall Study|Lost Light Box|0|||
48741510|NCT01193530|156903107|FG001|Overall Study|Lost Light Box|1|||
48741511|NCT01193530|156903106|FG000|Overall Study|Returned home - out of state|0|||
48741512|NCT01193530|156903107|FG001|Overall Study|Returned home - out of state|1|||
48741513|NCT01193530|156903106|FG000|Overall Study|Non-Compliance|0|||
48741514|NCT01193530|156903107|FG001|Overall Study|Non-Compliance|1|||
48741515|NCT01890473|156903108|FG000|Overall Study|Lost to Follow-up|1|||
48741516|NCT01890473|156903109|FG001|Overall Study|Lost to Follow-up|0|||
48323815|NCT02222493|155383702|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
48323816|NCT02222493|155383701|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
48323817|NCT02222493|155383702|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
48323818|NCT02222493|155383701|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
48323819|NCT02222493|155383702|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
48323820|NCT02222493|155383701|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
48323821|NCT02222493|155383702|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
48323822|NCT02222493|155383701|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
48323823|NCT02222493|155383702|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
48323824|NCT02222493|155383701|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
48323825|NCT02222493|155383702|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
48323826|NCT00145470|155383703|FG000|Overall Study|Adverse Event|19|||
48323827|NCT00145470|155383704|FG001|Overall Study|Adverse Event|25|||
48323828|NCT00145470|155383703|FG000|Overall Study|Lack of Efficacy|27|||
48323829|NCT00145470|155383704|FG001|Overall Study|Lack of Efficacy|13|||
48323830|NCT00145470|155383703|FG000|Overall Study|Withdrawal by Subject|36|||
48323831|NCT00145470|155383704|FG001|Overall Study|Withdrawal by Subject|34|||
48323832|NCT00145470|155383703|FG000|Overall Study|Lost to Follow-up|21|||
48323833|NCT00145470|155383704|FG001|Overall Study|Lost to Follow-up|17|||
48323834|NCT00145470|155383703|FG000|Overall Study|Reason Not Reported|9|||
48323835|NCT00145470|155383704|FG001|Overall Study|Reason Not Reported|9|||
48323836|NCT02130557|155383706|FG000|Overall Study|Withdrawal by Subject|12|||
48323837|NCT02130557|155383707|FG001|Overall Study|Withdrawal by Subject|12|||
48323838|NCT02130557|155383706|FG000|Overall Study|Investigator Request|0|||
48323839|NCT02130557|155383707|FG001|Overall Study|Investigator Request|2|||
48323840|NCT02130557|155383706|FG000|Overall Study|Deceased|14|||
48323841|NCT02130557|155383707|FG001|Overall Study|Deceased|14|||
48323842|NCT02130557|155383706|FG000|Overall Study|Lost to Follow-up|6|||
48323843|NCT02130557|155383707|FG001|Overall Study|Lost to Follow-up|7|||
48323844|NCT02130557|155383706|FG000|Overall Study|Other|2|||
48741517|NCT01890473|156903108|FG000|Overall Study|Poor/non-compliance|1|||
48741518|NCT01890473|156903109|FG001|Overall Study|Poor/non-compliance|0|||
48741519|NCT00983437|156903110|FG000|Overall Study|Adverse Event|9|||
48741520|NCT00983437|156903110|FG000|Overall Study|Lack of Efficacy|1|||
48741521|NCT00983437|156903110|FG000|Overall Study|Withdrawal by Subject|8|||
48741522|NCT00983437|156903110|FG000|Overall Study|Noncompliance to Study Procedures|1|||
48741523|NCT00983437|156903110|FG000|Overall Study|Lost to Follow-up|2|||
48741524|NCT00983437|156903110|FG000|Overall Study|Other Reason|26|||
48741525|NCT00094172|156903111|FG000|Overall Study|Adverse Event|0|||
48741526|NCT00094172|156903112|FG001|Overall Study|Adverse Event|1|||
48741527|NCT00094172|156903111|FG000|Overall Study|Lost to Follow-up|2|||
48741528|NCT00094172|156903112|FG001|Overall Study|Lost to Follow-up|0|||
48741529|NCT00094172|156903111|FG000|Overall Study|Protocol Violation|0|||
48741530|NCT00094172|156903112|FG001|Overall Study|Protocol Violation|1|||
48741531|NCT00094172|156903111|FG000|Overall Study|Withdrawal by Subject|10|||
48741532|NCT00094172|156903112|FG001|Overall Study|Withdrawal by Subject|5|||
48741533|NCT00094172|156903111|FG000|Overall Study|Primary endpoint met.|1|||
48741534|NCT00094172|156903112|FG001|Overall Study|Primary endpoint met.|0|||
48741535|NCT00094172|156903111|FG000|Overall Study|Started other MS therapy due to disease|1|||
48741536|NCT00094172|156903112|FG001|Overall Study|Started other MS therapy due to disease|0|||
48323845|NCT02130557|155383707|FG001|Overall Study|Other|1|||
48323846|NCT02130557|155383706|FG000|Overall Study|Missing|2|||
48323847|NCT02130557|155383707|FG001|Overall Study|Missing|1|||
48323848|NCT02972359|155383711|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
48323849|NCT02972359|155383711|FG000|Overall Study|Lack of Efficacy|1|||
48323850|NCT02972359|155383711|FG000|Overall Study|Adverse Event|4|||
48627224|NCT01421459|156493207|FG000|Overall Study|Withdrawal by Subject|12|||
48323851|NCT02972359|155383711|FG000|Overall Study|Death|1|||
48323852|NCT02972359|155383711|FG000|Overall Study|Withdrawal by Subject|30|||
48323853|NCT02972359|155383711|FG000|Overall Study|Protocol Violation|1|||
48323854|NCT02972359|155383711|FG000|Overall Study|Lost to Follow-up|26|||
48323855|NCT02972359|155383711|FG000|Overall Study|Other reasons|5|||
48323856|NCT02972359|155383711|FG000|Overall Study|Missing|1|||
48323857|NCT02928172|155383712|FG000|Overall Study|Device did not record data|1|||
48323858|NCT02909686|155383713|FG000|Overall Study|Physician Decision|3|||
48323859|NCT02909686|155383713|FG000|Overall Study|Withdrawal by Subject|2|||
48627225|NCT01421459|156493208|FG001|Overall Study|Withdrawal by Subject|16|||
48627226|NCT04126174|156493209|FG000|Overall Study|Lost to Follow-up|3|||
48627227|NCT04126174|156493210|FG001|Overall Study|Lost to Follow-up|3|||
48627228|NCT02231580|156493211|FG000|Overall Study|Adverse Event|5|||
48627229|NCT02231580|156493212|FG001|Overall Study|Adverse Event|0|||
48627230|NCT03238196|156493213|FG000|Overall Study|Adverse Event|3|||
48627231|NCT03238196|156493214|FG001|Overall Study|Adverse Event|0|||
48741537|NCT00003473|156903113|FG000|Overall Study|Three patients were not evaluable.|3|||
48741538|NCT00799383|156903118|FG000|Overall Study|Protocol Violation|1|||
48741539|NCT00799383|156903119|FG001|Overall Study|Protocol Violation|1|||
48323860|NCT03333109|155383714|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
48323861|NCT03333109|155383715|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
48323862|NCT03333109|155383716|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
48323863|NCT03333109|155383714|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48323864|NCT03333109|155383715|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
48323865|NCT03333109|155383716|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
48323866|NCT03333109|155383714|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
48323867|NCT03333109|155383715|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
48323868|NCT03333109|155383716|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
48323869|NCT03333109|155383714|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
48323870|NCT03333109|155383715|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
48323871|NCT03333109|155383716|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
48323872|NCT03333109|155383714|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
48323873|NCT03333109|155383715|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
48323874|NCT03333109|155383716|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
48323875|NCT03333109|155383714|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
48323876|NCT03333109|155383715|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
48323877|NCT03333109|155383716|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
48323878|NCT03333109|155383714|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
48323879|NCT03333109|155383715|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
48323880|NCT03333109|155383716|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
48323881|NCT03333109|155383714|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
48323882|NCT03333109|155383715|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
48323883|NCT03333109|155383716|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
48323884|NCT00918203|155383718|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
48323885|NCT00918203|155383719|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
48323886|NCT00918203|155383720|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
48323887|NCT00918203|155383718|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
48323888|NCT00918203|155383719|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
48323889|NCT00918203|155383720|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
48323890|NCT00918203|155383718|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
48323891|NCT00918203|155383719|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
48627232|NCT03238196|156493215|FG002|Overall Study|Adverse Event|2|||
48627233|NCT03238196|156493216|FG003|Overall Study|Adverse Event|2|||
48323892|NCT00918203|155383720|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
48323893|NCT00918203|155383718|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
48323894|NCT00918203|155383719|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
48323895|NCT00918203|155383720|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
48323896|NCT01075152|155383725|FG000|Overall Study|Withdrawal by Subject|1|||
48323897|NCT01075152|155383726|FG001|Overall Study|Withdrawal by Subject|0|||
48323898|NCT00589875|155383727|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
48323899|NCT00589875|155383727|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
48323900|NCT03488719|155383728|FG000|Overall Study|Adverse Event|0|||
48323901|NCT03488719|155383729|FG001|Overall Study|Adverse Event|4|||
48323902|NCT03488719|155383730|FG002|Overall Study|Adverse Event|2|||
48323903|NCT03488719|155383728|FG000|Overall Study|Other|0|||
48323904|NCT03488719|155383729|FG001|Overall Study|Other|0|||
48323905|NCT03488719|155383730|FG002|Overall Study|Other|5|||
48323906|NCT03476798|155383731|FG000|Overall Study|Death|1|||
48323907|NCT03476798|155383731|FG000|Overall Study|Withdrawal by Subject|2|||
48323908|NCT03476798|155383731|FG000|Overall Study|Protocol Violation|2|||
48323909|NCT05070741|155383732|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
48323910|NCT04647253|155383733|FG000|Overall Study|Death ≤ 365 Days|16|||
48323911|NCT04647253|155383734|FG001|Overall Study|Death ≤ 365 Days|7|||
48323912|NCT04647253|155383733|FG000|Overall Study|Physician Decision|0|||
48323913|NCT04647253|155383734|FG001|Overall Study|Physician Decision|1|||
48323914|NCT04647253|155383733|FG000|Overall Study|Withdrawal by Subject|7|||
48323915|NCT04647253|155383734|FG001|Overall Study|Withdrawal by Subject|2|||
48323916|NCT04647253|155383733|FG000|Overall Study|Missed 12-Month Visit|9|||
48323917|NCT04647253|155383734|FG001|Overall Study|Missed 12-Month Visit|7|||
48323918|NCT04647253|155383733|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
48627234|NCT03238196|156493213|FG000|Overall Study|Withdrawal by Subject|4|||
48627235|NCT03238196|156493214|FG001|Overall Study|Withdrawal by Subject|1|||
48323919|NCT04647253|155383734|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
48323920|NCT01084863|155383735|FG000|Main Study Treatment Period|Disease progression|11|||
48323921|NCT01084863|155383736|FG001|Main Study Treatment Period|Disease progression|7|||
48323922|NCT01084863|155383735|FG000|Main Study Treatment Period|Adverse Event|5|||
48627236|NCT03238196|156493215|FG002|Overall Study|Withdrawal by Subject|1|||
48627237|NCT03238196|156493216|FG003|Overall Study|Withdrawal by Subject|0|||
48323923|NCT01084863|155383736|FG001|Main Study Treatment Period|Adverse Event|3|||
48323924|NCT01084863|155383735|FG000|Main Study Treatment Period|Other Reason|0|||
48323925|NCT01084863|155383736|FG001|Main Study Treatment Period|Other Reason|1|||
48323926|NCT01084863|155383735|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
48323927|NCT01084863|155383736|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
48323928|NCT01084863|155383735|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
48323929|NCT01084863|155383736|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
48323930|NCT01084863|155383735|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
48323931|NCT01084863|155383736|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
48323932|NCT01084863|155383735|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
48323933|NCT01084863|155383736|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
48323934|NCT01084863|155383735|FG000|Treatment Period Beyond Cycle 8|Other|0|||
48627238|NCT03238196|156493213|FG000|Overall Study|Disease progression|14|||
48627239|NCT03238196|156493214|FG001|Overall Study|Disease progression|2|||
48627240|NCT03238196|156493215|FG002|Overall Study|Disease progression|3|||
48627241|NCT03238196|156493216|FG003|Overall Study|Disease progression|2|||
48627242|NCT03238196|156493213|FG000|Overall Study|Still on treatment|1|||
48627243|NCT03238196|156493214|FG001|Overall Study|Still on treatment|0|||
48627244|NCT03238196|156493215|FG002|Overall Study|Still on treatment|0|||
48627245|NCT03238196|156493216|FG003|Overall Study|Still on treatment|0|||
48627246|NCT04562090|156493217|FG000|Overall Study|Withdrawal by Subject|3|||
48627247|NCT04562090|156493218|FG001|Overall Study|Withdrawal by Subject|4|||
48627248|NCT04562090|156493217|FG000|Overall Study|Protocol Violation|2|||
48627249|NCT04562090|156493218|FG001|Overall Study|Protocol Violation|0|||
48627250|NCT04562090|156493217|FG000|Overall Study|Lack of Efficacy|0|||
48627251|NCT04562090|156493218|FG001|Overall Study|Lack of Efficacy|1|||
48323935|NCT01084863|155383736|FG001|Treatment Period Beyond Cycle 8|Other|1|||
48741540|NCT00799383|156903118|FG000|Overall Study|Adverse Event|0|||
48741541|NCT00799383|156903119|FG001|Overall Study|Adverse Event|1|||
48741542|NCT00799383|156903118|FG000|Overall Study|Lost to Follow-up|1|||
48741543|NCT00799383|156903119|FG001|Overall Study|Lost to Follow-up|2|||
48741544|NCT00799383|156903118|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
48741545|NCT00799383|156903119|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
48741546|NCT00799383|156903118|FG000|Overall Study|Withdrawal by Subject|0|||
48741547|NCT00799383|156903119|FG001|Overall Study|Withdrawal by Subject|1|||
48741548|NCT00850343|156903123|FG000|Overall Study|Withdrawal by Subject|11|||
48741549|NCT00850343|156903124|FG001|Overall Study|Withdrawal by Subject|0|||
48741550|NCT00850343|156903125|FG002|Overall Study|Withdrawal by Subject|3|||
48741551|NCT00850343|156903126|FG003|Overall Study|Withdrawal by Subject|2|||
48741552|NCT00850343|156903123|FG000|Overall Study|Adverse Event|15|||
48741553|NCT00850343|156903124|FG001|Overall Study|Adverse Event|2|||
48741554|NCT00850343|156903125|FG002|Overall Study|Adverse Event|6|||
48741555|NCT00850343|156903126|FG003|Overall Study|Adverse Event|6|||
48741556|NCT00850343|156903123|FG000|Overall Study|Pregnancy|0|||
48627252|NCT04562090|156493217|FG000|Overall Study|Adverse Event|1|||
48627253|NCT04562090|156493218|FG001|Overall Study|Adverse Event|4|||
48627254|NCT04562090|156493217|FG000|Overall Study|Miscellaneous|0|||
48627255|NCT04562090|156493218|FG001|Overall Study|Miscellaneous|3|||
48627256|NCT03934684|156493221|FG000|Overall Study|Participants continuing in study|11|||
48627257|NCT03934684|156493222|FG001|Overall Study|Participants continuing in study|4|||
48627258|NCT03934684|156493221|FG000|Overall Study|Discontinuation of carfilzomib|20|||
48741557|NCT00850343|156903124|FG001|Overall Study|Pregnancy|0|||
48741558|NCT00850343|156903125|FG002|Overall Study|Pregnancy|0|||
48323936|NCT01084863|155383735|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
48627259|NCT03934684|156493222|FG001|Overall Study|Discontinuation of carfilzomib|30|||
48627260|NCT03934684|156493221|FG000|Overall Study|Death|2|||
48627261|NCT03934684|156493222|FG001|Overall Study|Death|2|||
48627262|NCT03934684|156493221|FG000|Overall Study|Lost to Follow-up|2|||
48627263|NCT03934684|156493222|FG001|Overall Study|Lost to Follow-up|5|||
48627264|NCT03934684|156493221|FG000|Overall Study|Withdrawal by Subject|7|||
48323937|NCT01084863|155383736|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
48323938|NCT03936660|155385078|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
48323939|NCT03936660|155385079|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
48627265|NCT03934684|156493222|FG001|Overall Study|Withdrawal by Subject|8|||
48627266|NCT03312543|156493223|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
48627267|NCT03312543|156493224|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
48323940|NCT00968149|155385080|FG000|Overall Study|Adverse Event|5|||
48627268|NCT03312543|156493223|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
48627269|NCT03312543|156493224|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
48627270|NCT03312543|156493223|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
48627271|NCT03312543|156493224|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
48627272|NCT03312543|156493223|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
48741559|NCT00850343|156903126|FG003|Overall Study|Pregnancy|1|||
48741560|NCT00850343|156903123|FG000|Overall Study|Lack of Efficacy|17|||
48741561|NCT00850343|156903124|FG001|Overall Study|Lack of Efficacy|0|||
48627273|NCT03312543|156493224|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
48627274|NCT03312543|156493223|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
48627275|NCT03312543|156493224|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
48627276|NCT03312543|156493223|FG000|Regression (Week 12 to Week 24)|Death|0|||
48627277|NCT03312543|156493224|FG001|Regression (Week 12 to Week 24)|Death|1|||
48627278|NCT03034044|156493225|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
48627279|NCT05852470|156493226|FG000|Overall Study|Withdrawal by Subject|0|||
48627280|NCT05852470|156493227|FG001|Overall Study|Withdrawal by Subject|1|||
48627281|NCT03518060|156493228|FG000|Overall Study|Death|1|||
48627282|NCT03518060|156493228|FG000|Overall Study|Poor adherence|1|||
48627283|NCT03518060|156493228|FG000|Overall Study|Withdrawal of informed consent|2|||
48627284|NCT03518060|156493228|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
48627285|NCT03518060|156493228|FG000|Overall Study|Physician Decision|7|||
48627286|NCT03518060|156493228|FG000|Overall Study|Adverse drug reactions|23|||
48627287|NCT03518060|156493228|FG000|Overall Study|Withdrawal by Subject|25|||
48627288|NCT03518060|156493228|FG000|Overall Study|Lost to Follow-up|13|||
48627289|NCT02412436|156493229|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
48627290|NCT02412436|156493229|FG000|Overall Study|Lost to Follow-up|6|||
48627291|NCT02412436|156493229|FG000|Overall Study|Unable to get to clinic|3|||
48627292|NCT02412436|156493229|FG000|Overall Study|Death|1|||
48627293|NCT02412436|156493229|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
48627294|NCT02544763|156493230|FG000|Overall Study|Adverse Event|8|||
48627295|NCT02544763|156493231|FG001|Overall Study|Adverse Event|8|||
48627296|NCT02544763|156493232|FG002|Overall Study|Adverse Event|0|||
48627297|NCT02544763|156493230|FG000|Overall Study|Withdrawn by parent/guardian|1|||
48627298|NCT02544763|156493231|FG001|Overall Study|Withdrawn by parent/guardian|1|||
48627299|NCT02544763|156493232|FG002|Overall Study|Withdrawn by parent/guardian|1|||
48627300|NCT02544763|156493230|FG000|Overall Study|Met withdrawal criteria|0|||
48627301|NCT02544763|156493231|FG001|Overall Study|Met withdrawal criteria|2|||
48741562|NCT00850343|156903125|FG002|Overall Study|Lack of Efficacy|3|||
48741563|NCT00850343|156903126|FG003|Overall Study|Lack of Efficacy|2|||
48741564|NCT00850343|156903123|FG000|Overall Study|Non-compliance with Study Procedures|1|||
48741565|NCT00850343|156903124|FG001|Overall Study|Non-compliance with Study Procedures|0|||
48741566|NCT00850343|156903125|FG002|Overall Study|Non-compliance with Study Procedures|1|||
48741567|NCT00850343|156903126|FG003|Overall Study|Non-compliance with Study Procedures|1|||
48741568|NCT00850343|156903123|FG000|Overall Study|Physician Decision|2|||
48741569|NCT00850343|156903124|FG001|Overall Study|Physician Decision|1|||
48741570|NCT00850343|156903125|FG002|Overall Study|Physician Decision|1|||
48741571|NCT00850343|156903126|FG003|Overall Study|Physician Decision|1|||
48741572|NCT02570074|156903127|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
48741573|NCT02570074|156903128|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
48741574|NCT01626456|156903131|FG000|Overall Study|Withdrawal by Subject|21|||
48741575|NCT01626456|156903132|FG001|Overall Study|Withdrawal by Subject|46|||
48741576|NCT01626456|156903131|FG000|Overall Study|Adverse Event|2|||
48741577|NCT01626456|156903132|FG001|Overall Study|Adverse Event|27|||
48741578|NCT01626456|156903131|FG000|Overall Study|Lost to Follow-up|2|||
48741579|NCT01626456|156903132|FG001|Overall Study|Lost to Follow-up|27|||
48741580|NCT01626456|156903131|FG000|Overall Study|Lack of Efficacy|6|||
48741581|NCT01626456|156903132|FG001|Overall Study|Lack of Efficacy|7|||
48741582|NCT01626456|156903131|FG000|Overall Study|Physician Decision|1|||
48741583|NCT01626456|156903132|FG001|Overall Study|Physician Decision|4|||
48741584|NCT01626456|156903131|FG000|Overall Study|Protocol Violation|1|||
48741585|NCT01626456|156903132|FG001|Overall Study|Protocol Violation|1|||
48741586|NCT01626456|156903131|FG000|Overall Study|Site Closure|2|||
48741587|NCT01626456|156903132|FG001|Overall Study|Site Closure|3|||
48741588|NCT01626456|156903131|FG000|Overall Study|Incarceration|0|||
48741589|NCT01626456|156903132|FG001|Overall Study|Incarceration|2|||
48741590|NCT02587234|156903133|FG000|Overall Study|Withdrawal by Subject|1|||
48741591|NCT02587234|156903134|FG001|Overall Study|Withdrawal by Subject|1|||
48741592|NCT02587234|156903133|FG000|Overall Study|Lost to Follow-up|0|||
48741593|NCT02587234|156903134|FG001|Overall Study|Lost to Follow-up|2|||
48741594|NCT01826604|156903139|FG000|Overall Study|Lost to Follow-up|8|||
48741595|NCT01826604|156903140|FG001|Overall Study|Lost to Follow-up|9|||
48741596|NCT01397890|156903141|FG000|Overall Study|Withdrawal by Subject|7|||
48627302|NCT02544763|156493232|FG002|Overall Study|Met withdrawal criteria|0|||
48627303|NCT02544763|156493230|FG000|Overall Study|Physician Decision|0|||
48627304|NCT02544763|156493231|FG001|Overall Study|Physician Decision|1|||
48627305|NCT02544763|156493232|FG002|Overall Study|Physician Decision|0|||
48627306|NCT02544763|156493230|FG000|Overall Study|Difficulties taking IMP|1|||
48741597|NCT01397890|156903142|FG001|Overall Study|Withdrawal by Subject|11|||
48741598|NCT01397890|156903141|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
48741599|NCT01397890|156903142|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
48741600|NCT01397890|156903141|FG000|Overall Study|Death|2|||
48741601|NCT01397890|156903142|FG001|Overall Study|Death|3|||
48741602|NCT01397890|156903141|FG000|Overall Study|Lost to Follow-up|1|||
48741603|NCT01397890|156903142|FG001|Overall Study|Lost to Follow-up|4|||
48627307|NCT02544763|156493231|FG001|Overall Study|Difficulties taking IMP|0|||
48627308|NCT02544763|156493232|FG002|Overall Study|Difficulties taking IMP|0|||
48627309|NCT01877278|156493233|FG000|Overall Study|Lost to Follow-up|3|||
48627310|NCT01877278|156493234|FG001|Overall Study|Lost to Follow-up|3|||
48627311|NCT03726879|156493237|FG000|Overall Study|Death|11|||
48627312|NCT03726879|156493238|FG001|Overall Study|Death|13|||
48627313|NCT03726879|156493237|FG000|Overall Study|Physician Decision|0|||
48627314|NCT03726879|156493238|FG001|Overall Study|Physician Decision|2|||
48627315|NCT03726879|156493237|FG000|Overall Study|Protocol Violation|0|||
48627316|NCT03726879|156493238|FG001|Overall Study|Protocol Violation|1|||
48627317|NCT03726879|156493237|FG000|Overall Study|Withdrawal by Subject|5|||
48627318|NCT03726879|156493238|FG001|Overall Study|Withdrawal by Subject|6|||
48627319|NCT03726879|156493237|FG000|Overall Study|TSH result is unstable|0|||
48627320|NCT03726879|156493238|FG001|Overall Study|TSH result is unstable|1|||
48627321|NCT03726879|156493237|FG000|Overall Study|Disease relapse|1|||
48627322|NCT03726879|156493238|FG001|Overall Study|Disease relapse|0|||
48627323|NCT03726879|156493237|FG000|Overall Study|Lost to Follow-up|3|||
48627324|NCT03726879|156493238|FG001|Overall Study|Lost to Follow-up|0|||
48627325|NCT02766478|156493239|FG000|Overall Study|Withdrawal by Subject|1|||
48741604|NCT01397890|156903141|FG000|Overall Study|Condition under Investigation Worsened|1|||
48741605|NCT01397890|156903142|FG001|Overall Study|Condition under Investigation Worsened|3|||
48741606|NCT01397890|156903141|FG000|Overall Study|Adverse Event|1|||
48323941|NCT00968149|155385081|FG001|Overall Study|Adverse Event|1|||
48323942|NCT00968149|155385080|FG000|Overall Study|Lack of Efficacy|0|||
48323943|NCT00968149|155385081|FG001|Overall Study|Lack of Efficacy|4|||
48323944|NCT00968149|155385080|FG000|Overall Study|Lost to Follow-up|0|||
48323945|NCT00968149|155385081|FG001|Overall Study|Lost to Follow-up|1|||
48627326|NCT02766478|156493240|FG001|Overall Study|Withdrawal by Subject|1|||
48627327|NCT01793129|156494673|FG000|Overall Study|Lost to Follow-up|3|||
48627328|NCT01793129|156494674|FG001|Overall Study|Lost to Follow-up|7|||
48627329|NCT01793129|156494673|FG000|Overall Study|Withdrawal by Subject|0|||
48627330|NCT01793129|156494674|FG001|Overall Study|Withdrawal by Subject|2|||
48627331|NCT05654181|156494675|FG000|Overall Study|Adverse Event|1|||
48627332|NCT05654181|156494676|FG001|Overall Study|Adverse Event|0|||
48627333|NCT05654181|156494677|FG002|Overall Study|Adverse Event|0|||
48627334|NCT05654181|156494678|FG003|Overall Study|Adverse Event|0|||
48627335|NCT05654181|156494679|FG004|Overall Study|Adverse Event|0|||
48627336|NCT05654181|156494680|FG005|Overall Study|Adverse Event|0|||
48627337|NCT05654181|156494681|FG006|Overall Study|Adverse Event|0|||
48627338|NCT05654181|156494682|FG007|Overall Study|Adverse Event|1|||
48627339|NCT05654181|156494683|FG008|Overall Study|Adverse Event|0|||
48627340|NCT05654181|156494684|FG009|Overall Study|Adverse Event|0|||
48627341|NCT05654181|156494675|FG000|Overall Study|Withdrawal by Subject|0|||
48627342|NCT05654181|156494676|FG001|Overall Study|Withdrawal by Subject|0|||
48627343|NCT05654181|156494677|FG002|Overall Study|Withdrawal by Subject|0|||
48627344|NCT05654181|156494678|FG003|Overall Study|Withdrawal by Subject|0|||
48627345|NCT05654181|156494679|FG004|Overall Study|Withdrawal by Subject|0|||
48627346|NCT05654181|156494680|FG005|Overall Study|Withdrawal by Subject|0|||
48627347|NCT05654181|156494681|FG006|Overall Study|Withdrawal by Subject|0|||
48627348|NCT05654181|156494682|FG007|Overall Study|Withdrawal by Subject|1|||
48627349|NCT05654181|156494683|FG008|Overall Study|Withdrawal by Subject|0|||
48627350|NCT05654181|156494684|FG009|Overall Study|Withdrawal by Subject|0|||
48627351|NCT05654181|156494675|FG000|Overall Study|Other|0|||
48627352|NCT05654181|156494676|FG001|Overall Study|Other|0|||
48627353|NCT05654181|156494677|FG002|Overall Study|Other|0|||
48627354|NCT05654181|156494678|FG003|Overall Study|Other|0|||
48627355|NCT05654181|156494679|FG004|Overall Study|Other|1|||
48627356|NCT05654181|156494680|FG005|Overall Study|Other|1|||
48627357|NCT05654181|156494681|FG006|Overall Study|Other|0|||
48627358|NCT05654181|156494682|FG007|Overall Study|Other|0|||
48627359|NCT05654181|156494683|FG008|Overall Study|Other|0|||
48741607|NCT01397890|156903142|FG001|Overall Study|Adverse Event|2|||
48627360|NCT05654181|156494684|FG009|Overall Study|Other|0|||
48741608|NCT01397890|156903141|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
48627361|NCT01213251|156494685|FG000|Overall Study|Death|2|||
48627362|NCT01213251|156494686|FG001|Overall Study|Death|1|||
48627363|NCT01213251|156494687|FG002|Overall Study|Death|2|||
48627364|NCT01213251|156494685|FG000|Overall Study|Exit|3|||
48627365|NCT01213251|156494686|FG001|Overall Study|Exit|2|||
48627366|NCT01213251|156494687|FG002|Overall Study|Exit|8|||
48627367|NCT01213251|156494685|FG000|Overall Study|Protocol Violation|1|||
48627368|NCT01213251|156494686|FG001|Overall Study|Protocol Violation|1|||
48627369|NCT01213251|156494687|FG002|Overall Study|Protocol Violation|0|||
48627370|NCT01213251|156494685|FG000|Overall Study|Missed 18-Month Follow-up|0|||
48627371|NCT01213251|156494686|FG001|Overall Study|Missed 18-Month Follow-up|0|||
48627372|NCT01213251|156494687|FG002|Overall Study|Missed 18-Month Follow-up|1|||
48627373|NCT01629563|156494688|FG000|Overall Study|Adverse Event|16|||
48627374|NCT01629563|156494689|FG001|Overall Study|Adverse Event|16|||
48627375|NCT01629563|156494688|FG000|Overall Study|Death|2|||
48741609|NCT01397890|156903142|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
48627376|NCT01629563|156494689|FG001|Overall Study|Death|0|||
48627377|NCT01629563|156494688|FG000|Overall Study|Lack of Efficacy|2|||
48627378|NCT01629563|156494689|FG001|Overall Study|Lack of Efficacy|3|||
48627379|NCT01629563|156494688|FG000|Overall Study|Lost to Follow-up|1|||
48627380|NCT01629563|156494689|FG001|Overall Study|Lost to Follow-up|0|||
48627381|NCT01629563|156494688|FG000|Overall Study|Pregnancy|1|||
48627382|NCT01629563|156494689|FG001|Overall Study|Pregnancy|2|||
48627383|NCT01629563|156494688|FG000|Overall Study|Protocol Violation|0|||
48627384|NCT01629563|156494689|FG001|Overall Study|Protocol Violation|1|||
48627385|NCT01629563|156494688|FG000|Overall Study|Withdrawal by Subject|27|||
48627386|NCT01629563|156494689|FG001|Overall Study|Withdrawal by Subject|20|||
48627387|NCT01629563|156494688|FG000|Overall Study|surgery|0|||
48627388|NCT01629563|156494689|FG001|Overall Study|surgery|3|||
48627389|NCT01629563|156494688|FG000|Overall Study|Lack of return of menses|12|||
48627390|NCT01629563|156494689|FG001|Overall Study|Lack of return of menses|7|||
48627391|NCT01629563|156494688|FG000|Overall Study|Protocol Violation|0|||
48627392|NCT01629563|156494689|FG001|Overall Study|Protocol Violation|1|||
48627393|NCT03635996|156494690|FG000|Overall Study|Study terminated by Sponsor|94|||
48627394|NCT03635996|156494690|FG000|Overall Study|Withdrawal by Subject|20|||
48627395|NCT03635996|156494690|FG000|Overall Study|Ablation|26|||
48627396|NCT03635996|156494690|FG000|Overall Study|Adverse Event|7|||
48627397|NCT03635996|156494690|FG000|Overall Study|Physician Decision|3|||
48627398|NCT03635996|156494690|FG000|Overall Study|Prohibited medication|5|||
48627399|NCT03635996|156494690|FG000|Overall Study|Did not meet eligibility criteria|5|||
48627400|NCT03635996|156494690|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
48627401|NCT03635996|156494690|FG000|Overall Study|Protocol Violation|1|||
48627402|NCT03635996|156494690|FG000|Overall Study|Lost to Follow-up|1|||
48627403|NCT02933151|156494691|FG000|Overall Study|Lost to Follow-up|19|||
48627404|NCT02933151|156494692|FG001|Overall Study|Lost to Follow-up|18|||
48627405|NCT02933151|156494691|FG000|Overall Study|Death|1732|||
48627406|NCT02933151|156494692|FG001|Overall Study|Death|1827|||
48323946|NCT00968149|155385080|FG000|Overall Study|Protocol Violation|4|||
48323947|NCT00968149|155385081|FG001|Overall Study|Protocol Violation|0|||
48323948|NCT00968149|155385080|FG000|Overall Study|Withdrawal by Subject|2|||
48323949|NCT00968149|155385081|FG001|Overall Study|Withdrawal by Subject|0|||
48323950|NCT04989816|155385082|FG000|Overall Study|Death|77|||
48323951|NCT04989816|155385082|FG000|Overall Study|Lost to Follow-up|3|||
48323952|NCT02866942|155385083|FG000|Overall Study|Invalid consent|1|||
48323953|NCT01737021|155385087|FG000|Overall Study|Lost to Follow-up|5|||
48323954|NCT01737021|155385088|FG001|Overall Study|Lost to Follow-up|3|||
48323955|NCT02593149|155385089|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
48323956|NCT02593149|155385090|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
48323957|NCT02593149|155385089|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
48323958|NCT02593149|155385090|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
48323959|NCT00975585|155385092|FG000|Overall Study|Adverse Event|0|||
48323960|NCT00975585|155385093|FG001|Overall Study|Adverse Event|4|||
48323961|NCT00975585|155385092|FG000|Overall Study|Lost to Follow-up|3|||
48627407|NCT02933151|156494691|FG000|Overall Study|Transplant|210|||
48627408|NCT02933151|156494692|FG001|Overall Study|Transplant|278|||
48627409|NCT02933151|156494691|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
48627410|NCT02933151|156494692|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
48627411|NCT02933151|156494691|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
48627412|NCT02933151|156494692|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
48627413|NCT02933151|156494691|FG000|Overall Study|Recovered Kidney Function|47|||
48627414|NCT02933151|156494692|FG001|Overall Study|Recovered Kidney Function|29|||
48627415|NCT00912509|156494696|FG000|Overall Study|Lost to Follow-up|1|||
48627416|NCT00912509|156494697|FG001|Overall Study|Lost to Follow-up|0|||
48627417|NCT00912509|156494696|FG000|Overall Study|Lack of Efficacy|4|||
48627418|NCT00912509|156494697|FG001|Overall Study|Lack of Efficacy|3|||
48627419|NCT02837952|156494698|FG000|Overall Study|Adverse Event|0|||
48741610|NCT01397890|156903141|FG000|Overall Study|Others|2|||
48741611|NCT01397890|156903142|FG001|Overall Study|Others|1|||
48741612|NCT00736944|156903145|FG000|Induction|Death|1|||
48741613|NCT00736944|156903145|FG000|Definitive Treatment|Physician Decision|1|||
48741614|NCT03741062|156903146|FG000|Overall Study|Protocol Violation|1|||
48323962|NCT00975585|155385093|FG001|Overall Study|Lost to Follow-up|5|||
48323963|NCT00975585|155385092|FG000|Overall Study|Withdrawal by Subject|2|||
48323964|NCT00975585|155385093|FG001|Overall Study|Withdrawal by Subject|1|||
48323965|NCT00975585|155385092|FG000|Overall Study|Lens issue|2|||
48627420|NCT02837952|156494699|FG001|Overall Study|Adverse Event|1|||
48627421|NCT02837952|156494698|FG000|Overall Study|Withdrawal by Subject|4|||
48627422|NCT02837952|156494699|FG001|Overall Study|Withdrawal by Subject|5|||
48627423|NCT02837952|156494698|FG000|Overall Study|Medication Error|1|||
48627424|NCT02837952|156494699|FG001|Overall Study|Medication Error|0|||
48627425|NCT01557569|156494700|FG000|Overall Study|Adverse Event|2|||
48627426|NCT01557569|156494701|FG001|Overall Study|Adverse Event|0|||
48627427|NCT01557569|156494700|FG000|Overall Study|high blood pressure|0|||
48741615|NCT03741062|156903147|FG001|Overall Study|Protocol Violation|0|||
48741616|NCT01030536|156903148|FG000|Overall Study|Withdrawal by Subject|0|||
48323966|NCT00975585|155385093|FG001|Overall Study|Lens issue|2|||
48323967|NCT00795184|155385094|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
48323968|NCT00795184|155385095|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
48323969|NCT00205179|155385096|FG000|Overall Study|Death|0|||
48323970|NCT00205179|155385097|FG001|Overall Study|Death|2|||
48323971|NCT00205179|155385096|FG000|Overall Study|Physician Decision|1|||
48323972|NCT00205179|155385097|FG001|Overall Study|Physician Decision|1|||
48323973|NCT00205179|155385096|FG000|Overall Study|Adverse Event|1|||
48323974|NCT00205179|155385097|FG001|Overall Study|Adverse Event|1|||
48323975|NCT00586313|155385103|FG000|Overall Study|Lack of Efficacy|2|||
48323976|NCT01932970|155385123|FG000|Overall Study|Withdrawal by Subject|5|||
48627428|NCT01557569|156494701|FG001|Overall Study|high blood pressure|1|||
48627429|NCT01557569|156494700|FG000|Overall Study|Withdrawal by Subject|3|||
48627430|NCT01557569|156494701|FG001|Overall Study|Withdrawal by Subject|5|||
48627431|NCT01557569|156494700|FG000|Overall Study|noncompliance with rules of residential|0|||
48627432|NCT01557569|156494701|FG001|Overall Study|noncompliance with rules of residential|1|||
48627433|NCT00993473|156494702|FG000|Overall Study|Adverse Event|0|||
48627434|NCT00993473|156494703|FG001|Overall Study|Adverse Event|2|||
48741617|NCT01030536|156903149|FG001|Overall Study|Withdrawal by Subject|0|||
48627435|NCT00993473|156494702|FG000|Overall Study|Protocol Violation|1|||
48741618|NCT01030536|156903150|FG002|Overall Study|Withdrawal by Subject|1|||
48741619|NCT01030536|156903151|FG003|Overall Study|Withdrawal by Subject|0|||
48741620|NCT01030536|156903152|FG004|Overall Study|Withdrawal by Subject|0|||
48741621|NCT01030536|156903148|FG000|Overall Study|undefined|1|||
48741622|NCT01030536|156903149|FG001|Overall Study|undefined|0|||
48741623|NCT01030536|156903150|FG002|Overall Study|undefined|1|||
48627436|NCT00993473|156494703|FG001|Overall Study|Protocol Violation|2|||
48627437|NCT00993473|156494702|FG000|Overall Study|Lost to Follow-up|1|||
48627438|NCT00993473|156494703|FG001|Overall Study|Lost to Follow-up|0|||
48627439|NCT00993473|156494702|FG000|Overall Study|Withdrawal by Subject|1|||
48627440|NCT00993473|156494703|FG001|Overall Study|Withdrawal by Subject|5|||
48627441|NCT00993473|156494702|FG000|Overall Study|Technical problem with CGM device|0|||
48627442|NCT00993473|156494703|FG001|Overall Study|Technical problem with CGM device|1|||
48627443|NCT00993473|156494702|FG000|Overall Study|Family event|1|||
48627444|NCT00993473|156494703|FG001|Overall Study|Family event|0|||
48627445|NCT03757715|156494706|FG000|Overall Study|Lost to Follow-up|4|||
48627446|NCT03757715|156494707|FG001|Overall Study|Lost to Follow-up|9|||
48627447|NCT03757715|156494706|FG000|Overall Study|Withdrawal by Subject|1|||
48627448|NCT03757715|156494707|FG001|Overall Study|Withdrawal by Subject|1|||
48627449|NCT00552279|156494710|FG000|Overall Study|Adverse Event|0|||
48627450|NCT00552279|156494711|FG001|Overall Study|Adverse Event|1|||
48627451|NCT00552279|156494710|FG000|Overall Study|Withdrawal by Subject|12|||
48627452|NCT00552279|156494711|FG001|Overall Study|Withdrawal by Subject|1|||
48627453|NCT00552279|156494710|FG000|Overall Study|Lost to Follow-up|1|||
48627454|NCT00552279|156494711|FG001|Overall Study|Lost to Follow-up|0|||
48627455|NCT00552279|156494710|FG000|Overall Study|Other|1|||
48627456|NCT00552279|156494711|FG001|Overall Study|Other|1|||
48627457|NCT03647137|156494715|FG000|Overall Study|Scan Limitation|2|||
48627458|NCT03647137|156494716|FG001|Overall Study|Scan Limitation|1|||
48741624|NCT01030536|156903151|FG003|Overall Study|undefined|1|||
48741625|NCT01030536|156903152|FG004|Overall Study|undefined|0|||
48741626|NCT01030536|156903148|FG000|Overall Study|Adverse Event|0|||
48741627|NCT01030536|156903149|FG001|Overall Study|Adverse Event|3|||
48741628|NCT01030536|156903150|FG002|Overall Study|Adverse Event|1|||
48741629|NCT01030536|156903151|FG003|Overall Study|Adverse Event|0|||
48741630|NCT01030536|156903152|FG004|Overall Study|Adverse Event|1|||
48627459|NCT03647137|156494717|FG002|Overall Study|Scan Limitation|1|||
48741631|NCT01030536|156903148|FG000|Overall Study|Progressive disease|6|||
48323977|NCT01932970|155385123|FG000|Overall Study|Death|1|||
48627460|NCT03647137|156494718|FG003|Overall Study|Scan Limitation|2|||
48627461|NCT02661815|156494719|FG000|Overall Study|Withdrawal by Subject|1|||
48627462|NCT02661815|156494720|FG001|Overall Study|Withdrawal by Subject|0|||
48627463|NCT02661815|156494721|FG002|Overall Study|Withdrawal by Subject|0|||
48741632|NCT01030536|156903149|FG001|Overall Study|Progressive disease|2|||
48741633|NCT01030536|156903150|FG002|Overall Study|Progressive disease|3|||
48741634|NCT01030536|156903151|FG003|Overall Study|Progressive disease|2|||
48741635|NCT01030536|156903152|FG004|Overall Study|Progressive disease|0|||
48627464|NCT02661815|156494722|FG003|Overall Study|Withdrawal by Subject|0|||
48627465|NCT05451329|156494723|FG000|Overall Study|Adverse Event|1|||
48741636|NCT01030536|156903148|FG000|Overall Study|Death|0|||
48741637|NCT01030536|156903149|FG001|Overall Study|Death|1|||
48741638|NCT01030536|156903150|FG002|Overall Study|Death|0|||
48741639|NCT01030536|156903151|FG003|Overall Study|Death|0|||
48627466|NCT05451329|156494724|FG001|Overall Study|Adverse Event|1|||
48627467|NCT05451329|156494725|FG002|Overall Study|Adverse Event|0|||
48627468|NCT05451329|156494723|FG000|Overall Study|Withdrawal by Subject|1|||
48627469|NCT05451329|156494724|FG001|Overall Study|Withdrawal by Subject|0|||
48627470|NCT05451329|156494725|FG002|Overall Study|Withdrawal by Subject|0|||
48627471|NCT05451329|156494723|FG000|Overall Study|Investigational Product Lot exchange|1|||
48627472|NCT05451329|156494724|FG001|Overall Study|Investigational Product Lot exchange|1|||
48627473|NCT05451329|156494725|FG002|Overall Study|Investigational Product Lot exchange|0|||
48627474|NCT02034565|156494729|FG000|Overall Study|Adverse Event|1|||
48627475|NCT02034565|156494730|FG001|Overall Study|Adverse Event|0|||
48627476|NCT00265122|156494736|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
48627477|NCT00265122|156494737|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
48627478|NCT00265122|156494738|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
48627479|NCT00265122|156494739|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
48627480|NCT00265122|156494740|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
48627481|NCT00265122|156494741|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
48627482|NCT00265122|156494736|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
48627483|NCT00265122|156494737|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
48627484|NCT00265122|156494738|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
48627485|NCT00265122|156494739|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
48627486|NCT00265122|156494740|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
48627487|NCT00265122|156494741|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
48627488|NCT00265122|156494736|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
48627489|NCT00265122|156494737|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
48627490|NCT00265122|156494738|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
48627491|NCT00265122|156494739|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
48627492|NCT00265122|156494740|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
48627493|NCT00265122|156494741|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
48627494|NCT00265122|156494736|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
48627495|NCT00265122|156494737|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
48627496|NCT00265122|156494738|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
48627497|NCT00265122|156494739|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
48627498|NCT00265122|156494740|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
48627499|NCT00265122|156494741|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
48627500|NCT00265122|156494736|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
48627501|NCT00265122|156494737|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
48627502|NCT00265122|156494738|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
48627503|NCT00265122|156494739|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
48627504|NCT00265122|156494740|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
48627505|NCT00265122|156494741|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
48627506|NCT00265122|156494736|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
48627507|NCT00265122|156494737|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
48627508|NCT00265122|156494738|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
48627509|NCT00265122|156494739|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
48627510|NCT00265122|156494740|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
48627511|NCT00265122|156494741|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
48627512|NCT02251041|156494743|FG000|Overall Study|Did not receive intervention|15|||
48627513|NCT02251041|156494744|FG001|Overall Study|Did not receive intervention|4|||
48627514|NCT05430919|156494745|FG000|Overall Study|Protocol Violation|0|||
48627515|NCT05430919|156494746|FG001|Overall Study|Protocol Violation|0|||
48627516|NCT05430919|156494747|FG002|Overall Study|Protocol Violation|1|||
48627517|NCT05430919|156494748|FG003|Overall Study|Protocol Violation|0|||
48627518|NCT05430919|156494745|FG000|Overall Study|Lost to Follow-up|0|||
48627519|NCT05430919|156494746|FG001|Overall Study|Lost to Follow-up|1|||
48627520|NCT05430919|156494747|FG002|Overall Study|Lost to Follow-up|0|||
48627521|NCT05430919|156494748|FG003|Overall Study|Lost to Follow-up|0|||
48741640|NCT01030536|156903152|FG004|Overall Study|Death|0|||
48627522|NCT05430919|156494745|FG000|Overall Study|Withdrawal by Subject|3|||
48627523|NCT05430919|156494746|FG001|Overall Study|Withdrawal by Subject|0|||
48627524|NCT05430919|156494747|FG002|Overall Study|Withdrawal by Subject|0|||
48741641|NCT01189604|156903156|FG000|Overall Study|Impossible to visit|0|||
48741642|NCT01189604|156903157|FG001|Overall Study|Impossible to visit|0|||
48741643|NCT01189604|156903158|FG002|Overall Study|Impossible to visit|0|||
48627525|NCT05430919|156494748|FG003|Overall Study|Withdrawal by Subject|1|||
48627526|NCT02904096|156494758|FG000|Overall Study|Adverse Event|1|||
48627527|NCT02904096|156494759|FG001|Overall Study|Adverse Event|0|||
48627528|NCT02904096|156494758|FG000|Overall Study|Withdrawal by Subject|4|||
48627529|NCT02904096|156494759|FG001|Overall Study|Withdrawal by Subject|3|||
48627530|NCT02904096|156494758|FG000|Overall Study|Lost to Follow-up|10|||
48627531|NCT02904096|156494759|FG001|Overall Study|Lost to Follow-up|17|||
48627532|NCT02904096|156494758|FG000|Overall Study|Non-compliant|3|||
48627533|NCT02904096|156494759|FG001|Overall Study|Non-compliant|1|||
48627534|NCT02904096|156494758|FG000|Overall Study|Sponsor instructed|1|||
48627535|NCT02904096|156494759|FG001|Overall Study|Sponsor instructed|0|||
48627536|NCT01514422|156494764|FG000|Overall Study|Lost to Follow-up|1|||
48627537|NCT01813357|156494767|FG000|Overall Study|Lost to Follow-up|5|||
48627538|NCT01813357|156494768|FG001|Overall Study|Lost to Follow-up|6|||
48627539|NCT03773562|156494769|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
48627540|NCT03773562|156494769|FG000|Overall Study|Lost to Follow-up|10|||
48627541|NCT03773562|156494769|FG000|Overall Study|Withdrawal by Subject|1|||
48627542|NCT03378635|156494775|FG000|Overall Study|Adverse Event|1|||
48627543|NCT03378635|156494776|FG001|Overall Study|Adverse Event|0|||
48627544|NCT03378635|156494777|FG002|Overall Study|Adverse Event|0|||
48627545|NCT03378635|156494775|FG000|Overall Study|Withdrawal by Subject|1|||
48627546|NCT03378635|156494776|FG001|Overall Study|Withdrawal by Subject|0|||
48627547|NCT03378635|156494777|FG002|Overall Study|Withdrawal by Subject|0|||
48627548|NCT00913835|156494778|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
48627549|NCT00913835|156494779|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
48627550|NCT00913835|156494778|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
48627551|NCT00913835|156494779|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
48627552|NCT00913835|156494778|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
48627553|NCT00913835|156494779|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
48627554|NCT00913835|156494778|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
48627555|NCT00913835|156494779|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
48627556|NCT00913835|156494778|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
48627557|NCT00913835|156494779|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
48627558|NCT00773461|156494780|FG000|Overall Study|Adverse Event|1|||
48627559|NCT00773461|156494781|FG001|Overall Study|Adverse Event|3|||
48627560|NCT00773461|156494780|FG000|Overall Study|Withdrawal by Subject|4|||
48627561|NCT00773461|156494781|FG001|Overall Study|Withdrawal by Subject|1|||
48627562|NCT01308788|156494784|FG000|2-year Treatment|medication change by treating physician|4|||
48627563|NCT01308788|156494785|FG001|2-year Treatment|medication change by treating physician|11|||
48627564|NCT04976855|156494792|FG000|Part I|Withdrawal by Subject|0|||
48627565|NCT04976855|156494793|FG001|Part I|Withdrawal by Subject|1|||
48627566|NCT04976855|156494794|FG002|Part I|Withdrawal by Subject|0|||
48627567|NCT04976855|156494795|FG003|Part I|Withdrawal by Subject|0|||
48627568|NCT04976855|156494796|FG004|Part I|Withdrawal by Subject|0|||
48627569|NCT04976855|156494797|FG005|Part I|Withdrawal by Subject|0|||
48627570|NCT04976855|156494798|FG006|Part I|Withdrawal by Subject|0|||
48627571|NCT04976855|156494792|FG000|Part II|Adverse Event|0|||
48627572|NCT04976855|156494793|FG001|Part II|Adverse Event|0|||
48627573|NCT04976855|156494794|FG002|Part II|Adverse Event|0|||
48627574|NCT04976855|156494795|FG003|Part II|Adverse Event|1|||
48627575|NCT04976855|156494796|FG004|Part II|Adverse Event|0|||
48627576|NCT04976855|156494797|FG005|Part II|Adverse Event|0|||
48627577|NCT04976855|156494798|FG006|Part II|Adverse Event|0|||
48627578|NCT04976855|156494792|FG000|Part II|Withdrawal by Subject|0|||
48627579|NCT04976855|156494793|FG001|Part II|Withdrawal by Subject|0|||
48627580|NCT04976855|156494794|FG002|Part II|Withdrawal by Subject|0|||
48627581|NCT04976855|156494795|FG003|Part II|Withdrawal by Subject|0|||
48627582|NCT04976855|156494796|FG004|Part II|Withdrawal by Subject|1|||
48627583|NCT04976855|156494797|FG005|Part II|Withdrawal by Subject|0|||
48627584|NCT04976855|156494798|FG006|Part II|Withdrawal by Subject|0|||
48627585|NCT04976855|156494792|FG000|Part II|Lost to Follow-up|0|||
48627586|NCT04976855|156494793|FG001|Part II|Lost to Follow-up|0|||
48627587|NCT04976855|156494794|FG002|Part II|Lost to Follow-up|0|||
48627588|NCT04976855|156494795|FG003|Part II|Lost to Follow-up|0|||
48627589|NCT04976855|156494796|FG004|Part II|Lost to Follow-up|0|||
48627590|NCT04976855|156494797|FG005|Part II|Lost to Follow-up|1|||
48627591|NCT04976855|156494798|FG006|Part II|Lost to Follow-up|0|||
48627592|NCT02457793|156494799|FG000|Overall Study|Reason not specified|0|||
48627593|NCT02457793|156494800|FG001|Overall Study|Reason not specified|0|||
48627594|NCT02457793|156494801|FG002|Overall Study|Reason not specified|0|||
48627595|NCT02457793|156494802|FG003|Overall Study|Reason not specified|1|||
48627596|NCT02457793|156494803|FG004|Overall Study|Reason not specified|1|||
48627597|NCT02457793|156494804|FG005|Overall Study|Reason not specified|1|||
48627598|NCT02457793|156494799|FG000|Overall Study|Withdrawal by Subject|0|||
48627599|NCT02457793|156494800|FG001|Overall Study|Withdrawal by Subject|4|||
48627600|NCT02457793|156494801|FG002|Overall Study|Withdrawal by Subject|2|||
48627601|NCT02457793|156494802|FG003|Overall Study|Withdrawal by Subject|2|||
48627602|NCT02457793|156494803|FG004|Overall Study|Withdrawal by Subject|2|||
48627603|NCT02457793|156494804|FG005|Overall Study|Withdrawal by Subject|2|||
48627604|NCT02457793|156494799|FG000|Overall Study|Adverse Event|0|||
48627605|NCT02457793|156494800|FG001|Overall Study|Adverse Event|0|||
48627606|NCT02457793|156494801|FG002|Overall Study|Adverse Event|0|||
48627607|NCT02457793|156494802|FG003|Overall Study|Adverse Event|1|||
48627608|NCT02457793|156494803|FG004|Overall Study|Adverse Event|0|||
48627609|NCT02457793|156494804|FG005|Overall Study|Adverse Event|0|||
48627610|NCT02457793|156494799|FG000|Overall Study|Physician Decision|1|||
48627611|NCT02457793|156494800|FG001|Overall Study|Physician Decision|0|||
48741644|NCT01189604|156903159|FG003|Overall Study|Impossible to visit|0|||
48741645|NCT01189604|156903160|FG004|Overall Study|Impossible to visit|0|||
48741646|NCT01189604|156903161|FG005|Overall Study|Impossible to visit|1|||
48741647|NCT01189604|156903162|FG006|Overall Study|Impossible to visit|0|||
48741648|NCT01189604|156903156|FG000|Overall Study|Adverse Event|0|||
48741649|NCT01189604|156903157|FG001|Overall Study|Adverse Event|1|||
48627612|NCT02457793|156494801|FG002|Overall Study|Physician Decision|1|||
48627613|NCT02457793|156494802|FG003|Overall Study|Physician Decision|1|||
48627614|NCT02457793|156494803|FG004|Overall Study|Physician Decision|1|||
48627615|NCT02457793|156494804|FG005|Overall Study|Physician Decision|3|||
48627616|NCT02757768|156494805|FG000|Overall Study|Randomized Never Received Study Drug|3|||
48627617|NCT02757768|156494806|FG001|Overall Study|Randomized Never Received Study Drug|4|||
48627618|NCT02757768|156494805|FG000|Overall Study|Adverse Event|5|||
48627619|NCT02757768|156494806|FG001|Overall Study|Adverse Event|3|||
48627620|NCT02757768|156494805|FG000|Overall Study|Lack of Efficacy|2|||
48627621|NCT02757768|156494806|FG001|Overall Study|Lack of Efficacy|1|||
48627622|NCT02757768|156494805|FG000|Overall Study|Lost to Follow-up|1|||
48627623|NCT02757768|156494806|FG001|Overall Study|Lost to Follow-up|0|||
48627624|NCT02757768|156494805|FG000|Overall Study|Protocol Deviation|2|||
48627625|NCT02757768|156494806|FG001|Overall Study|Protocol Deviation|9|||
48627626|NCT02757768|156494805|FG000|Overall Study|Withdrawal by Subject|16|||
48627627|NCT02757768|156494806|FG001|Overall Study|Withdrawal by Subject|9|||
48627628|NCT02757768|156494805|FG000|Overall Study|Miscellaneous|4|||
48627629|NCT02757768|156494806|FG001|Overall Study|Miscellaneous|2|||
48627630|NCT01557244|156496012|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
48627631|NCT01557244|156496013|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
48627632|NCT01557244|156496014|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
48627633|NCT01557244|156496015|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
48627634|NCT01557244|156496016|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
48627635|NCT01557244|156496017|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
48627636|NCT01557244|156496018|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
48627637|NCT01557244|156496012|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
48741650|NCT01189604|156903158|FG002|Overall Study|Adverse Event|0|||
48741651|NCT01189604|156903159|FG003|Overall Study|Adverse Event|0|||
48627638|NCT01557244|156496013|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
48627639|NCT01557244|156496014|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
48627640|NCT01557244|156496015|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
48741652|NCT01189604|156903160|FG004|Overall Study|Adverse Event|2|||
48741653|NCT01189604|156903161|FG005|Overall Study|Adverse Event|0|||
48741654|NCT01189604|156903162|FG006|Overall Study|Adverse Event|1|||
48741655|NCT01189604|156903156|FG000|Overall Study|Withdrawal by Subject|1|||
48741656|NCT01189604|156903157|FG001|Overall Study|Withdrawal by Subject|0|||
48741657|NCT01189604|156903158|FG002|Overall Study|Withdrawal by Subject|0|||
48741658|NCT01189604|156903159|FG003|Overall Study|Withdrawal by Subject|0|||
48741659|NCT01189604|156903160|FG004|Overall Study|Withdrawal by Subject|0|||
48741660|NCT01189604|156903161|FG005|Overall Study|Withdrawal by Subject|0|||
48741661|NCT01189604|156903162|FG006|Overall Study|Withdrawal by Subject|0|||
48627641|NCT01557244|156496016|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
48627642|NCT01557244|156496017|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
48627643|NCT01557244|156496018|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
48627644|NCT01557244|156496012|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
48627645|NCT01557244|156496013|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
48741662|NCT02100514|156903163|FG000|Treatment Period|Adverse Event|0|||
48741663|NCT02100514|156903164|FG001|Treatment Period|Adverse Event|5|||
48741664|NCT02100514|156903165|FG002|Treatment Period|Adverse Event|0|||
48741665|NCT02100514|156903166|FG003|Treatment Period|Adverse Event|0|||
48741666|NCT02100514|156903167|FG004|Treatment Period|Adverse Event|0|||
48627646|NCT01557244|156496014|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
48627647|NCT01557244|156496015|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
48627648|NCT01557244|156496016|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
48627649|NCT01557244|156496017|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
48627650|NCT01557244|156496018|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
48627651|NCT01557244|156496012|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
48627652|NCT01557244|156496013|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
48627653|NCT01557244|156496014|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
48627654|NCT01557244|156496015|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
48627655|NCT01557244|156496016|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
48627656|NCT01557244|156496017|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
48627657|NCT01557244|156496018|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
48627658|NCT01557244|156496012|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
48627659|NCT01557244|156496013|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
48627660|NCT01557244|156496014|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
48741667|NCT02100514|156903163|FG000|Treatment Period|Death|2|||
48323978|NCT01932970|155385123|FG000|Overall Study|Lost to Follow-up|2|||
48323979|NCT01932970|155385123|FG000|Overall Study|Protocol Specified Criteria|10|||
48323980|NCT01500200|155385124|FG000|Stage 1|Adverse Event|1|||
48323981|NCT01500200|155385125|FG001|Stage 1|Adverse Event|4|||
48323982|NCT01500200|155385126|FG002|Stage 1|Adverse Event|5|||
48627661|NCT01557244|156496015|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
48627662|NCT01557244|156496016|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
48627663|NCT01557244|156496017|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
48627664|NCT01557244|156496018|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
48627665|NCT01557244|156496012|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
48741668|NCT02100514|156903164|FG001|Treatment Period|Death|2|||
48741669|NCT02100514|156903165|FG002|Treatment Period|Death|0|||
48741670|NCT02100514|156903166|FG003|Treatment Period|Death|0|||
48741671|NCT02100514|156903167|FG004|Treatment Period|Death|0|||
48323983|NCT01500200|155385127|FG003|Stage 1|Adverse Event|0|||
48627666|NCT01557244|156496013|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
48627667|NCT01557244|156496014|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
48627668|NCT01557244|156496015|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
48627669|NCT01557244|156496016|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
48627670|NCT01557244|156496017|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
48627671|NCT01557244|156496018|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
48627672|NCT01557244|156496012|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
48627673|NCT01557244|156496013|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
48627674|NCT01557244|156496014|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
48627675|NCT01557244|156496015|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
48627676|NCT01557244|156496016|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
48627677|NCT01557244|156496017|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
48741672|NCT02100514|156903163|FG000|Treatment Period|Lost to Follow-up|5|||
48741673|NCT02100514|156903164|FG001|Treatment Period|Lost to Follow-up|17|||
48741674|NCT02100514|156903165|FG002|Treatment Period|Lost to Follow-up|0|||
48741675|NCT02100514|156903166|FG003|Treatment Period|Lost to Follow-up|0|||
48741676|NCT02100514|156903167|FG004|Treatment Period|Lost to Follow-up|0|||
48741677|NCT02100514|156903163|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
48741678|NCT02100514|156903164|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
48741679|NCT02100514|156903165|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
48741680|NCT02100514|156903166|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
48741681|NCT02100514|156903167|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
48741682|NCT02100514|156903163|FG000|Treatment Period|Protocol Violation|1|||
48741683|NCT02100514|156903164|FG001|Treatment Period|Protocol Violation|1|||
48741684|NCT02100514|156903165|FG002|Treatment Period|Protocol Violation|0|||
48741685|NCT02100514|156903166|FG003|Treatment Period|Protocol Violation|0|||
48741686|NCT02100514|156903167|FG004|Treatment Period|Protocol Violation|0|||
48741687|NCT02100514|156903163|FG000|Treatment Period|Withdrawal by Subject|12|||
48741688|NCT02100514|156903164|FG001|Treatment Period|Withdrawal by Subject|37|||
48741689|NCT02100514|156903165|FG002|Treatment Period|Withdrawal by Subject|0|||
48741690|NCT02100514|156903166|FG003|Treatment Period|Withdrawal by Subject|0|||
48741691|NCT02100514|156903167|FG004|Treatment Period|Withdrawal by Subject|0|||
48323984|NCT01500200|155385128|FG004|Stage 1|Adverse Event|0|||
48323985|NCT01500200|155385129|FG005|Stage 1|Adverse Event|0|||
48323986|NCT01500200|155385124|FG000|Stage 1|Lost to Follow-up|2|||
48323987|NCT01500200|155385125|FG001|Stage 1|Lost to Follow-up|2|||
48741692|NCT02100514|156903163|FG000|Treatment Period|Other|9|||
48741693|NCT02100514|156903164|FG001|Treatment Period|Other|11|||
48741694|NCT02100514|156903165|FG002|Treatment Period|Other|0|||
48741695|NCT02100514|156903166|FG003|Treatment Period|Other|0|||
48741696|NCT02100514|156903167|FG004|Treatment Period|Other|0|||
48741697|NCT02100514|156903163|FG000|Extension Period|Withdrew consent|0|||
48741698|NCT02100514|156903164|FG001|Extension Period|Withdrew consent|0|||
48741699|NCT02100514|156903165|FG002|Extension Period|Withdrew consent|2|||
48323988|NCT01500200|155385126|FG002|Stage 1|Lost to Follow-up|1|||
48323989|NCT01500200|155385127|FG003|Stage 1|Lost to Follow-up|0|||
48627678|NCT01557244|156496018|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
48323990|NCT01500200|155385128|FG004|Stage 1|Lost to Follow-up|0|||
48323991|NCT01500200|155385129|FG005|Stage 1|Lost to Follow-up|0|||
48323992|NCT01500200|155385124|FG000|Stage 1|Withdrawal by Subject|3|||
48323993|NCT01500200|155385125|FG001|Stage 1|Withdrawal by Subject|0|||
48627679|NCT01557244|156496012|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
48741700|NCT02100514|156903166|FG003|Extension Period|Withdrew consent|0|||
48741701|NCT02100514|156903167|FG004|Extension Period|Withdrew consent|0|||
48741702|NCT01365052|156903169|FG000|Overall Study|Adverse Event|4|||
48741703|NCT01365052|156903170|FG001|Overall Study|Adverse Event|4|||
48741704|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
48741705|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
48741706|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
48741707|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
48741708|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
48741709|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
48741710|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
48741711|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
48741712|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
48741713|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
48741714|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
48741715|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
48741716|NCT00044083|156903173|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
48741717|NCT00044083|156903174|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
48741718|NCT00044083|156903173|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
48741719|NCT00044083|156903174|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
48741720|NCT00044083|156903173|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
48741721|NCT00044083|156903174|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
48741722|NCT00044083|156903173|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
48741723|NCT00044083|156903174|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
48741724|NCT04447794|156903180|FG000|Overall Study|Lost to Follow-up|2|||
48741725|NCT04447794|156903181|FG001|Overall Study|Lost to Follow-up|3|||
48741726|NCT04447794|156903182|FG002|Overall Study|Lost to Follow-up|8|||
48741727|NCT04447794|156903180|FG000|Overall Study|Withdrawal by Subject|1|||
48741728|NCT04447794|156903181|FG001|Overall Study|Withdrawal by Subject|1|||
48741729|NCT04447794|156903182|FG002|Overall Study|Withdrawal by Subject|0|||
48741730|NCT05306977|156903185|FG000|Overall Study|Withdrawal by Subject|1|||
48741731|NCT01443078|156903190|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
48741732|NCT01443078|156903190|FG000|Overall Study|Withdrawal by Subject|1|||
48741733|NCT01443078|156903190|FG000|Overall Study|Patient had brain mets|1|||
48741734|NCT00781274|156903191|FG000|Overall Study|Withdrawal by Subject|2|||
48741735|NCT00190671|156903193|FG000|Overall Study|Satisfactory Response|4|||
48741736|NCT00190671|156903194|FG001|Overall Study|Satisfactory Response|7|||
48741737|NCT00190671|156903193|FG000|Overall Study|Lack of Efficacy|19|||
48741738|NCT00190671|156903194|FG001|Overall Study|Lack of Efficacy|24|||
48741739|NCT00190671|156903193|FG000|Overall Study|Death from Study Disease|1|||
48741740|NCT00190671|156903194|FG001|Overall Study|Death from Study Disease|1|||
48741741|NCT00190671|156903193|FG000|Overall Study|Adverse Event|3|||
48741742|NCT00190671|156903194|FG001|Overall Study|Adverse Event|2|||
48741743|NCT00190671|156903193|FG000|Overall Study|Clinical Relapse|0|||
48741744|NCT00190671|156903194|FG001|Overall Study|Clinical Relapse|1|||
48741745|NCT00190671|156903193|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
48741746|NCT00190671|156903194|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
48741747|NCT00190671|156903193|FG000|Overall Study|Death from Other Causes|0|||
48741748|NCT00190671|156903194|FG001|Overall Study|Death from Other Causes|2|||
48741749|NCT00190671|156903193|FG000|Overall Study|Protocol Violation|0|||
48741750|NCT00190671|156903194|FG001|Overall Study|Protocol Violation|1|||
48741751|NCT00190671|156903193|FG000|Overall Study|Withdrawal by Subject|0|||
48741752|NCT00190671|156903194|FG001|Overall Study|Withdrawal by Subject|2|||
48741753|NCT00457301|156903195|FG000|Overall Study|Withdrawal by Subject|3|||
48741754|NCT00457301|156903196|FG001|Overall Study|Withdrawal by Subject|3|||
48741755|NCT00457301|156903195|FG000|Overall Study|Censored out of the study|15|||
48741756|NCT00457301|156903196|FG001|Overall Study|Censored out of the study|14|||
48627680|NCT01557244|156496013|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
48627681|NCT01557244|156496014|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
48627682|NCT01557244|156496015|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
48627683|NCT01557244|156496016|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
48627684|NCT01557244|156496017|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
48627685|NCT01557244|156496018|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
48627686|NCT01557244|156496012|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
48627687|NCT01557244|156496013|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
48627688|NCT01557244|156496014|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
48627689|NCT01557244|156496015|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
48627690|NCT01557244|156496016|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
48741757|NCT00457301|156903195|FG000|Overall Study|Death|5|||
48741758|NCT00457301|156903196|FG001|Overall Study|Death|7|||
48741759|NCT01702961|156903197|FG000|Overall Study|Additional treatment|3|||
48741760|NCT01702961|156903197|FG000|Overall Study|Progressive disease|5|||
48741761|NCT01702961|156903197|FG000|Overall Study|Relapse|20|||
48741762|NCT01702961|156903197|FG000|Overall Study|Death|6|||
48741763|NCT01702961|156903197|FG000|Overall Study|Lost to Follow-up|2|||
48741764|NCT01702961|156903197|FG000|Overall Study|Ongoing|11|||
48741765|NCT02229383|156903198|FG000|Overall Study|Adverse Event|7|||
48741766|NCT02229383|156903199|FG001|Overall Study|Adverse Event|4|||
48741767|NCT02229383|156903198|FG000|Overall Study|Death|0|||
48741768|NCT02229383|156903199|FG001|Overall Study|Death|1|||
48741769|NCT02229383|156903198|FG000|Overall Study|Lost to Follow-up|5|||
48741770|NCT02229383|156903199|FG001|Overall Study|Lost to Follow-up|3|||
48741771|NCT02229383|156903198|FG000|Overall Study|Withdrawal by Subject|4|||
48741772|NCT02229383|156903199|FG001|Overall Study|Withdrawal by Subject|6|||
48741773|NCT02229383|156903198|FG000|Overall Study|Did not receive treatment|1|||
48741774|NCT02229383|156903199|FG001|Overall Study|Did not receive treatment|0|||
48741775|NCT02229383|156903198|FG000|Overall Study|Other|3|||
48741776|NCT02229383|156903199|FG001|Overall Study|Other|8|||
48741777|NCT04057365|156903200|FG000|Overall Study|Withdrawal by Subject|2|||
48741778|NCT04057365|156903201|FG001|Overall Study|Withdrawal by Subject|0|||
48741779|NCT01133522|156903204|FG000|Overall Study|Withdrawal by Subject|0|||
48741780|NCT01133522|156903205|FG001|Overall Study|Withdrawal by Subject|1|||
48741781|NCT01133522|156903206|FG002|Overall Study|Withdrawal by Subject|0|||
48323994|NCT01500200|155385126|FG002|Stage 1|Withdrawal by Subject|0|||
48323995|NCT01500200|155385127|FG003|Stage 1|Withdrawal by Subject|0|||
48741782|NCT01133522|156903207|FG003|Overall Study|Withdrawal by Subject|1|||
48741783|NCT01133522|156903208|FG004|Overall Study|Withdrawal by Subject|0|||
48741784|NCT01133522|156903209|FG005|Overall Study|Withdrawal by Subject|0|||
48323996|NCT01500200|155385128|FG004|Stage 1|Withdrawal by Subject|0|||
48323997|NCT01500200|155385129|FG005|Stage 1|Withdrawal by Subject|0|||
48627691|NCT01557244|156496017|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
48627692|NCT01557244|156496018|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
48741785|NCT01133522|156903210|FG006|Overall Study|Withdrawal by Subject|0|||
48323998|NCT01500200|155385124|FG000|Stage 1|Noncompliance with Study Drug|1|||
48323999|NCT01500200|155385125|FG001|Stage 1|Noncompliance with Study Drug|0|||
48741786|NCT01133522|156903211|FG007|Overall Study|Withdrawal by Subject|0|||
48741787|NCT01133522|156903212|FG008|Overall Study|Withdrawal by Subject|0|||
48741788|NCT01133522|156903213|FG009|Overall Study|Withdrawal by Subject|0|||
48741789|NCT01133522|156903204|FG000|Overall Study|Physician Decision|0|||
48741790|NCT01133522|156903205|FG001|Overall Study|Physician Decision|0|||
48741791|NCT01133522|156903206|FG002|Overall Study|Physician Decision|0|||
48741792|NCT01133522|156903207|FG003|Overall Study|Physician Decision|0|||
48741793|NCT01133522|156903208|FG004|Overall Study|Physician Decision|1|||
48741794|NCT01133522|156903209|FG005|Overall Study|Physician Decision|0|||
48741795|NCT01133522|156903210|FG006|Overall Study|Physician Decision|0|||
48741796|NCT01133522|156903211|FG007|Overall Study|Physician Decision|0|||
48741797|NCT01133522|156903212|FG008|Overall Study|Physician Decision|0|||
48741798|NCT01133522|156903213|FG009|Overall Study|Physician Decision|0|||
48741799|NCT00668707|156903214|FG000|Overall Study|Cancer Recurrence|58|||
48741800|NCT00668707|156903215|FG001|Overall Study|Cancer Recurrence|58|||
48741801|NCT00668707|156903214|FG000|Overall Study|Withdrawal by Subject|117|||
48741802|NCT00668707|156903215|FG001|Overall Study|Withdrawal by Subject|100|||
48741803|NCT00668707|156903214|FG000|Overall Study|Lost to Follow-up|3|||
48741804|NCT00668707|156903215|FG001|Overall Study|Lost to Follow-up|6|||
48741805|NCT00668707|156903214|FG000|Overall Study|Protocol Violation|10|||
48324000|NCT01500200|155385126|FG002|Stage 1|Noncompliance with Study Drug|0|||
48324001|NCT01500200|155385127|FG003|Stage 1|Noncompliance with Study Drug|0|||
48324002|NCT01500200|155385128|FG004|Stage 1|Noncompliance with Study Drug|0|||
48324003|NCT01500200|155385129|FG005|Stage 1|Noncompliance with Study Drug|0|||
48324004|NCT01500200|155385124|FG000|Stage 1|Physician Decision|1|||
48324005|NCT01500200|155385125|FG001|Stage 1|Physician Decision|0|||
48324006|NCT01500200|155385126|FG002|Stage 1|Physician Decision|0|||
48324007|NCT01500200|155385127|FG003|Stage 1|Physician Decision|0|||
48324008|NCT01500200|155385128|FG004|Stage 1|Physician Decision|0|||
48324009|NCT01500200|155385129|FG005|Stage 1|Physician Decision|0|||
48324010|NCT01500200|155385124|FG000|Stage 2|Adverse Event|0|||
48324011|NCT01500200|155385125|FG001|Stage 2|Adverse Event|0|||
48324012|NCT01500200|155385126|FG002|Stage 2|Adverse Event|0|||
48324013|NCT01500200|155385127|FG003|Stage 2|Adverse Event|0|||
48324014|NCT01500200|155385128|FG004|Stage 2|Adverse Event|5|||
48324015|NCT01500200|155385129|FG005|Stage 2|Adverse Event|4|||
48324016|NCT01359150|155385130|FG000|Overall Study|Lack of Efficacy|1|||
48324017|NCT01359150|155385131|FG001|Overall Study|Lack of Efficacy|1|||
48324018|NCT01359150|155385130|FG000|Overall Study|Withdrawal by Subject|1|||
48324019|NCT01359150|155385131|FG001|Overall Study|Withdrawal by Subject|1|||
48324020|NCT01359150|155385130|FG000|Overall Study|Adverse Event|4|||
48324021|NCT01359150|155385131|FG001|Overall Study|Adverse Event|3|||
48324022|NCT01359150|155385130|FG000|Overall Study|Other|1|||
48324023|NCT01359150|155385131|FG001|Overall Study|Other|0|||
48324024|NCT01700205|155385132|FG000|Overall Study|Withdrawal by Subject|13|||
48324025|NCT01700205|155385133|FG001|Overall Study|Withdrawal by Subject|13|||
48324026|NCT01700205|155385132|FG000|Overall Study|Protocol Violation|2|||
48324027|NCT01700205|155385133|FG001|Overall Study|Protocol Violation|2|||
48324028|NCT01260896|155385134|FG000|First Intervention|Withdrawn Due to Emesis|2|||
48324029|NCT01260896|155385135|FG001|First Intervention|Withdrawn Due to Emesis|0|||
48324030|NCT00491894|155385136|FG000|Overall Study|Adverse Event|14|||
48324031|NCT00491894|155385136|FG000|Overall Study|Withdrawal by Subject|5|||
48324032|NCT00491894|155385136|FG000|Overall Study|Death|3|||
48324033|NCT00491894|155385136|FG000|Overall Study|Lost to Follow-up|3|||
48324034|NCT00491894|155385136|FG000|Overall Study|Lack of Efficacy|2|||
48324035|NCT00491894|155385136|FG000|Overall Study|Other-Failed to meet any criteria|2|||
48324036|NCT00491894|155385136|FG000|Overall Study|Physician Decision|2|||
48324037|NCT00491894|155385136|FG000|Overall Study|Protocol Violation|2|||
48324038|NCT00491894|155385136|FG000|Overall Study|Other-Intake of prohibited medication|1|||
48324039|NCT03066609|155385138|FG000|INDUCTION|Pregnancy|0|||
48324040|NCT03066609|155385139|FG001|INDUCTION|Pregnancy|0|||
48324041|NCT03066609|155385140|FG002|INDUCTION|Pregnancy|1|||
48324042|NCT03066609|155385141|FG003|INDUCTION|Pregnancy|0|||
48324043|NCT03066609|155385138|FG000|INDUCTION|Lack of Efficacy|0|||
48627693|NCT01557244|156496012|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
48627694|NCT01557244|156496013|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
48627695|NCT01557244|156496014|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
48627696|NCT01557244|156496015|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
48627697|NCT01557244|156496016|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
48627698|NCT01557244|156496017|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
48627699|NCT01557244|156496018|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
48627700|NCT01557244|156496012|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
48741806|NCT00668707|156903215|FG001|Overall Study|Protocol Violation|12|||
48741807|NCT00668707|156903214|FG000|Overall Study|Death|11|||
48741808|NCT00668707|156903215|FG001|Overall Study|Death|4|||
48741809|NCT00672646|156903217|FG000|Overall Study|Lost to Follow-up|0|||
48324044|NCT03066609|155385139|FG001|INDUCTION|Lack of Efficacy|0|||
48324045|NCT03066609|155385140|FG002|INDUCTION|Lack of Efficacy|1|||
48741810|NCT00672646|156903218|FG001|Overall Study|Lost to Follow-up|1|||
48324046|NCT03066609|155385141|FG003|INDUCTION|Lack of Efficacy|0|||
48324047|NCT03066609|155385138|FG000|INDUCTION|Adverse Event|2|||
48741811|NCT00672646|156903219|FG002|Overall Study|Lost to Follow-up|2|||
48741812|NCT00672646|156903217|FG000|Overall Study|Withdrawal by Subject|0|||
48627701|NCT01557244|156496013|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
48627702|NCT01557244|156496014|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
48627703|NCT01557244|156496015|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
48627704|NCT01557244|156496016|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
48627705|NCT01557244|156496017|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
48627706|NCT01557244|156496018|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
48741813|NCT00672646|156903218|FG001|Overall Study|Withdrawal by Subject|0|||
48741814|NCT00672646|156903219|FG002|Overall Study|Withdrawal by Subject|1|||
48741815|NCT03386448|156903220|FG000|Overall Study|Adverse Event|0|||
48741816|NCT03386448|156903221|FG001|Overall Study|Adverse Event|2|||
48741817|NCT02657369|156903222|FG000|Overall Study|Death|27|||
48741818|NCT02657369|156903222|FG000|Overall Study|Study terminated by sponsor|7|||
48741819|NCT04094883|156903225|FG000|Overall Study|Withdrawal by Subject|1|||
48741820|NCT03298867|156903226|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
48741821|NCT03298867|156903227|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
48741822|NCT03298867|156903226|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
48627707|NCT01557244|156496012|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
48627708|NCT01557244|156496013|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
48627709|NCT01557244|156496014|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
48627710|NCT01557244|156496015|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
48627711|NCT01557244|156496016|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
48627712|NCT01557244|156496017|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
48627713|NCT01557244|156496018|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
48627714|NCT02457546|156496019|FG000|Overall Study|Other reasons|4|||
48627715|NCT02457546|156496020|FG001|Overall Study|Other reasons|1|||
48627716|NCT02457546|156496019|FG000|Overall Study|Refused to complete study/procedures|1|||
48627717|NCT02457546|156496020|FG001|Overall Study|Refused to complete study/procedures|1|||
48741823|NCT03298867|156903227|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
48741824|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
48741825|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
48741826|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
48741827|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
48741828|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
48741829|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
48741830|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
48741831|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
48741832|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
48741833|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
48741834|NCT03298867|156903226|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
48741835|NCT03298867|156903227|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
48741836|NCT03298867|156903226|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
48741837|NCT03298867|156903227|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
48741838|NCT00300274|156903229|FG000|Overall Study|Withdrawal by Subject|12|||
48741839|NCT00300274|156903230|FG001|Overall Study|Withdrawal by Subject|3|||
48741840|NCT00300274|156903231|FG002|Overall Study|Withdrawal by Subject|14|||
48741841|NCT00300274|156903229|FG000|Overall Study|Lost to Follow-up|3|||
48324048|NCT03066609|155385139|FG001|INDUCTION|Adverse Event|2|||
48324049|NCT03066609|155385140|FG002|INDUCTION|Adverse Event|0|||
48324050|NCT03066609|155385141|FG003|INDUCTION|Adverse Event|0|||
48324051|NCT03066609|155385138|FG000|MAINTENANCE|Adverse Event|0|||
48627718|NCT02457546|156496019|FG000|Overall Study|Lost to Follow-up|4|||
48627719|NCT02457546|156496020|FG001|Overall Study|Lost to Follow-up|1|||
48741842|NCT00300274|156903230|FG001|Overall Study|Lost to Follow-up|4|||
48741843|NCT00300274|156903231|FG002|Overall Study|Lost to Follow-up|5|||
48741844|NCT00300274|156903229|FG000|Overall Study|Death|31|||
48741845|NCT00300274|156903230|FG001|Overall Study|Death|20|||
48741846|NCT00300274|156903231|FG002|Overall Study|Death|25|||
48741847|NCT00300274|156903229|FG000|Overall Study|Re-transplant|0|||
48741848|NCT00300274|156903230|FG001|Overall Study|Re-transplant|0|||
48741849|NCT00300274|156903231|FG002|Overall Study|Re-transplant|1|||
48741850|NCT02400333|156904345|FG000|Overall Study|Withdrawal by Subject|0|||
48741851|NCT02400333|156904346|FG001|Overall Study|Withdrawal by Subject|1|||
48741852|NCT02400333|156904347|FG002|Overall Study|Withdrawal by Subject|0|||
48741853|NCT02400333|156904348|FG003|Overall Study|Withdrawal by Subject|1|||
48741854|NCT02400333|156904345|FG000|Overall Study|Protocol Violation|1|||
48741855|NCT02400333|156904346|FG001|Overall Study|Protocol Violation|0|||
48741856|NCT02400333|156904347|FG002|Overall Study|Protocol Violation|2|||
48741857|NCT02400333|156904348|FG003|Overall Study|Protocol Violation|1|||
48741858|NCT00354744|156904349|FG000|Overall Study|Adverse Event|2|||
48741859|NCT00354744|156904349|FG000|Overall Study|Death|2|||
48741860|NCT00354744|156904349|FG000|Overall Study|Lack of Efficacy|11|||
48741861|NCT00354744|156904349|FG000|Overall Study|Lost to Follow-up|2|||
48741862|NCT00354744|156904349|FG000|Overall Study|Physician Decision|11|||
48741863|NCT00354744|156904349|FG000|Overall Study|Withdrawal by Subject|14|||
48741864|NCT00934089|156904350|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
48741865|NCT00934089|156904351|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
48741866|NCT00934089|156904350|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
48741867|NCT00934089|156904351|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
48741868|NCT05350410|156904356|FG000|Overall Study|Withdrawal by Subject|1|||
48741869|NCT03750955|156904357|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
48741870|NCT03750955|156904358|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
48741871|NCT03750955|156904357|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
48741872|NCT03750955|156904358|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
48741873|NCT00705289|156904362|FG000|Overall Study|Subject or treating physician's choice|131|||
48741874|NCT00091442|156904365|FG000|Overall Study|Progressive Disease|220|||
48741875|NCT00091442|156904366|FG001|Overall Study|Progressive Disease|189|||
48741876|NCT00091442|156904365|FG000|Overall Study|Physician Decision|61|||
48741877|NCT00091442|156904366|FG001|Overall Study|Physician Decision|58|||
48741878|NCT00091442|156904365|FG000|Overall Study|Withdrawal by Subject|38|||
48741879|NCT00091442|156904366|FG001|Overall Study|Withdrawal by Subject|46|||
48741880|NCT00091442|156904365|FG000|Overall Study|Adverse Event|29|||
48741881|NCT00091442|156904366|FG001|Overall Study|Adverse Event|48|||
48741882|NCT00091442|156904365|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
48741883|NCT00091442|156904366|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
48741884|NCT00091442|156904365|FG000|Overall Study|Death|9|||
48741885|NCT00091442|156904366|FG001|Overall Study|Death|7|||
48741886|NCT00091442|156904365|FG000|Overall Study|Lost to Follow-up|1|||
48741887|NCT00091442|156904366|FG001|Overall Study|Lost to Follow-up|3|||
48741888|NCT00091442|156904365|FG000|Overall Study|Other|2|||
48741889|NCT00091442|156904366|FG001|Overall Study|Other|6|||
48741890|NCT03417219|156904367|FG000|Overall Study|Lost to Follow-up|0|||
48741891|NCT03417219|156904368|FG001|Overall Study|Lost to Follow-up|3|||
48741892|NCT02038881|156904369|FG000|Overall Study|Withdrawal by Subject|0|||
48741893|NCT02038881|156904370|FG001|Overall Study|Withdrawal by Subject|0|||
48741894|NCT02038881|156904371|FG002|Overall Study|Withdrawal by Subject|1|||
48741895|NCT02038881|156904369|FG000|Overall Study|Lost to Follow-up|2|||
48741896|NCT02038881|156904370|FG001|Overall Study|Lost to Follow-up|0|||
48741897|NCT02038881|156904371|FG002|Overall Study|Lost to Follow-up|0|||
48741898|NCT02038881|156904369|FG000|Overall Study|incarcerated|1|||
48741899|NCT02038881|156904370|FG001|Overall Study|incarcerated|0|||
48627720|NCT02457546|156496019|FG000|Overall Study|Adverse Event|0|||
48324052|NCT03066609|155385139|FG001|MAINTENANCE|Adverse Event|0|||
48324053|NCT03066609|155385140|FG002|MAINTENANCE|Adverse Event|0|||
48324054|NCT03066609|155385141|FG003|MAINTENANCE|Adverse Event|1|||
48741900|NCT02038881|156904371|FG002|Overall Study|incarcerated|0|||
48741901|NCT03978832|156904372|FG000|Overall Study|Adverse Event|1|||
48741902|NCT03978832|156904372|FG000|Overall Study|Lost to Follow-up|1|||
48741903|NCT03978832|156904372|FG000|Overall Study|Withdrawal by Subject|6|||
48741904|NCT03978832|156904372|FG000|Overall Study|Physician Decision|2|||
48741905|NCT03978832|156904372|FG000|Overall Study|did not pass screening criteria|44|||
48741906|NCT00845858|156904373|FG000|Overall Study|Withdrawal by Subject|5|||
48741907|NCT00845858|156904374|FG001|Overall Study|Withdrawal by Subject|1|||
48741908|NCT00845858|156904375|FG002|Overall Study|Withdrawal by Subject|1|||
48741909|NCT00845858|156904373|FG000|Overall Study|Adverse Event|3|||
48627721|NCT02457546|156496020|FG001|Overall Study|Adverse Event|1|||
48627722|NCT05069415|156496021|FG000|Overall Study|Withdrawal by Subject|2|||
48627723|NCT05069415|156496022|FG001|Overall Study|Withdrawal by Subject|0|||
48627724|NCT05069415|156496021|FG000|Overall Study|Adverse Event|2|||
48627725|NCT05069415|156496022|FG001|Overall Study|Adverse Event|0|||
48627726|NCT02144337|156496023|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
48627727|NCT02144337|156496024|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
48627728|NCT02144337|156496023|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
48627729|NCT02144337|156496024|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
48627730|NCT02144337|156496023|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
48627731|NCT02144337|156496024|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
48627732|NCT02144337|156496023|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
48741910|NCT00845858|156904374|FG001|Overall Study|Adverse Event|8|||
48741911|NCT00845858|156904375|FG002|Overall Study|Adverse Event|4|||
48741912|NCT00845858|156904373|FG000|Overall Study|Protocol Violation|0|||
48741913|NCT00845858|156904374|FG001|Overall Study|Protocol Violation|0|||
48741914|NCT00845858|156904375|FG002|Overall Study|Protocol Violation|1|||
48741915|NCT00845858|156904373|FG000|Overall Study|not eligible|0|||
48741916|NCT00845858|156904374|FG001|Overall Study|not eligible|3|||
48741917|NCT00845858|156904375|FG002|Overall Study|not eligible|2|||
48741918|NCT02202980|156904377|FG000|Overall Study|Lack of Efficacy|1|||
48324055|NCT03066609|155385138|FG000|MAINTENANCE|Withdrawal by Subject|4|||
48324056|NCT03066609|155385139|FG001|MAINTENANCE|Withdrawal by Subject|2|||
48324057|NCT03066609|155385140|FG002|MAINTENANCE|Withdrawal by Subject|1|||
48324058|NCT03066609|155385141|FG003|MAINTENANCE|Withdrawal by Subject|1|||
48324059|NCT03066609|155385138|FG000|MAINTENANCE|Lost to Follow-up|0|||
48324060|NCT03066609|155385139|FG001|MAINTENANCE|Lost to Follow-up|1|||
48324061|NCT03066609|155385140|FG002|MAINTENANCE|Lost to Follow-up|1|||
48324062|NCT03066609|155385141|FG003|MAINTENANCE|Lost to Follow-up|0|||
48324063|NCT03066609|155385138|FG000|MAINTENANCE|Pregnancy|1|||
48324064|NCT03066609|155385139|FG001|MAINTENANCE|Pregnancy|0|||
48324065|NCT03066609|155385140|FG002|MAINTENANCE|Pregnancy|0|||
48324066|NCT03066609|155385141|FG003|MAINTENANCE|Pregnancy|0|||
48324067|NCT03066609|155385138|FG000|MAINTENANCE|Lack of Efficacy|2|||
48324068|NCT03066609|155385139|FG001|MAINTENANCE|Lack of Efficacy|1|||
48324069|NCT03066609|155385140|FG002|MAINTENANCE|Lack of Efficacy|0|||
48324070|NCT03066609|155385141|FG003|MAINTENANCE|Lack of Efficacy|1|||
48324071|NCT03066609|155385138|FG000|OVERALL STUDY|Adverse Event|2|||
48324072|NCT03066609|155385139|FG001|OVERALL STUDY|Adverse Event|2|||
48324073|NCT03066609|155385140|FG002|OVERALL STUDY|Adverse Event|0|||
48324074|NCT03066609|155385141|FG003|OVERALL STUDY|Adverse Event|1|||
48324075|NCT03066609|155385138|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
48324076|NCT03066609|155385139|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
48324077|NCT03066609|155385140|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
48324078|NCT03066609|155385141|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
48324079|NCT03066609|155385138|FG000|OVERALL STUDY|Lost to Follow-up|1|||
48324080|NCT03066609|155385139|FG001|OVERALL STUDY|Lost to Follow-up|1|||
48324081|NCT03066609|155385140|FG002|OVERALL STUDY|Lost to Follow-up|1|||
48324082|NCT03066609|155385141|FG003|OVERALL STUDY|Lost to Follow-up|1|||
48324083|NCT03066609|155385138|FG000|OVERALL STUDY|Pregnancy|1|||
48324084|NCT03066609|155385139|FG001|OVERALL STUDY|Pregnancy|0|||
48324085|NCT03066609|155385140|FG002|OVERALL STUDY|Pregnancy|1|||
48324086|NCT03066609|155385141|FG003|OVERALL STUDY|Pregnancy|0|||
48324087|NCT03066609|155385138|FG000|OVERALL STUDY|Lack of Efficacy|2|||
48324088|NCT03066609|155385139|FG001|OVERALL STUDY|Lack of Efficacy|1|||
48324089|NCT03066609|155385140|FG002|OVERALL STUDY|Lack of Efficacy|1|||
48324090|NCT03066609|155385141|FG003|OVERALL STUDY|Lack of Efficacy|1|||
48324091|NCT03066609|155385138|FG000|OVERALL STUDY|discontinued follow up|0|||
48324092|NCT03066609|155385139|FG001|OVERALL STUDY|discontinued follow up|2|||
48627733|NCT02144337|156496024|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
48324093|NCT03066609|155385140|FG002|OVERALL STUDY|discontinued follow up|0|||
48324094|NCT03066609|155385141|FG003|OVERALL STUDY|discontinued follow up|0|||
48324095|NCT02284113|155385142|FG000|Overall Study|Adverse Event|1|||
48324096|NCT02284113|155385143|FG001|Overall Study|Adverse Event|0|||
48324097|NCT02284113|155385142|FG000|Overall Study|non-compliance|0|||
48627734|NCT02144337|156496023|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
48627735|NCT02144337|156496024|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
48741919|NCT02202980|156904378|FG001|Overall Study|Lack of Efficacy|0|||
48741920|NCT02202980|156904379|FG002|Overall Study|Lack of Efficacy|7|||
48324098|NCT02284113|155385143|FG001|Overall Study|non-compliance|1|||
48324099|NCT02284113|155385142|FG000|Overall Study|Withdrawal by Subject|0|||
48324100|NCT02284113|155385143|FG001|Overall Study|Withdrawal by Subject|1|||
48324101|NCT02284113|155385142|FG000|Overall Study|not provided|0|||
48741921|NCT02202980|156904380|FG003|Overall Study|Lack of Efficacy|0|||
48324102|NCT02284113|155385143|FG001|Overall Study|not provided|1|||
48324103|NCT02284113|155385142|FG000|Overall Study|surgery cancelled|2|||
48324104|NCT02284113|155385143|FG001|Overall Study|surgery cancelled|0|||
48324105|NCT02275611|155385144|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
48627736|NCT00203242|156496027|FG000|Overall Study|Lost to Follow-up|1|||
48627737|NCT03449147|156496029|FG000|52-week Treatment Period|Death|0|||
48627738|NCT03449147|156496030|FG001|52-week Treatment Period|Death|1|||
48627739|NCT03449147|156496031|FG002|52-week Treatment Period|Death|0|||
48627740|NCT03449147|156496029|FG000|52-week Treatment Period|Lost to Follow-up|6|||
48627741|NCT03449147|156496030|FG001|52-week Treatment Period|Lost to Follow-up|2|||
48741922|NCT02202980|156904381|FG004|Overall Study|Lack of Efficacy|3|||
48741923|NCT02202980|156904382|FG005|Overall Study|Lack of Efficacy|1|||
48741924|NCT02202980|156904383|FG006|Overall Study|Lack of Efficacy|11|||
48741925|NCT02202980|156904384|FG007|Overall Study|Lack of Efficacy|2|||
48627742|NCT03449147|156496031|FG002|52-week Treatment Period|Lost to Follow-up|5|||
48627743|NCT03449147|156496029|FG000|52-week Treatment Period|Other|0|||
48627744|NCT03449147|156496030|FG001|52-week Treatment Period|Other|1|||
48627745|NCT03449147|156496031|FG002|52-week Treatment Period|Other|2|||
48627746|NCT03449147|156496029|FG000|52-week Treatment Period|Physician Decision|1|||
48627747|NCT03449147|156496030|FG001|52-week Treatment Period|Physician Decision|0|||
48627748|NCT03449147|156496031|FG002|52-week Treatment Period|Physician Decision|3|||
48627749|NCT03449147|156496029|FG000|52-week Treatment Period|Screen Failure|1|||
48627750|NCT03449147|156496030|FG001|52-week Treatment Period|Screen Failure|2|||
48741926|NCT02202980|156904385|FG008|Overall Study|Lack of Efficacy|2|||
48741927|NCT02202980|156904386|FG009|Overall Study|Lack of Efficacy|0|||
48324106|NCT02275611|155385145|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
48324107|NCT02275611|155385146|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
48741928|NCT02202980|156904387|FG010|Overall Study|Lack of Efficacy|0|||
48741929|NCT02202980|156904388|FG011|Overall Study|Lack of Efficacy|3|||
48324108|NCT02275611|155385147|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
48324109|NCT01171976|155385149|FG000|Overall Study|Protocol Violation|0|||
48324110|NCT01171976|155385150|FG001|Overall Study|Protocol Violation|0|||
48324111|NCT01171976|155385151|FG002|Overall Study|Protocol Violation|1|||
48324112|NCT01171976|155385149|FG000|Overall Study|Death|2|||
48324113|NCT01171976|155385150|FG001|Overall Study|Death|4|||
48324114|NCT01171976|155385151|FG002|Overall Study|Death|1|||
48324115|NCT01171976|155385149|FG000|Overall Study|Lost to Follow-up|4|||
48324116|NCT01171976|155385150|FG001|Overall Study|Lost to Follow-up|0|||
48324117|NCT01171976|155385151|FG002|Overall Study|Lost to Follow-up|2|||
48627751|NCT03449147|156496031|FG002|52-week Treatment Period|Screen Failure|0|||
48627752|NCT03449147|156496029|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
48627753|NCT03449147|156496030|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
48627754|NCT03449147|156496031|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
48627755|NCT03449147|156496029|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
48627756|NCT03449147|156496030|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
48627757|NCT03449147|156496031|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
48627758|NCT03449147|156496029|FG000|12-Week Off-Treatment Durability Period|Other|0|||
48627759|NCT03449147|156496030|FG001|12-Week Off-Treatment Durability Period|Other|1|||
48627760|NCT03449147|156496031|FG002|12-Week Off-Treatment Durability Period|Other|0|||
48627761|NCT00605657|156496032|FG000|Overall Study|Adverse Event|1|||
48627762|NCT00605657|156496032|FG000|Overall Study|Protocol Violation|1|||
48627763|NCT01050218|156496033|FG000|Overall Study|Adverse Event|37|||
48627764|NCT01050218|156496033|FG000|Overall Study|Lack of Efficacy|8|||
48627765|NCT01050218|156496033|FG000|Overall Study|Protocol Violation|3|||
48627766|NCT01050218|156496033|FG000|Overall Study|Withdrawal by Subject|18|||
48627767|NCT01050218|156496033|FG000|Overall Study|Discontinued by sponsor|18|||
48627768|NCT01050218|156496033|FG000|Overall Study|Compliance|2|||
48627769|NCT01050218|156496033|FG000|Overall Study|Failed to return|7|||
48627770|NCT01050218|156496033|FG000|Overall Study|Serious Adverse Event|1|||
48627771|NCT01050218|156496033|FG000|Overall Study|Family emergency|1|||
48627772|NCT01959919|156496034|FG000|Overall Study|Did not meet the eligibility criteria|2|||
48627773|NCT01550965|156496039|FG000|Overall Study|Adverse Event|26|||
48741930|NCT02202980|156904389|FG012|Overall Study|Lack of Efficacy|10|||
48741931|NCT02202980|156904390|FG013|Overall Study|Lack of Efficacy|0|||
48324118|NCT01171976|155385149|FG000|Overall Study|Withdrawal by Subject|1|||
48324119|NCT01171976|155385150|FG001|Overall Study|Withdrawal by Subject|5|||
48324120|NCT01171976|155385151|FG002|Overall Study|Withdrawal by Subject|6|||
48324121|NCT01171976|155385149|FG000|Overall Study|Abnormal test result|1|||
48324122|NCT01171976|155385150|FG001|Overall Study|Abnormal test result|0|||
48324123|NCT01171976|155385151|FG002|Overall Study|Abnormal test result|0|||
48627774|NCT01550965|156496039|FG000|Overall Study|Withdrawal by Subject|10|||
48627775|NCT01550965|156496039|FG000|Overall Study|Lost to Follow-up|2|||
48627776|NCT01550965|156496039|FG000|Overall Study|Lack of Efficacy|59|||
48627777|NCT01550965|156496039|FG000|Overall Study|Other|13|||
48627778|NCT04691115|156496044|FG000|Overall Study|Withdrawal by Subject|0|||
48741932|NCT02202980|156904377|FG000|Overall Study|Protocol Violation|0|||
48324124|NCT01171976|155385149|FG000|Overall Study|Adverse Event|6|||
48627779|NCT04691115|156496045|FG001|Overall Study|Withdrawal by Subject|0|||
48627780|NCT04691115|156496046|FG002|Overall Study|Withdrawal by Subject|0|||
48741933|NCT02202980|156904378|FG001|Overall Study|Protocol Violation|0|||
48741934|NCT02202980|156904379|FG002|Overall Study|Protocol Violation|0|||
48627781|NCT04691115|156496047|FG003|Overall Study|Withdrawal by Subject|0|||
48741935|NCT02202980|156904380|FG003|Overall Study|Protocol Violation|3|||
48741936|NCT02202980|156904381|FG004|Overall Study|Protocol Violation|3|||
48741937|NCT02202980|156904382|FG005|Overall Study|Protocol Violation|0|||
48741938|NCT02202980|156904383|FG006|Overall Study|Protocol Violation|0|||
48741939|NCT02202980|156904384|FG007|Overall Study|Protocol Violation|0|||
48741940|NCT02202980|156904385|FG008|Overall Study|Protocol Violation|0|||
48741941|NCT02202980|156904386|FG009|Overall Study|Protocol Violation|0|||
48741942|NCT02202980|156904387|FG010|Overall Study|Protocol Violation|0|||
48741943|NCT02202980|156904388|FG011|Overall Study|Protocol Violation|0|||
48741944|NCT02202980|156904389|FG012|Overall Study|Protocol Violation|0|||
48741945|NCT02202980|156904390|FG013|Overall Study|Protocol Violation|0|||
48741946|NCT02202980|156904377|FG000|Overall Study|Lost to Follow-up|0|||
48741947|NCT02202980|156904378|FG001|Overall Study|Lost to Follow-up|1|||
48741948|NCT02202980|156904379|FG002|Overall Study|Lost to Follow-up|1|||
48741949|NCT02202980|156904380|FG003|Overall Study|Lost to Follow-up|1|||
48741950|NCT02202980|156904381|FG004|Overall Study|Lost to Follow-up|0|||
48741951|NCT02202980|156904382|FG005|Overall Study|Lost to Follow-up|0|||
48741952|NCT02202980|156904383|FG006|Overall Study|Lost to Follow-up|0|||
48741953|NCT02202980|156904384|FG007|Overall Study|Lost to Follow-up|1|||
48741954|NCT02202980|156904385|FG008|Overall Study|Lost to Follow-up|1|||
48627782|NCT04691115|156496048|FG004|Overall Study|Withdrawal by Subject|0|||
48627783|NCT04691115|156496049|FG005|Overall Study|Withdrawal by Subject|1|||
48627784|NCT04691115|156496050|FG006|Overall Study|Withdrawal by Subject|0|||
48627785|NCT04691115|156496051|FG007|Overall Study|Withdrawal by Subject|0|||
48627786|NCT04691115|156496052|FG008|Overall Study|Withdrawal by Subject|0|||
48627787|NCT04691115|156496053|FG009|Overall Study|Withdrawal by Subject|0|||
48627788|NCT04691115|156496054|FG010|Overall Study|Withdrawal by Subject|0|||
48627789|NCT04691115|156496055|FG011|Overall Study|Withdrawal by Subject|0|||
48627790|NCT04691115|156496056|FG012|Overall Study|Withdrawal by Subject|0|||
48627791|NCT04691115|156496057|FG013|Overall Study|Withdrawal by Subject|0|||
48627792|NCT01472185|156496063|FG000|Overall Study|Randomized but Not Treated|0|||
48627793|NCT01472185|156496064|FG001|Overall Study|Randomized but Not Treated|1|||
48627794|NCT01472185|156496063|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
48627795|NCT01472185|156496064|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
48627796|NCT01472185|156496063|FG000|Overall Study|Hyperglycemia|5|||
48627797|NCT01472185|156496064|FG001|Overall Study|Hyperglycemia|2|||
48627798|NCT01472185|156496063|FG000|Overall Study|Investigator's Discretion|3|||
48627799|NCT01472185|156496064|FG001|Overall Study|Investigator's Discretion|1|||
48627800|NCT01472185|156496063|FG000|Overall Study|Lost to Follow-up|4|||
48627801|NCT01472185|156496064|FG001|Overall Study|Lost to Follow-up|1|||
48627802|NCT01472185|156496063|FG000|Overall Study|Protocol Violation|5|||
48627803|NCT01472185|156496064|FG001|Overall Study|Protocol Violation|1|||
48627804|NCT01472185|156496063|FG000|Overall Study|Subject Noncompliance|8|||
48627805|NCT01472185|156496064|FG001|Overall Study|Subject Noncompliance|15|||
48627806|NCT01472185|156496063|FG000|Overall Study|Subject Withdrew Consent|6|||
48627807|NCT01472185|156496064|FG001|Overall Study|Subject Withdrew Consent|3|||
48627808|NCT00979407|156496067|FG000|Overall Study|Withdrawal by Subject|3|||
48627809|NCT00979407|156496068|FG001|Overall Study|Withdrawal by Subject|4|||
48627810|NCT00979407|156496067|FG000|Overall Study|Lost to Follow-up|3|||
48627811|NCT00979407|156496068|FG001|Overall Study|Lost to Follow-up|3|||
48627812|NCT01166646|156496069|FG000|Overall Study|Protocol Violation|0|||
48627813|NCT01166646|156496070|FG001|Overall Study|Protocol Violation|1|||
48627814|NCT01166646|156496069|FG000|Overall Study|Adverse Event|1|||
48627815|NCT01166646|156496070|FG001|Overall Study|Adverse Event|0|||
48627816|NCT00437073|156496071|FG000|Overall Study|Sponsor Terminated Study|1|||
48627817|NCT00437073|156496072|FG001|Overall Study|Sponsor Terminated Study|0|||
48627818|NCT00437073|156496071|FG000|Overall Study|Physician Decision|0|||
48627819|NCT00437073|156496072|FG001|Overall Study|Physician Decision|1|||
48627820|NCT01422382|156496076|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
48627821|NCT05535972|156496082|FG000|Overall Study|Withdrawal by Subject|31|||
48627822|NCT05535972|156496082|FG000|Overall Study|Lost to Follow-up|5|||
48627823|NCT05535972|156496082|FG000|Overall Study|Adverse Event|6|||
48627824|NCT05535972|156496082|FG000|Overall Study|Protocol Deviation|2|||
48627825|NCT04507269|156496083|FG000|Overall Study|Withdrawal by Subject|1|||
48627826|NCT04507269|156496084|FG001|Overall Study|Withdrawal by Subject|1|||
48741955|NCT02202980|156904386|FG009|Overall Study|Lost to Follow-up|0|||
48741956|NCT02202980|156904387|FG010|Overall Study|Lost to Follow-up|0|||
48741957|NCT02202980|156904388|FG011|Overall Study|Lost to Follow-up|0|||
48741958|NCT02202980|156904389|FG012|Overall Study|Lost to Follow-up|1|||
48741959|NCT02202980|156904390|FG013|Overall Study|Lost to Follow-up|0|||
48627827|NCT04507269|156496085|FG002|Overall Study|Withdrawal by Subject|0|||
48627828|NCT04507269|156496086|FG003|Overall Study|Withdrawal by Subject|0|||
48627829|NCT04507269|156496087|FG004|Overall Study|Withdrawal by Subject|0|||
48741960|NCT02202980|156904377|FG000|Overall Study|Withdrew Consent|0|||
48324125|NCT01171976|155385150|FG001|Overall Study|Adverse Event|2|||
48627830|NCT04507269|156496088|FG005|Overall Study|Withdrawal by Subject|0|||
48627831|NCT04507269|156496083|FG000|Overall Study|Lost to Follow-up|0|||
48627832|NCT04507269|156496084|FG001|Overall Study|Lost to Follow-up|0|||
48627833|NCT04507269|156496085|FG002|Overall Study|Lost to Follow-up|0|||
48627834|NCT04507269|156496086|FG003|Overall Study|Lost to Follow-up|0|||
48627835|NCT04507269|156496087|FG004|Overall Study|Lost to Follow-up|1|||
48627836|NCT04507269|156496088|FG005|Overall Study|Lost to Follow-up|0|||
48627837|NCT04134936|156496089|FG000|Overall Study|Adverse Event|3|||
48627838|NCT04134936|156496090|FG001|Overall Study|Adverse Event|2|||
48627839|NCT04134936|156496089|FG000|Overall Study|Withdrawal by Subject|2|||
48627840|NCT04134936|156496090|FG001|Overall Study|Withdrawal by Subject|3|||
48627841|NCT04134936|156496089|FG000|Overall Study|Physician Decision|0|||
48627842|NCT04134936|156496090|FG001|Overall Study|Physician Decision|1|||
48627843|NCT04134936|156496089|FG000|Overall Study|Progressive disease, joined another trial|1|||
48627844|NCT04134936|156496090|FG001|Overall Study|Progressive disease, joined another trial|0|||
48627845|NCT04134936|156496089|FG000|Overall Study|Progressive disease|1|||
48627846|NCT04134936|156496090|FG001|Overall Study|Progressive disease|0|||
48627847|NCT01903863|156496091|FG000|Overall Study|Physician Decision|2|||
48627848|NCT01903863|156496092|FG001|Overall Study|Physician Decision|0|||
48627849|NCT04903093|156496094|FG000|Overall Study|Withdrawal by Subject|0|||
48627850|NCT04903093|156496095|FG001|Overall Study|Withdrawal by Subject|0|||
48627851|NCT04903093|156496096|FG002|Overall Study|Withdrawal by Subject|0|||
48627852|NCT04903093|156496097|FG003|Overall Study|Withdrawal by Subject|1|||
48627853|NCT04903093|156496098|FG004|Overall Study|Withdrawal by Subject|0|||
48627854|NCT04903093|156496099|FG005|Overall Study|Withdrawal by Subject|0|||
48627855|NCT00392288|156496102|FG000|Overall Study|Adverse Event|17|||
48627856|NCT00392288|156496103|FG001|Overall Study|Adverse Event|7|||
48627857|NCT00392288|156496104|FG002|Overall Study|Adverse Event|8|||
48627858|NCT00392288|156496102|FG000|Overall Study|Lack of Efficacy|8|||
48627859|NCT00392288|156496103|FG001|Overall Study|Lack of Efficacy|5|||
48627860|NCT00392288|156496104|FG002|Overall Study|Lack of Efficacy|3|||
48627861|NCT00392288|156496102|FG000|Overall Study|Protocol Violation|1|||
48627862|NCT00392288|156496103|FG001|Overall Study|Protocol Violation|3|||
48627863|NCT00392288|156496104|FG002|Overall Study|Protocol Violation|1|||
48627864|NCT00392288|156496102|FG000|Overall Study|Lost to Follow-up|1|||
48627865|NCT00392288|156496103|FG001|Overall Study|Lost to Follow-up|1|||
48627866|NCT00392288|156496104|FG002|Overall Study|Lost to Follow-up|1|||
48627867|NCT00392288|156496102|FG000|Overall Study|Withdrawal by Subject|1|||
48627868|NCT00392288|156496103|FG001|Overall Study|Withdrawal by Subject|0|||
48627869|NCT00392288|156496104|FG002|Overall Study|Withdrawal by Subject|2|||
48627870|NCT00392288|156496102|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
48627871|NCT00392288|156496103|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
48627872|NCT00392288|156496104|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
48627873|NCT00392288|156496102|FG000|Overall Study|Other|3|||
48627874|NCT00392288|156496103|FG001|Overall Study|Other|4|||
48627875|NCT00392288|156496104|FG002|Overall Study|Other|1|||
48627876|NCT01027351|156496105|FG000|Overall Study|Withdrawal by Subject|1|||
48627877|NCT01027351|156496106|FG001|Overall Study|Withdrawal by Subject|0|||
48627878|NCT01027351|156496107|FG002|Overall Study|Withdrawal by Subject|1|||
48627879|NCT01027351|156496108|FG003|Overall Study|Withdrawal by Subject|0|||
48627880|NCT01027351|156496109|FG004|Overall Study|Withdrawal by Subject|3|||
48627881|NCT01027351|156496110|FG005|Overall Study|Withdrawal by Subject|5|||
48627882|NCT01027351|156496105|FG000|Overall Study|Lost to Follow-up|1|||
48627883|NCT01027351|156496106|FG001|Overall Study|Lost to Follow-up|1|||
48627884|NCT01027351|156496107|FG002|Overall Study|Lost to Follow-up|0|||
48627885|NCT01027351|156496108|FG003|Overall Study|Lost to Follow-up|1|||
48627886|NCT01027351|156496109|FG004|Overall Study|Lost to Follow-up|6|||
48627887|NCT01027351|156496110|FG005|Overall Study|Lost to Follow-up|0|||
48627888|NCT01027351|156496105|FG000|Overall Study|Inappropriate enrollment|0|||
48627889|NCT01027351|156496106|FG001|Overall Study|Inappropriate enrollment|0|||
48627890|NCT01027351|156496107|FG002|Overall Study|Inappropriate enrollment|0|||
48627891|NCT01027351|156496108|FG003|Overall Study|Inappropriate enrollment|0|||
48627892|NCT01027351|156496109|FG004|Overall Study|Inappropriate enrollment|1|||
48627893|NCT01027351|156496110|FG005|Overall Study|Inappropriate enrollment|0|||
48627894|NCT01027351|156496105|FG000|Overall Study|Protocol Violation|1|||
48627895|NCT01027351|156496106|FG001|Overall Study|Protocol Violation|0|||
48627896|NCT01027351|156496107|FG002|Overall Study|Protocol Violation|0|||
48627897|NCT01027351|156496108|FG003|Overall Study|Protocol Violation|1|||
48627898|NCT01027351|156496109|FG004|Overall Study|Protocol Violation|1|||
48627899|NCT01027351|156496110|FG005|Overall Study|Protocol Violation|0|||
48627900|NCT00480025|156496112|FG000|Overall Study|Protocol Violation|12|||
48627901|NCT00480025|156496113|FG001|Overall Study|Protocol Violation|7|||
48627902|NCT00480025|156496112|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
48627903|NCT00480025|156496113|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
48627904|NCT00480025|156496112|FG000|Overall Study|Disease Progression / Recurrence|449|||
48627905|NCT00480025|156496113|FG001|Overall Study|Disease Progression / Recurrence|224|||
48627906|NCT00480025|156496112|FG000|Overall Study|Adverse Event|44|||
48324126|NCT01171976|155385151|FG002|Overall Study|Adverse Event|5|||
48324127|NCT00003222|155385152|FG000|Overall Study|Physician Decision|0|||
48324128|NCT00003222|155385153|FG001|Overall Study|Physician Decision|1|||
48324129|NCT00756574|155385171|FG000|Overall Study|Withdrawal by Subject|9|||
48324130|NCT00756574|155385172|FG001|Overall Study|Withdrawal by Subject|7|||
48627907|NCT00480025|156496113|FG001|Overall Study|Adverse Event|12|||
48627908|NCT00480025|156496112|FG000|Overall Study|Other|70|||
48627909|NCT00480025|156496113|FG001|Overall Study|Other|29|||
48627910|NCT00480025|156496112|FG000|Overall Study|SAE including intercurrent illness|76|||
48627911|NCT00480025|156496113|FG001|Overall Study|SAE including intercurrent illness|42|||
48324131|NCT00756574|155385171|FG000|Overall Study|Lost to Follow-up|4|||
48741961|NCT02202980|156904378|FG001|Overall Study|Withdrew Consent|1|||
48627912|NCT01500135|156497229|FG000|Overall Study|Withdrawal of Consent|4|||
48627913|NCT01500135|156497230|FG001|Overall Study|Withdrawal of Consent|0|||
48627914|NCT01500135|156497229|FG000|Overall Study|Lost to Follow-up|6|||
48627915|NCT01500135|156497230|FG001|Overall Study|Lost to Follow-up|4|||
48627916|NCT01500135|156497229|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
48627917|NCT01500135|156497230|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
48627918|NCT01500135|156497229|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
48627919|NCT01500135|156497230|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
48627920|NCT01500135|156497229|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
48627921|NCT01500135|156497230|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
48627922|NCT01500135|156497229|FG000|Overall Study|Participant was a Safety Concern|1|||
48627923|NCT01500135|156497230|FG001|Overall Study|Participant was a Safety Concern|0|||
48627924|NCT01500135|156497229|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
48627925|NCT01500135|156497230|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
48627926|NCT02180672|156497231|FG000|Overall Study|Lost to Follow-up|5|||
48627927|NCT02180672|156497232|FG001|Overall Study|Lost to Follow-up|7|||
48627928|NCT00661687|156497234|FG000|Overall Study|Study related symptoms and complaints|5|||
48627929|NCT00661687|156497234|FG000|Overall Study|Positive slit lamp findings|4|||
48627930|NCT00661687|156497234|FG000|Overall Study|Inability to maintain wearing schedule|3|||
48627931|NCT00661687|156497234|FG000|Overall Study|Physician Decision|1|||
48627932|NCT00661687|156497234|FG000|Overall Study|Adverse Event|2|||
48627933|NCT00003907|156497235|FG000|Overall Study|Adverse Event|2|||
48627934|NCT00003907|156497236|FG001|Overall Study|Adverse Event|11|||
48627935|NCT00003907|156497235|FG000|Overall Study|Death|2|||
48627936|NCT00003907|156497236|FG001|Overall Study|Death|0|||
48627937|NCT00003907|156497235|FG000|Overall Study|Withdrawal by Subject|1|||
48627938|NCT00003907|156497236|FG001|Overall Study|Withdrawal by Subject|3|||
48627939|NCT00003907|156497235|FG000|Overall Study|Progressive disease|4|||
48627940|NCT00003907|156497236|FG001|Overall Study|Progressive disease|4|||
48627941|NCT00003907|156497235|FG000|Overall Study|Complicating disease|1|||
48627942|NCT00003907|156497236|FG001|Overall Study|Complicating disease|0|||
48627943|NCT00003907|156497235|FG000|Overall Study|Other|1|||
48627944|NCT00003907|156497236|FG001|Overall Study|Other|3|||
48741962|NCT02202980|156904379|FG002|Overall Study|Withdrew Consent|2|||
48741963|NCT02202980|156904380|FG003|Overall Study|Withdrew Consent|0|||
48741964|NCT02202980|156904381|FG004|Overall Study|Withdrew Consent|0|||
48741965|NCT02202980|156904382|FG005|Overall Study|Withdrew Consent|0|||
48741966|NCT02202980|156904383|FG006|Overall Study|Withdrew Consent|0|||
48741967|NCT02202980|156904384|FG007|Overall Study|Withdrew Consent|0|||
48741968|NCT02202980|156904385|FG008|Overall Study|Withdrew Consent|1|||
48741969|NCT02202980|156904386|FG009|Overall Study|Withdrew Consent|0|||
48741970|NCT02202980|156904387|FG010|Overall Study|Withdrew Consent|0|||
48741971|NCT02202980|156904388|FG011|Overall Study|Withdrew Consent|0|||
48741972|NCT02202980|156904389|FG012|Overall Study|Withdrew Consent|0|||
48741973|NCT02202980|156904390|FG013|Overall Study|Withdrew Consent|0|||
48741974|NCT03641339|156904397|FG000|Overall Study|Physician Decision|1|||
48741975|NCT03641339|156904398|FG001|Overall Study|Physician Decision|0|||
48741976|NCT03641339|156904399|FG002|Overall Study|Physician Decision|0|||
48741977|NCT03641339|156904400|FG003|Overall Study|Physician Decision|0|||
48741978|NCT03641339|156904401|FG004|Overall Study|Physician Decision|0|||
48741979|NCT03641339|156904402|FG005|Overall Study|Physician Decision|0|||
48741980|NCT03641339|156904397|FG000|Overall Study|Withdrawal by Subject|0|||
48741981|NCT03641339|156904398|FG001|Overall Study|Withdrawal by Subject|2|||
48741982|NCT03641339|156904399|FG002|Overall Study|Withdrawal by Subject|0|||
48741983|NCT03641339|156904400|FG003|Overall Study|Withdrawal by Subject|2|||
48741984|NCT03641339|156904401|FG004|Overall Study|Withdrawal by Subject|0|||
48741985|NCT03641339|156904402|FG005|Overall Study|Withdrawal by Subject|1|||
48741986|NCT02296320|156904405|FG000|Overall Study|Withdrawal by Subject|4|||
48741987|NCT02296320|156904406|FG001|Overall Study|Withdrawal by Subject|0|||
48741988|NCT02296320|156904407|FG002|Overall Study|Withdrawal by Subject|2|||
48741989|NCT02296320|156904405|FG000|Overall Study|Death|24|||
48741990|NCT02296320|156904406|FG001|Overall Study|Death|3|||
48741991|NCT02296320|156904407|FG002|Overall Study|Death|27|||
48741992|NCT02296320|156904405|FG000|Overall Study|Lost to Follow-up|5|||
48627945|NCT00003907|156497235|FG000|Overall Study|ineligible or not treated|2|||
48627946|NCT00003907|156497236|FG001|Overall Study|ineligible or not treated|2|||
48627947|NCT01904279|156497243|FG000|Overall Study|Lack of Efficacy|2|||
48627948|NCT01904279|156497244|FG001|Overall Study|Lack of Efficacy|3|||
48741993|NCT02296320|156904406|FG001|Overall Study|Lost to Follow-up|2|||
48741994|NCT02296320|156904407|FG002|Overall Study|Lost to Follow-up|7|||
48741995|NCT02296320|156904405|FG000|Overall Study|Not treated|2|||
48741996|NCT02296320|156904406|FG001|Overall Study|Not treated|0|||
48741997|NCT02296320|156904407|FG002|Overall Study|Not treated|0|||
48627949|NCT01904279|156497243|FG000|Overall Study|Withdrawal by Subject|1|||
48627950|NCT01904279|156497244|FG001|Overall Study|Withdrawal by Subject|0|||
48627951|NCT03439072|156497247|FG000|Overall Study|Withdrawal by Subject|2|||
48741998|NCT02296320|156904405|FG000|Overall Study|Not - specified|0|||
48741999|NCT02296320|156904406|FG001|Overall Study|Not - specified|0|||
48324132|NCT00756574|155385172|FG001|Overall Study|Lost to Follow-up|4|||
48324133|NCT02787005|155385176|FG000|Overall Study|Adverse Event|24|||
48324134|NCT02787005|155385177|FG001|Overall Study|Adverse Event|9|||
48324135|NCT02787005|155385178|FG002|Overall Study|Adverse Event|9|||
48324136|NCT02787005|155385179|FG003|Overall Study|Adverse Event|7|||
48324137|NCT02787005|155385180|FG004|Overall Study|Adverse Event|2|||
48324138|NCT02787005|155385176|FG000|Overall Study|Death|100|||
48324139|NCT02787005|155385177|FG001|Overall Study|Death|53|||
48324140|NCT02787005|155385178|FG002|Overall Study|Death|48|||
48324141|NCT02787005|155385179|FG003|Overall Study|Death|69|||
48324142|NCT02787005|155385180|FG004|Overall Study|Death|38|||
48324143|NCT02787005|155385176|FG000|Overall Study|Sponsor Decision|7|||
48324144|NCT02787005|155385177|FG001|Overall Study|Sponsor Decision|4|||
48324145|NCT02787005|155385178|FG002|Overall Study|Sponsor Decision|0|||
48324146|NCT02787005|155385179|FG003|Overall Study|Sponsor Decision|4|||
48324147|NCT02787005|155385180|FG004|Overall Study|Sponsor Decision|5|||
48324148|NCT02787005|155385176|FG000|Overall Study|Withdrawal by Subject|2|||
48324149|NCT02787005|155385177|FG001|Overall Study|Withdrawal by Subject|1|||
48324150|NCT02787005|155385178|FG002|Overall Study|Withdrawal by Subject|1|||
48324151|NCT02787005|155385179|FG003|Overall Study|Withdrawal by Subject|0|||
48742000|NCT02296320|156904407|FG002|Overall Study|Not - specified|1|||
48742001|NCT01781975|156904408|FG000|Overall Study|Death|1|||
48742002|NCT01781975|156904409|FG001|Overall Study|Death|0|||
48742003|NCT01781975|156904408|FG000|Overall Study|Withdrawal by Subject|1|||
48742004|NCT01781975|156904409|FG001|Overall Study|Withdrawal by Subject|1|||
48742005|NCT01622231|156904410|FG000|Overall Study|Physician Decision|1|||
48742006|NCT01622231|156904410|FG000|Overall Study|Withdrawal by Subject|1|||
48742007|NCT01447433|156904413|FG000|Overall Study|Lost to Follow-up|0|||
48742008|NCT01447433|156904414|FG001|Overall Study|Lost to Follow-up|2|||
48742009|NCT01447433|156904413|FG000|Overall Study|Withdrawal by Subject|3|||
48324152|NCT02787005|155385180|FG004|Overall Study|Withdrawal by Subject|1|||
48324153|NCT02787005|155385176|FG000|Overall Study|Screen Failure|0|||
48324154|NCT02787005|155385177|FG001|Overall Study|Screen Failure|2|||
48627952|NCT03439072|156497248|FG001|Overall Study|Withdrawal by Subject|3|||
48627953|NCT03439072|156497247|FG000|Overall Study|Physician Decision|0|||
48627954|NCT03439072|156497248|FG001|Overall Study|Physician Decision|1|||
48627955|NCT03906071|156497250|FG000|Overall Study|Death|180|||
48627956|NCT03906071|156497251|FG001|Overall Study|Death|185|||
48627957|NCT03906071|156497250|FG000|Overall Study|Lost to Follow-up|3|||
48627958|NCT03906071|156497251|FG001|Overall Study|Lost to Follow-up|3|||
48627959|NCT03906071|156497250|FG000|Overall Study|Withdrawal by Subject|15|||
48627960|NCT03906071|156497251|FG001|Overall Study|Withdrawal by Subject|27|||
48627961|NCT03906071|156497250|FG000|Overall Study|Other|2|||
48627962|NCT03906071|156497251|FG001|Overall Study|Other|1|||
48627963|NCT00814983|156497252|FG000|Overall Study|Screen failure|1|||
48627964|NCT00814983|156497253|FG001|Overall Study|Screen failure|0|||
48627965|NCT00814983|156497252|FG000|Overall Study|Withdrawal by Subject|1|||
48627966|NCT00814983|156497253|FG001|Overall Study|Withdrawal by Subject|0|||
48627967|NCT00814983|156497252|FG000|Overall Study|Graft failure|1|||
48627968|NCT00814983|156497253|FG001|Overall Study|Graft failure|0|||
48627969|NCT02150863|156497257|FG000|Overall Study|Lost to Follow-up|0|||
48627970|NCT02150863|156497258|FG001|Overall Study|Lost to Follow-up|1|||
48627971|NCT02150863|156497259|FG002|Overall Study|Lost to Follow-up|0|||
48627972|NCT03729609|156497260|FG000|Overall Study|Protocol Violation|1|||
48627973|NCT01416831|156497262|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
48627974|NCT01416831|156497263|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
48627975|NCT00830336|156497264|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
48627976|NCT00830336|156497265|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
48627977|NCT06582732|156497271|FG000|Initial Study Period|Adverse Event|0|||
48627978|NCT06582732|156497272|FG001|Initial Study Period|Adverse Event|0|||
48627979|NCT06582732|156497273|FG002|Initial Study Period|Adverse Event|0|||
48627980|NCT06582732|156497274|FG003|Initial Study Period|Adverse Event|2|||
48627981|NCT06582732|156497275|FG004|Initial Study Period|Adverse Event|0|||
48627982|NCT06582732|156497276|FG005|Initial Study Period|Adverse Event|0|||
48627983|NCT06582732|156497277|FG006|Initial Study Period|Adverse Event|0|||
48627984|NCT06582732|156497271|FG000|Initial Study Period|Death|1|||
48742010|NCT01447433|156904414|FG001|Overall Study|Withdrawal by Subject|3|||
48742011|NCT01447433|156904413|FG000|Overall Study|Protocol Violation|1|||
48742012|NCT01447433|156904414|FG001|Overall Study|Protocol Violation|1|||
48742013|NCT00621582|156904415|FG000|Overall Study|Adverse Event|7|||
48742014|NCT00621582|156904415|FG000|Overall Study|Protocol Violation|57|||
48324155|NCT02787005|155385178|FG002|Overall Study|Screen Failure|0|||
48324156|NCT02787005|155385179|FG003|Overall Study|Screen Failure|0|||
48324157|NCT02787005|155385180|FG004|Overall Study|Screen Failure|1|||
48324158|NCT02787005|155385176|FG000|Overall Study|Lost to Follow-up|0|||
48324159|NCT02787005|155385177|FG001|Overall Study|Lost to Follow-up|0|||
48324160|NCT02787005|155385178|FG002|Overall Study|Lost to Follow-up|0|||
48742015|NCT00621582|156904415|FG000|Overall Study|Lost to Follow-up|24|||
48798212|NCT00441701|157098568|FG007|Overall Study|Lack of Efficacy|0|||
48324161|NCT02787005|155385179|FG003|Overall Study|Lost to Follow-up|1|||
48324162|NCT02787005|155385180|FG004|Overall Study|Lost to Follow-up|0|||
48324163|NCT02029235|155385183|FG000|Overall Study|Non-compliance with study meds or diary|4|||
48324164|NCT02029235|155385184|FG001|Overall Study|Non-compliance with study meds or diary|1|||
48324165|NCT03246724|155385186|FG000|Overall Study|Withdrawal by Subject|5|||
48324166|NCT03246724|155385187|FG001|Overall Study|Withdrawal by Subject|2|||
48324167|NCT03246724|155385188|FG002|Overall Study|Withdrawal by Subject|4|||
48324168|NCT03246724|155385189|FG003|Overall Study|Withdrawal by Subject|2|||
48324169|NCT03246724|155385186|FG000|Overall Study|Ineligible on day of surgery|7|||
48324170|NCT03246724|155385187|FG001|Overall Study|Ineligible on day of surgery|2|||
48324171|NCT03246724|155385188|FG002|Overall Study|Ineligible on day of surgery|0|||
48324172|NCT03246724|155385189|FG003|Overall Study|Ineligible on day of surgery|3|||
48324173|NCT03246724|155385186|FG000|Overall Study|Study completed before surgical date|2|||
48324174|NCT03246724|155385187|FG001|Overall Study|Study completed before surgical date|1|||
48324175|NCT03246724|155385188|FG002|Overall Study|Study completed before surgical date|8|||
48324176|NCT03246724|155385189|FG003|Overall Study|Study completed before surgical date|1|||
48324177|NCT03246724|155385186|FG000|Overall Study|Transferred to other arm|0|||
48324178|NCT03246724|155385187|FG001|Overall Study|Transferred to other arm|0|||
48324179|NCT03246724|155385188|FG002|Overall Study|Transferred to other arm|1|||
48324180|NCT03246724|155385189|FG003|Overall Study|Transferred to other arm|0|||
48324181|NCT03246724|155385186|FG000|Overall Study|Unable to obtain medication timely|0|||
48324182|NCT03246724|155385187|FG001|Overall Study|Unable to obtain medication timely|2|||
48324183|NCT03246724|155385188|FG002|Overall Study|Unable to obtain medication timely|2|||
48324184|NCT03246724|155385189|FG003|Overall Study|Unable to obtain medication timely|1|||
48324185|NCT03246724|155385186|FG000|Overall Study|Re-consented to participate|0|||
48324186|NCT03246724|155385187|FG001|Overall Study|Re-consented to participate|0|||
48324187|NCT03246724|155385188|FG002|Overall Study|Re-consented to participate|0|||
48324188|NCT03246724|155385189|FG003|Overall Study|Re-consented to participate|1|||
48324189|NCT03611075|155385195|FG000|Overall Study|Physician Decision|0|||
48324190|NCT03611075|155385196|FG001|Overall Study|Physician Decision|1|||
48324191|NCT03611075|155385197|FG002|Overall Study|Physician Decision|1|||
48324192|NCT03611075|155385198|FG003|Overall Study|Physician Decision|0|||
48324193|NCT03611075|155385199|FG004|Overall Study|Physician Decision|0|||
48324194|NCT03611075|155385200|FG005|Overall Study|Physician Decision|0|||
48324195|NCT03611075|155385201|FG006|Overall Study|Physician Decision|0|||
48324196|NCT03611075|155385202|FG007|Overall Study|Physician Decision|0|||
48324197|NCT03611075|155385203|FG008|Overall Study|Physician Decision|0|||
48324198|NCT03611075|155385195|FG000|Overall Study|Lost to Follow-up|1|||
48324199|NCT03611075|155385196|FG001|Overall Study|Lost to Follow-up|0|||
48324200|NCT03611075|155385197|FG002|Overall Study|Lost to Follow-up|0|||
48324201|NCT03611075|155385198|FG003|Overall Study|Lost to Follow-up|2|||
48324202|NCT03611075|155385199|FG004|Overall Study|Lost to Follow-up|0|||
48324203|NCT03611075|155385200|FG005|Overall Study|Lost to Follow-up|0|||
48324204|NCT03611075|155385201|FG006|Overall Study|Lost to Follow-up|0|||
48324205|NCT03611075|155385202|FG007|Overall Study|Lost to Follow-up|0|||
48324206|NCT03611075|155385203|FG008|Overall Study|Lost to Follow-up|0|||
48324207|NCT03611075|155385195|FG000|Overall Study|Withdrawal by Subject|0|||
48324208|NCT03611075|155385196|FG001|Overall Study|Withdrawal by Subject|1|||
48324209|NCT03611075|155385197|FG002|Overall Study|Withdrawal by Subject|1|||
48324210|NCT03611075|155385198|FG003|Overall Study|Withdrawal by Subject|1|||
48324211|NCT03611075|155385199|FG004|Overall Study|Withdrawal by Subject|0|||
48324212|NCT03611075|155385200|FG005|Overall Study|Withdrawal by Subject|0|||
48324213|NCT03611075|155385201|FG006|Overall Study|Withdrawal by Subject|1|||
48324214|NCT03611075|155385202|FG007|Overall Study|Withdrawal by Subject|0|||
48324215|NCT03611075|155385203|FG008|Overall Study|Withdrawal by Subject|0|||
48324216|NCT03611075|155385195|FG000|Overall Study|Reason unknown|0|||
48324217|NCT03611075|155385196|FG001|Overall Study|Reason unknown|0|||
48324218|NCT03611075|155385197|FG002|Overall Study|Reason unknown|0|||
48324219|NCT03611075|155385198|FG003|Overall Study|Reason unknown|1|||
48324220|NCT03611075|155385199|FG004|Overall Study|Reason unknown|0|||
48324221|NCT03611075|155385200|FG005|Overall Study|Reason unknown|0|||
48324222|NCT03611075|155385201|FG006|Overall Study|Reason unknown|1|||
48324223|NCT03611075|155385202|FG007|Overall Study|Reason unknown|0|||
48324224|NCT03611075|155385203|FG008|Overall Study|Reason unknown|0|||
48324225|NCT00676091|155385204|FG000|Infant Series|Parent or legal guardian request|10|||
48324226|NCT00676091|155385205|FG001|Infant Series|Parent or legal guardian request|8|||
48324227|NCT00676091|155385204|FG000|Infant Series|Protocol Violation|6|||
48324228|NCT00676091|155385205|FG001|Infant Series|Protocol Violation|3|||
48324229|NCT00676091|155385204|FG000|Infant Series|Adverse Event|2|||
48324230|NCT00676091|155385205|FG001|Infant Series|Adverse Event|3|||
48742016|NCT00621582|156904415|FG000|Overall Study|issues not identified by investigators|18|||
48742017|NCT03725852|156904416|FG000|Overall Study|Death|1|||
48324231|NCT00676091|155385204|FG000|Infant Series|Failed to return|1|||
48324232|NCT00676091|155385205|FG001|Infant Series|Failed to return|3|||
48324233|NCT00676091|155385204|FG000|Infant Series|Lost to Follow-up|1|||
48324234|NCT00676091|155385205|FG001|Infant Series|Lost to Follow-up|0|||
48324235|NCT00676091|155385204|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
48324236|NCT00676091|155385205|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
48324237|NCT00676091|155385204|FG000|After Infant Series|Adverse Event|0|||
48324238|NCT00676091|155385205|FG001|After Infant Series|Adverse Event|1|||
48324239|NCT00676091|155385204|FG000|After Infant Series|Protocol Violation|0|||
48324240|NCT00676091|155385205|FG001|After Infant Series|Protocol Violation|1|||
48324241|NCT00676091|155385204|FG000|After Infant Series|Failed to return|1|||
48324242|NCT00676091|155385205|FG001|After Infant Series|Failed to return|1|||
48324243|NCT00676091|155385204|FG000|Toddler Dose|Failed to return|2|||
48324244|NCT00676091|155385205|FG001|Toddler Dose|Failed to return|0|||
48324245|NCT00676091|155385204|FG000|Toddler Dose|Parent or legal guardian request|1|||
48324246|NCT00676091|155385205|FG001|Toddler Dose|Parent or legal guardian request|0|||
48324247|NCT01736475|155385207|FG000|Overall Study|Adverse Event|4|||
48324248|NCT01736475|155385208|FG001|Overall Study|Adverse Event|0|||
48324249|NCT01736475|155385207|FG000|Overall Study|Withdrawal by Subject|2|||
48324250|NCT01736475|155385208|FG001|Overall Study|Withdrawal by Subject|0|||
48324251|NCT01736475|155385207|FG000|Overall Study|Protocol Violation|4|||
48324252|NCT01736475|155385208|FG001|Overall Study|Protocol Violation|0|||
48324253|NCT01736475|155385207|FG000|Overall Study|Other - Screen failure|1|||
48324254|NCT01736475|155385208|FG001|Overall Study|Other - Screen failure|0|||
48324255|NCT01736475|155385207|FG000|Overall Study|Other - Surgical procedure|1|||
48324256|NCT01736475|155385208|FG001|Overall Study|Other - Surgical procedure|0|||
48742018|NCT03725852|156904417|FG001|Overall Study|Death|0|||
48742019|NCT03725852|156904416|FG000|Overall Study|Withdrawal by Subject|1|||
48742020|NCT03725852|156904417|FG001|Overall Study|Withdrawal by Subject|0|||
48742021|NCT03725852|156904416|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
48742022|NCT03725852|156904417|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
48742023|NCT02572401|156904429|FG000|Overall Study|Lost to Follow-up|5|||
48742024|NCT02572401|156904430|FG001|Overall Study|Lost to Follow-up|8|||
48324257|NCT02408887|155385209|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
48324258|NCT02408887|155385210|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
48324259|NCT02408887|155385209|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
48324260|NCT02408887|155385210|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
48324261|NCT03539952|155385211|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
48324262|NCT03539952|155385212|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
48324263|NCT03539952|155385211|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
48324264|NCT03539952|155385212|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
48627985|NCT06582732|156497272|FG001|Initial Study Period|Death|0|||
48742025|NCT02572401|156904431|FG002|Overall Study|Lost to Follow-up|9|||
48742026|NCT02572401|156904432|FG003|Overall Study|Lost to Follow-up|9|||
48742027|NCT02572401|156904429|FG000|Overall Study|Death|0|||
48742028|NCT02572401|156904430|FG001|Overall Study|Death|0|||
48742029|NCT02572401|156904431|FG002|Overall Study|Death|0|||
48742030|NCT02572401|156904432|FG003|Overall Study|Death|1|||
48324265|NCT03539952|155385211|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
48324266|NCT03539952|155385212|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
48324267|NCT03539952|155385211|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
48324268|NCT03539952|155385212|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
48324269|NCT03539952|155385211|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
48627986|NCT06582732|156497273|FG002|Initial Study Period|Death|0|||
48627987|NCT06582732|156497274|FG003|Initial Study Period|Death|0|||
48627988|NCT06582732|156497275|FG004|Initial Study Period|Death|1|||
48627989|NCT06582732|156497276|FG005|Initial Study Period|Death|0|||
48451241|NCT00355134|155841605|FG002|Core Phase|Adverse Event|16|||
48627990|NCT06582732|156497277|FG006|Initial Study Period|Death|0|||
48627991|NCT06582732|156497271|FG000|Initial Study Period|Lost to Follow-up|0|||
48627992|NCT06582732|156497272|FG001|Initial Study Period|Lost to Follow-up|0|||
48627993|NCT06582732|156497273|FG002|Initial Study Period|Lost to Follow-up|2|||
48627994|NCT06582732|156497274|FG003|Initial Study Period|Lost to Follow-up|0|||
48627995|NCT06582732|156497275|FG004|Initial Study Period|Lost to Follow-up|0|||
48627996|NCT06582732|156497276|FG005|Initial Study Period|Lost to Follow-up|0|||
48742031|NCT02993757|156904433|FG000|Overall Study|Non compliance with the protocol|155|||
48742032|NCT02993757|156904434|FG001|Overall Study|Non compliance with the protocol|170|||
48627997|NCT06582732|156497277|FG006|Initial Study Period|Lost to Follow-up|0|||
48627998|NCT06582732|156497271|FG000|Initial Study Period|Withdrawal by Subject|0|||
48627999|NCT06582732|156497272|FG001|Initial Study Period|Withdrawal by Subject|1|||
48628000|NCT06582732|156497273|FG002|Initial Study Period|Withdrawal by Subject|0|||
48628001|NCT06582732|156497274|FG003|Initial Study Period|Withdrawal by Subject|1|||
48628002|NCT06582732|156497275|FG004|Initial Study Period|Withdrawal by Subject|3|||
48628003|NCT06582732|156497276|FG005|Initial Study Period|Withdrawal by Subject|1|||
48628004|NCT06582732|156497277|FG006|Initial Study Period|Withdrawal by Subject|2|||
48628005|NCT06582732|156497271|FG000|Initial Study Period|Moved Away|0|||
48628006|NCT06582732|156497272|FG001|Initial Study Period|Moved Away|0|||
48628007|NCT06582732|156497273|FG002|Initial Study Period|Moved Away|0|||
48628008|NCT06582732|156497274|FG003|Initial Study Period|Moved Away|0|||
48628009|NCT06582732|156497275|FG004|Initial Study Period|Moved Away|1|||
48628010|NCT06582732|156497276|FG005|Initial Study Period|Moved Away|0|||
48628011|NCT06582732|156497277|FG006|Initial Study Period|Moved Away|0|||
48628012|NCT00835549|156497278|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
48628013|NCT00835549|156497279|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48628014|NCT00835042|156497280|FG000|First Intervention|Withdrawal by Subject|3|||
48628015|NCT00835042|156497281|FG001|First Intervention|Withdrawal by Subject|0|||
48628016|NCT00835042|156497280|FG000|First Intervention|Adverse Event|1|||
48628017|NCT00835042|156497281|FG001|First Intervention|Adverse Event|2|||
48628018|NCT00835042|156497280|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
48628019|NCT00835042|156497281|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
48628020|NCT00619918|156497282|FG000|Overall Study|Withdrawal by Subject|4|||
48628021|NCT00619918|156497283|FG001|Overall Study|Withdrawal by Subject|3|||
48628022|NCT00619918|156497282|FG000|Overall Study|Physician Decision|2|||
48628023|NCT00619918|156497283|FG001|Overall Study|Physician Decision|4|||
48628024|NCT00619918|156497282|FG000|Overall Study|Transfer to outside facility|3|||
48628025|NCT00619918|156497283|FG001|Overall Study|Transfer to outside facility|3|||
48628026|NCT00619918|156497282|FG000|Overall Study|Left before receiving first dose|7|||
48628027|NCT00619918|156497283|FG001|Overall Study|Left before receiving first dose|6|||
48628028|NCT00619918|156497282|FG000|Overall Study|ICU admission|4|||
48628029|NCT00619918|156497283|FG001|Overall Study|ICU admission|6|||
48628030|NCT02088554|156497289|FG000|Overall Study|Exited before procedure|130|||
48628031|NCT02088554|156497289|FG000|Overall Study|Attempted but not implanted|31|||
48628032|NCT02088554|156497289|FG000|Overall Study|Implant not attempted|19|||
48628033|NCT02088554|156497289|FG000|Overall Study|Pending next visit|532|||
48628034|NCT02088554|156497289|FG000|Overall Study|Death|170|||
48628035|NCT02088554|156497289|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
48628036|NCT02088554|156497289|FG000|Overall Study|Lost to Follow-up|23|||
48628037|NCT02088554|156497289|FG000|Overall Study|Explanted|32|||
48628038|NCT02088554|156497289|FG000|Overall Study|Any other reason not covered by previous categories|11|||
48628039|NCT02743221|156497290|FG000|Overall Study|Progressive disease|29|||
48628040|NCT02743221|156497291|FG001|Overall Study|Progressive disease|38|||
48628041|NCT02743221|156497290|FG000|Overall Study|Adverse Event|17|||
48628042|NCT02743221|156497291|FG001|Overall Study|Adverse Event|14|||
48628043|NCT02743221|156497290|FG000|Overall Study|non medical reason|8|||
48628044|NCT02743221|156497291|FG001|Overall Study|non medical reason|2|||
48628045|NCT02743221|156497290|FG000|Overall Study|Physician Decision|2|||
48628046|NCT02743221|156497291|FG001|Overall Study|Physician Decision|5|||
48628047|NCT02743221|156497290|FG000|Overall Study|Patient not eligible, not treated|0|||
48628048|NCT02743221|156497291|FG001|Overall Study|Patient not eligible, not treated|1|||
48742033|NCT02993757|156904433|FG000|Overall Study|Lost to Follow-up|1|||
48742034|NCT02993757|156904434|FG001|Overall Study|Lost to Follow-up|0|||
48628049|NCT03411044|156497292|FG000|Overall Study|Death|30|||
48628050|NCT03411044|156497292|FG000|Overall Study|Withdrawal by Subject|48|||
48628051|NCT03411044|156497292|FG000|Overall Study|Lost to Follow-up|78|||
48628052|NCT03411044|156497292|FG000|Overall Study|Adverse Event|30|||
48742035|NCT02993757|156904433|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
48628053|NCT03411044|156497292|FG000|Overall Study|Missing status|4|||
48628054|NCT03579719|156497299|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
48628055|NCT00581919|156497300|FG000|Overall Study|Adverse Event|8|||
48628056|NCT00581919|156497300|FG000|Overall Study|Death|1|||
48628057|NCT00581919|156497300|FG000|Overall Study|Disease Progression|10|||
48628058|NCT00581919|156497300|FG000|Overall Study|Physician Decision|1|||
48628059|NCT00581919|156497300|FG000|Overall Study|Other Complicating Disease|1|||
48628060|NCT00581919|156497300|FG000|Overall Study|Started Non-Protocol Therapy|2|||
48628061|NCT00581919|156497300|FG000|Overall Study|Withdrawal by Subject|1|||
48742036|NCT02993757|156904434|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
48742037|NCT00622284|156904437|FG000|Overall Study|Lack of Efficacy|45|||
48628062|NCT00522379|156497301|FG000|Overall Study|Adverse Event|12|||
48324270|NCT03539952|155385212|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
48324271|NCT03539952|155385211|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
48324272|NCT03539952|155385212|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
48324273|NCT03539952|155385211|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
48324274|NCT03539952|155385212|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
48324275|NCT00914966|155385213|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
48324276|NCT00914966|155385213|FG000|Step 1: 1500 Units|Physician Decision|1|||
48324277|NCT00914966|155385213|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
48324278|NCT00989196|155385214|FG000|Treatment Period|Lost to Follow-up|1|||
48324279|NCT00989196|155385215|FG001|Treatment Period|Lost to Follow-up|0|||
48324280|NCT03699163|155386975|FG000|Overall Study|Physician Decision|12|||
48324281|NCT03699163|155386976|FG001|Overall Study|Physician Decision|0|||
48324282|NCT03699163|155386975|FG000|Overall Study|failed QC measures|205|||
48324283|NCT03699163|155386976|FG001|Overall Study|failed QC measures|206|||
48324284|NCT00146172|155386978|FG000|Overall Study|Adverse Event|0|||
48324285|NCT00146172|155386979|FG001|Overall Study|Adverse Event|0|||
48324286|NCT00146172|155386980|FG002|Overall Study|Adverse Event|1|||
48742038|NCT00622284|156904438|FG001|Overall Study|Lack of Efficacy|15|||
48742039|NCT00622284|156904437|FG000|Overall Study|Adverse Event|61|||
48742040|NCT00622284|156904438|FG001|Overall Study|Adverse Event|90|||
48742041|NCT00622284|156904437|FG000|Overall Study|Protocol Violation|12|||
48742042|NCT00622284|156904438|FG001|Overall Study|Protocol Violation|5|||
48742043|NCT00622284|156904437|FG000|Overall Study|Lost to Follow-up|11|||
48742044|NCT00622284|156904438|FG001|Overall Study|Lost to Follow-up|13|||
48742045|NCT00622284|156904437|FG000|Overall Study|Withdrawal by Subject|27|||
48742046|NCT00622284|156904438|FG001|Overall Study|Withdrawal by Subject|24|||
48324287|NCT00146172|155386981|FG003|Overall Study|Adverse Event|1|||
48324288|NCT00146172|155386982|FG004|Overall Study|Adverse Event|0|||
48324289|NCT00146172|155386983|FG005|Overall Study|Adverse Event|2|||
48324290|NCT00146172|155386984|FG006|Overall Study|Adverse Event|3|||
48324291|NCT00146172|155386985|FG007|Overall Study|Adverse Event|10|||
48324292|NCT00146172|155386978|FG000|Overall Study|Lost to Follow-up|0|||
48324293|NCT00146172|155386979|FG001|Overall Study|Lost to Follow-up|0|||
48324294|NCT00146172|155386980|FG002|Overall Study|Lost to Follow-up|0|||
48324295|NCT00146172|155386981|FG003|Overall Study|Lost to Follow-up|0|||
48324296|NCT00146172|155386982|FG004|Overall Study|Lost to Follow-up|0|||
48324297|NCT00146172|155386983|FG005|Overall Study|Lost to Follow-up|0|||
48324298|NCT00146172|155386984|FG006|Overall Study|Lost to Follow-up|0|||
48324299|NCT00146172|155386985|FG007|Overall Study|Lost to Follow-up|1|||
48324300|NCT00146172|155386978|FG000|Overall Study|Disease Progression|2|||
48324301|NCT00146172|155386979|FG001|Overall Study|Disease Progression|4|||
48628063|NCT00522379|156497302|FG001|Overall Study|Adverse Event|15|||
48628064|NCT00522379|156497303|FG002|Overall Study|Adverse Event|12|||
48628065|NCT00522379|156497304|FG003|Overall Study|Adverse Event|5|||
48628066|NCT00522379|156497305|FG004|Overall Study|Adverse Event|17|||
48742047|NCT00622284|156904437|FG000|Overall Study|Other reason (not specified)|33|||
48742048|NCT00622284|156904438|FG001|Overall Study|Other reason (not specified)|24|||
48742049|NCT01300650|156904439|FG000|Overall Study|Adverse Event|1|||
48742050|NCT02639065|156904452|FG000|Study Treatment|Disease Progression|13|||
48742051|NCT02639065|156904452|FG000|Study Treatment|Adverse Event|9|||
48324302|NCT00146172|155386980|FG002|Overall Study|Disease Progression|2|||
48324303|NCT00146172|155386981|FG003|Overall Study|Disease Progression|5|||
48324304|NCT00146172|155386982|FG004|Overall Study|Disease Progression|2|||
48324305|NCT00146172|155386983|FG005|Overall Study|Disease Progression|2|||
48324306|NCT00146172|155386984|FG006|Overall Study|Disease Progression|1|||
48324307|NCT00146172|155386985|FG007|Overall Study|Disease Progression|22|||
48628067|NCT00522379|156497301|FG000|Overall Study|Lack of Efficacy|3|||
48324308|NCT00146172|155386978|FG000|Overall Study|Death|0|||
48324309|NCT00146172|155386979|FG001|Overall Study|Death|0|||
48324310|NCT00146172|155386980|FG002|Overall Study|Death|0|||
48324311|NCT00146172|155386981|FG003|Overall Study|Death|0|||
48324312|NCT00146172|155386982|FG004|Overall Study|Death|0|||
48324313|NCT00146172|155386983|FG005|Overall Study|Death|0|||
48324314|NCT00146172|155386984|FG006|Overall Study|Death|1|||
48324315|NCT00146172|155386985|FG007|Overall Study|Death|0|||
48324316|NCT00146172|155386978|FG000|Overall Study|Physician Decision|0|||
48324317|NCT00146172|155386979|FG001|Overall Study|Physician Decision|0|||
48324318|NCT00146172|155386980|FG002|Overall Study|Physician Decision|0|||
48324319|NCT00146172|155386981|FG003|Overall Study|Physician Decision|0|||
48324320|NCT00146172|155386982|FG004|Overall Study|Physician Decision|0|||
48324321|NCT00146172|155386983|FG005|Overall Study|Physician Decision|0|||
48324322|NCT00146172|155386984|FG006|Overall Study|Physician Decision|0|||
48324323|NCT00146172|155386985|FG007|Overall Study|Physician Decision|1|||
48628068|NCT00522379|156497302|FG001|Overall Study|Lack of Efficacy|0|||
48628069|NCT00522379|156497303|FG002|Overall Study|Lack of Efficacy|2|||
48628070|NCT00522379|156497304|FG003|Overall Study|Lack of Efficacy|2|||
48628071|NCT00522379|156497305|FG004|Overall Study|Lack of Efficacy|7|||
48628072|NCT00522379|156497301|FG000|Overall Study|Withdrawal by Subject|2|||
48628073|NCT00522379|156497302|FG001|Overall Study|Withdrawal by Subject|3|||
48628074|NCT00522379|156497303|FG002|Overall Study|Withdrawal by Subject|1|||
48628075|NCT00522379|156497304|FG003|Overall Study|Withdrawal by Subject|2|||
48628076|NCT00522379|156497305|FG004|Overall Study|Withdrawal by Subject|0|||
48324324|NCT00146172|155386978|FG000|Overall Study|Withdrawal by Subject|0|||
48324325|NCT00146172|155386979|FG001|Overall Study|Withdrawal by Subject|0|||
48324326|NCT00146172|155386980|FG002|Overall Study|Withdrawal by Subject|0|||
48324327|NCT00146172|155386981|FG003|Overall Study|Withdrawal by Subject|0|||
48324328|NCT00146172|155386982|FG004|Overall Study|Withdrawal by Subject|0|||
48324329|NCT00146172|155386983|FG005|Overall Study|Withdrawal by Subject|1|||
48324330|NCT00146172|155386984|FG006|Overall Study|Withdrawal by Subject|1|||
48324331|NCT00146172|155386985|FG007|Overall Study|Withdrawal by Subject|4|||
48324332|NCT00146172|155386978|FG000|Overall Study|Symptomatic Deterioration|1|||
48324333|NCT00146172|155386979|FG001|Overall Study|Symptomatic Deterioration|0|||
48324334|NCT00146172|155386980|FG002|Overall Study|Symptomatic Deterioration|1|||
48324335|NCT00146172|155386981|FG003|Overall Study|Symptomatic Deterioration|0|||
48324336|NCT00146172|155386982|FG004|Overall Study|Symptomatic Deterioration|1|||
48324337|NCT00146172|155386983|FG005|Overall Study|Symptomatic Deterioration|2|||
48324338|NCT00146172|155386984|FG006|Overall Study|Symptomatic Deterioration|0|||
48324339|NCT00146172|155386985|FG007|Overall Study|Symptomatic Deterioration|2|||
48324340|NCT02128113|155386988|FG000|Overall Study|Withdrawal by Subject|3|||
48324341|NCT02128113|155386989|FG001|Overall Study|Withdrawal by Subject|1|||
48324342|NCT02128113|155386990|FG002|Overall Study|Withdrawal by Subject|0|||
48628077|NCT00522379|156497301|FG000|Overall Study|Protocol Violation|1|||
48628078|NCT00522379|156497302|FG001|Overall Study|Protocol Violation|1|||
48628079|NCT00522379|156497303|FG002|Overall Study|Protocol Violation|2|||
48628080|NCT00522379|156497304|FG003|Overall Study|Protocol Violation|0|||
48628081|NCT00522379|156497305|FG004|Overall Study|Protocol Violation|0|||
48628082|NCT00522379|156497301|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
48628083|NCT00522379|156497302|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
48628084|NCT00522379|156497303|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
48628085|NCT00522379|156497304|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
48628086|NCT00522379|156497305|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
48628087|NCT00522379|156497301|FG000|Overall Study|Lost to Follow-up|1|||
48628088|NCT00522379|156497302|FG001|Overall Study|Lost to Follow-up|0|||
48628089|NCT00522379|156497303|FG002|Overall Study|Lost to Follow-up|4|||
48628090|NCT00522379|156497304|FG003|Overall Study|Lost to Follow-up|2|||
48628091|NCT00522379|156497305|FG004|Overall Study|Lost to Follow-up|2|||
48628092|NCT00522379|156497301|FG000|Overall Study|Randomization error|0|||
48324343|NCT02128113|155386988|FG000|Overall Study|Protocol Violation|0|||
48324344|NCT02128113|155386989|FG001|Overall Study|Protocol Violation|1|||
48324345|NCT02128113|155386990|FG002|Overall Study|Protocol Violation|0|||
48324346|NCT02128113|155386988|FG000|Overall Study|Surgery cancelled|0|||
48324347|NCT02128113|155386989|FG001|Overall Study|Surgery cancelled|1|||
48324348|NCT02128113|155386990|FG002|Overall Study|Surgery cancelled|0|||
48324349|NCT02128113|155386988|FG000|Overall Study|Adverse Event|0|||
48324350|NCT02128113|155386989|FG001|Overall Study|Adverse Event|0|||
48324351|NCT02128113|155386990|FG002|Overall Study|Adverse Event|1|||
48324352|NCT00945321|155386991|FG000|Period 1|Adverse Event|0|||
48324353|NCT00945321|155386992|FG001|Period 1|Adverse Event|0|||
48324354|NCT00945321|155386993|FG002|Period 1|Adverse Event|0|||
48324355|NCT00945321|155386994|FG003|Period 1|Adverse Event|0|||
48324356|NCT00945321|155386995|FG004|Period 1|Adverse Event|1|||
48628093|NCT00522379|156497302|FG001|Overall Study|Randomization error|0|||
48628094|NCT00522379|156497303|FG002|Overall Study|Randomization error|0|||
48628095|NCT00522379|156497304|FG003|Overall Study|Randomization error|0|||
48628096|NCT00522379|156497305|FG004|Overall Study|Randomization error|1|||
48628097|NCT00522379|156497301|FG000|Overall Study|Dispensing error|1|||
48628098|NCT00522379|156497302|FG001|Overall Study|Dispensing error|0|||
48324357|NCT00945321|155386996|FG005|Period 1|Adverse Event|0|||
48324358|NCT00945321|155386991|FG000|Period 4|Lost to Follow-up|0|||
48324359|NCT00945321|155386992|FG001|Period 4|Lost to Follow-up|0|||
48324360|NCT00945321|155386993|FG002|Period 4|Lost to Follow-up|0|||
48324361|NCT00945321|155386994|FG003|Period 4|Lost to Follow-up|0|||
48324362|NCT00945321|155386995|FG004|Period 4|Lost to Follow-up|0|||
48324363|NCT00945321|155386996|FG005|Period 4|Lost to Follow-up|1|||
48324364|NCT04876417|155386997|FG000|Overall Study|Lost to Follow-up|5|||
48324365|NCT04876417|155386998|FG001|Overall Study|Lost to Follow-up|8|||
48324366|NCT04876417|155386999|FG002|Overall Study|Lost to Follow-up|0|||
48324367|NCT04876417|155387000|FG003|Overall Study|Lost to Follow-up|0|||
48324368|NCT00774397|155387001|FG000|Overall Study|Adverse Event|1|||
48324369|NCT00774397|155387002|FG001|Overall Study|Adverse Event|3|||
48324370|NCT00774397|155387003|FG002|Overall Study|Adverse Event|16|||
48324371|NCT00774397|155387004|FG003|Overall Study|Adverse Event|8|||
48324372|NCT00774397|155387005|FG004|Overall Study|Adverse Event|8|||
48324373|NCT00774397|155387006|FG005|Overall Study|Adverse Event|3|||
48324374|NCT00774397|155387007|FG006|Overall Study|Adverse Event|16|||
48324375|NCT00774397|155387001|FG000|Overall Study|Lack of Efficacy|11|||
48324376|NCT00774397|155387002|FG001|Overall Study|Lack of Efficacy|4|||
48742052|NCT02639065|156904452|FG000|Study Treatment|Withdrawal by Subject|1|||
48742053|NCT02639065|156904452|FG000|Follow up|Subject refused to follow up|1|||
48742054|NCT02639065|156904452|FG000|Follow up|Symptomatic Deterioration|2|||
48742055|NCT02639065|156904452|FG000|Follow up|Death|2|||
48742056|NCT02639065|156904452|FG000|Follow up|Study Terminated|1|||
48742057|NCT02639065|156904452|FG000|Follow up|Disease Progression|3|||
48324377|NCT00774397|155387003|FG002|Overall Study|Lack of Efficacy|5|||
48324378|NCT00774397|155387004|FG003|Overall Study|Lack of Efficacy|3|||
48324379|NCT00774397|155387005|FG004|Overall Study|Lack of Efficacy|27|||
48324380|NCT00774397|155387006|FG005|Overall Study|Lack of Efficacy|15|||
48324381|NCT00774397|155387007|FG006|Overall Study|Lack of Efficacy|9|||
48324382|NCT00774397|155387001|FG000|Overall Study|Protocol Violation|0|||
48324383|NCT00774397|155387002|FG001|Overall Study|Protocol Violation|1|||
48324384|NCT00774397|155387003|FG002|Overall Study|Protocol Violation|3|||
48324385|NCT00774397|155387004|FG003|Overall Study|Protocol Violation|1|||
48324386|NCT00774397|155387005|FG004|Overall Study|Protocol Violation|2|||
48324387|NCT00774397|155387006|FG005|Overall Study|Protocol Violation|1|||
48324388|NCT00774397|155387007|FG006|Overall Study|Protocol Violation|0|||
48324389|NCT00774397|155387001|FG000|Overall Study|Lost to Follow-up|0|||
48628099|NCT00522379|156497303|FG002|Overall Study|Dispensing error|0|||
48628100|NCT00522379|156497304|FG003|Overall Study|Dispensing error|1|||
48628101|NCT00522379|156497305|FG004|Overall Study|Dispensing error|0|||
48628102|NCT00522379|156497301|FG000|Overall Study|Subject Moved|1|||
48628103|NCT00522379|156497302|FG001|Overall Study|Subject Moved|1|||
48628104|NCT00522379|156497303|FG002|Overall Study|Subject Moved|0|||
48628105|NCT00522379|156497304|FG003|Overall Study|Subject Moved|0|||
48628106|NCT00522379|156497305|FG004|Overall Study|Subject Moved|0|||
48628107|NCT00522379|156497301|FG000|Overall Study|Sponsor Request|0|||
48628108|NCT00522379|156497302|FG001|Overall Study|Sponsor Request|1|||
48628109|NCT00522379|156497303|FG002|Overall Study|Sponsor Request|0|||
48628110|NCT00522379|156497304|FG003|Overall Study|Sponsor Request|0|||
48324390|NCT00774397|155387002|FG001|Overall Study|Lost to Follow-up|1|||
48742058|NCT03128411|156904453|FG000|Treatment Phase|Adverse Event|21|||
48742059|NCT03128411|156904453|FG000|Treatment Phase|Physician Decision|1|||
48742060|NCT03128411|156904453|FG000|Treatment Phase|Other|2|||
48742061|NCT03128411|156904453|FG000|Long Term Follow-up Phase|Death|2|||
48324391|NCT00774397|155387003|FG002|Overall Study|Lost to Follow-up|1|||
48324392|NCT00774397|155387004|FG003|Overall Study|Lost to Follow-up|1|||
48324393|NCT00774397|155387005|FG004|Overall Study|Lost to Follow-up|0|||
48324394|NCT00774397|155387006|FG005|Overall Study|Lost to Follow-up|1|||
48324395|NCT00774397|155387007|FG006|Overall Study|Lost to Follow-up|0|||
48324396|NCT00774397|155387001|FG000|Overall Study|Refused to continue trial medication|1|||
48324397|NCT00774397|155387002|FG001|Overall Study|Refused to continue trial medication|3|||
48324398|NCT00774397|155387003|FG002|Overall Study|Refused to continue trial medication|2|||
48628111|NCT00522379|156497305|FG004|Overall Study|Sponsor Request|0|||
48742062|NCT01197560|156904454|FG000|Overall Study|Adverse Event|6|||
48742063|NCT01197560|156904455|FG001|Overall Study|Adverse Event|8|||
48742064|NCT01197560|156904454|FG000|Overall Study|Death|3|||
48324399|NCT00774397|155387004|FG003|Overall Study|Refused to continue trial medication|2|||
48324400|NCT00774397|155387005|FG004|Overall Study|Refused to continue trial medication|6|||
48324401|NCT00774397|155387006|FG005|Overall Study|Refused to continue trial medication|2|||
48324402|NCT00774397|155387007|FG006|Overall Study|Refused to continue trial medication|3|||
48324403|NCT00774397|155387001|FG000|Overall Study|Not treated|0|||
48324404|NCT00774397|155387002|FG001|Overall Study|Not treated|0|||
48324405|NCT00774397|155387003|FG002|Overall Study|Not treated|0|||
48324406|NCT00774397|155387004|FG003|Overall Study|Not treated|0|||
48324407|NCT00774397|155387005|FG004|Overall Study|Not treated|1|||
48324408|NCT00774397|155387006|FG005|Overall Study|Not treated|0|||
48628112|NCT00522379|156497301|FG000|Overall Study|Family Problem|0|||
48628113|NCT00522379|156497302|FG001|Overall Study|Family Problem|0|||
48628114|NCT00522379|156497303|FG002|Overall Study|Family Problem|1|||
48628115|NCT00522379|156497304|FG003|Overall Study|Family Problem|0|||
48628116|NCT00522379|156497305|FG004|Overall Study|Family Problem|0|||
48628117|NCT00522379|156497301|FG000|Overall Study|Site Closed|0|||
48628118|NCT00522379|156497302|FG001|Overall Study|Site Closed|0|||
48628119|NCT00522379|156497303|FG002|Overall Study|Site Closed|0|||
48628120|NCT00522379|156497304|FG003|Overall Study|Site Closed|1|||
48324409|NCT00774397|155387007|FG006|Overall Study|Not treated|1|||
48324410|NCT00774397|155387001|FG000|Overall Study|Other than those stated above|1|||
48324411|NCT00774397|155387002|FG001|Overall Study|Other than those stated above|1|||
48324412|NCT00774397|155387003|FG002|Overall Study|Other than those stated above|3|||
48324413|NCT00774397|155387004|FG003|Overall Study|Other than those stated above|2|||
48324414|NCT00774397|155387005|FG004|Overall Study|Other than those stated above|2|||
48628121|NCT00522379|156497305|FG004|Overall Study|Site Closed|0|||
48324415|NCT00774397|155387006|FG005|Overall Study|Other than those stated above|0|||
48324416|NCT00774397|155387007|FG006|Overall Study|Other than those stated above|1|||
48324417|NCT02285270|155387008|FG000|Overall Study|Lost to Follow-up|1|||
48324418|NCT02285270|155387008|FG000|Overall Study|Physician Decision|3|||
48324419|NCT02285270|155387008|FG000|Overall Study|Determined to be ineligible|1|||
48324420|NCT03801148|155387011|FG000|Period 1 (2 Days)|Adverse Event|1|||
48324421|NCT03801148|155387012|FG001|Period 1 (2 Days)|Adverse Event|1|||
48324422|NCT03801148|155387013|FG002|Period 1 (2 Days)|Adverse Event|0|||
48324423|NCT03801148|155387014|FG003|Period 1 (2 Days)|Adverse Event|0|||
48324424|NCT03801148|155387011|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
48324425|NCT03801148|155387012|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
48324426|NCT03801148|155387013|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
48324427|NCT03801148|155387014|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
48324428|NCT03801148|155387011|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48324429|NCT03801148|155387012|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48324430|NCT03801148|155387013|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
48324431|NCT03801148|155387014|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
48324432|NCT03801148|155387011|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
48324433|NCT03801148|155387012|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
48324434|NCT03801148|155387013|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
48324435|NCT03801148|155387014|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
48324436|NCT01268306|155387017|FG000|Overall Study|Lost to Follow-up|1|||
48324437|NCT02347332|155387027|FG000|Overall Study|Not treated|5|||
48324438|NCT02347332|155387028|FG001|Overall Study|Not treated|2|||
48324439|NCT02347332|155387027|FG000|Overall Study|Progressive disease|141|||
48324440|NCT02347332|155387028|FG001|Overall Study|Progressive disease|159|||
48324441|NCT02347332|155387027|FG000|Overall Study|Adverse Event|50|||
48324442|NCT02347332|155387028|FG001|Overall Study|Adverse Event|41|||
48628122|NCT00522379|156497301|FG000|Overall Study|Subject Withdrawal|0|||
48628123|NCT00522379|156497302|FG001|Overall Study|Subject Withdrawal|0|||
48628124|NCT00522379|156497303|FG002|Overall Study|Subject Withdrawal|0|||
48628125|NCT00522379|156497304|FG003|Overall Study|Subject Withdrawal|1|||
48628126|NCT00522379|156497305|FG004|Overall Study|Subject Withdrawal|0|||
48628127|NCT05252702|156497306|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
48628128|NCT05252702|156497306|FG000|Overall Study|Death|16|||
48324443|NCT02347332|155387027|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
48628129|NCT05252702|156497306|FG000|Overall Study|System explant|5|||
48628130|NCT05252702|156497306|FG000|Overall Study|Lost to Follow-up|1|||
48628131|NCT05252702|156497306|FG000|Overall Study|Withdrawn by investigator|1|||
48628132|NCT05252702|156497306|FG000|Overall Study|Visit not due|306|||
48628133|NCT05252702|156497306|FG000|Overall Study|Visit within window but not completed|92|||
48628134|NCT05252702|156497306|FG000|Overall Study|Unsuccessful implant|1|||
48628135|NCT04818229|156497307|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
48628136|NCT04818229|156497308|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
48628137|NCT04818229|156497309|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
48628138|NCT04818229|156497307|FG000|Overall Study|Adverse Event|3|||
48324444|NCT02347332|155387028|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
48324445|NCT02347332|155387027|FG000|Overall Study|Protocol Violation|1|||
48324446|NCT02347332|155387028|FG001|Overall Study|Protocol Violation|1|||
48324447|NCT02347332|155387027|FG000|Overall Study|Lost to Follow-up|2|||
48628139|NCT04818229|156497308|FG001|Overall Study|Adverse Event|1|||
48628140|NCT04818229|156497309|FG002|Overall Study|Adverse Event|1|||
48628141|NCT04818229|156497307|FG000|Overall Study|Withdrawal by Subject|0|||
48628142|NCT04818229|156497308|FG001|Overall Study|Withdrawal by Subject|0|||
48628143|NCT04818229|156497309|FG002|Overall Study|Withdrawal by Subject|2|||
48628144|NCT04818229|156497307|FG000|Overall Study|Lost to Follow-up|0|||
48628145|NCT04818229|156497308|FG001|Overall Study|Lost to Follow-up|0|||
48628146|NCT04818229|156497309|FG002|Overall Study|Lost to Follow-up|1|||
48628147|NCT01450631|156497310|FG000|Overall Study|Lost to Follow-up|2|||
48628148|NCT01450631|156497311|FG001|Overall Study|Lost to Follow-up|4|||
48628149|NCT01450631|156497310|FG000|Overall Study|Withdrawal by Subject|1|||
48742065|NCT01197560|156904455|FG001|Overall Study|Death|5|||
48742066|NCT01197560|156904454|FG000|Overall Study|Withdrawal by Subject|1|||
48742067|NCT01197560|156904455|FG001|Overall Study|Withdrawal by Subject|1|||
48742068|NCT01197560|156904454|FG000|Overall Study|Disease progression|40|||
48742069|NCT01197560|156904455|FG001|Overall Study|Disease progression|35|||
48742070|NCT01197560|156904454|FG000|Overall Study|Miscellaneous|4|||
48742071|NCT01197560|156904455|FG001|Overall Study|Miscellaneous|3|||
48742072|NCT01197560|156904454|FG000|Overall Study|Missing|0|||
48742073|NCT01197560|156904455|FG001|Overall Study|Missing|1|||
48742074|NCT04213079|156906151|FG000|Overall Study|Lost to Follow-up|0|||
48742075|NCT04213079|156906152|FG001|Overall Study|Lost to Follow-up|2|||
48742076|NCT03228433|156906153|FG000|Overall Study|Lost to Follow-up|1|||
48742077|NCT03228433|156906154|FG001|Overall Study|Lost to Follow-up|0|||
48742078|NCT03228433|156906155|FG002|Overall Study|Lost to Follow-up|0|||
48742079|NCT03228433|156906156|FG003|Overall Study|Lost to Follow-up|0|||
48742080|NCT03228433|156906157|FG004|Overall Study|Lost to Follow-up|0|||
48742081|NCT03228433|156906158|FG005|Overall Study|Lost to Follow-up|0|||
48742082|NCT03228433|156906153|FG000|Overall Study|Positive alcohol test|0|||
48742083|NCT03228433|156906154|FG001|Overall Study|Positive alcohol test|0|||
48628150|NCT01450631|156497311|FG001|Overall Study|Withdrawal by Subject|0|||
48742084|NCT03228433|156906155|FG002|Overall Study|Positive alcohol test|0|||
48742085|NCT03228433|156906156|FG003|Overall Study|Positive alcohol test|1|||
48742086|NCT03228433|156906157|FG004|Overall Study|Positive alcohol test|0|||
48742087|NCT03228433|156906158|FG005|Overall Study|Positive alcohol test|0|||
48798213|NCT00441701|157098569|FG008|Overall Study|Lack of Efficacy|0|||
48798214|NCT00441701|157098570|FG009|Overall Study|Lack of Efficacy|0|||
48798215|NCT00441701|157098561|FG000|Overall Study|Withdrawal by Subject|0|||
48798216|NCT00441701|157098562|FG001|Overall Study|Withdrawal by Subject|2|||
48798217|NCT00441701|157098563|FG002|Overall Study|Withdrawal by Subject|1|||
48798218|NCT00441701|157098564|FG003|Overall Study|Withdrawal by Subject|1|||
48798219|NCT00441701|157098565|FG004|Overall Study|Withdrawal by Subject|0|||
48798220|NCT00441701|157098566|FG005|Overall Study|Withdrawal by Subject|0|||
48798221|NCT00441701|157098567|FG006|Overall Study|Withdrawal by Subject|0|||
48798222|NCT00441701|157098568|FG007|Overall Study|Withdrawal by Subject|0|||
48798223|NCT00441701|157098569|FG008|Overall Study|Withdrawal by Subject|0|||
48798224|NCT00441701|157098570|FG009|Overall Study|Withdrawal by Subject|0|||
48798225|NCT01113502|157098573|FG000|Overall Study|Withdrawal by Subject|1|||
48798226|NCT01113502|157098574|FG001|Overall Study|Withdrawal by Subject|0|||
48798227|NCT01113502|157098575|FG002|Overall Study|Withdrawal by Subject|1|||
48798228|NCT01113502|157098576|FG003|Overall Study|Withdrawal by Subject|1|||
48798229|NCT01113502|157098577|FG004|Overall Study|Withdrawal by Subject|0|||
48798230|NCT01113502|157098573|FG000|Overall Study|Adverse Event|0|||
48798231|NCT01113502|157098574|FG001|Overall Study|Adverse Event|0|||
48798232|NCT01113502|157098575|FG002|Overall Study|Adverse Event|3|||
48798233|NCT01113502|157098576|FG003|Overall Study|Adverse Event|2|||
48798234|NCT01113502|157098577|FG004|Overall Study|Adverse Event|0|||
48798235|NCT04535947|157098578|FG000|Overall Study|Adverse Event|1|||
48798236|NCT04535947|157098579|FG001|Overall Study|Adverse Event|4|||
48798237|NCT04535947|157098578|FG000|Overall Study|Other reasons not specified|2|||
48798238|NCT04535947|157098579|FG001|Overall Study|Other reasons not specified|0|||
48798239|NCT04535947|157098578|FG000|Overall Study|Withdrawal by Subject|1|||
48798240|NCT04535947|157098579|FG001|Overall Study|Withdrawal by Subject|1|||
48798241|NCT02255357|157098581|FG000|Overall Study|Physician Decision|10|||
48798242|NCT02255357|157098582|FG001|Overall Study|Physician Decision|24|||
48798243|NCT03802123|157098583|FG000|Overall Study|Withdrawal by Subject|3|||
48798244|NCT03802123|157098583|FG000|Overall Study|Physician Decision|1|||
48798245|NCT03802123|157098583|FG000|Overall Study|Subject moved to hospice care|1|||
48798246|NCT03802123|157098583|FG000|Overall Study|technician error|1|||
48798247|NCT03802123|157098583|FG000|Overall Study|Death|3|||
48798248|NCT01274182|157098584|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
48798249|NCT01274182|157098585|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48798250|NCT01274182|157098586|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
48798251|NCT01274182|157098584|FG000|Overall Study|Adverse Event|4|||
48798252|NCT01274182|157098585|FG001|Overall Study|Adverse Event|5|||
48798253|NCT01274182|157098586|FG002|Overall Study|Adverse Event|3|||
48798254|NCT01274182|157098584|FG000|Overall Study|Withdrawal by Subject|5|||
48628151|NCT05375929|156497318|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
48628152|NCT05375929|156497319|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
48628153|NCT05375929|156497320|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
48628154|NCT05375929|156497321|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
48628155|NCT05375929|156497318|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
48742088|NCT01797731|156906161|FG000|Overall Study|Didn't have proper radiographs required|3|||
48742089|NCT01797731|156906162|FG001|Overall Study|Didn't have proper radiographs required|3|||
48742090|NCT00129272|156906163|FG000|Overall Study|Lost to Follow-up|12|||
48742091|NCT00129272|156906164|FG001|Overall Study|Lost to Follow-up|11|||
48742092|NCT00129272|156906163|FG000|Overall Study|Withdrawal by Subject|5|||
48742093|NCT00129272|156906164|FG001|Overall Study|Withdrawal by Subject|11|||
48742094|NCT00261807|156906165|FG000|Overall Study|Lost to Follow-up|2|||
48742095|NCT00261807|156906165|FG000|Overall Study|Adverse Event|2|||
48742096|NCT00261807|156906165|FG000|Overall Study|Death|1|||
48742097|NCT00261807|156906165|FG000|Overall Study|Protocol Violation|2|||
48742098|NCT02582983|156906169|FG000|Overall Study|Death|3|||
48742099|NCT02582983|156906169|FG000|Overall Study|Withdrawal by Subject|2|||
48742100|NCT02582983|156906169|FG000|Overall Study|Adverse Event|1|||
48742101|NCT04377620|156906170|FG000|Overall Study|Death|42|||
48742102|NCT04377620|156906171|FG001|Overall Study|Death|48|||
48742103|NCT04377620|156906172|FG002|Overall Study|Death|36|||
48742104|NCT04377620|156906170|FG000|Overall Study|Withdrawal by Subject|0|||
48742105|NCT04377620|156906171|FG001|Overall Study|Withdrawal by Subject|2|||
48742106|NCT04377620|156906172|FG002|Overall Study|Withdrawal by Subject|0|||
48742107|NCT00724932|156906173|FG000|Overall Study|Lost to Follow-up|1|||
48742108|NCT00724932|156906174|FG001|Overall Study|Lost to Follow-up|0|||
48742109|NCT00724932|156906173|FG000|Overall Study|Not treated|4|||
48742110|NCT00724932|156906174|FG001|Overall Study|Not treated|3|||
48742111|NCT02021331|156906175|FG000|Overall Study|Adverse Event|0|||
48742112|NCT02021331|156906176|FG001|Overall Study|Adverse Event|2|||
48742113|NCT04138810|156906182|FG000|Overall Study|Withdrawal by Subject|0|||
48742114|NCT04138810|156906183|FG001|Overall Study|Withdrawal by Subject|1|||
48742115|NCT04138810|156906182|FG000|Overall Study|Subject cancelled surgery|1|||
48742116|NCT04138810|156906183|FG001|Overall Study|Subject cancelled surgery|0|||
48742117|NCT03478657|156906186|FG000|Overall Study|Withdrawal by Subject|0|||
48742118|NCT03478657|156906187|FG001|Overall Study|Withdrawal by Subject|1|||
48742119|NCT01786668|156906188|FG000|Overall Study|Adverse Event|0|||
48742120|NCT01786668|156906189|FG001|Overall Study|Adverse Event|1|||
48742121|NCT01786668|156906190|FG002|Overall Study|Adverse Event|1|||
48742122|NCT01786668|156906191|FG003|Overall Study|Adverse Event|2|||
48742123|NCT01786668|156906188|FG000|Overall Study|Withdrawal by Subject|0|||
48742124|NCT01786668|156906189|FG001|Overall Study|Withdrawal by Subject|0|||
48742125|NCT01786668|156906190|FG002|Overall Study|Withdrawal by Subject|3|||
48742126|NCT01786668|156906191|FG003|Overall Study|Withdrawal by Subject|1|||
48742127|NCT01786668|156906188|FG000|Overall Study|Pregnancy|0|||
48742128|NCT01786668|156906189|FG001|Overall Study|Pregnancy|0|||
48742129|NCT01786668|156906190|FG002|Overall Study|Pregnancy|0|||
48742130|NCT01786668|156906191|FG003|Overall Study|Pregnancy|1|||
48742131|NCT01786668|156906188|FG000|Overall Study|Lost to Follow-up|1|||
48742132|NCT01786668|156906189|FG001|Overall Study|Lost to Follow-up|0|||
48742133|NCT01786668|156906190|FG002|Overall Study|Lost to Follow-up|1|||
48742134|NCT01786668|156906191|FG003|Overall Study|Lost to Follow-up|0|||
48742135|NCT01702805|156906193|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
48742136|NCT01702805|156906194|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
48742137|NCT01702805|156906193|FG000|Overall Study|Incomplete Follow-up|18|||
48742138|NCT01702805|156906194|FG001|Overall Study|Incomplete Follow-up|15|||
48742139|NCT01702805|156906193|FG000|Overall Study|Vital Status Assessment Only|40|||
48742140|NCT01702805|156906194|FG001|Overall Study|Vital Status Assessment Only|39|||
48742141|NCT01702805|156906193|FG000|Overall Study|Lost to Follow-up|5|||
48742142|NCT01702805|156906194|FG001|Overall Study|Lost to Follow-up|5|||
48742143|NCT01540838|156906201|FG000|Overall Study|Open nasogastric tube|9|||
48742144|NCT01540838|156906202|FG001|Overall Study|Open nasogastric tube|7|||
48742145|NCT01540838|156906201|FG000|Overall Study|Treatment doses missing|8|||
48742146|NCT01540838|156906202|FG001|Overall Study|Treatment doses missing|12|||
48742147|NCT01540838|156906201|FG000|Overall Study|Additional antibiotic treatment|1|||
48742148|NCT01540838|156906202|FG001|Overall Study|Additional antibiotic treatment|2|||
48742149|NCT01540838|156906201|FG000|Overall Study|Died before treatment initiation|1|||
48742150|NCT01540838|156906202|FG001|Overall Study|Died before treatment initiation|1|||
48742151|NCT01540838|156906201|FG000|Overall Study|Not BM. Other treatment|3|||
48742152|NCT01540838|156906202|FG001|Overall Study|Not BM. Other treatment|1|||
48742153|NCT01849783|156906205|FG000|Overall Study|Adverse Event|5|||
48742154|NCT01849783|156906205|FG000|Overall Study|Death|2|||
48742155|NCT01849783|156906205|FG000|Overall Study|Physician Decision|1|||
48742156|NCT01849783|156906205|FG000|Overall Study|Withdrawal by Subject|1|||
48628156|NCT05375929|156497319|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
48628157|NCT05375929|156497320|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
48628158|NCT05375929|156497321|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
48628159|NCT05375929|156497318|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
48628160|NCT05375929|156497319|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
48628161|NCT05375929|156497320|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
48628162|NCT05375929|156497321|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
48628163|NCT05375929|156497318|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
48628164|NCT05375929|156497319|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
48628165|NCT05375929|156497320|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
48628166|NCT05375929|156497321|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
48628167|NCT05375929|156497318|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
48628168|NCT05375929|156497319|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
48628169|NCT05375929|156497320|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
48628170|NCT05375929|156497321|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
48742157|NCT01849783|156906205|FG000|Overall Study|Unable to comply|2|||
48324448|NCT02347332|155387028|FG001|Overall Study|Lost to Follow-up|1|||
48324449|NCT02347332|155387027|FG000|Overall Study|Physician Decision|4|||
48324450|NCT02347332|155387028|FG001|Overall Study|Physician Decision|3|||
48324451|NCT02347332|155387027|FG000|Overall Study|Withdrawal by Subject|20|||
48324452|NCT02347332|155387028|FG001|Overall Study|Withdrawal by Subject|14|||
48324453|NCT02347332|155387027|FG000|Overall Study|Protocol requirement|1|||
48324454|NCT02347332|155387028|FG001|Overall Study|Protocol requirement|1|||
48324455|NCT02347332|155387027|FG000|Overall Study|Switch Post-Trial program|0|||
48324456|NCT02347332|155387028|FG001|Overall Study|Switch Post-Trial program|1|||
48324457|NCT02964741|155387034|FG000|Overall Study|Protocol Violation|1|||
48324458|NCT02964741|155387035|FG001|Overall Study|Protocol Violation|0|||
48324459|NCT02964741|155387036|FG002|Overall Study|Protocol Violation|0|||
48324460|NCT02964741|155387034|FG000|Overall Study|Withdrawal by Subject|0|||
48324461|NCT02964741|155387035|FG001|Overall Study|Withdrawal by Subject|1|||
48324462|NCT02964741|155387036|FG002|Overall Study|Withdrawal by Subject|0|||
48324463|NCT02964741|155387034|FG000|Overall Study|claustrophobia|1|||
48324464|NCT02964741|155387035|FG001|Overall Study|claustrophobia|0|||
48324465|NCT02964741|155387036|FG002|Overall Study|claustrophobia|0|||
48324466|NCT00683800|155387040|FG000|Overall Study|Adverse Event|195|||
48324467|NCT00683800|155387041|FG001|Overall Study|Adverse Event|102|||
48324468|NCT00683800|155387040|FG000|Overall Study|Death|0|||
48324469|NCT00683800|155387041|FG001|Overall Study|Death|1|||
48324470|NCT00683800|155387040|FG000|Overall Study|Lost to Follow-up|57|||
48324471|NCT00683800|155387041|FG001|Overall Study|Lost to Follow-up|44|||
48324472|NCT00683800|155387040|FG000|Overall Study|Other|5|||
48628171|NCT05375929|156497318|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
48628172|NCT05375929|156497319|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
48628173|NCT05375929|156497320|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
48628174|NCT05375929|156497321|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
48628175|NCT05375929|156497318|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
48628176|NCT05375929|156497319|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
48628177|NCT05375929|156497320|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
48628178|NCT05375929|156497321|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
48628179|NCT05375929|156497318|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
48628180|NCT05375929|156497319|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
48628181|NCT05375929|156497320|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
48628182|NCT05375929|156497321|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
48628183|NCT05375929|156497318|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
48628184|NCT05375929|156497319|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
48628185|NCT05375929|156497320|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
48628186|NCT05375929|156497321|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
48628187|NCT05375929|156497318|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
48628188|NCT05375929|156497319|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
48628189|NCT05375929|156497320|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
48628190|NCT05375929|156497321|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
48628191|NCT01107496|156497327|FG000|Overall Study|Adverse Event|1|||
48628192|NCT01107496|156497328|FG001|Overall Study|Adverse Event|0|||
48628193|NCT01107496|156497327|FG000|Overall Study|Lack of Efficacy|1|||
48324473|NCT00683800|155387041|FG001|Overall Study|Other|2|||
48628194|NCT01107496|156497328|FG001|Overall Study|Lack of Efficacy|0|||
48742158|NCT01849783|156906205|FG000|Overall Study|Disease progression|11|||
48324474|NCT00683800|155387040|FG000|Overall Study|Protocol Violation|13|||
48324475|NCT00683800|155387041|FG001|Overall Study|Protocol Violation|16|||
48324476|NCT00683800|155387040|FG000|Overall Study|Withdrawal by Subject|66|||
48324477|NCT00683800|155387041|FG001|Overall Study|Withdrawal by Subject|64|||
48324478|NCT00683800|155387040|FG000|Overall Study|Lack of Efficacy|61|||
48324479|NCT00683800|155387041|FG001|Overall Study|Lack of Efficacy|104|||
48324480|NCT00683800|155387040|FG000|Overall Study|Randomized, not treated|35|||
48324481|NCT00683800|155387041|FG001|Overall Study|Randomized, not treated|33|||
48324482|NCT04679675|155387042|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
48324483|NCT04679675|155387043|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
48324484|NCT04679675|155387044|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
48324485|NCT04679675|155387045|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
48324486|NCT04679675|155387042|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
48324487|NCT04679675|155387043|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
48324488|NCT04679675|155387044|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
48324489|NCT04679675|155387045|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
48324490|NCT01212744|155387047|FG000|Overall Study|Withdrawal by Subject|1|||
48324491|NCT01773993|155387048|FG000|Overall Study|No Visit After Treatment|35|||
48324492|NCT01968967|155387049|FG000|Treatment Period|Other|22|||
48324493|NCT01968967|155387050|FG001|Treatment Period|Other|22|||
48324494|NCT01968967|155387051|FG002|Treatment Period|Other|0|||
48324495|NCT01968967|155387052|FG003|Treatment Period|Other|0|||
48324496|NCT01968967|155387053|FG004|Treatment Period|Other|0|||
48324497|NCT01968967|155387049|FG000|Treatment Period|Withdrawal by Subject|71|||
48324498|NCT01968967|155387050|FG001|Treatment Period|Withdrawal by Subject|61|||
48324499|NCT01968967|155387051|FG002|Treatment Period|Withdrawal by Subject|0|||
48324500|NCT01968967|155387052|FG003|Treatment Period|Withdrawal by Subject|0|||
48324501|NCT01968967|155387053|FG004|Treatment Period|Withdrawal by Subject|0|||
48324502|NCT01968967|155387049|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
48324503|NCT01968967|155387050|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
48324504|NCT01968967|155387051|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
48324505|NCT01968967|155387052|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
48324506|NCT01968967|155387053|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
48324507|NCT01968967|155387049|FG000|Treatment Period|Lost to Follow-up|26|||
48324508|NCT01968967|155387050|FG001|Treatment Period|Lost to Follow-up|31|||
48324509|NCT01968967|155387051|FG002|Treatment Period|Lost to Follow-up|0|||
48324510|NCT01968967|155387052|FG003|Treatment Period|Lost to Follow-up|0|||
48324511|NCT01968967|155387053|FG004|Treatment Period|Lost to Follow-up|0|||
48324512|NCT01968967|155387049|FG000|Treatment Period|Protocol Violation|1|||
48324513|NCT01968967|155387050|FG001|Treatment Period|Protocol Violation|2|||
48324514|NCT01968967|155387051|FG002|Treatment Period|Protocol Violation|0|||
48324515|NCT01968967|155387052|FG003|Treatment Period|Protocol Violation|0|||
48324516|NCT01968967|155387053|FG004|Treatment Period|Protocol Violation|0|||
48324517|NCT01968967|155387049|FG000|Treatment Period|Adverse Event|9|||
48324518|NCT01968967|155387050|FG001|Treatment Period|Adverse Event|8|||
48324519|NCT01968967|155387051|FG002|Treatment Period|Adverse Event|0|||
48324520|NCT01968967|155387052|FG003|Treatment Period|Adverse Event|0|||
48324521|NCT01968967|155387053|FG004|Treatment Period|Adverse Event|0|||
48324522|NCT01968967|155387049|FG000|Treatment Period|Death|9|||
48324523|NCT01968967|155387050|FG001|Treatment Period|Death|2|||
48324524|NCT01968967|155387051|FG002|Treatment Period|Death|0|||
48324525|NCT01968967|155387052|FG003|Treatment Period|Death|0|||
48324526|NCT01968967|155387053|FG004|Treatment Period|Death|0|||
48324527|NCT01968967|155387049|FG000|Treatment Period|Randomized Not Treated|6|||
48324528|NCT01968967|155387050|FG001|Treatment Period|Randomized Not Treated|5|||
48324529|NCT01968967|155387051|FG002|Treatment Period|Randomized Not Treated|0|||
48798333|NCT04252742|157098608|FG001|Overall Study|Decision by sponsor|2|||
48324530|NCT01968967|155387052|FG003|Treatment Period|Randomized Not Treated|0|||
48324531|NCT01968967|155387053|FG004|Treatment Period|Randomized Not Treated|0|||
48324532|NCT01968967|155387049|FG000|Extension Period|Withdrew Consent|0|||
48324533|NCT01968967|155387050|FG001|Extension Period|Withdrew Consent|0|||
48324534|NCT01968967|155387051|FG002|Extension Period|Withdrew Consent|2|||
48324535|NCT01968967|155387052|FG003|Extension Period|Withdrew Consent|0|||
48324536|NCT01968967|155387053|FG004|Extension Period|Withdrew Consent|5|||
48324537|NCT01953692|155387060|FG000|Overall Study|Adverse Event|5|||
48324538|NCT01953692|155387061|FG001|Overall Study|Adverse Event|2|||
48798334|NCT04252742|157098607|FG000|Overall Study|Withdrawal by Subject|15|||
48798335|NCT04252742|157098608|FG001|Overall Study|Withdrawal by Subject|9|||
48798336|NCT04252742|157098607|FG000|Overall Study|Lost to Follow-up|0|||
48798337|NCT04252742|157098608|FG001|Overall Study|Lost to Follow-up|1|||
48798338|NCT04040751|157098609|FG000|Overall Study|Withdrawal by Subject|2|||
48798339|NCT04040751|157098610|FG001|Overall Study|Withdrawal by Subject|0|||
48798340|NCT04040751|157098611|FG002|Overall Study|Withdrawal by Subject|2|||
48798341|NCT04040751|157098612|FG003|Overall Study|Withdrawal by Subject|0|||
48798342|NCT02275065|157098619|FG000|Overall Study|Randomized but not treated|1|||
48798343|NCT02275065|157098620|FG001|Overall Study|Randomized but not treated|0|||
48798344|NCT02275065|157098621|FG002|Overall Study|Randomized but not treated|1|||
48798345|NCT02275065|157098622|FG003|Overall Study|Randomized but not treated|1|||
48798346|NCT02275065|157098623|FG004|Overall Study|Randomized but not treated|0|||
48798347|NCT00377403|157098624|FG000|Overall Study|Unable to contact for telephone intervie|4|||
48628195|NCT01107496|156497327|FG000|Overall Study|Protocol Violation|0|||
48628196|NCT01107496|156497328|FG001|Overall Study|Protocol Violation|1|||
48628197|NCT01107496|156497327|FG000|Overall Study|Lost to Follow-up|0|||
48628198|NCT01107496|156497328|FG001|Overall Study|Lost to Follow-up|1|||
48628199|NCT01854775|156497329|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
48628200|NCT01854775|156497330|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
48628201|NCT01854775|156497331|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
48628202|NCT01854775|156497329|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
48628203|NCT01854775|156497330|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
48628204|NCT01854775|156497331|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
48628205|NCT01854775|156497329|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
48628206|NCT01854775|156497330|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
48628207|NCT01854775|156497331|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
48628208|NCT01854775|156497329|FG000|Extension Phase|Pregnancy|3|||
48628209|NCT01854775|156497330|FG001|Extension Phase|Pregnancy|0|||
48742159|NCT02571777|156906206|FG000|Overall Study|Subject/guardian decision|34|||
48742160|NCT02571777|156906207|FG001|Overall Study|Subject/guardian decision|26|||
48742161|NCT02571777|156906208|FG002|Overall Study|Subject/guardian decision|26|||
48324539|NCT01953692|155387062|FG002|Overall Study|Adverse Event|4|||
48324540|NCT01953692|155387063|FG003|Overall Study|Adverse Event|2|||
48628210|NCT01854775|156497331|FG002|Extension Phase|Pregnancy|0|||
48628211|NCT01854775|156497329|FG000|Extension Phase|Investigator's Discretion|1|||
48628212|NCT01854775|156497330|FG001|Extension Phase|Investigator's Discretion|0|||
48628213|NCT01854775|156497331|FG002|Extension Phase|Investigator's Discretion|0|||
48628214|NCT01854775|156497329|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
48628215|NCT01854775|156497330|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
48742162|NCT02571777|156906209|FG003|Overall Study|Subject/guardian decision|25|||
48742163|NCT02571777|156906210|FG004|Overall Study|Subject/guardian decision|27|||
48742164|NCT02571777|156906206|FG000|Overall Study|Protocol Deviation|2|||
48742165|NCT02571777|156906207|FG001|Overall Study|Protocol Deviation|3|||
48742166|NCT02571777|156906208|FG002|Overall Study|Protocol Deviation|4|||
48742167|NCT02571777|156906209|FG003|Overall Study|Protocol Deviation|8|||
48742168|NCT02571777|156906210|FG004|Overall Study|Protocol Deviation|4|||
48742169|NCT02571777|156906206|FG000|Overall Study|Death|1|||
48742170|NCT02571777|156906207|FG001|Overall Study|Death|1|||
48742171|NCT02571777|156906208|FG002|Overall Study|Death|4|||
48742172|NCT02571777|156906209|FG003|Overall Study|Death|0|||
48742173|NCT02571777|156906210|FG004|Overall Study|Death|0|||
48324541|NCT01953692|155387064|FG004|Overall Study|Adverse Event|1|||
48324542|NCT01953692|155387065|FG005|Overall Study|Adverse Event|2|||
48324543|NCT01953692|155387066|FG006|Overall Study|Adverse Event|0|||
48324544|NCT01953692|155387067|FG007|Overall Study|Adverse Event|0|||
48628216|NCT01854775|156497331|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
48628217|NCT01854775|156497329|FG000|Extension Phase|Lost to Follow-up|2|||
48742174|NCT02571777|156906206|FG000|Overall Study|Lost to Follow-up|1|||
48742175|NCT02571777|156906207|FG001|Overall Study|Lost to Follow-up|1|||
48324545|NCT01953692|155387068|FG008|Overall Study|Adverse Event|0|||
48324546|NCT01953692|155387060|FG000|Overall Study|Clinical Progression|0|||
48324547|NCT01953692|155387061|FG001|Overall Study|Clinical Progression|15|||
48324548|NCT01953692|155387062|FG002|Overall Study|Clinical Progression|7|||
48324549|NCT01953692|155387063|FG003|Overall Study|Clinical Progression|5|||
48324550|NCT01953692|155387064|FG004|Overall Study|Clinical Progression|0|||
48324551|NCT01953692|155387065|FG005|Overall Study|Clinical Progression|7|||
48324552|NCT01953692|155387066|FG006|Overall Study|Clinical Progression|20|||
48324553|NCT01953692|155387067|FG007|Overall Study|Clinical Progression|3|||
48324554|NCT01953692|155387068|FG008|Overall Study|Clinical Progression|3|||
48324555|NCT01953692|155387060|FG000|Overall Study|Death|5|||
48324556|NCT01953692|155387061|FG001|Overall Study|Death|0|||
48324557|NCT01953692|155387062|FG002|Overall Study|Death|2|||
48324558|NCT01953692|155387063|FG003|Overall Study|Death|2|||
48324559|NCT01953692|155387064|FG004|Overall Study|Death|1|||
48324560|NCT01953692|155387065|FG005|Overall Study|Death|3|||
48324561|NCT01953692|155387066|FG006|Overall Study|Death|6|||
48324562|NCT01953692|155387067|FG007|Overall Study|Death|2|||
48324563|NCT01953692|155387068|FG008|Overall Study|Death|1|||
48324564|NCT01953692|155387060|FG000|Overall Study|Excluded Medication|1|||
48324565|NCT01953692|155387061|FG001|Overall Study|Excluded Medication|0|||
48324566|NCT01953692|155387062|FG002|Overall Study|Excluded Medication|0|||
48324567|NCT01953692|155387063|FG003|Overall Study|Excluded Medication|0|||
48324568|NCT01953692|155387064|FG004|Overall Study|Excluded Medication|0|||
48324569|NCT01953692|155387065|FG005|Overall Study|Excluded Medication|0|||
48324570|NCT01953692|155387066|FG006|Overall Study|Excluded Medication|0|||
48324571|NCT01953692|155387067|FG007|Overall Study|Excluded Medication|0|||
48324572|NCT01953692|155387068|FG008|Overall Study|Excluded Medication|0|||
48324573|NCT01953692|155387060|FG000|Overall Study|Lost to Follow-up|1|||
48324574|NCT01953692|155387061|FG001|Overall Study|Lost to Follow-up|0|||
48324575|NCT01953692|155387062|FG002|Overall Study|Lost to Follow-up|3|||
48324576|NCT01953692|155387063|FG003|Overall Study|Lost to Follow-up|1|||
48324577|NCT01953692|155387064|FG004|Overall Study|Lost to Follow-up|0|||
48324578|NCT01953692|155387065|FG005|Overall Study|Lost to Follow-up|1|||
48324579|NCT01953692|155387066|FG006|Overall Study|Lost to Follow-up|0|||
48324580|NCT01953692|155387067|FG007|Overall Study|Lost to Follow-up|0|||
48324581|NCT01953692|155387068|FG008|Overall Study|Lost to Follow-up|0|||
48324582|NCT01953692|155387060|FG000|Overall Study|Physician Decision|11|||
48324583|NCT01953692|155387061|FG001|Overall Study|Physician Decision|4|||
48628218|NCT01854775|156497330|FG001|Extension Phase|Lost to Follow-up|0|||
48628219|NCT01854775|156497331|FG002|Extension Phase|Lost to Follow-up|0|||
48628220|NCT01854775|156497329|FG000|Extension Phase|Still on Study|32|||
48628221|NCT01854775|156497330|FG001|Extension Phase|Still on Study|47|||
48628222|NCT01854775|156497331|FG002|Extension Phase|Still on Study|18|||
48742176|NCT02571777|156906208|FG002|Overall Study|Lost to Follow-up|2|||
48742177|NCT02571777|156906209|FG003|Overall Study|Lost to Follow-up|0|||
48742178|NCT02571777|156906210|FG004|Overall Study|Lost to Follow-up|1|||
48742179|NCT02571777|156906206|FG000|Overall Study|Physician Decision|1|||
48324584|NCT01953692|155387062|FG002|Overall Study|Physician Decision|2|||
48324585|NCT01953692|155387063|FG003|Overall Study|Physician Decision|2|||
48324586|NCT01953692|155387064|FG004|Overall Study|Physician Decision|1|||
48324587|NCT01953692|155387065|FG005|Overall Study|Physician Decision|2|||
48324588|NCT01953692|155387066|FG006|Overall Study|Physician Decision|4|||
48324589|NCT01953692|155387067|FG007|Overall Study|Physician Decision|1|||
48324590|NCT01953692|155387068|FG008|Overall Study|Physician Decision|0|||
48324591|NCT01953692|155387060|FG000|Overall Study|Protocol Violation|0|||
48628223|NCT03709472|156497332|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
48628224|NCT03709472|156497333|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
48742180|NCT02571777|156906207|FG001|Overall Study|Physician Decision|7|||
48324592|NCT01953692|155387061|FG001|Overall Study|Protocol Violation|2|||
48324593|NCT01953692|155387062|FG002|Overall Study|Protocol Violation|1|||
48324594|NCT01953692|155387063|FG003|Overall Study|Protocol Violation|0|||
48324595|NCT01953692|155387064|FG004|Overall Study|Protocol Violation|0|||
48324596|NCT01953692|155387065|FG005|Overall Study|Protocol Violation|0|||
48324597|NCT01953692|155387066|FG006|Overall Study|Protocol Violation|0|||
48324598|NCT01953692|155387067|FG007|Overall Study|Protocol Violation|1|||
48742181|NCT02571777|156906208|FG002|Overall Study|Physician Decision|5|||
48742182|NCT02571777|156906209|FG003|Overall Study|Physician Decision|2|||
48742183|NCT02571777|156906210|FG004|Overall Study|Physician Decision|4|||
48742184|NCT02571777|156906206|FG000|Overall Study|Pregnancy|0|||
48742185|NCT02571777|156906207|FG001|Overall Study|Pregnancy|0|||
48742186|NCT02571777|156906208|FG002|Overall Study|Pregnancy|0|||
48742187|NCT02571777|156906209|FG003|Overall Study|Pregnancy|2|||
48742188|NCT02571777|156906210|FG004|Overall Study|Pregnancy|0|||
48742189|NCT03706079|156906212|FG000|Predecessor Study|Death|0|||
48742190|NCT03706079|156906213|FG001|Predecessor Study|Death|2|||
48742191|NCT03706079|156906214|FG002|Predecessor Study|Death|0|||
48742192|NCT03706079|156906215|FG003|Predecessor Study|Death|1|||
48324599|NCT01953692|155387068|FG008|Overall Study|Protocol Violation|0|||
48742193|NCT03706079|156906216|FG004|Predecessor Study|Death|0|||
48324600|NCT01953692|155387060|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48628225|NCT03709472|156497332|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
48628226|NCT03709472|156497333|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
48628227|NCT03559556|156497334|FG000|Overall Study|Withdrawal by Subject|1|||
48628228|NCT02097225|156497335|FG000|Dose Level 4|Adverse Event|0|||
48628229|NCT02097225|156497336|FG001|Dose Level 4|Adverse Event|0|||
48628230|NCT02097225|156497337|FG002|Dose Level 4|Adverse Event|0|||
48628231|NCT02097225|156497338|FG003|Dose Level 4|Adverse Event|0|||
48628232|NCT02097225|156497339|FG004|Dose Level 4|Adverse Event|1|||
48628233|NCT02971137|156497340|FG000|Overall Study|Lost to Follow-up|44|||
48628234|NCT02971137|156497341|FG001|Overall Study|Lost to Follow-up|56|||
48628235|NCT04650893|156497346|FG000|Overall Study|Lost to Follow-up|11|||
48628236|NCT04650893|156497347|FG001|Overall Study|Lost to Follow-up|10|||
48628237|NCT04650893|156497348|FG002|Overall Study|Lost to Follow-up|11|||
48628238|NCT01044459|156497349|FG000|Overall Study|Withdrawal by Subject|21|||
48628239|NCT01044459|156497350|FG001|Overall Study|Withdrawal by Subject|28|||
48628240|NCT01044459|156497349|FG000|Overall Study|Terminated by Sponsor|22|||
48628241|NCT01044459|156497350|FG001|Overall Study|Terminated by Sponsor|21|||
48628242|NCT01044459|156497349|FG000|Overall Study|Adverse Event|22|||
48628243|NCT01044459|156497350|FG001|Overall Study|Adverse Event|20|||
48628244|NCT01044459|156497349|FG000|Overall Study|Lack of Efficacy|23|||
48628245|NCT01044459|156497350|FG001|Overall Study|Lack of Efficacy|12|||
48628246|NCT01044459|156497349|FG000|Overall Study|Protocol Violation|11|||
48628247|NCT01044459|156497350|FG001|Overall Study|Protocol Violation|16|||
48628248|NCT01044459|156497349|FG000|Overall Study|Other Reason|7|||
48628249|NCT01044459|156497350|FG001|Overall Study|Other Reason|14|||
48628250|NCT01044459|156497349|FG000|Overall Study|COPD exacerbation|9|||
48628251|NCT01044459|156497350|FG001|Overall Study|COPD exacerbation|8|||
48628252|NCT01044459|156497349|FG000|Overall Study|Lost to Follow-up|18|||
48628253|NCT01044459|156497350|FG001|Overall Study|Lost to Follow-up|12|||
48628254|NCT02781558|156497351|FG000|Overall Study|Lost to Follow-up|2|||
48628255|NCT02781558|156497352|FG001|Overall Study|Lost to Follow-up|2|||
48628256|NCT02781558|156497351|FG000|Overall Study|Adverse Event|1|||
48628257|NCT02781558|156497352|FG001|Overall Study|Adverse Event|0|||
48628258|NCT01586910|156498622|FG000|Overall Study|Death|4|||
48628259|NCT01586910|156498623|FG001|Overall Study|Death|4|||
48628260|NCT01586910|156498622|FG000|Overall Study|Withdrawal by Subject|6|||
48628261|NCT01586910|156498623|FG001|Overall Study|Withdrawal by Subject|43|||
48628262|NCT01586910|156498622|FG000|Overall Study|Physician withdrew Subject|5|||
48628263|NCT01586910|156498623|FG001|Overall Study|Physician withdrew Subject|24|||
48628264|NCT02113878|156498624|FG000|Overall Study|Adverse Event|1|||
48628265|NCT02113878|156498625|FG001|Overall Study|Adverse Event|0|||
48628266|NCT02113878|156498624|FG000|Overall Study|Withdrawal by Subject|1|||
48628267|NCT02113878|156498625|FG001|Overall Study|Withdrawal by Subject|0|||
48628268|NCT02113878|156498624|FG000|Overall Study|patient non-compliance|1|||
48628269|NCT02113878|156498625|FG001|Overall Study|patient non-compliance|0|||
48628270|NCT04280783|156498626|FG000|Overall Study|Family issues unrelated to the study.|1|||
48628271|NCT04280783|156498627|FG001|Overall Study|Family issues unrelated to the study.|0|||
48628272|NCT04280783|156498626|FG000|Overall Study|Withdrawal by Subject|0|||
48628273|NCT04280783|156498627|FG001|Overall Study|Withdrawal by Subject|1|||
48628274|NCT03443401|156498628|FG000|Overall Study|Lost to Follow-up|13|||
48628275|NCT03443401|156498628|FG000|Overall Study|Influential outlier|1|||
48628276|NCT00530257|156498629|FG000|Overall Study|Lost to Follow-up|1|||
48628277|NCT00944645|156498631|FG000|Period 2|Adverse Event|1|||
48628278|NCT00944645|156498632|FG001|Period 2|Adverse Event|0|||
48628279|NCT00944645|156498631|FG000|Period 2|Lost to Follow-up|0|||
48628280|NCT00944645|156498632|FG001|Period 2|Lost to Follow-up|3|||
48628281|NCT00944645|156498631|FG000|Period 2|Withdrawal by Subject|7|||
48628282|NCT00944645|156498632|FG001|Period 2|Withdrawal by Subject|6|||
48628283|NCT02579759|156498633|FG000|Overall Study|Protocol Violation|2|||
48742194|NCT03706079|156906217|FG005|Predecessor Study|Death|0|||
48742195|NCT03706079|156906212|FG000|Predecessor Study|Lost to Follow-up|5|||
48742196|NCT03706079|156906213|FG001|Predecessor Study|Lost to Follow-up|2|||
48742197|NCT03706079|156906214|FG002|Predecessor Study|Lost to Follow-up|0|||
48628284|NCT02579759|156498634|FG001|Overall Study|Protocol Violation|0|||
48742198|NCT03706079|156906215|FG003|Predecessor Study|Lost to Follow-up|0|||
48742199|NCT03706079|156906216|FG004|Predecessor Study|Lost to Follow-up|1|||
48628285|NCT02579759|156498635|FG002|Overall Study|Protocol Violation|0|||
48628286|NCT02579759|156498633|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
48628287|NCT02579759|156498634|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
48628288|NCT02579759|156498635|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
48628289|NCT02579759|156498633|FG000|Overall Study|BfArM hold|13|||
48628290|NCT02579759|156498634|FG001|Overall Study|BfArM hold|12|||
48628291|NCT02579759|156498635|FG002|Overall Study|BfArM hold|12|||
48628292|NCT02579759|156498633|FG000|Overall Study|Sponsor stopped Dose 2|0|||
48628293|NCT02579759|156498634|FG001|Overall Study|Sponsor stopped Dose 2|41|||
48628294|NCT02579759|156498635|FG002|Overall Study|Sponsor stopped Dose 2|0|||
48628295|NCT02579759|156498633|FG000|Overall Study|Non compliance|0|||
48628296|NCT02579759|156498634|FG001|Overall Study|Non compliance|1|||
48628297|NCT02579759|156498635|FG002|Overall Study|Non compliance|0|||
48742200|NCT03706079|156906217|FG005|Predecessor Study|Lost to Follow-up|0|||
48742201|NCT03706079|156906212|FG000|Predecessor Study|Withdrawal by Subject|8|||
48742202|NCT03706079|156906213|FG001|Predecessor Study|Withdrawal by Subject|15|||
48742203|NCT03706079|156906214|FG002|Predecessor Study|Withdrawal by Subject|0|||
48742204|NCT03706079|156906215|FG003|Predecessor Study|Withdrawal by Subject|5|||
48742205|NCT03706079|156906216|FG004|Predecessor Study|Withdrawal by Subject|2|||
48742206|NCT03706079|156906217|FG005|Predecessor Study|Withdrawal by Subject|0|||
48742207|NCT03706079|156906212|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
48742208|NCT03706079|156906213|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
48742209|NCT03706079|156906214|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
48742210|NCT03706079|156906215|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
48742211|NCT03706079|156906216|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
48742212|NCT03706079|156906217|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
48742213|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742214|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742215|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742216|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742217|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
48742218|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
48742219|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
48742220|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
48742221|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
48742222|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
48742223|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
48742224|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
48742225|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
48742226|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742227|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742228|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742229|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742230|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
48742231|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
48742232|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
48742233|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
48742234|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
48742235|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
48742236|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
48742237|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
48742238|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
48742239|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
48742240|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
48742241|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
48628298|NCT02579759|156498633|FG000|Overall Study|Pregnancy|0|||
48742242|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
48742243|NCT03706079|156906212|FG000|Long Term Extension (DESTINATION)|Death|8|||
48742244|NCT03706079|156906213|FG001|Long Term Extension (DESTINATION)|Death|2|||
48742245|NCT03706079|156906214|FG002|Long Term Extension (DESTINATION)|Death|2|||
48742246|NCT03706079|156906215|FG003|Long Term Extension (DESTINATION)|Death|1|||
48628299|NCT02579759|156498634|FG001|Overall Study|Pregnancy|1|||
48628300|NCT02579759|156498635|FG002|Overall Study|Pregnancy|0|||
48628301|NCT02579759|156498633|FG000|Overall Study|Inclusion/exclusion criteria|0|||
48628302|NCT02579759|156498634|FG001|Overall Study|Inclusion/exclusion criteria|0|||
48628303|NCT02579759|156498635|FG002|Overall Study|Inclusion/exclusion criteria|1|||
48628304|NCT02579759|156498633|FG000|Overall Study|Adverse Event|4|||
48628305|NCT02579759|156498634|FG001|Overall Study|Adverse Event|3|||
48628306|NCT02579759|156498635|FG002|Overall Study|Adverse Event|1|||
48742247|NCT03706079|156906216|FG004|Long Term Extension (DESTINATION)|Death|0|||
48628307|NCT02579759|156498633|FG000|Overall Study|Withdrawal by Subject|3|||
48742248|NCT03706079|156906217|FG005|Long Term Extension (DESTINATION)|Death|0|||
48742249|NCT03095612|156906218|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742250|NCT03095612|156906219|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
48742251|NCT03095612|156906220|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742252|NCT03095612|156906221|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742253|NCT03095612|156906222|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742254|NCT03095612|156906223|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742255|NCT03095612|156906224|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
48742256|NCT00633750|156906225|FG000|Overall Study|Adverse Event|2|||
48742257|NCT00633750|156906225|FG000|Overall Study|Withdrawal by Subject|3|||
48742258|NCT02362269|156906226|FG000|Overall Study|Moved|1|||
48742259|NCT02362269|156906227|FG001|Overall Study|Moved|0|||
48742260|NCT02362269|156906226|FG000|Overall Study|Lost to Follow-up|0|||
48742261|NCT02362269|156906227|FG001|Overall Study|Lost to Follow-up|6|||
48742262|NCT03953820|156906228|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
48742263|NCT03953820|156906229|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
48742264|NCT03953820|156906230|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
48742265|NCT03953820|156906228|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
48742266|NCT03953820|156906229|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
48742267|NCT03953820|156906230|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
48742268|NCT03988088|156906235|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
48742269|NCT03988088|156906236|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
48742270|NCT03988088|156906237|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
48742271|NCT03988088|156906238|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
48742272|NCT03988088|156906235|FG000|Open-Label Addendum|Lost to Follow-up|0|||
48742273|NCT03988088|156906236|FG001|Open-Label Addendum|Lost to Follow-up|0|||
48742274|NCT03988088|156906237|FG002|Open-Label Addendum|Lost to Follow-up|1|||
48742275|NCT03988088|156906238|FG003|Open-Label Addendum|Lost to Follow-up|0|||
48742276|NCT01218243|156906240|FG000|Overall Study|Lack of Efficacy|1|||
48742277|NCT01218243|156906241|FG001|Overall Study|Lack of Efficacy|1|||
48742278|NCT01218243|156906240|FG000|Overall Study|Lost to Follow-up|3|||
48742279|NCT01218243|156906241|FG001|Overall Study|Lost to Follow-up|3|||
48742280|NCT01218243|156906240|FG000|Overall Study|Protocol Violation|5|||
48742281|NCT01218243|156906241|FG001|Overall Study|Protocol Violation|10|||
48742282|NCT01387789|156906243|FG000|Overall Study|Adverse Event|5|||
48742283|NCT01387789|156906243|FG000|Overall Study|Lack of Efficacy|2|||
48742284|NCT01387789|156906243|FG000|Overall Study|Lost to Follow-up|1|||
48742285|NCT01233258|156906244|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
48742286|NCT01233258|156906245|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
48742287|NCT01233258|156906246|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
48742288|NCT01233258|156906247|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
48742289|NCT01233258|156906248|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
48742290|NCT01233258|156906249|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
48742291|NCT01233258|156906244|FG000|First Intervention (6 Months)|Protocol Violation|0|||
48742292|NCT01233258|156906245|FG001|First Intervention (6 Months)|Protocol Violation|0|||
48742293|NCT01233258|156906246|FG002|First Intervention (6 Months)|Protocol Violation|1|||
48742294|NCT01233258|156906247|FG003|First Intervention (6 Months)|Protocol Violation|0|||
48742295|NCT01233258|156906248|FG004|First Intervention (6 Months)|Protocol Violation|0|||
48742296|NCT01233258|156906249|FG005|First Intervention (6 Months)|Protocol Violation|0|||
48742297|NCT01233258|156906244|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
48628308|NCT02579759|156498634|FG001|Overall Study|Withdrawal by Subject|3|||
48742298|NCT01233258|156906245|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742299|NCT01233258|156906246|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742300|NCT01233258|156906247|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742301|NCT01233258|156906248|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742302|NCT01233258|156906249|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
48742303|NCT01546883|156906250|FG000|Overall Study|Withdrawal by Subject|3|||
48742304|NCT01546883|156906250|FG000|Overall Study|Adverse Event|4|||
48742305|NCT01546883|156906250|FG000|Overall Study|Lost to Follow-up|2|||
48742306|NCT01546883|156906250|FG000|Overall Study|early closure of study|2|||
48628309|NCT02579759|156498635|FG002|Overall Study|Withdrawal by Subject|5|||
48628310|NCT02579759|156498633|FG000|Overall Study|Lost to Follow-up|2|||
48628311|NCT02579759|156498634|FG001|Overall Study|Lost to Follow-up|2|||
48628312|NCT02579759|156498635|FG002|Overall Study|Lost to Follow-up|2|||
48628313|NCT03436732|156498636|FG000|Overall Study|Not treated-enrolled in different study|1|||
48628314|NCT03436732|156498637|FG001|Overall Study|Not treated-enrolled in different study|0|||
48628315|NCT03436732|156498636|FG000|Overall Study|Off study after cycle 1|1|||
48628316|NCT03436732|156498637|FG001|Overall Study|Off study after cycle 1|0|||
48628317|NCT03436732|156498636|FG000|Overall Study|Adverse Event|2|||
48628318|NCT03436732|156498637|FG001|Overall Study|Adverse Event|0|||
48628319|NCT03436732|156498636|FG000|Overall Study|Death|0|||
48628320|NCT03436732|156498637|FG001|Overall Study|Death|1|||
48628321|NCT02254460|156498640|FG000|Overall Study|Adverse Event|1|||
48628322|NCT02254460|156498641|FG001|Overall Study|Adverse Event|0|||
48628323|NCT02093520|156498642|FG000|Overall Study|Not treated|6|||
48628324|NCT02093520|156498643|FG001|Overall Study|Not treated|22|||
48628325|NCT01149460|156498644|FG000|Overall Study|Withdrawal by Subject|0|||
48628326|NCT01149460|156498645|FG001|Overall Study|Withdrawal by Subject|2|||
48628327|NCT01892189|156498657|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
48628328|NCT01892189|156498658|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
48628329|NCT01892189|156498659|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
48628330|NCT01892189|156498660|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
48628331|NCT01892189|156498661|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
48628332|NCT01892189|156498662|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
48628333|NCT01892189|156498663|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
48628334|NCT01892189|156498664|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
48628335|NCT01892189|156498665|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
48628336|NCT01892189|156498657|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48742307|NCT01546883|156906250|FG000|Overall Study|other unrelated illness|1|||
48742308|NCT01534962|156906253|FG000|Overall Study|Randomized but did not start treatment|2|||
48742309|NCT01534962|156906254|FG001|Overall Study|Randomized but did not start treatment|0|||
48742310|NCT01534962|156906255|FG002|Overall Study|Randomized but did not start treatment|0|||
48324601|NCT01953692|155387061|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48324602|NCT01953692|155387062|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48742311|NCT01534962|156906256|FG003|Overall Study|Randomized but did not start treatment|1|||
48742312|NCT01534962|156906253|FG000|Overall Study|Discontinued at AF recurrence|35|||
48742313|NCT01534962|156906254|FG001|Overall Study|Discontinued at AF recurrence|26|||
48742314|NCT01534962|156906255|FG002|Overall Study|Discontinued at AF recurrence|24|||
48742315|NCT01534962|156906256|FG003|Overall Study|Discontinued at AF recurrence|31|||
48742316|NCT02243696|156906257|FG000|Overall Study|Death|282|||
48742317|NCT02243696|156906257|FG000|Overall Study|Withdrawal by Subject|79|||
48742318|NCT02243696|156906257|FG000|Overall Study|Lost to Follow-up|57|||
48742319|NCT02243696|156906257|FG000|Overall Study|Subject No Longer has Study System|42|||
48742320|NCT02243696|156906257|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
48742321|NCT02243696|156906257|FG000|Overall Study|Study Terminated for EP PASSION|961|||
48324603|NCT01953692|155387063|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48324604|NCT01953692|155387064|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48628337|NCT01892189|156498658|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48628338|NCT01892189|156498659|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
48628339|NCT01892189|156498660|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
48742322|NCT00282984|156906258|FG000|Overall Study|Death|2|||
48742323|NCT00282984|156906259|FG001|Overall Study|Death|5|||
48742324|NCT00282984|156906258|FG000|Overall Study|Adverse Event|8|||
48628340|NCT01892189|156498661|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48628341|NCT01892189|156498662|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48628342|NCT01892189|156498663|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
48628343|NCT01892189|156498664|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48324605|NCT01953692|155387065|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48324606|NCT01953692|155387066|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48324607|NCT01953692|155387067|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
48324608|NCT01953692|155387068|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
48324609|NCT01953692|155387060|FG000|Overall Study|Withdrawal by Subject|4|||
48324610|NCT01953692|155387061|FG001|Overall Study|Withdrawal by Subject|2|||
48324611|NCT01953692|155387062|FG002|Overall Study|Withdrawal by Subject|1|||
48324612|NCT01953692|155387063|FG003|Overall Study|Withdrawal by Subject|2|||
48324613|NCT01953692|155387064|FG004|Overall Study|Withdrawal by Subject|0|||
48324614|NCT01953692|155387065|FG005|Overall Study|Withdrawal by Subject|3|||
48324615|NCT01953692|155387066|FG006|Overall Study|Withdrawal by Subject|2|||
48324616|NCT01953692|155387067|FG007|Overall Study|Withdrawal by Subject|1|||
48324617|NCT01953692|155387068|FG008|Overall Study|Withdrawal by Subject|1|||
48324618|NCT02251652|155387069|FG000|Overall Study|Withdrawal by Subject|1|||
48324619|NCT00822120|155387072|FG000|Initial Registration|Adverse Event|1|||
48324620|NCT00822120|155387073|FG001|Initial Registration|Adverse Event|0|||
48324621|NCT00822120|155387074|FG002|Initial Registration|Adverse Event|0|||
48324622|NCT00822120|155387075|FG003|Initial Registration|Adverse Event|0|||
48628344|NCT01892189|156498665|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
48628345|NCT01892189|156498657|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48628346|NCT01892189|156498658|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48628347|NCT01892189|156498659|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48628348|NCT01892189|156498660|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48628349|NCT01892189|156498661|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48628350|NCT01892189|156498662|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
48628351|NCT01892189|156498663|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48628352|NCT01892189|156498664|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48628353|NCT01892189|156498665|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
48628354|NCT03802916|156498666|FG000|Overall Study|Adverse Event|0|||
48628355|NCT03802916|156498667|FG001|Overall Study|Adverse Event|1|||
48628356|NCT03802916|156498666|FG000|Overall Study|Withdrawal by Subject|0|||
48628357|NCT03802916|156498667|FG001|Overall Study|Withdrawal by Subject|1|||
48628358|NCT00605189|156498668|FG000|Overall Study|Adverse Event|1|||
48628359|NCT00605189|156498669|FG001|Overall Study|Adverse Event|0|||
48628360|NCT00605189|156498670|FG002|Overall Study|Adverse Event|0|||
48628361|NCT00605189|156498668|FG000|Overall Study|Other|2|||
48628362|NCT00605189|156498669|FG001|Overall Study|Other|2|||
48628363|NCT00605189|156498670|FG002|Overall Study|Other|0|||
48628364|NCT03253627|156498671|FG000|Overall Study|Lost to Follow-up|1|||
48628365|NCT03253627|156498672|FG001|Overall Study|Lost to Follow-up|2|||
48628366|NCT03253627|156498671|FG000|Overall Study|Withdrawal by Subject|0|||
48628367|NCT03253627|156498672|FG001|Overall Study|Withdrawal by Subject|2|||
48628368|NCT03253627|156498671|FG000|Overall Study|Inability to complete MRI|1|||
48628369|NCT03253627|156498672|FG001|Overall Study|Inability to complete MRI|0|||
48628370|NCT00539500|156498678|FG000|Overall Study|Disease Progression|1|||
48628371|NCT00539500|156498678|FG000|Overall Study|Lost to Follow-up|2|||
48628372|NCT03777020|156498679|FG000|Overall Study|Withdrawal by Subject|4|||
48628373|NCT03777020|156498680|FG001|Overall Study|Withdrawal by Subject|4|||
48628374|NCT03777020|156498679|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
48628375|NCT03777020|156498680|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
48628376|NCT00803049|156498682|FG000|Overall Study|Adverse Event|21|||
48628377|NCT00803049|156498683|FG001|Overall Study|Adverse Event|33|||
48628378|NCT00803049|156498684|FG002|Overall Study|Adverse Event|13|||
48628379|NCT00803049|156498685|FG003|Overall Study|Adverse Event|27|||
48628380|NCT00803049|156498682|FG000|Overall Study|Lack of Efficacy|10|||
48628381|NCT00803049|156498683|FG001|Overall Study|Lack of Efficacy|19|||
48628382|NCT00803049|156498684|FG002|Overall Study|Lack of Efficacy|6|||
48628383|NCT00803049|156498685|FG003|Overall Study|Lack of Efficacy|13|||
48628384|NCT00803049|156498682|FG000|Overall Study|Lost to Follow-up|0|||
48628385|NCT00803049|156498683|FG001|Overall Study|Lost to Follow-up|2|||
48628386|NCT00803049|156498684|FG002|Overall Study|Lost to Follow-up|0|||
48628387|NCT00803049|156498685|FG003|Overall Study|Lost to Follow-up|3|||
48628388|NCT00803049|156498682|FG000|Overall Study|Death|2|||
48628389|NCT00803049|156498683|FG001|Overall Study|Death|1|||
48628390|NCT00803049|156498684|FG002|Overall Study|Death|0|||
48628391|NCT00803049|156498685|FG003|Overall Study|Death|2|||
48628392|NCT00803049|156498682|FG000|Overall Study|Progressive Disease|6|||
48628393|NCT00803049|156498683|FG001|Overall Study|Progressive Disease|10|||
48628394|NCT00803049|156498684|FG002|Overall Study|Progressive Disease|6|||
48628395|NCT00803049|156498685|FG003|Overall Study|Progressive Disease|6|||
48628396|NCT00803049|156498682|FG000|Overall Study|Withdrawal by Subject|19|||
48742325|NCT00282984|156906259|FG001|Overall Study|Adverse Event|5|||
48742326|NCT00282984|156906258|FG000|Overall Study|Lack of Efficacy|0|||
48628397|NCT00803049|156498683|FG001|Overall Study|Withdrawal by Subject|43|||
48742327|NCT00282984|156906259|FG001|Overall Study|Lack of Efficacy|2|||
48742328|NCT00282984|156906258|FG000|Overall Study|Lost to Follow-up|14|||
48628398|NCT00803049|156498684|FG002|Overall Study|Withdrawal by Subject|16|||
48628399|NCT00803049|156498685|FG003|Overall Study|Withdrawal by Subject|44|||
48628400|NCT00803049|156498682|FG000|Overall Study|Protocol Violation|0|||
48628401|NCT00803049|156498683|FG001|Overall Study|Protocol Violation|1|||
48628402|NCT00803049|156498684|FG002|Overall Study|Protocol Violation|1|||
48628403|NCT00803049|156498685|FG003|Overall Study|Protocol Violation|0|||
48742329|NCT00282984|156906259|FG001|Overall Study|Lost to Follow-up|10|||
48742330|NCT00282984|156906258|FG000|Overall Study|Withdrawal by Participant|22|||
48742331|NCT00282984|156906259|FG001|Overall Study|Withdrawal by Participant|34|||
48628404|NCT00803049|156498682|FG000|Overall Study|Randomized and Not Treated|0|||
48628405|NCT00803049|156498683|FG001|Overall Study|Randomized and Not Treated|0|||
48628406|NCT00803049|156498684|FG002|Overall Study|Randomized and Not Treated|0|||
48628407|NCT00803049|156498685|FG003|Overall Study|Randomized and Not Treated|2|||
48628408|NCT00803049|156498682|FG000|Overall Study|Other than Specified Above|3|||
48628409|NCT00803049|156498683|FG001|Overall Study|Other than Specified Above|9|||
48628410|NCT00803049|156498684|FG002|Overall Study|Other than Specified Above|2|||
48628411|NCT00803049|156498685|FG003|Overall Study|Other than Specified Above|5|||
48628412|NCT02052882|156498686|FG000|Overall Study|Not treated|11|||
48628413|NCT02052882|156498686|FG000|Overall Study|Protocol Violation|1|||
48628414|NCT02052882|156498686|FG000|Overall Study|Inadequate testing|1|||
48628415|NCT01344226|156498687|FG000|Overall Study|Protocol Violation|2|||
48628416|NCT01344226|156498687|FG000|Overall Study|Withdrawal by Subject|3|||
48742332|NCT00282984|156906258|FG000|Overall Study|Participant stopped study medication|2|||
48742333|NCT00282984|156906259|FG001|Overall Study|Participant stopped study medication|2|||
48742334|NCT00282984|156906258|FG000|Overall Study|Participant only allowed phone follow-up|0|||
48742335|NCT00282984|156906259|FG001|Overall Study|Participant only allowed phone follow-up|1|||
48742336|NCT00282984|156906258|FG000|Overall Study|Participant used antipsychosis meds|0|||
48742337|NCT00282984|156906259|FG001|Overall Study|Participant used antipsychosis meds|1|||
48742338|NCT00282984|156906258|FG000|Overall Study|lack of motivation|1|||
48742339|NCT00282984|156906259|FG001|Overall Study|lack of motivation|0|||
48742340|NCT00282984|156906258|FG000|Overall Study|in prison|0|||
48742341|NCT00282984|156906259|FG001|Overall Study|in prison|1|||
48742342|NCT00282984|156906258|FG000|Overall Study|Protocol Violation|2|||
48742343|NCT00282984|156906259|FG001|Overall Study|Protocol Violation|0|||
48742344|NCT00087607|156906260|FG000|Overall Study|Adverse Event|14|||
48742345|NCT00087607|156906261|FG001|Overall Study|Adverse Event|24|||
48324623|NCT00822120|155387076|FG004|Initial Registration|Adverse Event|0|||
48324624|NCT00822120|155387077|FG005|Initial Registration|Adverse Event|0|||
48324625|NCT00822120|155387072|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
48324626|NCT00822120|155387073|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48324627|NCT00822120|155387074|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48324628|NCT00822120|155387075|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48324629|NCT00822120|155387076|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48324630|NCT00822120|155387077|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48324631|NCT00822120|155387072|FG000|Initial Registration|Reasons not Protocol Specified|2|||
48324632|NCT00822120|155387073|FG001|Initial Registration|Reasons not Protocol Specified|0|||
48324633|NCT00822120|155387074|FG002|Initial Registration|Reasons not Protocol Specified|0|||
48324634|NCT00822120|155387075|FG003|Initial Registration|Reasons not Protocol Specified|0|||
48324635|NCT00822120|155387076|FG004|Initial Registration|Reasons not Protocol Specified|0|||
48324636|NCT00822120|155387077|FG005|Initial Registration|Reasons not Protocol Specified|0|||
48324637|NCT00822120|155387072|FG000|Initial Registration|Ineligible|22|||
48324638|NCT00822120|155387073|FG001|Initial Registration|Ineligible|1|||
48324639|NCT00822120|155387074|FG002|Initial Registration|Ineligible|0|||
48628417|NCT01344226|156498687|FG000|Overall Study|Lack of Efficacy|3|||
48628418|NCT02255656|156498688|FG000|Overall Study|Adverse Event|11|||
48628419|NCT02255656|156498688|FG000|Overall Study|Poor compliance to protocol|3|||
48628420|NCT02255656|156498688|FG000|Overall Study|Lost to Follow-up|30|||
48628421|NCT02255656|156498688|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
48628422|NCT02255656|156498688|FG000|Overall Study|Other|126|||
48628423|NCT02321514|156498690|FG000|Overall Study|Death|15|||
48628424|NCT02321514|156498690|FG000|Overall Study|Missed Visit|7|||
48628425|NCT02321514|156498690|FG000|Overall Study|Study Exit|3|||
48628426|NCT04576455|156498691|FG000|Overall Study|Ongoing in the Study|122|||
48628427|NCT04576455|156498692|FG001|Overall Study|Ongoing in the Study|135|||
48628428|NCT04576455|156498691|FG000|Overall Study|Death|18|||
48628429|NCT04576455|156498692|FG001|Overall Study|Death|12|||
48628430|NCT04576455|156498691|FG000|Overall Study|Lost to Follow-up|1|||
48628431|NCT04576455|156498692|FG001|Overall Study|Lost to Follow-up|0|||
48628432|NCT04576455|156498691|FG000|Overall Study|Withdrawal by Subject|10|||
48628433|NCT04576455|156498692|FG001|Overall Study|Withdrawal by Subject|5|||
48628434|NCT02679274|156498693|FG000|Overall Study|Withdrawal by Subject|1|||
48628435|NCT02679274|156498694|FG001|Overall Study|Withdrawal by Subject|0|||
48628436|NCT03510715|156498695|FG000|Overall Study|Adverse Event|1|||
48742346|NCT00087607|156906260|FG000|Overall Study|Death|0|||
48742347|NCT00087607|156906261|FG001|Overall Study|Death|1|||
48742348|NCT00087607|156906260|FG000|Overall Study|Insufficient Therapeutic Response|53|||
48628437|NCT03510715|156498696|FG001|Overall Study|Adverse Event|0|||
48628438|NCT00322218|156498702|FG000|Overall Study|Death|3|||
48628439|NCT00322218|156498703|FG001|Overall Study|Death|6|||
48628440|NCT05185453|156498711|FG000|Overall Study|Lost to Follow-up|13|||
48628441|NCT05185453|156498712|FG001|Overall Study|Lost to Follow-up|3|||
48628442|NCT05715827|156498721|FG000|Overall Study|Physician Decision|0|||
48628443|NCT05715827|156498722|FG001|Overall Study|Physician Decision|1|||
48628444|NCT05715827|156498721|FG000|Overall Study|console communication error|0|||
48324640|NCT00822120|155387075|FG003|Initial Registration|Ineligible|0|||
48628445|NCT05715827|156498722|FG001|Overall Study|console communication error|1|||
48628446|NCT03274466|156498736|FG000|Overall Study|Withdrawal by Subject|7|||
48628447|NCT03274466|156498737|FG001|Overall Study|Withdrawal by Subject|3|||
48628448|NCT03274466|156498736|FG000|Overall Study|Protocol Specified Withdrawal|5|||
48628449|NCT03274466|156498737|FG001|Overall Study|Protocol Specified Withdrawal|11|||
48628450|NCT03274466|156498736|FG000|Overall Study|Lost to Follow-up|5|||
48628451|NCT03274466|156498737|FG001|Overall Study|Lost to Follow-up|7|||
48628452|NCT03274466|156498736|FG000|Overall Study|Subject Non-compliance|0|||
48628453|NCT03274466|156498737|FG001|Overall Study|Subject Non-compliance|1|||
48628454|NCT03274466|156498736|FG000|Overall Study|Adverse Event|3|||
48628455|NCT03274466|156498737|FG001|Overall Study|Adverse Event|3|||
48628456|NCT03274466|156498736|FG000|Overall Study|Physician Decision|0|||
48628457|NCT03274466|156498737|FG001|Overall Study|Physician Decision|1|||
48324641|NCT00822120|155387076|FG004|Initial Registration|Ineligible|0|||
48324642|NCT00822120|155387077|FG005|Initial Registration|Ineligible|0|||
48324643|NCT00822120|155387072|FG000|PET-directed Therapy|Adverse Event|0|||
48324644|NCT00822120|155387073|FG001|PET-directed Therapy|Adverse Event|0|||
48324645|NCT00822120|155387074|FG002|PET-directed Therapy|Adverse Event|0|||
48324646|NCT00822120|155387075|FG003|PET-directed Therapy|Adverse Event|1|||
48324647|NCT00822120|155387076|FG004|PET-directed Therapy|Adverse Event|0|||
48324648|NCT00822120|155387077|FG005|PET-directed Therapy|Adverse Event|0|||
48324649|NCT00822120|155387072|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48324650|NCT00822120|155387073|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48324651|NCT00822120|155387074|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48324652|NCT00822120|155387075|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
48324653|NCT00822120|155387076|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48324654|NCT00822120|155387077|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
48324655|NCT00822120|155387072|FG000|PET-directed Therapy|Death|0|||
48324656|NCT00822120|155387073|FG001|PET-directed Therapy|Death|0|||
48324657|NCT00822120|155387074|FG002|PET-directed Therapy|Death|0|||
48324658|NCT00822120|155387075|FG003|PET-directed Therapy|Death|2|||
48324659|NCT00822120|155387076|FG004|PET-directed Therapy|Death|0|||
48324660|NCT00822120|155387077|FG005|PET-directed Therapy|Death|0|||
48324661|NCT00822120|155387072|FG000|PET-directed Therapy|Protocol Violation|0|||
48324662|NCT00822120|155387073|FG001|PET-directed Therapy|Protocol Violation|0|||
48324663|NCT00822120|155387074|FG002|PET-directed Therapy|Protocol Violation|0|||
48324664|NCT00822120|155387075|FG003|PET-directed Therapy|Protocol Violation|6|||
48324665|NCT00822120|155387076|FG004|PET-directed Therapy|Protocol Violation|0|||
48324666|NCT00822120|155387077|FG005|PET-directed Therapy|Protocol Violation|0|||
48324667|NCT00503906|155387078|FG000|Overall Study|Withdrawal by Subject|1|||
48324668|NCT01324310|155387079|FG000|Overall Study|Adverse Event|1|||
48628458|NCT03274466|156498736|FG000|Overall Study|Protocol Violation|3|||
48628459|NCT03274466|156498737|FG001|Overall Study|Protocol Violation|3|||
48628460|NCT02776735|156498746|FG000|Overall Study|Adverse Event|0|||
48628461|NCT02776735|156498747|FG001|Overall Study|Adverse Event|0|||
48628462|NCT02776735|156498748|FG002|Overall Study|Adverse Event|0|||
48628463|NCT02776735|156498749|FG003|Overall Study|Adverse Event|1|||
48628464|NCT02776735|156498750|FG004|Overall Study|Adverse Event|0|||
48628465|NCT02776735|156498751|FG005|Overall Study|Adverse Event|1|||
48628466|NCT02776735|156498746|FG000|Overall Study|Lost to Follow-up|0|||
48628467|NCT02776735|156498747|FG001|Overall Study|Lost to Follow-up|0|||
48628468|NCT02776735|156498748|FG002|Overall Study|Lost to Follow-up|0|||
48628469|NCT02776735|156498749|FG003|Overall Study|Lost to Follow-up|1|||
48628470|NCT02776735|156498750|FG004|Overall Study|Lost to Follow-up|0|||
48628471|NCT02776735|156498751|FG005|Overall Study|Lost to Follow-up|0|||
48742349|NCT00087607|156906261|FG001|Overall Study|Insufficient Therapeutic Response|42|||
48742350|NCT00087607|156906260|FG000|Overall Study|Failure to return|21|||
48742351|NCT00087607|156906261|FG001|Overall Study|Failure to return|17|||
48742352|NCT00087607|156906260|FG000|Overall Study|Withdrew Consent|12|||
48742353|NCT00087607|156906261|FG001|Overall Study|Withdrew Consent|16|||
48742354|NCT00087607|156906260|FG000|Overall Study|Administrative|12|||
48324669|NCT01324310|155387079|FG000|Overall Study|Disease Progression|1|||
48324670|NCT01437319|155387082|FG000|Phase I|Lost to Follow-up|2|||
48324671|NCT01437319|155387083|FG001|Phase I|Lost to Follow-up|0|||
48628472|NCT02776735|156498746|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48628473|NCT02776735|156498747|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48628474|NCT02776735|156498748|FG002|Overall Study|Withdrawal by parent/guardian|2|||
48742355|NCT00087607|156906261|FG001|Overall Study|Administrative|12|||
48742356|NCT00087607|156906260|FG000|Overall Study|Refused Treatment|5|||
48628475|NCT02776735|156498749|FG003|Overall Study|Withdrawal by parent/guardian|2|||
48628476|NCT02776735|156498750|FG004|Overall Study|Withdrawal by parent/guardian|0|||
48628477|NCT02776735|156498751|FG005|Overall Study|Withdrawal by parent/guardian|0|||
48628478|NCT02776735|156498746|FG000|Overall Study|Withdrawal by Subject|1|||
48628479|NCT02776735|156498747|FG001|Overall Study|Withdrawal by Subject|0|||
48628480|NCT02776735|156498748|FG002|Overall Study|Withdrawal by Subject|0|||
48628481|NCT02776735|156498749|FG003|Overall Study|Withdrawal by Subject|0|||
48628482|NCT02776735|156498750|FG004|Overall Study|Withdrawal by Subject|0|||
48628483|NCT02776735|156498751|FG005|Overall Study|Withdrawal by Subject|1|||
48628484|NCT02776735|156498746|FG000|Overall Study|Other|0|||
48628485|NCT02776735|156498747|FG001|Overall Study|Other|0|||
48628486|NCT02776735|156498748|FG002|Overall Study|Other|3|||
48628487|NCT02776735|156498749|FG003|Overall Study|Other|0|||
48628488|NCT02776735|156498750|FG004|Overall Study|Other|0|||
48628489|NCT02776735|156498751|FG005|Overall Study|Other|0|||
48628490|NCT03984188|156498752|FG000|Overall Study|Death|2|||
48628491|NCT03984188|156498753|FG001|Overall Study|Death|4|||
48628492|NCT03984188|156498752|FG000|Overall Study|Physician Decision|0|||
48628493|NCT03984188|156498753|FG001|Overall Study|Physician Decision|2|||
48628494|NCT03984188|156498752|FG000|Overall Study|Lost to Follow-up|3|||
48628495|NCT03984188|156498753|FG001|Overall Study|Lost to Follow-up|2|||
48628496|NCT03984188|156498752|FG000|Overall Study|Withdrawal by Subject|6|||
48628497|NCT03984188|156498753|FG001|Overall Study|Withdrawal by Subject|0|||
48628498|NCT00267488|156499787|FG000|Overall Study|Sponsor Terminated Study|9|||
48628499|NCT00267488|156499787|FG000|Overall Study|Protocol Violation|1|||
48628500|NCT00267488|156499787|FG000|Overall Study|Other (Disease Progression)|1|||
48628501|NCT02374255|156499788|FG000|Overall Study|Withdrawal by Subject|2|||
48628502|NCT02374255|156499789|FG001|Overall Study|Withdrawal by Subject|0|||
48628503|NCT02374255|156499790|FG002|Overall Study|Withdrawal by Subject|0|||
48628504|NCT02374255|156499791|FG003|Overall Study|Withdrawal by Subject|0|||
48628505|NCT03384966|156499796|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
48628506|NCT03384966|156499797|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
48628507|NCT03384966|156499798|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
48628508|NCT03384966|156499796|FG000|Follow-up Period|Adverse Event|1|||
48628509|NCT03384966|156499797|FG001|Follow-up Period|Adverse Event|0|||
48628510|NCT03384966|156499798|FG002|Follow-up Period|Adverse Event|0|||
48628511|NCT02801578|156499799|FG000|Overall Study|Adverse Event|2|||
48628512|NCT00137449|156499800|FG000|Overall Study|Disease Progression|8|||
48628513|NCT00137449|156499801|FG001|Overall Study|Disease Progression|13|||
48628514|NCT00137449|156499800|FG000|Overall Study|Death|4|||
48628515|NCT00137449|156499801|FG001|Overall Study|Death|3|||
48628516|NCT00137449|156499800|FG000|Overall Study|Adverse Event|3|||
48628517|NCT00137449|156499801|FG001|Overall Study|Adverse Event|1|||
48628518|NCT00137449|156499800|FG000|Overall Study|Withdrawal by Subject|1|||
48628519|NCT00137449|156499801|FG001|Overall Study|Withdrawal by Subject|1|||
48628520|NCT01356940|156499802|FG000|First Intervention (28 Days)|Adverse Event|1|||
48628521|NCT01356940|156499803|FG001|First Intervention (28 Days)|Adverse Event|0|||
48628522|NCT01356940|156499802|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
48628523|NCT01356940|156499803|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
48628524|NCT03412591|156499806|FG000|Overall Study|Withdrawal by Subject|1|||
48628525|NCT03412591|156499807|FG001|Overall Study|Withdrawal by Subject|8|||
48628526|NCT03412591|156499806|FG000|Overall Study|Adverse Event|0|||
48628527|NCT03412591|156499807|FG001|Overall Study|Adverse Event|1|||
48628528|NCT02263547|156499808|FG000|Overall Study|Adverse Event|1|||
48628529|NCT02263547|156499808|FG000|Overall Study|Lost to Follow-up|2|||
48628530|NCT05166902|156499809|FG000|First Intervention|Lost to Follow-up|0|||
48628531|NCT05166902|156499810|FG001|First Intervention|Lost to Follow-up|1|||
48628532|NCT01381679|156499811|FG000|Overall Study|Adverse Event|3|||
48628533|NCT01381679|156499811|FG000|Overall Study|Lost to Follow-up|885|||
48628534|NCT01969409|156499814|FG000|Overall Study|Death|2|||
48628535|NCT01969409|156499815|FG001|Overall Study|Death|2|||
48628536|NCT01969409|156499814|FG000|Overall Study|Transplant|1|||
48628537|NCT01969409|156499815|FG001|Overall Study|Transplant|1|||
48628538|NCT01969409|156499814|FG000|Overall Study|Withdrawal by Subject|0|||
48628539|NCT01969409|156499815|FG001|Overall Study|Withdrawal by Subject|1|||
48628540|NCT00815633|156499816|FG000|Overall Study|study terminated|1|||
48628541|NCT02943473|156499820|FG000|Overall Study|enrolled but not dosed|1|||
48628542|NCT02943473|156499820|FG000|Overall Study|screen failure|1|||
48628543|NCT02943473|156499820|FG000|Overall Study|Physician Decision|4|||
48628544|NCT02038647|156499821|FG000|Overall Study|Progressive Disease|50|||
48628545|NCT02038647|156499822|FG001|Overall Study|Progressive Disease|59|||
48628546|NCT02038647|156499821|FG000|Overall Study|Adverse Event|18|||
48628547|NCT02038647|156499822|FG001|Overall Study|Adverse Event|10|||
48628548|NCT02038647|156499821|FG000|Overall Study|Symptomatic Deterioration|7|||
48628549|NCT02038647|156499822|FG001|Overall Study|Symptomatic Deterioration|7|||
48628550|NCT02038647|156499821|FG000|Overall Study|Withdrawal by Subject|5|||
48324672|NCT01437319|155387084|FG002|Phase I|Lost to Follow-up|0|||
48324673|NCT01437319|155387082|FG000|Phase I|Protocol Violation|1|||
48324674|NCT01437319|155387083|FG001|Phase I|Protocol Violation|0|||
48324675|NCT01437319|155387084|FG002|Phase I|Protocol Violation|0|||
48324676|NCT01437319|155387082|FG000|Phase I|Study related symptoms/complaints|27|||
48324677|NCT01437319|155387083|FG001|Phase I|Study related symptoms/complaints|0|||
48324678|NCT01437319|155387084|FG002|Phase I|Study related symptoms/complaints|0|||
48324679|NCT01437319|155387082|FG000|Phase I|Withdrawal by Subject|25|||
48628551|NCT02038647|156499822|FG001|Overall Study|Withdrawal by Subject|2|||
48628552|NCT02038647|156499821|FG000|Overall Study|Not Reported|0|||
48628553|NCT02038647|156499822|FG001|Overall Study|Not Reported|1|||
48628554|NCT02038647|156499821|FG000|Overall Study|Ongoing at Datacut|9|||
48628555|NCT02038647|156499822|FG001|Overall Study|Ongoing at Datacut|10|||
48628556|NCT05805150|156499823|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
48628557|NCT05805150|156499824|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
48628558|NCT02284893|156499827|FG000|26 Week (Short Term)|Adverse Event|1|||
48628559|NCT02284893|156499828|FG001|26 Week (Short Term)|Adverse Event|9|||
48628560|NCT02284893|156499827|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
48628561|NCT02284893|156499828|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
48628562|NCT02284893|156499827|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
48628563|NCT02284893|156499828|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
48324680|NCT01437319|155387083|FG001|Phase I|Withdrawal by Subject|0|||
48628564|NCT02284893|156499827|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
48628565|NCT02284893|156499828|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
48628566|NCT02284893|156499827|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
48742357|NCT00087607|156906261|FG001|Overall Study|Refused Treatment|7|||
48742358|NCT00087607|156906260|FG000|Overall Study|Other Protocol Violation|5|||
48742359|NCT00087607|156906261|FG001|Overall Study|Other Protocol Violation|2|||
48628567|NCT02284893|156499828|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
48628568|NCT02284893|156499827|FG000|26 Week (Short Term)|Other|1|||
48628569|NCT02284893|156499828|FG001|26 Week (Short Term)|Other|1|||
48628570|NCT02284893|156499827|FG000|52 Week (Long Term)|Adverse Event|3|||
48628571|NCT02284893|156499828|FG001|52 Week (Long Term)|Adverse Event|1|||
48628572|NCT02284893|156499827|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
48742360|NCT00087607|156906260|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
48742361|NCT00087607|156906261|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48742362|NCT00868608|156906262|FG000|Overall Study|Withdrawal by Subject|3|||
48742363|NCT00868608|156906263|FG001|Overall Study|Withdrawal by Subject|1|||
48742364|NCT00868608|156906264|FG002|Overall Study|Withdrawal by Subject|0|||
48742365|NCT00868608|156906262|FG000|Overall Study|Lost to Follow-up|3|||
48742366|NCT00868608|156906263|FG001|Overall Study|Lost to Follow-up|0|||
48742367|NCT00868608|156906264|FG002|Overall Study|Lost to Follow-up|1|||
48742368|NCT00868608|156906262|FG000|Overall Study|Death|16|||
48742369|NCT00868608|156906263|FG001|Overall Study|Death|2|||
48742370|NCT00868608|156906264|FG002|Overall Study|Death|4|||
48742371|NCT00868608|156906262|FG000|Overall Study|Other - Unspecified|1|||
48742372|NCT00868608|156906263|FG001|Overall Study|Other - Unspecified|0|||
48742373|NCT00868608|156906264|FG002|Overall Study|Other - Unspecified|0|||
48742374|NCT02015754|156906265|FG000|Overall Study|Disease progression|5|||
48742375|NCT02015754|156906265|FG000|Overall Study|Change in treatment modality|5|||
48742376|NCT02015754|156906265|FG000|Overall Study|Lost to Follow-up|1|||
48742377|NCT00667875|156906273|FG000|Overall Study|Adverse Event|0|||
48742378|NCT00667875|156906274|FG001|Overall Study|Adverse Event|2|||
48742379|NCT00667875|156906275|FG002|Overall Study|Adverse Event|6|||
48742380|NCT00667875|156906273|FG000|Overall Study|Withdrawal by Subject|10|||
48742381|NCT00667875|156906274|FG001|Overall Study|Withdrawal by Subject|9|||
48324681|NCT01437319|155387084|FG002|Phase I|Withdrawal by Subject|0|||
48324682|NCT01437319|155387082|FG000|Phase II|Withdrawal by Subject|0|||
48324683|NCT01437319|155387083|FG001|Phase II|Withdrawal by Subject|8|||
48324684|NCT01437319|155387084|FG002|Phase II|Withdrawal by Subject|16|||
48324685|NCT01437319|155387082|FG000|Phase II|Lost to Follow-up|0|||
48324686|NCT01437319|155387083|FG001|Phase II|Lost to Follow-up|7|||
48324687|NCT01437319|155387084|FG002|Phase II|Lost to Follow-up|2|||
48324688|NCT01437319|155387082|FG000|Phase II|Study related symptoms/complaints|0|||
48324689|NCT01437319|155387083|FG001|Phase II|Study related symptoms/complaints|28|||
48324690|NCT01437319|155387084|FG002|Phase II|Study related symptoms/complaints|19|||
48324691|NCT01437319|155387082|FG000|Phase II|Protocol Violation|0|||
48324692|NCT01437319|155387083|FG001|Phase II|Protocol Violation|1|||
48628573|NCT02284893|156499828|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
48742382|NCT00667875|156906275|FG002|Overall Study|Withdrawal by Subject|7|||
48742383|NCT00478231|156906276|FG000|Overall Study|Death|7|||
48742384|NCT00478231|156906276|FG000|Overall Study|Lack of Efficacy|47|||
48742385|NCT00478231|156906276|FG000|Overall Study|Lost to Follow-up|7|||
48742386|NCT00478231|156906276|FG000|Overall Study|Withdrawal by Subject|6|||
48742387|NCT00478231|156906276|FG000|Overall Study|Other|9|||
48742388|NCT00478231|156906276|FG000|Overall Study|Adverse Event|5|||
48628574|NCT02284893|156499827|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
48742389|NCT00478231|156906276|FG000|Overall Study|Randomized, not treated|3|||
48742390|NCT00939770|156906282|FG000|Overall Study|Adverse Event|1|||
48742391|NCT00939770|156906283|FG001|Overall Study|Adverse Event|1|||
48742392|NCT00939770|156906284|FG002|Overall Study|Adverse Event|0|||
48742393|NCT00939770|156906285|FG003|Overall Study|Adverse Event|0|||
48742394|NCT00939770|156906286|FG004|Overall Study|Adverse Event|6|||
48742395|NCT00939770|156906287|FG005|Overall Study|Adverse Event|2|||
48742396|NCT00939770|156906288|FG006|Overall Study|Adverse Event|1|||
48742397|NCT00939770|156906289|FG007|Overall Study|Adverse Event|1|||
48742398|NCT00939770|156906282|FG000|Overall Study|Lack of Efficacy|4|||
48742399|NCT00939770|156906283|FG001|Overall Study|Lack of Efficacy|6|||
48742400|NCT00939770|156906284|FG002|Overall Study|Lack of Efficacy|13|||
48742401|NCT00939770|156906285|FG003|Overall Study|Lack of Efficacy|9|||
48742402|NCT00939770|156906286|FG004|Overall Study|Lack of Efficacy|16|||
48742403|NCT00939770|156906287|FG005|Overall Study|Lack of Efficacy|8|||
48742404|NCT00939770|156906288|FG006|Overall Study|Lack of Efficacy|11|||
48742405|NCT00939770|156906289|FG007|Overall Study|Lack of Efficacy|1|||
48742406|NCT00939770|156906282|FG000|Overall Study|Lost to Follow-up|0|||
48742407|NCT00939770|156906283|FG001|Overall Study|Lost to Follow-up|0|||
48742408|NCT00939770|156906284|FG002|Overall Study|Lost to Follow-up|0|||
48742409|NCT00939770|156906285|FG003|Overall Study|Lost to Follow-up|0|||
48742410|NCT00939770|156906286|FG004|Overall Study|Lost to Follow-up|1|||
48742411|NCT00939770|156906287|FG005|Overall Study|Lost to Follow-up|0|||
48742412|NCT00939770|156906288|FG006|Overall Study|Lost to Follow-up|0|||
48742413|NCT00939770|156906289|FG007|Overall Study|Lost to Follow-up|0|||
48742414|NCT00939770|156906282|FG000|Overall Study|Physician Decision|0|||
48742415|NCT00939770|156906283|FG001|Overall Study|Physician Decision|0|||
48742416|NCT00939770|156906284|FG002|Overall Study|Physician Decision|2|||
48742417|NCT00939770|156906285|FG003|Overall Study|Physician Decision|0|||
48742418|NCT00939770|156906286|FG004|Overall Study|Physician Decision|7|||
48742419|NCT00939770|156906287|FG005|Overall Study|Physician Decision|1|||
48742420|NCT00939770|156906288|FG006|Overall Study|Physician Decision|0|||
48742421|NCT00939770|156906289|FG007|Overall Study|Physician Decision|6|||
48742422|NCT00939770|156906282|FG000|Overall Study|Protocol Violation|0|||
48742423|NCT00939770|156906283|FG001|Overall Study|Protocol Violation|0|||
48742424|NCT00939770|156906284|FG002|Overall Study|Protocol Violation|0|||
48742425|NCT00939770|156906285|FG003|Overall Study|Protocol Violation|0|||
48742426|NCT00939770|156906286|FG004|Overall Study|Protocol Violation|1|||
48742427|NCT00939770|156906287|FG005|Overall Study|Protocol Violation|0|||
48742428|NCT00939770|156906288|FG006|Overall Study|Protocol Violation|0|||
48742429|NCT00939770|156906289|FG007|Overall Study|Protocol Violation|0|||
48742430|NCT00939770|156906282|FG000|Overall Study|Withdrawal by Subject|0|||
48742431|NCT00939770|156906283|FG001|Overall Study|Withdrawal by Subject|1|||
48742432|NCT00939770|156906284|FG002|Overall Study|Withdrawal by Subject|5|||
48742433|NCT00939770|156906285|FG003|Overall Study|Withdrawal by Subject|2|||
48742434|NCT00939770|156906286|FG004|Overall Study|Withdrawal by Subject|6|||
48742435|NCT00939770|156906287|FG005|Overall Study|Withdrawal by Subject|0|||
48742436|NCT00939770|156906288|FG006|Overall Study|Withdrawal by Subject|2|||
48742437|NCT00939770|156906289|FG007|Overall Study|Withdrawal by Subject|2|||
48742438|NCT01999179|156906290|FG000|Overall Study|Adverse Event|1|||
48742439|NCT01999179|156906290|FG000|Overall Study|Lost to Follow-up|1|||
48742440|NCT01999179|156906290|FG000|Overall Study|Change in Therapy|3|||
48742441|NCT01999179|156906290|FG000|Overall Study|New catheter|2|||
48742442|NCT00816595|156906291|FG000|Overall Study|Withdrawal by Subject|2|||
48742443|NCT00816595|156906292|FG001|Overall Study|Withdrawal by Subject|0|||
48742444|NCT03724032|156906293|FG000|Overall Study|Physician Decision|1|||
48628575|NCT02284893|156499828|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
48628576|NCT02284893|156499827|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
48628577|NCT02284893|156499828|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
48628578|NCT02284893|156499827|FG000|52 Week (Long Term)|Non-Compliance|2|||
48628579|NCT02284893|156499828|FG001|52 Week (Long Term)|Non-Compliance|3|||
48628580|NCT03078868|156499829|FG000|Overall Study|Physician Decision|3|||
48742445|NCT03724032|156906294|FG001|Overall Study|Physician Decision|0|||
48742446|NCT03724032|156906295|FG002|Overall Study|Physician Decision|0|||
48742447|NCT03724032|156906293|FG000|Overall Study|Protocol Violation|2|||
48742448|NCT03724032|156906294|FG001|Overall Study|Protocol Violation|2|||
48742449|NCT03724032|156906295|FG002|Overall Study|Protocol Violation|1|||
48742450|NCT01064310|156906299|FG000|Period 1|Adverse Event|7|||
48742451|NCT01064310|156906300|FG001|Period 1|Adverse Event|10|||
48742452|NCT01064310|156906301|FG002|Period 1|Adverse Event|0|||
48742453|NCT01064310|156906299|FG000|Period 1|Physician Decision|1|||
48742454|NCT01064310|156906300|FG001|Period 1|Physician Decision|0|||
48742455|NCT01064310|156906301|FG002|Period 1|Physician Decision|0|||
48742456|NCT01064310|156906299|FG000|Period 1|Withdrawal by Subject|2|||
48628581|NCT03502200|156499830|FG000|Overall Study|Adverse Event|1|||
48628582|NCT03502200|156499831|FG001|Overall Study|Adverse Event|0|||
48628583|NCT03502200|156499830|FG000|Overall Study|Lost to Follow-up|36|||
48324693|NCT01437319|155387084|FG002|Phase II|Protocol Violation|0|||
48324694|NCT03170882|155387085|FG000|Overall Study|Death|17|||
48324695|NCT03170882|155387086|FG001|Overall Study|Death|29|||
48324696|NCT03170882|155387085|FG000|Overall Study|Lost to Follow-up|0|||
48324697|NCT03170882|155387086|FG001|Overall Study|Lost to Follow-up|1|||
48324698|NCT03170882|155387085|FG000|Overall Study|Withdrawal by Subject|4|||
48324699|NCT03170882|155387086|FG001|Overall Study|Withdrawal by Subject|7|||
48324700|NCT03170882|155387085|FG000|Overall Study|Reason not Specified|28|||
48324701|NCT03170882|155387086|FG001|Overall Study|Reason not Specified|36|||
48324702|NCT02844439|155387089|FG000|Overall Study|Withdrawal by Subject|1|||
48324703|NCT02844439|155387089|FG000|Overall Study|Lost to Follow-up|2|||
48324704|NCT02844439|155387089|FG000|Overall Study|Termination by Sponsor|4|||
48628584|NCT03502200|156499831|FG001|Overall Study|Lost to Follow-up|38|||
48628585|NCT03502200|156499830|FG000|Overall Study|Study Team Decision|1|||
48628586|NCT03502200|156499831|FG001|Overall Study|Study Team Decision|1|||
48628587|NCT03502200|156499830|FG000|Overall Study|Withdrawal by Subject|5|||
48628588|NCT03502200|156499831|FG001|Overall Study|Withdrawal by Subject|7|||
48628589|NCT03502200|156499830|FG000|Overall Study|Death|0|||
48628590|NCT03502200|156499831|FG001|Overall Study|Death|2|||
48628591|NCT01435356|156499833|FG000|Overall Study|Adverse Event|2|||
48628592|NCT01435356|156499834|FG001|Overall Study|Adverse Event|0|||
48628593|NCT01435356|156499833|FG000|Overall Study|Disease progression/recurrence|17|||
48628594|NCT01435356|156499834|FG001|Overall Study|Disease progression/recurrence|10|||
48628595|NCT01435356|156499833|FG000|Overall Study|Protocol Violation|0|||
48628596|NCT01435356|156499834|FG001|Overall Study|Protocol Violation|1|||
48628597|NCT01435356|156499833|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
48628598|NCT01435356|156499834|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
48628599|NCT01435356|156499833|FG000|Overall Study|Withdrawal by Subject|1|||
48628600|NCT01435356|156499834|FG001|Overall Study|Withdrawal by Subject|1|||
48628601|NCT01435356|156499833|FG000|Overall Study|Facial palsy|1|||
48628602|NCT01435356|156499834|FG001|Overall Study|Facial palsy|0|||
48628603|NCT01435356|156499833|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
48628604|NCT01435356|156499834|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
48628605|NCT01435356|156499833|FG000|Overall Study|Physician Decision|1|||
48628606|NCT01435356|156499834|FG001|Overall Study|Physician Decision|0|||
48628607|NCT01435356|156499833|FG000|Overall Study|Patient decision|3|||
48628608|NCT01435356|156499834|FG001|Overall Study|Patient decision|0|||
48628609|NCT01435356|156499833|FG000|Overall Study|Patient moved to another city|1|||
48628610|NCT01435356|156499834|FG001|Overall Study|Patient moved to another city|1|||
48628611|NCT02971163|156499835|FG000|Overall Study|Lost to Follow-up|4|||
48742457|NCT01064310|156906300|FG001|Period 1|Withdrawal by Subject|2|||
48742458|NCT01064310|156906301|FG002|Period 1|Withdrawal by Subject|0|||
48742459|NCT01064310|156906299|FG000|Period 1|Lack of Efficacy|3|||
48742460|NCT01064310|156906300|FG001|Period 1|Lack of Efficacy|5|||
48742461|NCT01064310|156906301|FG002|Period 1|Lack of Efficacy|0|||
48742462|NCT01064310|156906299|FG000|Period 1|Entered Open-label Period|1|||
48742463|NCT01064310|156906300|FG001|Period 1|Entered Open-label Period|1|||
48742464|NCT01064310|156906301|FG002|Period 1|Entered Open-label Period|0|||
48742465|NCT01064310|156906299|FG000|Period 2|Adverse Event|2|||
48742466|NCT01064310|156906300|FG001|Period 2|Adverse Event|1|||
48742467|NCT01064310|156906301|FG002|Period 2|Adverse Event|0|||
48742468|NCT01064310|156906299|FG000|Period 2|Physician Decision|0|||
48742469|NCT01064310|156906300|FG001|Period 2|Physician Decision|1|||
48742470|NCT01064310|156906301|FG002|Period 2|Physician Decision|0|||
48742471|NCT01064310|156906299|FG000|Period 2|Entered Open-label Period|1|||
48742472|NCT01064310|156906300|FG001|Period 2|Entered Open-label Period|0|||
48742473|NCT01064310|156906301|FG002|Period 2|Entered Open-label Period|0|||
48742474|NCT01064310|156906299|FG000|Period 2|Lack of Efficacy|1|||
48742475|NCT01064310|156906300|FG001|Period 2|Lack of Efficacy|4|||
48742476|NCT01064310|156906301|FG002|Period 2|Lack of Efficacy|0|||
48742477|NCT01064310|156906299|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
48742478|NCT01064310|156906300|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
48742479|NCT01064310|156906301|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
48742480|NCT01064310|156906299|FG000|Open Label Pazopinib|Adverse Event|0|||
48628612|NCT02971163|156499836|FG001|Overall Study|Lost to Follow-up|2|||
48628613|NCT04100018|156499838|FG000|Pre-Treatment Period|Not Reported|0|||
48742481|NCT01064310|156906300|FG001|Open Label Pazopinib|Adverse Event|0|||
48628614|NCT04100018|156499839|FG001|Pre-Treatment Period|Not Reported|4|||
48628615|NCT04100018|156499838|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
48742482|NCT01064310|156906301|FG002|Open Label Pazopinib|Adverse Event|12|||
48742483|NCT01064310|156906299|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
48324705|NCT02844439|155387089|FG000|Overall Study|Death|28|||
48324706|NCT02844439|155387089|FG000|Overall Study|Other|5|||
48324707|NCT02397096|155387092|FG000|Day 1 to Week 24|Adverse Event|7|||
48742484|NCT01064310|156906300|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
48742485|NCT01064310|156906301|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
48742486|NCT01064310|156906299|FG000|Open Label Pazopinib|Physician Decision|0|||
48742487|NCT01064310|156906300|FG001|Open Label Pazopinib|Physician Decision|0|||
48324708|NCT02397096|155387093|FG001|Day 1 to Week 24|Adverse Event|1|||
48324709|NCT02397096|155387092|FG000|Day 1 to Week 24|Death|1|||
48324710|NCT02397096|155387093|FG001|Day 1 to Week 24|Death|0|||
48324711|NCT02397096|155387092|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
48628616|NCT04100018|156499839|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
48628617|NCT04100018|156499838|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
48628618|NCT04100018|156499839|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
48628619|NCT04100018|156499838|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
48628620|NCT04100018|156499839|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
48628621|NCT04100018|156499838|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
48628622|NCT04100018|156499839|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
48628623|NCT04100018|156499838|FG000|Treatment Period|Ongoing Treatment as of clinical cut off date|58|||
48628624|NCT04100018|156499839|FG001|Treatment Period|Ongoing Treatment as of clinical cut off date|52|||
48628625|NCT04100018|156499838|FG000|Treatment Period|Other Reason|18|||
48628626|NCT04100018|156499839|FG001|Treatment Period|Other Reason|29|||
48628627|NCT04100018|156499838|FG000|Treatment Period|Completed treatment as per protocol|0|||
48628628|NCT04100018|156499839|FG001|Treatment Period|Completed treatment as per protocol|1|||
48628629|NCT04100018|156499838|FG000|Treatment Period|Maximum clinical benefit|3|||
48628630|NCT04100018|156499839|FG001|Treatment Period|Maximum clinical benefit|0|||
48628631|NCT04100018|156499838|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
48628632|NCT04100018|156499839|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
48628633|NCT04100018|156499838|FG000|Treatment Period|Study drug toxicity|67|||
48628634|NCT04100018|156499839|FG001|Treatment Period|Study drug toxicity|28|||
48628635|NCT04100018|156499838|FG000|Treatment Period|Disease Progression|269|||
48628636|NCT04100018|156499839|FG001|Treatment Period|Disease Progression|318|||
48628637|NCT04100018|156499838|FG000|Treatment Period|Administrative reasons by sponsor|1|||
48628638|NCT04100018|156499839|FG001|Treatment Period|Administrative reasons by sponsor|1|||
48628639|NCT04100018|156499838|FG000|Treatment Period|Poor/Non-Compliance|1|||
48742488|NCT01064310|156906301|FG002|Open Label Pazopinib|Physician Decision|20|||
48628640|NCT04100018|156499839|FG001|Treatment Period|Poor/Non-Compliance|0|||
48628641|NCT04100018|156499838|FG000|Treatment Period|Lost to Follow-up|2|||
48628642|NCT04100018|156499839|FG001|Treatment Period|Lost to Follow-up|2|||
48742489|NCT00679432|156906302|FG000|Overall Study|Adverse Event|5|||
48742490|NCT00679432|156906303|FG001|Overall Study|Adverse Event|6|||
48742491|NCT00679432|156906304|FG002|Overall Study|Adverse Event|10|||
48742492|NCT00679432|156906305|FG003|Overall Study|Adverse Event|7|||
48628643|NCT04100018|156499838|FG000|Treatment Period|Death|14|||
48628644|NCT04100018|156499839|FG001|Treatment Period|Death|11|||
48628645|NCT04100018|156499838|FG000|Treatment Period|Participant withdrew consent|8|||
48628646|NCT04100018|156499839|FG001|Treatment Period|Participant withdrew consent|10|||
48742493|NCT00679432|156906302|FG000|Overall Study|Protocol Violation|1|||
48742494|NCT00679432|156906303|FG001|Overall Study|Protocol Violation|1|||
48742495|NCT00679432|156906304|FG002|Overall Study|Protocol Violation|2|||
48324712|NCT02397096|155387093|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
48324713|NCT02397096|155387092|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
48324714|NCT02397096|155387093|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
48324715|NCT02397096|155387092|FG000|Day 1 to Week 24|Physician Decision|2|||
48324716|NCT02397096|155387093|FG001|Day 1 to Week 24|Physician Decision|3|||
48324717|NCT02397096|155387092|FG000|Day 1 to Week 24|Protocol Violation|1|||
48324718|NCT02397096|155387093|FG001|Day 1 to Week 24|Protocol Violation|4|||
48324719|NCT02397096|155387092|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
48324720|NCT02397096|155387093|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
48324721|NCT02397096|155387092|FG000|Day 1 to Week 24|Randomized, not treated|3|||
48324722|NCT02397096|155387093|FG001|Day 1 to Week 24|Randomized, not treated|0|||
48324723|NCT02397096|155387092|FG000|Week 24 to Week 48|Adverse Event|6|||
48324724|NCT02397096|155387093|FG001|Week 24 to Week 48|Adverse Event|2|||
48324725|NCT02397096|155387092|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
48324726|NCT02397096|155387093|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
48324727|NCT02397096|155387092|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
48324728|NCT02397096|155387093|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
48324729|NCT02397096|155387092|FG000|Week 24 to Week 48|Physician Decision|2|||
48324730|NCT02397096|155387093|FG001|Week 24 to Week 48|Physician Decision|1|||
48324731|NCT02397096|155387092|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
48628647|NCT04100018|156499838|FG000|Treatment Period|Participant request to discontinue study treatment|32|||
48628648|NCT04100018|156499839|FG001|Treatment Period|Participant request to discontinue study treatment|31|||
48628649|NCT04100018|156499838|FG000|Treatment Period|Adverse Event|12|||
48742496|NCT00679432|156906305|FG003|Overall Study|Protocol Violation|1|||
48742497|NCT00679432|156906302|FG000|Overall Study|Withdrawal by Subject|8|||
48742498|NCT00679432|156906303|FG001|Overall Study|Withdrawal by Subject|11|||
48742499|NCT00679432|156906304|FG002|Overall Study|Withdrawal by Subject|10|||
48742500|NCT00679432|156906305|FG003|Overall Study|Withdrawal by Subject|9|||
48324732|NCT02397096|155387093|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
48324733|NCT02397096|155387092|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
48742501|NCT00679432|156906302|FG000|Overall Study|Lost to Follow-up|1|||
48628650|NCT04100018|156499839|FG001|Treatment Period|Adverse Event|6|||
48628651|NCT04100018|156499838|FG000|Treatment Period|Lack of Efficacy|4|||
48628652|NCT04100018|156499839|FG001|Treatment Period|Lack of Efficacy|2|||
48628653|NCT00663260|156499840|FG000|Overall Study|Lack of Efficacy|2|||
48628654|NCT00663260|156499841|FG001|Overall Study|Lack of Efficacy|0|||
48628655|NCT00663260|156499842|FG002|Overall Study|Lack of Efficacy|0|||
48628656|NCT00663260|156499840|FG000|Overall Study|Adverse Event|12|||
48742502|NCT00679432|156906303|FG001|Overall Study|Lost to Follow-up|5|||
48742503|NCT00679432|156906304|FG002|Overall Study|Lost to Follow-up|4|||
48628657|NCT00663260|156499841|FG001|Overall Study|Adverse Event|7|||
48628658|NCT00663260|156499842|FG002|Overall Study|Adverse Event|6|||
48628659|NCT00663260|156499840|FG000|Overall Study|Withdrawal by Subject|3|||
48628660|NCT00663260|156499841|FG001|Overall Study|Withdrawal by Subject|1|||
48628661|NCT00663260|156499842|FG002|Overall Study|Withdrawal by Subject|6|||
48628662|NCT00663260|156499840|FG000|Overall Study|Death|1|||
48628663|NCT00663260|156499841|FG001|Overall Study|Death|0|||
48628664|NCT00663260|156499842|FG002|Overall Study|Death|1|||
48628665|NCT00663260|156499840|FG000|Overall Study|Lost to Follow-up|0|||
48628666|NCT00663260|156499841|FG001|Overall Study|Lost to Follow-up|1|||
48628667|NCT00663260|156499842|FG002|Overall Study|Lost to Follow-up|0|||
48628668|NCT00663260|156499840|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
48628669|NCT00663260|156499841|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
48628670|NCT00663260|156499842|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
48628671|NCT02607722|156499846|FG000|Overall Study|No data reliability|1|||
48628672|NCT02607722|156499846|FG000|Overall Study|no patient visit|18|||
48628673|NCT02607722|156499846|FG000|Overall Study|missing info in CRF|13|||
48628674|NCT02607722|156499846|FG000|Overall Study|Withdrawal by Subject|616|||
48628675|NCT02607722|156499846|FG000|Overall Study|Lost to Follow-up|312|||
48628676|NCT02607722|156499846|FG000|Overall Study|Improved|22|||
48628677|NCT02607722|156499846|FG000|Overall Study|Lack of Efficacy|316|||
48628678|NCT02607722|156499846|FG000|Overall Study|Adverse Event|2553|||
48628679|NCT02607722|156499846|FG000|Overall Study|Not treated|1|||
48628680|NCT02607722|156499846|FG000|Overall Study|No CRF collected|138|||
48324734|NCT02397096|155387093|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
48324735|NCT02397096|155387092|FG000|Study Extension 1|Adverse Event|7|||
48324736|NCT02397096|155387093|FG001|Study Extension 1|Adverse Event|5|||
48324737|NCT02397096|155387092|FG000|Study Extension 1|Death|1|||
48324738|NCT02397096|155387093|FG001|Study Extension 1|Death|0|||
48324739|NCT02397096|155387092|FG000|Study Extension 1|Lack of Efficacy|2|||
48324740|NCT02397096|155387093|FG001|Study Extension 1|Lack of Efficacy|5|||
48628681|NCT02607722|156499846|FG000|Overall Study|without CRF|4225|||
48628682|NCT02607722|156499846|FG000|Overall Study|Physician Decision|367|||
48628683|NCT05852340|156499857|FG000|Period 5|Not completing the meal|0|||
48628684|NCT05852340|156499858|FG001|Period 5|Not completing the meal|1|||
48628685|NCT05852340|156499859|FG002|Period 5|Not completing the meal|0|||
48628686|NCT05852340|156499860|FG003|Period 5|Not completing the meal|0|||
48628687|NCT05852340|156499857|FG000|Period 5|Adverse Event|0|||
48628688|NCT05852340|156499858|FG001|Period 5|Adverse Event|0|||
48628689|NCT05852340|156499859|FG002|Period 5|Adverse Event|0|||
48628690|NCT05852340|156499860|FG003|Period 5|Adverse Event|1|||
48628691|NCT00432965|156499861|FG000|Overall Study|Lost to Follow-up|22|||
48628692|NCT00432965|156499862|FG001|Overall Study|Lost to Follow-up|19|||
48628693|NCT00432965|156499861|FG000|Overall Study|Withdrawal by Subject|13|||
48628694|NCT00432965|156499862|FG001|Overall Study|Withdrawal by Subject|13|||
48628695|NCT00432965|156499861|FG000|Overall Study|Physician Decision|14|||
48628696|NCT00432965|156499862|FG001|Overall Study|Physician Decision|13|||
48628697|NCT00432965|156499861|FG000|Overall Study|Lack of Efficacy|8|||
48628698|NCT00432965|156499862|FG001|Overall Study|Lack of Efficacy|13|||
48628699|NCT00432965|156499861|FG000|Overall Study|Non-compliance|7|||
48742504|NCT00679432|156906305|FG003|Overall Study|Lost to Follow-up|2|||
48742505|NCT00679432|156906302|FG000|Overall Study|Physician Decision|3|||
48742506|NCT00679432|156906303|FG001|Overall Study|Physician Decision|2|||
48742507|NCT00679432|156906304|FG002|Overall Study|Physician Decision|2|||
48742508|NCT00679432|156906305|FG003|Overall Study|Physician Decision|2|||
48324741|NCT02397096|155387092|FG000|Study Extension 1|Lost to Follow-up|2|||
48324742|NCT02397096|155387093|FG001|Study Extension 1|Lost to Follow-up|3|||
48628700|NCT00432965|156499862|FG001|Overall Study|Non-compliance|0|||
48324743|NCT02397096|155387092|FG000|Study Extension 1|Non-compliance with study drug|3|||
48628701|NCT00432965|156499861|FG000|Overall Study|Adverse Event|22|||
48628702|NCT00432965|156499862|FG001|Overall Study|Adverse Event|19|||
48628703|NCT00432965|156499861|FG000|Overall Study|Death|3|||
48628704|NCT00432965|156499862|FG001|Overall Study|Death|4|||
48628705|NCT00432965|156499861|FG000|Overall Study|Exclusionary Methods|1|||
48628706|NCT00432965|156499862|FG001|Overall Study|Exclusionary Methods|2|||
48628707|NCT00432965|156499861|FG000|Overall Study|Incomplete Data|4|||
48628708|NCT00432965|156499862|FG001|Overall Study|Incomplete Data|3|||
48628709|NCT02402647|156499865|FG000|Overall Study|Lost to Follow-up|13|||
48628710|NCT02402647|156499866|FG001|Overall Study|Lost to Follow-up|7|||
48742509|NCT00679432|156906302|FG000|Overall Study|Sponsor decision|1|||
48742510|NCT00679432|156906303|FG001|Overall Study|Sponsor decision|0|||
48628711|NCT02402647|156499865|FG000|Overall Study|Protocol Violation|1|||
48628712|NCT02402647|156499866|FG001|Overall Study|Protocol Violation|1|||
48628713|NCT02402647|156499865|FG000|Overall Study|scheduled and timed out|2|||
48628714|NCT02402647|156499866|FG001|Overall Study|scheduled and timed out|1|||
48628715|NCT02402647|156499865|FG000|Overall Study|medical illness|2|||
48628716|NCT02402647|156499866|FG001|Overall Study|medical illness|4|||
48628717|NCT02402647|156499865|FG000|Overall Study|Moved|2|||
48628718|NCT02402647|156499866|FG001|Overall Study|Moved|0|||
48628719|NCT02402647|156499865|FG000|Overall Study|loved one illness|1|||
48628720|NCT02402647|156499866|FG001|Overall Study|loved one illness|0|||
48628721|NCT02402647|156499865|FG000|Overall Study|deceased preexisting condition|2|||
48628722|NCT02402647|156499866|FG001|Overall Study|deceased preexisting condition|0|||
48628723|NCT02402647|156499865|FG000|Overall Study|Other|2|||
48628724|NCT02402647|156499866|FG001|Overall Study|Other|1|||
48628725|NCT05810597|156499867|FG000|Period 1|Adverse Event|2|||
48628726|NCT05810597|156499868|FG001|Period 1|Adverse Event|0|||
48628727|NCT05810597|156499867|FG000|Period 1|Physician Decision|1|||
48628728|NCT05810597|156499868|FG001|Period 1|Physician Decision|0|||
48628729|NCT00835354|156499869|FG000|First Intervention|Adverse Event|0|||
48628730|NCT00835354|156499870|FG001|First Intervention|Adverse Event|1|||
48628731|NCT02302222|156499879|FG000|Overall Study|Physician Decision|0|||
48628732|NCT02302222|156499880|FG001|Overall Study|Physician Decision|4|||
48628733|NCT02302222|156499879|FG000|Overall Study|Lost to Follow-up|1|||
48628734|NCT02302222|156499880|FG001|Overall Study|Lost to Follow-up|0|||
48628735|NCT02302222|156499879|FG000|Overall Study|Treatment discontinued before day 5|0|||
48628736|NCT02302222|156499880|FG001|Overall Study|Treatment discontinued before day 5|1|||
48628737|NCT02302222|156499879|FG000|Overall Study|Withdrawn prior to any treatment|0|||
48628738|NCT02302222|156499880|FG001|Overall Study|Withdrawn prior to any treatment|1|||
48628739|NCT04116489|156499884|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
48628740|NCT04116489|156499884|FG000|Overall Study|Withdrawal by Subject|1|||
48628741|NCT03189719|156499885|FG000|Overall Study|Death|325|||
48628742|NCT03189719|156499886|FG001|Overall Study|Death|361|||
48628743|NCT03189719|156499885|FG000|Overall Study|Physician Decision|1|||
48628744|NCT03189719|156499886|FG001|Overall Study|Physician Decision|0|||
48628745|NCT03189719|156499885|FG000|Overall Study|Sponsor Decision|40|||
48628746|NCT03189719|156499886|FG001|Overall Study|Sponsor Decision|12|||
48628747|NCT03189719|156499885|FG000|Overall Study|Withdrawal by Subject|7|||
48628748|NCT03189719|156499886|FG001|Overall Study|Withdrawal by Subject|3|||
48628749|NCT01400412|156499902|FG000|Overall Study|Lost to Follow-up|4|||
48628750|NCT01400412|156499903|FG001|Overall Study|Lost to Follow-up|7|||
48628751|NCT01400412|156499902|FG000|Overall Study|Withdrawal by Subject|3|||
48628752|NCT01400412|156499903|FG001|Overall Study|Withdrawal by Subject|4|||
48628753|NCT01400412|156499902|FG000|Overall Study|Unable to complete|3|||
48628754|NCT01400412|156499903|FG001|Overall Study|Unable to complete|3|||
48324744|NCT02397096|155387093|FG001|Study Extension 1|Non-compliance with study drug|0|||
48324745|NCT02397096|155387092|FG000|Study Extension 1|Physician Decision|4|||
48324746|NCT02397096|155387093|FG001|Study Extension 1|Physician Decision|2|||
48324747|NCT02397096|155387092|FG000|Study Extension 1|Pregnancy|1|||
48324748|NCT02397096|155387093|FG001|Study Extension 1|Pregnancy|0|||
48324749|NCT02397096|155387092|FG000|Study Extension 1|Protocol Violation|0|||
48324750|NCT02397096|155387093|FG001|Study Extension 1|Protocol Violation|1|||
48324751|NCT02397096|155387092|FG000|Study Extension 1|Withdrawal by Subject|21|||
48324752|NCT02397096|155387093|FG001|Study Extension 1|Withdrawal by Subject|7|||
48628755|NCT01400412|156499902|FG000|Overall Study|Never started study treatment|0|||
48628756|NCT01400412|156499903|FG001|Overall Study|Never started study treatment|3|||
48628757|NCT01926509|156501634|FG000|Overall Study|vital sign met discontinuation criteria|1|||
48628758|NCT01926509|156501635|FG001|Overall Study|vital sign met discontinuation criteria|0|||
48628759|NCT01926509|156501636|FG002|Overall Study|vital sign met discontinuation criteria|0|||
48628760|NCT01926509|156501637|FG003|Overall Study|vital sign met discontinuation criteria|0|||
48628761|NCT02730169|156501638|FG000|Overall Study|Protocol Violation|1|||
48628762|NCT02730169|156501639|FG001|Overall Study|Protocol Violation|0|||
48628763|NCT02730169|156501640|FG002|Overall Study|Protocol Violation|0|||
48628764|NCT02730169|156501641|FG003|Overall Study|Protocol Violation|1|||
48628765|NCT02730169|156501638|FG000|Overall Study|Adverse Event|2|||
48628766|NCT02730169|156501639|FG001|Overall Study|Adverse Event|3|||
48628767|NCT02730169|156501640|FG002|Overall Study|Adverse Event|3|||
48628768|NCT02730169|156501641|FG003|Overall Study|Adverse Event|0|||
48742511|NCT00679432|156906304|FG002|Overall Study|Sponsor decision|0|||
48324753|NCT02397096|155387092|FG000|Study Extension 2|Adverse Event|3|||
48324754|NCT02397096|155387093|FG001|Study Extension 2|Adverse Event|3|||
48324755|NCT02397096|155387092|FG000|Study Extension 2|Availability of study medication locally|152|||
48324756|NCT02397096|155387093|FG001|Study Extension 2|Availability of study medication locally|64|||
48324757|NCT02397096|155387092|FG000|Study Extension 2|Death|2|||
48324758|NCT02397096|155387093|FG001|Study Extension 2|Death|0|||
48324759|NCT02397096|155387092|FG000|Study Extension 2|Lack of Efficacy|1|||
48324760|NCT02397096|155387093|FG001|Study Extension 2|Lack of Efficacy|0|||
48324761|NCT02397096|155387092|FG000|Study Extension 2|Lost to Follow-up|2|||
48324762|NCT02397096|155387093|FG001|Study Extension 2|Lost to Follow-up|1|||
48324763|NCT02397096|155387092|FG000|Study Extension 2|Non-compliance with study drug|1|||
48324764|NCT02397096|155387093|FG001|Study Extension 2|Non-compliance with study drug|0|||
48742512|NCT00679432|156906305|FG003|Overall Study|Sponsor decision|0|||
48742513|NCT00679432|156906302|FG000|Overall Study|Lack of Efficacy|13|||
48324765|NCT02397096|155387092|FG000|Study Extension 2|Physician Decision|2|||
48324766|NCT02397096|155387093|FG001|Study Extension 2|Physician Decision|5|||
48324767|NCT02397096|155387092|FG000|Study Extension 2|Pregnancy|1|||
48324768|NCT02397096|155387093|FG001|Study Extension 2|Pregnancy|0|||
48324769|NCT02397096|155387092|FG000|Study Extension 2|Withdrawal by Subject|10|||
48324770|NCT02397096|155387093|FG001|Study Extension 2|Withdrawal by Subject|3|||
48324771|NCT02397096|155387092|FG000|Study Extension 3|Adverse Event|1|||
48324772|NCT02397096|155387093|FG001|Study Extension 3|Adverse Event|0|||
48324773|NCT02397096|155387092|FG000|Study Extension 3|Availability of study medication locally|11|||
48324774|NCT02397096|155387093|FG001|Study Extension 3|Availability of study medication locally|3|||
48324775|NCT02397096|155387092|FG000|Study Extension 3|Lost to Follow-up|1|||
48324776|NCT02397096|155387093|FG001|Study Extension 3|Lost to Follow-up|0|||
48324777|NCT02397096|155387092|FG000|Study Extension 3|Withdrawal by Subject|2|||
48324778|NCT02397096|155387093|FG001|Study Extension 3|Withdrawal by Subject|1|||
48324779|NCT01638000|155387094|FG000|Overall Study|Randomized but Never Received Drug|7|||
48324780|NCT01638000|155387095|FG001|Overall Study|Randomized but Never Received Drug|10|||
48324781|NCT01638000|155387094|FG000|Overall Study|Adverse Event|14|||
48324782|NCT01638000|155387095|FG001|Overall Study|Adverse Event|16|||
48324783|NCT01638000|155387094|FG000|Overall Study|Lack of Efficacy|5|||
48324784|NCT01638000|155387095|FG001|Overall Study|Lack of Efficacy|6|||
48324785|NCT01638000|155387094|FG000|Overall Study|Protocol Violation|11|||
48324786|NCT01638000|155387095|FG001|Overall Study|Protocol Violation|13|||
48324787|NCT01638000|155387094|FG000|Overall Study|Withdrawal by Subject|21|||
48324788|NCT01638000|155387095|FG001|Overall Study|Withdrawal by Subject|24|||
48628769|NCT02730169|156501638|FG000|Overall Study|Adverse Event of Special Interest|0|||
48628770|NCT02730169|156501639|FG001|Overall Study|Adverse Event of Special Interest|1|||
48742514|NCT00679432|156906303|FG001|Overall Study|Lack of Efficacy|9|||
48324789|NCT01638000|155387094|FG000|Overall Study|Miscellaneous|2|||
48324790|NCT01638000|155387095|FG001|Overall Study|Miscellaneous|2|||
48324791|NCT05580003|155387096|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324792|NCT05580003|155387097|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324793|NCT05580003|155387098|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324794|NCT05580003|155387099|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48451242|NCT00355134|155841606|FG003|Core Phase|Adverse Event|0|||
48324795|NCT05580003|155387100|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324796|NCT05580003|155387101|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324797|NCT05580003|155387102|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
48324798|NCT05580003|155387103|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324799|NCT05580003|155387104|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324800|NCT05580003|155387105|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324801|NCT05580003|155387106|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324802|NCT05580003|155387107|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324803|NCT05580003|155387108|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324804|NCT05580003|155387109|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324805|NCT05580003|155387110|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324806|NCT05580003|155387111|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324807|NCT05580003|155387112|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48628771|NCT02730169|156501640|FG002|Overall Study|Adverse Event of Special Interest|2|||
48628772|NCT02730169|156501641|FG003|Overall Study|Adverse Event of Special Interest|0|||
48628773|NCT02730169|156501638|FG000|Overall Study|Withdrawal by Subject|6|||
48628774|NCT02730169|156501639|FG001|Overall Study|Withdrawal by Subject|11|||
48628775|NCT02730169|156501640|FG002|Overall Study|Withdrawal by Subject|6|||
48628776|NCT02730169|156501641|FG003|Overall Study|Withdrawal by Subject|8|||
48628777|NCT02730169|156501638|FG000|Overall Study|Lost to Follow-up|5|||
48628778|NCT02730169|156501639|FG001|Overall Study|Lost to Follow-up|6|||
48628779|NCT02730169|156501640|FG002|Overall Study|Lost to Follow-up|5|||
48628780|NCT02730169|156501641|FG003|Overall Study|Lost to Follow-up|6|||
48628781|NCT02730169|156501638|FG000|Overall Study|Other|0|||
48628782|NCT02730169|156501639|FG001|Overall Study|Other|0|||
48628783|NCT02730169|156501640|FG002|Overall Study|Other|1|||
48628784|NCT02730169|156501641|FG003|Overall Study|Other|1|||
48628785|NCT00581100|156501644|FG000|Overall Study|Death|1|||
48628786|NCT00581100|156501645|FG001|Overall Study|Death|0|||
48628787|NCT00581100|156501644|FG000|Overall Study|Adverse Event|2|||
48628788|NCT00581100|156501645|FG001|Overall Study|Adverse Event|1|||
48628789|NCT00581100|156501644|FG000|Overall Study|Withdrawal by Subject|1|||
48628790|NCT00581100|156501645|FG001|Overall Study|Withdrawal by Subject|4|||
48628791|NCT00581100|156501644|FG000|Overall Study|Other|3|||
48628792|NCT00581100|156501645|FG001|Overall Study|Other|0|||
48628793|NCT03977155|156501648|FG000|Overall Study|Adverse Event|3|||
48628794|NCT03977155|156501649|FG001|Overall Study|Adverse Event|0|||
48628795|NCT03977155|156501650|FG002|Overall Study|Adverse Event|0|||
48628796|NCT03977155|156501648|FG000|Overall Study|Lost to Follow-up|0|||
48628797|NCT03977155|156501649|FG001|Overall Study|Lost to Follow-up|1|||
48628798|NCT03977155|156501650|FG002|Overall Study|Lost to Follow-up|0|||
48628799|NCT03977155|156501648|FG000|Overall Study|Withdrawal by Subject|1|||
48628800|NCT03977155|156501649|FG001|Overall Study|Withdrawal by Subject|1|||
48628801|NCT03977155|156501650|FG002|Overall Study|Withdrawal by Subject|2|||
48628802|NCT03977155|156501648|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
48628803|NCT03977155|156501649|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
48628804|NCT03977155|156501650|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
48628805|NCT00500331|156501654|FG000|Overall Study|Adverse Event|0|||
48628806|NCT00500331|156501655|FG001|Overall Study|Adverse Event|2|||
48628807|NCT00500331|156501656|FG002|Overall Study|Adverse Event|0|||
48628808|NCT00500331|156501657|FG003|Overall Study|Adverse Event|1|||
48628809|NCT00500331|156501658|FG004|Overall Study|Adverse Event|2|||
48628810|NCT00500331|156501659|FG005|Overall Study|Adverse Event|2|||
48628811|NCT00500331|156501660|FG006|Overall Study|Adverse Event|0|||
48628812|NCT00500331|156501654|FG000|Overall Study|Lost to Follow-up|1|||
48628813|NCT00500331|156501655|FG001|Overall Study|Lost to Follow-up|1|||
48628814|NCT00500331|156501656|FG002|Overall Study|Lost to Follow-up|1|||
48628815|NCT00500331|156501657|FG003|Overall Study|Lost to Follow-up|2|||
48628816|NCT00500331|156501658|FG004|Overall Study|Lost to Follow-up|1|||
48628817|NCT00500331|156501659|FG005|Overall Study|Lost to Follow-up|0|||
48628818|NCT00500331|156501660|FG006|Overall Study|Lost to Follow-up|0|||
48628819|NCT00500331|156501654|FG000|Overall Study|Protocol Violation|3|||
48628820|NCT00500331|156501655|FG001|Overall Study|Protocol Violation|1|||
48628821|NCT00500331|156501656|FG002|Overall Study|Protocol Violation|1|||
48628822|NCT00500331|156501657|FG003|Overall Study|Protocol Violation|0|||
48628823|NCT00500331|156501658|FG004|Overall Study|Protocol Violation|1|||
48628824|NCT00500331|156501659|FG005|Overall Study|Protocol Violation|1|||
48628825|NCT00500331|156501660|FG006|Overall Study|Protocol Violation|1|||
48628826|NCT00500331|156501654|FG000|Overall Study|Withdrawal by Subject|4|||
48628827|NCT00500331|156501655|FG001|Overall Study|Withdrawal by Subject|0|||
48628828|NCT00500331|156501656|FG002|Overall Study|Withdrawal by Subject|1|||
48628829|NCT00500331|156501657|FG003|Overall Study|Withdrawal by Subject|5|||
48628830|NCT00500331|156501658|FG004|Overall Study|Withdrawal by Subject|0|||
48628831|NCT00500331|156501659|FG005|Overall Study|Withdrawal by Subject|1|||
48628832|NCT00500331|156501660|FG006|Overall Study|Withdrawal by Subject|1|||
48628833|NCT00500331|156501654|FG000|Overall Study|Lack of Efficacy|3|||
48628834|NCT00500331|156501655|FG001|Overall Study|Lack of Efficacy|1|||
48742515|NCT00679432|156906304|FG002|Overall Study|Lack of Efficacy|14|||
48742516|NCT00679432|156906305|FG003|Overall Study|Lack of Efficacy|8|||
48742517|NCT00679432|156906302|FG000|Overall Study|Infectious colitis, normal histology|5|||
48324808|NCT05580003|155387113|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324809|NCT05580003|155387114|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324810|NCT05580003|155387115|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324811|NCT05580003|155387116|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324812|NCT05580003|155387117|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324813|NCT05580003|155387118|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324814|NCT05580003|155387119|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324815|NCT05580003|155387120|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48628835|NCT00500331|156501656|FG002|Overall Study|Lack of Efficacy|0|||
48628836|NCT00500331|156501657|FG003|Overall Study|Lack of Efficacy|0|||
48628837|NCT00500331|156501658|FG004|Overall Study|Lack of Efficacy|0|||
48628838|NCT00500331|156501659|FG005|Overall Study|Lack of Efficacy|0|||
48628839|NCT00500331|156501660|FG006|Overall Study|Lack of Efficacy|0|||
48628840|NCT00500331|156501654|FG000|Overall Study|Liver function test abnormality|0|||
48628841|NCT00500331|156501655|FG001|Overall Study|Liver function test abnormality|0|||
48628842|NCT00500331|156501656|FG002|Overall Study|Liver function test abnormality|1|||
48628843|NCT00500331|156501657|FG003|Overall Study|Liver function test abnormality|0|||
48628844|NCT00500331|156501658|FG004|Overall Study|Liver function test abnormality|0|||
48628845|NCT00500331|156501659|FG005|Overall Study|Liver function test abnormality|0|||
48628846|NCT00500331|156501660|FG006|Overall Study|Liver function test abnormality|0|||
48628847|NCT00500331|156501654|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
48628848|NCT00500331|156501655|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
48628849|NCT00500331|156501656|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
48628850|NCT00500331|156501657|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
48628851|NCT00500331|156501658|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
48628852|NCT00500331|156501659|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
48628853|NCT00500331|156501660|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
48628854|NCT00500331|156501654|FG000|Overall Study|Didn't return for continuation of study|1|||
48628855|NCT00500331|156501655|FG001|Overall Study|Didn't return for continuation of study|0|||
48628856|NCT00500331|156501656|FG002|Overall Study|Didn't return for continuation of study|0|||
48628857|NCT00500331|156501657|FG003|Overall Study|Didn't return for continuation of study|0|||
48628858|NCT00500331|156501658|FG004|Overall Study|Didn't return for continuation of study|0|||
48628859|NCT00500331|156501659|FG005|Overall Study|Didn't return for continuation of study|0|||
48628860|NCT00500331|156501660|FG006|Overall Study|Didn't return for continuation of study|0|||
48628861|NCT00500331|156501654|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
48628862|NCT00500331|156501655|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
48628863|NCT00500331|156501656|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
48628864|NCT00500331|156501657|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
48628865|NCT00500331|156501658|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
48628866|NCT00500331|156501659|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
48628867|NCT00500331|156501660|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
48628868|NCT00500331|156501654|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
48628869|NCT00500331|156501655|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
48628870|NCT00500331|156501656|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
48628871|NCT00500331|156501657|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
48628872|NCT00500331|156501658|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
48628873|NCT00500331|156501659|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
48628874|NCT00500331|156501660|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
48628875|NCT00500331|156501654|FG000|Overall Study|Participant was randomized by mistake|1|||
48628876|NCT00500331|156501655|FG001|Overall Study|Participant was randomized by mistake|0|||
48742518|NCT00679432|156906303|FG001|Overall Study|Infectious colitis, normal histology|4|||
48324816|NCT05580003|155387121|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324817|NCT05580003|155387122|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324818|NCT05580003|155387123|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48324819|NCT05580003|155387096|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324820|NCT05580003|155387097|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48628877|NCT00500331|156501656|FG002|Overall Study|Participant was randomized by mistake|0|||
48628878|NCT00500331|156501657|FG003|Overall Study|Participant was randomized by mistake|0|||
48628879|NCT00500331|156501658|FG004|Overall Study|Participant was randomized by mistake|0|||
48628880|NCT00500331|156501659|FG005|Overall Study|Participant was randomized by mistake|0|||
48742519|NCT00679432|156906304|FG002|Overall Study|Infectious colitis, normal histology|8|||
48742520|NCT00679432|156906305|FG003|Overall Study|Infectious colitis, normal histology|3|||
48324821|NCT05580003|155387098|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324822|NCT05580003|155387099|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324823|NCT05580003|155387100|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324824|NCT05580003|155387101|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
48324825|NCT05580003|155387102|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324826|NCT05580003|155387103|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324827|NCT05580003|155387104|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324828|NCT05580003|155387105|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324829|NCT05580003|155387106|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324830|NCT05580003|155387107|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324831|NCT05580003|155387108|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324832|NCT05580003|155387109|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324833|NCT05580003|155387110|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48628881|NCT00500331|156501660|FG006|Overall Study|Participant was randomized by mistake|0|||
48324834|NCT05580003|155387111|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324835|NCT05580003|155387112|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324836|NCT05580003|155387113|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48742521|NCT00679432|156906302|FG000|Overall Study|Randomization error, return to prior Rx|0|||
48742522|NCT00679432|156906303|FG001|Overall Study|Randomization error, return to prior Rx|0|||
48742523|NCT00679432|156906304|FG002|Overall Study|Randomization error, return to prior Rx|3|||
48742524|NCT00679432|156906305|FG003|Overall Study|Randomization error, return to prior Rx|0|||
48742525|NCT02339584|156906306|FG000|Overall Study|Adverse Event|11|||
48742526|NCT02339584|156906307|FG001|Overall Study|Adverse Event|7|||
48742527|NCT02339584|156906306|FG000|Overall Study|Lack of Efficacy|0|||
48324837|NCT05580003|155387114|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324838|NCT05580003|155387115|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324839|NCT05580003|155387116|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324840|NCT05580003|155387117|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324841|NCT05580003|155387118|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324842|NCT05580003|155387119|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324843|NCT05580003|155387120|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324844|NCT05580003|155387121|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324845|NCT05580003|155387122|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324846|NCT05580003|155387123|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
48324847|NCT05580003|155387096|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324848|NCT05580003|155387097|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324849|NCT05580003|155387098|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48628882|NCT00500331|156501654|FG000|Overall Study|Diabetologist nurse in the study|0|||
48628883|NCT00500331|156501655|FG001|Overall Study|Diabetologist nurse in the study|0|||
48628884|NCT00500331|156501656|FG002|Overall Study|Diabetologist nurse in the study|1|||
48628885|NCT00500331|156501657|FG003|Overall Study|Diabetologist nurse in the study|0|||
48628886|NCT00500331|156501658|FG004|Overall Study|Diabetologist nurse in the study|0|||
48628887|NCT00500331|156501659|FG005|Overall Study|Diabetologist nurse in the study|0|||
48628888|NCT00500331|156501660|FG006|Overall Study|Diabetologist nurse in the study|0|||
48628889|NCT00500331|156501654|FG000|Overall Study|State ban of biological samples export|0|||
48628890|NCT00500331|156501655|FG001|Overall Study|State ban of biological samples export|0|||
48628891|NCT00500331|156501656|FG002|Overall Study|State ban of biological samples export|0|||
48628892|NCT00500331|156501657|FG003|Overall Study|State ban of biological samples export|1|||
48628893|NCT00500331|156501658|FG004|Overall Study|State ban of biological samples export|0|||
48628894|NCT00500331|156501659|FG005|Overall Study|State ban of biological samples export|0|||
48628895|NCT00500331|156501660|FG006|Overall Study|State ban of biological samples export|0|||
48628896|NCT00500331|156501654|FG000|Overall Study|Protocol violated|0|||
48324850|NCT05580003|155387099|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
48628897|NCT00500331|156501655|FG001|Overall Study|Protocol violated|0|||
48628898|NCT00500331|156501656|FG002|Overall Study|Protocol violated|0|||
48628899|NCT00500331|156501657|FG003|Overall Study|Protocol violated|1|||
48628900|NCT00500331|156501658|FG004|Overall Study|Protocol violated|0|||
48628901|NCT00500331|156501659|FG005|Overall Study|Protocol violated|0|||
48628902|NCT00500331|156501660|FG006|Overall Study|Protocol violated|0|||
48628903|NCT00959049|156501667|FG000|Overall Study|Adverse Event|1|||
48628904|NCT00959049|156501668|FG001|Overall Study|Adverse Event|0|||
48628905|NCT00959049|156501669|FG002|Overall Study|Adverse Event|0|||
48628906|NCT00959049|156501670|FG003|Overall Study|Adverse Event|0|||
48628907|NCT00959049|156501671|FG004|Overall Study|Adverse Event|0|||
48628908|NCT00959049|156501672|FG005|Overall Study|Adverse Event|0|||
48628909|NCT00959049|156501667|FG000|Overall Study|Lost to Follow-up|17|||
48742528|NCT02339584|156906307|FG001|Overall Study|Lack of Efficacy|1|||
48742529|NCT02339584|156906306|FG000|Overall Study|Physician Decision|1|||
48742530|NCT02339584|156906307|FG001|Overall Study|Physician Decision|2|||
48742531|NCT02339584|156906306|FG000|Overall Study|Protocol Violation|1|||
48742532|NCT02339584|156906307|FG001|Overall Study|Protocol Violation|1|||
48628910|NCT00959049|156501668|FG001|Overall Study|Lost to Follow-up|5|||
48628911|NCT00959049|156501669|FG002|Overall Study|Lost to Follow-up|1|||
48628912|NCT00959049|156501670|FG003|Overall Study|Lost to Follow-up|10|||
48628913|NCT00959049|156501671|FG004|Overall Study|Lost to Follow-up|9|||
48628914|NCT00959049|156501672|FG005|Overall Study|Lost to Follow-up|1|||
48628915|NCT00959049|156501667|FG000|Overall Study|Contraindicated medication|0|||
48628916|NCT00959049|156501668|FG001|Overall Study|Contraindicated medication|0|||
48628917|NCT00959049|156501669|FG002|Overall Study|Contraindicated medication|0|||
48628918|NCT00959049|156501670|FG003|Overall Study|Contraindicated medication|1|||
48628919|NCT00959049|156501671|FG004|Overall Study|Contraindicated medication|0|||
48628920|NCT00959049|156501672|FG005|Overall Study|Contraindicated medication|0|||
48628921|NCT00959049|156501667|FG000|Overall Study|Withdrawal by Subject|0|||
48628922|NCT00959049|156501668|FG001|Overall Study|Withdrawal by Subject|2|||
48628923|NCT00959049|156501669|FG002|Overall Study|Withdrawal by Subject|0|||
48628924|NCT00959049|156501670|FG003|Overall Study|Withdrawal by Subject|0|||
48628925|NCT00959049|156501671|FG004|Overall Study|Withdrawal by Subject|0|||
48628926|NCT00959049|156501672|FG005|Overall Study|Withdrawal by Subject|0|||
48628927|NCT00770679|156501673|FG000|Overall Study|Lost to Follow-up|3|||
48628928|NCT00770679|156501673|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
48628929|NCT01285102|156501674|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
48628930|NCT03242434|156501675|FG000|Overall Study|Death|0|||
48628931|NCT03242434|156501676|FG001|Overall Study|Death|2|||
48628932|NCT02367885|156501677|FG000|Overall Study|Lost to Follow-up|1|||
48628933|NCT02367885|156501678|FG001|Overall Study|Lost to Follow-up|0|||
48628934|NCT02367885|156501679|FG002|Overall Study|Lost to Follow-up|0|||
48628935|NCT02367885|156501677|FG000|Overall Study|Withdrawal by Subject|1|||
48628936|NCT02367885|156501678|FG001|Overall Study|Withdrawal by Subject|0|||
48628937|NCT02367885|156501679|FG002|Overall Study|Withdrawal by Subject|0|||
48628938|NCT03847519|156501680|FG000|Overall Study|Death|5|||
48628939|NCT03847519|156501681|FG001|Overall Study|Death|8|||
48628940|NCT03847519|156501682|FG002|Overall Study|Death|1|||
48628941|NCT03847519|156501680|FG000|Overall Study|Lost to Follow-up|1|||
48628942|NCT03847519|156501681|FG001|Overall Study|Lost to Follow-up|2|||
48628943|NCT03847519|156501682|FG002|Overall Study|Lost to Follow-up|0|||
48628944|NCT03847519|156501680|FG000|Overall Study|Study Terminated by Sponsor|0|||
48628945|NCT03847519|156501681|FG001|Overall Study|Study Terminated by Sponsor|3|||
48628946|NCT03847519|156501682|FG002|Overall Study|Study Terminated by Sponsor|2|||
48628947|NCT00754572|156501683|FG000|Overall Study|Adverse Event|19|||
48628948|NCT00754572|156501683|FG000|Overall Study|Other|39|||
48628949|NCT00754572|156501683|FG000|Overall Study|Protocol Violation|3|||
48628950|NCT00754572|156501683|FG000|Overall Study|Withdrawal by Subject|3|||
48628951|NCT00754572|156501683|FG000|Overall Study|Lack of Efficacy|2|||
48628952|NCT00754572|156501683|FG000|Overall Study|Death|1|||
48628953|NCT00754572|156501683|FG000|Overall Study|Administrative Reason|3|||
48628954|NCT00754572|156501683|FG000|Overall Study|Lost to Follow-up|1|||
48628955|NCT01148771|156501686|FG000|Washout Period|Withdrawal by Subject|0|||
48628956|NCT01148771|156501687|FG001|Washout Period|Withdrawal by Subject|1|||
48628957|NCT01437189|156501688|FG000|Overall Study|Adverse Event|3|||
48628958|NCT01437189|156501688|FG000|Overall Study|Lack of Efficacy|4|||
48628959|NCT01437189|156501688|FG000|Overall Study|Withdrawal by Subject|8|||
48628960|NCT00347269|156501691|FG000|Overall Study|Lost to Follow-up|74|||
48628961|NCT00347269|156501692|FG001|Overall Study|Lost to Follow-up|65|||
48628962|NCT00347269|156501691|FG000|Overall Study|Withdrawal by Subject|18|||
48628963|NCT00347269|156501692|FG001|Overall Study|Withdrawal by Subject|38|||
48628964|NCT00347269|156501691|FG000|Overall Study|Death|2|||
48742533|NCT02339584|156906306|FG000|Overall Study|Withdrawal by Subject|2|||
48742534|NCT02339584|156906307|FG001|Overall Study|Withdrawal by Subject|4|||
48742535|NCT01348165|156906308|FG000|Overall Study|Adverse Event|0|||
48742536|NCT01348165|156906309|FG001|Overall Study|Adverse Event|0|||
48742537|NCT01348165|156906310|FG002|Overall Study|Adverse Event|0|||
48742538|NCT01348165|156906311|FG003|Overall Study|Adverse Event|0|||
48742539|NCT01348165|156906312|FG004|Overall Study|Adverse Event|0|||
48742540|NCT01348165|156906313|FG005|Overall Study|Adverse Event|0|||
48742541|NCT01348165|156906314|FG006|Overall Study|Adverse Event|1|||
48742542|NCT03547583|156906317|FG000|Overall Study|Adverse Event|16|||
48742543|NCT03547583|156906318|FG001|Overall Study|Adverse Event|11|||
48742544|NCT03547583|156906319|FG002|Overall Study|Adverse Event|10|||
48742545|NCT03547583|156906317|FG000|Overall Study|Death|11|||
48742546|NCT03547583|156906318|FG001|Overall Study|Death|7|||
48742547|NCT03547583|156906319|FG002|Overall Study|Death|4|||
48742548|NCT03547583|156906317|FG000|Overall Study|Lost to Follow-up|1|||
48742549|NCT03547583|156906318|FG001|Overall Study|Lost to Follow-up|0|||
48742550|NCT03547583|156906319|FG002|Overall Study|Lost to Follow-up|0|||
48324851|NCT05580003|155387100|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48628965|NCT00347269|156501692|FG001|Overall Study|Death|3|||
48628966|NCT01853280|156501693|FG000|Overall Study|Lack of Efficacy|2|||
48628967|NCT01853280|156501694|FG001|Overall Study|Lack of Efficacy|2|||
48628968|NCT01853280|156501693|FG000|Overall Study|Lost to Follow-up|0|||
48628969|NCT01853280|156501694|FG001|Overall Study|Lost to Follow-up|1|||
48628970|NCT01853280|156501693|FG000|Overall Study|Physician Decision|0|||
48628971|NCT01853280|156501694|FG001|Overall Study|Physician Decision|1|||
48628972|NCT01853280|156501693|FG000|Overall Study|Withdrawal by Subject|0|||
48628973|NCT01853280|156501694|FG001|Overall Study|Withdrawal by Subject|1|||
48628974|NCT01853280|156501693|FG000|Overall Study|Ineligible|0|||
48628975|NCT01853280|156501694|FG001|Overall Study|Ineligible|1|||
48628976|NCT00104884|156501695|FG000|Overall Study|Disease progression|4|||
48628977|NCT03032484|156501696|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
48628978|NCT03032484|156501697|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
48628979|NCT03032484|156501696|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
48628980|NCT03032484|156501697|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
48628981|NCT04023487|156501698|FG000|Overall Study|Lost to Follow-up|5|||
48628982|NCT04023487|156501699|FG001|Overall Study|Lost to Follow-up|4|||
48628983|NCT04023487|156501698|FG000|Overall Study|Pregnancy|1|||
48628984|NCT04023487|156501699|FG001|Overall Study|Pregnancy|2|||
48628985|NCT04023487|156501698|FG000|Overall Study|Withdrawal by Subject|4|||
48628986|NCT04023487|156501699|FG001|Overall Study|Withdrawal by Subject|5|||
48628987|NCT04023487|156501698|FG000|Overall Study|Partially completed testing|8|||
48628988|NCT04023487|156501699|FG001|Overall Study|Partially completed testing|4|||
48628989|NCT02697448|156501700|FG000|Overall Study|Protocol Violation|2|||
48628990|NCT02697448|156501701|FG001|Overall Study|Protocol Violation|4|||
48628991|NCT02697448|156501700|FG000|Overall Study|Clinical concerns during ablation|1|||
48628992|NCT02697448|156501701|FG001|Overall Study|Clinical concerns during ablation|1|||
48628993|NCT02697448|156501700|FG000|Overall Study|No data collected|2|||
48628994|NCT02697448|156501701|FG001|Overall Study|No data collected|0|||
48628995|NCT02507934|156501702|FG000|Overall Study|Lost to Follow-up|2|||
48628996|NCT02507934|156501703|FG001|Overall Study|Lost to Follow-up|0|||
48628997|NCT02507934|156501702|FG000|Overall Study|Withdrawal by Subject|2|||
48628998|NCT02507934|156501703|FG001|Overall Study|Withdrawal by Subject|0|||
48628999|NCT02592863|156501708|FG000|Overall Study|Withdrawal by Subject|2|||
48629000|NCT02592863|156501709|FG001|Overall Study|Withdrawal by Subject|2|||
48629001|NCT02592863|156501708|FG000|Overall Study|Lost to Follow-up|1|||
48629002|NCT02592863|156501709|FG001|Overall Study|Lost to Follow-up|1|||
48742551|NCT03547583|156906317|FG000|Overall Study|Non-compliance with study drug|0|||
48742552|NCT03547583|156906318|FG001|Overall Study|Non-compliance with study drug|0|||
48324852|NCT05580003|155387101|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324853|NCT05580003|155387102|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324854|NCT05580003|155387103|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324855|NCT05580003|155387104|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324856|NCT05580003|155387105|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48742553|NCT03547583|156906319|FG002|Overall Study|Non-compliance with study drug|1|||
48742554|NCT03547583|156906317|FG000|Overall Study|Physician Decision|1|||
48742555|NCT03547583|156906318|FG001|Overall Study|Physician Decision|0|||
48742556|NCT03547583|156906319|FG002|Overall Study|Physician Decision|3|||
48324857|NCT05580003|155387106|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324858|NCT05580003|155387107|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324859|NCT05580003|155387108|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48629003|NCT04770285|156501711|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
48629004|NCT04770285|156501712|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
48629005|NCT04770285|156501711|FG000|Overall Study|Lack of Efficacy|0|||
48629006|NCT04770285|156501712|FG001|Overall Study|Lack of Efficacy|1|||
48629007|NCT04770285|156501711|FG000|Overall Study|Lost to Follow-up|11|||
48629008|NCT04770285|156501712|FG001|Overall Study|Lost to Follow-up|8|||
48629009|NCT04770285|156501711|FG000|Overall Study|Protocol Deviation|6|||
48742557|NCT03547583|156906317|FG000|Overall Study|Protocol Violation|2|||
48742558|NCT03547583|156906318|FG001|Overall Study|Protocol Violation|1|||
48742559|NCT03547583|156906319|FG002|Overall Study|Protocol Violation|1|||
48742560|NCT03547583|156906317|FG000|Overall Study|Withdrawal by Subject|12|||
48742561|NCT03547583|156906318|FG001|Overall Study|Withdrawal by Subject|19|||
48742562|NCT03547583|156906319|FG002|Overall Study|Withdrawal by Subject|10|||
48742563|NCT03547583|156906317|FG000|Overall Study|Other|2|||
48742564|NCT03547583|156906318|FG001|Overall Study|Other|2|||
48742565|NCT03547583|156906319|FG002|Overall Study|Other|3|||
48451243|NCT00355134|155841607|FG004|Core Phase|Adverse Event|0|||
48629010|NCT04770285|156501712|FG001|Overall Study|Protocol Deviation|6|||
48629011|NCT04770285|156501711|FG000|Overall Study|Technical Problem|0|||
48629012|NCT04770285|156501712|FG001|Overall Study|Technical Problem|1|||
48629013|NCT04770285|156501711|FG000|Overall Study|Withdrawal by Subject|9|||
48629014|NCT04770285|156501712|FG001|Overall Study|Withdrawal by Subject|8|||
48629015|NCT04770285|156501711|FG000|Overall Study|Reason Not Specified|0|||
48629016|NCT04770285|156501712|FG001|Overall Study|Reason Not Specified|1|||
48629017|NCT03766399|156501713|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629018|NCT03766399|156501714|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629019|NCT03766399|156501715|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629020|NCT03766399|156501716|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629021|NCT03766399|156501717|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629022|NCT03766399|156501718|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629023|NCT03766399|156501719|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629024|NCT03766399|156501720|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629025|NCT03766399|156501721|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629026|NCT03766399|156501722|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629027|NCT03766399|156501723|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629028|NCT03766399|156501724|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629029|NCT03766399|156501725|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629030|NCT03766399|156501726|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
48629031|NCT03766399|156501727|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629032|NCT03766399|156501728|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629033|NCT03766399|156501729|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629034|NCT03766399|156501730|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
48629035|NCT02758626|156501731|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
48629036|NCT02758626|156501732|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
48629037|NCT02758626|156501731|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
48629038|NCT02758626|156501732|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
48629039|NCT02758626|156501731|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
48629040|NCT02758626|156501732|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
48629041|NCT02758626|156501731|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
48629042|NCT02758626|156501732|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
48629043|NCT00855335|156501733|FG000|Overall Study|Lost to Follow-up|0|||
48629044|NCT00855335|156501734|FG001|Overall Study|Lost to Follow-up|0|||
48629045|NCT00855335|156501735|FG002|Overall Study|Lost to Follow-up|3|||
48629046|NCT00855335|156501736|FG003|Overall Study|Lost to Follow-up|1|||
48629047|NCT00855335|156501737|FG004|Overall Study|Lost to Follow-up|0|||
48629048|NCT00855335|156501733|FG000|Overall Study|Withdrawal by Subject|0|||
48629049|NCT00855335|156501734|FG001|Overall Study|Withdrawal by Subject|0|||
48629050|NCT00855335|156501735|FG002|Overall Study|Withdrawal by Subject|0|||
48629051|NCT00855335|156501736|FG003|Overall Study|Withdrawal by Subject|1|||
48629052|NCT00855335|156501737|FG004|Overall Study|Withdrawal by Subject|0|||
48629053|NCT00855335|156501733|FG000|Overall Study|Adverse Event|2|||
48629054|NCT00855335|156501734|FG001|Overall Study|Adverse Event|0|||
48629055|NCT00855335|156501735|FG002|Overall Study|Adverse Event|0|||
48629056|NCT00855335|156501736|FG003|Overall Study|Adverse Event|0|||
48629057|NCT00855335|156501737|FG004|Overall Study|Adverse Event|0|||
48629058|NCT00855335|156501733|FG000|Overall Study|Physician Decision|1|||
48629059|NCT00855335|156501734|FG001|Overall Study|Physician Decision|1|||
48629060|NCT00855335|156501735|FG002|Overall Study|Physician Decision|0|||
48629061|NCT00855335|156501736|FG003|Overall Study|Physician Decision|0|||
48629062|NCT00855335|156501737|FG004|Overall Study|Physician Decision|0|||
48629063|NCT00855335|156501733|FG000|Overall Study|Other|2|||
48629064|NCT00855335|156501734|FG001|Overall Study|Other|1|||
48742566|NCT03307967|156906327|FG000|Overall Study|Lost to Follow-up|4|||
48629065|NCT00855335|156501735|FG002|Overall Study|Other|2|||
48629066|NCT00855335|156501736|FG003|Overall Study|Other|5|||
48629067|NCT00855335|156501737|FG004|Overall Study|Other|1|||
48629068|NCT00879398|156501742|FG000|Overall Study|Visit Stop|399|||
48629069|NCT00879398|156501742|FG000|Overall Study|Lack of Efficacy|64|||
48742567|NCT02166905|156906328|FG000|Overall Study|Withdrawal by Subject|1|||
48742568|NCT02166905|156906329|FG001|Overall Study|Withdrawal by Subject|0|||
48742569|NCT02166905|156906330|FG002|Overall Study|Withdrawal by Subject|0|||
48742570|NCT02166905|156906331|FG003|Overall Study|Withdrawal by Subject|0|||
48742571|NCT01218113|156908167|FG000|Overall Study|Withdrawal by Subject|1|||
48324860|NCT05580003|155387109|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324861|NCT05580003|155387110|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324862|NCT05580003|155387111|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324863|NCT05580003|155387112|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324864|NCT05580003|155387113|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324865|NCT05580003|155387114|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324866|NCT05580003|155387115|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324867|NCT05580003|155387116|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324868|NCT05580003|155387117|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324869|NCT05580003|155387118|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324870|NCT05580003|155387119|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324871|NCT05580003|155387120|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324872|NCT05580003|155387121|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324873|NCT05580003|155387122|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324874|NCT05580003|155387123|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
48324875|NCT05580003|155387096|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324876|NCT05580003|155387097|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
48324877|NCT05580003|155387098|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324878|NCT05580003|155387099|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324879|NCT05580003|155387100|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324880|NCT05580003|155387101|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324881|NCT05580003|155387102|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324882|NCT05580003|155387103|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324883|NCT05580003|155387104|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324884|NCT05580003|155387105|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324885|NCT05580003|155387106|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324886|NCT05580003|155387107|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324887|NCT05580003|155387108|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48629070|NCT00879398|156501742|FG000|Overall Study|Adverse Event|41|||
48629071|NCT00879398|156501742|FG000|Overall Study|Other Reasons|171|||
48629072|NCT03131479|156501746|FG000|Overall Study|Adverse Event|0|||
48629073|NCT03131479|156501747|FG001|Overall Study|Adverse Event|0|||
48629074|NCT03131479|156501748|FG002|Overall Study|Adverse Event|1|||
48629075|NCT03131479|156501749|FG003|Overall Study|Adverse Event|1|||
48629076|NCT03131479|156501750|FG004|Overall Study|Adverse Event|0|||
48629077|NCT03131479|156501746|FG000|Overall Study|Subject/Guardian Decision|0|||
48629078|NCT03131479|156501747|FG001|Overall Study|Subject/Guardian Decision|0|||
48629079|NCT03131479|156501748|FG002|Overall Study|Subject/Guardian Decision|0|||
48629080|NCT03131479|156501749|FG003|Overall Study|Subject/Guardian Decision|1|||
48629081|NCT03131479|156501750|FG004|Overall Study|Subject/Guardian Decision|0|||
48629082|NCT05305651|156501751|FG000|Overall Study|Death|1|||
48629083|NCT05305651|156501751|FG000|Overall Study|Withdrawal by Subject|4|||
48629084|NCT05305651|156501751|FG000|Overall Study|Lost to Follow-up|4|||
48629085|NCT00980798|156501752|FG000|Overall Study|Adverse Event|7|||
48629086|NCT00980798|156501753|FG001|Overall Study|Adverse Event|36|||
48629087|NCT00980798|156501752|FG000|Overall Study|Lack of Efficacy|16|||
48629088|NCT00980798|156501753|FG001|Overall Study|Lack of Efficacy|5|||
48629089|NCT00980798|156501752|FG000|Overall Study|Lost to Follow-up|0|||
48629090|NCT00980798|156501753|FG001|Overall Study|Lost to Follow-up|1|||
48629091|NCT00980798|156501752|FG000|Overall Study|Physician Decision|2|||
48629092|NCT00980798|156501753|FG001|Overall Study|Physician Decision|1|||
48629093|NCT00980798|156501752|FG000|Overall Study|Withdrawal by Subject|8|||
48629094|NCT00980798|156501753|FG001|Overall Study|Withdrawal by Subject|11|||
48629095|NCT00980798|156501752|FG000|Overall Study|Other|0|||
48629096|NCT00980798|156501753|FG001|Overall Study|Other|1|||
48629097|NCT01506726|156501754|FG000|Overall Study|Adverse Event|1|||
48629098|NCT01506726|156501755|FG001|Overall Study|Adverse Event|2|||
48629099|NCT01491919|156501756|FG000|Overall Study|Insufficient PK sampling|1|||
48629100|NCT01491919|156501757|FG001|Overall Study|Insufficient PK sampling|2|||
48629101|NCT01491919|156501758|FG002|Overall Study|Insufficient PK sampling|1|||
48629102|NCT04724837|156501759|FG000|Overall Study|Other|4|||
48629103|NCT04724837|156501760|FG001|Overall Study|Other|16|||
48742572|NCT01218113|156908168|FG001|Overall Study|Withdrawal by Subject|0|||
48742573|NCT01218113|156908169|FG002|Overall Study|Withdrawal by Subject|1|||
48324888|NCT05580003|155387109|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324889|NCT05580003|155387110|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48629104|NCT04724837|156501761|FG002|Overall Study|Other|0|||
48629105|NCT04724837|156501759|FG000|Overall Study|Withdrawal by Subject|2|||
48742574|NCT01218113|156908167|FG000|Overall Study|Lost to Follow-up|4|||
48324890|NCT05580003|155387111|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48629106|NCT04724837|156501760|FG001|Overall Study|Withdrawal by Subject|9|||
48629107|NCT04724837|156501761|FG002|Overall Study|Withdrawal by Subject|9|||
48629108|NCT04724837|156501759|FG000|Overall Study|Adverse Event|2|||
48629109|NCT04724837|156501760|FG001|Overall Study|Adverse Event|7|||
48629110|NCT04724837|156501761|FG002|Overall Study|Adverse Event|4|||
48629111|NCT04724837|156501759|FG000|Overall Study|Lost to Follow-up|0|||
48629112|NCT04724837|156501760|FG001|Overall Study|Lost to Follow-up|1|||
48629113|NCT04724837|156501761|FG002|Overall Study|Lost to Follow-up|3|||
48629114|NCT04724837|156501759|FG000|Overall Study|Physician Decision|1|||
48629115|NCT04724837|156501760|FG001|Overall Study|Physician Decision|2|||
48629116|NCT04724837|156501761|FG002|Overall Study|Physician Decision|0|||
48629117|NCT04724837|156501759|FG000|Overall Study|Death|0|||
48629118|NCT04724837|156501760|FG001|Overall Study|Death|0|||
48629119|NCT04724837|156501761|FG002|Overall Study|Death|1|||
48629120|NCT04724837|156501759|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
48629121|NCT04724837|156501760|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
48629122|NCT04724837|156501761|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
48629123|NCT04724837|156501759|FG000|Overall Study|Study Terminated by Sponsor|0|||
48629124|NCT04724837|156501760|FG001|Overall Study|Study Terminated by Sponsor|1|||
48629125|NCT04724837|156501761|FG002|Overall Study|Study Terminated by Sponsor|0|||
48629126|NCT04347538|156501765|FG000|Overall Study|Lost to Follow-up|4|||
48629127|NCT04347538|156501766|FG001|Overall Study|Lost to Follow-up|5|||
48629128|NCT04347538|156501767|FG002|Overall Study|Lost to Follow-up|7|||
48629129|NCT04938427|156501768|FG000|Overall Study|Adverse Event|5|||
48629130|NCT04938427|156501769|FG001|Overall Study|Adverse Event|19|||
48629131|NCT04938427|156501768|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48629132|NCT04938427|156501769|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48629133|NCT04938427|156501768|FG000|Overall Study|Withdrawal by Subject|1|||
48629134|NCT04938427|156501769|FG001|Overall Study|Withdrawal by Subject|0|||
48629135|NCT04938427|156501768|FG000|Overall Study|Reason Not Specified|2|||
48629136|NCT04938427|156501769|FG001|Overall Study|Reason Not Specified|1|||
48629137|NCT03537508|156501782|FG000|Overall Study|Adverse Event|2|||
48629138|NCT03537508|156501783|FG001|Overall Study|Adverse Event|1|||
48629139|NCT03537508|156501782|FG000|Overall Study|Protocol Violation|65|||
48629140|NCT03537508|156501783|FG001|Overall Study|Protocol Violation|48|||
48629141|NCT03537508|156501782|FG000|Overall Study|Lost to Follow-up|86|||
48629142|NCT03537508|156501783|FG001|Overall Study|Lost to Follow-up|60|||
48629143|NCT03537508|156501782|FG000|Overall Study|Withdrawal by parent/guardian|263|||
48629144|NCT03537508|156501783|FG001|Overall Study|Withdrawal by parent/guardian|149|||
48629145|NCT01649869|156501786|FG000|Overall Study|Family member illness|1|||
48629146|NCT01649869|156501787|FG001|Overall Study|Family member illness|0|||
48629147|NCT01649869|156501786|FG000|Overall Study|Required treatment outside protocol|1|||
48629148|NCT01649869|156501787|FG001|Overall Study|Required treatment outside protocol|0|||
48629149|NCT01649869|156501786|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
48629150|NCT01649869|156501787|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
48629151|NCT01313676|156502711|FG000|Overall Study|Adverse Event|395|||
48629152|NCT01313676|156502712|FG001|Overall Study|Adverse Event|365|||
48629153|NCT01313676|156502713|FG002|Overall Study|Adverse Event|372|||
48629154|NCT01313676|156502714|FG003|Overall Study|Adverse Event|333|||
48629155|NCT01313676|156502711|FG000|Overall Study|Lack of Efficacy|98|||
48629156|NCT01313676|156502712|FG001|Overall Study|Lack of Efficacy|90|||
48629157|NCT01313676|156502713|FG002|Overall Study|Lack of Efficacy|65|||
48629158|NCT01313676|156502714|FG003|Overall Study|Lack of Efficacy|46|||
48629159|NCT01313676|156502711|FG000|Overall Study|Protocol Violation|37|||
48629160|NCT01313676|156502712|FG001|Overall Study|Protocol Violation|44|||
48629161|NCT01313676|156502713|FG002|Overall Study|Protocol Violation|46|||
48629162|NCT01313676|156502714|FG003|Overall Study|Protocol Violation|44|||
48629163|NCT01313676|156502711|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
48629164|NCT01313676|156502712|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
48629165|NCT01313676|156502713|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
48629166|NCT01313676|156502714|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
48629167|NCT01313676|156502711|FG000|Overall Study|Study Closed/terminated|7|||
48629168|NCT01313676|156502712|FG001|Overall Study|Study Closed/terminated|6|||
48629169|NCT01313676|156502713|FG002|Overall Study|Study Closed/terminated|9|||
48629170|NCT01313676|156502714|FG003|Overall Study|Study Closed/terminated|9|||
48629171|NCT01313676|156502711|FG000|Overall Study|Lost to Follow-up|0|||
48629172|NCT01313676|156502712|FG001|Overall Study|Lost to Follow-up|0|||
48629173|NCT01313676|156502713|FG002|Overall Study|Lost to Follow-up|1|||
48629174|NCT01313676|156502714|FG003|Overall Study|Lost to Follow-up|0|||
48324891|NCT05580003|155387112|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324892|NCT05580003|155387113|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48629175|NCT01313676|156502711|FG000|Overall Study|Physician Decision|53|||
48629176|NCT01313676|156502712|FG001|Overall Study|Physician Decision|64|||
48629177|NCT01313676|156502713|FG002|Overall Study|Physician Decision|62|||
48629178|NCT01313676|156502714|FG003|Overall Study|Physician Decision|48|||
48629179|NCT01313676|156502711|FG000|Overall Study|Decision by Participant or Proxy|643|||
48629180|NCT01313676|156502712|FG001|Overall Study|Decision by Participant or Proxy|527|||
48629181|NCT01313676|156502713|FG002|Overall Study|Decision by Participant or Proxy|515|||
48629182|NCT01313676|156502714|FG003|Overall Study|Decision by Participant or Proxy|492|||
48629183|NCT01313676|156502711|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
48629184|NCT01313676|156502712|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
48629185|NCT01313676|156502713|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
48629186|NCT01313676|156502714|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
48629187|NCT01313676|156502711|FG000|Overall Study|Investigator Site Closed|12|||
48629188|NCT01313676|156502712|FG001|Overall Study|Investigator Site Closed|11|||
48629189|NCT01313676|156502713|FG002|Overall Study|Investigator Site Closed|15|||
48629190|NCT01313676|156502714|FG003|Overall Study|Investigator Site Closed|10|||
48629191|NCT01313676|156502711|FG000|Overall Study|Missing|1|||
48629192|NCT01313676|156502712|FG001|Overall Study|Missing|1|||
48629193|NCT01313676|156502713|FG002|Overall Study|Missing|1|||
48629194|NCT01313676|156502714|FG003|Overall Study|Missing|0|||
48629195|NCT03312114|156502715|FG000|Overall Study|All the five enrolled dropped out of the|5|||
48629196|NCT03345550|156502718|FG000|Overall Study|Withdrawal by Subject|1|||
48629197|NCT03345550|156502719|FG001|Overall Study|Withdrawal by Subject|0|||
48629198|NCT03345550|156502718|FG000|Overall Study|Lost to Follow-up|4|||
48629199|NCT03345550|156502719|FG001|Overall Study|Lost to Follow-up|5|||
48629200|NCT03701074|156502720|FG000|Overall Study|Physician Decision|1|||
48629201|NCT03701074|156502721|FG001|Overall Study|Physician Decision|0|||
48629202|NCT01998477|156502732|FG000|Overall Study|Lost to Follow-up|4|||
48629203|NCT01998477|156502733|FG001|Overall Study|Lost to Follow-up|5|||
48629204|NCT01998477|156502732|FG000|Overall Study|Withdrawal by Subject|6|||
48629205|NCT01998477|156502733|FG001|Overall Study|Withdrawal by Subject|0|||
48629206|NCT00480532|156502734|FG000|Overall Study|Withdrawal by Subject|2|||
48629207|NCT00480532|156502735|FG001|Overall Study|Withdrawal by Subject|4|||
48629208|NCT00480532|156502736|FG002|Overall Study|Withdrawal by Subject|3|||
48629209|NCT00480532|156502737|FG003|Overall Study|Withdrawal by Subject|1|||
48629210|NCT00480532|156502734|FG000|Overall Study|Protocol Violation|0|||
48629211|NCT00480532|156502735|FG001|Overall Study|Protocol Violation|0|||
48629212|NCT00480532|156502736|FG002|Overall Study|Protocol Violation|1|||
48629213|NCT00480532|156502737|FG003|Overall Study|Protocol Violation|0|||
48629214|NCT01817777|156502738|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
48629215|NCT01817777|156502739|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
48629216|NCT01817777|156502740|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
48629217|NCT01817777|156502738|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
48629218|NCT01817777|156502739|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
48629219|NCT01817777|156502740|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
48629220|NCT01817777|156502738|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
48629221|NCT01817777|156502739|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
48629222|NCT01817777|156502740|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
48629223|NCT01817777|156502738|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
48629224|NCT01817777|156502739|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
48629225|NCT01817777|156502740|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
48629226|NCT01817777|156502738|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
48629227|NCT01817777|156502739|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
48629228|NCT01817777|156502740|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
48629229|NCT03524157|156502741|FG000|Overall Study|cytology not readable|0|||
48629230|NCT03524157|156502742|FG001|Overall Study|cytology not readable|0|||
48629231|NCT03524157|156502743|FG002|Overall Study|cytology not readable|1|||
48629232|NCT03627468|156502745|FG000|Overall Study|Adverse Event|5|||
48629233|NCT03627468|156502746|FG001|Overall Study|Adverse Event|33|||
48629234|NCT03627468|156502745|FG000|Overall Study|Withdrawal by Subject|13|||
48629235|NCT03627468|156502746|FG001|Overall Study|Withdrawal by Subject|23|||
48629236|NCT03627468|156502745|FG000|Overall Study|Physician Decision|1|||
48629237|NCT03627468|156502746|FG001|Overall Study|Physician Decision|0|||
48629238|NCT03627468|156502745|FG000|Overall Study|Protocol Violation|0|||
48629239|NCT03627468|156502746|FG001|Overall Study|Protocol Violation|2|||
48629240|NCT03627468|156502745|FG000|Overall Study|Lost to Follow-up|10|||
48629241|NCT03627468|156502746|FG001|Overall Study|Lost to Follow-up|16|||
48629242|NCT03627468|156502745|FG000|Overall Study|Death|1|||
48629243|NCT03627468|156502746|FG001|Overall Study|Death|0|||
48324893|NCT05580003|155387114|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48629244|NCT03627468|156502745|FG000|Overall Study|Pregnancy|1|||
48629245|NCT03627468|156502746|FG001|Overall Study|Pregnancy|1|||
48629246|NCT03627468|156502745|FG000|Overall Study|Lack of Efficacy|0|||
48629247|NCT03627468|156502746|FG001|Overall Study|Lack of Efficacy|2|||
48629248|NCT03627468|156502745|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
48629249|NCT03627468|156502746|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
48629250|NCT01514357|156502747|FG000|Overall Study|Screen failure|2|||
48629251|NCT01514357|156502748|FG001|Overall Study|Screen failure|0|||
48629252|NCT01514357|156502747|FG000|Overall Study|Withdrawal by Subject|2|||
48629253|NCT01514357|156502748|FG001|Overall Study|Withdrawal by Subject|0|||
48451244|NCT00355134|155841603|FG000|Core Phase|Lost to Follow-up|17|||
48629254|NCT00752219|156502749|FG000|Overall Study|Clinical failure|0|||
48629255|NCT00752219|156502750|FG001|Overall Study|Clinical failure|1|||
48629256|NCT00752219|156502749|FG000|Overall Study|Adverse Event|5|||
48324894|NCT05580003|155387115|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324895|NCT05580003|155387116|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324896|NCT05580003|155387117|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324897|NCT05580003|155387118|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324898|NCT05580003|155387119|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324899|NCT05580003|155387120|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48629257|NCT00752219|156502750|FG001|Overall Study|Adverse Event|3|||
48629258|NCT00752219|156502749|FG000|Overall Study|Protocol deviation|1|||
48629259|NCT00752219|156502750|FG001|Overall Study|Protocol deviation|0|||
48629260|NCT00752219|156502749|FG000|Overall Study|Lost to Follow-up|1|||
48629261|NCT00752219|156502750|FG001|Overall Study|Lost to Follow-up|2|||
48629262|NCT00752219|156502749|FG000|Overall Study|Randomized but not treated|1|||
48629263|NCT00752219|156502750|FG001|Overall Study|Randomized but not treated|0|||
48629264|NCT00752219|156502749|FG000|Overall Study|Other|3|||
48629265|NCT00752219|156502750|FG001|Overall Study|Other|0|||
48629266|NCT01651208|156502754|FG000|Overall Study|Lost to Follow-up|14|||
48629267|NCT01651208|156502755|FG001|Overall Study|Lost to Follow-up|16|||
48629268|NCT00425555|156502756|FG000|Overall Study|Withdrawal by Subject|11|||
48629269|NCT00425555|156502757|FG001|Overall Study|Withdrawal by Subject|8|||
48629270|NCT00425555|156502756|FG000|Overall Study|Lost to Follow-up|0|||
48629271|NCT00425555|156502757|FG001|Overall Study|Lost to Follow-up|1|||
48629272|NCT00425555|156502756|FG000|Overall Study|Administrative problems|3|||
48629273|NCT00425555|156502757|FG001|Overall Study|Administrative problems|0|||
48629274|NCT00425555|156502756|FG000|Overall Study|Death|1|||
48629275|NCT00425555|156502757|FG001|Overall Study|Death|2|||
48629276|NCT00425555|156502756|FG000|Overall Study|New cancer therapy|2|||
48629277|NCT00425555|156502757|FG001|Overall Study|New cancer therapy|1|||
48629278|NCT00425555|156502756|FG000|Overall Study|Disease progression|36|||
48629279|NCT00425555|156502757|FG001|Overall Study|Disease progression|33|||
48629280|NCT00425555|156502756|FG000|Overall Study|Adverse Event|25|||
48742575|NCT01218113|156908168|FG001|Overall Study|Lost to Follow-up|1|||
48742576|NCT01218113|156908169|FG002|Overall Study|Lost to Follow-up|4|||
48742577|NCT01218113|156908167|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
48742578|NCT01218113|156908168|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
48742579|NCT01218113|156908169|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
48742580|NCT04092582|156908181|FG000|Overall Study|Death|1|||
48742581|NCT04092582|156908182|FG001|Overall Study|Death|1|||
48742582|NCT04092582|156908181|FG000|Overall Study|Withdrawal by Subject|4|||
48742583|NCT04092582|156908182|FG001|Overall Study|Withdrawal by Subject|1|||
48742584|NCT04092582|156908181|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
48742585|NCT04092582|156908182|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
48742586|NCT00709761|156908187|FG000|Overall Study|Withdrawal by Subject|8|||
48742587|NCT00709761|156908187|FG000|Overall Study|study closed/terminated|17|||
48742588|NCT00709761|156908187|FG000|Overall Study|Lost to Follow-up|2|||
48742589|NCT00283400|156908196|FG000|Overall Study|Withdrawal by Subject|1|||
48742590|NCT00283400|156908197|FG001|Overall Study|Withdrawal by Subject|1|||
48742591|NCT00283400|156908198|FG002|Overall Study|Withdrawal by Subject|0|||
48742592|NCT00283400|156908199|FG003|Overall Study|Withdrawal by Subject|0|||
48742593|NCT00283400|156908196|FG000|Overall Study|Death|1|||
48742594|NCT00283400|156908197|FG001|Overall Study|Death|0|||
48742595|NCT00283400|156908198|FG002|Overall Study|Death|1|||
48742596|NCT00283400|156908199|FG003|Overall Study|Death|0|||
48742597|NCT01970397|156908203|FG000|Overall Study|Adverse Event|0|||
48742598|NCT01970397|156908204|FG001|Overall Study|Adverse Event|1|||
48742599|NCT01970397|156908203|FG000|Overall Study|Lost to Follow-up|0|||
48742600|NCT01970397|156908204|FG001|Overall Study|Lost to Follow-up|1|||
48742601|NCT01970397|156908203|FG000|Overall Study|Personal Reasons|1|||
48742602|NCT01970397|156908204|FG001|Overall Study|Personal Reasons|2|||
48742603|NCT01970397|156908203|FG000|Overall Study|Protocol Violation|1|||
48742604|NCT01970397|156908204|FG001|Overall Study|Protocol Violation|1|||
48629281|NCT00425555|156502757|FG001|Overall Study|Adverse Event|15|||
48629282|NCT00425555|156502756|FG000|Overall Study|Protocol Violation|1|||
48629283|NCT00425555|156502757|FG001|Overall Study|Protocol Violation|0|||
48629284|NCT03880019|156502758|FG000|Overall Study|Competing disease|1|||
48629285|NCT05308004|156502759|FG000|Overall Study|Not seen by Palliative Care NP|0|||
48629286|NCT05308004|156502760|FG001|Overall Study|Not seen by Palliative Care NP|1|||
48629287|NCT01767987|156502767|FG000|Overall Study|Physician Decision|4|||
48742605|NCT00926328|156908205|FG000|Overall Study|Lost to Follow-up|12|||
48742606|NCT00926328|156908206|FG001|Overall Study|Lost to Follow-up|14|||
48742607|NCT00726986|156908207|FG000|Induction Phase|Adverse Event|4|||
48742608|NCT00726986|156908207|FG000|Induction Phase|Withdrawal by Subject|2|||
48742609|NCT00726986|156908207|FG000|Induction Phase|Death|2|||
48742610|NCT00726986|156908207|FG000|Induction Phase|Lack of Efficacy|5|||
48742611|NCT00726986|156908207|FG000|Induction Phase|Secondary Disease|2|||
48629288|NCT01767987|156502768|FG001|Overall Study|Physician Decision|1|||
48742612|NCT00726986|156908207|FG000|Maintenance Phase|Adverse Event|1|||
48742613|NCT00726986|156908207|FG000|Maintenance Phase|Lack of Efficacy|2|||
48324900|NCT05580003|155387121|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48629289|NCT00829868|156502769|FG000|Washout|Physician Decision|1|||
48629290|NCT00829868|156502770|FG001|Washout|Physician Decision|0|||
48324901|NCT05580003|155387122|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48324902|NCT05580003|155387123|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
48629291|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
48324903|NCT05580003|155387096|FG000|Part 2 (up to 10 Days)|Other|0|||
48324904|NCT05580003|155387097|FG001|Part 2 (up to 10 Days)|Other|0|||
48324905|NCT05580003|155387098|FG002|Part 2 (up to 10 Days)|Other|0|||
48324906|NCT05580003|155387099|FG003|Part 2 (up to 10 Days)|Other|0|||
48324907|NCT05580003|155387100|FG004|Part 2 (up to 10 Days)|Other|0|||
48629292|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48629293|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48629294|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48629295|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48324908|NCT05580003|155387101|FG005|Part 2 (up to 10 Days)|Other|0|||
48324909|NCT05580003|155387102|FG006|Part 2 (up to 10 Days)|Other|0|||
48629296|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48629297|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
48629298|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
48629299|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
48629300|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
48629301|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
48742614|NCT00639678|156908208|FG000|Overall Study|Withdrawal by Subject|3|||
48742615|NCT00639678|156908209|FG001|Overall Study|Withdrawal by Subject|0|||
48742616|NCT00639678|156908210|FG002|Overall Study|Withdrawal by Subject|4|||
48742617|NCT00639678|156908211|FG003|Overall Study|Withdrawal by Subject|0|||
48742618|NCT00639678|156908208|FG000|Overall Study|Lost to Follow-up|1|||
48742619|NCT00639678|156908209|FG001|Overall Study|Lost to Follow-up|0|||
48742620|NCT00639678|156908210|FG002|Overall Study|Lost to Follow-up|6|||
48742621|NCT00639678|156908211|FG003|Overall Study|Lost to Follow-up|0|||
48742622|NCT00639678|156908208|FG000|Overall Study|Adverse Event|0|||
48742623|NCT00639678|156908209|FG001|Overall Study|Adverse Event|1|||
48742624|NCT00639678|156908210|FG002|Overall Study|Adverse Event|0|||
48742625|NCT00639678|156908211|FG003|Overall Study|Adverse Event|0|||
48742626|NCT00639678|156908208|FG000|Overall Study|Lack of Compliance|0|||
48742627|NCT00639678|156908209|FG001|Overall Study|Lack of Compliance|0|||
48742628|NCT00639678|156908210|FG002|Overall Study|Lack of Compliance|1|||
48742629|NCT00639678|156908211|FG003|Overall Study|Lack of Compliance|0|||
48742630|NCT01513343|156908220|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
48742631|NCT01513343|156908221|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
48742632|NCT01513343|156908220|FG000|Post Data Collection|Dropped/withdrew from study|7|||
48742633|NCT01513343|156908221|FG001|Post Data Collection|Dropped/withdrew from study|1|||
48742634|NCT01513343|156908220|FG000|Post Data Collection|Lost to Follow-up|10|||
48742635|NCT01513343|156908221|FG001|Post Data Collection|Lost to Follow-up|23|||
48742636|NCT01513343|156908220|FG000|6-month Follow-up|Lost to Follow-up|28|||
48742637|NCT01513343|156908221|FG001|6-month Follow-up|Lost to Follow-up|17|||
48742638|NCT01513343|156908220|FG000|12-month Follow-up|Lost to Follow-up|10|||
48742639|NCT01513343|156908221|FG001|12-month Follow-up|Lost to Follow-up|3|||
48742640|NCT00040365|156908222|FG000|Overall Study|Death|1|||
48742641|NCT00040365|156908222|FG000|Overall Study|Progressive disease|7|||
48324910|NCT05580003|155387103|FG007|Part 2 (up to 10 Days)|Other|0|||
48324911|NCT05580003|155387104|FG008|Part 2 (up to 10 Days)|Other|0|||
48324912|NCT05580003|155387105|FG009|Part 2 (up to 10 Days)|Other|1|||
48324913|NCT05580003|155387106|FG010|Part 2 (up to 10 Days)|Other|0|||
48324914|NCT05580003|155387107|FG011|Part 2 (up to 10 Days)|Other|0|||
48324915|NCT05580003|155387108|FG012|Part 2 (up to 10 Days)|Other|0|||
48324916|NCT05580003|155387109|FG013|Part 2 (up to 10 Days)|Other|0|||
48324917|NCT05580003|155387110|FG014|Part 2 (up to 10 Days)|Other|0|||
48324918|NCT05580003|155387111|FG015|Part 2 (up to 10 Days)|Other|0|||
48324919|NCT05580003|155387112|FG016|Part 2 (up to 10 Days)|Other|0|||
48324920|NCT05580003|155387113|FG017|Part 2 (up to 10 Days)|Other|0|||
48324921|NCT05580003|155387114|FG018|Part 2 (up to 10 Days)|Other|0|||
48324922|NCT05580003|155387115|FG019|Part 2 (up to 10 Days)|Other|0|||
48324923|NCT05580003|155387116|FG020|Part 2 (up to 10 Days)|Other|0|||
48324924|NCT05580003|155387117|FG021|Part 2 (up to 10 Days)|Other|0|||
48324925|NCT05580003|155387118|FG022|Part 2 (up to 10 Days)|Other|0|||
48324926|NCT05580003|155387119|FG023|Part 2 (up to 10 Days)|Other|0|||
48324927|NCT05580003|155387120|FG024|Part 2 (up to 10 Days)|Other|0|||
48324928|NCT05580003|155387121|FG025|Part 2 (up to 10 Days)|Other|0|||
48324929|NCT05580003|155387122|FG026|Part 2 (up to 10 Days)|Other|0|||
48324930|NCT05580003|155387123|FG027|Part 2 (up to 10 Days)|Other|0|||
48324931|NCT05580003|155387096|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324932|NCT05580003|155387097|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324933|NCT05580003|155387098|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324934|NCT05580003|155387099|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324935|NCT05580003|155387100|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324936|NCT05580003|155387101|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324937|NCT05580003|155387102|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324938|NCT05580003|155387103|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324939|NCT05580003|155387104|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324940|NCT05580003|155387105|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324941|NCT05580003|155387106|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324942|NCT05580003|155387107|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324943|NCT05580003|155387108|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324944|NCT05580003|155387109|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324945|NCT05580003|155387110|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324946|NCT05580003|155387111|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48629302|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
48629303|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
48629304|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
48742642|NCT00040365|156908222|FG000|Overall Study|Lost to Follow-up|3|||
48742643|NCT00713323|156908223|FG000|Overall Study|Adverse Event|75|||
48629305|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
48629306|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
48629307|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
48629308|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
48629309|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
48629310|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
48629311|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
48629312|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
48629313|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
48629314|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
48629315|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
48629316|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
48629317|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
48629318|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
48629319|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
48629320|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
48629321|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
48629322|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
48629323|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
48629324|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
48629325|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
48742644|NCT00713323|156908223|FG000|Overall Study|Withdrawal by Subject|15|||
48324947|NCT05580003|155387112|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324948|NCT05580003|155387113|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324949|NCT05580003|155387114|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324950|NCT05580003|155387115|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
48324951|NCT05580003|155387116|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324952|NCT05580003|155387117|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324953|NCT05580003|155387118|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324954|NCT05580003|155387119|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324955|NCT05580003|155387120|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324956|NCT05580003|155387121|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324957|NCT05580003|155387122|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324958|NCT05580003|155387123|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
48324959|NCT05580003|155387096|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324960|NCT05580003|155387097|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324961|NCT05580003|155387098|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324962|NCT05580003|155387099|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324963|NCT05580003|155387100|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324964|NCT05580003|155387101|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324965|NCT05580003|155387102|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324966|NCT05580003|155387103|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324967|NCT05580003|155387104|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324968|NCT05580003|155387105|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324969|NCT05580003|155387106|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324970|NCT05580003|155387107|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324971|NCT05580003|155387108|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48629326|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
48629327|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
48629328|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
48629329|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
48629330|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
48629331|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
48629332|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
48629333|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
48629334|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
48629335|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
48629336|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
48629337|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
48629338|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
48629339|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
48629340|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
48629341|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
48629342|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
48629343|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
48629344|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
48629345|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
48629346|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
48742645|NCT00713323|156908223|FG000|Overall Study|Lost to Follow-up|11|||
48324972|NCT05580003|155387109|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48629347|NCT01362790|156502771|FG000|Pilot Phase & Phase 2|Death on study|0|||
48629348|NCT01362790|156502772|FG001|Pilot Phase & Phase 2|Death on study|0|||
48629349|NCT01362790|156502773|FG002|Pilot Phase & Phase 2|Death on study|0|||
48629350|NCT01362790|156502774|FG003|Pilot Phase & Phase 2|Death on study|1|||
48629351|NCT01362790|156502775|FG004|Pilot Phase & Phase 2|Death on study|0|||
48629352|NCT01362790|156502776|FG005|Pilot Phase & Phase 2|Death on study|0|||
48742646|NCT00713323|156908223|FG000|Overall Study|Lack of Efficacy|36|||
48324973|NCT05580003|155387110|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324974|NCT05580003|155387111|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324975|NCT05580003|155387112|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324976|NCT05580003|155387113|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324977|NCT05580003|155387114|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324978|NCT05580003|155387115|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324979|NCT05580003|155387116|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
48324980|NCT05580003|155387117|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324981|NCT05580003|155387118|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324982|NCT05580003|155387119|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324983|NCT05580003|155387120|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324984|NCT05580003|155387121|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324985|NCT05580003|155387122|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324986|NCT05580003|155387123|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
48324987|NCT05580003|155387096|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324988|NCT05580003|155387097|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324989|NCT05580003|155387098|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324990|NCT05580003|155387099|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324991|NCT05580003|155387100|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324992|NCT05580003|155387101|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324993|NCT05580003|155387102|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324994|NCT05580003|155387103|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324995|NCT05580003|155387104|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324996|NCT05580003|155387105|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324997|NCT05580003|155387106|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324998|NCT05580003|155387107|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48324999|NCT05580003|155387108|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325000|NCT05580003|155387109|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325001|NCT05580003|155387110|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325002|NCT05580003|155387111|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325003|NCT05580003|155387112|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325004|NCT05580003|155387113|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325005|NCT05580003|155387114|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325006|NCT05580003|155387115|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325007|NCT05580003|155387116|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325008|NCT05580003|155387117|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
48325009|NCT05580003|155387118|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48629353|NCT01362790|156502777|FG006|Pilot Phase & Phase 2|Death on study|0|||
48629354|NCT01362790|156502771|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
48742647|NCT00713323|156908223|FG000|Overall Study|Low creatine clearance at screening|1|||
48742648|NCT00713323|156908223|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
48742649|NCT00713323|156908223|FG000|Overall Study|Surgery cured allodynic pain|1|||
48742650|NCT00713323|156908223|FG000|Overall Study|Pain free|1|||
48742651|NCT00713323|156908223|FG000|Overall Study|Non-compliance|1|||
48742652|NCT00713323|156908223|FG000|Overall Study|Pain resolved|1|||
48742653|NCT00713323|156908223|FG000|Overall Study|Subject travelling to USA|1|||
48742654|NCT00713323|156908223|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
48742655|NCT00713323|156908223|FG000|Overall Study|Treatment that may interact with Sativex|1|||
48742656|NCT01706146|156908226|FG000|Overall Study|Withdrawal by Subject|1|||
48742657|NCT01706146|156908226|FG000|Overall Study|Adverse Event|3|||
48742658|NCT01706146|156908226|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
48742659|NCT01488370|156908227|FG000|Overall Study|Protocol Violation|0|||
48742660|NCT01488370|156908228|FG001|Overall Study|Protocol Violation|1|||
48742661|NCT01488370|156908229|FG002|Overall Study|Protocol Violation|1|||
48742662|NCT01471171|156908230|FG000|Treatment Period 1|Adverse Event|4|||
48742663|NCT01471171|156908231|FG001|Treatment Period 1|Adverse Event|1|||
48629355|NCT01362790|156502772|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
48629356|NCT01362790|156502773|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
48742664|NCT01471171|156908230|FG000|Treatment Period 2|Adverse Event|1|||
48742665|NCT01471171|156908231|FG001|Treatment Period 2|Adverse Event|0|||
48742666|NCT00705484|156908239|FG000|Overall Study|Adverse Event|28|||
48742667|NCT00705484|156908240|FG001|Overall Study|Adverse Event|27|||
48742668|NCT00705484|156908239|FG000|Overall Study|Lost to Follow-up|169|||
48325010|NCT05580003|155387119|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325011|NCT05580003|155387120|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325012|NCT05580003|155387121|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325013|NCT05580003|155387122|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325014|NCT05580003|155387123|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
48325015|NCT05580003|155387096|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325016|NCT05580003|155387097|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325017|NCT05580003|155387098|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325018|NCT05580003|155387099|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325019|NCT05580003|155387100|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48629357|NCT01362790|156502774|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
48325020|NCT05580003|155387101|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325021|NCT05580003|155387102|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325022|NCT05580003|155387103|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325023|NCT05580003|155387104|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325024|NCT05580003|155387105|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325025|NCT05580003|155387106|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325026|NCT05580003|155387107|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325027|NCT05580003|155387108|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325028|NCT05580003|155387109|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325029|NCT05580003|155387110|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325030|NCT05580003|155387111|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325031|NCT05580003|155387112|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325032|NCT05580003|155387113|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325033|NCT05580003|155387114|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325034|NCT05580003|155387115|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48742669|NCT00705484|156908240|FG001|Overall Study|Lost to Follow-up|250|||
48742670|NCT00705484|156908239|FG000|Overall Study|Withdrawal by Subject|96|||
48742671|NCT00705484|156908240|FG001|Overall Study|Withdrawal by Subject|72|||
48742672|NCT00705484|156908239|FG000|Overall Study|Administrative|89|||
48742673|NCT00705484|156908240|FG001|Overall Study|Administrative|59|||
48742674|NCT00444912|156908241|FG000|Overall Study|Death|1|||
48742675|NCT00444912|156908242|FG001|Overall Study|Death|2|||
48742676|NCT00444912|156908241|FG000|Overall Study|Lost to Follow-up|1|||
48742677|NCT00444912|156908242|FG001|Overall Study|Lost to Follow-up|0|||
48742678|NCT00444912|156908241|FG000|Overall Study|Participant Failed Mobilization|1|||
48742679|NCT00444912|156908242|FG001|Overall Study|Participant Failed Mobilization|0|||
48742680|NCT03758066|156908243|FG000|Overall Study|Lost to Follow-up|14|||
48742681|NCT03733470|156908244|FG000|Overall Study|PI Decision|1|||
48742682|NCT03733470|156908245|FG001|Overall Study|PI Decision|1|||
48325035|NCT05580003|155387116|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325036|NCT05580003|155387117|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325037|NCT05580003|155387118|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325038|NCT05580003|155387119|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48742683|NCT01866293|156908247|FG000|Overall Study|Adverse Event|2|||
48742684|NCT00493025|156908248|FG000|Overall Study|Physician Decision|19|||
48629358|NCT01362790|156502775|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
48629359|NCT01362790|156502776|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
48629360|NCT01362790|156502777|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
48629361|NCT01362790|156502771|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
48629362|NCT01362790|156502772|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
48629363|NCT01362790|156502773|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
48629364|NCT01362790|156502774|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
48629365|NCT01362790|156502775|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
48629366|NCT01362790|156502776|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
48629367|NCT01362790|156502777|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
48629368|NCT01362790|156502771|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
48629369|NCT01362790|156502772|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
48629370|NCT01362790|156502773|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
48629371|NCT01362790|156502774|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
48629372|NCT01362790|156502775|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
48629373|NCT01362790|156502776|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
48629374|NCT01362790|156502777|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
48629375|NCT03163667|156502784|FG000|Overall Study|Death|15|||
48629376|NCT03163667|156502785|FG001|Overall Study|Death|27|||
48629377|NCT03163667|156502784|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
48629378|NCT03163667|156502785|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
48629379|NCT05360784|156502786|FG000|Overall Study|Discontinued|25|||
48629380|NCT05360784|156502787|FG001|Overall Study|Discontinued|11|||
48629381|NCT02706392|156502790|FG000|Overall Study|Death|1|||
48629382|NCT02706392|156502791|FG001|Overall Study|Death|0|||
48629383|NCT02706392|156502792|FG002|Overall Study|Death|2|||
48629384|NCT02706392|156502793|FG003|Overall Study|Death|2|||
48629385|NCT02706392|156502794|FG004|Overall Study|Death|5|||
48742685|NCT01876420|156908249|FG000|Overall Study|Missed 30 day visit|1|||
48629386|NCT02706392|156502795|FG005|Overall Study|Death|2|||
48629387|NCT00619866|156502796|FG000|Weeks 1 - 12|Adverse Event|0|||
48629388|NCT00619866|156502797|FG001|Weeks 1 - 12|Adverse Event|1|||
48629389|NCT00619866|156502798|FG002|Weeks 1 - 12|Adverse Event|2|||
48629390|NCT00619866|156502799|FG003|Weeks 1 - 12|Adverse Event|0|||
48629391|NCT00619866|156502800|FG004|Weeks 1 - 12|Adverse Event|0|||
48629392|NCT00619866|156502796|FG000|Weeks 1 - 12|Non-compliance|0|||
48629393|NCT00619866|156502797|FG001|Weeks 1 - 12|Non-compliance|0|||
48629394|NCT00619866|156502798|FG002|Weeks 1 - 12|Non-compliance|1|||
48629395|NCT00619866|156502799|FG003|Weeks 1 - 12|Non-compliance|0|||
48629396|NCT00619866|156502800|FG004|Weeks 1 - 12|Non-compliance|0|||
48629397|NCT00619866|156502796|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
48629398|NCT00619866|156502797|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
48629399|NCT00619866|156502798|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
48629400|NCT00619866|156502799|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
48629401|NCT00619866|156502800|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
48629402|NCT00619866|156502796|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
48629403|NCT00619866|156502797|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
48629404|NCT00619866|156502798|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
48629405|NCT00619866|156502799|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
48742686|NCT05229406|156908253|FG000|Overall Study|Withdrawal by Subject|1|||
48742687|NCT05229406|156908254|FG001|Overall Study|Withdrawal by Subject|2|||
48629406|NCT00619866|156502800|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
48629407|NCT00619866|156502796|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
48629408|NCT00619866|156502797|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
48629409|NCT00619866|156502798|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
48629410|NCT00619866|156502799|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
48629411|NCT00619866|156502800|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
48629412|NCT00619866|156502796|FG000|Weeks 1 - 12|Sponsor Decision|0|||
48629413|NCT00619866|156502797|FG001|Weeks 1 - 12|Sponsor Decision|1|||
48742688|NCT05466682|156908257|FG000|Overall Study|Withdrawal by Subject|0|||
48629414|NCT00619866|156502798|FG002|Weeks 1 - 12|Sponsor Decision|0|||
48629415|NCT00619866|156502799|FG003|Weeks 1 - 12|Sponsor Decision|0|||
48629416|NCT00619866|156502800|FG004|Weeks 1 - 12|Sponsor Decision|0|||
48742689|NCT05466682|156908258|FG001|Overall Study|Withdrawal by Subject|2|||
48742690|NCT05466682|156908257|FG000|Overall Study|Lost to Follow-up|2|||
48742691|NCT05466682|156908258|FG001|Overall Study|Lost to Follow-up|1|||
48325039|NCT05580003|155387120|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325040|NCT05580003|155387121|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325041|NCT05580003|155387122|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
48325042|NCT05580003|155387123|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
48325043|NCT05580003|155387096|FG000|Part 6 Period 2 (Day 1)|Other|0|||
48325044|NCT05580003|155387097|FG001|Part 6 Period 2 (Day 1)|Other|0|||
48325045|NCT05580003|155387098|FG002|Part 6 Period 2 (Day 1)|Other|0|||
48325046|NCT05580003|155387099|FG003|Part 6 Period 2 (Day 1)|Other|0|||
48629417|NCT00619866|156502796|FG000|Weeks 13 - 24|Adverse Event|0|||
48629418|NCT00619866|156502797|FG001|Weeks 13 - 24|Adverse Event|0|||
48629419|NCT00619866|156502798|FG002|Weeks 13 - 24|Adverse Event|2|||
48629420|NCT00619866|156502799|FG003|Weeks 13 - 24|Adverse Event|1|||
48629421|NCT00619866|156502800|FG004|Weeks 13 - 24|Adverse Event|0|||
48629422|NCT00619866|156502796|FG000|Weeks 13 - 24|Protocol Deviation|0|||
48629423|NCT00619866|156502797|FG001|Weeks 13 - 24|Protocol Deviation|0|||
48629424|NCT00619866|156502798|FG002|Weeks 13 - 24|Protocol Deviation|0|||
48629425|NCT00619866|156502799|FG003|Weeks 13 - 24|Protocol Deviation|1|||
48629426|NCT00619866|156502800|FG004|Weeks 13 - 24|Protocol Deviation|0|||
48629427|NCT00619866|156502796|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
48629428|NCT00619866|156502797|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
48742692|NCT00036270|156908259|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
48742693|NCT00036270|156908260|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
48742694|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
48325047|NCT05580003|155387100|FG004|Part 6 Period 2 (Day 1)|Other|0|||
48325048|NCT05580003|155387101|FG005|Part 6 Period 2 (Day 1)|Other|0|||
48325049|NCT05580003|155387102|FG006|Part 6 Period 2 (Day 1)|Other|0|||
48325050|NCT05580003|155387103|FG007|Part 6 Period 2 (Day 1)|Other|0|||
48325051|NCT05580003|155387104|FG008|Part 6 Period 2 (Day 1)|Other|0|||
48325052|NCT05580003|155387105|FG009|Part 6 Period 2 (Day 1)|Other|0|||
48629429|NCT00619866|156502798|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
48629430|NCT00619866|156502799|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
48629431|NCT00619866|156502800|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
48629432|NCT00619866|156502796|FG000|Weeks 13 - 24|Non-compliance|0|||
48629433|NCT00619866|156502797|FG001|Weeks 13 - 24|Non-compliance|1|||
48629434|NCT00619866|156502798|FG002|Weeks 13 - 24|Non-compliance|1|||
48629435|NCT00619866|156502799|FG003|Weeks 13 - 24|Non-compliance|0|||
48629436|NCT00619866|156502800|FG004|Weeks 13 - 24|Non-compliance|0|||
48629437|NCT00619866|156502796|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
48629438|NCT00619866|156502797|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
48629439|NCT00619866|156502798|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
48742695|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
48742696|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
48325053|NCT05580003|155387106|FG010|Part 6 Period 2 (Day 1)|Other|0|||
48325054|NCT05580003|155387107|FG011|Part 6 Period 2 (Day 1)|Other|0|||
48325055|NCT05580003|155387108|FG012|Part 6 Period 2 (Day 1)|Other|0|||
48742697|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
48742698|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
48742699|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
48742700|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Other|277|||
48742701|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Other|288|||
48742702|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
48742703|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
48742704|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
48742705|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
48742706|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
48742707|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
48742708|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
48742709|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
48629440|NCT00619866|156502799|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
48629441|NCT00619866|156502800|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
48629442|NCT00835367|156502801|FG000|Washout|Adverse Event|2|||
48629443|NCT00835367|156502802|FG001|Washout|Adverse Event|0|||
48629444|NCT00835367|156502801|FG000|Washout|Withdrawal by Subject|1|||
48629445|NCT00835367|156502802|FG001|Washout|Withdrawal by Subject|0|||
48629446|NCT00835367|156502801|FG000|Second Intervention|Adverse Event|1|||
48629447|NCT00835367|156502802|FG001|Second Intervention|Adverse Event|1|||
48629448|NCT00835172|156502803|FG000|Washout|Protocol Violation|0|||
48629449|NCT00835172|156502804|FG001|Washout|Protocol Violation|1|||
48629450|NCT00618787|156502811|FG000|Overall Study|Adverse Event|0|||
48629451|NCT00618787|156502812|FG001|Overall Study|Adverse Event|1|||
48629452|NCT00618787|156502811|FG000|Overall Study|Withdrawal by Subject|2|||
48629453|NCT00618787|156502812|FG001|Overall Study|Withdrawal by Subject|1|||
48629454|NCT00618787|156502811|FG000|Overall Study|Lost to Follow-up|1|||
48629455|NCT00618787|156502812|FG001|Overall Study|Lost to Follow-up|0|||
48629456|NCT03423979|156502813|FG000|Overall Study|Death|1|||
48629457|NCT03599713|156502814|FG000|Overall Study|Death|26|||
48629458|NCT03599713|156502815|FG001|Overall Study|Death|3|||
48629459|NCT03599713|156502814|FG000|Overall Study|Withdrawal by Subject|6|||
48629460|NCT03599713|156502815|FG001|Overall Study|Withdrawal by Subject|0|||
48629461|NCT03599713|156502814|FG000|Overall Study|Ongoing|69|||
48629462|NCT03599713|156502815|FG001|Overall Study|Ongoing|3|||
48629463|NCT00492050|156502816|FG000|Overall Study|Adverse Event|1|||
48629464|NCT00492050|156502816|FG000|Overall Study|Lack of Efficacy|1|||
48629465|NCT00492050|156502816|FG000|Overall Study|Withdrawal by Subject|3|||
48629466|NCT00492050|156502816|FG000|Overall Study|Unable to collect SCT|2|||
48629467|NCT00492050|156502816|FG000|Overall Study|Progressive Disease|2|||
48629468|NCT04486716|156504810|FG000|Overall Study|Subject decision|6|||
48629469|NCT04486716|156504810|FG000|Overall Study|Adverse Event|5|||
48629470|NCT04486716|156504810|FG000|Overall Study|Lost to Follow-up|1|||
48629471|NCT04486716|156504810|FG000|Overall Study|Physician Decision|1|||
48629472|NCT04486716|156504810|FG000|Overall Study|Enrolled subjects not treated|9|||
48629473|NCT03379870|156504811|FG000|Overall Study|Lost to Follow-up|1|||
48629474|NCT03379870|156504812|FG001|Overall Study|Lost to Follow-up|0|||
48629475|NCT03379870|156504811|FG000|Overall Study|Protocol Violation|1|||
48629476|NCT03379870|156504812|FG001|Overall Study|Protocol Violation|1|||
48629477|NCT02723955|156504813|FG000|Escalation Phase|Death|1|||
48629478|NCT02723955|156504814|FG001|Escalation Phase|Death|1|||
48629479|NCT02723955|156504815|FG002|Escalation Phase|Death|2|||
48629480|NCT02723955|156504816|FG003|Escalation Phase|Death|7|||
48629481|NCT02723955|156504817|FG004|Escalation Phase|Death|18|||
48629482|NCT02723955|156504818|FG005|Escalation Phase|Death|17|||
48629483|NCT02723955|156504819|FG006|Escalation Phase|Death|11|||
48629484|NCT02723955|156504820|FG007|Escalation Phase|Death|21|||
48629485|NCT02723955|156504821|FG008|Escalation Phase|Death|3|||
48629486|NCT02723955|156504822|FG009|Escalation Phase|Death|0|||
48629487|NCT02723955|156504823|FG010|Escalation Phase|Death|0|||
48629488|NCT02723955|156504824|FG011|Escalation Phase|Death|0|||
48742710|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
48742711|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
48742712|NCT00036270|156908259|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
48629489|NCT02723955|156504825|FG012|Escalation Phase|Death|2|||
48629490|NCT02723955|156504826|FG013|Escalation Phase|Death|4|||
48629491|NCT02723955|156504827|FG014|Escalation Phase|Death|5|||
48629492|NCT02723955|156504828|FG015|Escalation Phase|Death|6|||
48629493|NCT02723955|156504829|FG016|Escalation Phase|Death|6|||
48742713|NCT00036270|156908260|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
48742714|NCT01387932|156908261|FG000|Randomized and Treated|Physician Decision|3|||
48629494|NCT02723955|156504830|FG017|Escalation Phase|Death|7|||
48629495|NCT02723955|156504831|FG018|Escalation Phase|Death|1|||
48629496|NCT02723955|156504832|FG019|Escalation Phase|Death|3|||
48629497|NCT02723955|156504833|FG020|Escalation Phase|Death|13|||
48629498|NCT02723955|156504834|FG021|Escalation Phase|Death|3|||
48629499|NCT02723955|156504835|FG022|Escalation Phase|Death|2|||
48629500|NCT02723955|156504836|FG023|Escalation Phase|Death|4|||
48742715|NCT01387932|156908262|FG001|Randomized and Treated|Physician Decision|2|||
48742716|NCT01387932|156908261|FG000|Randomized and Treated|Withdrawal by Subject|4|||
48742717|NCT01387932|156908262|FG001|Randomized and Treated|Withdrawal by Subject|2|||
48742718|NCT01387932|156908261|FG000|Survival Follow-up|Liver Transplant|24|||
48742719|NCT01387932|156908262|FG001|Survival Follow-up|Liver Transplant|28|||
48742720|NCT01387932|156908261|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
48742721|NCT01387932|156908262|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
48742722|NCT01387932|156908261|FG000|Survival Follow-up|Withdrawal by Subject|2|||
48742723|NCT01387932|156908262|FG001|Survival Follow-up|Withdrawal by Subject|4|||
48742724|NCT01387932|156908261|FG000|Survival Follow-up|Lost to Follow-up|6|||
48742725|NCT01387932|156908262|FG001|Survival Follow-up|Lost to Follow-up|5|||
48742726|NCT01416272|156908263|FG000|Overall Study|Unacceptable distance visual acuity|2|||
48742727|NCT01416272|156908263|FG000|Overall Study|Lost to Follow-up|1|||
48742728|NCT01416272|156908263|FG000|Overall Study|Study related complaints|1|||
48742729|NCT02571075|156908264|FG000|Overall Study|Lost to Follow-up|20|||
48742730|NCT02571075|156908265|FG001|Overall Study|Lost to Follow-up|24|||
48742731|NCT02002091|156908266|FG000|Screening|Lost to Follow-up|10|||
48742732|NCT02002091|156908267|FG001|Screening|Lost to Follow-up|12|||
48742733|NCT02002091|156908266|FG000|Screening|Death|3|||
48742734|NCT02002091|156908267|FG001|Screening|Death|2|||
48742735|NCT05213481|156908268|FG000|Overall Study|Adverse Event|3|||
48742736|NCT05213481|156908268|FG000|Overall Study|Lost to Follow-up|1|||
48742737|NCT02217878|156908269|FG000|Overall Study|required morphine due to chest pain|1|||
48742738|NCT02217878|156908270|FG001|Overall Study|required morphine due to chest pain|2|||
48742739|NCT02217878|156908269|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
48742740|NCT02217878|156908270|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
48742741|NCT00003487|156908271|FG000|Overall Study|Not evaluable|2|||
48742742|NCT00334958|156908272|FG000|Overall Study|Medication Noncompliance|0|||
48742743|NCT00334958|156908273|FG001|Overall Study|Medication Noncompliance|3|||
48742744|NCT00334958|156908272|FG000|Overall Study|Protocol Violation|2|||
48742745|NCT00334958|156908273|FG001|Overall Study|Protocol Violation|2|||
48742746|NCT00334958|156908272|FG000|Overall Study|Request of the investigator or sponsor|0|||
48742747|NCT00334958|156908273|FG001|Overall Study|Request of the investigator or sponsor|1|||
48742748|NCT00334958|156908272|FG000|Overall Study|Withdrawal by Subject|7|||
48742749|NCT00334958|156908273|FG001|Overall Study|Withdrawal by Subject|4|||
48742750|NCT00334958|156908272|FG000|Overall Study|Adverse Event|27|||
48742751|NCT00334958|156908273|FG001|Overall Study|Adverse Event|12|||
48629501|NCT02723955|156504837|FG024|Escalation Phase|Death|31|||
48742752|NCT00334958|156908272|FG000|Overall Study|Other|1|||
48742753|NCT00334958|156908273|FG001|Overall Study|Other|2|||
48742754|NCT04431453|156908274|FG000|Overall Study|Withdrew Consent|0|||
48742755|NCT04431453|156908275|FG001|Overall Study|Withdrew Consent|1|||
48629502|NCT02723955|156504838|FG025|Escalation Phase|Death|7|||
48742756|NCT04431453|156908276|FG002|Overall Study|Withdrew Consent|0|||
48742757|NCT04431453|156908277|FG003|Overall Study|Withdrew Consent|2|||
48742758|NCT04431453|156908278|FG004|Overall Study|Withdrew Consent|0|||
48742759|NCT04431453|156908279|FG005|Overall Study|Withdrew Consent|0|||
48629503|NCT02723955|156504839|FG026|Escalation Phase|Death|13|||
48325056|NCT05580003|155387109|FG013|Part 6 Period 2 (Day 1)|Other|0|||
48325057|NCT05580003|155387110|FG014|Part 6 Period 2 (Day 1)|Other|0|||
48325058|NCT05580003|155387111|FG015|Part 6 Period 2 (Day 1)|Other|0|||
48325059|NCT05580003|155387112|FG016|Part 6 Period 2 (Day 1)|Other|0|||
48325060|NCT05580003|155387113|FG017|Part 6 Period 2 (Day 1)|Other|0|||
48629504|NCT02723955|156504840|FG027|Escalation Phase|Death|0|||
48629505|NCT02723955|156504841|FG028|Escalation Phase|Death|1|||
48629506|NCT02723955|156504842|FG029|Escalation Phase|Death|0|||
48629507|NCT02723955|156504843|FG030|Escalation Phase|Death|0|||
48629508|NCT02723955|156504844|FG031|Escalation Phase|Death|0|||
48629509|NCT02723955|156504845|FG032|Escalation Phase|Death|0|||
48629510|NCT02723955|156504846|FG033|Escalation Phase|Death|0|||
48629511|NCT02723955|156504847|FG034|Escalation Phase|Death|0|||
48629512|NCT02723955|156504848|FG035|Escalation Phase|Death|0|||
48629513|NCT02723955|156504849|FG036|Escalation Phase|Death|0|||
48629514|NCT02723955|156504850|FG037|Escalation Phase|Death|0|||
48629515|NCT02723955|156504851|FG038|Escalation Phase|Death|0|||
48629516|NCT02723955|156504852|FG039|Escalation Phase|Death|0|||
48629517|NCT02723955|156504853|FG040|Escalation Phase|Death|0|||
48629518|NCT02723955|156504854|FG041|Escalation Phase|Death|0|||
48629519|NCT02723955|156504855|FG042|Escalation Phase|Death|0|||
48629520|NCT02723955|156504813|FG000|Escalation Phase|Lost to Follow-up|0|||
48629521|NCT02723955|156504814|FG001|Escalation Phase|Lost to Follow-up|0|||
48629522|NCT02723955|156504815|FG002|Escalation Phase|Lost to Follow-up|0|||
48629523|NCT02723955|156504816|FG003|Escalation Phase|Lost to Follow-up|0|||
48629524|NCT02723955|156504817|FG004|Escalation Phase|Lost to Follow-up|0|||
48629525|NCT02723955|156504818|FG005|Escalation Phase|Lost to Follow-up|2|||
48629526|NCT02723955|156504819|FG006|Escalation Phase|Lost to Follow-up|1|||
48629527|NCT02723955|156504820|FG007|Escalation Phase|Lost to Follow-up|1|||
48629528|NCT02723955|156504821|FG008|Escalation Phase|Lost to Follow-up|1|||
48629529|NCT02723955|156504822|FG009|Escalation Phase|Lost to Follow-up|0|||
48629530|NCT02723955|156504823|FG010|Escalation Phase|Lost to Follow-up|0|||
48629531|NCT02723955|156504824|FG011|Escalation Phase|Lost to Follow-up|0|||
48629532|NCT02723955|156504825|FG012|Escalation Phase|Lost to Follow-up|1|||
48629533|NCT02723955|156504826|FG013|Escalation Phase|Lost to Follow-up|0|||
48629534|NCT02723955|156504827|FG014|Escalation Phase|Lost to Follow-up|0|||
48629535|NCT02723955|156504828|FG015|Escalation Phase|Lost to Follow-up|0|||
48629536|NCT02723955|156504829|FG016|Escalation Phase|Lost to Follow-up|1|||
48629537|NCT02723955|156504830|FG017|Escalation Phase|Lost to Follow-up|2|||
48629538|NCT02723955|156504831|FG018|Escalation Phase|Lost to Follow-up|0|||
48629539|NCT02723955|156504832|FG019|Escalation Phase|Lost to Follow-up|1|||
48629540|NCT02723955|156504833|FG020|Escalation Phase|Lost to Follow-up|2|||
48629541|NCT02723955|156504834|FG021|Escalation Phase|Lost to Follow-up|1|||
48629542|NCT02723955|156504835|FG022|Escalation Phase|Lost to Follow-up|0|||
48629543|NCT02723955|156504836|FG023|Escalation Phase|Lost to Follow-up|0|||
48629544|NCT02723955|156504837|FG024|Escalation Phase|Lost to Follow-up|1|||
48629545|NCT02723955|156504838|FG025|Escalation Phase|Lost to Follow-up|1|||
48629546|NCT02723955|156504839|FG026|Escalation Phase|Lost to Follow-up|3|||
48629547|NCT02723955|156504840|FG027|Escalation Phase|Lost to Follow-up|0|||
48629548|NCT02723955|156504841|FG028|Escalation Phase|Lost to Follow-up|1|||
48629549|NCT02723955|156504842|FG029|Escalation Phase|Lost to Follow-up|0|||
48629550|NCT02723955|156504843|FG030|Escalation Phase|Lost to Follow-up|0|||
48325061|NCT05580003|155387114|FG018|Part 6 Period 2 (Day 1)|Other|0|||
48629551|NCT02723955|156504844|FG031|Escalation Phase|Lost to Follow-up|0|||
48629552|NCT02723955|156504845|FG032|Escalation Phase|Lost to Follow-up|0|||
48629553|NCT02723955|156504846|FG033|Escalation Phase|Lost to Follow-up|0|||
48629554|NCT02723955|156504847|FG034|Escalation Phase|Lost to Follow-up|0|||
48629555|NCT02723955|156504848|FG035|Escalation Phase|Lost to Follow-up|0|||
48629556|NCT02723955|156504849|FG036|Escalation Phase|Lost to Follow-up|0|||
48629557|NCT02723955|156504850|FG037|Escalation Phase|Lost to Follow-up|0|||
48629558|NCT02723955|156504851|FG038|Escalation Phase|Lost to Follow-up|0|||
48629559|NCT02723955|156504852|FG039|Escalation Phase|Lost to Follow-up|0|||
48629560|NCT02723955|156504853|FG040|Escalation Phase|Lost to Follow-up|0|||
48629561|NCT02723955|156504854|FG041|Escalation Phase|Lost to Follow-up|0|||
48629562|NCT02723955|156504855|FG042|Escalation Phase|Lost to Follow-up|0|||
48629563|NCT02723955|156504813|FG000|Escalation Phase|Physician Decision|0|||
48629564|NCT02723955|156504814|FG001|Escalation Phase|Physician Decision|0|||
48629565|NCT02723955|156504815|FG002|Escalation Phase|Physician Decision|0|||
48629566|NCT02723955|156504816|FG003|Escalation Phase|Physician Decision|0|||
48629567|NCT02723955|156504817|FG004|Escalation Phase|Physician Decision|0|||
48629568|NCT02723955|156504818|FG005|Escalation Phase|Physician Decision|2|||
48629569|NCT02723955|156504819|FG006|Escalation Phase|Physician Decision|0|||
48629570|NCT02723955|156504820|FG007|Escalation Phase|Physician Decision|0|||
48629571|NCT02723955|156504821|FG008|Escalation Phase|Physician Decision|0|||
48629572|NCT02723955|156504822|FG009|Escalation Phase|Physician Decision|0|||
48629573|NCT02723955|156504823|FG010|Escalation Phase|Physician Decision|0|||
48325062|NCT05580003|155387115|FG019|Part 6 Period 2 (Day 1)|Other|0|||
48325063|NCT05580003|155387116|FG020|Part 6 Period 2 (Day 1)|Other|0|||
48325064|NCT05580003|155387117|FG021|Part 6 Period 2 (Day 1)|Other|0|||
48325065|NCT05580003|155387118|FG022|Part 6 Period 2 (Day 1)|Other|0|||
48325066|NCT05580003|155387119|FG023|Part 6 Period 2 (Day 1)|Other|0|||
48325067|NCT05580003|155387120|FG024|Part 6 Period 2 (Day 1)|Other|1|||
48325068|NCT05580003|155387121|FG025|Part 6 Period 2 (Day 1)|Other|0|||
48325069|NCT05580003|155387122|FG026|Part 6 Period 2 (Day 1)|Other|0|||
48742760|NCT04431453|156908280|FG006|Overall Study|Withdrew Consent|0|||
48325070|NCT05580003|155387123|FG027|Part 6 Period 2 (Day 1)|Other|0|||
48325071|NCT03890289|155387124|FG000|Overall Study|Adverse Event|1|||
48325072|NCT03890289|155387124|FG000|Overall Study|Physician Decision|1|||
48325073|NCT03890289|155387124|FG000|Overall Study|Lack of Efficacy|2|||
48325074|NCT03840902|155387125|FG000|Overall Study|Randomized but not treated|1|||
48325075|NCT03840902|155387126|FG001|Overall Study|Randomized but not treated|1|||
48325076|NCT02426138|155387127|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
48325077|NCT02426138|155387128|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
48325078|NCT02392234|155387133|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
48325079|NCT02392234|155387134|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
48325080|NCT02392234|155387135|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
48325081|NCT02392234|155387136|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
48325082|NCT02392234|155387137|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
48325083|NCT02392234|155387138|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
48325084|NCT02392234|155387133|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48325085|NCT02392234|155387134|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48325086|NCT02392234|155387135|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48325087|NCT02392234|155387136|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48325088|NCT02392234|155387137|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
48325089|NCT02392234|155387138|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
48325090|NCT02392234|155387133|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48325091|NCT02392234|155387134|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48325092|NCT02392234|155387135|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48325093|NCT02392234|155387136|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48325094|NCT02392234|155387137|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
48325095|NCT02392234|155387138|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
48629574|NCT02723955|156504824|FG011|Escalation Phase|Physician Decision|0|||
48629575|NCT02723955|156504825|FG012|Escalation Phase|Physician Decision|0|||
48629576|NCT02723955|156504826|FG013|Escalation Phase|Physician Decision|0|||
48629577|NCT02723955|156504827|FG014|Escalation Phase|Physician Decision|0|||
48629578|NCT02723955|156504828|FG015|Escalation Phase|Physician Decision|0|||
48629579|NCT02723955|156504829|FG016|Escalation Phase|Physician Decision|0|||
48629580|NCT02723955|156504830|FG017|Escalation Phase|Physician Decision|0|||
48629581|NCT02723955|156504831|FG018|Escalation Phase|Physician Decision|0|||
48629582|NCT02723955|156504832|FG019|Escalation Phase|Physician Decision|0|||
48629583|NCT02723955|156504833|FG020|Escalation Phase|Physician Decision|0|||
48629584|NCT02723955|156504834|FG021|Escalation Phase|Physician Decision|0|||
48629585|NCT02723955|156504835|FG022|Escalation Phase|Physician Decision|0|||
48629586|NCT02723955|156504836|FG023|Escalation Phase|Physician Decision|0|||
48629587|NCT02723955|156504837|FG024|Escalation Phase|Physician Decision|0|||
48629588|NCT02723955|156504838|FG025|Escalation Phase|Physician Decision|0|||
48629589|NCT02723955|156504839|FG026|Escalation Phase|Physician Decision|2|||
48629590|NCT02723955|156504840|FG027|Escalation Phase|Physician Decision|0|||
48629591|NCT02723955|156504841|FG028|Escalation Phase|Physician Decision|0|||
48629592|NCT02723955|156504842|FG029|Escalation Phase|Physician Decision|0|||
48629593|NCT02723955|156504843|FG030|Escalation Phase|Physician Decision|0|||
48629594|NCT02723955|156504844|FG031|Escalation Phase|Physician Decision|0|||
48629595|NCT02723955|156504845|FG032|Escalation Phase|Physician Decision|0|||
48629596|NCT02723955|156504846|FG033|Escalation Phase|Physician Decision|0|||
48629597|NCT02723955|156504847|FG034|Escalation Phase|Physician Decision|0|||
48629598|NCT02723955|156504848|FG035|Escalation Phase|Physician Decision|0|||
48629599|NCT02723955|156504849|FG036|Escalation Phase|Physician Decision|0|||
48629600|NCT02723955|156504850|FG037|Escalation Phase|Physician Decision|0|||
48629601|NCT02723955|156504851|FG038|Escalation Phase|Physician Decision|0|||
48742761|NCT04431453|156908281|FG007|Overall Study|Withdrew Consent|0|||
48325096|NCT02392234|155387133|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
48742762|NCT04431453|156908274|FG000|Overall Study|Death|1|||
48742763|NCT04431453|156908275|FG001|Overall Study|Death|0|||
48325097|NCT02392234|155387134|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
48325098|NCT02392234|155387135|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
48325099|NCT02392234|155387136|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
48629602|NCT02723955|156504852|FG039|Escalation Phase|Physician Decision|0|||
48629603|NCT02723955|156504853|FG040|Escalation Phase|Physician Decision|0|||
48629604|NCT02723955|156504854|FG041|Escalation Phase|Physician Decision|0|||
48629605|NCT02723955|156504855|FG042|Escalation Phase|Physician Decision|0|||
48629606|NCT02723955|156504813|FG000|Escalation Phase|Withdrawal by Subject|0|||
48742764|NCT04431453|156908276|FG002|Overall Study|Death|0|||
48742765|NCT04431453|156908277|FG003|Overall Study|Death|0|||
48325100|NCT02392234|155387137|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
48325101|NCT02392234|155387138|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
48629607|NCT02723955|156504814|FG001|Escalation Phase|Withdrawal by Subject|0|||
48629608|NCT02723955|156504815|FG002|Escalation Phase|Withdrawal by Subject|0|||
48629609|NCT02723955|156504816|FG003|Escalation Phase|Withdrawal by Subject|0|||
48325102|NCT02392234|155387133|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48325103|NCT02392234|155387134|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48325104|NCT02392234|155387135|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48325105|NCT02392234|155387136|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48325106|NCT02392234|155387137|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
48325107|NCT02392234|155387138|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
48325108|NCT02392234|155387133|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
48325109|NCT02392234|155387134|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
48629610|NCT02723955|156504817|FG004|Escalation Phase|Withdrawal by Subject|1|||
48629611|NCT02723955|156504818|FG005|Escalation Phase|Withdrawal by Subject|1|||
48629612|NCT02723955|156504819|FG006|Escalation Phase|Withdrawal by Subject|1|||
48325110|NCT02392234|155387135|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
48325111|NCT02392234|155387136|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
48325112|NCT02392234|155387137|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
48325113|NCT02392234|155387138|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
48325114|NCT02392234|155387133|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
48325115|NCT02392234|155387134|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
48325116|NCT02392234|155387135|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
48325117|NCT02392234|155387136|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
48325118|NCT02392234|155387137|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
48325119|NCT02392234|155387138|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
48325120|NCT02392234|155387133|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
48325121|NCT02392234|155387134|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48325122|NCT02392234|155387135|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48325123|NCT02392234|155387136|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48629613|NCT02723955|156504820|FG007|Escalation Phase|Withdrawal by Subject|1|||
48629614|NCT02723955|156504821|FG008|Escalation Phase|Withdrawal by Subject|0|||
48629615|NCT02723955|156504822|FG009|Escalation Phase|Withdrawal by Subject|0|||
48629616|NCT02723955|156504823|FG010|Escalation Phase|Withdrawal by Subject|0|||
48629617|NCT02723955|156504824|FG011|Escalation Phase|Withdrawal by Subject|0|||
48629618|NCT02723955|156504825|FG012|Escalation Phase|Withdrawal by Subject|1|||
48629619|NCT02723955|156504826|FG013|Escalation Phase|Withdrawal by Subject|0|||
48629620|NCT02723955|156504827|FG014|Escalation Phase|Withdrawal by Subject|0|||
48629621|NCT02723955|156504828|FG015|Escalation Phase|Withdrawal by Subject|0|||
48629622|NCT02723955|156504829|FG016|Escalation Phase|Withdrawal by Subject|1|||
48629623|NCT02723955|156504830|FG017|Escalation Phase|Withdrawal by Subject|0|||
48629624|NCT02723955|156504831|FG018|Escalation Phase|Withdrawal by Subject|0|||
48629625|NCT02723955|156504832|FG019|Escalation Phase|Withdrawal by Subject|0|||
48629626|NCT02723955|156504833|FG020|Escalation Phase|Withdrawal by Subject|0|||
48629627|NCT02723955|156504834|FG021|Escalation Phase|Withdrawal by Subject|0|||
48629628|NCT02723955|156504835|FG022|Escalation Phase|Withdrawal by Subject|0|||
48629629|NCT02723955|156504836|FG023|Escalation Phase|Withdrawal by Subject|2|||
48629630|NCT02723955|156504837|FG024|Escalation Phase|Withdrawal by Subject|0|||
48629631|NCT02723955|156504838|FG025|Escalation Phase|Withdrawal by Subject|1|||
48629632|NCT02723955|156504839|FG026|Escalation Phase|Withdrawal by Subject|0|||
48629633|NCT02723955|156504840|FG027|Escalation Phase|Withdrawal by Subject|0|||
48629634|NCT02723955|156504841|FG028|Escalation Phase|Withdrawal by Subject|1|||
48629635|NCT02723955|156504842|FG029|Escalation Phase|Withdrawal by Subject|0|||
48325124|NCT02392234|155387137|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48325125|NCT02392234|155387138|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
48325126|NCT01588951|155387146|FG000|Overall Study|Ineligible in retrospect|0|||
48325127|NCT01588951|155387147|FG001|Overall Study|Ineligible in retrospect|0|||
48629636|NCT02723955|156504843|FG030|Escalation Phase|Withdrawal by Subject|0|||
48629637|NCT02723955|156504844|FG031|Escalation Phase|Withdrawal by Subject|0|||
48629638|NCT02723955|156504845|FG032|Escalation Phase|Withdrawal by Subject|0|||
48629639|NCT02723955|156504846|FG033|Escalation Phase|Withdrawal by Subject|0|||
48629640|NCT02723955|156504847|FG034|Escalation Phase|Withdrawal by Subject|0|||
48629641|NCT02723955|156504848|FG035|Escalation Phase|Withdrawal by Subject|0|||
48629642|NCT02723955|156504849|FG036|Escalation Phase|Withdrawal by Subject|0|||
48325128|NCT01588951|155387148|FG002|Overall Study|Ineligible in retrospect|1|||
48325129|NCT00467272|155387152|FG000|Overall Study|Pneumonia|2|||
48325130|NCT00467272|155387152|FG000|Overall Study|Thrombophlebitis|1|||
48325131|NCT02972034|155388988|FG000|Overall Study|Death|11|||
48325132|NCT02972034|155388989|FG001|Overall Study|Death|1|||
48325133|NCT02972034|155388990|FG002|Overall Study|Death|3|||
48325134|NCT02972034|155388991|FG003|Overall Study|Death|3|||
48629643|NCT02723955|156504850|FG037|Escalation Phase|Withdrawal by Subject|0|||
48629644|NCT02723955|156504851|FG038|Escalation Phase|Withdrawal by Subject|0|||
48629645|NCT02723955|156504852|FG039|Escalation Phase|Withdrawal by Subject|0|||
48629646|NCT02723955|156504853|FG040|Escalation Phase|Withdrawal by Subject|0|||
48629647|NCT02723955|156504854|FG041|Escalation Phase|Withdrawal by Subject|0|||
48629648|NCT02723955|156504855|FG042|Escalation Phase|Withdrawal by Subject|0|||
48629649|NCT02723955|156504813|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629650|NCT02723955|156504814|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629651|NCT02723955|156504815|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629652|NCT02723955|156504816|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629653|NCT02723955|156504817|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
48629654|NCT02723955|156504818|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
48629655|NCT02723955|156504819|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
48629656|NCT02723955|156504820|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
48629657|NCT02723955|156504821|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
48629658|NCT02723955|156504822|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48325135|NCT02972034|155388992|FG004|Overall Study|Death|2|||
48325136|NCT02972034|155388993|FG005|Overall Study|Death|2|||
48629659|NCT02723955|156504823|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629660|NCT02723955|156504824|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629661|NCT02723955|156504825|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629662|NCT02723955|156504826|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629663|NCT02723955|156504827|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629664|NCT02723955|156504828|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48742766|NCT04431453|156908278|FG004|Overall Study|Death|0|||
48325137|NCT02972034|155388994|FG006|Overall Study|Death|3|||
48325138|NCT02972034|155388995|FG007|Overall Study|Death|4|||
48325139|NCT02972034|155388996|FG008|Overall Study|Death|8|||
48325140|NCT02972034|155388997|FG009|Overall Study|Death|11|||
48325141|NCT02972034|155388998|FG010|Overall Study|Death|3|||
48325142|NCT02972034|155388999|FG011|Overall Study|Death|2|||
48325143|NCT02972034|155389000|FG012|Overall Study|Death|11|||
48325144|NCT02972034|155389001|FG013|Overall Study|Death|10|||
48325145|NCT02972034|155389002|FG014|Overall Study|Death|9|||
48325146|NCT02972034|155388988|FG000|Overall Study|Lost to Follow-up|0|||
48325147|NCT02972034|155388989|FG001|Overall Study|Lost to Follow-up|0|||
48325148|NCT02972034|155388990|FG002|Overall Study|Lost to Follow-up|0|||
48325149|NCT02972034|155388991|FG003|Overall Study|Lost to Follow-up|0|||
48325150|NCT02972034|155388992|FG004|Overall Study|Lost to Follow-up|1|||
48325151|NCT02972034|155388993|FG005|Overall Study|Lost to Follow-up|0|||
48325152|NCT02972034|155388994|FG006|Overall Study|Lost to Follow-up|0|||
48325153|NCT02972034|155388995|FG007|Overall Study|Lost to Follow-up|1|||
48325154|NCT02972034|155388996|FG008|Overall Study|Lost to Follow-up|0|||
48325155|NCT02972034|155388997|FG009|Overall Study|Lost to Follow-up|0|||
48325156|NCT02972034|155388998|FG010|Overall Study|Lost to Follow-up|0|||
48325157|NCT02972034|155388999|FG011|Overall Study|Lost to Follow-up|0|||
48325158|NCT02972034|155389000|FG012|Overall Study|Lost to Follow-up|0|||
48325159|NCT02972034|155389001|FG013|Overall Study|Lost to Follow-up|0|||
48325160|NCT02972034|155389002|FG014|Overall Study|Lost to Follow-up|1|||
48325161|NCT02972034|155388988|FG000|Overall Study|Physician Decision|0|||
48325162|NCT02972034|155388989|FG001|Overall Study|Physician Decision|0|||
48325163|NCT02972034|155388990|FG002|Overall Study|Physician Decision|0|||
48325164|NCT02972034|155388991|FG003|Overall Study|Physician Decision|0|||
48325165|NCT02972034|155388992|FG004|Overall Study|Physician Decision|0|||
48325166|NCT02972034|155388993|FG005|Overall Study|Physician Decision|0|||
48325167|NCT02972034|155388994|FG006|Overall Study|Physician Decision|0|||
48325168|NCT02972034|155388995|FG007|Overall Study|Physician Decision|1|||
48325169|NCT02972034|155388996|FG008|Overall Study|Physician Decision|0|||
48325170|NCT02972034|155388997|FG009|Overall Study|Physician Decision|0|||
48325171|NCT02972034|155388998|FG010|Overall Study|Physician Decision|1|||
48325172|NCT02972034|155388999|FG011|Overall Study|Physician Decision|0|||
48325173|NCT02972034|155389000|FG012|Overall Study|Physician Decision|0|||
48325174|NCT02972034|155389001|FG013|Overall Study|Physician Decision|0|||
48325175|NCT02972034|155389002|FG014|Overall Study|Physician Decision|0|||
48325176|NCT02972034|155388988|FG000|Overall Study|Sponsor Decision|0|||
48325177|NCT02972034|155388989|FG001|Overall Study|Sponsor Decision|0|||
48325178|NCT02972034|155388990|FG002|Overall Study|Sponsor Decision|0|||
48325179|NCT02972034|155388991|FG003|Overall Study|Sponsor Decision|1|||
48325180|NCT02972034|155388992|FG004|Overall Study|Sponsor Decision|0|||
48325181|NCT02972034|155388993|FG005|Overall Study|Sponsor Decision|0|||
48325182|NCT02972034|155388994|FG006|Overall Study|Sponsor Decision|1|||
48325183|NCT02972034|155388995|FG007|Overall Study|Sponsor Decision|1|||
48325184|NCT02972034|155388996|FG008|Overall Study|Sponsor Decision|1|||
48325185|NCT02972034|155388997|FG009|Overall Study|Sponsor Decision|2|||
48325186|NCT02972034|155388998|FG010|Overall Study|Sponsor Decision|2|||
48325187|NCT02972034|155388999|FG011|Overall Study|Sponsor Decision|0|||
48325188|NCT02972034|155389000|FG012|Overall Study|Sponsor Decision|1|||
48325189|NCT02972034|155389001|FG013|Overall Study|Sponsor Decision|0|||
48325190|NCT02972034|155389002|FG014|Overall Study|Sponsor Decision|1|||
48325191|NCT02972034|155388988|FG000|Overall Study|Withdrawal by Subject|3|||
48325192|NCT02972034|155388989|FG001|Overall Study|Withdrawal by Subject|0|||
48325193|NCT02972034|155388990|FG002|Overall Study|Withdrawal by Subject|0|||
48325194|NCT02972034|155388991|FG003|Overall Study|Withdrawal by Subject|0|||
48325195|NCT02972034|155388992|FG004|Overall Study|Withdrawal by Subject|1|||
48325196|NCT02972034|155388993|FG005|Overall Study|Withdrawal by Subject|1|||
48325197|NCT02972034|155388994|FG006|Overall Study|Withdrawal by Subject|0|||
48325198|NCT02972034|155388995|FG007|Overall Study|Withdrawal by Subject|0|||
48325199|NCT02972034|155388996|FG008|Overall Study|Withdrawal by Subject|1|||
48325200|NCT02972034|155388997|FG009|Overall Study|Withdrawal by Subject|1|||
48325201|NCT02972034|155388998|FG010|Overall Study|Withdrawal by Subject|2|||
48325202|NCT02972034|155388999|FG011|Overall Study|Withdrawal by Subject|1|||
48325203|NCT02972034|155389000|FG012|Overall Study|Withdrawal by Subject|1|||
48325204|NCT02972034|155389001|FG013|Overall Study|Withdrawal by Subject|1|||
48325205|NCT02972034|155389002|FG014|Overall Study|Withdrawal by Subject|0|||
48325206|NCT02972034|155388988|FG000|Overall Study|Screen Failure|0|||
48325207|NCT02972034|155388989|FG001|Overall Study|Screen Failure|0|||
48325208|NCT02972034|155388990|FG002|Overall Study|Screen Failure|0|||
48325209|NCT02972034|155388991|FG003|Overall Study|Screen Failure|0|||
48325210|NCT02972034|155388992|FG004|Overall Study|Screen Failure|0|||
48325211|NCT02972034|155388993|FG005|Overall Study|Screen Failure|0|||
48325212|NCT02972034|155388994|FG006|Overall Study|Screen Failure|0|||
48325213|NCT02972034|155388995|FG007|Overall Study|Screen Failure|0|||
48325214|NCT02972034|155388996|FG008|Overall Study|Screen Failure|0|||
48325215|NCT02972034|155388997|FG009|Overall Study|Screen Failure|0|||
48325216|NCT02972034|155388998|FG010|Overall Study|Screen Failure|0|||
48325217|NCT02972034|155388999|FG011|Overall Study|Screen Failure|0|||
48325218|NCT02972034|155389000|FG012|Overall Study|Screen Failure|1|||
48325219|NCT02972034|155389001|FG013|Overall Study|Screen Failure|0|||
48325220|NCT02972034|155389002|FG014|Overall Study|Screen Failure|0|||
48325221|NCT00210106|155389014|FG000|Overall Study|Death|1|||
48325222|NCT00210106|155389014|FG000|Overall Study|Protocol Violation|13|||
48325223|NCT03876457|155389015|FG000|Overall Study|Lost to Follow-up|1|||
48325224|NCT03876457|155389016|FG001|Overall Study|Lost to Follow-up|3|||
48629665|NCT02723955|156504829|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629666|NCT02723955|156504830|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629667|NCT02723955|156504831|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629668|NCT02723955|156504832|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629669|NCT02723955|156504833|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629670|NCT02723955|156504834|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48325225|NCT01596972|155389017|FG000|Overall Study|Physician Decision|1|||
48325226|NCT01596972|155389018|FG001|Overall Study|Physician Decision|9|||
48325227|NCT01596972|155389017|FG000|Overall Study|Lost to Follow-up|0|||
48325228|NCT01596972|155389018|FG001|Overall Study|Lost to Follow-up|4|||
48325229|NCT01596972|155389017|FG000|Overall Study|Withdrawal by Subject|0|||
48325230|NCT01596972|155389018|FG001|Overall Study|Withdrawal by Subject|1|||
48325231|NCT01084694|155389019|FG000|Overall Study|Withdrawal by Subject|2|||
48325232|NCT01084694|155389020|FG001|Overall Study|Withdrawal by Subject|1|||
48325233|NCT01084694|155389019|FG000|Overall Study|Death|2|||
48325234|NCT01084694|155389020|FG001|Overall Study|Death|12|||
48325235|NCT01084694|155389019|FG000|Overall Study|eligibility not maintained|2|||
48325236|NCT01084694|155389020|FG001|Overall Study|eligibility not maintained|7|||
48325237|NCT02633215|155389026|FG000|Overall Study|Lost to Follow-up|2|||
48325238|NCT02633215|155389027|FG001|Overall Study|Lost to Follow-up|3|||
48325239|NCT02291913|155389028|FG000|Overall Study|Progressive Disease|32|||
48325240|NCT02291913|155389028|FG000|Overall Study|Adverse Event|11|||
48325241|NCT02291913|155389028|FG000|Overall Study|Death|2|||
48325242|NCT02291913|155389028|FG000|Overall Study|Physician Decision|1|||
48325243|NCT02291913|155389028|FG000|Overall Study|Withdrawal by Subject|1|||
48325244|NCT02291913|155389028|FG000|Overall Study|Protocol Violation|1|||
48325245|NCT01637402|155389029|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
48325246|NCT01637402|155389030|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
48325247|NCT01637402|155389029|FG000|Standard Dose Regimen|Adverse Event|1|||
48325248|NCT01637402|155389030|FG001|Standard Dose Regimen|Adverse Event|0|||
48325249|NCT01637402|155389029|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
48325250|NCT01637402|155389030|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
48325251|NCT01637402|155389029|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
48325252|NCT01637402|155389030|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
48325253|NCT01637402|155389029|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
48325254|NCT01637402|155389030|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
48325255|NCT01637402|155389029|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
48325256|NCT01637402|155389030|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
48325257|NCT02132949|155389031|FG000|Overall Study|Death|7|||
48325258|NCT02132949|155389032|FG001|Overall Study|Death|13|||
48325259|NCT02132949|155389031|FG000|Overall Study|Lost to Follow-up|14|||
48325260|NCT02132949|155389032|FG001|Overall Study|Lost to Follow-up|4|||
48325261|NCT02132949|155389031|FG000|Overall Study|Withdrawal by Subject|6|||
48325262|NCT02132949|155389032|FG001|Overall Study|Withdrawal by Subject|5|||
48325263|NCT02132949|155389031|FG000|Overall Study|Noncompliance|5|||
48325264|NCT02132949|155389032|FG001|Overall Study|Noncompliance|1|||
48325265|NCT02132949|155389031|FG000|Overall Study|Physician Decision|3|||
48325266|NCT02132949|155389032|FG001|Overall Study|Physician Decision|1|||
48325267|NCT02132949|155389031|FG000|Overall Study|Disease Progression|3|||
48325268|NCT02132949|155389032|FG001|Overall Study|Disease Progression|0|||
48325269|NCT02132949|155389031|FG000|Overall Study|Adverse Event|2|||
48325270|NCT02132949|155389032|FG001|Overall Study|Adverse Event|1|||
48325271|NCT02132949|155389031|FG000|Overall Study|Withdrew Prior to Treatment|1|||
48325272|NCT02132949|155389032|FG001|Overall Study|Withdrew Prior to Treatment|2|||
48325273|NCT02132949|155389031|FG000|Overall Study|Reason Unspecified|0|||
48629671|NCT02723955|156504835|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629672|NCT02723955|156504836|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629673|NCT02723955|156504837|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629674|NCT02723955|156504838|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629675|NCT02723955|156504839|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629676|NCT02723955|156504840|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629677|NCT02723955|156504841|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629678|NCT02723955|156504842|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629679|NCT02723955|156504843|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629680|NCT02723955|156504844|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629681|NCT02723955|156504845|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629682|NCT02723955|156504846|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629683|NCT02723955|156504847|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629684|NCT02723955|156504848|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629685|NCT02723955|156504849|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629686|NCT02723955|156504850|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629687|NCT02723955|156504851|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629688|NCT02723955|156504852|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629689|NCT02723955|156504853|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629690|NCT02723955|156504854|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629691|NCT02723955|156504855|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
48629692|NCT02723955|156504813|FG000|Escalation Phase|Site Closed|0|||
48629693|NCT02723955|156504814|FG001|Escalation Phase|Site Closed|0|||
48629694|NCT02723955|156504815|FG002|Escalation Phase|Site Closed|0|||
48629695|NCT02723955|156504816|FG003|Escalation Phase|Site Closed|0|||
48629696|NCT02723955|156504817|FG004|Escalation Phase|Site Closed|0|||
48629697|NCT02723955|156504818|FG005|Escalation Phase|Site Closed|0|||
48629698|NCT02723955|156504819|FG006|Escalation Phase|Site Closed|0|||
48629699|NCT02723955|156504820|FG007|Escalation Phase|Site Closed|0|||
48629700|NCT02723955|156504821|FG008|Escalation Phase|Site Closed|0|||
48629701|NCT02723955|156504822|FG009|Escalation Phase|Site Closed|0|||
48629702|NCT02723955|156504823|FG010|Escalation Phase|Site Closed|0|||
48629703|NCT02723955|156504824|FG011|Escalation Phase|Site Closed|0|||
48629704|NCT02723955|156504825|FG012|Escalation Phase|Site Closed|0|||
48629705|NCT02723955|156504826|FG013|Escalation Phase|Site Closed|0|||
48629706|NCT02723955|156504827|FG014|Escalation Phase|Site Closed|0|||
48629707|NCT02723955|156504828|FG015|Escalation Phase|Site Closed|1|||
48742767|NCT04431453|156908279|FG005|Overall Study|Death|0|||
48742768|NCT04431453|156908280|FG006|Overall Study|Death|0|||
48742769|NCT04431453|156908281|FG007|Overall Study|Death|1|||
48742770|NCT04431453|156908274|FG000|Overall Study|Lost to Follow-up|0|||
48742771|NCT04431453|156908275|FG001|Overall Study|Lost to Follow-up|0|||
48325274|NCT02132949|155389032|FG001|Overall Study|Reason Unspecified|1|||
48325275|NCT04334317|155389038|FG000|Overall Study|Adverse Event|1|||
48742772|NCT04431453|156908276|FG002|Overall Study|Lost to Follow-up|1|||
48742773|NCT04431453|156908277|FG003|Overall Study|Lost to Follow-up|1|||
48325276|NCT04334317|155389039|FG001|Overall Study|Adverse Event|2|||
48325277|NCT04334317|155389040|FG002|Overall Study|Adverse Event|0|||
48325278|NCT04334317|155389041|FG003|Overall Study|Adverse Event|0|||
48325279|NCT04334317|155389038|FG000|Overall Study|Protocol Deviation|0|||
48325280|NCT04334317|155389039|FG001|Overall Study|Protocol Deviation|1|||
48629708|NCT02723955|156504829|FG016|Escalation Phase|Site Closed|0|||
48629709|NCT02723955|156504830|FG017|Escalation Phase|Site Closed|2|||
48629710|NCT02723955|156504831|FG018|Escalation Phase|Site Closed|0|||
48629711|NCT02723955|156504832|FG019|Escalation Phase|Site Closed|0|||
48629712|NCT02723955|156504833|FG020|Escalation Phase|Site Closed|1|||
48629713|NCT02723955|156504834|FG021|Escalation Phase|Site Closed|0|||
48629714|NCT02723955|156504835|FG022|Escalation Phase|Site Closed|0|||
48629715|NCT02723955|156504836|FG023|Escalation Phase|Site Closed|0|||
48629716|NCT02723955|156504837|FG024|Escalation Phase|Site Closed|3|||
48629717|NCT02723955|156504838|FG025|Escalation Phase|Site Closed|1|||
48629718|NCT02723955|156504839|FG026|Escalation Phase|Site Closed|3|||
48629719|NCT02723955|156504840|FG027|Escalation Phase|Site Closed|1|||
48629720|NCT02723955|156504841|FG028|Escalation Phase|Site Closed|1|||
48629721|NCT02723955|156504842|FG029|Escalation Phase|Site Closed|0|||
48629722|NCT02723955|156504843|FG030|Escalation Phase|Site Closed|0|||
48629723|NCT02723955|156504844|FG031|Escalation Phase|Site Closed|0|||
48629724|NCT02723955|156504845|FG032|Escalation Phase|Site Closed|0|||
48629725|NCT02723955|156504846|FG033|Escalation Phase|Site Closed|0|||
48629726|NCT02723955|156504847|FG034|Escalation Phase|Site Closed|0|||
48629727|NCT02723955|156504848|FG035|Escalation Phase|Site Closed|0|||
48629728|NCT02723955|156504849|FG036|Escalation Phase|Site Closed|0|||
48629729|NCT02723955|156504850|FG037|Escalation Phase|Site Closed|0|||
48742774|NCT04431453|156908278|FG004|Overall Study|Lost to Follow-up|0|||
48629730|NCT02723955|156504851|FG038|Escalation Phase|Site Closed|0|||
48742775|NCT04431453|156908279|FG005|Overall Study|Lost to Follow-up|0|||
48629731|NCT02723955|156504852|FG039|Escalation Phase|Site Closed|0|||
48629732|NCT02723955|156504853|FG040|Escalation Phase|Site Closed|0|||
48629733|NCT02723955|156504854|FG041|Escalation Phase|Site Closed|0|||
48629734|NCT02723955|156504855|FG042|Escalation Phase|Site Closed|0|||
48629735|NCT02723955|156504813|FG000|Expansion Phase|Death|0|||
48629736|NCT02723955|156504814|FG001|Expansion Phase|Death|0|||
48629737|NCT02723955|156504815|FG002|Expansion Phase|Death|0|||
48629738|NCT02723955|156504816|FG003|Expansion Phase|Death|0|||
48629739|NCT02723955|156504817|FG004|Expansion Phase|Death|0|||
48629740|NCT02723955|156504818|FG005|Expansion Phase|Death|0|||
48629741|NCT02723955|156504819|FG006|Expansion Phase|Death|0|||
48629742|NCT02723955|156504820|FG007|Expansion Phase|Death|0|||
48629743|NCT02723955|156504821|FG008|Expansion Phase|Death|0|||
48629744|NCT02723955|156504822|FG009|Expansion Phase|Death|25|||
48629745|NCT02723955|156504823|FG010|Expansion Phase|Death|69|||
48629746|NCT02723955|156504824|FG011|Expansion Phase|Death|48|||
48629747|NCT02723955|156504825|FG012|Expansion Phase|Death|0|||
48629748|NCT02723955|156504826|FG013|Expansion Phase|Death|0|||
48629749|NCT02723955|156504827|FG014|Expansion Phase|Death|0|||
48629750|NCT02723955|156504828|FG015|Expansion Phase|Death|0|||
48629751|NCT02723955|156504829|FG016|Expansion Phase|Death|0|||
48629752|NCT02723955|156504830|FG017|Expansion Phase|Death|0|||
48629753|NCT02723955|156504831|FG018|Expansion Phase|Death|0|||
48629754|NCT02723955|156504832|FG019|Expansion Phase|Death|0|||
48629755|NCT02723955|156504833|FG020|Expansion Phase|Death|0|||
48629756|NCT02723955|156504834|FG021|Expansion Phase|Death|0|||
48629757|NCT02723955|156504835|FG022|Expansion Phase|Death|0|||
48629758|NCT02723955|156504836|FG023|Expansion Phase|Death|0|||
48629759|NCT02723955|156504837|FG024|Expansion Phase|Death|0|||
48629760|NCT02723955|156504838|FG025|Expansion Phase|Death|0|||
48629761|NCT02723955|156504839|FG026|Expansion Phase|Death|0|||
48629762|NCT02723955|156504840|FG027|Expansion Phase|Death|0|||
48629763|NCT02723955|156504841|FG028|Expansion Phase|Death|0|||
48629764|NCT02723955|156504842|FG029|Expansion Phase|Death|12|||
48629765|NCT02723955|156504843|FG030|Expansion Phase|Death|202|||
48629766|NCT02723955|156504844|FG031|Expansion Phase|Death|31|||
48629767|NCT02723955|156504845|FG032|Expansion Phase|Death|17|||
48629768|NCT02723955|156504846|FG033|Expansion Phase|Death|2|||
48629769|NCT02723955|156504847|FG034|Expansion Phase|Death|3|||
48629770|NCT02723955|156504848|FG035|Expansion Phase|Death|3|||
48629771|NCT02723955|156504849|FG036|Expansion Phase|Death|1|||
48629772|NCT02723955|156504850|FG037|Expansion Phase|Death|0|||
48629773|NCT02723955|156504851|FG038|Expansion Phase|Death|0|||
48629774|NCT02723955|156504852|FG039|Expansion Phase|Death|0|||
48629775|NCT02723955|156504853|FG040|Expansion Phase|Death|0|||
48629776|NCT02723955|156504854|FG041|Expansion Phase|Death|0|||
48629777|NCT02723955|156504855|FG042|Expansion Phase|Death|0|||
48629778|NCT02723955|156504813|FG000|Expansion Phase|Lost to Follow-up|0|||
48629779|NCT02723955|156504814|FG001|Expansion Phase|Lost to Follow-up|0|||
48629780|NCT02723955|156504815|FG002|Expansion Phase|Lost to Follow-up|0|||
48629781|NCT02723955|156504816|FG003|Expansion Phase|Lost to Follow-up|0|||
48629782|NCT02723955|156504817|FG004|Expansion Phase|Lost to Follow-up|0|||
48629783|NCT02723955|156504818|FG005|Expansion Phase|Lost to Follow-up|0|||
48629784|NCT02723955|156504819|FG006|Expansion Phase|Lost to Follow-up|0|||
48629785|NCT02723955|156504820|FG007|Expansion Phase|Lost to Follow-up|0|||
48629786|NCT02723955|156504821|FG008|Expansion Phase|Lost to Follow-up|0|||
48629787|NCT02723955|156504822|FG009|Expansion Phase|Lost to Follow-up|0|||
48629788|NCT02723955|156504823|FG010|Expansion Phase|Lost to Follow-up|4|||
48629789|NCT02723955|156504824|FG011|Expansion Phase|Lost to Follow-up|1|||
48629790|NCT02723955|156504825|FG012|Expansion Phase|Lost to Follow-up|0|||
48629791|NCT02723955|156504826|FG013|Expansion Phase|Lost to Follow-up|0|||
48629792|NCT02723955|156504827|FG014|Expansion Phase|Lost to Follow-up|0|||
48629793|NCT02723955|156504828|FG015|Expansion Phase|Lost to Follow-up|0|||
48629794|NCT02723955|156504829|FG016|Expansion Phase|Lost to Follow-up|0|||
48629795|NCT02723955|156504830|FG017|Expansion Phase|Lost to Follow-up|0|||
48629796|NCT02723955|156504831|FG018|Expansion Phase|Lost to Follow-up|0|||
48629797|NCT02723955|156504832|FG019|Expansion Phase|Lost to Follow-up|0|||
48629798|NCT02723955|156504833|FG020|Expansion Phase|Lost to Follow-up|0|||
48629799|NCT02723955|156504834|FG021|Expansion Phase|Lost to Follow-up|0|||
48629800|NCT02723955|156504835|FG022|Expansion Phase|Lost to Follow-up|0|||
48629801|NCT02723955|156504836|FG023|Expansion Phase|Lost to Follow-up|0|||
48629802|NCT02723955|156504837|FG024|Expansion Phase|Lost to Follow-up|0|||
48629803|NCT02723955|156504838|FG025|Expansion Phase|Lost to Follow-up|0|||
48629804|NCT02723955|156504839|FG026|Expansion Phase|Lost to Follow-up|0|||
48629805|NCT02723955|156504840|FG027|Expansion Phase|Lost to Follow-up|0|||
48629806|NCT02723955|156504841|FG028|Expansion Phase|Lost to Follow-up|0|||
48629807|NCT02723955|156504842|FG029|Expansion Phase|Lost to Follow-up|1|||
48629808|NCT02723955|156504843|FG030|Expansion Phase|Lost to Follow-up|19|||
48629809|NCT02723955|156504844|FG031|Expansion Phase|Lost to Follow-up|2|||
48629810|NCT02723955|156504845|FG032|Expansion Phase|Lost to Follow-up|1|||
48629811|NCT02723955|156504846|FG033|Expansion Phase|Lost to Follow-up|0|||
48629812|NCT02723955|156504847|FG034|Expansion Phase|Lost to Follow-up|0|||
48629813|NCT02723955|156504848|FG035|Expansion Phase|Lost to Follow-up|0|||
48629814|NCT02723955|156504849|FG036|Expansion Phase|Lost to Follow-up|0|||
48629815|NCT02723955|156504850|FG037|Expansion Phase|Lost to Follow-up|0|||
48629816|NCT02723955|156504851|FG038|Expansion Phase|Lost to Follow-up|0|||
48629817|NCT02723955|156504852|FG039|Expansion Phase|Lost to Follow-up|0|||
48629818|NCT02723955|156504853|FG040|Expansion Phase|Lost to Follow-up|0|||
48629819|NCT02723955|156504854|FG041|Expansion Phase|Lost to Follow-up|0|||
48629820|NCT02723955|156504855|FG042|Expansion Phase|Lost to Follow-up|0|||
48629821|NCT02723955|156504813|FG000|Expansion Phase|Physician Decision|0|||
48629822|NCT02723955|156504814|FG001|Expansion Phase|Physician Decision|0|||
48629823|NCT02723955|156504815|FG002|Expansion Phase|Physician Decision|0|||
48629824|NCT02723955|156504816|FG003|Expansion Phase|Physician Decision|0|||
48629825|NCT02723955|156504817|FG004|Expansion Phase|Physician Decision|0|||
48629826|NCT02723955|156504818|FG005|Expansion Phase|Physician Decision|0|||
48629827|NCT02723955|156504819|FG006|Expansion Phase|Physician Decision|0|||
48629828|NCT02723955|156504820|FG007|Expansion Phase|Physician Decision|0|||
48629829|NCT02723955|156504821|FG008|Expansion Phase|Physician Decision|0|||
48629830|NCT02723955|156504822|FG009|Expansion Phase|Physician Decision|0|||
48629831|NCT02723955|156504823|FG010|Expansion Phase|Physician Decision|0|||
48629832|NCT02723955|156504824|FG011|Expansion Phase|Physician Decision|0|||
48629833|NCT02723955|156504825|FG012|Expansion Phase|Physician Decision|0|||
48629834|NCT02723955|156504826|FG013|Expansion Phase|Physician Decision|0|||
48629835|NCT02723955|156504827|FG014|Expansion Phase|Physician Decision|0|||
48629836|NCT02723955|156504828|FG015|Expansion Phase|Physician Decision|0|||
48629837|NCT02723955|156504829|FG016|Expansion Phase|Physician Decision|0|||
48629838|NCT02723955|156504830|FG017|Expansion Phase|Physician Decision|0|||
48629839|NCT02723955|156504831|FG018|Expansion Phase|Physician Decision|0|||
48629840|NCT02723955|156504832|FG019|Expansion Phase|Physician Decision|0|||
48629841|NCT02723955|156504833|FG020|Expansion Phase|Physician Decision|0|||
48629842|NCT02723955|156504834|FG021|Expansion Phase|Physician Decision|0|||
48629843|NCT02723955|156504835|FG022|Expansion Phase|Physician Decision|0|||
48629844|NCT02723955|156504836|FG023|Expansion Phase|Physician Decision|0|||
48629845|NCT02723955|156504837|FG024|Expansion Phase|Physician Decision|0|||
48629846|NCT02723955|156504838|FG025|Expansion Phase|Physician Decision|0|||
48629847|NCT02723955|156504839|FG026|Expansion Phase|Physician Decision|0|||
48629848|NCT02723955|156504840|FG027|Expansion Phase|Physician Decision|0|||
48629849|NCT02723955|156504841|FG028|Expansion Phase|Physician Decision|0|||
48629850|NCT02723955|156504842|FG029|Expansion Phase|Physician Decision|0|||
48629851|NCT02723955|156504843|FG030|Expansion Phase|Physician Decision|1|||
48629852|NCT02723955|156504844|FG031|Expansion Phase|Physician Decision|1|||
48629853|NCT02723955|156504845|FG032|Expansion Phase|Physician Decision|0|||
48742776|NCT04431453|156908280|FG006|Overall Study|Lost to Follow-up|0|||
48742777|NCT04431453|156908281|FG007|Overall Study|Lost to Follow-up|0|||
48742778|NCT04431453|156908274|FG000|Overall Study|Enrolled but Never Treated|0|||
48742779|NCT04431453|156908275|FG001|Overall Study|Enrolled but Never Treated|0|||
48742780|NCT04431453|156908276|FG002|Overall Study|Enrolled but Never Treated|0|||
48742781|NCT04431453|156908277|FG003|Overall Study|Enrolled but Never Treated|0|||
48742782|NCT04431453|156908278|FG004|Overall Study|Enrolled but Never Treated|1|||
48742783|NCT04431453|156908279|FG005|Overall Study|Enrolled but Never Treated|0|||
48629854|NCT02723955|156504846|FG033|Expansion Phase|Physician Decision|0|||
48629855|NCT02723955|156504847|FG034|Expansion Phase|Physician Decision|0|||
48629856|NCT02723955|156504848|FG035|Expansion Phase|Physician Decision|0|||
48629857|NCT02723955|156504849|FG036|Expansion Phase|Physician Decision|0|||
48629858|NCT02723955|156504850|FG037|Expansion Phase|Physician Decision|0|||
48742784|NCT04431453|156908280|FG006|Overall Study|Enrolled but Never Treated|0|||
48629859|NCT02723955|156504851|FG038|Expansion Phase|Physician Decision|0|||
48629860|NCT02723955|156504852|FG039|Expansion Phase|Physician Decision|0|||
48629861|NCT02723955|156504853|FG040|Expansion Phase|Physician Decision|0|||
48629862|NCT02723955|156504854|FG041|Expansion Phase|Physician Decision|0|||
48629863|NCT02723955|156504855|FG042|Expansion Phase|Physician Decision|0|||
48629864|NCT02723955|156504813|FG000|Expansion Phase|Withdrawal by Subject|0|||
48629865|NCT02723955|156504814|FG001|Expansion Phase|Withdrawal by Subject|0|||
48629866|NCT02723955|156504815|FG002|Expansion Phase|Withdrawal by Subject|0|||
48629867|NCT02723955|156504816|FG003|Expansion Phase|Withdrawal by Subject|0|||
48629868|NCT02723955|156504817|FG004|Expansion Phase|Withdrawal by Subject|0|||
48629869|NCT02723955|156504818|FG005|Expansion Phase|Withdrawal by Subject|0|||
48629870|NCT02723955|156504819|FG006|Expansion Phase|Withdrawal by Subject|0|||
48629871|NCT02723955|156504820|FG007|Expansion Phase|Withdrawal by Subject|0|||
48629872|NCT02723955|156504821|FG008|Expansion Phase|Withdrawal by Subject|0|||
48629873|NCT02723955|156504822|FG009|Expansion Phase|Withdrawal by Subject|2|||
48629874|NCT02723955|156504823|FG010|Expansion Phase|Withdrawal by Subject|1|||
48629875|NCT02723955|156504824|FG011|Expansion Phase|Withdrawal by Subject|0|||
48629876|NCT02723955|156504825|FG012|Expansion Phase|Withdrawal by Subject|0|||
48629877|NCT02723955|156504826|FG013|Expansion Phase|Withdrawal by Subject|0|||
48629878|NCT02723955|156504827|FG014|Expansion Phase|Withdrawal by Subject|0|||
48629879|NCT02723955|156504828|FG015|Expansion Phase|Withdrawal by Subject|0|||
48629880|NCT02723955|156504829|FG016|Expansion Phase|Withdrawal by Subject|0|||
48629881|NCT02723955|156504830|FG017|Expansion Phase|Withdrawal by Subject|0|||
48629882|NCT02723955|156504831|FG018|Expansion Phase|Withdrawal by Subject|0|||
48629883|NCT02723955|156504832|FG019|Expansion Phase|Withdrawal by Subject|0|||
48629884|NCT02723955|156504833|FG020|Expansion Phase|Withdrawal by Subject|0|||
48629885|NCT02723955|156504834|FG021|Expansion Phase|Withdrawal by Subject|0|||
48629886|NCT02723955|156504835|FG022|Expansion Phase|Withdrawal by Subject|0|||
48629887|NCT02723955|156504836|FG023|Expansion Phase|Withdrawal by Subject|0|||
48629888|NCT02723955|156504837|FG024|Expansion Phase|Withdrawal by Subject|0|||
48629889|NCT02723955|156504838|FG025|Expansion Phase|Withdrawal by Subject|0|||
48629890|NCT02723955|156504839|FG026|Expansion Phase|Withdrawal by Subject|0|||
48629891|NCT02723955|156504840|FG027|Expansion Phase|Withdrawal by Subject|0|||
48629892|NCT02723955|156504841|FG028|Expansion Phase|Withdrawal by Subject|0|||
48629893|NCT02723955|156504842|FG029|Expansion Phase|Withdrawal by Subject|0|||
48629894|NCT02723955|156504843|FG030|Expansion Phase|Withdrawal by Subject|8|||
48629895|NCT02723955|156504844|FG031|Expansion Phase|Withdrawal by Subject|4|||
48629896|NCT02723955|156504845|FG032|Expansion Phase|Withdrawal by Subject|0|||
48629897|NCT02723955|156504846|FG033|Expansion Phase|Withdrawal by Subject|0|||
48629898|NCT02723955|156504847|FG034|Expansion Phase|Withdrawal by Subject|0|||
48629899|NCT02723955|156504848|FG035|Expansion Phase|Withdrawal by Subject|1|||
48629900|NCT02723955|156504849|FG036|Expansion Phase|Withdrawal by Subject|0|||
48629901|NCT02723955|156504850|FG037|Expansion Phase|Withdrawal by Subject|0|||
48629902|NCT02723955|156504851|FG038|Expansion Phase|Withdrawal by Subject|0|||
48629903|NCT02723955|156504852|FG039|Expansion Phase|Withdrawal by Subject|0|||
48629904|NCT02723955|156504853|FG040|Expansion Phase|Withdrawal by Subject|0|||
48629905|NCT02723955|156504854|FG041|Expansion Phase|Withdrawal by Subject|0|||
48629906|NCT02723955|156504855|FG042|Expansion Phase|Withdrawal by Subject|0|||
48629907|NCT02723955|156504813|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629908|NCT02723955|156504814|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629909|NCT02723955|156504815|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629910|NCT02723955|156504816|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629911|NCT02723955|156504817|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629912|NCT02723955|156504818|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629913|NCT02723955|156504819|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629914|NCT02723955|156504820|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629915|NCT02723955|156504821|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629916|NCT02723955|156504822|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
48629917|NCT02723955|156504823|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
48630351|NCT02082977|156504930|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
48742785|NCT04431453|156908281|FG007|Overall Study|Enrolled but Never Treated|0|||
48742786|NCT00622401|156908282|FG000|Overall Study|Disease progression prior to treatment|3|||
48742787|NCT00622401|156908283|FG001|Overall Study|Disease progression prior to treatment|2|||
48742788|NCT00622401|156908284|FG002|Overall Study|Disease progression prior to treatment|0|||
48742789|NCT03087643|156908285|FG000|Overall Study|Withdrawal by Subject|2|||
48742790|NCT03087643|156908286|FG001|Overall Study|Withdrawal by Subject|4|||
48742791|NCT03087643|156908285|FG000|Overall Study|Death|2|||
48742792|NCT03087643|156908286|FG001|Overall Study|Death|2|||
48742793|NCT01449539|156908289|FG000|Overall Study|Withdrawal by Subject|3|||
48742794|NCT01449539|156908289|FG000|Overall Study|Toxicity not study related|1|||
48742795|NCT00957580|156908294|FG000|Overall Study|Ongoing at data cut-off|0|||
48742796|NCT00957580|156908295|FG001|Overall Study|Ongoing at data cut-off|1|||
48742797|NCT00957580|156908296|FG002|Overall Study|Ongoing at data cut-off|0|||
48325281|NCT04334317|155389040|FG002|Overall Study|Protocol Deviation|0|||
48325282|NCT04334317|155389041|FG003|Overall Study|Protocol Deviation|0|||
48325283|NCT04334317|155389038|FG000|Overall Study|Withdrawal by Subject|2|||
48325284|NCT04334317|155389039|FG001|Overall Study|Withdrawal by Subject|2|||
48325285|NCT04334317|155389040|FG002|Overall Study|Withdrawal by Subject|0|||
48325286|NCT04334317|155389041|FG003|Overall Study|Withdrawal by Subject|0|||
48325287|NCT01532648|155389045|FG000|Overall Study|Lost to Follow-up|3|||
48325288|NCT01532648|155389046|FG001|Overall Study|Lost to Follow-up|4|||
48325289|NCT01532648|155389045|FG000|Overall Study|Lack of Efficacy|4|||
48325290|NCT01532648|155389046|FG001|Overall Study|Lack of Efficacy|1|||
48325291|NCT01532648|155389045|FG000|Overall Study|Protocol Violation|1|||
48325292|NCT01532648|155389046|FG001|Overall Study|Protocol Violation|1|||
48325293|NCT01532648|155389045|FG000|Overall Study|Adverse Event|12|||
48325294|NCT01532648|155389046|FG001|Overall Study|Adverse Event|9|||
48325295|NCT01532648|155389045|FG000|Overall Study|Withdrawal by Subject|16|||
48325296|NCT01532648|155389046|FG001|Overall Study|Withdrawal by Subject|2|||
48325297|NCT01750684|155389047|FG000|Overall Study|Death|1|||
48325298|NCT01750684|155389048|FG001|Overall Study|Death|0|||
48325299|NCT01750684|155389047|FG000|Overall Study|Non-compliance with Study Drug|0|||
48325300|NCT01750684|155389048|FG001|Overall Study|Non-compliance with Study Drug|1|||
48325301|NCT01750684|155389047|FG000|Overall Study|Withdrawn by Sponsor|0|||
48325302|NCT01750684|155389048|FG001|Overall Study|Withdrawn by Sponsor|1|||
48325303|NCT01750684|155389047|FG000|Overall Study|Protocol Violation|1|||
48325304|NCT01750684|155389048|FG001|Overall Study|Protocol Violation|0|||
48325305|NCT02568215|155389054|FG000|Overall Study|Death|1|||
48629918|NCT02723955|156504824|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
48629919|NCT02723955|156504825|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629920|NCT02723955|156504826|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629921|NCT02723955|156504827|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629922|NCT02723955|156504828|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629923|NCT02723955|156504829|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629924|NCT02723955|156504830|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629925|NCT02723955|156504831|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629926|NCT02723955|156504832|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629927|NCT02723955|156504833|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629928|NCT02723955|156504834|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629929|NCT02723955|156504835|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629930|NCT02723955|156504836|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629931|NCT02723955|156504837|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629932|NCT02723955|156504838|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629933|NCT02723955|156504839|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629934|NCT02723955|156504840|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629935|NCT02723955|156504841|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48742798|NCT00957580|156908294|FG000|Overall Study|Enrolled but not treated|0|||
48742799|NCT00957580|156908295|FG001|Overall Study|Enrolled but not treated|1|||
48742800|NCT00957580|156908296|FG002|Overall Study|Enrolled but not treated|0|||
48742801|NCT00799422|156908297|FG000|First Week of Wear|Lost to Follow-up|0|||
48742802|NCT00799422|156908298|FG001|First Week of Wear|Lost to Follow-up|0|||
48742803|NCT00799422|156908299|FG002|First Week of Wear|Lost to Follow-up|1|||
48325306|NCT02568215|155389055|FG001|Overall Study|Death|2|||
48325307|NCT02568215|155389056|FG002|Overall Study|Death|0|||
48325308|NCT02568215|155389054|FG000|Overall Study|Physician Decision|2|||
48325309|NCT02568215|155389055|FG001|Overall Study|Physician Decision|2|||
48325310|NCT02568215|155389056|FG002|Overall Study|Physician Decision|2|||
48325311|NCT02568215|155389054|FG000|Overall Study|Lost to Follow-up|29|||
48629936|NCT02723955|156504842|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629937|NCT02723955|156504843|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
48629938|NCT02723955|156504844|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629939|NCT02723955|156504845|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629940|NCT02723955|156504846|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629941|NCT02723955|156504847|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629942|NCT02723955|156504848|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629943|NCT02723955|156504849|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629944|NCT02723955|156504850|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629945|NCT02723955|156504851|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629946|NCT02723955|156504852|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629947|NCT02723955|156504853|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629948|NCT02723955|156504854|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629949|NCT02723955|156504855|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
48629950|NCT02723955|156504813|FG000|Expansion Phase|Site Closed|0|||
48629951|NCT02723955|156504814|FG001|Expansion Phase|Site Closed|0|||
48629952|NCT02723955|156504815|FG002|Expansion Phase|Site Closed|0|||
48629953|NCT02723955|156504816|FG003|Expansion Phase|Site Closed|0|||
48629954|NCT02723955|156504817|FG004|Expansion Phase|Site Closed|0|||
48629955|NCT02723955|156504818|FG005|Expansion Phase|Site Closed|0|||
48629956|NCT02723955|156504819|FG006|Expansion Phase|Site Closed|0|||
48629957|NCT02723955|156504820|FG007|Expansion Phase|Site Closed|0|||
48629958|NCT02723955|156504821|FG008|Expansion Phase|Site Closed|0|||
48629959|NCT02723955|156504822|FG009|Expansion Phase|Site Closed|1|||
48629960|NCT02723955|156504823|FG010|Expansion Phase|Site Closed|2|||
48629961|NCT02723955|156504824|FG011|Expansion Phase|Site Closed|6|||
48629962|NCT02723955|156504825|FG012|Expansion Phase|Site Closed|0|||
48629963|NCT02723955|156504826|FG013|Expansion Phase|Site Closed|0|||
48629964|NCT02723955|156504827|FG014|Expansion Phase|Site Closed|0|||
48629965|NCT02723955|156504828|FG015|Expansion Phase|Site Closed|0|||
48629966|NCT02723955|156504829|FG016|Expansion Phase|Site Closed|0|||
48629967|NCT02723955|156504830|FG017|Expansion Phase|Site Closed|0|||
48629968|NCT02723955|156504831|FG018|Expansion Phase|Site Closed|0|||
48629969|NCT02723955|156504832|FG019|Expansion Phase|Site Closed|0|||
48629970|NCT02723955|156504833|FG020|Expansion Phase|Site Closed|0|||
48629971|NCT02723955|156504834|FG021|Expansion Phase|Site Closed|0|||
48629972|NCT02723955|156504835|FG022|Expansion Phase|Site Closed|0|||
48629973|NCT02723955|156504836|FG023|Expansion Phase|Site Closed|0|||
48629974|NCT02723955|156504837|FG024|Expansion Phase|Site Closed|0|||
48629975|NCT02723955|156504838|FG025|Expansion Phase|Site Closed|0|||
48629976|NCT02723955|156504839|FG026|Expansion Phase|Site Closed|0|||
48629977|NCT02723955|156504840|FG027|Expansion Phase|Site Closed|0|||
48629978|NCT02723955|156504841|FG028|Expansion Phase|Site Closed|0|||
48629979|NCT02723955|156504842|FG029|Expansion Phase|Site Closed|0|||
48629980|NCT02723955|156504843|FG030|Expansion Phase|Site Closed|8|||
48629981|NCT02723955|156504844|FG031|Expansion Phase|Site Closed|4|||
48629982|NCT02723955|156504845|FG032|Expansion Phase|Site Closed|2|||
48629983|NCT02723955|156504846|FG033|Expansion Phase|Site Closed|2|||
48629984|NCT02723955|156504847|FG034|Expansion Phase|Site Closed|0|||
48629985|NCT02723955|156504848|FG035|Expansion Phase|Site Closed|0|||
48629986|NCT02723955|156504849|FG036|Expansion Phase|Site Closed|0|||
48629987|NCT02723955|156504850|FG037|Expansion Phase|Site Closed|0|||
48629988|NCT02723955|156504851|FG038|Expansion Phase|Site Closed|0|||
48629989|NCT02723955|156504852|FG039|Expansion Phase|Site Closed|0|||
48629990|NCT02723955|156504853|FG040|Expansion Phase|Site Closed|0|||
48629991|NCT02723955|156504854|FG041|Expansion Phase|Site Closed|0|||
48629992|NCT02723955|156504855|FG042|Expansion Phase|Site Closed|0|||
48742804|NCT00799422|156908300|FG003|First Week of Wear|Lost to Follow-up|0|||
48742805|NCT00799422|156908301|FG004|First Week of Wear|Lost to Follow-up|0|||
48742806|NCT00799422|156908302|FG005|First Week of Wear|Lost to Follow-up|0|||
48742807|NCT00799422|156908297|FG000|First Week of Wear|Adverse Event|0|||
48742808|NCT00799422|156908298|FG001|First Week of Wear|Adverse Event|0|||
48742809|NCT00799422|156908299|FG002|First Week of Wear|Adverse Event|0|||
48629993|NCT02723955|156504813|FG000|Crossover/ Re-treatment Phase|Death|0|||
48629994|NCT02723955|156504814|FG001|Crossover/ Re-treatment Phase|Death|0|||
48629995|NCT02723955|156504815|FG002|Crossover/ Re-treatment Phase|Death|0|||
48629996|NCT02723955|156504816|FG003|Crossover/ Re-treatment Phase|Death|0|||
48629997|NCT02723955|156504817|FG004|Crossover/ Re-treatment Phase|Death|0|||
48629998|NCT02723955|156504818|FG005|Crossover/ Re-treatment Phase|Death|0|||
48629999|NCT02723955|156504819|FG006|Crossover/ Re-treatment Phase|Death|0|||
48630000|NCT02723955|156504820|FG007|Crossover/ Re-treatment Phase|Death|0|||
48742810|NCT00799422|156908300|FG003|First Week of Wear|Adverse Event|1|||
48742811|NCT00799422|156908301|FG004|First Week of Wear|Adverse Event|0|||
48742812|NCT00799422|156908302|FG005|First Week of Wear|Adverse Event|0|||
48325312|NCT02568215|155389055|FG001|Overall Study|Lost to Follow-up|32|||
48325313|NCT02568215|155389056|FG002|Overall Study|Lost to Follow-up|41|||
48325314|NCT02568215|155389054|FG000|Overall Study|Withdrawal by Subject|21|||
48325315|NCT02568215|155389055|FG001|Overall Study|Withdrawal by Subject|19|||
48742813|NCT02151110|156908303|FG000|Overall Study|Withdrawal by Subject|0|||
48742814|NCT02151110|156908304|FG001|Overall Study|Withdrawal by Subject|0|||
48742815|NCT02151110|156908305|FG002|Overall Study|Withdrawal by Subject|0|||
48325316|NCT02568215|155389056|FG002|Overall Study|Withdrawal by Subject|22|||
48742816|NCT02151110|156908306|FG003|Overall Study|Withdrawal by Subject|0|||
48742817|NCT02151110|156908307|FG004|Overall Study|Withdrawal by Subject|0|||
48742818|NCT02151110|156908308|FG005|Overall Study|Withdrawal by Subject|0|||
48742819|NCT02151110|156908309|FG006|Overall Study|Withdrawal by Subject|0|||
48742820|NCT02151110|156908310|FG007|Overall Study|Withdrawal by Subject|1|||
48742821|NCT02151110|156908303|FG000|Overall Study|Lost to Follow-up|0|||
48742822|NCT02151110|156908304|FG001|Overall Study|Lost to Follow-up|0|||
48742823|NCT02151110|156908305|FG002|Overall Study|Lost to Follow-up|0|||
48742824|NCT02151110|156908306|FG003|Overall Study|Lost to Follow-up|0|||
48630001|NCT02723955|156504821|FG008|Crossover/ Re-treatment Phase|Death|0|||
48630002|NCT02723955|156504822|FG009|Crossover/ Re-treatment Phase|Death|0|||
48630003|NCT02723955|156504823|FG010|Crossover/ Re-treatment Phase|Death|0|||
48630004|NCT02723955|156504824|FG011|Crossover/ Re-treatment Phase|Death|0|||
48630005|NCT02723955|156504825|FG012|Crossover/ Re-treatment Phase|Death|0|||
48630006|NCT02723955|156504826|FG013|Crossover/ Re-treatment Phase|Death|0|||
48630007|NCT02723955|156504827|FG014|Crossover/ Re-treatment Phase|Death|0|||
48630008|NCT02723955|156504828|FG015|Crossover/ Re-treatment Phase|Death|0|||
48630009|NCT02723955|156504829|FG016|Crossover/ Re-treatment Phase|Death|0|||
48630010|NCT02723955|156504830|FG017|Crossover/ Re-treatment Phase|Death|0|||
48630011|NCT02723955|156504831|FG018|Crossover/ Re-treatment Phase|Death|0|||
48630012|NCT02723955|156504832|FG019|Crossover/ Re-treatment Phase|Death|0|||
48630013|NCT02723955|156504833|FG020|Crossover/ Re-treatment Phase|Death|0|||
48630014|NCT02723955|156504834|FG021|Crossover/ Re-treatment Phase|Death|0|||
48630015|NCT02723955|156504835|FG022|Crossover/ Re-treatment Phase|Death|0|||
48630016|NCT02723955|156504836|FG023|Crossover/ Re-treatment Phase|Death|0|||
48630017|NCT02723955|156504837|FG024|Crossover/ Re-treatment Phase|Death|0|||
48630018|NCT02723955|156504838|FG025|Crossover/ Re-treatment Phase|Death|0|||
48630019|NCT02723955|156504839|FG026|Crossover/ Re-treatment Phase|Death|0|||
48630020|NCT02723955|156504840|FG027|Crossover/ Re-treatment Phase|Death|0|||
48630021|NCT02723955|156504841|FG028|Crossover/ Re-treatment Phase|Death|0|||
48630022|NCT02723955|156504842|FG029|Crossover/ Re-treatment Phase|Death|0|||
48630023|NCT02723955|156504843|FG030|Crossover/ Re-treatment Phase|Death|0|||
48630024|NCT02723955|156504844|FG031|Crossover/ Re-treatment Phase|Death|0|||
48630025|NCT02723955|156504845|FG032|Crossover/ Re-treatment Phase|Death|0|||
48630026|NCT02723955|156504846|FG033|Crossover/ Re-treatment Phase|Death|0|||
48630027|NCT02723955|156504847|FG034|Crossover/ Re-treatment Phase|Death|0|||
48630028|NCT02723955|156504848|FG035|Crossover/ Re-treatment Phase|Death|0|||
48630029|NCT02723955|156504849|FG036|Crossover/ Re-treatment Phase|Death|0|||
48630030|NCT02723955|156504850|FG037|Crossover/ Re-treatment Phase|Death|1|||
48630031|NCT02723955|156504851|FG038|Crossover/ Re-treatment Phase|Death|14|||
48630032|NCT02723955|156504852|FG039|Crossover/ Re-treatment Phase|Death|32|||
48630033|NCT02723955|156504853|FG040|Crossover/ Re-treatment Phase|Death|2|||
48630034|NCT02723955|156504854|FG041|Crossover/ Re-treatment Phase|Death|1|||
48630035|NCT02723955|156504855|FG042|Crossover/ Re-treatment Phase|Death|0|||
48630036|NCT02723955|156504813|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630037|NCT02723955|156504814|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630038|NCT02723955|156504815|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630039|NCT02723955|156504816|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630040|NCT02723955|156504817|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630041|NCT02723955|156504818|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630042|NCT02723955|156504819|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630043|NCT02723955|156504820|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630044|NCT02723955|156504821|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630045|NCT02723955|156504822|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630046|NCT02723955|156504823|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630047|NCT02723955|156504824|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630048|NCT02723955|156504825|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630049|NCT02723955|156504826|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630050|NCT02723955|156504827|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630051|NCT02723955|156504828|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630052|NCT02723955|156504829|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630053|NCT02723955|156504830|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630054|NCT02723955|156504831|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630055|NCT02723955|156504832|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630056|NCT02723955|156504833|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630057|NCT02723955|156504834|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48742825|NCT02151110|156908307|FG004|Overall Study|Lost to Follow-up|0|||
48742826|NCT02151110|156908308|FG005|Overall Study|Lost to Follow-up|0|||
48325317|NCT02568215|155389054|FG000|Overall Study|Protocol Violation|1|||
48325318|NCT02568215|155389055|FG001|Overall Study|Protocol Violation|1|||
48325319|NCT02568215|155389056|FG002|Overall Study|Protocol Violation|0|||
48325320|NCT02568215|155389054|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
48325321|NCT02568215|155389055|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
48630058|NCT02723955|156504835|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630059|NCT02723955|156504836|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630060|NCT02723955|156504837|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630061|NCT02723955|156504838|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630062|NCT02723955|156504839|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630063|NCT02723955|156504840|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630064|NCT02723955|156504841|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48742827|NCT02151110|156908309|FG006|Overall Study|Lost to Follow-up|0|||
48742828|NCT02151110|156908310|FG007|Overall Study|Lost to Follow-up|2|||
48742829|NCT01253408|156908311|FG000|Overall Study|Adverse Event|0|||
48742830|NCT01253408|156908312|FG001|Overall Study|Adverse Event|1|||
48742831|NCT01253408|156908313|FG002|Overall Study|Adverse Event|0|||
48742832|NCT05399641|156908314|FG000|Overall Study|Adverse Event|0|||
48742833|NCT05399641|156908315|FG001|Overall Study|Adverse Event|1|||
48742834|NCT05399641|156908316|FG002|Overall Study|Adverse Event|1|||
48742835|NCT05399641|156908314|FG000|Overall Study|Lost to Follow-up|1|||
48742836|NCT05399641|156908315|FG001|Overall Study|Lost to Follow-up|2|||
48742837|NCT05399641|156908316|FG002|Overall Study|Lost to Follow-up|2|||
48742838|NCT05399641|156908314|FG000|Overall Study|Physician Decision|1|||
48742839|NCT05399641|156908315|FG001|Overall Study|Physician Decision|3|||
48742840|NCT05399641|156908316|FG002|Overall Study|Physician Decision|3|||
48742841|NCT05399641|156908314|FG000|Overall Study|Withdrawal by Subject|4|||
48742842|NCT05399641|156908315|FG001|Overall Study|Withdrawal by Subject|11|||
48742843|NCT05399641|156908316|FG002|Overall Study|Withdrawal by Subject|7|||
48742844|NCT05399641|156908314|FG000|Overall Study|Reason not defined|3|||
48742845|NCT05399641|156908315|FG001|Overall Study|Reason not defined|5|||
48742846|NCT05399641|156908316|FG002|Overall Study|Reason not defined|6|||
48742847|NCT00923156|156908318|FG000|Overall Study|Adverse Event|0|||
48742848|NCT00923156|156908319|FG001|Overall Study|Adverse Event|2|||
48742849|NCT00923156|156908320|FG002|Overall Study|Adverse Event|1|||
48742850|NCT00923156|156908318|FG000|Overall Study|Abnormal laboratory values|0|||
48742851|NCT00923156|156908319|FG001|Overall Study|Abnormal laboratory values|0|||
48742852|NCT00923156|156908320|FG002|Overall Study|Abnormal laboratory values|1|||
48742853|NCT00923156|156908318|FG000|Overall Study|Withdrawal by Subject|0|||
48742854|NCT00923156|156908319|FG001|Overall Study|Withdrawal by Subject|1|||
48742855|NCT00923156|156908320|FG002|Overall Study|Withdrawal by Subject|0|||
48742856|NCT00923156|156908318|FG000|Overall Study|Death|0|||
48742857|NCT00923156|156908319|FG001|Overall Study|Death|1|||
48742858|NCT00923156|156908320|FG002|Overall Study|Death|0|||
48742859|NCT00923156|156908318|FG000|Overall Study|Lack of Efficacy|0|||
48742860|NCT00923156|156908319|FG001|Overall Study|Lack of Efficacy|0|||
48742861|NCT00923156|156908320|FG002|Overall Study|Lack of Efficacy|1|||
48742862|NCT01146665|156908323|FG000|Overall Study|Withdrawal by Subject|10|||
48742863|NCT01146665|156908324|FG001|Overall Study|Withdrawal by Subject|16|||
48742864|NCT00365508|156908332|FG000|Overall Study|Lost to Follow-up|139|||
48742865|NCT00365508|156908333|FG001|Overall Study|Lost to Follow-up|154|||
48742866|NCT00751933|156908334|FG000|Overall Study|Withdrawal by Subject|0|||
48742867|NCT00751933|156908335|FG001|Overall Study|Withdrawal by Subject|1|||
48742868|NCT00751933|156908336|FG002|Overall Study|Withdrawal by Subject|0|||
48742869|NCT00751933|156908337|FG003|Overall Study|Withdrawal by Subject|0|||
48742870|NCT00751933|156908334|FG000|Overall Study|Physician Decision|0|||
48742871|NCT00751933|156908335|FG001|Overall Study|Physician Decision|0|||
48742872|NCT00751933|156908336|FG002|Overall Study|Physician Decision|1|||
48742873|NCT00751933|156908337|FG003|Overall Study|Physician Decision|1|||
48742874|NCT01084083|156908339|FG000|Overall Study|Adverse Event|5|||
48742875|NCT01084083|156908339|FG000|Overall Study|Death|1|||
48742876|NCT01084083|156908339|FG000|Overall Study|Withdrawal by Subject|2|||
48742877|NCT01084083|156908339|FG000|Overall Study|Complicating disease|1|||
48742878|NCT01084083|156908339|FG000|Overall Study|Other|2|||
48742879|NCT01084083|156908339|FG000|Overall Study|Never started assigned therapy|1|||
48742880|NCT00393029|156908341|FG000|Overall Study|Not treated|0|||
48742881|NCT00393029|156908342|FG001|Overall Study|Not treated|1|||
48742882|NCT02197130|156908345|FG000|Overall Study|Adverse Event|13|||
48742883|NCT02197130|156908346|FG001|Overall Study|Adverse Event|4|||
48742884|NCT02197130|156908347|FG002|Overall Study|Adverse Event|23|||
48742885|NCT02197130|156908345|FG000|Overall Study|Death|0|||
48742886|NCT02197130|156908346|FG001|Overall Study|Death|1|||
48742887|NCT02197130|156908347|FG002|Overall Study|Death|0|||
48742888|NCT02197130|156908345|FG000|Overall Study|Lost to Follow-up|2|||
48742889|NCT02197130|156908346|FG001|Overall Study|Lost to Follow-up|0|||
48742890|NCT02197130|156908347|FG002|Overall Study|Lost to Follow-up|1|||
48742891|NCT02197130|156908345|FG000|Overall Study|Does not meet entrance criteria|0|||
48742892|NCT02197130|156908346|FG001|Overall Study|Does not meet entrance criteria|0|||
48325322|NCT02568215|155389056|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
48630065|NCT02723955|156504842|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630066|NCT02723955|156504843|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630067|NCT02723955|156504844|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630068|NCT02723955|156504845|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630069|NCT02723955|156504846|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630070|NCT02723955|156504847|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630071|NCT02723955|156504848|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630072|NCT02723955|156504849|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630073|NCT02723955|156504850|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48742893|NCT02197130|156908347|FG002|Overall Study|Does not meet entrance criteria|1|||
48325323|NCT02568215|155389054|FG000|Overall Study|Other|0|||
48742894|NCT02197130|156908345|FG000|Overall Study|Withdrawal by Subject|0|||
48325324|NCT02568215|155389055|FG001|Overall Study|Other|1|||
48325325|NCT02568215|155389056|FG002|Overall Study|Other|4|||
48325326|NCT02148705|155389057|FG000|Overall Study|Death|2|||
48325327|NCT02148705|155389058|FG001|Overall Study|Death|0|||
48325328|NCT02148705|155389059|FG002|Overall Study|Death|0|||
48630074|NCT02723955|156504851|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630075|NCT02723955|156504852|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
48325329|NCT02148705|155389057|FG000|Overall Study|Lost to Follow-up|13|||
48325330|NCT02148705|155389058|FG001|Overall Study|Lost to Follow-up|4|||
48630076|NCT02723955|156504853|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630077|NCT02723955|156504854|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630078|NCT02723955|156504855|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
48630079|NCT02723955|156504813|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630080|NCT02723955|156504814|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630081|NCT02723955|156504815|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630082|NCT02723955|156504816|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630083|NCT02723955|156504817|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630084|NCT02723955|156504818|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
48742895|NCT02197130|156908346|FG001|Overall Study|Withdrawal by Subject|3|||
48742896|NCT02197130|156908347|FG002|Overall Study|Withdrawal by Subject|4|||
48742897|NCT02197130|156908345|FG000|Overall Study|Other|1|||
48742898|NCT02197130|156908346|FG001|Overall Study|Other|0|||
48325331|NCT02148705|155389059|FG002|Overall Study|Lost to Follow-up|10|||
48325332|NCT02148705|155389057|FG000|Overall Study|Withdrawal by Subject|3|||
48325333|NCT02148705|155389058|FG001|Overall Study|Withdrawal by Subject|0|||
48325334|NCT02148705|155389059|FG002|Overall Study|Withdrawal by Subject|2|||
48325335|NCT02148705|155389057|FG000|Overall Study|Not Treated|0|||
48325336|NCT02148705|155389058|FG001|Overall Study|Not Treated|1|||
48325337|NCT02148705|155389059|FG002|Overall Study|Not Treated|5|||
48325338|NCT03709706|155389062|FG000|Overall Study|Adverse Event|0|||
48325339|NCT03709706|155389063|FG001|Overall Study|Adverse Event|1|||
48325340|NCT03709706|155389062|FG000|Overall Study|Physician Decision|14|||
48325341|NCT03709706|155389063|FG001|Overall Study|Physician Decision|8|||
48325342|NCT03709706|155389062|FG000|Overall Study|Withdrawal by Subject|2|||
48325343|NCT03709706|155389063|FG001|Overall Study|Withdrawal by Subject|1|||
48325344|NCT03709706|155389062|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
48325345|NCT03709706|155389063|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
48325346|NCT01105975|155389066|FG000|Overall Study|Adverse Event|2|||
48325347|NCT01105975|155389067|FG001|Overall Study|Adverse Event|1|||
48325348|NCT01105975|155389068|FG002|Overall Study|Adverse Event|5|||
48325349|NCT01105975|155389069|FG003|Overall Study|Adverse Event|1|||
48325350|NCT01105975|155389070|FG004|Overall Study|Adverse Event|0|||
48325351|NCT01105975|155389071|FG005|Overall Study|Adverse Event|1|||
48325352|NCT01105975|155389072|FG006|Overall Study|Adverse Event|2|||
48325353|NCT01105975|155389073|FG007|Overall Study|Adverse Event|4|||
48325354|NCT01105975|155389074|FG008|Overall Study|Adverse Event|1|||
48325355|NCT01105975|155389075|FG009|Overall Study|Adverse Event|4|||
48325356|NCT01105975|155389066|FG000|Overall Study|Withdrawal by Subject|2|||
48325357|NCT01105975|155389067|FG001|Overall Study|Withdrawal by Subject|2|||
48325358|NCT01105975|155389068|FG002|Overall Study|Withdrawal by Subject|2|||
48325359|NCT01105975|155389069|FG003|Overall Study|Withdrawal by Subject|0|||
48325360|NCT01105975|155389070|FG004|Overall Study|Withdrawal by Subject|4|||
48325361|NCT01105975|155389071|FG005|Overall Study|Withdrawal by Subject|1|||
48630085|NCT02723955|156504819|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630086|NCT02723955|156504820|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
48742899|NCT02197130|156908347|FG002|Overall Study|Other|3|||
48742900|NCT01594762|156908348|FG000|Overall Study|Withdrawal by Subject|1|||
48742901|NCT01594762|156908349|FG001|Overall Study|Withdrawal by Subject|0|||
48742902|NCT01594762|156908348|FG000|Overall Study|Lost to Follow-up|10|||
48742903|NCT01594762|156908349|FG001|Overall Study|Lost to Follow-up|10|||
48742904|NCT02280304|156910409|FG000|Overall Study|Lost to Follow-up|7|||
48742905|NCT02280304|156910410|FG001|Overall Study|Lost to Follow-up|8|||
48742906|NCT01606800|156910411|FG000|Overall Study|Adverse Event|3|||
48742907|NCT01606800|156910412|FG001|Overall Study|Adverse Event|1|||
48742908|NCT01606800|156910411|FG000|Overall Study|Participant withdrew consent|0|||
48325362|NCT01105975|155389072|FG006|Overall Study|Withdrawal by Subject|2|||
48325363|NCT01105975|155389073|FG007|Overall Study|Withdrawal by Subject|1|||
48742909|NCT01606800|156910412|FG001|Overall Study|Participant withdrew consent|1|||
48325364|NCT01105975|155389074|FG008|Overall Study|Withdrawal by Subject|0|||
48325365|NCT01105975|155389075|FG009|Overall Study|Withdrawal by Subject|3|||
48325366|NCT01105975|155389066|FG000|Overall Study|Lost to Follow-up|1|||
48325367|NCT01105975|155389067|FG001|Overall Study|Lost to Follow-up|0|||
48325368|NCT01105975|155389068|FG002|Overall Study|Lost to Follow-up|0|||
48325369|NCT01105975|155389069|FG003|Overall Study|Lost to Follow-up|1|||
48325370|NCT01105975|155389070|FG004|Overall Study|Lost to Follow-up|1|||
48630087|NCT02723955|156504821|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
48742910|NCT01606800|156910411|FG000|Overall Study|Missing completion status|2|||
48742911|NCT01606800|156910412|FG001|Overall Study|Missing completion status|0|||
48630088|NCT02723955|156504822|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630089|NCT02723955|156504823|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630090|NCT02723955|156504824|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630091|NCT02723955|156504825|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630092|NCT02723955|156504826|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630093|NCT02723955|156504827|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630094|NCT02723955|156504828|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630095|NCT02723955|156504829|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630096|NCT02723955|156504830|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630097|NCT02723955|156504831|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630098|NCT02723955|156504832|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630099|NCT02723955|156504833|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630100|NCT02723955|156504834|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630101|NCT02723955|156504835|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630102|NCT02723955|156504836|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630103|NCT02723955|156504837|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630104|NCT02723955|156504838|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630105|NCT02723955|156504839|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630106|NCT02723955|156504840|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630107|NCT02723955|156504841|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630108|NCT02723955|156504842|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630109|NCT02723955|156504843|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630110|NCT02723955|156504844|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630111|NCT02723955|156504845|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630112|NCT02723955|156504846|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630113|NCT02723955|156504847|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630114|NCT02723955|156504848|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630115|NCT02723955|156504849|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630116|NCT02723955|156504850|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630117|NCT02723955|156504851|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
48630118|NCT02723955|156504852|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
48630119|NCT02723955|156504853|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630120|NCT02723955|156504854|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
48630121|NCT02723955|156504855|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
48630122|NCT02723955|156504813|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
48630123|NCT02723955|156504814|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
48630124|NCT02723955|156504815|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
48630125|NCT02723955|156504816|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
48630126|NCT02723955|156504817|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
48630127|NCT02723955|156504818|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
48630128|NCT02723955|156504819|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
48630129|NCT02723955|156504820|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
48630130|NCT02723955|156504821|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
48630131|NCT02723955|156504822|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
48630132|NCT02723955|156504823|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
48630133|NCT02723955|156504824|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
48630134|NCT02723955|156504825|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
48630135|NCT02723955|156504826|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
48630136|NCT02723955|156504827|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
48630137|NCT02723955|156504828|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
48630138|NCT02723955|156504829|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
48630139|NCT02723955|156504830|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
48630140|NCT02723955|156504831|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
48630141|NCT02723955|156504832|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
48630142|NCT02723955|156504833|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
48630143|NCT02723955|156504834|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
48630144|NCT02723955|156504835|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
48630145|NCT02723955|156504836|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
48630146|NCT02723955|156504837|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
48630422|NCT05014919|156504945|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
48630423|NCT05014919|156504946|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
48630424|NCT05014919|156504947|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
48630425|NCT02657343|156504952|FG000|Overall Study|Death|0|||
48630426|NCT02657343|156504953|FG001|Overall Study|Death|2|||
48630427|NCT02657343|156504954|FG002|Overall Study|Death|0|||
48630428|NCT02657343|156504955|FG003|Overall Study|Death|0|||
48630429|NCT02657343|156504956|FG004|Overall Study|Death|0|||
48630430|NCT02657343|156504957|FG005|Overall Study|Death|0|||
48630431|NCT02657343|156504952|FG000|Overall Study|Patient went to hospice|1|||
48630432|NCT02657343|156504953|FG001|Overall Study|Patient went to hospice|0|||
48630433|NCT02657343|156504954|FG002|Overall Study|Patient went to hospice|0|||
48630434|NCT02657343|156504955|FG003|Overall Study|Patient went to hospice|0|||
48630435|NCT02657343|156504956|FG004|Overall Study|Patient went to hospice|0|||
48630436|NCT02657343|156504957|FG005|Overall Study|Patient went to hospice|0|||
48630437|NCT02657343|156504952|FG000|Overall Study|Withdrawal by Subject|0|||
48630438|NCT02657343|156504953|FG001|Overall Study|Withdrawal by Subject|0|||
48630439|NCT02657343|156504954|FG002|Overall Study|Withdrawal by Subject|0|||
48630440|NCT02657343|156504955|FG003|Overall Study|Withdrawal by Subject|0|||
48630441|NCT02657343|156504956|FG004|Overall Study|Withdrawal by Subject|1|||
48630442|NCT02657343|156504957|FG005|Overall Study|Withdrawal by Subject|0|||
48630443|NCT01979185|156504966|FG000|Period 2|Other|0|||
48630444|NCT01979185|156504967|FG001|Period 2|Other|1|||
48630445|NCT01380080|156504968|FG000|Overall Study|Death|36|||
48630446|NCT01380080|156504969|FG001|Overall Study|Death|44|||
48630447|NCT01380080|156504968|FG000|Overall Study|Site is closing|28|||
48630448|NCT01380080|156504969|FG001|Overall Study|Site is closing|31|||
48630449|NCT01380080|156504968|FG000|Overall Study|Not able to get to clinic|7|||
48630450|NCT01380080|156504969|FG001|Overall Study|Not able to get to clinic|1|||
48630451|NCT01380080|156504968|FG000|Overall Study|Not willing to adhere to requirements|6|||
48743077|NCT00968201|156910495|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
48743078|NCT00968201|156910496|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
48743079|NCT00968201|156910494|FG000|Extension Study - (Period III)|Protocol Violation|0|||
48743080|NCT00968201|156910495|FG001|Extension Study - (Period III)|Protocol Violation|17|||
48743081|NCT00968201|156910496|FG002|Extension Study - (Period III)|Protocol Violation|14|||
48743082|NCT00968201|156910494|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
48743083|NCT00968201|156910495|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
48743084|NCT00968201|156910496|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
48743085|NCT00968201|156910494|FG000|Extension Study - (Period III)|Patient Relocated|0|||
48743086|NCT00968201|156910495|FG001|Extension Study - (Period III)|Patient Relocated|1|||
48743087|NCT00968201|156910496|FG002|Extension Study - (Period III)|Patient Relocated|1|||
48743088|NCT00968201|156910494|FG000|Extension Study - (Period III)|Noncompliance|0|||
48743089|NCT00968201|156910495|FG001|Extension Study - (Period III)|Noncompliance|0|||
48743090|NCT00968201|156910496|FG002|Extension Study - (Period III)|Noncompliance|3|||
48743091|NCT00968201|156910494|FG000|Extension Study - (Period III)|Other|0|||
48743092|NCT00968201|156910495|FG001|Extension Study - (Period III)|Other|0|||
48743093|NCT00968201|156910496|FG002|Extension Study - (Period III)|Other|2|||
48743094|NCT00968201|156910494|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
48743095|NCT00968201|156910495|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
48743096|NCT00968201|156910496|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
48743097|NCT00289783|156910498|FG000|Primary Phase|Adverse Event|10|||
48743098|NCT00289783|156910499|FG001|Primary Phase|Adverse Event|1|||
48743099|NCT00289783|156910498|FG000|Primary Phase|Protocol Violation|27|||
48630452|NCT01380080|156504969|FG001|Overall Study|Not willing to adhere to requirements|2|||
48630453|NCT01380080|156504968|FG000|Overall Study|Withdrawal by Subject|5|||
48630454|NCT01380080|156504969|FG001|Overall Study|Withdrawal by Subject|2|||
48630455|NCT01380080|156504968|FG000|Overall Study|Lost to Follow-up|3|||
48630456|NCT01380080|156504969|FG001|Overall Study|Lost to Follow-up|3|||
48630457|NCT02135133|156504970|FG000|Overall Study|Adverse Event|10|||
48630458|NCT02135133|156504970|FG000|Overall Study|regulatory mandate|5|||
48630459|NCT00847730|156504974|FG000|Overall Study|Multiple interruptions in therapy|8|||
48630460|NCT02185768|156504976|FG000|Overall Study|Patients were not treated|2|||
48630461|NCT00071032|156504977|FG000|Overall Study|Lost to Follow-up|1|||
48630462|NCT00071032|156504978|FG001|Overall Study|Lost to Follow-up|1|||
48743100|NCT00289783|156910499|FG001|Primary Phase|Protocol Violation|6|||
48630463|NCT00071032|156504977|FG000|Overall Study|Withdrawal by Subject|8|||
48630464|NCT00071032|156504978|FG001|Overall Study|Withdrawal by Subject|6|||
48630465|NCT00071032|156504977|FG000|Overall Study|Missing Primary Outcome|0|||
48630466|NCT00071032|156504978|FG001|Overall Study|Missing Primary Outcome|1|||
48630467|NCT01889251|156504979|FG000|Overall Study|Adverse Event|1|||
48630468|NCT01889251|156504980|FG001|Overall Study|Adverse Event|0|||
48630469|NCT02936323|156504981|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
48630470|NCT02936323|156504982|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
48630471|NCT02936323|156504983|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
48743101|NCT00289783|156910498|FG000|Primary Phase|Withdrawal by Subject|93|||
48743102|NCT00289783|156910499|FG001|Primary Phase|Withdrawal by Subject|40|||
48743103|NCT00289783|156910498|FG000|Primary Phase|Lost to Follow-up|60|||
48743104|NCT00289783|156910499|FG001|Primary Phase|Lost to Follow-up|14|||
48743105|NCT00289783|156910498|FG000|Primary Phase|Migration from the study area|26|||
48743106|NCT00289783|156910499|FG001|Primary Phase|Migration from the study area|10|||
48743107|NCT00289783|156910498|FG000|Primary Phase|Other|32|||
48743108|NCT00289783|156910499|FG001|Primary Phase|Other|12|||
48743109|NCT00289783|156910498|FG000|Fourth Dose Phase|Adverse Event|1|||
48743110|NCT00289783|156910499|FG001|Fourth Dose Phase|Adverse Event|0|||
48743111|NCT00289783|156910498|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
48325509|NCT02502526|155389132|FG002|Overall Study|Withdrawal by Subject|1|||
48743112|NCT00289783|156910499|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
48743113|NCT00289783|156910498|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
48743114|NCT00289783|156910499|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
48743115|NCT00289783|156910498|FG000|Fourth Dose Phase|Migration from the study area|1|||
48743116|NCT00289783|156910499|FG001|Fourth Dose Phase|Migration from the study area|1|||
48743117|NCT00289783|156910498|FG000|Fourth Dose Phase|Other|22|||
48743118|NCT00289783|156910499|FG001|Fourth Dose Phase|Other|10|||
48743119|NCT03302234|156910500|FG000|Overall Study|Death|191|||
48743120|NCT03302234|156910501|FG001|Overall Study|Death|192|||
48743121|NCT03302234|156910500|FG000|Overall Study|Withdrawal by Subject|2|||
48743122|NCT03302234|156910501|FG001|Overall Study|Withdrawal by Subject|2|||
48743123|NCT03302234|156910500|FG000|Overall Study|Sponsor Decision|90|||
48743124|NCT03302234|156910501|FG001|Overall Study|Sponsor Decision|89|||
48743125|NCT03302234|156910500|FG000|Overall Study|Laryngeal carcinoma|0|||
48743126|NCT03302234|156910501|FG001|Overall Study|Laryngeal carcinoma|1|||
48743127|NCT03302234|156910500|FG000|Overall Study|Not Reported|1|||
48743128|NCT03302234|156910501|FG001|Overall Study|Not Reported|0|||
48743129|NCT00361569|156910502|FG000|Overall Study|Protocol Violation|3|||
48743130|NCT00361569|156910503|FG001|Overall Study|Protocol Violation|2|||
48743131|NCT00361569|156910504|FG002|Overall Study|Protocol Violation|4|||
48743132|NCT00361569|156910505|FG003|Overall Study|Protocol Violation|2|||
48743133|NCT00361569|156910502|FG000|Overall Study|Withdrawal by Subject|2|||
48743134|NCT00361569|156910503|FG001|Overall Study|Withdrawal by Subject|1|||
48743135|NCT00361569|156910504|FG002|Overall Study|Withdrawal by Subject|9|||
48743136|NCT00361569|156910505|FG003|Overall Study|Withdrawal by Subject|14|||
48743137|NCT00361569|156910502|FG000|Overall Study|Adverse Event|3|||
48743138|NCT00361569|156910503|FG001|Overall Study|Adverse Event|5|||
48743139|NCT00361569|156910504|FG002|Overall Study|Adverse Event|2|||
48743140|NCT00361569|156910505|FG003|Overall Study|Adverse Event|2|||
48743141|NCT00361569|156910502|FG000|Overall Study|Lost to Follow-up|2|||
48743142|NCT00361569|156910503|FG001|Overall Study|Lost to Follow-up|3|||
48743143|NCT00361569|156910504|FG002|Overall Study|Lost to Follow-up|3|||
48743144|NCT00361569|156910505|FG003|Overall Study|Lost to Follow-up|2|||
48743145|NCT00361569|156910502|FG000|Overall Study|Not specified by investigator|2|||
48743146|NCT00361569|156910503|FG001|Overall Study|Not specified by investigator|0|||
48743147|NCT00361569|156910504|FG002|Overall Study|Not specified by investigator|0|||
48743148|NCT00361569|156910505|FG003|Overall Study|Not specified by investigator|1|||
48743149|NCT04523220|156910506|FG000|Main Treatment Period|Physician Decision|1|||
48743150|NCT04523220|156910507|FG001|Main Treatment Period|Physician Decision|1|||
48743151|NCT04523220|156910508|FG002|Main Treatment Period|Physician Decision|0|||
48743152|NCT04523220|156910506|FG000|Main Treatment Period|Other|5|||
48743153|NCT04523220|156910507|FG001|Main Treatment Period|Other|2|||
48743154|NCT04523220|156910508|FG002|Main Treatment Period|Other|4|||
48325510|NCT02502526|155389130|FG000|Overall Study|Disqualified due to cataract grading|0|||
48325511|NCT02502526|155389131|FG001|Overall Study|Disqualified due to cataract grading|0|||
48325512|NCT02502526|155389132|FG002|Overall Study|Disqualified due to cataract grading|1|||
48325513|NCT02502526|155389130|FG000|Overall Study|Enrollment suspension|4|||
48325514|NCT02502526|155389131|FG001|Overall Study|Enrollment suspension|1|||
48325515|NCT02502526|155389132|FG002|Overall Study|Enrollment suspension|1|||
48325516|NCT00229658|155389142|FG000|Overall Study|Administrative|2|||
48325517|NCT00229658|155389143|FG001|Overall Study|Administrative|1|||
48743155|NCT04523220|156910506|FG000|Main Treatment Period|Subject Decision|5|||
48743156|NCT04523220|156910507|FG001|Main Treatment Period|Subject Decision|7|||
48743157|NCT04523220|156910508|FG002|Main Treatment Period|Subject Decision|3|||
48743158|NCT04523220|156910506|FG000|Main Treatment Period|Death|5|||
48743159|NCT04523220|156910507|FG001|Main Treatment Period|Death|11|||
48743160|NCT04523220|156910508|FG002|Main Treatment Period|Death|4|||
48743161|NCT04523220|156910506|FG000|Main Treatment Period|Adverse Event|11|||
48743162|NCT04523220|156910507|FG001|Main Treatment Period|Adverse Event|9|||
48743163|NCT04523220|156910508|FG002|Main Treatment Period|Adverse Event|9|||
48743164|NCT04523220|156910506|FG000|Main Treatment Period|Withdrawal by Subject|3|||
48743165|NCT04523220|156910507|FG001|Main Treatment Period|Withdrawal by Subject|3|||
48743166|NCT04523220|156910508|FG002|Main Treatment Period|Withdrawal by Subject|4|||
48743167|NCT04523220|156910506|FG000|Main Treatment Period|Study drug never adminstered|10|||
48743168|NCT04523220|156910507|FG001|Main Treatment Period|Study drug never adminstered|3|||
48630472|NCT02936323|156504984|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
48630473|NCT02936323|156504985|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
48630474|NCT02936323|156504986|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
48630475|NCT02936323|156504987|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
48630476|NCT02936323|156504988|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
48630477|NCT02936323|156504989|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
48630478|NCT02936323|156504990|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
48630479|NCT02936323|156504981|FG000|Phase 1 Dose Escalation|Death|2|||
48630480|NCT02936323|156504982|FG001|Phase 1 Dose Escalation|Death|1|||
48630481|NCT02936323|156504983|FG002|Phase 1 Dose Escalation|Death|3|||
48630482|NCT02936323|156504984|FG003|Phase 1 Dose Escalation|Death|1|||
48630483|NCT02936323|156504985|FG004|Phase 1 Dose Escalation|Death|2|||
48630484|NCT02936323|156504986|FG005|Phase 1 Dose Escalation|Death|3|||
48630485|NCT02936323|156504987|FG006|Phase 1 Dose Escalation|Death|3|||
48630486|NCT02936323|156504988|FG007|Phase 1 Dose Escalation|Death|0|||
48630487|NCT02936323|156504989|FG008|Phase 1 Dose Escalation|Death|0|||
48630488|NCT02936323|156504990|FG009|Phase 1 Dose Escalation|Death|0|||
48630489|NCT02936323|156504981|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630490|NCT02936323|156504982|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630491|NCT02936323|156504983|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630492|NCT02936323|156504984|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630493|NCT02936323|156504985|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630494|NCT02936323|156504986|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
48630495|NCT02936323|156504987|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630496|NCT02936323|156504988|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630497|NCT02936323|156504989|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630498|NCT02936323|156504990|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
48630499|NCT02936323|156504981|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
48630500|NCT02936323|156504982|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
48630501|NCT02936323|156504983|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
48630502|NCT02936323|156504984|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
48630503|NCT02936323|156504985|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
48630504|NCT02936323|156504986|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
48630505|NCT02936323|156504987|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
48630506|NCT02936323|156504988|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
48630507|NCT02936323|156504989|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
48630508|NCT02936323|156504990|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
48630509|NCT02936323|156504981|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
48630510|NCT02936323|156504982|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
48630511|NCT02936323|156504983|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
48630512|NCT02936323|156504984|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
48630513|NCT02936323|156504985|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
48630514|NCT02936323|156504986|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
48630515|NCT02936323|156504987|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
48630516|NCT02936323|156504988|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
48630517|NCT02936323|156504989|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
48630518|NCT02936323|156504990|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
48325518|NCT00229658|155389142|FG000|Overall Study|Investigator decision|13|||
48325519|NCT00229658|155389143|FG001|Overall Study|Investigator decision|10|||
48325520|NCT00229658|155389142|FG000|Overall Study|Other|80|||
48325521|NCT00229658|155389143|FG001|Overall Study|Other|60|||
48325522|NCT00229658|155389142|FG000|Overall Study|Lost to Follow-up|82|||
48325523|NCT00229658|155389143|FG001|Overall Study|Lost to Follow-up|55|||
48630519|NCT02936323|156504981|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
48630520|NCT02936323|156504982|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
48630521|NCT02936323|156504983|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
48630522|NCT02936323|156504984|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
48630523|NCT02936323|156504985|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
48630524|NCT02936323|156504986|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
48630525|NCT02936323|156504987|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
48630526|NCT02936323|156504988|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
48630527|NCT02936323|156504989|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
48630528|NCT02936323|156504990|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
48630529|NCT02936323|156504981|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48630530|NCT02936323|156504982|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48630531|NCT02936323|156504983|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48325524|NCT00229658|155389142|FG000|Overall Study|Serious Adverse Event|2|||
48325525|NCT00229658|155389143|FG001|Overall Study|Serious Adverse Event|2|||
48630532|NCT02936323|156504984|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48630533|NCT02936323|156504985|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48630534|NCT02936323|156504986|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48630535|NCT02936323|156504987|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48630536|NCT02936323|156504988|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48630537|NCT02936323|156504989|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
48630538|NCT02936323|156504990|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
48630539|NCT02936323|156504981|FG000|Phase 2a Dose Expansion|Death|0|||
48630540|NCT02936323|156504982|FG001|Phase 2a Dose Expansion|Death|0|||
48630541|NCT02936323|156504983|FG002|Phase 2a Dose Expansion|Death|0|||
48630542|NCT02936323|156504984|FG003|Phase 2a Dose Expansion|Death|0|||
48630543|NCT02936323|156504985|FG004|Phase 2a Dose Expansion|Death|0|||
48630544|NCT02936323|156504986|FG005|Phase 2a Dose Expansion|Death|0|||
48630545|NCT02936323|156504987|FG006|Phase 2a Dose Expansion|Death|0|||
48630546|NCT02936323|156504988|FG007|Phase 2a Dose Expansion|Death|4|||
48630547|NCT02936323|156504989|FG008|Phase 2a Dose Expansion|Death|8|||
48630548|NCT02936323|156504990|FG009|Phase 2a Dose Expansion|Death|10|||
48630549|NCT05309291|156504993|FG000|Overall Study|Adverse Event|0|||
48630550|NCT05309291|156504994|FG001|Overall Study|Adverse Event|1|||
48630551|NCT02371889|156506706|FG000|Overall Study|Adverse medication effect|11|||
48630552|NCT02371889|156506707|FG001|Overall Study|Adverse medication effect|2|||
48630553|NCT02371889|156506706|FG000|Overall Study|Lost to Follow-up|6|||
48630554|NCT02371889|156506707|FG001|Overall Study|Lost to Follow-up|5|||
48630555|NCT02371889|156506706|FG000|Overall Study|Personal time constraints|2|||
48630556|NCT02371889|156506707|FG001|Overall Study|Personal time constraints|4|||
48630557|NCT02371889|156506706|FG000|Overall Study|Lack of Efficacy|0|||
48630558|NCT02371889|156506707|FG001|Overall Study|Lack of Efficacy|2|||
48630559|NCT02371889|156506706|FG000|Overall Study|Relapse|0|||
48630560|NCT02371889|156506707|FG001|Overall Study|Relapse|1|||
48630561|NCT00095576|156506708|FG000|Overall Study|Adverse Event|5|||
48630562|NCT00095576|156506709|FG001|Overall Study|Adverse Event|3|||
48630563|NCT00095576|156506708|FG000|Overall Study|Lost to Follow-up|233|||
48630564|NCT00095576|156506709|FG001|Overall Study|Lost to Follow-up|229|||
48630565|NCT00095576|156506708|FG000|Overall Study|Protocol Violation|1|||
48630566|NCT00095576|156506709|FG001|Overall Study|Protocol Violation|0|||
48630567|NCT00095576|156506708|FG000|Overall Study|Withdrawal by Subject|34|||
48630568|NCT00095576|156506709|FG001|Overall Study|Withdrawal by Subject|47|||
48630569|NCT00095576|156506708|FG000|Overall Study|Option to switch to a rollover study|1097|||
48630570|NCT00095576|156506709|FG001|Overall Study|Option to switch to a rollover study|1099|||
48630571|NCT00095576|156506708|FG000|Overall Study|Site terminated|75|||
48630572|NCT00095576|156506709|FG001|Overall Study|Site terminated|67|||
48630573|NCT00095576|156506708|FG000|Overall Study|Subject moved|30|||
48630574|NCT00095576|156506709|FG001|Overall Study|Subject moved|36|||
48630575|NCT03341936|156506710|FG000|Overall Study|Ineligible|1|||
48630576|NCT03341936|156506710|FG000|Overall Study|Disease Progression|2|||
48630577|NCT03341936|156506710|FG000|Overall Study|Withdrew Consent|4|||
48630578|NCT03341936|156506710|FG000|Overall Study|Non-Compliance|1|||
48630579|NCT03341936|156506710|FG000|Overall Study|Physician Decision|1|||
48630580|NCT03341936|156506710|FG000|Overall Study|Withdrawal by Subject|1|||
48630581|NCT03341936|156506710|FG000|Overall Study|Other|1|||
48630582|NCT03639935|156506711|FG000|Overall Study|Death|3|||
48630583|NCT03639935|156506711|FG000|Overall Study|Adverse Event|1|||
48630584|NCT02919618|156506712|FG000|Overall Study|Death|1|||
48630585|NCT06136897|156506713|FG000|Overall Study|Ineligible|3|||
48630586|NCT06136897|156506713|FG000|Overall Study|Mutation status not confirmed|7|||
48630587|NCT06136897|156506713|FG000|Overall Study|Adverse Event|2|||
48630588|NCT06136897|156506713|FG000|Overall Study|Death|1|||
48630589|NCT06136897|156506713|FG000|Overall Study|Disease progression|18|||
48630590|NCT06136897|156506713|FG000|Overall Study|Other complicating disease|1|||
48630591|NCT06136897|156506713|FG000|Overall Study|Withdrawal by Subject|1|||
48743169|NCT04523220|156910508|FG002|Main Treatment Period|Study drug never adminstered|5|||
48743170|NCT04523220|156910506|FG000|Extension Treatment Period|Physician Decision|1|||
48743171|NCT04523220|156910507|FG001|Extension Treatment Period|Physician Decision|0|||
48325526|NCT00229658|155389142|FG000|Overall Study|Withdrawal of consent|46|||
48630592|NCT06136897|156506713|FG000|Overall Study|Still on treatment|1|||
48630593|NCT06136897|156506713|FG000|Overall Study|Lost to Follow-up|1|||
48630594|NCT04802967|156506716|FG000|Part B|Withdrawal by Subject|0|||
48630595|NCT04802967|156506717|FG001|Part B|Withdrawal by Subject|0|||
48630596|NCT04802967|156506718|FG002|Part B|Withdrawal by Subject|0|||
48630597|NCT04802967|156506719|FG003|Part B|Withdrawal by Subject|0|||
48630598|NCT04802967|156506720|FG004|Part B|Withdrawal by Subject|0|||
48630599|NCT04802967|156506721|FG005|Part B|Withdrawal by Subject|1|||
48630600|NCT04802967|156506722|FG006|Part B|Withdrawal by Subject|0|||
48630601|NCT04802967|156506723|FG007|Part B|Withdrawal by Subject|0|||
48630602|NCT04802967|156506724|FG008|Part B|Withdrawal by Subject|0|||
48630603|NCT04802967|156506725|FG009|Part B|Withdrawal by Subject|0|||
48630604|NCT00023595|156506726|FG000|5 Year Follow up|Lost to Follow-up|2|||
48630605|NCT00023595|156506727|FG001|5 Year Follow up|Lost to Follow-up|2|||
48630606|NCT00023595|156506728|FG002|5 Year Follow up|Lost to Follow-up|1|||
48630607|NCT00023595|156506729|FG003|5 Year Follow up|Lost to Follow-up|7|||
48630608|NCT00023595|156506730|FG004|5 Year Follow up|Lost to Follow-up|3|||
48630609|NCT00023595|156506726|FG000|10 Year Follow up|Lost to Follow-up|12|||
48630610|NCT00023595|156506727|FG001|10 Year Follow up|Lost to Follow-up|10|||
48630611|NCT00023595|156506728|FG002|10 Year Follow up|Lost to Follow-up|3|||
48630612|NCT00023595|156506729|FG003|10 Year Follow up|Lost to Follow-up|0|||
48630613|NCT00023595|156506730|FG004|10 Year Follow up|Lost to Follow-up|0|||
48630614|NCT02096354|156506731|FG000|Overall Study|Physician Decision|4|||
48630615|NCT02096354|156506732|FG001|Overall Study|Physician Decision|5|||
48630616|NCT02096354|156506733|FG002|Overall Study|Physician Decision|0|||
48743172|NCT04523220|156910508|FG002|Extension Treatment Period|Physician Decision|3|||
48743173|NCT04523220|156910506|FG000|Extension Treatment Period|Other|2|||
48743174|NCT04523220|156910507|FG001|Extension Treatment Period|Other|6|||
48743175|NCT04523220|156910508|FG002|Extension Treatment Period|Other|6|||
48743176|NCT04523220|156910506|FG000|Extension Treatment Period|Subject Decision|5|||
48743177|NCT04523220|156910507|FG001|Extension Treatment Period|Subject Decision|2|||
48743178|NCT04523220|156910508|FG002|Extension Treatment Period|Subject Decision|4|||
48743179|NCT04523220|156910506|FG000|Extension Treatment Period|Death|6|||
48743180|NCT04523220|156910507|FG001|Extension Treatment Period|Death|4|||
48743181|NCT04523220|156910508|FG002|Extension Treatment Period|Death|7|||
48743182|NCT04523220|156910506|FG000|Extension Treatment Period|Adverse Event|6|||
48743183|NCT04523220|156910507|FG001|Extension Treatment Period|Adverse Event|7|||
48630617|NCT02096354|156506731|FG000|Overall Study|Withdrawal by Subject|3|||
48630618|NCT02096354|156506732|FG001|Overall Study|Withdrawal by Subject|1|||
48630619|NCT02096354|156506733|FG002|Overall Study|Withdrawal by Subject|0|||
48630620|NCT02096354|156506731|FG000|Overall Study|Adverse Event|7|||
48630621|NCT02096354|156506732|FG001|Overall Study|Adverse Event|4|||
48630622|NCT02096354|156506733|FG002|Overall Study|Adverse Event|0|||
48630623|NCT02096354|156506731|FG000|Overall Study|Ineligible|0|||
48630624|NCT02096354|156506732|FG001|Overall Study|Ineligible|0|||
48743184|NCT04523220|156910508|FG002|Extension Treatment Period|Adverse Event|9|||
48743185|NCT04523220|156910506|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
48743186|NCT04523220|156910507|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
48743187|NCT04523220|156910508|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
48743188|NCT04523220|156910506|FG000|Extension Treatment Period|Study drug never administered|0|||
48743189|NCT04523220|156910507|FG001|Extension Treatment Period|Study drug never administered|1|||
48743190|NCT04523220|156910508|FG002|Extension Treatment Period|Study drug never administered|0|||
48743191|NCT02605824|156910509|FG000|Overall Study|Physician Decision|1|||
48743192|NCT02605824|156910510|FG001|Overall Study|Physician Decision|0|||
48743193|NCT00481078|156910511|FG000|Overall Study|Progression of disease|11|||
48743194|NCT00481078|156910512|FG001|Overall Study|Progression of disease|11|||
48743195|NCT00481078|156910511|FG000|Overall Study|Adverse Event|15|||
48743196|NCT00481078|156910512|FG001|Overall Study|Adverse Event|3|||
48743197|NCT00481078|156910511|FG000|Overall Study|Death|5|||
48743198|NCT00481078|156910512|FG001|Overall Study|Death|3|||
48743199|NCT00481078|156910511|FG000|Overall Study|Intercurrent illness|1|||
48743200|NCT00481078|156910512|FG001|Overall Study|Intercurrent illness|0|||
48743201|NCT00481078|156910511|FG000|Overall Study|Withdrawal by Subject|7|||
48743202|NCT00481078|156910512|FG001|Overall Study|Withdrawal by Subject|1|||
48743203|NCT00481078|156910511|FG000|Overall Study|Information not available|1|||
48743204|NCT00481078|156910512|FG001|Overall Study|Information not available|0|||
48743205|NCT00481078|156910511|FG000|Overall Study|Received other treatment|2|||
48743206|NCT00481078|156910512|FG001|Overall Study|Received other treatment|1|||
48743207|NCT00481078|156910511|FG000|Overall Study|Brain metastasis|0|||
48743208|NCT00481078|156910512|FG001|Overall Study|Brain metastasis|1|||
48743209|NCT01845831|156910513|FG000|Inpatient Phase|Withdrawal by Subject|1|||
48743210|NCT01845831|156910514|FG001|Inpatient Phase|Withdrawal by Subject|1|||
48743211|NCT01845831|156910515|FG002|Inpatient Phase|Withdrawal by Subject|0|||
48743212|NCT01845831|156910516|FG003|Inpatient Phase|Withdrawal by Subject|0|||
48743213|NCT01845831|156910517|FG004|Inpatient Phase|Withdrawal by Subject|0|||
48743214|NCT00873015|156910518|FG000|Overall Study|Withdrawal by Subject|0|||
48743215|NCT00873015|156910519|FG001|Overall Study|Withdrawal by Subject|1|||
48743216|NCT00873015|156910520|FG002|Overall Study|Withdrawal by Subject|0|||
48743217|NCT00873015|156910521|FG003|Overall Study|Withdrawal by Subject|0|||
48743218|NCT00256750|156910527|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
48743219|NCT00256750|156910528|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
48743220|NCT00256750|156910529|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
48743221|NCT00256750|156910527|FG000|Transplanted Pre-Treatment|Other|2|||
48743222|NCT00256750|156910528|FG001|Transplanted Pre-Treatment|Other|0|||
48630625|NCT02096354|156506733|FG002|Overall Study|Ineligible|11|||
48630626|NCT03900650|156506735|FG000|Overall Study|Withdrawal by Subject|1|||
48630627|NCT03900650|156506736|FG001|Overall Study|Withdrawal by Subject|1|||
48630628|NCT03900650|156506737|FG002|Overall Study|Withdrawal by Subject|0|||
48743223|NCT00256750|156910529|FG002|Transplanted Pre-Treatment|Other|0|||
48743224|NCT00256750|156910527|FG000|Transplanted Pre-Treatment|Death|1|||
48743225|NCT00256750|156910528|FG001|Transplanted Pre-Treatment|Death|0|||
48743226|NCT00256750|156910529|FG002|Transplanted Pre-Treatment|Death|0|||
48743227|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
48743228|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
48743229|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
48743230|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Death|3|||
48743231|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Death|2|||
48743232|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Death|4|||
48743233|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
48743234|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
48743235|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
48743236|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
48743237|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
48743238|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
48743239|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Other|5|||
48743240|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Other|4|||
48743241|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Other|2|||
48743242|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
48743243|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
48743244|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
48743245|NCT00256750|156910527|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
48743246|NCT00256750|156910528|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
48743247|NCT00256750|156910529|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
48743248|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
48743249|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
48743250|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
48743251|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
48743252|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
48743253|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
48743254|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Death|3|||
48743255|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Death|0|||
48743256|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Death|0|||
48743257|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
48743258|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
48743259|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
48743260|NCT00256750|156910527|FG000|Post-Transplant Treated (24 Months)|Other|2|||
48743261|NCT00256750|156910528|FG001|Post-Transplant Treated (24 Months)|Other|0|||
48743262|NCT00256750|156910529|FG002|Post-Transplant Treated (24 Months)|Other|1|||
48743263|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
48743264|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
48743265|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
48743266|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
48743267|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
48743268|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
48743269|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Death|0|||
48743270|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Death|2|||
48743271|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Death|1|||
48743272|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
48743273|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
48743274|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
48743275|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
48743276|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
48743277|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
48743278|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
48325527|NCT00229658|155389143|FG001|Overall Study|Withdrawal of consent|39|||
48325528|NCT00249769|155389144|FG000|Overall Study|Withdrawal by Subject|1|||
48325529|NCT00249769|155389145|FG001|Overall Study|Withdrawal by Subject|10|||
48325530|NCT00249769|155389146|FG002|Overall Study|Withdrawal by Subject|6|||
48325531|NCT00249769|155389144|FG000|Overall Study|Migration from Study Area|1|||
48325532|NCT00249769|155389145|FG001|Overall Study|Migration from Study Area|3|||
48325533|NCT00249769|155389146|FG002|Overall Study|Migration from Study Area|14|||
48630629|NCT03900650|156506738|FG003|Overall Study|Withdrawal by Subject|0|||
48630630|NCT03900650|156506735|FG000|Overall Study|Withdrawn by staff|1|||
48630631|NCT03900650|156506736|FG001|Overall Study|Withdrawn by staff|0|||
48630632|NCT03900650|156506737|FG002|Overall Study|Withdrawn by staff|0|||
48630633|NCT03900650|156506738|FG003|Overall Study|Withdrawn by staff|0|||
48630634|NCT02014376|156506741|FG000|Overall Study|Adverse Event|1|||
48630635|NCT02014376|156506742|FG001|Overall Study|Adverse Event|1|||
48630636|NCT02014376|156506743|FG002|Overall Study|Adverse Event|0|||
48630637|NCT02014376|156506741|FG000|Overall Study|Lost to Follow-up|2|||
48630638|NCT02014376|156506742|FG001|Overall Study|Lost to Follow-up|0|||
48630639|NCT02014376|156506743|FG002|Overall Study|Lost to Follow-up|0|||
48630640|NCT03038087|156506744|FG000|Overall Study|lost data|1|||
48630641|NCT01051661|156506745|FG000|Overall Study|Adverse Event|1|||
48630642|NCT01051661|156506746|FG001|Overall Study|Adverse Event|1|||
48630643|NCT01051661|156506747|FG002|Overall Study|Adverse Event|1|||
48630644|NCT01051661|156506748|FG003|Overall Study|Adverse Event|1|||
48630645|NCT01051661|156506749|FG004|Overall Study|Adverse Event|0|||
48630646|NCT01051661|156506750|FG005|Overall Study|Adverse Event|0|||
48630647|NCT01051661|156506745|FG000|Overall Study|Lost to Follow-up|13|||
48630648|NCT01051661|156506746|FG001|Overall Study|Lost to Follow-up|22|||
48630649|NCT01051661|156506747|FG002|Overall Study|Lost to Follow-up|15|||
48630650|NCT01051661|156506748|FG003|Overall Study|Lost to Follow-up|17|||
48630651|NCT01051661|156506749|FG004|Overall Study|Lost to Follow-up|10|||
48630652|NCT01051661|156506750|FG005|Overall Study|Lost to Follow-up|24|||
48630653|NCT01051661|156506745|FG000|Overall Study|Migrated/moved from study area|1|||
48630654|NCT01051661|156506746|FG001|Overall Study|Migrated/moved from study area|6|||
48630655|NCT01051661|156506747|FG002|Overall Study|Migrated/moved from study area|6|||
48630656|NCT01051661|156506748|FG003|Overall Study|Migrated/moved from study area|8|||
48630657|NCT01051661|156506749|FG004|Overall Study|Migrated/moved from study area|7|||
48630658|NCT01051661|156506750|FG005|Overall Study|Migrated/moved from study area|3|||
48630659|NCT01051661|156506745|FG000|Overall Study|Refused blood sampling|0|||
48630660|NCT01051661|156506746|FG001|Overall Study|Refused blood sampling|0|||
48630661|NCT01051661|156506747|FG002|Overall Study|Refused blood sampling|0|||
48630662|NCT01051661|156506748|FG003|Overall Study|Refused blood sampling|0|||
48630663|NCT01051661|156506749|FG004|Overall Study|Refused blood sampling|0|||
48630664|NCT01051661|156506750|FG005|Overall Study|Refused blood sampling|1|||
48630665|NCT01051661|156506745|FG000|Overall Study|Data not reliable|1|||
48630666|NCT01051661|156506746|FG001|Overall Study|Data not reliable|0|||
48630667|NCT01051661|156506747|FG002|Overall Study|Data not reliable|0|||
48630668|NCT01051661|156506748|FG003|Overall Study|Data not reliable|0|||
48630669|NCT01051661|156506749|FG004|Overall Study|Data not reliable|0|||
48630670|NCT01051661|156506750|FG005|Overall Study|Data not reliable|1|||
48630671|NCT01051661|156506745|FG000|Overall Study|Unable to attend visit(s)|2|||
48630672|NCT01051661|156506746|FG001|Overall Study|Unable to attend visit(s)|4|||
48630673|NCT01051661|156506747|FG002|Overall Study|Unable to attend visit(s)|2|||
48630674|NCT01051661|156506748|FG003|Overall Study|Unable to attend visit(s)|1|||
48630675|NCT01051661|156506749|FG004|Overall Study|Unable to attend visit(s)|3|||
48630676|NCT01051661|156506750|FG005|Overall Study|Unable to attend visit(s)|2|||
48630677|NCT01051661|156506745|FG000|Overall Study|Consent not received from both parents|0|||
48630678|NCT01051661|156506746|FG001|Overall Study|Consent not received from both parents|0|||
48630679|NCT01051661|156506747|FG002|Overall Study|Consent not received from both parents|0|||
48630680|NCT01051661|156506748|FG003|Overall Study|Consent not received from both parents|0|||
48630681|NCT01051661|156506749|FG004|Overall Study|Consent not received from both parents|0|||
48630682|NCT01051661|156506750|FG005|Overall Study|Consent not received from both parents|1|||
48630683|NCT01051661|156506745|FG000|Overall Study|Failure to comply with protocol|0|||
48630684|NCT01051661|156506746|FG001|Overall Study|Failure to comply with protocol|0|||
48630685|NCT01051661|156506747|FG002|Overall Study|Failure to comply with protocol|2|||
48743279|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
48743280|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
48743281|NCT00256750|156910527|FG000|Post-Transplant Treated (36 Months)|Other|0|||
48325534|NCT00249769|155389144|FG000|Overall Study|Miscellaneous|0|||
48325535|NCT00249769|155389145|FG001|Overall Study|Miscellaneous|2|||
48325536|NCT00249769|155389146|FG002|Overall Study|Miscellaneous|2|||
48325537|NCT00249769|155389144|FG000|Overall Study|Adverse Event|0|||
48325538|NCT00249769|155389145|FG001|Overall Study|Adverse Event|0|||
48325539|NCT00249769|155389146|FG002|Overall Study|Adverse Event|1|||
48325540|NCT00249769|155389144|FG000|Overall Study|Physician Decision|0|||
48630686|NCT01051661|156506748|FG003|Overall Study|Failure to comply with protocol|0|||
48630687|NCT01051661|156506749|FG004|Overall Study|Failure to comply with protocol|0|||
48630688|NCT01051661|156506750|FG005|Overall Study|Failure to comply with protocol|0|||
48630689|NCT01051661|156506745|FG000|Overall Study|Subject lost legal representation|0|||
48630690|NCT01051661|156506746|FG001|Overall Study|Subject lost legal representation|0|||
48630691|NCT01051661|156506747|FG002|Overall Study|Subject lost legal representation|0|||
48630692|NCT01051661|156506748|FG003|Overall Study|Subject lost legal representation|0|||
48325541|NCT00249769|155389145|FG001|Overall Study|Physician Decision|0|||
48630693|NCT01051661|156506749|FG004|Overall Study|Subject lost legal representation|1|||
48630694|NCT01051661|156506750|FG005|Overall Study|Subject lost legal representation|0|||
48630695|NCT01051661|156506745|FG000|Overall Study|Protocol Violation|0|||
48630696|NCT01051661|156506746|FG001|Overall Study|Protocol Violation|0|||
48630697|NCT01051661|156506747|FG002|Overall Study|Protocol Violation|0|||
48630698|NCT01051661|156506748|FG003|Overall Study|Protocol Violation|1|||
48630699|NCT01051661|156506749|FG004|Overall Study|Protocol Violation|2|||
48630700|NCT01051661|156506750|FG005|Overall Study|Protocol Violation|1|||
48630701|NCT01051661|156506745|FG000|Overall Study|Withdrawal by Subject|16|||
48630702|NCT01051661|156506746|FG001|Overall Study|Withdrawal by Subject|30|||
48630703|NCT01051661|156506747|FG002|Overall Study|Withdrawal by Subject|13|||
48630704|NCT01051661|156506748|FG003|Overall Study|Withdrawal by Subject|28|||
48630705|NCT01051661|156506749|FG004|Overall Study|Withdrawal by Subject|12|||
48630706|NCT01051661|156506750|FG005|Overall Study|Withdrawal by Subject|34|||
48630707|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
48630708|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
48630709|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
48630710|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
48630711|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
48630712|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
48630713|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
48630714|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
48630715|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
48630716|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
48630717|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
48630718|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
48630719|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
48630720|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
48630721|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
48630722|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
48630723|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
48630724|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
48630725|NCT00086515|156506751|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
48630726|NCT00086515|156506752|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
48630727|NCT00086515|156506751|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
48630728|NCT00086515|156506752|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
48630729|NCT00086515|156506751|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
48630730|NCT00086515|156506752|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
48630731|NCT00086515|156506751|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
48630732|NCT00086515|156506752|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
48630733|NCT00086515|156506751|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
48630734|NCT00086515|156506752|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
48630735|NCT00086515|156506751|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
48630736|NCT00086515|156506752|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
48630737|NCT00086515|156506751|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
48630738|NCT00086515|156506752|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
48630739|NCT00086515|156506751|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
48630740|NCT00086515|156506752|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
48630741|NCT00086515|156506751|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
48630742|NCT00086515|156506752|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
48630743|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
48630744|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
48630745|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
48630746|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
48630747|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
48630748|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
48630749|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
48630750|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
48630751|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
48630752|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
48630753|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
48743282|NCT00256750|156910528|FG001|Post-Transplant Treated (36 Months)|Other|1|||
48743283|NCT00256750|156910529|FG002|Post-Transplant Treated (36 Months)|Other|1|||
48743284|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
48743285|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
48743286|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
48743287|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
48325542|NCT00249769|155389146|FG002|Overall Study|Physician Decision|2|||
48325543|NCT00249769|155389144|FG000|Overall Study|Lost to Follow-up|0|||
48325544|NCT00249769|155389145|FG001|Overall Study|Lost to Follow-up|0|||
48325545|NCT00249769|155389146|FG002|Overall Study|Lost to Follow-up|3|||
48325546|NCT03489369|155389151|FG000|Overall Study|Documented Progressive Disease|3|||
48325547|NCT03489369|155389152|FG001|Overall Study|Documented Progressive Disease|2|||
48325548|NCT03489369|155389153|FG002|Overall Study|Documented Progressive Disease|3|||
48325549|NCT03489369|155389154|FG003|Overall Study|Documented Progressive Disease|6|||
48743288|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
48630754|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
48630755|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
48630756|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
48630757|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
48630758|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
48630759|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
48325550|NCT03489369|155389151|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
48325551|NCT03489369|155389152|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
48325552|NCT03489369|155389153|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
48325553|NCT03489369|155389154|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
48325554|NCT01170208|155389157|FG000|Overall Study|Withdrawal by Subject|5|||
48325555|NCT01170208|155389158|FG001|Overall Study|Withdrawal by Subject|0|||
48325556|NCT01170208|155389159|FG002|Overall Study|Withdrawal by Subject|1|||
48325557|NCT01170208|155389157|FG000|Overall Study|Protocol Violation|1|||
48325558|NCT01170208|155389158|FG001|Overall Study|Protocol Violation|0|||
48325559|NCT01170208|155389159|FG002|Overall Study|Protocol Violation|1|||
48325560|NCT03113409|155389160|FG000|Overall Study|Withdrawal by Subject|5|||
48325561|NCT03113409|155389161|FG001|Overall Study|Withdrawal by Subject|0|||
48325562|NCT03113409|155389162|FG002|Overall Study|Withdrawal by Subject|0|||
48325563|NCT00582972|155389163|FG000|Overall Study|Protocol Violation|2|||
48325564|NCT03355573|155389164|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
48325565|NCT03355573|155389164|FG000|Overall Study|Sponsor's decision|1|||
48325566|NCT03355573|155389164|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
48325567|NCT03355573|155389164|FG000|Overall Study|PI's decision|2|||
48325568|NCT03355573|155389164|FG000|Overall Study|Withdrawal by Subject|23|||
48325569|NCT03355573|155389164|FG000|Overall Study|Lost to Follow-up|4|||
48325570|NCT03355573|155389164|FG000|Overall Study|Lack of Efficacy|2|||
48325571|NCT03355573|155389164|FG000|Overall Study|Adverse Event, non-fatal|17|||
48325572|NCT03355573|155389164|FG000|Overall Study|Adverse Event, serious fatal|2|||
48325573|NCT01566890|155389166|FG000|Overall Study|Adverse Event|1|||
48325574|NCT01566890|155389167|FG001|Overall Study|Adverse Event|0|||
48325575|NCT01566890|155389168|FG002|Overall Study|Adverse Event|0|||
48325576|NCT01566890|155389169|FG003|Overall Study|Adverse Event|0|||
48325577|NCT01566890|155389170|FG004|Overall Study|Adverse Event|0|||
48325578|NCT01566890|155389166|FG000|Overall Study|Withdrawal by Subject|3|||
48325579|NCT01566890|155389167|FG001|Overall Study|Withdrawal by Subject|1|||
48325580|NCT01566890|155389168|FG002|Overall Study|Withdrawal by Subject|1|||
48630760|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
48630761|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
48630762|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
48630763|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
48630764|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
48630765|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
48325581|NCT01566890|155389169|FG003|Overall Study|Withdrawal by Subject|1|||
48325582|NCT01566890|155389170|FG004|Overall Study|Withdrawal by Subject|0|||
48325583|NCT01566890|155389166|FG000|Overall Study|Screen failure|6|||
48743289|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
48743290|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
48743291|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
48743292|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
48743293|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
48743294|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
48743295|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
48743296|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
48743297|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
48743298|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
48743299|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
48743300|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
48743301|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
48743302|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
48743303|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
48743304|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
48743305|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
48743306|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
48743307|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
48743308|NCT00256750|156910527|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
48743309|NCT00256750|156910528|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
48743310|NCT00256750|156910529|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
48743311|NCT02610725|156910530|FG000|Overall Study|Lost to Follow-up|197|||
48743312|NCT02610725|156910530|FG000|Overall Study|self-reported contraindication|9|||
48743313|NCT01032837|156910531|FG000|Overall Study|Adverse event/internal illness|0|||
48743314|NCT01032837|156910532|FG001|Overall Study|Adverse event/internal illness|1|||
48743315|NCT01032837|156910533|FG002|Overall Study|Adverse event/internal illness|0|||
48743316|NCT01032837|156910534|FG003|Overall Study|Adverse event/internal illness|1|||
48743317|NCT01032837|156910531|FG000|Overall Study|Withdrew consent|0|||
48743318|NCT01032837|156910532|FG001|Overall Study|Withdrew consent|2|||
48743319|NCT01032837|156910533|FG002|Overall Study|Withdrew consent|0|||
48743320|NCT01032837|156910534|FG003|Overall Study|Withdrew consent|1|||
48743321|NCT01032837|156910531|FG000|Overall Study|Failed to return|0|||
48743322|NCT01032837|156910532|FG001|Overall Study|Failed to return|0|||
48743323|NCT01032837|156910533|FG002|Overall Study|Failed to return|1|||
48743324|NCT01032837|156910534|FG003|Overall Study|Failed to return|0|||
48743325|NCT01032837|156910531|FG000|Overall Study|Refused treatment|0|||
48743326|NCT01032837|156910532|FG001|Overall Study|Refused treatment|0|||
48743327|NCT01032837|156910533|FG002|Overall Study|Refused treatment|0|||
48743328|NCT01032837|156910534|FG003|Overall Study|Refused treatment|1|||
48743329|NCT01382212|156910535|FG000|Overall Study|Kidney transplant|1|||
48743330|NCT01382212|156910535|FG000|Overall Study|Withdrew consent|1|||
48743331|NCT00743483|156910536|FG000|Baseline Period|Physician Decision|1|||
48743332|NCT00743483|156910536|FG000|Treatment Period|Adverse Event|1|||
48743333|NCT01929343|156910537|FG000|Overall Study|Physician Decision|0|||
48743334|NCT01929343|156910538|FG001|Overall Study|Physician Decision|2|||
48743335|NCT01929343|156910539|FG002|Overall Study|Physician Decision|0|||
48743336|NCT01929343|156910537|FG000|Overall Study|Withdrawal by Subject|1|||
48743337|NCT01929343|156910538|FG001|Overall Study|Withdrawal by Subject|0|||
48743338|NCT01929343|156910539|FG002|Overall Study|Withdrawal by Subject|0|||
48743339|NCT03715530|156910540|FG000|Overall Study|Lost to Follow-up|3|||
48743340|NCT03715530|156910541|FG001|Overall Study|Lost to Follow-up|1|||
48743341|NCT03715530|156910542|FG002|Overall Study|Lost to Follow-up|2|||
48743342|NCT00211510|156910548|FG000|Overall Study|Physician Decision|3|||
48743343|NCT00211510|156910549|FG001|Overall Study|Physician Decision|1|||
48743344|NCT00211510|156910548|FG000|Overall Study|Withdrawal by Subject|3|||
48743345|NCT00211510|156910549|FG001|Overall Study|Withdrawal by Subject|1|||
48743346|NCT00833794|156910553|FG000|Open-label Phase|Adverse Event|225|||
48743347|NCT00833794|156910554|FG001|Open-label Phase|Adverse Event|0|||
48743348|NCT00833794|156910553|FG000|Open-label Phase|Lack of Efficacy|28|||
48743349|NCT00833794|156910554|FG001|Open-label Phase|Lack of Efficacy|0|||
48743350|NCT00833794|156910553|FG000|Open-label Phase|Withdrawal by Subject|48|||
48743351|NCT00833794|156910554|FG001|Open-label Phase|Withdrawal by Subject|0|||
48743352|NCT00833794|156910553|FG000|Open-label Phase|Physician Decision|20|||
48743353|NCT00833794|156910554|FG001|Open-label Phase|Physician Decision|0|||
48743354|NCT00833794|156910553|FG000|Open-label Phase|Administrative reason|1|||
48743355|NCT00833794|156910554|FG001|Open-label Phase|Administrative reason|0|||
48743356|NCT00833794|156910553|FG000|Open-label Phase|Protocol Violation|47|||
48743357|NCT00833794|156910554|FG001|Open-label Phase|Protocol Violation|0|||
48743358|NCT00833794|156910553|FG000|Open-label Phase|Did not complete wash-out period|12|||
48743359|NCT00833794|156910554|FG001|Open-label Phase|Did not complete wash-out period|0|||
48630766|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
48630767|NCT00086515|156506751|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
48630768|NCT00086515|156506752|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
48630769|NCT00209131|156506753|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
48630770|NCT00209131|156506754|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
48630771|NCT03770286|156506769|FG000|Overall Study|Lost to Follow-up|6|||
48630772|NCT03770286|156506770|FG001|Overall Study|Lost to Follow-up|4|||
48630773|NCT03770286|156506771|FG002|Overall Study|Lost to Follow-up|3|||
48630774|NCT03770286|156506769|FG000|Overall Study|Protocol Violation|1|||
48743360|NCT00833794|156910553|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
48743361|NCT00833794|156910554|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
48743362|NCT00833794|156910553|FG000|Double-blind Phase|Adverse Event|44|||
48743363|NCT00833794|156910554|FG001|Double-blind Phase|Adverse Event|11|||
48743364|NCT00833794|156910553|FG000|Double-blind Phase|Lack of Efficacy|34|||
48743365|NCT00833794|156910554|FG001|Double-blind Phase|Lack of Efficacy|22|||
48743366|NCT00833794|156910553|FG000|Double-blind Phase|Withdrawal by Subject|23|||
48743367|NCT00833794|156910554|FG001|Double-blind Phase|Withdrawal by Subject|6|||
48743368|NCT00833794|156910553|FG000|Double-blind Phase|Physician Decision|4|||
48743369|NCT00833794|156910554|FG001|Double-blind Phase|Physician Decision|7|||
48743370|NCT00833794|156910553|FG000|Double-blind Phase|Administrative reason|1|||
48743371|NCT00833794|156910554|FG001|Double-blind Phase|Administrative reason|3|||
48743372|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
48743373|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
48743374|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
48743375|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743376|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743377|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743378|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743379|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743380|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743381|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743382|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
48743383|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
48743384|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743385|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
48743386|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743387|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743388|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743389|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743390|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743391|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743392|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743393|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
48743394|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
48743395|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
48743396|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
48743397|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743398|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743399|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743400|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743401|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743402|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743403|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743404|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
48743405|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
48743406|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
48743407|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743408|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743409|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48630775|NCT03770286|156506770|FG001|Overall Study|Protocol Violation|0|||
48630776|NCT03770286|156506771|FG002|Overall Study|Protocol Violation|2|||
48743410|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743411|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743412|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743413|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743414|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743415|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
48743416|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
48743417|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
48743418|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
48743419|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743420|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48325584|NCT01566890|155389167|FG001|Overall Study|Screen failure|0|||
48325585|NCT01566890|155389168|FG002|Overall Study|Screen failure|1|||
48325586|NCT01566890|155389169|FG003|Overall Study|Screen failure|1|||
48325587|NCT01566890|155389170|FG004|Overall Study|Screen failure|0|||
48325588|NCT01566890|155389166|FG000|Overall Study|Incomplete CEU data|1|||
48325589|NCT01566890|155389167|FG001|Overall Study|Incomplete CEU data|3|||
48325590|NCT01566890|155389168|FG002|Overall Study|Incomplete CEU data|5|||
48325591|NCT01566890|155389169|FG003|Overall Study|Incomplete CEU data|8|||
48325592|NCT01566890|155389170|FG004|Overall Study|Incomplete CEU data|0|||
48630777|NCT03204812|156506774|FG000|Overall Study|Adverse Event|3|||
48630778|NCT04197583|156506776|FG000|Overall Study|Study Stent Replacement|34|||
48630779|NCT04197583|156506777|FG001|Overall Study|Study Stent Replacement|8|||
48630780|NCT04197583|156506776|FG000|Overall Study|Lost to Follow-up|14|||
48630781|NCT04197583|156506777|FG001|Overall Study|Lost to Follow-up|3|||
48630782|NCT04197583|156506776|FG000|Overall Study|Death|3|||
48630783|NCT04197583|156506777|FG001|Overall Study|Death|0|||
48630784|NCT04197583|156506776|FG000|Overall Study|Physician Decision|1|||
48630785|NCT04197583|156506777|FG001|Overall Study|Physician Decision|0|||
48630786|NCT04197583|156506776|FG000|Overall Study|Withdrawal by Subject|1|||
48630787|NCT04197583|156506777|FG001|Overall Study|Withdrawal by Subject|1|||
48630788|NCT04197583|156506776|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
48630789|NCT04197583|156506777|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
48630790|NCT04197583|156506776|FG000|Overall Study|Screen Failure|0|||
48630791|NCT04197583|156506777|FG001|Overall Study|Screen Failure|20|||
48630792|NCT04629196|156506778|FG000|Overall Study|Subject discontinued study drug|1|||
48630793|NCT04629196|156506779|FG001|Overall Study|Subject discontinued study drug|0|||
48630794|NCT04629196|156506778|FG000|Overall Study|Subject study drug dosing increased|1|||
48630795|NCT04629196|156506779|FG001|Overall Study|Subject study drug dosing increased|1|||
48630796|NCT04629196|156506778|FG000|Overall Study|Withdrawal by Subject|1|||
48630797|NCT04629196|156506779|FG001|Overall Study|Withdrawal by Subject|2|||
48630798|NCT00323622|156506786|FG000|Overall Study|Other|30|||
48630799|NCT00323622|156506787|FG001|Overall Study|Other|91|||
48630800|NCT00323622|156506788|FG002|Overall Study|Other|4|||
48630801|NCT00323622|156506789|FG003|Overall Study|Other|12|||
48630802|NCT00323622|156506790|FG004|Overall Study|Other|32|||
48630803|NCT00323622|156506791|FG005|Overall Study|Other|74|||
48630804|NCT00323622|156506792|FG006|Overall Study|Other|5|||
48630805|NCT00323622|156506793|FG007|Overall Study|Other|13|||
48630806|NCT00323622|156506786|FG000|Overall Study|Death|1|||
48630807|NCT00323622|156506787|FG001|Overall Study|Death|1|||
48630808|NCT00323622|156506788|FG002|Overall Study|Death|0|||
48630809|NCT00323622|156506789|FG003|Overall Study|Death|0|||
48630810|NCT00323622|156506790|FG004|Overall Study|Death|7|||
48630811|NCT00323622|156506791|FG005|Overall Study|Death|0|||
48630812|NCT00323622|156506792|FG006|Overall Study|Death|0|||
48630813|NCT00323622|156506793|FG007|Overall Study|Death|2|||
48630814|NCT05646355|156506801|FG000|Overall Study|Lost to Follow-up|1|||
48630815|NCT05646355|156506802|FG001|Overall Study|Lost to Follow-up|0|||
48630816|NCT05646355|156506801|FG000|Overall Study|translated materials not available for pilot|2|||
48630817|NCT05646355|156506802|FG001|Overall Study|translated materials not available for pilot|0|||
48630818|NCT05646355|156506801|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
48630819|NCT05646355|156506802|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
48630820|NCT03110562|156506803|FG000|Initial Treatment Period|Disease Progression|1|||
48630821|NCT03110562|156506804|FG001|Initial Treatment Period|Disease Progression|1|||
48630822|NCT03110562|156506805|FG002|Initial Treatment Period|Disease Progression|0|||
48630823|NCT03110562|156506806|FG003|Initial Treatment Period|Disease Progression|0|||
48743421|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743422|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743423|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743424|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743425|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743426|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
48743427|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743428|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
48743429|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
48630824|NCT03110562|156506803|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
48630825|NCT03110562|156506804|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
48743430|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48630826|NCT03110562|156506805|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
48630827|NCT03110562|156506806|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
48630828|NCT03110562|156506803|FG000|Initial Treatment Period|Adverse Event|1|||
48630829|NCT03110562|156506804|FG001|Initial Treatment Period|Adverse Event|0|||
48630830|NCT03110562|156506805|FG002|Initial Treatment Period|Adverse Event|0|||
48630831|NCT03110562|156506806|FG003|Initial Treatment Period|Adverse Event|0|||
48630832|NCT03110562|156506803|FG000|Initial Treatment Period|Death|74|||
48630833|NCT03110562|156506804|FG001|Initial Treatment Period|Death|82|||
48630834|NCT03110562|156506805|FG002|Initial Treatment Period|Death|0|||
48630835|NCT03110562|156506806|FG003|Initial Treatment Period|Death|0|||
48630836|NCT03110562|156506803|FG000|Initial Treatment Period|Lost to Follow-up|13|||
48630837|NCT03110562|156506804|FG001|Initial Treatment Period|Lost to Follow-up|8|||
48630838|NCT03110562|156506805|FG002|Initial Treatment Period|Lost to Follow-up|0|||
48630839|NCT03110562|156506806|FG003|Initial Treatment Period|Lost to Follow-up|0|||
48630840|NCT03110562|156506803|FG000|Initial Treatment Period|Protocol Deviation|1|||
48630841|NCT03110562|156506804|FG001|Initial Treatment Period|Protocol Deviation|0|||
48630842|NCT03110562|156506805|FG002|Initial Treatment Period|Protocol Deviation|0|||
48630843|NCT03110562|156506806|FG003|Initial Treatment Period|Protocol Deviation|0|||
48630844|NCT03110562|156506803|FG000|Initial Treatment Period|Physician Decision|2|||
48630845|NCT03110562|156506804|FG001|Initial Treatment Period|Physician Decision|1|||
48630846|NCT03110562|156506805|FG002|Initial Treatment Period|Physician Decision|0|||
48630847|NCT03110562|156506806|FG003|Initial Treatment Period|Physician Decision|0|||
48630848|NCT03110562|156506803|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
48630849|NCT03110562|156506804|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
48630850|NCT03110562|156506805|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
48630851|NCT03110562|156506806|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
48630852|NCT03110562|156506803|FG000|Initial Treatment Period|Other|5|||
48630853|NCT03110562|156506804|FG001|Initial Treatment Period|Other|4|||
48630854|NCT03110562|156506805|FG002|Initial Treatment Period|Other|0|||
48630855|NCT03110562|156506806|FG003|Initial Treatment Period|Other|0|||
48630856|NCT03110562|156506803|FG000|Initial Treatment Period|Randomized but never treated|0|||
48630857|NCT03110562|156506804|FG001|Initial Treatment Period|Randomized but never treated|3|||
48630858|NCT03110562|156506805|FG002|Initial Treatment Period|Randomized but never treated|0|||
48630859|NCT03110562|156506806|FG003|Initial Treatment Period|Randomized but never treated|0|||
48630860|NCT03110562|156506803|FG000|Crossover Period|Disease Progression|0|||
48630861|NCT03110562|156506804|FG001|Crossover Period|Disease Progression|0|||
48630862|NCT03110562|156506805|FG002|Crossover Period|Disease Progression|1|||
48630863|NCT03110562|156506806|FG003|Crossover Period|Disease Progression|0|||
48630864|NCT03110562|156506803|FG000|Crossover Period|Withdrawal by Subject|0|||
48630865|NCT03110562|156506804|FG001|Crossover Period|Withdrawal by Subject|0|||
48630866|NCT03110562|156506805|FG002|Crossover Period|Withdrawal by Subject|8|||
48630867|NCT03110562|156506806|FG003|Crossover Period|Withdrawal by Subject|6|||
48630868|NCT03110562|156506803|FG000|Crossover Period|Death|0|||
48630869|NCT03110562|156506804|FG001|Crossover Period|Death|0|||
48630870|NCT03110562|156506805|FG002|Crossover Period|Death|37|||
48630871|NCT03110562|156506806|FG003|Crossover Period|Death|3|||
48630872|NCT03110562|156506803|FG000|Crossover Period|Lost to Follow-up|0|||
48630873|NCT03110562|156506804|FG001|Crossover Period|Lost to Follow-up|0|||
48630874|NCT03110562|156506805|FG002|Crossover Period|Lost to Follow-up|0|||
48630875|NCT03110562|156506806|FG003|Crossover Period|Lost to Follow-up|1|||
48630876|NCT03110562|156506803|FG000|Crossover Period|Other|0|||
48630877|NCT03110562|156506804|FG001|Crossover Period|Other|0|||
48630878|NCT03110562|156506805|FG002|Crossover Period|Other|1|||
48630879|NCT03110562|156506806|FG003|Crossover Period|Other|1|||
48630880|NCT03110562|156506803|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
48630881|NCT03110562|156506804|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
48630882|NCT03110562|156506805|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
48630883|NCT03110562|156506806|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
48630884|NCT01111552|156506807|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
48630885|NCT01111552|156506808|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48630886|NCT01111552|156506809|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48630887|NCT01111552|156506810|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48630888|NCT01111552|156506811|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48630889|NCT01111552|156506807|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
48630890|NCT01111552|156506808|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48743431|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743432|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743433|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743434|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743435|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743436|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743437|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
48743438|NCT02207244|156910555|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743439|NCT02207244|156910556|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
48743440|NCT02207244|156910557|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743441|NCT02207244|156910558|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743442|NCT02207244|156910559|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743443|NCT02207244|156910560|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743444|NCT02207244|156910561|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743445|NCT02207244|156910562|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743446|NCT02207244|156910563|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743447|NCT02207244|156910564|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743448|NCT02207244|156910565|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
48743449|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743450|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743451|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743452|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743453|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
48743454|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
48743455|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743456|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743457|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743458|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743459|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
48743460|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743461|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743462|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743463|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743464|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743465|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
48743466|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743467|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743468|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743469|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743470|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
48743471|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743472|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743473|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743474|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
48743475|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
48743476|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
48743477|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743478|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743479|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743480|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743481|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
48743482|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743483|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743484|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743485|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
48743486|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
48743487|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
48743488|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743489|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743490|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743491|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743492|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
48743493|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743494|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48325593|NCT01566890|155389166|FG000|Overall Study|Lost to Follow-up|0|||
48743495|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743496|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
48743497|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743498|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
48743499|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743500|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743501|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743502|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743503|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
48743504|NCT02207244|156910555|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743505|NCT02207244|156910556|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743506|NCT02207244|156910557|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743507|NCT02207244|156910558|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
48743508|NCT02207244|156910559|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743509|NCT02207244|156910560|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743510|NCT02207244|156910561|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
48325594|NCT01566890|155389167|FG001|Overall Study|Lost to Follow-up|0|||
48325595|NCT01566890|155389168|FG002|Overall Study|Lost to Follow-up|4|||
48325596|NCT01566890|155389169|FG003|Overall Study|Lost to Follow-up|4|||
48325597|NCT01566890|155389170|FG004|Overall Study|Lost to Follow-up|0|||
48325598|NCT01566890|155389166|FG000|Overall Study|Other|0|||
48325599|NCT01566890|155389167|FG001|Overall Study|Other|0|||
48325600|NCT01566890|155389168|FG002|Overall Study|Other|0|||
48325601|NCT01566890|155389169|FG003|Overall Study|Other|0|||
48325602|NCT01566890|155389170|FG004|Overall Study|Other|7|||
48325603|NCT04638816|155389171|FG000|Overall Study|Withdrawal by Subject|0|||
48630891|NCT01111552|156506809|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48630892|NCT01111552|156506810|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48630893|NCT01111552|156506811|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48630894|NCT01111552|156506807|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
48630895|NCT01111552|156506808|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48630896|NCT01111552|156506809|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48630897|NCT01111552|156506810|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48630898|NCT01111552|156506811|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48630899|NCT01111552|156506807|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
48630900|NCT01111552|156506808|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
48630901|NCT01111552|156506809|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
48630902|NCT01111552|156506810|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
48630903|NCT01111552|156506811|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
48630904|NCT01111552|156506807|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
48630905|NCT01111552|156506808|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
48630906|NCT01111552|156506809|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
48630907|NCT01111552|156506810|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
48630908|NCT01111552|156506811|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
48630909|NCT01111552|156506807|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
48630910|NCT01111552|156506808|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
48630911|NCT01111552|156506809|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
48630912|NCT01111552|156506810|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
48630913|NCT01111552|156506811|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
48630914|NCT01111552|156506807|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
48630915|NCT01111552|156506808|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48630916|NCT01111552|156506809|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48630917|NCT01111552|156506810|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48630918|NCT01111552|156506811|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48630919|NCT01111552|156506807|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
48630920|NCT01111552|156506808|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
48630921|NCT01111552|156506809|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
48630922|NCT01111552|156506810|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
48630923|NCT01111552|156506811|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
48630924|NCT01111552|156506807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48630925|NCT01111552|156506808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48630926|NCT01111552|156506809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48630927|NCT01111552|156506810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
48630928|NCT01111552|156506811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48630929|NCT01111552|156506807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
48630930|NCT01111552|156506808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
48630931|NCT01111552|156506809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
48743511|NCT02207244|156910562|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743512|NCT02207244|156910563|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743513|NCT02207244|156910564|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743514|NCT02207244|156910565|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
48743515|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743516|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743517|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743518|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743519|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48325604|NCT04638816|155389172|FG001|Overall Study|Withdrawal by Subject|1|||
48325605|NCT04638816|155389171|FG000|Overall Study|Lost to Follow-up|0|||
48325606|NCT04638816|155389172|FG001|Overall Study|Lost to Follow-up|1|||
48325607|NCT00879710|155389177|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
48325608|NCT00879710|155389178|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
48325609|NCT00879710|155389179|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
48630932|NCT01111552|156506810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
48630933|NCT01111552|156506811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
48630934|NCT01111552|156506807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
48630935|NCT01111552|156506808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
48630936|NCT01111552|156506809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
48630937|NCT01111552|156506810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
48630938|NCT01111552|156506811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
48630939|NCT01111552|156506807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
48630940|NCT01111552|156506808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
48630941|NCT01111552|156506809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
48630942|NCT01111552|156506810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
48630943|NCT01111552|156506811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
48630944|NCT01111552|156506807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
48630945|NCT01111552|156506808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
48630946|NCT01111552|156506809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
48630947|NCT01111552|156506810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
48630948|NCT01111552|156506811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
48630949|NCT01111552|156506807|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48630950|NCT01111552|156506808|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48630951|NCT01111552|156506809|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
48630952|NCT01111552|156506810|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48630953|NCT01111552|156506811|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48630954|NCT03926130|156506812|FG000|Overall Study|Adverse Event|9|||
48630955|NCT03926130|156506813|FG001|Overall Study|Adverse Event|11|||
48325610|NCT00879710|155389180|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
48325611|NCT00879710|155389177|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
48630956|NCT03926130|156506814|FG002|Overall Study|Adverse Event|2|||
48630957|NCT03926130|156506815|FG003|Overall Study|Adverse Event|0|||
48630958|NCT03926130|156506812|FG000|Overall Study|Death|2|||
48630959|NCT03926130|156506813|FG001|Overall Study|Death|0|||
48630960|NCT03926130|156506814|FG002|Overall Study|Death|1|||
48630961|NCT03926130|156506815|FG003|Overall Study|Death|0|||
48325612|NCT00879710|155389178|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
48743520|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743521|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
48743522|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
48743523|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
48743524|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
48743525|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
48743526|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743527|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743528|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743529|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743530|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743531|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743532|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743533|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
48743534|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743535|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743536|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
48743537|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743538|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743539|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743540|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743541|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743542|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743543|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
48743544|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
48743545|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
48743546|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
48743547|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
48743548|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48630962|NCT03926130|156506812|FG000|Overall Study|Lack of Efficacy|14|||
48630963|NCT03926130|156506813|FG001|Overall Study|Lack of Efficacy|11|||
48630964|NCT03926130|156506814|FG002|Overall Study|Lack of Efficacy|7|||
48630965|NCT03926130|156506815|FG003|Overall Study|Lack of Efficacy|1|||
48630966|NCT03926130|156506812|FG000|Overall Study|Lost to Follow-up|0|||
48630967|NCT03926130|156506813|FG001|Overall Study|Lost to Follow-up|7|||
48630968|NCT03926130|156506814|FG002|Overall Study|Lost to Follow-up|1|||
48630969|NCT03926130|156506815|FG003|Overall Study|Lost to Follow-up|0|||
48630970|NCT03926130|156506812|FG000|Overall Study|As Reported by Investigator|2|||
48630971|NCT03926130|156506813|FG001|Overall Study|As Reported by Investigator|6|||
48630972|NCT03926130|156506814|FG002|Overall Study|As Reported by Investigator|6|||
48630973|NCT03926130|156506815|FG003|Overall Study|As Reported by Investigator|0|||
48630974|NCT03926130|156506812|FG000|Overall Study|Physician Decision|3|||
48630975|NCT03926130|156506813|FG001|Overall Study|Physician Decision|2|||
48630976|NCT03926130|156506814|FG002|Overall Study|Physician Decision|1|||
48630977|NCT03926130|156506815|FG003|Overall Study|Physician Decision|0|||
48630978|NCT03926130|156506812|FG000|Overall Study|Pregnancy|2|||
48630979|NCT03926130|156506813|FG001|Overall Study|Pregnancy|2|||
48630980|NCT03926130|156506814|FG002|Overall Study|Pregnancy|1|||
48630981|NCT03926130|156506815|FG003|Overall Study|Pregnancy|0|||
48630982|NCT03926130|156506812|FG000|Overall Study|Withdrawal by Subject|20|||
48630983|NCT03926130|156506813|FG001|Overall Study|Withdrawal by Subject|28|||
48630984|NCT03926130|156506814|FG002|Overall Study|Withdrawal by Subject|18|||
48630985|NCT03926130|156506815|FG003|Overall Study|Withdrawal by Subject|1|||
48630986|NCT03926130|156506812|FG000|Overall Study|Non-Compliance|1|||
48630987|NCT03926130|156506813|FG001|Overall Study|Non-Compliance|1|||
48630988|NCT03926130|156506814|FG002|Overall Study|Non-Compliance|0|||
48630989|NCT03926130|156506815|FG003|Overall Study|Non-Compliance|0|||
48630990|NCT03926130|156506812|FG000|Overall Study|Disposition Not Captured|0|||
48630991|NCT03926130|156506813|FG001|Overall Study|Disposition Not Captured|2|||
48630992|NCT03926130|156506814|FG002|Overall Study|Disposition Not Captured|1|||
48630993|NCT03926130|156506815|FG003|Overall Study|Disposition Not Captured|0|||
48743549|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48630994|NCT01969058|156506816|FG000|Overall Study|Withdrawal by Subject|2|||
48630995|NCT01969058|156506817|FG001|Overall Study|Withdrawal by Subject|0|||
48630996|NCT01969058|156506816|FG000|Overall Study|Adverse Event|1|||
48630997|NCT01969058|156506817|FG001|Overall Study|Adverse Event|0|||
48630998|NCT03913130|156506818|FG000|Overall Study|Sponsor Decision|1|||
48630999|NCT01587196|156506819|FG000|Overall Study|Lost to Follow-up|50|||
48325613|NCT00879710|155389179|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
48325614|NCT00879710|155389180|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
48631000|NCT01587196|156506819|FG000|Overall Study|Withdrawal by Subject|4|||
48631001|NCT01355627|156506821|FG000|Overall Study|Request By the Patient to Discontinue|5|||
48325615|NCT00293397|155389183|FG000|Overall Study|Death|2|||
48743550|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743551|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743552|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743553|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743554|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
48743555|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
48743556|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743557|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
48743558|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
48743559|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743560|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743561|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743562|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743563|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743564|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743565|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
48743566|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
48743567|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
48743568|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
48743569|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
48743570|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743571|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743572|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743573|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743574|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743575|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743576|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743577|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
48631002|NCT01355627|156506822|FG001|Overall Study|Request By the Patient to Discontinue|7|||
48631003|NCT01355627|156506821|FG000|Overall Study|Lost to Follow-up|8|||
48631004|NCT01355627|156506822|FG001|Overall Study|Lost to Follow-up|7|||
48631005|NCT01355627|156506821|FG000|Overall Study|Fatal Adverse Event|19|||
48631006|NCT01355627|156506822|FG001|Overall Study|Fatal Adverse Event|23|||
48631007|NCT01355627|156506821|FG000|Overall Study|Other|1|||
48631008|NCT01355627|156506822|FG001|Overall Study|Other|1|||
48631009|NCT02022202|156506823|FG000|Overall Study|Withdrawal by Subject|2|||
48631010|NCT02022202|156506823|FG000|Overall Study|Disease Progression|3|||
48631011|NCT02022202|156506823|FG000|Overall Study|Desire go to immediately to surgery|3|||
48631012|NCT00642759|156506825|FG000|Overall Study|Protocol Violation|1|||
48631013|NCT02038036|156506830|FG000|Core Study|Adverse Event|7|||
48631014|NCT02038036|156506831|FG001|Core Study|Adverse Event|7|||
48631015|NCT02038036|156506830|FG000|Core Study|Death|1|||
48631016|NCT02038036|156506831|FG001|Core Study|Death|1|||
48631017|NCT02038036|156506830|FG000|Core Study|Disease progression|2|||
48631018|NCT02038036|156506831|FG001|Core Study|Disease progression|2|||
48631019|NCT02038036|156506830|FG000|Core Study|Lost to Follow-up|0|||
48631020|NCT02038036|156506831|FG001|Core Study|Lost to Follow-up|1|||
48631021|NCT02038036|156506830|FG000|Core Study|Physician Decision|2|||
48631022|NCT02038036|156506831|FG001|Core Study|Physician Decision|1|||
48631023|NCT02038036|156506830|FG000|Core Study|Subject/guardian decision|0|||
48631024|NCT02038036|156506831|FG001|Core Study|Subject/guardian decision|1|||
48631025|NCT02038036|156506830|FG000|Core Study|Withdrawal by Subject|3|||
48631026|NCT02038036|156506831|FG001|Core Study|Withdrawal by Subject|1|||
48631027|NCT02038036|156506830|FG000|Crossover Period|Withdrawal by Subject|0|||
48631028|NCT02038036|156506831|FG001|Crossover Period|Withdrawal by Subject|3|||
48631029|NCT02038036|156506830|FG000|Crossover Period|Adverse Event|0|||
48631030|NCT02038036|156506831|FG001|Crossover Period|Adverse Event|9|||
48631031|NCT02038036|156506830|FG000|Crossover Period|Death|0|||
48631032|NCT02038036|156506831|FG001|Crossover Period|Death|2|||
48631033|NCT02038036|156506830|FG000|Crossover Period|Disease progression|0|||
48631034|NCT02038036|156506831|FG001|Crossover Period|Disease progression|3|||
48631035|NCT02038036|156506830|FG000|Crossover Period|Lost to Follow-up|0|||
48743578|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
48743579|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743580|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
48743581|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743582|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743583|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743584|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743585|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743586|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743587|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743588|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743589|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
48743590|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743591|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
48743592|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743593|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743594|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743595|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743596|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743597|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743598|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743599|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
48743600|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743601|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743602|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
48743603|NCT02207244|156910555|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743604|NCT02207244|156910556|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743605|NCT02207244|156910557|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743606|NCT02207244|156910558|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743607|NCT02207244|156910559|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743608|NCT02207244|156910560|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743609|NCT02207244|156910561|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
48743610|NCT02207244|156910562|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743611|NCT02207244|156910563|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743612|NCT02207244|156910564|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743613|NCT02207244|156910565|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
48743614|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743615|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743616|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743617|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743618|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743619|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743620|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743621|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743622|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
48743623|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
48743624|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
48743625|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743626|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743627|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743628|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48631036|NCT02038036|156506831|FG001|Crossover Period|Lost to Follow-up|1|||
48631037|NCT02038036|156506830|FG000|Crossover Period|Physician Decision|0|||
48631038|NCT02038036|156506831|FG001|Crossover Period|Physician Decision|2|||
48631039|NCT04756531|156506832|FG000|Overall Study|Adverse Event|0|||
48631040|NCT04756531|156506833|FG001|Overall Study|Adverse Event|0|||
48631041|NCT04756531|156506834|FG002|Overall Study|Adverse Event|0|||
48631042|NCT04756531|156506835|FG003|Overall Study|Adverse Event|0|||
48631043|NCT04756531|156506836|FG004|Overall Study|Adverse Event|1|||
48631044|NCT04756531|156506837|FG005|Overall Study|Adverse Event|0|||
48631045|NCT04756531|156506838|FG006|Overall Study|Adverse Event|0|||
48631046|NCT04756531|156506839|FG007|Overall Study|Adverse Event|0|||
48631047|NCT04756531|156506840|FG008|Overall Study|Adverse Event|0|||
48631048|NCT04756531|156506841|FG009|Overall Study|Adverse Event|0|||
48743629|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743630|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743631|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743632|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743633|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
48743634|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
48743635|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
48743636|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743637|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743638|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743639|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743640|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743641|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743642|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743643|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743644|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
48743645|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
48743646|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
48743647|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743648|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743649|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743650|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743651|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743652|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743653|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743654|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743655|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
48743656|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
48743657|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
48743658|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
48743659|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
48743660|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
48743661|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
48743662|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
48743663|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
48325616|NCT01211184|155389185|FG000|Overall Study|Withdrawal by Subject|0|||
48325617|NCT01211184|155389186|FG001|Overall Study|Withdrawal by Subject|2|||
48325618|NCT01211184|155389187|FG002|Overall Study|Withdrawal by Subject|1|||
48325619|NCT01759862|155389188|FG000|Overall Study|Physician Decision|3|||
48631049|NCT04756531|156506842|FG010|Overall Study|Adverse Event|0|||
48631050|NCT04756531|156506843|FG011|Overall Study|Adverse Event|0|||
48631051|NCT04756531|156506844|FG012|Overall Study|Adverse Event|0|||
48631052|NCT04756531|156506845|FG013|Overall Study|Adverse Event|0|||
48631053|NCT04756531|156506846|FG014|Overall Study|Adverse Event|0|||
48631054|NCT04756531|156506847|FG015|Overall Study|Adverse Event|0|||
48631055|NCT04756531|156506848|FG016|Overall Study|Adverse Event|0|||
48631056|NCT04756531|156506849|FG017|Overall Study|Adverse Event|0|||
48631057|NCT04756531|156506832|FG000|Overall Study|Withdrawal by Subject|0|||
48631058|NCT04756531|156506833|FG001|Overall Study|Withdrawal by Subject|0|||
48631059|NCT04756531|156506834|FG002|Overall Study|Withdrawal by Subject|0|||
48631060|NCT04756531|156506835|FG003|Overall Study|Withdrawal by Subject|0|||
48631061|NCT04756531|156506836|FG004|Overall Study|Withdrawal by Subject|0|||
48631062|NCT04756531|156506837|FG005|Overall Study|Withdrawal by Subject|0|||
48631063|NCT04756531|156506838|FG006|Overall Study|Withdrawal by Subject|1|||
48631064|NCT04756531|156506839|FG007|Overall Study|Withdrawal by Subject|0|||
48631065|NCT04756531|156506840|FG008|Overall Study|Withdrawal by Subject|0|||
48631066|NCT04756531|156506841|FG009|Overall Study|Withdrawal by Subject|0|||
48631067|NCT04756531|156506842|FG010|Overall Study|Withdrawal by Subject|0|||
48631068|NCT04756531|156506843|FG011|Overall Study|Withdrawal by Subject|0|||
48631069|NCT04756531|156506844|FG012|Overall Study|Withdrawal by Subject|0|||
48631070|NCT04756531|156506845|FG013|Overall Study|Withdrawal by Subject|0|||
48631071|NCT04756531|156506846|FG014|Overall Study|Withdrawal by Subject|0|||
48631072|NCT04756531|156506847|FG015|Overall Study|Withdrawal by Subject|0|||
48631073|NCT04756531|156506848|FG016|Overall Study|Withdrawal by Subject|0|||
48631074|NCT04756531|156506849|FG017|Overall Study|Withdrawal by Subject|0|||
48631075|NCT04704193|156506852|FG000|Overall Study|Withdrawal by Subject|1|||
48631076|NCT04144517|156506853|FG000|Overall Study|Physician Decision|0|||
48631077|NCT04144517|156506854|FG001|Overall Study|Physician Decision|1|||
48631078|NCT04144517|156506853|FG000|Overall Study|Other|2|||
48631079|NCT04144517|156506854|FG001|Overall Study|Other|2|||
48631080|NCT04144517|156506853|FG000|Overall Study|Death|6|||
48631081|NCT04144517|156506854|FG001|Overall Study|Death|3|||
48631082|NCT03814044|156506859|FG000|Overall Study|Protocol deviation|1|||
48631083|NCT00381641|156506864|FG000|Overall Study|Withdrawal by Subject|0|||
48631084|NCT00381641|156506865|FG001|Overall Study|Withdrawal by Subject|2|||
48631085|NCT04890509|156506866|FG000|Overall Study|Death|4|||
48631086|NCT04890509|156506867|FG001|Overall Study|Death|4|||
48631087|NCT05788991|156506868|FG000|Overall Study|Not treated with study medication|1|||
48631088|NCT05788991|156506869|FG001|Overall Study|Not treated with study medication|3|||
48631089|NCT05788991|156506868|FG000|Overall Study|Withdrawal by Subject|1|||
48631090|NCT05788991|156506869|FG001|Overall Study|Withdrawal by Subject|0|||
48631091|NCT05788991|156506868|FG000|Overall Study|Lack of Efficacy|0|||
48631092|NCT05788991|156506869|FG001|Overall Study|Lack of Efficacy|1|||
48631093|NCT05788991|156506868|FG000|Overall Study|Protocol Violation|1|||
48631094|NCT05788991|156506869|FG001|Overall Study|Protocol Violation|2|||
48631095|NCT03802396|156506870|FG000|Overall Study|Withdrawal by Subject|2|||
48631096|NCT03802396|156506871|FG001|Overall Study|Withdrawal by Subject|0|||
48631097|NCT03802396|156506870|FG000|Overall Study|Surgery Cancelled|1|||
48631098|NCT03802396|156506871|FG001|Overall Study|Surgery Cancelled|0|||
48631099|NCT00939185|156507990|FG000|Overall Study|Adverse Event|3|||
48631100|NCT00939185|156507990|FG000|Overall Study|Lack of Efficacy|1|||
48631101|NCT00939185|156507990|FG000|Overall Study|Lost to Follow-up|6|||
48631102|NCT00939185|156507990|FG000|Overall Study|Other|3|||
48631103|NCT00939185|156507990|FG000|Overall Study|Withdrawal by Subject|2|||
48631104|NCT00939185|156507990|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
48631105|NCT00363298|156507991|FG000|First Study Week|Lack of Efficacy|6|||
48631106|NCT00363298|156507992|FG001|First Study Week|Lack of Efficacy|5|||
48631107|NCT00363298|156507991|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
48631108|NCT00363298|156507992|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
48631109|NCT03552029|156507994|FG000|Overall Study|Death|3|||
48631110|NCT03552029|156507995|FG001|Overall Study|Death|0|||
48631111|NCT03552029|156507994|FG000|Overall Study|Adverse Event|1|||
48631112|NCT03552029|156507995|FG001|Overall Study|Adverse Event|0|||
48631113|NCT03552029|156507994|FG000|Overall Study|Lack of Efficacy|0|||
48631114|NCT03552029|156507995|FG001|Overall Study|Lack of Efficacy|2|||
48631115|NCT03552029|156507994|FG000|Overall Study|Physician Decision|0|||
48631116|NCT03552029|156507995|FG001|Overall Study|Physician Decision|1|||
48631117|NCT03552029|156507994|FG000|Overall Study|Study terminated by Sponsor|0|||
48631118|NCT03552029|156507995|FG001|Overall Study|Study terminated by Sponsor|1|||
48631119|NCT03552029|156507994|FG000|Overall Study|Other|0|||
48631120|NCT03552029|156507995|FG001|Overall Study|Other|2|||
48631121|NCT03332056|156507996|FG000|Overall Study|Incomplete questionnaires|8|||
48631122|NCT03332056|156507997|FG001|Overall Study|Incomplete questionnaires|9|||
48325620|NCT01759862|155389189|FG001|Overall Study|Physician Decision|1|||
48325621|NCT01759862|155389188|FG000|Overall Study|Adverse Event|0|||
48325622|NCT01759862|155389189|FG001|Overall Study|Adverse Event|1|||
48325623|NCT02157116|155390734|FG000|Overall Study|Withdrawal by Subject|4|||
48325624|NCT02157116|155390734|FG000|Overall Study|Physician Decision|3|||
48325625|NCT02157116|155390734|FG000|Overall Study|Failed Screening|2|||
48325626|NCT00093496|155390735|FG000|Overall Study|Protocol Violation|1|||
48325627|NCT00093496|155390736|FG001|Overall Study|Protocol Violation|3|||
48325628|NCT02022657|155390737|FG000|Overall Study|Withdrawal by Subject|2|||
48325629|NCT02022657|155390738|FG001|Overall Study|Withdrawal by Subject|0|||
48325630|NCT02022657|155390739|FG002|Overall Study|Withdrawal by Subject|1|||
48325631|NCT02022657|155390740|FG003|Overall Study|Withdrawal by Subject|0|||
48325632|NCT02022657|155390741|FG004|Overall Study|Withdrawal by Subject|0|||
48325633|NCT02022657|155390742|FG005|Overall Study|Withdrawal by Subject|0|||
48325634|NCT02022657|155390737|FG000|Overall Study|Physician Decision|0|||
48325635|NCT02022657|155390738|FG001|Overall Study|Physician Decision|0|||
48325636|NCT02022657|155390739|FG002|Overall Study|Physician Decision|0|||
48325637|NCT02022657|155390740|FG003|Overall Study|Physician Decision|0|||
48325638|NCT02022657|155390741|FG004|Overall Study|Physician Decision|0|||
48325639|NCT02022657|155390742|FG005|Overall Study|Physician Decision|1|||
48325640|NCT01629589|155390743|FG000|Overall Study|Protocol Violation|4|||
48325641|NCT01629589|155390744|FG001|Overall Study|Protocol Violation|2|||
48325642|NCT01629589|155390743|FG000|Overall Study|Lost to Follow-up|2|||
48325643|NCT01629589|155390744|FG001|Overall Study|Lost to Follow-up|1|||
48325644|NCT01629589|155390743|FG000|Overall Study|Withdrawal by Subject|2|||
48325645|NCT01629589|155390744|FG001|Overall Study|Withdrawal by Subject|3|||
48325646|NCT01629589|155390743|FG000|Overall Study|Did not receive study vaccine|0|||
48325647|NCT01629589|155390744|FG001|Overall Study|Did not receive study vaccine|1|||
48325648|NCT02079649|155390745|FG000|Overall Study|Lost to Follow-up|0|||
48325649|NCT02079649|155390746|FG001|Overall Study|Lost to Follow-up|0|||
48325650|NCT02079649|155390747|FG002|Overall Study|Lost to Follow-up|0|||
48325651|NCT02079649|155390748|FG003|Overall Study|Lost to Follow-up|1|||
48325652|NCT02079649|155390745|FG000|Overall Study|Withdrawal by Subject|0|||
48325653|NCT02079649|155390746|FG001|Overall Study|Withdrawal by Subject|0|||
48325654|NCT02079649|155390747|FG002|Overall Study|Withdrawal by Subject|0|||
48325655|NCT02079649|155390748|FG003|Overall Study|Withdrawal by Subject|1|||
48325656|NCT02079649|155390745|FG000|Overall Study|Randomization error (prior to treatment)|1|||
48325657|NCT02079649|155390746|FG001|Overall Study|Randomization error (prior to treatment)|0|||
48325658|NCT02079649|155390747|FG002|Overall Study|Randomization error (prior to treatment)|1|||
48325659|NCT02079649|155390748|FG003|Overall Study|Randomization error (prior to treatment)|0|||
48325660|NCT00640159|155390749|FG000|Overall Study|Lost to Follow-up|2|||
48325661|NCT00463229|155390750|FG000|Overall Study|Lost to Follow-up|5|||
48325662|NCT00463229|155390751|FG001|Overall Study|Lost to Follow-up|7|||
48325663|NCT00463229|155390750|FG000|Overall Study|Death|4|||
48325664|NCT00463229|155390751|FG001|Overall Study|Death|3|||
48631123|NCT03332056|156507996|FG000|Overall Study|Passed stone prior to surgery date|1|||
48631124|NCT03332056|156507997|FG001|Overall Study|Passed stone prior to surgery date|0|||
48631125|NCT03332056|156507996|FG000|Overall Study|Did not require a ureteral stent|0|||
48631126|NCT03332056|156507997|FG001|Overall Study|Did not require a ureteral stent|1|||
48631127|NCT03014089|156507998|FG000|Overall Study|Withdrawal by Subject|0|||
48631128|NCT03014089|156507999|FG001|Overall Study|Withdrawal by Subject|1|||
48631129|NCT03014089|156508000|FG002|Overall Study|Withdrawal by Subject|1|||
48631130|NCT03014089|156508001|FG003|Overall Study|Withdrawal by Subject|1|||
48631131|NCT03014089|156507998|FG000|Overall Study|Lost to Follow-up|1|||
48631132|NCT03014089|156507999|FG001|Overall Study|Lost to Follow-up|0|||
48631133|NCT03014089|156508000|FG002|Overall Study|Lost to Follow-up|0|||
48631134|NCT03014089|156508001|FG003|Overall Study|Lost to Follow-up|0|||
48631135|NCT03014089|156507998|FG000|Overall Study|Adverse Event|1|||
48631136|NCT03014089|156507999|FG001|Overall Study|Adverse Event|0|||
48631137|NCT03014089|156508000|FG002|Overall Study|Adverse Event|1|||
48631138|NCT03014089|156508001|FG003|Overall Study|Adverse Event|0|||
48631139|NCT00321932|156508003|FG000|Overall Study|Death|3|||
48631140|NCT00321932|156508004|FG001|Overall Study|Death|6|||
48631141|NCT00321932|156508003|FG000|Overall Study|Withdrawal by Subject|3|||
48631142|NCT00321932|156508004|FG001|Overall Study|Withdrawal by Subject|6|||
48631143|NCT00321932|156508003|FG000|Overall Study|Early relapse|2|||
48631144|NCT00321932|156508004|FG001|Overall Study|Early relapse|8|||
48631145|NCT00321932|156508003|FG000|Overall Study|Missing data|2|||
48631146|NCT00321932|156508004|FG001|Overall Study|Missing data|1|||
48631147|NCT00734032|156508005|FG000|Overall Study|Adverse Event|0|||
48631148|NCT00734032|156508006|FG001|Overall Study|Adverse Event|1|||
48631149|NCT00734032|156508007|FG002|Overall Study|Adverse Event|0|||
48631150|NCT00734032|156508008|FG003|Overall Study|Adverse Event|0|||
48631151|NCT01344356|156508015|FG000|Overall Study|Physician Decision|0|||
48631152|NCT01344356|156508016|FG001|Overall Study|Physician Decision|3|||
48631153|NCT01344356|156508015|FG000|Overall Study|Lost to Follow-up|0|||
48631154|NCT01344356|156508016|FG001|Overall Study|Lost to Follow-up|6|||
48631155|NCT03682367|156508019|FG000|Overall Study|Protocol Violation|2|||
48631156|NCT03682367|156508020|FG001|Overall Study|Protocol Violation|1|||
48631157|NCT03682367|156508019|FG000|Overall Study|Closed Study Early|0|||
48631158|NCT03682367|156508020|FG001|Overall Study|Closed Study Early|3|||
48631159|NCT03707821|156508021|FG000|Overall Study|Protocol Violation|0|||
48631160|NCT03707821|156508022|FG001|Overall Study|Protocol Violation|1|||
48631161|NCT03707821|156508021|FG000|Overall Study|Unsatisfactory Visual Response|1|||
48631162|NCT03707821|156508022|FG001|Overall Study|Unsatisfactory Visual Response|0|||
48631163|NCT03707821|156508021|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
48631164|NCT03707821|156508022|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
48631165|NCT01432444|156508023|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
48631166|NCT01432444|156508024|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
48631167|NCT01432444|156508025|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
48631168|NCT01432444|156508023|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
48631169|NCT01432444|156508024|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
48631170|NCT01432444|156508025|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
48631171|NCT01432444|156508023|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
48631172|NCT01432444|156508024|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
48631173|NCT01432444|156508025|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
48631174|NCT01432444|156508023|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
48631175|NCT01432444|156508024|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
48631176|NCT01432444|156508025|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
48631177|NCT01432444|156508023|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
48631178|NCT01432444|156508024|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
48631179|NCT01432444|156508025|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
48631180|NCT01432444|156508023|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
48631181|NCT01432444|156508024|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
48631182|NCT01432444|156508025|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
48631183|NCT01432444|156508023|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
48631184|NCT01432444|156508024|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
48631185|NCT01432444|156508025|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
48631186|NCT01432444|156508023|FG000|Treatment Phase|Lost to Follow-up|0|||
48631187|NCT01432444|156508024|FG001|Treatment Phase|Lost to Follow-up|33|||
48631188|NCT01432444|156508025|FG002|Treatment Phase|Lost to Follow-up|0|||
48631189|NCT01432444|156508023|FG000|Treatment Phase|Adverse Event|0|||
48631190|NCT01432444|156508024|FG001|Treatment Phase|Adverse Event|37|||
48631191|NCT01432444|156508025|FG002|Treatment Phase|Adverse Event|0|||
48743664|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
48743665|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
48743666|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
48743667|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
48743668|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
48743669|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
48743670|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
48743671|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
48743672|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
48743673|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
48743674|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
48743675|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
48743676|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
48743677|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
48743678|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
48743679|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
48743680|NCT02207244|156910555|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743681|NCT02207244|156910556|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743682|NCT02207244|156910557|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743683|NCT02207244|156910558|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743684|NCT02207244|156910559|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743685|NCT02207244|156910560|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743686|NCT02207244|156910561|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743687|NCT02207244|156910562|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743688|NCT02207244|156910563|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743689|NCT02207244|156910564|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
48743690|NCT02207244|156910565|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
48743691|NCT01088997|156910568|FG000|Overall Study|Physician Decision|1|||
48743692|NCT01088997|156910569|FG001|Overall Study|Physician Decision|1|||
48743693|NCT01088997|156910568|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
48743694|NCT01088997|156910569|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
48743695|NCT01088997|156910568|FG000|Overall Study|Excluded prior to receiving drug|1|||
48743696|NCT01088997|156910569|FG001|Overall Study|Excluded prior to receiving drug|1|||
48743697|NCT00259649|156912376|FG000|Overall Study|Lost to Follow-up|7|||
48743698|NCT00259649|156912376|FG000|Overall Study|irregular menses|3|||
48743699|NCT00042289|156912377|FG000|Overall Study|Lost to Follow-up|3|||
48743700|NCT00042289|156912378|FG001|Overall Study|Lost to Follow-up|0|||
48743701|NCT00042289|156912379|FG002|Overall Study|Lost to Follow-up|0|||
48743702|NCT00042289|156912380|FG003|Overall Study|Lost to Follow-up|1|||
48743703|NCT00042289|156912381|FG004|Overall Study|Lost to Follow-up|3|||
48743704|NCT00042289|156912382|FG005|Overall Study|Lost to Follow-up|3|||
48743705|NCT00042289|156912383|FG006|Overall Study|Lost to Follow-up|6|||
48743706|NCT00042289|156912384|FG007|Overall Study|Lost to Follow-up|1|||
48743707|NCT00042289|156912385|FG008|Overall Study|Lost to Follow-up|1|||
48743708|NCT00042289|156912386|FG009|Overall Study|Lost to Follow-up|0|||
48743709|NCT00042289|156912387|FG010|Overall Study|Lost to Follow-up|0|||
48743710|NCT00042289|156912388|FG011|Overall Study|Lost to Follow-up|0|||
48743711|NCT00042289|156912389|FG012|Overall Study|Lost to Follow-up|0|||
48743712|NCT00042289|156912390|FG013|Overall Study|Lost to Follow-up|0|||
48743713|NCT00042289|156912391|FG014|Overall Study|Lost to Follow-up|0|||
48743714|NCT00042289|156912392|FG015|Overall Study|Lost to Follow-up|1|||
48743715|NCT00042289|156912393|FG016|Overall Study|Lost to Follow-up|1|||
48743716|NCT00042289|156912394|FG017|Overall Study|Lost to Follow-up|0|||
48743717|NCT00042289|156912395|FG018|Overall Study|Lost to Follow-up|3|||
48743718|NCT00042289|156912396|FG019|Overall Study|Lost to Follow-up|2|||
48743719|NCT00042289|156912397|FG020|Overall Study|Lost to Follow-up|0|||
48743720|NCT00042289|156912398|FG021|Overall Study|Lost to Follow-up|0|||
48743721|NCT00042289|156912399|FG022|Overall Study|Lost to Follow-up|0|||
48743722|NCT00042289|156912400|FG023|Overall Study|Lost to Follow-up|0|||
48743723|NCT00042289|156912401|FG024|Overall Study|Lost to Follow-up|0|||
48743724|NCT00042289|156912402|FG025|Overall Study|Lost to Follow-up|0|||
48743725|NCT00042289|156912403|FG026|Overall Study|Lost to Follow-up|2|||
48743726|NCT00042289|156912404|FG027|Overall Study|Lost to Follow-up|2|||
48743727|NCT00042289|156912405|FG028|Overall Study|Lost to Follow-up|2|||
48743728|NCT00042289|156912406|FG029|Overall Study|Lost to Follow-up|0|||
48743729|NCT00042289|156912407|FG030|Overall Study|Lost to Follow-up|0|||
48743730|NCT00042289|156912408|FG031|Overall Study|Lost to Follow-up|2|||
48743731|NCT00042289|156912409|FG032|Overall Study|Lost to Follow-up|1|||
48743732|NCT00042289|156912410|FG033|Overall Study|Lost to Follow-up|1|||
48743733|NCT00042289|156912411|FG034|Overall Study|Lost to Follow-up|1|||
48743734|NCT00042289|156912412|FG035|Overall Study|Lost to Follow-up|2|||
48743735|NCT00042289|156912413|FG036|Overall Study|Lost to Follow-up|1|||
48743736|NCT00042289|156912414|FG037|Overall Study|Lost to Follow-up|1|||
48743737|NCT00042289|156912415|FG038|Overall Study|Lost to Follow-up|0|||
48743738|NCT00042289|156912416|FG039|Overall Study|Lost to Follow-up|5|||
48743739|NCT00042289|156912417|FG040|Overall Study|Lost to Follow-up|0|||
48743740|NCT00042289|156912418|FG041|Overall Study|Lost to Follow-up|2|||
48743741|NCT00042289|156912419|FG042|Overall Study|Lost to Follow-up|2|||
48743742|NCT00042289|156912420|FG043|Overall Study|Lost to Follow-up|0|||
48743743|NCT00042289|156912421|FG044|Overall Study|Lost to Follow-up|0|||
48743744|NCT00042289|156912422|FG045|Overall Study|Lost to Follow-up|1|||
48743745|NCT00042289|156912423|FG046|Overall Study|Lost to Follow-up|0|||
48743746|NCT00042289|156912377|FG000|Overall Study|Other reason|0|||
48743747|NCT00042289|156912378|FG001|Overall Study|Other reason|0|||
48743748|NCT00042289|156912379|FG002|Overall Study|Other reason|0|||
48743749|NCT00042289|156912380|FG003|Overall Study|Other reason|2|||
48743750|NCT00042289|156912381|FG004|Overall Study|Other reason|0|||
48743751|NCT00042289|156912382|FG005|Overall Study|Other reason|0|||
48743752|NCT00042289|156912383|FG006|Overall Study|Other reason|0|||
48743753|NCT00042289|156912384|FG007|Overall Study|Other reason|0|||
48743754|NCT00042289|156912385|FG008|Overall Study|Other reason|0|||
48743755|NCT00042289|156912386|FG009|Overall Study|Other reason|0|||
48743756|NCT00042289|156912387|FG010|Overall Study|Other reason|0|||
48743757|NCT00042289|156912388|FG011|Overall Study|Other reason|0|||
48743758|NCT00042289|156912389|FG012|Overall Study|Other reason|0|||
48743759|NCT00042289|156912390|FG013|Overall Study|Other reason|0|||
48743760|NCT00042289|156912391|FG014|Overall Study|Other reason|0|||
48743761|NCT00042289|156912392|FG015|Overall Study|Other reason|0|||
48743762|NCT00042289|156912393|FG016|Overall Study|Other reason|0|||
48743763|NCT00042289|156912394|FG017|Overall Study|Other reason|0|||
48743764|NCT00042289|156912395|FG018|Overall Study|Other reason|1|||
48743765|NCT00042289|156912396|FG019|Overall Study|Other reason|0|||
48743766|NCT00042289|156912397|FG020|Overall Study|Other reason|0|||
48743767|NCT00042289|156912398|FG021|Overall Study|Other reason|0|||
48743768|NCT00042289|156912399|FG022|Overall Study|Other reason|0|||
48631192|NCT01432444|156508023|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
48631193|NCT01432444|156508024|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
48631194|NCT01432444|156508025|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
48631195|NCT01432444|156508023|FG000|Treatment Phase|Physician Decision|0|||
48631196|NCT01432444|156508024|FG001|Treatment Phase|Physician Decision|5|||
48631197|NCT01432444|156508025|FG002|Treatment Phase|Physician Decision|0|||
48631198|NCT01432444|156508023|FG000|Treatment Phase|Withdrawal by Subject|0|||
48631199|NCT01432444|156508024|FG001|Treatment Phase|Withdrawal by Subject|41|||
48631200|NCT01432444|156508025|FG002|Treatment Phase|Withdrawal by Subject|0|||
48631201|NCT01432444|156508023|FG000|Treatment Phase|Protocol Deviation|0|||
48631202|NCT01432444|156508024|FG001|Treatment Phase|Protocol Deviation|3|||
48631203|NCT01432444|156508025|FG002|Treatment Phase|Protocol Deviation|0|||
48631204|NCT01432444|156508023|FG000|Treatment Phase|Lack of Efficacy|0|||
48631205|NCT01432444|156508024|FG001|Treatment Phase|Lack of Efficacy|10|||
48631206|NCT01432444|156508025|FG002|Treatment Phase|Lack of Efficacy|0|||
48631207|NCT01432444|156508023|FG000|Extension Phase|Lost to Follow-up|0|||
48631208|NCT01432444|156508024|FG001|Extension Phase|Lost to Follow-up|0|||
48631209|NCT01432444|156508025|FG002|Extension Phase|Lost to Follow-up|17|||
48631210|NCT01432444|156508023|FG000|Extension Phase|Adverse Event|0|||
48631211|NCT01432444|156508024|FG001|Extension Phase|Adverse Event|0|||
48631212|NCT01432444|156508025|FG002|Extension Phase|Adverse Event|10|||
48631213|NCT01432444|156508023|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
48631214|NCT01432444|156508024|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
48631215|NCT01432444|156508025|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
48631216|NCT01432444|156508023|FG000|Extension Phase|Met Withdrawal Criteria|0|||
48631217|NCT01432444|156508024|FG001|Extension Phase|Met Withdrawal Criteria|0|||
48631218|NCT01432444|156508025|FG002|Extension Phase|Met Withdrawal Criteria|144|||
48631219|NCT01432444|156508023|FG000|Extension Phase|Physician Decision|0|||
48631220|NCT01432444|156508024|FG001|Extension Phase|Physician Decision|0|||
48631221|NCT01432444|156508025|FG002|Extension Phase|Physician Decision|1|||
48631222|NCT01432444|156508023|FG000|Extension Phase|Withdrawal by Subject|0|||
48631223|NCT01432444|156508024|FG001|Extension Phase|Withdrawal by Subject|0|||
48631224|NCT01432444|156508025|FG002|Extension Phase|Withdrawal by Subject|13|||
48631225|NCT02439957|156508026|FG000|Overall Study|Study Terminated|3|||
48631226|NCT02439957|156508027|FG001|Overall Study|Study Terminated|3|||
48631227|NCT00889005|156508028|FG000|Overall Study|Lost to Follow-up|4|||
48631228|NCT00889005|156508029|FG001|Overall Study|Lost to Follow-up|2|||
48631229|NCT00889005|156508028|FG000|Overall Study|Withdrawal by Subject|4|||
48631230|NCT00889005|156508029|FG001|Overall Study|Withdrawal by Subject|0|||
48743769|NCT00042289|156912400|FG023|Overall Study|Other reason|1|||
48743770|NCT00042289|156912401|FG024|Overall Study|Other reason|0|||
48743771|NCT00042289|156912402|FG025|Overall Study|Other reason|0|||
48743772|NCT00042289|156912403|FG026|Overall Study|Other reason|1|||
48743773|NCT00042289|156912404|FG027|Overall Study|Other reason|0|||
48631231|NCT01052779|156508031|FG000|Overall Study|Adverse Event|1|||
48631232|NCT01052779|156508032|FG001|Overall Study|Adverse Event|4|||
48631233|NCT01052779|156508031|FG000|Overall Study|Withdrawal by Subject|1|||
48631234|NCT01052779|156508032|FG001|Overall Study|Withdrawal by Subject|2|||
48743774|NCT00042289|156912405|FG028|Overall Study|Other reason|3|||
48743775|NCT00042289|156912406|FG029|Overall Study|Other reason|0|||
48743776|NCT00042289|156912407|FG030|Overall Study|Other reason|0|||
48743777|NCT00042289|156912408|FG031|Overall Study|Other reason|1|||
48743778|NCT00042289|156912409|FG032|Overall Study|Other reason|0|||
48743779|NCT00042289|156912410|FG033|Overall Study|Other reason|1|||
48743780|NCT00042289|156912411|FG034|Overall Study|Other reason|0|||
48743781|NCT00042289|156912412|FG035|Overall Study|Other reason|2|||
48743782|NCT00042289|156912413|FG036|Overall Study|Other reason|0|||
48743783|NCT00042289|156912414|FG037|Overall Study|Other reason|0|||
48743784|NCT00042289|156912415|FG038|Overall Study|Other reason|0|||
48743785|NCT00042289|156912416|FG039|Overall Study|Other reason|0|||
48743786|NCT00042289|156912417|FG040|Overall Study|Other reason|0|||
48743787|NCT00042289|156912418|FG041|Overall Study|Other reason|0|||
48743788|NCT00042289|156912419|FG042|Overall Study|Other reason|0|||
48743789|NCT00042289|156912420|FG043|Overall Study|Other reason|1|||
48743790|NCT00042289|156912421|FG044|Overall Study|Other reason|0|||
48743791|NCT00042289|156912422|FG045|Overall Study|Other reason|0|||
48743792|NCT00042289|156912423|FG046|Overall Study|Other reason|0|||
48743793|NCT00042289|156912377|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48743794|NCT00042289|156912378|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48743795|NCT00042289|156912379|FG002|Overall Study|Severe debilitation, unable to continue|0|||
48743796|NCT00042289|156912380|FG003|Overall Study|Severe debilitation, unable to continue|0|||
48743797|NCT00042289|156912381|FG004|Overall Study|Severe debilitation, unable to continue|0|||
48743798|NCT00042289|156912382|FG005|Overall Study|Severe debilitation, unable to continue|0|||
48743799|NCT00042289|156912383|FG006|Overall Study|Severe debilitation, unable to continue|0|||
48743800|NCT00042289|156912384|FG007|Overall Study|Severe debilitation, unable to continue|0|||
48743801|NCT00042289|156912385|FG008|Overall Study|Severe debilitation, unable to continue|0|||
48743802|NCT00042289|156912386|FG009|Overall Study|Severe debilitation, unable to continue|0|||
48743803|NCT00042289|156912387|FG010|Overall Study|Severe debilitation, unable to continue|0|||
48743804|NCT00042289|156912388|FG011|Overall Study|Severe debilitation, unable to continue|0|||
48743805|NCT00042289|156912389|FG012|Overall Study|Severe debilitation, unable to continue|0|||
48743806|NCT00042289|156912390|FG013|Overall Study|Severe debilitation, unable to continue|0|||
48743807|NCT00042289|156912391|FG014|Overall Study|Severe debilitation, unable to continue|0|||
48743808|NCT00042289|156912392|FG015|Overall Study|Severe debilitation, unable to continue|0|||
48743809|NCT00042289|156912393|FG016|Overall Study|Severe debilitation, unable to continue|0|||
48743810|NCT00042289|156912394|FG017|Overall Study|Severe debilitation, unable to continue|0|||
48743811|NCT00042289|156912395|FG018|Overall Study|Severe debilitation, unable to continue|0|||
48743812|NCT00042289|156912396|FG019|Overall Study|Severe debilitation, unable to continue|0|||
48743813|NCT00042289|156912397|FG020|Overall Study|Severe debilitation, unable to continue|0|||
48743814|NCT00042289|156912398|FG021|Overall Study|Severe debilitation, unable to continue|1|||
48743815|NCT00042289|156912399|FG022|Overall Study|Severe debilitation, unable to continue|0|||
48743816|NCT00042289|156912400|FG023|Overall Study|Severe debilitation, unable to continue|1|||
48743817|NCT00042289|156912401|FG024|Overall Study|Severe debilitation, unable to continue|0|||
48743818|NCT00042289|156912402|FG025|Overall Study|Severe debilitation, unable to continue|0|||
48743819|NCT00042289|156912403|FG026|Overall Study|Severe debilitation, unable to continue|0|||
48743820|NCT00042289|156912404|FG027|Overall Study|Severe debilitation, unable to continue|1|||
48743821|NCT00042289|156912405|FG028|Overall Study|Severe debilitation, unable to continue|0|||
48743822|NCT00042289|156912406|FG029|Overall Study|Severe debilitation, unable to continue|0|||
48743823|NCT00042289|156912407|FG030|Overall Study|Severe debilitation, unable to continue|0|||
48743824|NCT00042289|156912408|FG031|Overall Study|Severe debilitation, unable to continue|1|||
48743825|NCT00042289|156912409|FG032|Overall Study|Severe debilitation, unable to continue|1|||
48743826|NCT00042289|156912410|FG033|Overall Study|Severe debilitation, unable to continue|0|||
48743827|NCT00042289|156912411|FG034|Overall Study|Severe debilitation, unable to continue|0|||
48743828|NCT00042289|156912412|FG035|Overall Study|Severe debilitation, unable to continue|0|||
48743829|NCT00042289|156912413|FG036|Overall Study|Severe debilitation, unable to continue|0|||
48743830|NCT00042289|156912414|FG037|Overall Study|Severe debilitation, unable to continue|0|||
48743831|NCT00042289|156912415|FG038|Overall Study|Severe debilitation, unable to continue|0|||
48743832|NCT00042289|156912416|FG039|Overall Study|Severe debilitation, unable to continue|0|||
48743833|NCT00042289|156912417|FG040|Overall Study|Severe debilitation, unable to continue|0|||
48743834|NCT00042289|156912418|FG041|Overall Study|Severe debilitation, unable to continue|0|||
48743835|NCT00042289|156912419|FG042|Overall Study|Severe debilitation, unable to continue|0|||
48743836|NCT00042289|156912420|FG043|Overall Study|Severe debilitation, unable to continue|0|||
48743837|NCT00042289|156912421|FG044|Overall Study|Severe debilitation, unable to continue|0|||
48743838|NCT00042289|156912422|FG045|Overall Study|Severe debilitation, unable to continue|0|||
48743839|NCT00042289|156912423|FG046|Overall Study|Severe debilitation, unable to continue|0|||
48743840|NCT00042289|156912377|FG000|Overall Study|Site closed|0|||
48743841|NCT00042289|156912378|FG001|Overall Study|Site closed|0|||
48743842|NCT00042289|156912379|FG002|Overall Study|Site closed|0|||
48743843|NCT00042289|156912380|FG003|Overall Study|Site closed|0|||
48743844|NCT00042289|156912381|FG004|Overall Study|Site closed|0|||
48743845|NCT00042289|156912382|FG005|Overall Study|Site closed|0|||
48743846|NCT00042289|156912383|FG006|Overall Study|Site closed|0|||
48743847|NCT00042289|156912384|FG007|Overall Study|Site closed|0|||
48743848|NCT00042289|156912385|FG008|Overall Study|Site closed|0|||
48743849|NCT00042289|156912386|FG009|Overall Study|Site closed|0|||
48743850|NCT00042289|156912387|FG010|Overall Study|Site closed|0|||
48743851|NCT00042289|156912388|FG011|Overall Study|Site closed|0|||
48743852|NCT00042289|156912389|FG012|Overall Study|Site closed|0|||
48743853|NCT00042289|156912390|FG013|Overall Study|Site closed|0|||
48743854|NCT00042289|156912391|FG014|Overall Study|Site closed|0|||
48743855|NCT00042289|156912392|FG015|Overall Study|Site closed|0|||
48743856|NCT00042289|156912393|FG016|Overall Study|Site closed|0|||
48743857|NCT00042289|156912394|FG017|Overall Study|Site closed|0|||
48743858|NCT00042289|156912395|FG018|Overall Study|Site closed|0|||
48743859|NCT00042289|156912396|FG019|Overall Study|Site closed|0|||
48743860|NCT00042289|156912397|FG020|Overall Study|Site closed|0|||
48743861|NCT00042289|156912398|FG021|Overall Study|Site closed|0|||
48743862|NCT00042289|156912399|FG022|Overall Study|Site closed|0|||
48743863|NCT00042289|156912400|FG023|Overall Study|Site closed|0|||
48743864|NCT00042289|156912401|FG024|Overall Study|Site closed|0|||
48743865|NCT00042289|156912402|FG025|Overall Study|Site closed|0|||
48743866|NCT00042289|156912403|FG026|Overall Study|Site closed|0|||
48743867|NCT00042289|156912404|FG027|Overall Study|Site closed|0|||
48743868|NCT00042289|156912405|FG028|Overall Study|Site closed|0|||
48743869|NCT00042289|156912406|FG029|Overall Study|Site closed|0|||
48743870|NCT00042289|156912407|FG030|Overall Study|Site closed|0|||
48743871|NCT00042289|156912408|FG031|Overall Study|Site closed|3|||
48743872|NCT00042289|156912409|FG032|Overall Study|Site closed|0|||
48743873|NCT00042289|156912410|FG033|Overall Study|Site closed|0|||
48743874|NCT00042289|156912411|FG034|Overall Study|Site closed|0|||
48743875|NCT00042289|156912412|FG035|Overall Study|Site closed|0|||
48743876|NCT00042289|156912413|FG036|Overall Study|Site closed|1|||
48743877|NCT00042289|156912414|FG037|Overall Study|Site closed|0|||
48743878|NCT00042289|156912415|FG038|Overall Study|Site closed|0|||
48743879|NCT00042289|156912416|FG039|Overall Study|Site closed|0|||
48743880|NCT00042289|156912417|FG040|Overall Study|Site closed|0|||
48743881|NCT00042289|156912418|FG041|Overall Study|Site closed|0|||
48743882|NCT00042289|156912419|FG042|Overall Study|Site closed|1|||
48325665|NCT02404441|155390752|FG000|Phase 1 Part|Adverse Event|1|||
48325666|NCT02404441|155390753|FG001|Phase 1 Part|Adverse Event|0|||
48325667|NCT02404441|155390754|FG002|Phase 1 Part|Adverse Event|0|||
48325668|NCT02404441|155390755|FG003|Phase 1 Part|Adverse Event|0|||
48325669|NCT02404441|155390756|FG004|Phase 1 Part|Adverse Event|0|||
48743883|NCT00042289|156912420|FG043|Overall Study|Site closed|0|||
48743884|NCT00042289|156912421|FG044|Overall Study|Site closed|0|||
48325670|NCT02404441|155390757|FG005|Phase 1 Part|Adverse Event|0|||
48325671|NCT02404441|155390758|FG006|Phase 1 Part|Adverse Event|0|||
48743885|NCT00042289|156912422|FG045|Overall Study|Site closed|0|||
48743886|NCT00042289|156912423|FG046|Overall Study|Site closed|0|||
48743887|NCT00042289|156912377|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
48743888|NCT00042289|156912378|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
48743889|NCT00042289|156912379|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
48743890|NCT00042289|156912380|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
48743891|NCT00042289|156912381|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
48743892|NCT00042289|156912382|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
48743893|NCT00042289|156912383|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
48743894|NCT00042289|156912384|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
48743895|NCT00042289|156912385|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
48743896|NCT00042289|156912386|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
48743897|NCT00042289|156912387|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
48325672|NCT02404441|155390759|FG007|Phase 1 Part|Adverse Event|0|||
48631235|NCT01052779|156508031|FG000|Overall Study|Other-Protocol Violation|1|||
48631236|NCT01052779|156508032|FG001|Overall Study|Other-Protocol Violation|1|||
48631237|NCT01052779|156508031|FG000|Overall Study|Other-Surgery|0|||
48631238|NCT01052779|156508032|FG001|Overall Study|Other-Surgery|2|||
48631239|NCT01052779|156508031|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
48631240|NCT01052779|156508032|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
48631241|NCT05034952|156508034|FG000|Overall Study|Adverse Event|1|||
48631242|NCT05034952|156508035|FG001|Overall Study|Adverse Event|0|||
48631243|NCT05034952|156508036|FG002|Overall Study|Adverse Event|0|||
48631244|NCT05034952|156508037|FG003|Overall Study|Adverse Event|0|||
48631245|NCT05034952|156508034|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48743898|NCT00042289|156912388|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
48325673|NCT02404441|155390760|FG008|Phase 1 Part|Adverse Event|0|||
48325674|NCT02404441|155390761|FG009|Phase 1 Part|Adverse Event|0|||
48743899|NCT00042289|156912389|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
48743900|NCT00042289|156912390|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
48743901|NCT00042289|156912391|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
48743902|NCT00042289|156912392|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
48743903|NCT00042289|156912393|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
48743904|NCT00042289|156912394|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
48743905|NCT00042289|156912395|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
48743906|NCT00042289|156912396|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
48743907|NCT00042289|156912397|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
48743908|NCT00042289|156912398|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
48325675|NCT02404441|155390752|FG000|Phase 1 Part|Physician Decision|0|||
48743909|NCT00042289|156912399|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
48743910|NCT00042289|156912400|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
48743911|NCT00042289|156912401|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
48743912|NCT00042289|156912402|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
48743913|NCT00042289|156912403|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
48325676|NCT02404441|155390753|FG001|Phase 1 Part|Physician Decision|1|||
48325677|NCT02404441|155390754|FG002|Phase 1 Part|Physician Decision|0|||
48325678|NCT02404441|155390755|FG003|Phase 1 Part|Physician Decision|0|||
48325679|NCT02404441|155390756|FG004|Phase 1 Part|Physician Decision|0|||
48325680|NCT02404441|155390757|FG005|Phase 1 Part|Physician Decision|0|||
48325681|NCT02404441|155390758|FG006|Phase 1 Part|Physician Decision|0|||
48325682|NCT02404441|155390759|FG007|Phase 1 Part|Physician Decision|0|||
48325683|NCT02404441|155390760|FG008|Phase 1 Part|Physician Decision|0|||
48325684|NCT02404441|155390761|FG009|Phase 1 Part|Physician Decision|0|||
48325685|NCT02404441|155390752|FG000|Phase 1 Part|Progressive Disease|14|||
48325686|NCT02404441|155390753|FG001|Phase 1 Part|Progressive Disease|11|||
48325687|NCT02404441|155390754|FG002|Phase 1 Part|Progressive Disease|7|||
48325688|NCT02404441|155390755|FG003|Phase 1 Part|Progressive Disease|6|||
48325689|NCT02404441|155390756|FG004|Phase 1 Part|Progressive Disease|9|||
48325690|NCT02404441|155390757|FG005|Phase 1 Part|Progressive Disease|0|||
48631246|NCT05034952|156508035|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
48325691|NCT02404441|155390758|FG006|Phase 1 Part|Progressive Disease|0|||
48325692|NCT02404441|155390759|FG007|Phase 1 Part|Progressive Disease|0|||
48325693|NCT02404441|155390760|FG008|Phase 1 Part|Progressive Disease|0|||
48325694|NCT02404441|155390761|FG009|Phase 1 Part|Progressive Disease|0|||
48325695|NCT02404441|155390752|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
48325696|NCT02404441|155390753|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
48631247|NCT05034952|156508036|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
48631248|NCT05034952|156508037|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
48631249|NCT05034952|156508034|FG000|Overall Study|Lost to Follow-up|1|||
48631250|NCT05034952|156508035|FG001|Overall Study|Lost to Follow-up|4|||
48631251|NCT05034952|156508036|FG002|Overall Study|Lost to Follow-up|3|||
48631252|NCT05034952|156508037|FG003|Overall Study|Lost to Follow-up|3|||
48631253|NCT05034952|156508034|FG000|Overall Study|Other|0|||
48631254|NCT05034952|156508035|FG001|Overall Study|Other|0|||
48631255|NCT05034952|156508036|FG002|Overall Study|Other|0|||
48631256|NCT05034952|156508037|FG003|Overall Study|Other|1|||
48631257|NCT01073293|156508038|FG000|Overall Study|Lost to Follow-up|0|||
48631258|NCT01073293|156508039|FG001|Overall Study|Lost to Follow-up|1|||
48631259|NCT01073293|156508038|FG000|Overall Study|Withdrawal by Subject|5|||
48631260|NCT01073293|156508039|FG001|Overall Study|Withdrawal by Subject|10|||
48631261|NCT03427619|156508040|FG000|Overall Study|Physician Decision|3|||
48631262|NCT03427619|156508040|FG000|Overall Study|Withdrawal by Subject|4|||
48631263|NCT03427619|156508040|FG000|Overall Study|Lost to Follow-up|5|||
48631264|NCT03427619|156508040|FG000|Overall Study|Administrative|4|||
48631265|NCT03427619|156508040|FG000|Overall Study|Other|2|||
48743914|NCT00042289|156912404|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
48743915|NCT00042289|156912405|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
48743916|NCT00042289|156912406|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
48743917|NCT00042289|156912407|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
48631266|NCT03427619|156508040|FG000|Overall Study|Unknown or Missing Completion Status|48|||
48631267|NCT01948427|156508041|FG000|Overall Study|Serious Adverse Event|3|||
48631268|NCT01948427|156508042|FG001|Overall Study|Serious Adverse Event|0|||
48631269|NCT01948427|156508043|FG002|Overall Study|Serious Adverse Event|0|||
48631270|NCT01948427|156508044|FG003|Overall Study|Serious Adverse Event|0|||
48631271|NCT01948427|156508045|FG004|Overall Study|Serious Adverse Event|1|||
48631272|NCT01948427|156508041|FG000|Overall Study|Investigator Request|0|||
48631273|NCT01948427|156508042|FG001|Overall Study|Investigator Request|8|||
48631274|NCT01948427|156508043|FG002|Overall Study|Investigator Request|0|||
48631275|NCT01948427|156508044|FG003|Overall Study|Investigator Request|0|||
48743918|NCT00042289|156912408|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
48743919|NCT00042289|156912409|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
48743920|NCT00042289|156912410|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
48743921|NCT00042289|156912411|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
48743922|NCT00042289|156912412|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
48743923|NCT00042289|156912413|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
48743924|NCT00042289|156912414|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
48743925|NCT00042289|156912415|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
48743926|NCT00042289|156912416|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
48743927|NCT00042289|156912417|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
48743928|NCT00042289|156912418|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
48743929|NCT00042289|156912419|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
48743930|NCT00042289|156912420|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
48743931|NCT00042289|156912421|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
48743932|NCT00042289|156912422|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
48743933|NCT00042289|156912423|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
48743934|NCT00042289|156912377|FG000|Overall Study|Protocol Violation|0|||
48743935|NCT00042289|156912378|FG001|Overall Study|Protocol Violation|0|||
48743936|NCT00042289|156912379|FG002|Overall Study|Protocol Violation|0|||
48743937|NCT00042289|156912380|FG003|Overall Study|Protocol Violation|0|||
48743938|NCT00042289|156912381|FG004|Overall Study|Protocol Violation|0|||
48743939|NCT00042289|156912382|FG005|Overall Study|Protocol Violation|1|||
48743940|NCT00042289|156912383|FG006|Overall Study|Protocol Violation|0|||
48743941|NCT00042289|156912384|FG007|Overall Study|Protocol Violation|1|||
48743942|NCT00042289|156912385|FG008|Overall Study|Protocol Violation|0|||
48743943|NCT00042289|156912386|FG009|Overall Study|Protocol Violation|0|||
48743944|NCT00042289|156912387|FG010|Overall Study|Protocol Violation|0|||
48743945|NCT00042289|156912388|FG011|Overall Study|Protocol Violation|0|||
48743946|NCT00042289|156912389|FG012|Overall Study|Protocol Violation|0|||
48743947|NCT00042289|156912390|FG013|Overall Study|Protocol Violation|0|||
48631276|NCT01948427|156508045|FG004|Overall Study|Investigator Request|6|||
48631277|NCT01948427|156508041|FG000|Overall Study|Lost to Follow-up|1|||
48631278|NCT01948427|156508042|FG001|Overall Study|Lost to Follow-up|0|||
48631279|NCT01948427|156508043|FG002|Overall Study|Lost to Follow-up|0|||
48743948|NCT00042289|156912391|FG014|Overall Study|Protocol Violation|0|||
48743949|NCT00042289|156912392|FG015|Overall Study|Protocol Violation|0|||
48743950|NCT00042289|156912393|FG016|Overall Study|Protocol Violation|0|||
48743951|NCT00042289|156912394|FG017|Overall Study|Protocol Violation|0|||
48743952|NCT00042289|156912395|FG018|Overall Study|Protocol Violation|0|||
48743953|NCT00042289|156912396|FG019|Overall Study|Protocol Violation|0|||
48743954|NCT00042289|156912397|FG020|Overall Study|Protocol Violation|0|||
48743955|NCT00042289|156912398|FG021|Overall Study|Protocol Violation|0|||
48743956|NCT00042289|156912399|FG022|Overall Study|Protocol Violation|0|||
48743957|NCT00042289|156912400|FG023|Overall Study|Protocol Violation|1|||
48743958|NCT00042289|156912401|FG024|Overall Study|Protocol Violation|1|||
48325697|NCT02404441|155390754|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
48325698|NCT02404441|155390755|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
48325699|NCT02404441|155390756|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
48325700|NCT02404441|155390757|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
48743959|NCT00042289|156912402|FG025|Overall Study|Protocol Violation|0|||
48743960|NCT00042289|156912403|FG026|Overall Study|Protocol Violation|2|||
48743961|NCT00042289|156912404|FG027|Overall Study|Protocol Violation|0|||
48743962|NCT00042289|156912405|FG028|Overall Study|Protocol Violation|0|||
48743963|NCT00042289|156912406|FG029|Overall Study|Protocol Violation|0|||
48743964|NCT00042289|156912407|FG030|Overall Study|Protocol Violation|1|||
48743965|NCT00042289|156912408|FG031|Overall Study|Protocol Violation|0|||
48743966|NCT00042289|156912409|FG032|Overall Study|Protocol Violation|0|||
48743967|NCT00042289|156912410|FG033|Overall Study|Protocol Violation|0|||
48743968|NCT00042289|156912411|FG034|Overall Study|Protocol Violation|0|||
48743969|NCT00042289|156912412|FG035|Overall Study|Protocol Violation|0|||
48743970|NCT00042289|156912413|FG036|Overall Study|Protocol Violation|0|||
48743971|NCT00042289|156912414|FG037|Overall Study|Protocol Violation|0|||
48743972|NCT00042289|156912415|FG038|Overall Study|Protocol Violation|0|||
48743973|NCT00042289|156912416|FG039|Overall Study|Protocol Violation|0|||
48743974|NCT00042289|156912417|FG040|Overall Study|Protocol Violation|0|||
48743975|NCT00042289|156912418|FG041|Overall Study|Protocol Violation|1|||
48743976|NCT00042289|156912419|FG042|Overall Study|Protocol Violation|1|||
48743977|NCT00042289|156912420|FG043|Overall Study|Protocol Violation|1|||
48743978|NCT00042289|156912421|FG044|Overall Study|Protocol Violation|0|||
48743979|NCT00042289|156912422|FG045|Overall Study|Protocol Violation|0|||
48743980|NCT00042289|156912423|FG046|Overall Study|Protocol Violation|0|||
48743981|NCT00042289|156912377|FG000|Overall Study|Withdrawal by Subject|4|||
48325701|NCT02404441|155390758|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
48325702|NCT02404441|155390759|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
48325703|NCT02404441|155390760|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
48325704|NCT02404441|155390761|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
48743982|NCT00042289|156912378|FG001|Overall Study|Withdrawal by Subject|1|||
48743983|NCT00042289|156912379|FG002|Overall Study|Withdrawal by Subject|0|||
48743984|NCT00042289|156912380|FG003|Overall Study|Withdrawal by Subject|2|||
48743985|NCT00042289|156912381|FG004|Overall Study|Withdrawal by Subject|0|||
48743986|NCT00042289|156912382|FG005|Overall Study|Withdrawal by Subject|2|||
48743987|NCT00042289|156912383|FG006|Overall Study|Withdrawal by Subject|0|||
48325705|NCT02404441|155390752|FG000|Phase 1 Part|Death|1|||
48325706|NCT02404441|155390753|FG001|Phase 1 Part|Death|1|||
48325707|NCT02404441|155390754|FG002|Phase 1 Part|Death|1|||
48325708|NCT02404441|155390755|FG003|Phase 1 Part|Death|0|||
48325709|NCT02404441|155390756|FG004|Phase 1 Part|Death|1|||
48325710|NCT02404441|155390757|FG005|Phase 1 Part|Death|0|||
48325711|NCT02404441|155390758|FG006|Phase 1 Part|Death|0|||
48325712|NCT02404441|155390759|FG007|Phase 1 Part|Death|0|||
48325713|NCT02404441|155390760|FG008|Phase 1 Part|Death|0|||
48325714|NCT02404441|155390761|FG009|Phase 1 Part|Death|0|||
48325715|NCT02404441|155390752|FG000|Phase 2 Part|Adverse Event|0|||
48325716|NCT02404441|155390753|FG001|Phase 2 Part|Adverse Event|0|||
48325717|NCT02404441|155390754|FG002|Phase 2 Part|Adverse Event|0|||
48325718|NCT02404441|155390755|FG003|Phase 2 Part|Adverse Event|0|||
48325719|NCT02404441|155390756|FG004|Phase 2 Part|Adverse Event|0|||
48325720|NCT02404441|155390757|FG005|Phase 2 Part|Adverse Event|2|||
48325721|NCT02404441|155390758|FG006|Phase 2 Part|Adverse Event|3|||
48325722|NCT02404441|155390759|FG007|Phase 2 Part|Adverse Event|3|||
48325723|NCT02404441|155390760|FG008|Phase 2 Part|Adverse Event|6|||
48743988|NCT00042289|156912384|FG007|Overall Study|Withdrawal by Subject|0|||
48743989|NCT00042289|156912385|FG008|Overall Study|Withdrawal by Subject|0|||
48743990|NCT00042289|156912386|FG009|Overall Study|Withdrawal by Subject|1|||
48743991|NCT00042289|156912387|FG010|Overall Study|Withdrawal by Subject|0|||
48743992|NCT00042289|156912388|FG011|Overall Study|Withdrawal by Subject|0|||
48743993|NCT00042289|156912389|FG012|Overall Study|Withdrawal by Subject|2|||
48325724|NCT02404441|155390761|FG009|Phase 2 Part|Adverse Event|1|||
48325725|NCT02404441|155390752|FG000|Phase 2 Part|Physician Decision|0|||
48325726|NCT02404441|155390753|FG001|Phase 2 Part|Physician Decision|0|||
48325727|NCT02404441|155390754|FG002|Phase 2 Part|Physician Decision|0|||
48325728|NCT02404441|155390755|FG003|Phase 2 Part|Physician Decision|0|||
48325729|NCT02404441|155390756|FG004|Phase 2 Part|Physician Decision|0|||
48325730|NCT02404441|155390757|FG005|Phase 2 Part|Physician Decision|7|||
48325731|NCT02404441|155390758|FG006|Phase 2 Part|Physician Decision|9|||
48325732|NCT02404441|155390759|FG007|Phase 2 Part|Physician Decision|2|||
48325733|NCT02404441|155390760|FG008|Phase 2 Part|Physician Decision|1|||
48325734|NCT02404441|155390761|FG009|Phase 2 Part|Physician Decision|3|||
48325735|NCT02404441|155390752|FG000|Phase 2 Part|Progressive disease|0|||
48325736|NCT02404441|155390753|FG001|Phase 2 Part|Progressive disease|0|||
48325737|NCT02404441|155390754|FG002|Phase 2 Part|Progressive disease|0|||
48325738|NCT02404441|155390755|FG003|Phase 2 Part|Progressive disease|0|||
48325739|NCT02404441|155390756|FG004|Phase 2 Part|Progressive disease|0|||
48325740|NCT02404441|155390757|FG005|Phase 2 Part|Progressive disease|43|||
48631280|NCT01948427|156508044|FG003|Overall Study|Lost to Follow-up|0|||
48631281|NCT01948427|156508045|FG004|Overall Study|Lost to Follow-up|4|||
48631282|NCT01948427|156508041|FG000|Overall Study|Withdrawal by Subject|2|||
48631283|NCT01948427|156508042|FG001|Overall Study|Withdrawal by Subject|0|||
48631284|NCT01948427|156508043|FG002|Overall Study|Withdrawal by Subject|0|||
48631285|NCT01948427|156508044|FG003|Overall Study|Withdrawal by Subject|0|||
48631286|NCT01948427|156508045|FG004|Overall Study|Withdrawal by Subject|1|||
48631287|NCT01948427|156508041|FG000|Overall Study|Other, Not Specified|1|||
48631288|NCT01948427|156508042|FG001|Overall Study|Other, Not Specified|9|||
48631289|NCT01948427|156508043|FG002|Overall Study|Other, Not Specified|0|||
48631290|NCT01948427|156508044|FG003|Overall Study|Other, Not Specified|0|||
48631291|NCT01948427|156508045|FG004|Overall Study|Other, Not Specified|2|||
48631292|NCT02314923|156508048|FG000|Overall Study|Death|0|||
48631293|NCT02314923|156508049|FG001|Overall Study|Death|0|||
48631294|NCT02314923|156508050|FG002|Overall Study|Death|0|||
48631295|NCT02314923|156508051|FG003|Overall Study|Death|1|||
48631296|NCT02314923|156508052|FG004|Overall Study|Death|0|||
48631297|NCT02314923|156508053|FG005|Overall Study|Death|0|||
48631298|NCT02314923|156508054|FG006|Overall Study|Death|0|||
48631299|NCT02314923|156508055|FG007|Overall Study|Death|0|||
48631300|NCT02314923|156508056|FG008|Overall Study|Death|0|||
48631301|NCT02314923|156508057|FG009|Overall Study|Death|0|||
48631302|NCT02314923|156508048|FG000|Overall Study|Lost to Follow-up|2|||
48631303|NCT02314923|156508049|FG001|Overall Study|Lost to Follow-up|3|||
48631304|NCT02314923|156508050|FG002|Overall Study|Lost to Follow-up|1|||
48631305|NCT02314923|156508051|FG003|Overall Study|Lost to Follow-up|0|||
48631306|NCT02314923|156508052|FG004|Overall Study|Lost to Follow-up|0|||
48631307|NCT02314923|156508053|FG005|Overall Study|Lost to Follow-up|0|||
48631308|NCT02314923|156508054|FG006|Overall Study|Lost to Follow-up|3|||
48631309|NCT02314923|156508055|FG007|Overall Study|Lost to Follow-up|4|||
48631310|NCT02314923|156508056|FG008|Overall Study|Lost to Follow-up|2|||
48631311|NCT02314923|156508057|FG009|Overall Study|Lost to Follow-up|0|||
48631312|NCT02314923|156508048|FG000|Overall Study|Withdrawal by Subject|0|||
48631313|NCT02314923|156508049|FG001|Overall Study|Withdrawal by Subject|0|||
48631314|NCT02314923|156508050|FG002|Overall Study|Withdrawal by Subject|1|||
48631315|NCT02314923|156508051|FG003|Overall Study|Withdrawal by Subject|0|||
48631316|NCT02314923|156508052|FG004|Overall Study|Withdrawal by Subject|1|||
48631317|NCT02314923|156508053|FG005|Overall Study|Withdrawal by Subject|0|||
48631318|NCT02314923|156508054|FG006|Overall Study|Withdrawal by Subject|1|||
48631319|NCT02314923|156508055|FG007|Overall Study|Withdrawal by Subject|0|||
48631320|NCT02314923|156508056|FG008|Overall Study|Withdrawal by Subject|0|||
48631321|NCT02314923|156508057|FG009|Overall Study|Withdrawal by Subject|0|||
48631322|NCT02314923|156508048|FG000|Overall Study|Physician Decision|0|||
48631323|NCT02314923|156508049|FG001|Overall Study|Physician Decision|1|||
48631324|NCT02314923|156508050|FG002|Overall Study|Physician Decision|0|||
48631325|NCT02314923|156508051|FG003|Overall Study|Physician Decision|0|||
48631326|NCT02314923|156508052|FG004|Overall Study|Physician Decision|0|||
48631327|NCT02314923|156508053|FG005|Overall Study|Physician Decision|0|||
48631328|NCT02314923|156508054|FG006|Overall Study|Physician Decision|0|||
48631329|NCT02314923|156508055|FG007|Overall Study|Physician Decision|0|||
48631330|NCT02314923|156508056|FG008|Overall Study|Physician Decision|0|||
48631331|NCT02314923|156508057|FG009|Overall Study|Physician Decision|0|||
48631332|NCT02314923|156508048|FG000|Overall Study|Participant unavailable|0|||
48631333|NCT02314923|156508049|FG001|Overall Study|Participant unavailable|0|||
48631334|NCT02314923|156508050|FG002|Overall Study|Participant unavailable|0|||
48631335|NCT02314923|156508051|FG003|Overall Study|Participant unavailable|0|||
48631336|NCT02314923|156508052|FG004|Overall Study|Participant unavailable|0|||
48631337|NCT02314923|156508053|FG005|Overall Study|Participant unavailable|1|||
48631338|NCT02314923|156508054|FG006|Overall Study|Participant unavailable|0|||
48631339|NCT02314923|156508055|FG007|Overall Study|Participant unavailable|0|||
48631340|NCT02314923|156508056|FG008|Overall Study|Participant unavailable|0|||
48631341|NCT02314923|156508057|FG009|Overall Study|Participant unavailable|0|||
48631342|NCT02314923|156508048|FG000|Overall Study|Screen failure|0|||
48631343|NCT02314923|156508049|FG001|Overall Study|Screen failure|0|||
48631344|NCT02314923|156508050|FG002|Overall Study|Screen failure|0|||
48631345|NCT02314923|156508051|FG003|Overall Study|Screen failure|0|||
48631346|NCT02314923|156508052|FG004|Overall Study|Screen failure|0|||
48325741|NCT02404441|155390758|FG006|Phase 2 Part|Progressive disease|32|||
48325742|NCT02404441|155390759|FG007|Phase 2 Part|Progressive disease|31|||
48743994|NCT00042289|156912390|FG013|Overall Study|Withdrawal by Subject|0|||
48743995|NCT00042289|156912391|FG014|Overall Study|Withdrawal by Subject|0|||
48743996|NCT00042289|156912392|FG015|Overall Study|Withdrawal by Subject|0|||
48743997|NCT00042289|156912393|FG016|Overall Study|Withdrawal by Subject|0|||
48743998|NCT00042289|156912394|FG017|Overall Study|Withdrawal by Subject|0|||
48743999|NCT00042289|156912395|FG018|Overall Study|Withdrawal by Subject|0|||
48744000|NCT00042289|156912396|FG019|Overall Study|Withdrawal by Subject|0|||
48744001|NCT00042289|156912397|FG020|Overall Study|Withdrawal by Subject|0|||
48744002|NCT00042289|156912398|FG021|Overall Study|Withdrawal by Subject|1|||
48744003|NCT00042289|156912399|FG022|Overall Study|Withdrawal by Subject|1|||
48744004|NCT00042289|156912400|FG023|Overall Study|Withdrawal by Subject|1|||
48631347|NCT02314923|156508053|FG005|Overall Study|Screen failure|0|||
48631348|NCT02314923|156508054|FG006|Overall Study|Screen failure|1|||
48744005|NCT00042289|156912401|FG024|Overall Study|Withdrawal by Subject|0|||
48744006|NCT00042289|156912402|FG025|Overall Study|Withdrawal by Subject|0|||
48744007|NCT00042289|156912403|FG026|Overall Study|Withdrawal by Subject|1|||
48744008|NCT00042289|156912404|FG027|Overall Study|Withdrawal by Subject|0|||
48744009|NCT00042289|156912405|FG028|Overall Study|Withdrawal by Subject|2|||
48744010|NCT00042289|156912406|FG029|Overall Study|Withdrawal by Subject|0|||
48631349|NCT02314923|156508055|FG007|Overall Study|Screen failure|0|||
48631350|NCT02314923|156508056|FG008|Overall Study|Screen failure|0|||
48631351|NCT02314923|156508057|FG009|Overall Study|Screen failure|0|||
48631352|NCT02314923|156508048|FG000|Overall Study|Participant relocation|1|||
48631353|NCT02314923|156508049|FG001|Overall Study|Participant relocation|0|||
48631354|NCT02314923|156508050|FG002|Overall Study|Participant relocation|0|||
48631355|NCT02314923|156508051|FG003|Overall Study|Participant relocation|0|||
48631356|NCT02314923|156508052|FG004|Overall Study|Participant relocation|0|||
48631357|NCT02314923|156508053|FG005|Overall Study|Participant relocation|0|||
48631358|NCT02314923|156508054|FG006|Overall Study|Participant relocation|0|||
48631359|NCT02314923|156508055|FG007|Overall Study|Participant relocation|1|||
48631360|NCT02314923|156508056|FG008|Overall Study|Participant relocation|0|||
48631361|NCT02314923|156508057|FG009|Overall Study|Participant relocation|0|||
48631362|NCT04476784|156508058|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
48631363|NCT04476784|156508059|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
48631364|NCT00841815|156508060|FG000|Washout|Withdrawal by Subject|0|||
48631365|NCT00841815|156508061|FG001|Washout|Withdrawal by Subject|1|||
48631366|NCT00863304|156508067|FG000|Overall Study|Adverse Event|10|||
48631367|NCT00863304|156508068|FG001|Overall Study|Adverse Event|4|||
48631368|NCT00863304|156508069|FG002|Overall Study|Adverse Event|14|||
48631369|NCT00863304|156508070|FG003|Overall Study|Adverse Event|16|||
48631370|NCT00863304|156508067|FG000|Overall Study|Lost to Follow-up|1|||
48631371|NCT00863304|156508068|FG001|Overall Study|Lost to Follow-up|5|||
48631372|NCT00863304|156508069|FG002|Overall Study|Lost to Follow-up|4|||
48631373|NCT00863304|156508070|FG003|Overall Study|Lost to Follow-up|2|||
48631374|NCT00863304|156508067|FG000|Overall Study|Lack of Efficacy|57|||
48631375|NCT00863304|156508068|FG001|Overall Study|Lack of Efficacy|26|||
48631376|NCT00863304|156508069|FG002|Overall Study|Lack of Efficacy|30|||
48744011|NCT00042289|156912407|FG030|Overall Study|Withdrawal by Subject|0|||
48744012|NCT00042289|156912408|FG031|Overall Study|Withdrawal by Subject|1|||
48744013|NCT00042289|156912409|FG032|Overall Study|Withdrawal by Subject|2|||
48744014|NCT00042289|156912410|FG033|Overall Study|Withdrawal by Subject|1|||
48744015|NCT00042289|156912411|FG034|Overall Study|Withdrawal by Subject|0|||
48744016|NCT00042289|156912412|FG035|Overall Study|Withdrawal by Subject|0|||
48744017|NCT00042289|156912413|FG036|Overall Study|Withdrawal by Subject|0|||
48744018|NCT00042289|156912414|FG037|Overall Study|Withdrawal by Subject|1|||
48744019|NCT00042289|156912415|FG038|Overall Study|Withdrawal by Subject|0|||
48744020|NCT00042289|156912416|FG039|Overall Study|Withdrawal by Subject|0|||
48744021|NCT00042289|156912417|FG040|Overall Study|Withdrawal by Subject|0|||
48744022|NCT00042289|156912418|FG041|Overall Study|Withdrawal by Subject|0|||
48744023|NCT00042289|156912419|FG042|Overall Study|Withdrawal by Subject|1|||
48744024|NCT00042289|156912420|FG043|Overall Study|Withdrawal by Subject|0|||
48744025|NCT00042289|156912421|FG044|Overall Study|Withdrawal by Subject|0|||
48744026|NCT00042289|156912422|FG045|Overall Study|Withdrawal by Subject|0|||
48744027|NCT00042289|156912423|FG046|Overall Study|Withdrawal by Subject|0|||
48744028|NCT04805541|156912430|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
48744029|NCT02195583|156912431|FG000|Overall Study|Lost to Follow-up|1|||
48744030|NCT02195583|156912431|FG000|Overall Study|Withdrawal by Subject|4|||
48744031|NCT02195583|156912431|FG000|Overall Study|Adverse Event|2|||
48744032|NCT02195583|156912431|FG000|Overall Study|Other Reason|2|||
48744033|NCT00395304|156912432|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48744034|NCT00395304|156912433|FG001|Treatment Period 1|Withdrawal by Subject|3|||
48744035|NCT00395304|156912434|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48744036|NCT00395304|156912435|FG003|Treatment Period 1|Withdrawal by Subject|2|||
48631377|NCT00863304|156508070|FG003|Overall Study|Lack of Efficacy|28|||
48631378|NCT00863304|156508067|FG000|Overall Study|Withdrawal by Subject|19|||
48631379|NCT00863304|156508068|FG001|Overall Study|Withdrawal by Subject|14|||
48744037|NCT00395304|156912436|FG004|Treatment Period 1|Withdrawal by Subject|1|||
48744038|NCT00395304|156912437|FG005|Treatment Period 1|Withdrawal by Subject|1|||
48744039|NCT00395304|156912432|FG000|Treatment Period 1|Lost to Follow-up|1|||
48744040|NCT00395304|156912433|FG001|Treatment Period 1|Lost to Follow-up|0|||
48744041|NCT00395304|156912434|FG002|Treatment Period 1|Lost to Follow-up|0|||
48325743|NCT02404441|155390760|FG008|Phase 2 Part|Progressive disease|39|||
48325744|NCT02404441|155390761|FG009|Phase 2 Part|Progressive disease|27|||
48325745|NCT02404441|155390752|FG000|Phase 2 Part|Subject/guardian decision|0|||
48325746|NCT02404441|155390753|FG001|Phase 2 Part|Subject/guardian decision|0|||
48325747|NCT02404441|155390754|FG002|Phase 2 Part|Subject/guardian decision|0|||
48631380|NCT00863304|156508069|FG002|Overall Study|Withdrawal by Subject|20|||
48631381|NCT00863304|156508070|FG003|Overall Study|Withdrawal by Subject|18|||
48631382|NCT00863304|156508067|FG000|Overall Study|Other|1|||
48631383|NCT00863304|156508068|FG001|Overall Study|Other|0|||
48631384|NCT00863304|156508069|FG002|Overall Study|Other|0|||
48631385|NCT00863304|156508070|FG003|Overall Study|Other|1|||
48631386|NCT00863304|156508067|FG000|Overall Study|Protocol Violation|2|||
48631387|NCT00863304|156508068|FG001|Overall Study|Protocol Violation|6|||
48631388|NCT00863304|156508069|FG002|Overall Study|Protocol Violation|2|||
48631389|NCT00863304|156508070|FG003|Overall Study|Protocol Violation|0|||
48631390|NCT00863304|156508067|FG000|Overall Study|Randomized, but not Treated|3|||
48631391|NCT00863304|156508068|FG001|Overall Study|Randomized, but not Treated|1|||
48631392|NCT00863304|156508069|FG002|Overall Study|Randomized, but not Treated|4|||
48631393|NCT00863304|156508070|FG003|Overall Study|Randomized, but not Treated|1|||
48631394|NCT00863304|156508067|FG000|Overall Study|Entered extension study|101|||
48631395|NCT00863304|156508068|FG001|Overall Study|Entered extension study|129|||
48631396|NCT00863304|156508069|FG002|Overall Study|Entered extension study|113|||
48631397|NCT00863304|156508070|FG003|Overall Study|Entered extension study|125|||
48631398|NCT04617860|156508071|FG000|Overall Study|Adverse Event|0|||
48631399|NCT04617860|156508072|FG001|Overall Study|Adverse Event|2|||
48631400|NCT04617860|156508073|FG002|Overall Study|Adverse Event|2|||
48631401|NCT04617860|156508071|FG000|Overall Study|Withdrawal by Subject|0|||
48631402|NCT04617860|156508072|FG001|Overall Study|Withdrawal by Subject|0|||
48631403|NCT04617860|156508073|FG002|Overall Study|Withdrawal by Subject|2|||
48631404|NCT04617860|156508071|FG000|Overall Study|Physician Decision|0|||
48631405|NCT04617860|156508072|FG001|Overall Study|Physician Decision|1|||
48631406|NCT04617860|156508073|FG002|Overall Study|Physician Decision|0|||
48631407|NCT04617860|156508071|FG000|Overall Study|Sponsor Decision|0|||
48631408|NCT04617860|156508072|FG001|Overall Study|Sponsor Decision|3|||
48631409|NCT04617860|156508073|FG002|Overall Study|Sponsor Decision|1|||
48631410|NCT04617860|156508071|FG000|Overall Study|Termination of Study by Sponsor|8|||
48631411|NCT04617860|156508072|FG001|Overall Study|Termination of Study by Sponsor|4|||
48631412|NCT04617860|156508073|FG002|Overall Study|Termination of Study by Sponsor|13|||
48631413|NCT00478257|156508074|FG000|Overall Study|Withdrawal by Subject|8|||
48631414|NCT00478257|156508075|FG001|Overall Study|Withdrawal by Subject|3|||
48631415|NCT03931330|156508078|FG000|Overall Study|Physician Decision|1|||
48631416|NCT03738228|156508079|FG000|Overall Study|Never received study treatment|2|||
48631417|NCT03738228|156508080|FG001|Overall Study|Never received study treatment|2|||
48631418|NCT05473715|156508085|FG000|Overall Study|Trial terminate|2|||
48631419|NCT05473715|156508086|FG001|Overall Study|Trial terminate|1|||
48631420|NCT02496000|156508095|FG000|Overall Study|Withdrawal by Subject|1|||
48631421|NCT02496000|156508096|FG001|Overall Study|Withdrawal by Subject|2|||
48631422|NCT02496000|156508097|FG002|Overall Study|Withdrawal by Subject|0|||
48631423|NCT02496000|156508095|FG000|Overall Study|Lost to Follow-up|1|||
48631424|NCT02496000|156508096|FG001|Overall Study|Lost to Follow-up|0|||
48631425|NCT02496000|156508097|FG002|Overall Study|Lost to Follow-up|1|||
48631426|NCT02496000|156508095|FG000|Overall Study|Protocol Violation|0|||
48631427|NCT02496000|156508096|FG001|Overall Study|Protocol Violation|0|||
48631428|NCT02496000|156508097|FG002|Overall Study|Protocol Violation|1|||
48631429|NCT02496000|156508095|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
48631430|NCT02496000|156508096|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
48631431|NCT02496000|156508097|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
48631432|NCT02496000|156508095|FG000|Overall Study|undetermined|0|||
48631433|NCT02496000|156508096|FG001|Overall Study|undetermined|1|||
48631434|NCT02496000|156508097|FG002|Overall Study|undetermined|0|||
48631435|NCT03636022|156508098|FG000|Overall Study|Withdrawal by Subject|1|||
48631436|NCT03636022|156508099|FG001|Overall Study|Withdrawal by Subject|3|||
48631437|NCT01174563|156508102|FG000|Overall Study|Progressive Disease|45|||
48631438|NCT01174563|156508102|FG000|Overall Study|Death|5|||
48631439|NCT01174563|156508102|FG000|Overall Study|Investigator's Discretion|5|||
48631440|NCT01174563|156508102|FG000|Overall Study|Participant Withdrew Consent|3|||
48631441|NCT01174563|156508102|FG000|Overall Study|Rash Adverse Event|1|||
48631442|NCT01174563|156508102|FG000|Overall Study|Sponsor's decision|1|||
48325748|NCT02404441|155390755|FG003|Phase 2 Part|Subject/guardian decision|0|||
48631443|NCT00643279|156508106|FG000|Overall Study|Death|13|||
48631444|NCT00643279|156508107|FG001|Overall Study|Death|11|||
48631445|NCT00643279|156508106|FG000|Overall Study|Withdrawal by Subject|3|||
48744042|NCT00395304|156912435|FG003|Treatment Period 1|Lost to Follow-up|1|||
48744043|NCT00395304|156912436|FG004|Treatment Period 1|Lost to Follow-up|0|||
48744044|NCT00395304|156912437|FG005|Treatment Period 1|Lost to Follow-up|1|||
48744045|NCT00395304|156912432|FG000|Treatment Period 1|Physician Decision|0|||
48744046|NCT00395304|156912433|FG001|Treatment Period 1|Physician Decision|1|||
48744047|NCT00395304|156912434|FG002|Treatment Period 1|Physician Decision|0|||
48744048|NCT00395304|156912435|FG003|Treatment Period 1|Physician Decision|0|||
48744049|NCT00395304|156912436|FG004|Treatment Period 1|Physician Decision|0|||
48744050|NCT00395304|156912437|FG005|Treatment Period 1|Physician Decision|0|||
48744051|NCT00395304|156912432|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48631446|NCT00643279|156508107|FG001|Overall Study|Withdrawal by Subject|0|||
48744052|NCT00395304|156912433|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48744053|NCT00395304|156912434|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48744054|NCT00395304|156912435|FG003|Treatment Period 2|Withdrawal by Subject|1|||
48631447|NCT00643279|156508106|FG000|Overall Study|Lost to Follow-up|0|||
48631448|NCT00643279|156508107|FG001|Overall Study|Lost to Follow-up|1|||
48631449|NCT00643279|156508106|FG000|Overall Study|Physician Decision|0|||
48631450|NCT00643279|156508107|FG001|Overall Study|Physician Decision|1|||
48631451|NCT00404248|156508108|FG000|Overall Study|pts declining status|0|||
48631452|NCT00404248|156508109|FG001|Overall Study|pts declining status|1|||
48631453|NCT00404248|156508110|FG002|Overall Study|pts declining status|0|||
48631454|NCT00404248|156508111|FG003|Overall Study|pts declining status|0|||
48631455|NCT00404248|156508112|FG004|Overall Study|pts declining status|0|||
48631456|NCT00404248|156508113|FG005|Overall Study|pts declining status|0|||
48631457|NCT00404248|156508114|FG006|Overall Study|pts declining status|0|||
48631458|NCT00404248|156508115|FG007|Overall Study|pts declining status|0|||
48631459|NCT00404248|156508116|FG008|Overall Study|pts declining status|0|||
48631460|NCT01405196|156508117|FG000|Overall Study|Study Terminated by Sponsor|0|||
48631461|NCT01405196|156508118|FG001|Overall Study|Study Terminated by Sponsor|0|||
48631462|NCT01405196|156508119|FG002|Overall Study|Study Terminated by Sponsor|9|||
48631463|NCT01405196|156508120|FG003|Overall Study|Study Terminated by Sponsor|0|||
48631464|NCT01405196|156508117|FG000|Overall Study|Other|2|||
48631465|NCT01405196|156508118|FG001|Overall Study|Other|2|||
48631466|NCT01405196|156508119|FG002|Overall Study|Other|5|||
48631467|NCT01405196|156508120|FG003|Overall Study|Other|0|||
48631468|NCT01405196|156508117|FG000|Overall Study|Withdrawal by Subject|4|||
48631469|NCT01405196|156508118|FG001|Overall Study|Withdrawal by Subject|6|||
48631470|NCT01405196|156508119|FG002|Overall Study|Withdrawal by Subject|3|||
48631471|NCT01405196|156508120|FG003|Overall Study|Withdrawal by Subject|6|||
48631472|NCT01405196|156508117|FG000|Overall Study|Adverse Event|2|||
48631473|NCT01405196|156508118|FG001|Overall Study|Adverse Event|2|||
48744055|NCT00395304|156912436|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48744056|NCT00395304|156912437|FG005|Treatment Period 2|Withdrawal by Subject|2|||
48325749|NCT02404441|155390756|FG004|Phase 2 Part|Subject/guardian decision|0|||
48325750|NCT02404441|155390757|FG005|Phase 2 Part|Subject/guardian decision|3|||
48325751|NCT02404441|155390758|FG006|Phase 2 Part|Subject/guardian decision|9|||
48325752|NCT02404441|155390759|FG007|Phase 2 Part|Subject/guardian decision|0|||
48325753|NCT02404441|155390760|FG008|Phase 2 Part|Subject/guardian decision|3|||
48325754|NCT02404441|155390761|FG009|Phase 2 Part|Subject/guardian decision|2|||
48325755|NCT02404441|155390752|FG000|Phase 2 Part|Death|0|||
48325756|NCT02404441|155390753|FG001|Phase 2 Part|Death|0|||
48325757|NCT02404441|155390754|FG002|Phase 2 Part|Death|0|||
48325758|NCT02404441|155390755|FG003|Phase 2 Part|Death|0|||
48325759|NCT02404441|155390756|FG004|Phase 2 Part|Death|0|||
48325760|NCT02404441|155390757|FG005|Phase 2 Part|Death|4|||
48325761|NCT02404441|155390758|FG006|Phase 2 Part|Death|8|||
48325762|NCT02404441|155390759|FG007|Phase 2 Part|Death|4|||
48325763|NCT02404441|155390760|FG008|Phase 2 Part|Death|10|||
48631474|NCT01405196|156508119|FG002|Overall Study|Adverse Event|0|||
48744057|NCT00395304|156912432|FG000|Treatment Period 2|Lost to Follow-up|0|||
48744058|NCT00395304|156912433|FG001|Treatment Period 2|Lost to Follow-up|3|||
48744059|NCT00395304|156912434|FG002|Treatment Period 2|Lost to Follow-up|0|||
48744060|NCT00395304|156912435|FG003|Treatment Period 2|Lost to Follow-up|0|||
48325764|NCT02404441|155390761|FG009|Phase 2 Part|Death|9|||
48325765|NCT03205566|155390762|FG000|Phase 1|Protocol Violation|1|||
48325766|NCT03205566|155390763|FG001|Phase 1|Protocol Violation|1|||
48325767|NCT03739866|155390764|FG000|Overall Study|Lost to Follow-up|0|||
48325768|NCT03739866|155390765|FG001|Overall Study|Lost to Follow-up|0|||
48325769|NCT03739866|155390766|FG002|Overall Study|Lost to Follow-up|0|||
48631475|NCT01405196|156508120|FG003|Overall Study|Adverse Event|2|||
48631476|NCT01405196|156508117|FG000|Overall Study|Death|1|||
48631477|NCT01405196|156508118|FG001|Overall Study|Death|0|||
48631478|NCT01405196|156508119|FG002|Overall Study|Death|3|||
48631479|NCT01405196|156508120|FG003|Overall Study|Death|0|||
48631480|NCT01405196|156508117|FG000|Overall Study|Lost to Follow-up|2|||
48631481|NCT01405196|156508118|FG001|Overall Study|Lost to Follow-up|2|||
48631482|NCT01405196|156508119|FG002|Overall Study|Lost to Follow-up|3|||
48631483|NCT01405196|156508120|FG003|Overall Study|Lost to Follow-up|1|||
48631484|NCT04038957|156509528|FG000|Overall Study|Withdrawal by Subject|1|||
48744061|NCT00395304|156912436|FG004|Treatment Period 2|Lost to Follow-up|0|||
48744062|NCT00395304|156912437|FG005|Treatment Period 2|Lost to Follow-up|0|||
48744063|NCT00395304|156912432|FG000|Treatment Period 2|Physician Decision|0|||
48744064|NCT00395304|156912433|FG001|Treatment Period 2|Physician Decision|0|||
48744065|NCT00395304|156912434|FG002|Treatment Period 2|Physician Decision|1|||
48744066|NCT00395304|156912435|FG003|Treatment Period 2|Physician Decision|0|||
48744067|NCT00395304|156912436|FG004|Treatment Period 2|Physician Decision|0|||
48744068|NCT00395304|156912437|FG005|Treatment Period 2|Physician Decision|0|||
48325770|NCT03739866|155390767|FG003|Overall Study|Lost to Follow-up|1|||
48325771|NCT03739866|155390768|FG004|Overall Study|Lost to Follow-up|0|||
48325772|NCT03739866|155390769|FG005|Overall Study|Lost to Follow-up|0|||
48631485|NCT04038957|156509528|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
48631486|NCT03189524|156509529|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
48631487|NCT03189524|156509530|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
48631488|NCT03189524|156509531|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
48631489|NCT03189524|156509529|FG000|Overall Study|Death|2|||
48631490|NCT03189524|156509530|FG001|Overall Study|Death|2|||
48631491|NCT03189524|156509531|FG002|Overall Study|Death|1|||
48631492|NCT03189524|156509529|FG000|Overall Study|Lost to Follow-up|1|||
48631493|NCT03189524|156509530|FG001|Overall Study|Lost to Follow-up|0|||
48631494|NCT03189524|156509531|FG002|Overall Study|Lost to Follow-up|8|||
48631495|NCT03189524|156509529|FG000|Overall Study|Withdrawal by Subject|1|||
48631496|NCT03189524|156509530|FG001|Overall Study|Withdrawal by Subject|1|||
48631497|NCT03189524|156509531|FG002|Overall Study|Withdrawal by Subject|3|||
48631498|NCT03189524|156509529|FG000|Overall Study|Progressive Disease|0|||
48631499|NCT03189524|156509530|FG001|Overall Study|Progressive Disease|2|||
48631500|NCT03189524|156509531|FG002|Overall Study|Progressive Disease|0|||
48631501|NCT04129398|156509532|FG000|Overall Study|Physician Decision|2|||
48631502|NCT03058952|156509533|FG000|Overall Study|Adverse Event|1|||
48631503|NCT03058952|156509534|FG001|Overall Study|Adverse Event|0|||
48631504|NCT03058952|156509533|FG000|Overall Study|Lost to Follow-up|15|||
48631505|NCT03058952|156509534|FG001|Overall Study|Lost to Follow-up|15|||
48631506|NCT03058952|156509533|FG000|Overall Study|Withdrawal by Subject|7|||
48631507|NCT03058952|156509534|FG001|Overall Study|Withdrawal by Subject|11|||
48631508|NCT03271151|156509536|FG000|Overall Study|Lost to Follow-up|1|||
48631509|NCT03271151|156509537|FG001|Overall Study|Lost to Follow-up|3|||
48631510|NCT03271151|156509536|FG000|Overall Study|Withdrawal by Subject|1|||
48631511|NCT03271151|156509537|FG001|Overall Study|Withdrawal by Subject|0|||
48631512|NCT04439253|156509538|FG000|Overall Study|Adverse Event|1|||
48744069|NCT00395304|156912432|FG000|Treatment Period 2|Other|0|||
48744070|NCT00395304|156912433|FG001|Treatment Period 2|Other|1|||
48744071|NCT00395304|156912434|FG002|Treatment Period 2|Other|0|||
48325773|NCT03739866|155390770|FG006|Overall Study|Lost to Follow-up|0|||
48325774|NCT03739866|155390771|FG007|Overall Study|Lost to Follow-up|0|||
48325775|NCT03739866|155390764|FG000|Overall Study|Enrolled but not treated|0|||
48325776|NCT03739866|155390765|FG001|Overall Study|Enrolled but not treated|0|||
48325777|NCT03739866|155390766|FG002|Overall Study|Enrolled but not treated|1|||
48325778|NCT03739866|155390767|FG003|Overall Study|Enrolled but not treated|0|||
48325779|NCT03739866|155390768|FG004|Overall Study|Enrolled but not treated|1|||
48325780|NCT03739866|155390769|FG005|Overall Study|Enrolled but not treated|0|||
48325781|NCT03739866|155390770|FG006|Overall Study|Enrolled but not treated|0|||
48325782|NCT03739866|155390771|FG007|Overall Study|Enrolled but not treated|0|||
48325783|NCT01767467|155390772|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
48325784|NCT01767467|155390773|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
48325785|NCT01767467|155390772|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
48325786|NCT01767467|155390773|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
48325787|NCT01767467|155390772|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
48325788|NCT01767467|155390773|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
48325789|NCT01767467|155390772|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
48325790|NCT01767467|155390773|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
48325791|NCT01767467|155390772|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
48325792|NCT01767467|155390773|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
48325793|NCT01767467|155390772|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
48325794|NCT01767467|155390773|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
48325795|NCT01767467|155390772|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
48325796|NCT01767467|155390773|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
48426292|NCT00053846|155749528|FG001|Overall Study|Did not return data|2|||
48631513|NCT04439253|156509538|FG000|Overall Study|Disease progression|2|||
48631514|NCT04439253|156509538|FG000|Overall Study|Complicating disease|1|||
48631515|NCT03433339|156509539|FG000|Overall Study|Lost to Follow-up|2|||
48631516|NCT03433339|156509540|FG001|Overall Study|Lost to Follow-up|0|||
48631517|NCT03433339|156509539|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
48631518|NCT03433339|156509540|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
48325797|NCT01767467|155390772|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
48325798|NCT01767467|155390773|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
48325799|NCT01767467|155390772|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
48631519|NCT03433339|156509539|FG000|Overall Study|Withdrawal by Subject|0|||
48631520|NCT03433339|156509540|FG001|Overall Study|Withdrawal by Subject|2|||
48631521|NCT00936936|156509542|FG000|Overall Study|Adverse Event|7|||
48631522|NCT00936936|156509543|FG001|Overall Study|Adverse Event|1|||
48631523|NCT00936936|156509542|FG000|Overall Study|Disease Progression|2|||
48631524|NCT00936936|156509543|FG001|Overall Study|Disease Progression|2|||
48631525|NCT00936936|156509542|FG000|Overall Study|Unrelated|3|||
48631526|NCT00936936|156509543|FG001|Overall Study|Unrelated|1|||
48631527|NCT01394185|156509545|FG000|Overall Study|Withdrawal by Subject|2|||
48631528|NCT01394185|156509546|FG001|Overall Study|Withdrawal by Subject|0|||
48631529|NCT01394185|156509547|FG002|Overall Study|Withdrawal by Subject|0|||
48631530|NCT01394185|156509548|FG003|Overall Study|Withdrawal by Subject|0|||
48631531|NCT01394185|156509549|FG004|Overall Study|Withdrawal by Subject|1|||
48631532|NCT01394185|156509550|FG005|Overall Study|Withdrawal by Subject|0|||
48631533|NCT01394185|156509545|FG000|Overall Study|Change in protocol|3|||
48631534|NCT01394185|156509546|FG001|Overall Study|Change in protocol|0|||
48631535|NCT01394185|156509547|FG002|Overall Study|Change in protocol|0|||
48631536|NCT01394185|156509548|FG003|Overall Study|Change in protocol|0|||
48631537|NCT01394185|156509549|FG004|Overall Study|Change in protocol|3|||
48631538|NCT01394185|156509550|FG005|Overall Study|Change in protocol|0|||
48631539|NCT01394185|156509545|FG000|Overall Study|Protocol Violation|1|||
48631540|NCT01394185|156509546|FG001|Overall Study|Protocol Violation|0|||
48631541|NCT01394185|156509547|FG002|Overall Study|Protocol Violation|0|||
48631542|NCT01394185|156509548|FG003|Overall Study|Protocol Violation|1|||
48631543|NCT01394185|156509549|FG004|Overall Study|Protocol Violation|0|||
48631544|NCT01394185|156509550|FG005|Overall Study|Protocol Violation|1|||
48631545|NCT01585025|156509551|FG000|Overall Study|Withdrawal by Subject|0|||
48631546|NCT01585025|156509552|FG001|Overall Study|Withdrawal by Subject|3|||
48631547|NCT01585025|156509553|FG002|Overall Study|Withdrawal by Subject|4|||
48631548|NCT04123704|156509557|FG000|Overall Study|Disease progression|2|||
48631549|NCT02965716|156509558|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
48631550|NCT02965716|156509559|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
48631551|NCT02965716|156509558|FG000|Overall Study|Progression/Relapse|8|||
48631552|NCT02965716|156509559|FG001|Overall Study|Progression/Relapse|16|||
48631553|NCT02965716|156509558|FG000|Overall Study|Death|1|||
48631554|NCT02965716|156509559|FG001|Overall Study|Death|0|||
48631555|NCT02965716|156509558|FG000|Overall Study|Not Protocol Specified|1|||
48631556|NCT02965716|156509559|FG001|Overall Study|Not Protocol Specified|3|||
48631557|NCT03360344|156509561|FG000|Overall Study|Withdrawal by Subject|0|||
48631558|NCT03360344|156509562|FG001|Overall Study|Withdrawal by Subject|1|||
48631559|NCT03360344|156509563|FG002|Overall Study|Withdrawal by Subject|1|||
48631560|NCT03468998|156509564|FG000|Overall Study|Withdrawal by Subject|1|||
48631561|NCT03468998|156509565|FG001|Overall Study|Withdrawal by Subject|1|||
48631562|NCT03468998|156509566|FG002|Overall Study|Withdrawal by Subject|0|||
48631563|NCT03468998|156509567|FG003|Overall Study|Withdrawal by Subject|4|||
48631564|NCT03468998|156509568|FG004|Overall Study|Withdrawal by Subject|1|||
48631565|NCT03468998|156509569|FG005|Overall Study|Withdrawal by Subject|0|||
48631566|NCT03257657|156509571|FG000|Overall Study|Lost to Follow-up|0|||
48631567|NCT03257657|156509572|FG001|Overall Study|Lost to Follow-up|3|||
48631568|NCT03257657|156509571|FG000|Overall Study|Withdrawn|0|||
48631569|NCT03257657|156509572|FG001|Overall Study|Withdrawn|1|||
48631570|NCT03257657|156509571|FG000|Overall Study|Noted not eligible right after enrolled|0|||
48631571|NCT03257657|156509572|FG001|Overall Study|Noted not eligible right after enrolled|1|||
48631572|NCT02989857|156509576|FG000|Randomization Phase|Not Treated|3|||
48631573|NCT02989857|156509577|FG001|Randomization Phase|Not Treated|2|||
48631574|NCT02989857|156509578|FG002|Randomization Phase|Not Treated|0|||
48744072|NCT00395304|156912435|FG003|Treatment Period 2|Other|0|||
48744073|NCT00395304|156912436|FG004|Treatment Period 2|Other|0|||
48744074|NCT00395304|156912437|FG005|Treatment Period 2|Other|0|||
48744075|NCT00395304|156912432|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48325800|NCT01767467|155390773|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
48325801|NCT01767467|155390772|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
48631575|NCT02489279|156509579|FG000|Overall Study|Lost to Follow-up|12|||
48631576|NCT02489279|156509580|FG001|Overall Study|Lost to Follow-up|10|||
48631577|NCT04150718|156509581|FG000|Overall Study|Withdrawal by Subject|2|||
48631578|NCT04150718|156509582|FG001|Overall Study|Withdrawal by Subject|7|||
48631579|NCT04150718|156509583|FG002|Overall Study|Withdrawal by Subject|1|||
48631580|NCT04150718|156509581|FG000|Overall Study|Lost to Follow-up|1|||
48631581|NCT04150718|156509582|FG001|Overall Study|Lost to Follow-up|2|||
48631582|NCT04150718|156509583|FG002|Overall Study|Lost to Follow-up|0|||
48631583|NCT04150718|156509581|FG000|Overall Study|Ineligible|1|||
48631584|NCT04150718|156509582|FG001|Overall Study|Ineligible|0|||
48631585|NCT04150718|156509583|FG002|Overall Study|Ineligible|10|||
48631586|NCT01992757|156509584|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
48744076|NCT00395304|156912433|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48631587|NCT04992273|156509585|FG000|Overall Study|Lost to Follow-up|0|||
48631588|NCT04992273|156509586|FG001|Overall Study|Lost to Follow-up|1|||
48631589|NCT03440411|156509587|FG000|Overall Study|Adverse Event|0|||
48631590|NCT03440411|156509588|FG001|Overall Study|Adverse Event|0|||
48631591|NCT03440411|156509589|FG002|Overall Study|Adverse Event|1|||
48631592|NCT03440411|156509590|FG003|Overall Study|Adverse Event|0|||
48631593|NCT03440411|156509587|FG000|Overall Study|PD|2|||
48631594|NCT03440411|156509588|FG001|Overall Study|PD|1|||
48631595|NCT03440411|156509589|FG002|Overall Study|PD|1|||
48631596|NCT03440411|156509590|FG003|Overall Study|PD|1|||
48631597|NCT03440411|156509587|FG000|Overall Study|Withdrawal by Subject|1|||
48631598|NCT03440411|156509588|FG001|Overall Study|Withdrawal by Subject|0|||
48631599|NCT03440411|156509589|FG002|Overall Study|Withdrawal by Subject|0|||
48631600|NCT03440411|156509590|FG003|Overall Study|Withdrawal by Subject|0|||
48631601|NCT03440411|156509587|FG000|Overall Study|Closed study by sponsor|0|||
48631602|NCT03440411|156509588|FG001|Overall Study|Closed study by sponsor|0|||
48631603|NCT03440411|156509589|FG002|Overall Study|Closed study by sponsor|0|||
48631604|NCT03440411|156509590|FG003|Overall Study|Closed study by sponsor|1|||
48631605|NCT02014467|156509593|FG000|Overall Study|Adverse Event|4|||
48631606|NCT02014467|156509594|FG001|Overall Study|Adverse Event|0|||
48631607|NCT02014467|156509593|FG000|Overall Study|Protocol Violation|3|||
48631608|NCT02014467|156509594|FG001|Overall Study|Protocol Violation|0|||
48631609|NCT02014467|156509593|FG000|Overall Study|Physician Decision|2|||
48631610|NCT02014467|156509594|FG001|Overall Study|Physician Decision|3|||
48631611|NCT02014467|156509593|FG000|Overall Study|Withdrawal by Subject|16|||
48631612|NCT02014467|156509594|FG001|Overall Study|Withdrawal by Subject|4|||
48631613|NCT01217892|156509595|FG000|Overall Study|Adverse Event|1|||
48631614|NCT01217892|156509596|FG001|Overall Study|Adverse Event|1|||
48631615|NCT01217892|156509597|FG002|Overall Study|Adverse Event|1|||
48631616|NCT01217892|156509598|FG003|Overall Study|Adverse Event|0|||
48631617|NCT01217892|156509595|FG000|Overall Study|Withdrawal by Subject|0|||
48631618|NCT01217892|156509596|FG001|Overall Study|Withdrawal by Subject|2|||
48631619|NCT01217892|156509597|FG002|Overall Study|Withdrawal by Subject|1|||
48631620|NCT01217892|156509598|FG003|Overall Study|Withdrawal by Subject|0|||
48631621|NCT01217892|156509595|FG000|Overall Study|Lab value|1|||
48631622|NCT01217892|156509596|FG001|Overall Study|Lab value|0|||
48631623|NCT01217892|156509597|FG002|Overall Study|Lab value|1|||
48631624|NCT01217892|156509598|FG003|Overall Study|Lab value|0|||
48631625|NCT01217892|156509595|FG000|Overall Study|Subject no longer meets study criteria|5|||
48631626|NCT01217892|156509596|FG001|Overall Study|Subject no longer meets study criteria|2|||
48631627|NCT01217892|156509597|FG002|Overall Study|Subject no longer meets study criteria|4|||
48631628|NCT01217892|156509598|FG003|Overall Study|Subject no longer meets study criteria|8|||
48631629|NCT01217892|156509595|FG000|Overall Study|Incorrect enrollment|0|||
48631630|NCT01217892|156509596|FG001|Overall Study|Incorrect enrollment|1|||
48631631|NCT01217892|156509597|FG002|Overall Study|Incorrect enrollment|1|||
48631632|NCT01217892|156509598|FG003|Overall Study|Incorrect enrollment|0|||
48631633|NCT01217892|156509595|FG000|Overall Study|Poor/Non-Compliance|0|||
48631634|NCT01217892|156509596|FG001|Overall Study|Poor/Non-Compliance|0|||
48631635|NCT01217892|156509597|FG002|Overall Study|Poor/Non-Compliance|1|||
48631636|NCT01217892|156509598|FG003|Overall Study|Poor/Non-Compliance|0|||
48631637|NCT00183248|156509600|FG000|Overall Study|Lost to Follow-up|0|||
48631638|NCT00183248|156509601|FG001|Overall Study|Lost to Follow-up|1|||
48631639|NCT00183248|156509600|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
48631640|NCT00183248|156509601|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
48631641|NCT00779909|156509602|FG000|Overall Study|Lost to Follow-up|1|||
48631642|NCT00779909|156509603|FG001|Overall Study|Lost to Follow-up|0|||
48631643|NCT00779909|156509604|FG002|Overall Study|Lost to Follow-up|0|||
48631644|NCT00779909|156509605|FG003|Overall Study|Lost to Follow-up|1|||
48631645|NCT00779909|156509602|FG000|Overall Study|Withdrawal by Subject|0|||
48631646|NCT00779909|156509603|FG001|Overall Study|Withdrawal by Subject|1|||
48631647|NCT00779909|156509604|FG002|Overall Study|Withdrawal by Subject|0|||
48631648|NCT00779909|156509605|FG003|Overall Study|Withdrawal by Subject|0|||
48631649|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
48631650|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
48631651|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
48631652|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
48631653|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
48631654|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
48631655|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
48631656|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
48631657|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
48631658|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
48631659|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
48631660|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
48744077|NCT00395304|156912434|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48744078|NCT00395304|156912435|FG003|Treatment Period 3|Withdrawal by Subject|1|||
48744079|NCT00395304|156912436|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48744080|NCT00395304|156912437|FG005|Treatment Period 3|Withdrawal by Subject|1|||
48744081|NCT00395304|156912432|FG000|Treatment Period 3|Lost to Follow-up|1|||
48744082|NCT00395304|156912433|FG001|Treatment Period 3|Lost to Follow-up|1|||
48631661|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
48631662|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
48631663|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
48631664|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
48631665|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
48631666|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
48744083|NCT00395304|156912434|FG002|Treatment Period 3|Lost to Follow-up|0|||
48744084|NCT00395304|156912435|FG003|Treatment Period 3|Lost to Follow-up|0|||
48744085|NCT00395304|156912436|FG004|Treatment Period 3|Lost to Follow-up|0|||
48744086|NCT00395304|156912437|FG005|Treatment Period 3|Lost to Follow-up|0|||
48744087|NCT00395304|156912432|FG000|Treatment Period 3|Physician Decision|0|||
48744088|NCT00395304|156912433|FG001|Treatment Period 3|Physician Decision|1|||
48631667|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
48631668|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
48744089|NCT00395304|156912434|FG002|Treatment Period 3|Physician Decision|0|||
48744090|NCT00395304|156912435|FG003|Treatment Period 3|Physician Decision|0|||
48744091|NCT00395304|156912436|FG004|Treatment Period 3|Physician Decision|0|||
48744092|NCT00395304|156912437|FG005|Treatment Period 3|Physician Decision|0|||
48744093|NCT00395304|156912432|FG000|Treatment Period 3|Other|0|||
48744094|NCT00395304|156912433|FG001|Treatment Period 3|Other|0|||
48744095|NCT00395304|156912434|FG002|Treatment Period 3|Other|0|||
48744096|NCT00395304|156912435|FG003|Treatment Period 3|Other|1|||
48744097|NCT00395304|156912436|FG004|Treatment Period 3|Other|0|||
48744098|NCT00395304|156912437|FG005|Treatment Period 3|Other|0|||
48744099|NCT03486223|156912447|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
48744100|NCT03486223|156912448|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
48744101|NCT01819831|156912449|FG000|Overall Study|Withdrawal by Subject|1|||
48744102|NCT01749137|156912453|FG000|Overall Study|Adverse Event|4|||
48744103|NCT01749137|156912454|FG001|Overall Study|Adverse Event|4|||
48744104|NCT01749137|156912453|FG000|Overall Study|Lost to Follow-up|2|||
48744105|NCT01749137|156912454|FG001|Overall Study|Lost to Follow-up|3|||
48744106|NCT01749137|156912453|FG000|Overall Study|Physician Decision|1|||
48744107|NCT01749137|156912454|FG001|Overall Study|Physician Decision|0|||
48744108|NCT01749137|156912453|FG000|Overall Study|Withdrawal by Subject|8|||
48744109|NCT01749137|156912454|FG001|Overall Study|Withdrawal by Subject|4|||
48744110|NCT00680017|156912464|FG000|Overall Study|Adverse Event|13|||
48744111|NCT00680017|156912465|FG001|Overall Study|Adverse Event|7|||
48744112|NCT00680017|156912464|FG000|Overall Study|Withdrawal by Subject|2|||
48744113|NCT00680017|156912465|FG001|Overall Study|Withdrawal by Subject|5|||
48744114|NCT00680017|156912464|FG000|Overall Study|Lost to Follow-up|2|||
48744115|NCT00680017|156912465|FG001|Overall Study|Lost to Follow-up|0|||
48744116|NCT01434667|156912469|FG000|Overall Study|Lost to Follow-up|5|||
48744117|NCT01434667|156912470|FG001|Overall Study|Lost to Follow-up|10|||
48744118|NCT01546207|156912471|FG000|Overall Study|Death|1|||
48744119|NCT02601469|156912472|FG000|Overall Study|Enrolled in Error|1|||
48744120|NCT02601469|156912473|FG001|Overall Study|Enrolled in Error|0|||
48744121|NCT02555683|156912474|FG000|Overall Study|Physician Decision|1|||
48744122|NCT02555683|156912475|FG001|Overall Study|Physician Decision|0|||
48744123|NCT02555683|156912476|FG002|Overall Study|Physician Decision|2|||
48744124|NCT02555683|156912474|FG000|Overall Study|Lost to Follow-up|2|||
48744125|NCT02555683|156912475|FG001|Overall Study|Lost to Follow-up|1|||
48744126|NCT02555683|156912476|FG002|Overall Study|Lost to Follow-up|2|||
48744127|NCT02555683|156912474|FG000|Overall Study|Technical Problems|1|||
48744128|NCT02555683|156912475|FG001|Overall Study|Technical Problems|1|||
48744129|NCT02555683|156912476|FG002|Overall Study|Technical Problems|0|||
48744130|NCT02555683|156912474|FG000|Overall Study|Protocol deviation|0|||
48744131|NCT02555683|156912475|FG001|Overall Study|Protocol deviation|1|||
48744132|NCT02555683|156912476|FG002|Overall Study|Protocol deviation|0|||
48744133|NCT02555683|156912474|FG000|Overall Study|Lack of Efficacy|2|||
48744134|NCT02555683|156912475|FG001|Overall Study|Lack of Efficacy|0|||
48744135|NCT02555683|156912476|FG002|Overall Study|Lack of Efficacy|0|||
48744136|NCT02555683|156912474|FG000|Overall Study|Death|0|||
48744137|NCT02555683|156912475|FG001|Overall Study|Death|1|||
48744138|NCT02555683|156912476|FG002|Overall Study|Death|2|||
48744139|NCT02555683|156912474|FG000|Overall Study|Adverse Event|1|||
48744140|NCT02555683|156912475|FG001|Overall Study|Adverse Event|0|||
48744141|NCT02555683|156912476|FG002|Overall Study|Adverse Event|1|||
48744142|NCT02555683|156912474|FG000|Overall Study|Subject/guardian decision|12|||
48744143|NCT02555683|156912475|FG001|Overall Study|Subject/guardian decision|12|||
48744144|NCT02555683|156912476|FG002|Overall Study|Subject/guardian decision|22|||
48631669|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
48631670|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
48631671|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
48631672|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
48631673|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
48631674|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
48631675|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
48631676|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
48631677|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
48631678|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
48631679|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
48631680|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
48631681|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631682|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631683|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
48631684|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631685|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631686|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48744145|NCT02555683|156912474|FG000|Overall Study|Death post Treatment/safety period|0|||
48744146|NCT02555683|156912475|FG001|Overall Study|Death post Treatment/safety period|1|||
48744147|NCT02555683|156912476|FG002|Overall Study|Death post Treatment/safety period|0|||
48744148|NCT02165215|156912477|FG000|Induction Phase|Adverse Event|1|||
48744149|NCT02165215|156912478|FG001|Induction Phase|Adverse Event|0|||
48744150|NCT02165215|156912479|FG002|Induction Phase|Adverse Event|0|||
48744151|NCT02165215|156912477|FG000|Induction Phase|Withdrawal by Subject|10|||
48744152|NCT02165215|156912478|FG001|Induction Phase|Withdrawal by Subject|0|||
48744153|NCT02165215|156912479|FG002|Induction Phase|Withdrawal by Subject|0|||
48744154|NCT02165215|156912477|FG000|Induction Phase|Protocol Violation|1|||
48744155|NCT02165215|156912478|FG001|Induction Phase|Protocol Violation|0|||
48744156|NCT02165215|156912479|FG002|Induction Phase|Protocol Violation|0|||
48744157|NCT02165215|156912477|FG000|Induction Phase|Physician Decision|1|||
48744158|NCT02165215|156912478|FG001|Induction Phase|Physician Decision|0|||
48744159|NCT02165215|156912479|FG002|Induction Phase|Physician Decision|0|||
48744160|NCT02165215|156912477|FG000|Induction Phase|Lack of Efficacy|2|||
48744161|NCT02165215|156912478|FG001|Induction Phase|Lack of Efficacy|0|||
48744162|NCT02165215|156912479|FG002|Induction Phase|Lack of Efficacy|0|||
48744163|NCT02165215|156912477|FG000|Induction Phase|Non-Compliance|2|||
48744164|NCT02165215|156912478|FG001|Induction Phase|Non-Compliance|0|||
48744165|NCT02165215|156912479|FG002|Induction Phase|Non-Compliance|0|||
48744166|NCT02165215|156912477|FG000|Induction Phase|Lost to Follow-up|6|||
48744167|NCT02165215|156912478|FG001|Induction Phase|Lost to Follow-up|0|||
48744168|NCT02165215|156912479|FG002|Induction Phase|Lost to Follow-up|0|||
48744169|NCT02165215|156912477|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48744170|NCT02165215|156912478|FG001|Maintenance Phase|Withdrawal by Subject|7|||
48744171|NCT02165215|156912479|FG002|Maintenance Phase|Withdrawal by Subject|3|||
48744172|NCT02165215|156912477|FG000|Maintenance Phase|Multiple reasons|0|||
48744173|NCT02165215|156912478|FG001|Maintenance Phase|Multiple reasons|2|||
48744174|NCT02165215|156912479|FG002|Maintenance Phase|Multiple reasons|1|||
48744175|NCT02165215|156912477|FG000|Maintenance Phase|Lost to Follow-up|0|||
48744176|NCT02165215|156912478|FG001|Maintenance Phase|Lost to Follow-up|2|||
48744177|NCT02165215|156912479|FG002|Maintenance Phase|Lost to Follow-up|0|||
48744178|NCT02165215|156912477|FG000|Maintenance Phase|Adverse Event|0|||
48744179|NCT02165215|156912478|FG001|Maintenance Phase|Adverse Event|1|||
48744180|NCT02165215|156912479|FG002|Maintenance Phase|Adverse Event|1|||
48744181|NCT01877265|156912481|FG000|Treatment Period 1|Sponsor Decision|0|||
48744182|NCT01877265|156912482|FG001|Treatment Period 1|Sponsor Decision|0|||
48744183|NCT01877265|156912483|FG002|Treatment Period 1|Sponsor Decision|1|||
48744184|NCT01877265|156912484|FG003|Treatment Period 1|Sponsor Decision|0|||
48744185|NCT01877265|156912485|FG004|Treatment Period 1|Sponsor Decision|0|||
48744186|NCT01877265|156912486|FG005|Treatment Period 1|Sponsor Decision|0|||
48744187|NCT01877265|156912481|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744188|NCT01877265|156912482|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744189|NCT01877265|156912483|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744190|NCT01877265|156912484|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744191|NCT01877265|156912485|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
48744192|NCT01877265|156912486|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
48692648|NCT03001557|156724544|FG003|Extension Phase|Administrative Reason|0|||
48744193|NCT01877265|156912481|FG000|Treatment Period 3|Lost to Follow-up|1|||
48744194|NCT01877265|156912482|FG001|Treatment Period 3|Lost to Follow-up|0|||
48744195|NCT01877265|156912483|FG002|Treatment Period 3|Lost to Follow-up|0|||
48744196|NCT01877265|156912484|FG003|Treatment Period 3|Lost to Follow-up|0|||
48744197|NCT01877265|156912485|FG004|Treatment Period 3|Lost to Follow-up|0|||
48744198|NCT01877265|156912486|FG005|Treatment Period 3|Lost to Follow-up|0|||
48744199|NCT01947582|156912487|FG000|Overall Study|Withdrawal by Subject|1|||
48744200|NCT03130257|156912488|FG000|Overall Study|Withdrawal by Subject|1|||
48744201|NCT03130257|156912489|FG001|Overall Study|Withdrawal by Subject|0|||
48744202|NCT03130257|156912490|FG002|Overall Study|Withdrawal by Subject|2|||
48744203|NCT00827502|156912492|FG000|Overall Study|randomized but not treated|11|||
48744204|NCT00827502|156912492|FG000|Overall Study|Adverse Event|1|||
48744205|NCT00827502|156912492|FG000|Overall Study|Lost to Follow-up|4|||
48744206|NCT00827502|156912492|FG000|Overall Study|Withdrawal by Subject|5|||
48744207|NCT04390191|156912493|FG000|Overall Study|Withdrawal by Subject|1|||
48744208|NCT04390191|156912494|FG001|Overall Study|Withdrawal by Subject|0|||
48744209|NCT00885846|156912498|FG000|Overall Study|Withdrawal by Subject|2|||
48744210|NCT00885846|156912499|FG001|Overall Study|Withdrawal by Subject|5|||
48744211|NCT00885846|156912500|FG002|Overall Study|Withdrawal by Subject|2|||
48744212|NCT02197247|156912501|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
48744213|NCT02197247|156912501|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
48744214|NCT02197247|156912501|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
48631687|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
48631688|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631689|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
48631690|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
48631691|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
48631692|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
48631693|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
48631694|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
48631695|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
48631696|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
48631697|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
48631698|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
48631699|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
48631700|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
48631701|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
48631702|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
48631703|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
48744215|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
48744216|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
48631704|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
48631705|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
48631706|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
48631707|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
48631708|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
48631709|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
48631710|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
48631711|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
48631712|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
48631713|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
48631714|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
48631715|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
48631716|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
48631717|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
48631718|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
48631719|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
48631720|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
48631721|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631722|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631723|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631724|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631725|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631726|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
48631727|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631728|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
48631729|NCT03896503|156509608|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
48631730|NCT03896503|156509609|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
48631731|NCT03896503|156509610|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
48631732|NCT03896503|156509611|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
48631733|NCT03896503|156509612|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
48631734|NCT03896503|156509613|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
48631735|NCT03896503|156509614|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
48631736|NCT03896503|156509615|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
48631737|NCT02367456|156509616|FG000|Overall Study|Death|8|||
48631738|NCT02367456|156509617|FG001|Overall Study|Death|24|||
48631739|NCT02367456|156509618|FG002|Overall Study|Death|17|||
48631740|NCT02367456|156509616|FG000|Overall Study|Lost to Follow-up|1|||
48631741|NCT02367456|156509617|FG001|Overall Study|Lost to Follow-up|3|||
48631742|NCT02367456|156509618|FG002|Overall Study|Lost to Follow-up|1|||
48631743|NCT02367456|156509616|FG000|Overall Study|Other reason|3|||
48631744|NCT02367456|156509617|FG001|Overall Study|Other reason|3|||
48631745|NCT02367456|156509618|FG002|Overall Study|Other reason|9|||
48631746|NCT02367456|156509616|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
48631747|NCT02367456|156509617|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
48631748|NCT02367456|156509618|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
48631749|NCT00329420|156509619|FG000|Re-induction Phase|Lack of Efficacy|0|||
48631750|NCT00329420|156509620|FG001|Re-induction Phase|Lack of Efficacy|1|||
48631751|NCT00329420|156509621|FG002|Re-induction Phase|Lack of Efficacy|0|||
48631752|NCT00329420|156509619|FG000|Re-induction Phase|Withdrawal of Consent|0|||
48631753|NCT00329420|156509620|FG001|Re-induction Phase|Withdrawal of Consent|0|||
48631754|NCT00329420|156509621|FG002|Re-induction Phase|Withdrawal of Consent|1|||
48631755|NCT00329420|156509619|FG000|Re-induction Phase|Did not respond to re-induction|6|||
48631756|NCT00329420|156509620|FG001|Re-induction Phase|Did not respond to re-induction|5|||
48631757|NCT00329420|156509621|FG002|Re-induction Phase|Did not respond to re-induction|7|||
48631758|NCT00329420|156509619|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
48631759|NCT00329420|156509620|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
48631760|NCT00329420|156509621|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
48631761|NCT00329420|156509619|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
48744217|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
48744218|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
48744219|NCT02197247|156912501|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
48744220|NCT03068455|156912502|FG000|Pre-treatment Period|Disease progression|0|||
48744221|NCT03068455|156912503|FG001|Pre-treatment Period|Disease progression|1|||
48631762|NCT00329420|156509620|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
48631763|NCT00329420|156509621|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
48631764|NCT00329420|156509619|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
48631765|NCT00329420|156509620|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
48631766|NCT00329420|156509621|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
48631767|NCT01358734|156509622|FG000|Overall Study|Adverse Event|4|||
48631768|NCT01358734|156509623|FG001|Overall Study|Adverse Event|7|||
48631769|NCT01358734|156509624|FG002|Overall Study|Adverse Event|3|||
48631770|NCT01358734|156509622|FG000|Overall Study|Lack of Efficacy|0|||
48631771|NCT01358734|156509623|FG001|Overall Study|Lack of Efficacy|1|||
48631772|NCT01358734|156509624|FG002|Overall Study|Lack of Efficacy|3|||
48631773|NCT01358734|156509622|FG000|Overall Study|Withdrawal by Subject|1|||
48631774|NCT01358734|156509623|FG001|Overall Study|Withdrawal by Subject|6|||
48631775|NCT01358734|156509624|FG002|Overall Study|Withdrawal by Subject|3|||
48631776|NCT01358734|156509622|FG000|Overall Study|Death|3|||
48631777|NCT01358734|156509623|FG001|Overall Study|Death|7|||
48631778|NCT01358734|156509624|FG002|Overall Study|Death|2|||
48631779|NCT01358734|156509622|FG000|Overall Study|Progressive Disease|5|||
48631780|NCT01358734|156509623|FG001|Overall Study|Progressive Disease|13|||
48631781|NCT01358734|156509624|FG002|Overall Study|Progressive Disease|16|||
48631782|NCT01358734|156509622|FG000|Overall Study|Non-compliance with study drug|0|||
48631783|NCT01358734|156509623|FG001|Overall Study|Non-compliance with study drug|0|||
48631784|NCT01358734|156509624|FG002|Overall Study|Non-compliance with study drug|1|||
48631785|NCT01358734|156509622|FG000|Overall Study|Other|2|||
48631786|NCT01358734|156509623|FG001|Overall Study|Other|5|||
48631787|NCT01358734|156509624|FG002|Overall Study|Other|4|||
48631788|NCT01358734|156509622|FG000|Overall Study|Protocol Violation|0|||
48631789|NCT01358734|156509623|FG001|Overall Study|Protocol Violation|0|||
48631790|NCT01358734|156509624|FG002|Overall Study|Protocol Violation|2|||
48631791|NCT02157610|156509627|FG000|Overall Study|Death|4|||
48631792|NCT02157610|156509628|FG001|Overall Study|Death|4|||
48631793|NCT05878067|156509629|FG000|Overall Study|Lost to Follow-up|2|||
48631794|NCT02853136|156509639|FG000|Wash-out|Adverse Event|0|||
48631795|NCT02853136|156509640|FG001|Wash-out|Adverse Event|0|||
48631796|NCT02853136|156509641|FG002|Wash-out|Adverse Event|0|||
48631797|NCT02853136|156509642|FG003|Wash-out|Adverse Event|1|||
48631798|NCT01156844|156509644|FG000|Overall Study|Adverse Event|0|||
48631799|NCT01156844|156509645|FG001|Overall Study|Adverse Event|0|||
48631800|NCT01156844|156509646|FG002|Overall Study|Adverse Event|1|||
48631801|NCT01156844|156509647|FG003|Overall Study|Adverse Event|1|||
48631802|NCT01156844|156509644|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48631803|NCT01156844|156509645|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48631804|NCT01156844|156509646|FG002|Overall Study|Abnormal test procedure result(s)|2|||
48631805|NCT01156844|156509647|FG003|Overall Study|Abnormal test procedure result(s)|2|||
48631806|NCT01156844|156509644|FG000|Overall Study|Withdrawal by Subject|0|||
48631807|NCT01156844|156509645|FG001|Overall Study|Withdrawal by Subject|0|||
48631808|NCT01156844|156509646|FG002|Overall Study|Withdrawal by Subject|2|||
48631809|NCT01156844|156509647|FG003|Overall Study|Withdrawal by Subject|2|||
48631810|NCT01156844|156509644|FG000|Overall Study|Lost to Follow-up|0|||
48631811|NCT01156844|156509645|FG001|Overall Study|Lost to Follow-up|0|||
48631812|NCT01156844|156509646|FG002|Overall Study|Lost to Follow-up|1|||
48631813|NCT01156844|156509647|FG003|Overall Study|Lost to Follow-up|0|||
48631814|NCT01156844|156509644|FG000|Overall Study|Administrative problems|0|||
48631815|NCT01156844|156509645|FG001|Overall Study|Administrative problems|1|||
48631816|NCT01156844|156509646|FG002|Overall Study|Administrative problems|0|||
48631817|NCT01156844|156509647|FG003|Overall Study|Administrative problems|1|||
48631818|NCT01156844|156509644|FG000|Overall Study|Protocol deviation|2|||
48631819|NCT01156844|156509645|FG001|Overall Study|Protocol deviation|0|||
48631820|NCT01156844|156509646|FG002|Overall Study|Protocol deviation|0|||
48631821|NCT01156844|156509647|FG003|Overall Study|Protocol deviation|0|||
48631822|NCT02457065|156509649|FG000|Overall Study|Lost to Follow-up|9|||
48631823|NCT02457065|156509650|FG001|Overall Study|Lost to Follow-up|11|||
48631824|NCT00526799|156509659|FG000|Overall Study|Withdrawal by Subject|1|||
48631825|NCT00526799|156509660|FG001|Overall Study|Withdrawal by Subject|0|||
48631826|NCT00526799|156509659|FG000|Overall Study|Intercurrent Complicating Disease|0|||
48631827|NCT00526799|156509660|FG001|Overall Study|Intercurrent Complicating Disease|1|||
48631828|NCT00337168|156511158|FG000|Overall Study|Death|5|||
48631829|NCT00337168|156511158|FG000|Overall Study|Not protocol specified|2|||
48631830|NCT00337168|156511158|FG000|Overall Study|Did not start therapy|1|||
48631831|NCT03283241|156511159|FG000|Overall Study|Adverse Event|4|||
48631832|NCT03283241|156511160|FG001|Overall Study|Adverse Event|1|||
48631833|NCT03283241|156511159|FG000|Overall Study|Withdrawal by Subject|0|||
48631834|NCT03283241|156511160|FG001|Overall Study|Withdrawal by Subject|1|||
48631835|NCT03283241|156511159|FG000|Overall Study|Subject relocated to Finland|0|||
48631836|NCT03283241|156511160|FG001|Overall Study|Subject relocated to Finland|1|||
48631837|NCT02724839|156511161|FG000|Overall Study|Withdrawal by Subject|1|||
48631838|NCT02724839|156511162|FG001|Overall Study|Withdrawal by Subject|1|||
48325802|NCT01767467|155390773|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
48325803|NCT01767467|155390772|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
48325804|NCT01767467|155390773|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
48325805|NCT01767467|155390772|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
48325806|NCT01767467|155390773|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
48325807|NCT01767467|155390772|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
48325808|NCT01767467|155390773|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
48325809|NCT01767467|155390772|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
48325810|NCT01767467|155390773|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
48325811|NCT00853580|155390774|FG000|Overall Study|Lost to Follow-up|3|||
48325812|NCT00853580|155390775|FG001|Overall Study|Lost to Follow-up|5|||
48325813|NCT00853580|155390774|FG000|Overall Study|Protocol Violation|2|||
48325814|NCT00853580|155390775|FG001|Overall Study|Protocol Violation|1|||
48325815|NCT00853580|155390774|FG000|Overall Study|Withdrawal by Subject|2|||
48325816|NCT00853580|155390775|FG001|Overall Study|Withdrawal by Subject|8|||
48325817|NCT00853580|155390774|FG000|Overall Study|Commenced contraindicated therapy|0|||
48325818|NCT00853580|155390775|FG001|Overall Study|Commenced contraindicated therapy|2|||
48325819|NCT04860505|155390776|FG000|Overall Study|Lost to Follow-up|2|||
48631839|NCT02724839|156511163|FG002|Overall Study|Withdrawal by Subject|0|||
48631840|NCT02724839|156511161|FG000|Overall Study|Lost to Follow-up|0|||
48631841|NCT02724839|156511162|FG001|Overall Study|Lost to Follow-up|3|||
48631842|NCT02724839|156511163|FG002|Overall Study|Lost to Follow-up|2|||
48631843|NCT02724839|156511161|FG000|Overall Study|Physician Decision|0|||
48631844|NCT02724839|156511162|FG001|Overall Study|Physician Decision|0|||
48631845|NCT02724839|156511163|FG002|Overall Study|Physician Decision|3|||
48631846|NCT01155050|156511164|FG000|Overall Study|Lost to Follow-up|15|||
48631847|NCT01155050|156511165|FG001|Overall Study|Lost to Follow-up|20|||
48631848|NCT01155050|156511166|FG002|Overall Study|Lost to Follow-up|19|||
48631849|NCT01155050|156511167|FG003|Overall Study|Lost to Follow-up|22|||
48631850|NCT03322566|156511169|FG000|Overall Study|Death|34|||
48631851|NCT03322566|156511170|FG001|Overall Study|Death|35|||
48631852|NCT03322566|156511171|FG002|Overall Study|Death|23|||
48631853|NCT03322566|156511169|FG000|Overall Study|Physician Decision|6|||
48631854|NCT03322566|156511170|FG001|Overall Study|Physician Decision|7|||
48631855|NCT03322566|156511171|FG002|Overall Study|Physician Decision|2|||
48631856|NCT03322566|156511169|FG000|Overall Study|Withdrawal by Subject|4|||
48631857|NCT03322566|156511170|FG001|Overall Study|Withdrawal by Subject|3|||
48631858|NCT03322566|156511171|FG002|Overall Study|Withdrawal by Subject|6|||
48631859|NCT03322566|156511169|FG000|Overall Study|Lost to Follow-up|0|||
48631860|NCT03322566|156511170|FG001|Overall Study|Lost to Follow-up|0|||
48631861|NCT03322566|156511171|FG002|Overall Study|Lost to Follow-up|1|||
48631862|NCT03322566|156511169|FG000|Overall Study|Study terminated by sponsor|1|||
48631863|NCT03322566|156511170|FG001|Overall Study|Study terminated by sponsor|0|||
48631864|NCT03322566|156511171|FG002|Overall Study|Study terminated by sponsor|1|||
48631865|NCT00560417|156511172|FG000|Overall Study|Adverse Event|3|||
48631866|NCT00560417|156511173|FG001|Overall Study|Adverse Event|2|||
48631867|NCT00560417|156511172|FG000|Overall Study|Entry Criteria Not Met|1|||
48631868|NCT00560417|156511173|FG001|Overall Study|Entry Criteria Not Met|0|||
48631869|NCT00560417|156511172|FG000|Overall Study|Lost to Follow-up|0|||
48631870|NCT00560417|156511173|FG001|Overall Study|Lost to Follow-up|1|||
48631871|NCT00560417|156511172|FG000|Overall Study|Physician Decision|2|||
48631872|NCT00560417|156511173|FG001|Overall Study|Physician Decision|6|||
48631873|NCT00560417|156511172|FG000|Overall Study|Protocol Violation|6|||
48631874|NCT00560417|156511173|FG001|Overall Study|Protocol Violation|5|||
48631875|NCT00560417|156511172|FG000|Overall Study|Sponsor Decision|2|||
48631876|NCT00560417|156511173|FG001|Overall Study|Sponsor Decision|0|||
48631877|NCT00560417|156511172|FG000|Overall Study|Withdrawal by Subject|3|||
48631878|NCT00560417|156511173|FG001|Overall Study|Withdrawal by Subject|3|||
48631879|NCT00652834|156511174|FG000|Overall Study|Withdrawal by Subject|3|||
48631880|NCT00652834|156511174|FG000|Overall Study|Lost to Follow-up|2|||
48631881|NCT00553254|156511175|FG000|Overall Study|Death|3|||
48631882|NCT00553254|156511176|FG001|Overall Study|Death|6|||
48631883|NCT00553254|156511177|FG002|Overall Study|Death|25|||
48631884|NCT00553254|156511175|FG000|Overall Study|Lost to Follow-up|0|||
48631885|NCT00553254|156511176|FG001|Overall Study|Lost to Follow-up|0|||
48631886|NCT00553254|156511177|FG002|Overall Study|Lost to Follow-up|2|||
48631887|NCT00553254|156511175|FG000|Overall Study|Withdrawal by Subject|2|||
48631888|NCT00553254|156511176|FG001|Overall Study|Withdrawal by Subject|0|||
48631889|NCT00553254|156511177|FG002|Overall Study|Withdrawal by Subject|2|||
48631890|NCT00553254|156511175|FG000|Overall Study|Study terminated by Sponsor|0|||
48325820|NCT00836498|155390777|FG000|Overall Study|Adverse Event|1|||
48325821|NCT00836498|155390778|FG001|Overall Study|Adverse Event|0|||
48325822|NCT00836498|155390777|FG000|Overall Study|Lost to Follow-up|1|||
48325823|NCT00836498|155390778|FG001|Overall Study|Lost to Follow-up|0|||
48631891|NCT00553254|156511176|FG001|Overall Study|Study terminated by Sponsor|0|||
48631892|NCT00553254|156511177|FG002|Overall Study|Study terminated by Sponsor|1|||
48631893|NCT00553254|156511175|FG000|Overall Study|Other|1|||
48631894|NCT00553254|156511176|FG001|Overall Study|Other|0|||
48631895|NCT00553254|156511177|FG002|Overall Study|Other|13|||
48631896|NCT02327169|156511183|FG000|Overall Study|Progressive Disease|1|||
48631897|NCT02327169|156511184|FG001|Overall Study|Progressive Disease|3|||
48631898|NCT02327169|156511185|FG002|Overall Study|Progressive Disease|4|||
48631899|NCT02327169|156511186|FG003|Overall Study|Progressive Disease|3|||
48631900|NCT02327169|156511187|FG004|Overall Study|Progressive Disease|4|||
48631901|NCT02327169|156511188|FG005|Overall Study|Progressive Disease|3|||
48631902|NCT02327169|156511189|FG006|Overall Study|Progressive Disease|3|||
48631903|NCT02327169|156511190|FG007|Overall Study|Progressive Disease|3|||
48631904|NCT02327169|156511191|FG008|Overall Study|Progressive Disease|4|||
48631905|NCT02327169|156511192|FG009|Overall Study|Progressive Disease|4|||
48631906|NCT02327169|156511193|FG010|Overall Study|Progressive Disease|4|||
48631907|NCT02327169|156511194|FG011|Overall Study|Progressive Disease|3|||
48631908|NCT02327169|156511195|FG012|Overall Study|Progressive Disease|1|||
48631909|NCT02327169|156511196|FG013|Overall Study|Progressive Disease|3|||
48631910|NCT02327169|156511197|FG014|Overall Study|Progressive Disease|3|||
48631911|NCT02327169|156511183|FG000|Overall Study|Adverse Event|2|||
48631912|NCT02327169|156511184|FG001|Overall Study|Adverse Event|0|||
48631913|NCT02327169|156511185|FG002|Overall Study|Adverse Event|1|||
48631914|NCT02327169|156511186|FG003|Overall Study|Adverse Event|0|||
48631915|NCT02327169|156511187|FG004|Overall Study|Adverse Event|1|||
48631916|NCT02327169|156511188|FG005|Overall Study|Adverse Event|0|||
48631917|NCT02327169|156511189|FG006|Overall Study|Adverse Event|0|||
48631918|NCT02327169|156511190|FG007|Overall Study|Adverse Event|0|||
48631919|NCT02327169|156511191|FG008|Overall Study|Adverse Event|0|||
48631920|NCT02327169|156511192|FG009|Overall Study|Adverse Event|2|||
48631921|NCT02327169|156511193|FG010|Overall Study|Adverse Event|0|||
48631922|NCT02327169|156511194|FG011|Overall Study|Adverse Event|3|||
48631923|NCT02327169|156511195|FG012|Overall Study|Adverse Event|0|||
48631924|NCT02327169|156511196|FG013|Overall Study|Adverse Event|2|||
48631925|NCT02327169|156511197|FG014|Overall Study|Adverse Event|1|||
48631926|NCT02327169|156511183|FG000|Overall Study|Symptomatic Deterioration|0|||
48631927|NCT02327169|156511184|FG001|Overall Study|Symptomatic Deterioration|0|||
48631928|NCT02327169|156511185|FG002|Overall Study|Symptomatic Deterioration|1|||
48631929|NCT02327169|156511186|FG003|Overall Study|Symptomatic Deterioration|0|||
48631930|NCT02327169|156511187|FG004|Overall Study|Symptomatic Deterioration|1|||
48631931|NCT02327169|156511188|FG005|Overall Study|Symptomatic Deterioration|1|||
48631932|NCT02327169|156511189|FG006|Overall Study|Symptomatic Deterioration|0|||
48631933|NCT02327169|156511190|FG007|Overall Study|Symptomatic Deterioration|0|||
48631934|NCT02327169|156511191|FG008|Overall Study|Symptomatic Deterioration|2|||
48631935|NCT02327169|156511192|FG009|Overall Study|Symptomatic Deterioration|1|||
48631936|NCT02327169|156511193|FG010|Overall Study|Symptomatic Deterioration|0|||
48631937|NCT02327169|156511194|FG011|Overall Study|Symptomatic Deterioration|0|||
48631938|NCT02327169|156511195|FG012|Overall Study|Symptomatic Deterioration|0|||
48631939|NCT02327169|156511196|FG013|Overall Study|Symptomatic Deterioration|2|||
48631940|NCT02327169|156511197|FG014|Overall Study|Symptomatic Deterioration|1|||
48631941|NCT02327169|156511183|FG000|Overall Study|Reason Not Specified|0|||
48631942|NCT02327169|156511184|FG001|Overall Study|Reason Not Specified|0|||
48631943|NCT02327169|156511185|FG002|Overall Study|Reason Not Specified|1|||
48631944|NCT02327169|156511186|FG003|Overall Study|Reason Not Specified|0|||
48631945|NCT02327169|156511187|FG004|Overall Study|Reason Not Specified|0|||
48631946|NCT02327169|156511188|FG005|Overall Study|Reason Not Specified|0|||
48631947|NCT02327169|156511189|FG006|Overall Study|Reason Not Specified|0|||
48631948|NCT02327169|156511190|FG007|Overall Study|Reason Not Specified|0|||
48631949|NCT02327169|156511191|FG008|Overall Study|Reason Not Specified|0|||
48631950|NCT02327169|156511192|FG009|Overall Study|Reason Not Specified|1|||
48631951|NCT02327169|156511193|FG010|Overall Study|Reason Not Specified|2|||
48631952|NCT02327169|156511194|FG011|Overall Study|Reason Not Specified|1|||
48631953|NCT02327169|156511195|FG012|Overall Study|Reason Not Specified|0|||
48631954|NCT02327169|156511196|FG013|Overall Study|Reason Not Specified|0|||
48631955|NCT02327169|156511197|FG014|Overall Study|Reason Not Specified|2|||
48631956|NCT02327169|156511183|FG000|Overall Study|Withdrawal by Subject|1|||
48631957|NCT02327169|156511184|FG001|Overall Study|Withdrawal by Subject|0|||
48631958|NCT02327169|156511185|FG002|Overall Study|Withdrawal by Subject|0|||
48631959|NCT02327169|156511186|FG003|Overall Study|Withdrawal by Subject|0|||
48631960|NCT02327169|156511187|FG004|Overall Study|Withdrawal by Subject|1|||
48631961|NCT02327169|156511188|FG005|Overall Study|Withdrawal by Subject|0|||
48631962|NCT02327169|156511189|FG006|Overall Study|Withdrawal by Subject|0|||
48631963|NCT02327169|156511190|FG007|Overall Study|Withdrawal by Subject|1|||
48631964|NCT02327169|156511191|FG008|Overall Study|Withdrawal by Subject|0|||
48631965|NCT02327169|156511192|FG009|Overall Study|Withdrawal by Subject|0|||
48631966|NCT02327169|156511193|FG010|Overall Study|Withdrawal by Subject|0|||
48631967|NCT02327169|156511194|FG011|Overall Study|Withdrawal by Subject|0|||
48631968|NCT02327169|156511195|FG012|Overall Study|Withdrawal by Subject|0|||
48631969|NCT02327169|156511196|FG013|Overall Study|Withdrawal by Subject|0|||
48631970|NCT02327169|156511197|FG014|Overall Study|Withdrawal by Subject|3|||
48631971|NCT02327169|156511183|FG000|Overall Study|Lost to Follow-up|0|||
48631972|NCT02327169|156511184|FG001|Overall Study|Lost to Follow-up|0|||
48631973|NCT02327169|156511185|FG002|Overall Study|Lost to Follow-up|0|||
48631974|NCT02327169|156511186|FG003|Overall Study|Lost to Follow-up|0|||
48631975|NCT02327169|156511187|FG004|Overall Study|Lost to Follow-up|1|||
48631976|NCT02327169|156511188|FG005|Overall Study|Lost to Follow-up|0|||
48631977|NCT02327169|156511189|FG006|Overall Study|Lost to Follow-up|0|||
48631978|NCT02327169|156511190|FG007|Overall Study|Lost to Follow-up|0|||
48631979|NCT02327169|156511191|FG008|Overall Study|Lost to Follow-up|0|||
48631980|NCT02327169|156511192|FG009|Overall Study|Lost to Follow-up|0|||
48631981|NCT02327169|156511193|FG010|Overall Study|Lost to Follow-up|0|||
48631982|NCT02327169|156511194|FG011|Overall Study|Lost to Follow-up|0|||
48631983|NCT02327169|156511195|FG012|Overall Study|Lost to Follow-up|0|||
48631984|NCT02327169|156511196|FG013|Overall Study|Lost to Follow-up|0|||
48631985|NCT02327169|156511197|FG014|Overall Study|Lost to Follow-up|0|||
48631986|NCT01047540|156511198|FG000|Overall Study|Protocol Violation|1|||
48631987|NCT01047540|156511199|FG001|Overall Study|Protocol Violation|0|||
48631988|NCT01047540|156511200|FG002|Overall Study|Protocol Violation|0|||
48631989|NCT01047540|156511201|FG003|Overall Study|Protocol Violation|0|||
48631990|NCT01047540|156511202|FG004|Overall Study|Protocol Violation|0|||
48631991|NCT01047540|156511198|FG000|Overall Study|Lost to Follow-up|1|||
48631992|NCT01047540|156511199|FG001|Overall Study|Lost to Follow-up|0|||
48631993|NCT01047540|156511200|FG002|Overall Study|Lost to Follow-up|0|||
48744222|NCT03068455|156912502|FG000|Pre-treatment Period|Participant withdrew consent|1|||
48744223|NCT03068455|156912503|FG001|Pre-treatment Period|Participant withdrew consent|1|||
48325824|NCT00836498|155390777|FG000|Overall Study|Withdrawal by Subject|2|||
48325825|NCT00836498|155390778|FG001|Overall Study|Withdrawal by Subject|1|||
48631994|NCT01047540|156511201|FG003|Overall Study|Lost to Follow-up|0|||
48631995|NCT01047540|156511202|FG004|Overall Study|Lost to Follow-up|0|||
48631996|NCT01047540|156511198|FG000|Overall Study|Withdrawal by Subject|1|||
48631997|NCT01047540|156511199|FG001|Overall Study|Withdrawal by Subject|0|||
48631998|NCT01047540|156511200|FG002|Overall Study|Withdrawal by Subject|3|||
48631999|NCT01047540|156511201|FG003|Overall Study|Withdrawal by Subject|0|||
48632000|NCT01047540|156511202|FG004|Overall Study|Withdrawal by Subject|1|||
48632001|NCT01047540|156511198|FG000|Overall Study|Pregnancy|1|||
48632002|NCT01047540|156511199|FG001|Overall Study|Pregnancy|0|||
48632003|NCT01047540|156511200|FG002|Overall Study|Pregnancy|0|||
48632004|NCT01047540|156511201|FG003|Overall Study|Pregnancy|0|||
48632005|NCT01047540|156511202|FG004|Overall Study|Pregnancy|0|||
48632006|NCT01047540|156511198|FG000|Overall Study|Adverse Event|1|||
48632007|NCT01047540|156511199|FG001|Overall Study|Adverse Event|0|||
48632008|NCT01047540|156511200|FG002|Overall Study|Adverse Event|0|||
48632009|NCT01047540|156511201|FG003|Overall Study|Adverse Event|0|||
48632010|NCT01047540|156511202|FG004|Overall Study|Adverse Event|0|||
48632011|NCT03787615|156511203|FG000|Overall Study|Withdrawal by Subject|2|||
48632012|NCT03787615|156511203|FG000|Overall Study|Lost to Follow-up|2|||
48632013|NCT01055028|156511205|FG000|Screening|Screen Failure|1|||
48632014|NCT01055028|156511206|FG001|Screening|Screen Failure|1|||
48632015|NCT01055028|156511205|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
48632016|NCT01055028|156511206|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
48632017|NCT01055028|156511205|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
48632018|NCT01055028|156511206|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
48632019|NCT01055028|156511205|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
48632020|NCT01055028|156511206|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
48744224|NCT03068455|156912502|FG000|Pre-treatment Period|Poor/non-compliance|0|||
48325826|NCT01034306|155390779|FG000|Overall Study|Adverse Event|1|||
48632021|NCT03056040|156511209|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
48744225|NCT03068455|156912503|FG001|Pre-treatment Period|Poor/non-compliance|1|||
48744226|NCT03068455|156912502|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
48744227|NCT03068455|156912503|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
48744228|NCT03068455|156912502|FG000|Pre-treatment Period|Not reported|2|||
48744229|NCT03068455|156912503|FG001|Pre-treatment Period|Not reported|1|||
48744230|NCT03068455|156912502|FG000|Treatment Period|Disease progression|166|||
48744231|NCT03068455|156912503|FG001|Treatment Period|Disease progression|208|||
48744232|NCT03068455|156912502|FG000|Treatment Period|Study drug toxicity|317|||
48325827|NCT01034306|155390780|FG001|Overall Study|Adverse Event|0|||
48632022|NCT03056040|156511210|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
48632023|NCT03056040|156511209|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
48632024|NCT03056040|156511210|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
48632025|NCT03056040|156511209|FG000|Primary Evaluation Period|Pregnancy|0|||
48632026|NCT03056040|156511210|FG001|Primary Evaluation Period|Pregnancy|1|||
48632027|NCT03056040|156511209|FG000|Primary Evaluation Period|Randomized, not treated|1|||
48632028|NCT03056040|156511210|FG001|Primary Evaluation Period|Randomized, not treated|1|||
48325828|NCT01034306|155390779|FG000|Overall Study|Lost to Follow-up|0|||
48632029|NCT03056040|156511209|FG000|Extension Period|Physician Decision|3|||
48632030|NCT03056040|156511210|FG001|Extension Period|Physician Decision|3|||
48632031|NCT03056040|156511209|FG000|Extension Period|Lost to Follow-up|0|||
48632032|NCT03056040|156511210|FG001|Extension Period|Lost to Follow-up|1|||
48632033|NCT03056040|156511209|FG000|Extension Period|Death|0|||
48632034|NCT03056040|156511210|FG001|Extension Period|Death|3|||
48632035|NCT03056040|156511209|FG000|Extension Period|Withdrawal by Subject|1|||
48632036|NCT03056040|156511210|FG001|Extension Period|Withdrawal by Subject|0|||
48632037|NCT02836249|156511211|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
48632038|NCT02836249|156511212|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
48632039|NCT02836249|156511213|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
48632040|NCT02836249|156511214|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
48632041|NCT02836249|156511211|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
48632042|NCT02836249|156511212|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
48632043|NCT02836249|156511213|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
48632044|NCT02836249|156511214|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
48632045|NCT02836249|156511211|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
48632046|NCT02836249|156511212|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
48632047|NCT02836249|156511213|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
48632048|NCT02836249|156511214|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
48632049|NCT02836249|156511211|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48632050|NCT02836249|156511212|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48632051|NCT02836249|156511213|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48632052|NCT02836249|156511214|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48632053|NCT02836249|156511211|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
48632054|NCT02836249|156511212|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
48632055|NCT02836249|156511213|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
48632056|NCT02836249|156511214|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
48632057|NCT02836249|156511211|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
48632058|NCT02836249|156511212|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
48632059|NCT02836249|156511213|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
48632060|NCT02836249|156511214|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
48632061|NCT02836249|156511211|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
48632062|NCT02836249|156511212|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
48632063|NCT02836249|156511213|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
48632064|NCT02836249|156511214|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
48632065|NCT02836249|156511211|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
48632066|NCT02836249|156511212|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
48632067|NCT02836249|156511213|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
48632068|NCT02836249|156511214|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
48632069|NCT02836249|156511211|FG000|Open-Label TAF Treatment Phase|Death|0|||
48632070|NCT02836249|156511212|FG001|Open-Label TAF Treatment Phase|Death|0|||
48632071|NCT02836249|156511213|FG002|Open-Label TAF Treatment Phase|Death|1|||
48632072|NCT02836249|156511214|FG003|Open-Label TAF Treatment Phase|Death|0|||
48632073|NCT02836249|156511211|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
48632074|NCT02836249|156511212|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
48632075|NCT02836249|156511213|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
48632076|NCT02836249|156511214|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
48632077|NCT02836249|156511211|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
48632078|NCT02836249|156511212|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
48632079|NCT02836249|156511213|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
48632080|NCT02836249|156511214|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
48632081|NCT03559530|156511216|FG000|Overall Study|non-location of medical records|44|||
48632082|NCT03559530|156511217|FG001|Overall Study|non-location of medical records|0|||
48632083|NCT03559530|156511216|FG000|Overall Study|culture results not considered for treat|29|||
48632084|NCT03559530|156511217|FG001|Overall Study|culture results not considered for treat|0|||
48632085|NCT03559530|156511216|FG000|Overall Study|duplicate cases|8|||
48632086|NCT03559530|156511217|FG001|Overall Study|duplicate cases|0|||
48632087|NCT03559530|156511216|FG000|Overall Study|other species of Acinetobacte|7|||
48632088|NCT03559530|156511217|FG001|Overall Study|other species of Acinetobacte|0|||
48632089|NCT03559530|156511216|FG000|Overall Study|contamination / colonization|3|||
48632090|NCT03559530|156511217|FG001|Overall Study|contamination / colonization|0|||
48632091|NCT03232567|156511228|FG000|Overall Study|Withdrawal by Subject|0|||
48744233|NCT03068455|156912503|FG001|Treatment Period|Study drug toxicity|104|||
48744234|NCT03068455|156912502|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
48632092|NCT03232567|156511229|FG001|Overall Study|Withdrawal by Subject|1|||
48744235|NCT03068455|156912503|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
48325829|NCT01034306|155390780|FG001|Overall Study|Lost to Follow-up|1|||
48632093|NCT03232567|156511230|FG002|Overall Study|Withdrawal by Subject|0|||
48744236|NCT03068455|156912502|FG000|Treatment Period|Participant request to stop therapy|33|||
48744237|NCT03068455|156912503|FG001|Treatment Period|Participant request to stop therapy|20|||
48632094|NCT03232567|156511231|FG003|Overall Study|Withdrawal by Subject|0|||
48632095|NCT01153516|156511232|FG000|Overall Study|Both subjects refused surgery|2|||
48632096|NCT01153516|156511233|FG001|Overall Study|Both subjects refused surgery|0|||
48632097|NCT05837481|156511234|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
48632098|NCT05837481|156511235|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
48632099|NCT01554904|156511249|FG000|Overall Study|Withdrawal by Subject|3|||
48632100|NCT01554904|156511249|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
48632101|NCT00654355|156511250|FG000|Overall Study|Lost to Follow-up|2|||
48632102|NCT00654355|156511251|FG001|Overall Study|Lost to Follow-up|2|||
48632103|NCT01911260|156511252|FG000|Supplementation Period|transference or evasion of school|7|||
48632104|NCT01911260|156511253|FG001|Supplementation Period|transference or evasion of school|9|||
48632105|NCT01911260|156511254|FG002|Supplementation Period|transference or evasion of school|7|||
48632106|NCT01911260|156511255|FG003|Supplementation Period|transference or evasion of school|6|||
48632107|NCT01911260|156511252|FG000|Supplementation Period|Adverse Event|2|||
48744238|NCT03068455|156912502|FG000|Treatment Period|Participant withdrew consent|5|||
48744239|NCT03068455|156912503|FG001|Treatment Period|Participant withdrew consent|10|||
48744240|NCT03068455|156912502|FG000|Treatment Period|Poor/non-compliance|3|||
48744241|NCT03068455|156912503|FG001|Treatment Period|Poor/non-compliance|0|||
48744242|NCT03068455|156912502|FG000|Treatment Period|Participant no longer meets study criteria|1|||
48744243|NCT03068455|156912503|FG001|Treatment Period|Participant no longer meets study criteria|3|||
48744244|NCT03068455|156912502|FG000|Treatment Period|Other reasons|12|||
48744245|NCT03068455|156912503|FG001|Treatment Period|Other reasons|4|||
48744246|NCT01203098|156912504|FG000|Overall Study|Adverse Event|3|||
48744247|NCT01203098|156912505|FG001|Overall Study|Adverse Event|1|||
48744248|NCT01203098|156912506|FG002|Overall Study|Adverse Event|7|||
48744249|NCT01203098|156912504|FG000|Overall Study|Lost to Follow-up|0|||
48744250|NCT01203098|156912505|FG001|Overall Study|Lost to Follow-up|0|||
48744251|NCT01203098|156912506|FG002|Overall Study|Lost to Follow-up|1|||
48744252|NCT01203098|156912504|FG000|Overall Study|Physician Decision|2|||
48744253|NCT01203098|156912505|FG001|Overall Study|Physician Decision|2|||
48744254|NCT01203098|156912506|FG002|Overall Study|Physician Decision|0|||
48744255|NCT01203098|156912504|FG000|Overall Study|Withdrawal by Subject|1|||
48744256|NCT01203098|156912505|FG001|Overall Study|Withdrawal by Subject|1|||
48744257|NCT01203098|156912506|FG002|Overall Study|Withdrawal by Subject|3|||
48744258|NCT01930123|156912507|FG000|Overall Study|Adverse Event|1|||
48744259|NCT01930123|156912508|FG001|Overall Study|Adverse Event|0|||
48744260|NCT01930123|156912507|FG000|Overall Study|Physician Decision|21|||
48744261|NCT01930123|156912508|FG001|Overall Study|Physician Decision|8|||
48744262|NCT01930123|156912507|FG000|Overall Study|Withdrawal by Subject|1|||
48744263|NCT01930123|156912508|FG001|Overall Study|Withdrawal by Subject|0|||
48744264|NCT01964430|156912509|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
48744265|NCT01964430|156912510|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
48744266|NCT01964430|156912509|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
48744267|NCT01964430|156912510|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
48744268|NCT01964430|156912509|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
48744269|NCT01964430|156912510|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
48744270|NCT01964430|156912509|FG000|Treatment Period|Adverse Event|71|||
48744271|NCT01964430|156912510|FG001|Treatment Period|Adverse Event|37|||
48744272|NCT01964430|156912509|FG000|Treatment Period|Withdrawal by Subject|36|||
48744273|NCT01964430|156912510|FG001|Treatment Period|Withdrawal by Subject|27|||
48744274|NCT01964430|156912509|FG000|Treatment Period|Death|1|||
48744275|NCT01964430|156912510|FG001|Treatment Period|Death|3|||
48744276|NCT01964430|156912509|FG000|Treatment Period|Protocol Deviation|0|||
48632108|NCT01911260|156511253|FG001|Supplementation Period|Adverse Event|0|||
48632109|NCT01911260|156511254|FG002|Supplementation Period|Adverse Event|1|||
48632110|NCT01911260|156511255|FG003|Supplementation Period|Adverse Event|0|||
48632111|NCT01911260|156511252|FG000|Supplementation Period|refused to receive supplement|1|||
48632112|NCT01911260|156511253|FG001|Supplementation Period|refused to receive supplement|0|||
48632113|NCT01911260|156511254|FG002|Supplementation Period|refused to receive supplement|1|||
48632114|NCT01911260|156511255|FG003|Supplementation Period|refused to receive supplement|0|||
48632115|NCT01911260|156511252|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
48632116|NCT01911260|156511253|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
48632117|NCT01911260|156511254|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
48632118|NCT01911260|156511255|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
48744277|NCT01964430|156912510|FG001|Treatment Period|Protocol Deviation|1|||
48744278|NCT01964430|156912509|FG000|Treatment Period|Physician Decision|5|||
48744279|NCT01964430|156912510|FG001|Treatment Period|Physician Decision|4|||
48744280|NCT01964430|156912509|FG000|Treatment Period|Disease Relapse|28|||
48744281|NCT01964430|156912510|FG001|Treatment Period|Disease Relapse|38|||
48744282|NCT01964430|156912509|FG000|Treatment Period|Other reasons|1|||
48744283|NCT01964430|156912510|FG001|Treatment Period|Other reasons|3|||
48744284|NCT02591290|156912511|FG000|Overall Study|Withdrawal by Subject|2|||
48744285|NCT04545060|156912512|FG000|Overall Study|Adverse Event|0|||
48744286|NCT04545060|156912513|FG001|Overall Study|Adverse Event|1|||
48744287|NCT04545060|156912512|FG000|Overall Study|Death|0|||
48744288|NCT04545060|156912513|FG001|Overall Study|Death|5|||
48744289|NCT04545060|156912512|FG000|Overall Study|Lost to Follow-up|10|||
48744290|NCT04545060|156912513|FG001|Overall Study|Lost to Follow-up|13|||
48744291|NCT04545060|156912512|FG000|Overall Study|Physician Decision|3|||
48744292|NCT04545060|156912513|FG001|Overall Study|Physician Decision|0|||
48744293|NCT04545060|156912512|FG000|Overall Study|Withdrawal by Subject|17|||
48744294|NCT04545060|156912513|FG001|Overall Study|Withdrawal by Subject|22|||
48744295|NCT01370356|156912514|FG000|Overall Study|Death|1|||
48744296|NCT01370356|156912515|FG001|Overall Study|Death|0|||
48744297|NCT01370356|156912514|FG000|Overall Study|Lack of Efficacy|6|||
48632119|NCT01911260|156511252|FG000|Follow-up Period|transference or evasion of school|13|||
48632120|NCT01911260|156511253|FG001|Follow-up Period|transference or evasion of school|20|||
48632121|NCT01911260|156511254|FG002|Follow-up Period|transference or evasion of school|15|||
48632122|NCT01911260|156511255|FG003|Follow-up Period|transference or evasion of school|12|||
48632123|NCT00654732|156511256|FG000|Overall Study|Adverse Event|4|||
48632124|NCT00654732|156511257|FG001|Overall Study|Adverse Event|6|||
48632125|NCT01463033|156511258|FG000|Overall Study|Lost to Follow-up|4|||
48632126|NCT01463033|156511259|FG001|Overall Study|Lost to Follow-up|4|||
48632127|NCT01463033|156511258|FG000|Overall Study|Death|3|||
48744298|NCT01370356|156912515|FG001|Overall Study|Lack of Efficacy|28|||
48744299|NCT01370356|156912514|FG000|Overall Study|Lost to Follow-up|76|||
48744300|NCT01370356|156912515|FG001|Overall Study|Lost to Follow-up|81|||
48744301|NCT01370356|156912514|FG000|Overall Study|Withdrawal by Subject|54|||
48744302|NCT01370356|156912515|FG001|Overall Study|Withdrawal by Subject|59|||
48744303|NCT01370356|156912514|FG000|Overall Study|Reason not specified|39|||
48744304|NCT01370356|156912515|FG001|Overall Study|Reason not specified|43|||
48744305|NCT01370356|156912514|FG000|Overall Study|Protocol Violation|3|||
48744306|NCT01370356|156912515|FG001|Overall Study|Protocol Violation|3|||
48744307|NCT01370356|156912514|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
48744308|NCT01370356|156912515|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
48744309|NCT01370356|156912514|FG000|Overall Study|AE Not Related to Study Drug|1|||
48744310|NCT01370356|156912515|FG001|Overall Study|AE Not Related to Study Drug|4|||
48744311|NCT00702923|156912516|FG000|Overall Study|Adverse Event|1|||
48744312|NCT03408483|156912522|FG000|Overall Study|Physician Decision|3|||
48632128|NCT01463033|156511259|FG001|Overall Study|Death|2|||
48632129|NCT00982280|156511260|FG000|Observation Period|Not eligible to be dosed|19|||
48632130|NCT00982280|156511260|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
48632131|NCT00982280|156511260|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
48632132|NCT00982280|156511260|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
48632133|NCT00982280|156511260|FG000|Maintenance Period|Adverse Event|1|||
48632134|NCT01121757|156511261|FG000|First Drug|Death|1|||
48632135|NCT01121757|156511262|FG001|First Drug|Death|0|||
48632136|NCT01121757|156511261|FG000|First Drug|Disease Progression|0|||
48632137|NCT01121757|156511262|FG001|First Drug|Disease Progression|2|||
48632138|NCT01121757|156511261|FG000|Combination|Physician Decision|0|||
48632139|NCT01121757|156511262|FG001|Combination|Physician Decision|1|||
48325830|NCT01034306|155390779|FG000|Overall Study|Withdrawal by Subject|2|||
48325831|NCT01034306|155390780|FG001|Overall Study|Withdrawal by Subject|2|||
48632140|NCT01121757|156511261|FG000|Combination|Disease Progression|2|||
48632141|NCT01121757|156511262|FG001|Combination|Disease Progression|0|||
48632142|NCT00829244|156511266|FG000|Overall Study|Adverse Event|1|||
48632143|NCT00829244|156511267|FG001|Overall Study|Adverse Event|3|||
48632144|NCT00829244|156511266|FG000|Overall Study|Protocol Violation|1|||
48632145|NCT00829244|156511267|FG001|Overall Study|Protocol Violation|0|||
48632146|NCT00829244|156511266|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
48744313|NCT03408483|156912523|FG001|Overall Study|Physician Decision|3|||
48744314|NCT03408483|156912522|FG000|Overall Study|Lost to Follow-up|3|||
48744315|NCT03408483|156912523|FG001|Overall Study|Lost to Follow-up|0|||
48744316|NCT04066023|156912524|FG000|Overall Study|Adverse Event|0|||
48744317|NCT04066023|156912525|FG001|Overall Study|Adverse Event|0|||
48744318|NCT04066023|156912526|FG002|Overall Study|Adverse Event|1|||
48744319|NCT04066023|156912524|FG000|Overall Study|Sponsor decision|3|||
48744320|NCT04066023|156912525|FG001|Overall Study|Sponsor decision|6|||
48744321|NCT04066023|156912526|FG002|Overall Study|Sponsor decision|2|||
48744322|NCT04066023|156912524|FG000|Overall Study|Physician Decision|0|||
48744323|NCT04066023|156912525|FG001|Overall Study|Physician Decision|0|||
48744324|NCT04066023|156912526|FG002|Overall Study|Physician Decision|1|||
48744325|NCT04066023|156912524|FG000|Overall Study|Lost to Follow-up|0|||
48744326|NCT04066023|156912525|FG001|Overall Study|Lost to Follow-up|1|||
48744327|NCT04066023|156912526|FG002|Overall Study|Lost to Follow-up|1|||
48744328|NCT04066023|156912524|FG000|Overall Study|Noncompliance|0|||
48744329|NCT04066023|156912525|FG001|Overall Study|Noncompliance|1|||
48744330|NCT04066023|156912526|FG002|Overall Study|Noncompliance|1|||
48744331|NCT01552694|156912527|FG000|Overall Study|Lost to Follow-up|0|||
48744332|NCT01552694|156912528|FG001|Overall Study|Lost to Follow-up|1|||
48744333|NCT01552694|156912527|FG000|Overall Study|Protocol Violation|0|||
48744334|NCT01552694|156912528|FG001|Overall Study|Protocol Violation|1|||
48744335|NCT03736447|156912529|FG000|Overall Study|Adverse Event|5|||
48744336|NCT03736447|156912530|FG001|Overall Study|Adverse Event|1|||
48744337|NCT03736447|156912529|FG000|Overall Study|Withdrawal by Subject|5|||
48744338|NCT03736447|156912530|FG001|Overall Study|Withdrawal by Subject|1|||
48744339|NCT03736447|156912529|FG000|Overall Study|Lost to Follow-up|1|||
48744340|NCT03736447|156912530|FG001|Overall Study|Lost to Follow-up|0|||
48744341|NCT03736447|156912529|FG000|Overall Study|Physician Decision|1|||
48744342|NCT03736447|156912530|FG001|Overall Study|Physician Decision|0|||
48744343|NCT03736447|156912529|FG000|Overall Study|Continued commitment to study treatment|3|||
48744344|NCT03736447|156912530|FG001|Overall Study|Continued commitment to study treatment|0|||
48744345|NCT03736447|156912529|FG000|Overall Study|Taste aversion to study product|0|||
48744346|NCT03736447|156912530|FG001|Overall Study|Taste aversion to study product|1|||
48744347|NCT02619175|156912531|FG000|Overall Study|Withdrawal by Subject|1|||
48744348|NCT02619175|156912532|FG001|Overall Study|Withdrawal by Subject|0|||
48744349|NCT02619175|156912531|FG000|Overall Study|foot pain|1|||
48744350|NCT02619175|156912532|FG001|Overall Study|foot pain|0|||
48744351|NCT02795832|156912534|FG000|Overall Study|Adverse Event|0|||
48744352|NCT02795832|156912535|FG001|Overall Study|Adverse Event|0|||
48744353|NCT02795832|156912536|FG002|Overall Study|Adverse Event|0|||
48744354|NCT02795832|156912537|FG003|Overall Study|Adverse Event|0|||
48744355|NCT02795832|156912538|FG004|Overall Study|Adverse Event|0|||
48744356|NCT02795832|156912539|FG005|Overall Study|Adverse Event|3|||
48744357|NCT02030041|156912540|FG000|Overall Study|Withdrawal by Subject|2|||
48744358|NCT02030041|156912541|FG001|Overall Study|Withdrawal by Subject|2|||
48744359|NCT02030041|156912542|FG002|Overall Study|Withdrawal by Subject|1|||
48744360|NCT00826943|156912543|FG000|Overall Study|Withdrawal by Subject|0|||
48744361|NCT00826943|156912544|FG001|Overall Study|Withdrawal by Subject|0|||
48744362|NCT00826943|156912545|FG002|Overall Study|Withdrawal by Subject|0|||
48744363|NCT00826943|156912546|FG003|Overall Study|Withdrawal by Subject|0|||
48744364|NCT00826943|156912547|FG004|Overall Study|Withdrawal by Subject|1|||
48744365|NCT00826943|156912548|FG005|Overall Study|Withdrawal by Subject|0|||
48744366|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
48744367|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
48744368|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
48744369|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
48744370|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
48744371|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
48744372|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
48744373|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
48744374|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
48744375|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
48744376|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
48744377|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
48744378|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
48744379|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
48744380|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
48744381|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
48325832|NCT01034306|155390779|FG000|Overall Study|hospitalized and decided to stop|1|||
48744382|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
48744383|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
48744384|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
48744385|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
48744386|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
48744387|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
48744388|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
48744389|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
48632147|NCT00829244|156511267|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
48632148|NCT00829244|156511266|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
48632149|NCT00829244|156511267|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
48632150|NCT00829244|156511266|FG000|Overall Study|No fertilization|2|||
48632151|NCT00829244|156511267|FG001|Overall Study|No fertilization|2|||
48632152|NCT00829244|156511266|FG000|Overall Study|All embryos discarded|0|||
48632153|NCT00829244|156511267|FG001|Overall Study|All embryos discarded|3|||
48632154|NCT00829244|156511266|FG000|Overall Study|No embryo cleavage|0|||
48632155|NCT00829244|156511267|FG001|Overall Study|No embryo cleavage|2|||
48632156|NCT01197378|156511272|FG000|Overall Study|Adverse Event|3|||
48632157|NCT01197378|156511272|FG000|Overall Study|Withdrawal by Subject|1|||
48632158|NCT01197378|156511272|FG000|Overall Study|Physician Decision|1|||
48632159|NCT01197378|156511272|FG000|Overall Study|Other|2|||
48632160|NCT03370276|156511274|FG000|Overall Study|Death|0|||
48632161|NCT03370276|156511275|FG001|Overall Study|Death|2|||
48632162|NCT03370276|156511276|FG002|Overall Study|Death|5|||
48632163|NCT01928394|156511279|FG000|Treatment Period|Disease progression|17|||
48632164|NCT01928394|156511280|FG001|Treatment Period|Disease progression|2|||
48632165|NCT01928394|156511281|FG002|Treatment Period|Disease progression|12|||
48632166|NCT01928394|156511282|FG003|Treatment Period|Disease progression|48|||
48632167|NCT01928394|156511283|FG004|Treatment Period|Disease progression|3|||
48632168|NCT01928394|156511284|FG005|Treatment Period|Disease progression|25|||
48632169|NCT01928394|156511285|FG006|Treatment Period|Disease progression|38|||
48632170|NCT01928394|156511286|FG007|Treatment Period|Disease progression|16|||
48632171|NCT01928394|156511287|FG008|Treatment Period|Disease progression|3|||
48632172|NCT01928394|156511288|FG009|Treatment Period|Disease progression|11|||
48632173|NCT01928394|156511289|FG010|Treatment Period|Disease progression|22|||
48632174|NCT01928394|156511290|FG011|Treatment Period|Disease progression|73|||
48632175|NCT01928394|156511291|FG012|Treatment Period|Disease progression|38|||
48632176|NCT01928394|156511292|FG013|Treatment Period|Disease progression|118|||
48632177|NCT01928394|156511293|FG014|Treatment Period|Disease progression|59|||
48632178|NCT01928394|156511294|FG015|Treatment Period|Disease progression|1|||
48632179|NCT01928394|156511295|FG016|Treatment Period|Disease progression|43|||
48632180|NCT01928394|156511296|FG017|Treatment Period|Disease progression|56|||
48632181|NCT01928394|156511297|FG018|Treatment Period|Disease progression|50|||
48632182|NCT01928394|156511298|FG019|Treatment Period|Disease progression|71|||
48632183|NCT01928394|156511299|FG020|Treatment Period|Disease progression|30|||
48632184|NCT01928394|156511300|FG021|Treatment Period|Disease progression|31|||
48632185|NCT01928394|156511301|FG022|Treatment Period|Disease progression|31|||
48632186|NCT01928394|156511279|FG000|Treatment Period|Study drug toxicity|1|||
48632187|NCT01928394|156511280|FG001|Treatment Period|Study drug toxicity|1|||
48632188|NCT01928394|156511281|FG002|Treatment Period|Study drug toxicity|3|||
48632189|NCT01928394|156511282|FG003|Treatment Period|Study drug toxicity|3|||
48632190|NCT01928394|156511283|FG004|Treatment Period|Study drug toxicity|0|||
48632191|NCT01928394|156511284|FG005|Treatment Period|Study drug toxicity|9|||
48632192|NCT01928394|156511285|FG006|Treatment Period|Study drug toxicity|7|||
48632193|NCT01928394|156511286|FG007|Treatment Period|Study drug toxicity|1|||
48632194|NCT01928394|156511287|FG008|Treatment Period|Study drug toxicity|0|||
48632195|NCT01928394|156511288|FG009|Treatment Period|Study drug toxicity|5|||
48632196|NCT01928394|156511289|FG010|Treatment Period|Study drug toxicity|2|||
48632197|NCT01928394|156511290|FG011|Treatment Period|Study drug toxicity|3|||
48632198|NCT01928394|156511291|FG012|Treatment Period|Study drug toxicity|7|||
48632199|NCT01928394|156511292|FG013|Treatment Period|Study drug toxicity|5|||
48632200|NCT01928394|156511293|FG014|Treatment Period|Study drug toxicity|12|||
48632201|NCT01928394|156511294|FG015|Treatment Period|Study drug toxicity|0|||
48632202|NCT01928394|156511295|FG016|Treatment Period|Study drug toxicity|3|||
48632203|NCT01928394|156511296|FG017|Treatment Period|Study drug toxicity|3|||
48632204|NCT01928394|156511297|FG018|Treatment Period|Study drug toxicity|12|||
48632205|NCT01928394|156511298|FG019|Treatment Period|Study drug toxicity|15|||
48632206|NCT01928394|156511299|FG020|Treatment Period|Study drug toxicity|4|||
48744390|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
48325833|NCT01034306|155390780|FG001|Overall Study|hospitalized and decided to stop|0|||
48632207|NCT01928394|156511300|FG021|Treatment Period|Study drug toxicity|7|||
48744391|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
48744392|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
48632208|NCT01928394|156511301|FG022|Treatment Period|Study drug toxicity|4|||
48632209|NCT01928394|156511279|FG000|Treatment Period|AE unrelated to study drug|0|||
48632210|NCT01928394|156511280|FG001|Treatment Period|AE unrelated to study drug|0|||
48632211|NCT01928394|156511281|FG002|Treatment Period|AE unrelated to study drug|2|||
48632212|NCT01928394|156511282|FG003|Treatment Period|AE unrelated to study drug|3|||
48632213|NCT01928394|156511283|FG004|Treatment Period|AE unrelated to study drug|0|||
48632214|NCT01928394|156511284|FG005|Treatment Period|AE unrelated to study drug|5|||
48632215|NCT01928394|156511285|FG006|Treatment Period|AE unrelated to study drug|1|||
48325834|NCT01034306|155390779|FG000|Overall Study|Noncomplience|1|||
48744393|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
48744394|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
48744395|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
48744396|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744397|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
48744398|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744399|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744400|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744401|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
48744402|NCT00843024|156912550|FG000|Single-blind Placebo Run-In Phase|Other|0|||
48744403|NCT00843024|156912551|FG001|Single-blind Placebo Run-In Phase|Other|1|||
48744404|NCT00843024|156912552|FG002|Single-blind Placebo Run-In Phase|Other|0|||
48744405|NCT00843024|156912553|FG003|Single-blind Placebo Run-In Phase|Other|0|||
48744406|NCT00843024|156912554|FG004|Single-blind Placebo Run-In Phase|Other|0|||
48744407|NCT00843024|156912555|FG005|Single-blind Placebo Run-In Phase|Other|0|||
48744408|NCT00843024|156912550|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
48744409|NCT00843024|156912551|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
48744410|NCT00843024|156912552|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
48744411|NCT00843024|156912553|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
48744412|NCT00843024|156912554|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
48744413|NCT00843024|156912555|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
48744414|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48744415|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
48744416|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
48744417|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
48744418|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
48744419|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
48744420|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48744421|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48744422|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48744423|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
48744424|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48744425|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
48744426|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
48744427|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
48744428|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
48744429|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
48325835|NCT01034306|155390780|FG001|Overall Study|Noncomplience|0|||
48325836|NCT01988402|155390781|FG000|Overall Study|Adverse Event|1|||
48744430|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
48744431|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
48744432|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Physician Decision|0|||
48744433|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Physician Decision|0|||
48744434|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Physician Decision|0|||
48744435|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Physician Decision|3|||
48744436|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Physician Decision|1|||
48744437|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Physician Decision|1|||
48744438|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Adverse Event|0|||
48744439|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Adverse Event|0|||
48744440|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Adverse Event|0|||
48744441|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Adverse Event|0|||
48744442|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Adverse Event|1|||
48632216|NCT01928394|156511286|FG007|Treatment Period|AE unrelated to study drug|0|||
48744443|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Adverse Event|1|||
48744444|NCT00843024|156912550|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
48632217|NCT01928394|156511287|FG008|Treatment Period|AE unrelated to study drug|0|||
48632218|NCT01928394|156511288|FG009|Treatment Period|AE unrelated to study drug|2|||
48632219|NCT01928394|156511289|FG010|Treatment Period|AE unrelated to study drug|0|||
48632220|NCT01928394|156511290|FG011|Treatment Period|AE unrelated to study drug|12|||
48632221|NCT01928394|156511291|FG012|Treatment Period|AE unrelated to study drug|6|||
48632222|NCT01928394|156511292|FG013|Treatment Period|AE unrelated to study drug|13|||
48632223|NCT01928394|156511293|FG014|Treatment Period|AE unrelated to study drug|6|||
48632224|NCT01928394|156511294|FG015|Treatment Period|AE unrelated to study drug|1|||
48632225|NCT01928394|156511295|FG016|Treatment Period|AE unrelated to study drug|1|||
48632226|NCT01928394|156511296|FG017|Treatment Period|AE unrelated to study drug|6|||
48632227|NCT01928394|156511297|FG018|Treatment Period|AE unrelated to study drug|3|||
48632228|NCT01928394|156511298|FG019|Treatment Period|AE unrelated to study drug|5|||
48632229|NCT01928394|156511299|FG020|Treatment Period|AE unrelated to study drug|1|||
48632230|NCT01928394|156511300|FG021|Treatment Period|AE unrelated to study drug|1|||
48632231|NCT01928394|156511301|FG022|Treatment Period|AE unrelated to study drug|0|||
48632232|NCT01928394|156511279|FG000|Treatment Period|Participant request to stop therapy|0|||
48632233|NCT01928394|156511280|FG001|Treatment Period|Participant request to stop therapy|0|||
48632234|NCT01928394|156511281|FG002|Treatment Period|Participant request to stop therapy|0|||
48632235|NCT01928394|156511282|FG003|Treatment Period|Participant request to stop therapy|0|||
48632236|NCT01928394|156511283|FG004|Treatment Period|Participant request to stop therapy|0|||
48632237|NCT01928394|156511284|FG005|Treatment Period|Participant request to stop therapy|3|||
48632238|NCT01928394|156511285|FG006|Treatment Period|Participant request to stop therapy|3|||
48632239|NCT01928394|156511286|FG007|Treatment Period|Participant request to stop therapy|0|||
48632240|NCT01928394|156511287|FG008|Treatment Period|Participant request to stop therapy|0|||
48632241|NCT01928394|156511288|FG009|Treatment Period|Participant request to stop therapy|0|||
48632242|NCT01928394|156511289|FG010|Treatment Period|Participant request to stop therapy|3|||
48632243|NCT01928394|156511290|FG011|Treatment Period|Participant request to stop therapy|2|||
48632244|NCT01928394|156511291|FG012|Treatment Period|Participant request to stop therapy|1|||
48632245|NCT01928394|156511292|FG013|Treatment Period|Participant request to stop therapy|2|||
48632246|NCT01928394|156511293|FG014|Treatment Period|Participant request to stop therapy|4|||
48632247|NCT01928394|156511294|FG015|Treatment Period|Participant request to stop therapy|0|||
48632248|NCT01928394|156511295|FG016|Treatment Period|Participant request to stop therapy|1|||
48632249|NCT01928394|156511296|FG017|Treatment Period|Participant request to stop therapy|3|||
48632250|NCT01928394|156511297|FG018|Treatment Period|Participant request to stop therapy|1|||
48632251|NCT01928394|156511298|FG019|Treatment Period|Participant request to stop therapy|1|||
48632252|NCT01928394|156511299|FG020|Treatment Period|Participant request to stop therapy|3|||
48632253|NCT01928394|156511300|FG021|Treatment Period|Participant request to stop therapy|1|||
48632254|NCT01928394|156511301|FG022|Treatment Period|Participant request to stop therapy|3|||
48632255|NCT01928394|156511279|FG000|Treatment Period|Participant withdrew consent|0|||
48632256|NCT01928394|156511280|FG001|Treatment Period|Participant withdrew consent|0|||
48632257|NCT01928394|156511281|FG002|Treatment Period|Participant withdrew consent|1|||
48632258|NCT01928394|156511282|FG003|Treatment Period|Participant withdrew consent|1|||
48632259|NCT01928394|156511283|FG004|Treatment Period|Participant withdrew consent|0|||
48632260|NCT01928394|156511284|FG005|Treatment Period|Participant withdrew consent|1|||
48632261|NCT01928394|156511285|FG006|Treatment Period|Participant withdrew consent|0|||
48632262|NCT01928394|156511286|FG007|Treatment Period|Participant withdrew consent|1|||
48632263|NCT01928394|156511287|FG008|Treatment Period|Participant withdrew consent|0|||
48632264|NCT01928394|156511288|FG009|Treatment Period|Participant withdrew consent|0|||
48632265|NCT01928394|156511289|FG010|Treatment Period|Participant withdrew consent|1|||
48632266|NCT01928394|156511290|FG011|Treatment Period|Participant withdrew consent|1|||
48632267|NCT01928394|156511291|FG012|Treatment Period|Participant withdrew consent|1|||
48632268|NCT01928394|156511292|FG013|Treatment Period|Participant withdrew consent|0|||
48632269|NCT01928394|156511293|FG014|Treatment Period|Participant withdrew consent|2|||
48632270|NCT01928394|156511294|FG015|Treatment Period|Participant withdrew consent|0|||
48632271|NCT01928394|156511295|FG016|Treatment Period|Participant withdrew consent|2|||
48632272|NCT01928394|156511296|FG017|Treatment Period|Participant withdrew consent|1|||
48632273|NCT01928394|156511297|FG018|Treatment Period|Participant withdrew consent|1|||
48632274|NCT01928394|156511298|FG019|Treatment Period|Participant withdrew consent|1|||
48632275|NCT01928394|156511299|FG020|Treatment Period|Participant withdrew consent|0|||
48632276|NCT01928394|156511300|FG021|Treatment Period|Participant withdrew consent|2|||
48744445|NCT00843024|156912551|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744446|NCT00843024|156912552|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744447|NCT00843024|156912553|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744448|NCT00843024|156912554|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
48744449|NCT00843024|156912555|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
48744450|NCT02439138|156912556|FG000|Overall Study|Adverse Event|1|||
48744451|NCT02439138|156912556|FG000|Overall Study|PI decision to terminate the study|2|||
48744452|NCT04659161|156912557|FG000|Overall Study|Adverse Event|10|||
48744453|NCT04659161|156912558|FG001|Overall Study|Adverse Event|6|||
48744454|NCT04659161|156912557|FG000|Overall Study|Withdrawal by Subject|13|||
48744455|NCT04659161|156912558|FG001|Overall Study|Withdrawal by Subject|12|||
48744456|NCT04659161|156912557|FG000|Overall Study|Other|9|||
48744457|NCT04659161|156912558|FG001|Overall Study|Other|8|||
48744458|NCT01487200|156912559|FG000|Overall Study|Withdrawal by Subject|0|||
48632277|NCT01928394|156511301|FG022|Treatment Period|Participant withdrew consent|0|||
48632278|NCT01928394|156511279|FG000|Treatment Period|Poor/non-compliance|0|||
48632279|NCT01928394|156511280|FG001|Treatment Period|Poor/non-compliance|0|||
48632280|NCT01928394|156511281|FG002|Treatment Period|Poor/non-compliance|0|||
48632281|NCT01928394|156511282|FG003|Treatment Period|Poor/non-compliance|1|||
48632282|NCT01928394|156511283|FG004|Treatment Period|Poor/non-compliance|0|||
48632283|NCT01928394|156511284|FG005|Treatment Period|Poor/non-compliance|0|||
48632284|NCT01928394|156511285|FG006|Treatment Period|Poor/non-compliance|0|||
48632285|NCT01928394|156511286|FG007|Treatment Period|Poor/non-compliance|0|||
48632286|NCT01928394|156511287|FG008|Treatment Period|Poor/non-compliance|0|||
48632287|NCT01928394|156511288|FG009|Treatment Period|Poor/non-compliance|0|||
48632288|NCT01928394|156511289|FG010|Treatment Period|Poor/non-compliance|0|||
48632289|NCT01928394|156511290|FG011|Treatment Period|Poor/non-compliance|0|||
48632290|NCT01928394|156511291|FG012|Treatment Period|Poor/non-compliance|1|||
48632291|NCT01928394|156511292|FG013|Treatment Period|Poor/non-compliance|0|||
48632292|NCT01928394|156511293|FG014|Treatment Period|Poor/non-compliance|1|||
48632293|NCT01928394|156511294|FG015|Treatment Period|Poor/non-compliance|0|||
48632294|NCT01928394|156511295|FG016|Treatment Period|Poor/non-compliance|0|||
48632295|NCT01928394|156511296|FG017|Treatment Period|Poor/non-compliance|1|||
48632296|NCT01928394|156511297|FG018|Treatment Period|Poor/non-compliance|0|||
48632297|NCT01928394|156511298|FG019|Treatment Period|Poor/non-compliance|1|||
48632298|NCT01928394|156511299|FG020|Treatment Period|Poor/non-compliance|0|||
48632299|NCT01928394|156511300|FG021|Treatment Period|Poor/non-compliance|0|||
48632300|NCT01928394|156511301|FG022|Treatment Period|Poor/non-compliance|0|||
48632301|NCT01928394|156511279|FG000|Treatment Period|other reason|0|||
48632302|NCT01928394|156511280|FG001|Treatment Period|other reason|0|||
48632303|NCT01928394|156511281|FG002|Treatment Period|other reason|0|||
48632304|NCT01928394|156511282|FG003|Treatment Period|other reason|0|||
48632305|NCT01928394|156511283|FG004|Treatment Period|other reason|0|||
48632306|NCT01928394|156511284|FG005|Treatment Period|other reason|0|||
48632307|NCT01928394|156511285|FG006|Treatment Period|other reason|0|||
48632308|NCT01928394|156511286|FG007|Treatment Period|other reason|0|||
48632309|NCT01928394|156511287|FG008|Treatment Period|other reason|0|||
48632310|NCT01928394|156511288|FG009|Treatment Period|other reason|0|||
48632311|NCT01928394|156511289|FG010|Treatment Period|other reason|1|||
48632312|NCT01928394|156511290|FG011|Treatment Period|other reason|1|||
48632313|NCT01928394|156511291|FG012|Treatment Period|other reason|1|||
48632314|NCT01928394|156511292|FG013|Treatment Period|other reason|0|||
48632315|NCT01928394|156511293|FG014|Treatment Period|other reason|1|||
48632316|NCT01928394|156511294|FG015|Treatment Period|other reason|0|||
48632317|NCT01928394|156511295|FG016|Treatment Period|other reason|0|||
48632318|NCT01928394|156511296|FG017|Treatment Period|other reason|0|||
48632319|NCT01928394|156511297|FG018|Treatment Period|other reason|2|||
48632320|NCT01928394|156511298|FG019|Treatment Period|other reason|2|||
48632321|NCT01928394|156511299|FG020|Treatment Period|other reason|0|||
48632322|NCT01928394|156511300|FG021|Treatment Period|other reason|0|||
48632323|NCT01928394|156511301|FG022|Treatment Period|other reason|0|||
48632324|NCT01928394|156511279|FG000|Treatment Period|Maximum clinical benefit|0|||
48632325|NCT01928394|156511280|FG001|Treatment Period|Maximum clinical benefit|0|||
48632326|NCT01928394|156511281|FG002|Treatment Period|Maximum clinical benefit|0|||
48632327|NCT01928394|156511282|FG003|Treatment Period|Maximum clinical benefit|0|||
48632328|NCT01928394|156511283|FG004|Treatment Period|Maximum clinical benefit|0|||
48632329|NCT01928394|156511284|FG005|Treatment Period|Maximum clinical benefit|0|||
48744459|NCT01487200|156912560|FG001|Overall Study|Withdrawal by Subject|1|||
48632330|NCT01928394|156511285|FG006|Treatment Period|Maximum clinical benefit|0|||
48632331|NCT01928394|156511286|FG007|Treatment Period|Maximum clinical benefit|0|||
48632332|NCT01928394|156511287|FG008|Treatment Period|Maximum clinical benefit|0|||
48632333|NCT01928394|156511288|FG009|Treatment Period|Maximum clinical benefit|0|||
48632334|NCT01928394|156511289|FG010|Treatment Period|Maximum clinical benefit|1|||
48632335|NCT01928394|156511290|FG011|Treatment Period|Maximum clinical benefit|1|||
48632336|NCT01928394|156511291|FG012|Treatment Period|Maximum clinical benefit|0|||
48632337|NCT01928394|156511292|FG013|Treatment Period|Maximum clinical benefit|0|||
48325837|NCT01988402|155390782|FG001|Overall Study|Adverse Event|2|||
48632338|NCT01928394|156511293|FG014|Treatment Period|Maximum clinical benefit|1|||
48632339|NCT01928394|156511294|FG015|Treatment Period|Maximum clinical benefit|0|||
48632340|NCT01928394|156511295|FG016|Treatment Period|Maximum clinical benefit|0|||
48632341|NCT01928394|156511296|FG017|Treatment Period|Maximum clinical benefit|1|||
48632342|NCT01928394|156511297|FG018|Treatment Period|Maximum clinical benefit|1|||
48632343|NCT01928394|156511298|FG019|Treatment Period|Maximum clinical benefit|0|||
48632344|NCT01928394|156511299|FG020|Treatment Period|Maximum clinical benefit|2|||
48632345|NCT01928394|156511300|FG021|Treatment Period|Maximum clinical benefit|0|||
48632346|NCT01928394|156511301|FG022|Treatment Period|Maximum clinical benefit|0|||
48632347|NCT01928394|156511279|FG000|Treatment Period|Lost to Follow-up|0|||
48632348|NCT01928394|156511280|FG001|Treatment Period|Lost to Follow-up|0|||
48632349|NCT01928394|156511281|FG002|Treatment Period|Lost to Follow-up|0|||
48632350|NCT01928394|156511282|FG003|Treatment Period|Lost to Follow-up|0|||
48632351|NCT01928394|156511283|FG004|Treatment Period|Lost to Follow-up|0|||
48632352|NCT01928394|156511284|FG005|Treatment Period|Lost to Follow-up|0|||
48632353|NCT01928394|156511285|FG006|Treatment Period|Lost to Follow-up|0|||
48632354|NCT01928394|156511286|FG007|Treatment Period|Lost to Follow-up|0|||
48632355|NCT01928394|156511287|FG008|Treatment Period|Lost to Follow-up|0|||
48632356|NCT01928394|156511288|FG009|Treatment Period|Lost to Follow-up|0|||
48632357|NCT01928394|156511289|FG010|Treatment Period|Lost to Follow-up|0|||
48632358|NCT01928394|156511290|FG011|Treatment Period|Lost to Follow-up|0|||
48632359|NCT01928394|156511291|FG012|Treatment Period|Lost to Follow-up|0|||
48632360|NCT01928394|156511292|FG013|Treatment Period|Lost to Follow-up|0|||
48632361|NCT01928394|156511293|FG014|Treatment Period|Lost to Follow-up|0|||
48632362|NCT01928394|156511294|FG015|Treatment Period|Lost to Follow-up|0|||
48632363|NCT01928394|156511295|FG016|Treatment Period|Lost to Follow-up|0|||
48632364|NCT01928394|156511296|FG017|Treatment Period|Lost to Follow-up|0|||
48632365|NCT01928394|156511297|FG018|Treatment Period|Lost to Follow-up|0|||
48632366|NCT01928394|156511298|FG019|Treatment Period|Lost to Follow-up|0|||
48632367|NCT01928394|156511299|FG020|Treatment Period|Lost to Follow-up|0|||
48632368|NCT01928394|156511300|FG021|Treatment Period|Lost to Follow-up|0|||
48632369|NCT01928394|156511301|FG022|Treatment Period|Lost to Follow-up|1|||
48632370|NCT01928394|156511279|FG000|Treatment Period|Death|0|||
48632371|NCT01928394|156511280|FG001|Treatment Period|Death|0|||
48632372|NCT01928394|156511281|FG002|Treatment Period|Death|0|||
48632373|NCT01928394|156511282|FG003|Treatment Period|Death|0|||
48632374|NCT01928394|156511283|FG004|Treatment Period|Death|0|||
48632375|NCT01928394|156511284|FG005|Treatment Period|Death|0|||
48325838|NCT01988402|155390781|FG000|Overall Study|Withdrawal by Subject|1|||
48325839|NCT01988402|155390782|FG001|Overall Study|Withdrawal by Subject|0|||
48632376|NCT01928394|156511285|FG006|Treatment Period|Death|0|||
48632377|NCT01928394|156511286|FG007|Treatment Period|Death|0|||
48632378|NCT01928394|156511287|FG008|Treatment Period|Death|0|||
48632379|NCT01928394|156511288|FG009|Treatment Period|Death|0|||
48632380|NCT01928394|156511289|FG010|Treatment Period|Death|0|||
48744460|NCT01487200|156912561|FG002|Overall Study|Withdrawal by Subject|0|||
48744461|NCT01487200|156912562|FG003|Overall Study|Withdrawal by Subject|0|||
48744462|NCT01858389|156912570|FG000|Overall Study|Death|1|||
48744463|NCT01858389|156912571|FG001|Overall Study|Death|3|||
48744464|NCT01858389|156912570|FG000|Overall Study|Study terminated by sponsor|0|||
48744465|NCT01858389|156912571|FG001|Overall Study|Study terminated by sponsor|2|||
48744466|NCT01858389|156912570|FG000|Overall Study|Withdrawal by Subject|0|||
48744467|NCT01858389|156912571|FG001|Overall Study|Withdrawal by Subject|1|||
48744468|NCT01858389|156912570|FG000|Overall Study|Progressive disease|10|||
48744469|NCT01858389|156912571|FG001|Overall Study|Progressive disease|11|||
48744470|NCT01858389|156912570|FG000|Overall Study|Other|2|||
48744471|NCT01858389|156912571|FG001|Overall Study|Other|4|||
48744472|NCT01858389|156912570|FG000|Overall Study|Adverse Event|3|||
48744473|NCT01858389|156912571|FG001|Overall Study|Adverse Event|1|||
48744474|NCT01858389|156912570|FG000|Overall Study|Did not receive treatment|0|||
48744475|NCT01858389|156912571|FG001|Overall Study|Did not receive treatment|3|||
48744476|NCT01269463|156912572|FG000|First Intervention|Withdrawal by Subject|1|||
48744477|NCT01269463|156912573|FG001|First Intervention|Withdrawal by Subject|0|||
48744478|NCT01269463|156912572|FG000|First Intervention|Adverse Event|1|||
48744479|NCT01269463|156912573|FG001|First Intervention|Adverse Event|0|||
48744480|NCT01269463|156912572|FG000|First Intervention|Lack of Efficacy|0|||
48744481|NCT01269463|156912573|FG001|First Intervention|Lack of Efficacy|1|||
48744482|NCT01269463|156912572|FG000|First Intervention|Physician Decision|0|||
48744483|NCT01269463|156912573|FG001|First Intervention|Physician Decision|1|||
48744484|NCT04404361|156912577|FG000|Overall Study|Death|12|||
48744485|NCT04404361|156912578|FG001|Overall Study|Death|12|||
48744486|NCT04404361|156912577|FG000|Overall Study|Withdrawal by Subject|13|||
48744487|NCT04404361|156912578|FG001|Overall Study|Withdrawal by Subject|5|||
48744488|NCT04404361|156912577|FG000|Overall Study|Lost to Follow-up|6|||
48744489|NCT04404361|156912578|FG001|Overall Study|Lost to Follow-up|3|||
48744490|NCT04404361|156912577|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
48744491|NCT04404361|156912578|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
48744492|NCT00558558|156912579|FG000|Overall Study|Unable to swallow|1|||
48744493|NCT00558558|156912579|FG000|Overall Study|Withdrawal by Subject|1|||
48744494|NCT00558558|156912579|FG000|Overall Study|Lack of Efficacy|4|||
48744495|NCT01744197|156912582|FG000|Overall Study|Received 1 patch|2|||
48744496|NCT01744197|156912583|FG001|Overall Study|Received 1 patch|1|||
48744497|NCT01744197|156912582|FG000|Overall Study|No patch received|2|||
48744498|NCT01744197|156912583|FG001|Overall Study|No patch received|2|||
48744499|NCT04706091|156912588|FG000|Treatment 2|Withdrawal by Subject|1|||
48744500|NCT04706091|156912589|FG001|Treatment 2|Withdrawal by Subject|0|||
48744501|NCT00621153|156912590|FG000|Overall Study|Safety Reason|8|||
48744502|NCT00621153|156912591|FG001|Overall Study|Safety Reason|7|||
48744503|NCT00621153|156912590|FG000|Overall Study|Adverse Event|3|||
48744504|NCT00621153|156912591|FG001|Overall Study|Adverse Event|2|||
48744505|NCT00621153|156912590|FG000|Overall Study|Lost to Follow-up|5|||
48744506|NCT00621153|156912591|FG001|Overall Study|Lost to Follow-up|1|||
48744507|NCT00621153|156912590|FG000|Overall Study|Withdrawal by Subject|4|||
48744508|NCT00621153|156912591|FG001|Overall Study|Withdrawal by Subject|5|||
48744509|NCT02915016|156912592|FG000|Overall Study|Lost to Follow-up|4|||
48744510|NCT02915016|156912593|FG001|Overall Study|Lost to Follow-up|2|||
48744511|NCT02915016|156912594|FG002|Overall Study|Lost to Follow-up|5|||
48744512|NCT02915016|156912595|FG003|Overall Study|Lost to Follow-up|3|||
48744513|NCT02915016|156912596|FG004|Overall Study|Lost to Follow-up|5|||
48744514|NCT02915016|156912597|FG005|Overall Study|Lost to Follow-up|2|||
48744515|NCT02915016|156912598|FG006|Overall Study|Lost to Follow-up|8|||
48744516|NCT02915016|156912599|FG007|Overall Study|Lost to Follow-up|2|||
48744517|NCT02915016|156912592|FG000|Overall Study|Physician Decision|0|||
48744518|NCT02915016|156912593|FG001|Overall Study|Physician Decision|0|||
48744519|NCT02915016|156912594|FG002|Overall Study|Physician Decision|1|||
48744520|NCT02915016|156912595|FG003|Overall Study|Physician Decision|0|||
48744521|NCT02915016|156912596|FG004|Overall Study|Physician Decision|0|||
48744522|NCT02915016|156912597|FG005|Overall Study|Physician Decision|1|||
48744523|NCT02915016|156912598|FG006|Overall Study|Physician Decision|2|||
48744524|NCT02915016|156912599|FG007|Overall Study|Physician Decision|0|||
48744525|NCT02915016|156912592|FG000|Overall Study|Withdrawal by Subject|2|||
48744526|NCT02915016|156912593|FG001|Overall Study|Withdrawal by Subject|0|||
48744527|NCT02915016|156912594|FG002|Overall Study|Withdrawal by Subject|1|||
48744528|NCT02915016|156912595|FG003|Overall Study|Withdrawal by Subject|0|||
48744529|NCT02915016|156912596|FG004|Overall Study|Withdrawal by Subject|1|||
48744530|NCT02915016|156912597|FG005|Overall Study|Withdrawal by Subject|3|||
48744531|NCT02915016|156912598|FG006|Overall Study|Withdrawal by Subject|1|||
48744532|NCT02915016|156912599|FG007|Overall Study|Withdrawal by Subject|1|||
48744533|NCT02915016|156912592|FG000|Overall Study|Elected not to continue|0|||
48744534|NCT02915016|156912593|FG001|Overall Study|Elected not to continue|0|||
48744535|NCT02915016|156912594|FG002|Overall Study|Elected not to continue|0|||
48744536|NCT02915016|156912595|FG003|Overall Study|Elected not to continue|1|||
48744537|NCT02915016|156912596|FG004|Overall Study|Elected not to continue|0|||
48632381|NCT01928394|156511290|FG011|Treatment Period|Death|0|||
48632382|NCT01928394|156511291|FG012|Treatment Period|Death|0|||
48632383|NCT01928394|156511292|FG013|Treatment Period|Death|1|||
48744538|NCT02915016|156912597|FG005|Overall Study|Elected not to continue|0|||
48744539|NCT02915016|156912598|FG006|Overall Study|Elected not to continue|1|||
48744540|NCT02915016|156912599|FG007|Overall Study|Elected not to continue|0|||
48744541|NCT02915016|156912592|FG000|Overall Study|HIV infection|1|||
48744542|NCT02915016|156912593|FG001|Overall Study|HIV infection|1|||
48744543|NCT02915016|156912594|FG002|Overall Study|HIV infection|1|||
48744544|NCT02915016|156912595|FG003|Overall Study|HIV infection|0|||
48744545|NCT02915016|156912596|FG004|Overall Study|HIV infection|1|||
48744546|NCT02915016|156912597|FG005|Overall Study|HIV infection|0|||
48744547|NCT02915016|156912598|FG006|Overall Study|HIV infection|0|||
48632384|NCT01928394|156511293|FG014|Treatment Period|Death|2|||
48744548|NCT02915016|156912599|FG007|Overall Study|HIV infection|0|||
48744549|NCT02915016|156912592|FG000|Overall Study|Participant unable to adhere|0|||
48744550|NCT02915016|156912593|FG001|Overall Study|Participant unable to adhere|0|||
48744551|NCT02915016|156912594|FG002|Overall Study|Participant unable to adhere|0|||
48744552|NCT02915016|156912595|FG003|Overall Study|Participant unable to adhere|0|||
48744553|NCT02915016|156912596|FG004|Overall Study|Participant unable to adhere|0|||
48632385|NCT01928394|156511294|FG015|Treatment Period|Death|0|||
48632386|NCT01928394|156511295|FG016|Treatment Period|Death|0|||
48632387|NCT01928394|156511296|FG017|Treatment Period|Death|0|||
48632388|NCT01928394|156511297|FG018|Treatment Period|Death|0|||
48632389|NCT01928394|156511298|FG019|Treatment Period|Death|0|||
48632390|NCT01928394|156511299|FG020|Treatment Period|Death|0|||
48632391|NCT01928394|156511300|FG021|Treatment Period|Death|0|||
48632392|NCT01928394|156511301|FG022|Treatment Period|Death|0|||
48632393|NCT01928394|156511279|FG000|Follow-up Period|Participant withdrew consent|3|||
48632394|NCT01928394|156511280|FG001|Follow-up Period|Participant withdrew consent|0|||
48632395|NCT01928394|156511281|FG002|Follow-up Period|Participant withdrew consent|1|||
48632396|NCT01928394|156511282|FG003|Follow-up Period|Participant withdrew consent|4|||
48632397|NCT01928394|156511283|FG004|Follow-up Period|Participant withdrew consent|0|||
48632398|NCT01928394|156511284|FG005|Follow-up Period|Participant withdrew consent|2|||
48744554|NCT02915016|156912597|FG005|Overall Study|Participant unable to adhere|0|||
48632399|NCT01928394|156511285|FG006|Follow-up Period|Participant withdrew consent|5|||
48632400|NCT01928394|156511286|FG007|Follow-up Period|Participant withdrew consent|1|||
48632401|NCT01928394|156511287|FG008|Follow-up Period|Participant withdrew consent|0|||
48632402|NCT01928394|156511288|FG009|Follow-up Period|Participant withdrew consent|0|||
48744555|NCT02915016|156912598|FG006|Overall Study|Participant unable to adhere|0|||
48744556|NCT02915016|156912599|FG007|Overall Study|Participant unable to adhere|1|||
48744557|NCT02200211|156914412|FG000|Overall Study|Lost to Follow-up|7|||
48744558|NCT02200211|156914413|FG001|Overall Study|Lost to Follow-up|7|||
48744559|NCT02200211|156914414|FG002|Overall Study|Lost to Follow-up|1|||
48744560|NCT02200211|156914415|FG003|Overall Study|Lost to Follow-up|2|||
48744561|NCT02200211|156914412|FG000|Overall Study|Withdrawal by Subject|1|||
48744562|NCT02200211|156914413|FG001|Overall Study|Withdrawal by Subject|0|||
48632403|NCT01928394|156511289|FG010|Follow-up Period|Participant withdrew consent|5|||
48632404|NCT01928394|156511290|FG011|Follow-up Period|Participant withdrew consent|8|||
48632405|NCT01928394|156511291|FG012|Follow-up Period|Participant withdrew consent|2|||
48632406|NCT01928394|156511292|FG013|Follow-up Period|Participant withdrew consent|12|||
48632407|NCT01928394|156511293|FG014|Follow-up Period|Participant withdrew consent|7|||
48632408|NCT01928394|156511294|FG015|Follow-up Period|Participant withdrew consent|0|||
48632409|NCT01928394|156511295|FG016|Follow-up Period|Participant withdrew consent|5|||
48632410|NCT01928394|156511296|FG017|Follow-up Period|Participant withdrew consent|3|||
48632411|NCT01928394|156511297|FG018|Follow-up Period|Participant withdrew consent|2|||
48632412|NCT01928394|156511298|FG019|Follow-up Period|Participant withdrew consent|7|||
48632413|NCT01928394|156511299|FG020|Follow-up Period|Participant withdrew consent|4|||
48632414|NCT01928394|156511300|FG021|Follow-up Period|Participant withdrew consent|6|||
48632415|NCT01928394|156511301|FG022|Follow-up Period|Participant withdrew consent|2|||
48632416|NCT01928394|156511279|FG000|Follow-up Period|Death|0|||
48632417|NCT01928394|156511280|FG001|Follow-up Period|Death|0|||
48632418|NCT01928394|156511281|FG002|Follow-up Period|Death|2|||
48632419|NCT01928394|156511282|FG003|Follow-up Period|Death|6|||
48632420|NCT01928394|156511283|FG004|Follow-up Period|Death|0|||
48632421|NCT01928394|156511284|FG005|Follow-up Period|Death|6|||
48744563|NCT02200211|156914414|FG002|Overall Study|Withdrawal by Subject|0|||
48744564|NCT02200211|156914415|FG003|Overall Study|Withdrawal by Subject|0|||
48744565|NCT01687998|156914416|FG000|Overall Study|Withdrawal by Subject|49|||
48744566|NCT01687998|156914417|FG001|Overall Study|Withdrawal by Subject|51|||
48744567|NCT01687998|156914416|FG000|Overall Study|Known to be Alive at Study End|54|||
48744568|NCT01687998|156914417|FG001|Overall Study|Known to be Alive at Study End|62|||
48744569|NCT01687998|156914416|FG000|Overall Study|Lost to Follow-up|9|||
48744570|NCT01687998|156914417|FG001|Overall Study|Lost to Follow-up|7|||
48744571|NCT03166735|156914420|FG000|Overall Study|Not Treated|1|||
48744572|NCT03166735|156914421|FG001|Overall Study|Not Treated|0|||
48744573|NCT03166735|156914422|FG002|Overall Study|Not Treated|0|||
48744574|NCT03166735|156914423|FG003|Overall Study|Not Treated|0|||
48744575|NCT03166735|156914424|FG004|Overall Study|Not Treated|0|||
48744576|NCT03166735|156914420|FG000|Overall Study|follow-up not completed as planned|0|||
48744577|NCT03166735|156914421|FG001|Overall Study|follow-up not completed as planned|1|||
48744578|NCT03166735|156914422|FG002|Overall Study|follow-up not completed as planned|1|||
48744579|NCT03166735|156914423|FG003|Overall Study|follow-up not completed as planned|0|||
48744580|NCT03166735|156914424|FG004|Overall Study|follow-up not completed as planned|1|||
48744581|NCT03166735|156914420|FG000|Overall Study|Withdrawal by Subject|0|||
48744582|NCT03166735|156914421|FG001|Overall Study|Withdrawal by Subject|0|||
48744583|NCT03166735|156914422|FG002|Overall Study|Withdrawal by Subject|1|||
48744584|NCT03166735|156914423|FG003|Overall Study|Withdrawal by Subject|1|||
48744585|NCT03166735|156914424|FG004|Overall Study|Withdrawal by Subject|2|||
48744586|NCT03166735|156914420|FG000|Overall Study|Lost to Follow-up|0|||
48744587|NCT03166735|156914421|FG001|Overall Study|Lost to Follow-up|2|||
48744588|NCT03166735|156914422|FG002|Overall Study|Lost to Follow-up|1|||
48744589|NCT03166735|156914423|FG003|Overall Study|Lost to Follow-up|0|||
48744590|NCT03166735|156914424|FG004|Overall Study|Lost to Follow-up|1|||
48744591|NCT04401423|156914425|FG000|Overall Study|Withdrawal by Subject|3|||
48744592|NCT04401423|156914426|FG001|Overall Study|Withdrawal by Subject|1|||
48744593|NCT04401423|156914425|FG000|Overall Study|Physician Decision|2|||
48744594|NCT04401423|156914426|FG001|Overall Study|Physician Decision|1|||
48744595|NCT03797014|156914427|FG000|Overall Study|Withdrawal by Subject|1|||
48744596|NCT03797014|156914427|FG000|Overall Study|Lost to Follow-up|1|||
48744597|NCT03797014|156914427|FG000|Overall Study|Protocol Violation|1|||
48744598|NCT03305575|156914431|FG000|Overall Study|Physician Decision|1|||
48744599|NCT03305575|156914432|FG001|Overall Study|Physician Decision|0|||
48744600|NCT05074667|156914437|FG000|Overall Study|Death|1|||
48744601|NCT05074667|156914437|FG000|Overall Study|Withdrawal by Subject|4|||
48632422|NCT01928394|156511285|FG006|Follow-up Period|Death|6|||
48632423|NCT01928394|156511286|FG007|Follow-up Period|Death|2|||
48632424|NCT01928394|156511287|FG008|Follow-up Period|Death|1|||
48744602|NCT05074667|156914437|FG000|Overall Study|Lost to Follow-up|10|||
48744603|NCT00612040|156914444|FG000|Overall Study|Adverse Event|0|||
48744604|NCT00612040|156914445|FG001|Overall Study|Adverse Event|2|||
48744605|NCT00612040|156914446|FG002|Overall Study|Adverse Event|1|||
48744606|NCT00612040|156914444|FG000|Overall Study|Protocol Violation|1|||
48325840|NCT01961609|155390783|FG000|Initiation|Missing|3|||
48325841|NCT01961609|155390784|FG001|Initiation|Missing|2|||
48744607|NCT00612040|156914445|FG001|Overall Study|Protocol Violation|2|||
48744608|NCT00612040|156914446|FG002|Overall Study|Protocol Violation|1|||
48632425|NCT01928394|156511288|FG009|Follow-up Period|Death|2|||
48632426|NCT01928394|156511289|FG010|Follow-up Period|Death|4|||
48632427|NCT01928394|156511290|FG011|Follow-up Period|Death|12|||
48632428|NCT01928394|156511291|FG012|Follow-up Period|Death|11|||
48632429|NCT01928394|156511292|FG013|Follow-up Period|Death|25|||
48632430|NCT01928394|156511293|FG014|Follow-up Period|Death|18|||
48632431|NCT01928394|156511294|FG015|Follow-up Period|Death|0|||
48632432|NCT01928394|156511295|FG016|Follow-up Period|Death|6|||
48632433|NCT01928394|156511296|FG017|Follow-up Period|Death|5|||
48632434|NCT01928394|156511297|FG018|Follow-up Period|Death|13|||
48632435|NCT01928394|156511298|FG019|Follow-up Period|Death|13|||
48632436|NCT01928394|156511299|FG020|Follow-up Period|Death|5|||
48632437|NCT01928394|156511300|FG021|Follow-up Period|Death|3|||
48632438|NCT01928394|156511301|FG022|Follow-up Period|Death|2|||
48632439|NCT01928394|156511279|FG000|Follow-up Period|other reason|0|||
48632440|NCT01928394|156511280|FG001|Follow-up Period|other reason|0|||
48632441|NCT01928394|156511281|FG002|Follow-up Period|other reason|0|||
48632442|NCT01928394|156511282|FG003|Follow-up Period|other reason|0|||
48632443|NCT01928394|156511283|FG004|Follow-up Period|other reason|0|||
48632444|NCT01928394|156511284|FG005|Follow-up Period|other reason|0|||
48632445|NCT01928394|156511285|FG006|Follow-up Period|other reason|1|||
48632446|NCT01928394|156511286|FG007|Follow-up Period|other reason|3|||
48632447|NCT01928394|156511287|FG008|Follow-up Period|other reason|0|||
48632448|NCT01928394|156511288|FG009|Follow-up Period|other reason|0|||
48632449|NCT01928394|156511289|FG010|Follow-up Period|other reason|2|||
48632450|NCT01928394|156511290|FG011|Follow-up Period|other reason|1|||
48632451|NCT01928394|156511291|FG012|Follow-up Period|other reason|0|||
48632452|NCT01928394|156511292|FG013|Follow-up Period|other reason|1|||
48632453|NCT01928394|156511293|FG014|Follow-up Period|other reason|4|||
48632454|NCT01928394|156511294|FG015|Follow-up Period|other reason|0|||
48632455|NCT01928394|156511295|FG016|Follow-up Period|other reason|2|||
48632456|NCT01928394|156511296|FG017|Follow-up Period|other reason|0|||
48632457|NCT01928394|156511297|FG018|Follow-up Period|other reason|1|||
48632458|NCT01928394|156511298|FG019|Follow-up Period|other reason|1|||
48632459|NCT01928394|156511299|FG020|Follow-up Period|other reason|0|||
48632460|NCT01928394|156511300|FG021|Follow-up Period|other reason|0|||
48632461|NCT01928394|156511301|FG022|Follow-up Period|other reason|1|||
48632462|NCT01928394|156511279|FG000|Follow-up Period|Lost to Follow-up|0|||
48632463|NCT01928394|156511280|FG001|Follow-up Period|Lost to Follow-up|0|||
48632464|NCT01928394|156511281|FG002|Follow-up Period|Lost to Follow-up|0|||
48632465|NCT01928394|156511282|FG003|Follow-up Period|Lost to Follow-up|0|||
48632466|NCT01928394|156511283|FG004|Follow-up Period|Lost to Follow-up|0|||
48632467|NCT01928394|156511284|FG005|Follow-up Period|Lost to Follow-up|0|||
48632468|NCT01928394|156511285|FG006|Follow-up Period|Lost to Follow-up|0|||
48632469|NCT01928394|156511286|FG007|Follow-up Period|Lost to Follow-up|0|||
48632470|NCT01928394|156511287|FG008|Follow-up Period|Lost to Follow-up|0|||
48632471|NCT01928394|156511288|FG009|Follow-up Period|Lost to Follow-up|0|||
48632472|NCT01928394|156511289|FG010|Follow-up Period|Lost to Follow-up|0|||
48632473|NCT01928394|156511290|FG011|Follow-up Period|Lost to Follow-up|1|||
48632474|NCT01928394|156511291|FG012|Follow-up Period|Lost to Follow-up|1|||
48632475|NCT01928394|156511292|FG013|Follow-up Period|Lost to Follow-up|0|||
48632476|NCT01928394|156511293|FG014|Follow-up Period|Lost to Follow-up|1|||
48632477|NCT01928394|156511294|FG015|Follow-up Period|Lost to Follow-up|0|||
48744609|NCT00612040|156914444|FG000|Overall Study|Lack of Efficacy|2|||
48744610|NCT00612040|156914445|FG001|Overall Study|Lack of Efficacy|1|||
48744611|NCT00612040|156914446|FG002|Overall Study|Lack of Efficacy|0|||
48744612|NCT00612040|156914444|FG000|Overall Study|Unclassified|2|||
48744613|NCT00612040|156914445|FG001|Overall Study|Unclassified|2|||
48744614|NCT00612040|156914446|FG002|Overall Study|Unclassified|5|||
48744615|NCT00590720|156914447|FG000|Overall Study|Lost to Follow-up|1|||
48632478|NCT01928394|156511295|FG016|Follow-up Period|Lost to Follow-up|1|||
48632479|NCT01928394|156511296|FG017|Follow-up Period|Lost to Follow-up|0|||
48632480|NCT01928394|156511297|FG018|Follow-up Period|Lost to Follow-up|0|||
48632481|NCT01928394|156511298|FG019|Follow-up Period|Lost to Follow-up|0|||
48744616|NCT00590720|156914448|FG001|Overall Study|Lost to Follow-up|0|||
48744617|NCT00590720|156914447|FG000|Overall Study|Withdrawal by Subject|0|||
48744618|NCT00590720|156914448|FG001|Overall Study|Withdrawal by Subject|1|||
48744619|NCT00224042|156914449|FG000|Overall Study|Adverse Event|2|||
48744620|NCT00224042|156914450|FG001|Overall Study|Adverse Event|1|||
48744621|NCT00224042|156914449|FG000|Overall Study|Protocol Violation|0|||
48744622|NCT00224042|156914450|FG001|Overall Study|Protocol Violation|1|||
48632482|NCT01928394|156511299|FG020|Follow-up Period|Lost to Follow-up|0|||
48632483|NCT01928394|156511300|FG021|Follow-up Period|Lost to Follow-up|0|||
48632484|NCT01928394|156511301|FG022|Follow-up Period|Lost to Follow-up|1|||
48632485|NCT04549454|156511303|FG000|T1 to T2|Lost to Follow-up|22|||
48632486|NCT04549454|156511304|FG001|T1 to T2|Lost to Follow-up|26|||
48632487|NCT04549454|156511303|FG000|T1 to T3|Lost to Follow-up|31|||
48632488|NCT04549454|156511304|FG001|T1 to T3|Lost to Follow-up|36|||
48632489|NCT01542788|156511315|FG000|Overall Study|Randomized but Not Treated|2|||
48632490|NCT01542788|156511316|FG001|Overall Study|Randomized but Not Treated|0|||
48632491|NCT01542788|156511315|FG000|Overall Study|Lack of Efficacy|41|||
48632492|NCT01542788|156511316|FG001|Overall Study|Lack of Efficacy|71|||
48632493|NCT01542788|156511315|FG000|Overall Study|Lost to Follow-up|5|||
48632494|NCT01542788|156511316|FG001|Overall Study|Lost to Follow-up|0|||
48325842|NCT01961609|155390785|FG002|Initiation|Missing|0|||
48325843|NCT01961609|155390786|FG003|Initiation|Missing|0|||
48325844|NCT01961609|155390783|FG000|Initiation|Protocol deviation|1|||
48325845|NCT01961609|155390784|FG001|Initiation|Protocol deviation|0|||
48325846|NCT01961609|155390785|FG002|Initiation|Protocol deviation|0|||
48325847|NCT01961609|155390786|FG003|Initiation|Protocol deviation|0|||
48325848|NCT01961609|155390783|FG000|Initiation|Death|0|||
48325849|NCT01961609|155390784|FG001|Initiation|Death|1|||
48325850|NCT01961609|155390785|FG002|Initiation|Death|0|||
48325851|NCT01961609|155390786|FG003|Initiation|Death|0|||
48325852|NCT01961609|155390783|FG000|Initiation|Administrative problems|1|||
48325853|NCT01961609|155390784|FG001|Initiation|Administrative problems|0|||
48325854|NCT01961609|155390785|FG002|Initiation|Administrative problems|0|||
48325855|NCT01961609|155390786|FG003|Initiation|Administrative problems|0|||
48325856|NCT01961609|155390783|FG000|Initiation|Withdrawal by Subject|1|||
48325857|NCT01961609|155390784|FG001|Initiation|Withdrawal by Subject|2|||
48325858|NCT01961609|155390785|FG002|Initiation|Withdrawal by Subject|0|||
48325859|NCT01961609|155390786|FG003|Initiation|Withdrawal by Subject|0|||
48325860|NCT01961609|155390783|FG000|Initiation|Lack of Efficacy|2|||
48325861|NCT01961609|155390784|FG001|Initiation|Lack of Efficacy|1|||
48325862|NCT01961609|155390785|FG002|Initiation|Lack of Efficacy|0|||
48325863|NCT01961609|155390786|FG003|Initiation|Lack of Efficacy|0|||
48325864|NCT01961609|155390783|FG000|Initiation|Abnormal lab values|0|||
48325865|NCT01961609|155390784|FG001|Initiation|Abnormal lab values|1|||
48325866|NCT01961609|155390785|FG002|Initiation|Abnormal lab values|0|||
48325867|NCT01961609|155390786|FG003|Initiation|Abnormal lab values|0|||
48632495|NCT01542788|156511315|FG000|Overall Study|Death|3|||
48632496|NCT01542788|156511316|FG001|Overall Study|Death|0|||
48632497|NCT01542788|156511315|FG000|Overall Study|Protocol Violation|2|||
48632498|NCT01542788|156511316|FG001|Overall Study|Protocol Violation|0|||
48632499|NCT01542788|156511315|FG000|Overall Study|Physician Decision|1|||
48632500|NCT01542788|156511316|FG001|Overall Study|Physician Decision|0|||
48632501|NCT01542788|156511315|FG000|Overall Study|Withdrawal by Subject|1|||
48632502|NCT01542788|156511316|FG001|Overall Study|Withdrawal by Subject|0|||
48632503|NCT01972659|156511317|FG000|Overall Study|Protocol Violation|2|||
48632504|NCT01972659|156511318|FG001|Overall Study|Protocol Violation|2|||
48632505|NCT01972659|156511317|FG000|Overall Study|problems realted to acceleromyograph|2|||
48632506|NCT01972659|156511318|FG001|Overall Study|problems realted to acceleromyograph|1|||
48632507|NCT01107886|156511335|FG000|Overall Study|Lost to Follow-up|15|||
48632508|NCT01107886|156511336|FG001|Overall Study|Lost to Follow-up|13|||
48632509|NCT01107886|156511335|FG000|Overall Study|Withdrawal by Subject|180|||
48632510|NCT01107886|156511336|FG001|Overall Study|Withdrawal by Subject|196|||
48632511|NCT01107886|156511335|FG000|Overall Study|Administrative withdrawal of consent|7|||
48632512|NCT01107886|156511336|FG001|Overall Study|Administrative withdrawal of consent|5|||
48632513|NCT04237584|156511338|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
48632514|NCT04237584|156511339|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
48632515|NCT04237584|156511340|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
48632516|NCT04237584|156511341|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
48632517|NCT04237584|156511338|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
48632518|NCT04237584|156511339|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
48632519|NCT04237584|156511340|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
48632520|NCT04237584|156511341|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
48632521|NCT04237584|156511338|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
48632522|NCT04237584|156511339|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
48632523|NCT04237584|156511340|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
48632524|NCT04237584|156511341|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
48632525|NCT04237584|156511338|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
48632526|NCT04237584|156511339|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
48632527|NCT04237584|156511340|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
48632528|NCT04237584|156511341|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
48632529|NCT04237584|156511338|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
48325868|NCT01961609|155390783|FG000|Initiation|Adverse Event|3|||
48325869|NCT01961609|155390784|FG001|Initiation|Adverse Event|5|||
48325870|NCT01961609|155390785|FG002|Initiation|Adverse Event|0|||
48325871|NCT01961609|155390786|FG003|Initiation|Adverse Event|0|||
48325872|NCT01961609|155390783|FG000|Initiation|Randomized but not treated|1|||
48325873|NCT01961609|155390784|FG001|Initiation|Randomized but not treated|1|||
48325874|NCT01961609|155390785|FG002|Initiation|Randomized but not treated|0|||
48325875|NCT01961609|155390786|FG003|Initiation|Randomized but not treated|0|||
48325876|NCT01961609|155390783|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
48426413|NCT01172288|155749579|FG000|Overall Study|Protocol Violation|0|||
48325877|NCT01961609|155390784|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
48325878|NCT01961609|155390785|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
48325879|NCT01961609|155390786|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
48325880|NCT01961609|155390783|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
48325881|NCT01961609|155390784|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
48325882|NCT01961609|155390785|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
48325883|NCT01961609|155390786|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
48325884|NCT01961609|155390783|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
48325885|NCT01961609|155390784|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
48325886|NCT01961609|155390785|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
48325887|NCT01961609|155390786|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
48325888|NCT01961609|155390783|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
48325889|NCT01961609|155390784|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
48325890|NCT01961609|155390785|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
48325891|NCT01961609|155390786|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
48325892|NCT01961609|155390783|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
48325893|NCT01961609|155390784|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
48325894|NCT01961609|155390785|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
48325895|NCT01961609|155390786|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
48325896|NCT01961609|155390783|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
48325897|NCT01961609|155390784|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
48632530|NCT04237584|156511339|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
48632531|NCT04237584|156511340|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
48632532|NCT04237584|156511341|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
48632533|NCT00590317|156512816|FG000|Overall Study|Lack of Efficacy|1|||
48325898|NCT01961609|155390785|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
48325899|NCT01961609|155390786|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
48325900|NCT01961609|155390783|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
48325901|NCT01961609|155390784|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
48325902|NCT01961609|155390785|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
48325903|NCT01961609|155390786|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
48325904|NCT01961609|155390783|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
48325905|NCT01961609|155390784|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
48325906|NCT01961609|155390785|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
48325907|NCT01961609|155390786|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
48325908|NCT01961609|155390783|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
48325909|NCT01961609|155390784|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
48325910|NCT01961609|155390785|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
48325911|NCT01961609|155390786|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
48325912|NCT01961609|155390783|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
48325913|NCT01961609|155390784|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
48632534|NCT00590317|156512817|FG001|Overall Study|Lack of Efficacy|5|||
48632535|NCT03837509|156512818|FG000|Phase 1|Death|5|||
48632536|NCT03837509|156512819|FG001|Phase 1|Death|2|||
48632537|NCT03837509|156512820|FG002|Phase 1|Death|0|||
48632538|NCT03837509|156512821|FG003|Phase 1|Death|0|||
48632539|NCT03837509|156512822|FG004|Phase 1|Death|0|||
48632540|NCT03837509|156512818|FG000|Phase 2|Death|0|||
48632541|NCT03837509|156512819|FG001|Phase 2|Death|0|||
48632542|NCT03837509|156512820|FG002|Phase 2|Death|0|||
48632543|NCT03837509|156512821|FG003|Phase 2|Death|1|||
48632544|NCT03837509|156512822|FG004|Phase 2|Death|1|||
48632545|NCT02278003|156512827|FG000|Overall Study|Withdrawal by Subject|11|||
48632546|NCT02278003|156512828|FG001|Overall Study|Withdrawal by Subject|0|||
48632547|NCT02278003|156512827|FG000|Overall Study|Not Treated|1|||
48632548|NCT02278003|156512828|FG001|Overall Study|Not Treated|0|||
48632549|NCT02278003|156512827|FG000|Overall Study|Recognition task improperly completed|7|||
48632550|NCT02278003|156512828|FG001|Overall Study|Recognition task improperly completed|0|||
48632551|NCT04110145|156512829|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
48632552|NCT04110145|156512830|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
48632553|NCT04110145|156512831|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
48632554|NCT04110145|156512832|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
48632555|NCT04110145|156512833|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
48632556|NCT00851084|156512839|FG000|Overall Study|Randomized but not treated|1|||
48632557|NCT00851084|156512840|FG001|Overall Study|Randomized but not treated|0|||
48325914|NCT01961609|155390785|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
48325915|NCT01961609|155390786|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
48325916|NCT01961609|155390783|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
48632558|NCT00851084|156512839|FG000|Overall Study|Adverse Event|26|||
48632559|NCT00851084|156512840|FG001|Overall Study|Adverse Event|36|||
48632560|NCT00851084|156512839|FG000|Overall Study|Disease progression|52|||
48632561|NCT00851084|156512840|FG001|Overall Study|Disease progression|47|||
48632562|NCT00851084|156512839|FG000|Overall Study|Poor compliance to protocol|1|||
48632563|NCT00851084|156512840|FG001|Overall Study|Poor compliance to protocol|1|||
48744623|NCT00224042|156914449|FG000|Overall Study|Physician Decision|0|||
48744624|NCT00224042|156914450|FG001|Overall Study|Physician Decision|1|||
48744625|NCT00224042|156914449|FG000|Overall Study|Did not meet lab incusion criteria|2|||
48744626|NCT00224042|156914450|FG001|Overall Study|Did not meet lab incusion criteria|3|||
48744627|NCT00224042|156914449|FG000|Overall Study|Other|2|||
48744628|NCT00224042|156914450|FG001|Overall Study|Other|0|||
48744629|NCT01976338|156914453|FG000|Overall Study|Physician Decision|0|||
48744630|NCT01976338|156914454|FG001|Overall Study|Physician Decision|1|||
48744631|NCT01976338|156914453|FG000|Overall Study|Lost to Follow-up|3|||
48325917|NCT01961609|155390784|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
48325918|NCT01961609|155390785|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
48325919|NCT01961609|155390786|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
48325920|NCT01961609|155390783|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
48325921|NCT01961609|155390784|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
48325922|NCT01961609|155390785|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
48325923|NCT01961609|155390786|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
48325924|NCT02022670|155390793|FG000|Overall Study|Adverse Event|1|||
48325925|NCT02022670|155390794|FG001|Overall Study|Adverse Event|0|||
48325926|NCT02022670|155390795|FG002|Overall Study|Adverse Event|1|||
48325927|NCT01536093|155390796|FG000|Overall Study|Death|1|||
48325928|NCT01536093|155390797|FG001|Overall Study|Death|2|||
48325929|NCT01536093|155390796|FG000|Overall Study|absence of maternal colostrum|2|||
48325930|NCT01536093|155390797|FG001|Overall Study|absence of maternal colostrum|0|||
48325931|NCT01536093|155390796|FG000|Overall Study|Withdrawal by Subject|0|||
48325932|NCT01536093|155390797|FG001|Overall Study|Withdrawal by Subject|1|||
48325933|NCT03861234|155390798|FG000|Overall Study|Not treated|0|||
48325934|NCT03861234|155390799|FG001|Overall Study|Not treated|0|||
48325935|NCT03861234|155390800|FG002|Overall Study|Not treated|0|||
48325936|NCT03861234|155390801|FG003|Overall Study|Not treated|0|||
48325937|NCT03861234|155390802|FG004|Overall Study|Not treated|0|||
48325938|NCT03861234|155390803|FG005|Overall Study|Not treated|1|||
48325939|NCT03861234|155390804|FG006|Overall Study|Not treated|0|||
48744632|NCT01976338|156914454|FG001|Overall Study|Lost to Follow-up|0|||
48325940|NCT03861234|155390805|FG007|Overall Study|Not treated|0|||
48744633|NCT01976338|156914453|FG000|Overall Study|Withdrawal by Subject|5|||
48744634|NCT01976338|156914454|FG001|Overall Study|Withdrawal by Subject|2|||
48744635|NCT01976338|156914453|FG000|Overall Study|Adverse Event|5|||
48744636|NCT01976338|156914454|FG001|Overall Study|Adverse Event|1|||
48744637|NCT03039283|156914460|FG000|Overall Study|Protocol Violation|2|||
48744638|NCT00520936|156914462|FG000|Overall Study|Physician Decision|0|||
48325941|NCT03861234|155390798|FG000|Overall Study|Adverse Event|0|||
48325942|NCT03861234|155390799|FG001|Overall Study|Adverse Event|0|||
48325943|NCT03861234|155390800|FG002|Overall Study|Adverse Event|0|||
48325944|NCT03861234|155390801|FG003|Overall Study|Adverse Event|0|||
48325945|NCT03861234|155390802|FG004|Overall Study|Adverse Event|0|||
48325946|NCT03861234|155390803|FG005|Overall Study|Adverse Event|1|||
48325947|NCT03861234|155390804|FG006|Overall Study|Adverse Event|0|||
48325948|NCT03861234|155390805|FG007|Overall Study|Adverse Event|0|||
48325949|NCT03861234|155390798|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
48325950|NCT03861234|155390799|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
48325951|NCT03861234|155390800|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
48325952|NCT03861234|155390801|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
48325953|NCT03861234|155390802|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
48632564|NCT00851084|156512839|FG000|Overall Study|Physician Decision|13|||
48632565|NCT00851084|156512840|FG001|Overall Study|Physician Decision|14|||
48632566|NCT00851084|156512839|FG000|Overall Study|Consent withdrawn|0|||
48632567|NCT00851084|156512840|FG001|Overall Study|Consent withdrawn|2|||
48744639|NCT00520936|156914463|FG001|Overall Study|Physician Decision|2|||
48744640|NCT00520936|156914464|FG002|Overall Study|Physician Decision|1|||
48744641|NCT00520936|156914465|FG003|Overall Study|Physician Decision|0|||
48744642|NCT00520936|156914466|FG004|Overall Study|Physician Decision|0|||
48744643|NCT00520936|156914467|FG005|Overall Study|Physician Decision|0|||
48744644|NCT00520936|156914468|FG006|Overall Study|Physician Decision|0|||
48744645|NCT00520936|156914469|FG007|Overall Study|Physician Decision|0|||
48744646|NCT00520936|156914462|FG000|Overall Study|Withdrawal by Subject|0|||
48744647|NCT00520936|156914463|FG001|Overall Study|Withdrawal by Subject|0|||
48325954|NCT03861234|155390803|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
48744648|NCT00520936|156914464|FG002|Overall Study|Withdrawal by Subject|0|||
48325955|NCT03861234|155390804|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
48325956|NCT03861234|155390805|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
48632568|NCT00851084|156512839|FG000|Overall Study|Withdrawal by Subject|11|||
48744649|NCT00520936|156914465|FG003|Overall Study|Withdrawal by Subject|0|||
48744650|NCT00520936|156914466|FG004|Overall Study|Withdrawal by Subject|0|||
48744651|NCT00520936|156914467|FG005|Overall Study|Withdrawal by Subject|0|||
48632569|NCT00851084|156512840|FG001|Overall Study|Withdrawal by Subject|12|||
48632570|NCT00851084|156512839|FG000|Overall Study|Metastatic surgery|6|||
48632571|NCT00851084|156512840|FG001|Overall Study|Metastatic surgery|6|||
48632572|NCT00851084|156512839|FG000|Overall Study|Other|7|||
48632573|NCT00851084|156512840|FG001|Overall Study|Other|1|||
48632586|NCT00730327|156512843|FG000|Overall Study|Lost to Follow-up|14|||
48632587|NCT00730327|156512844|FG001|Overall Study|Lost to Follow-up|16|||
48632588|NCT00730327|156512843|FG000|Overall Study|Adverse Event|8|||
48632589|NCT00730327|156512844|FG001|Overall Study|Adverse Event|1|||
48632590|NCT00730327|156512843|FG000|Overall Study|Withdrawal by Subject|3|||
48632591|NCT00730327|156512844|FG001|Overall Study|Withdrawal by Subject|13|||
48632592|NCT00730327|156512843|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
48632593|NCT00730327|156512844|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
48632594|NCT02552225|156512847|FG000|Overall Study|Withdrawal by Subject|1|||
48632595|NCT02552225|156512848|FG001|Overall Study|Withdrawal by Subject|0|||
48632596|NCT00688740|156512861|FG000|Overall Study|Adverse Event|45|||
48632597|NCT00688740|156512862|FG001|Overall Study|Adverse Event|8|||
48632598|NCT00688740|156512861|FG000|Overall Study|Death|2|||
48632599|NCT00688740|156512862|FG001|Overall Study|Death|2|||
48632600|NCT00688740|156512861|FG000|Overall Study|Lost to Follow-up|0|||
48632601|NCT00688740|156512862|FG001|Overall Study|Lost to Follow-up|1|||
48632602|NCT00688740|156512861|FG000|Overall Study|Consent Withdrawn|17|||
48632603|NCT00688740|156512862|FG001|Overall Study|Consent Withdrawn|17|||
48632604|NCT00688740|156512861|FG000|Overall Study|Breast Cancer Relapse|1|||
48632605|NCT00688740|156512862|FG001|Overall Study|Breast Cancer Relapse|4|||
48632606|NCT00688740|156512861|FG000|Overall Study|Violation of Inclusion Criteria|1|||
48632607|NCT00688740|156512862|FG001|Overall Study|Violation of Inclusion Criteria|3|||
48632608|NCT01168596|156512863|FG000|Overall Study|Withdrawal by Subject|3|||
48632609|NCT01168596|156512864|FG001|Overall Study|Withdrawal by Subject|1|||
48632610|NCT03090152|156512865|FG000|Overall Study|Withdrawal by Subject|0|||
48632611|NCT03090152|156512866|FG001|Overall Study|Withdrawal by Subject|2|||
48632612|NCT03090152|156512867|FG002|Overall Study|Withdrawal by Subject|1|||
48632613|NCT03090152|156512865|FG000|Overall Study|Surgery Canceled|1|||
48632614|NCT03090152|156512866|FG001|Overall Study|Surgery Canceled|0|||
48632615|NCT03090152|156512867|FG002|Overall Study|Surgery Canceled|0|||
48632616|NCT03090152|156512865|FG000|Overall Study|Epidural catheter could not be placed|0|||
48632617|NCT03090152|156512866|FG001|Overall Study|Epidural catheter could not be placed|2|||
48632618|NCT03090152|156512867|FG002|Overall Study|Epidural catheter could not be placed|0|||
48632619|NCT00856557|156512868|FG000|Overall Study|No patients with contextual flags|12|||
48632620|NCT00856557|156512869|FG001|Overall Study|No patients with contextual flags|16|||
48632621|NCT03673176|156512870|FG000|Overall Study|Death prior to intervention|1|||
48632622|NCT03673176|156512870|FG000|Overall Study|Death following intervention|3|||
48632623|NCT03673176|156512870|FG000|Overall Study|Withdrawal by Subject|1|||
48632624|NCT01230060|156512877|FG000|Overall Study|Withdrawal by Subject|1|||
48632625|NCT00565747|156512878|FG000|Overall Study|No embryo transfer|67|||
48632626|NCT00565747|156512879|FG001|Overall Study|No embryo transfer|73|||
48632627|NCT03309202|156512880|FG000|Overall Study|Lost to Follow-up|1|||
48632628|NCT03309202|156512881|FG001|Overall Study|Lost to Follow-up|0|||
48744652|NCT00520936|156914468|FG006|Overall Study|Withdrawal by Subject|0|||
48744653|NCT00520936|156914469|FG007|Overall Study|Withdrawal by Subject|1|||
48744654|NCT00520936|156914462|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
48632629|NCT03309202|156512882|FG002|Overall Study|Lost to Follow-up|0|||
48632630|NCT03309202|156512883|FG003|Overall Study|Lost to Follow-up|0|||
48632631|NCT00415636|156512884|FG000|Overall Study|Symptomatic deterioration|1|||
48632632|NCT00415636|156512885|FG001|Overall Study|Symptomatic deterioration|0|||
48632633|NCT00415636|156512886|FG002|Overall Study|Symptomatic deterioration|1|||
48632634|NCT00415636|156512887|FG003|Overall Study|Symptomatic deterioration|2|||
48632635|NCT00415636|156512888|FG004|Overall Study|Symptomatic deterioration|0|||
48632636|NCT00415636|156512889|FG005|Overall Study|Symptomatic deterioration|1|||
48632637|NCT00415636|156512884|FG000|Overall Study|Adverse Event|0|||
48632638|NCT00415636|156512885|FG001|Overall Study|Adverse Event|0|||
48632639|NCT00415636|156512886|FG002|Overall Study|Adverse Event|0|||
48744655|NCT00520936|156914463|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
48744656|NCT00520936|156914464|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
48744657|NCT00520936|156914465|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
48744658|NCT00520936|156914466|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
48744659|NCT00520936|156914467|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
48744660|NCT00520936|156914468|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
48744661|NCT00520936|156914469|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
48744662|NCT00520936|156914462|FG000|Overall Study|Death|0|||
48744663|NCT00520936|156914463|FG001|Overall Study|Death|0|||
48744664|NCT00520936|156914464|FG002|Overall Study|Death|0|||
48744665|NCT00520936|156914465|FG003|Overall Study|Death|0|||
48744666|NCT00520936|156914466|FG004|Overall Study|Death|0|||
48744667|NCT00520936|156914467|FG005|Overall Study|Death|0|||
48744668|NCT00520936|156914468|FG006|Overall Study|Death|1|||
48744669|NCT00520936|156914469|FG007|Overall Study|Death|0|||
48744670|NCT00520936|156914462|FG000|Overall Study|Protocol Violation|0|||
48744671|NCT00520936|156914463|FG001|Overall Study|Protocol Violation|1|||
48744672|NCT00520936|156914464|FG002|Overall Study|Protocol Violation|1|||
48744673|NCT00520936|156914465|FG003|Overall Study|Protocol Violation|0|||
48744674|NCT00520936|156914466|FG004|Overall Study|Protocol Violation|1|||
48744675|NCT00520936|156914467|FG005|Overall Study|Protocol Violation|0|||
48744676|NCT00520936|156914468|FG006|Overall Study|Protocol Violation|1|||
48744677|NCT00520936|156914469|FG007|Overall Study|Protocol Violation|0|||
48744678|NCT00867568|156914470|FG000|Overall Study|Lack of Efficacy|10|||
48744679|NCT00867568|156914470|FG000|Overall Study|Adverse Event|4|||
48744680|NCT00867568|156914470|FG000|Overall Study|Withdrawal by Subject|1|||
48744681|NCT01056653|156914474|FG000|Overall Study|Lost to Follow-up|0|||
48744682|NCT01056653|156914475|FG001|Overall Study|Lost to Follow-up|0|||
48744683|NCT01056653|156914476|FG002|Overall Study|Lost to Follow-up|2|||
48744684|NCT01061177|156914477|FG000|Overall Study|Adverse Event|117|||
48744685|NCT01061177|156914477|FG000|Overall Study|Withdrawal by Subject|27|||
48744686|NCT01061177|156914477|FG000|Overall Study|Disease progression|17|||
48744687|NCT01061177|156914477|FG000|Overall Study|Protocol Violation|11|||
48744688|NCT01061177|156914477|FG000|Overall Study|Lost to Follow-up|9|||
48744689|NCT01061177|156914477|FG000|Overall Study|New cancer therapy|9|||
48744690|NCT01061177|156914477|FG000|Overall Study|Abnormal laboratory values|6|||
48744691|NCT01061177|156914477|FG000|Overall Study|Abnormal test procedure results|4|||
48744692|NCT01061177|156914477|FG000|Overall Study|Administratie problems|4|||
48744693|NCT01061177|156914477|FG000|Overall Study|Death|4|||
48744694|NCT00299104|156914478|FG000|Treatment Period|Adverse Event|14|||
48744695|NCT00299104|156914479|FG001|Treatment Period|Adverse Event|9|||
48744696|NCT00299104|156914480|FG002|Treatment Period|Adverse Event|7|||
48744697|NCT00299104|156914478|FG000|Treatment Period|Death|1|||
48744698|NCT00299104|156914479|FG001|Treatment Period|Death|1|||
48744699|NCT00299104|156914480|FG002|Treatment Period|Death|1|||
48744700|NCT00299104|156914478|FG000|Treatment Period|Insufficient therapeutic response|34|||
48632640|NCT00415636|156512887|FG003|Overall Study|Adverse Event|1|||
48632641|NCT00415636|156512888|FG004|Overall Study|Adverse Event|1|||
48632642|NCT00415636|156512889|FG005|Overall Study|Adverse Event|0|||
48632643|NCT00415636|156512884|FG000|Overall Study|Withdrawal by Subject|0|||
48632644|NCT00415636|156512885|FG001|Overall Study|Withdrawal by Subject|0|||
48632645|NCT00415636|156512886|FG002|Overall Study|Withdrawal by Subject|0|||
48632646|NCT00415636|156512887|FG003|Overall Study|Withdrawal by Subject|0|||
48632647|NCT00415636|156512888|FG004|Overall Study|Withdrawal by Subject|1|||
48632648|NCT00415636|156512889|FG005|Overall Study|Withdrawal by Subject|0|||
48632649|NCT00415636|156512884|FG000|Overall Study|Disease progression|0|||
48632650|NCT00415636|156512885|FG001|Overall Study|Disease progression|0|||
48632651|NCT00415636|156512886|FG002|Overall Study|Disease progression|0|||
48632652|NCT00415636|156512887|FG003|Overall Study|Disease progression|3|||
48632653|NCT00415636|156512888|FG004|Overall Study|Disease progression|0|||
48744701|NCT00299104|156914479|FG001|Treatment Period|Insufficient therapeutic response|13|||
48744702|NCT00299104|156914480|FG002|Treatment Period|Insufficient therapeutic response|8|||
48744703|NCT00299104|156914478|FG000|Treatment Period|Failure to return|9|||
48744704|NCT00299104|156914479|FG001|Treatment Period|Failure to return|8|||
48744705|NCT00299104|156914480|FG002|Treatment Period|Failure to return|8|||
48744706|NCT00299104|156914478|FG000|Treatment Period|Violation of selection criteria|1|||
48325957|NCT03861234|155390798|FG000|Overall Study|As per sponsor decision|0|||
48325958|NCT03861234|155390799|FG001|Overall Study|As per sponsor decision|0|||
48632654|NCT00415636|156512889|FG005|Overall Study|Disease progression|1|||
48632655|NCT04507204|156512893|FG000|Overall Study|Adverse Event|8|||
48632656|NCT04507204|156512894|FG001|Overall Study|Adverse Event|13|||
48632657|NCT04507204|156512893|FG000|Overall Study|Death|0|||
48632658|NCT04507204|156512894|FG001|Overall Study|Death|1|||
48744707|NCT00299104|156914479|FG001|Treatment Period|Violation of selection criteria|2|||
48744708|NCT00299104|156914480|FG002|Treatment Period|Violation of selection criteria|0|||
48744709|NCT00299104|156914478|FG000|Treatment Period|Protocol Violation|1|||
48744710|NCT00299104|156914479|FG001|Treatment Period|Protocol Violation|1|||
48744711|NCT00299104|156914480|FG002|Treatment Period|Protocol Violation|0|||
48632659|NCT04507204|156512893|FG000|Overall Study|Lost to Follow-up|15|||
48632660|NCT04507204|156512894|FG001|Overall Study|Lost to Follow-up|14|||
48632661|NCT04507204|156512893|FG000|Overall Study|Poor Compliance with Protocol|2|||
48632662|NCT04507204|156512894|FG001|Overall Study|Poor Compliance with Protocol|4|||
48632663|NCT04507204|156512893|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
48632664|NCT04507204|156512894|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
48632665|NCT04507204|156512893|FG000|Overall Study|Withdrawal of Patient Consent|21|||
48632666|NCT04507204|156512894|FG001|Overall Study|Withdrawal of Patient Consent|13|||
48632667|NCT01702298|156512895|FG000|Overall Study|Withdrawal by Subject|1|||
48632668|NCT04388826|156512898|FG000|Overall Study|Lost to Follow-up|3|||
48632669|NCT04388826|156512899|FG001|Overall Study|Lost to Follow-up|2|||
48632670|NCT04388826|156512898|FG000|Overall Study|Adverse Event|1|||
48632671|NCT04388826|156512899|FG001|Overall Study|Adverse Event|0|||
48632672|NCT00443456|156512900|FG000|Overall Study|Adverse Event|16|||
48632673|NCT00443456|156512900|FG000|Overall Study|Move|1|||
48632674|NCT00443456|156512900|FG000|Overall Study|Withdrawal by Subject|1|||
48632675|NCT00557440|156512910|FG000|Treatment Period 1|Adverse Event|0|||
48632676|NCT00557440|156512911|FG001|Treatment Period 1|Adverse Event|0|||
48632677|NCT00557440|156512912|FG002|Treatment Period 1|Adverse Event|1|||
48632678|NCT03386773|156512914|FG000|Overall Study|Lost to Follow-up|24|||
48632679|NCT03386773|156512915|FG001|Overall Study|Lost to Follow-up|33|||
48632680|NCT03386773|156512914|FG000|Overall Study|Withdrawal by Subject|3|||
48632681|NCT03386773|156512915|FG001|Overall Study|Withdrawal by Subject|2|||
48632682|NCT02164864|156512916|FG000|Overall Study|Trial disease worsening|7|||
48632683|NCT02164864|156512917|FG001|Overall Study|Trial disease worsening|5|||
48632684|NCT02164864|156512918|FG002|Overall Study|Trial disease worsening|1|||
48632685|NCT02164864|156512916|FG000|Overall Study|Other pre-existing disease worsening|6|||
48632686|NCT02164864|156512917|FG001|Overall Study|Other pre-existing disease worsening|4|||
48632687|NCT02164864|156512918|FG002|Overall Study|Other pre-existing disease worsening|9|||
48632688|NCT02164864|156512916|FG000|Overall Study|Other Adverse Event (AE)|52|||
48632689|NCT02164864|156512917|FG001|Overall Study|Other Adverse Event (AE)|32|||
48632690|NCT02164864|156512918|FG002|Overall Study|Other Adverse Event (AE)|49|||
48632691|NCT02164864|156512916|FG000|Overall Study|Protocol Violation|2|||
48632692|NCT02164864|156512917|FG001|Overall Study|Protocol Violation|4|||
48632693|NCT02164864|156512918|FG002|Overall Study|Protocol Violation|1|||
48632694|NCT02164864|156512916|FG000|Overall Study|Lost to Follow-up|4|||
48632695|NCT02164864|156512917|FG001|Overall Study|Lost to Follow-up|3|||
48632696|NCT02164864|156512918|FG002|Overall Study|Lost to Follow-up|2|||
48632697|NCT02164864|156512916|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
48632698|NCT02164864|156512917|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
48632699|NCT02164864|156512918|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
48632700|NCT02164864|156512916|FG000|Overall Study|Other than stated|3|||
48632701|NCT02164864|156512917|FG001|Overall Study|Other than stated|4|||
48632702|NCT02164864|156512918|FG002|Overall Study|Other than stated|14|||
48632703|NCT00261833|156512919|FG000|Overall Study|Death|1|||
48632704|NCT00261833|156512920|FG001|Overall Study|Death|3|||
48632705|NCT00261833|156512919|FG000|Overall Study|Adverse Event|1|||
48632706|NCT00261833|156512920|FG001|Overall Study|Adverse Event|4|||
48632707|NCT00261833|156512919|FG000|Overall Study|Withdrawal by Subject|5|||
48632708|NCT00261833|156512920|FG001|Overall Study|Withdrawal by Subject|7|||
48632709|NCT00261833|156512919|FG000|Overall Study|Protocol Violation|0|||
48632710|NCT00261833|156512920|FG001|Overall Study|Protocol Violation|1|||
48632711|NCT00261833|156512919|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
48632712|NCT00261833|156512920|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
48632713|NCT00261833|156512919|FG000|Overall Study|Lung transplantation|1|||
48632714|NCT00261833|156512920|FG001|Overall Study|Lung transplantation|1|||
48632715|NCT00261833|156512919|FG000|Overall Study|Missing reason|1|||
48632716|NCT00261833|156512920|FG001|Overall Study|Missing reason|0|||
48632717|NCT00261833|156512919|FG000|Overall Study|Not interested in being participant|0|||
48632718|NCT00261833|156512920|FG001|Overall Study|Not interested in being participant|1|||
48632719|NCT01378195|156512921|FG000|Overall Study|Lost to Follow-up|29|||
48632720|NCT01378195|156512922|FG001|Overall Study|Lost to Follow-up|18|||
48632721|NCT02434081|156512923|FG000|Overall Study|Death (never started treatment)|2|||
48632722|NCT02434081|156512923|FG000|Overall Study|Death|2|||
48632723|NCT02434081|156512923|FG000|Overall Study|Progression|20|||
48632724|NCT02434081|156512923|FG000|Overall Study|Adverse Event|20|||
48632725|NCT02434081|156512923|FG000|Overall Study|Physician Decision|2|||
48632726|NCT02434081|156512923|FG000|Overall Study|Withdrawal by Subject|1|||
48632727|NCT02434081|156512923|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
48632728|NCT04164901|156512924|FG000|Overall Study|Withdrawal by Subject|4|||
48632729|NCT04164901|156512925|FG001|Overall Study|Withdrawal by Subject|4|||
48632730|NCT00725985|156512927|FG000|ITP- Treatment Disposition|Adverse Event|20|||
48632731|NCT00725985|156512928|FG001|ITP- Treatment Disposition|Adverse Event|10|||
48632732|NCT00725985|156512929|FG002|ITP- Treatment Disposition|Adverse Event|5|||
48632733|NCT00725985|156512930|FG003|ITP- Treatment Disposition|Adverse Event|0|||
48632734|NCT00725985|156512931|FG004|ITP- Treatment Disposition|Adverse Event|0|||
48632735|NCT00725985|156512932|FG005|ITP- Treatment Disposition|Adverse Event|0|||
48632736|NCT00725985|156512933|FG006|ITP- Treatment Disposition|Adverse Event|0|||
48632737|NCT00725985|156512934|FG007|ITP- Treatment Disposition|Adverse Event|0|||
48632738|NCT00725985|156512935|FG008|ITP- Treatment Disposition|Adverse Event|0|||
48632739|NCT00725985|156512936|FG009|ITP- Treatment Disposition|Adverse Event|0|||
48744712|NCT00299104|156914478|FG000|Treatment Period|Refused treatment|9|||
48744713|NCT00299104|156914479|FG001|Treatment Period|Refused treatment|2|||
48744714|NCT00299104|156914480|FG002|Treatment Period|Refused treatment|2|||
48325959|NCT03861234|155390800|FG002|Overall Study|As per sponsor decision|0|||
48325960|NCT03861234|155390801|FG003|Overall Study|As per sponsor decision|0|||
48325961|NCT03861234|155390802|FG004|Overall Study|As per sponsor decision|0|||
48325962|NCT03861234|155390803|FG005|Overall Study|As per sponsor decision|0|||
48325963|NCT03861234|155390804|FG006|Overall Study|As per sponsor decision|1|||
48325964|NCT03861234|155390805|FG007|Overall Study|As per sponsor decision|0|||
48325965|NCT03861234|155390798|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
48325966|NCT03861234|155390799|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
48325967|NCT03861234|155390800|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
48325968|NCT03861234|155390801|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
48325969|NCT03861234|155390802|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
48325970|NCT03861234|155390803|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
48325971|NCT03861234|155390804|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
48325972|NCT03861234|155390805|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
48325973|NCT00982644|155390807|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
48325974|NCT00982644|155390808|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
48632740|NCT00725985|156512937|FG010|ITP- Treatment Disposition|Adverse Event|0|||
48632741|NCT00725985|156512938|FG011|ITP- Treatment Disposition|Adverse Event|0|||
48744715|NCT00299104|156914478|FG000|Treatment Period|Withdrew consent|14|||
48744716|NCT00299104|156914479|FG001|Treatment Period|Withdrew consent|19|||
48744717|NCT00299104|156914480|FG002|Treatment Period|Withdrew consent|9|||
48744718|NCT00299104|156914478|FG000|Treatment Period|Administrative reasons|106|||
48744719|NCT00299104|156914479|FG001|Treatment Period|Administrative reasons|120|||
48744720|NCT00299104|156914480|FG002|Treatment Period|Administrative reasons|137|||
48744721|NCT00299104|156914478|FG000|Safety Follow-Up (SFU) Period|Death|3|||
48744722|NCT00299104|156914479|FG001|Safety Follow-Up (SFU) Period|Death|2|||
48744723|NCT00299104|156914480|FG002|Safety Follow-Up (SFU) Period|Death|1|||
48744724|NCT00299104|156914478|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
48744725|NCT00299104|156914479|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
48744726|NCT00299104|156914480|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
48744727|NCT00299104|156914478|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
48744728|NCT00299104|156914479|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
48744729|NCT00299104|156914480|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
48744730|NCT00299104|156914478|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
48744731|NCT00299104|156914479|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
48744732|NCT00299104|156914480|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
48744733|NCT00299104|156914478|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
48744734|NCT00299104|156914479|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
48744735|NCT00299104|156914480|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
48744736|NCT00299104|156914478|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
48744737|NCT00299104|156914479|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
48744738|NCT00299104|156914480|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
48744739|NCT00299104|156914478|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
48744740|NCT00299104|156914479|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
48744741|NCT00299104|156914480|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
48744742|NCT00299104|156914478|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
48744743|NCT00299104|156914479|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
48744744|NCT00299104|156914480|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
48744745|NCT03616600|156914483|FG000|Overall Study|Withdrawal by Subject|1|||
48325975|NCT00982644|155390807|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
48632742|NCT00725985|156512927|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632743|NCT00725985|156512928|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
48744746|NCT03616600|156914484|FG001|Overall Study|Withdrawal by Subject|0|||
48744747|NCT01651039|156914485|FG000|Overall Study|Non-evaluables|5|||
48744748|NCT01651039|156914485|FG000|Overall Study|Physician Decision|2|||
48744749|NCT01651039|156914485|FG000|Overall Study|Withdrawal by Subject|1|||
48744750|NCT01651039|156914485|FG000|Overall Study|Progressive Disease|22|||
48325976|NCT00982644|155390808|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
48325977|NCT00982644|155390807|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
48325978|NCT00982644|155390808|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
48744751|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
48325979|NCT00982644|155390807|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
48325980|NCT00982644|155390808|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
48325981|NCT00982644|155390807|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
48325982|NCT00982644|155390808|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
48744752|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
48744753|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
48744754|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
48744755|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744756|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48325983|NCT00982644|155390807|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
48325984|NCT00982644|155390808|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
48325985|NCT00982644|155390807|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
48325986|NCT00982644|155390808|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
48632744|NCT00725985|156512929|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
48632745|NCT00725985|156512930|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632746|NCT00725985|156512931|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632747|NCT00725985|156512932|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632748|NCT00725985|156512933|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632749|NCT00725985|156512934|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632750|NCT00725985|156512935|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632751|NCT00725985|156512936|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632752|NCT00725985|156512937|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632753|NCT00725985|156512938|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
48632754|NCT00725985|156512927|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
48632755|NCT00725985|156512928|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
48632756|NCT00725985|156512929|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
48632757|NCT00725985|156512930|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
48632758|NCT00725985|156512931|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
48632759|NCT00725985|156512932|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
48632760|NCT00725985|156512933|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
48632761|NCT00725985|156512934|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
48632762|NCT00725985|156512935|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
48632763|NCT00725985|156512936|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
48632764|NCT00725985|156512937|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
48632765|NCT00725985|156512938|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
48632766|NCT00725985|156512927|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
48632767|NCT00725985|156512928|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
48632768|NCT00725985|156512929|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
48632769|NCT00725985|156512930|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
48632770|NCT00725985|156512931|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
48632771|NCT00725985|156512932|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
48632772|NCT00725985|156512933|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
48632773|NCT00725985|156512934|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
48632774|NCT00725985|156512935|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
48632775|NCT00725985|156512936|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
48744757|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744758|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744759|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744760|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744761|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
48744762|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
48744763|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
48744764|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
48744765|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
48744766|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744767|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744768|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744769|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744770|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744771|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744772|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
48744773|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
48325987|NCT00982644|155390807|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
48325988|NCT00982644|155390808|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
48632776|NCT00725985|156512937|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
48632777|NCT00725985|156512938|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
48325989|NCT00982644|155390807|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
48325990|NCT00982644|155390808|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
48325991|NCT00982644|155390807|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
48325992|NCT00982644|155390808|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
48325993|NCT04060212|155390809|FG000|Overall Study|Withdrawal by Subject|7|||
48325994|NCT00174252|155390816|FG000|Overall Study|Protocol Violation|2|||
48325995|NCT00811941|155390817|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
48325996|NCT00811941|155390818|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
48325997|NCT00811941|155390817|FG000|All Treated Patients|Adverse Event|2|||
48325998|NCT00811941|155390818|FG001|All Treated Patients|Adverse Event|43|||
48325999|NCT00811941|155390817|FG000|All Treated Patients|Lack of Efficacy|2|||
48326000|NCT00811941|155390818|FG001|All Treated Patients|Lack of Efficacy|3|||
48326001|NCT00811941|155390817|FG000|All Treated Patients|Non-compliance|1|||
48326002|NCT00811941|155390818|FG001|All Treated Patients|Non-compliance|8|||
48326003|NCT00811941|155390817|FG000|All Treated Patients|Protocol Violation|5|||
48326004|NCT00811941|155390818|FG001|All Treated Patients|Protocol Violation|17|||
48326005|NCT00811941|155390817|FG000|All Treated Patients|Withdrawal by Subject|35|||
48326006|NCT00811941|155390818|FG001|All Treated Patients|Withdrawal by Subject|94|||
48326007|NCT00811941|155390817|FG000|All Treated Patients|Lost to Follow-up|3|||
48326008|NCT00811941|155390818|FG001|All Treated Patients|Lost to Follow-up|12|||
48326009|NCT00811941|155390817|FG000|All Treated Patients|Other Reason|4|||
48326010|NCT00811941|155390818|FG001|All Treated Patients|Other Reason|14|||
48326011|NCT01394276|155390823|FG000|Overall Study|Related Adverse event (AEs)|15|||
48326012|NCT01394276|155390823|FG000|Overall Study|Not related AEs|9|||
48326013|NCT01394276|155390823|FG000|Overall Study|Remission of disease|2|||
48326014|NCT01394276|155390823|FG000|Overall Study|Insufficient therapeutic effect|17|||
48326015|NCT01394276|155390823|FG000|Overall Study|Insufficient compliance|9|||
48326016|NCT01394276|155390823|FG000|Overall Study|Lost to Follow-up|5|||
48326017|NCT01394276|155390823|FG000|Overall Study|Participant moved to another site|1|||
48326018|NCT01394276|155390823|FG000|Overall Study|Pregnancy|1|||
48632778|NCT00725985|156512927|FG000|ITP- Treatment Disposition|Other|50|||
48632779|NCT00725985|156512928|FG001|ITP- Treatment Disposition|Other|38|||
48632780|NCT00725985|156512929|FG002|ITP- Treatment Disposition|Other|24|||
48632781|NCT00725985|156512930|FG003|ITP- Treatment Disposition|Other|0|||
48632782|NCT00725985|156512931|FG004|ITP- Treatment Disposition|Other|0|||
48632783|NCT00725985|156512932|FG005|ITP- Treatment Disposition|Other|0|||
48632784|NCT00725985|156512933|FG006|ITP- Treatment Disposition|Other|0|||
48632785|NCT00725985|156512934|FG007|ITP- Treatment Disposition|Other|0|||
48632786|NCT00725985|156512935|FG008|ITP- Treatment Disposition|Other|0|||
48632787|NCT00725985|156512936|FG009|ITP- Treatment Disposition|Other|0|||
48632788|NCT00725985|156512937|FG010|ITP- Treatment Disposition|Other|0|||
48632789|NCT00725985|156512938|FG011|ITP- Treatment Disposition|Other|0|||
48632790|NCT00725985|156512927|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632791|NCT00725985|156512928|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632792|NCT00725985|156512929|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632793|NCT00725985|156512930|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
48632794|NCT00725985|156512931|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
48632795|NCT00725985|156512932|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
48632796|NCT00725985|156512933|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632797|NCT00725985|156512934|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632798|NCT00725985|156512935|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632799|NCT00725985|156512936|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632800|NCT00725985|156512937|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632801|NCT00725985|156512938|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
48632802|NCT00725985|156512927|FG000|OLMP (Up to 96 Weeks)|Death|0|||
48744774|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
48744775|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
48744776|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
48744777|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744778|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744779|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744780|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48326019|NCT01394276|155390823|FG000|Overall Study|unavailability of drug at the Hospital|2|||
48326020|NCT01394276|155390823|FG000|Overall Study|Symptoms of concurrent diseases|1|||
48326021|NCT03802994|155390824|FG000|Overall Study|Lost to Follow-up|0|||
48326022|NCT03802994|155390825|FG001|Overall Study|Lost to Follow-up|2|||
48326023|NCT03802994|155390826|FG002|Overall Study|Lost to Follow-up|3|||
48326024|NCT03802994|155390827|FG003|Overall Study|Lost to Follow-up|2|||
48326025|NCT03802994|155390828|FG004|Overall Study|Lost to Follow-up|2|||
48326026|NCT00600353|155390835|FG000|Overall Study|history of malignancy within 5 years|1|||
48632803|NCT00725985|156512928|FG001|OLMP (Up to 96 Weeks)|Death|0|||
48632804|NCT00725985|156512929|FG002|OLMP (Up to 96 Weeks)|Death|0|||
48632805|NCT00725985|156512930|FG003|OLMP (Up to 96 Weeks)|Death|0|||
48632806|NCT00725985|156512931|FG004|OLMP (Up to 96 Weeks)|Death|1|||
48632807|NCT00725985|156512932|FG005|OLMP (Up to 96 Weeks)|Death|0|||
48632808|NCT00725985|156512933|FG006|OLMP (Up to 96 Weeks)|Death|0|||
48632809|NCT00725985|156512934|FG007|OLMP (Up to 96 Weeks)|Death|0|||
48632810|NCT00725985|156512935|FG008|OLMP (Up to 96 Weeks)|Death|0|||
48632811|NCT00725985|156512936|FG009|OLMP (Up to 96 Weeks)|Death|0|||
48632812|NCT00725985|156512937|FG010|OLMP (Up to 96 Weeks)|Death|0|||
48326027|NCT00600353|155390836|FG001|Overall Study|history of malignancy within 5 years|0|||
48326028|NCT00600353|155390835|FG000|Overall Study|History of prepartive regimen|0|||
48326029|NCT00600353|155390836|FG001|Overall Study|History of prepartive regimen|1|||
48326030|NCT00912964|155390840|FG000|Overall Study|Eligibility criterion not met|1|||
48326031|NCT00912964|155390841|FG001|Overall Study|Eligibility criterion not met|1|||
48326032|NCT00912964|155390842|FG002|Overall Study|Eligibility criterion not met|0|||
48326033|NCT00912964|155390840|FG000|Overall Study|Adverse Event|15|||
48632813|NCT00725985|156512938|FG011|OLMP (Up to 96 Weeks)|Death|0|||
48632814|NCT00725985|156512927|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632815|NCT00725985|156512928|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632816|NCT00725985|156512929|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632817|NCT00725985|156512930|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
48632818|NCT00725985|156512931|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632819|NCT00725985|156512932|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632820|NCT00725985|156512933|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632821|NCT00725985|156512934|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48326034|NCT00912964|155390841|FG001|Overall Study|Adverse Event|18|||
48632822|NCT00725985|156512935|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632823|NCT00725985|156512936|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632824|NCT00725985|156512937|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632825|NCT00725985|156512938|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
48632826|NCT00725985|156512927|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632827|NCT00725985|156512928|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632828|NCT00725985|156512929|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632829|NCT00725985|156512930|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632830|NCT00725985|156512931|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632831|NCT00725985|156512932|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
48632832|NCT00725985|156512933|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632833|NCT00725985|156512934|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632834|NCT00725985|156512935|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632835|NCT00725985|156512936|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632836|NCT00725985|156512937|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632837|NCT00725985|156512938|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
48632838|NCT00725985|156512927|FG000|OLMP (Up to 96 Weeks)|Other|0|||
48632839|NCT00725985|156512928|FG001|OLMP (Up to 96 Weeks)|Other|0|||
48632840|NCT00725985|156512929|FG002|OLMP (Up to 96 Weeks)|Other|0|||
48632841|NCT00725985|156512930|FG003|OLMP (Up to 96 Weeks)|Other|15|||
48632842|NCT00725985|156512931|FG004|OLMP (Up to 96 Weeks)|Other|20|||
48632843|NCT00725985|156512932|FG005|OLMP (Up to 96 Weeks)|Other|44|||
48632844|NCT00725985|156512933|FG006|OLMP (Up to 96 Weeks)|Other|0|||
48632845|NCT00725985|156512934|FG007|OLMP (Up to 96 Weeks)|Other|0|||
48632846|NCT00725985|156512935|FG008|OLMP (Up to 96 Weeks)|Other|0|||
48632847|NCT00725985|156512936|FG009|OLMP (Up to 96 Weeks)|Other|0|||
48632848|NCT00725985|156512937|FG010|OLMP (Up to 96 Weeks)|Other|0|||
48632849|NCT00725985|156512938|FG011|OLMP (Up to 96 Weeks)|Other|0|||
48632850|NCT00725985|156512927|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632851|NCT00725985|156512928|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632852|NCT00725985|156512929|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48326035|NCT00912964|155390842|FG002|Overall Study|Adverse Event|12|||
48326036|NCT00912964|155390840|FG000|Overall Study|Lack of Efficacy|11|||
48326037|NCT00912964|155390841|FG001|Overall Study|Lack of Efficacy|4|||
48326038|NCT00912964|155390842|FG002|Overall Study|Lack of Efficacy|3|||
48326039|NCT00912964|155390840|FG000|Overall Study|Withdrawal by Subject|20|||
48326040|NCT00912964|155390841|FG001|Overall Study|Withdrawal by Subject|12|||
48326041|NCT00912964|155390842|FG002|Overall Study|Withdrawal by Subject|18|||
48326042|NCT00912964|155390840|FG000|Overall Study|Lost to Follow-up|4|||
48326043|NCT00912964|155390841|FG001|Overall Study|Lost to Follow-up|3|||
48326044|NCT00912964|155390842|FG002|Overall Study|Lost to Follow-up|3|||
48326045|NCT00912964|155390840|FG000|Overall Study|Protocol Violation|5|||
48326046|NCT00912964|155390841|FG001|Overall Study|Protocol Violation|3|||
48326047|NCT00912964|155390842|FG002|Overall Study|Protocol Violation|8|||
48326048|NCT00912964|155390840|FG000|Overall Study|Taking exclusionary medications|7|||
48426414|NCT01172288|155749580|FG001|Overall Study|Protocol Violation|1|||
48632853|NCT00725985|156512930|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632854|NCT00725985|156512931|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632855|NCT00725985|156512932|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632856|NCT00725985|156512933|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632857|NCT00725985|156512934|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
48632858|NCT00725985|156512935|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632859|NCT00725985|156512936|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632860|NCT00725985|156512937|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632861|NCT00725985|156512938|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
48632862|NCT00725985|156512927|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632863|NCT00725985|156512928|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632864|NCT00725985|156512929|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48744781|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744782|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48744783|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
48326049|NCT00912964|155390841|FG001|Overall Study|Taking exclusionary medications|4|||
48326050|NCT00912964|155390842|FG002|Overall Study|Taking exclusionary medications|8|||
48744784|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48326051|NCT00912964|155390840|FG000|Overall Study|Medical History|1|||
48326052|NCT00912964|155390841|FG001|Overall Study|Medical History|0|||
48326053|NCT00912964|155390842|FG002|Overall Study|Medical History|0|||
48326054|NCT00912964|155390840|FG000|Overall Study|Non-compliance with study procedures|2|||
48326055|NCT00912964|155390841|FG001|Overall Study|Non-compliance with study procedures|0|||
48326056|NCT00912964|155390842|FG002|Overall Study|Non-compliance with study procedures|0|||
48326057|NCT00912964|155390840|FG000|Overall Study|Violation of exclusion criterion|0|||
48326058|NCT00912964|155390841|FG001|Overall Study|Violation of exclusion criterion|0|||
48326059|NCT00912964|155390842|FG002|Overall Study|Violation of exclusion criterion|2|||
48326060|NCT00912964|155390840|FG000|Overall Study|Randomized but never received study drug|0|||
48326061|NCT00912964|155390841|FG001|Overall Study|Randomized but never received study drug|1|||
48326062|NCT00912964|155390842|FG002|Overall Study|Randomized but never received study drug|0|||
48326063|NCT04447287|155390843|FG000|Period 1: Run-in Period|Adverse Event|3|||
48326064|NCT04447287|155390844|FG001|Period 1: Run-in Period|Adverse Event|0|||
48326065|NCT04447287|155390845|FG002|Period 1: Run-in Period|Adverse Event|0|||
48326066|NCT04447287|155390843|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
48326067|NCT04447287|155390844|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
48326068|NCT04447287|155390845|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
48326069|NCT04447287|155390843|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
48326070|NCT04447287|155390844|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
48326071|NCT04447287|155390845|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
48632865|NCT00725985|156512930|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632866|NCT00725985|156512931|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632867|NCT00725985|156512932|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632868|NCT00725985|156512933|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632869|NCT00725985|156512934|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632870|NCT00725985|156512935|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
48632871|NCT00725985|156512936|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632872|NCT00725985|156512937|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632873|NCT00725985|156512938|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
48632874|NCT00725985|156512927|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48744785|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744786|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744787|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
48744788|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744789|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744790|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48326072|NCT00090519|155390846|FG000|Overall Study|Adverse Event|5|||
48326073|NCT00090519|155390847|FG001|Overall Study|Adverse Event|4|||
48326074|NCT00090519|155390846|FG000|Overall Study|Death|9|||
48632875|NCT00725985|156512928|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48632876|NCT00725985|156512929|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48632877|NCT00725985|156512930|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48632878|NCT00725985|156512931|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48632879|NCT00725985|156512932|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48632880|NCT00725985|156512933|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
48632881|NCT00725985|156512934|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
48632882|NCT00725985|156512935|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
48632883|NCT00725985|156512936|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48632884|NCT00725985|156512937|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48632885|NCT00725985|156512938|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
48632886|NCT00725985|156512927|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632887|NCT00725985|156512928|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632888|NCT00725985|156512929|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632889|NCT00725985|156512930|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632890|NCT00725985|156512931|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632891|NCT00725985|156512932|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632892|NCT00725985|156512933|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632893|NCT00725985|156512934|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632894|NCT00725985|156512935|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
48632895|NCT00725985|156512936|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
48632896|NCT00725985|156512937|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
48632897|NCT00725985|156512938|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
48326075|NCT00090519|155390847|FG001|Overall Study|Death|9|||
48326076|NCT00090519|155390846|FG000|Overall Study|Lost to Follow-up|26|||
48326077|NCT00090519|155390847|FG001|Overall Study|Lost to Follow-up|29|||
48326078|NCT00090519|155390846|FG000|Overall Study|Withdrawal by Subject|28|||
48326079|NCT00090519|155390847|FG001|Overall Study|Withdrawal by Subject|29|||
48326080|NCT00090519|155390846|FG000|Overall Study|Physician Decision|2|||
48326081|NCT00090519|155390847|FG001|Overall Study|Physician Decision|3|||
48326082|NCT00090519|155390846|FG000|Overall Study|Sponsor Decision|3|||
48326083|NCT00090519|155390847|FG001|Overall Study|Sponsor Decision|1|||
48326084|NCT01000805|155390850|FG000|Overall Study|Adverse Event|21|||
48326085|NCT01000805|155390851|FG001|Overall Study|Adverse Event|9|||
48326086|NCT01000805|155390850|FG000|Overall Study|Lack of Efficacy|5|||
48326087|NCT01000805|155390851|FG001|Overall Study|Lack of Efficacy|16|||
48326088|NCT01000805|155390850|FG000|Overall Study|Lost to Follow-up|16|||
48632898|NCT02448381|156512939|FG000|Overall Study|Adverse Event|2|||
48632899|NCT02448381|156512940|FG001|Overall Study|Adverse Event|0|||
48326089|NCT01000805|155390851|FG001|Overall Study|Lost to Follow-up|21|||
48632900|NCT02448381|156512939|FG000|Overall Study|Lost to Follow-up|16|||
48632901|NCT02448381|156512940|FG001|Overall Study|Lost to Follow-up|9|||
48632902|NCT02448381|156512939|FG000|Overall Study|Physician Decision|1|||
48632903|NCT02448381|156512940|FG001|Overall Study|Physician Decision|1|||
48632904|NCT02448381|156512939|FG000|Overall Study|Pregnancy|1|||
48632905|NCT02448381|156512940|FG001|Overall Study|Pregnancy|0|||
48632906|NCT02448381|156512939|FG000|Overall Study|Withdrawal by Subject|13|||
48632907|NCT02448381|156512940|FG001|Overall Study|Withdrawal by Subject|9|||
48632908|NCT02448381|156512939|FG000|Overall Study|Noncompliance with Study Procedures|2|||
48632909|NCT02448381|156512940|FG001|Overall Study|Noncompliance with Study Procedures|0|||
48632910|NCT02090764|156512941|FG000|Overall Study|Adverse Event|1|||
48632911|NCT02090764|156512942|FG001|Overall Study|Adverse Event|3|||
48632912|NCT02090764|156512941|FG000|Overall Study|Lack of Efficacy|0|||
48632913|NCT02090764|156512942|FG001|Overall Study|Lack of Efficacy|13|||
48632914|NCT02090764|156512941|FG000|Overall Study|Withdrawal by Subject|2|||
48632915|NCT02090764|156512942|FG001|Overall Study|Withdrawal by Subject|1|||
48632916|NCT02090764|156512941|FG000|Overall Study|Intercurrent illness and other|1|||
48632917|NCT02090764|156512942|FG001|Overall Study|Intercurrent illness and other|1|||
48632918|NCT02090764|156512941|FG000|Overall Study|Lost to Follow-up|2|||
48632919|NCT02090764|156512942|FG001|Overall Study|Lost to Follow-up|2|||
48632920|NCT03773484|156512943|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
48632921|NCT00967499|156512946|FG000|Overall Study|Adverse Event|0|||
48632922|NCT00967499|156512947|FG001|Overall Study|Adverse Event|1|||
48632923|NCT00967499|156512946|FG000|Overall Study|Protocol Violation|1|||
48632924|NCT00967499|156512947|FG001|Overall Study|Protocol Violation|0|||
48632925|NCT00967499|156512946|FG000|Overall Study|Sponsor Decision|1|||
48632926|NCT00967499|156512947|FG001|Overall Study|Sponsor Decision|0|||
48632927|NCT00967499|156512946|FG000|Overall Study|Randomized but not treated|63|||
48632928|NCT00967499|156512947|FG001|Overall Study|Randomized but not treated|59|||
48632929|NCT02460458|156512952|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
48632930|NCT02460458|156512952|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
48632931|NCT02460458|156512952|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
48632932|NCT02460458|156512952|FG000|First Prospective Phase|Lost to Follow-up|84|||
48632933|NCT02460458|156512952|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
48632934|NCT03478956|156512957|FG000|Randomized Treatment Period|Adverse Event|1|||
48632935|NCT03478956|156512958|FG001|Randomized Treatment Period|Adverse Event|0|||
48632936|NCT03478956|156512959|FG002|Randomized Treatment Period|Adverse Event|0|||
48632937|NCT03478956|156512960|FG003|Randomized Treatment Period|Adverse Event|0|||
48632938|NCT03478956|156512957|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
48632939|NCT03478956|156512958|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
48632940|NCT03478956|156512959|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
48632941|NCT03478956|156512960|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
48632942|NCT03478956|156512957|FG000|Open Label Extension Period|Adverse Event|0|||
48632943|NCT03478956|156512958|FG001|Open Label Extension Period|Adverse Event|0|||
48632944|NCT03478956|156512959|FG002|Open Label Extension Period|Adverse Event|4|||
48632945|NCT03478956|156512960|FG003|Open Label Extension Period|Adverse Event|0|||
48632946|NCT03478956|156512957|FG000|Open Label Extension Period|Lack of Efficacy|0|||
48632947|NCT03478956|156512958|FG001|Open Label Extension Period|Lack of Efficacy|0|||
48632948|NCT03478956|156512959|FG002|Open Label Extension Period|Lack of Efficacy|8|||
48632949|NCT03478956|156512960|FG003|Open Label Extension Period|Lack of Efficacy|0|||
48632950|NCT03478956|156512957|FG000|Open Label Extension Period|Reason Not Provided|0|||
48632951|NCT03478956|156512958|FG001|Open Label Extension Period|Reason Not Provided|0|||
48632952|NCT03478956|156512959|FG002|Open Label Extension Period|Reason Not Provided|1|||
48326090|NCT01000805|155390850|FG000|Overall Study|Physician Decision|0|||
48326091|NCT01000805|155390851|FG001|Overall Study|Physician Decision|1|||
48326092|NCT01000805|155390850|FG000|Overall Study|Protocol Violation|12|||
48326093|NCT01000805|155390851|FG001|Overall Study|Protocol Violation|8|||
48326094|NCT01000805|155390850|FG000|Overall Study|Withdrawal by Subject|16|||
48326095|NCT01000805|155390851|FG001|Overall Study|Withdrawal by Subject|6|||
48326096|NCT01000805|155390850|FG000|Overall Study|Sponsor Decision|0|||
48326097|NCT01000805|155390851|FG001|Overall Study|Sponsor Decision|1|||
48632953|NCT03478956|156512960|FG003|Open Label Extension Period|Reason Not Provided|0|||
48632954|NCT03478956|156512957|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
48632955|NCT03478956|156512958|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
48632956|NCT03478956|156512959|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
48632957|NCT03478956|156512960|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
48632958|NCT03478956|156512957|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
48632959|NCT03478956|156512958|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
48632960|NCT03478956|156512959|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
48632961|NCT03478956|156512960|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
48632962|NCT03478956|156512957|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
48632963|NCT03478956|156512958|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
48632964|NCT03478956|156512959|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
48632965|NCT03478956|156512960|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
48632966|NCT00867035|156512961|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
48632967|NCT00867035|156512962|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
48632968|NCT00867035|156512961|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
48632969|NCT00867035|156512962|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
48632970|NCT02473445|156512964|FG000|Overall Study|Withdrawal by Subject|2|||
48632971|NCT02473445|156512964|FG000|Overall Study|Sponsor Decision|20|||
48632972|NCT01085214|156512966|FG000|Overall Study|Alternate treatment required|1|||
48632973|NCT00789555|156512967|FG000|Overall Study|Protocol Amendment|78|||
48632974|NCT00789555|156512968|FG001|Overall Study|Protocol Amendment|76|||
48632975|NCT00789555|156512969|FG002|Overall Study|Protocol Amendment|80|||
48632976|NCT00789555|156512967|FG000|Overall Study|Adverse Event|17|||
48632977|NCT00789555|156512968|FG001|Overall Study|Adverse Event|7|||
48632978|NCT00789555|156512969|FG002|Overall Study|Adverse Event|10|||
48632979|NCT00789555|156512967|FG000|Overall Study|Lost to Follow-up|9|||
48632980|NCT00789555|156512968|FG001|Overall Study|Lost to Follow-up|10|||
48632981|NCT00789555|156512969|FG002|Overall Study|Lost to Follow-up|18|||
48632982|NCT00789555|156512967|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
48632983|NCT00789555|156512968|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
48632984|NCT00789555|156512969|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
48632985|NCT00789555|156512967|FG000|Overall Study|Treatment failure|11|||
48632986|NCT00789555|156512968|FG001|Overall Study|Treatment failure|8|||
48632987|NCT00789555|156512969|FG002|Overall Study|Treatment failure|12|||
48632988|NCT00789555|156512967|FG000|Overall Study|Protocol Violation|6|||
48632989|NCT00789555|156512968|FG001|Overall Study|Protocol Violation|9|||
48632990|NCT00789555|156512969|FG002|Overall Study|Protocol Violation|13|||
48632991|NCT03612570|156512970|FG000|Overall Study|Lost to Follow-up|1|||
48632992|NCT00829998|156512973|FG000|Washout|Adverse Event|0|||
48632993|NCT00829998|156512974|FG001|Washout|Adverse Event|1|||
48632994|NCT01088906|156512977|FG000|Overall Study|Inclusion error|1|||
48632995|NCT01088906|156512977|FG000|Overall Study|Did not receive study treatment|3|||
48632996|NCT01088906|156512977|FG000|Overall Study|Missing data|1|||
48632997|NCT00622726|156514799|FG000|March, 2008 to August, 2010|Death|5|||
48632998|NCT00622726|156514800|FG001|March, 2008 to August, 2010|Death|2|||
48632999|NCT00622726|156514799|FG000|August, 2010 to April, 2013|Death|1|||
48633000|NCT00622726|156514800|FG001|August, 2010 to April, 2013|Death|5|||
48633001|NCT00163189|156514801|FG000|Overall Study|Other|6|||
48633002|NCT00163189|156514801|FG000|Overall Study|Lost to Follow-up|1|||
48633003|NCT00163189|156514801|FG000|Overall Study|Protocol Violation|2|||
48633004|NCT00163189|156514801|FG000|Overall Study|Death|3|||
48633005|NCT00163189|156514801|FG000|Overall Study|Adverse Event|6|||
48633006|NCT00163189|156514801|FG000|Overall Study|Lack of Efficacy|7|||
48633007|NCT00163189|156514801|FG000|Overall Study|Study terminated by sponsor|11|||
48633008|NCT00163189|156514801|FG000|Overall Study|Withdrawal by Subject|11|||
48633009|NCT00163189|156514801|FG000|Overall Study|Did not meet continuation criterion|16|||
48633010|NCT02519842|156514803|FG000|Base Study: Cycle 1|Screening Failure|1|||
48633011|NCT02519842|156514804|FG001|Base Study: Cycle 1|Screening Failure|1|||
48633012|NCT02519842|156514805|FG002|Base Study: Cycle 1|Screening Failure|0|||
48633013|NCT02519842|156514803|FG000|Base Study: Cycle 1|Adverse Event|1|||
48633014|NCT02519842|156514804|FG001|Base Study: Cycle 1|Adverse Event|0|||
48633015|NCT02519842|156514805|FG002|Base Study: Cycle 1|Adverse Event|0|||
48633016|NCT02519842|156514803|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
48633017|NCT02519842|156514804|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
48633018|NCT02519842|156514805|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
48633019|NCT02519842|156514803|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
48633020|NCT02519842|156514804|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
48633021|NCT02519842|156514805|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
48633022|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
48326098|NCT03345095|155390857|FG000|Overall Study|Lack of Efficacy|184|||
48326099|NCT03345095|155390858|FG001|Overall Study|Lack of Efficacy|156|||
48744791|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744792|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744793|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744794|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
48744795|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
48744796|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
48744797|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
48744798|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
48744799|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744800|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744801|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744802|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744803|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744804|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744805|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
48744806|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
48744807|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
48744808|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
48744809|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
48744810|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744811|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744812|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744813|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744814|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744815|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744816|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
48744817|NCT01847274|156914486|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
48744818|NCT01847274|156914487|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
48744819|NCT01847274|156914488|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
48744820|NCT01847274|156914489|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
48744821|NCT01847274|156914490|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744822|NCT01847274|156914491|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744823|NCT01847274|156914492|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744824|NCT01847274|156914493|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744825|NCT01847274|156914494|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744826|NCT01847274|156914495|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744827|NCT01847274|156914496|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
48744828|NCT01847274|156914486|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744829|NCT01847274|156914487|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744830|NCT01847274|156914488|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744831|NCT01847274|156914489|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744832|NCT01847274|156914490|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744833|NCT01847274|156914491|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
48744834|NCT01847274|156914492|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744835|NCT01847274|156914493|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744836|NCT01847274|156914494|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744837|NCT01847274|156914495|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744838|NCT01847274|156914496|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
48744839|NCT01847274|156914486|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744840|NCT01847274|156914487|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744841|NCT01847274|156914488|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744842|NCT01847274|156914489|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744843|NCT01847274|156914490|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
48744844|NCT01847274|156914491|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744845|NCT01847274|156914492|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744846|NCT01847274|156914493|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744847|NCT01847274|156914494|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744848|NCT01847274|156914495|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744849|NCT01847274|156914496|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
48744850|NCT01847274|156914486|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744851|NCT01847274|156914487|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744852|NCT01847274|156914488|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744853|NCT01847274|156914489|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744854|NCT01847274|156914490|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744855|NCT01847274|156914491|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744856|NCT01847274|156914492|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
48744857|NCT01847274|156914493|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744858|NCT01847274|156914494|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744859|NCT01847274|156914495|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744860|NCT01847274|156914496|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
48744861|NCT01847274|156914486|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744862|NCT01847274|156914487|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744863|NCT01847274|156914488|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744864|NCT01847274|156914489|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744865|NCT01847274|156914490|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744866|NCT01847274|156914491|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744867|NCT01847274|156914492|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
48744868|NCT01847274|156914493|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744869|NCT01847274|156914494|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744870|NCT01847274|156914495|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744871|NCT01847274|156914496|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
48744872|NCT01847274|156914486|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744873|NCT01847274|156914487|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744874|NCT01847274|156914488|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744875|NCT01847274|156914489|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744876|NCT01847274|156914490|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744877|NCT01847274|156914491|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744878|NCT01847274|156914492|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
48744879|NCT01847274|156914493|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744880|NCT01847274|156914494|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744881|NCT01847274|156914495|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744882|NCT01847274|156914496|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
48744883|NCT01847274|156914486|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744884|NCT01847274|156914487|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744885|NCT01847274|156914488|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744886|NCT01847274|156914489|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744887|NCT01847274|156914490|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744888|NCT01847274|156914491|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744889|NCT01847274|156914492|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
48744890|NCT01847274|156914493|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
48744891|NCT01847274|156914494|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
48744892|NCT01847274|156914495|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
48744893|NCT01847274|156914496|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
48744894|NCT01847274|156914486|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744895|NCT01847274|156914487|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744896|NCT01847274|156914488|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744897|NCT01847274|156914489|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744898|NCT01847274|156914490|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744899|NCT01847274|156914491|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744900|NCT01847274|156914492|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744901|NCT01847274|156914493|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
48744902|NCT01847274|156914494|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744903|NCT01847274|156914495|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
48744904|NCT01847274|156914496|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
48744905|NCT01847274|156914486|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744906|NCT01847274|156914487|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744907|NCT01847274|156914488|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744908|NCT01847274|156914489|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744909|NCT01847274|156914490|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744910|NCT01847274|156914491|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744911|NCT01847274|156914492|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744912|NCT01847274|156914493|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
48744913|NCT01847274|156914494|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
48744914|NCT01847274|156914495|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
48744915|NCT01847274|156914496|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
48744916|NCT01847274|156914486|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744917|NCT01847274|156914487|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744918|NCT01847274|156914488|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744919|NCT01847274|156914489|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744920|NCT01847274|156914490|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744921|NCT01847274|156914491|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744922|NCT01847274|156914492|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744923|NCT01847274|156914493|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744924|NCT01847274|156914494|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744925|NCT01847274|156914495|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
48744926|NCT01847274|156914496|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
48744927|NCT01180985|156914497|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
48744928|NCT01180985|156914498|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
48744929|NCT05209360|156914505|FG000|Overall Study|Withdrawal by Subject|0|||
48744930|NCT05209360|156914506|FG001|Overall Study|Withdrawal by Subject|0|||
48744931|NCT05209360|156914507|FG002|Overall Study|Withdrawal by Subject|1|||
48744932|NCT05209360|156914508|FG003|Overall Study|Withdrawal by Subject|0|||
48744933|NCT05209360|156914509|FG004|Overall Study|Withdrawal by Subject|0|||
48744934|NCT05209360|156914510|FG005|Overall Study|Withdrawal by Subject|0|||
48744935|NCT02969369|156914513|FG000|Study|Adverse Event|1|||
48744936|NCT02969369|156914514|FG001|Study|Adverse Event|6|||
48744937|NCT02969369|156914513|FG000|Study|Lack of Efficacy|0|||
48744938|NCT02969369|156914514|FG001|Study|Lack of Efficacy|1|||
48744939|NCT02969369|156914513|FG000|Study|Lost to Follow-up|0|||
48744940|NCT02969369|156914514|FG001|Study|Lost to Follow-up|1|||
48744941|NCT02969369|156914513|FG000|Study|Withdrawal by Subject|3|||
48744942|NCT02969369|156914514|FG001|Study|Withdrawal by Subject|5|||
48744943|NCT02969369|156914513|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
48744944|NCT02969369|156914514|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
48744945|NCT02969369|156914513|FG000|Double-blind Period|Adverse Event|1|||
48744946|NCT02969369|156914514|FG001|Double-blind Period|Adverse Event|5|||
48744947|NCT02969369|156914513|FG000|Double-blind Period|Lost to Follow-up|0|||
48744948|NCT02969369|156914514|FG001|Double-blind Period|Lost to Follow-up|1|||
48744949|NCT02969369|156914513|FG000|Double-blind Period|Withdrawal by Subject|2|||
48744950|NCT02969369|156914514|FG001|Double-blind Period|Withdrawal by Subject|3|||
48744951|NCT02969369|156914513|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
48744952|NCT02969369|156914514|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
48744953|NCT02969369|156914513|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
48744954|NCT02969369|156914514|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
48744955|NCT02969369|156914513|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
48744956|NCT02969369|156914514|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
48744957|NCT02969369|156914513|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
48744958|NCT02969369|156914514|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
48744959|NCT02849678|156914515|FG000|Overall Study|Protocol Violation|3|||
48744960|NCT02849678|156914516|FG001|Overall Study|Protocol Violation|6|||
48744961|NCT00288054|156914522|FG000|Overall Study|Protocol Violation|2|||
48744962|NCT00288054|156914522|FG000|Overall Study|Lack of Efficacy|16|||
48744963|NCT00288054|156914522|FG000|Overall Study|Adverse Event|3|||
48744964|NCT00288054|156914522|FG000|Overall Study|Withdrawal by Subject|1|||
48744965|NCT00288054|156914522|FG000|Overall Study|Not protocol specified|2|||
48744966|NCT01281865|156914526|FG000|Overall Study|Adverse Event|1|||
48744967|NCT01281865|156914527|FG001|Overall Study|Adverse Event|1|||
48744968|NCT01281865|156914526|FG000|Overall Study|Withdrawal by Subject|1|||
48744969|NCT01281865|156914527|FG001|Overall Study|Withdrawal by Subject|0|||
48744970|NCT01281865|156914526|FG000|Overall Study|Lack of Efficacy|1|||
48744971|NCT01281865|156914527|FG001|Overall Study|Lack of Efficacy|0|||
48744972|NCT01007812|156914530|FG000|Period 1, One Week|Lost to Follow-up|0|||
48744973|NCT01007812|156914531|FG001|Period 1, One Week|Lost to Follow-up|1|||
48744974|NCT01007812|156914530|FG000|Period 1, One Week|Discomfort|1|||
48744975|NCT01007812|156914531|FG001|Period 1, One Week|Discomfort|0|||
48744976|NCT02499783|156914534|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
48744977|NCT02499783|156914535|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
48744978|NCT02499783|156914536|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
48744979|NCT02499783|156914534|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
48744980|NCT02499783|156914535|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
48744981|NCT02499783|156914536|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
48744982|NCT02499783|156914534|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
48326100|NCT03345095|155390857|FG000|Overall Study|Adverse Event|36|||
48326101|NCT03345095|155390858|FG001|Overall Study|Adverse Event|118|||
48326102|NCT03345095|155390857|FG000|Overall Study|Withdrawal by Subject|22|||
48326103|NCT03345095|155390858|FG001|Overall Study|Withdrawal by Subject|59|||
48326104|NCT03345095|155390857|FG000|Overall Study|Physician Decision|3|||
48326105|NCT03345095|155390858|FG001|Overall Study|Physician Decision|18|||
48326106|NCT03345095|155390857|FG000|Overall Study|Death|2|||
48326107|NCT03345095|155390858|FG001|Overall Study|Death|4|||
48326108|NCT03345095|155390857|FG000|Overall Study|Other reasons|2|||
48326109|NCT03345095|155390858|FG001|Overall Study|Other reasons|11|||
48326110|NCT03345095|155390857|FG000|Overall Study|Protocol Violation|0|||
48326111|NCT03345095|155390858|FG001|Overall Study|Protocol Violation|1|||
48326112|NCT02542943|155390859|FG000|Overall Study|Lost to Follow-up|1|||
48326113|NCT02542943|155390860|FG001|Overall Study|Lost to Follow-up|0|||
48326114|NCT02542943|155390861|FG002|Overall Study|Lost to Follow-up|0|||
48326115|NCT02542943|155390859|FG000|Overall Study|Withdrawal by Subject|0|||
48326116|NCT02542943|155390860|FG001|Overall Study|Withdrawal by Subject|1|||
48633023|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
48633024|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
48633025|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
48633026|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
48633027|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
48633028|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48633029|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
48633030|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
48633031|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
48633032|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
48633033|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
48633034|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Death|0|||
48633035|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Death|0|||
48633036|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Death|1|||
48633037|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
48633038|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
48633039|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
48633040|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
48633041|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
48633042|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
48633043|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
48633044|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
48633045|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
48633046|NCT02519842|156514803|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
48633047|NCT02519842|156514804|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
48633048|NCT02519842|156514805|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
48633049|NCT00833690|156514806|FG000|Overall Study|Withdrawal by Subject|1|||
48633050|NCT00833690|156514807|FG001|Overall Study|Withdrawal by Subject|0|||
48633051|NCT00833690|156514808|FG002|Overall Study|Withdrawal by Subject|0|||
48633052|NCT00833690|156514806|FG000|Overall Study|Discontinued study drug|3|||
48633053|NCT00833690|156514807|FG001|Overall Study|Discontinued study drug|2|||
48633054|NCT00833690|156514808|FG002|Overall Study|Discontinued study drug|0|||
48633055|NCT01744782|156514809|FG000|Overall Study|Death|1|||
48633056|NCT04256941|156514814|FG000|Overall Study|Withdrawal by Subject|0|||
48633057|NCT04256941|156514815|FG001|Overall Study|Withdrawal by Subject|1|||
48633058|NCT04256941|156514814|FG000|Overall Study|Death|1|||
48633059|NCT04256941|156514815|FG001|Overall Study|Death|0|||
48633060|NCT04256941|156514814|FG000|Overall Study|Disease Progession|0|||
48633061|NCT04256941|156514815|FG001|Overall Study|Disease Progession|2|||
48633062|NCT00645658|156514816|FG000|Overall Study|Withdrawal by Subject|1|||
48633063|NCT00645658|156514817|FG001|Overall Study|Withdrawal by Subject|0|||
48633064|NCT00645658|156514816|FG000|Overall Study|Did not complete all assesments|0|||
48633065|NCT00645658|156514817|FG001|Overall Study|Did not complete all assesments|2|||
48326117|NCT02542943|155390861|FG002|Overall Study|Withdrawal by Subject|0|||
48326118|NCT02180724|155392332|FG000|Overall Study|Death|26|||
48326119|NCT02180724|155392333|FG001|Overall Study|Death|1|||
48326120|NCT02180724|155392332|FG000|Overall Study|Lost to Follow-up|3|||
48326121|NCT02180724|155392333|FG001|Overall Study|Lost to Follow-up|1|||
48326122|NCT02180724|155392332|FG000|Overall Study|Withdrawal by Subject|4|||
48326123|NCT02180724|155392333|FG001|Overall Study|Withdrawal by Subject|2|||
48326124|NCT02180724|155392332|FG000|Overall Study|PI Decision|5|||
48326125|NCT02180724|155392333|FG001|Overall Study|PI Decision|2|||
48326126|NCT02180724|155392332|FG000|Overall Study|Study terminated by sponsor|54|||
48326127|NCT02180724|155392333|FG001|Overall Study|Study terminated by sponsor|8|||
48326128|NCT04503681|155392337|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
48326129|NCT04503681|155392338|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
48585167|NCT01094782|156333788|FG005|Overall Study|Wrong Pain Condition|1|||
48585168|NCT01094782|156333783|FG000|Overall Study|Recent Interventional Injection|0|||
48585169|NCT01094782|156333784|FG001|Overall Study|Recent Interventional Injection|0|||
48585170|NCT01094782|156333785|FG002|Overall Study|Recent Interventional Injection|0|||
48585171|NCT01094782|156333786|FG003|Overall Study|Recent Interventional Injection|0|||
48585172|NCT01094782|156333787|FG004|Overall Study|Recent Interventional Injection|0|||
48585173|NCT01094782|156333788|FG005|Overall Study|Recent Interventional Injection|1|||
48585174|NCT01094782|156333783|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
48585175|NCT01094782|156333784|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
48585176|NCT01094782|156333785|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
48585177|NCT01094782|156333786|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
48585178|NCT01094782|156333787|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
48585179|NCT01094782|156333788|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
48585180|NCT01094782|156333783|FG000|Overall Study|Noncompliance With Study Schedule|0|||
48585181|NCT01094782|156333784|FG001|Overall Study|Noncompliance With Study Schedule|0|||
48585182|NCT01094782|156333785|FG002|Overall Study|Noncompliance With Study Schedule|0|||
48585183|NCT01094782|156333786|FG003|Overall Study|Noncompliance With Study Schedule|1|||
48585184|NCT01094782|156333787|FG004|Overall Study|Noncompliance With Study Schedule|0|||
48585185|NCT01094782|156333788|FG005|Overall Study|Noncompliance With Study Schedule|0|||
48585186|NCT04326439|156333791|FG000|Overall Study|Withdrawal by Subject|1|||
48585187|NCT04326439|156333792|FG001|Overall Study|Withdrawal by Subject|0|||
48585188|NCT04326439|156333791|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
48585189|NCT04326439|156333792|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
48585190|NCT04326439|156333791|FG000|Overall Study|Relapse after Induction 2|0|||
48585191|NCT04326439|156333792|FG001|Overall Study|Relapse after Induction 2|1|||
48585192|NCT04326439|156333791|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
48585193|NCT04326439|156333792|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
48326160|NCT01808534|155392347|FG000|Overall Study|Disease progression|3|||
48326161|NCT01808534|155392347|FG000|Overall Study|Physician Decision|1|||
48326162|NCT02111096|155392348|FG000|Overall Study|Adverse Event|4|||
48326163|NCT02111096|155392349|FG001|Overall Study|Adverse Event|1|||
48326164|NCT02111096|155392350|FG002|Overall Study|Adverse Event|2|||
48326165|NCT02111096|155392348|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48326166|NCT02111096|155392349|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48326167|NCT02111096|155392350|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48326168|NCT02111096|155392348|FG000|Overall Study|Lost to Follow Up|1|||
48326169|NCT02111096|155392349|FG001|Overall Study|Lost to Follow Up|1|||
48326170|NCT02111096|155392350|FG002|Overall Study|Lost to Follow Up|1|||
48326171|NCT02111096|155392348|FG000|Overall Study|Physician Decision|0|||
48326172|NCT02111096|155392349|FG001|Overall Study|Physician Decision|1|||
48326173|NCT02111096|155392350|FG002|Overall Study|Physician Decision|0|||
48326174|NCT02111096|155392348|FG000|Overall Study|Protocol Violation|1|||
48326175|NCT02111096|155392349|FG001|Overall Study|Protocol Violation|0|||
48326176|NCT02111096|155392350|FG002|Overall Study|Protocol Violation|1|||
48326177|NCT02111096|155392348|FG000|Overall Study|Terminated by Sponsor|53|||
48326178|NCT02111096|155392349|FG001|Overall Study|Terminated by Sponsor|35|||
48326179|NCT02111096|155392350|FG002|Overall Study|Terminated by Sponsor|54|||
48326180|NCT02111096|155392348|FG000|Overall Study|Withdrawal by Subject|4|||
48326181|NCT02111096|155392349|FG001|Overall Study|Withdrawal by Subject|2|||
48326182|NCT02111096|155392350|FG002|Overall Study|Withdrawal by Subject|8|||
48326183|NCT00345046|155392351|FG000|Overall Study|Protocol Violation|1|||
48326184|NCT00345046|155392352|FG001|Overall Study|Protocol Violation|1|||
48326185|NCT00345046|155392353|FG002|Overall Study|Protocol Violation|2|||
48326186|NCT02824198|155392356|FG000|Overall Study|Non-compliance with the protocol|5|||
48326187|NCT02824198|155392357|FG001|Overall Study|Non-compliance with the protocol|1|||
48326188|NCT02824198|155392356|FG000|Overall Study|Lost to Follow-up|5|||
48326189|NCT02824198|155392357|FG001|Overall Study|Lost to Follow-up|2|||
48326190|NCT02824198|155392356|FG000|Overall Study|Withdrawal by Subject|5|||
48326191|NCT02824198|155392357|FG001|Overall Study|Withdrawal by Subject|0|||
48326192|NCT04250636|155392358|FG000|Overall Study|Lost to Follow-up|2|||
48326193|NCT00609869|155392359|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
48326194|NCT00609869|155392359|FG000|Overall Study|Severe hematologic toxicity|1|||
48326195|NCT00609869|155392359|FG000|Overall Study|Withdrawal by Subject|1|||
48326196|NCT00609869|155392359|FG000|Overall Study|Seizures|1|||
48326197|NCT00609869|155392359|FG000|Overall Study|Severe tumor flare reaction|1|||
48326198|NCT00609869|155392359|FG000|Overall Study|Hepatitis B infection|1|||
48326199|NCT00609869|155392359|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
48744983|NCT02499783|156914535|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
48744984|NCT02499783|156914536|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
48744985|NCT02499783|156914534|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
48744986|NCT02499783|156914535|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
48744987|NCT02499783|156914536|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
48744988|NCT02499783|156914534|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
48744989|NCT02499783|156914535|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
48744990|NCT02499783|156914536|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
48633066|NCT03575897|156514818|FG000|Overall Study|Lost to Follow-up|12|||
48633067|NCT03575897|156514819|FG001|Overall Study|Lost to Follow-up|13|||
48633068|NCT05730335|156514826|FG000|Overall Study|Continuing in ongoing study|58|||
48633069|NCT05730335|156514826|FG000|Overall Study|Withdrawal by Subject|1|||
48633070|NCT04749615|156514827|FG000|Overall Study|Lost to Follow-up|6|||
48633071|NCT04749615|156514828|FG001|Overall Study|Lost to Follow-up|10|||
48633072|NCT03895372|156514829|FG000|Investigational Treatment Period|Adverse Event|1|||
48633073|NCT03895372|156514830|FG001|Investigational Treatment Period|Adverse Event|0|||
48633074|NCT03895372|156514831|FG002|Investigational Treatment Period|Adverse Event|0|||
48633075|NCT03895372|156514832|FG003|Investigational Treatment Period|Adverse Event|0|||
48633076|NCT03895372|156514833|FG004|Investigational Treatment Period|Adverse Event|0|||
48633077|NCT03895372|156514834|FG005|Investigational Treatment Period|Adverse Event|0|||
48633078|NCT03895372|156514835|FG006|Investigational Treatment Period|Adverse Event|4|||
48633079|NCT03895372|156514836|FG007|Investigational Treatment Period|Adverse Event|3|||
48633080|NCT03895372|156514829|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
48633081|NCT03895372|156514830|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
48633082|NCT03895372|156514831|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
48633083|NCT03895372|156514832|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
48633084|NCT03895372|156514833|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
48633085|NCT03895372|156514834|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
48633086|NCT03895372|156514835|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
48633087|NCT03895372|156514836|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
48633088|NCT03895372|156514829|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
48633089|NCT03895372|156514830|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
48633090|NCT03895372|156514831|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
48633091|NCT03895372|156514832|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
48633092|NCT03895372|156514833|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
48633093|NCT03895372|156514834|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
48633094|NCT03895372|156514835|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
48633095|NCT03895372|156514836|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
48633096|NCT03895372|156514829|FG000|Investigational Treatment Period|Other|0|||
48633097|NCT03895372|156514830|FG001|Investigational Treatment Period|Other|0|||
48633098|NCT03895372|156514831|FG002|Investigational Treatment Period|Other|0|||
48633099|NCT03895372|156514832|FG003|Investigational Treatment Period|Other|0|||
48633100|NCT03895372|156514833|FG004|Investigational Treatment Period|Other|0|||
48633101|NCT03895372|156514834|FG005|Investigational Treatment Period|Other|1|||
48633102|NCT03895372|156514835|FG006|Investigational Treatment Period|Other|0|||
48633103|NCT03895372|156514836|FG007|Investigational Treatment Period|Other|2|||
48633104|NCT03895372|156514829|FG000|Investigational Treatment Period|Protocol Violation|0|||
48633105|NCT03895372|156514830|FG001|Investigational Treatment Period|Protocol Violation|0|||
48633106|NCT03895372|156514831|FG002|Investigational Treatment Period|Protocol Violation|0|||
48633107|NCT03895372|156514832|FG003|Investigational Treatment Period|Protocol Violation|1|||
48633108|NCT03895372|156514833|FG004|Investigational Treatment Period|Protocol Violation|0|||
48633109|NCT03895372|156514834|FG005|Investigational Treatment Period|Protocol Violation|0|||
48633110|NCT03895372|156514835|FG006|Investigational Treatment Period|Protocol Violation|0|||
48633111|NCT03895372|156514836|FG007|Investigational Treatment Period|Protocol Violation|0|||
48633112|NCT03895372|156514829|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
48633113|NCT03895372|156514830|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
48633114|NCT03895372|156514831|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
48633115|NCT03895372|156514832|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
48633116|NCT03895372|156514833|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
48633117|NCT03895372|156514834|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
48633118|NCT03895372|156514835|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
48633119|NCT03895372|156514836|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
48633120|NCT03895372|156514829|FG000|Extension Treatment Period|Adverse Event|0|||
48744991|NCT02499783|156914534|FG000|DB Period: Weeks 0-8|Other|1|||
48744992|NCT02499783|156914535|FG001|DB Period: Weeks 0-8|Other|1|||
48744993|NCT02499783|156914536|FG002|DB Period: Weeks 0-8|Other|0|||
48326200|NCT00609869|155392359|FG000|Overall Study|Mantle cell: not evaluable|4|||
48326201|NCT03478969|155392361|FG000|Overall Study|Withdrawal by Subject|4|||
48633121|NCT03895372|156514830|FG001|Extension Treatment Period|Adverse Event|1|||
48633122|NCT03895372|156514831|FG002|Extension Treatment Period|Adverse Event|0|||
48633123|NCT03895372|156514832|FG003|Extension Treatment Period|Adverse Event|1|||
48633124|NCT03895372|156514833|FG004|Extension Treatment Period|Adverse Event|0|||
48633125|NCT03895372|156514834|FG005|Extension Treatment Period|Adverse Event|0|||
48633126|NCT03895372|156514835|FG006|Extension Treatment Period|Adverse Event|3|||
48633127|NCT03895372|156514836|FG007|Extension Treatment Period|Adverse Event|3|||
48633128|NCT03895372|156514829|FG000|Extension Treatment Period|Other|1|||
48633129|NCT03895372|156514830|FG001|Extension Treatment Period|Other|3|||
48633130|NCT03895372|156514831|FG002|Extension Treatment Period|Other|0|||
48633131|NCT03895372|156514832|FG003|Extension Treatment Period|Other|0|||
48633132|NCT03895372|156514833|FG004|Extension Treatment Period|Other|1|||
48633133|NCT03895372|156514834|FG005|Extension Treatment Period|Other|0|||
48633134|NCT03895372|156514835|FG006|Extension Treatment Period|Other|0|||
48633135|NCT03895372|156514836|FG007|Extension Treatment Period|Other|2|||
48633136|NCT03895372|156514829|FG000|Extension Treatment Period|Pregnancy|0|||
48633137|NCT03895372|156514830|FG001|Extension Treatment Period|Pregnancy|0|||
48633138|NCT03895372|156514831|FG002|Extension Treatment Period|Pregnancy|0|||
48633139|NCT03895372|156514832|FG003|Extension Treatment Period|Pregnancy|0|||
48633140|NCT03895372|156514833|FG004|Extension Treatment Period|Pregnancy|1|||
48633141|NCT03895372|156514834|FG005|Extension Treatment Period|Pregnancy|0|||
48633142|NCT03895372|156514835|FG006|Extension Treatment Period|Pregnancy|0|||
48633143|NCT03895372|156514836|FG007|Extension Treatment Period|Pregnancy|0|||
48633144|NCT03895372|156514829|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
48633145|NCT03895372|156514830|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
48633146|NCT03895372|156514831|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
48633147|NCT03895372|156514832|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
48633148|NCT03895372|156514833|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
48633149|NCT03895372|156514834|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
48633150|NCT03895372|156514835|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
48633151|NCT03895372|156514836|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
48633152|NCT00928668|156514839|FG000|Overall Study|Adverse Event|1|||
48633153|NCT00928668|156514840|FG001|Overall Study|Adverse Event|0|||
48633154|NCT00928668|156514841|FG002|Overall Study|Adverse Event|0|||
48633155|NCT00928668|156514842|FG003|Overall Study|Adverse Event|0|||
48633156|NCT00928668|156514843|FG004|Overall Study|Adverse Event|0|||
48633157|NCT00928668|156514839|FG000|Overall Study|Protocol Violation|0|||
48633158|NCT00928668|156514840|FG001|Overall Study|Protocol Violation|0|||
48633159|NCT00928668|156514841|FG002|Overall Study|Protocol Violation|0|||
48633160|NCT00928668|156514842|FG003|Overall Study|Protocol Violation|0|||
48633161|NCT00928668|156514843|FG004|Overall Study|Protocol Violation|1|||
48633162|NCT00928668|156514839|FG000|Overall Study|Withdrawal by Subject|0|||
48633163|NCT00928668|156514840|FG001|Overall Study|Withdrawal by Subject|1|||
48633164|NCT00928668|156514841|FG002|Overall Study|Withdrawal by Subject|1|||
48633165|NCT00928668|156514842|FG003|Overall Study|Withdrawal by Subject|0|||
48633166|NCT00928668|156514843|FG004|Overall Study|Withdrawal by Subject|0|||
48633167|NCT00928668|156514839|FG000|Overall Study|Other reasons not listed above|0|||
48633168|NCT00928668|156514840|FG001|Overall Study|Other reasons not listed above|0|||
48633169|NCT00928668|156514841|FG002|Overall Study|Other reasons not listed above|0|||
48633170|NCT00928668|156514842|FG003|Overall Study|Other reasons not listed above|1|||
48633171|NCT00928668|156514843|FG004|Overall Study|Other reasons not listed above|0|||
48633172|NCT02303262|156514844|FG000|Overall Study|Withdrawal by Subject|2|||
48633173|NCT02023866|156514845|FG000|Overall Study|Non-compliance|2|||
48633174|NCT02023866|156514845|FG000|Overall Study|Adverse Event|3|||
48633175|NCT02023866|156514845|FG000|Overall Study|Withdrawal by Subject|1|||
48633176|NCT02573493|156514848|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
48633177|NCT02573493|156514849|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
48633178|NCT02573493|156514850|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
48633179|NCT02573493|156514851|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
48326202|NCT03478969|155392362|FG001|Overall Study|Withdrawal by Subject|7|||
48633180|NCT04581395|156514852|FG000|Overall Study|Protocol Violation|4|||
48633181|NCT04581395|156514853|FG001|Overall Study|Protocol Violation|3|||
48633182|NCT04581395|156514854|FG002|Overall Study|Protocol Violation|2|||
48633183|NCT04581395|156514852|FG000|Overall Study|Physician Decision|0|||
48744994|NCT02499783|156914534|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
48744995|NCT02499783|156914535|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
48744996|NCT02499783|156914536|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
48744997|NCT02499783|156914534|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
48744998|NCT02499783|156914535|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
48744999|NCT02499783|156914536|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
48745000|NCT02499783|156914534|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
48745001|NCT02499783|156914535|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
48745002|NCT02499783|156914536|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
48745003|NCT02499783|156914534|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
48745004|NCT02499783|156914535|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
48745005|NCT02499783|156914536|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
48745006|NCT01626391|156914538|FG000|Overall Study|Physician Decision|1|||
48745007|NCT01626391|156914539|FG001|Overall Study|Physician Decision|0|||
48745008|NCT01626391|156914538|FG000|Overall Study|Withdrawal by Subject|1|||
48745009|NCT01626391|156914539|FG001|Overall Study|Withdrawal by Subject|0|||
48745010|NCT00518284|156914540|FG000|Overall Study|Adverse Event|0|||
48745011|NCT00518284|156914541|FG001|Overall Study|Adverse Event|1|||
48745012|NCT00518284|156914542|FG002|Overall Study|Adverse Event|0|||
48745013|NCT00518284|156914543|FG003|Overall Study|Adverse Event|0|||
48745014|NCT00518284|156914540|FG000|Overall Study|Study Termination|0|||
48745015|NCT00518284|156914541|FG001|Overall Study|Study Termination|2|||
48745016|NCT00518284|156914542|FG002|Overall Study|Study Termination|1|||
48745017|NCT00518284|156914543|FG003|Overall Study|Study Termination|2|||
48745018|NCT01350492|156914544|FG000|Intervention|Lost to Follow-up|2|||
48745019|NCT01350492|156914545|FG001|Intervention|Lost to Follow-up|5|||
48745020|NCT01350492|156914544|FG000|Intervention|Withdrawal by Subject|3|||
48745021|NCT01350492|156914545|FG001|Intervention|Withdrawal by Subject|1|||
48745022|NCT01350492|156914544|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
48745023|NCT01350492|156914545|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
48745024|NCT01350492|156914544|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
48745025|NCT01350492|156914545|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
48745026|NCT00602797|156914552|FG000|Overall Study|Adverse Event|1|||
48745027|NCT03845985|156914556|FG000|Overall Study|Lost to Follow-up|2|||
48745028|NCT03845985|156914557|FG001|Overall Study|Lost to Follow-up|1|||
48745029|NCT03845985|156914556|FG000|Overall Study|Physician Decision|1|||
48745030|NCT03845985|156914557|FG001|Overall Study|Physician Decision|0|||
48745031|NCT03845985|156914556|FG000|Overall Study|Withdrawal by Subject|4|||
48745032|NCT03845985|156914557|FG001|Overall Study|Withdrawal by Subject|1|||
48745033|NCT01318993|156914558|FG000|Overall Study|Adverse Event|53|||
48745034|NCT01318993|156914558|FG000|Overall Study|Lack of Efficacy|121|||
48745035|NCT01318993|156914558|FG000|Overall Study|Protocol Violation|3|||
48745036|NCT01318993|156914558|FG000|Overall Study|Protocol based stopping criteria|6|||
48745037|NCT01318993|156914558|FG000|Overall Study|Study closed or terminated|174|||
48745038|NCT01318993|156914558|FG000|Overall Study|Lost to Follow-up|4|||
48745039|NCT01318993|156914558|FG000|Overall Study|Physician Decision|13|||
48745040|NCT01318993|156914558|FG000|Overall Study|Withdrawal by Subject|24|||
48745041|NCT00228384|156914562|FG000|Overall Study|Death|9|||
48745042|NCT00228384|156914563|FG001|Overall Study|Death|3|||
48745043|NCT00228384|156914562|FG000|Overall Study|Lost to Follow-up|6|||
48745044|NCT00228384|156914563|FG001|Overall Study|Lost to Follow-up|10|||
48745045|NCT00228384|156914562|FG000|Overall Study|Surgical Intervention (bypass)|5|||
48745046|NCT00228384|156914563|FG001|Overall Study|Surgical Intervention (bypass)|5|||
48745047|NCT00228384|156914562|FG000|Overall Study|Withdrawal by Subject|9|||
48745048|NCT00228384|156914563|FG001|Overall Study|Withdrawal by Subject|10|||
48745049|NCT00228384|156914562|FG000|Overall Study|Physician Decision|0|||
48745050|NCT00228384|156914563|FG001|Overall Study|Physician Decision|1|||
48745051|NCT01962896|156914564|FG000|Overall Study|Lack of Efficacy|4|||
48745052|NCT00458211|156914577|FG000|Overall Study|Lack of Efficacy|12|||
48745053|NCT00458211|156914577|FG000|Overall Study|Withdrawal by Subject|2|||
48745054|NCT00458211|156914577|FG000|Overall Study|Protocol Violation|2|||
48745055|NCT00687323|156914578|FG000|Overall Study|Death|25|||
48745056|NCT00687323|156914578|FG000|Overall Study|Withdrawal by Subject|1|||
48745057|NCT00687323|156914578|FG000|Overall Study|Excluded from efficacy evaluations|6|||
48745058|NCT00687323|156914578|FG000|Overall Study|Screen failure|148|||
48745059|NCT02578316|156914583|FG000|Extension Phase|Progression of disease|6|||
48745060|NCT00217620|156916107|FG000|Overall Study|Adverse Event|2|||
48745061|NCT00217620|156916107|FG000|Overall Study|Progression|31|||
48745062|NCT00217620|156916107|FG000|Overall Study|Not Protocol Specified|4|||
48745063|NCT00217620|156916107|FG000|Overall Study|Ineligible|13|||
48745064|NCT00217620|156916107|FG000|Overall Study|Never received treatment|1|||
48745065|NCT03281577|156916108|FG000|Overall Study|Adverse Event|0|||
48745066|NCT03281577|156916109|FG001|Overall Study|Adverse Event|0|||
48745067|NCT03281577|156916110|FG002|Overall Study|Adverse Event|0|||
48745068|NCT03281577|156916111|FG003|Overall Study|Adverse Event|1|||
48633184|NCT04581395|156514853|FG001|Overall Study|Physician Decision|1|||
48633185|NCT04581395|156514854|FG002|Overall Study|Physician Decision|0|||
48633186|NCT04064905|156514855|FG000|Overall Study|Lost to Follow-up|0|||
48633187|NCT04064905|156514856|FG001|Overall Study|Lost to Follow-up|3|||
48633188|NCT04064905|156514857|FG002|Overall Study|Lost to Follow-up|1|||
48633189|NCT04064905|156514858|FG003|Overall Study|Lost to Follow-up|4|||
48633190|NCT04064905|156514859|FG004|Overall Study|Lost to Follow-up|2|||
48633191|NCT01188967|156514862|FG000|Overall Study|Withdrawal by Subject|1|||
48633192|NCT01188967|156514863|FG001|Overall Study|Withdrawal by Subject|1|||
48633193|NCT01188967|156514862|FG000|Overall Study|Physician Decision|1|||
48633194|NCT01188967|156514863|FG001|Overall Study|Physician Decision|1|||
48633195|NCT01188967|156514862|FG000|Overall Study|Lost to Follow-up|3|||
48633196|NCT01188967|156514863|FG001|Overall Study|Lost to Follow-up|2|||
48633197|NCT01983111|156514872|FG000|Overall Study|Withdrawal by Subject|8|||
48633198|NCT01983111|156514873|FG001|Overall Study|Withdrawal by Subject|6|||
48633199|NCT01983111|156514872|FG000|Overall Study|Adverse Event|4|||
48633200|NCT01983111|156514873|FG001|Overall Study|Adverse Event|0|||
48633201|NCT01983111|156514872|FG000|Overall Study|Protocol Violation|0|||
48633202|NCT01983111|156514873|FG001|Overall Study|Protocol Violation|1|||
48633203|NCT02191618|156514874|FG000|Overall Study|Withdrawal by Subject|3|||
48633204|NCT02191618|156514874|FG000|Overall Study|Missed Visit|4|||
48633205|NCT03038620|156514875|FG000|Overall Study|Lost to Follow-up|18|||
48633206|NCT03038620|156514876|FG001|Overall Study|Lost to Follow-up|23|||
48633207|NCT03038620|156514875|FG000|Overall Study|Withdrawal by Subject|0|||
48633208|NCT03038620|156514876|FG001|Overall Study|Withdrawal by Subject|15|||
48633209|NCT03038620|156514875|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
48633210|NCT03038620|156514876|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
48633211|NCT00759395|156514879|FG000|Overall Study|Adverse Event|1|||
48633212|NCT00759395|156514880|FG001|Overall Study|Adverse Event|0|||
48633213|NCT00759395|156514879|FG000|Overall Study|Withdrawal by Subject|1|||
48633214|NCT00759395|156514880|FG001|Overall Study|Withdrawal by Subject|0|||
48633215|NCT00759395|156514879|FG000|Overall Study|Lack of Efficacy|0|||
48633216|NCT00759395|156514880|FG001|Overall Study|Lack of Efficacy|2|||
48633217|NCT00049543|156514883|FG000|Overall Study|still on treatment|2|||
48633218|NCT00049543|156514884|FG001|Overall Study|still on treatment|9|||
48633219|NCT04380142|156514885|FG000|LD/CD Stabilization Period|Adverse Event|3|||
48633220|NCT04380142|156514886|FG001|LD/CD Stabilization Period|Adverse Event|0|||
48633221|NCT04380142|156514887|FG002|LD/CD Stabilization Period|Adverse Event|0|||
48633222|NCT04380142|156514885|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
48633223|NCT04380142|156514886|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
48745069|NCT03281577|156916108|FG000|Overall Study|Withdrawal by Subject|1|||
48745070|NCT03281577|156916109|FG001|Overall Study|Withdrawal by Subject|0|||
48745071|NCT03281577|156916110|FG002|Overall Study|Withdrawal by Subject|0|||
48745072|NCT03281577|156916111|FG003|Overall Study|Withdrawal by Subject|0|||
48633224|NCT04380142|156514887|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
48633225|NCT04380142|156514885|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
48633226|NCT04380142|156514886|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
48633227|NCT04380142|156514887|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
48633228|NCT04380142|156514885|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
48633229|NCT04380142|156514886|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
48745073|NCT01898806|156916119|FG000|Overall Study|Withdrawal by Subject|2|||
48745074|NCT01898806|156916119|FG000|Overall Study|Physician Decision|1|||
48633230|NCT04380142|156514887|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
48633231|NCT04380142|156514885|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
48633232|NCT04380142|156514886|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
48633233|NCT04380142|156514887|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
48633234|NCT04380142|156514885|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
48633235|NCT04380142|156514886|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
48633236|NCT04380142|156514887|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
48633237|NCT04380142|156514885|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48633238|NCT04380142|156514886|FG001|Double-Blind Treatment Period|Adverse Event|1|||
48633239|NCT04380142|156514887|FG002|Double-Blind Treatment Period|Adverse Event|14|||
48633240|NCT04380142|156514885|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
48633241|NCT04380142|156514886|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
48633242|NCT04380142|156514887|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
48633243|NCT04380142|156514885|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
48633244|NCT04380142|156514886|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
48633245|NCT04380142|156514887|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
48692649|NCT03001557|156724545|FG004|Extension Phase|Administrative Reason|0|||
48692650|NCT03001557|156724546|FG005|Extension Phase|Administrative Reason|1|||
48692651|NCT03001557|156724547|FG006|Extension Phase|Administrative Reason|3|||
48692652|NCT03001557|156724548|FG007|Extension Phase|Administrative Reason|3|||
48692653|NCT03001557|156724541|FG000|Extension Phase|Loss of caregiver|0|||
48692654|NCT03001557|156724542|FG001|Extension Phase|Loss of caregiver|0|||
48692655|NCT03001557|156724543|FG002|Extension Phase|Loss of caregiver|0|||
48692656|NCT03001557|156724544|FG003|Extension Phase|Loss of caregiver|0|||
48692657|NCT03001557|156724545|FG004|Extension Phase|Loss of caregiver|0|||
48692658|NCT03001557|156724546|FG005|Extension Phase|Loss of caregiver|0|||
48692659|NCT03001557|156724547|FG006|Extension Phase|Loss of caregiver|1|||
48692660|NCT03001557|156724548|FG007|Extension Phase|Loss of caregiver|0|||
48692661|NCT03001557|156724541|FG000|Extension Phase|Others|0|||
48692662|NCT03001557|156724542|FG001|Extension Phase|Others|0|||
48692663|NCT03001557|156724543|FG002|Extension Phase|Others|0|||
48692664|NCT03001557|156724544|FG003|Extension Phase|Others|0|||
48692665|NCT03001557|156724545|FG004|Extension Phase|Others|0|||
48692666|NCT03001557|156724546|FG005|Extension Phase|Others|1|||
48692667|NCT03001557|156724547|FG006|Extension Phase|Others|3|||
48692668|NCT03001557|156724548|FG007|Extension Phase|Others|0|||
48692669|NCT01620060|156724550|FG000|Overall Study|Adverse Event|9|||
48692670|NCT01620060|156724550|FG000|Overall Study|Protocol Violation|1|||
48692671|NCT01620060|156724550|FG000|Overall Study|Withdrawal by Subject|1|||
48692672|NCT01620060|156724550|FG000|Overall Study|Did not comply with Study Produre|1|||
48692673|NCT01620060|156724550|FG000|Overall Study|Family emergency|1|||
48692674|NCT01620060|156724550|FG000|Overall Study|Per Sponsor Decision|2|||
48692675|NCT04664153|156724563|FG000|Overall Study|Lack of Efficacy|0|||
48692676|NCT04664153|156724564|FG001|Overall Study|Lack of Efficacy|0|||
48692677|NCT04664153|156724565|FG002|Overall Study|Lack of Efficacy|1|||
48692678|NCT04664153|156724566|FG003|Overall Study|Lack of Efficacy|0|||
48692679|NCT04664153|156724563|FG000|Overall Study|Physician Decision|0|||
48692680|NCT04664153|156724564|FG001|Overall Study|Physician Decision|0|||
48692681|NCT04664153|156724565|FG002|Overall Study|Physician Decision|1|||
48692682|NCT04664153|156724566|FG003|Overall Study|Physician Decision|0|||
48692683|NCT04664153|156724563|FG000|Overall Study|Withdrawal by Subject|3|||
48692684|NCT04664153|156724564|FG001|Overall Study|Withdrawal by Subject|2|||
48692685|NCT04664153|156724565|FG002|Overall Study|Withdrawal by Subject|1|||
48692686|NCT04664153|156724566|FG003|Overall Study|Withdrawal by Subject|2|||
48692687|NCT04664153|156724563|FG000|Overall Study|Other|0|||
48692688|NCT04664153|156724564|FG001|Overall Study|Other|1|||
48692689|NCT04664153|156724565|FG002|Overall Study|Other|0|||
48692690|NCT04664153|156724566|FG003|Overall Study|Other|0|||
48692691|NCT04664153|156724563|FG000|Overall Study|Adverse Event|4|||
48692692|NCT04664153|156724564|FG001|Overall Study|Adverse Event|0|||
48692693|NCT04664153|156724565|FG002|Overall Study|Adverse Event|1|||
48692694|NCT04664153|156724566|FG003|Overall Study|Adverse Event|0|||
48692695|NCT00189540|156724569|FG000|Overall Study|Withdrawal by Subject|3|||
48692696|NCT00189540|156724570|FG001|Overall Study|Withdrawal by Subject|0|||
48692697|NCT00189540|156724569|FG000|Overall Study|Death|4|||
48692698|NCT00189540|156724570|FG001|Overall Study|Death|1|||
48692699|NCT04887129|156724582|FG000|Overall Study|Lost to Follow-up|0|||
48692700|NCT04887129|156724583|FG001|Overall Study|Lost to Follow-up|24|||
48692701|NCT04887129|156724582|FG000|Overall Study|Withdrawal by Subject|9|||
48692702|NCT04887129|156724583|FG001|Overall Study|Withdrawal by Subject|57|||
48692703|NCT04887129|156724582|FG000|Overall Study|Other|2|||
48692704|NCT04887129|156724583|FG001|Overall Study|Other|9|||
48326203|NCT03478969|155392363|FG002|Overall Study|Withdrawal by Subject|6|||
48326204|NCT03478969|155392361|FG000|Overall Study|Adverse Event|2|||
48326205|NCT03478969|155392362|FG001|Overall Study|Adverse Event|0|||
48326206|NCT03478969|155392363|FG002|Overall Study|Adverse Event|1|||
48326207|NCT03478969|155392361|FG000|Overall Study|Pregnancy|1|||
48326208|NCT03478969|155392362|FG001|Overall Study|Pregnancy|0|||
48326209|NCT03478969|155392363|FG002|Overall Study|Pregnancy|0|||
48326210|NCT03478969|155392361|FG000|Overall Study|Personal Reasons|1|||
48326211|NCT03478969|155392362|FG001|Overall Study|Personal Reasons|0|||
48326212|NCT03478969|155392363|FG002|Overall Study|Personal Reasons|1|||
48633246|NCT04380142|156514885|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
48633247|NCT04380142|156514886|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
48633248|NCT04380142|156514887|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
48633249|NCT04380142|156514885|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
48633250|NCT04380142|156514886|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
48633251|NCT04380142|156514887|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
48633252|NCT04380142|156514885|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
48633253|NCT04380142|156514886|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
48633254|NCT04380142|156514887|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
48633255|NCT02106832|156514896|FG000|Overall Study|Adverse Event|1|||
48633256|NCT02106832|156514897|FG001|Overall Study|Adverse Event|2|||
48633257|NCT02106832|156514898|FG002|Overall Study|Adverse Event|3|||
48633258|NCT02106832|156514899|FG003|Overall Study|Adverse Event|0|||
48633259|NCT02106832|156514896|FG000|Overall Study|Death|4|||
48633260|NCT02106832|156514897|FG001|Overall Study|Death|4|||
48633261|NCT02106832|156514898|FG002|Overall Study|Death|1|||
48633262|NCT02106832|156514899|FG003|Overall Study|Death|4|||
48633263|NCT02106832|156514896|FG000|Overall Study|Deterioration of general conditions|0|||
48633264|NCT02106832|156514897|FG001|Overall Study|Deterioration of general conditions|0|||
48633265|NCT02106832|156514898|FG002|Overall Study|Deterioration of general conditions|1|||
48633266|NCT02106832|156514899|FG003|Overall Study|Deterioration of general conditions|0|||
48633267|NCT02106832|156514896|FG000|Overall Study|Lost to Follow-up|0|||
48633268|NCT02106832|156514897|FG001|Overall Study|Lost to Follow-up|1|||
48633269|NCT02106832|156514898|FG002|Overall Study|Lost to Follow-up|1|||
48633270|NCT02106832|156514899|FG003|Overall Study|Lost to Follow-up|3|||
48633271|NCT02106832|156514896|FG000|Overall Study|Physician Decision|1|||
48633272|NCT02106832|156514897|FG001|Overall Study|Physician Decision|0|||
48633273|NCT02106832|156514898|FG002|Overall Study|Physician Decision|0|||
48633274|NCT02106832|156514899|FG003|Overall Study|Physician Decision|0|||
48633275|NCT02106832|156514896|FG000|Overall Study|Protocol Violation|0|||
48633276|NCT02106832|156514897|FG001|Overall Study|Protocol Violation|0|||
48633277|NCT02106832|156514898|FG002|Overall Study|Protocol Violation|0|||
48633278|NCT02106832|156514899|FG003|Overall Study|Protocol Violation|1|||
48326213|NCT03478969|155392361|FG000|Overall Study|Covid-19|1|||
48326214|NCT03478969|155392362|FG001|Overall Study|Covid-19|4|||
48633279|NCT02106832|156514896|FG000|Overall Study|Withdrawal by Subject|17|||
48633280|NCT02106832|156514897|FG001|Overall Study|Withdrawal by Subject|17|||
48633281|NCT02106832|156514898|FG002|Overall Study|Withdrawal by Subject|10|||
48633282|NCT02106832|156514899|FG003|Overall Study|Withdrawal by Subject|7|||
48633283|NCT02106832|156514896|FG000|Overall Study|Technical problems|0|||
48633284|NCT02106832|156514897|FG001|Overall Study|Technical problems|1|||
48633285|NCT02106832|156514898|FG002|Overall Study|Technical problems|0|||
48633286|NCT02106832|156514899|FG003|Overall Study|Technical problems|0|||
48633287|NCT01734902|156514902|FG000|Overall Study|Other than listed|0|||
48633288|NCT01734902|156514903|FG001|Overall Study|Other than listed|2|||
48633289|NCT01959932|156514904|FG000|Overall Study|Withdrawal by Subject|1|||
48633290|NCT01959932|156514905|FG001|Overall Study|Withdrawal by Subject|0|||
48633291|NCT01959932|156514906|FG002|Overall Study|Withdrawal by Subject|0|||
48633292|NCT04025554|156514907|FG000|Overall Study|Adverse Event|3|||
48633293|NCT00397540|156514910|FG000|Overall Study|short follow-up duration < 12 months|1|||
48633294|NCT00397540|156514911|FG001|Overall Study|short follow-up duration < 12 months|0|||
48326215|NCT03478969|155392363|FG002|Overall Study|Covid-19|3|||
48633295|NCT03485157|156514919|FG000|Double Blind Phase|Lost to Follow-up|4|||
48633296|NCT03485157|156514920|FG001|Double Blind Phase|Lost to Follow-up|4|||
48633297|NCT03485157|156514919|FG000|Double Blind Phase|Adverse Event|2|||
48633298|NCT03485157|156514920|FG001|Double Blind Phase|Adverse Event|1|||
48633299|NCT03485157|156514919|FG000|Double Blind Phase|Withdrawal by Subject|6|||
48326216|NCT03478969|155392361|FG000|Overall Study|Multiple Reasons|0|||
48633300|NCT03485157|156514920|FG001|Double Blind Phase|Withdrawal by Subject|9|||
48633301|NCT03485157|156514919|FG000|Double Blind Phase|Removal by PI|3|||
48633302|NCT03485157|156514920|FG001|Double Blind Phase|Removal by PI|7|||
48633303|NCT03485157|156514919|FG000|Open Label Phase|Lost to Follow-up|1|||
48633304|NCT03485157|156514920|FG001|Open Label Phase|Lost to Follow-up|2|||
48633305|NCT03485157|156514919|FG000|Open Label Phase|Adverse Event|0|||
48633306|NCT03485157|156514920|FG001|Open Label Phase|Adverse Event|1|||
48633307|NCT03485157|156514919|FG000|Open Label Phase|Withdrawal by Subject|1|||
48633308|NCT03485157|156514920|FG001|Open Label Phase|Withdrawal by Subject|2|||
48633309|NCT03485157|156514919|FG000|Open Label Phase|Removal by PI|2|||
48633310|NCT03485157|156514920|FG001|Open Label Phase|Removal by PI|0|||
48633311|NCT04881760|156514924|FG000|Overall Study|Adverse Event|0|||
48633312|NCT04881760|156514925|FG001|Overall Study|Adverse Event|1|||
48633313|NCT04881760|156514926|FG002|Overall Study|Adverse Event|1|||
48633314|NCT04881760|156514927|FG003|Overall Study|Adverse Event|0|||
48633315|NCT04881760|156514928|FG004|Overall Study|Adverse Event|1|||
48633316|NCT04881760|156514929|FG005|Overall Study|Adverse Event|1|||
48633317|NCT04881760|156514930|FG006|Overall Study|Adverse Event|2|||
48633318|NCT04881760|156514924|FG000|Overall Study|Death|0|||
48633319|NCT04881760|156514925|FG001|Overall Study|Death|0|||
48745075|NCT03003390|156916120|FG000|Overall Study|Physician Decision|2|||
48745076|NCT03003390|156916121|FG001|Overall Study|Physician Decision|0|||
48745077|NCT03003390|156916120|FG000|Overall Study|Parent refused intervention|2|||
48745078|NCT03003390|156916121|FG001|Overall Study|Parent refused intervention|0|||
48633320|NCT04881760|156514926|FG002|Overall Study|Death|0|||
48745079|NCT01663532|156916122|FG000|Overall Study|Lost to Follow-up|9|||
48745080|NCT01663532|156916123|FG001|Overall Study|Lost to Follow-up|10|||
48633321|NCT04881760|156514927|FG003|Overall Study|Death|1|||
48633322|NCT04881760|156514928|FG004|Overall Study|Death|0|||
48633323|NCT04881760|156514929|FG005|Overall Study|Death|0|||
48633324|NCT04881760|156514930|FG006|Overall Study|Death|0|||
48633325|NCT04881760|156514924|FG000|Overall Study|Lost to Follow-up|5|||
48633326|NCT04881760|156514925|FG001|Overall Study|Lost to Follow-up|7|||
48633327|NCT04881760|156514926|FG002|Overall Study|Lost to Follow-up|5|||
48633328|NCT04881760|156514927|FG003|Overall Study|Lost to Follow-up|1|||
48633329|NCT04881760|156514928|FG004|Overall Study|Lost to Follow-up|2|||
48633330|NCT04881760|156514929|FG005|Overall Study|Lost to Follow-up|4|||
48633331|NCT04881760|156514930|FG006|Overall Study|Lost to Follow-up|4|||
48633332|NCT04881760|156514924|FG000|Overall Study|Withdrawal by Subject|13|||
48633333|NCT04881760|156514925|FG001|Overall Study|Withdrawal by Subject|1|||
48633334|NCT04881760|156514926|FG002|Overall Study|Withdrawal by Subject|1|||
48633335|NCT04881760|156514927|FG003|Overall Study|Withdrawal by Subject|4|||
48745081|NCT01663532|156916122|FG000|Overall Study|Adverse Event|7|||
48745082|NCT01663532|156916123|FG001|Overall Study|Adverse Event|13|||
48745083|NCT01663532|156916122|FG000|Overall Study|Met Withdrawal Criteria|7|||
48745084|NCT01663532|156916123|FG001|Overall Study|Met Withdrawal Criteria|6|||
48745085|NCT01663532|156916122|FG000|Overall Study|Physician Decision|1|||
48745086|NCT01663532|156916123|FG001|Overall Study|Physician Decision|1|||
48633336|NCT04881760|156514928|FG004|Overall Study|Withdrawal by Subject|2|||
48633337|NCT04881760|156514929|FG005|Overall Study|Withdrawal by Subject|1|||
48633338|NCT04881760|156514930|FG006|Overall Study|Withdrawal by Subject|2|||
48633339|NCT04881760|156514924|FG000|Overall Study|Randomized but Never Treated|0|||
48633340|NCT04881760|156514925|FG001|Overall Study|Randomized but Never Treated|0|||
48633341|NCT04881760|156514926|FG002|Overall Study|Randomized but Never Treated|0|||
48633342|NCT04881760|156514927|FG003|Overall Study|Randomized but Never Treated|1|||
48633343|NCT04881760|156514928|FG004|Overall Study|Randomized but Never Treated|0|||
48633344|NCT04881760|156514929|FG005|Overall Study|Randomized but Never Treated|0|||
48633345|NCT04881760|156514930|FG006|Overall Study|Randomized but Never Treated|0|||
48633346|NCT04881760|156514924|FG000|Overall Study|Inadvertent Enrollment|2|||
48326217|NCT03478969|155392362|FG001|Overall Study|Multiple Reasons|1|||
48326218|NCT03478969|155392363|FG002|Overall Study|Multiple Reasons|1|||
48633347|NCT04881760|156514925|FG001|Overall Study|Inadvertent Enrollment|0|||
48633348|NCT04881760|156514926|FG002|Overall Study|Inadvertent Enrollment|0|||
48326219|NCT03478969|155392361|FG000|Overall Study|Eligibility Criteria|0|||
48326220|NCT03478969|155392362|FG001|Overall Study|Eligibility Criteria|0|||
48326221|NCT03478969|155392363|FG002|Overall Study|Eligibility Criteria|5|||
48326222|NCT03478969|155392361|FG000|Overall Study|Lost to Follow-up|0|||
48326223|NCT03478969|155392362|FG001|Overall Study|Lost to Follow-up|0|||
48326224|NCT03478969|155392363|FG002|Overall Study|Lost to Follow-up|1|||
48326225|NCT03653364|155392371|FG000|Overall Study|Withdrawal by Subject|1|||
48326226|NCT03653364|155392371|FG000|Overall Study|Enrolled in Error|1|||
48326227|NCT03653364|155392371|FG000|Overall Study|Death|1|||
48326228|NCT02941549|155392372|FG000|Overall Study|Adverse Event|1|||
48326229|NCT02941549|155392373|FG001|Overall Study|Adverse Event|0|||
48326230|NCT02941549|155392374|FG002|Overall Study|Adverse Event|0|||
48326231|NCT02941549|155392372|FG000|Overall Study|Withdrawal by Subject|2|||
48326232|NCT02941549|155392373|FG001|Overall Study|Withdrawal by Subject|1|||
48326233|NCT02941549|155392374|FG002|Overall Study|Withdrawal by Subject|2|||
48326234|NCT00512252|155392376|FG000|Overall Study|Lost to Follow-up|0|||
48326235|NCT00512252|155392377|FG001|Overall Study|Lost to Follow-up|0|||
48326236|NCT00512252|155392378|FG002|Overall Study|Lost to Follow-up|1|||
48326237|NCT00512252|155392376|FG000|Overall Study|Protocol Violation|0|||
48326238|NCT00512252|155392377|FG001|Overall Study|Protocol Violation|0|||
48326239|NCT00512252|155392378|FG002|Overall Study|Protocol Violation|1|||
48326240|NCT00512252|155392376|FG000|Overall Study|Death|0|||
48326241|NCT00512252|155392377|FG001|Overall Study|Death|0|||
48326242|NCT00512252|155392378|FG002|Overall Study|Death|1|||
48326243|NCT00705406|155392381|FG000|Overall Study|Lost to Follow-up|3|||
48326244|NCT00705406|155392382|FG001|Overall Study|Lost to Follow-up|3|||
48326245|NCT00705406|155392381|FG000|Overall Study|Did not receive study drug|1|||
48326246|NCT00705406|155392382|FG001|Overall Study|Did not receive study drug|2|||
48326247|NCT01079806|155392383|FG000|Day 1 to Week 96|Adverse Event|0|||
48326248|NCT01079806|155392384|FG001|Day 1 to Week 96|Adverse Event|3|||
48326249|NCT01079806|155392383|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
48326250|NCT01079806|155392384|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
48326251|NCT01079806|155392383|FG000|Day 1 to Week 96|Pregnancy|0|||
48326252|NCT01079806|155392384|FG001|Day 1 to Week 96|Pregnancy|1|||
48326253|NCT01079806|155392383|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
48326254|NCT01079806|155392384|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
48326255|NCT01079806|155392383|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
48326256|NCT01079806|155392384|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
48326257|NCT01079806|155392383|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
48326258|NCT01079806|155392384|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
48326259|NCT01079806|155392383|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
48326260|NCT01079806|155392384|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
48326261|NCT01079806|155392383|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
48326262|NCT01079806|155392384|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
48326263|NCT01079806|155392383|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
48326264|NCT01079806|155392384|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
48326265|NCT01079806|155392383|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
48326266|NCT01079806|155392384|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
48326267|NCT01779700|155392385|FG000|Overall Study|Adverse Event|4|||
48326268|NCT01779700|155392386|FG001|Overall Study|Adverse Event|3|||
48326269|NCT01779700|155392385|FG000|Overall Study|Withdrawal by Subject|0|||
48326270|NCT01779700|155392386|FG001|Overall Study|Withdrawal by Subject|2|||
48326271|NCT00739934|155392389|FG000|Voriconazole IV|Adverse Event|6|||
48326272|NCT00739934|155392389|FG000|Voriconazole Oral|Other|3|||
48326273|NCT02455557|155392390|FG000|Overall Study|Withdrawal by Subject|2|||
48326274|NCT03418922|155392391|FG000|Overall Study|Withdrawal by Subject|0|||
48326275|NCT03418922|155392392|FG001|Overall Study|Withdrawal by Subject|2|||
48326276|NCT03418922|155392391|FG000|Overall Study|Adverse Event|2|||
48326277|NCT03418922|155392392|FG001|Overall Study|Adverse Event|2|||
48326278|NCT03418922|155392391|FG000|Overall Study|Death|0|||
48326279|NCT03418922|155392392|FG001|Overall Study|Death|1|||
48326280|NCT03418922|155392391|FG000|Overall Study|Physician Decision|0|||
48326281|NCT03418922|155392392|FG001|Overall Study|Physician Decision|1|||
48633349|NCT04881760|156514927|FG003|Overall Study|Inadvertent Enrollment|0|||
48326282|NCT00918333|155392395|FG000|Overall Study|Drug not taken per protocol|1|||
48326283|NCT00918333|155392396|FG001|Overall Study|Drug not taken per protocol|0|||
48326284|NCT00918333|155392395|FG000|Overall Study|Inadequate amount of drugs provided|1|||
48326285|NCT00918333|155392396|FG001|Overall Study|Inadequate amount of drugs provided|4|||
48326286|NCT00918333|155392395|FG000|Overall Study|Ineligible|1|||
48326287|NCT00918333|155392396|FG001|Overall Study|Ineligible|0|||
48326288|NCT00918333|155392395|FG000|Overall Study|Withdrawal by Subject|0|||
48326289|NCT00918333|155392396|FG001|Overall Study|Withdrawal by Subject|1|||
48326290|NCT00713596|155392401|FG000|Overall Study|Study was terminated|2|||
48326291|NCT00713596|155392402|FG001|Overall Study|Study was terminated|3|||
48326292|NCT00713596|155392403|FG002|Overall Study|Study was terminated|2|||
48326293|NCT01953224|155392404|FG000|Overall Study|Lost to Follow-up|1|||
48326294|NCT01953224|155392405|FG001|Overall Study|Lost to Follow-up|1|||
48326295|NCT01953224|155392404|FG000|Overall Study|Withdrawal by Subject|1|||
48326296|NCT01953224|155392405|FG001|Overall Study|Withdrawal by Subject|2|||
48326297|NCT03781375|155392414|FG000|Double-blind Phase|Adverse Event|0|||
48326298|NCT03781375|155392415|FG001|Double-blind Phase|Adverse Event|1|||
48326299|NCT03781375|155392414|FG000|Double-blind Phase|Lack of Response|6|||
48326300|NCT03781375|155392415|FG001|Double-blind Phase|Lack of Response|2|||
48633350|NCT04881760|156514928|FG004|Overall Study|Inadvertent Enrollment|0|||
48633351|NCT04881760|156514929|FG005|Overall Study|Inadvertent Enrollment|0|||
48633352|NCT04881760|156514930|FG006|Overall Study|Inadvertent Enrollment|0|||
48633353|NCT04881760|156514924|FG000|Overall Study|Site Closure|0|||
48633354|NCT04881760|156514925|FG001|Overall Study|Site Closure|0|||
48633355|NCT04881760|156514926|FG002|Overall Study|Site Closure|0|||
48633356|NCT04881760|156514927|FG003|Overall Study|Site Closure|1|||
48633357|NCT04881760|156514928|FG004|Overall Study|Site Closure|0|||
48633358|NCT04881760|156514929|FG005|Overall Study|Site Closure|0|||
48633359|NCT04881760|156514930|FG006|Overall Study|Site Closure|0|||
48633360|NCT00787150|156514935|FG000|Overall Study|Adverse Event|4|||
48633361|NCT00787150|156514936|FG001|Overall Study|Adverse Event|4|||
48633362|NCT00787150|156514937|FG002|Overall Study|Adverse Event|4|||
48633363|NCT00787150|156514935|FG000|Overall Study|Physician Decision|1|||
48633364|NCT00787150|156514936|FG001|Overall Study|Physician Decision|2|||
48633365|NCT00787150|156514937|FG002|Overall Study|Physician Decision|1|||
48633366|NCT00787150|156514935|FG000|Overall Study|Withdrawal by Subject|2|||
48633367|NCT00787150|156514936|FG001|Overall Study|Withdrawal by Subject|1|||
48633368|NCT00787150|156514937|FG002|Overall Study|Withdrawal by Subject|0|||
48633369|NCT00787150|156514935|FG000|Overall Study|Dosing incorrect study durg|2|||
48633370|NCT00787150|156514936|FG001|Overall Study|Dosing incorrect study durg|0|||
48633371|NCT00787150|156514937|FG002|Overall Study|Dosing incorrect study durg|0|||
48633372|NCT02626533|156514943|FG000|Overall Study|Protocol Violation|14|||
48633373|NCT02626533|156514943|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
48633374|NCT02626533|156514943|FG000|Overall Study|Withdrawal by Subject|1|||
48633375|NCT03950856|156514944|FG000|Overall Study|Death|1|||
48633376|NCT03950856|156514945|FG001|Overall Study|Death|2|||
48633377|NCT03950856|156514946|FG002|Overall Study|Death|0|||
48633378|NCT03950856|156514947|FG003|Overall Study|Death|0|||
48633379|NCT03950856|156514944|FG000|Overall Study|Lost to Follow-up|5|||
48633380|NCT03950856|156514945|FG001|Overall Study|Lost to Follow-up|6|||
48633381|NCT03950856|156514946|FG002|Overall Study|Lost to Follow-up|8|||
48633382|NCT03950856|156514947|FG003|Overall Study|Lost to Follow-up|2|||
48633383|NCT03950856|156514944|FG000|Overall Study|Protocol Violation|2|||
48633384|NCT03950856|156514945|FG001|Overall Study|Protocol Violation|0|||
48633385|NCT03950856|156514946|FG002|Overall Study|Protocol Violation|0|||
48633386|NCT03950856|156514947|FG003|Overall Study|Protocol Violation|1|||
48633387|NCT03950856|156514944|FG000|Overall Study|Withdrawal by Subject|4|||
48633388|NCT03950856|156514945|FG001|Overall Study|Withdrawal by Subject|1|||
48633389|NCT03950856|156514946|FG002|Overall Study|Withdrawal by Subject|3|||
48633390|NCT03950856|156514947|FG003|Overall Study|Withdrawal by Subject|1|||
48633391|NCT03950856|156514944|FG000|Overall Study|Unable to phone|7|||
48633392|NCT03950856|156514945|FG001|Overall Study|Unable to phone|6|||
48633393|NCT03950856|156514946|FG002|Overall Study|Unable to phone|7|||
48633394|NCT03950856|156514947|FG003|Overall Study|Unable to phone|2|||
48633395|NCT04971109|156514950|FG000|Overall Study|Adverse Event|4|||
48633396|NCT04971109|156514951|FG001|Overall Study|Adverse Event|3|||
48633397|NCT04971109|156514950|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
48633398|NCT04971109|156514951|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
48633399|NCT04971109|156514950|FG000|Overall Study|Lost to Follow-up|8|||
48326301|NCT03781375|155392414|FG000|Double-blind Phase|Other|1|||
48326302|NCT03781375|155392415|FG001|Double-blind Phase|Other|3|||
48633400|NCT04971109|156514951|FG001|Overall Study|Lost to Follow-up|2|||
48633401|NCT04971109|156514950|FG000|Overall Study|Physician Decision|5|||
48633402|NCT04971109|156514951|FG001|Overall Study|Physician Decision|0|||
48633403|NCT04971109|156514950|FG000|Overall Study|Protocol Violation|0|||
48633404|NCT04971109|156514951|FG001|Overall Study|Protocol Violation|1|||
48633405|NCT04971109|156514950|FG000|Overall Study|Withdrawal by Subject|18|||
48633406|NCT04971109|156514951|FG001|Overall Study|Withdrawal by Subject|3|||
48633407|NCT04971109|156514950|FG000|Overall Study|Subject was randomized in error|1|||
48633408|NCT04971109|156514951|FG001|Overall Study|Subject was randomized in error|0|||
48633409|NCT05270863|156514955|FG000|Visit 2 First Intervention|Randomization error|0|||
48633410|NCT05270863|156514956|FG001|Visit 2 First Intervention|Randomization error|0|||
48633411|NCT05270863|156514957|FG002|Visit 2 First Intervention|Randomization error|0|||
48633412|NCT05270863|156514958|FG003|Visit 2 First Intervention|Randomization error|1|||
48633413|NCT05270863|156514959|FG004|Visit 2 First Intervention|Randomization error|0|||
48633414|NCT05270863|156514960|FG005|Visit 2 First Intervention|Randomization error|0|||
48633415|NCT05270863|156514955|FG000|First Washout|Withdrawal by Subject|0|||
48745087|NCT01663532|156916122|FG000|Overall Study|Withdrawal by Subject|35|||
48745088|NCT01663532|156916123|FG001|Overall Study|Withdrawal by Subject|17|||
48745089|NCT01663532|156916122|FG000|Overall Study|Lack of Efficacy|15|||
48745090|NCT01663532|156916123|FG001|Overall Study|Lack of Efficacy|60|||
48745091|NCT04669600|156916124|FG000|Overall Study|Withdrawal by Subject|1|||
48745092|NCT04669600|156916124|FG000|Overall Study|Other|6|||
48745093|NCT01897454|156916127|FG000|Overall Study|Withdrawal by Subject|1|||
48745094|NCT01709513|156916128|FG000|Overall Study|Randomized but not treated|0|||
48745095|NCT01709513|156916129|FG001|Overall Study|Randomized but not treated|1|||
48745096|NCT01709513|156916130|FG002|Overall Study|Randomized but not treated|0|||
48745097|NCT01709513|156916128|FG000|Overall Study|Adverse Event|16|||
48745098|NCT01709513|156916129|FG001|Overall Study|Adverse Event|31|||
48745099|NCT01709513|156916130|FG002|Overall Study|Adverse Event|23|||
48745100|NCT01709513|156916128|FG000|Overall Study|Poor compliance to protocol|2|||
48745101|NCT01709513|156916129|FG001|Overall Study|Poor compliance to protocol|0|||
48745102|NCT01709513|156916130|FG002|Overall Study|Poor compliance to protocol|0|||
48745103|NCT01709513|156916128|FG000|Overall Study|Other|3|||
48745104|NCT01709513|156916129|FG001|Overall Study|Other|11|||
48745105|NCT01709513|156916130|FG002|Overall Study|Other|7|||
48745106|NCT00980057|156916136|FG000|Overall Study|Death|13|||
48745107|NCT00980057|156916137|FG001|Overall Study|Death|3|||
48745108|NCT00980057|156916136|FG000|Overall Study|Adverse Event|0|||
48745109|NCT00980057|156916137|FG001|Overall Study|Adverse Event|1|||
48745110|NCT00980057|156916136|FG000|Overall Study|Physician Decision|4|||
48745111|NCT00980057|156916137|FG001|Overall Study|Physician Decision|0|||
48745112|NCT00980057|156916136|FG000|Overall Study|Lost to Follow-up|1|||
48745113|NCT00980057|156916137|FG001|Overall Study|Lost to Follow-up|0|||
48745114|NCT00980057|156916136|FG000|Overall Study|Withdrawal by Subject|1|||
48745115|NCT00980057|156916137|FG001|Overall Study|Withdrawal by Subject|1|||
48745116|NCT01408485|156916138|FG000|Overall Study|Withdrawal by Subject|21|||
48745117|NCT02059395|156916142|FG000|Overall Study|Lost to Follow-up|2|||
48745118|NCT02059395|156916143|FG001|Overall Study|Lost to Follow-up|4|||
48745119|NCT00847379|156916144|FG000|Overall Study|Study terminated by Sponsor|59|||
48745120|NCT00847379|156916145|FG001|Overall Study|Study terminated by Sponsor|57|||
48745121|NCT00847379|156916146|FG002|Overall Study|Study terminated by Sponsor|57|||
48745122|NCT00319553|156916151|FG000|Overall Study|Protocol Violation|1|||
48745123|NCT00319553|156916152|FG001|Overall Study|Protocol Violation|2|||
48745124|NCT00319553|156916151|FG000|Overall Study|Lost to Follow-up|2|||
48633416|NCT05270863|156514956|FG001|First Washout|Withdrawal by Subject|0|||
48633417|NCT05270863|156514957|FG002|First Washout|Withdrawal by Subject|0|||
48633418|NCT05270863|156514958|FG003|First Washout|Withdrawal by Subject|0|||
48745125|NCT00319553|156916152|FG001|Overall Study|Lost to Follow-up|1|||
48745126|NCT00319553|156916151|FG000|Overall Study|Withdrawal by Subject|1|||
48745127|NCT00319553|156916152|FG001|Overall Study|Withdrawal by Subject|1|||
48745128|NCT01896102|156916153|FG000|Overall Study|Death|1|||
48745129|NCT01896102|156916153|FG000|Overall Study|Participant to receive allogenic transplant|2|||
48633419|NCT05270863|156514959|FG004|First Washout|Withdrawal by Subject|1|||
48745130|NCT02042183|156916154|FG000|Overall Study|Physician Decision|7|||
48745131|NCT02042183|156916155|FG001|Overall Study|Physician Decision|2|||
48745132|NCT02042183|156916154|FG000|Overall Study|Lack of Efficacy|4|||
48745133|NCT02042183|156916155|FG001|Overall Study|Lack of Efficacy|3|||
48745134|NCT02042183|156916154|FG000|Overall Study|Non-compliance with Study Drug|2|||
48326303|NCT03781375|155392414|FG000|Open-label Phase|Protocol Issues|0|||
48326304|NCT03781375|155392415|FG001|Open-label Phase|Protocol Issues|1|||
48326305|NCT03781375|155392414|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
48326306|NCT03781375|155392415|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
48326307|NCT03781375|155392414|FG000|Open-label Phase|Other|2|||
48326308|NCT03781375|155392415|FG001|Open-label Phase|Other|2|||
48326309|NCT01303510|155392417|FG000|Overall Study|Lost to Follow-up|1|||
48326310|NCT01303510|155392418|FG001|Overall Study|Lost to Follow-up|0|||
48326311|NCT01485887|155392419|FG000|Overall Study|Withdrawal by Subject|2|||
48326312|NCT01485887|155392419|FG000|Overall Study|Adverse Event|8|||
48326313|NCT01485887|155392419|FG000|Overall Study|Deterioration of primary disease|1|||
48326314|NCT01485887|155392419|FG000|Overall Study|Primary disease markedly improved|1|||
48326315|NCT00857766|155392420|FG000|Overall Study|Adverse Event|13|||
48326316|NCT00857766|155392421|FG001|Overall Study|Adverse Event|12|||
48326317|NCT00857766|155392420|FG000|Overall Study|Protocol Violation|11|||
48326318|NCT00857766|155392421|FG001|Overall Study|Protocol Violation|11|||
48326319|NCT00857766|155392420|FG000|Overall Study|Lost to Follow-up|1|||
48326320|NCT00857766|155392421|FG001|Overall Study|Lost to Follow-up|0|||
48326321|NCT00857766|155392420|FG000|Overall Study|Investigator Discretion|2|||
48326322|NCT00857766|155392421|FG001|Overall Study|Investigator Discretion|3|||
48326323|NCT00857766|155392420|FG000|Overall Study|Participant Withdrew Consent|4|||
48326324|NCT00857766|155392421|FG001|Overall Study|Participant Withdrew Consent|4|||
48326325|NCT03418545|155392422|FG000|Overall Study|Withdrawal by Participant|2|||
48326326|NCT03418545|155392423|FG001|Overall Study|Withdrawal by Participant|4|||
48326327|NCT03418545|155392422|FG000|Overall Study|Lost to Follow-up|3|||
48326328|NCT03418545|155392423|FG001|Overall Study|Lost to Follow-up|5|||
48326329|NCT03418545|155392422|FG000|Overall Study|Reason Not Specified|0|||
48326330|NCT03418545|155392423|FG001|Overall Study|Reason Not Specified|1|||
48326331|NCT03418545|155392422|FG000|Overall Study|Missing Completion Status|0|||
48326332|NCT03418545|155392423|FG001|Overall Study|Missing Completion Status|1|||
48326333|NCT00776009|155392424|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
48326334|NCT00776009|155392425|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
48326335|NCT00776009|155392426|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
48326336|NCT00776009|155392427|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
48326337|NCT00776009|155392428|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
48326338|NCT00776009|155392429|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
48326339|NCT00776009|155392424|FG000|Period 1: First Intervention|Protocol Violation|0|||
48326340|NCT00776009|155392425|FG001|Period 1: First Intervention|Protocol Violation|1|||
48326341|NCT00776009|155392426|FG002|Period 1: First Intervention|Protocol Violation|0|||
48426557|NCT00486226|155751213|FG000|Overall Study|Death|3|||
48633420|NCT05270863|156514960|FG005|First Washout|Withdrawal by Subject|1|||
48633421|NCT05270863|156514955|FG000|First Washout|Lost to Follow-up|0|||
48633422|NCT05270863|156514956|FG001|First Washout|Lost to Follow-up|0|||
48633423|NCT05270863|156514957|FG002|First Washout|Lost to Follow-up|0|||
48633424|NCT05270863|156514958|FG003|First Washout|Lost to Follow-up|0|||
48633425|NCT05270863|156514959|FG004|First Washout|Lost to Follow-up|0|||
48633426|NCT05270863|156514960|FG005|First Washout|Lost to Follow-up|1|||
48633427|NCT05270863|156514955|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
48633428|NCT05270863|156514956|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
48633429|NCT05270863|156514957|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
48633430|NCT05270863|156514958|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
48633431|NCT05270863|156514959|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
48633432|NCT05270863|156514960|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
48633433|NCT05270863|156514955|FG000|Second Washout|Withdrawal by Subject|1|||
48633434|NCT05270863|156514956|FG001|Second Washout|Withdrawal by Subject|1|||
48633435|NCT05270863|156514957|FG002|Second Washout|Withdrawal by Subject|0|||
48633436|NCT05270863|156514958|FG003|Second Washout|Withdrawal by Subject|0|||
48633437|NCT05270863|156514959|FG004|Second Washout|Withdrawal by Subject|0|||
48633438|NCT05270863|156514960|FG005|Second Washout|Withdrawal by Subject|0|||
48633439|NCT05270863|156514955|FG000|Second Washout|Lost to Follow-up|0|||
48633440|NCT05270863|156514956|FG001|Second Washout|Lost to Follow-up|0|||
48633441|NCT05270863|156514957|FG002|Second Washout|Lost to Follow-up|0|||
48633442|NCT05270863|156514958|FG003|Second Washout|Lost to Follow-up|1|||
48633443|NCT05270863|156514959|FG004|Second Washout|Lost to Follow-up|0|||
48633444|NCT05270863|156514960|FG005|Second Washout|Lost to Follow-up|0|||
48633445|NCT01365455|156514961|FG000|Induction Period|Adverse Event|5|||
48633446|NCT01365455|156514962|FG001|Induction Period|Adverse Event|3|||
48633447|NCT01365455|156514963|FG002|Induction Period|Adverse Event|4|||
48633448|NCT01365455|156514964|FG003|Induction Period|Adverse Event|0|||
48633449|NCT01365455|156514965|FG004|Induction Period|Adverse Event|0|||
48633450|NCT01365455|156514961|FG000|Induction Period|Lack of Efficacy|1|||
48633451|NCT01365455|156514962|FG001|Induction Period|Lack of Efficacy|1|||
48633452|NCT01365455|156514963|FG002|Induction Period|Lack of Efficacy|0|||
48633453|NCT01365455|156514964|FG003|Induction Period|Lack of Efficacy|0|||
48633454|NCT01365455|156514965|FG004|Induction Period|Lack of Efficacy|0|||
48633455|NCT01365455|156514961|FG000|Induction Period|Pregnancy|0|||
48633456|NCT01365455|156514962|FG001|Induction Period|Pregnancy|1|||
48633457|NCT01365455|156514963|FG002|Induction Period|Pregnancy|0|||
48633458|NCT01365455|156514964|FG003|Induction Period|Pregnancy|0|||
48633459|NCT01365455|156514965|FG004|Induction Period|Pregnancy|0|||
48633460|NCT01365455|156514961|FG000|Induction Period|Protocol deviation|0|||
48633461|NCT01365455|156514962|FG001|Induction Period|Protocol deviation|1|||
48633462|NCT01365455|156514963|FG002|Induction Period|Protocol deviation|1|||
48633463|NCT01365455|156514964|FG003|Induction Period|Protocol deviation|0|||
48633464|NCT01365455|156514965|FG004|Induction Period|Protocol deviation|0|||
48633465|NCT01365455|156514961|FG000|Induction Period|Subject/guardian decision|9|||
48633466|NCT01365455|156514962|FG001|Induction Period|Subject/guardian decision|1|||
48633467|NCT01365455|156514963|FG002|Induction Period|Subject/guardian decision|8|||
48633468|NCT01365455|156514964|FG003|Induction Period|Subject/guardian decision|0|||
48633469|NCT01365455|156514965|FG004|Induction Period|Subject/guardian decision|0|||
48633470|NCT01365455|156514961|FG000|Induction Period|Lost to Follow-up|0|||
48633471|NCT01365455|156514962|FG001|Induction Period|Lost to Follow-up|0|||
48633472|NCT01365455|156514963|FG002|Induction Period|Lost to Follow-up|3|||
48633473|NCT01365455|156514964|FG003|Induction Period|Lost to Follow-up|0|||
48633474|NCT01365455|156514965|FG004|Induction Period|Lost to Follow-up|0|||
48633475|NCT01365455|156514961|FG000|Maintenance Period|Adverse Event|12|||
48633476|NCT01365455|156514962|FG001|Maintenance Period|Adverse Event|5|||
48633477|NCT01365455|156514963|FG002|Maintenance Period|Adverse Event|1|||
48633478|NCT01365455|156514964|FG003|Maintenance Period|Adverse Event|2|||
48633479|NCT01365455|156514965|FG004|Maintenance Period|Adverse Event|4|||
48633480|NCT01365455|156514961|FG000|Maintenance Period|Lack of Efficacy|10|||
48633481|NCT01365455|156514962|FG001|Maintenance Period|Lack of Efficacy|2|||
48633482|NCT01365455|156514963|FG002|Maintenance Period|Lack of Efficacy|0|||
48633483|NCT01365455|156514964|FG003|Maintenance Period|Lack of Efficacy|2|||
48633484|NCT01365455|156514965|FG004|Maintenance Period|Lack of Efficacy|2|||
48633485|NCT01365455|156514961|FG000|Maintenance Period|Lost to Follow-up|2|||
48633486|NCT01365455|156514962|FG001|Maintenance Period|Lost to Follow-up|4|||
48633487|NCT01365455|156514963|FG002|Maintenance Period|Lost to Follow-up|0|||
48633488|NCT01365455|156514964|FG003|Maintenance Period|Lost to Follow-up|0|||
48633489|NCT01365455|156514965|FG004|Maintenance Period|Lost to Follow-up|3|||
48633490|NCT01365455|156514961|FG000|Maintenance Period|Non-compliance with study treatment|0|||
48633491|NCT01365455|156514962|FG001|Maintenance Period|Non-compliance with study treatment|0|||
48633492|NCT01365455|156514963|FG002|Maintenance Period|Non-compliance with study treatment|0|||
48633493|NCT01365455|156514964|FG003|Maintenance Period|Non-compliance with study treatment|1|||
48633494|NCT01365455|156514965|FG004|Maintenance Period|Non-compliance with study treatment|0|||
48633495|NCT01365455|156514961|FG000|Maintenance Period|Physician Decision|0|||
48633496|NCT01365455|156514962|FG001|Maintenance Period|Physician Decision|1|||
48633497|NCT01365455|156514963|FG002|Maintenance Period|Physician Decision|0|||
48633498|NCT01365455|156514964|FG003|Maintenance Period|Physician Decision|0|||
48633499|NCT01365455|156514965|FG004|Maintenance Period|Physician Decision|1|||
48633500|NCT01365455|156514961|FG000|Maintenance Period|Pregnancy|0|||
48633501|NCT01365455|156514962|FG001|Maintenance Period|Pregnancy|4|||
48633502|NCT01365455|156514963|FG002|Maintenance Period|Pregnancy|0|||
48633503|NCT01365455|156514964|FG003|Maintenance Period|Pregnancy|0|||
48633504|NCT01365455|156514965|FG004|Maintenance Period|Pregnancy|2|||
48633505|NCT01365455|156514961|FG000|Maintenance Period|Protocol deviation|1|||
48633506|NCT01365455|156514962|FG001|Maintenance Period|Protocol deviation|1|||
48633507|NCT01365455|156514963|FG002|Maintenance Period|Protocol deviation|0|||
48633508|NCT01365455|156514964|FG003|Maintenance Period|Protocol deviation|0|||
48633509|NCT01365455|156514965|FG004|Maintenance Period|Protocol deviation|0|||
48633510|NCT01365455|156514961|FG000|Maintenance Period|Subject/guardian decision|4|||
48633511|NCT01365455|156514962|FG001|Maintenance Period|Subject/guardian decision|6|||
48633512|NCT01365455|156514963|FG002|Maintenance Period|Subject/guardian decision|2|||
48633513|NCT01365455|156514964|FG003|Maintenance Period|Subject/guardian decision|4|||
48633514|NCT01365455|156514965|FG004|Maintenance Period|Subject/guardian decision|1|||
48633515|NCT03514134|156517126|FG000|Overall Study|Lost to Follow-up|0|||
48633516|NCT03514134|156517127|FG001|Overall Study|Lost to Follow-up|1|||
48633517|NCT01373281|156517131|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
48633518|NCT01373281|156517132|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
48633519|NCT01373281|156517131|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
48633520|NCT01373281|156517132|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
48633521|NCT01373281|156517131|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
48633522|NCT01373281|156517132|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
48633523|NCT01373281|156517131|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
48633524|NCT01373281|156517132|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
48633525|NCT01373281|156517131|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
48633526|NCT01373281|156517132|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
48633527|NCT01373281|156517131|FG000|Surveillance Expansion Period|Protocol Violation|9|||
48633528|NCT01373281|156517132|FG001|Surveillance Expansion Period|Protocol Violation|1|||
48633529|NCT01373281|156517131|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
48633530|NCT01373281|156517132|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
48633531|NCT01373281|156517131|FG000|Surveillance Expansion Period|Serious adverse event|3|||
48633532|NCT01373281|156517132|FG001|Surveillance Expansion Period|Serious adverse event|4|||
48633533|NCT01397253|156517133|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
48633534|NCT01397253|156517134|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
48326342|NCT00776009|155392427|FG003|Period 1: First Intervention|Protocol Violation|0|||
48326343|NCT00776009|155392428|FG004|Period 1: First Intervention|Protocol Violation|1|||
48326344|NCT00776009|155392429|FG005|Period 1: First Intervention|Protocol Violation|0|||
48326345|NCT00776009|155392424|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
48633535|NCT00980044|156517135|FG000|Overall Study|Withdrawal by Subject|5|||
48633536|NCT00980044|156517136|FG001|Overall Study|Withdrawal by Subject|7|||
48633537|NCT00980044|156517137|FG002|Overall Study|Withdrawal by Subject|3|||
48633538|NCT00980044|156517135|FG000|Overall Study|Protocol Violation|0|||
48633539|NCT00980044|156517136|FG001|Overall Study|Protocol Violation|0|||
48633540|NCT00980044|156517137|FG002|Overall Study|Protocol Violation|2|||
48633541|NCT03502681|156517140|FG000|Overall Study|Adverse Event|1|||
48633542|NCT03502681|156517141|FG001|Overall Study|Adverse Event|1|||
48633543|NCT03502681|156517140|FG000|Overall Study|Disease Progression|2|||
48633544|NCT03502681|156517141|FG001|Overall Study|Disease Progression|1|||
48633545|NCT00442702|156517142|FG000|Titration Period|Adverse Event|2|||
48633546|NCT00442702|156517143|FG001|Titration Period|Adverse Event|0|||
48633547|NCT00442702|156517142|FG000|Titration Period|Death|3|||
48633548|NCT00442702|156517143|FG001|Titration Period|Death|2|||
48633549|NCT00442702|156517142|FG000|Titration Period|Insufficient Therapeutic Response|1|||
48633550|NCT00442702|156517143|FG001|Titration Period|Insufficient Therapeutic Response|0|||
48633551|NCT00442702|156517142|FG000|Titration Period|Refused Treatment|4|||
48633552|NCT00442702|156517143|FG001|Titration Period|Refused Treatment|1|||
48633553|NCT00442702|156517142|FG000|Titration Period|Failure to return|1|||
48633554|NCT00442702|156517143|FG001|Titration Period|Failure to return|0|||
48633555|NCT00442702|156517142|FG000|Titration Period|Hospitalized in another hospital|1|||
48633556|NCT00442702|156517143|FG001|Titration Period|Hospitalized in another hospital|0|||
48633557|NCT00442702|156517142|FG000|Evaluation Period|Adverse Event|1|||
48633558|NCT00442702|156517143|FG001|Evaluation Period|Adverse Event|0|||
48633559|NCT00442702|156517142|FG000|Evaluation Period|Death|1|||
48633560|NCT00442702|156517143|FG001|Evaluation Period|Death|1|||
48633561|NCT00442702|156517142|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
48633562|NCT00442702|156517143|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
48633563|NCT00442702|156517142|FG000|Evaluation Period|Refused treatment|1|||
48633564|NCT00442702|156517143|FG001|Evaluation Period|Refused treatment|1|||
48633565|NCT00442702|156517142|FG000|Evaluation Period|Renal transplant|0|||
48633566|NCT00442702|156517143|FG001|Evaluation Period|Renal transplant|1|||
48633567|NCT00442702|156517142|FG000|Evaluation Period|Failure to return|1|||
48633568|NCT00442702|156517143|FG001|Evaluation Period|Failure to return|0|||
48633569|NCT00442702|156517142|FG000|Evaluation Period|Site closure|0|||
48633570|NCT00442702|156517143|FG001|Evaluation Period|Site closure|1|||
48633571|NCT01444781|156517144|FG000|Overall Study|Lost to Follow-up|0|||
48633572|NCT01444781|156517145|FG001|Overall Study|Lost to Follow-up|3|||
48633573|NCT01444781|156517146|FG002|Overall Study|Lost to Follow-up|1|||
48633574|NCT01444781|156517144|FG000|Overall Study|Withdrawal by Subject|3|||
48633575|NCT01444781|156517145|FG001|Overall Study|Withdrawal by Subject|1|||
48633576|NCT01444781|156517146|FG002|Overall Study|Withdrawal by Subject|2|||
48633577|NCT02254291|156517147|FG000|Overall Study|Withdrawal by Subject|0|||
48633578|NCT02254291|156517148|FG001|Overall Study|Withdrawal by Subject|3|||
48633579|NCT02254291|156517149|FG002|Overall Study|Withdrawal by Subject|1|||
48633580|NCT02254291|156517147|FG000|Overall Study|Missing follow-up information|0|||
48633581|NCT02254291|156517148|FG001|Overall Study|Missing follow-up information|0|||
48633582|NCT02254291|156517149|FG002|Overall Study|Missing follow-up information|1|||
48633583|NCT05538728|156517152|FG000|Overall Study|Withdrawal by Subject|1|||
48633584|NCT05538728|156517153|FG001|Overall Study|Withdrawal by Subject|1|||
48633585|NCT00133705|156517154|FG000|Overall Study|Withdrawal by Subject|2|||
48633586|NCT00133705|156517155|FG001|Overall Study|Withdrawal by Subject|3|||
48633587|NCT03122184|156517159|FG000|Overall Study|Lost to Follow-up|4|||
48633588|NCT03122184|156517160|FG001|Overall Study|Lost to Follow-up|6|||
48633589|NCT03122184|156517159|FG000|Overall Study|Withdrawal by Subject|3|||
48633590|NCT03122184|156517160|FG001|Overall Study|Withdrawal by Subject|0|||
48633591|NCT03122184|156517159|FG000|Overall Study|Terminated due to cognitive problem|1|||
48633592|NCT03122184|156517160|FG001|Overall Study|Terminated due to cognitive problem|0|||
48633593|NCT00876447|156517169|FG000|Overall Study|Other miscellaneous reasons|3|||
48633594|NCT00876447|156517170|FG001|Overall Study|Other miscellaneous reasons|8|||
48633595|NCT00876447|156517169|FG000|Overall Study|Site closure|19|||
48633596|NCT00876447|156517170|FG001|Overall Study|Site closure|14|||
48745135|NCT02042183|156916155|FG001|Overall Study|Non-compliance with Study Drug|3|||
48745136|NCT02042183|156916154|FG000|Overall Study|Adverse Event|17|||
48633597|NCT00876447|156517169|FG000|Overall Study|Protocol Violation|9|||
48633598|NCT00876447|156517170|FG001|Overall Study|Protocol Violation|3|||
48633599|NCT00876447|156517169|FG000|Overall Study|Personal reasons|30|||
48633600|NCT00876447|156517170|FG001|Overall Study|Personal reasons|28|||
48633601|NCT00876447|156517169|FG000|Overall Study|Lost to Follow-up|6|||
48633602|NCT00876447|156517170|FG001|Overall Study|Lost to Follow-up|15|||
48633603|NCT00876447|156517169|FG000|Overall Study|Pregnancy|4|||
48633604|NCT00876447|156517170|FG001|Overall Study|Pregnancy|2|||
48633605|NCT00876447|156517169|FG000|Overall Study|Lack of Efficacy|5|||
48633606|NCT00876447|156517170|FG001|Overall Study|Lack of Efficacy|3|||
48633607|NCT00876447|156517169|FG000|Overall Study|Adverse Event|4|||
48633608|NCT00876447|156517170|FG001|Overall Study|Adverse Event|8|||
48745137|NCT02042183|156916155|FG001|Overall Study|Adverse Event|6|||
48745138|NCT02042183|156916154|FG000|Overall Study|Other|3|||
48633609|NCT03674281|156517171|FG000|Overall Study|screen failure|2|||
48633610|NCT03674281|156517172|FG001|Overall Study|screen failure|0|||
48633611|NCT03674281|156517173|FG002|Overall Study|screen failure|0|||
48745139|NCT02042183|156916155|FG001|Overall Study|Other|3|||
48745140|NCT02042183|156916154|FG000|Overall Study|Withdrawal by Subject|21|||
48745141|NCT02042183|156916155|FG001|Overall Study|Withdrawal by Subject|16|||
48745142|NCT02042183|156916154|FG000|Overall Study|Site Terminated by Sponsor|2|||
48326346|NCT00776009|155392425|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
48633612|NCT03674281|156517171|FG000|Overall Study|Withdrawal by Subject|1|||
48633613|NCT03674281|156517172|FG001|Overall Study|Withdrawal by Subject|3|||
48633614|NCT03674281|156517173|FG002|Overall Study|Withdrawal by Subject|3|||
48633615|NCT02301897|156517174|FG000|Treatment Course 1|Non-Compliance|0|||
48633616|NCT02301897|156517175|FG001|Treatment Course 1|Non-Compliance|0|||
48633617|NCT02301897|156517176|FG002|Treatment Course 1|Non-Compliance|1|||
48633618|NCT02301897|156517174|FG000|Treatment Course 1|Adverse Event|1|||
48633619|NCT02301897|156517175|FG001|Treatment Course 1|Adverse Event|1|||
48633620|NCT02301897|156517176|FG002|Treatment Course 1|Adverse Event|0|||
48633621|NCT02301897|156517174|FG000|Treatment Course 1|Lost to Follow-up|1|||
48633622|NCT02301897|156517175|FG001|Treatment Course 1|Lost to Follow-up|2|||
48633623|NCT02301897|156517176|FG002|Treatment Course 1|Lost to Follow-up|1|||
48633624|NCT02301897|156517174|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
48633625|NCT02301897|156517175|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
48633626|NCT02301897|156517176|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
48633627|NCT02301897|156517174|FG000|Treatment Course 1|Withdrawal by Subject|0|||
48633628|NCT02301897|156517175|FG001|Treatment Course 1|Withdrawal by Subject|0|||
48633629|NCT02301897|156517176|FG002|Treatment Course 1|Withdrawal by Subject|2|||
48633630|NCT02301897|156517174|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
48633631|NCT02301897|156517175|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
48633632|NCT02301897|156517176|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
48633633|NCT02301897|156517174|FG000|Treatment Course 2|Lost to Follow-up|0|||
48633634|NCT02301897|156517175|FG001|Treatment Course 2|Lost to Follow-up|2|||
48633635|NCT02301897|156517176|FG002|Treatment Course 2|Lost to Follow-up|0|||
48633636|NCT02301897|156517174|FG000|Treatment Course 2|Pregnancy|0|||
48633637|NCT02301897|156517175|FG001|Treatment Course 2|Pregnancy|1|||
48745143|NCT02042183|156916155|FG001|Overall Study|Site Terminated by Sponsor|1|||
48326347|NCT00776009|155392426|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
48745144|NCT02042183|156916154|FG000|Overall Study|Lost to Follow-up|9|||
48633638|NCT02301897|156517176|FG002|Treatment Course 2|Pregnancy|1|||
48745145|NCT02042183|156916155|FG001|Overall Study|Lost to Follow-up|2|||
48745146|NCT01081678|156916156|FG000|Overall Study|Ineligibility Determined|0|||
48745147|NCT01081678|156916157|FG001|Overall Study|Ineligibility Determined|0|||
48745148|NCT01081678|156916158|FG002|Overall Study|Ineligibility Determined|1|||
48745149|NCT01081678|156916159|FG003|Overall Study|Ineligibility Determined|1|||
48745150|NCT01081678|156916156|FG000|Overall Study|Noncompliance|3|||
48745151|NCT01081678|156916157|FG001|Overall Study|Noncompliance|4|||
48745152|NCT01081678|156916158|FG002|Overall Study|Noncompliance|5|||
48745153|NCT01081678|156916159|FG003|Overall Study|Noncompliance|2|||
48745154|NCT01081678|156916156|FG000|Overall Study|Adverse Event|2|||
48745155|NCT01081678|156916157|FG001|Overall Study|Adverse Event|1|||
48745156|NCT01081678|156916158|FG002|Overall Study|Adverse Event|2|||
48745157|NCT01081678|156916159|FG003|Overall Study|Adverse Event|2|||
48745158|NCT01081678|156916156|FG000|Overall Study|Withdrawal by Subject|15|||
48745159|NCT01081678|156916157|FG001|Overall Study|Withdrawal by Subject|7|||
48745160|NCT01081678|156916158|FG002|Overall Study|Withdrawal by Subject|17|||
48745161|NCT01081678|156916159|FG003|Overall Study|Withdrawal by Subject|14|||
48745162|NCT01081678|156916156|FG000|Overall Study|Administrative Decision|1|||
48745163|NCT01081678|156916157|FG001|Overall Study|Administrative Decision|0|||
48745164|NCT01081678|156916158|FG002|Overall Study|Administrative Decision|0|||
48745165|NCT01081678|156916159|FG003|Overall Study|Administrative Decision|1|||
48745166|NCT01081678|156916156|FG000|Overall Study|Lost to Follow-up|4|||
48745167|NCT01081678|156916157|FG001|Overall Study|Lost to Follow-up|1|||
48745168|NCT01081678|156916158|FG002|Overall Study|Lost to Follow-up|4|||
48745169|NCT01081678|156916159|FG003|Overall Study|Lost to Follow-up|3|||
48745170|NCT01081678|156916156|FG000|Overall Study|Death|2|||
48745171|NCT01081678|156916157|FG001|Overall Study|Death|2|||
48745172|NCT01081678|156916158|FG002|Overall Study|Death|2|||
48745173|NCT01081678|156916159|FG003|Overall Study|Death|6|||
48745174|NCT01081678|156916156|FG000|Overall Study|Other|0|||
48745175|NCT01081678|156916157|FG001|Overall Study|Other|1|||
48745176|NCT01081678|156916158|FG002|Overall Study|Other|0|||
48745177|NCT01081678|156916159|FG003|Overall Study|Other|0|||
48745178|NCT00378378|156916160|FG000|Overall Study|Withdrawal by Subject|0|||
48745179|NCT00378378|156916161|FG001|Overall Study|Withdrawal by Subject|1|||
48745180|NCT00378378|156916162|FG002|Overall Study|Withdrawal by Subject|0|||
48745181|NCT00378378|156916160|FG000|Overall Study|Treatment Failure|0|||
48745182|NCT00378378|156916161|FG001|Overall Study|Treatment Failure|0|||
48745183|NCT00378378|156916162|FG002|Overall Study|Treatment Failure|1|||
48745184|NCT00378378|156916160|FG000|Overall Study|Non-compliance with protocol|0|||
48326348|NCT00776009|155392427|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
48326349|NCT00776009|155392428|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
48326350|NCT00776009|155392429|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
48326351|NCT00776009|155392424|FG000|Period 2: Second Intervention|Protocol Violation|1|||
48326352|NCT00776009|155392425|FG001|Period 2: Second Intervention|Protocol Violation|0|||
48326353|NCT00776009|155392426|FG002|Period 2: Second Intervention|Protocol Violation|1|||
48326354|NCT00776009|155392427|FG003|Period 2: Second Intervention|Protocol Violation|0|||
48745185|NCT00378378|156916161|FG001|Overall Study|Non-compliance with protocol|0|||
48745186|NCT00378378|156916162|FG002|Overall Study|Non-compliance with protocol|1|||
48745187|NCT00289991|156916165|FG000|Overall Study|Death|35|||
48745188|NCT00289991|156916166|FG001|Overall Study|Death|38|||
48745189|NCT00289991|156916165|FG000|Overall Study|Adverse Event|15|||
48745190|NCT00289991|156916166|FG001|Overall Study|Adverse Event|13|||
48745191|NCT00289991|156916165|FG000|Overall Study|Failure of prophylaxis|1|||
48745192|NCT00289991|156916166|FG001|Overall Study|Failure of prophylaxis|1|||
48745193|NCT00289991|156916165|FG000|Overall Study|Fungal breakthrough infection|0|||
48326355|NCT00776009|155392428|FG004|Period 2: Second Intervention|Protocol Violation|0|||
48326356|NCT00776009|155392429|FG005|Period 2: Second Intervention|Protocol Violation|0|||
48326357|NCT00776009|155392424|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
48326358|NCT00776009|155392425|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
48326359|NCT00776009|155392426|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
48633639|NCT02301897|156517174|FG000|Treatment Course 2|Withdrawal by Subject|0|||
48633640|NCT02301897|156517175|FG001|Treatment Course 2|Withdrawal by Subject|2|||
48633641|NCT02301897|156517176|FG002|Treatment Course 2|Withdrawal by Subject|0|||
48633642|NCT02301897|156517174|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
48633643|NCT02301897|156517175|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
48633644|NCT02301897|156517176|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
48633645|NCT02538614|156517180|FG000|Overall Study|Progressive Disease|2|||
48633646|NCT00666263|156517183|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
48633647|NCT00666263|156517184|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
48633648|NCT00666263|156517183|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
48633649|NCT00666263|156517184|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
48633650|NCT00666263|156517183|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
48633651|NCT00666263|156517184|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
48633652|NCT00189423|156517185|FG000|Overall Study|Death|746|||
48633653|NCT00189423|156517186|FG001|Overall Study|Death|747|||
48633654|NCT00189423|156517185|FG000|Overall Study|Withdrawal by Subject|9|||
48633655|NCT00189423|156517186|FG001|Overall Study|Withdrawal by Subject|9|||
48633656|NCT00189423|156517185|FG000|Overall Study|Lost to Follow-up|10|||
48633657|NCT00189423|156517186|FG001|Overall Study|Lost to Follow-up|10|||
48633658|NCT04622592|156517188|FG000|Overall Study|Death|0|||
48633659|NCT04622592|156517189|FG001|Overall Study|Death|0|||
48633660|NCT04622592|156517190|FG002|Overall Study|Death|1|||
48633661|NCT04622592|156517191|FG003|Overall Study|Death|0|||
48633662|NCT04622592|156517192|FG004|Overall Study|Death|0|||
48633663|NCT04622592|156517193|FG005|Overall Study|Death|0|||
48633664|NCT04622592|156517194|FG006|Overall Study|Death|0|||
48633665|NCT04622592|156517195|FG007|Overall Study|Death|1|||
48633666|NCT04622592|156517188|FG000|Overall Study|Lost to Follow-up|0|||
48633667|NCT04622592|156517189|FG001|Overall Study|Lost to Follow-up|0|||
48633668|NCT04622592|156517190|FG002|Overall Study|Lost to Follow-up|0|||
48633669|NCT04622592|156517191|FG003|Overall Study|Lost to Follow-up|3|||
48633670|NCT04622592|156517192|FG004|Overall Study|Lost to Follow-up|1|||
48633671|NCT04622592|156517193|FG005|Overall Study|Lost to Follow-up|0|||
48633672|NCT04622592|156517194|FG006|Overall Study|Lost to Follow-up|2|||
48633673|NCT04622592|156517195|FG007|Overall Study|Lost to Follow-up|2|||
48633674|NCT04622592|156517188|FG000|Overall Study|Physician Decision|0|||
48633675|NCT04622592|156517189|FG001|Overall Study|Physician Decision|0|||
48633676|NCT04622592|156517190|FG002|Overall Study|Physician Decision|0|||
48633677|NCT04622592|156517191|FG003|Overall Study|Physician Decision|0|||
48633678|NCT04622592|156517192|FG004|Overall Study|Physician Decision|1|||
48745194|NCT00289991|156916166|FG001|Overall Study|Fungal breakthrough infection|1|||
48745195|NCT00289991|156916165|FG000|Overall Study|Lost to Follow-up|0|||
48745196|NCT00289991|156916166|FG001|Overall Study|Lost to Follow-up|1|||
48745197|NCT00289991|156916165|FG000|Overall Study|Withdrawal by Subject|2|||
48745198|NCT00289991|156916166|FG001|Overall Study|Withdrawal by Subject|12|||
48745199|NCT00289991|156916165|FG000|Overall Study|Other|5|||
48745200|NCT00289991|156916166|FG001|Overall Study|Other|14|||
48745201|NCT01606007|156916167|FG000|Overall Study|Reason 'Other' in the protocol|0|||
48633679|NCT04622592|156517193|FG005|Overall Study|Physician Decision|0|||
48633680|NCT04622592|156517194|FG006|Overall Study|Physician Decision|0|||
48633681|NCT04622592|156517195|FG007|Overall Study|Physician Decision|0|||
48633682|NCT04622592|156517188|FG000|Overall Study|Withdrawal by Subject|1|||
48633683|NCT04622592|156517189|FG001|Overall Study|Withdrawal by Subject|0|||
48745202|NCT01606007|156916168|FG001|Overall Study|Reason 'Other' in the protocol|1|||
48326360|NCT00776009|155392427|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
48633684|NCT04622592|156517190|FG002|Overall Study|Withdrawal by Subject|2|||
48633685|NCT04622592|156517191|FG003|Overall Study|Withdrawal by Subject|0|||
48633686|NCT04622592|156517192|FG004|Overall Study|Withdrawal by Subject|0|||
48633687|NCT04622592|156517193|FG005|Overall Study|Withdrawal by Subject|0|||
48745203|NCT01606007|156916169|FG002|Overall Study|Reason 'Other' in the protocol|1|||
48745204|NCT01606007|156916167|FG000|Overall Study|Pregnancy|0|||
48633688|NCT04622592|156517194|FG006|Overall Study|Withdrawal by Subject|1|||
48326361|NCT00776009|155392428|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
48326362|NCT00776009|155392429|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
48633689|NCT04622592|156517195|FG007|Overall Study|Withdrawal by Subject|4|||
48633690|NCT04622592|156517188|FG000|Overall Study|Other than specified above|0|||
48633691|NCT04622592|156517189|FG001|Overall Study|Other than specified above|0|||
48633692|NCT04622592|156517190|FG002|Overall Study|Other than specified above|1|||
48633693|NCT04622592|156517191|FG003|Overall Study|Other than specified above|0|||
48633694|NCT04622592|156517192|FG004|Overall Study|Other than specified above|0|||
48633695|NCT04622592|156517193|FG005|Overall Study|Other than specified above|0|||
48633696|NCT04622592|156517194|FG006|Overall Study|Other than specified above|0|||
48633697|NCT04622592|156517195|FG007|Overall Study|Other than specified above|0|||
48633698|NCT00586157|156517196|FG000|First Intervention|Worsening behavior|1|||
48633699|NCT00586157|156517197|FG001|First Intervention|Worsening behavior|0|||
48633700|NCT00586157|156517196|FG000|Second Intervention|Withdrawal by Subject|1|||
48633701|NCT00586157|156517197|FG001|Second Intervention|Withdrawal by Subject|0|||
48633702|NCT00586157|156517196|FG000|Second Intervention|Worsening behavior|1|||
48633703|NCT00586157|156517197|FG001|Second Intervention|Worsening behavior|0|||
48633704|NCT00586157|156517196|FG000|Second Intervention|Adverse Event|0|||
48633705|NCT00586157|156517197|FG001|Second Intervention|Adverse Event|1|||
48633706|NCT04484857|156517198|FG000|Overall Study|Adverse Event|2|||
48633707|NCT04484857|156517198|FG000|Overall Study|Death|10|||
48633708|NCT04484857|156517198|FG000|Overall Study|Withdrawal by Subject|3|||
48633709|NCT04484857|156517198|FG000|Overall Study|Transferred/Relocation|5|||
48633710|NCT04484857|156517198|FG000|Overall Study|Kidney Transplant|7|||
48633711|NCT04484857|156517198|FG000|Overall Study|Other than specified|4|||
48633712|NCT04484857|156517198|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
48633713|NCT03663582|156517199|FG000|Overall Study|Physician Decision|1|||
48633714|NCT00278161|156517200|FG000|Overall Study|Death|11|||
48633715|NCT03610048|156517206|FG000|Overall Study|Study terminated by sponsor|84|||
48633716|NCT03610048|156517206|FG000|Overall Study|Adverse Event|32|||
48633717|NCT03610048|156517206|FG000|Overall Study|Withdrawal by Subject|31|||
48745205|NCT01606007|156916168|FG001|Overall Study|Pregnancy|1|||
48745206|NCT01606007|156916169|FG002|Overall Study|Pregnancy|1|||
48745207|NCT01606007|156916167|FG000|Overall Study|Withdrawal by Subject|8|||
48745208|NCT01606007|156916168|FG001|Overall Study|Withdrawal by Subject|6|||
48745209|NCT01606007|156916169|FG002|Overall Study|Withdrawal by Subject|1|||
48745210|NCT01606007|156916167|FG000|Overall Study|Adverse Event|0|||
48745211|NCT01606007|156916168|FG001|Overall Study|Adverse Event|1|||
48745212|NCT01606007|156916169|FG002|Overall Study|Adverse Event|1|||
48745213|NCT01606007|156916167|FG000|Overall Study|discontinue study treatment|0|||
48745214|NCT01606007|156916168|FG001|Overall Study|discontinue study treatment|2|||
48745215|NCT01606007|156916169|FG002|Overall Study|discontinue study treatment|1|||
48745216|NCT01606007|156916167|FG000|Overall Study|Lost to Follow-up|6|||
48745217|NCT01606007|156916168|FG001|Overall Study|Lost to Follow-up|8|||
48745218|NCT01606007|156916169|FG002|Overall Study|Lost to Follow-up|5|||
48633718|NCT03610048|156517206|FG000|Overall Study|Lost to Follow-up|8|||
48633719|NCT03610048|156517206|FG000|Overall Study|Other|4|||
48633720|NCT03610048|156517206|FG000|Overall Study|Physician Decision|1|||
48633721|NCT03610048|156517206|FG000|Overall Study|Pregnancy|1|||
48633722|NCT02743962|156517209|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
48633723|NCT02743962|156517210|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
48633724|NCT00806585|156517215|FG000|Overall Study|Study terminated by Sponsor|0|||
48633725|NCT00806585|156517216|FG001|Overall Study|Study terminated by Sponsor|0|||
48633726|NCT00806585|156517217|FG002|Overall Study|Study terminated by Sponsor|1|||
48633727|NCT00806585|156517218|FG003|Overall Study|Study terminated by Sponsor|2|||
48633728|NCT00806585|156517219|FG004|Overall Study|Study terminated by Sponsor|0|||
48633729|NCT00806585|156517215|FG000|Overall Study|Protocol Violation|3|||
48633730|NCT00806585|156517216|FG001|Overall Study|Protocol Violation|1|||
48633731|NCT00806585|156517217|FG002|Overall Study|Protocol Violation|2|||
48633732|NCT00806585|156517218|FG003|Overall Study|Protocol Violation|0|||
48745219|NCT01606007|156916167|FG000|Overall Study|Poor/Non-compliance|1|||
48745220|NCT01606007|156916168|FG001|Overall Study|Poor/Non-compliance|0|||
48745221|NCT01606007|156916169|FG002|Overall Study|Poor/Non-compliance|0|||
48745222|NCT00119106|156916175|FG000|Overall Study|HIV infected at baseline|179|||
48745223|NCT00119106|156916176|FG001|Overall Study|HIV infected at baseline|178|||
48745224|NCT00730132|156916177|FG000|Overall Study|Protocol Violation|154|||
48633733|NCT00806585|156517219|FG004|Overall Study|Protocol Violation|0|||
48633734|NCT00806585|156517215|FG000|Overall Study|Physician Decision|0|||
48633735|NCT00806585|156517216|FG001|Overall Study|Physician Decision|2|||
48633736|NCT00806585|156517217|FG002|Overall Study|Physician Decision|3|||
48633737|NCT00806585|156517218|FG003|Overall Study|Physician Decision|0|||
48633738|NCT00806585|156517219|FG004|Overall Study|Physician Decision|1|||
48633739|NCT00806585|156517215|FG000|Overall Study|Lost to Follow-up|2|||
48633740|NCT00806585|156517216|FG001|Overall Study|Lost to Follow-up|1|||
48633741|NCT00806585|156517217|FG002|Overall Study|Lost to Follow-up|2|||
48745225|NCT00730132|156916177|FG000|Overall Study|Death|1|||
48745226|NCT02130570|156916178|FG000|Overall Study|Death|3|||
48326363|NCT01640951|155392436|FG000|Overall Study|Adverse Event|8|||
48326364|NCT01640951|155392437|FG001|Overall Study|Adverse Event|3|||
48745227|NCT02130570|156916179|FG001|Overall Study|Death|5|||
48745228|NCT02130570|156916178|FG000|Overall Study|Withdrawal by Subject|6|||
48745229|NCT02130570|156916179|FG001|Overall Study|Withdrawal by Subject|3|||
48745230|NCT02130570|156916178|FG000|Overall Study|Part of practice that discontinued study|0|||
48745231|NCT02130570|156916179|FG001|Overall Study|Part of practice that discontinued study|5|||
48745232|NCT00329238|156916180|FG000|Overall Study|Adverse Event|147|||
48745233|NCT00329238|156916181|FG001|Overall Study|Adverse Event|129|||
48745234|NCT00329238|156916180|FG000|Overall Study|Protocol Violation|23|||
48745235|NCT00329238|156916181|FG001|Overall Study|Protocol Violation|34|||
48745236|NCT00329238|156916180|FG000|Overall Study|Lost to Follow-up|2|||
48745237|NCT00329238|156916181|FG001|Overall Study|Lost to Follow-up|6|||
48745238|NCT00329238|156916180|FG000|Overall Study|Withdrawal by Subject|64|||
48745239|NCT00329238|156916181|FG001|Overall Study|Withdrawal by Subject|58|||
48745240|NCT00329238|156916180|FG000|Overall Study|Other reason (not specified)|40|||
48745241|NCT00329238|156916181|FG001|Overall Study|Other reason (not specified)|54|||
48745242|NCT02099708|156916182|FG000|Overall Study|Data Not Available|30|||
48745243|NCT02099708|156916182|FG000|Overall Study|Lost to Follow-up|141|||
48745244|NCT02099708|156916182|FG000|Overall Study|Other|29|||
48745245|NCT00963937|156916191|FG000|Overall Study|Protocol Violation|1|||
48745246|NCT00963937|156916192|FG001|Overall Study|Protocol Violation|1|||
48745247|NCT00963937|156916193|FG002|Overall Study|Protocol Violation|0|||
48745248|NCT00963937|156916191|FG000|Overall Study|Physician Decision|18|||
48745249|NCT00963937|156916192|FG001|Overall Study|Physician Decision|10|||
48745250|NCT00963937|156916193|FG002|Overall Study|Physician Decision|4|||
48745251|NCT03385564|156916202|FG000|Overall Study|Adverse Event|0|||
48745252|NCT03385564|156916203|FG001|Overall Study|Adverse Event|0|||
48745253|NCT03385564|156916204|FG002|Overall Study|Adverse Event|3|||
48745254|NCT03385564|156916205|FG003|Overall Study|Adverse Event|3|||
48745255|NCT03385564|156916202|FG000|Overall Study|Other than listed|0|||
48745256|NCT03385564|156916203|FG001|Overall Study|Other than listed|0|||
48745257|NCT03385564|156916204|FG002|Overall Study|Other than listed|0|||
48745258|NCT03385564|156916205|FG003|Overall Study|Other than listed|5|||
48745259|NCT03385564|156916202|FG000|Overall Study|Withdrawal by Subject|0|||
48745260|NCT03385564|156916203|FG001|Overall Study|Withdrawal by Subject|1|||
48745261|NCT03385564|156916204|FG002|Overall Study|Withdrawal by Subject|1|||
48745262|NCT03385564|156916205|FG003|Overall Study|Withdrawal by Subject|0|||
48745263|NCT03385564|156916202|FG000|Overall Study|Lack of Efficacy|0|||
48745264|NCT03385564|156916203|FG001|Overall Study|Lack of Efficacy|0|||
48745265|NCT03385564|156916204|FG002|Overall Study|Lack of Efficacy|0|||
48745266|NCT03385564|156916205|FG003|Overall Study|Lack of Efficacy|1|||
48745267|NCT03385564|156916202|FG000|Overall Study|Death|0|||
48745268|NCT03385564|156916203|FG001|Overall Study|Death|0|||
48745269|NCT03385564|156916204|FG002|Overall Study|Death|1|||
48745270|NCT03385564|156916205|FG003|Overall Study|Death|0|||
48745271|NCT02256631|156916208|FG000|Overall Study|Lost to Follow-up|1|||
48745272|NCT02256631|156916209|FG001|Overall Study|Lost to Follow-up|1|||
48745273|NCT02256631|156916210|FG002|Overall Study|Lost to Follow-up|0|||
48745274|NCT02256631|156916211|FG003|Overall Study|Lost to Follow-up|2|||
48745275|NCT02256631|156916212|FG004|Overall Study|Lost to Follow-up|0|||
48745276|NCT02256631|156916213|FG005|Overall Study|Lost to Follow-up|4|||
48745277|NCT02256631|156916214|FG006|Overall Study|Lost to Follow-up|1|||
48745278|NCT02256631|156916208|FG000|Overall Study|Withdrawal by Subject|0|||
48745279|NCT02256631|156916209|FG001|Overall Study|Withdrawal by Subject|0|||
48745280|NCT02256631|156916210|FG002|Overall Study|Withdrawal by Subject|0|||
48745281|NCT02256631|156916211|FG003|Overall Study|Withdrawal by Subject|1|||
48745282|NCT02256631|156916212|FG004|Overall Study|Withdrawal by Subject|1|||
48745283|NCT02256631|156916213|FG005|Overall Study|Withdrawal by Subject|0|||
48745284|NCT02256631|156916214|FG006|Overall Study|Withdrawal by Subject|1|||
48745285|NCT02256631|156916208|FG000|Overall Study|Unable to get to clinic|0|||
48745286|NCT02256631|156916209|FG001|Overall Study|Unable to get to clinic|2|||
48745287|NCT02256631|156916210|FG002|Overall Study|Unable to get to clinic|0|||
48745288|NCT02256631|156916211|FG003|Overall Study|Unable to get to clinic|1|||
48745289|NCT02256631|156916212|FG004|Overall Study|Unable to get to clinic|0|||
48745290|NCT02256631|156916213|FG005|Overall Study|Unable to get to clinic|1|||
48745291|NCT02256631|156916214|FG006|Overall Study|Unable to get to clinic|2|||
48745292|NCT01427972|156916216|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745293|NCT01427972|156916217|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745294|NCT01427972|156916218|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745295|NCT01427972|156916219|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745296|NCT01427972|156916220|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745297|NCT01427972|156916221|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745298|NCT01427972|156916222|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745299|NCT01427972|156916223|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
48745300|NCT01427972|156916224|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745301|NCT01427972|156916225|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745302|NCT01427972|156916226|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48326365|NCT01640951|155392438|FG002|Overall Study|Adverse Event|10|||
48326366|NCT01640951|155392439|FG003|Overall Study|Adverse Event|6|||
48326367|NCT01640951|155392440|FG004|Overall Study|Adverse Event|1|||
48326368|NCT01640951|155392441|FG005|Overall Study|Adverse Event|11|||
48633742|NCT00806585|156517218|FG003|Overall Study|Lost to Follow-up|2|||
48633743|NCT00806585|156517219|FG004|Overall Study|Lost to Follow-up|5|||
48633744|NCT00806585|156517215|FG000|Overall Study|Lack of Efficacy|1|||
48633745|NCT00806585|156517216|FG001|Overall Study|Lack of Efficacy|0|||
48633746|NCT00806585|156517217|FG002|Overall Study|Lack of Efficacy|0|||
48633747|NCT00806585|156517218|FG003|Overall Study|Lack of Efficacy|0|||
48326369|NCT01640951|155392442|FG006|Overall Study|Adverse Event|1|||
48633748|NCT00806585|156517219|FG004|Overall Study|Lack of Efficacy|0|||
48633749|NCT00806585|156517215|FG000|Overall Study|Adverse Event|1|||
48633750|NCT00806585|156517216|FG001|Overall Study|Adverse Event|5|||
48633751|NCT00806585|156517217|FG002|Overall Study|Adverse Event|3|||
48633752|NCT00806585|156517218|FG003|Overall Study|Adverse Event|4|||
48633753|NCT00806585|156517219|FG004|Overall Study|Adverse Event|2|||
48633754|NCT00806585|156517215|FG000|Overall Study|Withdrawal by Subject|10|||
48633755|NCT00806585|156517216|FG001|Overall Study|Withdrawal by Subject|8|||
48633756|NCT00806585|156517217|FG002|Overall Study|Withdrawal by Subject|9|||
48633757|NCT00806585|156517218|FG003|Overall Study|Withdrawal by Subject|3|||
48633758|NCT00806585|156517219|FG004|Overall Study|Withdrawal by Subject|11|||
48633759|NCT00806585|156517215|FG000|Overall Study|Completion status unknown|15|||
48633760|NCT00806585|156517216|FG001|Overall Study|Completion status unknown|14|||
48633761|NCT00806585|156517217|FG002|Overall Study|Completion status unknown|12|||
48633762|NCT00806585|156517218|FG003|Overall Study|Completion status unknown|4|||
48633763|NCT00806585|156517219|FG004|Overall Study|Completion status unknown|12|||
48633764|NCT01936831|156517220|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
48633765|NCT01936831|156517221|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
48633766|NCT01936831|156517222|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
48633767|NCT01936831|156517223|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
48633768|NCT01936831|156517224|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
48633769|NCT01936831|156517225|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
48633770|NCT01936831|156517226|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
48633771|NCT01936831|156517227|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
48633772|NCT01936831|156517228|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
48633773|NCT03435380|156517229|FG000|Overall Study|Death|1|||
48633774|NCT03435380|156517230|FG001|Overall Study|Death|2|||
48633775|NCT03435380|156517231|FG002|Overall Study|Death|1|||
48633776|NCT03435380|156517229|FG000|Overall Study|Lost to Follow-up|12|||
48633777|NCT03435380|156517230|FG001|Overall Study|Lost to Follow-up|8|||
48633778|NCT03435380|156517231|FG002|Overall Study|Lost to Follow-up|6|||
48745303|NCT01427972|156916227|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
48745304|NCT01427972|156916216|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745305|NCT01427972|156916217|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745306|NCT01427972|156916218|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745307|NCT01427972|156916219|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745308|NCT01427972|156916220|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745309|NCT01427972|156916221|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
48745310|NCT01427972|156916222|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745311|NCT01427972|156916223|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745312|NCT01427972|156916224|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745313|NCT01427972|156916225|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745314|NCT01427972|156916226|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745315|NCT01427972|156916227|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
48745316|NCT01427972|156916216|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745317|NCT01427972|156916217|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
48745318|NCT01427972|156916218|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48633779|NCT03435380|156517229|FG000|Overall Study|Physician Decision|1|||
48745319|NCT01427972|156916219|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745320|NCT01427972|156916220|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48633780|NCT03435380|156517230|FG001|Overall Study|Physician Decision|0|||
48633781|NCT03435380|156517231|FG002|Overall Study|Physician Decision|0|||
48326370|NCT01640951|155392443|FG007|Overall Study|Adverse Event|3|||
48633782|NCT03435380|156517229|FG000|Overall Study|Withdrawal by Subject|0|||
48633783|NCT03435380|156517230|FG001|Overall Study|Withdrawal by Subject|1|||
48633784|NCT03435380|156517231|FG002|Overall Study|Withdrawal by Subject|1|||
48633785|NCT03435380|156517229|FG000|Overall Study|Ineligible|0|||
48633786|NCT03435380|156517230|FG001|Overall Study|Ineligible|1|||
48633787|NCT03435380|156517231|FG002|Overall Study|Ineligible|1|||
48633788|NCT01170663|156517232|FG000|Overall Study|Lost to Follow-up|3|||
48633789|NCT01170663|156517233|FG001|Overall Study|Lost to Follow-up|9|||
48633790|NCT01170663|156517232|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
48633791|NCT01170663|156517233|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
48633792|NCT00744861|156517236|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
48633793|NCT00744861|156517237|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
48633794|NCT00744861|156517238|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
48633795|NCT00744861|156517239|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
48633796|NCT00744861|156517236|FG000|Feasibility Stage 1|Pregnancy|0|||
48633797|NCT00744861|156517237|FG001|Feasibility Stage 1|Pregnancy|1|||
48633798|NCT00744861|156517238|FG002|Feasibility Stage 1|Pregnancy|0|||
48633799|NCT00744861|156517239|FG003|Feasibility Stage 1|Pregnancy|0|||
48633800|NCT00744861|156517236|FG000|Pivotal Stage 2|Adverse Event|0|||
48633801|NCT00744861|156517237|FG001|Pivotal Stage 2|Adverse Event|0|||
48633802|NCT00744861|156517238|FG002|Pivotal Stage 2|Adverse Event|6|||
48633803|NCT00744861|156517239|FG003|Pivotal Stage 2|Adverse Event|11|||
48633804|NCT00744861|156517236|FG000|Pivotal Stage 2|Death|0|||
48633805|NCT00744861|156517237|FG001|Pivotal Stage 2|Death|0|||
48633806|NCT00744861|156517238|FG002|Pivotal Stage 2|Death|0|||
48633807|NCT00744861|156517239|FG003|Pivotal Stage 2|Death|1|||
48633808|NCT00744861|156517236|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
48633809|NCT00744861|156517237|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
48633810|NCT00744861|156517238|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
48633811|NCT00744861|156517239|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
48633812|NCT00744861|156517236|FG000|Pivotal Stage 2|Physician Decision|0|||
48633813|NCT00744861|156517237|FG001|Pivotal Stage 2|Physician Decision|0|||
48745321|NCT01427972|156916221|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48633814|NCT00744861|156517238|FG002|Pivotal Stage 2|Physician Decision|3|||
48633815|NCT00744861|156517239|FG003|Pivotal Stage 2|Physician Decision|1|||
48326371|NCT01640951|155392436|FG000|Overall Study|Lack of Efficacy|20|||
48326372|NCT01640951|155392437|FG001|Overall Study|Lack of Efficacy|1|||
48326373|NCT01640951|155392438|FG002|Overall Study|Lack of Efficacy|7|||
48326374|NCT01640951|155392439|FG003|Overall Study|Lack of Efficacy|14|||
48326375|NCT01640951|155392440|FG004|Overall Study|Lack of Efficacy|0|||
48326376|NCT01640951|155392441|FG005|Overall Study|Lack of Efficacy|6|||
48326377|NCT01640951|155392442|FG006|Overall Study|Lack of Efficacy|5|||
48326378|NCT01640951|155392443|FG007|Overall Study|Lack of Efficacy|6|||
48326379|NCT01640951|155392436|FG000|Overall Study|Lost to Follow-up|1|||
48326380|NCT01640951|155392437|FG001|Overall Study|Lost to Follow-up|0|||
48326381|NCT01640951|155392438|FG002|Overall Study|Lost to Follow-up|6|||
48326382|NCT01640951|155392439|FG003|Overall Study|Lost to Follow-up|2|||
48326383|NCT01640951|155392440|FG004|Overall Study|Lost to Follow-up|2|||
48326384|NCT01640951|155392441|FG005|Overall Study|Lost to Follow-up|3|||
48326385|NCT01640951|155392442|FG006|Overall Study|Lost to Follow-up|1|||
48326386|NCT01640951|155392443|FG007|Overall Study|Lost to Follow-up|1|||
48326387|NCT01640951|155392436|FG000|Overall Study|Non-compliance with study treatment|0|||
48326388|NCT01640951|155392437|FG001|Overall Study|Non-compliance with study treatment|0|||
48326389|NCT01640951|155392438|FG002|Overall Study|Non-compliance with study treatment|1|||
48326390|NCT01640951|155392439|FG003|Overall Study|Non-compliance with study treatment|1|||
48326391|NCT01640951|155392440|FG004|Overall Study|Non-compliance with study treatment|1|||
48326392|NCT01640951|155392441|FG005|Overall Study|Non-compliance with study treatment|4|||
48326393|NCT01640951|155392442|FG006|Overall Study|Non-compliance with study treatment|1|||
48326394|NCT01640951|155392443|FG007|Overall Study|Non-compliance with study treatment|0|||
48326395|NCT01640951|155392436|FG000|Overall Study|Physician Decision|2|||
48326396|NCT01640951|155392437|FG001|Overall Study|Physician Decision|5|||
48326397|NCT01640951|155392438|FG002|Overall Study|Physician Decision|2|||
48326398|NCT01640951|155392439|FG003|Overall Study|Physician Decision|2|||
48326399|NCT01640951|155392440|FG004|Overall Study|Physician Decision|2|||
48326400|NCT01640951|155392441|FG005|Overall Study|Physician Decision|3|||
48326401|NCT01640951|155392442|FG006|Overall Study|Physician Decision|3|||
48326402|NCT01640951|155392443|FG007|Overall Study|Physician Decision|0|||
48326403|NCT01640951|155392436|FG000|Overall Study|Pregnancy|3|||
48326404|NCT01640951|155392437|FG001|Overall Study|Pregnancy|0|||
48326405|NCT01640951|155392438|FG002|Overall Study|Pregnancy|0|||
48326406|NCT01640951|155392439|FG003|Overall Study|Pregnancy|4|||
48326407|NCT01640951|155392440|FG004|Overall Study|Pregnancy|0|||
48326408|NCT01640951|155392441|FG005|Overall Study|Pregnancy|0|||
48326409|NCT01640951|155392442|FG006|Overall Study|Pregnancy|2|||
48326410|NCT01640951|155392443|FG007|Overall Study|Pregnancy|0|||
48326411|NCT01640951|155392436|FG000|Overall Study|Protocol Deviation|0|||
48326412|NCT01640951|155392437|FG001|Overall Study|Protocol Deviation|1|||
48633816|NCT00744861|156517236|FG000|Pivotal Stage 2|Protocol Violation|0|||
48633817|NCT00744861|156517237|FG001|Pivotal Stage 2|Protocol Violation|0|||
48326413|NCT01640951|155392438|FG002|Overall Study|Protocol Deviation|2|||
48326414|NCT01640951|155392439|FG003|Overall Study|Protocol Deviation|1|||
48326415|NCT01640951|155392440|FG004|Overall Study|Protocol Deviation|0|||
48326416|NCT01640951|155392441|FG005|Overall Study|Protocol Deviation|1|||
48326417|NCT01640951|155392442|FG006|Overall Study|Protocol Deviation|0|||
48326418|NCT01640951|155392443|FG007|Overall Study|Protocol Deviation|0|||
48326419|NCT01640951|155392436|FG000|Overall Study|Subject/Guardian decision|12|||
48326420|NCT01640951|155392437|FG001|Overall Study|Subject/Guardian decision|4|||
48326421|NCT01640951|155392438|FG002|Overall Study|Subject/Guardian decision|13|||
48326422|NCT01640951|155392439|FG003|Overall Study|Subject/Guardian decision|15|||
48633818|NCT00744861|156517238|FG002|Pivotal Stage 2|Protocol Violation|0|||
48633819|NCT00744861|156517239|FG003|Pivotal Stage 2|Protocol Violation|1|||
48633820|NCT00744861|156517236|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
48633821|NCT00744861|156517237|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
48633822|NCT00744861|156517238|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
48633823|NCT00744861|156517239|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
48633824|NCT00744861|156517236|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
48633825|NCT00744861|156517237|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
48633826|NCT00744861|156517238|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
48633827|NCT00744861|156517239|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
48633828|NCT01561976|156517240|FG000|Period 1|Adverse Event|0|||
48633829|NCT01561976|156517241|FG001|Period 1|Adverse Event|0|||
48633830|NCT01561976|156517242|FG002|Period 1|Adverse Event|1|||
48633831|NCT01561976|156517243|FG003|Period 1|Adverse Event|0|||
48633832|NCT01561976|156517244|FG004|Period 1|Adverse Event|0|||
48745322|NCT01427972|156916222|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745323|NCT01427972|156916223|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745324|NCT01427972|156916224|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48326423|NCT01640951|155392440|FG004|Overall Study|Subject/Guardian decision|7|||
48326424|NCT01640951|155392441|FG005|Overall Study|Subject/Guardian decision|19|||
48326425|NCT01640951|155392442|FG006|Overall Study|Subject/Guardian decision|5|||
48326426|NCT01640951|155392443|FG007|Overall Study|Subject/Guardian decision|4|||
48633833|NCT01561976|156517245|FG005|Period 1|Adverse Event|0|||
48633834|NCT01561976|156517240|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
48633835|NCT01561976|156517241|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
48633836|NCT01561976|156517242|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
48633837|NCT01561976|156517243|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
48633838|NCT01561976|156517244|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
48633839|NCT01561976|156517245|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
48633840|NCT01561976|156517240|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48633841|NCT01561976|156517241|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48633842|NCT01561976|156517242|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48633843|NCT01561976|156517243|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48633844|NCT01561976|156517244|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48633845|NCT01561976|156517245|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
48633846|NCT01561976|156517240|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
48633847|NCT01561976|156517241|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
48326427|NCT01640951|155392436|FG000|Overall Study|Death|0|||
48633848|NCT01561976|156517242|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
48745325|NCT01427972|156916225|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745326|NCT01427972|156916226|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745327|NCT01427972|156916227|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
48745328|NCT00530946|156916231|FG000|Overall Study|Adverse Event|1|||
48745329|NCT00530946|156916232|FG001|Overall Study|Adverse Event|2|||
48326428|NCT01640951|155392437|FG001|Overall Study|Death|1|||
48326429|NCT01640951|155392438|FG002|Overall Study|Death|1|||
48633849|NCT01561976|156517243|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
48326430|NCT01640951|155392439|FG003|Overall Study|Death|0|||
48326431|NCT01640951|155392440|FG004|Overall Study|Death|0|||
48633850|NCT01561976|156517244|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
48633851|NCT01561976|156517245|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
48633852|NCT01307449|156517246|FG000|Overall Study|Adverse Event|1|||
48633853|NCT01307449|156517247|FG001|Overall Study|Adverse Event|0|||
48633854|NCT01307449|156517248|FG002|Overall Study|Adverse Event|0|||
48326432|NCT01640951|155392441|FG005|Overall Study|Death|0|||
48745330|NCT00530946|156916233|FG002|Overall Study|Adverse Event|1|||
48745331|NCT00530946|156916234|FG003|Overall Study|Adverse Event|1|||
48745332|NCT00530946|156916231|FG000|Overall Study|Protocol Violation|0|||
48745333|NCT00530946|156916232|FG001|Overall Study|Protocol Violation|0|||
48745334|NCT00530946|156916233|FG002|Overall Study|Protocol Violation|0|||
48745335|NCT00530946|156916234|FG003|Overall Study|Protocol Violation|1|||
48745336|NCT00530946|156916231|FG000|Overall Study|Noncompliance|1|||
48745337|NCT00530946|156916232|FG001|Overall Study|Noncompliance|0|||
48745338|NCT00530946|156916233|FG002|Overall Study|Noncompliance|0|||
48745339|NCT00530946|156916234|FG003|Overall Study|Noncompliance|0|||
48745340|NCT03322631|156916237|FG000|Overall Study|Withdrawal by Subject|0|||
48745341|NCT03322631|156916238|FG001|Overall Study|Withdrawal by Subject|1|||
48745342|NCT03322631|156916239|FG002|Overall Study|Withdrawal by Subject|0|||
48745343|NCT03322631|156916240|FG003|Overall Study|Withdrawal by Subject|0|||
48745344|NCT03322631|156916237|FG000|Overall Study|Adverse Event|0|||
48633855|NCT01307449|156517249|FG003|Overall Study|Adverse Event|0|||
48633856|NCT03412929|156517252|FG000|Overall Study|Protocol Violation|3|||
48633857|NCT01493414|156517253|FG000|Overall Study|Adverse Event|405|||
48633858|NCT01493414|156517253|FG000|Overall Study|Disease progression|204|||
48633859|NCT01493414|156517253|FG000|Overall Study|Death|101|||
48633860|NCT01493414|156517253|FG000|Overall Study|Physician Decision|93|||
48633861|NCT01493414|156517253|FG000|Overall Study|Withdrawal by Subject|79|||
48633862|NCT01493414|156517253|FG000|Overall Study|Protocol deviation|27|||
48633863|NCT01493414|156517253|FG000|Overall Study|Administrative problems|25|||
48633864|NCT01493414|156517253|FG000|Overall Study|Lost to Follow-up|16|||
48633865|NCT05104476|156517254|FG000|Overall Study|Randomized But Not Treated|1|||
48633866|NCT05104476|156517255|FG001|Overall Study|Randomized But Not Treated|2|||
48633867|NCT05104476|156517254|FG000|Overall Study|Adverse Event|2|||
48633868|NCT05104476|156517255|FG001|Overall Study|Adverse Event|2|||
48633869|NCT05104476|156517254|FG000|Overall Study|Withdrawal by Subject|3|||
48633870|NCT05104476|156517255|FG001|Overall Study|Withdrawal by Subject|3|||
48633871|NCT05104476|156517254|FG000|Overall Study|Other Than Specified|0|||
48633872|NCT05104476|156517255|FG001|Overall Study|Other Than Specified|3|||
48633873|NCT03498716|156517258|FG000|Overall Study|Withdrawal by Subject|88|||
48633874|NCT03498716|156517259|FG001|Overall Study|Withdrawal by Subject|73|||
48633875|NCT03498716|156517258|FG000|Overall Study|Study Terminated By Sponsor|933|||
48745345|NCT03322631|156916238|FG001|Overall Study|Adverse Event|0|||
48745346|NCT03322631|156916239|FG002|Overall Study|Adverse Event|1|||
48633876|NCT03498716|156517259|FG001|Overall Study|Study Terminated By Sponsor|927|||
48633877|NCT03498716|156517258|FG000|Overall Study|Lost to Follow-up|15|||
48745347|NCT03322631|156916240|FG003|Overall Study|Adverse Event|0|||
48745348|NCT02412618|156916241|FG000|Overall Study|Withdrawal by Subject|1|||
48745349|NCT02412618|156916242|FG001|Overall Study|Withdrawal by Subject|1|||
48745350|NCT02412618|156916241|FG000|Overall Study|Expulsion|1|||
48633878|NCT03498716|156517259|FG001|Overall Study|Lost to Follow-up|26|||
48633879|NCT03498716|156517258|FG000|Overall Study|Disease Relapse|0|||
48745351|NCT02412618|156916242|FG001|Overall Study|Expulsion|1|||
48745352|NCT02378961|156916243|FG000|Overall Study|Lack of Efficacy|4|||
48745353|NCT02378961|156916244|FG001|Overall Study|Lack of Efficacy|2|||
48745354|NCT02378961|156916245|FG002|Overall Study|Lack of Efficacy|0|||
48633880|NCT03498716|156517259|FG001|Overall Study|Disease Relapse|1|||
48633881|NCT03498716|156517258|FG000|Overall Study|Death|58|||
48633882|NCT03498716|156517259|FG001|Overall Study|Death|72|||
48633883|NCT03498716|156517258|FG000|Overall Study|Physician Decision|4|||
48633884|NCT03498716|156517259|FG001|Overall Study|Physician Decision|2|||
48633885|NCT02257684|156517263|FG000|Overall Study|Adverse Event|2|||
48633886|NCT02257684|156517263|FG000|Overall Study|Lack of Efficacy|1|||
48745355|NCT02378961|156916246|FG003|Overall Study|Lack of Efficacy|1|||
48745356|NCT02378961|156916243|FG000|Overall Study|Death|0|||
48745357|NCT02378961|156916244|FG001|Overall Study|Death|0|||
48326433|NCT01640951|155392442|FG006|Overall Study|Death|0|||
48326434|NCT01640951|155392443|FG007|Overall Study|Death|2|||
48745358|NCT02378961|156916245|FG002|Overall Study|Death|1|||
48326435|NCT04492475|155392452|FG000|Overall Study|Enrolled but not treated|8|||
48745359|NCT02378961|156916246|FG003|Overall Study|Death|0|||
48633887|NCT02257684|156517263|FG000|Overall Study|Sponsor's Decision|1|||
48633888|NCT02921256|156517264|FG000|Arm 1a v. Arm II|Adverse Event|6|||
48745360|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
48745361|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
48745362|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
48745363|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
48745364|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
48745365|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
48745366|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
48745367|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
48633889|NCT02921256|156517265|FG001|Arm 1a v. Arm II|Adverse Event|15|||
48633890|NCT02921256|156517266|FG002|Arm 1a v. Arm II|Adverse Event|0|||
48633891|NCT02921256|156517264|FG000|Arm 1a v. Arm II|Death|0|||
48633892|NCT02921256|156517265|FG001|Arm 1a v. Arm II|Death|2|||
48633893|NCT02921256|156517266|FG002|Arm 1a v. Arm II|Death|0|||
48633894|NCT02921256|156517264|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
48633895|NCT02921256|156517265|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
48633896|NCT02921256|156517266|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
48745368|NCT03943147|156916251|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
48745369|NCT03943147|156916252|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
48745370|NCT03943147|156916251|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
48745371|NCT03943147|156916252|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
48745372|NCT02784431|156916255|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
48745373|NCT02784431|156916255|FG000|Overall Study|Early Study Termination|19|||
48745374|NCT00345839|156916257|FG000|Overall Study|Withdrawal by Subject|91|||
48745375|NCT00345839|156916258|FG001|Overall Study|Withdrawal by Subject|98|||
48745376|NCT00345839|156916257|FG000|Overall Study|Lost to Follow-up|58|||
48745377|NCT00345839|156916258|FG001|Overall Study|Lost to Follow-up|61|||
48745378|NCT02216591|156916261|FG000|Overall Study|Lost to Follow-up|0|||
48745379|NCT02216591|156916262|FG001|Overall Study|Lost to Follow-up|1|||
48745380|NCT02862171|156916263|FG000|Overall Study|Death|1|||
48633897|NCT02921256|156517264|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
48745381|NCT02862171|156916263|FG000|Overall Study|Lost to Follow-up|13|||
48745382|NCT02862171|156916263|FG000|Overall Study|Withdrawal by Subject|57|||
48745383|NCT02862171|156916263|FG000|Overall Study|Non-compliance|4|||
48326436|NCT04492475|155392453|FG001|Overall Study|Enrolled but not treated|8|||
48326437|NCT04492475|155392452|FG000|Overall Study|Withdrawal by Subject|4|||
48326438|NCT04492475|155392453|FG001|Overall Study|Withdrawal by Subject|0|||
48633898|NCT02921256|156517265|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
48633899|NCT02921256|156517266|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
48633900|NCT02921256|156517264|FG000|Arm 1a v. Arm II|Physician Decision|1|||
48633901|NCT02921256|156517265|FG001|Arm 1a v. Arm II|Physician Decision|1|||
48326439|NCT04492475|155392452|FG000|Overall Study|Became ineligible after enrollment|2|||
48633902|NCT02921256|156517266|FG002|Arm 1a v. Arm II|Physician Decision|0|||
48745384|NCT02862171|156916263|FG000|Overall Study|HIV-1 seroconversion|18|||
48745385|NCT02549937|156916264|FG000|Overall Study|Death|0|||
48745386|NCT02549937|156916265|FG001|Overall Study|Death|1|||
48633903|NCT02921256|156517264|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
48745387|NCT02549937|156916266|FG002|Overall Study|Death|0|||
48326440|NCT04492475|155392453|FG001|Overall Study|Became ineligible after enrollment|0|||
48633904|NCT02921256|156517265|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
48633905|NCT02921256|156517266|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
48633906|NCT02921256|156517264|FG000|Arm Ib v Arm III|Adverse Event|9|||
48633907|NCT02921256|156517265|FG001|Arm Ib v Arm III|Adverse Event|0|||
48633908|NCT02921256|156517266|FG002|Arm Ib v Arm III|Adverse Event|4|||
48633909|NCT02921256|156517264|FG000|Arm Ib v Arm III|Death|1|||
48633910|NCT02921256|156517265|FG001|Arm Ib v Arm III|Death|0|||
48633911|NCT02921256|156517266|FG002|Arm Ib v Arm III|Death|1|||
48633912|NCT02921256|156517264|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
48633913|NCT02921256|156517265|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
48633914|NCT02921256|156517266|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
48745388|NCT02549937|156916267|FG003|Overall Study|Death|1|||
48745389|NCT02549937|156916268|FG004|Overall Study|Death|0|||
48745390|NCT02549937|156916269|FG005|Overall Study|Death|8|||
48745391|NCT02549937|156916270|FG006|Overall Study|Death|0|||
48745392|NCT02549937|156916271|FG007|Overall Study|Death|0|||
48633915|NCT02921256|156517264|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
48633916|NCT02921256|156517265|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
48633917|NCT02921256|156517266|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
48633918|NCT02921256|156517264|FG000|Arm Ib v Arm III|Physician Decision|4|||
48633919|NCT02921256|156517265|FG001|Arm Ib v Arm III|Physician Decision|0|||
48745393|NCT02549937|156916272|FG008|Overall Study|Death|19|||
48745394|NCT02549937|156916264|FG000|Overall Study|No follow up required|3|||
48745395|NCT02549937|156916265|FG001|Overall Study|No follow up required|6|||
48745396|NCT02549937|156916266|FG002|Overall Study|No follow up required|3|||
48745397|NCT02549937|156916267|FG003|Overall Study|No follow up required|8|||
48745398|NCT02549937|156916268|FG004|Overall Study|No follow up required|12|||
48745399|NCT02549937|156916269|FG005|Overall Study|No follow up required|21|||
48745400|NCT02549937|156916270|FG006|Overall Study|No follow up required|9|||
48745401|NCT02549937|156916271|FG007|Overall Study|No follow up required|11|||
48745402|NCT02549937|156916272|FG008|Overall Study|No follow up required|0|||
48745403|NCT02549937|156916264|FG000|Overall Study|Other|0|||
48745404|NCT02549937|156916265|FG001|Overall Study|Other|0|||
48745405|NCT02549937|156916266|FG002|Overall Study|Other|0|||
48745406|NCT02549937|156916267|FG003|Overall Study|Other|0|||
48745407|NCT02549937|156916268|FG004|Overall Study|Other|1|||
48633920|NCT02921256|156517266|FG002|Arm Ib v Arm III|Physician Decision|1|||
48633921|NCT02921256|156517264|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
48633922|NCT02921256|156517265|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
48633923|NCT02921256|156517266|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
48633924|NCT00760552|156517267|FG000|Overall Study|Death|2|||
48633925|NCT00760552|156517268|FG001|Overall Study|Death|0|||
48633926|NCT00760552|156517267|FG000|Overall Study|Lost to Follow-up|11|||
48633927|NCT00760552|156517268|FG001|Overall Study|Lost to Follow-up|10|||
48633928|NCT01605097|156517269|FG000|Overall Study|Protocol Violation|1|||
48633929|NCT01728246|156517270|FG000|Overall Study|Participant needed rescue medication|1|||
48633930|NCT01728246|156517271|FG001|Overall Study|Participant needed rescue medication|5|||
48633931|NCT01728246|156517270|FG000|Overall Study|Protocol Violation|1|||
48633932|NCT01728246|156517271|FG001|Overall Study|Protocol Violation|0|||
48633933|NCT01728246|156517270|FG000|Overall Study|Withdrawal by Subject|2|||
48633934|NCT01728246|156517271|FG001|Overall Study|Withdrawal by Subject|3|||
48633935|NCT01728246|156517270|FG000|Overall Study|Lost to Follow-up|23|||
48633936|NCT01728246|156517271|FG001|Overall Study|Lost to Follow-up|22|||
48633937|NCT01728246|156517270|FG000|Overall Study|Lack of Efficacy|1|||
48633938|NCT01728246|156517271|FG001|Overall Study|Lack of Efficacy|1|||
48633939|NCT01728246|156517270|FG000|Overall Study|Adverse Event|8|||
48633940|NCT01728246|156517271|FG001|Overall Study|Adverse Event|5|||
48633941|NCT04194450|156517274|FG000|Overall Study|not eligible|1|||
48633942|NCT04194450|156517275|FG001|Overall Study|not eligible|0|||
48633943|NCT00575666|156517276|FG000|Overall Study|Withdrawal by Subject|3|||
48633944|NCT00575666|156517277|FG001|Overall Study|Withdrawal by Subject|2|||
48745408|NCT02549937|156916269|FG005|Overall Study|Other|0|||
48745409|NCT02549937|156916270|FG006|Overall Study|Other|3|||
48745410|NCT02549937|156916271|FG007|Overall Study|Other|2|||
48745411|NCT02549937|156916272|FG008|Overall Study|Other|3|||
48745412|NCT02549937|156916264|FG000|Overall Study|Lost to Follow-up|0|||
48633945|NCT00575666|156517276|FG000|Overall Study|Physician Decision|1|||
48745413|NCT02549937|156916265|FG001|Overall Study|Lost to Follow-up|0|||
48745414|NCT02549937|156916266|FG002|Overall Study|Lost to Follow-up|0|||
48745415|NCT02549937|156916267|FG003|Overall Study|Lost to Follow-up|0|||
48633946|NCT00575666|156517277|FG001|Overall Study|Physician Decision|1|||
48745416|NCT02549937|156916268|FG004|Overall Study|Lost to Follow-up|0|||
48633947|NCT01368614|156517278|FG000|Screening Period|Screen Failure|58|||
48633948|NCT01368614|156517279|FG001|Screening Period|Screen Failure|0|||
48633949|NCT01368614|156517280|FG002|Screening Period|Screen Failure|0|||
48633950|NCT01368614|156517281|FG003|Screening Period|Screen Failure|0|||
48745417|NCT02549937|156916269|FG005|Overall Study|Lost to Follow-up|0|||
48745418|NCT02549937|156916270|FG006|Overall Study|Lost to Follow-up|0|||
48745419|NCT02549937|156916271|FG007|Overall Study|Lost to Follow-up|0|||
48745420|NCT02549937|156916272|FG008|Overall Study|Lost to Follow-up|3|||
48745421|NCT02549937|156916264|FG000|Overall Study|Withdrawal by Subject|0|||
48745422|NCT02549937|156916265|FG001|Overall Study|Withdrawal by Subject|0|||
48745423|NCT02549937|156916266|FG002|Overall Study|Withdrawal by Subject|0|||
48745424|NCT02549937|156916267|FG003|Overall Study|Withdrawal by Subject|0|||
48745425|NCT02549937|156916268|FG004|Overall Study|Withdrawal by Subject|0|||
48745426|NCT02549937|156916269|FG005|Overall Study|Withdrawal by Subject|1|||
48745427|NCT02549937|156916270|FG006|Overall Study|Withdrawal by Subject|4|||
48745428|NCT02549937|156916271|FG007|Overall Study|Withdrawal by Subject|3|||
48745429|NCT02549937|156916272|FG008|Overall Study|Withdrawal by Subject|2|||
48745430|NCT02549937|156916264|FG000|Overall Study|Sponsor Decision|0|||
48745431|NCT02549937|156916265|FG001|Overall Study|Sponsor Decision|0|||
48745432|NCT02549937|156916266|FG002|Overall Study|Sponsor Decision|0|||
48745433|NCT02549937|156916267|FG003|Overall Study|Sponsor Decision|0|||
48745434|NCT02549937|156916268|FG004|Overall Study|Sponsor Decision|0|||
48745435|NCT02549937|156916269|FG005|Overall Study|Sponsor Decision|0|||
48745436|NCT02549937|156916270|FG006|Overall Study|Sponsor Decision|0|||
48745437|NCT02549937|156916271|FG007|Overall Study|Sponsor Decision|0|||
48745438|NCT02549937|156916272|FG008|Overall Study|Sponsor Decision|6|||
48745439|NCT05059600|156916275|FG000|Overall Study|Enrolled but not Treated|10|||
48745440|NCT01385566|156917930|FG000|Overall Study|Lost to Follow-up|1|||
48745441|NCT01385566|156917931|FG001|Overall Study|Lost to Follow-up|0|||
48745442|NCT01385566|156917932|FG002|Overall Study|Lost to Follow-up|0|||
48745443|NCT01385566|156917933|FG003|Overall Study|Lost to Follow-up|0|||
48745444|NCT01385566|156917934|FG004|Overall Study|Lost to Follow-up|0|||
48745445|NCT01385566|156917935|FG005|Overall Study|Lost to Follow-up|0|||
48745446|NCT01385566|156917930|FG000|Overall Study|Withdrawal by Subject|0|||
48745447|NCT01385566|156917931|FG001|Overall Study|Withdrawal by Subject|0|||
48745448|NCT01385566|156917932|FG002|Overall Study|Withdrawal by Subject|0|||
48745449|NCT01385566|156917933|FG003|Overall Study|Withdrawal by Subject|1|||
48745450|NCT01385566|156917934|FG004|Overall Study|Withdrawal by Subject|0|||
48745451|NCT01385566|156917935|FG005|Overall Study|Withdrawal by Subject|0|||
48745452|NCT02025621|156917936|FG000|Overall Study|Withdrawal by Subject|1|||
48745453|NCT02025621|156917937|FG001|Overall Study|Withdrawal by Subject|0|||
48745454|NCT02025621|156917936|FG000|Overall Study|Death|0|||
48745455|NCT02025621|156917937|FG001|Overall Study|Death|1|||
48745456|NCT02025621|156917936|FG000|Overall Study|No longer eligible|10|||
48745457|NCT02025621|156917937|FG001|Overall Study|No longer eligible|15|||
48745458|NCT02025621|156917936|FG000|Overall Study|Surgery initiated before infusion|3|||
48745459|NCT02025621|156917937|FG001|Overall Study|Surgery initiated before infusion|3|||
48745460|NCT01594281|156917938|FG000|Interventional Core Phase|Protocol Deviation|1|||
48745461|NCT01594281|156917939|FG001|Interventional Core Phase|Protocol Deviation|0|||
48745462|NCT01594281|156917940|FG002|Interventional Core Phase|Protocol Deviation|0|||
48745463|NCT01594281|156917938|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
48745464|NCT01594281|156917939|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
48745465|NCT01594281|156917940|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
48745466|NCT01594281|156917938|FG000|Interventional Core Phase|Death|1|||
48745467|NCT01594281|156917939|FG001|Interventional Core Phase|Death|1|||
48745468|NCT01594281|156917940|FG002|Interventional Core Phase|Death|2|||
48745469|NCT01594281|156917938|FG000|Interventional Core Phase|Lost to Follow-up|1|||
48745470|NCT01594281|156917939|FG001|Interventional Core Phase|Lost to Follow-up|4|||
48745471|NCT01594281|156917940|FG002|Interventional Core Phase|Lost to Follow-up|1|||
48745472|NCT01594281|156917938|FG000|Interventional Core Phase|Adverse Event|4|||
48745473|NCT01594281|156917939|FG001|Interventional Core Phase|Adverse Event|4|||
48745474|NCT01594281|156917940|FG002|Interventional Core Phase|Adverse Event|4|||
48745475|NCT01594281|156917938|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
48745476|NCT01594281|156917939|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
48745477|NCT01594281|156917940|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
48745478|NCT01594281|156917938|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
48745479|NCT01594281|156917939|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
48745480|NCT01594281|156917940|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
48745481|NCT01594281|156917938|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
48745482|NCT01594281|156917939|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
48745483|NCT01594281|156917940|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
48745484|NCT01673867|156917941|FG000|Randomization|Adverse event unrelated to study drug|1|||
48745485|NCT01673867|156917942|FG001|Randomization|Adverse event unrelated to study drug|0|||
48745486|NCT01673867|156917941|FG000|Randomization|Participant request to discontinue study treatment|0|||
48745487|NCT01673867|156917942|FG001|Randomization|Participant request to discontinue study treatment|4|||
48745488|NCT01673867|156917941|FG000|Randomization|Withdrawal by participant|0|||
48745489|NCT01673867|156917942|FG001|Randomization|Withdrawal by participant|12|||
48745490|NCT01673867|156917941|FG000|Randomization|Lost to Follow-up|0|||
48633951|NCT01368614|156517278|FG000|Study Period|Withdrawal by Subject|0|||
48633952|NCT01368614|156517279|FG001|Study Period|Withdrawal by Subject|1|||
48633953|NCT01368614|156517280|FG002|Study Period|Withdrawal by Subject|1|||
48633954|NCT01368614|156517281|FG003|Study Period|Withdrawal by Subject|3|||
48633955|NCT01368614|156517278|FG000|Study Period|Lost to Follow-up|0|||
48633956|NCT01368614|156517279|FG001|Study Period|Lost to Follow-up|0|||
48745491|NCT01673867|156917942|FG001|Randomization|Lost to Follow-up|1|||
48745492|NCT01673867|156917941|FG000|Randomization|Participant no longer meets study criteria|4|||
48745493|NCT01673867|156917942|FG001|Randomization|Participant no longer meets study criteria|5|||
48745494|NCT01673867|156917941|FG000|Treatment|Disease Progression|208|||
48745495|NCT01673867|156917942|FG001|Treatment|Disease Progression|178|||
48745496|NCT01673867|156917941|FG000|Treatment|Study Drug Toxicity|23|||
48745497|NCT01673867|156917942|FG001|Treatment|Study Drug Toxicity|43|||
48745498|NCT01673867|156917941|FG000|Treatment|Death|2|||
48326441|NCT00705159|155392454|FG000|Overall Study|Withdrawal by Subject|0|||
48326442|NCT00705159|155392455|FG001|Overall Study|Withdrawal by Subject|1|||
48326443|NCT00705159|155392456|FG002|Overall Study|Withdrawal by Subject|1|||
48326444|NCT00705159|155392457|FG003|Overall Study|Withdrawal by Subject|1|||
48326445|NCT00705159|155392454|FG000|Overall Study|Protocol Violation|0|||
48326446|NCT00705159|155392455|FG001|Overall Study|Protocol Violation|1|||
48326447|NCT00705159|155392456|FG002|Overall Study|Protocol Violation|0|||
48745499|NCT01673867|156917942|FG001|Treatment|Death|3|||
48745500|NCT01673867|156917941|FG000|Treatment|Adverse event unrelated to study drug|23|||
48326448|NCT00705159|155392457|FG003|Overall Study|Protocol Violation|0|||
48326449|NCT00705159|155392454|FG000|Overall Study|Adverse Event|0|||
48633957|NCT01368614|156517280|FG002|Study Period|Lost to Follow-up|1|||
48745501|NCT01673867|156917942|FG001|Treatment|Adverse event unrelated to study drug|10|||
48633958|NCT01368614|156517281|FG003|Study Period|Lost to Follow-up|0|||
48633959|NCT00518180|156517282|FG000|Overall Study|Withdrawal by Subject|29|||
48633960|NCT00518180|156517283|FG001|Overall Study|Withdrawal by Subject|30|||
48633961|NCT00518180|156517284|FG002|Overall Study|Withdrawal by Subject|42|||
48745502|NCT01673867|156917941|FG000|Treatment|Participant request to discontinue study treatment|7|||
48633962|NCT00518180|156517282|FG000|Overall Study|Lost to Follow-up|30|||
48633963|NCT00518180|156517283|FG001|Overall Study|Lost to Follow-up|28|||
48633964|NCT00518180|156517284|FG002|Overall Study|Lost to Follow-up|34|||
48633965|NCT00518180|156517282|FG000|Overall Study|Administrative reason|0|||
48633966|NCT00518180|156517283|FG001|Overall Study|Administrative reason|2|||
48633967|NCT00518180|156517284|FG002|Overall Study|Administrative reason|2|||
48633968|NCT00518180|156517282|FG000|Overall Study|Protocol Violation|5|||
48633969|NCT00518180|156517283|FG001|Overall Study|Protocol Violation|7|||
48633970|NCT00518180|156517284|FG002|Overall Study|Protocol Violation|4|||
48633971|NCT00518180|156517282|FG000|Overall Study|Unable to classify|0|||
48633972|NCT00518180|156517283|FG001|Overall Study|Unable to classify|2|||
48633973|NCT00518180|156517284|FG002|Overall Study|Unable to classify|0|||
48745503|NCT01673867|156917942|FG001|Treatment|Participant request to discontinue study treatment|17|||
48745504|NCT01673867|156917941|FG000|Treatment|Withdrawal by participant|5|||
48633974|NCT00518180|156517282|FG000|Overall Study|Adverse Event|1|||
48633975|NCT00518180|156517283|FG001|Overall Study|Adverse Event|0|||
48633976|NCT00518180|156517284|FG002|Overall Study|Adverse Event|0|||
48633977|NCT03314454|156517289|FG000|Overall Study|Protocol Violation|1|||
48633978|NCT00485173|156517290|FG000|Overall Study|Death|4|||
48633979|NCT00485173|156517291|FG001|Overall Study|Death|3|||
48633980|NCT00485173|156517290|FG000|Overall Study|Lost to Follow-up|32|||
48633981|NCT00485173|156517291|FG001|Overall Study|Lost to Follow-up|61|||
48633982|NCT00746811|156517292|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
48633983|NCT00746811|156517293|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
48633984|NCT04016714|156517294|FG000|Overall Study|Death|1|||
48633985|NCT04016714|156517295|FG001|Overall Study|Death|0|||
48633986|NCT04016714|156517294|FG000|Overall Study|Lost to Follow-up|3|||
48633987|NCT04016714|156517295|FG001|Overall Study|Lost to Follow-up|1|||
48633988|NCT04016714|156517294|FG000|Overall Study|Physician Decision|3|||
48633989|NCT04016714|156517295|FG001|Overall Study|Physician Decision|3|||
48633990|NCT04016714|156517294|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
48633991|NCT04016714|156517295|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
48633992|NCT05281562|156517299|FG000|Overall Study|Ineligible patient|1|||
48633993|NCT05281562|156517300|FG001|Overall Study|Ineligible patient|0|||
48633994|NCT00791648|156518848|FG000|Overall Study|Physician Decision|0|||
48633995|NCT00791648|156518849|FG001|Overall Study|Physician Decision|1|||
48633996|NCT00791648|156518848|FG000|Overall Study|Withdrawal by Subject|0|||
48633997|NCT00791648|156518849|FG001|Overall Study|Withdrawal by Subject|1|||
48633998|NCT03299049|156518850|FG000|Overall Study|On-going|486|||
48633999|NCT03299049|156518851|FG001|Overall Study|On-going|481|||
48634000|NCT03299049|156518850|FG000|Overall Study|Withdrawal by Subject|6|||
48634001|NCT03299049|156518851|FG001|Overall Study|Withdrawal by Subject|21|||
48634002|NCT03299049|156518850|FG000|Overall Study|Physician Decision|5|||
48634003|NCT03299049|156518851|FG001|Overall Study|Physician Decision|1|||
48634004|NCT03299049|156518850|FG000|Overall Study|Lost to Follow-up|2|||
48634005|NCT03299049|156518851|FG001|Overall Study|Lost to Follow-up|0|||
48634006|NCT03299049|156518850|FG000|Overall Study|Pregnancy|1|||
48634007|NCT03299049|156518851|FG001|Overall Study|Pregnancy|3|||
48634008|NCT03299049|156518850|FG000|Overall Study|Protocol Violation|1|||
48634009|NCT03299049|156518851|FG001|Overall Study|Protocol Violation|1|||
48634010|NCT03299049|156518850|FG000|Overall Study|Lack of Efficacy|9|||
48634011|NCT03299049|156518851|FG001|Overall Study|Lack of Efficacy|3|||
48634012|NCT03299049|156518850|FG000|Overall Study|Adverse Event|12|||
48634013|NCT03299049|156518851|FG001|Overall Study|Adverse Event|13|||
48634014|NCT03038672|156518852|FG000|Initial Treatment|Unacceptable chemistry|0|||
48634015|NCT03038672|156518853|FG001|Initial Treatment|Unacceptable chemistry|1|||
48634016|NCT03038672|156518852|FG000|Initial Treatment|Progression prior to treatment|1|||
48634017|NCT03038672|156518853|FG001|Initial Treatment|Progression prior to treatment|0|||
48634018|NCT03038672|156518852|FG000|Initial Treatment|No treatment per protocol|1|||
48634019|NCT03038672|156518853|FG001|Initial Treatment|No treatment per protocol|0|||
48634020|NCT01246960|156518854|FG000|Overall Study|Lost to Follow-up|3|||
48634021|NCT01246960|156518855|FG001|Overall Study|Lost to Follow-up|1|||
48634022|NCT01246960|156518854|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
48634023|NCT01246960|156518855|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
48634024|NCT01225952|156518857|FG000|Overall Study|Lost to Follow-up|1|||
48634025|NCT01225952|156518858|FG001|Overall Study|Lost to Follow-up|0|||
48634026|NCT01225952|156518859|FG002|Overall Study|Lost to Follow-up|0|||
48745505|NCT01673867|156917942|FG001|Treatment|Withdrawal by participant|5|||
48745506|NCT01673867|156917941|FG000|Treatment|Maximum clinical benefit|1|||
48745507|NCT01673867|156917942|FG001|Treatment|Maximum clinical benefit|10|||
48745508|NCT01673867|156917941|FG000|Treatment|Participant no longer meets study criteria|2|||
48745509|NCT01673867|156917942|FG001|Treatment|Participant no longer meets study criteria|0|||
48634027|NCT01225952|156518857|FG000|Overall Study|Study Eye Explanted|0|||
48634028|NCT01225952|156518858|FG001|Overall Study|Study Eye Explanted|0|||
48634029|NCT01225952|156518859|FG002|Overall Study|Study Eye Explanted|1|||
48634030|NCT01225952|156518857|FG000|Overall Study|Withdrawal by Subject|4|||
48634031|NCT01225952|156518858|FG001|Overall Study|Withdrawal by Subject|4|||
48634032|NCT01225952|156518859|FG002|Overall Study|Withdrawal by Subject|5|||
48634033|NCT01225952|156518857|FG000|Overall Study|Surgical complications|1|||
48634034|NCT01225952|156518858|FG001|Overall Study|Surgical complications|0|||
48634035|NCT01225952|156518859|FG002|Overall Study|Surgical complications|0|||
48634036|NCT02378480|156518860|FG000|Overall Study|Physician Decision|1|||
48634037|NCT02378480|156518861|FG001|Overall Study|Physician Decision|1|||
48634038|NCT02378480|156518860|FG000|Overall Study|Death|1|||
48634039|NCT02378480|156518861|FG001|Overall Study|Death|2|||
48634040|NCT02378480|156518860|FG000|Overall Study|Randomized, but Not Treated|6|||
48634041|NCT02378480|156518861|FG001|Overall Study|Randomized, but Not Treated|4|||
48634042|NCT02378480|156518860|FG000|Overall Study|Adverse Event|0|||
48634043|NCT02378480|156518861|FG001|Overall Study|Adverse Event|1|||
48634044|NCT02378480|156518860|FG000|Overall Study|Missed EOT/PTE Visit|1|||
48745510|NCT01673867|156917941|FG000|Treatment|Administrative reason by sponsor|3|||
48745511|NCT01673867|156917942|FG001|Treatment|Administrative reason by sponsor|0|||
48745512|NCT01673867|156917941|FG000|Treatment|Other reason|11|||
48634045|NCT02378480|156518861|FG001|Overall Study|Missed EOT/PTE Visit|2|||
48634046|NCT02378480|156518860|FG000|Overall Study|Withdrawal by Subject|9|||
48634047|NCT02378480|156518861|FG001|Overall Study|Withdrawal by Subject|4|||
48745513|NCT01673867|156917942|FG001|Treatment|Other reason|2|||
48745514|NCT01977794|156917943|FG000|Overall Study|Adverse Event|2|||
48634048|NCT02378480|156518860|FG000|Overall Study|Lost to Follow-up|10|||
48634049|NCT02378480|156518861|FG001|Overall Study|Lost to Follow-up|18|||
48634050|NCT00954447|156518863|FG000|Overall Study|Adverse Event|33|||
48634051|NCT00954447|156518864|FG001|Overall Study|Adverse Event|25|||
48634052|NCT00954447|156518863|FG000|Overall Study|Lack of Efficacy|17|||
48634053|NCT00954447|156518864|FG001|Overall Study|Lack of Efficacy|3|||
48634054|NCT00954447|156518863|FG000|Overall Study|Protocol Violation|5|||
48634055|NCT00954447|156518864|FG001|Overall Study|Protocol Violation|7|||
48634056|NCT00954447|156518863|FG000|Overall Study|Lost to Follow-up|8|||
48634057|NCT00954447|156518864|FG001|Overall Study|Lost to Follow-up|14|||
48634058|NCT00954447|156518863|FG000|Overall Study|Withdrawal by Subject|26|||
48634059|NCT00954447|156518864|FG001|Overall Study|Withdrawal by Subject|21|||
48634060|NCT00954447|156518863|FG000|Overall Study|Other|21|||
48634061|NCT00954447|156518864|FG001|Overall Study|Other|18|||
48634062|NCT05201807|156518867|FG000|Overall Study|Adverse Event|1|||
48326450|NCT00705159|155392455|FG001|Overall Study|Adverse Event|0|||
48326451|NCT00705159|155392456|FG002|Overall Study|Adverse Event|1|||
48326452|NCT00705159|155392457|FG003|Overall Study|Adverse Event|0|||
48326453|NCT00705159|155392454|FG000|Overall Study|Lost to Follow-up|0|||
48326454|NCT00705159|155392455|FG001|Overall Study|Lost to Follow-up|0|||
48326455|NCT00705159|155392456|FG002|Overall Study|Lost to Follow-up|3|||
48326456|NCT00705159|155392457|FG003|Overall Study|Lost to Follow-up|2|||
48326457|NCT00705159|155392454|FG000|Overall Study|Screen Failure|0|||
48326458|NCT00705159|155392455|FG001|Overall Study|Screen Failure|0|||
48326459|NCT00705159|155392456|FG002|Overall Study|Screen Failure|0|||
48326460|NCT00705159|155392457|FG003|Overall Study|Screen Failure|1|||
48326461|NCT01499849|155392458|FG000|Overall Study|Adverse Event|28|||
48326462|NCT01499849|155392459|FG001|Overall Study|Adverse Event|32|||
48326463|NCT01499849|155392458|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
48326464|NCT01499849|155392459|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
48326465|NCT01499849|155392458|FG000|Overall Study|Withdrawal by Subject|43|||
48326466|NCT01499849|155392459|FG001|Overall Study|Withdrawal by Subject|43|||
48326467|NCT01499849|155392458|FG000|Overall Study|Death|5|||
48326468|NCT01499849|155392459|FG001|Overall Study|Death|7|||
48326469|NCT01499849|155392458|FG000|Overall Study|Disease Progression|11|||
48326470|NCT01499849|155392459|FG001|Overall Study|Disease Progression|10|||
48326471|NCT01499849|155392458|FG000|Overall Study|Protocol Violation|11|||
48326472|NCT01499849|155392459|FG001|Overall Study|Protocol Violation|11|||
48326473|NCT01499849|155392458|FG000|Overall Study|Physician Decision|20|||
48326474|NCT01499849|155392459|FG001|Overall Study|Physician Decision|19|||
48326475|NCT01499849|155392458|FG000|Overall Study|Lack of Efficacy|3|||
48326476|NCT01499849|155392459|FG001|Overall Study|Lack of Efficacy|4|||
48326477|NCT01499849|155392458|FG000|Overall Study|Lost to Follow-up|6|||
48326478|NCT01499849|155392459|FG001|Overall Study|Lost to Follow-up|3|||
48326479|NCT01499849|155392458|FG000|Overall Study|Other Reasons|27|||
48326480|NCT01499849|155392459|FG001|Overall Study|Other Reasons|30|||
48326481|NCT02644122|155392468|FG000|Overall Study|Withdrawal by Subject|1|||
48326482|NCT02816398|155392479|FG000|Overall Study|Death|5|||
48326483|NCT02816398|155392479|FG000|Overall Study|Lack of Efficacy|8|||
48326484|NCT02816398|155392479|FG000|Overall Study|Lost to Follow-up|1|||
48326485|NCT03803475|155392480|FG000|Overall Study|Physician Decision|1|||
48326486|NCT02235298|155392481|FG000|Overall Study|Lost to Follow-up|6|||
48326487|NCT02235298|155392482|FG001|Overall Study|Lost to Follow-up|5|||
48326488|NCT02235298|155392481|FG000|Overall Study|Adverse Event|2|||
48326489|NCT02235298|155392482|FG001|Overall Study|Adverse Event|2|||
48326490|NCT02235298|155392481|FG000|Overall Study|Withdrawal by Subject|0|||
48326491|NCT02235298|155392482|FG001|Overall Study|Withdrawal by Subject|1|||
48326492|NCT00655499|155394015|FG000|Overall Study|not eligible|4|||
48326493|NCT03140670|155394016|FG000|Overall Study|Withdrawal by Subject|2|||
48326494|NCT03140670|155394016|FG000|Overall Study|Lost to Follow-up|1|||
48326495|NCT03140670|155394016|FG000|Overall Study|Physician Decision|1|||
48326496|NCT02325466|155394017|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
48326497|NCT02325466|155394018|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
48326498|NCT02325466|155394019|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
48326499|NCT02325466|155394017|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
48326500|NCT02325466|155394018|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
48326501|NCT02325466|155394019|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
48326502|NCT02325466|155394017|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
48326503|NCT02325466|155394018|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
48326504|NCT02325466|155394019|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
48326505|NCT02325466|155394017|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
48634063|NCT05201807|156518867|FG000|Overall Study|COVID-19 Related|1|||
48634064|NCT01209767|156518868|FG000|Overall Study|Withdrawal by Subject|1|||
48634065|NCT01209767|156518868|FG000|Overall Study|Lost to Follow-up|3|||
48745515|NCT01977794|156917944|FG001|Overall Study|Adverse Event|2|||
48326506|NCT02325466|155394018|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
48634066|NCT03580044|156518873|FG000|Overall Study|Death|2|||
48634067|NCT03580044|156518874|FG001|Overall Study|Death|1|||
48634068|NCT03580044|156518873|FG000|Overall Study|Withdrawal by Subject|1|||
48326507|NCT02325466|155394019|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
48326508|NCT02325466|155394017|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
48326509|NCT02325466|155394018|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
48634069|NCT03580044|156518874|FG001|Overall Study|Withdrawal by Subject|1|||
48634070|NCT00129974|156518875|FG000|Overall Study|Other|1|||
48634071|NCT03983421|156518876|FG000|Overall Study|Lost to Follow-up|1|||
48634072|NCT04573972|156518877|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
48634073|NCT04573972|156518878|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
48634074|NCT00399529|156518880|FG000|Overall Study|Off Study Prior to Treatment|2|||
48634075|NCT02006927|156518886|FG000|Overall Study|Adverse Event|2|||
48634076|NCT02006927|156518886|FG000|Overall Study|Withdrawal by Subject|1|||
48634077|NCT02735200|156518887|FG000|Overall Study|Lost to Follow-up|0|||
48634078|NCT02735200|156518888|FG001|Overall Study|Lost to Follow-up|5|||
48634079|NCT02735200|156518887|FG000|Overall Study|Withdrawal by Subject|8|||
48634080|NCT02735200|156518888|FG001|Overall Study|Withdrawal by Subject|0|||
48634081|NCT02746809|156518889|FG000|Enrollment|Inclusion Exclusion not met|9|||
48634082|NCT02746809|156518889|FG000|Enrollment|Withdrawal by Subject|1|||
48634083|NCT02746809|156518889|FG000|Enrollment|Expected Enrollment Met|2|||
48634084|NCT02746809|156518889|FG000|Procedure|Death|1|||
48634085|NCT02746809|156518889|FG000|1-Month|Death|5|||
48634086|NCT02746809|156518889|FG000|6-Month|Death|2|||
48634087|NCT02746809|156518889|FG000|6-Month|Withdrawal by Subject|1|||
48634088|NCT02746809|156518889|FG000|12-Month|Death|3|||
48634089|NCT02746809|156518889|FG000|12-Month|Withdrawal by Subject|2|||
48634090|NCT02746809|156518889|FG000|24-Month|Death|1|||
48634091|NCT02746809|156518889|FG000|24-Month|Withdrawal by Subject|1|||
48634092|NCT02746809|156518889|FG000|36-Month|Death|8|||
48634093|NCT02746809|156518889|FG000|36-Month|Withdrawal by Subject|1|||
48634094|NCT02746809|156518889|FG000|48-Month|Death|7|||
48745516|NCT01977794|156917943|FG000|Overall Study|Lost to Follow-up|2|||
48326510|NCT02325466|155394019|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
48326511|NCT02325466|155394017|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
48426558|NCT00486226|155751213|FG000|Overall Study|Adverse Event|1|||
48745517|NCT01977794|156917944|FG001|Overall Study|Lost to Follow-up|1|||
48745518|NCT01977794|156917943|FG000|Overall Study|Protocol Violation|1|||
48745519|NCT01977794|156917944|FG001|Overall Study|Protocol Violation|0|||
48745520|NCT01977794|156917943|FG000|Overall Study|Death|1|||
48745521|NCT01977794|156917944|FG001|Overall Study|Death|1|||
48745522|NCT01977794|156917943|FG000|Overall Study|Withdrew consent|2|||
48745523|NCT01977794|156917944|FG001|Overall Study|Withdrew consent|1|||
48745524|NCT01977794|156917943|FG000|Overall Study|Other|0|||
48745525|NCT01977794|156917944|FG001|Overall Study|Other|1|||
48745526|NCT04115839|156917947|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
48585194|NCT00634049|156333795|FG000|Overall Study|Never received study drug|1|||
48585195|NCT00634049|156333795|FG000|Overall Study|Died prior to receiving study drug|1|||
48585196|NCT00634049|156333795|FG000|Overall Study|Screening failure|1|||
48585197|NCT01068626|156333798|FG000|Overall Study|Adverse Event|3|||
48585198|NCT01068626|156333799|FG001|Overall Study|Adverse Event|0|||
48585199|NCT01068626|156333798|FG000|Overall Study|Withdrawal by Subject|0|||
48585200|NCT01068626|156333799|FG001|Overall Study|Withdrawal by Subject|2|||
48585201|NCT02670382|156333800|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
48585202|NCT02670382|156333801|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
48585203|NCT04529850|156333802|FG000|Overall Study|Death|2|||
48585204|NCT04529850|156333802|FG000|Overall Study|Physician Decision|1|||
48585205|NCT04529850|156333802|FG000|Overall Study|Withdrawal by Subject|2|||
48585206|NCT00334295|156333803|FG000|Overall Study|Patients received fewer than 3 injection|5|||
48585207|NCT00335959|156333804|FG000|Overall Study|Adverse Event|2|||
48585208|NCT00335959|156333804|FG000|Overall Study|Ineligible|1|||
48585209|NCT03759366|156333807|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
48745527|NCT04115839|156917948|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
48745528|NCT04115839|156917949|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
48745529|NCT04115839|156917950|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
48745530|NCT04115839|156917951|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
48745531|NCT04115839|156917952|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
48745532|NCT04115839|156917953|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
48745533|NCT04115839|156917947|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
48745534|NCT04115839|156917948|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
48745535|NCT04115839|156917949|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
48745536|NCT04115839|156917950|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
48745537|NCT04115839|156917951|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
48745538|NCT04115839|156917952|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
48745539|NCT04115839|156917953|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
48745540|NCT04115839|156917947|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
48634095|NCT02746809|156518889|FG000|48-Month|Withdrawal by Subject|1|||
48634096|NCT02746809|156518889|FG000|60-Month|Death|1|||
48634097|NCT02746809|156518889|FG000|60-Month|Lost to Follow-up|2|||
48634098|NCT00673920|156518890|FG000|Baseline up to Week 48|Withdrew consent|1|||
48634099|NCT00673920|156518891|FG001|Baseline up to Week 48|Withdrew consent|0|||
48634100|NCT00673920|156518892|FG002|Baseline up to Week 48|Withdrew consent|2|||
48634101|NCT00673920|156518893|FG003|Baseline up to Week 48|Withdrew consent|0|||
48634102|NCT00673920|156518894|FG004|Baseline up to Week 48|Withdrew consent|0|||
48634103|NCT00673920|156518895|FG005|Baseline up to Week 48|Withdrew consent|0|||
48634104|NCT00673920|156518896|FG006|Baseline up to Week 48|Withdrew consent|0|||
48634105|NCT00673920|156518897|FG007|Baseline up to Week 48|Withdrew consent|0|||
48634106|NCT00673920|156518890|FG000|Baseline up to Week 48|Refused treatment|1|||
48634107|NCT00673920|156518891|FG001|Baseline up to Week 48|Refused treatment|0|||
48634108|NCT00673920|156518892|FG002|Baseline up to Week 48|Refused treatment|0|||
48745541|NCT04115839|156917948|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745542|NCT04115839|156917949|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745543|NCT04115839|156917950|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745544|NCT04115839|156917951|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745545|NCT04115839|156917952|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745546|NCT04115839|156917953|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
48745547|NCT04115839|156917947|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745548|NCT04115839|156917948|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745549|NCT04115839|156917949|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
48745550|NCT04115839|156917950|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745551|NCT04115839|156917951|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745552|NCT04115839|156917952|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745553|NCT04115839|156917953|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
48745554|NCT04115839|156917947|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
48745555|NCT04115839|156917948|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
48745556|NCT04115839|156917949|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
48634109|NCT00673920|156518893|FG003|Baseline up to Week 48|Refused treatment|0|||
48634110|NCT00673920|156518894|FG004|Baseline up to Week 48|Refused treatment|0|||
48745557|NCT04115839|156917950|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
48745558|NCT04115839|156917951|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
48745559|NCT04115839|156917952|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
48745560|NCT04115839|156917953|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
48745561|NCT04115839|156917947|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745562|NCT04115839|156917948|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745563|NCT04115839|156917949|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745564|NCT04115839|156917950|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
48745565|NCT04115839|156917951|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
48745566|NCT04115839|156917952|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745567|NCT04115839|156917953|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
48745568|NCT00506662|156917954|FG000|Overall Study|Adverse Event|0|||
48745569|NCT00506662|156917955|FG001|Overall Study|Adverse Event|2|||
48745570|NCT00506662|156917954|FG000|Overall Study|Lack of Efficacy|1|||
48745571|NCT00506662|156917955|FG001|Overall Study|Lack of Efficacy|0|||
48745572|NCT00506662|156917954|FG000|Overall Study|Protocol Violation|2|||
48745573|NCT00506662|156917955|FG001|Overall Study|Protocol Violation|4|||
48745574|NCT00506662|156917954|FG000|Overall Study|Trial terminated|10|||
48745575|NCT00506662|156917955|FG001|Overall Study|Trial terminated|16|||
48745576|NCT00506662|156917954|FG000|Overall Study|Not recorded|4|||
48745577|NCT00506662|156917955|FG001|Overall Study|Not recorded|6|||
48745578|NCT00491075|156917956|FG000|Overall Study|Withdrawal by Subject|1|||
48745579|NCT00491075|156917956|FG000|Overall Study|Physician Decision|1|||
48745580|NCT04160195|156917957|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
48745581|NCT04160195|156917958|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
48745582|NCT01731990|156917959|FG000|Overall Study|Adverse Event|1|||
48745583|NCT01731990|156917960|FG001|Overall Study|Adverse Event|5|||
48745584|NCT01731990|156917959|FG000|Overall Study|Withdrawal by Subject|1|||
48745585|NCT01731990|156917960|FG001|Overall Study|Withdrawal by Subject|1|||
48745586|NCT01731990|156917959|FG000|Overall Study|Protocol deviation|1|||
48745587|NCT01731990|156917960|FG001|Overall Study|Protocol deviation|2|||
48634111|NCT00673920|156518895|FG005|Baseline up to Week 48|Refused treatment|0|||
48634112|NCT00673920|156518896|FG006|Baseline up to Week 48|Refused treatment|0|||
48745588|NCT01731990|156917959|FG000|Overall Study|Death|1|||
48745589|NCT01731990|156917960|FG001|Overall Study|Death|0|||
48745590|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
48745591|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
48745592|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Progression|3|||
48745593|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
48745594|NCT00064337|156917961|FG000|PBSCC or Induction/PBSCC|Death|2|||
48745595|NCT00064337|156917961|FG000|Transplant|Adverse Event|9|||
48745596|NCT00064337|156917961|FG000|Transplant|Not protocol-specified|5|||
48745597|NCT00064337|156917961|FG000|Transplant|Death|3|||
48745598|NCT00064337|156917961|FG000|Transplant|Patient Refusal|2|||
48745599|NCT00064337|156917961|FG000|Transplant|Progression|2|||
48745600|NCT00064337|156917961|FG000|Maintenance|Adverse Event|3|||
48745601|NCT00064337|156917961|FG000|Maintenance|Progression|2|||
48745602|NCT00064337|156917961|FG000|Maintenance|On treatment at time of analysis|2|||
48745603|NCT00064337|156917961|FG000|Maintenance|Not protocol-specified|2|||
48745604|NCT00064337|156917961|FG000|Maintenance|Death|1|||
48745605|NCT00790023|156917962|FG000|Overall Study|Adverse Event|2|||
48745606|NCT00790023|156917963|FG001|Overall Study|Adverse Event|1|||
48745607|NCT00790023|156917964|FG002|Overall Study|Adverse Event|4|||
48745608|NCT00790023|156917962|FG000|Overall Study|Protocol Violation|2|||
48745609|NCT00790023|156917963|FG001|Overall Study|Protocol Violation|4|||
48745610|NCT00790023|156917964|FG002|Overall Study|Protocol Violation|2|||
48745611|NCT00790023|156917962|FG000|Overall Study|Withdrawal by Subject|2|||
48745612|NCT00790023|156917963|FG001|Overall Study|Withdrawal by Subject|0|||
48745613|NCT00790023|156917964|FG002|Overall Study|Withdrawal by Subject|6|||
48745614|NCT00790023|156917962|FG000|Overall Study|Lost to Follow-up|0|||
48745615|NCT00790023|156917963|FG001|Overall Study|Lost to Follow-up|0|||
48745616|NCT00790023|156917964|FG002|Overall Study|Lost to Follow-up|1|||
48745617|NCT00790023|156917962|FG000|Overall Study|Other|5|||
48745618|NCT00790023|156917963|FG001|Overall Study|Other|5|||
48745619|NCT00790023|156917964|FG002|Overall Study|Other|8|||
48745620|NCT01603355|156917968|FG000|Overall Study|Lack of Efficacy|2|||
48745621|NCT00660023|156917971|FG000|Overall Study|Adverse Event|2|||
48745622|NCT00660023|156917971|FG000|Overall Study|Death|8|||
48745623|NCT00660023|156917971|FG000|Overall Study|Blood Transfusion|5|||
48745624|NCT00660023|156917971|FG000|Overall Study|Renal Transplantation|3|||
48745625|NCT00660023|156917971|FG000|Overall Study|Withdrawal by Subject|1|||
48745626|NCT00660023|156917971|FG000|Overall Study|Missed Pregnancy Test|1|||
48745627|NCT00660023|156917971|FG000|Overall Study|Other Screening Failure|9|||
48745628|NCT03217175|156917972|FG000|Overall Study|Physician Decision|4|||
48745629|NCT03217175|156917973|FG001|Overall Study|Physician Decision|1|||
48426638|NCT02084134|155751286|FG001|Overall Study|Death|1|||
48634113|NCT00673920|156518897|FG007|Baseline up to Week 48|Refused treatment|0|||
48634114|NCT00673920|156518890|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
48634115|NCT00673920|156518891|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
48634116|NCT00673920|156518892|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
48634117|NCT00673920|156518893|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
48634118|NCT00673920|156518894|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
48634119|NCT00673920|156518895|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
48634120|NCT00673920|156518896|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
48634121|NCT00673920|156518897|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
48634122|NCT00673920|156518890|FG000|Baseline up to Week 48|Protocol Violation|0|||
48634123|NCT00673920|156518891|FG001|Baseline up to Week 48|Protocol Violation|0|||
48634124|NCT00673920|156518892|FG002|Baseline up to Week 48|Protocol Violation|1|||
48634125|NCT00673920|156518893|FG003|Baseline up to Week 48|Protocol Violation|0|||
48634126|NCT00673920|156518894|FG004|Baseline up to Week 48|Protocol Violation|0|||
48634127|NCT00673920|156518895|FG005|Baseline up to Week 48|Protocol Violation|0|||
48634128|NCT00673920|156518896|FG006|Baseline up to Week 48|Protocol Violation|0|||
48634129|NCT00673920|156518897|FG007|Baseline up to Week 48|Protocol Violation|0|||
48634130|NCT00673920|156518890|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
48634131|NCT00673920|156518891|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
48634132|NCT00673920|156518892|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
48634133|NCT00673920|156518893|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
48634134|NCT00673920|156518894|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
48634135|NCT00673920|156518895|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
48634136|NCT00673920|156518896|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
48634137|NCT00673920|156518897|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
48745630|NCT00297830|156917974|FG000|6 Month Visit|Death|1|||
48745631|NCT00297830|156917975|FG001|6 Month Visit|Death|0|||
48745632|NCT00297830|156917976|FG002|6 Month Visit|Death|2|||
48745633|NCT00297830|156917974|FG000|6 Month Visit|Withdrawal by Subject|2|||
48745634|NCT00297830|156917975|FG001|6 Month Visit|Withdrawal by Subject|1|||
48745635|NCT00297830|156917976|FG002|6 Month Visit|Withdrawal by Subject|1|||
48745636|NCT00297830|156917974|FG000|6 Month Visit|Adverse Event|0|||
48745637|NCT00297830|156917975|FG001|6 Month Visit|Adverse Event|1|||
48745638|NCT00297830|156917976|FG002|6 Month Visit|Adverse Event|0|||
48634138|NCT00673920|156518890|FG000|Baseline up to Week 48|Administrative/Other|0|||
48634139|NCT00673920|156518891|FG001|Baseline up to Week 48|Administrative/Other|1|||
48634140|NCT00673920|156518892|FG002|Baseline up to Week 48|Administrative/Other|2|||
48634141|NCT00673920|156518893|FG003|Baseline up to Week 48|Administrative/Other|0|||
48634142|NCT00673920|156518894|FG004|Baseline up to Week 48|Administrative/Other|0|||
48634143|NCT00673920|156518895|FG005|Baseline up to Week 48|Administrative/Other|0|||
48634144|NCT00673920|156518896|FG006|Baseline up to Week 48|Administrative/Other|0|||
48634145|NCT00673920|156518897|FG007|Baseline up to Week 48|Administrative/Other|0|||
48634146|NCT00673920|156518890|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
48634147|NCT00673920|156518891|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
48634148|NCT00673920|156518892|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
48634149|NCT00673920|156518893|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
48634150|NCT00673920|156518894|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
48634151|NCT00673920|156518895|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
48634152|NCT00673920|156518896|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
48634153|NCT00673920|156518897|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
48634154|NCT00673920|156518890|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
48634155|NCT00673920|156518891|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
48634156|NCT00673920|156518892|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
48634157|NCT00673920|156518893|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
48634158|NCT00673920|156518894|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
48634159|NCT00673920|156518895|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
48634160|NCT00673920|156518896|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
48634161|NCT00673920|156518897|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
48634162|NCT00673920|156518890|FG000|Week 24 to Week 48|Failure to return|0|||
48634163|NCT00673920|156518891|FG001|Week 24 to Week 48|Failure to return|0|||
48634164|NCT00673920|156518892|FG002|Week 24 to Week 48|Failure to return|0|||
48634165|NCT00673920|156518893|FG003|Week 24 to Week 48|Failure to return|0|||
48634166|NCT00673920|156518894|FG004|Week 24 to Week 48|Failure to return|0|||
48634167|NCT00673920|156518895|FG005|Week 24 to Week 48|Failure to return|1|||
48634168|NCT00673920|156518896|FG006|Week 24 to Week 48|Failure to return|0|||
48634169|NCT00673920|156518897|FG007|Week 24 to Week 48|Failure to return|0|||
48634170|NCT00673920|156518890|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
48634171|NCT00673920|156518891|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
48634172|NCT00673920|156518892|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
48634173|NCT00673920|156518893|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
48634174|NCT00673920|156518894|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
48634175|NCT00673920|156518895|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
48634176|NCT00673920|156518896|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
48634177|NCT00673920|156518897|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
48634178|NCT00673920|156518890|FG000|Week 24 to Week 48|Death|0|||
48634179|NCT00673920|156518891|FG001|Week 24 to Week 48|Death|0|||
48634180|NCT00673920|156518892|FG002|Week 24 to Week 48|Death|0|||
48634181|NCT00673920|156518893|FG003|Week 24 to Week 48|Death|0|||
48634182|NCT00673920|156518894|FG004|Week 24 to Week 48|Death|0|||
48634183|NCT00673920|156518895|FG005|Week 24 to Week 48|Death|1|||
48634184|NCT00673920|156518896|FG006|Week 24 to Week 48|Death|0|||
48634185|NCT00673920|156518897|FG007|Week 24 to Week 48|Death|0|||
48634186|NCT00673920|156518890|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
48634187|NCT00673920|156518891|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
48745639|NCT00297830|156917974|FG000|12 Month Visit|Lost to Follow-up|1|||
48745640|NCT00297830|156917975|FG001|12 Month Visit|Lost to Follow-up|0|||
48745641|NCT00297830|156917976|FG002|12 Month Visit|Lost to Follow-up|0|||
48745642|NCT00297830|156917974|FG000|12 Month Visit|Adverse Event|0|||
48745643|NCT00297830|156917975|FG001|12 Month Visit|Adverse Event|3|||
48745644|NCT00297830|156917976|FG002|12 Month Visit|Adverse Event|0|||
48745645|NCT00297830|156917974|FG000|12 Month Visit|Withdrawal by Subject|0|||
48745646|NCT00297830|156917975|FG001|12 Month Visit|Withdrawal by Subject|3|||
48745647|NCT00297830|156917976|FG002|12 Month Visit|Withdrawal by Subject|0|||
48745648|NCT01001377|156917977|FG000|Overall Study|Ineligibility determined|2|||
48745649|NCT01001377|156917978|FG001|Overall Study|Ineligibility determined|0|||
48745650|NCT01001377|156917977|FG000|Overall Study|Withdrawal by Subject|19|||
48745651|NCT01001377|156917978|FG001|Overall Study|Withdrawal by Subject|20|||
48745652|NCT01001377|156917977|FG000|Overall Study|Lost to Follow-up|14|||
48745653|NCT01001377|156917978|FG001|Overall Study|Lost to Follow-up|17|||
48745654|NCT01001377|156917977|FG000|Overall Study|Death|391|||
48745655|NCT01001377|156917978|FG001|Overall Study|Death|384|||
48745656|NCT01537393|156917990|FG000|Overall Study|Exclude prior to study|32|||
48745657|NCT01537393|156917991|FG001|Overall Study|Exclude prior to study|44|||
48745658|NCT01537393|156917990|FG000|Overall Study|Death|20|||
48745659|NCT01537393|156917991|FG001|Overall Study|Death|32|||
48634188|NCT00673920|156518892|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
48326512|NCT02325466|155394018|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
48326513|NCT02325466|155394019|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
48326514|NCT02325466|155394017|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
48326515|NCT02325466|155394018|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
48745660|NCT01537393|156917990|FG000|Overall Study|Withdrawal by Subject|18|||
48745661|NCT01537393|156917991|FG001|Overall Study|Withdrawal by Subject|17|||
48745662|NCT01537393|156917990|FG000|Overall Study|Lost to Follow-up|53|||
48745663|NCT01537393|156917991|FG001|Overall Study|Lost to Follow-up|48|||
48745664|NCT01537393|156917990|FG000|Overall Study|Failure - Regrafted|28|||
48745665|NCT01537393|156917991|FG001|Overall Study|Failure - Regrafted|43|||
48745666|NCT01537393|156917990|FG000|Overall Study|Failure - Not regrafted|2|||
48745667|NCT01537393|156917991|FG001|Overall Study|Failure - Not regrafted|6|||
48745668|NCT01537393|156917990|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
48745669|NCT01537393|156917991|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
48745670|NCT01578187|156917992|FG000|Usability Phase|Withdrawal by Subject|1|||
48745671|NCT02197520|156917993|FG000|Period 1|Withdrawal by Subject|1|||
48745672|NCT02197520|156917994|FG001|Period 1|Withdrawal by Subject|0|||
48745673|NCT02197520|156917993|FG000|Period 2|Adverse Event|0|||
48745674|NCT02197520|156917994|FG001|Period 2|Adverse Event|2|||
48745675|NCT02197520|156917993|FG000|Period 2|Withdrawal by Subject|1|||
48745676|NCT02197520|156917994|FG001|Period 2|Withdrawal by Subject|0|||
48745677|NCT00913497|156917995|FG000|Overall Study|Adverse Event|1|||
48745678|NCT00913497|156917995|FG000|Overall Study|Withdrawal by Subject|2|||
48745679|NCT01306942|156917996|FG000|Phase I|Adverse Event|2|||
48745680|NCT01306942|156917997|FG001|Phase I|Adverse Event|2|||
48745681|NCT01306942|156917998|FG002|Phase I|Adverse Event|0|||
48745682|NCT01306942|156917999|FG003|Phase I|Adverse Event|0|||
48745683|NCT01306942|156917996|FG000|Phase I|Physician Decision|3|||
48745684|NCT01306942|156917997|FG001|Phase I|Physician Decision|1|||
48745685|NCT01306942|156917998|FG002|Phase I|Physician Decision|0|||
48745686|NCT01306942|156917999|FG003|Phase I|Physician Decision|0|||
48745687|NCT01306942|156917996|FG000|Phase II|Adverse Event|0|||
48745688|NCT01306942|156917997|FG001|Phase II|Adverse Event|0|||
48745689|NCT01306942|156917998|FG002|Phase II|Adverse Event|0|||
48745690|NCT01306942|156917999|FG003|Phase II|Adverse Event|6|||
48745691|NCT01306942|156917996|FG000|Phase II|Physician Decision|2|||
48745692|NCT01306942|156917997|FG001|Phase II|Physician Decision|0|||
48745693|NCT01306942|156917998|FG002|Phase II|Physician Decision|0|||
48745694|NCT01306942|156917999|FG003|Phase II|Physician Decision|5|||
48745695|NCT01306942|156917996|FG000|Phase II|Withdrawal by Subject|0|||
48745696|NCT01306942|156917997|FG001|Phase II|Withdrawal by Subject|0|||
48745697|NCT01306942|156917998|FG002|Phase II|Withdrawal by Subject|0|||
48745698|NCT01306942|156917999|FG003|Phase II|Withdrawal by Subject|2|||
48745699|NCT01306942|156917996|FG000|Phase II|Death|0|||
48745700|NCT01306942|156917997|FG001|Phase II|Death|0|||
48585210|NCT03759366|156333807|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
48585211|NCT03759366|156333807|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
48585212|NCT03759366|156333807|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
48585213|NCT03759366|156333807|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
48585214|NCT03759366|156333807|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
48585215|NCT03759366|156333807|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
48585216|NCT00597012|156333808|FG000|Overall Study|Death|1|||
48745701|NCT01306942|156917998|FG002|Phase II|Death|0|||
48745702|NCT01306942|156917999|FG003|Phase II|Death|1|||
48745703|NCT01306942|156917996|FG000|Phase II|Not finished treatment|0|||
48745704|NCT01306942|156917997|FG001|Phase II|Not finished treatment|0|||
48745705|NCT01306942|156917998|FG002|Phase II|Not finished treatment|0|||
48745706|NCT01306942|156917999|FG003|Phase II|Not finished treatment|1|||
48745707|NCT01306942|156917996|FG000|Phase II|Protocol Violation|0|||
48745708|NCT01306942|156917997|FG001|Phase II|Protocol Violation|0|||
48745709|NCT01306942|156917998|FG002|Phase II|Protocol Violation|0|||
48745710|NCT01306942|156917999|FG003|Phase II|Protocol Violation|1|||
48745711|NCT03208244|156918000|FG000|Overall Study|Death|1|||
48585217|NCT00597012|156333809|FG001|Overall Study|Death|1|||
48585218|NCT00597012|156333808|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
48585219|NCT00597012|156333809|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
48585220|NCT00597012|156333808|FG000|Overall Study|Withdrawal by Subject|7|||
48585221|NCT00597012|156333809|FG001|Overall Study|Withdrawal by Subject|4|||
48585222|NCT00597012|156333808|FG000|Overall Study|Ineligible|2|||
48585223|NCT00597012|156333809|FG001|Overall Study|Ineligible|0|||
48585224|NCT00597012|156333808|FG000|Overall Study|Lost to Follow-up|0|||
48585225|NCT00597012|156333809|FG001|Overall Study|Lost to Follow-up|2|||
48585226|NCT03755518|156333810|FG000|Overall Study|Lack of Efficacy|10|||
48585227|NCT03755518|156333810|FG000|Overall Study|Adverse Event|7|||
48585228|NCT03755518|156333810|FG000|Overall Study|Study Terminated by Sponsor|5|||
48585229|NCT03755518|156333810|FG000|Overall Study|Death|1|||
48585230|NCT03755518|156333810|FG000|Overall Study|Withdrawal by Subject|3|||
48585231|NCT03755518|156333810|FG000|Overall Study|Progressive Disease|4|||
48585232|NCT03755518|156333810|FG000|Overall Study|Bone Marrow Transplant|4|||
48585233|NCT03755518|156333810|FG000|Overall Study|Physicians Decision|1|||
48585234|NCT03755518|156333810|FG000|Overall Study|Relapse|1|||
48585235|NCT03755518|156333810|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
48745712|NCT01874054|156918001|FG000|Overall Study|Withdrawal by Subject|3|||
48745713|NCT01874054|156918001|FG000|Overall Study|Study Termination by Sponsor|42|||
48326516|NCT02325466|155394019|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
48326517|NCT02325466|155394017|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
48326518|NCT02325466|155394018|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
48326519|NCT02325466|155394019|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
48745714|NCT01874054|156918001|FG000|Overall Study|Lost to Follow-up|5|||
48745715|NCT01874054|156918001|FG000|Overall Study|Death|5|||
48745716|NCT01637272|156918013|FG000|Overall Study|Adverse Event|6|||
48326520|NCT02325466|155394017|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
48326521|NCT02325466|155394018|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
48326522|NCT02325466|155394019|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
48326523|NCT03352713|155394021|FG000|Overall Study|Lost to Follow-up|8|||
48326524|NCT03352713|155394021|FG000|Overall Study|Withdrawn by investigator|5|||
48326525|NCT03352713|155394021|FG000|Overall Study|Completed 0 EMAs|8|||
48326526|NCT03352713|155394021|FG000|Overall Study|Device incompatible/stolen|5|||
48745717|NCT01637272|156918013|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48326527|NCT01812759|155394022|FG000|Overall Study|Physician Decision|0|||
48326528|NCT01812759|155394023|FG001|Overall Study|Physician Decision|0|||
48745718|NCT01637272|156918013|FG000|Overall Study|Withdrawal by Subject|3|||
48745719|NCT01637272|156918013|FG000|Overall Study|Lost to Follow-up|2|||
48745720|NCT01637272|156918013|FG000|Overall Study|completed core, did not enter ext. phase|4|||
48745721|NCT01637272|156918013|FG000|Overall Study|Administrative problems|1|||
48745722|NCT01637272|156918013|FG000|Overall Study|Protocol Violation|2|||
48745723|NCT00390468|156918015|FG000|Overall Study|Protocol Violation|2|||
48745724|NCT00390468|156918015|FG000|Overall Study|Lack of Efficacy|1|||
48745725|NCT01201850|156918016|FG000|Overall Study|Tumor progression|4|||
48745726|NCT00571948|156918019|FG000|Overall Study|Lost to Follow-up|2|||
48745727|NCT00571948|156918020|FG001|Overall Study|Lost to Follow-up|0|||
48745728|NCT00571948|156918019|FG000|Overall Study|Withdrawal by Subject|1|||
48585236|NCT03755518|156333810|FG000|Overall Study|Withdrawal by PI|1|||
48326529|NCT01812759|155394024|FG002|Overall Study|Physician Decision|1|||
48326530|NCT00536120|155394025|FG000|Overall Study|Lost to Follow-up|1|||
48326531|NCT00536120|155394026|FG001|Overall Study|Lost to Follow-up|0|||
48585237|NCT01416155|156333811|FG000|Overall Study|Adverse Event|8|||
48585238|NCT01416155|156333811|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
48585239|NCT01416155|156333811|FG000|Overall Study|Withdrawal by Subject|33|||
48585240|NCT01416155|156333811|FG000|Overall Study|Investigator decision|8|||
48585241|NCT01416155|156333811|FG000|Overall Study|Other|7|||
48585242|NCT00539032|156333817|FG000|Overall Study|Withdrawal by Subject|2|||
48585243|NCT00539032|156333818|FG001|Overall Study|Withdrawal by Subject|1|||
48585244|NCT01714609|156333819|FG000|Overall Study|Protocol Violation|1|||
48585245|NCT01714609|156333820|FG001|Overall Study|Protocol Violation|0|||
48585246|NCT00630747|156333821|FG000|Overall Study|Death|1|||
48326532|NCT00536120|155394025|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
48326533|NCT00536120|155394026|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
48326534|NCT00536120|155394025|FG000|Overall Study|Non-compliance|1|||
48326535|NCT00536120|155394026|FG001|Overall Study|Non-compliance|0|||
48326536|NCT00536120|155394025|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
48326537|NCT00536120|155394026|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
48326538|NCT00536120|155394025|FG000|Overall Study|Steroid Use|0|||
48326539|NCT00536120|155394026|FG001|Overall Study|Steroid Use|2|||
48326540|NCT00536120|155394025|FG000|Overall Study|Missed Study Visit|0|||
48326541|NCT00536120|155394026|FG001|Overall Study|Missed Study Visit|1|||
48326542|NCT02722434|155394027|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
48326543|NCT02722434|155394028|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
48326544|NCT02722434|155394027|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
48326545|NCT02722434|155394028|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
48326546|NCT00949117|155394029|FG000|Overall Study|Lack of Efficacy|2|||
48326547|NCT00949117|155394030|FG001|Overall Study|Lack of Efficacy|3|||
48585247|NCT00630747|156333821|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
48326548|NCT00949117|155394029|FG000|Overall Study|Protocol Violation|1|||
48585248|NCT00630747|156333821|FG000|Overall Study|Returned to country of origin|1|||
48585249|NCT02732327|156333822|FG000|Overall Study|Protocol Violation|0|||
48585250|NCT02732327|156333823|FG001|Overall Study|Protocol Violation|1|||
48585251|NCT02306694|156333824|FG000|Overall Study|Withdrawal by Subject|3|||
48585252|NCT02306694|156333824|FG000|Overall Study|Lost to Follow-up|1|||
48585253|NCT02012959|156333825|FG000|Treatment Phase A|Adverse Event|2|||
48585254|NCT02012959|156333826|FG001|Treatment Phase A|Adverse Event|0|||
48585255|NCT02012959|156333827|FG002|Treatment Phase A|Adverse Event|0|||
48585256|NCT02012959|156333828|FG003|Treatment Phase A|Adverse Event|0|||
48585257|NCT02012959|156333829|FG004|Treatment Phase A|Adverse Event|0|||
48585258|NCT03535194|156335687|FG000|Induction Period|Adverse Event|2|||
48585259|NCT03535194|156335688|FG001|Induction Period|Adverse Event|2|||
48585260|NCT03535194|156335689|FG002|Induction Period|Adverse Event|1|||
48585261|NCT03535194|156335690|FG003|Induction Period|Adverse Event|3|||
48585262|NCT03535194|156335691|FG004|Induction Period|Adverse Event|0|||
48585263|NCT03535194|156335687|FG000|Induction Period|Death|0|||
48585264|NCT03535194|156335688|FG001|Induction Period|Death|1|||
48585265|NCT03535194|156335689|FG002|Induction Period|Death|0|||
48585266|NCT03535194|156335690|FG003|Induction Period|Death|0|||
48585267|NCT03535194|156335691|FG004|Induction Period|Death|0|||
48585268|NCT03535194|156335687|FG000|Induction Period|Lack of Efficacy|1|||
48585269|NCT03535194|156335688|FG001|Induction Period|Lack of Efficacy|3|||
48585270|NCT03535194|156335689|FG002|Induction Period|Lack of Efficacy|2|||
48585271|NCT03535194|156335690|FG003|Induction Period|Lack of Efficacy|2|||
48585272|NCT03535194|156335691|FG004|Induction Period|Lack of Efficacy|0|||
48585273|NCT03535194|156335687|FG000|Induction Period|Lost to Follow-up|3|||
48585274|NCT03535194|156335688|FG001|Induction Period|Lost to Follow-up|5|||
48585275|NCT03535194|156335689|FG002|Induction Period|Lost to Follow-up|2|||
48585276|NCT03535194|156335690|FG003|Induction Period|Lost to Follow-up|3|||
48585277|NCT03535194|156335691|FG004|Induction Period|Lost to Follow-up|0|||
48585278|NCT03535194|156335687|FG000|Induction Period|Physician Decision|1|||
48585279|NCT03535194|156335688|FG001|Induction Period|Physician Decision|1|||
48585280|NCT03535194|156335689|FG002|Induction Period|Physician Decision|0|||
48585281|NCT03535194|156335690|FG003|Induction Period|Physician Decision|0|||
48585282|NCT03535194|156335691|FG004|Induction Period|Physician Decision|0|||
48585283|NCT03535194|156335687|FG000|Induction Period|Protocol Violation|1|||
48585284|NCT03535194|156335688|FG001|Induction Period|Protocol Violation|0|||
48585285|NCT03535194|156335689|FG002|Induction Period|Protocol Violation|0|||
48585286|NCT03535194|156335690|FG003|Induction Period|Protocol Violation|1|||
48585287|NCT03535194|156335691|FG004|Induction Period|Protocol Violation|0|||
48585288|NCT03535194|156335687|FG000|Induction Period|Screen Failure|0|||
48585289|NCT03535194|156335688|FG001|Induction Period|Screen Failure|1|||
48585290|NCT03535194|156335689|FG002|Induction Period|Screen Failure|0|||
48585291|NCT03535194|156335690|FG003|Induction Period|Screen Failure|0|||
48585292|NCT03535194|156335691|FG004|Induction Period|Screen Failure|0|||
48585293|NCT03535194|156335687|FG000|Induction Period|Withdrawal by Subject|3|||
48585294|NCT03535194|156335688|FG001|Induction Period|Withdrawal by Subject|4|||
48585295|NCT03535194|156335689|FG002|Induction Period|Withdrawal by Subject|3|||
48585296|NCT03535194|156335690|FG003|Induction Period|Withdrawal by Subject|2|||
48585297|NCT03535194|156335691|FG004|Induction Period|Withdrawal by Subject|0|||
48585298|NCT03535194|156335687|FG000|Maintenance Period|Adverse Event|6|||
48585299|NCT03535194|156335688|FG001|Maintenance Period|Adverse Event|5|||
48585300|NCT03535194|156335689|FG002|Maintenance Period|Adverse Event|1|||
48585301|NCT03535194|156335690|FG003|Maintenance Period|Adverse Event|11|||
48585302|NCT03535194|156335691|FG004|Maintenance Period|Adverse Event|4|||
48585303|NCT03535194|156335687|FG000|Maintenance Period|Lack of Efficacy|3|||
48585304|NCT03535194|156335688|FG001|Maintenance Period|Lack of Efficacy|2|||
48585305|NCT03535194|156335689|FG002|Maintenance Period|Lack of Efficacy|5|||
48634189|NCT00673920|156518893|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
48634190|NCT00673920|156518894|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
48634191|NCT00673920|156518895|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
48634192|NCT00673920|156518896|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
48634193|NCT00673920|156518897|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
48634194|NCT04856527|156518903|FG000|Overall Study|Unable to complete experimental task|2|||
48634195|NCT04856527|156518904|FG001|Overall Study|Unable to complete experimental task|0|||
48634196|NCT02325154|156518905|FG000|Overall Study|Physician Decision|1|||
48634197|NCT02936752|156518907|FG000|Overall Study|Death|2|||
48634198|NCT02936752|156518908|FG001|Overall Study|Death|1|||
48634199|NCT02936752|156518907|FG000|Overall Study|Physician Decision|4|||
48634200|NCT02936752|156518908|FG001|Overall Study|Physician Decision|0|||
48634201|NCT02936752|156518907|FG000|Overall Study|Withdrawal by Subject|0|||
48634202|NCT02936752|156518908|FG001|Overall Study|Withdrawal by Subject|2|||
48326549|NCT00949117|155394030|FG001|Overall Study|Protocol Violation|1|||
48326550|NCT00949117|155394029|FG000|Overall Study|Adverse Event|0|||
48326551|NCT00949117|155394030|FG001|Overall Study|Adverse Event|1|||
48326552|NCT00360269|155394031|FG000|Overall Study|Lost to Follow-up|7|||
48326553|NCT00360269|155394032|FG001|Overall Study|Lost to Follow-up|9|||
48326554|NCT00360269|155394031|FG000|Overall Study|Physician Decision|1|||
48326555|NCT00360269|155394032|FG001|Overall Study|Physician Decision|2|||
48326556|NCT00360269|155394031|FG000|Overall Study|Adverse Event|1|||
48326557|NCT00360269|155394032|FG001|Overall Study|Adverse Event|0|||
48326558|NCT00360269|155394031|FG000|Overall Study|Withdrawal by Subject|1|||
48326559|NCT00360269|155394032|FG001|Overall Study|Withdrawal by Subject|1|||
48326560|NCT03002194|155394033|FG000|Overall Study|Lost to Follow-up|6|||
48326561|NCT03002194|155394033|FG000|Overall Study|Adverse Event|1|||
48326562|NCT03002194|155394033|FG000|Overall Study|Lack of Efficacy|1|||
48326563|NCT03002194|155394033|FG000|Overall Study|Withdrawal by Subject|2|||
48326564|NCT04559698|155394037|FG000|Overall Study|Lost to Follow-up|14|||
48326565|NCT04559698|155394038|FG001|Overall Study|Lost to Follow-up|15|||
48326566|NCT04559698|155394037|FG000|Overall Study|Withdrawal by Subject|0|||
48326567|NCT04559698|155394038|FG001|Overall Study|Withdrawal by Subject|1|||
48326568|NCT01278030|155394039|FG000|Overall Study|Withdrawal by Subject|8|||
48326569|NCT01278030|155394040|FG001|Overall Study|Withdrawal by Subject|4|||
48326570|NCT02760654|155394041|FG000|Overall Study|Lost to Follow-up|3|||
48326571|NCT02760654|155394042|FG001|Overall Study|Lost to Follow-up|3|||
48326572|NCT02760654|155394041|FG000|Overall Study|Withdrawal by Subject|4|||
48326573|NCT02760654|155394042|FG001|Overall Study|Withdrawal by Subject|3|||
48326574|NCT00786864|155394043|FG000|Overall Study|Lost to Follow-up|0|||
48326575|NCT00786864|155394044|FG001|Overall Study|Lost to Follow-up|1|||
48326576|NCT00786864|155394043|FG000|Overall Study|Sustained serious back injury|1|||
48326577|NCT00786864|155394044|FG001|Overall Study|Sustained serious back injury|0|||
48326578|NCT00065182|155394049|FG000|Overall Study|Adverse Event|24|||
48326579|NCT00065182|155394050|FG001|Overall Study|Adverse Event|17|||
48326580|NCT00065182|155394049|FG000|Overall Study|Lost to Follow-up|0|||
48326581|NCT00065182|155394050|FG001|Overall Study|Lost to Follow-up|4|||
48634203|NCT03605693|156518909|FG000|Overall Study|Lost to Follow-up|4|||
48634204|NCT03605693|156518910|FG001|Overall Study|Lost to Follow-up|0|||
48634205|NCT03605693|156518909|FG000|Overall Study|Physician Decision|1|||
48326582|NCT00065182|155394049|FG000|Overall Study|Protocol Violation|3|||
48326583|NCT00065182|155394050|FG001|Overall Study|Protocol Violation|4|||
48326584|NCT00065182|155394049|FG000|Overall Study|Serious adverse events (SAE)|1|||
48326585|NCT00065182|155394050|FG001|Overall Study|Serious adverse events (SAE)|0|||
48634206|NCT03605693|156518910|FG001|Overall Study|Physician Decision|0|||
48634207|NCT01538199|156518912|FG000|Overall Study|Lost to Follow-up|1|||
48634208|NCT01538199|156518913|FG001|Overall Study|Lost to Follow-up|2|||
48634209|NCT01538199|156518914|FG002|Overall Study|Lost to Follow-up|1|||
48634210|NCT01538199|156518915|FG003|Overall Study|Lost to Follow-up|0|||
48634211|NCT01538199|156518912|FG000|Overall Study|participant did not have time|1|||
48634212|NCT01538199|156518913|FG001|Overall Study|participant did not have time|0|||
48634213|NCT01538199|156518914|FG002|Overall Study|participant did not have time|0|||
48634214|NCT01538199|156518915|FG003|Overall Study|participant did not have time|2|||
48634215|NCT01538199|156518912|FG000|Overall Study|Lack of Efficacy|0|||
48634216|NCT01538199|156518913|FG001|Overall Study|Lack of Efficacy|1|||
48634217|NCT01538199|156518914|FG002|Overall Study|Lack of Efficacy|0|||
48634218|NCT01538199|156518915|FG003|Overall Study|Lack of Efficacy|0|||
48634219|NCT02081586|156518916|FG000|Overall Study|Lost to Follow-up|0|||
48634220|NCT02081586|156518917|FG001|Overall Study|Lost to Follow-up|1|||
48634221|NCT02081586|156518918|FG002|Overall Study|Lost to Follow-up|0|||
48634222|NCT02081586|156518919|FG003|Overall Study|Lost to Follow-up|1|||
48634223|NCT02081586|156518916|FG000|Overall Study|Head injury not related to study|0|||
48634224|NCT02081586|156518917|FG001|Overall Study|Head injury not related to study|0|||
48634225|NCT02081586|156518918|FG002|Overall Study|Head injury not related to study|1|||
48634226|NCT02081586|156518919|FG003|Overall Study|Head injury not related to study|0|||
48634227|NCT00659425|156518927|FG000|Overall Study|Disease progression|1|||
48634228|NCT00659425|156518928|FG001|Overall Study|Disease progression|0|||
48634229|NCT00659425|156518929|FG002|Overall Study|Disease progression|0|||
48634230|NCT00659425|156518930|FG003|Overall Study|Disease progression|1|||
48634231|NCT00659425|156518931|FG004|Overall Study|Disease progression|0|||
48634232|NCT00659425|156518932|FG005|Overall Study|Disease progression|2|||
48634233|NCT00659425|156518933|FG006|Overall Study|Disease progression|4|||
48634234|NCT00659425|156518934|FG007|Overall Study|Disease progression|3|||
48634235|NCT00659425|156518935|FG008|Overall Study|Disease progression|5|||
48634236|NCT00659425|156518936|FG009|Overall Study|Disease progression|3|||
48634237|NCT00659425|156518927|FG000|Overall Study|Death|0|||
48634238|NCT00659425|156518928|FG001|Overall Study|Death|0|||
48634239|NCT00659425|156518929|FG002|Overall Study|Death|0|||
48326586|NCT00065182|155394049|FG000|Overall Study|Sponsor Decision|11|||
48634240|NCT00659425|156518930|FG003|Overall Study|Death|1|||
48634241|NCT00659425|156518931|FG004|Overall Study|Death|0|||
48634242|NCT00659425|156518932|FG005|Overall Study|Death|0|||
48634243|NCT00659425|156518933|FG006|Overall Study|Death|1|||
48634244|NCT00659425|156518934|FG007|Overall Study|Death|0|||
48634245|NCT00659425|156518935|FG008|Overall Study|Death|0|||
48634246|NCT00659425|156518936|FG009|Overall Study|Death|0|||
48634247|NCT00659425|156518927|FG000|Overall Study|Adverse Event|0|||
48634248|NCT00659425|156518928|FG001|Overall Study|Adverse Event|0|||
48634249|NCT00659425|156518929|FG002|Overall Study|Adverse Event|0|||
48634250|NCT00659425|156518930|FG003|Overall Study|Adverse Event|0|||
48634251|NCT00659425|156518931|FG004|Overall Study|Adverse Event|0|||
48634252|NCT00659425|156518932|FG005|Overall Study|Adverse Event|1|||
48634253|NCT00659425|156518933|FG006|Overall Study|Adverse Event|0|||
48634254|NCT00659425|156518934|FG007|Overall Study|Adverse Event|3|||
48634255|NCT00659425|156518935|FG008|Overall Study|Adverse Event|1|||
48634256|NCT00659425|156518936|FG009|Overall Study|Adverse Event|4|||
48634257|NCT00659425|156518927|FG000|Overall Study|Investigator Discretion|0|||
48634258|NCT00659425|156518928|FG001|Overall Study|Investigator Discretion|0|||
48326587|NCT00065182|155394050|FG001|Overall Study|Sponsor Decision|7|||
48326588|NCT00065182|155394049|FG000|Overall Study|Withdrawal by Subject|8|||
48326589|NCT00065182|155394050|FG001|Overall Study|Withdrawal by Subject|3|||
48326590|NCT00065182|155394049|FG000|Overall Study|No clinical benefit|1|||
48326591|NCT00065182|155394050|FG001|Overall Study|No clinical benefit|0|||
48326592|NCT00065182|155394049|FG000|Overall Study|Death|0|||
48326593|NCT00065182|155394050|FG001|Overall Study|Death|1|||
48326594|NCT00065182|155394049|FG000|Overall Study|Decline in Status|0|||
48326595|NCT00065182|155394050|FG001|Overall Study|Decline in Status|1|||
48585306|NCT03535194|156335690|FG003|Maintenance Period|Lack of Efficacy|9|||
48585307|NCT03535194|156335691|FG004|Maintenance Period|Lack of Efficacy|0|||
48585308|NCT03535194|156335687|FG000|Maintenance Period|Lost to Follow-up|4|||
48326596|NCT03244800|155394051|FG000|Overall Study|Adverse Event|0|||
48585309|NCT03535194|156335688|FG001|Maintenance Period|Lost to Follow-up|2|||
48326597|NCT03244800|155394052|FG001|Overall Study|Adverse Event|1|||
48326598|NCT03244800|155394053|FG002|Overall Study|Adverse Event|0|||
48326599|NCT03244800|155394054|FG003|Overall Study|Adverse Event|1|||
48585310|NCT03535194|156335689|FG002|Maintenance Period|Lost to Follow-up|1|||
48585311|NCT03535194|156335690|FG003|Maintenance Period|Lost to Follow-up|5|||
48585312|NCT03535194|156335691|FG004|Maintenance Period|Lost to Follow-up|2|||
48585313|NCT03535194|156335687|FG000|Maintenance Period|Other|1|||
48585314|NCT03535194|156335688|FG001|Maintenance Period|Other|2|||
48585315|NCT03535194|156335689|FG002|Maintenance Period|Other|0|||
48585316|NCT03535194|156335690|FG003|Maintenance Period|Other|0|||
48585317|NCT03535194|156335691|FG004|Maintenance Period|Other|0|||
48585318|NCT03535194|156335687|FG000|Maintenance Period|Physician Decision|1|||
48585319|NCT03535194|156335688|FG001|Maintenance Period|Physician Decision|2|||
48585320|NCT03535194|156335689|FG002|Maintenance Period|Physician Decision|0|||
48585321|NCT03535194|156335690|FG003|Maintenance Period|Physician Decision|2|||
48585322|NCT03535194|156335691|FG004|Maintenance Period|Physician Decision|0|||
48585323|NCT03535194|156335687|FG000|Maintenance Period|Pregnancy|0|||
48585324|NCT03535194|156335688|FG001|Maintenance Period|Pregnancy|0|||
48585325|NCT03535194|156335689|FG002|Maintenance Period|Pregnancy|0|||
48585326|NCT03535194|156335690|FG003|Maintenance Period|Pregnancy|2|||
48585327|NCT03535194|156335691|FG004|Maintenance Period|Pregnancy|0|||
48585328|NCT03535194|156335687|FG000|Maintenance Period|Protocol Violation|0|||
48585329|NCT03535194|156335688|FG001|Maintenance Period|Protocol Violation|1|||
48585330|NCT03535194|156335689|FG002|Maintenance Period|Protocol Violation|0|||
48585331|NCT03535194|156335690|FG003|Maintenance Period|Protocol Violation|0|||
48585332|NCT03535194|156335691|FG004|Maintenance Period|Protocol Violation|0|||
48585333|NCT03535194|156335687|FG000|Maintenance Period|Withdrawal by Subject|7|||
48585334|NCT03535194|156335688|FG001|Maintenance Period|Withdrawal by Subject|2|||
48585335|NCT03535194|156335689|FG002|Maintenance Period|Withdrawal by Subject|1|||
48585336|NCT03535194|156335690|FG003|Maintenance Period|Withdrawal by Subject|8|||
48585337|NCT03535194|156335691|FG004|Maintenance Period|Withdrawal by Subject|0|||
48585338|NCT03535194|156335687|FG000|Post-Treatment Followup Period|Adverse Event|4|||
48585339|NCT03535194|156335688|FG001|Post-Treatment Followup Period|Adverse Event|5|||
48585340|NCT03535194|156335689|FG002|Post-Treatment Followup Period|Adverse Event|1|||
48585341|NCT03535194|156335690|FG003|Post-Treatment Followup Period|Adverse Event|8|||
48585342|NCT03535194|156335691|FG004|Post-Treatment Followup Period|Adverse Event|0|||
48585343|NCT03535194|156335687|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
48585344|NCT03535194|156335688|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
48585345|NCT03535194|156335689|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
48585346|NCT03535194|156335690|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
48585347|NCT03535194|156335691|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
48585348|NCT03535194|156335687|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
48585349|NCT03535194|156335688|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
48585350|NCT03535194|156335689|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
48585351|NCT03535194|156335690|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
48585352|NCT03535194|156335691|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
48585353|NCT03535194|156335687|FG000|Post-Treatment Followup Period|Other|1|||
48585354|NCT03535194|156335688|FG001|Post-Treatment Followup Period|Other|0|||
48585355|NCT03535194|156335689|FG002|Post-Treatment Followup Period|Other|0|||
48585356|NCT03535194|156335690|FG003|Post-Treatment Followup Period|Other|5|||
48585357|NCT03535194|156335691|FG004|Post-Treatment Followup Period|Other|0|||
48585358|NCT03535194|156335687|FG000|Post-Treatment Followup Period|Physician Decision|0|||
48585359|NCT03535194|156335688|FG001|Post-Treatment Followup Period|Physician Decision|2|||
48585360|NCT03535194|156335689|FG002|Post-Treatment Followup Period|Physician Decision|1|||
48585361|NCT03535194|156335690|FG003|Post-Treatment Followup Period|Physician Decision|1|||
48585362|NCT03535194|156335691|FG004|Post-Treatment Followup Period|Physician Decision|0|||
48585363|NCT03535194|156335687|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
48585364|NCT03535194|156335688|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
48585365|NCT03535194|156335689|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
48634259|NCT00659425|156518929|FG002|Overall Study|Investigator Discretion|0|||
48634260|NCT00659425|156518930|FG003|Overall Study|Investigator Discretion|0|||
48634261|NCT00659425|156518931|FG004|Overall Study|Investigator Discretion|0|||
48634262|NCT00659425|156518932|FG005|Overall Study|Investigator Discretion|1|||
48634263|NCT00659425|156518933|FG006|Overall Study|Investigator Discretion|0|||
48634264|NCT00659425|156518934|FG007|Overall Study|Investigator Discretion|3|||
48634265|NCT00659425|156518935|FG008|Overall Study|Investigator Discretion|0|||
48634266|NCT00659425|156518936|FG009|Overall Study|Investigator Discretion|0|||
48634267|NCT00659425|156518927|FG000|Overall Study|Other|0|||
48634268|NCT00659425|156518928|FG001|Overall Study|Other|1|||
48634269|NCT00659425|156518929|FG002|Overall Study|Other|1|||
48634270|NCT00659425|156518930|FG003|Overall Study|Other|2|||
48634271|NCT00659425|156518931|FG004|Overall Study|Other|4|||
48634272|NCT00659425|156518932|FG005|Overall Study|Other|0|||
48634273|NCT00659425|156518933|FG006|Overall Study|Other|3|||
48634274|NCT00659425|156518934|FG007|Overall Study|Other|2|||
48634275|NCT00659425|156518935|FG008|Overall Study|Other|0|||
48634276|NCT00659425|156518936|FG009|Overall Study|Other|6|||
48634277|NCT04540367|156518937|FG000|Overall Study|Withdrawal by Subject|0|||
48634278|NCT04540367|156518938|FG001|Overall Study|Withdrawal by Subject|0|||
48634279|NCT04540367|156518939|FG002|Overall Study|Withdrawal by Subject|0|||
48634280|NCT04540367|156518940|FG003|Overall Study|Withdrawal by Subject|2|||
48634281|NCT04540367|156518937|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
48634282|NCT04540367|156518938|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
48634283|NCT04540367|156518939|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
48634284|NCT04540367|156518940|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
48634285|NCT04540367|156518937|FG000|Overall Study|Adverse Event|0|||
48634286|NCT04540367|156518938|FG001|Overall Study|Adverse Event|0|||
48634287|NCT04540367|156518939|FG002|Overall Study|Adverse Event|1|||
48634288|NCT04540367|156518940|FG003|Overall Study|Adverse Event|1|||
48634289|NCT00907621|156518941|FG000|Overall Study|Lost to Follow-up|6|||
48634290|NCT00907621|156518942|FG001|Overall Study|Lost to Follow-up|3|||
48634291|NCT00907621|156518941|FG000|Overall Study|intercurrent febrile illness|1|||
48634292|NCT00907621|156518942|FG001|Overall Study|intercurrent febrile illness|1|||
48634293|NCT03958331|156518943|FG000|Overall Study|Withdrawal by Subject|3|||
48634294|NCT03958331|156518944|FG001|Overall Study|Withdrawal by Subject|1|||
48634295|NCT03958331|156518945|FG002|Overall Study|Withdrawal by Subject|5|||
48634296|NCT03958331|156518943|FG000|Overall Study|Weaned from medicine|2|||
48634297|NCT03958331|156518944|FG001|Overall Study|Weaned from medicine|0|||
48634298|NCT03958331|156518945|FG002|Overall Study|Weaned from medicine|0|||
48634299|NCT03958331|156518943|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
48634300|NCT03958331|156518944|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
48634301|NCT03958331|156518945|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
48634302|NCT03213509|156518946|FG000|Overall Study|Did not consent for verbal autopsy|4|||
48634303|NCT03213509|156518947|FG001|Overall Study|Did not consent for verbal autopsy|5|||
48634304|NCT04290624|156518948|FG000|Overall Study|Adverse Event|1|||
48634305|NCT04290624|156518949|FG001|Overall Study|Adverse Event|0|||
48634306|NCT04079738|156518950|FG000|Study Treatment|Death|1|||
48634307|NCT04079738|156518951|FG001|Study Treatment|Death|0|||
48634308|NCT04079738|156518952|FG002|Study Treatment|Death|0|||
48634309|NCT04079738|156518953|FG003|Study Treatment|Death|0|||
48634310|NCT04079738|156518950|FG000|Study Treatment|Adverse Event|2|||
48634311|NCT04079738|156518951|FG001|Study Treatment|Adverse Event|0|||
48634312|NCT04079738|156518952|FG002|Study Treatment|Adverse Event|0|||
48634313|NCT04079738|156518953|FG003|Study Treatment|Adverse Event|0|||
48634314|NCT04079738|156518950|FG000|Study Treatment|withdrawal before treatment|1|||
48634315|NCT04079738|156518951|FG001|Study Treatment|withdrawal before treatment|0|||
48634316|NCT04079738|156518952|FG002|Study Treatment|withdrawal before treatment|0|||
48634317|NCT04079738|156518953|FG003|Study Treatment|withdrawal before treatment|0|||
48634318|NCT04079738|156518950|FG000|Study Treatment|symptomatic deterioration|2|||
48634319|NCT04079738|156518951|FG001|Study Treatment|symptomatic deterioration|0|||
48634320|NCT04079738|156518952|FG002|Study Treatment|symptomatic deterioration|0|||
48634321|NCT04079738|156518953|FG003|Study Treatment|symptomatic deterioration|0|||
48634322|NCT04079738|156518950|FG000|Study Treatment|Disease Progression|1|||
48634323|NCT04079738|156518951|FG001|Study Treatment|Disease Progression|0|||
48634324|NCT04079738|156518952|FG002|Study Treatment|Disease Progression|0|||
48745729|NCT00571948|156918020|FG001|Overall Study|Withdrawal by Subject|2|||
48745730|NCT00571948|156918019|FG000|Overall Study|Protocol Violation|3|||
48745731|NCT00571948|156918020|FG001|Overall Study|Protocol Violation|3|||
48745732|NCT00571948|156918019|FG000|Overall Study|infant refused study meal|3|||
48745733|NCT00571948|156918020|FG001|Overall Study|infant refused study meal|4|||
48745734|NCT00571948|156918019|FG000|Overall Study|Parent were afraid of blood colection|2|||
48745735|NCT00571948|156918020|FG001|Overall Study|Parent were afraid of blood colection|5|||
48745736|NCT01862874|156918022|FG000|Overall Study|Randomized not treated|1|||
48745737|NCT01862874|156918023|FG001|Overall Study|Randomized not treated|0|||
48745738|NCT01862874|156918022|FG000|Overall Study|Adverse Event|0|||
48745739|NCT01862874|156918023|FG001|Overall Study|Adverse Event|3|||
48745740|NCT01862874|156918022|FG000|Overall Study|Lost to Follow-up|26|||
48745741|NCT01862874|156918023|FG001|Overall Study|Lost to Follow-up|29|||
48745742|NCT01862874|156918022|FG000|Overall Study|Physician Decision|5|||
48745743|NCT01862874|156918023|FG001|Overall Study|Physician Decision|3|||
48745744|NCT01862874|156918022|FG000|Overall Study|Withdrawn by parent/guardian|1|||
48585366|NCT03535194|156335690|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
48585367|NCT03535194|156335691|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48585368|NCT02638129|156335692|FG000|Overall Study|Study terminated|28|||
48745745|NCT01862874|156918023|FG001|Overall Study|Withdrawn by parent/guardian|1|||
48745746|NCT01862874|156918022|FG000|Overall Study|Withdrawal by Subject|46|||
48326600|NCT03244800|155394051|FG000|Overall Study|Withdrew treatment|0|||
48745747|NCT01862874|156918023|FG001|Overall Study|Withdrawal by Subject|40|||
48745748|NCT01862874|156918022|FG000|Overall Study|Death|0|||
48745749|NCT01862874|156918023|FG001|Overall Study|Death|1|||
48745750|NCT05201703|156918025|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
48745751|NCT05201703|156918026|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
48745752|NCT05201703|156918025|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
48745753|NCT05201703|156918026|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
48745754|NCT01782222|156918027|FG000|Overall Study|Adverse Event|4|||
48745755|NCT01782222|156918028|FG001|Overall Study|Adverse Event|5|||
48745756|NCT01782222|156918029|FG002|Overall Study|Adverse Event|3|||
48745757|NCT01782222|156918027|FG000|Overall Study|Lack of Efficacy|2|||
48745758|NCT01782222|156918028|FG001|Overall Study|Lack of Efficacy|1|||
48745759|NCT01782222|156918029|FG002|Overall Study|Lack of Efficacy|0|||
48745760|NCT01782222|156918027|FG000|Overall Study|Protocol Violation|1|||
48745761|NCT01782222|156918028|FG001|Overall Study|Protocol Violation|0|||
48745762|NCT01782222|156918029|FG002|Overall Study|Protocol Violation|0|||
48745763|NCT01782222|156918027|FG000|Overall Study|Withdrawal by Subject|1|||
48745764|NCT01782222|156918028|FG001|Overall Study|Withdrawal by Subject|4|||
48745765|NCT01782222|156918029|FG002|Overall Study|Withdrawal by Subject|1|||
48745766|NCT01782222|156918027|FG000|Overall Study|Moved to other state|0|||
48745767|NCT01782222|156918028|FG001|Overall Study|Moved to other state|1|||
48745768|NCT01782222|156918029|FG002|Overall Study|Moved to other state|0|||
48745769|NCT03727347|156918035|FG000|Overall Study|Withdrawal by Subject|2|||
48745770|NCT03727347|156918035|FG000|Overall Study|Lost to Follow-up|1|||
48326601|NCT03244800|155394052|FG001|Overall Study|Withdrew treatment|0|||
48326602|NCT03244800|155394053|FG002|Overall Study|Withdrew treatment|0|||
48585369|NCT02638129|156335693|FG001|Overall Study|Study terminated|30|||
48585370|NCT01473394|156335696|FG000|Overall Study|Adverse Event|13|||
48585371|NCT01473394|156335697|FG001|Overall Study|Adverse Event|16|||
48585372|NCT01473394|156335696|FG000|Overall Study|Insufficient Therapeutic Response|4|||
48585373|NCT01473394|156335697|FG001|Overall Study|Insufficient Therapeutic Response|1|||
48585374|NCT01473394|156335696|FG000|Overall Study|Protocol Violation|7|||
48585375|NCT01473394|156335697|FG001|Overall Study|Protocol Violation|5|||
48585376|NCT01473394|156335696|FG000|Overall Study|Withdrew Consent|12|||
48585377|NCT01473394|156335697|FG001|Overall Study|Withdrew Consent|10|||
48585378|NCT01473394|156335696|FG000|Overall Study|Lost to Follow-up|9|||
48585379|NCT01473394|156335697|FG001|Overall Study|Lost to Follow-up|11|||
48585380|NCT00869557|156335698|FG000|Randomized Phase|Lost to Follow-up|2|||
48585381|NCT00869557|156335699|FG001|Randomized Phase|Lost to Follow-up|1|||
48585382|NCT00869557|156335698|FG000|Randomized Phase|Investigator's Discretion|1|||
48585383|NCT00869557|156335699|FG001|Randomized Phase|Investigator's Discretion|0|||
48585384|NCT00869557|156335698|FG000|Randomized Phase|Withdrew Consent|0|||
48585385|NCT00869557|156335699|FG001|Randomized Phase|Withdrew Consent|1|||
48585386|NCT00869557|156335698|FG000|Extension Phase|Adverse Event|2|||
48585387|NCT00869557|156335699|FG001|Extension Phase|Adverse Event|2|||
48585388|NCT00869557|156335698|FG000|Extension Phase|Lack of Efficacy|1|||
48585389|NCT00869557|156335699|FG001|Extension Phase|Lack of Efficacy|0|||
48585390|NCT00869557|156335698|FG000|Extension Phase|Lost to Follow-up|3|||
48585391|NCT00869557|156335699|FG001|Extension Phase|Lost to Follow-up|1|||
48585392|NCT00869557|156335698|FG000|Extension Phase|Investigator's Discretion|2|||
48585393|NCT00869557|156335699|FG001|Extension Phase|Investigator's Discretion|0|||
48585394|NCT00869557|156335698|FG000|Extension Phase|Withdrew Consent|2|||
48745771|NCT00006237|156918036|FG000|Overall Study|Adverse Event|39|||
48745772|NCT00006237|156918037|FG001|Overall Study|Adverse Event|29|||
48745773|NCT00006237|156918036|FG000|Overall Study|Death|1|||
48745774|NCT00006237|156918037|FG001|Overall Study|Death|0|||
48745775|NCT00006237|156918036|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
48745776|NCT00006237|156918037|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
48745777|NCT00006237|156918036|FG000|Overall Study|Progression/relapse|54|||
48745778|NCT00006237|156918037|FG001|Overall Study|Progression/relapse|2|||
48745779|NCT00006237|156918036|FG000|Overall Study|Not eligible|9|||
48745780|NCT00006237|156918037|FG001|Overall Study|Not eligible|20|||
48585395|NCT00869557|156335699|FG001|Extension Phase|Withdrew Consent|0|||
48585396|NCT02949908|156335700|FG000|Overall Study|Study termination|2|||
48585397|NCT02998476|156335701|FG000|Overall Study|Lost to Follow-up|1|||
48585398|NCT02998476|156335702|FG001|Overall Study|Lost to Follow-up|0|||
48585399|NCT02998476|156335701|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
48585400|NCT02998476|156335702|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
48585401|NCT02998476|156335701|FG000|Overall Study|Withdrawal by Subject|1|||
48585402|NCT02998476|156335702|FG001|Overall Study|Withdrawal by Subject|2|||
48634325|NCT04079738|156518953|FG003|Study Treatment|Disease Progression|0|||
48634326|NCT04079738|156518950|FG000|Study Treatment|withdrawal after treatment|1|||
48634327|NCT04079738|156518951|FG001|Study Treatment|withdrawal after treatment|0|||
48585403|NCT02998476|156335701|FG000|Overall Study|Death|45|||
48585404|NCT02998476|156335702|FG001|Overall Study|Death|2|||
48585405|NCT02998476|156335701|FG000|Overall Study|Other|6|||
48585406|NCT02998476|156335702|FG001|Overall Study|Other|1|||
48585407|NCT00033657|156335703|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
48585408|NCT00033657|156335704|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
48634328|NCT04079738|156518952|FG002|Study Treatment|withdrawal after treatment|0|||
48634329|NCT04079738|156518953|FG003|Study Treatment|withdrawal after treatment|0|||
48745781|NCT00006237|156918036|FG000|Overall Study|Withdrawal by Subject|0|||
48745782|NCT00006237|156918037|FG001|Overall Study|Withdrawal by Subject|1|||
48745783|NCT00006237|156918036|FG000|Overall Study|Not protocol specified|14|||
48745784|NCT00006237|156918037|FG001|Overall Study|Not protocol specified|5|||
48745785|NCT02837783|156918038|FG000|Overall Study|Adverse Event|1|||
48745786|NCT02837783|156918039|FG001|Overall Study|Adverse Event|0|||
48745787|NCT02837783|156918038|FG000|Overall Study|Other, Not Specified|1|||
48745788|NCT02837783|156918039|FG001|Overall Study|Other, Not Specified|2|||
48745789|NCT03338998|156918041|FG000|Treatment Period|Withdrawal by Subject|1|||
48745790|NCT03338998|156918042|FG001|Treatment Period|Withdrawal by Subject|1|||
48745791|NCT03338998|156918041|FG000|Treatment Period|Adverse Event|0|||
48745792|NCT03338998|156918042|FG001|Treatment Period|Adverse Event|2|||
48745793|NCT03338998|156918041|FG000|Treatment Period|Protocol deviation|1|||
48745794|NCT03338998|156918042|FG001|Treatment Period|Protocol deviation|0|||
48745795|NCT03338998|156918041|FG000|Treatment Period|Physician Decision|2|||
48745796|NCT03338998|156918042|FG001|Treatment Period|Physician Decision|0|||
48634330|NCT04079738|156518950|FG000|Follow up|Withdrawal by Subject|3|||
48634331|NCT04079738|156518951|FG001|Follow up|Withdrawal by Subject|0|||
48634332|NCT04079738|156518952|FG002|Follow up|Withdrawal by Subject|0|||
48634333|NCT04079738|156518953|FG003|Follow up|Withdrawal by Subject|0|||
48634334|NCT04079738|156518950|FG000|Follow up|Death|5|||
48634335|NCT04079738|156518951|FG001|Follow up|Death|0|||
48634336|NCT04079738|156518952|FG002|Follow up|Death|0|||
48634337|NCT04079738|156518953|FG003|Follow up|Death|0|||
48634338|NCT01733316|156518955|FG000|RP103 Phase|Non-compliance|1|||
48745797|NCT03338998|156918041|FG000|Treatment Period|Subject failed swallow test|4|||
48745798|NCT03338998|156918042|FG001|Treatment Period|Subject failed swallow test|0|||
48745799|NCT03338998|156918041|FG000|Safety Follow-Up Period|Adverse Event|0|||
48745800|NCT03338998|156918042|FG001|Safety Follow-Up Period|Adverse Event|1|||
48745801|NCT03338998|156918041|FG000|Safety Follow-Up Period|Protocol deviation|1|||
48745802|NCT03338998|156918042|FG001|Safety Follow-Up Period|Protocol deviation|0|||
48745803|NCT03338998|156918041|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
48745804|NCT03338998|156918042|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
48745805|NCT03648983|156918043|FG000|Overall Study|Study was terminated due to PI departure|95|||
48745806|NCT03572062|156918044|FG000|Overall Study|Adverse Event|0|||
48745807|NCT03572062|156918045|FG001|Overall Study|Adverse Event|0|||
48745808|NCT03572062|156918046|FG002|Overall Study|Adverse Event|0|||
48745809|NCT03572062|156918047|FG003|Overall Study|Adverse Event|0|||
48745810|NCT03572062|156918048|FG004|Overall Study|Adverse Event|0|||
48634339|NCT01733316|156518955|FG000|Long Term Extension Phase|Adverse Event|1|||
48745811|NCT03572062|156918049|FG005|Overall Study|Adverse Event|0|||
48634340|NCT01733316|156518955|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
48745812|NCT03572062|156918050|FG006|Overall Study|Adverse Event|0|||
48745813|NCT03572062|156918051|FG007|Overall Study|Adverse Event|0|||
48745814|NCT03572062|156918052|FG008|Overall Study|Adverse Event|1|||
48745815|NCT03572062|156918053|FG009|Overall Study|Adverse Event|3|||
48745816|NCT03572062|156918044|FG000|Overall Study|Death|0|||
48634341|NCT01733316|156518955|FG000|Long Term Extension Phase|Sponsor Decision|2|||
48745817|NCT03572062|156918045|FG001|Overall Study|Death|0|||
48745818|NCT03572062|156918046|FG002|Overall Study|Death|0|||
48745819|NCT03572062|156918047|FG003|Overall Study|Death|0|||
48745820|NCT03572062|156918048|FG004|Overall Study|Death|0|||
48745821|NCT03572062|156918049|FG005|Overall Study|Death|1|||
48745822|NCT03572062|156918050|FG006|Overall Study|Death|0|||
48745823|NCT03572062|156918051|FG007|Overall Study|Death|0|||
48745824|NCT03572062|156918052|FG008|Overall Study|Death|0|||
48745825|NCT03572062|156918053|FG009|Overall Study|Death|0|||
48745826|NCT03572062|156918044|FG000|Overall Study|Lost to Follow-up|0|||
48745827|NCT03572062|156918045|FG001|Overall Study|Lost to Follow-up|0|||
48745828|NCT03572062|156918046|FG002|Overall Study|Lost to Follow-up|0|||
48585409|NCT00033657|156335703|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
48585410|NCT00033657|156335704|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
48585411|NCT00033657|156335703|FG000|Neoadjuvant Chemotherapy|Death|1|||
48585412|NCT00033657|156335704|FG001|Neoadjuvant Chemotherapy|Death|1|||
48585413|NCT00033657|156335703|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
48585414|NCT00033657|156335704|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
48585415|NCT00033657|156335703|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
48585416|NCT00033657|156335704|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
48585417|NCT00033657|156335703|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
48585418|NCT00033657|156335704|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
48585419|NCT00033657|156335703|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
48585420|NCT00033657|156335704|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
48585421|NCT00033657|156335703|FG000|Surgical Resection|not complete resection|0|||
48585422|NCT00033657|156335704|FG001|Surgical Resection|not complete resection|3|||
48585423|NCT00033657|156335703|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
48585424|NCT00033657|156335704|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
48326603|NCT03244800|155394054|FG003|Overall Study|Withdrew treatment|1|||
48326604|NCT03451422|155394055|FG000|Overall Study|Lost to Follow-up|0|||
48326605|NCT03451422|155394056|FG001|Overall Study|Lost to Follow-up|0|||
48634342|NCT00656370|156518961|FG000|Overall Study|Screen Failures|7|||
48634343|NCT00656370|156518961|FG000|Overall Study|Alternates|3|||
48634344|NCT03391882|156518964|FG000|Study Overall|Adverse Event|3|||
48634345|NCT03391882|156518965|FG001|Study Overall|Adverse Event|6|||
48634346|NCT03391882|156518966|FG002|Study Overall|Adverse Event|1|||
48634347|NCT03391882|156518967|FG003|Study Overall|Adverse Event|1|||
48634348|NCT03391882|156518968|FG004|Study Overall|Adverse Event|3|||
48634349|NCT03391882|156518969|FG005|Study Overall|Adverse Event|1|||
48634350|NCT03391882|156518964|FG000|Study Overall|Lack of Efficacy|13|||
48634351|NCT03391882|156518965|FG001|Study Overall|Lack of Efficacy|9|||
48634352|NCT03391882|156518966|FG002|Study Overall|Lack of Efficacy|0|||
48634353|NCT03391882|156518967|FG003|Study Overall|Lack of Efficacy|0|||
48634354|NCT03391882|156518968|FG004|Study Overall|Lack of Efficacy|0|||
48634355|NCT03391882|156518969|FG005|Study Overall|Lack of Efficacy|0|||
48634356|NCT03391882|156518964|FG000|Study Overall|Withdrawal by Subject|3|||
48634357|NCT03391882|156518965|FG001|Study Overall|Withdrawal by Subject|3|||
48634358|NCT03391882|156518966|FG002|Study Overall|Withdrawal by Subject|2|||
48634359|NCT03391882|156518967|FG003|Study Overall|Withdrawal by Subject|2|||
48634360|NCT03391882|156518968|FG004|Study Overall|Withdrawal by Subject|1|||
48585425|NCT00033657|156335703|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
48585426|NCT00033657|156335704|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
48585427|NCT00033657|156335703|FG000|Adjuvant Chemotherapy|Death|2|||
48585428|NCT00033657|156335704|FG001|Adjuvant Chemotherapy|Death|1|||
48585429|NCT00033657|156335703|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
48585430|NCT00033657|156335704|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
48585431|NCT00033657|156335703|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
48585432|NCT00033657|156335704|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
48326606|NCT03451422|155394057|FG002|Overall Study|Lost to Follow-up|0|||
48326607|NCT03451422|155394058|FG003|Overall Study|Lost to Follow-up|0|||
48326608|NCT03451422|155394059|FG004|Overall Study|Lost to Follow-up|0|||
48326609|NCT03451422|155394060|FG005|Overall Study|Lost to Follow-up|1|||
48326610|NCT03451422|155394055|FG000|Overall Study|Decision by sponsor|1|||
48634361|NCT03391882|156518969|FG005|Study Overall|Withdrawal by Subject|3|||
48634362|NCT03391882|156518964|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
48634363|NCT03391882|156518965|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
48634364|NCT03391882|156518966|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
48634365|NCT03391882|156518967|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
48634366|NCT03391882|156518968|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
48634367|NCT03391882|156518969|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
48326611|NCT03451422|155394056|FG001|Overall Study|Decision by sponsor|0|||
48326612|NCT03451422|155394057|FG002|Overall Study|Decision by sponsor|1|||
48326613|NCT03451422|155394058|FG003|Overall Study|Decision by sponsor|0|||
48634368|NCT03391882|156518964|FG000|Study Overall|Protocol Violation|1|||
48634369|NCT03391882|156518965|FG001|Study Overall|Protocol Violation|0|||
48634370|NCT03391882|156518966|FG002|Study Overall|Protocol Violation|0|||
48745829|NCT03572062|156918047|FG003|Overall Study|Lost to Follow-up|0|||
48745830|NCT03572062|156918048|FG004|Overall Study|Lost to Follow-up|0|||
48585433|NCT00033657|156335703|FG000|Adjuvant Chemotherapy|Other|0|||
48585434|NCT00033657|156335704|FG001|Adjuvant Chemotherapy|Other|2|||
48585435|NCT00006305|156335708|FG000|Overall Study|Withdrawal by Subject|17|||
48585436|NCT00006305|156335709|FG001|Overall Study|Withdrawal by Subject|10|||
48585437|NCT00006305|156335710|FG002|Overall Study|Withdrawal by Subject|15|||
48585438|NCT00006305|156335711|FG003|Overall Study|Withdrawal by Subject|14|||
48585439|NCT02631746|156335712|FG000|Overall Study|Lack of Efficacy|3|||
48585440|NCT00662558|156335713|FG000|Overall Study|Adverse Event|21|||
48585441|NCT00662558|156335714|FG001|Overall Study|Adverse Event|59|||
48585442|NCT00662558|156335713|FG000|Overall Study|Lack of Efficacy|4|||
48585443|NCT00662558|156335714|FG001|Overall Study|Lack of Efficacy|7|||
48585444|NCT00662558|156335713|FG000|Overall Study|Lost to Follow-up|13|||
48585445|NCT00662558|156335714|FG001|Overall Study|Lost to Follow-up|10|||
48585446|NCT00662558|156335713|FG000|Overall Study|Other|9|||
48585447|NCT00662558|156335714|FG001|Overall Study|Other|14|||
48585448|NCT00662558|156335713|FG000|Overall Study|Withdrawal by Subject|7|||
48585449|NCT00662558|156335714|FG001|Overall Study|Withdrawal by Subject|12|||
48585450|NCT00662558|156335713|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
48585451|NCT00662558|156335714|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
48585452|NCT01542034|156335715|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
48585453|NCT01542034|156335716|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
48585454|NCT01542034|156335715|FG000|Overall Study|Administrative decision|0|||
48585455|NCT01542034|156335716|FG001|Overall Study|Administrative decision|3|||
48585456|NCT01542034|156335715|FG000|Overall Study|Subject Noncompliance|1|||
48585457|NCT01542034|156335716|FG001|Overall Study|Subject Noncompliance|0|||
48585458|NCT01542034|156335715|FG000|Overall Study|Adverse Event|2|||
48585459|NCT01542034|156335716|FG001|Overall Study|Adverse Event|2|||
48585460|NCT01542034|156335715|FG000|Overall Study|Lost to Follow-up|7|||
48585461|NCT01542034|156335716|FG001|Overall Study|Lost to Follow-up|6|||
48585462|NCT01043705|156335717|FG000|Overall Study|Death|28|||
48585463|NCT01043705|156335718|FG001|Overall Study|Death|60|||
48585464|NCT01043705|156335719|FG002|Overall Study|Death|26|||
48585465|NCT01043705|156335717|FG000|Overall Study|Lost to Follow-up|27|||
48585466|NCT01043705|156335718|FG001|Overall Study|Lost to Follow-up|12|||
48585467|NCT01043705|156335719|FG002|Overall Study|Lost to Follow-up|0|||
48585468|NCT01043705|156335717|FG000|Overall Study|Multiple Reasons|4|||
48585469|NCT01043705|156335718|FG001|Overall Study|Multiple Reasons|7|||
48585470|NCT01043705|156335719|FG002|Overall Study|Multiple Reasons|0|||
48585471|NCT01043705|156335717|FG000|Overall Study|Protocol Violation|2|||
48585472|NCT01043705|156335718|FG001|Overall Study|Protocol Violation|1|||
48585473|NCT01043705|156335719|FG002|Overall Study|Protocol Violation|0|||
48585474|NCT01043705|156335717|FG000|Overall Study|Withdrawal by Subject|8|||
48585475|NCT01043705|156335718|FG001|Overall Study|Withdrawal by Subject|6|||
48585476|NCT01043705|156335719|FG002|Overall Study|Withdrawal by Subject|0|||
48585477|NCT01043705|156335717|FG000|Overall Study|Site Closure|8|||
48585478|NCT01043705|156335718|FG001|Overall Study|Site Closure|0|||
48585479|NCT01043705|156335719|FG002|Overall Study|Site Closure|0|||
48585480|NCT01043705|156335717|FG000|Overall Study|Subsequent Procedure|9|||
48585481|NCT01043705|156335718|FG001|Overall Study|Subsequent Procedure|24|||
48585482|NCT01043705|156335719|FG002|Overall Study|Subsequent Procedure|29|||
48585483|NCT01043705|156335717|FG000|Overall Study|Adverse Event|0|||
48585484|NCT01043705|156335718|FG001|Overall Study|Adverse Event|2|||
48585485|NCT01043705|156335719|FG002|Overall Study|Adverse Event|0|||
48585486|NCT01043705|156335717|FG000|Overall Study|Screen Fail|21|||
48585487|NCT01043705|156335718|FG001|Overall Study|Screen Fail|0|||
48585488|NCT01043705|156335719|FG002|Overall Study|Screen Fail|0|||
48585489|NCT01043705|156335717|FG000|Overall Study|Other|0|||
48585490|NCT01043705|156335718|FG001|Overall Study|Other|19|||
48585491|NCT01043705|156335719|FG002|Overall Study|Other|25|||
48585492|NCT00396877|156335720|FG000|Overall Study|Lost to Follow-up|2|||
48585493|NCT00396877|156335721|FG001|Overall Study|Lost to Follow-up|1|||
48585494|NCT00396877|156335720|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
48585495|NCT00396877|156335721|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
48585496|NCT02945254|156335724|FG000|Overall Study|Lost to Follow-up|1|||
48585497|NCT02945254|156335725|FG001|Overall Study|Lost to Follow-up|0|||
48585498|NCT02945254|156335724|FG000|Overall Study|Withdrawal by Subject|1|||
48634371|NCT03391882|156518967|FG003|Study Overall|Protocol Violation|0|||
48634372|NCT03391882|156518968|FG004|Study Overall|Protocol Violation|0|||
48585499|NCT02945254|156335725|FG001|Overall Study|Withdrawal by Subject|0|||
48585500|NCT02612610|156335726|FG000|Overall Study|Withdrawal by Subject|1|||
48585501|NCT02612610|156335727|FG001|Overall Study|Withdrawal by Subject|1|||
48585502|NCT02612610|156335728|FG002|Overall Study|Withdrawal by Subject|0|||
48585503|NCT02612610|156335729|FG003|Overall Study|Withdrawal by Subject|2|||
48585504|NCT02612610|156335726|FG000|Overall Study|Adverse Event|2|||
48585505|NCT02612610|156335727|FG001|Overall Study|Adverse Event|2|||
48585506|NCT02612610|156335728|FG002|Overall Study|Adverse Event|3|||
48585507|NCT02612610|156335729|FG003|Overall Study|Adverse Event|10|||
48585508|NCT02612610|156335726|FG000|Overall Study|Lost to Follow-up|0|||
48585509|NCT02612610|156335727|FG001|Overall Study|Lost to Follow-up|1|||
48585510|NCT02612610|156335728|FG002|Overall Study|Lost to Follow-up|0|||
48585511|NCT02612610|156335729|FG003|Overall Study|Lost to Follow-up|0|||
48585512|NCT02612610|156335726|FG000|Overall Study|Protocol Violation|0|||
48585513|NCT02612610|156335727|FG001|Overall Study|Protocol Violation|1|||
48585514|NCT02612610|156335728|FG002|Overall Study|Protocol Violation|1|||
48585515|NCT02612610|156335729|FG003|Overall Study|Protocol Violation|0|||
48585516|NCT02612610|156335726|FG000|Overall Study|Lack of Efficacy|1|||
48585517|NCT02612610|156335727|FG001|Overall Study|Lack of Efficacy|2|||
48585518|NCT02612610|156335728|FG002|Overall Study|Lack of Efficacy|0|||
48634373|NCT03391882|156518969|FG005|Study Overall|Protocol Violation|0|||
48634374|NCT03391882|156518964|FG000|Part A - Titration Phase|Adverse Event|3|||
48634375|NCT03391882|156518965|FG001|Part A - Titration Phase|Adverse Event|6|||
48634376|NCT03391882|156518966|FG002|Part A - Titration Phase|Adverse Event|0|||
48634377|NCT03391882|156518967|FG003|Part A - Titration Phase|Adverse Event|0|||
48634378|NCT03391882|156518968|FG004|Part A - Titration Phase|Adverse Event|0|||
48634379|NCT03391882|156518969|FG005|Part A - Titration Phase|Adverse Event|0|||
48634380|NCT03391882|156518964|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
48634381|NCT03391882|156518965|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
48634382|NCT03391882|156518966|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
48634383|NCT03391882|156518967|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
48634384|NCT03391882|156518968|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
48634385|NCT03391882|156518969|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
48634386|NCT03391882|156518964|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
48634387|NCT03391882|156518965|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
48634388|NCT03391882|156518966|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
48634389|NCT03391882|156518967|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
48634390|NCT03391882|156518968|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
48634391|NCT03391882|156518969|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
48634392|NCT03391882|156518964|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
48634393|NCT03391882|156518965|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
48634394|NCT03391882|156518966|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
48634395|NCT03391882|156518967|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
48585519|NCT02612610|156335729|FG003|Overall Study|Lack of Efficacy|1|||
48585520|NCT02612610|156335726|FG000|Overall Study|Physician Decision|0|||
48634396|NCT03391882|156518968|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
48634397|NCT03391882|156518969|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
48634398|NCT03391882|156518964|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
48634399|NCT03391882|156518965|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
48634400|NCT03391882|156518966|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
48634401|NCT03391882|156518967|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
48634402|NCT03391882|156518968|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
48634403|NCT03391882|156518969|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
48634404|NCT03391882|156518964|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
48585521|NCT02612610|156335727|FG001|Overall Study|Physician Decision|1|||
48585522|NCT02612610|156335728|FG002|Overall Study|Physician Decision|0|||
48585523|NCT02612610|156335729|FG003|Overall Study|Physician Decision|0|||
48585524|NCT02612610|156335726|FG000|Overall Study|Noncompliance|1|||
48585525|NCT02612610|156335727|FG001|Overall Study|Noncompliance|0|||
48634405|NCT03391882|156518965|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
48634406|NCT03391882|156518966|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
48634407|NCT03391882|156518967|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
48585526|NCT02612610|156335728|FG002|Overall Study|Noncompliance|0|||
48585527|NCT02612610|156335729|FG003|Overall Study|Noncompliance|0|||
48745831|NCT03572062|156918049|FG005|Overall Study|Lost to Follow-up|1|||
48326614|NCT03451422|155394059|FG004|Overall Study|Decision by sponsor|0|||
48634408|NCT03391882|156518968|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
48634409|NCT03391882|156518969|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
48634410|NCT03391882|156518964|FG000|Part B - Treatment Phase|Adverse Event|0|||
48634411|NCT03391882|156518965|FG001|Part B - Treatment Phase|Adverse Event|0|||
48634412|NCT03391882|156518966|FG002|Part B - Treatment Phase|Adverse Event|1|||
48634413|NCT03391882|156518967|FG003|Part B - Treatment Phase|Adverse Event|1|||
48634414|NCT03391882|156518968|FG004|Part B - Treatment Phase|Adverse Event|3|||
48634415|NCT03391882|156518969|FG005|Part B - Treatment Phase|Adverse Event|1|||
48634416|NCT03391882|156518964|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
48634417|NCT03391882|156518965|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
48634418|NCT03391882|156518966|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
48634419|NCT03391882|156518967|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
48634420|NCT03391882|156518968|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
48634421|NCT03391882|156518969|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
48634422|NCT01722669|156518970|FG000|Overall Study|Withdrawal by Subject|0|||
48634423|NCT01722669|156518971|FG001|Overall Study|Withdrawal by Subject|0|||
48634424|NCT01722669|156518972|FG002|Overall Study|Withdrawal by Subject|0|||
48634425|NCT01722669|156518973|FG003|Overall Study|Withdrawal by Subject|0|||
48634426|NCT01722669|156518974|FG004|Overall Study|Withdrawal by Subject|0|||
48634427|NCT01722669|156518975|FG005|Overall Study|Withdrawal by Subject|2|||
48634428|NCT04660539|156518978|FG000|Overall Study|Adverse Event|10|||
48634429|NCT04660539|156518978|FG000|Overall Study|Lack of Efficacy|4|||
48634430|NCT04660539|156518978|FG000|Overall Study|Lost to Follow-up|5|||
48634431|NCT04660539|156518978|FG000|Overall Study|Non-Compliance With Study Drug|3|||
48634432|NCT04660539|156518978|FG000|Overall Study|Reason not Specified|12|||
48634433|NCT04660539|156518978|FG000|Overall Study|Pregnancy|2|||
48634434|NCT04660539|156518978|FG000|Overall Study|Protocol Violation|2|||
48634435|NCT04660539|156518978|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
48634436|NCT04660539|156518978|FG000|Overall Study|Withdrawal by Subject|21|||
48634437|NCT03132467|156518986|FG000|Overall Study|Adverse Event|2|||
48634438|NCT03132467|156518986|FG000|Overall Study|Withdrawal by Subject|2|||
48634439|NCT00542178|156518987|FG000|Overall Study|did not complete year 4 follow-up|75|||
48634440|NCT00542178|156518988|FG001|Overall Study|did not complete year 4 follow-up|80|||
48634441|NCT00542178|156518989|FG002|Overall Study|did not complete year 4 follow-up|74|||
48634442|NCT00542178|156518990|FG003|Overall Study|did not complete year 4 follow-up|62|||
48634443|NCT00542178|156518991|FG004|Overall Study|did not complete year 4 follow-up|64|||
48634444|NCT00542178|156518992|FG005|Overall Study|did not complete year 4 follow-up|89|||
48745832|NCT03572062|156918050|FG006|Overall Study|Lost to Follow-up|1|||
48745833|NCT03572062|156918051|FG007|Overall Study|Lost to Follow-up|0|||
48745834|NCT03572062|156918052|FG008|Overall Study|Lost to Follow-up|0|||
48745835|NCT03572062|156918053|FG009|Overall Study|Lost to Follow-up|0|||
48745836|NCT03572062|156918044|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48585528|NCT02612610|156335726|FG000|Overall Study|Cough Improvement|0|||
48585529|NCT02612610|156335727|FG001|Overall Study|Cough Improvement|0|||
48585530|NCT02612610|156335728|FG002|Overall Study|Cough Improvement|1|||
48585531|NCT02612610|156335729|FG003|Overall Study|Cough Improvement|0|||
48585532|NCT01398410|156335730|FG000|Overall Study|Adverse Event|12|||
48585533|NCT01398410|156335731|FG001|Overall Study|Adverse Event|16|||
48585534|NCT01398410|156335730|FG000|Overall Study|Participants Choice|8|||
48634445|NCT00542178|156518993|FG006|Overall Study|did not complete year 4 follow-up|87|||
48634446|NCT00542178|156518994|FG007|Overall Study|did not complete year 4 follow-up|85|||
48585535|NCT01398410|156335731|FG001|Overall Study|Participants Choice|11|||
48585536|NCT01398410|156335730|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
48585537|NCT01398410|156335731|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
48585538|NCT01398410|156335730|FG000|Overall Study|Other|36|||
48326615|NCT03451422|155394060|FG005|Overall Study|Decision by sponsor|0|||
48326616|NCT03451422|155394055|FG000|Overall Study|Withdrawal by Subject|0|||
48634447|NCT03440385|156520610|FG000|Overall Study|Other Reason|4|||
48326617|NCT03451422|155394056|FG001|Overall Study|Withdrawal by Subject|0|||
48326618|NCT03451422|155394057|FG002|Overall Study|Withdrawal by Subject|2|||
48326619|NCT03451422|155394058|FG003|Overall Study|Withdrawal by Subject|3|||
48634448|NCT03440385|156520611|FG001|Overall Study|Other Reason|1|||
48634449|NCT03440385|156520610|FG000|Overall Study|Site Closed|1|||
48585539|NCT01398410|156335731|FG001|Overall Study|Other|29|||
48585540|NCT00783224|156335732|FG000|Overall Study|Adverse Event|0|||
48585541|NCT00783224|156335733|FG001|Overall Study|Adverse Event|0|||
48585542|NCT00783224|156335734|FG002|Overall Study|Adverse Event|1|||
48634450|NCT03440385|156520611|FG001|Overall Study|Site Closed|0|||
48634451|NCT03440385|156520610|FG000|Overall Study|Lost to Follow-up|2|||
48634452|NCT03440385|156520611|FG001|Overall Study|Lost to Follow-up|0|||
48634453|NCT03440385|156520610|FG000|Overall Study|Withdrawal by Subject|12|||
48634454|NCT03440385|156520611|FG001|Overall Study|Withdrawal by Subject|6|||
48585543|NCT00783224|156335735|FG003|Overall Study|Adverse Event|0|||
48585544|NCT00783224|156335732|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
48585545|NCT00783224|156335733|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
48634455|NCT03440385|156520610|FG000|Overall Study|Lack of Efficacy|9|||
48634456|NCT03440385|156520611|FG001|Overall Study|Lack of Efficacy|2|||
48634457|NCT03440385|156520610|FG000|Overall Study|Adverse Event|15|||
48634458|NCT03440385|156520611|FG001|Overall Study|Adverse Event|11|||
48634459|NCT02297516|156520614|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
48634460|NCT02297516|156520615|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
48634461|NCT02297516|156520614|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
48634462|NCT02297516|156520615|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
48634463|NCT02297516|156520614|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
48634464|NCT02297516|156520615|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
48634465|NCT01693367|156520624|FG000|Overall Study|Withdrawal by Subject|1|||
48634466|NCT01693367|156520625|FG001|Overall Study|Withdrawal by Subject|1|||
48634467|NCT01693367|156520624|FG000|Overall Study|Physician Decision|0|||
48634468|NCT01693367|156520625|FG001|Overall Study|Physician Decision|1|||
48634469|NCT01645176|156520626|FG000|Overall Study|Lack of Efficacy|4|||
48634470|NCT01645176|156520626|FG000|Overall Study|did not complete final MRI|1|||
48634471|NCT00949533|156520627|FG000|Overall Study|Lost to Follow-up|0|||
48585546|NCT00783224|156335734|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
48585547|NCT00783224|156335735|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
48585548|NCT00783224|156335732|FG000|Overall Study|Inappropriate as a study subject|0|||
48585549|NCT00783224|156335733|FG001|Overall Study|Inappropriate as a study subject|0|||
48585550|NCT00783224|156335734|FG002|Overall Study|Inappropriate as a study subject|0|||
48585551|NCT00783224|156335735|FG003|Overall Study|Inappropriate as a study subject|1|||
48585552|NCT04245202|156335737|FG000|Overall Study|Lack of Efficacy|10|||
48585553|NCT04245202|156335738|FG001|Overall Study|Lack of Efficacy|1|||
48585554|NCT00090584|156335739|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
48585555|NCT00090584|156335740|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
48585556|NCT00090584|156335739|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
48585557|NCT00090584|156335740|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
48585558|NCT02470403|156335741|FG000|Overall Study|Adverse Event|1|||
48585559|NCT02470403|156335742|FG001|Overall Study|Adverse Event|0|||
48585560|NCT02470403|156335743|FG002|Overall Study|Adverse Event|0|||
48585561|NCT02470403|156335744|FG003|Overall Study|Adverse Event|0|||
48585562|NCT02470403|156335745|FG004|Overall Study|Adverse Event|0|||
48585563|NCT02470403|156335741|FG000|Overall Study|Lost to Follow-up|0|||
48585564|NCT02470403|156335742|FG001|Overall Study|Lost to Follow-up|1|||
48585565|NCT02470403|156335743|FG002|Overall Study|Lost to Follow-up|0|||
48585566|NCT02470403|156335744|FG003|Overall Study|Lost to Follow-up|0|||
48585567|NCT02470403|156335745|FG004|Overall Study|Lost to Follow-up|0|||
48634472|NCT00949533|156520628|FG001|Overall Study|Lost to Follow-up|1|||
48634473|NCT04507763|156520629|FG000|Overall Study|Participants did not meet entrance criteria|201|||
48634474|NCT03243084|156520630|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
48634475|NCT03243084|156520631|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
48634476|NCT04618471|156520640|FG000|Overall Study|Screen Failure|62|||
48634477|NCT04618471|156520640|FG000|Overall Study|Withdrawal by Subject|6|||
48634478|NCT04618471|156520640|FG000|Overall Study|Physician Decision|2|||
48634479|NCT04618471|156520640|FG000|Overall Study|Lost to Follow-up|1|||
48634480|NCT04618471|156520640|FG000|Overall Study|Various other reasons|2|||
48634481|NCT04618471|156520640|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
48634482|NCT02441218|156520641|FG000|Overall Study|Death|503|||
48634483|NCT02441218|156520642|FG001|Overall Study|Death|553|||
48634484|NCT02441218|156520641|FG000|Overall Study|Withdrawal by Subject|73|||
48634485|NCT02441218|156520642|FG001|Overall Study|Withdrawal by Subject|58|||
48634486|NCT02441218|156520641|FG000|Overall Study|Lost to Follow-up|2|||
48634487|NCT02441218|156520642|FG001|Overall Study|Lost to Follow-up|1|||
48634488|NCT05136170|156520645|FG000|Overall Study|Withdrawal by Subject|2|||
48634489|NCT05136170|156520646|FG001|Overall Study|Withdrawal by Subject|2|||
48634490|NCT05136170|156520645|FG000|Overall Study|Can no longer make office visits|1|||
48585568|NCT02470403|156335741|FG000|Overall Study|Subject/guardian decision|1|||
48426639|NCT02399475|155751289|FG000|Overall Study|Physician Decision|1|||
48585569|NCT02470403|156335742|FG001|Overall Study|Subject/guardian decision|0|||
48585570|NCT02470403|156335743|FG002|Overall Study|Subject/guardian decision|0|||
48585571|NCT02470403|156335744|FG003|Overall Study|Subject/guardian decision|4|||
48585572|NCT02470403|156335745|FG004|Overall Study|Subject/guardian decision|0|||
48634491|NCT05136170|156520646|FG001|Overall Study|Can no longer make office visits|0|||
48634492|NCT03528902|156520654|FG000|Overall Study|Adverse Event|1|||
48634493|NCT03528902|156520655|FG001|Overall Study|Adverse Event|0|||
48634494|NCT04439266|156520658|FG000|Overall Study|Ineligible|1|||
48634495|NCT04439266|156520658|FG000|Overall Study|Adverse Event|1|||
48634496|NCT04439266|156520658|FG000|Overall Study|Death|1|||
48634497|NCT04439266|156520658|FG000|Overall Study|Disease progression|1|||
48634498|NCT04439266|156520658|FG000|Overall Study|Still on treatment|1|||
48634499|NCT01038323|156520663|FG000|Overall Study|Withdrawal by Subject|3|||
48326620|NCT03451422|155394059|FG004|Overall Study|Withdrawal by Subject|2|||
48585573|NCT00862459|156335751|FG000|Overall Study|Lost to Follow-up|1|||
48585574|NCT00862459|156335752|FG001|Overall Study|Lost to Follow-up|2|||
48585575|NCT00862459|156335753|FG002|Overall Study|Lost to Follow-up|2|||
48585576|NCT00862459|156335751|FG000|Overall Study|Protocol Violation|1|||
48326621|NCT03451422|155394060|FG005|Overall Study|Withdrawal by Subject|1|||
48326622|NCT00403494|155394061|FG000|Overall Study|Adverse Event|10|||
48585577|NCT00862459|156335752|FG001|Overall Study|Protocol Violation|0|||
48585578|NCT00862459|156335753|FG002|Overall Study|Protocol Violation|0|||
48585579|NCT00862459|156335751|FG000|Overall Study|Withdrawal by Subject|1|||
48585580|NCT00862459|156335752|FG001|Overall Study|Withdrawal by Subject|1|||
48585581|NCT00862459|156335753|FG002|Overall Study|Withdrawal by Subject|3|||
48585582|NCT00862459|156335751|FG000|Overall Study|Adverse Event|0|||
48585583|NCT00862459|156335752|FG001|Overall Study|Adverse Event|1|||
48585584|NCT00862459|156335753|FG002|Overall Study|Adverse Event|0|||
48585585|NCT00862459|156335751|FG000|Overall Study|Personal reasons|1|||
48585586|NCT00862459|156335752|FG001|Overall Study|Personal reasons|0|||
48585587|NCT00862459|156335753|FG002|Overall Study|Personal reasons|0|||
48585588|NCT00862459|156335751|FG000|Overall Study|Operation|1|||
48585589|NCT00862459|156335752|FG001|Overall Study|Operation|1|||
48585590|NCT00862459|156335753|FG002|Overall Study|Operation|0|||
48585591|NCT00862459|156335751|FG000|Overall Study|Intravenous (IV) site problems|1|||
48585592|NCT00862459|156335752|FG001|Overall Study|Intravenous (IV) site problems|0|||
48585593|NCT00862459|156335753|FG002|Overall Study|Intravenous (IV) site problems|1|||
48585594|NCT00862459|156335751|FG000|Overall Study|Unable to hold still for imaging|0|||
48585595|NCT00862459|156335752|FG001|Overall Study|Unable to hold still for imaging|1|||
48585596|NCT00862459|156335753|FG002|Overall Study|Unable to hold still for imaging|0|||
48585597|NCT00862459|156335751|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
48585598|NCT00862459|156335752|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
48585599|NCT00862459|156335753|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
48585600|NCT00862459|156335751|FG000|Overall Study|Administrative problems|0|||
48585601|NCT00862459|156335752|FG001|Overall Study|Administrative problems|1|||
48585602|NCT00862459|156335753|FG002|Overall Study|Administrative problems|0|||
48585603|NCT03422159|156335754|FG000|Overall Study|Exclusion due to terminal disease|2|||
48585604|NCT03422159|156335755|FG001|Overall Study|Exclusion due to terminal disease|1|||
48585605|NCT03436199|156335756|FG000|Overall Study|Adverse Event|15|||
48585606|NCT03436199|156335757|FG001|Overall Study|Adverse Event|40|||
48585607|NCT03436199|156335758|FG002|Overall Study|Adverse Event|7|||
48585608|NCT03436199|156335756|FG000|Overall Study|Withdrawal by Subject|4|||
48585609|NCT03436199|156335757|FG001|Overall Study|Withdrawal by Subject|10|||
48585610|NCT03436199|156335758|FG002|Overall Study|Withdrawal by Subject|3|||
48585611|NCT03436199|156335756|FG000|Overall Study|Lost to Follow-up|1|||
48585612|NCT03436199|156335757|FG001|Overall Study|Lost to Follow-up|0|||
48585613|NCT03436199|156335758|FG002|Overall Study|Lost to Follow-up|2|||
48585614|NCT03436199|156335756|FG000|Overall Study|Protocol Violation|1|||
48585615|NCT03436199|156335757|FG001|Overall Study|Protocol Violation|1|||
48585616|NCT03436199|156335758|FG002|Overall Study|Protocol Violation|0|||
48585617|NCT03436199|156335756|FG000|Overall Study|Physician Decision|0|||
48585618|NCT03436199|156335757|FG001|Overall Study|Physician Decision|1|||
48585619|NCT03436199|156335758|FG002|Overall Study|Physician Decision|0|||
48585620|NCT03436199|156335756|FG000|Overall Study|Could not return to clinic|1|||
48585621|NCT03436199|156335757|FG001|Overall Study|Could not return to clinic|0|||
48585622|NCT03436199|156335758|FG002|Overall Study|Could not return to clinic|0|||
48585623|NCT03436199|156335756|FG000|Overall Study|Withdrawn per physician|0|||
48585624|NCT03436199|156335757|FG001|Overall Study|Withdrawn per physician|1|||
48585625|NCT03436199|156335758|FG002|Overall Study|Withdrawn per physician|0|||
48585626|NCT00717275|156335759|FG000|Overall Study|Premature study termination.|3|||
48585627|NCT02631070|156335765|FG000|Overall Study|Withdrawal by Subject|35|||
48585628|NCT02631070|156335766|FG001|Overall Study|Withdrawal by Subject|13|||
48585629|NCT02631070|156335765|FG000|Overall Study|Death|45|||
48585630|NCT02631070|156335766|FG001|Overall Study|Death|24|||
48585631|NCT02631070|156335765|FG000|Overall Study|Lost to Follow-up|5|||
48585632|NCT02631070|156335766|FG001|Overall Study|Lost to Follow-up|1|||
48585633|NCT02631070|156335765|FG000|Overall Study|Transition to rollover protocol|52|||
48585634|NCT02631070|156335766|FG001|Overall Study|Transition to rollover protocol|21|||
48585635|NCT02631070|156335765|FG000|Overall Study|Other reasons|12|||
48585636|NCT02631070|156335766|FG001|Overall Study|Other reasons|5|||
48585637|NCT04631107|156335767|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
48585638|NCT04631107|156335767|FG000|Second Intervention (1 Night)|Adverse Event|1|||
48585639|NCT04631107|156335767|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
48585640|NCT04631107|156335767|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
48585641|NCT02003963|156335768|FG000|Overall Study|Lost to Follow-up|2|||
48585642|NCT02003963|156335769|FG001|Overall Study|Lost to Follow-up|1|||
48585643|NCT02735096|156335770|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
48634500|NCT01038323|156520664|FG001|Overall Study|Withdrawal by Subject|2|||
48634501|NCT01038323|156520665|FG002|Overall Study|Withdrawal by Subject|4|||
48634502|NCT02757430|156520666|FG000|Overall Study|Physician Decision|6|||
48634503|NCT02757430|156520666|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
48634504|NCT02757430|156520666|FG000|Overall Study|No informed consent|1|||
48634505|NCT02757430|156520666|FG000|Overall Study|No procedure performed|2|||
48634506|NCT02394561|156520668|FG000|CORE Phase|Adverse Event|7|||
48634507|NCT02394561|156520669|FG001|CORE Phase|Adverse Event|9|||
48634508|NCT02394561|156520668|FG000|CORE Phase|Death|0|||
48634509|NCT02394561|156520669|FG001|CORE Phase|Death|1|||
48634510|NCT02394561|156520668|FG000|CORE Phase|Pregnancy|1|||
48634511|NCT02394561|156520669|FG001|CORE Phase|Pregnancy|0|||
48634512|NCT02394561|156520668|FG000|CORE Phase|Lost to Follow-up|1|||
48634513|NCT02394561|156520669|FG001|CORE Phase|Lost to Follow-up|0|||
48634514|NCT02394561|156520668|FG000|CORE Phase|Physician Decision|1|||
48634515|NCT02394561|156520669|FG001|CORE Phase|Physician Decision|1|||
48634516|NCT02394561|156520668|FG000|CORE Phase|Withdrawal by Subject|2|||
48634517|NCT02394561|156520669|FG001|CORE Phase|Withdrawal by Subject|2|||
48634518|NCT02394561|156520668|FG000|CORE Phase|Lack of Efficacy|1|||
48634519|NCT02394561|156520669|FG001|CORE Phase|Lack of Efficacy|6|||
48634520|NCT02394561|156520668|FG000|Extension Phase|Adverse Event|6|||
48634521|NCT02394561|156520669|FG001|Extension Phase|Adverse Event|1|||
48634522|NCT02394561|156520668|FG000|Extension Phase|Death|0|||
48634523|NCT02394561|156520669|FG001|Extension Phase|Death|1|||
48634524|NCT02394561|156520668|FG000|Extension Phase|Protocol Violation|1|||
48634525|NCT02394561|156520669|FG001|Extension Phase|Protocol Violation|0|||
48634526|NCT02394561|156520668|FG000|Extension Phase|Lost to Follow-up|1|||
48634527|NCT02394561|156520669|FG001|Extension Phase|Lost to Follow-up|0|||
48634528|NCT02394561|156520668|FG000|Extension Phase|Physician Decision|0|||
48634529|NCT02394561|156520669|FG001|Extension Phase|Physician Decision|2|||
48634530|NCT02394561|156520668|FG000|Extension Phase|Withdrawal by Subject|0|||
48634531|NCT02394561|156520669|FG001|Extension Phase|Withdrawal by Subject|5|||
48634532|NCT02394561|156520668|FG000|Extension Phase|Lack of Efficacy|3|||
48634533|NCT02394561|156520669|FG001|Extension Phase|Lack of Efficacy|3|||
48634534|NCT03434834|156520670|FG000|Overall Study|unable to swallow OCT probe|16|||
48634535|NCT03047135|156520671|FG000|Overall Study|Still being treated|3|||
48634536|NCT01736917|156520672|FG000|Overall Study|Adverse Event|1|||
48634537|NCT01736917|156520672|FG000|Overall Study|Protocol Violation|10|||
48634538|NCT04138056|156520677|FG000|Primary Study|Lost to Follow-up|3|||
48634539|NCT04138056|156520678|FG001|Primary Study|Lost to Follow-up|4|||
48634540|NCT04138056|156520679|FG002|Primary Study|Lost to Follow-up|1|||
48634541|NCT04138056|156520680|FG003|Primary Study|Lost to Follow-up|1|||
48634542|NCT04138056|156520681|FG004|Primary Study|Lost to Follow-up|4|||
48634543|NCT04138056|156520677|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
48634544|NCT04138056|156520678|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
48634545|NCT04138056|156520679|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
48634546|NCT04138056|156520680|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
48634547|NCT04138056|156520681|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
48634548|NCT04138056|156520677|FG000|Extension Study|Lost to Follow-up|1|||
48745837|NCT03572062|156918045|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745838|NCT03572062|156918046|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745839|NCT03572062|156918047|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745840|NCT03572062|156918048|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745841|NCT03572062|156918049|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745842|NCT03572062|156918050|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745843|NCT03572062|156918051|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745844|NCT03572062|156918052|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
48745845|NCT03572062|156918053|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
48745846|NCT03572062|156918044|FG000|Overall Study|Study Terminated By Sponsor|0|||
48745847|NCT03572062|156918045|FG001|Overall Study|Study Terminated By Sponsor|0|||
48634549|NCT04138056|156520678|FG001|Extension Study|Lost to Follow-up|2|||
48634550|NCT04138056|156520679|FG002|Extension Study|Lost to Follow-up|1|||
48634551|NCT04138056|156520680|FG003|Extension Study|Lost to Follow-up|0|||
48634552|NCT04138056|156520681|FG004|Extension Study|Lost to Follow-up|1|||
48634553|NCT04103450|156520682|FG000|Overall Study|Adverse Event|4|||
48634554|NCT04103450|156520683|FG001|Overall Study|Adverse Event|2|||
48634555|NCT04103450|156520682|FG000|Overall Study|Lack of Efficacy|3|||
48634556|NCT04103450|156520683|FG001|Overall Study|Lack of Efficacy|0|||
48585644|NCT00586508|156335774|FG000|Overall Study|Progressive disease|52|||
48585645|NCT00586508|156335775|FG001|Overall Study|Progressive disease|8|||
48585646|NCT00586508|156335774|FG000|Overall Study|Death|0|||
48585647|NCT00586508|156335775|FG001|Overall Study|Death|1|||
48585648|NCT00586508|156335774|FG000|Overall Study|Adverse Event|12|||
48585649|NCT00586508|156335775|FG001|Overall Study|Adverse Event|4|||
48585650|NCT00586508|156335774|FG000|Overall Study|Withdrawal by Subject|4|||
48585651|NCT00586508|156335775|FG001|Overall Study|Withdrawal by Subject|0|||
48585652|NCT03564795|156335779|FG000|Overall Study|Withdrawal by Subject|3|||
48585653|NCT03564795|156335779|FG000|Overall Study|Lost to Follow-up|6|||
48585654|NCT03564795|156335779|FG000|Overall Study|Physician Decision|2|||
48585655|NCT00085098|156335780|FG000|Overall Study|Withdrawal by Subject|0|||
48585656|NCT00085098|156335781|FG001|Overall Study|Withdrawal by Subject|1|||
48326623|NCT00403494|155394062|FG001|Overall Study|Adverse Event|8|||
48326624|NCT00403494|155394061|FG000|Overall Study|Withdrew Consent|3|||
48326625|NCT00403494|155394062|FG001|Overall Study|Withdrew Consent|2|||
48585657|NCT00085098|156335780|FG000|Overall Study|Ineligible|1|||
48585658|NCT00085098|156335781|FG001|Overall Study|Ineligible|1|||
48585659|NCT01195844|156335784|FG000|Overall Study|Fecal sample not collected|40|||
48585660|NCT03515629|156335785|FG000|Overall Study|Death|0|||
48634557|NCT04103450|156520682|FG000|Overall Study|Withdrawal by Subject|5|||
48634558|NCT04103450|156520683|FG001|Overall Study|Withdrawal by Subject|3|||
48634559|NCT04103450|156520682|FG000|Overall Study|Lost to Follow-up|1|||
48634560|NCT04103450|156520683|FG001|Overall Study|Lost to Follow-up|2|||
48634561|NCT04103450|156520682|FG000|Overall Study|Physician Decision|1|||
48634562|NCT04103450|156520683|FG001|Overall Study|Physician Decision|2|||
48634563|NCT04103450|156520682|FG000|Overall Study|Protocol Violation|1|||
48634564|NCT04103450|156520683|FG001|Overall Study|Protocol Violation|0|||
48634565|NCT04103450|156520682|FG000|Overall Study|Other|1|||
48634566|NCT04103450|156520683|FG001|Overall Study|Other|1|||
48634567|NCT01133847|156520697|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
48634568|NCT01133847|156520698|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
48585661|NCT03515629|156335786|FG001|Overall Study|Death|1|||
48585662|NCT03515629|156335787|FG002|Overall Study|Death|1|||
48585663|NCT03515629|156335785|FG000|Overall Study|Progressive disease|0|||
48585664|NCT03515629|156335786|FG001|Overall Study|Progressive disease|1|||
48585665|NCT03515629|156335787|FG002|Overall Study|Progressive disease|0|||
48585666|NCT03329248|156335788|FG000|Overall Study|Progressive Disease|6|||
48585667|NCT01886781|156335795|FG000|Overall Study|Protocol Violation|5|||
48585668|NCT01886781|156335796|FG001|Overall Study|Protocol Violation|0|||
48585669|NCT01886781|156335795|FG000|Overall Study|Adverse Event|1|||
48585670|NCT01886781|156335796|FG001|Overall Study|Adverse Event|0|||
48585671|NCT01886781|156335795|FG000|Overall Study|Lost to Follow-up|5|||
48585672|NCT01886781|156335796|FG001|Overall Study|Lost to Follow-up|0|||
48585673|NCT01886781|156335795|FG000|Overall Study|Withdrawal by Subject|2|||
48585674|NCT01886781|156335796|FG001|Overall Study|Withdrawal by Subject|1|||
48326626|NCT00403494|155394061|FG000|Overall Study|Inappropriately enrolled|0|||
48326627|NCT00403494|155394062|FG001|Overall Study|Inappropriately enrolled|1|||
48326628|NCT00403494|155394061|FG000|Overall Study|Lost to Follow-up|0|||
48326629|NCT00403494|155394062|FG001|Overall Study|Lost to Follow-up|2|||
48326630|NCT00403494|155394061|FG000|Overall Study|Protocol noncompliance|0|||
48326631|NCT00403494|155394062|FG001|Overall Study|Protocol noncompliance|1|||
48326632|NCT00403494|155394061|FG000|Overall Study|Death|1|||
48326633|NCT00403494|155394062|FG001|Overall Study|Death|0|||
48326634|NCT00403494|155394061|FG000|Overall Study|Sponsor Request|1|||
48634569|NCT01133847|156520699|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
48634570|NCT01133847|156520697|FG000|Follow-Up Phase|Lost to Follow-up|1|||
48634571|NCT01133847|156520698|FG001|Follow-Up Phase|Lost to Follow-up|3|||
48745848|NCT03572062|156918046|FG002|Overall Study|Study Terminated By Sponsor|0|||
48745849|NCT03572062|156918047|FG003|Overall Study|Study Terminated By Sponsor|0|||
48326635|NCT00403494|155394062|FG001|Overall Study|Sponsor Request|0|||
48326636|NCT03274076|155394066|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
48326637|NCT03274076|155394067|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
48634572|NCT01133847|156520699|FG002|Follow-Up Phase|Lost to Follow-up|7|||
48634573|NCT00940602|156520700|FG000|Overall Study|Administrative problems|1|||
48634574|NCT00940602|156520701|FG001|Overall Study|Administrative problems|1|||
48634575|NCT00940602|156520700|FG000|Overall Study|Patient/guardian decision|13|||
48634576|NCT00940602|156520701|FG001|Overall Study|Patient/guardian decision|28|||
48634577|NCT00940602|156520700|FG000|Overall Study|Physician Decision|8|||
48634578|NCT00940602|156520701|FG001|Overall Study|Physician Decision|5|||
48634579|NCT00940602|156520700|FG000|Overall Study|Pregnancy|1|||
48634580|NCT00940602|156520701|FG001|Overall Study|Pregnancy|0|||
48634581|NCT00940602|156520700|FG000|Overall Study|Protocol Deviation (untreated)|1|||
48634582|NCT00940602|156520701|FG001|Overall Study|Protocol Deviation (untreated)|0|||
48634583|NCT00940602|156520700|FG000|Overall Study|Disease progression|8|||
48634584|NCT00940602|156520701|FG001|Overall Study|Disease progression|2|||
48634585|NCT00940602|156520700|FG000|Overall Study|Death|38|||
48634586|NCT00940602|156520701|FG001|Overall Study|Death|19|||
48634587|NCT00940602|156520700|FG000|Overall Study|Lost to Follow-up|3|||
48634588|NCT00940602|156520701|FG001|Overall Study|Lost to Follow-up|1|||
48634589|NCT00940602|156520700|FG000|Overall Study|Patient withdrew consent|26|||
48634590|NCT00940602|156520701|FG001|Overall Study|Patient withdrew consent|13|||
48634591|NCT00940602|156520700|FG000|Overall Study|Adverse Event|7|||
48634592|NCT00940602|156520701|FG001|Overall Study|Adverse Event|2|||
48634593|NCT00940602|156520700|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
48634594|NCT00940602|156520701|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
48634595|NCT01854528|156520702|FG000|Overall Study|Adverse Event|0|||
48634596|NCT01854528|156520703|FG001|Overall Study|Adverse Event|4|||
48634597|NCT01854528|156520702|FG000|Overall Study|Withdrawal by Subject|0|||
48634598|NCT01854528|156520703|FG001|Overall Study|Withdrawal by Subject|2|||
48634599|NCT01854528|156520702|FG000|Overall Study|Virologic Failure|0|||
48634600|NCT01854528|156520703|FG001|Overall Study|Virologic Failure|9|||
48634601|NCT01696643|156520705|FG000|Overall Study|Adverse Event|15|||
48634602|NCT01696643|156520706|FG001|Overall Study|Adverse Event|7|||
48634603|NCT01696643|156520705|FG000|Overall Study|Death|1|||
48634604|NCT01696643|156520706|FG001|Overall Study|Death|2|||
48634605|NCT01696643|156520705|FG000|Overall Study|Lack of Efficacy|3|||
48634606|NCT01696643|156520706|FG001|Overall Study|Lack of Efficacy|0|||
48634607|NCT01696643|156520705|FG000|Overall Study|Lost to Follow-up|67|||
48634608|NCT01696643|156520706|FG001|Overall Study|Lost to Follow-up|67|||
48326638|NCT03274076|155394068|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
48326639|NCT03274076|155394069|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
48326640|NCT03274076|155394066|FG000|24 Weeks Open Label|Adverse Event|0|||
48326641|NCT03274076|155394067|FG001|24 Weeks Open Label|Adverse Event|0|||
48326642|NCT03274076|155394068|FG002|24 Weeks Open Label|Adverse Event|2|||
48326643|NCT03274076|155394069|FG003|24 Weeks Open Label|Adverse Event|0|||
48326644|NCT03274076|155394066|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
48326645|NCT03274076|155394067|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
48326646|NCT03274076|155394068|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
48326647|NCT03274076|155394069|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
48326648|NCT01530334|155394070|FG000|Overall Study|Adverse Event|3|||
48326649|NCT01530334|155394070|FG000|Overall Study|unknown reason|1|||
48326650|NCT01530334|155394070|FG000|Overall Study|Progressive disease|47|||
48634609|NCT01696643|156520705|FG000|Overall Study|Physician Decision|3|||
48634610|NCT01696643|156520706|FG001|Overall Study|Physician Decision|2|||
48326651|NCT01619059|155394075|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
48326652|NCT01619059|155394076|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
48326653|NCT01619059|155394075|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
48634611|NCT01696643|156520705|FG000|Overall Study|Pregnancy|0|||
48426640|NCT02399475|155751290|FG001|Overall Study|Physician Decision|0|||
48634612|NCT01696643|156520706|FG001|Overall Study|Pregnancy|1|||
48634613|NCT01696643|156520705|FG000|Overall Study|Protocol Violation|7|||
48634614|NCT01696643|156520706|FG001|Overall Study|Protocol Violation|7|||
48634615|NCT01696643|156520705|FG000|Overall Study|Study Terminated by Sponsor|286|||
48634616|NCT01696643|156520706|FG001|Overall Study|Study Terminated by Sponsor|294|||
48634617|NCT01696643|156520705|FG000|Overall Study|Withdrawal by Subject|142|||
48326654|NCT01619059|155394076|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
48326655|NCT01619059|155394075|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
48326656|NCT01619059|155394076|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
48326657|NCT01619059|155394075|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
48326658|NCT01619059|155394076|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
48326659|NCT01619059|155394075|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
48326660|NCT01619059|155394076|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
48326661|NCT01619059|155394075|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
48326662|NCT01619059|155394076|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
48326663|NCT01619059|155394075|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
48326664|NCT01619059|155394076|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
48326665|NCT01619059|155394075|FG000|Long-Term (LT) Treatment Period|Death|1|||
48326666|NCT01619059|155394076|FG001|Long-Term (LT) Treatment Period|Death|0|||
48326667|NCT01619059|155394075|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
48326668|NCT01619059|155394076|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
48326669|NCT01619059|155394075|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
48326670|NCT01619059|155394076|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
48326671|NCT01972776|155394081|FG000|Part 1|Withdrawal by Subject|0|||
48326672|NCT01972776|155394082|FG001|Part 1|Withdrawal by Subject|0|||
48634618|NCT01696643|156520706|FG001|Overall Study|Withdrawal by Subject|149|||
48634619|NCT01696643|156520705|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
48634620|NCT01696643|156520706|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
48634621|NCT01696643|156520705|FG000|Overall Study|Site Error|2|||
48634622|NCT01696643|156520706|FG001|Overall Study|Site Error|1|||
48634623|NCT01696643|156520705|FG000|Overall Study|Participant Incarcerated|0|||
48634624|NCT01696643|156520706|FG001|Overall Study|Participant Incarcerated|1|||
48634625|NCT01696643|156520705|FG000|Overall Study|Medical Monitor Decision|0|||
48634626|NCT01696643|156520706|FG001|Overall Study|Medical Monitor Decision|2|||
48634627|NCT01696643|156520705|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
48634628|NCT01696643|156520706|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
48634629|NCT00016354|156520707|FG000|Overall Study|Lack of Efficacy|0|||
48634630|NCT00016354|156520708|FG001|Overall Study|Lack of Efficacy|0|||
48634631|NCT00016354|156520709|FG002|Overall Study|Lack of Efficacy|0|||
48634632|NCT00016354|156520710|FG003|Overall Study|Lack of Efficacy|0|||
48634633|NCT00016354|156520711|FG004|Overall Study|Lack of Efficacy|0|||
48634634|NCT00016354|156520712|FG005|Overall Study|Lack of Efficacy|0|||
48634635|NCT00016354|156520713|FG006|Overall Study|Lack of Efficacy|0|||
48634636|NCT00016354|156520714|FG007|Overall Study|Lack of Efficacy|1|||
48634637|NCT01968980|156520715|FG000|Overall Study|Death|0|||
48634638|NCT01968980|156520716|FG001|Overall Study|Death|1|||
48634639|NCT01968980|156520715|FG000|Overall Study|Adverse Event|1|||
48634640|NCT01968980|156520716|FG001|Overall Study|Adverse Event|3|||
48634641|NCT01968980|156520715|FG000|Overall Study|Does not meet entry criteria|1|||
48634642|NCT01968980|156520716|FG001|Overall Study|Does not meet entry criteria|3|||
48634643|NCT01968980|156520715|FG000|Overall Study|Withdrawal by Subject|13|||
48634644|NCT01968980|156520716|FG001|Overall Study|Withdrawal by Subject|5|||
48634645|NCT01968980|156520715|FG000|Overall Study|Other unspecified|1|||
48634646|NCT01968980|156520716|FG001|Overall Study|Other unspecified|2|||
48634647|NCT01374425|156520717|FG000|Overall Study|Radiographic Disease Progression|86|||
48634648|NCT01374425|156520718|FG001|Overall Study|Radiographic Disease Progression|81|||
48634649|NCT01374425|156520717|FG000|Overall Study|Clinical Disease Progression|9|||
48634650|NCT01374425|156520718|FG001|Overall Study|Clinical Disease Progression|6|||
48634651|NCT01374425|156520717|FG000|Overall Study|Adverse Event|29|||
48634652|NCT01374425|156520718|FG001|Overall Study|Adverse Event|18|||
48634653|NCT01374425|156520717|FG000|Overall Study|Death (Progression of Disease)|1|||
48634654|NCT01374425|156520718|FG001|Overall Study|Death (Progression of Disease)|0|||
48634655|NCT01374425|156520717|FG000|Overall Study|Death (Adverse Event)|2|||
48634656|NCT01374425|156520718|FG001|Overall Study|Death (Adverse Event)|4|||
48634657|NCT01374425|156520717|FG000|Overall Study|Withdrawal by Subject|6|||
48634658|NCT01374425|156520718|FG001|Overall Study|Withdrawal by Subject|7|||
48634659|NCT01374425|156520717|FG000|Overall Study|Refused Treatment|10|||
48634660|NCT01374425|156520718|FG001|Overall Study|Refused Treatment|24|||
48634661|NCT01374425|156520717|FG000|Overall Study|Protocol Violation|2|||
48634662|NCT01374425|156520718|FG001|Overall Study|Protocol Violation|3|||
48634663|NCT01374425|156520717|FG000|Overall Study|Sponsor Decision|0|||
48634664|NCT01374425|156520718|FG001|Overall Study|Sponsor Decision|1|||
48634665|NCT01374425|156520717|FG000|Overall Study|Lost to Follow-up|2|||
48634666|NCT01374425|156520718|FG001|Overall Study|Lost to Follow-up|1|||
48634667|NCT01374425|156520717|FG000|Overall Study|Other|41|||
48634668|NCT01374425|156520718|FG001|Overall Study|Other|43|||
48634669|NCT03383666|156520719|FG000|Overall Study|Withdrawal by Subject|2|||
48634670|NCT03383666|156520719|FG000|Overall Study|Lost to Follow-up|2|||
48634671|NCT04046939|156520724|FG000|Primary Assessment Period|Adverse Event|1|||
48634672|NCT04046939|156520725|FG001|Primary Assessment Period|Adverse Event|0|||
48634673|NCT04046939|156520726|FG002|Primary Assessment Period|Adverse Event|0|||
48634674|NCT04046939|156520727|FG003|Primary Assessment Period|Adverse Event|0|||
48634675|NCT04046939|156520724|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
48634676|NCT04046939|156520725|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
48634677|NCT04046939|156520726|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
48634678|NCT04046939|156520727|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
48634679|NCT04046939|156520724|FG000|Primary Assessment Period|Physician Decision|0|||
48745850|NCT03572062|156918048|FG004|Overall Study|Study Terminated By Sponsor|0|||
48634680|NCT04046939|156520725|FG001|Primary Assessment Period|Physician Decision|0|||
48634681|NCT04046939|156520726|FG002|Primary Assessment Period|Physician Decision|1|||
48634682|NCT04046939|156520727|FG003|Primary Assessment Period|Physician Decision|0|||
48634683|NCT04046939|156520724|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
48634684|NCT04046939|156520725|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
48634685|NCT04046939|156520726|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
48634686|NCT04046939|156520727|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
48634687|NCT04614324|156520728|FG000|Overall Study|Lost to Follow-up|3|||
48634688|NCT04614324|156520728|FG000|Overall Study|Physician Decision|1|||
48634689|NCT04614324|156520728|FG000|Overall Study|Withdrawal by Subject|2|||
48634690|NCT04614324|156520728|FG000|Overall Study|Remaining in Follow up|123|||
48634691|NCT02561962|156520729|FG000|Overall Study|Withdrawal by Subject|1|||
48326673|NCT01972776|155394083|FG002|Part 1|Withdrawal by Subject|1|||
48634692|NCT02561962|156520730|FG001|Overall Study|Withdrawal by Subject|0|||
48634693|NCT02561962|156520731|FG002|Overall Study|Withdrawal by Subject|0|||
48326674|NCT01972776|155394084|FG003|Part 1|Withdrawal by Subject|0|||
48326675|NCT01972776|155394085|FG004|Part 1|Withdrawal by Subject|0|||
48326676|NCT01972776|155394086|FG005|Part 1|Withdrawal by Subject|0|||
48326677|NCT01972776|155394081|FG000|Part 1|Adverse Event|0|||
48326678|NCT01972776|155394082|FG001|Part 1|Adverse Event|0|||
48326679|NCT01972776|155394083|FG002|Part 1|Adverse Event|1|||
48326680|NCT01972776|155394084|FG003|Part 1|Adverse Event|1|||
48326681|NCT01972776|155394085|FG004|Part 1|Adverse Event|0|||
48326682|NCT01972776|155394086|FG005|Part 1|Adverse Event|0|||
48326683|NCT01972776|155394081|FG000|Part 2|Adverse Event|0|||
48326684|NCT01972776|155394082|FG001|Part 2|Adverse Event|0|||
48326685|NCT01972776|155394083|FG002|Part 2|Adverse Event|0|||
48326686|NCT01972776|155394084|FG003|Part 2|Adverse Event|0|||
48326687|NCT01972776|155394085|FG004|Part 2|Adverse Event|3|||
48326688|NCT01972776|155394086|FG005|Part 2|Adverse Event|0|||
48326689|NCT01972776|155394081|FG000|Part 2|Administrative problems|0|||
48326690|NCT01972776|155394082|FG001|Part 2|Administrative problems|0|||
48326691|NCT01972776|155394083|FG002|Part 2|Administrative problems|0|||
48326692|NCT01972776|155394084|FG003|Part 2|Administrative problems|0|||
48326693|NCT01972776|155394085|FG004|Part 2|Administrative problems|10|||
48326694|NCT01972776|155394086|FG005|Part 2|Administrative problems|7|||
48634694|NCT02561962|156520732|FG003|Overall Study|Withdrawal by Subject|0|||
48634695|NCT02561962|156520733|FG004|Overall Study|Withdrawal by Subject|1|||
48326695|NCT02410278|155394092|FG000|Run-in Period|Adverse Event|5|||
48326696|NCT02410278|155394093|FG001|Run-in Period|Adverse Event|0|||
48326697|NCT02410278|155394094|FG002|Run-in Period|Adverse Event|0|||
48326698|NCT02410278|155394092|FG000|Run-in Period|GSRS Threshold Not Met|30|||
48326699|NCT02410278|155394093|FG001|Run-in Period|GSRS Threshold Not Met|0|||
48326700|NCT02410278|155394094|FG002|Run-in Period|GSRS Threshold Not Met|0|||
48326701|NCT02410278|155394092|FG000|Run-in Period|Lost to Follow-up|1|||
48326702|NCT02410278|155394093|FG001|Run-in Period|Lost to Follow-up|0|||
48326703|NCT02410278|155394094|FG002|Run-in Period|Lost to Follow-up|0|||
48326704|NCT02410278|155394092|FG000|Run-in Period|Withdrawal by Subject|1|||
48326705|NCT02410278|155394093|FG001|Run-in Period|Withdrawal by Subject|0|||
48326706|NCT02410278|155394094|FG002|Run-in Period|Withdrawal by Subject|0|||
48326707|NCT02410278|155394092|FG000|Run-in Period|Pregnancy|1|||
48326708|NCT02410278|155394093|FG001|Run-in Period|Pregnancy|0|||
48326709|NCT02410278|155394094|FG002|Run-in Period|Pregnancy|0|||
48326710|NCT02410278|155394092|FG000|Study Treatment Period|Adverse Event|0|||
48326711|NCT02410278|155394093|FG001|Study Treatment Period|Adverse Event|6|||
48326712|NCT02410278|155394094|FG002|Study Treatment Period|Adverse Event|3|||
48326713|NCT02410278|155394092|FG000|Study Treatment Period|Physician Decision|0|||
48326714|NCT02410278|155394093|FG001|Study Treatment Period|Physician Decision|0|||
48326715|NCT02410278|155394094|FG002|Study Treatment Period|Physician Decision|1|||
48326716|NCT02410278|155394092|FG000|Study Treatment Period|Withdrawal by Subject|0|||
48326717|NCT02410278|155394093|FG001|Study Treatment Period|Withdrawal by Subject|1|||
48326718|NCT02410278|155394094|FG002|Study Treatment Period|Withdrawal by Subject|0|||
48326719|NCT02410278|155394092|FG000|Study Treatment Period|Other|0|||
48326720|NCT02410278|155394093|FG001|Study Treatment Period|Other|3|||
48326721|NCT02410278|155394094|FG002|Study Treatment Period|Other|0|||
48326722|NCT02410278|155394092|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
48326723|NCT02410278|155394093|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
48326724|NCT02410278|155394094|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
48326725|NCT00148122|155394095|FG000|Overall Study|Withdrawal by Subject|2|||
48634696|NCT02561962|156520734|FG005|Overall Study|Withdrawal by Subject|1|||
48634697|NCT02561962|156520735|FG006|Overall Study|Withdrawal by Subject|2|||
48634698|NCT02561962|156520736|FG007|Overall Study|Withdrawal by Subject|1|||
48634699|NCT02561962|156520737|FG008|Overall Study|Withdrawal by Subject|0|||
48326727|NCT00523419|155394099|FG000|Overall Study|Adverse Event|1|||
48326728|NCT00523419|155394099|FG000|Overall Study|Withdrawal by Subject|1|||
48326729|NCT00523419|155394099|FG000|Overall Study|Physician Decision|2|||
48326730|NCT00523419|155394099|FG000|Overall Study|Progressive Disease|22|||
48326731|NCT00523419|155394099|FG000|Overall Study|Death due to Study Disease|4|||
48326732|NCT00523419|155394099|FG000|Overall Study|Death due to Adverse Event|2|||
48326733|NCT01957163|155394100|FG000|Overall Study|Adverse Event|5|||
48326734|NCT01957163|155394101|FG001|Overall Study|Adverse Event|2|||
48745851|NCT03572062|156918049|FG005|Overall Study|Study Terminated By Sponsor|0|||
48326735|NCT01957163|155394102|FG002|Overall Study|Adverse Event|4|||
48326736|NCT01957163|155394100|FG000|Overall Study|Lack of Efficacy|5|||
48326737|NCT01957163|155394101|FG001|Overall Study|Lack of Efficacy|4|||
48326738|NCT01957163|155394102|FG002|Overall Study|Lack of Efficacy|9|||
48326739|NCT01957163|155394100|FG000|Overall Study|Protocol Violation|1|||
48326740|NCT01957163|155394101|FG001|Overall Study|Protocol Violation|2|||
48326741|NCT01957163|155394102|FG002|Overall Study|Protocol Violation|0|||
48326742|NCT01957163|155394100|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
48426716|NCT00893113|155752831|FG000|Overall Study|Withdrew Consent|8|||
48326743|NCT01957163|155394101|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
48326744|NCT01957163|155394102|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
48326745|NCT01957163|155394100|FG000|Overall Study|Lost to Follow-up|0|||
48326746|NCT01957163|155394101|FG001|Overall Study|Lost to Follow-up|1|||
48326747|NCT01957163|155394102|FG002|Overall Study|Lost to Follow-up|0|||
48326748|NCT01957163|155394100|FG000|Overall Study|Withdrawal by Subject|4|||
48326749|NCT01957163|155394101|FG001|Overall Study|Withdrawal by Subject|2|||
48326750|NCT01957163|155394102|FG002|Overall Study|Withdrawal by Subject|4|||
48326751|NCT02091752|155394103|FG000|Overall Study|Study terminated by Sponsor|2|||
48326752|NCT02091752|155394103|FG000|Overall Study|Adverse Event|1|||
48326753|NCT04029090|155394104|FG000|Overall Study|Protocol Violation|1|||
48326754|NCT04029090|155394105|FG001|Overall Study|Protocol Violation|0|||
48326755|NCT04029090|155394106|FG002|Overall Study|Protocol Violation|0|||
48326756|NCT04029090|155394104|FG000|Overall Study|Withdrawal by Subject|0|||
48326757|NCT04029090|155394105|FG001|Overall Study|Withdrawal by Subject|1|||
48326758|NCT04029090|155394106|FG002|Overall Study|Withdrawal by Subject|0|||
48326759|NCT02157948|155394110|FG000|Overall Study|Withdrawal by Subject|4|||
48326760|NCT02157948|155394111|FG001|Overall Study|Withdrawal by Subject|5|||
48326761|NCT02157948|155394110|FG000|Overall Study|Lost to Follow-up|3|||
48326762|NCT02157948|155394111|FG001|Overall Study|Lost to Follow-up|2|||
48326763|NCT02157948|155394110|FG000|Overall Study|Protocol Specified Criteria|2|||
48326764|NCT02157948|155394111|FG001|Overall Study|Protocol Specified Criteria|1|||
48326765|NCT02157948|155394110|FG000|Overall Study|Decision by Sponsor|0|||
48745852|NCT03572062|156918050|FG006|Overall Study|Study Terminated By Sponsor|0|||
48745853|NCT03572062|156918051|FG007|Overall Study|Study Terminated By Sponsor|0|||
48745854|NCT03572062|156918052|FG008|Overall Study|Study Terminated By Sponsor|29|||
48745855|NCT03572062|156918053|FG009|Overall Study|Study Terminated By Sponsor|27|||
48745856|NCT03572062|156918044|FG000|Overall Study|Physician Decision|0|||
48745857|NCT03572062|156918045|FG001|Overall Study|Physician Decision|0|||
48745858|NCT03572062|156918046|FG002|Overall Study|Physician Decision|0|||
48745859|NCT03572062|156918047|FG003|Overall Study|Physician Decision|0|||
48745860|NCT03572062|156918048|FG004|Overall Study|Physician Decision|0|||
48745861|NCT03572062|156918049|FG005|Overall Study|Physician Decision|0|||
48745862|NCT03572062|156918050|FG006|Overall Study|Physician Decision|0|||
48745863|NCT03572062|156918051|FG007|Overall Study|Physician Decision|0|||
48745864|NCT03572062|156918052|FG008|Overall Study|Physician Decision|1|||
48745865|NCT03572062|156918053|FG009|Overall Study|Physician Decision|0|||
48745866|NCT03572062|156918044|FG000|Overall Study|Withdrawal by Subject|0|||
48745867|NCT03572062|156918045|FG001|Overall Study|Withdrawal by Subject|0|||
48745868|NCT03572062|156918046|FG002|Overall Study|Withdrawal by Subject|0|||
48745869|NCT03572062|156918047|FG003|Overall Study|Withdrawal by Subject|0|||
48745870|NCT03572062|156918048|FG004|Overall Study|Withdrawal by Subject|0|||
48745871|NCT03572062|156918049|FG005|Overall Study|Withdrawal by Subject|0|||
48745872|NCT03572062|156918050|FG006|Overall Study|Withdrawal by Subject|0|||
48745873|NCT03572062|156918051|FG007|Overall Study|Withdrawal by Subject|0|||
48745874|NCT03572062|156918052|FG008|Overall Study|Withdrawal by Subject|0|||
48745875|NCT03572062|156918053|FG009|Overall Study|Withdrawal by Subject|1|||
48745876|NCT03572062|156918044|FG000|Overall Study|Randomized But Not Treated|0|||
48745877|NCT03572062|156918045|FG001|Overall Study|Randomized But Not Treated|0|||
48745878|NCT03572062|156918046|FG002|Overall Study|Randomized But Not Treated|0|||
48745879|NCT03572062|156918047|FG003|Overall Study|Randomized But Not Treated|0|||
48745880|NCT03572062|156918048|FG004|Overall Study|Randomized But Not Treated|1|||
48585675|NCT01886781|156335795|FG000|Overall Study|Worsening of symptoms|1|||
48585676|NCT01886781|156335796|FG001|Overall Study|Worsening of symptoms|1|||
48326766|NCT02157948|155394111|FG001|Overall Study|Decision by Sponsor|1|||
48745881|NCT03572062|156918049|FG005|Overall Study|Randomized But Not Treated|2|||
48745882|NCT03572062|156918050|FG006|Overall Study|Randomized But Not Treated|0|||
48745883|NCT03572062|156918051|FG007|Overall Study|Randomized But Not Treated|1|||
48634700|NCT02561962|156520729|FG000|Overall Study|Decision by sponsor|0|||
48634701|NCT02561962|156520730|FG001|Overall Study|Decision by sponsor|0|||
48634702|NCT02561962|156520731|FG002|Overall Study|Decision by sponsor|0|||
48634703|NCT02561962|156520732|FG003|Overall Study|Decision by sponsor|0|||
48634704|NCT02561962|156520733|FG004|Overall Study|Decision by sponsor|1|||
48634705|NCT02561962|156520734|FG005|Overall Study|Decision by sponsor|1|||
48634706|NCT02561962|156520735|FG006|Overall Study|Decision by sponsor|0|||
48634707|NCT02561962|156520736|FG007|Overall Study|Decision by sponsor|3|||
48634708|NCT02561962|156520737|FG008|Overall Study|Decision by sponsor|0|||
48634709|NCT02561962|156520729|FG000|Overall Study|Lost to Follow-up|0|||
48634710|NCT02561962|156520730|FG001|Overall Study|Lost to Follow-up|0|||
48634711|NCT02561962|156520731|FG002|Overall Study|Lost to Follow-up|0|||
48634712|NCT02561962|156520732|FG003|Overall Study|Lost to Follow-up|0|||
48634713|NCT02561962|156520733|FG004|Overall Study|Lost to Follow-up|0|||
48634714|NCT02561962|156520734|FG005|Overall Study|Lost to Follow-up|1|||
48634715|NCT02561962|156520735|FG006|Overall Study|Lost to Follow-up|0|||
48634716|NCT02561962|156520736|FG007|Overall Study|Lost to Follow-up|0|||
48634717|NCT02561962|156520737|FG008|Overall Study|Lost to Follow-up|0|||
48634718|NCT00457626|156520738|FG000|Overall Study|Adverse Event|3|||
48634719|NCT00457626|156520738|FG000|Overall Study|Administrative Problems|2|||
48634720|NCT00457626|156520738|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
48634721|NCT03586973|156520741|FG000|Overall Study|Death|15|||
48634722|NCT03586973|156520742|FG001|Overall Study|Death|8|||
48634723|NCT03586973|156520741|FG000|Overall Study|Site Terminated by Sponsor|3|||
48634724|NCT03586973|156520742|FG001|Overall Study|Site Terminated by Sponsor|6|||
48634725|NCT03586973|156520741|FG000|Overall Study|Withdrawal by Subject|1|||
48634726|NCT03586973|156520742|FG001|Overall Study|Withdrawal by Subject|0|||
48634727|NCT03586973|156520741|FG000|Overall Study|Lost to Follow-up|1|||
48634728|NCT03586973|156520742|FG001|Overall Study|Lost to Follow-up|0|||
48634729|NCT04976777|156522013|FG000|Overall Study|COVID-19 Infection|1|||
48634730|NCT04976777|156522014|FG001|Overall Study|COVID-19 Infection|0|||
48634731|NCT01441960|156522017|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
48634732|NCT01441960|156522018|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
48634733|NCT01441960|156522017|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
48634734|NCT01441960|156522018|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
48634735|NCT01441960|156522017|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
48634736|NCT01441960|156522018|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
48634737|NCT03639610|156522021|FG000|Overall Study|Adverse Event|7|||
48634738|NCT03639610|156522022|FG001|Overall Study|Adverse Event|1|||
48634739|NCT03639610|156522023|FG002|Overall Study|Adverse Event|0|||
48634740|NCT03639610|156522021|FG000|Overall Study|Physician Decision|3|||
48634741|NCT03639610|156522022|FG001|Overall Study|Physician Decision|1|||
48634742|NCT03639610|156522023|FG002|Overall Study|Physician Decision|0|||
48634743|NCT03639610|156522021|FG000|Overall Study|Disease progression|8|||
48634744|NCT03639610|156522022|FG001|Overall Study|Disease progression|5|||
48634745|NCT03639610|156522023|FG002|Overall Study|Disease progression|3|||
48634746|NCT03639610|156522021|FG000|Overall Study|Study terminated by sponsor|2|||
48634747|NCT03639610|156522022|FG001|Overall Study|Study terminated by sponsor|1|||
48634748|NCT03639610|156522023|FG002|Overall Study|Study terminated by sponsor|1|||
48634749|NCT03639610|156522021|FG000|Overall Study|Patient request to stop treatment|1|||
48634750|NCT03639610|156522022|FG001|Overall Study|Patient request to stop treatment|2|||
48634751|NCT03639610|156522023|FG002|Overall Study|Patient request to stop treatment|0|||
48634752|NCT02660229|156522024|FG000|Overall Study|Adverse Event|2|||
48634753|NCT02660229|156522025|FG001|Overall Study|Adverse Event|0|||
48634754|NCT02660229|156522024|FG000|Overall Study|Withdrawal by Subject|0|||
48634755|NCT02660229|156522025|FG001|Overall Study|Withdrawal by Subject|1|||
48634756|NCT01935947|156522026|FG000|Overall Study|Adverse Event|0|||
48634757|NCT01935947|156522027|FG001|Overall Study|Adverse Event|2|||
48634758|NCT01935947|156522028|FG002|Overall Study|Adverse Event|0|||
48634759|NCT01935947|156522026|FG000|Overall Study|Diease Progression|2|||
48634760|NCT01935947|156522027|FG001|Overall Study|Diease Progression|2|||
48634761|NCT01935947|156522028|FG002|Overall Study|Diease Progression|2|||
48634762|NCT01935947|156522026|FG000|Overall Study|Death|1|||
48634763|NCT01935947|156522027|FG001|Overall Study|Death|0|||
48634764|NCT01935947|156522028|FG002|Overall Study|Death|0|||
48634765|NCT02037529|156522033|FG000|Overall Study|Withdrawal by Subject|1|||
48634766|NCT02037529|156522034|FG001|Overall Study|Withdrawal by Subject|3|||
48634767|NCT02037529|156522033|FG000|Overall Study|Adverse Event|0|||
48634768|NCT02037529|156522034|FG001|Overall Study|Adverse Event|1|||
48634769|NCT02154061|156522035|FG000|Overall Study|Pregnancy|1|||
48634770|NCT02154061|156522036|FG001|Overall Study|Pregnancy|0|||
48634771|NCT02154061|156522035|FG000|Overall Study|enrolled but not vaccinated|1|||
48634772|NCT02154061|156522036|FG001|Overall Study|enrolled but not vaccinated|0|||
48634773|NCT00427700|156522045|FG000|Overall Study|Lost to Follow-up|2|||
48634774|NCT00427700|156522046|FG001|Overall Study|Lost to Follow-up|5|||
48634775|NCT00427700|156522045|FG000|Overall Study|no induction of menses|1|||
48634776|NCT00427700|156522046|FG001|Overall Study|no induction of menses|4|||
48634777|NCT00427700|156522045|FG000|Overall Study|Pregnancy|0|||
48326767|NCT02852824|155394112|FG000|Overall Study|Withdrawal by Subject|1|||
48326768|NCT02852824|155394113|FG001|Overall Study|Withdrawal by Subject|0|||
48326769|NCT02852824|155394114|FG002|Overall Study|Withdrawal by Subject|0|||
48326770|NCT02852824|155394115|FG003|Overall Study|Withdrawal by Subject|0|||
48326771|NCT02852824|155394116|FG004|Overall Study|Withdrawal by Subject|0|||
48326772|NCT02852824|155394117|FG005|Overall Study|Withdrawal by Subject|0|||
48326773|NCT02852824|155394118|FG006|Overall Study|Withdrawal by Subject|0|||
48326774|NCT02852824|155394112|FG000|Overall Study|Adverse Event|0|||
48326775|NCT02852824|155394113|FG001|Overall Study|Adverse Event|0|||
48326776|NCT02852824|155394114|FG002|Overall Study|Adverse Event|0|||
48326777|NCT02852824|155394115|FG003|Overall Study|Adverse Event|0|||
48326778|NCT02852824|155394116|FG004|Overall Study|Adverse Event|2|||
48326779|NCT02852824|155394117|FG005|Overall Study|Adverse Event|0|||
48326780|NCT02852824|155394118|FG006|Overall Study|Adverse Event|0|||
48326781|NCT02646618|155394125|FG000|Overall Study|Lost to Follow-up|10|||
48326782|NCT02646618|155394126|FG001|Overall Study|Lost to Follow-up|14|||
48326783|NCT00680771|155394127|FG000|Overall Study|Withdrawal by Subject|1|||
48326784|NCT00680771|155394128|FG001|Overall Study|Withdrawal by Subject|0|||
48326785|NCT00680771|155394127|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
48326786|NCT00680771|155394128|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
48326787|NCT00680771|155394127|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
48326788|NCT00680771|155394128|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
48326789|NCT02630966|155394129|FG000|Overall Study|Adverse Event|1|||
48326790|NCT02630966|155394130|FG001|Overall Study|Adverse Event|3|||
48326791|NCT02630966|155394129|FG000|Overall Study|Significant Protocol Deviation|0|||
48326792|NCT02630966|155394130|FG001|Overall Study|Significant Protocol Deviation|2|||
48326793|NCT02630966|155394129|FG000|Overall Study|Voluntary Withdrawal|1|||
48326794|NCT02630966|155394130|FG001|Overall Study|Voluntary Withdrawal|1|||
48326795|NCT02630966|155394129|FG000|Overall Study|Lack of Efficacy|0|||
48326796|NCT02630966|155394130|FG001|Overall Study|Lack of Efficacy|2|||
48326797|NCT00390884|155394131|FG000|Overall Study|Withdrawal by Subject|2|||
48326798|NCT00390884|155394132|FG001|Overall Study|Withdrawal by Subject|2|||
48326799|NCT05484661|155394134|FG000|Overall Study|Withdrawal by Subject|1|||
48326800|NCT05484661|155394135|FG001|Overall Study|Withdrawal by Subject|0|||
48326801|NCT01856569|155394138|FG000|Overall Study|Other|1|||
48326802|NCT01856569|155394138|FG000|Overall Study|Changed Site/Structure|1|||
48326803|NCT01856569|155394138|FG000|Overall Study|Lost to Follow-up|3|||
48326804|NCT01856569|155394138|FG000|Overall Study|Did not met inclusion criteria|8|||
48326805|NCT01683409|155394139|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
48326806|NCT01683409|155394140|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
48326807|NCT01683409|155394141|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
48326808|NCT01683409|155394142|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
48326809|NCT01683409|155394143|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
48326810|NCT01683409|155394139|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
48326811|NCT01683409|155394140|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
48326812|NCT01683409|155394141|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
48326813|NCT01683409|155394142|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
48326814|NCT01683409|155394143|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
48326815|NCT01683409|155394139|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
48326816|NCT01683409|155394140|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
48326817|NCT01683409|155394141|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
48326818|NCT01683409|155394142|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
48326819|NCT01683409|155394143|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
48326820|NCT01683409|155394139|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
48326821|NCT01683409|155394140|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
48326822|NCT01683409|155394141|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
48326823|NCT01683409|155394142|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
48326824|NCT01683409|155394143|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
48326825|NCT01683409|155394139|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
48326826|NCT01683409|155394140|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
48326827|NCT01683409|155394141|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
48326828|NCT01683409|155394142|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
48326829|NCT01683409|155394143|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
48326830|NCT01683409|155394139|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
48326831|NCT01683409|155394140|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
48326832|NCT01683409|155394141|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
48326833|NCT01683409|155394142|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
48326834|NCT01683409|155394143|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
48326835|NCT01683409|155394139|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
48326836|NCT01683409|155394140|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
48585677|NCT02539134|156335801|FG000|Overall Study|Lost to Follow-up|1|||
48745884|NCT03572062|156918052|FG008|Overall Study|Randomized But Not Treated|0|||
48745885|NCT03572062|156918053|FG009|Overall Study|Randomized But Not Treated|0|||
48745886|NCT00519831|156918054|FG000|Overall Study|Adverse Event|3|||
48745887|NCT03200860|156918055|FG000|Overall Study|Withdrawal by Subject|1|||
48745888|NCT03200860|156918056|FG001|Overall Study|Withdrawal by Subject|0|||
48745889|NCT00662012|156918057|FG000|Overall Study|Lost to Follow-up|85|||
48745890|NCT00662012|156918057|FG000|Overall Study|Death|1|||
48745891|NCT00662012|156918057|FG000|Overall Study|Withdrawal by Subject|1|||
48745892|NCT02144012|156918058|FG000|Overall Study|Adverse Event|1|||
48745893|NCT02144012|156918059|FG001|Overall Study|Adverse Event|0|||
48745894|NCT02144012|156918058|FG000|Overall Study|Death|1|||
48745895|NCT02144012|156918059|FG001|Overall Study|Death|0|||
48745896|NCT02144012|156918058|FG000|Overall Study|Withdrawal by Subject|11|||
48745897|NCT02144012|156918059|FG001|Overall Study|Withdrawal by Subject|3|||
48745898|NCT02144012|156918058|FG000|Overall Study|Study Terminated by Sponsor|18|||
48745899|NCT02144012|156918059|FG001|Overall Study|Study Terminated by Sponsor|12|||
48745900|NCT02144012|156918058|FG000|Overall Study|Other|3|||
48745901|NCT02144012|156918059|FG001|Overall Study|Other|0|||
48745902|NCT02612727|156918060|FG000|Overall Study|Parent request|4|||
48745903|NCT02612727|156918061|FG001|Overall Study|Parent request|1|||
48745904|NCT02612727|156918060|FG000|Overall Study|Needed treatment incompatible with PT|1|||
48745905|NCT02612727|156918061|FG001|Overall Study|Needed treatment incompatible with PT|1|||
48745906|NCT02612727|156918060|FG000|Overall Study|Direct hyperbilirubinemia|0|||
48745907|NCT02612727|156918061|FG001|Overall Study|Direct hyperbilirubinemia|2|||
48745908|NCT03310775|156918065|FG000|Overall Study|Lost to Follow-up|2|||
48745909|NCT03310775|156918066|FG001|Overall Study|Lost to Follow-up|3|||
48745910|NCT03310775|156918065|FG000|Overall Study|aggravation of depression|0|||
48745911|NCT03310775|156918066|FG001|Overall Study|aggravation of depression|1|||
48745912|NCT03329573|156918067|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
48745913|NCT03329573|156918068|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
48745914|NCT03329573|156918069|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
48745915|NCT03329573|156918070|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
48745916|NCT03329573|156918067|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
48745917|NCT03329573|156918068|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
48745918|NCT03329573|156918069|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48745919|NCT03329573|156918070|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48745920|NCT03329573|156918067|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
48745921|NCT03329573|156918068|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
48745922|NCT03329573|156918069|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
48745923|NCT03329573|156918070|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
48745924|NCT03329573|156918067|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
48745925|NCT03329573|156918068|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
48745926|NCT03329573|156918069|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
48745927|NCT03329573|156918070|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
48745928|NCT00837811|156918071|FG000|Overall Study|Adverse Event|4|||
48745929|NCT00837811|156918072|FG001|Overall Study|Adverse Event|6|||
48745930|NCT00837811|156918073|FG002|Overall Study|Adverse Event|0|||
48745931|NCT00837811|156918071|FG000|Overall Study|Death|1|||
48745932|NCT00837811|156918072|FG001|Overall Study|Death|1|||
48745933|NCT00837811|156918073|FG002|Overall Study|Death|0|||
48745934|NCT00837811|156918071|FG000|Overall Study|Lack of Efficacy|0|||
48745935|NCT00837811|156918072|FG001|Overall Study|Lack of Efficacy|11|||
48745936|NCT00837811|156918073|FG002|Overall Study|Lack of Efficacy|0|||
48745937|NCT00837811|156918071|FG000|Overall Study|Lost to Follow-up|1|||
48745938|NCT00837811|156918072|FG001|Overall Study|Lost to Follow-up|3|||
48745939|NCT00837811|156918073|FG002|Overall Study|Lost to Follow-up|0|||
48745940|NCT00837811|156918071|FG000|Overall Study|Physician Decision|0|||
48745941|NCT00837811|156918072|FG001|Overall Study|Physician Decision|2|||
48745942|NCT00837811|156918073|FG002|Overall Study|Physician Decision|1|||
48745943|NCT00837811|156918071|FG000|Overall Study|Withdrawal by Subject|1|||
48745944|NCT00837811|156918072|FG001|Overall Study|Withdrawal by Subject|9|||
48745945|NCT00837811|156918073|FG002|Overall Study|Withdrawal by Subject|0|||
48745946|NCT00837811|156918071|FG000|Overall Study|Sponsor Decision|0|||
48745947|NCT00837811|156918072|FG001|Overall Study|Sponsor Decision|2|||
48745948|NCT00837811|156918073|FG002|Overall Study|Sponsor Decision|0|||
48745949|NCT01405456|156918074|FG000|Overall Study|Lost to Follow-up|2|||
48745950|NCT01405456|156918075|FG001|Overall Study|Lost to Follow-up|1|||
48585678|NCT02539134|156335802|FG001|Overall Study|Lost to Follow-up|0|||
48585679|NCT02539134|156335803|FG002|Overall Study|Lost to Follow-up|0|||
48585680|NCT02539134|156335804|FG003|Overall Study|Lost to Follow-up|0|||
48585681|NCT02539134|156335805|FG004|Overall Study|Lost to Follow-up|0|||
48585682|NCT02539134|156335806|FG005|Overall Study|Lost to Follow-up|0|||
48585683|NCT00394771|156335807|FG000|Overall Study|Did not meet protocol requirements|1|||
48634778|NCT00427700|156522046|FG001|Overall Study|Pregnancy|2|||
48634779|NCT02284191|156522047|FG000|Overall Study|Withdrawal by Subject|1|||
48634780|NCT02284191|156522048|FG001|Overall Study|Withdrawal by Subject|3|||
48634781|NCT02284191|156522047|FG000|Overall Study|Lost to Follow-up|1|||
48634782|NCT02284191|156522048|FG001|Overall Study|Lost to Follow-up|0|||
48634783|NCT01448616|156522049|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
48634784|NCT01448616|156522050|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
48634785|NCT01448616|156522051|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
48634786|NCT01448616|156522052|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
48634787|NCT01448616|156522049|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
48634788|NCT01448616|156522050|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
48634789|NCT01448616|156522051|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
48634790|NCT01448616|156522052|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
48634791|NCT01448616|156522049|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
48634792|NCT01448616|156522050|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
48634793|NCT01448616|156522051|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
48634794|NCT01448616|156522052|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
48634795|NCT01448616|156522049|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
48634796|NCT01448616|156522050|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
48585684|NCT00394771|156335808|FG001|Overall Study|Did not meet protocol requirements|0|||
48585685|NCT00394771|156335809|FG002|Overall Study|Did not meet protocol requirements|2|||
48585686|NCT00394771|156335810|FG003|Overall Study|Did not meet protocol requirements|0|||
48745951|NCT01405456|156918074|FG000|Overall Study|Physician Decision|1|||
48745952|NCT01405456|156918075|FG001|Overall Study|Physician Decision|0|||
48745953|NCT01774968|156918076|FG000|Overall Study|Adverse Event|4|||
48745954|NCT01774968|156918077|FG001|Overall Study|Adverse Event|4|||
48745955|NCT01774968|156918076|FG000|Overall Study|Death|0|||
48745956|NCT01774968|156918077|FG001|Overall Study|Death|1|||
48745957|NCT01774968|156918076|FG000|Overall Study|Lost to Follow-up|1|||
48745958|NCT01774968|156918077|FG001|Overall Study|Lost to Follow-up|3|||
48745959|NCT01774968|156918076|FG000|Overall Study|Physician Decision|5|||
48745960|NCT01774968|156918077|FG001|Overall Study|Physician Decision|1|||
48745961|NCT01774968|156918076|FG000|Overall Study|Protocol Violation|14|||
48745962|NCT01774968|156918077|FG001|Overall Study|Protocol Violation|13|||
48745963|NCT01774968|156918076|FG000|Overall Study|Sponsor Decision|0|||
48745964|NCT01774968|156918077|FG001|Overall Study|Sponsor Decision|2|||
48585687|NCT00394771|156335807|FG000|Overall Study|Protocol Violation|2|||
48585688|NCT00394771|156335808|FG001|Overall Study|Protocol Violation|4|||
48585689|NCT00394771|156335809|FG002|Overall Study|Protocol Violation|9|||
48585690|NCT00394771|156335810|FG003|Overall Study|Protocol Violation|7|||
48585691|NCT00394771|156335807|FG000|Overall Study|Withdrawal by Subject|10|||
48326837|NCT01683409|155394141|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
48585692|NCT00394771|156335808|FG001|Overall Study|Withdrawal by Subject|6|||
48585693|NCT00394771|156335809|FG002|Overall Study|Withdrawal by Subject|8|||
48326838|NCT01683409|155394142|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
48326839|NCT01683409|155394143|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
48326840|NCT01683409|155394139|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
48326841|NCT01683409|155394140|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
48326842|NCT01683409|155394141|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
48326843|NCT01683409|155394142|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
48326844|NCT01683409|155394143|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
48326845|NCT01683409|155394139|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
48326846|NCT01683409|155394140|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
48326847|NCT01683409|155394141|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
48326848|NCT01683409|155394142|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
48326849|NCT01683409|155394143|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
48326850|NCT01683409|155394139|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
48326851|NCT01683409|155394140|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
48326852|NCT01683409|155394141|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
48326853|NCT01683409|155394142|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
48326854|NCT01683409|155394143|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
48634797|NCT01448616|156522051|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
48326855|NCT01683409|155394139|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
48326856|NCT01683409|155394140|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
48326857|NCT01683409|155394141|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
48326858|NCT01683409|155394142|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
48326859|NCT01683409|155394143|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
48326860|NCT01860079|155394145|FG000|Overall Study|Physician Decision|14|||
48326861|NCT01860079|155394146|FG001|Overall Study|Physician Decision|22|||
48585694|NCT00394771|156335810|FG003|Overall Study|Withdrawal by Subject|12|||
48585695|NCT00394771|156335807|FG000|Overall Study|Adverse Event|10|||
48634798|NCT01448616|156522052|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
48585696|NCT00394771|156335808|FG001|Overall Study|Adverse Event|5|||
48634799|NCT01448616|156522049|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
48634800|NCT01448616|156522050|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
48634801|NCT01448616|156522051|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
48634802|NCT01448616|156522052|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
48634803|NCT01570387|156522055|FG000|Overall Study|Adverse Event|1|||
48634804|NCT01570387|156522056|FG001|Overall Study|Adverse Event|0|||
48634805|NCT01570387|156522057|FG002|Overall Study|Adverse Event|0|||
48585697|NCT00394771|156335809|FG002|Overall Study|Adverse Event|12|||
48585698|NCT00394771|156335810|FG003|Overall Study|Adverse Event|8|||
48585699|NCT00394771|156335807|FG000|Overall Study|Participant pregnant|0|||
48585700|NCT00394771|156335808|FG001|Overall Study|Participant pregnant|1|||
48585701|NCT00394771|156335809|FG002|Overall Study|Participant pregnant|2|||
48585702|NCT00394771|156335810|FG003|Overall Study|Participant pregnant|2|||
48585703|NCT00394771|156335807|FG000|Overall Study|Lost to Follow-up|15|||
48585704|NCT00394771|156335808|FG001|Overall Study|Lost to Follow-up|15|||
48585705|NCT00394771|156335809|FG002|Overall Study|Lost to Follow-up|13|||
48585706|NCT00394771|156335810|FG003|Overall Study|Lost to Follow-up|10|||
48585707|NCT00394771|156335807|FG000|Overall Study|Other|3|||
48585708|NCT00394771|156335808|FG001|Overall Study|Other|3|||
48585709|NCT00394771|156335809|FG002|Overall Study|Other|1|||
48745965|NCT01774968|156918076|FG000|Overall Study|Withdrawal by Subject|6|||
48745966|NCT01774968|156918077|FG001|Overall Study|Withdrawal by Subject|11|||
48745967|NCT01995825|156919684|FG000|Overall Study|Withdrawal by Subject|1|||
48745968|NCT01995825|156919685|FG001|Overall Study|Withdrawal by Subject|0|||
48745969|NCT01367002|156919688|FG000|Overall Study|Withdrawal by Subject|1|||
48745970|NCT01367002|156919689|FG001|Overall Study|Withdrawal by Subject|0|||
48745971|NCT01367002|156919688|FG000|Overall Study|Physician Decision|0|||
48745972|NCT01367002|156919689|FG001|Overall Study|Physician Decision|2|||
48745973|NCT02206048|156919690|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
48745974|NCT03311724|156919691|FG000|Overall Study|Physician Decision|0|||
48745975|NCT03311724|156919692|FG001|Overall Study|Physician Decision|0|||
48745976|NCT03311724|156919693|FG002|Overall Study|Physician Decision|0|||
48745977|NCT03311724|156919694|FG003|Overall Study|Physician Decision|1|||
48745978|NCT03311724|156919691|FG000|Overall Study|Protocol Violation|1|||
48745979|NCT03311724|156919692|FG001|Overall Study|Protocol Violation|0|||
48745980|NCT03311724|156919693|FG002|Overall Study|Protocol Violation|1|||
48745981|NCT03311724|156919694|FG003|Overall Study|Protocol Violation|0|||
48745982|NCT03311724|156919691|FG000|Overall Study|Withdrawal by Subject|1|||
48745983|NCT03311724|156919692|FG001|Overall Study|Withdrawal by Subject|1|||
48745984|NCT03311724|156919693|FG002|Overall Study|Withdrawal by Subject|0|||
48745985|NCT03311724|156919694|FG003|Overall Study|Withdrawal by Subject|0|||
48745986|NCT03311724|156919691|FG000|Overall Study|Lost to Follow-up|1|||
48745987|NCT03311724|156919692|FG001|Overall Study|Lost to Follow-up|0|||
48745988|NCT03311724|156919693|FG002|Overall Study|Lost to Follow-up|0|||
48745989|NCT03311724|156919694|FG003|Overall Study|Lost to Follow-up|0|||
48745990|NCT03311724|156919691|FG000|Overall Study|Sponsor Decision|0|||
48745991|NCT03311724|156919692|FG001|Overall Study|Sponsor Decision|0|||
48745992|NCT03311724|156919693|FG002|Overall Study|Sponsor Decision|1|||
48745993|NCT03311724|156919694|FG003|Overall Study|Sponsor Decision|0|||
48745994|NCT00777608|156919698|FG000|Overall Study|Lost to Follow-up|1|||
48745995|NCT00777608|156919699|FG001|Overall Study|Lost to Follow-up|1|||
48745996|NCT00777608|156919698|FG000|Overall Study|Withdrawal by Subject|1|||
48745997|NCT00777608|156919699|FG001|Overall Study|Withdrawal by Subject|3|||
48745998|NCT00777608|156919698|FG000|Overall Study|Protocol Violation|1|||
48634806|NCT01570387|156522058|FG003|Overall Study|Adverse Event|0|||
48634807|NCT01570387|156522055|FG000|Overall Study|Death|0|||
48634808|NCT01570387|156522056|FG001|Overall Study|Death|0|||
48634809|NCT01570387|156522057|FG002|Overall Study|Death|0|||
48745999|NCT00777608|156919699|FG001|Overall Study|Protocol Violation|0|||
48746000|NCT00777608|156919698|FG000|Overall Study|Investigator Decision|1|||
48634810|NCT01570387|156522058|FG003|Overall Study|Death|1|||
48634811|NCT01570387|156522055|FG000|Overall Study|Withdrawal by Subject|0|||
48634812|NCT01570387|156522056|FG001|Overall Study|Withdrawal by Subject|0|||
48634813|NCT01570387|156522057|FG002|Overall Study|Withdrawal by Subject|0|||
48634814|NCT01570387|156522058|FG003|Overall Study|Withdrawal by Subject|1|||
48634815|NCT03139448|156522059|FG000|Overall Study|Lack of Efficacy|6|||
48746001|NCT00777608|156919699|FG001|Overall Study|Investigator Decision|2|||
48746002|NCT01909674|156919701|FG000|Overall Study|Withdrawal by Subject|5|||
48746003|NCT01909674|156919702|FG001|Overall Study|Withdrawal by Subject|2|||
48746004|NCT00134082|156919703|FG000|Overall Study|Adverse Event|2|||
48746005|NCT00134082|156919703|FG000|Overall Study|Death|1|||
48746006|NCT00003499|156919704|FG000|Overall Study|Not evaluable|8|||
48585710|NCT00394771|156335810|FG003|Overall Study|Other|0|||
48585711|NCT01926197|156335811|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
48634816|NCT03139448|156522060|FG001|Overall Study|Lack of Efficacy|7|||
48634817|NCT03139448|156522059|FG000|Overall Study|Location of procedure changed|2|||
48634818|NCT03139448|156522060|FG001|Overall Study|Location of procedure changed|8|||
48634819|NCT03139448|156522059|FG000|Overall Study|Withdrawal by Subject|3|||
48634820|NCT03139448|156522060|FG001|Overall Study|Withdrawal by Subject|6|||
48634821|NCT03139448|156522059|FG000|Overall Study|Screen fail|1|||
48634822|NCT03139448|156522060|FG001|Overall Study|Screen fail|3|||
48634823|NCT03139448|156522059|FG000|Overall Study|Physician Decision|0|||
48634824|NCT03139448|156522060|FG001|Overall Study|Physician Decision|2|||
48634825|NCT00523978|156522061|FG000|Overall Study|Withdrawal by Subject|3|||
48634826|NCT00523978|156522062|FG001|Overall Study|Withdrawal by Subject|7|||
48634827|NCT00523978|156522061|FG000|Overall Study|Screen Failures|5|||
48746007|NCT00407797|156919705|FG000|Overall Study|Lost to Follow-up|2|||
48746008|NCT00407797|156919705|FG000|Overall Study|Adverse Event|6|||
48746009|NCT00407797|156919705|FG000|Overall Study|Other|7|||
48746010|NCT00407797|156919705|FG000|Overall Study|Withdrawal by Subject|3|||
48746011|NCT05228132|156919708|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
48746012|NCT05228132|156919708|FG000|Overall Study|Adverse Event|3|||
48746013|NCT05228132|156919708|FG000|Overall Study|Lost to Follow-up|1|||
48746014|NCT05228132|156919708|FG000|Overall Study|Arteriovenous-fistula mature|1|||
48746015|NCT02228460|156919709|FG000|Overall Study|Adverse Event|1|||
48746016|NCT02228460|156919709|FG000|Overall Study|Lost to Follow-up|1|||
48746017|NCT02627144|156919710|FG000|Overall Study|Serious adverse event|32|||
48746018|NCT02627144|156919710|FG000|Overall Study|Cancer progression|171|||
48746019|NCT02627144|156919710|FG000|Overall Study|Death from cancer|20|||
48746020|NCT02627144|156919710|FG000|Overall Study|Death from other cause|8|||
48746021|NCT02627144|156919710|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
48746022|NCT02627144|156919710|FG000|Overall Study|Administrative reasons|65|||
48746023|NCT02627144|156919710|FG000|Overall Study|Lost to Follow-up|8|||
48746024|NCT02627144|156919710|FG000|Overall Study|Enrolled, not treated|6|||
48746025|NCT02627144|156919710|FG000|Overall Study|Other|17|||
48746026|NCT01010061|156919712|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
48746027|NCT01010061|156919713|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
48746028|NCT01010061|156919712|FG000|Overall Study|Disease Progression|2|||
48746029|NCT01010061|156919713|FG001|Overall Study|Disease Progression|8|||
48746030|NCT01010061|156919712|FG000|Overall Study|Withdrew Consent|5|||
48746031|NCT01010061|156919713|FG001|Overall Study|Withdrew Consent|1|||
48746032|NCT01010061|156919712|FG000|Overall Study|Death|3|||
48746033|NCT01010061|156919713|FG001|Overall Study|Death|6|||
48746034|NCT01010061|156919712|FG000|Overall Study|Administrative/Other|0|||
48746035|NCT01010061|156919713|FG001|Overall Study|Administrative/Other|1|||
48746036|NCT01010061|156919712|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
48746037|NCT01010061|156919713|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
48746038|NCT01010061|156919712|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48746039|NCT01010061|156919713|FG001|Overall Study|Insufficient Therapeutic Response|5|||
48746040|NCT01010061|156919712|FG000|Overall Study|Violation of Selection Criteria|0|||
48746041|NCT01010061|156919713|FG001|Overall Study|Violation of Selection Criteria|1|||
48746042|NCT01010061|156919712|FG000|Overall Study|Did Not Receive Treatment|2|||
48746043|NCT01010061|156919713|FG001|Overall Study|Did Not Receive Treatment|2|||
48746044|NCT03470441|156919716|FG000|Overall Study|Death|0|||
48746045|NCT03470441|156919717|FG001|Overall Study|Death|1|||
48746046|NCT03470441|156919718|FG002|Overall Study|Death|1|||
48746047|NCT03470441|156919719|FG003|Overall Study|Death|0|||
48634828|NCT00523978|156522062|FG001|Overall Study|Screen Failures|1|||
48634829|NCT00523978|156522061|FG000|Overall Study|Death|1|||
48634830|NCT00523978|156522062|FG001|Overall Study|Death|0|||
48746048|NCT03470441|156919716|FG000|Overall Study|Adverse Event|0|||
48746049|NCT03470441|156919717|FG001|Overall Study|Adverse Event|0|||
48746050|NCT03470441|156919718|FG002|Overall Study|Adverse Event|0|||
48746051|NCT03470441|156919719|FG003|Overall Study|Adverse Event|1|||
48634831|NCT01832727|156522068|FG000|Overall Study|Adverse Event|4|||
48634832|NCT01832727|156522069|FG001|Overall Study|Adverse Event|6|||
48634833|NCT01832727|156522070|FG002|Overall Study|Adverse Event|1|||
48634834|NCT01832727|156522071|FG003|Overall Study|Adverse Event|0|||
48634835|NCT01832727|156522072|FG004|Overall Study|Adverse Event|1|||
48746052|NCT03470441|156919716|FG000|Overall Study|Withdrawal by Subject|1|||
48634836|NCT01832727|156522073|FG005|Overall Study|Adverse Event|1|||
48634837|NCT01832727|156522074|FG006|Overall Study|Adverse Event|2|||
48634838|NCT01832727|156522075|FG007|Overall Study|Adverse Event|1|||
48746053|NCT03470441|156919717|FG001|Overall Study|Withdrawal by Subject|4|||
48746054|NCT03470441|156919718|FG002|Overall Study|Withdrawal by Subject|1|||
48746055|NCT03470441|156919719|FG003|Overall Study|Withdrawal by Subject|3|||
48746056|NCT03982368|156919724|FG000|Overall Study|Adverse Event|6|||
48746057|NCT03982368|156919725|FG001|Overall Study|Adverse Event|4|||
48746058|NCT03982368|156919726|FG002|Overall Study|Adverse Event|3|||
48746059|NCT03982368|156919724|FG000|Overall Study|Lost to Follow-up|2|||
48326862|NCT00326183|155394147|FG000|Overall Study|Lost to Follow-up|104|||
48326863|NCT00326183|155394148|FG001|Overall Study|Lost to Follow-up|56|||
48326864|NCT00326183|155394147|FG000|Overall Study|Protocol Violation|6|||
48326865|NCT00326183|155394148|FG001|Overall Study|Protocol Violation|3|||
48326866|NCT00326183|155394147|FG000|Overall Study|Withdrawal by Subject|35|||
48326867|NCT00326183|155394148|FG001|Overall Study|Withdrawal by Subject|7|||
48326868|NCT00326183|155394147|FG000|Overall Study|Subject Moved|7|||
48326869|NCT00326183|155394148|FG001|Overall Study|Subject Moved|4|||
48326870|NCT00326183|155394147|FG000|Overall Study|Other|47|||
48326871|NCT00326183|155394148|FG001|Overall Study|Other|13|||
48326872|NCT00326183|155394147|FG000|Overall Study|Adverse Event|1|||
48326873|NCT00326183|155394148|FG001|Overall Study|Adverse Event|0|||
48634839|NCT01832727|156522076|FG008|Overall Study|Adverse Event|9|||
48326874|NCT03509909|155394152|FG000|Overall Study|Withdrawal by Subject|16|||
48326875|NCT03509909|155394153|FG001|Overall Study|Withdrawal by Subject|9|||
48634840|NCT01832727|156522068|FG000|Overall Study|Disease progression|3|||
48634841|NCT01832727|156522069|FG001|Overall Study|Disease progression|0|||
48634842|NCT01832727|156522070|FG002|Overall Study|Disease progression|2|||
48634843|NCT01832727|156522071|FG003|Overall Study|Disease progression|1|||
48634844|NCT01832727|156522072|FG004|Overall Study|Disease progression|3|||
48634845|NCT01832727|156522073|FG005|Overall Study|Disease progression|3|||
48634846|NCT01832727|156522074|FG006|Overall Study|Disease progression|6|||
48634847|NCT01832727|156522075|FG007|Overall Study|Disease progression|2|||
48634848|NCT01832727|156522076|FG008|Overall Study|Disease progression|7|||
48634849|NCT01832727|156522068|FG000|Overall Study|Lost to Follow-up|0|||
48634850|NCT01832727|156522069|FG001|Overall Study|Lost to Follow-up|0|||
48634851|NCT01832727|156522070|FG002|Overall Study|Lost to Follow-up|0|||
48634852|NCT01832727|156522071|FG003|Overall Study|Lost to Follow-up|1|||
48634853|NCT01832727|156522072|FG004|Overall Study|Lost to Follow-up|0|||
48634854|NCT01832727|156522073|FG005|Overall Study|Lost to Follow-up|0|||
48634855|NCT01832727|156522074|FG006|Overall Study|Lost to Follow-up|0|||
48746060|NCT03982368|156919725|FG001|Overall Study|Lost to Follow-up|1|||
48326876|NCT03509909|155394152|FG000|Overall Study|Lost to Follow-up|3|||
48326877|NCT03509909|155394153|FG001|Overall Study|Lost to Follow-up|4|||
48326878|NCT03509909|155394152|FG000|Overall Study|Adverse Event|2|||
48634856|NCT01832727|156522075|FG007|Overall Study|Lost to Follow-up|0|||
48634857|NCT01832727|156522076|FG008|Overall Study|Lost to Follow-up|0|||
48634858|NCT01832727|156522068|FG000|Overall Study|Physician Decision|1|||
48634859|NCT01832727|156522069|FG001|Overall Study|Physician Decision|0|||
48634860|NCT01832727|156522070|FG002|Overall Study|Physician Decision|0|||
48634861|NCT01832727|156522071|FG003|Overall Study|Physician Decision|1|||
48634862|NCT01832727|156522072|FG004|Overall Study|Physician Decision|0|||
48634863|NCT01832727|156522073|FG005|Overall Study|Physician Decision|1|||
48634864|NCT01832727|156522074|FG006|Overall Study|Physician Decision|0|||
48634865|NCT01832727|156522075|FG007|Overall Study|Physician Decision|0|||
48634866|NCT01832727|156522076|FG008|Overall Study|Physician Decision|0|||
48634867|NCT01832727|156522068|FG000|Overall Study|Withdrawal by Subject|1|||
48634868|NCT01832727|156522069|FG001|Overall Study|Withdrawal by Subject|1|||
48634869|NCT01832727|156522070|FG002|Overall Study|Withdrawal by Subject|0|||
48634870|NCT01832727|156522071|FG003|Overall Study|Withdrawal by Subject|1|||
48634871|NCT01832727|156522072|FG004|Overall Study|Withdrawal by Subject|0|||
48634872|NCT01832727|156522073|FG005|Overall Study|Withdrawal by Subject|1|||
48634873|NCT01832727|156522074|FG006|Overall Study|Withdrawal by Subject|0|||
48634874|NCT01832727|156522075|FG007|Overall Study|Withdrawal by Subject|2|||
48634875|NCT01832727|156522076|FG008|Overall Study|Withdrawal by Subject|1|||
48634876|NCT01832727|156522068|FG000|Overall Study|Study terminated by sponsor|0|||
48634877|NCT01832727|156522069|FG001|Overall Study|Study terminated by sponsor|0|||
48634878|NCT01832727|156522070|FG002|Overall Study|Study terminated by sponsor|0|||
48634879|NCT01832727|156522071|FG003|Overall Study|Study terminated by sponsor|0|||
48634880|NCT01832727|156522072|FG004|Overall Study|Study terminated by sponsor|0|||
48634881|NCT01832727|156522073|FG005|Overall Study|Study terminated by sponsor|0|||
48634882|NCT01832727|156522074|FG006|Overall Study|Study terminated by sponsor|0|||
48746061|NCT03982368|156919726|FG002|Overall Study|Lost to Follow-up|0|||
48746062|NCT03982368|156919724|FG000|Overall Study|Withdrawal by Subject|1|||
48746063|NCT03982368|156919725|FG001|Overall Study|Withdrawal by Subject|2|||
48746064|NCT03982368|156919726|FG002|Overall Study|Withdrawal by Subject|0|||
48326879|NCT03509909|155394153|FG001|Overall Study|Adverse Event|0|||
48326880|NCT02513667|155394154|FG000|Overall Study|Withdrawal by Subject|0|||
48326881|NCT02513667|155394155|FG001|Overall Study|Withdrawal by Subject|1|||
48326882|NCT03520036|155394164|FG000|Overall Study|Adverse Event|1|||
48326883|NCT03520036|155394165|FG001|Overall Study|Adverse Event|2|||
48326884|NCT03520036|155394166|FG002|Overall Study|Adverse Event|0|||
48326885|NCT03520036|155394164|FG000|Overall Study|Protocol Violation|1|||
48326886|NCT03520036|155394165|FG001|Overall Study|Protocol Violation|0|||
48326887|NCT03520036|155394166|FG002|Overall Study|Protocol Violation|0|||
48326888|NCT03520036|155394164|FG000|Overall Study|Withdrawal by Subject|0|||
48326889|NCT03520036|155394165|FG001|Overall Study|Withdrawal by Subject|1|||
48326890|NCT03520036|155394166|FG002|Overall Study|Withdrawal by Subject|4|||
48326891|NCT03520036|155394164|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
48326892|NCT03520036|155394165|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
48634883|NCT01832727|156522075|FG007|Overall Study|Study terminated by sponsor|1|||
48634884|NCT01832727|156522076|FG008|Overall Study|Study terminated by sponsor|1|||
48634885|NCT02750930|156522085|FG000|Overall Study|Study closed/terminated|8|||
48326893|NCT03520036|155394166|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
48326894|NCT03683576|155394167|FG000|Overall Study|Withdrawal by Subject|2|||
48326895|NCT03683576|155394168|FG001|Overall Study|Withdrawal by Subject|0|||
48326896|NCT03683576|155394169|FG002|Overall Study|Withdrawal by Subject|8|||
48326897|NCT03683576|155394170|FG003|Overall Study|Withdrawal by Subject|3|||
48326898|NCT03683576|155394167|FG000|Overall Study|Adverse Event|3|||
48326899|NCT03683576|155394168|FG001|Overall Study|Adverse Event|0|||
48326900|NCT03683576|155394169|FG002|Overall Study|Adverse Event|0|||
48326901|NCT03683576|155394170|FG003|Overall Study|Adverse Event|4|||
48326902|NCT03683576|155394167|FG000|Overall Study|Lack of Efficacy|1|||
48326903|NCT03683576|155394168|FG001|Overall Study|Lack of Efficacy|0|||
48326904|NCT03683576|155394169|FG002|Overall Study|Lack of Efficacy|1|||
48326905|NCT03683576|155394170|FG003|Overall Study|Lack of Efficacy|1|||
48326906|NCT03683576|155394167|FG000|Overall Study|Lost to Follow-up|0|||
48326907|NCT03683576|155394168|FG001|Overall Study|Lost to Follow-up|1|||
48634886|NCT03961308|156522086|FG000|Overall Study|Withdrawal by Subject|1|||
48746065|NCT03982368|156919724|FG000|Overall Study|unknow|4|||
48746066|NCT03982368|156919725|FG001|Overall Study|unknow|0|||
48746067|NCT03982368|156919726|FG002|Overall Study|unknow|2|||
48746068|NCT00660309|156919729|FG000|Overall Study|Adverse Event|2|||
48326908|NCT03683576|155394169|FG002|Overall Study|Lost to Follow-up|2|||
48326909|NCT03683576|155394170|FG003|Overall Study|Lost to Follow-up|0|||
48326910|NCT03683576|155394167|FG000|Overall Study|Other, Not Specified|0|||
48326911|NCT03683576|155394168|FG001|Overall Study|Other, Not Specified|2|||
48326912|NCT03683576|155394169|FG002|Overall Study|Other, Not Specified|0|||
48634887|NCT03961308|156522087|FG001|Overall Study|Withdrawal by Subject|0|||
48634888|NCT03961308|156522086|FG000|Overall Study|Other|1|||
48634889|NCT03961308|156522087|FG001|Overall Study|Other|0|||
48634890|NCT03961308|156522086|FG000|Overall Study|Lost to Follow-up|0|||
48634891|NCT03961308|156522087|FG001|Overall Study|Lost to Follow-up|1|||
48634892|NCT03961308|156522086|FG000|Overall Study|Adverse Event|0|||
48634893|NCT03961308|156522087|FG001|Overall Study|Adverse Event|1|||
48634894|NCT01849276|156522091|FG000|Followed for Survival for 5 Years|Death|1|||
48634895|NCT01849276|156522091|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
48634896|NCT00271544|156522104|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
48634897|NCT00271544|156522104|FG000|Overall Study|Model 4196 lead not attempted|9|||
48634898|NCT00271544|156522104|FG000|Overall Study|Implant not attempted|4|||
48634899|NCT03342560|156522116|FG000|Overall Study|Lost to Follow-up|2|||
48634900|NCT02604511|156522121|FG000|Overall Study|Adverse Event|3|||
48634901|NCT02604511|156522121|FG000|Overall Study|Disease Progression|4|||
48634902|NCT02604511|156522121|FG000|Overall Study|Withdrawal by Subject|3|||
48634903|NCT02604511|156522121|FG000|Overall Study|Participant ineligible|1|||
48634904|NCT02604511|156522121|FG000|Overall Study|Intercurrent illness|1|||
48634905|NCT01816984|156522122|FG000|Overall Study|declining health status|1|||
48634906|NCT00545779|156522130|FG000|Overall Study|Violation of selection criteria at entry|8|||
48634907|NCT00545779|156522130|FG000|Overall Study|Other protocol violation|1|||
48634908|NCT00545779|156522130|FG000|Overall Study|Did not cooperate|7|||
48634909|NCT00545779|156522130|FG000|Overall Study|Withdrawal by Subject|20|||
48634910|NCT00545779|156522130|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
48634911|NCT00545779|156522130|FG000|Overall Study|Failure to return|3|||
48634912|NCT01152437|156522144|FG000|Overall Study|Other Adverse Event|8|||
48634913|NCT01152437|156522145|FG001|Overall Study|Other Adverse Event|1|||
48326913|NCT03683576|155394170|FG003|Overall Study|Other, Not Specified|0|||
48326914|NCT03683576|155394167|FG000|Overall Study|Protocol Violation|0|||
48326915|NCT03683576|155394168|FG001|Overall Study|Protocol Violation|1|||
48326916|NCT03683576|155394169|FG002|Overall Study|Protocol Violation|1|||
48326917|NCT03683576|155394170|FG003|Overall Study|Protocol Violation|0|||
48326918|NCT02978716|155394174|FG000|Overall Study|Death|25|||
48326919|NCT02978716|155394175|FG001|Overall Study|Death|13|||
48326920|NCT02978716|155394176|FG002|Overall Study|Death|20|||
48326921|NCT02978716|155394174|FG000|Overall Study|Lost to Follow-up|0|||
48326922|NCT02978716|155394175|FG001|Overall Study|Lost to Follow-up|0|||
48326923|NCT02978716|155394176|FG002|Overall Study|Lost to Follow-up|1|||
48326924|NCT02978716|155394174|FG000|Overall Study|Withdrawal by Subject|6|||
48326925|NCT02978716|155394175|FG001|Overall Study|Withdrawal by Subject|4|||
48326926|NCT02978716|155394176|FG002|Overall Study|Withdrawal by Subject|5|||
48326927|NCT02978716|155394174|FG000|Overall Study|Sponsor terminated|2|||
48326928|NCT02978716|155394175|FG001|Overall Study|Sponsor terminated|13|||
48326929|NCT02978716|155394176|FG002|Overall Study|Sponsor terminated|9|||
48326930|NCT02978716|155394174|FG000|Overall Study|Other|1|||
48326931|NCT02978716|155394175|FG001|Overall Study|Other|3|||
48326932|NCT02978716|155394176|FG002|Overall Study|Other|0|||
48326933|NCT00116649|155394177|FG000|Overall Study|Adverse Event|20|||
48326934|NCT00116649|155394177|FG000|Overall Study|Lack of Efficacy|1|||
48326935|NCT00116649|155394177|FG000|Overall Study|Lost to Follow-up|32|||
48326936|NCT00116649|155394177|FG000|Overall Study|Withdrawal by Subject|68|||
48326937|NCT00116649|155394177|FG000|Overall Study|Local Skin Reaction|9|||
48326938|NCT00116649|155394177|FG000|Overall Study|Various Reasons|18|||
48326939|NCT00116649|155394177|FG000|Overall Study|Protocol Specified|7|||
48326940|NCT00933270|155394178|FG000|Overall Study|Withdrawal by Subject|26|||
48326941|NCT00933270|155394178|FG000|Overall Study|Insufficient Follow-up|10|||
48326942|NCT00933270|155394178|FG000|Overall Study|Lost to Follow-up|14|||
48326943|NCT00933270|155394178|FG000|Overall Study|Adverse Event|1|||
48326944|NCT00933270|155394178|FG000|Overall Study|Missed Visit|2|||
48326945|NCT00933270|155394178|FG000|Overall Study|Death|24|||
48326946|NCT00933270|155394178|FG000|Overall Study|Moved or would not return|10|||
48326947|NCT02189759|155394179|FG000|Overall Study|Lost to Follow-up|0|||
48326948|NCT02189759|155394180|FG001|Overall Study|Lost to Follow-up|0|||
48326949|NCT02189759|155394181|FG002|Overall Study|Lost to Follow-up|2|||
48326950|NCT02189759|155394182|FG003|Overall Study|Lost to Follow-up|5|||
48326951|NCT01662505|155394183|FG000|Overall Study|Progressive disease|6|||
48326952|NCT01662505|155394184|FG001|Overall Study|Progressive disease|1|||
48326953|NCT01662505|155394185|FG002|Overall Study|Progressive disease|5|||
48326954|NCT01662505|155394183|FG000|Overall Study|Refused cont. medication|0|||
48326955|NCT01662505|155394184|FG001|Overall Study|Refused cont. medication|0|||
48326956|NCT01662505|155394185|FG002|Overall Study|Refused cont. medication|1|||
48326957|NCT01662505|155394183|FG000|Overall Study|Not specified above|1|||
48326958|NCT01662505|155394184|FG001|Overall Study|Not specified above|3|||
48326959|NCT01662505|155394185|FG002|Overall Study|Not specified above|2|||
48326960|NCT00357994|155396099|FG000|Overall Study|Adverse Event|1|||
48326961|NCT00357994|155396100|FG001|Overall Study|Adverse Event|2|||
48326962|NCT00357994|155396099|FG000|Overall Study|Lack of Efficacy|0|||
48326963|NCT00357994|155396100|FG001|Overall Study|Lack of Efficacy|1|||
48326964|NCT00357994|155396099|FG000|Overall Study|Protocol Violation|1|||
48326965|NCT00357994|155396100|FG001|Overall Study|Protocol Violation|0|||
48326966|NCT04213807|155396101|FG000|Overall Study|Physician Decision|0|||
48634914|NCT01152437|156522146|FG002|Overall Study|Other Adverse Event|7|||
48326967|NCT04213807|155396102|FG001|Overall Study|Physician Decision|0|||
48326968|NCT04213807|155396103|FG002|Overall Study|Physician Decision|1|||
48326969|NCT02698475|155396104|FG000|Main Study Period|Lack of Efficacy|1|||
48326970|NCT02698475|155396104|FG000|Main Study Period|Protocol Violation|2|||
48326971|NCT02698475|155396104|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
48326972|NCT02698475|155396104|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
48326973|NCT02698475|155396104|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
48326974|NCT02698475|155396104|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
48326975|NCT02698475|155396104|FG000|Long-Term Extension Period|Other|1|||
48326976|NCT00692913|155396110|FG000|Overall Study|Adverse Event|8|||
48326977|NCT00692913|155396111|FG001|Overall Study|Adverse Event|4|||
48326978|NCT00692913|155396110|FG000|Overall Study|Lost to Follow-up|3|||
48326979|NCT00692913|155396111|FG001|Overall Study|Lost to Follow-up|5|||
48326980|NCT00692913|155396110|FG000|Overall Study|Physician Decision|2|||
48326981|NCT00692913|155396111|FG001|Overall Study|Physician Decision|0|||
48326982|NCT00692913|155396110|FG000|Overall Study|Protocol Violation|1|||
48326983|NCT00692913|155396111|FG001|Overall Study|Protocol Violation|1|||
48326984|NCT00692913|155396110|FG000|Overall Study|Withdrawal by Subject|15|||
48326985|NCT00692913|155396111|FG001|Overall Study|Withdrawal by Subject|20|||
48326986|NCT04017611|155396112|FG000|Overall Study|Withdrawn prior to completion|1|||
48326987|NCT03442777|155396121|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
48326988|NCT03442777|155396122|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
48326989|NCT03442777|155396123|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
48326990|NCT01823224|155396124|FG000|Overall Study|Lost to Follow-up|5|||
48326991|NCT01823224|155396125|FG001|Overall Study|Lost to Follow-up|6|||
48326992|NCT01823224|155396124|FG000|Overall Study|didn't qualify|1|||
48326993|NCT01823224|155396125|FG001|Overall Study|didn't qualify|2|||
48326994|NCT01823224|155396124|FG000|Overall Study|pharmacy error|0|||
48326995|NCT01823224|155396125|FG001|Overall Study|pharmacy error|1|||
48326996|NCT01823224|155396124|FG000|Overall Study|missed med dose|0|||
48326997|NCT01823224|155396125|FG001|Overall Study|missed med dose|1|||
48326998|NCT01823224|155396124|FG000|Overall Study|Withdrawal by Subject|0|||
48326999|NCT01823224|155396125|FG001|Overall Study|Withdrawal by Subject|1|||
48327000|NCT02605174|155396127|FG000|Overall Study|Adverse Event|0|||
48327001|NCT02605174|155396128|FG001|Overall Study|Adverse Event|0|||
48327002|NCT02605174|155396129|FG002|Overall Study|Adverse Event|1|||
48327003|NCT02605174|155396130|FG003|Overall Study|Adverse Event|0|||
48327004|NCT02605174|155396131|FG004|Overall Study|Adverse Event|4|||
48327005|NCT02605174|155396132|FG005|Overall Study|Adverse Event|0|||
48327006|NCT02605174|155396133|FG006|Overall Study|Adverse Event|0|||
48327007|NCT02605174|155396127|FG000|Overall Study|Lost to Follow-up|20|||
48327008|NCT02605174|155396128|FG001|Overall Study|Lost to Follow-up|7|||
48327009|NCT02605174|155396129|FG002|Overall Study|Lost to Follow-up|27|||
48327010|NCT02605174|155396130|FG003|Overall Study|Lost to Follow-up|10|||
48327011|NCT02605174|155396131|FG004|Overall Study|Lost to Follow-up|20|||
48327012|NCT02605174|155396132|FG005|Overall Study|Lost to Follow-up|10|||
48327013|NCT02605174|155396133|FG006|Overall Study|Lost to Follow-up|29|||
48327014|NCT02605174|155396127|FG000|Overall Study|Protocol Violation|10|||
48327015|NCT02605174|155396128|FG001|Overall Study|Protocol Violation|4|||
48327016|NCT02605174|155396129|FG002|Overall Study|Protocol Violation|14|||
48634915|NCT01152437|156522144|FG000|Overall Study|Not treated|0|||
48634916|NCT01152437|156522145|FG001|Overall Study|Not treated|1|||
48634917|NCT01152437|156522146|FG002|Overall Study|Not treated|2|||
48634918|NCT01152437|156522144|FG000|Overall Study|Progressive disease|27|||
48634919|NCT01152437|156522145|FG001|Overall Study|Progressive disease|13|||
48634920|NCT01152437|156522146|FG002|Overall Study|Progressive disease|32|||
48634921|NCT01152437|156522144|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
48634922|NCT01152437|156522145|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
48634923|NCT01152437|156522146|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
48634924|NCT02317627|156522147|FG000|Overall Study|Withdrawal by Subject|0|||
48634925|NCT02317627|156522148|FG001|Overall Study|Withdrawal by Subject|1|||
48634926|NCT02317627|156522149|FG002|Overall Study|Withdrawal by Subject|1|||
48634927|NCT02317627|156522147|FG000|Overall Study|Lost to Follow-up|2|||
48634928|NCT02317627|156522148|FG001|Overall Study|Lost to Follow-up|0|||
48634929|NCT02317627|156522149|FG002|Overall Study|Lost to Follow-up|0|||
48634930|NCT02317627|156522147|FG000|Overall Study|Stopped by Investigator|0|||
48634931|NCT02317627|156522148|FG001|Overall Study|Stopped by Investigator|1|||
48634932|NCT02317627|156522149|FG002|Overall Study|Stopped by Investigator|0|||
48634933|NCT02317627|156522147|FG000|Overall Study|Adverse Event|0|||
48634934|NCT02317627|156522148|FG001|Overall Study|Adverse Event|2|||
48746069|NCT00660309|156919730|FG001|Overall Study|Adverse Event|0|||
48327017|NCT02605174|155396130|FG003|Overall Study|Protocol Violation|6|||
48327018|NCT02605174|155396131|FG004|Overall Study|Protocol Violation|7|||
48327019|NCT02605174|155396132|FG005|Overall Study|Protocol Violation|7|||
48327020|NCT02605174|155396133|FG006|Overall Study|Protocol Violation|12|||
48327021|NCT02605174|155396127|FG000|Overall Study|Pregnancy|1|||
48327022|NCT02605174|155396128|FG001|Overall Study|Pregnancy|0|||
48327023|NCT02605174|155396129|FG002|Overall Study|Pregnancy|0|||
48634935|NCT02317627|156522149|FG002|Overall Study|Adverse Event|3|||
48634936|NCT02317627|156522147|FG000|Overall Study|Non-compliance with study drug|0|||
48634937|NCT02317627|156522148|FG001|Overall Study|Non-compliance with study drug|1|||
48634938|NCT02317627|156522149|FG002|Overall Study|Non-compliance with study drug|0|||
48634939|NCT04743973|156522151|FG000|Overall Study|Withdrawal by Subject|5|||
48634940|NCT05489328|156523903|FG000|Overall Study|Lost to Follow-up|0|||
48634941|NCT05489328|156523904|FG001|Overall Study|Lost to Follow-up|0|||
48634942|NCT05489328|156523905|FG002|Overall Study|Lost to Follow-up|1|||
48634943|NCT05489328|156523906|FG003|Overall Study|Lost to Follow-up|0|||
48634944|NCT05489328|156523907|FG004|Overall Study|Lost to Follow-up|2|||
48634945|NCT05489328|156523908|FG005|Overall Study|Lost to Follow-up|0|||
48634946|NCT05489328|156523909|FG006|Overall Study|Lost to Follow-up|0|||
48634947|NCT05489328|156523910|FG007|Overall Study|Lost to Follow-up|1|||
48634948|NCT05489328|156523911|FG008|Overall Study|Lost to Follow-up|0|||
48634949|NCT05489328|156523903|FG000|Overall Study|Withdrawal by Subject|0|||
48634950|NCT05489328|156523904|FG001|Overall Study|Withdrawal by Subject|0|||
48634951|NCT05489328|156523905|FG002|Overall Study|Withdrawal by Subject|0|||
48634952|NCT05489328|156523906|FG003|Overall Study|Withdrawal by Subject|0|||
48634953|NCT05489328|156523907|FG004|Overall Study|Withdrawal by Subject|0|||
48634954|NCT05489328|156523908|FG005|Overall Study|Withdrawal by Subject|0|||
48634955|NCT05489328|156523909|FG006|Overall Study|Withdrawal by Subject|1|||
48634956|NCT05489328|156523910|FG007|Overall Study|Withdrawal by Subject|1|||
48634957|NCT05489328|156523911|FG008|Overall Study|Withdrawal by Subject|0|||
48634958|NCT05489328|156523903|FG000|Overall Study|Other|0|||
48634959|NCT05489328|156523904|FG001|Overall Study|Other|0|||
48634960|NCT05489328|156523905|FG002|Overall Study|Other|0|||
48634961|NCT05489328|156523906|FG003|Overall Study|Other|0|||
48634962|NCT05489328|156523907|FG004|Overall Study|Other|0|||
48634963|NCT05489328|156523908|FG005|Overall Study|Other|0|||
48634964|NCT05489328|156523909|FG006|Overall Study|Other|0|||
48634965|NCT05489328|156523910|FG007|Overall Study|Other|1|||
48634966|NCT05489328|156523911|FG008|Overall Study|Other|1|||
48634967|NCT04795531|156523913|FG000|Overall Study|Withdrawal by Subject|4|||
48634968|NCT04795531|156523914|FG001|Overall Study|Withdrawal by Subject|4|||
48634969|NCT04795531|156523913|FG000|Overall Study|Lost to Follow-up|0|||
48634970|NCT04795531|156523914|FG001|Overall Study|Lost to Follow-up|1|||
48634971|NCT04795531|156523913|FG000|Overall Study|Physician Decision|0|||
48634972|NCT04795531|156523914|FG001|Overall Study|Physician Decision|2|||
48634973|NCT04795531|156523913|FG000|Overall Study|Death|2|||
48634974|NCT04795531|156523914|FG001|Overall Study|Death|1|||
48634975|NCT01323192|156523915|FG000|Overall Study|Adverse Event|6|||
48634976|NCT01323192|156523916|FG001|Overall Study|Adverse Event|1|||
48634977|NCT01323192|156523915|FG000|Overall Study|Withdrawal by Subject|3|||
48634978|NCT01323192|156523916|FG001|Overall Study|Withdrawal by Subject|1|||
48634979|NCT01323192|156523915|FG000|Overall Study|Noncompliance with study medication|0|||
48634980|NCT01323192|156523916|FG001|Overall Study|Noncompliance with study medication|3|||
48634981|NCT01323192|156523915|FG000|Overall Study|Nonmedical reasons|0|||
48634982|NCT01323192|156523916|FG001|Overall Study|Nonmedical reasons|1|||
48634983|NCT00805389|156523917|FG000|Overall Study|Adverse Event|0|||
48634984|NCT00805389|156523918|FG001|Overall Study|Adverse Event|0|||
48634985|NCT00805389|156523919|FG002|Overall Study|Adverse Event|1|||
48634986|NCT00805389|156523920|FG003|Overall Study|Adverse Event|2|||
48634987|NCT00805389|156523921|FG004|Overall Study|Adverse Event|0|||
48634988|NCT00805389|156523917|FG000|Overall Study|Lost to Follow-up|4|||
48634989|NCT00805389|156523918|FG001|Overall Study|Lost to Follow-up|3|||
48634990|NCT00805389|156523919|FG002|Overall Study|Lost to Follow-up|6|||
48634991|NCT00805389|156523920|FG003|Overall Study|Lost to Follow-up|10|||
48634992|NCT00805389|156523921|FG004|Overall Study|Lost to Follow-up|9|||
48634993|NCT00805389|156523917|FG000|Overall Study|Protocol Violation|0|||
48634994|NCT00805389|156523918|FG001|Overall Study|Protocol Violation|0|||
48634995|NCT00805389|156523919|FG002|Overall Study|Protocol Violation|1|||
48634996|NCT00805389|156523920|FG003|Overall Study|Protocol Violation|0|||
48634997|NCT00805389|156523921|FG004|Overall Study|Protocol Violation|0|||
48634998|NCT00805389|156523917|FG000|Overall Study|Withdrawal by Subject|3|||
48634999|NCT00805389|156523918|FG001|Overall Study|Withdrawal by Subject|2|||
48327024|NCT02605174|155396130|FG003|Overall Study|Pregnancy|2|||
48327025|NCT02605174|155396131|FG004|Overall Study|Pregnancy|0|||
48327026|NCT02605174|155396132|FG005|Overall Study|Pregnancy|0|||
48327027|NCT02605174|155396133|FG006|Overall Study|Pregnancy|0|||
48327028|NCT02605174|155396127|FG000|Overall Study|Withdrawal by Subject|9|||
48327029|NCT02605174|155396128|FG001|Overall Study|Withdrawal by Subject|6|||
48327030|NCT02605174|155396129|FG002|Overall Study|Withdrawal by Subject|14|||
48327031|NCT02605174|155396130|FG003|Overall Study|Withdrawal by Subject|11|||
48327032|NCT02605174|155396131|FG004|Overall Study|Withdrawal by Subject|6|||
48327033|NCT02605174|155396132|FG005|Overall Study|Withdrawal by Subject|4|||
48327034|NCT02605174|155396133|FG006|Overall Study|Withdrawal by Subject|15|||
48327035|NCT02605174|155396127|FG000|Overall Study|Physician Decision|2|||
48327036|NCT02605174|155396128|FG001|Overall Study|Physician Decision|0|||
48327037|NCT02605174|155396129|FG002|Overall Study|Physician Decision|0|||
48327038|NCT02605174|155396130|FG003|Overall Study|Physician Decision|0|||
48327039|NCT02605174|155396131|FG004|Overall Study|Physician Decision|0|||
48327040|NCT02605174|155396132|FG005|Overall Study|Physician Decision|0|||
48327041|NCT02605174|155396133|FG006|Overall Study|Physician Decision|3|||
48327042|NCT02605174|155396127|FG000|Overall Study|Randomization Failure|22|||
48327043|NCT02605174|155396128|FG001|Overall Study|Randomization Failure|6|||
48327044|NCT02605174|155396129|FG002|Overall Study|Randomization Failure|20|||
48327045|NCT02605174|155396130|FG003|Overall Study|Randomization Failure|7|||
48327046|NCT02605174|155396131|FG004|Overall Study|Randomization Failure|16|||
48327047|NCT02605174|155396132|FG005|Overall Study|Randomization Failure|11|||
48327048|NCT02605174|155396133|FG006|Overall Study|Randomization Failure|30|||
48327049|NCT00562094|155396134|FG000|Overall Study|Lost to Follow-up|62|||
48327050|NCT00887224|155396135|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
48327051|NCT00887224|155396136|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
48327052|NCT00887224|155396137|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
48327053|NCT00887224|155396135|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
48327054|NCT00887224|155396136|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
48327055|NCT00887224|155396137|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
48327056|NCT00887224|155396135|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
48327057|NCT00887224|155396136|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
48327058|NCT00887224|155396137|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
48327059|NCT00887224|155396135|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
48327060|NCT00887224|155396136|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
48327061|NCT00887224|155396137|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
48327062|NCT00887224|155396135|FG000|Open-label Response (OLR) Phase|Other|1|||
48327063|NCT00887224|155396136|FG001|Open-label Response (OLR) Phase|Other|0|||
48327064|NCT00887224|155396137|FG002|Open-label Response (OLR) Phase|Other|0|||
48327065|NCT00887224|155396135|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
48327066|NCT00887224|155396136|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
48327067|NCT00887224|155396137|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
48327068|NCT00887224|155396135|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
48327069|NCT00887224|155396136|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
48327070|NCT00887224|155396137|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
48327071|NCT00887224|155396135|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
48327072|NCT00887224|155396136|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
48327073|NCT00887224|155396137|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
48635000|NCT00805389|156523919|FG002|Overall Study|Withdrawal by Subject|4|||
48635001|NCT00805389|156523920|FG003|Overall Study|Withdrawal by Subject|5|||
48635002|NCT00805389|156523921|FG004|Overall Study|Withdrawal by Subject|4|||
48635003|NCT00633126|156523923|FG000|Overall Study|Did not receive full dose|1|||
48635004|NCT00140140|156523924|FG000|Overall Study|Unacceptable toxicity|1|||
48635005|NCT00140140|156523925|FG001|Overall Study|Unacceptable toxicity|1|||
48746070|NCT00660309|156919729|FG000|Overall Study|Withdrawal by Subject|0|||
48746071|NCT00660309|156919730|FG001|Overall Study|Withdrawal by Subject|3|||
48746072|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
48746073|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
48746074|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
48746075|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
48746076|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
48746077|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
48746078|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
48746079|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
48746080|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
48746081|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
48746082|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
48746083|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
48746084|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
48746085|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
48746086|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
48746087|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
48746088|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
48746089|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
48746090|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
48746091|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
48746092|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
48746093|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
48746094|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
48746095|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
48746096|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
48746097|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
48746098|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
48746099|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
48746100|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
48746101|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
48746102|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
48746103|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
48746104|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
48746105|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
48746106|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
48746107|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
48746108|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
48746109|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
48746110|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
48746111|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
48746112|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
48746113|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
48635006|NCT00140140|156523926|FG002|Overall Study|Unacceptable toxicity|2|||
48635007|NCT00140140|156523924|FG000|Overall Study|Physician Decision|1|||
48635008|NCT00140140|156523925|FG001|Overall Study|Physician Decision|1|||
48635009|NCT00140140|156523926|FG002|Overall Study|Physician Decision|0|||
48635010|NCT01276704|156523927|FG000|Overall Study|Lost to Follow-up|2|||
48635011|NCT01276704|156523928|FG001|Overall Study|Lost to Follow-up|3|||
48635012|NCT01276704|156523927|FG000|Overall Study|Non-compliant|2|||
48635013|NCT01276704|156523928|FG001|Overall Study|Non-compliant|2|||
48635014|NCT01276704|156523927|FG000|Overall Study|Withdrawal by Subject|7|||
48635015|NCT01276704|156523928|FG001|Overall Study|Withdrawal by Subject|1|||
48635016|NCT01276704|156523927|FG000|Overall Study|Physician Decision|3|||
48635017|NCT01276704|156523928|FG001|Overall Study|Physician Decision|5|||
48635018|NCT02835690|156523929|FG000|Overall Study|Death|12|||
48635019|NCT02835690|156523930|FG001|Overall Study|Death|11|||
48635020|NCT02835690|156523931|FG002|Overall Study|Death|13|||
48635021|NCT02835690|156523929|FG000|Overall Study|Transferred to Extension Study|2|||
48635022|NCT02835690|156523930|FG001|Overall Study|Transferred to Extension Study|2|||
48635023|NCT02835690|156523931|FG002|Overall Study|Transferred to Extension Study|1|||
48635024|NCT02835690|156523929|FG000|Overall Study|Did Not Continue on Extension Study|0|||
48746114|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
48635025|NCT02835690|156523930|FG001|Overall Study|Did Not Continue on Extension Study|0|||
48635026|NCT02835690|156523931|FG002|Overall Study|Did Not Continue on Extension Study|1|||
48635027|NCT02835690|156523929|FG000|Overall Study|Not Treated|0|||
48635028|NCT02835690|156523930|FG001|Overall Study|Not Treated|2|||
48635029|NCT02835690|156523931|FG002|Overall Study|Not Treated|0|||
48746115|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
48746116|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
48746117|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
48746118|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
48746119|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
48746120|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
48746121|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
48746122|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
48746123|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
48746124|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
48746125|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
48746126|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
48746127|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
48746128|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
48746129|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
48746130|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
48746131|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
48746132|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
48746133|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
48746134|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
48746135|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
48746136|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
48635030|NCT04490278|156523932|FG000|Overall Study|Lost to Follow-up|6|||
48635031|NCT01784029|156523933|FG000|Overall Study|Lost to Follow-up|19|||
48635032|NCT01784029|156523934|FG001|Overall Study|Lost to Follow-up|20|||
48746137|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
48746138|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
48746139|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
48746140|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
48746141|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
48746142|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Change of location|0|||
48746143|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Change of location|0|||
48746144|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Change of location|0|||
48746145|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Change of location|1|||
48746146|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Change of location|0|||
48746147|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
48746148|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
48635033|NCT01784029|156523935|FG002|Overall Study|Lost to Follow-up|22|||
48635034|NCT00366457|156523936|FG000|Overall Study|never began study therapy|2|||
48635035|NCT03235050|156523937|FG000|Overall Study|Adverse Event|0|||
48635036|NCT03235050|156523938|FG001|Overall Study|Adverse Event|0|||
48635037|NCT03235050|156523939|FG002|Overall Study|Adverse Event|1|||
48635038|NCT03235050|156523940|FG003|Overall Study|Adverse Event|4|||
48635039|NCT03235050|156523941|FG004|Overall Study|Adverse Event|1|||
48635040|NCT03235050|156523937|FG000|Overall Study|Death|0|||
48635041|NCT03235050|156523938|FG001|Overall Study|Death|0|||
48635042|NCT03235050|156523939|FG002|Overall Study|Death|0|||
48635043|NCT03235050|156523940|FG003|Overall Study|Death|2|||
48635044|NCT03235050|156523941|FG004|Overall Study|Death|1|||
48635045|NCT03235050|156523937|FG000|Overall Study|Lost to Follow-up|1|||
48635046|NCT03235050|156523938|FG001|Overall Study|Lost to Follow-up|2|||
48635047|NCT03235050|156523939|FG002|Overall Study|Lost to Follow-up|1|||
48635048|NCT03235050|156523940|FG003|Overall Study|Lost to Follow-up|2|||
48635049|NCT03235050|156523941|FG004|Overall Study|Lost to Follow-up|0|||
48635050|NCT03235050|156523937|FG000|Overall Study|Withdrawal by Subject|3|||
48635051|NCT03235050|156523938|FG001|Overall Study|Withdrawal by Subject|2|||
48635052|NCT03235050|156523939|FG002|Overall Study|Withdrawal by Subject|2|||
48635053|NCT03235050|156523940|FG003|Overall Study|Withdrawal by Subject|5|||
48635054|NCT03235050|156523941|FG004|Overall Study|Withdrawal by Subject|7|||
48635055|NCT03235050|156523937|FG000|Overall Study|Other reasons|0|||
48635056|NCT03235050|156523938|FG001|Overall Study|Other reasons|1|||
48635057|NCT03235050|156523939|FG002|Overall Study|Other reasons|0|||
48635058|NCT03235050|156523940|FG003|Overall Study|Other reasons|1|||
48746149|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
48746150|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
48746151|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
48746152|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
48746153|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
48746154|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
48746155|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
48746156|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
48746157|NCT00730405|156919733|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
48746158|NCT00730405|156919734|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
48746159|NCT00730405|156919735|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
48746160|NCT00730405|156919736|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
48746161|NCT00730405|156919737|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
48746162|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
48746163|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
48746164|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
48746165|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
48746166|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
48746167|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
48746168|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
48635059|NCT03235050|156523941|FG004|Overall Study|Other reasons|2|||
48635060|NCT01425814|156523944|FG000|Period 1|Stability criteria not fulfilled|0|||
48635061|NCT01425814|156523945|FG001|Period 1|Stability criteria not fulfilled|1|||
48635062|NCT01425814|156523946|FG002|Period 1|Stability criteria not fulfilled|0|||
48635063|NCT01425814|156523947|FG003|Period 1|Stability criteria not fulfilled|0|||
48635064|NCT01425814|156523948|FG004|Period 1|Stability criteria not fulfilled|0|||
48635065|NCT01425814|156523949|FG005|Period 1|Stability criteria not fulfilled|0|||
48635066|NCT01425814|156523944|FG000|Period 2|Stability criteria not fulfilled|0|||
48635067|NCT01425814|156523945|FG001|Period 2|Stability criteria not fulfilled|1|||
48635068|NCT01425814|156523946|FG002|Period 2|Stability criteria not fulfilled|0|||
48635069|NCT01425814|156523947|FG003|Period 2|Stability criteria not fulfilled|0|||
48635070|NCT01425814|156523948|FG004|Period 2|Stability criteria not fulfilled|0|||
48635071|NCT01425814|156523949|FG005|Period 2|Stability criteria not fulfilled|0|||
48635072|NCT01425814|156523944|FG000|Period 3|Adverse Event|0|||
48635073|NCT01425814|156523945|FG001|Period 3|Adverse Event|0|||
48635074|NCT01425814|156523946|FG002|Period 3|Adverse Event|0|||
48635075|NCT01425814|156523947|FG003|Period 3|Adverse Event|0|||
48635076|NCT01425814|156523948|FG004|Period 3|Adverse Event|0|||
48635077|NCT01425814|156523949|FG005|Period 3|Adverse Event|1|||
48635078|NCT01425814|156523944|FG000|Period 4|Adverse Event|1|||
48635079|NCT01425814|156523945|FG001|Period 4|Adverse Event|0|||
48635080|NCT01425814|156523946|FG002|Period 4|Adverse Event|1|||
48635081|NCT01425814|156523947|FG003|Period 4|Adverse Event|0|||
48635082|NCT01425814|156523948|FG004|Period 4|Adverse Event|0|||
48635083|NCT01425814|156523949|FG005|Period 4|Adverse Event|0|||
48635084|NCT01425814|156523944|FG000|Period 5|Stability criteria not fulfilled|0|||
48635085|NCT01425814|156523945|FG001|Period 5|Stability criteria not fulfilled|0|||
48635086|NCT01425814|156523946|FG002|Period 5|Stability criteria not fulfilled|1|||
48635087|NCT01425814|156523947|FG003|Period 5|Stability criteria not fulfilled|0|||
48635088|NCT01425814|156523948|FG004|Period 5|Stability criteria not fulfilled|0|||
48635089|NCT01425814|156523949|FG005|Period 5|Stability criteria not fulfilled|1|||
48746169|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
48746170|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
48635090|NCT03801525|156523956|FG000|Overall Study|Adverse Event|17|||
48635091|NCT03801525|156523957|FG001|Overall Study|Adverse Event|1|||
48635092|NCT03801525|156523958|FG002|Overall Study|Adverse Event|0|||
48635093|NCT03801525|156523956|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
48635094|NCT03801525|156523957|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
48635095|NCT03801525|156523958|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
48635096|NCT03801525|156523956|FG000|Overall Study|Death|29|||
48635097|NCT03801525|156523957|FG001|Overall Study|Death|1|||
48635098|NCT03801525|156523958|FG002|Overall Study|Death|4|||
48635099|NCT03801525|156523956|FG000|Overall Study|Disease Progression|6|||
48635100|NCT03801525|156523957|FG001|Overall Study|Disease Progression|0|||
48635101|NCT03801525|156523958|FG002|Overall Study|Disease Progression|1|||
48635102|NCT03801525|156523956|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
48635103|NCT03801525|156523957|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
48635104|NCT03801525|156523958|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
48635105|NCT03801525|156523956|FG000|Overall Study|Investigator Decision|18|||
48635106|NCT03801525|156523957|FG001|Overall Study|Investigator Decision|1|||
48746171|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
48746172|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
48746173|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
48635107|NCT03801525|156523958|FG002|Overall Study|Investigator Decision|0|||
48635108|NCT03801525|156523956|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
48635109|NCT03801525|156523957|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
48635110|NCT03801525|156523958|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
48635111|NCT03801525|156523956|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
48635112|NCT03801525|156523957|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
48635113|NCT03801525|156523958|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
48635114|NCT03801525|156523956|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
48635115|NCT03801525|156523957|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
48635116|NCT03801525|156523958|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
48635117|NCT03801525|156523956|FG000|Overall Study|Withdrawal of Subject Consent|38|||
48635118|NCT03801525|156523957|FG001|Overall Study|Withdrawal of Subject Consent|2|||
48635119|NCT03801525|156523958|FG002|Overall Study|Withdrawal of Subject Consent|1|||
48635120|NCT03801525|156523956|FG000|Overall Study|Reason not Specified|4|||
48635121|NCT03801525|156523957|FG001|Overall Study|Reason not Specified|0|||
48635122|NCT03801525|156523958|FG002|Overall Study|Reason not Specified|4|||
48746174|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
48746175|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
48746176|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
48746177|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Death|0|||
48746178|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Death|1|||
48635123|NCT02684461|156523962|FG000|Overall Study|Adverse Event|1|||
48635124|NCT02684461|156523963|FG001|Overall Study|Adverse Event|0|||
48635125|NCT02684461|156523964|FG002|Overall Study|Adverse Event|0|||
48635126|NCT02684461|156523962|FG000|Overall Study|Lack of Efficacy|1|||
48635127|NCT02684461|156523963|FG001|Overall Study|Lack of Efficacy|2|||
48746179|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Death|0|||
48746180|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Death|1|||
48746181|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Death|0|||
48746182|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Change of location|1|||
48746183|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Change of location|1|||
48746184|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Change of location|0|||
48746185|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Change of location|1|||
48746186|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Change of location|0|||
48746187|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
48746188|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
48746189|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
48746190|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
48746191|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
48746192|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
48746193|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
48746194|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
48746195|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
48746196|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
48746197|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
48746198|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
48746199|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
48746200|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
48746201|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
48746202|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
48746203|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
48746204|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
48746205|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
48746206|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
48635128|NCT02684461|156523964|FG002|Overall Study|Lack of Efficacy|0|||
48635129|NCT02138825|156523965|FG000|Main Study Treatment|Adverse Event|11|||
48635130|NCT02138825|156523966|FG001|Main Study Treatment|Adverse Event|3|||
48635131|NCT02138825|156523965|FG000|Main Study Treatment|Death|1|||
48635132|NCT02138825|156523966|FG001|Main Study Treatment|Death|2|||
48635133|NCT02138825|156523965|FG000|Main Study Treatment|Protocol Violation|2|||
48635134|NCT02138825|156523966|FG001|Main Study Treatment|Protocol Violation|2|||
48635135|NCT02138825|156523965|FG000|Main Study Treatment|Sponsor decision|12|||
48635136|NCT02138825|156523966|FG001|Main Study Treatment|Sponsor decision|18|||
48635137|NCT02138825|156523965|FG000|Main Study Treatment|Study terminated by sponsor|10|||
48635138|NCT02138825|156523966|FG001|Main Study Treatment|Study terminated by sponsor|9|||
48635139|NCT02138825|156523965|FG000|Main Study Treatment|Withdrawal by Subject|3|||
48746207|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
48746208|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
48746209|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
48746210|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
48746211|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
48746212|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
48746213|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
48746214|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
48746215|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
48746216|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
48746217|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
48746218|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
48746219|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
48746220|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
48746221|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
48746222|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
48746223|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
48746224|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
48746225|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
48746226|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
48746227|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
48746228|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
48746229|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
48746230|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
48746231|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
48746232|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
48746233|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
48746234|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
48746235|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
48635140|NCT02138825|156523966|FG001|Main Study Treatment|Withdrawal by Subject|1|||
48635141|NCT02138825|156523965|FG000|Main Study Treatment|Medical decision|1|||
48635142|NCT02138825|156523966|FG001|Main Study Treatment|Medical decision|0|||
48635143|NCT02138825|156523965|FG000|Long-term Extension|Study termination by sponsor|32|||
48635144|NCT02138825|156523966|FG001|Long-term Extension|Study termination by sponsor|38|||
48635145|NCT02138825|156523965|FG000|Safety Follow-up|Adverse Event|4|||
48635146|NCT02138825|156523966|FG001|Safety Follow-up|Adverse Event|3|||
48635147|NCT02138825|156523965|FG000|Safety Follow-up|Death|11|||
48635148|NCT02138825|156523966|FG001|Safety Follow-up|Death|5|||
48635149|NCT02138825|156523965|FG000|Safety Follow-up|Withdrawal by Subject|5|||
48635150|NCT02138825|156523966|FG001|Safety Follow-up|Withdrawal by Subject|3|||
48635151|NCT02138825|156523965|FG000|Safety Follow-up|clinic worsening|1|||
48635152|NCT02138825|156523966|FG001|Safety Follow-up|clinic worsening|0|||
48635153|NCT02138825|156523965|FG000|Safety Follow-up|withdrawal by PI|1|||
48635154|NCT02138825|156523966|FG001|Safety Follow-up|withdrawal by PI|0|||
48635155|NCT02138825|156523965|FG000|Safety Follow-up|logistical difficulties|0|||
48635156|NCT02138825|156523966|FG001|Safety Follow-up|logistical difficulties|1|||
48635157|NCT02138825|156523965|FG000|Safety Follow-up|progressive disease|0|||
48635158|NCT02138825|156523966|FG001|Safety Follow-up|progressive disease|2|||
48635159|NCT02138825|156523965|FG000|Safety Follow-up|too unwell to attend the visit|0|||
48635160|NCT02138825|156523966|FG001|Safety Follow-up|too unwell to attend the visit|1|||
48635161|NCT02138825|156523965|FG000|Safety Follow-up|treatment unblinded|0|||
48635162|NCT02138825|156523966|FG001|Safety Follow-up|treatment unblinded|1|||
48635163|NCT02138825|156523965|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
48635164|NCT02138825|156523966|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
48635165|NCT02415556|156523967|FG000|Overall Study|Adverse Event|3|||
48635166|NCT02415556|156523968|FG001|Overall Study|Adverse Event|4|||
48635167|NCT02415556|156523969|FG002|Overall Study|Adverse Event|2|||
48635168|NCT02415556|156523970|FG003|Overall Study|Adverse Event|4|||
48635169|NCT02415556|156523967|FG000|Overall Study|Lost to Follow-up|4|||
48635170|NCT02415556|156523968|FG001|Overall Study|Lost to Follow-up|5|||
48635171|NCT02415556|156523969|FG002|Overall Study|Lost to Follow-up|4|||
48635172|NCT02415556|156523970|FG003|Overall Study|Lost to Follow-up|1|||
48635173|NCT02415556|156523967|FG000|Overall Study|Withdrawal by Subject|13|||
48635174|NCT02415556|156523968|FG001|Overall Study|Withdrawal by Subject|4|||
48635175|NCT02415556|156523969|FG002|Overall Study|Withdrawal by Subject|14|||
48635176|NCT02415556|156523970|FG003|Overall Study|Withdrawal by Subject|12|||
48635177|NCT02415556|156523967|FG000|Overall Study|Physician Decision|1|||
48635178|NCT02415556|156523968|FG001|Overall Study|Physician Decision|3|||
48635179|NCT02415556|156523969|FG002|Overall Study|Physician Decision|1|||
48635180|NCT02415556|156523970|FG003|Overall Study|Physician Decision|2|||
48635181|NCT02415556|156523967|FG000|Overall Study|Censored - study completion|4|||
48635182|NCT02415556|156523968|FG001|Overall Study|Censored - study completion|5|||
48635183|NCT02415556|156523969|FG002|Overall Study|Censored - study completion|1|||
48635184|NCT02415556|156523970|FG003|Overall Study|Censored - study completion|0|||
48635185|NCT02415556|156523967|FG000|Overall Study|Family-related issues|0|||
48635186|NCT02415556|156523968|FG001|Overall Study|Family-related issues|0|||
48635187|NCT02415556|156523969|FG002|Overall Study|Family-related issues|0|||
48635188|NCT02415556|156523970|FG003|Overall Study|Family-related issues|1|||
48635189|NCT02390076|156523971|FG000|Overall Study|Lost to Follow-up|2|||
48635190|NCT02390076|156523972|FG001|Overall Study|Lost to Follow-up|1|||
48635191|NCT02390076|156523973|FG002|Overall Study|Lost to Follow-up|4|||
48635192|NCT00492557|156523974|FG000|Overall Study|Subject request|12|||
48635193|NCT00492557|156523975|FG001|Overall Study|Subject request|11|||
48635194|NCT00492557|156523974|FG000|Overall Study|Protocol Violation|7|||
48635195|NCT00492557|156523975|FG001|Overall Study|Protocol Violation|8|||
48635196|NCT00492557|156523974|FG000|Overall Study|Other|2|||
48635197|NCT00492557|156523975|FG001|Overall Study|Other|2|||
48635198|NCT00492557|156523974|FG000|Overall Study|Death|1|||
48635199|NCT00492557|156523975|FG001|Overall Study|Death|1|||
48635200|NCT00492557|156523974|FG000|Overall Study|Adverse Event|1|||
48635201|NCT00492557|156523975|FG001|Overall Study|Adverse Event|0|||
48635202|NCT00492557|156523974|FG000|Overall Study|Failed to return|1|||
48327074|NCT00887224|155396135|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
48327075|NCT00887224|155396136|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
48327076|NCT00887224|155396137|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
48327077|NCT00887224|155396135|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
48327078|NCT00887224|155396136|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
48327079|NCT00887224|155396137|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
48327080|NCT00887224|155396135|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
48327081|NCT00887224|155396136|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
48327082|NCT00887224|155396137|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
48327083|NCT00887224|155396135|FG000|Open-label Stability (OLS) Phase|Other|1|||
48327084|NCT00887224|155396136|FG001|Open-label Stability (OLS) Phase|Other|0|||
48327085|NCT00887224|155396137|FG002|Open-label Stability (OLS) Phase|Other|0|||
48327086|NCT00887224|155396135|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
48327087|NCT00887224|155396136|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
48327088|NCT00887224|155396137|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
48327089|NCT00887224|155396135|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
48327090|NCT00887224|155396136|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
48327091|NCT00887224|155396137|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
48327092|NCT00887224|155396135|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
48327093|NCT00887224|155396136|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
48327094|NCT00887224|155396137|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
48327095|NCT00887224|155396135|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
48327096|NCT00887224|155396136|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
48327097|NCT00887224|155396137|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
48327098|NCT00887224|155396135|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
48327099|NCT00887224|155396136|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
48327100|NCT00887224|155396137|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
48327101|NCT00887224|155396135|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
48327102|NCT00887224|155396136|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
48327103|NCT00887224|155396137|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
48327104|NCT00887224|155396135|FG000|OL Taper Phase / OL Follow Up|Other|30|||
48635203|NCT00492557|156523975|FG001|Overall Study|Failed to return|0|||
48635204|NCT00492557|156523974|FG000|Overall Study|Lost to Follow-up|0|||
48635205|NCT00492557|156523975|FG001|Overall Study|Lost to Follow-up|1|||
48635206|NCT01664624|156523976|FG000|Overall Study|Adverse Event|0|||
48635207|NCT01664624|156523977|FG001|Overall Study|Adverse Event|1|||
48635208|NCT01664624|156523978|FG002|Overall Study|Adverse Event|0|||
48635209|NCT01664624|156523979|FG003|Overall Study|Adverse Event|0|||
48746236|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
48327105|NCT00887224|155396136|FG001|OL Taper Phase / OL Follow Up|Other|0|||
48327106|NCT00887224|155396137|FG002|OL Taper Phase / OL Follow Up|Other|0|||
48635210|NCT01517984|156523983|FG000|Overall Study|Lost to Follow-up|0|||
48635211|NCT01517984|156523984|FG001|Overall Study|Lost to Follow-up|1|||
48635212|NCT01517984|156523985|FG002|Overall Study|Lost to Follow-up|0|||
48635213|NCT01517984|156523986|FG003|Overall Study|Lost to Follow-up|0|||
48635214|NCT01517984|156523983|FG000|Overall Study|Withdrawal by Subject|1|||
48635215|NCT01517984|156523984|FG001|Overall Study|Withdrawal by Subject|8|||
48635216|NCT01517984|156523985|FG002|Overall Study|Withdrawal by Subject|4|||
48635217|NCT01517984|156523986|FG003|Overall Study|Withdrawal by Subject|1|||
48635218|NCT01517984|156523983|FG000|Overall Study|Screen Failure|4|||
48635219|NCT01517984|156523984|FG001|Overall Study|Screen Failure|0|||
48635220|NCT01517984|156523985|FG002|Overall Study|Screen Failure|0|||
48635221|NCT01517984|156523986|FG003|Overall Study|Screen Failure|0|||
48635222|NCT01517984|156523983|FG000|Overall Study|Ineligible for randomization|0|||
48635223|NCT01517984|156523984|FG001|Overall Study|Ineligible for randomization|14|||
48746237|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Missing|0|||
48746238|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Missing|0|||
48746239|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Missing|2|||
48746240|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Missing|0|||
48746241|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Missing|0|||
48746242|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
48746243|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
48746244|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
48746245|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
48746246|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
48746247|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
48746248|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
48746249|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
48746250|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
48746251|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
48746252|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
48746253|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
48746254|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
48746255|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
48746256|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
48746257|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
48746258|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
48746259|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
48327107|NCT00887224|155396135|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
48327108|NCT00887224|155396136|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
48327109|NCT00887224|155396137|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
48327110|NCT00887224|155396135|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
48327111|NCT00887224|155396136|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
48327112|NCT00887224|155396137|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
48746260|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
48746261|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
48746262|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
48327113|NCT00887224|155396135|FG000|Double-blind (DB) Phase|Adverse Event|0|||
48327114|NCT00887224|155396136|FG001|Double-blind (DB) Phase|Adverse Event|7|||
48327115|NCT00887224|155396137|FG002|Double-blind (DB) Phase|Adverse Event|2|||
48327116|NCT00887224|155396135|FG000|Double-blind (DB) Phase|Failed to return|0|||
48327117|NCT00887224|155396136|FG001|Double-blind (DB) Phase|Failed to return|2|||
48327118|NCT00887224|155396137|FG002|Double-blind (DB) Phase|Failed to return|2|||
48327119|NCT00887224|155396135|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
48327120|NCT00887224|155396136|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
48327121|NCT00887224|155396137|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
48327122|NCT00887224|155396135|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
48327123|NCT00887224|155396136|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
48327124|NCT00887224|155396137|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
48327125|NCT00887224|155396135|FG000|Double-blind (DB) Phase|Other|0|||
48327126|NCT00887224|155396136|FG001|Double-blind (DB) Phase|Other|2|||
48327127|NCT00887224|155396137|FG002|Double-blind (DB) Phase|Other|0|||
48327128|NCT00887224|155396135|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
48635224|NCT01517984|156523985|FG002|Overall Study|Ineligible for randomization|0|||
48635225|NCT01517984|156523986|FG003|Overall Study|Ineligible for randomization|0|||
48327129|NCT00887224|155396136|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
48327130|NCT00887224|155396137|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
48327131|NCT00887224|155396135|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
48327132|NCT00887224|155396136|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
48635226|NCT05067335|156523987|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
48635227|NCT05067335|156523988|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
48746263|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
48746264|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
48746265|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
48746266|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
48746267|NCT00730405|156919733|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
48746268|NCT00730405|156919734|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
48746269|NCT00730405|156919735|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
48746270|NCT00730405|156919736|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
48746271|NCT00730405|156919737|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
48746272|NCT01496807|156919741|FG000|Overall Study|Progressive Disease|21|||
48746273|NCT01496807|156919741|FG000|Overall Study|Participant preference/toxicity|8|||
48746274|NCT01496807|156919741|FG000|Overall Study|Change in diagnosis|1|||
48746275|NCT00496470|156919745|FG000|Overall Study|Adverse Event|8|||
48635228|NCT05067335|156523989|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
48635229|NCT05067335|156523990|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
48635230|NCT05067335|156523987|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
48635231|NCT05067335|156523988|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
48635232|NCT05067335|156523989|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
48635233|NCT05067335|156523990|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
48635234|NCT05067335|156523987|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
48635235|NCT05067335|156523988|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
48635236|NCT05067335|156523989|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
48635237|NCT05067335|156523990|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
48635238|NCT05067335|156523987|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
48635239|NCT05067335|156523988|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
48635240|NCT05067335|156523989|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
48635241|NCT05067335|156523990|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
48635242|NCT05067335|156523987|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
48635243|NCT05067335|156523988|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
48635244|NCT05067335|156523989|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
48635245|NCT05067335|156523990|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
48635246|NCT05067335|156523987|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
48635247|NCT05067335|156523988|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
48635248|NCT05067335|156523989|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
48635249|NCT05067335|156523990|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
48635250|NCT05067335|156523987|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
48635251|NCT05067335|156523988|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
48635252|NCT05067335|156523989|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
48635253|NCT05067335|156523990|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
48635254|NCT05067335|156523987|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
48635255|NCT05067335|156523988|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
48635256|NCT05067335|156523989|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
48635257|NCT05067335|156523990|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
48635258|NCT05067335|156523987|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
48635259|NCT05067335|156523988|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
48635260|NCT05067335|156523989|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
48635261|NCT05067335|156523990|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
48635262|NCT05067335|156523987|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
48635263|NCT05067335|156523988|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
48635264|NCT05067335|156523989|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
48635265|NCT05067335|156523990|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
48746276|NCT00496470|156919746|FG001|Overall Study|Adverse Event|10|||
48746277|NCT00496470|156919745|FG000|Overall Study|Withdrawal by Subject|5|||
48746278|NCT00496470|156919746|FG001|Overall Study|Withdrawal by Subject|12|||
48746279|NCT00496470|156919745|FG000|Overall Study|Incorrectly enrolled|13|||
48746280|NCT00496470|156919746|FG001|Overall Study|Incorrectly enrolled|5|||
48746281|NCT00496470|156919745|FG000|Overall Study|Other reason|0|||
48746282|NCT00496470|156919746|FG001|Overall Study|Other reason|2|||
48746283|NCT02516163|156919747|FG000|Overall Study|Withdrawal by Subject|1|||
48746284|NCT02516163|156919747|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
48746285|NCT02516163|156919747|FG000|Overall Study|Unfit/delay in surgery|3|||
48746286|NCT02516163|156919747|FG000|Overall Study|Use of incorrect measurement technique|5|||
48746287|NCT02516163|156919747|FG000|Overall Study|Data not recorded|2|||
48746288|NCT02516163|156919747|FG000|Overall Study|MRI contraindication exclusion|6|||
48746289|NCT02801396|156919753|FG000|Period 1|Withdrawal by Subject|0|||
48746290|NCT02801396|156919754|FG001|Period 1|Withdrawal by Subject|0|||
48746291|NCT02801396|156919755|FG002|Period 1|Withdrawal by Subject|0|||
48746292|NCT02801396|156919756|FG003|Period 1|Withdrawal by Subject|0|||
48746293|NCT02801396|156919757|FG004|Period 1|Withdrawal by Subject|1|||
48746294|NCT02801396|156919758|FG005|Period 1|Withdrawal by Subject|0|||
48746295|NCT00729651|156919759|FG000|Overall Study|Withdrawal by Subject|5|||
48746296|NCT00729651|156919760|FG001|Overall Study|Withdrawal by Subject|6|||
48746297|NCT00729651|156919759|FG000|Overall Study|Lost to Follow-up|5|||
48746298|NCT00729651|156919760|FG001|Overall Study|Lost to Follow-up|4|||
48746299|NCT00729651|156919759|FG000|Overall Study|Protocol Violation|0|||
48635266|NCT00557193|156523991|FG000|Induction|Adverse Event|2|||
48635267|NCT00557193|156523992|FG001|Induction|Adverse Event|0|||
48635268|NCT00557193|156523993|FG002|Induction|Adverse Event|0|||
48635269|NCT00557193|156523994|FG003|Induction|Adverse Event|0|||
48635270|NCT00557193|156523995|FG004|Induction|Adverse Event|0|||
48635271|NCT00557193|156523996|FG005|Induction|Adverse Event|0|||
48635272|NCT00557193|156523991|FG000|Induction|Death|6|||
48635273|NCT00557193|156523992|FG001|Induction|Death|0|||
48635274|NCT00557193|156523993|FG002|Induction|Death|0|||
48635275|NCT00557193|156523994|FG003|Induction|Death|0|||
48635276|NCT00557193|156523995|FG004|Induction|Death|0|||
48635277|NCT00557193|156523996|FG005|Induction|Death|0|||
48635278|NCT00557193|156523991|FG000|Induction|Physician Decision|3|||
48635279|NCT00557193|156523992|FG001|Induction|Physician Decision|0|||
48635280|NCT00557193|156523993|FG002|Induction|Physician Decision|0|||
48635281|NCT00557193|156523994|FG003|Induction|Physician Decision|0|||
48635282|NCT00557193|156523995|FG004|Induction|Physician Decision|0|||
48635283|NCT00557193|156523996|FG005|Induction|Physician Decision|0|||
48635284|NCT00557193|156523991|FG000|Induction|Withdrawal by Subject|1|||
48635285|NCT00557193|156523992|FG001|Induction|Withdrawal by Subject|0|||
48635286|NCT00557193|156523993|FG002|Induction|Withdrawal by Subject|0|||
48635287|NCT00557193|156523994|FG003|Induction|Withdrawal by Subject|0|||
48635288|NCT00557193|156523995|FG004|Induction|Withdrawal by Subject|0|||
48635289|NCT00557193|156523996|FG005|Induction|Withdrawal by Subject|0|||
48635290|NCT00557193|156523991|FG000|Induction|Refusal of Further Protocol Therapy|2|||
48635291|NCT00557193|156523992|FG001|Induction|Refusal of Further Protocol Therapy|0|||
48635292|NCT00557193|156523993|FG002|Induction|Refusal of Further Protocol Therapy|0|||
48635293|NCT00557193|156523994|FG003|Induction|Refusal of Further Protocol Therapy|0|||
48635294|NCT00557193|156523995|FG004|Induction|Refusal of Further Protocol Therapy|0|||
48635295|NCT00557193|156523996|FG005|Induction|Refusal of Further Protocol Therapy|0|||
48635296|NCT00557193|156523991|FG000|Induction|Ineligible|8|||
48635297|NCT00557193|156523992|FG001|Induction|Ineligible|0|||
48635298|NCT00557193|156523993|FG002|Induction|Ineligible|0|||
48635299|NCT00557193|156523994|FG003|Induction|Ineligible|0|||
48635300|NCT00557193|156523995|FG004|Induction|Ineligible|0|||
48635301|NCT00557193|156523996|FG005|Induction|Ineligible|0|||
48635302|NCT00557193|156523991|FG000|Induction|Inevaluable for post Induction|2|||
48635303|NCT00557193|156523992|FG001|Induction|Inevaluable for post Induction|0|||
48635304|NCT00557193|156523993|FG002|Induction|Inevaluable for post Induction|0|||
48635305|NCT00557193|156523994|FG003|Induction|Inevaluable for post Induction|0|||
48635306|NCT00557193|156523995|FG004|Induction|Inevaluable for post Induction|0|||
48635307|NCT00557193|156523996|FG005|Induction|Inevaluable for post Induction|0|||
48635308|NCT00557193|156523991|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
48635309|NCT00557193|156523992|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
48635310|NCT00557193|156523993|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
48635311|NCT00557193|156523994|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
48746300|NCT00729651|156919760|FG001|Overall Study|Protocol Violation|1|||
48746301|NCT00729651|156919759|FG000|Overall Study|Adverse Event|7|||
48746302|NCT00729651|156919760|FG001|Overall Study|Adverse Event|3|||
48746303|NCT00729651|156919759|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
48635312|NCT00557193|156523995|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
48635313|NCT00557193|156523996|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
48635314|NCT00557193|156523991|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
48635315|NCT00557193|156523992|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
48635316|NCT00557193|156523993|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
48635317|NCT00557193|156523994|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
48635318|NCT00557193|156523995|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
48635319|NCT00557193|156523996|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
48635320|NCT00557193|156523991|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
48635321|NCT00557193|156523992|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
48635322|NCT00557193|156523993|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
48635323|NCT00557193|156523994|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
48635324|NCT00557193|156523995|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
48635325|NCT00557193|156523996|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
48635326|NCT00557193|156523991|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
48635327|NCT00557193|156523992|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
48635328|NCT00557193|156523993|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
48635329|NCT00557193|156523994|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
48635330|NCT00557193|156523995|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
48635331|NCT00557193|156523996|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
48327133|NCT00887224|155396137|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
48327134|NCT00887224|155396135|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
48327135|NCT00887224|155396136|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
48635332|NCT00557193|156523991|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
48635333|NCT00557193|156523992|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
48635334|NCT00557193|156523993|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
48746304|NCT00729651|156919760|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
48746305|NCT00729651|156919759|FG000|Overall Study|Subject's private reason|2|||
48746306|NCT00729651|156919760|FG001|Overall Study|Subject's private reason|0|||
48746307|NCT00880009|156919761|FG000|Overall Study|Study terminated by sponsor|14|||
48746308|NCT00880009|156919761|FG000|Overall Study|Withdrawal by Subject|1|||
48746309|NCT00880009|156919761|FG000|Overall Study|Protocol Violation|1|||
48746310|NCT01844518|156919762|FG000|Overall Study|Adverse Event|7|||
48746311|NCT01844518|156919763|FG001|Overall Study|Adverse Event|1|||
48746312|NCT01844518|156919762|FG000|Overall Study|Lack of Efficacy|17|||
48746313|NCT01844518|156919763|FG001|Overall Study|Lack of Efficacy|5|||
48746314|NCT01844518|156919762|FG000|Overall Study|Participant's request to discontinue|4|||
48746315|NCT01844518|156919763|FG001|Overall Study|Participant's request to discontinue|1|||
48746316|NCT01844518|156919762|FG000|Overall Study|Poor/Non-compliance|1|||
48746317|NCT01844518|156919763|FG001|Overall Study|Poor/Non-compliance|0|||
48746318|NCT01844518|156919762|FG000|Overall Study|No Longer Met Study Criteria|2|||
48746319|NCT01844518|156919763|FG001|Overall Study|No Longer Met Study Criteria|0|||
48746320|NCT01844518|156919762|FG000|Overall Study|Withdrawal by Subject|9|||
48746321|NCT01844518|156919763|FG001|Overall Study|Withdrawal by Subject|0|||
48746322|NCT01844518|156919762|FG000|Overall Study|Pregnancy|1|||
48327136|NCT00887224|155396137|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
48327137|NCT00887224|155396135|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
48327138|NCT00887224|155396136|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
48635335|NCT00557193|156523994|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
48635336|NCT00557193|156523995|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
48635337|NCT00557193|156523996|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
48635338|NCT00557193|156523991|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
48635339|NCT00557193|156523992|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
48635340|NCT00557193|156523993|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
48635341|NCT00557193|156523994|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
48635342|NCT00557193|156523995|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
48635343|NCT00557193|156523996|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
48635344|NCT00557193|156523991|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
48635345|NCT00557193|156523992|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
48635346|NCT00557193|156523993|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
48635347|NCT00557193|156523994|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
48635348|NCT00557193|156523995|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
48635349|NCT00557193|156523996|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
48635350|NCT00557193|156523991|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
48635351|NCT00557193|156523992|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
48635352|NCT00557193|156523993|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
48746323|NCT01844518|156919763|FG001|Overall Study|Pregnancy|0|||
48746324|NCT02094677|156919764|FG000|Overall Study|Screening|3|||
48746325|NCT02094677|156919765|FG001|Overall Study|Screening|1|||
48746326|NCT00291577|156919766|FG000|Overall Study|Adverse Event|1|||
48746327|NCT00291577|156919766|FG000|Overall Study|Other|4|||
48746328|NCT00291577|156919766|FG000|Overall Study|Withdrawal by Subject|2|||
48327139|NCT00887224|155396137|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
48746329|NCT00291577|156919766|FG000|Overall Study|Lack of Efficacy|14|||
48746330|NCT01365910|156919769|FG000|Overall Study|Withdrawal by Subject|7|||
48746331|NCT01365910|156919769|FG000|Overall Study|disease progression|18|||
48746332|NCT01365910|156919769|FG000|Overall Study|Adverse Event|3|||
48746333|NCT01365910|156919769|FG000|Overall Study|other complicating disease|1|||
48426717|NCT00893113|155752832|FG001|Overall Study|Withdrew Consent|7|||
48746334|NCT01365910|156919769|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
48746335|NCT04502693|156919770|FG000|Overall Study|Adverse Event|7|||
48746336|NCT04502693|156919771|FG001|Overall Study|Adverse Event|6|||
48746337|NCT04502693|156919772|FG002|Overall Study|Adverse Event|11|||
48635353|NCT00557193|156523994|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
48635354|NCT00557193|156523995|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
48635355|NCT00557193|156523996|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
48635356|NCT00557193|156523991|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
48635357|NCT00557193|156523992|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
48746338|NCT04502693|156919773|FG003|Overall Study|Adverse Event|1|||
48746339|NCT04502693|156919770|FG000|Overall Study|Lost to Follow-up|32|||
48746340|NCT04502693|156919771|FG001|Overall Study|Lost to Follow-up|36|||
48746341|NCT04502693|156919772|FG002|Overall Study|Lost to Follow-up|69|||
48635358|NCT00557193|156523993|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
48635359|NCT00557193|156523994|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
48635360|NCT00557193|156523995|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
48635361|NCT00557193|156523996|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
48635362|NCT00320606|156523997|FG000|Overall Study|Adverse Event|1|||
48635363|NCT00320606|156523997|FG000|Overall Study|Protocol Violation|1|||
48635364|NCT00320606|156523997|FG000|Overall Study|Withdrawal by Subject|1|||
48635365|NCT03984825|156523998|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
48635366|NCT03984825|156523998|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
48746342|NCT04502693|156919773|FG003|Overall Study|Lost to Follow-up|4|||
48746343|NCT04502693|156919770|FG000|Overall Study|Protocol Violation|8|||
48746344|NCT04502693|156919771|FG001|Overall Study|Protocol Violation|8|||
48746345|NCT04502693|156919772|FG002|Overall Study|Protocol Violation|16|||
48746346|NCT04502693|156919773|FG003|Overall Study|Protocol Violation|1|||
48746347|NCT04502693|156919770|FG000|Overall Study|Withdrawal by Subject|46|||
48635367|NCT03984825|156523998|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
48635368|NCT01602484|156523999|FG000|Overall Study|Airway issues unrelated to study|0|||
48635369|NCT01602484|156524000|FG001|Overall Study|Airway issues unrelated to study|1|||
48635370|NCT00419744|156524001|FG000|Overall Study|Adverse Event|39|||
48635371|NCT00419744|156524002|FG001|Overall Study|Adverse Event|40|||
48635372|NCT00419744|156524003|FG002|Overall Study|Adverse Event|50|||
48635373|NCT00419744|156524001|FG000|Overall Study|Withdrawal by Subject|45|||
48635374|NCT00419744|156524002|FG001|Overall Study|Withdrawal by Subject|49|||
48635375|NCT00419744|156524003|FG002|Overall Study|Withdrawal by Subject|52|||
48635376|NCT00419744|156524001|FG000|Overall Study|Lost to Follow-up|8|||
48635377|NCT00419744|156524002|FG001|Overall Study|Lost to Follow-up|10|||
48635378|NCT00419744|156524003|FG002|Overall Study|Lost to Follow-up|6|||
48635379|NCT00419744|156524001|FG000|Overall Study|Protocol Violation|4|||
48635380|NCT00419744|156524002|FG001|Overall Study|Protocol Violation|7|||
48635381|NCT00419744|156524003|FG002|Overall Study|Protocol Violation|8|||
48635382|NCT00419744|156524001|FG000|Overall Study|Randomized in error|9|||
48635383|NCT00419744|156524002|FG001|Overall Study|Randomized in error|6|||
48635384|NCT00419744|156524003|FG002|Overall Study|Randomized in error|7|||
48635385|NCT00419744|156524001|FG000|Overall Study|Moving out of state|2|||
48635386|NCT00419744|156524002|FG001|Overall Study|Moving out of state|0|||
48635387|NCT00419744|156524003|FG002|Overall Study|Moving out of state|1|||
48635388|NCT00419744|156524001|FG000|Overall Study|Physician Decision|10|||
48635389|NCT00419744|156524002|FG001|Overall Study|Physician Decision|5|||
48635390|NCT00419744|156524003|FG002|Overall Study|Physician Decision|6|||
48635391|NCT00419744|156524001|FG000|Overall Study|Spirometry mouthpiece issues|0|||
48635392|NCT00419744|156524002|FG001|Overall Study|Spirometry mouthpiece issues|1|||
48635393|NCT00419744|156524003|FG002|Overall Study|Spirometry mouthpiece issues|2|||
48635394|NCT00419744|156524001|FG000|Overall Study|Incorrect medication kit dispensed|0|||
48635395|NCT00419744|156524002|FG001|Overall Study|Incorrect medication kit dispensed|0|||
48635396|NCT00419744|156524003|FG002|Overall Study|Incorrect medication kit dispensed|1|||
48635397|NCT02095106|156524004|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
48635398|NCT02095106|156524005|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
48635399|NCT00718315|156524007|FG000|Overall Study|Adverse Event|1|||
48635400|NCT00718315|156524008|FG001|Overall Study|Adverse Event|2|||
48746348|NCT04502693|156919771|FG001|Overall Study|Withdrawal by Subject|38|||
48746349|NCT04502693|156919772|FG002|Overall Study|Withdrawal by Subject|54|||
48746350|NCT04502693|156919773|FG003|Overall Study|Withdrawal by Subject|7|||
48746351|NCT04502693|156919770|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
48635401|NCT00718315|156524009|FG002|Overall Study|Adverse Event|3|||
48635402|NCT00718315|156524007|FG000|Overall Study|Death|6|||
48635403|NCT00718315|156524008|FG001|Overall Study|Death|6|||
48635404|NCT00718315|156524009|FG002|Overall Study|Death|5|||
48635405|NCT00718315|156524007|FG000|Overall Study|Lost to Follow-up|2|||
48635406|NCT00718315|156524008|FG001|Overall Study|Lost to Follow-up|3|||
48635407|NCT00718315|156524009|FG002|Overall Study|Lost to Follow-up|4|||
48635408|NCT00718315|156524007|FG000|Overall Study|Protocol Violation|5|||
48635409|NCT00718315|156524008|FG001|Overall Study|Protocol Violation|5|||
48635410|NCT00718315|156524009|FG002|Overall Study|Protocol Violation|3|||
48635411|NCT00718315|156524007|FG000|Overall Study|Erlotinib dose decreased|4|||
48635412|NCT00718315|156524008|FG001|Overall Study|Erlotinib dose decreased|3|||
48635413|NCT00718315|156524009|FG002|Overall Study|Erlotinib dose decreased|1|||
48746352|NCT04502693|156919771|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
48746353|NCT04502693|156919772|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
48746354|NCT04502693|156919773|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48746355|NCT04502693|156919770|FG000|Overall Study|Other|1|||
48746356|NCT04502693|156919771|FG001|Overall Study|Other|0|||
48746357|NCT04502693|156919772|FG002|Overall Study|Other|1|||
48746358|NCT04502693|156919773|FG003|Overall Study|Other|1|||
48746359|NCT01587001|156919774|FG000|Overall Study|Lost to Follow-up|2|||
48746360|NCT01587001|156919775|FG001|Overall Study|Lost to Follow-up|0|||
48746361|NCT01587001|156919774|FG000|Overall Study|Insufficient samples to complete testing|4|||
48746362|NCT01587001|156919775|FG001|Overall Study|Insufficient samples to complete testing|1|||
48746363|NCT02756013|156919776|FG000|Overall Study|Adverse Event|1|||
48746364|NCT02756013|156919776|FG000|Overall Study|Hypersensitivity|1|||
48635414|NCT00718315|156524007|FG000|Overall Study|Use of Minocyclin|1|||
48635415|NCT00718315|156524008|FG001|Overall Study|Use of Minocyclin|1|||
48635416|NCT00718315|156524009|FG002|Overall Study|Use of Minocyclin|1|||
48635417|NCT00718315|156524007|FG000|Overall Study|Disease progression|0|||
48635418|NCT00718315|156524008|FG001|Overall Study|Disease progression|1|||
48635419|NCT00718315|156524009|FG002|Overall Study|Disease progression|1|||
48635420|NCT00718315|156524007|FG000|Overall Study|Other|0|||
48635421|NCT00718315|156524008|FG001|Overall Study|Other|0|||
48635422|NCT00718315|156524009|FG002|Overall Study|Other|1|||
48635423|NCT00718315|156524007|FG000|Overall Study|Use of ATB and Corticoids|0|||
48635424|NCT00718315|156524008|FG001|Overall Study|Use of ATB and Corticoids|1|||
48635425|NCT00718315|156524009|FG002|Overall Study|Use of ATB and Corticoids|2|||
48635426|NCT03894891|156524016|FG000|Overall Study|Withdrawal by Subject|1|||
48635427|NCT03894891|156524016|FG000|Overall Study|Completed protocol treatment per protocol|5|||
48635428|NCT00862940|156524017|FG000|Overall Study|Adverse Event|15|||
48635429|NCT00862940|156524018|FG001|Overall Study|Adverse Event|12|||
48746365|NCT00629707|156919777|FG000|Overall Study|Withdrawal by Subject|0|||
48746366|NCT00629707|156919778|FG001|Overall Study|Withdrawal by Subject|1|||
48746367|NCT00629707|156919777|FG000|Overall Study|Physician Decision|0|||
48746368|NCT00629707|156919778|FG001|Overall Study|Physician Decision|1|||
48746369|NCT04974697|156919782|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
48746370|NCT04974697|156919782|FG000|Overall Study|Lens discomfort|1|||
48746371|NCT04112784|156919792|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
48746372|NCT04112784|156919792|FG000|Overall Study|Screen Failures|4|||
48746373|NCT01558271|156919793|FG000|Overall Study|Adverse Event|6|||
48746374|NCT01558271|156919794|FG001|Overall Study|Adverse Event|3|||
48746375|NCT01558271|156919795|FG002|Overall Study|Adverse Event|4|||
48746376|NCT01558271|156919793|FG000|Overall Study|Lost to Follow-up|1|||
48746377|NCT01558271|156919794|FG001|Overall Study|Lost to Follow-up|0|||
48746378|NCT01558271|156919795|FG002|Overall Study|Lost to Follow-up|0|||
48746379|NCT01558271|156919793|FG000|Overall Study|Protocol Violation|1|||
48746380|NCT01558271|156919794|FG001|Overall Study|Protocol Violation|0|||
48746381|NCT01558271|156919795|FG002|Overall Study|Protocol Violation|0|||
48746382|NCT01558271|156919793|FG000|Overall Study|Withdrawal by Subject|10|||
48746383|NCT01558271|156919794|FG001|Overall Study|Withdrawal by Subject|6|||
48746384|NCT01558271|156919795|FG002|Overall Study|Withdrawal by Subject|12|||
48746385|NCT01558271|156919793|FG000|Overall Study|Physician Decision|0|||
48746386|NCT01558271|156919794|FG001|Overall Study|Physician Decision|2|||
48746387|NCT01558271|156919795|FG002|Overall Study|Physician Decision|1|||
48746388|NCT00221403|156919796|FG000|Overall Study|Protocol Violation|1|||
48746389|NCT00221403|156919797|FG001|Overall Study|Protocol Violation|0|||
48635430|NCT00862940|156524017|FG000|Overall Study|Lack of Efficacy|1|||
48746390|NCT00221403|156919798|FG002|Overall Study|Protocol Violation|0|||
48746391|NCT00221403|156919796|FG000|Overall Study|Physician Decision|1|||
48746392|NCT00221403|156919797|FG001|Overall Study|Physician Decision|0|||
48746393|NCT00221403|156919798|FG002|Overall Study|Physician Decision|0|||
48746394|NCT00221403|156919796|FG000|Overall Study|Withdrawal by Subject|0|||
48746395|NCT00221403|156919797|FG001|Overall Study|Withdrawal by Subject|3|||
48746396|NCT00221403|156919798|FG002|Overall Study|Withdrawal by Subject|0|||
48746397|NCT00221403|156919796|FG000|Overall Study|Lack of Efficacy|0|||
48746398|NCT00221403|156919797|FG001|Overall Study|Lack of Efficacy|1|||
48635431|NCT00862940|156524018|FG001|Overall Study|Lack of Efficacy|3|||
48635432|NCT00862940|156524017|FG000|Overall Study|Protocol Violation|2|||
48635433|NCT00862940|156524018|FG001|Overall Study|Protocol Violation|5|||
48635434|NCT00862940|156524017|FG000|Overall Study|Withdrawal by Subject|4|||
48746399|NCT00221403|156919798|FG002|Overall Study|Lack of Efficacy|0|||
48746400|NCT00221403|156919796|FG000|Overall Study|Adverse Event|0|||
48746401|NCT00221403|156919797|FG001|Overall Study|Adverse Event|1|||
48635435|NCT00862940|156524018|FG001|Overall Study|Withdrawal by Subject|6|||
48327140|NCT00887224|155396135|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
48635436|NCT00862940|156524017|FG000|Overall Study|Non-compliance|4|||
48635437|NCT00862940|156524018|FG001|Overall Study|Non-compliance|0|||
48635438|NCT00862940|156524017|FG000|Overall Study|Lost to Follow-up|0|||
48635439|NCT00862940|156524018|FG001|Overall Study|Lost to Follow-up|1|||
48635440|NCT00862940|156524017|FG000|Overall Study|Administrative or other reason(s)|4|||
48635441|NCT00862940|156524018|FG001|Overall Study|Administrative or other reason(s)|3|||
48635442|NCT01677988|156524025|FG000|Overall Study|Lack of Efficacy|2|||
48635443|NCT02629861|156524026|FG000|Overall Study|Adverse Event|7|||
48635444|NCT02629861|156524027|FG001|Overall Study|Adverse Event|5|||
48635445|NCT02629861|156524028|FG002|Overall Study|Adverse Event|4|||
48635446|NCT02629861|156524026|FG000|Overall Study|Withdrawal by Subject|5|||
48635447|NCT02629861|156524027|FG001|Overall Study|Withdrawal by Subject|8|||
48635448|NCT02629861|156524028|FG002|Overall Study|Withdrawal by Subject|13|||
48635449|NCT02629861|156524026|FG000|Overall Study|Protocol Violation|2|||
48635450|NCT02629861|156524027|FG001|Overall Study|Protocol Violation|3|||
48635451|NCT02629861|156524028|FG002|Overall Study|Protocol Violation|7|||
48635452|NCT02629861|156524026|FG000|Overall Study|Lost to Follow-up|12|||
48635453|NCT02629861|156524027|FG001|Overall Study|Lost to Follow-up|9|||
48635454|NCT02629861|156524028|FG002|Overall Study|Lost to Follow-up|4|||
48635455|NCT02629861|156524026|FG000|Overall Study|Other|1|||
48635456|NCT02629861|156524027|FG001|Overall Study|Other|1|||
48635457|NCT02629861|156524028|FG002|Overall Study|Other|0|||
48635458|NCT02629861|156524026|FG000|Overall Study|Pregnancy|2|||
48635459|NCT02629861|156524027|FG001|Overall Study|Pregnancy|1|||
48635460|NCT02629861|156524028|FG002|Overall Study|Pregnancy|0|||
48635461|NCT03366337|156524029|FG000|Overall Study|Lost to Follow-up|1|||
48635462|NCT03366337|156524030|FG001|Overall Study|Lost to Follow-up|0|||
48635463|NCT03366337|156524031|FG002|Overall Study|Lost to Follow-up|1|||
48635464|NCT03366337|156524032|FG003|Overall Study|Lost to Follow-up|0|||
48635465|NCT03366337|156524029|FG000|Overall Study|Withdrawal by Subject|2|||
48635466|NCT03366337|156524030|FG001|Overall Study|Withdrawal by Subject|0|||
48635467|NCT03366337|156524031|FG002|Overall Study|Withdrawal by Subject|1|||
48635468|NCT03366337|156524032|FG003|Overall Study|Withdrawal by Subject|1|||
48635469|NCT02709161|156524039|FG000|Overall Study|Withdrawal by Subject|1|||
48635470|NCT02709161|156524040|FG001|Overall Study|Withdrawal by Subject|0|||
48635471|NCT04089865|156524043|FG000|Overall Study|Withdrawal by Subject|2|||
48635472|NCT04089865|156524044|FG001|Overall Study|Withdrawal by Subject|2|||
48635473|NCT04089865|156524045|FG002|Overall Study|Withdrawal by Subject|7|||
48635474|NCT04089865|156524046|FG003|Overall Study|Withdrawal by Subject|2|||
48635475|NCT01729039|156524049|FG000|Overall Study|disqualified|2|||
48635476|NCT01729039|156524050|FG001|Overall Study|disqualified|5|||
48635477|NCT01729039|156524049|FG000|Overall Study|Withdrawal by Subject|8|||
48635478|NCT01729039|156524050|FG001|Overall Study|Withdrawal by Subject|7|||
48635479|NCT04570384|156524053|FG000|Overall Study|Adverse Event|2|||
48635480|NCT04570384|156524054|FG001|Overall Study|Adverse Event|1|||
48635481|NCT04570384|156524053|FG000|Overall Study|Death|2|||
48635482|NCT04570384|156524054|FG001|Overall Study|Death|5|||
48635483|NCT04570384|156524053|FG000|Overall Study|Lost to Follow-up|1|||
48635484|NCT04570384|156524054|FG001|Overall Study|Lost to Follow-up|0|||
48635485|NCT04570384|156524053|FG000|Overall Study|Other|1|||
48635486|NCT04570384|156524054|FG001|Overall Study|Other|0|||
48635487|NCT04570384|156524053|FG000|Overall Study|Protocol Violation|0|||
48635488|NCT04570384|156524054|FG001|Overall Study|Protocol Violation|1|||
48635489|NCT04570384|156524053|FG000|Overall Study|Sponsor Decision|1|||
48635490|NCT04570384|156524054|FG001|Overall Study|Sponsor Decision|0|||
48635491|NCT04570384|156524053|FG000|Overall Study|Withdrawal by Subject|4|||
48635492|NCT04570384|156524054|FG001|Overall Study|Withdrawal by Subject|2|||
48635493|NCT01673126|156524055|FG000|Overall Study|change of diagnosis|4|||
48635494|NCT01673126|156524056|FG001|Overall Study|change of diagnosis|3|||
48635495|NCT01404234|156524057|FG000|Overall Study|Withdrawal by Subject|2|||
48635496|NCT00698841|156524058|FG000|Overall Study|Withdrawal by Subject|2|||
48327141|NCT00887224|155396136|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
48327142|NCT00887224|155396137|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
48327143|NCT00887224|155396135|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
48327144|NCT00887224|155396136|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
48327145|NCT00887224|155396137|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
48327146|NCT00887224|155396135|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
48327147|NCT00887224|155396136|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
48327148|NCT00887224|155396137|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
48327149|NCT00887224|155396135|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
48327150|NCT00887224|155396136|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
48327151|NCT00887224|155396137|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
48327152|NCT00887224|155396135|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
48327153|NCT00887224|155396136|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
48327154|NCT00887224|155396137|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
48327155|NCT00790569|155396140|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
48327156|NCT00790569|155396141|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
48635497|NCT00698841|156524058|FG000|Overall Study|Adverse Event|3|||
48635498|NCT00698841|156524058|FG000|Overall Study|Disease progression|7|||
48635499|NCT00698841|156524058|FG000|Overall Study|Failure to meet eligibility criteria|2|||
48746402|NCT00221403|156919798|FG002|Overall Study|Adverse Event|0|||
48746403|NCT01846416|156919803|FG000|Treatment Phase|Death|2|||
48746404|NCT01846416|156919804|FG001|Treatment Phase|Death|9|||
48746405|NCT01846416|156919805|FG002|Treatment Phase|Death|1|||
48746406|NCT01846416|156919803|FG000|Treatment Phase|Withdrawal by Subject|2|||
48746407|NCT01846416|156919804|FG001|Treatment Phase|Withdrawal by Subject|4|||
48746408|NCT01846416|156919805|FG002|Treatment Phase|Withdrawal by Subject|2|||
48746409|NCT01846416|156919803|FG000|Treatment Phase|Other|1|||
48746410|NCT01846416|156919804|FG001|Treatment Phase|Other|5|||
48746411|NCT01846416|156919805|FG002|Treatment Phase|Other|1|||
48746412|NCT01846416|156919803|FG000|Treatment Phase|Physician Decision|1|||
48746413|NCT01846416|156919804|FG001|Treatment Phase|Physician Decision|2|||
48746414|NCT01846416|156919805|FG002|Treatment Phase|Physician Decision|0|||
48746415|NCT01846416|156919803|FG000|Treatment Phase|Adverse Event|3|||
48746416|NCT01846416|156919804|FG001|Treatment Phase|Adverse Event|4|||
48746417|NCT01846416|156919805|FG002|Treatment Phase|Adverse Event|0|||
48746418|NCT01846416|156919803|FG000|Treatment Phase|Non-compliance|0|||
48746419|NCT01846416|156919804|FG001|Treatment Phase|Non-compliance|2|||
48746420|NCT01846416|156919805|FG002|Treatment Phase|Non-compliance|0|||
48746421|NCT01846416|156919803|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
48746422|NCT01846416|156919804|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
48746423|NCT01846416|156919805|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
48746424|NCT01846416|156919803|FG000|Treatment Phase|Progressive Disease|21|||
48746425|NCT01846416|156919804|FG001|Treatment Phase|Progressive Disease|63|||
48746426|NCT01846416|156919805|FG002|Treatment Phase|Progressive Disease|9|||
48746427|NCT01846416|156919803|FG000|Survival Follow-up|Death|21|||
48746428|NCT01846416|156919804|FG001|Survival Follow-up|Death|62|||
48746429|NCT01846416|156919805|FG002|Survival Follow-up|Death|9|||
48746430|NCT01846416|156919803|FG000|Survival Follow-up|Lost to Follow-up|0|||
48746431|NCT01846416|156919804|FG001|Survival Follow-up|Lost to Follow-up|2|||
48746432|NCT01846416|156919805|FG002|Survival Follow-up|Lost to Follow-up|2|||
48746433|NCT01846416|156919803|FG000|Survival Follow-up|Withdrawal by Subject|2|||
48746434|NCT01846416|156919804|FG001|Survival Follow-up|Withdrawal by Subject|7|||
48746435|NCT01846416|156919805|FG002|Survival Follow-up|Withdrawal by Subject|0|||
48746436|NCT01846416|156919803|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
48746437|NCT01846416|156919804|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
48746438|NCT01846416|156919805|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
48746439|NCT01846416|156919803|FG000|Survival Follow-up|Other|3|||
48746440|NCT01846416|156919804|FG001|Survival Follow-up|Other|1|||
48746441|NCT01846416|156919805|FG002|Survival Follow-up|Other|1|||
48746442|NCT00039130|156919808|FG000|Overall Study|Adverse Event|11|||
48746443|NCT00039130|156919808|FG000|Overall Study|Death|9|||
48635500|NCT00698841|156524058|FG000|Overall Study|Study drug toxicity|2|||
48635501|NCT00698841|156524058|FG000|Overall Study|Other|2|||
48746444|NCT00039130|156919808|FG000|Overall Study|Withdrawal by Subject|3|||
48746445|NCT00039130|156919808|FG000|Overall Study|Progression|2|||
48746446|NCT00039130|156919808|FG000|Overall Study|Subsequent treatment|2|||
48746447|NCT00039130|156919808|FG000|Overall Study|Physician Decision|3|||
48746448|NCT03288129|156919810|FG000|Overall Study|Adverse Event|10|||
48746449|NCT03288129|156919810|FG000|Overall Study|Lost to Follow-up|3|||
48746450|NCT03288129|156919810|FG000|Overall Study|Withdrawal by Subject|3|||
48327157|NCT00790569|155396142|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
48327158|NCT00790569|155396140|FG000|End of Treatment (6 Month Interview)|Death|0|||
48327159|NCT00790569|155396141|FG001|End of Treatment (6 Month Interview)|Death|2|||
48327160|NCT00790569|155396142|FG002|End of Treatment (6 Month Interview)|Death|1|||
48327161|NCT00790569|155396140|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
48327162|NCT00790569|155396141|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
48327163|NCT00790569|155396142|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
48327164|NCT00790569|155396140|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
48327165|NCT00790569|155396141|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
48327166|NCT00790569|155396142|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
48327167|NCT00790569|155396140|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
48327168|NCT00790569|155396141|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
48327169|NCT00790569|155396142|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
48327170|NCT00790569|155396140|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
48327171|NCT00790569|155396141|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
48327172|NCT00790569|155396142|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
48746451|NCT03288129|156919810|FG000|Overall Study|Withdrawal of consent/assent|1|||
48746452|NCT03288129|156919810|FG000|Overall Study|Other|5|||
48746453|NCT01866930|156919811|FG000|Treatment Period|Other|1|||
48746454|NCT01866930|156919812|FG001|Treatment Period|Other|0|||
48746455|NCT01866930|156919811|FG000|Treatment Period|Death|0|||
48746456|NCT01866930|156919812|FG001|Treatment Period|Death|2|||
48746457|NCT01866930|156919811|FG000|Treatment Period|Poor/non compliance|0|||
48746458|NCT01866930|156919812|FG001|Treatment Period|Poor/non compliance|2|||
48746459|NCT01866930|156919811|FG000|Treatment Period|No longer meets study criteria|0|||
48746460|NCT01866930|156919812|FG001|Treatment Period|No longer meets study criteria|1|||
48746461|NCT01866930|156919811|FG000|Treatment Period|Withdrawal by Subject|2|||
48746462|NCT01866930|156919812|FG001|Treatment Period|Withdrawal by Subject|8|||
48746463|NCT01866930|156919811|FG000|Treatment Period|Lack of Efficacy|1|||
48746464|NCT01866930|156919812|FG001|Treatment Period|Lack of Efficacy|9|||
48746465|NCT01866930|156919811|FG000|Treatment Period|Adverse Event|4|||
48746466|NCT01866930|156919812|FG001|Treatment Period|Adverse Event|12|||
48746467|NCT01866930|156919811|FG000|Treatment Period|Lost to Follow-up|1|||
48746468|NCT01866930|156919812|FG001|Treatment Period|Lost to Follow-up|1|||
48746469|NCT01866930|156919811|FG000|Follow-up Period|Lost to Follow-up|1|||
48746470|NCT01866930|156919812|FG001|Follow-up Period|Lost to Follow-up|1|||
48585712|NCT01926197|156335812|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
48585713|NCT01926197|156335811|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
48585714|NCT01926197|156335812|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
48585715|NCT02515994|156335813|FG000|Overall Study|Protocol Violation|3|||
48585716|NCT02515994|156335814|FG001|Overall Study|Protocol Violation|5|||
48585717|NCT02515994|156335813|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
48327173|NCT01555138|155396143|FG000|Overall Study|Death|0|||
48327174|NCT01555138|155396144|FG001|Overall Study|Death|1|||
48327175|NCT01555138|155396143|FG000|Overall Study|Lost to Follow-up|1|||
48327176|NCT01555138|155396144|FG001|Overall Study|Lost to Follow-up|0|||
48327177|NCT01555138|155396143|FG000|Overall Study|Abnormal Lab reults|1|||
48327178|NCT01555138|155396144|FG001|Overall Study|Abnormal Lab reults|3|||
48327179|NCT01555138|155396143|FG000|Overall Study|Lack of Efficacy|2|||
48327180|NCT01555138|155396144|FG001|Overall Study|Lack of Efficacy|2|||
48327181|NCT01555138|155396143|FG000|Overall Study|Protocol Violation|5|||
48327182|NCT01555138|155396144|FG001|Overall Study|Protocol Violation|3|||
48585718|NCT02515994|156335814|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
48585719|NCT02515994|156335813|FG000|Overall Study|Adverse Event|3|||
48585720|NCT02515994|156335814|FG001|Overall Study|Adverse Event|1|||
48585721|NCT02515994|156335813|FG000|Overall Study|Withdrawal by Subject|2|||
48327183|NCT01555138|155396143|FG000|Overall Study|Administrative problems|8|||
48327184|NCT01555138|155396144|FG001|Overall Study|Administrative problems|0|||
48327185|NCT01555138|155396143|FG000|Overall Study|Withdrawal by Subject|16|||
48327186|NCT01555138|155396144|FG001|Overall Study|Withdrawal by Subject|15|||
48327187|NCT01555138|155396143|FG000|Overall Study|Adverse Event|14|||
48327188|NCT01555138|155396144|FG001|Overall Study|Adverse Event|14|||
48327189|NCT00686595|155396147|FG000|Overall Study|Adverse Event|3|||
48327190|NCT00686595|155396147|FG000|Overall Study|Protocol Violation|1|||
48327191|NCT00686595|155396147|FG000|Overall Study|Lost to Follow-up|1|||
48327192|NCT00686595|155396147|FG000|Overall Study|Lack of Efficacy|1|||
48327193|NCT00686595|155396147|FG000|Overall Study|Poor Compliance|1|||
48327194|NCT01478594|155396151|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
48327195|NCT01478594|155396152|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
48327196|NCT01478594|155396151|FG000|Overall Study|Death|45|||
48327197|NCT01478594|155396152|FG001|Overall Study|Death|18|||
48327198|NCT01478594|155396151|FG000|Overall Study|Lost to Follow-up|3|||
48327199|NCT01478594|155396152|FG001|Overall Study|Lost to Follow-up|1|||
48635502|NCT01280968|156524059|FG000|Overall Study|Lost to Follow-up|8|||
48635503|NCT01280968|156524060|FG001|Overall Study|Lost to Follow-up|2|||
48635504|NCT01280968|156524059|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
48635505|NCT01280968|156524060|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
48635506|NCT01280968|156524059|FG000|Overall Study|Commuting Problems|2|||
48635507|NCT01280968|156524060|FG001|Overall Study|Commuting Problems|0|||
48635508|NCT01280968|156524059|FG000|Overall Study|Anxiety|2|||
48635509|NCT01280968|156524060|FG001|Overall Study|Anxiety|0|||
48635510|NCT01280968|156524059|FG000|Overall Study|Adverse Event|1|||
48635511|NCT01280968|156524060|FG001|Overall Study|Adverse Event|0|||
48635512|NCT01280968|156524059|FG000|Overall Study|Scheduling Conflicts|1|||
48635513|NCT01280968|156524060|FG001|Overall Study|Scheduling Conflicts|1|||
48635514|NCT01280968|156524059|FG000|Overall Study|Pre-existing Neurological Condition|1|||
48635515|NCT01280968|156524060|FG001|Overall Study|Pre-existing Neurological Condition|0|||
48635516|NCT01280968|156524059|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
48635517|NCT01280968|156524060|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
48635518|NCT05870865|156524064|FG000|Randomized|Did not receive study treatment|2|||
48635519|NCT05870865|156524065|FG001|Randomized|Did not receive study treatment|4|||
48635520|NCT05870865|156524066|FG002|Randomized|Did not receive study treatment|4|||
48635521|NCT05870865|156524067|FG003|Randomized|Did not receive study treatment|3|||
48635522|NCT05870865|156524064|FG000|Treatment Period|Adverse Event|1|||
48635523|NCT05870865|156524065|FG001|Treatment Period|Adverse Event|1|||
48635524|NCT05870865|156524066|FG002|Treatment Period|Adverse Event|1|||
48635525|NCT05870865|156524067|FG003|Treatment Period|Adverse Event|1|||
48635526|NCT05870865|156524064|FG000|Treatment Period|Lost to Follow-up|0|||
48635527|NCT05870865|156524065|FG001|Treatment Period|Lost to Follow-up|1|||
48635528|NCT05870865|156524066|FG002|Treatment Period|Lost to Follow-up|2|||
48635529|NCT05870865|156524067|FG003|Treatment Period|Lost to Follow-up|0|||
48635530|NCT05870865|156524064|FG000|Treatment Period|Protocol Violation|0|||
48635531|NCT05870865|156524065|FG001|Treatment Period|Protocol Violation|0|||
48635532|NCT05870865|156524066|FG002|Treatment Period|Protocol Violation|0|||
48635533|NCT05870865|156524067|FG003|Treatment Period|Protocol Violation|1|||
48635534|NCT05870865|156524064|FG000|Treatment Period|Withdrawal by Subject|0|||
48635535|NCT05870865|156524065|FG001|Treatment Period|Withdrawal by Subject|1|||
48635536|NCT05870865|156524066|FG002|Treatment Period|Withdrawal by Subject|1|||
48635537|NCT05870865|156524067|FG003|Treatment Period|Withdrawal by Subject|1|||
48635538|NCT00276419|156525084|FG000|First Intervention|Adverse Event|1|||
48635539|NCT00276419|156525085|FG001|First Intervention|Adverse Event|0|||
48635540|NCT00276419|156525084|FG000|First Intervention|Withdrawal by Subject|0|||
48635541|NCT00276419|156525085|FG001|First Intervention|Withdrawal by Subject|2|||
48635542|NCT03186638|156525086|FG000|Overall Study|Withdrawal by Subject|4|||
48635543|NCT03186638|156525087|FG001|Overall Study|Withdrawal by Subject|4|||
48635544|NCT03186638|156525086|FG000|Overall Study|Withdrawn due to medical problem|3|||
48635545|NCT03186638|156525087|FG001|Overall Study|Withdrawn due to medical problem|2|||
48635546|NCT03186638|156525086|FG000|Overall Study|Lost to Follow-up|1|||
48635547|NCT03186638|156525087|FG001|Overall Study|Lost to Follow-up|0|||
48635548|NCT00688597|156525088|FG000|Overall Study|Adverse Event|2|||
48635549|NCT00688597|156525089|FG001|Overall Study|Adverse Event|0|||
48635550|NCT00688597|156525090|FG002|Overall Study|Adverse Event|0|||
48635551|NCT00688597|156525088|FG000|Overall Study|Physician Decision|1|||
48635552|NCT00688597|156525089|FG001|Overall Study|Physician Decision|0|||
48635553|NCT00688597|156525090|FG002|Overall Study|Physician Decision|0|||
48635554|NCT02546323|156525092|FG000|Overall Study|Withdrawal by Subject|36|||
48635555|NCT02546323|156525093|FG001|Overall Study|Withdrawal by Subject|33|||
48635556|NCT02546323|156525092|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
48635557|NCT02546323|156525093|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
48635558|NCT02546323|156525092|FG000|Overall Study|Adverse Event|17|||
48635559|NCT02546323|156525093|FG001|Overall Study|Adverse Event|11|||
48635560|NCT02546323|156525092|FG000|Overall Study|Patient Specific Reasons|1|||
48635561|NCT02546323|156525093|FG001|Overall Study|Patient Specific Reasons|2|||
48635562|NCT02546323|156525092|FG000|Overall Study|Lost to Follow-up|2|||
48635563|NCT02546323|156525093|FG001|Overall Study|Lost to Follow-up|3|||
48635564|NCT02546323|156525092|FG000|Overall Study|Non-compliance with Study Drug|2|||
48635565|NCT02546323|156525093|FG001|Overall Study|Non-compliance with Study Drug|2|||
48635566|NCT02546323|156525092|FG000|Overall Study|Met Withdrawal Criteria|2|||
48635567|NCT02546323|156525093|FG001|Overall Study|Met Withdrawal Criteria|14|||
48635568|NCT02271880|156525102|FG000|Overall Study|Premature discontinuation of study|3|||
48327200|NCT01478594|155396151|FG000|Overall Study|Withdrawal by Subject|9|||
48327201|NCT01478594|155396152|FG001|Overall Study|Withdrawal by Subject|3|||
48327202|NCT01478594|155396151|FG000|Overall Study|Study Closed by Sponsor|8|||
48327203|NCT01478594|155396152|FG001|Overall Study|Study Closed by Sponsor|5|||
48327204|NCT01313884|155396157|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
48327205|NCT00999596|155396158|FG000|Overall Study|Statistical population not required|101|||
48327206|NCT02085941|155396159|FG000|Overall Study|Lack of Efficacy|1|||
48327207|NCT02085941|155396160|FG001|Overall Study|Lack of Efficacy|0|||
48327208|NCT02085941|155396159|FG000|Overall Study|Death|6|||
48327209|NCT02085941|155396160|FG001|Overall Study|Death|1|||
48327210|NCT02085941|155396159|FG000|Overall Study|Lost to Follow-up|1|||
48327211|NCT02085941|155396160|FG001|Overall Study|Lost to Follow-up|0|||
48635569|NCT02271880|156525103|FG001|Overall Study|Premature discontinuation of study|4|||
48635570|NCT00474903|156525104|FG000|Overall Study|Protocol Violation|1|||
48635571|NCT00474903|156525105|FG001|Overall Study|Protocol Violation|5|||
48327212|NCT02085941|155396159|FG000|Overall Study|Physician Decision|0|||
48327213|NCT02085941|155396160|FG001|Overall Study|Physician Decision|2|||
48327214|NCT02234141|155396165|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
48327215|NCT02234141|155396166|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
48635572|NCT00474903|156525106|FG002|Overall Study|Protocol Violation|2|||
48635573|NCT02133573|156525107|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
48635574|NCT02133573|156525108|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
48635575|NCT02133573|156525107|FG000|Overall Study|Child Deaths|3|||
48635576|NCT02133573|156525108|FG001|Overall Study|Child Deaths|5|||
48635577|NCT02133573|156525107|FG000|Overall Study|Child Declined Follow Ups|2|||
48635578|NCT02133573|156525108|FG001|Overall Study|Child Declined Follow Ups|1|||
48635579|NCT02133573|156525107|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
48635580|NCT02133573|156525108|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
48327216|NCT02234141|155396167|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
48635581|NCT01917318|156525109|FG000|First Treatment|Withdrawal by Subject|0|||
48635582|NCT01917318|156525110|FG001|First Treatment|Withdrawal by Subject|1|||
48635583|NCT01646827|156525112|FG000|Overall Study|Lost to Follow-up|0|||
48635584|NCT01646827|156525113|FG001|Overall Study|Lost to Follow-up|3|||
48635585|NCT01646827|156525112|FG000|Overall Study|Physician Decision|1|||
48635586|NCT01646827|156525113|FG001|Overall Study|Physician Decision|2|||
48635587|NCT01646827|156525112|FG000|Overall Study|Withdrawal by Subject|1|||
48635588|NCT01646827|156525113|FG001|Overall Study|Withdrawal by Subject|0|||
48635589|NCT01987557|156525114|FG000|Overall Study|Protocol Violation|1|||
48635590|NCT01987557|156525115|FG001|Overall Study|Protocol Violation|0|||
48635591|NCT01987557|156525116|FG002|Overall Study|Protocol Violation|1|||
48635592|NCT01987557|156525114|FG000|Overall Study|Withdrawal by Subject|2|||
48635593|NCT01987557|156525115|FG001|Overall Study|Withdrawal by Subject|1|||
48635594|NCT01987557|156525116|FG002|Overall Study|Withdrawal by Subject|2|||
48327217|NCT02234141|155396168|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
48635595|NCT01987557|156525114|FG000|Overall Study|Adverse Event|0|||
48635596|NCT01987557|156525115|FG001|Overall Study|Adverse Event|2|||
48635597|NCT01987557|156525116|FG002|Overall Study|Adverse Event|0|||
48635598|NCT00431964|156525117|FG000|Overall Study|Adverse Event|1|||
48635599|NCT00431964|156525118|FG001|Overall Study|Adverse Event|0|||
48635600|NCT00431964|156525117|FG000|Overall Study|Lost to Follow-up|1|||
48635601|NCT00431964|156525118|FG001|Overall Study|Lost to Follow-up|2|||
48635602|NCT00431964|156525117|FG000|Overall Study|Physician Decision|2|||
48635603|NCT00431964|156525118|FG001|Overall Study|Physician Decision|2|||
48635604|NCT00431964|156525117|FG000|Overall Study|Withdrawal by Subject|2|||
48635605|NCT00431964|156525118|FG001|Overall Study|Withdrawal by Subject|1|||
48635606|NCT00431964|156525117|FG000|Overall Study|Parental Consent Withdrawn|0|||
48635607|NCT00431964|156525118|FG001|Overall Study|Parental Consent Withdrawn|2|||
48635608|NCT00431964|156525117|FG000|Overall Study|Due to Unstable Health|0|||
48635609|NCT00431964|156525118|FG001|Overall Study|Due to Unstable Health|1|||
48635610|NCT03323164|156525119|FG000|Overall Study|Poor quality imaging/scans|2|||
48635611|NCT03323164|156525120|FG001|Overall Study|Poor quality imaging/scans|2|||
48635612|NCT01882465|156525124|FG000|Period 1|Lens Discomfort|0|||
48635613|NCT01882465|156525125|FG001|Period 1|Lens Discomfort|0|||
48635614|NCT01882465|156525126|FG002|Period 1|Lens Discomfort|0|||
48635615|NCT01882465|156525127|FG003|Period 1|Lens Discomfort|1|||
48635616|NCT01882465|156525128|FG004|Period 1|Lens Discomfort|0|||
48635617|NCT01882465|156525129|FG005|Period 1|Lens Discomfort|0|||
48635618|NCT01882465|156525130|FG006|Period 1|Lens Discomfort|0|||
48635619|NCT01882465|156525124|FG000|Period 1|Withdrawal by Subject|0|||
48635620|NCT01882465|156525125|FG001|Period 1|Withdrawal by Subject|0|||
48635621|NCT01882465|156525126|FG002|Period 1|Withdrawal by Subject|0|||
48635622|NCT01882465|156525127|FG003|Period 1|Withdrawal by Subject|0|||
48635623|NCT01882465|156525128|FG004|Period 1|Withdrawal by Subject|0|||
48635624|NCT01882465|156525129|FG005|Period 1|Withdrawal by Subject|0|||
48635625|NCT01882465|156525130|FG006|Period 1|Withdrawal by Subject|1|||
48635626|NCT01882465|156525124|FG000|Period 2|Protocol Violation|0|||
48635627|NCT01882465|156525125|FG001|Period 2|Protocol Violation|0|||
48635628|NCT01882465|156525126|FG002|Period 2|Protocol Violation|0|||
48635629|NCT01882465|156525127|FG003|Period 2|Protocol Violation|0|||
48635630|NCT01882465|156525128|FG004|Period 2|Protocol Violation|1|||
48635631|NCT01882465|156525129|FG005|Period 2|Protocol Violation|0|||
48635632|NCT01882465|156525130|FG006|Period 2|Protocol Violation|0|||
48635633|NCT02712788|156525131|FG000|Overall Study|Physician Decision|1|||
48635634|NCT02712788|156525132|FG001|Overall Study|Physician Decision|0|||
48635635|NCT02712788|156525131|FG000|Overall Study|Protocol Violation|1|||
48635636|NCT02712788|156525132|FG001|Overall Study|Protocol Violation|0|||
48635637|NCT04436744|156525136|FG000|Overall Study|Adverse Event|1|||
48635638|NCT04436744|156525137|FG001|Overall Study|Adverse Event|1|||
48635639|NCT04436744|156525136|FG000|Overall Study|Death|1|||
48635640|NCT04436744|156525137|FG001|Overall Study|Death|0|||
48635641|NCT04436744|156525136|FG000|Overall Study|Lost to Follow-up|0|||
48635642|NCT04436744|156525137|FG001|Overall Study|Lost to Follow-up|2|||
48635643|NCT04436744|156525136|FG000|Overall Study|Physician Decision|0|||
48635644|NCT04436744|156525137|FG001|Overall Study|Physician Decision|1|||
48635645|NCT04436744|156525136|FG000|Overall Study|Progressive Disease|0|||
48635646|NCT04436744|156525137|FG001|Overall Study|Progressive Disease|4|||
48635647|NCT04436744|156525136|FG000|Overall Study|Protocol Deviation|1|||
48635648|NCT04436744|156525137|FG001|Overall Study|Protocol Deviation|1|||
48635649|NCT04436744|156525136|FG000|Overall Study|Withdrawal by Subject|1|||
48635650|NCT04436744|156525137|FG001|Overall Study|Withdrawal by Subject|2|||
48635651|NCT01378117|156525139|FG000|Overall Study|withdrawal|2|||
48635652|NCT01378117|156525140|FG001|Overall Study|withdrawal|1|||
48635653|NCT01378117|156525141|FG002|Overall Study|withdrawal|2|||
48635654|NCT01378117|156525139|FG000|Overall Study|discharged before med given|2|||
48635655|NCT01378117|156525140|FG001|Overall Study|discharged before med given|0|||
48635656|NCT01378117|156525141|FG002|Overall Study|discharged before med given|1|||
48635657|NCT02951780|156525145|FG000|Period 1|Adverse Event|0|||
48635658|NCT02951780|156525146|FG001|Period 1|Adverse Event|0|||
48635659|NCT02951780|156525147|FG002|Period 1|Adverse Event|0|||
48635660|NCT02951780|156525148|FG003|Period 1|Adverse Event|1|||
48635661|NCT02951780|156525149|FG004|Period 1|Adverse Event|0|||
48635662|NCT02951780|156525150|FG005|Period 1|Adverse Event|0|||
48635663|NCT02951780|156525151|FG006|Period 1|Adverse Event|0|||
48635664|NCT02951780|156525152|FG007|Period 1|Adverse Event|0|||
48635665|NCT02951780|156525153|FG008|Period 1|Adverse Event|0|||
48635666|NCT02951780|156525145|FG000|Period 1|Scheduling Conflicts|0|||
48635667|NCT02951780|156525146|FG001|Period 1|Scheduling Conflicts|0|||
48635668|NCT02951780|156525147|FG002|Period 1|Scheduling Conflicts|0|||
48635669|NCT02951780|156525148|FG003|Period 1|Scheduling Conflicts|0|||
48635670|NCT02951780|156525149|FG004|Period 1|Scheduling Conflicts|0|||
48635671|NCT02951780|156525150|FG005|Period 1|Scheduling Conflicts|0|||
48635672|NCT02951780|156525151|FG006|Period 1|Scheduling Conflicts|0|||
48635673|NCT02951780|156525152|FG007|Period 1|Scheduling Conflicts|1|||
48635674|NCT02951780|156525153|FG008|Period 1|Scheduling Conflicts|0|||
48635675|NCT02951780|156525145|FG000|Period 2|Scheduling Conflicts|0|||
48635676|NCT02951780|156525146|FG001|Period 2|Scheduling Conflicts|0|||
48327218|NCT02234141|155396169|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
48635677|NCT02951780|156525147|FG002|Period 2|Scheduling Conflicts|0|||
48635678|NCT02951780|156525148|FG003|Period 2|Scheduling Conflicts|0|||
48635679|NCT02951780|156525149|FG004|Period 2|Scheduling Conflicts|0|||
48635680|NCT02951780|156525150|FG005|Period 2|Scheduling Conflicts|0|||
48635681|NCT02951780|156525151|FG006|Period 2|Scheduling Conflicts|0|||
48327219|NCT02234141|155396170|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
48327220|NCT02234141|155396171|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
48635682|NCT02951780|156525152|FG007|Period 2|Scheduling Conflicts|1|||
48635683|NCT02951780|156525153|FG008|Period 2|Scheduling Conflicts|0|||
48635684|NCT02359903|156525154|FG000|Overall Study|Adverse Event|0|||
48635685|NCT02359903|156525155|FG001|Overall Study|Adverse Event|2|||
48635686|NCT01077063|156525156|FG000|Overall Study|Adverse Event|3|||
48635687|NCT01077063|156525157|FG001|Overall Study|Adverse Event|0|||
48635688|NCT01077063|156525156|FG000|Overall Study|Death|1|||
48635689|NCT01077063|156525157|FG001|Overall Study|Death|1|||
48635690|NCT01077063|156525156|FG000|Overall Study|Withdrawal by Subject|0|||
48635691|NCT01077063|156525157|FG001|Overall Study|Withdrawal by Subject|2|||
48635692|NCT04117347|156525160|FG000|Overall Study|Adverse Event|0|||
48635693|NCT04117347|156525161|FG001|Overall Study|Adverse Event|0|||
48635694|NCT04117347|156525162|FG002|Overall Study|Adverse Event|1|||
48635695|NCT04117347|156525160|FG000|Overall Study|No time for study|0|||
48635696|NCT04117347|156525161|FG001|Overall Study|No time for study|2|||
48635697|NCT04117347|156525162|FG002|Overall Study|No time for study|0|||
48635698|NCT04117347|156525160|FG000|Overall Study|Family emergency|1|||
48635699|NCT04117347|156525161|FG001|Overall Study|Family emergency|0|||
48635700|NCT04117347|156525162|FG002|Overall Study|Family emergency|0|||
48635701|NCT02121509|156525164|FG000|Washout Period (35 Days)|Adverse Event|1|||
48635702|NCT02121509|156525165|FG001|Washout Period (35 Days)|Adverse Event|1|||
48635703|NCT02121509|156525166|FG002|Washout Period (35 Days)|Adverse Event|0|||
48635704|NCT02121509|156525167|FG003|Washout Period (35 Days)|Adverse Event|0|||
48635705|NCT02121509|156525164|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
48635706|NCT02121509|156525165|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
48635707|NCT02121509|156525166|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
48635708|NCT02121509|156525167|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
48635709|NCT02121509|156525164|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
48635710|NCT02121509|156525165|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
48635711|NCT02121509|156525166|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
48635712|NCT02121509|156525167|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
48635713|NCT03069716|156525170|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
48635714|NCT03069716|156525171|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
48635715|NCT03069716|156525172|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
48635716|NCT03069716|156525170|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
48635717|NCT03069716|156525171|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
48635718|NCT03069716|156525172|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
48635719|NCT03069716|156525170|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
48635720|NCT03069716|156525171|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
48635721|NCT03069716|156525172|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
48635722|NCT03069716|156525170|FG000|Randomized Treatment|Withdrawal by Subject|0|||
48635723|NCT03069716|156525171|FG001|Randomized Treatment|Withdrawal by Subject|2|||
48635724|NCT03069716|156525172|FG002|Randomized Treatment|Withdrawal by Subject|0|||
48635725|NCT02993263|156525173|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
48635726|NCT00543985|156525174|FG000|Overall Study|Withdrawal by Subject|4|||
48635727|NCT01634152|156525175|FG000|Overall Study|Adverse Event|2|||
48585722|NCT02515994|156335814|FG001|Overall Study|Withdrawal by Subject|0|||
48585723|NCT01124292|156335817|FG000|Overall Study|Lost to Follow-up|2|||
48585724|NCT01124292|156335818|FG001|Overall Study|Lost to Follow-up|4|||
48585725|NCT01124292|156335819|FG002|Overall Study|Lost to Follow-up|3|||
48585726|NCT01124292|156335817|FG000|Overall Study|Physician Decision|0|||
48585727|NCT01124292|156335818|FG001|Overall Study|Physician Decision|3|||
48585728|NCT01124292|156335819|FG002|Overall Study|Physician Decision|2|||
48585729|NCT01124292|156335817|FG000|Overall Study|Withdrawal by Subject|0|||
48585730|NCT01124292|156335818|FG001|Overall Study|Withdrawal by Subject|6|||
48585731|NCT01124292|156335819|FG002|Overall Study|Withdrawal by Subject|2|||
48585732|NCT01124292|156335817|FG000|Overall Study|medical issue unrelated to the study|0|||
48585733|NCT01124292|156335818|FG001|Overall Study|medical issue unrelated to the study|0|||
48635728|NCT01634152|156525176|FG001|Overall Study|Adverse Event|0|||
48635729|NCT01634152|156525177|FG002|Overall Study|Adverse Event|2|||
48635730|NCT01634152|156525175|FG000|Overall Study|Consent withdrawn not due to AE|1|||
48635731|NCT01634152|156525176|FG001|Overall Study|Consent withdrawn not due to AE|0|||
48635732|NCT01634152|156525177|FG002|Overall Study|Consent withdrawn not due to AE|1|||
48635733|NCT01634152|156525175|FG000|Overall Study|Not treated|0|||
48635734|NCT01634152|156525176|FG001|Overall Study|Not treated|1|||
48635735|NCT01634152|156525177|FG002|Overall Study|Not treated|0|||
48635736|NCT01634152|156525175|FG000|Overall Study|Other reason not defined above|1|||
48635737|NCT01634152|156525176|FG001|Overall Study|Other reason not defined above|0|||
48635738|NCT01634152|156525177|FG002|Overall Study|Other reason not defined above|1|||
48635739|NCT04749914|156525181|FG000|Period 1|Adverse Event|1|||
48635740|NCT04749914|156525182|FG001|Period 1|Adverse Event|0|||
48635741|NCT04749914|156525183|FG002|Period 1|Adverse Event|0|||
48635742|NCT04749914|156525184|FG003|Period 1|Adverse Event|0|||
48635743|NCT04749914|156525181|FG000|Period 1|Withdrawal by Subject|1|||
48635744|NCT04749914|156525182|FG001|Period 1|Withdrawal by Subject|0|||
48635745|NCT04749914|156525183|FG002|Period 1|Withdrawal by Subject|1|||
48635746|NCT04749914|156525184|FG003|Period 1|Withdrawal by Subject|0|||
48635747|NCT00279214|156525185|FG000|Overall Study|Physician Decision|3|||
48635748|NCT00279214|156525186|FG001|Overall Study|Physician Decision|2|||
48635749|NCT00237042|156525191|FG000|Treatment|Became ineligible post-randomization|0|||
48635750|NCT00237042|156525192|FG001|Treatment|Became ineligible post-randomization|1|||
48635751|NCT00237042|156525193|FG002|Treatment|Became ineligible post-randomization|16|||
48635752|NCT00237042|156525191|FG000|Treatment|Moved out of state|1|||
48635753|NCT00237042|156525192|FG001|Treatment|Moved out of state|1|||
48635754|NCT00237042|156525193|FG002|Treatment|Moved out of state|1|||
48635755|NCT00237042|156525191|FG000|Treatment|Completed no treatment|5|||
48635756|NCT00237042|156525192|FG001|Treatment|Completed no treatment|5|||
48635757|NCT00237042|156525193|FG002|Treatment|Completed no treatment|21|||
48635758|NCT00237042|156525191|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
48635759|NCT00237042|156525192|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
48635760|NCT00237042|156525193|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
48635761|NCT00237042|156525191|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
48635762|NCT00237042|156525192|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
48635763|NCT00237042|156525193|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
48635764|NCT01074931|156525194|FG000|Overall Study|Economic reasons|1|||
48635765|NCT01074931|156525194|FG000|Overall Study|Death|5|||
48635766|NCT04466891|156525195|FG000|Overall Study|Death|52|||
48635767|NCT04466891|156525196|FG001|Overall Study|Death|5|||
48635768|NCT04466891|156525195|FG000|Overall Study|Withdrawal by Subject|8|||
48635769|NCT04466891|156525196|FG001|Overall Study|Withdrawal by Subject|1|||
48635770|NCT01214837|156525197|FG000|Overall Study|Death|0|||
48635771|NCT01214837|156525198|FG001|Overall Study|Death|0|||
48635772|NCT01214837|156525199|FG002|Overall Study|Death|1|||
48635773|NCT01214837|156525197|FG000|Overall Study|Adverse Event|1|||
48635774|NCT01214837|156525198|FG001|Overall Study|Adverse Event|2|||
48635775|NCT01214837|156525199|FG002|Overall Study|Adverse Event|1|||
48635776|NCT01214837|156525197|FG000|Overall Study|Withdrawal by Subject|27|||
48635777|NCT01214837|156525198|FG001|Overall Study|Withdrawal by Subject|36|||
48635778|NCT01214837|156525199|FG002|Overall Study|Withdrawal by Subject|28|||
48635779|NCT01214837|156525197|FG000|Overall Study|Lost to Follow-up|20|||
48635780|NCT01214837|156525198|FG001|Overall Study|Lost to Follow-up|15|||
48635781|NCT01214837|156525199|FG002|Overall Study|Lost to Follow-up|21|||
48635782|NCT01214837|156525197|FG000|Overall Study|Inappropriate Enrolment|0|||
48635783|NCT01214837|156525198|FG001|Overall Study|Inappropriate Enrolment|1|||
48635784|NCT01214837|156525199|FG002|Overall Study|Inappropriate Enrolment|2|||
48635785|NCT01214837|156525197|FG000|Overall Study|Administrative Reason|2|||
48585734|NCT01124292|156335819|FG002|Overall Study|medical issue unrelated to the study|2|||
48585735|NCT01124292|156335817|FG000|Overall Study|piercing track closed|0|||
48635786|NCT01214837|156525198|FG001|Overall Study|Administrative Reason|6|||
48746471|NCT01866930|156919811|FG000|Follow-up Period|Other|1|||
48585736|NCT01124292|156335818|FG001|Overall Study|piercing track closed|2|||
48585737|NCT01124292|156335819|FG002|Overall Study|piercing track closed|1|||
48585738|NCT00603382|156335820|FG000|Overall Study|Adverse Event|0|||
48585739|NCT00603382|156335821|FG001|Overall Study|Adverse Event|1|||
48585740|NCT00603382|156335822|FG002|Overall Study|Adverse Event|1|||
48585741|NCT00603382|156335823|FG003|Overall Study|Adverse Event|2|||
48585742|NCT00603382|156335824|FG004|Overall Study|Adverse Event|1|||
48585743|NCT00603382|156335825|FG005|Overall Study|Adverse Event|2|||
48585744|NCT00603382|156335820|FG000|Overall Study|Lack of Efficacy|14|||
48585745|NCT00603382|156335821|FG001|Overall Study|Lack of Efficacy|9|||
48585746|NCT00603382|156335822|FG002|Overall Study|Lack of Efficacy|3|||
48746472|NCT01866930|156919812|FG001|Follow-up Period|Other|5|||
48746473|NCT01866930|156919811|FG000|Follow-up Period|No longer required per protocol|1|||
48746474|NCT01866930|156919812|FG001|Follow-up Period|No longer required per protocol|0|||
48746475|NCT01866930|156919811|FG000|Follow-up Period|Withdrawal by Subject|3|||
48585747|NCT00603382|156335823|FG003|Overall Study|Lack of Efficacy|6|||
48585748|NCT00603382|156335824|FG004|Overall Study|Lack of Efficacy|6|||
48585749|NCT00603382|156335825|FG005|Overall Study|Lack of Efficacy|11|||
48585750|NCT00603382|156335820|FG000|Overall Study|Protocol Violation|1|||
48327221|NCT02234141|155396165|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48327222|NCT02234141|155396166|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
48327223|NCT02234141|155396167|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48585751|NCT00603382|156335821|FG001|Overall Study|Protocol Violation|0|||
48585752|NCT00603382|156335822|FG002|Overall Study|Protocol Violation|1|||
48585753|NCT00603382|156335823|FG003|Overall Study|Protocol Violation|2|||
48327224|NCT02234141|155396168|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48327225|NCT02234141|155396169|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48585754|NCT00603382|156335824|FG004|Overall Study|Protocol Violation|1|||
48585755|NCT00603382|156335825|FG005|Overall Study|Protocol Violation|0|||
48585756|NCT00603382|156335820|FG000|Overall Study|Lost to Follow-up|0|||
48327226|NCT02234141|155396170|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48327227|NCT02234141|155396171|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
48635787|NCT01214837|156525199|FG002|Overall Study|Administrative Reason|4|||
48635788|NCT01214837|156525197|FG000|Overall Study|Protocol Violation|3|||
48635789|NCT01214837|156525198|FG001|Overall Study|Protocol Violation|1|||
48635790|NCT01214837|156525199|FG002|Overall Study|Protocol Violation|5|||
48635791|NCT01214837|156525197|FG000|Overall Study|Unable to Classify|1|||
48635792|NCT01214837|156525198|FG001|Overall Study|Unable to Classify|3|||
48635793|NCT01214837|156525199|FG002|Overall Study|Unable to Classify|0|||
48635794|NCT05223673|156525200|FG000|Overall Study|Protocol Violation|1|||
48585757|NCT00603382|156335821|FG001|Overall Study|Lost to Follow-up|1|||
48585758|NCT00603382|156335822|FG002|Overall Study|Lost to Follow-up|1|||
48585759|NCT00603382|156335823|FG003|Overall Study|Lost to Follow-up|1|||
48585760|NCT00603382|156335824|FG004|Overall Study|Lost to Follow-up|0|||
48585761|NCT00603382|156335825|FG005|Overall Study|Lost to Follow-up|1|||
48585762|NCT00603382|156335820|FG000|Overall Study|Physician Decision|0|||
48585763|NCT00603382|156335821|FG001|Overall Study|Physician Decision|0|||
48585764|NCT00603382|156335822|FG002|Overall Study|Physician Decision|2|||
48585765|NCT00603382|156335823|FG003|Overall Study|Physician Decision|0|||
48585766|NCT00603382|156335824|FG004|Overall Study|Physician Decision|1|||
48585767|NCT00603382|156335825|FG005|Overall Study|Physician Decision|3|||
48585768|NCT00603382|156335820|FG000|Overall Study|Withdrawal by Subject|3|||
48585769|NCT00603382|156335821|FG001|Overall Study|Withdrawal by Subject|3|||
48585770|NCT00603382|156335822|FG002|Overall Study|Withdrawal by Subject|1|||
48585771|NCT00603382|156335823|FG003|Overall Study|Withdrawal by Subject|1|||
48585772|NCT00603382|156335824|FG004|Overall Study|Withdrawal by Subject|0|||
48585773|NCT00603382|156335825|FG005|Overall Study|Withdrawal by Subject|1|||
48585774|NCT03782974|156335826|FG000|Overall Study|Withdrawal by Subject|7|||
48585775|NCT03782974|156335827|FG001|Overall Study|Withdrawal by Subject|7|||
48585776|NCT03782974|156335826|FG000|Overall Study|Pregnancy|1|||
48585777|NCT03782974|156335827|FG001|Overall Study|Pregnancy|0|||
48585778|NCT00583102|156335832|FG000|Overall Study|Adverse Event|3|||
48585779|NCT03403621|156335833|FG000|Overall Study|Withdrawal by Subject|2|||
48585780|NCT03403621|156335834|FG001|Overall Study|Withdrawal by Subject|2|||
48585781|NCT00395642|156335835|FG000|Overall Study|Death|4|||
48585782|NCT00395642|156335835|FG000|Overall Study|Lost to Follow-up|1|||
48585783|NCT00395642|156335835|FG000|Overall Study|Physician Decision|7|||
48585784|NCT00395642|156335835|FG000|Overall Study|Withdrawal by Subject|1|||
48585785|NCT00505661|156335837|FG000|Overall Study|Not Eligible|4|||
48585786|NCT02921750|156337217|FG000|Overall Study|Adverse Event|1|||
48585787|NCT02921750|156337218|FG001|Overall Study|Adverse Event|2|||
48585788|NCT02921750|156337217|FG000|Overall Study|Withdrawal by Subject|1|||
48585789|NCT02921750|156337218|FG001|Overall Study|Withdrawal by Subject|1|||
48585790|NCT02921750|156337217|FG000|Overall Study|Lost to Follow-up|3|||
48585791|NCT02921750|156337218|FG001|Overall Study|Lost to Follow-up|3|||
48585792|NCT02921750|156337217|FG000|Overall Study|Wound healed|3|||
48585793|NCT02921750|156337218|FG001|Overall Study|Wound healed|3|||
48585794|NCT02921750|156337217|FG000|Overall Study|Serious Adverse Event|1|||
48585795|NCT02921750|156337218|FG001|Overall Study|Serious Adverse Event|2|||
48585796|NCT01472939|156337219|FG000|Overall Study|Adverse Event|3|||
48585797|NCT01472939|156337220|FG001|Overall Study|Adverse Event|7|||
48585798|NCT01472939|156337221|FG002|Overall Study|Adverse Event|7|||
48585799|NCT01472939|156337222|FG003|Overall Study|Adverse Event|14|||
48585800|NCT01472939|156337219|FG000|Overall Study|Lack of Efficacy|1|||
48585801|NCT01472939|156337220|FG001|Overall Study|Lack of Efficacy|0|||
48585802|NCT01472939|156337221|FG002|Overall Study|Lack of Efficacy|0|||
48585803|NCT01472939|156337222|FG003|Overall Study|Lack of Efficacy|1|||
48585804|NCT01472939|156337219|FG000|Overall Study|Lost to Follow-up|3|||
48585805|NCT01472939|156337220|FG001|Overall Study|Lost to Follow-up|0|||
48585806|NCT01472939|156337221|FG002|Overall Study|Lost to Follow-up|2|||
48585807|NCT01472939|156337222|FG003|Overall Study|Lost to Follow-up|0|||
48585808|NCT01472939|156337219|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
48585809|NCT01472939|156337220|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
48585810|NCT01472939|156337221|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
48585811|NCT01472939|156337222|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
48585812|NCT01472939|156337219|FG000|Overall Study|Prohibited Medication|0|||
48585813|NCT01472939|156337220|FG001|Overall Study|Prohibited Medication|1|||
48585814|NCT01472939|156337221|FG002|Overall Study|Prohibited Medication|0|||
48585815|NCT01472939|156337222|FG003|Overall Study|Prohibited Medication|0|||
48585816|NCT01472939|156337219|FG000|Overall Study|Withdrawal By PI|1|||
48585817|NCT01472939|156337220|FG001|Overall Study|Withdrawal By PI|0|||
48585818|NCT01472939|156337221|FG002|Overall Study|Withdrawal By PI|0|||
48585819|NCT01472939|156337222|FG003|Overall Study|Withdrawal By PI|0|||
48585820|NCT01472939|156337219|FG000|Overall Study|Protocol Violation|3|||
48585821|NCT01472939|156337220|FG001|Overall Study|Protocol Violation|3|||
48585822|NCT01472939|156337221|FG002|Overall Study|Protocol Violation|0|||
48585823|NCT01472939|156337222|FG003|Overall Study|Protocol Violation|1|||
48585824|NCT01472939|156337219|FG000|Overall Study|Withdrawal by Subject|9|||
48585825|NCT01472939|156337220|FG001|Overall Study|Withdrawal by Subject|3|||
48585826|NCT01472939|156337221|FG002|Overall Study|Withdrawal by Subject|1|||
48585827|NCT01472939|156337222|FG003|Overall Study|Withdrawal by Subject|4|||
48635795|NCT05223673|156525200|FG000|Overall Study|Study termination|6|||
48635796|NCT02112656|156525201|FG000|Overall Study|Death|78|||
48635797|NCT02112656|156525202|FG001|Overall Study|Death|82|||
48635798|NCT02112656|156525201|FG000|Overall Study|Withdrawal by Subject|9|||
48635799|NCT02112656|156525202|FG001|Overall Study|Withdrawal by Subject|11|||
48635800|NCT02112656|156525201|FG000|Overall Study|Lost to Follow-up|2|||
48327228|NCT02234141|155396165|FG000|Treatment Period (24 Weeks)|Death|1|||
48327229|NCT02234141|155396166|FG001|Treatment Period (24 Weeks)|Death|2|||
48327230|NCT02234141|155396167|FG002|Treatment Period (24 Weeks)|Death|0|||
48327231|NCT02234141|155396168|FG003|Treatment Period (24 Weeks)|Death|1|||
48327232|NCT02234141|155396169|FG004|Treatment Period (24 Weeks)|Death|0|||
48327233|NCT02234141|155396170|FG005|Treatment Period (24 Weeks)|Death|0|||
48327234|NCT02234141|155396171|FG006|Treatment Period (24 Weeks)|Death|0|||
48327235|NCT02234141|155396165|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
48327236|NCT02234141|155396166|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
48327237|NCT02234141|155396167|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
48327238|NCT02234141|155396168|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
48327239|NCT02234141|155396169|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
48635801|NCT02112656|156525202|FG001|Overall Study|Lost to Follow-up|4|||
48635802|NCT02112656|156525201|FG000|Overall Study|Noncompliance|1|||
48635803|NCT02112656|156525202|FG001|Overall Study|Noncompliance|2|||
48635804|NCT00027560|156525203|FG000|Overall Study|Withdrawal by Subject|1|||
48635805|NCT01994876|156525204|FG000|Test Period 1|Withdrawal by Subject|0|||
48635806|NCT01994876|156525205|FG001|Test Period 1|Withdrawal by Subject|1|||
48635807|NCT01994876|156525204|FG000|Test Period 1|Adverse Event|0|||
48635808|NCT01994876|156525205|FG001|Test Period 1|Adverse Event|1|||
48635809|NCT01994876|156525204|FG000|Test Period 2|Adverse Event|1|||
48635810|NCT01994876|156525205|FG001|Test Period 2|Adverse Event|0|||
48635811|NCT01994876|156525204|FG000|Test Period 2|Protocol Violation|0|||
48635812|NCT01994876|156525205|FG001|Test Period 2|Protocol Violation|1|||
48635813|NCT01346176|156525206|FG000|Recruited|Protocol Violation|1|||
48635814|NCT01346176|156525207|FG001|Recruited|Protocol Violation|0|||
48635815|NCT01346176|156525208|FG002|Recruited|Protocol Violation|0|||
48635816|NCT01346176|156525206|FG000|Completed Advance Directive|Death|3|||
48585828|NCT03117881|156337225|FG000|Baseline|Withdrawal by Subject|21|||
48585829|NCT03117881|156337226|FG001|Baseline|Withdrawal by Subject|10|||
48585830|NCT03117881|156337227|FG002|Baseline|Withdrawal by Subject|0|||
48585831|NCT03117881|156337225|FG000|Baseline|Lost to Follow-up|22|||
48585832|NCT03117881|156337226|FG001|Baseline|Lost to Follow-up|25|||
48585833|NCT03117881|156337227|FG002|Baseline|Lost to Follow-up|0|||
48585834|NCT03117881|156337225|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
48585835|NCT03117881|156337226|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
48585836|NCT03117881|156337227|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
48585837|NCT03117881|156337225|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
48585838|NCT03117881|156337226|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
48585839|NCT03117881|156337227|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
48585840|NCT03117881|156337225|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
48585841|NCT03117881|156337226|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
48327240|NCT02234141|155396170|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
48635817|NCT01346176|156525207|FG001|Completed Advance Directive|Death|2|||
48635818|NCT01346176|156525208|FG002|Completed Advance Directive|Death|2|||
48635819|NCT01346176|156525206|FG000|Completed Advance Directive|Became Ineligible|3|||
48635820|NCT01346176|156525207|FG001|Completed Advance Directive|Became Ineligible|0|||
48635821|NCT01346176|156525208|FG002|Completed Advance Directive|Became Ineligible|1|||
48327241|NCT02234141|155396171|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
48327242|NCT02234141|155396165|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48635822|NCT01346176|156525206|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
48635823|NCT01346176|156525207|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
48635824|NCT01346176|156525208|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
48635825|NCT01346176|156525206|FG000|Completed Satisfaction Survey|Death|3|||
48635826|NCT01346176|156525207|FG001|Completed Satisfaction Survey|Death|0|||
48635827|NCT01346176|156525208|FG002|Completed Satisfaction Survey|Death|2|||
48327243|NCT02234141|155396166|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
48327244|NCT02234141|155396167|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48327245|NCT02234141|155396168|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48327246|NCT02234141|155396169|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48327247|NCT02234141|155396170|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48327248|NCT02234141|155396171|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
48327249|NCT02234141|155396165|FG000|Long-Term Treatment Period|Death|0|||
48327250|NCT02234141|155396166|FG001|Long-Term Treatment Period|Death|0|||
48327251|NCT02234141|155396167|FG002|Long-Term Treatment Period|Death|0|||
48327252|NCT02234141|155396168|FG003|Long-Term Treatment Period|Death|0|||
48327253|NCT02234141|155396169|FG004|Long-Term Treatment Period|Death|0|||
48327254|NCT02234141|155396170|FG005|Long-Term Treatment Period|Death|1|||
48327255|NCT02234141|155396171|FG006|Long-Term Treatment Period|Death|0|||
48327256|NCT02234141|155396165|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
48327257|NCT02234141|155396166|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
48327258|NCT02234141|155396167|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
48635828|NCT01346176|156525206|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
48635829|NCT01346176|156525207|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
48635830|NCT01346176|156525208|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
48635831|NCT03556891|156525212|FG000|Overall Study|Adverse Event|4|||
48635832|NCT03556891|156525212|FG000|Overall Study|MRI Need|3|||
48635833|NCT03556891|156525212|FG000|Overall Study|Device Failure|1|||
48635834|NCT03556891|156525212|FG000|Overall Study|Death|1|||
48635835|NCT03556891|156525212|FG000|Overall Study|Lost to Follow-up|1|||
48635836|NCT03556891|156525212|FG000|Overall Study|Missing at random|1|||
48635837|NCT03556891|156525212|FG000|Overall Study|Missing due to COVID|1|||
48635838|NCT03556891|156525212|FG000|Overall Study|Protocol Violation|1|||
48635839|NCT04696146|156526769|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
48635840|NCT04696146|156526770|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
48635841|NCT04696146|156526769|FG000|Overall Study|Off hours issue with product|1|||
48635842|NCT04696146|156526770|FG001|Overall Study|Off hours issue with product|0|||
48635843|NCT00529633|156526771|FG000|Overall Study|Withdrawal by Subject|1|||
48635844|NCT00529633|156526772|FG001|Overall Study|Withdrawal by Subject|1|||
48635845|NCT01334918|156526773|FG000|Overall Study|Did not receive study drug|6|||
48635846|NCT01334918|156526774|FG001|Overall Study|Did not receive study drug|0|||
48635847|NCT01334918|156526773|FG000|Overall Study|Adverse Event|2|||
48635848|NCT01334918|156526774|FG001|Overall Study|Adverse Event|0|||
48635849|NCT01334918|156526773|FG000|Overall Study|Withdrawal by Subject|0|||
48635850|NCT01334918|156526774|FG001|Overall Study|Withdrawal by Subject|1|||
48635851|NCT00462826|156526778|FG000|Overall Study|Ineligible - second primary|1|||
48635852|NCT00462826|156526778|FG000|Overall Study|Ineligible - wrong cell type|1|||
48635853|NCT00462826|156526778|FG000|Overall Study|Ineligible - wrong primary|2|||
48635854|NCT00462826|156526778|FG000|Overall Study|Never treated|1|||
48635855|NCT01083602|156526779|FG000|Overall Study|Adverse Event|11|||
48635856|NCT01083602|156526779|FG000|Overall Study|New Cancer Therapy|2|||
48635857|NCT01083602|156526779|FG000|Overall Study|Death|1|||
48635858|NCT01083602|156526779|FG000|Overall Study|Withdrawal by Subject|5|||
48635859|NCT01083602|156526779|FG000|Overall Study|Lack of Efficacy|36|||
48635860|NCT03545672|156526780|FG000|Overall Study|Uncertain diagnosis|2|||
48635861|NCT03545672|156526781|FG001|Overall Study|Uncertain diagnosis|1|||
48635862|NCT03545672|156526780|FG000|Overall Study|Protocol Violation|2|||
48635863|NCT03545672|156526781|FG001|Overall Study|Protocol Violation|2|||
48635864|NCT01263119|156526784|FG000|Period 1|Protocol Violation|2|||
48635865|NCT01263119|156526784|FG000|Period 2|Adverse Event|2|||
48635866|NCT01621178|156526785|FG000|Overall Study|Adverse Event|5|||
48635867|NCT01621178|156526786|FG001|Overall Study|Adverse Event|2|||
48635868|NCT01621178|156526787|FG002|Overall Study|Adverse Event|8|||
48635869|NCT01621178|156526785|FG000|Overall Study|Death|6|||
48635870|NCT01621178|156526786|FG001|Overall Study|Death|7|||
48635871|NCT01621178|156526787|FG002|Overall Study|Death|2|||
48635872|NCT01621178|156526785|FG000|Overall Study|Lost to Follow-up|1|||
48635873|NCT01621178|156526786|FG001|Overall Study|Lost to Follow-up|2|||
48635874|NCT01621178|156526787|FG002|Overall Study|Lost to Follow-up|1|||
48635875|NCT01621178|156526785|FG000|Overall Study|Withdrawal by Subject|14|||
48635876|NCT01621178|156526786|FG001|Overall Study|Withdrawal by Subject|17|||
48635877|NCT01621178|156526787|FG002|Overall Study|Withdrawal by Subject|18|||
48635878|NCT01621178|156526785|FG000|Overall Study|Physician Decision|5|||
48635879|NCT01621178|156526786|FG001|Overall Study|Physician Decision|2|||
48635880|NCT01621178|156526787|FG002|Overall Study|Physician Decision|7|||
48635881|NCT03493958|156526788|FG000|Overall Study|Withdrawal by Subject|6|||
48635882|NCT03493958|156526788|FG000|Overall Study|Lost to Follow-up|7|||
48635883|NCT03493958|156526788|FG000|Overall Study|Did not complete all required study procedures|2|||
48635884|NCT02862574|156526795|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48635885|NCT02862574|156526796|FG001|Double-Blind Treatment Period|Adverse Event|1|||
48635886|NCT02862574|156526797|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48635887|NCT02862574|156526795|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
48635888|NCT02862574|156526796|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
48635889|NCT02862574|156526797|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
48635890|NCT02862574|156526795|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
48635891|NCT02862574|156526796|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
48635892|NCT02862574|156526797|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
48635893|NCT01822925|156526800|FG000|Overall Study|Adverse Event|1|||
48635894|NCT01822925|156526801|FG001|Overall Study|Adverse Event|1|||
48635895|NCT01822925|156526802|FG002|Overall Study|Adverse Event|1|||
48635896|NCT01822925|156526803|FG003|Overall Study|Adverse Event|1|||
48635897|NCT01822925|156526800|FG000|Overall Study|Lost to Follow-up|0|||
48635898|NCT01822925|156526801|FG001|Overall Study|Lost to Follow-up|1|||
48635899|NCT01822925|156526802|FG002|Overall Study|Lost to Follow-up|0|||
48635900|NCT01822925|156526803|FG003|Overall Study|Lost to Follow-up|0|||
48635901|NCT01822925|156526800|FG000|Overall Study|Protocol Violation|1|||
48635902|NCT01822925|156526801|FG001|Overall Study|Protocol Violation|0|||
48635903|NCT01822925|156526802|FG002|Overall Study|Protocol Violation|0|||
48635904|NCT01822925|156526803|FG003|Overall Study|Protocol Violation|1|||
48635905|NCT01822925|156526800|FG000|Overall Study|Withdrawal by Subject|2|||
48635906|NCT01822925|156526801|FG001|Overall Study|Withdrawal by Subject|0|||
48635907|NCT01822925|156526802|FG002|Overall Study|Withdrawal by Subject|2|||
48635908|NCT01822925|156526803|FG003|Overall Study|Withdrawal by Subject|2|||
48635909|NCT01822925|156526800|FG000|Overall Study|Taking prohibited medication|2|||
48635910|NCT01822925|156526801|FG001|Overall Study|Taking prohibited medication|0|||
48635911|NCT01822925|156526802|FG002|Overall Study|Taking prohibited medication|0|||
48635912|NCT01822925|156526803|FG003|Overall Study|Taking prohibited medication|1|||
48635913|NCT01463527|156526810|FG000|Overall Study|Protocol Violation|1|||
48635914|NCT01463527|156526811|FG001|Overall Study|Protocol Violation|1|||
48635915|NCT01463527|156526810|FG000|Overall Study|Crying >20% of sedation|5|||
48635916|NCT01463527|156526811|FG001|Overall Study|Crying >20% of sedation|6|||
48635917|NCT01816295|156526814|FG000|Double Blind Phase|Adverse Event|11|||
48635918|NCT01816295|156526815|FG001|Double Blind Phase|Adverse Event|8|||
48635919|NCT01816295|156526814|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
48635920|NCT01816295|156526815|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
48635921|NCT01816295|156526814|FG000|Double Blind Phase|Lost to Follow-up|3|||
48635922|NCT01816295|156526815|FG001|Double Blind Phase|Lost to Follow-up|5|||
48635923|NCT01816295|156526814|FG000|Double Blind Phase|Physician Decision|2|||
48635924|NCT01816295|156526815|FG001|Double Blind Phase|Physician Decision|2|||
48327259|NCT02234141|155396168|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
48635925|NCT01816295|156526814|FG000|Double Blind Phase|Protocol Violation|17|||
48635926|NCT01816295|156526815|FG001|Double Blind Phase|Protocol Violation|11|||
48635927|NCT01816295|156526814|FG000|Double Blind Phase|Sponsor Decision|8|||
48635928|NCT01816295|156526815|FG001|Double Blind Phase|Sponsor Decision|8|||
48635929|NCT01816295|156526814|FG000|Double Blind Phase|Withdrawal by Subject|22|||
48635930|NCT01816295|156526815|FG001|Double Blind Phase|Withdrawal by Subject|20|||
48635931|NCT01816295|156526814|FG000|OLE Phase|Adverse Event|17|||
48635932|NCT01816295|156526815|FG001|OLE Phase|Adverse Event|15|||
48635933|NCT01816295|156526814|FG000|OLE Phase|Death|1|||
48635934|NCT01816295|156526815|FG001|OLE Phase|Death|0|||
48635935|NCT01816295|156526814|FG000|OLE Phase|Entry Criteria Not Met|3|||
48635936|NCT01816295|156526815|FG001|OLE Phase|Entry Criteria Not Met|5|||
48635937|NCT01816295|156526814|FG000|OLE Phase|Lost to Follow-up|5|||
48635938|NCT01816295|156526815|FG001|OLE Phase|Lost to Follow-up|5|||
48635939|NCT01816295|156526814|FG000|OLE Phase|Physician Decision|3|||
48635940|NCT01816295|156526815|FG001|OLE Phase|Physician Decision|1|||
48635941|NCT01816295|156526814|FG000|OLE Phase|Protocol Violation|4|||
48635942|NCT01816295|156526815|FG001|OLE Phase|Protocol Violation|4|||
48327260|NCT02234141|155396169|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
48327261|NCT02234141|155396170|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
48327262|NCT02234141|155396171|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
48327263|NCT02234141|155396165|FG000|Long-Term Treatment Period|Adverse Event|4|||
48327264|NCT02234141|155396166|FG001|Long-Term Treatment Period|Adverse Event|0|||
48327265|NCT02234141|155396167|FG002|Long-Term Treatment Period|Adverse Event|5|||
48327266|NCT02234141|155396168|FG003|Long-Term Treatment Period|Adverse Event|0|||
48327267|NCT02234141|155396169|FG004|Long-Term Treatment Period|Adverse Event|1|||
48327268|NCT02234141|155396170|FG005|Long-Term Treatment Period|Adverse Event|1|||
48327269|NCT02234141|155396171|FG006|Long-Term Treatment Period|Adverse Event|1|||
48327270|NCT02234141|155396165|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
48327271|NCT02234141|155396166|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
48327272|NCT02234141|155396167|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
48327273|NCT02234141|155396168|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
48327274|NCT02234141|155396169|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
48327275|NCT02234141|155396170|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
48327276|NCT02234141|155396171|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
48327277|NCT02234141|155396165|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
48327278|NCT02234141|155396166|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
48635943|NCT01816295|156526814|FG000|OLE Phase|Sponsor Decision|7|||
48635944|NCT01816295|156526815|FG001|OLE Phase|Sponsor Decision|9|||
48635945|NCT01816295|156526814|FG000|OLE Phase|Withdrawal by Subject|10|||
48635946|NCT01816295|156526815|FG001|OLE Phase|Withdrawal by Subject|10|||
48635947|NCT01816295|156526814|FG000|OLE Phase|Lack of Efficacy|3|||
48635948|NCT01816295|156526815|FG001|OLE Phase|Lack of Efficacy|7|||
48635949|NCT01182350|156526816|FG000|Overall Study|Adverse Event|5|||
48635950|NCT01182350|156526817|FG001|Overall Study|Adverse Event|0|||
48635951|NCT01182350|156526818|FG002|Overall Study|Adverse Event|0|||
48635952|NCT01182350|156526819|FG003|Overall Study|Adverse Event|0|||
48635953|NCT01182350|156526820|FG004|Overall Study|Adverse Event|0|||
48635954|NCT01182350|156526816|FG000|Overall Study|Disease Progression|15|||
48635955|NCT01182350|156526817|FG001|Overall Study|Disease Progression|12|||
48635956|NCT01182350|156526818|FG002|Overall Study|Disease Progression|0|||
48635957|NCT01182350|156526819|FG003|Overall Study|Disease Progression|1|||
48635958|NCT01182350|156526820|FG004|Overall Study|Disease Progression|0|||
48635959|NCT01182350|156526816|FG000|Overall Study|Death|0|||
48635960|NCT01182350|156526817|FG001|Overall Study|Death|1|||
48635961|NCT01182350|156526818|FG002|Overall Study|Death|1|||
48635962|NCT01182350|156526819|FG003|Overall Study|Death|0|||
48635963|NCT01182350|156526820|FG004|Overall Study|Death|0|||
48635964|NCT01182350|156526816|FG000|Overall Study|Withdrawal by Subject|3|||
48635965|NCT01182350|156526817|FG001|Overall Study|Withdrawal by Subject|1|||
48635966|NCT01182350|156526818|FG002|Overall Study|Withdrawal by Subject|0|||
48635967|NCT01182350|156526819|FG003|Overall Study|Withdrawal by Subject|1|||
48635968|NCT01182350|156526820|FG004|Overall Study|Withdrawal by Subject|0|||
48635969|NCT01182350|156526816|FG000|Overall Study|Alternative Therapy|2|||
48635970|NCT01182350|156526817|FG001|Overall Study|Alternative Therapy|0|||
48635971|NCT01182350|156526818|FG002|Overall Study|Alternative Therapy|1|||
48635972|NCT01182350|156526819|FG003|Overall Study|Alternative Therapy|0|||
48635973|NCT01182350|156526820|FG004|Overall Study|Alternative Therapy|0|||
48635974|NCT01182350|156526816|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
48635975|NCT01182350|156526817|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
48635976|NCT01182350|156526818|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
48635977|NCT01182350|156526819|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
48635978|NCT01182350|156526820|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
48635979|NCT01182350|156526816|FG000|Overall Study|Unevaluable for Biopsy|0|||
48635980|NCT01182350|156526817|FG001|Overall Study|Unevaluable for Biopsy|0|||
48635981|NCT01182350|156526818|FG002|Overall Study|Unevaluable for Biopsy|0|||
48635982|NCT01182350|156526819|FG003|Overall Study|Unevaluable for Biopsy|0|||
48635983|NCT01182350|156526820|FG004|Overall Study|Unevaluable for Biopsy|3|||
48635984|NCT01088503|156526821|FG000|Overall Study|Withdrawal by Subject|118|||
48635985|NCT01088503|156526822|FG001|Overall Study|Withdrawal by Subject|327|||
48635986|NCT01088503|156526823|FG002|Overall Study|Withdrawal by Subject|10|||
48635987|NCT01088503|156526821|FG000|Overall Study|Death|64|||
48635988|NCT01088503|156526822|FG001|Overall Study|Death|358|||
48635989|NCT01088503|156526823|FG002|Overall Study|Death|7|||
48635990|NCT01076010|156526824|FG000|Overall Study|Death|15|||
48635991|NCT01076010|156526825|FG001|Overall Study|Death|1|||
48635992|NCT01076010|156526826|FG002|Overall Study|Death|0|||
48635993|NCT01076010|156526824|FG000|Overall Study|Adverse Event|7|||
48635994|NCT01076010|156526825|FG001|Overall Study|Adverse Event|2|||
48635995|NCT01076010|156526826|FG002|Overall Study|Adverse Event|0|||
48635996|NCT01076010|156526824|FG000|Overall Study|Progressive disease|90|||
48635997|NCT01076010|156526825|FG001|Overall Study|Progressive disease|30|||
48635998|NCT01076010|156526826|FG002|Overall Study|Progressive disease|1|||
48635999|NCT01076010|156526824|FG000|Overall Study|Lack of Efficacy|4|||
48636000|NCT01076010|156526825|FG001|Overall Study|Lack of Efficacy|0|||
48636001|NCT01076010|156526826|FG002|Overall Study|Lack of Efficacy|0|||
48636002|NCT01076010|156526824|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
48636003|NCT01076010|156526825|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
48636004|NCT01076010|156526826|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
48636005|NCT01076010|156526824|FG000|Overall Study|Significant Surgical Procedure|0|||
48636006|NCT01076010|156526825|FG001|Overall Study|Significant Surgical Procedure|1|||
48636007|NCT01076010|156526826|FG002|Overall Study|Significant Surgical Procedure|0|||
48636008|NCT01076010|156526824|FG000|Overall Study|Protocol Violation|0|||
48636009|NCT01076010|156526825|FG001|Overall Study|Protocol Violation|1|||
48636010|NCT01076010|156526826|FG002|Overall Study|Protocol Violation|0|||
48636011|NCT01076010|156526824|FG000|Overall Study|Noncompliance|1|||
48636012|NCT01076010|156526825|FG001|Overall Study|Noncompliance|1|||
48636013|NCT01076010|156526826|FG002|Overall Study|Noncompliance|0|||
48636014|NCT01076010|156526824|FG000|Overall Study|Withdrawal by Subject|3|||
48636015|NCT01076010|156526825|FG001|Overall Study|Withdrawal by Subject|0|||
48636016|NCT01076010|156526826|FG002|Overall Study|Withdrawal by Subject|1|||
48636017|NCT01076010|156526824|FG000|Overall Study|Other|5|||
48636018|NCT01076010|156526825|FG001|Overall Study|Other|2|||
48636019|NCT01076010|156526826|FG002|Overall Study|Other|0|||
48636020|NCT00181844|156526830|FG000|Signed Consent|Withdrawal by Subject|5|||
48636021|NCT00181844|156526830|FG000|Signed Consent|Did not meet entrance criteria|7|||
48636022|NCT00181844|156526830|FG000|Exposed to Study Medication|Adverse Event|10|||
48636023|NCT00181844|156526830|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
48636024|NCT00181844|156526830|FG000|Exposed to Study Medication|Non-compliance|2|||
48636025|NCT00181844|156526830|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
48636026|NCT00181844|156526830|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
48636027|NCT00945659|156526831|FG000|Overall Study|Lost to Follow-up|7|||
48636028|NCT00945659|156526832|FG001|Overall Study|Lost to Follow-up|20|||
48636029|NCT00945659|156526833|FG002|Overall Study|Lost to Follow-up|17|||
48636030|NCT05134649|156526834|FG000|Overall Study|Lost to Follow-up|12|||
48636031|NCT05134649|156526834|FG000|Overall Study|Withdrawal by Subject|14|||
48327279|NCT02234141|155396167|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
48327280|NCT02234141|155396168|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
48327281|NCT02234141|155396169|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
48327282|NCT02234141|155396170|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
48327283|NCT02234141|155396171|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
48327284|NCT03589768|155396172|FG000|Overall Study|Death|1|||
48327285|NCT03589768|155396173|FG001|Overall Study|Death|0|||
48327286|NCT03589768|155396174|FG002|Overall Study|Death|8|||
48327287|NCT03589768|155396175|FG003|Overall Study|Death|3|||
48327288|NCT03589768|155396172|FG000|Overall Study|Withdrawal by Subject|2|||
48327289|NCT03589768|155396173|FG001|Overall Study|Withdrawal by Subject|0|||
48327290|NCT03589768|155396174|FG002|Overall Study|Withdrawal by Subject|0|||
48327291|NCT03589768|155396175|FG003|Overall Study|Withdrawal by Subject|0|||
48327292|NCT03589768|155396172|FG000|Overall Study|Protocol Violation|1|||
48327293|NCT03589768|155396173|FG001|Overall Study|Protocol Violation|0|||
48327294|NCT03589768|155396174|FG002|Overall Study|Protocol Violation|0|||
48327295|NCT03589768|155396175|FG003|Overall Study|Protocol Violation|0|||
48327296|NCT03567616|155396178|FG000|Overall Study|Disease progression|4|||
48327297|NCT03567616|155396178|FG000|Overall Study|Withdrawal by Subject|1|||
48327298|NCT03567616|155396178|FG000|Overall Study|Physician Decision|1|||
48327299|NCT03567616|155396178|FG000|Overall Study|Death|1|||
48327300|NCT03567616|155396178|FG000|Overall Study|Adverse Event|1|||
48327301|NCT01074242|155396179|FG000|Overall Study|Case report before date of contract|40|||
48327302|NCT01074242|155396179|FG000|Overall Study|Lost to Follow-up|1|||
48327303|NCT01074242|155396179|FG000|Overall Study|Case report unclear|6|||
48327304|NCT01074242|155396179|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
48327305|NCT01074242|155396179|FG000|Overall Study|Duplicate Case Report Form|5|||
48327306|NCT01822756|155396180|FG000|Overall Study|Adverse Event|0|||
48327307|NCT01822756|155396181|FG001|Overall Study|Adverse Event|0|||
48327308|NCT01822756|155396182|FG002|Overall Study|Adverse Event|0|||
48636032|NCT05134649|156526834|FG000|Overall Study|Pregnancy|1|||
48636033|NCT05134649|156526834|FG000|Overall Study|Other, not specified|3|||
48636034|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636035|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
48636036|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636037|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
48636038|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
48636039|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
48636040|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
48636041|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636042|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636043|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636044|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636045|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636046|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636047|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636048|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636049|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
48636050|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
48636051|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
48636052|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
48636053|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
48636054|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
48636055|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
48636056|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
48636057|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
48636058|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
48636059|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
48636060|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
48636061|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
48636062|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
48636063|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
48636064|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
48636065|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
48636066|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
48636067|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
48636068|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636069|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636070|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636071|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636072|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48585842|NCT03117881|156337227|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
48585843|NCT03117881|156337225|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
48585844|NCT03117881|156337226|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
48585845|NCT03117881|156337227|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
48585846|NCT03117881|156337225|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
48585847|NCT03117881|156337226|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
48585848|NCT03117881|156337227|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
48585849|NCT03117881|156337225|FG000|6-Month Follow-Up|Did not complete test|53|||
48585850|NCT03117881|156337226|FG001|6-Month Follow-Up|Did not complete test|25|||
48585851|NCT03117881|156337227|FG002|6-Month Follow-Up|Did not complete test|7|||
48585852|NCT03117881|156337225|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
48585853|NCT03117881|156337226|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
48585854|NCT03117881|156337227|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
48585855|NCT03117881|156337225|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
48585856|NCT03117881|156337226|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
48585857|NCT03117881|156337227|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
48585858|NCT03117881|156337225|FG000|12-Month Follow-Up|Did not complete test|40|||
48585859|NCT03117881|156337226|FG001|12-Month Follow-Up|Did not complete test|0|||
48585860|NCT03117881|156337227|FG002|12-Month Follow-Up|Did not complete test|0|||
48585861|NCT00114738|156337228|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
48585862|NCT00114738|156337229|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
48585863|NCT00114738|156337230|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
48585864|NCT00114738|156337228|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
48585865|NCT00114738|156337229|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
48585866|NCT00114738|156337230|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
48585867|NCT00114738|156337228|FG000|Screening for Randomization|Neuropathy|17|||
48585868|NCT00114738|156337229|FG001|Screening for Randomization|Neuropathy|0|||
48585869|NCT00114738|156337230|FG002|Screening for Randomization|Neuropathy|0|||
48585870|NCT00114738|156337228|FG000|Screening for Randomization|Progressive disease|2|||
48636073|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48585871|NCT00114738|156337229|FG001|Screening for Randomization|Progressive disease|0|||
48636074|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636075|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636076|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636077|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636078|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636079|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636080|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636081|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
48636082|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
48636083|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636084|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
48636085|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
48636086|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
48636087|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
48636088|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
48636089|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636090|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636091|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636092|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636093|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636094|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636095|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636096|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636097|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48636098|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636099|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636100|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636101|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
48636102|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636103|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636104|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
48636105|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636106|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636107|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636108|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636109|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636110|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636111|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48636112|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48585872|NCT00114738|156337230|FG002|Screening for Randomization|Progressive disease|0|||
48636113|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
48585873|NCT00114738|156337228|FG000|Screening for Randomization|CNS Hemorrhage|1|||
48585874|NCT00114738|156337229|FG001|Screening for Randomization|CNS Hemorrhage|0|||
48585875|NCT00114738|156337230|FG002|Screening for Randomization|CNS Hemorrhage|0|||
48585876|NCT00114738|156337228|FG000|Screening for Randomization|Other|1|||
48585877|NCT00114738|156337229|FG001|Screening for Randomization|Other|0|||
48585878|NCT00114738|156337230|FG002|Screening for Randomization|Other|0|||
48585879|NCT00552032|156337232|FG000|Overall Study|Withdrawal by Subject|2|||
48585880|NCT00552032|156337233|FG001|Overall Study|Withdrawal by Subject|2|||
48585881|NCT00552032|156337232|FG000|Overall Study|Protocol Violation|7|||
48585882|NCT00552032|156337233|FG001|Overall Study|Protocol Violation|12|||
48585883|NCT00552032|156337232|FG000|Overall Study|Lost to Follow-up|8|||
48585884|NCT00552032|156337233|FG001|Overall Study|Lost to Follow-up|5|||
48585885|NCT03391232|156337234|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
48585886|NCT03391232|156337235|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
48585887|NCT03391232|156337234|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
48585888|NCT03391232|156337235|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
48585889|NCT00345878|156337236|FG000|Overall Study|Adverse Event|1|||
48585890|NCT00345878|156337237|FG001|Overall Study|Adverse Event|0|||
48585891|NCT00345878|156337236|FG000|Overall Study|Lost to Follow-up|2|||
48585892|NCT00345878|156337237|FG001|Overall Study|Lost to Follow-up|1|||
48585893|NCT00345878|156337236|FG000|Overall Study|Other|1|||
48585894|NCT00345878|156337237|FG001|Overall Study|Other|0|||
48585895|NCT01522235|156337240|FG000|Overall Study|Physician Decision|1|||
48585896|NCT01522235|156337241|FG001|Overall Study|Physician Decision|1|||
48585897|NCT00980018|156337242|FG000|Overall Study|Adverse Event|8|||
48585898|NCT00980018|156337242|FG000|Overall Study|Patient withdrew consent|3|||
48585899|NCT00980018|156337242|FG000|Overall Study|Lost to Follow-up|1|||
48585900|NCT00424021|156337243|FG000|NCT00046319 Study Period|Adverse Event|1|||
48585901|NCT00424021|156337244|FG001|NCT00046319 Study Period|Adverse Event|0|||
48585902|NCT00424021|156337245|FG002|NCT00046319 Study Period|Adverse Event|1|||
48585903|NCT00424021|156337246|FG003|NCT00046319 Study Period|Adverse Event|1|||
48585904|NCT00424021|156337243|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
48636114|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636115|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636116|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
48636117|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636118|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636119|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636120|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636121|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636122|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636123|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636124|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636125|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636126|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636127|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636128|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636129|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
48636130|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
48636131|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
48585905|NCT00424021|156337244|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
48585906|NCT00424021|156337245|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
48585907|NCT00424021|156337246|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
48585908|NCT00424021|156337243|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
48585909|NCT00424021|156337244|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
48746476|NCT01866930|156919812|FG001|Follow-up Period|Withdrawal by Subject|3|||
48746477|NCT02521870|156919813|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746478|NCT02521870|156919814|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
48636132|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
48636133|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48585910|NCT00424021|156337245|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
48585911|NCT00424021|156337246|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
48585912|NCT00424021|156337243|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
48585913|NCT00424021|156337244|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
48636134|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636135|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636136|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636137|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636138|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636139|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636140|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636141|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636142|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636143|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636144|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636145|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48636146|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
48746479|NCT02521870|156919815|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746480|NCT02521870|156919816|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746481|NCT02521870|156919817|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746482|NCT02521870|156919818|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746483|NCT02521870|156919819|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48636147|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
48636148|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
48636149|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
48636150|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
48636151|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
48636152|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
48746484|NCT02521870|156919820|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746485|NCT02521870|156919821|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746486|NCT02521870|156919822|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746487|NCT02521870|156919823|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746488|NCT02521870|156919824|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
48746489|NCT02521870|156919813|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
48327309|NCT01822756|155396183|FG003|Overall Study|Adverse Event|2|||
48636153|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
48636154|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
48636155|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
48636156|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
48636157|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
48636158|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
48636159|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
48636160|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
48636161|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
48636162|NCT02958865|156526835|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636163|NCT02958865|156526836|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636164|NCT02958865|156526837|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636165|NCT02958865|156526838|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636166|NCT02958865|156526839|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
48636167|NCT02958865|156526840|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636168|NCT02958865|156526841|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636169|NCT02958865|156526842|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636170|NCT02958865|156526843|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636171|NCT02958865|156526844|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636172|NCT02958865|156526845|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636173|NCT02958865|156526846|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636174|NCT02958865|156526847|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636175|NCT02958865|156526848|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636176|NCT02958865|156526849|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636177|NCT02958865|156526850|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48636178|NCT02958865|156526835|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
48636179|NCT02958865|156526836|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
48636180|NCT02958865|156526837|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
48636181|NCT02958865|156526838|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
48636182|NCT02958865|156526839|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
48327310|NCT01822756|155396184|FG004|Overall Study|Adverse Event|0|||
48327311|NCT01822756|155396180|FG000|Overall Study|Disease progression|11|||
48636183|NCT02958865|156526840|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
48636184|NCT02958865|156526841|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
48636185|NCT02958865|156526842|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
48636186|NCT02958865|156526843|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
48746490|NCT02521870|156919814|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
48746491|NCT02521870|156919815|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
48746492|NCT02521870|156919816|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
48746493|NCT02521870|156919817|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
48746494|NCT02521870|156919818|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
48746495|NCT02521870|156919819|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
48746496|NCT02521870|156919820|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
48746497|NCT02521870|156919821|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
48746498|NCT02521870|156919822|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
48746499|NCT02521870|156919823|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
48746500|NCT02521870|156919824|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
48746501|NCT02521870|156919813|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
48746502|NCT02521870|156919814|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
48746503|NCT02521870|156919815|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
48746504|NCT02521870|156919816|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
48746505|NCT02521870|156919817|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
48746506|NCT02521870|156919818|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
48746507|NCT02521870|156919819|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
48746508|NCT02521870|156919820|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
48746509|NCT02521870|156919821|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
48746510|NCT02521870|156919822|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
48746511|NCT02521870|156919823|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
48746512|NCT02521870|156919824|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
48746513|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746514|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746515|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746516|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746517|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
48746518|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
48585914|NCT00424021|156337245|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
48327312|NCT01822756|155396181|FG001|Overall Study|Disease progression|1|||
48585915|NCT00424021|156337246|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
48585916|NCT00424021|156337243|FG000|AMB-220-E Study Period|Adverse Event|1|||
48585917|NCT00424021|156337244|FG001|AMB-220-E Study Period|Adverse Event|1|||
48585918|NCT00424021|156337245|FG002|AMB-220-E Study Period|Adverse Event|3|||
48585919|NCT00424021|156337246|FG003|AMB-220-E Study Period|Adverse Event|7|||
48585920|NCT00424021|156337243|FG000|AMB-220-E Study Period|Death|0|||
48327313|NCT01822756|155396182|FG002|Overall Study|Disease progression|7|||
48585921|NCT00424021|156337244|FG001|AMB-220-E Study Period|Death|0|||
48585922|NCT00424021|156337245|FG002|AMB-220-E Study Period|Death|1|||
48585923|NCT00424021|156337246|FG003|AMB-220-E Study Period|Death|1|||
48585924|NCT00424021|156337243|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
48585925|NCT00424021|156337244|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
48585926|NCT00424021|156337245|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
48585927|NCT00424021|156337246|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
48585928|NCT00424021|156337243|FG000|AMB-220-E Study Period|Physician Decision|0|||
48585929|NCT00424021|156337244|FG001|AMB-220-E Study Period|Physician Decision|0|||
48585930|NCT00424021|156337245|FG002|AMB-220-E Study Period|Physician Decision|0|||
48585931|NCT00424021|156337246|FG003|AMB-220-E Study Period|Physician Decision|1|||
48636187|NCT02958865|156526844|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
48636188|NCT02958865|156526845|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
48636189|NCT02958865|156526846|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
48636190|NCT02958865|156526847|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
48636191|NCT02958865|156526848|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
48636192|NCT02958865|156526849|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
48636193|NCT02958865|156526850|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
48636194|NCT02958865|156526835|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636195|NCT02958865|156526836|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636196|NCT02958865|156526837|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636197|NCT02958865|156526838|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48585932|NCT01254721|156337247|FG000|Overall Study|Lost to Follow-up|0|||
48585933|NCT01254721|156337248|FG001|Overall Study|Lost to Follow-up|4|||
48585934|NCT01254721|156337247|FG000|Overall Study|Lack of Efficacy|4|||
48585935|NCT01254721|156337248|FG001|Overall Study|Lack of Efficacy|2|||
48585936|NCT01254721|156337247|FG000|Overall Study|Death|0|||
48585937|NCT01254721|156337248|FG001|Overall Study|Death|1|||
48585938|NCT01254721|156337247|FG000|Overall Study|technical problum|1|||
48585939|NCT01254721|156337248|FG001|Overall Study|technical problum|0|||
48585940|NCT01254721|156337247|FG000|Overall Study|Adverse Event|2|||
48585941|NCT01254721|156337248|FG001|Overall Study|Adverse Event|3|||
48585942|NCT01254721|156337247|FG000|Overall Study|Withdrawal by Subject|8|||
48585943|NCT01254721|156337248|FG001|Overall Study|Withdrawal by Subject|11|||
48585944|NCT01254721|156337247|FG000|Overall Study|Wrongly randomization|0|||
48746519|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
48636198|NCT02958865|156526839|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636199|NCT02958865|156526840|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48746520|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48746521|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
48746522|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
48746523|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
48746524|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
48636200|NCT02958865|156526841|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636201|NCT02958865|156526842|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636202|NCT02958865|156526843|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
48636203|NCT02958865|156526844|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
48636204|NCT02958865|156526845|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636205|NCT02958865|156526846|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
48636206|NCT02958865|156526847|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636207|NCT02958865|156526848|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
48636208|NCT02958865|156526849|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
48636209|NCT02958865|156526850|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
48636210|NCT02958865|156526835|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636211|NCT02958865|156526836|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636212|NCT02958865|156526837|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636213|NCT02958865|156526838|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636214|NCT02958865|156526839|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636215|NCT02958865|156526840|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636216|NCT02958865|156526841|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636217|NCT02958865|156526842|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636218|NCT02958865|156526843|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636219|NCT02958865|156526844|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
48636220|NCT02958865|156526845|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636221|NCT02958865|156526846|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636222|NCT02958865|156526847|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636223|NCT02958865|156526848|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636224|NCT02958865|156526849|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
48636225|NCT02958865|156526850|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
48746525|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
48746526|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
48746527|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
48746528|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
48746529|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
48746530|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
48746531|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
48746532|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
48746533|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
48746534|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
48746535|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
48746536|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
48746537|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
48746538|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
48327314|NCT01822756|155396183|FG003|Overall Study|Disease progression|2|||
48746539|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
48746540|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
48746541|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
48327315|NCT01822756|155396184|FG004|Overall Study|Disease progression|6|||
48327316|NCT01822756|155396180|FG000|Overall Study|Death|2|||
48327317|NCT01822756|155396181|FG001|Overall Study|Death|2|||
48327318|NCT01822756|155396182|FG002|Overall Study|Death|1|||
48327319|NCT01822756|155396183|FG003|Overall Study|Death|0|||
48327320|NCT01822756|155396184|FG004|Overall Study|Death|0|||
48327321|NCT01822756|155396180|FG000|Overall Study|Lost to Follow-up|1|||
48327322|NCT01822756|155396181|FG001|Overall Study|Lost to Follow-up|0|||
48327323|NCT01822756|155396182|FG002|Overall Study|Lost to Follow-up|1|||
48327324|NCT01822756|155396183|FG003|Overall Study|Lost to Follow-up|0|||
48327325|NCT01822756|155396184|FG004|Overall Study|Lost to Follow-up|1|||
48327326|NCT01822756|155396180|FG000|Overall Study|Physician Decision|0|||
48327327|NCT01822756|155396181|FG001|Overall Study|Physician Decision|1|||
48327328|NCT01822756|155396182|FG002|Overall Study|Physician Decision|0|||
48327329|NCT01822756|155396183|FG003|Overall Study|Physician Decision|0|||
48327330|NCT01822756|155396184|FG004|Overall Study|Physician Decision|0|||
48327331|NCT01822756|155396180|FG000|Overall Study|disease progression & patient preference|2|||
48327332|NCT01822756|155396181|FG001|Overall Study|disease progression & patient preference|0|||
48327333|NCT01822756|155396182|FG002|Overall Study|disease progression & patient preference|1|||
48327334|NCT01822756|155396183|FG003|Overall Study|disease progression & patient preference|0|||
48327335|NCT01822756|155396184|FG004|Overall Study|disease progression & patient preference|0|||
48327336|NCT03041233|155396185|FG000|Overall Study|Death|5|||
48327337|NCT03041233|155396185|FG000|Overall Study|Physician Decision|1|||
48327338|NCT03041233|155396185|FG000|Overall Study|Lost to Follow-up|16|||
48327339|NCT03041233|155396185|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
48327340|NCT03041233|155396185|FG000|Overall Study|Sponsor Request|1|||
48327341|NCT03041233|155396185|FG000|Overall Study|Duplicate subject|1|||
48327342|NCT03041233|155396185|FG000|Overall Study|Re-ablation|1|||
48327343|NCT00274261|155396190|FG000|Overall Study|Adverse Event|19|||
48327344|NCT00274261|155396191|FG001|Overall Study|Adverse Event|11|||
48327345|NCT00274261|155396190|FG000|Overall Study|Pregnancy|114|||
48327346|NCT00274261|155396191|FG001|Overall Study|Pregnancy|83|||
48327347|NCT00274261|155396190|FG000|Overall Study|Withdrawal by Subject|179|||
48327348|NCT00274261|155396191|FG001|Overall Study|Withdrawal by Subject|126|||
48327349|NCT00274261|155396190|FG000|Overall Study|Protocol Violation|71|||
48327350|NCT00274261|155396191|FG001|Overall Study|Protocol Violation|42|||
48327351|NCT00274261|155396190|FG000|Overall Study|Lost to Follow-up|106|||
48327352|NCT00274261|155396191|FG001|Overall Study|Lost to Follow-up|75|||
48327353|NCT01880736|155396195|FG000|Overall Study|Adverse Event|0|||
48327354|NCT01880736|155396196|FG001|Overall Study|Adverse Event|0|||
48746542|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
48327355|NCT01880736|155396197|FG002|Overall Study|Adverse Event|0|||
48746543|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
48746544|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
48585945|NCT01254721|156337248|FG001|Overall Study|Wrongly randomization|1|||
48585946|NCT00987402|156337249|FG000|Overall Study|Insufficient data entry|86|||
48585947|NCT00987402|156337250|FG001|Overall Study|Insufficient data entry|98|||
48585948|NCT01955109|156337251|FG000|Overall Study|Adverse Event|2|||
48585949|NCT01955109|156337252|FG001|Overall Study|Adverse Event|0|||
48585950|NCT01955109|156337251|FG000|Overall Study|Participant unwilling to continue|35|||
48585951|NCT01955109|156337252|FG001|Overall Study|Participant unwilling to continue|7|||
48585952|NCT01955109|156337251|FG000|Overall Study|Physician Decision|2|||
48585953|NCT01955109|156337252|FG001|Overall Study|Physician Decision|0|||
48327356|NCT01880736|155396198|FG003|Overall Study|Adverse Event|1|||
48327357|NCT01880736|155396195|FG000|Overall Study|Withdrawal Criteria|1|||
48327358|NCT01880736|155396196|FG001|Overall Study|Withdrawal Criteria|2|||
48327359|NCT01880736|155396197|FG002|Overall Study|Withdrawal Criteria|1|||
48327360|NCT01880736|155396198|FG003|Overall Study|Withdrawal Criteria|5|||
48327361|NCT01227421|155396199|FG000|Overall Study|Lost to Follow-up|6|||
48585954|NCT01955109|156337251|FG000|Overall Study|Lost to Follow-up|3|||
48746545|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
48746546|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
48746547|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
48746548|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
48746549|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Death|0|||
48746550|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Death|0|||
48746551|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Death|0|||
48746552|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Death|0|||
48746553|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Death|1|||
48746554|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Death|1|||
48746555|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Death|3|||
48746556|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Death|1|||
48746557|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Death|1|||
48746558|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Death|5|||
48746559|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Death|2|||
48746560|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Death|2|||
48746561|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Other|0|||
48746562|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Other|0|||
48746563|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Other|0|||
48746564|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Other|0|||
48327362|NCT01227421|155396200|FG001|Overall Study|Lost to Follow-up|7|||
48327363|NCT01227421|155396201|FG002|Overall Study|Lost to Follow-up|5|||
48327364|NCT01227421|155396199|FG000|Overall Study|Adverse Event|2|||
48327365|NCT01227421|155396200|FG001|Overall Study|Adverse Event|7|||
48327366|NCT01227421|155396201|FG002|Overall Study|Adverse Event|2|||
48327367|NCT01227421|155396199|FG000|Overall Study|Withdrawal by Subject|1|||
48327368|NCT01227421|155396200|FG001|Overall Study|Withdrawal by Subject|2|||
48327369|NCT01227421|155396201|FG002|Overall Study|Withdrawal by Subject|1|||
48327370|NCT01227421|155396199|FG000|Overall Study|Protocol Violation|1|||
48327371|NCT01227421|155396200|FG001|Overall Study|Protocol Violation|1|||
48327372|NCT01227421|155396201|FG002|Overall Study|Protocol Violation|2|||
48327373|NCT01227421|155396199|FG000|Overall Study|Randomized in error|1|||
48327374|NCT01227421|155396200|FG001|Overall Study|Randomized in error|1|||
48327375|NCT01227421|155396201|FG002|Overall Study|Randomized in error|0|||
48327376|NCT01827839|155396204|FG000|Overall Study|Adverse Event|1|||
48327377|NCT01827839|155396204|FG000|Overall Study|Consent Withdrawal|2|||
48327378|NCT02628626|155396206|FG000|Overall Study|Withdrawal by Subject|2|||
48327379|NCT02628626|155396207|FG001|Overall Study|Withdrawal by Subject|2|||
48746565|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Other|10|||
48746566|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Other|3|||
48746567|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Other|2|||
48746568|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Other|0|||
48746569|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Other|10|||
48746570|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Other|5|||
48327380|NCT00266656|155396208|FG000|Overall Study|Death|1|||
48746571|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Other|1|||
48746572|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Other|7|||
48746573|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746574|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746575|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48585955|NCT01955109|156337252|FG001|Overall Study|Lost to Follow-up|1|||
48585956|NCT01955109|156337251|FG000|Overall Study|Non-compliance|3|||
48585957|NCT01955109|156337252|FG001|Overall Study|Non-compliance|1|||
48585958|NCT03769194|156337253|FG000|Overall Study|Withdrawal by Subject|0|||
48585959|NCT03769194|156337254|FG001|Overall Study|Withdrawal by Subject|7|||
48585960|NCT03769194|156337255|FG002|Overall Study|Withdrawal by Subject|4|||
48585961|NCT03769194|156337256|FG003|Overall Study|Withdrawal by Subject|1|||
48585962|NCT03769194|156337253|FG000|Overall Study|moved from study area|0|||
48585963|NCT03769194|156337254|FG001|Overall Study|moved from study area|2|||
48585964|NCT03769194|156337255|FG002|Overall Study|moved from study area|1|||
48585965|NCT03769194|156337256|FG003|Overall Study|moved from study area|1|||
48585966|NCT03769194|156337253|FG000|Overall Study|Lost to Follow-up|3|||
48585967|NCT03769194|156337254|FG001|Overall Study|Lost to Follow-up|6|||
48585968|NCT03769194|156337255|FG002|Overall Study|Lost to Follow-up|3|||
48585969|NCT03769194|156337256|FG003|Overall Study|Lost to Follow-up|6|||
48585970|NCT03769194|156337253|FG000|Overall Study|other|1|||
48585971|NCT03769194|156337254|FG001|Overall Study|other|3|||
48585972|NCT03769194|156337255|FG002|Overall Study|other|0|||
48585973|NCT03769194|156337256|FG003|Overall Study|other|1|||
48585974|NCT03000530|156337257|FG000|Overall Study|Adverse Event|0|||
48585975|NCT03000530|156337258|FG001|Overall Study|Adverse Event|0|||
48585976|NCT03000530|156337259|FG002|Overall Study|Adverse Event|2|||
48585977|NCT03000530|156337257|FG000|Overall Study|Lost to Follow-up|0|||
48585978|NCT03000530|156337258|FG001|Overall Study|Lost to Follow-up|3|||
48585979|NCT03000530|156337259|FG002|Overall Study|Lost to Follow-up|1|||
48585980|NCT03000530|156337257|FG000|Overall Study|Withdrawal by Subject|0|||
48585981|NCT03000530|156337258|FG001|Overall Study|Withdrawal by Subject|2|||
48585982|NCT03000530|156337259|FG002|Overall Study|Withdrawal by Subject|1|||
48585983|NCT00106639|156337263|FG000|Overall Study|Adverse Event|3|||
48585984|NCT00106639|156337264|FG001|Overall Study|Adverse Event|4|||
48585985|NCT00106639|156337265|FG002|Overall Study|Adverse Event|1|||
48585986|NCT00106639|156337263|FG000|Overall Study|Protocol Violation|0|||
48585987|NCT00106639|156337264|FG001|Overall Study|Protocol Violation|1|||
48585988|NCT00106639|156337265|FG002|Overall Study|Protocol Violation|0|||
48585989|NCT00106639|156337263|FG000|Overall Study|Withdrawal by Subject|0|||
48585990|NCT00106639|156337264|FG001|Overall Study|Withdrawal by Subject|1|||
48585991|NCT00106639|156337265|FG002|Overall Study|Withdrawal by Subject|0|||
48585992|NCT00106639|156337263|FG000|Overall Study|Participant defaulted|0|||
48585993|NCT00106639|156337264|FG001|Overall Study|Participant defaulted|1|||
48585994|NCT00106639|156337265|FG002|Overall Study|Participant defaulted|1|||
48585995|NCT00904839|156337266|FG000|Overall Study|Adverse Event|0|||
48585996|NCT00904839|156337267|FG001|Overall Study|Adverse Event|5|||
48585997|NCT00904839|156337268|FG002|Overall Study|Adverse Event|4|||
48585998|NCT00904839|156337266|FG000|Overall Study|Protocol Violation|0|||
48585999|NCT00904839|156337267|FG001|Overall Study|Protocol Violation|1|||
48586000|NCT00904839|156337268|FG002|Overall Study|Protocol Violation|1|||
48327381|NCT00266656|155396209|FG001|Overall Study|Death|0|||
48327382|NCT00266656|155396208|FG000|Overall Study|Lost to Follow-up|4|||
48327383|NCT00266656|155396209|FG001|Overall Study|Lost to Follow-up|1|||
48327384|NCT00266656|155396208|FG000|Overall Study|Withdrawal by Subject|4|||
48586001|NCT00904839|156337266|FG000|Overall Study|Lost to Follow-up|0|||
48586002|NCT00904839|156337267|FG001|Overall Study|Lost to Follow-up|1|||
48586003|NCT00904839|156337268|FG002|Overall Study|Lost to Follow-up|2|||
48586004|NCT00904839|156337266|FG000|Overall Study|Withdrawal by Subject|0|||
48746576|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746577|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
48746578|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48636226|NCT02958865|156526835|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636227|NCT02958865|156526836|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636228|NCT02958865|156526837|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636229|NCT02958865|156526838|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636230|NCT02958865|156526839|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636231|NCT02958865|156526840|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636232|NCT02958865|156526841|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636233|NCT02958865|156526842|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636234|NCT02958865|156526843|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636235|NCT02958865|156526844|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636236|NCT02958865|156526845|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
48636237|NCT02958865|156526846|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
48636238|NCT02958865|156526847|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
48636239|NCT02958865|156526848|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
48636240|NCT02958865|156526849|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
48636241|NCT02958865|156526850|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
48636242|NCT02958865|156526835|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
48636243|NCT02958865|156526836|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
48636244|NCT02958865|156526837|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
48636245|NCT02958865|156526838|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
48586005|NCT00904839|156337267|FG001|Overall Study|Withdrawal by Subject|2|||
48586006|NCT00904839|156337268|FG002|Overall Study|Withdrawal by Subject|0|||
48586007|NCT00904839|156337266|FG000|Overall Study|Not treated|1|||
48586008|NCT00904839|156337267|FG001|Overall Study|Not treated|0|||
48586009|NCT00904839|156337268|FG002|Overall Study|Not treated|1|||
48586010|NCT00904839|156337266|FG000|Overall Study|Other than above|0|||
48586011|NCT00904839|156337267|FG001|Overall Study|Other than above|9|||
48586012|NCT00904839|156337268|FG002|Overall Study|Other than above|7|||
48586013|NCT01430624|156337269|FG000|Overall Study|Lost to Follow-up|23|||
48586014|NCT01430624|156337270|FG001|Overall Study|Lost to Follow-up|29|||
48586015|NCT01430624|156337271|FG002|Overall Study|Lost to Follow-up|27|||
48586016|NCT01430624|156337269|FG000|Overall Study|technical or eligibility|5|||
48586017|NCT01430624|156337270|FG001|Overall Study|technical or eligibility|5|||
48586018|NCT01430624|156337271|FG002|Overall Study|technical or eligibility|2|||
48586019|NCT02614131|156337274|FG000|Overall Study|Withdrawal by Subject|1|||
48586020|NCT02614131|156337275|FG001|Overall Study|Withdrawal by Subject|0|||
48586021|NCT02614131|156337276|FG002|Overall Study|Withdrawal by Subject|0|||
48586022|NCT02614131|156337277|FG003|Overall Study|Withdrawal by Subject|0|||
48586023|NCT02614131|156337278|FG004|Overall Study|Withdrawal by Subject|0|||
48586024|NCT02614131|156337279|FG005|Overall Study|Withdrawal by Subject|0|||
48586025|NCT02614131|156337280|FG006|Overall Study|Withdrawal by Subject|0|||
48586026|NCT02614131|156337274|FG000|Overall Study|Adverse Event|0|||
48586027|NCT02614131|156337275|FG001|Overall Study|Adverse Event|0|||
48586028|NCT02614131|156337276|FG002|Overall Study|Adverse Event|0|||
48586029|NCT02614131|156337277|FG003|Overall Study|Adverse Event|0|||
48586030|NCT02614131|156337278|FG004|Overall Study|Adverse Event|0|||
48586031|NCT02614131|156337279|FG005|Overall Study|Adverse Event|0|||
48586032|NCT02614131|156337280|FG006|Overall Study|Adverse Event|1|||
48586033|NCT00087126|156337281|FG000|Overall Study|Ineligible - second primary|1|||
48586034|NCT00087126|156337281|FG000|Overall Study|Never treated|1|||
48586035|NCT01832818|156337282|FG000|Overall Study|Lost to Follow-up|6|||
48586036|NCT03209518|156337283|FG000|Overall Study|Case Report Forms Uncollected|1|||
48586037|NCT03209518|156337283|FG000|Overall Study|Protocol Deviation|1|||
48586038|NCT00236899|156337289|FG000|Overall Study|Adverse Event (Study Related)|1|||
48586039|NCT00236899|156337290|FG001|Overall Study|Adverse Event (Study Related)|1|||
48586040|NCT00236899|156337291|FG002|Overall Study|Adverse Event (Study Related)|2|||
48586041|NCT00236899|156337292|FG003|Overall Study|Adverse Event (Study Related)|1|||
48586042|NCT00236899|156337289|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
48586043|NCT00236899|156337290|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
48586044|NCT00236899|156337291|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
48586045|NCT00236899|156337292|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
48586046|NCT00236899|156337289|FG000|Overall Study|Death (Study Disease)|1|||
48636246|NCT02958865|156526839|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
48586047|NCT00236899|156337290|FG001|Overall Study|Death (Study Disease)|4|||
48327385|NCT00266656|155396209|FG001|Overall Study|Withdrawal by Subject|2|||
48327386|NCT00266656|155396208|FG000|Overall Study|Did Not Reach Final Height|4|||
48636247|NCT02958865|156526840|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
48636248|NCT02958865|156526841|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
48636249|NCT02958865|156526842|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
48636250|NCT02958865|156526843|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
48636251|NCT02958865|156526844|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
48636252|NCT02958865|156526845|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
48636253|NCT02958865|156526846|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
48636254|NCT02958865|156526847|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
48636255|NCT02958865|156526848|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
48636256|NCT02958865|156526849|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
48636257|NCT02958865|156526850|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
48636258|NCT02958865|156526835|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636259|NCT02958865|156526836|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636260|NCT02958865|156526837|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636261|NCT02958865|156526838|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636262|NCT02958865|156526839|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636263|NCT02958865|156526840|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48327387|NCT00266656|155396209|FG001|Overall Study|Did Not Reach Final Height|8|||
48327388|NCT00266656|155396208|FG000|Overall Study|Parent/Caregiver Decision|1|||
48327389|NCT00266656|155396209|FG001|Overall Study|Parent/Caregiver Decision|2|||
48327390|NCT01593020|155396210|FG000|Overall Study|Adverse Event|1|||
48327391|NCT01593020|155396211|FG001|Overall Study|Adverse Event|1|||
48327392|NCT01593020|155396210|FG000|Overall Study|Death|0|||
48327393|NCT01593020|155396211|FG001|Overall Study|Death|1|||
48327394|NCT01593020|155396210|FG000|Overall Study|Ineligible|1|||
48327395|NCT01593020|155396211|FG001|Overall Study|Ineligible|0|||
48327396|NCT02203032|155396212|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
48327397|NCT02203032|155396213|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
48327398|NCT02203032|155396214|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
48327399|NCT02203032|155396215|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
48327400|NCT02203032|155396212|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
48327401|NCT02203032|155396213|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
48327402|NCT02203032|155396214|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
48327403|NCT02203032|155396215|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
48327404|NCT02203032|155396212|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
48327405|NCT02203032|155396213|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
48327406|NCT02203032|155396214|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
48327407|NCT02203032|155396215|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
48327408|NCT02203032|155396212|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
48327409|NCT02203032|155396213|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
48327410|NCT02203032|155396214|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
48327411|NCT02203032|155396215|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
48327412|NCT02203032|155396212|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
48327413|NCT02203032|155396213|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
48327414|NCT02203032|155396214|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
48327415|NCT02203032|155396215|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
48327416|NCT02203032|155396212|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
48327417|NCT02203032|155396213|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
48636264|NCT02958865|156526841|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636265|NCT02958865|156526842|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48327418|NCT02203032|155396214|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
48327419|NCT02203032|155396215|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
48327420|NCT02203032|155396212|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
48327421|NCT02203032|155396213|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
48327422|NCT02203032|155396214|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
48327423|NCT02203032|155396215|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
48327424|NCT02203032|155396212|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
48327425|NCT02203032|155396213|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
48327426|NCT02203032|155396214|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
48327427|NCT02203032|155396215|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
48327428|NCT02203032|155396212|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
48327429|NCT02203032|155396213|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
48327430|NCT02203032|155396214|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
48327431|NCT02203032|155396215|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
48327432|NCT02203032|155396212|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
48327433|NCT02203032|155396213|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
48327434|NCT02203032|155396214|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
48636266|NCT02958865|156526843|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636267|NCT02958865|156526844|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636268|NCT02958865|156526845|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636269|NCT02958865|156526846|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636270|NCT02958865|156526847|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636271|NCT02958865|156526848|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
48586048|NCT00236899|156337291|FG002|Overall Study|Death (Study Disease)|0|||
48586049|NCT00236899|156337292|FG003|Overall Study|Death (Study Disease)|0|||
48586050|NCT00236899|156337289|FG000|Overall Study|Death (Not Study Related)|2|||
48586051|NCT00236899|156337290|FG001|Overall Study|Death (Not Study Related)|0|||
48586052|NCT00236899|156337291|FG002|Overall Study|Death (Not Study Related)|0|||
48586053|NCT00236899|156337292|FG003|Overall Study|Death (Not Study Related)|0|||
48327435|NCT02203032|155396215|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
48327436|NCT02203032|155396212|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
48586054|NCT00236899|156337289|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
48636272|NCT02958865|156526849|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636273|NCT02958865|156526850|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
48636274|NCT02958865|156526835|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636275|NCT02958865|156526836|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636276|NCT02958865|156526837|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636277|NCT02958865|156526838|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636278|NCT02958865|156526839|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636279|NCT02958865|156526840|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636280|NCT02958865|156526841|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636281|NCT02958865|156526842|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636282|NCT02958865|156526843|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636283|NCT02958865|156526844|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636284|NCT02958865|156526845|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636285|NCT02958865|156526846|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636286|NCT02958865|156526847|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636287|NCT02958865|156526848|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
48636288|NCT02958865|156526849|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636289|NCT02958865|156526850|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
48636290|NCT02958865|156526835|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636291|NCT02958865|156526836|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636292|NCT02958865|156526837|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636293|NCT02958865|156526838|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636294|NCT02958865|156526839|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636295|NCT02958865|156526840|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636296|NCT02958865|156526841|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636297|NCT02958865|156526842|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636298|NCT02958865|156526843|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636299|NCT02958865|156526844|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
48636300|NCT02958865|156526845|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636301|NCT02958865|156526846|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636302|NCT02958865|156526847|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636303|NCT02958865|156526848|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636304|NCT02958865|156526849|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636305|NCT02958865|156526850|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
48636306|NCT01567722|156526851|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
48636307|NCT01567722|156526852|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
48636308|NCT01567722|156526853|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
48636309|NCT01567722|156526851|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
48636310|NCT01567722|156526852|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
48586055|NCT00236899|156337290|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
48586056|NCT00236899|156337291|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
48586057|NCT00236899|156337292|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
48586058|NCT00236899|156337289|FG000|Overall Study|Lost to Follow-up|0|||
48586059|NCT00236899|156337290|FG001|Overall Study|Lost to Follow-up|1|||
48586060|NCT00236899|156337291|FG002|Overall Study|Lost to Follow-up|0|||
48586061|NCT00236899|156337292|FG003|Overall Study|Lost to Follow-up|0|||
48586062|NCT00236899|156337289|FG000|Overall Study|Entry Criteria Exclusion|0|||
48327437|NCT02203032|155396213|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
48636311|NCT01567722|156526853|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
48636312|NCT01567722|156526851|FG000|Overall Study|Protocol closure by the OCG|2|||
48636313|NCT01567722|156526852|FG001|Overall Study|Protocol closure by the OCG|0|||
48586063|NCT00236899|156337290|FG001|Overall Study|Entry Criteria Exclusion|1|||
48586064|NCT00236899|156337291|FG002|Overall Study|Entry Criteria Exclusion|1|||
48586065|NCT00236899|156337292|FG003|Overall Study|Entry Criteria Exclusion|0|||
48586066|NCT00236899|156337289|FG000|Overall Study|Protocol Violation|1|||
48586067|NCT00236899|156337290|FG001|Overall Study|Protocol Violation|0|||
48586068|NCT00236899|156337291|FG002|Overall Study|Protocol Violation|0|||
48586069|NCT00236899|156337292|FG003|Overall Study|Protocol Violation|0|||
48586070|NCT00236899|156337289|FG000|Overall Study|Withdrawal by Subject|6|||
48586071|NCT00236899|156337290|FG001|Overall Study|Withdrawal by Subject|4|||
48586072|NCT00236899|156337291|FG002|Overall Study|Withdrawal by Subject|5|||
48586073|NCT00236899|156337292|FG003|Overall Study|Withdrawal by Subject|2|||
48586074|NCT00236899|156337289|FG000|Overall Study|Physician Decision|7|||
48586075|NCT00236899|156337290|FG001|Overall Study|Physician Decision|8|||
48586076|NCT00236899|156337291|FG002|Overall Study|Physician Decision|7|||
48586077|NCT00236899|156337292|FG003|Overall Study|Physician Decision|6|||
48586078|NCT00236899|156337289|FG000|Overall Study|Satisfactory Response|2|||
48586079|NCT00236899|156337290|FG001|Overall Study|Satisfactory Response|0|||
48586080|NCT00236899|156337291|FG002|Overall Study|Satisfactory Response|0|||
48586081|NCT00236899|156337292|FG003|Overall Study|Satisfactory Response|1|||
48586082|NCT00236899|156337289|FG000|Overall Study|Lack of Efficacy|18|||
48586083|NCT00236899|156337290|FG001|Overall Study|Lack of Efficacy|18|||
48586084|NCT00236899|156337291|FG002|Overall Study|Lack of Efficacy|25|||
48746579|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746580|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746581|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48586085|NCT00236899|156337292|FG003|Overall Study|Lack of Efficacy|23|||
48586086|NCT01717391|156337295|FG000|Overall Study|Withdrawal by Subject|5|||
48586087|NCT01717391|156337295|FG000|Overall Study|Physician Decision|1|||
48586088|NCT01717391|156337295|FG000|Overall Study|FLT technical failure|3|||
48586089|NCT01785849|156337296|FG000|Overall Study|Death|7|||
48586090|NCT01785849|156337297|FG001|Overall Study|Death|9|||
48586091|NCT01785849|156337296|FG000|Overall Study|Protocol Specified Criteria|29|||
48586092|NCT01785849|156337297|FG001|Overall Study|Protocol Specified Criteria|1|||
48636314|NCT01567722|156526853|FG002|Overall Study|Protocol closure by the OCG|0|||
48586093|NCT01785849|156337296|FG000|Overall Study|Withdrawal by Subject|15|||
48636315|NCT01567722|156526851|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
48636316|NCT01567722|156526852|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
48636317|NCT01567722|156526853|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
48636318|NCT01847443|156526854|FG000|Study Period 1|Withdrawal by Subject|0|||
48636319|NCT01847443|156526855|FG001|Study Period 1|Withdrawal by Subject|1|||
48636320|NCT01847443|156526856|FG002|Study Period 1|Withdrawal by Subject|0|||
48636321|NCT01847443|156526857|FG003|Study Period 1|Withdrawal by Subject|0|||
48636322|NCT01847443|156526854|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
48586094|NCT01785849|156337297|FG001|Overall Study|Withdrawal by Subject|12|||
48636323|NCT01847443|156526855|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
48636324|NCT01847443|156526856|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
48586095|NCT01785849|156337296|FG000|Overall Study|Sponsor Decision|0|||
48746582|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48586096|NCT01785849|156337297|FG001|Overall Study|Sponsor Decision|1|||
48586097|NCT01785849|156337296|FG000|Overall Study|Lost to Follow-up|10|||
48586098|NCT01785849|156337297|FG001|Overall Study|Lost to Follow-up|11|||
48586099|NCT01451164|156337302|FG000|Overall Study|Adverse Event|19|||
48586100|NCT01451164|156337303|FG001|Overall Study|Adverse Event|12|||
48586101|NCT01451164|156337304|FG002|Overall Study|Adverse Event|18|||
48586102|NCT01451164|156337305|FG003|Overall Study|Adverse Event|21|||
48586103|NCT01451164|156337302|FG000|Overall Study|Withdrawal Criteria|1|||
48586104|NCT01451164|156337303|FG001|Overall Study|Withdrawal Criteria|1|||
48586105|NCT01451164|156337304|FG002|Overall Study|Withdrawal Criteria|1|||
48586106|NCT01451164|156337305|FG003|Overall Study|Withdrawal Criteria|1|||
48586107|NCT01451164|156337302|FG000|Overall Study|Physician Decision|2|||
48586108|NCT01451164|156337303|FG001|Overall Study|Physician Decision|0|||
48586109|NCT01451164|156337304|FG002|Overall Study|Physician Decision|1|||
48586110|NCT01451164|156337305|FG003|Overall Study|Physician Decision|0|||
48586111|NCT01451164|156337302|FG000|Overall Study|Withdrawal by Subject|14|||
48586112|NCT01451164|156337303|FG001|Overall Study|Withdrawal by Subject|11|||
48586113|NCT01451164|156337304|FG002|Overall Study|Withdrawal by Subject|16|||
48586114|NCT01451164|156337305|FG003|Overall Study|Withdrawal by Subject|17|||
48586115|NCT01451164|156337302|FG000|Overall Study|Protocol Violation|0|||
48586116|NCT01451164|156337303|FG001|Overall Study|Protocol Violation|1|||
48586117|NCT01451164|156337304|FG002|Overall Study|Protocol Violation|0|||
48586118|NCT01451164|156337305|FG003|Overall Study|Protocol Violation|0|||
48586119|NCT01451164|156337302|FG000|Overall Study|Lack of Efficacy|7|||
48586120|NCT01451164|156337303|FG001|Overall Study|Lack of Efficacy|9|||
48586121|NCT01451164|156337304|FG002|Overall Study|Lack of Efficacy|9|||
48586122|NCT01451164|156337305|FG003|Overall Study|Lack of Efficacy|7|||
48586123|NCT03244618|156337306|FG000|Overall Study|Lost to Follow-up|3|||
48586124|NCT03244618|156337307|FG001|Overall Study|Lost to Follow-up|4|||
48586125|NCT03244618|156337306|FG000|Overall Study|Protocol Violation|4|||
48586126|NCT03244618|156337307|FG001|Overall Study|Protocol Violation|3|||
48586127|NCT03244618|156337306|FG000|Overall Study|Withdrawal by Subject|0|||
48586128|NCT03244618|156337307|FG001|Overall Study|Withdrawal by Subject|2|||
48586129|NCT01952080|156337310|FG000|Overall Study|Withdrawal by Subject|0|||
48586130|NCT01952080|156337311|FG001|Overall Study|Withdrawal by Subject|0|||
48586131|NCT01952080|156337312|FG002|Overall Study|Withdrawal by Subject|0|||
48586132|NCT01952080|156337313|FG003|Overall Study|Withdrawal by Subject|1|||
48586133|NCT01952080|156337310|FG000|Overall Study|Protocol Non-compliance|0|||
48586134|NCT01952080|156337311|FG001|Overall Study|Protocol Non-compliance|1|||
48586135|NCT01952080|156337312|FG002|Overall Study|Protocol Non-compliance|0|||
48586136|NCT01952080|156337313|FG003|Overall Study|Protocol Non-compliance|0|||
48586137|NCT01900431|156337323|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
48586138|NCT01900431|156337324|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
48586139|NCT01900431|156337325|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
48586140|NCT01900431|156337323|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
48586141|NCT01900431|156337324|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
48586142|NCT01900431|156337325|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
48586143|NCT01900431|156337323|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
48746583|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746584|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
48746585|NCT02521870|156919813|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746586|NCT02521870|156919814|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48586144|NCT01900431|156337324|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
48586145|NCT01900431|156337325|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
48586146|NCT01900431|156337323|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
48586147|NCT01900431|156337324|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
48746587|NCT02521870|156919815|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48586148|NCT01900431|156337325|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
48327438|NCT02203032|155396214|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
48327439|NCT02203032|155396215|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
48327440|NCT02203032|155396212|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
48327441|NCT02203032|155396213|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
48327442|NCT02203032|155396214|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
48327443|NCT02203032|155396215|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
48586149|NCT01900431|156337323|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
48586150|NCT01900431|156337324|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
48586151|NCT01900431|156337325|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
48586152|NCT01900431|156337323|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
48586153|NCT01900431|156337324|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
48586154|NCT01900431|156337325|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
48586155|NCT01900431|156337323|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
48586156|NCT01900431|156337324|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
48586157|NCT01900431|156337325|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
48586158|NCT01900431|156337323|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
48586159|NCT01900431|156337324|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
48586160|NCT01900431|156337325|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
48586161|NCT01900431|156337323|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
48327444|NCT04748341|155396216|FG000|Overall Study|Lost to Follow-up|1|||
48327445|NCT04748341|155396217|FG001|Overall Study|Lost to Follow-up|1|||
48586162|NCT01900431|156337324|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
48746588|NCT02521870|156919816|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746589|NCT02521870|156919817|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
48746590|NCT02521870|156919818|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746591|NCT02521870|156919819|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746592|NCT02521870|156919820|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746593|NCT02521870|156919821|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746594|NCT02521870|156919822|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746595|NCT02521870|156919823|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48636325|NCT01847443|156526857|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
48636326|NCT01847443|156526854|FG000|Washout Period Before Study Period 2|Other reason|1|||
48636327|NCT01847443|156526855|FG001|Washout Period Before Study Period 2|Other reason|0|||
48636328|NCT01847443|156526856|FG002|Washout Period Before Study Period 2|Other reason|0|||
48636329|NCT01847443|156526857|FG003|Washout Period Before Study Period 2|Other reason|0|||
48746596|NCT02521870|156919824|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
48746597|NCT00279305|156919825|FG000|Overall Study|Pregnancy|1|||
48746598|NCT00279305|156919826|FG001|Overall Study|Pregnancy|0|||
48746599|NCT00279305|156919825|FG000|Overall Study|Withdrawal by Subject|2|||
48746600|NCT00279305|156919826|FG001|Overall Study|Withdrawal by Subject|0|||
48327446|NCT00392197|155396218|FG000|Overall Study|Adverse Event|4|||
48327447|NCT00392197|155396219|FG001|Overall Study|Adverse Event|12|||
48586163|NCT01900431|156337325|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
48586164|NCT01841567|156337326|FG000|Overall Study|Adverse Event|3|||
48586165|NCT04226495|156337327|FG000|Overall Study|Withdrawal by Subject|3|||
48586166|NCT04226495|156337328|FG001|Overall Study|Withdrawal by Subject|3|||
48586167|NCT04226495|156337327|FG000|Overall Study|PI discretion|3|||
48586168|NCT04226495|156337328|FG001|Overall Study|PI discretion|4|||
48586169|NCT03172364|156337329|FG000|Overall Study|Adverse Event|1|||
48586170|NCT03172364|156337330|FG001|Overall Study|Adverse Event|1|||
48586171|NCT03172364|156337329|FG000|Overall Study|Protocol Violation|1|||
48586172|NCT03172364|156337330|FG001|Overall Study|Protocol Violation|0|||
48586173|NCT03611582|156337335|FG000|Overall Study|Adverse Event|26|||
48586174|NCT03611582|156337336|FG001|Overall Study|Adverse Event|6|||
48586175|NCT03611582|156337335|FG000|Overall Study|Protocol Violation|0|||
48586176|NCT03611582|156337336|FG001|Overall Study|Protocol Violation|1|||
48586177|NCT03611582|156337335|FG000|Overall Study|Pregnancy|1|||
48586178|NCT03611582|156337336|FG001|Overall Study|Pregnancy|2|||
48586179|NCT03611582|156337335|FG000|Overall Study|Lack of Efficacy|0|||
48586180|NCT03611582|156337336|FG001|Overall Study|Lack of Efficacy|1|||
48586181|NCT03611582|156337335|FG000|Overall Study|At the discretion of the investigator|1|||
48586182|NCT03611582|156337336|FG001|Overall Study|At the discretion of the investigator|0|||
48586183|NCT03611582|156337335|FG000|Overall Study|Safety concern as judged by the investigator|1|||
48586184|NCT03611582|156337336|FG001|Overall Study|Safety concern as judged by the investigator|2|||
48586185|NCT03611582|156337335|FG000|Overall Study|Withdrawal by Subject|4|||
48586186|NCT03611582|156337336|FG001|Overall Study|Withdrawal by Subject|3|||
48586187|NCT03611582|156337335|FG000|Overall Study|Lost to Follow-up|18|||
48586188|NCT03611582|156337336|FG001|Overall Study|Lost to Follow-up|7|||
48586189|NCT03611582|156337335|FG000|Overall Study|other|17|||
48586190|NCT03611582|156337336|FG001|Overall Study|other|16|||
48586191|NCT01783821|156337337|FG000|Overall Study|Screen Failure|1|||
48586192|NCT01783821|156337338|FG001|Overall Study|Screen Failure|1|||
48586193|NCT04459598|156337339|FG000|Overall Study|Adverse Event|1|||
48586194|NCT04459598|156337340|FG001|Overall Study|Adverse Event|1|||
48586195|NCT02305446|156338924|FG000|Overall Study|Adverse Event|1|||
48586196|NCT00308750|156338927|FG000|Overall Study|Adverse Event|9|||
48586197|NCT00308750|156338928|FG001|Overall Study|Adverse Event|9|||
48586198|NCT00308750|156338929|FG002|Overall Study|Adverse Event|13|||
48586199|NCT00308750|156338927|FG000|Overall Study|Withdrawal by Subject|6|||
48586200|NCT00308750|156338928|FG001|Overall Study|Withdrawal by Subject|2|||
48586201|NCT00308750|156338929|FG002|Overall Study|Withdrawal by Subject|3|||
48586202|NCT00308750|156338927|FG000|Overall Study|Physician Decision|3|||
48586203|NCT00308750|156338928|FG001|Overall Study|Physician Decision|4|||
48586204|NCT00308750|156338929|FG002|Overall Study|Physician Decision|3|||
48586205|NCT00308750|156338927|FG000|Overall Study|Sponsor Decision|1|||
48586206|NCT00308750|156338928|FG001|Overall Study|Sponsor Decision|0|||
48586207|NCT00308750|156338929|FG002|Overall Study|Sponsor Decision|0|||
48586208|NCT00308750|156338927|FG000|Overall Study|Disease Progression|47|||
48586209|NCT00308750|156338928|FG001|Overall Study|Disease Progression|24|||
48586210|NCT00308750|156338929|FG002|Overall Study|Disease Progression|28|||
48586211|NCT00308750|156338927|FG000|Overall Study|Unrelated Complication|3|||
48586212|NCT00308750|156338928|FG001|Overall Study|Unrelated Complication|0|||
48586213|NCT00308750|156338929|FG002|Overall Study|Unrelated Complication|1|||
48586214|NCT00308750|156338927|FG000|Overall Study|Death|1|||
48586215|NCT00308750|156338928|FG001|Overall Study|Death|0|||
48746601|NCT00279305|156919825|FG000|Overall Study|Dificulting establishing IV|1|||
48746602|NCT00279305|156919826|FG001|Overall Study|Dificulting establishing IV|0|||
48746603|NCT00279305|156919825|FG000|Overall Study|FDA Safety Alert|4|||
48746604|NCT00279305|156919826|FG001|Overall Study|FDA Safety Alert|1|||
48746605|NCT00471328|156919827|FG000|Core Phase|Adverse Event|18|||
48746606|NCT00471328|156919828|FG001|Core Phase|Adverse Event|6|||
48746607|NCT00471328|156919827|FG000|Core Phase|Death|8|||
48746608|NCT00471328|156919828|FG001|Core Phase|Death|4|||
48746609|NCT00471328|156919827|FG000|Core Phase|Withdrawal by Subject|2|||
48746610|NCT00471328|156919828|FG001|Core Phase|Withdrawal by Subject|2|||
48746611|NCT00471328|156919827|FG000|Core Phase|Abnormal laboratory value|1|||
48746612|NCT00471328|156919828|FG001|Core Phase|Abnormal laboratory value|0|||
48746613|NCT00471328|156919827|FG000|Core Phase|Disease Progression|78|||
48746614|NCT00471328|156919828|FG001|Core Phase|Disease Progression|53|||
48746615|NCT00471328|156919827|FG000|Core Phase|Administrative Problem|0|||
48746616|NCT00471328|156919828|FG001|Core Phase|Administrative Problem|1|||
48746617|NCT00471328|156919827|FG000|Core Phase|Protocol Deviation|0|||
48746618|NCT00471328|156919828|FG001|Core Phase|Protocol Deviation|1|||
48746619|NCT00471328|156919827|FG000|Extension Phase|Adverse Event|3|||
48746620|NCT00471328|156919828|FG001|Extension Phase|Adverse Event|12|||
48327448|NCT00392197|155396218|FG000|Overall Study|Lack of Efficacy|3|||
48327449|NCT00392197|155396219|FG001|Overall Study|Lack of Efficacy|4|||
48327450|NCT00392197|155396218|FG000|Overall Study|Lost to Follow-up|0|||
48636330|NCT01847443|156526854|FG000|Washout Period Before Study Period 3|Other reason|1|||
48636331|NCT01847443|156526855|FG001|Washout Period Before Study Period 3|Other reason|0|||
48636332|NCT01847443|156526856|FG002|Washout Period Before Study Period 3|Other reason|0|||
48636333|NCT01847443|156526857|FG003|Washout Period Before Study Period 3|Other reason|0|||
48636334|NCT01847443|156526854|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
48636335|NCT01847443|156526855|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
48636336|NCT01847443|156526856|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
48636337|NCT01847443|156526857|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
48636338|NCT01847443|156526854|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
48636339|NCT01847443|156526855|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
48636340|NCT01847443|156526856|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
48636341|NCT01847443|156526857|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
48636342|NCT04447755|156526859|FG000|Overall Study|Death|8|||
48636343|NCT04447755|156526860|FG001|Overall Study|Death|14|||
48636344|NCT04447755|156526861|FG002|Overall Study|Death|8|||
48636345|NCT04447755|156526862|FG003|Overall Study|Death|9|||
48636346|NCT04447755|156526863|FG004|Overall Study|Death|7|||
48636347|NCT04447755|156526864|FG005|Overall Study|Death|7|||
48636348|NCT04447755|156526865|FG006|Overall Study|Death|40|||
48636349|NCT04447755|156526859|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48636350|NCT04447755|156526860|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48636351|NCT04447755|156526861|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48636352|NCT04447755|156526862|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48636353|NCT04447755|156526863|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48636354|NCT04447755|156526864|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
48636355|NCT04447755|156526865|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
48636356|NCT04447755|156526859|FG000|Overall Study|Ongoing in Study|1|||
48636357|NCT04447755|156526860|FG001|Overall Study|Ongoing in Study|2|||
48636358|NCT04447755|156526861|FG002|Overall Study|Ongoing in Study|0|||
48636359|NCT04447755|156526862|FG003|Overall Study|Ongoing in Study|0|||
48636360|NCT04447755|156526863|FG004|Overall Study|Ongoing in Study|2|||
48636361|NCT04447755|156526864|FG005|Overall Study|Ongoing in Study|2|||
48636362|NCT04447755|156526865|FG006|Overall Study|Ongoing in Study|26|||
48636363|NCT01342094|156526868|FG000|Overall Study|Adverse Event|5|||
48636364|NCT01342094|156526869|FG001|Overall Study|Adverse Event|0|||
48636365|NCT01342094|156526868|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48636366|NCT01342094|156526869|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
48636367|NCT01342094|156526868|FG000|Overall Study|Withdrawal by Subject|0|||
48636368|NCT01342094|156526869|FG001|Overall Study|Withdrawal by Subject|2|||
48746621|NCT00471328|156919827|FG000|Extension Phase|Withdrawal by Subject|0|||
48327451|NCT00392197|155396219|FG001|Overall Study|Lost to Follow-up|1|||
48327452|NCT00392197|155396218|FG000|Overall Study|Physician Decision|3|||
48327453|NCT00392197|155396219|FG001|Overall Study|Physician Decision|2|||
48327454|NCT00392197|155396218|FG000|Overall Study|Protocol Violation|7|||
48636369|NCT05899829|156526871|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
48636370|NCT05899829|156526872|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
48636371|NCT05899829|156526871|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
48746622|NCT00471328|156919828|FG001|Extension Phase|Withdrawal by Subject|2|||
48327455|NCT00392197|155396219|FG001|Overall Study|Protocol Violation|5|||
48746623|NCT00471328|156919827|FG000|Extension Phase|Death|1|||
48746624|NCT00471328|156919828|FG001|Extension Phase|Death|7|||
48746625|NCT00471328|156919827|FG000|Extension Phase|Protocol Deviation|3|||
48746626|NCT00471328|156919828|FG001|Extension Phase|Protocol Deviation|1|||
48636372|NCT05899829|156526872|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
48636373|NCT05076045|156526881|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
48636374|NCT05076045|156526882|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
48636375|NCT02268383|156526883|FG000|Overall Study|Death|12|||
48636376|NCT02268383|156526883|FG000|Overall Study|Lost to Follow-up|2|||
48636377|NCT02268383|156526883|FG000|Overall Study|Withdrawal by Subject|9|||
48636378|NCT02268383|156526883|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
48636379|NCT02268383|156526883|FG000|Overall Study|Protocol deviation|3|||
48636380|NCT02268383|156526883|FG000|Overall Study|Sponsor decision|22|||
48636381|NCT02268383|156526883|FG000|Overall Study|Not reported|12|||
48636382|NCT00714948|156526884|FG000|Overall Study|Adverse Event|2|||
48636383|NCT02891226|156526885|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
48586216|NCT00308750|156338929|FG002|Overall Study|Death|1|||
48586217|NCT00308750|156338927|FG000|Overall Study|Protocol Violation|1|||
48586218|NCT00308750|156338928|FG001|Overall Study|Protocol Violation|0|||
48636384|NCT02891226|156526886|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
48636385|NCT02891226|156526887|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
48636386|NCT02891226|156526888|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636387|NCT02891226|156526889|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636388|NCT02891226|156526890|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636389|NCT02891226|156526891|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636390|NCT02891226|156526892|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48586219|NCT00308750|156338929|FG002|Overall Study|Protocol Violation|0|||
48586220|NCT00308750|156338927|FG000|Overall Study|New Primary Disease Identified|1|||
48586221|NCT00308750|156338928|FG001|Overall Study|New Primary Disease Identified|1|||
48586222|NCT00308750|156338929|FG002|Overall Study|New Primary Disease Identified|0|||
48586223|NCT01358578|156338930|FG000|Induction Period|Adverse Event|2|||
48586224|NCT01358578|156338931|FG001|Induction Period|Adverse Event|4|||
48586225|NCT01358578|156338932|FG002|Induction Period|Adverse Event|2|||
48586226|NCT01358578|156338933|FG003|Induction Period|Adverse Event|6|||
48586227|NCT01358578|156338934|FG004|Induction Period|Adverse Event|0|||
48586228|NCT01358578|156338935|FG005|Induction Period|Adverse Event|0|||
48586229|NCT01358578|156338930|FG000|Induction Period|Lack of Efficacy|0|||
48746627|NCT00471328|156919827|FG000|Extension Phase|Treatment duration as per protocol|0|||
48746628|NCT00471328|156919828|FG001|Extension Phase|Treatment duration as per protocol|1|||
48746629|NCT00471328|156919827|FG000|Extension Phase|Disease Progression|32|||
48746630|NCT00471328|156919828|FG001|Extension Phase|Disease Progression|44|||
48746631|NCT00471328|156919827|FG000|Extension Phase|New cancer Therapy|1|||
48636391|NCT02891226|156526893|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636392|NCT02891226|156526894|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636393|NCT02891226|156526895|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636394|NCT02891226|156526896|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636395|NCT02891226|156526897|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636396|NCT02891226|156526898|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48746632|NCT00471328|156919828|FG001|Extension Phase|New cancer Therapy|0|||
48746633|NCT00471328|156919827|FG000|Extension Phase|Administrative Problem|1|||
48746634|NCT00471328|156919828|FG001|Extension Phase|Administrative Problem|0|||
48746635|NCT00844896|156919829|FG000|Overall Study|Lost to Follow-up|12|||
48746636|NCT00844896|156919830|FG001|Overall Study|Lost to Follow-up|16|||
48746637|NCT00844896|156919829|FG000|Overall Study|Parents did not have time to complete|0|||
48746638|NCT00844896|156919830|FG001|Overall Study|Parents did not have time to complete|1|||
48586230|NCT01358578|156338931|FG001|Induction Period|Lack of Efficacy|0|||
48797668|NCT01410474|157097040|FG001|Overall Study|Withdrawal by Subject|1|||
48797669|NCT02163733|157097041|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
48797670|NCT02163733|157097042|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
48586231|NCT01358578|156338932|FG002|Induction Period|Lack of Efficacy|9|||
48586232|NCT01358578|156338933|FG003|Induction Period|Lack of Efficacy|1|||
48636397|NCT02891226|156526899|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48636398|NCT02891226|156526900|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
48586233|NCT01358578|156338934|FG004|Induction Period|Lack of Efficacy|0|||
48586234|NCT01358578|156338935|FG005|Induction Period|Lack of Efficacy|0|||
48586235|NCT01358578|156338930|FG000|Induction Period|Lost to Follow-up|0|||
48586236|NCT01358578|156338931|FG001|Induction Period|Lost to Follow-up|0|||
48586237|NCT01358578|156338932|FG002|Induction Period|Lost to Follow-up|1|||
48636399|NCT02891226|156526885|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
48797671|NCT02163733|157097043|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
48797672|NCT02163733|157097041|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
48797673|NCT02163733|157097042|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
48797674|NCT02163733|157097043|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
48797675|NCT00828984|157097046|FG000|Overall Study|Adverse Event|2|||
48797676|NCT00828984|157097047|FG001|Overall Study|Adverse Event|3|||
48797677|NCT00828984|157097048|FG002|Overall Study|Adverse Event|0|||
48797678|NCT00828984|157097046|FG000|Overall Study|Lost to Follow-up|5|||
48797679|NCT00828984|157097047|FG001|Overall Study|Lost to Follow-up|3|||
48797680|NCT00828984|157097048|FG002|Overall Study|Lost to Follow-up|1|||
48586238|NCT01358578|156338933|FG003|Induction Period|Lost to Follow-up|4|||
48327456|NCT00392197|155396218|FG000|Overall Study|Withdrawal by Subject|4|||
48327457|NCT00392197|155396219|FG001|Overall Study|Withdrawal by Subject|6|||
48327458|NCT02432274|155396221|FG000|Overall Study|Death|2|||
48327459|NCT02432274|155396222|FG001|Overall Study|Death|6|||
48327460|NCT02432274|155396223|FG002|Overall Study|Death|7|||
48327461|NCT02432274|155396224|FG003|Overall Study|Death|0|||
48327462|NCT02432274|155396225|FG004|Overall Study|Death|27|||
48327463|NCT02432274|155396226|FG005|Overall Study|Death|7|||
48327464|NCT02432274|155396227|FG006|Overall Study|Death|9|||
48327465|NCT02432274|155396228|FG007|Overall Study|Death|14|||
48327466|NCT02432274|155396221|FG000|Overall Study|Withdrawal of Consent|0|||
48327467|NCT02432274|155396222|FG001|Overall Study|Withdrawal of Consent|0|||
48327468|NCT02432274|155396223|FG002|Overall Study|Withdrawal of Consent|0|||
48327469|NCT02432274|155396224|FG003|Overall Study|Withdrawal of Consent|0|||
48327470|NCT02432274|155396225|FG004|Overall Study|Withdrawal of Consent|2|||
48327471|NCT02432274|155396226|FG005|Overall Study|Withdrawal of Consent|0|||
48327472|NCT02432274|155396227|FG006|Overall Study|Withdrawal of Consent|1|||
48327473|NCT02432274|155396228|FG007|Overall Study|Withdrawal of Consent|2|||
48327474|NCT00960206|155396231|FG000|Overall Study|Death|7|||
48327475|NCT00960206|155396232|FG001|Overall Study|Death|4|||
48327476|NCT00960206|155396233|FG002|Overall Study|Death|1|||
48327477|NCT00960206|155396231|FG000|Overall Study|Unwilling/Unable to return|1|||
48327478|NCT00960206|155396232|FG001|Overall Study|Unwilling/Unable to return|2|||
48327479|NCT00960206|155396233|FG002|Overall Study|Unwilling/Unable to return|0|||
48327480|NCT00960206|155396231|FG000|Overall Study|Lost to Follow-up|8|||
48327481|NCT00960206|155396232|FG001|Overall Study|Lost to Follow-up|14|||
48327482|NCT00960206|155396233|FG002|Overall Study|Lost to Follow-up|8|||
48327483|NCT00960206|155396231|FG000|Overall Study|Withdrawal by Subject|2|||
48327484|NCT00960206|155396232|FG001|Overall Study|Withdrawal by Subject|4|||
48327485|NCT00960206|155396233|FG002|Overall Study|Withdrawal by Subject|0|||
48586239|NCT01358578|156338934|FG004|Induction Period|Lost to Follow-up|0|||
48327486|NCT00960206|155396231|FG000|Overall Study|Revision of study component|2|||
48327487|NCT00960206|155396232|FG001|Overall Study|Revision of study component|2|||
48327488|NCT00960206|155396233|FG002|Overall Study|Revision of study component|2|||
48327489|NCT00960206|155396231|FG000|Overall Study|Missing 10 year data|20|||
48327490|NCT00960206|155396232|FG001|Overall Study|Missing 10 year data|1|||
48327491|NCT00960206|155396233|FG002|Overall Study|Missing 10 year data|1|||
48327492|NCT02161146|155396234|FG000|Overall Study|Adverse Event|1|||
48327493|NCT02161146|155396235|FG001|Overall Study|Adverse Event|1|||
48327494|NCT02161146|155396236|FG002|Overall Study|Adverse Event|0|||
48586240|NCT01358578|156338935|FG005|Induction Period|Lost to Follow-up|0|||
48586241|NCT01358578|156338930|FG000|Induction Period|Physician Decision|2|||
48586242|NCT01358578|156338931|FG001|Induction Period|Physician Decision|1|||
48586243|NCT01358578|156338932|FG002|Induction Period|Physician Decision|2|||
48586244|NCT01358578|156338933|FG003|Induction Period|Physician Decision|0|||
48586245|NCT01358578|156338934|FG004|Induction Period|Physician Decision|0|||
48586246|NCT01358578|156338935|FG005|Induction Period|Physician Decision|0|||
48586247|NCT01358578|156338930|FG000|Induction Period|Protocol Deviation|3|||
48586248|NCT01358578|156338931|FG001|Induction Period|Protocol Deviation|5|||
48586249|NCT01358578|156338932|FG002|Induction Period|Protocol Deviation|0|||
48586250|NCT01358578|156338933|FG003|Induction Period|Protocol Deviation|3|||
48586251|NCT01358578|156338934|FG004|Induction Period|Protocol Deviation|0|||
48586252|NCT01358578|156338935|FG005|Induction Period|Protocol Deviation|0|||
48586253|NCT01358578|156338930|FG000|Induction Period|technical problems|0|||
48586254|NCT01358578|156338931|FG001|Induction Period|technical problems|0|||
48586255|NCT01358578|156338932|FG002|Induction Period|technical problems|1|||
48586256|NCT01358578|156338933|FG003|Induction Period|technical problems|1|||
48586257|NCT01358578|156338934|FG004|Induction Period|technical problems|0|||
48586258|NCT01358578|156338935|FG005|Induction Period|technical problems|0|||
48586259|NCT01358578|156338930|FG000|Induction Period|Withdrawal by Subject|5|||
48586260|NCT01358578|156338931|FG001|Induction Period|Withdrawal by Subject|5|||
48586261|NCT01358578|156338932|FG002|Induction Period|Withdrawal by Subject|10|||
48586262|NCT01358578|156338933|FG003|Induction Period|Withdrawal by Subject|6|||
48586263|NCT01358578|156338934|FG004|Induction Period|Withdrawal by Subject|0|||
48586264|NCT01358578|156338935|FG005|Induction Period|Withdrawal by Subject|0|||
48586265|NCT01358578|156338930|FG000|Maintenance Period|Adverse Event|2|||
48586266|NCT01358578|156338931|FG001|Maintenance Period|Adverse Event|7|||
48586267|NCT01358578|156338932|FG002|Maintenance Period|Adverse Event|0|||
48586268|NCT01358578|156338933|FG003|Maintenance Period|Adverse Event|6|||
48586269|NCT01358578|156338934|FG004|Maintenance Period|Adverse Event|4|||
48586270|NCT01358578|156338935|FG005|Maintenance Period|Adverse Event|3|||
48586271|NCT01358578|156338930|FG000|Maintenance Period|Lack of Efficacy|10|||
48586272|NCT01358578|156338931|FG001|Maintenance Period|Lack of Efficacy|2|||
48586273|NCT01358578|156338932|FG002|Maintenance Period|Lack of Efficacy|0|||
48586274|NCT01358578|156338933|FG003|Maintenance Period|Lack of Efficacy|11|||
48636400|NCT02891226|156526886|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
48636401|NCT02891226|156526887|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636402|NCT02891226|156526888|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636403|NCT02891226|156526889|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636404|NCT02891226|156526890|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636405|NCT02891226|156526891|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636406|NCT02891226|156526892|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636407|NCT02891226|156526893|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636408|NCT02891226|156526894|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636409|NCT02891226|156526895|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636410|NCT02891226|156526896|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636411|NCT02891226|156526897|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636412|NCT02891226|156526898|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636413|NCT02891226|156526899|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636414|NCT02891226|156526900|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48636415|NCT02891226|156526885|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48327495|NCT02161146|155396237|FG003|Overall Study|Adverse Event|1|||
48327496|NCT02161146|155396238|FG004|Overall Study|Adverse Event|0|||
48327497|NCT02161146|155396234|FG000|Overall Study|Lost to Follow-up|0|||
48327498|NCT02161146|155396235|FG001|Overall Study|Lost to Follow-up|1|||
48636416|NCT02891226|156526886|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48586275|NCT01358578|156338934|FG004|Maintenance Period|Lack of Efficacy|3|||
48586276|NCT01358578|156338935|FG005|Maintenance Period|Lack of Efficacy|0|||
48586277|NCT01358578|156338930|FG000|Maintenance Period|Lost to Follow-up|4|||
48586278|NCT01358578|156338931|FG001|Maintenance Period|Lost to Follow-up|0|||
48586279|NCT01358578|156338932|FG002|Maintenance Period|Lost to Follow-up|0|||
48586280|NCT01358578|156338933|FG003|Maintenance Period|Lost to Follow-up|5|||
48586281|NCT01358578|156338934|FG004|Maintenance Period|Lost to Follow-up|1|||
48586282|NCT01358578|156338935|FG005|Maintenance Period|Lost to Follow-up|1|||
48586283|NCT01358578|156338930|FG000|Maintenance Period|Non-compliance with study treatment|3|||
48586284|NCT01358578|156338931|FG001|Maintenance Period|Non-compliance with study treatment|1|||
48586285|NCT01358578|156338932|FG002|Maintenance Period|Non-compliance with study treatment|0|||
48586286|NCT01358578|156338933|FG003|Maintenance Period|Non-compliance with study treatment|2|||
48586287|NCT01358578|156338934|FG004|Maintenance Period|Non-compliance with study treatment|1|||
48586288|NCT01358578|156338935|FG005|Maintenance Period|Non-compliance with study treatment|2|||
48586289|NCT01358578|156338930|FG000|Maintenance Period|Physician Decision|0|||
48586290|NCT01358578|156338931|FG001|Maintenance Period|Physician Decision|1|||
48586291|NCT01358578|156338932|FG002|Maintenance Period|Physician Decision|0|||
48586292|NCT01358578|156338933|FG003|Maintenance Period|Physician Decision|1|||
48636417|NCT02891226|156526887|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636418|NCT02891226|156526888|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
48636419|NCT02891226|156526889|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636420|NCT02891226|156526890|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636421|NCT02891226|156526891|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636422|NCT02891226|156526892|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636423|NCT02891226|156526893|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636424|NCT02891226|156526894|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636425|NCT02891226|156526895|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48586293|NCT01358578|156338934|FG004|Maintenance Period|Physician Decision|0|||
48586294|NCT01358578|156338935|FG005|Maintenance Period|Physician Decision|0|||
48586295|NCT01358578|156338930|FG000|Maintenance Period|Pregnancy|1|||
48586296|NCT01358578|156338931|FG001|Maintenance Period|Pregnancy|0|||
48586297|NCT01358578|156338932|FG002|Maintenance Period|Pregnancy|0|||
48586298|NCT01358578|156338933|FG003|Maintenance Period|Pregnancy|0|||
48586299|NCT01358578|156338934|FG004|Maintenance Period|Pregnancy|0|||
48586300|NCT01358578|156338935|FG005|Maintenance Period|Pregnancy|0|||
48586301|NCT01358578|156338930|FG000|Maintenance Period|Protocol deviation|7|||
48586302|NCT01358578|156338931|FG001|Maintenance Period|Protocol deviation|4|||
48586303|NCT01358578|156338932|FG002|Maintenance Period|Protocol deviation|0|||
48327499|NCT02161146|155396236|FG002|Overall Study|Lost to Follow-up|0|||
48327500|NCT02161146|155396237|FG003|Overall Study|Lost to Follow-up|0|||
48636426|NCT02891226|156526896|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48586304|NCT01358578|156338933|FG003|Maintenance Period|Protocol deviation|2|||
48586305|NCT01358578|156338934|FG004|Maintenance Period|Protocol deviation|2|||
48636427|NCT02891226|156526897|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48586306|NCT01358578|156338935|FG005|Maintenance Period|Protocol deviation|2|||
48327501|NCT02161146|155396238|FG004|Overall Study|Lost to Follow-up|0|||
48327502|NCT02161146|155396234|FG000|Overall Study|Personal Reasons|0|||
48636428|NCT02891226|156526898|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636429|NCT02891226|156526899|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48636430|NCT02891226|156526900|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48327503|NCT02161146|155396235|FG001|Overall Study|Personal Reasons|1|||
48327504|NCT02161146|155396236|FG002|Overall Study|Personal Reasons|0|||
48327505|NCT02161146|155396237|FG003|Overall Study|Personal Reasons|2|||
48636431|NCT02891226|156526885|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636432|NCT02891226|156526886|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636433|NCT02891226|156526887|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
48636434|NCT02891226|156526888|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636435|NCT02891226|156526889|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636436|NCT02891226|156526890|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636437|NCT02891226|156526891|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636438|NCT02891226|156526892|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636439|NCT02891226|156526893|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636440|NCT02891226|156526894|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636441|NCT02891226|156526895|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636442|NCT02891226|156526896|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636443|NCT02891226|156526897|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636444|NCT02891226|156526898|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636445|NCT02891226|156526899|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636446|NCT02891226|156526900|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
48636447|NCT02891226|156526885|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636448|NCT02891226|156526886|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636449|NCT02891226|156526887|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636450|NCT02891226|156526888|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
48636451|NCT02891226|156526889|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636452|NCT02891226|156526890|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636453|NCT02891226|156526891|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636454|NCT02891226|156526892|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636455|NCT02891226|156526893|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636456|NCT02891226|156526894|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636457|NCT02891226|156526895|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636458|NCT02891226|156526896|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636459|NCT02891226|156526897|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636460|NCT02891226|156526898|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636461|NCT02891226|156526899|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636462|NCT02891226|156526900|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
48636463|NCT02891226|156526885|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636464|NCT02891226|156526886|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636465|NCT02891226|156526887|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636466|NCT02891226|156526888|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
48636467|NCT02891226|156526889|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636468|NCT02891226|156526890|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636469|NCT02891226|156526891|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636470|NCT02891226|156526892|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636471|NCT02891226|156526893|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636472|NCT02891226|156526894|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636473|NCT02891226|156526895|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636474|NCT02891226|156526896|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636475|NCT02891226|156526897|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636476|NCT02891226|156526898|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636477|NCT02891226|156526899|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636478|NCT02891226|156526900|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
48636479|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48327506|NCT02161146|155396238|FG004|Overall Study|Personal Reasons|1|||
48327507|NCT02161146|155396234|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48636480|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636481|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636482|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636483|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636484|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636485|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
48636486|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
48636487|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
48636488|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
48636489|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636490|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636491|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636492|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636493|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636494|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
48636495|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636496|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636497|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636498|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636499|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636500|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
48636501|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636502|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636503|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636504|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
48636505|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636506|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636507|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636508|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636509|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636510|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
48636511|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636512|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636513|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636514|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636515|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636516|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636517|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
48636518|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
48636519|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
48636520|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
48636521|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636522|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636523|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636524|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636525|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636526|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
48636527|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636528|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636529|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636530|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636531|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
48636532|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636533|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636534|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636535|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636536|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636537|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636538|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48586307|NCT01358578|156338930|FG000|Maintenance Period|Withdrawal by Subject|12|||
48586308|NCT01358578|156338931|FG001|Maintenance Period|Withdrawal by Subject|7|||
48586309|NCT01358578|156338932|FG002|Maintenance Period|Withdrawal by Subject|2|||
48746639|NCT01516437|156921063|FG000|Overall Study|Reason not specified|0|||
48746640|NCT01516437|156921064|FG001|Overall Study|Reason not specified|0|||
48746641|NCT01516437|156921065|FG002|Overall Study|Reason not specified|1|||
48746642|NCT01516437|156921066|FG003|Overall Study|Reason not specified|1|||
48746643|NCT00403234|156921067|FG000|Overall Study|Withdrawal by Subject|0|||
48586310|NCT01358578|156338933|FG003|Maintenance Period|Withdrawal by Subject|15|||
48586311|NCT01358578|156338934|FG004|Maintenance Period|Withdrawal by Subject|6|||
48586312|NCT01358578|156338935|FG005|Maintenance Period|Withdrawal by Subject|3|||
48586313|NCT01358578|156338930|FG000|Follow-up Period|Adverse Event|1|||
48586314|NCT01358578|156338931|FG001|Follow-up Period|Adverse Event|1|||
48586315|NCT01358578|156338932|FG002|Follow-up Period|Adverse Event|0|||
48586316|NCT01358578|156338933|FG003|Follow-up Period|Adverse Event|0|||
48586317|NCT01358578|156338934|FG004|Follow-up Period|Adverse Event|0|||
48586318|NCT01358578|156338935|FG005|Follow-up Period|Adverse Event|0|||
48586319|NCT01358578|156338930|FG000|Follow-up Period|Lack of Efficacy|3|||
48586320|NCT01358578|156338931|FG001|Follow-up Period|Lack of Efficacy|0|||
48586321|NCT01358578|156338932|FG002|Follow-up Period|Lack of Efficacy|4|||
48586322|NCT01358578|156338933|FG003|Follow-up Period|Lack of Efficacy|1|||
48586323|NCT01358578|156338934|FG004|Follow-up Period|Lack of Efficacy|0|||
48327508|NCT02161146|155396235|FG001|Overall Study|Other Miscellaneous Reasons|1|||
48327509|NCT02161146|155396236|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48327510|NCT02161146|155396237|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48327511|NCT02161146|155396238|FG004|Overall Study|Other Miscellaneous Reasons|0|||
48327512|NCT02063659|155396239|FG000|Double-Blind Treatment Period|Adverse Event|1|||
48327513|NCT02063659|155396240|FG001|Double-Blind Treatment Period|Adverse Event|2|||
48327514|NCT02063659|155396241|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48327515|NCT02063659|155396242|FG003|Double-Blind Treatment Period|Adverse Event|0|||
48327516|NCT02063659|155396239|FG000|Double-Blind Treatment Period|Physician Decision|1|||
48327517|NCT02063659|155396240|FG001|Double-Blind Treatment Period|Physician Decision|0|||
48327518|NCT02063659|155396241|FG002|Double-Blind Treatment Period|Physician Decision|0|||
48327519|NCT02063659|155396242|FG003|Double-Blind Treatment Period|Physician Decision|0|||
48327520|NCT02063659|155396239|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
48327521|NCT02063659|155396240|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
48327522|NCT02063659|155396241|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
48327523|NCT02063659|155396242|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
48327524|NCT02063659|155396239|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
48327525|NCT02063659|155396240|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
48327526|NCT02063659|155396241|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
48327527|NCT02063659|155396242|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
48327528|NCT02063659|155396239|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48327529|NCT02063659|155396240|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48327530|NCT02063659|155396241|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
48327531|NCT02063659|155396242|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
48327532|NCT02063659|155396239|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48327533|NCT02063659|155396240|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48327534|NCT02063659|155396241|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
48586324|NCT01358578|156338935|FG005|Follow-up Period|Lack of Efficacy|0|||
48636539|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636540|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636541|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636542|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
48636543|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636544|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636545|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636546|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636547|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636548|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636549|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
48636550|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636551|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636552|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636553|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48586325|NCT01358578|156338930|FG000|Follow-up Period|Lost to Follow-up|0|||
48636554|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48586326|NCT01358578|156338931|FG001|Follow-up Period|Lost to Follow-up|1|||
48586327|NCT01358578|156338932|FG002|Follow-up Period|Lost to Follow-up|0|||
48327535|NCT02063659|155396242|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
48636555|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636556|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636557|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48327536|NCT02063659|155396239|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
48636558|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
48636559|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636560|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636561|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636562|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636563|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636564|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636565|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636566|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
48636567|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
48636568|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
48636569|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636570|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636571|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636572|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636573|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636574|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
48636575|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636576|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636577|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636578|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636579|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636580|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636581|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636582|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
48636583|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636584|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636585|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636586|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636587|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636588|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636589|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636590|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
48636591|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636592|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636593|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636594|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636595|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636596|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636597|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636598|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636599|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
48636600|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636601|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636602|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636603|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636604|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636605|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636606|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
48636607|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636608|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636609|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636610|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636611|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636612|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636613|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636614|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636615|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636616|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
48636617|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636618|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636619|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636620|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48746644|NCT00403234|156921068|FG001|Overall Study|Withdrawal by Subject|1|||
48636621|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636622|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
48636623|NCT02891226|156526885|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636624|NCT02891226|156526886|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636625|NCT02891226|156526887|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636626|NCT02891226|156526888|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636627|NCT02891226|156526889|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636628|NCT02891226|156526890|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636629|NCT02891226|156526891|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636630|NCT02891226|156526892|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636631|NCT02891226|156526893|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636632|NCT02891226|156526894|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
48636633|NCT02891226|156526895|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636634|NCT02891226|156526896|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636635|NCT02891226|156526897|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636636|NCT02891226|156526898|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636637|NCT02891226|156526899|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636638|NCT02891226|156526900|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
48636639|NCT02891226|156526885|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636640|NCT02891226|156526886|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636641|NCT02891226|156526887|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48746645|NCT00403234|156921069|FG002|Overall Study|Withdrawal by Subject|0|||
48746646|NCT00403234|156921070|FG003|Overall Study|Withdrawal by Subject|0|||
48746647|NCT00403234|156921067|FG000|Overall Study|Adverse Event|1|||
48746648|NCT00403234|156921068|FG001|Overall Study|Adverse Event|0|||
48746649|NCT00403234|156921069|FG002|Overall Study|Adverse Event|1|||
48746650|NCT00403234|156921070|FG003|Overall Study|Adverse Event|0|||
48746651|NCT00982137|156921071|FG000|Overall Study|Lost to Follow-up|0|||
48746652|NCT00982137|156921072|FG001|Overall Study|Lost to Follow-up|0|||
48746653|NCT00982137|156921073|FG002|Overall Study|Lost to Follow-up|0|||
48746654|NCT00982137|156921074|FG003|Overall Study|Lost to Follow-up|1|||
48746655|NCT00982137|156921071|FG000|Overall Study|Withdrawal by Subject|0|||
48746656|NCT00982137|156921072|FG001|Overall Study|Withdrawal by Subject|1|||
48746657|NCT00982137|156921073|FG002|Overall Study|Withdrawal by Subject|0|||
48746658|NCT00982137|156921074|FG003|Overall Study|Withdrawal by Subject|0|||
48746659|NCT02871297|156921080|FG000|Overall Study|Adverse Event|34|||
48746660|NCT02871297|156921080|FG000|Overall Study|Lack of Efficacy|10|||
48746661|NCT02871297|156921080|FG000|Overall Study|Non-compliance with study drug|15|||
48746662|NCT02871297|156921080|FG000|Overall Study|Protocol Violation|3|||
48746663|NCT02871297|156921080|FG000|Overall Study|Withdrawal by Subject|20|||
48746664|NCT02871297|156921080|FG000|Overall Study|Lost to Follow-up|13|||
48636642|NCT02891226|156526888|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636643|NCT02891226|156526889|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48746665|NCT02871297|156921080|FG000|Overall Study|Rolled over to 13546A|2|||
48746666|NCT02871297|156921080|FG000|Overall Study|Other than specified|39|||
48746667|NCT00541931|156921081|FG000|Overall Study|Adverse Event|1|||
48746668|NCT00541931|156921082|FG001|Overall Study|Adverse Event|0|||
48746669|NCT00541931|156921081|FG000|Overall Study|Lost to Follow-up|3|||
48746670|NCT00541931|156921082|FG001|Overall Study|Lost to Follow-up|3|||
48746671|NCT00541931|156921081|FG000|Overall Study|Withdrawal by Subject|1|||
48746672|NCT00541931|156921082|FG001|Overall Study|Withdrawal by Subject|0|||
48746673|NCT00541931|156921081|FG000|Overall Study|Transportation Issue|0|||
48746674|NCT00541931|156921082|FG001|Overall Study|Transportation Issue|1|||
48746675|NCT02161731|156921083|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
48746676|NCT02161731|156921084|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
48746677|NCT02161731|156921083|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
48746678|NCT02161731|156921084|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
48746679|NCT03633695|156921088|FG000|Overall Study|Lost to Follow-up|4|||
48746680|NCT03633695|156921089|FG001|Overall Study|Lost to Follow-up|5|||
48746681|NCT03633695|156921088|FG000|Overall Study|Discontinued|8|||
48746682|NCT03633695|156921089|FG001|Overall Study|Discontinued|4|||
48746683|NCT00160693|156921092|FG000|Overall Study|Adverse Event|97|||
48746684|NCT00160693|156921092|FG000|Overall Study|Lack of Efficacy|30|||
48746685|NCT00160693|156921092|FG000|Overall Study|Protocol Violation|24|||
48746686|NCT00160693|156921092|FG000|Overall Study|Lost to Follow-up|15|||
48746687|NCT00160693|156921092|FG000|Overall Study|Withdrawal by Subject|54|||
48746688|NCT00160693|156921092|FG000|Overall Study|Study terminated by sponsor|15|||
48327537|NCT02063659|155396240|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
48327538|NCT02063659|155396241|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
48636644|NCT02891226|156526890|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636645|NCT02891226|156526891|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48746689|NCT03052725|156921094|FG000|Overall Study|Adverse Event|2|||
48746690|NCT03052725|156921095|FG001|Overall Study|Adverse Event|0|||
48746691|NCT03052725|156921094|FG000|Overall Study|Withdrawal by Subject|3|||
48746692|NCT03052725|156921095|FG001|Overall Study|Withdrawal by Subject|4|||
48746693|NCT03052725|156921094|FG000|Overall Study|Pregnancy|0|||
48746694|NCT03052725|156921095|FG001|Overall Study|Pregnancy|1|||
48746695|NCT03052725|156921094|FG000|Overall Study|Site closure|0|||
48746696|NCT03052725|156921095|FG001|Overall Study|Site closure|1|||
48426797|NCT04760314|155752866|FG007|Induction Period|Adverse Event|0|||
48636646|NCT02891226|156526892|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636647|NCT02891226|156526893|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636648|NCT02891226|156526894|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636649|NCT02891226|156526895|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
48636650|NCT02891226|156526896|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636651|NCT02891226|156526897|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636652|NCT02891226|156526898|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48746697|NCT03052725|156921094|FG000|Overall Study|Study terminated by sponsor|143|||
48746698|NCT03052725|156921095|FG001|Overall Study|Study terminated by sponsor|144|||
48746699|NCT01867424|156921096|FG000|Overall Study|Patient noncompliance|2|||
48746700|NCT01867424|156921097|FG001|Overall Study|Patient noncompliance|1|||
48636653|NCT02891226|156526899|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636654|NCT02891226|156526900|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
48636655|NCT02891226|156526885|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636656|NCT02891226|156526886|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636657|NCT02891226|156526887|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636658|NCT02891226|156526888|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636659|NCT02891226|156526889|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636660|NCT02891226|156526890|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636661|NCT02891226|156526891|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636662|NCT02891226|156526892|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636663|NCT02891226|156526893|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48327539|NCT02063659|155396242|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
48327540|NCT02063659|155396239|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48327541|NCT02063659|155396240|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48327542|NCT02063659|155396241|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
48327543|NCT02063659|155396242|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
48327544|NCT01532999|155396243|FG000|Overall Study|Lost to Follow-up|14|||
48327545|NCT01532999|155396244|FG001|Overall Study|Lost to Follow-up|8|||
48327546|NCT01532999|155396243|FG000|Overall Study|Physician Decision|1|||
48327547|NCT01532999|155396244|FG001|Overall Study|Physician Decision|2|||
48327548|NCT01532999|155396243|FG000|Overall Study|Withdrawal by Subject|5|||
48327549|NCT01532999|155396244|FG001|Overall Study|Withdrawal by Subject|0|||
48327550|NCT01532999|155396243|FG000|Overall Study|Relocated|2|||
48327551|NCT01532999|155396244|FG001|Overall Study|Relocated|0|||
48327552|NCT01532999|155396243|FG000|Overall Study|should not have been randomized|1|||
48327553|NCT01532999|155396244|FG001|Overall Study|should not have been randomized|0|||
48327554|NCT01532999|155396243|FG000|Overall Study|substantial noncompliance|2|||
48327555|NCT01532999|155396244|FG001|Overall Study|substantial noncompliance|0|||
48327556|NCT01532999|155396243|FG000|Overall Study|no show for week 9 assessments|6|||
48327557|NCT01532999|155396244|FG001|Overall Study|no show for week 9 assessments|4|||
48636664|NCT02891226|156526894|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636665|NCT02891226|156526895|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
48636666|NCT02891226|156526896|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636667|NCT02891226|156526897|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636668|NCT02891226|156526898|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636669|NCT02891226|156526899|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636670|NCT02891226|156526900|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
48636671|NCT02891226|156526885|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636672|NCT02891226|156526886|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636673|NCT02891226|156526887|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636674|NCT02891226|156526888|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636675|NCT02891226|156526889|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636676|NCT02891226|156526890|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636677|NCT02891226|156526891|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636678|NCT02891226|156526892|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636679|NCT02891226|156526893|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636680|NCT02891226|156526894|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636681|NCT02891226|156526895|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
48636682|NCT02891226|156526896|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636683|NCT02891226|156526897|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636684|NCT02891226|156526898|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636685|NCT02891226|156526899|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48327558|NCT01532999|155396243|FG000|Overall Study|Adverse Event|0|||
48327559|NCT01532999|155396244|FG001|Overall Study|Adverse Event|1|||
48327560|NCT01532999|155396243|FG000|Overall Study|incarcerated|0|||
48327561|NCT01532999|155396244|FG001|Overall Study|incarcerated|1|||
48636686|NCT02891226|156526900|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
48636687|NCT02891226|156526885|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636688|NCT02891226|156526886|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636689|NCT02891226|156526887|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636690|NCT02891226|156526888|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636691|NCT02891226|156526889|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636692|NCT02891226|156526890|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636693|NCT02891226|156526891|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636694|NCT02891226|156526892|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636695|NCT02891226|156526893|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636696|NCT02891226|156526894|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636697|NCT02891226|156526895|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
48636698|NCT02891226|156526896|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48327562|NCT01532999|155396243|FG000|Overall Study|New job|0|||
48327563|NCT01532999|155396244|FG001|Overall Study|New job|2|||
48327564|NCT02470806|155396245|FG000|Overall Study|Lost to Follow-up|1|||
48327565|NCT02470806|155396246|FG001|Overall Study|Lost to Follow-up|1|||
48327566|NCT02470806|155396245|FG000|Overall Study|Adverse Event|5|||
48327567|NCT02470806|155396246|FG001|Overall Study|Adverse Event|2|||
48327568|NCT02470806|155396245|FG000|Overall Study|Protocol Violation|4|||
48327569|NCT02470806|155396246|FG001|Overall Study|Protocol Violation|11|||
48327570|NCT02470806|155396245|FG000|Overall Study|Physician Decision|0|||
48327571|NCT02470806|155396246|FG001|Overall Study|Physician Decision|3|||
48327572|NCT02470806|155396245|FG000|Overall Study|Withdrawal by Subject|3|||
48327573|NCT02470806|155396246|FG001|Overall Study|Withdrawal by Subject|10|||
48327574|NCT02470806|155396245|FG000|Overall Study|Lack of Efficacy|5|||
48327575|NCT02470806|155396246|FG001|Overall Study|Lack of Efficacy|15|||
48327576|NCT02659540|155396249|FG000|Overall Study|Adverse Event|3|||
48327577|NCT02659540|155396250|FG001|Overall Study|Adverse Event|2|||
48327578|NCT02659540|155396249|FG000|Overall Study|Death|1|||
48327579|NCT02659540|155396250|FG001|Overall Study|Death|0|||
48327580|NCT02659540|155396249|FG000|Overall Study|Progressive disease|2|||
48327581|NCT02659540|155396250|FG001|Overall Study|Progressive disease|6|||
48327582|NCT01529632|155396254|FG000|Overall Study|Administrative problem|2|||
48327583|NCT01529632|155396255|FG001|Overall Study|Administrative problem|1|||
48327584|NCT01529632|155396254|FG000|Overall Study|Protocol Violation|0|||
48327585|NCT01529632|155396255|FG001|Overall Study|Protocol Violation|1|||
48327586|NCT01529632|155396254|FG000|Overall Study|Adverse Event|1|||
48327587|NCT01529632|155396255|FG001|Overall Study|Adverse Event|1|||
48327588|NCT02386098|155398078|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
48327589|NCT02386098|155398079|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
48327590|NCT02386098|155398080|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
48327591|NCT02386098|155398081|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
48327592|NCT02386098|155398082|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
48327593|NCT02386098|155398078|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
48327594|NCT02386098|155398079|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
48327595|NCT02386098|155398080|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
48327596|NCT02386098|155398081|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
48327597|NCT02386098|155398082|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
48327598|NCT02386098|155398078|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
48327599|NCT02386098|155398079|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
48327600|NCT02386098|155398080|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
48327601|NCT02386098|155398081|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
48327602|NCT02386098|155398082|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
48327603|NCT02386098|155398078|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
48327604|NCT02386098|155398079|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
48327605|NCT02386098|155398080|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
48327606|NCT02386098|155398081|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
48327607|NCT02386098|155398082|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
48327608|NCT02386098|155398078|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
48327609|NCT02386098|155398079|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
48327610|NCT02386098|155398080|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
48327611|NCT02386098|155398081|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
48636699|NCT02891226|156526897|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636700|NCT02891226|156526898|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636701|NCT02891226|156526899|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636702|NCT02891226|156526900|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
48636703|NCT02891226|156526885|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48327612|NCT02386098|155398082|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
48327613|NCT02386098|155398078|FG000|Stage 1 (96 Weeks)|Other|1|||
48327614|NCT02386098|155398079|FG001|Stage 1 (96 Weeks)|Other|0|||
48327615|NCT02386098|155398080|FG002|Stage 1 (96 Weeks)|Other|0|||
48327616|NCT02386098|155398081|FG003|Stage 1 (96 Weeks)|Other|0|||
48327617|NCT02386098|155398082|FG004|Stage 1 (96 Weeks)|Other|0|||
48327618|NCT02386098|155398078|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
48327619|NCT02386098|155398079|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
48636704|NCT02891226|156526886|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48426798|NCT04760314|155752867|FG008|Induction Period|Adverse Event|0|||
48327620|NCT02386098|155398080|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
48327621|NCT02386098|155398081|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
48327622|NCT02386098|155398082|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
48327623|NCT03861052|155398083|FG000|Overall Study|Adverse Event|1|||
48327624|NCT03861052|155398084|FG001|Overall Study|Adverse Event|1|||
48327625|NCT03861052|155398085|FG002|Overall Study|Adverse Event|2|||
48327626|NCT03861052|155398086|FG003|Overall Study|Adverse Event|4|||
48327627|NCT03861052|155398083|FG000|Overall Study|Lost to Follow-up|0|||
48327628|NCT03861052|155398084|FG001|Overall Study|Lost to Follow-up|0|||
48327629|NCT03861052|155398085|FG002|Overall Study|Lost to Follow-up|0|||
48327630|NCT03861052|155398086|FG003|Overall Study|Lost to Follow-up|1|||
48327631|NCT03861052|155398083|FG000|Overall Study|Physician Decision|0|||
48327632|NCT03861052|155398084|FG001|Overall Study|Physician Decision|1|||
48327633|NCT03861052|155398085|FG002|Overall Study|Physician Decision|0|||
48327634|NCT03861052|155398086|FG003|Overall Study|Physician Decision|0|||
48327635|NCT03861052|155398083|FG000|Overall Study|Withdrawal by Subject|2|||
48327636|NCT03861052|155398084|FG001|Overall Study|Withdrawal by Subject|5|||
48327637|NCT03861052|155398085|FG002|Overall Study|Withdrawal by Subject|3|||
48327638|NCT03861052|155398086|FG003|Overall Study|Withdrawal by Subject|0|||
48327639|NCT03861052|155398083|FG000|Overall Study|Relocation to other city|1|||
48327640|NCT03861052|155398084|FG001|Overall Study|Relocation to other city|0|||
48327641|NCT03861052|155398085|FG002|Overall Study|Relocation to other city|0|||
48327642|NCT03861052|155398086|FG003|Overall Study|Relocation to other city|0|||
48327643|NCT00220805|155398087|FG000|Overall Study|Adverse Event|1|||
48327644|NCT00220805|155398088|FG001|Overall Study|Adverse Event|3|||
48327645|NCT00220805|155398087|FG000|Overall Study|Withdrawal by Subject|3|||
48327646|NCT00220805|155398088|FG001|Overall Study|Withdrawal by Subject|0|||
48327647|NCT00220805|155398087|FG000|Overall Study|Lack of Efficacy|1|||
48327648|NCT00220805|155398088|FG001|Overall Study|Lack of Efficacy|0|||
48327649|NCT00220805|155398087|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
48327650|NCT00220805|155398088|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
48327651|NCT03136159|155398091|FG000|Overall Study|chorioamnionitis|2|||
48327652|NCT03136159|155398092|FG001|Overall Study|chorioamnionitis|0|||
48327653|NCT03136159|155398091|FG000|Overall Study|vertical skin incision|1|||
48636705|NCT02891226|156526887|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636706|NCT02891226|156526888|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636707|NCT02891226|156526889|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636708|NCT02891226|156526890|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636709|NCT02891226|156526891|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636710|NCT02891226|156526892|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636711|NCT02891226|156526893|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636712|NCT02891226|156526894|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636713|NCT02891226|156526895|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
48636714|NCT02891226|156526896|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636715|NCT02891226|156526897|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636716|NCT02891226|156526898|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636717|NCT02891226|156526899|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636718|NCT02891226|156526900|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
48636719|NCT02891226|156526885|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636720|NCT02891226|156526886|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636721|NCT02891226|156526887|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636722|NCT02891226|156526888|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636723|NCT02891226|156526889|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636724|NCT02891226|156526890|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636725|NCT02891226|156526891|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636726|NCT02891226|156526892|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636727|NCT02891226|156526893|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636728|NCT02891226|156526894|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636729|NCT02891226|156526895|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
48636730|NCT02891226|156526896|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636731|NCT02891226|156526897|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636732|NCT02891226|156526898|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636733|NCT02891226|156526899|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636734|NCT02891226|156526900|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
48636735|NCT02891226|156526885|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636736|NCT02891226|156526886|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48327654|NCT03136159|155398092|FG001|Overall Study|vertical skin incision|0|||
48746701|NCT02794883|156921098|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
48746702|NCT02794883|156921099|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
48746703|NCT02794883|156921100|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
48746704|NCT02794883|156921098|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
48746705|NCT02794883|156921099|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
48746706|NCT02794883|156921100|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
48746707|NCT02794883|156921098|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
48746708|NCT02794883|156921099|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
48746709|NCT02794883|156921100|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
48746710|NCT02794883|156921098|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
48746711|NCT02794883|156921099|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
48746712|NCT02794883|156921100|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
48746713|NCT02794883|156921098|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
48746714|NCT02794883|156921099|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
48746715|NCT02794883|156921100|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
48746716|NCT02794883|156921098|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
48746717|NCT02794883|156921099|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
48746718|NCT02794883|156921100|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
48746719|NCT02794883|156921098|FG000|Follow-up Period (up to 2 Years)|Death|12|||
48746720|NCT02794883|156921099|FG001|Follow-up Period (up to 2 Years)|Death|10|||
48327655|NCT03136159|155398091|FG000|Overall Study|additional dressing|1|||
48327656|NCT03136159|155398092|FG001|Overall Study|additional dressing|0|||
48327657|NCT03136159|155398091|FG000|Overall Study|never got dressing placed|1|||
48327658|NCT03136159|155398092|FG001|Overall Study|never got dressing placed|0|||
48327659|NCT00799409|155398093|FG000|Overall Study|Withdrawal by Subject|1|||
48327660|NCT00799409|155398094|FG001|Overall Study|Withdrawal by Subject|0|||
48327661|NCT00799409|155398095|FG002|Overall Study|Withdrawal by Subject|0|||
48327662|NCT00799409|155398093|FG000|Overall Study|Lost to Follow-up|1|||
48327663|NCT00799409|155398094|FG001|Overall Study|Lost to Follow-up|0|||
48746721|NCT02794883|156921100|FG002|Follow-up Period (up to 2 Years)|Death|10|||
48746722|NCT01751178|156921102|FG000|Overall Study|Adverse Event|2|||
48746723|NCT01751178|156921103|FG001|Overall Study|Adverse Event|0|||
48746724|NCT01751178|156921104|FG002|Overall Study|Adverse Event|0|||
48746725|NCT01751178|156921102|FG000|Overall Study|Other Reason (unknown)|1|||
48746726|NCT01751178|156921103|FG001|Overall Study|Other Reason (unknown)|0|||
48746727|NCT01751178|156921104|FG002|Overall Study|Other Reason (unknown)|2|||
48746728|NCT02864498|156921105|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
48746729|NCT02864498|156921106|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
48746730|NCT02864498|156921107|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
48746731|NCT02864498|156921105|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
48746732|NCT02864498|156921106|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
48746733|NCT02864498|156921107|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
48746734|NCT02864498|156921105|FG000|Overall Study|Investigator Discretion|0|||
48746735|NCT02864498|156921106|FG001|Overall Study|Investigator Discretion|2|||
48746736|NCT02864498|156921107|FG002|Overall Study|Investigator Discretion|1|||
48746737|NCT02864498|156921105|FG000|Overall Study|Lost to Follow-up|8|||
48746738|NCT02864498|156921106|FG001|Overall Study|Lost to Follow-up|6|||
48746739|NCT02864498|156921107|FG002|Overall Study|Lost to Follow-up|3|||
48746740|NCT02864498|156921105|FG000|Overall Study|Lack of Efficacy|5|||
48746741|NCT02864498|156921106|FG001|Overall Study|Lack of Efficacy|3|||
48746742|NCT02864498|156921107|FG002|Overall Study|Lack of Efficacy|3|||
48746743|NCT02864498|156921105|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
48746744|NCT02864498|156921106|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
48746745|NCT02864498|156921107|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
48746746|NCT02864498|156921105|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
48746747|NCT02864498|156921106|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
48746748|NCT02864498|156921107|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
48746749|NCT02864498|156921105|FG000|Overall Study|Subject moved out of the country.|0|||
48746750|NCT02864498|156921106|FG001|Overall Study|Subject moved out of the country.|0|||
48746751|NCT02864498|156921107|FG002|Overall Study|Subject moved out of the country.|1|||
48746752|NCT01256008|156921108|FG000|Overall Study|Lost to Follow-up|6|||
48746753|NCT01256008|156921109|FG001|Overall Study|Lost to Follow-up|4|||
48746754|NCT01256008|156921110|FG002|Overall Study|Lost to Follow-up|11|||
48746755|NCT01256008|156921108|FG000|Overall Study|Withdrawal by Subject|2|||
48746756|NCT01256008|156921109|FG001|Overall Study|Withdrawal by Subject|3|||
48746757|NCT01256008|156921110|FG002|Overall Study|Withdrawal by Subject|10|||
48746758|NCT04189081|156921111|FG000|Overall Study|Lost to Follow-up|1|||
48746759|NCT04189081|156921112|FG001|Overall Study|Lost to Follow-up|0|||
48327664|NCT00799409|155398095|FG002|Overall Study|Lost to Follow-up|0|||
48327665|NCT00799409|155398093|FG000|Overall Study|Optimal Dose Not Achieved|2|||
48327666|NCT00799409|155398094|FG001|Overall Study|Optimal Dose Not Achieved|0|||
48327667|NCT00799409|155398095|FG002|Overall Study|Optimal Dose Not Achieved|0|||
48327668|NCT00799409|155398093|FG000|Overall Study|Failure to follow study protocol)|1|||
48327669|NCT00799409|155398094|FG001|Overall Study|Failure to follow study protocol)|0|||
48327670|NCT00799409|155398095|FG002|Overall Study|Failure to follow study protocol)|0|||
48327671|NCT00799409|155398093|FG000|Overall Study|Did not attend lab school day 1|1|||
48327672|NCT00799409|155398094|FG001|Overall Study|Did not attend lab school day 1|0|||
48327673|NCT00799409|155398095|FG002|Overall Study|Did not attend lab school day 1|0|||
48327674|NCT00799409|155398093|FG000|Overall Study|medication compliance|1|||
48327675|NCT00799409|155398094|FG001|Overall Study|medication compliance|0|||
48327676|NCT00799409|155398095|FG002|Overall Study|medication compliance|0|||
48327677|NCT03964974|155398096|FG000|Overall Study|Lost to Follow-up|3|||
48327678|NCT03964974|155398097|FG001|Overall Study|Lost to Follow-up|2|||
48327679|NCT03964974|155398096|FG000|Overall Study|Withdrawal by Subject|0|||
48327680|NCT03964974|155398097|FG001|Overall Study|Withdrawal by Subject|3|||
48327681|NCT00747006|155398103|FG000|Overall Study|Adverse Event|1|||
48327682|NCT00747006|155398104|FG001|Overall Study|Adverse Event|0|||
48327683|NCT00747006|155398105|FG002|Overall Study|Adverse Event|0|||
48327684|NCT00747006|155398103|FG000|Overall Study|Lost to Follow-up|0|||
48327685|NCT00747006|155398104|FG001|Overall Study|Lost to Follow-up|1|||
48327686|NCT00747006|155398105|FG002|Overall Study|Lost to Follow-up|0|||
48327687|NCT00747006|155398103|FG000|Overall Study|Physician Decision|2|||
48327688|NCT00747006|155398104|FG001|Overall Study|Physician Decision|0|||
48327689|NCT00747006|155398105|FG002|Overall Study|Physician Decision|1|||
48327690|NCT00745875|155398110|FG000|Overall Study|Continuing study treatment|4|||
48327691|NCT00745875|155398111|FG001|Overall Study|Continuing study treatment|4|||
48327692|NCT01128595|155398114|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48327693|NCT01128595|155398115|FG001|Treatment Period 3|Withdrawal by Subject|1|||
48327694|NCT01128595|155398116|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48327695|NCT01128595|155398117|FG003|Treatment Period 3|Withdrawal by Subject|0|||
48636737|NCT02891226|156526887|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48327696|NCT00605306|155398118|FG000|Overall Study|Adverse Event|0|||
48327697|NCT00605306|155398119|FG001|Overall Study|Adverse Event|1|||
48636738|NCT02891226|156526888|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636739|NCT02891226|156526889|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636740|NCT02891226|156526890|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636741|NCT02891226|156526891|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636742|NCT02891226|156526892|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636743|NCT02891226|156526893|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636744|NCT02891226|156526894|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636745|NCT02891226|156526895|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
48636746|NCT02891226|156526896|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636747|NCT02891226|156526897|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636748|NCT02891226|156526898|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636749|NCT02891226|156526899|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636750|NCT02891226|156526900|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
48636751|NCT02891226|156526885|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636752|NCT02891226|156526886|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636753|NCT02891226|156526887|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636754|NCT02891226|156526888|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636755|NCT02891226|156526889|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636756|NCT02891226|156526890|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636757|NCT02891226|156526891|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636758|NCT02891226|156526892|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636759|NCT02891226|156526893|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636760|NCT02891226|156526894|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636761|NCT02891226|156526895|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
48636762|NCT02891226|156526896|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636763|NCT02891226|156526897|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636764|NCT02891226|156526898|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636765|NCT02891226|156526899|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636766|NCT02891226|156526900|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
48636767|NCT02891226|156526885|FG000|Follow-up Period|Withdrawal by Subject|0|||
48636768|NCT02891226|156526886|FG001|Follow-up Period|Withdrawal by Subject|0|||
48636769|NCT02891226|156526887|FG002|Follow-up Period|Withdrawal by Subject|0|||
48327698|NCT01641900|155398122|FG000|Overall Study|Withdrawal by Subject|2|||
48636770|NCT02891226|156526888|FG003|Follow-up Period|Withdrawal by Subject|0|||
48636771|NCT02891226|156526889|FG004|Follow-up Period|Withdrawal by Subject|0|||
48636772|NCT02891226|156526890|FG005|Follow-up Period|Withdrawal by Subject|0|||
48636773|NCT02891226|156526891|FG006|Follow-up Period|Withdrawal by Subject|0|||
48636774|NCT02891226|156526892|FG007|Follow-up Period|Withdrawal by Subject|0|||
48636775|NCT02891226|156526893|FG008|Follow-up Period|Withdrawal by Subject|0|||
48636776|NCT02891226|156526894|FG009|Follow-up Period|Withdrawal by Subject|0|||
48636777|NCT02891226|156526895|FG010|Follow-up Period|Withdrawal by Subject|0|||
48636778|NCT02891226|156526896|FG011|Follow-up Period|Withdrawal by Subject|1|||
48636779|NCT02891226|156526897|FG012|Follow-up Period|Withdrawal by Subject|0|||
48636780|NCT02891226|156526898|FG013|Follow-up Period|Withdrawal by Subject|0|||
48746760|NCT04189081|156921113|FG002|Overall Study|Lost to Follow-up|0|||
48746761|NCT04189081|156921111|FG000|Overall Study|Withdrawal by Subject|0|||
48746762|NCT04189081|156921112|FG001|Overall Study|Withdrawal by Subject|0|||
48746763|NCT04189081|156921113|FG002|Overall Study|Withdrawal by Subject|1|||
48746764|NCT02706691|156921117|FG000|Overall Study|Adverse Event|1|||
48746765|NCT03033394|156921118|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
48746766|NCT03033394|156921118|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
48746767|NCT03033394|156921118|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
48746768|NCT03033394|156921118|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
48746769|NCT03033394|156921118|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
48746770|NCT01619423|156921119|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
48746771|NCT01619423|156921120|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
48746772|NCT01619423|156921121|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
48746773|NCT01619423|156921122|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
48746774|NCT00814164|156921124|FG000|Overall Study|Progression|7|||
48746775|NCT00814164|156921124|FG000|Overall Study|not stated|7|||
48746776|NCT00814164|156921124|FG000|Overall Study|Death|5|||
48746777|NCT00851747|156921126|FG000|Overall Study|Physician Decision|6|||
48746778|NCT00851747|156921127|FG001|Overall Study|Physician Decision|6|||
48746779|NCT00851747|156921128|FG002|Overall Study|Physician Decision|6|||
48746780|NCT02321800|156921129|FG000|Overall Study|Withdrawal by Subject|3|||
48746781|NCT02321800|156921130|FG001|Overall Study|Withdrawal by Subject|3|||
48746782|NCT02321800|156921129|FG000|Overall Study|Death|1|||
48746783|NCT02321800|156921130|FG001|Overall Study|Death|0|||
48746784|NCT02321800|156921129|FG000|Overall Study|Protocol Violation|1|||
48636781|NCT02891226|156526899|FG014|Follow-up Period|Withdrawal by Subject|1|||
48636782|NCT02891226|156526900|FG015|Follow-up Period|Withdrawal by Subject|1|||
48746785|NCT02321800|156921130|FG001|Overall Study|Protocol Violation|0|||
48746786|NCT02321800|156921129|FG000|Overall Study|Lost to Follow-up|10|||
48746787|NCT02321800|156921130|FG001|Overall Study|Lost to Follow-up|4|||
48746788|NCT02321800|156921129|FG000|Overall Study|Adverse Event|2|||
48746789|NCT02321800|156921130|FG001|Overall Study|Adverse Event|3|||
48746790|NCT02321800|156921129|FG000|Overall Study|Other, Miscellaneous|3|||
48746791|NCT02321800|156921130|FG001|Overall Study|Other, Miscellaneous|1|||
48746792|NCT02340975|156921131|FG000|Overall Study|Death|6|||
48746793|NCT02340975|156921132|FG001|Overall Study|Death|23|||
48746794|NCT02340975|156921133|FG002|Overall Study|Death|21|||
48746795|NCT02340975|156921134|FG003|Overall Study|Death|7|||
48746796|NCT02340975|156921135|FG004|Overall Study|Death|21|||
48746797|NCT02340975|156921136|FG005|Overall Study|Death|13|||
48746798|NCT02340975|156921131|FG000|Overall Study|Lost to Follow-up|0|||
48746799|NCT02340975|156921132|FG001|Overall Study|Lost to Follow-up|0|||
48746800|NCT02340975|156921133|FG002|Overall Study|Lost to Follow-up|0|||
48746801|NCT02340975|156921134|FG003|Overall Study|Lost to Follow-up|0|||
48746802|NCT02340975|156921135|FG004|Overall Study|Lost to Follow-up|2|||
48746803|NCT02340975|156921136|FG005|Overall Study|Lost to Follow-up|0|||
48746804|NCT02340975|156921131|FG000|Overall Study|Withdrawal by Subject|0|||
48746805|NCT02340975|156921132|FG001|Overall Study|Withdrawal by Subject|0|||
48746806|NCT02340975|156921133|FG002|Overall Study|Withdrawal by Subject|3|||
48746807|NCT02340975|156921134|FG003|Overall Study|Withdrawal by Subject|3|||
48746808|NCT02340975|156921135|FG004|Overall Study|Withdrawal by Subject|2|||
48746809|NCT02340975|156921136|FG005|Overall Study|Withdrawal by Subject|0|||
48746810|NCT02340975|156921131|FG000|Overall Study|Other|0|||
48746811|NCT02340975|156921132|FG001|Overall Study|Other|4|||
48746812|NCT02340975|156921133|FG002|Overall Study|Other|0|||
48746813|NCT02340975|156921134|FG003|Overall Study|Other|2|||
48746814|NCT02340975|156921135|FG004|Overall Study|Other|0|||
48746815|NCT02340975|156921136|FG005|Overall Study|Other|6|||
48746816|NCT04661839|156921139|FG000|Overall Study|Not Treated|0|||
48746817|NCT04661839|156921140|FG001|Overall Study|Not Treated|0|||
48746818|NCT04661839|156921141|FG002|Overall Study|Not Treated|1|||
48746819|NCT04661839|156921142|FG003|Overall Study|Not Treated|0|||
48746820|NCT04661839|156921139|FG000|Overall Study|Lost to Follow-up|1|||
48746821|NCT04661839|156921140|FG001|Overall Study|Lost to Follow-up|0|||
48746822|NCT04661839|156921141|FG002|Overall Study|Lost to Follow-up|0|||
48746823|NCT04661839|156921142|FG003|Overall Study|Lost to Follow-up|1|||
48746824|NCT01169493|156921143|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
48746825|NCT01169493|156921144|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
48746826|NCT01169493|156921145|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
48746827|NCT01169493|156921146|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
48746828|NCT01169493|156921147|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
48746829|NCT01169493|156921148|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
48746830|NCT01169493|156921143|FG000|Period 3 (6 Months)|Adverse Event|0|||
48746831|NCT01169493|156921144|FG001|Period 3 (6 Months)|Adverse Event|1|||
48746832|NCT01169493|156921145|FG002|Period 3 (6 Months)|Adverse Event|0|||
48746833|NCT01169493|156921146|FG003|Period 3 (6 Months)|Adverse Event|0|||
48746834|NCT01169493|156921147|FG004|Period 3 (6 Months)|Adverse Event|0|||
48746835|NCT01169493|156921148|FG005|Period 3 (6 Months)|Adverse Event|0|||
48746836|NCT01169493|156921143|FG000|Period 3 (6 Months)|Physician Decision|0|||
48746837|NCT01169493|156921144|FG001|Period 3 (6 Months)|Physician Decision|1|||
48746838|NCT01169493|156921145|FG002|Period 3 (6 Months)|Physician Decision|1|||
48746839|NCT01169493|156921146|FG003|Period 3 (6 Months)|Physician Decision|0|||
48746840|NCT01169493|156921147|FG004|Period 3 (6 Months)|Physician Decision|0|||
48746841|NCT01169493|156921148|FG005|Period 3 (6 Months)|Physician Decision|0|||
48746842|NCT03066804|156921149|FG000|Overall Study|Physician Decision|0|||
48746843|NCT03066804|156921150|FG001|Overall Study|Physician Decision|4|||
48746844|NCT03066804|156921149|FG000|Overall Study|Death|23|||
48746845|NCT03066804|156921150|FG001|Overall Study|Death|17|||
48327699|NCT01641900|155398123|FG001|Overall Study|Withdrawal by Subject|2|||
48327700|NCT02310581|155398126|FG000|Overall Study|Adverse Event|1|||
48746846|NCT03066804|156921149|FG000|Overall Study|Withdrawal by Subject|19|||
48746847|NCT03066804|156921150|FG001|Overall Study|Withdrawal by Subject|25|||
48746848|NCT03066804|156921149|FG000|Overall Study|Lost to Follow-up|2|||
48746849|NCT03066804|156921150|FG001|Overall Study|Lost to Follow-up|0|||
48746850|NCT03066804|156921149|FG000|Overall Study|Adverse Event|2|||
48746851|NCT03066804|156921150|FG001|Overall Study|Adverse Event|3|||
48746852|NCT03066804|156921149|FG000|Overall Study|Technical problems|5|||
48746853|NCT03066804|156921150|FG001|Overall Study|Technical problems|1|||
48746854|NCT00370032|156921151|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
48746855|NCT00370032|156921152|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
48746856|NCT00370032|156921151|FG000|Washout Period|Withdrawal by Subject|0|||
48746857|NCT00370032|156921152|FG001|Washout Period|Withdrawal by Subject|1|||
48746858|NCT00370032|156921151|FG000|Washout Period|Lost to Follow-up|0|||
48746859|NCT00370032|156921152|FG001|Washout Period|Lost to Follow-up|1|||
48746860|NCT00370032|156921151|FG000|Washout Period|Adverse Event|1|||
48746861|NCT00370032|156921152|FG001|Washout Period|Adverse Event|0|||
48746862|NCT00370032|156921151|FG000|Follow-up Period|Withdrawal by Subject|1|||
48327701|NCT02310581|155398127|FG001|Overall Study|Adverse Event|1|||
48327702|NCT02310581|155398128|FG002|Overall Study|Adverse Event|1|||
48327703|NCT02310581|155398129|FG003|Overall Study|Adverse Event|0|||
48636783|NCT03402841|156526901|FG000|Overall Study|Withdrawal by Subject|3|||
48636784|NCT03402841|156526901|FG000|Overall Study|Lost to Follow-up|2|||
48636785|NCT03402841|156526901|FG000|Overall Study|Death|146|||
48636786|NCT04442269|156526904|FG000|Overall Study|Adverse Event|1|||
48636787|NCT04442269|156526905|FG001|Overall Study|Adverse Event|0|||
48636788|NCT04442269|156526904|FG000|Overall Study|Death|0|||
48636789|NCT04442269|156526905|FG001|Overall Study|Death|1|||
48636790|NCT04442269|156526904|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
48636791|NCT04442269|156526905|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
48636792|NCT04442269|156526904|FG000|Overall Study|Lost to Follow-up|1|||
48636793|NCT04442269|156526905|FG001|Overall Study|Lost to Follow-up|0|||
48636794|NCT04442269|156526904|FG000|Overall Study|Withdrawal by Subject|3|||
48636795|NCT04442269|156526905|FG001|Overall Study|Withdrawal by Subject|2|||
48636796|NCT04442269|156526904|FG000|Overall Study|Protocol Deviation|0|||
48636797|NCT04442269|156526905|FG001|Overall Study|Protocol Deviation|1|||
48636798|NCT04442269|156526904|FG000|Overall Study|Travel Limitations|1|||
48636799|NCT04442269|156526905|FG001|Overall Study|Travel Limitations|1|||
48636800|NCT00710593|156528507|FG000|Overall Study|Incarceration|1|||
48636801|NCT00710593|156528508|FG001|Overall Study|Incarceration|0|||
48636802|NCT00710593|156528507|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
48636803|NCT00710593|156528508|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
48636804|NCT00710593|156528507|FG000|Overall Study|Lost to Follow-up|3|||
48636805|NCT00710593|156528508|FG001|Overall Study|Lost to Follow-up|1|||
48636806|NCT00710593|156528507|FG000|Overall Study|Moved out of area|1|||
48636807|NCT00710593|156528508|FG001|Overall Study|Moved out of area|0|||
48636808|NCT00710593|156528507|FG000|Overall Study|Failure to adhere or complete study eval|1|||
48636809|NCT00710593|156528508|FG001|Overall Study|Failure to adhere or complete study eval|1|||
48636810|NCT00710593|156528507|FG000|Overall Study|Protocol Violation|1|||
48636811|NCT00710593|156528508|FG001|Overall Study|Protocol Violation|1|||
48636812|NCT00710593|156528507|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
48636813|NCT00710593|156528508|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
48636814|NCT00069641|156528509|FG000|Overall Study|Death|1|||
48636815|NCT00069641|156528510|FG001|Overall Study|Death|0|||
48636816|NCT00069641|156528511|FG002|Overall Study|Death|1|||
48636817|NCT00105534|156528512|FG000|Overall Study|Adverse Event|2|||
48636818|NCT00105534|156528513|FG001|Overall Study|Adverse Event|5|||
48636819|NCT00105534|156528512|FG000|Overall Study|Protocol Violation|1|||
48636820|NCT00105534|156528513|FG001|Overall Study|Protocol Violation|4|||
48636821|NCT00105534|156528512|FG000|Overall Study|Withdrawal by Subject|6|||
48636822|NCT00105534|156528513|FG001|Overall Study|Withdrawal by Subject|6|||
48636823|NCT00105534|156528512|FG000|Overall Study|Lost to Follow-up|5|||
48636824|NCT00105534|156528513|FG001|Overall Study|Lost to Follow-up|1|||
48636825|NCT00105534|156528512|FG000|Overall Study|Lack of Efficacy|7|||
48636826|NCT00105534|156528513|FG001|Overall Study|Lack of Efficacy|15|||
48636827|NCT00105534|156528512|FG000|Overall Study|Treatment unmasked|1|||
48636828|NCT00105534|156528513|FG001|Overall Study|Treatment unmasked|0|||
48636829|NCT00105534|156528512|FG000|Overall Study|Other Reason|0|||
48636830|NCT00105534|156528513|FG001|Overall Study|Other Reason|2|||
48636831|NCT00831389|156528515|FG000|Overall Study|Withdrawal by Subject|0|||
48636832|NCT00831389|156528516|FG001|Overall Study|Withdrawal by Subject|1|||
48636833|NCT04778592|156528524|FG000|Overall Study|Adverse Event|1|||
48636834|NCT04778592|156528525|FG001|Overall Study|Adverse Event|2|||
48636835|NCT04778592|156528524|FG000|Overall Study|Withdrawal by Subject|1|||
48636836|NCT04778592|156528525|FG001|Overall Study|Withdrawal by Subject|2|||
48636837|NCT01029535|156528526|FG000|Overall Study|Lost to Follow-up|24|||
48636838|NCT01029535|156528526|FG000|Overall Study|Protocol Violation|2|||
48636839|NCT01029535|156528526|FG000|Overall Study|Participant Withdrew Consent|2|||
48636840|NCT01029535|156528526|FG000|Overall Study|Adverse Event|1|||
48636841|NCT01029535|156528526|FG000|Overall Study|Use of Another Treatment|1|||
48636842|NCT01029535|156528526|FG000|Overall Study|Death|1|||
48636843|NCT03257358|156528527|FG000|Overall Study|Adverse Event|25|||
48636844|NCT03257358|156528528|FG001|Overall Study|Adverse Event|12|||
48636845|NCT03257358|156528527|FG000|Overall Study|Lack of Efficacy|1|||
48636846|NCT03257358|156528528|FG001|Overall Study|Lack of Efficacy|1|||
48636847|NCT03257358|156528527|FG000|Overall Study|Lost to Follow-up|12|||
48636848|NCT03257358|156528528|FG001|Overall Study|Lost to Follow-up|4|||
48636849|NCT03257358|156528527|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
48636850|NCT03257358|156528528|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
48636851|NCT03257358|156528527|FG000|Overall Study|Physician Decision|2|||
48636852|NCT03257358|156528528|FG001|Overall Study|Physician Decision|2|||
48636853|NCT03257358|156528527|FG000|Overall Study|Protocol Violation|5|||
48636854|NCT03257358|156528528|FG001|Overall Study|Protocol Violation|3|||
48636855|NCT03257358|156528527|FG000|Overall Study|Technical problems|4|||
48636856|NCT03257358|156528528|FG001|Overall Study|Technical problems|1|||
48636857|NCT03257358|156528527|FG000|Overall Study|Withdrawal by Subject|8|||
48636858|NCT03257358|156528528|FG001|Overall Study|Withdrawal by Subject|3|||
48636859|NCT03257358|156528527|FG000|Overall Study|Withdrawal of informed consent|9|||
48636860|NCT03257358|156528528|FG001|Overall Study|Withdrawal of informed consent|5|||
48636861|NCT03257358|156528527|FG000|Overall Study|New therapy for study indication|1|||
48636862|NCT03257358|156528528|FG001|Overall Study|New therapy for study indication|0|||
48636863|NCT03257358|156528527|FG000|Overall Study|No longer requires treatment|0|||
48636864|NCT03257358|156528528|FG001|Overall Study|No longer requires treatment|1|||
48636865|NCT02410772|156528529|FG000|Overall Study|Death|3|||
48636866|NCT02410772|156528530|FG001|Overall Study|Death|4|||
48636867|NCT02410772|156528531|FG002|Overall Study|Death|8|||
48636868|NCT02410772|156528529|FG000|Overall Study|Lost to Follow-up|31|||
48636869|NCT02410772|156528530|FG001|Overall Study|Lost to Follow-up|23|||
48636870|NCT02410772|156528531|FG002|Overall Study|Lost to Follow-up|22|||
48636871|NCT02410772|156528529|FG000|Overall Study|Pregnancy|8|||
48636872|NCT02410772|156528530|FG001|Overall Study|Pregnancy|4|||
48636873|NCT02410772|156528531|FG002|Overall Study|Pregnancy|5|||
48636874|NCT02410772|156528529|FG000|Overall Study|Protocol Violation|8|||
48636875|NCT02410772|156528530|FG001|Overall Study|Protocol Violation|8|||
48636876|NCT02410772|156528531|FG002|Overall Study|Protocol Violation|4|||
48636877|NCT02410772|156528529|FG000|Overall Study|Baseline Drug Resistance|49|||
48636878|NCT02410772|156528530|FG001|Overall Study|Baseline Drug Resistance|40|||
48636879|NCT02410772|156528531|FG002|Overall Study|Baseline Drug Resistance|51|||
48636880|NCT02410772|156528529|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
48636881|NCT02410772|156528530|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
48636882|NCT02410772|156528531|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
48636883|NCT02410772|156528529|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
48636884|NCT02410772|156528530|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
48636885|NCT02410772|156528531|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
48636886|NCT01475721|156528533|FG000|Overall Study|Death|3|||
48636887|NCT01475721|156528534|FG001|Overall Study|Death|6|||
48636888|NCT01475721|156528533|FG000|Overall Study|Withdrawal by Subject|8|||
48636889|NCT01475721|156528534|FG001|Overall Study|Withdrawal by Subject|8|||
48636890|NCT01198587|156528537|FG000|Overall Study|Lost to Follow-up|8|||
48636891|NCT01198587|156528538|FG001|Overall Study|Lost to Follow-up|0|||
48636892|NCT01198587|156528539|FG002|Overall Study|Lost to Follow-up|9|||
48636893|NCT01198587|156528540|FG003|Overall Study|Lost to Follow-up|0|||
48636894|NCT01959529|156528541|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
48636895|NCT01959529|156528542|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
48636896|NCT01959529|156528541|FG000|Overall Study|Lost to Follow-up|4|||
48636897|NCT01959529|156528542|FG001|Overall Study|Lost to Follow-up|1|||
48636898|NCT01959529|156528541|FG000|Overall Study|Other|70|||
48636899|NCT01959529|156528542|FG001|Overall Study|Other|68|||
48636900|NCT01959529|156528541|FG000|Overall Study|Hypoglycaemia|1|||
48636901|NCT01959529|156528542|FG001|Overall Study|Hypoglycaemia|1|||
48636902|NCT01959529|156528541|FG000|Overall Study|Lack of glycaemic control|1|||
48636903|NCT01959529|156528542|FG001|Overall Study|Lack of glycaemic control|1|||
48636904|NCT00904371|156528544|FG000|Overall Study|Adverse Event|2|||
48636905|NCT00904371|156528544|FG000|Overall Study|Lost to Follow-up|4|||
48636906|NCT00904371|156528544|FG000|Overall Study|Discontinued at target blood pressure|2|||
48636907|NCT00904371|156528544|FG000|Overall Study|Continued with Tritace|1|||
48636908|NCT02569853|156528545|FG000|Overall Study|Adverse Event|2|||
48636909|NCT02569853|156528546|FG001|Overall Study|Adverse Event|0|||
48636910|NCT02569853|156528545|FG000|Overall Study|Withdrawal by Subject|3|||
48636911|NCT02569853|156528546|FG001|Overall Study|Withdrawal by Subject|2|||
48636912|NCT02569853|156528545|FG000|Overall Study|Lost to Follow-up|3|||
48636913|NCT02569853|156528546|FG001|Overall Study|Lost to Follow-up|3|||
48636914|NCT02569853|156528545|FG000|Overall Study|Protocol Violation|1|||
48636915|NCT02569853|156528546|FG001|Overall Study|Protocol Violation|1|||
48636916|NCT02569853|156528545|FG000|Overall Study|Did not experience migraine attack|10|||
48636917|NCT02569853|156528546|FG001|Overall Study|Did not experience migraine attack|7|||
48746863|NCT00370032|156921152|FG001|Follow-up Period|Withdrawal by Subject|0|||
48746864|NCT02220205|156921153|FG000|Overall Study|Withdrawal by Subject|1|||
48746865|NCT02220205|156921154|FG001|Overall Study|Withdrawal by Subject|0|||
48746866|NCT01465997|156921155|FG000|Overall Study|Adverse Event|12|||
48746867|NCT01465997|156921156|FG001|Overall Study|Adverse Event|22|||
48746868|NCT01465997|156921155|FG000|Overall Study|Lack of Efficacy|13|||
48746869|NCT01465997|156921156|FG001|Overall Study|Lack of Efficacy|1|||
48746870|NCT01465997|156921155|FG000|Overall Study|Protocol Violation|1|||
48746871|NCT01465997|156921156|FG001|Overall Study|Protocol Violation|4|||
48746872|NCT01465997|156921155|FG000|Overall Study|Lost to Follow-up|6|||
48636918|NCT02569853|156528545|FG000|Overall Study|Physician Decision|1|||
48636919|NCT02569853|156528546|FG001|Overall Study|Physician Decision|1|||
48636920|NCT00002766|156528547|FG000|Overall Study|Withdrawal by Subject|0|||
48636921|NCT00002766|156528548|FG001|Overall Study|Withdrawal by Subject|1|||
48636922|NCT00002766|156528547|FG000|Overall Study|Patient Not Treated|1|||
48636923|NCT00002766|156528548|FG001|Overall Study|Patient Not Treated|2|||
48636924|NCT00002766|156528547|FG000|Overall Study|Adverse Event|1|||
48636925|NCT00002766|156528548|FG001|Overall Study|Adverse Event|1|||
48636926|NCT00002766|156528547|FG000|Overall Study|Protocol Violation|1|||
48636927|NCT00002766|156528548|FG001|Overall Study|Protocol Violation|0|||
48636928|NCT01668004|156528554|FG000|Overall Study|Adverse Event|7|||
48636929|NCT01668004|156528554|FG000|Overall Study|Withdrawal by Subject|2|||
48636930|NCT01668004|156528554|FG000|Overall Study|Lost to Follow-up|5|||
48636931|NCT01668004|156528554|FG000|Overall Study|Lack of Efficacy|9|||
48636932|NCT01668004|156528554|FG000|Overall Study|Non-compliance with treatment|2|||
48636933|NCT02431325|156528559|FG000|Overall Study|Adverse Event|3|||
48636934|NCT02431325|156528560|FG001|Overall Study|Adverse Event|0|||
48636935|NCT02431325|156528559|FG000|Overall Study|Lost to Follow-up|0|||
48636936|NCT02431325|156528560|FG001|Overall Study|Lost to Follow-up|1|||
48636937|NCT02431325|156528559|FG000|Overall Study|Withdrawal by Subject|1|||
48636938|NCT02431325|156528560|FG001|Overall Study|Withdrawal by Subject|2|||
48636939|NCT02431325|156528559|FG000|Overall Study|Declined to take study medication|1|||
48636940|NCT02431325|156528560|FG001|Overall Study|Declined to take study medication|0|||
48636941|NCT02431325|156528559|FG000|Overall Study|Withdrew before starting study medication|1|||
48636942|NCT02431325|156528560|FG001|Overall Study|Withdrew before starting study medication|0|||
48636943|NCT02431325|156528559|FG000|Overall Study|Placebo shortage|2|||
48636944|NCT02431325|156528560|FG001|Overall Study|Placebo shortage|0|||
48636945|NCT01128569|156528561|FG000|Washout Period 1|Adverse Event|0|||
48636946|NCT01128569|156528562|FG001|Washout Period 1|Adverse Event|0|||
48636947|NCT01128569|156528563|FG002|Washout Period 1|Adverse Event|1|||
48636948|NCT01128569|156528564|FG003|Washout Period 1|Adverse Event|0|||
48636949|NCT01128569|156528565|FG004|Washout Period 1|Adverse Event|0|||
48636950|NCT01128569|156528566|FG005|Washout Period 1|Adverse Event|0|||
48636951|NCT01128569|156528561|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48636952|NCT01128569|156528562|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48636953|NCT01128569|156528563|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48636954|NCT01128569|156528564|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48636955|NCT01128569|156528565|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48636956|NCT01128569|156528566|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48636957|NCT00894387|156528567|FG000|Overall Study|Adverse Event|44|||
48636958|NCT00894387|156528568|FG001|Overall Study|Adverse Event|45|||
48636959|NCT00894387|156528567|FG000|Overall Study|Abnormal Laboratory values|2|||
48636960|NCT00894387|156528568|FG001|Overall Study|Abnormal Laboratory values|2|||
48636961|NCT00894387|156528567|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48636962|NCT00894387|156528568|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48636963|NCT00894387|156528567|FG000|Overall Study|Lost to Follow-up|3|||
48636964|NCT00894387|156528568|FG001|Overall Study|Lost to Follow-up|5|||
48636965|NCT00894387|156528567|FG000|Overall Study|Administrative problems|2|||
48636966|NCT00894387|156528568|FG001|Overall Study|Administrative problems|2|||
48636967|NCT00894387|156528567|FG000|Overall Study|Death|77|||
48636968|NCT00894387|156528568|FG001|Overall Study|Death|76|||
48636969|NCT00894387|156528567|FG000|Overall Study|Protocol Deviation|4|||
48636970|NCT00894387|156528568|FG001|Overall Study|Protocol Deviation|0|||
48746873|NCT01465997|156921156|FG001|Overall Study|Lost to Follow-up|9|||
48746874|NCT01465997|156921155|FG000|Overall Study|Withdrawal by Subject|32|||
48746875|NCT01465997|156921156|FG001|Overall Study|Withdrawal by Subject|35|||
48746876|NCT01465997|156921155|FG000|Overall Study|investigator's decision|1|||
48746877|NCT01465997|156921156|FG001|Overall Study|investigator's decision|1|||
48746878|NCT01465997|156921155|FG000|Overall Study|Death|0|||
48746879|NCT01465997|156921156|FG001|Overall Study|Death|1|||
48746880|NCT01465997|156921155|FG000|Overall Study|sponsor's decision|1|||
48636971|NCT00894387|156528567|FG000|Overall Study|Patient's request|25|||
48636972|NCT00894387|156528568|FG001|Overall Study|Patient's request|30|||
48636973|NCT00894387|156528567|FG000|Overall Study|Other (Missing)|5|||
48636974|NCT00894387|156528568|FG001|Overall Study|Other (Missing)|3|||
48746881|NCT01465997|156921156|FG001|Overall Study|sponsor's decision|1|||
48636975|NCT00894387|156528567|FG000|Overall Study|Mis-randomized|13|||
48636976|NCT00894387|156528568|FG001|Overall Study|Mis-randomized|9|||
48636977|NCT00894387|156528567|FG000|Overall Study|GCP non-compliance|0|||
48636978|NCT00894387|156528568|FG001|Overall Study|GCP non-compliance|2|||
48636979|NCT02300233|156528569|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
48636980|NCT02300233|156528570|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
48636981|NCT02300233|156528571|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
48636982|NCT02300233|156528569|FG000|Overall Study|Withdrawal by Subject|1|||
48636983|NCT02300233|156528570|FG001|Overall Study|Withdrawal by Subject|0|||
48636984|NCT02300233|156528571|FG002|Overall Study|Withdrawal by Subject|3|||
48636985|NCT02300233|156528569|FG000|Overall Study|Investigator Judgement|0|||
48636986|NCT02300233|156528570|FG001|Overall Study|Investigator Judgement|0|||
48636987|NCT02300233|156528571|FG002|Overall Study|Investigator Judgement|1|||
48636988|NCT02300233|156528569|FG000|Overall Study|Reason Not Specified|0|||
48636989|NCT02300233|156528570|FG001|Overall Study|Reason Not Specified|0|||
48636990|NCT02300233|156528571|FG002|Overall Study|Reason Not Specified|5|||
48636991|NCT05525910|156528572|FG000|Period 4|Per sponsor due to study timelines|0|||
48636992|NCT05525910|156528573|FG001|Period 4|Per sponsor due to study timelines|0|||
48746882|NCT01465997|156921155|FG000|Overall Study|subject withdrew consent|1|||
48746883|NCT01465997|156921156|FG001|Overall Study|subject withdrew consent|0|||
48746884|NCT01465997|156921155|FG000|Overall Study|local lab unblinded site|1|||
48746885|NCT01465997|156921156|FG001|Overall Study|local lab unblinded site|0|||
48746886|NCT01465997|156921155|FG000|Overall Study|withdrew before follow-up|0|||
48746887|NCT01465997|156921156|FG001|Overall Study|withdrew before follow-up|13|||
48746888|NCT01465997|156921155|FG000|Overall Study|decision by site staff|0|||
48746889|NCT01465997|156921156|FG001|Overall Study|decision by site staff|1|||
48746890|NCT01465997|156921155|FG000|Overall Study|subject left participation SP0993|0|||
48746891|NCT01465997|156921156|FG001|Overall Study|subject left participation SP0993|1|||
48746892|NCT00619177|156921158|FG000|Overall Study|Adverse Event|18|||
48746893|NCT00619177|156921158|FG000|Overall Study|Lost to Follow-up|2|||
48746894|NCT00619177|156921158|FG000|Overall Study|Lack of Efficacy|1|||
48746895|NCT00619177|156921158|FG000|Overall Study|Missing termination information|481|||
48746896|NCT00619177|156921158|FG000|Overall Study|Not specified reasons|6|||
48746897|NCT00205881|156921159|FG000|Overall Study|Withdrawal by Subject|16|||
48746898|NCT02083783|156921161|FG000|Overall Study|Withdrawal by Subject|1|||
48746899|NCT02083783|156921162|FG001|Overall Study|Withdrawal by Subject|0|||
48746900|NCT01496612|156921163|FG000|1st Intervention|Adverse Event|1|||
48746901|NCT01496612|156921164|FG001|1st Intervention|Adverse Event|0|||
48746902|NCT01496612|156921163|FG000|1st Intervention|Withdrawal by Subject|1|||
48746903|NCT01496612|156921164|FG001|1st Intervention|Withdrawal by Subject|0|||
48746904|NCT01654536|156921165|FG000|Overall Study|Lost to Follow-up|5|||
48746905|NCT01654536|156921166|FG001|Overall Study|Lost to Follow-up|5|||
48746906|NCT01654536|156921165|FG000|Overall Study|Physician Decision|12|||
48746907|NCT01654536|156921166|FG001|Overall Study|Physician Decision|8|||
48746908|NCT01654536|156921165|FG000|Overall Study|Withdrawal by Subject|27|||
48746909|NCT01654536|156921166|FG001|Overall Study|Withdrawal by Subject|25|||
48746910|NCT03681405|156921172|FG000|Overall Study|Found to be ineligible after randomized|1|||
48746911|NCT03681405|156921173|FG001|Overall Study|Found to be ineligible after randomized|0|||
48746912|NCT05570500|156921176|FG000|Overall Study|Lost to Follow-up|7|||
48746913|NCT05570500|156921177|FG001|Overall Study|Lost to Follow-up|5|||
48746914|NCT01446289|156921180|FG000|Overall Study|Withdrawal by Subject|1|||
48746915|NCT01446289|156921181|FG001|Overall Study|Withdrawal by Subject|0|||
48746916|NCT01446289|156921182|FG002|Overall Study|Withdrawal by Subject|1|||
48746917|NCT01446289|156921183|FG003|Overall Study|Withdrawal by Subject|0|||
48746918|NCT00838578|156921186|FG000|Overall Study|Protocol Violation|2|||
48746919|NCT02760069|156921187|FG000|Overall Study|Withdrawal by Subject|0|||
48746920|NCT02760069|156921188|FG001|Overall Study|Withdrawal by Subject|1|||
48636993|NCT05525910|156528574|FG002|Period 4|Per sponsor due to study timelines|1|||
48636994|NCT05525910|156528575|FG003|Period 4|Per sponsor due to study timelines|1|||
48746921|NCT02760069|156921189|FG002|Overall Study|Withdrawal by Subject|1|||
48746922|NCT03031678|156921192|FG000|Overall Study|Study closed prior to completion|1|||
48746923|NCT03782116|156921199|FG000|Completed Intervetion|Lost to Follow-up|11|||
48746924|NCT03782116|156921200|FG001|Completed Intervetion|Lost to Follow-up|7|||
48746925|NCT03782116|156921199|FG000|Completed Intervetion|Withdrawal by Subject|6|||
48746926|NCT03782116|156921200|FG001|Completed Intervetion|Withdrawal by Subject|5|||
48746927|NCT03782116|156921199|FG000|Included in Analysis|Protocol Violation|5|||
48746928|NCT03782116|156921200|FG001|Included in Analysis|Protocol Violation|5|||
48746929|NCT00967668|156922840|FG000|Overall Study|Withdrawal by Subject|13|||
48746930|NCT00967668|156922841|FG001|Overall Study|Withdrawal by Subject|8|||
48746931|NCT00967668|156922842|FG002|Overall Study|Withdrawal by Subject|8|||
48636995|NCT05525910|156528576|FG004|Period 4|Per sponsor due to study timelines|1|||
48636996|NCT05448950|156528577|FG000|Overall Study|Death|2|||
48636997|NCT05448950|156528577|FG000|Overall Study|Withdrawal by Subject|1|||
48636998|NCT05448950|156528577|FG000|Overall Study|AVG abandoned|4|||
48636999|NCT02412670|156528578|FG000|Overall Study|Adverse Event|4|||
48637000|NCT02412670|156528579|FG001|Overall Study|Adverse Event|1|||
48637001|NCT02412670|156528578|FG000|Overall Study|Physician Decision|1|||
48637002|NCT02412670|156528579|FG001|Overall Study|Physician Decision|0|||
48637003|NCT02412670|156528578|FG000|Overall Study|Withdrawal by Subject|1|||
48746932|NCT00967668|156922840|FG000|Overall Study|Death|0|||
48746933|NCT00967668|156922841|FG001|Overall Study|Death|2|||
48746934|NCT00967668|156922842|FG002|Overall Study|Death|4|||
48746935|NCT00967668|156922840|FG000|Overall Study|Removed due to behavior|1|||
48746936|NCT00967668|156922841|FG001|Overall Study|Removed due to behavior|1|||
48746937|NCT00967668|156922842|FG002|Overall Study|Removed due to behavior|2|||
48746938|NCT00967668|156922840|FG000|Overall Study|Refused Year 2|11|||
48746939|NCT00967668|156922841|FG001|Overall Study|Refused Year 2|6|||
48426799|NCT04760314|155752868|FG009|Induction Period|Adverse Event|0|||
48637004|NCT02412670|156528579|FG001|Overall Study|Withdrawal by Subject|0|||
48746940|NCT00967668|156922842|FG002|Overall Study|Refused Year 2|4|||
48637005|NCT02412670|156528578|FG000|Overall Study|Ineligible|1|||
48637006|NCT02412670|156528579|FG001|Overall Study|Ineligible|0|||
48637007|NCT03440008|156528582|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
48637008|NCT03440008|156528583|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
48637009|NCT03440008|156528582|FG000|Overall Study|Withdrawal by Subject|1|||
48637010|NCT03440008|156528583|FG001|Overall Study|Withdrawal by Subject|0|||
48637011|NCT01876381|156528589|FG000|Overall Study|Lack of Efficacy|5|||
48637012|NCT01876381|156528589|FG000|Overall Study|Physician Decision|1|||
48637013|NCT01876381|156528589|FG000|Overall Study|Withdrawal by Subject|1|||
48637014|NCT00332696|156528590|FG000|Overall Study|Death|24|||
48637015|NCT00332696|156528591|FG001|Overall Study|Death|14|||
48637016|NCT00332696|156528590|FG000|Overall Study|Insufficient therapeutic effect|4|||
48637017|NCT00332696|156528591|FG001|Overall Study|Insufficient therapeutic effect|11|||
48637018|NCT00332696|156528590|FG000|Overall Study|Adverse Event|1|||
48637019|NCT00332696|156528591|FG001|Overall Study|Adverse Event|2|||
48637020|NCT00332696|156528590|FG000|Overall Study|Condition does not justify treatment|0|||
48637021|NCT00332696|156528591|FG001|Overall Study|Condition does not justify treatment|2|||
48637022|NCT00332696|156528590|FG000|Overall Study|Lost to Follow-up|0|||
48637023|NCT00332696|156528591|FG001|Overall Study|Lost to Follow-up|1|||
48637024|NCT00332696|156528590|FG000|Overall Study|Withdrawal by Subject|1|||
48637025|NCT00332696|156528591|FG001|Overall Study|Withdrawal by Subject|0|||
48637026|NCT00060944|156528600|FG000|Overall Study|Adverse Event|12|||
48637027|NCT00060944|156528601|FG001|Overall Study|Adverse Event|10|||
48637028|NCT00060944|156528600|FG000|Overall Study|Death|2|||
48637029|NCT00060944|156528601|FG001|Overall Study|Death|3|||
48637030|NCT00060944|156528600|FG000|Overall Study|Withdrawal by Subject|18|||
48637031|NCT00060944|156528601|FG001|Overall Study|Withdrawal by Subject|5|||
48637032|NCT00060944|156528600|FG000|Overall Study|Disease Progression|93|||
48637033|NCT00060944|156528601|FG001|Overall Study|Disease Progression|94|||
48637034|NCT00060944|156528600|FG000|Overall Study|Lost to Follow-up|1|||
48637035|NCT00060944|156528601|FG001|Overall Study|Lost to Follow-up|0|||
48637036|NCT00060944|156528600|FG000|Overall Study|Subject Ineligible To Continue|2|||
48637037|NCT00060944|156528601|FG001|Overall Study|Subject Ineligible To Continue|1|||
48637038|NCT00060944|156528600|FG000|Overall Study|Treatment Switch|0|||
48637039|NCT00060944|156528601|FG001|Overall Study|Treatment Switch|13|||
48637040|NCT00060944|156528600|FG000|Overall Study|Other|2|||
48637041|NCT00060944|156528601|FG001|Overall Study|Other|4|||
48637042|NCT00060944|156528600|FG000|Overall Study|randomized but not treated|6|||
48637043|NCT00060944|156528601|FG001|Overall Study|randomized but not treated|4|||
48637044|NCT01656161|156528603|FG000|Overall Study|Death|3|||
48637045|NCT01656161|156528603|FG000|Overall Study|Adverse Event|2|||
48637046|NCT01656161|156528603|FG000|Overall Study|Protocol Violation|1|||
48637047|NCT01656161|156528603|FG000|Overall Study|Withdrawal by Subject|1|||
48637048|NCT00967616|156528604|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
48637049|NCT00967616|156528605|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
48637050|NCT00967616|156528604|FG000|Overall Study|Death|0|||
48637051|NCT00967616|156528605|FG001|Overall Study|Death|3|||
48637052|NCT00967616|156528604|FG000|Overall Study|Withdrawal by Subject|8|||
48637053|NCT00967616|156528605|FG001|Overall Study|Withdrawal by Subject|4|||
48637054|NCT00967616|156528604|FG000|Overall Study|Progressive Disease|31|||
48637055|NCT00967616|156528605|FG001|Overall Study|Progressive Disease|18|||
48637056|NCT00967616|156528604|FG000|Overall Study|Other|8|||
48637057|NCT00967616|156528605|FG001|Overall Study|Other|8|||
48637058|NCT00967616|156528604|FG000|Overall Study|Protocol Violation|1|||
48637059|NCT00967616|156528605|FG001|Overall Study|Protocol Violation|0|||
48637060|NCT00127855|156528606|FG000|Primary Vaccination Course|Adverse Event|0|||
48637061|NCT00127855|156528607|FG001|Primary Vaccination Course|Adverse Event|0|||
48637062|NCT00127855|156528608|FG002|Primary Vaccination Course|Adverse Event|1|||
48637063|NCT00127855|156528609|FG003|Primary Vaccination Course|Adverse Event|0|||
48637064|NCT00127855|156528610|FG004|Primary Vaccination Course|Adverse Event|0|||
48637065|NCT00127855|156528606|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
48637066|NCT00127855|156528607|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
48637067|NCT00127855|156528608|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
48637068|NCT00127855|156528609|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
48637069|NCT00127855|156528610|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
48637070|NCT00127855|156528606|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
48327704|NCT02310581|155398126|FG000|Overall Study|Withdrawal by Subject|2|||
48327705|NCT02310581|155398127|FG001|Overall Study|Withdrawal by Subject|1|||
48327706|NCT02310581|155398128|FG002|Overall Study|Withdrawal by Subject|0|||
48327707|NCT02310581|155398129|FG003|Overall Study|Withdrawal by Subject|1|||
48327708|NCT00336505|155398130|FG000|Overall Study|Adverse Event|10|||
48327709|NCT00336505|155398131|FG001|Overall Study|Adverse Event|9|||
48327710|NCT00336505|155398130|FG000|Overall Study|Lack of Efficacy|8|||
48327711|NCT00336505|155398131|FG001|Overall Study|Lack of Efficacy|4|||
48327712|NCT00336505|155398130|FG000|Overall Study|Lost to Follow-up|7|||
48327713|NCT00336505|155398131|FG001|Overall Study|Lost to Follow-up|4|||
48637071|NCT00127855|156528607|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
48746941|NCT00967668|156922840|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
48746942|NCT00967668|156922841|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
48746943|NCT00967668|156922842|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
48746944|NCT00967668|156922840|FG000|Overall Study|Lost to Follow-up|15|||
48746945|NCT00967668|156922841|FG001|Overall Study|Lost to Follow-up|9|||
48746946|NCT00967668|156922842|FG002|Overall Study|Lost to Follow-up|16|||
48746947|NCT00967668|156922840|FG000|Overall Study|Refused 12-mo assessment|3|||
48327714|NCT00336505|155398130|FG000|Overall Study|Withdrawal by Subject|5|||
48327715|NCT00336505|155398131|FG001|Overall Study|Withdrawal by Subject|3|||
48637072|NCT00127855|156528608|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
48637073|NCT00127855|156528609|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
48637074|NCT00127855|156528610|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
48637075|NCT00127855|156528606|FG000|Primary Vaccination Course|Other|0|||
48637076|NCT00127855|156528607|FG001|Primary Vaccination Course|Other|0|||
48637077|NCT00127855|156528608|FG002|Primary Vaccination Course|Other|0|||
48637078|NCT00127855|156528609|FG003|Primary Vaccination Course|Other|0|||
48637079|NCT00127855|156528610|FG004|Primary Vaccination Course|Other|1|||
48637080|NCT01215851|156528614|FG000|Treatment Period|Adverse Event|1|||
48637081|NCT01215851|156528615|FG001|Treatment Period|Adverse Event|1|||
48637082|NCT01215851|156528616|FG002|Treatment Period|Adverse Event|1|||
48637083|NCT01215851|156528617|FG003|Treatment Period|Adverse Event|3|||
48637084|NCT01215851|156528618|FG004|Treatment Period|Adverse Event|0|||
48637085|NCT01215851|156528619|FG005|Treatment Period|Adverse Event|1|||
48637086|NCT01215851|156528614|FG000|Follow up Period|Lost to Follow-up|0|||
48637087|NCT01215851|156528615|FG001|Follow up Period|Lost to Follow-up|0|||
48637088|NCT01215851|156528616|FG002|Follow up Period|Lost to Follow-up|0|||
48637089|NCT01215851|156528617|FG003|Follow up Period|Lost to Follow-up|0|||
48637090|NCT01215851|156528618|FG004|Follow up Period|Lost to Follow-up|0|||
48637091|NCT01215851|156528619|FG005|Follow up Period|Lost to Follow-up|1|||
48637092|NCT00546481|156528622|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
48746948|NCT00967668|156922841|FG001|Overall Study|Refused 12-mo assessment|1|||
48327716|NCT00336505|155398130|FG000|Overall Study|Other|7|||
48327717|NCT00336505|155398131|FG001|Overall Study|Other|7|||
48327718|NCT04652869|155398132|FG000|Overall Study|Withdrawal by Subject|0|||
48327719|NCT04652869|155398133|FG001|Overall Study|Withdrawal by Subject|2|||
48327720|NCT04652869|155398134|FG002|Overall Study|Withdrawal by Subject|0|||
48327721|NCT01833455|155398137|FG000|Overall Study|Withdrawal by Subject|1|||
48327722|NCT01833455|155398138|FG001|Overall Study|Withdrawal by Subject|0|||
48327723|NCT01779050|155398140|FG000|Overall Study|Withdrawal by Subject|1|||
48327724|NCT01779050|155398141|FG001|Overall Study|Withdrawal by Subject|0|||
48327725|NCT02202317|155398143|FG000|Overall Study|Lost to Follow-up|1|||
48327726|NCT01613417|155398144|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
48327727|NCT01613417|155398145|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
48327728|NCT01128959|155398146|FG000|Lead in Period|Adverse Event|3|||
48327729|NCT01128959|155398146|FG000|Treatment Period|Adverse Event|3|||
48327730|NCT01128959|155398146|FG000|Treatment Period|Withdrawal by Subject|1|||
48327731|NCT02701296|155398147|FG000|Overall Study|Incomplete Data|0|||
48327732|NCT02701296|155398148|FG001|Overall Study|Incomplete Data|2|||
48327733|NCT01409837|155398149|FG000|Overall Study|Withdrawal by Subject|2|||
48327734|NCT01409837|155398150|FG001|Overall Study|Withdrawal by Subject|1|||
48327735|NCT01409837|155398149|FG000|Overall Study|Lost to Follow-up|1|||
48327736|NCT01409837|155398150|FG001|Overall Study|Lost to Follow-up|0|||
48327737|NCT01409837|155398149|FG000|Overall Study|Physician Decision|0|||
48327738|NCT01409837|155398150|FG001|Overall Study|Physician Decision|1|||
48327739|NCT00724126|155398151|FG000|Overall Study|Adverse Event|2|||
48327740|NCT00724126|155398152|FG001|Overall Study|Adverse Event|0|||
48327741|NCT00724126|155398151|FG000|Overall Study|Withdrawal by Subject|8|||
48327742|NCT00724126|155398152|FG001|Overall Study|Withdrawal by Subject|6|||
48327743|NCT00724126|155398151|FG000|Overall Study|Lost to Follow-up|6|||
48327744|NCT00724126|155398152|FG001|Overall Study|Lost to Follow-up|6|||
48327745|NCT00724126|155398151|FG000|Overall Study|Noncompliance|2|||
48327746|NCT00724126|155398152|FG001|Overall Study|Noncompliance|1|||
48327747|NCT00724126|155398151|FG000|Overall Study|Subject randomized although ineligible|1|||
48327748|NCT00724126|155398152|FG001|Overall Study|Subject randomized although ineligible|1|||
48327749|NCT00724126|155398151|FG000|Overall Study|Subject had to leave vicinity of site|0|||
48327750|NCT00724126|155398152|FG001|Overall Study|Subject had to leave vicinity of site|1|||
48327751|NCT01436175|155398153|FG000|Overall Study|Adverse Event|111|||
48327752|NCT01436175|155398153|FG000|Overall Study|Protocol Violation|49|||
48637093|NCT00546481|156528623|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
48637094|NCT00546481|156528624|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
48637095|NCT00546481|156528622|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
48637096|NCT00546481|156528623|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
48637097|NCT00546481|156528624|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
48746949|NCT00967668|156922842|FG002|Overall Study|Refused 12-mo assessment|9|||
48746950|NCT00967668|156922840|FG000|Overall Study|Pregnancy|1|||
48327753|NCT01436175|155398153|FG000|Overall Study|Withdrawal by Subject|108|||
48327754|NCT01436175|155398153|FG000|Overall Study|Lost to Follow-up|89|||
48327755|NCT01436175|155398153|FG000|Overall Study|Lack of Efficacy|24|||
48327756|NCT01436175|155398153|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
48327757|NCT01436175|155398153|FG000|Overall Study|Other|826|||
48327758|NCT03732807|155398155|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
48327759|NCT03732807|155398156|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
48327760|NCT03732807|155398157|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
48327761|NCT03732807|155398158|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
48327762|NCT03732807|155398159|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
48327763|NCT03732807|155398160|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
48327764|NCT03732807|155398161|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
48327765|NCT03732807|155398155|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
48327766|NCT03732807|155398156|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48327767|NCT03732807|155398157|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
48327768|NCT03732807|155398158|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
48327769|NCT03732807|155398159|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
48327770|NCT03732807|155398160|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48637098|NCT00546481|156528622|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
48746951|NCT00967668|156922841|FG001|Overall Study|Pregnancy|0|||
48746952|NCT00967668|156922842|FG002|Overall Study|Pregnancy|0|||
48327771|NCT03732807|155398161|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48327772|NCT03732807|155398155|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
48327773|NCT03732807|155398156|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
48327774|NCT03732807|155398157|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
48327775|NCT03732807|155398158|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
48327776|NCT03732807|155398159|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
48327777|NCT03732807|155398160|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
48327778|NCT03732807|155398161|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
48637099|NCT00546481|156528623|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
48637100|NCT00546481|156528624|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
48637101|NCT00546481|156528622|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
48637102|NCT00546481|156528623|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
48637103|NCT00546481|156528624|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
48637104|NCT00546481|156528622|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
48637105|NCT00546481|156528623|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
48637106|NCT00546481|156528624|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
48637107|NCT00546481|156528622|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
48637108|NCT00546481|156528623|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
48637109|NCT00546481|156528624|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
48637110|NCT00546481|156528622|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
48637111|NCT00546481|156528623|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
48637112|NCT00546481|156528624|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
48637113|NCT00546481|156528622|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
48637114|NCT00546481|156528623|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
48637115|NCT00546481|156528624|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
48637116|NCT00546481|156528622|FG000|Maintenance Phase (CERA)|Other Reason|0|||
48637117|NCT00546481|156528623|FG001|Maintenance Phase (CERA)|Other Reason|0|||
48637118|NCT00546481|156528624|FG002|Maintenance Phase (CERA)|Other Reason|1|||
48637119|NCT00613106|156528625|FG000|Overall Study|Adverse Event|3|||
48637120|NCT00613106|156528626|FG001|Overall Study|Adverse Event|1|||
48637121|NCT00613106|156528625|FG000|Overall Study|Withdrawal by Subject|6|||
48637122|NCT00613106|156528626|FG001|Overall Study|Withdrawal by Subject|3|||
48637123|NCT00613106|156528625|FG000|Overall Study|Lost to Follow-up|7|||
48637124|NCT00613106|156528626|FG001|Overall Study|Lost to Follow-up|2|||
48637125|NCT00613106|156528625|FG000|Overall Study|misc|4|||
48637126|NCT00613106|156528626|FG001|Overall Study|misc|3|||
48637127|NCT02834819|156528627|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
48637128|NCT02834819|156528628|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
48637129|NCT03508050|156528631|FG000|Overall Study|Pleural adhesions|1|||
48637130|NCT03508050|156528632|FG001|Overall Study|Pleural adhesions|0|||
48637131|NCT03508050|156528631|FG000|Overall Study|Mucus plug|1|||
48637132|NCT03508050|156528632|FG001|Overall Study|Mucus plug|0|||
48637133|NCT03508050|156528631|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
48637134|NCT03508050|156528632|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
48637135|NCT03508050|156528631|FG000|Overall Study|Sustained desaturation|0|||
48637136|NCT03508050|156528632|FG001|Overall Study|Sustained desaturation|1|||
48637137|NCT01242514|156528633|FG000|Overall Study|e.g., project closure|1042|||
48637138|NCT01242514|156528634|FG001|Overall Study|e.g., project closure|305|||
48637139|NCT01242514|156528635|FG002|Overall Study|e.g., project closure|171|||
48637140|NCT01242514|156528633|FG000|Overall Study|Subject decision|33|||
48637141|NCT01242514|156528634|FG001|Overall Study|Subject decision|8|||
48637142|NCT01242514|156528635|FG002|Overall Study|Subject decision|2|||
48637143|NCT01242514|156528633|FG000|Overall Study|Severe non-compliance to protocol|5|||
48637144|NCT01242514|156528634|FG001|Overall Study|Severe non-compliance to protocol|2|||
48637145|NCT01242514|156528635|FG002|Overall Study|Severe non-compliance to protocol|1|||
48637146|NCT01242514|156528633|FG000|Overall Study|Lack of therapeutic response|99|||
48637147|NCT01242514|156528634|FG001|Overall Study|Lack of therapeutic response|16|||
48637148|NCT01242514|156528635|FG002|Overall Study|Lack of therapeutic response|10|||
48637149|NCT01242514|156528633|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
48746953|NCT01433991|156922849|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
48746954|NCT01433991|156922850|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
48746955|NCT01433991|156922851|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
48746956|NCT01433991|156922852|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
48746957|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
48746958|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
48746959|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
48746960|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
48637150|NCT01242514|156528634|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
48637151|NCT01242514|156528635|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
48637152|NCT01242514|156528633|FG000|Overall Study|Lost to Follow-up|14|||
48637153|NCT01242514|156528634|FG001|Overall Study|Lost to Follow-up|5|||
48637154|NCT01242514|156528635|FG002|Overall Study|Lost to Follow-up|4|||
48637155|NCT01242514|156528633|FG000|Overall Study|Adverse Event|129|||
48637156|NCT01242514|156528634|FG001|Overall Study|Adverse Event|18|||
48637157|NCT01242514|156528635|FG002|Overall Study|Adverse Event|19|||
48637158|NCT02756403|156528636|FG000|Overall Study|Unable to swallow medication|0|||
48637159|NCT02756403|156528637|FG001|Overall Study|Unable to swallow medication|1|||
48637160|NCT02756403|156528638|FG002|Overall Study|Unable to swallow medication|1|||
48637161|NCT02756403|156528639|FG003|Overall Study|Unable to swallow medication|1|||
48637162|NCT02756403|156528636|FG000|Overall Study|Did not complete Procedure|0|||
48637163|NCT02756403|156528637|FG001|Overall Study|Did not complete Procedure|1|||
48637164|NCT02756403|156528638|FG002|Overall Study|Did not complete Procedure|0|||
48637165|NCT02756403|156528639|FG003|Overall Study|Did not complete Procedure|0|||
48637166|NCT02756403|156528636|FG000|Overall Study|Changed Mind About Procedure|0|||
48637167|NCT02756403|156528637|FG001|Overall Study|Changed Mind About Procedure|0|||
48637168|NCT02756403|156528638|FG002|Overall Study|Changed Mind About Procedure|1|||
48637169|NCT02756403|156528639|FG003|Overall Study|Changed Mind About Procedure|0|||
48637170|NCT02756403|156528636|FG000|Overall Study|Protocol Violation|0|||
48637171|NCT02756403|156528637|FG001|Overall Study|Protocol Violation|1|||
48637172|NCT02756403|156528638|FG002|Overall Study|Protocol Violation|0|||
48637173|NCT02756403|156528639|FG003|Overall Study|Protocol Violation|1|||
48637174|NCT00776789|156528642|FG000|Overall Study|Consent refusal|2|||
48637175|NCT00776789|156528643|FG001|Overall Study|Consent refusal|2|||
48637176|NCT00776789|156528642|FG000|Overall Study|Poor quality video|1|||
48637177|NCT00776789|156528643|FG001|Overall Study|Poor quality video|1|||
48637178|NCT03358030|156528648|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
48637179|NCT03358030|156528649|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
48637180|NCT03358030|156528650|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
48746961|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
48637181|NCT03358030|156528651|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
48637182|NCT03358030|156528648|FG000|Overall Study|Ineligibility|0|||
48637183|NCT03358030|156528649|FG001|Overall Study|Ineligibility|0|||
48637184|NCT03358030|156528650|FG002|Overall Study|Ineligibility|0|||
48637185|NCT03358030|156528651|FG003|Overall Study|Ineligibility|2|||
48637186|NCT03358030|156528648|FG000|Overall Study|Voluntary Withdrawal|1|||
48637187|NCT03358030|156528649|FG001|Overall Study|Voluntary Withdrawal|1|||
48637188|NCT03358030|156528650|FG002|Overall Study|Voluntary Withdrawal|3|||
48637189|NCT03358030|156528651|FG003|Overall Study|Voluntary Withdrawal|1|||
48637190|NCT03358030|156528648|FG000|Overall Study|Other|0|||
48637191|NCT03358030|156528649|FG001|Overall Study|Other|0|||
48637192|NCT03358030|156528650|FG002|Overall Study|Other|1|||
48637193|NCT03358030|156528651|FG003|Overall Study|Other|0|||
48637194|NCT00730886|156528653|FG000|Overall Study|Lost to Follow-up|1|||
48637195|NCT00730886|156528654|FG001|Overall Study|Lost to Follow-up|0|||
48637196|NCT00730886|156528653|FG000|Overall Study|Physician Decision|1|||
48637197|NCT00730886|156528654|FG001|Overall Study|Physician Decision|0|||
48637198|NCT01150357|156528655|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
48637199|NCT01150357|156528656|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
48637200|NCT01150357|156528657|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
48637201|NCT01150357|156528655|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
48637202|NCT01150357|156528656|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
48637203|NCT01150357|156528657|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
48746962|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
48637204|NCT01150357|156528655|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
48637205|NCT01150357|156528656|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
48637206|NCT01150357|156528657|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
48637207|NCT01150357|156528655|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
48637208|NCT01150357|156528656|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
48637209|NCT01150357|156528657|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
48637210|NCT01150357|156528655|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
48637211|NCT01150357|156528656|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
48637212|NCT01150357|156528657|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
48637213|NCT01150357|156528655|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
48637214|NCT01150357|156528656|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
48637215|NCT01150357|156528657|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
48637216|NCT01150357|156528655|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
48637217|NCT01150357|156528656|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
48637218|NCT01150357|156528657|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
48637219|NCT00657267|156528658|FG000|Overall Study|Progressive disease|45|||
48746963|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
48746964|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
48327779|NCT03732807|155398155|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
48637220|NCT00657267|156528658|FG000|Overall Study|Adverse Event|9|||
48637221|NCT02297412|156528660|FG000|Overall Study|Canceled|1|||
48637222|NCT02297412|156528661|FG001|Overall Study|Canceled|1|||
48637223|NCT02031302|156528662|FG000|Overall Study|Death|115|||
48637224|NCT02031302|156528663|FG001|Overall Study|Death|0|||
48637225|NCT02031302|156528662|FG000|Overall Study|Not treated with study valve system|18|||
48746965|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
48746966|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
48746967|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
48746968|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
48746969|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
48746970|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
48746971|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
48746972|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
48746973|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
48746974|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
48746975|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
48746976|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
48637226|NCT02031302|156528663|FG001|Overall Study|Not treated with study valve system|0|||
48637227|NCT02031302|156528662|FG000|Overall Study|Missed Follow Up|27|||
48637228|NCT02031302|156528663|FG001|Overall Study|Missed Follow Up|0|||
48746977|NCT01433991|156922849|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
48746978|NCT01433991|156922850|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
48746979|NCT01433991|156922851|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
48746980|NCT01433991|156922852|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
48746981|NCT03539081|156922853|FG000|Overall Study|Withdrawal by Subject|2|||
48746982|NCT03539081|156922854|FG001|Overall Study|Withdrawal by Subject|3|||
48746983|NCT03539081|156922855|FG002|Overall Study|Withdrawal by Subject|0|||
48746984|NCT03539081|156922853|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
48327780|NCT03732807|155398156|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
48327781|NCT03732807|155398157|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
48327782|NCT03732807|155398158|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
48327783|NCT03732807|155398159|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
48327784|NCT03732807|155398160|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
48327785|NCT03732807|155398161|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
48327786|NCT03732807|155398155|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
48327787|NCT03732807|155398156|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
48327788|NCT03732807|155398157|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
48327789|NCT03732807|155398158|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
48327790|NCT03732807|155398159|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
48327791|NCT03732807|155398160|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
48327792|NCT03732807|155398161|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
48327793|NCT03732807|155398155|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
48383890|NCT02606461|155601478|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48637229|NCT02031302|156528662|FG000|Overall Study|Lost to Follow-up|4|||
48637230|NCT02031302|156528663|FG001|Overall Study|Lost to Follow-up|0|||
48637231|NCT02806414|156528664|FG000|Overall Study|Lost to Follow-up|2|||
48637232|NCT03816176|156528667|FG000|Overall Study|Miscellaneous|5|||
48637233|NCT03816176|156528667|FG000|Overall Study|Lack of Efficacy|4|||
48637234|NCT03816176|156528667|FG000|Overall Study|Adverse Event|3|||
48637235|NCT02471144|156530649|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
48637236|NCT02471144|156530650|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
48637237|NCT02471144|156530651|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
48637238|NCT02471144|156530652|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
48637239|NCT02471144|156530653|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
48637240|NCT02471144|156530654|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
48637241|NCT02471144|156530655|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
48637242|NCT02471144|156530656|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
48746985|NCT03539081|156922854|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
48746986|NCT03539081|156922855|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
48746987|NCT01473836|156922859|FG000|Overall Study|Adverse Event|4|||
48746988|NCT01473836|156922859|FG000|Overall Study|Lack of Efficacy|1|||
48746989|NCT01473836|156922859|FG000|Overall Study|Does not meet entrance criteria|1|||
48327794|NCT03732807|155398156|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
48327795|NCT03732807|155398157|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
48327796|NCT03732807|155398158|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
48327797|NCT03732807|155398159|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
48637243|NCT02471144|156530657|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
48637244|NCT02471144|156530658|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
48637245|NCT02471144|156530659|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
48637246|NCT02471144|156530649|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48637247|NCT02471144|156530650|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48637248|NCT02471144|156530651|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48637249|NCT02471144|156530652|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
48637250|NCT02471144|156530653|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48637251|NCT02471144|156530654|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48637252|NCT02471144|156530655|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48637253|NCT02471144|156530656|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48637254|NCT02471144|156530657|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48637255|NCT02471144|156530658|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48746990|NCT03602482|156922860|FG000|Overall Study|Withdrawal by Subject|6|||
48327798|NCT03732807|155398160|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
48327799|NCT03732807|155398161|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
48327800|NCT03732807|155398155|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48327801|NCT03732807|155398156|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48637256|NCT02471144|156530659|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
48746991|NCT03602482|156922861|FG001|Overall Study|Withdrawal by Subject|7|||
48746992|NCT03602482|156922862|FG002|Overall Study|Withdrawal by Subject|0|||
48746993|NCT03602482|156922863|FG003|Overall Study|Withdrawal by Subject|0|||
48746994|NCT01389817|156922864|FG000|Overall Study|Physician Decision|1|||
48746995|NCT01389817|156922865|FG001|Overall Study|Physician Decision|0|||
48746996|NCT01389817|156922864|FG000|Overall Study|Lost to Follow-up|1|||
48746997|NCT01389817|156922865|FG001|Overall Study|Lost to Follow-up|0|||
48746998|NCT01389817|156922864|FG000|Overall Study|Withdrawal by Subject|2|||
48746999|NCT01389817|156922865|FG001|Overall Study|Withdrawal by Subject|0|||
48747000|NCT00621985|156922869|FG000|Dexamethasone Admission|Adverse Event|1|||
48327802|NCT03732807|155398157|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48327803|NCT03732807|155398158|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48327804|NCT03732807|155398159|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48327805|NCT03732807|155398160|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
48327806|NCT03732807|155398161|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48327807|NCT03732807|155398155|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
48327808|NCT03732807|155398156|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
48327809|NCT03732807|155398157|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
48327810|NCT03732807|155398158|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
48327811|NCT03732807|155398159|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
48327812|NCT03732807|155398160|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
48327813|NCT03732807|155398161|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
48327814|NCT03732807|155398155|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
48327815|NCT03732807|155398156|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
48327816|NCT03732807|155398157|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
48327817|NCT03732807|155398158|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
48327818|NCT03732807|155398159|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
48327819|NCT03732807|155398160|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
48327820|NCT03732807|155398161|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
48327821|NCT03732807|155398155|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
48327822|NCT03732807|155398156|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
48327823|NCT03732807|155398157|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
48327824|NCT03732807|155398158|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
48327825|NCT03732807|155398159|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
48327826|NCT03732807|155398160|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
48327827|NCT03732807|155398161|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
48327828|NCT03732807|155398155|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48327829|NCT03732807|155398156|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
48327830|NCT03732807|155398157|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48327831|NCT03732807|155398158|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48637257|NCT02471144|156530649|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637258|NCT02471144|156530650|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48747001|NCT00630396|156922874|FG000|Overall Study|Death|4|||
48747002|NCT00630396|156922874|FG000|Overall Study|Lost to Follow-up|3|||
48747003|NCT02155608|156922875|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
48637259|NCT02471144|156530651|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
48637260|NCT02471144|156530652|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637261|NCT02471144|156530653|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637262|NCT02471144|156530654|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637263|NCT02471144|156530655|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637264|NCT02471144|156530656|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637265|NCT02471144|156530657|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637266|NCT02471144|156530658|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637267|NCT02471144|156530659|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
48637268|NCT02471144|156530649|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
48637269|NCT02471144|156530650|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
48637270|NCT02471144|156530651|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637271|NCT02471144|156530652|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637272|NCT02471144|156530653|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637273|NCT02471144|156530654|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637274|NCT02471144|156530655|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637275|NCT02471144|156530656|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637276|NCT02471144|156530657|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637277|NCT02471144|156530658|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637278|NCT02471144|156530659|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
48637279|NCT02471144|156530649|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
48637280|NCT02471144|156530650|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
48637281|NCT02471144|156530651|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
48637282|NCT02471144|156530652|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
48637283|NCT02471144|156530653|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
48637284|NCT02471144|156530654|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
48637285|NCT02471144|156530655|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
48637286|NCT02471144|156530656|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
48637287|NCT02471144|156530657|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
48637288|NCT02471144|156530658|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
48637289|NCT02471144|156530659|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
48637290|NCT02471144|156530649|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637291|NCT02471144|156530650|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637292|NCT02471144|156530651|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637293|NCT02471144|156530652|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637294|NCT02471144|156530653|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637295|NCT02471144|156530654|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
48637296|NCT02471144|156530655|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637297|NCT02471144|156530656|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637298|NCT02471144|156530657|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
48637299|NCT02471144|156530658|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637300|NCT02471144|156530659|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
48637301|NCT02471144|156530649|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637302|NCT02471144|156530650|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637303|NCT02471144|156530651|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637304|NCT02471144|156530652|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637305|NCT02471144|156530653|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637306|NCT02471144|156530654|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637307|NCT02471144|156530655|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637308|NCT02471144|156530656|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637309|NCT02471144|156530657|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
48637310|NCT02471144|156530658|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637311|NCT02471144|156530659|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
48637312|NCT02471144|156530649|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637313|NCT02471144|156530650|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637314|NCT02471144|156530651|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637315|NCT02471144|156530652|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637316|NCT02471144|156530653|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637317|NCT02471144|156530654|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637318|NCT02471144|156530655|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637319|NCT02471144|156530656|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
48637320|NCT02471144|156530657|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
48637321|NCT02471144|156530658|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637322|NCT02471144|156530659|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
48637323|NCT02471144|156530649|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637324|NCT02471144|156530650|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637325|NCT02471144|156530651|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637326|NCT02471144|156530652|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637327|NCT02471144|156530653|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637328|NCT02471144|156530654|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637329|NCT02471144|156530655|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637330|NCT02471144|156530656|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637331|NCT02471144|156530657|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
48637332|NCT02471144|156530658|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
48747004|NCT02155608|156922876|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
48747005|NCT02155608|156922875|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
48327832|NCT03732807|155398159|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48327833|NCT03732807|155398160|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48327834|NCT03732807|155398161|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
48327835|NCT03732807|155398155|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
48327836|NCT03732807|155398156|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
48327837|NCT03732807|155398157|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
48327838|NCT03732807|155398158|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
48327839|NCT03732807|155398159|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
48327840|NCT03732807|155398160|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
48327841|NCT03732807|155398161|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
48327842|NCT03732807|155398155|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
48327843|NCT03732807|155398156|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
48327844|NCT03732807|155398157|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
48327845|NCT03732807|155398158|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
48327846|NCT03732807|155398159|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
48327847|NCT03732807|155398160|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
48327848|NCT03732807|155398161|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
48327849|NCT03732807|155398155|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
48327850|NCT03732807|155398156|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
48327851|NCT03732807|155398157|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
48327852|NCT03732807|155398158|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
48327853|NCT03732807|155398159|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
48327854|NCT03732807|155398160|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
48327855|NCT03732807|155398161|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
48327856|NCT03851094|155398164|FG000|Overall Study|Withdrawal by Subject|0|||
48327857|NCT03851094|155398165|FG001|Overall Study|Withdrawal by Subject|1|||
48327858|NCT03851094|155398164|FG000|Overall Study|Participant lost device|0|||
48327859|NCT03851094|155398165|FG001|Overall Study|Participant lost device|1|||
48327860|NCT03851094|155398164|FG000|Overall Study|Participant returned device|0|||
48327861|NCT03851094|155398165|FG001|Overall Study|Participant returned device|2|||
48327862|NCT03490032|155398169|FG000|Overall Study|family issue (child custody)|1|||
48327863|NCT03490032|155398170|FG001|Overall Study|family issue (child custody)|0|||
48327864|NCT03490032|155398171|FG002|Overall Study|family issue (child custody)|0|||
48327865|NCT02575365|155398172|FG000|Overall Study|Lost to Follow-up|4|||
48327866|NCT00273052|155398183|FG000|Overall Study|Withdrawal by Subject|16|||
48327867|NCT00273052|155398184|FG001|Overall Study|Withdrawal by Subject|19|||
48327868|NCT00273052|155398183|FG000|Overall Study|Adverse Event|21|||
48327869|NCT00273052|155398184|FG001|Overall Study|Adverse Event|19|||
48327870|NCT00273052|155398183|FG000|Overall Study|Protocol Violation|14|||
48327871|NCT00273052|155398184|FG001|Overall Study|Protocol Violation|18|||
48327872|NCT00273052|155398183|FG000|Overall Study|Lost to Follow-up|7|||
48327873|NCT00273052|155398184|FG001|Overall Study|Lost to Follow-up|25|||
48327874|NCT00273052|155398183|FG000|Overall Study|Lack of Efficacy|6|||
48327875|NCT00273052|155398184|FG001|Overall Study|Lack of Efficacy|4|||
48327876|NCT00273052|155398183|FG000|Overall Study|Non-Compliance|3|||
48327877|NCT00273052|155398184|FG001|Overall Study|Non-Compliance|1|||
48327878|NCT00273052|155398183|FG000|Overall Study|Other|2|||
48327879|NCT00273052|155398184|FG001|Overall Study|Other|0|||
48327880|NCT00273052|155398183|FG000|Overall Study|Worsening serum lipid levels|0|||
48327881|NCT00273052|155398184|FG001|Overall Study|Worsening serum lipid levels|2|||
48327882|NCT00454194|155398185|FG000|Overall Study|Adverse Event|7|||
48327883|NCT00454194|155398186|FG001|Overall Study|Adverse Event|2|||
48327884|NCT00454194|155398185|FG000|Overall Study|Withdrawal by Subject|12|||
48327885|NCT00454194|155398186|FG001|Overall Study|Withdrawal by Subject|8|||
48327886|NCT00454194|155398185|FG000|Overall Study|Other Medical Problems|1|||
48327887|NCT00454194|155398186|FG001|Overall Study|Other Medical Problems|2|||
48327888|NCT00454194|155398185|FG000|Overall Study|Other Unspecified Reason|2|||
48327889|NCT00454194|155398186|FG001|Overall Study|Other Unspecified Reason|2|||
48327890|NCT00734578|155398188|FG000|Overall Study|Adverse Event|4|||
48637333|NCT02471144|156530659|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
48637334|NCT02471144|156530649|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637335|NCT02471144|156530650|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637336|NCT02471144|156530651|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637337|NCT02471144|156530652|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637338|NCT02471144|156530653|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637339|NCT02471144|156530654|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637340|NCT02471144|156530655|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48747006|NCT02155608|156922876|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
48747007|NCT02430311|156922877|FG000|Part A|Adverse Event|0|||
48747008|NCT02430311|156922878|FG001|Part A|Adverse Event|1|||
48747009|NCT02430311|156922877|FG000|Part A|Withdrawal by Subject|1|||
48637341|NCT02471144|156530656|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637342|NCT02471144|156530657|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637343|NCT02471144|156530658|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
48327891|NCT00734578|155398189|FG001|Overall Study|Adverse Event|6|||
48327892|NCT00734578|155398190|FG002|Overall Study|Adverse Event|1|||
48637344|NCT02471144|156530659|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
48637345|NCT02471144|156530649|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48747010|NCT02430311|156922878|FG001|Part A|Withdrawal by Subject|0|||
48747011|NCT02430311|156922877|FG000|Part B|Meet study-specific withdrawal criteria|6|||
48747012|NCT02430311|156922878|FG001|Part B|Meet study-specific withdrawal criteria|6|||
48747013|NCT02430311|156922877|FG000|Part B|Withdrawal by Subject|2|||
48747014|NCT02430311|156922878|FG001|Part B|Withdrawal by Subject|2|||
48747015|NCT02430311|156922877|FG000|Part B|Adverse Event|1|||
48747016|NCT02430311|156922878|FG001|Part B|Adverse Event|0|||
48747017|NCT02430311|156922877|FG000|Part B|Death|1|||
48747018|NCT02430311|156922878|FG001|Part B|Death|0|||
48747019|NCT01153347|156922883|FG000|Overall Study|Withdrawal by Subject|7|||
48747020|NCT01153347|156922884|FG001|Overall Study|Withdrawal by Subject|7|||
48747021|NCT01153347|156922885|FG002|Overall Study|Withdrawal by Subject|7|||
48747022|NCT01153347|156922886|FG003|Overall Study|Withdrawal by Subject|7|||
48747023|NCT01153347|156922883|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48747024|NCT01153347|156922884|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48747025|NCT01153347|156922885|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
48747026|NCT01153347|156922886|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48747027|NCT01153347|156922883|FG000|Overall Study|Adverse Event|3|||
48747028|NCT01153347|156922884|FG001|Overall Study|Adverse Event|9|||
48747029|NCT01153347|156922885|FG002|Overall Study|Adverse Event|21|||
48747030|NCT01153347|156922886|FG003|Overall Study|Adverse Event|7|||
48747031|NCT01153347|156922883|FG000|Overall Study|Severe non-compliance to protocol|6|||
48747032|NCT01153347|156922884|FG001|Overall Study|Severe non-compliance to protocol|7|||
48747033|NCT01153347|156922885|FG002|Overall Study|Severe non-compliance to protocol|4|||
48747034|NCT01153347|156922886|FG003|Overall Study|Severe non-compliance to protocol|3|||
48747035|NCT01153347|156922883|FG000|Overall Study|Condition under investigation worsened|1|||
48747036|NCT01153347|156922884|FG001|Overall Study|Condition under investigation worsened|1|||
48747037|NCT01153347|156922885|FG002|Overall Study|Condition under investigation worsened|0|||
48747038|NCT01153347|156922886|FG003|Overall Study|Condition under investigation worsened|0|||
48747039|NCT01153347|156922883|FG000|Overall Study|Lack of Efficacy|2|||
48747040|NCT01153347|156922884|FG001|Overall Study|Lack of Efficacy|2|||
48747041|NCT01153347|156922885|FG002|Overall Study|Lack of Efficacy|0|||
48747042|NCT01153347|156922886|FG003|Overall Study|Lack of Efficacy|4|||
48747043|NCT01153347|156922883|FG000|Overall Study|Study-specific withdrawal criteria|4|||
48747044|NCT01153347|156922884|FG001|Overall Study|Study-specific withdrawal criteria|3|||
48747045|NCT01153347|156922885|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48747046|NCT01153347|156922886|FG003|Overall Study|Study-specific withdrawal criteria|2|||
48747047|NCT01153347|156922883|FG000|Overall Study|Lost to Follow-up|4|||
48747048|NCT01153347|156922884|FG001|Overall Study|Lost to Follow-up|9|||
48747049|NCT01153347|156922885|FG002|Overall Study|Lost to Follow-up|11|||
48747050|NCT01153347|156922886|FG003|Overall Study|Lost to Follow-up|8|||
48747051|NCT01153347|156922883|FG000|Overall Study|Other|5|||
48747052|NCT01153347|156922884|FG001|Overall Study|Other|5|||
48747053|NCT01153347|156922885|FG002|Overall Study|Other|4|||
48747054|NCT01153347|156922886|FG003|Overall Study|Other|0|||
48747055|NCT01153347|156922883|FG000|Overall Study|Death|1|||
48747056|NCT01153347|156922884|FG001|Overall Study|Death|0|||
48747057|NCT01153347|156922885|FG002|Overall Study|Death|0|||
48747058|NCT01153347|156922886|FG003|Overall Study|Death|0|||
48747059|NCT02835820|156922887|FG000|Overall Study|Baseline Screen Failure|0|||
48747060|NCT02835820|156922888|FG001|Overall Study|Baseline Screen Failure|3|||
48747061|NCT01396148|156922891|FG000|Overall Study|Patient Decision|1|||
48747062|NCT00840450|156922892|FG000|Overall Study|Adverse Event|1|||
48747063|NCT00840450|156922892|FG000|Overall Study|Lack of Efficacy|2|||
48747064|NCT02495168|156922893|FG000|Overall Study|Other than Specified|18|||
48747065|NCT02495168|156922894|FG001|Overall Study|Other than Specified|22|||
48747066|NCT02495168|156922895|FG002|Overall Study|Other than Specified|5|||
48747067|NCT02495168|156922893|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
48747068|NCT02495168|156922894|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
48747069|NCT02495168|156922895|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
48747070|NCT02495168|156922893|FG000|Overall Study|Physician Decision|1|||
48747071|NCT02495168|156922894|FG001|Overall Study|Physician Decision|1|||
48747072|NCT02495168|156922895|FG002|Overall Study|Physician Decision|0|||
48747073|NCT02495168|156922893|FG000|Overall Study|Lost to Follow-up|10|||
48637346|NCT02471144|156530650|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48637347|NCT02471144|156530651|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48637348|NCT02471144|156530652|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48747074|NCT02495168|156922894|FG001|Overall Study|Lost to Follow-up|6|||
48747075|NCT02495168|156922895|FG002|Overall Study|Lost to Follow-up|1|||
48747076|NCT02495168|156922893|FG000|Overall Study|Withdrawal by Subject|1|||
48747077|NCT02495168|156922894|FG001|Overall Study|Withdrawal by Subject|4|||
48747078|NCT02495168|156922895|FG002|Overall Study|Withdrawal by Subject|2|||
48747079|NCT02495168|156922893|FG000|Overall Study|Protocol Violation|0|||
48747080|NCT02495168|156922894|FG001|Overall Study|Protocol Violation|10|||
48747081|NCT02495168|156922895|FG002|Overall Study|Protocol Violation|1|||
48747082|NCT02495168|156922893|FG000|Overall Study|Adverse Event|4|||
48747083|NCT02495168|156922894|FG001|Overall Study|Adverse Event|8|||
48747084|NCT02495168|156922895|FG002|Overall Study|Adverse Event|3|||
48747085|NCT02495168|156922893|FG000|Overall Study|Lack of Efficacy|0|||
48747086|NCT02495168|156922894|FG001|Overall Study|Lack of Efficacy|0|||
48747087|NCT02495168|156922895|FG002|Overall Study|Lack of Efficacy|3|||
48747088|NCT00133952|156922896|FG000|Overall Study|Adverse Event|1|||
48747089|NCT00133952|156922897|FG001|Overall Study|Adverse Event|2|||
48747090|NCT00133952|156922896|FG000|Overall Study|Death|3|||
48747091|NCT00133952|156922897|FG001|Overall Study|Death|2|||
48747092|NCT00133952|156922896|FG000|Overall Study|Lost to Follow-up|9|||
48747093|NCT00133952|156922897|FG001|Overall Study|Lost to Follow-up|14|||
48747094|NCT00133952|156922896|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
48747095|NCT00133952|156922897|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
48747096|NCT00133952|156922896|FG000|Overall Study|Protocol Violation|1|||
48747097|NCT00133952|156922897|FG001|Overall Study|Protocol Violation|1|||
48747098|NCT00133952|156922896|FG000|Overall Study|Withdrawal by Subject|20|||
48327893|NCT00734578|155398188|FG000|Overall Study|Protocol Violation|8|||
48637349|NCT02471144|156530653|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48637350|NCT02471144|156530654|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48637351|NCT02471144|156530655|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48637352|NCT02471144|156530656|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48637353|NCT02471144|156530657|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48637354|NCT02471144|156530658|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
48637355|NCT02471144|156530659|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
48637356|NCT02471144|156530649|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637357|NCT02471144|156530650|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637358|NCT02471144|156530651|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637359|NCT02471144|156530652|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637360|NCT02471144|156530653|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637361|NCT02471144|156530654|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637362|NCT02471144|156530655|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637363|NCT02471144|156530656|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637364|NCT02471144|156530657|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
48637365|NCT02471144|156530658|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
48637366|NCT02471144|156530659|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
48637367|NCT02471144|156530649|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637368|NCT02471144|156530650|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637369|NCT02471144|156530651|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637370|NCT02471144|156530652|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637371|NCT02471144|156530653|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637372|NCT02471144|156530654|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637373|NCT02471144|156530655|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637374|NCT02471144|156530656|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637375|NCT02471144|156530657|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48747099|NCT00133952|156922897|FG001|Overall Study|Withdrawal by Subject|4|||
48747100|NCT00133952|156922896|FG000|Overall Study|Physician Decision|4|||
48747101|NCT00133952|156922897|FG001|Overall Study|Physician Decision|3|||
48747102|NCT00133952|156922896|FG000|Overall Study|Sponsor Decision|0|||
48747103|NCT00133952|156922897|FG001|Overall Study|Sponsor Decision|1|||
48747104|NCT00727025|156922902|FG000|Overall Study|Physician Decision|23|||
48747105|NCT00964860|156922903|FG000|Overall Study|Withdrawal by Subject|0|||
48747106|NCT00964860|156922904|FG001|Overall Study|Withdrawal by Subject|1|||
48637376|NCT02471144|156530658|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
48747107|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Physician Decision|0|||
48327894|NCT00734578|155398189|FG001|Overall Study|Protocol Violation|6|||
48637377|NCT02471144|156530659|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
48637378|NCT02471144|156530649|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48747108|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Physician Decision|1|||
48747109|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Physician Decision|0|||
48747110|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
48747111|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
48747112|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
48747113|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
48747114|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
48747115|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
48747116|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Other|4|||
48747117|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Other|4|||
48747118|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Other|0|||
48747119|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
48747120|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
48747121|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
48747122|NCT02585960|156922905|FG000|PK/Safety Assessment Period|Screen Failure|0|||
48747123|NCT02585960|156922906|FG001|PK/Safety Assessment Period|Screen Failure|0|||
48747124|NCT02585960|156922907|FG002|PK/Safety Assessment Period|Screen Failure|1|||
48747125|NCT02585960|156922905|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
48747126|NCT02585960|156922906|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
48747127|NCT02585960|156922907|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
48747128|NCT02585960|156922905|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
48747129|NCT02585960|156922906|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
48747130|NCT02585960|156922907|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
48747131|NCT02509156|156922908|FG000|Randomized Phase|Death|1|||
48747132|NCT02509156|156922909|FG001|Randomized Phase|Death|0|||
48747133|NCT02509156|156922908|FG000|Randomized Phase|Withdrawal by Subject|1|||
48747134|NCT02509156|156922909|FG001|Randomized Phase|Withdrawal by Subject|1|||
48747135|NCT01083576|156922910|FG000|Overall Study|Treatment Failure|6|||
48747136|NCT01083576|156922911|FG001|Overall Study|Treatment Failure|1|||
48327895|NCT00734578|155398190|FG002|Overall Study|Protocol Violation|3|||
48747137|NCT01539538|156922922|FG000|Overall Study|Adverse Event|13|||
48747138|NCT01539538|156922923|FG001|Overall Study|Adverse Event|18|||
48327896|NCT00734578|155398188|FG000|Overall Study|Withdrawal by Subject|7|||
48327897|NCT00734578|155398189|FG001|Overall Study|Withdrawal by Subject|8|||
48637379|NCT02471144|156530650|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48637380|NCT02471144|156530651|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48637381|NCT02471144|156530652|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48637382|NCT02471144|156530653|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48637383|NCT02471144|156530654|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48637384|NCT02471144|156530655|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48747139|NCT01539538|156922922|FG000|Overall Study|Lack of Efficacy|13|||
48747140|NCT01539538|156922923|FG001|Overall Study|Lack of Efficacy|16|||
48747141|NCT01539538|156922922|FG000|Overall Study|Withdrawal by Subject|2|||
48747142|NCT01539538|156922923|FG001|Overall Study|Withdrawal by Subject|3|||
48747143|NCT01539538|156922922|FG000|Overall Study|PCA no longer required or PCA problem|3|||
48747144|NCT01539538|156922923|FG001|Overall Study|PCA no longer required or PCA problem|7|||
48747145|NCT01727297|156922924|FG000|Overall Study|Death|13|||
48747146|NCT01727297|156922925|FG001|Overall Study|Death|0|||
48747147|NCT01727297|156922924|FG000|Overall Study|Protocol Violation|1|||
48747148|NCT01727297|156922925|FG001|Overall Study|Protocol Violation|10|||
48747149|NCT01727297|156922924|FG000|Overall Study|Adverse Event|3|||
48747150|NCT01727297|156922925|FG001|Overall Study|Adverse Event|1|||
48747151|NCT01727297|156922924|FG000|Overall Study|Lost to Follow-up|11|||
48747152|NCT01727297|156922925|FG001|Overall Study|Lost to Follow-up|0|||
48747153|NCT01727297|156922924|FG000|Overall Study|Withdrawal by Subject|26|||
48747154|NCT01727297|156922925|FG001|Overall Study|Withdrawal by Subject|27|||
48747155|NCT01727297|156922924|FG000|Overall Study|Physician Decision|19|||
48747156|NCT01727297|156922925|FG001|Overall Study|Physician Decision|5|||
48747157|NCT01727297|156922924|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
48747158|NCT01727297|156922925|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
48747159|NCT01192516|156922926|FG000|Overall Study|Lost to Follow-up|7|||
48747160|NCT01192516|156922927|FG001|Overall Study|Lost to Follow-up|10|||
48747161|NCT01192516|156922928|FG002|Overall Study|Lost to Follow-up|7|||
48747162|NCT01192516|156922926|FG000|Overall Study|Withdrawal by Subject|4|||
48747163|NCT01192516|156922927|FG001|Overall Study|Withdrawal by Subject|4|||
48747164|NCT01192516|156922928|FG002|Overall Study|Withdrawal by Subject|1|||
48747165|NCT01192516|156922926|FG000|Overall Study|started new treatment|5|||
48747166|NCT01192516|156922927|FG001|Overall Study|started new treatment|1|||
48747167|NCT01192516|156922928|FG002|Overall Study|started new treatment|0|||
48747168|NCT01192516|156922926|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
48327898|NCT00734578|155398190|FG002|Overall Study|Withdrawal by Subject|11|||
48327899|NCT00734578|155398188|FG000|Overall Study|Lost to Follow-up|9|||
48327900|NCT00734578|155398189|FG001|Overall Study|Lost to Follow-up|3|||
48637385|NCT02471144|156530656|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48637386|NCT02471144|156530657|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
48637387|NCT02471144|156530658|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
48637388|NCT02471144|156530659|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
48747169|NCT01192516|156922927|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
48327901|NCT00734578|155398190|FG002|Overall Study|Lost to Follow-up|5|||
48747170|NCT01192516|156922928|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
48327902|NCT00734578|155398188|FG000|Overall Study|Lack of Efficacy|3|||
48327903|NCT00734578|155398189|FG001|Overall Study|Lack of Efficacy|2|||
48327904|NCT00734578|155398190|FG002|Overall Study|Lack of Efficacy|5|||
48327905|NCT00734578|155398188|FG000|Overall Study|Randomized in error|1|||
48327906|NCT00734578|155398189|FG001|Overall Study|Randomized in error|0|||
48327907|NCT00734578|155398190|FG002|Overall Study|Randomized in error|0|||
48327908|NCT00734578|155398188|FG000|Overall Study|Exclusion criteria|1|||
48327909|NCT00734578|155398189|FG001|Overall Study|Exclusion criteria|0|||
48327910|NCT00734578|155398190|FG002|Overall Study|Exclusion criteria|0|||
48327911|NCT02169414|155398191|FG000|Overall Study|Withdrawal by Subject|1|||
48327912|NCT02169414|155398192|FG001|Overall Study|Withdrawal by Subject|0|||
48327913|NCT02169414|155398193|FG002|Overall Study|Withdrawal by Subject|0|||
48327914|NCT02169414|155398194|FG003|Overall Study|Withdrawal by Subject|0|||
48327915|NCT02169414|155398191|FG000|Overall Study|Adverse Event|0|||
48327916|NCT02169414|155398192|FG001|Overall Study|Adverse Event|1|||
48327917|NCT02169414|155398193|FG002|Overall Study|Adverse Event|0|||
48637389|NCT05523323|156530662|FG000|Overall Study|Death|26|||
48637390|NCT05523323|156530663|FG001|Overall Study|Death|21|||
48747171|NCT03782792|156922931|FG000|Overall Study|Patient left the country|0|||
48747172|NCT03782792|156922932|FG001|Overall Study|Patient left the country|1|||
48327918|NCT02169414|155398194|FG003|Overall Study|Adverse Event|0|||
48637391|NCT05523323|156530662|FG000|Overall Study|Ongoing participants|35|||
48327919|NCT03547154|155398195|FG000|Overall Study|Disease Progression/Recurrence|6|||
48327920|NCT03547154|155398196|FG001|Overall Study|Disease Progression/Recurrence|14|||
48327921|NCT03547154|155398195|FG000|Overall Study|Adverse Event|26|||
48747173|NCT03782792|156922931|FG000|Overall Study|Withdrawal by Subject|1|||
48747174|NCT03782792|156922932|FG001|Overall Study|Withdrawal by Subject|2|||
48327922|NCT03547154|155398196|FG001|Overall Study|Adverse Event|31|||
48637392|NCT05523323|156530663|FG001|Overall Study|Ongoing participants|30|||
48637393|NCT04047446|156530670|FG000|Overall Study|Physician Decision|1|||
48637394|NCT04047446|156530671|FG001|Overall Study|Physician Decision|0|||
48637395|NCT02234362|156530677|FG000|Overall Study|Not eligible after first screening visit|17|||
48637396|NCT02234362|156530677|FG000|Overall Study|Lost to Follow-up|6|||
48637397|NCT02234362|156530677|FG000|Overall Study|Withdrawal by Subject|3|||
48637398|NCT00329030|156530678|FG000|Overall Study|Withdrawal by Subject|1|||
48637399|NCT00329030|156530679|FG001|Overall Study|Withdrawal by Subject|3|||
48637400|NCT00329030|156530678|FG000|Overall Study|Progressive Disease|6|||
48637401|NCT00329030|156530679|FG001|Overall Study|Progressive Disease|2|||
48637402|NCT00329030|156530678|FG000|Overall Study|Ineligible Pathology|1|||
48637403|NCT00329030|156530679|FG001|Overall Study|Ineligible Pathology|1|||
48637404|NCT02286895|156530680|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
48637405|NCT02286895|156530681|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
48637406|NCT02286895|156530680|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
48637407|NCT02286895|156530681|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
48637408|NCT02286895|156530680|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
48637409|NCT02286895|156530681|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
48637410|NCT00328172|156530688|FG000|Overall Study|Adverse Event|3|||
48637411|NCT00328172|156530689|FG001|Overall Study|Adverse Event|2|||
48637412|NCT00328172|156530690|FG002|Overall Study|Adverse Event|1|||
48637413|NCT00328172|156530691|FG003|Overall Study|Adverse Event|2|||
48637414|NCT00328172|156530692|FG004|Overall Study|Adverse Event|1|||
48747175|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
48747176|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
48747177|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
48747178|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
48747179|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
48637415|NCT00328172|156530688|FG000|Overall Study|Protocol Violation|0|||
48637416|NCT00328172|156530689|FG001|Overall Study|Protocol Violation|1|||
48637417|NCT00328172|156530690|FG002|Overall Study|Protocol Violation|1|||
48637418|NCT00328172|156530691|FG003|Overall Study|Protocol Violation|0|||
48637419|NCT00328172|156530692|FG004|Overall Study|Protocol Violation|0|||
48637420|NCT00328172|156530688|FG000|Overall Study|Lost to Follow-up|1|||
48637421|NCT00328172|156530689|FG001|Overall Study|Lost to Follow-up|1|||
48637422|NCT00328172|156530690|FG002|Overall Study|Lost to Follow-up|2|||
48637423|NCT00328172|156530691|FG003|Overall Study|Lost to Follow-up|1|||
48637424|NCT00328172|156530692|FG004|Overall Study|Lost to Follow-up|1|||
48637425|NCT00328172|156530688|FG000|Overall Study|Withdrawal by Subject|1|||
48637426|NCT00328172|156530689|FG001|Overall Study|Withdrawal by Subject|1|||
48637427|NCT00328172|156530690|FG002|Overall Study|Withdrawal by Subject|1|||
48637428|NCT00328172|156530691|FG003|Overall Study|Withdrawal by Subject|6|||
48637429|NCT00328172|156530692|FG004|Overall Study|Withdrawal by Subject|0|||
48637430|NCT00328172|156530688|FG000|Overall Study|Lack of Efficacy|14|||
48637431|NCT00328172|156530689|FG001|Overall Study|Lack of Efficacy|9|||
48637432|NCT00328172|156530690|FG002|Overall Study|Lack of Efficacy|4|||
48637433|NCT00328172|156530691|FG003|Overall Study|Lack of Efficacy|4|||
48637434|NCT00328172|156530692|FG004|Overall Study|Lack of Efficacy|3|||
48637435|NCT00328172|156530688|FG000|Overall Study|Other reason (not specified)|3|||
48637436|NCT00328172|156530689|FG001|Overall Study|Other reason (not specified)|0|||
48637437|NCT00328172|156530690|FG002|Overall Study|Other reason (not specified)|1|||
48637438|NCT00328172|156530691|FG003|Overall Study|Other reason (not specified)|0|||
48637439|NCT00328172|156530692|FG004|Overall Study|Other reason (not specified)|0|||
48637440|NCT00077974|156530693|FG000|Overall Study|Adverse Event|22|||
48637441|NCT00077974|156530693|FG000|Overall Study|Protocol Violation|1|||
48637442|NCT00077974|156530693|FG000|Overall Study|Withdrawal by Subject|3|||
48637443|NCT00077974|156530693|FG000|Overall Study|Lack of Efficacy|76|||
48747180|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
48637444|NCT00077974|156530693|FG000|Overall Study|Decision of Sponsor|2|||
48637445|NCT01343888|156530694|FG000|Overall Study|Adverse Event|12|||
48637446|NCT01343888|156530695|FG001|Overall Study|Adverse Event|22|||
48637447|NCT01343888|156530696|FG002|Overall Study|Adverse Event|5|||
48747181|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
48637448|NCT01343888|156530694|FG000|Overall Study|Lack of Efficacy|9|||
48637449|NCT01343888|156530695|FG001|Overall Study|Lack of Efficacy|9|||
48637450|NCT01343888|156530696|FG002|Overall Study|Lack of Efficacy|13|||
48637451|NCT01343888|156530694|FG000|Overall Study|Lost to Follow-up|0|||
48637452|NCT01343888|156530695|FG001|Overall Study|Lost to Follow-up|2|||
48637453|NCT01343888|156530696|FG002|Overall Study|Lost to Follow-up|1|||
48637454|NCT01343888|156530694|FG000|Overall Study|Protocol Violation|0|||
48637455|NCT01343888|156530695|FG001|Overall Study|Protocol Violation|2|||
48637456|NCT01343888|156530696|FG002|Overall Study|Protocol Violation|0|||
48637457|NCT01343888|156530694|FG000|Overall Study|Withdrawal by Subject|4|||
48637458|NCT01343888|156530695|FG001|Overall Study|Withdrawal by Subject|4|||
48637459|NCT01343888|156530696|FG002|Overall Study|Withdrawal by Subject|2|||
48637460|NCT01343888|156530694|FG000|Overall Study|other than stated above|0|||
48637461|NCT01343888|156530695|FG001|Overall Study|other than stated above|0|||
48637462|NCT01343888|156530696|FG002|Overall Study|other than stated above|1|||
48327923|NCT03547154|155398195|FG000|Overall Study|Protocol Violation|6|||
48637463|NCT00402987|156530697|FG000|Overall Study|Lack of Efficacy|0|||
48637464|NCT00402987|156530698|FG001|Overall Study|Lack of Efficacy|0|||
48637465|NCT00402987|156530699|FG002|Overall Study|Lack of Efficacy|1|||
48637466|NCT00402987|156530700|FG003|Overall Study|Lack of Efficacy|0|||
48637467|NCT01990742|156530704|FG000|Overall Study|Withdrawal by facility|407|||
48637468|NCT01990742|156530705|FG001|Overall Study|Withdrawal by facility|1083|||
48637469|NCT01990742|156530704|FG000|Overall Study|Facility closed|0|||
48637470|NCT01990742|156530705|FG001|Overall Study|Facility closed|270|||
48637471|NCT00976456|156530706|FG000|Overall Study|Adverse Event|17|||
48637472|NCT00976456|156530707|FG001|Overall Study|Adverse Event|22|||
48637473|NCT00976456|156530706|FG000|Overall Study|Death|7|||
48637474|NCT00976456|156530707|FG001|Overall Study|Death|9|||
48637475|NCT00976456|156530706|FG000|Overall Study|Lack of Efficacy|5|||
48637476|NCT00976456|156530707|FG001|Overall Study|Lack of Efficacy|2|||
48637477|NCT00976456|156530706|FG000|Overall Study|Withdrawal by Subject|3|||
48637478|NCT00976456|156530707|FG001|Overall Study|Withdrawal by Subject|1|||
48637479|NCT00976456|156530706|FG000|Overall Study|screening failure, unknown|11|||
48637480|NCT00976456|156530707|FG001|Overall Study|screening failure, unknown|4|||
48637481|NCT00335829|156530708|FG000|Overall Study|Withdrawal by Subject|1|||
48637482|NCT00335829|156530708|FG000|Overall Study|Lost to Follow-up|1|||
48637483|NCT00335829|156530708|FG000|Overall Study|Adverse Event|1|||
48637484|NCT00583219|156530709|FG000|Phase 2|Withdrawal by Subject|1|||
48637485|NCT00854360|156530710|FG000|Overall Study|Adverse Event|0|||
48637486|NCT00854360|156530711|FG001|Overall Study|Adverse Event|1|||
48637487|NCT00854360|156530712|FG002|Overall Study|Adverse Event|2|||
48637488|NCT00854360|156530713|FG003|Overall Study|Adverse Event|6|||
48637489|NCT00854360|156530710|FG000|Overall Study|Withdrawal by Subject|0|||
48637490|NCT00854360|156530711|FG001|Overall Study|Withdrawal by Subject|0|||
48637491|NCT00854360|156530712|FG002|Overall Study|Withdrawal by Subject|0|||
48637492|NCT00854360|156530713|FG003|Overall Study|Withdrawal by Subject|1|||
48637493|NCT00854360|156530710|FG000|Overall Study|Pregnancy|0|||
48637494|NCT00854360|156530711|FG001|Overall Study|Pregnancy|1|||
48637495|NCT00854360|156530712|FG002|Overall Study|Pregnancy|0|||
48637496|NCT00854360|156530713|FG003|Overall Study|Pregnancy|0|||
48637497|NCT00854360|156530710|FG000|Overall Study|Lack of Efficacy|2|||
48637498|NCT00854360|156530711|FG001|Overall Study|Lack of Efficacy|1|||
48637499|NCT00854360|156530712|FG002|Overall Study|Lack of Efficacy|0|||
48637500|NCT00854360|156530713|FG003|Overall Study|Lack of Efficacy|0|||
48637501|NCT00854360|156530710|FG000|Overall Study|Other|0|||
48637502|NCT00854360|156530711|FG001|Overall Study|Other|0|||
48637503|NCT00854360|156530712|FG002|Overall Study|Other|0|||
48637504|NCT00854360|156530713|FG003|Overall Study|Other|3|||
48637505|NCT02949011|156530714|FG000|Overall Study|Adverse Event|6|||
48637506|NCT02949011|156530715|FG001|Overall Study|Adverse Event|7|||
48637507|NCT02949011|156530716|FG002|Overall Study|Adverse Event|3|||
48637508|NCT02949011|156530714|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
48637509|NCT02949011|156530715|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
48637510|NCT02949011|156530716|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
48637511|NCT02949011|156530714|FG000|Overall Study|Protocol Deviation|5|||
48637512|NCT02949011|156530715|FG001|Overall Study|Protocol Deviation|3|||
48637513|NCT02949011|156530716|FG002|Overall Study|Protocol Deviation|3|||
48637514|NCT02949011|156530714|FG000|Overall Study|Lack of Efficacy|0|||
48637515|NCT02949011|156530715|FG001|Overall Study|Lack of Efficacy|2|||
48637516|NCT02949011|156530716|FG002|Overall Study|Lack of Efficacy|0|||
48637517|NCT02949011|156530714|FG000|Overall Study|Withdrawal by Subject|13|||
48637518|NCT02949011|156530715|FG001|Overall Study|Withdrawal by Subject|13|||
48637519|NCT02949011|156530716|FG002|Overall Study|Withdrawal by Subject|21|||
48637520|NCT02949011|156530714|FG000|Overall Study|Lost to Follow-up|7|||
48637521|NCT02949011|156530715|FG001|Overall Study|Lost to Follow-up|5|||
48637522|NCT02949011|156530716|FG002|Overall Study|Lost to Follow-up|5|||
48637523|NCT02949011|156530714|FG000|Overall Study|Death|0|||
48637524|NCT02949011|156530715|FG001|Overall Study|Death|0|||
48637525|NCT02949011|156530716|FG002|Overall Study|Death|1|||
48637526|NCT02949011|156530714|FG000|Overall Study|Miscellaneous|2|||
48637527|NCT02949011|156530715|FG001|Overall Study|Miscellaneous|4|||
48637528|NCT02949011|156530716|FG002|Overall Study|Miscellaneous|6|||
48637529|NCT04108273|156530720|FG000|Overall Study|COVID Pandemic|1|||
48637530|NCT04108273|156530721|FG001|Overall Study|COVID Pandemic|0|||
48637531|NCT02131766|156530722|FG000|Overall Study|Withdrawal by Subject|4|||
48637532|NCT01541371|156530723|FG000|Overall Study|Withdrawal by Subject|14|||
48637533|NCT01541371|156530723|FG000|Overall Study|Lost to Follow-up|21|||
48637534|NCT01541371|156530723|FG000|Overall Study|Adverse Event|15|||
48637535|NCT01541371|156530723|FG000|Overall Study|Lack of Efficacy|12|||
48637536|NCT01541371|156530723|FG000|Overall Study|Protocol Violation|6|||
48637537|NCT01541371|156530723|FG000|Overall Study|Study medication non-compliance|3|||
48637538|NCT01541371|156530723|FG000|Overall Study|Other|6|||
48637539|NCT00800735|156530726|FG000|Overall Study|Administrative/Other|2|||
48637540|NCT00800735|156530726|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48637541|NCT00800735|156530726|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
48637542|NCT00800735|156530726|FG000|Overall Study|Withdrew Consent|3|||
48637543|NCT00506142|156530727|FG000|Overall Study|Adverse Event|8|||
48637544|NCT00506142|156530728|FG001|Overall Study|Adverse Event|7|||
48637545|NCT00506142|156530727|FG000|Overall Study|Lack of Efficacy|21|||
48637546|NCT00506142|156530728|FG001|Overall Study|Lack of Efficacy|7|||
48637547|NCT00506142|156530727|FG000|Overall Study|Withdrawal by Subject|4|||
48637548|NCT00506142|156530728|FG001|Overall Study|Withdrawal by Subject|5|||
48637549|NCT00506142|156530727|FG000|Overall Study|Physician Decision|1|||
48637550|NCT00506142|156530728|FG001|Overall Study|Physician Decision|0|||
48637551|NCT00506142|156530727|FG000|Overall Study|New health condition|1|||
48637552|NCT00506142|156530728|FG001|Overall Study|New health condition|0|||
48637553|NCT00454116|156530731|FG000|Overall Study|Adverse Event|5|||
48637554|NCT00454116|156530732|FG001|Overall Study|Adverse Event|11|||
48637555|NCT00454116|156530733|FG002|Overall Study|Adverse Event|9|||
48637556|NCT00454116|156530731|FG000|Overall Study|Condition under investigation worsened|17|||
48637557|NCT00454116|156530732|FG001|Overall Study|Condition under investigation worsened|13|||
48637558|NCT00454116|156530733|FG002|Overall Study|Condition under investigation worsened|18|||
48637559|NCT00454116|156530731|FG000|Overall Study|Withdrawal by Subject|3|||
48637560|NCT00454116|156530732|FG001|Overall Study|Withdrawal by Subject|3|||
48637561|NCT00454116|156530733|FG002|Overall Study|Withdrawal by Subject|1|||
48637562|NCT00454116|156530731|FG000|Overall Study|Other|2|||
48637563|NCT00454116|156530732|FG001|Overall Study|Other|2|||
48637564|NCT00454116|156530733|FG002|Overall Study|Other|0|||
48637565|NCT01164007|156530739|FG000|Overall Study|Adverse Event|5|||
48637566|NCT01164007|156530739|FG000|Overall Study|Progression of Disease|30|||
48637567|NCT01164007|156530739|FG000|Overall Study|Protocol Violation|1|||
48637568|NCT01164007|156530739|FG000|Overall Study|Withdrawal by Subject|1|||
48637569|NCT01164007|156530739|FG000|Overall Study|Medical Decision|3|||
48637570|NCT02115321|156530740|FG000|Overall Study|Death|1|||
48637571|NCT02115321|156530741|FG001|Overall Study|Death|0|||
48637572|NCT03218917|156530742|FG000|Overall Study|Adverse Event|3|||
48637573|NCT03218917|156530743|FG001|Overall Study|Adverse Event|3|||
48637574|NCT03218917|156530744|FG002|Overall Study|Adverse Event|2|||
48637575|NCT03218917|156530742|FG000|Overall Study|Subject withdrew consent|2|||
48637576|NCT03218917|156530743|FG001|Overall Study|Subject withdrew consent|4|||
48637577|NCT03218917|156530744|FG002|Overall Study|Subject withdrew consent|10|||
48637578|NCT03218917|156530742|FG000|Overall Study|Physician Decision|0|||
48637579|NCT03218917|156530743|FG001|Overall Study|Physician Decision|1|||
48637580|NCT03218917|156530744|FG002|Overall Study|Physician Decision|1|||
48637581|NCT03218917|156530742|FG000|Overall Study|Lost to Follow-up|1|||
48637582|NCT03218917|156530743|FG001|Overall Study|Lost to Follow-up|0|||
48637583|NCT03218917|156530744|FG002|Overall Study|Lost to Follow-up|0|||
48637584|NCT03218917|156530742|FG000|Overall Study|Reason Missing|0|||
48637585|NCT03218917|156530743|FG001|Overall Study|Reason Missing|2|||
48637586|NCT03218917|156530744|FG002|Overall Study|Reason Missing|0|||
48637587|NCT03218917|156530742|FG000|Overall Study|Death|0|||
48637588|NCT03218917|156530743|FG001|Overall Study|Death|1|||
48637589|NCT03218917|156530744|FG002|Overall Study|Death|0|||
48637590|NCT03218917|156530742|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48637591|NCT03218917|156530743|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48637592|NCT03218917|156530744|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48637593|NCT01977222|156530745|FG000|Overall Study|Withdrawal by Subject|1|||
48637594|NCT01612676|156530746|FG000|Overall Study|Adverse Event|2|||
48637595|NCT01612676|156530747|FG001|Overall Study|Adverse Event|3|||
48637596|NCT01612676|156530748|FG002|Overall Study|Adverse Event|1|||
48637597|NCT01612676|156530749|FG003|Overall Study|Adverse Event|3|||
48637598|NCT01612676|156530746|FG000|Overall Study|Protocol Violation|0|||
48637599|NCT01612676|156530747|FG001|Overall Study|Protocol Violation|1|||
48637600|NCT01612676|156530748|FG002|Overall Study|Protocol Violation|0|||
48747182|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
48747183|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Patient Request|1|||
48747184|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Patient Request|0|||
48747185|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
48747186|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
48747187|NCT04649060|156922933|FG000|Arm A/Arm B Treatment|Other|1|||
48747188|NCT04649060|156922934|FG001|Arm A/Arm B Treatment|Other|0|||
48747189|NCT04649060|156922933|FG000|Crossover (Arm B)|Adverse Event|0|||
48747190|NCT04649060|156922934|FG001|Crossover (Arm B)|Adverse Event|1|||
48747191|NCT04649060|156922933|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
48747192|NCT04649060|156922934|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
48637601|NCT01612676|156530749|FG003|Overall Study|Protocol Violation|0|||
48637602|NCT01143402|156530763|FG000|Overall Study|Rapid clinical decline|1|||
48637603|NCT01143402|156530764|FG001|Overall Study|Rapid clinical decline|1|||
48637604|NCT01143402|156530765|FG002|Overall Study|Rapid clinical decline|0|||
48637605|NCT01143402|156530763|FG000|Overall Study|Not Treated|0|||
48637606|NCT01143402|156530764|FG001|Overall Study|Not Treated|0|||
48637607|NCT01143402|156530765|FG002|Overall Study|Not Treated|1|||
48637608|NCT02216526|156530774|FG000|Overall Study|Adverse Event|1|||
48637609|NCT02216526|156530775|FG001|Overall Study|Adverse Event|1|||
48637610|NCT02216526|156530776|FG002|Overall Study|Adverse Event|0|||
48637611|NCT02216526|156530774|FG000|Overall Study|Death|0|||
48637612|NCT02216526|156530775|FG001|Overall Study|Death|1|||
48637613|NCT02216526|156530776|FG002|Overall Study|Death|3|||
48747193|NCT01243892|156922942|FG000|Overall Study|Did not meet eligibility criteria|2|||
48747194|NCT01243892|156922943|FG001|Overall Study|Did not meet eligibility criteria|0|||
48747195|NCT01051323|156922944|FG000|Overall Study|Discontinuation of treatment|103|||
48747196|NCT01051323|156922944|FG000|Overall Study|Transplantation|28|||
48747197|NCT01051323|156922944|FG000|Overall Study|Dialysis dependency|22|||
48747198|NCT01051323|156922944|FG000|Overall Study|Withdrawal by Subject|13|||
48747199|NCT01051323|156922944|FG000|Overall Study|Lost to Follow-up|31|||
48747200|NCT01051323|156922944|FG000|Overall Study|Death|129|||
48747201|NCT01051323|156922944|FG000|Overall Study|Hospitalization|28|||
48747202|NCT01051323|156922944|FG000|Overall Study|Other|148|||
48747203|NCT01051323|156922944|FG000|Overall Study|Missing|37|||
48747204|NCT00582166|156922945|FG000|Overall Study|Death|1|||
48747205|NCT00582166|156922945|FG000|Overall Study|Ineligible pathology|1|||
48747206|NCT03706456|156922954|FG000|Overall Study|Adverse Event|1|||
48747207|NCT03706456|156922954|FG000|Overall Study|Lack of Efficacy|2|||
48747208|NCT02695329|156922956|FG000|Overall Study|Adverse Event|1|||
48747209|NCT02695329|156922957|FG001|Overall Study|Adverse Event|0|||
48747210|NCT02695329|156922956|FG000|Overall Study|Poor X-ray quality for measurement|4|||
48747211|NCT02695329|156922957|FG001|Overall Study|Poor X-ray quality for measurement|5|||
48747212|NCT00074152|156922958|FG000|Overall Study|Death|21|||
48747213|NCT00074152|156922959|FG001|Overall Study|Death|9|||
48747214|NCT00074152|156922958|FG000|Overall Study|Lack of Efficacy|34|||
48747215|NCT00074152|156922959|FG001|Overall Study|Lack of Efficacy|24|||
48747216|NCT02006719|156922960|FG000|Overall Study|Withdrawal by Subject|10|||
48747217|NCT02006719|156922961|FG001|Overall Study|Withdrawal by Subject|2|||
48747218|NCT02006719|156922960|FG000|Overall Study|Lost to Follow-up|5|||
48747219|NCT02006719|156922961|FG001|Overall Study|Lost to Follow-up|1|||
48747220|NCT02006719|156922960|FG000|Overall Study|Protocol Violation|2|||
48747221|NCT02006719|156922961|FG001|Overall Study|Protocol Violation|0|||
48747222|NCT02006719|156922960|FG000|Overall Study|Adverse Event|1|||
48747223|NCT02006719|156922961|FG001|Overall Study|Adverse Event|1|||
48747224|NCT02006719|156922960|FG000|Overall Study|Other/Unknown|0|||
48747225|NCT02006719|156922961|FG001|Overall Study|Other/Unknown|1|||
48747226|NCT01756898|156922962|FG000|Overall Study|Adverse Event|7|||
48747227|NCT01756898|156922963|FG001|Overall Study|Adverse Event|1|||
48747228|NCT01756898|156922964|FG002|Overall Study|Adverse Event|0|||
48747229|NCT01756898|156922965|FG003|Overall Study|Adverse Event|0|||
48747230|NCT01756898|156922962|FG000|Overall Study|Lack of Efficacy|4|||
48747231|NCT01756898|156922963|FG001|Overall Study|Lack of Efficacy|7|||
48747232|NCT01756898|156922964|FG002|Overall Study|Lack of Efficacy|6|||
48747233|NCT01756898|156922965|FG003|Overall Study|Lack of Efficacy|6|||
48747234|NCT01756898|156922962|FG000|Overall Study|Lost to Follow-up|2|||
48747235|NCT01756898|156922963|FG001|Overall Study|Lost to Follow-up|4|||
48747236|NCT01756898|156922964|FG002|Overall Study|Lost to Follow-up|2|||
48747237|NCT01756898|156922965|FG003|Overall Study|Lost to Follow-up|3|||
48747238|NCT01756898|156922962|FG000|Overall Study|Protocol Violation|1|||
48327924|NCT03547154|155398196|FG001|Overall Study|Protocol Violation|1|||
48747239|NCT01756898|156922963|FG001|Overall Study|Protocol Violation|2|||
48747240|NCT01756898|156922964|FG002|Overall Study|Protocol Violation|2|||
48747241|NCT01756898|156922965|FG003|Overall Study|Protocol Violation|1|||
48747242|NCT01756898|156922962|FG000|Overall Study|Withdrew Consent|5|||
48327925|NCT03547154|155398195|FG000|Overall Study|Physician Decision|4|||
48637614|NCT02216526|156530774|FG000|Overall Study|Protocol Violation|2|||
48637615|NCT02216526|156530775|FG001|Overall Study|Protocol Violation|0|||
48637616|NCT02216526|156530776|FG002|Overall Study|Protocol Violation|2|||
48747243|NCT01756898|156922963|FG001|Overall Study|Withdrew Consent|3|||
48747244|NCT01756898|156922964|FG002|Overall Study|Withdrew Consent|5|||
48747245|NCT01756898|156922965|FG003|Overall Study|Withdrew Consent|6|||
48747246|NCT01756898|156922962|FG000|Overall Study|Other|0|||
48747247|NCT01756898|156922963|FG001|Overall Study|Other|2|||
48747248|NCT01756898|156922964|FG002|Overall Study|Other|2|||
48747249|NCT01756898|156922965|FG003|Overall Study|Other|0|||
48747250|NCT00353262|156922970|FG000|Overall Study|Adverse Event|8|||
48747251|NCT00353262|156922970|FG000|Overall Study|Withdrawal by Subject|2|||
48747252|NCT00353262|156922970|FG000|Overall Study|Insufficient Therapeutic Response|13|||
48637617|NCT02216526|156530774|FG000|Overall Study|Hospitalization|2|||
48747253|NCT00353262|156922970|FG000|Overall Study|Progression|1|||
48747254|NCT00353262|156922970|FG000|Overall Study|Surgery|4|||
48747255|NCT00353262|156922970|FG000|Overall Study|Break from Chemotherapy|1|||
48747256|NCT02007109|156922971|FG000|Overall Study|Diary not returned or excluded|102|||
48747257|NCT02007109|156922971|FG000|Overall Study|Excluded - Age<7yo|9|||
48747258|NCT00496054|156922972|FG000|Overall Study|Adverse Event|1|||
48747259|NCT00496054|156922972|FG000|Overall Study|Lost to Follow-up|7|||
48747260|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48637618|NCT02216526|156530775|FG001|Overall Study|Hospitalization|1|||
48637619|NCT02216526|156530776|FG002|Overall Study|Hospitalization|3|||
48637620|NCT04409834|156530777|FG000|Overall Study|Death|55|||
48637621|NCT04409834|156530778|FG001|Overall Study|Death|62|||
48637622|NCT02170064|156530779|FG000|Overall Study|Withdrawal by Subject|5|||
48637623|NCT02170064|156530780|FG001|Overall Study|Withdrawal by Subject|1|||
48637624|NCT02170064|156530781|FG002|Overall Study|Withdrawal by Subject|1|||
48637625|NCT02170064|156530779|FG000|Overall Study|Physician Decision|1|||
48637626|NCT02170064|156530780|FG001|Overall Study|Physician Decision|1|||
48637627|NCT02170064|156530781|FG002|Overall Study|Physician Decision|0|||
48637628|NCT04211363|156530784|FG000|Overall Study|Adverse Event|5|||
48637629|NCT04211363|156530785|FG001|Overall Study|Adverse Event|2|||
48637630|NCT04211363|156530784|FG000|Overall Study|Physician Decision|0|||
48637631|NCT04211363|156530785|FG001|Overall Study|Physician Decision|1|||
48637632|NCT04211363|156530784|FG000|Overall Study|Protocol Violation|1|||
48637633|NCT04211363|156530785|FG001|Overall Study|Protocol Violation|0|||
48637634|NCT04211363|156530784|FG000|Overall Study|Pregnancy|1|||
48637635|NCT04211363|156530785|FG001|Overall Study|Pregnancy|0|||
48637636|NCT04211363|156530784|FG000|Overall Study|Lost to Follow-up|12|||
48637637|NCT04211363|156530785|FG001|Overall Study|Lost to Follow-up|4|||
48637638|NCT04211363|156530784|FG000|Overall Study|Withdrawal by Subject|11|||
48637639|NCT04211363|156530785|FG001|Overall Study|Withdrawal by Subject|11|||
48637640|NCT04211363|156530784|FG000|Overall Study|Other|1|||
48637641|NCT04211363|156530785|FG001|Overall Study|Other|2|||
48637642|NCT00461708|156530786|FG000|Overall Study|Adverse Event|17|||
48637643|NCT00461708|156530787|FG001|Overall Study|Adverse Event|7|||
48637644|NCT00461708|156530786|FG000|Overall Study|Lack of Efficacy|68|||
48637645|NCT00461708|156530787|FG001|Overall Study|Lack of Efficacy|20|||
48637646|NCT00461708|156530786|FG000|Overall Study|Physician Decision|10|||
48637647|NCT00461708|156530787|FG001|Overall Study|Physician Decision|4|||
48637648|NCT00461708|156530786|FG000|Overall Study|Withdrawal by Subject|8|||
48637649|NCT00461708|156530787|FG001|Overall Study|Withdrawal by Subject|2|||
48637650|NCT00461708|156530786|FG000|Overall Study|Other|4|||
48637651|NCT00461708|156530787|FG001|Overall Study|Other|4|||
48637652|NCT00461708|156530786|FG000|Overall Study|Death|8|||
48637653|NCT00461708|156530787|FG001|Overall Study|Death|1|||
48637654|NCT03097289|156530789|FG000|Overall Study|Adverse Event|1|||
48637655|NCT03097289|156530789|FG000|Overall Study|Equipment failure|2|||
48747261|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
48747262|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747263|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
48747264|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
48747265|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48637656|NCT03097289|156530789|FG000|Overall Study|Collected platelet product unusable|3|||
48637657|NCT02750514|156530790|FG000|Track 1|Disease progression|20|||
48637658|NCT02750514|156530791|FG001|Track 1|Disease progression|1|||
48637659|NCT02750514|156530792|FG002|Track 1|Disease progression|0|||
48637660|NCT02750514|156530793|FG003|Track 1|Disease progression|1|||
48637661|NCT02750514|156530794|FG004|Track 1|Disease progression|0|||
48637662|NCT02750514|156530790|FG000|Track 1|Adverse event unrelated to study drug|1|||
48637663|NCT02750514|156530791|FG001|Track 1|Adverse event unrelated to study drug|0|||
48637664|NCT02750514|156530792|FG002|Track 1|Adverse event unrelated to study drug|0|||
48637665|NCT02750514|156530793|FG003|Track 1|Adverse event unrelated to study drug|0|||
48637666|NCT02750514|156530794|FG004|Track 1|Adverse event unrelated to study drug|0|||
48637667|NCT02750514|156530790|FG000|Track 1|Study drug toxicity|4|||
48637668|NCT02750514|156530791|FG001|Track 1|Study drug toxicity|1|||
48637669|NCT02750514|156530792|FG002|Track 1|Study drug toxicity|0|||
48747266|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747267|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747268|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747269|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747270|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747271|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747272|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747273|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747274|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
48747275|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
48747276|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
48747277|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
48747278|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747279|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747280|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747281|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747282|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747283|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747284|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747285|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747286|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747287|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747288|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747289|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
48747290|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747291|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747292|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747293|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
48747294|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747295|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747296|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747297|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747298|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
48637670|NCT02750514|156530793|FG003|Track 1|Study drug toxicity|1|||
48637671|NCT02750514|156530794|FG004|Track 1|Study drug toxicity|0|||
48637672|NCT02750514|156530790|FG000|Track 1|Participant request to discontinue|1|||
48637673|NCT02750514|156530791|FG001|Track 1|Participant request to discontinue|0|||
48637674|NCT02750514|156530792|FG002|Track 1|Participant request to discontinue|0|||
48637675|NCT02750514|156530793|FG003|Track 1|Participant request to discontinue|0|||
48747299|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747300|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747301|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
48327926|NCT03547154|155398196|FG001|Overall Study|Physician Decision|3|||
48327927|NCT03547154|155398195|FG000|Overall Study|Insufficient Therapeutic Response|13|||
48637676|NCT02750514|156530794|FG004|Track 1|Participant request to discontinue|0|||
48637677|NCT02750514|156530790|FG000|Track 1|Other reasons|1|||
48637678|NCT02750514|156530791|FG001|Track 1|Other reasons|0|||
48637679|NCT02750514|156530792|FG002|Track 1|Other reasons|0|||
48637680|NCT02750514|156530793|FG003|Track 1|Other reasons|0|||
48637681|NCT02750514|156530794|FG004|Track 1|Other reasons|0|||
48637682|NCT02750514|156530790|FG000|Track 2|Disease progression|4|||
48637683|NCT02750514|156530791|FG001|Track 2|Disease progression|5|||
48637684|NCT02750514|156530792|FG002|Track 2|Disease progression|2|||
48637685|NCT02750514|156530793|FG003|Track 2|Disease progression|5|||
48637686|NCT02750514|156530794|FG004|Track 2|Disease progression|0|||
48637687|NCT02750514|156530790|FG000|Track 2|Adverse event unrelated to study drug|1|||
48637688|NCT02750514|156530791|FG001|Track 2|Adverse event unrelated to study drug|0|||
48637689|NCT02750514|156530792|FG002|Track 2|Adverse event unrelated to study drug|0|||
48637690|NCT02750514|156530793|FG003|Track 2|Adverse event unrelated to study drug|0|||
48637691|NCT02750514|156530794|FG004|Track 2|Adverse event unrelated to study drug|0|||
48637692|NCT02750514|156530790|FG000|Track 2|Study drug toxicity|1|||
48637693|NCT02750514|156530791|FG001|Track 2|Study drug toxicity|2|||
48637694|NCT02750514|156530792|FG002|Track 2|Study drug toxicity|0|||
48637695|NCT02750514|156530793|FG003|Track 2|Study drug toxicity|2|||
48637696|NCT02750514|156530794|FG004|Track 2|Study drug toxicity|0|||
48747302|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
48327928|NCT03547154|155398196|FG001|Overall Study|Insufficient Therapeutic Response|10|||
48327929|NCT03547154|155398195|FG000|Overall Study|Withdrawal by Subject|10|||
48637697|NCT02750514|156530790|FG000|Track 2|Participant withdrew consent|0|||
48637698|NCT02750514|156530791|FG001|Track 2|Participant withdrew consent|1|||
48327930|NCT03547154|155398196|FG001|Overall Study|Withdrawal by Subject|6|||
48637699|NCT02750514|156530792|FG002|Track 2|Participant withdrew consent|0|||
48637700|NCT02750514|156530793|FG003|Track 2|Participant withdrew consent|0|||
48637701|NCT02750514|156530794|FG004|Track 2|Participant withdrew consent|0|||
48637702|NCT02750514|156530790|FG000|Track 3|Disease progression|0|||
48327931|NCT03547154|155398195|FG000|Overall Study|Not Selected|0|||
48327932|NCT03547154|155398196|FG001|Overall Study|Not Selected|1|||
48637703|NCT02750514|156530791|FG001|Track 3|Disease progression|24|||
48637704|NCT02750514|156530792|FG002|Track 3|Disease progression|13|||
48637705|NCT02750514|156530793|FG003|Track 3|Disease progression|14|||
48637706|NCT02750514|156530794|FG004|Track 3|Disease progression|0|||
48637707|NCT02750514|156530790|FG000|Track 3|Adverse event unrelated to study drug|0|||
48637708|NCT02750514|156530791|FG001|Track 3|Adverse event unrelated to study drug|1|||
48637709|NCT02750514|156530792|FG002|Track 3|Adverse event unrelated to study drug|1|||
48637710|NCT02750514|156530793|FG003|Track 3|Adverse event unrelated to study drug|1|||
48637711|NCT02750514|156530794|FG004|Track 3|Adverse event unrelated to study drug|0|||
48747303|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747304|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
48747305|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747306|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
48747307|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747308|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747309|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747310|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747311|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747312|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747313|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747314|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747315|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747316|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747317|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747318|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747319|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
48747320|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747321|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747322|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747323|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747324|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
48747325|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747326|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747327|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747328|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747329|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747330|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747331|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48327933|NCT03547154|155398195|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
48327934|NCT03547154|155398196|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
48637712|NCT02750514|156530790|FG000|Track 3|Study drug toxicity|0|||
48637713|NCT02750514|156530791|FG001|Track 3|Study drug toxicity|3|||
48747332|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747333|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747334|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
48747335|NCT01737697|156922973|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747336|NCT01737697|156922974|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
48747337|NCT01737697|156922975|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
48747338|NCT01737697|156922976|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
48747339|NCT01737697|156922977|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
48747340|NCT01737697|156922978|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747341|NCT01737697|156922979|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747342|NCT01737697|156922980|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747343|NCT01737697|156922981|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747344|NCT01737697|156922982|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747345|NCT01737697|156922983|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747346|NCT01737697|156922984|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747347|NCT01737697|156922985|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747348|NCT01737697|156922986|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747349|NCT01737697|156922987|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
48747350|NCT01737697|156922973|FG000|Subacute Phase|Adverse Event|0|||
48747351|NCT01737697|156922974|FG001|Subacute Phase|Adverse Event|0|||
48747352|NCT01737697|156922975|FG002|Subacute Phase|Adverse Event|0|||
48327935|NCT03057600|155398200|FG000|Overall Study|Adverse Event|0|||
48327936|NCT03057600|155398201|FG001|Overall Study|Adverse Event|0|||
48327937|NCT03057600|155398202|FG002|Overall Study|Adverse Event|4|||
48637714|NCT02750514|156530792|FG002|Track 3|Study drug toxicity|0|||
48637715|NCT02750514|156530793|FG003|Track 3|Study drug toxicity|1|||
48637716|NCT02750514|156530794|FG004|Track 3|Study drug toxicity|0|||
48637717|NCT02750514|156530790|FG000|Track 3|Participant request to discontinue|0|||
48637718|NCT02750514|156530791|FG001|Track 3|Participant request to discontinue|2|||
48637719|NCT02750514|156530792|FG002|Track 3|Participant request to discontinue|0|||
48637720|NCT02750514|156530793|FG003|Track 3|Participant request to discontinue|0|||
48637721|NCT02750514|156530794|FG004|Track 3|Participant request to discontinue|0|||
48637722|NCT02750514|156530790|FG000|Track 3|Participant withdrew consent|0|||
48637723|NCT02750514|156530791|FG001|Track 3|Participant withdrew consent|3|||
48637724|NCT02750514|156530792|FG002|Track 3|Participant withdrew consent|1|||
48637725|NCT02750514|156530793|FG003|Track 3|Participant withdrew consent|0|||
48637726|NCT02750514|156530794|FG004|Track 3|Participant withdrew consent|0|||
48637727|NCT02750514|156530790|FG000|Track 3|Other reasons|0|||
48637728|NCT02750514|156530791|FG001|Track 3|Other reasons|3|||
48637729|NCT02750514|156530792|FG002|Track 3|Other reasons|0|||
48637730|NCT02750514|156530793|FG003|Track 3|Other reasons|0|||
48637731|NCT02750514|156530794|FG004|Track 3|Other reasons|0|||
48637732|NCT02750514|156530790|FG000|Track 4|Study drug toxicity|0|||
48637733|NCT02750514|156530791|FG001|Track 4|Study drug toxicity|6|||
48637734|NCT02750514|156530792|FG002|Track 4|Study drug toxicity|0|||
48637735|NCT02750514|156530793|FG003|Track 4|Study drug toxicity|5|||
48637736|NCT02750514|156530794|FG004|Track 4|Study drug toxicity|0|||
48637737|NCT02750514|156530790|FG000|Track 4|Participant request to discontinue|0|||
48637738|NCT02750514|156530791|FG001|Track 4|Participant request to discontinue|1|||
48637739|NCT02750514|156530792|FG002|Track 4|Participant request to discontinue|0|||
48637740|NCT02750514|156530793|FG003|Track 4|Participant request to discontinue|1|||
48637741|NCT02750514|156530794|FG004|Track 4|Participant request to discontinue|0|||
48637742|NCT02750514|156530790|FG000|Track 4|Participant withdrew consent|0|||
48637743|NCT02750514|156530791|FG001|Track 4|Participant withdrew consent|1|||
48637744|NCT02750514|156530792|FG002|Track 4|Participant withdrew consent|0|||
48637745|NCT02750514|156530793|FG003|Track 4|Participant withdrew consent|0|||
48637746|NCT02750514|156530794|FG004|Track 4|Participant withdrew consent|0|||
48637747|NCT02750514|156530790|FG000|Track 4|Other reasons|0|||
48637748|NCT02750514|156530791|FG001|Track 4|Other reasons|5|||
48637749|NCT02750514|156530792|FG002|Track 4|Other reasons|0|||
48637750|NCT02750514|156530793|FG003|Track 4|Other reasons|3|||
48637751|NCT02750514|156530794|FG004|Track 4|Other reasons|0|||
48637752|NCT02750514|156530790|FG000|Track 4|Disease progression|0|||
48637753|NCT02750514|156530791|FG001|Track 4|Disease progression|33|||
48637754|NCT02750514|156530792|FG002|Track 4|Disease progression|0|||
48637755|NCT02750514|156530793|FG003|Track 4|Disease progression|32|||
48637756|NCT02750514|156530794|FG004|Track 4|Disease progression|0|||
48637757|NCT02750514|156530790|FG000|Track 4|Adverse event unrelated to study drug|0|||
48637758|NCT02750514|156530791|FG001|Track 4|Adverse event unrelated to study drug|5|||
48637759|NCT02750514|156530792|FG002|Track 4|Adverse event unrelated to study drug|0|||
48637760|NCT02750514|156530793|FG003|Track 4|Adverse event unrelated to study drug|0|||
48637761|NCT02750514|156530794|FG004|Track 4|Adverse event unrelated to study drug|0|||
48637762|NCT02750514|156530790|FG000|Track 4|Death|0|||
48637763|NCT02750514|156530791|FG001|Track 4|Death|0|||
48637764|NCT02750514|156530792|FG002|Track 4|Death|0|||
48747353|NCT01737697|156922976|FG003|Subacute Phase|Adverse Event|0|||
48747354|NCT01737697|156922977|FG004|Subacute Phase|Adverse Event|0|||
48747355|NCT01737697|156922978|FG005|Subacute Phase|Adverse Event|1|||
48747356|NCT01737697|156922979|FG006|Subacute Phase|Adverse Event|1|||
48747357|NCT01737697|156922980|FG007|Subacute Phase|Adverse Event|1|||
48747358|NCT01737697|156922981|FG008|Subacute Phase|Adverse Event|1|||
48747359|NCT01737697|156922982|FG009|Subacute Phase|Adverse Event|1|||
48747360|NCT01737697|156922983|FG010|Subacute Phase|Adverse Event|4|||
48747361|NCT01737697|156922984|FG011|Subacute Phase|Adverse Event|1|||
48747362|NCT01737697|156922985|FG012|Subacute Phase|Adverse Event|1|||
48747363|NCT01737697|156922986|FG013|Subacute Phase|Adverse Event|0|||
48747364|NCT01737697|156922987|FG014|Subacute Phase|Adverse Event|0|||
48747365|NCT01737697|156922973|FG000|Subacute Phase|Withdrawal by Subject|0|||
48747366|NCT01737697|156922974|FG001|Subacute Phase|Withdrawal by Subject|0|||
48747367|NCT01737697|156922975|FG002|Subacute Phase|Withdrawal by Subject|0|||
48747368|NCT01737697|156922976|FG003|Subacute Phase|Withdrawal by Subject|0|||
48747369|NCT01737697|156922977|FG004|Subacute Phase|Withdrawal by Subject|0|||
48747370|NCT01737697|156922978|FG005|Subacute Phase|Withdrawal by Subject|1|||
48747371|NCT01737697|156922979|FG006|Subacute Phase|Withdrawal by Subject|0|||
48747372|NCT01737697|156922980|FG007|Subacute Phase|Withdrawal by Subject|2|||
48747373|NCT01737697|156922981|FG008|Subacute Phase|Withdrawal by Subject|0|||
48747374|NCT01737697|156922982|FG009|Subacute Phase|Withdrawal by Subject|1|||
48747375|NCT01737697|156922983|FG010|Subacute Phase|Withdrawal by Subject|0|||
48747376|NCT01737697|156922984|FG011|Subacute Phase|Withdrawal by Subject|1|||
48747377|NCT01737697|156922985|FG012|Subacute Phase|Withdrawal by Subject|1|||
48747378|NCT01737697|156922986|FG013|Subacute Phase|Withdrawal by Subject|1|||
48747379|NCT01737697|156922987|FG014|Subacute Phase|Withdrawal by Subject|0|||
48747380|NCT01737697|156922973|FG000|Subacute Phase|Lost to Follow-up|0|||
48747381|NCT01737697|156922974|FG001|Subacute Phase|Lost to Follow-up|0|||
48747382|NCT01737697|156922975|FG002|Subacute Phase|Lost to Follow-up|0|||
48747383|NCT01737697|156922976|FG003|Subacute Phase|Lost to Follow-up|0|||
48747384|NCT01737697|156922977|FG004|Subacute Phase|Lost to Follow-up|0|||
48747385|NCT01737697|156922978|FG005|Subacute Phase|Lost to Follow-up|0|||
48747386|NCT01737697|156922979|FG006|Subacute Phase|Lost to Follow-up|0|||
48747387|NCT01737697|156922980|FG007|Subacute Phase|Lost to Follow-up|0|||
48747388|NCT01737697|156922981|FG008|Subacute Phase|Lost to Follow-up|0|||
48747389|NCT01737697|156922982|FG009|Subacute Phase|Lost to Follow-up|0|||
48747390|NCT01737697|156922983|FG010|Subacute Phase|Lost to Follow-up|0|||
48747391|NCT01737697|156922984|FG011|Subacute Phase|Lost to Follow-up|0|||
48747392|NCT01737697|156922985|FG012|Subacute Phase|Lost to Follow-up|0|||
48747393|NCT01737697|156922986|FG013|Subacute Phase|Lost to Follow-up|0|||
48747394|NCT01737697|156922987|FG014|Subacute Phase|Lost to Follow-up|1|||
48747395|NCT01737697|156922973|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
48747396|NCT01737697|156922974|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
48747397|NCT01737697|156922975|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
48747398|NCT01737697|156922976|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
48747399|NCT01737697|156922977|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
48747400|NCT01737697|156922978|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
48747401|NCT01737697|156922979|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
48747402|NCT01737697|156922980|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
48747403|NCT01737697|156922981|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
48747404|NCT01737697|156922982|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
48637765|NCT02750514|156530793|FG003|Track 4|Death|1|||
48637766|NCT02750514|156530794|FG004|Track 4|Death|0|||
48637767|NCT02750514|156530790|FG000|Track 5|Disease progression|0|||
48637768|NCT02750514|156530791|FG001|Track 5|Disease progression|0|||
48637769|NCT02750514|156530792|FG002|Track 5|Disease progression|0|||
48637770|NCT02750514|156530793|FG003|Track 5|Disease progression|0|||
48637771|NCT02750514|156530794|FG004|Track 5|Disease progression|34|||
48637772|NCT02750514|156530790|FG000|Track 5|Adverse event unrelated to study drug|0|||
48637773|NCT02750514|156530791|FG001|Track 5|Adverse event unrelated to study drug|0|||
48637774|NCT02750514|156530792|FG002|Track 5|Adverse event unrelated to study drug|0|||
48637775|NCT02750514|156530793|FG003|Track 5|Adverse event unrelated to study drug|0|||
48637776|NCT02750514|156530794|FG004|Track 5|Adverse event unrelated to study drug|2|||
48637777|NCT02750514|156530790|FG000|Track 5|Study drug toxicity|0|||
48747405|NCT01737697|156922983|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
48747406|NCT01737697|156922984|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
48747407|NCT01737697|156922985|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
48747408|NCT01737697|156922986|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
48747409|NCT01737697|156922987|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
48747410|NCT01737697|156922973|FG000|Subacute Phase|Protocol Violation|0|||
48747411|NCT01737697|156922974|FG001|Subacute Phase|Protocol Violation|0|||
48747412|NCT01737697|156922975|FG002|Subacute Phase|Protocol Violation|0|||
48747413|NCT01737697|156922976|FG003|Subacute Phase|Protocol Violation|0|||
48637778|NCT02750514|156530791|FG001|Track 5|Study drug toxicity|0|||
48637779|NCT02750514|156530792|FG002|Track 5|Study drug toxicity|0|||
48747414|NCT01737697|156922977|FG004|Subacute Phase|Protocol Violation|0|||
48747415|NCT01737697|156922978|FG005|Subacute Phase|Protocol Violation|1|||
48747416|NCT01737697|156922979|FG006|Subacute Phase|Protocol Violation|0|||
48747417|NCT01737697|156922980|FG007|Subacute Phase|Protocol Violation|0|||
48747418|NCT01737697|156922981|FG008|Subacute Phase|Protocol Violation|0|||
48747419|NCT01737697|156922982|FG009|Subacute Phase|Protocol Violation|0|||
48747420|NCT01737697|156922983|FG010|Subacute Phase|Protocol Violation|1|||
48747421|NCT01737697|156922984|FG011|Subacute Phase|Protocol Violation|0|||
48747422|NCT01737697|156922985|FG012|Subacute Phase|Protocol Violation|0|||
48747423|NCT01737697|156922986|FG013|Subacute Phase|Protocol Violation|0|||
48747424|NCT01737697|156922987|FG014|Subacute Phase|Protocol Violation|0|||
48747425|NCT01737697|156922973|FG000|Subacute Phase|Physician Decision|0|||
48747426|NCT01737697|156922974|FG001|Subacute Phase|Physician Decision|0|||
48747427|NCT01737697|156922975|FG002|Subacute Phase|Physician Decision|0|||
48637780|NCT02750514|156530793|FG003|Track 5|Study drug toxicity|0|||
48637781|NCT02750514|156530794|FG004|Track 5|Study drug toxicity|2|||
48637782|NCT02750514|156530790|FG000|Track 5|Participant request to discontinue|0|||
48637783|NCT02750514|156530791|FG001|Track 5|Participant request to discontinue|0|||
48637784|NCT02750514|156530792|FG002|Track 5|Participant request to discontinue|0|||
48747428|NCT01737697|156922976|FG003|Subacute Phase|Physician Decision|0|||
48747429|NCT01737697|156922977|FG004|Subacute Phase|Physician Decision|0|||
48747430|NCT01737697|156922978|FG005|Subacute Phase|Physician Decision|0|||
48747431|NCT01737697|156922979|FG006|Subacute Phase|Physician Decision|0|||
48747432|NCT01737697|156922980|FG007|Subacute Phase|Physician Decision|0|||
48747433|NCT01737697|156922981|FG008|Subacute Phase|Physician Decision|1|||
48747434|NCT01737697|156922982|FG009|Subacute Phase|Physician Decision|0|||
48747435|NCT01737697|156922983|FG010|Subacute Phase|Physician Decision|0|||
48747436|NCT01737697|156922984|FG011|Subacute Phase|Physician Decision|0|||
48747437|NCT01737697|156922985|FG012|Subacute Phase|Physician Decision|0|||
48637785|NCT02750514|156530793|FG003|Track 5|Participant request to discontinue|0|||
48637786|NCT02750514|156530794|FG004|Track 5|Participant request to discontinue|3|||
48747438|NCT01737697|156922986|FG013|Subacute Phase|Physician Decision|0|||
48747439|NCT01737697|156922987|FG014|Subacute Phase|Physician Decision|0|||
48747440|NCT01737697|156922973|FG000|Subacute Phase|Death|0|||
48747441|NCT01737697|156922974|FG001|Subacute Phase|Death|0|||
48747442|NCT01737697|156922975|FG002|Subacute Phase|Death|0|||
48747443|NCT01737697|156922976|FG003|Subacute Phase|Death|0|||
48637787|NCT02750514|156530790|FG000|Track 5|Other reasons|0|||
48637788|NCT02750514|156530791|FG001|Track 5|Other reasons|0|||
48637789|NCT02750514|156530792|FG002|Track 5|Other reasons|0|||
48637790|NCT02750514|156530793|FG003|Track 5|Other reasons|0|||
48747444|NCT01737697|156922977|FG004|Subacute Phase|Death|0|||
48747445|NCT01737697|156922978|FG005|Subacute Phase|Death|0|||
48747446|NCT01737697|156922979|FG006|Subacute Phase|Death|0|||
48747447|NCT01737697|156922980|FG007|Subacute Phase|Death|0|||
48747448|NCT01737697|156922981|FG008|Subacute Phase|Death|0|||
48747449|NCT01737697|156922982|FG009|Subacute Phase|Death|0|||
48747450|NCT01737697|156922983|FG010|Subacute Phase|Death|1|||
48747451|NCT01737697|156922984|FG011|Subacute Phase|Death|0|||
48747452|NCT01737697|156922985|FG012|Subacute Phase|Death|0|||
48747453|NCT01737697|156922986|FG013|Subacute Phase|Death|0|||
48747454|NCT01737697|156922987|FG014|Subacute Phase|Death|0|||
48747455|NCT02879305|156922988|FG000|Overall Study|Investigator Site Closed|55|||
48637791|NCT02750514|156530794|FG004|Track 5|Other reasons|2|||
48637792|NCT02553629|156530795|FG000|Overall Study|Logistic reasons|3|||
48637793|NCT02553629|156530796|FG001|Overall Study|Logistic reasons|6|||
48637794|NCT01812057|156530801|FG000|Overall Study|Protocol Violation|1|||
48747456|NCT02879305|156922989|FG001|Overall Study|Investigator Site Closed|57|||
48747457|NCT02879305|156922988|FG000|Overall Study|Withdrawal by Subject|44|||
48327938|NCT03057600|155398203|FG003|Overall Study|Adverse Event|0|||
48747458|NCT02879305|156922989|FG001|Overall Study|Withdrawal by Subject|42|||
48747459|NCT02879305|156922988|FG000|Overall Study|Lost to Follow-up|17|||
48747460|NCT02879305|156922989|FG001|Overall Study|Lost to Follow-up|12|||
48327939|NCT03057600|155398200|FG000|Overall Study|Radiologic Disease Progression|8|||
48327940|NCT03057600|155398201|FG001|Overall Study|Radiologic Disease Progression|7|||
48327941|NCT03057600|155398202|FG002|Overall Study|Radiologic Disease Progression|13|||
48637795|NCT01812057|156530802|FG001|Overall Study|Protocol Violation|0|||
48637796|NCT01812057|156530801|FG000|Overall Study|Physician Decision|1|||
48747461|NCT02879305|156922988|FG000|Overall Study|Other|1|||
48747462|NCT02879305|156922989|FG001|Overall Study|Other|0|||
48747463|NCT01950741|156922990|FG000|Overall Study|Lost to Follow-up|1|||
48747464|NCT01950741|156922990|FG000|Overall Study|Death|1|||
48637797|NCT01812057|156530802|FG001|Overall Study|Physician Decision|0|||
48637798|NCT04577781|156530803|FG000|Overall Study|Adverse Event|2|||
48637799|NCT04577781|156530804|FG001|Overall Study|Adverse Event|2|||
48637800|NCT04577781|156530803|FG000|Overall Study|Physician Decision|1|||
48747465|NCT01950741|156922990|FG000|Overall Study|Withdrawal by Subject|1|||
48747466|NCT01405742|156922991|FG000|Overall Study|Lost to Follow-up|1|||
48747467|NCT01405742|156922992|FG001|Overall Study|Lost to Follow-up|0|||
48747468|NCT01063868|156922993|FG000|Overall Study|Adverse Event|9|||
48747469|NCT01063868|156922994|FG001|Overall Study|Adverse Event|7|||
48747470|NCT01063868|156922993|FG000|Overall Study|Withdrawal by Subject|3|||
48747471|NCT01063868|156922994|FG001|Overall Study|Withdrawal by Subject|1|||
48637801|NCT04577781|156530804|FG001|Overall Study|Physician Decision|0|||
48637802|NCT01464879|156530811|FG000|Overall Study|Physician Decision|1|||
48637803|NCT01464879|156530811|FG000|Overall Study|Non-compliance|1|||
48637804|NCT01657305|156530812|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
48637805|NCT01657305|156530812|FG000|Overall Study|Withdrawal by Subject|4|||
48637806|NCT01657305|156530812|FG000|Overall Study|Adverse Event|1|||
48637807|NCT01657305|156530812|FG000|Overall Study|Lost to Follow-up|1|||
48637808|NCT01657305|156530812|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
48637809|NCT03937479|156530814|FG000|Overall Study|Adverse Event|2|||
48637810|NCT03937479|156530815|FG001|Overall Study|Adverse Event|3|||
48637811|NCT03937479|156530816|FG002|Overall Study|Adverse Event|0|||
48637812|NCT03937479|156530817|FG003|Overall Study|Adverse Event|0|||
48637813|NCT03937479|156530818|FG004|Overall Study|Adverse Event|1|||
48637814|NCT03937479|156530814|FG000|Overall Study|Withdrawal by Subject|3|||
48747472|NCT01063868|156922993|FG000|Overall Study|Study Terminated By Sponsor|23|||
48747473|NCT01063868|156922994|FG001|Overall Study|Study Terminated By Sponsor|4|||
48747474|NCT01949506|156922995|FG000|Overall Study|Physician Decision|1|||
48747475|NCT00753415|156922996|FG000|Part A|Disease progression|1|||
48747476|NCT00753415|156922997|FG001|Part A|Disease progression|0|||
48747477|NCT00753415|156922998|FG002|Part A|Disease progression|1|||
48747478|NCT00753415|156922999|FG003|Part A|Disease progression|2|||
48747479|NCT00753415|156923000|FG004|Part A|Disease progression|0|||
48747480|NCT00753415|156923001|FG005|Part A|Disease progression|0|||
48637815|NCT03937479|156530815|FG001|Overall Study|Withdrawal by Subject|5|||
48637816|NCT03937479|156530816|FG002|Overall Study|Withdrawal by Subject|2|||
48637817|NCT03937479|156530817|FG003|Overall Study|Withdrawal by Subject|2|||
48637818|NCT03937479|156530818|FG004|Overall Study|Withdrawal by Subject|1|||
48637819|NCT03937479|156530814|FG000|Overall Study|Protocol Violation|5|||
48637820|NCT03937479|156530815|FG001|Overall Study|Protocol Violation|6|||
48637821|NCT03937479|156530816|FG002|Overall Study|Protocol Violation|4|||
48637822|NCT03937479|156530817|FG003|Overall Study|Protocol Violation|3|||
48637823|NCT03937479|156530818|FG004|Overall Study|Protocol Violation|2|||
48637824|NCT03937479|156530814|FG000|Overall Study|Lost to Follow-up|0|||
48637825|NCT03937479|156530815|FG001|Overall Study|Lost to Follow-up|1|||
48637826|NCT03937479|156530816|FG002|Overall Study|Lost to Follow-up|0|||
48637827|NCT03937479|156530817|FG003|Overall Study|Lost to Follow-up|1|||
48637828|NCT03937479|156530818|FG004|Overall Study|Lost to Follow-up|0|||
48637829|NCT03937479|156530814|FG000|Overall Study|Physician Decision|0|||
48637830|NCT03937479|156530815|FG001|Overall Study|Physician Decision|0|||
48637831|NCT03937479|156530816|FG002|Overall Study|Physician Decision|1|||
48637832|NCT03937479|156530817|FG003|Overall Study|Physician Decision|0|||
48637833|NCT03937479|156530818|FG004|Overall Study|Physician Decision|1|||
48637834|NCT01880957|156530819|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
48637835|NCT01880957|156530820|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
48637836|NCT01880957|156530819|FG000|Overall Study|Lost to Follow-up|11|||
48637837|NCT01880957|156530820|FG001|Overall Study|Lost to Follow-up|0|||
48637838|NCT01880957|156530819|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
48637839|NCT01880957|156530820|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
48637840|NCT01957865|156530821|FG000|Overall Study|Found HIV negative|0|||
48637841|NCT01957865|156530822|FG001|Overall Study|Found HIV negative|0|||
48637842|NCT01957865|156530823|FG002|Overall Study|Found HIV negative|1|||
48637843|NCT01957865|156530821|FG000|Overall Study|Lost to Follow-up|0|||
48637844|NCT01957865|156530822|FG001|Overall Study|Lost to Follow-up|2|||
48637845|NCT01957865|156530823|FG002|Overall Study|Lost to Follow-up|2|||
48637846|NCT03559270|156530824|FG000|Overall Study|Adverse Event|6|||
48637847|NCT03559270|156530825|FG001|Overall Study|Adverse Event|5|||
48747481|NCT00753415|156923002|FG006|Part A|Disease progression|0|||
48747482|NCT00753415|156923003|FG007|Part A|Disease progression|0|||
48637848|NCT03559270|156530826|FG002|Overall Study|Adverse Event|3|||
48747483|NCT00753415|156923004|FG008|Part A|Disease progression|0|||
48637849|NCT03559270|156530827|FG003|Overall Study|Adverse Event|0|||
48637850|NCT03559270|156530824|FG000|Overall Study|Lack of Efficacy|34|||
48637851|NCT03559270|156530825|FG001|Overall Study|Lack of Efficacy|52|||
48637852|NCT03559270|156530826|FG002|Overall Study|Lack of Efficacy|37|||
48637853|NCT03559270|156530827|FG003|Overall Study|Lack of Efficacy|2|||
48637854|NCT03559270|156530824|FG000|Overall Study|Death|0|||
48747484|NCT00753415|156923005|FG009|Part A|Disease progression|0|||
48747485|NCT00753415|156922996|FG000|Part A|Withdrawal by Subject|0|||
48747486|NCT00753415|156922997|FG001|Part A|Withdrawal by Subject|0|||
48637855|NCT03559270|156530825|FG001|Overall Study|Death|2|||
48637856|NCT03559270|156530826|FG002|Overall Study|Death|0|||
48637857|NCT03559270|156530827|FG003|Overall Study|Death|0|||
48637858|NCT03559270|156530824|FG000|Overall Study|Lost to Follow-up|16|||
48747487|NCT00753415|156922998|FG002|Part A|Withdrawal by Subject|1|||
48637859|NCT03559270|156530825|FG001|Overall Study|Lost to Follow-up|4|||
48637860|NCT03559270|156530826|FG002|Overall Study|Lost to Follow-up|12|||
48637861|NCT03559270|156530827|FG003|Overall Study|Lost to Follow-up|3|||
48637862|NCT03559270|156530824|FG000|Overall Study|Sponsor Decision|38|||
48637863|NCT03559270|156530825|FG001|Overall Study|Sponsor Decision|31|||
48637864|NCT03559270|156530826|FG002|Overall Study|Sponsor Decision|35|||
48637865|NCT03559270|156530827|FG003|Overall Study|Sponsor Decision|18|||
48637866|NCT03559270|156530824|FG000|Overall Study|Withdrawal by Subject|19|||
48637867|NCT03559270|156530825|FG001|Overall Study|Withdrawal by Subject|21|||
48637868|NCT03559270|156530826|FG002|Overall Study|Withdrawal by Subject|18|||
48637869|NCT03559270|156530827|FG003|Overall Study|Withdrawal by Subject|7|||
48637870|NCT03559270|156530824|FG000|Overall Study|Physician Decision|3|||
48637871|NCT03559270|156530825|FG001|Overall Study|Physician Decision|2|||
48637872|NCT03559270|156530826|FG002|Overall Study|Physician Decision|1|||
48637873|NCT03559270|156530827|FG003|Overall Study|Physician Decision|0|||
48747488|NCT00753415|156922999|FG003|Part A|Withdrawal by Subject|0|||
48747489|NCT00753415|156923000|FG004|Part A|Withdrawal by Subject|0|||
48637874|NCT03559270|156530824|FG000|Overall Study|Pregnancy|0|||
48637875|NCT03559270|156530825|FG001|Overall Study|Pregnancy|1|||
48637876|NCT03559270|156530826|FG002|Overall Study|Pregnancy|0|||
48637877|NCT03559270|156530827|FG003|Overall Study|Pregnancy|0|||
48637878|NCT03559270|156530824|FG000|Overall Study|Protocol Violation|1|||
48637879|NCT03559270|156530825|FG001|Overall Study|Protocol Violation|0|||
48637880|NCT03559270|156530826|FG002|Overall Study|Protocol Violation|2|||
48637881|NCT03559270|156530827|FG003|Overall Study|Protocol Violation|0|||
48637882|NCT03217266|156531923|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
48637883|NCT03217266|156531924|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
48637884|NCT03217266|156531925|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
48637885|NCT03217266|156531926|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
48747490|NCT00753415|156923001|FG005|Part A|Withdrawal by Subject|0|||
48747491|NCT00753415|156923002|FG006|Part A|Withdrawal by Subject|0|||
48747492|NCT00753415|156923003|FG007|Part A|Withdrawal by Subject|0|||
48747493|NCT00753415|156923004|FG008|Part A|Withdrawal by Subject|0|||
48747494|NCT00753415|156923005|FG009|Part A|Withdrawal by Subject|0|||
48747495|NCT00753415|156922996|FG000|Part B|Lost to Follow-up|0|||
48637886|NCT03217266|156531923|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
48637887|NCT03217266|156531924|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
48637888|NCT03217266|156531925|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
48637889|NCT03217266|156531926|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
48637890|NCT03217266|156531923|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
48637891|NCT03217266|156531924|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
48637892|NCT03217266|156531925|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
48637893|NCT03217266|156531926|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
48637894|NCT00696878|156531933|FG000|Overall Study|Adverse Event|8|||
48637895|NCT00696878|156531933|FG000|Overall Study|Withdrawal by Subject|87|||
48637896|NCT00696878|156531933|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
48637897|NCT00696878|156531933|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
48637898|NCT00696878|156531933|FG000|Overall Study|Trial stopped|32|||
48747496|NCT00753415|156922997|FG001|Part B|Lost to Follow-up|0|||
48747497|NCT00753415|156922998|FG002|Part B|Lost to Follow-up|0|||
48747498|NCT00753415|156922999|FG003|Part B|Lost to Follow-up|0|||
48747499|NCT00753415|156923000|FG004|Part B|Lost to Follow-up|0|||
48747500|NCT00753415|156923001|FG005|Part B|Lost to Follow-up|0|||
48747501|NCT00753415|156923002|FG006|Part B|Lost to Follow-up|0|||
48747502|NCT00753415|156923003|FG007|Part B|Lost to Follow-up|1|||
48747503|NCT00753415|156923004|FG008|Part B|Lost to Follow-up|1|||
48747504|NCT00753415|156923005|FG009|Part B|Lost to Follow-up|0|||
48747505|NCT00753415|156922996|FG000|Part B|Disease progression|0|||
48747506|NCT00753415|156922997|FG001|Part B|Disease progression|0|||
48747507|NCT00753415|156922998|FG002|Part B|Disease progression|0|||
48747508|NCT00753415|156922999|FG003|Part B|Disease progression|0|||
48747509|NCT00753415|156923000|FG004|Part B|Disease progression|0|||
48747510|NCT00753415|156923001|FG005|Part B|Disease progression|0|||
48747511|NCT00753415|156923002|FG006|Part B|Disease progression|0|||
48747512|NCT00753415|156923003|FG007|Part B|Disease progression|0|||
48747513|NCT00753415|156923004|FG008|Part B|Disease progression|2|||
48637899|NCT00696878|156531933|FG000|Overall Study|Other reason (not specified)|55|||
48637900|NCT01276106|156531934|FG000|Overall Study|Adverse Event|3|||
48637901|NCT01276106|156531935|FG001|Overall Study|Adverse Event|3|||
48637902|NCT01276106|156531936|FG002|Overall Study|Adverse Event|11|||
48637903|NCT01276106|156531937|FG003|Overall Study|Adverse Event|3|||
48747514|NCT00753415|156923005|FG009|Part B|Disease progression|1|||
48747515|NCT01664533|156924865|FG000|Overall Study|Death|42|||
48747516|NCT01664533|156924865|FG000|Overall Study|Lost to Follow-up|3|||
48747517|NCT01664533|156924865|FG000|Overall Study|Study termination|9|||
48637904|NCT01276106|156531934|FG000|Overall Study|Withdrawal by Subject|6|||
48637905|NCT01276106|156531935|FG001|Overall Study|Withdrawal by Subject|3|||
48637906|NCT01276106|156531936|FG002|Overall Study|Withdrawal by Subject|1|||
48637907|NCT01276106|156531937|FG003|Overall Study|Withdrawal by Subject|6|||
48637908|NCT01276106|156531934|FG000|Overall Study|Lack of Efficacy|0|||
48747518|NCT01664533|156924865|FG000|Overall Study|Protocol Violation|3|||
48747519|NCT00739674|156924866|FG000|Overall Study|Screening failures|19|||
48747520|NCT00739674|156924867|FG001|Overall Study|Screening failures|17|||
48747521|NCT00739674|156924866|FG000|Overall Study|Site 212 removal|19|||
48747522|NCT00739674|156924867|FG001|Overall Study|Site 212 removal|13|||
48747523|NCT00739674|156924866|FG000|Overall Study|No follow-up data|33|||
48747524|NCT00739674|156924867|FG001|Overall Study|No follow-up data|18|||
48747525|NCT00739674|156924866|FG000|Overall Study|Dietician consultation >30 days|1|||
48747526|NCT00739674|156924867|FG001|Overall Study|Dietician consultation >30 days|9|||
48747527|NCT00739674|156924866|FG000|Overall Study|Adverse Event|22|||
48747528|NCT00739674|156924867|FG001|Overall Study|Adverse Event|13|||
48747529|NCT00739674|156924866|FG000|Overall Study|Death|1|||
48637909|NCT01276106|156531935|FG001|Overall Study|Lack of Efficacy|1|||
48637910|NCT01276106|156531936|FG002|Overall Study|Lack of Efficacy|0|||
48637911|NCT01276106|156531937|FG003|Overall Study|Lack of Efficacy|1|||
48637912|NCT01276106|156531934|FG000|Overall Study|Lost to Follow-up|2|||
48637913|NCT01276106|156531935|FG001|Overall Study|Lost to Follow-up|1|||
48637914|NCT01276106|156531936|FG002|Overall Study|Lost to Follow-up|1|||
48637915|NCT01276106|156531937|FG003|Overall Study|Lost to Follow-up|0|||
48637916|NCT01276106|156531934|FG000|Overall Study|Physician Decision|0|||
48637917|NCT01276106|156531935|FG001|Overall Study|Physician Decision|0|||
48747530|NCT00739674|156924867|FG001|Overall Study|Death|0|||
48747531|NCT00739674|156924866|FG000|Overall Study|Lack of Efficacy|1|||
48747532|NCT00739674|156924867|FG001|Overall Study|Lack of Efficacy|0|||
48327942|NCT03057600|155398203|FG003|Overall Study|Radiologic Disease Progression|10|||
48747533|NCT00739674|156924866|FG000|Overall Study|Lost to Follow-up|52|||
48747534|NCT00739674|156924867|FG001|Overall Study|Lost to Follow-up|30|||
48747535|NCT00739674|156924866|FG000|Overall Study|Protocol Violation|5|||
48747536|NCT00739674|156924867|FG001|Overall Study|Protocol Violation|5|||
48327943|NCT03057600|155398200|FG000|Overall Study|Symptomatic Deterioration|0|||
48637918|NCT01276106|156531936|FG002|Overall Study|Physician Decision|1|||
48637919|NCT01276106|156531937|FG003|Overall Study|Physician Decision|1|||
48637920|NCT01276106|156531934|FG000|Overall Study|Protocol Violation|1|||
48637921|NCT01276106|156531935|FG001|Overall Study|Protocol Violation|1|||
48637922|NCT01276106|156531936|FG002|Overall Study|Protocol Violation|0|||
48637923|NCT01276106|156531937|FG003|Overall Study|Protocol Violation|2|||
48637924|NCT01276106|156531934|FG000|Overall Study|Insufficient therapeutic effects|0|||
48747537|NCT00739674|156924866|FG000|Overall Study|Withdrawal by Subject|9|||
48637925|NCT01276106|156531935|FG001|Overall Study|Insufficient therapeutic effects|0|||
48327944|NCT03057600|155398201|FG001|Overall Study|Symptomatic Deterioration|1|||
48327945|NCT03057600|155398202|FG002|Overall Study|Symptomatic Deterioration|1|||
48327946|NCT03057600|155398203|FG003|Overall Study|Symptomatic Deterioration|0|||
48327947|NCT03057600|155398200|FG000|Overall Study|Investigator Decision|0|||
48327948|NCT03057600|155398201|FG001|Overall Study|Investigator Decision|0|||
48327949|NCT03057600|155398202|FG002|Overall Study|Investigator Decision|1|||
48327950|NCT03057600|155398203|FG003|Overall Study|Investigator Decision|0|||
48327951|NCT03057600|155398200|FG000|Overall Study|Study Termination by Sponsor|0|||
48637926|NCT01276106|156531936|FG002|Overall Study|Insufficient therapeutic effects|2|||
48637927|NCT01276106|156531937|FG003|Overall Study|Insufficient therapeutic effects|0|||
48637928|NCT04716894|156531938|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
48637929|NCT04716894|156531938|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
48747538|NCT00739674|156924867|FG001|Overall Study|Withdrawal by Subject|9|||
48747539|NCT00739674|156924866|FG000|Overall Study|Reason missing|2|||
48747540|NCT00739674|156924867|FG001|Overall Study|Reason missing|0|||
48747541|NCT00739674|156924866|FG000|Overall Study|Clinic closed|6|||
48747542|NCT00739674|156924867|FG001|Overall Study|Clinic closed|4|||
48327952|NCT03057600|155398201|FG001|Overall Study|Study Termination by Sponsor|0|||
48327953|NCT03057600|155398202|FG002|Overall Study|Study Termination by Sponsor|0|||
48327954|NCT03057600|155398203|FG003|Overall Study|Study Termination by Sponsor|2|||
48637930|NCT00846846|156531940|FG000|Overall Study|Death|56|||
48637931|NCT00846846|156531940|FG000|Overall Study|Withdrawal by Subject|19|||
48637932|NCT01030822|156531941|FG000|Overall Study|Moved/migrated from study area|6|||
48637933|NCT01030822|156531942|FG001|Overall Study|Moved/migrated from study area|7|||
48637934|NCT01030822|156531943|FG002|Overall Study|Moved/migrated from study area|3|||
48637935|NCT01030822|156531941|FG000|Overall Study|Withdrawal by Subject|16|||
48637936|NCT01030822|156531942|FG001|Overall Study|Withdrawal by Subject|13|||
48637937|NCT01030822|156531943|FG002|Overall Study|Withdrawal by Subject|16|||
48747543|NCT00739674|156924866|FG000|Overall Study|Patient moved|3|||
48747544|NCT00739674|156924867|FG001|Overall Study|Patient moved|2|||
48747545|NCT00739674|156924866|FG000|Overall Study|Non compliant|4|||
48747546|NCT00739674|156924867|FG001|Overall Study|Non compliant|0|||
48327955|NCT03057600|155398200|FG000|Overall Study|Withdrawal by Subject|0|||
48327956|NCT03057600|155398201|FG001|Overall Study|Withdrawal by Subject|1|||
48327957|NCT03057600|155398202|FG002|Overall Study|Withdrawal by Subject|0|||
48747547|NCT00739674|156924866|FG000|Overall Study|Unable to attend visit|3|||
48327958|NCT03057600|155398203|FG003|Overall Study|Withdrawal by Subject|0|||
48327959|NCT03057600|155398200|FG000|Overall Study|Other, Not Specified|1|||
48327960|NCT03057600|155398201|FG001|Overall Study|Other, Not Specified|1|||
48327961|NCT03057600|155398202|FG002|Overall Study|Other, Not Specified|1|||
48327962|NCT03057600|155398203|FG003|Overall Study|Other, Not Specified|1|||
48327963|NCT02167451|155398204|FG000|Overall Study|Withdrawal by Subject|1|||
48327964|NCT01218659|155398205|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
48327965|NCT01218659|155398206|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
48327966|NCT01218659|155398207|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
48327967|NCT01218659|155398205|FG000|18-Month Randomized Period|Did not receive study drug|0|||
48327968|NCT01218659|155398206|FG001|18-Month Randomized Period|Did not receive study drug|3|||
48327969|NCT01218659|155398207|FG002|18-Month Randomized Period|Did not receive study drug|0|||
48327970|NCT01218659|155398205|FG000|12-Month OLE|Withdrawal by Subject|0|||
48327971|NCT01218659|155398206|FG001|12-Month OLE|Withdrawal by Subject|0|||
48327972|NCT01218659|155398207|FG002|12-Month OLE|Withdrawal by Subject|2|||
48327973|NCT01218659|155398205|FG000|12-Month OLE|Physician Decision|0|||
48327974|NCT01218659|155398206|FG001|12-Month OLE|Physician Decision|0|||
48327975|NCT01218659|155398207|FG002|12-Month OLE|Physician Decision|1|||
48327976|NCT01218659|155398205|FG000|12-Month OLE|Lost to Follow-up|0|||
48637938|NCT01030822|156531941|FG000|Overall Study|Lost to Follow-up|9|||
48637939|NCT01030822|156531942|FG001|Overall Study|Lost to Follow-up|4|||
48637940|NCT01030822|156531943|FG002|Overall Study|Lost to Follow-up|7|||
48637941|NCT04068922|156531944|FG000|Overall Study|Lost to Follow-up|5|||
48637942|NCT04068922|156531944|FG000|Overall Study|Withdrawal by Subject|7|||
48637943|NCT04068922|156531944|FG000|Overall Study|Adverse Event|1|||
48637944|NCT00716274|156531951|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
48637945|NCT00716274|156531952|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
48637946|NCT00716274|156531953|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
48637947|NCT00716274|156531954|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
48637948|NCT00716274|156531955|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
48637949|NCT00716274|156531956|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
48637950|NCT00716274|156531951|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
48637951|NCT00716274|156531952|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
48637952|NCT00716274|156531953|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
48637953|NCT00716274|156531954|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
48747548|NCT00739674|156924867|FG001|Overall Study|Unable to attend visit|1|||
48747549|NCT00739674|156924866|FG000|Overall Study|Home monitoring off meds|1|||
48747550|NCT00739674|156924867|FG001|Overall Study|Home monitoring off meds|0|||
48327977|NCT01218659|155398206|FG001|12-Month OLE|Lost to Follow-up|0|||
48327978|NCT01218659|155398207|FG002|12-Month OLE|Lost to Follow-up|1|||
48327979|NCT01218659|155398205|FG000|12-Month OLE|Pregnancy|0|||
48637954|NCT00716274|156531955|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
48637955|NCT00716274|156531956|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
48637956|NCT00716274|156531951|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
48637957|NCT00716274|156531952|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
48637958|NCT00716274|156531953|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
48637959|NCT00716274|156531954|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
48637960|NCT00716274|156531955|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
48637961|NCT00716274|156531956|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
48637962|NCT00716274|156531951|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
48637963|NCT00716274|156531952|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
48637964|NCT00716274|156531953|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
48637965|NCT00716274|156531954|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
48637966|NCT00716274|156531955|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
48637967|NCT00716274|156531956|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
48637968|NCT00716274|156531951|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
48637969|NCT00716274|156531952|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
48637970|NCT00716274|156531953|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
48637971|NCT00716274|156531954|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
48637972|NCT00716274|156531955|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
48637973|NCT00716274|156531956|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
48637974|NCT00716274|156531951|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
48637975|NCT00716274|156531952|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
48637976|NCT00716274|156531953|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
48637977|NCT00716274|156531954|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
48637978|NCT00716274|156531955|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
48637979|NCT00716274|156531956|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
48637980|NCT00716274|156531951|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
48637981|NCT00716274|156531952|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
48637982|NCT00716274|156531953|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
48637983|NCT00716274|156531954|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
48637984|NCT00716274|156531955|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
48637985|NCT00716274|156531956|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
48637986|NCT00716274|156531951|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
48637987|NCT00716274|156531952|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
48637988|NCT00716274|156531953|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
48637989|NCT00716274|156531954|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
48637990|NCT00716274|156531955|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
48637991|NCT00716274|156531956|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
48637992|NCT00716274|156531951|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
48637993|NCT00716274|156531952|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
48637994|NCT00716274|156531953|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
48637995|NCT00716274|156531954|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
48637996|NCT00716274|156531955|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
48637997|NCT00716274|156531956|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
48637998|NCT00716274|156531951|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
48637999|NCT00716274|156531952|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
48638000|NCT00716274|156531953|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
48638001|NCT00716274|156531954|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
48638002|NCT00716274|156531955|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
48638003|NCT00716274|156531956|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
48638004|NCT03571971|156531960|FG000|Overall Study|Lost to Follow-up|2|||
48638005|NCT03571971|156531961|FG001|Overall Study|Lost to Follow-up|2|||
48638006|NCT03571971|156531960|FG000|Overall Study|Protocol Violation|2|||
48638007|NCT03571971|156531961|FG001|Overall Study|Protocol Violation|3|||
48638008|NCT03571971|156531960|FG000|Overall Study|Withdrawal by Subject|2|||
48638009|NCT03571971|156531961|FG001|Overall Study|Withdrawal by Subject|0|||
48638010|NCT03571971|156531960|FG000|Overall Study|Incomplete primary outcome data|2|||
48638011|NCT03571971|156531961|FG001|Overall Study|Incomplete primary outcome data|0|||
48638012|NCT04021290|156531965|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
48638013|NCT04021290|156531966|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
48638014|NCT04021290|156531967|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
48638015|NCT04021290|156531965|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
48638016|NCT04021290|156531966|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
48638017|NCT04021290|156531967|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
48747551|NCT00739674|156924866|FG000|Overall Study|Erectile dysfunction|0|||
48327980|NCT01218659|155398206|FG001|12-Month OLE|Pregnancy|0|||
48327981|NCT01218659|155398207|FG002|12-Month OLE|Pregnancy|1|||
48327982|NCT01218659|155398205|FG000|12-Month OLE|Lack of Efficacy|0|||
48638018|NCT04021290|156531965|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
48638019|NCT04021290|156531966|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
48638020|NCT04021290|156531967|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
48638021|NCT04021290|156531965|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
48638022|NCT04021290|156531966|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
48638023|NCT04021290|156531967|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
48638024|NCT04021290|156531965|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
48638025|NCT04021290|156531966|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
48638026|NCT04021290|156531967|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
48747552|NCT00739674|156924867|FG001|Overall Study|Erectile dysfunction|1|||
48747553|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
48747554|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
48747555|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
48747556|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
48747557|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
48747558|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
48747559|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
48747560|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
48747561|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
48747562|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
48747563|NCT00787891|156924868|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
48747564|NCT00787891|156924869|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
48747565|NCT00787891|156924868|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
48747566|NCT00787891|156924869|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
48747567|NCT00787891|156924868|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
48747568|NCT00787891|156924869|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
48747569|NCT00787891|156924868|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
48747570|NCT00787891|156924869|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
48747571|NCT00787891|156924868|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
48747572|NCT00787891|156924869|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
48747573|NCT01575769|156924870|FG000|Overall Study|Adverse Event|1|||
48747574|NCT01575769|156924870|FG000|Overall Study|Study terminated by sponsor|40|||
48747575|NCT02370160|156924871|FG000|Overall Study|Death|3|||
48747576|NCT02370160|156924872|FG001|Overall Study|Death|4|||
48747577|NCT02370160|156924873|FG002|Overall Study|Death|1|||
48747578|NCT01871532|156924874|FG000|Overall Study|Withdrawal by Subject|1|||
48747579|NCT01871532|156924875|FG001|Overall Study|Withdrawal by Subject|2|||
48747580|NCT02550106|156924877|FG000|Overall Study|Adverse Event|1|||
48747581|NCT02550106|156924877|FG000|Overall Study|Lack of Efficacy|3|||
48747582|NCT02550106|156924877|FG000|Overall Study|Protocol Violation|6|||
48747583|NCT02550106|156924877|FG000|Overall Study|Withdrawal by Subject|2|||
48747584|NCT00105469|156924878|FG000|Overall Study|Adverse Event|9|||
48747585|NCT00105469|156924879|FG001|Overall Study|Adverse Event|8|||
48747586|NCT00105469|156924878|FG000|Overall Study|Protocol Violation|4|||
48747587|NCT00105469|156924879|FG001|Overall Study|Protocol Violation|0|||
48747588|NCT00105469|156924878|FG000|Overall Study|Withdrawal by Subject|2|||
48747589|NCT00105469|156924879|FG001|Overall Study|Withdrawal by Subject|3|||
48747590|NCT00105469|156924878|FG000|Overall Study|Lost to Follow-up|1|||
48747591|NCT00105469|156924879|FG001|Overall Study|Lost to Follow-up|0|||
48747592|NCT00105469|156924878|FG000|Overall Study|Lack of Efficacy|2|||
48747593|NCT00105469|156924879|FG001|Overall Study|Lack of Efficacy|0|||
48747594|NCT00105469|156924878|FG000|Overall Study|Other Reason|4|||
48747595|NCT00105469|156924879|FG001|Overall Study|Other Reason|0|||
48747596|NCT01806298|156924883|FG000|Overall Study|Adverse Event|3|||
48747597|NCT01806298|156924883|FG000|Overall Study|Protocol Non-compliance|1|||
48747598|NCT01806298|156924883|FG000|Overall Study|Withdrawal by Subject|1|||
48747599|NCT01806298|156924883|FG000|Overall Study|Other|5|||
48747600|NCT02279420|156924889|FG000|Overall Study|Lost to Follow-up|23|||
48638027|NCT04021290|156531965|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
48747601|NCT03535844|156924893|FG000|Overall Study|Withdrawal by Subject|0|||
48747602|NCT03535844|156924894|FG001|Overall Study|Withdrawal by Subject|1|||
48747603|NCT03766581|156924904|FG000|Randomization|Other reasons|2|||
48747604|NCT03766581|156924905|FG001|Randomization|Other reasons|1|||
48747605|NCT03766581|156924906|FG002|Randomization|Other reasons|0|||
48747606|NCT03766581|156924907|FG003|Randomization|Other reasons|1|||
48747607|NCT03766581|156924908|FG004|Randomization|Other reasons|0|||
48638028|NCT04021290|156531966|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
48638029|NCT04021290|156531967|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
48638030|NCT04021290|156531965|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
48638031|NCT04021290|156531966|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
48638032|NCT04021290|156531967|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
48638033|NCT04021290|156531965|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
48638034|NCT04021290|156531966|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
48638035|NCT04021290|156531967|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
48638036|NCT04021290|156531965|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
48638037|NCT04021290|156531966|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
48638038|NCT04021290|156531967|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
48638039|NCT04021290|156531965|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
48638040|NCT04021290|156531966|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
48638041|NCT04021290|156531967|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
48638042|NCT04021290|156531965|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
48638043|NCT04021290|156531966|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
48638044|NCT04021290|156531967|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
48638045|NCT04021290|156531965|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
48638046|NCT04021290|156531966|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
48638047|NCT04021290|156531967|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
48638048|NCT01342926|156531969|FG000|Overall Study|Adverse Event|5|||
48638049|NCT01342926|156531970|FG001|Overall Study|Adverse Event|8|||
48638050|NCT01342926|156531971|FG002|Overall Study|Adverse Event|10|||
48638051|NCT01342926|156531972|FG003|Overall Study|Adverse Event|7|||
48638052|NCT01342926|156531969|FG000|Overall Study|Lost to Follow-up|0|||
48638053|NCT01342926|156531970|FG001|Overall Study|Lost to Follow-up|1|||
48638054|NCT01342926|156531971|FG002|Overall Study|Lost to Follow-up|1|||
48638055|NCT01342926|156531972|FG003|Overall Study|Lost to Follow-up|0|||
48638056|NCT01342926|156531969|FG000|Overall Study|Investigator Discretion|2|||
48638057|NCT01342926|156531970|FG001|Overall Study|Investigator Discretion|2|||
48638058|NCT01342926|156531971|FG002|Overall Study|Investigator Discretion|0|||
48638059|NCT01342926|156531972|FG003|Overall Study|Investigator Discretion|0|||
48638060|NCT01342926|156531969|FG000|Overall Study|Withdrawal by Subject|2|||
48638061|NCT01342926|156531970|FG001|Overall Study|Withdrawal by Subject|4|||
48638062|NCT01342926|156531971|FG002|Overall Study|Withdrawal by Subject|3|||
48638063|NCT01342926|156531972|FG003|Overall Study|Withdrawal by Subject|5|||
48638064|NCT03092479|156531973|FG000|Overall Study|Lost to Follow-up|3|||
48638065|NCT03092479|156531974|FG001|Overall Study|Lost to Follow-up|2|||
48638066|NCT03092479|156531973|FG000|Overall Study|Withdrawal by Subject|4|||
48638067|NCT03092479|156531974|FG001|Overall Study|Withdrawal by Subject|0|||
48638068|NCT03382912|156531975|FG000|Overall Study|Physician Decision|0|||
48638069|NCT03382912|156531976|FG001|Overall Study|Physician Decision|1|||
48638070|NCT03382912|156531975|FG000|Overall Study|Sponsor Decision|6|||
48638071|NCT03382912|156531976|FG001|Overall Study|Sponsor Decision|6|||
48638072|NCT03382912|156531975|FG000|Overall Study|Withdrawal by Subject|0|||
48638073|NCT03382912|156531976|FG001|Overall Study|Withdrawal by Subject|5|||
48638074|NCT04422431|156531982|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
48638075|NCT04422431|156531982|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
48638076|NCT04422431|156531982|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
48638077|NCT04422431|156531982|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
48638078|NCT04422431|156531982|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
48638079|NCT04422431|156531982|FG000|Extension Period (48 Weeks)|Other than specified|2|||
48638080|NCT04288089|156531983|FG000|Overall Study|Ongoing Treatment|2|||
48638081|NCT04288089|156531984|FG001|Overall Study|Ongoing Treatment|1|||
48638082|NCT04288089|156531985|FG002|Overall Study|Ongoing Treatment|1|||
48638083|NCT04288089|156531986|FG003|Overall Study|Ongoing Treatment|4|||
48638084|NCT03929913|156531987|FG000|Overall Study|Death|4|||
48638085|NCT03929913|156531987|FG000|Overall Study|Lost to Follow-up|1|||
48638086|NCT03929913|156531987|FG000|Overall Study|Failed Procedure|2|||
48638087|NCT01928433|156531988|FG000|Overall Study|Adverse Event|5|||
48638088|NCT01928433|156531989|FG001|Overall Study|Adverse Event|2|||
48638089|NCT01928433|156531990|FG002|Overall Study|Adverse Event|5|||
48327983|NCT01218659|155398206|FG001|12-Month OLE|Lack of Efficacy|0|||
48638090|NCT01928433|156531988|FG000|Overall Study|Protocol Violation|0|||
48638091|NCT01928433|156531989|FG001|Overall Study|Protocol Violation|0|||
48638092|NCT01928433|156531990|FG002|Overall Study|Protocol Violation|2|||
48638093|NCT01928433|156531988|FG000|Overall Study|Lack of Efficacy|5|||
48638094|NCT01928433|156531989|FG001|Overall Study|Lack of Efficacy|4|||
48638095|NCT01928433|156531990|FG002|Overall Study|Lack of Efficacy|4|||
48638096|NCT01928433|156531988|FG000|Overall Study|Withdrawal by Subject|0|||
48638097|NCT01928433|156531989|FG001|Overall Study|Withdrawal by Subject|4|||
48638098|NCT01928433|156531990|FG002|Overall Study|Withdrawal by Subject|0|||
48747608|NCT03766581|156924909|FG005|Randomization|Other reasons|0|||
48638099|NCT01928433|156531988|FG000|Overall Study|Negative screening urine culture|7|||
48638100|NCT01928433|156531989|FG001|Overall Study|Negative screening urine culture|6|||
48638101|NCT01928433|156531990|FG002|Overall Study|Negative screening urine culture|10|||
48638102|NCT01928433|156531988|FG000|Overall Study|Lost to Follow-up|0|||
48638103|NCT01928433|156531989|FG001|Overall Study|Lost to Follow-up|2|||
48638104|NCT01928433|156531990|FG002|Overall Study|Lost to Follow-up|3|||
48638105|NCT01928433|156531988|FG000|Overall Study|Other reasons|3|||
48638106|NCT01928433|156531989|FG001|Overall Study|Other reasons|3|||
48638107|NCT01928433|156531990|FG002|Overall Study|Other reasons|4|||
48638108|NCT00403130|156531994|FG000|2 Years From Start of Treatment|Not Eligible|3|||
48638109|NCT00403130|156531994|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
48638110|NCT00403130|156531994|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
48638111|NCT00403130|156531994|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
48638112|NCT01913327|156531997|FG000|Overall Study|Withdrawal by Subject|0|||
48638113|NCT01913327|156531998|FG001|Overall Study|Withdrawal by Subject|1|||
48638114|NCT01897532|156531999|FG000|Discontinuation From Treatment|Not Treated|7|||
48638115|NCT01897532|156532000|FG001|Discontinuation From Treatment|Not Treated|5|||
48638116|NCT01897532|156531999|FG000|Discontinuation From Treatment|Other reason than specified|196|||
48638117|NCT01897532|156532000|FG001|Discontinuation From Treatment|Other reason than specified|176|||
48638118|NCT01897532|156531999|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
48327984|NCT01218659|155398207|FG002|12-Month OLE|Lack of Efficacy|1|||
48327985|NCT01218659|155398205|FG000|12-Month OLE|Declined to participate in the OLE|0|||
48327986|NCT01218659|155398206|FG001|12-Month OLE|Declined to participate in the OLE|0|||
48327987|NCT01218659|155398207|FG002|12-Month OLE|Declined to participate in the OLE|4|||
48327988|NCT01787032|155398210|FG000|Overall Study|Protocol Violation|0|||
48327989|NCT01787032|155398211|FG001|Overall Study|Protocol Violation|0|||
48327990|NCT01787032|155398212|FG002|Overall Study|Protocol Violation|0|||
48638119|NCT01897532|156532000|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
48638120|NCT01897532|156531999|FG000|Discontinuation From Treatment|Non compliance|24|||
48638121|NCT01897532|156532000|FG001|Discontinuation From Treatment|Non compliance|15|||
48638122|NCT01897532|156531999|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
48638123|NCT01897532|156532000|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
48638124|NCT01897532|156531999|FG000|Discontinuation From Trial|Not Treated|7|||
48638125|NCT01897532|156532000|FG001|Discontinuation From Trial|Not Treated|5|||
48638126|NCT01897532|156531999|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
48638127|NCT01897532|156532000|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
48638128|NCT00953706|156532001|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
48638129|NCT00953706|156532002|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
48638130|NCT00953706|156532003|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
48638131|NCT00953706|156532004|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
48638132|NCT00953706|156532001|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
48638133|NCT00953706|156532002|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
48638134|NCT00953706|156532003|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
48638135|NCT00953706|156532004|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
48638136|NCT00953706|156532001|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
48638137|NCT00953706|156532002|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
48638138|NCT00953706|156532003|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
48638139|NCT00953706|156532004|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
48638140|NCT00953706|156532001|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
48638141|NCT00953706|156532002|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
48638142|NCT00953706|156532003|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
48638143|NCT00953706|156532004|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
48638144|NCT00953706|156532001|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
48638145|NCT00953706|156532002|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
48638146|NCT00953706|156532003|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
48638147|NCT00953706|156532004|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
48638148|NCT00953706|156532001|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
48638149|NCT00953706|156532002|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
48638150|NCT00953706|156532003|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
48638151|NCT00953706|156532004|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
48638152|NCT00953706|156532001|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
48638153|NCT00953706|156532002|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
48638154|NCT00953706|156532003|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
48692705|NCT04908683|156724584|FG000|Overall Study|Failure to meet continuation criteria|34|||
48692706|NCT04908683|156724585|FG001|Overall Study|Failure to meet continuation criteria|22|||
48692707|NCT04908683|156724584|FG000|Overall Study|Initiated prohibited medication|3|||
48747609|NCT03766581|156924910|FG006|Randomization|Other reasons|0|||
48638155|NCT00953706|156532004|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
48638156|NCT00953706|156532001|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
48638157|NCT00953706|156532002|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
48638158|NCT00953706|156532003|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
48638159|NCT00953706|156532004|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
48638160|NCT00953706|156532001|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
48747610|NCT03766581|156924911|FG007|Randomization|Other reasons|0|||
48747611|NCT03766581|156924904|FG000|Randomization|Participant no longer meets study criteria|5|||
48747612|NCT03766581|156924905|FG001|Randomization|Participant no longer meets study criteria|3|||
48747613|NCT03766581|156924906|FG002|Randomization|Participant no longer meets study criteria|4|||
48747614|NCT03766581|156924907|FG003|Randomization|Participant no longer meets study criteria|0|||
48747615|NCT03766581|156924908|FG004|Randomization|Participant no longer meets study criteria|2|||
48747616|NCT03766581|156924909|FG005|Randomization|Participant no longer meets study criteria|3|||
48747617|NCT03766581|156924910|FG006|Randomization|Participant no longer meets study criteria|0|||
48747618|NCT03766581|156924911|FG007|Randomization|Participant no longer meets study criteria|1|||
48747619|NCT03766581|156924904|FG000|Randomization|Participant request to discontinue study treatment|1|||
48747620|NCT03766581|156924905|FG001|Randomization|Participant request to discontinue study treatment|0|||
48747621|NCT03766581|156924906|FG002|Randomization|Participant request to discontinue study treatment|0|||
48747622|NCT03766581|156924907|FG003|Randomization|Participant request to discontinue study treatment|0|||
48747623|NCT03766581|156924908|FG004|Randomization|Participant request to discontinue study treatment|1|||
48747624|NCT03766581|156924909|FG005|Randomization|Participant request to discontinue study treatment|2|||
48747625|NCT03766581|156924910|FG006|Randomization|Participant request to discontinue study treatment|0|||
48747626|NCT03766581|156924911|FG007|Randomization|Participant request to discontinue study treatment|0|||
48747627|NCT03766581|156924904|FG000|Randomization|Participant withdrew consent|1|||
48747628|NCT03766581|156924905|FG001|Randomization|Participant withdrew consent|0|||
48747629|NCT03766581|156924906|FG002|Randomization|Participant withdrew consent|1|||
48747630|NCT03766581|156924907|FG003|Randomization|Participant withdrew consent|2|||
48747631|NCT03766581|156924908|FG004|Randomization|Participant withdrew consent|1|||
48747632|NCT03766581|156924909|FG005|Randomization|Participant withdrew consent|1|||
48747633|NCT03766581|156924910|FG006|Randomization|Participant withdrew consent|0|||
48747634|NCT03766581|156924911|FG007|Randomization|Participant withdrew consent|0|||
48327991|NCT01787032|155398213|FG003|Overall Study|Protocol Violation|0|||
48327992|NCT01787032|155398214|FG004|Overall Study|Protocol Violation|1|||
48327993|NCT01787032|155398215|FG005|Overall Study|Protocol Violation|1|||
48327994|NCT05270460|155398216|FG000|Overall Study|Adverse Event|0|||
48327995|NCT05270460|155398217|FG001|Overall Study|Adverse Event|1|||
48327996|NCT05270460|155398218|FG002|Overall Study|Adverse Event|0|||
48327997|NCT05270460|155398216|FG000|Overall Study|Early Termination|0|||
48327998|NCT05270460|155398217|FG001|Overall Study|Early Termination|1|||
48327999|NCT05270460|155398218|FG002|Overall Study|Early Termination|0|||
48328000|NCT05445557|155398221|FG000|Double Blind Part|Lost to Follow-up|1|||
48638161|NCT00953706|156532002|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
48638162|NCT00953706|156532003|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
48638163|NCT00953706|156532004|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
48638164|NCT00953706|156532001|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
48638165|NCT00953706|156532002|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
48638166|NCT00953706|156532003|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
48638167|NCT00953706|156532004|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
48638168|NCT00953706|156532001|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
48638169|NCT00953706|156532002|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
48638170|NCT00953706|156532003|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
48638171|NCT00953706|156532004|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
48638172|NCT02137070|156532005|FG000|Overall Study|Adverse Event|12|||
48638173|NCT02137070|156532006|FG001|Overall Study|Adverse Event|3|||
48638174|NCT02137070|156532005|FG000|Overall Study|Death|2|||
48328001|NCT00070317|155398224|FG000|Overall Study|Inevaluable (Never Treated)|1|||
48328002|NCT00070317|155398224|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
48638175|NCT02137070|156532006|FG001|Overall Study|Death|0|||
48328003|NCT00070317|155398224|FG000|Overall Study|Ineligible required test not done|1|||
48328004|NCT00070317|155398224|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
48638176|NCT02137070|156532005|FG000|Overall Study|Lost to Follow-up|24|||
48638177|NCT02137070|156532006|FG001|Overall Study|Lost to Follow-up|9|||
48638178|NCT02137070|156532005|FG000|Overall Study|Physician Decision|0|||
48638179|NCT02137070|156532006|FG001|Overall Study|Physician Decision|1|||
48638180|NCT02137070|156532005|FG000|Overall Study|Protocol Violation|18|||
48638181|NCT02137070|156532006|FG001|Overall Study|Protocol Violation|4|||
48638182|NCT02137070|156532005|FG000|Overall Study|Withdrawal by Subject|18|||
48638183|NCT02137070|156532006|FG001|Overall Study|Withdrawal by Subject|1|||
48638184|NCT00003645|156533816|FG000|Overall Study|Death|4|||
48638185|NCT00003645|156533817|FG001|Overall Study|Death|1|||
48638186|NCT00003645|156533816|FG000|Overall Study|Lost to Follow-up|7|||
48638187|NCT00003645|156533817|FG001|Overall Study|Lost to Follow-up|8|||
48638188|NCT00003645|156533816|FG000|Overall Study|Withdrawal by Subject|1|||
48638189|NCT00003645|156533817|FG001|Overall Study|Withdrawal by Subject|3|||
48638190|NCT01173679|156533818|FG000|Overall Study|Death|1|||
48638191|NCT01657370|156533820|FG000|Overall Study|Withdrawal by Subject|0|||
48638192|NCT01657370|156533821|FG001|Overall Study|Withdrawal by Subject|0|||
48638193|NCT01657370|156533822|FG002|Overall Study|Withdrawal by Subject|1|||
48638194|NCT01657370|156533823|FG003|Overall Study|Withdrawal by Subject|0|||
48638195|NCT01657370|156533824|FG004|Overall Study|Withdrawal by Subject|0|||
48638196|NCT01657370|156533825|FG005|Overall Study|Withdrawal by Subject|1|||
48638197|NCT01657370|156533820|FG000|Overall Study|Physician Decision|2|||
48638198|NCT01657370|156533821|FG001|Overall Study|Physician Decision|3|||
48638199|NCT01657370|156533822|FG002|Overall Study|Physician Decision|1|||
48638200|NCT01657370|156533823|FG003|Overall Study|Physician Decision|2|||
48638201|NCT01657370|156533824|FG004|Overall Study|Physician Decision|5|||
48638202|NCT01657370|156533825|FG005|Overall Study|Physician Decision|0|||
48638203|NCT01657370|156533820|FG000|Overall Study|Lack of Qualifying Event|1|||
48638204|NCT01657370|156533821|FG001|Overall Study|Lack of Qualifying Event|0|||
48638205|NCT01657370|156533822|FG002|Overall Study|Lack of Qualifying Event|3|||
48638206|NCT01657370|156533823|FG003|Overall Study|Lack of Qualifying Event|2|||
48638207|NCT01657370|156533824|FG004|Overall Study|Lack of Qualifying Event|1|||
48638208|NCT01657370|156533825|FG005|Overall Study|Lack of Qualifying Event|2|||
48638209|NCT01657370|156533820|FG000|Overall Study|Adverse Event|0|||
48638210|NCT01657370|156533821|FG001|Overall Study|Adverse Event|0|||
48638211|NCT01657370|156533822|FG002|Overall Study|Adverse Event|0|||
48638212|NCT01657370|156533823|FG003|Overall Study|Adverse Event|0|||
48638213|NCT01657370|156533824|FG004|Overall Study|Adverse Event|1|||
48638214|NCT01657370|156533825|FG005|Overall Study|Adverse Event|0|||
48638215|NCT01657370|156533820|FG000|Overall Study|Protocol Violation|1|||
48638216|NCT01657370|156533821|FG001|Overall Study|Protocol Violation|1|||
48638217|NCT01657370|156533822|FG002|Overall Study|Protocol Violation|1|||
48638218|NCT01657370|156533823|FG003|Overall Study|Protocol Violation|1|||
48638219|NCT01657370|156533824|FG004|Overall Study|Protocol Violation|0|||
48638220|NCT01657370|156533825|FG005|Overall Study|Protocol Violation|0|||
48638221|NCT01657370|156533820|FG000|Overall Study|Lost to Follow-up|2|||
48638222|NCT01657370|156533821|FG001|Overall Study|Lost to Follow-up|0|||
48638223|NCT01657370|156533822|FG002|Overall Study|Lost to Follow-up|1|||
48638224|NCT01657370|156533823|FG003|Overall Study|Lost to Follow-up|0|||
48638225|NCT01657370|156533824|FG004|Overall Study|Lost to Follow-up|0|||
48638226|NCT01657370|156533825|FG005|Overall Study|Lost to Follow-up|1|||
48638227|NCT01250054|156533826|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
48638228|NCT01250054|156533827|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
48638229|NCT04043286|156533828|FG000|Overall Study|Withdrawal by Subject|2|||
48638230|NCT04043286|156533829|FG001|Overall Study|Withdrawal by Subject|2|||
48328005|NCT00070317|155398224|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
48328006|NCT00866619|155398225|FG000|Overall Study|Adverse Event|112|||
48328007|NCT00866619|155398226|FG001|Overall Study|Adverse Event|106|||
48328008|NCT00866619|155398227|FG002|Overall Study|Adverse Event|47|||
48328009|NCT00866619|155398228|FG003|Overall Study|Adverse Event|44|||
48328010|NCT00866619|155398225|FG000|Overall Study|Protocol Violation|2|||
48328011|NCT00866619|155398226|FG001|Overall Study|Protocol Violation|39|||
48328012|NCT00866619|155398227|FG002|Overall Study|Protocol Violation|2|||
48328013|NCT00866619|155398228|FG003|Overall Study|Protocol Violation|17|||
48328014|NCT00866619|155398225|FG000|Overall Study|Withdrawal by Subject|587|||
48638231|NCT00503984|156533830|FG000|Overall Study|Protocol Violation|0|||
48638232|NCT00503984|156533831|FG001|Overall Study|Protocol Violation|1|||
48638233|NCT00503984|156533832|FG002|Overall Study|Protocol Violation|0|||
48638234|NCT00503984|156533833|FG003|Overall Study|Protocol Violation|0|||
48638235|NCT00503984|156533834|FG004|Overall Study|Protocol Violation|0|||
48638236|NCT00503984|156533835|FG005|Overall Study|Protocol Violation|0|||
48638237|NCT00503984|156533830|FG000|Overall Study|Adverse Event|0|||
48638238|NCT00503984|156533831|FG001|Overall Study|Adverse Event|1|||
48328015|NCT00866619|155398226|FG001|Overall Study|Withdrawal by Subject|295|||
48638239|NCT00503984|156533832|FG002|Overall Study|Adverse Event|0|||
48638240|NCT00503984|156533833|FG003|Overall Study|Adverse Event|0|||
48638241|NCT00503984|156533834|FG004|Overall Study|Adverse Event|0|||
48638242|NCT00503984|156533835|FG005|Overall Study|Adverse Event|0|||
48638243|NCT00503984|156533830|FG000|Overall Study|Death|0|||
48747635|NCT03766581|156924904|FG000|Treatment|Adverse Event|82|||
48747636|NCT03766581|156924905|FG001|Treatment|Adverse Event|44|||
48747637|NCT03766581|156924906|FG002|Treatment|Adverse Event|47|||
48747638|NCT03766581|156924907|FG003|Treatment|Adverse Event|46|||
48747639|NCT03766581|156924908|FG004|Treatment|Adverse Event|50|||
48747640|NCT03766581|156924909|FG005|Treatment|Adverse Event|77|||
48328016|NCT00866619|155398227|FG002|Overall Study|Withdrawal by Subject|272|||
48328017|NCT00866619|155398228|FG003|Overall Study|Withdrawal by Subject|144|||
48328018|NCT00866619|155398225|FG000|Overall Study|Lost to Follow-up|1145|||
48328019|NCT00866619|155398226|FG001|Overall Study|Lost to Follow-up|830|||
48328020|NCT00866619|155398227|FG002|Overall Study|Lost to Follow-up|568|||
48328021|NCT00866619|155398228|FG003|Overall Study|Lost to Follow-up|425|||
48383891|NCT02606461|155601479|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48383892|NCT02606461|155601480|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
48383893|NCT02606461|155601481|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48383894|NCT02606461|155601482|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48383895|NCT02606461|155601483|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
48383896|NCT00024167|155601486|FG000|Overall Study|Death|53|||
48383897|NCT00024167|155601487|FG001|Overall Study|Death|47|||
48383898|NCT00931944|155601488|FG000|Overall Study|Adverse Event|4|||
48383899|NCT00931944|155601488|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
48383900|NCT00931944|155601488|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
48383901|NCT00931944|155601488|FG000|Overall Study|Death|28|||
48383902|NCT00931944|155601488|FG000|Overall Study|Other|2|||
48383903|NCT00239226|155601489|FG000|Overall Study|permAF during stabilization period|0|||
48383904|NCT00239226|155601490|FG001|Overall Study|permAF during stabilization period|0|||
48383905|NCT00239226|155601491|FG002|Overall Study|permAF during stabilization period|0|||
48383906|NCT00239226|155601492|FG003|Overall Study|permAF during stabilization period|3|||
48383907|NCT00239226|155601489|FG000|Overall Study|Lost to Follow-up|1|||
48383908|NCT00239226|155601490|FG001|Overall Study|Lost to Follow-up|0|||
48383909|NCT00239226|155601491|FG002|Overall Study|Lost to Follow-up|1|||
48383910|NCT00239226|155601492|FG003|Overall Study|Lost to Follow-up|0|||
48383911|NCT01109173|155601493|FG000|Overall Study|Adverse Event|15|||
48383912|NCT01109173|155601494|FG001|Overall Study|Adverse Event|17|||
48638244|NCT00503984|156533831|FG001|Overall Study|Death|0|||
48638245|NCT00503984|156533832|FG002|Overall Study|Death|0|||
48638246|NCT00503984|156533833|FG003|Overall Study|Death|0|||
48638247|NCT00503984|156533834|FG004|Overall Study|Death|1|||
48638248|NCT00503984|156533835|FG005|Overall Study|Death|0|||
48638249|NCT03698279|156533839|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48638250|NCT03698279|156533840|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48638251|NCT03698279|156533841|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48383913|NCT01109173|155601495|FG002|Overall Study|Adverse Event|9|||
48383914|NCT01109173|155601496|FG003|Overall Study|Adverse Event|6|||
48383915|NCT01109173|155601493|FG000|Overall Study|Lost to Follow-up|0|||
48383916|NCT01109173|155601494|FG001|Overall Study|Lost to Follow-up|1|||
48383917|NCT01109173|155601495|FG002|Overall Study|Lost to Follow-up|0|||
48383918|NCT01109173|155601496|FG003|Overall Study|Lost to Follow-up|0|||
48383919|NCT01109173|155601493|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
48383920|NCT01109173|155601494|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
48383921|NCT01109173|155601495|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
48383922|NCT01109173|155601496|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
48383923|NCT01109173|155601493|FG000|Overall Study|Noncompliance|0|||
48383924|NCT01109173|155601494|FG001|Overall Study|Noncompliance|1|||
48383925|NCT01109173|155601495|FG002|Overall Study|Noncompliance|0|||
48383926|NCT01109173|155601496|FG003|Overall Study|Noncompliance|0|||
48638252|NCT03698279|156533842|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48638253|NCT03698279|156533843|FG004|Overall Study|Withdrawal by parent/guardian|0|||
48638254|NCT03698279|156533844|FG005|Overall Study|Withdrawal by parent/guardian|0|||
48747641|NCT03766581|156924910|FG006|Treatment|Adverse Event|5|||
48383927|NCT01109173|155601493|FG000|Overall Study|Treatment Failure|25|||
48747642|NCT03766581|156924911|FG007|Treatment|Adverse Event|2|||
48383928|NCT01109173|155601494|FG001|Overall Study|Treatment Failure|32|||
48747643|NCT03766581|156924904|FG000|Treatment|Participant request to discontinue treatment|34|||
48383929|NCT01109173|155601495|FG002|Overall Study|Treatment Failure|69|||
48383930|NCT01109173|155601496|FG003|Overall Study|Treatment Failure|64|||
48383931|NCT01109173|155601493|FG000|Overall Study|Protocol Violation|4|||
48383932|NCT01109173|155601494|FG001|Overall Study|Protocol Violation|5|||
48383933|NCT01109173|155601495|FG002|Overall Study|Protocol Violation|1|||
48383934|NCT01109173|155601496|FG003|Overall Study|Protocol Violation|2|||
48638255|NCT03698279|156533839|FG000|Overall Study|Protocol deviation|1|||
48638256|NCT03698279|156533840|FG001|Overall Study|Protocol deviation|0|||
48747644|NCT03766581|156924905|FG001|Treatment|Participant request to discontinue treatment|6|||
48383935|NCT01109173|155601493|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
48383936|NCT01109173|155601494|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
48383937|NCT01109173|155601495|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
48328022|NCT01214200|155400046|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
48328023|NCT01214200|155400046|FG000|Overall Study|Withdrawal by Subject|2|||
48328024|NCT00667017|155400047|FG000|Overall Study|Withdrawal by Subject|1|||
48328025|NCT01332266|155400048|FG000|Phase 1b|Death|3|||
48328026|NCT01332266|155400049|FG001|Phase 1b|Death|3|||
48328027|NCT01332266|155400050|FG002|Phase 1b|Death|2|||
48328028|NCT01332266|155400051|FG003|Phase 1b|Death|0|||
48328029|NCT01332266|155400052|FG004|Phase 1b|Death|0|||
48328030|NCT01332266|155400048|FG000|Phase 1b|Lost to Follow-up|0|||
48328031|NCT01332266|155400049|FG001|Phase 1b|Lost to Follow-up|1|||
48328032|NCT01332266|155400050|FG002|Phase 1b|Lost to Follow-up|0|||
48328033|NCT01332266|155400051|FG003|Phase 1b|Lost to Follow-up|0|||
48638257|NCT03698279|156533841|FG002|Overall Study|Protocol deviation|1|||
48638258|NCT03698279|156533842|FG003|Overall Study|Protocol deviation|0|||
48638259|NCT03698279|156533843|FG004|Overall Study|Protocol deviation|0|||
48638260|NCT03698279|156533844|FG005|Overall Study|Protocol deviation|0|||
48638261|NCT03698279|156533839|FG000|Overall Study|Withdrawal by Subject|0|||
48638262|NCT03698279|156533840|FG001|Overall Study|Withdrawal by Subject|0|||
48638263|NCT03698279|156533841|FG002|Overall Study|Withdrawal by Subject|1|||
48638264|NCT03698279|156533842|FG003|Overall Study|Withdrawal by Subject|0|||
48638265|NCT03698279|156533843|FG004|Overall Study|Withdrawal by Subject|0|||
48638266|NCT03698279|156533844|FG005|Overall Study|Withdrawal by Subject|0|||
48328034|NCT01332266|155400052|FG004|Phase 1b|Lost to Follow-up|0|||
48328035|NCT01332266|155400048|FG000|Phase 1b|Withdrawal by Subject|1|||
48328036|NCT01332266|155400049|FG001|Phase 1b|Withdrawal by Subject|1|||
48328037|NCT01332266|155400050|FG002|Phase 1b|Withdrawal by Subject|1|||
48328038|NCT01332266|155400051|FG003|Phase 1b|Withdrawal by Subject|0|||
48328039|NCT01332266|155400052|FG004|Phase 1b|Withdrawal by Subject|0|||
48328040|NCT01332266|155400048|FG000|Phase 2|Death|0|||
48328041|NCT01332266|155400049|FG001|Phase 2|Death|0|||
48328042|NCT01332266|155400050|FG002|Phase 2|Death|0|||
48328043|NCT01332266|155400051|FG003|Phase 2|Death|33|||
48328044|NCT01332266|155400052|FG004|Phase 2|Death|36|||
48328045|NCT01332266|155400048|FG000|Phase 2|Lost to Follow-up|0|||
48638267|NCT03698279|156533839|FG000|Overall Study|Lost to Follow-up|3|||
48638268|NCT03698279|156533840|FG001|Overall Study|Lost to Follow-up|1|||
48638269|NCT03698279|156533841|FG002|Overall Study|Lost to Follow-up|4|||
48638270|NCT03698279|156533842|FG003|Overall Study|Lost to Follow-up|5|||
48638271|NCT03698279|156533843|FG004|Overall Study|Lost to Follow-up|0|||
48638272|NCT03698279|156533844|FG005|Overall Study|Lost to Follow-up|0|||
48638273|NCT00272792|156533845|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
48638274|NCT00272792|156533846|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
48638275|NCT00272792|156533845|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
48638276|NCT00272792|156533846|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
48638277|NCT00272792|156533845|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
48638278|NCT00272792|156533846|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
48638279|NCT00272792|156533845|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
48638280|NCT00272792|156533846|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
48638281|NCT01359956|156533855|FG000|Overall Study|Death|58|||
48747645|NCT03766581|156924906|FG002|Treatment|Participant request to discontinue treatment|10|||
48328046|NCT01332266|155400049|FG001|Phase 2|Lost to Follow-up|0|||
48328047|NCT01332266|155400050|FG002|Phase 2|Lost to Follow-up|0|||
48328048|NCT01332266|155400051|FG003|Phase 2|Lost to Follow-up|2|||
48328049|NCT01332266|155400052|FG004|Phase 2|Lost to Follow-up|0|||
48328050|NCT01332266|155400048|FG000|Phase 2|Physician Decision|0|||
48638282|NCT01359956|156533856|FG001|Overall Study|Death|60|||
48747646|NCT03766581|156924907|FG003|Treatment|Participant request to discontinue treatment|10|||
48747647|NCT03766581|156924908|FG004|Treatment|Participant request to discontinue treatment|14|||
48747648|NCT03766581|156924909|FG005|Treatment|Participant request to discontinue treatment|15|||
48747649|NCT03766581|156924910|FG006|Treatment|Participant request to discontinue treatment|0|||
48747650|NCT03766581|156924911|FG007|Treatment|Participant request to discontinue treatment|1|||
48747651|NCT03766581|156924904|FG000|Treatment|Participant withdrew consent|11|||
48747652|NCT03766581|156924905|FG001|Treatment|Participant withdrew consent|4|||
48747653|NCT03766581|156924906|FG002|Treatment|Participant withdrew consent|5|||
48747654|NCT03766581|156924907|FG003|Treatment|Participant withdrew consent|5|||
48747655|NCT03766581|156924908|FG004|Treatment|Participant withdrew consent|4|||
48747656|NCT03766581|156924909|FG005|Treatment|Participant withdrew consent|4|||
48328051|NCT01332266|155400049|FG001|Phase 2|Physician Decision|0|||
48328052|NCT01332266|155400050|FG002|Phase 2|Physician Decision|0|||
48328053|NCT01332266|155400051|FG003|Phase 2|Physician Decision|3|||
48328054|NCT01332266|155400052|FG004|Phase 2|Physician Decision|1|||
48328055|NCT01332266|155400048|FG000|Phase 2|Symptomatic deterioration|0|||
48328056|NCT01332266|155400049|FG001|Phase 2|Symptomatic deterioration|0|||
48328057|NCT01332266|155400050|FG002|Phase 2|Symptomatic deterioration|0|||
48328058|NCT01332266|155400051|FG003|Phase 2|Symptomatic deterioration|0|||
48638283|NCT01359956|156533857|FG002|Overall Study|Death|66|||
48638284|NCT01359956|156533858|FG003|Overall Study|Death|57|||
48638285|NCT01359956|156533855|FG000|Overall Study|Lost to Follow-up|3|||
48328059|NCT01332266|155400052|FG004|Phase 2|Symptomatic deterioration|1|||
48638286|NCT01359956|156533856|FG001|Overall Study|Lost to Follow-up|4|||
48638287|NCT01359956|156533857|FG002|Overall Study|Lost to Follow-up|1|||
48638288|NCT01359956|156533858|FG003|Overall Study|Lost to Follow-up|1|||
48638289|NCT03728933|156533859|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48638290|NCT03728933|156533860|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48638291|NCT03728933|156533861|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48638292|NCT03728933|156533859|FG000|Overall Study|Withdrawal by Subject|0|||
48638293|NCT03728933|156533860|FG001|Overall Study|Withdrawal by Subject|0|||
48638294|NCT03728933|156533861|FG002|Overall Study|Withdrawal by Subject|1|||
48638295|NCT03728933|156533859|FG000|Overall Study|Lost to Follow-up|0|||
48638296|NCT03728933|156533860|FG001|Overall Study|Lost to Follow-up|1|||
48638297|NCT03728933|156533861|FG002|Overall Study|Lost to Follow-up|0|||
48638298|NCT03728933|156533859|FG000|Overall Study|Adverse Event|1|||
48638299|NCT03728933|156533860|FG001|Overall Study|Adverse Event|0|||
48638300|NCT03728933|156533861|FG002|Overall Study|Adverse Event|0|||
48638301|NCT00582907|156533862|FG000|1st Course|Withdrawal by Subject|1|||
48638302|NCT00582907|156533863|FG001|1st Course|Withdrawal by Subject|0|||
48638303|NCT00582907|156533864|FG002|1st Course|Withdrawal by Subject|0|||
48638304|NCT00582907|156533865|FG003|1st Course|Withdrawal by Subject|0|||
48638305|NCT00582907|156533862|FG000|1st Course|Lost to Follow-up|0|||
48638306|NCT00582907|156533863|FG001|1st Course|Lost to Follow-up|0|||
48638307|NCT00582907|156533864|FG002|1st Course|Lost to Follow-up|0|||
48638308|NCT00582907|156533865|FG003|1st Course|Lost to Follow-up|1|||
48638309|NCT00582907|156533862|FG000|2nd Course|Lack of Efficacy|1|||
48638310|NCT00582907|156533863|FG001|2nd Course|Lack of Efficacy|0|||
48638311|NCT00582907|156533864|FG002|2nd Course|Lack of Efficacy|0|||
48638312|NCT00582907|156533865|FG003|2nd Course|Lack of Efficacy|0|||
48638313|NCT02332928|156533870|FG000|Overall Study|Withdrawal by Subject|0|||
48638314|NCT02332928|156533871|FG001|Overall Study|Withdrawal by Subject|2|||
48638315|NCT02332928|156533870|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
48638316|NCT02332928|156533871|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
48638317|NCT00639457|156533872|FG000|Overall Study|Withdrawal by Subject|2|||
48747657|NCT03766581|156924910|FG006|Treatment|Participant withdrew consent|0|||
48747658|NCT03766581|156924911|FG007|Treatment|Participant withdrew consent|0|||
48747659|NCT03766581|156924904|FG000|Treatment|Death|1|||
48747660|NCT03766581|156924905|FG001|Treatment|Death|0|||
48747661|NCT03766581|156924906|FG002|Treatment|Death|0|||
48747662|NCT03766581|156924907|FG003|Treatment|Death|0|||
48747663|NCT03766581|156924908|FG004|Treatment|Death|0|||
48747664|NCT03766581|156924909|FG005|Treatment|Death|0|||
48328060|NCT01332266|155400048|FG000|Phase 2|Progression Disease|0|||
48328061|NCT01332266|155400049|FG001|Phase 2|Progression Disease|0|||
48747665|NCT03766581|156924910|FG006|Treatment|Death|0|||
48747666|NCT03766581|156924911|FG007|Treatment|Death|0|||
48747667|NCT03766581|156924904|FG000|Treatment|Lost to Follow-up|1|||
48747668|NCT03766581|156924905|FG001|Treatment|Lost to Follow-up|0|||
48747669|NCT03766581|156924906|FG002|Treatment|Lost to Follow-up|0|||
48328062|NCT01332266|155400050|FG002|Phase 2|Progression Disease|0|||
48328063|NCT01332266|155400051|FG003|Phase 2|Progression Disease|2|||
48328064|NCT01332266|155400052|FG004|Phase 2|Progression Disease|1|||
48328065|NCT01332266|155400048|FG000|Phase 2|Withdrawal by Subject|0|||
48328066|NCT01332266|155400049|FG001|Phase 2|Withdrawal by Subject|0|||
48747670|NCT03766581|156924907|FG003|Treatment|Lost to Follow-up|1|||
48328067|NCT01332266|155400050|FG002|Phase 2|Withdrawal by Subject|0|||
48328068|NCT01332266|155400051|FG003|Phase 2|Withdrawal by Subject|2|||
48638318|NCT00639457|156533873|FG001|Overall Study|Withdrawal by Subject|3|||
48638319|NCT00370292|156533874|FG000|Overall Study|Disease Progression|4|||
48638320|NCT00370292|156533874|FG000|Overall Study|Adverse Event|7|||
48638321|NCT00370292|156533874|FG000|Overall Study|Physician Decision|2|||
48638322|NCT02239926|156533876|FG000|Overall Study|Withdrawal by Subject|0|||
48747671|NCT03766581|156924908|FG004|Treatment|Lost to Follow-up|0|||
48638323|NCT02239926|156533877|FG001|Overall Study|Withdrawal by Subject|1|||
48638324|NCT02921789|156533878|FG000|Overall Study|Adverse Event|0|||
48638325|NCT02921789|156533879|FG001|Overall Study|Adverse Event|1|||
48638326|NCT02921789|156533878|FG000|Overall Study|Lost to Follow-up|1|||
48638327|NCT02921789|156533879|FG001|Overall Study|Lost to Follow-up|0|||
48638328|NCT02921789|156533878|FG000|Overall Study|Protocol Deviation|2|||
48638329|NCT02921789|156533879|FG001|Overall Study|Protocol Deviation|0|||
48638330|NCT02921789|156533878|FG000|Overall Study|Withdrawal by Subject|2|||
48638331|NCT02921789|156533879|FG001|Overall Study|Withdrawal by Subject|1|||
48638332|NCT02921789|156533878|FG000|Overall Study|Miscellaneous|3|||
48328069|NCT01332266|155400052|FG004|Phase 2|Withdrawal by Subject|2|||
48328070|NCT00666705|155400054|FG000|Overall Study|Withdrawal by Subject|1|||
48328071|NCT03259568|155400055|FG000|Overall Study|Participant performance was low|3|||
48328072|NCT04660799|155400056|FG000|Overall Study|Progressive Disease|1|||
48638333|NCT02921789|156533879|FG001|Overall Study|Miscellaneous|2|||
48638334|NCT01334554|156533880|FG000|Overall Study|Adverse Event|4|||
48328073|NCT04660799|155400057|FG001|Overall Study|Progressive Disease|1|||
48638335|NCT01334554|156533881|FG001|Overall Study|Adverse Event|2|||
48638336|NCT02704208|156533882|FG000|Overall Study|Lost to Follow-up|42|||
48328074|NCT04660799|155400056|FG000|Overall Study|Death|2|||
48638337|NCT02704208|156533883|FG001|Overall Study|Lost to Follow-up|37|||
48638338|NCT04099277|156533884|FG000|Overall Study|Physician Decision|1|||
48638339|NCT04099277|156533884|FG000|Overall Study|Withdrawal by Subject|1|||
48638340|NCT02393859|156533885|FG000|Overall Study|Decision by Sponsor|2|||
48747672|NCT03766581|156924909|FG005|Treatment|Lost to Follow-up|0|||
48747673|NCT03766581|156924910|FG006|Treatment|Lost to Follow-up|0|||
48747674|NCT03766581|156924911|FG007|Treatment|Lost to Follow-up|0|||
48747675|NCT03766581|156924904|FG000|Treatment|Poor/Non compliance|2|||
48747676|NCT03766581|156924905|FG001|Treatment|Poor/Non compliance|2|||
48747677|NCT03766581|156924906|FG002|Treatment|Poor/Non compliance|1|||
48747678|NCT03766581|156924907|FG003|Treatment|Poor/Non compliance|1|||
48747679|NCT03766581|156924908|FG004|Treatment|Poor/Non compliance|1|||
48747680|NCT03766581|156924909|FG005|Treatment|Poor/Non compliance|1|||
48747681|NCT03766581|156924910|FG006|Treatment|Poor/Non compliance|0|||
48747682|NCT03766581|156924911|FG007|Treatment|Poor/Non compliance|0|||
48747683|NCT03766581|156924904|FG000|Treatment|Participant no longer meets study criteria|9|||
48747684|NCT03766581|156924905|FG001|Treatment|Participant no longer meets study criteria|1|||
48747685|NCT03766581|156924906|FG002|Treatment|Participant no longer meets study criteria|5|||
48747686|NCT03766581|156924907|FG003|Treatment|Participant no longer meets study criteria|4|||
48747687|NCT03766581|156924908|FG004|Treatment|Participant no longer meets study criteria|4|||
48747688|NCT03766581|156924909|FG005|Treatment|Participant no longer meets study criteria|4|||
48747689|NCT03766581|156924910|FG006|Treatment|Participant no longer meets study criteria|2|||
48747690|NCT03766581|156924911|FG007|Treatment|Participant no longer meets study criteria|0|||
48747691|NCT03766581|156924904|FG000|Treatment|Other reasons|13|||
48747692|NCT03766581|156924905|FG001|Treatment|Other reasons|8|||
48747693|NCT03766581|156924906|FG002|Treatment|Other reasons|3|||
48747694|NCT03766581|156924907|FG003|Treatment|Other reasons|7|||
48747695|NCT03766581|156924908|FG004|Treatment|Other reasons|3|||
48747696|NCT03766581|156924909|FG005|Treatment|Other reasons|3|||
48747697|NCT03766581|156924910|FG006|Treatment|Other reasons|0|||
48747698|NCT03766581|156924911|FG007|Treatment|Other reasons|0|||
48747699|NCT02732119|156924912|FG000|Phase I|Adverse Event|1|||
48747700|NCT02732119|156924913|FG001|Phase I|Adverse Event|3|||
48747701|NCT02732119|156924914|FG002|Phase I|Adverse Event|1|||
48747702|NCT02732119|156924915|FG003|Phase I|Adverse Event|0|||
48747703|NCT02732119|156924916|FG004|Phase I|Adverse Event|0|||
48747704|NCT02732119|156924912|FG000|Phase I|Progressive disease|7|||
48747705|NCT02732119|156924913|FG001|Phase I|Progressive disease|3|||
48747706|NCT02732119|156924914|FG002|Phase I|Progressive disease|2|||
48747707|NCT02732119|156924915|FG003|Phase I|Progressive disease|0|||
48747708|NCT02732119|156924916|FG004|Phase I|Progressive disease|0|||
48747709|NCT02732119|156924912|FG000|Phase I|Protocol deviation|0|||
48747710|NCT02732119|156924913|FG001|Phase I|Protocol deviation|1|||
48747711|NCT02732119|156924914|FG002|Phase I|Protocol deviation|0|||
48747712|NCT02732119|156924915|FG003|Phase I|Protocol deviation|0|||
48747713|NCT02732119|156924916|FG004|Phase I|Protocol deviation|0|||
48747714|NCT02732119|156924912|FG000|Phase I|Physician Decision|0|||
48747715|NCT02732119|156924913|FG001|Phase I|Physician Decision|3|||
48747716|NCT02732119|156924914|FG002|Phase I|Physician Decision|4|||
48747717|NCT02732119|156924915|FG003|Phase I|Physician Decision|0|||
48747718|NCT02732119|156924916|FG004|Phase I|Physician Decision|0|||
48747719|NCT02732119|156924912|FG000|Phase II|Adverse Event|0|||
48747720|NCT02732119|156924913|FG001|Phase II|Adverse Event|0|||
48747721|NCT02732119|156924914|FG002|Phase II|Adverse Event|0|||
48747722|NCT02732119|156924915|FG003|Phase II|Adverse Event|3|||
48747723|NCT02732119|156924916|FG004|Phase II|Adverse Event|3|||
48747724|NCT02732119|156924912|FG000|Phase II|Death|0|||
48747725|NCT02732119|156924913|FG001|Phase II|Death|0|||
48638341|NCT02393859|156533886|FG001|Overall Study|Decision by Sponsor|4|||
48638342|NCT02393859|156533885|FG000|Overall Study|Withdrawal by Subject|11|||
48638343|NCT02393859|156533886|FG001|Overall Study|Withdrawal by Subject|6|||
48638344|NCT02393859|156533885|FG000|Overall Study|Death|27|||
48638345|NCT02393859|156533886|FG001|Overall Study|Death|10|||
48638346|NCT02393859|156533885|FG000|Overall Study|Lost to Follow-up|1|||
48638347|NCT02393859|156533886|FG001|Overall Study|Lost to Follow-up|1|||
48638348|NCT00598650|156533887|FG000|Overall Study|Withdrawal by Subject|3|||
48638349|NCT00598650|156533887|FG000|Overall Study|Adverse Event|18|||
48638350|NCT00598650|156533887|FG000|Overall Study|No treatment for 3 weeks|1|||
48638351|NCT00598650|156533887|FG000|Overall Study|Not eligible|1|||
48638352|NCT00598650|156533887|FG000|Overall Study|Prohibited Concomitant Medication|2|||
48638353|NCT00598650|156533887|FG000|Overall Study|Physician Decision|2|||
48638354|NCT01669902|156533888|FG000|Overall Study|Adverse Event|11|||
48638355|NCT01669902|156533888|FG000|Overall Study|Lack of Efficacy|10|||
48638356|NCT01669902|156533888|FG000|Overall Study|Other|8|||
48747726|NCT02732119|156924914|FG002|Phase II|Death|0|||
48747727|NCT02732119|156924915|FG003|Phase II|Death|1|||
48638357|NCT02332187|156533891|FG000|Overall Study|Withdrawal by Subject|2|||
48638358|NCT02332187|156533892|FG001|Overall Study|Withdrawal by Subject|2|||
48747728|NCT02732119|156924916|FG004|Phase II|Death|0|||
48747729|NCT02732119|156924912|FG000|Phase II|Progressive dissease|0|||
48747730|NCT02732119|156924913|FG001|Phase II|Progressive dissease|0|||
48638359|NCT02332187|156533891|FG000|Overall Study|Adverse Event|0|||
48638360|NCT02332187|156533892|FG001|Overall Study|Adverse Event|1|||
48638361|NCT01114737|156533893|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
48638362|NCT01114737|156533894|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
48328075|NCT04660799|155400057|FG001|Overall Study|Death|1|||
48328076|NCT04660799|155400056|FG000|Overall Study|Adverse Event|2|||
48328077|NCT04660799|155400057|FG001|Overall Study|Adverse Event|1|||
48638363|NCT01114737|156533893|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
48638364|NCT01114737|156533894|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
48638365|NCT01114737|156533893|FG000|Randomized Treatment Period|Pregnancy|1|||
48638366|NCT01114737|156533894|FG001|Randomized Treatment Period|Pregnancy|0|||
48638367|NCT01114737|156533893|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
48638368|NCT01114737|156533894|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
48638369|NCT01114737|156533893|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
48638370|NCT01114737|156533894|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
48638371|NCT01114737|156533893|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
48638372|NCT01114737|156533894|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
48638373|NCT00457392|156533895|FG000|Overall Study|Objective Progression or Relapse|229|||
48638374|NCT00457392|156533896|FG001|Overall Study|Objective Progression or Relapse|296|||
48638375|NCT00457392|156533895|FG000|Overall Study|Death|106|||
48638376|NCT00457392|156533896|FG001|Overall Study|Death|106|||
48638377|NCT00457392|156533895|FG000|Overall Study|Adverse Event|84|||
48638378|NCT00457392|156533896|FG001|Overall Study|Adverse Event|41|||
48638379|NCT00457392|156533895|FG000|Overall Study|Global Deterioration of Health Status|22|||
48638380|NCT00457392|156533896|FG001|Overall Study|Global Deterioration of Health Status|8|||
48638381|NCT00457392|156533895|FG000|Overall Study|Withdrawal by Subject|14|||
48638382|NCT00457392|156533896|FG001|Overall Study|Withdrawal by Subject|8|||
48638383|NCT00457392|156533895|FG000|Overall Study|Lost to Follow-up|6|||
48638384|NCT00457392|156533896|FG001|Overall Study|Lost to Follow-up|7|||
48638385|NCT00457392|156533895|FG000|Overall Study|Protocol Violation|4|||
48638386|NCT00457392|156533896|FG001|Overall Study|Protocol Violation|3|||
48638387|NCT00457392|156533895|FG000|Overall Study|Other|7|||
48638388|NCT00457392|156533896|FG001|Overall Study|Other|4|||
48638389|NCT00457392|156533895|FG000|Overall Study|Study Terminated by Sponsor|1|||
48638390|NCT00457392|156533896|FG001|Overall Study|Study Terminated by Sponsor|4|||
48638391|NCT00457392|156533895|FG000|Overall Study|Randomized, Not Treated|7|||
48638392|NCT00457392|156533896|FG001|Overall Study|Randomized, Not Treated|3|||
48638393|NCT00812955|156533897|FG000|Overall Study|Adverse Event|7|||
48638394|NCT00812955|156533898|FG001|Overall Study|Adverse Event|6|||
48638395|NCT00812955|156533899|FG002|Overall Study|Adverse Event|3|||
48638396|NCT00812955|156533900|FG003|Overall Study|Adverse Event|4|||
48638397|NCT00812955|156533897|FG000|Overall Study|Lost to Follow-up|2|||
48638398|NCT00812955|156533898|FG001|Overall Study|Lost to Follow-up|1|||
48638399|NCT00812955|156533899|FG002|Overall Study|Lost to Follow-up|1|||
48638400|NCT00812955|156533900|FG003|Overall Study|Lost to Follow-up|2|||
48638401|NCT00812955|156533897|FG000|Overall Study|Withdrawal by Subject|1|||
48638402|NCT00812955|156533898|FG001|Overall Study|Withdrawal by Subject|0|||
48638403|NCT00812955|156533899|FG002|Overall Study|Withdrawal by Subject|1|||
48638404|NCT00812955|156533900|FG003|Overall Study|Withdrawal by Subject|2|||
48638405|NCT00812955|156533897|FG000|Overall Study|randomized in error|0|||
48638406|NCT00812955|156533898|FG001|Overall Study|randomized in error|0|||
48638407|NCT00812955|156533899|FG002|Overall Study|randomized in error|1|||
48638408|NCT00812955|156533900|FG003|Overall Study|randomized in error|0|||
48638409|NCT01905540|156533901|FG000|Period 3|Other|1|||
48638410|NCT01905540|156533902|FG001|Period 3|Other|0|||
48638411|NCT01905540|156533903|FG002|Period 3|Other|1|||
48638412|NCT01905540|156533904|FG003|Period 3|Other|1|||
48638413|NCT04661033|156533905|FG000|Overall Study|Adverse Event|0|||
48328078|NCT04660799|155400056|FG000|Overall Study|Withdrawal by Subject|2|||
48328079|NCT04660799|155400057|FG001|Overall Study|Withdrawal by Subject|5|||
48328080|NCT02106884|155400062|FG000|Overall Study|Change of diagnosis/exclusion|0|||
48328081|NCT02106884|155400063|FG001|Overall Study|Change of diagnosis/exclusion|1|||
48328082|NCT00089791|155400064|FG000|Overall Study|Physician Decision|6|||
48328083|NCT00089791|155400065|FG001|Overall Study|Physician Decision|3|||
48328084|NCT00089791|155400064|FG000|Overall Study|Adverse Event|81|||
48328085|NCT00089791|155400065|FG001|Overall Study|Adverse Event|93|||
48328086|NCT00089791|155400064|FG000|Overall Study|Withdrawal by Subject|403|||
48328087|NCT00089791|155400065|FG001|Overall Study|Withdrawal by Subject|344|||
48328088|NCT00089791|155400064|FG000|Overall Study|Death|78|||
48328089|NCT00089791|155400065|FG001|Overall Study|Death|62|||
48328090|NCT00089791|155400064|FG000|Overall Study|Disease progression|7|||
48328091|NCT00089791|155400065|FG001|Overall Study|Disease progression|3|||
48328092|NCT00089791|155400064|FG000|Overall Study|Ineligibility determined|12|||
48328093|NCT00089791|155400065|FG001|Overall Study|Ineligibility determined|9|||
48328094|NCT00089791|155400064|FG000|Overall Study|Lost to Follow-up|57|||
48638414|NCT04661033|156533906|FG001|Overall Study|Adverse Event|0|||
48638415|NCT04661033|156533907|FG002|Overall Study|Adverse Event|1|||
48638416|NCT04661033|156533908|FG003|Overall Study|Adverse Event|0|||
48638417|NCT04661033|156533905|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
48328095|NCT00089791|155400065|FG001|Overall Study|Lost to Follow-up|57|||
48328096|NCT00089791|155400064|FG000|Overall Study|Noncompliance|17|||
48328097|NCT00089791|155400065|FG001|Overall Study|Noncompliance|13|||
48328098|NCT00089791|155400064|FG000|Overall Study|Other|20|||
48328099|NCT00089791|155400065|FG001|Overall Study|Other|32|||
48328100|NCT00089791|155400064|FG000|Overall Study|Protocol deviation|12|||
48328101|NCT00089791|155400065|FG001|Overall Study|Protocol deviation|10|||
48328102|NCT00089791|155400064|FG000|Overall Study|Requirement for alternative therapy|7|||
48328103|NCT00089791|155400065|FG001|Overall Study|Requirement for alternative therapy|4|||
48328104|NCT02161458|155400066|FG000|Overall Study|Withdrawal by Subject|0|||
48328105|NCT02161458|155400067|FG001|Overall Study|Withdrawal by Subject|4|||
48638418|NCT04661033|156533906|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
48638419|NCT04661033|156533907|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
48638420|NCT04661033|156533908|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
48638421|NCT04661033|156533905|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
48638422|NCT04661033|156533906|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
48638423|NCT04661033|156533907|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
48638424|NCT04661033|156533908|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
48638425|NCT04661033|156533905|FG000|Overall Study|Early discontinuation as per PI|1|||
48638426|NCT04661033|156533906|FG001|Overall Study|Early discontinuation as per PI|0|||
48638427|NCT04661033|156533907|FG002|Overall Study|Early discontinuation as per PI|0|||
48638428|NCT04661033|156533908|FG003|Overall Study|Early discontinuation as per PI|0|||
48638429|NCT04562116|156533909|FG000|Overall Study|Lost to Follow-up|1|||
48638430|NCT04562116|156533909|FG000|Overall Study|Withdrawal by Subject|3|||
48638431|NCT00448448|156533910|FG000|Overall Study|Withdrawal by Subject|13|||
48638432|NCT00448448|156533911|FG001|Overall Study|Withdrawal by Subject|2|||
48638433|NCT00448448|156533910|FG000|Overall Study|On protocol when study ended|83|||
48638434|NCT00448448|156533911|FG001|Overall Study|On protocol when study ended|36|||
48638435|NCT00448448|156533910|FG000|Overall Study|Lost to Follow-up|2|||
48638436|NCT00448448|156533911|FG001|Overall Study|Lost to Follow-up|1|||
48638437|NCT00448448|156533910|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
48638438|NCT00448448|156533911|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
48638439|NCT00448448|156533910|FG000|Overall Study|Signed consent lost|0|||
48638440|NCT00448448|156533911|FG001|Overall Study|Signed consent lost|1|||
48638441|NCT01071954|156533916|FG000|Overall Study|Noncompliance|4|||
48638442|NCT01071954|156533916|FG000|Overall Study|Adverse Event|1|||
48638443|NCT01071954|156533916|FG000|Overall Study|Withdrawal by Subject|11|||
48638444|NCT01071954|156533916|FG000|Overall Study|Requirement for Alternative Therapy|5|||
48638445|NCT01071954|156533916|FG000|Overall Study|Administrative Decision|5|||
48638446|NCT01071954|156533916|FG000|Overall Study|Protocol Specified Criteria|1|||
48638447|NCT01823289|156533917|FG000|Overall Study|Lost to Follow-up|5|||
48638448|NCT01823289|156533917|FG000|Overall Study|Adverse Event|5|||
48638449|NCT01823289|156533917|FG000|Overall Study|Lack of Efficacy|1|||
48638450|NCT01823289|156533917|FG000|Overall Study|Physician Decision|9|||
48638451|NCT01823289|156533917|FG000|Overall Study|Administered contraindicated medicine|1|||
48638452|NCT01823289|156533917|FG000|Overall Study|Transaminase increased more than 3 times|1|||
48638453|NCT01823289|156533917|FG000|Overall Study|Drug affected efficacy and safety|1|||
48328106|NCT02161458|155400068|FG002|Overall Study|Withdrawal by Subject|4|||
48328107|NCT02161458|155400069|FG003|Overall Study|Withdrawal by Subject|0|||
48328108|NCT02161458|155400066|FG000|Overall Study|Lost to Follow-up|0|||
48328109|NCT02161458|155400067|FG001|Overall Study|Lost to Follow-up|2|||
48328110|NCT02161458|155400068|FG002|Overall Study|Lost to Follow-up|1|||
48328111|NCT02161458|155400069|FG003|Overall Study|Lost to Follow-up|0|||
48638454|NCT01823289|156533917|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
48638455|NCT02803203|156533918|FG000|Overall Study|Adverse Event|4|||
48638456|NCT02803203|156533918|FG000|Overall Study|Death|4|||
48638457|NCT02803203|156533918|FG000|Overall Study|Progressive disease|29|||
48638458|NCT02803203|156533918|FG000|Overall Study|Withdrawal by Subject|8|||
48638459|NCT02803203|156533918|FG000|Overall Study|Complete resection of target disease|2|||
48638460|NCT02803203|156533918|FG000|Overall Study|Switched to commercial Osi|1|||
48638461|NCT02803203|156533918|FG000|Overall Study|Participant moved away|1|||
48638462|NCT02259114|156533920|FG000|Overall Study|Progressive Disease|14|||
48638463|NCT02259114|156533921|FG001|Overall Study|Progressive Disease|2|||
48638464|NCT02259114|156533922|FG002|Overall Study|Progressive Disease|10|||
48638465|NCT02259114|156533923|FG003|Overall Study|Progressive Disease|2|||
48638466|NCT02259114|156533924|FG004|Overall Study|Progressive Disease|5|||
48638467|NCT02259114|156533920|FG000|Overall Study|Adverse Event|2|||
48638468|NCT02259114|156533921|FG001|Overall Study|Adverse Event|1|||
48638469|NCT02259114|156533922|FG002|Overall Study|Adverse Event|0|||
48638470|NCT02259114|156533923|FG003|Overall Study|Adverse Event|0|||
48638471|NCT02259114|156533924|FG004|Overall Study|Adverse Event|1|||
48638472|NCT02259114|156533920|FG000|Overall Study|Death|3|||
48638473|NCT02259114|156533921|FG001|Overall Study|Death|0|||
48638474|NCT02259114|156533922|FG002|Overall Study|Death|1|||
48328112|NCT02384382|155400075|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
48328113|NCT02384382|155400075|FG000|Overall Study|Death|1|||
48638475|NCT02259114|156533923|FG003|Overall Study|Death|0|||
48638476|NCT02259114|156533924|FG004|Overall Study|Death|0|||
48747731|NCT02732119|156924914|FG002|Phase II|Progressive dissease|0|||
48747732|NCT02732119|156924915|FG003|Phase II|Progressive dissease|30|||
48747733|NCT02732119|156924916|FG004|Phase II|Progressive dissease|23|||
48747734|NCT02732119|156924912|FG000|Phase II|Study terminated by sponsor|0|||
48747735|NCT02732119|156924913|FG001|Phase II|Study terminated by sponsor|0|||
48747736|NCT02732119|156924914|FG002|Phase II|Study terminated by sponsor|0|||
48747737|NCT02732119|156924915|FG003|Phase II|Study terminated by sponsor|2|||
48747738|NCT02732119|156924916|FG004|Phase II|Study terminated by sponsor|2|||
48747739|NCT02732119|156924912|FG000|Phase II|Other|0|||
48638477|NCT02259114|156533920|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
48747740|NCT02732119|156924913|FG001|Phase II|Other|0|||
48638478|NCT02259114|156533921|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
48638479|NCT02259114|156533922|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
48747741|NCT02732119|156924914|FG002|Phase II|Other|0|||
48747742|NCT02732119|156924915|FG003|Phase II|Other|2|||
48638480|NCT02259114|156533923|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
48747743|NCT02732119|156924916|FG004|Phase II|Other|0|||
48638481|NCT02259114|156533924|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
48638482|NCT02259114|156533920|FG000|Overall Study|Withdrawal by Subject|0|||
48638483|NCT02259114|156533921|FG001|Overall Study|Withdrawal by Subject|0|||
48638484|NCT02259114|156533922|FG002|Overall Study|Withdrawal by Subject|1|||
48747744|NCT02732119|156924912|FG000|Phase II|Physician Decision|0|||
48747745|NCT02732119|156924913|FG001|Phase II|Physician Decision|0|||
48747746|NCT02732119|156924914|FG002|Phase II|Physician Decision|0|||
48747747|NCT02732119|156924915|FG003|Phase II|Physician Decision|8|||
48747748|NCT02732119|156924916|FG004|Phase II|Physician Decision|5|||
48747749|NCT02193867|156924917|FG000|Overall Study|Death|2|||
48747750|NCT02193867|156924917|FG000|Overall Study|Sponsor Study Termination|2|||
48747751|NCT02270957|156924918|FG000|Overall Study|Lack of Efficacy|2|||
48747752|NCT02270957|156924919|FG001|Overall Study|Lack of Efficacy|4|||
48638485|NCT02259114|156533923|FG003|Overall Study|Withdrawal by Subject|1|||
48638486|NCT02259114|156533924|FG004|Overall Study|Withdrawal by Subject|0|||
48638487|NCT02259114|156533920|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
48638488|NCT02259114|156533921|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
48638489|NCT02259114|156533922|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
48638490|NCT02259114|156533923|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
48638491|NCT02259114|156533924|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
48638492|NCT02259114|156533920|FG000|Overall Study|Not Treated|1|||
48638493|NCT02259114|156533921|FG001|Overall Study|Not Treated|0|||
48638494|NCT02259114|156533922|FG002|Overall Study|Not Treated|0|||
48638495|NCT02259114|156533923|FG003|Overall Study|Not Treated|0|||
48638496|NCT02259114|156533924|FG004|Overall Study|Not Treated|0|||
48638497|NCT03789292|156533927|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
48638498|NCT03789292|156533928|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
48638499|NCT03789292|156533929|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
48638500|NCT03789292|156533927|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
48638501|NCT03789292|156533928|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
48638502|NCT03789292|156533929|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
48638503|NCT03789292|156533927|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
48638504|NCT03789292|156533928|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
48638505|NCT03789292|156533929|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
48638506|NCT03789292|156533927|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
48638507|NCT03789292|156533928|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
48638508|NCT03789292|156533929|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
48638509|NCT03789292|156533927|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
48638510|NCT03789292|156533928|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
48638511|NCT03789292|156533929|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
48638512|NCT03789292|156533927|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
48638513|NCT03789292|156533928|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
48638514|NCT03789292|156533929|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
48638515|NCT03789292|156533927|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
48638516|NCT03789292|156533928|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
48638517|NCT03789292|156533929|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
48638518|NCT03789292|156533927|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
48638519|NCT03789292|156533928|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
48638520|NCT03789292|156533929|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
48638521|NCT03789292|156533927|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
48638522|NCT03789292|156533928|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
48638523|NCT03789292|156533929|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
48638524|NCT03789292|156533927|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
48638525|NCT03789292|156533928|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
48747753|NCT02270957|156924918|FG000|Overall Study|Adverse Event|2|||
48747754|NCT02270957|156924919|FG001|Overall Study|Adverse Event|0|||
48638526|NCT03789292|156533929|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
48638527|NCT03789292|156533927|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
48638528|NCT03789292|156533928|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
48638529|NCT03789292|156533929|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
48638530|NCT03789292|156533927|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
48638531|NCT03789292|156533928|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
48638532|NCT03789292|156533929|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
48638533|NCT03789292|156533927|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
48638534|NCT03789292|156533928|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
48638535|NCT03789292|156533929|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
48638536|NCT01240863|156533931|FG000|Open-label Titration Period|Adverse Event|47|||
48638537|NCT01240863|156533932|FG001|Open-label Titration Period|Adverse Event|0|||
48638538|NCT01240863|156533933|FG002|Open-label Titration Period|Adverse Event|0|||
48638539|NCT01240863|156533931|FG000|Open-label Titration Period|Lack of Efficacy|19|||
48638540|NCT01240863|156533932|FG001|Open-label Titration Period|Lack of Efficacy|0|||
48638541|NCT01240863|156533933|FG002|Open-label Titration Period|Lack of Efficacy|0|||
48638542|NCT01240863|156533931|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
48638543|NCT01240863|156533932|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
48638544|NCT01240863|156533933|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
48638545|NCT01240863|156533931|FG000|Open-label Titration Period|Protocol Violation|7|||
48638546|NCT01240863|156533932|FG001|Open-label Titration Period|Protocol Violation|0|||
48638547|NCT01240863|156533933|FG002|Open-label Titration Period|Protocol Violation|0|||
48638548|NCT01240863|156533931|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
48638549|NCT01240863|156533932|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
48638550|NCT01240863|156533933|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
48638551|NCT01240863|156533931|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
48638552|NCT01240863|156533932|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
48638553|NCT01240863|156533933|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
48638554|NCT01240863|156533931|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
48638555|NCT01240863|156533932|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
48328114|NCT02384382|155400075|FG000|Overall Study|Adverse Event|1|||
48328115|NCT02384382|155400075|FG000|Overall Study|Disease progression|16|||
48328116|NCT02542696|155400076|FG000|Overall Study|Adverse Event|167|||
48328117|NCT02542696|155400076|FG000|Overall Study|Lack of Efficacy|26|||
48328118|NCT02542696|155400076|FG000|Overall Study|Lost to Follow-up|6|||
48328119|NCT02542696|155400076|FG000|Overall Study|Withdrawal by Subject|104|||
48328120|NCT02542696|155400076|FG000|Overall Study|Protocol Violation|5|||
48328121|NCT02542696|155400076|FG000|Overall Study|Death|8|||
48328122|NCT02542696|155400076|FG000|Overall Study|DECREASED OFF TIME|1|||
48328123|NCT02542696|155400076|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
48328124|NCT02542696|155400076|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
48328125|NCT02542696|155400076|FG000|Overall Study|MEDICAL HISTORY|1|||
48328126|NCT02542696|155400076|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
48328127|NCT02542696|155400076|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
48328128|NCT02542696|155400076|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
48328129|NCT02542696|155400076|FG000|Overall Study|SPONSOR DECISION|3|||
48328130|NCT02542696|155400076|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
48328131|NCT02542696|155400076|FG000|Overall Study|SUBJECT DECISION|2|||
48328132|NCT02113449|155400080|FG000|Overall Study|Adverse Event|4|||
48328133|NCT05376397|155400083|FG000|Overall Study|Lost to Follow-up|1|||
48328134|NCT01218009|155400089|FG000|Overall Study|Protocol Violation|2|||
48328135|NCT01218009|155400090|FG001|Overall Study|Protocol Violation|1|||
48328136|NCT01218009|155400089|FG000|Overall Study|Withdrawal by Subject|3|||
48328137|NCT01218009|155400090|FG001|Overall Study|Withdrawal by Subject|1|||
48328138|NCT01218009|155400089|FG000|Overall Study|Sponsor terminated study|161|||
48328139|NCT01218009|155400090|FG001|Overall Study|Sponsor terminated study|163|||
48328140|NCT01328496|155400093|FG000|Overall Study|Significant Change in Health Status|1|||
48328141|NCT01328496|155400094|FG001|Overall Study|Significant Change in Health Status|0|||
48328142|NCT00526994|155400098|FG000|Overall Study|Lost to Follow-up|98|||
48328143|NCT00526994|155400099|FG001|Overall Study|Lost to Follow-up|108|||
48328144|NCT00526994|155400100|FG002|Overall Study|Lost to Follow-up|96|||
48328145|NCT00526994|155400098|FG000|Overall Study|Death|4|||
48328146|NCT00526994|155400099|FG001|Overall Study|Death|3|||
48328147|NCT00526994|155400100|FG002|Overall Study|Death|3|||
48328148|NCT00526994|155400098|FG000|Overall Study|Withdrawal by Subject|2|||
48328149|NCT00526994|155400099|FG001|Overall Study|Withdrawal by Subject|7|||
48328150|NCT00526994|155400100|FG002|Overall Study|Withdrawal by Subject|5|||
48328151|NCT00526994|155400098|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
48328152|NCT00526994|155400099|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
48328153|NCT00526994|155400100|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
48747755|NCT04343261|156924922|FG000|Overall Study|Adverse Event|1|||
48747756|NCT04343261|156924922|FG000|Overall Study|received inadequate amount of antibodies|7|||
48747757|NCT00743340|156924925|FG000|Overall Study|Study medication non-compliance|1|||
48747758|NCT00743340|156924925|FG000|Overall Study|Lost to Follow-up|1|||
48747759|NCT00743340|156924925|FG000|Overall Study|Withdrawal from the Study|5|||
48747760|NCT00743340|156924925|FG000|Overall Study|Protocol Violation|1|||
48328154|NCT04009291|155400106|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
48328155|NCT04009291|155400107|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
48328156|NCT04009291|155400108|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
48328157|NCT04009291|155400109|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
48328158|NCT04009291|155400110|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
48328159|NCT04009291|155400106|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
48328160|NCT04009291|155400107|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
48328161|NCT04009291|155400108|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
48328162|NCT04009291|155400109|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
48328163|NCT04009291|155400110|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
48328164|NCT03288506|155400111|FG000|Overall Study|Withdrawal by Subject|52|||
48328165|NCT00853593|155400112|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
48328166|NCT00853593|155400112|FG000|Overall Study|Model 4396 lead not attempted|29|||
48328167|NCT00853593|155400112|FG000|Overall Study|Implant not attempted|4|||
48328168|NCT00622700|155400113|FG000|Core Treatment Period|Randomized but Not Treated|0|||
48328169|NCT00622700|155400114|FG001|Core Treatment Period|Randomized but Not Treated|2|||
48328170|NCT00622700|155400115|FG002|Core Treatment Period|Randomized but Not Treated|2|||
48328171|NCT00622700|155400116|FG003|Core Treatment Period|Randomized but Not Treated|0|||
48328172|NCT00622700|155400117|FG004|Core Treatment Period|Randomized but Not Treated|0|||
48328173|NCT00622700|155400118|FG005|Core Treatment Period|Randomized but Not Treated|0|||
48328174|NCT00622700|155400119|FG006|Core Treatment Period|Randomized but Not Treated|0|||
48328175|NCT00622700|155400113|FG000|Core Treatment Period|Adverse Event|18|||
48638556|NCT01240863|156533933|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
48638557|NCT01240863|156533931|FG000|Open-label Titration Period|Other|7|||
48638558|NCT01240863|156533932|FG001|Open-label Titration Period|Other|0|||
48638559|NCT01240863|156533933|FG002|Open-label Titration Period|Other|0|||
48638560|NCT01240863|156533931|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
48638561|NCT01240863|156533932|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
48638562|NCT01240863|156533933|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
48638563|NCT01240863|156533931|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
48638564|NCT01240863|156533932|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
48638565|NCT01240863|156533933|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
48638566|NCT01240863|156533931|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48638567|NCT01240863|156533932|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
48638568|NCT01240863|156533933|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
48638569|NCT01240863|156533931|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48638570|NCT01240863|156533932|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
48638571|NCT01240863|156533933|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
48638572|NCT01240863|156533931|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
48638573|NCT01240863|156533932|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
48638574|NCT01240863|156533933|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
48638575|NCT01240863|156533931|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
48638576|NCT01240863|156533932|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
48638577|NCT01240863|156533933|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
48638578|NCT01240863|156533931|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
48638579|NCT01240863|156533932|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
48638580|NCT01240863|156533933|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
48747761|NCT00743340|156924925|FG000|Overall Study|Virologic failure|8|||
48747762|NCT00743340|156924925|FG000|Overall Study|Pregnancy|1|||
48747763|NCT00743340|156924925|FG000|Overall Study|Rolled over to other Gilead Study|23|||
48747764|NCT00743340|156924925|FG000|Overall Study|Participant Relocated|1|||
48747765|NCT00127660|156924926|FG000|Overall Study|Protocol Violation|3|||
48747766|NCT00127660|156924927|FG001|Overall Study|Protocol Violation|3|||
48747767|NCT00127660|156924928|FG002|Overall Study|Protocol Violation|5|||
48747768|NCT00127660|156924929|FG003|Overall Study|Protocol Violation|0|||
48747769|NCT01191801|156924934|FG000|Overall Study|Death|36|||
48747770|NCT01191801|156924935|FG001|Overall Study|Death|12|||
48747771|NCT01191801|156924934|FG000|Overall Study|Lack of Efficacy|176|||
48747772|NCT01191801|156924935|FG001|Overall Study|Lack of Efficacy|258|||
48747773|NCT01191801|156924934|FG000|Overall Study|Adverse Event|9|||
48747774|NCT01191801|156924935|FG001|Overall Study|Adverse Event|8|||
48747775|NCT01191801|156924934|FG000|Overall Study|Protocol Violation|2|||
48328176|NCT00622700|155400114|FG001|Core Treatment Period|Adverse Event|25|||
48638581|NCT01240863|156533931|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
48328177|NCT00622700|155400115|FG002|Core Treatment Period|Adverse Event|18|||
48328178|NCT00622700|155400116|FG003|Core Treatment Period|Adverse Event|0|||
48328179|NCT00622700|155400117|FG004|Core Treatment Period|Adverse Event|0|||
48328180|NCT00622700|155400118|FG005|Core Treatment Period|Adverse Event|0|||
48328181|NCT00622700|155400119|FG006|Core Treatment Period|Adverse Event|0|||
48328182|NCT00622700|155400113|FG000|Core Treatment Period|Lack of Efficacy|19|||
48328183|NCT00622700|155400114|FG001|Core Treatment Period|Lack of Efficacy|6|||
48328184|NCT00622700|155400115|FG002|Core Treatment Period|Lack of Efficacy|12|||
48328185|NCT00622700|155400116|FG003|Core Treatment Period|Lack of Efficacy|0|||
48328186|NCT00622700|155400117|FG004|Core Treatment Period|Lack of Efficacy|0|||
48328187|NCT00622700|155400118|FG005|Core Treatment Period|Lack of Efficacy|0|||
48328188|NCT00622700|155400119|FG006|Core Treatment Period|Lack of Efficacy|0|||
48638582|NCT01240863|156533932|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
48638583|NCT01240863|156533933|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
48638584|NCT02761642|156533934|FG000|Overall Study|Did not Receive Study Treatment|3|||
48328189|NCT00622700|155400113|FG000|Core Treatment Period|Lost to Follow-up|1|||
48328190|NCT00622700|155400114|FG001|Core Treatment Period|Lost to Follow-up|1|||
48328191|NCT00622700|155400115|FG002|Core Treatment Period|Lost to Follow-up|1|||
48638585|NCT02761642|156533934|FG000|Overall Study|Adverse Event|13|||
48638586|NCT02761642|156533934|FG000|Overall Study|Withdrawal by Subject|2|||
48638587|NCT02761642|156533934|FG000|Overall Study|Non-compliant|7|||
48638588|NCT02761642|156533934|FG000|Overall Study|Death|3|||
48638589|NCT02761642|156533934|FG000|Overall Study|Lack of Efficacy|20|||
48638590|NCT02761642|156533934|FG000|Overall Study|Physician Decision|1|||
48638591|NCT02761642|156533934|FG000|Overall Study|Reason Unspecified|21|||
48638592|NCT03710889|156533935|FG000|Overall Study|Adverse Event|2|||
48638593|NCT03710889|156533935|FG000|Overall Study|Protocol Deviation|1|||
48638594|NCT01644643|156533936|FG000|Overall Study|Death|1|||
48638595|NCT01644643|156533937|FG001|Overall Study|Death|0|||
48638596|NCT01644643|156533938|FG002|Overall Study|Death|3|||
48638597|NCT01644643|156533939|FG003|Overall Study|Death|3|||
48638598|NCT01644643|156533936|FG000|Overall Study|Lost to Follow-up|0|||
48638599|NCT01644643|156533937|FG001|Overall Study|Lost to Follow-up|0|||
48638600|NCT01644643|156533938|FG002|Overall Study|Lost to Follow-up|0|||
48638601|NCT01644643|156533939|FG003|Overall Study|Lost to Follow-up|4|||
48638602|NCT01644643|156533936|FG000|Overall Study|Withdrawal by Subject|1|||
48638603|NCT01644643|156533937|FG001|Overall Study|Withdrawal by Subject|0|||
48638604|NCT01644643|156533938|FG002|Overall Study|Withdrawal by Subject|2|||
48638605|NCT01644643|156533939|FG003|Overall Study|Withdrawal by Subject|1|||
48638606|NCT01644643|156533936|FG000|Overall Study|Other Eligibility criteria|0|||
48638607|NCT01644643|156533937|FG001|Overall Study|Other Eligibility criteria|0|||
48638608|NCT01644643|156533938|FG002|Overall Study|Other Eligibility criteria|0|||
48638609|NCT01644643|156533939|FG003|Overall Study|Other Eligibility criteria|2|||
48638610|NCT04940130|156533940|FG000|Overall Study|Travel|1|||
48638611|NCT04940130|156533941|FG001|Overall Study|Travel|0|||
48638612|NCT04940130|156533942|FG002|Overall Study|Travel|2|||
48638613|NCT04940130|156533940|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
48638614|NCT04940130|156533941|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
48638615|NCT04940130|156533942|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
48638616|NCT04940130|156533940|FG000|Overall Study|Adverse Event|0|||
48638617|NCT04940130|156533941|FG001|Overall Study|Adverse Event|0|||
48638618|NCT04940130|156533942|FG002|Overall Study|Adverse Event|2|||
48638619|NCT04940130|156533940|FG000|Overall Study|Disease progression/treatment failure|0|||
48638620|NCT04940130|156533941|FG001|Overall Study|Disease progression/treatment failure|0|||
48638621|NCT04940130|156533942|FG002|Overall Study|Disease progression/treatment failure|1|||
48638622|NCT04940130|156533940|FG000|Overall Study|Participant refusal|0|||
48638623|NCT04940130|156533941|FG001|Overall Study|Participant refusal|0|||
48638624|NCT04940130|156533942|FG002|Overall Study|Participant refusal|1|||
48638625|NCT02850978|156533946|FG000|Overall Study|Uncollectable CRF|27|||
48638626|NCT02850978|156533946|FG000|Overall Study|No visit since the first visit|35|||
48638627|NCT02850978|156533946|FG000|Overall Study|Adverse Event|81|||
48638628|NCT02850978|156533946|FG000|Overall Study|Lack of Efficacy|40|||
48638629|NCT02850978|156533946|FG000|Overall Study|Improvement in condition|34|||
48638630|NCT02850978|156533946|FG000|Overall Study|Lost to Follow-up|121|||
48638631|NCT02850978|156533946|FG000|Overall Study|Reason not listed|88|||
48638632|NCT00881894|156533947|FG000|Overall Study|Consent withdrawn|0|||
48638633|NCT00881894|156533948|FG001|Overall Study|Consent withdrawn|1|||
48638634|NCT00881894|156533947|FG000|Overall Study|Other reasons for premature termination|1|||
48638635|NCT00881894|156533948|FG001|Overall Study|Other reasons for premature termination|2|||
48638636|NCT03289533|156533949|FG000|Overall Study|Death|12|||
48638637|NCT03289533|156533949|FG000|Overall Study|Terminated from study by sponsor|10|||
48638638|NCT00539240|156533950|FG000|Overall Study|Withdrawal by Subject|0|||
48638639|NCT00539240|156533951|FG001|Overall Study|Withdrawal by Subject|2|||
48638640|NCT00539240|156533952|FG002|Overall Study|Withdrawal by Subject|0|||
48638641|NCT00539240|156533950|FG000|Overall Study|Protocol Violation|1|||
48328192|NCT00622700|155400116|FG003|Core Treatment Period|Lost to Follow-up|0|||
48638642|NCT00539240|156533951|FG001|Overall Study|Protocol Violation|1|||
48747776|NCT01191801|156924935|FG001|Overall Study|Protocol Violation|4|||
48747777|NCT01191801|156924934|FG000|Overall Study|Physician Decision|47|||
48747778|NCT01191801|156924935|FG001|Overall Study|Physician Decision|24|||
48747779|NCT01191801|156924934|FG000|Overall Study|Withdrawal by Subject|1|||
48747780|NCT01191801|156924935|FG001|Overall Study|Withdrawal by Subject|4|||
48747781|NCT01191801|156924934|FG000|Overall Study|Not Provided|45|||
48747782|NCT01191801|156924935|FG001|Overall Study|Not Provided|27|||
48747783|NCT00587054|156924936|FG000|Overall Study|Patient not treated|9|||
48747784|NCT00521014|156924937|FG000|Overall Study|Inevaluable, not treated|1|||
48747785|NCT01217814|156924944|FG000|Overall Study|Adverse Event|1|||
48747786|NCT01217814|156924945|FG001|Overall Study|Adverse Event|1|||
48747787|NCT01217814|156924946|FG002|Overall Study|Adverse Event|0|||
48747788|NCT01217814|156924944|FG000|Overall Study|Lack of Efficacy|0|||
48747789|NCT01217814|156924945|FG001|Overall Study|Lack of Efficacy|0|||
48747790|NCT01217814|156924946|FG002|Overall Study|Lack of Efficacy|1|||
48747791|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
48747792|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
48747793|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
48747794|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
48747795|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
48747796|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48747797|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
48747798|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
48747799|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Other|1|||
48747800|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Other|4|||
48747801|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Other|3|||
48747802|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Other|6|||
48747803|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
48747804|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
48747805|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
48638643|NCT00539240|156533952|FG002|Overall Study|Protocol Violation|4|||
48638644|NCT00539240|156533950|FG000|Overall Study|Lost to Follow-up|2|||
48638645|NCT00539240|156533951|FG001|Overall Study|Lost to Follow-up|3|||
48638646|NCT00539240|156533952|FG002|Overall Study|Lost to Follow-up|1|||
48638647|NCT00539240|156533950|FG000|Overall Study|Adverse Event|3|||
48638648|NCT00539240|156533951|FG001|Overall Study|Adverse Event|1|||
48638649|NCT00539240|156533952|FG002|Overall Study|Adverse Event|10|||
48638650|NCT02765399|156533953|FG000|Overall Study|Nausea|1|||
48638651|NCT02765399|156533954|FG001|Overall Study|Nausea|0|||
48638652|NCT00363311|156533955|FG000|Overall Study|Adverse Event|6|||
48638653|NCT00363311|156533956|FG001|Overall Study|Adverse Event|4|||
48638654|NCT00363311|156533955|FG000|Overall Study|Lost to Follow-up|3|||
48638655|NCT00363311|156533956|FG001|Overall Study|Lost to Follow-up|0|||
48638656|NCT00363311|156533955|FG000|Overall Study|Protocol Violation|1|||
48638657|NCT00363311|156533956|FG001|Overall Study|Protocol Violation|2|||
48747806|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
48747807|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
48747808|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
48747809|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
48747810|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
48426800|NCT04760314|155752869|FG010|Induction Period|Adverse Event|0|||
48747811|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
48747812|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
48747813|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
48638658|NCT00363311|156533955|FG000|Overall Study|Withdrawal by Subject|12|||
48638659|NCT00363311|156533956|FG001|Overall Study|Withdrawal by Subject|6|||
48638660|NCT00363311|156533955|FG000|Overall Study|Physician Decision|1|||
48638661|NCT00363311|156533956|FG001|Overall Study|Physician Decision|1|||
48638662|NCT00363311|156533955|FG000|Overall Study|Sponsor Terminated Study|2|||
48747814|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
48328193|NCT00622700|155400117|FG004|Core Treatment Period|Lost to Follow-up|0|||
48328194|NCT00622700|155400118|FG005|Core Treatment Period|Lost to Follow-up|0|||
48328195|NCT00622700|155400119|FG006|Core Treatment Period|Lost to Follow-up|0|||
48328196|NCT00622700|155400113|FG000|Core Treatment Period|Death|1|||
48328197|NCT00622700|155400114|FG001|Core Treatment Period|Death|0|||
48328198|NCT00622700|155400115|FG002|Core Treatment Period|Death|0|||
48328199|NCT00622700|155400116|FG003|Core Treatment Period|Death|0|||
48328200|NCT00622700|155400117|FG004|Core Treatment Period|Death|0|||
48328201|NCT00622700|155400118|FG005|Core Treatment Period|Death|0|||
48328202|NCT00622700|155400119|FG006|Core Treatment Period|Death|0|||
48328203|NCT00622700|155400113|FG000|Core Treatment Period|Progressive Disease|3|||
48328204|NCT00622700|155400114|FG001|Core Treatment Period|Progressive Disease|1|||
48328205|NCT00622700|155400115|FG002|Core Treatment Period|Progressive Disease|0|||
48328206|NCT00622700|155400116|FG003|Core Treatment Period|Progressive Disease|0|||
48328207|NCT00622700|155400117|FG004|Core Treatment Period|Progressive Disease|0|||
48328208|NCT00622700|155400118|FG005|Core Treatment Period|Progressive Disease|0|||
48328209|NCT00622700|155400119|FG006|Core Treatment Period|Progressive Disease|0|||
48328210|NCT00622700|155400113|FG000|Core Treatment Period|Withdrawal by Subject|12|||
48328211|NCT00622700|155400114|FG001|Core Treatment Period|Withdrawal by Subject|18|||
48328212|NCT00622700|155400115|FG002|Core Treatment Period|Withdrawal by Subject|15|||
48328213|NCT00622700|155400116|FG003|Core Treatment Period|Withdrawal by Subject|0|||
48328214|NCT00622700|155400117|FG004|Core Treatment Period|Withdrawal by Subject|0|||
48328215|NCT00622700|155400118|FG005|Core Treatment Period|Withdrawal by Subject|0|||
48328216|NCT00622700|155400119|FG006|Core Treatment Period|Withdrawal by Subject|0|||
48328217|NCT00622700|155400113|FG000|Core Treatment Period|Other than specified above|2|||
48328218|NCT00622700|155400114|FG001|Core Treatment Period|Other than specified above|2|||
48328219|NCT00622700|155400115|FG002|Core Treatment Period|Other than specified above|5|||
48328220|NCT00622700|155400116|FG003|Core Treatment Period|Other than specified above|0|||
48328221|NCT00622700|155400117|FG004|Core Treatment Period|Other than specified above|0|||
48328222|NCT00622700|155400118|FG005|Core Treatment Period|Other than specified above|0|||
48328223|NCT00622700|155400119|FG006|Core Treatment Period|Other than specified above|0|||
48638663|NCT00363311|156533956|FG001|Overall Study|Sponsor Terminated Study|2|||
48638664|NCT00363311|156533955|FG000|Overall Study|Disease Progression|46|||
48638665|NCT00363311|156533956|FG001|Overall Study|Disease Progression|26|||
48638666|NCT00363311|156533955|FG000|Overall Study|Non-Compliance|1|||
48638667|NCT00363311|156533956|FG001|Overall Study|Non-Compliance|1|||
48638668|NCT00363311|156533955|FG000|Overall Study|Participant Refused Biopsy|1|||
48638669|NCT00363311|156533956|FG001|Overall Study|Participant Refused Biopsy|0|||
48638670|NCT00363311|156533955|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
48638671|NCT00363311|156533956|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
48638672|NCT00363311|156533955|FG000|Overall Study|Participant Opted for Treatment|1|||
48638673|NCT00363311|156533956|FG001|Overall Study|Participant Opted for Treatment|0|||
48638674|NCT00363311|156533955|FG000|Overall Study|Participant Moved to Another Country|1|||
48638675|NCT00363311|156533956|FG001|Overall Study|Participant Moved to Another Country|0|||
48638676|NCT00363311|156533955|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
48638677|NCT00363311|156533956|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
48638678|NCT00363311|156533955|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
48638679|NCT00363311|156533956|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
48638680|NCT00363311|156533955|FG000|Overall Study|Participant Moved to Louisiana|0|||
48638681|NCT00363311|156533956|FG001|Overall Study|Participant Moved to Louisiana|1|||
48638682|NCT00636181|156533958|FG000|Overall Study|Withdrawal by Subject|8|||
48638683|NCT00636181|156533959|FG001|Overall Study|Withdrawal by Subject|6|||
48638684|NCT00636181|156533960|FG002|Overall Study|Withdrawal by Subject|10|||
48638685|NCT00943761|156533970|FG000|Overall Study|Lost to Follow-up|2|||
48638686|NCT00943761|156533971|FG001|Overall Study|Lost to Follow-up|0|||
48638687|NCT00943761|156533970|FG000|Overall Study|Withdrawal by Subject|2|||
48638688|NCT00943761|156533971|FG001|Overall Study|Withdrawal by Subject|1|||
48638689|NCT00444106|156533976|FG000|Overall Study|Lost to Follow-up|2|||
48638690|NCT00444106|156533977|FG001|Overall Study|Lost to Follow-up|1|||
48638691|NCT00444106|156533978|FG002|Overall Study|Lost to Follow-up|0|||
48638692|NCT00444106|156533976|FG000|Overall Study|Abnormal Test Procedure Results|0|||
48638693|NCT00444106|156533977|FG001|Overall Study|Abnormal Test Procedure Results|0|||
48638694|NCT00444106|156533978|FG002|Overall Study|Abnormal Test Procedure Results|1|||
48638695|NCT00145626|156533979|FG000|Overall Study|Did not have NK infusions|2|||
48638696|NCT00145626|156533979|FG000|Overall Study|Turned 2 years old before treatment|1|||
48638697|NCT00145626|156533979|FG000|Overall Study|Death|1|||
48638698|NCT00145626|156533979|FG000|Overall Study|Withdrawal by Subject|1|||
48638699|NCT04592341|156535207|FG000|Overall Study|Physician Decision|5|||
48638700|NCT04592341|156535207|FG000|Overall Study|Study Terminated by Sponsor|5|||
48638701|NCT04592341|156535207|FG000|Overall Study|Withdrawal by Subject|53|||
48638702|NCT04592341|156535207|FG000|Overall Study|Lost to Follow-up|3|||
48638703|NCT04592341|156535207|FG000|Overall Study|Death|1|||
48638704|NCT04592341|156535207|FG000|Overall Study|Adverse Event|5|||
48328224|NCT00622700|155400113|FG000|Extension Treatment Period|Adverse Event|0|||
48328225|NCT00622700|155400114|FG001|Extension Treatment Period|Adverse Event|0|||
48328226|NCT00622700|155400115|FG002|Extension Treatment Period|Adverse Event|0|||
48328227|NCT00622700|155400116|FG003|Extension Treatment Period|Adverse Event|5|||
48328228|NCT00622700|155400117|FG004|Extension Treatment Period|Adverse Event|9|||
48328229|NCT00622700|155400118|FG005|Extension Treatment Period|Adverse Event|6|||
48328230|NCT00622700|155400119|FG006|Extension Treatment Period|Adverse Event|8|||
48328231|NCT00622700|155400113|FG000|Extension Treatment Period|Lack of Efficacy|0|||
48328232|NCT00622700|155400114|FG001|Extension Treatment Period|Lack of Efficacy|0|||
48328233|NCT00622700|155400115|FG002|Extension Treatment Period|Lack of Efficacy|0|||
48638705|NCT04592341|156535207|FG000|Overall Study|other|4|||
48638706|NCT03423121|156535208|FG000|Overall Study|Lost to Follow-up|2|||
48638707|NCT03423121|156535209|FG001|Overall Study|Lost to Follow-up|6|||
48747815|NCT02925494|156924947|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
48747816|NCT02925494|156924948|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
48747817|NCT02925494|156924949|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
48747818|NCT02925494|156924950|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
48747819|NCT00640601|156924955|FG000|Overall Study|Adverse Event|43|||
48747820|NCT00640601|156924955|FG000|Overall Study|Withdrawal by Subject|20|||
48747821|NCT00640601|156924955|FG000|Overall Study|Protocol Violation|6|||
48747822|NCT00640601|156924955|FG000|Overall Study|Lack of Efficacy|16|||
48747823|NCT00640601|156924955|FG000|Overall Study|Lost to Follow-up|9|||
48747824|NCT00640601|156924955|FG000|Overall Study|Physician Decision|8|||
48747825|NCT00640601|156924955|FG000|Overall Study|treatment naive, combination therapy|10|||
48747826|NCT03060629|156924956|FG000|Overall Study|Death|4|||
48747827|NCT03060629|156924957|FG001|Overall Study|Death|5|||
48747828|NCT03060629|156924956|FG000|Overall Study|Withdrawal by Subject|50|||
48747829|NCT03060629|156924957|FG001|Overall Study|Withdrawal by Subject|35|||
48747830|NCT03060629|156924956|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
48747831|NCT03060629|156924957|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
48747832|NCT03060629|156924956|FG000|Overall Study|Participant Relocate|15|||
48747833|NCT03060629|156924957|FG001|Overall Study|Participant Relocate|15|||
48747834|NCT03060629|156924956|FG000|Overall Study|Unable to Contact Participant|34|||
48747835|NCT03060629|156924957|FG001|Overall Study|Unable to Contact Participant|23|||
48328234|NCT00622700|155400116|FG003|Extension Treatment Period|Lack of Efficacy|2|||
48328235|NCT00622700|155400117|FG004|Extension Treatment Period|Lack of Efficacy|8|||
48328236|NCT00622700|155400118|FG005|Extension Treatment Period|Lack of Efficacy|1|||
48328237|NCT00622700|155400119|FG006|Extension Treatment Period|Lack of Efficacy|9|||
48328238|NCT00622700|155400113|FG000|Extension Treatment Period|Protocol Violation|0|||
48328239|NCT00622700|155400114|FG001|Extension Treatment Period|Protocol Violation|0|||
48328240|NCT00622700|155400115|FG002|Extension Treatment Period|Protocol Violation|0|||
48328241|NCT00622700|155400116|FG003|Extension Treatment Period|Protocol Violation|0|||
48328242|NCT00622700|155400117|FG004|Extension Treatment Period|Protocol Violation|0|||
48638708|NCT03423121|156535208|FG000|Overall Study|Adverse Event|1|||
48638709|NCT03423121|156535209|FG001|Overall Study|Adverse Event|0|||
48638710|NCT01049373|156535210|FG000|Overall Study|Protocol Violation|9|||
48638711|NCT01049373|156535211|FG001|Overall Study|Protocol Violation|9|||
48638712|NCT01049373|156535210|FG000|Overall Study|Withdrawal by Subject|8|||
48638713|NCT01049373|156535211|FG001|Overall Study|Withdrawal by Subject|5|||
48638714|NCT01049373|156535210|FG000|Overall Study|Adverse Event|3|||
48638715|NCT01049373|156535211|FG001|Overall Study|Adverse Event|3|||
48638716|NCT01049373|156535210|FG000|Overall Study|Lost to Follow-up|9|||
48328243|NCT00622700|155400118|FG005|Extension Treatment Period|Protocol Violation|2|||
48328244|NCT00622700|155400119|FG006|Extension Treatment Period|Protocol Violation|0|||
48328245|NCT00622700|155400113|FG000|Extension Treatment Period|Lost to Follow-up|0|||
48638717|NCT01049373|156535211|FG001|Overall Study|Lost to Follow-up|4|||
48638718|NCT01049373|156535210|FG000|Overall Study|no evaluable study values|9|||
48638719|NCT01049373|156535211|FG001|Overall Study|no evaluable study values|21|||
48638720|NCT01049373|156535210|FG000|Overall Study|Other|1|||
48747836|NCT03060629|156924956|FG000|Overall Study|Investigator Decision|7|||
48747837|NCT03060629|156924957|FG001|Overall Study|Investigator Decision|7|||
48747838|NCT03060629|156924956|FG000|Overall Study|Study Terminated by Sponsor|1100|||
48747839|NCT03060629|156924957|FG001|Overall Study|Study Terminated by Sponsor|1123|||
48747840|NCT03060629|156924956|FG000|Overall Study|Other|4|||
48328246|NCT00622700|155400114|FG001|Extension Treatment Period|Lost to Follow-up|0|||
48328247|NCT00622700|155400115|FG002|Extension Treatment Period|Lost to Follow-up|0|||
48328248|NCT00622700|155400116|FG003|Extension Treatment Period|Lost to Follow-up|0|||
48328249|NCT00622700|155400117|FG004|Extension Treatment Period|Lost to Follow-up|1|||
48638721|NCT01049373|156535211|FG001|Overall Study|Other|1|||
48638722|NCT01049373|156535210|FG000|Overall Study|Non-cooperation|0|||
48638723|NCT01049373|156535211|FG001|Overall Study|Non-cooperation|1|||
48638724|NCT01493089|156535212|FG000|Overall Study|Protocol Violation|2|||
48638725|NCT01493089|156535213|FG001|Overall Study|Protocol Violation|2|||
48747841|NCT03060629|156924957|FG001|Overall Study|Other|4|||
48747842|NCT01666782|156924958|FG000|Overall Study|Received 2 doses of vaccine|0|||
48638726|NCT01493089|156535212|FG000|Overall Study|Withdrawal by Subject|1|||
48638727|NCT01493089|156535213|FG001|Overall Study|Withdrawal by Subject|0|||
48638728|NCT01493089|156535212|FG000|Overall Study|Physician Decision|0|||
48638729|NCT01493089|156535213|FG001|Overall Study|Physician Decision|1|||
48638730|NCT01870869|156535221|FG000|Overall Study|Implanted with nonstudy device|1|||
48747843|NCT01666782|156924959|FG001|Overall Study|Received 2 doses of vaccine|1|||
48747844|NCT01666782|156924958|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
48747845|NCT01666782|156924959|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
48747846|NCT04786990|156924960|FG000|Overall Study|Withdrawal by Subject|1|||
48328250|NCT00622700|155400118|FG005|Extension Treatment Period|Lost to Follow-up|0|||
48328251|NCT00622700|155400119|FG006|Extension Treatment Period|Lost to Follow-up|0|||
48638731|NCT01870869|156535222|FG001|Overall Study|Implanted with nonstudy device|3|||
48638732|NCT01870869|156535223|FG002|Overall Study|Implanted with nonstudy device|14|||
48328252|NCT00622700|155400113|FG000|Extension Treatment Period|Progressive Disease|0|||
48328253|NCT00622700|155400114|FG001|Extension Treatment Period|Progressive Disease|0|||
48328254|NCT00622700|155400115|FG002|Extension Treatment Period|Progressive Disease|0|||
48328255|NCT00622700|155400116|FG003|Extension Treatment Period|Progressive Disease|1|||
48328256|NCT00622700|155400117|FG004|Extension Treatment Period|Progressive Disease|2|||
48328257|NCT00622700|155400118|FG005|Extension Treatment Period|Progressive Disease|0|||
48328258|NCT00622700|155400119|FG006|Extension Treatment Period|Progressive Disease|2|||
48328259|NCT00622700|155400113|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
48328260|NCT00622700|155400114|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
48328261|NCT00622700|155400115|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
48328262|NCT00622700|155400116|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
48328263|NCT00622700|155400117|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
48328264|NCT00622700|155400118|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
48328265|NCT00622700|155400119|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
48328266|NCT00622700|155400113|FG000|Extension Treatment Period|Missing|0|||
48328267|NCT00622700|155400114|FG001|Extension Treatment Period|Missing|0|||
48328268|NCT00622700|155400115|FG002|Extension Treatment Period|Missing|0|||
48328269|NCT00622700|155400116|FG003|Extension Treatment Period|Missing|2|||
48328270|NCT00622700|155400117|FG004|Extension Treatment Period|Missing|3|||
48328271|NCT00622700|155400118|FG005|Extension Treatment Period|Missing|1|||
48328272|NCT00622700|155400119|FG006|Extension Treatment Period|Missing|0|||
48328273|NCT00622700|155400113|FG000|Extension Treatment Period|Other than specified above|0|||
48328274|NCT00622700|155400114|FG001|Extension Treatment Period|Other than specified above|0|||
48328275|NCT00622700|155400115|FG002|Extension Treatment Period|Other than specified above|0|||
48638733|NCT01870869|156535224|FG003|Overall Study|Implanted with nonstudy device|4|||
48638734|NCT01870869|156535221|FG000|Overall Study|Death|0|||
48638735|NCT01870869|156535222|FG001|Overall Study|Death|0|||
48638736|NCT01870869|156535223|FG002|Overall Study|Death|7|||
48638737|NCT01870869|156535224|FG003|Overall Study|Death|1|||
48638738|NCT01870869|156535221|FG000|Overall Study|Subject choice|6|||
48638739|NCT01870869|156535222|FG001|Overall Study|Subject choice|2|||
48638740|NCT01870869|156535223|FG002|Overall Study|Subject choice|22|||
48638741|NCT01870869|156535224|FG003|Overall Study|Subject choice|8|||
48638742|NCT01870869|156535221|FG000|Overall Study|Lost to Follow-up|10|||
48638743|NCT01870869|156535222|FG001|Overall Study|Lost to Follow-up|2|||
48638744|NCT01870869|156535223|FG002|Overall Study|Lost to Follow-up|25|||
48638745|NCT01870869|156535224|FG003|Overall Study|Lost to Follow-up|3|||
48638746|NCT01870869|156535221|FG000|Overall Study|Reason not Specified|1|||
48638747|NCT01870869|156535222|FG001|Overall Study|Reason not Specified|2|||
48638748|NCT01870869|156535223|FG002|Overall Study|Reason not Specified|20|||
48638749|NCT01870869|156535224|FG003|Overall Study|Reason not Specified|4|||
48638750|NCT01870869|156535221|FG000|Overall Study|Not evaluable|10|||
48638751|NCT01870869|156535222|FG001|Overall Study|Not evaluable|5|||
48638752|NCT01870869|156535223|FG002|Overall Study|Not evaluable|42|||
48638753|NCT01870869|156535224|FG003|Overall Study|Not evaluable|10|||
48638754|NCT00256126|156535225|FG000|Overall Study|Adverse Event|1|||
48638755|NCT00256126|156535226|FG001|Overall Study|Adverse Event|0|||
48638756|NCT00256126|156535225|FG000|Overall Study|Other|1|||
48638757|NCT00256126|156535226|FG001|Overall Study|Other|2|||
48638758|NCT00387088|156535231|FG000|Overall Study|Adverse Event|143|||
48328276|NCT00622700|155400116|FG003|Extension Treatment Period|Other than specified above|0|||
48638759|NCT00387088|156535232|FG001|Overall Study|Adverse Event|156|||
48638760|NCT00387088|156535231|FG000|Overall Study|Protocol Violation|47|||
48638761|NCT00387088|156535232|FG001|Overall Study|Protocol Violation|35|||
48638762|NCT00387088|156535231|FG000|Overall Study|Withdrawal by Subject|20|||
48638763|NCT00387088|156535232|FG001|Overall Study|Withdrawal by Subject|35|||
48638764|NCT00387088|156535231|FG000|Overall Study|Lack of Efficacy|28|||
48328277|NCT00622700|155400117|FG004|Extension Treatment Period|Other than specified above|0|||
48638765|NCT00387088|156535232|FG001|Overall Study|Lack of Efficacy|67|||
48638766|NCT00387088|156535231|FG000|Overall Study|Lost to Follow-up|22|||
48638767|NCT00387088|156535232|FG001|Overall Study|Lost to Follow-up|28|||
48638768|NCT00387088|156535231|FG000|Overall Study|Other|58|||
48638769|NCT00387088|156535232|FG001|Overall Study|Other|52|||
48638770|NCT00399035|156535233|FG000|Overall Study|Death|289|||
48638771|NCT00399035|156535234|FG001|Overall Study|Death|141|||
48638772|NCT00399035|156535235|FG002|Overall Study|Death|234|||
48638773|NCT00399035|156535233|FG000|Overall Study|Lost to Follow-up|2|||
48638774|NCT00399035|156535234|FG001|Overall Study|Lost to Follow-up|1|||
48638775|NCT00399035|156535235|FG002|Overall Study|Lost to Follow-up|5|||
48638776|NCT00399035|156535233|FG000|Overall Study|Withdrawal by Subject|19|||
48638777|NCT00399035|156535234|FG001|Overall Study|Withdrawal by Subject|15|||
48638778|NCT00399035|156535235|FG002|Overall Study|Withdrawal by Subject|12|||
48638779|NCT00399035|156535233|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
48638780|NCT00399035|156535234|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
48638781|NCT00399035|156535235|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
48638782|NCT00399035|156535233|FG000|Overall Study|Severe non-compliance with protocol|2|||
48638783|NCT00399035|156535234|FG001|Overall Study|Severe non-compliance with protocol|1|||
48638784|NCT00399035|156535235|FG002|Overall Study|Severe non-compliance with protocol|0|||
48638785|NCT02805790|156535238|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
48638786|NCT02805790|156535239|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
48638787|NCT02493764|156535241|FG000|Overall Study|Adverse Event|2|||
48638788|NCT02493764|156535242|FG001|Overall Study|Adverse Event|2|||
48638789|NCT02493764|156535241|FG000|Overall Study|Death|44|||
48638790|NCT02493764|156535242|FG001|Overall Study|Death|58|||
48638791|NCT02493764|156535241|FG000|Overall Study|Lost to Follow-up|2|||
48638792|NCT02493764|156535242|FG001|Overall Study|Lost to Follow-up|1|||
48638793|NCT02493764|156535241|FG000|Overall Study|Protocol Violation|6|||
48638794|NCT02493764|156535242|FG001|Overall Study|Protocol Violation|7|||
48638795|NCT02493764|156535241|FG000|Overall Study|Physician Decision|1|||
48638796|NCT02493764|156535242|FG001|Overall Study|Physician Decision|1|||
48638797|NCT02493764|156535241|FG000|Overall Study|Participant moved|17|||
48638798|NCT02493764|156535242|FG001|Overall Study|Participant moved|5|||
48638799|NCT02493764|156535241|FG000|Overall Study|Withdrawal parent/guardian|0|||
48638800|NCT02493764|156535242|FG001|Overall Study|Withdrawal parent/guardian|1|||
48638801|NCT02493764|156535241|FG000|Overall Study|Withdrawal by Subject|11|||
48638802|NCT02493764|156535242|FG001|Overall Study|Withdrawal by Subject|7|||
48638803|NCT01130337|156535247|FG000|Overall Study|Withdrawal by Subject|3|||
48638804|NCT01130337|156535247|FG000|Overall Study|Principal investigator decision|1|||
48638805|NCT01130337|156535247|FG000|Overall Study|Death|1|||
48638806|NCT01130337|156535247|FG000|Overall Study|Disease progression|1|||
48638807|NCT01130337|156535247|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
48638808|NCT01130337|156535247|FG000|Overall Study|Surgical resection (R2)|1|||
48328278|NCT00622700|155400118|FG005|Extension Treatment Period|Other than specified above|1|||
48638809|NCT00616642|156535248|FG000|Overall Study|Withdrawal by Subject|0|||
48638810|NCT00616642|156535249|FG001|Overall Study|Withdrawal by Subject|1|||
48638811|NCT03064074|156535250|FG000|Overall Study|Physician Decision|0|||
48638812|NCT03064074|156535251|FG001|Overall Study|Physician Decision|0|||
48638813|NCT03064074|156535252|FG002|Overall Study|Physician Decision|0|||
48638814|NCT03064074|156535253|FG003|Overall Study|Physician Decision|1|||
48638815|NCT01193101|156535255|FG000|Overall Study|Adverse Event|0|||
48638816|NCT01193101|156535256|FG001|Overall Study|Adverse Event|1|||
48638817|NCT01193101|156535257|FG002|Overall Study|Adverse Event|1|||
48638818|NCT01193101|156535258|FG003|Overall Study|Adverse Event|3|||
48638819|NCT01193101|156535255|FG000|Overall Study|Lack of Efficacy|3|||
48638820|NCT01193101|156535256|FG001|Overall Study|Lack of Efficacy|1|||
48638821|NCT01193101|156535257|FG002|Overall Study|Lack of Efficacy|0|||
48638822|NCT01193101|156535258|FG003|Overall Study|Lack of Efficacy|8|||
48638823|NCT01193101|156535255|FG000|Overall Study|Withdrawal by Subject|2|||
48638824|NCT01193101|156535256|FG001|Overall Study|Withdrawal by Subject|4|||
48638825|NCT01193101|156535257|FG002|Overall Study|Withdrawal by Subject|1|||
48638826|NCT01193101|156535258|FG003|Overall Study|Withdrawal by Subject|1|||
48638827|NCT01193101|156535255|FG000|Overall Study|Administrative problems|0|||
48638828|NCT01193101|156535256|FG001|Overall Study|Administrative problems|0|||
48638829|NCT01193101|156535257|FG002|Overall Study|Administrative problems|1|||
48638830|NCT01193101|156535258|FG003|Overall Study|Administrative problems|0|||
48638831|NCT01193101|156535255|FG000|Overall Study|Abnormal test procedure results|0|||
48638832|NCT01193101|156535256|FG001|Overall Study|Abnormal test procedure results|1|||
48747847|NCT04786990|156924960|FG000|Overall Study|Adverse Event|1|||
48328279|NCT00622700|155400119|FG006|Extension Treatment Period|Other than specified above|1|||
48638833|NCT01193101|156535257|FG002|Overall Study|Abnormal test procedure results|0|||
48638834|NCT01193101|156535258|FG003|Overall Study|Abnormal test procedure results|0|||
48638835|NCT02271529|156535259|FG000|Overall Study|Withdrawal by Subject|1|||
48638836|NCT05142306|156535260|FG000|Overall Study|Withdrawal by Subject|0|||
48638837|NCT05142306|156535261|FG001|Overall Study|Withdrawal by Subject|0|||
48638838|NCT05142306|156535262|FG002|Overall Study|Withdrawal by Subject|1|||
48638839|NCT01082614|156535263|FG000|Overall Study|Adverse Event|1|||
48638840|NCT01082614|156535264|FG001|Overall Study|Adverse Event|4|||
48638841|NCT01082614|156535263|FG000|Overall Study|Equipment Malfunction|0|||
48638842|NCT01082614|156535264|FG001|Overall Study|Equipment Malfunction|1|||
48638843|NCT01082614|156535263|FG000|Overall Study|Physician Decision|2|||
48638844|NCT01082614|156535264|FG001|Overall Study|Physician Decision|0|||
48638845|NCT00553631|156535269|FG000|Overall Study|Withdrawal by Subject|0|||
48638846|NCT00553631|156535270|FG001|Overall Study|Withdrawal by Subject|1|||
48638847|NCT00553631|156535269|FG000|Overall Study|Lost to Follow-up|1|||
48638848|NCT00553631|156535270|FG001|Overall Study|Lost to Follow-up|0|||
48638849|NCT00950651|156535271|FG000|Overall Study|Adverse Event|17|||
48638850|NCT00950651|156535272|FG001|Overall Study|Adverse Event|20|||
48638851|NCT00950651|156535271|FG000|Overall Study|Death|1|||
48638852|NCT00950651|156535272|FG001|Overall Study|Death|0|||
48638853|NCT00950651|156535271|FG000|Overall Study|Lack of Efficacy|2|||
48747848|NCT04786990|156924960|FG000|Overall Study|Lost to Follow-up|1|||
48747849|NCT04786990|156924960|FG000|Overall Study|Noncompliance|1|||
48747850|NCT04786990|156924960|FG000|Overall Study|Unable to complete site visits|1|||
48747851|NCT04786990|156924960|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
48747852|NCT02615145|156924973|FG000|Overall Study|Did Not Start Treatment|0|||
48747853|NCT02615145|156924974|FG001|Overall Study|Did Not Start Treatment|0|||
48638854|NCT00950651|156535272|FG001|Overall Study|Lack of Efficacy|2|||
48747854|NCT02615145|156924975|FG002|Overall Study|Did Not Start Treatment|1|||
48747855|NCT02615145|156924976|FG003|Overall Study|Did Not Start Treatment|1|||
48747856|NCT02615145|156924973|FG000|Overall Study|Failure to Return|20|||
48747857|NCT02615145|156924974|FG001|Overall Study|Failure to Return|10|||
48747858|NCT02615145|156924975|FG002|Overall Study|Failure to Return|7|||
48328280|NCT00942266|155400123|FG000|Overall Study|Withdrawal by Subject|1|||
48328281|NCT00942266|155400124|FG001|Overall Study|Withdrawal by Subject|0|||
48328282|NCT00942266|155400123|FG000|Overall Study|Adverse Event|2|||
48328283|NCT00942266|155400124|FG001|Overall Study|Adverse Event|1|||
48328284|NCT00942266|155400123|FG000|Overall Study|Disease Progression|38|||
48328285|NCT00942266|155400124|FG001|Overall Study|Disease Progression|11|||
48328286|NCT00942266|155400123|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
48328287|NCT00942266|155400124|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
48328288|NCT00942266|155400123|FG000|Overall Study|Intercurrent illness|0|||
48328289|NCT00942266|155400124|FG001|Overall Study|Intercurrent illness|1|||
48328290|NCT00942266|155400123|FG000|Overall Study|Physician Decision|2|||
48328291|NCT00942266|155400124|FG001|Overall Study|Physician Decision|0|||
48328292|NCT00942266|155400123|FG000|Overall Study|medical deterioration (pneumonia)|0|||
48328293|NCT00942266|155400124|FG001|Overall Study|medical deterioration (pneumonia)|1|||
48328294|NCT01604824|155400133|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48328295|NCT01604824|155400134|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48328296|NCT01604824|155400135|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48328297|NCT01604824|155400136|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48328298|NCT01604824|155400137|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
48638855|NCT00950651|156535271|FG000|Overall Study|Protocol Violation|3|||
48638856|NCT00950651|156535272|FG001|Overall Study|Protocol Violation|4|||
48638857|NCT00950651|156535271|FG000|Overall Study|Withdrawal by Subject|8|||
48638858|NCT00950651|156535272|FG001|Overall Study|Withdrawal by Subject|9|||
48638859|NCT03783780|156535273|FG000|Overall Study|Withdrawn prior to completion|1|||
48747859|NCT02615145|156924976|FG003|Overall Study|Failure to Return|0|||
48747860|NCT02615145|156924973|FG000|Overall Study|Death|2|||
48747861|NCT02615145|156924974|FG001|Overall Study|Death|3|||
48328299|NCT01604824|155400138|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
48638860|NCT03768427|156535276|FG000|Overall Study|Death|0|||
48638861|NCT03768427|156535277|FG001|Overall Study|Death|0|||
48638862|NCT03768427|156535278|FG002|Overall Study|Death|1|||
48747862|NCT02615145|156924975|FG002|Overall Study|Death|0|||
48747863|NCT02615145|156924976|FG003|Overall Study|Death|0|||
48638863|NCT03768427|156535279|FG003|Overall Study|Death|0|||
48638864|NCT03768427|156535276|FG000|Overall Study|Lost to Follow-up|2|||
48638865|NCT03768427|156535277|FG001|Overall Study|Lost to Follow-up|0|||
48638866|NCT03768427|156535278|FG002|Overall Study|Lost to Follow-up|0|||
48638867|NCT03768427|156535279|FG003|Overall Study|Lost to Follow-up|0|||
48638868|NCT03768427|156535276|FG000|Overall Study|Physician Decision|3|||
48638869|NCT03768427|156535277|FG001|Overall Study|Physician Decision|2|||
48638870|NCT03768427|156535278|FG002|Overall Study|Physician Decision|4|||
48638871|NCT03768427|156535279|FG003|Overall Study|Physician Decision|4|||
48638872|NCT03768427|156535276|FG000|Overall Study|Withdrawal by Subject|7|||
48638873|NCT03768427|156535277|FG001|Overall Study|Withdrawal by Subject|2|||
48638874|NCT03768427|156535278|FG002|Overall Study|Withdrawal by Subject|6|||
48638875|NCT03768427|156535279|FG003|Overall Study|Withdrawal by Subject|7|||
48638876|NCT00087698|156535283|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
48747864|NCT02615145|156924973|FG000|Overall Study|Other, Not Specified|5|||
48747865|NCT02615145|156924974|FG001|Overall Study|Other, Not Specified|2|||
48747866|NCT02615145|156924975|FG002|Overall Study|Other, Not Specified|0|||
48747867|NCT02615145|156924976|FG003|Overall Study|Other, Not Specified|0|||
48747868|NCT00382252|156924977|FG000|Overall Study|Death|4|||
48747869|NCT00382252|156924977|FG000|Overall Study|Protocol Violation|8|||
48328300|NCT01604824|155400133|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
48747870|NCT00382252|156924977|FG000|Overall Study|Not treated by RFA|1|||
48747871|NCT02854631|156924979|FG000|Overall Study|Adverse Event|1|||
48747872|NCT02854631|156924980|FG001|Overall Study|Adverse Event|2|||
48747873|NCT02854631|156924979|FG000|Overall Study|Withdrew Consent|3|||
48747874|NCT02854631|156924980|FG001|Overall Study|Withdrew Consent|2|||
48747875|NCT02854631|156924979|FG000|Overall Study|Investigator's Discretion|2|||
48747876|NCT02854631|156924980|FG001|Overall Study|Investigator's Discretion|0|||
48747877|NCT02854631|156924979|FG000|Overall Study|Death|12|||
48747878|NCT02854631|156924980|FG001|Overall Study|Death|8|||
48747879|NCT02854631|156924979|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
48747880|NCT02854631|156924980|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
48747881|NCT02854631|156924979|FG000|Overall Study|Protocol Violation|0|||
48747882|NCT02854631|156924980|FG001|Overall Study|Protocol Violation|1|||
48747883|NCT02854631|156924979|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
48747884|NCT02854631|156924980|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
48747885|NCT02854631|156924979|FG000|Overall Study|Lost to Follow-up|4|||
48747886|NCT02854631|156924980|FG001|Overall Study|Lost to Follow-up|2|||
48747887|NCT04051008|156924981|FG000|Overall Study|Withdrawal by Subject|2|||
48747888|NCT04051008|156924982|FG001|Overall Study|Withdrawal by Subject|0|||
48747889|NCT04051008|156924983|FG002|Overall Study|Withdrawal by Subject|1|||
48747890|NCT03930797|156924984|FG000|Overall Study|Lost to Follow-up|3|||
48747891|NCT03930797|156924985|FG001|Overall Study|Lost to Follow-up|10|||
48747892|NCT03334903|156924987|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
48747893|NCT03334903|156924988|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
48747894|NCT03334903|156924987|FG000|Overall Study|Protocol Violation|1|||
48747895|NCT03334903|156924988|FG001|Overall Study|Protocol Violation|3|||
48747896|NCT03334903|156924987|FG000|Overall Study|Surgery postponed|1|||
48328301|NCT01604824|155400134|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
48328302|NCT01604824|155400135|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
48328303|NCT01604824|155400136|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
48328304|NCT01604824|155400137|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
48328305|NCT01604824|155400138|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
48328306|NCT01316913|155400139|FG000|Overall Study|Adverse Event|17|||
48328307|NCT01316913|155400140|FG001|Overall Study|Adverse Event|20|||
48328308|NCT01316913|155400141|FG002|Overall Study|Adverse Event|15|||
48328309|NCT01316913|155400142|FG003|Overall Study|Adverse Event|11|||
48328310|NCT01316913|155400139|FG000|Overall Study|Lack of Efficacy|22|||
48638877|NCT00087698|156535283|FG000|Overall Study|Death from Other Causes|3|||
48638878|NCT00087698|156535283|FG000|Overall Study|Adverse Event|4|||
48638879|NCT00087698|156535283|FG000|Overall Study|Withdrawal by Subject|4|||
48638880|NCT00087698|156535283|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
48638881|NCT00087698|156535283|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
48747897|NCT03334903|156924988|FG001|Overall Study|Surgery postponed|0|||
48747898|NCT03334903|156924987|FG000|Overall Study|Adverse Event|1|||
48747899|NCT03334903|156924988|FG001|Overall Study|Adverse Event|1|||
48747900|NCT03334903|156924987|FG000|Overall Study|Withdrawal by Subject|0|||
48747901|NCT03334903|156924988|FG001|Overall Study|Withdrawal by Subject|1|||
48747902|NCT00317356|156924989|FG000|Overall Study|Adverse Event|0|||
48747903|NCT00317356|156924990|FG001|Overall Study|Adverse Event|0|||
48638882|NCT00087698|156535283|FG000|Overall Study|Clinical Relapse|1|||
48638883|NCT00087698|156535283|FG000|Overall Study|Death from Study Disease|2|||
48638884|NCT00087698|156535283|FG000|Overall Study|Death from Study Drug Toxicity|2|||
48747904|NCT00317356|156924991|FG002|Overall Study|Adverse Event|1|||
48747905|NCT00317356|156924992|FG003|Overall Study|Adverse Event|0|||
48747906|NCT00317356|156924989|FG000|Overall Study|Lack of Efficacy|1|||
48747907|NCT00317356|156924990|FG001|Overall Study|Lack of Efficacy|1|||
48747908|NCT00317356|156924991|FG002|Overall Study|Lack of Efficacy|0|||
48747909|NCT00317356|156924992|FG003|Overall Study|Lack of Efficacy|3|||
48747910|NCT00317356|156924989|FG000|Overall Study|Physician Decision|0|||
48747911|NCT00317356|156924990|FG001|Overall Study|Physician Decision|1|||
48747912|NCT00317356|156924991|FG002|Overall Study|Physician Decision|0|||
48747913|NCT00317356|156924992|FG003|Overall Study|Physician Decision|0|||
48747914|NCT04342897|156924993|FG000|Overall Study|Death|7|||
48747915|NCT04342897|156924994|FG001|Overall Study|Death|4|||
48747916|NCT04342897|156924993|FG000|Overall Study|Lost to Follow-up|6|||
48747917|NCT04342897|156924994|FG001|Overall Study|Lost to Follow-up|6|||
48747918|NCT04342897|156924993|FG000|Overall Study|Withdrawal by Subject|1|||
48328311|NCT01316913|155400140|FG001|Overall Study|Lack of Efficacy|12|||
48328312|NCT01316913|155400141|FG002|Overall Study|Lack of Efficacy|9|||
48328313|NCT01316913|155400142|FG003|Overall Study|Lack of Efficacy|13|||
48747919|NCT04342897|156924994|FG001|Overall Study|Withdrawal by Subject|2|||
48328314|NCT01316913|155400139|FG000|Overall Study|Protocol Violation|1|||
48747920|NCT01835587|156924999|FG000|Overall Study|Disease Recurrence or Relapse|0|||
48638885|NCT00087698|156535283|FG000|Overall Study|Protocol Violation|1|||
48638886|NCT00326599|156535284|FG000|Overall Study|Withdrawal by Subject|1|||
48638887|NCT00326599|156535285|FG001|Overall Study|Withdrawal by Subject|0|||
48638888|NCT00326599|156535286|FG002|Overall Study|Withdrawal by Subject|5|||
48638889|NCT00326599|156535287|FG003|Overall Study|Withdrawal by Subject|2|||
48638890|NCT00326599|156535284|FG000|Overall Study|Adverse Event|1|||
48328315|NCT01316913|155400140|FG001|Overall Study|Protocol Violation|4|||
48328316|NCT01316913|155400141|FG002|Overall Study|Protocol Violation|4|||
48328317|NCT01316913|155400142|FG003|Overall Study|Protocol Violation|1|||
48638891|NCT00326599|156535285|FG001|Overall Study|Adverse Event|0|||
48638892|NCT00326599|156535286|FG002|Overall Study|Adverse Event|32|||
48328318|NCT01316913|155400139|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
48328319|NCT01316913|155400140|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
48328320|NCT01316913|155400141|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
48328321|NCT01316913|155400142|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
48328322|NCT01316913|155400139|FG000|Overall Study|Lost to Follow-up|0|||
48328323|NCT01316913|155400140|FG001|Overall Study|Lost to Follow-up|1|||
48328324|NCT01316913|155400141|FG002|Overall Study|Lost to Follow-up|0|||
48328325|NCT01316913|155400142|FG003|Overall Study|Lost to Follow-up|2|||
48328326|NCT01316913|155400139|FG000|Overall Study|Withdrawal by Subject|10|||
48328327|NCT01316913|155400140|FG001|Overall Study|Withdrawal by Subject|9|||
48328328|NCT01316913|155400141|FG002|Overall Study|Withdrawal by Subject|10|||
48328329|NCT01316913|155400142|FG003|Overall Study|Withdrawal by Subject|6|||
48328330|NCT03697603|155400143|FG000|Overall Study|Adverse Event|3|||
48328331|NCT03697603|155400144|FG001|Overall Study|Adverse Event|18|||
48638893|NCT00326599|156535287|FG003|Overall Study|Adverse Event|3|||
48638894|NCT00326599|156535284|FG000|Overall Study|Disease Progression|3|||
48638895|NCT00326599|156535285|FG001|Overall Study|Disease Progression|1|||
48638896|NCT00326599|156535286|FG002|Overall Study|Disease Progression|13|||
48328332|NCT03697603|155400145|FG002|Overall Study|Adverse Event|3|||
48638897|NCT00326599|156535287|FG003|Overall Study|Disease Progression|11|||
48328333|NCT03697603|155400143|FG000|Overall Study|Physician Decision|1|||
48328334|NCT03697603|155400144|FG001|Overall Study|Physician Decision|0|||
48638898|NCT00326599|156535284|FG000|Overall Study|Alternate Treatment|1|||
48638899|NCT00326599|156535285|FG001|Overall Study|Alternate Treatment|0|||
48638900|NCT00326599|156535286|FG002|Overall Study|Alternate Treatment|0|||
48638901|NCT00326599|156535287|FG003|Overall Study|Alternate Treatment|0|||
48638902|NCT00326599|156535284|FG000|Overall Study|Death|0|||
48638903|NCT00326599|156535285|FG001|Overall Study|Death|0|||
48638904|NCT00326599|156535286|FG002|Overall Study|Death|1|||
48638905|NCT00326599|156535287|FG003|Overall Study|Death|2|||
48328335|NCT03697603|155400145|FG002|Overall Study|Physician Decision|2|||
48328336|NCT03697603|155400143|FG000|Overall Study|Protocol Violation|3|||
48328337|NCT03697603|155400144|FG001|Overall Study|Protocol Violation|8|||
48328338|NCT03697603|155400145|FG002|Overall Study|Protocol Violation|5|||
48328339|NCT03697603|155400143|FG000|Overall Study|Withdrawal by Subject|5|||
48638906|NCT00326599|156535284|FG000|Overall Study|Other Unspecified Reason|0|||
48638907|NCT00326599|156535285|FG001|Overall Study|Other Unspecified Reason|0|||
48638908|NCT00326599|156535286|FG002|Overall Study|Other Unspecified Reason|2|||
48638909|NCT00326599|156535287|FG003|Overall Study|Other Unspecified Reason|1|||
48638910|NCT01508910|156535288|FG000|Treatment|Death|2|||
48638911|NCT01508910|156535289|FG001|Treatment|Death|3|||
48638912|NCT01508910|156535290|FG002|Treatment|Death|2|||
48638913|NCT01508910|156535291|FG003|Treatment|Death|0|||
48638914|NCT01508910|156535288|FG000|Treatment|Lost to Follow-up|0|||
48638915|NCT01508910|156535289|FG001|Treatment|Lost to Follow-up|0|||
48638916|NCT01508910|156535290|FG002|Treatment|Lost to Follow-up|2|||
48328340|NCT03697603|155400144|FG001|Overall Study|Withdrawal by Subject|1|||
48328341|NCT03697603|155400145|FG002|Overall Study|Withdrawal by Subject|1|||
48638917|NCT01508910|156535291|FG003|Treatment|Lost to Follow-up|1|||
48638918|NCT01508910|156535288|FG000|Treatment|Withdrawal by Subject|0|||
48638919|NCT01508910|156535289|FG001|Treatment|Withdrawal by Subject|1|||
48638920|NCT01508910|156535290|FG002|Treatment|Withdrawal by Subject|6|||
48638921|NCT01508910|156535291|FG003|Treatment|Withdrawal by Subject|1|||
48638922|NCT01508910|156535288|FG000|Treatment|Sponsor Decision|0|||
48638923|NCT01508910|156535289|FG001|Treatment|Sponsor Decision|0|||
48638924|NCT01508910|156535290|FG002|Treatment|Sponsor Decision|0|||
48638925|NCT01508910|156535291|FG003|Treatment|Sponsor Decision|1|||
48638926|NCT00902330|156535294|FG000|Overall Study|Too overwhelmed by treatment|2|||
48638927|NCT00902330|156535295|FG001|Overall Study|Too overwhelmed by treatment|5|||
48638928|NCT00902330|156535294|FG000|Overall Study|Adverse Event|1|||
48638929|NCT00902330|156535295|FG001|Overall Study|Adverse Event|0|||
48638930|NCT00902330|156535294|FG000|Overall Study|No post baseline data|1|||
48638931|NCT00902330|156535295|FG001|Overall Study|No post baseline data|0|||
48638932|NCT01261975|156535296|FG000|Overall Study|Surgical complication|1|||
48638933|NCT01932788|156535298|FG000|Overall Study|Protocol Violation|18|||
48638934|NCT01932788|156535299|FG001|Overall Study|Protocol Violation|0|||
48638935|NCT01932788|156535298|FG000|Overall Study|Lost to Follow-up|18|||
48328342|NCT03697603|155400143|FG000|Overall Study|Protocol Violation|0|||
48638936|NCT01932788|156535299|FG001|Overall Study|Lost to Follow-up|46|||
48638937|NCT01932788|156535298|FG000|Overall Study|Lack of Efficacy|2|||
48638938|NCT01932788|156535299|FG001|Overall Study|Lack of Efficacy|0|||
48638939|NCT01932788|156535298|FG000|Overall Study|Withdrawal by Subject|0|||
48328343|NCT03697603|155400144|FG001|Overall Study|Protocol Violation|0|||
48638940|NCT01932788|156535299|FG001|Overall Study|Withdrawal by Subject|5|||
48638941|NCT02505425|156535300|FG000|Overall Study|Lost to Follow-up|41|||
48328344|NCT03697603|155400145|FG002|Overall Study|Protocol Violation|1|||
48328345|NCT03775213|155400148|FG000|Overall Study|Withdrawal by Subject|51|||
48638942|NCT02505425|156535301|FG001|Overall Study|Lost to Follow-up|61|||
48638943|NCT02505425|156535302|FG002|Overall Study|Lost to Follow-up|31|||
48638944|NCT02505425|156535303|FG003|Overall Study|Lost to Follow-up|19|||
48638945|NCT02505425|156535300|FG000|Overall Study|Withdrawal by Subject|39|||
48638946|NCT02505425|156535301|FG001|Overall Study|Withdrawal by Subject|9|||
48638947|NCT02505425|156535302|FG002|Overall Study|Withdrawal by Subject|19|||
48638948|NCT02505425|156535303|FG003|Overall Study|Withdrawal by Subject|7|||
48638949|NCT02505425|156535300|FG000|Overall Study|Death|8|||
48638950|NCT02505425|156535301|FG001|Overall Study|Death|12|||
48638951|NCT02505425|156535302|FG002|Overall Study|Death|0|||
48638952|NCT02505425|156535303|FG003|Overall Study|Death|0|||
48638953|NCT04819113|156535304|FG000|Overall Study|Withdrawal by parent/guardian|3|||
48638954|NCT04819113|156535304|FG000|Overall Study|Lost to Follow-up|1|||
48638955|NCT04819113|156535304|FG000|Overall Study|Withdrawn before vaccination|2|||
48638956|NCT00786422|156535307|FG000|Rivaroxaban Treatment|Death|2|||
48638957|NCT00786422|156535307|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
48638958|NCT00786422|156535307|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
48638959|NCT00786422|156535307|FG000|Rivaroxaban Treatment|Physician Decision|1|||
48638960|NCT00786422|156535307|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
48638961|NCT00786422|156535307|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
48638962|NCT00786422|156535307|FG000|Rivaroxaban Treatment|Adverse Event|2|||
48638963|NCT00786422|156535307|FG000|Follow-up Period|Death|1|||
48638964|NCT00786422|156535307|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
48638965|NCT02708680|156535310|FG000|Overall Study|Withdrawal by Subject|4|||
48638966|NCT02708680|156535311|FG001|Overall Study|Withdrawal by Subject|12|||
48638967|NCT02708680|156535312|FG002|Overall Study|Withdrawal by Subject|12|||
48638968|NCT02708680|156535310|FG000|Overall Study|Death|4|||
48638969|NCT02708680|156535311|FG001|Overall Study|Death|19|||
48638970|NCT02708680|156535312|FG002|Overall Study|Death|21|||
48638971|NCT02708680|156535310|FG000|Overall Study|Lost to Follow-up|0|||
48638972|NCT02708680|156535311|FG001|Overall Study|Lost to Follow-up|3|||
48638973|NCT02708680|156535312|FG002|Overall Study|Lost to Follow-up|3|||
48638974|NCT02708680|156535310|FG000|Overall Study|Study Terminated By Sponsor|0|||
48638975|NCT02708680|156535311|FG001|Overall Study|Study Terminated By Sponsor|5|||
48638976|NCT02708680|156535312|FG002|Overall Study|Study Terminated By Sponsor|4|||
48638977|NCT02708680|156535310|FG000|Overall Study|Other than Specified|0|||
48638978|NCT02708680|156535311|FG001|Overall Study|Other than Specified|0|||
48638979|NCT02708680|156535312|FG002|Overall Study|Other than Specified|1|||
48638980|NCT02708680|156535310|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
48638981|NCT02708680|156535311|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
48638982|NCT02708680|156535312|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
48638983|NCT05588440|156535313|FG000|Overall Study|Sponsor Decision|2|||
48638984|NCT05588440|156535314|FG001|Overall Study|Sponsor Decision|0|||
48638985|NCT05588440|156535315|FG002|Overall Study|Sponsor Decision|1|||
48638986|NCT05588440|156535313|FG000|Overall Study|Death|1|||
48638987|NCT05588440|156535314|FG001|Overall Study|Death|1|||
48638988|NCT05588440|156535315|FG002|Overall Study|Death|1|||
48638989|NCT05588440|156535313|FG000|Overall Study|Screen Fail|0|||
48638990|NCT05588440|156535314|FG001|Overall Study|Screen Fail|1|||
48638991|NCT05588440|156535315|FG002|Overall Study|Screen Fail|1|||
48747921|NCT01835587|156925000|FG001|Overall Study|Disease Recurrence or Relapse|3|||
48638992|NCT05588440|156535313|FG000|Overall Study|Withdrawal by Subject|0|||
48638993|NCT05588440|156535314|FG001|Overall Study|Withdrawal by Subject|0|||
48638994|NCT05588440|156535315|FG002|Overall Study|Withdrawal by Subject|1|||
48638995|NCT04619004|156535316|FG000|Overall Study|Death|114|||
48638996|NCT04619004|156535317|FG001|Overall Study|Death|28|||
48638997|NCT04619004|156535316|FG000|Overall Study|Lost to Follow-up|1|||
48638998|NCT04619004|156535317|FG001|Overall Study|Lost to Follow-up|1|||
48638999|NCT04619004|156535316|FG000|Overall Study|Withdrawal by Subject|24|||
48639000|NCT04619004|156535317|FG001|Overall Study|Withdrawal by Subject|7|||
48639001|NCT04619004|156535316|FG000|Overall Study|Other - Not specified|0|||
48639002|NCT04619004|156535317|FG001|Overall Study|Other - Not specified|1|||
48639003|NCT03381287|156535318|FG000|Overall Study|Withdrawal by Subject|0|||
48639004|NCT03381287|156535319|FG001|Overall Study|Withdrawal by Subject|1|||
48639005|NCT03381287|156535320|FG002|Overall Study|Withdrawal by Subject|0|||
48639006|NCT03381287|156535321|FG003|Overall Study|Withdrawal by Subject|0|||
48747922|NCT01835587|156925001|FG002|Overall Study|Disease Recurrence or Relapse|0|||
48747923|NCT01835587|156925002|FG003|Overall Study|Disease Recurrence or Relapse|3|||
48639007|NCT03381287|156535318|FG000|Overall Study|Adverse Event|0|||
48639008|NCT03381287|156535319|FG001|Overall Study|Adverse Event|0|||
48639009|NCT03381287|156535320|FG002|Overall Study|Adverse Event|0|||
48639010|NCT03381287|156535321|FG003|Overall Study|Adverse Event|1|||
48639011|NCT03381287|156535318|FG000|Overall Study|Physician Decision|0|||
48639012|NCT03381287|156535319|FG001|Overall Study|Physician Decision|0|||
48639013|NCT03381287|156535320|FG002|Overall Study|Physician Decision|0|||
48639014|NCT03381287|156535321|FG003|Overall Study|Physician Decision|1|||
48639015|NCT03384875|156535325|FG000|Overall Study|Death|1|||
48639016|NCT03384875|156535326|FG001|Overall Study|Death|1|||
48639017|NCT03384875|156535327|FG002|Overall Study|Death|0|||
48639018|NCT03384875|156535325|FG000|Overall Study|Reason not provided|1|||
48639019|NCT03384875|156535326|FG001|Overall Study|Reason not provided|0|||
48639020|NCT03384875|156535327|FG002|Overall Study|Reason not provided|0|||
48747924|NCT01835587|156924999|FG000|Overall Study|Withdrawal by Subject|2|||
48747925|NCT01835587|156925000|FG001|Overall Study|Withdrawal by Subject|0|||
48747926|NCT01835587|156925001|FG002|Overall Study|Withdrawal by Subject|0|||
48747927|NCT01835587|156925002|FG003|Overall Study|Withdrawal by Subject|3|||
48747928|NCT01835587|156924999|FG000|Overall Study|Adverse Event|0|||
48747929|NCT01835587|156925000|FG001|Overall Study|Adverse Event|0|||
48747930|NCT01835587|156925001|FG002|Overall Study|Adverse Event|2|||
48747931|NCT01835587|156925002|FG003|Overall Study|Adverse Event|2|||
48747932|NCT01835587|156924999|FG000|Overall Study|Death|0|||
48747933|NCT01835587|156925000|FG001|Overall Study|Death|0|||
48747934|NCT01835587|156925001|FG002|Overall Study|Death|0|||
48747935|NCT01835587|156925002|FG003|Overall Study|Death|1|||
48747936|NCT01835587|156924999|FG000|Overall Study|Miscellaneous|0|||
48747937|NCT01835587|156925000|FG001|Overall Study|Miscellaneous|1|||
48747938|NCT01835587|156925001|FG002|Overall Study|Miscellaneous|0|||
48747939|NCT01835587|156925002|FG003|Overall Study|Miscellaneous|0|||
48747940|NCT00357968|156925003|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
48747941|NCT00357968|156925004|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
48747942|NCT00357968|156925003|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
48747943|NCT00357968|156925004|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
48747944|NCT03919799|156925005|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
48747945|NCT03919799|156925006|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
48747946|NCT03919799|156925007|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
48747947|NCT03919799|156925008|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
48747948|NCT03919799|156925009|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
48747949|NCT03919799|156925005|FG000|DB Period (28 Weeks)|Adverse Event|1|||
48747950|NCT03919799|156925006|FG001|DB Period (28 Weeks)|Adverse Event|1|||
48747951|NCT03919799|156925007|FG002|DB Period (28 Weeks)|Adverse Event|1|||
48747952|NCT03919799|156925008|FG003|DB Period (28 Weeks)|Adverse Event|0|||
48747953|NCT03919799|156925009|FG004|DB Period (28 Weeks)|Adverse Event|0|||
48747954|NCT03919799|156925005|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
48639021|NCT03376516|156536520|FG000|Overall Study|Not treated|1|||
48639022|NCT03376516|156536520|FG000|Overall Study|Consent withdrawn|1|||
48639023|NCT02465931|156536521|FG000|Overall Study|Lost to Follow-up|9|||
48639024|NCT02465931|156536522|FG001|Overall Study|Lost to Follow-up|11|||
48639025|NCT02465931|156536521|FG000|Overall Study|Protocol Violation|1|||
48639026|NCT02465931|156536522|FG001|Overall Study|Protocol Violation|0|||
48639027|NCT02465931|156536521|FG000|Overall Study|Withdrawal by Subject|1|||
48639028|NCT02465931|156536522|FG001|Overall Study|Withdrawal by Subject|0|||
48639029|NCT03423602|156536523|FG000|Overall Study|Death|1|||
48639030|NCT03423602|156536523|FG000|Overall Study|Lost to Follow-up|6|||
48639031|NCT03423602|156536523|FG000|Overall Study|Protocol Violation|1|||
48639032|NCT03423602|156536523|FG000|Overall Study|Withdrawal by Subject|4|||
48639033|NCT04749745|156536524|FG000|Overall Study|Withdrawal by Subject|1|||
48639034|NCT04749745|156536525|FG001|Overall Study|Withdrawal by Subject|0|||
48639035|NCT01500317|156536532|FG000|Overall Study|Withdrawal by Subject|3|||
48639036|NCT01500317|156536533|FG001|Overall Study|Withdrawal by Subject|2|||
48639037|NCT01500317|156536534|FG002|Overall Study|Withdrawal by Subject|0|||
48639038|NCT01865487|156536535|FG000|Overall Study|Lost to Follow-up|0|||
48639039|NCT01865487|156536536|FG001|Overall Study|Lost to Follow-up|0|||
48639040|NCT01865487|156536537|FG002|Overall Study|Lost to Follow-up|0|||
48639041|NCT01865487|156536538|FG003|Overall Study|Lost to Follow-up|1|||
48639042|NCT01865487|156536539|FG004|Overall Study|Lost to Follow-up|0|||
48639043|NCT01865487|156536540|FG005|Overall Study|Lost to Follow-up|0|||
48639044|NCT01865487|156536541|FG006|Overall Study|Lost to Follow-up|1|||
48639045|NCT01865487|156536542|FG007|Overall Study|Lost to Follow-up|0|||
48639046|NCT01865487|156536543|FG008|Overall Study|Lost to Follow-up|0|||
48639047|NCT01865487|156536544|FG009|Overall Study|Lost to Follow-up|0|||
48639048|NCT01865487|156536535|FG000|Overall Study|Withdrawal by Subject|0|||
48747955|NCT03919799|156925006|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
48747956|NCT03919799|156925007|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
48747957|NCT03919799|156925008|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
48747958|NCT03919799|156925009|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
48747959|NCT03919799|156925005|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
48747960|NCT03919799|156925006|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
48639049|NCT01865487|156536536|FG001|Overall Study|Withdrawal by Subject|0|||
48639050|NCT01865487|156536537|FG002|Overall Study|Withdrawal by Subject|0|||
48639051|NCT01865487|156536538|FG003|Overall Study|Withdrawal by Subject|0|||
48639052|NCT01865487|156536539|FG004|Overall Study|Withdrawal by Subject|1|||
48328346|NCT03775213|155400149|FG001|Overall Study|Withdrawal by Subject|53|||
48639053|NCT01865487|156536540|FG005|Overall Study|Withdrawal by Subject|0|||
48639054|NCT01865487|156536541|FG006|Overall Study|Withdrawal by Subject|0|||
48639055|NCT01865487|156536542|FG007|Overall Study|Withdrawal by Subject|0|||
48639056|NCT01865487|156536543|FG008|Overall Study|Withdrawal by Subject|0|||
48639057|NCT01865487|156536544|FG009|Overall Study|Withdrawal by Subject|0|||
48639058|NCT02639390|156536545|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
48639059|NCT02639390|156536546|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
48639060|NCT02013609|156536550|FG000|Overall Study|Withdrawal by Subject|9|||
48639061|NCT02013609|156536550|FG000|Overall Study|Lost to Follow-up|3|||
48639062|NCT02013609|156536550|FG000|Overall Study|Adverse Event|3|||
48639063|NCT02013609|156536550|FG000|Overall Study|Met Withdrawal Criteria|3|||
48639064|NCT01119287|156536551|FG000|Overall Study|Patient Decision, not related to AE|0|||
48639065|NCT01119287|156536552|FG001|Overall Study|Patient Decision, not related to AE|0|||
48639066|NCT01119287|156536553|FG002|Overall Study|Patient Decision, not related to AE|2|||
48639067|NCT01119287|156536554|FG003|Overall Study|Patient Decision, not related to AE|2|||
48639068|NCT01119287|156536555|FG004|Overall Study|Patient Decision, not related to AE|1|||
48639069|NCT01119287|156536556|FG005|Overall Study|Patient Decision, not related to AE|0|||
48639070|NCT03273907|156536566|FG000|Overall Study|Death|1|||
48639071|NCT03273907|156536566|FG000|Overall Study|Lost to Follow-up|4|||
48639072|NCT03273907|156536566|FG000|Overall Study|Withdrawal by Subject|2|||
48639073|NCT03273907|156536566|FG000|Overall Study|COVID 19|2|||
48639074|NCT00775268|156536569|FG000|Baseline|Drug not synthesize dose|1|||
48639075|NCT00775268|156536570|FG001|Baseline|Drug not synthesize dose|0|||
48639076|NCT00775268|156536569|FG000|Baseline|Not treated-ineligible per CT|0|||
48639077|NCT00775268|156536570|FG001|Baseline|Not treated-ineligible per CT|1|||
48639078|NCT00775268|156536569|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
48639079|NCT00775268|156536570|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
48639080|NCT00775268|156536569|FG000|After Completion|Participant missed scan appointment|1|||
48639081|NCT00775268|156536570|FG001|After Completion|Participant missed scan appointment|0|||
48639082|NCT01531998|156536571|FG000|Overall Study|Withdrawal by Subject|3|||
48639083|NCT00186628|156536576|FG000|Overall Study|Death|2|||
48639084|NCT00186628|156536576|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
48639085|NCT02581891|156536577|FG000|Overall Study|Adverse Event|4|||
48639086|NCT02581891|156536578|FG001|Overall Study|Adverse Event|6|||
48639087|NCT02581891|156536577|FG000|Overall Study|Death|3|||
48639088|NCT02581891|156536578|FG001|Overall Study|Death|4|||
48639089|NCT02581891|156536577|FG000|Overall Study|Lost to Follow-up|1|||
48639090|NCT02581891|156536578|FG001|Overall Study|Lost to Follow-up|2|||
48639091|NCT02581891|156536577|FG000|Overall Study|Physician Decision|0|||
48639092|NCT02581891|156536578|FG001|Overall Study|Physician Decision|1|||
48639093|NCT02581891|156536577|FG000|Overall Study|Withdrawal by Subject|4|||
48639094|NCT02581891|156536578|FG001|Overall Study|Withdrawal by Subject|5|||
48639095|NCT02581891|156536577|FG000|Overall Study|Other Reasons|3|||
48639096|NCT02581891|156536578|FG001|Overall Study|Other Reasons|1|||
48639097|NCT02581891|156536577|FG000|Overall Study|Discontinued during followup|1|||
48639098|NCT02581891|156536578|FG001|Overall Study|Discontinued during followup|0|||
48639099|NCT02927795|156536579|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
48639100|NCT02927795|156536579|FG000|Overall Study|Not Treated|4|||
48639101|NCT03745768|156536585|FG000|Overall Study|discontinued study|2|||
48639102|NCT03745768|156536586|FG001|Overall Study|discontinued study|0|||
48639103|NCT00107276|156536588|FG000|Overall Study|Progression|46|||
48639104|NCT00107276|156536588|FG000|Overall Study|Adverse Event|6|||
48639105|NCT00107276|156536588|FG000|Overall Study|M.D. decision|2|||
48639106|NCT00107276|156536588|FG000|Overall Study|Patient refusal|1|||
48639107|NCT00107276|156536588|FG000|Overall Study|Death|1|||
48639108|NCT00107276|156536588|FG000|Overall Study|Ineligible|16|||
48639109|NCT03179761|156536589|FG000|Overall Study|Death|2|||
48639110|NCT03179761|156536590|FG001|Overall Study|Death|5|||
48639111|NCT03179761|156536589|FG000|Overall Study|Lost to Follow-up|2|||
48639112|NCT03179761|156536590|FG001|Overall Study|Lost to Follow-up|2|||
48639113|NCT03179761|156536589|FG000|Overall Study|Protocol Violation|1|||
48639114|NCT03179761|156536590|FG001|Overall Study|Protocol Violation|0|||
48639115|NCT03179761|156536589|FG000|Overall Study|Withdrawal by Subject|1|||
48639116|NCT03179761|156536590|FG001|Overall Study|Withdrawal by Subject|4|||
48639117|NCT03179761|156536589|FG000|Overall Study|Investigator Request|0|||
48639118|NCT03179761|156536590|FG001|Overall Study|Investigator Request|2|||
48639119|NCT03962855|156536591|FG000|Overall Study|Death|0|||
48639120|NCT03962855|156536592|FG001|Overall Study|Death|1|||
48639121|NCT03962855|156536591|FG000|Overall Study|Lost to Follow-up|0|||
48639122|NCT03962855|156536592|FG001|Overall Study|Lost to Follow-up|1|||
48639123|NCT03962855|156536591|FG000|Overall Study|Adverse Event|0|||
48639124|NCT03962855|156536592|FG001|Overall Study|Adverse Event|1|||
48639125|NCT03962855|156536591|FG000|Overall Study|Physician Decision|0|||
48639126|NCT03962855|156536592|FG001|Overall Study|Physician Decision|2|||
48639127|NCT00382174|156536593|FG000|Overall Study|Lost to Follow-up|1|||
48639128|NCT00382174|156536594|FG001|Overall Study|Lost to Follow-up|4|||
48639129|NCT00382174|156536595|FG002|Overall Study|Lost to Follow-up|5|||
48639130|NCT00382174|156536593|FG000|Overall Study|Adverse Event|1|||
48639131|NCT00382174|156536594|FG001|Overall Study|Adverse Event|4|||
48639132|NCT00382174|156536595|FG002|Overall Study|Adverse Event|5|||
48639133|NCT00382174|156536593|FG000|Overall Study|Withdrawal by Subject|1|||
48639134|NCT00382174|156536594|FG001|Overall Study|Withdrawal by Subject|4|||
48639135|NCT00382174|156536595|FG002|Overall Study|Withdrawal by Subject|5|||
48639136|NCT00382174|156536593|FG000|Overall Study|Non compliance|1|||
48639137|NCT00382174|156536594|FG001|Overall Study|Non compliance|0|||
48639138|NCT00382174|156536595|FG002|Overall Study|Non compliance|1|||
48639139|NCT00382174|156536593|FG000|Overall Study|Physician Decision|0|||
48639140|NCT00382174|156536594|FG001|Overall Study|Physician Decision|2|||
48639141|NCT00382174|156536595|FG002|Overall Study|Physician Decision|2|||
48639142|NCT00382174|156536593|FG000|Overall Study|Failed to meet criteria|0|||
48639143|NCT00382174|156536594|FG001|Overall Study|Failed to meet criteria|1|||
48639144|NCT00382174|156536595|FG002|Overall Study|Failed to meet criteria|1|||
48639145|NCT00382174|156536593|FG000|Overall Study|Wounds merged|0|||
48639146|NCT00382174|156536594|FG001|Overall Study|Wounds merged|2|||
48639147|NCT00382174|156536595|FG002|Overall Study|Wounds merged|2|||
48639148|NCT00501644|156536596|FG000|Overall Study|Adverse Event|4|||
48639149|NCT00501644|156536596|FG000|Overall Study|Withdrawal by Subject|1|||
48639150|NCT02379052|156536597|FG000|Overall Study|Protocol Violation|0|||
48639151|NCT02379052|156536598|FG001|Overall Study|Protocol Violation|1|||
48639152|NCT02379052|156536597|FG000|Overall Study|Adverse Event|0|||
48639153|NCT02379052|156536598|FG001|Overall Study|Adverse Event|1|||
48639154|NCT02379052|156536597|FG000|Overall Study|Physician Decision|1|||
48639155|NCT02379052|156536598|FG001|Overall Study|Physician Decision|1|||
48639156|NCT02379052|156536597|FG000|Overall Study|Withdrawal by Subject|2|||
48639157|NCT02379052|156536598|FG001|Overall Study|Withdrawal by Subject|0|||
48639158|NCT02379052|156536597|FG000|Overall Study|Lost to Follow-up|2|||
48639159|NCT02379052|156536598|FG001|Overall Study|Lost to Follow-up|1|||
48639160|NCT02379052|156536597|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
48639161|NCT02379052|156536598|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
48639162|NCT02379052|156536597|FG000|Overall Study|Subject was Incarcerated|0|||
48639163|NCT02379052|156536598|FG001|Overall Study|Subject was Incarcerated|1|||
48639164|NCT02230189|156536599|FG000|Overall Study|Withdrawal by Subject|3|||
48639165|NCT02230189|156536600|FG001|Overall Study|Withdrawal by Subject|0|||
48639166|NCT02230189|156536601|FG002|Overall Study|Withdrawal by Subject|1|||
48639167|NCT02230189|156536599|FG000|Overall Study|Lost to Follow-up|1|||
48639168|NCT02230189|156536600|FG001|Overall Study|Lost to Follow-up|0|||
48639169|NCT02230189|156536601|FG002|Overall Study|Lost to Follow-up|0|||
48639170|NCT02230189|156536599|FG000|Overall Study|Physician Decision|1|||
48639171|NCT02230189|156536600|FG001|Overall Study|Physician Decision|0|||
48639172|NCT02230189|156536601|FG002|Overall Study|Physician Decision|0|||
48639173|NCT02343302|156536603|FG000|Overall Study|Physician Decision|1|||
48639174|NCT02343302|156536604|FG001|Overall Study|Physician Decision|1|||
48639175|NCT00776230|156536605|FG000|Overall Study|Lost to Follow-up|2|||
48639176|NCT00776230|156536606|FG001|Overall Study|Lost to Follow-up|1|||
48639177|NCT00776230|156536607|FG002|Overall Study|Lost to Follow-up|5|||
48639178|NCT00776230|156536605|FG000|Overall Study|Not vaccinated at Day 0|1|||
48639179|NCT00776230|156536606|FG001|Overall Study|Not vaccinated at Day 0|0|||
48639180|NCT00776230|156536607|FG002|Overall Study|Not vaccinated at Day 0|0|||
48639181|NCT00776230|156536605|FG000|Overall Study|Withdrawal by Subject|0|||
48639182|NCT00776230|156536606|FG001|Overall Study|Withdrawal by Subject|1|||
48639183|NCT00776230|156536607|FG002|Overall Study|Withdrawal by Subject|0|||
48639184|NCT00776230|156536605|FG000|Overall Study|Subject missed Visit 4|0|||
48639185|NCT00776230|156536606|FG001|Overall Study|Subject missed Visit 4|1|||
48639186|NCT00776230|156536607|FG002|Overall Study|Subject missed Visit 4|0|||
48639187|NCT01887717|156536608|FG000|Overall Study|Withdrawal by Subject|1|||
48639188|NCT01887717|156536609|FG001|Overall Study|Withdrawal by Subject|7|||
48639189|NCT01887717|156536608|FG000|Overall Study|Physician Decision|0|||
48639190|NCT01887717|156536609|FG001|Overall Study|Physician Decision|2|||
48639191|NCT01887717|156536608|FG000|Overall Study|Administrative reasons|5|||
48639192|NCT01887717|156536609|FG001|Overall Study|Administrative reasons|2|||
48639193|NCT00508482|156536610|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
48639194|NCT00508482|156536611|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
48639195|NCT00508482|156536612|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
48639196|NCT00508482|156536610|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
48639197|NCT00508482|156536611|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
48639198|NCT00508482|156536612|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
48639199|NCT00508482|156536610|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
48639200|NCT00508482|156536611|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
48639201|NCT00508482|156536612|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
48639202|NCT02536664|156536616|FG000|Overall Study|Inadequate completion of documentation|2|||
48328347|NCT03775213|155400148|FG000|Overall Study|Incomplete Survey|7|||
48639203|NCT02536664|156536617|FG001|Overall Study|Inadequate completion of documentation|4|||
48639204|NCT02536664|156536616|FG000|Overall Study|Progression|13|||
48639205|NCT02536664|156536617|FG001|Overall Study|Progression|18|||
48639206|NCT02536664|156536616|FG000|Overall Study|Death due to lymphoma|2|||
48639207|NCT02536664|156536617|FG001|Overall Study|Death due to lymphoma|1|||
48639208|NCT02536664|156536616|FG000|Overall Study|Death due to other reason|3|||
48639209|NCT02536664|156536617|FG001|Overall Study|Death due to other reason|2|||
48639210|NCT02536664|156536616|FG000|Overall Study|Intolerability|8|||
48639211|NCT02536664|156536617|FG001|Overall Study|Intolerability|6|||
48639212|NCT02536664|156536616|FG000|Overall Study|Withdrawal by Subject|8|||
48639213|NCT02536664|156536617|FG001|Overall Study|Withdrawal by Subject|5|||
48639214|NCT02536664|156536616|FG000|Overall Study|Other|18|||
48639215|NCT02536664|156536617|FG001|Overall Study|Other|24|||
48639216|NCT02536664|156536616|FG000|Overall Study|Missing|53|||
48639217|NCT02536664|156536617|FG001|Overall Study|Missing|20|||
48639218|NCT02655887|156536618|FG000|Overall Study|Lost to Follow-up|3|||
48639219|NCT02655887|156536618|FG000|Overall Study|Death|4|||
48639220|NCT02655887|156536618|FG000|Overall Study|Withdrawal by Subject|3|||
48639221|NCT02655887|156536618|FG000|Overall Study|Missed 12-month follow-up visit|4|||
48639222|NCT00244621|156536619|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48639223|NCT00244621|156536620|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
48639224|NCT00244621|156536621|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
48639225|NCT00244621|156536619|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
48639226|NCT00244621|156536620|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48639227|NCT00244621|156536621|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48639228|NCT00244621|156536619|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
48639229|NCT00244621|156536620|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
48639230|NCT00244621|156536621|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
48639231|NCT00244621|156536619|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
48639232|NCT00244621|156536620|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
48639233|NCT00244621|156536621|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
48639234|NCT00244621|156536619|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
48639235|NCT00244621|156536620|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
48639236|NCT00244621|156536621|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
48639237|NCT00244621|156536619|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
48639238|NCT00244621|156536620|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48639239|NCT00244621|156536621|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
48639240|NCT00244621|156536619|FG000|Open-label Treatment Period|Adverse Event|0|||
48639241|NCT00244621|156536620|FG001|Open-label Treatment Period|Adverse Event|0|||
48639242|NCT00244621|156536621|FG002|Open-label Treatment Period|Adverse Event|1|||
48639243|NCT00244621|156536619|FG000|Open-label Treatment Period|Moved abroad|0|||
48639244|NCT00244621|156536620|FG001|Open-label Treatment Period|Moved abroad|0|||
48639245|NCT00244621|156536621|FG002|Open-label Treatment Period|Moved abroad|1|||
48639246|NCT01847755|156536625|FG000|Overall Study|Adverse Event|2|||
48639247|NCT01847755|156536625|FG000|Overall Study|Withdrawal by Subject|2|||
48639248|NCT01847755|156536625|FG000|Overall Study|Physician Decision|1|||
48639249|NCT00920556|156536626|FG000|Overall Study|Adverse Event|16|||
48639250|NCT00920556|156536626|FG000|Overall Study|Physician Decision|7|||
48639251|NCT00920556|156536626|FG000|Overall Study|Withdrawal by Subject|1|||
48639252|NCT01299389|156536627|FG000|Double-blind|Adverse Event|45|||
48639253|NCT01299389|156536628|FG001|Double-blind|Adverse Event|27|||
48639254|NCT01299389|156536629|FG002|Double-blind|Adverse Event|0|||
48639255|NCT01299389|156536630|FG003|Double-blind|Adverse Event|0|||
48639256|NCT01299389|156536627|FG000|Double-blind|Lack of Efficacy|45|||
48639257|NCT01299389|156536628|FG001|Double-blind|Lack of Efficacy|21|||
48639258|NCT01299389|156536629|FG002|Double-blind|Lack of Efficacy|0|||
48639259|NCT01299389|156536630|FG003|Double-blind|Lack of Efficacy|0|||
48639260|NCT01299389|156536627|FG000|Double-blind|Lost to Follow-up|2|||
48639261|NCT01299389|156536628|FG001|Double-blind|Lost to Follow-up|1|||
48639262|NCT01299389|156536629|FG002|Double-blind|Lost to Follow-up|0|||
48639263|NCT01299389|156536630|FG003|Double-blind|Lost to Follow-up|0|||
48639264|NCT01299389|156536627|FG000|Double-blind|Withdrawal by Subject|16|||
48639265|NCT01299389|156536628|FG001|Double-blind|Withdrawal by Subject|13|||
48639266|NCT01299389|156536629|FG002|Double-blind|Withdrawal by Subject|0|||
48639267|NCT01299389|156536630|FG003|Double-blind|Withdrawal by Subject|0|||
48639268|NCT01299389|156536627|FG000|Double-blind|Other|1|||
48639269|NCT01299389|156536628|FG001|Double-blind|Other|1|||
48639270|NCT01299389|156536629|FG002|Double-blind|Other|0|||
48747961|NCT03919799|156925007|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
48639271|NCT01299389|156536630|FG003|Double-blind|Other|0|||
48639272|NCT01299389|156536627|FG000|Double-blind|"fail to meet study population criteria"|0|||
48639273|NCT01299389|156536628|FG001|Double-blind|"fail to meet study population criteria"|1|||
48639274|NCT01299389|156536629|FG002|Double-blind|"fail to meet study population criteria"|0|||
48639275|NCT01299389|156536630|FG003|Double-blind|"fail to meet study population criteria"|0|||
48747962|NCT03919799|156925008|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
48747963|NCT03919799|156925009|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
48639276|NCT01299389|156536627|FG000|Post-observational|Other|0|||
48639277|NCT01299389|156536628|FG001|Post-observational|Other|0|||
48639278|NCT01299389|156536629|FG002|Post-observational|Other|12|||
48639279|NCT01299389|156536630|FG003|Post-observational|Other|6|||
48639280|NCT02347085|156536631|FG000|Overall Study|Adverse Event|2|||
48328348|NCT03775213|155400149|FG001|Overall Study|Incomplete Survey|7|||
48328349|NCT00553332|155400152|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
48328350|NCT03072862|155400156|FG000|Overall Study|Withdrawal by Subject|4|||
48328351|NCT03072862|155400156|FG000|Overall Study|Lost to Follow-up|6|||
48328352|NCT03072862|155400156|FG000|Overall Study|Protocol Violation|4|||
48328353|NCT03072862|155400156|FG000|Overall Study|Physician Decision|2|||
48328354|NCT03072862|155400156|FG000|Overall Study|Death|1|||
48328355|NCT03072862|155400156|FG000|Overall Study|Adverse Event|1|||
48328356|NCT03347396|155400157|FG000|Part A (26 Weeks)|Adverse Event|1|||
48328357|NCT03347396|155400158|FG001|Part A (26 Weeks)|Adverse Event|0|||
48328358|NCT03347396|155400157|FG000|Part A (26 Weeks)|Death|0|||
48328359|NCT03347396|155400158|FG001|Part A (26 Weeks)|Death|1|||
48328360|NCT03347396|155400157|FG000|Part B (149 Weeks)|Adverse Event|1|||
48328361|NCT03347396|155400158|FG001|Part B (149 Weeks)|Adverse Event|1|||
48639281|NCT02347085|156536631|FG000|Overall Study|Lack of Efficacy|1|||
48639282|NCT02347085|156536631|FG000|Overall Study|Withdrawal by Subject|4|||
48639283|NCT02347085|156536631|FG000|Overall Study|Lost to Follow-up|1|||
48639284|NCT02347085|156536631|FG000|Overall Study|Protocol Criteria|2|||
48639285|NCT03507127|156536634|FG000|Overall Study|Withdrawal by Subject|1|||
48639286|NCT03507127|156536635|FG001|Overall Study|Withdrawal by Subject|0|||
48639287|NCT03507127|156536634|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
48639288|NCT03507127|156536635|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
48639289|NCT03314935|156536636|FG000|Phase 1|Death|4|||
48639290|NCT03314935|156536637|FG001|Phase 1|Death|2|||
48639291|NCT03314935|156536638|FG002|Phase 1|Death|5|||
48639292|NCT03314935|156536639|FG003|Phase 1|Death|4|||
48639293|NCT03314935|156536640|FG004|Phase 1|Death|3|||
48639294|NCT03314935|156536641|FG005|Phase 1|Death|4|||
48639295|NCT03314935|156536642|FG006|Phase 1|Death|5|||
48639296|NCT03314935|156536643|FG007|Phase 1|Death|4|||
48639297|NCT03314935|156536644|FG008|Phase 1|Death|3|||
48639298|NCT03314935|156536645|FG009|Phase 1|Death|0|||
48639299|NCT03314935|156536646|FG010|Phase 1|Death|0|||
48639300|NCT03314935|156536647|FG011|Phase 1|Death|0|||
48639301|NCT03314935|156536648|FG012|Phase 1|Death|0|||
48639302|NCT03314935|156536649|FG013|Phase 1|Death|0|||
48639303|NCT03314935|156536650|FG014|Phase 1|Death|0|||
48639304|NCT03314935|156536636|FG000|Phase 1|Withdrawal by Subject|2|||
48639305|NCT03314935|156536637|FG001|Phase 1|Withdrawal by Subject|1|||
48639306|NCT03314935|156536638|FG002|Phase 1|Withdrawal by Subject|1|||
48639307|NCT03314935|156536639|FG003|Phase 1|Withdrawal by Subject|2|||
48639308|NCT03314935|156536640|FG004|Phase 1|Withdrawal by Subject|1|||
48639309|NCT03314935|156536641|FG005|Phase 1|Withdrawal by Subject|0|||
48639310|NCT03314935|156536642|FG006|Phase 1|Withdrawal by Subject|1|||
48328362|NCT03347396|155400157|FG000|Part B (149 Weeks)|Death|1|||
48328363|NCT03347396|155400158|FG001|Part B (149 Weeks)|Death|0|||
48328364|NCT02309294|155400159|FG000|Overall Study|Withdrawal by Subject|2|||
48328365|NCT01263496|155400160|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
48328366|NCT01263496|155400161|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48328367|NCT01263496|155400162|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48328368|NCT01263496|155400163|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48328369|NCT01263496|155400164|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48328370|NCT01263496|155400165|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48328371|NCT01263496|155400166|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48328372|NCT01263496|155400167|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48328373|NCT01263496|155400168|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
48328374|NCT01263496|155400160|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48328375|NCT01263496|155400161|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48328376|NCT01263496|155400162|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48328377|NCT01263496|155400163|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
48639311|NCT03314935|156536643|FG007|Phase 1|Withdrawal by Subject|0|||
48328378|NCT01263496|155400164|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
48328379|NCT01263496|155400165|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48328380|NCT01263496|155400166|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48328381|NCT01263496|155400167|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48328382|NCT01263496|155400168|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48328383|NCT01263496|155400160|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
48639312|NCT03314935|156536644|FG008|Phase 1|Withdrawal by Subject|1|||
48639313|NCT03314935|156536645|FG009|Phase 1|Withdrawal by Subject|0|||
48639314|NCT03314935|156536646|FG010|Phase 1|Withdrawal by Subject|0|||
48639315|NCT03314935|156536647|FG011|Phase 1|Withdrawal by Subject|0|||
48639316|NCT03314935|156536648|FG012|Phase 1|Withdrawal by Subject|0|||
48639317|NCT03314935|156536649|FG013|Phase 1|Withdrawal by Subject|0|||
48639318|NCT03314935|156536650|FG014|Phase 1|Withdrawal by Subject|0|||
48639319|NCT03314935|156536636|FG000|Phase 1|Progressive Disease|2|||
48639320|NCT03314935|156536637|FG001|Phase 1|Progressive Disease|0|||
48639321|NCT03314935|156536638|FG002|Phase 1|Progressive Disease|0|||
48639322|NCT03314935|156536639|FG003|Phase 1|Progressive Disease|1|||
48639323|NCT03314935|156536640|FG004|Phase 1|Progressive Disease|0|||
48639324|NCT03314935|156536641|FG005|Phase 1|Progressive Disease|0|||
48639325|NCT03314935|156536642|FG006|Phase 1|Progressive Disease|0|||
48639326|NCT03314935|156536643|FG007|Phase 1|Progressive Disease|0|||
48639327|NCT03314935|156536644|FG008|Phase 1|Progressive Disease|0|||
48328384|NCT01263496|155400161|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
48328385|NCT01263496|155400162|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
48639328|NCT03314935|156536645|FG009|Phase 1|Progressive Disease|0|||
48639329|NCT03314935|156536646|FG010|Phase 1|Progressive Disease|0|||
48639330|NCT03314935|156536647|FG011|Phase 1|Progressive Disease|0|||
48639331|NCT03314935|156536648|FG012|Phase 1|Progressive Disease|0|||
48639332|NCT03314935|156536649|FG013|Phase 1|Progressive Disease|0|||
48639333|NCT03314935|156536650|FG014|Phase 1|Progressive Disease|0|||
48328386|NCT01263496|155400163|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
48328387|NCT01263496|155400164|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
48328388|NCT01263496|155400165|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
48328389|NCT01263496|155400166|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
48328390|NCT01263496|155400167|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
48328391|NCT01263496|155400168|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
48328392|NCT01263496|155400160|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48328393|NCT01263496|155400161|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
48639334|NCT03314935|156536636|FG000|Phase 1|Study Terminated by Sponsor|0|||
48639335|NCT03314935|156536637|FG001|Phase 1|Study Terminated by Sponsor|1|||
48639336|NCT03314935|156536638|FG002|Phase 1|Study Terminated by Sponsor|0|||
48639337|NCT03314935|156536639|FG003|Phase 1|Study Terminated by Sponsor|0|||
48639338|NCT03314935|156536640|FG004|Phase 1|Study Terminated by Sponsor|0|||
48639339|NCT03314935|156536641|FG005|Phase 1|Study Terminated by Sponsor|0|||
48639340|NCT03314935|156536642|FG006|Phase 1|Study Terminated by Sponsor|0|||
48639341|NCT03314935|156536643|FG007|Phase 1|Study Terminated by Sponsor|0|||
48639342|NCT03314935|156536644|FG008|Phase 1|Study Terminated by Sponsor|1|||
48639343|NCT03314935|156536645|FG009|Phase 1|Study Terminated by Sponsor|0|||
48639344|NCT03314935|156536646|FG010|Phase 1|Study Terminated by Sponsor|0|||
48639345|NCT03314935|156536647|FG011|Phase 1|Study Terminated by Sponsor|0|||
48639346|NCT03314935|156536648|FG012|Phase 1|Study Terminated by Sponsor|0|||
48639347|NCT03314935|156536649|FG013|Phase 1|Study Terminated by Sponsor|0|||
48639348|NCT03314935|156536650|FG014|Phase 1|Study Terminated by Sponsor|0|||
48639349|NCT03314935|156536636|FG000|Phase 1|"Captured as Other in Database"|0|||
48639350|NCT03314935|156536637|FG001|Phase 1|"Captured as Other in Database"|2|||
48639351|NCT03314935|156536638|FG002|Phase 1|"Captured as Other in Database"|0|||
48639352|NCT03314935|156536639|FG003|Phase 1|"Captured as Other in Database"|0|||
48639353|NCT03314935|156536640|FG004|Phase 1|"Captured as Other in Database"|0|||
48639354|NCT03314935|156536641|FG005|Phase 1|"Captured as Other in Database"|0|||
48639355|NCT03314935|156536642|FG006|Phase 1|"Captured as Other in Database"|1|||
48639356|NCT03314935|156536643|FG007|Phase 1|"Captured as Other in Database"|1|||
48639357|NCT03314935|156536644|FG008|Phase 1|"Captured as Other in Database"|1|||
48639358|NCT03314935|156536645|FG009|Phase 1|"Captured as Other in Database"|0|||
48639359|NCT03314935|156536646|FG010|Phase 1|"Captured as Other in Database"|0|||
48639360|NCT03314935|156536647|FG011|Phase 1|"Captured as Other in Database"|0|||
48639361|NCT03314935|156536648|FG012|Phase 1|"Captured as Other in Database"|0|||
48639362|NCT03314935|156536649|FG013|Phase 1|"Captured as Other in Database"|0|||
48639363|NCT03314935|156536650|FG014|Phase 1|"Captured as Other in Database"|0|||
48639364|NCT03314935|156536636|FG000|Phase 1|Lost to Follow-up|0|||
48639365|NCT03314935|156536637|FG001|Phase 1|Lost to Follow-up|0|||
48639366|NCT03314935|156536638|FG002|Phase 1|Lost to Follow-up|0|||
48747964|NCT03919799|156925005|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
48747965|NCT03919799|156925006|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
48747966|NCT03919799|156925007|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
48747967|NCT03919799|156925008|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
48747968|NCT03919799|156925009|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
48747969|NCT02028065|156925010|FG000|Randomization Through Start Treatment|Not treated|1|||
48328394|NCT01263496|155400162|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48639367|NCT03314935|156536639|FG003|Phase 1|Lost to Follow-up|0|||
48639368|NCT03314935|156536640|FG004|Phase 1|Lost to Follow-up|0|||
48639369|NCT03314935|156536641|FG005|Phase 1|Lost to Follow-up|0|||
48639370|NCT03314935|156536642|FG006|Phase 1|Lost to Follow-up|0|||
48639371|NCT03314935|156536643|FG007|Phase 1|Lost to Follow-up|0|||
48639372|NCT03314935|156536644|FG008|Phase 1|Lost to Follow-up|1|||
48639373|NCT03314935|156536645|FG009|Phase 1|Lost to Follow-up|0|||
48639374|NCT03314935|156536646|FG010|Phase 1|Lost to Follow-up|0|||
48639375|NCT03314935|156536647|FG011|Phase 1|Lost to Follow-up|0|||
48639376|NCT03314935|156536648|FG012|Phase 1|Lost to Follow-up|0|||
48639377|NCT03314935|156536649|FG013|Phase 1|Lost to Follow-up|0|||
48639378|NCT03314935|156536650|FG014|Phase 1|Lost to Follow-up|0|||
48639379|NCT03314935|156536636|FG000|Phase 2|Death|0|||
48639380|NCT03314935|156536637|FG001|Phase 2|Death|0|||
48328395|NCT01263496|155400163|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48328396|NCT01263496|155400164|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48328397|NCT01263496|155400165|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48328398|NCT01263496|155400166|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48639381|NCT03314935|156536638|FG002|Phase 2|Death|0|||
48639382|NCT03314935|156536639|FG003|Phase 2|Death|0|||
48639383|NCT03314935|156536640|FG004|Phase 2|Death|0|||
48639384|NCT03314935|156536641|FG005|Phase 2|Death|0|||
48639385|NCT03314935|156536642|FG006|Phase 2|Death|0|||
48639386|NCT03314935|156536643|FG007|Phase 2|Death|0|||
48639387|NCT03314935|156536644|FG008|Phase 2|Death|0|||
48639388|NCT03314935|156536645|FG009|Phase 2|Death|5|||
48639389|NCT03314935|156536646|FG010|Phase 2|Death|20|||
48747970|NCT02028065|156925011|FG001|Randomization Through Start Treatment|Not treated|3|||
48747971|NCT02028065|156925012|FG002|Randomization Through Start Treatment|Not treated|3|||
48747972|NCT02028065|156925010|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
48747973|NCT02028065|156925011|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
48747974|NCT02028065|156925012|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
48747975|NCT02028065|156925010|FG000|Treatment Through Study Completion|Physician Decision|1|||
48747976|NCT02028065|156925011|FG001|Treatment Through Study Completion|Physician Decision|0|||
48747977|NCT02028065|156925012|FG002|Treatment Through Study Completion|Physician Decision|0|||
48747978|NCT02028065|156925010|FG000|Treatment Through Study Completion|Protocol Violation|1|||
48747979|NCT02028065|156925011|FG001|Treatment Through Study Completion|Protocol Violation|4|||
48747980|NCT02028065|156925012|FG002|Treatment Through Study Completion|Protocol Violation|0|||
48747981|NCT02028065|156925010|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
48747982|NCT02028065|156925011|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
48747983|NCT02028065|156925012|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
48747984|NCT02028065|156925010|FG000|Treatment Through Study Completion|Adverse Event|3|||
48747985|NCT02028065|156925011|FG001|Treatment Through Study Completion|Adverse Event|3|||
48747986|NCT02028065|156925012|FG002|Treatment Through Study Completion|Adverse Event|5|||
48747987|NCT00439244|156925014|FG000|Overall Study|Adverse Event|5|||
48747988|NCT00439244|156925015|FG001|Overall Study|Adverse Event|2|||
48747989|NCT00439244|156925016|FG002|Overall Study|Adverse Event|3|||
48747990|NCT00439244|156925014|FG000|Overall Study|Withdrawal by Subject|3|||
48747991|NCT00439244|156925015|FG001|Overall Study|Withdrawal by Subject|1|||
48747992|NCT00439244|156925016|FG002|Overall Study|Withdrawal by Subject|2|||
48747993|NCT00439244|156925014|FG000|Overall Study|Lost to Follow-up|2|||
48747994|NCT00439244|156925015|FG001|Overall Study|Lost to Follow-up|1|||
48747995|NCT00439244|156925016|FG002|Overall Study|Lost to Follow-up|2|||
48747996|NCT00439244|156925014|FG000|Overall Study|Death|0|||
48747997|NCT00439244|156925015|FG001|Overall Study|Death|1|||
48639390|NCT03314935|156536647|FG011|Phase 2|Death|6|||
48639391|NCT03314935|156536648|FG012|Phase 2|Death|7|||
48747998|NCT00439244|156925016|FG002|Overall Study|Death|0|||
48747999|NCT00439244|156925014|FG000|Overall Study|Protocol Violation|0|||
48748000|NCT00439244|156925015|FG001|Overall Study|Protocol Violation|1|||
48639392|NCT03314935|156536649|FG013|Phase 2|Death|6|||
48328399|NCT01263496|155400167|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48328400|NCT01263496|155400168|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48328401|NCT01263496|155400160|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48328402|NCT01263496|155400161|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48328403|NCT01263496|155400162|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48748001|NCT00439244|156925016|FG002|Overall Study|Protocol Violation|0|||
48748002|NCT00439244|156925014|FG000|Overall Study|Administrative problems|1|||
48748003|NCT00439244|156925015|FG001|Overall Study|Administrative problems|0|||
48748004|NCT00439244|156925016|FG002|Overall Study|Administrative problems|0|||
48748005|NCT01325584|156925019|FG000|Overall Study|Death|1|||
48748006|NCT00887978|156925020|FG000|Overall Study|Adverse Event|18|||
48328404|NCT01263496|155400163|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48328405|NCT01263496|155400164|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
48639393|NCT03314935|156536650|FG014|Phase 2|Death|17|||
48639394|NCT03314935|156536636|FG000|Phase 2|Withdrawal by Subject|0|||
48639395|NCT03314935|156536637|FG001|Phase 2|Withdrawal by Subject|0|||
48639396|NCT03314935|156536638|FG002|Phase 2|Withdrawal by Subject|0|||
48639397|NCT03314935|156536639|FG003|Phase 2|Withdrawal by Subject|0|||
48639398|NCT03314935|156536640|FG004|Phase 2|Withdrawal by Subject|0|||
48639399|NCT03314935|156536641|FG005|Phase 2|Withdrawal by Subject|0|||
48639400|NCT03314935|156536642|FG006|Phase 2|Withdrawal by Subject|0|||
48639401|NCT03314935|156536643|FG007|Phase 2|Withdrawal by Subject|0|||
48639402|NCT03314935|156536644|FG008|Phase 2|Withdrawal by Subject|0|||
48639403|NCT03314935|156536645|FG009|Phase 2|Withdrawal by Subject|1|||
48639404|NCT03314935|156536646|FG010|Phase 2|Withdrawal by Subject|4|||
48639405|NCT03314935|156536647|FG011|Phase 2|Withdrawal by Subject|0|||
48639406|NCT03314935|156536648|FG012|Phase 2|Withdrawal by Subject|1|||
48639407|NCT03314935|156536649|FG013|Phase 2|Withdrawal by Subject|0|||
48639408|NCT03314935|156536650|FG014|Phase 2|Withdrawal by Subject|1|||
48639409|NCT03314935|156536636|FG000|Phase 2|Progressive Disease|0|||
48639410|NCT03314935|156536637|FG001|Phase 2|Progressive Disease|0|||
48639411|NCT03314935|156536638|FG002|Phase 2|Progressive Disease|0|||
48639412|NCT03314935|156536639|FG003|Phase 2|Progressive Disease|0|||
48639413|NCT03314935|156536640|FG004|Phase 2|Progressive Disease|0|||
48639414|NCT03314935|156536641|FG005|Phase 2|Progressive Disease|0|||
48639415|NCT03314935|156536642|FG006|Phase 2|Progressive Disease|0|||
48639416|NCT03314935|156536643|FG007|Phase 2|Progressive Disease|0|||
48639417|NCT03314935|156536644|FG008|Phase 2|Progressive Disease|0|||
48639418|NCT03314935|156536645|FG009|Phase 2|Progressive Disease|1|||
48639419|NCT03314935|156536646|FG010|Phase 2|Progressive Disease|1|||
48639420|NCT03314935|156536647|FG011|Phase 2|Progressive Disease|1|||
48639421|NCT03314935|156536648|FG012|Phase 2|Progressive Disease|2|||
48639422|NCT03314935|156536649|FG013|Phase 2|Progressive Disease|0|||
48639423|NCT03314935|156536650|FG014|Phase 2|Progressive Disease|1|||
48639424|NCT03314935|156536636|FG000|Phase 2|Study Terminated by Sponsor|0|||
48639425|NCT03314935|156536637|FG001|Phase 2|Study Terminated by Sponsor|0|||
48639426|NCT03314935|156536638|FG002|Phase 2|Study Terminated by Sponsor|0|||
48639427|NCT03314935|156536639|FG003|Phase 2|Study Terminated by Sponsor|0|||
48639428|NCT03314935|156536640|FG004|Phase 2|Study Terminated by Sponsor|0|||
48639429|NCT03314935|156536641|FG005|Phase 2|Study Terminated by Sponsor|0|||
48639430|NCT03314935|156536642|FG006|Phase 2|Study Terminated by Sponsor|0|||
48639431|NCT03314935|156536643|FG007|Phase 2|Study Terminated by Sponsor|0|||
48639432|NCT03314935|156536644|FG008|Phase 2|Study Terminated by Sponsor|0|||
48639433|NCT03314935|156536645|FG009|Phase 2|Study Terminated by Sponsor|0|||
48639434|NCT03314935|156536646|FG010|Phase 2|Study Terminated by Sponsor|7|||
48639435|NCT03314935|156536647|FG011|Phase 2|Study Terminated by Sponsor|2|||
48639436|NCT03314935|156536648|FG012|Phase 2|Study Terminated by Sponsor|1|||
48639437|NCT03314935|156536649|FG013|Phase 2|Study Terminated by Sponsor|4|||
48639438|NCT03314935|156536650|FG014|Phase 2|Study Terminated by Sponsor|4|||
48639439|NCT03314935|156536636|FG000|Phase 2|Lost to Follow-up|0|||
48639440|NCT03314935|156536637|FG001|Phase 2|Lost to Follow-up|0|||
48328406|NCT01263496|155400165|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48639441|NCT03314935|156536638|FG002|Phase 2|Lost to Follow-up|0|||
48639442|NCT03314935|156536639|FG003|Phase 2|Lost to Follow-up|0|||
48639443|NCT03314935|156536640|FG004|Phase 2|Lost to Follow-up|0|||
48639444|NCT03314935|156536641|FG005|Phase 2|Lost to Follow-up|0|||
48639445|NCT03314935|156536642|FG006|Phase 2|Lost to Follow-up|0|||
48639446|NCT03314935|156536643|FG007|Phase 2|Lost to Follow-up|0|||
48639447|NCT03314935|156536644|FG008|Phase 2|Lost to Follow-up|0|||
48639448|NCT03314935|156536645|FG009|Phase 2|Lost to Follow-up|1|||
48639449|NCT03314935|156536646|FG010|Phase 2|Lost to Follow-up|0|||
48639450|NCT03314935|156536647|FG011|Phase 2|Lost to Follow-up|0|||
48639451|NCT03314935|156536648|FG012|Phase 2|Lost to Follow-up|0|||
48639452|NCT03314935|156536649|FG013|Phase 2|Lost to Follow-up|0|||
48639453|NCT03314935|156536650|FG014|Phase 2|Lost to Follow-up|1|||
48639454|NCT03314935|156536636|FG000|Phase 2|Physician Decision|0|||
48639455|NCT03314935|156536637|FG001|Phase 2|Physician Decision|0|||
48639456|NCT03314935|156536638|FG002|Phase 2|Physician Decision|0|||
48748007|NCT00887978|156925021|FG001|Overall Study|Adverse Event|5|||
48748008|NCT00887978|156925020|FG000|Overall Study|Clinical Worsening|4|||
48748009|NCT00887978|156925021|FG001|Overall Study|Clinical Worsening|4|||
48748010|NCT00887978|156925020|FG000|Overall Study|Death|2|||
48748011|NCT00887978|156925021|FG001|Overall Study|Death|3|||
48748012|NCT00887978|156925020|FG000|Overall Study|Withdrawal by Subject|1|||
48748013|NCT00887978|156925021|FG001|Overall Study|Withdrawal by Subject|2|||
48748014|NCT00887978|156925020|FG000|Overall Study|Lost to Follow-up|0|||
48748015|NCT00887978|156925021|FG001|Overall Study|Lost to Follow-up|1|||
48748016|NCT02617628|156925022|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
48748017|NCT02617628|156925023|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
48748018|NCT03064451|156925024|FG000|Overall Study|Lost to Follow-up|1|||
48748019|NCT03064451|156925024|FG000|Overall Study|Mapping Failure|4|||
48748020|NCT03064451|156925024|FG000|Overall Study|Exited prior to procedure|8|||
48748021|NCT03064451|156925024|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
48748022|NCT02034110|156926423|FG000|Overall Study|Physician Decision|0|||
48748023|NCT02034110|156926424|FG001|Overall Study|Physician Decision|0|||
48748024|NCT02034110|156926425|FG002|Overall Study|Physician Decision|0|||
48748025|NCT02034110|156926426|FG003|Overall Study|Physician Decision|0|||
48748026|NCT02034110|156926427|FG004|Overall Study|Physician Decision|2|||
48748027|NCT02034110|156926428|FG005|Overall Study|Physician Decision|0|||
48748028|NCT02034110|156926429|FG006|Overall Study|Physician Decision|1|||
48748029|NCT02034110|156926430|FG007|Overall Study|Physician Decision|0|||
48748030|NCT02034110|156926423|FG000|Overall Study|Lost to Follow-up|1|||
48748031|NCT02034110|156926424|FG001|Overall Study|Lost to Follow-up|0|||
48748032|NCT02034110|156926425|FG002|Overall Study|Lost to Follow-up|0|||
48748033|NCT02034110|156926426|FG003|Overall Study|Lost to Follow-up|0|||
48748034|NCT02034110|156926427|FG004|Overall Study|Lost to Follow-up|1|||
48748035|NCT02034110|156926428|FG005|Overall Study|Lost to Follow-up|0|||
48748036|NCT02034110|156926429|FG006|Overall Study|Lost to Follow-up|1|||
48748037|NCT02034110|156926430|FG007|Overall Study|Lost to Follow-up|0|||
48748038|NCT02034110|156926423|FG000|Overall Study|Withdrawal by Subject|5|||
48748039|NCT02034110|156926424|FG001|Overall Study|Withdrawal by Subject|7|||
48748040|NCT02034110|156926425|FG002|Overall Study|Withdrawal by Subject|0|||
48748041|NCT02034110|156926426|FG003|Overall Study|Withdrawal by Subject|3|||
48748042|NCT02034110|156926427|FG004|Overall Study|Withdrawal by Subject|7|||
48748043|NCT02034110|156926428|FG005|Overall Study|Withdrawal by Subject|0|||
48748044|NCT02034110|156926429|FG006|Overall Study|Withdrawal by Subject|3|||
48748045|NCT02034110|156926430|FG007|Overall Study|Withdrawal by Subject|1|||
48748046|NCT02034110|156926423|FG000|Overall Study|Study closed by sponsor|6|||
48748047|NCT02034110|156926424|FG001|Overall Study|Study closed by sponsor|2|||
48748048|NCT02034110|156926425|FG002|Overall Study|Study closed by sponsor|0|||
48748049|NCT02034110|156926426|FG003|Overall Study|Study closed by sponsor|6|||
48748050|NCT02034110|156926427|FG004|Overall Study|Study closed by sponsor|7|||
48748051|NCT02034110|156926428|FG005|Overall Study|Study closed by sponsor|0|||
48748052|NCT02034110|156926429|FG006|Overall Study|Study closed by sponsor|42|||
48748053|NCT02034110|156926430|FG007|Overall Study|Study closed by sponsor|0|||
48748054|NCT02380677|156926432|FG000|Overall Study|Adverse Event|0|||
48748055|NCT02380677|156926433|FG001|Overall Study|Adverse Event|0|||
48748056|NCT02380677|156926434|FG002|Overall Study|Adverse Event|0|||
48748057|NCT02380677|156926435|FG003|Overall Study|Adverse Event|1|||
48748058|NCT02380677|156926436|FG004|Overall Study|Adverse Event|1|||
48748059|NCT02380677|156926437|FG005|Overall Study|Adverse Event|4|||
48748060|NCT02380677|156926438|FG006|Overall Study|Adverse Event|2|||
48748061|NCT02380677|156926439|FG007|Overall Study|Adverse Event|2|||
48748062|NCT02380677|156926440|FG008|Overall Study|Adverse Event|2|||
48748063|NCT02380677|156926441|FG009|Overall Study|Adverse Event|1|||
48748064|NCT02380677|156926442|FG010|Overall Study|Adverse Event|2|||
48748065|NCT02380677|156926443|FG011|Overall Study|Adverse Event|1|||
48748066|NCT02380677|156926432|FG000|Overall Study|Physician Decision|1|||
48748067|NCT02380677|156926433|FG001|Overall Study|Physician Decision|0|||
48748068|NCT02380677|156926434|FG002|Overall Study|Physician Decision|1|||
48748069|NCT02380677|156926435|FG003|Overall Study|Physician Decision|1|||
48748070|NCT02380677|156926436|FG004|Overall Study|Physician Decision|0|||
48748071|NCT02380677|156926437|FG005|Overall Study|Physician Decision|0|||
48748072|NCT02380677|156926438|FG006|Overall Study|Physician Decision|0|||
48748073|NCT02380677|156926439|FG007|Overall Study|Physician Decision|0|||
48748074|NCT02380677|156926440|FG008|Overall Study|Physician Decision|0|||
48748075|NCT02380677|156926441|FG009|Overall Study|Physician Decision|0|||
48748076|NCT02380677|156926442|FG010|Overall Study|Physician Decision|0|||
48748077|NCT02380677|156926443|FG011|Overall Study|Physician Decision|0|||
48748078|NCT02380677|156926432|FG000|Overall Study|Lack of Efficacy|0|||
48748079|NCT02380677|156926433|FG001|Overall Study|Lack of Efficacy|1|||
48748080|NCT02380677|156926434|FG002|Overall Study|Lack of Efficacy|2|||
48748081|NCT02380677|156926435|FG003|Overall Study|Lack of Efficacy|0|||
48748082|NCT02380677|156926436|FG004|Overall Study|Lack of Efficacy|4|||
48748083|NCT02380677|156926437|FG005|Overall Study|Lack of Efficacy|1|||
48748084|NCT02380677|156926438|FG006|Overall Study|Lack of Efficacy|1|||
48748085|NCT02380677|156926439|FG007|Overall Study|Lack of Efficacy|2|||
48748086|NCT02380677|156926440|FG008|Overall Study|Lack of Efficacy|2|||
48748087|NCT02380677|156926441|FG009|Overall Study|Lack of Efficacy|0|||
48748088|NCT02380677|156926442|FG010|Overall Study|Lack of Efficacy|2|||
48748089|NCT02380677|156926443|FG011|Overall Study|Lack of Efficacy|1|||
48748090|NCT02380677|156926432|FG000|Overall Study|Withdrawal by Subject|0|||
48748091|NCT02380677|156926433|FG001|Overall Study|Withdrawal by Subject|0|||
48748092|NCT02380677|156926434|FG002|Overall Study|Withdrawal by Subject|0|||
48748093|NCT02380677|156926435|FG003|Overall Study|Withdrawal by Subject|0|||
48748094|NCT02380677|156926436|FG004|Overall Study|Withdrawal by Subject|0|||
48748095|NCT02380677|156926437|FG005|Overall Study|Withdrawal by Subject|0|||
48748096|NCT02380677|156926438|FG006|Overall Study|Withdrawal by Subject|0|||
48328407|NCT01263496|155400166|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48328408|NCT01263496|155400167|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48328409|NCT01263496|155400168|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48328410|NCT01263496|155400160|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
48328411|NCT01263496|155400161|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
48328412|NCT01263496|155400162|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
48328413|NCT01263496|155400163|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48328414|NCT01263496|155400164|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
48328415|NCT01263496|155400165|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48328416|NCT01263496|155400166|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48328417|NCT01263496|155400167|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48328418|NCT01263496|155400168|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48328419|NCT01263496|155400160|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48328420|NCT01263496|155400161|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48328421|NCT01263496|155400162|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48328422|NCT01263496|155400163|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48328423|NCT01263496|155400164|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48328424|NCT01263496|155400165|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48328425|NCT01263496|155400166|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48328426|NCT01263496|155400167|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
48328427|NCT01263496|155400168|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48328428|NCT02744066|155400171|FG000|Overall Study|Withdrawal by parent|0|||
48328429|NCT02744066|155400172|FG001|Overall Study|Withdrawal by parent|1|||
48328430|NCT02744066|155400171|FG000|Overall Study|Discharged from NICU prior to completion|0|||
48328431|NCT02744066|155400172|FG001|Overall Study|Discharged from NICU prior to completion|4|||
48328432|NCT02241785|155400173|FG000|Overall Study|Sponsor Termination|43|||
48328433|NCT02241785|155400173|FG000|Overall Study|Withdrawal by Subject|1|||
48328434|NCT02241785|155400173|FG000|Overall Study|Lost to Follow-up|2|||
48328435|NCT02241785|155400173|FG000|Overall Study|Adverse Event|1|||
48328436|NCT01915914|155400174|FG000|Acute Phase|Withdrawal by Subject|4|||
48328437|NCT01915914|155400175|FG001|Acute Phase|Withdrawal by Subject|0|||
48328438|NCT01915914|155400176|FG002|Acute Phase|Withdrawal by Subject|0|||
48328439|NCT01915914|155400177|FG003|Acute Phase|Withdrawal by Subject|0|||
48328440|NCT01915914|155400174|FG000|Acute Phase|Lost to Follow-up|4|||
48328441|NCT01915914|155400175|FG001|Acute Phase|Lost to Follow-up|0|||
48328442|NCT01915914|155400176|FG002|Acute Phase|Lost to Follow-up|0|||
48328443|NCT01915914|155400177|FG003|Acute Phase|Lost to Follow-up|0|||
48328444|NCT01915914|155400174|FG000|Acute Phase|Physician Decision|1|||
48328445|NCT01915914|155400175|FG001|Acute Phase|Physician Decision|0|||
48328446|NCT01915914|155400176|FG002|Acute Phase|Physician Decision|0|||
48328447|NCT01915914|155400177|FG003|Acute Phase|Physician Decision|0|||
48328448|NCT01915914|155400174|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
48328449|NCT01915914|155400175|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
48328450|NCT01915914|155400176|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
48328451|NCT01915914|155400177|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
48328452|NCT01915914|155400174|FG000|Acute Phase|"Not Achieved treatment success"|1|||
48328453|NCT01915914|155400175|FG001|Acute Phase|"Not Achieved treatment success"|0|||
48328454|NCT01915914|155400176|FG002|Acute Phase|"Not Achieved treatment success"|0|||
48328455|NCT01915914|155400177|FG003|Acute Phase|"Not Achieved treatment success"|0|||
48328456|NCT01915914|155400174|FG000|Acute Phase|Missing|1|||
48328457|NCT01915914|155400175|FG001|Acute Phase|Missing|0|||
48328458|NCT01915914|155400176|FG002|Acute Phase|Missing|0|||
48328459|NCT01915914|155400177|FG003|Acute Phase|Missing|0|||
48639457|NCT03314935|156536639|FG003|Phase 2|Physician Decision|0|||
48748097|NCT02380677|156926439|FG007|Overall Study|Withdrawal by Subject|0|||
48748098|NCT02380677|156926440|FG008|Overall Study|Withdrawal by Subject|0|||
48328460|NCT01915914|155400174|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48328461|NCT01915914|155400175|FG001|Maintenance Phase|Withdrawal by Subject|1|||
48328462|NCT01915914|155400176|FG002|Maintenance Phase|Withdrawal by Subject|1|||
48328463|NCT01915914|155400177|FG003|Maintenance Phase|Withdrawal by Subject|0|||
48328464|NCT01915914|155400174|FG000|Maintenance Phase|Lost to Follow-up|0|||
48328465|NCT01915914|155400175|FG001|Maintenance Phase|Lost to Follow-up|4|||
48639458|NCT03314935|156536640|FG004|Phase 2|Physician Decision|0|||
48639459|NCT03314935|156536641|FG005|Phase 2|Physician Decision|0|||
48639460|NCT03314935|156536642|FG006|Phase 2|Physician Decision|0|||
48639461|NCT03314935|156536643|FG007|Phase 2|Physician Decision|0|||
48639462|NCT03314935|156536644|FG008|Phase 2|Physician Decision|0|||
48639463|NCT03314935|156536645|FG009|Phase 2|Physician Decision|0|||
48639464|NCT03314935|156536646|FG010|Phase 2|Physician Decision|1|||
48639465|NCT03314935|156536647|FG011|Phase 2|Physician Decision|0|||
48639466|NCT03314935|156536648|FG012|Phase 2|Physician Decision|0|||
48639467|NCT03314935|156536649|FG013|Phase 2|Physician Decision|0|||
48639468|NCT03314935|156536650|FG014|Phase 2|Physician Decision|0|||
48639469|NCT04781816|156536657|FG000|Overall Study|Adverse Event|0|||
48639470|NCT04781816|156536658|FG001|Overall Study|Adverse Event|1|||
48639471|NCT04781816|156536657|FG000|Overall Study|Withdrawal by Subject|1|||
48639472|NCT04781816|156536658|FG001|Overall Study|Withdrawal by Subject|1|||
48748099|NCT02380677|156926441|FG009|Overall Study|Withdrawal by Subject|1|||
48748100|NCT02380677|156926442|FG010|Overall Study|Withdrawal by Subject|0|||
48748101|NCT02380677|156926443|FG011|Overall Study|Withdrawal by Subject|3|||
48748102|NCT02380677|156926432|FG000|Overall Study|Other|0|||
48748103|NCT02380677|156926433|FG001|Overall Study|Other|0|||
48748104|NCT02380677|156926434|FG002|Overall Study|Other|0|||
48748105|NCT02380677|156926435|FG003|Overall Study|Other|1|||
48748106|NCT02380677|156926436|FG004|Overall Study|Other|1|||
48748107|NCT02380677|156926437|FG005|Overall Study|Other|1|||
48748108|NCT02380677|156926438|FG006|Overall Study|Other|0|||
48748109|NCT02380677|156926439|FG007|Overall Study|Other|0|||
48748110|NCT02380677|156926440|FG008|Overall Study|Other|0|||
48748111|NCT02380677|156926441|FG009|Overall Study|Other|0|||
48748112|NCT02380677|156926442|FG010|Overall Study|Other|0|||
48748113|NCT02380677|156926443|FG011|Overall Study|Other|0|||
48748114|NCT03902574|156926444|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
48748115|NCT03902574|156926445|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
48748116|NCT03902574|156926446|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
48748117|NCT01806545|156926451|FG000|Overall Study|Adverse Event|2|||
48328466|NCT01915914|155400176|FG002|Maintenance Phase|Lost to Follow-up|1|||
48328467|NCT01915914|155400177|FG003|Maintenance Phase|Lost to Follow-up|0|||
48328468|NCT01915914|155400174|FG000|Maintenance Phase|Missing|0|||
48328469|NCT01915914|155400175|FG001|Maintenance Phase|Missing|1|||
48328470|NCT01915914|155400176|FG002|Maintenance Phase|Missing|0|||
48328471|NCT01915914|155400177|FG003|Maintenance Phase|Missing|0|||
48328472|NCT01915914|155400174|FG000|Follow-up Phase|Withdrawal by Subject|0|||
48328473|NCT01915914|155400175|FG001|Follow-up Phase|Withdrawal by Subject|0|||
48328474|NCT01915914|155400176|FG002|Follow-up Phase|Withdrawal by Subject|0|||
48328475|NCT01915914|155400177|FG003|Follow-up Phase|Withdrawal by Subject|1|||
48328476|NCT01915914|155400174|FG000|Follow-up Phase|Physician Decision|0|||
48328477|NCT01915914|155400175|FG001|Follow-up Phase|Physician Decision|0|||
48328478|NCT01915914|155400176|FG002|Follow-up Phase|Physician Decision|0|||
48639473|NCT04781816|156536657|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
48639474|NCT04781816|156536658|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
48639475|NCT00165789|156536659|FG000|Overall Study|Adverse Event|0|||
48748118|NCT01806545|156926452|FG001|Overall Study|Adverse Event|3|||
48748119|NCT01806545|156926451|FG000|Overall Study|Lost to Follow-up|1|||
48748120|NCT01806545|156926452|FG001|Overall Study|Lost to Follow-up|0|||
48748121|NCT01806545|156926451|FG000|Overall Study|Withdrawal by Subject|3|||
48748122|NCT01806545|156926452|FG001|Overall Study|Withdrawal by Subject|2|||
48748123|NCT02853604|156926455|FG000|Overall Study|Withdrawal by Subject|12|||
48328479|NCT01915914|155400177|FG003|Follow-up Phase|Physician Decision|1|||
48328480|NCT02147093|155400180|FG000|Period 1|Lost to Follow-up|0|||
48639476|NCT00165789|156536660|FG001|Overall Study|Adverse Event|3|||
48639477|NCT00165789|156536661|FG002|Overall Study|Adverse Event|0|||
48639478|NCT00165789|156536662|FG003|Overall Study|Adverse Event|12|||
48639479|NCT00165789|156536659|FG000|Overall Study|Withdrawal by Subject|0|||
48639480|NCT00165789|156536660|FG001|Overall Study|Withdrawal by Subject|1|||
48639481|NCT00165789|156536661|FG002|Overall Study|Withdrawal by Subject|1|||
48639482|NCT00165789|156536662|FG003|Overall Study|Withdrawal by Subject|2|||
48639483|NCT02737501|156536663|FG000|Randomized Phase|Died|41|||
48748124|NCT02853604|156926456|FG001|Overall Study|Withdrawal by Subject|35|||
48639484|NCT02737501|156536664|FG001|Randomized Phase|Died|29|||
48639485|NCT02737501|156536665|FG002|Randomized Phase|Died|0|||
48639486|NCT02737501|156536663|FG000|Randomized Phase|Withdrawal by Subject|16|||
48639487|NCT02737501|156536664|FG001|Randomized Phase|Withdrawal by Subject|6|||
48639488|NCT02737501|156536665|FG002|Randomized Phase|Withdrawal by Subject|0|||
48639489|NCT02737501|156536663|FG000|Randomized Phase|Lost to Follow-up|0|||
48639490|NCT02737501|156536664|FG001|Randomized Phase|Lost to Follow-up|1|||
48748125|NCT02853604|156926455|FG000|Overall Study|Lost to Follow-up|4|||
48748126|NCT02853604|156926456|FG001|Overall Study|Lost to Follow-up|8|||
48328481|NCT02147093|155400181|FG001|Period 1|Lost to Follow-up|1|||
48639491|NCT02737501|156536665|FG002|Randomized Phase|Lost to Follow-up|0|||
48328482|NCT02147093|155400180|FG000|Period 2|Protocol Violation|2|||
48639492|NCT02737501|156536663|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
48639493|NCT02737501|156536664|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
48639494|NCT02737501|156536665|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
48639495|NCT02737501|156536663|FG000|Randomized Phase|Reason not Specified|1|||
48639496|NCT02737501|156536664|FG001|Randomized Phase|Reason not Specified|1|||
48639497|NCT02737501|156536665|FG002|Randomized Phase|Reason not Specified|0|||
48639498|NCT02737501|156536663|FG000|Randomized Phase|Never Treated|1|||
48639499|NCT02737501|156536664|FG001|Randomized Phase|Never Treated|1|||
48639500|NCT02737501|156536665|FG002|Randomized Phase|Never Treated|0|||
48639501|NCT02737501|156536663|FG000|Crossover Phase|Died|0|||
48639502|NCT02737501|156536664|FG001|Crossover Phase|Died|0|||
48639503|NCT02737501|156536665|FG002|Crossover Phase|Died|22|||
48639504|NCT02737501|156536663|FG000|Crossover Phase|Withdrew Consent|0|||
48639505|NCT02737501|156536664|FG001|Crossover Phase|Withdrew Consent|0|||
48328483|NCT02147093|155400181|FG001|Period 2|Protocol Violation|0|||
48328484|NCT00845520|155400188|FG000|Overall Study|Death|1|||
48328485|NCT00845520|155400189|FG001|Overall Study|Death|2|||
48328486|NCT00845520|155400190|FG002|Overall Study|Death|0|||
48328487|NCT00845520|155400188|FG000|Overall Study|Lost to Follow-up|1|||
48328488|NCT00845520|155400189|FG001|Overall Study|Lost to Follow-up|0|||
48328489|NCT00845520|155400190|FG002|Overall Study|Lost to Follow-up|0|||
48328490|NCT00845520|155400188|FG000|Overall Study|Adverse Event|0|||
48639506|NCT02737501|156536665|FG002|Crossover Phase|Withdrew Consent|9|||
48639507|NCT02737501|156536663|FG000|Crossover Phase|Physician Decision|0|||
48639508|NCT02737501|156536664|FG001|Crossover Phase|Physician Decision|0|||
48639509|NCT02737501|156536665|FG002|Crossover Phase|Physician Decision|1|||
48639510|NCT02737501|156536663|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
48639511|NCT02737501|156536664|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
48639512|NCT02737501|156536665|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
48639513|NCT01445847|156536666|FG000|Overall Study|Protocol Violation|13|||
48639514|NCT01445847|156536667|FG001|Overall Study|Protocol Violation|14|||
48639515|NCT01445847|156536666|FG000|Overall Study|Missed Data|1|||
48639516|NCT01445847|156536667|FG001|Overall Study|Missed Data|0|||
48639517|NCT01900665|156536668|FG000|Placebo Controlled Period|Death|9|||
48639518|NCT01900665|156536669|FG001|Placebo Controlled Period|Death|16|||
48639519|NCT01900665|156536668|FG000|Placebo Controlled Period|Adverse Event|48|||
48639520|NCT01900665|156536669|FG001|Placebo Controlled Period|Adverse Event|39|||
48639521|NCT01900665|156536668|FG000|Placebo Controlled Period|Protocol Violation|1|||
48639522|NCT01900665|156536669|FG001|Placebo Controlled Period|Protocol Violation|7|||
48639523|NCT01900665|156536668|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
48639524|NCT01900665|156536669|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
48639525|NCT01900665|156536668|FG000|Placebo Controlled Period|Physician Decision|11|||
48639526|NCT01900665|156536669|FG001|Placebo Controlled Period|Physician Decision|7|||
48639527|NCT01900665|156536668|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
48639528|NCT01900665|156536669|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
48639529|NCT01900665|156536668|FG000|Placebo Controlled Period|Caregiver Decision|33|||
48639530|NCT01900665|156536669|FG001|Placebo Controlled Period|Caregiver Decision|41|||
48639531|NCT01900665|156536668|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
48639532|NCT01900665|156536669|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
48639533|NCT01900665|156536668|FG000|Open Label Period|Adverse Event|16|||
48639534|NCT01900665|156536669|FG001|Open Label Period|Adverse Event|20|||
48639535|NCT01900665|156536668|FG000|Open Label Period|Death|5|||
48639536|NCT01900665|156536669|FG001|Open Label Period|Death|6|||
48639537|NCT01900665|156536668|FG000|Open Label Period|Lost to Follow-up|1|||
48639538|NCT01900665|156536669|FG001|Open Label Period|Lost to Follow-up|1|||
48639539|NCT01900665|156536668|FG000|Open Label Period|Parent/Caregiver Decision|33|||
48639540|NCT01900665|156536669|FG001|Open Label Period|Parent/Caregiver Decision|34|||
48639541|NCT01900665|156536668|FG000|Open Label Period|Physician Decision|4|||
48639542|NCT01900665|156536669|FG001|Open Label Period|Physician Decision|4|||
48639543|NCT01900665|156536668|FG000|Open Label Period|Protocol Violation|0|||
48639544|NCT01900665|156536669|FG001|Open Label Period|Protocol Violation|1|||
48639545|NCT01900665|156536668|FG000|Open Label Period|Sponsor Decision|802|||
48639546|NCT01900665|156536669|FG001|Open Label Period|Sponsor Decision|765|||
48639547|NCT01900665|156536668|FG000|Open Label Period|Withdrawal by Subject|20|||
48639548|NCT01900665|156536669|FG001|Open Label Period|Withdrawal by Subject|28|||
48639549|NCT05414175|156536673|FG000|Overall Study|Withdrawal by Subject|1|||
48639550|NCT05414175|156536673|FG000|Overall Study|Other Reasons|1|||
48639551|NCT02701764|156536674|FG000|Overall Study|Lost to Follow-up|0|||
48639552|NCT02701764|156536675|FG001|Overall Study|Lost to Follow-up|1|||
48328491|NCT00845520|155400189|FG001|Overall Study|Adverse Event|0|||
48328492|NCT00845520|155400190|FG002|Overall Study|Adverse Event|1|||
48639553|NCT03960684|156536676|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
48639554|NCT03761056|156536677|FG000|Overall Study|Death|8|||
48639555|NCT03761056|156536677|FG000|Overall Study|Enrolled but never treated|2|||
48639556|NCT03761056|156536677|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
48639557|NCT03761056|156536677|FG000|Overall Study|Investigator decision|1|||
48748127|NCT02853604|156926455|FG000|Overall Study|Death|1|||
48328493|NCT02807857|155400192|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
48328494|NCT02807857|155400192|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
48639558|NCT03965403|156536683|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
48639559|NCT03857620|156538238|FG000|Overall Study|Death|4|||
48639560|NCT03857620|156538239|FG001|Overall Study|Death|5|||
48639561|NCT03857620|156538240|FG002|Overall Study|Death|7|||
48639562|NCT03857620|156538238|FG000|Overall Study|Lost to Follow-up|2|||
48639563|NCT03857620|156538239|FG001|Overall Study|Lost to Follow-up|5|||
48639564|NCT03857620|156538240|FG002|Overall Study|Lost to Follow-up|3|||
48639565|NCT03857620|156538238|FG000|Overall Study|Disease progression or relapse after study registration|1|||
48639566|NCT03857620|156538239|FG001|Overall Study|Disease progression or relapse after study registration|5|||
48639567|NCT03857620|156538240|FG002|Overall Study|Disease progression or relapse after study registration|1|||
48639568|NCT03857620|156538238|FG000|Overall Study|Ineligible|5|||
48639569|NCT03857620|156538239|FG001|Overall Study|Ineligible|0|||
48639570|NCT03857620|156538240|FG002|Overall Study|Ineligible|2|||
48639571|NCT03857620|156538238|FG000|Overall Study|No malignancy|1|||
48639572|NCT03857620|156538239|FG001|Overall Study|No malignancy|0|||
48639573|NCT03857620|156538240|FG002|Overall Study|No malignancy|1|||
48639574|NCT03857620|156538238|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
48639575|NCT03857620|156538239|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
48639576|NCT03857620|156538240|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
48639577|NCT03857620|156538238|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
48639578|NCT03857620|156538239|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
48639579|NCT03857620|156538240|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
48639580|NCT03857620|156538238|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
48639581|NCT03857620|156538239|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
48639582|NCT03857620|156538240|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
48639583|NCT03857620|156538238|FG000|Overall Study|Surgery not performed, patient decision|0|||
48639584|NCT03857620|156538239|FG001|Overall Study|Surgery not performed, patient decision|3|||
48639585|NCT03857620|156538240|FG002|Overall Study|Surgery not performed, patient decision|1|||
48639586|NCT03857620|156538238|FG000|Overall Study|Surgery not performed, other reason|3|||
48639587|NCT03857620|156538239|FG001|Overall Study|Surgery not performed, other reason|1|||
48639588|NCT03857620|156538240|FG002|Overall Study|Surgery not performed, other reason|4|||
48639589|NCT03857620|156538238|FG000|Overall Study|Worsening performance status after surgery performed|0|||
48639590|NCT03857620|156538239|FG001|Overall Study|Worsening performance status after surgery performed|1|||
48639591|NCT03857620|156538240|FG002|Overall Study|Worsening performance status after surgery performed|1|||
48639592|NCT02122380|156538241|FG000|First Intervention (30 Days)|Adverse Event|1|||
48639593|NCT02122380|156538242|FG001|First Intervention (30 Days)|Adverse Event|0|||
48639594|NCT02122380|156538241|FG000|First Intervention (30 Days)|Physician Decision|0|||
48639595|NCT02122380|156538242|FG001|First Intervention (30 Days)|Physician Decision|1|||
48639596|NCT02122380|156538241|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
48639597|NCT02122380|156538242|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
48639598|NCT02122380|156538241|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
48639599|NCT02122380|156538242|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
48639600|NCT02122380|156538241|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
48639601|NCT02122380|156538242|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
48639602|NCT02296476|156538243|FG000|Overall Study|Disease Progression|6|||
48639603|NCT02296476|156538244|FG001|Overall Study|Disease Progression|4|||
48639604|NCT02296476|156538245|FG002|Overall Study|Disease Progression|2|||
48639605|NCT03247829|156538246|FG000|Overall Study|Death|3|||
48639606|NCT03247829|156538247|FG001|Overall Study|Death|4|||
48639607|NCT03247829|156538246|FG000|Overall Study|Enter Hospice Care|1|||
48639608|NCT03247829|156538247|FG001|Overall Study|Enter Hospice Care|0|||
48639609|NCT03247829|156538246|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
48639610|NCT03247829|156538247|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
48639611|NCT03247829|156538246|FG000|Overall Study|LVAD Explant|1|||
48639612|NCT03247829|156538247|FG001|Overall Study|LVAD Explant|1|||
48639613|NCT03247829|156538246|FG000|Overall Study|Transplant|1|||
48639614|NCT03247829|156538247|FG001|Overall Study|Transplant|1|||
48639615|NCT01783444|156538248|FG000|Treatment Phase|Adverse Event|9|||
48639616|NCT01783444|156538249|FG001|Treatment Phase|Adverse Event|20|||
48639617|NCT01783444|156538250|FG002|Treatment Phase|Adverse Event|19|||
48639618|NCT01783444|156538248|FG000|Treatment Phase|Disease Progression|76|||
48639619|NCT01783444|156538249|FG001|Treatment Phase|Disease Progression|66|||
48639620|NCT01783444|156538250|FG002|Treatment Phase|Disease Progression|64|||
48639621|NCT01783444|156538248|FG000|Treatment Phase|Death|2|||
48639622|NCT01783444|156538249|FG001|Treatment Phase|Death|2|||
48639623|NCT01783444|156538250|FG002|Treatment Phase|Death|2|||
48639624|NCT01783444|156538248|FG000|Treatment Phase|Protocol Violation|1|||
48639625|NCT01783444|156538249|FG001|Treatment Phase|Protocol Violation|1|||
48639626|NCT01783444|156538250|FG002|Treatment Phase|Protocol Violation|2|||
48639627|NCT01783444|156538248|FG000|Treatment Phase|Withdrawal by Subject|6|||
48748128|NCT02853604|156926456|FG001|Overall Study|Death|5|||
48748129|NCT02853604|156926455|FG000|Overall Study|Miscellaneous|11|||
48748130|NCT02853604|156926456|FG001|Overall Study|Miscellaneous|2|||
48748131|NCT02853604|156926455|FG000|Overall Study|Progressive Disease|0|||
48748132|NCT02853604|156926456|FG001|Overall Study|Progressive Disease|2|||
48748133|NCT02548650|156926457|FG000|Triple Therapy|Adverse Event|1|||
48748134|NCT02548650|156926458|FG001|Triple Therapy|Adverse Event|0|||
48748135|NCT02548650|156926457|FG000|Triple Therapy|Withdrawal by Subject|0|||
48748136|NCT02548650|156926458|FG001|Triple Therapy|Withdrawal by Subject|4|||
48748137|NCT02548650|156926457|FG000|Double Therapy|Adverse Event|1|||
48748138|NCT02548650|156926458|FG001|Double Therapy|Adverse Event|1|||
48748139|NCT02548650|156926457|FG000|Double Therapy|Withdrawal by Subject|0|||
48748140|NCT02548650|156926458|FG001|Double Therapy|Withdrawal by Subject|1|||
48748141|NCT02244606|156926463|FG000|Overall Study|Adverse Event|0|||
48639628|NCT01783444|156538249|FG001|Treatment Phase|Withdrawal by Subject|8|||
48639629|NCT01783444|156538250|FG002|Treatment Phase|Withdrawal by Subject|9|||
48639630|NCT01783444|156538248|FG000|Treatment Phase|Administrative problems|2|||
48639631|NCT01783444|156538249|FG001|Treatment Phase|Administrative problems|0|||
48639632|NCT01783444|156538250|FG002|Treatment Phase|Administrative problems|1|||
48639633|NCT01783444|156538248|FG000|Treatment Phase|Physician Decision|8|||
48639634|NCT01783444|156538249|FG001|Treatment Phase|Physician Decision|6|||
48639635|NCT01783444|156538250|FG002|Treatment Phase|Physician Decision|5|||
48639636|NCT01783444|156538248|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
48639637|NCT01783444|156538249|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
48639638|NCT01783444|156538250|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
48639639|NCT01783444|156538248|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
48639640|NCT01783444|156538249|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
48639641|NCT01783444|156538250|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
48639642|NCT01783444|156538248|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
48639643|NCT01783444|156538249|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
48639644|NCT01783444|156538250|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
48748142|NCT02244606|156926464|FG001|Overall Study|Adverse Event|1|||
48748143|NCT02244606|156926465|FG002|Overall Study|Adverse Event|1|||
48748144|NCT02244606|156926466|FG003|Overall Study|Adverse Event|0|||
48748145|NCT02244606|156926463|FG000|Overall Study|Lost to Follow-up|2|||
48748146|NCT02244606|156926464|FG001|Overall Study|Lost to Follow-up|2|||
48748147|NCT02244606|156926465|FG002|Overall Study|Lost to Follow-up|1|||
48748148|NCT02244606|156926466|FG003|Overall Study|Lost to Follow-up|0|||
48748149|NCT02244606|156926463|FG000|Overall Study|Protocol Violation|0|||
48748150|NCT02244606|156926464|FG001|Overall Study|Protocol Violation|0|||
48748151|NCT02244606|156926465|FG002|Overall Study|Protocol Violation|0|||
48748152|NCT02244606|156926466|FG003|Overall Study|Protocol Violation|1|||
48748153|NCT02244606|156926463|FG000|Overall Study|Withdrawal by Subject|1|||
48748154|NCT02244606|156926464|FG001|Overall Study|Withdrawal by Subject|1|||
48748155|NCT02244606|156926465|FG002|Overall Study|Withdrawal by Subject|0|||
48748156|NCT02244606|156926466|FG003|Overall Study|Withdrawal by Subject|0|||
48748157|NCT02244606|156926463|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
48748158|NCT02244606|156926464|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
48748159|NCT02244606|156926465|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
48748160|NCT02244606|156926466|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
48748161|NCT01678911|156926472|FG000|Second Intervention|Lost to Follow-up|2|||
48748162|NCT01678911|156926473|FG001|Second Intervention|Lost to Follow-up|0|||
48639645|NCT01783444|156538248|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
48639646|NCT01783444|156538249|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
48748163|NCT02036294|156926474|FG000|Overall Study|Death|7|||
48748164|NCT02036294|156926475|FG001|Overall Study|Death|8|||
48748165|NCT02036294|156926474|FG000|Overall Study|Withdrawal by Subject|2|||
48328495|NCT02807857|155400192|FG000|Follow-Up Set|Withdrawal by Subject|8|||
48639647|NCT01783444|156538250|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
48639648|NCT01783444|156538248|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
48639649|NCT01783444|156538249|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
48639650|NCT01783444|156538250|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
48748166|NCT02036294|156926475|FG001|Overall Study|Withdrawal by Subject|3|||
48748167|NCT01854710|156926480|FG000|Overall Study|Withdrawal by Subject|2|||
48748168|NCT01854710|156926481|FG001|Overall Study|Withdrawal by Subject|1|||
48748169|NCT01854710|156926482|FG002|Overall Study|Withdrawal by Subject|0|||
48748170|NCT01854710|156926483|FG003|Overall Study|Withdrawal by Subject|0|||
48748171|NCT01854710|156926484|FG004|Overall Study|Withdrawal by Subject|0|||
48748172|NCT01854710|156926485|FG005|Overall Study|Withdrawal by Subject|0|||
48639651|NCT01783444|156538248|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
48639652|NCT01783444|156538249|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
48748173|NCT01854710|156926480|FG000|Overall Study|CRI procedural error|2|||
48748174|NCT01854710|156926481|FG001|Overall Study|CRI procedural error|2|||
48639653|NCT01783444|156538250|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
48639654|NCT05111145|156538251|FG000|Overall Study|Commercial drug is available for participant|76|||
48639655|NCT05111145|156538251|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
48639656|NCT05246514|156538260|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
48639657|NCT05246514|156538260|FG000|Overall Study|Withdrawal by Subject|1|||
48639658|NCT05246514|156538260|FG000|Overall Study|Death|13|||
48639659|NCT04401267|156538261|FG000|Overall Study|Death|0|||
48639660|NCT04401267|156538262|FG001|Overall Study|Death|1|||
48639661|NCT04401267|156538261|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
48639662|NCT04401267|156538262|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
48639663|NCT04401267|156538261|FG000|Overall Study|Found to be Ineligible|1|||
48639664|NCT04401267|156538262|FG001|Overall Study|Found to be Ineligible|0|||
48639665|NCT01581684|156538263|FG000|Overall Study|Other reason not defined|0|||
48639666|NCT01581684|156538264|FG001|Overall Study|Other reason not defined|0|||
48639667|NCT01581684|156538265|FG002|Overall Study|Other reason not defined|0|||
48639668|NCT01581684|156538266|FG003|Overall Study|Other reason not defined|0|||
48639669|NCT01581684|156538267|FG004|Overall Study|Other reason not defined|0|||
48639670|NCT01581684|156538268|FG005|Overall Study|Other reason not defined|0|||
48639671|NCT01581684|156538269|FG006|Overall Study|Other reason not defined|0|||
48639672|NCT01581684|156538270|FG007|Overall Study|Other reason not defined|0|||
48639673|NCT01581684|156538271|FG008|Overall Study|Other reason not defined|1|||
48639674|NCT01581684|156538272|FG009|Overall Study|Other reason not defined|0|||
48639675|NCT02986074|156538273|FG000|First Trial Period|Adverse Event|1|||
48639676|NCT02986074|156538274|FG001|First Trial Period|Adverse Event|0|||
48639677|NCT02986074|156538275|FG002|First Trial Period|Adverse Event|0|||
48639678|NCT02986074|156538276|FG003|First Trial Period|Adverse Event|0|||
48639679|NCT02986074|156538273|FG000|Follow up Period|system explant|0|||
48639680|NCT02986074|156538274|FG001|Follow up Period|system explant|0|||
48639681|NCT02986074|156538275|FG002|Follow up Period|system explant|1|||
48639682|NCT02986074|156538276|FG003|Follow up Period|system explant|2|||
48639683|NCT02986074|156538273|FG000|Follow up Period|Physician Decision|0|||
48639684|NCT02986074|156538274|FG001|Follow up Period|Physician Decision|0|||
48639685|NCT02986074|156538275|FG002|Follow up Period|Physician Decision|0|||
48639686|NCT02986074|156538276|FG003|Follow up Period|Physician Decision|1|||
48639687|NCT05227209|156538277|FG000|Overall Study|Adverse Event|11|||
48639688|NCT05227209|156538277|FG000|Overall Study|Lost to Follow-up|1|||
48639689|NCT05227209|156538277|FG000|Overall Study|Withdrawal by Subject|7|||
48639690|NCT05227209|156538277|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
48639691|NCT02896257|156538278|FG000|Providers|Without eligible patients|21|||
48639692|NCT02896257|156538279|FG001|Providers|Without eligible patients|28|||
48639693|NCT02896257|156538278|FG000|Patients|PFT entry criteria not met|43|||
48639694|NCT02896257|156538279|FG001|Patients|PFT entry criteria not met|50|||
48639695|NCT02896257|156538278|FG000|Patients|No capacity to review|8|||
48639696|NCT02896257|156538279|FG001|Patients|No capacity to review|11|||
48639697|NCT02896257|156538278|FG000|Patients|Appointment rescheduled/cancelled|5|||
48639698|NCT02896257|156538279|FG001|Patients|Appointment rescheduled/cancelled|7|||
48639699|NCT02896257|156538278|FG000|Patients|PCP not assigned a clinic|4|||
48639700|NCT02896257|156538279|FG001|Patients|PCP not assigned a clinic|0|||
48639701|NCT02896257|156538278|FG000|Patients|No history of COPD|0|||
48639702|NCT02896257|156538279|FG001|Patients|No history of COPD|1|||
48639703|NCT02896257|156538278|FG000|Patients|Deceased between review and index date|0|||
48639704|NCT02896257|156538279|FG001|Patients|Deceased between review and index date|1|||
48639705|NCT02896257|156538278|FG000|Patients|No ICS Rx upon review|1|||
48639706|NCT02896257|156538279|FG001|Patients|No ICS Rx upon review|1|||
48639707|NCT02896257|156538278|FG000|Patients|Protocol Violation|2|||
48639708|NCT02896257|156538279|FG001|Patients|Protocol Violation|1|||
48639709|NCT02896257|156538278|FG000|Patients|Hospice care|0|||
48639710|NCT02896257|156538279|FG001|Patients|Hospice care|1|||
48639711|NCT01944020|156538280|FG000|Overall Study|Withdrawal by Subject|5|||
48639712|NCT01944020|156538281|FG001|Overall Study|Withdrawal by Subject|0|||
48639713|NCT01206517|156538282|FG000|Overall Study|Withdrawal by Subject|0|||
48639714|NCT01206517|156538283|FG001|Overall Study|Withdrawal by Subject|0|||
48639715|NCT01206517|156538284|FG002|Overall Study|Withdrawal by Subject|2|||
48639716|NCT01206517|156538285|FG003|Overall Study|Withdrawal by Subject|0|||
48639717|NCT01206517|156538286|FG004|Overall Study|Withdrawal by Subject|1|||
48639718|NCT01206517|156538287|FG005|Overall Study|Withdrawal by Subject|0|||
48639719|NCT00560508|156538289|FG000|12 Week Double-blind Period|Adverse Event|3|||
48639720|NCT00560508|156538290|FG001|12 Week Double-blind Period|Adverse Event|2|||
48639721|NCT00560508|156538289|FG000|12 Week Double-blind Period|Protocol Violation|1|||
48639722|NCT00560508|156538290|FG001|12 Week Double-blind Period|Protocol Violation|0|||
48639723|NCT00560508|156538289|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
48639724|NCT00560508|156538290|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
48639725|NCT00560508|156538289|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
48639726|NCT00560508|156538290|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
48639727|NCT00560508|156538289|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
48748175|NCT01854710|156926482|FG002|Overall Study|CRI procedural error|2|||
48748176|NCT01854710|156926483|FG003|Overall Study|CRI procedural error|2|||
48748177|NCT01854710|156926484|FG004|Overall Study|CRI procedural error|2|||
48328496|NCT02807857|155400192|FG000|Follow-Up Set|Lost to Follow-up|7|||
48328497|NCT02807857|155400192|FG000|Follow-Up Set|Physician Decision|6|||
48328498|NCT02807857|155400192|FG000|Follow-Up Set|Adverse Event|3|||
48328499|NCT02807857|155400192|FG000|Follow-Up Set|Death|27|||
48328500|NCT02807857|155400192|FG000|Follow-Up Set|Relocation|2|||
48328501|NCT00738400|155400198|FG000|Overall Study|Adverse Event|3|||
48639728|NCT00560508|156538290|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
48328502|NCT00738400|155400199|FG001|Overall Study|Adverse Event|1|||
48328503|NCT00738400|155400198|FG000|Overall Study|Withdrawal by Subject|0|||
48328504|NCT00738400|155400199|FG001|Overall Study|Withdrawal by Subject|1|||
48328505|NCT00738400|155400198|FG000|Overall Study|Lack of Efficacy|0|||
48328506|NCT00738400|155400199|FG001|Overall Study|Lack of Efficacy|1|||
48639729|NCT00560508|156538289|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
48639730|NCT00560508|156538290|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
48639731|NCT00560508|156538289|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
48639732|NCT00560508|156538290|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
48639733|NCT01354223|156538291|FG000|Overall Study|Withdrawal by Subject|3|||
48639734|NCT01354223|156538292|FG001|Overall Study|Withdrawal by Subject|1|||
48328507|NCT00738400|155400198|FG000|Overall Study|Lost to Follow-up|0|||
48328508|NCT00738400|155400199|FG001|Overall Study|Lost to Follow-up|3|||
48328509|NCT00738400|155400198|FG000|Overall Study|Protocol Violation|1|||
48328510|NCT00738400|155400199|FG001|Overall Study|Protocol Violation|0|||
48328511|NCT00738400|155400198|FG000|Overall Study|Non-compliant with study medication|0|||
48328512|NCT00738400|155400199|FG001|Overall Study|Non-compliant with study medication|1|||
48328513|NCT01307800|155400200|FG000|Overall Study|Adverse Event|9|||
48328514|NCT01307800|155400201|FG001|Overall Study|Adverse Event|8|||
48328515|NCT01307800|155400202|FG002|Overall Study|Adverse Event|10|||
48328516|NCT01307800|155400203|FG003|Overall Study|Adverse Event|14|||
48328517|NCT01307800|155400200|FG000|Overall Study|Entry Criteria Not Met|0|||
48328518|NCT01307800|155400201|FG001|Overall Study|Entry Criteria Not Met|0|||
48328519|NCT01307800|155400202|FG002|Overall Study|Entry Criteria Not Met|0|||
48328520|NCT01307800|155400203|FG003|Overall Study|Entry Criteria Not Met|2|||
48328521|NCT01307800|155400200|FG000|Overall Study|Lost to Follow-up|5|||
48328522|NCT01307800|155400201|FG001|Overall Study|Lost to Follow-up|6|||
48328523|NCT01307800|155400202|FG002|Overall Study|Lost to Follow-up|2|||
48328524|NCT01307800|155400203|FG003|Overall Study|Lost to Follow-up|8|||
48328525|NCT01307800|155400200|FG000|Overall Study|Perceived Lack of Efficacy|24|||
48328526|NCT01307800|155400201|FG001|Overall Study|Perceived Lack of Efficacy|23|||
48328527|NCT01307800|155400202|FG002|Overall Study|Perceived Lack of Efficacy|20|||
48328528|NCT01307800|155400203|FG003|Overall Study|Perceived Lack of Efficacy|33|||
48328529|NCT01307800|155400200|FG000|Overall Study|Protocol Violation|0|||
48328530|NCT01307800|155400201|FG001|Overall Study|Protocol Violation|3|||
48328531|NCT01307800|155400202|FG002|Overall Study|Protocol Violation|4|||
48328532|NCT01307800|155400203|FG003|Overall Study|Protocol Violation|5|||
48328533|NCT01307800|155400200|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
48639735|NCT01192126|156538293|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
48639736|NCT01192126|156538294|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
48639737|NCT01192126|156538293|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
48639738|NCT01192126|156538294|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
48639739|NCT04102007|156538298|FG000|Overall Study|Adverse Event|4|||
48639740|NCT04102007|156538298|FG000|Overall Study|Lost to Follow-up|3|||
48639741|NCT04102007|156538298|FG000|Overall Study|Withdrawal by Subject|12|||
48639742|NCT04102007|156538298|FG000|Overall Study|Eligibility Violation|5|||
48639743|NCT04102007|156538298|FG000|Overall Study|Lack of Efficacy|6|||
48639744|NCT04102007|156538298|FG000|Overall Study|Protocol Deviation|5|||
48639745|NCT04102007|156538298|FG000|Overall Study|Protocol Compliance|1|||
48639746|NCT04102007|156538298|FG000|Overall Study|Withdrew Treatment|2|||
48639747|NCT04102007|156538298|FG000|Overall Study|Pregnancy|1|||
48639748|NCT00692003|156538301|FG000|Overall Study|Sponsor Decision|5|||
48639749|NCT00692003|156538302|FG001|Overall Study|Sponsor Decision|1|||
48639750|NCT03289143|156538303|FG000|Overall Study|Caregiver Unavailability|1|||
48639751|NCT03289143|156538304|FG001|Overall Study|Caregiver Unavailability|1|||
48639752|NCT03289143|156538305|FG002|Overall Study|Caregiver Unavailability|0|||
48748178|NCT01854710|156926485|FG005|Overall Study|CRI procedural error|2|||
48328534|NCT01307800|155400201|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
48328535|NCT01307800|155400202|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
48328536|NCT01307800|155400203|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
48328537|NCT01307800|155400200|FG000|Overall Study|Sponsor Decision|6|||
48328538|NCT01307800|155400201|FG001|Overall Study|Sponsor Decision|9|||
48328539|NCT01307800|155400202|FG002|Overall Study|Sponsor Decision|12|||
48639753|NCT03289143|156538306|FG003|Overall Study|Caregiver Unavailability|0|||
48639754|NCT03289143|156538303|FG000|Overall Study|Research Department Closure|0|||
48748179|NCT00982878|156926486|FG000|Overall Study|Physician Decision|1|||
48748180|NCT03132220|156926487|FG000|Overall Study|Lost to Follow-up|17|||
48748181|NCT03132220|156926488|FG001|Overall Study|Lost to Follow-up|8|||
48748182|NCT03132220|156926487|FG000|Overall Study|Withdrawal by Subject|1|||
48328540|NCT01307800|155400203|FG003|Overall Study|Sponsor Decision|28|||
48328541|NCT01307800|155400200|FG000|Overall Study|Withdrawal by Subject|10|||
48328542|NCT01307800|155400201|FG001|Overall Study|Withdrawal by Subject|11|||
48328543|NCT01307800|155400202|FG002|Overall Study|Withdrawal by Subject|8|||
48328544|NCT01307800|155400203|FG003|Overall Study|Withdrawal by Subject|15|||
48328545|NCT01307800|155400200|FG000|Overall Study|Participant Moved|0|||
48328546|NCT01307800|155400201|FG001|Overall Study|Participant Moved|2|||
48328547|NCT01307800|155400202|FG002|Overall Study|Participant Moved|1|||
48328548|NCT01307800|155400203|FG003|Overall Study|Participant Moved|3|||
48328549|NCT00667732|155400211|FG000|Run -In (8 Weeks)|Adverse Event|4|||
48328550|NCT00667732|155400212|FG001|Run -In (8 Weeks)|Adverse Event|0|||
48328551|NCT00667732|155400213|FG002|Run -In (8 Weeks)|Adverse Event|0|||
48328552|NCT00667732|155400211|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
48328553|NCT00667732|155400212|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
48328554|NCT00667732|155400213|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
48328555|NCT00667732|155400211|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
48328556|NCT00667732|155400212|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
48328557|NCT00667732|155400213|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
48328558|NCT03890484|155400214|FG000|Overall Study|Lost to Follow-up|1|||
48328559|NCT03890484|155400215|FG001|Overall Study|Lost to Follow-up|1|||
48328560|NCT02993926|155400216|FG000|Enantone Treatment Phase|Adverse Event|1|||
48328561|NCT02993926|155400217|FG001|Enantone Treatment Phase|Adverse Event|0|||
48328562|NCT02993926|155400218|FG002|Enantone Treatment Phase|Adverse Event|0|||
48328563|NCT02993926|155400216|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
48328564|NCT02993926|155400217|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
48328565|NCT02993926|155400218|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
48328566|NCT02993926|155400216|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
48328567|NCT02993926|155400217|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
48328568|NCT02993926|155400218|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
48328569|NCT02993926|155400216|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
48328570|NCT02993926|155400217|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
48328571|NCT02993926|155400218|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
48328572|NCT00452114|155400219|FG000|Overall Study|Physician Decision|3|||
48328573|NCT00452114|155400220|FG001|Overall Study|Physician Decision|3|||
48328574|NCT00518206|155400221|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
48328575|NCT00518206|155400222|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
48328576|NCT00518206|155400221|FG000|Overall Study|Withdrawal by Subject|2|||
48328577|NCT00518206|155400222|FG001|Overall Study|Withdrawal by Subject|0|||
48328578|NCT00518206|155400221|FG000|Overall Study|Drug Supply Issue|1|||
48328579|NCT00518206|155400222|FG001|Overall Study|Drug Supply Issue|0|||
48328580|NCT00518206|155400221|FG000|Overall Study|Reason Unknown|1|||
48328581|NCT00518206|155400222|FG001|Overall Study|Reason Unknown|0|||
48328582|NCT00518206|155400221|FG000|Overall Study|Completion Status Unknown|1|||
48328583|NCT00518206|155400222|FG001|Overall Study|Completion Status Unknown|0|||
48328584|NCT03075878|155400223|FG000|Overall Study|Physician Decision|1|||
48328585|NCT01898299|155400229|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
48328586|NCT01898299|155400230|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
48328587|NCT03122548|155400234|FG000|Overall Study|Death|2|||
48328588|NCT03122548|155400234|FG000|Overall Study|Progression - subject went into hospice|1|||
48328589|NCT03122548|155400234|FG000|Overall Study|Study Terminated by Sponsor|2|||
48328590|NCT01719172|155401713|FG000|Overall Study|Lost to Follow-up|1|||
48328591|NCT01719172|155401713|FG000|Overall Study|Death|1|||
48328592|NCT01673594|155401714|FG000|Overall Study|Adverse Event|3|||
48328593|NCT01673594|155401715|FG001|Overall Study|Adverse Event|1|||
48328594|NCT01673594|155401714|FG000|Overall Study|Lost to Follow-up|1|||
48328595|NCT01673594|155401715|FG001|Overall Study|Lost to Follow-up|0|||
48328596|NCT01673594|155401714|FG000|Overall Study|Physician Decision|2|||
48328597|NCT01673594|155401715|FG001|Overall Study|Physician Decision|4|||
48328598|NCT01673594|155401714|FG000|Overall Study|Withdrawal by Subject|0|||
48328599|NCT01673594|155401715|FG001|Overall Study|Withdrawal by Subject|1|||
48328600|NCT01450007|155401719|FG000|Overall Study|Late exclusion before treatment|2|||
48639755|NCT03289143|156538304|FG001|Overall Study|Research Department Closure|0|||
48639756|NCT03289143|156538305|FG002|Overall Study|Research Department Closure|1|||
48639757|NCT03289143|156538306|FG003|Overall Study|Research Department Closure|0|||
48639758|NCT03289143|156538303|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
48639759|NCT03289143|156538304|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
48639760|NCT03289143|156538305|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
48639761|NCT03289143|156538306|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
48639762|NCT03289143|156538303|FG000|Overall Study|Medical Monitor Decision|1|||
48639763|NCT03289143|156538304|FG001|Overall Study|Medical Monitor Decision|0|||
48748183|NCT03132220|156926488|FG001|Overall Study|Withdrawal by Subject|4|||
48426945|NCT04705597|155752885|FG001|Overall Study|Death|9|||
48328601|NCT01450007|155401720|FG001|Overall Study|Late exclusion before treatment|3|||
48328602|NCT01450007|155401721|FG002|Overall Study|Late exclusion before treatment|2|||
48328603|NCT01450007|155401719|FG000|Overall Study|Protocol Violation|0|||
48328604|NCT01450007|155401720|FG001|Overall Study|Protocol Violation|1|||
48328605|NCT01450007|155401721|FG002|Overall Study|Protocol Violation|1|||
48328606|NCT01450007|155401719|FG000|Overall Study|Adverse Event|0|||
48328607|NCT01450007|155401720|FG001|Overall Study|Adverse Event|1|||
48328608|NCT01450007|155401721|FG002|Overall Study|Adverse Event|0|||
48328609|NCT00599196|155401723|FG000|Overall Study|Lack of Efficacy|22|||
48328610|NCT00599196|155401723|FG000|Overall Study|Adverse Event|93|||
48328611|NCT00599196|155401723|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
48639764|NCT03289143|156538305|FG002|Overall Study|Medical Monitor Decision|0|||
48639765|NCT03289143|156538306|FG003|Overall Study|Medical Monitor Decision|0|||
48639766|NCT03289143|156538303|FG000|Overall Study|Participant Non-Compliance|0|||
48639767|NCT03289143|156538304|FG001|Overall Study|Participant Non-Compliance|0|||
48748184|NCT01336764|156926489|FG000|Overall Study|Withdrawal by Subject|5|||
48748185|NCT01336764|156926490|FG001|Overall Study|Withdrawal by Subject|5|||
48748186|NCT03167411|156926491|FG000|Overall Study|Adverse Event|0|||
48748187|NCT03167411|156926492|FG001|Overall Study|Adverse Event|1|||
48748188|NCT01906008|156926493|FG000|Overall Study|Lost to Follow-up|2|||
48748189|NCT01906008|156926494|FG001|Overall Study|Lost to Follow-up|0|||
48748190|NCT01906008|156926493|FG000|Overall Study|Oxaliplatin toxicity|2|||
48748191|NCT01906008|156926494|FG001|Overall Study|Oxaliplatin toxicity|0|||
48748192|NCT01906008|156926493|FG000|Overall Study|Protocol Violation|0|||
48748193|NCT01906008|156926494|FG001|Overall Study|Protocol Violation|1|||
48748194|NCT01906008|156926493|FG000|Overall Study|Withdrawal by Subject|1|||
48748195|NCT01906008|156926494|FG001|Overall Study|Withdrawal by Subject|5|||
48748196|NCT01906008|156926493|FG000|Overall Study|Did not start study med|3|||
48748197|NCT01906008|156926494|FG001|Overall Study|Did not start study med|4|||
48639768|NCT03289143|156538305|FG002|Overall Study|Participant Non-Compliance|1|||
48639769|NCT03289143|156538306|FG003|Overall Study|Participant Non-Compliance|0|||
48639770|NCT03289143|156538303|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
48639771|NCT03289143|156538304|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
48639772|NCT03289143|156538305|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
48639773|NCT03289143|156538306|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
48639774|NCT03289143|156538303|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
48639775|NCT03289143|156538304|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
48639776|NCT03289143|156538305|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
48639777|NCT03289143|156538306|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
48639778|NCT03289143|156538303|FG000|Overall Study|Caregiver Passed Away|1|||
48639779|NCT03289143|156538304|FG001|Overall Study|Caregiver Passed Away|0|||
48639780|NCT03289143|156538305|FG002|Overall Study|Caregiver Passed Away|0|||
48639781|NCT03289143|156538306|FG003|Overall Study|Caregiver Passed Away|0|||
48639782|NCT03289143|156538303|FG000|Overall Study|Physician Decision|0|||
48639783|NCT03289143|156538304|FG001|Overall Study|Physician Decision|2|||
48639784|NCT03289143|156538305|FG002|Overall Study|Physician Decision|2|||
48639785|NCT03289143|156538306|FG003|Overall Study|Physician Decision|2|||
48639786|NCT03289143|156538303|FG000|Overall Study|Protocol Deviation|2|||
48639787|NCT03289143|156538304|FG001|Overall Study|Protocol Deviation|1|||
48639788|NCT03289143|156538305|FG002|Overall Study|Protocol Deviation|3|||
48639789|NCT03289143|156538306|FG003|Overall Study|Protocol Deviation|1|||
48639790|NCT03289143|156538303|FG000|Overall Study|Study Terminated By Sponsor|101|||
48639791|NCT03289143|156538304|FG001|Overall Study|Study Terminated By Sponsor|75|||
48639792|NCT03289143|156538305|FG002|Overall Study|Study Terminated By Sponsor|100|||
48639793|NCT03289143|156538306|FG003|Overall Study|Study Terminated By Sponsor|69|||
48639794|NCT03289143|156538303|FG000|Overall Study|Withdrawal by Subject|14|||
48639795|NCT03289143|156538304|FG001|Overall Study|Withdrawal by Subject|6|||
48639796|NCT03289143|156538305|FG002|Overall Study|Withdrawal by Subject|14|||
48639797|NCT03289143|156538306|FG003|Overall Study|Withdrawal by Subject|12|||
48748198|NCT01906008|156926493|FG000|Overall Study|Oxaliplatin stops|10|||
48748199|NCT01906008|156926494|FG001|Overall Study|Oxaliplatin stops|8|||
48639798|NCT03289143|156538303|FG000|Overall Study|Adverse Event|10|||
48748200|NCT01906008|156926493|FG000|Overall Study|Hospice|1|||
48639799|NCT03289143|156538304|FG001|Overall Study|Adverse Event|7|||
48639800|NCT03289143|156538305|FG002|Overall Study|Adverse Event|6|||
48639801|NCT03289143|156538306|FG003|Overall Study|Adverse Event|5|||
48639802|NCT03289143|156538303|FG000|Overall Study|Death|2|||
48639803|NCT03289143|156538304|FG001|Overall Study|Death|0|||
48748201|NCT01906008|156926494|FG001|Overall Study|Hospice|0|||
48748202|NCT01906008|156926493|FG000|Overall Study|Physician Decision|3|||
48748203|NCT01906008|156926494|FG001|Overall Study|Physician Decision|3|||
48748204|NCT01906008|156926493|FG000|Overall Study|Lack of compliance of study med|5|||
48328612|NCT00599196|155401723|FG000|Overall Study|Subject withdrew consent|43|||
48748205|NCT01906008|156926494|FG001|Overall Study|Lack of compliance of study med|3|||
48328613|NCT00599196|155401723|FG000|Overall Study|Study ended per sponsor|197|||
48748206|NCT01906008|156926493|FG000|Overall Study|Adverse Event|0|||
48748207|NCT01906008|156926494|FG001|Overall Study|Adverse Event|3|||
48639804|NCT03289143|156538305|FG002|Overall Study|Death|2|||
48639805|NCT03289143|156538306|FG003|Overall Study|Death|1|||
48639806|NCT03289143|156538303|FG000|Overall Study|Lost to Follow-up|2|||
48639807|NCT03289143|156538304|FG001|Overall Study|Lost to Follow-up|1|||
48639808|NCT03289143|156538305|FG002|Overall Study|Lost to Follow-up|1|||
48639809|NCT03289143|156538306|FG003|Overall Study|Lost to Follow-up|0|||
48639810|NCT03289143|156538303|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
48639811|NCT03289143|156538304|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
48639812|NCT03289143|156538305|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
48639813|NCT03289143|156538306|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
48639814|NCT03289143|156538303|FG000|Overall Study|Withdrawal by Caregiver|0|||
48639815|NCT03289143|156538304|FG001|Overall Study|Withdrawal by Caregiver|1|||
48639816|NCT03289143|156538305|FG002|Overall Study|Withdrawal by Caregiver|0|||
48639817|NCT03289143|156538306|FG003|Overall Study|Withdrawal by Caregiver|0|||
48639818|NCT03289143|156538303|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
48639819|NCT03289143|156538304|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
48639820|NCT03289143|156538305|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
48639821|NCT03289143|156538306|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
48639822|NCT03289143|156538303|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
48639823|NCT03289143|156538304|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
48639824|NCT03289143|156538305|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
48639825|NCT03289143|156538306|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
48639826|NCT04950660|156538307|FG000|Overall Study|Protocol Violation|4|||
48639827|NCT04950660|156538308|FG001|Overall Study|Protocol Violation|2|||
48639828|NCT04950660|156538307|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
48639829|NCT04950660|156538308|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
48639830|NCT04950660|156538307|FG000|Overall Study|Withdrawal by Subject|0|||
48639831|NCT04950660|156538308|FG001|Overall Study|Withdrawal by Subject|1|||
48639832|NCT04950660|156538307|FG000|Overall Study|Hypotension|1|||
48639833|NCT04950660|156538308|FG001|Overall Study|Hypotension|0|||
48639834|NCT00339040|156538309|FG000|Stage I|Not able to attend clinic|1|||
48639835|NCT00339040|156538310|FG001|Stage I|Not able to attend clinic|0|||
48639836|NCT00339040|156538309|FG000|Stage I|Protocol Violation|1|||
48639837|NCT00339040|156538310|FG001|Stage I|Protocol Violation|1|||
48639838|NCT00339040|156538309|FG000|Stage II|Lost to Follow-up|3|||
48639839|NCT00339040|156538310|FG001|Stage II|Lost to Follow-up|0|||
48639840|NCT00339040|156538309|FG000|Stage II|Withdrawal by Subject|1|||
48639841|NCT00339040|156538310|FG001|Stage II|Withdrawal by Subject|2|||
48639842|NCT00339040|156538309|FG000|Stage II|Protocol Violation|3|||
48328614|NCT00599196|155401723|FG000|Overall Study|Lost to Follow-up|17|||
48328615|NCT00599196|155401723|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
48639843|NCT00339040|156538310|FG001|Stage II|Protocol Violation|0|||
48639844|NCT00339040|156538309|FG000|Stage II|Not able to attend clinic|1|||
48639845|NCT00339040|156538310|FG001|Stage II|Not able to attend clinic|0|||
48748208|NCT00673465|156926501|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748209|NCT00673465|156926502|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748210|NCT00673465|156926503|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748211|NCT00673465|156926504|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748212|NCT00673465|156926505|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
48748213|NCT00673465|156926506|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
48748214|NCT00673465|156926507|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748215|NCT00673465|156926508|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748216|NCT00673465|156926509|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748217|NCT00673465|156926510|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
48328616|NCT00599196|155401723|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
48328617|NCT00599196|155401723|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
48328618|NCT00599196|155401723|FG000|Overall Study|Other: Pt Moved To Australia|1|||
48328619|NCT00599196|155401723|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
48328620|NCT00599196|155401723|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
48639846|NCT00339040|156538309|FG000|Stage II|Site closing|2|||
48639847|NCT00339040|156538310|FG001|Stage II|Site closing|0|||
48639848|NCT02136914|156538313|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
48639849|NCT02136914|156538314|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
48639850|NCT02136914|156538313|FG000|Overall Study|Withdrawal by Subject|3|||
48639851|NCT02136914|156538314|FG001|Overall Study|Withdrawal by Subject|10|||
48748218|NCT00673465|156926511|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748219|NCT00673465|156926512|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
48748220|NCT00673465|156926501|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
48639852|NCT02136914|156538313|FG000|Overall Study|Subject Unwilling to Proceed|7|||
48328621|NCT04497415|155401724|FG000|Overall Study|Lost to Follow-up|43|||
48639853|NCT02136914|156538314|FG001|Overall Study|Subject Unwilling to Proceed|2|||
48639854|NCT02136914|156538313|FG000|Overall Study|Lost to Follow-up|1|||
48639855|NCT02136914|156538314|FG001|Overall Study|Lost to Follow-up|1|||
48639856|NCT02136914|156538313|FG000|Overall Study|Did Not Receive Study Drug|2|||
48639857|NCT02136914|156538314|FG001|Overall Study|Did Not Receive Study Drug|0|||
48639858|NCT02136914|156538313|FG000|Overall Study|Lack of Efficacy|1|||
48639859|NCT02136914|156538314|FG001|Overall Study|Lack of Efficacy|0|||
48639860|NCT02136914|156538313|FG000|Overall Study|Death|0|||
48639861|NCT02136914|156538314|FG001|Overall Study|Death|1|||
48639862|NCT03692403|156538316|FG000|Overall Study|Withdrawal by Subject|1|||
48639863|NCT03692403|156538317|FG001|Overall Study|Withdrawal by Subject|0|||
48639864|NCT03692403|156538318|FG002|Overall Study|Withdrawal by Subject|1|||
48639865|NCT03692403|156538319|FG003|Overall Study|Withdrawal by Subject|0|||
48639866|NCT03692403|156538316|FG000|Overall Study|Adverse Event|0|||
48639867|NCT03692403|156538317|FG001|Overall Study|Adverse Event|0|||
48639868|NCT03692403|156538318|FG002|Overall Study|Adverse Event|0|||
48639869|NCT03692403|156538319|FG003|Overall Study|Adverse Event|1|||
48639870|NCT03692403|156538316|FG000|Overall Study|Pregnancy|0|||
48639871|NCT03692403|156538317|FG001|Overall Study|Pregnancy|1|||
48639872|NCT03692403|156538318|FG002|Overall Study|Pregnancy|0|||
48639873|NCT03692403|156538319|FG003|Overall Study|Pregnancy|0|||
48639874|NCT03692403|156538316|FG000|Overall Study|Other|0|||
48639875|NCT03692403|156538317|FG001|Overall Study|Other|0|||
48639876|NCT03692403|156538318|FG002|Overall Study|Other|1|||
48639877|NCT03692403|156538319|FG003|Overall Study|Other|0|||
48639878|NCT04567524|156538320|FG000|Overall Study|Adverse Event|1|||
48639879|NCT04567524|156538321|FG001|Overall Study|Adverse Event|1|||
48639880|NCT04567524|156538322|FG002|Overall Study|Adverse Event|0|||
48639881|NCT04567524|156538323|FG003|Overall Study|Adverse Event|0|||
48639882|NCT04567524|156538320|FG000|Overall Study|Withdrawal by Subject|2|||
48639883|NCT04567524|156538321|FG001|Overall Study|Withdrawal by Subject|0|||
48639884|NCT04567524|156538322|FG002|Overall Study|Withdrawal by Subject|0|||
48639885|NCT04567524|156538323|FG003|Overall Study|Withdrawal by Subject|1|||
48639886|NCT01008618|156538326|FG000|Period 1 (Titration Period)|Physician Decision|2|||
48639887|NCT01008618|156538327|FG001|Period 1 (Titration Period)|Physician Decision|0|||
48639888|NCT01008618|156538328|FG002|Period 1 (Titration Period)|Physician Decision|0|||
48639889|NCT01008618|156538326|FG000|Period 1 (Titration Period)|Adverse Event|33|||
48639890|NCT01008618|156538327|FG001|Period 1 (Titration Period)|Adverse Event|0|||
48639891|NCT01008618|156538328|FG002|Period 1 (Titration Period)|Adverse Event|0|||
48639892|NCT01008618|156538326|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
48639893|NCT01008618|156538327|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
48639894|NCT01008618|156538328|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
48639895|NCT01008618|156538326|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
48639896|NCT01008618|156538327|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
48639897|NCT01008618|156538328|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
48639898|NCT01008618|156538326|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
48639899|NCT01008618|156538327|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
48639900|NCT01008618|156538328|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
48639901|NCT01008618|156538326|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
48639902|NCT01008618|156538327|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
48639903|NCT01008618|156538328|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
48639904|NCT01008618|156538326|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
48639905|NCT01008618|156538327|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
48639906|NCT01008618|156538328|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
48639907|NCT01008618|156538326|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
48639908|NCT01008618|156538327|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
48639909|NCT01008618|156538328|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
48639910|NCT01008618|156538326|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
48639911|NCT01008618|156538327|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
48639912|NCT01008618|156538328|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
48639913|NCT01008618|156538326|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
48639914|NCT01008618|156538327|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
48328622|NCT04497415|155401725|FG001|Overall Study|Lost to Follow-up|27|||
48328623|NCT00263757|155401726|FG000|Overall Study|Withdrawal by Subject|5|||
48328624|NCT00263757|155401727|FG001|Overall Study|Withdrawal by Subject|4|||
48639915|NCT01008618|156538328|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
48328625|NCT00263757|155401726|FG000|Overall Study|Screen failure|0|||
48639916|NCT01008618|156538326|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
48639917|NCT01008618|156538327|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
48639918|NCT01008618|156538328|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
48639919|NCT01008618|156538326|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
48639920|NCT01008618|156538327|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
48639921|NCT01008618|156538328|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
48639922|NCT00487981|156538329|FG000|Overall Study|Hypothyroidism diagnosis|1|||
48639923|NCT00698828|156538332|FG000|Overall Study|Adverse Event|3|||
48639924|NCT00698828|156538333|FG001|Overall Study|Adverse Event|4|||
48639925|NCT00698828|156538334|FG002|Overall Study|Adverse Event|4|||
48639926|NCT00698828|156538332|FG000|Overall Study|Death|0|||
48639927|NCT00698828|156538333|FG001|Overall Study|Death|0|||
48639928|NCT00698828|156538334|FG002|Overall Study|Death|1|||
48639929|NCT00698828|156538332|FG000|Overall Study|Exacerbation of COPD|1|||
48639930|NCT00698828|156538333|FG001|Overall Study|Exacerbation of COPD|3|||
48639931|NCT00698828|156538334|FG002|Overall Study|Exacerbation of COPD|0|||
48639932|NCT00698828|156538332|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
48639933|NCT00698828|156538333|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
48639934|NCT00698828|156538334|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
48639935|NCT00698828|156538332|FG000|Overall Study|Investigator/Sponsor decision|1|||
48639936|NCT00698828|156538333|FG001|Overall Study|Investigator/Sponsor decision|0|||
48639937|NCT00698828|156538334|FG002|Overall Study|Investigator/Sponsor decision|2|||
48639938|NCT00698828|156538332|FG000|Overall Study|Lost to Follow-up|1|||
48639939|NCT00698828|156538333|FG001|Overall Study|Lost to Follow-up|1|||
48639940|NCT00698828|156538334|FG002|Overall Study|Lost to Follow-up|0|||
48639941|NCT00698828|156538332|FG000|Overall Study|Withdrew consent|0|||
48639942|NCT00698828|156538333|FG001|Overall Study|Withdrew consent|7|||
48639943|NCT00698828|156538334|FG002|Overall Study|Withdrew consent|4|||
48639944|NCT00698828|156538332|FG000|Overall Study|Withdrew consent (not treated)|2|||
48639945|NCT00698828|156538333|FG001|Overall Study|Withdrew consent (not treated)|0|||
48748221|NCT00673465|156926502|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748222|NCT00673465|156926503|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748223|NCT00673465|156926504|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748224|NCT00673465|156926505|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
48748225|NCT00673465|156926506|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748226|NCT00673465|156926507|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748227|NCT00673465|156926508|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748228|NCT00673465|156926509|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748229|NCT00673465|156926510|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748230|NCT00673465|156926511|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748231|NCT00673465|156926512|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
48748232|NCT00601458|156926513|FG000|Overall Study|Dosing Error|1|||
48748233|NCT00601458|156926514|FG001|Overall Study|Dosing Error|0|||
48748234|NCT00601458|156926515|FG002|Overall Study|Dosing Error|0|||
48748235|NCT00601458|156926513|FG000|Overall Study|Incomplete Data|0|||
48748236|NCT00601458|156926514|FG001|Overall Study|Incomplete Data|2|||
48748237|NCT00601458|156926515|FG002|Overall Study|Incomplete Data|0|||
48748238|NCT00601458|156926513|FG000|Overall Study|Protocol Violation|3|||
48748239|NCT00601458|156926514|FG001|Overall Study|Protocol Violation|2|||
48748240|NCT00601458|156926515|FG002|Overall Study|Protocol Violation|1|||
48748241|NCT00601458|156926513|FG000|Overall Study|Early Termination|0|||
48748242|NCT00601458|156926514|FG001|Overall Study|Early Termination|1|||
48748243|NCT00601458|156926515|FG002|Overall Study|Early Termination|1|||
48748244|NCT02670837|156926517|FG000|Overall Study|Death|2|||
48748245|NCT02670837|156926518|FG001|Overall Study|Death|0|||
48748246|NCT02670837|156926519|FG002|Overall Study|Death|0|||
48748247|NCT01276353|156926520|FG000|Double-blind|Adverse Event|2|||
48748248|NCT01276353|156926521|FG001|Double-blind|Adverse Event|0|||
48748249|NCT01276353|156926520|FG000|Double-blind|Withdrawal by Subject|1|||
48748250|NCT01276353|156926521|FG001|Double-blind|Withdrawal by Subject|0|||
48748251|NCT01276353|156926520|FG000|Extension|Adverse Event|2|||
48748252|NCT01276353|156926521|FG001|Extension|Adverse Event|5|||
48748253|NCT01276353|156926520|FG000|Extension|Withdrawal by Subject|1|||
48748254|NCT01276353|156926521|FG001|Extension|Withdrawal by Subject|2|||
48748255|NCT01276353|156926520|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
48748256|NCT01276353|156926521|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
48748257|NCT01276353|156926520|FG000|Extension|Physician Decision|1|||
48328626|NCT00263757|155401727|FG001|Overall Study|Screen failure|1|||
48748258|NCT01276353|156926521|FG001|Extension|Physician Decision|0|||
48748259|NCT01276353|156926520|FG000|Extension|Prohibited concomitant medications|0|||
48748260|NCT01276353|156926521|FG001|Extension|Prohibited concomitant medications|1|||
48748261|NCT00801632|156926522|FG000|Overall Study|Re-transplant|1|||
48639946|NCT00698828|156538334|FG002|Overall Study|Withdrew consent (not treated)|0|||
48328627|NCT00263757|155401726|FG000|Overall Study|Adverse Event|3|||
48639947|NCT01788943|156538337|FG000|Overall Study|Withdrawal by Subject|1|||
48639948|NCT01788943|156538338|FG001|Overall Study|Withdrawal by Subject|0|||
48748262|NCT03851705|156926534|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
48748263|NCT03851705|156926535|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
48639949|NCT04241068|156538344|FG000|Core Treatment Period|Adverse Event|91|||
48639950|NCT04241068|156538344|FG000|Core Treatment Period|Change of Treatment|4|||
48639951|NCT04241068|156538344|FG000|Core Treatment Period|Consent Withdrawn|143|||
48639952|NCT04241068|156538344|FG000|Core Treatment Period|Death|26|||
48639953|NCT04241068|156538344|FG000|Core Treatment Period|Disease Progression|67|||
48639954|NCT04241068|156538344|FG000|Core Treatment Period|Investigator Decision|40|||
48639955|NCT04241068|156538344|FG000|Core Treatment Period|Loss of Capacity|9|||
48639956|NCT04241068|156538344|FG000|Core Treatment Period|Lost to Follow-up|11|||
48639957|NCT04241068|156538344|FG000|Core Treatment Period|Relocation|4|||
48639958|NCT04241068|156538344|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
48639959|NCT04241068|156538344|FG000|Core Treatment Period|Study Visit Burden|40|||
48639960|NCT04241068|156538344|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
48639961|NCT04241068|156538344|FG000|Core Treatment Period|Missing|2|||
48639962|NCT04241068|156538344|FG000|Core Treatment Period|Reason Not Specified|41|||
48639963|NCT04241068|156538344|FG000|LTE Period|Adverse Event|19|||
48639964|NCT04241068|156538344|FG000|LTE Period|Change of Treatment|1|||
48639965|NCT04241068|156538344|FG000|LTE Period|Consent Withdrawn|71|||
48639966|NCT04241068|156538344|FG000|LTE Period|Death|8|||
48639967|NCT04241068|156538344|FG000|LTE Period|Disease Progression|11|||
48639968|NCT04241068|156538344|FG000|LTE Period|Investigator Decision|12|||
48639969|NCT04241068|156538344|FG000|LTE Period|Loss of Capacity|2|||
48639970|NCT04241068|156538344|FG000|LTE Period|Lost to Follow-up|7|||
48639971|NCT04241068|156538344|FG000|LTE Period|Relocation|6|||
48639972|NCT04241068|156538344|FG000|LTE Period|Site Terminated by Sponsor|26|||
48639973|NCT04241068|156538344|FG000|LTE Period|Study Terminated by Sponsor|276|||
48639974|NCT04241068|156538344|FG000|LTE Period|Study Visit Burden|10|||
48639975|NCT04241068|156538344|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
48639976|NCT04241068|156538344|FG000|LTE Period|Reason Not Specified|65|||
48639977|NCT04610892|156538346|FG000|Overall Study|Adverse Event|1|||
48639978|NCT04610892|156538347|FG001|Overall Study|Adverse Event|0|||
48639979|NCT04610892|156538348|FG002|Overall Study|Adverse Event|0|||
48639980|NCT04610892|156538349|FG003|Overall Study|Adverse Event|1|||
48639981|NCT04610892|156538350|FG004|Overall Study|Adverse Event|3|||
48639982|NCT04610892|156538346|FG000|Overall Study|Death|0|||
48639983|NCT04610892|156538347|FG001|Overall Study|Death|1|||
48639984|NCT04610892|156538348|FG002|Overall Study|Death|0|||
48639985|NCT04610892|156538349|FG003|Overall Study|Death|1|||
48639986|NCT04610892|156538350|FG004|Overall Study|Death|0|||
48639987|NCT04610892|156538346|FG000|Overall Study|Withdrawal by Subject|3|||
48639988|NCT04610892|156538347|FG001|Overall Study|Withdrawal by Subject|2|||
48639989|NCT04610892|156538348|FG002|Overall Study|Withdrawal by Subject|0|||
48639990|NCT04610892|156538349|FG003|Overall Study|Withdrawal by Subject|6|||
48639991|NCT04610892|156538350|FG004|Overall Study|Withdrawal by Subject|6|||
48639992|NCT04610892|156538346|FG000|Overall Study|Subjects who did not receive treatment|1|||
48639993|NCT04610892|156538347|FG001|Overall Study|Subjects who did not receive treatment|0|||
48639994|NCT04610892|156538348|FG002|Overall Study|Subjects who did not receive treatment|0|||
48639995|NCT04610892|156538349|FG003|Overall Study|Subjects who did not receive treatment|0|||
48639996|NCT04610892|156538350|FG004|Overall Study|Subjects who did not receive treatment|2|||
48639997|NCT02980107|156538351|FG000|Overall Study|Withdrawal by Subject|51|||
48639998|NCT02980107|156538352|FG001|Overall Study|Withdrawal by Subject|62|||
48639999|NCT01791517|156538353|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
48640000|NCT01791517|156538354|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
48640001|NCT01791517|156538355|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
48640002|NCT01791517|156538356|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
48640003|NCT01791517|156538357|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
48640004|NCT01791517|156538358|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
48640005|NCT01791517|156538359|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
48640006|NCT01791517|156538360|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
48640007|NCT01791517|156538361|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
48640008|NCT01791517|156538362|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
48640009|NCT01791517|156538363|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
48640010|NCT01791517|156538364|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
48640011|NCT01791517|156538353|FG000|Phase I: Period 1|Adverse Event|0|||
48640012|NCT01791517|156538354|FG001|Phase I: Period 1|Adverse Event|0|||
48640013|NCT01791517|156538355|FG002|Phase I: Period 1|Adverse Event|1|||
48640014|NCT01791517|156538356|FG003|Phase I: Period 1|Adverse Event|1|||
48640015|NCT01791517|156538357|FG004|Phase I: Period 1|Adverse Event|0|||
48640016|NCT01791517|156538358|FG005|Phase I: Period 1|Adverse Event|0|||
48640017|NCT01791517|156538359|FG006|Phase I: Period 1|Adverse Event|0|||
48640018|NCT01791517|156538360|FG007|Phase I: Period 1|Adverse Event|0|||
48640019|NCT01791517|156538361|FG008|Phase I: Period 1|Adverse Event|0|||
48640020|NCT01791517|156538362|FG009|Phase I: Period 1|Adverse Event|0|||
48640021|NCT01791517|156538363|FG010|Phase I: Period 1|Adverse Event|0|||
48640022|NCT01791517|156538364|FG011|Phase I: Period 1|Adverse Event|0|||
48640023|NCT01791517|156538353|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
48640024|NCT01791517|156538354|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640025|NCT01791517|156538355|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640026|NCT01791517|156538356|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640027|NCT01791517|156538357|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48748264|NCT03851705|156926536|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
48748265|NCT03851705|156926537|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
48748266|NCT03851705|156926534|FG000|Part 1: Double-Blind Period|Other reason|1|||
48748267|NCT03851705|156926535|FG001|Part 1: Double-Blind Period|Other reason|0|||
48748268|NCT03851705|156926536|FG002|Part 1: Double-Blind Period|Other reason|0|||
48748269|NCT03851705|156926537|FG003|Part 1: Double-Blind Period|Other reason|0|||
48748270|NCT03851705|156926534|FG000|Part 2: Open-Label Period|Other reason|0|||
48640028|NCT01791517|156538358|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640029|NCT01791517|156538359|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640030|NCT01791517|156538360|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640031|NCT01791517|156538361|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640032|NCT01791517|156538362|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640033|NCT01791517|156538363|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640034|NCT01791517|156538364|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
48640035|NCT01791517|156538353|FG000|Phase I: Period 1|Protocol Violation|0|||
48640036|NCT01791517|156538354|FG001|Phase I: Period 1|Protocol Violation|1|||
48640037|NCT01791517|156538355|FG002|Phase I: Period 1|Protocol Violation|0|||
48640038|NCT01791517|156538356|FG003|Phase I: Period 1|Protocol Violation|0|||
48640039|NCT01791517|156538357|FG004|Phase I: Period 1|Protocol Violation|0|||
48640040|NCT01791517|156538358|FG005|Phase I: Period 1|Protocol Violation|0|||
48640041|NCT01791517|156538359|FG006|Phase I: Period 1|Protocol Violation|0|||
48640042|NCT01791517|156538360|FG007|Phase I: Period 1|Protocol Violation|0|||
48640043|NCT01791517|156538361|FG008|Phase I: Period 1|Protocol Violation|0|||
48640044|NCT01791517|156538362|FG009|Phase I: Period 1|Protocol Violation|0|||
48640045|NCT01791517|156538363|FG010|Phase I: Period 1|Protocol Violation|0|||
48640046|NCT01791517|156538364|FG011|Phase I: Period 1|Protocol Violation|0|||
48640047|NCT01791517|156538353|FG000|Phase I: Period 1|Lost to Follow-up|0|||
48640048|NCT01791517|156538354|FG001|Phase I: Period 1|Lost to Follow-up|0|||
48640049|NCT01791517|156538355|FG002|Phase I: Period 1|Lost to Follow-up|0|||
48640050|NCT01791517|156538356|FG003|Phase I: Period 1|Lost to Follow-up|1|||
48640051|NCT01791517|156538357|FG004|Phase I: Period 1|Lost to Follow-up|0|||
48640052|NCT01791517|156538358|FG005|Phase I: Period 1|Lost to Follow-up|0|||
48640053|NCT01791517|156538359|FG006|Phase I: Period 1|Lost to Follow-up|1|||
48640054|NCT01791517|156538360|FG007|Phase I: Period 1|Lost to Follow-up|0|||
48640055|NCT01791517|156538361|FG008|Phase I: Period 1|Lost to Follow-up|1|||
48640056|NCT01791517|156538362|FG009|Phase I: Period 1|Lost to Follow-up|1|||
48640057|NCT01791517|156538363|FG010|Phase I: Period 1|Lost to Follow-up|0|||
48640058|NCT01791517|156538364|FG011|Phase I: Period 1|Lost to Follow-up|0|||
48640059|NCT01791517|156538353|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640060|NCT01791517|156538354|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640061|NCT01791517|156538355|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640062|NCT01791517|156538356|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640063|NCT01791517|156538357|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640064|NCT01791517|156538358|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640065|NCT01791517|156538359|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640066|NCT01791517|156538360|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640067|NCT01791517|156538361|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640068|NCT01791517|156538362|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640069|NCT01791517|156538363|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
48640070|NCT01791517|156538364|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
48640071|NCT01791517|156538353|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
48640072|NCT01791517|156538354|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640073|NCT01791517|156538355|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640074|NCT01791517|156538356|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640075|NCT01791517|156538357|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640076|NCT01791517|156538358|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640077|NCT01791517|156538359|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640078|NCT01791517|156538360|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640079|NCT01791517|156538361|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640080|NCT01791517|156538362|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640081|NCT01791517|156538363|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640082|NCT01791517|156538364|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
48640083|NCT01791517|156538353|FG000|Phase I: Period 2|Protocol Violation|0|||
48640084|NCT01791517|156538354|FG001|Phase I: Period 2|Protocol Violation|0|||
48640085|NCT01791517|156538355|FG002|Phase I: Period 2|Protocol Violation|0|||
48640086|NCT01791517|156538356|FG003|Phase I: Period 2|Protocol Violation|1|||
48640087|NCT01791517|156538357|FG004|Phase I: Period 2|Protocol Violation|0|||
48640088|NCT01791517|156538358|FG005|Phase I: Period 2|Protocol Violation|0|||
48640089|NCT01791517|156538359|FG006|Phase I: Period 2|Protocol Violation|0|||
48640090|NCT01791517|156538360|FG007|Phase I: Period 2|Protocol Violation|0|||
48640091|NCT01791517|156538361|FG008|Phase I: Period 2|Protocol Violation|0|||
48640092|NCT01791517|156538362|FG009|Phase I: Period 2|Protocol Violation|0|||
48328628|NCT00263757|155401727|FG001|Overall Study|Adverse Event|3|||
48328629|NCT00822900|155401728|FG000|Overall Study|Withdrawal by Subject|14|||
48640093|NCT01791517|156538363|FG010|Phase I: Period 2|Protocol Violation|0|||
48640094|NCT01791517|156538364|FG011|Phase I: Period 2|Protocol Violation|0|||
48640095|NCT01791517|156538353|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
48328630|NCT00822900|155401729|FG001|Overall Study|Withdrawal by Subject|14|||
48328631|NCT00822900|155401728|FG000|Overall Study|Lost to Follow-up|9|||
48640096|NCT01791517|156538354|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
48328632|NCT00822900|155401729|FG001|Overall Study|Lost to Follow-up|9|||
48640097|NCT01791517|156538355|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
48640098|NCT01791517|156538356|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
48640099|NCT01791517|156538357|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
48640100|NCT01791517|156538358|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
48640101|NCT01791517|156538359|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
48640102|NCT01791517|156538360|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
48640103|NCT01791517|156538361|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
48640104|NCT01791517|156538362|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
48640105|NCT01791517|156538363|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
48640106|NCT01791517|156538364|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
48640107|NCT01791517|156538353|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640108|NCT01791517|156538354|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640109|NCT01791517|156538355|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640110|NCT01791517|156538356|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640111|NCT01791517|156538357|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640112|NCT01791517|156538358|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640113|NCT01791517|156538359|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640114|NCT01791517|156538360|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640115|NCT01791517|156538361|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640116|NCT01791517|156538362|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640117|NCT01791517|156538363|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
48640118|NCT01791517|156538364|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
48640119|NCT01791517|156538353|FG000|Phase I: Period 2|Lens Discomfort|0|||
48640120|NCT01791517|156538354|FG001|Phase I: Period 2|Lens Discomfort|0|||
48640121|NCT01791517|156538355|FG002|Phase I: Period 2|Lens Discomfort|0|||
48640122|NCT01791517|156538356|FG003|Phase I: Period 2|Lens Discomfort|0|||
48640123|NCT01791517|156538357|FG004|Phase I: Period 2|Lens Discomfort|0|||
48640124|NCT01791517|156538358|FG005|Phase I: Period 2|Lens Discomfort|1|||
48640125|NCT01791517|156538359|FG006|Phase I: Period 2|Lens Discomfort|0|||
48640126|NCT01791517|156538360|FG007|Phase I: Period 2|Lens Discomfort|0|||
48640127|NCT01791517|156538361|FG008|Phase I: Period 2|Lens Discomfort|0|||
48640128|NCT01791517|156538362|FG009|Phase I: Period 2|Lens Discomfort|0|||
48640129|NCT01791517|156538363|FG010|Phase I: Period 2|Lens Discomfort|0|||
48640130|NCT01791517|156538364|FG011|Phase I: Period 2|Lens Discomfort|0|||
48640131|NCT01791517|156538353|FG000|Phase I: Period 2|Lost to Follow-up|0|||
48640132|NCT01791517|156538354|FG001|Phase I: Period 2|Lost to Follow-up|3|||
48640133|NCT01791517|156538355|FG002|Phase I: Period 2|Lost to Follow-up|2|||
48640134|NCT01791517|156538356|FG003|Phase I: Period 2|Lost to Follow-up|0|||
48640135|NCT01791517|156538357|FG004|Phase I: Period 2|Lost to Follow-up|0|||
48640136|NCT01791517|156538358|FG005|Phase I: Period 2|Lost to Follow-up|0|||
48640137|NCT01791517|156538359|FG006|Phase I: Period 2|Lost to Follow-up|0|||
48640138|NCT01791517|156538360|FG007|Phase I: Period 2|Lost to Follow-up|0|||
48640139|NCT01791517|156538361|FG008|Phase I: Period 2|Lost to Follow-up|0|||
48640140|NCT01791517|156538362|FG009|Phase I: Period 2|Lost to Follow-up|0|||
48640141|NCT01791517|156538363|FG010|Phase I: Period 2|Lost to Follow-up|0|||
48640142|NCT01791517|156538364|FG011|Phase I: Period 2|Lost to Follow-up|0|||
48640143|NCT01791517|156538353|FG000|Phase I: Period 3|Lens Discomfort|0|||
48640144|NCT01791517|156538354|FG001|Phase I: Period 3|Lens Discomfort|0|||
48640145|NCT01791517|156538355|FG002|Phase I: Period 3|Lens Discomfort|0|||
48640146|NCT01791517|156538356|FG003|Phase I: Period 3|Lens Discomfort|0|||
48640147|NCT01791517|156538357|FG004|Phase I: Period 3|Lens Discomfort|0|||
48640148|NCT01791517|156538358|FG005|Phase I: Period 3|Lens Discomfort|0|||
48640149|NCT01791517|156538359|FG006|Phase I: Period 3|Lens Discomfort|0|||
48640150|NCT01791517|156538360|FG007|Phase I: Period 3|Lens Discomfort|0|||
48640151|NCT01791517|156538361|FG008|Phase I: Period 3|Lens Discomfort|0|||
48640152|NCT01791517|156538362|FG009|Phase I: Period 3|Lens Discomfort|0|||
48640153|NCT01791517|156538363|FG010|Phase I: Period 3|Lens Discomfort|0|||
48640154|NCT01791517|156538364|FG011|Phase I: Period 3|Lens Discomfort|1|||
48640155|NCT01791517|156538353|FG000|Phase I: Period 3|Lost to Follow-up|0|||
48640156|NCT01791517|156538354|FG001|Phase I: Period 3|Lost to Follow-up|1|||
48640157|NCT01791517|156538355|FG002|Phase I: Period 3|Lost to Follow-up|0|||
48640158|NCT01791517|156538356|FG003|Phase I: Period 3|Lost to Follow-up|0|||
48640159|NCT01791517|156538357|FG004|Phase I: Period 3|Lost to Follow-up|1|||
48640160|NCT01791517|156538358|FG005|Phase I: Period 3|Lost to Follow-up|0|||
48640161|NCT01791517|156538359|FG006|Phase I: Period 3|Lost to Follow-up|0|||
48640162|NCT01791517|156538360|FG007|Phase I: Period 3|Lost to Follow-up|0|||
48640163|NCT01791517|156538361|FG008|Phase I: Period 3|Lost to Follow-up|0|||
48748271|NCT03851705|156926535|FG001|Part 2: Open-Label Period|Other reason|0|||
48748272|NCT03851705|156926536|FG002|Part 2: Open-Label Period|Other reason|0|||
48748273|NCT03851705|156926537|FG003|Part 2: Open-Label Period|Other reason|1|||
48748274|NCT03851705|156926534|FG000|Part 2: Open-Label Period|Death|0|||
48748275|NCT03851705|156926535|FG001|Part 2: Open-Label Period|Death|0|||
48748276|NCT03851705|156926536|FG002|Part 2: Open-Label Period|Death|3|||
48748277|NCT03851705|156926537|FG003|Part 2: Open-Label Period|Death|0|||
48748278|NCT03851705|156926534|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
48748279|NCT03851705|156926535|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
48748280|NCT03851705|156926536|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
48748281|NCT03851705|156926537|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
48748282|NCT02859454|156926538|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
48748283|NCT00563381|156926542|FG000|Overall Study|Adverse Event|264|||
48748284|NCT00563381|156926543|FG001|Overall Study|Adverse Event|292|||
48748285|NCT00563381|156926542|FG000|Overall Study|Protocol Violation|66|||
48748286|NCT00563381|156926543|FG001|Overall Study|Protocol Violation|74|||
48748287|NCT00563381|156926542|FG000|Overall Study|Lost to Follow-up|7|||
48748288|NCT00563381|156926543|FG001|Overall Study|Lost to Follow-up|15|||
48748289|NCT00563381|156926542|FG000|Overall Study|Withdrawal by Subject|192|||
48748290|NCT00563381|156926543|FG001|Overall Study|Withdrawal by Subject|209|||
48748291|NCT00563381|156926542|FG000|Overall Study|Lack of Efficacy|32|||
48748292|NCT00563381|156926543|FG001|Overall Study|Lack of Efficacy|24|||
48748293|NCT00563381|156926542|FG000|Overall Study|Individual different reasons|24|||
48748294|NCT00563381|156926543|FG001|Overall Study|Individual different reasons|34|||
48748295|NCT01683383|156926546|FG000|Overall Study|Infant was not transported|1|||
48748296|NCT01683383|156926547|FG001|Overall Study|Infant was not transported|0|||
48748297|NCT00996307|156926548|FG000|Overall Study|Adverse Event|0|||
48748298|NCT00996307|156926549|FG001|Overall Study|Adverse Event|1|||
48748299|NCT00996307|156926550|FG002|Overall Study|Adverse Event|0|||
48748300|NCT00996307|156926551|FG003|Overall Study|Adverse Event|0|||
48748301|NCT00996307|156926548|FG000|Overall Study|Withdrawal by Subject|3|||
48748302|NCT00996307|156926549|FG001|Overall Study|Withdrawal by Subject|2|||
48748303|NCT00996307|156926550|FG002|Overall Study|Withdrawal by Subject|5|||
48748304|NCT00996307|156926551|FG003|Overall Study|Withdrawal by Subject|5|||
48748305|NCT00996307|156926548|FG000|Overall Study|Lost to Follow-up|13|||
48748306|NCT00996307|156926549|FG001|Overall Study|Lost to Follow-up|13|||
48748307|NCT00996307|156926550|FG002|Overall Study|Lost to Follow-up|7|||
48748308|NCT00996307|156926551|FG003|Overall Study|Lost to Follow-up|15|||
48748309|NCT00996307|156926548|FG000|Overall Study|Administrative reason|0|||
48748310|NCT00996307|156926549|FG001|Overall Study|Administrative reason|1|||
48748311|NCT00996307|156926550|FG002|Overall Study|Administrative reason|0|||
48748312|NCT00996307|156926551|FG003|Overall Study|Administrative reason|0|||
48748313|NCT00996307|156926548|FG000|Overall Study|Unable to classify|4|||
48748314|NCT00996307|156926549|FG001|Overall Study|Unable to classify|0|||
48748315|NCT00996307|156926550|FG002|Overall Study|Unable to classify|2|||
48748316|NCT00996307|156926551|FG003|Overall Study|Unable to classify|1|||
48748317|NCT02496611|156926552|FG000|Overall Study|Lost to Follow-up|2|||
48748318|NCT02496611|156926553|FG001|Overall Study|Lost to Follow-up|1|||
48748319|NCT02496611|156926552|FG000|Overall Study|Withdrawal by Subject|5|||
48748320|NCT02496611|156926553|FG001|Overall Study|Withdrawal by Subject|2|||
48748321|NCT02850965|156926554|FG000|Overall Study|Other than listed|3|||
48748322|NCT02850965|156926555|FG001|Overall Study|Other than listed|4|||
48748323|NCT02850965|156926554|FG000|Overall Study|Protocol Violation|0|||
48748324|NCT02850965|156926555|FG001|Overall Study|Protocol Violation|2|||
48748325|NCT02850965|156926554|FG000|Overall Study|Lost to Follow-up|5|||
48748326|NCT02850965|156926555|FG001|Overall Study|Lost to Follow-up|3|||
48748327|NCT02850965|156926554|FG000|Overall Study|Lack of Efficacy|4|||
48748328|NCT02850965|156926555|FG001|Overall Study|Lack of Efficacy|8|||
48748329|NCT02850965|156926554|FG000|Overall Study|Adverse Event|3|||
48748330|NCT02850965|156926555|FG001|Overall Study|Adverse Event|2|||
48748331|NCT02850965|156926554|FG000|Overall Study|Withdrawal by Subject|3|||
48748332|NCT02850965|156926555|FG001|Overall Study|Withdrawal by Subject|4|||
48748333|NCT02850965|156926554|FG000|Overall Study|Physician Decision|0|||
48748334|NCT02850965|156926555|FG001|Overall Study|Physician Decision|1|||
48748335|NCT02850965|156926554|FG000|Overall Study|Randomized but not treated|0|||
48748336|NCT02850965|156926555|FG001|Overall Study|Randomized but not treated|1|||
48748337|NCT01049308|156926556|FG000|Pill Counts|Withdrawal by Subject|83|||
48748338|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
48748339|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
48748340|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
48748341|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
48748342|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
48748343|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
48748344|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
48748345|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
48748346|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
48748347|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
48328633|NCT00822900|155401728|FG000|Overall Study|Death|83|||
48640164|NCT01791517|156538362|FG009|Phase I: Period 3|Lost to Follow-up|0|||
48640165|NCT01791517|156538363|FG010|Phase I: Period 3|Lost to Follow-up|0|||
48640166|NCT01791517|156538364|FG011|Phase I: Period 3|Lost to Follow-up|0|||
48640167|NCT01791517|156538353|FG000|Phase I: Period 3|Adverse Event|0|||
48640168|NCT01791517|156538354|FG001|Phase I: Period 3|Adverse Event|0|||
48640169|NCT01791517|156538355|FG002|Phase I: Period 3|Adverse Event|0|||
48640170|NCT01791517|156538356|FG003|Phase I: Period 3|Adverse Event|1|||
48640171|NCT01791517|156538357|FG004|Phase I: Period 3|Adverse Event|0|||
48640172|NCT01791517|156538358|FG005|Phase I: Period 3|Adverse Event|0|||
48640173|NCT01791517|156538359|FG006|Phase I: Period 3|Adverse Event|0|||
48640174|NCT01791517|156538360|FG007|Phase I: Period 3|Adverse Event|0|||
48640175|NCT01791517|156538361|FG008|Phase I: Period 3|Adverse Event|0|||
48640176|NCT01791517|156538362|FG009|Phase I: Period 3|Adverse Event|0|||
48640177|NCT01791517|156538363|FG010|Phase I: Period 3|Adverse Event|0|||
48640178|NCT01791517|156538364|FG011|Phase I: Period 3|Adverse Event|0|||
48640179|NCT01791517|156538353|FG000|Phase II|Lost to Follow-up|1|||
48640180|NCT01791517|156538354|FG001|Phase II|Lost to Follow-up|0|||
48640181|NCT01791517|156538355|FG002|Phase II|Lost to Follow-up|1|||
48640182|NCT01791517|156538356|FG003|Phase II|Lost to Follow-up|0|||
48640183|NCT01791517|156538357|FG004|Phase II|Lost to Follow-up|1|||
48640184|NCT01791517|156538358|FG005|Phase II|Lost to Follow-up|2|||
48640185|NCT01791517|156538359|FG006|Phase II|Lost to Follow-up|0|||
48640186|NCT01791517|156538360|FG007|Phase II|Lost to Follow-up|1|||
48640187|NCT01791517|156538361|FG008|Phase II|Lost to Follow-up|1|||
48640188|NCT01791517|156538362|FG009|Phase II|Lost to Follow-up|1|||
48640189|NCT01791517|156538363|FG010|Phase II|Lost to Follow-up|0|||
48640190|NCT01791517|156538364|FG011|Phase II|Lost to Follow-up|0|||
48640191|NCT01791517|156538353|FG000|Phase II|Withdrawal by Subject|1|||
48640192|NCT01791517|156538354|FG001|Phase II|Withdrawal by Subject|0|||
48640193|NCT01791517|156538355|FG002|Phase II|Withdrawal by Subject|0|||
48640194|NCT01791517|156538356|FG003|Phase II|Withdrawal by Subject|0|||
48640195|NCT01791517|156538357|FG004|Phase II|Withdrawal by Subject|0|||
48640196|NCT01791517|156538358|FG005|Phase II|Withdrawal by Subject|2|||
48640197|NCT01791517|156538359|FG006|Phase II|Withdrawal by Subject|0|||
48640198|NCT01791517|156538360|FG007|Phase II|Withdrawal by Subject|1|||
48640199|NCT01791517|156538361|FG008|Phase II|Withdrawal by Subject|0|||
48640200|NCT01791517|156538362|FG009|Phase II|Withdrawal by Subject|0|||
48640201|NCT01791517|156538363|FG010|Phase II|Withdrawal by Subject|1|||
48640202|NCT01791517|156538364|FG011|Phase II|Withdrawal by Subject|0|||
48640203|NCT01791517|156538353|FG000|Phase II|Lack of Efficacy|0|||
48640204|NCT01791517|156538354|FG001|Phase II|Lack of Efficacy|0|||
48640205|NCT01791517|156538355|FG002|Phase II|Lack of Efficacy|0|||
48640206|NCT01791517|156538356|FG003|Phase II|Lack of Efficacy|0|||
48640207|NCT01791517|156538357|FG004|Phase II|Lack of Efficacy|1|||
48640208|NCT01791517|156538358|FG005|Phase II|Lack of Efficacy|0|||
48640209|NCT01791517|156538359|FG006|Phase II|Lack of Efficacy|0|||
48640210|NCT01791517|156538360|FG007|Phase II|Lack of Efficacy|0|||
48640211|NCT01791517|156538361|FG008|Phase II|Lack of Efficacy|0|||
48640212|NCT01791517|156538362|FG009|Phase II|Lack of Efficacy|0|||
48640213|NCT01791517|156538363|FG010|Phase II|Lack of Efficacy|0|||
48640214|NCT01791517|156538364|FG011|Phase II|Lack of Efficacy|0|||
48640215|NCT01791517|156538353|FG000|Phase II|Adverse Event|0|||
48640216|NCT01791517|156538354|FG001|Phase II|Adverse Event|0|||
48640217|NCT01791517|156538355|FG002|Phase II|Adverse Event|0|||
48640218|NCT01791517|156538356|FG003|Phase II|Adverse Event|0|||
48640219|NCT01791517|156538357|FG004|Phase II|Adverse Event|0|||
48640220|NCT01791517|156538358|FG005|Phase II|Adverse Event|0|||
48640221|NCT01791517|156538359|FG006|Phase II|Adverse Event|2|||
48640222|NCT01791517|156538360|FG007|Phase II|Adverse Event|1|||
48640223|NCT01791517|156538361|FG008|Phase II|Adverse Event|0|||
48640224|NCT01791517|156538362|FG009|Phase II|Adverse Event|1|||
48640225|NCT01791517|156538363|FG010|Phase II|Adverse Event|0|||
48640226|NCT01791517|156538364|FG011|Phase II|Adverse Event|0|||
48640227|NCT01791517|156538353|FG000|Phase II|Lens Handling Difficulties|0|||
48640228|NCT01791517|156538354|FG001|Phase II|Lens Handling Difficulties|0|||
48640229|NCT01791517|156538355|FG002|Phase II|Lens Handling Difficulties|0|||
48640230|NCT01791517|156538356|FG003|Phase II|Lens Handling Difficulties|0|||
48640231|NCT01791517|156538357|FG004|Phase II|Lens Handling Difficulties|0|||
48640232|NCT01791517|156538358|FG005|Phase II|Lens Handling Difficulties|0|||
48640233|NCT01791517|156538359|FG006|Phase II|Lens Handling Difficulties|0|||
48640234|NCT01791517|156538360|FG007|Phase II|Lens Handling Difficulties|0|||
48640235|NCT01791517|156538361|FG008|Phase II|Lens Handling Difficulties|1|||
48640236|NCT01791517|156538362|FG009|Phase II|Lens Handling Difficulties|0|||
48640237|NCT01791517|156538363|FG010|Phase II|Lens Handling Difficulties|0|||
48640238|NCT01791517|156538364|FG011|Phase II|Lens Handling Difficulties|0|||
48640239|NCT01791517|156538353|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
48640240|NCT01791517|156538354|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
48640241|NCT01791517|156538355|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
48640242|NCT01791517|156538356|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
48640243|NCT01791517|156538357|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
48640244|NCT01791517|156538358|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
48640245|NCT01791517|156538359|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
48640246|NCT01791517|156538360|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
48640247|NCT01791517|156538361|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
48640248|NCT01791517|156538362|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
48640249|NCT01791517|156538363|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
48748348|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
48748349|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
48748350|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
48748351|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
48748352|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
48640250|NCT01791517|156538364|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
48640251|NCT01791517|156538353|FG000|Phase II|Pre-Existing Ocular Issue|0|||
48640252|NCT01791517|156538354|FG001|Phase II|Pre-Existing Ocular Issue|0|||
48640253|NCT01791517|156538355|FG002|Phase II|Pre-Existing Ocular Issue|0|||
48640254|NCT01791517|156538356|FG003|Phase II|Pre-Existing Ocular Issue|0|||
48640255|NCT01791517|156538357|FG004|Phase II|Pre-Existing Ocular Issue|0|||
48640256|NCT01791517|156538358|FG005|Phase II|Pre-Existing Ocular Issue|0|||
48640257|NCT01791517|156538359|FG006|Phase II|Pre-Existing Ocular Issue|0|||
48640258|NCT01791517|156538360|FG007|Phase II|Pre-Existing Ocular Issue|0|||
48640259|NCT01791517|156538361|FG008|Phase II|Pre-Existing Ocular Issue|0|||
48640260|NCT01791517|156538362|FG009|Phase II|Pre-Existing Ocular Issue|0|||
48640261|NCT01791517|156538363|FG010|Phase II|Pre-Existing Ocular Issue|0|||
48640262|NCT01791517|156538364|FG011|Phase II|Pre-Existing Ocular Issue|1|||
48640263|NCT05518461|156538365|FG000|Overall Study|Lost to Follow-up|25|||
48640264|NCT02388906|156538366|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
48640265|NCT02388906|156538367|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
48640266|NCT02388906|156538366|FG000|Treatment Period|Disease progression|121|||
48640267|NCT02388906|156538367|FG001|Treatment Period|Disease progression|101|||
48640268|NCT02388906|156538366|FG000|Treatment Period|Study drug toxicity|41|||
48640269|NCT02388906|156538367|FG001|Treatment Period|Study drug toxicity|208|||
48640270|NCT02388906|156538366|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
48640271|NCT02388906|156538367|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
48640272|NCT02388906|156538366|FG000|Treatment Period|Participant request to stop treatment|5|||
48640273|NCT02388906|156538367|FG001|Treatment Period|Participant request to stop treatment|9|||
48640274|NCT02388906|156538366|FG000|Treatment Period|Participant withdrew consent|2|||
48640275|NCT02388906|156538367|FG001|Treatment Period|Participant withdrew consent|3|||
48640276|NCT02388906|156538366|FG000|Treatment Period|Poor/non-compliance|0|||
48640277|NCT02388906|156538367|FG001|Treatment Period|Poor/non-compliance|1|||
48640278|NCT02388906|156538366|FG000|Treatment Period|Participant no longer meets study criteria|0|||
48640279|NCT02388906|156538367|FG001|Treatment Period|Participant no longer meets study criteria|1|||
48640280|NCT02388906|156538366|FG000|Treatment Period|Other reasons|3|||
48640281|NCT02388906|156538367|FG001|Treatment Period|Other reasons|3|||
48748353|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
48748354|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
48748355|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
48748356|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
48748357|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
48640282|NCT00565409|156538368|FG000|Period 1 Open Label|Adverse Event|17|||
48640283|NCT00565409|156538369|FG001|Period 1 Open Label|Adverse Event|0|||
48640284|NCT00565409|156538370|FG002|Period 1 Open Label|Adverse Event|0|||
48640285|NCT00565409|156538371|FG003|Period 1 Open Label|Adverse Event|0|||
48640286|NCT00565409|156538368|FG000|Period 1 Open Label|Death|2|||
48640287|NCT00565409|156538369|FG001|Period 1 Open Label|Death|0|||
48640288|NCT00565409|156538370|FG002|Period 1 Open Label|Death|0|||
48640289|NCT00565409|156538371|FG003|Period 1 Open Label|Death|0|||
48640290|NCT00565409|156538368|FG000|Period 1 Open Label|Lost to Follow-up|1|||
48640291|NCT00565409|156538369|FG001|Period 1 Open Label|Lost to Follow-up|0|||
48640292|NCT00565409|156538370|FG002|Period 1 Open Label|Lost to Follow-up|0|||
48328634|NCT00822900|155401729|FG001|Overall Study|Death|69|||
48640293|NCT00565409|156538371|FG003|Period 1 Open Label|Lost to Follow-up|0|||
48748358|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
48748359|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
48748360|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
48748361|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
48748362|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
48748363|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
48748364|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
48748365|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48640294|NCT00565409|156538368|FG000|Period 1 Open Label|Other|21|||
48328635|NCT00822900|155401728|FG000|Overall Study|Became a ward of the state|2|||
48328636|NCT00822900|155401729|FG001|Overall Study|Became a ward of the state|1|||
48640295|NCT00565409|156538369|FG001|Period 1 Open Label|Other|0|||
48640296|NCT00565409|156538370|FG002|Period 1 Open Label|Other|0|||
48748366|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48640297|NCT00565409|156538371|FG003|Period 1 Open Label|Other|0|||
48640298|NCT00565409|156538368|FG000|Period 1 Open Label|Protocol Violation|14|||
48640299|NCT00565409|156538369|FG001|Period 1 Open Label|Protocol Violation|0|||
48640300|NCT00565409|156538370|FG002|Period 1 Open Label|Protocol Violation|0|||
48640301|NCT00565409|156538371|FG003|Period 1 Open Label|Protocol Violation|0|||
48640302|NCT00565409|156538368|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
48640303|NCT00565409|156538369|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
48640304|NCT00565409|156538370|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
48640305|NCT00565409|156538371|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
48640306|NCT00565409|156538368|FG000|Period 1 Open Label|no conclusion of participation record|1|||
48640307|NCT00565409|156538369|FG001|Period 1 Open Label|no conclusion of participation record|0|||
48640308|NCT00565409|156538370|FG002|Period 1 Open Label|no conclusion of participation record|0|||
48640309|NCT00565409|156538371|FG003|Period 1 Open Label|no conclusion of participation record|0|||
48640310|NCT00565409|156538368|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
48640311|NCT00565409|156538369|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
48640312|NCT00565409|156538370|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
48640313|NCT00565409|156538371|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
48640314|NCT00565409|156538368|FG000|Period 2 Double-Blind|Adverse Event|0|||
48640315|NCT00565409|156538369|FG001|Period 2 Double-Blind|Adverse Event|7|||
48640316|NCT00565409|156538370|FG002|Period 2 Double-Blind|Adverse Event|4|||
48640317|NCT00565409|156538371|FG003|Period 2 Double-Blind|Adverse Event|5|||
48640318|NCT00565409|156538368|FG000|Period 2 Double-Blind|Death|0|||
48640319|NCT00565409|156538369|FG001|Period 2 Double-Blind|Death|2|||
48640320|NCT00565409|156538370|FG002|Period 2 Double-Blind|Death|0|||
48640321|NCT00565409|156538371|FG003|Period 2 Double-Blind|Death|0|||
48640322|NCT00565409|156538368|FG000|Period 2 Double-Blind|Protocol Violation|0|||
48640323|NCT00565409|156538369|FG001|Period 2 Double-Blind|Protocol Violation|4|||
48640324|NCT00565409|156538370|FG002|Period 2 Double-Blind|Protocol Violation|6|||
48748367|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748368|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748369|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748370|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748371|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748372|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748373|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748374|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748375|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748376|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748377|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748378|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748379|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748380|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748381|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748382|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748383|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748384|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748385|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748386|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748387|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748388|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748389|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
48748390|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
48748391|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
48748392|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48328637|NCT02823574|155401730|FG000|Randomization|Disease Progression|0|||
48328638|NCT02823574|155401731|FG001|Randomization|Disease Progression|0|||
48328639|NCT02823574|155401732|FG002|Randomization|Disease Progression|1|||
48328640|NCT02823574|155401733|FG003|Randomization|Disease Progression|0|||
48328641|NCT02823574|155401730|FG000|Randomization|AE unrelated to Study Drug|1|||
48328642|NCT02823574|155401731|FG001|Randomization|AE unrelated to Study Drug|0|||
48328643|NCT02823574|155401732|FG002|Randomization|AE unrelated to Study Drug|0|||
48328644|NCT02823574|155401733|FG003|Randomization|AE unrelated to Study Drug|0|||
48328645|NCT02823574|155401730|FG000|Treatment Period|Poor/Non Compliance|1|||
48328646|NCT02823574|155401731|FG001|Treatment Period|Poor/Non Compliance|0|||
48328647|NCT02823574|155401732|FG002|Treatment Period|Poor/Non Compliance|0|||
48328648|NCT02823574|155401733|FG003|Treatment Period|Poor/Non Compliance|1|||
48328649|NCT02823574|155401730|FG000|Treatment Period|Maximum Clinical Benefit|8|||
48328650|NCT02823574|155401731|FG001|Treatment Period|Maximum Clinical Benefit|4|||
48328651|NCT02823574|155401732|FG002|Treatment Period|Maximum Clinical Benefit|7|||
48328652|NCT02823574|155401733|FG003|Treatment Period|Maximum Clinical Benefit|1|||
48328653|NCT02823574|155401730|FG000|Treatment Period|Lost to Follow-up|1|||
48328654|NCT02823574|155401731|FG001|Treatment Period|Lost to Follow-up|1|||
48328655|NCT02823574|155401732|FG002|Treatment Period|Lost to Follow-up|0|||
48328656|NCT02823574|155401733|FG003|Treatment Period|Lost to Follow-up|0|||
48328657|NCT02823574|155401730|FG000|Treatment Period|Participant withdrew consent|4|||
48328658|NCT02823574|155401731|FG001|Treatment Period|Participant withdrew consent|0|||
48328659|NCT02823574|155401732|FG002|Treatment Period|Participant withdrew consent|0|||
48328660|NCT02823574|155401733|FG003|Treatment Period|Participant withdrew consent|1|||
48328661|NCT02823574|155401730|FG000|Treatment Period|Participant request to discontinue|5|||
48328662|NCT02823574|155401731|FG001|Treatment Period|Participant request to discontinue|0|||
48328663|NCT02823574|155401732|FG002|Treatment Period|Participant request to discontinue|3|||
48328664|NCT02823574|155401733|FG003|Treatment Period|Participant request to discontinue|2|||
48328665|NCT02823574|155401730|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
48328666|NCT02823574|155401731|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
48328667|NCT02823574|155401732|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
48328668|NCT02823574|155401733|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
48328669|NCT02823574|155401730|FG000|Treatment Period|Study Drug Toxicity|11|||
48640325|NCT00565409|156538371|FG003|Period 2 Double-Blind|Protocol Violation|2|||
48640326|NCT00565409|156538368|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
48640327|NCT00565409|156538369|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
48640328|NCT00565409|156538370|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
48640329|NCT00565409|156538371|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
48328670|NCT02823574|155401731|FG001|Treatment Period|Study Drug Toxicity|2|||
48328671|NCT02823574|155401732|FG002|Treatment Period|Study Drug Toxicity|14|||
48328672|NCT02823574|155401733|FG003|Treatment Period|Study Drug Toxicity|4|||
48328673|NCT02823574|155401730|FG000|Treatment Period|Disease Progression|113|||
48328674|NCT02823574|155401731|FG001|Treatment Period|Disease Progression|64|||
48328675|NCT02823574|155401732|FG002|Treatment Period|Disease Progression|82|||
48328676|NCT02823574|155401733|FG003|Treatment Period|Disease Progression|43|||
48328677|NCT02823574|155401730|FG000|Treatment Period|Other reasons|5|||
48328678|NCT02823574|155401731|FG001|Treatment Period|Other reasons|9|||
48328679|NCT02823574|155401732|FG002|Treatment Period|Other reasons|3|||
48328680|NCT02823574|155401733|FG003|Treatment Period|Other reasons|6|||
48328681|NCT02823574|155401730|FG000|Treatment Period|Participant no longer meets study criteria|0|||
48328682|NCT02823574|155401731|FG001|Treatment Period|Participant no longer meets study criteria|0|||
48328683|NCT02823574|155401732|FG002|Treatment Period|Participant no longer meets study criteria|1|||
48328684|NCT02823574|155401733|FG003|Treatment Period|Participant no longer meets study criteria|0|||
48328685|NCT02823574|155401730|FG000|Treatment Period|Death|0|||
48328686|NCT02823574|155401731|FG001|Treatment Period|Death|0|||
48328687|NCT02823574|155401732|FG002|Treatment Period|Death|3|||
48328688|NCT02823574|155401733|FG003|Treatment Period|Death|1|||
48328689|NCT01728324|155401734|FG000|Termination of DBV|Adverse Event|14|||
48328690|NCT01728324|155401735|FG001|Termination of DBV|Adverse Event|13|||
48328691|NCT01728324|155401736|FG002|Termination of DBV|Adverse Event|4|||
48640330|NCT00565409|156538368|FG000|Period 2 Double-Blind|Other|0|||
48640331|NCT00565409|156538369|FG001|Period 2 Double-Blind|Other|4|||
48640332|NCT00565409|156538370|FG002|Period 2 Double-Blind|Other|5|||
48328692|NCT01728324|155401734|FG000|Termination of DBV|Lack of Efficacy|14|||
48328693|NCT01728324|155401735|FG001|Termination of DBV|Lack of Efficacy|12|||
48328694|NCT01728324|155401736|FG002|Termination of DBV|Lack of Efficacy|8|||
48328695|NCT01728324|155401734|FG000|Termination of DBV|Withdrawal by Subject|9|||
48328696|NCT01728324|155401735|FG001|Termination of DBV|Withdrawal by Subject|6|||
48328697|NCT01728324|155401736|FG002|Termination of DBV|Withdrawal by Subject|2|||
48328698|NCT01728324|155401734|FG000|Termination of DBV|Other than stated|1|||
48328699|NCT01728324|155401735|FG001|Termination of DBV|Other than stated|3|||
48328700|NCT01728324|155401736|FG002|Termination of DBV|Other than stated|0|||
48328701|NCT01728324|155401734|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
48328702|NCT01728324|155401735|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
48328703|NCT01728324|155401736|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
48328704|NCT01728324|155401734|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
48328705|NCT01728324|155401735|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
48328706|NCT01728324|155401736|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
48328707|NCT01728324|155401734|FG000|Termination of FDV|Adverse Event|14|||
48328708|NCT01728324|155401735|FG001|Termination of FDV|Adverse Event|13|||
48328709|NCT01728324|155401736|FG002|Termination of FDV|Adverse Event|4|||
48640333|NCT00565409|156538371|FG003|Period 2 Double-Blind|Other|9|||
48640334|NCT00565409|156538368|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
48640335|NCT00565409|156538369|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
48640336|NCT00565409|156538370|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
48640337|NCT00565409|156538371|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
48640338|NCT01496976|156539427|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
48640339|NCT03783026|156539428|FG000|Treatment Phase|Adverse Event|15|||
48640340|NCT03783026|156539428|FG000|Treatment Phase|Lack of Efficacy|11|||
48640341|NCT03783026|156539428|FG000|Treatment Phase|Withdrawal by Subject|6|||
48640342|NCT03783026|156539428|FG000|Treatment Phase|Lost to Follow-up|2|||
48640343|NCT03783026|156539428|FG000|Treatment Phase|Protocol Deviation|8|||
48640344|NCT03783026|156539428|FG000|Treatment Phase|Did Not Receive Treatment|1|||
48640345|NCT03783026|156539428|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
48640346|NCT00092534|156539429|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
48640347|NCT00092534|156539430|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
48328710|NCT01728324|155401734|FG000|Termination of FDV|Lack of Efficacy|14|||
48328711|NCT01728324|155401735|FG001|Termination of FDV|Lack of Efficacy|12|||
48328712|NCT01728324|155401736|FG002|Termination of FDV|Lack of Efficacy|8|||
48328713|NCT01728324|155401734|FG000|Termination of FDV|Withdrawal by Subject|9|||
48328714|NCT01728324|155401735|FG001|Termination of FDV|Withdrawal by Subject|6|||
48748393|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748394|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748395|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748396|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748397|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748398|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748399|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748400|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748401|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748402|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748403|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748404|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748405|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748406|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748407|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748408|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748409|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748410|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748411|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748412|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748413|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748414|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748415|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
48748416|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
48640348|NCT00092534|156539431|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
48640349|NCT00092534|156539432|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
48748417|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
48748418|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48640350|NCT00092534|156539433|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
48640351|NCT00092534|156539429|FG000|Base Study Vaccination Period|Adverse Event|3|||
48748419|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748420|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748421|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748422|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748423|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748424|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748425|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748426|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748427|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748428|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748429|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748430|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748431|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48640352|NCT00092534|156539430|FG001|Base Study Vaccination Period|Adverse Event|1|||
48640353|NCT00092534|156539431|FG002|Base Study Vaccination Period|Adverse Event|0|||
48640354|NCT00092534|156539432|FG003|Base Study Vaccination Period|Adverse Event|0|||
48640355|NCT00092534|156539433|FG004|Base Study Vaccination Period|Adverse Event|0|||
48640356|NCT00092534|156539429|FG000|Base Study Vaccination Period|Death|5|||
48640357|NCT00092534|156539430|FG001|Base Study Vaccination Period|Death|4|||
48640358|NCT00092534|156539431|FG002|Base Study Vaccination Period|Death|0|||
48640359|NCT00092534|156539432|FG003|Base Study Vaccination Period|Death|0|||
48640360|NCT00092534|156539433|FG004|Base Study Vaccination Period|Death|0|||
48640361|NCT00092534|156539429|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
48640362|NCT00092534|156539430|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
48640363|NCT00092534|156539431|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
48640364|NCT00092534|156539432|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
48640365|NCT00092534|156539433|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
48748432|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748433|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748434|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748435|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748436|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48640366|NCT00092534|156539429|FG000|Base Study Vaccination Period|Physician Decision|1|||
48640367|NCT00092534|156539430|FG001|Base Study Vaccination Period|Physician Decision|0|||
48328715|NCT01728324|155401736|FG002|Termination of FDV|Withdrawal by Subject|2|||
48328716|NCT01728324|155401734|FG000|Termination of FDV|Other than stated|1|||
48328717|NCT01728324|155401735|FG001|Termination of FDV|Other than stated|3|||
48328718|NCT01728324|155401736|FG002|Termination of FDV|Other than stated|0|||
48328719|NCT01728324|155401734|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
48328720|NCT01728324|155401735|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
48328721|NCT01728324|155401736|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
48328722|NCT01728324|155401734|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
48328723|NCT01728324|155401735|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
48328724|NCT01728324|155401736|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
48328725|NCT01728324|155401734|FG000|Termination of RBV|Adverse Event|15|||
48328726|NCT01728324|155401735|FG001|Termination of RBV|Adverse Event|16|||
48328727|NCT01728324|155401736|FG002|Termination of RBV|Adverse Event|5|||
48640368|NCT00092534|156539431|FG002|Base Study Vaccination Period|Physician Decision|0|||
48640369|NCT00092534|156539432|FG003|Base Study Vaccination Period|Physician Decision|0|||
48328728|NCT01728324|155401734|FG000|Termination of RBV|Lack of Efficacy|14|||
48328729|NCT01728324|155401735|FG001|Termination of RBV|Lack of Efficacy|11|||
48328730|NCT01728324|155401736|FG002|Termination of RBV|Lack of Efficacy|7|||
48640370|NCT00092534|156539433|FG004|Base Study Vaccination Period|Physician Decision|0|||
48640371|NCT00092534|156539429|FG000|Base Study Vaccination Period|Pregnancy|9|||
48640372|NCT00092534|156539430|FG001|Base Study Vaccination Period|Pregnancy|7|||
48640373|NCT00092534|156539431|FG002|Base Study Vaccination Period|Pregnancy|0|||
48640374|NCT00092534|156539432|FG003|Base Study Vaccination Period|Pregnancy|0|||
48640375|NCT00092534|156539433|FG004|Base Study Vaccination Period|Pregnancy|0|||
48640376|NCT00092534|156539429|FG000|Base Study Vaccination Period|Protocol Violation|2|||
48640377|NCT00092534|156539430|FG001|Base Study Vaccination Period|Protocol Violation|1|||
48640378|NCT00092534|156539431|FG002|Base Study Vaccination Period|Protocol Violation|0|||
48640379|NCT00092534|156539432|FG003|Base Study Vaccination Period|Protocol Violation|0|||
48640380|NCT00092534|156539433|FG004|Base Study Vaccination Period|Protocol Violation|0|||
48640381|NCT00092534|156539429|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
48640382|NCT00092534|156539430|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
48640383|NCT00092534|156539431|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
48640384|NCT00092534|156539432|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
48640385|NCT00092534|156539433|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
48640386|NCT00092534|156539429|FG000|Base Study Vaccination Period|Moved|14|||
48640387|NCT00092534|156539430|FG001|Base Study Vaccination Period|Moved|12|||
48640388|NCT00092534|156539431|FG002|Base Study Vaccination Period|Moved|0|||
48640389|NCT00092534|156539432|FG003|Base Study Vaccination Period|Moved|0|||
48640390|NCT00092534|156539433|FG004|Base Study Vaccination Period|Moved|0|||
48640391|NCT00092534|156539429|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
48640392|NCT00092534|156539430|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
48640393|NCT00092534|156539431|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
48640394|NCT00092534|156539432|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
48640395|NCT00092534|156539433|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
48640396|NCT00092534|156539429|FG000|Base Study Vaccination Period|Travel|1|||
48640397|NCT00092534|156539430|FG001|Base Study Vaccination Period|Travel|0|||
48640398|NCT00092534|156539431|FG002|Base Study Vaccination Period|Travel|0|||
48640399|NCT00092534|156539432|FG003|Base Study Vaccination Period|Travel|0|||
48640400|NCT00092534|156539433|FG004|Base Study Vaccination Period|Travel|0|||
48640401|NCT00092534|156539429|FG000|Base Study Vaccination Period|Site Closed|0|||
48328731|NCT01728324|155401734|FG000|Termination of RBV|Withdrawal by Subject|9|||
48328732|NCT01728324|155401735|FG001|Termination of RBV|Withdrawal by Subject|5|||
48328733|NCT01728324|155401736|FG002|Termination of RBV|Withdrawal by Subject|2|||
48748437|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748438|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48640402|NCT00092534|156539430|FG001|Base Study Vaccination Period|Site Closed|1|||
48748439|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748440|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748441|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
48748442|NCT03129100|156926557|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748443|NCT03129100|156926558|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
48748444|NCT03129100|156926559|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748445|NCT03129100|156926560|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748446|NCT03129100|156926561|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
48640403|NCT00092534|156539431|FG002|Base Study Vaccination Period|Site Closed|0|||
48640404|NCT00092534|156539432|FG003|Base Study Vaccination Period|Site Closed|0|||
48640405|NCT00092534|156539433|FG004|Base Study Vaccination Period|Site Closed|0|||
48640406|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Adverse Event|2|||
48640407|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Adverse Event|4|||
48640408|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Adverse Event|0|||
48748447|NCT03129100|156926562|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748448|NCT03129100|156926563|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748449|NCT03129100|156926564|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748450|NCT03129100|156926565|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748451|NCT03129100|156926566|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748452|NCT03129100|156926567|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748453|NCT03129100|156926568|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748454|NCT03129100|156926569|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748455|NCT03129100|156926570|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748456|NCT03129100|156926571|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748457|NCT03129100|156926572|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748458|NCT03129100|156926573|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748459|NCT03129100|156926574|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748460|NCT03129100|156926575|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748461|NCT03129100|156926576|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748462|NCT03129100|156926577|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748463|NCT03129100|156926578|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748464|NCT03129100|156926579|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748465|NCT03129100|156926580|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
48640409|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Adverse Event|0|||
48748466|NCT03129100|156926581|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748467|NCT03129100|156926582|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
48748468|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748469|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748470|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
48748471|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
48748472|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48640410|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Adverse Event|0|||
48640411|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Death|2|||
48640412|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Death|1|||
48640413|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Death|0|||
48640414|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Death|0|||
48640415|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Death|0|||
48640416|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
48640417|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
48640418|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
48748473|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
48748474|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748475|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748476|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748477|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748478|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48640419|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
48640420|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
48640421|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Pregnancy|6|||
48640422|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Pregnancy|10|||
48640423|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Pregnancy|0|||
48640424|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Pregnancy|0|||
48640425|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Pregnancy|0|||
48640426|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
48640427|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
48640428|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
48640429|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
48640430|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
48640431|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
48640432|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
48640433|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
48640434|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
48640435|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
48640436|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Moved|62|||
48640437|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Moved|58|||
48640438|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Moved|0|||
48640439|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Moved|0|||
48640440|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Moved|0|||
48640441|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Travel|10|||
48640442|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Travel|7|||
48640443|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Travel|0|||
48640444|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Travel|0|||
48640445|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Travel|0|||
48640446|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Site Closed|0|||
48640447|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Site Closed|2|||
48640448|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Site Closed|0|||
48640449|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Site Closed|0|||
48640450|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Site Closed|0|||
48640451|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
48640452|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
48640453|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
48640454|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
48640455|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
48640456|NCT00092534|156539429|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
48640457|NCT00092534|156539430|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
48640458|NCT00092534|156539431|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
48640459|NCT00092534|156539432|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
48640460|NCT00092534|156539433|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
48640461|NCT00092534|156539429|FG000|Base Study EXT|Lost to Follow-up|0|||
48640462|NCT00092534|156539430|FG001|Base Study EXT|Lost to Follow-up|0|||
48640463|NCT00092534|156539431|FG002|Base Study EXT|Lost to Follow-up|41|||
48640464|NCT00092534|156539432|FG003|Base Study EXT|Lost to Follow-up|0|||
48640465|NCT00092534|156539433|FG004|Base Study EXT|Lost to Follow-up|0|||
48640466|NCT00092534|156539429|FG000|Base Study EXT|Physician Decision|0|||
48640467|NCT00092534|156539430|FG001|Base Study EXT|Physician Decision|0|||
48640468|NCT00092534|156539431|FG002|Base Study EXT|Physician Decision|1|||
48640469|NCT00092534|156539432|FG003|Base Study EXT|Physician Decision|0|||
48640470|NCT00092534|156539433|FG004|Base Study EXT|Physician Decision|0|||
48640471|NCT00092534|156539429|FG000|Base Study EXT|Pregnancy|0|||
48640472|NCT00092534|156539430|FG001|Base Study EXT|Pregnancy|0|||
48640473|NCT00092534|156539431|FG002|Base Study EXT|Pregnancy|12|||
48640474|NCT00092534|156539432|FG003|Base Study EXT|Pregnancy|0|||
48640475|NCT00092534|156539433|FG004|Base Study EXT|Pregnancy|0|||
48640476|NCT00092534|156539429|FG000|Base Study EXT|Withdrawal by Subject|0|||
48640477|NCT00092534|156539430|FG001|Base Study EXT|Withdrawal by Subject|0|||
48640478|NCT00092534|156539431|FG002|Base Study EXT|Withdrawal by Subject|18|||
48640479|NCT00092534|156539432|FG003|Base Study EXT|Withdrawal by Subject|0|||
48640480|NCT00092534|156539433|FG004|Base Study EXT|Withdrawal by Subject|0|||
48640481|NCT00092534|156539429|FG000|Base Study EXT|Participant moved|0|||
48640482|NCT00092534|156539430|FG001|Base Study EXT|Participant moved|0|||
48640483|NCT00092534|156539431|FG002|Base Study EXT|Participant moved|6|||
48640484|NCT00092534|156539432|FG003|Base Study EXT|Participant moved|0|||
48640485|NCT00092534|156539433|FG004|Base Study EXT|Participant moved|0|||
48640486|NCT00092534|156539429|FG000|Base Study EXT|Travel|0|||
48640487|NCT00092534|156539430|FG001|Base Study EXT|Travel|0|||
48640488|NCT00092534|156539431|FG002|Base Study EXT|Travel|2|||
48640489|NCT00092534|156539432|FG003|Base Study EXT|Travel|0|||
48640490|NCT00092534|156539433|FG004|Base Study EXT|Travel|0|||
48640491|NCT00092534|156539429|FG000|Base Study EXT|Site closed|0|||
48640492|NCT00092534|156539430|FG001|Base Study EXT|Site closed|0|||
48748479|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748480|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748481|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748482|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748483|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748484|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748485|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748486|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748487|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748488|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748489|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748490|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748491|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748492|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748493|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
48748494|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Death|0|||
48748495|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Death|0|||
48748496|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Death|1|||
48748497|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Death|0|||
48640493|NCT00092534|156539431|FG002|Base Study EXT|Site closed|21|||
48640494|NCT00092534|156539432|FG003|Base Study EXT|Site closed|0|||
48328734|NCT01728324|155401734|FG000|Termination of RBV|Other than stated|1|||
48328735|NCT01728324|155401735|FG001|Termination of RBV|Other than stated|3|||
48328736|NCT01728324|155401736|FG002|Termination of RBV|Other than stated|1|||
48328737|NCT01728324|155401734|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
48640495|NCT00092534|156539433|FG004|Base Study EXT|Site closed|0|||
48640496|NCT00092534|156539429|FG000|Base Study EXT|Study ended|0|||
48328738|NCT01728324|155401735|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
48328739|NCT01728324|155401736|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
48640497|NCT00092534|156539430|FG001|Base Study EXT|Study ended|0|||
48640498|NCT00092534|156539431|FG002|Base Study EXT|Study ended|29|||
48640499|NCT00092534|156539432|FG003|Base Study EXT|Study ended|0|||
48640500|NCT00092534|156539433|FG004|Base Study EXT|Study ended|0|||
48640501|NCT00092534|156539429|FG000|Base Study EXT|Protocol Violation|0|||
48328740|NCT01728324|155401734|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
48328741|NCT01728324|155401735|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
48328742|NCT01728324|155401736|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
48328743|NCT04248868|155401743|FG000|Overall Study|Death|1|||
48328744|NCT04248868|155401743|FG000|Overall Study|Lost to Follow-up|3|||
48328745|NCT04248868|155401743|FG000|Overall Study|Protocol Violation|2|||
48328746|NCT02406092|155401746|FG000|Overall Study|Screen failure|10|||
48640502|NCT00092534|156539430|FG001|Base Study EXT|Protocol Violation|0|||
48640503|NCT00092534|156539431|FG002|Base Study EXT|Protocol Violation|15|||
48640504|NCT00092534|156539432|FG003|Base Study EXT|Protocol Violation|0|||
48328747|NCT02406092|155401747|FG001|Overall Study|Screen failure|7|||
48640505|NCT00092534|156539433|FG004|Base Study EXT|Protocol Violation|0|||
48640506|NCT00092534|156539429|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
48748498|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Death|0|||
48640507|NCT00092534|156539430|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
48640508|NCT00092534|156539431|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
48640509|NCT00092534|156539432|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
48640510|NCT00092534|156539433|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
48640511|NCT06194214|156539438|FG000|Overall Study|Adverse Event|1|||
48640512|NCT04218201|156539439|FG000|Overall Study|Death|0|||
48640513|NCT04218201|156539440|FG001|Overall Study|Death|0|||
48640514|NCT04218201|156539441|FG002|Overall Study|Death|2|||
48640515|NCT04218201|156539442|FG003|Overall Study|Death|0|||
48640516|NCT04218201|156539439|FG000|Overall Study|Unable to contact participant|4|||
48640517|NCT04218201|156539440|FG001|Overall Study|Unable to contact participant|0|||
48640518|NCT04218201|156539441|FG002|Overall Study|Unable to contact participant|3|||
48640519|NCT04218201|156539442|FG003|Overall Study|Unable to contact participant|0|||
48640520|NCT04218201|156539439|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
48640521|NCT04218201|156539440|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
48640522|NCT04218201|156539441|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
48640523|NCT04218201|156539442|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
48640524|NCT04218201|156539439|FG000|Overall Study|Withdrawal by Subject|2|||
48640525|NCT04218201|156539440|FG001|Overall Study|Withdrawal by Subject|0|||
48640526|NCT04218201|156539441|FG002|Overall Study|Withdrawal by Subject|0|||
48640527|NCT04218201|156539442|FG003|Overall Study|Withdrawal by Subject|0|||
48640528|NCT04218201|156539439|FG000|Overall Study|PCP plans to leave practice|0|||
48640529|NCT04218201|156539440|FG001|Overall Study|PCP plans to leave practice|8|||
48640530|NCT04218201|156539441|FG002|Overall Study|PCP plans to leave practice|0|||
48640531|NCT04218201|156539442|FG003|Overall Study|PCP plans to leave practice|5|||
48640532|NCT04218201|156539439|FG000|Overall Study|Reduced panel|0|||
48640533|NCT04218201|156539440|FG001|Overall Study|Reduced panel|0|||
48640534|NCT04218201|156539441|FG002|Overall Study|Reduced panel|0|||
48640535|NCT04218201|156539442|FG003|Overall Study|Reduced panel|1|||
48640536|NCT04218201|156539439|FG000|Overall Study|No longer interested in participating|0|||
48640537|NCT04218201|156539440|FG001|Overall Study|No longer interested in participating|1|||
48640538|NCT04218201|156539441|FG002|Overall Study|No longer interested in participating|0|||
48640539|NCT04218201|156539442|FG003|Overall Study|No longer interested in participating|0|||
48640540|NCT01631214|156539443|FG000|Overall Study|Withdrawal by Subject|276|||
48640541|NCT01631214|156539444|FG001|Overall Study|Withdrawal by Subject|290|||
48640542|NCT01631214|156539443|FG000|Overall Study|Death|113|||
48640543|NCT01631214|156539444|FG001|Overall Study|Death|106|||
48640544|NCT01631214|156539443|FG000|Overall Study|Lost to Follow-up|54|||
48640545|NCT01631214|156539444|FG001|Overall Study|Lost to Follow-up|40|||
48640546|NCT01631214|156539443|FG000|Overall Study|Adverse Event|45|||
48640547|NCT01631214|156539444|FG001|Overall Study|Adverse Event|45|||
48640548|NCT01631214|156539443|FG000|Overall Study|Other|22|||
48640549|NCT01631214|156539444|FG001|Overall Study|Other|19|||
48640550|NCT01631214|156539443|FG000|Overall Study|Noncompliance|16|||
48640551|NCT01631214|156539444|FG001|Overall Study|Noncompliance|15|||
48640552|NCT01631214|156539443|FG000|Overall Study|Requirement for Alternative Therapy|8|||
48640553|NCT01631214|156539444|FG001|Overall Study|Requirement for Alternative Therapy|3|||
48640554|NCT01631214|156539443|FG000|Overall Study|Protocol Deviation|4|||
48640555|NCT01631214|156539444|FG001|Overall Study|Protocol Deviation|3|||
48640556|NCT01631214|156539443|FG000|Overall Study|Ineligibility determined|5|||
48640557|NCT01631214|156539444|FG001|Overall Study|Ineligibility determined|2|||
48640558|NCT01631214|156539443|FG000|Overall Study|Administrative Decision|1|||
48640559|NCT01631214|156539444|FG001|Overall Study|Administrative Decision|0|||
48640560|NCT04732221|156539445|FG000|Base Period|Death|2|||
48640561|NCT04732221|156539446|FG001|Base Period|Death|0|||
48640562|NCT04732221|156539447|FG002|Base Period|Death|0|||
48640563|NCT04732221|156539448|FG003|Base Period|Death|0|||
48640564|NCT04732221|156539449|FG004|Base Period|Death|0|||
48640565|NCT04732221|156539450|FG005|Base Period|Death|0|||
48640566|NCT04732221|156539451|FG006|Base Period|Death|0|||
48640567|NCT04732221|156539445|FG000|Base Period|Withdrawal by Subject|0|||
48640568|NCT04732221|156539446|FG001|Base Period|Withdrawal by Subject|1|||
48748499|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Death|0|||
48748500|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Death|0|||
48748501|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Death|0|||
48748502|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Death|0|||
48748503|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Death|0|||
48748504|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Death|0|||
48748505|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Death|0|||
48748506|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Death|0|||
48748507|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Death|0|||
48748508|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Death|0|||
48748509|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Death|0|||
48748510|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Death|0|||
48748511|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Death|0|||
48748512|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Death|0|||
48748513|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Death|0|||
48748514|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Death|0|||
48748515|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Death|0|||
48748516|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Death|0|||
48748517|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Death|0|||
48748518|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Death|0|||
48748519|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Death|0|||
48748520|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748521|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748522|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
48748523|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
48748524|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
48748525|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
48748526|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
48748527|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748528|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748529|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748530|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748531|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748532|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748533|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48640569|NCT04732221|156539447|FG002|Base Period|Withdrawal by Subject|1|||
48640570|NCT04732221|156539448|FG003|Base Period|Withdrawal by Subject|0|||
48640571|NCT04732221|156539449|FG004|Base Period|Withdrawal by Subject|0|||
48640572|NCT04732221|156539450|FG005|Base Period|Withdrawal by Subject|0|||
48640573|NCT04732221|156539451|FG006|Base Period|Withdrawal by Subject|0|||
48640574|NCT04732221|156539445|FG000|Extension Period|Adverse Event|0|||
48640575|NCT04732221|156539446|FG001|Extension Period|Adverse Event|0|||
48640576|NCT04732221|156539447|FG002|Extension Period|Adverse Event|0|||
48640577|NCT04732221|156539448|FG003|Extension Period|Adverse Event|0|||
48640578|NCT04732221|156539449|FG004|Extension Period|Adverse Event|0|||
48640579|NCT04732221|156539450|FG005|Extension Period|Adverse Event|1|||
48640580|NCT04732221|156539451|FG006|Extension Period|Adverse Event|0|||
48328748|NCT02406092|155401746|FG000|Overall Study|Death|22|||
48328749|NCT02406092|155401747|FG001|Overall Study|Death|5|||
48328750|NCT02406092|155401746|FG000|Overall Study|Lost to Follow-up|4|||
48328751|NCT02406092|155401747|FG001|Overall Study|Lost to Follow-up|1|||
48328752|NCT02406092|155401746|FG000|Overall Study|Adverse Event|1|||
48328753|NCT02406092|155401747|FG001|Overall Study|Adverse Event|0|||
48328754|NCT02406092|155401746|FG000|Overall Study|Withdrawal by Subject|1|||
48640581|NCT04732221|156539445|FG000|Extension Period|Death|0|||
48640582|NCT04732221|156539446|FG001|Extension Period|Death|0|||
48748534|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748535|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48328755|NCT02406092|155401747|FG001|Overall Study|Withdrawal by Subject|0|||
48328756|NCT00109031|155401748|FG000|Overall Study|Adverse Event|0|||
48328757|NCT00109031|155401749|FG001|Overall Study|Adverse Event|0|||
48328758|NCT00109031|155401750|FG002|Overall Study|Adverse Event|1|||
48748536|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748537|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748538|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748539|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748540|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48328759|NCT00109031|155401751|FG003|Overall Study|Adverse Event|0|||
48328760|NCT00109031|155401748|FG000|Overall Study|Withdrawal by Subject|0|||
48328761|NCT00109031|155401749|FG001|Overall Study|Withdrawal by Subject|1|||
48328762|NCT00109031|155401750|FG002|Overall Study|Withdrawal by Subject|0|||
48328763|NCT00109031|155401751|FG003|Overall Study|Withdrawal by Subject|0|||
48328764|NCT00109031|155401748|FG000|Overall Study|Physician Decision|0|||
48328765|NCT00109031|155401749|FG001|Overall Study|Physician Decision|1|||
48328766|NCT00109031|155401750|FG002|Overall Study|Physician Decision|0|||
48328767|NCT00109031|155401751|FG003|Overall Study|Physician Decision|0|||
48328768|NCT00109031|155401748|FG000|Overall Study|Protocol Violation|0|||
48328769|NCT00109031|155401749|FG001|Overall Study|Protocol Violation|0|||
48328770|NCT00109031|155401750|FG002|Overall Study|Protocol Violation|1|||
48328771|NCT00109031|155401751|FG003|Overall Study|Protocol Violation|0|||
48328772|NCT03611556|155401767|FG000|Overall Study|Death|7|||
48328773|NCT03611556|155401768|FG001|Overall Study|Death|7|||
48328774|NCT03611556|155401769|FG002|Overall Study|Death|3|||
48328775|NCT03611556|155401770|FG003|Overall Study|Death|8|||
48328776|NCT03611556|155401771|FG004|Overall Study|Death|47|||
48328777|NCT03611556|155401772|FG005|Overall Study|Death|32|||
48328778|NCT03611556|155401773|FG006|Overall Study|Death|53|||
48328779|NCT03611556|155401767|FG000|Overall Study|Withdrawal by Subject|0|||
48328780|NCT03611556|155401768|FG001|Overall Study|Withdrawal by Subject|0|||
48328781|NCT03611556|155401769|FG002|Overall Study|Withdrawal by Subject|0|||
48328782|NCT03611556|155401770|FG003|Overall Study|Withdrawal by Subject|0|||
48640583|NCT04732221|156539447|FG002|Extension Period|Death|0|||
48640584|NCT04732221|156539448|FG003|Extension Period|Death|0|||
48328783|NCT03611556|155401771|FG004|Overall Study|Withdrawal by Subject|4|||
48328784|NCT03611556|155401772|FG005|Overall Study|Withdrawal by Subject|2|||
48328785|NCT03611556|155401773|FG006|Overall Study|Withdrawal by Subject|4|||
48328786|NCT03611556|155401767|FG000|Overall Study|Sponsor decision|0|||
48328787|NCT03611556|155401768|FG001|Overall Study|Sponsor decision|0|||
48328788|NCT03611556|155401769|FG002|Overall Study|Sponsor decision|0|||
48328789|NCT03611556|155401770|FG003|Overall Study|Sponsor decision|0|||
48640585|NCT04732221|156539449|FG004|Extension Period|Death|1|||
48328790|NCT03611556|155401771|FG004|Overall Study|Sponsor decision|9|||
48328791|NCT03611556|155401772|FG005|Overall Study|Sponsor decision|4|||
48328792|NCT03611556|155401773|FG006|Overall Study|Sponsor decision|12|||
48328793|NCT03611556|155401767|FG000|Overall Study|Reasons|0|||
48328794|NCT03611556|155401768|FG001|Overall Study|Reasons|0|||
48328795|NCT03611556|155401769|FG002|Overall Study|Reasons|0|||
48328796|NCT03611556|155401770|FG003|Overall Study|Reasons|0|||
48640586|NCT04732221|156539450|FG005|Extension Period|Death|0|||
48640587|NCT04732221|156539451|FG006|Extension Period|Death|2|||
48640588|NCT04732221|156539445|FG000|Extension Period|Pregnancy|0|||
48640589|NCT04732221|156539446|FG001|Extension Period|Pregnancy|0|||
48640590|NCT04732221|156539447|FG002|Extension Period|Pregnancy|0|||
48640591|NCT04732221|156539448|FG003|Extension Period|Pregnancy|0|||
48640592|NCT04732221|156539449|FG004|Extension Period|Pregnancy|1|||
48640593|NCT04732221|156539450|FG005|Extension Period|Pregnancy|0|||
48640594|NCT04732221|156539451|FG006|Extension Period|Pregnancy|0|||
48640595|NCT04732221|156539445|FG000|Extension Period|Sponsors Decision|0|||
48640596|NCT04732221|156539446|FG001|Extension Period|Sponsors Decision|0|||
48640597|NCT04732221|156539447|FG002|Extension Period|Sponsors Decision|0|||
48640598|NCT04732221|156539448|FG003|Extension Period|Sponsors Decision|0|||
48640599|NCT04732221|156539449|FG004|Extension Period|Sponsors Decision|41|||
48640600|NCT04732221|156539450|FG005|Extension Period|Sponsors Decision|40|||
48640601|NCT04732221|156539451|FG006|Extension Period|Sponsors Decision|40|||
48640602|NCT04732221|156539445|FG000|Extension Period|Withdrawal by Subject|0|||
48640603|NCT04732221|156539446|FG001|Extension Period|Withdrawal by Subject|0|||
48640604|NCT04732221|156539447|FG002|Extension Period|Withdrawal by Subject|0|||
48640605|NCT04732221|156539448|FG003|Extension Period|Withdrawal by Subject|0|||
48640606|NCT04732221|156539449|FG004|Extension Period|Withdrawal by Subject|1|||
48640607|NCT04732221|156539450|FG005|Extension Period|Withdrawal by Subject|5|||
48640608|NCT04732221|156539451|FG006|Extension Period|Withdrawal by Subject|2|||
48640609|NCT04784559|156539454|FG000|Overall Study|Withdrawal by Subject|3|||
48640610|NCT04784559|156539455|FG001|Overall Study|Withdrawal by Subject|2|||
48640611|NCT04784559|156539456|FG002|Overall Study|Withdrawal by Subject|1|||
48640612|NCT04784559|156539454|FG000|Overall Study|Death|2|||
48640613|NCT04784559|156539455|FG001|Overall Study|Death|1|||
48640614|NCT04784559|156539456|FG002|Overall Study|Death|2|||
48640615|NCT04784559|156539454|FG000|Overall Study|Lost to Follow-up|0|||
48640616|NCT04784559|156539455|FG001|Overall Study|Lost to Follow-up|0|||
48328797|NCT03611556|155401771|FG004|Overall Study|Reasons|2|||
48328798|NCT03611556|155401772|FG005|Overall Study|Reasons|0|||
48328799|NCT03611556|155401773|FG006|Overall Study|Reasons|1|||
48328800|NCT02399449|155401774|FG000|Overall Study|Withdrawal by Subject|3|||
48328801|NCT02399449|155401775|FG001|Overall Study|Withdrawal by Subject|9|||
48328802|NCT02399449|155401774|FG000|Overall Study|Physician Decision|0|||
48328803|NCT02399449|155401775|FG001|Overall Study|Physician Decision|1|||
48328804|NCT02159352|155401776|FG000|Overall Study|Adverse Event|3|||
48328805|NCT02159352|155401777|FG001|Overall Study|Adverse Event|1|||
48328806|NCT02159352|155401776|FG000|Overall Study|Withdrawal by Subject|0|||
48328807|NCT02159352|155401777|FG001|Overall Study|Withdrawal by Subject|1|||
48328808|NCT01801007|155401778|FG000|Overall Study|Adverse Event|2|||
48328809|NCT01801007|155401778|FG000|Overall Study|Lost to Follow-up|4|||
48328810|NCT01801007|155401778|FG000|Overall Study|Withdrawal by Subject|5|||
48328811|NCT02060487|155401779|FG000|Overall Study|Other|1|||
48328812|NCT02060487|155401780|FG001|Overall Study|Other|2|||
48328813|NCT02060487|155401781|FG002|Overall Study|Other|1|||
48328814|NCT02060487|155401779|FG000|Overall Study|Lack of Efficacy|0|||
48328815|NCT02060487|155401780|FG001|Overall Study|Lack of Efficacy|1|||
48328816|NCT02060487|155401781|FG002|Overall Study|Lack of Efficacy|0|||
48328817|NCT02060487|155401779|FG000|Overall Study|Withdrawal by Subject|3|||
48328818|NCT02060487|155401780|FG001|Overall Study|Withdrawal by Subject|10|||
48328819|NCT02060487|155401781|FG002|Overall Study|Withdrawal by Subject|4|||
48328820|NCT02060487|155401779|FG000|Overall Study|Study Terminated By Sponsor|87|||
48328821|NCT02060487|155401780|FG001|Overall Study|Study Terminated By Sponsor|89|||
48640617|NCT04784559|156539456|FG002|Overall Study|Lost to Follow-up|2|||
48328822|NCT02060487|155401781|FG002|Overall Study|Study Terminated By Sponsor|100|||
48640618|NCT04784559|156539454|FG000|Overall Study|Participant worsened, PI decision|1|||
48640619|NCT04784559|156539455|FG001|Overall Study|Participant worsened, PI decision|0|||
48640620|NCT04784559|156539456|FG002|Overall Study|Participant worsened, PI decision|0|||
48640621|NCT04784559|156539454|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
48328823|NCT02060487|155401779|FG000|Overall Study|Randomized in error|1|||
48640622|NCT04784559|156539455|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
48640623|NCT04784559|156539456|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
48640624|NCT04784559|156539454|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
48328824|NCT02060487|155401780|FG001|Overall Study|Randomized in error|0|||
48328825|NCT02060487|155401781|FG002|Overall Study|Randomized in error|0|||
48328826|NCT02060487|155401779|FG000|Overall Study|Protocol Violation|0|||
48328827|NCT02060487|155401780|FG001|Overall Study|Protocol Violation|1|||
48748541|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748542|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48640625|NCT04784559|156539455|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
48640626|NCT04784559|156539456|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
48640627|NCT04784559|156539454|FG000|Overall Study|Did not meet all inclusion criteria|0|||
48640628|NCT04784559|156539455|FG001|Overall Study|Did not meet all inclusion criteria|1|||
48640629|NCT04784559|156539456|FG002|Overall Study|Did not meet all inclusion criteria|0|||
48640630|NCT04784559|156539454|FG000|Overall Study|The participant was transferred to IRCU|0|||
48640631|NCT04784559|156539455|FG001|Overall Study|The participant was transferred to IRCU|1|||
48640632|NCT04784559|156539456|FG002|Overall Study|The participant was transferred to IRCU|0|||
48640633|NCT04784559|156539454|FG000|Overall Study|SAE|0|||
48640634|NCT04784559|156539455|FG001|Overall Study|SAE|1|||
48640635|NCT04784559|156539456|FG002|Overall Study|SAE|0|||
48640636|NCT04784559|156539454|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
48748543|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748544|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48748545|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
48328828|NCT02060487|155401781|FG002|Overall Study|Protocol Violation|1|||
48328829|NCT02060487|155401779|FG000|Overall Study|Lost to Follow-up|3|||
48328830|NCT02060487|155401780|FG001|Overall Study|Lost to Follow-up|0|||
48328831|NCT02060487|155401781|FG002|Overall Study|Lost to Follow-up|2|||
48640637|NCT04784559|156539455|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
48640638|NCT04784559|156539456|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
48328832|NCT02060487|155401779|FG000|Overall Study|Death|34|||
48328833|NCT02060487|155401780|FG001|Overall Study|Death|25|||
48328834|NCT02060487|155401781|FG002|Overall Study|Death|19|||
48640639|NCT02307565|156539457|FG000|Overall Study|Adverse Event|3|||
48640640|NCT02307565|156539458|FG001|Overall Study|Adverse Event|2|||
48640641|NCT02307565|156539457|FG000|Overall Study|Withdrawal by Subject|2|||
48640642|NCT02307565|156539458|FG001|Overall Study|Withdrawal by Subject|2|||
48640643|NCT03846505|156539459|FG000|Treatment Phase|Withdrawal by Subject|9|||
48640644|NCT03846505|156539460|FG001|Treatment Phase|Withdrawal by Subject|11|||
48640645|NCT03846505|156539459|FG000|Treatment Phase|Lost to Follow-up|6|||
48640646|NCT03846505|156539460|FG001|Treatment Phase|Lost to Follow-up|2|||
48640647|NCT03846505|156539459|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
48640648|NCT03846505|156539460|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
48640649|NCT03846505|156539459|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
48640650|NCT03846505|156539460|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
48640651|NCT05197049|156539461|FG000|Overall Study|Death|0|||
48640652|NCT05197049|156539462|FG001|Overall Study|Death|1|||
48640653|NCT05197049|156539463|FG002|Overall Study|Death|0|||
48640654|NCT05197049|156539461|FG000|Overall Study|Lost to Follow-up|3|||
48640655|NCT05197049|156539462|FG001|Overall Study|Lost to Follow-up|1|||
48640656|NCT05197049|156539463|FG002|Overall Study|Lost to Follow-up|0|||
48640657|NCT05197049|156539461|FG000|Overall Study|Withdrawal by Subject|15|||
48640658|NCT05197049|156539462|FG001|Overall Study|Withdrawal by Subject|3|||
48640659|NCT05197049|156539463|FG002|Overall Study|Withdrawal by Subject|1|||
48640660|NCT05197049|156539461|FG000|Overall Study|GCP non-compliance|1|||
48328835|NCT02060487|155401779|FG000|Overall Study|Adverse Event|0|||
48328836|NCT02060487|155401780|FG001|Overall Study|Adverse Event|0|||
48328837|NCT02060487|155401781|FG002|Overall Study|Adverse Event|1|||
48328838|NCT00875706|155401784|FG000|Overall Study|Withdrawal by Subject|1|||
48328839|NCT00875706|155401785|FG001|Overall Study|Withdrawal by Subject|0|||
48328840|NCT00875706|155401786|FG002|Overall Study|Withdrawal by Subject|0|||
48328841|NCT01706159|155401787|FG000|Overall Study|Withdrawal Criteria|2|||
48328842|NCT01706159|155401788|FG001|Overall Study|Withdrawal Criteria|1|||
48328843|NCT01706159|155401787|FG000|Overall Study|Unclassified|6|||
48328844|NCT01706159|155401788|FG001|Overall Study|Unclassified|1|||
48328845|NCT00824408|155401789|FG000|Run-in Phase|Progressive disease|4|||
48328846|NCT00824408|155401790|FG001|Run-in Phase|Progressive disease|4|||
48328847|NCT00824408|155401791|FG002|Run-in Phase|Progressive disease|0|||
48328848|NCT00824408|155401792|FG003|Run-in Phase|Progressive disease|0|||
48328849|NCT00824408|155401793|FG004|Run-in Phase|Progressive disease|0|||
48328850|NCT00824408|155401789|FG000|Run-in Phase|Adverse Event|1|||
48328851|NCT00824408|155401790|FG001|Run-in Phase|Adverse Event|1|||
48328852|NCT00824408|155401791|FG002|Run-in Phase|Adverse Event|0|||
48328853|NCT00824408|155401792|FG003|Run-in Phase|Adverse Event|0|||
48328854|NCT00824408|155401793|FG004|Run-in Phase|Adverse Event|0|||
48328855|NCT00824408|155401789|FG000|Run-in Phase|Refused to continue medication|1|||
48328856|NCT00824408|155401790|FG001|Run-in Phase|Refused to continue medication|0|||
48328857|NCT00824408|155401791|FG002|Run-in Phase|Refused to continue medication|0|||
48328858|NCT00824408|155401792|FG003|Run-in Phase|Refused to continue medication|0|||
48328859|NCT00824408|155401793|FG004|Run-in Phase|Refused to continue medication|0|||
48328860|NCT00824408|155401789|FG000|Run-in Phase|Other reason not defined above|0|||
48640661|NCT05197049|156539462|FG001|Overall Study|GCP non-compliance|2|||
48640662|NCT05197049|156539463|FG002|Overall Study|GCP non-compliance|0|||
48640663|NCT03362502|156539464|FG000|Overall Study|Death|0|||
48640664|NCT03362502|156539465|FG001|Overall Study|Death|0|||
48640665|NCT03362502|156539466|FG002|Overall Study|Death|1|||
48640666|NCT03232073|156539467|FG000|Overall Study|Death|1|||
48640667|NCT03232073|156539468|FG001|Overall Study|Death|0|||
48640668|NCT03232073|156539467|FG000|Overall Study|Adverse Event|7|||
48640669|NCT03232073|156539468|FG001|Overall Study|Adverse Event|12|||
48640670|NCT03232073|156539467|FG000|Overall Study|Lost to Follow-up|6|||
48640671|NCT03232073|156539468|FG001|Overall Study|Lost to Follow-up|6|||
48640672|NCT03232073|156539467|FG000|Overall Study|Lack of Efficacy|10|||
48640673|NCT03232073|156539468|FG001|Overall Study|Lack of Efficacy|8|||
48640674|NCT03232073|156539467|FG000|Overall Study|Physician Decision|9|||
48640675|NCT03232073|156539468|FG001|Overall Study|Physician Decision|2|||
48640676|NCT03232073|156539467|FG000|Overall Study|Withdrawal by Subject|54|||
48640677|NCT03232073|156539468|FG001|Overall Study|Withdrawal by Subject|39|||
48640678|NCT02883049|156539472|FG000|Induction|Adverse Event|52|||
48640679|NCT02883049|156539473|FG001|Induction|Adverse Event|2|||
48640680|NCT02883049|156539474|FG002|Induction|Adverse Event|0|||
48640681|NCT02883049|156539475|FG003|Induction|Adverse Event|0|||
48640682|NCT02883049|156539476|FG004|Induction|Adverse Event|0|||
48640683|NCT02883049|156539477|FG005|Induction|Adverse Event|0|||
48640684|NCT02883049|156539478|FG006|Induction|Adverse Event|0|||
48640685|NCT02883049|156539479|FG007|Induction|Adverse Event|0|||
48640686|NCT02883049|156539480|FG008|Induction|Adverse Event|0|||
48640687|NCT02883049|156539481|FG009|Induction|Adverse Event|0|||
48640688|NCT02883049|156539482|FG010|Induction|Adverse Event|0|||
48640689|NCT02883049|156539483|FG011|Induction|Adverse Event|0|||
48640690|NCT02883049|156539484|FG012|Induction|Adverse Event|0|||
48640691|NCT02883049|156539485|FG013|Induction|Adverse Event|0|||
48640692|NCT02883049|156539486|FG014|Induction|Adverse Event|0|||
48640693|NCT02883049|156539487|FG015|Induction|Adverse Event|0|||
48640694|NCT02883049|156539472|FG000|Induction|Death|76|||
48640695|NCT02883049|156539473|FG001|Induction|Death|8|||
48640696|NCT02883049|156539474|FG002|Induction|Death|0|||
48640697|NCT02883049|156539475|FG003|Induction|Death|0|||
48640698|NCT02883049|156539476|FG004|Induction|Death|0|||
48640699|NCT02883049|156539477|FG005|Induction|Death|0|||
48640700|NCT02883049|156539478|FG006|Induction|Death|0|||
48640701|NCT02883049|156539479|FG007|Induction|Death|0|||
48640702|NCT02883049|156539480|FG008|Induction|Death|0|||
48640703|NCT02883049|156539481|FG009|Induction|Death|0|||
48640704|NCT02883049|156539482|FG010|Induction|Death|0|||
48640705|NCT02883049|156539483|FG011|Induction|Death|0|||
48640706|NCT02883049|156539484|FG012|Induction|Death|0|||
48640707|NCT02883049|156539485|FG013|Induction|Death|0|||
48640708|NCT02883049|156539486|FG014|Induction|Death|0|||
48640709|NCT02883049|156539487|FG015|Induction|Death|0|||
48640710|NCT02883049|156539472|FG000|Induction|Lost to Follow-up|2|||
48640711|NCT02883049|156539473|FG001|Induction|Lost to Follow-up|0|||
48640712|NCT02883049|156539474|FG002|Induction|Lost to Follow-up|0|||
48640713|NCT02883049|156539475|FG003|Induction|Lost to Follow-up|0|||
48640714|NCT02883049|156539476|FG004|Induction|Lost to Follow-up|0|||
48640715|NCT02883049|156539477|FG005|Induction|Lost to Follow-up|0|||
48640716|NCT02883049|156539478|FG006|Induction|Lost to Follow-up|0|||
48640717|NCT02883049|156539479|FG007|Induction|Lost to Follow-up|0|||
48640718|NCT02883049|156539480|FG008|Induction|Lost to Follow-up|0|||
48640719|NCT02883049|156539481|FG009|Induction|Lost to Follow-up|0|||
48640720|NCT02883049|156539482|FG010|Induction|Lost to Follow-up|0|||
48640721|NCT02883049|156539483|FG011|Induction|Lost to Follow-up|0|||
48640722|NCT02883049|156539484|FG012|Induction|Lost to Follow-up|0|||
48640723|NCT02883049|156539485|FG013|Induction|Lost to Follow-up|0|||
48640724|NCT02883049|156539486|FG014|Induction|Lost to Follow-up|0|||
48640725|NCT02883049|156539487|FG015|Induction|Lost to Follow-up|0|||
48640726|NCT02883049|156539472|FG000|Induction|Physician Decision|1407|||
48640727|NCT02883049|156539473|FG001|Induction|Physician Decision|8|||
48640728|NCT02883049|156539474|FG002|Induction|Physician Decision|0|||
48640729|NCT02883049|156539475|FG003|Induction|Physician Decision|0|||
48640730|NCT02883049|156539476|FG004|Induction|Physician Decision|0|||
48640731|NCT02883049|156539477|FG005|Induction|Physician Decision|0|||
48640732|NCT02883049|156539478|FG006|Induction|Physician Decision|0|||
48640733|NCT02883049|156539479|FG007|Induction|Physician Decision|0|||
48640734|NCT02883049|156539480|FG008|Induction|Physician Decision|0|||
48640735|NCT02883049|156539481|FG009|Induction|Physician Decision|0|||
48640736|NCT02883049|156539482|FG010|Induction|Physician Decision|0|||
48640737|NCT02883049|156539483|FG011|Induction|Physician Decision|0|||
48640738|NCT02883049|156539484|FG012|Induction|Physician Decision|0|||
48640739|NCT02883049|156539485|FG013|Induction|Physician Decision|0|||
48640740|NCT02883049|156539486|FG014|Induction|Physician Decision|0|||
48640741|NCT02883049|156539487|FG015|Induction|Physician Decision|0|||
48640742|NCT02883049|156539472|FG000|Induction|Protocol Violation|6|||
48640743|NCT02883049|156539473|FG001|Induction|Protocol Violation|0|||
48640744|NCT02883049|156539474|FG002|Induction|Protocol Violation|0|||
48640745|NCT02883049|156539475|FG003|Induction|Protocol Violation|0|||
48640746|NCT02883049|156539476|FG004|Induction|Protocol Violation|0|||
48640747|NCT02883049|156539477|FG005|Induction|Protocol Violation|0|||
48640748|NCT02883049|156539478|FG006|Induction|Protocol Violation|0|||
48640749|NCT02883049|156539479|FG007|Induction|Protocol Violation|0|||
48640750|NCT02883049|156539480|FG008|Induction|Protocol Violation|0|||
48640751|NCT02883049|156539481|FG009|Induction|Protocol Violation|0|||
48640752|NCT02883049|156539482|FG010|Induction|Protocol Violation|0|||
48640753|NCT02883049|156539483|FG011|Induction|Protocol Violation|0|||
48640754|NCT02883049|156539484|FG012|Induction|Protocol Violation|0|||
48640755|NCT02883049|156539485|FG013|Induction|Protocol Violation|0|||
48640756|NCT02883049|156539486|FG014|Induction|Protocol Violation|0|||
48640757|NCT02883049|156539487|FG015|Induction|Protocol Violation|0|||
48640758|NCT02883049|156539472|FG000|Induction|Withdrawal by Subject|6|||
48640759|NCT02883049|156539473|FG001|Induction|Withdrawal by Subject|0|||
48640760|NCT02883049|156539474|FG002|Induction|Withdrawal by Subject|0|||
48640761|NCT02883049|156539475|FG003|Induction|Withdrawal by Subject|0|||
48640762|NCT02883049|156539476|FG004|Induction|Withdrawal by Subject|0|||
48640763|NCT02883049|156539477|FG005|Induction|Withdrawal by Subject|0|||
48640764|NCT02883049|156539478|FG006|Induction|Withdrawal by Subject|0|||
48640765|NCT02883049|156539479|FG007|Induction|Withdrawal by Subject|0|||
48640766|NCT02883049|156539480|FG008|Induction|Withdrawal by Subject|0|||
48640767|NCT02883049|156539481|FG009|Induction|Withdrawal by Subject|0|||
48640768|NCT02883049|156539482|FG010|Induction|Withdrawal by Subject|0|||
48640769|NCT02883049|156539483|FG011|Induction|Withdrawal by Subject|0|||
48640770|NCT02883049|156539484|FG012|Induction|Withdrawal by Subject|0|||
48640771|NCT02883049|156539485|FG013|Induction|Withdrawal by Subject|0|||
48640772|NCT02883049|156539486|FG014|Induction|Withdrawal by Subject|0|||
48640773|NCT02883049|156539487|FG015|Induction|Withdrawal by Subject|0|||
48640774|NCT02883049|156539472|FG000|Induction|Ineligible|35|||
48640775|NCT02883049|156539473|FG001|Induction|Ineligible|1|||
48640776|NCT02883049|156539474|FG002|Induction|Ineligible|0|||
48640777|NCT02883049|156539475|FG003|Induction|Ineligible|0|||
48640778|NCT02883049|156539476|FG004|Induction|Ineligible|0|||
48640779|NCT02883049|156539477|FG005|Induction|Ineligible|0|||
48640780|NCT02883049|156539478|FG006|Induction|Ineligible|0|||
48640781|NCT02883049|156539479|FG007|Induction|Ineligible|0|||
48640782|NCT02883049|156539480|FG008|Induction|Ineligible|0|||
48640783|NCT02883049|156539481|FG009|Induction|Ineligible|0|||
48748546|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48640784|NCT02883049|156539482|FG010|Induction|Ineligible|0|||
48640785|NCT02883049|156539483|FG011|Induction|Ineligible|0|||
48640786|NCT02883049|156539484|FG012|Induction|Ineligible|0|||
48640787|NCT02883049|156539485|FG013|Induction|Ineligible|0|||
48640788|NCT02883049|156539486|FG014|Induction|Ineligible|0|||
48640789|NCT02883049|156539487|FG015|Induction|Ineligible|0|||
48748547|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748548|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
48748549|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748550|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748551|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748552|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748553|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748554|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748555|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748556|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748557|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748558|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748559|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748560|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748561|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748562|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748563|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748564|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748565|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748566|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748567|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748568|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48328861|NCT00824408|155401790|FG001|Run-in Phase|Other reason not defined above|1|||
48748569|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748570|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748571|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
48748572|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748573|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748574|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
48328862|NCT00824408|155401791|FG002|Run-in Phase|Other reason not defined above|0|||
48640790|NCT02883049|156539472|FG000|Induction|Refusal of further protocol therapy|466|||
48748575|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748576|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748577|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748578|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48640791|NCT02883049|156539473|FG001|Induction|Refusal of further protocol therapy|2|||
48640792|NCT02883049|156539474|FG002|Induction|Refusal of further protocol therapy|0|||
48640793|NCT02883049|156539475|FG003|Induction|Refusal of further protocol therapy|0|||
48640794|NCT02883049|156539476|FG004|Induction|Refusal of further protocol therapy|0|||
48640795|NCT02883049|156539477|FG005|Induction|Refusal of further protocol therapy|0|||
48640796|NCT02883049|156539478|FG006|Induction|Refusal of further protocol therapy|0|||
48640797|NCT02883049|156539479|FG007|Induction|Refusal of further protocol therapy|0|||
48640798|NCT02883049|156539480|FG008|Induction|Refusal of further protocol therapy|0|||
48640799|NCT02883049|156539481|FG009|Induction|Refusal of further protocol therapy|0|||
48640800|NCT02883049|156539482|FG010|Induction|Refusal of further protocol therapy|0|||
48640801|NCT02883049|156539483|FG011|Induction|Refusal of further protocol therapy|0|||
48640802|NCT02883049|156539484|FG012|Induction|Refusal of further protocol therapy|0|||
48640803|NCT02883049|156539485|FG013|Induction|Refusal of further protocol therapy|0|||
48748579|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48328863|NCT00824408|155401792|FG003|Run-in Phase|Other reason not defined above|0|||
48640804|NCT02883049|156539486|FG014|Induction|Refusal of further protocol therapy|0|||
48640805|NCT02883049|156539487|FG015|Induction|Refusal of further protocol therapy|0|||
48640806|NCT02883049|156539472|FG000|Induction|Identified as Ph+ patients|279|||
48640807|NCT02883049|156539473|FG001|Induction|Identified as Ph+ patients|1|||
48328864|NCT00824408|155401793|FG004|Run-in Phase|Other reason not defined above|0|||
48328865|NCT00824408|155401789|FG000|Randomized Phase|Not treated|0|||
48328866|NCT00824408|155401790|FG001|Randomized Phase|Not treated|0|||
48328867|NCT00824408|155401791|FG002|Randomized Phase|Not treated|1|||
48328868|NCT00824408|155401792|FG003|Randomized Phase|Not treated|1|||
48328869|NCT00824408|155401793|FG004|Randomized Phase|Not treated|1|||
48328870|NCT00824408|155401789|FG000|Randomized Phase|Progressive disease|0|||
48328871|NCT00824408|155401790|FG001|Randomized Phase|Progressive disease|0|||
48328872|NCT00824408|155401791|FG002|Randomized Phase|Progressive disease|25|||
48328873|NCT00824408|155401792|FG003|Randomized Phase|Progressive disease|36|||
48328874|NCT00824408|155401793|FG004|Randomized Phase|Progressive disease|34|||
48640808|NCT02883049|156539474|FG002|Induction|Identified as Ph+ patients|0|||
48640809|NCT02883049|156539475|FG003|Induction|Identified as Ph+ patients|0|||
48640810|NCT02883049|156539476|FG004|Induction|Identified as Ph+ patients|0|||
48640811|NCT02883049|156539477|FG005|Induction|Identified as Ph+ patients|0|||
48640812|NCT02883049|156539478|FG006|Induction|Identified as Ph+ patients|0|||
48640813|NCT02883049|156539479|FG007|Induction|Identified as Ph+ patients|0|||
48640814|NCT02883049|156539480|FG008|Induction|Identified as Ph+ patients|0|||
48640815|NCT02883049|156539481|FG009|Induction|Identified as Ph+ patients|0|||
48640816|NCT02883049|156539482|FG010|Induction|Identified as Ph+ patients|0|||
48640817|NCT02883049|156539483|FG011|Induction|Identified as Ph+ patients|0|||
48640818|NCT02883049|156539484|FG012|Induction|Identified as Ph+ patients|0|||
48640819|NCT02883049|156539485|FG013|Induction|Identified as Ph+ patients|0|||
48640820|NCT02883049|156539486|FG014|Induction|Identified as Ph+ patients|0|||
48640821|NCT02883049|156539487|FG015|Induction|Identified as Ph+ patients|0|||
48640822|NCT02883049|156539472|FG000|Induction|M3 Marrow at Day29|8|||
48640823|NCT02883049|156539473|FG001|Induction|M3 Marrow at Day29|1|||
48640824|NCT02883049|156539474|FG002|Induction|M3 Marrow at Day29|0|||
48640825|NCT02883049|156539475|FG003|Induction|M3 Marrow at Day29|0|||
48640826|NCT02883049|156539476|FG004|Induction|M3 Marrow at Day29|0|||
48640827|NCT02883049|156539477|FG005|Induction|M3 Marrow at Day29|0|||
48640828|NCT02883049|156539478|FG006|Induction|M3 Marrow at Day29|0|||
48640829|NCT02883049|156539479|FG007|Induction|M3 Marrow at Day29|0|||
48640830|NCT02883049|156539480|FG008|Induction|M3 Marrow at Day29|0|||
48640831|NCT02883049|156539481|FG009|Induction|M3 Marrow at Day29|0|||
48640832|NCT02883049|156539482|FG010|Induction|M3 Marrow at Day29|0|||
48640833|NCT02883049|156539483|FG011|Induction|M3 Marrow at Day29|0|||
48640834|NCT02883049|156539484|FG012|Induction|M3 Marrow at Day29|0|||
48328875|NCT00824408|155401789|FG000|Randomized Phase|Adverse Event|0|||
48640835|NCT02883049|156539485|FG013|Induction|M3 Marrow at Day29|0|||
48640836|NCT02883049|156539486|FG014|Induction|M3 Marrow at Day29|0|||
48640837|NCT02883049|156539487|FG015|Induction|M3 Marrow at Day29|0|||
48640838|NCT02883049|156539472|FG000|Induction|Inevaluable|33|||
48328876|NCT00824408|155401790|FG001|Randomized Phase|Adverse Event|0|||
48328877|NCT00824408|155401791|FG002|Randomized Phase|Adverse Event|4|||
48640839|NCT02883049|156539473|FG001|Induction|Inevaluable|1|||
48640840|NCT02883049|156539474|FG002|Induction|Inevaluable|0|||
48640841|NCT02883049|156539475|FG003|Induction|Inevaluable|0|||
48640842|NCT02883049|156539476|FG004|Induction|Inevaluable|0|||
48640843|NCT02883049|156539477|FG005|Induction|Inevaluable|0|||
48640844|NCT02883049|156539478|FG006|Induction|Inevaluable|0|||
48640845|NCT02883049|156539479|FG007|Induction|Inevaluable|0|||
48748580|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48640846|NCT02883049|156539480|FG008|Induction|Inevaluable|0|||
48748581|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48328878|NCT00824408|155401792|FG003|Randomized Phase|Adverse Event|5|||
48328879|NCT00824408|155401793|FG004|Randomized Phase|Adverse Event|5|||
48328880|NCT00824408|155401789|FG000|Randomized Phase|Refused to continue medication|0|||
48328881|NCT00824408|155401790|FG001|Randomized Phase|Refused to continue medication|0|||
48328882|NCT00824408|155401791|FG002|Randomized Phase|Refused to continue medication|2|||
48640847|NCT02883049|156539481|FG009|Induction|Inevaluable|0|||
48640848|NCT02883049|156539482|FG010|Induction|Inevaluable|0|||
48640849|NCT02883049|156539483|FG011|Induction|Inevaluable|0|||
48640850|NCT02883049|156539484|FG012|Induction|Inevaluable|0|||
48640851|NCT02883049|156539485|FG013|Induction|Inevaluable|0|||
48640852|NCT02883049|156539486|FG014|Induction|Inevaluable|0|||
48640853|NCT02883049|156539487|FG015|Induction|Inevaluable|0|||
48640854|NCT02883049|156539472|FG000|Induction|Identified as VHR at end of Induction|244|||
48640855|NCT02883049|156539473|FG001|Induction|Identified as VHR at end of Induction|0|||
48640856|NCT02883049|156539474|FG002|Induction|Identified as VHR at end of Induction|0|||
48640857|NCT02883049|156539475|FG003|Induction|Identified as VHR at end of Induction|0|||
48640858|NCT02883049|156539476|FG004|Induction|Identified as VHR at end of Induction|0|||
48640859|NCT02883049|156539477|FG005|Induction|Identified as VHR at end of Induction|0|||
48640860|NCT02883049|156539478|FG006|Induction|Identified as VHR at end of Induction|0|||
48640861|NCT02883049|156539479|FG007|Induction|Identified as VHR at end of Induction|0|||
48640862|NCT02883049|156539480|FG008|Induction|Identified as VHR at end of Induction|0|||
48640863|NCT02883049|156539481|FG009|Induction|Identified as VHR at end of Induction|0|||
48640864|NCT02883049|156539482|FG010|Induction|Identified as VHR at end of Induction|0|||
48640865|NCT02883049|156539483|FG011|Induction|Identified as VHR at end of Induction|0|||
48640866|NCT02883049|156539484|FG012|Induction|Identified as VHR at end of Induction|0|||
48640867|NCT02883049|156539485|FG013|Induction|Identified as VHR at end of Induction|0|||
48640868|NCT02883049|156539486|FG014|Induction|Identified as VHR at end of Induction|0|||
48640869|NCT02883049|156539487|FG015|Induction|Identified as VHR at end of Induction|0|||
48640870|NCT02883049|156539472|FG000|Induction|Moved to another non-COG institution|3|||
48640871|NCT02883049|156539473|FG001|Induction|Moved to another non-COG institution|0|||
48640872|NCT02883049|156539474|FG002|Induction|Moved to another non-COG institution|0|||
48640873|NCT02883049|156539475|FG003|Induction|Moved to another non-COG institution|0|||
48640874|NCT02883049|156539476|FG004|Induction|Moved to another non-COG institution|0|||
48640875|NCT02883049|156539477|FG005|Induction|Moved to another non-COG institution|0|||
48640876|NCT02883049|156539478|FG006|Induction|Moved to another non-COG institution|0|||
48640877|NCT02883049|156539479|FG007|Induction|Moved to another non-COG institution|0|||
48640878|NCT02883049|156539480|FG008|Induction|Moved to another non-COG institution|0|||
48640879|NCT02883049|156539481|FG009|Induction|Moved to another non-COG institution|0|||
48640880|NCT02883049|156539482|FG010|Induction|Moved to another non-COG institution|0|||
48640881|NCT02883049|156539483|FG011|Induction|Moved to another non-COG institution|0|||
48640882|NCT02883049|156539484|FG012|Induction|Moved to another non-COG institution|0|||
48640883|NCT02883049|156539485|FG013|Induction|Moved to another non-COG institution|0|||
48640884|NCT02883049|156539486|FG014|Induction|Moved to another non-COG institution|0|||
48640885|NCT02883049|156539487|FG015|Induction|Moved to another non-COG institution|0|||
48640886|NCT02883049|156539472|FG000|Induction|Randomization closed|41|||
48640887|NCT02883049|156539473|FG001|Induction|Randomization closed|0|||
48640888|NCT02883049|156539474|FG002|Induction|Randomization closed|0|||
48640889|NCT02883049|156539475|FG003|Induction|Randomization closed|0|||
48640890|NCT02883049|156539476|FG004|Induction|Randomization closed|0|||
48640891|NCT02883049|156539477|FG005|Induction|Randomization closed|0|||
48640892|NCT02883049|156539478|FG006|Induction|Randomization closed|0|||
48640893|NCT02883049|156539479|FG007|Induction|Randomization closed|0|||
48640894|NCT02883049|156539480|FG008|Induction|Randomization closed|0|||
48640895|NCT02883049|156539481|FG009|Induction|Randomization closed|0|||
48640896|NCT02883049|156539482|FG010|Induction|Randomization closed|0|||
48640897|NCT02883049|156539483|FG011|Induction|Randomization closed|0|||
48640898|NCT02883049|156539484|FG012|Induction|Randomization closed|0|||
48640899|NCT02883049|156539485|FG013|Induction|Randomization closed|0|||
48640900|NCT02883049|156539486|FG014|Induction|Randomization closed|0|||
48640901|NCT02883049|156539487|FG015|Induction|Randomization closed|0|||
48640902|NCT02883049|156539472|FG000|Induction|MRD negative|36|||
48640903|NCT02883049|156539473|FG001|Induction|MRD negative|0|||
48640904|NCT02883049|156539474|FG002|Induction|MRD negative|0|||
48640905|NCT02883049|156539475|FG003|Induction|MRD negative|0|||
48640906|NCT02883049|156539476|FG004|Induction|MRD negative|0|||
48640907|NCT02883049|156539477|FG005|Induction|MRD negative|0|||
48640908|NCT02883049|156539478|FG006|Induction|MRD negative|0|||
48640909|NCT02883049|156539479|FG007|Induction|MRD negative|0|||
48640910|NCT02883049|156539480|FG008|Induction|MRD negative|0|||
48640911|NCT02883049|156539481|FG009|Induction|MRD negative|0|||
48640912|NCT02883049|156539482|FG010|Induction|MRD negative|0|||
48328883|NCT00824408|155401792|FG003|Randomized Phase|Refused to continue medication|2|||
48640913|NCT02883049|156539483|FG011|Induction|MRD negative|0|||
48748582|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748583|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748584|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748585|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748586|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748587|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748588|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748589|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748590|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748591|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748592|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748593|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748594|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748595|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748596|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748597|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
48748598|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748599|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748600|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
48748601|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748602|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748603|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748604|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748605|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748606|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748607|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748608|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748609|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748610|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748611|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748612|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48328884|NCT00824408|155401793|FG004|Randomized Phase|Refused to continue medication|2|||
48328885|NCT00824408|155401789|FG000|Randomized Phase|Other reason not defined above|0|||
48328886|NCT00824408|155401790|FG001|Randomized Phase|Other reason not defined above|0|||
48328887|NCT00824408|155401791|FG002|Randomized Phase|Other reason not defined above|4|||
48328888|NCT00824408|155401792|FG003|Randomized Phase|Other reason not defined above|2|||
48328889|NCT00824408|155401793|FG004|Randomized Phase|Other reason not defined above|4|||
48328890|NCT04867382|155401794|FG000|Overall Study|Did not complete the survey|2|||
48328891|NCT04867382|155401795|FG001|Overall Study|Did not complete the survey|1|||
48640914|NCT02883049|156539484|FG012|Induction|MRD negative|0|||
48640915|NCT02883049|156539485|FG013|Induction|MRD negative|0|||
48640916|NCT02883049|156539486|FG014|Induction|MRD negative|0|||
48640917|NCT02883049|156539487|FG015|Induction|MRD negative|0|||
48640918|NCT02883049|156539472|FG000|Induction|Identified as HR patients|165|||
48640919|NCT02883049|156539473|FG001|Induction|Identified as HR patients|0|||
48640920|NCT02883049|156539474|FG002|Induction|Identified as HR patients|0|||
48640921|NCT02883049|156539475|FG003|Induction|Identified as HR patients|0|||
48640922|NCT02883049|156539476|FG004|Induction|Identified as HR patients|0|||
48640923|NCT02883049|156539477|FG005|Induction|Identified as HR patients|0|||
48640924|NCT02883049|156539478|FG006|Induction|Identified as HR patients|0|||
48640925|NCT02883049|156539479|FG007|Induction|Identified as HR patients|0|||
48640926|NCT02883049|156539480|FG008|Induction|Identified as HR patients|0|||
48640927|NCT02883049|156539481|FG009|Induction|Identified as HR patients|0|||
48640928|NCT02883049|156539482|FG010|Induction|Identified as HR patients|0|||
48640929|NCT02883049|156539483|FG011|Induction|Identified as HR patients|0|||
48640930|NCT02883049|156539484|FG012|Induction|Identified as HR patients|0|||
48328892|NCT03065400|155401798|FG000|Overall Study|Adverse Event|1|||
48640931|NCT02883049|156539485|FG013|Induction|Identified as HR patients|0|||
48640932|NCT02883049|156539486|FG014|Induction|Identified as HR patients|0|||
48640933|NCT02883049|156539487|FG015|Induction|Identified as HR patients|0|||
48640934|NCT02883049|156539472|FG000|Induction|Developed SMN|0|||
48640935|NCT02883049|156539473|FG001|Induction|Developed SMN|1|||
48640936|NCT02883049|156539474|FG002|Induction|Developed SMN|0|||
48640937|NCT02883049|156539475|FG003|Induction|Developed SMN|0|||
48640938|NCT02883049|156539476|FG004|Induction|Developed SMN|0|||
48640939|NCT02883049|156539477|FG005|Induction|Developed SMN|0|||
48640940|NCT02883049|156539478|FG006|Induction|Developed SMN|0|||
48640941|NCT02883049|156539479|FG007|Induction|Developed SMN|0|||
48640942|NCT02883049|156539480|FG008|Induction|Developed SMN|0|||
48640943|NCT02883049|156539481|FG009|Induction|Developed SMN|0|||
48640944|NCT02883049|156539482|FG010|Induction|Developed SMN|0|||
48640945|NCT02883049|156539483|FG011|Induction|Developed SMN|0|||
48640946|NCT02883049|156539484|FG012|Induction|Developed SMN|0|||
48640947|NCT02883049|156539485|FG013|Induction|Developed SMN|0|||
48640948|NCT02883049|156539486|FG014|Induction|Developed SMN|0|||
48640949|NCT02883049|156539487|FG015|Induction|Developed SMN|0|||
48640950|NCT02883049|156539472|FG000|Induction|Enrolled onto another COG study|72|||
48640951|NCT02883049|156539473|FG001|Induction|Enrolled onto another COG study|0|||
48640952|NCT02883049|156539474|FG002|Induction|Enrolled onto another COG study|0|||
48640953|NCT02883049|156539475|FG003|Induction|Enrolled onto another COG study|0|||
48640954|NCT02883049|156539476|FG004|Induction|Enrolled onto another COG study|0|||
48640955|NCT02883049|156539477|FG005|Induction|Enrolled onto another COG study|0|||
48640956|NCT02883049|156539478|FG006|Induction|Enrolled onto another COG study|0|||
48640957|NCT02883049|156539479|FG007|Induction|Enrolled onto another COG study|0|||
48640958|NCT02883049|156539480|FG008|Induction|Enrolled onto another COG study|0|||
48640959|NCT02883049|156539481|FG009|Induction|Enrolled onto another COG study|0|||
48640960|NCT02883049|156539482|FG010|Induction|Enrolled onto another COG study|0|||
48640961|NCT02883049|156539483|FG011|Induction|Enrolled onto another COG study|0|||
48640962|NCT02883049|156539484|FG012|Induction|Enrolled onto another COG study|0|||
48640963|NCT02883049|156539485|FG013|Induction|Enrolled onto another COG study|0|||
48640964|NCT02883049|156539486|FG014|Induction|Enrolled onto another COG study|0|||
48640965|NCT02883049|156539487|FG015|Induction|Enrolled onto another COG study|0|||
48640966|NCT02883049|156539472|FG000|Induction|Incomplete induction data|17|||
48640967|NCT02883049|156539473|FG001|Induction|Incomplete induction data|0|||
48640968|NCT02883049|156539474|FG002|Induction|Incomplete induction data|0|||
48640969|NCT02883049|156539475|FG003|Induction|Incomplete induction data|0|||
48640970|NCT02883049|156539476|FG004|Induction|Incomplete induction data|0|||
48640971|NCT02883049|156539477|FG005|Induction|Incomplete induction data|0|||
48640972|NCT02883049|156539478|FG006|Induction|Incomplete induction data|0|||
48640973|NCT02883049|156539479|FG007|Induction|Incomplete induction data|0|||
48748613|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748614|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748615|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748616|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748617|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748618|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748619|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748620|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748621|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748622|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748623|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
48748624|NCT03129100|156926557|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748625|NCT03129100|156926558|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748626|NCT03129100|156926559|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748627|NCT03129100|156926560|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748628|NCT03129100|156926561|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
48748629|NCT03129100|156926562|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
48748630|NCT03129100|156926563|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
48748631|NCT03129100|156926564|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748632|NCT03129100|156926565|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748633|NCT03129100|156926566|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48640974|NCT02883049|156539480|FG008|Induction|Incomplete induction data|0|||
48640975|NCT02883049|156539481|FG009|Induction|Incomplete induction data|0|||
48640976|NCT02883049|156539482|FG010|Induction|Incomplete induction data|0|||
48640977|NCT02883049|156539483|FG011|Induction|Incomplete induction data|0|||
48640978|NCT02883049|156539484|FG012|Induction|Incomplete induction data|0|||
48640979|NCT02883049|156539485|FG013|Induction|Incomplete induction data|0|||
48640980|NCT02883049|156539486|FG014|Induction|Incomplete induction data|0|||
48640981|NCT02883049|156539487|FG015|Induction|Incomplete induction data|0|||
48640982|NCT02883049|156539472|FG000|Post Induction|Adverse Event|0|||
48328893|NCT03065400|155401798|FG000|Overall Study|Physician Decision|3|||
48328894|NCT03065400|155401798|FG000|Overall Study|Withdrawal by Subject|1|||
48640983|NCT02883049|156539473|FG001|Post Induction|Adverse Event|0|||
48640984|NCT02883049|156539474|FG002|Post Induction|Adverse Event|0|||
48640985|NCT02883049|156539475|FG003|Post Induction|Adverse Event|7|||
48640986|NCT02883049|156539476|FG004|Post Induction|Adverse Event|8|||
48640987|NCT02883049|156539477|FG005|Post Induction|Adverse Event|3|||
48640988|NCT02883049|156539478|FG006|Post Induction|Adverse Event|4|||
48640989|NCT02883049|156539479|FG007|Post Induction|Adverse Event|5|||
48640990|NCT02883049|156539480|FG008|Post Induction|Adverse Event|6|||
48640991|NCT02883049|156539481|FG009|Post Induction|Adverse Event|7|||
48640992|NCT02883049|156539482|FG010|Post Induction|Adverse Event|2|||
48328895|NCT03065400|155401798|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
48748634|NCT03129100|156926567|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748635|NCT03129100|156926568|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748636|NCT03129100|156926569|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748637|NCT03129100|156926570|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748638|NCT03129100|156926571|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748639|NCT03129100|156926572|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748640|NCT03129100|156926573|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748641|NCT03129100|156926574|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748642|NCT03129100|156926575|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748643|NCT03129100|156926576|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748644|NCT03129100|156926577|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748645|NCT03129100|156926578|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748646|NCT03129100|156926579|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748647|NCT03129100|156926580|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748648|NCT03129100|156926581|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748649|NCT03129100|156926582|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
48748650|NCT03129100|156926557|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748651|NCT03129100|156926558|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748652|NCT03129100|156926559|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748653|NCT03129100|156926560|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748654|NCT03129100|156926561|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48328896|NCT00570505|155401802|FG000|Overall Study|Adverse Event|7|||
48328897|NCT00570505|155401802|FG000|Overall Study|Withdrawal by Subject|7|||
48328898|NCT00570505|155401802|FG000|Overall Study|Lost to Follow-up|23|||
48328899|NCT00570505|155401802|FG000|Overall Study|Other loss to follow-up|4|||
48328900|NCT02454959|155401804|FG000|Overall Study|Protocol-Specified Criteria|3|||
48328901|NCT02454959|155401804|FG000|Overall Study|Physician Decision|1|||
48328902|NCT02454959|155401804|FG000|Overall Study|Withdrawal by Subject|3|||
48328903|NCT02454959|155401804|FG000|Overall Study|Adverse Event|2|||
48328904|NCT02915783|155401805|FG000|Overall Study|Death|21|||
48328905|NCT02915783|155401805|FG000|Overall Study|Lost to Follow-up|1|||
48328906|NCT02915783|155401805|FG000|Overall Study|Withdrawal by Subject|2|||
48328907|NCT02260154|155401811|FG000|Overall Study|Screening failure|2|||
48328908|NCT03905512|155401814|FG000|Overall Study|Withdrawal by Subject|9|||
48328909|NCT03905512|155401815|FG001|Overall Study|Withdrawal by Subject|8|||
48328910|NCT03905512|155401814|FG000|Overall Study|Adverse Event|1|||
48328911|NCT03905512|155401815|FG001|Overall Study|Adverse Event|2|||
48328912|NCT03905512|155401814|FG000|Overall Study|Lost to Follow-up|4|||
48328913|NCT03905512|155401815|FG001|Overall Study|Lost to Follow-up|3|||
48328914|NCT03905512|155401814|FG000|Overall Study|Other than Specified|7|||
48328915|NCT03905512|155401815|FG001|Overall Study|Other than Specified|4|||
48328916|NCT02613403|155401822|FG000|Overall Study|Lost to Follow-up|0|||
48328917|NCT02613403|155401823|FG001|Overall Study|Lost to Follow-up|1|||
48328918|NCT02613403|155401824|FG002|Overall Study|Lost to Follow-up|0|||
48328919|NCT02613403|155401825|FG003|Overall Study|Lost to Follow-up|0|||
48328920|NCT02613403|155401826|FG004|Overall Study|Lost to Follow-up|0|||
48328921|NCT02613403|155401822|FG000|Overall Study|Withdrawal by Subject|2|||
48328922|NCT02613403|155401823|FG001|Overall Study|Withdrawal by Subject|0|||
48328923|NCT02613403|155401824|FG002|Overall Study|Withdrawal by Subject|0|||
48328924|NCT02613403|155401825|FG003|Overall Study|Withdrawal by Subject|0|||
48328925|NCT02613403|155401826|FG004|Overall Study|Withdrawal by Subject|0|||
48328926|NCT03032198|155401831|FG000|Overall Study|Screen Fail|1|||
48328927|NCT01147471|155401832|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
48640993|NCT02883049|156539483|FG011|Post Induction|Adverse Event|2|||
48640994|NCT02883049|156539484|FG012|Post Induction|Adverse Event|0|||
48640995|NCT02883049|156539485|FG013|Post Induction|Adverse Event|0|||
48640996|NCT02883049|156539486|FG014|Post Induction|Adverse Event|5|||
48640997|NCT02883049|156539487|FG015|Post Induction|Adverse Event|2|||
48640998|NCT02883049|156539472|FG000|Post Induction|Death|0|||
48640999|NCT02883049|156539473|FG001|Post Induction|Death|0|||
48641000|NCT02883049|156539474|FG002|Post Induction|Death|0|||
48641001|NCT02883049|156539475|FG003|Post Induction|Death|9|||
48641002|NCT02883049|156539476|FG004|Post Induction|Death|9|||
48748655|NCT03129100|156926562|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748656|NCT03129100|156926563|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48328928|NCT01147471|155401833|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
48328929|NCT01147471|155401832|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
48328930|NCT01147471|155401833|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
48328931|NCT01147471|155401832|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
48328932|NCT01147471|155401833|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
48641003|NCT02883049|156539477|FG005|Post Induction|Death|0|||
48641004|NCT02883049|156539478|FG006|Post Induction|Death|1|||
48748657|NCT03129100|156926564|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748658|NCT03129100|156926565|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748659|NCT03129100|156926566|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
48748660|NCT03129100|156926567|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748661|NCT03129100|156926568|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748662|NCT03129100|156926569|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748663|NCT03129100|156926570|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48328933|NCT01147471|155401832|FG000|3 Month Follow Up|Lost to Follow-up|1|||
48328934|NCT01147471|155401833|FG001|3 Month Follow Up|Lost to Follow-up|1|||
48328935|NCT01147471|155401832|FG000|3 Month Follow Up|Physician Decision|0|||
48328936|NCT01147471|155401833|FG001|3 Month Follow Up|Physician Decision|1|||
48328937|NCT01147471|155401832|FG000|6 Month Follow Up|Lost to Follow-up|4|||
48328938|NCT01147471|155401833|FG001|6 Month Follow Up|Lost to Follow-up|2|||
48328939|NCT02188459|155401837|FG000|Overall Study|Lost to Follow-up|3|||
48328940|NCT02188459|155401838|FG001|Overall Study|Lost to Follow-up|4|||
48328941|NCT02188459|155401837|FG000|Overall Study|Early Termination|0|||
48328942|NCT02188459|155401838|FG001|Overall Study|Early Termination|3|||
48328943|NCT02158806|155401839|FG000|Overall Study|Death|2|||
48328944|NCT02158806|155401840|FG001|Overall Study|Death|0|||
48328945|NCT02158806|155401839|FG000|Overall Study|Withdrawal by Subject|2|||
48328946|NCT02158806|155401840|FG001|Overall Study|Withdrawal by Subject|0|||
48328947|NCT02158806|155401839|FG000|Overall Study|Lost to Follow-up|0|||
48328948|NCT02158806|155401840|FG001|Overall Study|Lost to Follow-up|3|||
48328949|NCT02158806|155401839|FG000|Overall Study|Moved out of area|0|||
48641005|NCT02883049|156539479|FG007|Post Induction|Death|6|||
48328950|NCT02158806|155401840|FG001|Overall Study|Moved out of area|1|||
48328951|NCT02158806|155401839|FG000|Overall Study|Transferred to palliative care|0|||
48328952|NCT02158806|155401840|FG001|Overall Study|Transferred to palliative care|1|||
48328953|NCT04820491|155401841|FG000|Overall Study|Withdrawal by Subject|1|||
48328954|NCT04820491|155401842|FG001|Overall Study|Withdrawal by Subject|0|||
48328955|NCT00452452|155401845|FG000|Overall Study|Protocol Violation|0|||
48748664|NCT03129100|156926571|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48328956|NCT00452452|155401846|FG001|Overall Study|Protocol Violation|0|||
48328957|NCT00452452|155401847|FG002|Overall Study|Protocol Violation|1|||
48328958|NCT00452452|155401845|FG000|Overall Study|Withdrawal by Subject|1|||
48328959|NCT00452452|155401846|FG001|Overall Study|Withdrawal by Subject|0|||
48328960|NCT00452452|155401847|FG002|Overall Study|Withdrawal by Subject|0|||
48328961|NCT00452452|155401845|FG000|Overall Study|Lost to Follow-up|1|||
48328962|NCT00452452|155401846|FG001|Overall Study|Lost to Follow-up|0|||
48328963|NCT00452452|155401847|FG002|Overall Study|Lost to Follow-up|0|||
48328964|NCT02334215|155401848|FG000|Overall Study|Death|1|||
48328965|NCT02334215|155401849|FG001|Overall Study|Death|1|||
48328966|NCT02334215|155401850|FG002|Overall Study|Death|0|||
48641006|NCT02883049|156539480|FG008|Post Induction|Death|5|||
48641007|NCT02883049|156539481|FG009|Post Induction|Death|3|||
48641008|NCT02883049|156539482|FG010|Post Induction|Death|1|||
48641009|NCT02883049|156539483|FG011|Post Induction|Death|0|||
48641010|NCT02883049|156539484|FG012|Post Induction|Death|1|||
48641011|NCT02883049|156539485|FG013|Post Induction|Death|1|||
48641012|NCT02883049|156539486|FG014|Post Induction|Death|10|||
48641013|NCT02883049|156539487|FG015|Post Induction|Death|2|||
48641014|NCT02883049|156539472|FG000|Post Induction|Lost to Follow-up|0|||
48641015|NCT02883049|156539473|FG001|Post Induction|Lost to Follow-up|0|||
48748665|NCT03129100|156926572|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748666|NCT03129100|156926573|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748667|NCT03129100|156926574|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748668|NCT03129100|156926575|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748669|NCT03129100|156926576|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748670|NCT03129100|156926577|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748671|NCT03129100|156926578|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748672|NCT03129100|156926579|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748673|NCT03129100|156926580|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748674|NCT03129100|156926581|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748675|NCT03129100|156926582|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
48748676|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748677|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48328967|NCT02334215|155401848|FG000|Overall Study|Lost to Follow-up|1|||
48328968|NCT02334215|155401849|FG001|Overall Study|Lost to Follow-up|0|||
48328969|NCT02334215|155401850|FG002|Overall Study|Lost to Follow-up|4|||
48328970|NCT02334215|155401848|FG000|Overall Study|Withdrawal by Subject|2|||
48328971|NCT02334215|155401849|FG001|Overall Study|Withdrawal by Subject|2|||
48328972|NCT02334215|155401850|FG002|Overall Study|Withdrawal by Subject|1|||
48328973|NCT02334215|155401848|FG000|Overall Study|Not released from incarceration on time|3|||
48641016|NCT02883049|156539474|FG002|Post Induction|Lost to Follow-up|0|||
48328974|NCT02334215|155401849|FG001|Overall Study|Not released from incarceration on time|3|||
48328975|NCT02334215|155401850|FG002|Overall Study|Not released from incarceration on time|3|||
48328976|NCT02334215|155401848|FG000|Overall Study|Incarcerated|0|||
48328977|NCT02334215|155401849|FG001|Overall Study|Incarcerated|0|||
48641017|NCT02883049|156539475|FG003|Post Induction|Lost to Follow-up|0|||
48641018|NCT02883049|156539476|FG004|Post Induction|Lost to Follow-up|1|||
48641019|NCT02883049|156539477|FG005|Post Induction|Lost to Follow-up|1|||
48641020|NCT02883049|156539478|FG006|Post Induction|Lost to Follow-up|0|||
48641021|NCT02883049|156539479|FG007|Post Induction|Lost to Follow-up|0|||
48641022|NCT02883049|156539480|FG008|Post Induction|Lost to Follow-up|3|||
48641023|NCT02883049|156539481|FG009|Post Induction|Lost to Follow-up|0|||
48641024|NCT02883049|156539482|FG010|Post Induction|Lost to Follow-up|1|||
48641025|NCT02883049|156539483|FG011|Post Induction|Lost to Follow-up|0|||
48641026|NCT02883049|156539484|FG012|Post Induction|Lost to Follow-up|0|||
48328978|NCT02334215|155401850|FG002|Overall Study|Incarcerated|7|||
48641027|NCT02883049|156539485|FG013|Post Induction|Lost to Follow-up|0|||
48641028|NCT02883049|156539486|FG014|Post Induction|Lost to Follow-up|0|||
48641029|NCT02883049|156539487|FG015|Post Induction|Lost to Follow-up|0|||
48641030|NCT02883049|156539472|FG000|Post Induction|Physician Decision|0|||
48641031|NCT02883049|156539473|FG001|Post Induction|Physician Decision|0|||
48641032|NCT02883049|156539474|FG002|Post Induction|Physician Decision|0|||
48641033|NCT02883049|156539475|FG003|Post Induction|Physician Decision|27|||
48641034|NCT02883049|156539476|FG004|Post Induction|Physician Decision|27|||
48641035|NCT02883049|156539477|FG005|Post Induction|Physician Decision|23|||
48641036|NCT02883049|156539478|FG006|Post Induction|Physician Decision|30|||
48641037|NCT02883049|156539479|FG007|Post Induction|Physician Decision|56|||
48641038|NCT02883049|156539480|FG008|Post Induction|Physician Decision|85|||
48641039|NCT02883049|156539481|FG009|Post Induction|Physician Decision|12|||
48641040|NCT02883049|156539482|FG010|Post Induction|Physician Decision|5|||
48641041|NCT02883049|156539483|FG011|Post Induction|Physician Decision|14|||
48641042|NCT02883049|156539484|FG012|Post Induction|Physician Decision|1|||
48641043|NCT02883049|156539485|FG013|Post Induction|Physician Decision|11|||
48641044|NCT02883049|156539486|FG014|Post Induction|Physician Decision|19|||
48641045|NCT02883049|156539487|FG015|Post Induction|Physician Decision|5|||
48641046|NCT02883049|156539472|FG000|Post Induction|Protocol Violation|0|||
48641047|NCT02883049|156539473|FG001|Post Induction|Protocol Violation|0|||
48641048|NCT02883049|156539474|FG002|Post Induction|Protocol Violation|0|||
48748678|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748679|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748680|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748681|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748682|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748683|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748684|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748685|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748686|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48641049|NCT02883049|156539475|FG003|Post Induction|Protocol Violation|0|||
48641050|NCT02883049|156539476|FG004|Post Induction|Protocol Violation|0|||
48641051|NCT02883049|156539477|FG005|Post Induction|Protocol Violation|0|||
48641052|NCT02883049|156539478|FG006|Post Induction|Protocol Violation|0|||
48641053|NCT02883049|156539479|FG007|Post Induction|Protocol Violation|1|||
48641054|NCT02883049|156539480|FG008|Post Induction|Protocol Violation|0|||
48641055|NCT02883049|156539481|FG009|Post Induction|Protocol Violation|0|||
48641056|NCT02883049|156539482|FG010|Post Induction|Protocol Violation|0|||
48748687|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
48328979|NCT04895085|155401851|FG000|Overall Study|Death|1|||
48641057|NCT02883049|156539483|FG011|Post Induction|Protocol Violation|0|||
48641058|NCT02883049|156539484|FG012|Post Induction|Protocol Violation|0|||
48641059|NCT02883049|156539485|FG013|Post Induction|Protocol Violation|0|||
48641060|NCT02883049|156539486|FG014|Post Induction|Protocol Violation|0|||
48641061|NCT02883049|156539487|FG015|Post Induction|Protocol Violation|0|||
48748688|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748689|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748690|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748691|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748692|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748693|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748694|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748695|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748696|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748697|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748698|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748699|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748700|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748701|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
48748702|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748703|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748704|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748705|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748706|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748707|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748708|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748709|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748710|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748711|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748712|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748713|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
48748714|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
48641062|NCT02883049|156539472|FG000|Post Induction|Withdrawal by Subject|0|||
48641063|NCT02883049|156539473|FG001|Post Induction|Withdrawal by Subject|0|||
48641064|NCT02883049|156539474|FG002|Post Induction|Withdrawal by Subject|0|||
48641065|NCT02883049|156539475|FG003|Post Induction|Withdrawal by Subject|5|||
48641066|NCT02883049|156539476|FG004|Post Induction|Withdrawal by Subject|2|||
48641067|NCT02883049|156539477|FG005|Post Induction|Withdrawal by Subject|1|||
48641068|NCT02883049|156539478|FG006|Post Induction|Withdrawal by Subject|0|||
48641069|NCT02883049|156539479|FG007|Post Induction|Withdrawal by Subject|0|||
48641070|NCT02883049|156539480|FG008|Post Induction|Withdrawal by Subject|2|||
48748715|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
48748716|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
48748717|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748718|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748719|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48641071|NCT02883049|156539481|FG009|Post Induction|Withdrawal by Subject|0|||
48641072|NCT02883049|156539482|FG010|Post Induction|Withdrawal by Subject|1|||
48641073|NCT02883049|156539483|FG011|Post Induction|Withdrawal by Subject|1|||
48748720|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748721|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748722|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748723|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748724|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48641074|NCT02883049|156539484|FG012|Post Induction|Withdrawal by Subject|0|||
48641075|NCT02883049|156539485|FG013|Post Induction|Withdrawal by Subject|0|||
48641076|NCT02883049|156539486|FG014|Post Induction|Withdrawal by Subject|1|||
48641077|NCT02883049|156539487|FG015|Post Induction|Withdrawal by Subject|0|||
48641078|NCT02883049|156539472|FG000|Post Induction|Ineligible|0|||
48641079|NCT02883049|156539473|FG001|Post Induction|Ineligible|0|||
48748725|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748726|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748727|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
48748728|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748729|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748730|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748731|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748732|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748733|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748734|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748735|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748736|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748737|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748738|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748739|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
48748740|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748741|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
48748742|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
48748743|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748744|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748745|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748746|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748747|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748748|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748749|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748750|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748751|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748752|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748753|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
48748754|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748755|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748756|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748757|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748758|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748759|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748760|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748761|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748762|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748763|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748764|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748765|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748766|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748767|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748768|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748769|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
48641080|NCT02883049|156539474|FG002|Post Induction|Ineligible|2|||
48641081|NCT02883049|156539475|FG003|Post Induction|Ineligible|0|||
48641082|NCT02883049|156539476|FG004|Post Induction|Ineligible|0|||
48641083|NCT02883049|156539477|FG005|Post Induction|Ineligible|0|||
48641084|NCT02883049|156539478|FG006|Post Induction|Ineligible|1|||
48641085|NCT02883049|156539479|FG007|Post Induction|Ineligible|0|||
48641086|NCT02883049|156539480|FG008|Post Induction|Ineligible|0|||
48641087|NCT02883049|156539481|FG009|Post Induction|Ineligible|0|||
48641088|NCT02883049|156539482|FG010|Post Induction|Ineligible|1|||
48641089|NCT02883049|156539483|FG011|Post Induction|Ineligible|0|||
48641090|NCT02883049|156539484|FG012|Post Induction|Ineligible|0|||
48641091|NCT02883049|156539485|FG013|Post Induction|Ineligible|0|||
48641092|NCT02883049|156539486|FG014|Post Induction|Ineligible|0|||
48641093|NCT02883049|156539487|FG015|Post Induction|Ineligible|1|||
48641094|NCT02883049|156539472|FG000|Post Induction|Refusal of further protocol therapy|0|||
48641095|NCT02883049|156539473|FG001|Post Induction|Refusal of further protocol therapy|0|||
48641096|NCT02883049|156539474|FG002|Post Induction|Refusal of further protocol therapy|0|||
48641097|NCT02883049|156539475|FG003|Post Induction|Refusal of further protocol therapy|11|||
48641098|NCT02883049|156539476|FG004|Post Induction|Refusal of further protocol therapy|15|||
48641099|NCT02883049|156539477|FG005|Post Induction|Refusal of further protocol therapy|9|||
48641100|NCT02883049|156539478|FG006|Post Induction|Refusal of further protocol therapy|13|||
48641101|NCT02883049|156539479|FG007|Post Induction|Refusal of further protocol therapy|5|||
48641102|NCT02883049|156539480|FG008|Post Induction|Refusal of further protocol therapy|21|||
48641103|NCT02883049|156539481|FG009|Post Induction|Refusal of further protocol therapy|7|||
48641104|NCT02883049|156539482|FG010|Post Induction|Refusal of further protocol therapy|0|||
48641105|NCT02883049|156539483|FG011|Post Induction|Refusal of further protocol therapy|7|||
48641106|NCT02883049|156539484|FG012|Post Induction|Refusal of further protocol therapy|3|||
48641107|NCT02883049|156539485|FG013|Post Induction|Refusal of further protocol therapy|0|||
48641108|NCT02883049|156539486|FG014|Post Induction|Refusal of further protocol therapy|4|||
48641109|NCT02883049|156539487|FG015|Post Induction|Refusal of further protocol therapy|1|||
48641110|NCT02883049|156539472|FG000|Post Induction|Inevaluable|0|||
48641111|NCT02883049|156539473|FG001|Post Induction|Inevaluable|0|||
48641112|NCT02883049|156539474|FG002|Post Induction|Inevaluable|0|||
48641113|NCT02883049|156539475|FG003|Post Induction|Inevaluable|1|||
48641114|NCT02883049|156539476|FG004|Post Induction|Inevaluable|1|||
48641115|NCT02883049|156539477|FG005|Post Induction|Inevaluable|2|||
48641116|NCT02883049|156539478|FG006|Post Induction|Inevaluable|7|||
48641117|NCT02883049|156539479|FG007|Post Induction|Inevaluable|6|||
48641118|NCT02883049|156539480|FG008|Post Induction|Inevaluable|4|||
48641119|NCT02883049|156539481|FG009|Post Induction|Inevaluable|4|||
48641120|NCT02883049|156539482|FG010|Post Induction|Inevaluable|1|||
48641121|NCT02883049|156539483|FG011|Post Induction|Inevaluable|1|||
48641122|NCT02883049|156539484|FG012|Post Induction|Inevaluable|2|||
48641123|NCT02883049|156539485|FG013|Post Induction|Inevaluable|0|||
48641124|NCT02883049|156539486|FG014|Post Induction|Inevaluable|0|||
48641125|NCT02883049|156539487|FG015|Post Induction|Inevaluable|1|||
48641126|NCT02883049|156539472|FG000|Post Induction|Moved to another non-COG institution|0|||
48641127|NCT02883049|156539473|FG001|Post Induction|Moved to another non-COG institution|0|||
48641128|NCT02883049|156539474|FG002|Post Induction|Moved to another non-COG institution|0|||
48641129|NCT02883049|156539475|FG003|Post Induction|Moved to another non-COG institution|0|||
48641130|NCT02883049|156539476|FG004|Post Induction|Moved to another non-COG institution|0|||
48641131|NCT02883049|156539477|FG005|Post Induction|Moved to another non-COG institution|0|||
48641132|NCT02883049|156539478|FG006|Post Induction|Moved to another non-COG institution|0|||
48641133|NCT02883049|156539479|FG007|Post Induction|Moved to another non-COG institution|2|||
48641134|NCT02883049|156539480|FG008|Post Induction|Moved to another non-COG institution|2|||
48641135|NCT02883049|156539481|FG009|Post Induction|Moved to another non-COG institution|0|||
48641136|NCT02883049|156539482|FG010|Post Induction|Moved to another non-COG institution|0|||
48641137|NCT02883049|156539483|FG011|Post Induction|Moved to another non-COG institution|1|||
48641138|NCT02883049|156539484|FG012|Post Induction|Moved to another non-COG institution|0|||
48641139|NCT02883049|156539485|FG013|Post Induction|Moved to another non-COG institution|0|||
48641140|NCT02883049|156539486|FG014|Post Induction|Moved to another non-COG institution|0|||
48641141|NCT02883049|156539487|FG015|Post Induction|Moved to another non-COG institution|0|||
48641142|NCT02883049|156539472|FG000|Post Induction|Randomization closed|0|||
48641143|NCT02883049|156539473|FG001|Post Induction|Randomization closed|0|||
48641144|NCT02883049|156539474|FG002|Post Induction|Randomization closed|0|||
48748770|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748771|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748772|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748773|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748774|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748775|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748776|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748777|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748778|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748779|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
48748780|NCT03129100|156926557|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748781|NCT03129100|156926558|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748782|NCT03129100|156926559|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748783|NCT03129100|156926560|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748784|NCT03129100|156926561|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748785|NCT03129100|156926562|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748786|NCT03129100|156926563|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48641145|NCT02883049|156539475|FG003|Post Induction|Randomization closed|0|||
48748787|NCT03129100|156926564|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748788|NCT03129100|156926565|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748789|NCT03129100|156926566|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748790|NCT03129100|156926567|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748791|NCT03129100|156926568|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748792|NCT03129100|156926569|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
48641146|NCT02883049|156539476|FG004|Post Induction|Randomization closed|0|||
48641147|NCT02883049|156539477|FG005|Post Induction|Randomization closed|0|||
48641148|NCT02883049|156539478|FG006|Post Induction|Randomization closed|0|||
48641149|NCT02883049|156539479|FG007|Post Induction|Randomization closed|20|||
48748793|NCT03129100|156926570|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748794|NCT03129100|156926571|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
48748795|NCT03129100|156926572|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
48748796|NCT03129100|156926573|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748797|NCT03129100|156926574|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748798|NCT03129100|156926575|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748799|NCT03129100|156926576|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748800|NCT03129100|156926577|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748801|NCT03129100|156926578|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748802|NCT03129100|156926579|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748803|NCT03129100|156926580|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48641150|NCT02883049|156539480|FG008|Post Induction|Randomization closed|0|||
48641151|NCT02883049|156539481|FG009|Post Induction|Randomization closed|0|||
48641152|NCT02883049|156539482|FG010|Post Induction|Randomization closed|0|||
48641153|NCT02883049|156539483|FG011|Post Induction|Randomization closed|0|||
48641154|NCT02883049|156539484|FG012|Post Induction|Randomization closed|0|||
48641155|NCT02883049|156539485|FG013|Post Induction|Randomization closed|0|||
48748804|NCT03129100|156926581|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748805|NCT03129100|156926582|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
48748806|NCT03129100|156926557|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748807|NCT03129100|156926558|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748808|NCT03129100|156926559|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748809|NCT03129100|156926560|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48641156|NCT02883049|156539486|FG014|Post Induction|Randomization closed|0|||
48748810|NCT03129100|156926561|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48641157|NCT02883049|156539487|FG015|Post Induction|Randomization closed|0|||
48641158|NCT02883049|156539472|FG000|Post Induction|MRD negative|0|||
48641159|NCT02883049|156539473|FG001|Post Induction|MRD negative|0|||
48641160|NCT02883049|156539474|FG002|Post Induction|MRD negative|0|||
48748811|NCT03129100|156926562|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748812|NCT03129100|156926563|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748813|NCT03129100|156926564|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748814|NCT03129100|156926565|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48641161|NCT02883049|156539475|FG003|Post Induction|MRD negative|0|||
48748815|NCT03129100|156926566|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748816|NCT03129100|156926567|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48641162|NCT02883049|156539476|FG004|Post Induction|MRD negative|0|||
48641163|NCT02883049|156539477|FG005|Post Induction|MRD negative|0|||
48641164|NCT02883049|156539478|FG006|Post Induction|MRD negative|0|||
48641165|NCT02883049|156539479|FG007|Post Induction|MRD negative|11|||
48641166|NCT02883049|156539480|FG008|Post Induction|MRD negative|0|||
48641167|NCT02883049|156539481|FG009|Post Induction|MRD negative|0|||
48641168|NCT02883049|156539482|FG010|Post Induction|MRD negative|0|||
48641169|NCT02883049|156539483|FG011|Post Induction|MRD negative|0|||
48641170|NCT02883049|156539484|FG012|Post Induction|MRD negative|0|||
48641171|NCT02883049|156539485|FG013|Post Induction|MRD negative|0|||
48641172|NCT02883049|156539486|FG014|Post Induction|MRD negative|0|||
48641173|NCT02883049|156539487|FG015|Post Induction|MRD negative|0|||
48641174|NCT02883049|156539472|FG000|Post Induction|Developed SMN|0|||
48641175|NCT02883049|156539473|FG001|Post Induction|Developed SMN|0|||
48641176|NCT02883049|156539474|FG002|Post Induction|Developed SMN|0|||
48641177|NCT02883049|156539475|FG003|Post Induction|Developed SMN|0|||
48641178|NCT02883049|156539476|FG004|Post Induction|Developed SMN|1|||
48641179|NCT02883049|156539477|FG005|Post Induction|Developed SMN|0|||
48641180|NCT02883049|156539478|FG006|Post Induction|Developed SMN|1|||
48641181|NCT02883049|156539479|FG007|Post Induction|Developed SMN|0|||
48641182|NCT02883049|156539480|FG008|Post Induction|Developed SMN|0|||
48641183|NCT02883049|156539481|FG009|Post Induction|Developed SMN|0|||
48641184|NCT02883049|156539482|FG010|Post Induction|Developed SMN|1|||
48641185|NCT02883049|156539483|FG011|Post Induction|Developed SMN|1|||
48641186|NCT02883049|156539484|FG012|Post Induction|Developed SMN|0|||
48641187|NCT02883049|156539485|FG013|Post Induction|Developed SMN|0|||
48641188|NCT02883049|156539486|FG014|Post Induction|Developed SMN|1|||
48641189|NCT02883049|156539487|FG015|Post Induction|Developed SMN|0|||
48641190|NCT02883049|156539472|FG000|Post Induction|Enrolled onto another COG study|0|||
48641191|NCT02883049|156539473|FG001|Post Induction|Enrolled onto another COG study|0|||
48641192|NCT02883049|156539474|FG002|Post Induction|Enrolled onto another COG study|0|||
48641193|NCT02883049|156539475|FG003|Post Induction|Enrolled onto another COG study|1|||
48641194|NCT02883049|156539476|FG004|Post Induction|Enrolled onto another COG study|1|||
48641195|NCT02883049|156539477|FG005|Post Induction|Enrolled onto another COG study|0|||
48641196|NCT02883049|156539478|FG006|Post Induction|Enrolled onto another COG study|0|||
48641197|NCT02883049|156539479|FG007|Post Induction|Enrolled onto another COG study|4|||
48641198|NCT02883049|156539480|FG008|Post Induction|Enrolled onto another COG study|0|||
48641199|NCT02883049|156539481|FG009|Post Induction|Enrolled onto another COG study|0|||
48641200|NCT02883049|156539482|FG010|Post Induction|Enrolled onto another COG study|0|||
48641201|NCT02883049|156539483|FG011|Post Induction|Enrolled onto another COG study|2|||
48641202|NCT02883049|156539484|FG012|Post Induction|Enrolled onto another COG study|0|||
48641203|NCT02883049|156539485|FG013|Post Induction|Enrolled onto another COG study|1|||
48641204|NCT02883049|156539486|FG014|Post Induction|Enrolled onto another COG study|0|||
48641205|NCT02883049|156539487|FG015|Post Induction|Enrolled onto another COG study|0|||
48641206|NCT02883049|156539472|FG000|Post Induction|Recurrent leukemia|0|||
48641207|NCT02883049|156539473|FG001|Post Induction|Recurrent leukemia|0|||
48641208|NCT02883049|156539474|FG002|Post Induction|Recurrent leukemia|0|||
48641209|NCT02883049|156539475|FG003|Post Induction|Recurrent leukemia|17|||
48641210|NCT02883049|156539476|FG004|Post Induction|Recurrent leukemia|12|||
48641211|NCT02883049|156539477|FG005|Post Induction|Recurrent leukemia|4|||
48641212|NCT02883049|156539478|FG006|Post Induction|Recurrent leukemia|1|||
48641213|NCT02883049|156539479|FG007|Post Induction|Recurrent leukemia|13|||
48641214|NCT02883049|156539480|FG008|Post Induction|Recurrent leukemia|27|||
48641215|NCT02883049|156539481|FG009|Post Induction|Recurrent leukemia|5|||
48641216|NCT02883049|156539482|FG010|Post Induction|Recurrent leukemia|3|||
48641217|NCT02883049|156539483|FG011|Post Induction|Recurrent leukemia|12|||
48641218|NCT02883049|156539484|FG012|Post Induction|Recurrent leukemia|1|||
48641219|NCT02883049|156539485|FG013|Post Induction|Recurrent leukemia|1|||
48641220|NCT02883049|156539486|FG014|Post Induction|Recurrent leukemia|9|||
48641221|NCT02883049|156539487|FG015|Post Induction|Recurrent leukemia|3|||
48641222|NCT02883049|156539472|FG000|Post Induction|Induction Failure|0|||
48641223|NCT02883049|156539473|FG001|Post Induction|Induction Failure|0|||
48641224|NCT02883049|156539474|FG002|Post Induction|Induction Failure|0|||
48641225|NCT02883049|156539475|FG003|Post Induction|Induction Failure|0|||
48641226|NCT02883049|156539476|FG004|Post Induction|Induction Failure|0|||
48641227|NCT02883049|156539477|FG005|Post Induction|Induction Failure|0|||
48641228|NCT02883049|156539478|FG006|Post Induction|Induction Failure|0|||
48641229|NCT02883049|156539479|FG007|Post Induction|Induction Failure|2|||
48641230|NCT02883049|156539480|FG008|Post Induction|Induction Failure|2|||
48641231|NCT02883049|156539481|FG009|Post Induction|Induction Failure|0|||
48641232|NCT02883049|156539482|FG010|Post Induction|Induction Failure|0|||
48641233|NCT02883049|156539483|FG011|Post Induction|Induction Failure|0|||
48641234|NCT02883049|156539484|FG012|Post Induction|Induction Failure|0|||
48641235|NCT02883049|156539485|FG013|Post Induction|Induction Failure|2|||
48641236|NCT02883049|156539486|FG014|Post Induction|Induction Failure|0|||
48641237|NCT02883049|156539487|FG015|Post Induction|Induction Failure|0|||
48641238|NCT05319600|156539488|FG000|Overall Study|Withdrawal by Subject|1|||
48641239|NCT05319600|156539489|FG001|Overall Study|Withdrawal by Subject|0|||
48641240|NCT05319600|156539488|FG000|Overall Study|Lost to Follow-up|0|||
48641241|NCT05319600|156539489|FG001|Overall Study|Lost to Follow-up|4|||
48641242|NCT03916185|156539490|FG000|Overall Study|Lost to Follow-up|0|||
48641243|NCT03916185|156539491|FG001|Overall Study|Lost to Follow-up|1|||
48641244|NCT03916185|156539492|FG002|Overall Study|Lost to Follow-up|0|||
48641245|NCT03916185|156539493|FG003|Overall Study|Lost to Follow-up|0|||
48641246|NCT03916185|156539490|FG000|Overall Study|Moved|1|||
48641247|NCT03916185|156539491|FG001|Overall Study|Moved|0|||
48641248|NCT03916185|156539492|FG002|Overall Study|Moved|0|||
48641249|NCT03916185|156539493|FG003|Overall Study|Moved|1|||
48641250|NCT03916185|156539490|FG000|Overall Study|Not Able to Get to Clinic|1|||
48641251|NCT03916185|156539491|FG001|Overall Study|Not Able to Get to Clinic|0|||
48641252|NCT03916185|156539492|FG002|Overall Study|Not Able to Get to Clinic|0|||
48641253|NCT03916185|156539493|FG003|Overall Study|Not Able to Get to Clinic|0|||
48641254|NCT05477186|156539496|FG000|Overall Study|Vaccine not administered|0|||
48641255|NCT05477186|156539497|FG001|Overall Study|Vaccine not administered|2|||
48641256|NCT05477186|156539498|FG002|Overall Study|Vaccine not administered|1|||
48641257|NCT05477186|156539499|FG003|Overall Study|Vaccine not administered|0|||
48641258|NCT05477186|156539500|FG004|Overall Study|Vaccine not administered|1|||
48641259|NCT05477186|156539501|FG005|Overall Study|Vaccine not administered|0|||
48748817|NCT03129100|156926568|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748818|NCT03129100|156926569|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748819|NCT03129100|156926570|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748820|NCT03129100|156926571|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748821|NCT03129100|156926572|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748822|NCT03129100|156926573|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748823|NCT03129100|156926574|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
48748824|NCT03129100|156926575|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748825|NCT03129100|156926576|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
48748826|NCT03129100|156926577|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748827|NCT03129100|156926578|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748828|NCT03129100|156926579|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748829|NCT03129100|156926580|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748830|NCT03129100|156926581|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48748831|NCT03129100|156926582|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
48641260|NCT05477186|156539502|FG006|Overall Study|Vaccine not administered|0|||
48641261|NCT05477186|156539496|FG000|Overall Study|Withdrawal by Subject|1|||
48641262|NCT05477186|156539497|FG001|Overall Study|Withdrawal by Subject|0|||
48641263|NCT05477186|156539498|FG002|Overall Study|Withdrawal by Subject|0|||
48641264|NCT05477186|156539499|FG003|Overall Study|Withdrawal by Subject|0|||
48641265|NCT05477186|156539500|FG004|Overall Study|Withdrawal by Subject|0|||
48641266|NCT05477186|156539501|FG005|Overall Study|Withdrawal by Subject|1|||
48748832|NCT03129100|156926557|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748833|NCT03129100|156926558|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48426946|NCT04705597|155752884|FG000|Overall Study|Lost to Follow-up|1|||
48748834|NCT03129100|156926559|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48426947|NCT04705597|155752885|FG001|Overall Study|Lost to Follow-up|0|||
48748835|NCT03129100|156926560|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748836|NCT03129100|156926561|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748837|NCT03129100|156926562|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748838|NCT03129100|156926563|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748839|NCT03129100|156926564|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748840|NCT03129100|156926565|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748841|NCT03129100|156926566|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748842|NCT03129100|156926567|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748843|NCT03129100|156926568|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748844|NCT03129100|156926569|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748845|NCT03129100|156926570|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748846|NCT03129100|156926571|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748847|NCT03129100|156926572|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748848|NCT03129100|156926573|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748849|NCT03129100|156926574|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748850|NCT03129100|156926575|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748851|NCT03129100|156926576|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748852|NCT03129100|156926577|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
48748853|NCT03129100|156926578|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748854|NCT03129100|156926579|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748855|NCT03129100|156926580|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748856|NCT03129100|156926581|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748857|NCT03129100|156926582|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
48748858|NCT03129100|156926557|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
48748859|NCT03129100|156926558|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
48748860|NCT03129100|156926559|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
48748861|NCT03129100|156926560|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
48748862|NCT03129100|156926561|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
48748863|NCT03129100|156926562|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
48748864|NCT03129100|156926563|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
48748865|NCT03129100|156926564|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
48748866|NCT03129100|156926565|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
48748867|NCT03129100|156926566|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
48748868|NCT03129100|156926567|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
48748869|NCT03129100|156926568|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
48748870|NCT03129100|156926569|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
48748871|NCT03129100|156926570|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
48748872|NCT03129100|156926571|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
48748873|NCT03129100|156926572|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
48748874|NCT03129100|156926573|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
48748875|NCT03129100|156926574|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
48748876|NCT03129100|156926575|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
48748877|NCT03129100|156926576|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
48748878|NCT03129100|156926577|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
48748879|NCT03129100|156926578|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
48748880|NCT03129100|156926579|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
48748881|NCT03129100|156926580|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
48748882|NCT03129100|156926581|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
48748883|NCT03129100|156926582|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
48748884|NCT03129100|156926557|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748885|NCT03129100|156926558|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748886|NCT03129100|156926559|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748887|NCT03129100|156926560|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748888|NCT03129100|156926561|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748889|NCT03129100|156926562|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748890|NCT03129100|156926563|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748891|NCT03129100|156926564|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748892|NCT03129100|156926565|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748893|NCT03129100|156926566|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748894|NCT03129100|156926567|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748895|NCT03129100|156926568|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748896|NCT03129100|156926569|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748897|NCT03129100|156926570|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748898|NCT03129100|156926571|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748899|NCT03129100|156926572|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748900|NCT03129100|156926573|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48328980|NCT04895085|155401851|FG000|Overall Study|Withdrawal by Subject|1|||
48641267|NCT05477186|156539502|FG006|Overall Study|Withdrawal by Subject|0|||
48641268|NCT05477186|156539496|FG000|Overall Study|Lost to Follow-up|1|||
48641269|NCT05477186|156539497|FG001|Overall Study|Lost to Follow-up|0|||
48641270|NCT05477186|156539498|FG002|Overall Study|Lost to Follow-up|2|||
48641271|NCT05477186|156539499|FG003|Overall Study|Lost to Follow-up|1|||
48641272|NCT05477186|156539500|FG004|Overall Study|Lost to Follow-up|1|||
48641273|NCT05477186|156539501|FG005|Overall Study|Lost to Follow-up|0|||
48641274|NCT05477186|156539502|FG006|Overall Study|Lost to Follow-up|2|||
48328981|NCT04895085|155401851|FG000|Overall Study|No longer eligible: Moved from area|1|||
48641275|NCT03829319|156539503|FG000|Overall Study|Ongoing|4|||
48641276|NCT03829319|156539504|FG001|Overall Study|Ongoing|125|||
48641277|NCT03829319|156539505|FG002|Overall Study|Ongoing|130|||
48641278|NCT03829319|156539503|FG000|Overall Study|Withdrawal by Subject|1|||
48641279|NCT03829319|156539504|FG001|Overall Study|Withdrawal by Subject|6|||
48641280|NCT03829319|156539505|FG002|Overall Study|Withdrawal by Subject|8|||
48641281|NCT03829319|156539503|FG000|Overall Study|Physician Decision|0|||
48641282|NCT03829319|156539504|FG001|Overall Study|Physician Decision|1|||
48641283|NCT03829319|156539505|FG002|Overall Study|Physician Decision|0|||
48641284|NCT03829319|156539503|FG000|Overall Study|Lost to Follow-up|0|||
48641285|NCT03829319|156539504|FG001|Overall Study|Lost to Follow-up|0|||
48328982|NCT04433091|155401854|FG000|Overall Study|Lost to Follow-up|1|||
48328983|NCT04433091|155401855|FG001|Overall Study|Lost to Follow-up|0|||
48328984|NCT04433091|155401854|FG000|Overall Study|Withdrawn .|2|||
48328985|NCT04433091|155401855|FG001|Overall Study|Withdrawn .|4|||
48328986|NCT04448561|155401856|FG000|Overall Study|Noncompliance|1|||
48328987|NCT04448561|155401857|FG001|Overall Study|Noncompliance|0|||
48328988|NCT04919499|155401858|FG000|Overall Study|Adverse Event|0|||
48641286|NCT03829319|156539505|FG002|Overall Study|Lost to Follow-up|1|||
48641287|NCT03829319|156539503|FG000|Overall Study|Death|8|||
48641288|NCT03829319|156539504|FG001|Overall Study|Death|243|||
48641289|NCT03829319|156539505|FG002|Overall Study|Death|234|||
48641290|NCT01615029|156539509|FG000|Overall Study|Adverse Event|0|||
48641291|NCT01615029|156539510|FG001|Overall Study|Adverse Event|0|||
48641292|NCT01615029|156539511|FG002|Overall Study|Adverse Event|0|||
48641293|NCT01615029|156539512|FG003|Overall Study|Adverse Event|0|||
48641294|NCT01615029|156539513|FG004|Overall Study|Adverse Event|1|||
48641295|NCT01615029|156539509|FG000|Overall Study|Death|0|||
48641296|NCT01615029|156539510|FG001|Overall Study|Death|0|||
48641297|NCT01615029|156539511|FG002|Overall Study|Death|0|||
48641298|NCT01615029|156539512|FG003|Overall Study|Death|0|||
48641299|NCT01615029|156539513|FG004|Overall Study|Death|1|||
48641300|NCT01615029|156539509|FG000|Overall Study|Lost to Follow-up|0|||
48641301|NCT01615029|156539510|FG001|Overall Study|Lost to Follow-up|0|||
48641302|NCT01615029|156539511|FG002|Overall Study|Lost to Follow-up|0|||
48641303|NCT01615029|156539512|FG003|Overall Study|Lost to Follow-up|0|||
48641304|NCT01615029|156539513|FG004|Overall Study|Lost to Follow-up|1|||
48641305|NCT01615029|156539509|FG000|Overall Study|Progressive disease|2|||
48641306|NCT01615029|156539510|FG001|Overall Study|Progressive disease|1|||
48641307|NCT01615029|156539511|FG002|Overall Study|Progressive disease|1|||
48641308|NCT01615029|156539512|FG003|Overall Study|Progressive disease|1|||
48641309|NCT01615029|156539513|FG004|Overall Study|Progressive disease|5|||
48641310|NCT01615029|156539509|FG000|Overall Study|Physician Decision|0|||
48641311|NCT01615029|156539510|FG001|Overall Study|Physician Decision|0|||
48641312|NCT01615029|156539511|FG002|Overall Study|Physician Decision|0|||
48641313|NCT01615029|156539512|FG003|Overall Study|Physician Decision|0|||
48641314|NCT01615029|156539513|FG004|Overall Study|Physician Decision|1|||
48641315|NCT01615029|156539509|FG000|Overall Study|Ongoing|1|||
48641316|NCT01615029|156539510|FG001|Overall Study|Ongoing|2|||
48748901|NCT03129100|156926574|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748902|NCT03129100|156926575|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748903|NCT03129100|156926576|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748904|NCT03129100|156926577|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
48748905|NCT03129100|156926578|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748906|NCT03129100|156926579|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748907|NCT03129100|156926580|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748908|NCT03129100|156926581|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748909|NCT03129100|156926582|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
48748910|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
48748911|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
48748912|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
48748913|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
48748914|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
48748915|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
48748916|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
48748917|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
48748918|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
48748919|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
48748920|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
48748921|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
48748922|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
48748923|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
48748924|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
48748925|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
48748926|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
48748927|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
48748928|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
48748929|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
48641317|NCT01615029|156539511|FG002|Overall Study|Ongoing|3|||
48641318|NCT01615029|156539512|FG003|Overall Study|Ongoing|2|||
48641319|NCT01615029|156539513|FG004|Overall Study|Ongoing|23|||
48641320|NCT04630756|156539514|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
48748930|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
48748931|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
48748932|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
48328989|NCT04919499|155401859|FG001|Overall Study|Adverse Event|0|||
48641321|NCT04630756|156539515|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
48328990|NCT04919499|155401860|FG002|Overall Study|Adverse Event|0|||
48641322|NCT04630756|156539516|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
48641323|NCT03181516|156539521|FG000|Overall Study|Withdrawal by Subject|14|||
48641324|NCT03181516|156539522|FG001|Overall Study|Withdrawal by Subject|7|||
48641325|NCT03181516|156539521|FG000|Overall Study|Lost to Follow-up|2|||
48641326|NCT03181516|156539522|FG001|Overall Study|Lost to Follow-up|2|||
48641327|NCT03290079|156539523|FG000|Overall Study|Death|2|||
48641328|NCT00948688|156540130|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
48641329|NCT00948688|156540131|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
48641330|NCT00948688|156540130|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
48641331|NCT00948688|156540131|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
48641332|NCT00948688|156540130|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
48641333|NCT00948688|156540131|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
48641334|NCT00305877|156540133|FG000|Overall Study|Lack of Efficacy|6|||
48641335|NCT00305877|156540134|FG001|Overall Study|Lack of Efficacy|9|||
48641336|NCT00305877|156540133|FG000|Overall Study|Adverse Event|9|||
48641337|NCT00305877|156540134|FG001|Overall Study|Adverse Event|14|||
48328991|NCT04919499|155401861|FG003|Overall Study|Adverse Event|0|||
48328992|NCT04919499|155401862|FG004|Overall Study|Adverse Event|2|||
48328993|NCT04919499|155401858|FG000|Overall Study|Not treated|0|||
48328994|NCT04919499|155401859|FG001|Overall Study|Not treated|0|||
48328995|NCT04919499|155401860|FG002|Overall Study|Not treated|0|||
48328996|NCT04919499|155401861|FG003|Overall Study|Not treated|1|||
48328997|NCT04919499|155401862|FG004|Overall Study|Not treated|0|||
48328998|NCT04705051|155403453|FG000|Overall Study|Enrolled but not treated|1|||
48328999|NCT04705051|155403453|FG000|Overall Study|Study terminated by sponsor|23|||
48329000|NCT03009344|155403454|FG000|Overall Study|Lack of Efficacy|5|||
48329001|NCT03009344|155403454|FG000|Overall Study|Withdrawal by Subject|1|||
48329002|NCT03009344|155403454|FG000|Overall Study|Adverse Event|1|||
48329003|NCT04131556|155403455|FG000|Overall Study|Adverse Event|1|||
48329004|NCT04131556|155403455|FG000|Overall Study|Withdrawal by Subject|1|||
48329005|NCT00597376|155403456|FG000|Overall Study|Withdrawal by Subject|4|||
48329006|NCT00597376|155403457|FG001|Overall Study|Withdrawal by Subject|3|||
48329007|NCT00597376|155403456|FG000|Overall Study|Adverse Event|4|||
48641338|NCT00305877|156540133|FG000|Overall Study|Death|0|||
48641339|NCT00305877|156540134|FG001|Overall Study|Death|1|||
48329008|NCT00597376|155403457|FG001|Overall Study|Adverse Event|1|||
48329009|NCT02634307|155403458|FG000|Overall Study|Adverse Event|50|||
48329010|NCT02634307|155403459|FG001|Overall Study|Adverse Event|24|||
48748933|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
48748934|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
48748935|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
48748936|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748937|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748938|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748939|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48329011|NCT02634307|155403460|FG002|Overall Study|Adverse Event|14|||
48329012|NCT02634307|155403458|FG000|Overall Study|Lost to Follow-up|21|||
48329013|NCT02634307|155403459|FG001|Overall Study|Lost to Follow-up|5|||
48329014|NCT02634307|155403460|FG002|Overall Study|Lost to Follow-up|6|||
48329015|NCT02634307|155403458|FG000|Overall Study|Pregnancy|5|||
48329016|NCT02634307|155403459|FG001|Overall Study|Pregnancy|1|||
48329017|NCT02634307|155403460|FG002|Overall Study|Pregnancy|3|||
48641340|NCT00305877|156540133|FG000|Overall Study|Withdrawal by Subject|4|||
48641341|NCT00305877|156540134|FG001|Overall Study|Withdrawal by Subject|2|||
48641342|NCT00305877|156540133|FG000|Overall Study|Physician Decision|1|||
48641343|NCT00305877|156540134|FG001|Overall Study|Physician Decision|1|||
48641344|NCT00305877|156540133|FG000|Overall Study|Never start treatment|2|||
48641345|NCT00305877|156540134|FG001|Overall Study|Never start treatment|5|||
48641346|NCT00305877|156540133|FG000|Overall Study|Ineligible|2|||
48641347|NCT00305877|156540134|FG001|Overall Study|Ineligible|1|||
48641348|NCT00305877|156540133|FG000|Overall Study|Transportation issue with daily RT|0|||
48641349|NCT00305877|156540134|FG001|Overall Study|Transportation issue with daily RT|1|||
48641350|NCT01248793|156540135|FG000|Overall Study|Lost to Follow-up|0|||
48641351|NCT01248793|156540136|FG001|Overall Study|Lost to Follow-up|1|||
48641352|NCT01248793|156540135|FG000|Overall Study|Adverse Event|1|||
48641353|NCT01248793|156540136|FG001|Overall Study|Adverse Event|1|||
48641354|NCT01248793|156540135|FG000|Overall Study|Protocol Violation|0|||
48641355|NCT01248793|156540136|FG001|Overall Study|Protocol Violation|1|||
48641356|NCT01248793|156540135|FG000|Overall Study|Withdrawal by Subject|3|||
48641357|NCT01248793|156540136|FG001|Overall Study|Withdrawal by Subject|3|||
48641358|NCT00517699|156540137|FG000|Overall Study|Withdrawal by Subject|1|||
48641359|NCT00517699|156540137|FG000|Overall Study|Lack of Efficacy|1|||
48641360|NCT00517699|156540137|FG000|Overall Study|Administrative error|1|||
48641361|NCT00517699|156540137|FG000|Overall Study|Study terminated by Sponsor|2|||
48641362|NCT02727322|156540140|FG000|Overall Study|Withdrawal by Subject|1|||
48641363|NCT02727322|156540141|FG001|Overall Study|Withdrawal by Subject|1|||
48641364|NCT02727322|156540140|FG000|Overall Study|Protocol Violation|1|||
48641365|NCT02727322|156540141|FG001|Overall Study|Protocol Violation|0|||
48641366|NCT00558636|156540142|FG000|Treatment|Adverse Event|9|||
48641367|NCT00558636|156540143|FG001|Treatment|Adverse Event|2|||
48641368|NCT00558636|156540142|FG000|Treatment|Withdrawal by Subject|2|||
48641369|NCT00558636|156540143|FG001|Treatment|Withdrawal by Subject|0|||
48641370|NCT00558636|156540142|FG000|Treatment|Premature termination of the study|35|||
48641371|NCT00558636|156540143|FG001|Treatment|Premature termination of the study|37|||
48641372|NCT00558636|156540142|FG000|Treatment|Disease progression|1|||
48641373|NCT00558636|156540143|FG001|Treatment|Disease progression|5|||
48641374|NCT00558636|156540142|FG000|Follow-up|Premature termination of the study|12|||
48641375|NCT00558636|156540143|FG001|Follow-up|Premature termination of the study|7|||
48641376|NCT01213082|156540144|FG000|Overall Study|Lost to Follow-up|6|||
48641377|NCT01213082|156540145|FG001|Overall Study|Lost to Follow-up|7|||
48641378|NCT01213082|156540146|FG002|Overall Study|Lost to Follow-up|4|||
48641379|NCT01213082|156540144|FG000|Overall Study|Physician Decision|0|||
48641380|NCT01213082|156540145|FG001|Overall Study|Physician Decision|0|||
48641381|NCT01213082|156540146|FG002|Overall Study|Physician Decision|1|||
48641382|NCT04403919|156540151|FG000|Overall Study|Lost to Follow-up|0|||
48641383|NCT04403919|156540152|FG001|Overall Study|Lost to Follow-up|0|||
48641384|NCT04403919|156540153|FG002|Overall Study|Lost to Follow-up|0|||
48641385|NCT04403919|156540154|FG003|Overall Study|Lost to Follow-up|1|||
48641386|NCT01904721|156540160|FG000|Overall Study|Other Reasons|0|||
48641387|NCT01904721|156540161|FG001|Overall Study|Other Reasons|0|||
48641388|NCT01904721|156540162|FG002|Overall Study|Other Reasons|1|||
48641389|NCT01904721|156540163|FG003|Overall Study|Other Reasons|1|||
48641390|NCT01904721|156540164|FG004|Overall Study|Other Reasons|2|||
48748940|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48641391|NCT01904721|156540165|FG005|Overall Study|Other Reasons|2|||
48641392|NCT01904721|156540166|FG006|Overall Study|Other Reasons|2|||
48641393|NCT01904721|156540160|FG000|Overall Study|Personal Reasons|0|||
48641394|NCT01904721|156540161|FG001|Overall Study|Personal Reasons|0|||
48641395|NCT01904721|156540162|FG002|Overall Study|Personal Reasons|0|||
48641396|NCT01904721|156540163|FG003|Overall Study|Personal Reasons|0|||
48641397|NCT01904721|156540164|FG004|Overall Study|Personal Reasons|2|||
48329018|NCT02634307|155403458|FG000|Overall Study|Withdrawal by Subject|38|||
48329019|NCT02634307|155403459|FG001|Overall Study|Withdrawal by Subject|24|||
48329020|NCT02634307|155403460|FG002|Overall Study|Withdrawal by Subject|18|||
48641398|NCT01904721|156540165|FG005|Overall Study|Personal Reasons|3|||
48641399|NCT01904721|156540166|FG006|Overall Study|Personal Reasons|3|||
48329021|NCT02634307|155403458|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48329022|NCT02634307|155403459|FG001|Overall Study|Non-Compliance with Study Drug|2|||
48329023|NCT02634307|155403460|FG002|Overall Study|Non-Compliance with Study Drug|2|||
48329024|NCT02634307|155403458|FG000|Overall Study|Lack of Efficacy|1|||
48329025|NCT02634307|155403459|FG001|Overall Study|Lack of Efficacy|5|||
48329026|NCT02634307|155403460|FG002|Overall Study|Lack of Efficacy|3|||
48329027|NCT02634307|155403458|FG000|Overall Study|Physician Decision|7|||
48641400|NCT01904721|156540160|FG000|Overall Study|Lost to Follow-up|0|||
48329028|NCT02634307|155403459|FG001|Overall Study|Physician Decision|5|||
48329029|NCT02634307|155403460|FG002|Overall Study|Physician Decision|5|||
48329030|NCT02634307|155403458|FG000|Overall Study|Reason not Specified|3|||
48329031|NCT02634307|155403459|FG001|Overall Study|Reason not Specified|5|||
48329032|NCT02634307|155403460|FG002|Overall Study|Reason not Specified|10|||
48329033|NCT00754325|155403461|FG000|Initial Treatment|Continuing Active Treatment|4|||
48329034|NCT00754325|155403462|FG001|Initial Treatment|Continuing Active Treatment|5|||
48329035|NCT00754325|155403461|FG000|Initial Treatment|Adverse Event|7|||
48329036|NCT00754325|155403462|FG001|Initial Treatment|Adverse Event|6|||
48329037|NCT00754325|155403461|FG000|Initial Treatment|Withdrawal by Subject|2|||
48329038|NCT00754325|155403462|FG001|Initial Treatment|Withdrawal by Subject|2|||
48641401|NCT01904721|156540161|FG001|Overall Study|Lost to Follow-up|0|||
48329039|NCT00754325|155403461|FG000|Initial Treatment|Physician Decision|2|||
48329040|NCT00754325|155403462|FG001|Initial Treatment|Physician Decision|0|||
48329041|NCT00754325|155403461|FG000|Initial Treatment|Sponsor Request|0|||
48329042|NCT00754325|155403462|FG001|Initial Treatment|Sponsor Request|1|||
48329043|NCT00754325|155403461|FG000|Initial Treatment|Disease Progression|35|||
48329044|NCT00754325|155403462|FG001|Initial Treatment|Disease Progression|35|||
48329045|NCT02185794|155403463|FG000|Overall Study|Enrolled but Never Dosed|1|||
48329046|NCT02185794|155403464|FG001|Overall Study|Enrolled but Never Dosed|6|||
48329047|NCT02185794|155403465|FG002|Overall Study|Enrolled but Never Dosed|3|||
48329048|NCT02185794|155403466|FG003|Overall Study|Enrolled but Never Dosed|1|||
48329049|NCT02185794|155403467|FG004|Overall Study|Enrolled but Never Dosed|1|||
48641402|NCT01904721|156540162|FG002|Overall Study|Lost to Follow-up|0|||
48641403|NCT01904721|156540163|FG003|Overall Study|Lost to Follow-up|0|||
48641404|NCT01904721|156540164|FG004|Overall Study|Lost to Follow-up|1|||
48641405|NCT01904721|156540165|FG005|Overall Study|Lost to Follow-up|3|||
48641406|NCT01904721|156540166|FG006|Overall Study|Lost to Follow-up|1|||
48641407|NCT01904721|156540160|FG000|Overall Study|Lack of Efficacy|0|||
48641408|NCT01904721|156540161|FG001|Overall Study|Lack of Efficacy|0|||
48641409|NCT01904721|156540162|FG002|Overall Study|Lack of Efficacy|0|||
48641410|NCT01904721|156540163|FG003|Overall Study|Lack of Efficacy|0|||
48641411|NCT01904721|156540164|FG004|Overall Study|Lack of Efficacy|0|||
48641412|NCT01904721|156540165|FG005|Overall Study|Lack of Efficacy|0|||
48641413|NCT01904721|156540166|FG006|Overall Study|Lack of Efficacy|1|||
48641414|NCT01904721|156540160|FG000|Overall Study|Adverse Event|0|||
48641415|NCT01904721|156540161|FG001|Overall Study|Adverse Event|0|||
48641416|NCT01904721|156540162|FG002|Overall Study|Adverse Event|0|||
48641417|NCT01904721|156540163|FG003|Overall Study|Adverse Event|0|||
48641418|NCT01904721|156540164|FG004|Overall Study|Adverse Event|3|||
48641419|NCT01904721|156540165|FG005|Overall Study|Adverse Event|1|||
48641420|NCT01904721|156540166|FG006|Overall Study|Adverse Event|0|||
48641421|NCT00532844|156540167|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
48641422|NCT00532844|156540168|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
48641423|NCT00532844|156540167|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
48641424|NCT00532844|156540168|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
48641425|NCT00532844|156540167|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
48641426|NCT00532844|156540168|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
48641427|NCT00532844|156540167|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
48641428|NCT00532844|156540168|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
48641429|NCT00532844|156540167|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
48641430|NCT00532844|156540168|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
48641431|NCT03637491|156540169|FG000|Overall Study|Death|9|||
48641432|NCT03637491|156540170|FG001|Overall Study|Death|9|||
48641433|NCT03637491|156540171|FG002|Overall Study|Death|5|||
48641434|NCT03637491|156540172|FG003|Overall Study|Death|3|||
48641435|NCT03637491|156540169|FG000|Overall Study|Lost to Follow-up|0|||
48641436|NCT03637491|156540170|FG001|Overall Study|Lost to Follow-up|1|||
48641437|NCT03637491|156540171|FG002|Overall Study|Lost to Follow-up|0|||
48641438|NCT03637491|156540172|FG003|Overall Study|Lost to Follow-up|1|||
48641439|NCT03637491|156540169|FG000|Overall Study|Study Terminated By Sponsor|0|||
48329050|NCT02185794|155403468|FG005|Overall Study|Enrolled but Never Dosed|0|||
48329051|NCT02185794|155403463|FG000|Overall Study|Investigator's Discretion|1|||
48329052|NCT02185794|155403464|FG001|Overall Study|Investigator's Discretion|0|||
48641440|NCT03637491|156540170|FG001|Overall Study|Study Terminated By Sponsor|2|||
48641441|NCT03637491|156540171|FG002|Overall Study|Study Terminated By Sponsor|1|||
48641442|NCT03637491|156540172|FG003|Overall Study|Study Terminated By Sponsor|0|||
48641443|NCT03637491|156540169|FG000|Overall Study|Withdrawal by Subject|1|||
48641444|NCT03637491|156540170|FG001|Overall Study|Withdrawal by Subject|0|||
48329053|NCT02185794|155403465|FG002|Overall Study|Investigator's Discretion|1|||
48329054|NCT02185794|155403466|FG003|Overall Study|Investigator's Discretion|2|||
48329055|NCT02185794|155403467|FG004|Overall Study|Investigator's Discretion|2|||
48329056|NCT02185794|155403468|FG005|Overall Study|Investigator's Discretion|15|||
48329057|NCT02185794|155403463|FG000|Overall Study|Withdrew Consent|2|||
48641445|NCT03637491|156540171|FG002|Overall Study|Withdrawal by Subject|1|||
48641446|NCT03637491|156540172|FG003|Overall Study|Withdrawal by Subject|2|||
48641447|NCT04141891|156540184|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
48641448|NCT04141891|156540185|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
48641449|NCT04141891|156540184|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
48641450|NCT04141891|156540185|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
48329058|NCT02185794|155403464|FG001|Overall Study|Withdrew Consent|5|||
48329059|NCT02185794|155403465|FG002|Overall Study|Withdrew Consent|10|||
48329060|NCT02185794|155403466|FG003|Overall Study|Withdrew Consent|2|||
48641451|NCT04141891|156540184|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
48641452|NCT04141891|156540185|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
48641453|NCT04141891|156540184|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
48641454|NCT04141891|156540185|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
48641455|NCT04141891|156540184|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
48641456|NCT04141891|156540185|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
48641457|NCT04141891|156540184|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
48641458|NCT04141891|156540185|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
48641459|NCT04141891|156540184|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
48641460|NCT04141891|156540185|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
48641461|NCT04141891|156540184|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
48641462|NCT04141891|156540185|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
48641463|NCT04141891|156540184|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
48641464|NCT04141891|156540185|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
48641465|NCT04141891|156540184|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
48641466|NCT04141891|156540185|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
48641467|NCT04141891|156540184|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
48641468|NCT04141891|156540185|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
48748941|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748942|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748943|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748944|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748945|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748946|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748947|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748948|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748949|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748950|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748951|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748952|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748953|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748954|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748955|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748956|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748957|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748958|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748959|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
48748960|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
48748961|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
48748962|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748963|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748964|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748965|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748966|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748967|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748968|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748969|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748970|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748971|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748972|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748973|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48641469|NCT04141891|156540184|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
48641470|NCT04141891|156540185|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
48641471|NCT04141891|156540184|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
48641472|NCT04141891|156540185|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
48641473|NCT04141891|156540184|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
48641474|NCT04141891|156540185|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
48641475|NCT05856435|156540190|FG000|Overall Study|Lost to Follow-up|6|||
48641476|NCT02890329|156540191|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
48641477|NCT02890329|156540192|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
48641478|NCT02890329|156540193|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
48641479|NCT02890329|156540194|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
48641480|NCT02890329|156540195|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
48641481|NCT02890329|156540196|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
48641482|NCT02890329|156540191|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
48641483|NCT02890329|156540192|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
48641484|NCT02890329|156540193|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
48748974|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748975|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748976|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748977|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748978|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748979|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748980|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748981|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748982|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748983|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748984|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
48748985|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
48641485|NCT02890329|156540194|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
48641486|NCT02890329|156540195|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
48641487|NCT02890329|156540196|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
48641488|NCT02890329|156540191|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
48641489|NCT02890329|156540192|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
48641490|NCT02890329|156540193|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
48641491|NCT02890329|156540194|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
48641492|NCT02890329|156540195|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
48641493|NCT02890329|156540196|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
48641494|NCT02890329|156540191|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
48641495|NCT02890329|156540192|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
48641496|NCT02890329|156540193|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
48641497|NCT02890329|156540194|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
48641498|NCT02890329|156540195|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
48641499|NCT02890329|156540196|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
48641500|NCT04055012|156540197|FG000|Overall Study|Withdrawal by Subject|1|||
48641501|NCT04055012|156540198|FG001|Overall Study|Withdrawal by Subject|3|||
48641502|NCT04055012|156540199|FG002|Overall Study|Withdrawal by Subject|1|||
48641503|NCT04055012|156540200|FG003|Overall Study|Withdrawal by Subject|0|||
48641504|NCT04055012|156540197|FG000|Overall Study|Metformin Recall|1|||
48641505|NCT04055012|156540198|FG001|Overall Study|Metformin Recall|1|||
48641506|NCT04055012|156540199|FG002|Overall Study|Metformin Recall|1|||
48641507|NCT04055012|156540200|FG003|Overall Study|Metformin Recall|0|||
48641508|NCT05347485|156540201|FG000|Overall Study|Death|14|||
48641509|NCT05347485|156540201|FG000|Overall Study|Lost to Follow-up|2|||
48641510|NCT05347485|156540201|FG000|Overall Study|Withdrawal by Subject|13|||
48641511|NCT05347485|156540201|FG000|Overall Study|Progressive Disease|1|||
48641512|NCT05347485|156540201|FG000|Overall Study|Study Terminated by Sponsor|49|||
48641513|NCT05347485|156540201|FG000|Overall Study|Other|1|||
48641514|NCT05347485|156540201|FG000|Overall Study|Enrolled (consented) but not treated|4|||
48641515|NCT05347485|156540201|FG000|Overall Study|Disease Relapse|2|||
48641516|NCT05541484|156540202|FG000|Overall Study|Withdrawal by Subject|1|||
48641517|NCT05541484|156540203|FG001|Overall Study|Withdrawal by Subject|0|||
48641518|NCT02919917|156540204|FG000|Overall Study|Withdrawal by Subject|4|||
48641519|NCT02919917|156540205|FG001|Overall Study|Withdrawal by Subject|8|||
48641520|NCT05025384|156540208|FG000|Overall Study|Physician Decision|5|||
48641521|NCT05025384|156540209|FG001|Overall Study|Physician Decision|6|||
48641522|NCT04057131|156540210|FG000|Overall Study|Protocol Violation|24|||
48641523|NCT04577651|156540213|FG000|Overall Study|Screen Failure|7|||
48641524|NCT04577651|156540213|FG000|Overall Study|Adverse Event|1|||
48641525|NCT04577651|156540213|FG000|Overall Study|Death|1|||
48641526|NCT04577651|156540213|FG000|Overall Study|Physician Decision|1|||
48641527|NCT04577651|156540213|FG000|Overall Study|Withdrawal by Subject|3|||
48641528|NCT04459416|156541606|FG000|Overall Study|Lost to Follow-up|2|||
48641529|NCT04459416|156541607|FG001|Overall Study|Lost to Follow-up|0|||
48641530|NCT04459416|156541606|FG000|Overall Study|Withdrawal by Subject|8|||
48641531|NCT04459416|156541607|FG001|Overall Study|Withdrawal by Subject|10|||
48641532|NCT04459416|156541606|FG000|Overall Study|Disease progression|0|||
48641533|NCT04459416|156541607|FG001|Overall Study|Disease progression|3|||
48641534|NCT01576783|156541608|FG000|Overall Study|Change in Medical Care|1|||
48641535|NCT01576783|156541609|FG001|Overall Study|Change in Medical Care|0|||
48641536|NCT01576783|156541608|FG000|Overall Study|Lost to Follow-up|14|||
48641537|NCT01576783|156541609|FG001|Overall Study|Lost to Follow-up|16|||
48641538|NCT01576783|156541608|FG000|Overall Study|Withdrawal by Subject|5|||
48641539|NCT01576783|156541609|FG001|Overall Study|Withdrawal by Subject|1|||
48641540|NCT02114177|156541610|FG000|Overall Study|Lost to Follow-up|1|||
48641541|NCT02114177|156541611|FG001|Overall Study|Lost to Follow-up|2|||
48641542|NCT02114177|156541610|FG000|Overall Study|Withdrawal by Subject|6|||
48641543|NCT02114177|156541611|FG001|Overall Study|Withdrawal by Subject|1|||
48641544|NCT02114177|156541610|FG000|Overall Study|Other|2|||
48641545|NCT02114177|156541611|FG001|Overall Study|Other|1|||
48641546|NCT02026011|156541612|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
48641547|NCT02026011|156541613|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
48641548|NCT02026011|156541612|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
48641549|NCT02026011|156541613|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
48329061|NCT02185794|155403467|FG004|Overall Study|Withdrew Consent|0|||
48329062|NCT02185794|155403468|FG005|Overall Study|Withdrew Consent|0|||
48641550|NCT02026011|156541612|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
48641551|NCT02026011|156541613|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
48641552|NCT02026011|156541612|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
48641553|NCT02026011|156541613|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
48329063|NCT02185794|155403463|FG000|Overall Study|Lost to Follow-up|1|||
48748986|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
48329064|NCT02185794|155403464|FG001|Overall Study|Lost to Follow-up|2|||
48329065|NCT02185794|155403465|FG002|Overall Study|Lost to Follow-up|2|||
48329066|NCT02185794|155403466|FG003|Overall Study|Lost to Follow-up|3|||
48329067|NCT02185794|155403467|FG004|Overall Study|Lost to Follow-up|0|||
48329068|NCT02185794|155403468|FG005|Overall Study|Lost to Follow-up|1|||
48329069|NCT01092416|155403469|FG000|Enrollment|Atherectomy device not inserted|3|||
48329070|NCT01092416|155403469|FG000|30-Day Follow-up|Death|2|||
48329071|NCT01092416|155403469|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
48329072|NCT01092416|155403469|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
48329073|NCT01092416|155403469|FG000|12-Month Follow-up|Death|16|||
48329074|NCT01092416|155403469|FG000|12-Month Follow-up|Lost to Follow-up|4|||
48329075|NCT01092416|155403469|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
48641554|NCT02777086|156541614|FG000|Overall Study|Lost to Follow-up|96|||
48641555|NCT02777086|156541615|FG001|Overall Study|Lost to Follow-up|99|||
48641556|NCT01770743|156541616|FG000|Overall Study|Adverse Event|1|||
48641557|NCT01770743|156541617|FG001|Overall Study|Adverse Event|0|||
48641558|NCT01770743|156541618|FG002|Overall Study|Adverse Event|0|||
48641559|NCT01770743|156541619|FG003|Overall Study|Adverse Event|0|||
48641560|NCT01770743|156541620|FG004|Overall Study|Adverse Event|0|||
48641561|NCT01770743|156541616|FG000|Overall Study|Withdrawal by Subject|0|||
48641562|NCT01770743|156541617|FG001|Overall Study|Withdrawal by Subject|0|||
48641563|NCT01770743|156541618|FG002|Overall Study|Withdrawal by Subject|1|||
48641564|NCT01770743|156541619|FG003|Overall Study|Withdrawal by Subject|1|||
48641565|NCT01770743|156541620|FG004|Overall Study|Withdrawal by Subject|1|||
48641566|NCT01770743|156541616|FG000|Overall Study|Lost to Follow-up|0|||
48641567|NCT01770743|156541617|FG001|Overall Study|Lost to Follow-up|2|||
48641568|NCT01770743|156541618|FG002|Overall Study|Lost to Follow-up|0|||
48641569|NCT01770743|156541619|FG003|Overall Study|Lost to Follow-up|0|||
48641570|NCT01770743|156541620|FG004|Overall Study|Lost to Follow-up|1|||
48641571|NCT01770743|156541616|FG000|Overall Study|Sponsor Terminated Subject|1|||
48641572|NCT01770743|156541617|FG001|Overall Study|Sponsor Terminated Subject|0|||
48641573|NCT01770743|156541618|FG002|Overall Study|Sponsor Terminated Subject|0|||
48641574|NCT01770743|156541619|FG003|Overall Study|Sponsor Terminated Subject|1|||
48641575|NCT01770743|156541620|FG004|Overall Study|Sponsor Terminated Subject|0|||
48641576|NCT01770743|156541616|FG000|Overall Study|Moving Out of State|0|||
48641577|NCT01770743|156541617|FG001|Overall Study|Moving Out of State|1|||
48641578|NCT01770743|156541618|FG002|Overall Study|Moving Out of State|0|||
48641579|NCT01770743|156541619|FG003|Overall Study|Moving Out of State|0|||
48641580|NCT01770743|156541620|FG004|Overall Study|Moving Out of State|0|||
48641581|NCT00937495|156541627|FG000|Overall Study|Protocol Violation|2|||
48641582|NCT00441272|156541628|FG000|Overall Study|Study terminated prior to enrollment|25|||
48641583|NCT00441272|156541629|FG001|Overall Study|Study terminated prior to enrollment|25|||
48641584|NCT01856322|156541630|FG000|Overall Study|off study due to lack of accrual|0|||
48641585|NCT01856322|156541631|FG001|Overall Study|off study due to lack of accrual|0|||
48641586|NCT01856322|156541632|FG002|Overall Study|off study due to lack of accrual|3|||
48641587|NCT00427011|156541633|FG000|Overall Study|Adverse Event|10|||
48641588|NCT00427011|156541633|FG000|Overall Study|Withdrawal by Subject|1|||
48641589|NCT00427011|156541633|FG000|Overall Study|Lack of Efficacy|2|||
48641590|NCT00427011|156541633|FG000|Overall Study|Other|12|||
48641591|NCT00952705|156541634|FG000|Overall Study|Lost to Follow-up|24|||
48641592|NCT00952705|156541635|FG001|Overall Study|Lost to Follow-up|8|||
48641593|NCT00952705|156541636|FG002|Overall Study|Lost to Follow-up|9|||
48641594|NCT00952705|156541634|FG000|Overall Study|Withdrawal by Subject|2|||
48641595|NCT00952705|156541635|FG001|Overall Study|Withdrawal by Subject|1|||
48641596|NCT00952705|156541636|FG002|Overall Study|Withdrawal by Subject|1|||
48641597|NCT00952705|156541634|FG000|Overall Study|Death|2|||
48641598|NCT00952705|156541635|FG001|Overall Study|Death|0|||
48641599|NCT00952705|156541636|FG002|Overall Study|Death|0|||
48641600|NCT00952705|156541634|FG000|Overall Study|Incarcerated post dose|5|||
48641601|NCT00952705|156541635|FG001|Overall Study|Incarcerated post dose|0|||
48641602|NCT00952705|156541636|FG002|Overall Study|Incarcerated post dose|0|||
48641603|NCT00952705|156541634|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
48329076|NCT01092416|155403469|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
48329077|NCT01092416|155403469|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
48641604|NCT00952705|156541635|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
48641605|NCT00952705|156541636|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
48641606|NCT01497197|156541638|FG000|Overall Study|Lost to Follow-up|1|||
48641607|NCT01497197|156541639|FG001|Overall Study|Lost to Follow-up|0|||
48641608|NCT01497197|156541638|FG000|Overall Study|Protocol Violation|0|||
48641609|NCT01497197|156541639|FG001|Overall Study|Protocol Violation|2|||
48329078|NCT03883828|155403473|FG000|Overall Study|Did not start radiotherapy|1|||
48329079|NCT03883828|155403474|FG001|Overall Study|Did not start radiotherapy|2|||
48641610|NCT01497197|156541638|FG000|Overall Study|Withdrawal by Subject|2|||
48641611|NCT01497197|156541639|FG001|Overall Study|Withdrawal by Subject|1|||
48641612|NCT01497197|156541638|FG000|Overall Study|Excessive/lack of response to treatment|1|||
48641613|NCT01497197|156541639|FG001|Overall Study|Excessive/lack of response to treatment|0|||
48748987|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
48748988|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748989|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748990|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748991|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748992|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748993|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48641614|NCT01497197|156541638|FG000|Overall Study|Risk of OHSS|1|||
48641615|NCT01497197|156541639|FG001|Overall Study|Risk of OHSS|0|||
48641616|NCT01497197|156541638|FG000|Overall Study|No oocytes retrieved|3|||
48641617|NCT01497197|156541639|FG001|Overall Study|No oocytes retrieved|2|||
48641618|NCT01497197|156541638|FG000|Overall Study|No fertilisation|6|||
48641619|NCT01497197|156541639|FG001|Overall Study|No fertilisation|5|||
48641620|NCT01497197|156541638|FG000|Overall Study|Intention to freeze all embryos|0|||
48641621|NCT01497197|156541639|FG001|Overall Study|Intention to freeze all embryos|1|||
48641622|NCT01497197|156541638|FG000|Overall Study|All embryos discarded|0|||
48641623|NCT01497197|156541639|FG001|Overall Study|All embryos discarded|3|||
48641624|NCT01497197|156541638|FG000|Overall Study|Other|3|||
48641625|NCT01497197|156541639|FG001|Overall Study|Other|1|||
48641626|NCT01628913|156541640|FG000|Overall Study|Adverse Event|12|||
48641627|NCT01628913|156541641|FG001|Overall Study|Adverse Event|5|||
48641628|NCT01628913|156541640|FG000|Overall Study|Disease Progression|11|||
48641629|NCT01628913|156541641|FG001|Overall Study|Disease Progression|14|||
48641630|NCT01628913|156541640|FG000|Overall Study|Protocol Violation|1|||
48641631|NCT01628913|156541641|FG001|Overall Study|Protocol Violation|0|||
48641632|NCT01628913|156541640|FG000|Overall Study|Death|1|||
48641633|NCT01628913|156541641|FG001|Overall Study|Death|0|||
48748994|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748995|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748996|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748997|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748998|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48748999|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749000|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749001|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749002|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749003|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749004|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749005|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749006|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749007|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749008|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749009|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749010|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749011|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48749012|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
48749013|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
48641634|NCT01628913|156541640|FG000|Overall Study|study terminated by Sponsor|4|||
48641635|NCT01628913|156541641|FG001|Overall Study|study terminated by Sponsor|9|||
48641636|NCT01628913|156541640|FG000|Overall Study|Withdrawal by Subject|1|||
48641637|NCT01628913|156541641|FG001|Overall Study|Withdrawal by Subject|0|||
48641638|NCT01628913|156541640|FG000|Overall Study|Physician Decision|1|||
48641639|NCT01628913|156541641|FG001|Overall Study|Physician Decision|3|||
48641640|NCT02935192|156541644|FG000|Overall Study|Withdrawal by Subject|8|||
48641641|NCT02935192|156541645|FG001|Overall Study|Withdrawal by Subject|4|||
48641642|NCT05173974|156541646|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
48641643|NCT05173974|156541647|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
48641644|NCT05173974|156541648|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
48641645|NCT05173974|156541649|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
48641646|NCT05173974|156541646|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
48641647|NCT05173974|156541647|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
48641648|NCT05173974|156541648|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
48641649|NCT05173974|156541649|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
48641650|NCT01979614|156541650|FG000|Overall Study|Adverse Event|1|||
48641651|NCT01979614|156541651|FG001|Overall Study|Adverse Event|1|||
48641652|NCT00661830|156541652|FG000|Overall Study|Death|37|||
48641653|NCT00661830|156541653|FG001|Overall Study|Death|33|||
48641654|NCT00661830|156541652|FG000|Overall Study|Lost to Follow-up|1|||
48641655|NCT00661830|156541653|FG001|Overall Study|Lost to Follow-up|3|||
48641656|NCT00661830|156541652|FG000|Overall Study|Withdrawal by Subject|1|||
48641657|NCT00661830|156541653|FG001|Overall Study|Withdrawal by Subject|1|||
48641658|NCT00661830|156541652|FG000|Overall Study|Other reason|1|||
48641659|NCT00661830|156541653|FG001|Overall Study|Other reason|5|||
48641660|NCT00488514|156541654|FG000|Overall Study|Adverse Event|41|||
48641661|NCT00488514|156541654|FG000|Overall Study|Lost to Follow-up|44|||
48641662|NCT00488514|156541654|FG000|Overall Study|Protocol Violation|32|||
48641663|NCT00488514|156541654|FG000|Overall Study|Withdrawal by Subject|106|||
48641664|NCT00488514|156541654|FG000|Overall Study|Lack of Efficacy|28|||
48641665|NCT00488514|156541654|FG000|Overall Study|Did not meet criteria for treatment|30|||
48641666|NCT00488514|156541654|FG000|Overall Study|Postive drug screen|1|||
48641667|NCT00488514|156541654|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
48641668|NCT00488514|156541654|FG000|Overall Study|Investigator decision|1|||
48641669|NCT00488514|156541654|FG000|Overall Study|Participant had too few migraines|5|||
48641670|NCT00488514|156541654|FG000|Overall Study|Increase in number of migraines|2|||
48641671|NCT00488514|156541654|FG000|Overall Study|Increased use of concomitant medication|1|||
48641672|NCT00730756|156541655|FG000|Overall Study|Adverse Event|2|||
48641673|NCT00730756|156541656|FG001|Overall Study|Adverse Event|0|||
48641674|NCT00730756|156541655|FG000|Overall Study|Lack of Efficacy|1|||
48641675|NCT00730756|156541656|FG001|Overall Study|Lack of Efficacy|1|||
48329080|NCT03041090|155403475|FG000|Overall Study|technical error|0|||
48329081|NCT03041090|155403476|FG001|Overall Study|technical error|3|||
48329082|NCT01353274|155403477|FG000|Overall Study|No case report form (CRF) collected|28|||
48329083|NCT03675321|155403478|FG000|Overall Study|Lack of Efficacy|2|||
48329084|NCT03675321|155403479|FG001|Overall Study|Lack of Efficacy|2|||
48329085|NCT03675321|155403478|FG000|Overall Study|Withdrawal by Subject|1|||
48329086|NCT03675321|155403479|FG001|Overall Study|Withdrawal by Subject|3|||
48329087|NCT03735849|155403480|FG000|Overall Study|Lost to Follow-up|1|||
48329088|NCT03735849|155403481|FG001|Overall Study|Lost to Follow-up|0|||
48329089|NCT03735849|155403482|FG002|Overall Study|Lost to Follow-up|0|||
48329090|NCT03735849|155403480|FG000|Overall Study|Participant unable to adhere to visit|1|||
48329091|NCT03735849|155403481|FG001|Overall Study|Participant unable to adhere to visit|0|||
48641676|NCT00730756|156541655|FG000|Overall Study|Protocol Deviation|1|||
48641677|NCT00730756|156541656|FG001|Overall Study|Protocol Deviation|2|||
48641678|NCT00730756|156541655|FG000|Overall Study|Lost to Follow-up|0|||
48641679|NCT00730756|156541656|FG001|Overall Study|Lost to Follow-up|1|||
48641680|NCT00730756|156541655|FG000|Overall Study|Withdrew Consent|0|||
48641681|NCT00730756|156541656|FG001|Overall Study|Withdrew Consent|1|||
48641682|NCT01535287|156541657|FG000|Overall Study|drug not prepared in time|5|||
48641683|NCT01535287|156541658|FG001|Overall Study|drug not prepared in time|6|||
48641684|NCT00524121|156541661|FG000|Overall Study|Disease progression|6|||
48641685|NCT00524121|156541661|FG000|Overall Study|Adverse Event|4|||
48641686|NCT00524121|156541661|FG000|Overall Study|Patient refused|2|||
48641687|NCT00524121|156541661|FG000|Overall Study|Other|1|||
48329092|NCT03735849|155403482|FG002|Overall Study|Participant unable to adhere to visit|0|||
48329093|NCT03735849|155403480|FG000|Overall Study|Not Randomized|0|||
48329094|NCT03735849|155403481|FG001|Overall Study|Not Randomized|0|||
48329095|NCT03735849|155403482|FG002|Overall Study|Not Randomized|4|||
48329096|NCT00022672|155403485|FG000|Main Phase: 24 Months|Adverse Event|6|||
48329097|NCT00022672|155403486|FG001|Main Phase: 24 Months|Adverse Event|0|||
48749014|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749015|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749016|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749017|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749018|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48329098|NCT00022672|155403485|FG000|Main Phase: 24 Months|Death|0|||
48329099|NCT00022672|155403486|FG001|Main Phase: 24 Months|Death|3|||
48749019|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749020|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749021|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749022|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749023|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749024|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749025|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749026|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749027|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749028|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749029|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749030|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749031|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749032|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749033|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749034|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749035|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749036|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749037|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749038|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
48749039|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
48749040|NCT03129100|156926557|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
48749041|NCT03129100|156926558|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
48749042|NCT03129100|156926559|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
48749043|NCT03129100|156926560|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
48749044|NCT03129100|156926561|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
48329100|NCT00022672|155403485|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
48329101|NCT00022672|155403486|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
48427299|NCT01544595|155752940|FG002|Status at Week 68|Adverse Event|1|||
48641688|NCT00524121|156541661|FG000|Overall Study|Death|1|||
48749045|NCT03129100|156926562|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
48749046|NCT03129100|156926563|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
48749047|NCT03129100|156926564|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
48749048|NCT03129100|156926565|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
48749049|NCT03129100|156926566|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
48749050|NCT03129100|156926567|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
48641689|NCT00524121|156541661|FG000|Overall Study|Not treated (became ineligible)|4|||
48641690|NCT00524121|156541661|FG000|Overall Study|Not treated (changed mind)|1|||
48641691|NCT01840943|156541662|FG000|Overall Study|Withdrawal by Subject|5|||
48641692|NCT01840943|156541663|FG001|Overall Study|Withdrawal by Subject|6|||
48641693|NCT01840943|156541662|FG000|Overall Study|Physician Decision|4|||
48641694|NCT01840943|156541663|FG001|Overall Study|Physician Decision|2|||
48641695|NCT01840943|156541662|FG000|Overall Study|Lost to Follow-up|4|||
48641696|NCT01840943|156541663|FG001|Overall Study|Lost to Follow-up|4|||
48749051|NCT03129100|156926568|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
48749052|NCT03129100|156926569|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
48749053|NCT03129100|156926570|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
48749054|NCT03129100|156926571|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
48641697|NCT01446874|156541664|FG000|Overall Study|Not eligible|1|||
48641698|NCT01446874|156541665|FG001|Overall Study|Not eligible|0|||
48641699|NCT01446874|156541666|FG002|Overall Study|Not eligible|0|||
48641700|NCT01446874|156541664|FG000|Overall Study|No surgery/No qualifying surgery|1|||
48641701|NCT01446874|156541665|FG001|Overall Study|No surgery/No qualifying surgery|0|||
48641702|NCT01446874|156541666|FG002|Overall Study|No surgery/No qualifying surgery|12|||
48641703|NCT01446874|156541664|FG000|Overall Study|Non-compliance|0|||
48641704|NCT01446874|156541665|FG001|Overall Study|Non-compliance|4|||
48641705|NCT01446874|156541666|FG002|Overall Study|Non-compliance|0|||
48641706|NCT01446874|156541664|FG000|Overall Study|Antibiotics for pre-op infection|0|||
48641707|NCT01446874|156541665|FG001|Overall Study|Antibiotics for pre-op infection|0|||
48641708|NCT01446874|156541666|FG002|Overall Study|Antibiotics for pre-op infection|2|||
48641709|NCT01446874|156541664|FG000|Overall Study|Withdrawal by Subject|0|||
48641710|NCT01446874|156541665|FG001|Overall Study|Withdrawal by Subject|0|||
48641711|NCT01446874|156541666|FG002|Overall Study|Withdrawal by Subject|4|||
48641712|NCT02580877|156541667|FG000|Overall Study|Withdrawal by Subject|1|||
48641713|NCT02580877|156541668|FG001|Overall Study|Withdrawal by Subject|3|||
48641714|NCT02580877|156541667|FG000|Overall Study|Adverse Event|0|||
48641715|NCT02580877|156541668|FG001|Overall Study|Adverse Event|1|||
48641716|NCT03500211|156541675|FG000|Overall Study|Withdrawal by Subject|1|||
48641717|NCT03500211|156541676|FG001|Overall Study|Withdrawal by Subject|1|||
48641718|NCT02897115|156541677|FG000|Overall Study|Early termination of study by sponsor|11|||
48641719|NCT02897115|156541678|FG001|Overall Study|Early termination of study by sponsor|8|||
48641720|NCT03886493|156541681|FG000|Overall Study|Adverse Event|1|||
48641721|NCT02639247|156541682|FG000|Overall Study|Lost to Follow-up|2|||
48641722|NCT02639247|156541683|FG001|Overall Study|Lost to Follow-up|1|||
48641723|NCT02639247|156541682|FG000|Overall Study|Death|2|||
48641724|NCT02639247|156541683|FG001|Overall Study|Death|0|||
48641725|NCT02639247|156541682|FG000|Overall Study|Withdrew Consent|0|||
48641726|NCT02639247|156541683|FG001|Overall Study|Withdrew Consent|1|||
48641727|NCT02639247|156541682|FG000|Overall Study|Protocol Violation|1|||
48641728|NCT02639247|156541683|FG001|Overall Study|Protocol Violation|0|||
48641729|NCT01061385|156541687|FG000|Overall Study|Lost to Follow-up|1|||
48749055|NCT03129100|156926572|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
48749056|NCT03129100|156926573|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
48749057|NCT03129100|156926574|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
48749058|NCT03129100|156926575|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
48749059|NCT03129100|156926576|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
48749060|NCT03129100|156926577|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
48749061|NCT03129100|156926578|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
48749062|NCT03129100|156926579|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
48641730|NCT01061385|156541688|FG001|Overall Study|Lost to Follow-up|0|||
48641731|NCT01061385|156541687|FG000|Overall Study|subject decision not related to AE|0|||
48641732|NCT01061385|156541688|FG001|Overall Study|subject decision not related to AE|1|||
48641733|NCT01881789|156541692|FG000|Overall Study|Withdrawal by Subject|0|||
48641734|NCT01881789|156541693|FG001|Overall Study|Withdrawal by Subject|2|||
48641735|NCT01881789|156541694|FG002|Overall Study|Withdrawal by Subject|1|||
48641736|NCT01881789|156541695|FG003|Overall Study|Withdrawal by Subject|0|||
48641737|NCT01881789|156541696|FG004|Overall Study|Withdrawal by Subject|1|||
48641738|NCT01881789|156541697|FG005|Overall Study|Withdrawal by Subject|1|||
48641739|NCT01881789|156541692|FG000|Overall Study|Study Terminated by Sponsor|0|||
48641740|NCT01881789|156541693|FG001|Overall Study|Study Terminated by Sponsor|0|||
48641741|NCT01881789|156541694|FG002|Overall Study|Study Terminated by Sponsor|0|||
48641742|NCT01881789|156541695|FG003|Overall Study|Study Terminated by Sponsor|0|||
48641743|NCT01881789|156541696|FG004|Overall Study|Study Terminated by Sponsor|0|||
48641744|NCT01881789|156541697|FG005|Overall Study|Study Terminated by Sponsor|1|||
48749063|NCT03129100|156926580|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
48329102|NCT00022672|155403485|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
48329103|NCT00022672|155403486|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
48329104|NCT00022672|155403485|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
48329105|NCT00022672|155403486|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
48329106|NCT00022672|155403485|FG000|Main Phase: 24 Months|Refused Treatment|3|||
48329107|NCT00022672|155403486|FG001|Main Phase: 24 Months|Refused Treatment|4|||
48329108|NCT00022672|155403485|FG000|Main Phase: 24 Months|Failure to Return|1|||
48329109|NCT00022672|155403486|FG001|Main Phase: 24 Months|Failure to Return|1|||
48329110|NCT00022672|155403485|FG000|Main Phase: 24 Months|Other|1|||
48329111|NCT00022672|155403486|FG001|Main Phase: 24 Months|Other|0|||
48329112|NCT00022672|155403485|FG000|Extension Phase|Adverse Event|1|||
48329113|NCT00022672|155403486|FG001|Extension Phase|Adverse Event|3|||
48329114|NCT00022672|155403485|FG000|Extension Phase|Death|0|||
48329115|NCT00022672|155403486|FG001|Extension Phase|Death|1|||
48641745|NCT01881789|156541692|FG000|Overall Study|Other|3|||
48641746|NCT01881789|156541693|FG001|Overall Study|Other|5|||
48641747|NCT01881789|156541694|FG002|Overall Study|Other|2|||
48329116|NCT00022672|155403485|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
48329117|NCT00022672|155403486|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
48329118|NCT00022672|155403485|FG000|Extension Phase|Refused Treatment|0|||
48641748|NCT01881789|156541695|FG003|Overall Study|Other|3|||
48641749|NCT01881789|156541696|FG004|Overall Study|Other|1|||
48641750|NCT01881789|156541697|FG005|Overall Study|Other|1|||
48641751|NCT02961244|156541700|FG000|Overall Study|Protocol Violation|0|||
48641752|NCT02961244|156541701|FG001|Overall Study|Protocol Violation|1|||
48641753|NCT02961244|156541700|FG000|Overall Study|Withdrawal by Subject|1|||
48641754|NCT02961244|156541701|FG001|Overall Study|Withdrawal by Subject|2|||
48641755|NCT02961244|156541700|FG000|Overall Study|Surgery plan change after study approval|0|||
48641756|NCT02961244|156541701|FG001|Overall Study|Surgery plan change after study approval|2|||
48641757|NCT02961244|156541700|FG000|Overall Study|Lost to Follow-up|0|||
48641758|NCT02961244|156541701|FG001|Overall Study|Lost to Follow-up|2|||
48641759|NCT02961244|156541700|FG000|Overall Study|İnadequate data|0|||
48641760|NCT02961244|156541701|FG001|Overall Study|İnadequate data|2|||
48641761|NCT03824392|156541702|FG000|Overall Study|Adverse Event|1|||
48641762|NCT03824392|156541703|FG001|Overall Study|Adverse Event|0|||
48641763|NCT03824392|156541704|FG002|Overall Study|Adverse Event|0|||
48641764|NCT03824392|156541705|FG003|Overall Study|Adverse Event|0|||
48641765|NCT03824392|156541702|FG000|Overall Study|Investigator Decision|0|||
48641766|NCT03824392|156541703|FG001|Overall Study|Investigator Decision|1|||
48641767|NCT03824392|156541704|FG002|Overall Study|Investigator Decision|0|||
48641768|NCT03824392|156541705|FG003|Overall Study|Investigator Decision|0|||
48641769|NCT03824392|156541702|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
48641770|NCT03824392|156541703|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
48641771|NCT03824392|156541704|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
48641772|NCT03824392|156541705|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
48641773|NCT03510273|156541707|FG000|Overall Study|Withdrawal by Subject|2|||
48641774|NCT03510273|156541707|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
48641775|NCT03510273|156541707|FG000|Overall Study|Moved away from study area|4|||
48641776|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
48641777|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
48641778|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
48641779|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Death|0|||
48641780|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Death|0|||
48641781|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Death|1|||
48749064|NCT03129100|156926581|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
48749065|NCT03129100|156926582|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
48749066|NCT02725710|156926583|FG000|Overall Study|Lost to Follow-up|1|||
48749067|NCT02725710|156926584|FG001|Overall Study|Lost to Follow-up|0|||
48749068|NCT00230607|156926591|FG000|Overall Study|Other|3|||
48749069|NCT03667924|156926599|FG000|Baseline Completed|Lost to Follow-up|0|||
48749070|NCT03667924|156926600|FG001|Baseline Completed|Lost to Follow-up|2|||
48749071|NCT03667924|156926601|FG002|Baseline Completed|Lost to Follow-up|0|||
48749072|NCT03667924|156926599|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
48749073|NCT03667924|156926600|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
48749074|NCT03667924|156926601|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
48749075|NCT03667924|156926599|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
48749076|NCT03667924|156926600|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
48749077|NCT03667924|156926601|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
48749078|NCT03667924|156926599|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
48749079|NCT03667924|156926600|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
48749080|NCT03667924|156926601|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
48749081|NCT03667924|156926599|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
48329119|NCT00022672|155403486|FG001|Extension Phase|Refused Treatment|2|||
48329120|NCT00022672|155403485|FG000|Extension Phase|Other|1|||
48329121|NCT00022672|155403486|FG001|Extension Phase|Other|1|||
48329122|NCT02958553|155403487|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
48329123|NCT02958553|155403487|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
48329124|NCT03340961|155403488|FG000|Overall Study|Adverse Event|1|||
48329125|NCT03340961|155403489|FG001|Overall Study|Adverse Event|3|||
48329126|NCT03340961|155403490|FG002|Overall Study|Adverse Event|2|||
48329127|NCT03340961|155403491|FG003|Overall Study|Adverse Event|4|||
48329128|NCT03340961|155403488|FG000|Overall Study|Lost to Follow-up|0|||
48329129|NCT03340961|155403489|FG001|Overall Study|Lost to Follow-up|1|||
48329130|NCT03340961|155403490|FG002|Overall Study|Lost to Follow-up|0|||
48329131|NCT03340961|155403491|FG003|Overall Study|Lost to Follow-up|1|||
48329132|NCT03340961|155403488|FG000|Overall Study|Withdrawal by Subject|3|||
48329133|NCT03340961|155403489|FG001|Overall Study|Withdrawal by Subject|2|||
48329134|NCT03340961|155403490|FG002|Overall Study|Withdrawal by Subject|4|||
48329135|NCT03340961|155403491|FG003|Overall Study|Withdrawal by Subject|7|||
48329136|NCT03340961|155403488|FG000|Overall Study|Use of prohibited treatment|0|||
48329137|NCT03340961|155403489|FG001|Overall Study|Use of prohibited treatment|3|||
48329138|NCT03340961|155403490|FG002|Overall Study|Use of prohibited treatment|2|||
48329139|NCT03340961|155403491|FG003|Overall Study|Use of prohibited treatment|4|||
48641782|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
48641783|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
48641784|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
48641785|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
48641786|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
48641787|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
48641788|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
48641789|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
48641790|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
48641791|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Graft loss|0|||
48641792|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Graft loss|0|||
48641793|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Graft loss|7|||
48641794|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
48641795|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
48641796|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
48641797|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
48641798|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
48641799|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
48641800|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
48641801|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
48641802|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
48641803|NCT00956293|156541708|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
48641804|NCT00956293|156541709|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
48641805|NCT00956293|156541710|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
48641806|NCT00956293|156541708|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
48641807|NCT00956293|156541709|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
48641808|NCT00956293|156541710|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
48329140|NCT03340961|155403488|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
48329141|NCT03340961|155403489|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
48329142|NCT03340961|155403490|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
48641809|NCT00956293|156541708|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
48641810|NCT00956293|156541709|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
48641811|NCT00956293|156541710|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
48641812|NCT00956293|156541708|FG000|Main Period (Randomization)|Adverse Event|0|||
48641813|NCT00956293|156541709|FG001|Main Period (Randomization)|Adverse Event|15|||
48749082|NCT03667924|156926600|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
48749083|NCT03667924|156926601|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
48749084|NCT03667924|156926599|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
48749085|NCT03667924|156926600|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
48749086|NCT03667924|156926601|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
48749087|NCT03667924|156926599|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
48329143|NCT03340961|155403491|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
48329144|NCT03340961|155403488|FG000|Overall Study|Subject developed an exclusion criterion|0|||
48329145|NCT03340961|155403489|FG001|Overall Study|Subject developed an exclusion criterion|1|||
48641814|NCT00956293|156541710|FG002|Main Period (Randomization)|Adverse Event|0|||
48641815|NCT00956293|156541708|FG000|Follow-up Period|Follow-up period was terminated.|20|||
48329146|NCT03340961|155403490|FG002|Overall Study|Subject developed an exclusion criterion|0|||
48641816|NCT00956293|156541709|FG001|Follow-up Period|Follow-up period was terminated.|32|||
48641817|NCT00956293|156541710|FG002|Follow-up Period|Follow-up period was terminated.|0|||
48641818|NCT00800982|156541711|FG000|Overall Study|Lost to Follow-up|1|||
48641819|NCT00800982|156541712|FG001|Overall Study|Lost to Follow-up|2|||
48641820|NCT00800982|156541711|FG000|Overall Study|Withdrawal by Subject|0|||
48641821|NCT00800982|156541712|FG001|Overall Study|Withdrawal by Subject|1|||
48641822|NCT00800982|156541711|FG000|Overall Study|Patient moved out of state|1|||
48641823|NCT00800982|156541712|FG001|Overall Study|Patient moved out of state|0|||
48641824|NCT01824290|156541713|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
48641825|NCT01824290|156541714|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
48641826|NCT01824290|156541715|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
48641827|NCT01824290|156541716|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
48641828|NCT01824290|156541713|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
48641829|NCT01824290|156541714|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
48641830|NCT01824290|156541715|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
48641831|NCT01824290|156541716|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
48641832|NCT01824290|156541713|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
48641833|NCT01824290|156541714|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
48641834|NCT01824290|156541715|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
48641835|NCT01824290|156541716|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
48641836|NCT01824290|156541713|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
48641837|NCT01824290|156541714|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
48641838|NCT01824290|156541715|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
48641839|NCT01824290|156541716|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
48641840|NCT01824290|156541713|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
48641841|NCT01824290|156541714|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
48641842|NCT01824290|156541715|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
48641843|NCT01824290|156541716|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
48641844|NCT01824290|156541713|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
48641845|NCT01824290|156541714|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
48641846|NCT01824290|156541715|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
48641847|NCT01824290|156541716|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
48641848|NCT04419467|156541721|FG000|Overall Study|Not treated with IP|0|||
48641849|NCT04419467|156541722|FG001|Overall Study|Not treated with IP|0|||
48641850|NCT04419467|156541723|FG002|Overall Study|Not treated with IP|2|||
48641851|NCT04419467|156541721|FG000|Overall Study|Adverse Event|0|||
48641852|NCT04419467|156541722|FG001|Overall Study|Adverse Event|2|||
48641853|NCT04419467|156541723|FG002|Overall Study|Adverse Event|0|||
48749088|NCT03667924|156926600|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
48749089|NCT03667924|156926601|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
48641854|NCT04419467|156541721|FG000|Overall Study|Death|1|||
48641855|NCT04419467|156541722|FG001|Overall Study|Death|0|||
48749090|NCT00600483|156926604|FG000|Overall Study|Lost to Follow-up|26|||
48749091|NCT00600483|156926605|FG001|Overall Study|Lost to Follow-up|47|||
48749092|NCT00600483|156926604|FG000|Overall Study|Randomized but not treated|10|||
48749093|NCT00600483|156926605|FG001|Overall Study|Randomized but not treated|0|||
48641856|NCT04419467|156541723|FG002|Overall Study|Death|0|||
48641857|NCT04419467|156541721|FG000|Overall Study|Lost to Follow-up|0|||
48641858|NCT04419467|156541722|FG001|Overall Study|Lost to Follow-up|1|||
48641859|NCT04419467|156541723|FG002|Overall Study|Lost to Follow-up|2|||
48641860|NCT04419467|156541721|FG000|Overall Study|Withdrawal by Subject|0|||
48641861|NCT04419467|156541722|FG001|Overall Study|Withdrawal by Subject|0|||
48749094|NCT01317160|156926606|FG000|Overall Study|Incorrect inclusion|1|||
48641862|NCT04419467|156541723|FG002|Overall Study|Withdrawal by Subject|4|||
48641863|NCT04419467|156541721|FG000|Overall Study|Pandemic related|0|||
48641864|NCT04419467|156541722|FG001|Overall Study|Pandemic related|0|||
48641865|NCT04419467|156541723|FG002|Overall Study|Pandemic related|1|||
48641866|NCT04419467|156541721|FG000|Overall Study|Reason not known|1|||
48641867|NCT04419467|156541722|FG001|Overall Study|Reason not known|0|||
48749095|NCT01317160|156926607|FG001|Overall Study|Incorrect inclusion|1|||
48749096|NCT01317160|156926606|FG000|Overall Study|Lost to Follow-up|3|||
48749097|NCT01317160|156926607|FG001|Overall Study|Lost to Follow-up|3|||
48749098|NCT01317160|156926606|FG000|Overall Study|Withdrawal by Subject|0|||
48749099|NCT01317160|156926607|FG001|Overall Study|Withdrawal by Subject|2|||
48749100|NCT00691015|156928218|FG000|Overall Study|Refused further treatment|1|||
48749101|NCT00062374|156928219|FG000|Overall Study|Not treated|12|||
48749102|NCT00578812|156928220|FG000|Overall Study|Not treated|6|||
48749103|NCT00578812|156928221|FG001|Overall Study|Not treated|7|||
48749104|NCT04532164|156928224|FG000|Overall Study|Adverse Event|1|||
48749105|NCT04532164|156928224|FG000|Overall Study|Protocol Violation|5|||
48749106|NCT04532164|156928224|FG000|Overall Study|Lost to Follow-up|1|||
48749107|NCT04532164|156928224|FG000|Overall Study|Found to be Ineligible|3|||
48749108|NCT04532164|156928224|FG000|Overall Study|Withdrawal by Subject|14|||
48749109|NCT02599129|156928225|FG000|Overall Study|Lack of Efficacy|2|||
48749110|NCT02599129|156928226|FG001|Overall Study|Lack of Efficacy|2|||
48749111|NCT02599129|156928225|FG000|Overall Study|Lost to Follow-up|1|||
48749112|NCT02599129|156928226|FG001|Overall Study|Lost to Follow-up|0|||
48749113|NCT02599129|156928225|FG000|Overall Study|Withdrawal by Subject|2|||
48749114|NCT02599129|156928226|FG001|Overall Study|Withdrawal by Subject|1|||
48749115|NCT01599234|156928228|FG000|Overall Study|Adverse Event|9|||
48749116|NCT01599234|156928229|FG001|Overall Study|Adverse Event|5|||
48641868|NCT04419467|156541723|FG002|Overall Study|Reason not known|0|||
48749117|NCT01599234|156928228|FG000|Overall Study|Withdrawal by Subject|2|||
48749118|NCT01599234|156928229|FG001|Overall Study|Withdrawal by Subject|1|||
48749119|NCT01599234|156928228|FG000|Overall Study|Lost to Follow-up|1|||
48749120|NCT01599234|156928229|FG001|Overall Study|Lost to Follow-up|2|||
48749121|NCT01599234|156928228|FG000|Overall Study|Lack of Efficacy|2|||
48329147|NCT03340961|155403491|FG003|Overall Study|Subject developed an exclusion criterion|0|||
48329148|NCT03340961|155403488|FG000|Overall Study|Protocol Violation|1|||
48329149|NCT03340961|155403489|FG001|Overall Study|Protocol Violation|0|||
48329150|NCT03340961|155403490|FG002|Overall Study|Protocol Violation|1|||
48329151|NCT03340961|155403491|FG003|Overall Study|Protocol Violation|0|||
48329152|NCT03340961|155403488|FG000|Overall Study|Adverse Event|1|||
48329153|NCT03340961|155403489|FG001|Overall Study|Adverse Event|1|||
48329154|NCT03340961|155403490|FG002|Overall Study|Adverse Event|0|||
48329155|NCT03340961|155403491|FG003|Overall Study|Adverse Event|0|||
48329156|NCT03340961|155403488|FG000|Overall Study|Lack of Efficacy|0|||
48329157|NCT03340961|155403489|FG001|Overall Study|Lack of Efficacy|0|||
48329158|NCT03340961|155403490|FG002|Overall Study|Lack of Efficacy|0|||
48329159|NCT03340961|155403491|FG003|Overall Study|Lack of Efficacy|1|||
48329160|NCT01951703|155403495|FG000|First Intervention|Withdrawal by Subject|1|||
48329161|NCT01951703|155403496|FG001|First Intervention|Withdrawal by Subject|0|||
48329162|NCT01951703|155403495|FG000|First Intervention|Subject was not compliant|1|||
48329163|NCT01951703|155403496|FG001|First Intervention|Subject was not compliant|1|||
48329164|NCT01951703|155403495|FG000|First Intervention|Physician Decision|1|||
48329165|NCT01951703|155403496|FG001|First Intervention|Physician Decision|0|||
48329166|NCT01951703|155403495|FG000|Second Intervention|Protocol Violation|0|||
48329167|NCT01951703|155403496|FG001|Second Intervention|Protocol Violation|1|||
48329168|NCT01951703|155403495|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
48329169|NCT01951703|155403496|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
48329170|NCT01852045|155403497|FG000|Overall Study|Adverse Event|1|||
48329171|NCT01852045|155403498|FG001|Overall Study|Adverse Event|0|||
48329172|NCT01852045|155403499|FG002|Overall Study|Adverse Event|0|||
48329173|NCT01852045|155403497|FG000|Overall Study|Lack of Efficacy|3|||
48329174|NCT01852045|155403498|FG001|Overall Study|Lack of Efficacy|0|||
48329175|NCT01852045|155403499|FG002|Overall Study|Lack of Efficacy|0|||
48329176|NCT01852045|155403497|FG000|Overall Study|Lost to Follow-up|0|||
48329177|NCT01852045|155403498|FG001|Overall Study|Lost to Follow-up|1|||
48329178|NCT01852045|155403499|FG002|Overall Study|Lost to Follow-up|1|||
48329179|NCT01852045|155403497|FG000|Overall Study|Withdrawal by Subject|1|||
48329180|NCT01852045|155403498|FG001|Overall Study|Withdrawal by Subject|0|||
48329181|NCT01852045|155403499|FG002|Overall Study|Withdrawal by Subject|1|||
48329182|NCT01852045|155403497|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48329183|NCT01852045|155403498|FG001|Overall Study|Other Miscellaneous Reasons|3|||
48329184|NCT01852045|155403499|FG002|Overall Study|Other Miscellaneous Reasons|2|||
48329185|NCT00620854|155403500|FG000|Washout 1|Withdrawal by Subject|0|||
48329186|NCT00620854|155403501|FG001|Washout 1|Withdrawal by Subject|0|||
48329187|NCT00620854|155403502|FG002|Washout 1|Withdrawal by Subject|1|||
48329188|NCT00620854|155403503|FG003|Washout 1|Withdrawal by Subject|1|||
48329189|NCT00620854|155403504|FG004|Washout 1|Withdrawal by Subject|0|||
48329190|NCT00620854|155403505|FG005|Washout 1|Withdrawal by Subject|0|||
48329191|NCT03137784|155403506|FG000|Overall Study|Adverse Event|1|||
48329192|NCT03137784|155403507|FG001|Overall Study|Adverse Event|1|||
48329193|NCT03137784|155403508|FG002|Overall Study|Adverse Event|0|||
48641869|NCT03606486|156541733|FG000|Overall Study|Unable to collect sample|5|||
48641870|NCT01544348|156541736|FG000|Overall Study|Lost to Follow-up|1|||
48641871|NCT01544348|156541737|FG001|Overall Study|Lost to Follow-up|0|||
48329194|NCT03137784|155403509|FG003|Overall Study|Adverse Event|0|||
48329195|NCT03137784|155403510|FG004|Overall Study|Adverse Event|0|||
48329196|NCT03137784|155403511|FG005|Overall Study|Adverse Event|0|||
48329197|NCT03137784|155403506|FG000|Overall Study|Subject/guardian decision|1|||
48329198|NCT03137784|155403507|FG001|Overall Study|Subject/guardian decision|0|||
48329199|NCT03137784|155403508|FG002|Overall Study|Subject/guardian decision|0|||
48329200|NCT03137784|155403509|FG003|Overall Study|Subject/guardian decision|0|||
48329201|NCT03137784|155403510|FG004|Overall Study|Subject/guardian decision|0|||
48329202|NCT03137784|155403511|FG005|Overall Study|Subject/guardian decision|0|||
48329203|NCT03137784|155403506|FG000|Overall Study|Non-compliance with study treatment|0|||
48329204|NCT03137784|155403507|FG001|Overall Study|Non-compliance with study treatment|0|||
48329205|NCT03137784|155403508|FG002|Overall Study|Non-compliance with study treatment|0|||
48641872|NCT01544348|156541738|FG002|Overall Study|Lost to Follow-up|0|||
48329206|NCT03137784|155403509|FG003|Overall Study|Non-compliance with study treatment|0|||
48329207|NCT03137784|155403510|FG004|Overall Study|Non-compliance with study treatment|1|||
48329208|NCT03137784|155403511|FG005|Overall Study|Non-compliance with study treatment|0|||
48329209|NCT01698918|155403514|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
48329210|NCT01698918|155403514|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
48329211|NCT01698918|155403514|FG000|First Line Treatment (Core+Extension)|Death|2|||
48329212|NCT01698918|155403514|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
48329213|NCT01698918|155403514|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
48329214|NCT01698918|155403514|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
48329215|NCT01698918|155403514|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
48329216|NCT01698918|155403514|FG000|Second Line Treatment (Core+Extension)|Death|1|||
48329217|NCT01698918|155403514|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
48641873|NCT01544348|156541739|FG003|Overall Study|Lost to Follow-up|0|||
48329218|NCT01698918|155403514|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
48329219|NCT03176407|155403516|FG000|Overall Study|Protocol Violation|1|||
48329220|NCT03176407|155403516|FG000|Overall Study|human failure|1|||
48329221|NCT03176407|155403516|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
48329222|NCT03142932|155403517|FG000|Overall Study|Lost to Follow-up|2|||
48329223|NCT03142932|155403518|FG001|Overall Study|Lost to Follow-up|11|||
48329224|NCT03374254|155403519|FG000|Overall Study|Death|5|||
48329225|NCT03374254|155403520|FG001|Overall Study|Death|16|||
48329226|NCT03374254|155403521|FG002|Overall Study|Death|13|||
48329227|NCT03374254|155403522|FG003|Overall Study|Death|11|||
48329228|NCT03374254|155403523|FG004|Overall Study|Death|9|||
48329229|NCT03374254|155403524|FG005|Overall Study|Death|12|||
48329230|NCT03374254|155403525|FG006|Overall Study|Death|11|||
48329231|NCT03374254|155403526|FG007|Overall Study|Death|6|||
48329232|NCT03374254|155403527|FG008|Overall Study|Death|7|||
48329233|NCT03374254|155403519|FG000|Overall Study|Lost to Follow-up|0|||
48329234|NCT03374254|155403520|FG001|Overall Study|Lost to Follow-up|0|||
48329235|NCT03374254|155403521|FG002|Overall Study|Lost to Follow-up|0|||
48329236|NCT03374254|155403522|FG003|Overall Study|Lost to Follow-up|0|||
48329237|NCT03374254|155403523|FG004|Overall Study|Lost to Follow-up|0|||
48329238|NCT03374254|155403524|FG005|Overall Study|Lost to Follow-up|0|||
48329239|NCT03374254|155403525|FG006|Overall Study|Lost to Follow-up|2|||
48329240|NCT03374254|155403526|FG007|Overall Study|Lost to Follow-up|0|||
48329241|NCT03374254|155403527|FG008|Overall Study|Lost to Follow-up|0|||
48329242|NCT03374254|155403519|FG000|Overall Study|Sponsor Decision|1|||
48329243|NCT03374254|155403520|FG001|Overall Study|Sponsor Decision|0|||
48329244|NCT03374254|155403521|FG002|Overall Study|Sponsor Decision|2|||
48329245|NCT03374254|155403522|FG003|Overall Study|Sponsor Decision|3|||
48329246|NCT03374254|155403523|FG004|Overall Study|Sponsor Decision|2|||
48329247|NCT03374254|155403524|FG005|Overall Study|Sponsor Decision|3|||
48329248|NCT03374254|155403525|FG006|Overall Study|Sponsor Decision|3|||
48329249|NCT03374254|155403526|FG007|Overall Study|Sponsor Decision|3|||
48329250|NCT03374254|155403527|FG008|Overall Study|Sponsor Decision|4|||
48329251|NCT03374254|155403519|FG000|Overall Study|Withdrawal by Subject|0|||
48329252|NCT03374254|155403520|FG001|Overall Study|Withdrawal by Subject|0|||
48329253|NCT03374254|155403521|FG002|Overall Study|Withdrawal by Subject|0|||
48329254|NCT03374254|155403522|FG003|Overall Study|Withdrawal by Subject|2|||
48329255|NCT03374254|155403523|FG004|Overall Study|Withdrawal by Subject|0|||
48329256|NCT03374254|155403524|FG005|Overall Study|Withdrawal by Subject|1|||
48329257|NCT03374254|155403525|FG006|Overall Study|Withdrawal by Subject|0|||
48329258|NCT03374254|155403526|FG007|Overall Study|Withdrawal by Subject|0|||
48329259|NCT03374254|155403527|FG008|Overall Study|Withdrawal by Subject|0|||
48329260|NCT04070105|155403528|FG000|Overall Study|Lost to Follow-up|0|||
48329261|NCT04070105|155403529|FG001|Overall Study|Lost to Follow-up|0|||
48329262|NCT04070105|155403530|FG002|Overall Study|Lost to Follow-up|0|||
48329263|NCT04070105|155403531|FG003|Overall Study|Lost to Follow-up|0|||
48329264|NCT04070105|155403532|FG004|Overall Study|Lost to Follow-up|0|||
48329265|NCT04070105|155403533|FG005|Overall Study|Lost to Follow-up|1|||
48329266|NCT03184987|155403534|FG000|Overall Study|Withdrawal by Subject|0|||
48329267|NCT03184987|155403535|FG001|Overall Study|Withdrawal by Subject|1|||
48329268|NCT03184987|155403536|FG002|Overall Study|Withdrawal by Subject|2|||
48329269|NCT03184987|155403534|FG000|Overall Study|Physician Decision|0|||
48641874|NCT01544348|156541740|FG004|Overall Study|Lost to Follow-up|0|||
48641875|NCT01544348|156541741|FG005|Overall Study|Lost to Follow-up|0|||
48329270|NCT03184987|155403535|FG001|Overall Study|Physician Decision|0|||
48641876|NCT01544348|156541742|FG006|Overall Study|Lost to Follow-up|1|||
48329271|NCT03184987|155403536|FG002|Overall Study|Physician Decision|1|||
48329272|NCT03184987|155403534|FG000|Overall Study|Adverse Event|1|||
48329273|NCT03184987|155403535|FG001|Overall Study|Adverse Event|0|||
48329274|NCT03184987|155403536|FG002|Overall Study|Adverse Event|1|||
48329275|NCT02040870|155403537|FG000|Overall Study|Completed treatment phase|6|||
48641877|NCT01544348|156541743|FG007|Overall Study|Lost to Follow-up|0|||
48641878|NCT01544348|156541736|FG000|Overall Study|Withdrawal by Subject|1|||
48329276|NCT02040870|155403537|FG000|Overall Study|Adverse Event|7|||
48329277|NCT02040870|155403537|FG000|Overall Study|Progressive disease|58|||
48329278|NCT02040870|155403537|FG000|Overall Study|Physician Decision|6|||
48329279|NCT02040870|155403537|FG000|Overall Study|Subject/guardian decision|10|||
48329280|NCT02040870|155403537|FG000|Overall Study|Lost to Follow-up|3|||
48329281|NCT02040870|155403537|FG000|Overall Study|Death|13|||
48641879|NCT01544348|156541737|FG001|Overall Study|Withdrawal by Subject|0|||
48329282|NCT03131713|155403538|FG000|Overall Study|Lost to Follow-up|5|||
48329283|NCT03131713|155403539|FG001|Overall Study|Lost to Follow-up|0|||
48329284|NCT00701415|155403540|FG000|Overall Study|Adverse Event|0|||
48329285|NCT00701415|155403541|FG001|Overall Study|Adverse Event|1|||
48329286|NCT00701415|155403540|FG000|Overall Study|Social/family issues and needle phobia|1|||
48329287|NCT00701415|155403541|FG001|Overall Study|Social/family issues and needle phobia|0|||
48329288|NCT02208843|155403542|FG000|Overall Study|Clinical symptoms of progression|2|||
48329289|NCT02208843|155403542|FG000|Overall Study|Progression disease according to RECIST|24|||
48329290|NCT02208843|155403542|FG000|Overall Study|Adverse Event|12|||
48749122|NCT01599234|156928229|FG001|Overall Study|Lack of Efficacy|4|||
48749123|NCT01599234|156928228|FG000|Overall Study|Unable to operate spray|1|||
48749124|NCT01599234|156928229|FG001|Overall Study|Unable to operate spray|0|||
48749125|NCT01599234|156928228|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
48749126|NCT01599234|156928229|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
48749127|NCT01599234|156928228|FG000|Overall Study|Death|1|||
48749128|NCT01599234|156928229|FG001|Overall Study|Death|0|||
48749129|NCT01599234|156928228|FG000|Overall Study|Patient would not stop driving|1|||
48749130|NCT01599234|156928229|FG001|Overall Study|Patient would not stop driving|0|||
48749131|NCT01599234|156928228|FG000|Overall Study|Contra-indication discovered|0|||
48749132|NCT01599234|156928229|FG001|Overall Study|Contra-indication discovered|1|||
48749133|NCT01599234|156928228|FG000|Overall Study|Pregnancy|0|||
48749134|NCT01599234|156928229|FG001|Overall Study|Pregnancy|1|||
48641880|NCT01544348|156541738|FG002|Overall Study|Withdrawal by Subject|0|||
48641881|NCT01544348|156541739|FG003|Overall Study|Withdrawal by Subject|0|||
48641882|NCT01544348|156541740|FG004|Overall Study|Withdrawal by Subject|1|||
48641883|NCT01544348|156541741|FG005|Overall Study|Withdrawal by Subject|2|||
48641884|NCT01544348|156541742|FG006|Overall Study|Withdrawal by Subject|1|||
48641885|NCT01544348|156541743|FG007|Overall Study|Withdrawal by Subject|0|||
48641886|NCT01544348|156541736|FG000|Overall Study|Physician Decision|0|||
48641887|NCT01544348|156541737|FG001|Overall Study|Physician Decision|0|||
48641888|NCT01544348|156541738|FG002|Overall Study|Physician Decision|0|||
48749135|NCT01401283|156928230|FG000|Overall Study|surgery cancelled|5|||
48749136|NCT01401283|156928231|FG001|Overall Study|surgery cancelled|8|||
48749137|NCT01401283|156928230|FG000|Overall Study|preoperative arrhythmia|5|||
48749138|NCT01401283|156928231|FG001|Overall Study|preoperative arrhythmia|0|||
48749139|NCT01401283|156928230|FG000|Overall Study|no central venous access|0|||
48749140|NCT01401283|156928231|FG001|Overall Study|no central venous access|1|||
48749141|NCT01401283|156928230|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
48749142|NCT01401283|156928231|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
48749143|NCT02433483|156928232|FG000|Overall Study|Unacceptable toxicity|1|||
48641889|NCT01544348|156541739|FG003|Overall Study|Physician Decision|0|||
48641890|NCT01544348|156541740|FG004|Overall Study|Physician Decision|0|||
48641891|NCT01544348|156541741|FG005|Overall Study|Physician Decision|1|||
48749144|NCT02433483|156928232|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
48749145|NCT05035550|156928233|FG000|Overall Study|Withdrawal by Subject|3|||
48749146|NCT05035550|156928234|FG001|Overall Study|Withdrawal by Subject|0|||
48749147|NCT01508650|156928236|FG000|Overall Study|Lost to Follow-up|0|||
48749148|NCT01508650|156928237|FG001|Overall Study|Lost to Follow-up|3|||
48329291|NCT02208843|155403542|FG000|Overall Study|Protocol Violation|1|||
48329292|NCT02208843|155403542|FG000|Overall Study|Withdrawal by Subject|1|||
48329293|NCT02208843|155403542|FG000|Overall Study|Switched to commercial afatinib|20|||
48329294|NCT01794299|155403547|FG000|Overall Study|ATIR manufacturing not possible|1|||
48329295|NCT01794299|155403547|FG000|Overall Study|Death|14|||
48329296|NCT01794299|155403547|FG000|Overall Study|Graft failure|1|||
48329297|NCT01794299|155403547|FG000|Overall Study|ATIR batch rejected|2|||
48641892|NCT01544348|156541742|FG006|Overall Study|Physician Decision|0|||
48641893|NCT01544348|156541743|FG007|Overall Study|Physician Decision|0|||
48641894|NCT01985022|156541744|FG000|Overall Study|Lost to Follow-up|0|||
48641895|NCT01985022|156541745|FG001|Overall Study|Lost to Follow-up|1|||
48641896|NCT01985022|156541744|FG000|Overall Study|Protocol Violation|0|||
48641897|NCT01985022|156541745|FG001|Overall Study|Protocol Violation|1|||
48641898|NCT01985022|156541744|FG000|Overall Study|Withdrawal by Subject|4|||
48641899|NCT01985022|156541745|FG001|Overall Study|Withdrawal by Subject|1|||
48641900|NCT01740687|156541746|FG000|Overall Study|Lost to Follow-up|11|||
48641901|NCT01740687|156541746|FG000|Overall Study|Withdrawal by Subject|2|||
48641902|NCT01740687|156541746|FG000|Overall Study|other reason|22|||
48641903|NCT01740687|156541746|FG000|Overall Study|treatment not received|2|||
48641904|NCT03654274|156541754|FG000|Overall Study|Adverse Event|19|||
48641905|NCT03654274|156541755|FG001|Overall Study|Adverse Event|23|||
48641906|NCT03654274|156541756|FG002|Overall Study|Adverse Event|24|||
48641907|NCT03654274|156541754|FG000|Overall Study|Protocol Deviation|0|||
48641908|NCT03654274|156541755|FG001|Overall Study|Protocol Deviation|2|||
48641909|NCT03654274|156541756|FG002|Overall Study|Protocol Deviation|0|||
48641910|NCT03654274|156541754|FG000|Overall Study|Lost to Follow-up|8|||
48641911|NCT03654274|156541755|FG001|Overall Study|Lost to Follow-up|6|||
48749149|NCT02692703|156928238|FG000|Overall Study|Lost to Follow-up|1|||
48641912|NCT03654274|156541756|FG002|Overall Study|Lost to Follow-up|5|||
48749150|NCT02692703|156928238|FG000|Overall Study|Other|1|||
48749151|NCT03521934|156928239|FG000|Overall Study|Death|65|||
48329298|NCT01794299|155403547|FG000|Overall Study|Relapse|2|||
48641913|NCT03654274|156541754|FG000|Overall Study|Withdrawal by Subject|46|||
48641914|NCT03654274|156541755|FG001|Overall Study|Withdrawal by Subject|25|||
48641915|NCT03654274|156541756|FG002|Overall Study|Withdrawal by Subject|33|||
48641916|NCT03654274|156541754|FG000|Overall Study|Lack of Efficacy|4|||
48641917|NCT03654274|156541755|FG001|Overall Study|Lack of Efficacy|5|||
48641918|NCT03654274|156541756|FG002|Overall Study|Lack of Efficacy|7|||
48641919|NCT03654274|156541754|FG000|Overall Study|Pregnancy|2|||
48749152|NCT03521934|156928240|FG001|Overall Study|Death|73|||
48749153|NCT03521934|156928239|FG000|Overall Study|Withdrawal by Subject|18|||
48749154|NCT03521934|156928240|FG001|Overall Study|Withdrawal by Subject|23|||
48749155|NCT03521934|156928239|FG000|Overall Study|Site Terminated by Sponsor|39|||
48749156|NCT03521934|156928240|FG001|Overall Study|Site Terminated by Sponsor|35|||
48749157|NCT03521934|156928239|FG000|Overall Study|Study Terminated by Sponsor|483|||
48749158|NCT03521934|156928240|FG001|Overall Study|Study Terminated by Sponsor|477|||
48749159|NCT03521934|156928239|FG000|Overall Study|Reason not Specified|3|||
48749160|NCT03521934|156928240|FG001|Overall Study|Reason not Specified|6|||
48749161|NCT05048784|156928241|FG000|Period 1|Adverse Event|3|||
48749162|NCT05048784|156928242|FG001|Period 1|Adverse Event|1|||
48749163|NCT05048784|156928243|FG002|Period 1|Adverse Event|0|||
48749164|NCT05048784|156928244|FG003|Period 1|Adverse Event|0|||
48749165|NCT05048784|156928241|FG000|Period 2|Lost to Follow-up|0|||
48749166|NCT05048784|156928242|FG001|Period 2|Lost to Follow-up|1|||
48749167|NCT05048784|156928243|FG002|Period 2|Lost to Follow-up|0|||
48749168|NCT05048784|156928244|FG003|Period 2|Lost to Follow-up|0|||
48749169|NCT02101060|156928245|FG000|Overall Study|Adverse Event|1|||
48749170|NCT02101060|156928246|FG001|Overall Study|Adverse Event|0|||
48749171|NCT02101060|156928245|FG000|Overall Study|Withdrawal by Subject|1|||
48749172|NCT02101060|156928246|FG001|Overall Study|Withdrawal by Subject|1|||
48749173|NCT02101060|156928245|FG000|Overall Study|Lost to Follow-up|3|||
48749174|NCT02101060|156928246|FG001|Overall Study|Lost to Follow-up|3|||
48749175|NCT03519932|156928247|FG000|First Intervention|Adverse Event|1|||
48749176|NCT03519932|156928248|FG001|First Intervention|Adverse Event|3|||
48749177|NCT02269241|156928249|FG000|Overall Study|Lost to Follow-up|269|||
48749178|NCT02269241|156928249|FG000|Overall Study|Withdrawal by Subject|155|||
48749179|NCT02269241|156928249|FG000|Overall Study|Protocol Violation|1|||
48749180|NCT02269241|156928249|FG000|Overall Study|Physician Decision|7|||
48749181|NCT02269241|156928249|FG000|Overall Study|Pregnancy|15|||
48749182|NCT02269241|156928249|FG000|Overall Study|Wish for pregnancy|5|||
48749183|NCT02269241|156928249|FG000|Overall Study|Development of an exclusion criteria|16|||
48749184|NCT02269241|156928249|FG000|Overall Study|Adverse Event|113|||
48749185|NCT02269241|156928249|FG000|Overall Study|At the specific request of the sponsor|20|||
48749186|NCT02269241|156928249|FG000|Overall Study|Several reasons not classified|53|||
48749187|NCT02269241|156928249|FG000|Overall Study|Screening failures|546|||
48749188|NCT01513473|156928250|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
48641920|NCT03654274|156541755|FG001|Overall Study|Pregnancy|2|||
48641921|NCT03654274|156541756|FG002|Overall Study|Pregnancy|1|||
48641922|NCT03654274|156541754|FG000|Overall Study|Other|27|||
48641923|NCT03654274|156541755|FG001|Overall Study|Other|29|||
48641924|NCT03654274|156541756|FG002|Overall Study|Other|32|||
48641925|NCT03654274|156541754|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
48641926|NCT03654274|156541755|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
48641927|NCT03654274|156541756|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
48692708|NCT04908683|156724585|FG001|Overall Study|Initiated prohibited medication|0|||
48692709|NCT04908683|156724584|FG000|Overall Study|Randomized by mistake|1|||
48692710|NCT04908683|156724585|FG001|Overall Study|Randomized by mistake|0|||
48692711|NCT04908683|156724584|FG000|Overall Study|Lost to Follow-up|679|||
48692712|NCT04908683|156724585|FG001|Overall Study|Lost to Follow-up|341|||
48692713|NCT04908683|156724584|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
48692714|NCT04908683|156724585|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
48692715|NCT04908683|156724584|FG000|Overall Study|Physician Decision|44|||
48692716|NCT04908683|156724585|FG001|Overall Study|Physician Decision|35|||
48692717|NCT04908683|156724584|FG000|Overall Study|Technical problems|12|||
48692718|NCT04908683|156724585|FG001|Overall Study|Technical problems|9|||
48692719|NCT04908683|156724584|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
48692720|NCT04908683|156724585|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
48692721|NCT04908683|156724584|FG000|Overall Study|Protocol Violation|2|||
48692722|NCT04908683|156724585|FG001|Overall Study|Protocol Violation|0|||
48749189|NCT01513473|156928251|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
48749190|NCT01513473|156928250|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
48749191|NCT01513473|156928251|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
48749192|NCT01513473|156928250|FG000|Main Trial (26 Weeks)|Unclassified|0|||
48749193|NCT01513473|156928251|FG001|Main Trial (26 Weeks)|Unclassified|2|||
48749194|NCT01513473|156928250|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
48749195|NCT01513473|156928251|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
48749196|NCT01513473|156928250|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
48749197|NCT01513473|156928251|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
48692723|NCT04908683|156724584|FG000|Overall Study|Withdrawal by Subject|1188|||
48692724|NCT04908683|156724585|FG001|Overall Study|Withdrawal by Subject|570|||
48692725|NCT04908683|156724584|FG000|Overall Study|Site Closure by Sponsor|6|||
48749198|NCT01350414|156928258|FG000|Overall Study|Lost to Follow-up|13|||
48329299|NCT01794299|155403547|FG000|Overall Study|Discontinued from active follow-up|1|||
48329300|NCT01794299|155403547|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
48329301|NCT01228734|155403548|FG000|Overall Study|Randomized, but not treated|0|||
48329302|NCT01228734|155403549|FG001|Overall Study|Randomized, but not treated|4|||
48329303|NCT03128099|155403552|FG000|Overall Study|High dose task was too long|0|||
48329304|NCT03128099|155403553|FG001|Overall Study|High dose task was too long|4|||
48329305|NCT03128099|155403554|FG002|Overall Study|High dose task was too long|0|||
48329306|NCT03128099|155403552|FG000|Overall Study|Participant got a full time job.|1|||
48329307|NCT03128099|155403553|FG001|Overall Study|Participant got a full time job.|0|||
48329308|NCT03128099|155403554|FG002|Overall Study|Participant got a full time job.|0|||
48329309|NCT03128099|155403552|FG000|Overall Study|Became homeless and lost contact|1|||
48329310|NCT03128099|155403553|FG001|Overall Study|Became homeless and lost contact|0|||
48329311|NCT03128099|155403554|FG002|Overall Study|Became homeless and lost contact|0|||
48329312|NCT03128099|155403552|FG000|Overall Study|Did not complete all the assessments|0|||
48329313|NCT03128099|155403553|FG001|Overall Study|Did not complete all the assessments|0|||
48329314|NCT03128099|155403554|FG002|Overall Study|Did not complete all the assessments|1|||
48329315|NCT03335488|155403555|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
48329316|NCT03335488|155403556|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
48329317|NCT03335488|155403555|FG000|Safety Extension Period|Adverse Event|1|||
48329318|NCT03335488|155403556|FG001|Safety Extension Period|Adverse Event|0|||
48329319|NCT03335488|155403555|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
48329320|NCT03335488|155403556|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
48329321|NCT03456856|155403559|FG000|Overall Study|Lost to Follow-up|2|||
48329322|NCT03456856|155403559|FG000|Overall Study|Withdrawal by Subject|1|||
48329323|NCT00388726|155403560|FG000|Overall Study|Adverse Event|50|||
48329324|NCT00388726|155403561|FG001|Overall Study|Adverse Event|24|||
48329325|NCT00388726|155403560|FG000|Overall Study|Progressive Disease|336|||
48329326|NCT00388726|155403561|FG001|Overall Study|Progressive Disease|153|||
48329327|NCT00388726|155403560|FG000|Overall Study|Clinical Progression|61|||
48329328|NCT00388726|155403561|FG001|Overall Study|Clinical Progression|36|||
48329329|NCT00388726|155403560|FG000|Overall Study|Withdrawal by Subject|10|||
48329330|NCT00388726|155403561|FG001|Overall Study|Withdrawal by Subject|7|||
48329331|NCT00388726|155403560|FG000|Overall Study|Administrative|6|||
48329332|NCT00388726|155403561|FG001|Overall Study|Administrative|9|||
48329333|NCT00388726|155403560|FG000|Overall Study|Physician Decision|18|||
48329334|NCT00388726|155403561|FG001|Overall Study|Physician Decision|13|||
48329335|NCT00388726|155403560|FG000|Overall Study|Death|3|||
48329336|NCT00388726|155403561|FG001|Overall Study|Death|2|||
48329337|NCT01584648|155403562|FG000|Overall Study|Death|136|||
48329338|NCT01584648|155403563|FG001|Overall Study|Death|146|||
48329339|NCT01584648|155403562|FG000|Overall Study|Lost to Follow-up|9|||
48329340|NCT01584648|155403563|FG001|Overall Study|Lost to Follow-up|9|||
48329341|NCT01584648|155403562|FG000|Overall Study|Investigator discretion|3|||
48329342|NCT01584648|155403563|FG001|Overall Study|Investigator discretion|2|||
48329343|NCT01584648|155403562|FG000|Overall Study|Withdrew consent|13|||
48329344|NCT01584648|155403563|FG001|Overall Study|Withdrew consent|4|||
48329345|NCT01584648|155403562|FG000|Overall Study|Study closed/terminated|50|||
48329346|NCT01584648|155403563|FG001|Overall Study|Study closed/terminated|23|||
48641928|NCT01977898|156542997|FG000|Overall Study|Non functioning catheter|1|||
48641929|NCT01977898|156542998|FG001|Overall Study|Non functioning catheter|1|||
48641930|NCT00980148|156543000|FG000|Overall Study|Discharged from facility|89|||
48641931|NCT00980148|156543001|FG001|Overall Study|Discharged from facility|96|||
48641932|NCT00980148|156543000|FG000|Overall Study|Received other antichlamydia treatment|20|||
48641933|NCT00980148|156543001|FG001|Overall Study|Received other antichlamydia treatment|14|||
48641934|NCT00980148|156543000|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
48641935|NCT00980148|156543001|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
48641936|NCT00980148|156543000|FG000|Overall Study|Various other reasons|8|||
48641937|NCT00980148|156543001|FG001|Overall Study|Various other reasons|9|||
48641938|NCT02973997|156543002|FG000|Overall Study|Withdrawal by Subject|4|||
48641939|NCT02973997|156543003|FG001|Overall Study|Withdrawal by Subject|0|||
48641940|NCT02973997|156543002|FG000|Overall Study|Adverse Event|4|||
48641941|NCT02973997|156543003|FG001|Overall Study|Adverse Event|1|||
48641942|NCT02973997|156543002|FG000|Overall Study|Disease Progression|11|||
48641943|NCT02973997|156543003|FG001|Overall Study|Disease Progression|20|||
48329347|NCT01584648|155403562|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
48329348|NCT01584648|155403563|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
48329349|NCT03162614|155403564|FG000|Overall Study|Lost to Follow-up|2|||
48641944|NCT02973997|156543002|FG000|Overall Study|Alternative Therapy|3|||
48329350|NCT03162614|155403565|FG001|Overall Study|Lost to Follow-up|1|||
48329351|NCT03162614|155403566|FG002|Overall Study|Lost to Follow-up|1|||
48329352|NCT03162614|155403567|FG003|Overall Study|Lost to Follow-up|1|||
48329353|NCT03162614|155403568|FG004|Overall Study|Lost to Follow-up|2|||
48329354|NCT03162614|155403569|FG005|Overall Study|Lost to Follow-up|0|||
48329355|NCT03162614|155403564|FG000|Overall Study|Protocol Violation|0|||
48641945|NCT02973997|156543003|FG001|Overall Study|Alternative Therapy|0|||
48641946|NCT02973997|156543002|FG000|Overall Study|Other complicating disease|0|||
48641947|NCT02973997|156543003|FG001|Overall Study|Other complicating disease|1|||
48641948|NCT02973997|156543002|FG000|Overall Study|Death|0|||
48641949|NCT02973997|156543003|FG001|Overall Study|Death|1|||
48641950|NCT03341637|156543006|FG000|Overall Study|Lost to Follow-up|1|||
48641951|NCT03341637|156543007|FG001|Overall Study|Lost to Follow-up|0|||
48641952|NCT03341637|156543006|FG000|Overall Study|Withdrawal by Subject|3|||
48641953|NCT03341637|156543007|FG001|Overall Study|Withdrawal by Subject|3|||
48641954|NCT03341637|156543006|FG000|Overall Study|Reason not Specified|1|||
48641955|NCT03341637|156543007|FG001|Overall Study|Reason not Specified|1|||
48641956|NCT00925002|156543008|FG000|Overall Study|Other|1|||
48641957|NCT00925002|156543009|FG001|Overall Study|Other|4|||
48641958|NCT00925002|156543010|FG002|Overall Study|Other|0|||
48641959|NCT00925002|156543008|FG000|Overall Study|Death|1|||
48641960|NCT00925002|156543009|FG001|Overall Study|Death|1|||
48641961|NCT00925002|156543010|FG002|Overall Study|Death|5|||
48641962|NCT00925002|156543008|FG000|Overall Study|Adverse Event|3|||
48641963|NCT00925002|156543009|FG001|Overall Study|Adverse Event|1|||
48641964|NCT00925002|156543010|FG002|Overall Study|Adverse Event|2|||
48641965|NCT00925002|156543008|FG000|Overall Study|Participant withdrew consent|1|||
48641966|NCT00925002|156543009|FG001|Overall Study|Participant withdrew consent|3|||
48641967|NCT00925002|156543010|FG002|Overall Study|Participant withdrew consent|3|||
48641968|NCT02808897|156543011|FG000|Overall Study|Lost to Follow-up|9|||
48641969|NCT02808897|156543012|FG001|Overall Study|Lost to Follow-up|11|||
48641970|NCT03443687|156543016|FG000|Overall Study|Lost to Follow-up|3|||
48641971|NCT03443687|156543017|FG001|Overall Study|Lost to Follow-up|5|||
48641972|NCT03443687|156543016|FG000|Overall Study|Withdrawal by Subject|1|||
48641973|NCT03443687|156543017|FG001|Overall Study|Withdrawal by Subject|0|||
48641974|NCT03443687|156543016|FG000|Overall Study|Discontinued intervention|1|||
48641975|NCT03443687|156543017|FG001|Overall Study|Discontinued intervention|1|||
48641976|NCT04460183|156543018|FG000|Overall Study|Lost to Follow-up|3|||
48641977|NCT04460183|156543019|FG001|Overall Study|Lost to Follow-up|1|||
48641978|NCT04460183|156543018|FG000|Overall Study|Withdrawal by Subject|1|||
48641979|NCT04460183|156543019|FG001|Overall Study|Withdrawal by Subject|0|||
48641980|NCT03848416|156543020|FG000|Overall Study|Withdrawal by Subject|1|||
48641981|NCT03848416|156543021|FG001|Overall Study|Withdrawal by Subject|0|||
48641982|NCT03848416|156543022|FG002|Overall Study|Withdrawal by Subject|0|||
48749199|NCT01350414|156928258|FG000|Overall Study|Withdrawal by Subject|4|||
48749200|NCT01350414|156928258|FG000|Overall Study|Physician Decision|2|||
48749201|NCT04016285|156928260|FG000|Overall Study|Did not progress to surgery|2|||
48749202|NCT04016285|156928261|FG001|Overall Study|Did not progress to surgery|5|||
48641983|NCT03848416|156543020|FG000|Overall Study|Death|0|||
48641984|NCT03848416|156543021|FG001|Overall Study|Death|0|||
48641985|NCT03848416|156543022|FG002|Overall Study|Death|1|||
48641986|NCT01534481|156543025|FG000|Overall Study|Lost to Follow-up|29|||
48749203|NCT04016285|156928260|FG000|Overall Study|Failed to collect outcome data|5|||
48749204|NCT04016285|156928261|FG001|Overall Study|Failed to collect outcome data|3|||
48329356|NCT03162614|155403565|FG001|Overall Study|Protocol Violation|1|||
48641987|NCT01534481|156543026|FG001|Overall Study|Lost to Follow-up|24|||
48641988|NCT01534481|156543025|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
48641989|NCT01534481|156543026|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
48641990|NCT04846231|156543027|FG000|Overall Study|Lost to Follow-up|1|||
48641991|NCT04846231|156543028|FG001|Overall Study|Lost to Follow-up|0|||
48641992|NCT04846231|156543029|FG002|Overall Study|Lost to Follow-up|0|||
48641993|NCT04846231|156543030|FG003|Overall Study|Lost to Follow-up|0|||
48641994|NCT04846231|156543031|FG004|Overall Study|Lost to Follow-up|0|||
48641995|NCT04846231|156543032|FG005|Overall Study|Lost to Follow-up|0|||
48641996|NCT04846231|156543033|FG006|Overall Study|Lost to Follow-up|0|||
48641997|NCT04846231|156543034|FG007|Overall Study|Lost to Follow-up|1|||
48641998|NCT04846231|156543027|FG000|Overall Study|Withdrawal by Subject|0|||
48641999|NCT04846231|156543028|FG001|Overall Study|Withdrawal by Subject|1|||
48642000|NCT04846231|156543029|FG002|Overall Study|Withdrawal by Subject|2|||
48642001|NCT04846231|156543030|FG003|Overall Study|Withdrawal by Subject|1|||
48642002|NCT04846231|156543031|FG004|Overall Study|Withdrawal by Subject|0|||
48642003|NCT04846231|156543032|FG005|Overall Study|Withdrawal by Subject|0|||
48749205|NCT03716024|156928262|FG000|Overall Study|Randomized, not Treated|7|||
48749206|NCT03716024|156928263|FG001|Overall Study|Randomized, not Treated|8|||
48749207|NCT03716024|156928262|FG000|Overall Study|Adverse Event|1|||
48749208|NCT03716024|156928263|FG001|Overall Study|Adverse Event|2|||
48749209|NCT03716024|156928262|FG000|Overall Study|Treatment Failure|1|||
48642004|NCT04846231|156543033|FG006|Overall Study|Withdrawal by Subject|0|||
48642005|NCT04846231|156543034|FG007|Overall Study|Withdrawal by Subject|0|||
48642006|NCT04846231|156543027|FG000|Overall Study|Protocol Violation|0|||
48642007|NCT04846231|156543028|FG001|Overall Study|Protocol Violation|1|||
48642008|NCT04846231|156543029|FG002|Overall Study|Protocol Violation|0|||
48642009|NCT04846231|156543030|FG003|Overall Study|Protocol Violation|0|||
48642010|NCT04846231|156543031|FG004|Overall Study|Protocol Violation|0|||
48642011|NCT04846231|156543032|FG005|Overall Study|Protocol Violation|0|||
48749210|NCT03716024|156928263|FG001|Overall Study|Treatment Failure|0|||
48749211|NCT03716024|156928262|FG000|Overall Study|Lost to Follow-up|2|||
48749212|NCT03716024|156928263|FG001|Overall Study|Lost to Follow-up|6|||
48749213|NCT03716024|156928262|FG000|Overall Study|Withdrawal by Subject|0|||
48749214|NCT03716024|156928263|FG001|Overall Study|Withdrawal by Subject|1|||
48749215|NCT03716024|156928262|FG000|Overall Study|Missing Reason|0|||
48749216|NCT03716024|156928263|FG001|Overall Study|Missing Reason|1|||
48749217|NCT01218204|156928266|FG000|Part B Washout|Adverse Event|0|||
48749218|NCT01218204|156928267|FG001|Part B Washout|Adverse Event|1|||
48749219|NCT01218204|156928268|FG002|Part B Washout|Adverse Event|0|||
48749220|NCT01218204|156928269|FG003|Part B Washout|Adverse Event|0|||
48749221|NCT01218204|156928266|FG000|Part B Washout|Lost to Follow-up|0|||
48749222|NCT01218204|156928267|FG001|Part B Washout|Lost to Follow-up|2|||
48749223|NCT01218204|156928268|FG002|Part B Washout|Lost to Follow-up|0|||
48749224|NCT01218204|156928269|FG003|Part B Washout|Lost to Follow-up|0|||
48749225|NCT01218204|156928266|FG000|Part B Washout|Physician Decision|0|||
48749226|NCT01218204|156928267|FG001|Part B Washout|Physician Decision|14|||
48642012|NCT04846231|156543033|FG006|Overall Study|Protocol Violation|0|||
48642013|NCT04846231|156543034|FG007|Overall Study|Protocol Violation|0|||
48642014|NCT04846231|156543027|FG000|Overall Study|Adverse Event|0|||
48642015|NCT04846231|156543028|FG001|Overall Study|Adverse Event|0|||
48642016|NCT04846231|156543029|FG002|Overall Study|Adverse Event|0|||
48642017|NCT04846231|156543030|FG003|Overall Study|Adverse Event|0|||
48642018|NCT04846231|156543031|FG004|Overall Study|Adverse Event|0|||
48642019|NCT04846231|156543032|FG005|Overall Study|Adverse Event|0|||
48642020|NCT04846231|156543033|FG006|Overall Study|Adverse Event|1|||
48642021|NCT04846231|156543034|FG007|Overall Study|Adverse Event|1|||
48642022|NCT00503425|156543037|FG000|Overall Study|Participant files lost|6|||
48642023|NCT00503425|156543037|FG000|Overall Study|Adverse Event|5|||
48642024|NCT00503425|156543037|FG000|Overall Study|Lack of Efficacy|25|||
48642025|NCT00503425|156543037|FG000|Overall Study|Withdrawal by Subject|8|||
48642026|NCT00503425|156543037|FG000|Overall Study|Lost to Follow-up|3|||
48642027|NCT00503425|156543037|FG000|Overall Study|Death|3|||
48642028|NCT00503425|156543037|FG000|Overall Study|Missing Data/Unknown|4|||
48642029|NCT01595529|156543038|FG000|Overall Study|Adverse Event|2|||
48642030|NCT01595529|156543039|FG001|Overall Study|Adverse Event|0|||
48642031|NCT01595529|156543038|FG000|Overall Study|Subject Non-Compliant|2|||
48642032|NCT01595529|156543039|FG001|Overall Study|Subject Non-Compliant|0|||
48642033|NCT01595529|156543038|FG000|Overall Study|Lost to Follow-up|8|||
48642034|NCT01595529|156543039|FG001|Overall Study|Lost to Follow-up|14|||
48642035|NCT01595529|156543038|FG000|Overall Study|Protocol Violation|1|||
48642036|NCT01595529|156543039|FG001|Overall Study|Protocol Violation|2|||
48749227|NCT01218204|156928268|FG002|Part B Washout|Physician Decision|0|||
48749228|NCT01218204|156928269|FG003|Part B Washout|Physician Decision|0|||
48642037|NCT01595529|156543038|FG000|Overall Study|Physician Decision|1|||
48642038|NCT01595529|156543039|FG001|Overall Study|Physician Decision|0|||
48642039|NCT01595529|156543038|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
48642040|NCT01595529|156543039|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
48642041|NCT01595529|156543038|FG000|Overall Study|Administrative Decision|1|||
48642042|NCT01595529|156543039|FG001|Overall Study|Administrative Decision|0|||
48642043|NCT01595529|156543038|FG000|Overall Study|Entry Failure/Screening Failure|6|||
48642044|NCT01595529|156543039|FG001|Overall Study|Entry Failure/Screening Failure|1|||
48642045|NCT01822665|156543040|FG000|Overall Study|Adverse Event|3|||
48749229|NCT01218204|156928266|FG000|Part B Washout|Withdrawal by Subject|0|||
48749230|NCT01218204|156928267|FG001|Part B Washout|Withdrawal by Subject|14|||
48749231|NCT01218204|156928268|FG002|Part B Washout|Withdrawal by Subject|0|||
48749232|NCT01218204|156928269|FG003|Part B Washout|Withdrawal by Subject|0|||
48749233|NCT01218204|156928266|FG000|Part B Washout|Reached defined stopping criteria|0|||
48749234|NCT01218204|156928267|FG001|Part B Washout|Reached defined stopping criteria|2|||
48749235|NCT01218204|156928268|FG002|Part B Washout|Reached defined stopping criteria|0|||
48749236|NCT01218204|156928269|FG003|Part B Washout|Reached defined stopping criteria|0|||
48749237|NCT01218204|156928266|FG000|Part B Washout|Did not meet continuation criteria|0|||
48749238|NCT01218204|156928267|FG001|Part B Washout|Did not meet continuation criteria|112|||
48642046|NCT01822665|156543040|FG000|Overall Study|Other Reason|5|||
48642047|NCT00414076|156543041|FG000|Overall Study|Progression|1|||
48642048|NCT00414076|156543042|FG001|Overall Study|Progression|2|||
48642049|NCT00414076|156543041|FG000|Overall Study|Withdrawal by Subject|1|||
48642050|NCT00414076|156543042|FG001|Overall Study|Withdrawal by Subject|3|||
48749239|NCT01218204|156928268|FG002|Part B Washout|Did not meet continuation criteria|0|||
48642051|NCT00414076|156543041|FG000|Overall Study|Adverse Event|1|||
48749240|NCT01218204|156928269|FG003|Part B Washout|Did not meet continuation criteria|0|||
48642052|NCT00414076|156543042|FG001|Overall Study|Adverse Event|0|||
48642053|NCT02030821|156543045|FG000|Overall Study|Physician Decision|2|||
48749241|NCT01218204|156928266|FG000|Part B Run-in|Adverse Event|0|||
48642054|NCT02030821|156543046|FG001|Overall Study|Physician Decision|2|||
48642055|NCT02030821|156543047|FG002|Overall Study|Physician Decision|5|||
48749242|NCT01218204|156928267|FG001|Part B Run-in|Adverse Event|0|||
48749243|NCT01218204|156928268|FG002|Part B Run-in|Adverse Event|1|||
48642056|NCT02030821|156543048|FG003|Overall Study|Physician Decision|2|||
48329357|NCT03162614|155403566|FG002|Overall Study|Protocol Violation|0|||
48329358|NCT03162614|155403567|FG003|Overall Study|Protocol Violation|1|||
48329359|NCT03162614|155403568|FG004|Overall Study|Protocol Violation|0|||
48329360|NCT03162614|155403569|FG005|Overall Study|Protocol Violation|0|||
48329361|NCT03162614|155403564|FG000|Overall Study|Withdrawal by Subject|2|||
48329362|NCT03162614|155403565|FG001|Overall Study|Withdrawal by Subject|1|||
48329363|NCT03162614|155403566|FG002|Overall Study|Withdrawal by Subject|1|||
48329364|NCT03162614|155403567|FG003|Overall Study|Withdrawal by Subject|1|||
48329365|NCT03162614|155403568|FG004|Overall Study|Withdrawal by Subject|0|||
48642057|NCT01816048|156543049|FG000|Overall Study|Adverse Event|1|||
48642058|NCT01816048|156543049|FG000|Overall Study|Death|1|||
48642059|NCT01816048|156543049|FG000|Overall Study|Withdrawal by Subject|1|||
48642060|NCT01816048|156543049|FG000|Overall Study|Disease Progression|3|||
48642061|NCT01171677|156543052|FG000|Overall Study|Withdrawal by Subject|0|||
48642062|NCT01171677|156543053|FG001|Overall Study|Withdrawal by Subject|3|||
48642063|NCT01171677|156543052|FG000|Overall Study|Adverse Event|1|||
48642064|NCT01171677|156543053|FG001|Overall Study|Adverse Event|0|||
48642065|NCT01171677|156543052|FG000|Overall Study|completed <70% IntenSati classes|5|||
48642066|NCT01171677|156543053|FG001|Overall Study|completed <70% IntenSati classes|0|||
48642067|NCT01070979|156543054|FG000|Overall Study|Adverse Event|2|||
48642068|NCT01070979|156543055|FG001|Overall Study|Adverse Event|3|||
48642069|NCT01070979|156543056|FG002|Overall Study|Adverse Event|3|||
48642070|NCT01070979|156543054|FG000|Overall Study|Lost to Follow-up|2|||
48642071|NCT01070979|156543055|FG001|Overall Study|Lost to Follow-up|1|||
48642072|NCT01070979|156543056|FG002|Overall Study|Lost to Follow-up|1|||
48642073|NCT01070979|156543054|FG000|Overall Study|Protocol Violation|0|||
48642074|NCT01070979|156543055|FG001|Overall Study|Protocol Violation|2|||
48642075|NCT01070979|156543056|FG002|Overall Study|Protocol Violation|6|||
48642076|NCT01070979|156543054|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
48642077|NCT01070979|156543055|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
48642078|NCT01070979|156543056|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
48642079|NCT01070979|156543054|FG000|Overall Study|Withdrawal by Subject|3|||
48329366|NCT03162614|155403569|FG005|Overall Study|Withdrawal by Subject|0|||
48329367|NCT03162614|155403564|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
48329368|NCT03162614|155403565|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
48329369|NCT03162614|155403566|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
48329370|NCT03162614|155403567|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
48329371|NCT03162614|155403568|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
48329372|NCT03162614|155403569|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
48329373|NCT02561195|155403576|FG000|Vaccination 1 to 3|Adverse Event|4|||
48329374|NCT02561195|155403577|FG001|Vaccination 1 to 3|Adverse Event|5|||
48329375|NCT02561195|155403578|FG002|Vaccination 1 to 3|Adverse Event|0|||
48329376|NCT02561195|155403579|FG003|Vaccination 1 to 3|Adverse Event|3|||
48329377|NCT02561195|155403580|FG004|Vaccination 1 to 3|Adverse Event|4|||
48329378|NCT02561195|155403581|FG005|Vaccination 1 to 3|Adverse Event|0|||
48329379|NCT02561195|155403582|FG006|Vaccination 1 to 3|Adverse Event|0|||
48329380|NCT02561195|155403583|FG007|Vaccination 1 to 3|Adverse Event|0|||
48642080|NCT01070979|156543055|FG001|Overall Study|Withdrawal by Subject|1|||
48642081|NCT01070979|156543056|FG002|Overall Study|Withdrawal by Subject|1|||
48642082|NCT01070979|156543054|FG000|Overall Study|No study drug taken|0|||
48642083|NCT01070979|156543055|FG001|Overall Study|No study drug taken|1|||
48642084|NCT01070979|156543056|FG002|Overall Study|No study drug taken|0|||
48642085|NCT00444925|156543060|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
48329381|NCT02561195|155403584|FG008|Vaccination 1 to 3|Adverse Event|0|||
48329382|NCT02561195|155403585|FG009|Vaccination 1 to 3|Adverse Event|0|||
48329383|NCT02561195|155403586|FG010|Vaccination 1 to 3|Adverse Event|0|||
48329384|NCT02561195|155403587|FG011|Vaccination 1 to 3|Adverse Event|0|||
48329385|NCT02561195|155403588|FG012|Vaccination 1 to 3|Adverse Event|0|||
48642086|NCT00444925|156543061|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
48642087|NCT00444925|156543062|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
48642088|NCT00444925|156543060|FG000|Double-blind Treatment Period|Death|2|||
48749244|NCT01218204|156928269|FG003|Part B Run-in|Adverse Event|0|||
48749245|NCT01218204|156928266|FG000|Part B Run-in|Protocol Violation|0|||
48749246|NCT01218204|156928267|FG001|Part B Run-in|Protocol Violation|0|||
48749247|NCT01218204|156928268|FG002|Part B Run-in|Protocol Violation|2|||
48749248|NCT01218204|156928269|FG003|Part B Run-in|Protocol Violation|0|||
48749249|NCT01218204|156928266|FG000|Part B Run-in|Withdrawal by Subject|0|||
48749250|NCT01218204|156928267|FG001|Part B Run-in|Withdrawal by Subject|0|||
48749251|NCT01218204|156928268|FG002|Part B Run-in|Withdrawal by Subject|3|||
48749252|NCT01218204|156928269|FG003|Part B Run-in|Withdrawal by Subject|0|||
48749253|NCT01218204|156928266|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
48749254|NCT01218204|156928267|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
48749255|NCT01218204|156928268|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
48749256|NCT01218204|156928269|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
48749257|NCT01218204|156928266|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
48749258|NCT01218204|156928267|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
48749259|NCT01218204|156928268|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
48749260|NCT01218204|156928269|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
48749261|NCT02573350|156928270|FG000|Overall Study|Lost to Follow-up|2|||
48749262|NCT02573350|156928271|FG001|Overall Study|Lost to Follow-up|1|||
48749263|NCT02573350|156928270|FG000|Overall Study|Adverse Event|3|||
48749264|NCT02573350|156928271|FG001|Overall Study|Adverse Event|4|||
48749265|NCT02573350|156928270|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
48749266|NCT02573350|156928271|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
48749267|NCT02573350|156928270|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
48749268|NCT02573350|156928271|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
48749269|NCT02573350|156928270|FG000|Overall Study|Subject withdrew consent to participate|6|||
48749270|NCT02573350|156928271|FG001|Overall Study|Subject withdrew consent to participate|1|||
48749271|NCT02573350|156928270|FG000|Overall Study|Protocol Deviation|1|||
48749272|NCT02573350|156928271|FG001|Overall Study|Protocol Deviation|1|||
48749273|NCT02708121|156928274|FG000|Overall Study|Withdrawn by Study Team|1|||
48749274|NCT02708121|156928275|FG001|Overall Study|Withdrawn by Study Team|1|||
48749275|NCT02708121|156928274|FG000|Overall Study|Withdrawal by Subject|0|||
48749276|NCT02708121|156928275|FG001|Overall Study|Withdrawal by Subject|4|||
48749277|NCT01425281|156928278|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
48749278|NCT01425281|156928279|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
48642089|NCT00444925|156543061|FG001|Double-blind Treatment Period|Death|0|||
48642090|NCT00444925|156543062|FG002|Double-blind Treatment Period|Death|0|||
48642091|NCT00444925|156543060|FG000|Double-blind Treatment Period|Adverse Event|6|||
48642092|NCT00444925|156543061|FG001|Double-blind Treatment Period|Adverse Event|28|||
48749279|NCT01425281|156928278|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
48749280|NCT01425281|156928279|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
48749281|NCT01425281|156928278|FG000|At 180-day Clinical Follow-up|Death|0|||
48749282|NCT01425281|156928279|FG001|At 180-day Clinical Follow-up|Death|1|||
48749283|NCT01425281|156928278|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
48749284|NCT01425281|156928279|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
48642093|NCT00444925|156543062|FG002|Double-blind Treatment Period|Adverse Event|44|||
48642094|NCT00444925|156543060|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
48642095|NCT00444925|156543061|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
48642096|NCT00444925|156543062|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
48642097|NCT00444925|156543060|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
48642098|NCT00444925|156543061|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
48642099|NCT00444925|156543062|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
48642100|NCT00444925|156543060|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
48642101|NCT00444925|156543061|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
48642102|NCT00444925|156543062|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
48642103|NCT00444925|156543060|FG000|Double-blind Treatment Period|Other|7|||
48642104|NCT00444925|156543061|FG001|Double-blind Treatment Period|Other|7|||
48642105|NCT00444925|156543062|FG002|Double-blind Treatment Period|Other|12|||
48642106|NCT03484429|156543065|FG000|Overall Study|Withdrawal by Subject|1|||
48642107|NCT03484429|156543066|FG001|Overall Study|Withdrawal by Subject|0|||
48642108|NCT03484429|156543065|FG000|Overall Study|Adverse Event|2|||
48642109|NCT03484429|156543066|FG001|Overall Study|Adverse Event|0|||
48642110|NCT01402869|156543071|FG000|Overall Study|Required Tooth Extraction|0|||
48642111|NCT01402869|156543072|FG001|Overall Study|Required Tooth Extraction|0|||
48642112|NCT01402869|156543073|FG002|Overall Study|Required Tooth Extraction|1|||
48642113|NCT01392573|156543076|FG000|Overall Study|Adverse Event|1|||
48642114|NCT01392573|156543077|FG001|Overall Study|Adverse Event|3|||
48642115|NCT01392573|156543076|FG000|Overall Study|Lack of Efficacy|1|||
48642116|NCT01392573|156543077|FG001|Overall Study|Lack of Efficacy|2|||
48642117|NCT01392573|156543076|FG000|Overall Study|Protocol Violation|0|||
48642118|NCT01392573|156543077|FG001|Overall Study|Protocol Violation|2|||
48642119|NCT01392573|156543076|FG000|Overall Study|Withdrawal Criteria|13|||
48642120|NCT01392573|156543077|FG001|Overall Study|Withdrawal Criteria|15|||
48642121|NCT01392573|156543076|FG000|Overall Study|Site closure|8|||
48642122|NCT01392573|156543077|FG001|Overall Study|Site closure|7|||
48642123|NCT01392573|156543076|FG000|Overall Study|Unclassified|9|||
48642124|NCT01392573|156543077|FG001|Overall Study|Unclassified|6|||
48642125|NCT00806260|156543078|FG000|Period 1 (1 Day)|Adverse Event|0|||
48642126|NCT00806260|156543079|FG001|Period 1 (1 Day)|Adverse Event|0|||
48642127|NCT00806260|156543080|FG002|Period 1 (1 Day)|Adverse Event|0|||
48642128|NCT00806260|156543081|FG003|Period 1 (1 Day)|Adverse Event|0|||
48642129|NCT00806260|156543082|FG004|Period 1 (1 Day)|Adverse Event|3|||
48642130|NCT00806260|156543083|FG005|Period 1 (1 Day)|Adverse Event|0|||
48642131|NCT00806260|156543078|FG000|Period 2|Adverse Event|0|||
48642132|NCT00806260|156543079|FG001|Period 2|Adverse Event|0|||
48642133|NCT00806260|156543080|FG002|Period 2|Adverse Event|0|||
48642134|NCT00806260|156543081|FG003|Period 2|Adverse Event|1|||
48642135|NCT00806260|156543082|FG004|Period 2|Adverse Event|0|||
48749285|NCT01425281|156928278|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
48749286|NCT01425281|156928279|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
48749287|NCT01425281|156928278|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
48749288|NCT01425281|156928279|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
48749289|NCT01425281|156928278|FG000|At 2-year Clinical Follow-up|Death|2|||
48749290|NCT01425281|156928279|FG001|At 2-year Clinical Follow-up|Death|0|||
48749291|NCT01425281|156928278|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
48749292|NCT01425281|156928279|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
48749293|NCT01425281|156928278|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
48749294|NCT01425281|156928279|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
48749295|NCT01425281|156928278|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
48749296|NCT01425281|156928279|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
48749297|NCT01425281|156928278|FG000|At 3-year Clinical Follow-up|Death|2|||
48749298|NCT01425281|156928279|FG001|At 3-year Clinical Follow-up|Death|3|||
48749299|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Death|7|||
48749300|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Death|3|||
48749301|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
48749302|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
48749303|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
48749304|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
48749305|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
48749306|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
48749307|NCT01425281|156928278|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
48642136|NCT00806260|156543083|FG005|Period 2|Adverse Event|0|||
48642137|NCT00806260|156543078|FG000|Period 2|Protocol Violation|1|||
48642138|NCT00806260|156543079|FG001|Period 2|Protocol Violation|0|||
48642139|NCT00806260|156543080|FG002|Period 2|Protocol Violation|1|||
48642140|NCT00806260|156543081|FG003|Period 2|Protocol Violation|0|||
48642141|NCT00806260|156543082|FG004|Period 2|Protocol Violation|0|||
48642142|NCT00806260|156543083|FG005|Period 2|Protocol Violation|0|||
48642143|NCT00806260|156543078|FG000|Period 2|Need to take concomitant medication|1|||
48642144|NCT00806260|156543079|FG001|Period 2|Need to take concomitant medication|0|||
48642145|NCT00806260|156543080|FG002|Period 2|Need to take concomitant medication|0|||
48642146|NCT00806260|156543081|FG003|Period 2|Need to take concomitant medication|0|||
48642147|NCT00806260|156543082|FG004|Period 2|Need to take concomitant medication|0|||
48642148|NCT00806260|156543083|FG005|Period 2|Need to take concomitant medication|0|||
48642149|NCT00806260|156543078|FG000|Period 2|sponsor request|0|||
48642150|NCT00806260|156543079|FG001|Period 2|sponsor request|0|||
48749308|NCT01425281|156928279|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
48749309|NCT01425281|156928278|FG000|At 5-year Clinical Follow-up|Death|2|||
48749310|NCT01425281|156928279|FG001|At 5-year Clinical Follow-up|Death|0|||
48749311|NCT01425281|156928278|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
48749312|NCT01425281|156928279|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
48329386|NCT02561195|155403589|FG013|Vaccination 1 to 3|Adverse Event|0|||
48749313|NCT01425281|156928278|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
48749314|NCT01425281|156928279|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
48749315|NCT01425281|156928278|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
48749316|NCT01425281|156928279|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
48749317|NCT01833520|156928280|FG000|Overall Study|Lack of Efficacy|3|||
48749318|NCT01833520|156928281|FG001|Overall Study|Lack of Efficacy|3|||
48749319|NCT01833520|156928282|FG002|Overall Study|Lack of Efficacy|8|||
48749320|NCT01833520|156928283|FG003|Overall Study|Lack of Efficacy|3|||
48749321|NCT03247530|156928284|FG000|Overall Study|Withdrawal by caregiver|19|||
48749322|NCT03247530|156928285|FG001|Overall Study|Withdrawal by caregiver|8|||
48749323|NCT03247530|156928286|FG002|Overall Study|Withdrawal by caregiver|10|||
48749324|NCT03247530|156928284|FG000|Overall Study|Lost to Follow-up|3|||
48749325|NCT03247530|156928285|FG001|Overall Study|Lost to Follow-up|9|||
48329387|NCT02561195|155403576|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
48329388|NCT02561195|155403577|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
48329389|NCT02561195|155403578|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
48329390|NCT02561195|155403579|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
48329391|NCT02561195|155403580|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
48329392|NCT02561195|155403581|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
48642151|NCT00806260|156543080|FG002|Period 2|sponsor request|1|||
48642152|NCT00806260|156543081|FG003|Period 2|sponsor request|1|||
48642153|NCT00806260|156543082|FG004|Period 2|sponsor request|0|||
48642154|NCT00806260|156543083|FG005|Period 2|sponsor request|0|||
48642155|NCT00806260|156543078|FG000|Period 3|Protocol Violation|0|||
48642156|NCT00806260|156543079|FG001|Period 3|Protocol Violation|1|||
48642157|NCT00806260|156543080|FG002|Period 3|Protocol Violation|1|||
48642158|NCT00806260|156543081|FG003|Period 3|Protocol Violation|0|||
48642159|NCT00806260|156543082|FG004|Period 3|Protocol Violation|0|||
48642160|NCT00806260|156543083|FG005|Period 3|Protocol Violation|0|||
48642161|NCT00806260|156543078|FG000|Period 3|Pregnancy|1|||
48642162|NCT00806260|156543079|FG001|Period 3|Pregnancy|0|||
48642163|NCT00806260|156543080|FG002|Period 3|Pregnancy|0|||
48642164|NCT00806260|156543081|FG003|Period 3|Pregnancy|0|||
48642165|NCT00806260|156543082|FG004|Period 3|Pregnancy|0|||
48642166|NCT00806260|156543083|FG005|Period 3|Pregnancy|0|||
48642167|NCT00100802|156543085|FG000|Overall Study|Adverse Event|9|||
48642168|NCT00100802|156543085|FG000|Overall Study|Death|1|||
48642169|NCT00100802|156543085|FG000|Overall Study|Lack of Efficacy|47|||
48642170|NCT00100802|156543085|FG000|Overall Study|Physician Decision|5|||
48642171|NCT00100802|156543085|FG000|Overall Study|Protocol Violation|1|||
48642172|NCT00100802|156543085|FG000|Overall Study|Withdrawal by Subject|5|||
48642173|NCT00100802|156543085|FG000|Overall Study|Ineligible|12|||
48642174|NCT03110029|156543087|FG000|Overall Study|Withdrawal by Subject|1|||
48642175|NCT03110029|156543088|FG001|Overall Study|Withdrawal by Subject|1|||
48642176|NCT03154476|156543089|FG000|Overall Study|Lost to Follow-up|4|||
48642177|NCT03154476|156543090|FG001|Overall Study|Lost to Follow-up|4|||
48642178|NCT02685826|156543091|FG000|Overall Study|Adverse Event|2|||
48749326|NCT03247530|156928286|FG002|Overall Study|Lost to Follow-up|6|||
48749327|NCT03247530|156928284|FG000|Overall Study|Adverse Event|2|||
48642179|NCT02685826|156543092|FG001|Overall Study|Adverse Event|0|||
48642180|NCT02685826|156543093|FG002|Overall Study|Adverse Event|1|||
48642181|NCT02685826|156543091|FG000|Overall Study|Progressive Disease|2|||
48642182|NCT02685826|156543092|FG001|Overall Study|Progressive Disease|1|||
48749328|NCT03247530|156928285|FG001|Overall Study|Adverse Event|5|||
48749329|NCT03247530|156928286|FG002|Overall Study|Adverse Event|2|||
48329393|NCT02561195|155403582|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
48329394|NCT02561195|155403583|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
48642183|NCT02685826|156543093|FG002|Overall Study|Progressive Disease|0|||
48642184|NCT02685826|156543091|FG000|Overall Study|Withdrawal by Subject|2|||
48642185|NCT02685826|156543092|FG001|Overall Study|Withdrawal by Subject|0|||
48749330|NCT03247530|156928284|FG000|Overall Study|Failure to follow procedure|1|||
48749331|NCT03247530|156928285|FG001|Overall Study|Failure to follow procedure|1|||
48749332|NCT03247530|156928286|FG002|Overall Study|Failure to follow procedure|1|||
48749333|NCT03247530|156928284|FG000|Overall Study|Withdrawal by Subject|1|||
48329395|NCT02561195|155403584|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
48329396|NCT02561195|155403585|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
48329397|NCT02561195|155403586|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
48329398|NCT02561195|155403587|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
48329399|NCT02561195|155403588|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
48329400|NCT02561195|155403589|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
48329401|NCT02561195|155403576|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329402|NCT02561195|155403577|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
48642186|NCT02685826|156543093|FG002|Overall Study|Withdrawal by Subject|0|||
48642187|NCT02685826|156543091|FG000|Overall Study|Full Clinical Hold by FDA|19|||
48642188|NCT02685826|156543092|FG001|Overall Study|Full Clinical Hold by FDA|9|||
48642189|NCT02685826|156543093|FG002|Overall Study|Full Clinical Hold by FDA|20|||
48642190|NCT00670930|156543094|FG000|Overall Study|Adminstrative Problem|0|||
48642191|NCT00670930|156543095|FG001|Overall Study|Adminstrative Problem|1|||
48642192|NCT00670930|156543094|FG000|Overall Study|Lost to Follow-up|1|||
48642193|NCT00670930|156543095|FG001|Overall Study|Lost to Follow-up|0|||
48642194|NCT00200967|156543096|FG000|First Treatment Period|Withdrawal by Subject|5|||
48642195|NCT00200967|156543097|FG001|First Treatment Period|Withdrawal by Subject|1|||
48642196|NCT00200967|156543096|FG000|First Treatment Period|Pregnancy|1|||
48642197|NCT00200967|156543097|FG001|First Treatment Period|Pregnancy|0|||
48642198|NCT00200967|156543096|FG000|Wash-out Period|Lost to Follow-up|0|||
48642199|NCT00200967|156543097|FG001|Wash-out Period|Lost to Follow-up|1|||
48642200|NCT00200967|156543096|FG000|Second Treatment Period|Withdrawal by Subject|1|||
48642201|NCT00200967|156543097|FG001|Second Treatment Period|Withdrawal by Subject|2|||
48642202|NCT00200967|156543096|FG000|Run-out Period|Lost to Follow-up|1|||
48642203|NCT00200967|156543097|FG001|Run-out Period|Lost to Follow-up|0|||
48642204|NCT01444430|156543098|FG000|Overall Study|Withdrawal by Subject|53|||
48642205|NCT01444430|156543099|FG001|Overall Study|Withdrawal by Subject|72|||
48642206|NCT01444430|156543098|FG000|Overall Study|Death|6|||
48642207|NCT01444430|156543099|FG001|Overall Study|Death|8|||
48642208|NCT01444430|156543098|FG000|Overall Study|Lost to Follow-up|2|||
48642209|NCT01444430|156543099|FG001|Overall Study|Lost to Follow-up|0|||
48642210|NCT01444430|156543098|FG000|Overall Study|CRF termination module not completed.|0|||
48642211|NCT01444430|156543099|FG001|Overall Study|CRF termination module not completed.|1|||
48642212|NCT01819272|156544280|FG000|Overall Study|Adverse Event|1|||
48642213|NCT01819272|156544281|FG001|Overall Study|Adverse Event|0|||
48642214|NCT01819272|156544282|FG002|Overall Study|Adverse Event|0|||
48642215|NCT01819272|156544283|FG003|Overall Study|Adverse Event|2|||
48642216|NCT01819272|156544284|FG004|Overall Study|Adverse Event|0|||
48642217|NCT01819272|156544285|FG005|Overall Study|Adverse Event|0|||
48642218|NCT01819272|156544280|FG000|Overall Study|Lost to Follow-up|3|||
48642219|NCT01819272|156544281|FG001|Overall Study|Lost to Follow-up|0|||
48642220|NCT01819272|156544282|FG002|Overall Study|Lost to Follow-up|1|||
48642221|NCT01819272|156544283|FG003|Overall Study|Lost to Follow-up|0|||
48642222|NCT01819272|156544284|FG004|Overall Study|Lost to Follow-up|0|||
48642223|NCT01819272|156544285|FG005|Overall Study|Lost to Follow-up|3|||
48642224|NCT01819272|156544280|FG000|Overall Study|Protocol Violation|0|||
48642225|NCT01819272|156544281|FG001|Overall Study|Protocol Violation|0|||
48642226|NCT01819272|156544282|FG002|Overall Study|Protocol Violation|0|||
48642227|NCT01819272|156544283|FG003|Overall Study|Protocol Violation|1|||
48642228|NCT01819272|156544284|FG004|Overall Study|Protocol Violation|2|||
48642229|NCT01819272|156544285|FG005|Overall Study|Protocol Violation|3|||
48642230|NCT01819272|156544280|FG000|Overall Study|Physician Decision|0|||
48642231|NCT01819272|156544281|FG001|Overall Study|Physician Decision|1|||
48642232|NCT01819272|156544282|FG002|Overall Study|Physician Decision|0|||
48642233|NCT01819272|156544283|FG003|Overall Study|Physician Decision|0|||
48642234|NCT01819272|156544284|FG004|Overall Study|Physician Decision|0|||
48642235|NCT01819272|156544285|FG005|Overall Study|Physician Decision|0|||
48642236|NCT01819272|156544280|FG000|Overall Study|Withdrawal of Consent|0|||
48642237|NCT01819272|156544281|FG001|Overall Study|Withdrawal of Consent|1|||
48642238|NCT01819272|156544282|FG002|Overall Study|Withdrawal of Consent|2|||
48642239|NCT01819272|156544283|FG003|Overall Study|Withdrawal of Consent|1|||
48749334|NCT03247530|156928285|FG001|Overall Study|Withdrawal by Subject|1|||
48749335|NCT03247530|156928286|FG002|Overall Study|Withdrawal by Subject|0|||
48749336|NCT03247530|156928284|FG000|Overall Study|Study medication misuse|0|||
48749337|NCT03247530|156928285|FG001|Overall Study|Study medication misuse|1|||
48642240|NCT01819272|156544284|FG004|Overall Study|Withdrawal of Consent|0|||
48642241|NCT01819272|156544285|FG005|Overall Study|Withdrawal of Consent|1|||
48642242|NCT01819272|156544280|FG000|Overall Study|Loss of Glucose Control|2|||
48642243|NCT01819272|156544281|FG001|Overall Study|Loss of Glucose Control|1|||
48749338|NCT03247530|156928286|FG002|Overall Study|Study medication misuse|0|||
48749339|NCT03247530|156928284|FG000|Overall Study|Other, multiple categories|1|||
48329403|NCT02561195|155403578|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48642244|NCT01819272|156544282|FG002|Overall Study|Loss of Glucose Control|0|||
48642245|NCT01819272|156544283|FG003|Overall Study|Loss of Glucose Control|1|||
48642246|NCT01819272|156544284|FG004|Overall Study|Loss of Glucose Control|2|||
48642247|NCT01819272|156544285|FG005|Overall Study|Loss of Glucose Control|0|||
48642248|NCT01732536|156544292|FG000|Overall Study|Withdrawal by Subject|1|||
48642249|NCT01732536|156544293|FG001|Overall Study|Withdrawal by Subject|1|||
48642250|NCT02197572|156544294|FG000|Overall Study|Progressive Disease|28|||
48642251|NCT02197572|156544294|FG000|Overall Study|Withdrawal by Subject|9|||
48642252|NCT02197572|156544294|FG000|Overall Study|Adverse Event|3|||
48642253|NCT02197572|156544294|FG000|Overall Study|Reason Not Specified|4|||
48642254|NCT01627691|156544298|FG000|Overall Study|Death|11|||
48642255|NCT01627691|156544298|FG000|Overall Study|Lost to Follow-up|3|||
48642256|NCT01627691|156544298|FG000|Overall Study|Withdrawal by Subject|1|||
48642257|NCT01627691|156544298|FG000|Overall Study|Missed the visit|3|||
48642258|NCT00856323|156544301|FG000|Overall Study|Withdrawal by Subject|2|||
48642259|NCT02808429|156544302|FG000|Overall Study|Lost to Follow-up|1|||
48642260|NCT02808429|156544303|FG001|Overall Study|Lost to Follow-up|0|||
48642261|NCT02808429|156544304|FG002|Overall Study|Lost to Follow-up|0|||
48642262|NCT02808429|156544302|FG000|Overall Study|Protocol Violation|0|||
48642263|NCT02808429|156544303|FG001|Overall Study|Protocol Violation|1|||
48642264|NCT02808429|156544304|FG002|Overall Study|Protocol Violation|0|||
48642265|NCT02808429|156544302|FG000|Overall Study|Premature study termination by sponsor|2|||
48642266|NCT02808429|156544303|FG001|Overall Study|Premature study termination by sponsor|0|||
48642267|NCT02808429|156544304|FG002|Overall Study|Premature study termination by sponsor|1|||
48642268|NCT02808429|156544302|FG000|Overall Study|Relocation|0|||
48642269|NCT02808429|156544303|FG001|Overall Study|Relocation|0|||
48642270|NCT02808429|156544304|FG002|Overall Study|Relocation|1|||
48642271|NCT01147393|156544308|FG000|Dose Level 1|Dose limiting Toxicity|2|||
48642272|NCT01147393|156544308|FG000|Dose Level -1|Dose Limited Toxicity|1|||
48642273|NCT01428219|156544309|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
48642274|NCT02071771|156544310|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
48642275|NCT02071771|156544311|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
48749340|NCT03247530|156928285|FG001|Overall Study|Other, multiple categories|3|||
48749341|NCT03247530|156928286|FG002|Overall Study|Other, multiple categories|1|||
48749342|NCT01937559|156928287|FG000|Overall Study|Physician Decision|3|||
48749343|NCT01937559|156928288|FG001|Overall Study|Physician Decision|3|||
48749344|NCT01937559|156928289|FG002|Overall Study|Physician Decision|0|||
48749345|NCT01937559|156928287|FG000|Overall Study|Withdrawal by Subject|6|||
48749346|NCT01937559|156928288|FG001|Overall Study|Withdrawal by Subject|4|||
48749347|NCT01937559|156928289|FG002|Overall Study|Withdrawal by Subject|0|||
48749348|NCT01937559|156928287|FG000|Overall Study|screen fail|2|||
48749349|NCT01937559|156928288|FG001|Overall Study|screen fail|4|||
48749350|NCT01937559|156928289|FG002|Overall Study|screen fail|0|||
48749351|NCT02547649|156928292|FG000|Overall Study|Lost to Follow-up|3|||
48749352|NCT02547649|156928293|FG001|Overall Study|Lost to Follow-up|1|||
48749353|NCT02547649|156928294|FG002|Overall Study|Lost to Follow-up|1|||
48642276|NCT02071771|156544310|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
48642277|NCT02071771|156544311|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
48642278|NCT00783432|156544312|FG000|Overall Study|Adverse Event|22|||
48642279|NCT00783432|156544313|FG001|Overall Study|Adverse Event|17|||
48642280|NCT00783432|156544312|FG000|Overall Study|Lack of Efficacy|20|||
48642281|NCT00783432|156544313|FG001|Overall Study|Lack of Efficacy|21|||
48642282|NCT00783432|156544312|FG000|Overall Study|Lost to Follow-up|11|||
48642283|NCT00783432|156544313|FG001|Overall Study|Lost to Follow-up|6|||
48642284|NCT00783432|156544312|FG000|Overall Study|Withdrawal by Subject|23|||
48642285|NCT00783432|156544313|FG001|Overall Study|Withdrawal by Subject|20|||
48642286|NCT00783432|156544312|FG000|Overall Study|subject moved|3|||
48642287|NCT00783432|156544313|FG001|Overall Study|subject moved|5|||
48642288|NCT00783432|156544312|FG000|Overall Study|Protocol Violation|6|||
48749354|NCT02547649|156928292|FG000|Overall Study|Not vaccinated|0|||
48329404|NCT02561195|155403579|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
48642289|NCT00783432|156544313|FG001|Overall Study|Protocol Violation|9|||
48642290|NCT02479880|156544314|FG000|Overall Study|Study Terminated by Sponsor|13|||
48642291|NCT02479880|156544315|FG001|Overall Study|Study Terminated by Sponsor|12|||
48749355|NCT02547649|156928293|FG001|Overall Study|Not vaccinated|0|||
48642292|NCT02479880|156544314|FG000|Overall Study|Pregnancy|0|||
48642293|NCT02479880|156544315|FG001|Overall Study|Pregnancy|1|||
48642294|NCT00355368|156544318|FG000|Overall Study|Protocol Violation|8|||
48642295|NCT00355368|156544319|FG001|Overall Study|Protocol Violation|7|||
48642296|NCT00355368|156544318|FG000|Overall Study|cardiac arrest prior to intubation|2|||
48642297|NCT00355368|156544319|FG001|Overall Study|cardiac arrest prior to intubation|2|||
48749356|NCT02547649|156928294|FG002|Overall Study|Not vaccinated|1|||
48749357|NCT02547649|156928292|FG000|Overall Study|Withdrawal by Subject|0|||
48749358|NCT02547649|156928293|FG001|Overall Study|Withdrawal by Subject|4|||
48427300|NCT01544595|155752941|FG003|Status at Week 68|Adverse Event|0|||
48642298|NCT00110214|156544325|FG000|Overall Study|Never started treatment|21|||
48642299|NCT00110214|156544326|FG001|Overall Study|Never started treatment|20|||
48749359|NCT02547649|156928294|FG002|Overall Study|Withdrawal by Subject|2|||
48642300|NCT00110214|156544325|FG000|Overall Study|Disease progression or death|260|||
48642301|NCT00110214|156544326|FG001|Overall Study|Disease progression or death|151|||
48329405|NCT02561195|155403580|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
48329406|NCT02561195|155403581|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
48329407|NCT02561195|155403582|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329408|NCT02561195|155403583|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329409|NCT02561195|155403584|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329410|NCT02561195|155403585|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329411|NCT02561195|155403586|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329412|NCT02561195|155403587|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329413|NCT02561195|155403588|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329414|NCT02561195|155403589|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
48329415|NCT02561195|155403576|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
48329416|NCT02561195|155403577|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
48642302|NCT00110214|156544325|FG000|Overall Study|Adverse Event|115|||
48642303|NCT00110214|156544326|FG001|Overall Study|Adverse Event|192|||
48642304|NCT00110214|156544325|FG000|Overall Study|Refused further treatment|52|||
48642305|NCT00110214|156544326|FG001|Overall Study|Refused further treatment|65|||
48642306|NCT00110214|156544325|FG000|Overall Study|Other (not specified)|61|||
48642307|NCT00110214|156544326|FG001|Overall Study|Other (not specified)|75|||
48642308|NCT00473889|156544329|FG000|Overall Study|Did not receive study medication|1|||
48642309|NCT00473889|156544330|FG001|Overall Study|Did not receive study medication|4|||
48642310|NCT00473889|156544329|FG000|Overall Study|Adverse Event|30|||
48642311|NCT00473889|156544330|FG001|Overall Study|Adverse Event|17|||
48642312|NCT00473889|156544329|FG000|Overall Study|Protocol Violation|4|||
48642313|NCT00473889|156544330|FG001|Overall Study|Protocol Violation|2|||
48642314|NCT00473889|156544329|FG000|Overall Study|Lack of Efficacy|28|||
48642315|NCT00473889|156544330|FG001|Overall Study|Lack of Efficacy|29|||
48642316|NCT00473889|156544329|FG000|Overall Study|Lost to Follow-up|2|||
48642317|NCT00473889|156544330|FG001|Overall Study|Lost to Follow-up|1|||
48642318|NCT00473889|156544329|FG000|Overall Study|Physician Decision|10|||
48642319|NCT00473889|156544330|FG001|Overall Study|Physician Decision|5|||
48642320|NCT00473889|156544329|FG000|Overall Study|Trial Terminated|3|||
48642321|NCT00473889|156544330|FG001|Overall Study|Trial Terminated|6|||
48642322|NCT00473889|156544329|FG000|Overall Study|Withdrawal by Subject|5|||
48642323|NCT00473889|156544330|FG001|Overall Study|Withdrawal by Subject|0|||
48642324|NCT00811954|156544331|FG000|Overall Study|Death|10|||
48642325|NCT00811954|156544332|FG001|Overall Study|Death|6|||
48642326|NCT00811954|156544333|FG002|Overall Study|Death|13|||
48642327|NCT00811954|156544331|FG000|Overall Study|Lost to Follow-up|29|||
48642328|NCT00811954|156544332|FG001|Overall Study|Lost to Follow-up|23|||
48642329|NCT00811954|156544333|FG002|Overall Study|Lost to Follow-up|34|||
48642330|NCT00811954|156544331|FG000|Overall Study|Not able to get to clinic|28|||
48642331|NCT00811954|156544332|FG001|Overall Study|Not able to get to clinic|35|||
48642332|NCT00811954|156544333|FG002|Overall Study|Not able to get to clinic|30|||
48642333|NCT00811954|156544331|FG000|Overall Study|Not willing to adhere to requirements|12|||
48642334|NCT00811954|156544332|FG001|Overall Study|Not willing to adhere to requirements|2|||
48642335|NCT00811954|156544333|FG002|Overall Study|Not willing to adhere to requirements|16|||
48642336|NCT00811954|156544331|FG000|Overall Study|Withdraw consent prior study completion|4|||
48642337|NCT00811954|156544332|FG001|Overall Study|Withdraw consent prior study completion|6|||
48642338|NCT00811954|156544333|FG002|Overall Study|Withdraw consent prior study completion|5|||
48642339|NCT00811954|156544331|FG000|Overall Study|Site Closure|4|||
48642340|NCT00811954|156544332|FG001|Overall Study|Site Closure|0|||
48642341|NCT00811954|156544333|FG002|Overall Study|Site Closure|1|||
48642342|NCT00811954|156544331|FG000|Overall Study|Severe Debilitation|2|||
48642343|NCT00811954|156544332|FG001|Overall Study|Severe Debilitation|0|||
48642344|NCT00811954|156544333|FG002|Overall Study|Severe Debilitation|1|||
48642345|NCT00811954|156544331|FG000|Overall Study|Complete Protocol: No follow-up|0|||
48642346|NCT00811954|156544332|FG001|Overall Study|Complete Protocol: No follow-up|0|||
48642347|NCT00811954|156544333|FG002|Overall Study|Complete Protocol: No follow-up|1|||
48642348|NCT03389308|156544341|FG000|Overall Study|Withdrawal by Subject|5|||
48642349|NCT03389308|156544341|FG000|Overall Study|Lost to Follow-up|3|||
48642350|NCT03389308|156544341|FG000|Overall Study|Adverse Event|2|||
48642351|NCT03389308|156544341|FG000|Overall Study|Sponsor Request|2|||
48642352|NCT02504372|156544343|FG000|Overall Study|Death|136|||
48642353|NCT02504372|156544344|FG001|Overall Study|Death|154|||
48642354|NCT02504372|156544343|FG000|Overall Study|Lost to Follow-up|0|||
48642355|NCT02504372|156544344|FG001|Overall Study|Lost to Follow-up|2|||
48642356|NCT02504372|156544343|FG000|Overall Study|Withdrawal of consent|25|||
48642357|NCT02504372|156544344|FG001|Overall Study|Withdrawal of consent|16|||
48329417|NCT02561195|155403578|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
48642358|NCT02504372|156544343|FG000|Overall Study|Participants ongoing|429|||
48642359|NCT02504372|156544344|FG001|Overall Study|Participants ongoing|415|||
48642360|NCT01459666|156544346|FG000|Overall Study|PI left institution|5|||
48642361|NCT01459666|156544347|FG001|Overall Study|PI left institution|4|||
48749360|NCT03648541|156928295|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
48749361|NCT03648541|156928296|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
48749362|NCT03648541|156928295|FG000|Re-induction Period Only|Lack of Efficacy|7|||
48749363|NCT03648541|156928296|FG001|Re-induction Period Only|Lack of Efficacy|0|||
48749364|NCT03648541|156928295|FG000|Maintenance Period Only|Missing|0|||
48749365|NCT03648541|156928296|FG001|Maintenance Period Only|Missing|1|||
48749366|NCT03648541|156928295|FG000|Maintenance Period Only|Other not listed below|0|||
48749367|NCT03648541|156928296|FG001|Maintenance Period Only|Other not listed below|4|||
48749368|NCT03648541|156928295|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
48749369|NCT03648541|156928296|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
48749370|NCT03648541|156928295|FG000|Maintenance Period Only|Protocol Violation|0|||
48749371|NCT03648541|156928296|FG001|Maintenance Period Only|Protocol Violation|1|||
48749372|NCT03648541|156928295|FG000|Maintenance Period Only|Lack of Efficacy|0|||
48749373|NCT03648541|156928296|FG001|Maintenance Period Only|Lack of Efficacy|18|||
48749374|NCT03648541|156928295|FG000|Maintenance Period Only|Adverse Event|0|||
48749375|NCT03648541|156928296|FG001|Maintenance Period Only|Adverse Event|4|||
48749376|NCT03648541|156928295|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
48749377|NCT03648541|156928296|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
48749378|NCT03230097|156928299|FG000|Overall Study|Adverse Event|2|||
48749379|NCT03230097|156928300|FG001|Overall Study|Adverse Event|1|||
48749380|NCT03230097|156928299|FG000|Overall Study|non-compliance|0|||
48749381|NCT03230097|156928300|FG001|Overall Study|non-compliance|1|||
48749382|NCT03230097|156928299|FG000|Overall Study|Lost to Follow-up|2|||
48749383|NCT03230097|156928300|FG001|Overall Study|Lost to Follow-up|4|||
48749384|NCT03230097|156928299|FG000|Overall Study|Withdrawal by Subject|7|||
48749385|NCT03230097|156928300|FG001|Overall Study|Withdrawal by Subject|3|||
48749386|NCT03230097|156928299|FG000|Overall Study|Trial termination|4|||
48749387|NCT03230097|156928300|FG001|Overall Study|Trial termination|5|||
48749388|NCT03230097|156928299|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
48749389|NCT03230097|156928300|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
48749390|NCT03230097|156928299|FG000|Overall Study|outcome event|0|||
48749391|NCT03230097|156928300|FG001|Overall Study|outcome event|1|||
48749392|NCT01985867|156928306|FG000|Overall Study|Lost to Follow-up|3|||
48749393|NCT01985867|156928307|FG001|Overall Study|Lost to Follow-up|4|||
48749394|NCT01985867|156928306|FG000|Overall Study|Adverse Event|3|||
48749395|NCT01985867|156928307|FG001|Overall Study|Adverse Event|2|||
48749396|NCT01985867|156928306|FG000|Overall Study|Lack of Efficacy|1|||
48749397|NCT01985867|156928307|FG001|Overall Study|Lack of Efficacy|0|||
48749398|NCT04605484|156928310|FG000|Overall Study|Lost to Follow-up|0|||
48749399|NCT04605484|156928311|FG001|Overall Study|Lost to Follow-up|1|||
48749400|NCT04605484|156928312|FG002|Overall Study|Lost to Follow-up|1|||
48749401|NCT04605484|156928310|FG000|Overall Study|Other|0|||
48749402|NCT04605484|156928311|FG001|Overall Study|Other|1|||
48749403|NCT04605484|156928312|FG002|Overall Study|Other|0|||
48749404|NCT01606436|156928315|FG000|Overall Study|Withdrawal by Subject|0|||
48749405|NCT01606436|156928316|FG001|Overall Study|Withdrawal by Subject|0|||
48749406|NCT01606436|156928317|FG002|Overall Study|Withdrawal by Subject|1|||
48749407|NCT01606436|156928318|FG003|Overall Study|Withdrawal by Subject|1|||
48749408|NCT01606436|156928319|FG004|Overall Study|Withdrawal by Subject|1|||
48642362|NCT00533429|156544348|FG000|Overall Study|Adverse Event|3|||
48642363|NCT00533429|156544349|FG001|Overall Study|Adverse Event|1|||
48642364|NCT00533429|156544348|FG000|Overall Study|Death|1|||
48642365|NCT00533429|156544349|FG001|Overall Study|Death|0|||
48642366|NCT00533429|156544348|FG000|Overall Study|Withdrawal by Subject|2|||
48642367|NCT00533429|156544349|FG001|Overall Study|Withdrawal by Subject|0|||
48642368|NCT00533429|156544348|FG000|Overall Study|Progressive Disease|12|||
48642369|NCT00533429|156544349|FG001|Overall Study|Progressive Disease|13|||
48642370|NCT00533429|156544348|FG000|Overall Study|Symptomatic deterioration|1|||
48642371|NCT00533429|156544349|FG001|Overall Study|Symptomatic deterioration|2|||
48749409|NCT01606436|156928320|FG005|Overall Study|Withdrawal by Subject|0|||
48749410|NCT01606436|156928315|FG000|Overall Study|Adverse Event|0|||
48749411|NCT01606436|156928316|FG001|Overall Study|Adverse Event|0|||
48749412|NCT01606436|156928317|FG002|Overall Study|Adverse Event|1|||
48749413|NCT01606436|156928318|FG003|Overall Study|Adverse Event|0|||
48749414|NCT01606436|156928319|FG004|Overall Study|Adverse Event|0|||
48749415|NCT01606436|156928320|FG005|Overall Study|Adverse Event|0|||
48749416|NCT01606436|156928315|FG000|Overall Study|Sponsor Decision|0|||
48749417|NCT01606436|156928316|FG001|Overall Study|Sponsor Decision|0|||
48749418|NCT01606436|156928317|FG002|Overall Study|Sponsor Decision|0|||
48749419|NCT01606436|156928318|FG003|Overall Study|Sponsor Decision|1|||
48749420|NCT01606436|156928319|FG004|Overall Study|Sponsor Decision|0|||
48427301|NCT01544595|155752942|FG004|Status at Week 68|Adverse Event|0|||
48642372|NCT04834726|156544356|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
48749421|NCT01606436|156928320|FG005|Overall Study|Sponsor Decision|0|||
48749422|NCT01658072|156928324|FG000|Overall Study|Protocol Violation|4|||
48749423|NCT01658072|156928325|FG001|Overall Study|Protocol Violation|2|||
48749424|NCT04967443|156928328|FG000|Open Label Treatment|Death|1|||
48749425|NCT04967443|156928329|FG001|Open Label Treatment|Death|0|||
48749426|NCT04967443|156928330|FG002|Open Label Treatment|Death|0|||
48749427|NCT04967443|156928331|FG003|Open Label Treatment|Death|0|||
48749428|NCT04967443|156928332|FG004|Open Label Treatment|Death|0|||
48749429|NCT04967443|156928333|FG005|Open Label Treatment|Death|0|||
48749430|NCT04967443|156928334|FG006|Open Label Treatment|Death|0|||
48749431|NCT04967443|156928335|FG007|Open Label Treatment|Death|0|||
48749432|NCT04967443|156928328|FG000|Open Label Treatment|Lost to Follow-up|0|||
48749433|NCT04967443|156928329|FG001|Open Label Treatment|Lost to Follow-up|0|||
48749434|NCT04967443|156928330|FG002|Open Label Treatment|Lost to Follow-up|1|||
48749435|NCT04967443|156928331|FG003|Open Label Treatment|Lost to Follow-up|0|||
48749436|NCT04967443|156928332|FG004|Open Label Treatment|Lost to Follow-up|0|||
48749437|NCT04967443|156928333|FG005|Open Label Treatment|Lost to Follow-up|0|||
48749438|NCT04967443|156928334|FG006|Open Label Treatment|Lost to Follow-up|0|||
48749439|NCT04967443|156928335|FG007|Open Label Treatment|Lost to Follow-up|0|||
48749440|NCT04967443|156928328|FG000|Open Label Treatment|Withdrawal by Subject|0|||
48749441|NCT04967443|156928329|FG001|Open Label Treatment|Withdrawal by Subject|1|||
48749442|NCT04967443|156928330|FG002|Open Label Treatment|Withdrawal by Subject|0|||
48749443|NCT04967443|156928331|FG003|Open Label Treatment|Withdrawal by Subject|1|||
48749444|NCT04967443|156928332|FG004|Open Label Treatment|Withdrawal by Subject|0|||
48749445|NCT04967443|156928333|FG005|Open Label Treatment|Withdrawal by Subject|1|||
48749446|NCT04967443|156928334|FG006|Open Label Treatment|Withdrawal by Subject|2|||
48749447|NCT04967443|156928335|FG007|Open Label Treatment|Withdrawal by Subject|3|||
48749448|NCT04967443|156928328|FG000|Follow-Up|Death|1|||
48749449|NCT04967443|156928329|FG001|Follow-Up|Death|0|||
48749450|NCT04967443|156928330|FG002|Follow-Up|Death|0|||
48749451|NCT04967443|156928331|FG003|Follow-Up|Death|0|||
48749452|NCT04967443|156928332|FG004|Follow-Up|Death|0|||
48749453|NCT04967443|156928333|FG005|Follow-Up|Death|0|||
48642373|NCT04834726|156544357|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
48642374|NCT04834726|156544358|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
48642375|NCT04834726|156544359|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
48642376|NCT04834726|156544360|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
48642377|NCT04834726|156544361|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
48642378|NCT04834726|156544362|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
48642379|NCT04834726|156544363|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
48642380|NCT04834726|156544364|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
48642381|NCT00889707|156544368|FG000|Overall Study|Adverse Event|1|||
48642382|NCT00889707|156544369|FG001|Overall Study|Adverse Event|0|||
48642383|NCT00889707|156544368|FG000|Overall Study|Withdrawal by Subject|4|||
48642384|NCT00889707|156544369|FG001|Overall Study|Withdrawal by Subject|3|||
48642385|NCT00889707|156544368|FG000|Overall Study|Lost to Follow-up|0|||
48642386|NCT00889707|156544369|FG001|Overall Study|Lost to Follow-up|2|||
48642387|NCT00889707|156544368|FG000|Overall Study|Lack of Efficacy|2|||
48642388|NCT00889707|156544369|FG001|Overall Study|Lack of Efficacy|5|||
48642389|NCT00600067|156544378|FG000|Overall Study|Adverse Event|0|||
48642390|NCT00600067|156544379|FG001|Overall Study|Adverse Event|1|||
48642391|NCT00600067|156544378|FG000|Overall Study|Lost to Follow-up|2|||
48642392|NCT00600067|156544379|FG001|Overall Study|Lost to Follow-up|3|||
48642393|NCT00600067|156544378|FG000|Overall Study|protocol non-compliance|0|||
48642394|NCT00600067|156544379|FG001|Overall Study|protocol non-compliance|3|||
48749454|NCT04967443|156928334|FG006|Follow-Up|Death|0|||
48749455|NCT04967443|156928335|FG007|Follow-Up|Death|0|||
48749456|NCT04967443|156928328|FG000|Follow-Up|Lost to Follow-up|0|||
48749457|NCT04967443|156928329|FG001|Follow-Up|Lost to Follow-up|0|||
48642395|NCT00600067|156544378|FG000|Overall Study|Lack of Efficacy|1|||
48642396|NCT00600067|156544379|FG001|Overall Study|Lack of Efficacy|0|||
48749458|NCT04967443|156928330|FG002|Follow-Up|Lost to Follow-up|1|||
48749459|NCT04967443|156928331|FG003|Follow-Up|Lost to Follow-up|1|||
48749460|NCT04967443|156928332|FG004|Follow-Up|Lost to Follow-up|0|||
48749461|NCT04967443|156928333|FG005|Follow-Up|Lost to Follow-up|0|||
48749462|NCT04967443|156928334|FG006|Follow-Up|Lost to Follow-up|0|||
48642397|NCT00469833|156544386|FG000|Overall Study|No IV access|2|||
48642398|NCT03554018|156544389|FG000|Overall Study|Lost to Follow-up|3|||
48642399|NCT03554018|156544390|FG001|Overall Study|Lost to Follow-up|7|||
48642400|NCT01154452|156544391|FG000|Phase Ib|Not Treated|1|||
48642401|NCT01154452|156544392|FG001|Phase Ib|Not Treated|0|||
48642402|NCT01154452|156544393|FG002|Phase Ib|Not Treated|0|||
48642403|NCT01154452|156544394|FG003|Phase Ib|Not Treated|0|||
48642404|NCT01154452|156544391|FG000|Phase Ib|Adverse Event|2|||
48642405|NCT01154452|156544392|FG001|Phase Ib|Adverse Event|1|||
48642406|NCT01154452|156544393|FG002|Phase Ib|Adverse Event|0|||
48642407|NCT01154452|156544394|FG003|Phase Ib|Adverse Event|0|||
48642408|NCT01154452|156544391|FG000|Phase II|Withdrawal by Subject|0|||
48642409|NCT01154452|156544392|FG001|Phase II|Withdrawal by Subject|0|||
48642410|NCT01154452|156544393|FG002|Phase II|Withdrawal by Subject|1|||
48642411|NCT01154452|156544394|FG003|Phase II|Withdrawal by Subject|2|||
48642412|NCT01154452|156544391|FG000|Phase II|Adverse Event|0|||
48642413|NCT01154452|156544392|FG001|Phase II|Adverse Event|0|||
48642414|NCT01154452|156544393|FG002|Phase II|Adverse Event|4|||
48642415|NCT01154452|156544394|FG003|Phase II|Adverse Event|4|||
48642416|NCT05653700|156544395|FG000|Overall Study|Non Responders|9|||
48642417|NCT05653700|156544396|FG001|Overall Study|Non Responders|0|||
48642418|NCT02015039|156544397|FG000|Overall Study|Not eligible|0|||
48642419|NCT02015039|156544398|FG001|Overall Study|Not eligible|1|||
48642420|NCT02670473|156544399|FG000|Overall Study|Withdrawal by Subject|1|||
48642421|NCT02573948|156544401|FG000|Longitudinal Cohort|Death|9|||
48642422|NCT02573948|156544401|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
48642423|NCT02573948|156544401|FG000|Longitudinal Cohort|Incarcerated|25|||
48642424|NCT00707993|156544405|FG000|Overall Study|Adverse Event|16|||
48642425|NCT00707993|156544406|FG001|Overall Study|Adverse Event|20|||
48642426|NCT00707993|156544405|FG000|Overall Study|Protocol Violation|4|||
48642427|NCT00707993|156544406|FG001|Overall Study|Protocol Violation|7|||
48642428|NCT00707993|156544405|FG000|Overall Study|Lost to Follow-up|0|||
48642429|NCT00707993|156544406|FG001|Overall Study|Lost to Follow-up|4|||
48642430|NCT00707993|156544405|FG000|Overall Study|Withdrawal by Subject|12|||
48642431|NCT00707993|156544406|FG001|Overall Study|Withdrawal by Subject|16|||
48642432|NCT00707993|156544405|FG000|Overall Study|Hyperglycemic Rescue|55|||
48642433|NCT00707993|156544406|FG001|Overall Study|Hyperglycemic Rescue|47|||
48642434|NCT00707993|156544405|FG000|Overall Study|Other|2|||
48642435|NCT00707993|156544406|FG001|Overall Study|Other|0|||
48642436|NCT02712996|156544407|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
48642437|NCT02712996|156544408|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
48642438|NCT01451749|156544414|FG000|Overall Study|Protocol Violation|14|||
48642439|NCT01451749|156544415|FG001|Overall Study|Protocol Violation|7|||
48642440|NCT01451749|156544414|FG000|Overall Study|Lost to Follow-up|15|||
48642441|NCT01451749|156544415|FG001|Overall Study|Lost to Follow-up|5|||
48642442|NCT01451749|156544414|FG000|Overall Study|Meet the exclusion criteria,and|1|||
48642443|NCT01451749|156544415|FG001|Overall Study|Meet the exclusion criteria,and|1|||
48642444|NCT01451749|156544414|FG000|Overall Study|Adverse Event|2|||
48642445|NCT01451749|156544415|FG001|Overall Study|Adverse Event|0|||
48642446|NCT01451749|156544414|FG000|Overall Study|Withdrawal by Subject|0|||
48642447|NCT01451749|156544415|FG001|Overall Study|Withdrawal by Subject|1|||
48642448|NCT03533660|156544419|FG000|Overall Study|Withdrawal by Subject|2|||
48642449|NCT03533660|156544420|FG001|Overall Study|Withdrawal by Subject|2|||
48642450|NCT03533660|156544419|FG000|Overall Study|Death|2|||
48642451|NCT03533660|156544420|FG001|Overall Study|Death|4|||
48642452|NCT03533660|156544419|FG000|Overall Study|Adverse Event|0|||
48642453|NCT03533660|156544420|FG001|Overall Study|Adverse Event|2|||
48642454|NCT01837680|156544421|FG000|Overall Study|Lost to Follow-up|2|||
48642455|NCT01837680|156544422|FG001|Overall Study|Lost to Follow-up|2|||
48642456|NCT01837680|156544421|FG000|Overall Study|lack of insurance|0|||
48642457|NCT01837680|156544422|FG001|Overall Study|lack of insurance|2|||
48642458|NCT01837680|156544421|FG000|Overall Study|allergic reaction|6|||
48642459|NCT01837680|156544422|FG001|Overall Study|allergic reaction|0|||
48642460|NCT01837680|156544421|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
48642461|NCT01837680|156544422|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
48642462|NCT03941483|156544429|FG000|Overall Study|Miscellaneous|2|||
48642463|NCT03941483|156544430|FG001|Overall Study|Miscellaneous|3|||
48642464|NCT03941483|156544431|FG002|Overall Study|Miscellaneous|0|||
48642465|NCT03941483|156544429|FG000|Overall Study|Study Terminated by Sponsor|1|||
48642466|NCT03941483|156544430|FG001|Overall Study|Study Terminated by Sponsor|0|||
48642467|NCT03941483|156544431|FG002|Overall Study|Study Terminated by Sponsor|0|||
48642468|NCT03941483|156544429|FG000|Overall Study|Withdrawal by Subject|1|||
48642469|NCT03941483|156544430|FG001|Overall Study|Withdrawal by Subject|4|||
48642470|NCT03941483|156544431|FG002|Overall Study|Withdrawal by Subject|1|||
48642471|NCT03941483|156544429|FG000|Overall Study|Lost to Follow-up|2|||
48642472|NCT03941483|156544430|FG001|Overall Study|Lost to Follow-up|1|||
48642473|NCT03941483|156544431|FG002|Overall Study|Lost to Follow-up|8|||
48642474|NCT03941483|156544429|FG000|Overall Study|Death|3|||
48642475|NCT03941483|156544430|FG001|Overall Study|Death|2|||
48749463|NCT04967443|156928335|FG007|Follow-Up|Lost to Follow-up|0|||
48749464|NCT04967443|156928328|FG000|Follow-Up|Withdrawal by Subject|0|||
48749465|NCT04967443|156928329|FG001|Follow-Up|Withdrawal by Subject|1|||
48749466|NCT04967443|156928330|FG002|Follow-Up|Withdrawal by Subject|0|||
48642476|NCT03941483|156544431|FG002|Overall Study|Death|6|||
48642477|NCT05219253|156546059|FG000|Overall Study|Withdrawal by Subject|1|||
48642478|NCT05219253|156546060|FG001|Overall Study|Withdrawal by Subject|2|||
48642479|NCT02336815|156546061|FG000|Overall Study|Disease Progression|45|||
48642480|NCT02336815|156546062|FG001|Overall Study|Disease Progression|70|||
48642481|NCT02336815|156546061|FG000|Overall Study|Adverse Event|18|||
48642482|NCT02336815|156546062|FG001|Overall Study|Adverse Event|39|||
48642483|NCT02336815|156546061|FG000|Overall Study|Physician Decision|11|||
48642484|NCT02336815|156546062|FG001|Overall Study|Physician Decision|4|||
48642485|NCT02336815|156546061|FG000|Overall Study|Withdrawal by Subject|3|||
48749467|NCT04967443|156928331|FG003|Follow-Up|Withdrawal by Subject|1|||
48749468|NCT04967443|156928332|FG004|Follow-Up|Withdrawal by Subject|0|||
48749469|NCT04967443|156928333|FG005|Follow-Up|Withdrawal by Subject|1|||
48749470|NCT04967443|156928334|FG006|Follow-Up|Withdrawal by Subject|2|||
48749471|NCT04967443|156928335|FG007|Follow-Up|Withdrawal by Subject|3|||
48749472|NCT04584645|156928336|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
48749473|NCT04584645|156928337|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
48749474|NCT03798483|156928340|FG000|Overall Study|Lost to Follow-up|2|||
48749475|NCT02289417|156928341|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
48749476|NCT02289417|156928342|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749477|NCT02289417|156928343|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
48749478|NCT02289417|156928344|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749479|NCT02289417|156928345|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749480|NCT02289417|156928346|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749481|NCT02289417|156928347|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749482|NCT02289417|156928348|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749483|NCT02289417|156928349|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
48749484|NCT02289417|156928341|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
48749485|NCT02289417|156928342|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
48749486|NCT02289417|156928343|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
48749487|NCT02289417|156928344|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749488|NCT02289417|156928345|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749489|NCT02289417|156928346|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749490|NCT02289417|156928347|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749491|NCT02289417|156928348|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749492|NCT02289417|156928349|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
48749493|NCT02289417|156928341|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749494|NCT02289417|156928342|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
48749495|NCT02289417|156928343|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749496|NCT02289417|156928344|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749497|NCT02289417|156928345|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749498|NCT02289417|156928346|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749499|NCT02289417|156928347|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749500|NCT02289417|156928348|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749501|NCT02289417|156928349|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
48749502|NCT02289417|156928341|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
48749503|NCT02289417|156928342|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749504|NCT02289417|156928343|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749505|NCT02289417|156928344|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749506|NCT02289417|156928345|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749507|NCT02289417|156928346|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749508|NCT02289417|156928347|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749509|NCT02289417|156928348|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749510|NCT02289417|156928349|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
48749511|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
48749512|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
48749513|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
48749514|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
48749515|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
48749516|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
48749517|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
48749518|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
48749519|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
48427302|NCT01544595|155752943|FG005|Status at Week 68|Adverse Event|0|||
48642486|NCT02336815|156546062|FG001|Overall Study|Withdrawal by Subject|2|||
48642487|NCT02336815|156546061|FG000|Overall Study|Lost to Follow-up|1|||
48329418|NCT02561195|155403579|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
48749520|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749521|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749522|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
48749523|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749524|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749525|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749526|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749527|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749528|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
48749529|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
48749530|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
48749531|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
48749532|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
48749533|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
48749534|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
48749535|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
48749536|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
48749537|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
48749538|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749539|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749540|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
48749541|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749542|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
48749543|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
48749544|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749545|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749546|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
48749547|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749548|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749549|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749550|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749551|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749552|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749553|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
48749554|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749555|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
48749556|NCT02289417|156928341|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749557|NCT02289417|156928342|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749558|NCT02289417|156928343|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749559|NCT02289417|156928344|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
48749560|NCT02289417|156928345|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749561|NCT02289417|156928346|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749562|NCT02289417|156928347|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
48749563|NCT02289417|156928348|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749564|NCT02289417|156928349|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
48749565|NCT02289417|156928341|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
48749566|NCT02289417|156928342|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
48749567|NCT02289417|156928343|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
48329419|NCT02561195|155403580|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
48329420|NCT02561195|155403581|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
48329421|NCT02561195|155403582|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
48329422|NCT02561195|155403583|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
48329423|NCT02561195|155403584|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
48329424|NCT02561195|155403585|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
48329425|NCT02561195|155403586|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
48329426|NCT02561195|155403587|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
48329427|NCT02561195|155403588|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
48329428|NCT02561195|155403589|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
48329429|NCT02561195|155403576|FG000|Vaccination 1 to 3|Other|7|||
48329430|NCT02561195|155403577|FG001|Vaccination 1 to 3|Other|3|||
48329431|NCT02561195|155403578|FG002|Vaccination 1 to 3|Other|1|||
48329432|NCT02561195|155403579|FG003|Vaccination 1 to 3|Other|7|||
48329433|NCT02561195|155403580|FG004|Vaccination 1 to 3|Other|5|||
48329434|NCT02561195|155403581|FG005|Vaccination 1 to 3|Other|1|||
48329435|NCT02561195|155403582|FG006|Vaccination 1 to 3|Other|0|||
48329436|NCT02561195|155403583|FG007|Vaccination 1 to 3|Other|0|||
48329437|NCT02561195|155403584|FG008|Vaccination 1 to 3|Other|0|||
48329438|NCT02561195|155403585|FG009|Vaccination 1 to 3|Other|0|||
48329439|NCT02561195|155403586|FG010|Vaccination 1 to 3|Other|0|||
48329440|NCT02561195|155403587|FG011|Vaccination 1 to 3|Other|0|||
48329441|NCT02561195|155403588|FG012|Vaccination 1 to 3|Other|0|||
48329442|NCT02561195|155403589|FG013|Vaccination 1 to 3|Other|0|||
48329443|NCT02561195|155403576|FG000|Vaccination 1 to 3|Protocol Violation|1|||
48329444|NCT02561195|155403577|FG001|Vaccination 1 to 3|Protocol Violation|0|||
48329445|NCT02561195|155403578|FG002|Vaccination 1 to 3|Protocol Violation|1|||
48329446|NCT02561195|155403579|FG003|Vaccination 1 to 3|Protocol Violation|2|||
48329447|NCT02561195|155403580|FG004|Vaccination 1 to 3|Protocol Violation|5|||
48329448|NCT02561195|155403581|FG005|Vaccination 1 to 3|Protocol Violation|2|||
48329449|NCT02561195|155403582|FG006|Vaccination 1 to 3|Protocol Violation|0|||
48329450|NCT02561195|155403583|FG007|Vaccination 1 to 3|Protocol Violation|0|||
48329451|NCT02561195|155403584|FG008|Vaccination 1 to 3|Protocol Violation|0|||
48329452|NCT02561195|155403585|FG009|Vaccination 1 to 3|Protocol Violation|0|||
48329453|NCT02561195|155403586|FG010|Vaccination 1 to 3|Protocol Violation|0|||
48329454|NCT02561195|155403587|FG011|Vaccination 1 to 3|Protocol Violation|0|||
48329455|NCT02561195|155403588|FG012|Vaccination 1 to 3|Protocol Violation|0|||
48329456|NCT02561195|155403589|FG013|Vaccination 1 to 3|Protocol Violation|0|||
48329457|NCT02561195|155403576|FG000|Vaccination 1 to 3|Death|2|||
48329458|NCT02561195|155403577|FG001|Vaccination 1 to 3|Death|1|||
48329459|NCT02561195|155403578|FG002|Vaccination 1 to 3|Death|0|||
48329460|NCT02561195|155403579|FG003|Vaccination 1 to 3|Death|2|||
48329461|NCT02561195|155403580|FG004|Vaccination 1 to 3|Death|0|||
48329462|NCT02561195|155403581|FG005|Vaccination 1 to 3|Death|0|||
48329463|NCT02561195|155403582|FG006|Vaccination 1 to 3|Death|0|||
48329464|NCT02561195|155403583|FG007|Vaccination 1 to 3|Death|0|||
48329465|NCT02561195|155403584|FG008|Vaccination 1 to 3|Death|0|||
48329466|NCT02561195|155403585|FG009|Vaccination 1 to 3|Death|0|||
48642488|NCT02336815|156546062|FG001|Overall Study|Lost to Follow-up|3|||
48642489|NCT02336815|156546061|FG000|Overall Study|Other|1|||
48749568|NCT02289417|156928344|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
48329467|NCT02561195|155403586|FG010|Vaccination 1 to 3|Death|0|||
48329468|NCT02561195|155403587|FG011|Vaccination 1 to 3|Death|0|||
48329469|NCT02561195|155403588|FG012|Vaccination 1 to 3|Death|0|||
48329470|NCT02561195|155403589|FG013|Vaccination 1 to 3|Death|0|||
48329471|NCT02561195|155403576|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
48329472|NCT02561195|155403577|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
48329473|NCT02561195|155403578|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
48329474|NCT02561195|155403579|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
48642490|NCT02336815|156546062|FG001|Overall Study|Other|5|||
48642491|NCT00784368|156546063|FG000|Overall Study|Physician Decision|0|||
48642492|NCT00784368|156546064|FG001|Overall Study|Physician Decision|0|||
48642493|NCT00784368|156546065|FG002|Overall Study|Physician Decision|6|||
48642494|NCT00784368|156546063|FG000|Overall Study|Lack of Efficacy|2|||
48642495|NCT00784368|156546064|FG001|Overall Study|Lack of Efficacy|0|||
48642496|NCT00784368|156546065|FG002|Overall Study|Lack of Efficacy|1|||
48642497|NCT00784368|156546063|FG000|Overall Study|Adverse Event|6|||
48642498|NCT00784368|156546064|FG001|Overall Study|Adverse Event|9|||
48642499|NCT00784368|156546065|FG002|Overall Study|Adverse Event|2|||
48642500|NCT00784368|156546063|FG000|Overall Study|Diagnosis of fever|0|||
48642501|NCT00784368|156546064|FG001|Overall Study|Diagnosis of fever|0|||
48642502|NCT00784368|156546065|FG002|Overall Study|Diagnosis of fever|1|||
48749569|NCT02289417|156928345|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
48749570|NCT02289417|156928346|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
48749571|NCT02289417|156928347|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
48749572|NCT02289417|156928348|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
48749573|NCT02289417|156928349|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
48749574|NCT02289417|156928341|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749575|NCT02289417|156928342|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749576|NCT02289417|156928343|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749577|NCT02289417|156928344|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749578|NCT02289417|156928345|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749579|NCT02289417|156928346|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749580|NCT02289417|156928347|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
48749581|NCT02289417|156928348|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
48749582|NCT02289417|156928349|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
48749583|NCT02289417|156928341|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749584|NCT02289417|156928342|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749585|NCT02289417|156928343|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749586|NCT02289417|156928344|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749587|NCT02289417|156928345|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749588|NCT02289417|156928346|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749589|NCT02289417|156928347|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
48749590|NCT02289417|156928348|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
48749591|NCT02289417|156928349|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
48749592|NCT02289417|156928341|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749593|NCT02289417|156928342|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749594|NCT02289417|156928343|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749595|NCT02289417|156928344|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749596|NCT02289417|156928345|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749597|NCT02289417|156928346|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749598|NCT02289417|156928347|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749599|NCT02289417|156928348|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
48749600|NCT02289417|156928349|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
48749601|NCT00276744|156928350|FG000|PART A|Reason unknown|98|||
48749602|NCT02010775|156928354|FG000|Overall Study|Adverse Event|0|||
48749603|NCT02010775|156928355|FG001|Overall Study|Adverse Event|0|||
48749604|NCT02010775|156928356|FG002|Overall Study|Adverse Event|0|||
48749605|NCT02010775|156928357|FG003|Overall Study|Adverse Event|0|||
48749606|NCT02010775|156928358|FG004|Overall Study|Adverse Event|1|||
48749607|NCT02010775|156928354|FG000|Overall Study|Pregnancy|0|||
48642503|NCT00784368|156546063|FG000|Overall Study|Worsening of complications|0|||
48642504|NCT00784368|156546064|FG001|Overall Study|Worsening of complications|0|||
48642505|NCT00784368|156546065|FG002|Overall Study|Worsening of complications|1|||
48642506|NCT00784368|156546063|FG000|Overall Study|Worsening of symptoms|0|||
48642507|NCT00784368|156546064|FG001|Overall Study|Worsening of symptoms|1|||
48642508|NCT00784368|156546065|FG002|Overall Study|Worsening of symptoms|0|||
48642509|NCT00784368|156546063|FG000|Overall Study|Withdrawal of informed consent|0|||
48642510|NCT00784368|156546064|FG001|Overall Study|Withdrawal of informed consent|1|||
48642511|NCT00784368|156546065|FG002|Overall Study|Withdrawal of informed consent|0|||
48642512|NCT01126190|156546068|FG000|Double-Blind Phase|Death|0|||
48642513|NCT01126190|156546069|FG001|Double-Blind Phase|Death|1|||
48642514|NCT01126190|156546070|FG002|Double-Blind Phase|Death|0|||
48642515|NCT01126190|156546068|FG000|Double-Blind Phase|Adverse Event|1|||
48642516|NCT01126190|156546069|FG001|Double-Blind Phase|Adverse Event|2|||
48642517|NCT01126190|156546070|FG002|Double-Blind Phase|Adverse Event|0|||
48642518|NCT01126190|156546068|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
48642519|NCT01126190|156546069|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
48642520|NCT01126190|156546070|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48642521|NCT01126190|156546068|FG000|Double-Blind Phase|Request of Investigator|1|||
48642522|NCT01126190|156546069|FG001|Double-Blind Phase|Request of Investigator|0|||
48642523|NCT01126190|156546070|FG002|Double-Blind Phase|Request of Investigator|0|||
48749608|NCT02010775|156928355|FG001|Overall Study|Pregnancy|0|||
48749609|NCT02010775|156928356|FG002|Overall Study|Pregnancy|2|||
48749610|NCT02010775|156928357|FG003|Overall Study|Pregnancy|0|||
48642524|NCT01126190|156546068|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
48642525|NCT01126190|156546069|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
48642526|NCT01126190|156546070|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
48642527|NCT01126190|156546068|FG000|Double-Blind Phase|Non-compliance|1|||
48642528|NCT01126190|156546069|FG001|Double-Blind Phase|Non-compliance|0|||
48642529|NCT01126190|156546070|FG002|Double-Blind Phase|Non-compliance|0|||
48642530|NCT01126190|156546068|FG000|Double-Blind Phase|Lost to Follow-up|1|||
48642531|NCT01126190|156546069|FG001|Double-Blind Phase|Lost to Follow-up|3|||
48642532|NCT01126190|156546070|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48642533|NCT01126190|156546068|FG000|Open-Label Phase|Death|0|||
48642534|NCT01126190|156546069|FG001|Open-Label Phase|Death|0|||
48642535|NCT01126190|156546070|FG002|Open-Label Phase|Death|1|||
48642536|NCT01126190|156546068|FG000|Open-Label Phase|Adverse Event|0|||
48642537|NCT01126190|156546069|FG001|Open-Label Phase|Adverse Event|0|||
48749611|NCT02010775|156928358|FG004|Overall Study|Pregnancy|0|||
48749612|NCT02010775|156928354|FG000|Overall Study|Lost to Follow-up|2|||
48749613|NCT02010775|156928355|FG001|Overall Study|Lost to Follow-up|0|||
48749614|NCT02010775|156928356|FG002|Overall Study|Lost to Follow-up|0|||
48749615|NCT02010775|156928357|FG003|Overall Study|Lost to Follow-up|1|||
48749616|NCT02010775|156928358|FG004|Overall Study|Lost to Follow-up|1|||
48642538|NCT01126190|156546070|FG002|Open-Label Phase|Adverse Event|4|||
48642539|NCT01126190|156546068|FG000|Open-Label Phase|Withdrawal by Subject|0|||
48642540|NCT01126190|156546069|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48642541|NCT01126190|156546070|FG002|Open-Label Phase|Withdrawal by Subject|6|||
48642542|NCT00628446|156546071|FG000|Overall Study|Lost to Follow-up|3|||
48642543|NCT00628446|156546071|FG000|Overall Study|Withdrawal by Subject|1|||
48749617|NCT02010775|156928354|FG000|Overall Study|Personal Reasons|3|||
48749618|NCT02010775|156928355|FG001|Overall Study|Personal Reasons|3|||
48749619|NCT02010775|156928356|FG002|Overall Study|Personal Reasons|1|||
48749620|NCT02010775|156928357|FG003|Overall Study|Personal Reasons|2|||
48749621|NCT02010775|156928358|FG004|Overall Study|Personal Reasons|4|||
48749622|NCT02505867|156928359|FG000|Overall Study|Lack of Efficacy|6|||
48749623|NCT02505867|156928360|FG001|Overall Study|Lack of Efficacy|6|||
48749624|NCT02233647|156928367|FG000|Overall Study|Adverse Event|1|||
48749625|NCT01543698|156930143|FG000|Phase 1b|Disease progression|2|||
48749626|NCT01543698|156930144|FG001|Phase 1b|Disease progression|4|||
48749627|NCT01543698|156930145|FG002|Phase 1b|Disease progression|3|||
48749628|NCT01543698|156930146|FG003|Phase 1b|Disease progression|2|||
48749629|NCT01543698|156930147|FG004|Phase 1b|Disease progression|10|||
48749630|NCT01543698|156930148|FG005|Phase 1b|Disease progression|6|||
48749631|NCT01543698|156930149|FG006|Phase 1b|Disease progression|5|||
48749632|NCT01543698|156930150|FG007|Phase 1b|Disease progression|3|||
48749633|NCT01543698|156930151|FG008|Phase 1b|Disease progression|4|||
48749634|NCT01543698|156930152|FG009|Phase 1b|Disease progression|5|||
48749635|NCT01543698|156930153|FG010|Phase 1b|Disease progression|1|||
48749636|NCT01543698|156930154|FG011|Phase 1b|Disease progression|0|||
48749637|NCT01543698|156930155|FG012|Phase 1b|Disease progression|0|||
48642544|NCT00628446|156546071|FG000|Overall Study|Protocol Violation|3|||
48642545|NCT01135992|156546072|FG000|Overall Study|Adverse Event|1|||
48642546|NCT01135992|156546072|FG000|Overall Study|Lack of Efficacy|1|||
48642547|NCT01135992|156546072|FG000|Overall Study|Protocol Violation|2|||
48642548|NCT01135992|156546072|FG000|Overall Study|Withdrawal criteria|10|||
48642549|NCT01135992|156546072|FG000|Overall Study|Unclassified|7|||
48642550|NCT04971967|156546073|FG000|Overall Study|Lost to Follow-up|6|||
48642551|NCT04971967|156546074|FG001|Overall Study|Lost to Follow-up|7|||
48749638|NCT01543698|156930156|FG013|Phase 1b|Disease progression|0|||
48642552|NCT01349673|156546078|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
48642553|NCT01349673|156546078|FG000|Overall Study|No Longer Qualified For Study|1|||
48642554|NCT01349673|156546078|FG000|Overall Study|Site Closure|10|||
48749639|NCT01543698|156930157|FG014|Phase 1b|Disease progression|0|||
48749640|NCT01543698|156930143|FG000|Phase 1b|Death|0|||
48749641|NCT01543698|156930144|FG001|Phase 1b|Death|0|||
48749642|NCT01543698|156930145|FG002|Phase 1b|Death|1|||
48749643|NCT01543698|156930146|FG003|Phase 1b|Death|1|||
48749644|NCT01543698|156930147|FG004|Phase 1b|Death|0|||
48749645|NCT01543698|156930148|FG005|Phase 1b|Death|0|||
48749646|NCT01543698|156930149|FG006|Phase 1b|Death|0|||
48749647|NCT01543698|156930150|FG007|Phase 1b|Death|0|||
48749648|NCT01543698|156930151|FG008|Phase 1b|Death|0|||
48749649|NCT01543698|156930152|FG009|Phase 1b|Death|0|||
48749650|NCT01543698|156930153|FG010|Phase 1b|Death|1|||
48329475|NCT02561195|155403580|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
48329476|NCT02561195|155403581|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
48642555|NCT01349673|156546078|FG000|Overall Study|Withdrawal by Subject|21|||
48642556|NCT01349673|156546078|FG000|Overall Study|Lost to Follow-up|6|||
48642557|NCT01349673|156546078|FG000|Overall Study|Adverse Event|17|||
48642558|NCT01349673|156546078|FG000|Overall Study|Study Terminated By Sponsor|50|||
48749651|NCT01543698|156930154|FG011|Phase 1b|Death|0|||
48749652|NCT01543698|156930155|FG012|Phase 1b|Death|0|||
48329477|NCT02561195|155403582|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
48329478|NCT02561195|155403583|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
48329479|NCT02561195|155403584|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
48329480|NCT02561195|155403585|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
48642559|NCT01349673|156546078|FG000|Overall Study|Lack of Efficacy|8|||
48642560|NCT02383862|156546079|FG000|3 Month Follow up|Lost to Follow-up|23|||
48642561|NCT02383862|156546080|FG001|3 Month Follow up|Lost to Follow-up|21|||
48642562|NCT03801928|156546082|FG000|Overall Study|Adverse Event|1|||
48642563|NCT03801928|156546083|FG001|Overall Study|Adverse Event|0|||
48642564|NCT03801928|156546084|FG002|Overall Study|Adverse Event|1|||
48642565|NCT03801928|156546085|FG003|Overall Study|Adverse Event|2|||
48642566|NCT03801928|156546086|FG004|Overall Study|Adverse Event|0|||
48642567|NCT03801928|156546087|FG005|Overall Study|Adverse Event|2|||
48642568|NCT03801928|156546082|FG000|Overall Study|Lack of Efficacy|0|||
48642569|NCT03801928|156546083|FG001|Overall Study|Lack of Efficacy|0|||
48642570|NCT03801928|156546084|FG002|Overall Study|Lack of Efficacy|1|||
48642571|NCT03801928|156546085|FG003|Overall Study|Lack of Efficacy|0|||
48642572|NCT03801928|156546086|FG004|Overall Study|Lack of Efficacy|0|||
48642573|NCT03801928|156546087|FG005|Overall Study|Lack of Efficacy|0|||
48642574|NCT03801928|156546082|FG000|Overall Study|Lost to Follow-up|5|||
48642575|NCT03801928|156546083|FG001|Overall Study|Lost to Follow-up|1|||
48642576|NCT03801928|156546084|FG002|Overall Study|Lost to Follow-up|1|||
48642577|NCT03801928|156546085|FG003|Overall Study|Lost to Follow-up|4|||
48642578|NCT03801928|156546086|FG004|Overall Study|Lost to Follow-up|4|||
48642579|NCT03801928|156546087|FG005|Overall Study|Lost to Follow-up|2|||
48642580|NCT03801928|156546082|FG000|Overall Study|Withdrawal by Subject|0|||
48642581|NCT03801928|156546083|FG001|Overall Study|Withdrawal by Subject|0|||
48642582|NCT03801928|156546084|FG002|Overall Study|Withdrawal by Subject|2|||
48642583|NCT03801928|156546085|FG003|Overall Study|Withdrawal by Subject|1|||
48642584|NCT03801928|156546086|FG004|Overall Study|Withdrawal by Subject|0|||
48642585|NCT03801928|156546087|FG005|Overall Study|Withdrawal by Subject|0|||
48642586|NCT03801928|156546082|FG000|Overall Study|Other|0|||
48749653|NCT01543698|156930156|FG013|Phase 1b|Death|0|||
48749654|NCT01543698|156930157|FG014|Phase 1b|Death|0|||
48749655|NCT01543698|156930143|FG000|Phase 1b|Withdrawal by Subject|0|||
48749656|NCT01543698|156930144|FG001|Phase 1b|Withdrawal by Subject|1|||
48749657|NCT01543698|156930145|FG002|Phase 1b|Withdrawal by Subject|0|||
48749658|NCT01543698|156930146|FG003|Phase 1b|Withdrawal by Subject|1|||
48749659|NCT01543698|156930147|FG004|Phase 1b|Withdrawal by Subject|0|||
48329481|NCT02561195|155403586|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
48329482|NCT02561195|155403587|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
48642587|NCT03801928|156546083|FG001|Overall Study|Other|2|||
48642588|NCT03801928|156546084|FG002|Overall Study|Other|0|||
48642589|NCT03801928|156546085|FG003|Overall Study|Other|1|||
48642590|NCT03801928|156546086|FG004|Overall Study|Other|0|||
48642591|NCT03801928|156546087|FG005|Overall Study|Other|1|||
48642592|NCT03688919|156546088|FG000|Overall Study|Lost to Follow-up|2|||
48642593|NCT03688919|156546089|FG001|Overall Study|Lost to Follow-up|1|||
48642594|NCT03688919|156546088|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
48749660|NCT01543698|156930148|FG005|Phase 1b|Withdrawal by Subject|0|||
48749661|NCT01543698|156930149|FG006|Phase 1b|Withdrawal by Subject|1|||
48749662|NCT01543698|156930150|FG007|Phase 1b|Withdrawal by Subject|0|||
48749663|NCT01543698|156930151|FG008|Phase 1b|Withdrawal by Subject|0|||
48749664|NCT01543698|156930152|FG009|Phase 1b|Withdrawal by Subject|0|||
48329483|NCT02561195|155403588|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
48329484|NCT02561195|155403589|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
48642595|NCT03688919|156546089|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
48749665|NCT01543698|156930153|FG010|Phase 1b|Withdrawal by Subject|0|||
48749666|NCT01543698|156930154|FG011|Phase 1b|Withdrawal by Subject|0|||
48642596|NCT04232943|156546094|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
48642597|NCT04232943|156546095|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
48642598|NCT04232943|156546096|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
48642599|NCT04232943|156546094|FG000|Overall Study|Withdrawal by Subject|1|||
48642600|NCT04232943|156546095|FG001|Overall Study|Withdrawal by Subject|1|||
48642601|NCT04232943|156546096|FG002|Overall Study|Withdrawal by Subject|0|||
48329485|NCT02561195|155403576|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
48329486|NCT02561195|155403577|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
48329487|NCT02561195|155403578|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
48642602|NCT00573391|156546097|FG000|Overall Study|study stopped|2|||
48329488|NCT02561195|155403579|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
48329489|NCT02561195|155403580|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
48329490|NCT02561195|155403581|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
48642603|NCT00573391|156546098|FG001|Overall Study|study stopped|2|||
48642604|NCT00573391|156546097|FG000|Overall Study|Death|1|||
48642605|NCT00573391|156546098|FG001|Overall Study|Death|0|||
48642606|NCT02553928|156546100|FG000|Overall Study|Adverse Event|2|||
48642607|NCT02553928|156546101|FG001|Overall Study|Adverse Event|1|||
48642608|NCT02553928|156546100|FG000|Overall Study|Lost to Follow-up|0|||
48642609|NCT02553928|156546101|FG001|Overall Study|Lost to Follow-up|1|||
48642610|NCT02553928|156546100|FG000|Overall Study|Administrative reason(s)|0|||
48642611|NCT02553928|156546101|FG001|Overall Study|Administrative reason(s)|1|||
48642612|NCT01664247|156546102|FG000|Overall Study|Adverse Event|5|||
48642613|NCT01664247|156546103|FG001|Overall Study|Adverse Event|3|||
48642614|NCT01664247|156546102|FG000|Overall Study|Protocol Violation|3|||
48642615|NCT01664247|156546103|FG001|Overall Study|Protocol Violation|5|||
48642616|NCT01664247|156546102|FG000|Overall Study|Withdrawal Criteria|1|||
48642617|NCT01664247|156546103|FG001|Overall Study|Withdrawal Criteria|4|||
48642618|NCT01664247|156546102|FG000|Overall Study|Unclassified|5|||
48642619|NCT01664247|156546103|FG001|Overall Study|Unclassified|29|||
48642620|NCT01282866|156546108|FG000|Overall Study|Adverse Event|1|||
48642621|NCT02289469|156546109|FG000|Overall Study|Unable to match a control|6|||
48642622|NCT02289469|156546110|FG001|Overall Study|Unable to match a control|0|||
48642623|NCT00803361|156546111|FG000|Overall Study|Adverse Event|13|||
48642624|NCT00803361|156546112|FG001|Overall Study|Adverse Event|3|||
48642625|NCT00803361|156546111|FG000|Overall Study|Lack of Efficacy|4|||
48642626|NCT00803361|156546112|FG001|Overall Study|Lack of Efficacy|13|||
48642627|NCT00803361|156546111|FG000|Overall Study|Lost to Follow-up|1|||
48642628|NCT00803361|156546112|FG001|Overall Study|Lost to Follow-up|2|||
48642629|NCT00803361|156546111|FG000|Overall Study|Physician Decision|1|||
48749667|NCT01543698|156930155|FG012|Phase 1b|Withdrawal by Subject|0|||
48749668|NCT01543698|156930156|FG013|Phase 1b|Withdrawal by Subject|0|||
48642630|NCT00803361|156546112|FG001|Overall Study|Physician Decision|0|||
48642631|NCT00803361|156546111|FG000|Overall Study|Protocol Violation|2|||
48642632|NCT00803361|156546112|FG001|Overall Study|Protocol Violation|4|||
48642633|NCT00803361|156546111|FG000|Overall Study|Withdrawal by Subject|5|||
48642634|NCT00803361|156546112|FG001|Overall Study|Withdrawal by Subject|6|||
48642635|NCT02185534|156546116|FG000|First Period|Withdrawal by Subject|0|||
48642636|NCT02185534|156546117|FG001|First Period|Withdrawal by Subject|0|||
48642637|NCT02185534|156546118|FG002|First Period|Withdrawal by Subject|0|||
48642638|NCT02185534|156546119|FG003|First Period|Withdrawal by Subject|1|||
48642639|NCT02185534|156546120|FG004|First Period|Withdrawal by Subject|0|||
48642640|NCT02185534|156546121|FG005|First Period|Withdrawal by Subject|0|||
48642641|NCT02185534|156546116|FG000|First Washout Period|Withdrawal by Subject|1|||
48642642|NCT02185534|156546117|FG001|First Washout Period|Withdrawal by Subject|0|||
48642643|NCT02185534|156546118|FG002|First Washout Period|Withdrawal by Subject|0|||
48642644|NCT02185534|156546119|FG003|First Washout Period|Withdrawal by Subject|0|||
48642645|NCT02185534|156546120|FG004|First Washout Period|Withdrawal by Subject|1|||
48642646|NCT02185534|156546121|FG005|First Washout Period|Withdrawal by Subject|0|||
48642647|NCT02185534|156546116|FG000|First Washout Period|Protocol Violation|0|||
48749669|NCT01543698|156930157|FG014|Phase 1b|Withdrawal by Subject|0|||
48749670|NCT01543698|156930143|FG000|Phase 1b|Adverse Event|1|||
48749671|NCT01543698|156930144|FG001|Phase 1b|Adverse Event|0|||
48749672|NCT01543698|156930145|FG002|Phase 1b|Adverse Event|0|||
48749673|NCT01543698|156930146|FG003|Phase 1b|Adverse Event|1|||
48749674|NCT01543698|156930147|FG004|Phase 1b|Adverse Event|2|||
48749675|NCT01543698|156930148|FG005|Phase 1b|Adverse Event|2|||
48749676|NCT01543698|156930149|FG006|Phase 1b|Adverse Event|0|||
48642648|NCT02185534|156546117|FG001|First Washout Period|Protocol Violation|0|||
48749677|NCT01543698|156930150|FG007|Phase 1b|Adverse Event|0|||
48749678|NCT01543698|156930151|FG008|Phase 1b|Adverse Event|1|||
48749679|NCT01543698|156930152|FG009|Phase 1b|Adverse Event|1|||
48642649|NCT02185534|156546118|FG002|First Washout Period|Protocol Violation|0|||
48642650|NCT02185534|156546119|FG003|First Washout Period|Protocol Violation|0|||
48642651|NCT02185534|156546120|FG004|First Washout Period|Protocol Violation|0|||
48642652|NCT02185534|156546121|FG005|First Washout Period|Protocol Violation|1|||
48642653|NCT00363142|156546122|FG000|Overall Study|Adverse Event|2|||
48642654|NCT00363142|156546123|FG001|Overall Study|Adverse Event|0|||
48642655|NCT00363142|156546122|FG000|Overall Study|Lack of Efficacy|0|||
48642656|NCT00363142|156546123|FG001|Overall Study|Lack of Efficacy|1|||
48642657|NCT00363142|156546122|FG000|Overall Study|Lost to Follow-up|1|||
48642658|NCT00363142|156546123|FG001|Overall Study|Lost to Follow-up|0|||
48642659|NCT00363142|156546122|FG000|Overall Study|Non-compliance|1|||
48642660|NCT00363142|156546123|FG001|Overall Study|Non-compliance|1|||
48642661|NCT00363142|156546122|FG000|Overall Study|Withdrawal by Subject|3|||
48642662|NCT00363142|156546123|FG001|Overall Study|Withdrawal by Subject|1|||
48642663|NCT00527618|156546124|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
48642664|NCT00527618|156546125|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
48642665|NCT00527618|156546124|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
48642666|NCT00527618|156546125|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
48642667|NCT00527618|156546124|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
48642668|NCT00527618|156546125|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
48642669|NCT00527618|156546124|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
48642670|NCT00527618|156546125|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
48749680|NCT01543698|156930153|FG010|Phase 1b|Adverse Event|2|||
48749681|NCT01543698|156930154|FG011|Phase 1b|Adverse Event|0|||
48749682|NCT01543698|156930155|FG012|Phase 1b|Adverse Event|0|||
48749683|NCT01543698|156930156|FG013|Phase 1b|Adverse Event|0|||
48749684|NCT01543698|156930157|FG014|Phase 1b|Adverse Event|0|||
48749685|NCT01543698|156930143|FG000|Phase 1b|Administrative problems|1|||
48749686|NCT01543698|156930144|FG001|Phase 1b|Administrative problems|0|||
48329491|NCT02561195|155403582|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
48329492|NCT02561195|155403583|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
48329493|NCT02561195|155403584|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
48329494|NCT02561195|155403585|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
48329495|NCT02561195|155403586|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
48642671|NCT00527618|156546124|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
48642672|NCT00527618|156546125|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
48642673|NCT00527618|156546124|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
48642674|NCT00527618|156546125|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
48329496|NCT02561195|155403587|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
48329497|NCT02561195|155403588|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
48642675|NCT00648037|156546128|FG000|Overall Study|Not Treated|1|||
48642676|NCT00648037|156546128|FG000|Overall Study|Withdrawal by Subject|1|||
48642677|NCT00648037|156546128|FG000|Overall Study|Adverse Event|11|||
48329498|NCT02561195|155403589|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
48329499|NCT02561195|155403576|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48329500|NCT02561195|155403577|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48329501|NCT02561195|155403578|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48329502|NCT02561195|155403579|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48329503|NCT02561195|155403580|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48329504|NCT02561195|155403581|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48329505|NCT02561195|155403582|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48329506|NCT02561195|155403583|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48642678|NCT00648037|156546128|FG000|Overall Study|Relapse|2|||
48642679|NCT00648037|156546128|FG000|Overall Study|Other|1|||
48642680|NCT00251693|156546129|FG000|Overall Study|Adverse Event|17|||
48642681|NCT00251693|156546130|FG001|Overall Study|Adverse Event|9|||
48642682|NCT00251693|156546131|FG002|Overall Study|Adverse Event|9|||
48642683|NCT00251693|156546129|FG000|Overall Study|Protocol Violation|2|||
48642684|NCT00251693|156546130|FG001|Overall Study|Protocol Violation|0|||
48642685|NCT00251693|156546131|FG002|Overall Study|Protocol Violation|2|||
48642686|NCT00251693|156546129|FG000|Overall Study|Lost to Follow-up|12|||
48642687|NCT00251693|156546130|FG001|Overall Study|Lost to Follow-up|7|||
48642688|NCT00251693|156546131|FG002|Overall Study|Lost to Follow-up|8|||
48642689|NCT00251693|156546129|FG000|Overall Study|Withdrawal by Subject|11|||
48642690|NCT00251693|156546130|FG001|Overall Study|Withdrawal by Subject|17|||
48642691|NCT00251693|156546131|FG002|Overall Study|Withdrawal by Subject|14|||
48642692|NCT00251693|156546129|FG000|Overall Study|Lack of Efficacy|0|||
48749687|NCT01543698|156930145|FG002|Phase 1b|Administrative problems|0|||
48749688|NCT01543698|156930146|FG003|Phase 1b|Administrative problems|0|||
48749689|NCT01543698|156930147|FG004|Phase 1b|Administrative problems|1|||
48329507|NCT02561195|155403584|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
48329508|NCT02561195|155403585|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
48642693|NCT00251693|156546130|FG001|Overall Study|Lack of Efficacy|1|||
48642694|NCT00251693|156546131|FG002|Overall Study|Lack of Efficacy|0|||
48642695|NCT00251693|156546129|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
48642696|NCT00251693|156546130|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
48329509|NCT02561195|155403586|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
48329510|NCT02561195|155403587|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
48329511|NCT02561195|155403588|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
48642697|NCT00251693|156546131|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
48642698|NCT00251693|156546129|FG000|Overall Study|Noncompliant|0|||
48642699|NCT00251693|156546130|FG001|Overall Study|Noncompliant|0|||
48642700|NCT00251693|156546131|FG002|Overall Study|Noncompliant|2|||
48642701|NCT00251693|156546129|FG000|Overall Study|Possible Barrett's esophagus|3|||
48642702|NCT00251693|156546130|FG001|Overall Study|Possible Barrett's esophagus|5|||
48642703|NCT00251693|156546131|FG002|Overall Study|Possible Barrett's esophagus|2|||
48642704|NCT00251693|156546129|FG000|Overall Study|Subject request/subject unavailable|1|||
48642705|NCT00251693|156546130|FG001|Overall Study|Subject request/subject unavailable|2|||
48642706|NCT00251693|156546131|FG002|Overall Study|Subject request/subject unavailable|0|||
48642707|NCT00251693|156546129|FG000|Overall Study|Abnormal laboratory findings|0|||
48642708|NCT00251693|156546130|FG001|Overall Study|Abnormal laboratory findings|0|||
48642709|NCT00251693|156546131|FG002|Overall Study|Abnormal laboratory findings|1|||
48642710|NCT00421148|156546134|FG000|Overall Study|Lost to Follow-up|0|||
48642711|NCT00421148|156546135|FG001|Overall Study|Lost to Follow-up|0|||
48642712|NCT00421148|156546136|FG002|Overall Study|Lost to Follow-up|0|||
48642713|NCT00421148|156546137|FG003|Overall Study|Lost to Follow-up|0|||
48642714|NCT00421148|156546138|FG004|Overall Study|Lost to Follow-up|0|||
48642715|NCT00421148|156546139|FG005|Overall Study|Lost to Follow-up|0|||
48642716|NCT00421148|156546140|FG006|Overall Study|Lost to Follow-up|0|||
48642717|NCT00421148|156546141|FG007|Overall Study|Lost to Follow-up|0|||
48642718|NCT00421148|156546142|FG008|Overall Study|Lost to Follow-up|0|||
48642719|NCT00421148|156546143|FG009|Overall Study|Lost to Follow-up|0|||
48642720|NCT00421148|156546144|FG010|Overall Study|Lost to Follow-up|0|||
48642721|NCT00421148|156546145|FG011|Overall Study|Lost to Follow-up|0|||
48642722|NCT00421148|156546146|FG012|Overall Study|Lost to Follow-up|0|||
48642723|NCT00421148|156546147|FG013|Overall Study|Lost to Follow-up|0|||
48642724|NCT00421148|156546148|FG014|Overall Study|Lost to Follow-up|0|||
48642725|NCT00421148|156546149|FG015|Overall Study|Lost to Follow-up|0|||
48749690|NCT01543698|156930148|FG005|Phase 1b|Administrative problems|0|||
48749691|NCT01543698|156930149|FG006|Phase 1b|Administrative problems|0|||
48749692|NCT01543698|156930150|FG007|Phase 1b|Administrative problems|1|||
48749693|NCT01543698|156930151|FG008|Phase 1b|Administrative problems|0|||
48642726|NCT00421148|156546150|FG016|Overall Study|Lost to Follow-up|0|||
48642727|NCT00421148|156546151|FG017|Overall Study|Lost to Follow-up|1|||
48642728|NCT00421148|156546152|FG018|Overall Study|Lost to Follow-up|0|||
48642729|NCT00421148|156546153|FG019|Overall Study|Lost to Follow-up|0|||
48642730|NCT00421148|156546134|FG000|Overall Study|Withdrawal by Subject|0|||
48642731|NCT00421148|156546135|FG001|Overall Study|Withdrawal by Subject|0|||
48642732|NCT00421148|156546136|FG002|Overall Study|Withdrawal by Subject|0|||
48642733|NCT00421148|156546137|FG003|Overall Study|Withdrawal by Subject|0|||
48642734|NCT00421148|156546138|FG004|Overall Study|Withdrawal by Subject|0|||
48749694|NCT01543698|156930152|FG009|Phase 1b|Administrative problems|0|||
48749695|NCT01543698|156930153|FG010|Phase 1b|Administrative problems|2|||
48749696|NCT01543698|156930154|FG011|Phase 1b|Administrative problems|0|||
48642735|NCT00421148|156546139|FG005|Overall Study|Withdrawal by Subject|0|||
48642736|NCT00421148|156546140|FG006|Overall Study|Withdrawal by Subject|0|||
48642737|NCT00421148|156546141|FG007|Overall Study|Withdrawal by Subject|0|||
48642738|NCT00421148|156546142|FG008|Overall Study|Withdrawal by Subject|0|||
48642739|NCT00421148|156546143|FG009|Overall Study|Withdrawal by Subject|0|||
48642740|NCT00421148|156546144|FG010|Overall Study|Withdrawal by Subject|0|||
48642741|NCT00421148|156546145|FG011|Overall Study|Withdrawal by Subject|0|||
48642742|NCT00421148|156546146|FG012|Overall Study|Withdrawal by Subject|0|||
48642743|NCT00421148|156546147|FG013|Overall Study|Withdrawal by Subject|0|||
48642744|NCT00421148|156546148|FG014|Overall Study|Withdrawal by Subject|0|||
48642745|NCT00421148|156546149|FG015|Overall Study|Withdrawal by Subject|0|||
48642746|NCT00421148|156546150|FG016|Overall Study|Withdrawal by Subject|0|||
48642747|NCT00421148|156546151|FG017|Overall Study|Withdrawal by Subject|1|||
48642748|NCT00421148|156546152|FG018|Overall Study|Withdrawal by Subject|0|||
48642749|NCT00421148|156546153|FG019|Overall Study|Withdrawal by Subject|0|||
48642750|NCT00421148|156546134|FG000|Overall Study|Protocol Violation|0|||
48642751|NCT00421148|156546135|FG001|Overall Study|Protocol Violation|0|||
48642752|NCT00421148|156546136|FG002|Overall Study|Protocol Violation|0|||
48642753|NCT00421148|156546137|FG003|Overall Study|Protocol Violation|0|||
48642754|NCT00421148|156546138|FG004|Overall Study|Protocol Violation|0|||
48642755|NCT00421148|156546139|FG005|Overall Study|Protocol Violation|1|||
48642756|NCT00421148|156546140|FG006|Overall Study|Protocol Violation|0|||
48642757|NCT00421148|156546141|FG007|Overall Study|Protocol Violation|0|||
48642758|NCT00421148|156546142|FG008|Overall Study|Protocol Violation|0|||
48642759|NCT00421148|156546143|FG009|Overall Study|Protocol Violation|0|||
48642760|NCT00421148|156546144|FG010|Overall Study|Protocol Violation|0|||
48642761|NCT00421148|156546145|FG011|Overall Study|Protocol Violation|0|||
48642762|NCT00421148|156546146|FG012|Overall Study|Protocol Violation|0|||
48642763|NCT00421148|156546147|FG013|Overall Study|Protocol Violation|0|||
48642764|NCT00421148|156546148|FG014|Overall Study|Protocol Violation|0|||
48642765|NCT00421148|156546149|FG015|Overall Study|Protocol Violation|0|||
48642766|NCT00421148|156546150|FG016|Overall Study|Protocol Violation|0|||
48642767|NCT00421148|156546151|FG017|Overall Study|Protocol Violation|0|||
48642768|NCT00421148|156546152|FG018|Overall Study|Protocol Violation|1|||
48642769|NCT00421148|156546153|FG019|Overall Study|Protocol Violation|0|||
48642770|NCT00997984|156546155|FG000|Overall Study|Adverse Event|1|||
48642771|NCT00997984|156546156|FG001|Overall Study|Adverse Event|8|||
48642772|NCT00997984|156546157|FG002|Overall Study|Adverse Event|8|||
48642773|NCT00997984|156546155|FG000|Overall Study|Protocol Violation|1|||
48642774|NCT00997984|156546156|FG001|Overall Study|Protocol Violation|3|||
48642775|NCT00997984|156546157|FG002|Overall Study|Protocol Violation|0|||
48642776|NCT00997984|156546155|FG000|Overall Study|Withdrawal by Subject|6|||
48642777|NCT00997984|156546156|FG001|Overall Study|Withdrawal by Subject|9|||
48642778|NCT00997984|156546157|FG002|Overall Study|Withdrawal by Subject|5|||
48642779|NCT00997984|156546155|FG000|Overall Study|Lost to Follow-up|8|||
48642780|NCT00997984|156546156|FG001|Overall Study|Lost to Follow-up|5|||
48642781|NCT00997984|156546157|FG002|Overall Study|Lost to Follow-up|4|||
48642782|NCT00997984|156546155|FG000|Overall Study|Lack of Efficacy|20|||
48642783|NCT00997984|156546156|FG001|Overall Study|Lack of Efficacy|6|||
48642784|NCT00997984|156546157|FG002|Overall Study|Lack of Efficacy|3|||
48642785|NCT00997984|156546155|FG000|Overall Study|Met exclusion criteria|1|||
48642786|NCT00997984|156546156|FG001|Overall Study|Met exclusion criteria|0|||
48642787|NCT00997984|156546157|FG002|Overall Study|Met exclusion criteria|0|||
48642788|NCT00997984|156546155|FG000|Overall Study|non-compliance|0|||
48642789|NCT00997984|156546156|FG001|Overall Study|non-compliance|2|||
48642790|NCT00997984|156546157|FG002|Overall Study|non-compliance|3|||
48642791|NCT00997984|156546155|FG000|Overall Study|Wrong medication dispensed|0|||
48642792|NCT00997984|156546156|FG001|Overall Study|Wrong medication dispensed|1|||
48642793|NCT00997984|156546157|FG002|Overall Study|Wrong medication dispensed|0|||
48642794|NCT00997984|156546155|FG000|Overall Study|Suicidal ideation|0|||
48642795|NCT00997984|156546156|FG001|Overall Study|Suicidal ideation|0|||
48642796|NCT00997984|156546157|FG002|Overall Study|Suicidal ideation|1|||
48642797|NCT00997984|156546155|FG000|Overall Study|Work schedule|0|||
48642798|NCT00997984|156546156|FG001|Overall Study|Work schedule|0|||
48642799|NCT00997984|156546157|FG002|Overall Study|Work schedule|2|||
48642800|NCT00295646|156546163|FG000|Overall Study|Protocol Violation|18|||
48642801|NCT00295646|156546164|FG001|Overall Study|Protocol Violation|20|||
48642802|NCT00295646|156546165|FG002|Overall Study|Protocol Violation|20|||
48642803|NCT00295646|156546166|FG003|Overall Study|Protocol Violation|18|||
48642804|NCT00295646|156546163|FG000|Overall Study|Withdrawal by Subject|8|||
48642805|NCT00295646|156546164|FG001|Overall Study|Withdrawal by Subject|9|||
48642806|NCT00295646|156546165|FG002|Overall Study|Withdrawal by Subject|11|||
48642807|NCT00295646|156546166|FG003|Overall Study|Withdrawal by Subject|14|||
48642808|NCT00295646|156546163|FG000|Overall Study|Lost to Follow-up|0|||
48642809|NCT00295646|156546164|FG001|Overall Study|Lost to Follow-up|5|||
48642810|NCT00295646|156546165|FG002|Overall Study|Lost to Follow-up|1|||
48642811|NCT00295646|156546166|FG003|Overall Study|Lost to Follow-up|5|||
48642812|NCT00295646|156546163|FG000|Overall Study|Death|9|||
48642813|NCT00295646|156546164|FG001|Overall Study|Death|7|||
48642814|NCT00295646|156546165|FG002|Overall Study|Death|18|||
48642815|NCT00295646|156546166|FG003|Overall Study|Death|8|||
48642816|NCT01603043|156546167|FG000|Overall Study|Study Futility|7|||
48642817|NCT01603043|156546168|FG001|Overall Study|Study Futility|3|||
48642818|NCT01284959|156546169|FG000|Overall Study|Withdrawal by Subject|1|||
48642819|NCT01284959|156546170|FG001|Overall Study|Withdrawal by Subject|0|||
48642820|NCT01284959|156546171|FG002|Overall Study|Withdrawal by Subject|0|||
48642821|NCT01284959|156546169|FG000|Overall Study|Adverse Event|0|||
48642822|NCT01284959|156546170|FG001|Overall Study|Adverse Event|0|||
48642823|NCT01284959|156546171|FG002|Overall Study|Adverse Event|1|||
48642824|NCT04179305|156546174|FG000|Overall Study|Death|1|||
48642825|NCT04179305|156546175|FG001|Overall Study|Death|1|||
48642826|NCT04179305|156546176|FG002|Overall Study|Death|0|||
48642827|NCT04179305|156546177|FG003|Overall Study|Death|0|||
48642828|NCT04179305|156546174|FG000|Overall Study|Lost to Follow-up|1|||
48642829|NCT04179305|156546175|FG001|Overall Study|Lost to Follow-up|1|||
48642830|NCT04179305|156546176|FG002|Overall Study|Lost to Follow-up|0|||
48642831|NCT04179305|156546177|FG003|Overall Study|Lost to Follow-up|0|||
48642832|NCT04179305|156546174|FG000|Overall Study|Withdrawal by Subject|0|||
48642833|NCT04179305|156546175|FG001|Overall Study|Withdrawal by Subject|1|||
48642834|NCT04179305|156546176|FG002|Overall Study|Withdrawal by Subject|0|||
48642835|NCT04179305|156546177|FG003|Overall Study|Withdrawal by Subject|0|||
48642836|NCT04179305|156546174|FG000|Overall Study|Did not have scan|1|||
48642837|NCT04179305|156546175|FG001|Overall Study|Did not have scan|0|||
48642838|NCT04179305|156546176|FG002|Overall Study|Did not have scan|0|||
48642839|NCT04179305|156546177|FG003|Overall Study|Did not have scan|0|||
48642840|NCT04179305|156546174|FG000|Overall Study|In hospice care|3|||
48642841|NCT04179305|156546175|FG001|Overall Study|In hospice care|0|||
48642842|NCT04179305|156546176|FG002|Overall Study|In hospice care|0|||
48642843|NCT04179305|156546177|FG003|Overall Study|In hospice care|0|||
48642844|NCT00401843|156546179|FG000|Overall Study|Achieved Complete Response|1|||
48642845|NCT00401843|156546180|FG001|Overall Study|Achieved Complete Response|5|||
48642846|NCT00401843|156546181|FG002|Overall Study|Achieved Complete Response|11|||
48642847|NCT00401843|156546179|FG000|Overall Study|Adverse Event|7|||
48642848|NCT00401843|156546180|FG001|Overall Study|Adverse Event|26|||
48642849|NCT00401843|156546181|FG002|Overall Study|Adverse Event|27|||
48642850|NCT00401843|156546179|FG000|Overall Study|Death|0|||
48642851|NCT00401843|156546180|FG001|Overall Study|Death|8|||
48642852|NCT00401843|156546181|FG002|Overall Study|Death|10|||
48642853|NCT00401843|156546179|FG000|Overall Study|Disease progression|10|||
48642854|NCT00401843|156546180|FG001|Overall Study|Disease progression|60|||
48642855|NCT00401843|156546181|FG002|Overall Study|Disease progression|49|||
48642856|NCT00401843|156546179|FG000|Overall Study|End of Study|1|||
48642857|NCT00401843|156546180|FG001|Overall Study|End of Study|1|||
48642858|NCT00401843|156546181|FG002|Overall Study|End of Study|2|||
48642859|NCT00401843|156546179|FG000|Overall Study|Lost to Follow-up|0|||
48642860|NCT00401843|156546180|FG001|Overall Study|Lost to Follow-up|0|||
48642861|NCT00401843|156546181|FG002|Overall Study|Lost to Follow-up|2|||
48642862|NCT00401843|156546179|FG000|Overall Study|Other Unspecified|0|||
48642863|NCT00401843|156546180|FG001|Overall Study|Other Unspecified|3|||
48642864|NCT00401843|156546181|FG002|Overall Study|Other Unspecified|5|||
48642865|NCT00401843|156546179|FG000|Overall Study|Physician Decision|0|||
48642866|NCT00401843|156546180|FG001|Overall Study|Physician Decision|16|||
48642867|NCT00401843|156546181|FG002|Overall Study|Physician Decision|10|||
48749697|NCT01543698|156930155|FG012|Phase 1b|Administrative problems|0|||
48749698|NCT01543698|156930156|FG013|Phase 1b|Administrative problems|0|||
48749699|NCT01543698|156930157|FG014|Phase 1b|Administrative problems|0|||
48749700|NCT01543698|156930143|FG000|Phase 1b|Protocol Violation|2|||
48749701|NCT01543698|156930144|FG001|Phase 1b|Protocol Violation|0|||
48749702|NCT01543698|156930145|FG002|Phase 1b|Protocol Violation|0|||
48749703|NCT01543698|156930146|FG003|Phase 1b|Protocol Violation|0|||
48749704|NCT01543698|156930147|FG004|Phase 1b|Protocol Violation|0|||
48642868|NCT00401843|156546179|FG000|Overall Study|Protocol Violation|0|||
48642869|NCT00401843|156546180|FG001|Overall Study|Protocol Violation|0|||
48642870|NCT00401843|156546181|FG002|Overall Study|Protocol Violation|1|||
48642871|NCT00401843|156546179|FG000|Overall Study|Withdrawal by Subject|1|||
48642872|NCT00401843|156546180|FG001|Overall Study|Withdrawal by Subject|5|||
48642873|NCT00401843|156546181|FG002|Overall Study|Withdrawal by Subject|5|||
48642874|NCT00401843|156546179|FG000|Overall Study|Withdrawal of consent to study agent|1|||
48642875|NCT00401843|156546180|FG001|Overall Study|Withdrawal of consent to study agent|15|||
48642876|NCT00401843|156546181|FG002|Overall Study|Withdrawal of consent to study agent|17|||
48642877|NCT00401843|156546179|FG000|Overall Study|Randomized but not Treated|0|||
48642878|NCT00401843|156546180|FG001|Overall Study|Randomized but not Treated|2|||
48642879|NCT00401843|156546181|FG002|Overall Study|Randomized but not Treated|3|||
48642880|NCT00401843|156546179|FG000|Overall Study|Received incorrect treatment|0|||
48642881|NCT00401843|156546180|FG001|Overall Study|Received incorrect treatment|3|||
48642882|NCT00401843|156546181|FG002|Overall Study|Received incorrect treatment|0|||
48749705|NCT01543698|156930148|FG005|Phase 1b|Protocol Violation|0|||
48642883|NCT00003869|156546184|FG000|Overall Study|Adverse Event|14|||
48642884|NCT00003869|156546185|FG001|Overall Study|Adverse Event|3|||
48642885|NCT00003869|156546184|FG000|Overall Study|Withdrawal by Subject|21|||
48642886|NCT00003869|156546185|FG001|Overall Study|Withdrawal by Subject|3|||
48642887|NCT00003869|156546184|FG000|Overall Study|Death|1|||
48642888|NCT00003869|156546185|FG001|Overall Study|Death|2|||
48642889|NCT00003869|156546184|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
48642890|NCT00003869|156546185|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
48642891|NCT03364231|156546186|FG000|Overall Study|Adverse Event|1|||
48642892|NCT03364231|156546187|FG001|Overall Study|Adverse Event|4|||
48642893|NCT03364231|156546186|FG000|Overall Study|Death|1|||
48642894|NCT03364231|156546187|FG001|Overall Study|Death|0|||
48642895|NCT03364231|156546186|FG000|Overall Study|Investigator Decision|2|||
48642896|NCT03364231|156546187|FG001|Overall Study|Investigator Decision|2|||
48642897|NCT03364231|156546186|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
48642898|NCT03364231|156546187|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
48642899|NCT03364231|156546186|FG000|Overall Study|Withdrawal of Subject Consent|1|||
48642900|NCT03364231|156546187|FG001|Overall Study|Withdrawal of Subject Consent|0|||
48642901|NCT03364231|156546186|FG000|Overall Study|Reason Not Specified|1|||
48642902|NCT03364231|156546187|FG001|Overall Study|Reason Not Specified|0|||
48642903|NCT03364231|156546186|FG000|Overall Study|Disease Progression|0|||
48642904|NCT03364231|156546187|FG001|Overall Study|Disease Progression|6|||
48642905|NCT03386435|156546188|FG000|Overall Study|Protocol Violation|5|||
48642906|NCT03386435|156546189|FG001|Overall Study|Protocol Violation|7|||
48642907|NCT01182298|156546190|FG000|Overall Study|Lack of Efficacy|4|||
48642908|NCT01182298|156546190|FG000|Overall Study|Withdrawal by Subject|2|||
48642909|NCT00506454|156546200|FG000|Overall Study|Withdrawal by Subject|1|||
48642910|NCT00506454|156546201|FG001|Overall Study|Withdrawal by Subject|1|||
48642911|NCT03666988|156546202|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
48642912|NCT03666988|156546203|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
48642913|NCT03666988|156546204|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
48642914|NCT03666988|156546205|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
48642915|NCT03666988|156546206|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
48642916|NCT03666988|156546207|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
48642917|NCT03666988|156546202|FG000|Part 1 (Up to 28 Months)|Other|0|||
48642918|NCT03666988|156546203|FG001|Part 1 (Up to 28 Months)|Other|1|||
48642919|NCT03666988|156546204|FG002|Part 1 (Up to 28 Months)|Other|1|||
48642920|NCT03666988|156546205|FG003|Part 1 (Up to 28 Months)|Other|0|||
48642921|NCT03666988|156546206|FG004|Part 1 (Up to 28 Months)|Other|0|||
48642922|NCT03666988|156546207|FG005|Part 1 (Up to 28 Months)|Other|0|||
48642923|NCT03666988|156546202|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
48642924|NCT03666988|156546203|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
48642925|NCT03666988|156546204|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
48642926|NCT03666988|156546205|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
48642927|NCT03666988|156546206|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
48642928|NCT03666988|156546207|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
48642929|NCT03666988|156546202|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
48642930|NCT03666988|156546203|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
48642931|NCT03666988|156546204|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
48642932|NCT03666988|156546205|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
48642933|NCT03666988|156546206|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
48642934|NCT03666988|156546207|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
48642935|NCT03666988|156546202|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
48642936|NCT03666988|156546203|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
48642937|NCT03666988|156546204|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
48642938|NCT03666988|156546205|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
48642939|NCT03666988|156546206|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
48642940|NCT03666988|156546207|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
48642941|NCT02131662|156546212|FG000|Overall Study|Protocol Violation|1|||
48642942|NCT02131662|156546213|FG001|Overall Study|Protocol Violation|0|||
48642943|NCT02131662|156546214|FG002|Overall Study|Protocol Violation|0|||
48642944|NCT02131662|156546215|FG003|Overall Study|Protocol Violation|0|||
48642945|NCT02131662|156546216|FG004|Overall Study|Protocol Violation|0|||
48749706|NCT01543698|156930149|FG006|Phase 1b|Protocol Violation|0|||
48749707|NCT01543698|156930150|FG007|Phase 1b|Protocol Violation|0|||
48749708|NCT01543698|156930151|FG008|Phase 1b|Protocol Violation|0|||
48749709|NCT01543698|156930152|FG009|Phase 1b|Protocol Violation|0|||
48749710|NCT01543698|156930153|FG010|Phase 1b|Protocol Violation|0|||
48749711|NCT01543698|156930154|FG011|Phase 1b|Protocol Violation|0|||
48749712|NCT01543698|156930155|FG012|Phase 1b|Protocol Violation|0|||
48749713|NCT01543698|156930156|FG013|Phase 1b|Protocol Violation|0|||
48749714|NCT01543698|156930157|FG014|Phase 1b|Protocol Violation|0|||
48749715|NCT01543698|156930143|FG000|Phase 2|Protocol Violation|0|||
48749716|NCT01543698|156930144|FG001|Phase 2|Protocol Violation|0|||
48749717|NCT01543698|156930145|FG002|Phase 2|Protocol Violation|0|||
48749718|NCT01543698|156930146|FG003|Phase 2|Protocol Violation|0|||
48749719|NCT01543698|156930147|FG004|Phase 2|Protocol Violation|0|||
48749720|NCT01543698|156930148|FG005|Phase 2|Protocol Violation|0|||
48749721|NCT01543698|156930149|FG006|Phase 2|Protocol Violation|0|||
48749722|NCT01543698|156930150|FG007|Phase 2|Protocol Violation|0|||
48749723|NCT01543698|156930151|FG008|Phase 2|Protocol Violation|0|||
48749724|NCT01543698|156930152|FG009|Phase 2|Protocol Violation|0|||
48749725|NCT01543698|156930153|FG010|Phase 2|Protocol Violation|0|||
48749726|NCT01543698|156930154|FG011|Phase 2|Protocol Violation|0|||
48749727|NCT01543698|156930155|FG012|Phase 2|Protocol Violation|1|||
48749728|NCT01543698|156930156|FG013|Phase 2|Protocol Violation|0|||
48749729|NCT01543698|156930157|FG014|Phase 2|Protocol Violation|0|||
48749730|NCT01543698|156930143|FG000|Phase 2|Disease progression|0|||
48749731|NCT01543698|156930144|FG001|Phase 2|Disease progression|0|||
48749732|NCT01543698|156930145|FG002|Phase 2|Disease progression|0|||
48749733|NCT01543698|156930146|FG003|Phase 2|Disease progression|0|||
48749734|NCT01543698|156930147|FG004|Phase 2|Disease progression|0|||
48329512|NCT02561195|155403589|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
48329513|NCT02561195|155403576|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329514|NCT02561195|155403577|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329515|NCT02561195|155403578|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
48642946|NCT02131662|156546212|FG000|Overall Study|Other|2|||
48642947|NCT02131662|156546213|FG001|Overall Study|Other|4|||
48642948|NCT02131662|156546214|FG002|Overall Study|Other|3|||
48642949|NCT02131662|156546215|FG003|Overall Study|Other|3|||
48642950|NCT02131662|156546216|FG004|Overall Study|Other|4|||
48642951|NCT02131662|156546212|FG000|Overall Study|Adverse Event|0|||
48642952|NCT02131662|156546213|FG001|Overall Study|Adverse Event|1|||
48642953|NCT02131662|156546214|FG002|Overall Study|Adverse Event|1|||
48642954|NCT02131662|156546215|FG003|Overall Study|Adverse Event|1|||
48642955|NCT02131662|156546216|FG004|Overall Study|Adverse Event|3|||
48642956|NCT02131662|156546212|FG000|Overall Study|Pregnancy|0|||
48642957|NCT02131662|156546213|FG001|Overall Study|Pregnancy|1|||
48642958|NCT02131662|156546214|FG002|Overall Study|Pregnancy|0|||
48642959|NCT02131662|156546215|FG003|Overall Study|Pregnancy|1|||
48642960|NCT02131662|156546216|FG004|Overall Study|Pregnancy|0|||
48642961|NCT02131662|156546212|FG000|Overall Study|Wish for pregnancy|0|||
48642962|NCT02131662|156546213|FG001|Overall Study|Wish for pregnancy|0|||
48642963|NCT02131662|156546214|FG002|Overall Study|Wish for pregnancy|0|||
48642964|NCT02131662|156546215|FG003|Overall Study|Wish for pregnancy|0|||
48642965|NCT02131662|156546216|FG004|Overall Study|Wish for pregnancy|1|||
48642966|NCT02131662|156546212|FG000|Overall Study|Lack of Efficacy|1|||
48642967|NCT02131662|156546213|FG001|Overall Study|Lack of Efficacy|0|||
48642968|NCT02131662|156546214|FG002|Overall Study|Lack of Efficacy|0|||
48642969|NCT02131662|156546215|FG003|Overall Study|Lack of Efficacy|0|||
48642970|NCT02131662|156546216|FG004|Overall Study|Lack of Efficacy|1|||
48642971|NCT02131662|156546212|FG000|Overall Study|Withdrawal by Subject|1|||
48749735|NCT01543698|156930148|FG005|Phase 2|Disease progression|0|||
48329516|NCT02561195|155403579|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
48749736|NCT01543698|156930149|FG006|Phase 2|Disease progression|0|||
48642972|NCT02131662|156546213|FG001|Overall Study|Withdrawal by Subject|5|||
48642973|NCT02131662|156546214|FG002|Overall Study|Withdrawal by Subject|1|||
48642974|NCT02131662|156546215|FG003|Overall Study|Withdrawal by Subject|5|||
48642975|NCT02131662|156546216|FG004|Overall Study|Withdrawal by Subject|6|||
48642976|NCT02131662|156546212|FG000|Overall Study|Lost to Follow-up|1|||
48642977|NCT02131662|156546213|FG001|Overall Study|Lost to Follow-up|3|||
48642978|NCT02131662|156546214|FG002|Overall Study|Lost to Follow-up|0|||
48642979|NCT02131662|156546215|FG003|Overall Study|Lost to Follow-up|9|||
48642980|NCT02131662|156546216|FG004|Overall Study|Lost to Follow-up|0|||
48749737|NCT01543698|156930150|FG007|Phase 2|Disease progression|0|||
48749738|NCT01543698|156930151|FG008|Phase 2|Disease progression|0|||
48749739|NCT01543698|156930152|FG009|Phase 2|Disease progression|0|||
48749740|NCT01543698|156930153|FG010|Phase 2|Disease progression|0|||
48749741|NCT01543698|156930154|FG011|Phase 2|Disease progression|10|||
48749742|NCT01543698|156930155|FG012|Phase 2|Disease progression|21|||
48329517|NCT02561195|155403580|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
48749743|NCT01543698|156930156|FG013|Phase 2|Disease progression|30|||
48749744|NCT01543698|156930157|FG014|Phase 2|Disease progression|25|||
48749745|NCT01543698|156930143|FG000|Phase 2|Death|0|||
48749746|NCT01543698|156930144|FG001|Phase 2|Death|0|||
48749747|NCT01543698|156930145|FG002|Phase 2|Death|0|||
48749748|NCT01543698|156930146|FG003|Phase 2|Death|0|||
48749749|NCT01543698|156930147|FG004|Phase 2|Death|0|||
48749750|NCT01543698|156930148|FG005|Phase 2|Death|0|||
48749751|NCT01543698|156930149|FG006|Phase 2|Death|0|||
48749752|NCT01543698|156930150|FG007|Phase 2|Death|0|||
48749753|NCT01543698|156930151|FG008|Phase 2|Death|0|||
48749754|NCT01543698|156930152|FG009|Phase 2|Death|0|||
48749755|NCT01543698|156930153|FG010|Phase 2|Death|0|||
48749756|NCT01543698|156930154|FG011|Phase 2|Death|0|||
48749757|NCT01543698|156930155|FG012|Phase 2|Death|1|||
48749758|NCT01543698|156930156|FG013|Phase 2|Death|1|||
48749759|NCT01543698|156930157|FG014|Phase 2|Death|1|||
48749760|NCT01543698|156930143|FG000|Phase 2|Administrative problems|0|||
48749761|NCT01543698|156930144|FG001|Phase 2|Administrative problems|0|||
48329518|NCT02561195|155403581|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329519|NCT02561195|155403582|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329520|NCT02561195|155403583|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329521|NCT02561195|155403584|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329522|NCT02561195|155403585|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329523|NCT02561195|155403586|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329524|NCT02561195|155403587|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
48329525|NCT02561195|155403588|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
48642981|NCT02131662|156546212|FG000|Overall Study|Not treated|2|||
48642982|NCT02131662|156546213|FG001|Overall Study|Not treated|0|||
48642983|NCT02131662|156546214|FG002|Overall Study|Not treated|2|||
48642984|NCT02131662|156546215|FG003|Overall Study|Not treated|2|||
48642985|NCT02131662|156546216|FG004|Overall Study|Not treated|3|||
48642986|NCT01897493|156547492|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
48642987|NCT00755807|156547493|FG000|Acute Phase|Adverse Event|16|||
48642988|NCT00755807|156547494|FG001|Acute Phase|Adverse Event|5|||
48642989|NCT00755807|156547493|FG000|Acute Phase|Protocol Violation|1|||
48642990|NCT00755807|156547494|FG001|Acute Phase|Protocol Violation|3|||
48642991|NCT00755807|156547493|FG000|Acute Phase|Withdrawal by Subject|1|||
48329526|NCT02561195|155403589|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
48329527|NCT02561195|155403576|FG000|Extension Stage (Vaccination 4)|Death|0|||
48329528|NCT02561195|155403577|FG001|Extension Stage (Vaccination 4)|Death|0|||
48329529|NCT02561195|155403578|FG002|Extension Stage (Vaccination 4)|Death|0|||
48329530|NCT02561195|155403579|FG003|Extension Stage (Vaccination 4)|Death|0|||
48329531|NCT02561195|155403580|FG004|Extension Stage (Vaccination 4)|Death|0|||
48329532|NCT02561195|155403581|FG005|Extension Stage (Vaccination 4)|Death|0|||
48329533|NCT02561195|155403582|FG006|Extension Stage (Vaccination 4)|Death|0|||
48329534|NCT02561195|155403583|FG007|Extension Stage (Vaccination 4)|Death|0|||
48329535|NCT02561195|155403584|FG008|Extension Stage (Vaccination 4)|Death|0|||
48329536|NCT02561195|155403585|FG009|Extension Stage (Vaccination 4)|Death|1|||
48329537|NCT02561195|155403586|FG010|Extension Stage (Vaccination 4)|Death|0|||
48329538|NCT02561195|155403587|FG011|Extension Stage (Vaccination 4)|Death|0|||
48329539|NCT02561195|155403588|FG012|Extension Stage (Vaccination 4)|Death|0|||
48329540|NCT02561195|155403589|FG013|Extension Stage (Vaccination 4)|Death|0|||
48329541|NCT02561195|155403576|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48329542|NCT02561195|155403577|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48329543|NCT02561195|155403578|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48329544|NCT02561195|155403579|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48642992|NCT00755807|156547494|FG001|Acute Phase|Withdrawal by Subject|2|||
48642993|NCT00755807|156547493|FG000|Acute Phase|Lack of Efficacy|0|||
48642994|NCT00755807|156547494|FG001|Acute Phase|Lack of Efficacy|1|||
48642995|NCT00755807|156547493|FG000|Acute Phase|Physician Decision|0|||
48642996|NCT00755807|156547494|FG001|Acute Phase|Physician Decision|1|||
48642997|NCT00755807|156547493|FG000|Open-label Extension Phase|Adverse Event|7|||
48642998|NCT00755807|156547494|FG001|Open-label Extension Phase|Adverse Event|7|||
48642999|NCT00755807|156547493|FG000|Open-label Extension Phase|Protocol Violation|5|||
48643000|NCT00755807|156547494|FG001|Open-label Extension Phase|Protocol Violation|2|||
48643001|NCT00755807|156547493|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
48643002|NCT00755807|156547494|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
48643003|NCT00755807|156547493|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
48749762|NCT01543698|156930145|FG002|Phase 2|Administrative problems|0|||
48643004|NCT00755807|156547494|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
48749763|NCT01543698|156930146|FG003|Phase 2|Administrative problems|0|||
48749764|NCT01543698|156930147|FG004|Phase 2|Administrative problems|0|||
48749765|NCT01543698|156930148|FG005|Phase 2|Administrative problems|0|||
48749766|NCT01543698|156930149|FG006|Phase 2|Administrative problems|0|||
48329545|NCT02561195|155403580|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48329546|NCT02561195|155403581|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48329547|NCT02561195|155403582|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
48329548|NCT02561195|155403583|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
48749767|NCT01543698|156930150|FG007|Phase 2|Administrative problems|0|||
48749768|NCT01543698|156930151|FG008|Phase 2|Administrative problems|0|||
48749769|NCT01543698|156930152|FG009|Phase 2|Administrative problems|0|||
48749770|NCT01543698|156930153|FG010|Phase 2|Administrative problems|0|||
48749771|NCT01543698|156930154|FG011|Phase 2|Administrative problems|0|||
48749772|NCT01543698|156930155|FG012|Phase 2|Administrative problems|0|||
48749773|NCT01543698|156930156|FG013|Phase 2|Administrative problems|3|||
48749774|NCT01543698|156930157|FG014|Phase 2|Administrative problems|1|||
48749775|NCT01543698|156930143|FG000|Phase 2|Withdrawal by Subject|0|||
48749776|NCT01543698|156930144|FG001|Phase 2|Withdrawal by Subject|0|||
48749777|NCT01543698|156930145|FG002|Phase 2|Withdrawal by Subject|0|||
48749778|NCT01543698|156930146|FG003|Phase 2|Withdrawal by Subject|0|||
48749779|NCT01543698|156930147|FG004|Phase 2|Withdrawal by Subject|0|||
48749780|NCT01543698|156930148|FG005|Phase 2|Withdrawal by Subject|0|||
48749781|NCT01543698|156930149|FG006|Phase 2|Withdrawal by Subject|0|||
48749782|NCT01543698|156930150|FG007|Phase 2|Withdrawal by Subject|0|||
48749783|NCT01543698|156930151|FG008|Phase 2|Withdrawal by Subject|0|||
48749784|NCT01543698|156930152|FG009|Phase 2|Withdrawal by Subject|0|||
48749785|NCT01543698|156930153|FG010|Phase 2|Withdrawal by Subject|0|||
48749786|NCT01543698|156930154|FG011|Phase 2|Withdrawal by Subject|0|||
48749787|NCT01543698|156930155|FG012|Phase 2|Withdrawal by Subject|0|||
48749788|NCT01543698|156930156|FG013|Phase 2|Withdrawal by Subject|3|||
48749789|NCT01543698|156930157|FG014|Phase 2|Withdrawal by Subject|1|||
48643005|NCT00755807|156547493|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
48643006|NCT00755807|156547494|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
48643007|NCT00755807|156547493|FG000|Open-label Extension Phase|Sponsor Decision|0|||
48643008|NCT00755807|156547494|FG001|Open-label Extension Phase|Sponsor Decision|1|||
48643009|NCT03547908|156547495|FG000|Overall Study|Still On Study|115|||
48643010|NCT03547908|156547496|FG001|Overall Study|Still On Study|118|||
48643011|NCT03547908|156547495|FG000|Overall Study|Lost to Follow-up|2|||
48643012|NCT03547908|156547496|FG001|Overall Study|Lost to Follow-up|2|||
48643013|NCT03547908|156547495|FG000|Overall Study|Withdrew Consent|2|||
48643014|NCT03547908|156547496|FG001|Overall Study|Withdrew Consent|1|||
48643015|NCT03547908|156547495|FG000|Overall Study|Adverse Event|1|||
48643016|NCT03547908|156547496|FG001|Overall Study|Adverse Event|0|||
48643017|NCT03547908|156547495|FG000|Overall Study|Death|1|||
48643018|NCT03547908|156547496|FG001|Overall Study|Death|0|||
48643019|NCT03547908|156547495|FG000|Overall Study|Investigator's Discretion|0|||
48643020|NCT03547908|156547496|FG001|Overall Study|Investigator's Discretion|1|||
48643021|NCT03547908|156547495|FG000|Overall Study|Randomized But Never Treated|1|||
48643022|NCT03547908|156547496|FG001|Overall Study|Randomized But Never Treated|0|||
48643023|NCT05010070|156547497|FG000|Overall Study|Lost to Follow-up|1|||
48329549|NCT02561195|155403584|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48329550|NCT02561195|155403585|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
48643024|NCT05010070|156547497|FG000|Overall Study|Withdrawal by Subject|1|||
48643025|NCT00939107|156547498|FG000|Overall Study|Lost to Follow-up|14|||
48643026|NCT00939107|156547499|FG001|Overall Study|Lost to Follow-up|12|||
48643027|NCT00552071|156547500|FG000|Overall Study|Adverse Event|1|||
48643028|NCT00552071|156547501|FG001|Overall Study|Adverse Event|0|||
48643029|NCT00552071|156547500|FG000|Overall Study|Lack of Efficacy|1|||
48643030|NCT00552071|156547501|FG001|Overall Study|Lack of Efficacy|0|||
48643031|NCT00552071|156547500|FG000|Overall Study|Physician Decision|1|||
48643032|NCT00552071|156547501|FG001|Overall Study|Physician Decision|0|||
48643033|NCT00552071|156547500|FG000|Overall Study|Pregnancy|1|||
48643034|NCT00552071|156547501|FG001|Overall Study|Pregnancy|0|||
48643035|NCT00552071|156547500|FG000|Overall Study|Death|0|||
48643036|NCT00552071|156547501|FG001|Overall Study|Death|1|||
48643037|NCT00552071|156547500|FG000|Overall Study|Withdrawal by Subject|0|||
48643038|NCT00552071|156547501|FG001|Overall Study|Withdrawal by Subject|1|||
48329551|NCT02561195|155403586|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
48329552|NCT02561195|155403587|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
48643039|NCT02628444|156547506|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
48643040|NCT02628444|156547507|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
48749790|NCT01543698|156930143|FG000|Phase 2|Adverse Event|0|||
48749791|NCT01543698|156930144|FG001|Phase 2|Adverse Event|0|||
48643041|NCT02628444|156547508|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
48749792|NCT01543698|156930145|FG002|Phase 2|Adverse Event|0|||
48749793|NCT01543698|156930146|FG003|Phase 2|Adverse Event|0|||
48749794|NCT01543698|156930147|FG004|Phase 2|Adverse Event|0|||
48749795|NCT01543698|156930148|FG005|Phase 2|Adverse Event|0|||
48749796|NCT01543698|156930149|FG006|Phase 2|Adverse Event|0|||
48749797|NCT01543698|156930150|FG007|Phase 2|Adverse Event|0|||
48643042|NCT02628444|156547509|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
48643043|NCT02628444|156547510|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
48643044|NCT02628444|156547511|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
48749798|NCT01543698|156930151|FG008|Phase 2|Adverse Event|0|||
48749799|NCT01543698|156930152|FG009|Phase 2|Adverse Event|0|||
48749800|NCT01543698|156930153|FG010|Phase 2|Adverse Event|0|||
48749801|NCT01543698|156930154|FG011|Phase 2|Adverse Event|1|||
48749802|NCT01543698|156930155|FG012|Phase 2|Adverse Event|3|||
48643045|NCT02628444|156547512|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
48643046|NCT02628444|156547513|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
48643047|NCT02628444|156547514|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
48643048|NCT02628444|156547506|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
48643049|NCT02628444|156547507|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
48643050|NCT02628444|156547508|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
48643051|NCT02628444|156547509|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
48643052|NCT02628444|156547510|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
48643053|NCT02628444|156547511|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
48643054|NCT02628444|156547512|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
48643055|NCT02628444|156547513|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
48643056|NCT02628444|156547514|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
48643057|NCT02628444|156547506|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
48643058|NCT02628444|156547507|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
48643059|NCT02628444|156547508|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
48643060|NCT02628444|156547509|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643061|NCT02628444|156547510|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643062|NCT02628444|156547511|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643063|NCT02628444|156547512|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643064|NCT02628444|156547513|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643065|NCT02628444|156547514|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643066|NCT02628444|156547506|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
48643067|NCT02628444|156547507|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
48643068|NCT02628444|156547508|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
48643069|NCT02628444|156547509|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
48643070|NCT02628444|156547510|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
48643071|NCT02628444|156547511|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
48643072|NCT02628444|156547512|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
48643073|NCT02628444|156547513|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
48643074|NCT02628444|156547514|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
48643075|NCT02628444|156547506|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
48643076|NCT02628444|156547507|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
48643077|NCT02628444|156547508|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
48643078|NCT02628444|156547509|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
48643079|NCT02628444|156547510|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
48643080|NCT02628444|156547511|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
48643081|NCT02628444|156547512|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
48643082|NCT02628444|156547513|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
48643083|NCT02628444|156547514|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
48643084|NCT02628444|156547506|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
48643085|NCT02628444|156547507|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
48643086|NCT02628444|156547508|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
48643087|NCT02628444|156547509|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
48643088|NCT02628444|156547510|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
48643089|NCT02628444|156547511|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
48643090|NCT02628444|156547512|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
48643091|NCT02628444|156547513|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
48749803|NCT01543698|156930156|FG013|Phase 2|Adverse Event|5|||
48749804|NCT01543698|156930157|FG014|Phase 2|Adverse Event|14|||
48749805|NCT02323113|156930162|FG000|Overall Study|Adverse Event|3|||
48749806|NCT02323113|156930163|FG001|Overall Study|Adverse Event|3|||
48749807|NCT02323113|156930164|FG002|Overall Study|Adverse Event|2|||
48749808|NCT02323113|156930165|FG003|Overall Study|Adverse Event|5|||
48749809|NCT02323113|156930166|FG004|Overall Study|Adverse Event|8|||
48749810|NCT02323113|156930167|FG005|Overall Study|Adverse Event|3|||
48749811|NCT02323113|156930168|FG006|Overall Study|Adverse Event|6|||
48749812|NCT02323113|156930169|FG007|Overall Study|Adverse Event|0|||
48749813|NCT02323113|156930162|FG000|Overall Study|Progressive Disease|0|||
48749814|NCT02323113|156930163|FG001|Overall Study|Progressive Disease|1|||
48749815|NCT02323113|156930164|FG002|Overall Study|Progressive Disease|1|||
48749816|NCT02323113|156930165|FG003|Overall Study|Progressive Disease|0|||
48749817|NCT02323113|156930166|FG004|Overall Study|Progressive Disease|0|||
48749818|NCT02323113|156930167|FG005|Overall Study|Progressive Disease|3|||
48749819|NCT02323113|156930168|FG006|Overall Study|Progressive Disease|0|||
48749820|NCT02323113|156930169|FG007|Overall Study|Progressive Disease|0|||
48749821|NCT02323113|156930162|FG000|Overall Study|Symptomatic Deterioration|0|||
48749822|NCT02323113|156930163|FG001|Overall Study|Symptomatic Deterioration|0|||
48749823|NCT02323113|156930164|FG002|Overall Study|Symptomatic Deterioration|1|||
48749824|NCT02323113|156930165|FG003|Overall Study|Symptomatic Deterioration|0|||
48749825|NCT02323113|156930166|FG004|Overall Study|Symptomatic Deterioration|1|||
48749826|NCT02323113|156930167|FG005|Overall Study|Symptomatic Deterioration|0|||
48749827|NCT02323113|156930168|FG006|Overall Study|Symptomatic Deterioration|0|||
48749828|NCT02323113|156930169|FG007|Overall Study|Symptomatic Deterioration|0|||
48749829|NCT02323113|156930162|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
48749830|NCT02323113|156930163|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
48749831|NCT02323113|156930164|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749832|NCT02323113|156930165|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749833|NCT02323113|156930166|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749834|NCT02323113|156930167|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
48749835|NCT02323113|156930168|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
48643092|NCT02628444|156547514|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
48643093|NCT02628444|156547506|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
48643094|NCT02628444|156547507|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
48643095|NCT02628444|156547508|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
48643096|NCT02628444|156547509|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
48643097|NCT02628444|156547510|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
48643098|NCT02628444|156547511|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
48643099|NCT02628444|156547512|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
48643100|NCT02628444|156547513|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
48643101|NCT02628444|156547514|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
48643102|NCT02628444|156547506|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643103|NCT02628444|156547507|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643104|NCT02628444|156547508|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
48643105|NCT02628444|156547509|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
48643106|NCT02628444|156547510|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
48643107|NCT02628444|156547511|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
48643108|NCT02628444|156547512|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
48643109|NCT02628444|156547513|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
48643110|NCT02628444|156547514|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
48643111|NCT02628444|156547506|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
48643112|NCT02628444|156547507|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
48643113|NCT02628444|156547508|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
48643114|NCT02628444|156547509|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
48643115|NCT02628444|156547510|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
48643116|NCT02628444|156547511|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
48643117|NCT02628444|156547512|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
48643118|NCT02628444|156547513|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
48643119|NCT02628444|156547514|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
48643120|NCT02628444|156547506|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
48643121|NCT02628444|156547507|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
48643122|NCT02628444|156547508|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
48643123|NCT02628444|156547509|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
48643124|NCT02628444|156547510|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
48749836|NCT02323113|156930169|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
48749837|NCT02323113|156930162|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749838|NCT02323113|156930163|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
48749839|NCT02323113|156930164|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749840|NCT02323113|156930165|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749841|NCT02323113|156930166|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749842|NCT02323113|156930167|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749843|NCT02323113|156930168|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749844|NCT02323113|156930169|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
48749845|NCT00381485|156930174|FG000|Open-Label Run-In Period|Adverse Event|9|||
48749846|NCT00381485|156930175|FG001|Open-Label Run-In Period|Adverse Event|0|||
48749847|NCT00381485|156930176|FG002|Open-Label Run-In Period|Adverse Event|0|||
48749848|NCT00381485|156930177|FG003|Open-Label Run-In Period|Adverse Event|0|||
48749849|NCT00381485|156930174|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
48749850|NCT00381485|156930175|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
48749851|NCT00381485|156930176|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
48749852|NCT00381485|156930177|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
48749853|NCT00381485|156930174|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
48749854|NCT00381485|156930175|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
48749855|NCT00381485|156930176|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
48749856|NCT00381485|156930177|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
48749857|NCT00381485|156930174|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
48749858|NCT00381485|156930175|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
48749859|NCT00381485|156930176|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
48749860|NCT00381485|156930177|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
48749861|NCT00381485|156930174|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
48749862|NCT00381485|156930175|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
48749863|NCT00381485|156930176|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
48329553|NCT02561195|155403588|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
48329554|NCT02561195|155403589|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
48329555|NCT02561195|155403576|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48383938|NCT01109173|155601496|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
48643125|NCT02628444|156547511|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
48643126|NCT02628444|156547512|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
48643127|NCT02628444|156547513|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
48643128|NCT02628444|156547514|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
48643129|NCT02829996|156547515|FG000|Overall Study|Withdrawal by Subject|1|||
48643130|NCT02829996|156547516|FG001|Overall Study|Withdrawal by Subject|0|||
48643131|NCT02829996|156547517|FG002|Overall Study|Withdrawal by Subject|0|||
48643132|NCT02829996|156547518|FG003|Overall Study|Withdrawal by Subject|0|||
48643133|NCT02829996|156547519|FG004|Overall Study|Withdrawal by Subject|0|||
48643134|NCT00066690|156547520|FG000|Overall Study|Adverse Event|145|||
48643135|NCT00066690|156547521|FG001|Overall Study|Adverse Event|58|||
48643136|NCT00066690|156547522|FG002|Overall Study|Adverse Event|126|||
48643137|NCT00066690|156547520|FG000|Overall Study|Death|3|||
48643138|NCT00066690|156547521|FG001|Overall Study|Death|0|||
48643139|NCT00066690|156547522|FG002|Overall Study|Death|2|||
48643140|NCT00066690|156547520|FG000|Overall Study|Lack of Efficacy|114|||
48643141|NCT00066690|156547521|FG001|Overall Study|Lack of Efficacy|110|||
48643142|NCT00066690|156547522|FG002|Overall Study|Lack of Efficacy|76|||
48643143|NCT00066690|156547520|FG000|Overall Study|Lost to Follow-up|40|||
48643144|NCT00066690|156547521|FG001|Overall Study|Lost to Follow-up|21|||
48643145|NCT00066690|156547522|FG002|Overall Study|Lost to Follow-up|29|||
48643146|NCT00066690|156547520|FG000|Overall Study|Withdrawal by Subject|50|||
48643147|NCT00066690|156547521|FG001|Overall Study|Withdrawal by Subject|55|||
48643148|NCT00066690|156547522|FG002|Overall Study|Withdrawal by Subject|49|||
48643149|NCT00066690|156547520|FG000|Overall Study|Treatment Ongoing|246|||
48643150|NCT00066690|156547521|FG001|Overall Study|Treatment Ongoing|278|||
48643151|NCT00066690|156547522|FG002|Overall Study|Treatment Ongoing|282|||
48643152|NCT00892008|156547523|FG000|Overall Study|Death|5|||
48643153|NCT00892008|156547523|FG000|Overall Study|Lack of Efficacy|3|||
48643154|NCT00892008|156547523|FG000|Overall Study|Lost to Follow-up|142|||
48643155|NCT00892008|156547523|FG000|Overall Study|Other|378|||
48643156|NCT00892008|156547523|FG000|Overall Study|Adverse Event|37|||
48643157|NCT00551031|156547524|FG000|Overall Study|Adverse Event|0|||
48643158|NCT00551031|156547525|FG001|Overall Study|Adverse Event|1|||
48643159|NCT00551031|156547526|FG002|Overall Study|Adverse Event|0|||
48643160|NCT00551031|156547527|FG003|Overall Study|Adverse Event|0|||
48643161|NCT00551031|156547528|FG004|Overall Study|Adverse Event|0|||
48643162|NCT00551031|156547524|FG000|Overall Study|Protocol Violation|1|||
48643163|NCT00551031|156547525|FG001|Overall Study|Protocol Violation|1|||
48643164|NCT00551031|156547526|FG002|Overall Study|Protocol Violation|0|||
48643165|NCT00551031|156547527|FG003|Overall Study|Protocol Violation|0|||
48643166|NCT00551031|156547528|FG004|Overall Study|Protocol Violation|0|||
48749864|NCT00381485|156930177|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
48749865|NCT00381485|156930174|FG000|Open-Label Run-In Period|Treatment failure|1|||
48749866|NCT00381485|156930175|FG001|Open-Label Run-In Period|Treatment failure|0|||
48749867|NCT00381485|156930176|FG002|Open-Label Run-In Period|Treatment failure|0|||
48749868|NCT00381485|156930177|FG003|Open-Label Run-In Period|Treatment failure|0|||
48749869|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48749870|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Adverse Event|2|||
48749871|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Adverse Event|2|||
48749872|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Adverse Event|5|||
48749873|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
48749874|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
48749875|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
48749876|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
48749877|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48749878|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
48749879|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
48749880|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
48749881|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
48749882|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
48749883|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
48749884|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
48749885|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
48749886|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
48749887|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
48749888|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
48749889|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
48749890|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
48749891|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
48749892|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
48749893|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
48749894|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
48749895|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
48749896|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
48749897|NCT00381485|156930174|FG000|Double-Blind Treatment Period|Administrative|0|||
48749898|NCT00381485|156930175|FG001|Double-Blind Treatment Period|Administrative|1|||
48749899|NCT00381485|156930176|FG002|Double-Blind Treatment Period|Administrative|0|||
48749900|NCT00381485|156930177|FG003|Double-Blind Treatment Period|Administrative|1|||
48749901|NCT01235351|156930178|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
48749902|NCT01235351|156930179|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
48749903|NCT01918774|156930180|FG000|Overall Study|Lost prior to first CBTw session|4|||
48749904|NCT01918774|156930180|FG000|Overall Study|Lost to Follow-up|1|||
48749905|NCT02324569|156930203|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
48749906|NCT02324569|156930204|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
48749907|NCT02324569|156930203|FG000|Overall Study|Voluntary Withdrawal|3|||
48749908|NCT02324569|156930204|FG001|Overall Study|Voluntary Withdrawal|6|||
48749909|NCT02324569|156930203|FG000|Overall Study|Lack of Efficacy|2|||
48643167|NCT00551031|156547524|FG000|Overall Study|Lost to Follow-up|0|||
48643168|NCT00551031|156547525|FG001|Overall Study|Lost to Follow-up|1|||
48643169|NCT00551031|156547526|FG002|Overall Study|Lost to Follow-up|0|||
48643170|NCT00551031|156547527|FG003|Overall Study|Lost to Follow-up|1|||
48643171|NCT00551031|156547528|FG004|Overall Study|Lost to Follow-up|1|||
48643172|NCT00551031|156547524|FG000|Overall Study|Withdrawal by Subject|0|||
48643173|NCT00551031|156547525|FG001|Overall Study|Withdrawal by Subject|4|||
48643174|NCT00551031|156547526|FG002|Overall Study|Withdrawal by Subject|1|||
48643175|NCT00551031|156547527|FG003|Overall Study|Withdrawal by Subject|2|||
48643176|NCT00551031|156547528|FG004|Overall Study|Withdrawal by Subject|0|||
48643177|NCT00551031|156547524|FG000|Overall Study|Serious Adverse Event|0|||
48643178|NCT00551031|156547525|FG001|Overall Study|Serious Adverse Event|2|||
48643179|NCT00551031|156547526|FG002|Overall Study|Serious Adverse Event|1|||
48643180|NCT00551031|156547527|FG003|Overall Study|Serious Adverse Event|0|||
48643181|NCT00551031|156547528|FG004|Overall Study|Serious Adverse Event|0|||
48643182|NCT00551031|156547524|FG000|Overall Study|Did not receive vaccine|1|||
48643183|NCT00551031|156547525|FG001|Overall Study|Did not receive vaccine|2|||
48643184|NCT00551031|156547526|FG002|Overall Study|Did not receive vaccine|0|||
48643185|NCT00551031|156547527|FG003|Overall Study|Did not receive vaccine|0|||
48643186|NCT00551031|156547528|FG004|Overall Study|Did not receive vaccine|0|||
48643187|NCT02903823|156547529|FG000|Overall Study|Physician Decision|5|||
48643188|NCT02903823|156547529|FG000|Overall Study|Could not advance catheter|1|||
48749910|NCT02324569|156930204|FG001|Overall Study|Lack of Efficacy|3|||
48749911|NCT02324569|156930203|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
48749912|NCT02324569|156930204|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
48749913|NCT02324569|156930203|FG000|Overall Study|Inconvenient Schedule|2|||
48749914|NCT02324569|156930204|FG001|Overall Study|Inconvenient Schedule|0|||
48749915|NCT01892293|156930217|FG000|Overall Study|Apheresed but not treated|4|||
48749916|NCT00599924|156930218|FG000|Overall Study|Lack of Efficacy|3|||
48749917|NCT00599924|156930219|FG001|Overall Study|Lack of Efficacy|5|||
48749918|NCT00599924|156930220|FG002|Overall Study|Lack of Efficacy|1|||
48749919|NCT00599924|156930221|FG003|Overall Study|Lack of Efficacy|2|||
48749920|NCT00599924|156930222|FG004|Overall Study|Lack of Efficacy|3|||
48749921|NCT00599924|156930223|FG005|Overall Study|Lack of Efficacy|2|||
48749922|NCT00599924|156930224|FG006|Overall Study|Lack of Efficacy|0|||
48749923|NCT00599924|156930218|FG000|Overall Study|Adverse Event|0|||
48749924|NCT00599924|156930219|FG001|Overall Study|Adverse Event|0|||
48749925|NCT00599924|156930220|FG002|Overall Study|Adverse Event|0|||
48749926|NCT00599924|156930221|FG003|Overall Study|Adverse Event|2|||
48749927|NCT00599924|156930222|FG004|Overall Study|Adverse Event|0|||
48749928|NCT00599924|156930223|FG005|Overall Study|Adverse Event|0|||
48749929|NCT00599924|156930224|FG006|Overall Study|Adverse Event|2|||
48749930|NCT00599924|156930218|FG000|Overall Study|Death|0|||
48749931|NCT00599924|156930219|FG001|Overall Study|Death|0|||
48749932|NCT00599924|156930220|FG002|Overall Study|Death|0|||
48749933|NCT00599924|156930221|FG003|Overall Study|Death|2|||
48749934|NCT00599924|156930222|FG004|Overall Study|Death|0|||
48749935|NCT00599924|156930223|FG005|Overall Study|Death|2|||
48749936|NCT00599924|156930224|FG006|Overall Study|Death|1|||
48749937|NCT00599924|156930218|FG000|Overall Study|Protocol Violation|0|||
48749938|NCT00599924|156930219|FG001|Overall Study|Protocol Violation|0|||
48749939|NCT00599924|156930220|FG002|Overall Study|Protocol Violation|0|||
48749940|NCT00599924|156930221|FG003|Overall Study|Protocol Violation|1|||
48749941|NCT00599924|156930222|FG004|Overall Study|Protocol Violation|0|||
48749942|NCT00599924|156930223|FG005|Overall Study|Protocol Violation|0|||
48749943|NCT00599924|156930224|FG006|Overall Study|Protocol Violation|0|||
48749944|NCT00599924|156930218|FG000|Overall Study|Withdrawal by Subject|0|||
48749945|NCT00599924|156930219|FG001|Overall Study|Withdrawal by Subject|0|||
48749946|NCT00599924|156930220|FG002|Overall Study|Withdrawal by Subject|1|||
48749947|NCT00599924|156930221|FG003|Overall Study|Withdrawal by Subject|0|||
48749948|NCT00599924|156930222|FG004|Overall Study|Withdrawal by Subject|1|||
48749949|NCT00599924|156930223|FG005|Overall Study|Withdrawal by Subject|0|||
48749950|NCT00599924|156930224|FG006|Overall Study|Withdrawal by Subject|0|||
48749951|NCT00599924|156930218|FG000|Overall Study|Other|0|||
48749952|NCT00599924|156930219|FG001|Overall Study|Other|0|||
48749953|NCT00599924|156930220|FG002|Overall Study|Other|0|||
48749954|NCT00599924|156930221|FG003|Overall Study|Other|1|||
48749955|NCT00599924|156930222|FG004|Overall Study|Other|2|||
48749956|NCT00599924|156930223|FG005|Overall Study|Other|0|||
48749957|NCT00599924|156930224|FG006|Overall Study|Other|2|||
48749958|NCT01397084|156930240|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
48329556|NCT02561195|155403577|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48329557|NCT02561195|155403578|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48749959|NCT01397084|156930240|FG000|Overall Study|Protocol Violation|2|||
48329558|NCT02561195|155403579|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48749960|NCT01397084|156930240|FG000|Overall Study|Adverse Event|2|||
48749961|NCT01397084|156930240|FG000|Overall Study|Withdrawal by Subject|1|||
48749962|NCT01397084|156930240|FG000|Overall Study|Lost to Follow-up|1|||
48749963|NCT01397084|156930240|FG000|Overall Study|Used other proton pump inhibitor|1|||
48749964|NCT00331682|156930243|FG000|Overall Study|Adverse Event|1|||
48749965|NCT00618072|156930244|FG000|Overall Study|Lost to Follow-up|2|||
48749966|NCT00618072|156930245|FG001|Overall Study|Lost to Follow-up|0|||
48749967|NCT00618072|156930246|FG002|Overall Study|Lost to Follow-up|3|||
48643189|NCT02903823|156547529|FG000|Overall Study|Catheter dislodgement|1|||
48643190|NCT02852967|156547530|FG000|Overall Study|Adverse Event|3|||
48749968|NCT00618072|156930244|FG000|Overall Study|Physician Decision|0|||
48749969|NCT00618072|156930245|FG001|Overall Study|Physician Decision|1|||
48749970|NCT00618072|156930246|FG002|Overall Study|Physician Decision|1|||
48749971|NCT03292588|156930247|FG000|Overall Study|Death|1|||
48383939|NCT01109173|155601493|FG000|Overall Study|Not Specifiied|5|||
48643191|NCT02852967|156547531|FG001|Overall Study|Adverse Event|1|||
48643192|NCT02852967|156547532|FG002|Overall Study|Adverse Event|0|||
48643193|NCT02852967|156547533|FG003|Overall Study|Adverse Event|1|||
48643194|NCT02852967|156547534|FG004|Overall Study|Adverse Event|0|||
48643195|NCT02852967|156547530|FG000|Overall Study|Death|1|||
48643196|NCT02852967|156547531|FG001|Overall Study|Death|0|||
48643197|NCT02852967|156547532|FG002|Overall Study|Death|0|||
48643198|NCT02852967|156547533|FG003|Overall Study|Death|0|||
48643199|NCT02852967|156547534|FG004|Overall Study|Death|0|||
48643200|NCT02852967|156547530|FG000|Overall Study|Lost to Follow-up|1|||
48643201|NCT02852967|156547531|FG001|Overall Study|Lost to Follow-up|2|||
48643202|NCT02852967|156547532|FG002|Overall Study|Lost to Follow-up|3|||
48643203|NCT02852967|156547533|FG003|Overall Study|Lost to Follow-up|4|||
48643204|NCT02852967|156547534|FG004|Overall Study|Lost to Follow-up|4|||
48643205|NCT02852967|156547530|FG000|Overall Study|Withdrawal by Subject|6|||
48643206|NCT02852967|156547531|FG001|Overall Study|Withdrawal by Subject|12|||
48643207|NCT02852967|156547532|FG002|Overall Study|Withdrawal by Subject|7|||
48643208|NCT02852967|156547533|FG003|Overall Study|Withdrawal by Subject|10|||
48643209|NCT02852967|156547534|FG004|Overall Study|Withdrawal by Subject|10|||
48643210|NCT02852967|156547530|FG000|Overall Study|SAE|0|||
48643211|NCT02852967|156547531|FG001|Overall Study|SAE|0|||
48643212|NCT02852967|156547532|FG002|Overall Study|SAE|0|||
48643213|NCT02852967|156547533|FG003|Overall Study|SAE|3|||
48643214|NCT02852967|156547534|FG004|Overall Study|SAE|0|||
48643215|NCT02852967|156547530|FG000|Overall Study|Elevated Liver Enzymes|2|||
48643216|NCT02852967|156547531|FG001|Overall Study|Elevated Liver Enzymes|0|||
48643217|NCT02852967|156547532|FG002|Overall Study|Elevated Liver Enzymes|0|||
48643218|NCT02852967|156547533|FG003|Overall Study|Elevated Liver Enzymes|2|||
48643219|NCT02852967|156547534|FG004|Overall Study|Elevated Liver Enzymes|2|||
48643220|NCT02852967|156547530|FG000|Overall Study|Physician Decision|0|||
48643221|NCT02852967|156547531|FG001|Overall Study|Physician Decision|0|||
48643222|NCT02852967|156547532|FG002|Overall Study|Physician Decision|0|||
48643223|NCT02852967|156547533|FG003|Overall Study|Physician Decision|1|||
48643224|NCT02852967|156547534|FG004|Overall Study|Physician Decision|0|||
48643225|NCT02852967|156547530|FG000|Overall Study|Lack of Efficacy|0|||
48643226|NCT02852967|156547531|FG001|Overall Study|Lack of Efficacy|1|||
48643227|NCT02852967|156547532|FG002|Overall Study|Lack of Efficacy|0|||
48643228|NCT02852967|156547533|FG003|Overall Study|Lack of Efficacy|0|||
48643229|NCT02852967|156547534|FG004|Overall Study|Lack of Efficacy|0|||
48643230|NCT02852967|156547530|FG000|Overall Study|Non-compliance|0|||
48643231|NCT02852967|156547531|FG001|Overall Study|Non-compliance|0|||
48643232|NCT02852967|156547532|FG002|Overall Study|Non-compliance|1|||
48643233|NCT02852967|156547533|FG003|Overall Study|Non-compliance|1|||
48643234|NCT02852967|156547534|FG004|Overall Study|Non-compliance|0|||
48643235|NCT02852967|156547530|FG000|Overall Study|Dispensing Drug Violation|0|||
48643236|NCT02852967|156547531|FG001|Overall Study|Dispensing Drug Violation|0|||
48643237|NCT02852967|156547532|FG002|Overall Study|Dispensing Drug Violation|1|||
48643238|NCT02852967|156547533|FG003|Overall Study|Dispensing Drug Violation|0|||
48643239|NCT02852967|156547534|FG004|Overall Study|Dispensing Drug Violation|0|||
48643240|NCT02852967|156547530|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
48643241|NCT02852967|156547531|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
48643242|NCT02852967|156547532|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
48643243|NCT02852967|156547533|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
48643244|NCT02852967|156547534|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
48643245|NCT00355030|156547536|FG000|Study Period 1 Treatment|Adverse Event|1|||
48643246|NCT00355030|156547537|FG001|Study Period 1 Treatment|Adverse Event|1|||
48643247|NCT00355030|156547536|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
48643248|NCT00355030|156547537|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
48643249|NCT00355030|156547536|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
48749972|NCT03292588|156930248|FG001|Overall Study|Death|0|||
48643250|NCT00355030|156547537|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
48643251|NCT00355030|156547536|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
48643252|NCT00355030|156547537|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
48643253|NCT00355030|156547536|FG000|Study Period 1 Treatment|Physician Decision|0|||
48643254|NCT00355030|156547537|FG001|Study Period 1 Treatment|Physician Decision|1|||
48643255|NCT00355030|156547536|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
48643256|NCT00355030|156547537|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
48643257|NCT00355030|156547536|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
48643258|NCT00355030|156547537|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
48643259|NCT00355030|156547536|FG000|Study Period 1 Treatment|Other|2|||
48643260|NCT00355030|156547537|FG001|Study Period 1 Treatment|Other|6|||
48643261|NCT00355030|156547536|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
48643262|NCT00355030|156547537|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
48643263|NCT00355030|156547536|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
48749973|NCT03292588|156930247|FG000|Overall Study|Lost to Follow-up|12|||
48749974|NCT03292588|156930248|FG001|Overall Study|Lost to Follow-up|16|||
48749975|NCT03292588|156930247|FG000|Overall Study|Physician Decision|0|||
48749976|NCT03292588|156930248|FG001|Overall Study|Physician Decision|1|||
48749977|NCT03292588|156930247|FG000|Overall Study|Withdrawal by Subject|4|||
48749978|NCT03292588|156930248|FG001|Overall Study|Withdrawal by Subject|4|||
48749979|NCT03292588|156930247|FG000|Overall Study|Move out of town|1|||
48749980|NCT03292588|156930248|FG001|Overall Study|Move out of town|0|||
48749981|NCT03292588|156930247|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
48749982|NCT03292588|156930248|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
48749983|NCT00592384|156930249|FG000|Overall Study|Withdrawal by Subject|5|||
48749984|NCT00592384|156930250|FG001|Overall Study|Withdrawal by Subject|6|||
48749985|NCT02014597|156930254|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
48749986|NCT02014597|156930255|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
48749987|NCT03555591|156930256|FG000|Overall Study|Protocol Violation|77|||
48749988|NCT01532414|156930257|FG000|Overall Study|Lost to Follow-up|3|||
48749989|NCT01532414|156930258|FG001|Overall Study|Lost to Follow-up|0|||
48749990|NCT01532414|156930259|FG002|Overall Study|Lost to Follow-up|1|||
48749991|NCT01532414|156930257|FG000|Overall Study|Withdrawal by Subject|3|||
48643264|NCT00355030|156547537|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
48643265|NCT01123148|156547538|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
48643266|NCT01123148|156547538|FG000|Overall Study|Didn't meet milestone criteria|1|||
48749992|NCT01532414|156930258|FG001|Overall Study|Withdrawal by Subject|0|||
48749993|NCT01532414|156930259|FG002|Overall Study|Withdrawal by Subject|0|||
48749994|NCT01532414|156930257|FG000|Overall Study|No V6 semen sample|0|||
48749995|NCT01532414|156930258|FG001|Overall Study|No V6 semen sample|1|||
48643267|NCT04240886|156547545|FG000|Treatment Phase|Death|4|||
48643268|NCT04240886|156547545|FG000|Treatment Phase|Discontinuation by Subject|1|||
48643269|NCT04240886|156547545|FG000|Treatment Phase|Adverse Event|5|||
48749996|NCT01532414|156930259|FG002|Overall Study|No V6 semen sample|0|||
48749997|NCT01532414|156930257|FG000|Overall Study|Adverse Event|0|||
48749998|NCT01532414|156930258|FG001|Overall Study|Adverse Event|1|||
48749999|NCT01532414|156930259|FG002|Overall Study|Adverse Event|1|||
48750000|NCT01532414|156930257|FG000|Overall Study|Unable to complete 24 hour PK|0|||
48750001|NCT01532414|156930258|FG001|Overall Study|Unable to complete 24 hour PK|0|||
48750002|NCT01532414|156930259|FG002|Overall Study|Unable to complete 24 hour PK|1|||
48643270|NCT04240886|156547545|FG000|Follow-up Phase|Withdrawal by Subject|1|||
48643271|NCT04240886|156547545|FG000|Follow-up Phase|Discontinuation by Subject|1|||
48643272|NCT04240886|156547545|FG000|Follow-up Phase|Death|2|||
48643273|NCT01146613|156547546|FG000|Overall Study|Lost to Follow-up|3|||
48643274|NCT01146613|156547547|FG001|Overall Study|Lost to Follow-up|8|||
48643275|NCT01146613|156547546|FG000|Overall Study|Lack of Efficacy|0|||
48643276|NCT01146613|156547547|FG001|Overall Study|Lack of Efficacy|1|||
48643277|NCT01146613|156547546|FG000|Overall Study|Death|1|||
48643278|NCT01146613|156547547|FG001|Overall Study|Death|0|||
48643279|NCT01146613|156547546|FG000|Overall Study|Physician Decision|1|||
48643280|NCT01146613|156547547|FG001|Overall Study|Physician Decision|0|||
48643281|NCT01146613|156547546|FG000|Overall Study|Withdrawal by Subject|0|||
48643282|NCT01146613|156547547|FG001|Overall Study|Withdrawal by Subject|3|||
48643283|NCT01146613|156547546|FG000|Overall Study|schedule conflict|1|||
48643284|NCT01146613|156547547|FG001|Overall Study|schedule conflict|0|||
48643285|NCT01146613|156547546|FG000|Overall Study|Outpatient detox|1|||
48643286|NCT01146613|156547547|FG001|Overall Study|Outpatient detox|0|||
48643287|NCT01639469|156547548|FG000|Overall Study|Death|4|||
48643288|NCT01639469|156547549|FG001|Overall Study|Death|2|||
48643289|NCT01639469|156547548|FG000|Overall Study|Lost to Follow-up|1|||
48643290|NCT01639469|156547549|FG001|Overall Study|Lost to Follow-up|1|||
48643291|NCT00856609|156547556|FG000|Overall Study|Adverse Event|1|||
48643292|NCT00856609|156547557|FG001|Overall Study|Adverse Event|0|||
48643293|NCT01436110|156547558|FG000|Overall Study|Lack of Efficacy|23|||
48643294|NCT01436110|156547559|FG001|Overall Study|Lack of Efficacy|14|||
48643295|NCT01436110|156547560|FG002|Overall Study|Lack of Efficacy|9|||
48750003|NCT01532414|156930257|FG000|Overall Study|Withdrawn by sponsor|1|||
48750004|NCT01532414|156930258|FG001|Overall Study|Withdrawn by sponsor|0|||
48643296|NCT01436110|156547558|FG000|Overall Study|Withdrawal by Subject|6|||
48643297|NCT01436110|156547559|FG001|Overall Study|Withdrawal by Subject|8|||
48643298|NCT01436110|156547560|FG002|Overall Study|Withdrawal by Subject|4|||
48643299|NCT01436110|156547558|FG000|Overall Study|Adverse Event|2|||
48750005|NCT01532414|156930259|FG002|Overall Study|Withdrawn by sponsor|0|||
48750006|NCT00482612|156930260|FG000|In-treatment Period|No study medication administered|0|||
48643300|NCT01436110|156547559|FG001|Overall Study|Adverse Event|1|||
48643301|NCT01436110|156547560|FG002|Overall Study|Adverse Event|2|||
48750007|NCT00482612|156930261|FG001|In-treatment Period|No study medication administered|0|||
48750008|NCT00482612|156930262|FG002|In-treatment Period|No study medication administered|1|||
48750009|NCT00482612|156930263|FG003|In-treatment Period|No study medication administered|0|||
48750010|NCT00482612|156930260|FG000|Follow-up Period|Other|4|||
48750011|NCT00482612|156930261|FG001|Follow-up Period|Other|2|||
48750012|NCT00482612|156930262|FG002|Follow-up Period|Other|1|||
48750013|NCT00482612|156930263|FG003|Follow-up Period|Other|2|||
48750014|NCT00482612|156930260|FG000|Follow-up Period|Lack of compliance|0|||
48750015|NCT00482612|156930261|FG001|Follow-up Period|Lack of compliance|0|||
48750016|NCT00482612|156930262|FG002|Follow-up Period|Lack of compliance|1|||
48750017|NCT00482612|156930263|FG003|Follow-up Period|Lack of compliance|0|||
48750018|NCT00482612|156930260|FG000|Follow-up Period|Lost to Follow-up|0|||
48750019|NCT00482612|156930261|FG001|Follow-up Period|Lost to Follow-up|4|||
48750020|NCT00482612|156930262|FG002|Follow-up Period|Lost to Follow-up|2|||
48750021|NCT00482612|156930263|FG003|Follow-up Period|Lost to Follow-up|1|||
48750022|NCT00482612|156930260|FG000|Follow-up Period|Adverse Event|4|||
48750023|NCT00482612|156930261|FG001|Follow-up Period|Adverse Event|7|||
48750024|NCT00482612|156930262|FG002|Follow-up Period|Adverse Event|9|||
48750025|NCT00482612|156930263|FG003|Follow-up Period|Adverse Event|0|||
48750026|NCT00482612|156930260|FG000|Follow-up Period|Lack of Efficacy|2|||
48750027|NCT00482612|156930261|FG001|Follow-up Period|Lack of Efficacy|0|||
48643302|NCT01436110|156547558|FG000|Overall Study|Physician Decision|3|||
48643303|NCT01436110|156547559|FG001|Overall Study|Physician Decision|1|||
48643304|NCT01436110|156547560|FG002|Overall Study|Physician Decision|1|||
48643305|NCT01436110|156547558|FG000|Overall Study|Lost to Follow-up|1|||
48643306|NCT01436110|156547559|FG001|Overall Study|Lost to Follow-up|1|||
48643307|NCT01436110|156547560|FG002|Overall Study|Lost to Follow-up|3|||
48643308|NCT01436110|156547558|FG000|Overall Study|Protocol Violation|3|||
48643309|NCT01436110|156547559|FG001|Overall Study|Protocol Violation|1|||
48643310|NCT01436110|156547560|FG002|Overall Study|Protocol Violation|1|||
48643311|NCT01436110|156547558|FG000|Overall Study|Did Not Receive Trial Medication|1|||
48643312|NCT01436110|156547559|FG001|Overall Study|Did Not Receive Trial Medication|0|||
48643313|NCT01436110|156547560|FG002|Overall Study|Did Not Receive Trial Medication|3|||
48643314|NCT01847092|156547563|FG000|Overall Study|Adverse Event|12|||
48643315|NCT01847092|156547564|FG001|Overall Study|Adverse Event|3|||
48643316|NCT01847092|156547563|FG000|Overall Study|Withdrawal by Subject|5|||
48643317|NCT01847092|156547564|FG001|Overall Study|Withdrawal by Subject|5|||
48643318|NCT01847092|156547563|FG000|Overall Study|Protocol Specified|8|||
48643319|NCT01847092|156547564|FG001|Overall Study|Protocol Specified|0|||
48643320|NCT01847092|156547563|FG000|Overall Study|Physician Decision|1|||
48643321|NCT01847092|156547564|FG001|Overall Study|Physician Decision|1|||
48750028|NCT00482612|156930262|FG002|Follow-up Period|Lack of Efficacy|1|||
48750029|NCT00482612|156930263|FG003|Follow-up Period|Lack of Efficacy|0|||
48750030|NCT00482612|156930260|FG000|Follow-up Period|Withdrawal by Subject|3|||
48329559|NCT02561195|155403580|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48329560|NCT02561195|155403581|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48643322|NCT01847092|156547563|FG000|Overall Study|Protocol Violation|0|||
48643323|NCT01847092|156547564|FG001|Overall Study|Protocol Violation|2|||
48750031|NCT00482612|156930261|FG001|Follow-up Period|Withdrawal by Subject|5|||
48750032|NCT00482612|156930262|FG002|Follow-up Period|Withdrawal by Subject|7|||
48750033|NCT00482612|156930263|FG003|Follow-up Period|Withdrawal by Subject|2|||
48643324|NCT00825994|156547565|FG000|Overall Study|Withdrawal by Subject|2|||
48750034|NCT00482612|156930260|FG000|Follow-up Period|Reasons not related to trial|1|||
48750035|NCT00482612|156930261|FG001|Follow-up Period|Reasons not related to trial|0|||
48750036|NCT00482612|156930262|FG002|Follow-up Period|Reasons not related to trial|1|||
48750037|NCT00482612|156930263|FG003|Follow-up Period|Reasons not related to trial|3|||
48750038|NCT02483520|156930264|FG000|Overall Study|Lost to Follow-up|3|||
48750039|NCT02483520|156930265|FG001|Overall Study|Lost to Follow-up|4|||
48750040|NCT02483520|156930264|FG000|Overall Study|Withdrawal by Subject|4|||
48750041|NCT02483520|156930265|FG001|Overall Study|Withdrawal by Subject|14|||
48750042|NCT02483520|156930264|FG000|Overall Study|Hospitalized|2|||
48750043|NCT02483520|156930265|FG001|Overall Study|Hospitalized|3|||
48750044|NCT02483520|156930264|FG000|Overall Study|Moved to LTC|2|||
48750045|NCT02483520|156930265|FG001|Overall Study|Moved to LTC|3|||
48750046|NCT02057406|156930266|FG000|Overall Study|Physician Decision|0|||
48643325|NCT00825994|156547565|FG000|Overall Study|Lost to Follow-up|1|||
48643326|NCT00825994|156547565|FG000|Overall Study|Protocol Violation|1|||
48643327|NCT00825994|156547565|FG000|Overall Study|Placebo Responder at V2|1|||
48643328|NCT00443118|156547569|FG000|Overall Study|unknown primary outcome|3|||
48643329|NCT00443118|156547570|FG001|Overall Study|unknown primary outcome|1|||
48643330|NCT00443118|156547571|FG002|Overall Study|unknown primary outcome|0|||
48643331|NCT00443118|156547569|FG000|Overall Study|Withdrawal by Subject|1|||
48643332|NCT00443118|156547570|FG001|Overall Study|Withdrawal by Subject|0|||
48643333|NCT00443118|156547571|FG002|Overall Study|Withdrawal by Subject|0|||
48643334|NCT02651116|156547572|FG000|Overall Study|Adverse Event|0|||
48750047|NCT02057406|156930267|FG001|Overall Study|Physician Decision|0|||
48643335|NCT02651116|156547573|FG001|Overall Study|Adverse Event|1|||
48643336|NCT02651116|156547572|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
48643337|NCT02651116|156547573|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
48643338|NCT00590967|156547574|FG000|Overall Study|Withdrawal by Subject|1|||
48643339|NCT00590967|156547575|FG001|Overall Study|Withdrawal by Subject|1|||
48750048|NCT02057406|156930268|FG002|Overall Study|Physician Decision|2|||
48750049|NCT02057406|156930266|FG000|Overall Study|Withdrawal by Subject|0|||
48750050|NCT02057406|156930267|FG001|Overall Study|Withdrawal by Subject|2|||
48750051|NCT02057406|156930268|FG002|Overall Study|Withdrawal by Subject|0|||
48750052|NCT02057406|156930266|FG000|Overall Study|Lost to Follow-up|0|||
48750053|NCT02057406|156930267|FG001|Overall Study|Lost to Follow-up|0|||
48750054|NCT02057406|156930268|FG002|Overall Study|Lost to Follow-up|1|||
48750055|NCT02057406|156930266|FG000|Overall Study|Death|1|||
48643340|NCT00590967|156547574|FG000|Overall Study|Ineligible|1|||
48643341|NCT00590967|156547575|FG001|Overall Study|Ineligible|0|||
48643342|NCT00590967|156547574|FG000|Overall Study|Poor performance status|0|||
48643343|NCT00590967|156547575|FG001|Overall Study|Poor performance status|1|||
48643344|NCT00590967|156547574|FG000|Overall Study|Non-compliant|0|||
48643345|NCT00590967|156547575|FG001|Overall Study|Non-compliant|2|||
48643346|NCT00590967|156547574|FG000|Overall Study|Did not sign consent form|0|||
48750056|NCT02057406|156930267|FG001|Overall Study|Death|0|||
48750057|NCT02057406|156930268|FG002|Overall Study|Death|0|||
48750058|NCT02057406|156930266|FG000|Overall Study|Protocol Violation|0|||
48750059|NCT02057406|156930267|FG001|Overall Study|Protocol Violation|1|||
48750060|NCT02057406|156930268|FG002|Overall Study|Protocol Violation|0|||
48750061|NCT02057406|156930266|FG000|Overall Study|Patient transportation issues|0|||
48750062|NCT02057406|156930267|FG001|Overall Study|Patient transportation issues|0|||
48750063|NCT02057406|156930268|FG002|Overall Study|Patient transportation issues|1|||
48750064|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Death|3|||
48750065|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Death|3|||
48750066|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Death|0|||
48750067|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Death|0|||
48750068|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
48750069|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
48750070|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
48750071|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
48750072|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
48750073|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
48750074|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
48750075|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
48750076|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
48750077|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
48643347|NCT00590967|156547575|FG001|Overall Study|Did not sign consent form|1|||
48643348|NCT00590967|156547574|FG000|Overall Study|Did not receive chemo per protocol|1|||
48643349|NCT00590967|156547575|FG001|Overall Study|Did not receive chemo per protocol|0|||
48643350|NCT01434654|156547576|FG000|Overall Study|Withdrawal by Subject|1|||
48643351|NCT01434654|156547577|FG001|Overall Study|Withdrawal by Subject|0|||
48643352|NCT01434654|156547576|FG000|Overall Study|Lost to Follow-up|1|||
48643353|NCT01434654|156547577|FG001|Overall Study|Lost to Follow-up|0|||
48643354|NCT03328832|156547578|FG000|Overall Study|Lost to Follow-up|0|||
48643355|NCT03328832|156547579|FG001|Overall Study|Lost to Follow-up|1|||
48643356|NCT00959907|156547580|FG000|Overall Study|Protocol Violation|0|||
48643357|NCT00959907|156547581|FG001|Overall Study|Protocol Violation|1|||
48643358|NCT00959907|156547580|FG000|Overall Study|Adverse Event|1|||
48643359|NCT00959907|156547581|FG001|Overall Study|Adverse Event|0|||
48643360|NCT00959907|156547580|FG000|Overall Study|Withdrawal by Subject|2|||
48643361|NCT00959907|156547581|FG001|Overall Study|Withdrawal by Subject|0|||
48643362|NCT01991483|156547582|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
48643363|NCT01991483|156547583|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
48643364|NCT01991483|156547584|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
48643365|NCT01991483|156547585|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
48643366|NCT01991483|156547582|FG000|Dose Level 600 mg|Physician Decision|0|||
48643367|NCT01991483|156547583|FG001|Dose Level 600 mg|Physician Decision|0|||
48643368|NCT01991483|156547584|FG002|Dose Level 600 mg|Physician Decision|1|||
48643369|NCT01991483|156547585|FG003|Dose Level 600 mg|Physician Decision|0|||
48643370|NCT01991483|156547582|FG000|Dose Level 1000 mg|Protocol Violation|0|||
48643371|NCT01991483|156547583|FG001|Dose Level 1000 mg|Protocol Violation|0|||
48643372|NCT01991483|156547584|FG002|Dose Level 1000 mg|Protocol Violation|0|||
48643373|NCT01991483|156547585|FG003|Dose Level 1000 mg|Protocol Violation|1|||
48643374|NCT04067492|156547586|FG000|Overall Study|Lost to Follow-up|0|||
48643375|NCT04067492|156547587|FG001|Overall Study|Lost to Follow-up|0|||
48643376|NCT04067492|156547588|FG002|Overall Study|Lost to Follow-up|0|||
48643377|NCT04067492|156547589|FG003|Overall Study|Lost to Follow-up|0|||
48643378|NCT04067492|156547590|FG004|Overall Study|Lost to Follow-up|0|||
48643379|NCT04067492|156547591|FG005|Overall Study|Lost to Follow-up|1|||
48643380|NCT04067492|156547586|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
48643381|NCT04067492|156547587|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
48643382|NCT04067492|156547588|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
48643383|NCT04067492|156547589|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
48643384|NCT04067492|156547590|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
48643385|NCT04067492|156547591|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
48643386|NCT04067492|156547586|FG000|Overall Study|COVID-19 epidemiological situation|0|||
48643387|NCT04067492|156547587|FG001|Overall Study|COVID-19 epidemiological situation|0|||
48643388|NCT04067492|156547588|FG002|Overall Study|COVID-19 epidemiological situation|0|||
48643389|NCT04067492|156547589|FG003|Overall Study|COVID-19 epidemiological situation|1|||
48643390|NCT04067492|156547590|FG004|Overall Study|COVID-19 epidemiological situation|0|||
48643391|NCT04067492|156547591|FG005|Overall Study|COVID-19 epidemiological situation|0|||
48643392|NCT00437268|156547592|FG000|Overall Study|Adverse Event|1|||
48643393|NCT00437268|156547593|FG001|Overall Study|Adverse Event|1|||
48643394|NCT00437268|156547592|FG000|Overall Study|Withdrawal by Subject|2|||
48643395|NCT00437268|156547593|FG001|Overall Study|Withdrawal by Subject|2|||
48643396|NCT00437268|156547592|FG000|Overall Study|Progressive disease|9|||
48643397|NCT00437268|156547593|FG001|Overall Study|Progressive disease|9|||
48643398|NCT00437268|156547592|FG000|Overall Study|Physician Decision|1|||
48643399|NCT00437268|156547593|FG001|Overall Study|Physician Decision|0|||
48643400|NCT00437268|156547592|FG000|Overall Study|Death|0|||
48643401|NCT00437268|156547593|FG001|Overall Study|Death|1|||
48643402|NCT01890265|156547595|FG000|Overall Study|Other (Unspecified reason)|0|||
48643403|NCT01890265|156547596|FG001|Overall Study|Other (Unspecified reason)|1|||
48643404|NCT01890265|156547597|FG002|Overall Study|Other (Unspecified reason)|0|||
48643405|NCT01890265|156547598|FG003|Overall Study|Other (Unspecified reason)|0|||
48643406|NCT01890265|156547599|FG004|Overall Study|Other (Unspecified reason)|0|||
48643407|NCT01890265|156547600|FG005|Overall Study|Other (Unspecified reason)|0|||
48643408|NCT01890265|156547595|FG000|Overall Study|Progressive disease|6|||
48643409|NCT01890265|156547596|FG001|Overall Study|Progressive disease|6|||
48643410|NCT01890265|156547597|FG002|Overall Study|Progressive disease|0|||
48643411|NCT01890265|156547598|FG003|Overall Study|Progressive disease|0|||
48643412|NCT01890265|156547599|FG004|Overall Study|Progressive disease|0|||
48643413|NCT01890265|156547600|FG005|Overall Study|Progressive disease|0|||
48643414|NCT01890265|156547595|FG000|Overall Study|Adverse Event|2|||
48643415|NCT01890265|156547596|FG001|Overall Study|Adverse Event|1|||
48383940|NCT01109173|155601494|FG001|Overall Study|Not Specifiied|4|||
48643416|NCT01890265|156547597|FG002|Overall Study|Adverse Event|0|||
48643417|NCT01890265|156547598|FG003|Overall Study|Adverse Event|0|||
48643418|NCT01890265|156547599|FG004|Overall Study|Adverse Event|0|||
48643419|NCT01890265|156547600|FG005|Overall Study|Adverse Event|0|||
48643420|NCT01890265|156547595|FG000|Overall Study|Death|2|||
48643421|NCT01890265|156547596|FG001|Overall Study|Death|3|||
48643422|NCT01890265|156547597|FG002|Overall Study|Death|1|||
48643423|NCT01890265|156547598|FG003|Overall Study|Death|0|||
48643424|NCT01890265|156547599|FG004|Overall Study|Death|0|||
48643425|NCT01890265|156547600|FG005|Overall Study|Death|0|||
48643426|NCT01890265|156547595|FG000|Overall Study|Withdrawal by Subject|0|||
48643427|NCT01890265|156547596|FG001|Overall Study|Withdrawal by Subject|2|||
48643428|NCT01890265|156547597|FG002|Overall Study|Withdrawal by Subject|3|||
48643429|NCT01890265|156547598|FG003|Overall Study|Withdrawal by Subject|0|||
48643430|NCT01890265|156547599|FG004|Overall Study|Withdrawal by Subject|2|||
48643431|NCT01890265|156547600|FG005|Overall Study|Withdrawal by Subject|0|||
48643432|NCT00407602|156547601|FG000|Overall Study|Death - unrelated to device|1|||
48643433|NCT00407602|156547601|FG000|Overall Study|Device explanted|5|||
48643434|NCT00407602|156547601|FG000|Overall Study|Withdrawal by Subject|1|||
48750078|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
48329561|NCT02561195|155403582|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48329562|NCT02561195|155403583|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48329563|NCT02561195|155403584|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48329564|NCT02561195|155403585|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48329565|NCT02561195|155403586|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
48329566|NCT02561195|155403587|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
48329567|NCT02561195|155403588|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
48643435|NCT04466384|156547602|FG000|First Phase|Protocol Violation|1|||
48750079|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
48329568|NCT02561195|155403589|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
48329569|NCT02561195|155403576|FG000|Extension Stage (Vaccination 4)|Other|0|||
48329570|NCT02561195|155403577|FG001|Extension Stage (Vaccination 4)|Other|0|||
48329571|NCT02561195|155403578|FG002|Extension Stage (Vaccination 4)|Other|0|||
48329572|NCT02561195|155403579|FG003|Extension Stage (Vaccination 4)|Other|0|||
48329573|NCT02561195|155403580|FG004|Extension Stage (Vaccination 4)|Other|0|||
48329574|NCT02561195|155403581|FG005|Extension Stage (Vaccination 4)|Other|0|||
48329575|NCT02561195|155403582|FG006|Extension Stage (Vaccination 4)|Other|0|||
48329576|NCT02561195|155403583|FG007|Extension Stage (Vaccination 4)|Other|0|||
48329577|NCT02561195|155403584|FG008|Extension Stage (Vaccination 4)|Other|0|||
48329578|NCT02561195|155403585|FG009|Extension Stage (Vaccination 4)|Other|0|||
48329579|NCT02561195|155403586|FG010|Extension Stage (Vaccination 4)|Other|2|||
48329580|NCT02561195|155403587|FG011|Extension Stage (Vaccination 4)|Other|2|||
48329581|NCT02561195|155403588|FG012|Extension Stage (Vaccination 4)|Other|1|||
48329582|NCT02561195|155403589|FG013|Extension Stage (Vaccination 4)|Other|0|||
48329583|NCT02561195|155403576|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329584|NCT02561195|155403577|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329585|NCT02561195|155403578|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329586|NCT02561195|155403579|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329587|NCT02561195|155403580|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329588|NCT02561195|155403581|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329589|NCT02561195|155403582|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
48329590|NCT02561195|155403583|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329591|NCT02561195|155403584|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329592|NCT02561195|155403585|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329593|NCT02561195|155403586|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
48329594|NCT02561195|155403587|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
48329595|NCT02561195|155403588|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
48329596|NCT02561195|155403589|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
48329597|NCT00800176|155403593|FG000|Overall Study|Adverse Event|2|||
48329598|NCT00800176|155403594|FG001|Overall Study|Adverse Event|1|||
48329599|NCT00800176|155403595|FG002|Overall Study|Adverse Event|0|||
48643436|NCT04466384|156547603|FG001|First Phase|Protocol Violation|0|||
48643437|NCT04466384|156547602|FG000|First Phase|Missing data|1|||
48643438|NCT04466384|156547603|FG001|First Phase|Missing data|0|||
48643439|NCT04466384|156547602|FG000|Cross Over Phase|Physician Decision|1|||
48643440|NCT04466384|156547603|FG001|Cross Over Phase|Physician Decision|0|||
48643441|NCT04466384|156547602|FG000|Cross Over Phase|Withdrawal by Subject|0|||
48643442|NCT04466384|156547603|FG001|Cross Over Phase|Withdrawal by Subject|1|||
48643443|NCT00429182|156547608|FG000|Overall Study|Not evaluable, Disease Progression|2|||
48329600|NCT00800176|155403596|FG003|Overall Study|Adverse Event|2|||
48329601|NCT00800176|155403597|FG004|Overall Study|Adverse Event|1|||
48329602|NCT00800176|155403598|FG005|Overall Study|Adverse Event|1|||
48329603|NCT00800176|155403593|FG000|Overall Study|Refused treatment|3|||
48643444|NCT00429182|156547608|FG000|Overall Study|Not eligible|5|||
48643445|NCT04162470|156547612|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
48643446|NCT02146131|156547613|FG000|Overall Study|Physician Decision|61|||
48643447|NCT02146131|156547614|FG001|Overall Study|Physician Decision|56|||
48643448|NCT00038948|156547619|FG000|Overall Study|Adverse Event|131|||
48643449|NCT00038948|156547620|FG001|Overall Study|Adverse Event|43|||
48643450|NCT00038948|156547619|FG000|Overall Study|Lost to Follow-up|4|||
48643451|NCT00038948|156547620|FG001|Overall Study|Lost to Follow-up|4|||
48643452|NCT00038948|156547619|FG000|Overall Study|Nonmedical event|5|||
48643453|NCT00038948|156547620|FG001|Overall Study|Nonmedical event|7|||
48643454|NCT00038948|156547619|FG000|Overall Study|Withdrawal by Subject|23|||
48643455|NCT00038948|156547620|FG001|Overall Study|Withdrawal by Subject|10|||
48329604|NCT00800176|155403594|FG001|Overall Study|Refused treatment|2|||
48329605|NCT00800176|155403595|FG002|Overall Study|Refused treatment|0|||
48329606|NCT00800176|155403596|FG003|Overall Study|Refused treatment|0|||
48329607|NCT00800176|155403597|FG004|Overall Study|Refused treatment|1|||
48329608|NCT00800176|155403598|FG005|Overall Study|Refused treatment|4|||
48329609|NCT00800176|155403593|FG000|Overall Study|Failure to return|3|||
48329610|NCT00800176|155403594|FG001|Overall Study|Failure to return|3|||
48329611|NCT00800176|155403595|FG002|Overall Study|Failure to return|0|||
48329612|NCT00800176|155403596|FG003|Overall Study|Failure to return|2|||
48329613|NCT00800176|155403597|FG004|Overall Study|Failure to return|0|||
48329614|NCT00800176|155403598|FG005|Overall Study|Failure to return|0|||
48329615|NCT00800176|155403593|FG000|Overall Study|Other|1|||
48329616|NCT00800176|155403594|FG001|Overall Study|Other|0|||
48329617|NCT00800176|155403595|FG002|Overall Study|Other|0|||
48329618|NCT00800176|155403596|FG003|Overall Study|Other|0|||
48329619|NCT00800176|155403597|FG004|Overall Study|Other|2|||
48329620|NCT00800176|155403598|FG005|Overall Study|Other|0|||
48329621|NCT03987074|155403599|FG000|Overall Study|Withdrew Consent|1|||
48329622|NCT03987074|155403600|FG001|Overall Study|Withdrew Consent|1|||
48329623|NCT03987074|155403601|FG002|Overall Study|Withdrew Consent|0|||
48329624|NCT03987074|155403602|FG003|Overall Study|Withdrew Consent|2|||
48329625|NCT03987074|155403603|FG004|Overall Study|Withdrew Consent|1|||
48329626|NCT03987074|155403599|FG000|Overall Study|Adverse Event|2|||
48329627|NCT03987074|155403600|FG001|Overall Study|Adverse Event|1|||
48329628|NCT03987074|155403601|FG002|Overall Study|Adverse Event|0|||
48329629|NCT03987074|155403602|FG003|Overall Study|Adverse Event|0|||
48329630|NCT03987074|155403603|FG004|Overall Study|Adverse Event|1|||
48643456|NCT00038948|156547619|FG000|Overall Study|Protocol Violation|3|||
48643457|NCT00038948|156547620|FG001|Overall Study|Protocol Violation|7|||
48643458|NCT00038948|156547619|FG000|Overall Study|Lack of Efficacy|3|||
48643459|NCT00038948|156547620|FG001|Overall Study|Lack of Efficacy|6|||
48643460|NCT01462929|156549304|FG000|Overall Study|Adverse Event|3|||
48643461|NCT01462929|156549305|FG001|Overall Study|Adverse Event|3|||
48329631|NCT03987074|155403599|FG000|Overall Study|Lost to Follow-up|0|||
48329632|NCT03987074|155403600|FG001|Overall Study|Lost to Follow-up|0|||
48329633|NCT03987074|155403601|FG002|Overall Study|Lost to Follow-up|1|||
48329634|NCT03987074|155403602|FG003|Overall Study|Lost to Follow-up|1|||
48329635|NCT03987074|155403603|FG004|Overall Study|Lost to Follow-up|0|||
48329636|NCT03987074|155403599|FG000|Overall Study|Investigator's Discretion|0|||
48329637|NCT03987074|155403600|FG001|Overall Study|Investigator's Discretion|0|||
48329638|NCT03987074|155403601|FG002|Overall Study|Investigator's Discretion|0|||
48643462|NCT01462929|156549306|FG002|Overall Study|Adverse Event|4|||
48329639|NCT03987074|155403602|FG003|Overall Study|Investigator's Discretion|1|||
48329640|NCT03987074|155403603|FG004|Overall Study|Investigator's Discretion|0|||
48329641|NCT02892019|155403606|FG000|Overall Study|randomized but not treated|0|||
48329642|NCT02892019|155403607|FG001|Overall Study|randomized but not treated|1|||
48329643|NCT02892019|155403606|FG000|Overall Study|Withdrawal by Subject|0|||
48329644|NCT02892019|155403607|FG001|Overall Study|Withdrawal by Subject|1|||
48329645|NCT02892019|155403606|FG000|Overall Study|Adverse Event|1|||
48329646|NCT02892019|155403607|FG001|Overall Study|Adverse Event|1|||
48329647|NCT02326220|155403608|FG000|Double-blind Treatment Period|Adverse Event|1|||
48329648|NCT02326220|155403609|FG001|Double-blind Treatment Period|Adverse Event|2|||
48329649|NCT02326220|155403610|FG002|Double-blind Treatment Period|Adverse Event|0|||
48329650|NCT02326220|155403608|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48329651|NCT02326220|155403609|FG001|Double-blind Treatment Period|Protocol Violation|1|||
48329652|NCT02326220|155403610|FG002|Double-blind Treatment Period|Protocol Violation|0|||
48329653|NCT02326220|155403608|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
48329654|NCT02326220|155403609|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48329655|NCT02326220|155403610|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48329656|NCT02326220|155403608|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
48329657|NCT02326220|155403609|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48329658|NCT02326220|155403610|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
48329659|NCT02326220|155403608|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
48329660|NCT02326220|155403609|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
48329661|NCT02326220|155403610|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
48329662|NCT02114515|155403611|FG000|Overall Study|Lost to Follow-up|52|||
48329663|NCT02114515|155403612|FG001|Overall Study|Lost to Follow-up|55|||
48329664|NCT02114515|155403611|FG000|Overall Study|Death|12|||
48329665|NCT02114515|155403612|FG001|Overall Study|Death|12|||
48329666|NCT02114515|155403611|FG000|Overall Study|Withdrawal by Subject|4|||
48329667|NCT02114515|155403612|FG001|Overall Study|Withdrawal by Subject|22|||
48329668|NCT02114515|155403611|FG000|Overall Study|Other|65|||
48329669|NCT02114515|155403612|FG001|Overall Study|Other|61|||
48329670|NCT01661972|155403614|FG000|Overall Study|Adverse Event|1|||
48329671|NCT01661972|155403615|FG001|Overall Study|Adverse Event|2|||
48329672|NCT01661972|155403614|FG000|Overall Study|Death during Treatment period|1|||
48329673|NCT01661972|155403615|FG001|Overall Study|Death during Treatment period|1|||
48643463|NCT01462929|156549304|FG000|Overall Study|Withdrawal by Subject|2|||
48329674|NCT01661972|155403614|FG000|Overall Study|Withdrawal by Subject|0|||
48329675|NCT01661972|155403615|FG001|Overall Study|Withdrawal by Subject|1|||
48329676|NCT01240590|155403621|FG000|Phase I|Refused further treatment|0|||
48329677|NCT01240590|155403622|FG001|Phase I|Refused further treatment|0|||
48329678|NCT01240590|155403623|FG002|Phase I|Refused further treatment|3|||
48329679|NCT01240590|155403624|FG003|Phase I|Refused further treatment|0|||
48329680|NCT01240590|155403625|FG004|Phase I|Refused further treatment|0|||
48329681|NCT01240590|155403621|FG000|Phase II|Refused further treatment|0|||
48329682|NCT01240590|155403622|FG001|Phase II|Refused further treatment|0|||
48329683|NCT01240590|155403623|FG002|Phase II|Refused further treatment|0|||
48329684|NCT01240590|155403624|FG003|Phase II|Refused further treatment|2|||
48329685|NCT01240590|155403625|FG004|Phase II|Refused further treatment|1|||
48329686|NCT01920932|155405553|FG000|Overall Study|Death|1|||
48329687|NCT01920932|155405553|FG000|Overall Study|Withdrawal of consent|1|||
48329688|NCT03678688|155405554|FG000|Overall Study|Reason not Specified|0|||
48329689|NCT03678688|155405555|FG001|Overall Study|Reason not Specified|0|||
48329690|NCT03678688|155405556|FG002|Overall Study|Reason not Specified|3|||
48329691|NCT03678688|155405557|FG003|Overall Study|Reason not Specified|0|||
48329692|NCT03678688|155405558|FG004|Overall Study|Reason not Specified|1|||
48329693|NCT03678688|155405559|FG005|Overall Study|Reason not Specified|0|||
48329694|NCT03678688|155405560|FG006|Overall Study|Reason not Specified|0|||
48643464|NCT01462929|156549305|FG001|Overall Study|Withdrawal by Subject|1|||
48643465|NCT01462929|156549306|FG002|Overall Study|Withdrawal by Subject|0|||
48643466|NCT01462929|156549304|FG000|Overall Study|Lack of Efficacy|0|||
48329695|NCT03678688|155405561|FG007|Overall Study|Reason not Specified|0|||
48643467|NCT01462929|156549305|FG001|Overall Study|Lack of Efficacy|0|||
48643468|NCT01462929|156549306|FG002|Overall Study|Lack of Efficacy|1|||
48643469|NCT03046446|156549307|FG000|Overall Study|Lack of Efficacy|7|||
48643470|NCT03046446|156549307|FG000|Overall Study|Adverse Event|6|||
48643471|NCT03046446|156549307|FG000|Overall Study|Lost to Follow-up|3|||
48643472|NCT03046446|156549307|FG000|Overall Study|Withdrawal by Subject|14|||
48329696|NCT03678688|155405562|FG008|Overall Study|Reason not Specified|0|||
48329697|NCT03678688|155405554|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
48329698|NCT03678688|155405555|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
48329699|NCT03678688|155405556|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
48329700|NCT03678688|155405557|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
48329701|NCT03678688|155405558|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
48329702|NCT03678688|155405559|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
48329703|NCT03678688|155405560|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
48329704|NCT03678688|155405561|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
48329705|NCT03678688|155405562|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
48329706|NCT03678688|155405554|FG000|Overall Study|Covid Related Adverse Event|0|||
48329707|NCT03678688|155405555|FG001|Overall Study|Covid Related Adverse Event|0|||
48329708|NCT03678688|155405556|FG002|Overall Study|Covid Related Adverse Event|0|||
48329709|NCT03678688|155405557|FG003|Overall Study|Covid Related Adverse Event|0|||
48329710|NCT03678688|155405558|FG004|Overall Study|Covid Related Adverse Event|0|||
48329711|NCT03678688|155405559|FG005|Overall Study|Covid Related Adverse Event|3|||
48329712|NCT03678688|155405560|FG006|Overall Study|Covid Related Adverse Event|1|||
48329713|NCT03678688|155405561|FG007|Overall Study|Covid Related Adverse Event|1|||
48329714|NCT03678688|155405562|FG008|Overall Study|Covid Related Adverse Event|0|||
48329715|NCT03678688|155405554|FG000|Overall Study|Physician Decision|0|||
48329716|NCT03678688|155405555|FG001|Overall Study|Physician Decision|0|||
48329717|NCT03678688|155405556|FG002|Overall Study|Physician Decision|0|||
48329718|NCT03678688|155405557|FG003|Overall Study|Physician Decision|0|||
48329719|NCT03678688|155405558|FG004|Overall Study|Physician Decision|0|||
48329720|NCT03678688|155405559|FG005|Overall Study|Physician Decision|1|||
48329721|NCT03678688|155405560|FG006|Overall Study|Physician Decision|0|||
48329722|NCT03678688|155405561|FG007|Overall Study|Physician Decision|0|||
48329723|NCT03678688|155405562|FG008|Overall Study|Physician Decision|0|||
48329724|NCT03678688|155405554|FG000|Overall Study|Withdrawal by Subject|0|||
48329725|NCT03678688|155405555|FG001|Overall Study|Withdrawal by Subject|0|||
48329726|NCT03678688|155405556|FG002|Overall Study|Withdrawal by Subject|0|||
48329727|NCT03678688|155405557|FG003|Overall Study|Withdrawal by Subject|0|||
48329728|NCT03678688|155405558|FG004|Overall Study|Withdrawal by Subject|0|||
48329729|NCT03678688|155405559|FG005|Overall Study|Withdrawal by Subject|0|||
48329730|NCT03678688|155405560|FG006|Overall Study|Withdrawal by Subject|2|||
48329731|NCT03678688|155405561|FG007|Overall Study|Withdrawal by Subject|1|||
48643473|NCT03046446|156549307|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
48329732|NCT03678688|155405562|FG008|Overall Study|Withdrawal by Subject|0|||
48329733|NCT00378898|155405563|FG000|Overall Study|Withdrawal by Subject|10|||
48329734|NCT00378898|155405564|FG001|Overall Study|Withdrawal by Subject|5|||
48329735|NCT00378898|155405563|FG000|Overall Study|Protocol Violation|1|||
48329736|NCT00378898|155405564|FG001|Overall Study|Protocol Violation|1|||
48329737|NCT00048932|155405565|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
48329738|NCT00048932|155405566|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
48329739|NCT00048932|155405567|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
48329740|NCT00048932|155405565|FG000|Double Blind Period (DB)|Adverse Event|51|||
48329741|NCT00048932|155405566|FG001|Double Blind Period (DB)|Adverse Event|19|||
48329742|NCT00048932|155405567|FG002|Double Blind Period (DB)|Adverse Event|0|||
48329743|NCT00048932|155405565|FG000|Double Blind Period (DB)|Death|5|||
48329744|NCT00048932|155405566|FG001|Double Blind Period (DB)|Death|3|||
48329745|NCT00048932|155405567|FG002|Double Blind Period (DB)|Death|0|||
48329746|NCT00048932|155405565|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
48329747|NCT00048932|155405566|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
48329748|NCT00048932|155405567|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
48329749|NCT00048932|155405565|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
48329750|NCT00048932|155405566|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
48329751|NCT00048932|155405567|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
48329752|NCT00048932|155405565|FG000|Double Blind Period (DB)|Relocation|1|||
48329753|NCT00048932|155405566|FG001|Double Blind Period (DB)|Relocation|0|||
48329754|NCT00048932|155405567|FG002|Double Blind Period (DB)|Relocation|0|||
48329755|NCT00048932|155405565|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
48329756|NCT00048932|155405566|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
48329757|NCT00048932|155405567|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
48329758|NCT00048932|155405565|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
48329759|NCT00048932|155405566|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
48329760|NCT00048932|155405567|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
48329761|NCT00048932|155405565|FG000|Double Blind Period (DB)|Pregnancy|1|||
48329762|NCT00048932|155405566|FG001|Double Blind Period (DB)|Pregnancy|0|||
48329763|NCT00048932|155405567|FG002|Double Blind Period (DB)|Pregnancy|0|||
48329764|NCT00048932|155405565|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
48329765|NCT00048932|155405566|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
48329766|NCT00048932|155405567|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
48643474|NCT03046446|156549307|FG000|Overall Study|Disease Progression (see caveats)|25|||
48643475|NCT03046446|156549307|FG000|Overall Study|Non OA related knee surgery|1|||
48643476|NCT03012334|156549310|FG000|Period 1|Withdrawal by Subject|0|||
48643477|NCT03012334|156549311|FG001|Period 1|Withdrawal by Subject|0|||
48643478|NCT03012334|156549312|FG002|Period 1|Withdrawal by Subject|0|||
48643479|NCT03012334|156549313|FG003|Period 1|Withdrawal by Subject|0|||
48643480|NCT03012334|156549314|FG004|Period 1|Withdrawal by Subject|0|||
48643481|NCT03012334|156549315|FG005|Period 1|Withdrawal by Subject|0|||
48329767|NCT00048932|155405565|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
48329768|NCT00048932|155405566|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
48329769|NCT00048932|155405567|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
48329770|NCT00048932|155405565|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
48329771|NCT00048932|155405566|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
48329772|NCT00048932|155405567|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
48329773|NCT00048932|155405565|FG000|Open Label Period (OL)|Death|0|||
48329774|NCT00048932|155405566|FG001|Open Label Period (OL)|Death|0|||
48329775|NCT00048932|155405567|FG002|Open Label Period (OL)|Death|25|||
48329776|NCT00048932|155405565|FG000|Open Label Period (OL)|Adverse Event|0|||
48329777|NCT00048932|155405566|FG001|Open Label Period (OL)|Adverse Event|0|||
48329778|NCT00048932|155405567|FG002|Open Label Period (OL)|Adverse Event|103|||
48329779|NCT00048932|155405565|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
48329780|NCT00048932|155405566|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
48329781|NCT00048932|155405567|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
48329782|NCT00048932|155405565|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
48329783|NCT00048932|155405566|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
48329784|NCT00048932|155405567|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
48329785|NCT00048932|155405565|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
48329786|NCT00048932|155405566|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
48329787|NCT00048932|155405567|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
48329788|NCT00048932|155405565|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
48329789|NCT00048932|155405566|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
48329790|NCT00048932|155405567|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
48329791|NCT00048932|155405565|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
48329792|NCT00048932|155405566|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
48329793|NCT00048932|155405567|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
48329794|NCT00048932|155405565|FG000|Open Label Period (OL)|Pregnancy|0|||
48329795|NCT00048932|155405566|FG001|Open Label Period (OL)|Pregnancy|0|||
48329796|NCT00048932|155405567|FG002|Open Label Period (OL)|Pregnancy|6|||
48329797|NCT00048932|155405565|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
48329798|NCT00048932|155405566|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
48329799|NCT00048932|155405567|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
48329800|NCT00048932|155405565|FG000|Open Label Period (OL)|Investigator Retiring|0|||
48329801|NCT00048932|155405566|FG001|Open Label Period (OL)|Investigator Retiring|0|||
48329802|NCT00048932|155405567|FG002|Open Label Period (OL)|Investigator Retiring|2|||
48329803|NCT00048932|155405565|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
48329804|NCT00048932|155405566|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
48329805|NCT00048932|155405567|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
48329806|NCT00048932|155405565|FG000|Open Label Period (OL)|Participant Relocated|0|||
48329807|NCT00048932|155405566|FG001|Open Label Period (OL)|Participant Relocated|0|||
48329808|NCT00048932|155405567|FG002|Open Label Period (OL)|Participant Relocated|6|||
48329809|NCT00048932|155405565|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
48329810|NCT00048932|155405566|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
48329811|NCT00048932|155405567|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
48329812|NCT00048932|155405565|FG000|Open Label Period (OL)|Site Closure|0|||
48329813|NCT00048932|155405566|FG001|Open Label Period (OL)|Site Closure|0|||
48329814|NCT00048932|155405567|FG002|Open Label Period (OL)|Site Closure|3|||
48586328|NCT01358578|156338933|FG003|Follow-up Period|Lost to Follow-up|4|||
48586329|NCT01358578|156338934|FG004|Follow-up Period|Lost to Follow-up|0|||
48586330|NCT01358578|156338935|FG005|Follow-up Period|Lost to Follow-up|0|||
48586331|NCT01358578|156338930|FG000|Follow-up Period|non- compliance with study treatment|1|||
48586332|NCT01358578|156338931|FG001|Follow-up Period|non- compliance with study treatment|0|||
48586333|NCT01358578|156338932|FG002|Follow-up Period|non- compliance with study treatment|0|||
48586334|NCT01358578|156338933|FG003|Follow-up Period|non- compliance with study treatment|0|||
48586335|NCT01358578|156338934|FG004|Follow-up Period|non- compliance with study treatment|0|||
48586336|NCT01358578|156338935|FG005|Follow-up Period|non- compliance with study treatment|0|||
48586337|NCT01358578|156338930|FG000|Follow-up Period|Pregnancy|1|||
48586338|NCT01358578|156338931|FG001|Follow-up Period|Pregnancy|0|||
48586339|NCT01358578|156338932|FG002|Follow-up Period|Pregnancy|0|||
48586340|NCT01358578|156338933|FG003|Follow-up Period|Pregnancy|0|||
48586341|NCT01358578|156338934|FG004|Follow-up Period|Pregnancy|0|||
48586342|NCT01358578|156338935|FG005|Follow-up Period|Pregnancy|0|||
48586343|NCT01358578|156338930|FG000|Follow-up Period|Withdrawal by Subject|3|||
48586344|NCT01358578|156338931|FG001|Follow-up Period|Withdrawal by Subject|3|||
48586345|NCT01358578|156338932|FG002|Follow-up Period|Withdrawal by Subject|1|||
48586346|NCT01358578|156338933|FG003|Follow-up Period|Withdrawal by Subject|12|||
48586347|NCT01358578|156338934|FG004|Follow-up Period|Withdrawal by Subject|0|||
48586348|NCT01358578|156338935|FG005|Follow-up Period|Withdrawal by Subject|0|||
48586349|NCT01358578|156338930|FG000|Follow-up Period|Physician Decision|1|||
48586350|NCT01358578|156338931|FG001|Follow-up Period|Physician Decision|1|||
48586351|NCT01358578|156338932|FG002|Follow-up Period|Physician Decision|0|||
48586352|NCT01358578|156338933|FG003|Follow-up Period|Physician Decision|2|||
48643482|NCT03012334|156549316|FG006|Period 1|Withdrawal by Subject|0|||
48643483|NCT03012334|156549317|FG007|Period 1|Withdrawal by Subject|0|||
48643484|NCT03012334|156549318|FG008|Period 1|Withdrawal by Subject|0|||
48643485|NCT03012334|156549319|FG009|Period 1|Withdrawal by Subject|1|||
48643486|NCT03012334|156549310|FG000|Period 2|Withdrawal by Subject|0|||
48643487|NCT03012334|156549311|FG001|Period 2|Withdrawal by Subject|1|||
48643488|NCT03012334|156549312|FG002|Period 2|Withdrawal by Subject|0|||
48643489|NCT03012334|156549313|FG003|Period 2|Withdrawal by Subject|0|||
48643490|NCT03012334|156549314|FG004|Period 2|Withdrawal by Subject|0|||
48643491|NCT03012334|156549315|FG005|Period 2|Withdrawal by Subject|0|||
48643492|NCT03012334|156549316|FG006|Period 2|Withdrawal by Subject|0|||
48643493|NCT03012334|156549317|FG007|Period 2|Withdrawal by Subject|0|||
48643494|NCT03012334|156549318|FG008|Period 2|Withdrawal by Subject|0|||
48643495|NCT03012334|156549319|FG009|Period 2|Withdrawal by Subject|0|||
48643496|NCT03012334|156549310|FG000|Period 2|Protocol Violation|0|||
48643497|NCT03012334|156549311|FG001|Period 2|Protocol Violation|0|||
48643498|NCT03012334|156549312|FG002|Period 2|Protocol Violation|1|||
48643499|NCT03012334|156549313|FG003|Period 2|Protocol Violation|0|||
48643500|NCT03012334|156549314|FG004|Period 2|Protocol Violation|0|||
48643501|NCT03012334|156549315|FG005|Period 2|Protocol Violation|0|||
48643502|NCT03012334|156549316|FG006|Period 2|Protocol Violation|0|||
48643503|NCT03012334|156549317|FG007|Period 2|Protocol Violation|1|||
48643504|NCT03012334|156549318|FG008|Period 2|Protocol Violation|0|||
48643505|NCT03012334|156549319|FG009|Period 2|Protocol Violation|0|||
48643506|NCT03012334|156549310|FG000|Period 4|Non-Compliance|0|||
48643507|NCT03012334|156549311|FG001|Period 4|Non-Compliance|0|||
48643508|NCT03012334|156549312|FG002|Period 4|Non-Compliance|0|||
48643509|NCT03012334|156549313|FG003|Period 4|Non-Compliance|0|||
48643510|NCT03012334|156549314|FG004|Period 4|Non-Compliance|0|||
48643511|NCT03012334|156549315|FG005|Period 4|Non-Compliance|0|||
48643512|NCT03012334|156549316|FG006|Period 4|Non-Compliance|1|||
48643513|NCT03012334|156549317|FG007|Period 4|Non-Compliance|0|||
48643514|NCT03012334|156549318|FG008|Period 4|Non-Compliance|0|||
48643515|NCT03012334|156549319|FG009|Period 4|Non-Compliance|0|||
48643516|NCT03012334|156549310|FG000|Period 4|Adverse Event|0|||
48643517|NCT03012334|156549311|FG001|Period 4|Adverse Event|0|||
48643518|NCT03012334|156549312|FG002|Period 4|Adverse Event|0|||
48643519|NCT03012334|156549313|FG003|Period 4|Adverse Event|0|||
48643520|NCT03012334|156549314|FG004|Period 4|Adverse Event|0|||
48643521|NCT03012334|156549315|FG005|Period 4|Adverse Event|0|||
48643522|NCT03012334|156549316|FG006|Period 4|Adverse Event|0|||
48643523|NCT03012334|156549317|FG007|Period 4|Adverse Event|0|||
48643524|NCT03012334|156549318|FG008|Period 4|Adverse Event|1|||
48643525|NCT03012334|156549319|FG009|Period 4|Adverse Event|0|||
48750080|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
48750081|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
48329815|NCT00048932|155405565|FG000|Open Label Period (OL)|Trial Terminated|0|||
48329816|NCT00048932|155405566|FG001|Open Label Period (OL)|Trial Terminated|0|||
48329817|NCT00048932|155405567|FG002|Open Label Period (OL)|Trial Terminated|1|||
48329818|NCT00048932|155405565|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
48329819|NCT00048932|155405566|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
48329820|NCT00048932|155405567|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
48329821|NCT00048932|155405565|FG000|Open Label Period (OL)|Patient Decision|0|||
48329822|NCT00048932|155405566|FG001|Open Label Period (OL)|Patient Decision|0|||
48329823|NCT00048932|155405567|FG002|Open Label Period (OL)|Patient Decision|4|||
48329824|NCT00048932|155405565|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
48329825|NCT00048932|155405566|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
48329826|NCT00048932|155405567|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
48329827|NCT00048932|155405565|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
48329828|NCT00048932|155405566|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
48329829|NCT00048932|155405567|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
48329830|NCT00048932|155405565|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
48329831|NCT00048932|155405566|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
48643526|NCT00325143|156549320|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
48643527|NCT00325143|156549320|FG000|Overall Study|Migrated/moved from study area|1|||
48643528|NCT00325143|156549320|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
48750082|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
48750083|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
48750084|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
48643529|NCT00325143|156549320|FG000|Overall Study|Withdrawal by Subject|8|||
48643530|NCT03036852|156549321|FG000|Overall Study|Death|2|||
48643531|NCT03036852|156549321|FG000|Overall Study|Lack of Efficacy|2|||
48643532|NCT03036852|156549321|FG000|Overall Study|Adverse Event|1|||
48643533|NCT03036852|156549321|FG000|Overall Study|Lost to Follow-up|1|||
48643534|NCT00305448|156549322|FG000|Overall Study|Protocol Violation|0|||
48643535|NCT00305448|156549323|FG001|Overall Study|Protocol Violation|1|||
48643536|NCT00305448|156549324|FG002|Overall Study|Protocol Violation|0|||
48750085|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
48750086|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
48750087|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
48750088|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
48750089|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
48750090|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
48750091|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
48750092|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Other|6|||
48750093|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Other|3|||
48750094|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Other|0|||
48750095|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Other|0|||
48750096|NCT02051608|156930269|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
48750097|NCT02051608|156930270|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
48750098|NCT02051608|156930271|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
48750099|NCT02051608|156930272|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
48750100|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Adverse Event|0|||
48750101|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Adverse Event|0|||
48750102|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Adverse Event|6|||
48750103|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Adverse Event|8|||
48750104|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Death|0|||
48750105|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Death|0|||
48643537|NCT00305448|156549322|FG000|Overall Study|Withdrawal by Subject|2|||
48750106|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Death|7|||
48750107|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Death|4|||
48750108|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
48750109|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
48750110|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
48750111|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
48750112|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
48750113|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
48643538|NCT00305448|156549323|FG001|Overall Study|Withdrawal by Subject|0|||
48643539|NCT00305448|156549324|FG002|Overall Study|Withdrawal by Subject|1|||
48643540|NCT00305448|156549322|FG000|Overall Study|Adverse Event|1|||
48643541|NCT00305448|156549323|FG001|Overall Study|Adverse Event|0|||
48643542|NCT00305448|156549324|FG002|Overall Study|Adverse Event|1|||
48643543|NCT00305448|156549322|FG000|Overall Study|Disease Progression|27|||
48643544|NCT00305448|156549323|FG001|Overall Study|Disease Progression|31|||
48643545|NCT00305448|156549324|FG002|Overall Study|Disease Progression|28|||
48643546|NCT00305448|156549322|FG000|Overall Study|Subjective Disease Progression|1|||
48643547|NCT00305448|156549323|FG001|Overall Study|Subjective Disease Progression|2|||
48643548|NCT00305448|156549324|FG002|Overall Study|Subjective Disease Progression|2|||
48643549|NCT00305448|156549322|FG000|Overall Study|Tumor Marker Elevation|0|||
48750114|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
48750115|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
48750116|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
48643550|NCT00305448|156549323|FG001|Overall Study|Tumor Marker Elevation|0|||
48643551|NCT00305448|156549324|FG002|Overall Study|Tumor Marker Elevation|1|||
48643552|NCT03073525|156549325|FG000|Overall Study|Withdrawal by Subject|0|||
48643553|NCT03073525|156549326|FG001|Overall Study|Withdrawal by Subject|0|||
48643554|NCT03073525|156549327|FG002|Overall Study|Withdrawal by Subject|3|||
48750117|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
48750118|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
48750119|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
48750120|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
48750121|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
48329832|NCT00048932|155405567|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
48329833|NCT00048932|155405565|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
48329834|NCT00048932|155405566|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
48329835|NCT00048932|155405567|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
48329836|NCT00048932|155405565|FG000|Open Label Period (OL)|Investigator Decision|0|||
48329837|NCT00048932|155405566|FG001|Open Label Period (OL)|Investigator Decision|0|||
48329838|NCT00048932|155405567|FG002|Open Label Period (OL)|Investigator Decision|4|||
48643555|NCT01273038|156549328|FG000|Second Intervention (14 Days)|Adverse Event|0|||
48643556|NCT01273038|156549329|FG001|Second Intervention (14 Days)|Adverse Event|1|||
48643557|NCT01273038|156549328|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
48643558|NCT01273038|156549329|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
48750122|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
48750123|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
48643559|NCT01976299|156549330|FG000|Overall Study|Withdrawal by Subject|3|||
48643560|NCT01976299|156549331|FG001|Overall Study|Withdrawal by Subject|1|||
48643561|NCT01976299|156549330|FG000|Overall Study|Death|4|||
48643562|NCT01976299|156549331|FG001|Overall Study|Death|2|||
48643563|NCT01976299|156549330|FG000|Overall Study|Lost to Follow-up|7|||
48643564|NCT01976299|156549331|FG001|Overall Study|Lost to Follow-up|1|||
48643565|NCT01976299|156549330|FG000|Overall Study|See clarification above in comments|9|||
48750124|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Physician Decision|0|||
48750125|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Physician Decision|0|||
48750126|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Physician Decision|8|||
48643566|NCT01976299|156549331|FG001|Overall Study|See clarification above in comments|2|||
48643567|NCT00742625|156549332|FG000|Remission Induction|Progression|6|||
48643568|NCT00742625|156549332|FG000|Remission Induction|Failed induction|8|||
48643569|NCT00742625|156549332|FG000|Remission Induction|Adverse Event|3|||
48643570|NCT00742625|156549332|FG000|Remission Induction|Death|10|||
48643571|NCT00742625|156549332|FG000|Remission Induction|Refusal|5|||
48643572|NCT00742625|156549332|FG000|Remission Induction|Non protocol treatment|17|||
48643573|NCT00742625|156549332|FG000|Remission Induction|Other, not specified|5|||
48643574|NCT00742625|156549332|FG000|Consolidation|Progression|5|||
48643575|NCT00742625|156549332|FG000|Consolidation|Adverse Event|1|||
48643576|NCT00742625|156549332|FG000|Consolidation|Death|1|||
48643577|NCT00742625|156549332|FG000|Consolidation|Refused|1|||
48643578|NCT00742625|156549332|FG000|Consolidation|Non protocol therapy|13|||
48643579|NCT01306643|156549335|FG000|Overall Study|Adverse Event|5|||
48643580|NCT01306643|156549335|FG000|Overall Study|Disease Progression|7|||
48643581|NCT01306643|156549335|FG000|Overall Study|Other: Change in Eligibility Status|1|||
48643582|NCT01465386|156549339|FG000|Overall Study|Lack of Efficacy|3|||
48643583|NCT01465386|156549339|FG000|Overall Study|Adverse Event|1|||
48643584|NCT01908140|156549340|FG000|Overall Study|Other or Progressive Disease|5|||
48643585|NCT01908140|156549341|FG001|Overall Study|Other or Progressive Disease|12|||
48643586|NCT01908140|156549340|FG000|Overall Study|Lack of Efficacy|7|||
48643587|NCT01908140|156549341|FG001|Overall Study|Lack of Efficacy|5|||
48643588|NCT01908140|156549340|FG000|Overall Study|Withdrawal by Subject|23|||
48643589|NCT01908140|156549341|FG001|Overall Study|Withdrawal by Subject|24|||
48643590|NCT01908140|156549340|FG000|Overall Study|Lost to Follow-up|1|||
48643591|NCT01908140|156549341|FG001|Overall Study|Lost to Follow-up|6|||
48643592|NCT01908140|156549340|FG000|Overall Study|Protocol Violation|8|||
48643593|NCT01908140|156549341|FG001|Overall Study|Protocol Violation|9|||
48643594|NCT01908140|156549340|FG000|Overall Study|Adverse Event|22|||
48643595|NCT01908140|156549341|FG001|Overall Study|Adverse Event|23|||
48643596|NCT01119443|156549343|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
48643597|NCT01119443|156549344|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
48643598|NCT00420381|156549347|FG000|Overall Study|Protocol Violation|1|||
48643599|NCT02329743|156549348|FG000|Overall Study|Adverse Event|1|||
48643600|NCT02329743|156549349|FG001|Overall Study|Adverse Event|1|||
48643601|NCT02329743|156549350|FG002|Overall Study|Adverse Event|3|||
48643602|NCT02329743|156549348|FG000|Overall Study|Lost to Follow-up|1|||
48643603|NCT02329743|156549349|FG001|Overall Study|Lost to Follow-up|0|||
48643604|NCT02329743|156549350|FG002|Overall Study|Lost to Follow-up|1|||
48643605|NCT02329743|156549348|FG000|Overall Study|Withdrawal by Subject|4|||
48643606|NCT02329743|156549349|FG001|Overall Study|Withdrawal by Subject|4|||
48643607|NCT02329743|156549350|FG002|Overall Study|Withdrawal by Subject|1|||
48643608|NCT02329743|156549348|FG000|Overall Study|Other|0|||
48643609|NCT02329743|156549349|FG001|Overall Study|Other|2|||
48643610|NCT02329743|156549350|FG002|Overall Study|Other|3|||
48643611|NCT00506779|156549364|FG000|Overall Study|Withdrawal by Subject|1|||
48643612|NCT00506779|156549365|FG001|Overall Study|Withdrawal by Subject|0|||
48643613|NCT00506779|156549366|FG002|Overall Study|Withdrawal by Subject|1|||
48750127|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Physician Decision|5|||
48329839|NCT00048932|155405565|FG000|Open Label Period (OL)|Site Staff Issues|0|||
48643614|NCT00506779|156549367|FG003|Overall Study|Withdrawal by Subject|0|||
48643615|NCT00506779|156549364|FG000|Overall Study|Adverse Event|0|||
48643616|NCT00506779|156549365|FG001|Overall Study|Adverse Event|1|||
48643617|NCT00506779|156549366|FG002|Overall Study|Adverse Event|1|||
48643618|NCT00506779|156549367|FG003|Overall Study|Adverse Event|1|||
48750128|NCT02051608|156930269|FG000|Part 2: Open-label Extension|Other|0|||
48750129|NCT02051608|156930270|FG001|Part 2: Open-label Extension|Other|0|||
48643619|NCT00570323|156549370|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
48643620|NCT00570323|156549371|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
48643621|NCT00570323|156549370|FG000|Started Treatment After Randomization|Protocol Violation|1|||
48643622|NCT00570323|156549371|FG001|Started Treatment After Randomization|Protocol Violation|0|||
48643623|NCT00570323|156549370|FG000|Started Treatment After Randomization|Physician Decision|1|||
48643624|NCT00570323|156549371|FG001|Started Treatment After Randomization|Physician Decision|0|||
48643625|NCT00570323|156549370|FG000|Complete Study After Start|Lost to Follow-up|0|||
48643626|NCT00570323|156549371|FG001|Complete Study After Start|Lost to Follow-up|1|||
48383941|NCT01109173|155601495|FG002|Overall Study|Not Specifiied|9|||
48643627|NCT00570323|156549370|FG000|Complete Study After Start|Withdrawal by Subject|2|||
48643628|NCT00570323|156549371|FG001|Complete Study After Start|Withdrawal by Subject|0|||
48643629|NCT00570323|156549370|FG000|Complete Study After Start|Physician Decision|1|||
48643630|NCT00570323|156549371|FG001|Complete Study After Start|Physician Decision|0|||
48643631|NCT00310375|156549373|FG000|Primary Reporting Phase|Adverse Event|28|||
48643632|NCT00310375|156549374|FG001|Primary Reporting Phase|Adverse Event|22|||
48643633|NCT00310375|156549375|FG002|Primary Reporting Phase|Adverse Event|0|||
48643634|NCT00310375|156549373|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
48643635|NCT00310375|156549374|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
48643636|NCT00310375|156549375|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
48643637|NCT00310375|156549373|FG000|Primary Reporting Phase|Pregnancy|2|||
48643638|NCT00310375|156549374|FG001|Primary Reporting Phase|Pregnancy|2|||
48643639|NCT00310375|156549375|FG002|Primary Reporting Phase|Pregnancy|0|||
48643640|NCT00310375|156549373|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
48643641|NCT00310375|156549374|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
48643642|NCT00310375|156549375|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
48643643|NCT00310375|156549373|FG000|Primary Reporting Phase|Protocol Violation|8|||
48643644|NCT00310375|156549374|FG001|Primary Reporting Phase|Protocol Violation|5|||
48643645|NCT00310375|156549375|FG002|Primary Reporting Phase|Protocol Violation|0|||
48643646|NCT00310375|156549373|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
48643647|NCT00310375|156549374|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
48643648|NCT00310375|156549375|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
48643649|NCT00310375|156549373|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
48643650|NCT00310375|156549374|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
48643651|NCT00310375|156549375|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
48643652|NCT00310375|156549373|FG000|Primary Reporting Phase|Physician Decision|5|||
48643653|NCT00310375|156549374|FG001|Primary Reporting Phase|Physician Decision|3|||
48643654|NCT00310375|156549375|FG002|Primary Reporting Phase|Physician Decision|0|||
48643655|NCT00310375|156549373|FG000|Primary Reporting Phase|Request of the sponsor|2|||
48643656|NCT00310375|156549374|FG001|Primary Reporting Phase|Request of the sponsor|2|||
48643657|NCT00310375|156549375|FG002|Primary Reporting Phase|Request of the sponsor|0|||
48643658|NCT00310375|156549373|FG000|Primary Reporting Phase|Failed to return|1|||
48643659|NCT00310375|156549374|FG001|Primary Reporting Phase|Failed to return|3|||
48643660|NCT00310375|156549375|FG002|Primary Reporting Phase|Failed to return|0|||
48643661|NCT00310375|156549373|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
48643662|NCT00310375|156549374|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
48643663|NCT00310375|156549375|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
48643664|NCT00310375|156549373|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
48643665|NCT00310375|156549374|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
48643666|NCT00310375|156549375|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
48643667|NCT00310375|156549373|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
48643668|NCT00310375|156549374|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
48643669|NCT00310375|156549375|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
48643670|NCT00310375|156549373|FG000|Primary Reporting Phase|Site closure|3|||
48643671|NCT00310375|156549374|FG001|Primary Reporting Phase|Site closure|0|||
48643672|NCT00310375|156549375|FG002|Primary Reporting Phase|Site closure|0|||
48643673|NCT00310375|156549373|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
48643674|NCT00310375|156549374|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
48643675|NCT00310375|156549375|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
48643676|NCT00310375|156549373|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
48643677|NCT00310375|156549374|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
48643678|NCT00310375|156549375|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
48643679|NCT00310375|156549373|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
48643680|NCT00310375|156549374|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
48643681|NCT00310375|156549375|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
48643682|NCT00310375|156549373|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
48643683|NCT00310375|156549374|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
48643684|NCT00310375|156549375|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
48643685|NCT00413660|156549379|FG000|Up To Week 12|Adverse Event|1|||
48643686|NCT00413660|156549380|FG001|Up To Week 12|Adverse Event|3|||
48643687|NCT00413660|156549381|FG002|Up To Week 12|Adverse Event|1|||
48643688|NCT00413660|156549382|FG003|Up To Week 12|Adverse Event|4|||
48643689|NCT00413660|156549383|FG004|Up To Week 12|Adverse Event|6|||
48643690|NCT00413660|156549384|FG005|Up To Week 12|Adverse Event|4|||
48643691|NCT00413660|156549385|FG006|Up To Week 12|Adverse Event|1|||
48643692|NCT00413660|156549386|FG007|Up To Week 12|Adverse Event|0|||
48643693|NCT00413660|156549387|FG008|Up To Week 12|Adverse Event|0|||
48643694|NCT00413660|156549388|FG009|Up To Week 12|Adverse Event|0|||
48643695|NCT00413660|156549389|FG010|Up To Week 12|Adverse Event|0|||
48643696|NCT00413660|156549379|FG000|Up To Week 12|Lack of Efficacy|2|||
48643697|NCT00413660|156549380|FG001|Up To Week 12|Lack of Efficacy|0|||
48643698|NCT00413660|156549381|FG002|Up To Week 12|Lack of Efficacy|0|||
48643699|NCT00413660|156549382|FG003|Up To Week 12|Lack of Efficacy|0|||
48643700|NCT00413660|156549383|FG004|Up To Week 12|Lack of Efficacy|0|||
48750130|NCT02051608|156930271|FG002|Part 2: Open-label Extension|Other|9|||
48750131|NCT02051608|156930272|FG003|Part 2: Open-label Extension|Other|9|||
48750132|NCT05131646|156930273|FG000|Overall Study|Withdrawal by Subject|1|||
48750133|NCT05131646|156930274|FG001|Overall Study|Withdrawal by Subject|0|||
48750134|NCT05131646|156930275|FG002|Overall Study|Withdrawal by Subject|0|||
48750135|NCT03266107|156930276|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
48750136|NCT03266107|156930276|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
48750137|NCT03266107|156930276|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
48643701|NCT00413660|156549384|FG005|Up To Week 12|Lack of Efficacy|0|||
48643702|NCT00413660|156549385|FG006|Up To Week 12|Lack of Efficacy|5|||
48643703|NCT00413660|156549386|FG007|Up To Week 12|Lack of Efficacy|0|||
48643704|NCT00413660|156549387|FG008|Up To Week 12|Lack of Efficacy|0|||
48750138|NCT03266107|156930276|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
48750139|NCT01812174|156930277|FG000|Overall Study|Death|1|||
48750140|NCT01812174|156930278|FG001|Overall Study|Death|0|||
48750141|NCT01812174|156930277|FG000|Overall Study|Protocol Violation|2|||
48750142|NCT01812174|156930278|FG001|Overall Study|Protocol Violation|0|||
48750143|NCT00171730|156930279|FG000|Overall Study|Adverse Event|3|||
48750144|NCT00171730|156930279|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
48750145|NCT00171730|156930279|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
48750146|NCT00171730|156930279|FG000|Overall Study|Withdrawal by Subject|3|||
48750147|NCT01053221|156930280|FG000|Overall Study|The study was closed prematurely|5|||
48750148|NCT01053221|156930281|FG001|Overall Study|The study was closed prematurely|9|||
48643705|NCT00413660|156549388|FG009|Up To Week 12|Lack of Efficacy|0|||
48643706|NCT00413660|156549389|FG010|Up To Week 12|Lack of Efficacy|0|||
48643707|NCT00413660|156549379|FG000|Up To Week 12|Lost to Follow-up|0|||
48643708|NCT00413660|156549380|FG001|Up To Week 12|Lost to Follow-up|1|||
48643709|NCT00413660|156549381|FG002|Up To Week 12|Lost to Follow-up|0|||
48643710|NCT00413660|156549382|FG003|Up To Week 12|Lost to Follow-up|0|||
48643711|NCT00413660|156549383|FG004|Up To Week 12|Lost to Follow-up|1|||
48643712|NCT00413660|156549384|FG005|Up To Week 12|Lost to Follow-up|0|||
48643713|NCT00413660|156549385|FG006|Up To Week 12|Lost to Follow-up|0|||
48643714|NCT00413660|156549386|FG007|Up To Week 12|Lost to Follow-up|0|||
48643715|NCT00413660|156549387|FG008|Up To Week 12|Lost to Follow-up|0|||
48643716|NCT00413660|156549388|FG009|Up To Week 12|Lost to Follow-up|0|||
48750149|NCT00553514|156930282|FG000|Overall Study|Protocol deviation|0|||
48750150|NCT00553514|156930283|FG001|Overall Study|Protocol deviation|0|||
48329840|NCT00048932|155405566|FG001|Open Label Period (OL)|Site Staff Issues|0|||
48329841|NCT00048932|155405567|FG002|Open Label Period (OL)|Site Staff Issues|2|||
48643717|NCT00413660|156549389|FG010|Up To Week 12|Lost to Follow-up|0|||
48643718|NCT00413660|156549379|FG000|Up To Week 12|Withdrawal by Subject|0|||
48643719|NCT00413660|156549380|FG001|Up To Week 12|Withdrawal by Subject|2|||
48643720|NCT00413660|156549381|FG002|Up To Week 12|Withdrawal by Subject|0|||
48643721|NCT00413660|156549382|FG003|Up To Week 12|Withdrawal by Subject|2|||
48643722|NCT00413660|156549383|FG004|Up To Week 12|Withdrawal by Subject|0|||
48643723|NCT00413660|156549384|FG005|Up To Week 12|Withdrawal by Subject|2|||
48643724|NCT00413660|156549385|FG006|Up To Week 12|Withdrawal by Subject|2|||
48643725|NCT00413660|156549386|FG007|Up To Week 12|Withdrawal by Subject|0|||
48643726|NCT00413660|156549387|FG008|Up To Week 12|Withdrawal by Subject|0|||
48643727|NCT00413660|156549388|FG009|Up To Week 12|Withdrawal by Subject|0|||
48643728|NCT00413660|156549389|FG010|Up To Week 12|Withdrawal by Subject|0|||
48643729|NCT00413660|156549379|FG000|Up To Week 12|Randomized, Not Treated|1|||
48643730|NCT00413660|156549380|FG001|Up To Week 12|Randomized, Not Treated|0|||
48643731|NCT00413660|156549381|FG002|Up To Week 12|Randomized, Not Treated|0|||
48643732|NCT00413660|156549382|FG003|Up To Week 12|Randomized, Not Treated|1|||
48643733|NCT00413660|156549383|FG004|Up To Week 12|Randomized, Not Treated|0|||
48643734|NCT00413660|156549384|FG005|Up To Week 12|Randomized, Not Treated|0|||
48643735|NCT00413660|156549385|FG006|Up To Week 12|Randomized, Not Treated|0|||
48643736|NCT00413660|156549386|FG007|Up To Week 12|Randomized, Not Treated|0|||
48643737|NCT00413660|156549387|FG008|Up To Week 12|Randomized, Not Treated|0|||
48643738|NCT00413660|156549388|FG009|Up To Week 12|Randomized, Not Treated|0|||
48643739|NCT00413660|156549389|FG010|Up To Week 12|Randomized, Not Treated|0|||
48643740|NCT00413660|156549379|FG000|Up To Week 12|Other|3|||
48750151|NCT00553514|156930284|FG002|Overall Study|Protocol deviation|0|||
48750152|NCT00553514|156930285|FG003|Overall Study|Protocol deviation|1|||
48750153|NCT00553514|156930286|FG004|Overall Study|Protocol deviation|0|||
48750154|NCT00553514|156930282|FG000|Overall Study|Lack of ovarian response|4|||
48750155|NCT00553514|156930283|FG001|Overall Study|Lack of ovarian response|5|||
48750156|NCT00553514|156930284|FG002|Overall Study|Lack of ovarian response|5|||
48750157|NCT00553514|156930285|FG003|Overall Study|Lack of ovarian response|5|||
48329842|NCT00048932|155405565|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
48643741|NCT00413660|156549380|FG001|Up To Week 12|Other|1|||
48643742|NCT00413660|156549381|FG002|Up To Week 12|Other|6|||
48643743|NCT00413660|156549382|FG003|Up To Week 12|Other|1|||
48643744|NCT00413660|156549383|FG004|Up To Week 12|Other|2|||
48643745|NCT00413660|156549384|FG005|Up To Week 12|Other|4|||
48643746|NCT00413660|156549385|FG006|Up To Week 12|Other|3|||
48643747|NCT00413660|156549386|FG007|Up To Week 12|Other|0|||
48643748|NCT00413660|156549387|FG008|Up To Week 12|Other|0|||
48643749|NCT00413660|156549388|FG009|Up To Week 12|Other|0|||
48643750|NCT00413660|156549389|FG010|Up To Week 12|Other|0|||
48643751|NCT00413660|156549379|FG000|Post Week 12|Adverse Event|2|||
48643752|NCT00413660|156549380|FG001|Post Week 12|Adverse Event|0|||
48643753|NCT00413660|156549381|FG002|Post Week 12|Adverse Event|2|||
48643754|NCT00413660|156549382|FG003|Post Week 12|Adverse Event|1|||
48750158|NCT00553514|156930286|FG004|Overall Study|Lack of ovarian response|6|||
48750159|NCT00553514|156930282|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
48750160|NCT00553514|156930283|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
48750161|NCT00553514|156930284|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48750162|NCT00553514|156930285|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
48750163|NCT00553514|156930286|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
48750164|NCT00553514|156930282|FG000|Overall Study|Risk of multiple pregnancy|0|||
48750165|NCT00553514|156930283|FG001|Overall Study|Risk of multiple pregnancy|2|||
48750166|NCT00553514|156930284|FG002|Overall Study|Risk of multiple pregnancy|0|||
48750167|NCT00553514|156930285|FG003|Overall Study|Risk of multiple pregnancy|1|||
48750168|NCT00553514|156930286|FG004|Overall Study|Risk of multiple pregnancy|0|||
48750169|NCT00553514|156930282|FG000|Overall Study|Other|1|||
48750170|NCT00553514|156930283|FG001|Overall Study|Other|1|||
48750171|NCT00553514|156930284|FG002|Overall Study|Other|0|||
48750172|NCT00553514|156930285|FG003|Overall Study|Other|0|||
48329843|NCT00048932|155405566|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
48643755|NCT00413660|156549383|FG004|Post Week 12|Adverse Event|4|||
48643756|NCT00413660|156549384|FG005|Post Week 12|Adverse Event|2|||
48643757|NCT00413660|156549385|FG006|Post Week 12|Adverse Event|2|||
48643758|NCT00413660|156549386|FG007|Post Week 12|Adverse Event|0|||
48643759|NCT00413660|156549387|FG008|Post Week 12|Adverse Event|0|||
48643760|NCT00413660|156549388|FG009|Post Week 12|Adverse Event|0|||
48643761|NCT00413660|156549389|FG010|Post Week 12|Adverse Event|0|||
48643762|NCT00413660|156549379|FG000|Post Week 12|Lack of Efficacy|0|||
48643763|NCT00413660|156549380|FG001|Post Week 12|Lack of Efficacy|0|||
48750173|NCT00553514|156930286|FG004|Overall Study|Other|1|||
48750174|NCT02246660|156930287|FG000|Overall Study|Withdrawal by Subject|0|||
48750175|NCT02246660|156930288|FG001|Overall Study|Withdrawal by Subject|1|||
48750176|NCT02246660|156930289|FG002|Overall Study|Withdrawal by Subject|0|||
48750177|NCT02246660|156930287|FG000|Overall Study|Death|0|||
48329844|NCT00048932|155405567|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
48329845|NCT00048932|155405565|FG000|Open Label Period (OL)|Participant Surgery|0|||
48643764|NCT00413660|156549381|FG002|Post Week 12|Lack of Efficacy|1|||
48643765|NCT00413660|156549382|FG003|Post Week 12|Lack of Efficacy|0|||
48643766|NCT00413660|156549383|FG004|Post Week 12|Lack of Efficacy|0|||
48643767|NCT00413660|156549384|FG005|Post Week 12|Lack of Efficacy|0|||
48643768|NCT00413660|156549385|FG006|Post Week 12|Lack of Efficacy|0|||
48643769|NCT00413660|156549386|FG007|Post Week 12|Lack of Efficacy|0|||
48643770|NCT00413660|156549387|FG008|Post Week 12|Lack of Efficacy|0|||
48329846|NCT00048932|155405566|FG001|Open Label Period (OL)|Participant Surgery|0|||
48329847|NCT00048932|155405567|FG002|Open Label Period (OL)|Participant Surgery|1|||
48329848|NCT04809623|155405572|FG000|Overall Study|Study Terminated by Sponsor|1|||
48643771|NCT00413660|156549388|FG009|Post Week 12|Lack of Efficacy|1|||
48643772|NCT00413660|156549389|FG010|Post Week 12|Lack of Efficacy|0|||
48750178|NCT02246660|156930288|FG001|Overall Study|Death|0|||
48750179|NCT02246660|156930289|FG002|Overall Study|Death|1|||
48643773|NCT00413660|156549379|FG000|Post Week 12|Lost to Follow-up|0|||
48643774|NCT00413660|156549380|FG001|Post Week 12|Lost to Follow-up|1|||
48643775|NCT00413660|156549381|FG002|Post Week 12|Lost to Follow-up|1|||
48643776|NCT00413660|156549382|FG003|Post Week 12|Lost to Follow-up|0|||
48643777|NCT00413660|156549383|FG004|Post Week 12|Lost to Follow-up|0|||
48643778|NCT00413660|156549384|FG005|Post Week 12|Lost to Follow-up|0|||
48643779|NCT00413660|156549385|FG006|Post Week 12|Lost to Follow-up|0|||
48643780|NCT00413660|156549386|FG007|Post Week 12|Lost to Follow-up|0|||
48643781|NCT00413660|156549387|FG008|Post Week 12|Lost to Follow-up|0|||
48643782|NCT00413660|156549388|FG009|Post Week 12|Lost to Follow-up|0|||
48643783|NCT00413660|156549389|FG010|Post Week 12|Lost to Follow-up|0|||
48643784|NCT00413660|156549379|FG000|Post Week 12|Withdrawal by Subject|0|||
48643785|NCT00413660|156549380|FG001|Post Week 12|Withdrawal by Subject|1|||
48643786|NCT00413660|156549381|FG002|Post Week 12|Withdrawal by Subject|1|||
48643787|NCT00413660|156549382|FG003|Post Week 12|Withdrawal by Subject|0|||
48643788|NCT00413660|156549383|FG004|Post Week 12|Withdrawal by Subject|1|||
48643789|NCT00413660|156549384|FG005|Post Week 12|Withdrawal by Subject|0|||
48643790|NCT00413660|156549385|FG006|Post Week 12|Withdrawal by Subject|0|||
48643791|NCT00413660|156549386|FG007|Post Week 12|Withdrawal by Subject|0|||
48643792|NCT00413660|156549387|FG008|Post Week 12|Withdrawal by Subject|0|||
48643793|NCT00413660|156549388|FG009|Post Week 12|Withdrawal by Subject|0|||
48643794|NCT00413660|156549389|FG010|Post Week 12|Withdrawal by Subject|1|||
48643795|NCT00413660|156549379|FG000|Post Week 12|Other|1|||
48643796|NCT00413660|156549380|FG001|Post Week 12|Other|2|||
48643797|NCT00413660|156549381|FG002|Post Week 12|Other|3|||
48643798|NCT00413660|156549382|FG003|Post Week 12|Other|0|||
48643799|NCT00413660|156549383|FG004|Post Week 12|Other|1|||
48643800|NCT00413660|156549384|FG005|Post Week 12|Other|1|||
48643801|NCT00413660|156549385|FG006|Post Week 12|Other|1|||
48643802|NCT00413660|156549386|FG007|Post Week 12|Other|0|||
48643803|NCT00413660|156549387|FG008|Post Week 12|Other|0|||
48643804|NCT00413660|156549388|FG009|Post Week 12|Other|0|||
48643805|NCT00413660|156549389|FG010|Post Week 12|Other|0|||
48643806|NCT03369665|156549390|FG000|Overall Study|Adverse Event|3|||
48643807|NCT03369665|156549390|FG000|Overall Study|Lost to Follow-up|7|||
48643808|NCT03369665|156549390|FG000|Overall Study|Withdrawal by Subject|15|||
48643809|NCT03369665|156549390|FG000|Overall Study|Progression Disease|2|||
48643810|NCT03369665|156549390|FG000|Overall Study|Not classified|3|||
48643811|NCT01023217|156549395|FG000|Overall Study|Withdrawal by Subject|1|||
48643812|NCT01023217|156549396|FG001|Overall Study|Withdrawal by Subject|0|||
48643813|NCT00589797|156549397|FG000|Overall Study|Death|1|||
48643814|NCT00589797|156549398|FG001|Overall Study|Death|0|||
48643815|NCT00589797|156549397|FG000|Overall Study|Lost to Follow-up|12|||
48643816|NCT00589797|156549398|FG001|Overall Study|Lost to Follow-up|9|||
48643817|NCT00589797|156549397|FG000|Overall Study|Physician Decision|8|||
48643818|NCT00589797|156549398|FG001|Overall Study|Physician Decision|3|||
48643819|NCT00589797|156549397|FG000|Overall Study|Withdrawal by Subject|6|||
48643820|NCT00589797|156549398|FG001|Overall Study|Withdrawal by Subject|5|||
48643821|NCT00589797|156549397|FG000|Overall Study|Non-Randomized Training Subjects|46|||
48643822|NCT00589797|156549398|FG001|Overall Study|Non-Randomized Training Subjects|6|||
48643823|NCT04011735|156549399|FG000|Overall Study|Withdrawal by Subject|1|||
48643824|NCT04011735|156549400|FG001|Overall Study|Withdrawal by Subject|0|||
48643825|NCT04011735|156549401|FG002|Overall Study|Withdrawal by Subject|1|||
48643826|NCT04011735|156549399|FG000|Overall Study|Met exclusion criteria after study entry|0|||
48643827|NCT04011735|156549400|FG001|Overall Study|Met exclusion criteria after study entry|1|||
48643828|NCT04011735|156549401|FG002|Overall Study|Met exclusion criteria after study entry|0|||
48643829|NCT01000506|156549402|FG000|Overall Study|Adverse Event|6|||
48643830|NCT01000506|156549403|FG001|Overall Study|Adverse Event|5|||
48643831|NCT01000506|156549404|FG002|Overall Study|Adverse Event|8|||
48643832|NCT01000506|156549405|FG003|Overall Study|Adverse Event|9|||
48329849|NCT04809623|155405573|FG001|Overall Study|Study Terminated by Sponsor|0|||
48643833|NCT01000506|156549402|FG000|Overall Study|Lack of Efficacy|8|||
48750180|NCT03018704|156930290|FG000|Overall Study|Lost to Follow-up|1|||
48750181|NCT03018704|156930291|FG001|Overall Study|Lost to Follow-up|1|||
48750182|NCT00320411|156930292|FG000|Overall Study|No investigational product admin.|4|||
48750183|NCT00518986|156930295|FG000|Overall Study|Adverse Event|12|||
48750184|NCT00518986|156930296|FG001|Overall Study|Adverse Event|7|||
48750185|NCT00518986|156930295|FG000|Overall Study|Lack of Efficacy|0|||
48750186|NCT00518986|156930296|FG001|Overall Study|Lack of Efficacy|2|||
48750187|NCT00518986|156930295|FG000|Overall Study|Lost to Follow-up|3|||
48750188|NCT00518986|156930296|FG001|Overall Study|Lost to Follow-up|2|||
48750189|NCT00518986|156930295|FG000|Overall Study|Physician Decision|0|||
48750190|NCT00518986|156930296|FG001|Overall Study|Physician Decision|3|||
48750191|NCT00518986|156930295|FG000|Overall Study|Protocol Violation|5|||
48750192|NCT00518986|156930296|FG001|Overall Study|Protocol Violation|7|||
48750193|NCT00518986|156930295|FG000|Overall Study|Withdrawal by Subject|4|||
48750194|NCT00518986|156930296|FG001|Overall Study|Withdrawal by Subject|4|||
48750195|NCT00518986|156930295|FG000|Overall Study|Non-Specific|2|||
48750196|NCT00518986|156930296|FG001|Overall Study|Non-Specific|1|||
48750197|NCT04997161|156930297|FG000|Overall Study|Study terminated by sponsor|3|||
48750198|NCT04502589|156930298|FG000|Overall Study|Physician Decision|1|||
48750199|NCT04502589|156930299|FG001|Overall Study|Physician Decision|0|||
48750200|NCT00023764|156930303|FG000|Overall Study|Other|1|||
48750201|NCT00023764|156930303|FG000|Overall Study|Adverse Event|4|||
48750202|NCT00023764|156930303|FG000|Overall Study|Withdrawal by Subject|1|||
48750203|NCT00023764|156930303|FG000|Overall Study|Progression of disease|6|||
48750204|NCT00023764|156930303|FG000|Overall Study|patient received other treatment|1|||
48750205|NCT00023764|156930303|FG000|Overall Study|delay in obtaining staging images|1|||
48750206|NCT01709162|156930304|FG000|Overall Study|Disease progression|3|||
48750207|NCT01709162|156930305|FG001|Overall Study|Disease progression|3|||
48750208|NCT01709162|156930304|FG000|Overall Study|Study drug toxicity|2|||
48750209|NCT01709162|156930305|FG001|Overall Study|Study drug toxicity|0|||
48750210|NCT01709162|156930304|FG000|Overall Study|Administrative reason by sponsor|0|||
48750211|NCT01709162|156930305|FG001|Overall Study|Administrative reason by sponsor|1|||
48643834|NCT01000506|156549403|FG001|Overall Study|Lack of Efficacy|6|||
48643835|NCT01000506|156549404|FG002|Overall Study|Lack of Efficacy|4|||
48643836|NCT01000506|156549405|FG003|Overall Study|Lack of Efficacy|4|||
48643837|NCT01000506|156549402|FG000|Overall Study|Protocol Violation|1|||
48643838|NCT01000506|156549403|FG001|Overall Study|Protocol Violation|1|||
48643839|NCT01000506|156549404|FG002|Overall Study|Protocol Violation|0|||
48643840|NCT01000506|156549405|FG003|Overall Study|Protocol Violation|0|||
48643841|NCT01000506|156549402|FG000|Overall Study|Lost to Follow-up|1|||
48643842|NCT01000506|156549403|FG001|Overall Study|Lost to Follow-up|1|||
48643843|NCT01000506|156549404|FG002|Overall Study|Lost to Follow-up|4|||
48643844|NCT01000506|156549405|FG003|Overall Study|Lost to Follow-up|0|||
48643845|NCT01000506|156549402|FG000|Overall Study|Physician Decision|1|||
48643846|NCT01000506|156549403|FG001|Overall Study|Physician Decision|3|||
48643847|NCT01000506|156549404|FG002|Overall Study|Physician Decision|3|||
48643848|NCT01000506|156549405|FG003|Overall Study|Physician Decision|3|||
48643849|NCT01000506|156549402|FG000|Overall Study|Withdrawal by Subject|11|||
48643850|NCT01000506|156549403|FG001|Overall Study|Withdrawal by Subject|8|||
48643851|NCT01000506|156549404|FG002|Overall Study|Withdrawal by Subject|2|||
48643852|NCT01000506|156549405|FG003|Overall Study|Withdrawal by Subject|7|||
48643853|NCT01485796|156549406|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
48643854|NCT01485796|156549406|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
48643855|NCT01485796|156549406|FG000|Period 2: Epoch 2|Adverse Event|3|||
48643856|NCT01485796|156549406|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
48643857|NCT01485796|156549406|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
48643858|NCT01485796|156549406|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
48643859|NCT01485796|156549406|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
48643860|NCT01485796|156549406|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
48643861|NCT01063348|156549411|FG000|Overall Study|Lost to Follow-up|3|||
48643862|NCT01063348|156549412|FG001|Overall Study|Lost to Follow-up|10|||
48643863|NCT01194245|156549413|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
48643864|NCT01194245|156549414|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
48643865|NCT01194245|156549415|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
48643866|NCT01194245|156549416|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
48643867|NCT01194245|156549417|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
48643868|NCT01194245|156549413|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
48643869|NCT01194245|156549414|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
48643870|NCT01194245|156549415|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
48750212|NCT01709162|156930304|FG000|Overall Study|Other|1|||
48750213|NCT01709162|156930305|FG001|Overall Study|Other|0|||
48750214|NCT01709162|156930304|FG000|Overall Study|Withdrawal by Subject|0|||
48750215|NCT01709162|156930305|FG001|Overall Study|Withdrawal by Subject|1|||
48750216|NCT01500694|156930306|FG000|Overall Study|Adverse Event|4|||
48750217|NCT01500694|156930307|FG001|Overall Study|Adverse Event|3|||
48750218|NCT01500694|156930306|FG000|Overall Study|Protocol Violation|0|||
48750219|NCT01500694|156930307|FG001|Overall Study|Protocol Violation|1|||
48643871|NCT01194245|156549416|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
48643872|NCT01194245|156549417|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
48643873|NCT01194245|156549413|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
48643874|NCT01194245|156549414|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
48643875|NCT01194245|156549415|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
48643876|NCT01194245|156549416|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
48643877|NCT01194245|156549417|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
48643878|NCT01194245|156549413|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
48643879|NCT01194245|156549414|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
48329850|NCT01380145|155405574|FG000|Overall Study|Progressive disease|4|||
48329851|NCT01583166|155405575|FG000|Overall Study|Withdrawal by Subject|4|||
48329852|NCT01583166|155405576|FG001|Overall Study|Withdrawal by Subject|6|||
48329853|NCT05405244|155405580|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
48643880|NCT01194245|156549415|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
48750220|NCT01500694|156930306|FG000|Overall Study|Withdrawal by Subject|23|||
48750221|NCT01500694|156930307|FG001|Overall Study|Withdrawal by Subject|14|||
48750222|NCT01500694|156930306|FG000|Overall Study|Lost to Follow-up|2|||
48750223|NCT01500694|156930307|FG001|Overall Study|Lost to Follow-up|3|||
48750224|NCT01500694|156930306|FG000|Overall Study|Lack of Efficacy|14|||
48750225|NCT01500694|156930307|FG001|Overall Study|Lack of Efficacy|5|||
48750226|NCT01500694|156930306|FG000|Overall Study|Other|9|||
48750227|NCT01500694|156930307|FG001|Overall Study|Other|3|||
48750228|NCT03978520|156930309|FG000|Overall Study|Adverse Event|2|||
48750229|NCT03978520|156930310|FG001|Overall Study|Adverse Event|5|||
48750230|NCT03978520|156930311|FG002|Overall Study|Adverse Event|3|||
48750231|NCT03978520|156930312|FG003|Overall Study|Adverse Event|5|||
48750232|NCT03978520|156930313|FG004|Overall Study|Adverse Event|6|||
48750233|NCT03978520|156930309|FG000|Overall Study|Withdrawal by Subject|10|||
48750234|NCT03978520|156930310|FG001|Overall Study|Withdrawal by Subject|4|||
48750235|NCT03978520|156930311|FG002|Overall Study|Withdrawal by Subject|5|||
48750236|NCT03978520|156930312|FG003|Overall Study|Withdrawal by Subject|6|||
48750237|NCT03978520|156930313|FG004|Overall Study|Withdrawal by Subject|5|||
48750238|NCT03978520|156930309|FG000|Overall Study|Lost to Follow-up|2|||
48750239|NCT03978520|156930310|FG001|Overall Study|Lost to Follow-up|2|||
48750240|NCT03978520|156930311|FG002|Overall Study|Lost to Follow-up|2|||
48750241|NCT03978520|156930312|FG003|Overall Study|Lost to Follow-up|0|||
48750242|NCT03978520|156930313|FG004|Overall Study|Lost to Follow-up|1|||
48750243|NCT03978520|156930309|FG000|Overall Study|COVID-19 infection|0|||
48750244|NCT03978520|156930310|FG001|Overall Study|COVID-19 infection|1|||
48750245|NCT03978520|156930311|FG002|Overall Study|COVID-19 infection|0|||
48750246|NCT03978520|156930312|FG003|Overall Study|COVID-19 infection|0|||
48750247|NCT03978520|156930313|FG004|Overall Study|COVID-19 infection|0|||
48750248|NCT03978520|156930309|FG000|Overall Study|Other, not specified|9|||
48750249|NCT03978520|156930310|FG001|Overall Study|Other, not specified|4|||
48750250|NCT03978520|156930311|FG002|Overall Study|Other, not specified|1|||
48750251|NCT03978520|156930312|FG003|Overall Study|Other, not specified|1|||
48750252|NCT03978520|156930313|FG004|Overall Study|Other, not specified|2|||
48750253|NCT03978520|156930309|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
48329854|NCT05405244|155405581|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
48329855|NCT05405244|155405580|FG000|Washout (2 Weeks)|Adverse Event|2|||
48329856|NCT05405244|155405581|FG001|Washout (2 Weeks)|Adverse Event|0|||
48329857|NCT05405244|155405580|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
48329858|NCT05405244|155405581|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
48643881|NCT01194245|156549416|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
48643882|NCT01194245|156549417|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
48643883|NCT01194245|156549413|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48643884|NCT01194245|156549414|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48643885|NCT01194245|156549415|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48643886|NCT01194245|156549416|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
48643887|NCT01194245|156549417|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
48643888|NCT01194245|156549413|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48643889|NCT01194245|156549414|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
48643890|NCT01194245|156549415|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
48329859|NCT00019604|155405582|FG000|Overall Study|Death|1|||
48643891|NCT01194245|156549416|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
48643892|NCT01194245|156549417|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
48643893|NCT01118780|156549418|FG000|Overall Study|Adverse Event|15|||
48643894|NCT01118780|156549419|FG001|Overall Study|Adverse Event|15|||
48643895|NCT01118780|156549418|FG000|Overall Study|Death|1|||
48643896|NCT01118780|156549419|FG001|Overall Study|Death|0|||
48643897|NCT01118780|156549418|FG000|Overall Study|Lack of Efficacy|2|||
48643898|NCT01118780|156549419|FG001|Overall Study|Lack of Efficacy|6|||
48643899|NCT01118780|156549418|FG000|Overall Study|Physician Decision|2|||
48643900|NCT01118780|156549419|FG001|Overall Study|Physician Decision|0|||
48750254|NCT03978520|156930310|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
48750255|NCT03978520|156930311|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
48329860|NCT00019604|155405582|FG000|Overall Study|Progressive disease|23|||
48329861|NCT00019604|155405582|FG000|Overall Study|Refused treatment|1|||
48750256|NCT03978520|156930312|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
48750257|NCT03978520|156930313|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
48750258|NCT03672747|156930314|FG000|Overall Study|Lost to Follow-up|1|||
48750259|NCT03672747|156930315|FG001|Overall Study|Lost to Follow-up|1|||
48750260|NCT03672747|156930316|FG002|Overall Study|Lost to Follow-up|2|||
48750261|NCT03672747|156930317|FG003|Overall Study|Lost to Follow-up|2|||
48750262|NCT03672747|156930318|FG004|Overall Study|Lost to Follow-up|2|||
48643901|NCT01118780|156549418|FG000|Overall Study|Protocol Violation|3|||
48643902|NCT01118780|156549419|FG001|Overall Study|Protocol Violation|6|||
48643903|NCT01118780|156549418|FG000|Overall Study|Withdrawal by Subject|13|||
48643904|NCT01118780|156549419|FG001|Overall Study|Withdrawal by Subject|8|||
48643905|NCT05384834|156549420|FG000|Overall Study|Lost to Follow-up|43|||
48329862|NCT00019604|155405582|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
48329863|NCT00019604|155405582|FG000|Overall Study|Going to have liver transplant|1|||
48643906|NCT05384834|156549420|FG000|Overall Study|Withdrawal by Subject|5|||
48643907|NCT04828707|156549421|FG000|Overall Study|Lost to Follow-up|3|||
48643908|NCT04828707|156549422|FG001|Overall Study|Lost to Follow-up|2|||
48643909|NCT04828707|156549421|FG000|Overall Study|Withdrawal by Subject|2|||
48643910|NCT04828707|156549422|FG001|Overall Study|Withdrawal by Subject|1|||
48643911|NCT01775553|156549423|FG000|Overall Study|Adverse Event|1|||
48329864|NCT00019604|155405582|FG000|Overall Study|Move to a different study|1|||
48329865|NCT00019604|155405582|FG000|Overall Study|Non compliant on systemic CH|1|||
48329866|NCT00019604|155405582|FG000|Overall Study|Non compliant|1|||
48329867|NCT00019604|155405582|FG000|Overall Study|Resectable disease|1|||
48329868|NCT00019604|155405582|FG000|Overall Study|Started new chemo regimen|1|||
48329869|NCT00019604|155405582|FG000|Overall Study|Pt going to immunotherapy study|1|||
48329870|NCT00019604|155405582|FG000|Overall Study|Too much disease|1|||
48329871|NCT00019604|155405582|FG000|Overall Study|Unable to evaluate|1|||
48329872|NCT00019604|155405582|FG000|Overall Study|Details for other not available|4|||
48329873|NCT00569166|155405584|FG000|Overall Study|Withdrawal by Subject|7|||
48329874|NCT00569166|155405585|FG001|Overall Study|Withdrawal by Subject|5|||
48329875|NCT00569166|155405586|FG002|Overall Study|Withdrawal by Subject|3|||
48329876|NCT00569166|155405584|FG000|Overall Study|Lost to Follow-up|2|||
48329877|NCT00569166|155405585|FG001|Overall Study|Lost to Follow-up|1|||
48329878|NCT00569166|155405586|FG002|Overall Study|Lost to Follow-up|1|||
48329879|NCT03292406|155405587|FG000|Overall Study|Progressive Disease|6|||
48329880|NCT03292406|155405588|FG001|Overall Study|Progressive Disease|3|||
48329881|NCT03292406|155405589|FG002|Overall Study|Progressive Disease|4|||
48329882|NCT03292406|155405587|FG000|Overall Study|Adverse Event|7|||
48329883|NCT03292406|155405588|FG001|Overall Study|Adverse Event|1|||
48329884|NCT03292406|155405589|FG002|Overall Study|Adverse Event|4|||
48329885|NCT03292406|155405587|FG000|Overall Study|Withdrawal by Subject|0|||
48329886|NCT03292406|155405588|FG001|Overall Study|Withdrawal by Subject|7|||
48329887|NCT03292406|155405589|FG002|Overall Study|Withdrawal by Subject|2|||
48643912|NCT01775553|156549423|FG000|Overall Study|Disease Progression|12|||
48643913|NCT01152788|156549424|FG000|Overall Study|Withdrawal by Subject|0|||
48643914|NCT01152788|156549425|FG001|Overall Study|Withdrawal by Subject|3|||
48643915|NCT01152788|156549424|FG000|Overall Study|No treatment|0|||
48643916|NCT01152788|156549425|FG001|Overall Study|No treatment|1|||
48643917|NCT04245709|156549426|FG000|Overall Study|Adverse Event|13|||
48643918|NCT04245709|156549426|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
48643919|NCT00811720|156549428|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
48643920|NCT00811720|156549429|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
48643921|NCT00811720|156549428|FG000|All Treated Patients|Adverse Event|20|||
48643922|NCT00811720|156549429|FG001|All Treated Patients|Adverse Event|62|||
48643923|NCT00811720|156549428|FG000|All Treated Patients|Lack of Efficacy|22|||
48643924|NCT00811720|156549429|FG001|All Treated Patients|Lack of Efficacy|18|||
48643925|NCT00811720|156549428|FG000|All Treated Patients|Non-compliance|0|||
48643926|NCT00811720|156549429|FG001|All Treated Patients|Non-compliance|14|||
48643927|NCT00811720|156549428|FG000|All Treated Patients|Protocol Violation|9|||
48643928|NCT00811720|156549429|FG001|All Treated Patients|Protocol Violation|16|||
48643929|NCT00811720|156549428|FG000|All Treated Patients|Withdrawal by Subject|28|||
48643930|NCT00811720|156549429|FG001|All Treated Patients|Withdrawal by Subject|34|||
48643931|NCT00811720|156549428|FG000|All Treated Patients|Lost to Follow-up|10|||
48643932|NCT00811720|156549429|FG001|All Treated Patients|Lost to Follow-up|16|||
48643933|NCT00811720|156549428|FG000|All Treated Patients|Other Reason|7|||
48643934|NCT00811720|156549429|FG001|All Treated Patients|Other Reason|4|||
48643935|NCT03465722|156549430|FG000|Overall Study|Withdrawal by Subject|21|||
48643936|NCT03465722|156549431|FG001|Overall Study|Withdrawal by Subject|14|||
48750263|NCT03672747|156930319|FG005|Overall Study|Lost to Follow-up|1|||
48643937|NCT03465722|156549430|FG000|Overall Study|Death|89|||
48643938|NCT03465722|156549431|FG001|Overall Study|Death|87|||
48643939|NCT03465722|156549430|FG000|Overall Study|Lost to Follow-up|5|||
48329888|NCT03292406|155405587|FG000|Overall Study|Protocol Violation|0|||
48643940|NCT03465722|156549431|FG001|Overall Study|Lost to Follow-up|3|||
48643941|NCT03465722|156549430|FG000|Overall Study|Administrative/Other|33|||
48643942|NCT03465722|156549431|FG001|Overall Study|Administrative/Other|32|||
48643943|NCT03465722|156549430|FG000|Overall Study|Not treated|1|||
48329889|NCT03292406|155405588|FG001|Overall Study|Protocol Violation|1|||
48329890|NCT03292406|155405589|FG002|Overall Study|Protocol Violation|1|||
48329891|NCT03292406|155405587|FG000|Overall Study|Other|0|||
48329892|NCT03292406|155405588|FG001|Overall Study|Other|1|||
48329893|NCT03292406|155405589|FG002|Overall Study|Other|2|||
48643944|NCT03465722|156549431|FG001|Overall Study|Not treated|2|||
48750264|NCT00165776|156930320|FG000|Overall Study|Lack of Efficacy|0|||
48643945|NCT03465722|156549430|FG000|Overall Study|Sponsor decision|91|||
48643946|NCT03465722|156549431|FG001|Overall Study|Sponsor decision|98|||
48643947|NCT00442416|156549437|FG000|Overall Study|Adverse Event|4|||
48643948|NCT00442416|156549438|FG001|Overall Study|Adverse Event|1|||
48643949|NCT00442416|156549437|FG000|Overall Study|Death|1|||
48643950|NCT00442416|156549438|FG001|Overall Study|Death|0|||
48643951|NCT00442416|156549437|FG000|Overall Study|Lack of Efficacy|2|||
48643952|NCT00442416|156549438|FG001|Overall Study|Lack of Efficacy|0|||
48643953|NCT00442416|156549437|FG000|Overall Study|Protocol Violation|2|||
48643954|NCT00442416|156549438|FG001|Overall Study|Protocol Violation|3|||
48643955|NCT00442416|156549437|FG000|Overall Study|Withdrew consent|1|||
48329894|NCT00310037|155405592|FG000|Overall Study|Adverse Event|7|||
48329895|NCT00310037|155405593|FG001|Overall Study|Adverse Event|14|||
48329896|NCT00310037|155405592|FG000|Overall Study|Withdrawal by Subject|4|||
48329897|NCT00310037|155405593|FG001|Overall Study|Withdrawal by Subject|3|||
48329898|NCT00310037|155405592|FG000|Overall Study|Progression|6|||
48643956|NCT00442416|156549438|FG001|Overall Study|Withdrew consent|2|||
48643957|NCT00442416|156549437|FG000|Overall Study|Administrative/Other|27|||
48643958|NCT00442416|156549438|FG001|Overall Study|Administrative/Other|33|||
48643959|NCT00570713|156549439|FG000|Overall Study|Adverse Event|16|||
48643960|NCT00570713|156549440|FG001|Overall Study|Adverse Event|9|||
48643961|NCT00570713|156549439|FG000|Overall Study|Death|7|||
48643962|NCT00570713|156549440|FG001|Overall Study|Death|7|||
48643963|NCT00570713|156549439|FG000|Overall Study|Lack of Efficacy|40|||
48643964|NCT00570713|156549440|FG001|Overall Study|Lack of Efficacy|49|||
48643965|NCT00570713|156549439|FG000|Overall Study|Physician Decision|2|||
48643966|NCT00570713|156549440|FG001|Overall Study|Physician Decision|2|||
48643967|NCT00570713|156549439|FG000|Overall Study|Withdrawal by Subject|3|||
48643968|NCT00570713|156549440|FG001|Overall Study|Withdrawal by Subject|3|||
48643969|NCT00570713|156549439|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
48643970|NCT00570713|156549440|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
48643971|NCT02625220|156549441|FG000|Overall Study|Adverse Event|2|||
48643972|NCT02625220|156549441|FG000|Overall Study|Lost to Follow-up|2|||
48643973|NCT02625220|156549441|FG000|Overall Study|Protocol Violation|1|||
48643974|NCT02625220|156549441|FG000|Overall Study|Study discontinued at site|2|||
48643975|NCT02954458|156549444|FG000|Overall Study|Adverse Event|0|||
48643976|NCT02954458|156549445|FG001|Overall Study|Adverse Event|0|||
48643977|NCT02954458|156549446|FG002|Overall Study|Adverse Event|0|||
48643978|NCT02954458|156549447|FG003|Overall Study|Adverse Event|1|||
48643979|NCT02954458|156549444|FG000|Overall Study|Withdrawal by Subject|0|||
48643980|NCT02954458|156549445|FG001|Overall Study|Withdrawal by Subject|0|||
48643981|NCT02954458|156549446|FG002|Overall Study|Withdrawal by Subject|0|||
48643982|NCT02954458|156549447|FG003|Overall Study|Withdrawal by Subject|1|||
48643983|NCT02954458|156549444|FG000|Overall Study|Physician Decision|0|||
48643984|NCT02954458|156549445|FG001|Overall Study|Physician Decision|0|||
48643985|NCT02954458|156549446|FG002|Overall Study|Physician Decision|1|||
48643986|NCT02954458|156549447|FG003|Overall Study|Physician Decision|1|||
48643987|NCT02954458|156549444|FG000|Overall Study|Lost to Follow-up|1|||
48643988|NCT02954458|156549445|FG001|Overall Study|Lost to Follow-up|0|||
48643989|NCT02954458|156549446|FG002|Overall Study|Lost to Follow-up|0|||
48643990|NCT02954458|156549447|FG003|Overall Study|Lost to Follow-up|1|||
48643991|NCT02954458|156549444|FG000|Overall Study|Death|0|||
48643992|NCT02954458|156549445|FG001|Overall Study|Death|0|||
48643993|NCT02954458|156549446|FG002|Overall Study|Death|0|||
48643994|NCT02954458|156549447|FG003|Overall Study|Death|1|||
48643995|NCT02954458|156549444|FG000|Overall Study|Other|0|||
48643996|NCT02954458|156549445|FG001|Overall Study|Other|0|||
48643997|NCT02954458|156549446|FG002|Overall Study|Other|0|||
48329899|NCT00310037|155405593|FG001|Overall Study|Progression|0|||
48329900|NCT00310037|155405592|FG000|Overall Study|Non-protocol treatment|1|||
48750265|NCT00165776|156930321|FG001|Overall Study|Lack of Efficacy|0|||
48643998|NCT02954458|156549447|FG003|Overall Study|Other|7|||
48329901|NCT00310037|155405593|FG001|Overall Study|Non-protocol treatment|0|||
48329902|NCT02309515|155405594|FG000|Overall Study|Withdrawal by Subject|0|||
48329903|NCT02309515|155405595|FG001|Overall Study|Withdrawal by Subject|1|||
48329904|NCT00910962|155405596|FG000|Overall Study|Adverse Event|5|||
48643999|NCT01853462|156549450|FG000|Overall Study|Withdrawal by Subject|1|||
48644000|NCT01853462|156549451|FG001|Overall Study|Withdrawal by Subject|1|||
48644001|NCT00132301|156549453|FG000|Overall Study|Death|7|||
48644002|NCT00132301|156549454|FG001|Overall Study|Death|6|||
48644003|NCT00132301|156549453|FG000|Overall Study|Withdrawal by Subject|5|||
48644004|NCT00132301|156549454|FG001|Overall Study|Withdrawal by Subject|2|||
48644005|NCT00132301|156549453|FG000|Overall Study|Physician Decision|1|||
48644006|NCT00132301|156549454|FG001|Overall Study|Physician Decision|1|||
48644007|NCT00132301|156549453|FG000|Overall Study|Lost to Follow-up|5|||
48644008|NCT00132301|156549454|FG001|Overall Study|Lost to Follow-up|3|||
48644009|NCT00132301|156549453|FG000|Overall Study|Other|1|||
48644010|NCT00132301|156549454|FG001|Overall Study|Other|1|||
48329905|NCT00910962|155405597|FG001|Overall Study|Adverse Event|20|||
48329906|NCT00910962|155405598|FG002|Overall Study|Adverse Event|17|||
48750266|NCT00165776|156930322|FG002|Overall Study|Lack of Efficacy|0|||
48644011|NCT00132301|156549453|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
48644012|NCT00132301|156549454|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
48644013|NCT04154605|156549455|FG000|Overall Study|Procedure Canceled|1|||
48644014|NCT04154605|156549456|FG001|Overall Study|Procedure Canceled|1|||
48644015|NCT04154605|156549455|FG000|Overall Study|Missed follow up|1|||
48644016|NCT04154605|156549456|FG001|Overall Study|Missed follow up|1|||
48644017|NCT04154605|156549455|FG000|Overall Study|Withdrawal by Subject|1|||
48644018|NCT04154605|156549456|FG001|Overall Study|Withdrawal by Subject|0|||
48644019|NCT02623205|156549457|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
48644020|NCT02623205|156549458|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
48644021|NCT00142792|156549459|FG000|Overall Study|Death|0|||
48750267|NCT00165776|156930323|FG003|Overall Study|Lack of Efficacy|1|||
48750268|NCT00165776|156930320|FG000|Overall Study|Withdrawal by Subject|4|||
48750269|NCT00165776|156930321|FG001|Overall Study|Withdrawal by Subject|1|||
48750270|NCT00165776|156930322|FG002|Overall Study|Withdrawal by Subject|2|||
48750271|NCT00165776|156930323|FG003|Overall Study|Withdrawal by Subject|0|||
48750272|NCT00165776|156930320|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
48750273|NCT00165776|156930321|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
48750274|NCT00165776|156930322|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
48750275|NCT00165776|156930323|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
48750276|NCT04212650|156930324|FG000|Overall Study|Withdrawal by Subject|1|||
48750277|NCT04212650|156930325|FG001|Overall Study|Withdrawal by Subject|0|||
48750278|NCT02634320|156930329|FG000|Overall Study|Adverse Event|2|||
48750279|NCT02634320|156930329|FG000|Overall Study|Lost to Follow-up|3|||
48750280|NCT02634320|156930329|FG000|Overall Study|Moved out of area|2|||
48750281|NCT02634320|156930329|FG000|Overall Study|Out of window for study visits|1|||
48750282|NCT02634320|156930329|FG000|Overall Study|Protocol Violation|1|||
48750283|NCT02634320|156930329|FG000|Overall Study|Withdrawal by Subject|5|||
48750284|NCT02634320|156930329|FG000|Overall Study|Lack of Efficacy|2|||
48750285|NCT02132130|156930331|FG000|Overall Study|Lost to Follow-up|0|||
48750286|NCT02132130|156930332|FG001|Overall Study|Lost to Follow-up|2|||
48750287|NCT02132130|156930333|FG002|Overall Study|Lost to Follow-up|0|||
48750288|NCT02132130|156930334|FG003|Overall Study|Lost to Follow-up|0|||
48750289|NCT02132130|156930331|FG000|Overall Study|Withdrawal by Subject|0|||
48750290|NCT02132130|156930332|FG001|Overall Study|Withdrawal by Subject|0|||
48750291|NCT02132130|156930333|FG002|Overall Study|Withdrawal by Subject|0|||
48644022|NCT00142792|156549460|FG001|Overall Study|Death|0|||
48644023|NCT00142792|156549461|FG002|Overall Study|Death|1|||
48644024|NCT00142792|156549459|FG000|Overall Study|Withdrawal by Subject|3|||
48644025|NCT00142792|156549460|FG001|Overall Study|Withdrawal by Subject|2|||
48644026|NCT00142792|156549461|FG002|Overall Study|Withdrawal by Subject|3|||
48644027|NCT00142792|156549459|FG000|Overall Study|Lost to Follow-up|8|||
48644028|NCT00142792|156549460|FG001|Overall Study|Lost to Follow-up|11|||
48644029|NCT00142792|156549461|FG002|Overall Study|Lost to Follow-up|7|||
48644030|NCT00142792|156549459|FG000|Overall Study|No category|1|||
48750292|NCT02132130|156930334|FG003|Overall Study|Withdrawal by Subject|1|||
48750293|NCT00598832|156930337|FG000|Overall Study|Lack of Efficacy|3|||
48750294|NCT00598832|156930338|FG001|Overall Study|Lack of Efficacy|7|||
48750295|NCT00598832|156930337|FG000|Overall Study|Adverse Event|6|||
48750296|NCT00598832|156930338|FG001|Overall Study|Adverse Event|2|||
48750297|NCT00598832|156930337|FG000|Overall Study|Withdrawal by Subject|25|||
48750298|NCT00598832|156930338|FG001|Overall Study|Withdrawal by Subject|36|||
48750299|NCT00598832|156930337|FG000|Overall Study|Protocol Violation|0|||
48750300|NCT00598832|156930338|FG001|Overall Study|Protocol Violation|2|||
48750301|NCT00598832|156930337|FG000|Overall Study|Lost to Follow-up|24|||
48750302|NCT00598832|156930338|FG001|Overall Study|Lost to Follow-up|29|||
48750303|NCT00598832|156930337|FG000|Overall Study|Pregnancy|2|||
48750304|NCT00598832|156930338|FG001|Overall Study|Pregnancy|2|||
48750305|NCT00598832|156930337|FG000|Overall Study|Physician Decision|1|||
48750306|NCT00598832|156930338|FG001|Overall Study|Physician Decision|4|||
48750307|NCT00598832|156930337|FG000|Overall Study|Non compliance|1|||
48750308|NCT00598832|156930338|FG001|Overall Study|Non compliance|0|||
48750309|NCT03428360|156930350|FG000|Overall Study|Informed consent withdrawn|5|||
48750310|NCT03428360|156930350|FG000|Overall Study|Withdrawal by Subject|4|||
48750311|NCT03428360|156930350|FG000|Overall Study|Lost to Follow-up|5|||
48750312|NCT03428360|156930350|FG000|Overall Study|Physician Decision|2|||
48644031|NCT00142792|156549460|FG001|Overall Study|No category|2|||
48644032|NCT00142792|156549461|FG002|Overall Study|No category|1|||
48644033|NCT03089047|156549466|FG000|Overall Study|Lost to Follow-up|1|||
48644034|NCT03089047|156549467|FG001|Overall Study|Lost to Follow-up|0|||
48644035|NCT01466491|156551063|FG000|Overall Study|Protocol Violation|0|||
48644036|NCT01466491|156551064|FG001|Overall Study|Protocol Violation|3|||
48644037|NCT01466491|156551065|FG002|Overall Study|Protocol Violation|2|||
48644038|NCT01466491|156551066|FG003|Overall Study|Protocol Violation|0|||
48644039|NCT01466491|156551063|FG000|Overall Study|Missing Data|0|||
48644040|NCT01466491|156551064|FG001|Overall Study|Missing Data|0|||
48644041|NCT01466491|156551065|FG002|Overall Study|Missing Data|1|||
48644042|NCT01466491|156551066|FG003|Overall Study|Missing Data|0|||
48644043|NCT03374358|156551067|FG000|Overall Study|Withdrawal by Subject|0|||
48644044|NCT03374358|156551068|FG001|Overall Study|Withdrawal by Subject|2|||
48644045|NCT02848092|156551071|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
48644046|NCT02848092|156551072|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
48644047|NCT02848092|156551071|FG000|1-month Post-training Follow-up|Adverse Event|2|||
48644048|NCT02848092|156551072|FG001|1-month Post-training Follow-up|Adverse Event|1|||
48644049|NCT02848092|156551071|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
48644050|NCT02848092|156551072|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
48644051|NCT02848092|156551071|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
48644052|NCT02848092|156551072|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
48644053|NCT02848092|156551071|FG000|1-month Post-training Follow-up|fatigue|0|||
48644054|NCT02848092|156551072|FG001|1-month Post-training Follow-up|fatigue|1|||
48644055|NCT02848092|156551071|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
48644056|NCT02848092|156551072|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
48644057|NCT02848092|156551071|FG000|6-month Post-training Follow-up|Adverse Event|1|||
48644058|NCT02848092|156551072|FG001|6-month Post-training Follow-up|Adverse Event|1|||
48644059|NCT02848092|156551071|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
48644060|NCT02848092|156551072|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
48644061|NCT02848092|156551071|FG000|6-month Post-training Follow-up|frustrated with task|1|||
48644062|NCT02848092|156551072|FG001|6-month Post-training Follow-up|frustrated with task|0|||
48644063|NCT02848092|156551071|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
48644064|NCT02848092|156551072|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
48644065|NCT02848092|156551071|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
48644066|NCT02848092|156551072|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
48644067|NCT01016067|156551077|FG000|Overall Study|Lost to Follow-up|1|||
48644068|NCT01016067|156551078|FG001|Overall Study|Lost to Follow-up|2|||
48644069|NCT01016067|156551077|FG000|Overall Study|Physician Decision|1|||
48644070|NCT01016067|156551078|FG001|Overall Study|Physician Decision|1|||
48644071|NCT01016067|156551077|FG000|Overall Study|Withdrew due to Relocation|0|||
48644072|NCT01016067|156551078|FG001|Overall Study|Withdrew due to Relocation|1|||
48644073|NCT00592631|156551079|FG000|Overall Study|Lost to Follow-up|0|||
48644074|NCT00592631|156551080|FG001|Overall Study|Lost to Follow-up|2|||
48644075|NCT03896477|156551083|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
48644076|NCT03896477|156551084|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
48644077|NCT03896477|156551085|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
48644078|NCT03896477|156551083|FG000|Overall Study|Parent Requested Withdrawal|8|||
48644079|NCT03896477|156551084|FG001|Overall Study|Parent Requested Withdrawal|12|||
48644080|NCT03896477|156551085|FG002|Overall Study|Parent Requested Withdrawal|9|||
48644081|NCT03896477|156551083|FG000|Overall Study|Adverse Event|0|||
48644082|NCT03896477|156551084|FG001|Overall Study|Adverse Event|0|||
48644083|NCT03896477|156551085|FG002|Overall Study|Adverse Event|1|||
48644084|NCT03896477|156551083|FG000|Overall Study|Death|1|||
48644085|NCT03896477|156551084|FG001|Overall Study|Death|0|||
48644086|NCT03896477|156551085|FG002|Overall Study|Death|0|||
48644087|NCT03896477|156551083|FG000|Overall Study|Other|5|||
48644088|NCT03896477|156551084|FG001|Overall Study|Other|6|||
48644089|NCT03896477|156551085|FG002|Overall Study|Other|7|||
48644090|NCT03896477|156551083|FG000|Overall Study|Lost to Follow-up|2|||
48644091|NCT03896477|156551084|FG001|Overall Study|Lost to Follow-up|1|||
48644092|NCT03896477|156551085|FG002|Overall Study|Lost to Follow-up|1|||
48644093|NCT00131352|156551086|FG000|Initial Treatment Period|Adverse Event|1|||
48750313|NCT03428360|156930350|FG000|Overall Study|Informed consent withdrawn|5|||
48644094|NCT00131352|156551087|FG001|Initial Treatment Period|Adverse Event|3|||
48644095|NCT00131352|156551086|FG000|Initial Treatment Period|Non-compliant|1|||
48644096|NCT00131352|156551087|FG001|Initial Treatment Period|Non-compliant|2|||
48644097|NCT00131352|156551086|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
48644098|NCT00131352|156551087|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
48644099|NCT00131352|156551086|FG000|Initial Treatment Period|Lack of Efficacy|6|||
48644100|NCT00131352|156551087|FG001|Initial Treatment Period|Lack of Efficacy|4|||
48644101|NCT00131352|156551086|FG000|Initial Treatment Period|Other|0|||
48750314|NCT03428360|156930350|FG000|Overall Study|Study terminated by sponsor|10|||
48750315|NCT03428360|156930350|FG000|Overall Study|Non-compliant with study|1|||
48750316|NCT03428360|156930350|FG000|Overall Study|Non-compliant with study drug|3|||
48750317|NCT03428360|156930350|FG000|Overall Study|Death|3|||
48750318|NCT03428360|156930350|FG000|Overall Study|Adverse Event|1|||
48750319|NCT03428360|156930350|FG000|Overall Study|Not on antiepileptic drug|1|||
48750320|NCT01482884|156930351|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
48750321|NCT01482884|156930352|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
48750322|NCT01482884|156930351|FG000|Overall Study|Protocol Violation|1|||
48750323|NCT01482884|156930352|FG001|Overall Study|Protocol Violation|0|||
48750324|NCT01482884|156930351|FG000|Overall Study|Lost to Follow-up|2|||
48750325|NCT01482884|156930352|FG001|Overall Study|Lost to Follow-up|2|||
48750326|NCT01482884|156930351|FG000|Overall Study|Lack of Efficacy|0|||
48750327|NCT01482884|156930352|FG001|Overall Study|Lack of Efficacy|1|||
48750328|NCT01482884|156930351|FG000|Overall Study|Adverse Event|2|||
48750329|NCT01482884|156930352|FG001|Overall Study|Adverse Event|1|||
48750330|NCT01482884|156930351|FG000|Overall Study|Withdrawal by Subject|8|||
48750331|NCT01482884|156930352|FG001|Overall Study|Withdrawal by Subject|13|||
48750332|NCT00203996|156930353|FG000|Overall Study|Lost to Follow-up|0|||
48750333|NCT00203996|156930354|FG001|Overall Study|Lost to Follow-up|0|||
48750334|NCT00203996|156930355|FG002|Overall Study|Lost to Follow-up|0|||
48750335|NCT00203996|156930356|FG003|Overall Study|Lost to Follow-up|1|||
48750336|NCT00203996|156930357|FG004|Overall Study|Lost to Follow-up|0|||
48750337|NCT00203996|156930358|FG005|Overall Study|Lost to Follow-up|0|||
48750338|NCT00203996|156930359|FG006|Overall Study|Lost to Follow-up|0|||
48644102|NCT00131352|156551087|FG001|Initial Treatment Period|Other|2|||
48644103|NCT00131352|156551086|FG000|Repeat Treatment Period|Adverse Event|1|||
48644104|NCT00131352|156551087|FG001|Repeat Treatment Period|Adverse Event|0|||
48644105|NCT00131352|156551086|FG000|Repeat Treatment Period|Other|1|||
48644106|NCT00131352|156551087|FG001|Repeat Treatment Period|Other|0|||
48329907|NCT00910962|155405596|FG000|Overall Study|Protocol Violation|1|||
48329908|NCT00910962|155405597|FG001|Overall Study|Protocol Violation|3|||
48644107|NCT00658541|156551089|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
48644108|NCT00658541|156551090|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48644109|NCT00658541|156551089|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
48644110|NCT00658541|156551090|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48644111|NCT02457247|156551091|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
48644112|NCT02457247|156551092|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
48750339|NCT00203996|156930360|FG007|Overall Study|Lost to Follow-up|0|||
48750340|NCT00203996|156930361|FG008|Overall Study|Lost to Follow-up|0|||
48750341|NCT00203996|156930362|FG009|Overall Study|Lost to Follow-up|0|||
48750342|NCT00203996|156930353|FG000|Overall Study|Protocol Violation|0|||
48644113|NCT02457247|156551093|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
48750343|NCT00203996|156930354|FG001|Overall Study|Protocol Violation|0|||
48329909|NCT00910962|155405598|FG002|Overall Study|Protocol Violation|3|||
48329910|NCT00910962|155405596|FG000|Overall Study|Lost to Follow-up|0|||
48329911|NCT00910962|155405597|FG001|Overall Study|Lost to Follow-up|3|||
48329912|NCT00910962|155405598|FG002|Overall Study|Lost to Follow-up|1|||
48329913|NCT00910962|155405596|FG000|Overall Study|Physician Decision|0|||
48329914|NCT00910962|155405597|FG001|Overall Study|Physician Decision|6|||
48329915|NCT00910962|155405598|FG002|Overall Study|Physician Decision|6|||
48329916|NCT00910962|155405596|FG000|Overall Study|Withdrawal by Subject|25|||
48329917|NCT00910962|155405597|FG001|Overall Study|Withdrawal by Subject|32|||
48329918|NCT00910962|155405598|FG002|Overall Study|Withdrawal by Subject|32|||
48644114|NCT02457247|156551094|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
48644115|NCT02457247|156551091|FG000|Period 1|Significant Protocol Deviation|1|||
48644116|NCT02457247|156551092|FG001|Period 1|Significant Protocol Deviation|1|||
48644117|NCT02457247|156551093|FG002|Period 1|Significant Protocol Deviation|0|||
48644118|NCT02457247|156551094|FG003|Period 1|Significant Protocol Deviation|0|||
48644119|NCT02457247|156551091|FG000|Period 1|Voluntary Withdrawal|1|||
48644120|NCT02457247|156551092|FG001|Period 1|Voluntary Withdrawal|0|||
48644121|NCT02457247|156551093|FG002|Period 1|Voluntary Withdrawal|0|||
48644122|NCT02457247|156551094|FG003|Period 1|Voluntary Withdrawal|0|||
48644123|NCT02457247|156551091|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
48644124|NCT02457247|156551092|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
48644125|NCT02457247|156551093|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
48644126|NCT02457247|156551094|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
48644127|NCT02457247|156551091|FG000|Period 2|Significant Protocol Deviation|1|||
48644128|NCT02457247|156551092|FG001|Period 2|Significant Protocol Deviation|0|||
48644129|NCT02457247|156551093|FG002|Period 2|Significant Protocol Deviation|0|||
48644130|NCT02457247|156551094|FG003|Period 2|Significant Protocol Deviation|0|||
48644131|NCT02457247|156551091|FG000|Period 2|Lost to Follow-up|0|||
48644132|NCT02457247|156551092|FG001|Period 2|Lost to Follow-up|1|||
48644133|NCT02457247|156551093|FG002|Period 2|Lost to Follow-up|0|||
48644134|NCT02457247|156551094|FG003|Period 2|Lost to Follow-up|0|||
48644135|NCT02457247|156551091|FG000|Period 2|Voluntary Withdrawal|1|||
48644136|NCT02457247|156551092|FG001|Period 2|Voluntary Withdrawal|1|||
48644137|NCT02457247|156551093|FG002|Period 2|Voluntary Withdrawal|0|||
48644138|NCT02457247|156551094|FG003|Period 2|Voluntary Withdrawal|0|||
48644139|NCT01492088|156551104|FG000|Overall Study|Withdrawal by Patient|0|||
48644140|NCT01492088|156551105|FG001|Overall Study|Withdrawal by Patient|2|||
48644141|NCT01492088|156551106|FG002|Overall Study|Withdrawal by Patient|0|||
48644142|NCT01492088|156551104|FG000|Overall Study|Death|1|||
48644143|NCT01492088|156551105|FG001|Overall Study|Death|6|||
48644144|NCT01492088|156551106|FG002|Overall Study|Death|2|||
48644145|NCT01492088|156551104|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
48644146|NCT01492088|156551105|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
48644147|NCT01492088|156551106|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
48644148|NCT01492088|156551104|FG000|Overall Study|Alive at Last Follow-up|0|||
48644149|NCT01492088|156551105|FG001|Overall Study|Alive at Last Follow-up|6|||
48644150|NCT01492088|156551106|FG002|Overall Study|Alive at Last Follow-up|11|||
48644151|NCT02240121|156551107|FG000|Overall Study|Protocol Violation|1|||
48644152|NCT02240121|156551108|FG001|Overall Study|Protocol Violation|2|||
48644153|NCT02240121|156551107|FG000|Overall Study|Physician Decision|0|||
48644154|NCT02240121|156551108|FG001|Overall Study|Physician Decision|1|||
48644155|NCT02240121|156551107|FG000|Overall Study|Change in protocol interpretation|1|||
48644156|NCT02240121|156551108|FG001|Overall Study|Change in protocol interpretation|0|||
48644157|NCT02240121|156551107|FG000|Overall Study|Lack of Efficacy|2|||
48644158|NCT02240121|156551108|FG001|Overall Study|Lack of Efficacy|3|||
48644159|NCT02240121|156551107|FG000|Overall Study|Site closed|1|||
48644160|NCT02240121|156551108|FG001|Overall Study|Site closed|1|||
48644161|NCT02240121|156551107|FG000|Overall Study|Pregnancy|1|||
48329919|NCT00910962|155405596|FG000|Overall Study|Reached defined stopping criteria|12|||
48644162|NCT02240121|156551108|FG001|Overall Study|Pregnancy|0|||
48644163|NCT02240121|156551107|FG000|Overall Study|Adverse Event|2|||
48644164|NCT02240121|156551108|FG001|Overall Study|Adverse Event|4|||
48644165|NCT02240121|156551107|FG000|Overall Study|Withdrawal by Subject|6|||
48644166|NCT02240121|156551108|FG001|Overall Study|Withdrawal by Subject|2|||
48644167|NCT02240121|156551107|FG000|Overall Study|Lost to Follow-up|3|||
48644168|NCT02240121|156551108|FG001|Overall Study|Lost to Follow-up|4|||
48644169|NCT02240121|156551107|FG000|Overall Study|Other than specified|1|||
48644170|NCT02240121|156551108|FG001|Overall Study|Other than specified|3|||
48644171|NCT02041299|156551114|FG000|Overall Study|Adverse Event|9|||
48644172|NCT02041299|156551115|FG001|Overall Study|Adverse Event|3|||
48644173|NCT02041299|156551114|FG000|Overall Study|Lost to Follow-up|4|||
48644174|NCT02041299|156551115|FG001|Overall Study|Lost to Follow-up|1|||
48644175|NCT02041299|156551114|FG000|Overall Study|Physician Decision|1|||
48644176|NCT02041299|156551115|FG001|Overall Study|Physician Decision|1|||
48644177|NCT02041299|156551114|FG000|Overall Study|Withdrawal by Subject|13|||
48644178|NCT02041299|156551115|FG001|Overall Study|Withdrawal by Subject|7|||
48644179|NCT02041299|156551114|FG000|Overall Study|Protocol Violation|11|||
48750344|NCT00203996|156930355|FG002|Overall Study|Protocol Violation|0|||
48750345|NCT00203996|156930356|FG003|Overall Study|Protocol Violation|6|||
48750346|NCT00203996|156930357|FG004|Overall Study|Protocol Violation|1|||
48750347|NCT00203996|156930358|FG005|Overall Study|Protocol Violation|0|||
48750348|NCT00203996|156930359|FG006|Overall Study|Protocol Violation|0|||
48750349|NCT00203996|156930360|FG007|Overall Study|Protocol Violation|0|||
48750350|NCT00203996|156930361|FG008|Overall Study|Protocol Violation|0|||
48750351|NCT00203996|156930362|FG009|Overall Study|Protocol Violation|0|||
48750352|NCT00203996|156930353|FG000|Overall Study|Physician Decision|0|||
48750353|NCT00203996|156930354|FG001|Overall Study|Physician Decision|0|||
48750354|NCT00203996|156930355|FG002|Overall Study|Physician Decision|0|||
48750355|NCT00203996|156930356|FG003|Overall Study|Physician Decision|2|||
48750356|NCT00203996|156930357|FG004|Overall Study|Physician Decision|0|||
48750357|NCT00203996|156930358|FG005|Overall Study|Physician Decision|0|||
48750358|NCT00203996|156930359|FG006|Overall Study|Physician Decision|0|||
48750359|NCT00203996|156930360|FG007|Overall Study|Physician Decision|0|||
48750360|NCT00203996|156930361|FG008|Overall Study|Physician Decision|0|||
48750361|NCT00203996|156930362|FG009|Overall Study|Physician Decision|1|||
48750362|NCT00203996|156930353|FG000|Overall Study|CPAP machine malfunction|0|||
48750363|NCT00203996|156930354|FG001|Overall Study|CPAP machine malfunction|0|||
48750364|NCT00203996|156930355|FG002|Overall Study|CPAP machine malfunction|0|||
48383942|NCT01109173|155601496|FG003|Overall Study|Not Specifiied|14|||
48644180|NCT02041299|156551115|FG001|Overall Study|Protocol Violation|4|||
48644181|NCT02041299|156551114|FG000|Overall Study|Termination of the study|7|||
48644182|NCT02041299|156551115|FG001|Overall Study|Termination of the study|3|||
48644183|NCT02041299|156551114|FG000|Overall Study|Required bone marrow transplant|0|||
48644184|NCT02041299|156551115|FG001|Overall Study|Required bone marrow transplant|1|||
48644185|NCT02041299|156551114|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
48644186|NCT02041299|156551115|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
48644187|NCT00003631|156551118|FG000|Overall Study|Patient not treated|1|||
48644188|NCT00003631|156551119|FG001|Overall Study|Patient not treated|0|||
48644189|NCT00003631|156551120|FG002|Overall Study|Patient not treated|1|||
48644190|NCT00003631|156551118|FG000|Overall Study|Protocol Violation|1|||
48644191|NCT00003631|156551119|FG001|Overall Study|Protocol Violation|0|||
48644192|NCT00003631|156551120|FG002|Overall Study|Protocol Violation|0|||
48644193|NCT00003631|156551118|FG000|Overall Study|Adverse Event|1|||
48644194|NCT00003631|156551119|FG001|Overall Study|Adverse Event|1|||
48644195|NCT00003631|156551120|FG002|Overall Study|Adverse Event|5|||
48644196|NCT00003631|156551118|FG000|Overall Study|Death|0|||
48644197|NCT00003631|156551119|FG001|Overall Study|Death|0|||
48644198|NCT00003631|156551120|FG002|Overall Study|Death|1|||
48750365|NCT00203996|156930356|FG003|Overall Study|CPAP machine malfunction|1|||
48750366|NCT00203996|156930357|FG004|Overall Study|CPAP machine malfunction|0|||
48750367|NCT00203996|156930358|FG005|Overall Study|CPAP machine malfunction|0|||
48750368|NCT00203996|156930359|FG006|Overall Study|CPAP machine malfunction|0|||
48750369|NCT00203996|156930360|FG007|Overall Study|CPAP machine malfunction|0|||
48750370|NCT00203996|156930361|FG008|Overall Study|CPAP machine malfunction|0|||
48750371|NCT00203996|156930362|FG009|Overall Study|CPAP machine malfunction|0|||
48750372|NCT00203996|156930353|FG000|Overall Study|Scheduling issue|0|||
48750373|NCT00203996|156930354|FG001|Overall Study|Scheduling issue|0|||
48750374|NCT00203996|156930355|FG002|Overall Study|Scheduling issue|0|||
48750375|NCT00203996|156930356|FG003|Overall Study|Scheduling issue|0|||
48750376|NCT00203996|156930357|FG004|Overall Study|Scheduling issue|0|||
48750377|NCT00203996|156930358|FG005|Overall Study|Scheduling issue|0|||
48750378|NCT00203996|156930359|FG006|Overall Study|Scheduling issue|0|||
48750379|NCT00203996|156930360|FG007|Overall Study|Scheduling issue|2|||
48750380|NCT00203996|156930361|FG008|Overall Study|Scheduling issue|0|||
48750381|NCT00203996|156930362|FG009|Overall Study|Scheduling issue|0|||
48750382|NCT02848651|156930363|FG000|Overall Study|Death|85|||
48750383|NCT02848651|156930363|FG000|Overall Study|Lost to Follow-up|1|||
48750384|NCT02848651|156930363|FG000|Overall Study|Non-Compliance|1|||
48750385|NCT02848651|156930363|FG000|Overall Study|Symptomatic Deterioration|1|||
48750386|NCT02848651|156930363|FG000|Overall Study|Physician Decision|4|||
48750387|NCT02848651|156930363|FG000|Overall Study|Withdrawal by Subject|14|||
48750388|NCT01713686|156932277|FG000|Overall Study|Lost to Follow-up|9|||
48750389|NCT01713686|156932277|FG000|Overall Study|Withdrawal by Subject|6|||
48750390|NCT00612690|156932278|FG000|Overall Study|Lost to Follow-up|72|||
48750391|NCT00612690|156932279|FG001|Overall Study|Lost to Follow-up|98|||
48750392|NCT00612690|156932278|FG000|Overall Study|Withdrawal by Subject|32|||
48750393|NCT00612690|156932279|FG001|Overall Study|Withdrawal by Subject|20|||
48644199|NCT00003631|156551118|FG000|Overall Study|Evaluable for toxicity only|0|||
48644200|NCT00003631|156551119|FG001|Overall Study|Evaluable for toxicity only|0|||
48644201|NCT00003631|156551120|FG002|Overall Study|Evaluable for toxicity only|2|||
48644202|NCT00996658|156551121|FG000|Overall Study|Adverse Event|2|||
48644203|NCT00996658|156551122|FG001|Overall Study|Adverse Event|5|||
48644204|NCT00996658|156551121|FG000|Overall Study|Protocol Violation|0|||
48644205|NCT00996658|156551122|FG001|Overall Study|Protocol Violation|1|||
48644206|NCT00996658|156551121|FG000|Overall Study|Lost to Follow-up|2|||
48644207|NCT00996658|156551122|FG001|Overall Study|Lost to Follow-up|5|||
48644208|NCT00996658|156551121|FG000|Overall Study|Non-compliance issues|3|||
48644209|NCT00996658|156551122|FG001|Overall Study|Non-compliance issues|3|||
48644210|NCT00996658|156551121|FG000|Overall Study|Other|9|||
48644211|NCT00996658|156551122|FG001|Overall Study|Other|7|||
48644212|NCT04339413|156551124|FG000|Overall Study|Reason Not Specified|2|||
48644213|NCT04339413|156551125|FG001|Overall Study|Reason Not Specified|7|||
48644214|NCT04339413|156551124|FG000|Overall Study|Study Terminated by Sponsor|30|||
48644215|NCT04339413|156551125|FG001|Overall Study|Study Terminated by Sponsor|33|||
48644216|NCT04339413|156551124|FG000|Overall Study|Progressive Disease|9|||
48644217|NCT04339413|156551125|FG001|Overall Study|Progressive Disease|6|||
48329920|NCT00910962|155405597|FG001|Overall Study|Reached defined stopping criteria|14|||
48329921|NCT00910962|155405598|FG002|Overall Study|Reached defined stopping criteria|17|||
48750394|NCT00612690|156932278|FG000|Overall Study|Withdrawal by Site|11|||
48750395|NCT00612690|156932279|FG001|Overall Study|Withdrawal by Site|0|||
48750396|NCT02980601|156932280|FG000|Overall Study|Lost to Follow-up|2|||
48644218|NCT04339413|156551124|FG000|Overall Study|Withdrawal by Subject|9|||
48644219|NCT04339413|156551125|FG001|Overall Study|Withdrawal by Subject|10|||
48644220|NCT04339413|156551124|FG000|Overall Study|Physician Decision|3|||
48644221|NCT04339413|156551125|FG001|Overall Study|Physician Decision|1|||
48644222|NCT04339413|156551124|FG000|Overall Study|Death|2|||
48644223|NCT04339413|156551125|FG001|Overall Study|Death|0|||
48644224|NCT04339413|156551124|FG000|Overall Study|Adverse Event|3|||
48644225|NCT04339413|156551125|FG001|Overall Study|Adverse Event|0|||
48750397|NCT02980601|156932281|FG001|Overall Study|Lost to Follow-up|2|||
48644226|NCT02524145|156551126|FG000|Overall Study|Withdrawal by Subject|2|||
48644227|NCT02524145|156551127|FG001|Overall Study|Withdrawal by Subject|2|||
48644228|NCT02524145|156551128|FG002|Overall Study|Withdrawal by Subject|3|||
48644229|NCT00114127|156551137|FG000|Overall Study|Adverse Event|2|||
48644230|NCT00114127|156551138|FG001|Overall Study|Adverse Event|1|||
48644231|NCT00114127|156551137|FG000|Overall Study|Lost to Follow-up|1|||
48644232|NCT00114127|156551138|FG001|Overall Study|Lost to Follow-up|0|||
48644233|NCT00114127|156551137|FG000|Overall Study|Withdrawal by Subject|1|||
48644234|NCT00114127|156551138|FG001|Overall Study|Withdrawal by Subject|3|||
48644235|NCT03072043|156551139|FG000|Overall Study|Death|0|||
48329922|NCT00923078|155405599|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
48329923|NCT00923078|155405600|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
48329924|NCT00923078|155405601|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
48644236|NCT03072043|156551140|FG001|Overall Study|Death|0|||
48644237|NCT03072043|156551141|FG002|Overall Study|Death|3|||
48644238|NCT03072043|156551139|FG000|Overall Study|Adverse Event|0|||
48644239|NCT03072043|156551140|FG001|Overall Study|Adverse Event|0|||
48644240|NCT03072043|156551141|FG002|Overall Study|Adverse Event|2|||
48644241|NCT03072043|156551139|FG000|Overall Study|Withdrawal by Subject|0|||
48644242|NCT03072043|156551140|FG001|Overall Study|Withdrawal by Subject|0|||
48644243|NCT03072043|156551141|FG002|Overall Study|Withdrawal by Subject|4|||
48644244|NCT00645840|156551142|FG000|Overall Study|Protocol Violation|3|||
48644245|NCT00699413|156551145|FG000|Overall Study|Withdrawal by Subject|0|||
48644246|NCT00699413|156551146|FG001|Overall Study|Withdrawal by Subject|2|||
48644247|NCT00699413|156551145|FG000|Overall Study|Study terminated by sponsor|4|||
48644248|NCT00699413|156551146|FG001|Overall Study|Study terminated by sponsor|2|||
48644249|NCT02779777|156551147|FG000|Overall Study|Disease Progression|1|||
48644250|NCT02779777|156551148|FG001|Overall Study|Disease Progression|0|||
48644251|NCT02779777|156551149|FG002|Overall Study|Disease Progression|0|||
48644252|NCT02779777|156551147|FG000|Overall Study|Adverse Event|3|||
48644253|NCT02779777|156551148|FG001|Overall Study|Adverse Event|1|||
48644254|NCT02779777|156551149|FG002|Overall Study|Adverse Event|0|||
48644255|NCT02779777|156551147|FG000|Overall Study|Physician Decision|9|||
48644256|NCT02779777|156551148|FG001|Overall Study|Physician Decision|0|||
48644257|NCT02779777|156551149|FG002|Overall Study|Physician Decision|1|||
48644258|NCT02779777|156551147|FG000|Overall Study|Withdrawal by Subject|1|||
48644259|NCT02779777|156551148|FG001|Overall Study|Withdrawal by Subject|0|||
48644260|NCT02779777|156551149|FG002|Overall Study|Withdrawal by Subject|0|||
48644261|NCT04571060|156551150|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
48644262|NCT04571060|156551151|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
48644263|NCT04571060|156551150|FG000|Overall Study|Never treated migraine|47|||
48644264|NCT04571060|156551151|FG001|Overall Study|Never treated migraine|36|||
48644265|NCT04571060|156551150|FG000|Overall Study|Protocol Violation|4|||
48644266|NCT04571060|156551151|FG001|Overall Study|Protocol Violation|2|||
48644267|NCT04571060|156551150|FG000|Overall Study|Withdrawal by Subject|6|||
48644268|NCT04571060|156551151|FG001|Overall Study|Withdrawal by Subject|2|||
48644269|NCT04571060|156551150|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
48644270|NCT04571060|156551151|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
48644271|NCT03943290|156551152|FG000|Overall Study|Sponsor Terminated Study|6|||
48644272|NCT03943290|156551153|FG001|Overall Study|Sponsor Terminated Study|1|||
48644273|NCT03943290|156551154|FG002|Overall Study|Sponsor Terminated Study|11|||
48644274|NCT03943290|156551155|FG003|Overall Study|Sponsor Terminated Study|6|||
48644275|NCT03943290|156551156|FG004|Overall Study|Sponsor Terminated Study|7|||
48644276|NCT03943290|156551157|FG005|Overall Study|Sponsor Terminated Study|6|||
48644277|NCT03943290|156551158|FG006|Overall Study|Sponsor Terminated Study|6|||
48329925|NCT00923078|155405599|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
48329926|NCT00923078|155405600|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
48329927|NCT00923078|155405601|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
48329928|NCT00787176|155405602|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
48329929|NCT00787176|155405603|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
48329930|NCT00787176|155405604|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
48329931|NCT00787176|155405605|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
48329932|NCT01124045|155405606|FG000|Overall Study|Lost to Follow-up|0|||
48329933|NCT01124045|155405607|FG001|Overall Study|Lost to Follow-up|1|||
48644278|NCT03943290|156551159|FG007|Overall Study|Sponsor Terminated Study|7|||
48644279|NCT03943290|156551160|FG008|Overall Study|Sponsor Terminated Study|8|||
48644280|NCT03943290|156551152|FG000|Overall Study|Lost to Follow-up|1|||
48644281|NCT03943290|156551153|FG001|Overall Study|Lost to Follow-up|0|||
48644282|NCT03943290|156551154|FG002|Overall Study|Lost to Follow-up|1|||
48644283|NCT03943290|156551155|FG003|Overall Study|Lost to Follow-up|0|||
48644284|NCT03943290|156551156|FG004|Overall Study|Lost to Follow-up|0|||
48644285|NCT03943290|156551157|FG005|Overall Study|Lost to Follow-up|0|||
48644286|NCT03943290|156551158|FG006|Overall Study|Lost to Follow-up|0|||
48644287|NCT03943290|156551159|FG007|Overall Study|Lost to Follow-up|1|||
48644288|NCT03943290|156551160|FG008|Overall Study|Lost to Follow-up|0|||
48329934|NCT01124045|155405606|FG000|Overall Study|Physician Decision|0|||
48329935|NCT01124045|155405607|FG001|Overall Study|Physician Decision|2|||
48329936|NCT02988713|155405611|FG000|Overall Study|Withdrawal by Subject|1|||
48329937|NCT02988713|155405611|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
48329938|NCT00895245|155405614|FG000|Overall Study|Lack of Efficacy|6|||
48329939|NCT02095678|155405617|FG000|Overall Study|Withdrawal by Subject|0|||
48329940|NCT02095678|155405618|FG001|Overall Study|Withdrawal by Subject|1|||
48644289|NCT03943290|156551152|FG000|Overall Study|Withdrawal by Subject|0|||
48644290|NCT03943290|156551153|FG001|Overall Study|Withdrawal by Subject|0|||
48644291|NCT03943290|156551154|FG002|Overall Study|Withdrawal by Subject|1|||
48644292|NCT03943290|156551155|FG003|Overall Study|Withdrawal by Subject|0|||
48644293|NCT03943290|156551156|FG004|Overall Study|Withdrawal by Subject|0|||
48644294|NCT03943290|156551157|FG005|Overall Study|Withdrawal by Subject|0|||
48644295|NCT03943290|156551158|FG006|Overall Study|Withdrawal by Subject|0|||
48644296|NCT03943290|156551159|FG007|Overall Study|Withdrawal by Subject|0|||
48644297|NCT03943290|156551160|FG008|Overall Study|Withdrawal by Subject|0|||
48644298|NCT02441101|156551165|FG000|Overall Study|Withdrawal by Subject|1|||
48644299|NCT02441101|156551166|FG001|Overall Study|Withdrawal by Subject|0|||
48644300|NCT02441101|156551165|FG000|Overall Study|Lost to Follow-up|1|||
48644301|NCT02441101|156551166|FG001|Overall Study|Lost to Follow-up|0|||
48644302|NCT02441101|156551165|FG000|Overall Study|PI relocated and study terminated|1|||
48644303|NCT02441101|156551166|FG001|Overall Study|PI relocated and study terminated|0|||
48329941|NCT02095678|155405617|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
48644304|NCT01369199|156551167|FG000|Overall Study|Withdrawal by Subject|1|||
48644305|NCT01369199|156551167|FG000|Overall Study|Lost to Follow-up|2|||
48644306|NCT00955474|156551168|FG000|Overall Study|Physician Decision|7|||
48644307|NCT00955474|156551169|FG001|Overall Study|Physician Decision|5|||
48644308|NCT00625586|156551172|FG000|Overall Study|Adverse Event|1|||
48644309|NCT00625586|156551172|FG000|Overall Study|Progressive disease|1|||
48644310|NCT02503085|156551173|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
48644311|NCT02503085|156551174|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
48644312|NCT02503085|156551175|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
48644313|NCT02503085|156551176|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
48644314|NCT00886769|156551179|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
48644315|NCT00886769|156551180|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
48644316|NCT00049257|156551181|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
48644317|NCT00049257|156551181|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
48644318|NCT00049257|156551181|FG000|Carboplatin, Paclitaxel|Death|2|||
48644319|NCT00049257|156551181|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
48644320|NCT01558596|156551182|FG000|Overall Study|Withdrawal by Subject|1|||
48644321|NCT01558596|156551183|FG001|Overall Study|Withdrawal by Subject|0|||
48644322|NCT01558596|156551182|FG000|Overall Study|surgery elsewhere or cancelled|1|||
48644323|NCT01558596|156551183|FG001|Overall Study|surgery elsewhere or cancelled|1|||
48644324|NCT01558596|156551182|FG000|Overall Study|Protocol Violation|1|||
48644325|NCT01558596|156551183|FG001|Overall Study|Protocol Violation|0|||
48644326|NCT03192137|156551184|FG000|Overall Study|Adverse Event|10|||
48644327|NCT03192137|156551185|FG001|Overall Study|Adverse Event|11|||
48644328|NCT03192137|156551184|FG000|Overall Study|Physician Decision|1|||
48644329|NCT03192137|156551185|FG001|Overall Study|Physician Decision|0|||
48644330|NCT03192137|156551184|FG000|Overall Study|Lack of Efficacy|20|||
48644331|NCT03192137|156551185|FG001|Overall Study|Lack of Efficacy|37|||
48644332|NCT03192137|156551184|FG000|Overall Study|Withdrawal by Subject|3|||
48644333|NCT03192137|156551185|FG001|Overall Study|Withdrawal by Subject|3|||
48644334|NCT03192137|156551184|FG000|Overall Study|Protocol Violation|4|||
48644335|NCT03192137|156551185|FG001|Overall Study|Protocol Violation|3|||
48644336|NCT03192137|156551184|FG000|Overall Study|Surgery Cancelled|4|||
48644337|NCT03192137|156551185|FG001|Overall Study|Surgery Cancelled|1|||
48644338|NCT03192137|156551184|FG000|Overall Study|Other - Various Administrative Reasons|8|||
48644339|NCT03192137|156551185|FG001|Overall Study|Other - Various Administrative Reasons|3|||
48644340|NCT02012218|156551187|FG000|Overall Study|Withdrawal by Subject|1|||
48644341|NCT02012218|156551188|FG001|Overall Study|Withdrawal by Subject|0|||
48644342|NCT02012218|156551189|FG002|Overall Study|Withdrawal by Subject|1|||
48644343|NCT02012218|156551190|FG003|Overall Study|Withdrawal by Subject|1|||
48644344|NCT02012218|156551191|FG004|Overall Study|Withdrawal by Subject|1|||
48644345|NCT02012218|156551187|FG000|Overall Study|Adverse Event|1|||
48644346|NCT02012218|156551188|FG001|Overall Study|Adverse Event|0|||
48644347|NCT02012218|156551189|FG002|Overall Study|Adverse Event|0|||
48644348|NCT02012218|156551190|FG003|Overall Study|Adverse Event|1|||
48644349|NCT02012218|156551191|FG004|Overall Study|Adverse Event|0|||
48644350|NCT02012218|156551187|FG000|Overall Study|Lost to Follow-up|0|||
48644351|NCT02012218|156551188|FG001|Overall Study|Lost to Follow-up|1|||
48644352|NCT02012218|156551189|FG002|Overall Study|Lost to Follow-up|1|||
48644353|NCT02012218|156551190|FG003|Overall Study|Lost to Follow-up|0|||
48644354|NCT02012218|156551191|FG004|Overall Study|Lost to Follow-up|0|||
48644355|NCT02012218|156551187|FG000|Overall Study|Protocol Specified|1|||
48644356|NCT02012218|156551188|FG001|Overall Study|Protocol Specified|0|||
48644357|NCT02012218|156551189|FG002|Overall Study|Protocol Specified|0|||
48644358|NCT02012218|156551190|FG003|Overall Study|Protocol Specified|0|||
48644359|NCT02012218|156551191|FG004|Overall Study|Protocol Specified|0|||
48644360|NCT02012218|156551187|FG000|Overall Study|Protocol Deviation|1|||
48644361|NCT02012218|156551188|FG001|Overall Study|Protocol Deviation|0|||
48644362|NCT02012218|156551189|FG002|Overall Study|Protocol Deviation|0|||
48644363|NCT02012218|156551190|FG003|Overall Study|Protocol Deviation|0|||
48644364|NCT02012218|156551191|FG004|Overall Study|Protocol Deviation|0|||
48644365|NCT03082677|156551192|FG000|Overall Study|Not Treated|2|||
48644366|NCT04872569|156551193|FG000|Overall Study|Withdrawal by Subject|2|||
48644367|NCT00673231|156551195|FG000|Overall Study|Withdrawal by Subject|14|||
48644368|NCT00673231|156551196|FG001|Overall Study|Withdrawal by Subject|10|||
48644369|NCT00673231|156551197|FG002|Overall Study|Withdrawal by Subject|8|||
48644370|NCT00673231|156551198|FG003|Overall Study|Withdrawal by Subject|6|||
48644371|NCT00673231|156551195|FG000|Overall Study|Adverse Event|6|||
48644372|NCT00673231|156551196|FG001|Overall Study|Adverse Event|5|||
48644373|NCT00673231|156551197|FG002|Overall Study|Adverse Event|9|||
48644374|NCT00673231|156551198|FG003|Overall Study|Adverse Event|6|||
48644375|NCT00673231|156551195|FG000|Overall Study|Lost to Follow-up|1|||
48644376|NCT00673231|156551196|FG001|Overall Study|Lost to Follow-up|2|||
48644377|NCT00673231|156551197|FG002|Overall Study|Lost to Follow-up|1|||
48644378|NCT00673231|156551198|FG003|Overall Study|Lost to Follow-up|2|||
48644379|NCT00673231|156551195|FG000|Overall Study|Death|0|||
48644380|NCT00673231|156551196|FG001|Overall Study|Death|0|||
48644381|NCT00673231|156551197|FG002|Overall Study|Death|1|||
48644382|NCT00673231|156551198|FG003|Overall Study|Death|0|||
48644383|NCT00673231|156551195|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
48644384|NCT00673231|156551196|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
48750398|NCT02980601|156932280|FG000|Overall Study|Death|0|||
48750399|NCT02980601|156932281|FG001|Overall Study|Death|1|||
48750400|NCT02980601|156932280|FG000|Overall Study|Graft loss|1|||
48750401|NCT02980601|156932281|FG001|Overall Study|Graft loss|0|||
48644385|NCT00673231|156551197|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
48750402|NCT02980601|156932280|FG000|Overall Study|Failed to sign consent|2|||
48750403|NCT02980601|156932281|FG001|Overall Study|Failed to sign consent|0|||
48750404|NCT00907777|156932283|FG000|Overall Study|Withdrawal by Subject|0|||
48750405|NCT00907777|156932284|FG001|Overall Study|Withdrawal by Subject|1|||
48750406|NCT00674700|156932293|FG000|Year 1|Adverse Event|17|||
48750407|NCT00674700|156932294|FG001|Year 1|Adverse Event|20|||
48750408|NCT00674700|156932295|FG002|Year 1|Adverse Event|5|||
48750409|NCT00674700|156932293|FG000|Year 1|Withdrawal by Subject|7|||
48750410|NCT00674700|156932294|FG001|Year 1|Withdrawal by Subject|7|||
48750411|NCT00674700|156932295|FG002|Year 1|Withdrawal by Subject|6|||
48750412|NCT00674700|156932293|FG000|Year 1|Any other reason not above-mentioned|7|||
48750413|NCT00674700|156932294|FG001|Year 1|Any other reason not above-mentioned|7|||
48750414|NCT00674700|156932295|FG002|Year 1|Any other reason not above-mentioned|6|||
48750415|NCT00674700|156932293|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
48750416|NCT00674700|156932294|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
48750417|NCT00674700|156932295|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
48750418|NCT00674700|156932293|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
48644386|NCT00673231|156551198|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
48644387|NCT01016132|156551219|FG000|Overall Study|Discomfort|1|||
48644388|NCT02311881|156551220|FG000|Overall Study|Did not meet the study criteria|2|||
48644389|NCT02311881|156551221|FG001|Overall Study|Did not meet the study criteria|2|||
48644390|NCT02311881|156551222|FG002|Overall Study|Did not meet the study criteria|0|||
48644391|NCT02311881|156551220|FG000|Overall Study|Adverse Event|7|||
48644392|NCT02311881|156551221|FG001|Overall Study|Adverse Event|15|||
48644393|NCT02311881|156551222|FG002|Overall Study|Adverse Event|8|||
48750419|NCT00674700|156932294|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
48329942|NCT02095678|155405618|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
48329943|NCT02095678|155405617|FG000|Overall Study|lesion impacted by previous treatment|1|||
48329944|NCT02095678|155405618|FG001|Overall Study|lesion impacted by previous treatment|1|||
48329945|NCT02095678|155405617|FG000|Overall Study|No Confirmed Diagnosis|0|||
48329946|NCT02095678|155405618|FG001|Overall Study|No Confirmed Diagnosis|3|||
48329947|NCT02095678|155405617|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
48329948|NCT02095678|155405618|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
48329949|NCT02095678|155405617|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
48644394|NCT02311881|156551220|FG000|Overall Study|Lost to Follow-up|3|||
48644395|NCT02311881|156551221|FG001|Overall Study|Lost to Follow-up|3|||
48750420|NCT00674700|156932295|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
48750421|NCT00674700|156932293|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
48329950|NCT02095678|155405618|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
48644396|NCT02311881|156551222|FG002|Overall Study|Lost to Follow-up|2|||
48644397|NCT02311881|156551220|FG000|Overall Study|Protocol Violation|1|||
48644398|NCT02311881|156551221|FG001|Overall Study|Protocol Violation|2|||
48644399|NCT02311881|156551222|FG002|Overall Study|Protocol Violation|3|||
48329951|NCT01989689|155405620|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
48644400|NCT02311881|156551220|FG000|Overall Study|Withdrawal of consent|14|||
48644401|NCT02311881|156551221|FG001|Overall Study|Withdrawal of consent|16|||
48644402|NCT02311881|156551222|FG002|Overall Study|Withdrawal of consent|17|||
48644403|NCT02311881|156551220|FG000|Overall Study|Other|0|||
48644404|NCT02311881|156551221|FG001|Overall Study|Other|0|||
48644405|NCT02311881|156551222|FG002|Overall Study|Other|1|||
48644406|NCT02311881|156551220|FG000|Overall Study|Lack of Efficacy|1|||
48644407|NCT02311881|156551221|FG001|Overall Study|Lack of Efficacy|2|||
48644408|NCT02311881|156551222|FG002|Overall Study|Lack of Efficacy|0|||
48644409|NCT02311881|156551220|FG000|Overall Study|Subject has border line pregnancy test|1|||
48644410|NCT02311881|156551221|FG001|Overall Study|Subject has border line pregnancy test|0|||
48644411|NCT02311881|156551222|FG002|Overall Study|Subject has border line pregnancy test|0|||
48644412|NCT02311881|156551220|FG000|Overall Study|Withdrawal by Subject|3|||
48644413|NCT02311881|156551221|FG001|Overall Study|Withdrawal by Subject|1|||
48644414|NCT02311881|156551222|FG002|Overall Study|Withdrawal by Subject|4|||
48644415|NCT02311881|156551220|FG000|Overall Study|Sponsor Decision|1|||
48644416|NCT02311881|156551221|FG001|Overall Study|Sponsor Decision|1|||
48644417|NCT02311881|156551222|FG002|Overall Study|Sponsor Decision|1|||
48644418|NCT02311881|156551220|FG000|Overall Study|Protocol Deviation|1|||
48644419|NCT02311881|156551221|FG001|Overall Study|Protocol Deviation|0|||
48644420|NCT02311881|156551222|FG002|Overall Study|Protocol Deviation|0|||
48644421|NCT02311881|156551220|FG000|Overall Study|Non-Compliance|1|||
48644422|NCT02311881|156551221|FG001|Overall Study|Non-Compliance|0|||
48644423|NCT02311881|156551222|FG002|Overall Study|Non-Compliance|2|||
48644424|NCT02311881|156551220|FG000|Overall Study|Physician Decision|0|||
48644425|NCT02311881|156551221|FG001|Overall Study|Physician Decision|0|||
48644426|NCT02311881|156551222|FG002|Overall Study|Physician Decision|1|||
48644427|NCT02311881|156551220|FG000|Overall Study|Medical Monitor Discretion|0|||
48644428|NCT02311881|156551221|FG001|Overall Study|Medical Monitor Discretion|0|||
48644429|NCT02311881|156551222|FG002|Overall Study|Medical Monitor Discretion|1|||
48644430|NCT02311881|156551220|FG000|Overall Study|Participant taking another medication|0|||
48644431|NCT02311881|156551221|FG001|Overall Study|Participant taking another medication|0|||
48644432|NCT02311881|156551222|FG002|Overall Study|Participant taking another medication|1|||
48644433|NCT02311881|156551220|FG000|Overall Study|Serious Adverse Event|0|||
48644434|NCT02311881|156551221|FG001|Overall Study|Serious Adverse Event|1|||
48644435|NCT02311881|156551222|FG002|Overall Study|Serious Adverse Event|0|||
48644436|NCT01265992|156551223|FG000|Overall Study|Lost to Follow-up|1|||
48644437|NCT01265992|156551223|FG000|Overall Study|Withdrawal by Subject|1|||
48644438|NCT01265992|156551223|FG000|Overall Study|Adverse Event|1|||
48644439|NCT01265992|156551223|FG000|Overall Study|Administrative reasons|2|||
48644440|NCT01265992|156551223|FG000|Overall Study|Stopped treatment|3|||
48644441|NCT01265992|156551223|FG000|Overall Study|Did not receive treatment|1|||
48644442|NCT01963767|156551224|FG000|Overall Study|Withdrawal by Subject|4|||
48644443|NCT01963767|156551225|FG001|Overall Study|Withdrawal by Subject|2|||
48644444|NCT01963767|156551224|FG000|Overall Study|Adverse Event|2|||
48644445|NCT01963767|156551225|FG001|Overall Study|Adverse Event|0|||
48644446|NCT02949024|156551226|FG000|Overall Study|Withdrawal by Subject|0|||
48644447|NCT02949024|156551227|FG001|Overall Study|Withdrawal by Subject|1|||
48644448|NCT03159468|156551230|FG000|Overall Study|Withdrawal by Subject|0|||
48427376|NCT01544595|155752939|FG001|Status at Week 156|Pregnancy|3|||
48644449|NCT03159468|156551231|FG001|Overall Study|Withdrawal by Subject|0|||
48644450|NCT03159468|156551232|FG002|Overall Study|Withdrawal by Subject|3|||
48644451|NCT03159468|156551233|FG003|Overall Study|Withdrawal by Subject|0|||
48750422|NCT00674700|156932294|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
48750423|NCT00674700|156932295|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
48750424|NCT02954237|156932296|FG000|Overall Study|Withdrawal by Subject|25|||
48750425|NCT02954237|156932296|FG000|Overall Study|Missed visit|16|||
48750426|NCT02954237|156932296|FG000|Overall Study|Death|2|||
48750427|NCT02151591|156932308|FG000|Overall Study|Lost to Follow-up|6|||
48750428|NCT02151591|156932309|FG001|Overall Study|Lost to Follow-up|3|||
48750429|NCT02670083|156932312|FG000|Overall Study|Adverse Event|16|||
48750430|NCT02670083|156932313|FG001|Overall Study|Adverse Event|13|||
48750431|NCT02670083|156932312|FG000|Overall Study|Death|4|||
48750432|NCT02670083|156932313|FG001|Overall Study|Death|6|||
48750433|NCT02670083|156932312|FG000|Overall Study|Lost to Follow-up|2|||
48750434|NCT02670083|156932313|FG001|Overall Study|Lost to Follow-up|2|||
48750435|NCT02670083|156932312|FG000|Overall Study|Multiple Reasons|9|||
48750436|NCT02670083|156932313|FG001|Overall Study|Multiple Reasons|9|||
48750437|NCT02670083|156932312|FG000|Overall Study|Physician Decision|0|||
48750438|NCT02670083|156932313|FG001|Overall Study|Physician Decision|2|||
48750439|NCT02670083|156932312|FG000|Overall Study|Study Terminated By Sponsor|257|||
48750440|NCT02670083|156932313|FG001|Overall Study|Study Terminated By Sponsor|254|||
48750441|NCT02670083|156932312|FG000|Overall Study|Symptomatic Deterioration|0|||
48750442|NCT02670083|156932313|FG001|Overall Study|Symptomatic Deterioration|2|||
48750443|NCT02670083|156932312|FG000|Overall Study|Withdrawal by Subject|32|||
48750444|NCT02670083|156932313|FG001|Overall Study|Withdrawal by Subject|31|||
48750445|NCT02670083|156932312|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48750446|NCT02670083|156932313|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48750447|NCT01549860|156932314|FG000|Overall Study|Withdrawal by Subject|1|||
48750448|NCT01549860|156932315|FG001|Overall Study|Withdrawal by Subject|0|||
48750449|NCT01549860|156932314|FG000|Overall Study|Physician Decision|1|||
48750450|NCT01549860|156932315|FG001|Overall Study|Physician Decision|1|||
48750451|NCT00187486|156932317|FG000|Overall Study|Protocol Violation|1|||
48750452|NCT00684593|156932318|FG000|Overall Study|Adverse Event|0|||
48750453|NCT00684593|156932319|FG001|Overall Study|Adverse Event|2|||
48750454|NCT01366521|156932320|FG000|Overall Study|Adverse Event|1|||
48750455|NCT01366521|156932321|FG001|Overall Study|Adverse Event|0|||
48750456|NCT01366521|156932322|FG002|Overall Study|Adverse Event|0|||
48750457|NCT01366521|156932323|FG003|Overall Study|Adverse Event|0|||
48750458|NCT01366521|156932320|FG000|Overall Study|Protocol Violation|0|||
48750459|NCT01366521|156932321|FG001|Overall Study|Protocol Violation|0|||
48750460|NCT01366521|156932322|FG002|Overall Study|Protocol Violation|1|||
48644452|NCT03159468|156551234|FG004|Overall Study|Withdrawal by Subject|0|||
48644453|NCT03159468|156551235|FG005|Overall Study|Withdrawal by Subject|0|||
48750461|NCT01366521|156932323|FG003|Overall Study|Protocol Violation|0|||
48750462|NCT01366521|156932320|FG000|Overall Study|Physician Decision|0|||
48750463|NCT01366521|156932321|FG001|Overall Study|Physician Decision|0|||
48750464|NCT01366521|156932322|FG002|Overall Study|Physician Decision|1|||
48644454|NCT01133665|156552733|FG000|Overall Study|Physician Decision|2|||
48644455|NCT00529243|156552735|FG000|Overall Study|Adverse Event|1|||
48644456|NCT00529243|156552735|FG000|Overall Study|Death|1|||
48644457|NCT00529243|156552735|FG000|Overall Study|Relocated|1|||
48644458|NCT02549989|156552744|FG000|Overall Study|Adverse Event|4|||
48644459|NCT02549989|156552744|FG000|Overall Study|Death|1|||
48644460|NCT02549989|156552744|FG000|Overall Study|Lack of Efficacy|19|||
48644461|NCT02549989|156552744|FG000|Overall Study|Withdrawal by Subject|3|||
48644462|NCT00972023|156552745|FG000|Overall Study|Withdrawal by Subject|1|||
48644463|NCT00532129|156552746|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
48644464|NCT00532129|156552746|FG000|Treatment Period|Physician Decision|15|||
48644465|NCT00532129|156552746|FG000|Treatment Period|Disease progression|3|||
48750465|NCT01366521|156932323|FG003|Overall Study|Physician Decision|0|||
48750466|NCT01366521|156932320|FG000|Overall Study|Withdrawal by Subject|0|||
48750467|NCT01366521|156932321|FG001|Overall Study|Withdrawal by Subject|1|||
48750468|NCT01366521|156932322|FG002|Overall Study|Withdrawal by Subject|0|||
48750469|NCT01366521|156932323|FG003|Overall Study|Withdrawal by Subject|0|||
48750470|NCT00684307|156932324|FG000|Overall Study|Adverse Event|11|||
48750471|NCT00684307|156932325|FG001|Overall Study|Adverse Event|6|||
48750472|NCT00684307|156932326|FG002|Overall Study|Adverse Event|15|||
48644466|NCT00532129|156552746|FG000|Treatment Period|Protocol Violation|1|||
48750473|NCT00684307|156932327|FG003|Overall Study|Adverse Event|16|||
48750474|NCT00684307|156932328|FG004|Overall Study|Adverse Event|8|||
48750475|NCT00684307|156932324|FG000|Overall Study|Development of increasing Liver Function|0|||
48750476|NCT00684307|156932325|FG001|Overall Study|Development of increasing Liver Function|2|||
48750477|NCT00684307|156932326|FG002|Overall Study|Development of increasing Liver Function|0|||
48750478|NCT00684307|156932327|FG003|Overall Study|Development of increasing Liver Function|1|||
48644467|NCT00532129|156552746|FG000|Treatment Period|Other|5|||
48750479|NCT00684307|156932328|FG004|Overall Study|Development of increasing Liver Function|0|||
48750480|NCT00684307|156932324|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
48750481|NCT00684307|156932325|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
48750482|NCT00684307|156932326|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
48750483|NCT00684307|156932327|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
48750484|NCT00684307|156932328|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
48750485|NCT00684307|156932324|FG000|Overall Study|Incorrect enrolment or randomization|4|||
48750486|NCT00684307|156932325|FG001|Overall Study|Incorrect enrolment or randomization|0|||
48750487|NCT00684307|156932326|FG002|Overall Study|Incorrect enrolment or randomization|0|||
48750488|NCT00684307|156932327|FG003|Overall Study|Incorrect enrolment or randomization|0|||
48750489|NCT00684307|156932328|FG004|Overall Study|Incorrect enrolment or randomization|0|||
48750490|NCT00684307|156932324|FG000|Overall Study|Interupted IP for more than 7 days|0|||
48750491|NCT00684307|156932325|FG001|Overall Study|Interupted IP for more than 7 days|4|||
48750492|NCT00684307|156932326|FG002|Overall Study|Interupted IP for more than 7 days|1|||
48750493|NCT00684307|156932327|FG003|Overall Study|Interupted IP for more than 7 days|3|||
48750494|NCT00684307|156932328|FG004|Overall Study|Interupted IP for more than 7 days|3|||
48750495|NCT00684307|156932324|FG000|Overall Study|Severe non compliance to protocol|1|||
48750496|NCT00684307|156932325|FG001|Overall Study|Severe non compliance to protocol|0|||
48750497|NCT00684307|156932326|FG002|Overall Study|Severe non compliance to protocol|0|||
48750498|NCT00684307|156932327|FG003|Overall Study|Severe non compliance to protocol|1|||
48750499|NCT00684307|156932328|FG004|Overall Study|Severe non compliance to protocol|2|||
48750500|NCT00684307|156932324|FG000|Overall Study|Participant not willing to continue|7|||
48750501|NCT00684307|156932325|FG001|Overall Study|Participant not willing to continue|10|||
48750502|NCT00684307|156932326|FG002|Overall Study|Participant not willing to continue|11|||
48750503|NCT00684307|156932327|FG003|Overall Study|Participant not willing to continue|5|||
48750504|NCT00684307|156932328|FG004|Overall Study|Participant not willing to continue|8|||
48750505|NCT00684307|156932324|FG000|Overall Study|Criteria from the CSR|0|||
48750506|NCT00684307|156932325|FG001|Overall Study|Criteria from the CSR|0|||
48750507|NCT00684307|156932326|FG002|Overall Study|Criteria from the CSR|1|||
48750508|NCT00684307|156932327|FG003|Overall Study|Criteria from the CSR|3|||
48750509|NCT00684307|156932328|FG004|Overall Study|Criteria from the CSR|3|||
48750510|NCT00759031|156932329|FG000|First Intervention (1 Day)|Physician Decision|1|||
48750511|NCT00759031|156932330|FG001|First Intervention (1 Day)|Physician Decision|0|||
48750512|NCT00759031|156932329|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
48750513|NCT00759031|156932330|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
48750514|NCT00759031|156932329|FG000|First Intervention (1 Day)|Screening failure|1|||
48750515|NCT00759031|156932330|FG001|First Intervention (1 Day)|Screening failure|0|||
48750516|NCT00309387|156932335|FG000|Overall Study|Death|72|||
48750517|NCT00309387|156932336|FG001|Overall Study|Death|73|||
48750518|NCT00309387|156932335|FG000|Overall Study|Lost to Follow-up|70|||
48750519|NCT00309387|156932336|FG001|Overall Study|Lost to Follow-up|86|||
48750520|NCT01224431|156932341|FG000|Overall Study|not randomized|0|||
48750521|NCT01224431|156932342|FG001|Overall Study|not randomized|4|||
48750522|NCT01224431|156932341|FG000|Overall Study|no video record|0|||
48750523|NCT01224431|156932342|FG001|Overall Study|no video record|1|||
48750524|NCT00884312|156932343|FG000|Overall Study|Non-fatal Progressive Disease|0|||
48750525|NCT00884312|156932344|FG001|Overall Study|Non-fatal Progressive Disease|8|||
48750526|NCT00884312|156932343|FG000|Overall Study|Fatal Progressive Disease|0|||
48750527|NCT00884312|156932344|FG001|Overall Study|Fatal Progressive Disease|1|||
48750528|NCT00884312|156932343|FG000|Overall Study|Non-fatal Adverse Event|1|||
48750529|NCT00884312|156932344|FG001|Overall Study|Non-fatal Adverse Event|0|||
48750530|NCT00884312|156932343|FG000|Overall Study|Fatal Adverse Event|1|||
48750531|NCT00884312|156932344|FG001|Overall Study|Fatal Adverse Event|4|||
48750532|NCT00884312|156932343|FG000|Overall Study|Withdrawal by Subject|0|||
48750533|NCT00884312|156932344|FG001|Overall Study|Withdrawal by Subject|6|||
48750534|NCT00884312|156932343|FG000|Overall Study|Physician Decision|0|||
48750535|NCT00884312|156932344|FG001|Overall Study|Physician Decision|1|||
48750536|NCT00884312|156932343|FG000|Overall Study|Other|0|||
48750537|NCT00884312|156932344|FG001|Overall Study|Other|4|||
48750538|NCT00884312|156932343|FG000|Overall Study|Did Not Receive Study Drug|0|||
48644468|NCT00532129|156552746|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
48644469|NCT00532129|156552746|FG000|Follow-up Period|Disease progression|57|||
48644470|NCT00532129|156552746|FG000|Follow-up Period|Lost to Follow-up|1|||
48644471|NCT00532129|156552746|FG000|Follow-up Period|Other|6|||
48644472|NCT01333722|156552747|FG000|Overall Study|Lack of Efficacy|0|||
48644473|NCT01333722|156552748|FG001|Overall Study|Lack of Efficacy|2|||
48644474|NCT01333722|156552747|FG000|Overall Study|Withdrawal by Subject|0|||
48644475|NCT01333722|156552748|FG001|Overall Study|Withdrawal by Subject|1|||
48644476|NCT00443703|156552749|FG000|Overall Study|Never Treated|3|||
48644477|NCT00443703|156552750|FG001|Overall Study|Never Treated|1|||
48644478|NCT00443703|156552749|FG000|Overall Study|Adverse Event|7|||
48644479|NCT00443703|156552750|FG001|Overall Study|Adverse Event|3|||
48644480|NCT00443703|156552749|FG000|Overall Study|Lack of Efficacy|3|||
48644481|NCT00443703|156552750|FG001|Overall Study|Lack of Efficacy|1|||
48644482|NCT00443703|156552749|FG000|Overall Study|Lost to Follow-up|0|||
48644483|NCT00443703|156552750|FG001|Overall Study|Lost to Follow-up|4|||
48644484|NCT00443703|156552749|FG000|Overall Study|Physician Decision|4|||
48644485|NCT00443703|156552750|FG001|Overall Study|Physician Decision|2|||
48644486|NCT00443703|156552749|FG000|Overall Study|Protocol Violation|1|||
48644487|NCT00443703|156552750|FG001|Overall Study|Protocol Violation|1|||
48644488|NCT00443703|156552749|FG000|Overall Study|Withdrawal by Subject|9|||
48644489|NCT00443703|156552750|FG001|Overall Study|Withdrawal by Subject|6|||
48644490|NCT00443703|156552749|FG000|Overall Study|Progressive Disease|1|||
48644491|NCT00443703|156552750|FG001|Overall Study|Progressive Disease|0|||
48644492|NCT00375427|156552751|FG000|Overall Study|Adverse Event|21|||
48644493|NCT00375427|156552752|FG001|Overall Study|Adverse Event|27|||
48750539|NCT00884312|156932344|FG001|Overall Study|Did Not Receive Study Drug|1|||
48750540|NCT00284050|156932346|FG000|Overall Study|Adverse Event|1|||
48750541|NCT00284050|156932347|FG001|Overall Study|Adverse Event|1|||
48750542|NCT00284050|156932348|FG002|Overall Study|Adverse Event|1|||
48750543|NCT00284050|156932346|FG000|Overall Study|Lack of Efficacy|0|||
48750544|NCT00284050|156932347|FG001|Overall Study|Lack of Efficacy|1|||
48750545|NCT00284050|156932348|FG002|Overall Study|Lack of Efficacy|3|||
48750546|NCT00284050|156932346|FG000|Overall Study|Protocol Violation|0|||
48750547|NCT00284050|156932347|FG001|Overall Study|Protocol Violation|1|||
48750548|NCT00284050|156932348|FG002|Overall Study|Protocol Violation|2|||
48750549|NCT00284050|156932346|FG000|Overall Study|Withdrawal by Subject|2|||
48750550|NCT00284050|156932347|FG001|Overall Study|Withdrawal by Subject|2|||
48750551|NCT00284050|156932348|FG002|Overall Study|Withdrawal by Subject|2|||
48750552|NCT00284050|156932346|FG000|Overall Study|Lost to Follow-up|1|||
48750553|NCT00284050|156932347|FG001|Overall Study|Lost to Follow-up|0|||
48750554|NCT00284050|156932348|FG002|Overall Study|Lost to Follow-up|1|||
48644494|NCT00375427|156552751|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48644495|NCT00375427|156552752|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48750555|NCT00284050|156932346|FG000|Overall Study|Death|1|||
48427377|NCT01544595|155752940|FG002|Status at Week 156|Pregnancy|0|||
48644496|NCT00375427|156552751|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48644497|NCT00375427|156552752|FG001|Overall Study|Abnormal laboratory value(s)|2|||
48750556|NCT00284050|156932347|FG001|Overall Study|Death|0|||
48750557|NCT00284050|156932348|FG002|Overall Study|Death|0|||
48750558|NCT02743520|156932349|FG000|Overall Study|Withdrawal by Subject|1|||
48750559|NCT01749514|156932350|FG000|Overall Study|Lost to Follow-up|0|||
48750560|NCT01749514|156932351|FG001|Overall Study|Lost to Follow-up|0|||
48750561|NCT01749514|156932352|FG002|Overall Study|Lost to Follow-up|0|||
48750562|NCT01749514|156932353|FG003|Overall Study|Lost to Follow-up|0|||
48644498|NCT00375427|156552751|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48644499|NCT00375427|156552752|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48750563|NCT01749514|156932354|FG004|Overall Study|Lost to Follow-up|0|||
48329952|NCT01989689|155405621|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
48750564|NCT01749514|156932355|FG005|Overall Study|Lost to Follow-up|0|||
48644500|NCT00375427|156552751|FG000|Overall Study|Patient no longer requires study drug|3|||
48644501|NCT00375427|156552752|FG001|Overall Study|Patient no longer requires study drug|7|||
48750565|NCT01749514|156932356|FG006|Overall Study|Lost to Follow-up|0|||
48750566|NCT01749514|156932357|FG007|Overall Study|Lost to Follow-up|1|||
48750567|NCT01749514|156932350|FG000|Overall Study|Withdrawal by Subject|0|||
48750568|NCT01749514|156932351|FG001|Overall Study|Withdrawal by Subject|0|||
48644502|NCT00375427|156552751|FG000|Overall Study|Protocol Violation|10|||
48644503|NCT00375427|156552752|FG001|Overall Study|Protocol Violation|8|||
48644504|NCT00375427|156552751|FG000|Overall Study|Withdrawal by Subject|9|||
48644505|NCT00375427|156552752|FG001|Overall Study|Withdrawal by Subject|13|||
48644506|NCT00375427|156552751|FG000|Overall Study|Lost to Follow-up|1|||
48644507|NCT00375427|156552752|FG001|Overall Study|Lost to Follow-up|1|||
48644508|NCT00375427|156552751|FG000|Overall Study|Administrative reasons|0|||
48644509|NCT00375427|156552752|FG001|Overall Study|Administrative reasons|1|||
48644510|NCT00375427|156552751|FG000|Overall Study|Death|11|||
48644511|NCT00375427|156552752|FG001|Overall Study|Death|10|||
48644512|NCT01106157|156552753|FG000|Overall Study|Withdrawal by Subject|1|||
48644513|NCT01106157|156552754|FG001|Overall Study|Withdrawal by Subject|0|||
48644514|NCT03230318|156552755|FG000|Overall Study|Radiographic disease progression|72|||
48644515|NCT03230318|156552756|FG001|Overall Study|Radiographic disease progression|19|||
48644516|NCT03230318|156552755|FG000|Overall Study|Clinical progression|17|||
48644517|NCT03230318|156552756|FG001|Overall Study|Clinical progression|7|||
48644518|NCT03230318|156552755|FG000|Overall Study|Adverse Event|5|||
48644519|NCT03230318|156552756|FG001|Overall Study|Adverse Event|3|||
48644520|NCT03230318|156552755|FG000|Overall Study|Physician Decision|2|||
48644521|NCT03230318|156552756|FG001|Overall Study|Physician Decision|3|||
48644522|NCT03230318|156552755|FG000|Overall Study|Death|3|||
48644523|NCT03230318|156552756|FG001|Overall Study|Death|2|||
48644524|NCT03230318|156552755|FG000|Overall Study|Lost to Follow-up|1|||
48644525|NCT03230318|156552756|FG001|Overall Study|Lost to Follow-up|0|||
48644526|NCT03230318|156552755|FG000|Overall Study|Withdrawal by Subject|1|||
48644527|NCT03230318|156552756|FG001|Overall Study|Withdrawal by Subject|3|||
48644528|NCT03230318|156552755|FG000|Overall Study|Other|3|||
48644529|NCT03230318|156552756|FG001|Overall Study|Other|7|||
48644530|NCT01722994|156552757|FG000|Overall Study|Missing data|25|||
48644531|NCT01722994|156552758|FG001|Overall Study|Missing data|17|||
48644532|NCT00269087|156552760|FG000|Overall Study|Adverse Event|20|||
48644533|NCT00269087|156552760|FG000|Overall Study|Withdrawal by Subject|1|||
48644534|NCT00269087|156552760|FG000|Overall Study|Exacerbation of COPD|13|||
48644535|NCT00041470|156552761|FG000|Overall Study|Loss of Funding|38|||
48644536|NCT04389866|156552768|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
48644537|NCT04389866|156552769|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
48644538|NCT00928187|156552772|FG000|Overall Study|Death|1|||
48644539|NCT00928187|156552773|FG001|Overall Study|Death|2|||
48644540|NCT00928187|156552774|FG002|Overall Study|Death|3|||
48644541|NCT00928187|156552772|FG000|Overall Study|Lost to Follow-up|1|||
48644542|NCT00928187|156552773|FG001|Overall Study|Lost to Follow-up|2|||
48644543|NCT00928187|156552774|FG002|Overall Study|Lost to Follow-up|1|||
48644544|NCT00928187|156552772|FG000|Overall Study|Withdrawal by Subject|0|||
48750569|NCT01749514|156932352|FG002|Overall Study|Withdrawal by Subject|0|||
48750570|NCT01749514|156932353|FG003|Overall Study|Withdrawal by Subject|0|||
48750571|NCT01749514|156932354|FG004|Overall Study|Withdrawal by Subject|0|||
48750572|NCT01749514|156932355|FG005|Overall Study|Withdrawal by Subject|1|||
48750573|NCT01749514|156932356|FG006|Overall Study|Withdrawal by Subject|0|||
48750574|NCT01749514|156932357|FG007|Overall Study|Withdrawal by Subject|1|||
48750575|NCT01749514|156932350|FG000|Overall Study|Not Reported|0|||
48750576|NCT01749514|156932351|FG001|Overall Study|Not Reported|0|||
48329953|NCT01989689|155405620|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
48644545|NCT00928187|156552773|FG001|Overall Study|Withdrawal by Subject|1|||
48644546|NCT00928187|156552774|FG002|Overall Study|Withdrawal by Subject|1|||
48644547|NCT00928187|156552772|FG000|Overall Study|Protocol Violation|0|||
48644548|NCT00928187|156552773|FG001|Overall Study|Protocol Violation|1|||
48644549|NCT00928187|156552774|FG002|Overall Study|Protocol Violation|0|||
48644550|NCT01541865|156552775|FG000|Overall Study|Lost to Follow-up|11|||
48750577|NCT01749514|156932352|FG002|Overall Study|Not Reported|0|||
48329954|NCT01989689|155405621|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
48644551|NCT01541865|156552775|FG000|Overall Study|Withdrawal by Subject|9|||
48644552|NCT01541865|156552775|FG000|Overall Study|Adverse Event|1|||
48644553|NCT01541865|156552775|FG000|Overall Study|Protocol Violation|1|||
48644554|NCT02389465|156552780|FG000|Overall Study|Lost to Follow-up|1|||
48644555|NCT02389465|156552781|FG001|Overall Study|Lost to Follow-up|3|||
48644556|NCT02389465|156552782|FG002|Overall Study|Lost to Follow-up|3|||
48644557|NCT02389465|156552783|FG003|Overall Study|Lost to Follow-up|0|||
48750578|NCT01749514|156932353|FG003|Overall Study|Not Reported|0|||
48750579|NCT01749514|156932354|FG004|Overall Study|Not Reported|0|||
48750580|NCT01749514|156932355|FG005|Overall Study|Not Reported|0|||
48644558|NCT02389465|156552780|FG000|Overall Study|Physician Decision|0|||
48644559|NCT02389465|156552781|FG001|Overall Study|Physician Decision|0|||
48644560|NCT02389465|156552782|FG002|Overall Study|Physician Decision|0|||
48644561|NCT02389465|156552783|FG003|Overall Study|Physician Decision|1|||
48644562|NCT02389465|156552780|FG000|Overall Study|Withdrawal by Subject|0|||
48644563|NCT02389465|156552781|FG001|Overall Study|Withdrawal by Subject|1|||
48644564|NCT02389465|156552782|FG002|Overall Study|Withdrawal by Subject|2|||
48644565|NCT02389465|156552783|FG003|Overall Study|Withdrawal by Subject|2|||
48644566|NCT02967679|156552784|FG000|Overall Study|Adverse Event|1|||
48644567|NCT00703963|156552785|FG000|Overall Study|Withdrawal by Subject|7|||
48644568|NCT00703963|156552786|FG001|Overall Study|Withdrawal by Subject|13|||
48644569|NCT00703963|156552785|FG000|Overall Study|Physician Decision|0|||
48644570|NCT00703963|156552786|FG001|Overall Study|Physician Decision|1|||
48644571|NCT01055613|156552790|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
48644572|NCT01055613|156552791|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48644573|NCT01055613|156552790|FG000|Overall Study|Unacceptable lens fit|1|||
48644574|NCT01055613|156552791|FG001|Overall Study|Unacceptable lens fit|0|||
48644575|NCT01055613|156552790|FG000|Overall Study|Discomfort|2|||
48644576|NCT01055613|156552791|FG001|Overall Study|Discomfort|1|||
48644577|NCT01055613|156552790|FG000|Overall Study|Lost to Follow-up|1|||
48644578|NCT01055613|156552791|FG001|Overall Study|Lost to Follow-up|1|||
48644579|NCT01055613|156552790|FG000|Overall Study|Protocol Violation|1|||
48644580|NCT01055613|156552791|FG001|Overall Study|Protocol Violation|1|||
48644581|NCT01055613|156552790|FG000|Overall Study|Subject Disinterest|1|||
48644582|NCT01055613|156552791|FG001|Overall Study|Subject Disinterest|1|||
48750581|NCT01749514|156932356|FG006|Overall Study|Not Reported|0|||
48750582|NCT01749514|156932357|FG007|Overall Study|Not Reported|5|||
48750583|NCT01402544|156932358|FG000|Overall Study|Withdrawal by Subject|6|||
48750584|NCT01828281|156932359|FG000|Overall Study|Withdrawal by Subject|1|||
48750585|NCT01828281|156932360|FG001|Overall Study|Withdrawal by Subject|0|||
48750586|NCT00299975|156932362|FG000|Overall Study|Adverse Event|1|||
48644583|NCT03768089|156552795|FG000|Part A|Lost to Follow-up|0|||
48750587|NCT00299975|156932363|FG001|Overall Study|Adverse Event|0|||
48750588|NCT00299975|156932364|FG002|Overall Study|Adverse Event|2|||
48750589|NCT00299975|156932362|FG000|Overall Study|Pregnancy|0|||
48750590|NCT00299975|156932363|FG001|Overall Study|Pregnancy|0|||
48644584|NCT03768089|156552796|FG001|Part A|Lost to Follow-up|0|||
48644585|NCT03768089|156552797|FG002|Part A|Lost to Follow-up|0|||
48750591|NCT00299975|156932364|FG002|Overall Study|Pregnancy|1|||
48750592|NCT00299975|156932362|FG000|Overall Study|Lack of Efficacy|1|||
48750593|NCT00299975|156932363|FG001|Overall Study|Lack of Efficacy|0|||
48750594|NCT00299975|156932364|FG002|Overall Study|Lack of Efficacy|1|||
48750595|NCT00299975|156932362|FG000|Overall Study|Lost to Follow-up|1|||
48750596|NCT00299975|156932363|FG001|Overall Study|Lost to Follow-up|0|||
48750597|NCT00299975|156932364|FG002|Overall Study|Lost to Follow-up|0|||
48750598|NCT00299975|156932362|FG000|Overall Study|Withdrawal by Subject|0|||
48644586|NCT03768089|156552798|FG003|Part A|Lost to Follow-up|0|||
48644587|NCT03768089|156552799|FG004|Part A|Lost to Follow-up|1|||
48644588|NCT03768089|156552800|FG005|Part A|Lost to Follow-up|0|||
48750599|NCT00299975|156932363|FG001|Overall Study|Withdrawal by Subject|1|||
48750600|NCT00299975|156932364|FG002|Overall Study|Withdrawal by Subject|3|||
48750601|NCT00299975|156932362|FG000|Overall Study|Physician Decision|0|||
48644589|NCT03768089|156552801|FG006|Part A|Lost to Follow-up|0|||
48644590|NCT03768089|156552802|FG007|Part A|Lost to Follow-up|0|||
48644591|NCT03768089|156552803|FG008|Part A|Lost to Follow-up|0|||
48644592|NCT03768089|156552804|FG009|Part A|Lost to Follow-up|0|||
48750602|NCT00299975|156932363|FG001|Overall Study|Physician Decision|0|||
48750603|NCT00299975|156932364|FG002|Overall Study|Physician Decision|1|||
48750604|NCT01830972|156932369|FG000|Part II|Withdrawal by Subject|2|||
48750605|NCT01830972|156932370|FG001|Part II|Withdrawal by Subject|2|||
48750606|NCT01830972|156932369|FG000|Part III|Withdrawal by Subject|1|||
48750607|NCT01830972|156932370|FG001|Part III|Withdrawal by Subject|0|||
48644593|NCT03768089|156552805|FG010|Part A|Lost to Follow-up|0|||
48644594|NCT03768089|156552806|FG011|Part A|Lost to Follow-up|0|||
48644595|NCT03768089|156552807|FG012|Part A|Lost to Follow-up|0|||
48644596|NCT03768089|156552808|FG013|Part A|Lost to Follow-up|0|||
48644597|NCT03768089|156552809|FG014|Part A|Lost to Follow-up|0|||
48644598|NCT03768089|156552810|FG015|Part A|Lost to Follow-up|0|||
48644599|NCT03768089|156552811|FG016|Part A|Lost to Follow-up|0|||
48644600|NCT03768089|156552812|FG017|Part A|Lost to Follow-up|0|||
48644601|NCT03768089|156552795|FG000|Part C|Randomized, Never Dosed|0|||
48644602|NCT03768089|156552796|FG001|Part C|Randomized, Never Dosed|0|||
48644603|NCT03768089|156552797|FG002|Part C|Randomized, Never Dosed|0|||
48644604|NCT03768089|156552798|FG003|Part C|Randomized, Never Dosed|0|||
48644605|NCT03768089|156552799|FG004|Part C|Randomized, Never Dosed|0|||
48644606|NCT03768089|156552800|FG005|Part C|Randomized, Never Dosed|0|||
48644607|NCT03768089|156552801|FG006|Part C|Randomized, Never Dosed|0|||
48644608|NCT03768089|156552802|FG007|Part C|Randomized, Never Dosed|0|||
48644609|NCT03768089|156552803|FG008|Part C|Randomized, Never Dosed|0|||
48644610|NCT03768089|156552804|FG009|Part C|Randomized, Never Dosed|0|||
48644611|NCT03768089|156552805|FG010|Part C|Randomized, Never Dosed|0|||
48644612|NCT03768089|156552806|FG011|Part C|Randomized, Never Dosed|0|||
48644613|NCT03768089|156552807|FG012|Part C|Randomized, Never Dosed|0|||
48644614|NCT03768089|156552808|FG013|Part C|Randomized, Never Dosed|0|||
48644615|NCT03768089|156552809|FG014|Part C|Randomized, Never Dosed|1|||
48644616|NCT03768089|156552810|FG015|Part C|Randomized, Never Dosed|0|||
48644617|NCT03768089|156552811|FG016|Part C|Randomized, Never Dosed|0|||
48644618|NCT03768089|156552812|FG017|Part C|Randomized, Never Dosed|0|||
48644619|NCT02103062|156552813|FG000|Overall Study|Adverse Event|1|||
48329955|NCT00391170|155405628|FG000|Overall Study|Withdrawal by Subject|1|||
48329956|NCT00391170|155405629|FG001|Overall Study|Withdrawal by Subject|0|||
48329957|NCT00391170|155405628|FG000|Overall Study|Adverse Event|3|||
48329958|NCT00391170|155405629|FG001|Overall Study|Adverse Event|2|||
48329959|NCT00391170|155405628|FG000|Overall Study|Physician Decision|2|||
48329960|NCT00391170|155405629|FG001|Overall Study|Physician Decision|2|||
48644620|NCT02103062|156552814|FG001|Overall Study|Adverse Event|2|||
48644621|NCT02103062|156552813|FG000|Overall Study|Progressive Disease|17|||
48644622|NCT02103062|156552814|FG001|Overall Study|Progressive Disease|20|||
48644623|NCT02103062|156552813|FG000|Overall Study|Death|0|||
48644624|NCT02103062|156552814|FG001|Overall Study|Death|1|||
48644625|NCT01509846|156552815|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
48644626|NCT01509846|156552816|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
48644627|NCT01509846|156552817|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
48644628|NCT01509846|156552818|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
48644629|NCT01509846|156552819|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
48644630|NCT01509846|156552815|FG000|Received Vaccination 2|Illness|0|||
48644631|NCT01509846|156552816|FG001|Received Vaccination 2|Illness|0|||
48644632|NCT01509846|156552817|FG002|Received Vaccination 2|Illness|0|||
48329961|NCT00595959|155405630|FG000|Overall Study|Withdrawal by Subject|1|||
48329962|NCT00595959|155405630|FG000|Overall Study|Lost to Follow-up|1|||
48329963|NCT03035942|155405631|FG000|Overall Study|Adverse Event|8|||
48329964|NCT03035942|155405632|FG001|Overall Study|Adverse Event|4|||
48329965|NCT03035942|155405633|FG002|Overall Study|Adverse Event|5|||
48329966|NCT00380250|155405634|FG000|Overall Study|Withdrawal by Subject|39|||
48329967|NCT00380250|155405635|FG001|Overall Study|Withdrawal by Subject|28|||
48329968|NCT00380250|155405634|FG000|Overall Study|Adverse Event|20|||
48329969|NCT00380250|155405635|FG001|Overall Study|Adverse Event|9|||
48329970|NCT00380250|155405634|FG000|Overall Study|Lack of Efficacy|10|||
48329971|NCT00380250|155405635|FG001|Overall Study|Lack of Efficacy|8|||
48329972|NCT00380250|155405634|FG000|Overall Study|Protocol Violation|15|||
48329973|NCT00380250|155405635|FG001|Overall Study|Protocol Violation|5|||
48329974|NCT00380250|155405634|FG000|Overall Study|Lost to Follow-up|14|||
48329975|NCT00380250|155405635|FG001|Overall Study|Lost to Follow-up|5|||
48329976|NCT00380250|155405634|FG000|Overall Study|Physician Decision|1|||
48329977|NCT00380250|155405635|FG001|Overall Study|Physician Decision|0|||
48329978|NCT01262456|155405636|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
48329979|NCT01262456|155405637|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
48329980|NCT01262456|155405638|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
48383943|NCT04422990|155601506|FG000|Overall Study|Withdrawal by Subject|0|||
48644633|NCT01509846|156552818|FG003|Received Vaccination 2|Illness|0|||
48644634|NCT01509846|156552819|FG004|Received Vaccination 2|Illness|1|||
48644635|NCT01509846|156552815|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
48644636|NCT01509846|156552816|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
48644637|NCT01509846|156552817|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
48644638|NCT01509846|156552818|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
48644639|NCT01509846|156552819|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
48750608|NCT01830972|156932369|FG000|Part III|Noncompliance|1|||
48329981|NCT01262456|155405636|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
48329982|NCT01262456|155405637|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
48329983|NCT01262456|155405638|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
48427378|NCT01544595|155752941|FG003|Status at Week 156|Pregnancy|0|||
48644640|NCT01509846|156552815|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
48644641|NCT01509846|156552816|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
48644642|NCT01509846|156552817|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
48644643|NCT01509846|156552818|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
48644644|NCT01509846|156552819|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
48644645|NCT01509846|156552815|FG000|Received Vaccination 3|Pregnancy|0|||
48644646|NCT01509846|156552816|FG001|Received Vaccination 3|Pregnancy|0|||
48644647|NCT01509846|156552817|FG002|Received Vaccination 3|Pregnancy|0|||
48644648|NCT01509846|156552818|FG003|Received Vaccination 3|Pregnancy|1|||
48644649|NCT01509846|156552819|FG004|Received Vaccination 3|Pregnancy|0|||
48644650|NCT01509846|156552815|FG000|Received Vaccination 3|Lost to Follow-up|0|||
48644651|NCT01509846|156552816|FG001|Received Vaccination 3|Lost to Follow-up|0|||
48644652|NCT01509846|156552817|FG002|Received Vaccination 3|Lost to Follow-up|1|||
48644653|NCT01509846|156552818|FG003|Received Vaccination 3|Lost to Follow-up|0|||
48644654|NCT01509846|156552819|FG004|Received Vaccination 3|Lost to Follow-up|0|||
48644655|NCT01964378|156552820|FG000|Overall Study|Disc. due to death before first dosing|0|||
48750609|NCT01830972|156932370|FG001|Part III|Noncompliance|0|||
48750610|NCT01830972|156932369|FG000|Part IV|Withdrawal by Subject|2|||
48750611|NCT01830972|156932370|FG001|Part IV|Withdrawal by Subject|1|||
48750612|NCT01830972|156932369|FG000|Part IV|Non-Compliance|1|||
48750613|NCT01830972|156932370|FG001|Part IV|Non-Compliance|0|||
48750614|NCT01366209|156932373|FG000|Overall Study|Adverse Event|6|||
48750615|NCT01366209|156932374|FG001|Overall Study|Adverse Event|7|||
48750616|NCT01366209|156932373|FG000|Overall Study|Withdrawal by Subject|4|||
48750617|NCT01366209|156932374|FG001|Overall Study|Withdrawal by Subject|4|||
48750618|NCT01366209|156932373|FG000|Overall Study|Death|12|||
48750619|NCT01366209|156932374|FG001|Overall Study|Death|19|||
48750620|NCT01366209|156932373|FG000|Overall Study|Lung transplantation|6|||
48750621|NCT01366209|156932374|FG001|Overall Study|Lung transplantation|1|||
48750622|NCT01366209|156932373|FG000|Overall Study|Lost to Follow-up|2|||
48644656|NCT01964378|156552821|FG001|Overall Study|Disc. due to death before first dosing|1|||
48644657|NCT01964378|156552820|FG000|Overall Study|Disc. due to AE before first dosing|1|||
48644658|NCT01964378|156552821|FG001|Overall Study|Disc. due to AE before first dosing|0|||
48644659|NCT01964378|156552820|FG000|Overall Study|Death|3|||
48644660|NCT01964378|156552821|FG001|Overall Study|Death|2|||
48644661|NCT01964378|156552820|FG000|Overall Study|Adverse Event|12|||
48644662|NCT01964378|156552821|FG001|Overall Study|Adverse Event|5|||
48644663|NCT01964378|156552820|FG000|Overall Study|Lack of Efficacy|0|||
48644664|NCT01964378|156552821|FG001|Overall Study|Lack of Efficacy|1|||
48644665|NCT01964378|156552820|FG000|Overall Study|Protocol Violation|0|||
48644666|NCT01964378|156552821|FG001|Overall Study|Protocol Violation|1|||
48644667|NCT01964378|156552820|FG000|Overall Study|Lost to Follow-up|0|||
48644668|NCT01964378|156552821|FG001|Overall Study|Lost to Follow-up|1|||
48644669|NCT01964378|156552820|FG000|Overall Study|Withdrawal by Subject|7|||
48644670|NCT01964378|156552821|FG001|Overall Study|Withdrawal by Subject|5|||
48644671|NCT01964378|156552820|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
48750623|NCT01366209|156932374|FG001|Overall Study|Lost to Follow-up|1|||
48750624|NCT01366209|156932373|FG000|Overall Study|Physician Decision|1|||
48750625|NCT01366209|156932374|FG001|Overall Study|Physician Decision|0|||
48750626|NCT01366209|156932373|FG000|Overall Study|Sponsors decision|0|||
48750627|NCT01366209|156932374|FG001|Overall Study|Sponsors decision|1|||
48750628|NCT01366209|156932373|FG000|Overall Study|Withdrew consent|4|||
48750629|NCT01366209|156932374|FG001|Overall Study|Withdrew consent|3|||
48750630|NCT00420927|156932375|FG000|Period 1|Adverse Event|19|||
48750631|NCT00420927|156932376|FG001|Period 1|Adverse Event|15|||
48644672|NCT01964378|156552821|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
48644673|NCT01964378|156552820|FG000|Overall Study|Other|1|||
48644674|NCT01964378|156552821|FG001|Overall Study|Other|2|||
48644675|NCT00120627|156552822|FG000|Overall Study|Withdrawal by Subject|5|||
48644676|NCT00120627|156552823|FG001|Overall Study|Withdrawal by Subject|5|||
48644677|NCT02544750|156552824|FG000|Overall Study|Physician Decision|3|||
48644678|NCT02544750|156552825|FG001|Overall Study|Physician Decision|1|||
48644679|NCT02544750|156552824|FG000|Overall Study|Other reasons|69|||
48644680|NCT02544750|156552825|FG001|Overall Study|Other reasons|39|||
48644681|NCT02544750|156552824|FG000|Overall Study|Met withdrawal criteria|2|||
48644682|NCT02544750|156552825|FG001|Overall Study|Met withdrawal criteria|2|||
48644683|NCT02544750|156552824|FG000|Overall Study|Transition To Commercial Product|1|||
48644684|NCT02544750|156552825|FG001|Overall Study|Transition To Commercial Product|0|||
48644685|NCT02544750|156552824|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
48644686|NCT02544750|156552825|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
48750632|NCT00420927|156932377|FG002|Period 1|Adverse Event|0|||
48750633|NCT00420927|156932378|FG003|Period 1|Adverse Event|0|||
48750634|NCT00420927|156932379|FG004|Period 1|Adverse Event|0|||
48750635|NCT00420927|156932380|FG005|Period 1|Adverse Event|0|||
48750636|NCT00420927|156932381|FG006|Period 1|Adverse Event|0|||
48750637|NCT00420927|156932375|FG000|Period 1|Withdrawal by Subject|7|||
48644687|NCT02544750|156552824|FG000|Overall Study|Adverse Event|8|||
48750638|NCT00420927|156932376|FG001|Period 1|Withdrawal by Subject|12|||
48750639|NCT00420927|156932377|FG002|Period 1|Withdrawal by Subject|0|||
48644688|NCT02544750|156552825|FG001|Overall Study|Adverse Event|10|||
48644689|NCT02544750|156552824|FG000|Overall Study|Withdrawal by Subject|10|||
48644690|NCT02544750|156552825|FG001|Overall Study|Withdrawal by Subject|4|||
48644691|NCT02544750|156552824|FG000|Overall Study|Lost to Follow-up|1|||
48644692|NCT02544750|156552825|FG001|Overall Study|Lost to Follow-up|0|||
48644693|NCT02484443|156552826|FG000|Overall Study|Lack of Efficacy|28|||
48644694|NCT02484443|156552826|FG000|Overall Study|Physician Decision|2|||
48644695|NCT02484443|156552826|FG000|Overall Study|Ineligible|2|||
48644696|NCT03902392|156552827|FG000|Overall Study|Lost to Follow-up|7|||
48644697|NCT03902392|156552828|FG001|Overall Study|Lost to Follow-up|7|||
48644698|NCT01393899|156552829|FG000|Overall Study|Study terminated by sponsor|1|||
48644699|NCT01393899|156552830|FG001|Overall Study|Study terminated by sponsor|0|||
48750640|NCT00420927|156932378|FG003|Period 1|Withdrawal by Subject|0|||
48750641|NCT00420927|156932379|FG004|Period 1|Withdrawal by Subject|0|||
48644700|NCT01393899|156552831|FG002|Overall Study|Study terminated by sponsor|1|||
48644701|NCT01393899|156552829|FG000|Overall Study|Other|1|||
48644702|NCT01393899|156552830|FG001|Overall Study|Other|0|||
48644703|NCT01393899|156552831|FG002|Overall Study|Other|0|||
48644704|NCT01393899|156552829|FG000|Overall Study|Withdrawal by Subject|2|||
48644705|NCT01393899|156552830|FG001|Overall Study|Withdrawal by Subject|2|||
48644706|NCT01393899|156552831|FG002|Overall Study|Withdrawal by Subject|1|||
48644707|NCT01393899|156552829|FG000|Overall Study|Lost to Follow-up|0|||
48644708|NCT01393899|156552830|FG001|Overall Study|Lost to Follow-up|0|||
48644709|NCT01393899|156552831|FG002|Overall Study|Lost to Follow-up|1|||
48644710|NCT01393899|156552829|FG000|Overall Study|Does not meet entrance criteria|1|||
48644711|NCT01393899|156552830|FG001|Overall Study|Does not meet entrance criteria|0|||
48750642|NCT00420927|156932380|FG005|Period 1|Withdrawal by Subject|0|||
48750643|NCT00420927|156932381|FG006|Period 1|Withdrawal by Subject|0|||
48329984|NCT01262456|155405636|FG000|3-Month Double-Blind Period|Adverse Event|6|||
48329985|NCT01262456|155405637|FG001|3-Month Double-Blind Period|Adverse Event|4|||
48329986|NCT01262456|155405638|FG002|3-Month Double-Blind Period|Adverse Event|8|||
48329987|NCT01262456|155405636|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
48329988|NCT01262456|155405637|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
48329989|NCT01262456|155405638|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
48329990|NCT01262456|155405636|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
48329991|NCT01262456|155405637|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
48329992|NCT01262456|155405638|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
48329993|NCT01262456|155405636|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
48329994|NCT01262456|155405637|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
48329995|NCT01262456|155405638|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
48329996|NCT01262456|155405636|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
48644712|NCT01393899|156552831|FG002|Overall Study|Does not meet entrance criteria|1|||
48644713|NCT01393899|156552829|FG000|Overall Study|Lack of Efficacy|26|||
48644714|NCT01393899|156552830|FG001|Overall Study|Lack of Efficacy|21|||
48644715|NCT01393899|156552831|FG002|Overall Study|Lack of Efficacy|16|||
48644716|NCT01393899|156552829|FG000|Overall Study|Adverse Event|1|||
48644717|NCT01393899|156552830|FG001|Overall Study|Adverse Event|5|||
48644718|NCT01393899|156552831|FG002|Overall Study|Adverse Event|3|||
48644719|NCT02122146|156552832|FG000|Part 1: Dose Escalation|Death|0|||
48644720|NCT02122146|156552833|FG001|Part 1: Dose Escalation|Death|1|||
48644721|NCT02122146|156552834|FG002|Part 1: Dose Escalation|Death|1|||
48644722|NCT02122146|156552835|FG003|Part 1: Dose Escalation|Death|0|||
48644723|NCT02122146|156552836|FG004|Part 1: Dose Escalation|Death|0|||
48644724|NCT02122146|156552837|FG005|Part 1: Dose Escalation|Death|0|||
48644725|NCT02122146|156552838|FG006|Part 1: Dose Escalation|Death|0|||
48644726|NCT02122146|156552839|FG007|Part 1: Dose Escalation|Death|0|||
48644727|NCT02122146|156552832|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
48644728|NCT02122146|156552833|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
48644729|NCT02122146|156552834|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
48644730|NCT02122146|156552835|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
48644731|NCT02122146|156552836|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
48644732|NCT02122146|156552837|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
48750644|NCT00420927|156932375|FG000|Period 1|Lost to Follow-up|8|||
48329997|NCT01262456|155405637|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
48329998|NCT01262456|155405638|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
48644733|NCT02122146|156552838|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
48644734|NCT02122146|156552839|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
48644735|NCT02122146|156552832|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48644736|NCT02122146|156552833|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48644737|NCT02122146|156552834|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48644738|NCT02122146|156552835|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
48644739|NCT02122146|156552836|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48329999|NCT01262456|155405636|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
48644740|NCT02122146|156552837|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48644741|NCT02122146|156552838|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48750645|NCT00420927|156932376|FG001|Period 1|Lost to Follow-up|6|||
48644742|NCT02122146|156552839|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48644743|NCT02122146|156552832|FG000|Part 1: Dose Escalation|Other|1|||
48644744|NCT02122146|156552833|FG001|Part 1: Dose Escalation|Other|0|||
48644745|NCT02122146|156552834|FG002|Part 1: Dose Escalation|Other|0|||
48644746|NCT02122146|156552835|FG003|Part 1: Dose Escalation|Other|0|||
48644747|NCT02122146|156552836|FG004|Part 1: Dose Escalation|Other|0|||
48644748|NCT02122146|156552837|FG005|Part 1: Dose Escalation|Other|1|||
48644749|NCT02122146|156552838|FG006|Part 1: Dose Escalation|Other|1|||
48644750|NCT02122146|156552839|FG007|Part 1: Dose Escalation|Other|2|||
48644751|NCT02382991|156552846|FG000|Overall Study|Adverse Event|1|||
48644752|NCT02382991|156552847|FG001|Overall Study|Adverse Event|2|||
48644753|NCT02382991|156552846|FG000|Overall Study|Lost to Follow-up|1|||
48644754|NCT02382991|156552847|FG001|Overall Study|Lost to Follow-up|0|||
48644755|NCT02382991|156552846|FG000|Overall Study|Withdrawal by Subject|0|||
48644756|NCT02382991|156552847|FG001|Overall Study|Withdrawal by Subject|1|||
48644757|NCT00833027|156552848|FG000|Overall Study|Adverse Event|33|||
48644758|NCT00833027|156552848|FG000|Overall Study|Death|1|||
48644759|NCT00833027|156552848|FG000|Overall Study|Lack of Efficacy|12|||
48644760|NCT00833027|156552848|FG000|Overall Study|Lost to Follow-up|24|||
48644761|NCT00833027|156552848|FG000|Overall Study|Protocol Violation|115|||
48644762|NCT00833027|156552848|FG000|Overall Study|Withdrawal by Subject|16|||
48644763|NCT00833027|156552848|FG000|Overall Study|Missing|10|||
48644764|NCT01445613|156552852|FG000|30-day Follow-up|Withdrawal by Subject|6|||
48644765|NCT01445613|156552852|FG000|30-day Follow-up|Physician Decision|3|||
48644766|NCT01445613|156552852|FG000|30-day Follow-up|Missed visit|23|||
48644767|NCT01445613|156552852|FG000|30-day Follow-up|Death|3|||
48644768|NCT01445613|156552852|FG000|1-year Follow-up|Withdrawal by Subject|12|||
48644769|NCT01445613|156552852|FG000|1-year Follow-up|Missed visit|29|||
48644770|NCT01445613|156552852|FG000|1-year Follow-up|Lost to Follow-up|2|||
48644771|NCT01445613|156552852|FG000|1-year Follow-up|Death|30|||
48644772|NCT01445613|156552852|FG000|1-year Follow-up|Physician Decision|2|||
48644773|NCT01445613|156552852|FG000|1-year Follow-up|Received a non-study stent|2|||
48644774|NCT02063984|156552853|FG000|Overall Study|Lost to Follow-up|6|||
48644775|NCT02063984|156552854|FG001|Overall Study|Lost to Follow-up|5|||
48644776|NCT03599518|156552855|FG000|Overall Study|Clinical progression|0|||
48644777|NCT03599518|156552856|FG001|Overall Study|Clinical progression|0|||
48644778|NCT03599518|156552857|FG002|Overall Study|Clinical progression|0|||
48644779|NCT03599518|156552858|FG003|Overall Study|Clinical progression|0|||
48644780|NCT03599518|156552859|FG004|Overall Study|Clinical progression|1|||
48644781|NCT03599518|156552855|FG000|Overall Study|Adverse Event|0|||
48644782|NCT03599518|156552856|FG001|Overall Study|Adverse Event|0|||
48644783|NCT03599518|156552857|FG002|Overall Study|Adverse Event|0|||
48644784|NCT03599518|156552858|FG003|Overall Study|Adverse Event|0|||
48644785|NCT03599518|156552859|FG004|Overall Study|Adverse Event|1|||
48644786|NCT03599518|156552855|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
48644787|NCT03599518|156552856|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
48750646|NCT00420927|156932377|FG002|Period 1|Lost to Follow-up|0|||
48644788|NCT03599518|156552857|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
48644789|NCT03599518|156552858|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
48644790|NCT03599518|156552859|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
48644791|NCT03599518|156552855|FG000|Overall Study|Participant withdrawal from study treatment|0|||
48644792|NCT03599518|156552856|FG001|Overall Study|Participant withdrawal from study treatment|0|||
48644793|NCT03599518|156552857|FG002|Overall Study|Participant withdrawal from study treatment|1|||
48644794|NCT03599518|156552858|FG003|Overall Study|Participant withdrawal from study treatment|0|||
48644795|NCT03599518|156552859|FG004|Overall Study|Participant withdrawal from study treatment|0|||
48644796|NCT03497039|156552862|FG000|Overall Study|Withdrawal by Subject|1|||
48644797|NCT03497039|156552863|FG001|Overall Study|Withdrawal by Subject|0|||
48644798|NCT03497039|156552862|FG000|Overall Study|Protocol Violation|0|||
48644799|NCT03497039|156552863|FG001|Overall Study|Protocol Violation|1|||
48644800|NCT00436436|156552872|FG000|Overall Study|Progression|4|||
48644801|NCT00436436|156552872|FG000|Overall Study|Adverse Event|2|||
48644802|NCT00436436|156552872|FG000|Overall Study|Death|6|||
48644803|NCT00790582|156552873|FG000|Overall Study|Death|14|||
48644804|NCT00790582|156552874|FG001|Overall Study|Death|32|||
48750647|NCT00420927|156932378|FG003|Period 1|Lost to Follow-up|0|||
48750648|NCT00420927|156932379|FG004|Period 1|Lost to Follow-up|0|||
48644805|NCT00790582|156552873|FG000|Overall Study|Physician Decision|7|||
48644806|NCT00790582|156552874|FG001|Overall Study|Physician Decision|1|||
48644807|NCT00790582|156552873|FG000|Overall Study|Lost to Follow-up|3|||
48644808|NCT00790582|156552874|FG001|Overall Study|Lost to Follow-up|3|||
48644809|NCT00790582|156552873|FG000|Overall Study|Withdrawal by Subject|7|||
48644810|NCT00790582|156552874|FG001|Overall Study|Withdrawal by Subject|51|||
48644811|NCT03456700|156552876|FG000|Overall Study|Withdrawal by Subject|1|||
48644812|NCT01170273|156552877|FG000|Overall Study|Lost to Follow-up|6|||
48644813|NCT01170273|156552878|FG001|Overall Study|Lost to Follow-up|8|||
48330000|NCT01262456|155405637|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
48644814|NCT01170273|156552877|FG000|Overall Study|Protocol Violation|1|||
48750649|NCT00420927|156932380|FG005|Period 1|Lost to Follow-up|0|||
48750650|NCT00420927|156932381|FG006|Period 1|Lost to Follow-up|0|||
48750651|NCT00420927|156932375|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
48750652|NCT00420927|156932376|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
48750653|NCT00420927|156932377|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750654|NCT00420927|156932378|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750655|NCT00420927|156932379|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750656|NCT00420927|156932380|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750657|NCT00420927|156932381|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
48750658|NCT00420927|156932375|FG000|Period 1|Death|2|||
48750659|NCT00420927|156932376|FG001|Period 1|Death|0|||
48750660|NCT00420927|156932377|FG002|Period 1|Death|0|||
48750661|NCT00420927|156932378|FG003|Period 1|Death|0|||
48750662|NCT00420927|156932379|FG004|Period 1|Death|0|||
48750663|NCT00420927|156932380|FG005|Period 1|Death|0|||
48750664|NCT00420927|156932381|FG006|Period 1|Death|0|||
48750665|NCT00420927|156932375|FG000|Period 1|Subject moved/relocated|0|||
48750666|NCT00420927|156932376|FG001|Period 1|Subject moved/relocated|2|||
48750667|NCT00420927|156932377|FG002|Period 1|Subject moved/relocated|0|||
48750668|NCT00420927|156932378|FG003|Period 1|Subject moved/relocated|0|||
48750669|NCT00420927|156932379|FG004|Period 1|Subject moved/relocated|0|||
48750670|NCT00420927|156932380|FG005|Period 1|Subject moved/relocated|0|||
48750671|NCT00420927|156932381|FG006|Period 1|Subject moved/relocated|0|||
48750672|NCT00420927|156932375|FG000|Period 1|Noncompliant with study drug|1|||
48750673|NCT00420927|156932376|FG001|Period 1|Noncompliant with study drug|1|||
48750674|NCT00420927|156932377|FG002|Period 1|Noncompliant with study drug|0|||
48750675|NCT00420927|156932378|FG003|Period 1|Noncompliant with study drug|0|||
48750676|NCT00420927|156932379|FG004|Period 1|Noncompliant with study drug|0|||
48750677|NCT00420927|156932380|FG005|Period 1|Noncompliant with study drug|0|||
48750678|NCT00420927|156932381|FG006|Period 1|Noncompliant with study drug|0|||
48750679|NCT00420927|156932375|FG000|Period 1|Randomization error|1|||
48750680|NCT00420927|156932376|FG001|Period 1|Randomization error|0|||
48750681|NCT00420927|156932377|FG002|Period 1|Randomization error|0|||
48750682|NCT00420927|156932378|FG003|Period 1|Randomization error|0|||
48750683|NCT00420927|156932379|FG004|Period 1|Randomization error|0|||
48750684|NCT00420927|156932380|FG005|Period 1|Randomization error|0|||
48750685|NCT00420927|156932381|FG006|Period 1|Randomization error|0|||
48750686|NCT00420927|156932375|FG000|Period 1|Suspected tuberculosis/positive test|1|||
48750687|NCT00420927|156932376|FG001|Period 1|Suspected tuberculosis/positive test|1|||
48750688|NCT00420927|156932377|FG002|Period 1|Suspected tuberculosis/positive test|0|||
48750689|NCT00420927|156932378|FG003|Period 1|Suspected tuberculosis/positive test|0|||
48750690|NCT00420927|156932379|FG004|Period 1|Suspected tuberculosis/positive test|0|||
48750691|NCT00420927|156932380|FG005|Period 1|Suspected tuberculosis/positive test|0|||
48750692|NCT00420927|156932381|FG006|Period 1|Suspected tuberculosis/positive test|0|||
48750693|NCT00420927|156932375|FG000|Period 1|Study site closure|0|||
48750694|NCT00420927|156932376|FG001|Period 1|Study site closure|1|||
48750695|NCT00420927|156932377|FG002|Period 1|Study site closure|0|||
48750696|NCT00420927|156932378|FG003|Period 1|Study site closure|0|||
48750697|NCT00420927|156932379|FG004|Period 1|Study site closure|0|||
48750698|NCT00420927|156932380|FG005|Period 1|Study site closure|0|||
48750699|NCT00420927|156932381|FG006|Period 1|Study site closure|0|||
48644815|NCT01170273|156552878|FG001|Overall Study|Protocol Violation|0|||
48750700|NCT00420927|156932375|FG000|Period 1|Subject received new diagnosis|0|||
48750701|NCT00420927|156932376|FG001|Period 1|Subject received new diagnosis|2|||
48750702|NCT00420927|156932377|FG002|Period 1|Subject received new diagnosis|0|||
48644816|NCT01170273|156552877|FG000|Overall Study|Death|1|||
48644817|NCT01170273|156552878|FG001|Overall Study|Death|0|||
48644818|NCT01170273|156552877|FG000|Overall Study|Adverse Event|0|||
48644819|NCT01170273|156552878|FG001|Overall Study|Adverse Event|1|||
48644820|NCT02735421|156554695|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
48644821|NCT02735421|156554695|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
48644822|NCT02735421|156554695|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
48644823|NCT02735421|156554695|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
48644824|NCT02735421|156554695|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
48644825|NCT02735421|156554695|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
48750703|NCT00420927|156932378|FG003|Period 1|Subject received new diagnosis|0|||
48750704|NCT00420927|156932379|FG004|Period 1|Subject received new diagnosis|0|||
48750705|NCT00420927|156932380|FG005|Period 1|Subject received new diagnosis|0|||
48750706|NCT00420927|156932381|FG006|Period 1|Subject received new diagnosis|0|||
48750707|NCT00420927|156932375|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
48750708|NCT00420927|156932376|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
48750709|NCT00420927|156932377|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
48750710|NCT00420927|156932378|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
48750711|NCT00420927|156932379|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
48644826|NCT02735421|156554695|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
48644827|NCT01492426|156554696|FG000|Treatment|Death|0|||
48644828|NCT01492426|156554697|FG001|Treatment|Death|1|||
48644829|NCT01492426|156554696|FG000|Treatment|Other|1|||
48644830|NCT01492426|156554697|FG001|Treatment|Other|0|||
48644831|NCT01492426|156554696|FG000|Treatment|Adverse Event|25|||
48644832|NCT01492426|156554697|FG001|Treatment|Adverse Event|25|||
48644833|NCT01492426|156554696|FG000|Treatment|Lack of Efficacy|38|||
48644834|NCT01492426|156554697|FG001|Treatment|Lack of Efficacy|5|||
48644835|NCT01492426|156554696|FG000|Treatment|Participant withdrew consent|1|||
48644836|NCT01492426|156554697|FG001|Treatment|Participant withdrew consent|2|||
48644837|NCT01492426|156554696|FG000|Treatment|Poor compliance/noncompliance|1|||
48644838|NCT01492426|156554697|FG001|Treatment|Poor compliance/noncompliance|0|||
48644839|NCT01492426|156554696|FG000|Treatment|Subject requested discontinue study drug|7|||
48644840|NCT01492426|156554697|FG001|Treatment|Subject requested discontinue study drug|3|||
48644841|NCT01492426|156554696|FG000|Treatment|Lost to Follow-up|9|||
48644842|NCT01492426|156554697|FG001|Treatment|Lost to Follow-up|4|||
48644843|NCT01492426|156554696|FG000|Treatment|Participant does not meet study criteria|1|||
48644844|NCT01492426|156554697|FG001|Treatment|Participant does not meet study criteria|0|||
48644845|NCT01492426|156554696|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
48644846|NCT01492426|156554697|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
48644847|NCT01492426|156554696|FG000|Follow-Up|Death|1|||
48644848|NCT01492426|156554697|FG001|Follow-Up|Death|0|||
48644849|NCT01492426|156554696|FG000|Follow-Up|Other|4|||
48644850|NCT01492426|156554697|FG001|Follow-Up|Other|2|||
48644851|NCT01492426|156554696|FG000|Follow-Up|Participant Withdrew Consent|6|||
48644852|NCT01492426|156554697|FG001|Follow-Up|Participant Withdrew Consent|1|||
48644853|NCT01492426|156554696|FG000|Follow-Up|Lost to Follow-up|12|||
48644854|NCT01492426|156554697|FG001|Follow-Up|Lost to Follow-up|6|||
48644855|NCT03549338|156554698|FG000|Overall Study|Progressive Disease|1|||
48644856|NCT03549338|156554699|FG001|Overall Study|Progressive Disease|0|||
48644857|NCT03549338|156554700|FG002|Overall Study|Progressive Disease|0|||
48644858|NCT03549338|156554698|FG000|Overall Study|Clinical Progression|0|||
48644859|NCT03549338|156554699|FG001|Overall Study|Clinical Progression|1|||
48644860|NCT03549338|156554700|FG002|Overall Study|Clinical Progression|0|||
48644861|NCT04776161|156554702|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
48644862|NCT04776161|156554703|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
48644863|NCT04776161|156554704|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
48644864|NCT04776161|156554702|FG000|Overall Study|Withdrawal by Subject|1|||
48644865|NCT04776161|156554703|FG001|Overall Study|Withdrawal by Subject|0|||
48644866|NCT04776161|156554704|FG002|Overall Study|Withdrawal by Subject|1|||
48644867|NCT04776161|156554702|FG000|Overall Study|Adverse Event|0|||
48644868|NCT04776161|156554703|FG001|Overall Study|Adverse Event|1|||
48644869|NCT04776161|156554704|FG002|Overall Study|Adverse Event|1|||
48644870|NCT03759600|156554706|FG000|Overall Study|Adverse Event|2|||
48644871|NCT03759600|156554706|FG000|Overall Study|Progressive Disease|15|||
48750712|NCT00420927|156932380|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
48750713|NCT00420927|156932381|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
48750714|NCT00420927|156932375|FG000|Period 1|Failed to meet entry criteria|8|||
48750715|NCT00420927|156932376|FG001|Period 1|Failed to meet entry criteria|7|||
48750716|NCT00420927|156932377|FG002|Period 1|Failed to meet entry criteria|0|||
48750717|NCT00420927|156932378|FG003|Period 1|Failed to meet entry criteria|0|||
48750718|NCT00420927|156932379|FG004|Period 1|Failed to meet entry criteria|0|||
48750719|NCT00420927|156932380|FG005|Period 1|Failed to meet entry criteria|0|||
48750720|NCT00420927|156932381|FG006|Period 1|Failed to meet entry criteria|0|||
48750721|NCT00420927|156932375|FG000|Period 1|Took prohibited medication|1|||
48750722|NCT00420927|156932376|FG001|Period 1|Took prohibited medication|3|||
48750723|NCT00420927|156932377|FG002|Period 1|Took prohibited medication|0|||
48750724|NCT00420927|156932378|FG003|Period 1|Took prohibited medication|0|||
48750725|NCT00420927|156932379|FG004|Period 1|Took prohibited medication|0|||
48750726|NCT00420927|156932380|FG005|Period 1|Took prohibited medication|0|||
48750727|NCT00420927|156932381|FG006|Period 1|Took prohibited medication|0|||
48750728|NCT00420927|156932375|FG000|Period 2|Adverse Event|0|||
48750729|NCT00420927|156932376|FG001|Period 2|Adverse Event|0|||
48750730|NCT00420927|156932377|FG002|Period 2|Adverse Event|7|||
48644872|NCT03759600|156554706|FG000|Overall Study|Site Terminated by Sponsor|3|||
48644873|NCT00756275|156554707|FG000|Overall Study|Lost to Follow-up|25|||
48644874|NCT00756275|156554708|FG001|Overall Study|Lost to Follow-up|21|||
48644875|NCT00756275|156554707|FG000|Overall Study|Withdrawal by Subject|4|||
48644876|NCT00756275|156554708|FG001|Overall Study|Withdrawal by Subject|7|||
48644877|NCT02257242|156554709|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
48644878|NCT02257242|156554710|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
48644879|NCT02257242|156554711|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
48644880|NCT02257242|156554712|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
48750731|NCT00420927|156932378|FG003|Period 2|Adverse Event|3|||
48750732|NCT00420927|156932379|FG004|Period 2|Adverse Event|17|||
48750733|NCT00420927|156932380|FG005|Period 2|Adverse Event|6|||
48750734|NCT00420927|156932381|FG006|Period 2|Adverse Event|20|||
48750735|NCT00420927|156932375|FG000|Period 2|Withdrawal by Subject|0|||
48750736|NCT00420927|156932376|FG001|Period 2|Withdrawal by Subject|0|||
48750737|NCT00420927|156932377|FG002|Period 2|Withdrawal by Subject|1|||
48750738|NCT00420927|156932378|FG003|Period 2|Withdrawal by Subject|3|||
48750739|NCT00420927|156932379|FG004|Period 2|Withdrawal by Subject|11|||
48750740|NCT00420927|156932380|FG005|Period 2|Withdrawal by Subject|2|||
48750741|NCT00420927|156932381|FG006|Period 2|Withdrawal by Subject|12|||
48750742|NCT00420927|156932375|FG000|Period 2|Lost to Follow-up|0|||
48750743|NCT00420927|156932376|FG001|Period 2|Lost to Follow-up|0|||
48750744|NCT00420927|156932377|FG002|Period 2|Lost to Follow-up|2|||
48750745|NCT00420927|156932378|FG003|Period 2|Lost to Follow-up|2|||
48750746|NCT00420927|156932379|FG004|Period 2|Lost to Follow-up|6|||
48750747|NCT00420927|156932380|FG005|Period 2|Lost to Follow-up|3|||
48750748|NCT00420927|156932381|FG006|Period 2|Lost to Follow-up|9|||
48750749|NCT00420927|156932375|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
48644881|NCT02257242|156554713|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
48644882|NCT02257242|156554714|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
48644883|NCT02257242|156554715|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
48644884|NCT02257242|156554716|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
48644885|NCT02257242|156554717|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
48644886|NCT01747915|156554718|FG000|Overall Study|Other|1|||
48750750|NCT00420927|156932376|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
48750751|NCT00420927|156932377|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
48750752|NCT00420927|156932378|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
48750753|NCT00420927|156932379|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
48750754|NCT00420927|156932380|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
48750755|NCT00420927|156932381|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
48750756|NCT00420927|156932375|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
48750757|NCT00420927|156932376|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
48750758|NCT00420927|156932377|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
48750759|NCT00420927|156932378|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
48750760|NCT00420927|156932379|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
48750761|NCT00420927|156932380|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
48750762|NCT00420927|156932381|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
48750763|NCT00420927|156932375|FG000|Period 2|Subject unable to find transportation|0|||
48750764|NCT00420927|156932376|FG001|Period 2|Subject unable to find transportation|0|||
48750765|NCT00420927|156932377|FG002|Period 2|Subject unable to find transportation|0|||
48750766|NCT00420927|156932378|FG003|Period 2|Subject unable to find transportation|0|||
48750767|NCT00420927|156932379|FG004|Period 2|Subject unable to find transportation|0|||
48750768|NCT00420927|156932380|FG005|Period 2|Subject unable to find transportation|0|||
48750769|NCT00420927|156932381|FG006|Period 2|Subject unable to find transportation|1|||
48750770|NCT00420927|156932375|FG000|Period 2|Physician Decision|0|||
48750771|NCT00420927|156932376|FG001|Period 2|Physician Decision|0|||
48750772|NCT00420927|156932377|FG002|Period 2|Physician Decision|0|||
48750773|NCT00420927|156932378|FG003|Period 2|Physician Decision|0|||
48750774|NCT00420927|156932379|FG004|Period 2|Physician Decision|1|||
48750775|NCT00420927|156932380|FG005|Period 2|Physician Decision|1|||
48750776|NCT00420927|156932381|FG006|Period 2|Physician Decision|0|||
48750777|NCT00420927|156932375|FG000|Period 2|Sponsor decision|0|||
48750778|NCT00420927|156932376|FG001|Period 2|Sponsor decision|0|||
48750779|NCT00420927|156932377|FG002|Period 2|Sponsor decision|1|||
48750780|NCT00420927|156932378|FG003|Period 2|Sponsor decision|0|||
48644887|NCT01747915|156554719|FG001|Overall Study|Other|1|||
48644888|NCT01747915|156554720|FG002|Overall Study|Other|1|||
48644889|NCT01747915|156554718|FG000|Overall Study|Adverse Event|8|||
48750781|NCT00420927|156932379|FG004|Period 2|Sponsor decision|0|||
48750782|NCT00420927|156932380|FG005|Period 2|Sponsor decision|0|||
48750783|NCT00420927|156932381|FG006|Period 2|Sponsor decision|1|||
48750784|NCT00420927|156932375|FG000|Period 2|Randomization error|0|||
48750785|NCT00420927|156932376|FG001|Period 2|Randomization error|0|||
48750786|NCT00420927|156932377|FG002|Period 2|Randomization error|0|||
48750787|NCT00420927|156932378|FG003|Period 2|Randomization error|0|||
48750788|NCT00420927|156932379|FG004|Period 2|Randomization error|1|||
48750789|NCT00420927|156932380|FG005|Period 2|Randomization error|1|||
48750790|NCT00420927|156932381|FG006|Period 2|Randomization error|0|||
48750791|NCT00420927|156932375|FG000|Period 2|Noncompliant with study drug|0|||
48750792|NCT00420927|156932376|FG001|Period 2|Noncompliant with study drug|0|||
48750793|NCT00420927|156932377|FG002|Period 2|Noncompliant with study drug|0|||
48750794|NCT00420927|156932378|FG003|Period 2|Noncompliant with study drug|1|||
48750795|NCT00420927|156932379|FG004|Period 2|Noncompliant with study drug|0|||
48750796|NCT00420927|156932380|FG005|Period 2|Noncompliant with study drug|0|||
48750797|NCT00420927|156932381|FG006|Period 2|Noncompliant with study drug|2|||
48750798|NCT00420927|156932375|FG000|Period 2|Methotrexate intolerance|0|||
48750799|NCT00420927|156932376|FG001|Period 2|Methotrexate intolerance|0|||
48750800|NCT00420927|156932377|FG002|Period 2|Methotrexate intolerance|0|||
48750801|NCT00420927|156932378|FG003|Period 2|Methotrexate intolerance|0|||
48750802|NCT00420927|156932379|FG004|Period 2|Methotrexate intolerance|0|||
48750803|NCT00420927|156932380|FG005|Period 2|Methotrexate intolerance|0|||
48750804|NCT00420927|156932381|FG006|Period 2|Methotrexate intolerance|1|||
48750805|NCT00420927|156932375|FG000|Period 2|Took prohibited medication|0|||
48750806|NCT00420927|156932376|FG001|Period 2|Took prohibited medication|0|||
48750807|NCT00420927|156932377|FG002|Period 2|Took prohibited medication|0|||
48750808|NCT00420927|156932378|FG003|Period 2|Took prohibited medication|0|||
48750809|NCT00420927|156932379|FG004|Period 2|Took prohibited medication|1|||
48750810|NCT00420927|156932380|FG005|Period 2|Took prohibited medication|0|||
48750811|NCT00420927|156932381|FG006|Period 2|Took prohibited medication|0|||
48750812|NCT02088047|156932387|FG000|Overall Study|Withdrawal by Subject|1|||
48750813|NCT02088047|156932388|FG001|Overall Study|Withdrawal by Subject|0|||
48750814|NCT01919723|156932393|FG000|Overall Study|Blood Samples Hemolyzed|2|||
48750815|NCT01919723|156932394|FG001|Overall Study|Blood Samples Hemolyzed|2|||
48750816|NCT00752232|156932395|FG000|Overall Study|Protocol Violation|0|||
48750817|NCT00752232|156932396|FG001|Overall Study|Protocol Violation|0|||
48750818|NCT00752232|156932397|FG002|Overall Study|Protocol Violation|0|||
48750819|NCT00752232|156932398|FG003|Overall Study|Protocol Violation|0|||
48750820|NCT00752232|156932399|FG004|Overall Study|Protocol Violation|0|||
48750821|NCT00752232|156932400|FG005|Overall Study|Protocol Violation|1|||
48750822|NCT00752232|156932401|FG006|Overall Study|Protocol Violation|0|||
48750823|NCT00752232|156932395|FG000|Overall Study|Caregiver request|2|||
48750824|NCT00752232|156932396|FG001|Overall Study|Caregiver request|0|||
48750825|NCT00752232|156932397|FG002|Overall Study|Caregiver request|0|||
48750826|NCT00752232|156932398|FG003|Overall Study|Caregiver request|0|||
48750827|NCT00752232|156932399|FG004|Overall Study|Caregiver request|1|||
48750828|NCT00752232|156932400|FG005|Overall Study|Caregiver request|0|||
48750829|NCT00752232|156932401|FG006|Overall Study|Caregiver request|0|||
48750830|NCT00752232|156932395|FG000|Overall Study|Investigator request|0|||
48750831|NCT00752232|156932396|FG001|Overall Study|Investigator request|0|||
48750832|NCT00752232|156932397|FG002|Overall Study|Investigator request|0|||
48750833|NCT00752232|156932398|FG003|Overall Study|Investigator request|0|||
48750834|NCT00752232|156932399|FG004|Overall Study|Investigator request|1|||
48644890|NCT01747915|156554719|FG001|Overall Study|Adverse Event|5|||
48644891|NCT01747915|156554720|FG002|Overall Study|Adverse Event|2|||
48644892|NCT01747915|156554718|FG000|Overall Study|Death|0|||
48644893|NCT01747915|156554719|FG001|Overall Study|Death|0|||
48750835|NCT00752232|156932400|FG005|Overall Study|Investigator request|0|||
48750836|NCT00752232|156932401|FG006|Overall Study|Investigator request|0|||
48750837|NCT00752232|156932395|FG000|Overall Study|Subject request|0|||
48644894|NCT01747915|156554720|FG002|Overall Study|Death|1|||
48644895|NCT01747915|156554718|FG000|Overall Study|Lack of Efficacy|0|||
48644896|NCT01747915|156554719|FG001|Overall Study|Lack of Efficacy|1|||
48750838|NCT00752232|156932396|FG001|Overall Study|Subject request|0|||
48750839|NCT00752232|156932397|FG002|Overall Study|Subject request|1|||
48750840|NCT00752232|156932398|FG003|Overall Study|Subject request|0|||
48750841|NCT00752232|156932399|FG004|Overall Study|Subject request|0|||
48750842|NCT00752232|156932400|FG005|Overall Study|Subject request|0|||
48750843|NCT00752232|156932401|FG006|Overall Study|Subject request|0|||
48750844|NCT00752232|156932395|FG000|Overall Study|Group home admission|0|||
48750845|NCT00752232|156932396|FG001|Overall Study|Group home admission|0|||
48750846|NCT00752232|156932397|FG002|Overall Study|Group home admission|0|||
48644897|NCT01747915|156554720|FG002|Overall Study|Lack of Efficacy|0|||
48644898|NCT01747915|156554718|FG000|Overall Study|Lost to Follow-up|1|||
48644899|NCT01747915|156554719|FG001|Overall Study|Lost to Follow-up|0|||
48644900|NCT01747915|156554720|FG002|Overall Study|Lost to Follow-up|0|||
48644901|NCT01747915|156554718|FG000|Overall Study|Withdrawal by Subject|4|||
48644902|NCT01747915|156554719|FG001|Overall Study|Withdrawal by Subject|4|||
48644903|NCT01747915|156554720|FG002|Overall Study|Withdrawal by Subject|1|||
48644904|NCT01747915|156554718|FG000|Overall Study|Protocol Violation|1|||
48644905|NCT01747915|156554719|FG001|Overall Study|Protocol Violation|0|||
48644906|NCT01747915|156554720|FG002|Overall Study|Protocol Violation|0|||
48644907|NCT01747915|156554718|FG000|Overall Study|Pregnancy|0|||
48644908|NCT01747915|156554719|FG001|Overall Study|Pregnancy|0|||
48644909|NCT01747915|156554720|FG002|Overall Study|Pregnancy|1|||
48644910|NCT00803738|156554721|FG000|Overall Study|Adverse Event|3|||
48644911|NCT00803738|156554722|FG001|Overall Study|Adverse Event|5|||
48644912|NCT00803738|156554721|FG000|Overall Study|Lost to Follow-up|4|||
48644913|NCT00803738|156554722|FG001|Overall Study|Lost to Follow-up|4|||
48644914|NCT00803738|156554721|FG000|Overall Study|Protocol Violation|18|||
48644915|NCT00803738|156554722|FG001|Overall Study|Protocol Violation|10|||
48644916|NCT00803738|156554721|FG000|Overall Study|Withdrawal by Subject|1|||
48644917|NCT00803738|156554722|FG001|Overall Study|Withdrawal by Subject|4|||
48644918|NCT00803738|156554721|FG000|Overall Study|Lack of Efficacy|10|||
48644919|NCT00803738|156554722|FG001|Overall Study|Lack of Efficacy|16|||
48644920|NCT00803738|156554721|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
48644921|NCT00803738|156554722|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
48644922|NCT00803738|156554721|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
48644923|NCT00803738|156554722|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
48644924|NCT00856635|156554726|FG000|Overall Study|Lost to Follow-up|2|||
48644925|NCT00856635|156554727|FG001|Overall Study|Lost to Follow-up|5|||
48644926|NCT00856635|156554726|FG000|Overall Study|Pregnancy|1|||
48644927|NCT00856635|156554727|FG001|Overall Study|Pregnancy|0|||
48644928|NCT00856635|156554726|FG000|Overall Study|Withdrawal by Subject|3|||
48644929|NCT00856635|156554727|FG001|Overall Study|Withdrawal by Subject|1|||
48644930|NCT00856635|156554726|FG000|Overall Study|Serious Adverse Event|1|||
48644931|NCT00856635|156554727|FG001|Overall Study|Serious Adverse Event|0|||
48644932|NCT00856635|156554726|FG000|Overall Study|Other|1|||
48644933|NCT00856635|156554727|FG001|Overall Study|Other|0|||
48644934|NCT00856635|156554726|FG000|Overall Study|Discontinued at Randomization|2|||
48644935|NCT00856635|156554727|FG001|Overall Study|Discontinued at Randomization|2|||
48644936|NCT01244035|156554728|FG000|Part 1: Period 1|Adverse Event|0|||
48644937|NCT01244035|156554729|FG001|Part 1: Period 1|Adverse Event|0|||
48644938|NCT01244035|156554730|FG002|Part 1: Period 1|Adverse Event|0|||
48644939|NCT01244035|156554731|FG003|Part 1: Period 1|Adverse Event|0|||
48644940|NCT01244035|156554732|FG004|Part 1: Period 1|Adverse Event|0|||
48644941|NCT01244035|156554733|FG005|Part 1: Period 1|Adverse Event|1|||
48644942|NCT01244035|156554728|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
48644943|NCT01244035|156554729|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
48644944|NCT01244035|156554730|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
48644945|NCT01244035|156554731|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
48644946|NCT01244035|156554732|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
48644947|NCT01244035|156554733|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
48644948|NCT01244035|156554728|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
48644949|NCT01244035|156554729|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
48644950|NCT01244035|156554730|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
48644951|NCT01244035|156554731|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
48644952|NCT01244035|156554732|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
48644953|NCT01244035|156554733|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
48644954|NCT01244035|156554728|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
48644955|NCT01244035|156554729|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
48644956|NCT01244035|156554730|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
48644957|NCT01244035|156554731|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
48644958|NCT01244035|156554732|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
48644959|NCT01244035|156554733|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
48644960|NCT01244035|156554728|FG000|Part 1: Period 3|Adverse Event|0|||
48644961|NCT01244035|156554729|FG001|Part 1: Period 3|Adverse Event|0|||
48644962|NCT01244035|156554730|FG002|Part 1: Period 3|Adverse Event|0|||
48644963|NCT01244035|156554731|FG003|Part 1: Period 3|Adverse Event|0|||
48644964|NCT01244035|156554732|FG004|Part 1: Period 3|Adverse Event|0|||
48644965|NCT01244035|156554733|FG005|Part 1: Period 3|Adverse Event|1|||
48644966|NCT01244035|156554728|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
48644967|NCT01244035|156554729|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
48644968|NCT01244035|156554730|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
48644969|NCT01244035|156554731|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
48644970|NCT01244035|156554732|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
48644971|NCT01244035|156554733|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
48644972|NCT01244035|156554728|FG000|Part 1: Period 3|Protocol Deviation|0|||
48644973|NCT01244035|156554729|FG001|Part 1: Period 3|Protocol Deviation|1|||
48750847|NCT00752232|156932398|FG003|Overall Study|Group home admission|1|||
48750848|NCT00752232|156932399|FG004|Overall Study|Group home admission|0|||
48750849|NCT00752232|156932400|FG005|Overall Study|Group home admission|0|||
48750850|NCT00752232|156932401|FG006|Overall Study|Group home admission|0|||
48750851|NCT00752232|156932395|FG000|Overall Study|Caregiver could not attend the subject|0|||
48750852|NCT00752232|156932396|FG001|Overall Study|Caregiver could not attend the subject|0|||
48330001|NCT01262456|155405638|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
48330002|NCT01262456|155405636|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
48330003|NCT01262456|155405637|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
48330004|NCT01262456|155405638|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
48330005|NCT01419184|155405639|FG000|Overall Study|Site data not available|3|||
48330006|NCT01419184|155405640|FG001|Overall Study|Site data not available|2|||
48330007|NCT01419184|155405639|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
48330008|NCT01419184|155405640|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
48644974|NCT01244035|156554730|FG002|Part 1: Period 3|Protocol Deviation|0|||
48644975|NCT01244035|156554731|FG003|Part 1: Period 3|Protocol Deviation|0|||
48644976|NCT01244035|156554732|FG004|Part 1: Period 3|Protocol Deviation|0|||
48644977|NCT01244035|156554733|FG005|Part 1: Period 3|Protocol Deviation|0|||
48644978|NCT01694433|156554734|FG000|Overall Study|Adverse Event|7|||
48644979|NCT01694433|156554735|FG001|Overall Study|Adverse Event|0|||
48644980|NCT01694433|156554734|FG000|Overall Study|Physician Decision|1|||
48644981|NCT01694433|156554735|FG001|Overall Study|Physician Decision|0|||
48644982|NCT01694433|156554734|FG000|Overall Study|Withdrawal by Subject|3|||
48644983|NCT01694433|156554735|FG001|Overall Study|Withdrawal by Subject|4|||
48644984|NCT00374595|156554736|FG000|Overall Study|Death|23|||
48644985|NCT00374595|156554736|FG000|Overall Study|Withdrawal by Subject|39|||
48644986|NCT00374595|156554736|FG000|Overall Study|Lost to Follow-up|3|||
48644987|NCT00374595|156554736|FG000|Overall Study|too much time commitment|1|||
48644988|NCT00374595|156554736|FG000|Overall Study|transfer care to other clinical site|1|||
48644989|NCT00374595|156554736|FG000|Overall Study|relocation|3|||
48750853|NCT00752232|156932397|FG002|Overall Study|Caregiver could not attend the subject|0|||
48750854|NCT00752232|156932398|FG003|Overall Study|Caregiver could not attend the subject|0|||
48750855|NCT00752232|156932399|FG004|Overall Study|Caregiver could not attend the subject|1|||
48750856|NCT00752232|156932400|FG005|Overall Study|Caregiver could not attend the subject|0|||
48750857|NCT00752232|156932401|FG006|Overall Study|Caregiver could not attend the subject|0|||
48750858|NCT02573311|156932402|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
48750859|NCT02573311|156932403|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
48750860|NCT02573311|156932402|FG000|Disposition for Part 2|Physician Decision|25|||
48750861|NCT02573311|156932403|FG001|Disposition for Part 2|Physician Decision|7|||
48750862|NCT02573311|156932402|FG000|Disposition for Part 2|Adverse Event|36|||
48750863|NCT02573311|156932403|FG001|Disposition for Part 2|Adverse Event|5|||
48750864|NCT02573311|156932402|FG000|Disposition for Part 2|Lost to Follow-up|76|||
48750865|NCT02573311|156932403|FG001|Disposition for Part 2|Lost to Follow-up|7|||
48750866|NCT02573311|156932402|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
48750867|NCT02573311|156932403|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
48750868|NCT02573311|156932402|FG000|Disposition for Part 2|Investigator decision|0|||
48750869|NCT02573311|156932403|FG001|Disposition for Part 2|Investigator decision|1|||
48750870|NCT02573311|156932402|FG000|Disposition for Part 2|Other than specified above|13|||
48330009|NCT01419184|155405639|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
48644990|NCT00347932|156554739|FG000|Overall Study|Adverse Event|4|||
48644991|NCT00347932|156554740|FG001|Overall Study|Adverse Event|5|||
48644992|NCT00347932|156554739|FG000|Overall Study|Lack of Efficacy|3|||
48644993|NCT00347932|156554740|FG001|Overall Study|Lack of Efficacy|14|||
48644994|NCT00347932|156554739|FG000|Overall Study|Lost to Follow-up|10|||
48644995|NCT00347932|156554740|FG001|Overall Study|Lost to Follow-up|9|||
48644996|NCT00347932|156554739|FG000|Overall Study|Withdrawal by Subject|10|||
48750871|NCT02573311|156932403|FG001|Disposition for Part 2|Other than specified above|3|||
48750872|NCT00573534|156932405|FG000|Overall Study|oppositional behavior|3|||
48750873|NCT03926169|156932406|FG000|Period A|Adverse Event|2|||
48750874|NCT03926169|156932407|FG001|Period A|Adverse Event|2|||
48750875|NCT03926169|156932408|FG002|Period A|Adverse Event|1|||
48750876|NCT03926169|156932406|FG000|Period A|Withdrawal by Subject|2|||
48750877|NCT03926169|156932407|FG001|Period A|Withdrawal by Subject|2|||
48750878|NCT03926169|156932408|FG002|Period A|Withdrawal by Subject|2|||
48750879|NCT03926169|156932406|FG000|Period A|Lost to Follow-up|3|||
48750880|NCT03926169|156932407|FG001|Period A|Lost to Follow-up|1|||
48750881|NCT03926169|156932408|FG002|Period A|Lost to Follow-up|0|||
48750882|NCT03926169|156932406|FG000|Period A|Lack of Efficacy|0|||
48750883|NCT03926169|156932407|FG001|Period A|Lack of Efficacy|2|||
48750884|NCT03926169|156932408|FG002|Period A|Lack of Efficacy|2|||
48330010|NCT01419184|155405640|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
48750885|NCT03926169|156932406|FG000|Period A|COVID-19 Infection|0|||
48750886|NCT03926169|156932407|FG001|Period A|COVID-19 Infection|1|||
48750887|NCT03926169|156932408|FG002|Period A|COVID-19 Infection|0|||
48750888|NCT03926169|156932406|FG000|Period A|COVID-19 Logistical Restrictions|0|||
48750889|NCT03926169|156932407|FG001|Period A|COVID-19 Logistical Restrictions|2|||
48750890|NCT03926169|156932408|FG002|Period A|COVID-19 Logistical Restrictions|1|||
48644997|NCT00347932|156554740|FG001|Overall Study|Withdrawal by Subject|16|||
48644998|NCT00347932|156554739|FG000|Overall Study|Did not meet inclusion criteria|4|||
48644999|NCT00347932|156554740|FG001|Overall Study|Did not meet inclusion criteria|8|||
48645000|NCT04512001|156554741|FG000|Week 0 to Week 24|Adverse Event|14|||
48645001|NCT04512001|156554742|FG001|Week 0 to Week 24|Adverse Event|10|||
48645002|NCT04512001|156554743|FG002|Week 0 to Week 24|Adverse Event|0|||
48645003|NCT04512001|156554744|FG003|Week 0 to Week 24|Adverse Event|0|||
48645004|NCT04512001|156554745|FG004|Week 0 to Week 24|Adverse Event|0|||
48645005|NCT04512001|156554741|FG000|Week 0 to Week 24|Death|0|||
48645006|NCT04512001|156554742|FG001|Week 0 to Week 24|Death|2|||
48645007|NCT04512001|156554743|FG002|Week 0 to Week 24|Death|0|||
48645008|NCT04512001|156554744|FG003|Week 0 to Week 24|Death|0|||
48645009|NCT04512001|156554745|FG004|Week 0 to Week 24|Death|0|||
48645010|NCT04512001|156554741|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
48645011|NCT04512001|156554742|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
48645012|NCT04512001|156554743|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
48645013|NCT04512001|156554744|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
48750891|NCT03926169|156932406|FG000|Period A|Other, Not Specified|1|||
48750892|NCT03926169|156932407|FG001|Period A|Other, Not Specified|0|||
48750893|NCT03926169|156932408|FG002|Period A|Other, Not Specified|0|||
48750894|NCT03926169|156932406|FG000|Period B|Adverse Event|3|||
48330011|NCT01419184|155405639|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
48330012|NCT01419184|155405640|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
48645014|NCT04512001|156554745|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
48645015|NCT04512001|156554741|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
48645016|NCT04512001|156554742|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
48750895|NCT03926169|156932407|FG001|Period B|Adverse Event|1|||
48645017|NCT04512001|156554743|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
48645018|NCT04512001|156554744|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
48645019|NCT04512001|156554745|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
48750896|NCT03926169|156932408|FG002|Period B|Adverse Event|1|||
48750897|NCT03926169|156932406|FG000|Period B|Withdrawal by Subject|1|||
48750898|NCT03926169|156932407|FG001|Period B|Withdrawal by Subject|3|||
48750899|NCT03926169|156932408|FG002|Period B|Withdrawal by Subject|0|||
48750900|NCT03926169|156932406|FG000|Period B|Lack of Efficacy|3|||
48750901|NCT03926169|156932407|FG001|Period B|Lack of Efficacy|1|||
48645020|NCT04512001|156554741|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
48645021|NCT04512001|156554742|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
48645022|NCT04512001|156554743|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
48645023|NCT04512001|156554744|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
48645024|NCT04512001|156554745|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
48645025|NCT04512001|156554741|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
48645026|NCT04512001|156554742|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
48645027|NCT04512001|156554743|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
48645028|NCT04512001|156554744|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
48645029|NCT04512001|156554745|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
48645030|NCT04512001|156554741|FG000|Week 24 to Week 63|Adverse Event|0|||
48645031|NCT04512001|156554742|FG001|Week 24 to Week 63|Adverse Event|0|||
48645032|NCT04512001|156554743|FG002|Week 24 to Week 63|Adverse Event|13|||
48645033|NCT04512001|156554744|FG003|Week 24 to Week 63|Adverse Event|8|||
48645034|NCT04512001|156554745|FG004|Week 24 to Week 63|Adverse Event|6|||
48645035|NCT04512001|156554741|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
48645036|NCT04512001|156554742|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
48645037|NCT04512001|156554743|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
48645038|NCT04512001|156554744|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
48645039|NCT04512001|156554745|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
48645040|NCT04512001|156554741|FG000|Week 24 to Week 63|Death|0|||
48645041|NCT04512001|156554742|FG001|Week 24 to Week 63|Death|0|||
48645042|NCT04512001|156554743|FG002|Week 24 to Week 63|Death|0|||
48645043|NCT04512001|156554744|FG003|Week 24 to Week 63|Death|1|||
48645044|NCT04512001|156554745|FG004|Week 24 to Week 63|Death|1|||
48645045|NCT04512001|156554741|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
48645046|NCT04512001|156554742|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
48645047|NCT04512001|156554743|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
48645048|NCT04512001|156554744|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
48645049|NCT04512001|156554745|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
48645050|NCT04512001|156554741|FG000|Week 24 to Week 63|Miscellaneous|0|||
48645051|NCT04512001|156554742|FG001|Week 24 to Week 63|Miscellaneous|0|||
48645052|NCT04512001|156554743|FG002|Week 24 to Week 63|Miscellaneous|3|||
48645053|NCT04512001|156554744|FG003|Week 24 to Week 63|Miscellaneous|2|||
48645054|NCT04512001|156554745|FG004|Week 24 to Week 63|Miscellaneous|1|||
48645055|NCT01724216|156554746|FG000|Overall Study|Scan was not completed|1|||
48645056|NCT01331681|156554747|FG000|Overall Study|Adverse Event|10|||
48645057|NCT01331681|156554748|FG001|Overall Study|Adverse Event|13|||
48645058|NCT01331681|156554749|FG002|Overall Study|Adverse Event|10|||
48645059|NCT01331681|156554747|FG000|Overall Study|Death|6|||
48645060|NCT01331681|156554748|FG001|Overall Study|Death|6|||
48645061|NCT01331681|156554749|FG002|Overall Study|Death|2|||
48645062|NCT01331681|156554747|FG000|Overall Study|Lack of Efficacy|0|||
48645063|NCT01331681|156554748|FG001|Overall Study|Lack of Efficacy|1|||
48645064|NCT01331681|156554749|FG002|Overall Study|Lack of Efficacy|0|||
48645065|NCT01331681|156554747|FG000|Overall Study|Withdrawal by Subject|12|||
48645066|NCT01331681|156554748|FG001|Overall Study|Withdrawal by Subject|8|||
48645067|NCT01331681|156554749|FG002|Overall Study|Withdrawal by Subject|15|||
48645068|NCT01331681|156554747|FG000|Overall Study|Protocol Violation|1|||
48645069|NCT01331681|156554748|FG001|Overall Study|Protocol Violation|1|||
48645070|NCT01331681|156554749|FG002|Overall Study|Protocol Violation|0|||
48645071|NCT01331681|156554747|FG000|Overall Study|Lost to Follow-up|2|||
48645072|NCT01331681|156554748|FG001|Overall Study|Lost to Follow-up|4|||
48645073|NCT01331681|156554749|FG002|Overall Study|Lost to Follow-up|1|||
48645074|NCT01331681|156554747|FG000|Overall Study|Physician Decision|2|||
48645075|NCT01331681|156554748|FG001|Overall Study|Physician Decision|0|||
48645076|NCT01331681|156554749|FG002|Overall Study|Physician Decision|4|||
48645077|NCT01331681|156554747|FG000|Overall Study|Therapeutic procedure required|1|||
48645078|NCT01331681|156554748|FG001|Overall Study|Therapeutic procedure required|0|||
48645079|NCT01331681|156554749|FG002|Overall Study|Therapeutic procedure required|0|||
48645080|NCT01331681|156554747|FG000|Overall Study|Sponsor decision|1|||
48645081|NCT01331681|156554748|FG001|Overall Study|Sponsor decision|1|||
48645082|NCT01331681|156554749|FG002|Overall Study|Sponsor decision|0|||
48645083|NCT01331681|156554747|FG000|Overall Study|Switching to other therapy|0|||
48645084|NCT01331681|156554748|FG001|Overall Study|Switching to other therapy|0|||
48645085|NCT01331681|156554749|FG002|Overall Study|Switching to other therapy|1|||
48645086|NCT01331681|156554747|FG000|Overall Study|Not Received Study Treatment|0|||
48645087|NCT01331681|156554748|FG001|Overall Study|Not Received Study Treatment|0|||
48645088|NCT01331681|156554749|FG002|Overall Study|Not Received Study Treatment|2|||
48645089|NCT00540592|156554750|FG000|Overall Study|Adverse Event|0|||
48645090|NCT00540592|156554751|FG001|Overall Study|Adverse Event|1|||
48750902|NCT03926169|156932408|FG002|Period B|Lack of Efficacy|1|||
48750903|NCT03926169|156932406|FG000|Period B|Lost to Follow-up|1|||
48750904|NCT03926169|156932407|FG001|Period B|Lost to Follow-up|1|||
48750905|NCT03926169|156932408|FG002|Period B|Lost to Follow-up|4|||
48750906|NCT03926169|156932406|FG000|Period B|Other, Not Specified|62|||
48750907|NCT03926169|156932407|FG001|Period B|Other, Not Specified|57|||
48750908|NCT03926169|156932408|FG002|Period B|Other, Not Specified|65|||
48645091|NCT00540592|156554752|FG002|Overall Study|Adverse Event|0|||
48645092|NCT00540592|156554753|FG003|Overall Study|Adverse Event|0|||
48645093|NCT00540592|156554754|FG004|Overall Study|Adverse Event|1|||
48645094|NCT00540592|156554755|FG005|Overall Study|Adverse Event|0|||
48645095|NCT00540592|156554756|FG006|Overall Study|Adverse Event|0|||
48645096|NCT00540592|156554757|FG007|Overall Study|Adverse Event|1|||
48645097|NCT00540592|156554758|FG008|Overall Study|Adverse Event|1|||
48750909|NCT01691781|156932411|FG000|Overall Study|Withdrawal by Subject|4|||
48750910|NCT01691781|156932412|FG001|Overall Study|Withdrawal by Subject|3|||
48750911|NCT01691781|156932411|FG000|Overall Study|Physician Decision|1|||
48750912|NCT01691781|156932412|FG001|Overall Study|Physician Decision|1|||
48750913|NCT01691781|156932411|FG000|Overall Study|Protocol Violation|2|||
48645098|NCT00540592|156554759|FG009|Overall Study|Adverse Event|2|||
48645099|NCT00540592|156554750|FG000|Overall Study|Lost to Follow-up|2|||
48645100|NCT00540592|156554751|FG001|Overall Study|Lost to Follow-up|0|||
48645101|NCT00540592|156554752|FG002|Overall Study|Lost to Follow-up|0|||
48645102|NCT00540592|156554753|FG003|Overall Study|Lost to Follow-up|0|||
48645103|NCT00540592|156554754|FG004|Overall Study|Lost to Follow-up|0|||
48645104|NCT00540592|156554755|FG005|Overall Study|Lost to Follow-up|0|||
48645105|NCT00540592|156554756|FG006|Overall Study|Lost to Follow-up|0|||
48750914|NCT01691781|156932412|FG001|Overall Study|Protocol Violation|2|||
48750915|NCT01691781|156932411|FG000|Overall Study|Adverse Event|0|||
48750916|NCT01691781|156932412|FG001|Overall Study|Adverse Event|1|||
48750917|NCT04359654|156932413|FG000|Overall Study|Withdrawal by Subject|1|||
48750918|NCT04359654|156932414|FG001|Overall Study|Withdrawal by Subject|0|||
48750919|NCT04359654|156932413|FG000|Overall Study|Adverse Event|0|||
48750920|NCT04359654|156932414|FG001|Overall Study|Adverse Event|1|||
48750921|NCT01918085|156932415|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
48750922|NCT01918085|156932416|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
48750923|NCT02056340|156932417|FG000|Overall Study|Lost to Follow-up|5|||
48750924|NCT02056340|156932418|FG001|Overall Study|Lost to Follow-up|5|||
48750925|NCT02056340|156932417|FG000|Overall Study|Withdrawal by Subject|2|||
48750926|NCT02056340|156932418|FG001|Overall Study|Withdrawal by Subject|6|||
48750927|NCT00071513|156932419|FG000|Intervention Component|Withdrawal by Subject|2|||
48750928|NCT00071513|156932420|FG001|Intervention Component|Withdrawal by Subject|3|||
48750929|NCT00071513|156932419|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
48750930|NCT00071513|156932420|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
48750931|NCT02375113|156932421|FG000|Overall Study|Undisclosed Reason(s).|1|||
48750932|NCT02375113|156932422|FG001|Overall Study|Undisclosed Reason(s).|1|||
48750933|NCT02375113|156932421|FG000|Overall Study|Poor adherence (<70%).|1|||
48750934|NCT02375113|156932422|FG001|Overall Study|Poor adherence (<70%).|0|||
48750935|NCT02375113|156932421|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
48750936|NCT02375113|156932422|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
48750937|NCT01414855|156932427|FG000|Overall Study|Death|17|||
48750938|NCT01414855|156932427|FG000|Overall Study|Lost to Follow-up|5|||
48750939|NCT01414855|156932427|FG000|Overall Study|Withdrawal by Subject|7|||
48750940|NCT00850564|156932447|FG000|Overall Study|Withdrawal by Subject|2|||
48750941|NCT01535053|156932448|FG000|Overall Study|Ineligible|1|||
48750942|NCT01535053|156932449|FG001|Overall Study|Ineligible|2|||
48750943|NCT01031069|156932450|FG000|Overall Study|Serious Adverse Event|0|||
48750944|NCT01031069|156932451|FG001|Overall Study|Serious Adverse Event|1|||
48750945|NCT01031069|156932452|FG002|Overall Study|Serious Adverse Event|0|||
48750946|NCT01031069|156932453|FG003|Overall Study|Serious Adverse Event|0|||
48750947|NCT01031069|156932450|FG000|Overall Study|Withdrawal by Subject|2|||
48750948|NCT01031069|156932451|FG001|Overall Study|Withdrawal by Subject|3|||
48750949|NCT01031069|156932452|FG002|Overall Study|Withdrawal by Subject|18|||
48645106|NCT00540592|156554757|FG007|Overall Study|Lost to Follow-up|0|||
48645107|NCT00540592|156554758|FG008|Overall Study|Lost to Follow-up|0|||
48645108|NCT00540592|156554759|FG009|Overall Study|Lost to Follow-up|0|||
48645109|NCT00540592|156554750|FG000|Overall Study|Withdrawal by Subject|0|||
48645110|NCT00540592|156554751|FG001|Overall Study|Withdrawal by Subject|0|||
48645111|NCT00540592|156554752|FG002|Overall Study|Withdrawal by Subject|1|||
48750950|NCT01031069|156932453|FG003|Overall Study|Withdrawal by Subject|18|||
48750951|NCT01031069|156932450|FG000|Overall Study|Migrated/moved from study area|1|||
48750952|NCT01031069|156932451|FG001|Overall Study|Migrated/moved from study area|2|||
48750953|NCT01031069|156932452|FG002|Overall Study|Migrated/moved from study area|1|||
48750954|NCT01031069|156932453|FG003|Overall Study|Migrated/moved from study area|1|||
48750955|NCT01031069|156932450|FG000|Overall Study|Lost to Follow-up|9|||
48750956|NCT01031069|156932451|FG001|Overall Study|Lost to Follow-up|5|||
48750957|NCT01031069|156932452|FG002|Overall Study|Lost to Follow-up|21|||
48750958|NCT01031069|156932453|FG003|Overall Study|Lost to Follow-up|15|||
48750959|NCT01031069|156932450|FG000|Overall Study|Other|0|||
48750960|NCT01031069|156932451|FG001|Overall Study|Other|0|||
48750961|NCT01031069|156932452|FG002|Overall Study|Other|1|||
48750962|NCT01031069|156932453|FG003|Overall Study|Other|0|||
48750963|NCT03700671|156932454|FG000|Overall Study|Lack of Efficacy|1|||
48750964|NCT03700671|156932455|FG001|Overall Study|Lack of Efficacy|2|||
48750965|NCT00688753|156934379|FG000|Overall Study|Disease progression|55|||
48750966|NCT00688753|156934379|FG000|Overall Study|Missing|1|||
48750967|NCT00688753|156934379|FG000|Overall Study|Death|9|||
48330013|NCT01419184|155405639|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
48330014|NCT01419184|155405640|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
48330015|NCT01419184|155405639|FG000|Overall Study|Participant randomized, not treated|1|||
48330016|NCT01419184|155405640|FG001|Overall Study|Participant randomized, not treated|0|||
48750968|NCT00688753|156934379|FG000|Overall Study|Withdrawal by Subject|3|||
48750969|NCT00688753|156934379|FG000|Overall Study|Adverse Event|20|||
48750970|NCT00688753|156934379|FG000|Overall Study|Protocol Violation|1|||
48750971|NCT00688753|156934379|FG000|Overall Study|Lost to Follow-up|3|||
48750972|NCT02385045|156934382|FG000|Overall Study|Endoscopy could not be completed|4|||
48750973|NCT04840615|156934383|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
48750974|NCT04840615|156934384|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
48750975|NCT04840615|156934385|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
48750976|NCT03032705|156934386|FG000|Overall Study|Lost to Follow-up|16|||
48330017|NCT02514824|155405644|FG000|Overall Study|Withdrawal by Subject|1|||
48330018|NCT02514824|155405645|FG001|Overall Study|Withdrawal by Subject|0|||
48330019|NCT02514824|155405646|FG002|Overall Study|Withdrawal by Subject|0|||
48330020|NCT02514824|155405647|FG003|Overall Study|Withdrawal by Subject|0|||
48330021|NCT02514824|155405644|FG000|Overall Study|Dose-Limiting Toxicity|0|||
48330022|NCT02514824|155405645|FG001|Overall Study|Dose-Limiting Toxicity|1|||
48330023|NCT02514824|155405646|FG002|Overall Study|Dose-Limiting Toxicity|0|||
48330024|NCT02514824|155405647|FG003|Overall Study|Dose-Limiting Toxicity|0|||
48330025|NCT00886834|155405648|FG000|Overall Study|Protocol Violation|0|||
48330026|NCT00886834|155405649|FG001|Overall Study|Protocol Violation|3|||
48330027|NCT01138657|155405650|FG000|Overall Study|Adverse Event|3|||
48330028|NCT01138657|155405651|FG001|Overall Study|Adverse Event|10|||
48330029|NCT01138657|155405650|FG000|Overall Study|Lack of Efficacy|2|||
48330030|NCT01138657|155405651|FG001|Overall Study|Lack of Efficacy|1|||
48330031|NCT01138657|155405650|FG000|Overall Study|Lost to Follow-up|0|||
48330032|NCT01138657|155405651|FG001|Overall Study|Lost to Follow-up|3|||
48330033|NCT01138657|155405650|FG000|Overall Study|Miscellaneous Reasons|3|||
48330034|NCT01138657|155405651|FG001|Overall Study|Miscellaneous Reasons|4|||
48330035|NCT00337610|155405654|FG000|Overall Study|Adverse Event|2|||
48330036|NCT00337610|155405655|FG001|Overall Study|Adverse Event|2|||
48645112|NCT00540592|156554753|FG003|Overall Study|Withdrawal by Subject|1|||
48645113|NCT00540592|156554754|FG004|Overall Study|Withdrawal by Subject|0|||
48645114|NCT00540592|156554755|FG005|Overall Study|Withdrawal by Subject|0|||
48645115|NCT00540592|156554756|FG006|Overall Study|Withdrawal by Subject|0|||
48645116|NCT00540592|156554757|FG007|Overall Study|Withdrawal by Subject|0|||
48645117|NCT00540592|156554758|FG008|Overall Study|Withdrawal by Subject|0|||
48645118|NCT00540592|156554759|FG009|Overall Study|Withdrawal by Subject|0|||
48645119|NCT01456130|156554760|FG000|Overall Study|Adverse Event|4|||
48750977|NCT03032705|156934387|FG001|Overall Study|Lost to Follow-up|17|||
48330037|NCT00337610|155405654|FG000|Overall Study|Death|0|||
48330038|NCT00337610|155405655|FG001|Overall Study|Death|1|||
48330039|NCT00337610|155405654|FG000|Overall Study|Lack of Efficacy|6|||
48330040|NCT00337610|155405655|FG001|Overall Study|Lack of Efficacy|3|||
48330041|NCT00337610|155405654|FG000|Overall Study|Lost to Follow-up|3|||
48330042|NCT00337610|155405655|FG001|Overall Study|Lost to Follow-up|3|||
48645120|NCT01456130|156554760|FG000|Overall Study|Voluntary Withdrawal|1|||
48750978|NCT03032705|156934386|FG000|Overall Study|did not quality|6|||
48750979|NCT03032705|156934387|FG001|Overall Study|did not quality|6|||
48750980|NCT00911820|156934388|FG000|Overall Study|RECIST progression|12|||
48750981|NCT00911820|156934389|FG001|Overall Study|RECIST progression|8|||
48750982|NCT00911820|156934388|FG000|Overall Study|Adverse Event|8|||
48750983|NCT00911820|156934389|FG001|Overall Study|Adverse Event|8|||
48645121|NCT01456130|156554760|FG000|Overall Study|Lack of Efficacy|4|||
48645122|NCT01456130|156554760|FG000|Overall Study|Other|1|||
48645123|NCT00700622|156554764|FG000|Overall Study|Adverse Event|4|||
48645124|NCT00700622|156554765|FG001|Overall Study|Adverse Event|0|||
48645125|NCT00700622|156554764|FG000|Overall Study|Lost to Follow-up|0|||
48645126|NCT00700622|156554765|FG001|Overall Study|Lost to Follow-up|1|||
48645127|NCT00700622|156554764|FG000|Overall Study|Physician Decision|2|||
48645128|NCT00700622|156554765|FG001|Overall Study|Physician Decision|1|||
48645129|NCT00700622|156554764|FG000|Overall Study|Protocol Violation|0|||
48330043|NCT00337610|155405654|FG000|Overall Study|Withdrawal by Subject|6|||
48330044|NCT00337610|155405655|FG001|Overall Study|Withdrawal by Subject|5|||
48645130|NCT00700622|156554765|FG001|Overall Study|Protocol Violation|1|||
48645131|NCT00700622|156554764|FG000|Overall Study|Withdrawal by Subject|4|||
48645132|NCT00700622|156554765|FG001|Overall Study|Withdrawal by Subject|1|||
48645133|NCT00700622|156554764|FG000|Overall Study|Other|3|||
48645134|NCT00700622|156554765|FG001|Overall Study|Other|1|||
48645135|NCT01673646|156554767|FG000|Overall Study|Adverse Event|2|||
48645136|NCT01673646|156554768|FG001|Overall Study|Adverse Event|1|||
48645137|NCT01673646|156554769|FG002|Overall Study|Adverse Event|1|||
48645138|NCT01673646|156554767|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48645139|NCT01673646|156554768|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48645140|NCT01673646|156554769|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48645141|NCT01673646|156554767|FG000|Overall Study|Condition no longer requires study drug|0|||
48330045|NCT00641537|155405656|FG000|96-week Period|Adverse Event|0|||
48330046|NCT00641537|155405657|FG001|96-week Period|Adverse Event|1|||
48645142|NCT01673646|156554768|FG001|Overall Study|Condition no longer requires study drug|1|||
48645143|NCT01673646|156554769|FG002|Overall Study|Condition no longer requires study drug|0|||
48645144|NCT01673646|156554767|FG000|Overall Study|Withdrawal by Subject|0|||
48645145|NCT01673646|156554768|FG001|Overall Study|Withdrawal by Subject|2|||
48645146|NCT01673646|156554769|FG002|Overall Study|Withdrawal by Subject|2|||
48645147|NCT01673646|156554767|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
48330047|NCT00641537|155405658|FG002|96-week Period|Adverse Event|3|||
48330048|NCT00641537|155405659|FG003|96-week Period|Adverse Event|0|||
48330049|NCT00641537|155405660|FG004|96-week Period|Adverse Event|2|||
48330050|NCT00641537|155405661|FG005|96-week Period|Adverse Event|0|||
48330051|NCT00641537|155405662|FG006|96-week Period|Adverse Event|0|||
48330052|NCT00641537|155405663|FG007|96-week Period|Adverse Event|0|||
48330053|NCT00641537|155405656|FG000|96-week Period|Lost to Follow-up|3|||
48330054|NCT00641537|155405657|FG001|96-week Period|Lost to Follow-up|1|||
48330055|NCT00641537|155405658|FG002|96-week Period|Lost to Follow-up|2|||
48330056|NCT00641537|155405659|FG003|96-week Period|Lost to Follow-up|2|||
48330057|NCT00641537|155405660|FG004|96-week Period|Lost to Follow-up|4|||
48330058|NCT00641537|155405661|FG005|96-week Period|Lost to Follow-up|0|||
48330059|NCT00641537|155405662|FG006|96-week Period|Lost to Follow-up|1|||
48330060|NCT00641537|155405663|FG007|96-week Period|Lost to Follow-up|0|||
48330061|NCT00641537|155405656|FG000|96-week Period|Protocol Violation|0|||
48330062|NCT00641537|155405657|FG001|96-week Period|Protocol Violation|1|||
48330063|NCT00641537|155405658|FG002|96-week Period|Protocol Violation|0|||
48330064|NCT00641537|155405659|FG003|96-week Period|Protocol Violation|1|||
48330065|NCT00641537|155405660|FG004|96-week Period|Protocol Violation|0|||
48330066|NCT00641537|155405661|FG005|96-week Period|Protocol Violation|1|||
48330067|NCT00641537|155405662|FG006|96-week Period|Protocol Violation|0|||
48330068|NCT00641537|155405663|FG007|96-week Period|Protocol Violation|0|||
48330069|NCT00641537|155405656|FG000|96-week Period|Death|2|||
48330070|NCT00641537|155405657|FG001|96-week Period|Death|0|||
48330071|NCT00641537|155405658|FG002|96-week Period|Death|1|||
48330072|NCT00641537|155405659|FG003|96-week Period|Death|0|||
48330073|NCT00641537|155405660|FG004|96-week Period|Death|0|||
48645148|NCT01673646|156554768|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
48645149|NCT01673646|156554769|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
48330074|NCT00641537|155405661|FG005|96-week Period|Death|0|||
48645150|NCT03326063|156554771|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
48645151|NCT03326063|156554772|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
48645152|NCT01253369|156554776|FG000|Overall Study|Adverse Event|4|||
48645153|NCT01253369|156554776|FG000|Overall Study|Withdrawal by Subject|2|||
48645154|NCT01253369|156554776|FG000|Overall Study|Death|1|||
48645155|NCT01253369|156554776|FG000|Overall Study|Progressive disease|23|||
48645156|NCT01253369|156554776|FG000|Overall Study|Not Evaluable|3|||
48645157|NCT00690430|156554778|FG000|Core Phase|Abnormal Laboratory value|0|||
48330075|NCT00641537|155405662|FG006|96-week Period|Death|0|||
48330076|NCT00641537|155405663|FG007|96-week Period|Death|0|||
48330077|NCT00641537|155405656|FG000|96-week Period|Other|4|||
48330078|NCT00641537|155405657|FG001|96-week Period|Other|7|||
48330079|NCT00641537|155405658|FG002|96-week Period|Other|14|||
48330080|NCT00641537|155405659|FG003|96-week Period|Other|9|||
48330081|NCT00641537|155405660|FG004|96-week Period|Other|11|||
48645158|NCT00690430|156554779|FG001|Core Phase|Abnormal Laboratory value|1|||
48330082|NCT00641537|155405661|FG005|96-week Period|Other|6|||
48330083|NCT00641537|155405662|FG006|96-week Period|Other|4|||
48645159|NCT00690430|156554780|FG002|Core Phase|Abnormal Laboratory value|0|||
48645160|NCT00690430|156554778|FG000|Core Phase|Adverse Event|5|||
48645161|NCT00690430|156554779|FG001|Core Phase|Adverse Event|1|||
48645162|NCT00690430|156554780|FG002|Core Phase|Adverse Event|0|||
48645163|NCT00690430|156554778|FG000|Core Phase|Death|0|||
48645164|NCT00690430|156554779|FG001|Core Phase|Death|2|||
48645165|NCT00690430|156554780|FG002|Core Phase|Death|0|||
48645166|NCT00690430|156554778|FG000|Core Phase|Protocol Violation|1|||
48645167|NCT00690430|156554779|FG001|Core Phase|Protocol Violation|0|||
48645168|NCT00690430|156554780|FG002|Core Phase|Protocol Violation|0|||
48645169|NCT00690430|156554778|FG000|Core Phase|Withdrawal by Subject|3|||
48645170|NCT00690430|156554779|FG001|Core Phase|Withdrawal by Subject|3|||
48645171|NCT00690430|156554780|FG002|Core Phase|Withdrawal by Subject|0|||
48645172|NCT00690430|156554778|FG000|Core Phase|Subject no longer requires study drug|1|||
48645173|NCT00690430|156554779|FG001|Core Phase|Subject no longer requires study drug|0|||
48645174|NCT00690430|156554780|FG002|Core Phase|Subject no longer requires study drug|0|||
48330084|NCT00641537|155405663|FG007|96-week Period|Other|6|||
48330085|NCT00641537|155405656|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
48330086|NCT00641537|155405657|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
48330087|NCT00641537|155405658|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
48330088|NCT00641537|155405659|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
48330089|NCT00641537|155405660|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
48330090|NCT00641537|155405661|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
48330091|NCT00641537|155405662|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
48330092|NCT00641537|155405663|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
48330093|NCT00641537|155405656|FG000|24-Week Supplemental Follow-up Period|Other|0|||
48330094|NCT00641537|155405657|FG001|24-Week Supplemental Follow-up Period|Other|2|||
48330095|NCT00641537|155405658|FG002|24-Week Supplemental Follow-up Period|Other|2|||
48330096|NCT00641537|155405659|FG003|24-Week Supplemental Follow-up Period|Other|1|||
48330097|NCT00641537|155405660|FG004|24-Week Supplemental Follow-up Period|Other|3|||
48330098|NCT00641537|155405661|FG005|24-Week Supplemental Follow-up Period|Other|0|||
48330099|NCT00641537|155405662|FG006|24-Week Supplemental Follow-up Period|Other|1|||
48330100|NCT00641537|155405663|FG007|24-Week Supplemental Follow-up Period|Other|1|||
48330101|NCT03541369|155405666|FG000|Overall Study|Death|0|||
48330102|NCT03541369|155405667|FG001|Overall Study|Death|0|||
48330103|NCT03541369|155405668|FG002|Overall Study|Death|0|||
48645175|NCT00690430|156554778|FG000|Core Phase|Lack of Efficacy|8|||
48645176|NCT00690430|156554779|FG001|Core Phase|Lack of Efficacy|10|||
48645177|NCT00690430|156554780|FG002|Core Phase|Lack of Efficacy|0|||
48645178|NCT00690430|156554778|FG000|Core Phase|Administrative Problems|0|||
48645179|NCT00690430|156554779|FG001|Core Phase|Administrative Problems|1|||
48645180|NCT00690430|156554780|FG002|Core Phase|Administrative Problems|0|||
48645181|NCT00690430|156554778|FG000|Core Phase|Early Termination|0|||
48645182|NCT00690430|156554779|FG001|Core Phase|Early Termination|5|||
48645183|NCT00690430|156554780|FG002|Core Phase|Early Termination|0|||
48645184|NCT00690430|156554778|FG000|Extension Phase|Lack of Efficacy|3|||
48645185|NCT00690430|156554779|FG001|Extension Phase|Lack of Efficacy|1|||
48645186|NCT00690430|156554780|FG002|Extension Phase|Lack of Efficacy|4|||
48645187|NCT00690430|156554778|FG000|Extension Phase|Abnormal Lab Values|1|||
48645188|NCT00690430|156554779|FG001|Extension Phase|Abnormal Lab Values|0|||
48645189|NCT00690430|156554780|FG002|Extension Phase|Abnormal Lab Values|0|||
48645190|NCT00690430|156554778|FG000|Extension Phase|Abnormal test procedure results|1|||
48645191|NCT00690430|156554779|FG001|Extension Phase|Abnormal test procedure results|0|||
48645192|NCT00690430|156554780|FG002|Extension Phase|Abnormal test procedure results|0|||
48645193|NCT00690430|156554778|FG000|Extension Phase|Administrative Problems|0|||
48645194|NCT00690430|156554779|FG001|Extension Phase|Administrative Problems|1|||
48645195|NCT00690430|156554780|FG002|Extension Phase|Administrative Problems|1|||
48645196|NCT00690430|156554778|FG000|Extension Phase|Adverse Event|2|||
48645197|NCT00690430|156554779|FG001|Extension Phase|Adverse Event|1|||
48330104|NCT03541369|155405669|FG003|Overall Study|Death|0|||
48330105|NCT03541369|155405670|FG004|Overall Study|Death|1|||
48330106|NCT03541369|155405671|FG005|Overall Study|Death|1|||
48330107|NCT03541369|155405672|FG006|Overall Study|Death|0|||
48330108|NCT03541369|155405673|FG007|Overall Study|Death|2|||
48645198|NCT00690430|156554780|FG002|Extension Phase|Adverse Event|2|||
48645199|NCT00690430|156554778|FG000|Extension Phase|Death|1|||
48645200|NCT00690430|156554779|FG001|Extension Phase|Death|1|||
48645201|NCT00690430|156554780|FG002|Extension Phase|Death|1|||
48645202|NCT00690430|156554778|FG000|Extension Phase|Withdrawal by Subject|0|||
48645203|NCT00690430|156554779|FG001|Extension Phase|Withdrawal by Subject|0|||
48645204|NCT00690430|156554780|FG002|Extension Phase|Withdrawal by Subject|2|||
48645205|NCT00690430|156554778|FG000|Extension Phase|Early Termination|10|||
48645206|NCT00690430|156554779|FG001|Extension Phase|Early Termination|1|||
48750984|NCT00911820|156934388|FG000|Overall Study|Clinical Progression|7|||
48750985|NCT00911820|156934389|FG001|Overall Study|Clinical Progression|5|||
48750986|NCT00911820|156934388|FG000|Overall Study|Physician Decision|5|||
48645207|NCT00690430|156554780|FG002|Extension Phase|Early Termination|3|||
48750987|NCT00911820|156934389|FG001|Overall Study|Physician Decision|9|||
48645208|NCT00763256|156554781|FG000|Overall Study|Didn't return for appointments|7|||
48645209|NCT00763256|156554782|FG001|Overall Study|Didn't return for appointments|10|||
48645210|NCT04677543|156554783|FG000|Overall Study|Withdrawal by Subject|4|||
48645211|NCT04677543|156554784|FG001|Overall Study|Withdrawal by Subject|1|||
48645212|NCT04677543|156554783|FG000|Overall Study|Physician Decision|0|||
48645213|NCT04677543|156554784|FG001|Overall Study|Physician Decision|1|||
48645214|NCT04677543|156554783|FG000|Overall Study|Adverse Event|0|||
48645215|NCT04677543|156554784|FG001|Overall Study|Adverse Event|1|||
48645216|NCT02473471|156554788|FG000|Overall Study|poor oral hygiene|2|||
48645217|NCT02473471|156554788|FG000|Overall Study|Lost to Follow-up|1|||
48645218|NCT03745638|156554789|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
48645219|NCT03745638|156554790|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
48645220|NCT03745638|156554791|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
48645221|NCT03745638|156554792|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48645222|NCT03745638|156554793|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48645223|NCT03745638|156554794|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48645224|NCT03745638|156554795|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48645225|NCT03745638|156554789|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
48645226|NCT03745638|156554790|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48645227|NCT03745638|156554791|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48645228|NCT03745638|156554792|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48645229|NCT03745638|156554793|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48645230|NCT03745638|156554794|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48645231|NCT03745638|156554795|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48645232|NCT03745638|156554789|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
48645233|NCT03745638|156554790|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
48645234|NCT03745638|156554791|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
48645235|NCT03745638|156554792|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48645236|NCT03745638|156554793|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48645237|NCT03745638|156554794|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48645238|NCT03745638|156554795|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48645239|NCT03745638|156554789|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
48645240|NCT03745638|156554790|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
48645241|NCT03745638|156554791|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48645242|NCT03745638|156554792|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48645243|NCT03745638|156554793|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48645244|NCT03745638|156554794|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48645245|NCT03745638|156554795|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48645246|NCT03745638|156554789|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
48645247|NCT03745638|156554790|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
48645248|NCT03745638|156554791|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
48645249|NCT03745638|156554792|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
48645250|NCT03745638|156554793|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
48645251|NCT03745638|156554794|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
48750988|NCT00911820|156934388|FG000|Overall Study|Decline in Performance Status|4|||
48750989|NCT00911820|156934389|FG001|Overall Study|Decline in Performance Status|2|||
48750990|NCT00911820|156934388|FG000|Overall Study|Withdrawal by Subject|3|||
48750991|NCT00911820|156934389|FG001|Overall Study|Withdrawal by Subject|4|||
48750992|NCT00911820|156934388|FG000|Overall Study|Death|1|||
48750993|NCT00911820|156934389|FG001|Overall Study|Death|2|||
48645252|NCT03745638|156554795|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
48645253|NCT03745638|156554789|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48645254|NCT03745638|156554790|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
48750994|NCT00911820|156934388|FG000|Overall Study|Pursue surgery|1|||
48750995|NCT00911820|156934389|FG001|Overall Study|Pursue surgery|1|||
48750996|NCT00911820|156934388|FG000|Overall Study|Pursue Radiation|1|||
48750997|NCT00911820|156934389|FG001|Overall Study|Pursue Radiation|0|||
48750998|NCT00911820|156934388|FG000|Overall Study|Still on Therapy|2|||
48645255|NCT03745638|156554791|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48645256|NCT03745638|156554792|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48645257|NCT03745638|156554793|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48645258|NCT03745638|156554794|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48645259|NCT03745638|156554795|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48645260|NCT03745638|156554789|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
48645261|NCT03745638|156554790|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
48645262|NCT03745638|156554791|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
48645263|NCT03745638|156554792|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48645264|NCT03745638|156554793|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48645265|NCT03745638|156554794|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48645266|NCT03745638|156554795|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48645267|NCT03745638|156554789|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
48645268|NCT03745638|156554790|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
48645269|NCT03745638|156554791|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
48645270|NCT03745638|156554792|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
48645271|NCT03745638|156554793|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
48645272|NCT03745638|156554794|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
48645273|NCT03745638|156554795|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
48645274|NCT03745638|156554789|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48645275|NCT03745638|156554790|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48645276|NCT03745638|156554791|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48645277|NCT03745638|156554792|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48645278|NCT03745638|156554793|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48645279|NCT03745638|156554794|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
48645280|NCT03745638|156554795|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
48645281|NCT03745638|156554789|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48645282|NCT03745638|156554790|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48645283|NCT03745638|156554791|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48645284|NCT03745638|156554792|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
48645285|NCT03745638|156554793|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48645286|NCT03745638|156554794|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
48645287|NCT03745638|156554795|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
48750999|NCT00911820|156934389|FG001|Overall Study|Still on Therapy|2|||
48751000|NCT00911820|156934388|FG000|Overall Study|Pathology Not Confirmed|1|||
48751001|NCT00911820|156934389|FG001|Overall Study|Pathology Not Confirmed|0|||
48751002|NCT00911820|156934388|FG000|Overall Study|Withdraw before Receive Treatment|0|||
48751003|NCT00911820|156934389|FG001|Overall Study|Withdraw before Receive Treatment|2|||
48751004|NCT03364023|156934390|FG000|Overall Study|Lost to Follow-up|3|||
48751005|NCT03364023|156934390|FG000|Overall Study|Death|14|||
48751006|NCT02397278|156934393|FG000|Overall Study|Withdrawal by Subject|0|||
48751007|NCT02397278|156934394|FG001|Overall Study|Withdrawal by Subject|2|||
48751008|NCT02397278|156934393|FG000|Overall Study|Deemed ineligible following surgery|1|||
48751009|NCT02397278|156934394|FG001|Overall Study|Deemed ineligible following surgery|1|||
48330109|NCT03541369|155405674|FG008|Overall Study|Death|1|||
48330110|NCT03541369|155405675|FG009|Overall Study|Death|2|||
48330111|NCT03541369|155405676|FG010|Overall Study|Death|1|||
48330112|NCT03541369|155405677|FG011|Overall Study|Death|0|||
48330113|NCT03541369|155405678|FG012|Overall Study|Death|2|||
48330114|NCT03541369|155405679|FG013|Overall Study|Death|1|||
48330115|NCT03541369|155405680|FG014|Overall Study|Death|1|||
48330116|NCT03541369|155405681|FG015|Overall Study|Death|1|||
48330117|NCT03541369|155405682|FG016|Overall Study|Death|0|||
48330118|NCT03541369|155405683|FG017|Overall Study|Death|1|||
48330119|NCT03541369|155405666|FG000|Overall Study|Decision by sponsor|0|||
48330120|NCT03541369|155405667|FG001|Overall Study|Decision by sponsor|0|||
48330121|NCT03541369|155405668|FG002|Overall Study|Decision by sponsor|0|||
48330122|NCT03541369|155405669|FG003|Overall Study|Decision by sponsor|1|||
48330123|NCT03541369|155405670|FG004|Overall Study|Decision by sponsor|0|||
48330124|NCT03541369|155405671|FG005|Overall Study|Decision by sponsor|2|||
48330125|NCT03541369|155405672|FG006|Overall Study|Decision by sponsor|0|||
48330126|NCT03541369|155405673|FG007|Overall Study|Decision by sponsor|1|||
48330127|NCT03541369|155405674|FG008|Overall Study|Decision by sponsor|2|||
48330128|NCT03541369|155405675|FG009|Overall Study|Decision by sponsor|0|||
48330129|NCT03541369|155405676|FG010|Overall Study|Decision by sponsor|0|||
48330130|NCT03541369|155405677|FG011|Overall Study|Decision by sponsor|0|||
48330131|NCT03541369|155405678|FG012|Overall Study|Decision by sponsor|2|||
48330132|NCT03541369|155405679|FG013|Overall Study|Decision by sponsor|2|||
48330133|NCT03541369|155405680|FG014|Overall Study|Decision by sponsor|0|||
48330134|NCT03541369|155405681|FG015|Overall Study|Decision by sponsor|1|||
48330135|NCT03541369|155405682|FG016|Overall Study|Decision by sponsor|1|||
48751010|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
48751011|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
48751012|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
48751013|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
48751014|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
48751015|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
48751016|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
48751017|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
48751018|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
48751019|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
48751020|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Other|1|||
48751021|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Other|1|||
48751022|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Other|0|||
48751023|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Other|0|||
48751024|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Other|0|||
48751025|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
48751026|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
48751027|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
48751028|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
48751029|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
48751030|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
48751031|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
48751032|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
48751033|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
48751034|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
48751035|NCT02310568|156934395|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
48330136|NCT03541369|155405683|FG017|Overall Study|Decision by sponsor|1|||
48330137|NCT03541369|155405666|FG000|Overall Study|Withdrawal by Subject|0|||
48330138|NCT03541369|155405667|FG001|Overall Study|Withdrawal by Subject|0|||
48330139|NCT03541369|155405668|FG002|Overall Study|Withdrawal by Subject|0|||
48330140|NCT03541369|155405669|FG003|Overall Study|Withdrawal by Subject|0|||
48330141|NCT03541369|155405670|FG004|Overall Study|Withdrawal by Subject|0|||
48330142|NCT03541369|155405671|FG005|Overall Study|Withdrawal by Subject|0|||
48330143|NCT03541369|155405672|FG006|Overall Study|Withdrawal by Subject|1|||
48330144|NCT03541369|155405673|FG007|Overall Study|Withdrawal by Subject|0|||
48330145|NCT03541369|155405674|FG008|Overall Study|Withdrawal by Subject|0|||
48330146|NCT03541369|155405675|FG009|Overall Study|Withdrawal by Subject|0|||
48330147|NCT03541369|155405676|FG010|Overall Study|Withdrawal by Subject|0|||
48330148|NCT03541369|155405677|FG011|Overall Study|Withdrawal by Subject|1|||
48330149|NCT03541369|155405678|FG012|Overall Study|Withdrawal by Subject|0|||
48330150|NCT03541369|155405679|FG013|Overall Study|Withdrawal by Subject|0|||
48330151|NCT03541369|155405680|FG014|Overall Study|Withdrawal by Subject|3|||
48330152|NCT03541369|155405681|FG015|Overall Study|Withdrawal by Subject|0|||
48330153|NCT03541369|155405682|FG016|Overall Study|Withdrawal by Subject|4|||
48330154|NCT03541369|155405683|FG017|Overall Study|Withdrawal by Subject|2|||
48330155|NCT03541369|155405666|FG000|Overall Study|Lost to Follow-up|0|||
48645288|NCT03745638|156554789|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48645289|NCT03745638|156554790|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48645290|NCT03745638|156554791|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48645291|NCT03745638|156554792|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
48645292|NCT03745638|156554793|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
48645293|NCT03745638|156554794|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
48645294|NCT03745638|156554795|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
48645295|NCT03745638|156554789|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48645296|NCT03745638|156554790|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48645297|NCT03745638|156554791|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48645298|NCT03745638|156554792|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48645299|NCT03745638|156554793|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
48645300|NCT03745638|156554794|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
48645301|NCT03745638|156554795|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48645302|NCT03745638|156554789|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48645303|NCT03745638|156554790|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48645304|NCT03745638|156554791|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48645305|NCT03745638|156554792|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48645306|NCT03745638|156554793|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48645307|NCT03745638|156554794|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
48751036|NCT02310568|156934396|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
48330156|NCT03541369|155405667|FG001|Overall Study|Lost to Follow-up|0|||
48330157|NCT03541369|155405668|FG002|Overall Study|Lost to Follow-up|0|||
48751037|NCT02310568|156934397|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
48751038|NCT02310568|156934398|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
48751039|NCT02310568|156934399|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
48330158|NCT03541369|155405669|FG003|Overall Study|Lost to Follow-up|0|||
48330159|NCT03541369|155405670|FG004|Overall Study|Lost to Follow-up|1|||
48645308|NCT03745638|156554795|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48645309|NCT03745638|156554789|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48645310|NCT03745638|156554790|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48645311|NCT03745638|156554791|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48645312|NCT03745638|156554792|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
48330160|NCT03541369|155405671|FG005|Overall Study|Lost to Follow-up|0|||
48330161|NCT03541369|155405672|FG006|Overall Study|Lost to Follow-up|0|||
48330162|NCT03541369|155405673|FG007|Overall Study|Lost to Follow-up|0|||
48330163|NCT03541369|155405674|FG008|Overall Study|Lost to Follow-up|1|||
48330164|NCT03541369|155405675|FG009|Overall Study|Lost to Follow-up|0|||
48330165|NCT03541369|155405676|FG010|Overall Study|Lost to Follow-up|0|||
48330166|NCT03541369|155405677|FG011|Overall Study|Lost to Follow-up|0|||
48330167|NCT03541369|155405678|FG012|Overall Study|Lost to Follow-up|1|||
48645313|NCT03745638|156554793|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
48645314|NCT03745638|156554794|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
48645315|NCT03745638|156554795|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
48645316|NCT03745638|156554789|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
48645317|NCT03745638|156554790|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
48645318|NCT03745638|156554791|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
48645319|NCT03745638|156554792|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
48645320|NCT03745638|156554793|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
48645321|NCT03745638|156554794|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
48645322|NCT03745638|156554795|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
48645323|NCT02375373|156554798|FG000|Overall Study|Withdrawal by Subject|11|||
48645324|NCT02517398|156554799|FG000|Overall Study|Death|2|||
48645325|NCT02517398|156554800|FG001|Overall Study|Death|3|||
48645326|NCT02517398|156554801|FG002|Overall Study|Death|4|||
48645327|NCT02517398|156554802|FG003|Overall Study|Death|2|||
48645328|NCT02517398|156554803|FG004|Overall Study|Death|3|||
48645329|NCT02517398|156554804|FG005|Overall Study|Death|8|||
48645330|NCT02517398|156554805|FG006|Overall Study|Death|3|||
48645331|NCT02517398|156554806|FG007|Overall Study|Death|2|||
48645332|NCT02517398|156554807|FG008|Overall Study|Death|6|||
48645333|NCT02517398|156554808|FG009|Overall Study|Death|24|||
48645334|NCT02517398|156554809|FG010|Overall Study|Death|53|||
48645335|NCT02517398|156554810|FG011|Overall Study|Death|25|||
48645336|NCT02517398|156554811|FG012|Overall Study|Death|73|||
48645337|NCT02517398|156554812|FG013|Overall Study|Death|29|||
48645338|NCT02517398|156554813|FG014|Overall Study|Death|26|||
48645339|NCT02517398|156554814|FG015|Overall Study|Death|23|||
48645340|NCT02517398|156554815|FG016|Overall Study|Death|26|||
48645341|NCT02517398|156554816|FG017|Overall Study|Death|25|||
48330168|NCT03541369|155405679|FG013|Overall Study|Lost to Follow-up|0|||
48330169|NCT03541369|155405680|FG014|Overall Study|Lost to Follow-up|0|||
48330170|NCT03541369|155405681|FG015|Overall Study|Lost to Follow-up|0|||
48330171|NCT03541369|155405682|FG016|Overall Study|Lost to Follow-up|0|||
48330172|NCT03541369|155405683|FG017|Overall Study|Lost to Follow-up|0|||
48330173|NCT03205488|155405684|FG000|Overall Study|Adverse Event|1|||
48330174|NCT03205488|155405685|FG001|Overall Study|Adverse Event|2|||
48330175|NCT03205488|155405686|FG002|Overall Study|Adverse Event|4|||
48330176|NCT03205488|155405684|FG000|Overall Study|Protocol Violation|0|||
48330177|NCT03205488|155405685|FG001|Overall Study|Protocol Violation|0|||
48330178|NCT03205488|155405686|FG002|Overall Study|Protocol Violation|1|||
48330179|NCT01005914|155405687|FG000|Overall Study|Adverse Event|4|||
48330180|NCT01005914|155405687|FG000|Overall Study|Death|4|||
48330181|NCT01005914|155405687|FG000|Overall Study|Lack of Efficacy|1|||
48330182|NCT01005914|155405687|FG000|Overall Study|Withdrawal by Subject|1|||
48330183|NCT01240785|155405688|FG000|Overall Study|Lost to Follow-up|1|||
48330184|NCT01240785|155405689|FG001|Overall Study|Lost to Follow-up|0|||
48330185|NCT01240785|155405688|FG000|Overall Study|Protocol Violation|0|||
48330186|NCT01240785|155405689|FG001|Overall Study|Protocol Violation|3|||
48330187|NCT00786188|155405690|FG000|Overall Study|Adverse Event|3|||
48330188|NCT00786188|155405691|FG001|Overall Study|Adverse Event|1|||
48330189|NCT00786188|155405690|FG000|Overall Study|Withdrawal by Subject|2|||
48330190|NCT00786188|155405691|FG001|Overall Study|Withdrawal by Subject|0|||
48330191|NCT00614614|155405693|FG000|Primary Vaccination Phase|Adverse Event|6|||
48645342|NCT02517398|156554817|FG018|Overall Study|Death|22|||
48645343|NCT02517398|156554818|FG019|Overall Study|Death|7|||
48645344|NCT02517398|156554819|FG020|Overall Study|Death|26|||
48751040|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
48330192|NCT00614614|155405694|FG001|Primary Vaccination Phase|Adverse Event|0|||
48330193|NCT00614614|155405695|FG002|Primary Vaccination Phase|Adverse Event|0|||
48330194|NCT00614614|155405696|FG003|Primary Vaccination Phase|Adverse Event|0|||
48330195|NCT00614614|155405697|FG004|Primary Vaccination Phase|Adverse Event|0|||
48427379|NCT01544595|155752942|FG004|Status at Week 156|Pregnancy|0|||
48330196|NCT00614614|155405693|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
48330197|NCT00614614|155405694|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
48330198|NCT00614614|155405695|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
48330199|NCT00614614|155405696|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
48330200|NCT00614614|155405697|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
48330201|NCT00614614|155405693|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
48330202|NCT00614614|155405694|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
48330203|NCT00614614|155405695|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
48330204|NCT00614614|155405696|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
48330205|NCT00614614|155405697|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
48330206|NCT00614614|155405693|FG000|Primary Vaccination Phase|Protocol Violation|9|||
48330207|NCT00614614|155405694|FG001|Primary Vaccination Phase|Protocol Violation|3|||
48330208|NCT00614614|155405695|FG002|Primary Vaccination Phase|Protocol Violation|0|||
48330209|NCT00614614|155405696|FG003|Primary Vaccination Phase|Protocol Violation|0|||
48330210|NCT00614614|155405697|FG004|Primary Vaccination Phase|Protocol Violation|0|||
48330211|NCT00614614|155405693|FG000|Primary Vaccination Phase|Other|4|||
48330212|NCT00614614|155405694|FG001|Primary Vaccination Phase|Other|0|||
48330213|NCT00614614|155405695|FG002|Primary Vaccination Phase|Other|0|||
48330214|NCT00614614|155405696|FG003|Primary Vaccination Phase|Other|0|||
48330215|NCT00614614|155405697|FG004|Primary Vaccination Phase|Other|0|||
48330216|NCT00614614|155405693|FG000|Booster Vaccination Phase|Adverse Event|0|||
48330217|NCT00614614|155405694|FG001|Booster Vaccination Phase|Adverse Event|0|||
48645345|NCT02517398|156554820|FG021|Overall Study|Death|30|||
48645346|NCT02517398|156554821|FG022|Overall Study|Death|20|||
48645347|NCT02517398|156554799|FG000|Overall Study|Other|0|||
48330218|NCT00614614|155405695|FG002|Booster Vaccination Phase|Adverse Event|1|||
48330219|NCT00614614|155405696|FG003|Booster Vaccination Phase|Adverse Event|1|||
48330220|NCT00614614|155405697|FG004|Booster Vaccination Phase|Adverse Event|0|||
48645348|NCT02517398|156554800|FG001|Overall Study|Other|0|||
48645349|NCT02517398|156554801|FG002|Overall Study|Other|0|||
48645350|NCT02517398|156554802|FG003|Overall Study|Other|1|||
48645351|NCT02517398|156554803|FG004|Overall Study|Other|0|||
48645352|NCT02517398|156554804|FG005|Overall Study|Other|0|||
48645353|NCT02517398|156554805|FG006|Overall Study|Other|0|||
48645354|NCT02517398|156554806|FG007|Overall Study|Other|0|||
48645355|NCT02517398|156554807|FG008|Overall Study|Other|0|||
48645356|NCT02517398|156554808|FG009|Overall Study|Other|1|||
48645357|NCT02517398|156554809|FG010|Overall Study|Other|0|||
48645358|NCT02517398|156554810|FG011|Overall Study|Other|0|||
48330221|NCT00614614|155405693|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
48330222|NCT00614614|155405694|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
48330223|NCT00614614|155405695|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
48645359|NCT02517398|156554811|FG012|Overall Study|Other|0|||
48645360|NCT02517398|156554812|FG013|Overall Study|Other|1|||
48645361|NCT02517398|156554813|FG014|Overall Study|Other|0|||
48645362|NCT02517398|156554814|FG015|Overall Study|Other|1|||
48645363|NCT02517398|156554815|FG016|Overall Study|Other|1|||
48645364|NCT02517398|156554816|FG017|Overall Study|Other|0|||
48645365|NCT02517398|156554817|FG018|Overall Study|Other|0|||
48645366|NCT02517398|156554818|FG019|Overall Study|Other|1|||
48645367|NCT02517398|156554819|FG020|Overall Study|Other|0|||
48645368|NCT02517398|156554820|FG021|Overall Study|Other|0|||
48645369|NCT02517398|156554821|FG022|Overall Study|Other|0|||
48645370|NCT02517398|156554799|FG000|Overall Study|Lost to Follow-up|0|||
48645371|NCT02517398|156554800|FG001|Overall Study|Lost to Follow-up|0|||
48645372|NCT02517398|156554801|FG002|Overall Study|Lost to Follow-up|0|||
48645373|NCT02517398|156554802|FG003|Overall Study|Lost to Follow-up|0|||
48645374|NCT02517398|156554803|FG004|Overall Study|Lost to Follow-up|0|||
48645375|NCT02517398|156554804|FG005|Overall Study|Lost to Follow-up|0|||
48645376|NCT02517398|156554805|FG006|Overall Study|Lost to Follow-up|0|||
48645377|NCT02517398|156554806|FG007|Overall Study|Lost to Follow-up|0|||
48645378|NCT02517398|156554807|FG008|Overall Study|Lost to Follow-up|0|||
48645379|NCT02517398|156554808|FG009|Overall Study|Lost to Follow-up|1|||
48645380|NCT02517398|156554809|FG010|Overall Study|Lost to Follow-up|0|||
48645381|NCT02517398|156554810|FG011|Overall Study|Lost to Follow-up|2|||
48645382|NCT02517398|156554811|FG012|Overall Study|Lost to Follow-up|2|||
48645383|NCT02517398|156554812|FG013|Overall Study|Lost to Follow-up|0|||
48645384|NCT02517398|156554813|FG014|Overall Study|Lost to Follow-up|1|||
48645385|NCT02517398|156554814|FG015|Overall Study|Lost to Follow-up|1|||
48645386|NCT02517398|156554815|FG016|Overall Study|Lost to Follow-up|0|||
48645387|NCT02517398|156554816|FG017|Overall Study|Lost to Follow-up|3|||
48330224|NCT00614614|155405696|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
48330225|NCT00614614|155405697|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
48330226|NCT00614614|155405693|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
48330227|NCT00614614|155405694|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
48330228|NCT00614614|155405695|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
48330229|NCT00614614|155405696|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
48330230|NCT00614614|155405697|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
48330231|NCT00614614|155405693|FG000|Booster Vaccination Phase|Protocol Violation|0|||
48330232|NCT00614614|155405694|FG001|Booster Vaccination Phase|Protocol Violation|0|||
48330233|NCT00614614|155405695|FG002|Booster Vaccination Phase|Protocol Violation|2|||
48330234|NCT00614614|155405696|FG003|Booster Vaccination Phase|Protocol Violation|3|||
48330235|NCT00614614|155405697|FG004|Booster Vaccination Phase|Protocol Violation|0|||
48330236|NCT00614614|155405693|FG000|Booster Vaccination Phase|Other|0|||
48330237|NCT00614614|155405694|FG001|Booster Vaccination Phase|Other|1|||
48330238|NCT00614614|155405695|FG002|Booster Vaccination Phase|Other|3|||
48330239|NCT00614614|155405696|FG003|Booster Vaccination Phase|Other|2|||
48330240|NCT00614614|155405697|FG004|Booster Vaccination Phase|Other|1|||
48330241|NCT01885559|155405698|FG000|Overall Study|Lost to Follow-up|15|||
48330242|NCT01885559|155405699|FG001|Overall Study|Lost to Follow-up|16|||
48330243|NCT01885559|155405698|FG000|Overall Study|Less than full participation|9|||
48330244|NCT01885559|155405699|FG001|Overall Study|Less than full participation|19|||
48330245|NCT01885559|155405698|FG000|Overall Study|Protocol Violation|0|||
48330246|NCT01885559|155405699|FG001|Overall Study|Protocol Violation|1|||
48330247|NCT03100370|155405701|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48330248|NCT03100370|155405702|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48330249|NCT03100370|155405703|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48645388|NCT02517398|156554817|FG018|Overall Study|Lost to Follow-up|1|||
48645389|NCT02517398|156554818|FG019|Overall Study|Lost to Follow-up|0|||
48645390|NCT02517398|156554819|FG020|Overall Study|Lost to Follow-up|1|||
48645391|NCT02517398|156554820|FG021|Overall Study|Lost to Follow-up|0|||
48645392|NCT02517398|156554821|FG022|Overall Study|Lost to Follow-up|2|||
48645393|NCT02517398|156554799|FG000|Overall Study|Withdrew Consent|0|||
48645394|NCT02517398|156554800|FG001|Overall Study|Withdrew Consent|0|||
48645395|NCT02517398|156554801|FG002|Overall Study|Withdrew Consent|0|||
48645396|NCT02517398|156554802|FG003|Overall Study|Withdrew Consent|0|||
48645397|NCT02517398|156554803|FG004|Overall Study|Withdrew Consent|0|||
48645398|NCT02517398|156554804|FG005|Overall Study|Withdrew Consent|0|||
48645399|NCT02517398|156554805|FG006|Overall Study|Withdrew Consent|1|||
48645400|NCT02517398|156554806|FG007|Overall Study|Withdrew Consent|0|||
48645401|NCT02517398|156554807|FG008|Overall Study|Withdrew Consent|0|||
48645402|NCT02517398|156554808|FG009|Overall Study|Withdrew Consent|2|||
48645403|NCT02517398|156554809|FG010|Overall Study|Withdrew Consent|7|||
48645404|NCT02517398|156554810|FG011|Overall Study|Withdrew Consent|1|||
48645405|NCT02517398|156554811|FG012|Overall Study|Withdrew Consent|5|||
48645406|NCT02517398|156554812|FG013|Overall Study|Withdrew Consent|4|||
48645407|NCT02517398|156554813|FG014|Overall Study|Withdrew Consent|2|||
48645408|NCT02517398|156554814|FG015|Overall Study|Withdrew Consent|5|||
48645409|NCT02517398|156554815|FG016|Overall Study|Withdrew Consent|4|||
48645410|NCT02517398|156554816|FG017|Overall Study|Withdrew Consent|2|||
48645411|NCT02517398|156554817|FG018|Overall Study|Withdrew Consent|3|||
48645412|NCT02517398|156554818|FG019|Overall Study|Withdrew Consent|2|||
48645413|NCT02517398|156554819|FG020|Overall Study|Withdrew Consent|9|||
48645414|NCT02517398|156554820|FG021|Overall Study|Withdrew Consent|3|||
48645415|NCT02517398|156554821|FG022|Overall Study|Withdrew Consent|1|||
48645416|NCT02567799|156554822|FG000|Concurrent Chemoradiotherapy|Death|1|||
48645417|NCT02567799|156554823|FG001|Concurrent Chemoradiotherapy|Death|0|||
48645418|NCT02567799|156554824|FG002|Concurrent Chemoradiotherapy|Death|0|||
48645419|NCT02567799|156554822|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
48645420|NCT02567799|156554823|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
48645421|NCT02567799|156554824|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
48645422|NCT02567799|156554822|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
48645423|NCT02567799|156554823|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
48645424|NCT02567799|156554824|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
48645425|NCT02567799|156554822|FG000|Follow-up|Death|1|||
48645426|NCT02567799|156554823|FG001|Follow-up|Death|0|||
48645427|NCT02567799|156554824|FG002|Follow-up|Death|1|||
48645428|NCT02567799|156554822|FG000|Follow-up|Progressive Disease|1|||
48645429|NCT02567799|156554823|FG001|Follow-up|Progressive Disease|1|||
48645430|NCT02567799|156554824|FG002|Follow-up|Progressive Disease|3|||
48645431|NCT00465972|156554825|FG000|Overall Study|Withdrawal by Subject|2|||
48645432|NCT00465972|156554826|FG001|Overall Study|Withdrawal by Subject|1|||
48645433|NCT00130039|156554829|FG000|Overall Study|Withdrawal by Subject|15|||
48645434|NCT00130039|156554830|FG001|Overall Study|Withdrawal by Subject|11|||
48645435|NCT00130039|156554829|FG000|Overall Study|Lost to Follow-up|3|||
48645436|NCT00130039|156554830|FG001|Overall Study|Lost to Follow-up|1|||
48645437|NCT00130039|156554829|FG000|Overall Study|Adverse Event|4|||
48645438|NCT00130039|156554830|FG001|Overall Study|Adverse Event|2|||
48645439|NCT00130039|156554829|FG000|Overall Study|Physician Decision|3|||
48645440|NCT00130039|156554830|FG001|Overall Study|Physician Decision|0|||
48645441|NCT00130039|156554829|FG000|Overall Study|clinical events without follow up MRI|5|||
48645442|NCT00130039|156554830|FG001|Overall Study|clinical events without follow up MRI|4|||
48645443|NCT00642707|156554831|FG000|Overall Study|Adverse Event|0|||
48645444|NCT00642707|156554832|FG001|Overall Study|Adverse Event|0|||
48645445|NCT00642707|156554833|FG002|Overall Study|Adverse Event|0|||
48645446|NCT00642707|156554834|FG003|Overall Study|Adverse Event|2|||
48645447|NCT00642707|156554831|FG000|Overall Study|Withdrawal by Subject|1|||
48645448|NCT00642707|156554832|FG001|Overall Study|Withdrawal by Subject|0|||
48645449|NCT00642707|156554833|FG002|Overall Study|Withdrawal by Subject|0|||
48645450|NCT00642707|156554834|FG003|Overall Study|Withdrawal by Subject|0|||
48645451|NCT02709720|156554838|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
48751041|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
48751042|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
48751043|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
48751044|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
48751045|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Other|0|||
48751046|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Other|1|||
48751047|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Other|1|||
48751048|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Other|0|||
48751049|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Other|0|||
48751050|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
48751051|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
48751052|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
48751053|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
48751054|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
48751055|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
48751056|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
48751057|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
48751058|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
48751059|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
48751060|NCT02310568|156934395|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
48751061|NCT02310568|156934396|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
48751062|NCT02310568|156934397|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
48751063|NCT02310568|156934398|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
48751064|NCT02310568|156934399|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
48751065|NCT02966028|156934403|FG000|Overall Study|Adverse Event|7|||
48751066|NCT02966028|156934404|FG001|Overall Study|Adverse Event|13|||
48751067|NCT02966028|156934405|FG002|Overall Study|Adverse Event|10|||
48751068|NCT02966028|156934403|FG000|Overall Study|Physician Decision|1|||
48751069|NCT02966028|156934404|FG001|Overall Study|Physician Decision|0|||
48751070|NCT02966028|156934405|FG002|Overall Study|Physician Decision|2|||
48751071|NCT02966028|156934403|FG000|Overall Study|Withdrawal by Subject|7|||
48751072|NCT02966028|156934404|FG001|Overall Study|Withdrawal by Subject|5|||
48751073|NCT02966028|156934405|FG002|Overall Study|Withdrawal by Subject|5|||
48751074|NCT02966028|156934403|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
48751075|NCT02966028|156934404|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
48751076|NCT02966028|156934405|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
48751077|NCT02990910|156934406|FG000|Overall Study|Lack of Efficacy|6|||
48751078|NCT02990910|156934407|FG001|Overall Study|Lack of Efficacy|10|||
48751079|NCT02468414|156934417|FG000|Overall Study|Early Study Termination by Sponsor|1|||
48751080|NCT02468414|156934418|FG001|Overall Study|Early Study Termination by Sponsor|0|||
48751081|NCT02468414|156934417|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
48751082|NCT02468414|156934418|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
48751083|NCT02468414|156934417|FG000|Overall Study|Screen Failure|1|||
48751084|NCT02468414|156934418|FG001|Overall Study|Screen Failure|0|||
48751085|NCT03761277|156934419|FG000|Enrollment to Implant|Screen Failure|17|||
48751086|NCT03761277|156934419|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
48751087|NCT03761277|156934419|FG000|Enrollment to Implant|Physician Decision|2|||
48751088|NCT03761277|156934419|FG000|Enrollment to Implant|Site Closure|3|||
48751089|NCT03761277|156934419|FG000|Enrollment to Implant|Sponsor Request|2|||
48751090|NCT03761277|156934419|FG000|Post-Implant to 6 Months|Adverse Event|2|||
48751091|NCT03761277|156934419|FG000|Post-Implant to 6 Months|Death|1|||
48751092|NCT03761277|156934419|FG000|Post-Implant to 6 Months|Site Closure|2|||
48751093|NCT03761277|156934419|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
48751094|NCT03761277|156934419|FG000|6 Months to 12 Months|Physician Decision|2|||
48751095|NCT03761277|156934419|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
48751096|NCT04160091|156934430|FG000|Overall Study|Terminated by Sponsor|7|||
48751097|NCT04160091|156934431|FG001|Overall Study|Terminated by Sponsor|3|||
48751098|NCT04160091|156934432|FG002|Overall Study|Terminated by Sponsor|5|||
48751099|NCT04160091|156934433|FG003|Overall Study|Terminated by Sponsor|2|||
48751100|NCT04160091|156934430|FG000|Overall Study|Noncompliance|0|||
48751101|NCT04160091|156934431|FG001|Overall Study|Noncompliance|0|||
48751102|NCT04160091|156934432|FG002|Overall Study|Noncompliance|0|||
48751103|NCT04160091|156934433|FG003|Overall Study|Noncompliance|1|||
48751104|NCT04160091|156934430|FG000|Overall Study|Withdrawal by Subject|0|||
48751105|NCT04160091|156934431|FG001|Overall Study|Withdrawal by Subject|0|||
48751106|NCT04160091|156934432|FG002|Overall Study|Withdrawal by Subject|0|||
48645452|NCT02709720|156554838|FG000|Overall Study|Protocol Violation|1|||
48645453|NCT02709720|156554838|FG000|Overall Study|Not take study medication|1|||
48645454|NCT03306433|156554839|FG000|Overall Study|Lost to Follow-up|3|||
48645455|NCT03306433|156554839|FG000|Overall Study|Patient did not have teeth extracted|1|||
48645456|NCT03306433|156554839|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
48645457|NCT01198574|156554842|FG000|Overall Study|Resigned from schools|4|||
48645458|NCT01198574|156554843|FG001|Overall Study|Resigned from schools|1|||
48645459|NCT01198574|156554844|FG002|Overall Study|Resigned from schools|1|||
48645460|NCT01198574|156554845|FG003|Overall Study|Resigned from schools|4|||
48645461|NCT03135431|156554846|FG000|Overall Study|Study Surgeon not available|2|||
48645462|NCT03135431|156554847|FG001|Overall Study|Study Surgeon not available|0|||
48645463|NCT00326001|156554848|FG000|Overall Study|Adverse Event|4|||
48645464|NCT00326001|156554849|FG001|Overall Study|Adverse Event|5|||
48645465|NCT00326001|156554848|FG000|Overall Study|Physician Decision|3|||
48645466|NCT00326001|156554849|FG001|Overall Study|Physician Decision|3|||
48645467|NCT00837161|156554850|FG000|Overall Study|refused hysterectomy|2|||
48645468|NCT02931838|156554851|FG000|Overall Study|Reason not provided by investigator|1|||
48645469|NCT02931838|156554852|FG001|Overall Study|Reason not provided by investigator|0|||
48645470|NCT02931838|156554853|FG002|Overall Study|Reason not provided by investigator|1|||
48645471|NCT02931838|156554854|FG003|Overall Study|Reason not provided by investigator|0|||
48645472|NCT02931838|156554855|FG004|Overall Study|Reason not provided by investigator|0|||
48645473|NCT02931838|156554856|FG005|Overall Study|Reason not provided by investigator|0|||
48645474|NCT02931838|156554851|FG000|Overall Study|Poor/non-compliance|0|||
48645475|NCT02931838|156554852|FG001|Overall Study|Poor/non-compliance|0|||
48645476|NCT02931838|156554853|FG002|Overall Study|Poor/non-compliance|1|||
48645477|NCT02931838|156554854|FG003|Overall Study|Poor/non-compliance|0|||
48645478|NCT02931838|156554855|FG004|Overall Study|Poor/non-compliance|0|||
48645479|NCT02931838|156554856|FG005|Overall Study|Poor/non-compliance|0|||
48645480|NCT02931838|156554851|FG000|Overall Study|Lack of Efficacy|5|||
48645481|NCT02931838|156554852|FG001|Overall Study|Lack of Efficacy|4|||
48645482|NCT02931838|156554853|FG002|Overall Study|Lack of Efficacy|0|||
48645483|NCT02931838|156554854|FG003|Overall Study|Lack of Efficacy|0|||
48645484|NCT02931838|156554855|FG004|Overall Study|Lack of Efficacy|0|||
48645485|NCT02931838|156554856|FG005|Overall Study|Lack of Efficacy|1|||
48645486|NCT02931838|156554851|FG000|Overall Study|Lost to Follow-up|1|||
48645487|NCT02931838|156554852|FG001|Overall Study|Lost to Follow-up|0|||
48645488|NCT02931838|156554853|FG002|Overall Study|Lost to Follow-up|1|||
48645489|NCT02931838|156554854|FG003|Overall Study|Lost to Follow-up|1|||
48645490|NCT02931838|156554855|FG004|Overall Study|Lost to Follow-up|2|||
48645491|NCT02931838|156554856|FG005|Overall Study|Lost to Follow-up|0|||
48645492|NCT02931838|156554851|FG000|Overall Study|Subject request to discontinue treatment|4|||
48645493|NCT02931838|156554852|FG001|Overall Study|Subject request to discontinue treatment|3|||
48645494|NCT02931838|156554853|FG002|Overall Study|Subject request to discontinue treatment|3|||
48645495|NCT02931838|156554854|FG003|Overall Study|Subject request to discontinue treatment|0|||
48645496|NCT02931838|156554855|FG004|Overall Study|Subject request to discontinue treatment|1|||
48645497|NCT02931838|156554856|FG005|Overall Study|Subject request to discontinue treatment|0|||
48645498|NCT02931838|156554851|FG000|Overall Study|Withdrawal by Subject|1|||
48645499|NCT02931838|156554852|FG001|Overall Study|Withdrawal by Subject|2|||
48645500|NCT02931838|156554853|FG002|Overall Study|Withdrawal by Subject|0|||
48645501|NCT02931838|156554854|FG003|Overall Study|Withdrawal by Subject|1|||
48645502|NCT02931838|156554855|FG004|Overall Study|Withdrawal by Subject|0|||
48751107|NCT04160091|156934433|FG003|Overall Study|Withdrawal by Subject|1|||
48645503|NCT02931838|156554856|FG005|Overall Study|Withdrawal by Subject|0|||
48645504|NCT02931838|156554851|FG000|Overall Study|Adverse Event|2|||
48645505|NCT02931838|156554852|FG001|Overall Study|Adverse Event|1|||
48645506|NCT02931838|156554853|FG002|Overall Study|Adverse Event|2|||
48645507|NCT02931838|156554854|FG003|Overall Study|Adverse Event|1|||
48645508|NCT02931838|156554855|FG004|Overall Study|Adverse Event|3|||
48645509|NCT02931838|156554856|FG005|Overall Study|Adverse Event|1|||
48751108|NCT01342796|156934434|FG000|Overall Study|Withdrawal by Subject|2|||
48751109|NCT01342796|156934435|FG001|Overall Study|Withdrawal by Subject|0|||
48751110|NCT01342796|156934434|FG000|Overall Study|Lost to Follow-up|0|||
48751111|NCT01342796|156934435|FG001|Overall Study|Lost to Follow-up|3|||
48751112|NCT01342796|156934434|FG000|Overall Study|Inappropriate enrollment|1|||
48751113|NCT01342796|156934435|FG001|Overall Study|Inappropriate enrollment|0|||
48751114|NCT02692716|156934441|FG000|Overall Study|Lost to Follow-up|2|||
48751115|NCT02692716|156934442|FG001|Overall Study|Lost to Follow-up|5|||
48751116|NCT02692716|156934441|FG000|Overall Study|Withdrawal by Subject|3|||
48751117|NCT02692716|156934442|FG001|Overall Study|Withdrawal by Subject|1|||
48751118|NCT02782780|156934447|FG000|Overall Study|dropped out after randomization.|7|||
48751119|NCT02782780|156934448|FG001|Overall Study|dropped out after randomization.|5|||
48751120|NCT02782780|156934447|FG000|Overall Study|Protocol Violation|0|||
48751121|NCT02782780|156934448|FG001|Overall Study|Protocol Violation|2|||
48751122|NCT01463878|156934452|FG000|Overall Study|no longer met criteria for tube feed|2|||
48751123|NCT01463878|156934453|FG001|Overall Study|no longer met criteria for tube feed|2|||
48751124|NCT00085631|156934454|FG000|Overall Study|Missing Data|4|||
48751125|NCT00085631|156934455|FG001|Overall Study|Missing Data|11|||
48751126|NCT00085631|156934456|FG002|Overall Study|Missing Data|7|||
48751127|NCT04118166|156934457|FG000|Overall Study|Adverse Event|1|||
48751128|NCT01987505|156934462|FG000|Overall Study|Other|9|||
48751129|NCT01987505|156934462|FG000|Overall Study|Withdrawal by Subject|2|||
48751130|NCT01987505|156934462|FG000|Overall Study|Other Reason|2|||
48751131|NCT01987505|156934462|FG000|Overall Study|Lost to Follow-up|15|||
48751132|NCT01987505|156934462|FG000|Overall Study|Investigator Decision|2|||
48751133|NCT01987505|156934462|FG000|Overall Study|Death|4|||
48751134|NCT00546637|156934463|FG000|Overall Study|Adverse Event|46|||
48751135|NCT00546637|156934464|FG001|Overall Study|Adverse Event|20|||
48751136|NCT00546637|156934463|FG000|Overall Study|Lack of Efficacy|5|||
48751137|NCT00546637|156934464|FG001|Overall Study|Lack of Efficacy|5|||
48751138|NCT00546637|156934463|FG000|Overall Study|Lost to Follow-up|2|||
48751139|NCT00546637|156934464|FG001|Overall Study|Lost to Follow-up|2|||
48751140|NCT00546637|156934463|FG000|Overall Study|Other|10|||
48751141|NCT00546637|156934464|FG001|Overall Study|Other|12|||
48751142|NCT00546637|156934463|FG000|Overall Study|Withdrawal by Subject|7|||
48751143|NCT00546637|156934464|FG001|Overall Study|Withdrawal by Subject|9|||
48751144|NCT00546637|156934463|FG000|Overall Study|Randomized, but not treated|3|||
48751145|NCT00546637|156934464|FG001|Overall Study|Randomized, but not treated|1|||
48751146|NCT04983264|156934466|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
48751147|NCT04983264|156934467|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
48751148|NCT04983264|156934468|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
48751149|NCT04983264|156934466|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
48751150|NCT04983264|156934467|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
48751151|NCT04983264|156934468|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
48751152|NCT01484197|156934471|FG000|Treatment Period 1|Adverse Event|1|||
48751153|NCT01484197|156934472|FG001|Treatment Period 1|Adverse Event|0|||
48751154|NCT01484197|156934473|FG002|Treatment Period 1|Adverse Event|0|||
48751155|NCT01484197|156934474|FG003|Treatment Period 1|Adverse Event|0|||
48751156|NCT01484197|156934471|FG000|Treatment Period 2|Subject withdrew consent|0|||
48751157|NCT01484197|156934472|FG001|Treatment Period 2|Subject withdrew consent|0|||
48751158|NCT01484197|156934473|FG002|Treatment Period 2|Subject withdrew consent|0|||
48751159|NCT01484197|156934474|FG003|Treatment Period 2|Subject withdrew consent|1|||
48645510|NCT01027650|156554857|FG000|Overall Study|Personal Reasons|0|||
48751160|NCT00160251|156934475|FG000|Prior to Amendment 2|Adverse Event|2|||
48645511|NCT01027650|156554858|FG001|Overall Study|Personal Reasons|0|||
48751161|NCT00160251|156934476|FG001|Prior to Amendment 2|Adverse Event|1|||
48751162|NCT00160251|156934477|FG002|Prior to Amendment 2|Adverse Event|3|||
48751163|NCT00160251|156934478|FG003|Prior to Amendment 2|Adverse Event|1|||
48645512|NCT01027650|156554859|FG002|Overall Study|Personal Reasons|0|||
48751164|NCT00160251|156934479|FG004|Prior to Amendment 2|Adverse Event|1|||
48751165|NCT00160251|156934480|FG005|Prior to Amendment 2|Adverse Event|1|||
48751166|NCT00160251|156934481|FG006|Prior to Amendment 2|Adverse Event|1|||
48751167|NCT00160251|156934482|FG007|Prior to Amendment 2|Adverse Event|0|||
48751168|NCT00160251|156934475|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
48645513|NCT01027650|156554860|FG003|Overall Study|Personal Reasons|0|||
48645514|NCT01027650|156554861|FG004|Overall Study|Personal Reasons|2|||
48645515|NCT01027650|156554862|FG005|Overall Study|Personal Reasons|1|||
48645516|NCT01027650|156554863|FG006|Overall Study|Personal Reasons|0|||
48645517|NCT01027650|156554864|FG007|Overall Study|Personal Reasons|0|||
48645518|NCT01027650|156554857|FG000|Overall Study|Lost to Follow-up|0|||
48645519|NCT01027650|156554858|FG001|Overall Study|Lost to Follow-up|0|||
48645520|NCT01027650|156554859|FG002|Overall Study|Lost to Follow-up|0|||
48645521|NCT01027650|156554860|FG003|Overall Study|Lost to Follow-up|0|||
48645522|NCT01027650|156554861|FG004|Overall Study|Lost to Follow-up|0|||
48645523|NCT01027650|156554862|FG005|Overall Study|Lost to Follow-up|0|||
48645524|NCT01027650|156554863|FG006|Overall Study|Lost to Follow-up|1|||
48645525|NCT01027650|156554864|FG007|Overall Study|Lost to Follow-up|0|||
48645526|NCT01027650|156554857|FG000|Overall Study|Lack of Efficacy|0|||
48645527|NCT01027650|156554858|FG001|Overall Study|Lack of Efficacy|0|||
48645528|NCT01027650|156554859|FG002|Overall Study|Lack of Efficacy|0|||
48645529|NCT01027650|156554860|FG003|Overall Study|Lack of Efficacy|0|||
48645530|NCT01027650|156554861|FG004|Overall Study|Lack of Efficacy|0|||
48645531|NCT01027650|156554862|FG005|Overall Study|Lack of Efficacy|1|||
48645532|NCT01027650|156554863|FG006|Overall Study|Lack of Efficacy|0|||
48645533|NCT01027650|156554864|FG007|Overall Study|Lack of Efficacy|0|||
48645534|NCT03281629|156554865|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
48645535|NCT03281629|156554866|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
48645536|NCT03281629|156554865|FG000|Overall Study|Death|0|||
48645537|NCT03281629|156554866|FG001|Overall Study|Death|1|||
48645538|NCT03281629|156554865|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
48645539|NCT03281629|156554866|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
48645540|NCT01082081|156554867|FG000|Overall Study|Lost to Follow-up|0|||
48645541|NCT01082081|156554868|FG001|Overall Study|Lost to Follow-up|0|||
48645542|NCT01082081|156554869|FG002|Overall Study|Lost to Follow-up|1|||
48645543|NCT01082081|156554867|FG000|Overall Study|Withdrawal by Subject|0|||
48645544|NCT01082081|156554868|FG001|Overall Study|Withdrawal by Subject|0|||
48645545|NCT01082081|156554869|FG002|Overall Study|Withdrawal by Subject|1|||
48645546|NCT01082081|156554867|FG000|Overall Study|Other Reason|0|||
48645547|NCT01082081|156554868|FG001|Overall Study|Other Reason|1|||
48645548|NCT01082081|156554869|FG002|Overall Study|Other Reason|0|||
48645549|NCT02175277|156554870|FG000|Overall Study|Protocol-specified Criteria|1|||
48645550|NCT01042158|156554875|FG000|Overall Study|Physician Decision|1|||
48645551|NCT01575808|156554877|FG000|Overall Study|Death|2|||
48645552|NCT01575808|156554878|FG001|Overall Study|Death|0|||
48645553|NCT01575808|156554877|FG000|Overall Study|Withdrawal by Subject|1|||
48645554|NCT01575808|156554878|FG001|Overall Study|Withdrawal by Subject|0|||
48645555|NCT00375674|156554884|FG000|Overall Study|Other|26|||
48645556|NCT00375674|156554885|FG001|Overall Study|Other|18|||
48645557|NCT00375674|156554884|FG000|Overall Study|Death|67|||
48645558|NCT00375674|156554885|FG001|Overall Study|Death|76|||
48645559|NCT00375674|156554884|FG000|Overall Study|Participants refused further follow-up|31|||
48645560|NCT00375674|156554885|FG001|Overall Study|Participants refused further follow-up|30|||
48645561|NCT00375674|156554884|FG000|Overall Study|Lost to Follow-up|17|||
48645562|NCT00375674|156554885|FG001|Overall Study|Lost to Follow-up|15|||
48645563|NCT00375674|156554884|FG000|Overall Study|Enrolled but not treated|3|||
48645564|NCT00375674|156554885|FG001|Overall Study|Enrolled but not treated|2|||
48645565|NCT00912782|156554886|FG000|Overall Study|Death|2|||
48645566|NCT00912782|156554887|FG001|Overall Study|Death|1|||
48645567|NCT00912782|156554886|FG000|Overall Study|Lost to Follow-up|0|||
48645568|NCT00912782|156554887|FG001|Overall Study|Lost to Follow-up|1|||
48645569|NCT00912782|156554886|FG000|Overall Study|Did not receive vascular access type|1|||
48645570|NCT00912782|156554887|FG001|Overall Study|Did not receive vascular access type|2|||
48645571|NCT00912782|156554886|FG000|Overall Study|Relocated before study completion|0|||
48645572|NCT00912782|156554887|FG001|Overall Study|Relocated before study completion|1|||
48645573|NCT00288015|156556028|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
48645574|NCT00288015|156556028|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
48645575|NCT00288015|156556028|FG000|First Response Assessment|Withdrawal by Subject|1|||
48645576|NCT00288015|156556028|FG000|First Response Assessment|Death|1|||
48645577|NCT00288015|156556028|FG000|First Response Assessment|Physician Decision|2|||
48751169|NCT00160251|156934476|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
48751170|NCT00160251|156934477|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
48645578|NCT00288015|156556028|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
48645579|NCT00288015|156556028|FG000|Follow up for Survival x 2 Years|Death|13|||
48645580|NCT00288015|156556028|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
48645581|NCT00288015|156556028|FG000|Follow up for Survival x 2 Years|Other|9|||
48645582|NCT00938912|156556041|FG000|Overall Study|Withdrawal by Subject|28|||
48645583|NCT00938912|156556041|FG000|Overall Study|Lost to Follow-up|4|||
48645584|NCT00938912|156556041|FG000|Overall Study|Lack of Efficacy|43|||
48645585|NCT00938912|156556041|FG000|Overall Study|Adverse event, non-fatal|24|||
48751171|NCT00160251|156934478|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
48751172|NCT00160251|156934479|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
48645586|NCT00938912|156556041|FG000|Overall Study|Adverse event, fatal|1|||
48645587|NCT00938912|156556041|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
48645588|NCT00938912|156556041|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
48645589|NCT00938912|156556041|FG000|Overall Study|Participant needed prohibit medication|1|||
48645590|NCT00938912|156556041|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
48645591|NCT00938912|156556041|FG000|Overall Study|Did not meet Eligibility criteria|1|||
48645592|NCT00938912|156556041|FG000|Overall Study|Participant relocated not related to AE|1|||
48645593|NCT00938912|156556041|FG000|Overall Study|Participant moved to another city|1|||
48645594|NCT00938912|156556041|FG000|Overall Study|Participant experienced break through seizures|1|||
48645595|NCT00938912|156556041|FG000|Overall Study|No longer wished to participate in the study|1|||
48645596|NCT00938912|156556041|FG000|Overall Study|Protocol Deviation|2|||
48645597|NCT02078752|156556054|FG000|Overall Study|Death|0|||
48645598|NCT02078752|156556055|FG001|Overall Study|Death|3|||
48645599|NCT02078752|156556056|FG002|Overall Study|Death|0|||
48645600|NCT02078752|156556057|FG003|Overall Study|Death|0|||
48645601|NCT02078752|156556058|FG004|Overall Study|Death|0|||
48645602|NCT02078752|156556059|FG005|Overall Study|Death|1|||
48645603|NCT02078752|156556060|FG006|Overall Study|Death|0|||
48645604|NCT02078752|156556061|FG007|Overall Study|Death|1|||
48751173|NCT00160251|156934480|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
48751174|NCT00160251|156934481|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
48751175|NCT00160251|156934482|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
48751176|NCT00160251|156934475|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
48645605|NCT02078752|156556062|FG008|Overall Study|Death|0|||
48645606|NCT02078752|156556063|FG009|Overall Study|Death|4|||
48645607|NCT02078752|156556054|FG000|Overall Study|Lost to Follow-up|1|||
48645608|NCT02078752|156556055|FG001|Overall Study|Lost to Follow-up|0|||
48645609|NCT02078752|156556056|FG002|Overall Study|Lost to Follow-up|0|||
48645610|NCT02078752|156556057|FG003|Overall Study|Lost to Follow-up|1|||
48645611|NCT02078752|156556058|FG004|Overall Study|Lost to Follow-up|0|||
48645612|NCT02078752|156556059|FG005|Overall Study|Lost to Follow-up|0|||
48645613|NCT02078752|156556060|FG006|Overall Study|Lost to Follow-up|0|||
48330250|NCT03100370|155405704|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48645614|NCT02078752|156556061|FG007|Overall Study|Lost to Follow-up|0|||
48645615|NCT02078752|156556062|FG008|Overall Study|Lost to Follow-up|0|||
48645616|NCT02078752|156556063|FG009|Overall Study|Lost to Follow-up|0|||
48645617|NCT02078752|156556054|FG000|Overall Study|Withdrawal by Subject|1|||
48645618|NCT02078752|156556055|FG001|Overall Study|Withdrawal by Subject|1|||
48330251|NCT03100370|155405705|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48330252|NCT03100370|155405706|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48330253|NCT03138499|155405707|FG000|Overall Study|Lost to Follow-up|1|||
48330254|NCT03138499|155405708|FG001|Overall Study|Lost to Follow-up|0|||
48330255|NCT03138499|155405707|FG000|Overall Study|Participants withdrew consent|1|||
48330256|NCT03138499|155405708|FG001|Overall Study|Participants withdrew consent|0|||
48330257|NCT03138499|155405707|FG000|Overall Study|Participant discontinued study before treatment|0|||
48330258|NCT03138499|155405708|FG001|Overall Study|Participant discontinued study before treatment|1|||
48330259|NCT03138499|155405707|FG000|Overall Study|Disease Progression|2|||
48330260|NCT03138499|155405708|FG001|Overall Study|Disease Progression|6|||
48330261|NCT03138499|155405707|FG000|Overall Study|Study drug toxicity|2|||
48330262|NCT03138499|155405708|FG001|Overall Study|Study drug toxicity|2|||
48645619|NCT02078752|156556056|FG002|Overall Study|Withdrawal by Subject|1|||
48751177|NCT00160251|156934476|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
48751178|NCT00160251|156934477|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
48645620|NCT02078752|156556057|FG003|Overall Study|Withdrawal by Subject|1|||
48645621|NCT02078752|156556058|FG004|Overall Study|Withdrawal by Subject|0|||
48645622|NCT02078752|156556059|FG005|Overall Study|Withdrawal by Subject|3|||
48645623|NCT02078752|156556060|FG006|Overall Study|Withdrawal by Subject|2|||
48645624|NCT02078752|156556061|FG007|Overall Study|Withdrawal by Subject|1|||
48645625|NCT02078752|156556062|FG008|Overall Study|Withdrawal by Subject|0|||
48645626|NCT02078752|156556063|FG009|Overall Study|Withdrawal by Subject|1|||
48645627|NCT02078752|156556054|FG000|Overall Study|Other|0|||
48330263|NCT03138499|155405707|FG000|Overall Study|Participant request to discontinue study treatment|1|||
48645628|NCT02078752|156556055|FG001|Overall Study|Other|3|||
48751179|NCT00160251|156934478|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
48645629|NCT02078752|156556056|FG002|Overall Study|Other|0|||
48645630|NCT02078752|156556057|FG003|Overall Study|Other|0|||
48645631|NCT02078752|156556058|FG004|Overall Study|Other|1|||
48645632|NCT02078752|156556059|FG005|Overall Study|Other|0|||
48645633|NCT02078752|156556060|FG006|Overall Study|Other|0|||
48645634|NCT02078752|156556061|FG007|Overall Study|Other|1|||
48645635|NCT02078752|156556062|FG008|Overall Study|Other|0|||
48645636|NCT02078752|156556063|FG009|Overall Study|Other|0|||
48645637|NCT02078752|156556054|FG000|Overall Study|Study terminated by sponsor|0|||
48645638|NCT02078752|156556055|FG001|Overall Study|Study terminated by sponsor|0|||
48645639|NCT02078752|156556056|FG002|Overall Study|Study terminated by sponsor|0|||
48645640|NCT02078752|156556057|FG003|Overall Study|Study terminated by sponsor|0|||
48645641|NCT02078752|156556058|FG004|Overall Study|Study terminated by sponsor|0|||
48645642|NCT02078752|156556059|FG005|Overall Study|Study terminated by sponsor|0|||
48645643|NCT02078752|156556060|FG006|Overall Study|Study terminated by sponsor|0|||
48645644|NCT02078752|156556061|FG007|Overall Study|Study terminated by sponsor|0|||
48645645|NCT02078752|156556062|FG008|Overall Study|Study terminated by sponsor|0|||
48645646|NCT02078752|156556063|FG009|Overall Study|Study terminated by sponsor|5|||
48645647|NCT01408277|156556064|FG000|Overall Study|Adverse Event|3|||
48645648|NCT01408277|156556065|FG001|Overall Study|Adverse Event|4|||
48645649|NCT01408277|156556064|FG000|Overall Study|Lost to Follow-up|1|||
48645650|NCT01408277|156556065|FG001|Overall Study|Lost to Follow-up|0|||
48645651|NCT01408277|156556064|FG000|Overall Study|Withdrawal by Subject|2|||
48645652|NCT01408277|156556065|FG001|Overall Study|Withdrawal by Subject|0|||
48645653|NCT01408277|156556064|FG000|Overall Study|Protocol Violation|2|||
48645654|NCT01408277|156556065|FG001|Overall Study|Protocol Violation|0|||
48645655|NCT01582009|156556066|FG000|Overall Study|Withdrawal by Subject|1|||
48645656|NCT01582009|156556066|FG000|Overall Study|Physician Decision|1|||
48645657|NCT03432494|156556068|FG000|Overall Study|Death|1|||
48645658|NCT03432494|156556068|FG000|Overall Study|Noncompliance|1|||
48645659|NCT03604497|156556069|FG000|Overall Study|Protocol Violation|52|||
48645660|NCT01696773|156556074|FG000|Days 15-27, Washout|Adverse Event|1|||
48645661|NCT01696773|156556075|FG001|Days 15-27, Washout|Adverse Event|0|||
48645662|NCT00833469|156556078|FG000|Overall Study|Withdrawal by Subject|1|||
48645663|NCT00833469|156556078|FG000|Overall Study|Lost to Follow-up|1|||
48645664|NCT01665911|156556079|FG000|Overall Study|Protocol Violation|4|||
48645665|NCT01665911|156556079|FG000|Overall Study|Withdrawal by Subject|1|||
48645666|NCT01665911|156556079|FG000|Overall Study|Adverse Event|1|||
48645667|NCT02370368|156556080|FG000|Overall Study|Adverse Event|1|||
48645668|NCT02370368|156556081|FG001|Overall Study|Adverse Event|2|||
48645669|NCT02370368|156556080|FG000|Overall Study|Withdrawal by Subject|5|||
48645670|NCT02370368|156556081|FG001|Overall Study|Withdrawal by Subject|4|||
48645671|NCT00735553|156556084|FG000|Overall Study|Study prematurely terminated|77|||
48645672|NCT02776683|156556085|FG000|Pre-switch Period|Protocol Violation|1|||
48645673|NCT02776683|156556086|FG001|Pre-switch Period|Protocol Violation|0|||
48645674|NCT02776683|156556085|FG000|Pre-switch Period|Adverse Event|21|||
48645675|NCT02776683|156556086|FG001|Pre-switch Period|Adverse Event|0|||
48645676|NCT02776683|156556085|FG000|Pre-switch Period|Withdrawal by Subject|9|||
48645677|NCT02776683|156556086|FG001|Pre-switch Period|Withdrawal by Subject|0|||
48645678|NCT02776683|156556085|FG000|Pre-switch Period|Physician Decision|7|||
48645679|NCT02776683|156556086|FG001|Pre-switch Period|Physician Decision|0|||
48645680|NCT02776683|156556085|FG000|Pre-switch Period|Progressive disease|39|||
48645681|NCT02776683|156556086|FG001|Pre-switch Period|Progressive disease|0|||
48751180|NCT00160251|156934479|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
48751181|NCT00160251|156934480|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
48751182|NCT00160251|156934481|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
48751183|NCT00160251|156934482|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
48751184|NCT00160251|156934475|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
48751185|NCT00160251|156934476|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
48751186|NCT00160251|156934477|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
48645682|NCT02776683|156556085|FG000|Pre-switch Period|Other than listed|3|||
48645683|NCT02776683|156556086|FG001|Pre-switch Period|Other than listed|0|||
48751187|NCT00160251|156934478|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
48751188|NCT00160251|156934479|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
48751189|NCT00160251|156934480|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
48645684|NCT02776683|156556085|FG000|Post-switch Period|Adverse Event|0|||
48645685|NCT02776683|156556086|FG001|Post-switch Period|Adverse Event|3|||
48645686|NCT02776683|156556085|FG000|Post-switch Period|Withdrawal by Subject|0|||
48645687|NCT02776683|156556086|FG001|Post-switch Period|Withdrawal by Subject|2|||
48645688|NCT02776683|156556085|FG000|Post-switch Period|Physician Decision|0|||
48645689|NCT02776683|156556086|FG001|Post-switch Period|Physician Decision|3|||
48751190|NCT00160251|156934481|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
48751191|NCT00160251|156934482|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
48645690|NCT02776683|156556085|FG000|Post-switch Period|Progressive disease|0|||
48645691|NCT02776683|156556086|FG001|Post-switch Period|Progressive disease|20|||
48645692|NCT02776683|156556085|FG000|Post-switch Period|Other than listed|0|||
48645693|NCT02776683|156556086|FG001|Post-switch Period|Other than listed|15|||
48645694|NCT00175916|156556087|FG000|Overall Study|Death|19|||
48645695|NCT00175916|156556087|FG000|Overall Study|Adverse Event|81|||
48645696|NCT00175916|156556087|FG000|Overall Study|Lack of Efficacy|354|||
48645697|NCT00175916|156556087|FG000|Overall Study|Lost to Follow-up|17|||
48645698|NCT00175916|156556087|FG000|Overall Study|Subject Choice|98|||
48645699|NCT00175916|156556087|FG000|Overall Study|Lack of compliance|8|||
48645700|NCT00175916|156556087|FG000|Overall Study|Patient cannot record seizures|1|||
48645701|NCT00175916|156556087|FG000|Overall Study|Sponsor decision|17|||
48645702|NCT00175916|156556087|FG000|Overall Study|Vigabatrin intake|1|||
48645703|NCT00175916|156556087|FG000|Overall Study|Suicidal behaviour|1|||
48751192|NCT00160251|156934475|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
48751193|NCT00160251|156934476|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
48751194|NCT00160251|156934477|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
48645704|NCT00175916|156556087|FG000|Overall Study|Withdrawal by Subject|1|||
48645705|NCT00175916|156556087|FG000|Overall Study|Seizure - free|4|||
48645706|NCT00175916|156556087|FG000|Overall Study|Administrative reason|1|||
48645707|NCT00175916|156556087|FG000|Overall Study|Pregnancy|1|||
48645708|NCT00175916|156556087|FG000|Overall Study|Patient's request|2|||
48645709|NCT00175916|156556087|FG000|Overall Study|Treating physiciant's choice|1|||
48645710|NCT00175916|156556087|FG000|Overall Study|Moved overseas|1|||
48645711|NCT00175916|156556087|FG000|Overall Study|Loss of job and economic burden|1|||
48645712|NCT00175916|156556087|FG000|Overall Study|Site was closed|9|||
48645713|NCT00175916|156556087|FG000|Overall Study|Patient went to prison|1|||
48645714|NCT01484496|156556090|FG000|Period 1|Protocol Violation|3|||
48645715|NCT01484496|156556091|FG001|Period 1|Protocol Violation|4|||
48645716|NCT01484496|156556092|FG002|Period 1|Protocol Violation|0|||
48751195|NCT00160251|156934478|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
48751196|NCT00160251|156934479|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
48751197|NCT00160251|156934480|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
48751198|NCT00160251|156934481|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
48751199|NCT00160251|156934482|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
48645717|NCT01484496|156556093|FG003|Period 1|Protocol Violation|0|||
48645718|NCT01484496|156556090|FG000|Period 1|Physician Decision|5|||
48645719|NCT01484496|156556091|FG001|Period 1|Physician Decision|1|||
48645720|NCT01484496|156556092|FG002|Period 1|Physician Decision|0|||
48645721|NCT01484496|156556093|FG003|Period 1|Physician Decision|0|||
48645722|NCT01484496|156556090|FG000|Period 1|Lack of Efficacy|10|||
48645723|NCT01484496|156556091|FG001|Period 1|Lack of Efficacy|15|||
48645724|NCT01484496|156556092|FG002|Period 1|Lack of Efficacy|0|||
48645725|NCT01484496|156556093|FG003|Period 1|Lack of Efficacy|0|||
48645726|NCT01484496|156556090|FG000|Period 1|Adverse Event|25|||
48645727|NCT01484496|156556091|FG001|Period 1|Adverse Event|40|||
48645728|NCT01484496|156556092|FG002|Period 1|Adverse Event|0|||
48645729|NCT01484496|156556093|FG003|Period 1|Adverse Event|0|||
48645730|NCT01484496|156556090|FG000|Period 1|Withdrawal by Subject|15|||
48645731|NCT01484496|156556091|FG001|Period 1|Withdrawal by Subject|12|||
48645732|NCT01484496|156556092|FG002|Period 1|Withdrawal by Subject|0|||
48645733|NCT01484496|156556093|FG003|Period 1|Withdrawal by Subject|0|||
48645734|NCT01484496|156556090|FG000|Period 1|Lost to Follow-up|2|||
48645735|NCT01484496|156556091|FG001|Period 1|Lost to Follow-up|6|||
48645736|NCT01484496|156556092|FG002|Period 1|Lost to Follow-up|0|||
48645737|NCT01484496|156556093|FG003|Period 1|Lost to Follow-up|0|||
48645738|NCT01484496|156556090|FG000|Period 1|Positive Pregnancy|1|||
48645739|NCT01484496|156556091|FG001|Period 1|Positive Pregnancy|6|||
48645740|NCT01484496|156556092|FG002|Period 1|Positive Pregnancy|0|||
48645741|NCT01484496|156556093|FG003|Period 1|Positive Pregnancy|0|||
48645742|NCT01484496|156556090|FG000|Period 1|Treatment Failure|3|||
48645743|NCT01484496|156556091|FG001|Period 1|Treatment Failure|6|||
48645744|NCT01484496|156556092|FG002|Period 1|Treatment Failure|0|||
48645745|NCT01484496|156556093|FG003|Period 1|Treatment Failure|0|||
48645746|NCT01484496|156556090|FG000|Period 1|Lack of Compliance|2|||
48645747|NCT01484496|156556091|FG001|Period 1|Lack of Compliance|1|||
48751200|NCT00160251|156934475|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
48751201|NCT00160251|156934476|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
48751202|NCT00160251|156934477|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
48751203|NCT00160251|156934478|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
48751204|NCT00160251|156934479|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
48751205|NCT00160251|156934480|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
48751206|NCT00160251|156934481|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
48751207|NCT00160251|156934482|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
48751208|NCT00160251|156934475|FG000|Post-amendment 2|Adverse Event|0|||
48751209|NCT00160251|156934476|FG001|Post-amendment 2|Adverse Event|0|||
48751210|NCT00160251|156934477|FG002|Post-amendment 2|Adverse Event|0|||
48751211|NCT00160251|156934478|FG003|Post-amendment 2|Adverse Event|0|||
48645748|NCT01484496|156556092|FG002|Period 1|Lack of Compliance|0|||
48645749|NCT01484496|156556093|FG003|Period 1|Lack of Compliance|0|||
48645750|NCT01484496|156556090|FG000|Period 1|Unable to Visit Site|0|||
48645751|NCT01484496|156556091|FG001|Period 1|Unable to Visit Site|2|||
48645752|NCT01484496|156556092|FG002|Period 1|Unable to Visit Site|0|||
48645753|NCT01484496|156556093|FG003|Period 1|Unable to Visit Site|0|||
48645754|NCT01484496|156556090|FG000|Period 2|Lack of Efficacy|0|||
48645755|NCT01484496|156556091|FG001|Period 2|Lack of Efficacy|0|||
48645756|NCT01484496|156556092|FG002|Period 2|Lack of Efficacy|1|||
48645757|NCT01484496|156556093|FG003|Period 2|Lack of Efficacy|3|||
48645758|NCT01484496|156556090|FG000|Period 2|Adverse Event|0|||
48645759|NCT01484496|156556091|FG001|Period 2|Adverse Event|0|||
48645760|NCT01484496|156556092|FG002|Period 2|Adverse Event|5|||
48751212|NCT00160251|156934479|FG004|Post-amendment 2|Adverse Event|0|||
48751213|NCT00160251|156934480|FG005|Post-amendment 2|Adverse Event|0|||
48330264|NCT03138499|155405708|FG001|Overall Study|Participant request to discontinue study treatment|1|||
48330265|NCT03138499|155405707|FG000|Overall Study|Other reasons|2|||
48330266|NCT03138499|155405708|FG001|Overall Study|Other reasons|0|||
48330267|NCT02442622|155405711|FG000|Overall Study|Withdrawal by Subject|3|||
48645761|NCT01484496|156556093|FG003|Period 2|Adverse Event|13|||
48645762|NCT01484496|156556090|FG000|Period 2|Other|0|||
48645763|NCT01484496|156556091|FG001|Period 2|Other|0|||
48645764|NCT01484496|156556092|FG002|Period 2|Other|9|||
48645765|NCT01484496|156556093|FG003|Period 2|Other|6|||
48645766|NCT04703192|156556094|FG000|Overall Study|Withdrawal by Subject|2|||
48645767|NCT04703192|156556095|FG001|Overall Study|Withdrawal by Subject|0|||
48645768|NCT04703192|156556094|FG000|Overall Study|Death|3|||
48645769|NCT04703192|156556095|FG001|Overall Study|Death|1|||
48645770|NCT04703192|156556094|FG000|Overall Study|Adverse Event|13|||
48645771|NCT04703192|156556095|FG001|Overall Study|Adverse Event|2|||
48645772|NCT04703192|156556094|FG000|Overall Study|Progressive or Relapsed Disease|46|||
48645773|NCT04703192|156556095|FG001|Overall Study|Progressive or Relapsed Disease|7|||
48645774|NCT04703192|156556094|FG000|Overall Study|Clinical Progression|19|||
48645775|NCT04703192|156556095|FG001|Overall Study|Clinical Progression|8|||
48645776|NCT04703192|156556094|FG000|Overall Study|Lost to Follow-up|1|||
48645777|NCT04703192|156556095|FG001|Overall Study|Lost to Follow-up|0|||
48645778|NCT04703192|156556094|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
48645779|NCT04703192|156556095|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
48645780|NCT04703192|156556094|FG000|Overall Study|Other|5|||
48645781|NCT04703192|156556095|FG001|Overall Study|Other|1|||
48645782|NCT03462758|156556098|FG000|Overall Study|Chose no or other method of contraception|20|||
48645783|NCT03462758|156556099|FG001|Overall Study|Chose no or other method of contraception|23|||
48645784|NCT03462758|156556098|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
48645785|NCT03462758|156556099|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
48645786|NCT03462758|156556098|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
48645787|NCT03462758|156556099|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
48645788|NCT03462758|156556098|FG000|Overall Study|Medical contraindication|2|||
48645789|NCT03462758|156556099|FG001|Overall Study|Medical contraindication|2|||
48645790|NCT03462758|156556098|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
48645791|NCT03462758|156556099|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
48645792|NCT00400517|156556103|FG000|Overall Study|Withdrawal by Subject|1|||
48645793|NCT00400517|156556103|FG000|Overall Study|Physician Decision|1|||
48645794|NCT02141672|156556107|FG000|Overall Study|Adverse Event|0|||
48645795|NCT02141672|156556108|FG001|Overall Study|Adverse Event|1|||
48645796|NCT02141672|156556109|FG002|Overall Study|Adverse Event|0|||
48645797|NCT02141672|156556107|FG000|Overall Study|Death|10|||
48645798|NCT02141672|156556108|FG001|Overall Study|Death|2|||
48645799|NCT02141672|156556109|FG002|Overall Study|Death|1|||
48645800|NCT02141672|156556107|FG000|Overall Study|Lack of Efficacy|0|||
48645801|NCT02141672|156556108|FG001|Overall Study|Lack of Efficacy|0|||
48645802|NCT02141672|156556109|FG002|Overall Study|Lack of Efficacy|2|||
48645803|NCT02141672|156556107|FG000|Overall Study|Lost to Follow-up|1|||
48645804|NCT02141672|156556108|FG001|Overall Study|Lost to Follow-up|1|||
48645805|NCT02141672|156556109|FG002|Overall Study|Lost to Follow-up|3|||
48645806|NCT02141672|156556107|FG000|Overall Study|Physician Decision|1|||
48645807|NCT02141672|156556108|FG001|Overall Study|Physician Decision|2|||
48645808|NCT02141672|156556109|FG002|Overall Study|Physician Decision|5|||
48645809|NCT02141672|156556107|FG000|Overall Study|Protocol Violation|0|||
48645810|NCT02141672|156556108|FG001|Overall Study|Protocol Violation|0|||
48645811|NCT02141672|156556109|FG002|Overall Study|Protocol Violation|1|||
48645812|NCT02141672|156556107|FG000|Overall Study|Withdrawal by Subject|3|||
48645813|NCT02141672|156556108|FG001|Overall Study|Withdrawal by Subject|2|||
48645814|NCT02141672|156556109|FG002|Overall Study|Withdrawal by Subject|5|||
48645815|NCT02141672|156556107|FG000|Overall Study|refused to follow-up|1|||
48645816|NCT02141672|156556108|FG001|Overall Study|refused to follow-up|0|||
48645817|NCT02141672|156556109|FG002|Overall Study|refused to follow-up|1|||
48645818|NCT02688192|156556110|FG000|Overall Study|Lost to Follow-up|11|||
48645819|NCT02688192|156556111|FG001|Overall Study|Lost to Follow-up|5|||
48645820|NCT02688192|156556110|FG000|Overall Study|Physician Decision|1|||
48645821|NCT02688192|156556111|FG001|Overall Study|Physician Decision|0|||
48645822|NCT00211172|156556112|FG000|Overall Study|Died or lost health plan eligibility|39|||
48645823|NCT00211172|156556113|FG001|Overall Study|Died or lost health plan eligibility|32|||
48645824|NCT01194219|156556116|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
48645825|NCT01194219|156556117|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
48645826|NCT01194219|156556118|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
48645827|NCT01194219|156556119|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
48645828|NCT01194219|156556120|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
48645829|NCT01194219|156556121|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
48645830|NCT01194219|156556122|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
48645831|NCT01194219|156556123|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
48751214|NCT00160251|156934481|FG006|Post-amendment 2|Adverse Event|0|||
48751215|NCT00160251|156934482|FG007|Post-amendment 2|Adverse Event|20|||
48751216|NCT00160251|156934475|FG000|Post-amendment 2|Lack of Efficacy|0|||
48751217|NCT00160251|156934476|FG001|Post-amendment 2|Lack of Efficacy|0|||
48751218|NCT00160251|156934477|FG002|Post-amendment 2|Lack of Efficacy|0|||
48751219|NCT00160251|156934478|FG003|Post-amendment 2|Lack of Efficacy|0|||
48645832|NCT01194219|156556124|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
48645833|NCT01194219|156556125|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
48751220|NCT00160251|156934479|FG004|Post-amendment 2|Lack of Efficacy|0|||
48751221|NCT00160251|156934480|FG005|Post-amendment 2|Lack of Efficacy|0|||
48751222|NCT00160251|156934481|FG006|Post-amendment 2|Lack of Efficacy|0|||
48751223|NCT00160251|156934482|FG007|Post-amendment 2|Lack of Efficacy|24|||
48751224|NCT00160251|156934475|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751225|NCT00160251|156934476|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751226|NCT00160251|156934477|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751227|NCT00160251|156934478|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751228|NCT00160251|156934479|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751229|NCT00160251|156934480|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751230|NCT00160251|156934481|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
48751231|NCT00160251|156934482|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
48751232|NCT01025752|156934485|FG000|Overall Study|Lost to Follow-up|7|||
48751233|NCT01025752|156934486|FG001|Overall Study|Lost to Follow-up|10|||
48751234|NCT01025752|156934485|FG000|Overall Study|Physician Decision|1|||
48751235|NCT01025752|156934486|FG001|Overall Study|Physician Decision|3|||
48751236|NCT02407704|156934487|FG000|Overall Study|Lost to Follow-up|0|||
48751237|NCT02407704|156934488|FG001|Overall Study|Lost to Follow-up|0|||
48751238|NCT02407704|156934489|FG002|Overall Study|Lost to Follow-up|0|||
48645834|NCT01194219|156556116|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
48645835|NCT01194219|156556117|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
48645836|NCT01194219|156556118|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
48645837|NCT01194219|156556119|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
48645838|NCT01194219|156556120|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
48645839|NCT01194219|156556121|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
48751239|NCT02407704|156934490|FG003|Overall Study|Lost to Follow-up|2|||
48751240|NCT02407704|156934487|FG000|Overall Study|Protocol Violation|0|||
48645840|NCT01194219|156556122|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
48645841|NCT01194219|156556123|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
48645842|NCT01194219|156556124|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
48645843|NCT01194219|156556125|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
48645844|NCT01194219|156556116|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
48645845|NCT01194219|156556117|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48645846|NCT01194219|156556118|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48645847|NCT01194219|156556119|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48645848|NCT01194219|156556120|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48751241|NCT02407704|156934488|FG001|Overall Study|Protocol Violation|0|||
48751242|NCT02407704|156934489|FG002|Overall Study|Protocol Violation|0|||
48751243|NCT02407704|156934490|FG003|Overall Study|Protocol Violation|1|||
48751244|NCT02407704|156934487|FG000|Overall Study|Withdrawal by Subject|0|||
48751245|NCT02407704|156934488|FG001|Overall Study|Withdrawal by Subject|0|||
48751246|NCT02407704|156934489|FG002|Overall Study|Withdrawal by Subject|1|||
48751247|NCT02407704|156934490|FG003|Overall Study|Withdrawal by Subject|0|||
48751248|NCT03310021|156934494|FG000|Overall Study|Withdrawal by Subject|0|||
48751249|NCT03310021|156934495|FG001|Overall Study|Withdrawal by Subject|0|||
48751250|NCT03310021|156934496|FG002|Overall Study|Withdrawal by Subject|0|||
48645849|NCT01194219|156556121|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48330268|NCT02442622|155405712|FG001|Overall Study|Withdrawal by Subject|1|||
48330269|NCT05184062|155405713|FG000|Overall Study|Lost to Follow-up|5|||
48330270|NCT05184062|155405714|FG001|Overall Study|Lost to Follow-up|1|||
48330271|NCT05184062|155405713|FG000|Overall Study|Withdrawal by Subject|1|||
48330272|NCT05184062|155405714|FG001|Overall Study|Withdrawal by Subject|0|||
48330273|NCT04984889|155405715|FG000|Extension Part|Ongoing|5|||
48645850|NCT01194219|156556122|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48645851|NCT01194219|156556123|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48645852|NCT01194219|156556124|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48330274|NCT04097535|155405716|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
48330275|NCT03905642|155405717|FG000|Overall Study|Withdrawal by Subject|3|||
48330276|NCT03905642|155405717|FG000|Overall Study|Pregnancy|1|||
48330277|NCT03905642|155405717|FG000|Overall Study|Adverse Event|1|||
48330278|NCT03905642|155405717|FG000|Overall Study|Lack of Efficacy|1|||
48330279|NCT03905642|155405717|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
48330280|NCT04658784|155407400|FG000|6-month Follow-up|Lost to Follow-up|2|||
48330281|NCT04658784|155407401|FG001|6-month Follow-up|Lost to Follow-up|5|||
48330282|NCT03392194|155407402|FG000|Overall Study|Withdrawal by Subject|1|||
48330283|NCT03392194|155407403|FG001|Overall Study|Withdrawal by Subject|2|||
48330284|NCT03392194|155407402|FG000|Overall Study|Conflicts with personal schedule|1|||
48330285|NCT03392194|155407403|FG001|Overall Study|Conflicts with personal schedule|0|||
48645853|NCT01194219|156556125|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
48645854|NCT01194219|156556116|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
48645855|NCT01194219|156556117|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
48645856|NCT01194219|156556118|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48645857|NCT01194219|156556119|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48645858|NCT01194219|156556120|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48645859|NCT01194219|156556121|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48645860|NCT01194219|156556122|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48645861|NCT01194219|156556123|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48645862|NCT01194219|156556124|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48645863|NCT01194219|156556125|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
48645864|NCT01194219|156556116|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48645865|NCT01194219|156556117|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
48751251|NCT03310021|156934497|FG003|Overall Study|Withdrawal by Subject|0|||
48330286|NCT03865732|155407404|FG000|Overall Study|Adverse Event|0|||
48330287|NCT03865732|155407405|FG001|Overall Study|Adverse Event|1|||
48330288|NCT00308308|155407406|FG000|Overall Study|Adverse Event|17|||
48330289|NCT00308308|155407407|FG001|Overall Study|Adverse Event|2|||
48645866|NCT01194219|156556118|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48645867|NCT01194219|156556119|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48645868|NCT01194219|156556120|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48645869|NCT01194219|156556121|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48645870|NCT01194219|156556122|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48645871|NCT01194219|156556123|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48751252|NCT03310021|156934498|FG004|Overall Study|Withdrawal by Subject|0|||
48330290|NCT00308308|155407406|FG000|Overall Study|Lost to Follow-up|5|||
48330291|NCT00308308|155407407|FG001|Overall Study|Lost to Follow-up|5|||
48330292|NCT00308308|155407406|FG000|Overall Study|Physician Decision|15|||
48330293|NCT00308308|155407407|FG001|Overall Study|Physician Decision|7|||
48330294|NCT00308308|155407406|FG000|Overall Study|Protocol Violation|3|||
48330295|NCT00308308|155407407|FG001|Overall Study|Protocol Violation|14|||
48330296|NCT00308308|155407406|FG000|Overall Study|Withdrawal by Subject|47|||
48330297|NCT00308308|155407407|FG001|Overall Study|Withdrawal by Subject|19|||
48330298|NCT00308308|155407406|FG000|Overall Study|Various|7|||
48330299|NCT00308308|155407407|FG001|Overall Study|Various|5|||
48645872|NCT01194219|156556124|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48645873|NCT01194219|156556125|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
48645874|NCT01194219|156556116|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
48645875|NCT01194219|156556117|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
48645876|NCT01194219|156556118|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
48645877|NCT01194219|156556119|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
48645878|NCT01194219|156556120|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
48645879|NCT01194219|156556121|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
48645880|NCT01194219|156556122|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
48645881|NCT01194219|156556123|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
48645882|NCT01194219|156556124|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
48645883|NCT01194219|156556125|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
48645884|NCT01194219|156556116|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
48645885|NCT01194219|156556117|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
48751253|NCT03310021|156934499|FG005|Overall Study|Withdrawal by Subject|0|||
48751254|NCT03310021|156934500|FG006|Overall Study|Withdrawal by Subject|1|||
48751255|NCT03310021|156934501|FG007|Overall Study|Withdrawal by Subject|0|||
48751256|NCT03310021|156934502|FG008|Overall Study|Withdrawal by Subject|0|||
48751257|NCT03310021|156934503|FG009|Overall Study|Withdrawal by Subject|0|||
48751258|NCT03310021|156934504|FG010|Overall Study|Withdrawal by Subject|0|||
48751259|NCT03310021|156934505|FG011|Overall Study|Withdrawal by Subject|0|||
48751260|NCT03310021|156934506|FG012|Overall Study|Withdrawal by Subject|0|||
48751261|NCT03310021|156934507|FG013|Overall Study|Withdrawal by Subject|0|||
48751262|NCT03310021|156934508|FG014|Overall Study|Withdrawal by Subject|0|||
48751263|NCT03310021|156934509|FG015|Overall Study|Withdrawal by Subject|0|||
48751264|NCT03310021|156934510|FG016|Overall Study|Withdrawal by Subject|0|||
48751265|NCT03310021|156934511|FG017|Overall Study|Withdrawal by Subject|0|||
48751266|NCT03310021|156934512|FG018|Overall Study|Withdrawal by Subject|0|||
48751267|NCT03310021|156934513|FG019|Overall Study|Withdrawal by Subject|0|||
48751268|NCT03310021|156934494|FG000|Overall Study|Lost to Follow-up|0|||
48751269|NCT03310021|156934495|FG001|Overall Study|Lost to Follow-up|0|||
48751270|NCT03310021|156934496|FG002|Overall Study|Lost to Follow-up|0|||
48751271|NCT03310021|156934497|FG003|Overall Study|Lost to Follow-up|0|||
48751272|NCT03310021|156934498|FG004|Overall Study|Lost to Follow-up|0|||
48751273|NCT03310021|156934499|FG005|Overall Study|Lost to Follow-up|0|||
48751274|NCT03310021|156934500|FG006|Overall Study|Lost to Follow-up|0|||
48751275|NCT03310021|156934501|FG007|Overall Study|Lost to Follow-up|0|||
48751276|NCT03310021|156934502|FG008|Overall Study|Lost to Follow-up|0|||
48751277|NCT03310021|156934503|FG009|Overall Study|Lost to Follow-up|0|||
48751278|NCT03310021|156934504|FG010|Overall Study|Lost to Follow-up|1|||
48751279|NCT03310021|156934505|FG011|Overall Study|Lost to Follow-up|0|||
48751280|NCT03310021|156934506|FG012|Overall Study|Lost to Follow-up|0|||
48751281|NCT03310021|156934507|FG013|Overall Study|Lost to Follow-up|0|||
48751282|NCT03310021|156934508|FG014|Overall Study|Lost to Follow-up|0|||
48751283|NCT03310021|156934509|FG015|Overall Study|Lost to Follow-up|0|||
48751284|NCT03310021|156934510|FG016|Overall Study|Lost to Follow-up|0|||
48751285|NCT03310021|156934511|FG017|Overall Study|Lost to Follow-up|0|||
48751286|NCT03310021|156934512|FG018|Overall Study|Lost to Follow-up|0|||
48751287|NCT03310021|156934513|FG019|Overall Study|Lost to Follow-up|0|||
48330300|NCT00308308|155407406|FG000|Overall Study|Randomized but not dosed|8|||
48330301|NCT00308308|155407407|FG001|Overall Study|Randomized but not dosed|16|||
48330302|NCT00308308|155407406|FG000|Overall Study|Other|1|||
48330303|NCT00308308|155407407|FG001|Overall Study|Other|0|||
48330304|NCT01686152|155407408|FG000|Overall Study|Withdrawal by Subject|11|||
48751288|NCT03198234|156934521|FG000|Overall Study|Relapse of primary disease|0|||
48645886|NCT01194219|156556118|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
48645887|NCT01194219|156556119|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
48645888|NCT01194219|156556120|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
48645889|NCT01194219|156556121|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
48645890|NCT01194219|156556122|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
48645891|NCT01194219|156556123|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
48645892|NCT01194219|156556124|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
48645893|NCT01194219|156556125|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
48645894|NCT01194219|156556116|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
48645895|NCT01194219|156556117|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
48645896|NCT01194219|156556118|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
48645897|NCT01194219|156556119|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
48645898|NCT01194219|156556120|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
48645899|NCT01194219|156556121|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
48645900|NCT01194219|156556122|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
48645901|NCT01194219|156556123|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
48645902|NCT01194219|156556124|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
48427380|NCT01544595|155752943|FG005|Status at Week 156|Pregnancy|0|||
48645903|NCT01194219|156556125|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
48645904|NCT01194219|156556116|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
48645905|NCT01194219|156556117|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
48645906|NCT01194219|156556118|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
48645907|NCT01194219|156556119|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
48645908|NCT01194219|156556120|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
48645909|NCT01194219|156556121|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
48645910|NCT01194219|156556122|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
48645911|NCT01194219|156556123|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
48645912|NCT01194219|156556124|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
48645913|NCT01194219|156556125|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
48645914|NCT01194219|156556116|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
48645915|NCT01194219|156556117|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
48645916|NCT01194219|156556118|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
48645917|NCT01194219|156556119|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
48645918|NCT01194219|156556120|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
48645919|NCT01194219|156556121|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
48645920|NCT01194219|156556122|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
48645921|NCT01194219|156556123|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
48645922|NCT01194219|156556124|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
48645923|NCT01194219|156556125|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
48645924|NCT01194219|156556116|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
48645925|NCT01194219|156556117|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
48645926|NCT01194219|156556118|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
48645927|NCT01194219|156556119|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
48751289|NCT03198234|156934522|FG001|Overall Study|Relapse of primary disease|1|||
48751290|NCT03198234|156934523|FG002|Overall Study|Relapse of primary disease|0|||
48751291|NCT01648205|156934528|FG000|Placebo|Pregnancy|1|||
48645928|NCT01194219|156556120|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
48645929|NCT01194219|156556121|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
48645930|NCT01194219|156556122|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
48751292|NCT01648205|156934528|FG000|Placebo|Withdrawal by Subject|1|||
48751293|NCT01648205|156934528|FG000|Placebo|Protocol Violation|2|||
48751294|NCT01648205|156934528|FG000|Ranolazine|Death|1|||
48751295|NCT01648205|156934528|FG000|Ranolazine|Withdrawal by Subject|1|||
48751296|NCT01648205|156934528|FG000|Ranolazine|Protocol Violation|3|||
48751297|NCT02622321|156934529|FG000|Overall Study|Withdrawal by Subject|2|||
48330305|NCT01686152|155407409|FG001|Overall Study|Withdrawal by Subject|11|||
48330306|NCT01686152|155407410|FG002|Overall Study|Withdrawal by Subject|3|||
48330307|NCT01686152|155407408|FG000|Overall Study|Drug Code Unblinded|0|||
48330308|NCT01686152|155407409|FG001|Overall Study|Drug Code Unblinded|1|||
48330309|NCT01686152|155407410|FG002|Overall Study|Drug Code Unblinded|0|||
48330310|NCT01686152|155407408|FG000|Overall Study|Protocol Violation|6|||
48330311|NCT01686152|155407409|FG001|Overall Study|Protocol Violation|1|||
48330312|NCT01686152|155407410|FG002|Overall Study|Protocol Violation|0|||
48330313|NCT01686152|155407408|FG000|Overall Study|Adverse Event|12|||
48330314|NCT01686152|155407409|FG001|Overall Study|Adverse Event|11|||
48330315|NCT01686152|155407410|FG002|Overall Study|Adverse Event|0|||
48330316|NCT01686152|155407408|FG000|Overall Study|Lack of Efficacy|0|||
48330317|NCT01686152|155407409|FG001|Overall Study|Lack of Efficacy|0|||
48330318|NCT01686152|155407410|FG002|Overall Study|Lack of Efficacy|1|||
48330319|NCT01686152|155407408|FG000|Overall Study|IP Non-compliance|5|||
48330320|NCT01686152|155407409|FG001|Overall Study|IP Non-compliance|5|||
48330321|NCT01686152|155407410|FG002|Overall Study|IP Non-compliance|0|||
48330322|NCT01686152|155407408|FG000|Overall Study|Lost to Follow-up|7|||
48330323|NCT01686152|155407409|FG001|Overall Study|Lost to Follow-up|6|||
48330324|NCT01686152|155407410|FG002|Overall Study|Lost to Follow-up|5|||
48330325|NCT01853384|155407417|FG000|Randomized|Adverse Event|5|||
48330326|NCT01853384|155407418|FG001|Randomized|Adverse Event|3|||
48330327|NCT01853384|155407417|FG000|Randomized|Death|1|||
48645931|NCT01194219|156556123|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
48645932|NCT01194219|156556124|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
48645933|NCT01194219|156556125|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
48645934|NCT01194219|156556116|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48645935|NCT01194219|156556117|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48330328|NCT01853384|155407418|FG001|Randomized|Death|2|||
48751298|NCT02622321|156934530|FG001|Overall Study|Withdrawal by Subject|0|||
48751299|NCT02622321|156934531|FG002|Overall Study|Withdrawal by Subject|0|||
48330329|NCT01853384|155407417|FG000|Randomized|Lost to Follow-up|1|||
48330330|NCT01853384|155407418|FG001|Randomized|Lost to Follow-up|1|||
48330331|NCT01853384|155407417|FG000|Randomized|Withdrawal by Subject|5|||
48330332|NCT01853384|155407418|FG001|Randomized|Withdrawal by Subject|3|||
48330333|NCT01853384|155407417|FG000|Randomized|Sponsor Decision|47|||
48330334|NCT01853384|155407418|FG001|Randomized|Sponsor Decision|34|||
48645936|NCT01194219|156556118|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
48645937|NCT01194219|156556119|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
48645938|NCT01194219|156556120|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48645939|NCT01194219|156556121|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48645940|NCT01194219|156556122|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48645941|NCT01194219|156556123|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48645942|NCT01194219|156556124|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48751300|NCT02622321|156934532|FG003|Overall Study|Withdrawal by Subject|0|||
48645943|NCT01194219|156556125|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
48751301|NCT02622321|156934529|FG000|Overall Study|Death|0|||
48751302|NCT02622321|156934530|FG001|Overall Study|Death|0|||
48751303|NCT02622321|156934531|FG002|Overall Study|Death|1|||
48751304|NCT02622321|156934532|FG003|Overall Study|Death|0|||
48751305|NCT02622321|156934529|FG000|Overall Study|Physician Decision|1|||
48751306|NCT02622321|156934530|FG001|Overall Study|Physician Decision|0|||
48751307|NCT02622321|156934531|FG002|Overall Study|Physician Decision|0|||
48751308|NCT02622321|156934532|FG003|Overall Study|Physician Decision|0|||
48751309|NCT00241280|156934533|FG000|Overall Study|Adverse Event|2|||
48751310|NCT00241280|156934534|FG001|Overall Study|Adverse Event|6|||
48751311|NCT00241280|156934533|FG000|Overall Study|Discomfort|11|||
48751312|NCT00241280|156934534|FG001|Overall Study|Discomfort|16|||
48751313|NCT00241280|156934533|FG000|Overall Study|Pregnancy|1|||
48751314|NCT00241280|156934534|FG001|Overall Study|Pregnancy|5|||
48751315|NCT00241280|156934533|FG000|Overall Study|Lost to Follow-up|5|||
48751316|NCT00241280|156934534|FG001|Overall Study|Lost to Follow-up|8|||
48751317|NCT00241280|156934533|FG000|Overall Study|Withdrawal by Subject|7|||
48645944|NCT01194219|156556116|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48645945|NCT01194219|156556117|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48645946|NCT01194219|156556118|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
48645947|NCT01194219|156556119|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48751318|NCT00241280|156934534|FG001|Overall Study|Withdrawal by Subject|4|||
48751319|NCT00241280|156934533|FG000|Overall Study|Protocol Violation|4|||
48751320|NCT00241280|156934534|FG001|Overall Study|Protocol Violation|10|||
48751321|NCT00241280|156934533|FG000|Overall Study|Relocation|4|||
48751322|NCT00241280|156934534|FG001|Overall Study|Relocation|4|||
48751323|NCT00241280|156934533|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
48330335|NCT01853384|155407417|FG000|Randomized|Other|3|||
48330336|NCT01853384|155407418|FG001|Randomized|Other|3|||
48645948|NCT01194219|156556120|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48645949|NCT01194219|156556121|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48645950|NCT01194219|156556122|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48645951|NCT01194219|156556123|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48751324|NCT00241280|156934534|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
48751325|NCT00241280|156934533|FG000|Overall Study|Unsatisfactory Visual Response|1|||
48645952|NCT01194219|156556124|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48751326|NCT00241280|156934534|FG001|Overall Study|Unsatisfactory Visual Response|1|||
48751327|NCT00241280|156934533|FG000|Overall Study|Diabetic|1|||
48751328|NCT00241280|156934534|FG001|Overall Study|Diabetic|0|||
48330337|NCT01853384|155407417|FG000|Completed Follow up Visit 1|Early Termination|13|||
48645953|NCT01194219|156556125|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
48645954|NCT01194219|156556116|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48645955|NCT01194219|156556117|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48645956|NCT01194219|156556118|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48645957|NCT01194219|156556119|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
48645958|NCT01194219|156556120|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48645959|NCT01194219|156556121|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48645960|NCT01194219|156556122|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48645961|NCT01194219|156556123|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48645962|NCT01194219|156556124|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48645963|NCT01194219|156556125|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
48751329|NCT00241280|156934533|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
48330338|NCT01853384|155407418|FG001|Completed Follow up Visit 1|Early Termination|9|||
48330339|NCT01853384|155407417|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
48330340|NCT01853384|155407418|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
48330341|NCT01853384|155407417|FG000|Completed Follow up Visit 2|Adverse Event|1|||
48330342|NCT01853384|155407418|FG001|Completed Follow up Visit 2|Adverse Event|0|||
48330343|NCT01853384|155407417|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
48645964|NCT01194219|156556116|FG000|Maintenance Phase Weeks16-32|Other|0|||
48645965|NCT01194219|156556117|FG001|Maintenance Phase Weeks16-32|Other|0|||
48645966|NCT01194219|156556118|FG002|Maintenance Phase Weeks16-32|Other|2|||
48645967|NCT01194219|156556119|FG003|Maintenance Phase Weeks16-32|Other|1|||
48645968|NCT01194219|156556120|FG004|Maintenance Phase Weeks16-32|Other|0|||
48645969|NCT01194219|156556121|FG005|Maintenance Phase Weeks16-32|Other|0|||
48645970|NCT01194219|156556122|FG006|Maintenance Phase Weeks16-32|Other|0|||
48645971|NCT01194219|156556123|FG007|Maintenance Phase Weeks16-32|Other|0|||
48645972|NCT01194219|156556124|FG008|Maintenance Phase Weeks16-32|Other|0|||
48645973|NCT01194219|156556125|FG009|Maintenance Phase Weeks16-32|Other|0|||
48751330|NCT00241280|156934534|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
48751331|NCT00241280|156934533|FG000|Overall Study|Dispensed incorrect test article|1|||
48751332|NCT00241280|156934534|FG001|Overall Study|Dispensed incorrect test article|2|||
48751333|NCT00241280|156934533|FG000|Overall Study|Unacceptable Fit|0|||
48751334|NCT00241280|156934534|FG001|Overall Study|Unacceptable Fit|1|||
48751335|NCT00241280|156934533|FG000|Overall Study|Scheduling Conflict|0|||
48330344|NCT01853384|155407418|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
48330345|NCT01853384|155407417|FG000|Completed Follow up Visit 2|Death|1|||
48330346|NCT01853384|155407418|FG001|Completed Follow up Visit 2|Death|0|||
48645974|NCT01194219|156556116|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
48645975|NCT01194219|156556117|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
48645976|NCT01194219|156556118|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
48645977|NCT01194219|156556119|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
48751336|NCT00241280|156934534|FG001|Overall Study|Scheduling Conflict|2|||
48751337|NCT00241280|156934533|FG000|Overall Study|History of Ocular Surgery|0|||
48751338|NCT00241280|156934534|FG001|Overall Study|History of Ocular Surgery|1|||
48751339|NCT00241280|156934533|FG000|Overall Study|Coating on Lens|1|||
48751340|NCT00241280|156934534|FG001|Overall Study|Coating on Lens|0|||
48751341|NCT00241280|156934533|FG000|Overall Study|Excessive Dryness|0|||
48751342|NCT00241280|156934534|FG001|Overall Study|Excessive Dryness|1|||
48751343|NCT00965718|156934535|FG000|Overall Study|Withdrawal by Subject|4|||
48751344|NCT01958008|156934536|FG000|Overall Study|Worsening of disease under study|0|||
48751345|NCT01958008|156934537|FG001|Overall Study|Worsening of disease under study|0|||
48751346|NCT01958008|156934538|FG002|Overall Study|Worsening of disease under study|1|||
48751347|NCT01958008|156934539|FG003|Overall Study|Worsening of disease under study|0|||
48645978|NCT01194219|156556120|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
48751348|NCT01958008|156934536|FG000|Overall Study|Other adverse event|1|||
48645979|NCT01194219|156556121|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
48645980|NCT01194219|156556122|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
48645981|NCT01194219|156556123|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
48645982|NCT01194219|156556124|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
48645983|NCT01194219|156556125|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
48645984|NCT01194219|156556116|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
48645985|NCT01194219|156556117|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
48645986|NCT01194219|156556118|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
48645987|NCT01194219|156556119|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
48645988|NCT01194219|156556120|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
48645989|NCT01194219|156556121|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
48645990|NCT01194219|156556122|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
48645991|NCT01194219|156556123|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
48645992|NCT01194219|156556124|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
48645993|NCT01194219|156556125|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
48645994|NCT01194219|156556116|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48645995|NCT01194219|156556117|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48645996|NCT01194219|156556118|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48645997|NCT01194219|156556119|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48645998|NCT01194219|156556120|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
48645999|NCT01194219|156556121|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48646000|NCT01194219|156556122|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
48646001|NCT01194219|156556123|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48646002|NCT01194219|156556124|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48646003|NCT01194219|156556125|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
48646004|NCT01194219|156556116|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
48646005|NCT01194219|156556117|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
48646006|NCT01194219|156556118|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
48646007|NCT01194219|156556119|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
48646008|NCT01194219|156556120|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
48646009|NCT01194219|156556121|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
48646010|NCT01194219|156556122|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
48646011|NCT01194219|156556123|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
48646012|NCT01194219|156556124|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
48646013|NCT01194219|156556125|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
48646014|NCT01194219|156556116|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
48646015|NCT01194219|156556117|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
48646016|NCT01194219|156556118|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
48646017|NCT01194219|156556119|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
48646018|NCT01194219|156556120|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
48646019|NCT01194219|156556121|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
48646020|NCT01194219|156556122|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
48646021|NCT01194219|156556123|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
48646022|NCT01194219|156556124|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
48646023|NCT01194219|156556125|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
48646024|NCT01194219|156556116|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646025|NCT01194219|156556117|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646026|NCT01194219|156556118|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646027|NCT01194219|156556119|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646028|NCT01194219|156556120|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646029|NCT01194219|156556121|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646030|NCT01194219|156556122|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646031|NCT01194219|156556123|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
48646032|NCT01194219|156556124|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646033|NCT01194219|156556125|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
48646034|NCT01194219|156556116|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48646035|NCT01194219|156556117|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48646036|NCT01194219|156556118|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48646037|NCT01194219|156556119|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48646038|NCT01194219|156556120|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48751349|NCT01958008|156934537|FG001|Overall Study|Other adverse event|0|||
48751350|NCT01958008|156934538|FG002|Overall Study|Other adverse event|0|||
48751351|NCT01958008|156934539|FG003|Overall Study|Other adverse event|0|||
48751352|NCT01634360|156934541|FG000|Overall Study|Adverse Event|10|||
48646039|NCT01194219|156556121|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48646040|NCT01194219|156556122|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
48646041|NCT01194219|156556123|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48646042|NCT01194219|156556124|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48646043|NCT01194219|156556125|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
48751353|NCT01634360|156934542|FG001|Overall Study|Adverse Event|34|||
48751354|NCT01634360|156934541|FG000|Overall Study|subject withdrew consent|13|||
48751355|NCT01634360|156934542|FG001|Overall Study|subject withdrew consent|23|||
48751356|NCT01634360|156934541|FG000|Overall Study|Protocol Violation|1|||
48751357|NCT01634360|156934542|FG001|Overall Study|Protocol Violation|1|||
48751358|NCT01634360|156934541|FG000|Overall Study|Lack of Efficacy|4|||
48646044|NCT01194219|156556116|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
48646045|NCT01194219|156556117|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
48646046|NCT01194219|156556118|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
48646047|NCT01194219|156556119|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
48751359|NCT01634360|156934542|FG001|Overall Study|Lack of Efficacy|14|||
48751360|NCT01634360|156934541|FG000|Overall Study|Other|3|||
48751361|NCT01634360|156934542|FG001|Overall Study|Other|20|||
48751362|NCT01634360|156934541|FG000|Overall Study|Study termination by sponsor|18|||
48646048|NCT01194219|156556120|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
48646049|NCT01194219|156556121|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
48646050|NCT01194219|156556122|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
48646051|NCT01194219|156556123|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
48646052|NCT01194219|156556124|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
48646053|NCT01194219|156556125|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
48646054|NCT01194219|156556116|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
48751363|NCT01634360|156934542|FG001|Overall Study|Study termination by sponsor|44|||
48751364|NCT04851314|156934543|FG000|Overall Study|Unable to complete research set-up procedures|0|||
48751365|NCT04851314|156934544|FG001|Overall Study|Unable to complete research set-up procedures|2|||
48646055|NCT01194219|156556117|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
48646056|NCT01194219|156556118|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
48646057|NCT01194219|156556119|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
48646058|NCT01194219|156556120|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
48646059|NCT01194219|156556121|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
48646060|NCT01194219|156556122|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
48751366|NCT04851314|156934543|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
48751367|NCT04851314|156934544|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
48751368|NCT00646776|156934545|FG000|Overall Study|Adverse Event|1|||
48751369|NCT00646776|156934546|FG001|Overall Study|Adverse Event|9|||
48751370|NCT00646776|156934545|FG000|Overall Study|Investigator discretion|0|||
48751371|NCT00646776|156934546|FG001|Overall Study|Investigator discretion|4|||
48646061|NCT01194219|156556123|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
48646062|NCT01194219|156556124|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
48646063|NCT01194219|156556125|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
48646064|NCT01194219|156556116|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
48646065|NCT01194219|156556117|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
48646066|NCT01194219|156556118|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
48646067|NCT01194219|156556119|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
48646068|NCT01194219|156556120|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
48646069|NCT01194219|156556121|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
48646070|NCT01194219|156556122|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
48646071|NCT01194219|156556123|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
48646072|NCT01194219|156556124|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
48646073|NCT01194219|156556125|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
48646074|NCT01194219|156556116|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48646075|NCT01194219|156556117|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48646076|NCT01194219|156556118|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48751372|NCT00576927|156934550|FG000|Clinical Assessment|Lack of Efficacy|24|||
48751373|NCT00576927|156934550|FG000|Clinical Assessment|Death|1|||
48646077|NCT01194219|156556119|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48751374|NCT00576927|156934550|FG000|Clinical Assessment|Withdrawal by Subject|10|||
48751375|NCT00576927|156934550|FG000|Clinical Assessment|Physician Decision|1|||
48751376|NCT00576927|156934550|FG000|Baseline|Physician Decision|9|||
48646078|NCT01194219|156556120|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48646079|NCT01194219|156556121|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48646080|NCT01194219|156556122|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48646081|NCT01194219|156556123|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
48646082|NCT01194219|156556124|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
48646083|NCT01194219|156556125|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
48646084|NCT01194219|156556116|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
48751377|NCT00576927|156934550|FG000|Baseline|Medication Change by PCP of subject|1|||
48751378|NCT00576927|156934550|FG000|Baseline|Withdrawal by Subject|3|||
48751379|NCT00576927|156934550|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
48751380|NCT00576927|156934550|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
48751381|NCT00576927|156934550|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
48751382|NCT00576927|156934550|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
48751383|NCT00576927|156934550|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
48751384|NCT01753856|156934551|FG000|Overall Study|Adverse Event|1|||
48751385|NCT01753856|156934552|FG001|Overall Study|Adverse Event|0|||
48646085|NCT01194219|156556117|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
48646086|NCT01194219|156556118|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
48646087|NCT01194219|156556119|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
48646088|NCT01194219|156556120|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
48646089|NCT01194219|156556121|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
48646090|NCT01194219|156556122|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
48646091|NCT01194219|156556123|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
48646092|NCT01194219|156556124|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
48646093|NCT01194219|156556125|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
48646094|NCT01194219|156556116|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
48646095|NCT01194219|156556117|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
48646096|NCT01194219|156556118|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
48646097|NCT01194219|156556119|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
48646098|NCT01194219|156556120|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
48751386|NCT01753856|156934551|FG000|Overall Study|Withdrawal by Subject|0|||
48751387|NCT01753856|156934552|FG001|Overall Study|Withdrawal by Subject|2|||
48751388|NCT01753856|156934551|FG000|Overall Study|Sponsor Decision|2|||
48751389|NCT01753856|156934552|FG001|Overall Study|Sponsor Decision|0|||
48751390|NCT03171415|156934553|FG000|Overall Study|Lost to Follow-up|0|||
48751391|NCT03171415|156934554|FG001|Overall Study|Lost to Follow-up|0|||
48751392|NCT03171415|156934555|FG002|Overall Study|Lost to Follow-up|0|||
48751393|NCT03171415|156934556|FG003|Overall Study|Lost to Follow-up|0|||
48751394|NCT03171415|156934557|FG004|Overall Study|Lost to Follow-up|2|||
48751395|NCT03694821|156934558|FG000|Overall Study|Study terminated|4|||
48751396|NCT03694821|156934559|FG001|Overall Study|Study terminated|8|||
48751397|NCT03694821|156934560|FG002|Overall Study|Study terminated|4|||
48751398|NCT00897104|156934565|FG000|Overall Study|Lost to Follow-up|12|||
48751399|NCT00897104|156934566|FG001|Overall Study|Lost to Follow-up|17|||
48751400|NCT00897104|156934567|FG002|Overall Study|Lost to Follow-up|2|||
48751401|NCT00897104|156934565|FG000|Overall Study|Pregnancy|0|||
48751402|NCT00897104|156934566|FG001|Overall Study|Pregnancy|1|||
48751403|NCT00897104|156934567|FG002|Overall Study|Pregnancy|0|||
48751404|NCT00897104|156934565|FG000|Overall Study|Protocol Violation|0|||
48751405|NCT00897104|156934566|FG001|Overall Study|Protocol Violation|1|||
48751406|NCT00897104|156934567|FG002|Overall Study|Protocol Violation|0|||
48751407|NCT00897104|156934565|FG000|Overall Study|Withdrawal by Subject|23|||
48751408|NCT00897104|156934566|FG001|Overall Study|Withdrawal by Subject|27|||
48751409|NCT00897104|156934567|FG002|Overall Study|Withdrawal by Subject|3|||
48751410|NCT00897104|156934565|FG000|Overall Study|Abnormal Prestudy Labs|2|||
48751411|NCT00897104|156934566|FG001|Overall Study|Abnormal Prestudy Labs|0|||
48751412|NCT00897104|156934567|FG002|Overall Study|Abnormal Prestudy Labs|0|||
48751413|NCT00897104|156934565|FG000|Overall Study|Abnormal Baseline ECG|2|||
48751414|NCT00897104|156934566|FG001|Overall Study|Abnormal Baseline ECG|2|||
48751415|NCT00897104|156934567|FG002|Overall Study|Abnormal Baseline ECG|0|||
48751416|NCT00897104|156934565|FG000|Overall Study|Need for Concom. Med.|0|||
48751417|NCT00897104|156934566|FG001|Overall Study|Need for Concom. Med.|1|||
48751418|NCT00897104|156934567|FG002|Overall Study|Need for Concom. Med.|1|||
48751419|NCT00897104|156934565|FG000|Overall Study|Lack of Migraine Attack|20|||
48751420|NCT00897104|156934566|FG001|Overall Study|Lack of Migraine Attack|22|||
48751421|NCT00897104|156934567|FG002|Overall Study|Lack of Migraine Attack|1|||
48646099|NCT01194219|156556121|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
48646100|NCT01194219|156556122|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
48646101|NCT01194219|156556123|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
48751422|NCT00897104|156934565|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48646102|NCT01194219|156556124|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
48751423|NCT00897104|156934566|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48751424|NCT00897104|156934567|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48751425|NCT00897104|156934565|FG000|Overall Study|Other|3|||
48646103|NCT01194219|156556125|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
48646104|NCT01194219|156556116|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646105|NCT01194219|156556117|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646106|NCT01194219|156556118|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646107|NCT01194219|156556119|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646108|NCT01194219|156556120|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646109|NCT01194219|156556121|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646110|NCT01194219|156556122|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646111|NCT01194219|156556123|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646112|NCT01194219|156556124|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
48646113|NCT01194219|156556125|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
48646114|NCT01194219|156556116|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
48646115|NCT01194219|156556117|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
48646116|NCT01194219|156556118|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
48646117|NCT01194219|156556119|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
48646118|NCT01194219|156556120|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
48646119|NCT01194219|156556121|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
48646120|NCT01194219|156556122|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
48646121|NCT01194219|156556123|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
48646122|NCT01194219|156556124|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
48646123|NCT01194219|156556125|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
48646124|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
48646125|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
48646126|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
48646127|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
48646128|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
48646129|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
48646130|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
48646131|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
48646132|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
48646133|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
48646134|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
48646135|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
48646136|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
48646137|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
48646138|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
48646139|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
48646140|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
48646141|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
48646142|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
48646143|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
48646144|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
48646145|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
48646146|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
48646147|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
48646148|NCT01672879|156556126|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
48646149|NCT01672879|156556127|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
48646150|NCT01672879|156556128|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
48646151|NCT01672879|156556126|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
48646152|NCT01672879|156556127|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
48646153|NCT01672879|156556128|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
48646154|NCT01672879|156556126|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
48751426|NCT00897104|156934566|FG001|Overall Study|Other|0|||
48751427|NCT00897104|156934567|FG002|Overall Study|Other|0|||
48751428|NCT00897104|156934565|FG000|Overall Study|Protocol Violation|1|||
48751429|NCT00897104|156934566|FG001|Overall Study|Protocol Violation|0|||
48751430|NCT00897104|156934567|FG002|Overall Study|Protocol Violation|0|||
48751431|NCT00897104|156934565|FG000|Overall Study|Withdrawal by Subject|0|||
48751432|NCT00897104|156934566|FG001|Overall Study|Withdrawal by Subject|0|||
48646155|NCT01672879|156556127|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
48751433|NCT00897104|156934567|FG002|Overall Study|Withdrawal by Subject|1|||
48751434|NCT00883116|156934568|FG000|Overall Study|Adverse event unrelated to study drug|5|||
48751435|NCT00883116|156934569|FG001|Overall Study|Adverse event unrelated to study drug|10|||
48751436|NCT00883116|156934568|FG000|Overall Study|Death|6|||
48751437|NCT00883116|156934569|FG001|Overall Study|Death|2|||
48751438|NCT00883116|156934568|FG000|Overall Study|Disease progression|130|||
48751439|NCT00883116|156934569|FG001|Overall Study|Disease progression|128|||
48751440|NCT00883116|156934568|FG000|Overall Study|Lost to Follow-up|0|||
48751441|NCT00883116|156934569|FG001|Overall Study|Lost to Follow-up|1|||
48751442|NCT00883116|156934568|FG000|Overall Study|Maximum clinical benefit|13|||
48751443|NCT00883116|156934569|FG001|Overall Study|Maximum clinical benefit|46|||
48751444|NCT00883116|156934568|FG000|Overall Study|Not identified|3|||
48751445|NCT00883116|156934569|FG001|Overall Study|Not identified|6|||
48751446|NCT00883116|156934568|FG000|Overall Study|Study drug toxicity|36|||
48751447|NCT00883116|156934569|FG001|Overall Study|Study drug toxicity|16|||
48751448|NCT00883116|156934568|FG000|Overall Study|Withdrawal by Subject|14|||
48751449|NCT00883116|156934569|FG001|Overall Study|Withdrawal by Subject|8|||
48751450|NCT00883116|156934568|FG000|Overall Study|No longer meets study criteria|2|||
48751451|NCT00883116|156934569|FG001|Overall Study|No longer meets study criteria|2|||
48751452|NCT00662363|156934570|FG000|Overall Study|Withdrawal by Subject|6|||
48751453|NCT00662363|156934571|FG001|Overall Study|Withdrawal by Subject|5|||
48751454|NCT00662363|156934570|FG000|Overall Study|Adverse Event|0|||
48751455|NCT00662363|156934571|FG001|Overall Study|Adverse Event|3|||
48751456|NCT00662363|156934570|FG000|Overall Study|Discharged early from rehab|4|||
48751457|NCT00662363|156934571|FG001|Overall Study|Discharged early from rehab|1|||
48751458|NCT00662363|156934570|FG000|Overall Study|Protocol Violation|1|||
48751459|NCT00662363|156934571|FG001|Overall Study|Protocol Violation|1|||
48751460|NCT03789318|156934575|FG000|Overall Study|Adverse Event|0|||
48751461|NCT03789318|156934576|FG001|Overall Study|Adverse Event|0|||
48646156|NCT01672879|156556128|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
48646157|NCT01672879|156556126|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
48646158|NCT01672879|156556127|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
48646159|NCT01672879|156556128|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
48646160|NCT01672879|156556126|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
48646161|NCT01672879|156556127|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
48646162|NCT01672879|156556128|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
48646163|NCT01871545|156556131|FG000|Overall Study|Death|2|||
48646164|NCT01871545|156556132|FG001|Overall Study|Death|0|||
48646165|NCT01871545|156556131|FG000|Overall Study|Lack of Efficacy|11|||
48646166|NCT01871545|156556132|FG001|Overall Study|Lack of Efficacy|2|||
48646167|NCT01871545|156556131|FG000|Overall Study|Physician Decision|4|||
48646168|NCT01871545|156556132|FG001|Overall Study|Physician Decision|0|||
48646169|NCT01871545|156556131|FG000|Overall Study|Withdrawal by Subject|0|||
48646170|NCT01871545|156556132|FG001|Overall Study|Withdrawal by Subject|1|||
48646171|NCT02534883|156556136|FG000|Overall Study|Early Termination|8|||
48646172|NCT02534883|156556137|FG001|Overall Study|Early Termination|3|||
48646173|NCT04721158|156556138|FG000|Overall Study|Lost to Follow-up|4|||
48646174|NCT04721158|156556138|FG000|Overall Study|Device did not connect|1|||
48646175|NCT00260832|156556139|FG000|Overall Study|Adverse Event|26|||
48646176|NCT00260832|156556140|FG001|Overall Study|Adverse Event|19|||
48646177|NCT00260832|156556139|FG000|Overall Study|Progression|116|||
48751462|NCT03789318|156934577|FG002|Overall Study|Adverse Event|1|||
48751463|NCT03789318|156934578|FG003|Overall Study|Adverse Event|1|||
48751464|NCT03789318|156934579|FG004|Overall Study|Adverse Event|0|||
48751465|NCT03789318|156934575|FG000|Overall Study|Lost to Follow-up|0|||
48751466|NCT03789318|156934576|FG001|Overall Study|Lost to Follow-up|0|||
48751467|NCT03789318|156934577|FG002|Overall Study|Lost to Follow-up|1|||
48751468|NCT03789318|156934578|FG003|Overall Study|Lost to Follow-up|0|||
48751469|NCT03789318|156934579|FG004|Overall Study|Lost to Follow-up|0|||
48751470|NCT03789318|156934575|FG000|Overall Study|Withdrawal by Subject|0|||
48646178|NCT00260832|156556140|FG001|Overall Study|Progression|96|||
48646179|NCT00260832|156556139|FG000|Overall Study|Withdrawal by Subject|15|||
48646180|NCT00260832|156556140|FG001|Overall Study|Withdrawal by Subject|17|||
48751471|NCT03789318|156934576|FG001|Overall Study|Withdrawal by Subject|0|||
48751472|NCT03789318|156934577|FG002|Overall Study|Withdrawal by Subject|1|||
48646181|NCT00260832|156556139|FG000|Overall Study|Physician Decision|15|||
48751473|NCT03789318|156934578|FG003|Overall Study|Withdrawal by Subject|0|||
48751474|NCT03789318|156934579|FG004|Overall Study|Withdrawal by Subject|0|||
48751475|NCT02480114|156934580|FG000|Overall Study|Not completing surveys|3|||
48330347|NCT01853384|155407417|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
48646182|NCT00260832|156556140|FG001|Overall Study|Physician Decision|9|||
48646183|NCT00260832|156556139|FG000|Overall Study|Death|43|||
48646184|NCT00260832|156556140|FG001|Overall Study|Death|62|||
48646185|NCT00260832|156556139|FG000|Overall Study|Other|10|||
48646186|NCT00260832|156556140|FG001|Overall Study|Other|7|||
48646187|NCT00260832|156556139|FG000|Overall Study|Protocol Violation|3|||
48646188|NCT00260832|156556140|FG001|Overall Study|Protocol Violation|1|||
48646189|NCT00255723|156556141|FG000|Overall Study|Adverse Event|1|||
48646190|NCT00255723|156556142|FG001|Overall Study|Adverse Event|1|||
48646191|NCT00255723|156556141|FG000|Overall Study|Death|0|||
48646192|NCT00255723|156556142|FG001|Overall Study|Death|1|||
48646193|NCT00255723|156556141|FG000|Overall Study|Response Data Not Available|1|||
48646194|NCT00255723|156556142|FG001|Overall Study|Response Data Not Available|0|||
48646195|NCT00976716|156556143|FG000|Overall Study|Adverse Event|1|||
48646196|NCT00652743|156557931|FG000|Months 12-18|Lost to Follow-up|1|||
48646197|NCT00652743|156557932|FG001|Months 12-18|Lost to Follow-up|2|||
48646198|NCT00652743|156557933|FG002|Months 12-18|Lost to Follow-up|7|||
48646199|NCT00652743|156557931|FG000|Months 24-30|Other|5|||
48646200|NCT00652743|156557932|FG001|Months 24-30|Other|1|||
48646201|NCT00652743|156557933|FG002|Months 24-30|Other|11|||
48646202|NCT00652743|156557931|FG000|Months 36-42|Serious Adverse Events|0|||
48646203|NCT00652743|156557932|FG001|Months 36-42|Serious Adverse Events|1|||
48646204|NCT00652743|156557933|FG002|Months 36-42|Serious Adverse Events|1|||
48646205|NCT00652743|156557931|FG000|Months 36-42|Withdrawal by Subject|1|||
48646206|NCT00652743|156557932|FG001|Months 36-42|Withdrawal by Subject|1|||
48646207|NCT00652743|156557933|FG002|Months 36-42|Withdrawal by Subject|0|||
48646208|NCT00652743|156557931|FG000|Months 36-42|Lost to Follow-up|0|||
48646209|NCT00652743|156557932|FG001|Months 36-42|Lost to Follow-up|1|||
48646210|NCT00652743|156557933|FG002|Months 36-42|Lost to Follow-up|0|||
48646211|NCT00652743|156557931|FG000|Months 36-42|Migrated/moved from study area|1|||
48646212|NCT00652743|156557932|FG001|Months 36-42|Migrated/moved from study area|0|||
48646213|NCT00652743|156557933|FG002|Months 36-42|Migrated/moved from study area|0|||
48646214|NCT00652743|156557931|FG000|Months 36-42|Other|4|||
48646215|NCT00652743|156557932|FG001|Months 36-42|Other|2|||
48646216|NCT00652743|156557933|FG002|Months 36-42|Other|8|||
48646217|NCT01047007|156557943|FG000|Overall Study|Adverse Event|0|||
48646218|NCT01047007|156557944|FG001|Overall Study|Adverse Event|2|||
48646219|NCT01047007|156557945|FG002|Overall Study|Adverse Event|1|||
48646220|NCT01047007|156557946|FG003|Overall Study|Adverse Event|0|||
48646221|NCT01047007|156557943|FG000|Overall Study|Progressive Disease|2|||
48646222|NCT01047007|156557944|FG001|Overall Study|Progressive Disease|4|||
48646223|NCT01047007|156557945|FG002|Overall Study|Progressive Disease|1|||
48646224|NCT01047007|156557946|FG003|Overall Study|Progressive Disease|0|||
48646225|NCT01396187|156557950|FG000|Overall Study|Adverse Event|0|||
48646226|NCT01396187|156557951|FG001|Overall Study|Adverse Event|1|||
48646227|NCT01396187|156557952|FG002|Overall Study|Adverse Event|0|||
48646228|NCT01396187|156557953|FG003|Overall Study|Adverse Event|0|||
48646229|NCT01396187|156557954|FG004|Overall Study|Adverse Event|0|||
48646230|NCT01396187|156557950|FG000|Overall Study|Withdrawal by Subject|0|||
48646231|NCT01396187|156557951|FG001|Overall Study|Withdrawal by Subject|1|||
48646232|NCT01396187|156557952|FG002|Overall Study|Withdrawal by Subject|1|||
48646233|NCT01396187|156557953|FG003|Overall Study|Withdrawal by Subject|0|||
48646234|NCT01396187|156557954|FG004|Overall Study|Withdrawal by Subject|0|||
48646235|NCT01396187|156557950|FG000|Overall Study|Other|1|||
48646236|NCT01396187|156557951|FG001|Overall Study|Other|1|||
48646237|NCT01396187|156557952|FG002|Overall Study|Other|0|||
48646238|NCT01396187|156557953|FG003|Overall Study|Other|0|||
48646239|NCT01396187|156557954|FG004|Overall Study|Other|1|||
48646240|NCT01898286|156557955|FG000|Overall Study|Withdrawal by Subject|1|||
48646241|NCT01898286|156557955|FG000|Overall Study|Protocol Violation|1|||
48646242|NCT01898286|156557955|FG000|Overall Study|Lost to Follow-up|1|||
48646243|NCT06164691|156557961|FG000|Overall Study|Withdrawal by Subject|2|||
48646244|NCT06164691|156557962|FG001|Overall Study|Withdrawal by Subject|0|||
48646245|NCT06164691|156557963|FG002|Overall Study|Withdrawal by Subject|0|||
48646246|NCT01815424|156557966|FG000|Week 0 to 16|Adverse Event|1|||
48646247|NCT01815424|156557967|FG001|Week 0 to 16|Adverse Event|3|||
48646248|NCT01815424|156557968|FG002|Week 0 to 16|Adverse Event|3|||
48646249|NCT01815424|156557969|FG003|Week 0 to 16|Adverse Event|0|||
48646250|NCT01815424|156557970|FG004|Week 0 to 16|Adverse Event|0|||
48646251|NCT01815424|156557966|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
48646252|NCT01815424|156557967|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
48646253|NCT01815424|156557968|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
48646254|NCT01815424|156557969|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
48646255|NCT01815424|156557970|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
48646256|NCT01815424|156557966|FG000|Week 0 to 16|Lost to Follow-up|0|||
48646257|NCT01815424|156557967|FG001|Week 0 to 16|Lost to Follow-up|1|||
48646258|NCT01815424|156557968|FG002|Week 0 to 16|Lost to Follow-up|0|||
48646259|NCT01815424|156557969|FG003|Week 0 to 16|Lost to Follow-up|0|||
48646260|NCT01815424|156557970|FG004|Week 0 to 16|Lost to Follow-up|0|||
48330348|NCT01853384|155407418|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
48330349|NCT01947491|155407419|FG000|Overall Study|Lost to Follow-up|5|||
48330350|NCT01947491|155407420|FG001|Overall Study|Lost to Follow-up|3|||
48330351|NCT01947491|155407421|FG002|Overall Study|Lost to Follow-up|1|||
48330352|NCT01947491|155407422|FG003|Overall Study|Lost to Follow-up|2|||
48330353|NCT01947491|155407419|FG000|Overall Study|Lack of Efficacy|1|||
48751476|NCT02480114|156934581|FG001|Overall Study|Not completing surveys|2|||
48751477|NCT02480114|156934580|FG000|Overall Study|Withdrawal by Subject|2|||
48751478|NCT02480114|156934581|FG001|Overall Study|Withdrawal by Subject|4|||
48751479|NCT02480114|156934580|FG000|Overall Study|Disease progression|3|||
48751480|NCT02480114|156934581|FG001|Overall Study|Disease progression|0|||
48751481|NCT02480114|156934580|FG000|Overall Study|Improper completion of survey|1|||
48751482|NCT02480114|156934581|FG001|Overall Study|Improper completion of survey|1|||
48751483|NCT02480114|156934580|FG000|Overall Study|Not eligible|0|||
48751484|NCT02480114|156934581|FG001|Overall Study|Not eligible|1|||
48751485|NCT00477971|156934582|FG000|Overall Study|Disease progression|6|||
48751486|NCT00477971|156934583|FG001|Overall Study|Disease progression|0|||
48751487|NCT00477971|156934582|FG000|Overall Study|Withdrawal by Subject|3|||
48751488|NCT00477971|156934583|FG001|Overall Study|Withdrawal by Subject|1|||
48751489|NCT00477971|156934582|FG000|Overall Study|Adverse Event|3|||
48751490|NCT00477971|156934583|FG001|Overall Study|Adverse Event|0|||
48751491|NCT00477971|156934582|FG000|Overall Study|Death|2|||
48751492|NCT00477971|156934583|FG001|Overall Study|Death|4|||
48751493|NCT00477971|156934582|FG000|Overall Study|Alternative treatment|3|||
48751494|NCT00477971|156934583|FG001|Overall Study|Alternative treatment|1|||
48751495|NCT03156543|156936489|FG000|Overall Study|Withdrawal by Subject|1|||
48751496|NCT03156543|156936490|FG001|Overall Study|Withdrawal by Subject|0|||
48751497|NCT03098550|156936491|FG000|Overall Study|Disease Progression|30|||
48751498|NCT03098550|156936492|FG001|Overall Study|Disease Progression|19|||
48751499|NCT03098550|156936493|FG002|Overall Study|Disease Progression|41|||
48751500|NCT03098550|156936491|FG000|Overall Study|Study Drug Toxicity|2|||
48751501|NCT03098550|156936492|FG001|Overall Study|Study Drug Toxicity|1|||
48751502|NCT03098550|156936493|FG002|Overall Study|Study Drug Toxicity|0|||
48751503|NCT03098550|156936491|FG000|Overall Study|Death|1|||
48751504|NCT03098550|156936492|FG001|Overall Study|Death|0|||
48751505|NCT03098550|156936493|FG002|Overall Study|Death|0|||
48751506|NCT03098550|156936491|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
48751507|NCT03098550|156936492|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
48751508|NCT03098550|156936493|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
48751509|NCT03098550|156936491|FG000|Overall Study|Administrative reason by sponsor|0|||
48751510|NCT03098550|156936492|FG001|Overall Study|Administrative reason by sponsor|0|||
48751511|NCT03098550|156936493|FG002|Overall Study|Administrative reason by sponsor|1|||
48751512|NCT03098550|156936491|FG000|Overall Study|Other reasons|2|||
48751513|NCT03098550|156936492|FG001|Overall Study|Other reasons|0|||
48751514|NCT03098550|156936493|FG002|Overall Study|Other reasons|0|||
48751515|NCT01384760|156936497|FG000|Overall Study|Lost to Follow-up|0|||
48751516|NCT01384760|156936498|FG001|Overall Study|Lost to Follow-up|6|||
48751517|NCT01384760|156936497|FG000|Overall Study|Protocol Violation|16|||
48751518|NCT01384760|156936498|FG001|Overall Study|Protocol Violation|0|||
48751519|NCT01411774|156936499|FG000|Overall Study|Withdrawal by Subject|0|||
48751520|NCT01411774|156936500|FG001|Overall Study|Withdrawal by Subject|3|||
48751521|NCT03808545|156936501|FG000|Overall Study|Withdrawal by Subject|1|||
48751522|NCT03808545|156936502|FG001|Overall Study|Withdrawal by Subject|1|||
48751523|NCT00963547|156936503|FG000|Overall Study|Adverse Event|0|||
48751524|NCT00963547|156936504|FG001|Overall Study|Adverse Event|1|||
48751525|NCT00963547|156936505|FG002|Overall Study|Adverse Event|0|||
48751526|NCT00963547|156936506|FG003|Overall Study|Adverse Event|1|||
48751527|NCT00963547|156936507|FG004|Overall Study|Adverse Event|0|||
48751528|NCT00963547|156936508|FG005|Overall Study|Adverse Event|0|||
48751529|NCT00963547|156936509|FG006|Overall Study|Adverse Event|0|||
48751530|NCT00963547|156936503|FG000|Overall Study|Physician Decision|1|||
48751531|NCT00963547|156936504|FG001|Overall Study|Physician Decision|1|||
48751532|NCT00963547|156936505|FG002|Overall Study|Physician Decision|0|||
48751533|NCT00963547|156936506|FG003|Overall Study|Physician Decision|0|||
48751534|NCT00963547|156936507|FG004|Overall Study|Physician Decision|0|||
48751535|NCT00963547|156936508|FG005|Overall Study|Physician Decision|0|||
48751536|NCT00963547|156936509|FG006|Overall Study|Physician Decision|0|||
48751537|NCT00963547|156936503|FG000|Overall Study|Progressive Disease|3|||
48751538|NCT00963547|156936504|FG001|Overall Study|Progressive Disease|8|||
48751539|NCT00963547|156936505|FG002|Overall Study|Progressive Disease|9|||
48751540|NCT00963547|156936506|FG003|Overall Study|Progressive Disease|5|||
48751541|NCT00963547|156936507|FG004|Overall Study|Progressive Disease|0|||
48751542|NCT00963547|156936508|FG005|Overall Study|Progressive Disease|0|||
48751543|NCT00963547|156936509|FG006|Overall Study|Progressive Disease|0|||
48751544|NCT00963547|156936503|FG000|Overall Study|Withdrawal by Subject|0|||
48751545|NCT00963547|156936504|FG001|Overall Study|Withdrawal by Subject|0|||
48751546|NCT00963547|156936505|FG002|Overall Study|Withdrawal by Subject|3|||
48751547|NCT00963547|156936506|FG003|Overall Study|Withdrawal by Subject|0|||
48751548|NCT00963547|156936507|FG004|Overall Study|Withdrawal by Subject|0|||
48330354|NCT01947491|155407420|FG001|Overall Study|Lack of Efficacy|0|||
48330355|NCT01947491|155407421|FG002|Overall Study|Lack of Efficacy|0|||
48330356|NCT01947491|155407422|FG003|Overall Study|Lack of Efficacy|1|||
48330357|NCT01947491|155407419|FG000|Overall Study|Protocol Violation|1|||
48330358|NCT01947491|155407420|FG001|Overall Study|Protocol Violation|0|||
48330359|NCT01947491|155407421|FG002|Overall Study|Protocol Violation|0|||
48330360|NCT01947491|155407422|FG003|Overall Study|Protocol Violation|0|||
48330361|NCT01947491|155407419|FG000|Overall Study|Withdrawal by Subject|1|||
48330362|NCT01947491|155407420|FG001|Overall Study|Withdrawal by Subject|1|||
48330363|NCT01947491|155407421|FG002|Overall Study|Withdrawal by Subject|1|||
48330364|NCT01947491|155407422|FG003|Overall Study|Withdrawal by Subject|0|||
48330365|NCT01947491|155407419|FG000|Overall Study|Worsening of condition|0|||
48646261|NCT01815424|156557966|FG000|Week 0 to 16|Withdrawal by Subject|0|||
48646262|NCT01815424|156557967|FG001|Week 0 to 16|Withdrawal by Subject|0|||
48646263|NCT01815424|156557968|FG002|Week 0 to 16|Withdrawal by Subject|1|||
48646264|NCT01815424|156557969|FG003|Week 0 to 16|Withdrawal by Subject|0|||
48330366|NCT01947491|155407420|FG001|Overall Study|Worsening of condition|1|||
48646265|NCT01815424|156557970|FG004|Week 0 to 16|Withdrawal by Subject|0|||
48646266|NCT01815424|156557966|FG000|Week 0 to 16|Other|1|||
48646267|NCT01815424|156557967|FG001|Week 0 to 16|Other|0|||
48646268|NCT01815424|156557968|FG002|Week 0 to 16|Other|3|||
48646269|NCT01815424|156557969|FG003|Week 0 to 16|Other|0|||
48646270|NCT01815424|156557970|FG004|Week 0 to 16|Other|0|||
48646271|NCT01815424|156557966|FG000|Week 0 to 16|Protocol Violation|1|||
48646272|NCT01815424|156557967|FG001|Week 0 to 16|Protocol Violation|0|||
48646273|NCT01815424|156557968|FG002|Week 0 to 16|Protocol Violation|0|||
48646274|NCT01815424|156557969|FG003|Week 0 to 16|Protocol Violation|0|||
48646275|NCT01815424|156557970|FG004|Week 0 to 16|Protocol Violation|0|||
48646276|NCT01815424|156557966|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
48646277|NCT01815424|156557967|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
48646278|NCT01815424|156557968|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
48646279|NCT01815424|156557969|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
48646280|NCT01815424|156557970|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
48646281|NCT01815424|156557966|FG000|Week 16 to 52|Other|0|||
48646282|NCT01815424|156557967|FG001|Week 16 to 52|Other|1|||
48646283|NCT01815424|156557968|FG002|Week 16 to 52|Other|0|||
48646284|NCT01815424|156557969|FG003|Week 16 to 52|Other|0|||
48646285|NCT01815424|156557970|FG004|Week 16 to 52|Other|0|||
48646286|NCT01815424|156557966|FG000|Week 16 to 52|Adverse Event|0|||
48646287|NCT01815424|156557967|FG001|Week 16 to 52|Adverse Event|0|||
48646288|NCT01815424|156557968|FG002|Week 16 to 52|Adverse Event|0|||
48646289|NCT01815424|156557969|FG003|Week 16 to 52|Adverse Event|0|||
48646290|NCT01815424|156557970|FG004|Week 16 to 52|Adverse Event|1|||
48646291|NCT01815424|156557966|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
48646292|NCT01815424|156557967|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
48646293|NCT01815424|156557968|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
48646294|NCT01815424|156557969|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
48646295|NCT01815424|156557970|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
48646296|NCT01815424|156557966|FG000|Week 16 to 52|Lost to Follow-up|0|||
48646297|NCT01815424|156557967|FG001|Week 16 to 52|Lost to Follow-up|2|||
48646298|NCT01815424|156557968|FG002|Week 16 to 52|Lost to Follow-up|0|||
48646299|NCT01815424|156557969|FG003|Week 16 to 52|Lost to Follow-up|2|||
48646300|NCT01815424|156557970|FG004|Week 16 to 52|Lost to Follow-up|1|||
48646301|NCT01815424|156557966|FG000|Week 16 to 52|Withdrawal by Subject|1|||
48646302|NCT01815424|156557967|FG001|Week 16 to 52|Withdrawal by Subject|2|||
48646303|NCT01815424|156557968|FG002|Week 16 to 52|Withdrawal by Subject|0|||
48646304|NCT01815424|156557969|FG003|Week 16 to 52|Withdrawal by Subject|0|||
48646305|NCT01815424|156557970|FG004|Week 16 to 52|Withdrawal by Subject|0|||
48646306|NCT01309204|156557971|FG000|Overall Study|Adverse Event|48|||
48646307|NCT01309204|156557972|FG001|Overall Study|Adverse Event|58|||
48646308|NCT01309204|156557971|FG000|Overall Study|Lost to Follow-up|2|||
48646309|NCT01309204|156557972|FG001|Overall Study|Lost to Follow-up|2|||
48646310|NCT01309204|156557971|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
48646311|NCT01309204|156557972|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
48646312|NCT01309204|156557971|FG000|Overall Study|Inadequate control of IOP|4|||
48646313|NCT01309204|156557972|FG001|Overall Study|Inadequate control of IOP|4|||
48646314|NCT01309204|156557971|FG000|Overall Study|Other|4|||
48646315|NCT01309204|156557972|FG001|Overall Study|Other|1|||
48646316|NCT03183063|156557973|FG000|Overall Study|Withdrawal by Subject|2|||
48646317|NCT03183063|156557974|FG001|Overall Study|Withdrawal by Subject|0|||
48646318|NCT03183063|156557975|FG002|Overall Study|Withdrawal by Subject|0|||
48646319|NCT03183063|156557973|FG000|Overall Study|Physician Decision|3|||
48646320|NCT03183063|156557974|FG001|Overall Study|Physician Decision|4|||
48330367|NCT01947491|155407421|FG002|Overall Study|Worsening of condition|0|||
48330368|NCT01947491|155407422|FG003|Overall Study|Worsening of condition|0|||
48330369|NCT01947491|155407419|FG000|Overall Study|Adverse Event|0|||
48330370|NCT01947491|155407420|FG001|Overall Study|Adverse Event|1|||
48330371|NCT01947491|155407421|FG002|Overall Study|Adverse Event|0|||
48646321|NCT03183063|156557975|FG002|Overall Study|Physician Decision|4|||
48646322|NCT01127633|156557976|FG000|Overall Study|Adverse Event|74|||
48646323|NCT01127633|156557977|FG001|Overall Study|Adverse Event|73|||
48646324|NCT01127633|156557976|FG000|Overall Study|Death|40|||
48646325|NCT01127633|156557977|FG001|Overall Study|Death|43|||
48330372|NCT01947491|155407422|FG003|Overall Study|Adverse Event|2|||
48330373|NCT02067663|155407429|FG000|Overall Study|Lost to Follow-up|13|||
48646326|NCT01127633|156557976|FG000|Overall Study|Lost to Follow-up|4|||
48646327|NCT01127633|156557977|FG001|Overall Study|Lost to Follow-up|0|||
48646328|NCT01127633|156557976|FG000|Overall Study|Parent/Caregiver Decision|246|||
48330374|NCT02067663|155407430|FG001|Overall Study|Lost to Follow-up|14|||
48330375|NCT01009645|155407432|FG000|Overall Study|Lost to Follow-up|2|||
48330376|NCT01009645|155407433|FG001|Overall Study|Lost to Follow-up|8|||
48330377|NCT01009645|155407434|FG002|Overall Study|Lost to Follow-up|4|||
48330378|NCT01009645|155407435|FG003|Overall Study|Lost to Follow-up|5|||
48330379|NCT00704340|155407436|FG000|Overall Study|Lost to Follow-up|2|||
48330380|NCT00704340|155407437|FG001|Overall Study|Lost to Follow-up|1|||
48330381|NCT00704340|155407436|FG000|Overall Study|Death|0|||
48330382|NCT00704340|155407437|FG001|Overall Study|Death|1|||
48330383|NCT02827201|155407438|FG000|Overall Study|Death|1|||
48330384|NCT02827201|155407439|FG001|Overall Study|Death|2|||
48330385|NCT02827201|155407438|FG000|Overall Study|Patients not treated|1|||
48330386|NCT02827201|155407439|FG001|Overall Study|Patients not treated|1|||
48330387|NCT03345979|155407440|FG000|Overall Study|Withdrawal by Subject|20|||
48646329|NCT01127633|156557977|FG001|Overall Study|Parent/Caregiver Decision|228|||
48646330|NCT01127633|156557976|FG000|Overall Study|Physician Decision|60|||
48646331|NCT01127633|156557977|FG001|Overall Study|Physician Decision|45|||
48646332|NCT01127633|156557976|FG000|Overall Study|Withdrawal by Subject|57|||
48751549|NCT00963547|156936508|FG005|Overall Study|Withdrawal by Subject|0|||
48751550|NCT00963547|156936509|FG006|Overall Study|Withdrawal by Subject|0|||
48751551|NCT00963547|156936503|FG000|Overall Study|Reason Unknown|0|||
48751552|NCT00963547|156936504|FG001|Overall Study|Reason Unknown|1|||
48751553|NCT00963547|156936505|FG002|Overall Study|Reason Unknown|0|||
48751554|NCT00963547|156936506|FG003|Overall Study|Reason Unknown|0|||
48751555|NCT00963547|156936507|FG004|Overall Study|Reason Unknown|0|||
48751556|NCT00963547|156936508|FG005|Overall Study|Reason Unknown|0|||
48751557|NCT00963547|156936509|FG006|Overall Study|Reason Unknown|0|||
48751558|NCT00056316|156936510|FG000|Overall Study|Withdrawal by Subject|2|||
48646333|NCT01127633|156557977|FG001|Overall Study|Withdrawal by Subject|72|||
48751559|NCT00056316|156936511|FG001|Overall Study|Withdrawal by Subject|2|||
48751560|NCT00056316|156936510|FG000|Overall Study|Death/NH placement of pt|1|||
48751561|NCT00056316|156936511|FG001|Overall Study|Death/NH placement of pt|1|||
48751562|NCT04980040|156936512|FG000|Overall Study|Violated the Inclusion Criteria|260|||
48751563|NCT04980040|156936512|FG000|Overall Study|Violated the Administration & Dosage|225|||
48751564|NCT04980040|156936512|FG000|Overall Study|Lost to Safety-Follow-up|4|||
48751565|NCT04980040|156936512|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
48751566|NCT02820753|156936516|FG000|2 Month|Withdrawal by Subject|3|||
48751567|NCT02820753|156936517|FG001|2 Month|Withdrawal by Subject|3|||
48751568|NCT02820753|156936516|FG000|2 Month|Lost to Follow-up|24|||
48751569|NCT02820753|156936517|FG001|2 Month|Lost to Follow-up|26|||
48751570|NCT02820753|156936516|FG000|2 Month|Stopped per NIH Hold|51|||
48751571|NCT02820753|156936517|FG001|2 Month|Stopped per NIH Hold|13|||
48751572|NCT02820753|156936516|FG000|6 Month|Withdrawal by Subject|2|||
48751573|NCT02820753|156936517|FG001|6 Month|Withdrawal by Subject|2|||
48751574|NCT02820753|156936516|FG000|6 Month|Lost to Follow-up|20|||
48751575|NCT02820753|156936517|FG001|6 Month|Lost to Follow-up|27|||
48751576|NCT02820753|156936516|FG000|6 Month|Stopped per NIH Hold|81|||
48751577|NCT02820753|156936517|FG001|6 Month|Stopped per NIH Hold|81|||
48751578|NCT02820753|156936516|FG000|6 Month|Death|0|||
48751579|NCT02820753|156936517|FG001|6 Month|Death|1|||
48751580|NCT02167893|156936524|FG000|Overall Study|Investigator transferred|85|||
48751581|NCT02167893|156936524|FG000|Overall Study|Investigator health reasons|10|||
48751582|NCT02167893|156936524|FG000|Overall Study|Case report forms not collected|68|||
48751583|NCT01315678|156936525|FG000|Overall Study|Withdrawal by Subject|7|||
48646334|NCT01127633|156557976|FG000|Overall Study|Sponsor Decision|163|||
48646335|NCT01127633|156557977|FG001|Overall Study|Sponsor Decision|195|||
48646336|NCT01127633|156557976|FG000|Overall Study|Protocol Violation|8|||
48646337|NCT01127633|156557977|FG001|Overall Study|Protocol Violation|16|||
48646338|NCT01127633|156557976|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
48646339|NCT01127633|156557977|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
48646340|NCT01127633|156557976|FG000|Overall Study|Not treated|1|||
48751584|NCT01315678|156936526|FG001|Overall Study|Withdrawal by Subject|3|||
48751585|NCT01315678|156936525|FG000|Overall Study|Adverse Event|3|||
48751586|NCT01315678|156936526|FG001|Overall Study|Adverse Event|1|||
48751587|NCT01315678|156936525|FG000|Overall Study|Lost to Follow-up|1|||
48751588|NCT01315678|156936526|FG001|Overall Study|Lost to Follow-up|0|||
48751589|NCT01315678|156936525|FG000|Overall Study|similar reason to those listed above|3|||
48751590|NCT01315678|156936526|FG001|Overall Study|similar reason to those listed above|2|||
48751591|NCT00543140|156936527|FG000|Overall Study|Lost to Follow-up|33|||
48751592|NCT00543140|156936527|FG000|Overall Study|Withdrawal by Subject|13|||
48751593|NCT00543140|156936527|FG000|Overall Study|Protocol Violation|10|||
48751594|NCT00543140|156936527|FG000|Overall Study|Insufficient weight loss|10|||
48330388|NCT03345979|155407441|FG001|Overall Study|Withdrawal by Subject|31|||
48330389|NCT03345979|155407440|FG000|Overall Study|Adverse Event|10|||
48330390|NCT03345979|155407441|FG001|Overall Study|Adverse Event|11|||
48330391|NCT03345979|155407440|FG000|Overall Study|Lost to Follow-up|8|||
48330392|NCT03345979|155407441|FG001|Overall Study|Lost to Follow-up|9|||
48330393|NCT03345979|155407440|FG000|Overall Study|Lack of Efficacy|4|||
48330394|NCT03345979|155407441|FG001|Overall Study|Lack of Efficacy|2|||
48330395|NCT03345979|155407440|FG000|Overall Study|Protocol Violation|1|||
48646341|NCT01127633|156557977|FG001|Overall Study|Not treated|0|||
48646342|NCT00688467|156557978|FG000|Treatment Period 1|Adverse Event|2|||
48646343|NCT00688467|156557979|FG001|Treatment Period 1|Adverse Event|1|||
48646344|NCT00688467|156557978|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
48646345|NCT00688467|156557979|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
48646346|NCT00688467|156557978|FG000|Treatment Period 2|Protocol Violation|0|||
48646347|NCT00688467|156557979|FG001|Treatment Period 2|Protocol Violation|1|||
48646348|NCT00688467|156557978|FG000|Treatment Period 2|Adverse Event|0|||
48646349|NCT00688467|156557979|FG001|Treatment Period 2|Adverse Event|1|||
48646350|NCT00078806|156557985|FG000|Part 1A|Adverse Event|2|||
48646351|NCT00078806|156557986|FG001|Part 1A|Adverse Event|0|||
48646352|NCT00078806|156557987|FG002|Part 1A|Adverse Event|0|||
48646353|NCT00078806|156557988|FG003|Part 1A|Adverse Event|0|||
48646354|NCT00078806|156557985|FG000|Part 1A|Lack of Efficacy|7|||
48646355|NCT00078806|156557986|FG001|Part 1A|Lack of Efficacy|0|||
48646356|NCT00078806|156557987|FG002|Part 1A|Lack of Efficacy|0|||
48646357|NCT00078806|156557988|FG003|Part 1A|Lack of Efficacy|0|||
48646358|NCT00078806|156557985|FG000|Part 1A|Other|1|||
48646359|NCT00078806|156557986|FG001|Part 1A|Other|0|||
48646360|NCT00078806|156557987|FG002|Part 1A|Other|0|||
48646361|NCT00078806|156557988|FG003|Part 1A|Other|0|||
48646362|NCT00078806|156557985|FG000|Part 1B|Adverse Event|1|||
48646363|NCT00078806|156557986|FG001|Part 1B|Adverse Event|0|||
48646364|NCT00078806|156557987|FG002|Part 1B|Adverse Event|0|||
48646365|NCT00078806|156557988|FG003|Part 1B|Adverse Event|0|||
48646366|NCT00078806|156557985|FG000|Part 1B|Lack of Efficacy|7|||
48646367|NCT00078806|156557986|FG001|Part 1B|Lack of Efficacy|0|||
48646368|NCT00078806|156557987|FG002|Part 1B|Lack of Efficacy|0|||
48330396|NCT03345979|155407441|FG001|Overall Study|Protocol Violation|3|||
48646369|NCT00078806|156557988|FG003|Part 1B|Lack of Efficacy|0|||
48330397|NCT03345979|155407440|FG000|Overall Study|Physician Decision|0|||
48330398|NCT03345979|155407441|FG001|Overall Study|Physician Decision|2|||
48330399|NCT02736188|155407442|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
48646370|NCT00078806|156557985|FG000|Part 2|Adverse Event|0|||
48646371|NCT00078806|156557986|FG001|Part 2|Adverse Event|1|||
48646372|NCT00078806|156557987|FG002|Part 2|Adverse Event|0|||
48646373|NCT00078806|156557988|FG003|Part 2|Adverse Event|0|||
48646374|NCT03292874|156557989|FG000|Overall Study|Due to pandemic|5|||
48646375|NCT00161616|156557990|FG000|Overall Study|Withdrawal by Subject|6|||
48646376|NCT00161616|156557991|FG001|Overall Study|Withdrawal by Subject|5|||
48646377|NCT00161616|156557990|FG000|Overall Study|Physician Decision|1|||
48646378|NCT00161616|156557991|FG001|Overall Study|Physician Decision|0|||
48646379|NCT00161616|156557990|FG000|Overall Study|Death|1|||
48646380|NCT00161616|156557991|FG001|Overall Study|Death|1|||
48646381|NCT00161616|156557990|FG000|Overall Study|Lost to Follow-up|17|||
48646382|NCT00161616|156557991|FG001|Overall Study|Lost to Follow-up|13|||
48646383|NCT00161616|156557990|FG000|Overall Study|Protocol deviation|1|||
48646384|NCT00161616|156557991|FG001|Overall Study|Protocol deviation|0|||
48646385|NCT00690794|156557992|FG000|Overall Study|Adverse Event|12|||
48646386|NCT00690794|156557993|FG001|Overall Study|Adverse Event|10|||
48646387|NCT00690794|156557992|FG000|Overall Study|Lost to Follow-up|1|||
48646388|NCT00690794|156557993|FG001|Overall Study|Lost to Follow-up|4|||
48646389|NCT00690794|156557992|FG000|Overall Study|Withdrawal by Subject|0|||
48646390|NCT00690794|156557993|FG001|Overall Study|Withdrawal by Subject|9|||
48646391|NCT00690794|156557992|FG000|Overall Study|Protocol Violation|6|||
48646392|NCT00690794|156557993|FG001|Overall Study|Protocol Violation|7|||
48646393|NCT00690794|156557992|FG000|Overall Study|Noncompliance|1|||
48646394|NCT00690794|156557993|FG001|Overall Study|Noncompliance|2|||
48646395|NCT00690794|156557992|FG000|Overall Study|Other not specified|1|||
48646396|NCT00690794|156557993|FG001|Overall Study|Other not specified|3|||
48646397|NCT02477527|156557996|FG000|Overall Study|Lost to Follow-up|2|||
48646398|NCT02477527|156557996|FG000|Overall Study|Withdrawal by Subject|1|||
48646399|NCT02477527|156557996|FG000|Overall Study|Screen Failure|3|||
48646400|NCT03338400|156557997|FG000|Overall Study|Lost to Follow-up|1|||
48646401|NCT03338400|156557998|FG001|Overall Study|Lost to Follow-up|2|||
48646402|NCT01881009|156558003|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
48646403|NCT01881009|156558004|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
48646404|NCT01773967|156558008|FG000|Overall Study|Lost to Follow-up|15|||
48646405|NCT01773967|156558009|FG001|Overall Study|Lost to Follow-up|13|||
48646406|NCT01803880|156558010|FG000|Overall Study|Adverse Event|1|||
48646407|NCT01803880|156558011|FG001|Overall Study|Adverse Event|0|||
48646408|NCT01803880|156558012|FG002|Overall Study|Adverse Event|0|||
48646409|NCT01803880|156558010|FG000|Overall Study|Withdrawal by Subject|1|||
48646410|NCT01803880|156558011|FG001|Overall Study|Withdrawal by Subject|1|||
48646411|NCT01803880|156558012|FG002|Overall Study|Withdrawal by Subject|4|||
48646412|NCT01803880|156558010|FG000|Overall Study|Physician Decision|0|||
48646413|NCT01803880|156558011|FG001|Overall Study|Physician Decision|0|||
48646414|NCT01803880|156558012|FG002|Overall Study|Physician Decision|1|||
48646415|NCT01803880|156558010|FG000|Overall Study|Unable to return for follow-up visits|0|||
48646416|NCT01803880|156558011|FG001|Overall Study|Unable to return for follow-up visits|1|||
48646417|NCT01803880|156558012|FG002|Overall Study|Unable to return for follow-up visits|2|||
48646418|NCT01803880|156558010|FG000|Overall Study|Lost to Follow-up|1|||
48330400|NCT02736188|155407442|FG000|Overall Study|Adverse Event|1|||
48646419|NCT01803880|156558011|FG001|Overall Study|Lost to Follow-up|2|||
48646420|NCT01803880|156558012|FG002|Overall Study|Lost to Follow-up|3|||
48646421|NCT01803880|156558010|FG000|Overall Study|Protocol Violation|1|||
48646422|NCT01803880|156558011|FG001|Overall Study|Protocol Violation|0|||
48330401|NCT02736188|155407442|FG000|Overall Study|Withdrawal by Subject|1|||
48646423|NCT01803880|156558012|FG002|Overall Study|Protocol Violation|0|||
48646424|NCT01803880|156558010|FG000|Overall Study|Early study termination|0|||
48646425|NCT01803880|156558011|FG001|Overall Study|Early study termination|6|||
48646426|NCT01803880|156558012|FG002|Overall Study|Early study termination|5|||
48646427|NCT01803880|156558010|FG000|Overall Study|Incomplete data entry by sites|2|||
48646428|NCT01803880|156558011|FG001|Overall Study|Incomplete data entry by sites|0|||
48646429|NCT01803880|156558012|FG002|Overall Study|Incomplete data entry by sites|0|||
48646430|NCT01804049|156558014|FG000|Overall Study|Adverse Event|2|||
48646431|NCT01804049|156558015|FG001|Overall Study|Adverse Event|10|||
48646432|NCT01804049|156558014|FG000|Overall Study|Lost to Follow-up|2|||
48646433|NCT01804049|156558015|FG001|Overall Study|Lost to Follow-up|1|||
48646434|NCT01804049|156558014|FG000|Overall Study|Decreased interest/personal|4|||
48646435|NCT01804049|156558015|FG001|Overall Study|Decreased interest/personal|5|||
48646436|NCT01804049|156558014|FG000|Overall Study|Other health concerns|2|||
48646437|NCT01804049|156558015|FG001|Overall Study|Other health concerns|7|||
48646438|NCT01804049|156558014|FG000|Overall Study|Moved out of area|0|||
48646439|NCT01804049|156558015|FG001|Overall Study|Moved out of area|7|||
48646440|NCT01804049|156558014|FG000|Overall Study|other MD recommended|1|||
48646441|NCT01804049|156558015|FG001|Overall Study|other MD recommended|1|||
48646442|NCT01804049|156558014|FG000|Overall Study|Enrollment in dual studies|0|||
48646443|NCT01804049|156558015|FG001|Overall Study|Enrollment in dual studies|1|||
48646444|NCT00709319|156558016|FG000|Overall Study|Death|4|||
48646445|NCT00709319|156558016|FG000|Overall Study|Withdrawal by Subject|2|||
48646446|NCT02954887|156558017|FG000|Overall Study|Withdrawal by Subject|3|||
48646447|NCT02954887|156558017|FG000|Overall Study|Lack of Efficacy|3|||
48646448|NCT02954887|156558017|FG000|Overall Study|Other|1|||
48646449|NCT02948582|156558022|FG000|Washout Period 1|Adverse Event|0|||
48646450|NCT02948582|156558023|FG001|Washout Period 1|Adverse Event|2|||
48646451|NCT02948582|156558024|FG002|Washout Period 1|Adverse Event|0|||
48646452|NCT02948582|156558025|FG003|Washout Period 1|Adverse Event|0|||
48646453|NCT02948582|156558026|FG004|Washout Period 1|Adverse Event|0|||
48646454|NCT02948582|156558027|FG005|Washout Period 1|Adverse Event|0|||
48646455|NCT02948582|156558022|FG000|Washout Period 1|Protocol Violation|0|||
48646456|NCT02948582|156558023|FG001|Washout Period 1|Protocol Violation|0|||
48646457|NCT02948582|156558024|FG002|Washout Period 1|Protocol Violation|0|||
48646458|NCT02948582|156558025|FG003|Washout Period 1|Protocol Violation|0|||
48646459|NCT02948582|156558026|FG004|Washout Period 1|Protocol Violation|0|||
48646460|NCT02948582|156558027|FG005|Washout Period 1|Protocol Violation|1|||
48646461|NCT02948582|156558022|FG000|Washout Period 2|Adverse Event|0|||
48646462|NCT02948582|156558023|FG001|Washout Period 2|Adverse Event|1|||
48646463|NCT02948582|156558024|FG002|Washout Period 2|Adverse Event|0|||
48646464|NCT02948582|156558025|FG003|Washout Period 2|Adverse Event|0|||
48646465|NCT02948582|156558026|FG004|Washout Period 2|Adverse Event|0|||
48646466|NCT02948582|156558027|FG005|Washout Period 2|Adverse Event|0|||
48646467|NCT02948582|156558022|FG000|Washout Period 2|personal reasons|0|||
48646468|NCT02948582|156558023|FG001|Washout Period 2|personal reasons|0|||
48646469|NCT02948582|156558024|FG002|Washout Period 2|personal reasons|0|||
48646470|NCT02948582|156558025|FG003|Washout Period 2|personal reasons|1|||
48646471|NCT02948582|156558026|FG004|Washout Period 2|personal reasons|0|||
48646472|NCT02948582|156558027|FG005|Washout Period 2|personal reasons|0|||
48646473|NCT02948582|156558022|FG000|Washout Period 4|Adverse Event|1|||
48646474|NCT02948582|156558023|FG001|Washout Period 4|Adverse Event|0|||
48646475|NCT02948582|156558024|FG002|Washout Period 4|Adverse Event|1|||
48646476|NCT02948582|156558025|FG003|Washout Period 4|Adverse Event|0|||
48646477|NCT02948582|156558026|FG004|Washout Period 4|Adverse Event|0|||
48646478|NCT02948582|156558027|FG005|Washout Period 4|Adverse Event|0|||
48646479|NCT01635998|156558028|FG000|Overall Study|Death|1|||
48646480|NCT01635998|156558029|FG001|Overall Study|Death|1|||
48646481|NCT01635998|156558028|FG000|Overall Study|Lost to Follow-up|2|||
48646482|NCT01635998|156558029|FG001|Overall Study|Lost to Follow-up|1|||
48646483|NCT01635998|156558028|FG000|Overall Study|Withdrawal by Subject|1|||
48646484|NCT01635998|156558029|FG001|Overall Study|Withdrawal by Subject|5|||
48646485|NCT01925768|156558030|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48646486|NCT01925768|156558031|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48646487|NCT01925768|156558030|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
48646488|NCT01925768|156558031|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
48646489|NCT01925768|156558030|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
48646490|NCT01925768|156558031|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
48646491|NCT01925768|156558030|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
48751595|NCT00543140|156936527|FG000|Overall Study|SAE leading to explant of SAGB|3|||
48646492|NCT01925768|156558031|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
48330402|NCT02736188|155407442|FG000|Overall Study|Other|6|||
48646493|NCT01925768|156558030|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
48646494|NCT01925768|156558031|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
48646495|NCT01925768|156558030|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
48646496|NCT01925768|156558031|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
48646497|NCT01925768|156558030|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
48646498|NCT01925768|156558031|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
48646499|NCT01925768|156558030|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
48646500|NCT01925768|156558031|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
48646501|NCT01925768|156558030|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
48646502|NCT01925768|156558031|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
48646503|NCT01925768|156558030|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
48646504|NCT01925768|156558031|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
48646505|NCT01925768|156558030|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
48646506|NCT01925768|156558031|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
48646507|NCT01340664|156558033|FG000|Overall Study|Adverse Event|0|||
48646508|NCT01340664|156558034|FG001|Overall Study|Adverse Event|1|||
48646509|NCT01340664|156558035|FG002|Overall Study|Adverse Event|7|||
48646510|NCT01340664|156558033|FG000|Overall Study|Lost to Follow-up|2|||
48646511|NCT01340664|156558034|FG001|Overall Study|Lost to Follow-up|0|||
48646512|NCT01340664|156558035|FG002|Overall Study|Lost to Follow-up|2|||
48646513|NCT01340664|156558033|FG000|Overall Study|Withdrawal by Subject|2|||
48646514|NCT01340664|156558034|FG001|Overall Study|Withdrawal by Subject|4|||
48646515|NCT01340664|156558035|FG002|Overall Study|Withdrawal by Subject|0|||
48646516|NCT01340664|156558033|FG000|Overall Study|Glycemic withdrawal criteria|2|||
48646517|NCT01340664|156558034|FG001|Overall Study|Glycemic withdrawal criteria|0|||
48751596|NCT00543140|156936527|FG000|Overall Study|Death|1|||
48751597|NCT00543140|156936527|FG000|Overall Study|Subject moved|1|||
48751598|NCT00543140|156936527|FG000|Overall Study|Conversion to different procedure|1|||
48751599|NCT01029795|156936528|FG000|Overall Study|Entry Criteria Not Met|2|||
48751600|NCT01029795|156936529|FG001|Overall Study|Entry Criteria Not Met|1|||
48751601|NCT01029795|156936528|FG000|Overall Study|Physician Decision|2|||
48751602|NCT01029795|156936529|FG001|Overall Study|Physician Decision|1|||
48751603|NCT01029795|156936528|FG000|Overall Study|Sponsor Decision|11|||
48751604|NCT01029795|156936529|FG001|Overall Study|Sponsor Decision|17|||
48751605|NCT01029795|156936528|FG000|Overall Study|Withdrawal by Subject|1|||
48751606|NCT01029795|156936529|FG001|Overall Study|Withdrawal by Subject|3|||
48751607|NCT03489720|156936533|FG000|Overall Study|Withdrawal by Subject|2|||
48751608|NCT03489720|156936534|FG001|Overall Study|Withdrawal by Subject|0|||
48751609|NCT02170298|156936535|FG000|Overall Study|Withdrawal by Subject|0|||
48751610|NCT02170298|156936536|FG001|Overall Study|Withdrawal by Subject|1|||
48751611|NCT02170298|156936535|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
48751612|NCT02170298|156936536|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
48751613|NCT00644995|156936537|FG000|Overall Study|Lost to Follow-up|1|||
48751614|NCT00644995|156936538|FG001|Overall Study|Lost to Follow-up|4|||
48751615|NCT00644995|156936537|FG000|Overall Study|Refused|1|||
48751616|NCT00644995|156936538|FG001|Overall Study|Refused|0|||
48751617|NCT03020160|156936539|FG000|Overall Study|Withdrawal by Subject|1|||
48751618|NCT03020160|156936540|FG001|Overall Study|Withdrawal by Subject|0|||
48751619|NCT02254486|156936541|FG000|Overall Study|Adverse Event|1|||
48751620|NCT02254486|156936542|FG001|Overall Study|Adverse Event|1|||
48751621|NCT02254486|156936541|FG000|Overall Study|Lack of Efficacy|1|||
48751622|NCT02254486|156936542|FG001|Overall Study|Lack of Efficacy|0|||
48751623|NCT02254486|156936541|FG000|Overall Study|Lost to Follow-up|2|||
48751624|NCT02254486|156936542|FG001|Overall Study|Lost to Follow-up|4|||
48751625|NCT02254486|156936541|FG000|Overall Study|Protocol Violation|1|||
48751626|NCT02254486|156936542|FG001|Overall Study|Protocol Violation|2|||
48751627|NCT02254486|156936541|FG000|Overall Study|Withdrawal by Subject|17|||
48751628|NCT02254486|156936542|FG001|Overall Study|Withdrawal by Subject|15|||
48751629|NCT02254486|156936541|FG000|Overall Study|GFR<60mL/min|16|||
48751630|NCT02254486|156936542|FG001|Overall Study|GFR<60mL/min|21|||
48751631|NCT02254486|156936541|FG000|Overall Study|Various|12|||
48751632|NCT02254486|156936542|FG001|Overall Study|Various|12|||
48751633|NCT03274440|156936544|FG000|Overall Study|Time commitment too great|1|||
48751634|NCT03274440|156936545|FG001|Overall Study|Time commitment too great|0|||
48751635|NCT03274440|156936546|FG002|Overall Study|Time commitment too great|0|||
48751636|NCT03274440|156936547|FG003|Overall Study|Time commitment too great|1|||
48751637|NCT03274440|156936548|FG004|Overall Study|Time commitment too great|0|||
48330403|NCT00240994|155407443|FG000|Overall Study|Lost to Follow-up|1|||
48330404|NCT00240994|155407443|FG000|Overall Study|Protocol Violation|1|||
48646518|NCT01340664|156558035|FG002|Overall Study|Glycemic withdrawal criteria|0|||
48751638|NCT03274440|156936549|FG005|Overall Study|Time commitment too great|0|||
48751639|NCT02759471|156936550|FG000|Overall Study|discomfort|2|||
48751640|NCT01291173|156936551|FG000|Overall Study|Adverse Event|0|||
48751641|NCT01291173|156936552|FG001|Overall Study|Adverse Event|3|||
48751642|NCT01291173|156936553|FG002|Overall Study|Adverse Event|1|||
48646519|NCT01340664|156558033|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
48646520|NCT01340664|156558034|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
48646521|NCT01340664|156558035|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
48646522|NCT01340664|156558033|FG000|Overall Study|Other|1|||
48751643|NCT01291173|156936554|FG003|Overall Study|Adverse Event|3|||
48751644|NCT01291173|156936551|FG000|Overall Study|Protocol Violation|7|||
48751645|NCT01291173|156936552|FG001|Overall Study|Protocol Violation|2|||
48751646|NCT01291173|156936553|FG002|Overall Study|Protocol Violation|2|||
48751647|NCT01291173|156936554|FG003|Overall Study|Protocol Violation|5|||
48751648|NCT01291173|156936551|FG000|Overall Study|Withdrawal by Subject|6|||
48751649|NCT01291173|156936552|FG001|Overall Study|Withdrawal by Subject|4|||
48646523|NCT01340664|156558034|FG001|Overall Study|Other|2|||
48646524|NCT01340664|156558035|FG002|Overall Study|Other|2|||
48646525|NCT00935493|156558037|FG000|Overall Study|Lost to Follow-up|1|||
48646526|NCT00935493|156558038|FG001|Overall Study|Lost to Follow-up|1|||
48646527|NCT00935493|156558039|FG002|Overall Study|Lost to Follow-up|1|||
48646528|NCT00935493|156558037|FG000|Overall Study|Treatment Discontinued|0|||
48646529|NCT00935493|156558038|FG001|Overall Study|Treatment Discontinued|1|||
48646530|NCT00935493|156558039|FG002|Overall Study|Treatment Discontinued|0|||
48646531|NCT01119066|156558040|FG000|Overall Study|Withdrawal by Subject|4|||
48646532|NCT01119066|156558041|FG001|Overall Study|Withdrawal by Subject|6|||
48646533|NCT01119066|156558042|FG002|Overall Study|Withdrawal by Subject|0|||
48646534|NCT01119066|156558043|FG003|Overall Study|Withdrawal by Subject|0|||
48646535|NCT01119066|156558040|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
48646536|NCT01119066|156558041|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
48646537|NCT01119066|156558042|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
48646538|NCT01119066|156558043|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
48646539|NCT01119066|156558040|FG000|Overall Study|Relapse identified before transplant|1|||
48646540|NCT01119066|156558041|FG001|Overall Study|Relapse identified before transplant|0|||
48646541|NCT01119066|156558042|FG002|Overall Study|Relapse identified before transplant|0|||
48646542|NCT01119066|156558043|FG003|Overall Study|Relapse identified before transplant|0|||
48646543|NCT01119066|156558040|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
48646544|NCT01119066|156558041|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
48646545|NCT01119066|156558042|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
48646546|NCT01119066|156558043|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
48646547|NCT01119066|156558040|FG000|Overall Study|Relapse identified before transplant|0|||
48646548|NCT01119066|156558041|FG001|Overall Study|Relapse identified before transplant|4|||
48646549|NCT01119066|156558042|FG002|Overall Study|Relapse identified before transplant|0|||
48646550|NCT01119066|156558043|FG003|Overall Study|Relapse identified before transplant|0|||
48646551|NCT01926444|156558044|FG000|Overall Study|Colonoscopy not performed|0|||
48646552|NCT01926444|156558045|FG001|Overall Study|Colonoscopy not performed|0|||
48646553|NCT01926444|156558046|FG002|Overall Study|Colonoscopy not performed|4|||
48646554|NCT01926444|156558047|FG003|Overall Study|Colonoscopy not performed|2|||
48646557|NCT01737762|156558057|FG000|Overall Study|Adverse Event|2|||
48646558|NCT01737762|156558058|FG001|Overall Study|Adverse Event|2|||
48646559|NCT01737762|156558057|FG000|Overall Study|Lost to Follow-up|1|||
48646560|NCT01737762|156558058|FG001|Overall Study|Lost to Follow-up|0|||
48646561|NCT01737762|156558057|FG000|Overall Study|Withdrawal by Subject|2|||
48646562|NCT01737762|156558058|FG001|Overall Study|Withdrawal by Subject|2|||
48646563|NCT01737762|156558057|FG000|Overall Study|Progressive disease|1|||
48646564|NCT01737762|156558058|FG001|Overall Study|Progressive disease|2|||
48751650|NCT01291173|156936553|FG002|Overall Study|Withdrawal by Subject|4|||
48751651|NCT01291173|156936554|FG003|Overall Study|Withdrawal by Subject|2|||
48646565|NCT01737762|156558057|FG000|Overall Study|Physician Decision|1|||
48646566|NCT01737762|156558058|FG001|Overall Study|Physician Decision|1|||
48646567|NCT01737762|156558057|FG000|Overall Study|Moved from area|2|||
48646568|NCT01737762|156558058|FG001|Overall Study|Moved from area|1|||
48646569|NCT01737762|156558057|FG000|Overall Study|Trial termination|11|||
48646570|NCT01737762|156558058|FG001|Overall Study|Trial termination|9|||
48646571|NCT04396795|156558060|FG000|Month 1|Lost to Follow-up|2|||
48646572|NCT04396795|156558061|FG001|Month 1|Lost to Follow-up|3|||
48646573|NCT04396795|156558060|FG000|Month 3|Lost to Follow-up|1|||
48646574|NCT04396795|156558061|FG001|Month 3|Lost to Follow-up|3|||
48646575|NCT04396795|156558060|FG000|Month 6|Lost to Follow-up|3|||
48646576|NCT04396795|156558061|FG001|Month 6|Lost to Follow-up|3|||
48646577|NCT01467466|156558063|FG000|Overall Study|Withdrawal by Subject|15|||
48646578|NCT01467466|156558064|FG001|Overall Study|Withdrawal by Subject|18|||
48646579|NCT01467466|156558065|FG002|Overall Study|Withdrawal by Subject|13|||
48646580|NCT01467466|156558066|FG003|Overall Study|Withdrawal by Subject|11|||
48646581|NCT01467466|156558063|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
48646582|NCT01467466|156558064|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
48646583|NCT01467466|156558065|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
48646584|NCT01467466|156558066|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
48646585|NCT01467466|156558063|FG000|Overall Study|Procedure Cancelled|46|||
48646586|NCT01467466|156558064|FG001|Overall Study|Procedure Cancelled|45|||
48646587|NCT01467466|156558065|FG002|Overall Study|Procedure Cancelled|25|||
48646588|NCT01467466|156558066|FG003|Overall Study|Procedure Cancelled|29|||
48646589|NCT01467466|156558063|FG000|Overall Study|No Endpoint Blood Draw|38|||
48646590|NCT01467466|156558064|FG001|Overall Study|No Endpoint Blood Draw|32|||
48646591|NCT01467466|156558065|FG002|Overall Study|No Endpoint Blood Draw|51|||
48646592|NCT01467466|156558066|FG003|Overall Study|No Endpoint Blood Draw|43|||
48646593|NCT02131311|156558069|FG000|Overall Study|Adverse Event|2|||
48646594|NCT02131311|156558069|FG000|Overall Study|Protocol Violation|1|||
48646595|NCT02131311|156558069|FG000|Overall Study|Lost to Follow-up|1|||
48646596|NCT00851890|156558099|FG000|Overall Study|Lost to Follow-up|0|||
48646597|NCT00851890|156558100|FG001|Overall Study|Lost to Follow-up|1|||
48646598|NCT00851890|156558101|FG002|Overall Study|Lost to Follow-up|0|||
48646599|NCT00851890|156558102|FG003|Overall Study|Lost to Follow-up|1|||
48646600|NCT03008070|156558104|FG000|Overall Study|Adverse Event|3|||
48646601|NCT03008070|156558105|FG001|Overall Study|Adverse Event|3|||
48646602|NCT03008070|156558106|FG002|Overall Study|Adverse Event|3|||
48646603|NCT03008070|156558104|FG000|Overall Study|Lost to Follow-up|1|||
48646604|NCT03008070|156558105|FG001|Overall Study|Lost to Follow-up|1|||
48646605|NCT03008070|156558106|FG002|Overall Study|Lost to Follow-up|0|||
48646606|NCT03008070|156558104|FG000|Overall Study|Non compliance|0|||
48646607|NCT03008070|156558105|FG001|Overall Study|Non compliance|1|||
48646608|NCT03008070|156558106|FG002|Overall Study|Non compliance|1|||
48646609|NCT03008070|156558104|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
48646610|NCT03008070|156558105|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
48646611|NCT03008070|156558106|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
48646612|NCT03008070|156558104|FG000|Overall Study|Withdrawal by Subject|2|||
48646613|NCT03008070|156558105|FG001|Overall Study|Withdrawal by Subject|0|||
48646614|NCT03008070|156558106|FG002|Overall Study|Withdrawal by Subject|1|||
48646615|NCT03008070|156558104|FG000|Overall Study|Use of prohibited drug|0|||
48646616|NCT03008070|156558105|FG001|Overall Study|Use of prohibited drug|0|||
48646617|NCT03008070|156558106|FG002|Overall Study|Use of prohibited drug|2|||
48646618|NCT00556439|156558107|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
48646619|NCT00556439|156558108|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
48646620|NCT00556439|156558109|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
48646621|NCT00556439|156558110|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
48646622|NCT00556439|156558107|FG000|Study Entry to Week 12|Physician Decision|1|||
48646623|NCT00556439|156558108|FG001|Study Entry to Week 12|Physician Decision|0|||
48646624|NCT00556439|156558109|FG002|Study Entry to Week 12|Physician Decision|0|||
48646625|NCT00556439|156558110|FG003|Study Entry to Week 12|Physician Decision|0|||
48646626|NCT00556439|156558107|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
48646627|NCT00556439|156558108|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
48646628|NCT00556439|156558109|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
48646629|NCT00556439|156558110|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
48646630|NCT00556439|156558107|FG000|Study Entry to Week 12|Recurrent infection|1|||
48646631|NCT00556439|156558108|FG001|Study Entry to Week 12|Recurrent infection|0|||
48646632|NCT00556439|156558109|FG002|Study Entry to Week 12|Recurrent infection|0|||
48646633|NCT00556439|156558110|FG003|Study Entry to Week 12|Recurrent infection|0|||
48646634|NCT00556439|156558107|FG000|Study Entry to Week 12|Malignancy|0|||
48646635|NCT00556439|156558108|FG001|Study Entry to Week 12|Malignancy|0|||
48646636|NCT00556439|156558109|FG002|Study Entry to Week 12|Malignancy|1|||
48646637|NCT00556439|156558110|FG003|Study Entry to Week 12|Malignancy|0|||
48646638|NCT00556439|156558107|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
48646639|NCT00556439|156558108|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
48751652|NCT01291173|156936551|FG000|Overall Study|Lost to Follow-up|4|||
48330405|NCT00240994|155407443|FG000|Overall Study|Graft failure|1|||
48646640|NCT00556439|156558109|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
48646641|NCT00556439|156558110|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
48646642|NCT00556439|156558107|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
48646643|NCT00556439|156558108|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
48646644|NCT00556439|156558109|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
48646645|NCT00556439|156558110|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
48646646|NCT00556439|156558107|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
48646647|NCT00556439|156558108|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
48646648|NCT00556439|156558109|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
48646649|NCT00556439|156558110|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
48646650|NCT00556439|156558107|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
48646651|NCT00556439|156558108|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
48646652|NCT00556439|156558109|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
48646653|NCT00556439|156558110|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
48646654|NCT05005273|156558114|FG000|Overall Study|Study Terminated|1|||
48646655|NCT05005273|156558115|FG001|Overall Study|Study Terminated|0|||
48646656|NCT03108521|156558116|FG000|Overall Study|Lost to Follow-up|3|||
48646657|NCT03108521|156558117|FG001|Overall Study|Lost to Follow-up|0|||
48646658|NCT03108521|156558116|FG000|Overall Study|Lack of Efficacy|2|||
48646659|NCT03108521|156558117|FG001|Overall Study|Lack of Efficacy|0|||
48646660|NCT03108521|156558116|FG000|Overall Study|Physician Decision|4|||
48646661|NCT03108521|156558117|FG001|Overall Study|Physician Decision|0|||
48646662|NCT03108521|156558116|FG000|Overall Study|Adverse Event|3|||
48646663|NCT03108521|156558117|FG001|Overall Study|Adverse Event|0|||
48646664|NCT00678288|156559319|FG000|Overall Study|Adverse Event|0|||
48646665|NCT00678288|156559320|FG001|Overall Study|Adverse Event|2|||
48646666|NCT00678288|156559319|FG000|Overall Study|Withdrawal by Subject|1|||
48646667|NCT00678288|156559320|FG001|Overall Study|Withdrawal by Subject|1|||
48646668|NCT00678288|156559319|FG000|Overall Study|Study terminated by the sponsor|2|||
48646669|NCT00678288|156559320|FG001|Overall Study|Study terminated by the sponsor|0|||
48646670|NCT00678288|156559319|FG000|Overall Study|Not compliant with study medication|0|||
48646671|NCT00678288|156559320|FG001|Overall Study|Not compliant with study medication|1|||
48646672|NCT00678288|156559319|FG000|Overall Study|Switch to commercial drug|0|||
48646673|NCT00678288|156559320|FG001|Overall Study|Switch to commercial drug|1|||
48646674|NCT00678288|156559319|FG000|Overall Study|Reason not reported|1|||
48646675|NCT00678288|156559320|FG001|Overall Study|Reason not reported|0|||
48646676|NCT00678288|156559319|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
48646677|NCT00678288|156559320|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
48646678|NCT00720356|156559323|FG000|Registration to Study|Determined to have methylated MGMT|67|||
48646679|NCT00720356|156559323|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
48646680|NCT00720356|156559323|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
48646681|NCT00720356|156559323|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
48646682|NCT00720356|156559323|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
48646683|NCT00720356|156559323|FG000|Follow up Until Death|Withdrawal by Subject|1|||
48646684|NCT00720356|156559323|FG000|Follow up Until Death|Alive at last data collection|4|||
48646685|NCT01693250|156559324|FG000|Overall Study|Lost to Follow-up|2|||
48646686|NCT01693250|156559325|FG001|Overall Study|Lost to Follow-up|2|||
48646687|NCT00682929|156559326|FG000|Overall Study|Adverse Event|4|||
48646688|NCT00682929|156559327|FG001|Overall Study|Adverse Event|1|||
48646689|NCT00682929|156559328|FG002|Overall Study|Adverse Event|1|||
48646690|NCT00682929|156559326|FG000|Overall Study|Withdrawal by Subject|1|||
48646691|NCT00682929|156559327|FG001|Overall Study|Withdrawal by Subject|2|||
48646692|NCT00682929|156559328|FG002|Overall Study|Withdrawal by Subject|1|||
48646693|NCT00682929|156559326|FG000|Overall Study|dosing compliance < 80%|0|||
48646694|NCT00682929|156559327|FG001|Overall Study|dosing compliance < 80%|2|||
48646695|NCT00682929|156559328|FG002|Overall Study|dosing compliance < 80%|0|||
48646696|NCT00682929|156559326|FG000|Overall Study|lag in DEA renewal|1|||
48646697|NCT00682929|156559327|FG001|Overall Study|lag in DEA renewal|0|||
48646698|NCT00682929|156559328|FG002|Overall Study|lag in DEA renewal|0|||
48646699|NCT01650831|156559331|FG000|Overall Study|Screen failure|1|||
48646700|NCT00887159|156559332|FG000|Overall Study|Disease progression|6|||
48646701|NCT00887159|156559333|FG001|Overall Study|Disease progression|39|||
48646702|NCT00887159|156559334|FG002|Overall Study|Disease progression|33|||
48646703|NCT00887159|156559332|FG000|Overall Study|Adverse Event|3|||
48646704|NCT00887159|156559333|FG001|Overall Study|Adverse Event|4|||
48646705|NCT00887159|156559334|FG002|Overall Study|Adverse Event|17|||
48646706|NCT00887159|156559332|FG000|Overall Study|Death|2|||
48646707|NCT00887159|156559333|FG001|Overall Study|Death|2|||
48427671|NCT01254604|155754676|FG000|Overall Study|Protocol Violation|2|||
48646708|NCT00887159|156559334|FG002|Overall Study|Death|0|||
48646709|NCT00887159|156559332|FG000|Overall Study|Withdrawal by Subject|4|||
48646710|NCT00887159|156559333|FG001|Overall Study|Withdrawal by Subject|4|||
48646711|NCT00887159|156559334|FG002|Overall Study|Withdrawal by Subject|2|||
48646712|NCT00887159|156559332|FG000|Overall Study|Alternative therapy|2|||
48646713|NCT00887159|156559333|FG001|Overall Study|Alternative therapy|0|||
48646714|NCT00887159|156559334|FG002|Overall Study|Alternative therapy|0|||
48646715|NCT00887159|156559332|FG000|Overall Study|Physician Decision|1|||
48646716|NCT00887159|156559333|FG001|Overall Study|Physician Decision|1|||
48646717|NCT00887159|156559334|FG002|Overall Study|Physician Decision|0|||
48646718|NCT00887159|156559332|FG000|Overall Study|Sympomatic deterioration|1|||
48646719|NCT00887159|156559333|FG001|Overall Study|Sympomatic deterioration|0|||
48646720|NCT00887159|156559334|FG002|Overall Study|Sympomatic deterioration|0|||
48646721|NCT00887159|156559332|FG000|Overall Study|Treatment delayed|1|||
48646722|NCT00887159|156559333|FG001|Overall Study|Treatment delayed|1|||
48646723|NCT00887159|156559334|FG002|Overall Study|Treatment delayed|0|||
48646724|NCT00887159|156559332|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
48646725|NCT00887159|156559333|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
48646726|NCT00887159|156559334|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
48646727|NCT00887159|156559332|FG000|Overall Study|Received more tx instead of observation|1|||
48646728|NCT00887159|156559333|FG001|Overall Study|Received more tx instead of observation|0|||
48646729|NCT00887159|156559334|FG002|Overall Study|Received more tx instead of observation|0|||
48646730|NCT00887159|156559332|FG000|Overall Study|Ineligible|5|||
48646731|NCT00887159|156559333|FG001|Overall Study|Ineligible|1|||
48646732|NCT00887159|156559334|FG002|Overall Study|Ineligible|0|||
48646733|NCT00887159|156559332|FG000|Overall Study|Never started assigned therapy|3|||
48646734|NCT00887159|156559333|FG001|Overall Study|Never started assigned therapy|3|||
48646735|NCT00887159|156559334|FG002|Overall Study|Never started assigned therapy|4|||
48646736|NCT01048242|156559340|FG000|Overall Study|See study flow chart|4|||
48646737|NCT01048242|156559341|FG001|Overall Study|See study flow chart|2|||
48646738|NCT02391311|156559342|FG000|Overall Study|Lost to Follow-up|2|||
48646739|NCT02391311|156559343|FG001|Overall Study|Lost to Follow-up|1|||
48646740|NCT02391311|156559342|FG000|Overall Study|deemed ineligible after baseline|1|||
48646741|NCT02391311|156559343|FG001|Overall Study|deemed ineligible after baseline|1|||
48646742|NCT01772550|156559344|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
48646743|NCT01772550|156559345|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
48646744|NCT01772550|156559346|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
48646745|NCT01772550|156559344|FG000|Overall Study|Adverse Event|0|||
48646746|NCT01772550|156559345|FG001|Overall Study|Adverse Event|0|||
48646747|NCT01772550|156559346|FG002|Overall Study|Adverse Event|1|||
48646748|NCT04245449|156559351|FG000|Overall Study|COVID shutdown|7|||
48646749|NCT00861757|156559352|FG000|Overall Study|Adverse Event|1|||
48646750|NCT00861757|156559353|FG001|Overall Study|Adverse Event|5|||
48646751|NCT00861757|156559354|FG002|Overall Study|Adverse Event|7|||
48646752|NCT00861757|156559355|FG003|Overall Study|Adverse Event|2|||
48646753|NCT00861757|156559352|FG000|Overall Study|Entry Criteria Not Met|1|||
48646754|NCT00861757|156559353|FG001|Overall Study|Entry Criteria Not Met|2|||
48646755|NCT00861757|156559354|FG002|Overall Study|Entry Criteria Not Met|1|||
48646756|NCT00861757|156559355|FG003|Overall Study|Entry Criteria Not Met|1|||
48646757|NCT00861757|156559352|FG000|Overall Study|Lack of Efficacy|3|||
48646758|NCT00861757|156559353|FG001|Overall Study|Lack of Efficacy|1|||
48646759|NCT00861757|156559354|FG002|Overall Study|Lack of Efficacy|0|||
48646760|NCT00861757|156559355|FG003|Overall Study|Lack of Efficacy|1|||
48646761|NCT00861757|156559352|FG000|Overall Study|Lost to Follow-up|1|||
48646762|NCT00861757|156559353|FG001|Overall Study|Lost to Follow-up|0|||
48646763|NCT00861757|156559354|FG002|Overall Study|Lost to Follow-up|1|||
48646764|NCT00861757|156559355|FG003|Overall Study|Lost to Follow-up|1|||
48646765|NCT00861757|156559352|FG000|Overall Study|Physician Decision|0|||
48646766|NCT00861757|156559353|FG001|Overall Study|Physician Decision|0|||
48646767|NCT00861757|156559354|FG002|Overall Study|Physician Decision|0|||
48646768|NCT00861757|156559355|FG003|Overall Study|Physician Decision|1|||
48646769|NCT00861757|156559352|FG000|Overall Study|Protocol Violation|2|||
48646770|NCT00861757|156559353|FG001|Overall Study|Protocol Violation|2|||
48646771|NCT00861757|156559354|FG002|Overall Study|Protocol Violation|4|||
48646772|NCT00861757|156559355|FG003|Overall Study|Protocol Violation|1|||
48646773|NCT00861757|156559352|FG000|Overall Study|Withdrawal by Subject|1|||
48646774|NCT00861757|156559353|FG001|Overall Study|Withdrawal by Subject|5|||
48646775|NCT00861757|156559354|FG002|Overall Study|Withdrawal by Subject|5|||
48751653|NCT01291173|156936552|FG001|Overall Study|Lost to Follow-up|6|||
48751654|NCT01291173|156936553|FG002|Overall Study|Lost to Follow-up|3|||
48751655|NCT01291173|156936554|FG003|Overall Study|Lost to Follow-up|2|||
48751656|NCT01291173|156936551|FG000|Overall Study|Unable to meet visit schedule|0|||
48646776|NCT00861757|156559355|FG003|Overall Study|Withdrawal by Subject|2|||
48646777|NCT03308968|156559356|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
48646778|NCT03308968|156559357|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
48646779|NCT03308968|156559358|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
48646780|NCT03308968|156559356|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
48646781|NCT03308968|156559357|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
48646782|NCT03308968|156559358|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
48646783|NCT03308968|156559356|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
48751657|NCT01291173|156936552|FG001|Overall Study|Unable to meet visit schedule|0|||
48646784|NCT03308968|156559357|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
48646785|NCT03308968|156559358|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
48646786|NCT03308968|156559356|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
48646787|NCT03308968|156559357|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
48646788|NCT03308968|156559358|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
48646789|NCT03308968|156559356|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
48646790|NCT03308968|156559357|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
48646791|NCT03308968|156559358|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
48646792|NCT03308968|156559356|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
48646793|NCT03308968|156559357|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
48646794|NCT03308968|156559358|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
48646795|NCT03308968|156559356|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
48646796|NCT03308968|156559357|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
48646797|NCT03308968|156559358|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
48646798|NCT03308968|156559356|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
48646799|NCT03308968|156559357|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
48646800|NCT03308968|156559358|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
48646801|NCT03308968|156559356|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
48646802|NCT03308968|156559357|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
48646803|NCT03308968|156559358|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
48646804|NCT03308968|156559356|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
48646805|NCT03308968|156559357|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
48646806|NCT03308968|156559358|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
48646807|NCT03308968|156559356|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
48646808|NCT03308968|156559357|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
48646809|NCT03308968|156559358|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
48646810|NCT03308968|156559356|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
48646811|NCT03308968|156559357|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
48646812|NCT03308968|156559358|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
48646813|NCT03308968|156559356|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
48646814|NCT03308968|156559357|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
48646815|NCT03308968|156559358|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
48646816|NCT03308968|156559356|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
48646817|NCT03308968|156559357|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
48646818|NCT03308968|156559358|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
48646819|NCT01823107|156559359|FG000|Overall Study|Withdrawal by Subject|1|||
48646820|NCT02840253|156559360|FG000|Overall Study|Unsuccessful block|4|||
48646821|NCT03458325|156559361|FG000|Overall Study|Withdrawal by Subject|1|||
48646822|NCT01947283|156559365|FG000|Overall Study|Death|1|||
48646823|NCT01947283|156559366|FG001|Overall Study|Death|1|||
48646824|NCT01947283|156559367|FG002|Overall Study|Death|1|||
48646825|NCT01947283|156559368|FG003|Overall Study|Death|0|||
48646826|NCT01947283|156559369|FG004|Overall Study|Death|0|||
48646827|NCT01947283|156559370|FG005|Overall Study|Death|0|||
48646828|NCT01947283|156559371|FG006|Overall Study|Death|0|||
48646829|NCT01947283|156559365|FG000|Overall Study|Lost to Follow-up|4|||
48646830|NCT01947283|156559366|FG001|Overall Study|Lost to Follow-up|6|||
48646831|NCT01947283|156559367|FG002|Overall Study|Lost to Follow-up|5|||
48646832|NCT01947283|156559368|FG003|Overall Study|Lost to Follow-up|5|||
48646833|NCT01947283|156559369|FG004|Overall Study|Lost to Follow-up|0|||
48646834|NCT01947283|156559370|FG005|Overall Study|Lost to Follow-up|2|||
48646835|NCT01947283|156559371|FG006|Overall Study|Lost to Follow-up|5|||
48646836|NCT01947283|156559365|FG000|Overall Study|Withdrawal by Subject|10|||
48646837|NCT01947283|156559366|FG001|Overall Study|Withdrawal by Subject|8|||
48646838|NCT01947283|156559367|FG002|Overall Study|Withdrawal by Subject|4|||
48646839|NCT01947283|156559368|FG003|Overall Study|Withdrawal by Subject|1|||
48646840|NCT01947283|156559369|FG004|Overall Study|Withdrawal by Subject|0|||
48646841|NCT01947283|156559370|FG005|Overall Study|Withdrawal by Subject|0|||
48646842|NCT01947283|156559371|FG006|Overall Study|Withdrawal by Subject|2|||
48646843|NCT01947283|156559365|FG000|Overall Study|No Clinical Recording|12|||
48646844|NCT01947283|156559366|FG001|Overall Study|No Clinical Recording|6|||
48646845|NCT01947283|156559367|FG002|Overall Study|No Clinical Recording|8|||
48646846|NCT01947283|156559368|FG003|Overall Study|No Clinical Recording|10|||
48646847|NCT01947283|156559369|FG004|Overall Study|No Clinical Recording|0|||
48646848|NCT01947283|156559370|FG005|Overall Study|No Clinical Recording|0|||
48646849|NCT01947283|156559371|FG006|Overall Study|No Clinical Recording|0|||
48646850|NCT01947283|156559365|FG000|Overall Study|Non-coding Clinical Recording language|0|||
48646851|NCT01947283|156559366|FG001|Overall Study|Non-coding Clinical Recording language|0|||
48646852|NCT01947283|156559367|FG002|Overall Study|Non-coding Clinical Recording language|0|||
48646853|NCT01947283|156559368|FG003|Overall Study|Non-coding Clinical Recording language|1|||
48646854|NCT01947283|156559369|FG004|Overall Study|Non-coding Clinical Recording language|0|||
48646855|NCT01947283|156559370|FG005|Overall Study|Non-coding Clinical Recording language|0|||
48646856|NCT01947283|156559371|FG006|Overall Study|Non-coding Clinical Recording language|0|||
48646857|NCT01947283|156559365|FG000|Overall Study|Missing Follow-up Assessment|2|||
48646858|NCT01947283|156559366|FG001|Overall Study|Missing Follow-up Assessment|2|||
48646859|NCT01947283|156559367|FG002|Overall Study|Missing Follow-up Assessment|3|||
48646860|NCT01947283|156559368|FG003|Overall Study|Missing Follow-up Assessment|0|||
48646861|NCT01947283|156559369|FG004|Overall Study|Missing Follow-up Assessment|0|||
48646862|NCT01947283|156559370|FG005|Overall Study|Missing Follow-up Assessment|2|||
48646863|NCT01947283|156559371|FG006|Overall Study|Missing Follow-up Assessment|0|||
48646864|NCT01947283|156559365|FG000|Overall Study|No patients were enrolled in study|0|||
48646865|NCT01947283|156559366|FG001|Overall Study|No patients were enrolled in study|0|||
48646866|NCT01947283|156559367|FG002|Overall Study|No patients were enrolled in study|0|||
48646867|NCT01947283|156559368|FG003|Overall Study|No patients were enrolled in study|0|||
48646868|NCT01947283|156559369|FG004|Overall Study|No patients were enrolled in study|0|||
48646869|NCT01947283|156559370|FG005|Overall Study|No patients were enrolled in study|3|||
48646870|NCT01947283|156559371|FG006|Overall Study|No patients were enrolled in study|1|||
48646871|NCT00430989|156559372|FG000|Overall Study|Lost to Follow-up|2|||
48646872|NCT00430989|156559373|FG001|Overall Study|Lost to Follow-up|3|||
48646873|NCT00430989|156559372|FG000|Overall Study|Withdrawal by Subject|15|||
48646874|NCT00430989|156559373|FG001|Overall Study|Withdrawal by Subject|14|||
48646875|NCT00430989|156559372|FG000|Overall Study|Protocol Violation|30|||
48646876|NCT00430989|156559373|FG001|Overall Study|Protocol Violation|37|||
48646877|NCT00430989|156559372|FG000|Overall Study|Not eligible|13|||
48646878|NCT00430989|156559373|FG001|Overall Study|Not eligible|6|||
48646879|NCT01833494|156559374|FG000|Overall Study|Adverse Event|24|||
48646880|NCT01833494|156559374|FG000|Overall Study|Physician Decision|6|||
48646881|NCT01833494|156559374|FG000|Overall Study|Withdrawal by Subject|6|||
48646882|NCT01833494|156559374|FG000|Overall Study|Decrease in serum phosphorus|4|||
48646883|NCT01833494|156559374|FG000|Overall Study|Decrease in serum calcium|4|||
48646884|NCT01833494|156559374|FG000|Overall Study|Increase in serum ferritin|1|||
48646885|NCT01014767|156559375|FG000|Overall Study|PI left institution, data unavailable|12|||
48646886|NCT01014767|156559376|FG001|Overall Study|PI left institution, data unavailable|1|||
48646887|NCT01014767|156559377|FG002|Overall Study|PI left institution, data unavailable|4|||
48646888|NCT01014767|156559378|FG003|Overall Study|PI left institution, data unavailable|1|||
48646889|NCT04263766|156559379|FG000|Overall Study|Withdrawal by Subject|6|||
48646890|NCT04263766|156559380|FG001|Overall Study|Withdrawal by Subject|4|||
48646891|NCT04263766|156559379|FG000|Overall Study|Lack of Efficacy|1|||
48646892|NCT04263766|156559380|FG001|Overall Study|Lack of Efficacy|3|||
48646893|NCT02266147|156559381|FG000|PART 1: Dose Escalation|Physician Decision|0|||
48646894|NCT02266147|156559382|FG001|PART 1: Dose Escalation|Physician Decision|0|||
48646895|NCT02266147|156559383|FG002|PART 1: Dose Escalation|Physician Decision|1|||
48646896|NCT02266147|156559384|FG003|PART 1: Dose Escalation|Physician Decision|0|||
48646897|NCT02266147|156559381|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
48646898|NCT02266147|156559382|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
48646899|NCT02266147|156559383|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
48646900|NCT02266147|156559384|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
48646901|NCT02266147|156559381|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
48646902|NCT02266147|156559382|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
48646903|NCT02266147|156559383|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
48646904|NCT02266147|156559384|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
48646905|NCT02266147|156559381|FG000|PART 1: Dose Escalation|Other|1|||
48646906|NCT02266147|156559382|FG001|PART 1: Dose Escalation|Other|1|||
48646907|NCT02266147|156559383|FG002|PART 1: Dose Escalation|Other|0|||
48646908|NCT02266147|156559384|FG003|PART 1: Dose Escalation|Other|0|||
48646909|NCT02266147|156559381|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
48646910|NCT02266147|156559382|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
48646911|NCT02266147|156559383|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
48646912|NCT02266147|156559384|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
48646913|NCT02266147|156559381|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
48646914|NCT02266147|156559382|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
48751658|NCT01291173|156936553|FG002|Overall Study|Unable to meet visit schedule|1|||
48751659|NCT01291173|156936554|FG003|Overall Study|Unable to meet visit schedule|0|||
48751660|NCT01291173|156936551|FG000|Overall Study|Lack of compliance|0|||
48751661|NCT01291173|156936552|FG001|Overall Study|Lack of compliance|0|||
48751662|NCT01291173|156936553|FG002|Overall Study|Lack of compliance|0|||
48751663|NCT01291173|156936554|FG003|Overall Study|Lack of compliance|1|||
48751664|NCT01291173|156936551|FG000|Overall Study|Subject was unblinded|0|||
48751665|NCT01291173|156936552|FG001|Overall Study|Subject was unblinded|0|||
48751666|NCT01291173|156936553|FG002|Overall Study|Subject was unblinded|1|||
48751667|NCT01291173|156936554|FG003|Overall Study|Subject was unblinded|0|||
48751668|NCT01291173|156936551|FG000|Overall Study|Excluded therapy|0|||
48751669|NCT01291173|156936552|FG001|Overall Study|Excluded therapy|0|||
48751670|NCT01291173|156936553|FG002|Overall Study|Excluded therapy|1|||
48751671|NCT01291173|156936554|FG003|Overall Study|Excluded therapy|0|||
48751672|NCT00938639|156936555|FG000|Overall Study|Moved away from study area|0|||
48751673|NCT00938639|156936556|FG001|Overall Study|Moved away from study area|1|||
48751674|NCT00938639|156936555|FG000|Overall Study|Lost to Follow-up|1|||
48751675|NCT00938639|156936556|FG001|Overall Study|Lost to Follow-up|2|||
48751676|NCT00938639|156936555|FG000|Overall Study|Family issues|1|||
48751677|NCT00938639|156936556|FG001|Overall Study|Family issues|1|||
48751678|NCT00938639|156936555|FG000|Overall Study|Participant noncompliance|1|||
48751679|NCT00938639|156936556|FG001|Overall Study|Participant noncompliance|0|||
48751680|NCT04876274|156936557|FG000|Overall Study|Lost to Follow-up|9|||
48751681|NCT04876274|156936558|FG001|Overall Study|Lost to Follow-up|12|||
48751682|NCT00489541|156936559|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
48751683|NCT00489541|156936560|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
48751684|NCT00489541|156936559|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
48751685|NCT00489541|156936560|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
48751686|NCT00489541|156936559|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
48751687|NCT00489541|156936560|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
48751688|NCT00489541|156936559|FG000|12-Month Clinical Follow-up|Death|3|||
48751689|NCT00489541|156936560|FG001|12-Month Clinical Follow-up|Death|2|||
48751690|NCT00489541|156936559|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
48751691|NCT00489541|156936560|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
48751692|NCT00489541|156936559|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
48751693|NCT00489541|156936560|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
48751694|NCT04326231|156936561|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
48751695|NCT00003479|156936562|FG000|Overall Study|Not evaluable|3|||
48751696|NCT02709785|156936563|FG000|Overall Study|Withdrawal by Subject|1|||
48751697|NCT02709785|156936564|FG001|Overall Study|Withdrawal by Subject|2|||
48751698|NCT02709785|156936565|FG002|Overall Study|Withdrawal by Subject|1|||
48751699|NCT01980992|156936580|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
48751700|NCT01980992|156936581|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
48751701|NCT01980992|156936580|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
48751702|NCT01980992|156936581|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
48751703|NCT01980992|156936580|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
48646915|NCT02266147|156559383|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
48646916|NCT02266147|156559384|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
48646917|NCT02168101|156559385|FG000|Overall Study|Death|2|||
48646918|NCT02168101|156559386|FG001|Overall Study|Death|2|||
48751704|NCT01980992|156936581|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
48751705|NCT01980992|156936580|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
48751706|NCT01980992|156936581|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
48646919|NCT02168101|156559387|FG002|Overall Study|Death|1|||
48646920|NCT00383331|156559388|FG000|Overall Study|Protocol Violation|0|||
48646921|NCT00383331|156559389|FG001|Overall Study|Protocol Violation|1|||
48646922|NCT01766037|156559392|FG000|Overall Study|Adverse Event|1|||
48646923|NCT01766037|156559393|FG001|Overall Study|Adverse Event|0|||
48646924|NCT01766037|156559392|FG000|Overall Study|Lack of Efficacy|1|||
48646925|NCT01766037|156559393|FG001|Overall Study|Lack of Efficacy|0|||
48646926|NCT01766037|156559392|FG000|Overall Study|Lost to Follow-up|0|||
48646927|NCT01766037|156559393|FG001|Overall Study|Lost to Follow-up|10|||
48646928|NCT01766037|156559392|FG000|Overall Study|Physician Decision|0|||
48646929|NCT01766037|156559393|FG001|Overall Study|Physician Decision|1|||
48646930|NCT01766037|156559392|FG000|Overall Study|Withdrawal by Subject|18|||
48646931|NCT01766037|156559393|FG001|Overall Study|Withdrawal by Subject|16|||
48646932|NCT01766037|156559392|FG000|Overall Study|Moved from area|5|||
48646933|NCT01766037|156559393|FG001|Overall Study|Moved from area|0|||
48646934|NCT01766037|156559392|FG000|Overall Study|medical - unrelated|1|||
48646935|NCT01766037|156559393|FG001|Overall Study|medical - unrelated|2|||
48646936|NCT01766037|156559392|FG000|Overall Study|nausea / discomfort|3|||
48646937|NCT01766037|156559393|FG001|Overall Study|nausea / discomfort|0|||
48646938|NCT00770562|156559396|FG000|Overall Study|Did not take treatment|1|||
48646939|NCT00770562|156559397|FG001|Overall Study|Did not take treatment|1|||
48751707|NCT01980992|156936580|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
48751708|NCT01980992|156936581|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
48751709|NCT01980992|156936580|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
48751710|NCT01980992|156936581|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
48751711|NCT02651922|156936582|FG000|Overall Study|due to exclusion criteria|2|||
48751712|NCT01829191|156936583|FG000|Overall Study|Relocation|0|||
48751713|NCT01829191|156936584|FG001|Overall Study|Relocation|1|||
48751714|NCT01829191|156936583|FG000|Overall Study|Lens discomfort|0|||
48646940|NCT01643408|156559398|FG000|Overall Study|Adverse Event|12|||
48646941|NCT01643408|156559398|FG000|Overall Study|Other|2|||
48646942|NCT02236572|156559399|FG000|Overall Study|Withdrawal by Subject|1|||
48646943|NCT02236572|156559399|FG000|Overall Study|Protocol Violation|1|||
48646944|NCT02236572|156559399|FG000|Overall Study|Lost to Follow-up|1|||
48646945|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
48751715|NCT01829191|156936584|FG001|Overall Study|Lens discomfort|3|||
48751716|NCT01829191|156936583|FG000|Overall Study|Lens handling difficulty|1|||
48646946|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
48646947|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
48646948|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
48751717|NCT01829191|156936584|FG001|Overall Study|Lens handling difficulty|4|||
48751718|NCT01829191|156936583|FG000|Overall Study|Protocol Violation|4|||
48751719|NCT01829191|156936584|FG001|Overall Study|Protocol Violation|1|||
48751720|NCT01829191|156936583|FG000|Overall Study|Withdrawal by Subject|2|||
48751721|NCT01829191|156936584|FG001|Overall Study|Withdrawal by Subject|3|||
48751722|NCT01829191|156936583|FG000|Overall Study|Lost to Follow-up|0|||
48751723|NCT01829191|156936584|FG001|Overall Study|Lost to Follow-up|1|||
48751724|NCT01829191|156936583|FG000|Overall Study|Subject was fit for ortho - k|0|||
48751725|NCT01829191|156936584|FG001|Overall Study|Subject was fit for ortho - k|1|||
48646949|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Death|58|||
48646950|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Death|65|||
48646951|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Adverse Event|28|||
48646952|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Adverse Event|40|||
48646953|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Disease Progression|22|||
48751726|NCT01426373|156936585|FG000|Overall Study|Adverse Event|6|||
48751727|NCT01426373|156936585|FG000|Overall Study|Lost to Follow-up|14|||
48751728|NCT01426373|156936585|FG000|Overall Study|Participant Convenience|10|||
48751729|NCT01426373|156936585|FG000|Overall Study|Miscellaneous Reasons|4|||
48751730|NCT04952402|156936586|FG000|Overall Study|Lost to Follow-up|1|||
48751731|NCT04952402|156936587|FG001|Overall Study|Lost to Follow-up|3|||
48751732|NCT04952402|156936586|FG000|Overall Study|Lack Of Venous Access|0|||
48751733|NCT04952402|156936587|FG001|Overall Study|Lack Of Venous Access|1|||
48751734|NCT00587639|156936588|FG000|Overall Study|Withdrawal by Subject|1|||
48751735|NCT01896531|156936589|FG000|Overall Study|Death|57|||
48751736|NCT01896531|156936590|FG001|Overall Study|Death|59|||
48751737|NCT01896531|156936589|FG000|Overall Study|Lost to Follow-up|3|||
48751738|NCT01896531|156936590|FG001|Overall Study|Lost to Follow-up|0|||
48751739|NCT01896531|156936589|FG000|Overall Study|Non-compliance|0|||
48751740|NCT01896531|156936590|FG001|Overall Study|Non-compliance|1|||
48751741|NCT01896531|156936589|FG000|Overall Study|Study Ended by Sponsor|7|||
48751742|NCT01896531|156936590|FG001|Overall Study|Study Ended by Sponsor|20|||
48751743|NCT01896531|156936589|FG000|Overall Study|Withdrawal by Subject|3|||
48751744|NCT01896531|156936590|FG001|Overall Study|Withdrawal by Subject|2|||
48751745|NCT01896531|156936589|FG000|Overall Study|Death Prior to Treatment|1|||
48751746|NCT01896531|156936590|FG001|Overall Study|Death Prior to Treatment|0|||
48751747|NCT02532972|156936593|FG000|Overall Study|Withdrawal by Subject|1|||
48751748|NCT00459953|156936595|FG000|Overall Study|not analyzed-household member in study|1|||
48751749|NCT00459953|156936596|FG001|Overall Study|not analyzed-household member in study|1|||
48751750|NCT03944954|156936597|FG000|Overall Study|Withdrawal by Subject|22|||
48751751|NCT03944954|156936598|FG001|Overall Study|Withdrawal by Subject|4|||
48751752|NCT03944954|156936597|FG000|Overall Study|Lost to Follow-up|18|||
48751753|NCT03944954|156936598|FG001|Overall Study|Lost to Follow-up|0|||
48751754|NCT03944954|156936597|FG000|Overall Study|Failed Medical Screening|7|||
48751755|NCT03944954|156936598|FG001|Overall Study|Failed Medical Screening|0|||
48751756|NCT00736723|156936602|FG000|Overall Study|Withdrawal by Subject|4|||
48751757|NCT00736723|156936603|FG001|Overall Study|Withdrawal by Subject|3|||
48751758|NCT02268084|156936604|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
48751759|NCT02268084|156936605|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
48751760|NCT02268084|156936604|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
48751761|NCT02268084|156936605|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
48751762|NCT05227027|156936606|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
48751763|NCT05227027|156936607|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
48751764|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751765|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
48751766|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751767|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751768|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48646954|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Disease Progression|35|||
48646955|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Other|25|||
48646956|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Other|33|||
48646957|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
48751769|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
48751770|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
48751771|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
48751772|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
48751773|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
48751774|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
48751775|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
48751776|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
48646958|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
48646959|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Noncompliance|8|||
48646960|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Noncompliance|8|||
48646961|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
48646962|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
48646963|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
48646964|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
48646965|NCT00286091|156559405|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
48646966|NCT00286091|156559406|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
48751777|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
48751778|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
48751779|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
48751780|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
48751781|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
48646967|NCT00286091|156559405|FG000|Open-label Treatment Phase|Physician Decision|24|||
48646968|NCT00286091|156559406|FG001|Open-label Treatment Phase|Physician Decision|21|||
48646969|NCT00286091|156559405|FG000|Open-label Treatment Phase|Adverse Event|5|||
48646970|NCT00286091|156559406|FG001|Open-label Treatment Phase|Adverse Event|16|||
48646971|NCT00286091|156559405|FG000|Open-label Treatment Phase|Other|11|||
48646972|NCT00286091|156559406|FG001|Open-label Treatment Phase|Other|11|||
48646973|NCT00286091|156559405|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
48646974|NCT00286091|156559406|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
48646975|NCT00286091|156559405|FG000|Open-label Treatment Phase|Death|10|||
48646976|NCT00286091|156559406|FG001|Open-label Treatment Phase|Death|7|||
48646977|NCT00286091|156559405|FG000|Open-label Treatment Phase|Disease Progression|9|||
48646978|NCT00286091|156559406|FG001|Open-label Treatment Phase|Disease Progression|3|||
48646979|NCT00286091|156559405|FG000|Open-label Treatment Phase|Noncompliance|3|||
48646980|NCT00286091|156559406|FG001|Open-label Treatment Phase|Noncompliance|1|||
48646981|NCT00286091|156559405|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
48646982|NCT00286091|156559406|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
48646983|NCT00286091|156559405|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
48646984|NCT00286091|156559406|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
48646985|NCT00286091|156559405|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
48646986|NCT00286091|156559406|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
48751782|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751783|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751784|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751785|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751786|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
48751787|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
48751788|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48751789|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
48751790|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48646987|NCT01295944|156559407|FG000|Overall Study|Switched to alternative treatment|1|||
48751791|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48751792|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48751793|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
48751794|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
48751795|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
48751796|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
48646988|NCT01295944|156559407|FG000|Overall Study|Ineligible|9|||
48646989|NCT01295944|156559407|FG000|Overall Study|Withdrawal by Subject|4|||
48646990|NCT01295944|156559407|FG000|Overall Study|Participant chose to be treated in Peru|1|||
48646991|NCT01295944|156559407|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
48646992|NCT01295944|156559407|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
48646993|NCT01295944|156559407|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
48646994|NCT02520388|156559408|FG000|Overall Study|Physician Decision|1|||
48646995|NCT02520388|156559409|FG001|Overall Study|Physician Decision|0|||
48646996|NCT02520388|156559408|FG000|Overall Study|Subject or parent/guardian request|0|||
48646997|NCT02520388|156559409|FG001|Overall Study|Subject or parent/guardian request|6|||
48646998|NCT02520388|156559408|FG000|Overall Study|Adverse Event|1|||
48646999|NCT02520388|156559409|FG001|Overall Study|Adverse Event|4|||
48647000|NCT02520388|156559408|FG000|Overall Study|Lost to Follow-up|3|||
48647001|NCT02520388|156559409|FG001|Overall Study|Lost to Follow-up|2|||
48751797|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
48751798|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
48751799|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
48751800|NCT02603419|156936608|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751801|NCT02603419|156936609|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751802|NCT02603419|156936610|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751803|NCT02603419|156936611|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
48751804|NCT02603419|156936612|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751805|NCT02603419|156936613|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
48751806|NCT02603419|156936608|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751807|NCT02603419|156936609|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751808|NCT02603419|156936610|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751809|NCT02603419|156936611|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751810|NCT02603419|156936612|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
48751811|NCT02603419|156936613|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
48751812|NCT02603419|156936608|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751813|NCT02603419|156936609|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751814|NCT02603419|156936610|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751815|NCT02603419|156936611|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751816|NCT02603419|156936612|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
48751817|NCT02603419|156936613|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
48751818|NCT02603419|156936608|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751819|NCT02603419|156936609|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751820|NCT02603419|156936610|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751821|NCT02603419|156936611|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751822|NCT02603419|156936612|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
48751823|NCT02603419|156936613|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
48751824|NCT02049957|156936614|FG000|Overall Study|Progressive Disease|5|||
48751825|NCT02049957|156936615|FG001|Overall Study|Progressive Disease|4|||
48751826|NCT02049957|156936616|FG002|Overall Study|Progressive Disease|2|||
48751827|NCT02049957|156936617|FG003|Overall Study|Progressive Disease|2|||
48751828|NCT02049957|156936618|FG004|Overall Study|Progressive Disease|6|||
48751829|NCT02049957|156936619|FG005|Overall Study|Progressive Disease|35|||
48751830|NCT02049957|156936620|FG006|Overall Study|Progressive Disease|7|||
48751831|NCT02049957|156936621|FG007|Overall Study|Progressive Disease|26|||
48751832|NCT02049957|156936622|FG008|Overall Study|Progressive Disease|6|||
48751833|NCT02049957|156936614|FG000|Overall Study|Adverse Event|1|||
48751834|NCT02049957|156936615|FG001|Overall Study|Adverse Event|1|||
48751835|NCT02049957|156936616|FG002|Overall Study|Adverse Event|1|||
48751836|NCT02049957|156936617|FG003|Overall Study|Adverse Event|0|||
48751837|NCT02049957|156936618|FG004|Overall Study|Adverse Event|0|||
48751838|NCT02049957|156936619|FG005|Overall Study|Adverse Event|5|||
48751839|NCT02049957|156936620|FG006|Overall Study|Adverse Event|0|||
48751840|NCT02049957|156936621|FG007|Overall Study|Adverse Event|6|||
48751841|NCT02049957|156936622|FG008|Overall Study|Adverse Event|1|||
48751842|NCT02049957|156936614|FG000|Overall Study|Study Terminated by Sponsor|0|||
48751843|NCT02049957|156936615|FG001|Overall Study|Study Terminated by Sponsor|1|||
48751844|NCT02049957|156936616|FG002|Overall Study|Study Terminated by Sponsor|0|||
48647002|NCT02520388|156559408|FG000|Overall Study|Other (reason not defined)|4|||
48751845|NCT02049957|156936617|FG003|Overall Study|Study Terminated by Sponsor|0|||
48751846|NCT02049957|156936618|FG004|Overall Study|Study Terminated by Sponsor|0|||
48751847|NCT02049957|156936619|FG005|Overall Study|Study Terminated by Sponsor|0|||
48751848|NCT02049957|156936620|FG006|Overall Study|Study Terminated by Sponsor|1|||
48751849|NCT02049957|156936621|FG007|Overall Study|Study Terminated by Sponsor|0|||
48751850|NCT02049957|156936622|FG008|Overall Study|Study Terminated by Sponsor|0|||
48751851|NCT02049957|156936614|FG000|Overall Study|Withdrawal by Subject|0|||
48751852|NCT02049957|156936615|FG001|Overall Study|Withdrawal by Subject|0|||
48751853|NCT02049957|156936616|FG002|Overall Study|Withdrawal by Subject|0|||
48751854|NCT02049957|156936617|FG003|Overall Study|Withdrawal by Subject|1|||
48751855|NCT02049957|156936618|FG004|Overall Study|Withdrawal by Subject|0|||
48751856|NCT02049957|156936619|FG005|Overall Study|Withdrawal by Subject|2|||
48751857|NCT02049957|156936620|FG006|Overall Study|Withdrawal by Subject|0|||
48751858|NCT02049957|156936621|FG007|Overall Study|Withdrawal by Subject|3|||
48751859|NCT02049957|156936622|FG008|Overall Study|Withdrawal by Subject|1|||
48751860|NCT02049957|156936614|FG000|Overall Study|Physician Decision|0|||
48751861|NCT02049957|156936615|FG001|Overall Study|Physician Decision|0|||
48751862|NCT02049957|156936616|FG002|Overall Study|Physician Decision|0|||
48751863|NCT02049957|156936617|FG003|Overall Study|Physician Decision|0|||
48751864|NCT02049957|156936618|FG004|Overall Study|Physician Decision|0|||
48751865|NCT02049957|156936619|FG005|Overall Study|Physician Decision|1|||
48751866|NCT02049957|156936620|FG006|Overall Study|Physician Decision|0|||
48751867|NCT02049957|156936621|FG007|Overall Study|Physician Decision|0|||
48751868|NCT02049957|156936622|FG008|Overall Study|Physician Decision|0|||
48751869|NCT03049280|156936623|FG000|Overall Study|Physician Decision|1|||
48751870|NCT00855920|156936624|FG000|Overall Study|Protocol Violation|0|||
48751871|NCT00855920|156936625|FG001|Overall Study|Protocol Violation|0|||
48751872|NCT00855920|156936626|FG002|Overall Study|Protocol Violation|2|||
48751873|NCT00855920|156936624|FG000|Overall Study|Adverse Event|2|||
48751874|NCT00855920|156936625|FG001|Overall Study|Adverse Event|1|||
48751875|NCT00855920|156936626|FG002|Overall Study|Adverse Event|1|||
48751876|NCT00855920|156936624|FG000|Overall Study|Lack of Efficacy|2|||
48751877|NCT00855920|156936625|FG001|Overall Study|Lack of Efficacy|2|||
48751878|NCT00855920|156936626|FG002|Overall Study|Lack of Efficacy|2|||
48751879|NCT00855920|156936624|FG000|Overall Study|Withdrawal by Subject|2|||
48330406|NCT02630186|155407445|FG000|Overall Study|Withdrawal by Subject|1|||
48647003|NCT02520388|156559409|FG001|Overall Study|Other (reason not defined)|4|||
48647004|NCT01479764|156559413|FG000|Randomized|Adverse Event|1|||
48647005|NCT01479764|156559414|FG001|Randomized|Adverse Event|1|||
48647006|NCT01479764|156559413|FG000|Randomized|Withdrawal by Subject|1|||
48647007|NCT01479764|156559414|FG001|Randomized|Withdrawal by Subject|0|||
48647008|NCT01479764|156559413|FG000|Treated|Lost to Follow-up|0|||
48751880|NCT00855920|156936625|FG001|Overall Study|Withdrawal by Subject|3|||
48751881|NCT00855920|156936626|FG002|Overall Study|Withdrawal by Subject|2|||
48751882|NCT00855920|156936624|FG000|Overall Study|Lost to Follow-up|1|||
48751883|NCT00855920|156936625|FG001|Overall Study|Lost to Follow-up|0|||
48751884|NCT00855920|156936626|FG002|Overall Study|Lost to Follow-up|2|||
48751885|NCT00855920|156936624|FG000|Overall Study|Death|0|||
48751886|NCT00855920|156936625|FG001|Overall Study|Death|1|||
48751887|NCT00855920|156936626|FG002|Overall Study|Death|0|||
48751888|NCT00855920|156936624|FG000|Overall Study|Decision by the sponsor|0|||
48751889|NCT00855920|156936625|FG001|Overall Study|Decision by the sponsor|1|||
48751890|NCT00855920|156936626|FG002|Overall Study|Decision by the sponsor|1|||
48751891|NCT00855920|156936624|FG000|Overall Study|Other than specified above|1|||
48751892|NCT00855920|156936625|FG001|Overall Study|Other than specified above|1|||
48751893|NCT00855920|156936626|FG002|Overall Study|Other than specified above|1|||
48751894|NCT00371137|156936627|FG000|Overall Study|Adverse Event|20|||
48751895|NCT00371137|156936628|FG001|Overall Study|Adverse Event|35|||
48751896|NCT00371137|156936629|FG002|Overall Study|Adverse Event|42|||
48751897|NCT00371137|156936627|FG000|Overall Study|Withdrawal by Subject|11|||
48751898|NCT00371137|156936628|FG001|Overall Study|Withdrawal by Subject|10|||
48751899|NCT00371137|156936629|FG002|Overall Study|Withdrawal by Subject|15|||
48751900|NCT00371137|156936627|FG000|Overall Study|Lost to Follow-up|6|||
48751901|NCT00371137|156936628|FG001|Overall Study|Lost to Follow-up|3|||
48751902|NCT00371137|156936629|FG002|Overall Study|Lost to Follow-up|5|||
48751903|NCT00371137|156936627|FG000|Overall Study|Lack of Efficacy|30|||
48751904|NCT00371137|156936628|FG001|Overall Study|Lack of Efficacy|12|||
48751905|NCT00371137|156936629|FG002|Overall Study|Lack of Efficacy|13|||
48751906|NCT00371137|156936627|FG000|Overall Study|Sponsor Decision|2|||
48751907|NCT00371137|156936628|FG001|Overall Study|Sponsor Decision|1|||
48751908|NCT00371137|156936629|FG002|Overall Study|Sponsor Decision|2|||
48751909|NCT00371137|156936627|FG000|Overall Study|Physician Decision|1|||
48751910|NCT00371137|156936628|FG001|Overall Study|Physician Decision|1|||
48647009|NCT01479764|156559414|FG001|Treated|Lost to Follow-up|2|||
48647010|NCT03519997|156559415|FG000|Overall Study|Adverse Event|4|||
48647011|NCT03519997|156559415|FG000|Overall Study|Withdrawal by Subject|2|||
48647012|NCT03519997|156559415|FG000|Overall Study|Protocol Violation|1|||
48647013|NCT00923351|156559425|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
48647014|NCT00923351|156559426|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
48751911|NCT00371137|156936629|FG002|Overall Study|Physician Decision|1|||
48751912|NCT00371137|156936627|FG000|Overall Study|Protocol Violation|2|||
48751913|NCT00371137|156936628|FG001|Overall Study|Protocol Violation|1|||
48751914|NCT00371137|156936629|FG002|Overall Study|Protocol Violation|1|||
48647015|NCT00923351|156559427|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
48647016|NCT02454530|156559428|FG000|Overall Study|Other|8|||
48647017|NCT02454530|156559429|FG001|Overall Study|Other|13|||
48647018|NCT02454530|156559428|FG000|Overall Study|Missing information|56|||
48647019|NCT02454530|156559429|FG001|Overall Study|Missing information|69|||
48647020|NCT02454530|156559428|FG000|Overall Study|Death|2|||
48647021|NCT02454530|156559429|FG001|Overall Study|Death|41|||
48647022|NCT02454530|156559428|FG000|Overall Study|Lost to Follow-up|4|||
48647023|NCT02454530|156559429|FG001|Overall Study|Lost to Follow-up|4|||
48647024|NCT00451958|156559430|FG000|CS21A (NCT00451958)|Adverse Event|21|||
48647025|NCT00451958|156559431|FG001|CS21A (NCT00451958)|Adverse Event|34|||
48647026|NCT00451958|156559432|FG002|CS21A (NCT00451958)|Adverse Event|14|||
48647027|NCT00451958|156559433|FG003|CS21A (NCT00451958)|Adverse Event|17|||
48647028|NCT00451958|156559434|FG004|CS21A (NCT00451958)|Adverse Event|0|||
48647029|NCT00451958|156559430|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
48647030|NCT00451958|156559431|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
48647031|NCT00451958|156559432|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
48647032|NCT00451958|156559433|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
48647033|NCT00451958|156559434|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
48647034|NCT00451958|156559430|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
48647035|NCT00451958|156559431|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
48647036|NCT00451958|156559432|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
48647037|NCT00451958|156559433|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
48647038|NCT00451958|156559434|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
48647039|NCT00451958|156559430|FG000|CS21A (NCT00451958)|Physician Decision|2|||
48647040|NCT00451958|156559431|FG001|CS21A (NCT00451958)|Physician Decision|4|||
48647041|NCT00451958|156559432|FG002|CS21A (NCT00451958)|Physician Decision|4|||
48647042|NCT00451958|156559433|FG003|CS21A (NCT00451958)|Physician Decision|4|||
48647043|NCT00451958|156559434|FG004|CS21A (NCT00451958)|Physician Decision|0|||
48647044|NCT00451958|156559430|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
48647045|NCT00451958|156559431|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
48647046|NCT00451958|156559432|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
48647047|NCT00451958|156559433|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
48647048|NCT00451958|156559434|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
48647049|NCT00451958|156559430|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
48647050|NCT00451958|156559431|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
48647051|NCT00451958|156559432|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
48647052|NCT00451958|156559433|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
48647053|NCT00451958|156559434|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
48647054|NCT03783962|156560590|FG000|Overall Study|Lost to Follow-up|3|||
48647055|NCT03783962|156560591|FG001|Overall Study|Lost to Follow-up|6|||
48647056|NCT03783962|156560590|FG000|Overall Study|Protocol Violation|0|||
48647057|NCT03783962|156560591|FG001|Overall Study|Protocol Violation|1|||
48647058|NCT00603941|156560592|FG000|Overall Study|Disease progression|6|||
48647059|NCT00603941|156560593|FG001|Overall Study|Disease progression|7|||
48647060|NCT00603941|156560594|FG002|Overall Study|Disease progression|1|||
48647061|NCT00603941|156560592|FG000|Overall Study|Adverse Event|1|||
48647062|NCT00603941|156560593|FG001|Overall Study|Adverse Event|0|||
48647063|NCT00603941|156560594|FG002|Overall Study|Adverse Event|1|||
48647064|NCT00603941|156560592|FG000|Overall Study|Physician Decision|0|||
48647065|NCT00603941|156560593|FG001|Overall Study|Physician Decision|1|||
48647066|NCT00603941|156560594|FG002|Overall Study|Physician Decision|0|||
48647067|NCT00603941|156560592|FG000|Overall Study|Withdrawal by Subject|0|||
48647068|NCT00603941|156560593|FG001|Overall Study|Withdrawal by Subject|2|||
48647069|NCT00603941|156560594|FG002|Overall Study|Withdrawal by Subject|0|||
48647070|NCT01206140|156560595|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
48647071|NCT01206140|156560596|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
48647072|NCT00292045|156560599|FG000|Core Study (Through Week 13)|Adverse Event|1|||
48647073|NCT00292045|156560599|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
48647074|NCT03462641|156560601|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
48647075|NCT03462641|156560602|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
48647076|NCT03462641|156560601|FG000|Visit 2|Withdrawal by Subject|0|||
48647077|NCT03462641|156560602|FG001|Visit 2|Withdrawal by Subject|1|||
48647078|NCT02443337|156560603|FG000|Overall Study|Adverse Event|0|||
48647079|NCT02443337|156560604|FG001|Overall Study|Adverse Event|1|||
48647080|NCT02443337|156560603|FG000|Overall Study|Clinical Progressive Disease|3|||
48647081|NCT02443337|156560604|FG001|Overall Study|Clinical Progressive Disease|0|||
48647082|NCT02443337|156560603|FG000|Overall Study|Withdrawal by Subject|2|||
48647083|NCT02443337|156560604|FG001|Overall Study|Withdrawal by Subject|1|||
48647084|NCT00040742|156560605|FG000|Overall Study|Death|0|||
48647085|NCT00040742|156560606|FG001|Overall Study|Death|0|||
48647086|NCT00040742|156560607|FG002|Overall Study|Death|1|||
48647087|NCT00040742|156560608|FG003|Overall Study|Death|0|||
48647088|NCT00040742|156560605|FG000|Overall Study|Adverse Event|15|||
48647089|NCT00040742|156560606|FG001|Overall Study|Adverse Event|16|||
48647090|NCT00040742|156560607|FG002|Overall Study|Adverse Event|21|||
48647091|NCT00040742|156560608|FG003|Overall Study|Adverse Event|9|||
48647092|NCT00040742|156560605|FG000|Overall Study|Withdrawal by Subject|7|||
48647093|NCT00040742|156560606|FG001|Overall Study|Withdrawal by Subject|15|||
48647094|NCT00040742|156560607|FG002|Overall Study|Withdrawal by Subject|10|||
48647095|NCT00040742|156560608|FG003|Overall Study|Withdrawal by Subject|13|||
48647096|NCT00040742|156560605|FG000|Overall Study|Chemotoxicity|4|||
48647097|NCT00040742|156560606|FG001|Overall Study|Chemotoxicity|3|||
48647098|NCT00040742|156560607|FG002|Overall Study|Chemotoxicity|5|||
48647099|NCT00040742|156560608|FG003|Overall Study|Chemotoxicity|2|||
48647100|NCT00040742|156560605|FG000|Overall Study|Incomplete Forms|6|||
48647101|NCT00040742|156560606|FG001|Overall Study|Incomplete Forms|10|||
48647102|NCT00040742|156560607|FG002|Overall Study|Incomplete Forms|4|||
48647103|NCT00040742|156560608|FG003|Overall Study|Incomplete Forms|5|||
48647104|NCT00040742|156560605|FG000|Overall Study|Other medical|7|||
48647105|NCT00040742|156560606|FG001|Overall Study|Other medical|5|||
48647106|NCT00040742|156560607|FG002|Overall Study|Other medical|5|||
48647107|NCT00040742|156560608|FG003|Overall Study|Other medical|5|||
48647108|NCT00739310|156560613|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
48647109|NCT00739310|156560613|FG000|Overall Study|Withdrawal by Subject|1|||
48647110|NCT00739310|156560613|FG000|Overall Study|Lost to Follow-up|2|||
48647111|NCT03782064|156560616|FG000|Overall Study|Lack of Efficacy|2|||
48647112|NCT03782064|156560616|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
48647113|NCT01490918|156560617|FG000|Overall Study|Lost to Follow-up|2|||
48647114|NCT01490918|156560618|FG001|Overall Study|Lost to Follow-up|1|||
48647115|NCT01490918|156560619|FG002|Overall Study|Lost to Follow-up|0|||
48647116|NCT01490918|156560617|FG000|Overall Study|Withdrawal by Subject|7|||
48647117|NCT01490918|156560618|FG001|Overall Study|Withdrawal by Subject|8|||
48647118|NCT01490918|156560619|FG002|Overall Study|Withdrawal by Subject|3|||
48647119|NCT01490918|156560617|FG000|Overall Study|Adverse Event|0|||
48647120|NCT01490918|156560618|FG001|Overall Study|Adverse Event|0|||
48647121|NCT01490918|156560619|FG002|Overall Study|Adverse Event|1|||
48647122|NCT01490918|156560617|FG000|Overall Study|other cause|4|||
48647123|NCT01490918|156560618|FG001|Overall Study|other cause|5|||
48647124|NCT01490918|156560619|FG002|Overall Study|other cause|8|||
48647125|NCT01151020|156560620|FG000|Overall Study|Death|25|||
48647126|NCT01151020|156560620|FG000|Overall Study|Conversion to open repair|1|||
48647127|NCT01151020|156560620|FG000|Overall Study|Lost to Follow-up|4|||
48647128|NCT01151020|156560620|FG000|Overall Study|Withdrawal by Subject|22|||
48647129|NCT01151020|156560620|FG000|Overall Study|Patients did not receive the device|2|||
48330407|NCT00439218|155407446|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
48330408|NCT00486954|155407447|FG000|Pilot Part|Adverse Event|4|||
48330409|NCT00486954|155407448|FG001|Pilot Part|Adverse Event|0|||
48330410|NCT00486954|155407449|FG002|Pilot Part|Adverse Event|5|||
48330411|NCT00486954|155407450|FG003|Pilot Part|Adverse Event|0|||
48330412|NCT00486954|155407451|FG004|Pilot Part|Adverse Event|0|||
48330413|NCT00486954|155407447|FG000|Pilot Part|Disease Progression|2|||
48330414|NCT00486954|155407448|FG001|Pilot Part|Disease Progression|0|||
48330415|NCT00486954|155407449|FG002|Pilot Part|Disease Progression|1|||
48330416|NCT00486954|155407450|FG003|Pilot Part|Disease Progression|0|||
48330417|NCT00486954|155407451|FG004|Pilot Part|Disease Progression|0|||
48330418|NCT00486954|155407447|FG000|Randomized Part|Lost to Follow-up|0|||
48330419|NCT00486954|155407448|FG001|Randomized Part|Lost to Follow-up|0|||
48330420|NCT00486954|155407449|FG002|Randomized Part|Lost to Follow-up|0|||
48330421|NCT00486954|155407450|FG003|Randomized Part|Lost to Follow-up|0|||
48330422|NCT00486954|155407451|FG004|Randomized Part|Lost to Follow-up|1|||
48330423|NCT00486954|155407447|FG000|Randomized Part|Withdrawal by Subject|0|||
48330424|NCT00486954|155407448|FG001|Randomized Part|Withdrawal by Subject|0|||
48330425|NCT00486954|155407449|FG002|Randomized Part|Withdrawal by Subject|0|||
48330426|NCT00486954|155407450|FG003|Randomized Part|Withdrawal by Subject|1|||
48330427|NCT00486954|155407451|FG004|Randomized Part|Withdrawal by Subject|0|||
48330428|NCT00486954|155407447|FG000|Randomized Part|Sponsor Terminated Study|0|||
48330429|NCT00486954|155407448|FG001|Randomized Part|Sponsor Terminated Study|0|||
48330430|NCT00486954|155407449|FG002|Randomized Part|Sponsor Terminated Study|0|||
48330431|NCT00486954|155407450|FG003|Randomized Part|Sponsor Terminated Study|19|||
48647130|NCT02446769|156560621|FG000|Screening Period|Screen Failure|11|||
48647131|NCT02446769|156560622|FG001|Screening Period|Screen Failure|0|||
48647132|NCT02446769|156560623|FG002|Screening Period|Screen Failure|0|||
48647133|NCT02446769|156560621|FG000|Study Period|Randomized in Error|0|||
48647134|NCT02446769|156560622|FG001|Study Period|Randomized in Error|2|||
48647135|NCT02446769|156560623|FG002|Study Period|Randomized in Error|0|||
48647136|NCT00049322|156560624|FG000|Overall Study|disease burden|0|||
48647137|NCT00049322|156560625|FG001|Overall Study|disease burden|3|||
48647138|NCT00049322|156560624|FG000|Overall Study|Adverse Event|1|||
48647139|NCT00049322|156560625|FG001|Overall Study|Adverse Event|0|||
48647140|NCT00049322|156560624|FG000|Overall Study|refused angio|0|||
48647141|NCT00049322|156560625|FG001|Overall Study|refused angio|3|||
48647142|NCT02819297|156560626|FG000|Overall Study|Withdrawal by Subject|25|||
48647143|NCT02819297|156560627|FG001|Overall Study|Withdrawal by Subject|13|||
48647144|NCT02819297|156560626|FG000|Overall Study|Lost to Follow-up|12|||
48647145|NCT02819297|156560627|FG001|Overall Study|Lost to Follow-up|14|||
48647146|NCT02819297|156560626|FG000|Overall Study|Adverse Event|12|||
48647147|NCT02819297|156560627|FG001|Overall Study|Adverse Event|10|||
48647148|NCT02819297|156560626|FG000|Overall Study|Physician Decision|5|||
48647149|NCT02819297|156560627|FG001|Overall Study|Physician Decision|5|||
48647150|NCT02819297|156560626|FG000|Overall Study|Lack of Efficacy|5|||
48647151|NCT02819297|156560627|FG001|Overall Study|Lack of Efficacy|8|||
48647152|NCT02819297|156560626|FG000|Overall Study|Protocol Violation|1|||
48647153|NCT02819297|156560627|FG001|Overall Study|Protocol Violation|2|||
48647154|NCT02151903|156560628|FG000|Overall Study|Withdrawal by Subject|1|||
48647155|NCT02151903|156560629|FG001|Overall Study|Withdrawal by Subject|0|||
48647156|NCT02151903|156560628|FG000|Overall Study|Progressive disease|2|||
48330432|NCT00486954|155407451|FG004|Randomized Part|Sponsor Terminated Study|13|||
48330433|NCT05124210|155407454|FG000|Overall Study|Lost to Follow-up|1|||
48647157|NCT02151903|156560629|FG001|Overall Study|Progressive disease|1|||
48647158|NCT03188263|156560630|FG000|Overall Study|Withdrawal by Subject|3|||
48330434|NCT05124210|155407455|FG001|Overall Study|Lost to Follow-up|0|||
48330435|NCT05124210|155407454|FG000|Overall Study|Withdrawal by Subject|1|||
48330436|NCT05124210|155407455|FG001|Overall Study|Withdrawal by Subject|0|||
48330437|NCT00768755|155407456|FG000|Phase 1|Death|6|||
48330438|NCT00768755|155407457|FG001|Phase 1|Death|0|||
48647159|NCT03188263|156560631|FG001|Overall Study|Withdrawal by Subject|0|||
48647160|NCT03188263|156560630|FG000|Overall Study|Physician Decision|1|||
48647161|NCT03188263|156560631|FG001|Overall Study|Physician Decision|0|||
48647162|NCT01277822|156560636|FG000|Overall Study|Adverse Event|2|||
48647163|NCT01277822|156560637|FG001|Overall Study|Adverse Event|1|||
48647164|NCT01277822|156560636|FG000|Overall Study|Withdrawal by Subject|6|||
48647165|NCT01277822|156560637|FG001|Overall Study|Withdrawal by Subject|7|||
48647166|NCT01277822|156560636|FG000|Overall Study|Physician Decision|1|||
48647167|NCT01277822|156560637|FG001|Overall Study|Physician Decision|1|||
48647168|NCT01277822|156560636|FG000|Overall Study|Protocol Violation|1|||
48647169|NCT01277822|156560637|FG001|Overall Study|Protocol Violation|0|||
48647170|NCT01277822|156560636|FG000|Overall Study|Lost to Follow-up|2|||
48647171|NCT01277822|156560637|FG001|Overall Study|Lost to Follow-up|1|||
48647172|NCT01277822|156560636|FG000|Overall Study|Contraindicated medication used|2|||
48647173|NCT01277822|156560637|FG001|Overall Study|Contraindicated medication used|1|||
48647174|NCT01277822|156560636|FG000|Overall Study|Participant moved|1|||
48330439|NCT00768755|155407458|FG002|Phase 1|Death|0|||
48647175|NCT01277822|156560637|FG001|Overall Study|Participant moved|0|||
48647176|NCT02923531|156560638|FG000|Overall Study|Adverse Event|4|||
48330440|NCT00768755|155407459|FG003|Phase 1|Death|0|||
48330441|NCT00768755|155407456|FG000|Phase 1|Other|4|||
48647177|NCT02923531|156560638|FG000|Overall Study|Clinical Deterioration|1|||
48647178|NCT02923531|156560638|FG000|Overall Study|Disease Progression|3|||
48647179|NCT02923531|156560638|FG000|Overall Study|Study Termination|1|||
48647180|NCT02997865|156560639|FG000|Overall Study|Death|2|||
48647181|NCT02997865|156560640|FG001|Overall Study|Death|1|||
48647182|NCT02997865|156560639|FG000|Overall Study|Lost to Follow-up|6|||
48647183|NCT02997865|156560640|FG001|Overall Study|Lost to Follow-up|3|||
48647184|NCT02997865|156560639|FG000|Overall Study|Withdrawal by Subject|5|||
48647185|NCT02997865|156560640|FG001|Overall Study|Withdrawal by Subject|0|||
48647186|NCT01945996|156560645|FG000|Overall Study|Lost to Follow-up|3|||
48647187|NCT01945996|156560646|FG001|Overall Study|Lost to Follow-up|5|||
48647188|NCT02148263|156560647|FG000|Overall Study|Withdrawal by Subject|3|||
48647189|NCT02148263|156560648|FG001|Overall Study|Withdrawal by Subject|2|||
48647190|NCT03542266|156560649|FG000|Treatment Phase|Withdrawal by Subject|1|||
48647191|NCT03542266|156560649|FG000|Treatment Phase|Adverse Event|1|||
48647192|NCT03542266|156560649|FG000|Treatment Phase|PD|1|||
48647193|NCT01637584|156560650|FG000|Overall Study|Withdrawal by Subject|1|||
48647194|NCT01637584|156560651|FG001|Overall Study|Withdrawal by Subject|3|||
48647195|NCT01721486|156560654|FG000|Overall Study|Protocol Violation|1|||
48647196|NCT01721486|156560655|FG001|Overall Study|Protocol Violation|0|||
48647197|NCT01721486|156560654|FG000|Overall Study|Physician Decision|0|||
48647198|NCT01721486|156560655|FG001|Overall Study|Physician Decision|1|||
48647199|NCT02125838|156560656|FG000|Overall Study|Lost to Follow-up|4|||
48647200|NCT02125838|156560657|FG001|Overall Study|Lost to Follow-up|4|||
48647201|NCT00787839|156560658|FG000|Overall Study|Failure to have the OGTT was most common|404|||
48647202|NCT02969915|156560659|FG000|Overall Study|Death|104|||
48647203|NCT02969915|156560660|FG001|Overall Study|Death|125|||
48647204|NCT02969915|156560659|FG000|Overall Study|Lost to Follow-up|108|||
48647205|NCT02969915|156560660|FG001|Overall Study|Lost to Follow-up|112|||
48647206|NCT02969915|156560659|FG000|Overall Study|Censored due to COVID-19|481|||
48647207|NCT02969915|156560660|FG001|Overall Study|Censored due to COVID-19|471|||
48647208|NCT02725476|156560667|FG000|Overall Study|Physician Decision|2|||
48647209|NCT02725476|156560668|FG001|Overall Study|Physician Decision|0|||
48647210|NCT02725476|156560667|FG000|Overall Study|Adverse Event|1|||
48647211|NCT02725476|156560668|FG001|Overall Study|Adverse Event|1|||
48647212|NCT01270880|156560672|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
48647213|NCT01169701|156560679|FG000|Overall Study|Lost to Follow-up|1|||
48647214|NCT01169701|156560680|FG001|Overall Study|Lost to Follow-up|1|||
48647215|NCT01169701|156560679|FG000|Overall Study|Withdrawal by Subject|1|||
48647216|NCT01169701|156560680|FG001|Overall Study|Withdrawal by Subject|3|||
48647217|NCT01169701|156560679|FG000|Overall Study|Adverse Event|1|||
48647218|NCT01169701|156560680|FG001|Overall Study|Adverse Event|2|||
48647219|NCT01169701|156560679|FG000|Overall Study|Exclusion criteria|2|||
48647220|NCT01169701|156560680|FG001|Overall Study|Exclusion criteria|0|||
48647221|NCT01169701|156560679|FG000|Overall Study|Death|0|||
48647222|NCT01169701|156560680|FG001|Overall Study|Death|1|||
48647223|NCT01169701|156560679|FG000|Overall Study|Administrative problems|0|||
48647224|NCT01169701|156560680|FG001|Overall Study|Administrative problems|1|||
48647225|NCT01169701|156560679|FG000|Overall Study|Serious adverse event|0|||
48647226|NCT01169701|156560680|FG001|Overall Study|Serious adverse event|1|||
48647227|NCT01169701|156560679|FG000|Overall Study|Sponsor decision|0|||
48647228|NCT01169701|156560680|FG001|Overall Study|Sponsor decision|1|||
48647229|NCT03146663|156560681|FG000|Overall Study|Did not receive study treatment|1|||
48647230|NCT03146663|156560682|FG001|Overall Study|Did not receive study treatment|1|||
48647231|NCT03583359|156560683|FG000|Overall Study|Withdrawal by Subject|15|||
48647232|NCT03583359|156560684|FG001|Overall Study|Withdrawal by Subject|6|||
48647233|NCT03583359|156560683|FG000|Overall Study|Lost to Follow-up|12|||
48647234|NCT03583359|156560684|FG001|Overall Study|Lost to Follow-up|3|||
48647235|NCT03583359|156560683|FG000|Overall Study|Adverse Event|0|||
48647236|NCT03583359|156560684|FG001|Overall Study|Adverse Event|1|||
48647237|NCT03583359|156560683|FG000|Overall Study|Protocol Violation|0|||
48647238|NCT03583359|156560684|FG001|Overall Study|Protocol Violation|1|||
48647239|NCT03583359|156560683|FG000|Overall Study|Other|2|||
48647240|NCT03583359|156560684|FG001|Overall Study|Other|1|||
48647241|NCT00809926|156560685|FG000|Overall Study|Adverse Event|18|||
48647242|NCT00809926|156560686|FG001|Overall Study|Adverse Event|10|||
48647243|NCT00809926|156560685|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
48647244|NCT00809926|156560686|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48647245|NCT00809926|156560685|FG000|Overall Study|Patient withdrew consent|8|||
48647246|NCT00809926|156560686|FG001|Overall Study|Patient withdrew consent|6|||
48647247|NCT00809926|156560685|FG000|Overall Study|Lost to Follow-up|2|||
48647248|NCT00809926|156560686|FG001|Overall Study|Lost to Follow-up|1|||
48647249|NCT00809926|156560685|FG000|Overall Study|Administrative Problems|0|||
48647250|NCT00809926|156560686|FG001|Overall Study|Administrative Problems|1|||
48647251|NCT00809926|156560685|FG000|Overall Study|Protocol deviation|0|||
48647252|NCT00809926|156560686|FG001|Overall Study|Protocol deviation|2|||
48647253|NCT00972517|156560698|FG000|Overall Study|Adverse Event|0|||
48647254|NCT00972517|156560699|FG001|Overall Study|Adverse Event|0|||
48647255|NCT00972517|156560700|FG002|Overall Study|Adverse Event|0|||
48647256|NCT00972517|156560701|FG003|Overall Study|Adverse Event|1|||
48647257|NCT00972517|156560702|FG004|Overall Study|Adverse Event|0|||
48647258|NCT00972517|156560703|FG005|Overall Study|Adverse Event|0|||
48647259|NCT00972517|156560698|FG000|Overall Study|Withdrawal by Subject|0|||
48647260|NCT00972517|156560699|FG001|Overall Study|Withdrawal by Subject|1|||
48647261|NCT00972517|156560700|FG002|Overall Study|Withdrawal by Subject|0|||
48647262|NCT00972517|156560701|FG003|Overall Study|Withdrawal by Subject|2|||
48647263|NCT00972517|156560702|FG004|Overall Study|Withdrawal by Subject|1|||
48647264|NCT00972517|156560703|FG005|Overall Study|Withdrawal by Subject|0|||
48647265|NCT01102491|156560706|FG000|Overall Study|Protocol Violation|11|||
48647266|NCT01102491|156560707|FG001|Overall Study|Protocol Violation|12|||
48647267|NCT00984594|156560710|FG000|Overall Study|Lost to Follow-up|1|||
48647268|NCT00984594|156560711|FG001|Overall Study|Lost to Follow-up|0|||
48647269|NCT00984594|156560710|FG000|Overall Study|Withdrawal by Subject|0|||
48647270|NCT00984594|156560711|FG001|Overall Study|Withdrawal by Subject|1|||
48647271|NCT02100423|156560713|FG000|Overall Study|Death|1|||
48647272|NCT02100423|156560713|FG000|Overall Study|Withdrawal by Subject|3|||
48647273|NCT02100423|156560713|FG000|Overall Study|Adverse Event|1|||
48647274|NCT02100423|156560713|FG000|Overall Study|Physician Decision|1|||
48647275|NCT00703846|156560716|FG000|Overall Study|Adverse Event|8|||
48647276|NCT00703846|156560716|FG000|Overall Study|Lost to Follow-up|55|||
48647277|NCT00703846|156560716|FG000|Overall Study|Lack of Efficacy|15|||
48647278|NCT00703846|156560716|FG000|Overall Study|Noncompliance with Study Treatment|2|||
48647279|NCT00703846|156560716|FG000|Overall Study|Withdrawal by Subject|40|||
48647280|NCT00703846|156560716|FG000|Overall Study|Death|1|||
48647281|NCT00703846|156560716|FG000|Overall Study|Other|14|||
48647282|NCT00703846|156560716|FG000|Overall Study|Did Not Receive Study Drug|2|||
48647283|NCT00325130|156560717|FG000|Overall Study|Lost to Follow-up|6|||
48647284|NCT00325130|156560718|FG001|Overall Study|Lost to Follow-up|14|||
48647285|NCT00325130|156560717|FG000|Overall Study|Withdrawal by Subject|12|||
48647286|NCT00325130|156560718|FG001|Overall Study|Withdrawal by Subject|14|||
48647287|NCT00325130|156560717|FG000|Overall Study|Protocol Deviation|0|||
48647288|NCT00325130|156560718|FG001|Overall Study|Protocol Deviation|1|||
48647289|NCT00325130|156560717|FG000|Overall Study|Moved|0|||
48647290|NCT00325130|156560718|FG001|Overall Study|Moved|1|||
48647291|NCT00325130|156560717|FG000|Overall Study|Patient Discontinued for Other|1|||
48647292|NCT00325130|156560718|FG001|Overall Study|Patient Discontinued for Other|0|||
48647293|NCT02015481|156560719|FG000|Overall Study|Death|1|||
48647294|NCT03265145|156560720|FG000|Overall Study|Protocol Violation|2|||
48647295|NCT03265145|156560721|FG001|Overall Study|Protocol Violation|0|||
48647296|NCT03265145|156560720|FG000|Overall Study|Adverse Event|1|||
48647297|NCT03265145|156560721|FG001|Overall Study|Adverse Event|0|||
48647298|NCT03265145|156560720|FG000|Overall Study|Withdrawal by Subject|23|||
48647299|NCT03265145|156560721|FG001|Overall Study|Withdrawal by Subject|19|||
48647300|NCT03265145|156560720|FG000|Overall Study|Death|12|||
48647301|NCT03265145|156560721|FG001|Overall Study|Death|12|||
48647302|NCT03265145|156560720|FG000|Overall Study|Lost to Follow-up|13|||
48647303|NCT03265145|156560721|FG001|Overall Study|Lost to Follow-up|9|||
48647304|NCT03265145|156560720|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
48647305|NCT03265145|156560721|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
48647306|NCT03265145|156560720|FG000|Overall Study|Switched back to previous medication|1|||
48647307|NCT03265145|156560721|FG001|Overall Study|Switched back to previous medication|0|||
48647308|NCT03265145|156560720|FG000|Overall Study|Did not want to take medication|1|||
48647309|NCT03265145|156560721|FG001|Overall Study|Did not want to take medication|0|||
48647310|NCT03265145|156560720|FG000|Overall Study|Subject could not afford medication|0|||
48647311|NCT03265145|156560721|FG001|Overall Study|Subject could not afford medication|1|||
48647312|NCT03265145|156560720|FG000|Overall Study|Site closed|2|||
48647313|NCT03265145|156560721|FG001|Overall Study|Site closed|3|||
48647314|NCT03265145|156560720|FG000|Overall Study|Incorrectly randomized|16|||
48647315|NCT03265145|156560721|FG001|Overall Study|Incorrectly randomized|6|||
48647316|NCT03265145|156560720|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
48647317|NCT03265145|156560721|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
48751915|NCT02013791|156936630|FG000|Period 1|Lost to Follow-up|0|||
48751916|NCT02013791|156936631|FG001|Period 1|Lost to Follow-up|0|||
48751917|NCT02013791|156936632|FG002|Period 1|Lost to Follow-up|0|||
48751918|NCT02013791|156936633|FG003|Period 1|Lost to Follow-up|1|||
48751919|NCT02013791|156936634|FG004|Period 1|Lost to Follow-up|0|||
48751920|NCT02013791|156936635|FG005|Period 1|Lost to Follow-up|0|||
48751921|NCT02013791|156936636|FG006|Period 1|Lost to Follow-up|1|||
48751922|NCT02013791|156936637|FG007|Period 1|Lost to Follow-up|1|||
48751923|NCT02013791|156936638|FG008|Period 1|Lost to Follow-up|0|||
48751924|NCT02013791|156936630|FG000|Period 1|Other Miscellaneous Reasons|0|||
48751925|NCT02013791|156936631|FG001|Period 1|Other Miscellaneous Reasons|2|||
48751926|NCT02013791|156936632|FG002|Period 1|Other Miscellaneous Reasons|0|||
48751927|NCT02013791|156936633|FG003|Period 1|Other Miscellaneous Reasons|0|||
48751928|NCT02013791|156936634|FG004|Period 1|Other Miscellaneous Reasons|0|||
48751929|NCT02013791|156936635|FG005|Period 1|Other Miscellaneous Reasons|0|||
48751930|NCT02013791|156936636|FG006|Period 1|Other Miscellaneous Reasons|0|||
48751931|NCT02013791|156936637|FG007|Period 1|Other Miscellaneous Reasons|0|||
48751932|NCT02013791|156936638|FG008|Period 1|Other Miscellaneous Reasons|0|||
48751933|NCT02643082|156936639|FG000|Period 1|Adverse Event|1|||
48751934|NCT02643082|156936640|FG001|Period 1|Adverse Event|0|||
48751935|NCT01324999|156936641|FG000|Overall Study|Adverse Event|3|||
48751936|NCT01324999|156936641|FG000|Overall Study|Withdrawal by Subject|2|||
48751937|NCT01340898|156936644|FG000|Primary Phase|Serious Adverse Events|0|||
48751938|NCT01340898|156936645|FG001|Primary Phase|Serious Adverse Events|0|||
48751939|NCT01340898|156936646|FG002|Primary Phase|Serious Adverse Events|1|||
48751940|NCT01340898|156936644|FG000|Primary Phase|Withdrawal by Subject|8|||
48751941|NCT01340898|156936645|FG001|Primary Phase|Withdrawal by Subject|7|||
48751942|NCT01340898|156936646|FG002|Primary Phase|Withdrawal by Subject|5|||
48751943|NCT01340898|156936644|FG000|Primary Phase|Migrated/moved from study area|4|||
48751944|NCT01340898|156936645|FG001|Primary Phase|Migrated/moved from study area|1|||
48751945|NCT01340898|156936646|FG002|Primary Phase|Migrated/moved from study area|0|||
48751946|NCT01340898|156936644|FG000|Primary Phase|Lost to Follow-up|4|||
48751947|NCT01340898|156936645|FG001|Primary Phase|Lost to Follow-up|1|||
48751948|NCT01340898|156936646|FG002|Primary Phase|Lost to Follow-up|0|||
48751949|NCT01340898|156936644|FG000|Booster Phase|Withdrawal by Subject|3|||
48751950|NCT01340898|156936645|FG001|Booster Phase|Withdrawal by Subject|0|||
48647318|NCT03265145|156560720|FG000|Overall Study|Physician Decision|0|||
48647319|NCT03265145|156560721|FG001|Overall Study|Physician Decision|3|||
48647320|NCT03265145|156560720|FG000|Overall Study|Subject transferred to another facility|0|||
48647321|NCT03265145|156560721|FG001|Overall Study|Subject transferred to another facility|1|||
48751951|NCT01340898|156936646|FG002|Booster Phase|Withdrawal by Subject|4|||
48751952|NCT01340898|156936644|FG000|Booster Phase|Migrated/moved from study area|3|||
48751953|NCT01340898|156936645|FG001|Booster Phase|Migrated/moved from study area|0|||
48751954|NCT01340898|156936646|FG002|Booster Phase|Migrated/moved from study area|0|||
48751955|NCT01340898|156936644|FG000|Booster Phase|Lost to Follow-up|4|||
48751956|NCT01340898|156936645|FG001|Booster Phase|Lost to Follow-up|2|||
48751957|NCT01340898|156936646|FG002|Booster Phase|Lost to Follow-up|3|||
48751958|NCT01782495|156936651|FG000|Overall Study|Adverse Event|0|||
48647322|NCT03122145|156560722|FG000|Overall Study|Concurrent respiratory disease|3|||
48647323|NCT03122145|156560723|FG001|Overall Study|Concurrent respiratory disease|0|||
48647324|NCT02709577|156560728|FG000|Overall Study|non-accommodating anatomy|0|||
48647325|NCT02709577|156560729|FG001|Overall Study|non-accommodating anatomy|1|||
48647326|NCT02709577|156560730|FG002|Overall Study|non-accommodating anatomy|0|||
48647327|NCT02709577|156560731|FG003|Overall Study|non-accommodating anatomy|0|||
48647328|NCT02709577|156560728|FG000|Overall Study|procedural complication|0|||
48647329|NCT02709577|156560729|FG001|Overall Study|procedural complication|1|||
48647330|NCT02709577|156560730|FG002|Overall Study|procedural complication|0|||
48647331|NCT02709577|156560731|FG003|Overall Study|procedural complication|0|||
48647332|NCT02709577|156560728|FG000|Overall Study|Withdrawal by Subject|2|||
48647333|NCT02709577|156560729|FG001|Overall Study|Withdrawal by Subject|3|||
48647334|NCT02709577|156560730|FG002|Overall Study|Withdrawal by Subject|2|||
48647335|NCT02709577|156560731|FG003|Overall Study|Withdrawal by Subject|0|||
48647336|NCT00334737|156560732|FG000|Hospital Phase|Death|1|||
48647337|NCT00334737|156560733|FG001|Hospital Phase|Death|2|||
48647338|NCT00334737|156560734|FG002|Hospital Phase|Death|3|||
48647339|NCT00334737|156560732|FG000|Hospital Phase|Withdrawal by Subject|0|||
48647340|NCT00334737|156560733|FG001|Hospital Phase|Withdrawal by Subject|0|||
48647341|NCT00334737|156560734|FG002|Hospital Phase|Withdrawal by Subject|1|||
48647342|NCT00334737|156560732|FG000|Hospital Phase|Did not receive study drug|1|||
48647343|NCT00334737|156560733|FG001|Hospital Phase|Did not receive study drug|0|||
48647344|NCT00334737|156560734|FG002|Hospital Phase|Did not receive study drug|0|||
48647345|NCT00334737|156560732|FG000|Follow up Phase|Lost to Follow-up|5|||
48647346|NCT00334737|156560733|FG001|Follow up Phase|Lost to Follow-up|3|||
48647347|NCT00334737|156560734|FG002|Follow up Phase|Lost to Follow-up|6|||
48647348|NCT00269113|156562551|FG000|Overall Study|Adverse Event|14|||
48647349|NCT00269113|156562552|FG001|Overall Study|Adverse Event|7|||
48647350|NCT00269113|156562551|FG000|Overall Study|Lack of Efficacy|35|||
48647351|NCT00269113|156562552|FG001|Overall Study|Lack of Efficacy|18|||
48647352|NCT00269113|156562551|FG000|Overall Study|Early Improvement|2|||
48647353|NCT00269113|156562552|FG001|Overall Study|Early Improvement|0|||
48647354|NCT00269113|156562551|FG000|Overall Study|Withdrawal by Subject|0|||
48647355|NCT00269113|156562552|FG001|Overall Study|Withdrawal by Subject|2|||
48647356|NCT00269113|156562551|FG000|Overall Study|Death|6|||
48647357|NCT00269113|156562552|FG001|Overall Study|Death|2|||
48647358|NCT00269113|156562551|FG000|Overall Study|Lost to Follow-up|2|||
48647359|NCT00269113|156562552|FG001|Overall Study|Lost to Follow-up|1|||
48647360|NCT00269113|156562551|FG000|Overall Study|Protocol Violation|15|||
48647361|NCT00269113|156562552|FG001|Overall Study|Protocol Violation|5|||
48647362|NCT00269113|156562551|FG000|Overall Study|Other|0|||
48647363|NCT00269113|156562552|FG001|Overall Study|Other|2|||
48647364|NCT01978145|156562553|FG000|Treatment Period 1|Adverse Event|1|||
48647365|NCT01978145|156562554|FG001|Treatment Period 1|Adverse Event|9|||
48647366|NCT01978145|156562553|FG000|Treatment Period 1|Physician Decision|1|||
48647367|NCT01978145|156562554|FG001|Treatment Period 1|Physician Decision|0|||
48647368|NCT01978145|156562553|FG000|Treatment Period 1|Withdrawal by Subject|5|||
48647369|NCT01978145|156562554|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48647370|NCT01978145|156562553|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
48647371|NCT01978145|156562554|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
48647372|NCT01978145|156562553|FG000|Washout Period 1|Adverse Event|0|||
48647373|NCT01978145|156562554|FG001|Washout Period 1|Adverse Event|1|||
48647374|NCT01978145|156562553|FG000|Washout Period 1|Withdrawal by Subject|1|||
48647375|NCT01978145|156562554|FG001|Washout Period 1|Withdrawal by Subject|1|||
48647376|NCT01978145|156562553|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
48647377|NCT01978145|156562554|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
48647378|NCT01978145|156562553|FG000|Treatment Period 2|Adverse Event|3|||
48647379|NCT01978145|156562554|FG001|Treatment Period 2|Adverse Event|3|||
48647380|NCT01978145|156562553|FG000|Treatment Period 2|Protocol Violation|0|||
48647381|NCT01978145|156562554|FG001|Treatment Period 2|Protocol Violation|1|||
48647382|NCT01978145|156562553|FG000|Treatment Period 2|Lost to Follow-up|1|||
48647383|NCT01978145|156562554|FG001|Treatment Period 2|Lost to Follow-up|1|||
48647384|NCT01978145|156562553|FG000|Treatment Period 2|Withdrawal by Subject|7|||
48647385|NCT01978145|156562554|FG001|Treatment Period 2|Withdrawal by Subject|4|||
48647386|NCT01978145|156562553|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
48647387|NCT01978145|156562554|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
48647388|NCT03276728|156562555|FG000|Overall Study|Lost to Follow-up|0|||
48647389|NCT03276728|156562556|FG001|Overall Study|Lost to Follow-up|0|||
48647390|NCT03276728|156562557|FG002|Overall Study|Lost to Follow-up|2|||
48647391|NCT03276728|156562558|FG003|Overall Study|Lost to Follow-up|2|||
48647392|NCT03276728|156562559|FG004|Overall Study|Lost to Follow-up|0|||
48647393|NCT03276728|156562560|FG005|Overall Study|Lost to Follow-up|0|||
48751959|NCT01782495|156936652|FG001|Overall Study|Adverse Event|0|||
48751960|NCT01782495|156936653|FG002|Overall Study|Adverse Event|0|||
48751961|NCT01782495|156936654|FG003|Overall Study|Adverse Event|0|||
48751962|NCT01782495|156936655|FG004|Overall Study|Adverse Event|0|||
48751963|NCT01782495|156936656|FG005|Overall Study|Adverse Event|0|||
48751964|NCT01782495|156936657|FG006|Overall Study|Adverse Event|0|||
48751965|NCT01782495|156936658|FG007|Overall Study|Adverse Event|2|||
48751966|NCT01782495|156936659|FG008|Overall Study|Adverse Event|0|||
48751967|NCT01782495|156936660|FG009|Overall Study|Adverse Event|0|||
48330442|NCT00768755|155407457|FG001|Phase 1|Other|0|||
48330443|NCT00768755|155407458|FG002|Phase 1|Other|0|||
48330444|NCT00768755|155407459|FG003|Phase 1|Other|0|||
48647394|NCT03276728|156562561|FG006|Overall Study|Lost to Follow-up|0|||
48751968|NCT01782495|156936661|FG010|Overall Study|Adverse Event|0|||
48751969|NCT01782495|156936651|FG000|Overall Study|Withdrew Consent|0|||
48751970|NCT01782495|156936652|FG001|Overall Study|Withdrew Consent|1|||
48751971|NCT01782495|156936653|FG002|Overall Study|Withdrew Consent|0|||
48751972|NCT01782495|156936654|FG003|Overall Study|Withdrew Consent|0|||
48751973|NCT01782495|156936655|FG004|Overall Study|Withdrew Consent|0|||
48751974|NCT01782495|156936656|FG005|Overall Study|Withdrew Consent|0|||
48751975|NCT01782495|156936657|FG006|Overall Study|Withdrew Consent|0|||
48751976|NCT01782495|156936658|FG007|Overall Study|Withdrew Consent|1|||
48751977|NCT01782495|156936659|FG008|Overall Study|Withdrew Consent|0|||
48751978|NCT01782495|156936660|FG009|Overall Study|Withdrew Consent|0|||
48751979|NCT01782495|156936661|FG010|Overall Study|Withdrew Consent|0|||
48751980|NCT03547687|156936663|FG000|Overall Study|Withdrawal by Subject|1|||
48751981|NCT03547687|156936663|FG000|Overall Study|Death|1|||
48751982|NCT00679302|156936664|FG000|Overall Study|Lost to Follow-up|8|||
48751983|NCT00679302|156936665|FG001|Overall Study|Lost to Follow-up|4|||
48751984|NCT04656691|156936668|FG000|Overall Study|Adverse Event|1|||
48751985|NCT01850524|156936671|FG000|Overall Study|Lost to Follow-up|5|||
48751986|NCT01850524|156936672|FG001|Overall Study|Lost to Follow-up|10|||
48330445|NCT00768755|155407456|FG000|Phase 2|Death|0|||
48647395|NCT03276728|156562562|FG007|Overall Study|Lost to Follow-up|0|||
48647396|NCT03276728|156562555|FG000|Overall Study|Withdrawal by Subject|0|||
48647397|NCT03276728|156562556|FG001|Overall Study|Withdrawal by Subject|0|||
48647398|NCT03276728|156562557|FG002|Overall Study|Withdrawal by Subject|0|||
48751987|NCT01850524|156936671|FG000|Overall Study|Withdrawal by Subject|24|||
48751988|NCT01850524|156936672|FG001|Overall Study|Withdrawal by Subject|22|||
48751989|NCT01850524|156936671|FG000|Overall Study|Reason not Specified|142|||
48751990|NCT01850524|156936672|FG001|Overall Study|Reason not Specified|141|||
48751991|NCT00368355|156936673|FG000|Overall Study|Adverse Event|1|||
48751992|NCT00368355|156936674|FG001|Overall Study|Adverse Event|0|||
48751993|NCT00368355|156936673|FG000|Overall Study|Death|2|||
48751994|NCT00368355|156936674|FG001|Overall Study|Death|4|||
48330446|NCT00768755|155407457|FG001|Phase 2|Death|37|||
48330447|NCT00768755|155407458|FG002|Phase 2|Death|48|||
48751995|NCT00368355|156936673|FG000|Overall Study|Relapse|6|||
48751996|NCT00368355|156936674|FG001|Overall Study|Relapse|10|||
48751997|NCT00368355|156936673|FG000|Overall Study|Subsequent transplant|0|||
48751998|NCT00368355|156936674|FG001|Overall Study|Subsequent transplant|3|||
48647399|NCT03276728|156562558|FG003|Overall Study|Withdrawal by Subject|3|||
48647400|NCT03276728|156562559|FG004|Overall Study|Withdrawal by Subject|0|||
48647401|NCT03276728|156562560|FG005|Overall Study|Withdrawal by Subject|0|||
48647402|NCT03276728|156562561|FG006|Overall Study|Withdrawal by Subject|0|||
48647403|NCT03276728|156562562|FG007|Overall Study|Withdrawal by Subject|0|||
48647404|NCT03276728|156562555|FG000|Overall Study|Decision by sponsor|0|||
48647405|NCT03276728|156562556|FG001|Overall Study|Decision by sponsor|0|||
48647406|NCT03276728|156562557|FG002|Overall Study|Decision by sponsor|0|||
48647407|NCT03276728|156562558|FG003|Overall Study|Decision by sponsor|0|||
48647408|NCT03276728|156562559|FG004|Overall Study|Decision by sponsor|1|||
48647409|NCT03276728|156562560|FG005|Overall Study|Decision by sponsor|0|||
48647410|NCT03276728|156562561|FG006|Overall Study|Decision by sponsor|2|||
48647411|NCT03276728|156562562|FG007|Overall Study|Decision by sponsor|1|||
48647412|NCT02364037|156562566|FG000|Overall Study|Withdrawal by Subject|7|||
48647413|NCT02364037|156562567|FG001|Overall Study|Withdrawal by Subject|4|||
48647414|NCT02364037|156562566|FG000|Overall Study|Lost to Follow-up|37|||
48647415|NCT02364037|156562567|FG001|Overall Study|Lost to Follow-up|49|||
48330448|NCT00768755|155407459|FG003|Phase 2|Death|31|||
48647416|NCT00500357|156562570|FG000|Overall Study|Death|1|||
48647417|NCT01279044|156562574|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
48647418|NCT01279044|156562575|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
48330449|NCT00768755|155407456|FG000|Phase 2|Protocol Violation|0|||
48647419|NCT01279044|156562576|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
48647420|NCT01279044|156562574|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
48647421|NCT01279044|156562575|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
48647422|NCT01279044|156562576|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
48647423|NCT01279044|156562574|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
48647424|NCT01279044|156562575|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
48647425|NCT01279044|156562576|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
48647426|NCT02705105|156562577|FG000|Treatment|Objective Disease Progression|1|||
48647427|NCT02705105|156562578|FG001|Treatment|Objective Disease Progression|50|||
48647428|NCT02705105|156562577|FG000|Treatment|Withdrawal by Subject|3|||
48647429|NCT02705105|156562578|FG001|Treatment|Withdrawal by Subject|5|||
48647430|NCT02705105|156562577|FG000|Treatment|Adverse Event|0|||
48647431|NCT02705105|156562578|FG001|Treatment|Adverse Event|17|||
48647432|NCT02705105|156562577|FG000|Treatment|Clinical Disease Progression|0|||
48647433|NCT02705105|156562578|FG001|Treatment|Clinical Disease Progression|32|||
48647434|NCT02705105|156562577|FG000|Treatment|Physician Decision|0|||
48647435|NCT02705105|156562578|FG001|Treatment|Physician Decision|3|||
48647436|NCT02705105|156562577|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
48647437|NCT02705105|156562578|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
48647438|NCT02705105|156562577|FG000|Follow-Up|Death|3|||
48647439|NCT02705105|156562578|FG001|Follow-Up|Death|68|||
48647440|NCT02705105|156562577|FG000|Follow-Up|Withdrawal by Subject|1|||
48647441|NCT02705105|156562578|FG001|Follow-Up|Withdrawal by Subject|14|||
48647442|NCT02705105|156562577|FG000|Follow-Up|Study Terminated|0|||
48647443|NCT02705105|156562578|FG001|Follow-Up|Study Terminated|26|||
48647444|NCT02705105|156562577|FG000|Follow-Up|Discontinued per Amendment 3|0|||
48647445|NCT02705105|156562578|FG001|Follow-Up|Discontinued per Amendment 3|2|||
48647446|NCT05559905|156562581|FG000|Overall Study|Withdrawal by Subject|1|||
48647447|NCT05559905|156562582|FG001|Overall Study|Withdrawal by Subject|0|||
48647448|NCT05559905|156562583|FG002|Overall Study|Withdrawal by Subject|0|||
48647449|NCT05559905|156562581|FG000|Overall Study|Not Reported|1|||
48647450|NCT05559905|156562582|FG001|Overall Study|Not Reported|0|||
48647451|NCT05559905|156562583|FG002|Overall Study|Not Reported|0|||
48647452|NCT01645735|156562584|FG000|Overall Study|Physician Decision|2|||
48647453|NCT01645735|156562585|FG001|Overall Study|Physician Decision|0|||
48647454|NCT01645735|156562584|FG000|Overall Study|Withdrawal by Subject|1|||
48647455|NCT01645735|156562585|FG001|Overall Study|Withdrawal by Subject|0|||
48647456|NCT01645735|156562584|FG000|Overall Study|Protocol Violation|1|||
48647457|NCT01645735|156562585|FG001|Overall Study|Protocol Violation|0|||
48647458|NCT01645735|156562584|FG000|Overall Study|Adverse Event|0|||
48647459|NCT01645735|156562585|FG001|Overall Study|Adverse Event|1|||
48647460|NCT01891396|156562587|FG000|Overall Study|Withdrawal by Subject|4|||
48647461|NCT01891396|156562588|FG001|Overall Study|Withdrawal by Subject|4|||
48647462|NCT01891396|156562589|FG002|Overall Study|Withdrawal by Subject|3|||
48647463|NCT01891396|156562587|FG000|Overall Study|Lost to Follow-up|0|||
48647464|NCT01891396|156562588|FG001|Overall Study|Lost to Follow-up|1|||
48647465|NCT01891396|156562589|FG002|Overall Study|Lost to Follow-up|0|||
48751999|NCT00368355|156936673|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
48752000|NCT00368355|156936674|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
48752001|NCT03655691|156936675|FG000|Overall Study|Adverse Event|0|||
48752002|NCT03655691|156936676|FG001|Overall Study|Adverse Event|0|||
48752003|NCT03655691|156936677|FG002|Overall Study|Adverse Event|1|||
48752004|NCT03655691|156936675|FG000|Overall Study|Lost to Follow-up|1|||
48752005|NCT03655691|156936676|FG001|Overall Study|Lost to Follow-up|1|||
48752006|NCT03655691|156936677|FG002|Overall Study|Lost to Follow-up|2|||
48752007|NCT03655691|156936675|FG000|Overall Study|Protocol Violation|0|||
48752008|NCT03655691|156936676|FG001|Overall Study|Protocol Violation|1|||
48752009|NCT03655691|156936677|FG002|Overall Study|Protocol Violation|0|||
48752010|NCT03655691|156936675|FG000|Overall Study|Withdrawal by Subject|1|||
48752011|NCT03655691|156936676|FG001|Overall Study|Withdrawal by Subject|1|||
48752012|NCT03655691|156936677|FG002|Overall Study|Withdrawal by Subject|0|||
48330450|NCT00768755|155407457|FG001|Phase 2|Protocol Violation|2|||
48647466|NCT02820844|156562590|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
48647467|NCT02820844|156562591|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
48647468|NCT02820844|156562592|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
48647469|NCT02820844|156562593|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
48647470|NCT02820844|156562594|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
48647471|NCT02820844|156562595|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
48752013|NCT02846779|156936678|FG000|Overall Study|Lost Enrollment|83|||
48752014|NCT02846779|156936679|FG001|Overall Study|Lost Enrollment|82|||
48647472|NCT02820844|156562590|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
48647473|NCT02820844|156562591|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
48647474|NCT02820844|156562592|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
48647475|NCT02820844|156562593|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
48647476|NCT02820844|156562594|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
48647477|NCT02820844|156562595|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
48647478|NCT02820844|156562590|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
48647479|NCT02820844|156562591|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
48647480|NCT02820844|156562592|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
48647481|NCT02820844|156562593|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
48647482|NCT02820844|156562594|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
48647483|NCT02820844|156562595|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
48647484|NCT02820844|156562590|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
48647485|NCT02820844|156562591|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
48647486|NCT02820844|156562592|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
48647487|NCT02820844|156562593|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
48647488|NCT02820844|156562594|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
48647489|NCT02820844|156562595|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
48647490|NCT02820844|156562590|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
48647491|NCT02820844|156562591|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
48647492|NCT02820844|156562592|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
48647493|NCT02820844|156562593|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
48647494|NCT02820844|156562594|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
48647495|NCT02820844|156562595|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
48647496|NCT02820844|156562590|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
48647497|NCT02820844|156562591|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
48647498|NCT02820844|156562592|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
48647499|NCT02820844|156562593|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
48647500|NCT02820844|156562594|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
48647501|NCT02820844|156562595|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
48647502|NCT02820844|156562590|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
48647503|NCT02820844|156562591|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
48647504|NCT02820844|156562592|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
48647505|NCT02820844|156562593|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
48647506|NCT02820844|156562594|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
48647507|NCT02820844|156562595|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
48647508|NCT02820844|156562590|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647509|NCT02820844|156562591|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647510|NCT02820844|156562592|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
48647511|NCT02820844|156562593|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
48647512|NCT02820844|156562594|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647513|NCT02820844|156562595|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647514|NCT02820844|156562590|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
48647515|NCT02820844|156562591|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
48647516|NCT02820844|156562592|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
48647517|NCT02820844|156562593|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
48647518|NCT02820844|156562594|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
48647519|NCT02820844|156562595|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
48647520|NCT02820844|156562590|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647521|NCT02820844|156562591|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647522|NCT02820844|156562592|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647523|NCT02820844|156562593|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647524|NCT02820844|156562594|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
48647525|NCT02820844|156562595|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
48647526|NCT02010593|156562599|FG000|Overall Study|Lost to Follow-up|1|||
48647527|NCT02010593|156562600|FG001|Overall Study|Lost to Follow-up|0|||
48647528|NCT02010593|156562599|FG000|Overall Study|Physician Decision|1|||
48647529|NCT02010593|156562600|FG001|Overall Study|Physician Decision|0|||
48647530|NCT02010593|156562599|FG000|Overall Study|Unable to adhere to visit schedule|0|||
48647531|NCT02010593|156562600|FG001|Overall Study|Unable to adhere to visit schedule|2|||
48647532|NCT01135459|156562601|FG000|Overall Study|Adverse Event|8|||
48752015|NCT02846779|156936680|FG002|Overall Study|Lost Enrollment|86|||
48647533|NCT01135459|156562602|FG001|Overall Study|Adverse Event|10|||
48647534|NCT01135459|156562601|FG000|Overall Study|Lack of Efficacy|3|||
48647535|NCT01135459|156562602|FG001|Overall Study|Lack of Efficacy|1|||
48647536|NCT01135459|156562601|FG000|Overall Study|Withdrawal by Subject|2|||
48647537|NCT01135459|156562602|FG001|Overall Study|Withdrawal by Subject|3|||
48647538|NCT01135459|156562601|FG000|Overall Study|Protocol Violation|5|||
48752016|NCT02846779|156936678|FG000|Overall Study|Less than 31 days of follow-up|56|||
48752017|NCT02846779|156936679|FG001|Overall Study|Less than 31 days of follow-up|45|||
48752018|NCT02846779|156936680|FG002|Overall Study|Less than 31 days of follow-up|52|||
48752019|NCT01648101|156938200|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
48330451|NCT00768755|155407458|FG002|Phase 2|Protocol Violation|0|||
48330452|NCT00768755|155407459|FG003|Phase 2|Protocol Violation|1|||
48330453|NCT00768755|155407456|FG000|Phase 2|Lost to Follow-up|0|||
48330454|NCT00768755|155407457|FG001|Phase 2|Lost to Follow-up|1|||
48330455|NCT00768755|155407458|FG002|Phase 2|Lost to Follow-up|1|||
48330456|NCT00768755|155407459|FG003|Phase 2|Lost to Follow-up|4|||
48330457|NCT00768755|155407456|FG000|Phase 2|Withdrawal by Subject|0|||
48330458|NCT00768755|155407457|FG001|Phase 2|Withdrawal by Subject|1|||
48330459|NCT00768755|155407458|FG002|Phase 2|Withdrawal by Subject|0|||
48330460|NCT00768755|155407459|FG003|Phase 2|Withdrawal by Subject|1|||
48330461|NCT00768755|155407456|FG000|Phase 2|Other|0|||
48330462|NCT00768755|155407457|FG001|Phase 2|Other|1|||
48330463|NCT00768755|155407458|FG002|Phase 2|Other|2|||
48330464|NCT00768755|155407459|FG003|Phase 2|Other|4|||
48330465|NCT00768755|155407456|FG000|Phase 2|Study Terminated by Sponsor|0|||
48330466|NCT00768755|155407457|FG001|Phase 2|Study Terminated by Sponsor|13|||
48330467|NCT00768755|155407458|FG002|Phase 2|Study Terminated by Sponsor|7|||
48330468|NCT00768755|155407459|FG003|Phase 2|Study Terminated by Sponsor|14|||
48330469|NCT00768755|155407456|FG000|Phase 2|Randomized but not treated|0|||
48330470|NCT00768755|155407457|FG001|Phase 2|Randomized but not treated|0|||
48330471|NCT00768755|155407458|FG002|Phase 2|Randomized but not treated|0|||
48330472|NCT00768755|155407459|FG003|Phase 2|Randomized but not treated|2|||
48330473|NCT02128269|155407463|FG000|Treatment Period|Adverse Event|1|||
48330474|NCT02128269|155407463|FG000|Treatment Period|Physician Decision|1|||
48330475|NCT00878189|155407465|FG000|Overall Study|Death|0|||
48330476|NCT00878189|155407466|FG001|Overall Study|Death|1|||
48330477|NCT00878189|155407467|FG002|Overall Study|Death|0|||
48330478|NCT00878189|155407468|FG003|Overall Study|Death|1|||
48330479|NCT00878189|155407469|FG004|Overall Study|Death|0|||
48330480|NCT00878189|155407470|FG005|Overall Study|Death|0|||
48647539|NCT01135459|156562602|FG001|Overall Study|Protocol Violation|3|||
48647540|NCT01135459|156562601|FG000|Overall Study|Lost to Follow-up|2|||
48647541|NCT01135459|156562602|FG001|Overall Study|Lost to Follow-up|1|||
48647542|NCT01135459|156562601|FG000|Overall Study|Non-compliance to study procedures|0|||
48647543|NCT01135459|156562602|FG001|Overall Study|Non-compliance to study procedures|1|||
48647544|NCT01135459|156562601|FG000|Overall Study|Other than specified|1|||
48647545|NCT01135459|156562602|FG001|Overall Study|Other than specified|1|||
48647546|NCT01977729|156562603|FG000|Overall Study|Study terminated|1|||
48647547|NCT02229825|156562613|FG000|Overall Study|Personal Reasons|0|||
48752020|NCT01648101|156938201|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
48752021|NCT01648101|156938202|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
48647548|NCT02229825|156562614|FG001|Overall Study|Personal Reasons|1|||
48647549|NCT02229825|156562613|FG000|Overall Study|Refused continuing medication|7|||
48647550|NCT02229825|156562614|FG001|Overall Study|Refused continuing medication|6|||
48647551|NCT02229825|156562613|FG000|Overall Study|Lost to Follow-up|1|||
48647552|NCT02229825|156562614|FG001|Overall Study|Lost to Follow-up|2|||
48647553|NCT02229825|156562613|FG000|Overall Study|Protocol Violation|1|||
48647554|NCT02229825|156562614|FG001|Overall Study|Protocol Violation|1|||
48647555|NCT02229825|156562613|FG000|Overall Study|Lack of Efficacy|4|||
48647556|NCT02229825|156562614|FG001|Overall Study|Lack of Efficacy|10|||
48647557|NCT02229825|156562613|FG000|Overall Study|Adverse Event|11|||
48752022|NCT01648101|156938200|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
48752023|NCT01648101|156938201|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
48752024|NCT01648101|156938202|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
48752025|NCT01648101|156938200|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
48752026|NCT01648101|156938201|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
48752027|NCT01648101|156938202|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
48752028|NCT01648101|156938200|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
48752029|NCT01648101|156938201|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
48647558|NCT02229825|156562614|FG001|Overall Study|Adverse Event|9|||
48330481|NCT00878189|155407471|FG006|Overall Study|Death|0|||
48330482|NCT00878189|155407472|FG007|Overall Study|Death|0|||
48330483|NCT00878189|155407473|FG008|Overall Study|Death|1|||
48330484|NCT00878189|155407465|FG000|Overall Study|Participant Refused to Follow-up|0|||
48330485|NCT00878189|155407466|FG001|Overall Study|Participant Refused to Follow-up|0|||
48330486|NCT00878189|155407467|FG002|Overall Study|Participant Refused to Follow-up|0|||
48330487|NCT00878189|155407468|FG003|Overall Study|Participant Refused to Follow-up|0|||
48647559|NCT02229825|156562613|FG000|Overall Study|Not treated|0|||
48647560|NCT02229825|156562614|FG001|Overall Study|Not treated|1|||
48647561|NCT03226249|156562618|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
48647562|NCT03226249|156562618|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
48647563|NCT03226249|156562618|FG000|Survival Follow-up|Patients still in follow-up.|30|||
48647564|NCT04474197|156562619|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
48647565|NCT04474197|156562620|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
48647566|NCT04474197|156562621|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
48647567|NCT04474197|156562622|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
48647568|NCT01057693|156562623|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
48647569|NCT01057693|156562624|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
48647570|NCT01057693|156562625|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
48647571|NCT01057693|156562623|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
48647572|NCT01057693|156562624|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
48647573|NCT01057693|156562625|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
48647574|NCT01057693|156562623|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
48647575|NCT01057693|156562624|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
48647576|NCT01057693|156562625|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
48647577|NCT01057693|156562623|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
48647578|NCT01057693|156562624|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
48647579|NCT01057693|156562625|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
48647580|NCT01057693|156562623|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
48647581|NCT01057693|156562624|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
48647582|NCT01057693|156562625|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
48647583|NCT01057693|156562623|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
48647584|NCT01057693|156562624|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
48647585|NCT01057693|156562625|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
48647586|NCT01057693|156562623|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
48647587|NCT01057693|156562624|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
48647588|NCT01057693|156562625|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
48647589|NCT01057693|156562623|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
48647590|NCT01057693|156562624|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
48647591|NCT01057693|156562625|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
48647592|NCT01057693|156562623|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
48647593|NCT01057693|156562624|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
48647594|NCT01057693|156562625|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
48647595|NCT01057693|156562623|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
48647596|NCT01057693|156562624|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
48647597|NCT01057693|156562625|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
48647598|NCT01057693|156562623|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
48647599|NCT01057693|156562624|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
48647600|NCT01057693|156562625|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
48647601|NCT01057693|156562623|FG000|Between Single-Blind and Double-Blind|Other|6|||
48647602|NCT01057693|156562624|FG001|Between Single-Blind and Double-Blind|Other|0|||
48647603|NCT01057693|156562625|FG002|Between Single-Blind and Double-Blind|Other|0|||
48647604|NCT01057693|156562623|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
48647605|NCT01057693|156562624|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
48647606|NCT01057693|156562625|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
48647607|NCT01057693|156562623|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
48647608|NCT01057693|156562624|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
48647609|NCT01057693|156562625|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
48647610|NCT01057693|156562623|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
48647611|NCT01057693|156562624|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
48647612|NCT01057693|156562625|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
48647613|NCT01057693|156562623|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
48647614|NCT01057693|156562624|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
48647615|NCT01057693|156562625|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
48647616|NCT01057693|156562623|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
48752030|NCT01648101|156938202|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
48752031|NCT01648101|156938200|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
48752032|NCT01648101|156938201|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
48752033|NCT01648101|156938202|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
48752034|NCT01648101|156938200|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
48752035|NCT01648101|156938201|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
48752036|NCT01648101|156938202|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
48647617|NCT01057693|156562624|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
48752037|NCT01648101|156938200|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
48752038|NCT01648101|156938201|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
48752039|NCT01648101|156938202|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
48752040|NCT01648101|156938200|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
48752041|NCT01648101|156938201|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
48752042|NCT01648101|156938202|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
48752043|NCT01648101|156938200|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
48752044|NCT01648101|156938201|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
48752045|NCT01648101|156938202|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
48752046|NCT01648101|156938200|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
48752047|NCT01648101|156938201|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
48752048|NCT01648101|156938202|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
48752049|NCT01648101|156938200|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
48752050|NCT01648101|156938201|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
48752051|NCT01648101|156938202|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
48752052|NCT00307294|156938203|FG000|Overall Study|Withdrawal by Subject|1|||
48752053|NCT04203238|156938204|FG000|Overall Study|Withdrawal by Subject|1|||
48752054|NCT04203238|156938205|FG001|Overall Study|Withdrawal by Subject|1|||
48752055|NCT04203238|156938204|FG000|Overall Study|Covid-19|3|||
48752056|NCT04203238|156938205|FG001|Overall Study|Covid-19|0|||
48752057|NCT04221009|156938207|FG000|Overall Study|Withdrawal by Subject|4|||
48752058|NCT01438424|156938208|FG000|Overall Study|Continuing treatment|29|||
48752059|NCT01438424|156938208|FG000|Overall Study|Minimal virologic response|95|||
48752060|NCT01438424|156938208|FG000|Overall Study|Not identified|55|||
48752061|NCT01438424|156938208|FG000|Overall Study|Withdrawal by Subject|104|||
48752062|NCT01438424|156938208|FG000|Overall Study|Progression of chronic hepatitis B|22|||
48752063|NCT01438424|156938208|FG000|Overall Study|Death|22|||
48752064|NCT01438424|156938208|FG000|Overall Study|Adverse Event|17|||
48752065|NCT01438424|156938208|FG000|Overall Study|Lost to Follow-up|17|||
48752066|NCT01438424|156938208|FG000|Overall Study|Abnormal laboratory test result|14|||
48647618|NCT01057693|156562625|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
48647619|NCT01057693|156562623|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
48647620|NCT01057693|156562624|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
48647621|NCT01057693|156562625|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
48647622|NCT01057693|156562623|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
48647623|NCT01057693|156562624|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
48647624|NCT01057693|156562625|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
48647625|NCT02413996|156562626|FG000|Overall Study|not comfortable with the intervention|9|||
48647626|NCT02413996|156562627|FG001|Overall Study|not comfortable with the intervention|2|||
48647627|NCT02526212|156562628|FG000|Overall Study|Incarceration|1|||
48647628|NCT02526212|156562629|FG001|Overall Study|Incarceration|0|||
48647629|NCT02526212|156562628|FG000|Overall Study|Lost to Follow-up|1|||
48752067|NCT01438424|156938208|FG000|Overall Study|Need for drug prohibited by protocol|14|||
48752068|NCT01438424|156938208|FG000|Overall Study|Pregnancy|7|||
48752069|NCT01438424|156938208|FG000|Overall Study|No longer met inclusion criteria|1|||
48752070|NCT01438424|156938208|FG000|Overall Study|Participant noncompliance|20|||
48752071|NCT04232124|156938211|FG000|Overall Study|Lost to Follow-up|3|||
48752072|NCT02501473|156938220|FG000|Overall Study|Study Terminated|2|||
48752073|NCT02501473|156938221|FG001|Overall Study|Study Terminated|3|||
48752074|NCT02501473|156938222|FG002|Overall Study|Study Terminated|7|||
48752075|NCT02501473|156938223|FG003|Overall Study|Study Terminated|9|||
48752076|NCT02501473|156938224|FG004|Overall Study|Study Terminated|2|||
48752077|NCT02501473|156938225|FG005|Overall Study|Study Terminated|10|||
48752078|NCT02501473|156938226|FG006|Overall Study|Study Terminated|1|||
48752079|NCT02501473|156938227|FG007|Overall Study|Study Terminated|0|||
48752080|NCT02501473|156938220|FG000|Overall Study|Withdrawal by Subject|0|||
48752081|NCT02501473|156938221|FG001|Overall Study|Withdrawal by Subject|0|||
48752082|NCT02501473|156938222|FG002|Overall Study|Withdrawal by Subject|3|||
48752083|NCT02501473|156938223|FG003|Overall Study|Withdrawal by Subject|3|||
48752084|NCT02501473|156938224|FG004|Overall Study|Withdrawal by Subject|2|||
48752085|NCT02501473|156938225|FG005|Overall Study|Withdrawal by Subject|2|||
48752086|NCT02501473|156938226|FG006|Overall Study|Withdrawal by Subject|0|||
48752087|NCT02501473|156938227|FG007|Overall Study|Withdrawal by Subject|0|||
48752088|NCT02501473|156938220|FG000|Overall Study|Death|0|||
48752089|NCT02501473|156938221|FG001|Overall Study|Death|0|||
48752090|NCT02501473|156938222|FG002|Overall Study|Death|1|||
48752091|NCT02501473|156938223|FG003|Overall Study|Death|1|||
48752092|NCT02501473|156938224|FG004|Overall Study|Death|0|||
48752093|NCT02501473|156938225|FG005|Overall Study|Death|1|||
48752094|NCT02501473|156938226|FG006|Overall Study|Death|0|||
48647630|NCT02526212|156562629|FG001|Overall Study|Lost to Follow-up|0|||
48647631|NCT02526212|156562628|FG000|Overall Study|Death|0|||
48752095|NCT02501473|156938227|FG007|Overall Study|Death|0|||
48752096|NCT02501473|156938220|FG000|Overall Study|Lost to Follow-up|1|||
48752097|NCT02501473|156938221|FG001|Overall Study|Lost to Follow-up|0|||
48752098|NCT02501473|156938222|FG002|Overall Study|Lost to Follow-up|1|||
48752099|NCT02501473|156938223|FG003|Overall Study|Lost to Follow-up|0|||
48752100|NCT02501473|156938224|FG004|Overall Study|Lost to Follow-up|0|||
48752101|NCT02501473|156938225|FG005|Overall Study|Lost to Follow-up|1|||
48752102|NCT02501473|156938226|FG006|Overall Study|Lost to Follow-up|0|||
48752103|NCT02501473|156938227|FG007|Overall Study|Lost to Follow-up|0|||
48752104|NCT02501473|156938220|FG000|Overall Study|Reason not specified|0|||
48752105|NCT02501473|156938221|FG001|Overall Study|Reason not specified|0|||
48752106|NCT02501473|156938222|FG002|Overall Study|Reason not specified|1|||
48752107|NCT02501473|156938223|FG003|Overall Study|Reason not specified|1|||
48752108|NCT02501473|156938224|FG004|Overall Study|Reason not specified|0|||
48752109|NCT02501473|156938225|FG005|Overall Study|Reason not specified|0|||
48752110|NCT02501473|156938226|FG006|Overall Study|Reason not specified|0|||
48752111|NCT02501473|156938227|FG007|Overall Study|Reason not specified|0|||
48752112|NCT02927080|156938230|FG000|Overall Study|Withdrawal by Subject|0|||
48752113|NCT02927080|156938231|FG001|Overall Study|Withdrawal by Subject|0|||
48752114|NCT02927080|156938232|FG002|Overall Study|Withdrawal by Subject|0|||
48752115|NCT02927080|156938233|FG003|Overall Study|Withdrawal by Subject|0|||
48752116|NCT02927080|156938234|FG004|Overall Study|Withdrawal by Subject|1|||
48752117|NCT02927080|156938235|FG005|Overall Study|Withdrawal by Subject|0|||
48752118|NCT02927080|156938236|FG006|Overall Study|Withdrawal by Subject|1|||
48752119|NCT02927080|156938237|FG007|Overall Study|Withdrawal by Subject|1|||
48647632|NCT02526212|156562629|FG001|Overall Study|Death|1|||
48647633|NCT00606411|156562630|FG000|Overall Study|Adverse Event|1|||
48647634|NCT00606411|156562631|FG001|Overall Study|Adverse Event|2|||
48647635|NCT00606411|156562630|FG000|Overall Study|Lack of Adherence|1|||
48647636|NCT00606411|156562631|FG001|Overall Study|Lack of Adherence|1|||
48647637|NCT00606411|156562630|FG000|Overall Study|Lack of Efficacy|1|||
48647638|NCT00606411|156562631|FG001|Overall Study|Lack of Efficacy|1|||
48647639|NCT00606411|156562630|FG000|Overall Study|Withdrawal by Subject|2|||
48647640|NCT00606411|156562631|FG001|Overall Study|Withdrawal by Subject|0|||
48647641|NCT00606411|156562630|FG000|Overall Study|Lost to Follow-up|1|||
48647642|NCT00606411|156562631|FG001|Overall Study|Lost to Follow-up|2|||
48647643|NCT00606411|156562630|FG000|Overall Study|Move out of state|0|||
48647644|NCT00606411|156562631|FG001|Overall Study|Move out of state|1|||
48752120|NCT02927080|156938238|FG008|Overall Study|Withdrawal by Subject|0|||
48647645|NCT01390298|156562632|FG000|Overall Study|Death|1|||
48752121|NCT02927080|156938239|FG009|Overall Study|Withdrawal by Subject|2|||
48752122|NCT02927080|156938230|FG000|Overall Study|Willingness to comply with protocol|0|||
48752123|NCT02927080|156938231|FG001|Overall Study|Willingness to comply with protocol|0|||
48647646|NCT01390298|156562632|FG000|Overall Study|long term ICU admission|1|||
48647647|NCT01390298|156562632|FG000|Overall Study|Withdrawal by Subject|14|||
48647648|NCT01390298|156562632|FG000|Overall Study|Lost to Follow-up|7|||
48647649|NCT01390298|156562632|FG000|Overall Study|Surgery cancelled|1|||
48647650|NCT00579553|156562635|FG000|Overall Study|Lost to Follow-up|16|||
48647651|NCT00579553|156562636|FG001|Overall Study|Lost to Follow-up|13|||
48647652|NCT00615719|156562650|FG000|Overall Study|Physician Decision|5|||
48647653|NCT03951766|156562651|FG000|Treatment Phase|Lost to Follow-up|1|||
48647654|NCT03951766|156562651|FG000|Follow-up Phase|Lost to Follow-up|10|||
48647655|NCT03810014|156562654|FG000|Overall Study|Pregnancy|2|||
48647656|NCT03810014|156562655|FG001|Overall Study|Pregnancy|2|||
48647657|NCT03810014|156562656|FG002|Overall Study|Pregnancy|0|||
48647658|NCT03810014|156562657|FG003|Overall Study|Pregnancy|2|||
48647659|NCT02243371|156562665|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
48647660|NCT02243371|156562666|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
48647661|NCT02243371|156562665|FG000|Overall Study|Death (unrelated)|2|||
48752124|NCT02927080|156938232|FG002|Overall Study|Willingness to comply with protocol|0|||
48752125|NCT02927080|156938233|FG003|Overall Study|Willingness to comply with protocol|0|||
48752126|NCT02927080|156938234|FG004|Overall Study|Willingness to comply with protocol|0|||
48330488|NCT00878189|155407469|FG004|Overall Study|Participant Refused to Follow-up|0|||
48752127|NCT02927080|156938235|FG005|Overall Study|Willingness to comply with protocol|0|||
48752128|NCT02927080|156938236|FG006|Overall Study|Willingness to comply with protocol|0|||
48330489|NCT00878189|155407470|FG005|Overall Study|Participant Refused to Follow-up|4|||
48752129|NCT02927080|156938237|FG007|Overall Study|Willingness to comply with protocol|0|||
48752130|NCT02927080|156938238|FG008|Overall Study|Willingness to comply with protocol|0|||
48752131|NCT02927080|156938239|FG009|Overall Study|Willingness to comply with protocol|1|||
48647662|NCT02243371|156562666|FG001|Overall Study|Death (unrelated)|4|||
48647663|NCT02243371|156562665|FG000|Overall Study|Adverse Event (unrelated)|0|||
48647664|NCT02243371|156562666|FG001|Overall Study|Adverse Event (unrelated)|1|||
48752132|NCT02927080|156938230|FG000|Overall Study|Study terminated by Sponsor|0|||
48752133|NCT02927080|156938231|FG001|Overall Study|Study terminated by Sponsor|0|||
48752134|NCT02927080|156938232|FG002|Overall Study|Study terminated by Sponsor|0|||
48752135|NCT02927080|156938233|FG003|Overall Study|Study terminated by Sponsor|0|||
48752136|NCT02927080|156938234|FG004|Overall Study|Study terminated by Sponsor|0|||
48752137|NCT02927080|156938235|FG005|Overall Study|Study terminated by Sponsor|0|||
48752138|NCT02927080|156938236|FG006|Overall Study|Study terminated by Sponsor|6|||
48647665|NCT02243371|156562665|FG000|Overall Study|Lack of Clinical Benefit|0|||
48647666|NCT02243371|156562666|FG001|Overall Study|Lack of Clinical Benefit|1|||
48647667|NCT02243371|156562665|FG000|Overall Study|Withdrawal by Subject|0|||
48647668|NCT02243371|156562666|FG001|Overall Study|Withdrawal by Subject|2|||
48647669|NCT00881530|156562670|FG000|Overall Study|Adverse Event|5|||
48647670|NCT00881530|156562671|FG001|Overall Study|Adverse Event|1|||
48647671|NCT00881530|156562672|FG002|Overall Study|Adverse Event|1|||
48647672|NCT00881530|156562673|FG003|Overall Study|Adverse Event|4|||
48647673|NCT00881530|156562674|FG004|Overall Study|Adverse Event|10|||
48647674|NCT00881530|156562675|FG005|Overall Study|Adverse Event|2|||
48647675|NCT00881530|156562670|FG000|Overall Study|Lack of Efficacy|1|||
48647676|NCT00881530|156562671|FG001|Overall Study|Lack of Efficacy|0|||
48647677|NCT00881530|156562672|FG002|Overall Study|Lack of Efficacy|0|||
48647678|NCT00881530|156562673|FG003|Overall Study|Lack of Efficacy|0|||
48647679|NCT00881530|156562674|FG004|Overall Study|Lack of Efficacy|1|||
48647680|NCT00881530|156562675|FG005|Overall Study|Lack of Efficacy|1|||
48647681|NCT00881530|156562670|FG000|Overall Study|Not compliant with the protocol|0|||
48647682|NCT00881530|156562671|FG001|Overall Study|Not compliant with the protocol|0|||
48647683|NCT00881530|156562672|FG002|Overall Study|Not compliant with the protocol|0|||
48647684|NCT00881530|156562673|FG003|Overall Study|Not compliant with the protocol|0|||
48647685|NCT00881530|156562674|FG004|Overall Study|Not compliant with the protocol|2|||
48647686|NCT00881530|156562675|FG005|Overall Study|Not compliant with the protocol|0|||
48647687|NCT00881530|156562670|FG000|Overall Study|Lost to Follow-up|0|||
48647688|NCT00881530|156562671|FG001|Overall Study|Lost to Follow-up|1|||
48647689|NCT00881530|156562672|FG002|Overall Study|Lost to Follow-up|1|||
48647690|NCT00881530|156562673|FG003|Overall Study|Lost to Follow-up|3|||
48647691|NCT00881530|156562674|FG004|Overall Study|Lost to Follow-up|1|||
48647692|NCT00881530|156562675|FG005|Overall Study|Lost to Follow-up|0|||
48647693|NCT00881530|156562670|FG000|Overall Study|Refused to continue medication|7|||
48647694|NCT00881530|156562671|FG001|Overall Study|Refused to continue medication|2|||
48647695|NCT00881530|156562672|FG002|Overall Study|Refused to continue medication|1|||
48647696|NCT00881530|156562673|FG003|Overall Study|Refused to continue medication|2|||
48647697|NCT00881530|156562674|FG004|Overall Study|Refused to continue medication|0|||
48647698|NCT00881530|156562675|FG005|Overall Study|Refused to continue medication|0|||
48647699|NCT00881530|156562670|FG000|Overall Study|Other reason not defined above|1|||
48647700|NCT00881530|156562671|FG001|Overall Study|Other reason not defined above|1|||
48647701|NCT00881530|156562672|FG002|Overall Study|Other reason not defined above|2|||
48647702|NCT00881530|156562673|FG003|Overall Study|Other reason not defined above|0|||
48647703|NCT00881530|156562674|FG004|Overall Study|Other reason not defined above|0|||
48647704|NCT00881530|156562675|FG005|Overall Study|Other reason not defined above|2|||
48647705|NCT03900728|156562676|FG000|Overall Study|No text responses|0|||
48647706|NCT03900728|156562677|FG001|Overall Study|No text responses|0|||
48647707|NCT03900728|156562678|FG002|Overall Study|No text responses|4|||
48647708|NCT05141175|156562689|FG000|Overall Study|Withdrawal by Subject|1|||
48647709|NCT02036580|156562692|FG000|Overall Study|Withdrawal by Subject|0|||
48647710|NCT02036580|156562693|FG001|Overall Study|Withdrawal by Subject|1|||
48647711|NCT02036580|156562694|FG002|Overall Study|Withdrawal by Subject|0|||
48647712|NCT02036580|156562692|FG000|Overall Study|Adverse Event|1|||
48647713|NCT02036580|156562693|FG001|Overall Study|Adverse Event|0|||
48647714|NCT02036580|156562694|FG002|Overall Study|Adverse Event|0|||
48647715|NCT00992056|156562695|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
48647716|NCT00992056|156562696|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
48647717|NCT00992056|156562695|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
48647718|NCT00992056|156562696|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
48647719|NCT01162473|156562697|FG000|Overall Study|Adverse Event|2|||
48647720|NCT01162473|156562698|FG001|Overall Study|Adverse Event|1|||
48647721|NCT01162473|156562697|FG000|Overall Study|Withdrawal by Subject|0|||
48647722|NCT01162473|156562698|FG001|Overall Study|Withdrawal by Subject|4|||
48647723|NCT01144416|156562699|FG000|Intervention Period|Adverse Event|5|||
48647724|NCT01144416|156562700|FG001|Intervention Period|Adverse Event|6|||
48647725|NCT01144416|156562699|FG000|Intervention Period|Insufficient ovarian response|11|||
48647726|NCT01144416|156562700|FG001|Intervention Period|Insufficient ovarian response|17|||
48647727|NCT01144416|156562699|FG000|Intervention Period|Risk of OHSS|0|||
48330490|NCT00878189|155407471|FG006|Overall Study|Participant Refused to Follow-up|0|||
48647728|NCT01144416|156562700|FG001|Intervention Period|Risk of OHSS|1|||
48647729|NCT01144416|156562699|FG000|Intervention Period|Too high ovarian response|4|||
48647730|NCT01144416|156562700|FG001|Intervention Period|Too high ovarian response|2|||
48647731|NCT01144416|156562699|FG000|Intervention Period|No/too few/bad oocytes|7|||
48647732|NCT01144416|156562700|FG001|Intervention Period|No/too few/bad oocytes|5|||
48752139|NCT02927080|156938237|FG007|Overall Study|Study terminated by Sponsor|7|||
48647733|NCT01144416|156562699|FG000|Intervention Period|No or abnormal fertilization|25|||
48647734|NCT01144416|156562700|FG001|Intervention Period|No or abnormal fertilization|10|||
48647735|NCT01144416|156562699|FG000|Intervention Period|No/too few/bad quality embryos|3|||
48647736|NCT01144416|156562700|FG001|Intervention Period|No/too few/bad quality embryos|3|||
48647737|NCT01144416|156562699|FG000|Intervention Period|Other|7|||
48647738|NCT01144416|156562700|FG001|Intervention Period|Other|5|||
48647739|NCT01001767|156562701|FG000|Overall Study|no baseline study performed|1|||
48647740|NCT01001767|156562702|FG001|Overall Study|no baseline study performed|0|||
48647741|NCT01001767|156562701|FG000|Overall Study|Protocol Violation|1|||
48647742|NCT01001767|156562702|FG001|Overall Study|Protocol Violation|0|||
48647743|NCT01001767|156562701|FG000|Overall Study|Lost to Follow-up|1|||
48647744|NCT01001767|156562702|FG001|Overall Study|Lost to Follow-up|0|||
48647745|NCT01001767|156562701|FG000|Overall Study|Physician Decision|1|||
48647746|NCT01001767|156562702|FG001|Overall Study|Physician Decision|0|||
48647747|NCT01107392|156562703|FG000|Overall Study|Adverse Event|2|||
48647748|NCT01107392|156562704|FG001|Overall Study|Adverse Event|0|||
48647749|NCT01107392|156562703|FG000|Overall Study|Personal Reasons|2|||
48647750|NCT01107392|156562704|FG001|Overall Study|Personal Reasons|3|||
48647751|NCT01107392|156562703|FG000|Overall Study|Administrative decision|1|||
48647752|NCT01107392|156562704|FG001|Overall Study|Administrative decision|0|||
48647753|NCT02720523|156562705|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
48647754|NCT02720523|156562706|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
48647755|NCT02720523|156562707|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
48647756|NCT02720523|156562708|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
48647757|NCT02720523|156562709|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
48647758|NCT02720523|156562710|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
48647759|NCT02720523|156562711|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
48647760|NCT02720523|156562705|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
48647761|NCT02720523|156562706|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
48647762|NCT02720523|156562707|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
48647763|NCT02720523|156562708|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
48647764|NCT02720523|156562709|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
48647765|NCT02720523|156562710|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
48647766|NCT02720523|156562711|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
48647767|NCT02720523|156562705|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
48647768|NCT02720523|156562706|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
48330491|NCT00878189|155407472|FG007|Overall Study|Participant Refused to Follow-up|0|||
48427672|NCT01254604|155754677|FG001|Overall Study|Protocol Violation|2|||
48647769|NCT02720523|156562707|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
48647770|NCT02720523|156562708|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
48647771|NCT02720523|156562709|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
48647772|NCT02720523|156562710|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
48752140|NCT02927080|156938238|FG008|Overall Study|Study terminated by Sponsor|2|||
48752141|NCT02927080|156938239|FG009|Overall Study|Study terminated by Sponsor|3|||
48752142|NCT02927080|156938230|FG000|Overall Study|Adverse Event|0|||
48752143|NCT02927080|156938231|FG001|Overall Study|Adverse Event|1|||
48752144|NCT02927080|156938232|FG002|Overall Study|Adverse Event|0|||
48752145|NCT02927080|156938233|FG003|Overall Study|Adverse Event|0|||
48752146|NCT02927080|156938234|FG004|Overall Study|Adverse Event|0|||
48752147|NCT02927080|156938235|FG005|Overall Study|Adverse Event|0|||
48752148|NCT02927080|156938236|FG006|Overall Study|Adverse Event|0|||
48752149|NCT02927080|156938237|FG007|Overall Study|Adverse Event|1|||
48752150|NCT02927080|156938238|FG008|Overall Study|Adverse Event|0|||
48752151|NCT02927080|156938239|FG009|Overall Study|Adverse Event|1|||
48752152|NCT02927080|156938230|FG000|Overall Study|Other|0|||
48752153|NCT02927080|156938231|FG001|Overall Study|Other|0|||
48752154|NCT02927080|156938232|FG002|Overall Study|Other|0|||
48752155|NCT02927080|156938233|FG003|Overall Study|Other|0|||
48752156|NCT02927080|156938234|FG004|Overall Study|Other|0|||
48752157|NCT02927080|156938235|FG005|Overall Study|Other|0|||
48752158|NCT02927080|156938236|FG006|Overall Study|Other|1|||
48752159|NCT02927080|156938237|FG007|Overall Study|Other|0|||
48752160|NCT02927080|156938238|FG008|Overall Study|Other|1|||
48752161|NCT02927080|156938239|FG009|Overall Study|Other|0|||
48752162|NCT02507505|156938242|FG000|Overall Study|Withdrawal by Subject|13|||
48752163|NCT02507505|156938243|FG001|Overall Study|Withdrawal by Subject|11|||
48752164|NCT02507505|156938242|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
48752165|NCT02507505|156938243|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
48752166|NCT02507505|156938242|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
48752167|NCT02507505|156938243|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
48647773|NCT02720523|156562711|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
48647774|NCT02720523|156562705|FG000|Period 1: Placebo-controlled Period|Other|0|||
48647775|NCT02720523|156562706|FG001|Period 1: Placebo-controlled Period|Other|0|||
48647776|NCT02720523|156562707|FG002|Period 1: Placebo-controlled Period|Other|1|||
48647777|NCT02720523|156562708|FG003|Period 1: Placebo-controlled Period|Other|1|||
48647778|NCT02720523|156562709|FG004|Period 1: Placebo-controlled Period|Other|0|||
48647779|NCT02720523|156562710|FG005|Period 1: Placebo-controlled Period|Other|0|||
48647780|NCT02720523|156562711|FG006|Period 1: Placebo-controlled Period|Other|0|||
48647781|NCT02720523|156562705|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
48647782|NCT02720523|156562706|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
48647783|NCT02720523|156562707|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
48647784|NCT02720523|156562708|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
48647785|NCT02720523|156562709|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
48647786|NCT02720523|156562710|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
48647787|NCT02720523|156562711|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
48647788|NCT02720523|156562705|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
48647789|NCT02720523|156562706|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
48647790|NCT02720523|156562707|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
48647791|NCT02720523|156562708|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
48647792|NCT02720523|156562709|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
48647793|NCT02720523|156562710|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
48647794|NCT02720523|156562711|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
48647795|NCT02720523|156562705|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
48647796|NCT02720523|156562706|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
48647797|NCT02720523|156562707|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
48647798|NCT02720523|156562708|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
48647799|NCT02720523|156562709|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
48647800|NCT02720523|156562710|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
48647801|NCT02720523|156562711|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
48647802|NCT02720523|156562705|FG000|Period 2: Long-term Extension Period|Other|0|||
48647803|NCT02720523|156562706|FG001|Period 2: Long-term Extension Period|Other|0|||
48647804|NCT02720523|156562707|FG002|Period 2: Long-term Extension Period|Other|0|||
48647805|NCT02720523|156562708|FG003|Period 2: Long-term Extension Period|Other|0|||
48647806|NCT02720523|156562709|FG004|Period 2: Long-term Extension Period|Other|2|||
48647807|NCT02720523|156562710|FG005|Period 2: Long-term Extension Period|Other|0|||
48647808|NCT02720523|156562711|FG006|Period 2: Long-term Extension Period|Other|3|||
48647809|NCT00792740|156562714|FG000|Overall Study|Disease Worsening|3|||
48752168|NCT02507505|156938242|FG000|Overall Study|Death before receipt of anesthesia|0|||
48752169|NCT02507505|156938243|FG001|Overall Study|Death before receipt of anesthesia|1|||
48752170|NCT00609492|156938244|FG000|Overall Study|Withdrawal by Subject|0|||
48752171|NCT00609492|156938245|FG001|Overall Study|Withdrawal by Subject|2|||
48647810|NCT00792740|156562715|FG001|Overall Study|Disease Worsening|2|||
48647811|NCT00792740|156562714|FG000|Overall Study|Personal Reason|1|||
48647812|NCT00792740|156562715|FG001|Overall Study|Personal Reason|0|||
48647813|NCT00792740|156562714|FG000|Overall Study|Adverse Event|1|||
48647814|NCT00792740|156562715|FG001|Overall Study|Adverse Event|3|||
48647815|NCT00792740|156562714|FG000|Overall Study|Patient's withdrawal of consent|0|||
48647816|NCT00792740|156562715|FG001|Overall Study|Patient's withdrawal of consent|1|||
48647817|NCT00792740|156562714|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
48647818|NCT00792740|156562715|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
48647819|NCT00792740|156562714|FG000|Overall Study|Other reasons|0|||
48647820|NCT00792740|156562715|FG001|Overall Study|Other reasons|1|||
48647827|NCT02628600|156562720|FG000|Overall Study|Death|2|||
48647828|NCT02628600|156562721|FG001|Overall Study|Death|1|||
48647829|NCT02628600|156562720|FG000|Overall Study|Adverse Event|3|||
48647830|NCT02628600|156562721|FG001|Overall Study|Adverse Event|20|||
48752172|NCT00609492|156938246|FG002|Overall Study|Withdrawal by Subject|3|||
48752173|NCT00609492|156938244|FG000|Overall Study|Lost to Follow-up|1|||
48752174|NCT00609492|156938245|FG001|Overall Study|Lost to Follow-up|1|||
48752175|NCT00609492|156938246|FG002|Overall Study|Lost to Follow-up|4|||
48752176|NCT01104493|156938247|FG000|Overall Study|Lost to Follow-up|0|||
48752177|NCT01104493|156938248|FG001|Overall Study|Lost to Follow-up|2|||
48752178|NCT01414114|156938249|FG000|Overall Study|Adverse Event|2|||
48752179|NCT01414114|156938249|FG000|Overall Study|Withdrawal by Subject|1|||
48752180|NCT01414114|156938249|FG000|Overall Study|Other|2|||
48752181|NCT00010374|156938256|FG000|Overall Study|False positive phrenic nerve test|1|||
48752182|NCT00553644|156938257|FG000|Overall Study|Adverse Event|17|||
48752183|NCT00553644|156938257|FG000|Overall Study|Withdrawal by Subject|4|||
48752184|NCT00553644|156938257|FG000|Overall Study|Physician Decision|1|||
48752185|NCT00553644|156938257|FG000|Overall Study|Alternative therapy|6|||
48752186|NCT01402492|156938258|FG000|Overall Study|Withdrawal by Subject|17|||
48752187|NCT01402492|156938259|FG001|Overall Study|Withdrawal by Subject|11|||
48752188|NCT01402492|156938260|FG002|Overall Study|Withdrawal by Subject|11|||
48752189|NCT01402492|156938258|FG000|Overall Study|Adverse Event|2|||
48752190|NCT01402492|156938259|FG001|Overall Study|Adverse Event|3|||
48752191|NCT01402492|156938260|FG002|Overall Study|Adverse Event|4|||
48752192|NCT01402492|156938258|FG000|Overall Study|Physician Decision|0|||
48752193|NCT01402492|156938259|FG001|Overall Study|Physician Decision|3|||
48752194|NCT01402492|156938260|FG002|Overall Study|Physician Decision|0|||
48752195|NCT01402492|156938258|FG000|Overall Study|Incarcerated (N=3)|2|||
48752196|NCT01402492|156938259|FG001|Overall Study|Incarcerated (N=3)|0|||
48752197|NCT01402492|156938260|FG002|Overall Study|Incarcerated (N=3)|1|||
48752198|NCT02927431|156938261|FG000|Overall Study|Withdrawal by Subject|0|||
48752199|NCT02927431|156938262|FG001|Overall Study|Withdrawal by Subject|0|||
48752200|NCT02927431|156938263|FG002|Overall Study|Withdrawal by Subject|1|||
48752201|NCT02117648|156938264|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
48752202|NCT02117648|156938264|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
48752203|NCT02117648|156938264|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
48752204|NCT02117648|156938264|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
48752205|NCT02117648|156938264|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
48752206|NCT02117648|156938264|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
48752207|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
48330492|NCT00878189|155407473|FG008|Overall Study|Participant Refused to Follow-up|0|||
48647831|NCT02628600|156562720|FG000|Overall Study|Protocol Violation|0|||
48647832|NCT02628600|156562721|FG001|Overall Study|Protocol Violation|1|||
48647833|NCT02628600|156562720|FG000|Overall Study|Lack of Efficacy|2|||
48752208|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
48330493|NCT00878189|155407465|FG000|Overall Study|Other|3|||
48330494|NCT00878189|155407466|FG001|Overall Study|Other|2|||
48752209|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
48752210|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
48330495|NCT00878189|155407467|FG002|Overall Study|Other|4|||
48330496|NCT00878189|155407468|FG003|Overall Study|Other|7|||
48647834|NCT02628600|156562721|FG001|Overall Study|Lack of Efficacy|0|||
48647835|NCT02628600|156562720|FG000|Overall Study|Withdrawal by Subject|13|||
48647836|NCT02628600|156562721|FG001|Overall Study|Withdrawal by Subject|8|||
48752211|NCT02117648|156938264|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
48752212|NCT02266225|156938267|FG000|Overall Study|Lost to Follow-up|2|||
48752213|NCT02266225|156938267|FG000|Overall Study|Death|1|||
48752214|NCT02266225|156938267|FG000|Overall Study|Withdrawal by Subject|13|||
48752215|NCT01442675|156938269|FG000|Overall Study|Protocol Violation|6|||
48330497|NCT00878189|155407469|FG004|Overall Study|Other|4|||
48647837|NCT02628600|156562720|FG000|Overall Study|Lost to Follow-up|1|||
48647838|NCT02628600|156562721|FG001|Overall Study|Lost to Follow-up|0|||
48647839|NCT02628600|156562720|FG000|Overall Study|Physician Decision|2|||
48647840|NCT02628600|156562721|FG001|Overall Study|Physician Decision|2|||
48647841|NCT02628600|156562720|FG000|Overall Study|Other not specified|1|||
48647842|NCT02628600|156562721|FG001|Overall Study|Other not specified|0|||
48647843|NCT01059864|156562724|FG000|Open-Label Run-In Phase|Adverse Event|7|||
48647844|NCT01059864|156562725|FG001|Open-Label Run-In Phase|Adverse Event|0|||
48647845|NCT01059864|156562726|FG002|Open-Label Run-In Phase|Adverse Event|0|||
48647846|NCT01059864|156562724|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
48647847|NCT01059864|156562725|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
48647848|NCT01059864|156562726|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
48647849|NCT01059864|156562724|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
48647850|NCT01059864|156562725|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
48647851|NCT01059864|156562726|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
48647852|NCT01059864|156562724|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
48647853|NCT01059864|156562725|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
48647854|NCT01059864|156562726|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
48647855|NCT01059864|156562724|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
48647856|NCT01059864|156562725|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
48647857|NCT01059864|156562726|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
48647858|NCT01059864|156562724|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48647859|NCT01059864|156562725|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
48647860|NCT01059864|156562726|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
48647861|NCT03559517|156562733|FG000|Overall Study|Withdrawal by Subject|1|||
48647862|NCT03559517|156562734|FG001|Overall Study|Withdrawal by Subject|0|||
48647863|NCT03559517|156562735|FG002|Overall Study|Withdrawal by Subject|0|||
48330498|NCT00878189|155407470|FG005|Overall Study|Other|18|||
48647864|NCT00322049|156565138|FG000|Overall Study|Moved out of area|0|||
48647865|NCT00322049|156565139|FG001|Overall Study|Moved out of area|0|||
48647866|NCT00322049|156565140|FG002|Overall Study|Moved out of area|0|||
48647867|NCT00322049|156565141|FG003|Overall Study|Moved out of area|1|||
48647868|NCT00322049|156565138|FG000|Overall Study|Infected with Dengue during study|0|||
48647869|NCT00322049|156565139|FG001|Overall Study|Infected with Dengue during study|1|||
48647870|NCT00322049|156565140|FG002|Overall Study|Infected with Dengue during study|0|||
48752216|NCT01442675|156938269|FG000|Overall Study|Lost to Follow-up|2|||
48752217|NCT01442675|156938269|FG000|Overall Study|Withdrawal by Subject|4|||
48752218|NCT00211809|156938270|FG000|Overall Study|Lack of Efficacy|1|||
48752219|NCT00211809|156938270|FG000|Overall Study|Lost to Follow-up|2|||
48752220|NCT00211809|156938270|FG000|Overall Study|Pregnancy|1|||
48752221|NCT00211809|156938270|FG000|Overall Study|side effects|2|||
48752222|NCT01417234|156938271|FG000|Overall Study|Subject non-compliant|3|||
48752223|NCT01957644|156938276|FG000|Overall Study|Adverse Event|4|||
48752224|NCT01957644|156938277|FG001|Overall Study|Adverse Event|2|||
48752225|NCT01957644|156938278|FG002|Overall Study|Adverse Event|0|||
48752226|NCT01957644|156938279|FG003|Overall Study|Adverse Event|0|||
48752227|NCT01957644|156938280|FG004|Overall Study|Adverse Event|1|||
48752228|NCT01957644|156938276|FG000|Overall Study|Progressive disease / relapse|0|||
48752229|NCT01957644|156938277|FG001|Overall Study|Progressive disease / relapse|1|||
48752230|NCT01957644|156938278|FG002|Overall Study|Progressive disease / relapse|0|||
48752231|NCT01957644|156938279|FG003|Overall Study|Progressive disease / relapse|1|||
48752232|NCT01957644|156938280|FG004|Overall Study|Progressive disease / relapse|0|||
48752233|NCT01957644|156938276|FG000|Overall Study|Other reason|1|||
48752234|NCT01957644|156938277|FG001|Overall Study|Other reason|2|||
48752235|NCT01957644|156938278|FG002|Overall Study|Other reason|1|||
48752236|NCT01957644|156938279|FG003|Overall Study|Other reason|1|||
48752237|NCT01957644|156938280|FG004|Overall Study|Other reason|0|||
48752238|NCT01957644|156938276|FG000|Overall Study|Withdrawal by Subject|1|||
48752239|NCT01957644|156938277|FG001|Overall Study|Withdrawal by Subject|0|||
48752240|NCT01957644|156938278|FG002|Overall Study|Withdrawal by Subject|0|||
48752241|NCT01957644|156938279|FG003|Overall Study|Withdrawal by Subject|0|||
48752242|NCT01957644|156938280|FG004|Overall Study|Withdrawal by Subject|0|||
48752243|NCT01957644|156938276|FG000|Overall Study|Protocol Violation|0|||
48752244|NCT01957644|156938277|FG001|Overall Study|Protocol Violation|1|||
48752245|NCT01957644|156938278|FG002|Overall Study|Protocol Violation|0|||
48752246|NCT01957644|156938279|FG003|Overall Study|Protocol Violation|0|||
48752247|NCT01957644|156938280|FG004|Overall Study|Protocol Violation|0|||
48752248|NCT00040664|156938283|FG000|Overall Study|Adverse Event|12|||
48752249|NCT00040664|156938284|FG001|Overall Study|Adverse Event|3|||
48752250|NCT00040664|156938285|FG002|Overall Study|Adverse Event|2|||
48752251|NCT00040664|156938286|FG003|Overall Study|Adverse Event|7|||
48752252|NCT00040664|156938283|FG000|Overall Study|Lack of Efficacy|9|||
48752253|NCT00040664|156938284|FG001|Overall Study|Lack of Efficacy|2|||
48752254|NCT00040664|156938285|FG002|Overall Study|Lack of Efficacy|3|||
48752255|NCT00040664|156938286|FG003|Overall Study|Lack of Efficacy|4|||
48752256|NCT00040664|156938283|FG000|Overall Study|Insufficient CD4 response|1|||
48752257|NCT00040664|156938284|FG001|Overall Study|Insufficient CD4 response|0|||
48752258|NCT00040664|156938285|FG002|Overall Study|Insufficient CD4 response|1|||
48752259|NCT00040664|156938286|FG003|Overall Study|Insufficient CD4 response|0|||
48752260|NCT00040664|156938283|FG000|Overall Study|Lost to Follow-up|4|||
48752261|NCT00040664|156938284|FG001|Overall Study|Lost to Follow-up|2|||
48752262|NCT00040664|156938285|FG002|Overall Study|Lost to Follow-up|0|||
48752263|NCT00040664|156938286|FG003|Overall Study|Lost to Follow-up|2|||
48752264|NCT00040664|156938283|FG000|Overall Study|Protocol Violation|2|||
48752265|NCT00040664|156938284|FG001|Overall Study|Protocol Violation|1|||
48647871|NCT00322049|156565141|FG003|Overall Study|Infected with Dengue during study|0|||
48647872|NCT01897727|156565151|FG000|Overall Study|Exclusion: central sleep apnea|0|||
48647873|NCT01897727|156565152|FG001|Overall Study|Exclusion: central sleep apnea|1|||
48647874|NCT01496287|156565153|FG000|Overall Study|Lost to Follow-up|1|||
48647875|NCT01496287|156565153|FG000|Overall Study|Incomplete anesthesia|5|||
48647876|NCT01558115|156565156|FG000|Overall Study|Withdrawal by Subject|3|||
48647877|NCT01558115|156565156|FG000|Overall Study|Study closed due to poor enrollment|4|||
48752266|NCT00040664|156938285|FG002|Overall Study|Protocol Violation|0|||
48752267|NCT00040664|156938286|FG003|Overall Study|Protocol Violation|1|||
48752268|NCT00040664|156938283|FG000|Overall Study|Withdrawal by Subject|7|||
48752269|NCT00040664|156938284|FG001|Overall Study|Withdrawal by Subject|0|||
48752270|NCT00040664|156938285|FG002|Overall Study|Withdrawal by Subject|3|||
48752271|NCT00040664|156938286|FG003|Overall Study|Withdrawal by Subject|4|||
48752272|NCT00040664|156938283|FG000|Overall Study|Pregnancy|3|||
48752273|NCT00040664|156938284|FG001|Overall Study|Pregnancy|0|||
48752274|NCT00040664|156938285|FG002|Overall Study|Pregnancy|0|||
48752275|NCT00040664|156938286|FG003|Overall Study|Pregnancy|3|||
48752276|NCT00040664|156938283|FG000|Overall Study|Medication adherence/compliance problems|8|||
48752277|NCT00040664|156938284|FG001|Overall Study|Medication adherence/compliance problems|2|||
48752278|NCT00040664|156938285|FG002|Overall Study|Medication adherence/compliance problems|1|||
48752279|NCT00040664|156938286|FG003|Overall Study|Medication adherence/compliance problems|5|||
48752280|NCT00040664|156938283|FG000|Overall Study|Poor taste|2|||
48647878|NCT02140970|156565157|FG000|Overall Study|Lost to Follow-up|1|||
48647879|NCT02140970|156565158|FG001|Overall Study|Lost to Follow-up|2|||
48647880|NCT02140970|156565157|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
48647881|NCT02140970|156565158|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
48330499|NCT00878189|155407471|FG006|Overall Study|Other|15|||
48330500|NCT00878189|155407472|FG007|Overall Study|Other|3|||
48330501|NCT00878189|155407473|FG008|Overall Study|Other|4|||
48330502|NCT00878189|155407465|FG000|Overall Study|Lost to Follow-up|0|||
48647882|NCT02140970|156565157|FG000|Overall Study|Did not meet inclusion criteria|0|||
48647883|NCT02140970|156565158|FG001|Overall Study|Did not meet inclusion criteria|1|||
48330503|NCT00878189|155407466|FG001|Overall Study|Lost to Follow-up|0|||
48330504|NCT00878189|155407467|FG002|Overall Study|Lost to Follow-up|0|||
48330505|NCT00878189|155407468|FG003|Overall Study|Lost to Follow-up|0|||
48330506|NCT00878189|155407469|FG004|Overall Study|Lost to Follow-up|0|||
48330507|NCT00878189|155407470|FG005|Overall Study|Lost to Follow-up|1|||
48330508|NCT00878189|155407471|FG006|Overall Study|Lost to Follow-up|1|||
48330509|NCT00878189|155407472|FG007|Overall Study|Lost to Follow-up|0|||
48330510|NCT00878189|155407473|FG008|Overall Study|Lost to Follow-up|0|||
48330511|NCT00878189|155407465|FG000|Overall Study|Objection Progression or Relapse|0|||
48330512|NCT00878189|155407466|FG001|Overall Study|Objection Progression or Relapse|0|||
48330513|NCT00878189|155407467|FG002|Overall Study|Objection Progression or Relapse|0|||
48330514|NCT00878189|155407468|FG003|Overall Study|Objection Progression or Relapse|0|||
48330515|NCT00878189|155407469|FG004|Overall Study|Objection Progression or Relapse|0|||
48330516|NCT00878189|155407470|FG005|Overall Study|Objection Progression or Relapse|0|||
48330517|NCT00878189|155407471|FG006|Overall Study|Objection Progression or Relapse|0|||
48330518|NCT00878189|155407472|FG007|Overall Study|Objection Progression or Relapse|0|||
48330519|NCT00878189|155407473|FG008|Overall Study|Objection Progression or Relapse|3|||
48330520|NCT00703092|155407474|FG000|Overall Study|Withdrawal by Subject|2|||
48330521|NCT02007070|155407475|FG000|Overall Study|Adverse Event|4|||
48330522|NCT02007070|155407475|FG000|Overall Study|Clinical Progression|4|||
48330523|NCT02007070|155407475|FG000|Overall Study|Death|1|||
48330524|NCT02007070|155407475|FG000|Overall Study|Protocol Violation|2|||
48330525|NCT02007070|155407475|FG000|Overall Study|Physician Decision|1|||
48330526|NCT02007070|155407475|FG000|Overall Study|Progressive Disease|21|||
48330527|NCT04693637|155407476|FG000|Overall Study|Death|4|||
48330528|NCT04693637|155407476|FG000|Overall Study|Withdrawal by Subject|3|||
48330529|NCT04693637|155407476|FG000|Overall Study|Physician Decision|2|||
48330530|NCT04693637|155407476|FG000|Overall Study|Lost to Follow-up|1|||
48330531|NCT04237792|155407477|FG000|Treatment (Day 1)|Adverse Event|1|||
48330532|NCT04237792|155407478|FG001|Treatment (Day 1)|Adverse Event|0|||
48330533|NCT04237792|155407479|FG002|Treatment (Day 1)|Adverse Event|0|||
48330534|NCT04237792|155407480|FG003|Treatment (Day 1)|Adverse Event|0|||
48330535|NCT04237792|155407481|FG004|Treatment (Day 1)|Adverse Event|1|||
48330536|NCT04237792|155407482|FG005|Treatment (Day 1)|Adverse Event|1|||
48330537|NCT04237792|155407477|FG000|Treatment (Day 1)|Other|0|||
48330538|NCT04237792|155407478|FG001|Treatment (Day 1)|Other|0|||
48330539|NCT04237792|155407479|FG002|Treatment (Day 1)|Other|1|||
48330540|NCT04237792|155407480|FG003|Treatment (Day 1)|Other|0|||
48330541|NCT04237792|155407481|FG004|Treatment (Day 1)|Other|0|||
48330542|NCT04237792|155407482|FG005|Treatment (Day 1)|Other|1|||
48330543|NCT04237792|155407477|FG000|Treatment (Day 1)|Not treated|1|||
48330544|NCT04237792|155407478|FG001|Treatment (Day 1)|Not treated|1|||
48330545|NCT04237792|155407479|FG002|Treatment (Day 1)|Not treated|2|||
48330546|NCT04237792|155407480|FG003|Treatment (Day 1)|Not treated|1|||
48330547|NCT04237792|155407481|FG004|Treatment (Day 1)|Not treated|0|||
48330548|NCT04237792|155407482|FG005|Treatment (Day 1)|Not treated|1|||
48330549|NCT01021748|155407484|FG000|Overall Study|Adverse Event|2|||
48330550|NCT01021748|155407485|FG001|Overall Study|Adverse Event|1|||
48330551|NCT01021748|155407486|FG002|Overall Study|Adverse Event|2|||
48330552|NCT01021748|155407487|FG003|Overall Study|Adverse Event|0|||
48330553|NCT01021748|155407488|FG004|Overall Study|Adverse Event|2|||
48330554|NCT01021748|155407489|FG005|Overall Study|Adverse Event|0|||
48330555|NCT01021748|155407490|FG006|Overall Study|Adverse Event|1|||
48330556|NCT01021748|155407491|FG007|Overall Study|Adverse Event|0|||
48330557|NCT01021748|155407492|FG008|Overall Study|Adverse Event|7|||
48330558|NCT01021748|155407484|FG000|Overall Study|Physician Decision|1|||
48647884|NCT04294459|156565159|FG000|Overall Study|Adverse Event|0|||
48647885|NCT04294459|156565160|FG001|Overall Study|Adverse Event|1|||
48647886|NCT05002985|156565161|FG000|Overall Study|Withdrawal by Subject|1|||
48647887|NCT00460655|156565162|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
48330559|NCT01021748|155407485|FG001|Overall Study|Physician Decision|0|||
48330560|NCT01021748|155407486|FG002|Overall Study|Physician Decision|1|||
48330561|NCT01021748|155407487|FG003|Overall Study|Physician Decision|1|||
48330562|NCT01021748|155407488|FG004|Overall Study|Physician Decision|0|||
48330563|NCT01021748|155407489|FG005|Overall Study|Physician Decision|0|||
48330564|NCT01021748|155407490|FG006|Overall Study|Physician Decision|1|||
48330565|NCT01021748|155407491|FG007|Overall Study|Physician Decision|1|||
48647888|NCT00460655|156565163|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48647889|NCT00460655|156565164|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48647890|NCT00460655|156565165|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48330566|NCT01021748|155407492|FG008|Overall Study|Physician Decision|2|||
48330567|NCT01021748|155407484|FG000|Overall Study|Progressive Disease|3|||
48330568|NCT01021748|155407485|FG001|Overall Study|Progressive Disease|3|||
48330569|NCT01021748|155407486|FG002|Overall Study|Progressive Disease|4|||
48330570|NCT01021748|155407487|FG003|Overall Study|Progressive Disease|6|||
48330571|NCT01021748|155407488|FG004|Overall Study|Progressive Disease|7|||
48330572|NCT01021748|155407489|FG005|Overall Study|Progressive Disease|3|||
48330573|NCT01021748|155407490|FG006|Overall Study|Progressive Disease|0|||
48330574|NCT01021748|155407491|FG007|Overall Study|Progressive Disease|5|||
48330575|NCT01021748|155407492|FG008|Overall Study|Progressive Disease|6|||
48330576|NCT01021748|155407484|FG000|Overall Study|Withdrawal by Subject|0|||
48330577|NCT01021748|155407485|FG001|Overall Study|Withdrawal by Subject|0|||
48330578|NCT01021748|155407486|FG002|Overall Study|Withdrawal by Subject|0|||
48330579|NCT01021748|155407487|FG003|Overall Study|Withdrawal by Subject|0|||
48330580|NCT01021748|155407488|FG004|Overall Study|Withdrawal by Subject|0|||
48330581|NCT01021748|155407489|FG005|Overall Study|Withdrawal by Subject|0|||
48330582|NCT01021748|155407490|FG006|Overall Study|Withdrawal by Subject|1|||
48330583|NCT01021748|155407491|FG007|Overall Study|Withdrawal by Subject|0|||
48330584|NCT01021748|155407492|FG008|Overall Study|Withdrawal by Subject|1|||
48330585|NCT01021748|155407484|FG000|Overall Study|Not Treated|0|||
48330586|NCT01021748|155407485|FG001|Overall Study|Not Treated|1|||
48330587|NCT01021748|155407486|FG002|Overall Study|Not Treated|0|||
48330588|NCT01021748|155407487|FG003|Overall Study|Not Treated|0|||
48330589|NCT01021748|155407488|FG004|Overall Study|Not Treated|0|||
48330590|NCT01021748|155407489|FG005|Overall Study|Not Treated|0|||
48330591|NCT01021748|155407490|FG006|Overall Study|Not Treated|0|||
48647891|NCT00460655|156565162|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
48647892|NCT00460655|156565163|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48647893|NCT00460655|156565164|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48647894|NCT00460655|156565165|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48647895|NCT00460655|156565162|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
48647896|NCT00460655|156565163|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
48647897|NCT00460655|156565164|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
48647898|NCT00460655|156565165|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
48647899|NCT00460655|156565162|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48647900|NCT00460655|156565163|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48647901|NCT00460655|156565164|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
48647902|NCT00460655|156565165|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
48647903|NCT00460655|156565162|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48647904|NCT00460655|156565163|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48647905|NCT00460655|156565164|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
48647906|NCT00460655|156565165|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
48647907|NCT00460655|156565162|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
48647908|NCT00460655|156565163|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
48647909|NCT00460655|156565164|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
48647910|NCT00460655|156565165|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
48647911|NCT00590122|156565166|FG000|Overall Study|swallowed oral dissolving dose|1|||
48647912|NCT00590122|156565167|FG001|Overall Study|swallowed oral dissolving dose|0|||
48647913|NCT00466947|156565169|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
48647914|NCT00466947|156565170|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
48647915|NCT00466947|156565169|FG000|Study End Analysis Period|Adverse Event|35|||
48647916|NCT00466947|156565170|FG001|Study End Analysis Period|Adverse Event|43|||
48647917|NCT00466947|156565169|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
48647918|NCT00466947|156565170|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
48647919|NCT00466947|156565169|FG000|Study End Analysis Period|Physician Decision|29|||
48647920|NCT00466947|156565170|FG001|Study End Analysis Period|Physician Decision|29|||
48647921|NCT00466947|156565169|FG000|Study End Analysis Period|Protocol Violation|9|||
48647922|NCT00466947|156565170|FG001|Study End Analysis Period|Protocol Violation|17|||
48647923|NCT00466947|156565169|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
48647924|NCT00466947|156565170|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
48647925|NCT00466947|156565169|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
48647926|NCT00466947|156565170|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
48647927|NCT00466947|156565169|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
48647928|NCT00466947|156565170|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
48647929|NCT00466947|156565169|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
48647930|NCT00466947|156565170|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
48647931|NCT01973231|156565171|FG000|Overall Study|Protocol Violation|1|||
48647932|NCT01973231|156565172|FG001|Overall Study|Protocol Violation|1|||
48647933|NCT01973231|156565171|FG000|Overall Study|Lost to Follow-up|1|||
48647934|NCT01973231|156565172|FG001|Overall Study|Lost to Follow-up|1|||
48647935|NCT01973231|156565171|FG000|Overall Study|unclassified|2|||
48647936|NCT01973231|156565172|FG001|Overall Study|unclassified|1|||
48330592|NCT01021748|155407491|FG007|Overall Study|Not Treated|0|||
48647937|NCT01973231|156565171|FG000|Overall Study|Withdrawal by Subject|7|||
48647938|NCT01973231|156565172|FG001|Overall Study|Withdrawal by Subject|9|||
48647939|NCT03726658|156565176|FG000|Overall Study|Lost to Follow-up|0|||
48647940|NCT03726658|156565177|FG001|Overall Study|Lost to Follow-up|0|||
48330593|NCT01021748|155407492|FG008|Overall Study|Not Treated|0|||
48330594|NCT00929526|155407494|FG000|Overall Study|Withdrawal by Subject|1|||
48330595|NCT00929526|155407495|FG001|Overall Study|Withdrawal by Subject|11|||
48330596|NCT00929526|155407494|FG000|Overall Study|Lost to Follow-up|8|||
48330597|NCT00929526|155407495|FG001|Overall Study|Lost to Follow-up|12|||
48330598|NCT00929526|155407494|FG000|Overall Study|Other|8|||
48330599|NCT00929526|155407495|FG001|Overall Study|Other|6|||
48330600|NCT01829711|155407496|FG000|Overall Study|Lost to Follow-up|2|||
48330601|NCT01829711|155407496|FG000|Overall Study|Withdrawal by Subject|3|||
48330602|NCT01829711|155407496|FG000|Overall Study|Death|4|||
48330603|NCT01829711|155407496|FG000|Overall Study|Started new therapies|17|||
48752281|NCT00040664|156938284|FG001|Overall Study|Poor taste|0|||
48752282|NCT00040664|156938285|FG002|Overall Study|Poor taste|2|||
48752283|NCT00040664|156938286|FG003|Overall Study|Poor taste|0|||
48330604|NCT01829711|155407496|FG000|Overall Study|Adverse Event|3|||
48647941|NCT03726658|156565178|FG002|Overall Study|Lost to Follow-up|2|||
48647942|NCT03726658|156565179|FG003|Overall Study|Lost to Follow-up|0|||
48330605|NCT01829711|155407496|FG000|Overall Study|Due to progression of disease|13|||
48330606|NCT01829711|155407496|FG000|Overall Study|Due to lack of response|1|||
48330607|NCT02165202|155407499|FG000|Oral Phase|Refused further participation|5|||
48330608|NCT02165202|155407500|FG001|Oral Phase|Refused further participation|1|||
48647943|NCT03726658|156565180|FG004|Overall Study|Lost to Follow-up|0|||
48647944|NCT03726658|156565181|FG005|Overall Study|Lost to Follow-up|1|||
48647945|NCT03726658|156565182|FG006|Overall Study|Lost to Follow-up|1|||
48647946|NCT03726658|156565176|FG000|Overall Study|Withdrawal by Subject|1|||
48647947|NCT03726658|156565177|FG001|Overall Study|Withdrawal by Subject|0|||
48647948|NCT03726658|156565178|FG002|Overall Study|Withdrawal by Subject|0|||
48647949|NCT03726658|156565179|FG003|Overall Study|Withdrawal by Subject|0|||
48647950|NCT03726658|156565180|FG004|Overall Study|Withdrawal by Subject|6|||
48647951|NCT03726658|156565181|FG005|Overall Study|Withdrawal by Subject|4|||
48647952|NCT03726658|156565182|FG006|Overall Study|Withdrawal by Subject|2|||
48330609|NCT02165202|155407499|FG000|Oral Phase|Study product Related Toxicity|1|||
48330610|NCT02165202|155407500|FG001|Oral Phase|Study product Related Toxicity|0|||
48330611|NCT02165202|155407499|FG000|Oral Phase|Unable to contact Participant|1|||
48330612|NCT02165202|155407500|FG001|Oral Phase|Unable to contact Participant|1|||
48330613|NCT02165202|155407499|FG000|Oral Phase|Clinical reasons|1|||
48330614|NCT02165202|155407500|FG001|Oral Phase|Clinical reasons|0|||
48330615|NCT02165202|155407499|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
48330616|NCT02165202|155407500|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
48330617|NCT02165202|155407499|FG000|Oral Phase|CMC advised termination|1|||
48330618|NCT02165202|155407500|FG001|Oral Phase|CMC advised termination|0|||
48330619|NCT02165202|155407499|FG000|Oral Phase|Relocated, no follow-up planned|1|||
48330620|NCT02165202|155407500|FG001|Oral Phase|Relocated, no follow-up planned|0|||
48330621|NCT02165202|155407499|FG000|Oral Phase|Abnormal EKG|0|||
48330622|NCT02165202|155407500|FG001|Oral Phase|Abnormal EKG|1|||
48330623|NCT02165202|155407499|FG000|Injection Phase|Abnormal Lab Value|5|||
48330624|NCT02165202|155407500|FG001|Injection Phase|Abnormal Lab Value|1|||
48330625|NCT02165202|155407499|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
48330626|NCT02165202|155407500|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
48330627|NCT02165202|155407499|FG000|Injection Phase|Unable to attend within Visit Window|1|||
48330628|NCT02165202|155407500|FG001|Injection Phase|Unable to attend within Visit Window|0|||
48330629|NCT02165202|155407499|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
48330630|NCT02165202|155407500|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
48330631|NCT02165202|155407499|FG000|Injection Phase|End of Study|2|||
48330632|NCT02165202|155407500|FG001|Injection Phase|End of Study|1|||
48330633|NCT02165202|155407499|FG000|Injection Phase|Study Product related Toxicity|1|||
48330634|NCT02165202|155407500|FG001|Injection Phase|Study Product related Toxicity|0|||
48330635|NCT02165202|155407499|FG000|Injection Phase|No longer interested|0|||
48330636|NCT02165202|155407500|FG001|Injection Phase|No longer interested|1|||
48330637|NCT02165202|155407499|FG000|Injection Phase|Participant unwilling to comply|1|||
48330638|NCT02165202|155407500|FG001|Injection Phase|Participant unwilling to comply|0|||
48330639|NCT03909100|155407508|FG000|Overall Study|Protocol Deviation|2|||
48330640|NCT03909100|155407508|FG000|Overall Study|Technical Problems|4|||
48330641|NCT03909100|155407508|FG000|Overall Study|Withdrawal by Subject|4|||
48330642|NCT03909100|155407508|FG000|Overall Study|Lost to Follow-up|1|||
48330643|NCT03909100|155407508|FG000|Overall Study|Reason not Specified|4|||
48330644|NCT02203799|155407509|FG000|Overall Study|Withdrawal by Subject|3|||
48330645|NCT02671266|155407510|FG000|Overall Study|Withdrawal by Subject|1|||
48330646|NCT02671266|155407511|FG001|Overall Study|Withdrawal by Subject|1|||
48330647|NCT00681109|155407514|FG000|Overall Study|Lost to Follow-up|2|||
48330648|NCT00681109|155407515|FG001|Overall Study|Lost to Follow-up|6|||
48330649|NCT00681109|155407516|FG002|Overall Study|Lost to Follow-up|0|||
48330650|NCT02706483|155407517|FG000|Overall Study|Adverse Event|97|||
48330651|NCT02706483|155407517|FG000|Overall Study|Death|1|||
48330652|NCT02706483|155407517|FG000|Overall Study|Lack of Efficacy|39|||
48330653|NCT02706483|155407517|FG000|Overall Study|Lost to Follow-up|101|||
48647953|NCT03726658|156565176|FG000|Overall Study|Pregnancy|0|||
48752284|NCT00040664|156938283|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
48330654|NCT02706483|155407517|FG000|Overall Study|Non-compliance with study drug|15|||
48647954|NCT03726658|156565177|FG001|Overall Study|Pregnancy|0|||
48647955|NCT03726658|156565178|FG002|Overall Study|Pregnancy|0|||
48647956|NCT03726658|156565179|FG003|Overall Study|Pregnancy|0|||
48330655|NCT02706483|155407517|FG000|Overall Study|Physician Decision|6|||
48330656|NCT02706483|155407517|FG000|Overall Study|Pregnancy|6|||
48330657|NCT02706483|155407517|FG000|Overall Study|Protocol Violation|18|||
48330658|NCT02706483|155407517|FG000|Overall Study|Withdrawal by Subject|136|||
48330659|NCT02706483|155407517|FG000|Overall Study|Non-compliance with visits|6|||
48330660|NCT02706483|155407517|FG000|Overall Study|Site closure|4|||
48330661|NCT02706483|155407517|FG000|Overall Study|Subject moved|1|||
48330662|NCT00687297|155407527|FG000|Randomization|Withdrawal by Subject|2|||
48330663|NCT00687297|155407528|FG001|Randomization|Withdrawal by Subject|0|||
48330664|NCT00687297|155407527|FG000|Randomization|Withdrew before treatment, ineligible|1|||
48330665|NCT00687297|155407528|FG001|Randomization|Withdrew before treatment, ineligible|1|||
48330666|NCT00687297|155407527|FG000|Induction|Withdrawal by Subject|4|||
48330667|NCT00687297|155407528|FG001|Induction|Withdrawal by Subject|4|||
48330668|NCT00687297|155407527|FG000|Induction|Adverse Event|16|||
48330669|NCT00687297|155407528|FG001|Induction|Adverse Event|15|||
48330670|NCT00687297|155407527|FG000|Induction|Death|7|||
48330671|NCT00687297|155407528|FG001|Induction|Death|11|||
48330672|NCT00687297|155407527|FG000|Induction|Lack of Efficacy|17|||
48330673|NCT00687297|155407528|FG001|Induction|Lack of Efficacy|21|||
48330674|NCT00687297|155407527|FG000|Induction|Ineligible|0|||
48330675|NCT00687297|155407528|FG001|Induction|Ineligible|1|||
48330676|NCT00687297|155407527|FG000|Induction|Patient Noncompliance|1|||
48330677|NCT00687297|155407528|FG001|Induction|Patient Noncompliance|0|||
48330678|NCT00687297|155407527|FG000|Induction|Physician Decision|0|||
48330679|NCT00687297|155407528|FG001|Induction|Physician Decision|2|||
48330680|NCT00687297|155407527|FG000|Induction|Other|0|||
48330681|NCT00687297|155407528|FG001|Induction|Other|1|||
48330682|NCT02584257|155407531|FG000|Period 1|Withdrawal by Subject|0|||
48330683|NCT02584257|155407532|FG001|Period 1|Withdrawal by Subject|0|||
48330684|NCT02584257|155407533|FG002|Period 1|Withdrawal by Subject|0|||
48330685|NCT02584257|155407534|FG003|Period 1|Withdrawal by Subject|0|||
48330686|NCT02584257|155407535|FG004|Period 1|Withdrawal by Subject|0|||
48330687|NCT02584257|155407536|FG005|Period 1|Withdrawal by Subject|0|||
48647957|NCT03726658|156565180|FG004|Overall Study|Pregnancy|0|||
48647958|NCT03726658|156565181|FG005|Overall Study|Pregnancy|0|||
48647959|NCT03726658|156565182|FG006|Overall Study|Pregnancy|1|||
48647960|NCT03726658|156565176|FG000|Overall Study|Not Reported|0|||
48647961|NCT03726658|156565177|FG001|Overall Study|Not Reported|0|||
48647962|NCT03726658|156565178|FG002|Overall Study|Not Reported|0|||
48647963|NCT03726658|156565179|FG003|Overall Study|Not Reported|0|||
48647964|NCT03726658|156565180|FG004|Overall Study|Not Reported|0|||
48647965|NCT03726658|156565181|FG005|Overall Study|Not Reported|0|||
48647966|NCT03726658|156565182|FG006|Overall Study|Not Reported|1|||
48647967|NCT00412958|156565183|FG000|Overall Study|Withdrawal by Subject|3|||
48647968|NCT00412958|156565184|FG001|Overall Study|Withdrawal by Subject|0|||
48647969|NCT00412958|156565185|FG002|Overall Study|Withdrawal by Subject|0|||
48647970|NCT00412958|156565186|FG003|Overall Study|Withdrawal by Subject|1|||
48647971|NCT00412958|156565183|FG000|Overall Study|Adverse Event|0|||
48647972|NCT00412958|156565184|FG001|Overall Study|Adverse Event|1|||
48647973|NCT00412958|156565185|FG002|Overall Study|Adverse Event|0|||
48647974|NCT00412958|156565186|FG003|Overall Study|Adverse Event|0|||
48647975|NCT00412958|156565183|FG000|Overall Study|Lost to Follow-up|0|||
48647976|NCT00412958|156565184|FG001|Overall Study|Lost to Follow-up|1|||
48647977|NCT00412958|156565185|FG002|Overall Study|Lost to Follow-up|0|||
48647978|NCT00412958|156565186|FG003|Overall Study|Lost to Follow-up|0|||
48647979|NCT00412958|156565183|FG000|Overall Study|Death|0|||
48647980|NCT00412958|156565184|FG001|Overall Study|Death|1|||
48647981|NCT00412958|156565185|FG002|Overall Study|Death|0|||
48330688|NCT02584257|155407537|FG006|Period 1|Withdrawal by Subject|1|||
48330689|NCT02584257|155407538|FG007|Period 1|Withdrawal by Subject|0|||
48330690|NCT02584257|155407539|FG008|Period 1|Withdrawal by Subject|0|||
48330691|NCT02584257|155407531|FG000|Period 2|Physician Decision|1|||
48330692|NCT02584257|155407532|FG001|Period 2|Physician Decision|0|||
48330693|NCT02584257|155407533|FG002|Period 2|Physician Decision|0|||
48330694|NCT02584257|155407534|FG003|Period 2|Physician Decision|0|||
48330695|NCT02584257|155407535|FG004|Period 2|Physician Decision|0|||
48330696|NCT02584257|155407536|FG005|Period 2|Physician Decision|0|||
48330697|NCT02584257|155407537|FG006|Period 2|Physician Decision|0|||
48647982|NCT00412958|156565186|FG003|Overall Study|Death|0|||
48647983|NCT00412958|156565183|FG000|Overall Study|Transport issue|0|||
48647984|NCT00412958|156565184|FG001|Overall Study|Transport issue|1|||
48647985|NCT00412958|156565185|FG002|Overall Study|Transport issue|0|||
48647986|NCT00412958|156565186|FG003|Overall Study|Transport issue|0|||
48647987|NCT01318135|156565187|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
48647988|NCT01318135|156565188|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48330698|NCT02584257|155407538|FG007|Period 2|Physician Decision|0|||
48330699|NCT02584257|155407539|FG008|Period 2|Physician Decision|0|||
48330700|NCT02584257|155407531|FG000|Period 2|Adverse Event|0|||
48330701|NCT02584257|155407532|FG001|Period 2|Adverse Event|1|||
48330702|NCT02584257|155407533|FG002|Period 2|Adverse Event|0|||
48330703|NCT02584257|155407534|FG003|Period 2|Adverse Event|0|||
48647989|NCT01318135|156565189|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48647990|NCT01318135|156565190|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48647991|NCT01318135|156565191|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48647992|NCT01318135|156565192|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48647993|NCT01318135|156565193|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48647994|NCT01318135|156565194|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48647995|NCT01318135|156565187|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
48647996|NCT01318135|156565188|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
48647997|NCT01318135|156565189|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
48647998|NCT01318135|156565190|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
48330704|NCT02584257|155407535|FG004|Period 2|Adverse Event|0|||
48647999|NCT01318135|156565191|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
48648000|NCT01318135|156565192|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
48648001|NCT01318135|156565193|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
48648002|NCT01318135|156565194|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
48648003|NCT01318135|156565187|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
48648004|NCT01318135|156565188|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
48648005|NCT01318135|156565189|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
48648006|NCT01318135|156565190|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
48648007|NCT01318135|156565191|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
48648008|NCT01318135|156565192|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
48648009|NCT01318135|156565193|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
48648010|NCT01318135|156565194|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
48648011|NCT01318135|156565187|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
48648012|NCT01318135|156565188|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
48648013|NCT01318135|156565189|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
48648014|NCT01318135|156565190|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
48648015|NCT01318135|156565191|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
48648016|NCT01318135|156565192|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
48648017|NCT01318135|156565193|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
48648018|NCT01318135|156565194|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
48648019|NCT01318135|156565187|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48648020|NCT01318135|156565188|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48648021|NCT01318135|156565189|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48648022|NCT01318135|156565190|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48648023|NCT01318135|156565191|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48648024|NCT01318135|156565192|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48648025|NCT01318135|156565193|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48648026|NCT01318135|156565194|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48648027|NCT01318135|156565187|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
48648028|NCT01318135|156565188|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
48752285|NCT00040664|156938284|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
48648029|NCT01318135|156565189|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
48648030|NCT01318135|156565190|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
48648031|NCT01318135|156565191|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
48648032|NCT01318135|156565192|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
48648033|NCT01318135|156565193|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48648034|NCT01318135|156565194|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48648035|NCT01318135|156565187|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
48648036|NCT01318135|156565188|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
48648037|NCT01318135|156565189|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
48648038|NCT01318135|156565190|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
48648039|NCT01318135|156565191|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
48648040|NCT01318135|156565192|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
48648041|NCT01318135|156565193|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
48648042|NCT01318135|156565194|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
48648043|NCT03248531|156565197|FG000|Overall Study|Adverse Event|0|||
48648044|NCT03248531|156565198|FG001|Overall Study|Adverse Event|0|||
48330705|NCT02584257|155407536|FG005|Period 2|Adverse Event|0|||
48648045|NCT03248531|156565199|FG002|Overall Study|Adverse Event|1|||
48752286|NCT00040664|156938285|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
48330706|NCT02584257|155407537|FG006|Period 2|Adverse Event|0|||
48330707|NCT02584257|155407538|FG007|Period 2|Adverse Event|0|||
48330708|NCT02584257|155407539|FG008|Period 2|Adverse Event|0|||
48648046|NCT03248531|156565197|FG000|Overall Study|Lost to Follow-up|1|||
48648047|NCT03248531|156565198|FG001|Overall Study|Lost to Follow-up|0|||
48648048|NCT03248531|156565199|FG002|Overall Study|Lost to Follow-up|5|||
48648049|NCT03248531|156565197|FG000|Overall Study|Withdrawal by Subject|3|||
48330709|NCT02309892|155407540|FG000|Overall Study|Physician Decision|1|||
48330710|NCT02309892|155407541|FG001|Overall Study|Physician Decision|0|||
48330711|NCT02309892|155407542|FG002|Overall Study|Physician Decision|0|||
48330712|NCT02309892|155407543|FG003|Overall Study|Physician Decision|0|||
48330713|NCT02309892|155407544|FG004|Overall Study|Physician Decision|0|||
48330714|NCT02309892|155407545|FG005|Overall Study|Physician Decision|0|||
48330715|NCT02309892|155407546|FG006|Overall Study|Physician Decision|0|||
48330716|NCT02309892|155407540|FG000|Overall Study|Adverse Event|1|||
48330717|NCT02309892|155407541|FG001|Overall Study|Adverse Event|0|||
48330718|NCT02309892|155407542|FG002|Overall Study|Adverse Event|1|||
48330719|NCT02309892|155407543|FG003|Overall Study|Adverse Event|0|||
48330720|NCT02309892|155407544|FG004|Overall Study|Adverse Event|0|||
48330721|NCT02309892|155407545|FG005|Overall Study|Adverse Event|0|||
48330722|NCT02309892|155407546|FG006|Overall Study|Adverse Event|0|||
48330723|NCT02309892|155407540|FG000|Overall Study|Progressive Disease|0|||
48330724|NCT02309892|155407541|FG001|Overall Study|Progressive Disease|1|||
48330725|NCT02309892|155407542|FG002|Overall Study|Progressive Disease|0|||
48330726|NCT02309892|155407543|FG003|Overall Study|Progressive Disease|0|||
48330727|NCT02309892|155407544|FG004|Overall Study|Progressive Disease|1|||
48648050|NCT03248531|156565198|FG001|Overall Study|Withdrawal by Subject|3|||
48648051|NCT03248531|156565199|FG002|Overall Study|Withdrawal by Subject|2|||
48648052|NCT03248531|156565197|FG000|Overall Study|Sponsor Request|0|||
48648053|NCT03248531|156565198|FG001|Overall Study|Sponsor Request|2|||
48648054|NCT03248531|156565199|FG002|Overall Study|Sponsor Request|0|||
48648055|NCT04860869|156565200|FG000|Overall Study|Withdrawal by Subject|1|||
48648056|NCT04860869|156565201|FG001|Overall Study|Withdrawal by Subject|0|||
48648057|NCT02702609|156565204|FG000|Overall Study|Lost to Follow-up|8|||
48648058|NCT02702609|156565205|FG001|Overall Study|Lost to Follow-up|4|||
48648059|NCT02702609|156565204|FG000|Overall Study|Physician Decision|1|||
48648060|NCT02702609|156565205|FG001|Overall Study|Physician Decision|0|||
48648061|NCT01220401|156565206|FG000|Overall Study|Withdrawal by Subject|2|||
48648062|NCT01220401|156565206|FG000|Overall Study|Protocol Violation|1|||
48648063|NCT01864148|156565207|FG000|Overall Study|Other|2|||
48648064|NCT01864148|156565208|FG001|Overall Study|Other|1|||
48648065|NCT01864148|156565209|FG002|Overall Study|Other|1|||
48648066|NCT01864148|156565210|FG003|Overall Study|Other|3|||
48648067|NCT01864148|156565211|FG004|Overall Study|Other|1|||
48648068|NCT01864148|156565207|FG000|Overall Study|Death|0|||
48648069|NCT01864148|156565208|FG001|Overall Study|Death|0|||
48648070|NCT01864148|156565209|FG002|Overall Study|Death|0|||
48648071|NCT01864148|156565210|FG003|Overall Study|Death|1|||
48648072|NCT01864148|156565211|FG004|Overall Study|Death|0|||
48648073|NCT01864148|156565207|FG000|Overall Study|Investigator Decision|5|||
48330728|NCT02309892|155407545|FG005|Overall Study|Progressive Disease|0|||
48330729|NCT02309892|155407546|FG006|Overall Study|Progressive Disease|0|||
48330730|NCT02309892|155407540|FG000|Overall Study|Death|0|||
48330731|NCT02309892|155407541|FG001|Overall Study|Death|0|||
48330732|NCT02309892|155407542|FG002|Overall Study|Death|0|||
48330733|NCT02309892|155407543|FG003|Overall Study|Death|0|||
48330734|NCT02309892|155407544|FG004|Overall Study|Death|0|||
48330735|NCT02309892|155407545|FG005|Overall Study|Death|1|||
48330736|NCT02309892|155407546|FG006|Overall Study|Death|0|||
48330737|NCT01137682|155407548|FG000|Overall Study|Adverse Event-CORE|2|||
48330738|NCT01137682|155407549|FG001|Overall Study|Adverse Event-CORE|4|||
48330739|NCT01137682|155407550|FG002|Overall Study|Adverse Event-CORE|0|||
48330740|NCT01137682|155407548|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
48330741|NCT01137682|155407549|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
48648074|NCT01864148|156565208|FG001|Overall Study|Investigator Decision|0|||
48648075|NCT01864148|156565209|FG002|Overall Study|Investigator Decision|0|||
48648076|NCT01864148|156565210|FG003|Overall Study|Investigator Decision|4|||
48648077|NCT01864148|156565211|FG004|Overall Study|Investigator Decision|6|||
48648078|NCT01864148|156565207|FG000|Overall Study|Withdrawal by Subject|9|||
48648079|NCT01864148|156565208|FG001|Overall Study|Withdrawal by Subject|2|||
48648080|NCT01864148|156565209|FG002|Overall Study|Withdrawal by Subject|6|||
48648081|NCT01864148|156565210|FG003|Overall Study|Withdrawal by Subject|8|||
48752287|NCT00040664|156938286|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
48330742|NCT01137682|155407550|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
48330743|NCT01137682|155407548|FG000|Overall Study|Administrative problems-CORE|2|||
48330744|NCT01137682|155407549|FG001|Overall Study|Administrative problems-CORE|1|||
48330745|NCT01137682|155407550|FG002|Overall Study|Administrative problems-CORE|0|||
48330746|NCT01137682|155407548|FG000|Overall Study|Protocol Violation-CORE|0|||
48330747|NCT01137682|155407549|FG001|Overall Study|Protocol Violation-CORE|1|||
48330748|NCT01137682|155407550|FG002|Overall Study|Protocol Violation-CORE|1|||
48330749|NCT01137682|155407548|FG000|Overall Study|Adverse Event-Extension|4|||
48648082|NCT01864148|156565211|FG004|Overall Study|Withdrawal by Subject|8|||
48648083|NCT01864148|156565207|FG000|Overall Study|Lost to Follow-up|0|||
48648084|NCT01864148|156565208|FG001|Overall Study|Lost to Follow-up|0|||
48648085|NCT01864148|156565209|FG002|Overall Study|Lost to Follow-up|0|||
48648086|NCT01864148|156565210|FG003|Overall Study|Lost to Follow-up|2|||
48648087|NCT01864148|156565211|FG004|Overall Study|Lost to Follow-up|1|||
48330750|NCT01137682|155407549|FG001|Overall Study|Adverse Event-Extension|8|||
48330751|NCT01137682|155407550|FG002|Overall Study|Adverse Event-Extension|7|||
48330752|NCT01137682|155407548|FG000|Overall Study|Lack of Efficacy-Extension|15|||
48330753|NCT01137682|155407549|FG001|Overall Study|Lack of Efficacy-Extension|9|||
48330754|NCT01137682|155407550|FG002|Overall Study|Lack of Efficacy-Extension|13|||
48330755|NCT01137682|155407548|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
48330756|NCT01137682|155407549|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
48330757|NCT01137682|155407550|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
48330758|NCT01137682|155407548|FG000|Overall Study|Lost to Follow Up-Extension|0|||
48330759|NCT01137682|155407549|FG001|Overall Study|Lost to Follow Up-Extension|1|||
48330760|NCT01137682|155407550|FG002|Overall Study|Lost to Follow Up-Extension|0|||
48330761|NCT01137682|155407548|FG000|Overall Study|Administrative problems-Extension|0|||
48330762|NCT01137682|155407549|FG001|Overall Study|Administrative problems-Extension|2|||
48330763|NCT01137682|155407550|FG002|Overall Study|Administrative problems-Extension|0|||
48330764|NCT01137682|155407548|FG000|Overall Study|Death-Extension|2|||
48330765|NCT01137682|155407549|FG001|Overall Study|Death-Extension|0|||
48330766|NCT01137682|155407550|FG002|Overall Study|Death-Extension|0|||
48330767|NCT01137682|155407548|FG000|Overall Study|Protocol Violation-Extension|2|||
48330768|NCT01137682|155407549|FG001|Overall Study|Protocol Violation-Extension|1|||
48330769|NCT01137682|155407550|FG002|Overall Study|Protocol Violation-Extension|0|||
48330770|NCT01137682|155407548|FG000|Overall Study|Did not enter extension|2|||
48330771|NCT01137682|155407549|FG001|Overall Study|Did not enter extension|3|||
48330772|NCT01137682|155407550|FG002|Overall Study|Did not enter extension|2|||
48330773|NCT01137682|155407548|FG000|Overall Study|Did not receive treatment in extension|0|||
48330774|NCT01137682|155407549|FG001|Overall Study|Did not receive treatment in extension|0|||
48330775|NCT01137682|155407550|FG002|Overall Study|Did not receive treatment in extension|1|||
48330776|NCT02362789|155407551|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
48330777|NCT02362789|155407552|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
48330778|NCT02362789|155407553|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
48330779|NCT02362789|155407551|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
48330780|NCT02362789|155407552|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
48330781|NCT02362789|155407553|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
48330782|NCT02362789|155407551|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
48330783|NCT02362789|155407552|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
48330784|NCT02362789|155407553|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
48330785|NCT02362789|155407551|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
48330786|NCT02362789|155407552|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
48330787|NCT02362789|155407553|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
48330788|NCT02362789|155407551|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
48648088|NCT01864148|156565207|FG000|Overall Study|Adverse Event|4|||
48648089|NCT01864148|156565208|FG001|Overall Study|Adverse Event|2|||
48648090|NCT01864148|156565209|FG002|Overall Study|Adverse Event|4|||
48648091|NCT01864148|156565210|FG003|Overall Study|Adverse Event|7|||
48648092|NCT01864148|156565211|FG004|Overall Study|Adverse Event|7|||
48648093|NCT01864148|156565207|FG000|Overall Study|Not Dosed|0|||
48648094|NCT01864148|156565208|FG001|Overall Study|Not Dosed|0|||
48648095|NCT01864148|156565209|FG002|Overall Study|Not Dosed|0|||
48648096|NCT01864148|156565210|FG003|Overall Study|Not Dosed|1|||
48648097|NCT01864148|156565211|FG004|Overall Study|Not Dosed|0|||
48648098|NCT02528942|156565217|FG000|Overall Study|Did not meet imaging criteria|9|||
48648099|NCT02528942|156565217|FG000|Overall Study|Lost to Follow-up|25|||
48648100|NCT03012828|156565218|FG000|Overall Study|Lost to Follow-up|1|||
48648101|NCT03012828|156565219|FG001|Overall Study|Lost to Follow-up|0|||
48648102|NCT03012828|156565220|FG002|Overall Study|Lost to Follow-up|1|||
48648103|NCT03012828|156565221|FG003|Overall Study|Lost to Follow-up|0|||
48648104|NCT03012828|156565222|FG004|Overall Study|Lost to Follow-up|1|||
48648105|NCT03012828|156565223|FG005|Overall Study|Lost to Follow-up|0|||
48648106|NCT03012828|156565218|FG000|Overall Study|Withdrawal by Subject|0|||
48648107|NCT03012828|156565219|FG001|Overall Study|Withdrawal by Subject|0|||
48648108|NCT03012828|156565220|FG002|Overall Study|Withdrawal by Subject|1|||
48648109|NCT03012828|156565221|FG003|Overall Study|Withdrawal by Subject|0|||
48752288|NCT00040664|156938283|FG000|Overall Study|Change of formulation|2|||
48648110|NCT03012828|156565222|FG004|Overall Study|Withdrawal by Subject|0|||
48648111|NCT03012828|156565223|FG005|Overall Study|Withdrawal by Subject|1|||
48648112|NCT03012828|156565218|FG000|Overall Study|Non-compliance with protocol|0|||
48648113|NCT03012828|156565219|FG001|Overall Study|Non-compliance with protocol|0|||
48648114|NCT03012828|156565220|FG002|Overall Study|Non-compliance with protocol|0|||
48752289|NCT00040664|156938284|FG001|Overall Study|Change of formulation|2|||
48330789|NCT02362789|155407552|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
48330790|NCT02362789|155407553|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
48330791|NCT00761267|155407554|FG000|Overall Study|Death|1|||
48330792|NCT00761267|155407555|FG001|Overall Study|Death|2|||
48330793|NCT00761267|155407556|FG002|Overall Study|Death|5|||
48330794|NCT00761267|155407554|FG000|Overall Study|Lost to Follow-up|0|||
48330795|NCT00761267|155407555|FG001|Overall Study|Lost to Follow-up|0|||
48330796|NCT00761267|155407556|FG002|Overall Study|Lost to Follow-up|1|||
48648115|NCT03012828|156565221|FG003|Overall Study|Non-compliance with protocol|0|||
48648116|NCT03012828|156565222|FG004|Overall Study|Non-compliance with protocol|1|||
48648117|NCT03012828|156565223|FG005|Overall Study|Non-compliance with protocol|0|||
48648118|NCT03012828|156565218|FG000|Overall Study|Delay to last visit would delay DBL|0|||
48648119|NCT03012828|156565219|FG001|Overall Study|Delay to last visit would delay DBL|0|||
48648120|NCT03012828|156565220|FG002|Overall Study|Delay to last visit would delay DBL|0|||
48648121|NCT03012828|156565221|FG003|Overall Study|Delay to last visit would delay DBL|0|||
48648122|NCT03012828|156565222|FG004|Overall Study|Delay to last visit would delay DBL|0|||
48648123|NCT03012828|156565223|FG005|Overall Study|Delay to last visit would delay DBL|1|||
48648124|NCT00470262|156565224|FG000|Overall Study|Withdrawal by Subject|2|||
48648125|NCT00470262|156565225|FG001|Overall Study|Withdrawal by Subject|0|||
48648126|NCT02366923|156565228|FG000|Overall Study|Withdrawal by Subject|1|||
48648127|NCT02366923|156565228|FG000|Overall Study|Positive Slit Lamp Findings|2|||
48648128|NCT02366923|156565228|FG000|Overall Study|High Astigmatism|3|||
48648129|NCT03083665|156565229|FG000|Double-Blind Period|Adverse Event|5|||
48648130|NCT03083665|156565230|FG001|Double-Blind Period|Adverse Event|4|||
48648131|NCT03083665|156565231|FG002|Double-Blind Period|Adverse Event|5|||
48648132|NCT03083665|156565232|FG003|Double-Blind Period|Adverse Event|0|||
48648133|NCT03083665|156565233|FG004|Double-Blind Period|Adverse Event|0|||
48648134|NCT03083665|156565234|FG005|Double-Blind Period|Adverse Event|0|||
48648135|NCT03083665|156565229|FG000|Double-Blind Period|Lack of Efficacy|0|||
48648136|NCT03083665|156565230|FG001|Double-Blind Period|Lack of Efficacy|0|||
48648137|NCT03083665|156565231|FG002|Double-Blind Period|Lack of Efficacy|1|||
48648138|NCT03083665|156565232|FG003|Double-Blind Period|Lack of Efficacy|0|||
48648139|NCT03083665|156565233|FG004|Double-Blind Period|Lack of Efficacy|0|||
48648140|NCT03083665|156565234|FG005|Double-Blind Period|Lack of Efficacy|0|||
48648141|NCT03083665|156565229|FG000|Double-Blind Period|Protocol Violation|1|||
48648142|NCT03083665|156565230|FG001|Double-Blind Period|Protocol Violation|0|||
48648143|NCT03083665|156565231|FG002|Double-Blind Period|Protocol Violation|1|||
48648144|NCT03083665|156565232|FG003|Double-Blind Period|Protocol Violation|0|||
48648145|NCT03083665|156565233|FG004|Double-Blind Period|Protocol Violation|0|||
48648146|NCT03083665|156565234|FG005|Double-Blind Period|Protocol Violation|0|||
48648147|NCT03083665|156565229|FG000|Double-Blind Period|Lost to Follow-up|1|||
48648148|NCT03083665|156565230|FG001|Double-Blind Period|Lost to Follow-up|0|||
48648149|NCT03083665|156565231|FG002|Double-Blind Period|Lost to Follow-up|1|||
48648150|NCT03083665|156565232|FG003|Double-Blind Period|Lost to Follow-up|0|||
48648151|NCT03083665|156565233|FG004|Double-Blind Period|Lost to Follow-up|0|||
48648152|NCT03083665|156565234|FG005|Double-Blind Period|Lost to Follow-up|0|||
48648153|NCT03083665|156565229|FG000|Double-Blind Period|Withdrawal by Subject|3|||
48648154|NCT03083665|156565230|FG001|Double-Blind Period|Withdrawal by Subject|0|||
48648155|NCT03083665|156565231|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48648156|NCT03083665|156565232|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48648157|NCT03083665|156565233|FG004|Double-Blind Period|Withdrawal by Subject|0|||
48648158|NCT03083665|156565234|FG005|Double-Blind Period|Withdrawal by Subject|0|||
48648159|NCT03083665|156565229|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
48648160|NCT03083665|156565230|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
48648161|NCT03083665|156565231|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
48648162|NCT03083665|156565232|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
48648163|NCT03083665|156565233|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
48648164|NCT03083665|156565234|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
48648165|NCT03083665|156565229|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
48648166|NCT03083665|156565230|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
48648167|NCT03083665|156565231|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
48648168|NCT03083665|156565232|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
48648169|NCT03083665|156565233|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
48648170|NCT03083665|156565234|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
48648171|NCT03083665|156565229|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
48648172|NCT03083665|156565230|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
48648173|NCT03083665|156565231|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
48330797|NCT00761267|155407554|FG000|Overall Study|Randomized but not treated|1|||
48330798|NCT00761267|155407555|FG001|Overall Study|Randomized but not treated|1|||
48330799|NCT00761267|155407556|FG002|Overall Study|Randomized but not treated|0|||
48330800|NCT00761267|155407554|FG000|Overall Study|Withdrawal by Subject|0|||
48648174|NCT03083665|156565232|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
48648175|NCT03083665|156565233|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
48648176|NCT03083665|156565234|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
48648177|NCT03083665|156565229|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
48648178|NCT03083665|156565230|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
48330801|NCT00761267|155407555|FG001|Overall Study|Withdrawal by Subject|1|||
48648179|NCT03083665|156565231|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
48648180|NCT03083665|156565232|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
48648181|NCT03083665|156565233|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
48648182|NCT03083665|156565234|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
48648183|NCT03083665|156565229|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
48648184|NCT03083665|156565230|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
48648185|NCT03083665|156565231|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
48648186|NCT03083665|156565232|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
48648187|NCT03083665|156565233|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
48648188|NCT03083665|156565234|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
48648189|NCT03083665|156565229|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
48648190|NCT03083665|156565230|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
48648191|NCT03083665|156565231|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
48648192|NCT03083665|156565232|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
48648193|NCT03083665|156565233|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
48648194|NCT03083665|156565234|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
48648195|NCT03083665|156565229|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
48648196|NCT03083665|156565230|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
48648197|NCT03083665|156565231|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
48648198|NCT03083665|156565232|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
48648199|NCT03083665|156565233|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
48648200|NCT03083665|156565234|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
48648201|NCT03083665|156565229|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
48648202|NCT03083665|156565230|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
48648203|NCT03083665|156565231|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
48648204|NCT03083665|156565232|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
48648205|NCT03083665|156565233|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
48648206|NCT03083665|156565234|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
48648207|NCT03083665|156565229|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
48648208|NCT03083665|156565230|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
48648209|NCT03083665|156565231|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
48648210|NCT03083665|156565232|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
48648211|NCT03083665|156565233|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
48648212|NCT03083665|156565234|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
48648213|NCT02565147|156565235|FG000|Overall Study|Withdrawal by Subject|5|||
48648214|NCT02565147|156565236|FG001|Overall Study|Withdrawal by Subject|1|||
48648215|NCT02565147|156565235|FG000|Overall Study|Lost to Follow-up|0|||
48648216|NCT02565147|156565236|FG001|Overall Study|Lost to Follow-up|1|||
48648217|NCT02565147|156565235|FG000|Overall Study|Death|1|||
48648218|NCT02565147|156565236|FG001|Overall Study|Death|1|||
48648219|NCT00582712|156565238|FG000|Overall Study|Adverse Event|1|||
48648220|NCT00582712|156565238|FG000|Overall Study|Lack of Efficacy|1|||
48648221|NCT00582712|156565238|FG000|Overall Study|Withdrawal by Subject|1|||
48648222|NCT00582712|156565238|FG000|Overall Study|Complicating disease requiring treatment|1|||
48648223|NCT00244725|156565239|FG000|Overall Study|Lost to Follow-up|3|||
48648224|NCT00244725|156565240|FG001|Overall Study|Lost to Follow-up|4|||
48648225|NCT00244725|156565241|FG002|Overall Study|Lost to Follow-up|9|||
48648226|NCT00244725|156565242|FG003|Overall Study|Lost to Follow-up|2|||
48648227|NCT00244725|156565239|FG000|Overall Study|Withdrawal by Subject|9|||
48648228|NCT00244725|156565240|FG001|Overall Study|Withdrawal by Subject|7|||
48648229|NCT00244725|156565241|FG002|Overall Study|Withdrawal by Subject|7|||
48648230|NCT00244725|156565242|FG003|Overall Study|Withdrawal by Subject|8|||
48648231|NCT00244725|156565239|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
48648232|NCT00244725|156565240|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
48648233|NCT00244725|156565241|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
48648234|NCT00244725|156565242|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
48648235|NCT00244725|156565239|FG000|Overall Study|Physician Decision|3|||
48648236|NCT00244725|156565240|FG001|Overall Study|Physician Decision|0|||
48648237|NCT00244725|156565241|FG002|Overall Study|Physician Decision|1|||
48648238|NCT00244725|156565242|FG003|Overall Study|Physician Decision|2|||
48648239|NCT00244725|156565239|FG000|Overall Study|Adverse Events|3|||
48648240|NCT00244725|156565240|FG001|Overall Study|Adverse Events|1|||
48648241|NCT00244725|156565241|FG002|Overall Study|Adverse Events|4|||
48648242|NCT00244725|156565242|FG003|Overall Study|Adverse Events|4|||
48648243|NCT00244725|156565239|FG000|Overall Study|Withdrwal by participant|1|||
48648244|NCT00244725|156565240|FG001|Overall Study|Withdrwal by participant|0|||
48330802|NCT00761267|155407556|FG002|Overall Study|Withdrawal by Subject|0|||
48648245|NCT00244725|156565241|FG002|Overall Study|Withdrwal by participant|0|||
48648246|NCT00244725|156565242|FG003|Overall Study|Withdrwal by participant|1|||
48648247|NCT00244725|156565239|FG000|Overall Study|Liver function test abnormality|2|||
48648248|NCT00244725|156565240|FG001|Overall Study|Liver function test abnormality|0|||
48648249|NCT00244725|156565241|FG002|Overall Study|Liver function test abnormality|0|||
48648250|NCT00244725|156565242|FG003|Overall Study|Liver function test abnormality|1|||
48648251|NCT00244725|156565239|FG000|Overall Study|Sponsor withdrew the participant|1|||
48648252|NCT00244725|156565240|FG001|Overall Study|Sponsor withdrew the participant|0|||
48648253|NCT00244725|156565241|FG002|Overall Study|Sponsor withdrew the participant|0|||
48648254|NCT00244725|156565242|FG003|Overall Study|Sponsor withdrew the participant|1|||
48648255|NCT00244725|156565239|FG000|Overall Study|Mediciation Error|0|||
48648256|NCT00244725|156565240|FG001|Overall Study|Mediciation Error|1|||
48648257|NCT00244725|156565241|FG002|Overall Study|Mediciation Error|0|||
48648258|NCT00244725|156565242|FG003|Overall Study|Mediciation Error|0|||
48648259|NCT00244725|156565239|FG000|Overall Study|Rehab Refused to allow participantion|0|||
48648260|NCT00244725|156565240|FG001|Overall Study|Rehab Refused to allow participantion|1|||
48648261|NCT00244725|156565241|FG002|Overall Study|Rehab Refused to allow participantion|0|||
48648262|NCT00244725|156565242|FG003|Overall Study|Rehab Refused to allow participantion|0|||
48648263|NCT00244725|156565239|FG000|Overall Study|Headache|0|||
48648264|NCT00244725|156565240|FG001|Overall Study|Headache|1|||
48648265|NCT00244725|156565241|FG002|Overall Study|Headache|0|||
48648266|NCT00244725|156565242|FG003|Overall Study|Headache|0|||
48648267|NCT00244725|156565239|FG000|Overall Study|Received prohibited medication|0|||
48648268|NCT00244725|156565240|FG001|Overall Study|Received prohibited medication|1|||
48648269|NCT00244725|156565241|FG002|Overall Study|Received prohibited medication|0|||
48648270|NCT00244725|156565242|FG003|Overall Study|Received prohibited medication|1|||
48648271|NCT00244725|156565239|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
48648272|NCT00244725|156565240|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
48648273|NCT00244725|156565241|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
48648274|NCT00244725|156565242|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
48648275|NCT00244725|156565239|FG000|Overall Study|Administrative reason|0|||
48648276|NCT00244725|156565240|FG001|Overall Study|Administrative reason|0|||
48648277|NCT00244725|156565241|FG002|Overall Study|Administrative reason|1|||
48648278|NCT00244725|156565242|FG003|Overall Study|Administrative reason|0|||
48648279|NCT00244725|156565239|FG000|Overall Study|Vomit|0|||
48648280|NCT00244725|156565240|FG001|Overall Study|Vomit|0|||
48648281|NCT00244725|156565241|FG002|Overall Study|Vomit|1|||
48648282|NCT00244725|156565242|FG003|Overall Study|Vomit|0|||
48648283|NCT00244725|156565239|FG000|Overall Study|Failed to follow-up|0|||
48648284|NCT00244725|156565240|FG001|Overall Study|Failed to follow-up|0|||
48648285|NCT00244725|156565241|FG002|Overall Study|Failed to follow-up|1|||
48648286|NCT00244725|156565242|FG003|Overall Study|Failed to follow-up|1|||
48648287|NCT02936869|156565243|FG000|Overall Study|Lost to Follow-up|1|||
48648288|NCT02936869|156565244|FG001|Overall Study|Lost to Follow-up|3|||
48648289|NCT02936869|156565243|FG000|Overall Study|Death|0|||
48648290|NCT02936869|156565244|FG001|Overall Study|Death|1|||
48648291|NCT02936869|156565243|FG000|Overall Study|Legal Case|0|||
48648292|NCT02936869|156565244|FG001|Overall Study|Legal Case|1|||
48648293|NCT02936869|156565243|FG000|Overall Study|Protocol Violation|1|||
48648294|NCT02936869|156565244|FG001|Overall Study|Protocol Violation|0|||
48648295|NCT03799952|156565245|FG000|Overall Study|Program was too easy, discontinued|1|||
48648296|NCT03799952|156565246|FG001|Overall Study|Program was too easy, discontinued|0|||
48648297|NCT03799952|156565245|FG000|Overall Study|Lost to Follow-up|0|||
48648298|NCT03799952|156565246|FG001|Overall Study|Lost to Follow-up|2|||
48648299|NCT00335738|156565247|FG000|Overall Study|Physician Decision|6|||
48648300|NCT00335738|156565248|FG001|Overall Study|Physician Decision|0|||
48648301|NCT00335738|156565247|FG000|Overall Study|Withdrawal by Subject|2|||
48648302|NCT00335738|156565248|FG001|Overall Study|Withdrawal by Subject|0|||
48648303|NCT00335738|156565247|FG000|Overall Study|Ineligible|3|||
48648304|NCT00335738|156565248|FG001|Overall Study|Ineligible|4|||
48330803|NCT04183491|155407564|FG000|Overall Study|Withdrawal by Subject|0|||
48330804|NCT04183491|155407565|FG001|Overall Study|Withdrawal by Subject|0|||
48648305|NCT03472495|156565249|FG000|Overall Study|Treatment no longer indicated|1|||
48648306|NCT03472495|156565250|FG001|Overall Study|Treatment no longer indicated|2|||
48648307|NCT03472495|156565249|FG000|Overall Study|Physician Decision|0|||
48648308|NCT03472495|156565250|FG001|Overall Study|Physician Decision|2|||
48648309|NCT00124072|156565253|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
48648310|NCT00124072|156565254|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
48330805|NCT04183491|155407566|FG002|Overall Study|Withdrawal by Subject|1|||
48648311|NCT00124072|156565255|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
48648312|NCT00124072|156565256|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
48648313|NCT00124072|156565253|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
48648314|NCT00124072|156565254|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
48648315|NCT00124072|156565255|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
48330806|NCT04183491|155407567|FG003|Overall Study|Withdrawal by Subject|0|||
48330807|NCT04183491|155407568|FG004|Overall Study|Withdrawal by Subject|0|||
48330808|NCT04183491|155407569|FG005|Overall Study|Withdrawal by Subject|1|||
48330809|NCT04183491|155407570|FG006|Overall Study|Withdrawal by Subject|0|||
48330810|NCT02538094|155407571|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
48330811|NCT02538094|155407572|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
48330812|NCT02538094|155407571|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
48330813|NCT02538094|155407572|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
48330814|NCT01989104|155407573|FG000|Overall Study|Withdrawal by Subject|3|||
48330815|NCT01989104|155407574|FG001|Overall Study|Withdrawal by Subject|0|||
48330816|NCT01989104|155407575|FG002|Overall Study|Withdrawal by Subject|0|||
48330817|NCT01989104|155407576|FG003|Overall Study|Withdrawal by Subject|0|||
48330818|NCT01989104|155407577|FG004|Overall Study|Withdrawal by Subject|0|||
48648316|NCT00124072|156565256|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
48648317|NCT00124072|156565253|FG000|Overall Study|Death|499|||
48648318|NCT00124072|156565254|FG001|Overall Study|Death|484|||
48648319|NCT00124072|156565255|FG002|Overall Study|Death|471|||
48648320|NCT00124072|156565256|FG003|Overall Study|Death|480|||
48648321|NCT00995436|156565257|FG000|Overall Study|Withdrawal by Subject|2|||
48648322|NCT00995436|156565258|FG001|Overall Study|Withdrawal by Subject|5|||
48648323|NCT00995436|156565259|FG002|Overall Study|Withdrawal by Subject|0|||
48648324|NCT02689206|156565265|FG000|Overall Study|Adverse Event|0|||
48648325|NCT02689206|156565266|FG001|Overall Study|Adverse Event|0|||
48648326|NCT02689206|156565267|FG002|Overall Study|Adverse Event|1|||
48648327|NCT02689206|156565268|FG003|Overall Study|Adverse Event|0|||
48648328|NCT02689206|156565269|FG004|Overall Study|Adverse Event|2|||
48648329|NCT02689206|156565265|FG000|Overall Study|Protocol Violation|1|||
48648330|NCT02689206|156565266|FG001|Overall Study|Protocol Violation|0|||
48648331|NCT02689206|156565267|FG002|Overall Study|Protocol Violation|0|||
48648332|NCT02689206|156565268|FG003|Overall Study|Protocol Violation|1|||
48648333|NCT02689206|156565269|FG004|Overall Study|Protocol Violation|2|||
48648334|NCT02689206|156565265|FG000|Overall Study|Other: Reached stopping criteria|0|||
48648335|NCT02689206|156565266|FG001|Overall Study|Other: Reached stopping criteria|1|||
48648336|NCT02689206|156565267|FG002|Overall Study|Other: Reached stopping criteria|2|||
48648337|NCT02689206|156565268|FG003|Overall Study|Other: Reached stopping criteria|3|||
48648338|NCT02689206|156565269|FG004|Overall Study|Other: Reached stopping criteria|4|||
48648339|NCT02689206|156565265|FG000|Overall Study|Physician Decision|1|||
48648340|NCT02689206|156565266|FG001|Overall Study|Physician Decision|0|||
48648341|NCT02689206|156565267|FG002|Overall Study|Physician Decision|0|||
48648342|NCT02689206|156565268|FG003|Overall Study|Physician Decision|0|||
48648343|NCT02689206|156565269|FG004|Overall Study|Physician Decision|0|||
48648344|NCT02689206|156565265|FG000|Overall Study|Withdrawal by Subject|1|||
48648345|NCT02689206|156565266|FG001|Overall Study|Withdrawal by Subject|0|||
48648346|NCT02689206|156565267|FG002|Overall Study|Withdrawal by Subject|1|||
48648347|NCT02689206|156565268|FG003|Overall Study|Withdrawal by Subject|0|||
48648348|NCT02689206|156565269|FG004|Overall Study|Withdrawal by Subject|0|||
48648349|NCT02998671|156565270|FG000|Period 1|Study Terminated By Sponsor|2|||
48648350|NCT02998671|156565271|FG001|Period 1|Study Terminated By Sponsor|1|||
48648351|NCT02998671|156565272|FG002|Period 1|Study Terminated By Sponsor|0|||
48648352|NCT02998671|156565273|FG003|Period 1|Study Terminated By Sponsor|0|||
48648353|NCT02998671|156565274|FG004|Period 1|Study Terminated By Sponsor|1|||
48752290|NCT00040664|156938285|FG002|Overall Study|Change of formulation|0|||
48752291|NCT00040664|156938286|FG003|Overall Study|Change of formulation|0|||
48752292|NCT00040664|156938283|FG000|Overall Study|Non-viability of oral suspension|1|||
48648354|NCT02998671|156565270|FG000|Period 1|Withdrawal by Subject|1|||
48752293|NCT00040664|156938284|FG001|Overall Study|Non-viability of oral suspension|0|||
48752294|NCT00040664|156938285|FG002|Overall Study|Non-viability of oral suspension|1|||
48752295|NCT00040664|156938286|FG003|Overall Study|Non-viability of oral suspension|0|||
48752296|NCT00001723|156938289|FG000|Overall Study|Lack of Efficacy|6|||
48752297|NCT00001723|156938290|FG001|Overall Study|Lack of Efficacy|7|||
48752298|NCT00001723|156938289|FG000|Overall Study|Lack of family interest|4|||
48330819|NCT00068107|155407578|FG000|Overall Study|end-stage renal disease|6|||
48648355|NCT02998671|156565271|FG001|Period 1|Withdrawal by Subject|2|||
48648356|NCT02998671|156565272|FG002|Period 1|Withdrawal by Subject|0|||
48648357|NCT02998671|156565273|FG003|Period 1|Withdrawal by Subject|0|||
48648358|NCT02998671|156565274|FG004|Period 1|Withdrawal by Subject|2|||
48648359|NCT02998671|156565270|FG000|Period 1|Pregnancy|1|||
48648360|NCT02998671|156565271|FG001|Period 1|Pregnancy|0|||
48648361|NCT02998671|156565272|FG002|Period 1|Pregnancy|0|||
48648362|NCT02998671|156565273|FG003|Period 1|Pregnancy|0|||
48752299|NCT00001723|156938290|FG001|Overall Study|Lack of family interest|5|||
48752300|NCT00001723|156938289|FG000|Overall Study|Lost to Follow-up|2|||
48752301|NCT00001723|156938290|FG001|Overall Study|Lost to Follow-up|2|||
48330820|NCT00068107|155407578|FG000|Overall Study|Death|2|||
48330821|NCT00068107|155407578|FG000|Overall Study|Withdrawal by Subject|1|||
48330822|NCT02574286|155407582|FG000|Overall Study|Adverse Event|3|||
48648363|NCT02998671|156565274|FG004|Period 1|Pregnancy|0|||
48648364|NCT02998671|156565270|FG000|Period 1|Adverse Event|0|||
48330823|NCT02574286|155407582|FG000|Overall Study|Withdrawal by Subject|2|||
48330824|NCT01065779|155407583|FG000|Overall Study|Duplicate Investigation|1|||
48330825|NCT01065779|155407583|FG000|Overall Study|Investigation Before Contract Date|37|||
48330826|NCT01065779|155407583|FG000|Overall Study|Non-enrollment Period Administration|10|||
48330827|NCT01065779|155407583|FG000|Overall Study|Not Administered With Study Drug|17|||
48330828|NCT01065779|155407583|FG000|Overall Study|Failed to Follow-up|10|||
48330829|NCT01065779|155407583|FG000|Overall Study|Inclusion Criteria Violation|7|||
48330830|NCT02950961|155407585|FG000|Overall Study|Study had to stop due to COVID.|7|||
48330831|NCT00645411|155407586|FG000|Overall Study|Adverse Event|0|||
48330832|NCT00645411|155407587|FG001|Overall Study|Adverse Event|0|||
48330833|NCT00645411|155407588|FG002|Overall Study|Adverse Event|0|||
48330834|NCT00645411|155407589|FG003|Overall Study|Adverse Event|2|||
48330835|NCT00645411|155407586|FG000|Overall Study|Withdrawal by Subject|2|||
48330836|NCT00645411|155407587|FG001|Overall Study|Withdrawal by Subject|1|||
48330837|NCT00645411|155407588|FG002|Overall Study|Withdrawal by Subject|19|||
48330838|NCT00645411|155407589|FG003|Overall Study|Withdrawal by Subject|21|||
48330839|NCT00645411|155407586|FG000|Overall Study|Lost to Follow-up|10|||
48330840|NCT00645411|155407587|FG001|Overall Study|Lost to Follow-up|5|||
48330841|NCT00645411|155407588|FG002|Overall Study|Lost to Follow-up|124|||
48330842|NCT00645411|155407589|FG003|Overall Study|Lost to Follow-up|75|||
48330843|NCT00645411|155407586|FG000|Overall Study|Protocol Violation|1|||
48330844|NCT00645411|155407587|FG001|Overall Study|Protocol Violation|0|||
48330845|NCT00645411|155407588|FG002|Overall Study|Protocol Violation|1|||
48330846|NCT00645411|155407589|FG003|Overall Study|Protocol Violation|0|||
48330847|NCT00645411|155407586|FG000|Overall Study|Inappropriate enrollment|0|||
48648365|NCT02998671|156565271|FG001|Period 1|Adverse Event|0|||
48648366|NCT02998671|156565272|FG002|Period 1|Adverse Event|0|||
48648367|NCT02998671|156565273|FG003|Period 1|Adverse Event|0|||
48648368|NCT02998671|156565274|FG004|Period 1|Adverse Event|1|||
48648369|NCT02998671|156565270|FG000|Period 2|Adverse Event|0|||
48648370|NCT02998671|156565271|FG001|Period 2|Adverse Event|1|||
48648371|NCT02998671|156565272|FG002|Period 2|Adverse Event|0|||
48648372|NCT02998671|156565273|FG003|Period 2|Adverse Event|0|||
48648373|NCT02998671|156565274|FG004|Period 2|Adverse Event|0|||
48648374|NCT02998671|156565270|FG000|Period 2|Study Terminated By Sponsor|3|||
48648375|NCT02998671|156565271|FG001|Period 2|Study Terminated By Sponsor|5|||
48648376|NCT02998671|156565272|FG002|Period 2|Study Terminated By Sponsor|1|||
48648377|NCT02998671|156565273|FG003|Period 2|Study Terminated By Sponsor|3|||
48648378|NCT02998671|156565274|FG004|Period 2|Study Terminated By Sponsor|0|||
48648379|NCT02998671|156565270|FG000|Period 2|Withdrawal by Subject|0|||
48648380|NCT02998671|156565271|FG001|Period 2|Withdrawal by Subject|1|||
48648381|NCT02998671|156565272|FG002|Period 2|Withdrawal by Subject|0|||
48648382|NCT02998671|156565273|FG003|Period 2|Withdrawal by Subject|0|||
48648383|NCT02998671|156565274|FG004|Period 2|Withdrawal by Subject|0|||
48648384|NCT02998671|156565270|FG000|Period 2|Lost to Follow-up|0|||
48648385|NCT02998671|156565271|FG001|Period 2|Lost to Follow-up|0|||
48648386|NCT02998671|156565272|FG002|Period 2|Lost to Follow-up|0|||
48648387|NCT02998671|156565273|FG003|Period 2|Lost to Follow-up|1|||
48648388|NCT02998671|156565274|FG004|Period 2|Lost to Follow-up|0|||
48648389|NCT02038946|156565275|FG000|Overall Study|Death|5|||
48648390|NCT02038946|156565275|FG000|Overall Study|Withdrawal by Subject|3|||
48648391|NCT02038946|156565275|FG000|Overall Study|Lost to Follow-up|2|||
48648392|NCT02038946|156565275|FG000|Overall Study|Other reasons|2|||
48648393|NCT01232127|156565279|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
48330848|NCT00645411|155407587|FG001|Overall Study|Inappropriate enrollment|0|||
48330849|NCT00645411|155407588|FG002|Overall Study|Inappropriate enrollment|4|||
48648394|NCT01232127|156565280|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
48648395|NCT01232127|156565281|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
48648396|NCT03162796|156565283|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
48648397|NCT03162796|156565284|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
48648398|NCT03162796|156565285|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
48648399|NCT03162796|156565283|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
48648400|NCT03162796|156565284|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
48648401|NCT03162796|156565285|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
48648402|NCT03162796|156565283|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
48648403|NCT03162796|156565284|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
48648404|NCT03162796|156565285|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
48648405|NCT03162796|156565283|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
48648406|NCT03162796|156565284|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
48648407|NCT03162796|156565285|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
48648408|NCT03162796|156565283|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
48648409|NCT03162796|156565284|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
48648410|NCT03162796|156565285|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
48330850|NCT00645411|155407589|FG003|Overall Study|Inappropriate enrollment|1|||
48330851|NCT00645411|155407586|FG000|Overall Study|Unable to classify|0|||
48648411|NCT03162796|156565283|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
48648412|NCT03162796|156565284|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
48648413|NCT03162796|156565285|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
48648414|NCT03162796|156565283|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
48648415|NCT03162796|156565284|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
48648416|NCT03162796|156565285|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
48648417|NCT03162796|156565283|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
48648418|NCT03162796|156565284|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
48648419|NCT03162796|156565285|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
48648420|NCT03162796|156565283|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
48648421|NCT03162796|156565284|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
48648422|NCT03162796|156565285|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
48648423|NCT03162796|156565283|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
48648424|NCT03162796|156565284|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
48648425|NCT03162796|156565285|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
48648426|NCT03162796|156565283|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
48648427|NCT03162796|156565284|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
48648428|NCT03162796|156565285|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
48648429|NCT00902850|156565286|FG000|Overall Study|Physician Decision|2|||
48648430|NCT00902850|156565287|FG001|Overall Study|Physician Decision|2|||
48648431|NCT03035864|156565288|FG000|Treatment Period|Adverse Event|1|||
48648432|NCT03035864|156565289|FG001|Treatment Period|Adverse Event|0|||
48648433|NCT03035864|156565288|FG000|Treatment Period|Other|3|||
48648434|NCT03035864|156565289|FG001|Treatment Period|Other|1|||
48648435|NCT03035864|156565288|FG000|Follow-up Period|Adverse Event|1|||
48648436|NCT03035864|156565289|FG001|Follow-up Period|Adverse Event|0|||
48648437|NCT03035864|156565288|FG000|Follow-up Period|Lost to Follow-up|6|||
48648438|NCT03035864|156565289|FG001|Follow-up Period|Lost to Follow-up|2|||
48648439|NCT03035864|156565288|FG000|Follow-up Period|Physician Decision|1|||
48648440|NCT03035864|156565289|FG001|Follow-up Period|Physician Decision|0|||
48648441|NCT03035864|156565288|FG000|Follow-up Period|Other|3|||
48648442|NCT03035864|156565289|FG001|Follow-up Period|Other|2|||
48648443|NCT03098433|156565290|FG000|Overall Study|Withdrawal by Subject|10|||
48648444|NCT01667133|156565291|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
48648445|NCT01667133|156565292|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
48648446|NCT01667133|156565293|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
48648447|NCT01667133|156565294|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
48648448|NCT01667133|156565295|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
48330852|NCT00645411|155407587|FG001|Overall Study|Unable to classify|0|||
48330853|NCT00645411|155407588|FG002|Overall Study|Unable to classify|3|||
48330854|NCT00645411|155407589|FG003|Overall Study|Unable to classify|4|||
48330855|NCT00513071|155407590|FG000|Overall Study|Adverse Event|1|||
48330856|NCT00513071|155407590|FG000|Overall Study|Withdrawal by Subject|1|||
48330857|NCT00513071|155407590|FG000|Overall Study|Physician Decision|3|||
48330858|NCT00551421|155409330|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
48330859|NCT01567852|155409331|FG000|Overall Study|Withdrawal by Subject|3|||
48330860|NCT01567852|155409332|FG001|Overall Study|Withdrawal by Subject|6|||
48330861|NCT01567852|155409331|FG000|Overall Study|ECT discontinued|1|||
48330862|NCT01567852|155409332|FG001|Overall Study|ECT discontinued|1|||
48330863|NCT00089609|155409333|FG000|Overall Study|Withdrawal by Subject|3|||
48330864|NCT00089609|155409334|FG001|Overall Study|Withdrawal by Subject|1|||
48330865|NCT02637063|155409335|FG000|Overall Study|Lost to Follow-up|3|||
48330866|NCT02637063|155409336|FG001|Overall Study|Lost to Follow-up|2|||
48330867|NCT02637063|155409337|FG002|Overall Study|Lost to Follow-up|3|||
48330868|NCT02637063|155409335|FG000|Overall Study|Withdrawal by Subject|2|||
48330869|NCT02637063|155409336|FG001|Overall Study|Withdrawal by Subject|2|||
48330870|NCT02637063|155409337|FG002|Overall Study|Withdrawal by Subject|3|||
48330871|NCT01523392|155409338|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48330872|NCT01523392|155409339|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48330873|NCT01523392|155409338|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
48330874|NCT01523392|155409339|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
48330875|NCT01523392|155409338|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
48330876|NCT01523392|155409339|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
48330877|NCT02002689|155409341|FG000|Overall Study|Disease Progression|7|||
48330878|NCT02002689|155409341|FG000|Overall Study|Adverse Event|3|||
48752302|NCT00001723|156938289|FG000|Overall Study|medication intolerance|1|||
48330879|NCT00777049|155409347|FG000|Overall Study|Withdrawal by Subject|1|||
48330880|NCT00777049|155409348|FG001|Overall Study|Withdrawal by Subject|0|||
48648449|NCT01667133|156565296|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
48648450|NCT01667133|156565297|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
48648451|NCT01667133|156565298|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
48648452|NCT01667133|156565299|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
48648453|NCT01667133|156565300|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
48330881|NCT00777049|155409347|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
48330882|NCT00777049|155409348|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
48330883|NCT02236611|155409349|FG000|Overall Study|Adverse Event|10|||
48330884|NCT02236611|155409350|FG001|Overall Study|Adverse Event|16|||
48330885|NCT02236611|155409349|FG000|Overall Study|Lack of Efficacy|4|||
48330886|NCT02236611|155409350|FG001|Overall Study|Lack of Efficacy|7|||
48330887|NCT02236611|155409349|FG000|Overall Study|Lost to Follow-up|0|||
48330888|NCT02236611|155409350|FG001|Overall Study|Lost to Follow-up|2|||
48330889|NCT02236611|155409349|FG000|Overall Study|Protocol deviation|3|||
48330890|NCT02236611|155409350|FG001|Overall Study|Protocol deviation|5|||
48330891|NCT02236611|155409349|FG000|Overall Study|Withdrew consent|9|||
48330892|NCT02236611|155409350|FG001|Overall Study|Withdrew consent|4|||
48330893|NCT03403036|155409351|FG000|Overall Study|Lack of Efficacy|5|||
48330894|NCT01256359|155409352|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
48330895|NCT01256359|155409353|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
48330896|NCT01256359|155409352|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
48330897|NCT01256359|155409353|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
48330898|NCT01536704|155409354|FG000|Washout Period 1|Withdrawal by Subject|1|||
48330899|NCT01536704|155409355|FG001|Washout Period 1|Withdrawal by Subject|2|||
48330900|NCT01536704|155409356|FG002|Washout Period 1|Withdrawal by Subject|0|||
48330901|NCT01536704|155409357|FG003|Washout Period 1|Withdrawal by Subject|0|||
48330902|NCT01536704|155409354|FG000|Washout Period 2|Adverse Event|1|||
48330903|NCT01536704|155409355|FG001|Washout Period 2|Adverse Event|0|||
48330904|NCT01536704|155409356|FG002|Washout Period 2|Adverse Event|0|||
48330905|NCT01536704|155409357|FG003|Washout Period 2|Adverse Event|0|||
48330906|NCT01536704|155409354|FG000|Washout Period 2|Withdrawal by Subject|0|||
48330907|NCT01536704|155409355|FG001|Washout Period 2|Withdrawal by Subject|0|||
48330908|NCT01536704|155409356|FG002|Washout Period 2|Withdrawal by Subject|0|||
48330909|NCT01536704|155409357|FG003|Washout Period 2|Withdrawal by Subject|1|||
48330910|NCT01536704|155409354|FG000|Period 3|Adverse Event|0|||
48330911|NCT01536704|155409355|FG001|Period 3|Adverse Event|0|||
48330912|NCT01536704|155409356|FG002|Period 3|Adverse Event|0|||
48330913|NCT01536704|155409357|FG003|Period 3|Adverse Event|1|||
48330914|NCT01536704|155409354|FG000|Washout Period 3|Adverse Event|0|||
48330915|NCT01536704|155409355|FG001|Washout Period 3|Adverse Event|0|||
48330916|NCT01536704|155409356|FG002|Washout Period 3|Adverse Event|1|||
48330917|NCT01536704|155409357|FG003|Washout Period 3|Adverse Event|0|||
48330918|NCT01286311|155409360|FG000|Overall Study|Physician did not want outreach sent|14|||
48330919|NCT01286311|155409361|FG001|Overall Study|Physician did not want outreach sent|0|||
48330920|NCT01205126|155409362|FG000|Titration Phase|Adverse Event|5|||
48330921|NCT01205126|155409363|FG001|Titration Phase|Adverse Event|3|||
48648454|NCT01667133|156565301|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
48648455|NCT01667133|156565302|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
48648456|NCT01667133|156565291|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648457|NCT01667133|156565292|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648458|NCT01667133|156565293|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
48648459|NCT01667133|156565294|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648460|NCT01667133|156565295|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48330922|NCT01205126|155409362|FG000|Titration Phase|Withdrawal by Subject|5|||
48330923|NCT01205126|155409363|FG001|Titration Phase|Withdrawal by Subject|5|||
48330924|NCT01205126|155409362|FG000|Titration Phase|Lost to Follow-up|2|||
48330925|NCT01205126|155409363|FG001|Titration Phase|Lost to Follow-up|2|||
48330926|NCT01205126|155409362|FG000|Titration Phase|No stable titration dose|1|||
48648461|NCT01667133|156565296|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648462|NCT01667133|156565297|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648463|NCT01667133|156565298|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648464|NCT01667133|156565299|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648465|NCT01667133|156565300|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648466|NCT01667133|156565301|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48330927|NCT01205126|155409363|FG001|Titration Phase|No stable titration dose|0|||
48330928|NCT01205126|155409362|FG000|Titration Phase|More than maximum dosage required|2|||
48648467|NCT01667133|156565302|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
48648468|NCT01667133|156565291|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
48648469|NCT01667133|156565292|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
48648470|NCT01667133|156565293|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
48648471|NCT01667133|156565294|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
48330929|NCT01205126|155409363|FG001|Titration Phase|More than maximum dosage required|3|||
48330930|NCT01205126|155409362|FG000|Titration Phase|Other|8|||
48330931|NCT01205126|155409363|FG001|Titration Phase|Other|6|||
48330932|NCT01205126|155409362|FG000|Between Titration & Maintenance Phase|Other|0|||
48330933|NCT01205126|155409363|FG001|Between Titration & Maintenance Phase|Other|4|||
48330934|NCT01205126|155409362|FG000|Maintenance Phase|Adverse Event|3|||
48330935|NCT01205126|155409363|FG001|Maintenance Phase|Adverse Event|7|||
48648472|NCT01667133|156565295|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
48648473|NCT01667133|156565296|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
48648474|NCT01667133|156565297|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
48648475|NCT01667133|156565298|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
48330936|NCT01205126|155409362|FG000|Maintenance Phase|Death|4|||
48330937|NCT01205126|155409363|FG001|Maintenance Phase|Death|4|||
48330938|NCT01205126|155409362|FG000|Maintenance Phase|More than the maximum dosage required|5|||
48648476|NCT01667133|156565299|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
48648477|NCT01667133|156565300|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
48648478|NCT01667133|156565301|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
48648479|NCT01667133|156565302|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
48648480|NCT01667133|156565291|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648481|NCT01667133|156565292|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648482|NCT01667133|156565293|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648483|NCT01667133|156565294|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
48648484|NCT01667133|156565295|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648485|NCT01667133|156565296|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648486|NCT01667133|156565297|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648487|NCT01667133|156565298|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648488|NCT01667133|156565299|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648489|NCT01667133|156565300|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648490|NCT01667133|156565301|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648491|NCT01667133|156565302|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
48648492|NCT01667133|156565291|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
48752303|NCT00001723|156938290|FG001|Overall Study|medication intolerance|2|||
48752304|NCT02788357|156938292|FG000|Overall Study|Lost to Follow-up|3|||
48752305|NCT02788357|156938293|FG001|Overall Study|Lost to Follow-up|0|||
48752306|NCT00536198|156938294|FG000|Overall Study|Lost to Follow-up|15|||
48752307|NCT00536198|156938295|FG001|Overall Study|Lost to Follow-up|14|||
48752308|NCT00536198|156938294|FG000|Overall Study|Withdrawal by Subject|16|||
48752309|NCT00536198|156938295|FG001|Overall Study|Withdrawal by Subject|12|||
48752310|NCT00536198|156938294|FG000|Overall Study|Adverse Event|2|||
48752311|NCT00536198|156938295|FG001|Overall Study|Adverse Event|2|||
48752312|NCT00536198|156938294|FG000|Overall Study|Rescue|3|||
48752313|NCT00536198|156938295|FG001|Overall Study|Rescue|9|||
48752314|NCT00536198|156938294|FG000|Overall Study|Pregnancy|1|||
48752315|NCT00536198|156938295|FG001|Overall Study|Pregnancy|1|||
48752316|NCT00536198|156938294|FG000|Overall Study|Protocol Violation|0|||
48752317|NCT00536198|156938295|FG001|Overall Study|Protocol Violation|1|||
48752318|NCT01714635|156938297|FG000|Overall Study|Discontinued|1|||
48752319|NCT01714635|156938298|FG001|Overall Study|Discontinued|0|||
48752320|NCT01714635|156938299|FG002|Overall Study|Discontinued|2|||
48752321|NCT01714635|156938297|FG000|Overall Study|Missed 6-month exam|1|||
48752322|NCT01714635|156938298|FG001|Overall Study|Missed 6-month exam|0|||
48752323|NCT01714635|156938299|FG002|Overall Study|Missed 6-month exam|0|||
48752324|NCT01927367|156938300|FG000|Overall Study|Withdrawal by Subject|7|||
48752325|NCT01927367|156938301|FG001|Overall Study|Withdrawal by Subject|4|||
48752326|NCT01927367|156938300|FG000|Overall Study|No baseline data|0|||
48752327|NCT01927367|156938301|FG001|Overall Study|No baseline data|1|||
48752328|NCT01214629|156938302|FG000|Overall Study|Progressive Disease|1|||
48752329|NCT01214629|156938303|FG001|Overall Study|Progressive Disease|1|||
48752330|NCT01214629|156938304|FG002|Overall Study|Progressive Disease|0|||
48752331|NCT01214629|156938305|FG003|Overall Study|Progressive Disease|1|||
48752332|NCT01214629|156938306|FG004|Overall Study|Progressive Disease|2|||
48752333|NCT01214629|156938307|FG005|Overall Study|Progressive Disease|3|||
48752334|NCT01214629|156938308|FG006|Overall Study|Progressive Disease|1|||
48752335|NCT01214629|156938309|FG007|Overall Study|Progressive Disease|1|||
48752336|NCT01214629|156938310|FG008|Overall Study|Progressive Disease|1|||
48752337|NCT01214629|156938311|FG009|Overall Study|Progressive Disease|5|||
48752338|NCT01214629|156938312|FG010|Overall Study|Progressive Disease|1|||
48752339|NCT01214629|156938302|FG000|Overall Study|Adverse Event|0|||
48648493|NCT01667133|156565292|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
48648494|NCT01667133|156565293|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
48648495|NCT01667133|156565294|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
48648496|NCT01667133|156565295|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
48648497|NCT01667133|156565296|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
48648498|NCT01667133|156565297|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
48752340|NCT01214629|156938303|FG001|Overall Study|Adverse Event|0|||
48752341|NCT01214629|156938304|FG002|Overall Study|Adverse Event|0|||
48752342|NCT01214629|156938305|FG003|Overall Study|Adverse Event|1|||
48752343|NCT01214629|156938306|FG004|Overall Study|Adverse Event|0|||
48752344|NCT01214629|156938307|FG005|Overall Study|Adverse Event|1|||
48752345|NCT01214629|156938308|FG006|Overall Study|Adverse Event|0|||
48752346|NCT01214629|156938309|FG007|Overall Study|Adverse Event|0|||
48752347|NCT01214629|156938310|FG008|Overall Study|Adverse Event|0|||
48752348|NCT01214629|156938311|FG009|Overall Study|Adverse Event|1|||
48752349|NCT01214629|156938312|FG010|Overall Study|Adverse Event|0|||
48752350|NCT01214629|156938302|FG000|Overall Study|Physician Decision|0|||
48330939|NCT01205126|155409363|FG001|Maintenance Phase|More than the maximum dosage required|5|||
48330940|NCT01205126|155409362|FG000|Maintenance Phase|Prohibited drugs used|1|||
48330941|NCT01205126|155409363|FG001|Maintenance Phase|Prohibited drugs used|0|||
48330942|NCT01205126|155409362|FG000|Maintenance Phase|Other|11|||
48330943|NCT01205126|155409363|FG001|Maintenance Phase|Other|8|||
48648499|NCT01667133|156565298|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
48648500|NCT01667133|156565299|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
48648501|NCT01667133|156565300|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
48648502|NCT01667133|156565301|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
48648503|NCT01667133|156565302|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
48648504|NCT01667133|156565291|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648505|NCT01667133|156565292|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648506|NCT01667133|156565293|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648507|NCT01667133|156565294|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648508|NCT01667133|156565295|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648509|NCT01667133|156565296|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48330944|NCT01205126|155409362|FG000|Maintenance Phase|Lost to Follow-up|5|||
48330945|NCT01205126|155409363|FG001|Maintenance Phase|Lost to Follow-up|5|||
48330946|NCT01205126|155409362|FG000|Maintenance Phase|Withdrawal by Subject|8|||
48330947|NCT01205126|155409363|FG001|Maintenance Phase|Withdrawal by Subject|11|||
48330948|NCT01428583|155409364|FG000|Overall Study|Adverse Event|75|||
48330949|NCT01428583|155409364|FG000|Overall Study|Withdrawal by Subject|51|||
48330950|NCT01428583|155409364|FG000|Overall Study|Lack of Efficacy|37|||
48330951|NCT01428583|155409364|FG000|Overall Study|Lost to Follow-up|17|||
48330952|NCT01428583|155409364|FG000|Overall Study|Death|1|||
48648510|NCT01667133|156565297|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648511|NCT01667133|156565298|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648512|NCT01667133|156565299|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648513|NCT01667133|156565300|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
48648514|NCT01667133|156565301|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648515|NCT01667133|156565302|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
48648516|NCT01667133|156565291|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
48648517|NCT01667133|156565292|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
48648518|NCT01667133|156565293|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
48648519|NCT01667133|156565294|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
48648520|NCT01667133|156565295|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
48648521|NCT01667133|156565296|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
48648522|NCT01667133|156565297|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
48648523|NCT01667133|156565298|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
48648524|NCT01667133|156565299|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
48648525|NCT01667133|156565300|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
48648526|NCT01667133|156565301|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
48648527|NCT01667133|156565302|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
48648528|NCT01667133|156565291|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648529|NCT01667133|156565292|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648530|NCT01667133|156565293|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648531|NCT01667133|156565294|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648532|NCT01667133|156565295|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648533|NCT01667133|156565296|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648534|NCT01667133|156565297|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648535|NCT01667133|156565298|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648536|NCT01667133|156565299|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648537|NCT01667133|156565300|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
48648538|NCT01667133|156565301|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648539|NCT01667133|156565302|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
48648540|NCT01667133|156565291|FG000|Phase 2: Dose-expansion|Death|0|||
48648541|NCT01667133|156565292|FG001|Phase 2: Dose-expansion|Death|0|||
48648542|NCT01667133|156565293|FG002|Phase 2: Dose-expansion|Death|0|||
48648543|NCT01667133|156565294|FG003|Phase 2: Dose-expansion|Death|0|||
48330953|NCT01428583|155409364|FG000|Overall Study|Pregnancy|1|||
48330954|NCT01428583|155409364|FG000|Overall Study|Protocol Violation|1|||
48330955|NCT01428583|155409364|FG000|Overall Study|Physician Decision|12|||
48330956|NCT01428583|155409364|FG000|Overall Study|Non-compliant|25|||
48330957|NCT01428583|155409364|FG000|Overall Study|Confirmed positive urine drug test|8|||
48330958|NCT01428583|155409364|FG000|Overall Study|Sponsor's request|3|||
48330959|NCT01428583|155409364|FG000|Overall Study|Other|6|||
48330960|NCT00670488|155409367|FG000|Overall Study|Adverse Event|0|||
48330961|NCT00670488|155409368|FG001|Overall Study|Adverse Event|7|||
48330962|NCT00670488|155409369|FG002|Overall Study|Adverse Event|0|||
48330963|NCT00670488|155409370|FG003|Overall Study|Adverse Event|3|||
48330964|NCT00670488|155409371|FG004|Overall Study|Adverse Event|1|||
48330965|NCT00670488|155409372|FG005|Overall Study|Adverse Event|1|||
48330966|NCT00670488|155409373|FG006|Overall Study|Adverse Event|5|||
48330967|NCT00670488|155409374|FG007|Overall Study|Adverse Event|1|||
48330968|NCT00670488|155409375|FG008|Overall Study|Adverse Event|0|||
48330969|NCT00670488|155409376|FG009|Overall Study|Adverse Event|1|||
48330970|NCT00670488|155409367|FG000|Overall Study|Physician Decision|1|||
48330971|NCT00670488|155409368|FG001|Overall Study|Physician Decision|9|||
48330972|NCT00670488|155409369|FG002|Overall Study|Physician Decision|0|||
48330973|NCT00670488|155409370|FG003|Overall Study|Physician Decision|1|||
48330974|NCT00670488|155409371|FG004|Overall Study|Physician Decision|0|||
48330975|NCT00670488|155409372|FG005|Overall Study|Physician Decision|0|||
48330976|NCT00670488|155409373|FG006|Overall Study|Physician Decision|0|||
48330977|NCT00670488|155409374|FG007|Overall Study|Physician Decision|0|||
48330978|NCT00670488|155409375|FG008|Overall Study|Physician Decision|0|||
48330979|NCT00670488|155409376|FG009|Overall Study|Physician Decision|0|||
48330980|NCT00670488|155409367|FG000|Overall Study|Progressive Disease|2|||
48648544|NCT01667133|156565295|FG004|Phase 2: Dose-expansion|Death|0|||
48648545|NCT01667133|156565296|FG005|Phase 2: Dose-expansion|Death|0|||
48648546|NCT01667133|156565297|FG006|Phase 2: Dose-expansion|Death|0|||
48648547|NCT01667133|156565298|FG007|Phase 2: Dose-expansion|Death|0|||
48648548|NCT01667133|156565299|FG008|Phase 2: Dose-expansion|Death|0|||
48648549|NCT01667133|156565300|FG009|Phase 2: Dose-expansion|Death|1|||
48648550|NCT01667133|156565301|FG010|Phase 2: Dose-expansion|Death|0|||
48330981|NCT00670488|155409368|FG001|Overall Study|Progressive Disease|41|||
48330982|NCT00670488|155409369|FG002|Overall Study|Progressive Disease|3|||
48648551|NCT01667133|156565302|FG011|Phase 2: Dose-expansion|Death|0|||
48648552|NCT01667133|156565291|FG000|Phase 2: Dose-expansion|Other|0|||
48648553|NCT01667133|156565292|FG001|Phase 2: Dose-expansion|Other|0|||
48648554|NCT01667133|156565293|FG002|Phase 2: Dose-expansion|Other|0|||
48648555|NCT01667133|156565294|FG003|Phase 2: Dose-expansion|Other|0|||
48648556|NCT01667133|156565295|FG004|Phase 2: Dose-expansion|Other|0|||
48648557|NCT01667133|156565296|FG005|Phase 2: Dose-expansion|Other|0|||
48648558|NCT01667133|156565297|FG006|Phase 2: Dose-expansion|Other|0|||
48330983|NCT00670488|155409370|FG003|Overall Study|Progressive Disease|2|||
48330984|NCT00670488|155409371|FG004|Overall Study|Progressive Disease|2|||
48330985|NCT00670488|155409372|FG005|Overall Study|Progressive Disease|4|||
48330986|NCT00670488|155409373|FG006|Overall Study|Progressive Disease|11|||
48330987|NCT00670488|155409374|FG007|Overall Study|Progressive Disease|2|||
48330988|NCT00670488|155409375|FG008|Overall Study|Progressive Disease|2|||
48330989|NCT00670488|155409376|FG009|Overall Study|Progressive Disease|1|||
48330990|NCT00670488|155409367|FG000|Overall Study|Withdrawal by Subject|0|||
48330991|NCT00670488|155409368|FG001|Overall Study|Withdrawal by Subject|1|||
48330992|NCT00670488|155409369|FG002|Overall Study|Withdrawal by Subject|0|||
48330993|NCT00670488|155409370|FG003|Overall Study|Withdrawal by Subject|1|||
48330994|NCT00670488|155409371|FG004|Overall Study|Withdrawal by Subject|0|||
48330995|NCT00670488|155409372|FG005|Overall Study|Withdrawal by Subject|0|||
48330996|NCT00670488|155409373|FG006|Overall Study|Withdrawal by Subject|1|||
48648559|NCT01667133|156565298|FG007|Phase 2: Dose-expansion|Other|0|||
48648560|NCT01667133|156565299|FG008|Phase 2: Dose-expansion|Other|0|||
48648561|NCT01667133|156565300|FG009|Phase 2: Dose-expansion|Other|0|||
48648562|NCT01667133|156565301|FG010|Phase 2: Dose-expansion|Other|0|||
48330997|NCT00670488|155409374|FG007|Overall Study|Withdrawal by Subject|0|||
48330998|NCT00670488|155409375|FG008|Overall Study|Withdrawal by Subject|1|||
48648563|NCT01667133|156565302|FG011|Phase 2: Dose-expansion|Other|1|||
48648564|NCT01916824|156565305|FG000|Overall Study|Lost to Follow-up|3|||
48648565|NCT01916824|156565306|FG001|Overall Study|Lost to Follow-up|6|||
48648566|NCT01916824|156565305|FG000|Overall Study|Physician Decision|2|||
48648567|NCT01916824|156565306|FG001|Overall Study|Physician Decision|0|||
48648568|NCT01916824|156565305|FG000|Overall Study|Withdrawal by Subject|2|||
48330999|NCT00670488|155409376|FG009|Overall Study|Withdrawal by Subject|0|||
48331000|NCT01480258|155409377|FG000|Infant Series|Protocol Violation|2|||
48331001|NCT01480258|155409378|FG001|Infant Series|Protocol Violation|0|||
48331002|NCT01480258|155409377|FG000|Infant Series|Physician Decision|0|||
48331003|NCT01480258|155409378|FG001|Infant Series|Physician Decision|1|||
48331004|NCT01480258|155409377|FG000|Infant Series|Not Vaccinated|3|||
48648569|NCT01916824|156565306|FG001|Overall Study|Withdrawal by Subject|3|||
48648570|NCT00771927|156565307|FG000|Overall Study|Adverse Event|100|||
48648571|NCT00771927|156565308|FG001|Overall Study|Adverse Event|105|||
48331005|NCT01480258|155409378|FG001|Infant Series|Not Vaccinated|0|||
48331006|NCT01480258|155409377|FG000|Infant Series|Adverse Event|1|||
48331007|NCT01480258|155409378|FG001|Infant Series|Adverse Event|1|||
48331008|NCT01480258|155409377|FG000|Infant Series|Withdrawal by Subject|1|||
48331009|NCT01480258|155409378|FG001|Infant Series|Withdrawal by Subject|6|||
48331010|NCT01480258|155409377|FG000|Interim Period|Lost to Follow-up|0|||
48331011|NCT01480258|155409378|FG001|Interim Period|Lost to Follow-up|2|||
48648572|NCT00771927|156565307|FG000|Overall Study|Lack of Efficacy|70|||
48331012|NCT01480258|155409377|FG000|Interim Period|Physician Decision|1|||
48331013|NCT01480258|155409378|FG001|Interim Period|Physician Decision|0|||
48331014|NCT01480258|155409377|FG000|Interim Period|Protocol Violation|0|||
48331015|NCT01480258|155409378|FG001|Interim Period|Protocol Violation|1|||
48331016|NCT01480258|155409377|FG000|Interim Period|Withdrawal by Subject|9|||
48648573|NCT00771927|156565308|FG001|Overall Study|Lack of Efficacy|42|||
48648574|NCT00771927|156565307|FG000|Overall Study|Lost to Follow-up|46|||
48648575|NCT00771927|156565308|FG001|Overall Study|Lost to Follow-up|46|||
48648576|NCT00771927|156565307|FG000|Overall Study|Withdrawal by Subject|16|||
48648577|NCT00771927|156565308|FG001|Overall Study|Withdrawal by Subject|17|||
48648578|NCT00771927|156565307|FG000|Overall Study|Other reason|23|||
48648579|NCT00771927|156565308|FG001|Overall Study|Other reason|27|||
48648580|NCT02676895|156565309|FG000|Overall Study|Administrative reason|1|||
48648581|NCT02676895|156565310|FG001|Overall Study|Administrative reason|0|||
48648582|NCT02676895|156565311|FG002|Overall Study|Administrative reason|0|||
48648583|NCT02676895|156565309|FG000|Overall Study|Protocol Violation|1|||
48648584|NCT02676895|156565310|FG001|Overall Study|Protocol Violation|0|||
48648585|NCT02676895|156565311|FG002|Overall Study|Protocol Violation|0|||
48648586|NCT02676895|156565309|FG000|Overall Study|Adverse Event|0|||
48648587|NCT02676895|156565310|FG001|Overall Study|Adverse Event|3|||
48648588|NCT02676895|156565311|FG002|Overall Study|Adverse Event|1|||
48648589|NCT02676895|156565309|FG000|Overall Study|Lost to Follow-up|0|||
48648590|NCT02676895|156565310|FG001|Overall Study|Lost to Follow-up|0|||
48648591|NCT02676895|156565311|FG002|Overall Study|Lost to Follow-up|1|||
48648592|NCT02676895|156565309|FG000|Overall Study|Withdrawal by Subject|0|||
48648593|NCT02676895|156565310|FG001|Overall Study|Withdrawal by Subject|0|||
48648594|NCT02676895|156565311|FG002|Overall Study|Withdrawal by Subject|1|||
48648595|NCT03299244|156565315|FG000|Overall Study|Withdrawal by Subject|34|||
48648596|NCT03299244|156565316|FG001|Overall Study|Withdrawal by Subject|29|||
48648597|NCT03299244|156565315|FG000|Overall Study|Decision by Sponsor|4|||
48648598|NCT03299244|156565316|FG001|Overall Study|Decision by Sponsor|5|||
48648599|NCT03299244|156565315|FG000|Overall Study|Death|9|||
48648600|NCT03299244|156565316|FG001|Overall Study|Death|4|||
48648601|NCT02467192|156565317|FG000|Overall Study|Death|1|||
48648602|NCT02467192|156565317|FG000|Overall Study|revealed to have pneumonia before|2|||
48648603|NCT00375505|156565327|FG000|Overall Study|Adverse Event|1|||
48648604|NCT00375505|156565328|FG001|Overall Study|Adverse Event|2|||
48648605|NCT02151786|156565331|FG000|Overall Study|Unavailability of Case Report Form|26|||
48648606|NCT02151786|156565331|FG000|Overall Study|Outside the Contract Period|1|||
48648607|NCT02151786|156565331|FG000|Overall Study|Randomized, not Treated|1|||
48648608|NCT02151786|156565331|FG000|Overall Study|Unavailability of Information|8|||
48648609|NCT00819156|156565332|FG000|Overall Study|Adverse Event|1|||
48648610|NCT00819156|156565333|FG001|Overall Study|Adverse Event|4|||
48648611|NCT00819156|156565334|FG002|Overall Study|Adverse Event|2|||
48648612|NCT00819156|156565335|FG003|Overall Study|Adverse Event|1|||
48648613|NCT00819156|156565336|FG004|Overall Study|Adverse Event|2|||
48648614|NCT00819156|156565337|FG005|Overall Study|Adverse Event|3|||
48648615|NCT00819156|156565332|FG000|Overall Study|Withdrawal by Subject|0|||
48648616|NCT00819156|156565333|FG001|Overall Study|Withdrawal by Subject|3|||
48648617|NCT00819156|156565334|FG002|Overall Study|Withdrawal by Subject|2|||
48648618|NCT00819156|156565335|FG003|Overall Study|Withdrawal by Subject|0|||
48648619|NCT00819156|156565336|FG004|Overall Study|Withdrawal by Subject|1|||
48331017|NCT01480258|155409378|FG001|Interim Period|Withdrawal by Subject|6|||
48331018|NCT01836523|155409381|FG000|Overall Study|Adverse Event|15|||
48331019|NCT01836523|155409382|FG001|Overall Study|Adverse Event|41|||
48648620|NCT00819156|156565337|FG005|Overall Study|Withdrawal by Subject|0|||
48648621|NCT00819156|156565332|FG000|Overall Study|Protocol Violation|1|||
48648622|NCT00819156|156565333|FG001|Overall Study|Protocol Violation|0|||
48648623|NCT00819156|156565334|FG002|Overall Study|Protocol Violation|1|||
48648624|NCT00819156|156565335|FG003|Overall Study|Protocol Violation|0|||
48648625|NCT00819156|156565336|FG004|Overall Study|Protocol Violation|0|||
48648626|NCT00819156|156565337|FG005|Overall Study|Protocol Violation|1|||
48648627|NCT00819156|156565332|FG000|Overall Study|Lost to Follow-up|0|||
48648628|NCT00819156|156565333|FG001|Overall Study|Lost to Follow-up|1|||
48752351|NCT01214629|156938303|FG001|Overall Study|Physician Decision|0|||
48331020|NCT01836523|155409383|FG002|Overall Study|Adverse Event|49|||
48331021|NCT01836523|155409384|FG003|Overall Study|Adverse Event|14|||
48648629|NCT00819156|156565334|FG002|Overall Study|Lost to Follow-up|0|||
48648630|NCT00819156|156565335|FG003|Overall Study|Lost to Follow-up|0|||
48648631|NCT00819156|156565336|FG004|Overall Study|Lost to Follow-up|0|||
48648632|NCT00819156|156565337|FG005|Overall Study|Lost to Follow-up|2|||
48331022|NCT01836523|155409381|FG000|Overall Study|Protocol Violation|6|||
48648633|NCT00819156|156565332|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
48648634|NCT00819156|156565333|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
48648635|NCT00819156|156565334|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
48648636|NCT00819156|156565335|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
48648637|NCT00819156|156565336|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
48648638|NCT00819156|156565337|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
48648639|NCT00819156|156565332|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
48648640|NCT00819156|156565333|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
48648641|NCT00819156|156565334|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
48648642|NCT00819156|156565335|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
48648643|NCT00819156|156565336|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
48648644|NCT00819156|156565337|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
48648645|NCT00819156|156565332|FG000|Overall Study|Prostate-specific antigen progression|0|||
48648646|NCT00819156|156565333|FG001|Overall Study|Prostate-specific antigen progression|0|||
48648647|NCT00819156|156565334|FG002|Overall Study|Prostate-specific antigen progression|0|||
48648648|NCT00819156|156565335|FG003|Overall Study|Prostate-specific antigen progression|0|||
48648649|NCT00819156|156565336|FG004|Overall Study|Prostate-specific antigen progression|1|||
48648650|NCT00819156|156565337|FG005|Overall Study|Prostate-specific antigen progression|0|||
48648651|NCT00803595|156565338|FG000|Overall Study|Adverse Event|3|||
48648652|NCT00803595|156565339|FG001|Overall Study|Adverse Event|4|||
48648653|NCT00803595|156565340|FG002|Overall Study|Adverse Event|1|||
48648654|NCT00803595|156565338|FG000|Overall Study|Protocol Violation|7|||
48648655|NCT00803595|156565339|FG001|Overall Study|Protocol Violation|2|||
48648656|NCT00803595|156565340|FG002|Overall Study|Protocol Violation|12|||
48648657|NCT00803595|156565338|FG000|Overall Study|Withdrawal by Subject|5|||
48648658|NCT00803595|156565339|FG001|Overall Study|Withdrawal by Subject|2|||
48648659|NCT00803595|156565340|FG002|Overall Study|Withdrawal by Subject|3|||
48648660|NCT01248728|156565341|FG000|Overall Study|Adverse Event|1|||
48648661|NCT01248728|156565342|FG001|Overall Study|Adverse Event|1|||
48648662|NCT01248728|156565341|FG000|Overall Study|Withdrawal by Subject|2|||
48648663|NCT01248728|156565342|FG001|Overall Study|Withdrawal by Subject|1|||
48648664|NCT01248728|156565341|FG000|Overall Study|Lack of Efficacy|1|||
48648665|NCT01248728|156565342|FG001|Overall Study|Lack of Efficacy|0|||
48648666|NCT00104728|156565343|FG000|Overall Study|screen failures|19|||
48648667|NCT02079909|156566628|FG000|Overall Study|Adverse Event|23|||
48648668|NCT02079909|156566629|FG001|Overall Study|Adverse Event|23|||
48331023|NCT01836523|155409382|FG001|Overall Study|Protocol Violation|3|||
48331024|NCT01836523|155409383|FG002|Overall Study|Protocol Violation|2|||
48648669|NCT02079909|156566630|FG002|Overall Study|Adverse Event|7|||
48648670|NCT02079909|156566628|FG000|Overall Study|Withdrawal by Subject|9|||
48648671|NCT02079909|156566629|FG001|Overall Study|Withdrawal by Subject|17|||
48648672|NCT02079909|156566630|FG002|Overall Study|Withdrawal by Subject|4|||
48648673|NCT02079909|156566628|FG000|Overall Study|Lost to Follow-up|2|||
48648674|NCT02079909|156566629|FG001|Overall Study|Lost to Follow-up|3|||
48648675|NCT02079909|156566630|FG002|Overall Study|Lost to Follow-up|1|||
48648676|NCT02079909|156566628|FG000|Overall Study|Death|2|||
48648677|NCT02079909|156566629|FG001|Overall Study|Death|2|||
48648678|NCT02079909|156566630|FG002|Overall Study|Death|0|||
48648679|NCT02079909|156566628|FG000|Overall Study|Lack of Efficacy|0|||
48648680|NCT02079909|156566629|FG001|Overall Study|Lack of Efficacy|0|||
48648681|NCT02079909|156566630|FG002|Overall Study|Lack of Efficacy|1|||
48648682|NCT02079909|156566628|FG000|Overall Study|Protocol Violation|0|||
48648683|NCT02079909|156566629|FG001|Overall Study|Protocol Violation|1|||
48648684|NCT02079909|156566630|FG002|Overall Study|Protocol Violation|1|||
48648685|NCT02079909|156566628|FG000|Overall Study|Physician Decision|0|||
48648686|NCT02079909|156566629|FG001|Overall Study|Physician Decision|1|||
48648687|NCT02079909|156566630|FG002|Overall Study|Physician Decision|1|||
48648688|NCT02079909|156566628|FG000|Overall Study|Relocation etc.|2|||
48648689|NCT02079909|156566629|FG001|Overall Study|Relocation etc.|2|||
48648690|NCT02079909|156566630|FG002|Overall Study|Relocation etc.|3|||
48648691|NCT03846427|156566633|FG000|Overall Study|Death|13|||
48331025|NCT01836523|155409384|FG003|Overall Study|Protocol Violation|4|||
48331026|NCT01836523|155409381|FG000|Overall Study|Met Withdrawal Criteria|13|||
48331027|NCT01836523|155409382|FG001|Overall Study|Met Withdrawal Criteria|13|||
48648692|NCT03846427|156566633|FG000|Overall Study|Withdrawal by Subject|3|||
48648693|NCT03846427|156566633|FG000|Overall Study|Physician Decision|1|||
48648694|NCT02297815|156566636|FG000|Overall Study|Lost to Follow-up|236|||
48648695|NCT02297815|156566637|FG001|Overall Study|Lost to Follow-up|140|||
48648696|NCT02522429|156566641|FG000|Overall Study|Lost to Follow-up|8|||
48648697|NCT02522429|156566641|FG000|Overall Study|Adverse Event|2|||
48648698|NCT02522429|156566641|FG000|Overall Study|Death|1|||
48648699|NCT02522429|156566641|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
48648700|NCT00294671|156566642|FG000|Overall Study|Lack of Efficacy|11|||
48331028|NCT01836523|155409383|FG002|Overall Study|Met Withdrawal Criteria|21|||
48648701|NCT00294671|156566643|FG001|Overall Study|Lack of Efficacy|23|||
48648702|NCT00294671|156566642|FG000|Overall Study|Liver transplant|7|||
48331029|NCT01836523|155409384|FG003|Overall Study|Met Withdrawal Criteria|27|||
48331030|NCT01836523|155409381|FG000|Overall Study|Unclassified|17|||
48331031|NCT01836523|155409382|FG001|Overall Study|Unclassified|28|||
48648703|NCT00294671|156566643|FG001|Overall Study|Liver transplant|9|||
48648704|NCT00294671|156566642|FG000|Overall Study|Drug related adverse event (AE)|4|||
48648705|NCT00294671|156566643|FG001|Overall Study|Drug related adverse event (AE)|2|||
48648706|NCT00294671|156566642|FG000|Overall Study|Non-drug related AE|3|||
48648707|NCT00294671|156566643|FG001|Overall Study|Non-drug related AE|2|||
48648708|NCT00294671|156566642|FG000|Overall Study|Lost to Follow-up|1|||
48648709|NCT00294671|156566643|FG001|Overall Study|Lost to Follow-up|3|||
48648710|NCT00294671|156566642|FG000|Overall Study|Non-compliance|1|||
48648711|NCT00294671|156566643|FG001|Overall Study|Non-compliance|0|||
48648712|NCT00294671|156566642|FG000|Overall Study|Death|0|||
48648713|NCT00294671|156566643|FG001|Overall Study|Death|1|||
48648714|NCT00456755|156566650|FG000|Overall Study|Lost to Follow-up|2|||
48648715|NCT00456755|156566651|FG001|Overall Study|Lost to Follow-up|1|||
48648716|NCT02964273|156566652|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
48648717|NCT02964273|156566653|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
48648718|NCT02964273|156566654|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
48648719|NCT02964273|156566655|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
48648720|NCT02964273|156566652|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
48648721|NCT02964273|156566653|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
48648722|NCT02964273|156566654|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
48752352|NCT01214629|156938304|FG002|Overall Study|Physician Decision|0|||
48752353|NCT01214629|156938305|FG003|Overall Study|Physician Decision|0|||
48752354|NCT01214629|156938306|FG004|Overall Study|Physician Decision|0|||
48752355|NCT01214629|156938307|FG005|Overall Study|Physician Decision|0|||
48752356|NCT01214629|156938308|FG006|Overall Study|Physician Decision|0|||
48752357|NCT01214629|156938309|FG007|Overall Study|Physician Decision|0|||
48752358|NCT01214629|156938310|FG008|Overall Study|Physician Decision|0|||
48752359|NCT01214629|156938311|FG009|Overall Study|Physician Decision|0|||
48752360|NCT01214629|156938312|FG010|Overall Study|Physician Decision|1|||
48752361|NCT01214629|156938302|FG000|Overall Study|Withdrawal by Subject|0|||
48752362|NCT01214629|156938303|FG001|Overall Study|Withdrawal by Subject|0|||
48752363|NCT01214629|156938304|FG002|Overall Study|Withdrawal by Subject|0|||
48752364|NCT01214629|156938305|FG003|Overall Study|Withdrawal by Subject|0|||
48752365|NCT01214629|156938306|FG004|Overall Study|Withdrawal by Subject|0|||
48752366|NCT01214629|156938307|FG005|Overall Study|Withdrawal by Subject|0|||
48752367|NCT01214629|156938308|FG006|Overall Study|Withdrawal by Subject|0|||
48752368|NCT01214629|156938309|FG007|Overall Study|Withdrawal by Subject|0|||
48752369|NCT01214629|156938310|FG008|Overall Study|Withdrawal by Subject|0|||
48752370|NCT01214629|156938311|FG009|Overall Study|Withdrawal by Subject|1|||
48752371|NCT01214629|156938312|FG010|Overall Study|Withdrawal by Subject|0|||
48752372|NCT00126568|156938322|FG000|Overall Study|Death|2|||
48752373|NCT04868890|156938323|FG000|Overall Study|Death|2|||
48752374|NCT04868890|156938324|FG001|Overall Study|Death|1|||
48752375|NCT04868890|156938323|FG000|Overall Study|Withdrawal by Subject|1|||
48752376|NCT04868890|156938324|FG001|Overall Study|Withdrawal by Subject|5|||
48331032|NCT01836523|155409383|FG002|Overall Study|Unclassified|19|||
48648723|NCT02964273|156566655|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
48648724|NCT02964273|156566652|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
48648725|NCT02964273|156566653|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
48752377|NCT02260921|156938325|FG000|Overall Study|Adverse Event|1|||
48752378|NCT02260921|156938326|FG001|Overall Study|Adverse Event|0|||
48752379|NCT02260921|156938325|FG000|Overall Study|Lost to Follow-up|4|||
48752380|NCT02260921|156938326|FG001|Overall Study|Lost to Follow-up|3|||
48648726|NCT02964273|156566654|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
48648727|NCT02964273|156566655|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
48648728|NCT02964273|156566652|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
48648729|NCT02964273|156566653|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
48648730|NCT02964273|156566654|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
48752381|NCT02260921|156938325|FG000|Overall Study|Withdraw Consent|4|||
48752382|NCT02260921|156938326|FG001|Overall Study|Withdraw Consent|1|||
48752383|NCT02260921|156938325|FG000|Overall Study|Death|1|||
48752384|NCT02260921|156938326|FG001|Overall Study|Death|0|||
48331033|NCT01836523|155409384|FG003|Overall Study|Unclassified|29|||
48648731|NCT02964273|156566655|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
48648732|NCT02964273|156566652|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
48331034|NCT04803734|155409385|FG000|Overall Study|Withdrawal by Subject|0|||
48331035|NCT04803734|155409386|FG001|Overall Study|Withdrawal by Subject|1|||
48648733|NCT02964273|156566653|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
48648734|NCT02964273|156566654|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
48648735|NCT02964273|156566655|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
48648736|NCT02964273|156566652|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
48648737|NCT02964273|156566653|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
48648738|NCT02964273|156566654|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
48648739|NCT02964273|156566655|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
48648740|NCT01453036|156566659|FG000|Overall Study|Lost to Follow-up|26|||
48648741|NCT01453036|156566660|FG001|Overall Study|Lost to Follow-up|115|||
48648742|NCT01453036|156566661|FG002|Overall Study|Lost to Follow-up|31|||
48648743|NCT04072835|156566662|FG000|Overall Study|Overall trial ended|603|||
48648744|NCT04072835|156566662|FG000|Overall Study|Ablation|97|||
48648745|NCT04072835|156566662|FG000|Overall Study|Withdrawal of consent|66|||
48648746|NCT04072835|156566662|FG000|Overall Study|Physician Decision|50|||
48648747|NCT04072835|156566662|FG000|Overall Study|Lost to Follow-up|39|||
48648748|NCT04072835|156566662|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
48648749|NCT04072835|156566662|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
48648750|NCT04072835|156566662|FG000|Overall Study|Adverse Event|25|||
48648751|NCT04072835|156566662|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
48648752|NCT04072835|156566662|FG000|Overall Study|Death|11|||
48648753|NCT04072835|156566662|FG000|Overall Study|Participant felt the drug did not work|8|||
48648754|NCT04072835|156566662|FG000|Overall Study|Participant tolerability|5|||
48648755|NCT04072835|156566662|FG000|Overall Study|Missing|5|||
48648756|NCT04072835|156566662|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
48648757|NCT04072835|156566662|FG000|Overall Study|Pregnancy|3|||
48648758|NCT04723355|156566663|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
48648759|NCT04723355|156566663|FG000|Overall Study|Errors in the informed consent form|2|||
48648760|NCT00620373|156566664|FG000|Overall Study|Unverified cancer status|33|||
48648761|NCT00399568|156566665|FG000|Overall Study|Adverse Event|1|||
48648762|NCT00399568|156566666|FG001|Overall Study|Adverse Event|2|||
48648763|NCT00399568|156566665|FG000|Overall Study|Withdrawal by Subject|7|||
48648764|NCT00399568|156566666|FG001|Overall Study|Withdrawal by Subject|3|||
48648765|NCT00399568|156566665|FG000|Overall Study|Protocol non-compliance|2|||
48648766|NCT00399568|156566666|FG001|Overall Study|Protocol non-compliance|2|||
48648767|NCT00399568|156566665|FG000|Overall Study|Lost to Follow-up|2|||
48648768|NCT00399568|156566666|FG001|Overall Study|Lost to Follow-up|2|||
48648769|NCT01061723|156566667|FG000|Overall Study|Adverse Event|0|||
48648770|NCT01061723|156566668|FG001|Overall Study|Adverse Event|2|||
48648771|NCT01061723|156566669|FG002|Overall Study|Adverse Event|5|||
48648772|NCT01061723|156566670|FG003|Overall Study|Adverse Event|5|||
48648773|NCT01061723|156566671|FG004|Overall Study|Adverse Event|2|||
48648774|NCT01061723|156566672|FG005|Overall Study|Adverse Event|6|||
48648775|NCT01061723|156566667|FG000|Overall Study|Lack of Efficacy|2|||
48648776|NCT01061723|156566668|FG001|Overall Study|Lack of Efficacy|3|||
48648777|NCT01061723|156566669|FG002|Overall Study|Lack of Efficacy|4|||
48648778|NCT01061723|156566670|FG003|Overall Study|Lack of Efficacy|2|||
48648779|NCT01061723|156566671|FG004|Overall Study|Lack of Efficacy|1|||
48648780|NCT01061723|156566672|FG005|Overall Study|Lack of Efficacy|1|||
48331036|NCT04803734|155409385|FG000|Overall Study|Protocol Violation|0|||
48648781|NCT01061723|156566667|FG000|Overall Study|Randomized but not treated|0|||
48648782|NCT01061723|156566668|FG001|Overall Study|Randomized but not treated|0|||
48648783|NCT01061723|156566669|FG002|Overall Study|Randomized but not treated|0|||
48648784|NCT01061723|156566670|FG003|Overall Study|Randomized but not treated|0|||
48648785|NCT01061723|156566671|FG004|Overall Study|Randomized but not treated|0|||
48648786|NCT01061723|156566672|FG005|Overall Study|Randomized but not treated|1|||
48648787|NCT01061723|156566667|FG000|Overall Study|Other than specified above|2|||
48648788|NCT01061723|156566668|FG001|Overall Study|Other than specified above|1|||
48648789|NCT01061723|156566669|FG002|Overall Study|Other than specified above|1|||
48648790|NCT01061723|156566670|FG003|Overall Study|Other than specified above|1|||
48648791|NCT01061723|156566671|FG004|Overall Study|Other than specified above|0|||
48752385|NCT02260921|156938325|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
48752386|NCT02260921|156938326|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
48331037|NCT04803734|155409386|FG001|Overall Study|Protocol Violation|1|||
48648792|NCT01061723|156566672|FG005|Overall Study|Other than specified above|1|||
48648793|NCT01498692|156566679|FG000|Overall Study|Death|4|||
48752387|NCT01244425|156938327|FG000|Overall Study|Withdrawal by Subject|2|||
48752388|NCT01244425|156938328|FG001|Overall Study|Withdrawal by Subject|2|||
48752389|NCT01244425|156938327|FG000|Overall Study|Adverse Event|1|||
48752390|NCT01244425|156938328|FG001|Overall Study|Adverse Event|1|||
48752391|NCT00867009|156938329|FG000|Induction Period|Nonserious Adverse Event|5|||
48752392|NCT00867009|156938329|FG000|Induction Period|Serious Adverse Event|10|||
48752393|NCT00867009|156938329|FG000|Induction Period|Death due to serious adverse event|6|||
48752394|NCT00867009|156938329|FG000|Induction Period|Death due to Study Disease|4|||
48752395|NCT00867009|156938329|FG000|Induction Period|Protocol Violation|1|||
48752396|NCT00867009|156938329|FG000|Induction Period|Withdrawal by Subject|8|||
48752397|NCT00867009|156938329|FG000|Induction Period|Physician Decision|3|||
48752398|NCT00867009|156938329|FG000|Induction Period|Progressive Disease (PD)|25|||
48752399|NCT00867009|156938329|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
48752400|NCT00580606|156938331|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
48752401|NCT00580606|156938332|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
48752402|NCT00580606|156938331|FG000|Open Label (OL)|Withdrawal by Subject|4|||
48752403|NCT00580606|156938332|FG001|Open Label (OL)|Withdrawal by Subject|6|||
48752404|NCT00580606|156938331|FG000|Open Label (OL)|Dosing Symptoms|0|||
48752405|NCT00580606|156938332|FG001|Open Label (OL)|Dosing Symptoms|1|||
48752406|NCT00580606|156938331|FG000|Open Label (OL)|Lost to Follow-up|0|||
48752407|NCT00580606|156938332|FG001|Open Label (OL)|Lost to Follow-up|1|||
48752408|NCT00580606|156938331|FG000|Open Label (OL)|Pregnancy|0|||
48752409|NCT00580606|156938332|FG001|Open Label (OL)|Pregnancy|1|||
48752410|NCT00580606|156938331|FG000|Open Label (OL)|Non-compliance|2|||
48752411|NCT00580606|156938332|FG001|Open Label (OL)|Non-compliance|0|||
48752412|NCT00580606|156938331|FG000|Open Label (OL)|Physician Decision|1|||
48752413|NCT00580606|156938332|FG001|Open Label (OL)|Physician Decision|1|||
48752414|NCT00580606|156938331|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
48752415|NCT00580606|156938332|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
48752416|NCT04557371|156938336|FG000|Overall Study|Covid-19-related|0|||
48752417|NCT04557371|156938337|FG001|Overall Study|Covid-19-related|1|||
48752418|NCT04557371|156938338|FG002|Overall Study|Covid-19-related|0|||
48752419|NCT04557371|156938336|FG000|Overall Study|Withdrawal by Subject|0|||
48648794|NCT01498692|156566679|FG000|Overall Study|Withdrawal by Subject|1|||
48648795|NCT01498692|156566679|FG000|Overall Study|Missed 12-month visit|3|||
48648796|NCT03050450|156566680|FG000|Overall Study|Physician Decision|1|||
48648797|NCT03050450|156566681|FG001|Overall Study|Physician Decision|0|||
48648798|NCT03050450|156566682|FG002|Overall Study|Physician Decision|0|||
48648799|NCT03050450|156566683|FG003|Overall Study|Physician Decision|0|||
48648800|NCT03050450|156566684|FG004|Overall Study|Physician Decision|0|||
48648801|NCT01642901|156566688|FG000|12-month Follow-up|Withdrawal by Subject|1|||
48648802|NCT01642901|156566689|FG001|12-month Follow-up|Withdrawal by Subject|0|||
48648803|NCT03592771|156566690|FG000|Overall Study|Adverse Event|2|||
48648804|NCT03592771|156566691|FG001|Overall Study|Adverse Event|0|||
48648805|NCT03592771|156566692|FG002|Overall Study|Adverse Event|1|||
48648806|NCT03592771|156566690|FG000|Overall Study|Death|0|||
48648807|NCT03592771|156566691|FG001|Overall Study|Death|1|||
48648808|NCT03592771|156566692|FG002|Overall Study|Death|1|||
48648809|NCT03592771|156566690|FG000|Overall Study|Lost to Follow-up|5|||
48648810|NCT03592771|156566691|FG001|Overall Study|Lost to Follow-up|11|||
48648811|NCT03592771|156566692|FG002|Overall Study|Lost to Follow-up|15|||
48648812|NCT03592771|156566690|FG000|Overall Study|Withdrawal by Subject|0|||
48648813|NCT03592771|156566691|FG001|Overall Study|Withdrawal by Subject|2|||
48648814|NCT03592771|156566692|FG002|Overall Study|Withdrawal by Subject|0|||
48648815|NCT02943070|156566693|FG000|Overall Study|Physician Decision|1|||
48648816|NCT02943070|156566693|FG000|Overall Study|Adverse Event|2|||
48648817|NCT02943070|156566693|FG000|Overall Study|Death|2|||
48648818|NCT02943070|156566693|FG000|Overall Study|Withdrawal by Subject|3|||
48648819|NCT02943070|156566693|FG000|Overall Study|Lost to Follow-up|4|||
48648820|NCT02943070|156566693|FG000|Overall Study|Retreatment or TURP|13|||
48648821|NCT02943070|156566693|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
48648822|NCT03198767|156566694|FG000|Overall Study|Protocol Violation|0|||
48648823|NCT03198767|156566695|FG001|Overall Study|Protocol Violation|0|||
48648824|NCT03198767|156566696|FG002|Overall Study|Protocol Violation|0|||
48648825|NCT03198767|156566697|FG003|Overall Study|Protocol Violation|6|||
48648826|NCT03198767|156566698|FG004|Overall Study|Protocol Violation|0|||
48752420|NCT04557371|156938337|FG001|Overall Study|Withdrawal by Subject|1|||
48752421|NCT04557371|156938338|FG002|Overall Study|Withdrawal by Subject|0|||
48648827|NCT03198767|156566699|FG005|Overall Study|Protocol Violation|0|||
48752422|NCT04557371|156938336|FG000|Overall Study|Adverse Event|1|||
48752423|NCT04557371|156938337|FG001|Overall Study|Adverse Event|0|||
48752424|NCT04557371|156938338|FG002|Overall Study|Adverse Event|0|||
48648828|NCT03198767|156566700|FG006|Overall Study|Protocol Violation|0|||
48752425|NCT04140292|156938341|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
48752426|NCT04140292|156938342|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
48752427|NCT03715764|156938343|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
48752428|NCT03715764|156938344|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
48752429|NCT03715764|156938343|FG000|3 Month Follow-up|Lost to Follow-up|2|||
48752430|NCT03715764|156938344|FG001|3 Month Follow-up|Lost to Follow-up|2|||
48752431|NCT03715764|156938343|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
48752432|NCT03715764|156938344|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
48752433|NCT03715764|156938343|FG000|6 Month Follow-up|Lost to Follow-up|3|||
48752434|NCT03715764|156938344|FG001|6 Month Follow-up|Lost to Follow-up|0|||
48752435|NCT03715764|156938343|FG000|12 Month Follow-up|Lost to Follow-up|2|||
48752436|NCT03715764|156938344|FG001|12 Month Follow-up|Lost to Follow-up|3|||
48752437|NCT03715764|156938343|FG000|12 Month Follow-up|Pregnancy|0|||
48752438|NCT03715764|156938344|FG001|12 Month Follow-up|Pregnancy|1|||
48752439|NCT03715764|156938343|FG000|12 Month Follow-up|Surgery|2|||
48752440|NCT03715764|156938344|FG001|12 Month Follow-up|Surgery|0|||
48752441|NCT03715764|156938343|FG000|12 Month Follow-up|Wrong address|1|||
48331038|NCT01005602|155409387|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
48331039|NCT01005602|155409388|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
48648829|NCT04551963|156566701|FG000|Overall Study|Physician Decision|1|||
48648830|NCT04551963|156566702|FG001|Overall Study|Physician Decision|1|||
48648831|NCT04551963|156566701|FG000|Overall Study|Death|1|||
48648832|NCT04551963|156566702|FG001|Overall Study|Death|0|||
48648833|NCT03332173|156566703|FG000|Overall Study|Death|7|||
48648834|NCT03332173|156566703|FG000|Overall Study|Withdrawal by Subject|6|||
48648835|NCT03332173|156566703|FG000|Overall Study|Lost to Follow-up|2|||
48648836|NCT03332173|156566703|FG000|Overall Study|Transferred to long-term extension study|29|||
48648837|NCT00910910|156566704|FG000|Overall Study|Adverse Event|63|||
48648838|NCT00910910|156566705|FG001|Overall Study|Adverse Event|35|||
48648839|NCT00910910|156566704|FG000|Overall Study|PD without histologic change|27|||
48648840|NCT00910910|156566705|FG001|Overall Study|PD without histologic change|23|||
48648841|NCT00910910|156566704|FG000|Overall Study|PD with histologic change|0|||
48648842|NCT00910910|156566705|FG001|Overall Study|PD with histologic change|2|||
48648843|NCT00910910|156566704|FG000|Overall Study|Withdrawal by Subject|7|||
48648844|NCT00910910|156566705|FG001|Overall Study|Withdrawal by Subject|5|||
48648845|NCT00910910|156566704|FG000|Overall Study|Lost to Follow-up|2|||
48648846|NCT00910910|156566705|FG001|Overall Study|Lost to Follow-up|2|||
48648847|NCT00910910|156566704|FG000|Overall Study|Death|9|||
48648848|NCT00910910|156566705|FG001|Overall Study|Death|3|||
48648849|NCT00910910|156566704|FG000|Overall Study|Protocol Violation|2|||
48648850|NCT00910910|156566705|FG001|Overall Study|Protocol Violation|2|||
48648851|NCT00910910|156566704|FG000|Overall Study|Completed 13 cycles of treatment|0|||
48648852|NCT00910910|156566705|FG001|Overall Study|Completed 13 cycles of treatment|118|||
48648853|NCT00910910|156566704|FG000|Overall Study|Other|114|||
48648854|NCT00910910|156566705|FG001|Overall Study|Other|32|||
48648855|NCT00910910|156566704|FG000|Overall Study|Untreated before cycle 1|1|||
48648856|NCT00910910|156566705|FG001|Overall Study|Untreated before cycle 1|2|||
48648857|NCT00758069|156566713|FG000|Overall Study|Lack of Efficacy|0|||
48648858|NCT00758069|156566714|FG001|Overall Study|Lack of Efficacy|0|||
48648859|NCT00758069|156566715|FG002|Overall Study|Lack of Efficacy|1|||
48752442|NCT03715764|156938344|FG001|12 Month Follow-up|Wrong address|0|||
48331040|NCT00195819|155409391|FG000|Double-Blind|Withdrawal by Subject|1|||
48752443|NCT03715764|156938343|FG000|12 Month Follow-up|No symptoms|1|||
48752444|NCT03715764|156938344|FG001|12 Month Follow-up|No symptoms|0|||
48752445|NCT03715764|156938343|FG000|12 Month Follow-up|Changed primary care centre|0|||
48331041|NCT00195819|155409392|FG001|Double-Blind|Withdrawal by Subject|0|||
48331042|NCT00195819|155409391|FG000|Double-Blind|Moved|1|||
48331043|NCT00195819|155409392|FG001|Double-Blind|Moved|0|||
48648860|NCT00758069|156566713|FG000|Overall Study|Incorrect Study Drug|1|||
48648861|NCT00758069|156566714|FG001|Overall Study|Incorrect Study Drug|0|||
48648862|NCT00758069|156566715|FG002|Overall Study|Incorrect Study Drug|0|||
48648863|NCT03275246|156566716|FG000|Overall Study|Protocol Violation|5|||
48752446|NCT03715764|156938344|FG001|12 Month Follow-up|Changed primary care centre|1|||
48752447|NCT00434330|156938345|FG000|Overall Study|Adverse Event|0|||
48752448|NCT00434330|156938346|FG001|Overall Study|Adverse Event|0|||
48752449|NCT00434330|156938347|FG002|Overall Study|Adverse Event|1|||
48331044|NCT00195819|155409391|FG000|Open-label|Adverse Event|0|||
48331045|NCT00195819|155409392|FG001|Open-label|Adverse Event|9|||
48648864|NCT03275246|156566716|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
48648865|NCT05059301|156566717|FG000|Overall Study|Adverse Event|0|||
48648866|NCT05059301|156566718|FG001|Overall Study|Adverse Event|2|||
48648867|NCT05059301|156566719|FG002|Overall Study|Adverse Event|2|||
48648868|NCT05059301|156566717|FG000|Overall Study|Lost to Follow-up|2|||
48648869|NCT05059301|156566718|FG001|Overall Study|Lost to Follow-up|3|||
48648870|NCT05059301|156566719|FG002|Overall Study|Lost to Follow-up|3|||
48648871|NCT00635349|156566720|FG000|Overall Study|Other|8|||
48648872|NCT00635349|156566721|FG001|Overall Study|Other|6|||
48648873|NCT00635349|156566720|FG000|Overall Study|Protocol Violation|18|||
48648874|NCT00635349|156566721|FG001|Overall Study|Protocol Violation|22|||
48648875|NCT00635349|156566720|FG000|Overall Study|Withdrawal by Subject|3|||
48648876|NCT00635349|156566721|FG001|Overall Study|Withdrawal by Subject|8|||
48648877|NCT00635349|156566720|FG000|Overall Study|Lost to Follow-up|4|||
48648878|NCT00635349|156566721|FG001|Overall Study|Lost to Follow-up|3|||
48648879|NCT00635349|156566720|FG000|Overall Study|Adverse Event|11|||
48648880|NCT00635349|156566721|FG001|Overall Study|Adverse Event|9|||
48648881|NCT03748706|156566728|FG000|Overall Study|Lost to Follow-up|1|||
48648882|NCT01345929|156566729|FG000|Overall Study|Withdrawal by Subject|9|||
48648883|NCT01345929|156566730|FG001|Overall Study|Withdrawal by Subject|8|||
48648884|NCT01345929|156566729|FG000|Overall Study|Lost to Follow-up|9|||
48648885|NCT01345929|156566730|FG001|Overall Study|Lost to Follow-up|9|||
48648886|NCT01345929|156566729|FG000|Overall Study|Adverse Event|0|||
48648887|NCT01345929|156566730|FG001|Overall Study|Adverse Event|1|||
48648888|NCT01345929|156566729|FG000|Overall Study|Didn't meet eligibility criteria|2|||
48648889|NCT01345929|156566730|FG001|Overall Study|Didn't meet eligibility criteria|0|||
48648890|NCT01345929|156566729|FG000|Overall Study|40,000 CFU/ML|1|||
48648891|NCT01345929|156566730|FG001|Overall Study|40,000 CFU/ML|0|||
48648892|NCT01345929|156566729|FG000|Overall Study|Patient withdrawal|0|||
48648893|NCT01345929|156566730|FG001|Overall Study|Patient withdrawal|1|||
48648894|NCT04482439|156566735|FG000|Overall Study|Lost to Follow-up|1|||
48648895|NCT04482439|156566735|FG000|Overall Study|Unrelated illness|1|||
48648896|NCT00402324|156566736|FG000|Overall Study|Lost to Follow-up|11|||
48648897|NCT00402324|156566737|FG001|Overall Study|Lost to Follow-up|11|||
48648898|NCT00402324|156566736|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
48648899|NCT00402324|156566737|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
48648900|NCT00402324|156566736|FG000|Overall Study|Protocol Violation|8|||
48648901|NCT00402324|156566737|FG001|Overall Study|Protocol Violation|7|||
48648902|NCT00402324|156566736|FG000|Overall Study|Withdrawal by Subject|5|||
48648903|NCT00402324|156566737|FG001|Overall Study|Withdrawal by Subject|2|||
48648904|NCT00402324|156566736|FG000|Overall Study|Physician Decision|2|||
48648905|NCT00402324|156566737|FG001|Overall Study|Physician Decision|4|||
48648906|NCT00402324|156566736|FG000|Overall Study|Sponsor Decision|4|||
48648907|NCT00402324|156566737|FG001|Overall Study|Sponsor Decision|5|||
48648908|NCT00402324|156566736|FG000|Overall Study|Lack of Efficacy|1|||
48648909|NCT00402324|156566737|FG001|Overall Study|Lack of Efficacy|4|||
48331046|NCT00195819|155409391|FG000|Open-label|Lack of Efficacy|0|||
48331047|NCT00195819|155409392|FG001|Open-label|Lack of Efficacy|2|||
48331048|NCT00195819|155409391|FG000|Open-label|Pregnancy|0|||
48331049|NCT00195819|155409392|FG001|Open-label|Pregnancy|1|||
48331050|NCT00195819|155409391|FG000|Open-label|Protocol Violation|0|||
48331051|NCT00195819|155409392|FG001|Open-label|Protocol Violation|2|||
48331052|NCT00195819|155409391|FG000|Open-label|Moved|0|||
48331053|NCT00195819|155409392|FG001|Open-label|Moved|1|||
48331054|NCT00195819|155409391|FG000|Open-label|Withdrawal by Subject|0|||
48331055|NCT00195819|155409392|FG001|Open-label|Withdrawal by Subject|5|||
48331056|NCT01858688|155409393|FG000|Overall Study|Withdrawal by Subject|8|||
48331057|NCT01858688|155409393|FG000|Overall Study|Participant began another therapy|3|||
48331058|NCT01858688|155409393|FG000|Overall Study|Physician Decision|2|||
48331059|NCT01858688|155409393|FG000|Overall Study|Progressive Disease|2|||
48331060|NCT01858688|155409393|FG000|Overall Study|Reason not reproted|5|||
48331061|NCT01999335|155409394|FG000|Overall Study|Discontinued before receiving treatment|0|||
48331062|NCT01999335|155409395|FG001|Overall Study|Discontinued before receiving treatment|0|||
48331063|NCT01999335|155409396|FG002|Overall Study|Discontinued before receiving treatment|0|||
48331064|NCT01999335|155409397|FG003|Overall Study|Discontinued before receiving treatment|0|||
48331065|NCT01999335|155409398|FG004|Overall Study|Discontinued before receiving treatment|2|||
48331066|NCT04410445|155409399|FG000|Overall Study|Lost to Follow-up|3|||
48331067|NCT04410445|155409400|FG001|Overall Study|Lost to Follow-up|9|||
48331068|NCT04410445|155409399|FG000|Overall Study|Withdrawal by Subject|27|||
48331069|NCT04410445|155409400|FG001|Overall Study|Withdrawal by Subject|15|||
48648910|NCT00402324|156566736|FG000|Overall Study|Adverse Event|6|||
48648911|NCT00402324|156566737|FG001|Overall Study|Adverse Event|4|||
48648912|NCT00402324|156566736|FG000|Overall Study|Death|1|||
48648913|NCT00402324|156566737|FG001|Overall Study|Death|0|||
48331070|NCT04361617|155409401|FG000|Overall Study|Withdrawal by Subject|0|||
48331071|NCT04361617|155409402|FG001|Overall Study|Withdrawal by Subject|1|||
48331072|NCT01918033|155409403|FG000|Overall Study|Adverse Event|1|||
48648914|NCT01823198|156566738|FG000|Overall Study|Physician Decision|0|||
48331073|NCT01918033|155409404|FG001|Overall Study|Adverse Event|0|||
48331074|NCT01918033|155409405|FG002|Overall Study|Adverse Event|2|||
48648915|NCT01823198|156566739|FG001|Overall Study|Physician Decision|1|||
48648916|NCT01823198|156566740|FG002|Overall Study|Physician Decision|0|||
48648917|NCT01823198|156566741|FG003|Overall Study|Physician Decision|0|||
48648918|NCT01823198|156566742|FG004|Overall Study|Physician Decision|0|||
48648919|NCT01823198|156566743|FG005|Overall Study|Physician Decision|3|||
48648920|NCT01823198|156566744|FG006|Overall Study|Physician Decision|3|||
48648921|NCT02674464|156566745|FG000|Overall Study|Death|10|||
48752450|NCT00434330|156938348|FG003|Overall Study|Adverse Event|0|||
48752451|NCT00434330|156938349|FG004|Overall Study|Adverse Event|0|||
48752452|NCT00434330|156938350|FG005|Overall Study|Adverse Event|0|||
48752453|NCT00434330|156938345|FG000|Overall Study|Death|1|||
48752454|NCT00434330|156938346|FG001|Overall Study|Death|0|||
48752455|NCT00434330|156938347|FG002|Overall Study|Death|0|||
48752456|NCT00434330|156938348|FG003|Overall Study|Death|0|||
48331075|NCT01918033|155409403|FG000|Overall Study|Lost to Follow-up|0|||
48331076|NCT01918033|155409404|FG001|Overall Study|Lost to Follow-up|1|||
48331077|NCT01918033|155409405|FG002|Overall Study|Lost to Follow-up|0|||
48331078|NCT01918033|155409403|FG000|Overall Study|Protocol Violation|2|||
48331079|NCT01918033|155409404|FG001|Overall Study|Protocol Violation|0|||
48331080|NCT01918033|155409405|FG002|Overall Study|Protocol Violation|1|||
48331081|NCT01918033|155409403|FG000|Overall Study|Withdrawal by Subject|2|||
48331082|NCT01918033|155409404|FG001|Overall Study|Withdrawal by Subject|1|||
48331083|NCT01918033|155409405|FG002|Overall Study|Withdrawal by Subject|0|||
48331084|NCT03132636|155409408|FG000|Overall Study|Adverse Event|1|||
48331085|NCT03132636|155409409|FG001|Overall Study|Adverse Event|2|||
48331086|NCT03132636|155409408|FG000|Overall Study|Death|4|||
48331087|NCT03132636|155409409|FG001|Overall Study|Death|7|||
48331088|NCT03132636|155409408|FG000|Overall Study|Lost to Follow-up|3|||
48331089|NCT03132636|155409409|FG001|Overall Study|Lost to Follow-up|2|||
48331090|NCT03132636|155409408|FG000|Overall Study|Non compliance with protocol by participant|1|||
48331091|NCT03132636|155409409|FG001|Overall Study|Non compliance with protocol by participant|1|||
48331092|NCT03132636|155409408|FG000|Overall Study|Subject decision|1|||
48331093|NCT03132636|155409409|FG001|Overall Study|Subject decision|9|||
48648922|NCT02674464|156566746|FG001|Overall Study|Death|21|||
48648923|NCT02674464|156566745|FG000|Overall Study|Withdrawal by Subject|24|||
48648924|NCT02674464|156566746|FG001|Overall Study|Withdrawal by Subject|44|||
48648925|NCT02674464|156566745|FG000|Overall Study|Lost to Follow-up|97|||
48648926|NCT02674464|156566746|FG001|Overall Study|Lost to Follow-up|92|||
48648927|NCT02674464|156566745|FG000|Overall Study|Outside survey window|6|||
48648928|NCT02674464|156566746|FG001|Overall Study|Outside survey window|3|||
48648929|NCT04153981|156566747|FG000|Overall Study|Death|1|||
48648930|NCT04153981|156566747|FG000|Overall Study|Withdrawal by Subject|24|||
48648931|NCT04153981|156566747|FG000|Overall Study|Lost to Follow-up|1|||
48648932|NCT04153981|156566747|FG000|Overall Study|Physician Decision|1|||
48648933|NCT04153981|156566747|FG000|Overall Study|Due to Unavailable Glucometer|1|||
48648934|NCT04153981|156566747|FG000|Overall Study|Covid 19|52|||
48648935|NCT04153981|156566747|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
48648936|NCT04153981|156566747|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
48648937|NCT00783835|156566748|FG000|Overall Study|Adverse Event|3|||
48648938|NCT00783835|156566748|FG000|Overall Study|Medical Criteria|1|||
48648939|NCT00783835|156566748|FG000|Overall Study|Withdrawal by Subject|2|||
48648940|NCT00783835|156566748|FG000|Overall Study|Lost to Follow-up|1|||
48648941|NCT00783835|156566748|FG000|Overall Study|Participant not Adherent|3|||
48648942|NCT01500252|156566750|FG000|Overall Study|Death|4|||
48648943|NCT01500252|156566751|FG001|Overall Study|Death|2|||
48648944|NCT01500252|156566750|FG000|Overall Study|Lost to Follow-up|5|||
48331094|NCT03132636|155409408|FG000|Overall Study|Sponsor decision|0|||
48331095|NCT03132636|155409409|FG001|Overall Study|Sponsor decision|1|||
48648945|NCT01500252|156566751|FG001|Overall Study|Lost to Follow-up|4|||
48648946|NCT02466425|156566754|FG000|Overall Study|Adverse Event|3|||
48648947|NCT02466425|156566755|FG001|Overall Study|Adverse Event|11|||
48648948|NCT02466425|156566754|FG000|Overall Study|Lack of Efficacy|4|||
48648949|NCT02466425|156566755|FG001|Overall Study|Lack of Efficacy|1|||
48648950|NCT02466425|156566754|FG000|Overall Study|Lost to Follow-up|3|||
48331096|NCT03132636|155409408|FG000|Overall Study|Physician Decision|1|||
48331097|NCT03132636|155409409|FG001|Overall Study|Physician Decision|0|||
48331098|NCT03132636|155409408|FG000|Overall Study|Progressive disease|33|||
48331099|NCT03132636|155409409|FG001|Overall Study|Progressive disease|36|||
48648951|NCT02466425|156566755|FG001|Overall Study|Lost to Follow-up|0|||
48648952|NCT02466425|156566754|FG000|Overall Study|Protocol Violation|1|||
48648953|NCT02466425|156566755|FG001|Overall Study|Protocol Violation|0|||
48648954|NCT02466425|156566754|FG000|Overall Study|Withdrawal by Subject|0|||
48648955|NCT02466425|156566755|FG001|Overall Study|Withdrawal by Subject|1|||
48648956|NCT02466425|156566754|FG000|Overall Study|Other|1|||
48331100|NCT03132636|155409408|FG000|Overall Study|Withdrawal of consent|2|||
48331101|NCT03132636|155409409|FG001|Overall Study|Withdrawal of consent|5|||
48752457|NCT00434330|156938349|FG004|Overall Study|Death|1|||
48752458|NCT00434330|156938350|FG005|Overall Study|Death|1|||
48331102|NCT03132636|155409408|FG000|Overall Study|Did not re-consent|1|||
48331103|NCT03132636|155409409|FG001|Overall Study|Did not re-consent|0|||
48648957|NCT02466425|156566755|FG001|Overall Study|Other|3|||
48648958|NCT02466425|156566754|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
48648959|NCT02466425|156566755|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48648960|NCT03835481|156566760|FG000|Double-blind Period|Other not stated below|0|||
48648961|NCT03835481|156566761|FG001|Double-blind Period|Other not stated below|0|||
48752459|NCT00434330|156938345|FG000|Overall Study|Withdrawal by Subject|0|||
48331104|NCT03132636|155409408|FG000|Overall Study|Lost insurance coverage|1|||
48331105|NCT03132636|155409409|FG001|Overall Study|Lost insurance coverage|0|||
48331106|NCT03132636|155409408|FG000|Overall Study|Related to radiological outcomes|0|||
48331107|NCT03132636|155409409|FG001|Overall Study|Related to radiological outcomes|1|||
48331108|NCT03132636|155409408|FG000|Overall Study|Unable to come to site for continued visits|0|||
48331109|NCT03132636|155409409|FG001|Overall Study|Unable to come to site for continued visits|1|||
48331110|NCT03006393|155409410|FG000|Overall Study|Withdrawal by Subject|1|||
48331111|NCT03006393|155409411|FG001|Overall Study|Withdrawal by Subject|1|||
48331112|NCT03006393|155409410|FG000|Overall Study|Pregnancy|0|||
48331113|NCT03006393|155409411|FG001|Overall Study|Pregnancy|1|||
48331114|NCT03006393|155409410|FG000|Overall Study|Lost to Follow-up|0|||
48331115|NCT03006393|155409411|FG001|Overall Study|Lost to Follow-up|1|||
48331116|NCT00807599|155409413|FG000|Overall Study|Not treated on protocol study|0|||
48331117|NCT00807599|155409414|FG001|Overall Study|Not treated on protocol study|0|||
48331118|NCT00807599|155409415|FG002|Overall Study|Not treated on protocol study|2|||
48331119|NCT00807599|155409413|FG000|Overall Study|Adverse Event|0|||
48331120|NCT00807599|155409414|FG001|Overall Study|Adverse Event|0|||
48331121|NCT00807599|155409415|FG002|Overall Study|Adverse Event|5|||
48331122|NCT00807599|155409413|FG000|Overall Study|Inadequate response to induction|0|||
48331123|NCT00807599|155409414|FG001|Overall Study|Inadequate response to induction|0|||
48331124|NCT00807599|155409415|FG002|Overall Study|Inadequate response to induction|9|||
48331125|NCT00807599|155409413|FG000|Overall Study|Withdrawal by Subject|0|||
48331126|NCT00807599|155409414|FG001|Overall Study|Withdrawal by Subject|0|||
48331127|NCT00807599|155409415|FG002|Overall Study|Withdrawal by Subject|1|||
48331128|NCT02137785|155409416|FG000|Overall Study|Lost to Follow-up|1|||
48331129|NCT02137785|155409417|FG001|Overall Study|Lost to Follow-up|0|||
48331130|NCT02137785|155409416|FG000|Overall Study|Withdrawal by Subject|1|||
48331131|NCT02137785|155409417|FG001|Overall Study|Withdrawal by Subject|4|||
48331132|NCT02137785|155409416|FG000|Overall Study|subject moved out of state|1|||
48331133|NCT02137785|155409417|FG001|Overall Study|subject moved out of state|0|||
48648962|NCT03835481|156566762|FG002|Double-blind Period|Other not stated below|0|||
48648963|NCT03835481|156566763|FG003|Double-blind Period|Other not stated below|1|||
48648964|NCT03835481|156566764|FG004|Double-blind Period|Other not stated below|1|||
48648965|NCT03835481|156566760|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
48331134|NCT03042767|155409418|FG000|Overall Study|Lost to Follow-up|1|||
48331135|NCT03042767|155409419|FG001|Overall Study|Lost to Follow-up|2|||
48331136|NCT03146845|155409420|FG000|Overall Study|Reference ulcer healed|1|||
48331137|NCT03146845|155409421|FG001|Overall Study|Reference ulcer healed|0|||
48331138|NCT03146845|155409420|FG000|Overall Study|Physician Decision|1|||
48331139|NCT03146845|155409421|FG001|Overall Study|Physician Decision|0|||
48331140|NCT03146845|155409420|FG000|Overall Study|Adverse Event|1|||
48331141|NCT03146845|155409421|FG001|Overall Study|Adverse Event|0|||
48331142|NCT03146845|155409420|FG000|Overall Study|Withdrawal by Subject|2|||
48331143|NCT03146845|155409421|FG001|Overall Study|Withdrawal by Subject|0|||
48331144|NCT03146845|155409420|FG000|Overall Study|Noncompliance|0|||
48331145|NCT03146845|155409421|FG001|Overall Study|Noncompliance|1|||
48331146|NCT03146845|155409420|FG000|Overall Study|Protocol Violation|0|||
48331147|NCT03146845|155409421|FG001|Overall Study|Protocol Violation|2|||
48331148|NCT03146845|155409420|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
48331149|NCT03146845|155409421|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
48331150|NCT00721734|155409422|FG000|Overall Study|Progressive Disease|3|||
48331151|NCT00721734|155409423|FG001|Overall Study|Progressive Disease|10|||
48648966|NCT03835481|156566761|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
48648967|NCT03835481|156566762|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
48648968|NCT03835481|156566763|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
48648969|NCT03835481|156566764|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
48648970|NCT03835481|156566760|FG000|Double-blind Period|Withdrawal by Subject|0|||
48648971|NCT03835481|156566761|FG001|Double-blind Period|Withdrawal by Subject|0|||
48648972|NCT03835481|156566762|FG002|Double-blind Period|Withdrawal by Subject|1|||
48648973|NCT03835481|156566763|FG003|Double-blind Period|Withdrawal by Subject|0|||
48648974|NCT03835481|156566764|FG004|Double-blind Period|Withdrawal by Subject|5|||
48648975|NCT03835481|156566760|FG000|Double-blind Period|Lost to Follow-up|0|||
48648976|NCT03835481|156566761|FG001|Double-blind Period|Lost to Follow-up|0|||
48648977|NCT03835481|156566762|FG002|Double-blind Period|Lost to Follow-up|0|||
48648978|NCT03835481|156566763|FG003|Double-blind Period|Lost to Follow-up|1|||
48648979|NCT03835481|156566764|FG004|Double-blind Period|Lost to Follow-up|0|||
48648980|NCT03835481|156566760|FG000|Double-blind Period|Protocol Violation|0|||
48648981|NCT03835481|156566761|FG001|Double-blind Period|Protocol Violation|2|||
48648982|NCT03835481|156566762|FG002|Double-blind Period|Protocol Violation|0|||
48648983|NCT03835481|156566763|FG003|Double-blind Period|Protocol Violation|1|||
48331152|NCT00721734|155409424|FG002|Overall Study|Progressive Disease|4|||
48331153|NCT00721734|155409425|FG003|Overall Study|Progressive Disease|5|||
48648984|NCT03835481|156566764|FG004|Double-blind Period|Protocol Violation|0|||
48648985|NCT03835481|156566760|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
48648986|NCT03835481|156566761|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
48648987|NCT03835481|156566762|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
48648988|NCT03835481|156566763|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
48648989|NCT03835481|156566764|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
48648990|NCT03835481|156566760|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
48648991|NCT03835481|156566761|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
48648992|NCT03835481|156566762|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
48648993|NCT03835481|156566763|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
48648994|NCT03835481|156566764|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
48648995|NCT03835481|156566760|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
48648996|NCT03835481|156566761|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
48648997|NCT03835481|156566762|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
48648998|NCT03835481|156566763|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
48648999|NCT03835481|156566764|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
48649000|NCT03835481|156566760|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
48649001|NCT03835481|156566761|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
48649002|NCT03835481|156566762|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
48649003|NCT03835481|156566763|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
48649004|NCT03835481|156566764|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
48649005|NCT03835481|156566760|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
48649006|NCT03835481|156566761|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
48649007|NCT03835481|156566762|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
48649008|NCT03835481|156566763|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
48649009|NCT03835481|156566764|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
48649010|NCT03835481|156566760|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
48649011|NCT03835481|156566761|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
48649012|NCT03835481|156566762|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
48649013|NCT03835481|156566763|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
48649014|NCT03835481|156566764|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
48649015|NCT01221753|156566765|FG000|Overall Study|Adverse Event|1|||
48649016|NCT01673854|156566766|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
48649017|NCT01673854|156566766|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
48649018|NCT01673854|156566766|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
48649019|NCT01673854|156566766|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
48649020|NCT01673854|156566766|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
48649021|NCT01673854|156566766|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
48649022|NCT01673854|156566766|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
48649023|NCT01673854|156566766|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
48649024|NCT01673854|156566766|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
48649025|NCT01673854|156566766|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
48649026|NCT01673854|156566766|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
48649027|NCT01673854|156566766|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
48649028|NCT01336712|156568143|FG000|Overall Study|Death|2|||
48649029|NCT01336712|156568143|FG000|Overall Study|Lack of Efficacy|1|||
48649030|NCT00958360|156568145|FG000|Overall Study|Withdrawal by Subject|3|||
48649031|NCT00958360|156568146|FG001|Overall Study|Withdrawal by Subject|1|||
48649032|NCT00958360|156568145|FG000|Overall Study|Death|6|||
48649033|NCT00958360|156568146|FG001|Overall Study|Death|7|||
48649034|NCT00958360|156568145|FG000|Overall Study|Physician Decision|2|||
48649035|NCT00958360|156568146|FG001|Overall Study|Physician Decision|1|||
48649036|NCT00958360|156568145|FG000|Overall Study|Lost to Follow-up|0|||
48649037|NCT00958360|156568146|FG001|Overall Study|Lost to Follow-up|1|||
48649038|NCT00841776|156568147|FG000|Overall Study|Lack of Efficacy|0|||
48331154|NCT00721734|155409426|FG004|Overall Study|Progressive Disease|2|||
48331155|NCT00721734|155409422|FG000|Overall Study|Adverse Event|3|||
48331156|NCT00721734|155409423|FG001|Overall Study|Adverse Event|1|||
48331157|NCT00721734|155409424|FG002|Overall Study|Adverse Event|4|||
48331158|NCT00721734|155409425|FG003|Overall Study|Adverse Event|0|||
48331159|NCT00721734|155409426|FG004|Overall Study|Adverse Event|3|||
48331160|NCT00721734|155409422|FG000|Overall Study|Withdrawal by Subject|2|||
48331161|NCT00721734|155409423|FG001|Overall Study|Withdrawal by Subject|1|||
48331162|NCT00721734|155409424|FG002|Overall Study|Withdrawal by Subject|0|||
48331163|NCT00721734|155409425|FG003|Overall Study|Withdrawal by Subject|0|||
48331164|NCT00721734|155409426|FG004|Overall Study|Withdrawal by Subject|1|||
48331165|NCT00721734|155409422|FG000|Overall Study|Other|0|||
48331166|NCT00721734|155409423|FG001|Overall Study|Other|0|||
48331167|NCT00721734|155409424|FG002|Overall Study|Other|0|||
48331168|NCT00721734|155409425|FG003|Overall Study|Other|1|||
48331169|NCT00721734|155409426|FG004|Overall Study|Other|0|||
48331170|NCT03200574|155409427|FG000|Overall Study|Death|4|||
48331171|NCT03200574|155409427|FG000|Overall Study|Withdrawal by Subject|8|||
48331172|NCT03200574|155409427|FG000|Overall Study|Long-Term need for anticoagulation|1|||
48331173|NCT03200574|155409427|FG000|Overall Study|Relocation|2|||
48331174|NCT03200574|155409427|FG000|Overall Study|Lost to Follow-up|2|||
48331175|NCT03026166|155409428|FG000|Overall Study|Death|22|||
48331176|NCT03026166|155409429|FG001|Overall Study|Death|7|||
48331177|NCT03026166|155409428|FG000|Overall Study|Physician Decision|2|||
48331178|NCT03026166|155409429|FG001|Overall Study|Physician Decision|0|||
48331179|NCT03026166|155409428|FG000|Overall Study|Withdrawal by Subject|1|||
48331180|NCT03026166|155409429|FG001|Overall Study|Withdrawal by Subject|2|||
48331181|NCT03026166|155409428|FG000|Overall Study|Lost to Follow-up|1|||
48649039|NCT00841776|156568148|FG001|Overall Study|Lack of Efficacy|1|||
48331182|NCT03026166|155409429|FG001|Overall Study|Lost to Follow-up|0|||
48331183|NCT03026166|155409428|FG000|Overall Study|Study Terminated by Sponsor|3|||
48331184|NCT03026166|155409429|FG001|Overall Study|Study Terminated by Sponsor|3|||
48331185|NCT03026166|155409428|FG000|Overall Study|Other|1|||
48331186|NCT03026166|155409429|FG001|Overall Study|Other|0|||
48331187|NCT03938272|155409430|FG000|Overall Study|Withdrawal by Subject|1|||
48331188|NCT03938272|155409431|FG001|Overall Study|Withdrawal by Subject|0|||
48331189|NCT03938272|155409430|FG000|Overall Study|Physician Decision|0|||
48331190|NCT03938272|155409431|FG001|Overall Study|Physician Decision|2|||
48331191|NCT03938272|155409430|FG000|Overall Study|Study termination by sponsor|10|||
48331192|NCT03938272|155409431|FG001|Overall Study|Study termination by sponsor|8|||
48331193|NCT02991456|155409434|FG000|Overall Study|Adverse Event|2|||
48649040|NCT00841776|156568147|FG000|Overall Study|Lost to Follow-up|2|||
48649041|NCT00841776|156568148|FG001|Overall Study|Lost to Follow-up|1|||
48649042|NCT00841776|156568147|FG000|Overall Study|Withdrawal by Subject|0|||
48649043|NCT00841776|156568148|FG001|Overall Study|Withdrawal by Subject|1|||
48649044|NCT00933608|156568149|FG000|Overall Study|Adverse Event|4|||
48649045|NCT00933608|156568150|FG001|Overall Study|Adverse Event|2|||
48649046|NCT00933608|156568149|FG000|Overall Study|Physician Decision|1|||
48649047|NCT00933608|156568150|FG001|Overall Study|Physician Decision|0|||
48649048|NCT01701362|156568151|FG000|Overall Study|Adverse events not related to study drug|1|||
48649049|NCT01701362|156568152|FG001|Overall Study|Adverse events not related to study drug|6|||
48649050|NCT01701362|156568151|FG000|Overall Study|Adverse events related to study drug|12|||
48649051|NCT01701362|156568152|FG001|Overall Study|Adverse events related to study drug|10|||
48649052|NCT01701362|156568151|FG000|Overall Study|Protocol Violation|5|||
48649053|NCT01701362|156568152|FG001|Overall Study|Protocol Violation|3|||
48649054|NCT01701362|156568151|FG000|Overall Study|No longer willing to participate|8|||
48649055|NCT01701362|156568152|FG001|Overall Study|No longer willing to participate|14|||
48649056|NCT01701362|156568151|FG000|Overall Study|Lost to Follow-up|6|||
48649057|NCT01701362|156568152|FG001|Overall Study|Lost to Follow-up|9|||
48649058|NCT01701362|156568151|FG000|Overall Study|Insufficient clinical response|6|||
48649059|NCT01701362|156568152|FG001|Overall Study|Insufficient clinical response|6|||
48649060|NCT01701362|156568151|FG000|Overall Study|Death|0|||
48649061|NCT01701362|156568152|FG001|Overall Study|Death|1|||
48649062|NCT01701362|156568151|FG000|Overall Study|Randomized but not treated|1|||
48649063|NCT01701362|156568152|FG001|Overall Study|Randomized but not treated|2|||
48649064|NCT01701362|156568151|FG000|Overall Study|Reasons other than those mentioned above|3|||
48649065|NCT01701362|156568152|FG001|Overall Study|Reasons other than those mentioned above|5|||
48649066|NCT04556591|156568156|FG000|Overall Study|Lost to Follow-up|1|||
48331194|NCT02991456|155409435|FG001|Overall Study|Adverse Event|0|||
48331195|NCT02991456|155409434|FG000|Overall Study|Lost to Follow-up|0|||
48331196|NCT02991456|155409435|FG001|Overall Study|Lost to Follow-up|2|||
48331197|NCT02991456|155409434|FG000|Overall Study|Withdrawal by Subject|1|||
48331198|NCT02991456|155409435|FG001|Overall Study|Withdrawal by Subject|0|||
48331199|NCT00321555|155409436|FG000|Overall Study|Developed antibodies|1|||
48331200|NCT00321555|155409436|FG000|Overall Study|Switched to alternative treatment|3|||
48331201|NCT00321555|155409436|FG000|Overall Study|Physician Decision|1|||
48331202|NCT00321555|155409436|FG000|Overall Study|Disease progression on study|1|||
48649067|NCT04556591|156568157|FG001|Overall Study|Lost to Follow-up|0|||
48649068|NCT04556591|156568156|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
48649069|NCT04556591|156568157|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
48649070|NCT01268046|156568159|FG000|Overall Study|Withdrawal by Subject|1|||
48649071|NCT01268046|156568160|FG001|Overall Study|Withdrawal by Subject|0|||
48649072|NCT01268046|156568161|FG002|Overall Study|Withdrawal by Subject|0|||
48649073|NCT01268046|156568162|FG003|Overall Study|Withdrawal by Subject|1|||
48649074|NCT01268046|156568159|FG000|Overall Study|Lost to Follow-up|0|||
48752460|NCT00434330|156938346|FG001|Overall Study|Withdrawal by Subject|0|||
48752461|NCT00434330|156938347|FG002|Overall Study|Withdrawal by Subject|1|||
48752462|NCT00434330|156938348|FG003|Overall Study|Withdrawal by Subject|1|||
48331203|NCT03005106|155409437|FG000|Overall Study|Lost to Follow-up|16|||
48331204|NCT03005106|155409437|FG000|Overall Study|Adverse Event|1|||
48649075|NCT01268046|156568160|FG001|Overall Study|Lost to Follow-up|0|||
48649076|NCT01268046|156568161|FG002|Overall Study|Lost to Follow-up|1|||
48649077|NCT01268046|156568162|FG003|Overall Study|Lost to Follow-up|0|||
48752463|NCT00434330|156938349|FG004|Overall Study|Withdrawal by Subject|0|||
48752464|NCT00434330|156938350|FG005|Overall Study|Withdrawal by Subject|0|||
48752465|NCT00434330|156938345|FG000|Overall Study|Renal transplant|0|||
48752466|NCT00434330|156938346|FG001|Overall Study|Renal transplant|0|||
48752467|NCT00434330|156938347|FG002|Overall Study|Renal transplant|0|||
48752468|NCT00434330|156938348|FG003|Overall Study|Renal transplant|1|||
48752469|NCT00434330|156938349|FG004|Overall Study|Renal transplant|0|||
48752470|NCT00434330|156938350|FG005|Overall Study|Renal transplant|0|||
48752471|NCT00434330|156938345|FG000|Overall Study|Subject Not Compliant With Study|0|||
48752472|NCT00434330|156938346|FG001|Overall Study|Subject Not Compliant With Study|0|||
48752473|NCT00434330|156938347|FG002|Overall Study|Subject Not Compliant With Study|1|||
48752474|NCT00434330|156938348|FG003|Overall Study|Subject Not Compliant With Study|0|||
48752475|NCT00434330|156938349|FG004|Overall Study|Subject Not Compliant With Study|0|||
48752476|NCT00434330|156938350|FG005|Overall Study|Subject Not Compliant With Study|0|||
48752477|NCT00642941|156938351|FG000|Overall Study|Physician Decision|3|||
48752478|NCT00642941|156938352|FG001|Overall Study|Physician Decision|1|||
48752479|NCT00642941|156938353|FG002|Overall Study|Physician Decision|0|||
48649078|NCT02836717|156568167|FG000|Test Phase|Lack of Efficacy|14|||
48649079|NCT02836717|156568168|FG001|Test Phase|Lack of Efficacy|8|||
48649080|NCT02836717|156568169|FG002|Test Phase|Lack of Efficacy|0|||
48649081|NCT02836717|156568167|FG000|Study Phase|Adverse Event|2|||
48649082|NCT02836717|156568168|FG001|Study Phase|Adverse Event|0|||
48649083|NCT02836717|156568169|FG002|Study Phase|Adverse Event|0|||
48649084|NCT02836717|156568167|FG000|Study Phase|Lack of Efficacy|8|||
48649085|NCT02836717|156568168|FG001|Study Phase|Lack of Efficacy|6|||
48649086|NCT02836717|156568169|FG002|Study Phase|Lack of Efficacy|1|||
48649087|NCT02836717|156568167|FG000|Study Phase|Withdrawal by Subject|1|||
48649088|NCT02836717|156568168|FG001|Study Phase|Withdrawal by Subject|0|||
48649089|NCT02836717|156568169|FG002|Study Phase|Withdrawal by Subject|0|||
48649090|NCT02836717|156568167|FG000|Study Phase|Death|1|||
48649091|NCT02836717|156568168|FG001|Study Phase|Death|0|||
48649092|NCT02836717|156568169|FG002|Study Phase|Death|0|||
48649093|NCT02836717|156568167|FG000|Study Phase|abdominal surgeries|2|||
48649094|NCT02836717|156568168|FG001|Study Phase|abdominal surgeries|1|||
48649095|NCT02836717|156568169|FG002|Study Phase|abdominal surgeries|0|||
48649096|NCT00588237|156568170|FG000|Overall Study|Evaluable for toxicity only|3|||
48649097|NCT00588237|156568170|FG000|Overall Study|Patien not treated|1|||
48649098|NCT02096952|156568171|FG000|Overall Study|Adverse Event|1|||
48649099|NCT01670279|156568172|FG000|Overall Study|Adverse Event|0|||
48649100|NCT01670279|156568173|FG001|Overall Study|Adverse Event|1|||
48649101|NCT01670279|156568174|FG002|Overall Study|Adverse Event|0|||
48649102|NCT01670279|156568175|FG003|Overall Study|Adverse Event|0|||
48649103|NCT01670279|156568172|FG000|Overall Study|Physician Decision|0|||
48649104|NCT01670279|156568173|FG001|Overall Study|Physician Decision|1|||
48649105|NCT01670279|156568174|FG002|Overall Study|Physician Decision|0|||
48649106|NCT01670279|156568175|FG003|Overall Study|Physician Decision|0|||
48649107|NCT01670279|156568172|FG000|Overall Study|Participant met withdrawal criteria|0|||
48752480|NCT00642941|156938354|FG003|Overall Study|Physician Decision|0|||
48752481|NCT00642941|156938355|FG004|Overall Study|Physician Decision|0|||
48752482|NCT00642941|156938356|FG005|Overall Study|Physician Decision|0|||
48752483|NCT00642941|156938357|FG006|Overall Study|Physician Decision|1|||
48331205|NCT03005106|155409437|FG000|Overall Study|Physician Decision|1|||
48331206|NCT03005106|155409437|FG000|Overall Study|Death|2|||
48649108|NCT01670279|156568173|FG001|Overall Study|Participant met withdrawal criteria|0|||
48649109|NCT01670279|156568174|FG002|Overall Study|Participant met withdrawal criteria|0|||
48649110|NCT01670279|156568175|FG003|Overall Study|Participant met withdrawal criteria|1|||
48649111|NCT02318368|156568176|FG000|Overall Study|Withdrawal by Subject|2|||
48649112|NCT02318368|156568177|FG001|Overall Study|Withdrawal by Subject|0|||
48649113|NCT02318368|156568176|FG000|Overall Study|Study terminated by the sponsor|5|||
48649114|NCT02318368|156568177|FG001|Overall Study|Study terminated by the sponsor|2|||
48649115|NCT02318368|156568176|FG000|Overall Study|Death|0|||
48649116|NCT02318368|156568177|FG001|Overall Study|Death|1|||
48649117|NCT01901614|156568178|FG000|Overall Study|Adverse Event|0|||
48649118|NCT01901614|156568179|FG001|Overall Study|Adverse Event|1|||
48649119|NCT01901614|156568178|FG000|Overall Study|Lost to Follow-up|1|||
48649120|NCT01901614|156568179|FG001|Overall Study|Lost to Follow-up|0|||
48649121|NCT01901614|156568178|FG000|Overall Study|Screen Fail|1|||
48649122|NCT01901614|156568179|FG001|Overall Study|Screen Fail|0|||
48649123|NCT02201329|156568180|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
48649124|NCT02201329|156568180|FG000|Overall Study|Withdrawal by Subject|2|||
48752484|NCT00642941|156938358|FG007|Overall Study|Physician Decision|0|||
48649125|NCT03423238|156568183|FG000|Overall Study|Lost to Follow-up|1|||
48649126|NCT03423238|156568184|FG001|Overall Study|Lost to Follow-up|0|||
48649127|NCT03423238|156568183|FG000|Overall Study|Withdrawal by Subject|1|||
48649128|NCT03423238|156568184|FG001|Overall Study|Withdrawal by Subject|0|||
48649129|NCT03248167|156568187|FG000|Overall Study|Withdrawal by Subject|2|||
48649130|NCT03248167|156568188|FG001|Overall Study|Withdrawal by Subject|2|||
48649131|NCT03248167|156568187|FG000|Overall Study|Physician Decision|0|||
48752485|NCT00642941|156938359|FG008|Overall Study|Physician Decision|0|||
48752486|NCT00642941|156938360|FG009|Overall Study|Physician Decision|1|||
48752487|NCT00642941|156938361|FG010|Overall Study|Physician Decision|0|||
48752488|NCT00642941|156938362|FG011|Overall Study|Physician Decision|1|||
48752489|NCT00642941|156938351|FG000|Overall Study|Death|4|||
48752490|NCT00642941|156938352|FG001|Overall Study|Death|0|||
48752491|NCT00642941|156938353|FG002|Overall Study|Death|1|||
48752492|NCT00642941|156938354|FG003|Overall Study|Death|1|||
48752493|NCT00642941|156938355|FG004|Overall Study|Death|2|||
48752494|NCT00642941|156938356|FG005|Overall Study|Death|1|||
48752495|NCT00642941|156938357|FG006|Overall Study|Death|0|||
48752496|NCT00642941|156938358|FG007|Overall Study|Death|0|||
48752497|NCT00642941|156938359|FG008|Overall Study|Death|0|||
48752498|NCT00642941|156938360|FG009|Overall Study|Death|0|||
48752499|NCT00642941|156938361|FG010|Overall Study|Death|0|||
48752500|NCT00642941|156938362|FG011|Overall Study|Death|1|||
48752501|NCT00642941|156938351|FG000|Overall Study|Study closed by Sponsor|0|||
48752502|NCT00642941|156938352|FG001|Overall Study|Study closed by Sponsor|1|||
48752503|NCT00642941|156938353|FG002|Overall Study|Study closed by Sponsor|0|||
48649132|NCT03248167|156568188|FG001|Overall Study|Physician Decision|1|||
48649133|NCT03248167|156568187|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
48752504|NCT00642941|156938354|FG003|Overall Study|Study closed by Sponsor|0|||
48752505|NCT00642941|156938355|FG004|Overall Study|Study closed by Sponsor|0|||
48752506|NCT00642941|156938356|FG005|Overall Study|Study closed by Sponsor|0|||
48649134|NCT03248167|156568188|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
48649135|NCT03248167|156568187|FG000|Overall Study|Lost to Follow-up|1|||
48649136|NCT03248167|156568188|FG001|Overall Study|Lost to Follow-up|0|||
48649137|NCT01970241|156568189|FG000|Overall Study|Withdrawal by Subject|2|||
48752507|NCT00642941|156938357|FG006|Overall Study|Study closed by Sponsor|0|||
48752508|NCT00642941|156938358|FG007|Overall Study|Study closed by Sponsor|0|||
48752509|NCT00642941|156938359|FG008|Overall Study|Study closed by Sponsor|0|||
48752510|NCT00642941|156938360|FG009|Overall Study|Study closed by Sponsor|0|||
48649138|NCT01970241|156568190|FG001|Overall Study|Withdrawal by Subject|0|||
48649139|NCT01970241|156568189|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
48649140|NCT01970241|156568190|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
48649141|NCT01104545|156568197|FG000|Overall Study|Adverse Event|0|||
48649142|NCT01104545|156568198|FG001|Overall Study|Adverse Event|1|||
48649143|NCT01104545|156568199|FG002|Overall Study|Adverse Event|2|||
48649144|NCT03604172|156568200|FG000|Overall Study|Lost to Follow-up|1|||
48649145|NCT03604172|156568201|FG001|Overall Study|Lost to Follow-up|2|||
48649146|NCT03711370|156568202|FG000|Overall Study|Lost to Follow-up|16|||
48649147|NCT03711370|156568203|FG001|Overall Study|Lost to Follow-up|10|||
48649148|NCT03711370|156568202|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
48649149|NCT03711370|156568203|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
48649150|NCT00182078|156568210|FG000|Overall Study|Withdrawal by Subject|1|||
48649151|NCT00182078|156568211|FG001|Overall Study|Withdrawal by Subject|0|||
48649152|NCT00553436|156568213|FG000|Overall Study|Conversion to another procedure|1|||
48649153|NCT04188834|156568214|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
48649154|NCT01814046|156568221|FG000|Drug Administration|Death due to complications of RSV|1|||
48649155|NCT01814046|156568222|FG001|Drug Administration|Death due to complications of RSV|0|||
48649156|NCT01814046|156568223|FG002|Drug Administration|Death due to complications of RSV|0|||
48649157|NCT01221623|156568229|FG000|Overall Study|Withdrawal by Subject|19|||
48649158|NCT01221623|156568230|FG001|Overall Study|Withdrawal by Subject|8|||
48649159|NCT01221623|156568229|FG000|Overall Study|Lost to Follow-up|7|||
48649160|NCT01221623|156568230|FG001|Overall Study|Lost to Follow-up|1|||
48649161|NCT01221623|156568229|FG000|Overall Study|Adverse Event|6|||
48649162|NCT01221623|156568230|FG001|Overall Study|Adverse Event|3|||
48649163|NCT01221623|156568229|FG000|Overall Study|Death|1|||
48649164|NCT01221623|156568230|FG001|Overall Study|Death|0|||
48649165|NCT01221623|156568229|FG000|Overall Study|Other|5|||
48649166|NCT01221623|156568230|FG001|Overall Study|Other|2|||
48649167|NCT01831466|156568231|FG000|Overall Study|Protocol Violation|1|||
48649168|NCT01831466|156568232|FG001|Overall Study|Protocol Violation|1|||
48649169|NCT01831466|156568233|FG002|Overall Study|Protocol Violation|2|||
48649170|NCT01831466|156568234|FG003|Overall Study|Protocol Violation|0|||
48649171|NCT01831466|156568235|FG004|Overall Study|Protocol Violation|0|||
48649172|NCT01831466|156568236|FG005|Overall Study|Protocol Violation|1|||
48649173|NCT01831466|156568237|FG006|Overall Study|Protocol Violation|0|||
48649174|NCT01831466|156568238|FG007|Overall Study|Protocol Violation|0|||
48649175|NCT01831466|156568239|FG008|Overall Study|Protocol Violation|0|||
48649176|NCT01831466|156568240|FG009|Overall Study|Protocol Violation|0|||
48649177|NCT01831466|156568241|FG010|Overall Study|Protocol Violation|0|||
48649178|NCT01831466|156568242|FG011|Overall Study|Protocol Violation|0|||
48649179|NCT01831466|156568231|FG000|Overall Study|Other|2|||
48649180|NCT01831466|156568232|FG001|Overall Study|Other|3|||
48649181|NCT01831466|156568233|FG002|Overall Study|Other|2|||
48649182|NCT01831466|156568234|FG003|Overall Study|Other|2|||
48649183|NCT01831466|156568235|FG004|Overall Study|Other|2|||
48752511|NCT00642941|156938361|FG010|Overall Study|Study closed by Sponsor|0|||
48752512|NCT00642941|156938362|FG011|Overall Study|Study closed by Sponsor|0|||
48752513|NCT00642941|156938351|FG000|Overall Study|Withdrawal by Subject|1|||
48752514|NCT00642941|156938352|FG001|Overall Study|Withdrawal by Subject|0|||
48752515|NCT00642941|156938353|FG002|Overall Study|Withdrawal by Subject|0|||
48752516|NCT00642941|156938354|FG003|Overall Study|Withdrawal by Subject|2|||
48752517|NCT00642941|156938355|FG004|Overall Study|Withdrawal by Subject|0|||
48752518|NCT00642941|156938356|FG005|Overall Study|Withdrawal by Subject|0|||
48649184|NCT01831466|156568236|FG005|Overall Study|Other|1|||
48649185|NCT01831466|156568237|FG006|Overall Study|Other|0|||
48649186|NCT01831466|156568238|FG007|Overall Study|Other|0|||
48649187|NCT01831466|156568239|FG008|Overall Study|Other|0|||
48649188|NCT01831466|156568240|FG009|Overall Study|Other|0|||
48331207|NCT01218594|155409440|FG000|Overall Study|Death|1|||
48331208|NCT01218594|155409440|FG000|Overall Study|Withdrawal by Subject|3|||
48331209|NCT01218594|155409440|FG000|Overall Study|Adverse Event|2|||
48331210|NCT01218594|155409440|FG000|Overall Study|Physician Decision|6|||
48331211|NCT03055988|155409442|FG000|Period 1|Adverse Event|0|||
48331212|NCT03055988|155409443|FG001|Period 1|Adverse Event|1|||
48331213|NCT03055988|155409442|FG000|Period 1|Lost to Follow-up|1|||
48331214|NCT03055988|155409443|FG001|Period 1|Lost to Follow-up|0|||
48331215|NCT03055988|155409442|FG000|Period 1|Withdrawal by Subject|0|||
48331216|NCT03055988|155409443|FG001|Period 1|Withdrawal by Subject|4|||
48331217|NCT03055988|155409442|FG000|Period 2|Adverse Event|0|||
48331218|NCT03055988|155409443|FG001|Period 2|Adverse Event|1|||
48331219|NCT03055988|155409442|FG000|Period 2|Other than listed|1|||
48331220|NCT03055988|155409443|FG001|Period 2|Other than listed|1|||
48649189|NCT01831466|156568241|FG010|Overall Study|Other|0|||
48649190|NCT01831466|156568242|FG011|Overall Study|Other|0|||
48649191|NCT01831466|156568231|FG000|Overall Study|Non-compliance with study treatment|2|||
48649192|NCT01831466|156568232|FG001|Overall Study|Non-compliance with study treatment|1|||
48649193|NCT01831466|156568233|FG002|Overall Study|Non-compliance with study treatment|1|||
48649194|NCT01831466|156568234|FG003|Overall Study|Non-compliance with study treatment|0|||
48649195|NCT01831466|156568235|FG004|Overall Study|Non-compliance with study treatment|0|||
48649196|NCT01831466|156568236|FG005|Overall Study|Non-compliance with study treatment|1|||
48649197|NCT01831466|156568237|FG006|Overall Study|Non-compliance with study treatment|0|||
48649198|NCT01831466|156568238|FG007|Overall Study|Non-compliance with study treatment|0|||
48649199|NCT01831466|156568239|FG008|Overall Study|Non-compliance with study treatment|0|||
48649200|NCT01831466|156568240|FG009|Overall Study|Non-compliance with study treatment|0|||
48649201|NCT01831466|156568241|FG010|Overall Study|Non-compliance with study treatment|0|||
48649202|NCT01831466|156568242|FG011|Overall Study|Non-compliance with study treatment|0|||
48649203|NCT01831466|156568231|FG000|Overall Study|Death|0|||
48649204|NCT01831466|156568232|FG001|Overall Study|Death|1|||
48649205|NCT01831466|156568233|FG002|Overall Study|Death|0|||
48649206|NCT01831466|156568234|FG003|Overall Study|Death|0|||
48649207|NCT01831466|156568235|FG004|Overall Study|Death|0|||
48649208|NCT01831466|156568236|FG005|Overall Study|Death|0|||
48649209|NCT01831466|156568237|FG006|Overall Study|Death|0|||
48649210|NCT01831466|156568238|FG007|Overall Study|Death|0|||
48649211|NCT01831466|156568239|FG008|Overall Study|Death|0|||
48649212|NCT01831466|156568240|FG009|Overall Study|Death|0|||
48649213|NCT01831466|156568241|FG010|Overall Study|Death|0|||
48649214|NCT01831466|156568242|FG011|Overall Study|Death|0|||
48649215|NCT01831466|156568231|FG000|Overall Study|Withdrawal by Subject|6|||
48649216|NCT01831466|156568232|FG001|Overall Study|Withdrawal by Subject|3|||
48649217|NCT01831466|156568233|FG002|Overall Study|Withdrawal by Subject|3|||
48649218|NCT01831466|156568234|FG003|Overall Study|Withdrawal by Subject|3|||
48649219|NCT01831466|156568235|FG004|Overall Study|Withdrawal by Subject|3|||
48649220|NCT01831466|156568236|FG005|Overall Study|Withdrawal by Subject|5|||
48649221|NCT01831466|156568237|FG006|Overall Study|Withdrawal by Subject|0|||
48649222|NCT01831466|156568238|FG007|Overall Study|Withdrawal by Subject|0|||
48649223|NCT01831466|156568239|FG008|Overall Study|Withdrawal by Subject|0|||
48649224|NCT01831466|156568240|FG009|Overall Study|Withdrawal by Subject|1|||
48649225|NCT01831466|156568241|FG010|Overall Study|Withdrawal by Subject|0|||
48649226|NCT01831466|156568242|FG011|Overall Study|Withdrawal by Subject|1|||
48649227|NCT01831466|156568231|FG000|Overall Study|Lost to Follow-up|0|||
48649228|NCT01831466|156568232|FG001|Overall Study|Lost to Follow-up|1|||
48649229|NCT01831466|156568233|FG002|Overall Study|Lost to Follow-up|4|||
48649230|NCT01831466|156568234|FG003|Overall Study|Lost to Follow-up|2|||
48649231|NCT01831466|156568235|FG004|Overall Study|Lost to Follow-up|0|||
48649232|NCT01831466|156568236|FG005|Overall Study|Lost to Follow-up|3|||
48649233|NCT01831466|156568237|FG006|Overall Study|Lost to Follow-up|0|||
48649234|NCT01831466|156568238|FG007|Overall Study|Lost to Follow-up|0|||
48649235|NCT01831466|156568239|FG008|Overall Study|Lost to Follow-up|0|||
48649236|NCT01831466|156568240|FG009|Overall Study|Lost to Follow-up|1|||
48649237|NCT01831466|156568241|FG010|Overall Study|Lost to Follow-up|0|||
48649238|NCT01831466|156568242|FG011|Overall Study|Lost to Follow-up|1|||
48649239|NCT01831466|156568231|FG000|Overall Study|Lack of Efficacy|5|||
48649240|NCT01831466|156568232|FG001|Overall Study|Lack of Efficacy|8|||
48649241|NCT01831466|156568233|FG002|Overall Study|Lack of Efficacy|7|||
48649242|NCT01831466|156568234|FG003|Overall Study|Lack of Efficacy|6|||
48649243|NCT01831466|156568235|FG004|Overall Study|Lack of Efficacy|9|||
48649244|NCT01831466|156568236|FG005|Overall Study|Lack of Efficacy|8|||
48649245|NCT01831466|156568237|FG006|Overall Study|Lack of Efficacy|1|||
48649246|NCT01831466|156568238|FG007|Overall Study|Lack of Efficacy|1|||
48649247|NCT01831466|156568239|FG008|Overall Study|Lack of Efficacy|2|||
48649248|NCT01831466|156568240|FG009|Overall Study|Lack of Efficacy|2|||
48649249|NCT01831466|156568241|FG010|Overall Study|Lack of Efficacy|2|||
48649250|NCT01831466|156568242|FG011|Overall Study|Lack of Efficacy|0|||
48649251|NCT01831466|156568231|FG000|Overall Study|Adverse Event|0|||
48649252|NCT01831466|156568232|FG001|Overall Study|Adverse Event|0|||
48649253|NCT01831466|156568233|FG002|Overall Study|Adverse Event|4|||
48649254|NCT01831466|156568234|FG003|Overall Study|Adverse Event|6|||
48649255|NCT01831466|156568235|FG004|Overall Study|Adverse Event|3|||
48649256|NCT01831466|156568236|FG005|Overall Study|Adverse Event|7|||
48331221|NCT00428714|155409444|FG000|Overall Study|Progressive Disease|28|||
48649257|NCT01831466|156568237|FG006|Overall Study|Adverse Event|0|||
48649258|NCT01831466|156568238|FG007|Overall Study|Adverse Event|1|||
48649259|NCT01831466|156568239|FG008|Overall Study|Adverse Event|1|||
48649260|NCT01831466|156568240|FG009|Overall Study|Adverse Event|1|||
48649261|NCT01831466|156568241|FG010|Overall Study|Adverse Event|0|||
48649262|NCT01831466|156568242|FG011|Overall Study|Adverse Event|2|||
48649263|NCT02952313|156568247|FG000|Primary Endpoint|Lost to Follow-up|4|||
48649264|NCT02952313|156568247|FG000|Primary Endpoint|Withdrawal by Subject|1|||
48649265|NCT02952313|156568247|FG000|Primary Endpoint|Lack of Efficacy|1|||
48649266|NCT02952313|156568247|FG000|Primary Endpoint|Missed visit|1|||
48649267|NCT02952313|156568247|FG000|Long-term Follow-up|Lost to Follow-up|12|||
48649268|NCT02952313|156568247|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
48649269|NCT02952313|156568247|FG000|Long-term Follow-up|Lack of Efficacy|6|||
48649270|NCT02952313|156568247|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
48649271|NCT02952313|156568247|FG000|Long-term Follow-up|Physician Decision|1|||
48649272|NCT02952313|156568247|FG000|Long-term Follow-up|Death|1|||
48649273|NCT02798315|156568251|FG000|Overall Study|Failure to return|1|||
48649274|NCT02470585|156568252|FG000|Overall Study|Death|224|||
48649275|NCT02470585|156568253|FG001|Overall Study|Death|227|||
48649276|NCT02470585|156568254|FG002|Overall Study|Death|199|||
48649277|NCT02470585|156568252|FG000|Overall Study|Withdrew consent|21|||
48649278|NCT02470585|156568253|FG001|Overall Study|Withdrew consent|22|||
48649279|NCT02470585|156568254|FG002|Overall Study|Withdrew consent|31|||
48649280|NCT02470585|156568252|FG000|Overall Study|Lost to Follow-up|8|||
48649281|NCT02470585|156568253|FG001|Overall Study|Lost to Follow-up|15|||
48649282|NCT02470585|156568254|FG002|Overall Study|Lost to Follow-up|13|||
48649283|NCT02470585|156568252|FG000|Overall Study|Sponsor discontinued study|117|||
48649284|NCT02470585|156568253|FG001|Overall Study|Sponsor discontinued study|110|||
48649285|NCT02470585|156568254|FG002|Overall Study|Sponsor discontinued study|122|||
48649286|NCT02470585|156568252|FG000|Overall Study|Other, not specified|5|||
48649287|NCT02470585|156568253|FG001|Overall Study|Other, not specified|7|||
48649288|NCT02470585|156568254|FG002|Overall Study|Other, not specified|14|||
48649289|NCT02470585|156568252|FG000|Overall Study|Missing due to site non-compliance|0|||
48331222|NCT00428714|155409445|FG001|Overall Study|Progressive Disease|36|||
48331223|NCT00428714|155409444|FG000|Overall Study|Withdrawal by Subject|0|||
48331224|NCT00428714|155409445|FG001|Overall Study|Withdrawal by Subject|3|||
48331225|NCT00428714|155409444|FG000|Overall Study|Adverse Event|0|||
48331226|NCT00428714|155409445|FG001|Overall Study|Adverse Event|2|||
48331227|NCT00428714|155409444|FG000|Overall Study|Physician Decision|1|||
48331228|NCT00428714|155409445|FG001|Overall Study|Physician Decision|1|||
48331229|NCT00428714|155409444|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
48331230|NCT00428714|155409445|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
48331231|NCT00428714|155409444|FG000|Overall Study|Death due to other then PD|1|||
48331232|NCT00428714|155409445|FG001|Overall Study|Death due to other then PD|0|||
48331233|NCT03547167|155409446|FG000|Overall Study|Withdrawal by Subject|34|||
48331234|NCT03547167|155409447|FG001|Overall Study|Withdrawal by Subject|12|||
48331235|NCT03547167|155409446|FG000|Overall Study|Screen Failure|0|||
48331236|NCT03547167|155409447|FG001|Overall Study|Screen Failure|1|||
48331237|NCT03547167|155409446|FG000|Overall Study|Lost to Follow-up|59|||
48649290|NCT02470585|156568253|FG001|Overall Study|Missing due to site non-compliance|2|||
48649291|NCT02470585|156568254|FG002|Overall Study|Missing due to site non-compliance|3|||
48649292|NCT03335150|156568255|FG000|Overall Study|Withdrawal by Subject|10|||
48752519|NCT00642941|156938357|FG006|Overall Study|Withdrawal by Subject|2|||
48752520|NCT00642941|156938358|FG007|Overall Study|Withdrawal by Subject|0|||
48752521|NCT00642941|156938359|FG008|Overall Study|Withdrawal by Subject|1|||
48649293|NCT03335150|156568256|FG001|Overall Study|Withdrawal by Subject|4|||
48649294|NCT03335150|156568255|FG000|Overall Study|Adverse Event|0|||
48331238|NCT03547167|155409447|FG001|Overall Study|Lost to Follow-up|15|||
48649295|NCT03335150|156568256|FG001|Overall Study|Adverse Event|1|||
48649296|NCT01063062|156568257|FG000|Overall Study|Patient withdrew consent|0|||
48649297|NCT01063062|156568258|FG001|Overall Study|Patient withdrew consent|1|||
48649298|NCT01063062|156568257|FG000|Overall Study|Adverse Event|2|||
48649299|NCT01063062|156568258|FG001|Overall Study|Adverse Event|4|||
48649300|NCT01063062|156568257|FG000|Overall Study|Protocol Violation|5|||
48649301|NCT01063062|156568258|FG001|Overall Study|Protocol Violation|4|||
48649302|NCT01063062|156568257|FG000|Overall Study|Investigator's request|1|||
48649303|NCT01063062|156568258|FG001|Overall Study|Investigator's request|0|||
48752522|NCT00642941|156938360|FG009|Overall Study|Withdrawal by Subject|0|||
48752523|NCT00642941|156938361|FG010|Overall Study|Withdrawal by Subject|0|||
48752524|NCT00642941|156938362|FG011|Overall Study|Withdrawal by Subject|1|||
48752525|NCT00642941|156938351|FG000|Overall Study|Protocol Violation|0|||
48752526|NCT00642941|156938352|FG001|Overall Study|Protocol Violation|0|||
48752527|NCT00642941|156938353|FG002|Overall Study|Protocol Violation|0|||
48752528|NCT00642941|156938354|FG003|Overall Study|Protocol Violation|0|||
48752529|NCT00642941|156938355|FG004|Overall Study|Protocol Violation|0|||
48649304|NCT01063062|156568257|FG000|Overall Study|Lost to Follow-up|0|||
48752530|NCT00642941|156938356|FG005|Overall Study|Protocol Violation|0|||
48752531|NCT00642941|156938357|FG006|Overall Study|Protocol Violation|1|||
48331239|NCT03547167|155409446|FG000|Overall Study|Death|4|||
48331240|NCT03547167|155409447|FG001|Overall Study|Death|2|||
48331241|NCT00736502|155409448|FG000|Overall Study|Adverse Event|22|||
48331242|NCT00736502|155409448|FG000|Overall Study|Lack of Efficacy|16|||
48649305|NCT01063062|156568258|FG001|Overall Study|Lost to Follow-up|2|||
48649306|NCT01063062|156568257|FG000|Overall Study|Miscellaneous reason|0|||
48331243|NCT00736502|155409448|FG000|Overall Study|Lost to Follow-up|27|||
48331244|NCT03820024|155409452|FG000|Overall Study|Physician Decision|1|||
48331245|NCT03820024|155409453|FG001|Overall Study|Physician Decision|2|||
48331246|NCT02255474|155409454|FG000|Overall Study|Lost to Follow-up|1|||
48331247|NCT02255474|155409455|FG001|Overall Study|Lost to Follow-up|1|||
48331248|NCT02255474|155409456|FG002|Overall Study|Lost to Follow-up|3|||
48331249|NCT02255474|155409454|FG000|Overall Study|Withdrawal by Subject|1|||
48331250|NCT02255474|155409455|FG001|Overall Study|Withdrawal by Subject|1|||
48331251|NCT02255474|155409456|FG002|Overall Study|Withdrawal by Subject|0|||
48331252|NCT02699099|155409457|FG000|Overall Study|Adverse Event|1|||
48331253|NCT02699099|155409458|FG001|Overall Study|Adverse Event|0|||
48331254|NCT02699099|155409459|FG002|Overall Study|Adverse Event|2|||
48649307|NCT01063062|156568258|FG001|Overall Study|Miscellaneous reason|1|||
48649308|NCT02195700|156568261|FG000|Overall Study|Protocol Violation|0|||
48649309|NCT02195700|156568262|FG001|Overall Study|Protocol Violation|2|||
48649310|NCT02195700|156568261|FG000|Overall Study|Noncompliance|1|||
48649311|NCT02195700|156568262|FG001|Overall Study|Noncompliance|0|||
48649312|NCT02195700|156568261|FG000|Overall Study|Adverse Event|1|||
48649313|NCT02195700|156568262|FG001|Overall Study|Adverse Event|2|||
48649314|NCT02195700|156568261|FG000|Overall Study|Withdrawal by Subject|3|||
48649315|NCT02195700|156568262|FG001|Overall Study|Withdrawal by Subject|2|||
48649316|NCT02195700|156568261|FG000|Overall Study|Lost to Follow-up|1|||
48649317|NCT02195700|156568262|FG001|Overall Study|Lost to Follow-up|1|||
48649318|NCT03989349|156568263|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
48649319|NCT03989349|156568264|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48649320|NCT03989349|156568265|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48649321|NCT03989349|156568266|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48649322|NCT03989349|156568267|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48649323|NCT03989349|156568268|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48331255|NCT02699099|155409457|FG000|Overall Study|Lost to Follow-up|0|||
48331256|NCT02699099|155409458|FG001|Overall Study|Lost to Follow-up|1|||
48331257|NCT02699099|155409459|FG002|Overall Study|Lost to Follow-up|0|||
48331258|NCT02699099|155409457|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
48331259|NCT02699099|155409458|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
48331260|NCT02699099|155409459|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
48331261|NCT01084772|155409460|FG000|Baseline|Withdrawal by Subject|7|||
48331262|NCT01084772|155409461|FG001|Baseline|Withdrawal by Subject|6|||
48331263|NCT01084772|155409460|FG000|3 Months|Death|1|||
48331264|NCT01084772|155409461|FG001|3 Months|Death|0|||
48331265|NCT01084772|155409460|FG000|3 Months|Study Termination|2|||
48331266|NCT01084772|155409461|FG001|3 Months|Study Termination|2|||
48331267|NCT01084772|155409460|FG000|1 Year|Withdrawal by Subject|0|||
48331268|NCT01084772|155409461|FG001|1 Year|Withdrawal by Subject|1|||
48331269|NCT01084772|155409460|FG000|1 Year|Lost to Follow-up|3|||
48331270|NCT01084772|155409461|FG001|1 Year|Lost to Follow-up|0|||
48331271|NCT01084772|155409460|FG000|1 Year|Study Termination|0|||
48331272|NCT01084772|155409461|FG001|1 Year|Study Termination|7|||
48331273|NCT01084772|155409460|FG000|2 Years|Withdrawal by Subject|1|||
48331274|NCT01084772|155409461|FG001|2 Years|Withdrawal by Subject|0|||
48649324|NCT03989349|156568263|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
48649325|NCT03989349|156568264|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
48649326|NCT03989349|156568265|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48649327|NCT03989349|156568266|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48649328|NCT03989349|156568267|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48649329|NCT03989349|156568268|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48649330|NCT03989349|156568263|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
48649331|NCT03989349|156568264|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
48649332|NCT03989349|156568265|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
48649333|NCT03989349|156568266|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
48649334|NCT03989349|156568267|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
48649335|NCT03989349|156568268|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
48649336|NCT03989349|156568263|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
48649337|NCT03989349|156568264|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
48331275|NCT01084772|155409460|FG000|2 Years|Lost to Follow-up|5|||
48331276|NCT01084772|155409461|FG001|2 Years|Lost to Follow-up|2|||
48331277|NCT01084772|155409460|FG000|2 Years|Study Termination|3|||
48649338|NCT03989349|156568265|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48649339|NCT03989349|156568266|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48649340|NCT03989349|156568267|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48752532|NCT00642941|156938358|FG007|Overall Study|Protocol Violation|0|||
48331278|NCT01084772|155409461|FG001|2 Years|Study Termination|2|||
48331279|NCT01867307|155409462|FG000|Overall Study|Protocol Violation|2|||
48331280|NCT01867307|155409463|FG001|Overall Study|Protocol Violation|0|||
48331281|NCT01867307|155409462|FG000|Overall Study|Other Adverse Event|1|||
48331282|NCT01867307|155409463|FG001|Overall Study|Other Adverse Event|3|||
48752533|NCT00642941|156938359|FG008|Overall Study|Protocol Violation|0|||
48331283|NCT02372799|155411430|FG000|Treatment Period|Adverse Event|3|||
48331284|NCT02372799|155411431|FG001|Treatment Period|Adverse Event|10|||
48331285|NCT02372799|155411432|FG002|Treatment Period|Adverse Event|6|||
48331286|NCT02372799|155411430|FG000|Treatment Period|Insufficient therapeutic response|2|||
48331287|NCT02372799|155411431|FG001|Treatment Period|Insufficient therapeutic response|2|||
48331288|NCT02372799|155411432|FG002|Treatment Period|Insufficient therapeutic response|0|||
48331289|NCT02372799|155411430|FG000|Treatment Period|Withdrawal by Subject|10|||
48331290|NCT02372799|155411431|FG001|Treatment Period|Withdrawal by Subject|10|||
48331291|NCT02372799|155411432|FG002|Treatment Period|Withdrawal by Subject|2|||
48331292|NCT02372799|155411430|FG000|Treatment Period|Lost to Follow-up|11|||
48331293|NCT02372799|155411431|FG001|Treatment Period|Lost to Follow-up|5|||
48331294|NCT02372799|155411432|FG002|Treatment Period|Lost to Follow-up|3|||
48752534|NCT00642941|156938360|FG009|Overall Study|Protocol Violation|0|||
48752535|NCT00642941|156938361|FG010|Overall Study|Protocol Violation|0|||
48752536|NCT00642941|156938362|FG011|Overall Study|Protocol Violation|0|||
48752537|NCT00642941|156938351|FG000|Overall Study|Adverse Event|1|||
48752538|NCT00642941|156938352|FG001|Overall Study|Adverse Event|1|||
48752539|NCT00642941|156938353|FG002|Overall Study|Adverse Event|0|||
48752540|NCT00642941|156938354|FG003|Overall Study|Adverse Event|0|||
48752541|NCT00642941|156938355|FG004|Overall Study|Adverse Event|0|||
48752542|NCT00642941|156938356|FG005|Overall Study|Adverse Event|0|||
48752543|NCT00642941|156938357|FG006|Overall Study|Adverse Event|1|||
48752544|NCT00642941|156938358|FG007|Overall Study|Adverse Event|1|||
48752545|NCT00642941|156938359|FG008|Overall Study|Adverse Event|0|||
48752546|NCT00642941|156938360|FG009|Overall Study|Adverse Event|1|||
48752547|NCT00642941|156938361|FG010|Overall Study|Adverse Event|0|||
48752548|NCT00642941|156938362|FG011|Overall Study|Adverse Event|0|||
48752549|NCT00642941|156938351|FG000|Overall Study|Other|1|||
48331295|NCT02372799|155411430|FG000|Treatment Period|Protocol Violation|3|||
48331296|NCT02372799|155411431|FG001|Treatment Period|Protocol Violation|0|||
48331297|NCT02372799|155411432|FG002|Treatment Period|Protocol Violation|0|||
48331298|NCT02372799|155411430|FG000|Treatment Period|Non-compliance with study drug|4|||
48331299|NCT02372799|155411431|FG001|Treatment Period|Non-compliance with study drug|4|||
48331300|NCT02372799|155411432|FG002|Treatment Period|Non-compliance with study drug|4|||
48331301|NCT02372799|155411430|FG000|Treatment Period|Miscellaneous Reasons|1|||
48331302|NCT02372799|155411431|FG001|Treatment Period|Miscellaneous Reasons|1|||
48331303|NCT02372799|155411432|FG002|Treatment Period|Miscellaneous Reasons|0|||
48331304|NCT02372799|155411430|FG000|Down-taper Period|Lost to Follow-up|1|||
48331305|NCT02372799|155411431|FG001|Down-taper Period|Lost to Follow-up|2|||
48331306|NCT02372799|155411432|FG002|Down-taper Period|Lost to Follow-up|2|||
48331307|NCT01190124|155411433|FG000|Overall Study|Death|3|||
48331308|NCT01190124|155411434|FG001|Overall Study|Death|0|||
48331309|NCT01190124|155411435|FG002|Overall Study|Death|0|||
48331310|NCT01190124|155411433|FG000|Overall Study|Therapeutic Failure|12|||
48331311|NCT01190124|155411434|FG001|Overall Study|Therapeutic Failure|0|||
48331312|NCT01190124|155411435|FG002|Overall Study|Therapeutic Failure|1|||
48331313|NCT01190124|155411433|FG000|Overall Study|Lost to Follow-up|2|||
48331314|NCT01190124|155411434|FG001|Overall Study|Lost to Follow-up|0|||
48331315|NCT01190124|155411435|FG002|Overall Study|Lost to Follow-up|0|||
48331316|NCT00491400|155411436|FG000|Overall Study|Withdrawal by Subject|5|||
48331317|NCT00491400|155411437|FG001|Overall Study|Withdrawal by Subject|4|||
48331318|NCT02338999|155411442|FG000|First Intervention|Withdrawal by Subject|3|||
48649341|NCT03989349|156568268|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48649342|NCT03989349|156568263|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
48649343|NCT03989349|156568264|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
48649344|NCT03989349|156568265|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
48649345|NCT03989349|156568266|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
48649346|NCT03989349|156568267|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
48649347|NCT03989349|156568268|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
48649348|NCT03989349|156568263|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
48649349|NCT03989349|156568264|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
48649350|NCT03989349|156568265|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
48649351|NCT03989349|156568266|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
48752550|NCT00642941|156938352|FG001|Overall Study|Other|1|||
48331319|NCT02338999|155411443|FG001|First Intervention|Withdrawal by Subject|1|||
48331320|NCT02338999|155411442|FG000|Washout Period|Withdrawal by Subject|0|||
48331321|NCT02338999|155411443|FG001|Washout Period|Withdrawal by Subject|2|||
48752551|NCT00642941|156938353|FG002|Overall Study|Other|1|||
48752552|NCT00642941|156938354|FG003|Overall Study|Other|1|||
48752553|NCT00642941|156938355|FG004|Overall Study|Other|0|||
48752554|NCT00642941|156938356|FG005|Overall Study|Other|1|||
48752555|NCT00642941|156938357|FG006|Overall Study|Other|0|||
48331322|NCT02338999|155411442|FG000|Second Intervention|Withdrawal by Subject|0|||
48331323|NCT02338999|155411443|FG001|Second Intervention|Withdrawal by Subject|2|||
48331324|NCT03960645|155411444|FG000|Overall Study|Protocol Violation|1|||
48331325|NCT03960645|155411445|FG001|Overall Study|Protocol Violation|0|||
48331326|NCT02000752|155411446|FG000|Overall Study|Dystocic delivery|19|||
48331327|NCT02000752|155411447|FG001|Overall Study|Dystocic delivery|8|||
48331328|NCT02000752|155411446|FG000|Overall Study|Shift Changes|12|||
48331329|NCT02000752|155411447|FG001|Overall Study|Shift Changes|5|||
48331330|NCT03737110|155411448|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
48331331|NCT03737110|155411449|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
48331332|NCT03737110|155411450|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
48331333|NCT03737110|155411451|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
48331334|NCT03737110|155411452|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
48331335|NCT03737110|155411453|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
48331336|NCT03737110|155411448|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
48331337|NCT03737110|155411449|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48331338|NCT03737110|155411450|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48331339|NCT03737110|155411451|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48331340|NCT03737110|155411452|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48331341|NCT03737110|155411453|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
48331342|NCT03737110|155411448|FG000|Run-in (RI) Period|Adverse Event|4|||
48649352|NCT03989349|156568267|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
48649353|NCT03989349|156568268|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
48649354|NCT03989349|156568263|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
48649355|NCT03989349|156568264|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
48649356|NCT03989349|156568265|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
48649357|NCT03989349|156568266|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
48649358|NCT03989349|156568267|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
48649359|NCT03989349|156568268|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
48649360|NCT03989349|156568263|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48649361|NCT03989349|156568264|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48331343|NCT03737110|155411449|FG001|Run-in (RI) Period|Adverse Event|0|||
48649362|NCT03989349|156568265|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
48649363|NCT03989349|156568266|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
48649364|NCT03989349|156568267|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
48649365|NCT03989349|156568268|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
48649366|NCT03989349|156568263|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48649367|NCT03989349|156568264|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48649368|NCT03989349|156568265|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
48649369|NCT03989349|156568266|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
48649370|NCT03989349|156568267|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
48649371|NCT03989349|156568268|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
48331344|NCT03737110|155411450|FG002|Run-in (RI) Period|Adverse Event|0|||
48331345|NCT03737110|155411451|FG003|Run-in (RI) Period|Adverse Event|0|||
48331346|NCT03737110|155411452|FG004|Run-in (RI) Period|Adverse Event|0|||
48331347|NCT03737110|155411453|FG005|Run-in (RI) Period|Adverse Event|0|||
48331348|NCT03737110|155411448|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48649372|NCT03989349|156568263|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
48649373|NCT03989349|156568264|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
48649374|NCT03989349|156568265|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
48649375|NCT03989349|156568266|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
48649376|NCT03989349|156568267|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
48649377|NCT03989349|156568268|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
48649378|NCT03989349|156568263|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48649379|NCT03989349|156568264|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48649380|NCT03989349|156568265|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
48649381|NCT03989349|156568266|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48649382|NCT03989349|156568267|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
48752556|NCT00642941|156938358|FG007|Overall Study|Other|1|||
48331349|NCT03737110|155411449|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
48331350|NCT03737110|155411450|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48331351|NCT03737110|155411451|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48331352|NCT03737110|155411452|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48331353|NCT03737110|155411453|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
48331354|NCT03737110|155411448|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48649383|NCT03989349|156568268|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48649384|NCT03989349|156568263|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
48649385|NCT03989349|156568264|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
48649386|NCT03989349|156568265|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
48649387|NCT03989349|156568266|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
48649388|NCT03989349|156568267|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
48649389|NCT03989349|156568268|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
48649390|NCT03989349|156568263|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
48649391|NCT03989349|156568264|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
48649392|NCT03989349|156568265|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
48649393|NCT03989349|156568266|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
48649394|NCT03989349|156568267|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
48649395|NCT03989349|156568268|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
48649396|NCT03989349|156568263|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
48649397|NCT03989349|156568264|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
48649398|NCT03989349|156568265|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
48649399|NCT03989349|156568266|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
48649400|NCT03989349|156568267|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
48649401|NCT03989349|156568268|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
48649402|NCT00661726|156568273|FG000|Overall Study|Adverse Event|1|||
48331355|NCT03737110|155411449|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48331356|NCT03737110|155411450|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
48331357|NCT03737110|155411451|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48331358|NCT03737110|155411452|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48331359|NCT03737110|155411453|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
48331360|NCT03737110|155411448|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48331361|NCT03737110|155411449|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48331362|NCT03737110|155411450|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48331363|NCT03737110|155411451|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
48331364|NCT03737110|155411452|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48331365|NCT03737110|155411453|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
48331366|NCT03737110|155411448|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
48331367|NCT03737110|155411449|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
48331368|NCT03737110|155411450|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
48331369|NCT03737110|155411451|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
48331370|NCT03737110|155411452|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
48331371|NCT03737110|155411453|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
48331372|NCT03737110|155411448|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48331373|NCT03737110|155411449|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48331374|NCT03737110|155411450|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48331375|NCT03737110|155411451|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48331376|NCT03737110|155411452|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
48331377|NCT03737110|155411453|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
48331378|NCT00047385|155411458|FG000|Overall Study|Death before any screening|2|||
48331379|NCT00047385|155411459|FG001|Overall Study|Death before any screening|5|||
48331380|NCT00047385|155411458|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
48331381|NCT00047385|155411459|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
48331382|NCT00047385|155411458|FG000|Overall Study|Eligible for screening but had no screen|260|||
48331383|NCT00047385|155411459|FG001|Overall Study|Eligible for screening but had no screen|492|||
48331384|NCT01019135|155411462|FG000|Overall Study|Did not receive allocated intervention|12|||
48331385|NCT01019135|155411463|FG001|Overall Study|Did not receive allocated intervention|6|||
48331386|NCT01019135|155411464|FG002|Overall Study|Did not receive allocated intervention|25|||
48331387|NCT01019135|155411462|FG000|Overall Study|Did not attend CR|8|||
48331388|NCT01019135|155411463|FG001|Overall Study|Did not attend CR|13|||
48331389|NCT01019135|155411464|FG002|Overall Study|Did not attend CR|6|||
48331390|NCT00638456|155411465|FG000|Overall Study|Withdrawal by Subject|6|||
48331391|NCT00638456|155411466|FG001|Overall Study|Withdrawal by Subject|2|||
48331392|NCT03746015|155411470|FG000|Overall Study|Withdrawal of Consent|1|||
48331393|NCT03746015|155411471|FG001|Overall Study|Withdrawal of Consent|0|||
48331394|NCT03746015|155411472|FG002|Overall Study|Withdrawal of Consent|0|||
48331395|NCT05260437|155411475|FG000|Overall Study|Lost to Follow-up|5|||
48331396|NCT05260437|155411476|FG001|Overall Study|Lost to Follow-up|2|||
48331397|NCT05260437|155411477|FG002|Overall Study|Lost to Follow-up|1|||
48649403|NCT02316353|156568274|FG000|Overall Study|Pregnancy|1|||
48649404|NCT02316353|156568275|FG001|Overall Study|Pregnancy|3|||
48649405|NCT02316353|156568274|FG000|Overall Study|Adverse Event|1|||
48331398|NCT05260437|155411478|FG003|Overall Study|Lost to Follow-up|2|||
48649406|NCT02316353|156568275|FG001|Overall Study|Adverse Event|3|||
48649407|NCT02316353|156568274|FG000|Overall Study|Withdrawal by Subject|6|||
48649408|NCT02316353|156568275|FG001|Overall Study|Withdrawal by Subject|2|||
48649409|NCT01234480|156570339|FG000|Overall Study|Pregnancy|88|||
48649410|NCT01234480|156570339|FG000|Overall Study|>36/Normal History|50|||
48649411|NCT01234480|156570339|FG000|Overall Study|Age|3|||
48649412|NCT01234480|156570339|FG000|Overall Study|HPV Vaccine History|28|||
48649413|NCT01234480|156570339|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
48649414|NCT01234480|156570339|FG000|Overall Study|Hysterectomy|2|||
48752557|NCT00642941|156938359|FG008|Overall Study|Other|0|||
48649415|NCT01234480|156570339|FG000|Overall Study|Hysterectomy post enrollment|1|||
48649416|NCT01234480|156570339|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
48649417|NCT01234480|156570339|FG000|Overall Study|Informed Consent Form Violation|30|||
48649418|NCT01234480|156570339|FG000|Overall Study|Incorrect Visit|3|||
48649419|NCT01234480|156570339|FG000|Overall Study|No Florida Lab License|20|||
48649420|NCT01234480|156570339|FG000|Overall Study|Out of Window|42|||
48649421|NCT01234480|156570339|FG000|Overall Study|Sample Processing/Storage|92|||
48649422|NCT01234480|156570339|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
48649423|NCT01234480|156570339|FG000|Overall Study|Site/Subject non-compliance|44|||
48649424|NCT01234480|156570339|FG000|Overall Study|Missing Sample|9|||
48649425|NCT02574078|156570342|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649426|NCT02574078|156570343|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649427|NCT02574078|156570344|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649428|NCT02574078|156570345|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649429|NCT02574078|156570346|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649430|NCT02574078|156570347|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
48649431|NCT02574078|156570348|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
48649432|NCT02574078|156570349|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649433|NCT02574078|156570350|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
48649434|NCT02574078|156570351|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649435|NCT02574078|156570352|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649436|NCT02574078|156570353|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649437|NCT02574078|156570354|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48649438|NCT02574078|156570342|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
48649439|NCT02574078|156570343|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
48649440|NCT02574078|156570344|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
48649441|NCT02574078|156570345|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
48649442|NCT02574078|156570346|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
48649443|NCT02574078|156570347|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
48649444|NCT02574078|156570348|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
48649445|NCT02574078|156570349|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
48649446|NCT02574078|156570350|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
48649447|NCT02574078|156570351|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
48649448|NCT02574078|156570352|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
48649449|NCT02574078|156570353|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
48649450|NCT02574078|156570354|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
48649451|NCT02574078|156570342|FG000|Pre-Treatment Period|Other reasons|0|||
48649452|NCT02574078|156570343|FG001|Pre-Treatment Period|Other reasons|0|||
48649453|NCT02574078|156570344|FG002|Pre-Treatment Period|Other reasons|0|||
48649454|NCT02574078|156570345|FG003|Pre-Treatment Period|Other reasons|0|||
48649455|NCT02574078|156570346|FG004|Pre-Treatment Period|Other reasons|0|||
48649456|NCT02574078|156570347|FG005|Pre-Treatment Period|Other reasons|0|||
48649457|NCT02574078|156570348|FG006|Pre-Treatment Period|Other reasons|2|||
48649458|NCT02574078|156570349|FG007|Pre-Treatment Period|Other reasons|0|||
48649459|NCT02574078|156570350|FG008|Pre-Treatment Period|Other reasons|0|||
48649460|NCT02574078|156570351|FG009|Pre-Treatment Period|Other reasons|0|||
48649461|NCT02574078|156570352|FG010|Pre-Treatment Period|Other reasons|2|||
48649462|NCT02574078|156570353|FG011|Pre-Treatment Period|Other reasons|0|||
48649463|NCT02574078|156570354|FG012|Pre-Treatment Period|Other reasons|0|||
48649464|NCT02574078|156570342|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
48649465|NCT02574078|156570343|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
48649466|NCT02574078|156570344|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
48649467|NCT02574078|156570345|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
48649468|NCT02574078|156570346|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
48649469|NCT02574078|156570347|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
48649470|NCT02574078|156570348|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
48649471|NCT02574078|156570349|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
48649472|NCT02574078|156570350|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
48649473|NCT02574078|156570351|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
48649474|NCT02574078|156570352|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
48649475|NCT02574078|156570353|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
48649476|NCT02574078|156570354|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
48649477|NCT02574078|156570342|FG000|Treatment Period|Disease progression|6|||
48649478|NCT02574078|156570343|FG001|Treatment Period|Disease progression|4|||
48331399|NCT05260437|155411479|FG004|Overall Study|Lost to Follow-up|2|||
48331400|NCT05260437|155411475|FG000|Overall Study|Withdrawal by Subject|3|||
48331401|NCT05260437|155411476|FG001|Overall Study|Withdrawal by Subject|0|||
48331402|NCT05260437|155411477|FG002|Overall Study|Withdrawal by Subject|4|||
48331403|NCT05260437|155411478|FG003|Overall Study|Withdrawal by Subject|5|||
48331404|NCT05260437|155411479|FG004|Overall Study|Withdrawal by Subject|0|||
48331405|NCT05260437|155411475|FG000|Overall Study|Vaccine Not Administered|0|||
48331406|NCT05260437|155411476|FG001|Overall Study|Vaccine Not Administered|1|||
48331407|NCT05260437|155411477|FG002|Overall Study|Vaccine Not Administered|0|||
48331408|NCT05260437|155411478|FG003|Overall Study|Vaccine Not Administered|0|||
48331409|NCT05260437|155411479|FG004|Overall Study|Vaccine Not Administered|0|||
48331410|NCT01029704|155411480|FG000|Overall Study|Adverse Event|0|||
48331411|NCT01029704|155411481|FG001|Overall Study|Adverse Event|0|||
48331412|NCT01029704|155411482|FG002|Overall Study|Adverse Event|0|||
48331413|NCT01029704|155411483|FG003|Overall Study|Adverse Event|0|||
48331414|NCT01029704|155411484|FG004|Overall Study|Adverse Event|0|||
48331415|NCT01029704|155411485|FG005|Overall Study|Adverse Event|0|||
48331416|NCT01029704|155411486|FG006|Overall Study|Adverse Event|1|||
48331417|NCT01029704|155411487|FG007|Overall Study|Adverse Event|1|||
48331418|NCT01029704|155411488|FG008|Overall Study|Adverse Event|0|||
48331419|NCT01029704|155411480|FG000|Overall Study|Withdrawal by Subject|0|||
48331420|NCT01029704|155411481|FG001|Overall Study|Withdrawal by Subject|0|||
48331421|NCT01029704|155411482|FG002|Overall Study|Withdrawal by Subject|0|||
48331422|NCT01029704|155411483|FG003|Overall Study|Withdrawal by Subject|0|||
48331423|NCT01029704|155411484|FG004|Overall Study|Withdrawal by Subject|2|||
48331424|NCT01029704|155411485|FG005|Overall Study|Withdrawal by Subject|1|||
48331425|NCT01029704|155411486|FG006|Overall Study|Withdrawal by Subject|1|||
48331426|NCT01029704|155411487|FG007|Overall Study|Withdrawal by Subject|1|||
48331427|NCT01029704|155411488|FG008|Overall Study|Withdrawal by Subject|0|||
48331428|NCT01029704|155411480|FG000|Overall Study|Lost to Follow-up|0|||
48331429|NCT01029704|155411481|FG001|Overall Study|Lost to Follow-up|0|||
48331430|NCT01029704|155411482|FG002|Overall Study|Lost to Follow-up|0|||
48331431|NCT01029704|155411483|FG003|Overall Study|Lost to Follow-up|0|||
48331432|NCT01029704|155411484|FG004|Overall Study|Lost to Follow-up|0|||
48331433|NCT01029704|155411485|FG005|Overall Study|Lost to Follow-up|0|||
48331434|NCT01029704|155411486|FG006|Overall Study|Lost to Follow-up|1|||
48331435|NCT01029704|155411487|FG007|Overall Study|Lost to Follow-up|1|||
48331436|NCT01029704|155411488|FG008|Overall Study|Lost to Follow-up|1|||
48331437|NCT01029704|155411480|FG000|Overall Study|Lack of Efficacy|0|||
48331438|NCT01029704|155411481|FG001|Overall Study|Lack of Efficacy|0|||
48331439|NCT01029704|155411482|FG002|Overall Study|Lack of Efficacy|0|||
48331440|NCT01029704|155411483|FG003|Overall Study|Lack of Efficacy|0|||
48331441|NCT01029704|155411484|FG004|Overall Study|Lack of Efficacy|2|||
48331442|NCT01029704|155411485|FG005|Overall Study|Lack of Efficacy|3|||
48331443|NCT01029704|155411486|FG006|Overall Study|Lack of Efficacy|1|||
48331444|NCT01029704|155411487|FG007|Overall Study|Lack of Efficacy|2|||
48331445|NCT01029704|155411488|FG008|Overall Study|Lack of Efficacy|0|||
48331446|NCT01029704|155411480|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
48331447|NCT01029704|155411481|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
48331448|NCT01029704|155411482|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
48331449|NCT01029704|155411483|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
48331450|NCT01029704|155411484|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
48331451|NCT01029704|155411485|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
48331452|NCT01029704|155411486|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
48331453|NCT01029704|155411487|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
48331454|NCT01029704|155411488|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
48331455|NCT03695185|155411489|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
48649479|NCT02574078|156570344|FG002|Treatment Period|Disease progression|7|||
48649480|NCT02574078|156570345|FG003|Treatment Period|Disease progression|18|||
48649481|NCT02574078|156570346|FG004|Treatment Period|Disease progression|16|||
48649482|NCT02574078|156570347|FG005|Treatment Period|Disease progression|26|||
48331456|NCT03695185|155411489|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
48331457|NCT03695185|155411489|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
48331458|NCT03695185|155411489|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
48331459|NCT03695185|155411489|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
48331460|NCT03695185|155411489|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
48331461|NCT03390166|155411490|FG000|Overall Study|Death|0|||
48331462|NCT03390166|155411491|FG001|Overall Study|Death|1|||
48331463|NCT03390166|155411490|FG000|Overall Study|Lost to Follow-up|6|||
48331464|NCT03390166|155411491|FG001|Overall Study|Lost to Follow-up|4|||
48331465|NCT03390166|155411490|FG000|Overall Study|Physician Decision|2|||
48331466|NCT03390166|155411491|FG001|Overall Study|Physician Decision|1|||
48331467|NCT03390166|155411490|FG000|Overall Study|Move from study area|3|||
48331468|NCT03390166|155411491|FG001|Overall Study|Move from study area|2|||
48649483|NCT02574078|156570348|FG006|Treatment Period|Disease progression|5|||
48649484|NCT02574078|156570349|FG007|Treatment Period|Disease progression|9|||
48331469|NCT03390166|155411490|FG000|Overall Study|To militarycamp for conscript|1|||
48331470|NCT03390166|155411491|FG001|Overall Study|To militarycamp for conscript|0|||
48331471|NCT03390166|155411490|FG000|Overall Study|To drug therapy course|0|||
48331472|NCT03390166|155411491|FG001|Overall Study|To drug therapy course|1|||
48331473|NCT03390166|155411490|FG000|Overall Study|Move to work oversea|0|||
48331474|NCT03390166|155411491|FG001|Overall Study|Move to work oversea|1|||
48331475|NCT00659373|155411492|FG000|Overall Study|Withdrawal by Subject|3|||
48331476|NCT00659373|155411493|FG001|Overall Study|Withdrawal by Subject|5|||
48331477|NCT00659373|155411492|FG000|Overall Study|Assessment Missed|2|||
48331478|NCT00659373|155411493|FG001|Overall Study|Assessment Missed|2|||
48331479|NCT02382640|155411496|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
48331480|NCT02382640|155411497|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
48331481|NCT02382640|155411498|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
48331482|NCT02382640|155411499|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
48331483|NCT01052272|155411500|FG000|Overall Study|Death|0|||
48331484|NCT01052272|155411501|FG001|Overall Study|Death|0|||
48331485|NCT01052272|155411502|FG002|Overall Study|Death|1|||
48331486|NCT01052272|155411503|FG003|Overall Study|Death|1|||
48331487|NCT01052272|155411500|FG000|Overall Study|Physician Decision|0|||
48331488|NCT01052272|155411501|FG001|Overall Study|Physician Decision|1|||
48649485|NCT02574078|156570350|FG008|Treatment Period|Disease progression|8|||
48649486|NCT02574078|156570351|FG009|Treatment Period|Disease progression|5|||
48649487|NCT02574078|156570352|FG010|Treatment Period|Disease progression|20|||
48649488|NCT02574078|156570353|FG011|Treatment Period|Disease progression|29|||
48649489|NCT02574078|156570354|FG012|Treatment Period|Disease progression|2|||
48649490|NCT02574078|156570342|FG000|Treatment Period|Study drug toxicity|1|||
48649491|NCT02574078|156570343|FG001|Treatment Period|Study drug toxicity|1|||
48649492|NCT02574078|156570344|FG002|Treatment Period|Study drug toxicity|0|||
48649493|NCT02574078|156570345|FG003|Treatment Period|Study drug toxicity|5|||
48649494|NCT02574078|156570346|FG004|Treatment Period|Study drug toxicity|3|||
48649495|NCT02574078|156570347|FG005|Treatment Period|Study drug toxicity|1|||
48649496|NCT02574078|156570348|FG006|Treatment Period|Study drug toxicity|2|||
48649497|NCT02574078|156570349|FG007|Treatment Period|Study drug toxicity|0|||
48649498|NCT02574078|156570350|FG008|Treatment Period|Study drug toxicity|2|||
48649499|NCT02574078|156570351|FG009|Treatment Period|Study drug toxicity|1|||
48649500|NCT02574078|156570352|FG010|Treatment Period|Study drug toxicity|16|||
48649501|NCT02574078|156570353|FG011|Treatment Period|Study drug toxicity|2|||
48649502|NCT02574078|156570354|FG012|Treatment Period|Study drug toxicity|4|||
48649503|NCT02574078|156570342|FG000|Treatment Period|Death|2|||
48649504|NCT02574078|156570343|FG001|Treatment Period|Death|0|||
48649505|NCT02574078|156570344|FG002|Treatment Period|Death|0|||
48649506|NCT02574078|156570345|FG003|Treatment Period|Death|0|||
48649507|NCT02574078|156570346|FG004|Treatment Period|Death|1|||
48649508|NCT02574078|156570347|FG005|Treatment Period|Death|1|||
48649509|NCT02574078|156570348|FG006|Treatment Period|Death|1|||
48649510|NCT02574078|156570349|FG007|Treatment Period|Death|1|||
48649511|NCT02574078|156570350|FG008|Treatment Period|Death|7|||
48649512|NCT02574078|156570351|FG009|Treatment Period|Death|1|||
48649513|NCT02574078|156570352|FG010|Treatment Period|Death|0|||
48649514|NCT02574078|156570353|FG011|Treatment Period|Death|2|||
48649515|NCT02574078|156570354|FG012|Treatment Period|Death|1|||
48649516|NCT02574078|156570342|FG000|Treatment Period|Adverse event unrelated to drug|0|||
48649517|NCT02574078|156570343|FG001|Treatment Period|Adverse event unrelated to drug|0|||
48649518|NCT02574078|156570344|FG002|Treatment Period|Adverse event unrelated to drug|1|||
48649519|NCT02574078|156570345|FG003|Treatment Period|Adverse event unrelated to drug|0|||
48649520|NCT02574078|156570346|FG004|Treatment Period|Adverse event unrelated to drug|2|||
48649521|NCT02574078|156570347|FG005|Treatment Period|Adverse event unrelated to drug|3|||
48649522|NCT02574078|156570348|FG006|Treatment Period|Adverse event unrelated to drug|0|||
48649523|NCT02574078|156570349|FG007|Treatment Period|Adverse event unrelated to drug|0|||
48649524|NCT02574078|156570350|FG008|Treatment Period|Adverse event unrelated to drug|1|||
48649525|NCT02574078|156570351|FG009|Treatment Period|Adverse event unrelated to drug|2|||
48649526|NCT02574078|156570352|FG010|Treatment Period|Adverse event unrelated to drug|4|||
48331489|NCT01052272|155411502|FG002|Overall Study|Physician Decision|0|||
48649527|NCT02574078|156570353|FG011|Treatment Period|Adverse event unrelated to drug|1|||
48649528|NCT02574078|156570354|FG012|Treatment Period|Adverse event unrelated to drug|0|||
48331490|NCT01052272|155411503|FG003|Overall Study|Physician Decision|0|||
48331491|NCT01052272|155411500|FG000|Overall Study|patient refuses follow-up|5|||
48331492|NCT01052272|155411501|FG001|Overall Study|patient refuses follow-up|4|||
48649529|NCT02574078|156570342|FG000|Treatment Period|Administrative reason by Sponsor|0|||
48649530|NCT02574078|156570343|FG001|Treatment Period|Administrative reason by Sponsor|1|||
48649531|NCT02574078|156570344|FG002|Treatment Period|Administrative reason by Sponsor|0|||
48649532|NCT02574078|156570345|FG003|Treatment Period|Administrative reason by Sponsor|0|||
48649533|NCT02574078|156570346|FG004|Treatment Period|Administrative reason by Sponsor|0|||
48649534|NCT02574078|156570347|FG005|Treatment Period|Administrative reason by Sponsor|0|||
48331493|NCT01052272|155411502|FG002|Overall Study|patient refuses follow-up|2|||
48331494|NCT01052272|155411503|FG003|Overall Study|patient refuses follow-up|4|||
48649535|NCT02574078|156570348|FG006|Treatment Period|Administrative reason by Sponsor|1|||
48649536|NCT02574078|156570349|FG007|Treatment Period|Administrative reason by Sponsor|0|||
48649537|NCT02574078|156570350|FG008|Treatment Period|Administrative reason by Sponsor|0|||
48649538|NCT02574078|156570351|FG009|Treatment Period|Administrative reason by Sponsor|0|||
48649539|NCT02574078|156570352|FG010|Treatment Period|Administrative reason by Sponsor|0|||
48649540|NCT02574078|156570353|FG011|Treatment Period|Administrative reason by Sponsor|0|||
48649541|NCT02574078|156570354|FG012|Treatment Period|Administrative reason by Sponsor|3|||
48649542|NCT02574078|156570342|FG000|Treatment Period|Other reasons|1|||
48649543|NCT02574078|156570343|FG001|Treatment Period|Other reasons|0|||
48649544|NCT02574078|156570344|FG002|Treatment Period|Other reasons|1|||
48649545|NCT02574078|156570345|FG003|Treatment Period|Other reasons|3|||
48649546|NCT02574078|156570346|FG004|Treatment Period|Other reasons|3|||
48649547|NCT02574078|156570347|FG005|Treatment Period|Other reasons|1|||
48649548|NCT02574078|156570348|FG006|Treatment Period|Other reasons|2|||
48649549|NCT02574078|156570349|FG007|Treatment Period|Other reasons|1|||
48649550|NCT02574078|156570350|FG008|Treatment Period|Other reasons|3|||
48649551|NCT02574078|156570351|FG009|Treatment Period|Other reasons|1|||
48649552|NCT02574078|156570352|FG010|Treatment Period|Other reasons|1|||
48649553|NCT02574078|156570353|FG011|Treatment Period|Other reasons|3|||
48649554|NCT02574078|156570354|FG012|Treatment Period|Other reasons|1|||
48649555|NCT02574078|156570342|FG000|Treatment Period|Participant request to stop drug|0|||
48649556|NCT02574078|156570343|FG001|Treatment Period|Participant request to stop drug|0|||
48649557|NCT02574078|156570344|FG002|Treatment Period|Participant request to stop drug|0|||
48649558|NCT02574078|156570345|FG003|Treatment Period|Participant request to stop drug|2|||
48649559|NCT02574078|156570346|FG004|Treatment Period|Participant request to stop drug|4|||
48649560|NCT02574078|156570347|FG005|Treatment Period|Participant request to stop drug|0|||
48649561|NCT02574078|156570348|FG006|Treatment Period|Participant request to stop drug|1|||
48649562|NCT02574078|156570349|FG007|Treatment Period|Participant request to stop drug|0|||
48649563|NCT02574078|156570350|FG008|Treatment Period|Participant request to stop drug|3|||
48649564|NCT02574078|156570351|FG009|Treatment Period|Participant request to stop drug|2|||
48649565|NCT02574078|156570352|FG010|Treatment Period|Participant request to stop drug|2|||
48649566|NCT02574078|156570353|FG011|Treatment Period|Participant request to stop drug|4|||
48649567|NCT02574078|156570354|FG012|Treatment Period|Participant request to stop drug|1|||
48649568|NCT02574078|156570342|FG000|Treatment Period|Participant withdrew consent|0|||
48649569|NCT02574078|156570343|FG001|Treatment Period|Participant withdrew consent|0|||
48649570|NCT02574078|156570344|FG002|Treatment Period|Participant withdrew consent|0|||
48649571|NCT02574078|156570345|FG003|Treatment Period|Participant withdrew consent|0|||
48649572|NCT02574078|156570346|FG004|Treatment Period|Participant withdrew consent|1|||
48649573|NCT02574078|156570347|FG005|Treatment Period|Participant withdrew consent|1|||
48649574|NCT02574078|156570348|FG006|Treatment Period|Participant withdrew consent|0|||
48649575|NCT02574078|156570349|FG007|Treatment Period|Participant withdrew consent|1|||
48649576|NCT02574078|156570350|FG008|Treatment Period|Participant withdrew consent|0|||
48649577|NCT02574078|156570351|FG009|Treatment Period|Participant withdrew consent|2|||
48649578|NCT02574078|156570352|FG010|Treatment Period|Participant withdrew consent|1|||
48649579|NCT02574078|156570353|FG011|Treatment Period|Participant withdrew consent|4|||
48649580|NCT02574078|156570354|FG012|Treatment Period|Participant withdrew consent|1|||
48649581|NCT02574078|156570342|FG000|Treatment Period|Participant no longer meets criteria|0|||
48649582|NCT02574078|156570343|FG001|Treatment Period|Participant no longer meets criteria|0|||
48649583|NCT02574078|156570344|FG002|Treatment Period|Participant no longer meets criteria|0|||
48649584|NCT02574078|156570345|FG003|Treatment Period|Participant no longer meets criteria|0|||
48649585|NCT02574078|156570346|FG004|Treatment Period|Participant no longer meets criteria|1|||
48649586|NCT02574078|156570347|FG005|Treatment Period|Participant no longer meets criteria|0|||
48649587|NCT02574078|156570348|FG006|Treatment Period|Participant no longer meets criteria|0|||
48649588|NCT02574078|156570349|FG007|Treatment Period|Participant no longer meets criteria|0|||
48649589|NCT02574078|156570350|FG008|Treatment Period|Participant no longer meets criteria|0|||
48649590|NCT02574078|156570351|FG009|Treatment Period|Participant no longer meets criteria|1|||
48649591|NCT02574078|156570352|FG010|Treatment Period|Participant no longer meets criteria|1|||
48649592|NCT02574078|156570353|FG011|Treatment Period|Participant no longer meets criteria|1|||
48649593|NCT02574078|156570354|FG012|Treatment Period|Participant no longer meets criteria|0|||
48649594|NCT02574078|156570342|FG000|Treatment Period|Lost to Follow-up|0|||
48649595|NCT02574078|156570343|FG001|Treatment Period|Lost to Follow-up|0|||
48649596|NCT02574078|156570344|FG002|Treatment Period|Lost to Follow-up|0|||
48649597|NCT02574078|156570345|FG003|Treatment Period|Lost to Follow-up|0|||
48649598|NCT02574078|156570346|FG004|Treatment Period|Lost to Follow-up|0|||
48649599|NCT02574078|156570347|FG005|Treatment Period|Lost to Follow-up|0|||
48649600|NCT02574078|156570348|FG006|Treatment Period|Lost to Follow-up|0|||
48649601|NCT02574078|156570349|FG007|Treatment Period|Lost to Follow-up|0|||
48649602|NCT02574078|156570350|FG008|Treatment Period|Lost to Follow-up|0|||
48649603|NCT02574078|156570351|FG009|Treatment Period|Lost to Follow-up|1|||
48649604|NCT02574078|156570352|FG010|Treatment Period|Lost to Follow-up|0|||
48649605|NCT02574078|156570353|FG011|Treatment Period|Lost to Follow-up|1|||
48649606|NCT02574078|156570354|FG012|Treatment Period|Lost to Follow-up|0|||
48649607|NCT02574078|156570342|FG000|Treatment Period|Maximum clinical benefit|0|||
48649608|NCT02574078|156570343|FG001|Treatment Period|Maximum clinical benefit|0|||
48649609|NCT02574078|156570344|FG002|Treatment Period|Maximum clinical benefit|0|||
48649610|NCT02574078|156570345|FG003|Treatment Period|Maximum clinical benefit|0|||
48649611|NCT02574078|156570346|FG004|Treatment Period|Maximum clinical benefit|0|||
48649612|NCT02574078|156570347|FG005|Treatment Period|Maximum clinical benefit|0|||
48649613|NCT02574078|156570348|FG006|Treatment Period|Maximum clinical benefit|0|||
48752558|NCT00642941|156938360|FG009|Overall Study|Other|0|||
48752559|NCT00642941|156938361|FG010|Overall Study|Other|0|||
48752560|NCT00642941|156938362|FG011|Overall Study|Other|1|||
48752561|NCT00642941|156938351|FG000|Overall Study|Disease progression|60|||
48752562|NCT00642941|156938352|FG001|Overall Study|Disease progression|50|||
48752563|NCT00642941|156938353|FG002|Overall Study|Disease progression|5|||
48752564|NCT00642941|156938354|FG003|Overall Study|Disease progression|36|||
48752565|NCT00642941|156938355|FG004|Overall Study|Disease progression|23|||
48752566|NCT00642941|156938356|FG005|Overall Study|Disease progression|39|||
48752567|NCT00642941|156938357|FG006|Overall Study|Disease progression|18|||
48752568|NCT00642941|156938358|FG007|Overall Study|Disease progression|12|||
48752569|NCT00642941|156938359|FG008|Overall Study|Disease progression|10|||
48752570|NCT00642941|156938360|FG009|Overall Study|Disease progression|7|||
48752571|NCT00642941|156938361|FG010|Overall Study|Disease progression|12|||
48752572|NCT00642941|156938362|FG011|Overall Study|Disease progression|7|||
48752573|NCT01798004|156940028|FG000|Overall Study|Death|2|||
48752574|NCT01798004|156940028|FG000|Overall Study|Lack of Efficacy|8|||
48752575|NCT01798004|156940028|FG000|Overall Study|Physician Decision|25|||
48752576|NCT01798004|156940028|FG000|Overall Study|Withdrawal by Subject|4|||
48649614|NCT02574078|156570349|FG007|Treatment Period|Maximum clinical benefit|0|||
48649615|NCT02574078|156570350|FG008|Treatment Period|Maximum clinical benefit|0|||
48649616|NCT02574078|156570351|FG009|Treatment Period|Maximum clinical benefit|1|||
48649617|NCT02574078|156570352|FG010|Treatment Period|Maximum clinical benefit|0|||
48649618|NCT02574078|156570353|FG011|Treatment Period|Maximum clinical benefit|0|||
48649619|NCT02574078|156570354|FG012|Treatment Period|Maximum clinical benefit|0|||
48649620|NCT00342628|156570355|FG000|Overall Study|Withdrawal by Subject|19|||
48649621|NCT00342628|156570356|FG001|Overall Study|Withdrawal by Subject|19|||
48649622|NCT00342628|156570357|FG002|Overall Study|Withdrawal by Subject|18|||
48649623|NCT00342628|156570355|FG000|Overall Study|Death|1|||
48649624|NCT00342628|156570356|FG001|Overall Study|Death|1|||
48649625|NCT00342628|156570357|FG002|Overall Study|Death|0|||
48331495|NCT01052272|155411500|FG000|Overall Study|Withdrawal by Subject|0|||
48649626|NCT00342628|156570355|FG000|Overall Study|moved residence|0|||
48649627|NCT00342628|156570356|FG001|Overall Study|moved residence|1|||
48649628|NCT00342628|156570357|FG002|Overall Study|moved residence|1|||
48649629|NCT04551898|156570358|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
48649630|NCT04551898|156570359|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
48649631|NCT04551898|156570360|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
48649632|NCT04551898|156570361|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
48649633|NCT04551898|156570358|FG000|Overall Study|Withdrawal by Subject|5|||
48649634|NCT04551898|156570359|FG001|Overall Study|Withdrawal by Subject|1|||
48649635|NCT04551898|156570360|FG002|Overall Study|Withdrawal by Subject|2|||
48649636|NCT04551898|156570361|FG003|Overall Study|Withdrawal by Subject|2|||
48649637|NCT04551898|156570358|FG000|Overall Study|Lost to Follow-up|2|||
48649638|NCT04551898|156570359|FG001|Overall Study|Lost to Follow-up|1|||
48649639|NCT04551898|156570360|FG002|Overall Study|Lost to Follow-up|2|||
48649640|NCT04551898|156570361|FG003|Overall Study|Lost to Follow-up|2|||
48649641|NCT04551898|156570358|FG000|Overall Study|Death|1|||
48649642|NCT04551898|156570359|FG001|Overall Study|Death|0|||
48649643|NCT04551898|156570360|FG002|Overall Study|Death|0|||
48649644|NCT04551898|156570361|FG003|Overall Study|Death|0|||
48649645|NCT04551898|156570358|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
48649646|NCT04551898|156570359|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
48649647|NCT04551898|156570360|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
48649648|NCT04551898|156570361|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
48649649|NCT03427814|156570362|FG000|Overall Study|Withdrawal by Subject|4|||
48649650|NCT03427814|156570363|FG001|Overall Study|Withdrawal by Subject|4|||
48649651|NCT03427814|156570362|FG000|Overall Study|Lost to Follow-up|0|||
48649652|NCT03427814|156570363|FG001|Overall Study|Lost to Follow-up|2|||
48649653|NCT03427814|156570362|FG000|Overall Study|Death|42|||
48649654|NCT03427814|156570363|FG001|Overall Study|Death|31|||
48649655|NCT03427814|156570362|FG000|Overall Study|Sponsor's Decision|1|||
48649656|NCT03427814|156570363|FG001|Overall Study|Sponsor's Decision|0|||
48649657|NCT03427814|156570362|FG000|Overall Study|Investigator's Decision|1|||
48649658|NCT03427814|156570363|FG001|Overall Study|Investigator's Decision|2|||
48649659|NCT03427814|156570362|FG000|Overall Study|Disease progression|1|||
48649660|NCT03427814|156570363|FG001|Overall Study|Disease progression|0|||
48649661|NCT03427814|156570362|FG000|Overall Study|Treatment Completed|0|||
48649662|NCT03427814|156570363|FG001|Overall Study|Treatment Completed|1|||
48649663|NCT03427814|156570362|FG000|Overall Study|Sponsor's Decision to End study|21|||
48649664|NCT03427814|156570363|FG001|Overall Study|Sponsor's Decision to End study|25|||
48331496|NCT01052272|155411501|FG001|Overall Study|Withdrawal by Subject|2|||
48649665|NCT03427814|156570362|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
48649666|NCT03427814|156570363|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
48649667|NCT00662831|156570366|FG000|Overall Study|Death|4|||
48649668|NCT00662831|156570367|FG001|Overall Study|Death|1|||
48649669|NCT00662831|156570366|FG000|Overall Study|Lack of Efficacy|6|||
48649670|NCT00662831|156570367|FG001|Overall Study|Lack of Efficacy|6|||
48649671|NCT00662831|156570366|FG000|Overall Study|Lost to Follow-up|1|||
48649672|NCT00662831|156570367|FG001|Overall Study|Lost to Follow-up|0|||
48649673|NCT00662831|156570366|FG000|Overall Study|Withdrawal by Subject|2|||
48649674|NCT00662831|156570367|FG001|Overall Study|Withdrawal by Subject|1|||
48649675|NCT00662831|156570366|FG000|Overall Study|Other|62|||
48649676|NCT00662831|156570367|FG001|Overall Study|Other|31|||
48649677|NCT00662831|156570366|FG000|Overall Study|Protocol Violation|8|||
48649678|NCT00662831|156570367|FG001|Overall Study|Protocol Violation|4|||
48649679|NCT00662831|156570366|FG000|Overall Study|Adverse Event|23|||
48649680|NCT00662831|156570367|FG001|Overall Study|Adverse Event|16|||
48649681|NCT00600106|156570368|FG000|Overall Study|Withdrawal by Subject|1|||
48649682|NCT00600106|156570369|FG001|Overall Study|Withdrawal by Subject|1|||
48649683|NCT03015363|156570376|FG000|Overall Study|Physician Decision|14|||
48649684|NCT03015363|156570376|FG000|Overall Study|Withdrawal by Subject|3|||
48649685|NCT02263326|156570377|FG000|Overall Study|Lost to Follow-up|1|||
48649686|NCT02263326|156570378|FG001|Overall Study|Lost to Follow-up|1|||
48649687|NCT00301262|156570379|FG000|Double Blind Phase (DB)|Adverse Event|1|||
48649688|NCT00301262|156570380|FG001|Double Blind Phase (DB)|Adverse Event|0|||
48752577|NCT01798004|156940028|FG000|Overall Study|Ineligible|4|||
48649689|NCT00301262|156570379|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
48649690|NCT00301262|156570380|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
48649691|NCT00301262|156570379|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
48649692|NCT00301262|156570380|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
48649693|NCT00301262|156570379|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
48649694|NCT00301262|156570380|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
48649695|NCT00301262|156570379|FG000|Double Blind Phase (DB)|Other|1|||
48649696|NCT00301262|156570380|FG001|Double Blind Phase (DB)|Other|4|||
48649697|NCT00301262|156570379|FG000|Open Label Phase (OL)|Adverse Event|1|||
48649698|NCT00301262|156570380|FG001|Open Label Phase (OL)|Adverse Event|0|||
48649699|NCT00301262|156570379|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
48649700|NCT00301262|156570380|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
48649701|NCT00301262|156570379|FG000|Open Label Phase (OL)|Other|2|||
48649702|NCT00301262|156570380|FG001|Open Label Phase (OL)|Other|0|||
48649703|NCT02397915|156570381|FG000|Period 1|Protocol Violation|0|||
48649704|NCT02397915|156570382|FG001|Period 1|Protocol Violation|1|||
48649705|NCT02397915|156570383|FG002|Period 1|Protocol Violation|0|||
48649706|NCT02397915|156570384|FG003|Period 1|Protocol Violation|0|||
48649707|NCT02397915|156570381|FG000|Period 1|Physician Decision|1|||
48649708|NCT02397915|156570382|FG001|Period 1|Physician Decision|0|||
48649709|NCT02397915|156570383|FG002|Period 1|Physician Decision|0|||
48649710|NCT02397915|156570384|FG003|Period 1|Physician Decision|0|||
48649711|NCT02013778|156570386|FG000|Overall Study|Death|4|||
48649712|NCT02013778|156570386|FG000|Overall Study|Withdrawal by Subject|1|||
48649713|NCT02013778|156570386|FG000|Overall Study|Physician Decision|1|||
48649714|NCT02013778|156570386|FG000|Overall Study|Adverse Event|1|||
48649715|NCT00293813|156570387|FG000|Overall Study|Physician Decision|0|||
48649716|NCT00293813|156570388|FG001|Overall Study|Physician Decision|1|||
48649717|NCT00293813|156570389|FG002|Overall Study|Physician Decision|0|||
48649718|NCT00293813|156570387|FG000|Overall Study|Adverse Event|3|||
48649719|NCT00293813|156570388|FG001|Overall Study|Adverse Event|1|||
48649720|NCT00293813|156570389|FG002|Overall Study|Adverse Event|1|||
48649721|NCT00293813|156570387|FG000|Overall Study|Withdrawal by Subject|7|||
48649722|NCT00293813|156570388|FG001|Overall Study|Withdrawal by Subject|4|||
48649723|NCT00293813|156570389|FG002|Overall Study|Withdrawal by Subject|4|||
48649724|NCT00293813|156570387|FG000|Overall Study|Lost to Follow-up|3|||
48649725|NCT00293813|156570388|FG001|Overall Study|Lost to Follow-up|2|||
48649726|NCT00293813|156570389|FG002|Overall Study|Lost to Follow-up|3|||
48649727|NCT00293813|156570387|FG000|Overall Study|Noncompliance|0|||
48649728|NCT00293813|156570388|FG001|Overall Study|Noncompliance|1|||
48649729|NCT00293813|156570389|FG002|Overall Study|Noncompliance|0|||
48649730|NCT01521923|156570390|FG000|Overall Study|AE, serious fatal|1|||
48649731|NCT01521923|156570391|FG001|Overall Study|AE, serious fatal|0|||
48649732|NCT01521923|156570392|FG002|Overall Study|AE, serious fatal|0|||
48649733|NCT01521923|156570393|FG003|Overall Study|AE, serious fatal|0|||
48649734|NCT01521923|156570390|FG000|Overall Study|SAE, non-fatal|0|||
48649735|NCT01521923|156570391|FG001|Overall Study|SAE, non-fatal|2|||
48649736|NCT01521923|156570392|FG002|Overall Study|SAE, non-fatal|2|||
48649737|NCT01521923|156570393|FG003|Overall Study|SAE, non-fatal|0|||
48649738|NCT01521923|156570390|FG000|Overall Study|AE, non-serious, non-fatal|1|||
48649739|NCT01521923|156570391|FG001|Overall Study|AE, non-serious, non-fatal|3|||
48649740|NCT01521923|156570392|FG002|Overall Study|AE, non-serious, non-fatal|6|||
48649741|NCT01521923|156570393|FG003|Overall Study|AE, non-serious, non-fatal|2|||
48649742|NCT01521923|156570390|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
48649743|NCT01521923|156570391|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
48649744|NCT01521923|156570392|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
48649745|NCT01521923|156570393|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
48649746|NCT01521923|156570390|FG000|Overall Study|Lack of Efficacy|1|||
48649747|NCT01521923|156570391|FG001|Overall Study|Lack of Efficacy|1|||
48649748|NCT01521923|156570392|FG002|Overall Study|Lack of Efficacy|0|||
48649749|NCT01521923|156570393|FG003|Overall Study|Lack of Efficacy|0|||
48649750|NCT01521923|156570390|FG000|Overall Study|Protocol Violation|0|||
48649751|NCT01521923|156570391|FG001|Overall Study|Protocol Violation|0|||
48649752|NCT01521923|156570392|FG002|Overall Study|Protocol Violation|1|||
48649753|NCT01521923|156570393|FG003|Overall Study|Protocol Violation|0|||
48649754|NCT01521923|156570390|FG000|Overall Study|Lost to Follow-up|1|||
48649755|NCT01521923|156570391|FG001|Overall Study|Lost to Follow-up|0|||
48649756|NCT01521923|156570392|FG002|Overall Study|Lost to Follow-up|2|||
48649757|NCT01521923|156570393|FG003|Overall Study|Lost to Follow-up|1|||
48649758|NCT01521923|156570390|FG000|Overall Study|Withdrawal by Subject|1|||
48649759|NCT01521923|156570391|FG001|Overall Study|Withdrawal by Subject|1|||
48649760|NCT01521923|156570392|FG002|Overall Study|Withdrawal by Subject|1|||
48649761|NCT01521923|156570393|FG003|Overall Study|Withdrawal by Subject|2|||
48649762|NCT01521923|156570390|FG000|Overall Study|Other|2|||
48649763|NCT01521923|156570391|FG001|Overall Study|Other|1|||
48649764|NCT01521923|156570392|FG002|Overall Study|Other|3|||
48649765|NCT01521923|156570393|FG003|Overall Study|Other|6|||
48649766|NCT01521923|156570390|FG000|Overall Study|AE, captured in Period 1|0|||
48649767|NCT01521923|156570391|FG001|Overall Study|AE, captured in Period 1|1|||
48649768|NCT01521923|156570392|FG002|Overall Study|AE, captured in Period 1|0|||
48649769|NCT01521923|156570393|FG003|Overall Study|AE, captured in Period 1|1|||
48649770|NCT00880269|156570395|FG000|Overall Study|Protocol Violation|1|||
48649771|NCT00880269|156570396|FG001|Overall Study|Protocol Violation|0|||
48649772|NCT00880269|156570395|FG000|Overall Study|Disease Progression|13|||
48649773|NCT00880269|156570396|FG001|Overall Study|Disease Progression|11|||
48649774|NCT00880269|156570395|FG000|Overall Study|New Cancer Therapy|1|||
48649775|NCT00880269|156570396|FG001|Overall Study|New Cancer Therapy|0|||
48649776|NCT00880269|156570395|FG000|Overall Study|Death|4|||
48649777|NCT00880269|156570396|FG001|Overall Study|Death|2|||
48649778|NCT00880269|156570395|FG000|Overall Study|Lost to Follow-up|0|||
48649779|NCT00880269|156570396|FG001|Overall Study|Lost to Follow-up|1|||
48649780|NCT00880269|156570395|FG000|Overall Study|Withdrawal by Subject|3|||
48649781|NCT00880269|156570396|FG001|Overall Study|Withdrawal by Subject|4|||
48649782|NCT00880269|156570395|FG000|Overall Study|Adverse Event|10|||
48649783|NCT00880269|156570396|FG001|Overall Study|Adverse Event|9|||
48649784|NCT02707965|156570397|FG000|Overall Study|Withdrawal by Subject|0|||
48649785|NCT02707965|156570398|FG001|Overall Study|Withdrawal by Subject|0|||
48649786|NCT02707965|156570399|FG002|Overall Study|Withdrawal by Subject|1|||
48649787|NCT02707965|156570400|FG003|Overall Study|Withdrawal by Subject|0|||
48649788|NCT02707965|156570401|FG004|Overall Study|Withdrawal by Subject|0|||
48649789|NCT02707965|156570402|FG005|Overall Study|Withdrawal by Subject|0|||
48649790|NCT02707965|156570403|FG006|Overall Study|Withdrawal by Subject|0|||
48649791|NCT02707965|156570404|FG007|Overall Study|Withdrawal by Subject|2|||
48649792|NCT02707965|156570405|FG008|Overall Study|Withdrawal by Subject|0|||
48649793|NCT02707965|156570406|FG009|Overall Study|Withdrawal by Subject|0|||
48649794|NCT02707965|156570407|FG010|Overall Study|Withdrawal by Subject|0|||
48649795|NCT02707965|156570408|FG011|Overall Study|Withdrawal by Subject|0|||
48649796|NCT02707965|156570409|FG012|Overall Study|Withdrawal by Subject|0|||
48649797|NCT02707965|156570410|FG013|Overall Study|Withdrawal by Subject|0|||
48649798|NCT02707965|156570411|FG014|Overall Study|Withdrawal by Subject|0|||
48649799|NCT02707965|156570412|FG015|Overall Study|Withdrawal by Subject|0|||
48649800|NCT02707965|156570397|FG000|Overall Study|PI decisions|0|||
48649801|NCT02707965|156570398|FG001|Overall Study|PI decisions|0|||
48649802|NCT02707965|156570399|FG002|Overall Study|PI decisions|0|||
48649803|NCT02707965|156570400|FG003|Overall Study|PI decisions|0|||
48649804|NCT02707965|156570401|FG004|Overall Study|PI decisions|0|||
48649805|NCT02707965|156570402|FG005|Overall Study|PI decisions|0|||
48649806|NCT02707965|156570403|FG006|Overall Study|PI decisions|0|||
48649807|NCT02707965|156570404|FG007|Overall Study|PI decisions|0|||
48649808|NCT02707965|156570405|FG008|Overall Study|PI decisions|0|||
48649809|NCT02707965|156570406|FG009|Overall Study|PI decisions|0|||
48649810|NCT02707965|156570407|FG010|Overall Study|PI decisions|0|||
48649811|NCT02707965|156570408|FG011|Overall Study|PI decisions|0|||
48649812|NCT02707965|156570409|FG012|Overall Study|PI decisions|0|||
48649813|NCT02707965|156570410|FG013|Overall Study|PI decisions|0|||
48649814|NCT02707965|156570411|FG014|Overall Study|PI decisions|2|||
48649815|NCT02707965|156570412|FG015|Overall Study|PI decisions|0|||
48649816|NCT02707965|156570397|FG000|Overall Study|Protocol deviation|1|||
48649817|NCT02707965|156570398|FG001|Overall Study|Protocol deviation|1|||
48649818|NCT02707965|156570399|FG002|Overall Study|Protocol deviation|0|||
48649819|NCT02707965|156570400|FG003|Overall Study|Protocol deviation|0|||
48649820|NCT02707965|156570401|FG004|Overall Study|Protocol deviation|0|||
48649821|NCT02707965|156570402|FG005|Overall Study|Protocol deviation|0|||
48649822|NCT02707965|156570403|FG006|Overall Study|Protocol deviation|0|||
48649823|NCT02707965|156570404|FG007|Overall Study|Protocol deviation|1|||
48649824|NCT02707965|156570405|FG008|Overall Study|Protocol deviation|0|||
48649825|NCT02707965|156570406|FG009|Overall Study|Protocol deviation|0|||
48649826|NCT02707965|156570407|FG010|Overall Study|Protocol deviation|0|||
48649827|NCT02707965|156570408|FG011|Overall Study|Protocol deviation|0|||
48649828|NCT02707965|156570409|FG012|Overall Study|Protocol deviation|0|||
48649829|NCT02707965|156570410|FG013|Overall Study|Protocol deviation|0|||
48649830|NCT02707965|156570411|FG014|Overall Study|Protocol deviation|0|||
48649831|NCT02707965|156570412|FG015|Overall Study|Protocol deviation|0|||
48649832|NCT00711594|156570413|FG000|Overall Study|Progressive disease|2|||
48649833|NCT00711594|156570414|FG001|Overall Study|Progressive disease|2|||
48649834|NCT00711594|156570415|FG002|Overall Study|Progressive disease|6|||
48649835|NCT00711594|156570416|FG003|Overall Study|Progressive disease|44|||
48649836|NCT00711594|156570413|FG000|Overall Study|Other Adverse Event|1|||
48649837|NCT00711594|156570414|FG001|Overall Study|Other Adverse Event|0|||
48649838|NCT00711594|156570415|FG002|Overall Study|Other Adverse Event|0|||
48752578|NCT01798004|156940028|FG000|Overall Study|Patient/parent refusal|7|||
48752579|NCT01798004|156940028|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
48752580|NCT01798004|156940028|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
48752581|NCT03187197|156940029|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
48752582|NCT03187197|156940030|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
48752583|NCT03187197|156940031|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
48752584|NCT03187197|156940029|FG000|Overall Study|Withdrawal by Subject|8|||
48752585|NCT03187197|156940030|FG001|Overall Study|Withdrawal by Subject|63|||
48752586|NCT03187197|156940031|FG002|Overall Study|Withdrawal by Subject|4|||
48649839|NCT00711594|156570416|FG003|Overall Study|Other Adverse Event|16|||
48649840|NCT00711594|156570413|FG000|Overall Study|Withdrawal by Subject|0|||
48649841|NCT00711594|156570414|FG001|Overall Study|Withdrawal by Subject|1|||
48649842|NCT00711594|156570415|FG002|Overall Study|Withdrawal by Subject|0|||
48752587|NCT03187197|156940029|FG000|Overall Study|Lost to Follow-up|1|||
48752588|NCT03187197|156940030|FG001|Overall Study|Lost to Follow-up|60|||
48649843|NCT00711594|156570416|FG003|Overall Study|Withdrawal by Subject|2|||
48649844|NCT00564733|156570417|FG000|Overall Study|Withdrawal by Subject|4|||
48649845|NCT00564733|156570417|FG000|Overall Study|Ineligible|5|||
48649846|NCT00485758|156570420|FG000|Overall Study|Adverse Event|102|||
48649847|NCT00485758|156570421|FG001|Overall Study|Adverse Event|31|||
48649848|NCT00485758|156570420|FG000|Overall Study|Death|0|||
48649849|NCT00485758|156570421|FG001|Overall Study|Death|1|||
48649850|NCT00485758|156570420|FG000|Overall Study|Lost to Follow-up|5|||
48649851|NCT00485758|156570421|FG001|Overall Study|Lost to Follow-up|1|||
48649852|NCT00485758|156570420|FG000|Overall Study|Physician Decision|3|||
48649853|NCT00485758|156570421|FG001|Overall Study|Physician Decision|3|||
48649854|NCT00485758|156570420|FG000|Overall Study|Protocol Violation|11|||
48649855|NCT00485758|156570421|FG001|Overall Study|Protocol Violation|2|||
48649856|NCT00485758|156570420|FG000|Overall Study|Withdrawal by Subject|32|||
48649857|NCT00485758|156570421|FG001|Overall Study|Withdrawal by Subject|27|||
48649858|NCT00485758|156570420|FG000|Overall Study|Study Terminated by Sponsor|3|||
48649859|NCT00485758|156570421|FG001|Overall Study|Study Terminated by Sponsor|0|||
48649860|NCT01995526|156570422|FG000|Overall Study|Physician Decision|1|||
48649861|NCT00135330|156570427|FG000|Overall Study|Adverse Event|2|||
48649862|NCT00135330|156570428|FG001|Overall Study|Adverse Event|5|||
48649863|NCT00135330|156570429|FG002|Overall Study|Adverse Event|1|||
48649864|NCT00135330|156570427|FG000|Overall Study|Lost to Follow-up|0|||
48649865|NCT00135330|156570428|FG001|Overall Study|Lost to Follow-up|2|||
48649866|NCT00135330|156570429|FG002|Overall Study|Lost to Follow-up|3|||
48649867|NCT00135330|156570427|FG000|Overall Study|Physician Decision|1|||
48649868|NCT00135330|156570428|FG001|Overall Study|Physician Decision|1|||
48649869|NCT00135330|156570429|FG002|Overall Study|Physician Decision|0|||
48649870|NCT00135330|156570427|FG000|Overall Study|Protocol Violation|4|||
48649871|NCT00135330|156570428|FG001|Overall Study|Protocol Violation|3|||
48649872|NCT00135330|156570429|FG002|Overall Study|Protocol Violation|3|||
48649873|NCT00135330|156570427|FG000|Overall Study|Patient Decision|5|||
48649874|NCT00135330|156570428|FG001|Overall Study|Patient Decision|1|||
48649875|NCT00135330|156570429|FG002|Overall Study|Patient Decision|4|||
48649876|NCT00135330|156570427|FG000|Overall Study|Sponsor Decision|0|||
48649877|NCT00135330|156570428|FG001|Overall Study|Sponsor Decision|1|||
48649878|NCT00135330|156570429|FG002|Overall Study|Sponsor Decision|0|||
48649879|NCT04830215|156570430|FG000|Overall Study|Adverse Event|6|||
48649880|NCT04830215|156570430|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
48649881|NCT04830215|156570430|FG000|Overall Study|Withdrawal by Subject|3|||
48649882|NCT04830215|156570430|FG000|Overall Study|Protocol Deviation|1|||
48649883|NCT03367403|156570431|FG000|Overall Study|Adverse Event|20|||
48649884|NCT03367403|156570432|FG001|Overall Study|Adverse Event|6|||
48649885|NCT03367403|156570433|FG002|Overall Study|Adverse Event|2|||
48649886|NCT03367403|156570431|FG000|Overall Study|Withdrawal by Subject|12|||
48752589|NCT03187197|156940031|FG002|Overall Study|Lost to Follow-up|7|||
48649887|NCT03367403|156570432|FG001|Overall Study|Withdrawal by Subject|13|||
48649888|NCT03367403|156570433|FG002|Overall Study|Withdrawal by Subject|1|||
48649889|NCT03367403|156570431|FG000|Overall Study|Death|1|||
48649890|NCT03367403|156570432|FG001|Overall Study|Death|2|||
48649891|NCT03367403|156570433|FG002|Overall Study|Death|0|||
48649892|NCT03367403|156570431|FG000|Overall Study|Physician Decision|0|||
48649893|NCT03367403|156570432|FG001|Overall Study|Physician Decision|1|||
48649894|NCT03367403|156570433|FG002|Overall Study|Physician Decision|0|||
48649895|NCT03367403|156570431|FG000|Overall Study|Protocol Violation|1|||
48752590|NCT03187197|156940029|FG000|Overall Study|Adverse Event|6|||
48752591|NCT03187197|156940030|FG001|Overall Study|Adverse Event|29|||
48331497|NCT01052272|155411502|FG002|Overall Study|Withdrawal by Subject|3|||
48331498|NCT01052272|155411503|FG003|Overall Study|Withdrawal by Subject|2|||
48331499|NCT01052272|155411500|FG000|Overall Study|placed in long-term care|0|||
48331500|NCT01052272|155411501|FG001|Overall Study|placed in long-term care|0|||
48331501|NCT01052272|155411502|FG002|Overall Study|placed in long-term care|1|||
48331502|NCT01052272|155411503|FG003|Overall Study|placed in long-term care|0|||
48331503|NCT01052272|155411500|FG000|Overall Study|decline in health|0|||
48331504|NCT01052272|155411501|FG001|Overall Study|decline in health|0|||
48331505|NCT01052272|155411502|FG002|Overall Study|decline in health|1|||
48649896|NCT03367403|156570432|FG001|Overall Study|Protocol Violation|1|||
48649897|NCT03367403|156570433|FG002|Overall Study|Protocol Violation|0|||
48649898|NCT03367403|156570431|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
48649899|NCT03367403|156570432|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
48649900|NCT03367403|156570433|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
48649901|NCT03367403|156570431|FG000|Overall Study|COVID-19|3|||
48649902|NCT03367403|156570432|FG001|Overall Study|COVID-19|6|||
48331506|NCT01052272|155411503|FG003|Overall Study|decline in health|0|||
48331507|NCT01328756|155411504|FG000|Overall Study|Protocol Violation|4|||
48331508|NCT01328756|155411504|FG000|Overall Study|Adverse Event|39|||
48331509|NCT01328756|155411504|FG000|Overall Study|Lack of Efficacy|5|||
48331510|NCT01328756|155411504|FG000|Overall Study|Withdrawal by Subject|41|||
48331511|NCT01328756|155411504|FG000|Overall Study|Lost to Follow-up|5|||
48331512|NCT01328756|155411504|FG000|Overall Study|Other|29|||
48331513|NCT01560429|155411509|FG000|Overall Study|Protocol Violation|3|||
48331514|NCT01560429|155411510|FG001|Overall Study|Protocol Violation|6|||
48331515|NCT01365546|155411511|FG000|Overall Study|Withdrawal by Subject|1|||
48331516|NCT01365546|155411511|FG000|Overall Study|Screen failure|9|||
48331517|NCT01365546|155411511|FG000|Overall Study|Study termination|1|||
48331518|NCT02066636|155411514|FG000|Overall Study|Disease progression|51|||
48331519|NCT02066636|155411515|FG001|Overall Study|Disease progression|60|||
48331520|NCT02066636|155411516|FG002|Overall Study|Disease progression|700|||
48331521|NCT02066636|155411514|FG000|Overall Study|Study drug toxicity|13|||
48331522|NCT02066636|155411515|FG001|Overall Study|Study drug toxicity|2|||
48331523|NCT02066636|155411516|FG002|Overall Study|Study drug toxicity|58|||
48331524|NCT02066636|155411514|FG000|Overall Study|Death|4|||
48331525|NCT02066636|155411515|FG001|Overall Study|Death|2|||
48331526|NCT02066636|155411516|FG002|Overall Study|Death|158|||
48331527|NCT02066636|155411514|FG000|Overall Study|Adverse event unrelated to study drug|6|||
48331528|NCT02066636|155411515|FG001|Overall Study|Adverse event unrelated to study drug|4|||
48331529|NCT02066636|155411516|FG002|Overall Study|Adverse event unrelated to study drug|45|||
48331530|NCT02066636|155411514|FG000|Overall Study|Participant request to discontinue treatment|12|||
48331531|NCT02066636|155411515|FG001|Overall Study|Participant request to discontinue treatment|12|||
48331532|NCT02066636|155411516|FG002|Overall Study|Participant request to discontinue treatment|70|||
48331533|NCT02066636|155411514|FG000|Overall Study|Participant withdrew consent|10|||
48331534|NCT02066636|155411515|FG001|Overall Study|Participant withdrew consent|18|||
48331535|NCT02066636|155411516|FG002|Overall Study|Participant withdrew consent|61|||
48331536|NCT02066636|155411514|FG000|Overall Study|Lost to Follow-up|0|||
48331537|NCT02066636|155411515|FG001|Overall Study|Lost to Follow-up|2|||
48331538|NCT02066636|155411516|FG002|Overall Study|Lost to Follow-up|2|||
48331539|NCT02066636|155411514|FG000|Overall Study|Maximum clinical benefit|2|||
48331540|NCT02066636|155411515|FG001|Overall Study|Maximum clinical benefit|2|||
48331541|NCT02066636|155411516|FG002|Overall Study|Maximum clinical benefit|3|||
48331542|NCT02066636|155411514|FG000|Overall Study|Poor/non-compliance|2|||
48331543|NCT02066636|155411515|FG001|Overall Study|Poor/non-compliance|1|||
48331544|NCT02066636|155411516|FG002|Overall Study|Poor/non-compliance|1|||
48331545|NCT02066636|155411514|FG000|Overall Study|Participant no loner meets study criteria|3|||
48331546|NCT02066636|155411515|FG001|Overall Study|Participant no loner meets study criteria|2|||
48331547|NCT02066636|155411516|FG002|Overall Study|Participant no loner meets study criteria|28|||
48331548|NCT02066636|155411514|FG000|Overall Study|Administrative reasons by sponsor|8|||
48331549|NCT02066636|155411515|FG001|Overall Study|Administrative reasons by sponsor|5|||
48331550|NCT02066636|155411516|FG002|Overall Study|Administrative reasons by sponsor|0|||
48331551|NCT02066636|155411514|FG000|Overall Study|Other reasons|16|||
48331552|NCT02066636|155411515|FG001|Overall Study|Other reasons|15|||
48331553|NCT02066636|155411516|FG002|Overall Study|Other reasons|50|||
48331554|NCT02991118|155411520|FG000|Overall Study|Death|3|||
48331555|NCT02991118|155411521|FG001|Overall Study|Death|8|||
48331556|NCT02991118|155411520|FG000|Overall Study|Protocol Violation|0|||
48331557|NCT02991118|155411521|FG001|Overall Study|Protocol Violation|3|||
48331558|NCT02991118|155411520|FG000|Overall Study|Physician Decision|0|||
48331559|NCT02991118|155411521|FG001|Overall Study|Physician Decision|1|||
48331560|NCT02991118|155411520|FG000|Overall Study|Moved out of the country|0|||
48331561|NCT02991118|155411521|FG001|Overall Study|Moved out of the country|1|||
48331562|NCT02991118|155411520|FG000|Overall Study|Adverse Event|2|||
48331563|NCT02991118|155411521|FG001|Overall Study|Adverse Event|2|||
48331564|NCT02991118|155411520|FG000|Overall Study|Withdrawal by Subject|1|||
48427965|NCT02538666|155754777|FG002|Pre-Treatment|Disease progression|0|||
48649903|NCT03367403|156570433|FG002|Overall Study|COVID-19|0|||
48649904|NCT03367403|156570431|FG000|Overall Study|Abuse of Alcohol Intake|0|||
48649905|NCT03367403|156570432|FG001|Overall Study|Abuse of Alcohol Intake|1|||
48649906|NCT03367403|156570433|FG002|Overall Study|Abuse of Alcohol Intake|0|||
48649907|NCT03367403|156570431|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
48649908|NCT03367403|156570432|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
48649909|NCT03367403|156570433|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
48649910|NCT01822899|156570436|FG000|Overall Study|Adverse Event|6|||
48649911|NCT01822899|156570437|FG001|Overall Study|Adverse Event|5|||
48649912|NCT01822899|156570436|FG000|Overall Study|Lack of Efficacy|6|||
48649913|NCT01822899|156570437|FG001|Overall Study|Lack of Efficacy|3|||
48649914|NCT01822899|156570436|FG000|Overall Study|Protocol Violation|6|||
48649915|NCT01822899|156570437|FG001|Overall Study|Protocol Violation|3|||
48649916|NCT01822899|156570436|FG000|Overall Study|Lost to Follow-up|1|||
48649917|NCT01822899|156570437|FG001|Overall Study|Lost to Follow-up|0|||
48649918|NCT01822899|156570436|FG000|Overall Study|Withdrawal by Subject|5|||
48649919|NCT01822899|156570437|FG001|Overall Study|Withdrawal by Subject|7|||
48649920|NCT02253433|156570438|FG000|Overall Study|Unable to Contact|9|||
48649921|NCT02253433|156570439|FG001|Overall Study|Unable to Contact|16|||
48649922|NCT02253433|156570438|FG000|Overall Study|Death|1|||
48649923|NCT02253433|156570439|FG001|Overall Study|Death|1|||
48649924|NCT02253433|156570438|FG000|Overall Study|No Longer Interested|3|||
48649925|NCT02253433|156570439|FG001|Overall Study|No Longer Interested|15|||
48649926|NCT02253433|156570438|FG000|Overall Study|Out of Study Area|2|||
48649927|NCT02253433|156570439|FG001|Overall Study|Out of Study Area|7|||
48649928|NCT02253433|156570438|FG000|Overall Study|Uncomfortable with home visitors|0|||
48649929|NCT02253433|156570439|FG001|Overall Study|Uncomfortable with home visitors|3|||
48649930|NCT02253433|156570438|FG000|Overall Study|Unstable Housing/Homeless|0|||
48649931|NCT02253433|156570439|FG001|Overall Study|Unstable Housing/Homeless|7|||
48649932|NCT02253433|156570438|FG000|Overall Study|Too Busy|0|||
48649933|NCT02253433|156570439|FG001|Overall Study|Too Busy|4|||
48649934|NCT02253433|156570438|FG000|Overall Study|Medical or Other Concerns|1|||
48649935|NCT02253433|156570439|FG001|Overall Study|Medical or Other Concerns|2|||
48649936|NCT00759876|156570440|FG000|Overall Study|Sponsor terminated study early|36|||
48649937|NCT00224120|156570441|FG000|Overall Study|Adverse Event|10|||
48649938|NCT00224120|156570442|FG001|Overall Study|Adverse Event|4|||
48649939|NCT00224120|156570441|FG000|Overall Study|Protocol Violation|1|||
48649940|NCT00224120|156570442|FG001|Overall Study|Protocol Violation|0|||
48649941|NCT00224120|156570441|FG000|Overall Study|Withdrawal by Subject|5|||
48649942|NCT00224120|156570442|FG001|Overall Study|Withdrawal by Subject|10|||
48649943|NCT00224120|156570441|FG000|Overall Study|Lack of Efficacy|0|||
48649944|NCT00224120|156570442|FG001|Overall Study|Lack of Efficacy|2|||
48649945|NCT00224120|156570441|FG000|Overall Study|Lost to Follow-up|2|||
48649946|NCT00224120|156570442|FG001|Overall Study|Lost to Follow-up|3|||
48649947|NCT00224120|156570441|FG000|Overall Study|Other|4|||
48649948|NCT00224120|156570442|FG001|Overall Study|Other|5|||
48649949|NCT00988052|156570443|FG000|Overall Study|Missing|1|||
48649950|NCT00988052|156570444|FG001|Overall Study|Missing|0|||
48649951|NCT00988052|156570443|FG000|Overall Study|Teva requested subject withdrawal|3|||
48649952|NCT00988052|156570444|FG001|Overall Study|Teva requested subject withdrawal|1|||
48649953|NCT00988052|156570443|FG000|Overall Study|Death|1|||
48649954|NCT00988052|156570444|FG001|Overall Study|Death|3|||
48649955|NCT00988052|156570443|FG000|Overall Study|Protocol Violation|6|||
48649956|NCT00988052|156570444|FG001|Overall Study|Protocol Violation|5|||
48649957|NCT00988052|156570443|FG000|Overall Study|Pregnancy|6|||
48649958|NCT00988052|156570444|FG001|Overall Study|Pregnancy|6|||
48649959|NCT00988052|156570443|FG000|Overall Study|Lack of Efficacy|8|||
48649960|NCT00988052|156570444|FG001|Overall Study|Lack of Efficacy|7|||
48649961|NCT00988052|156570443|FG000|Overall Study|Lost to Follow-up|6|||
48649962|NCT00988052|156570444|FG001|Overall Study|Lost to Follow-up|11|||
48649963|NCT00988052|156570443|FG000|Overall Study|Physician Decision|27|||
48649964|NCT00988052|156570444|FG001|Overall Study|Physician Decision|28|||
48649965|NCT00988052|156570443|FG000|Overall Study|Adverse Event|35|||
48428044|NCT02518620|155754793|FG000|Overall Study|Pregnancy|1|||
48649966|NCT00988052|156570444|FG001|Overall Study|Adverse Event|28|||
48649967|NCT00988052|156570443|FG000|Overall Study|Withdrawal by Subject|90|||
48649968|NCT00988052|156570444|FG001|Overall Study|Withdrawal by Subject|91|||
48649969|NCT00988052|156570443|FG000|Overall Study|Study terminated by sponsor|240|||
48649970|NCT00988052|156570444|FG001|Overall Study|Study terminated by sponsor|236|||
48649971|NCT02584452|156570445|FG000|Overall Study|Physician Decision|1|||
48649972|NCT02584452|156570446|FG001|Overall Study|Physician Decision|1|||
48649973|NCT02584452|156570445|FG000|Overall Study|Lost to Follow-up|1|||
48649974|NCT02584452|156570446|FG001|Overall Study|Lost to Follow-up|1|||
48649975|NCT03640507|156570449|FG000|Overall Study|Withdrawal by Subject|0|||
48649976|NCT03640507|156570450|FG001|Overall Study|Withdrawal by Subject|0|||
48752592|NCT03187197|156940031|FG002|Overall Study|Adverse Event|0|||
48649977|NCT03640507|156570451|FG002|Overall Study|Withdrawal by Subject|1|||
48649978|NCT03525600|156570452|FG000|Overall Study|Adverse Event|9|||
48649979|NCT03525600|156570453|FG001|Overall Study|Adverse Event|6|||
48649980|NCT03525600|156570454|FG002|Overall Study|Adverse Event|5|||
48752593|NCT03187197|156940029|FG000|Overall Study|Death|0|||
48649981|NCT03525600|156570455|FG003|Overall Study|Adverse Event|3|||
48649982|NCT03525600|156570452|FG000|Overall Study|Lost to Follow-up|2|||
48649983|NCT03525600|156570453|FG001|Overall Study|Lost to Follow-up|4|||
48649984|NCT03525600|156570454|FG002|Overall Study|Lost to Follow-up|4|||
48649985|NCT03525600|156570455|FG003|Overall Study|Lost to Follow-up|0|||
48649986|NCT03525600|156570452|FG000|Overall Study|Physician Decision|1|||
48649987|NCT03525600|156570453|FG001|Overall Study|Physician Decision|0|||
48649988|NCT03525600|156570454|FG002|Overall Study|Physician Decision|2|||
48649989|NCT03525600|156570455|FG003|Overall Study|Physician Decision|0|||
48649990|NCT03525600|156570452|FG000|Overall Study|Consent withdrawal|36|||
48649991|NCT03525600|156570453|FG001|Overall Study|Consent withdrawal|20|||
48649992|NCT03525600|156570454|FG002|Overall Study|Consent withdrawal|6|||
48752594|NCT03187197|156940030|FG001|Overall Study|Death|11|||
48752595|NCT03187197|156940031|FG002|Overall Study|Death|0|||
48752596|NCT03187197|156940029|FG000|Overall Study|Administrative problem|1|||
48752597|NCT03187197|156940030|FG001|Overall Study|Administrative problem|1|||
48752598|NCT03187197|156940031|FG002|Overall Study|Administrative problem|0|||
48752599|NCT03187197|156940029|FG000|Overall Study|Reason not listed|2|||
48752600|NCT03187197|156940030|FG001|Overall Study|Reason not listed|54|||
48752601|NCT03187197|156940031|FG002|Overall Study|Reason not listed|1|||
48752602|NCT03187197|156940029|FG000|Overall Study|Missing|1|||
48752603|NCT03187197|156940030|FG001|Overall Study|Missing|32|||
48752604|NCT03187197|156940031|FG002|Overall Study|Missing|3|||
48752605|NCT03187197|156940029|FG000|Overall Study|Status missing|2|||
48752606|NCT03187197|156940030|FG001|Overall Study|Status missing|33|||
48752607|NCT03187197|156940031|FG002|Overall Study|Status missing|3|||
48752608|NCT03187197|156940029|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
48752609|NCT03187197|156940030|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
48752610|NCT03187197|156940031|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
48752611|NCT01955733|156940032|FG000|Period 1|Lost to Follow-up|1|||
48752612|NCT01955733|156940033|FG001|Period 1|Lost to Follow-up|0|||
48752613|NCT01955733|156940034|FG002|Period 1|Lost to Follow-up|0|||
48752614|NCT01955733|156940032|FG000|Period 2|Adverse Event|1|||
48752615|NCT01955733|156940033|FG001|Period 2|Adverse Event|0|||
48752616|NCT01955733|156940034|FG002|Period 2|Adverse Event|0|||
48752617|NCT01955733|156940032|FG000|Period 2|Physician Decision|0|||
48752618|NCT01955733|156940033|FG001|Period 2|Physician Decision|0|||
48752619|NCT01955733|156940034|FG002|Period 2|Physician Decision|1|||
48752620|NCT01955733|156940032|FG000|Period 2|Withdrawal by Subject|1|||
48649993|NCT03525600|156570455|FG003|Overall Study|Consent withdrawal|13|||
48649994|NCT03525600|156570452|FG000|Overall Study|Death|7|||
48649995|NCT03525600|156570453|FG001|Overall Study|Death|6|||
48649996|NCT03525600|156570454|FG002|Overall Study|Death|4|||
48649997|NCT03525600|156570455|FG003|Overall Study|Death|3|||
48649998|NCT03525600|156570452|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
48649999|NCT03525600|156570453|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
48650000|NCT03525600|156570454|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
48650001|NCT03525600|156570455|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
48650002|NCT03525600|156570452|FG000|Overall Study|Other|0|||
48331565|NCT02991118|155411521|FG001|Overall Study|Withdrawal by Subject|7|||
48331566|NCT02991118|155411520|FG000|Overall Study|Could not attend study visits|0|||
48331567|NCT02991118|155411521|FG001|Overall Study|Could not attend study visits|1|||
48331568|NCT02991118|155411520|FG000|Overall Study|Lost to Follow-up|1|||
48650003|NCT03525600|156570453|FG001|Overall Study|Other|1|||
48650004|NCT03525600|156570454|FG002|Overall Study|Other|0|||
48650005|NCT03525600|156570455|FG003|Overall Study|Other|0|||
48650006|NCT00289289|156570456|FG000|Overall Study|Withdrawal by Subject|5|||
48650007|NCT00289289|156570457|FG001|Overall Study|Withdrawal by Subject|3|||
48650008|NCT00289289|156570458|FG002|Overall Study|Withdrawal by Subject|15|||
48650009|NCT00289289|156570456|FG000|Overall Study|Lost to Follow-up|1|||
48650010|NCT00289289|156570457|FG001|Overall Study|Lost to Follow-up|0|||
48331569|NCT02991118|155411521|FG001|Overall Study|Lost to Follow-up|9|||
48331570|NCT01777932|155411524|FG000|Overall Study|Disease progression|136|||
48331571|NCT01777932|155411524|FG000|Overall Study|Death|3|||
48650011|NCT00289289|156570458|FG002|Overall Study|Lost to Follow-up|1|||
48650012|NCT00289289|156570456|FG000|Overall Study|Death|4|||
48650013|NCT00289289|156570457|FG001|Overall Study|Death|2|||
48650014|NCT00289289|156570458|FG002|Overall Study|Death|5|||
48650015|NCT00289289|156570456|FG000|Overall Study|No implant attempted|0|||
48650016|NCT00289289|156570457|FG001|Overall Study|No implant attempted|0|||
48650017|NCT00289289|156570458|FG002|Overall Study|No implant attempted|1|||
48650018|NCT00289289|156570456|FG000|Overall Study|Physician Decision|1|||
48650019|NCT00289289|156570457|FG001|Overall Study|Physician Decision|0|||
48650020|NCT00289289|156570458|FG002|Overall Study|Physician Decision|6|||
48650021|NCT00289289|156570456|FG000|Overall Study|Non-study device implanted|2|||
48650022|NCT00289289|156570457|FG001|Overall Study|Non-study device implanted|1|||
48650023|NCT00289289|156570458|FG002|Overall Study|Non-study device implanted|3|||
48650024|NCT00289289|156570456|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
48752621|NCT01955733|156940033|FG001|Period 2|Withdrawal by Subject|3|||
48752622|NCT01955733|156940034|FG002|Period 2|Withdrawal by Subject|2|||
48752623|NCT01955733|156940032|FG000|Period 2|Study terminated by sponsor|8|||
48752624|NCT01955733|156940033|FG001|Period 2|Study terminated by sponsor|14|||
48752625|NCT01955733|156940034|FG002|Period 2|Study terminated by sponsor|16|||
48752626|NCT01955733|156940032|FG000|Period 2|Lost to Follow-up|2|||
48752627|NCT01955733|156940033|FG001|Period 2|Lost to Follow-up|0|||
48752628|NCT01955733|156940034|FG002|Period 2|Lost to Follow-up|0|||
48331572|NCT01777932|155411524|FG000|Overall Study|Adverse Event|34|||
48331573|NCT01777932|155411524|FG000|Overall Study|Lost to Follow-up|3|||
48650025|NCT00289289|156570457|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
48650026|NCT00289289|156570458|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
48650027|NCT00289289|156570456|FG000|Overall Study|Other Exit Reason|6|||
48650028|NCT00289289|156570457|FG001|Overall Study|Other Exit Reason|4|||
48650029|NCT00289289|156570458|FG002|Overall Study|Other Exit Reason|12|||
48752629|NCT01955733|156940032|FG000|Period 2|Other not defined above|0|||
48752630|NCT01955733|156940033|FG001|Period 2|Other not defined above|2|||
48752631|NCT01955733|156940034|FG002|Period 2|Other not defined above|2|||
48650030|NCT01832493|156570465|FG000|Overall Study|Physician Decision|2|||
48650031|NCT01832493|156570465|FG000|Overall Study|Protocol Violation|4|||
48650032|NCT01832493|156570465|FG000|Overall Study|Unable to place LV lead|2|||
48650033|NCT01536561|156570466|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
48650034|NCT01536561|156570466|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
48650035|NCT01536561|156570466|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
48650036|NCT01536561|156570466|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
48650037|NCT01536561|156570466|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
48650038|NCT01536561|156570466|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
48650039|NCT01939977|156570467|FG000|Overall Study|Adverse Event|4|||
48650040|NCT01939977|156570468|FG001|Overall Study|Adverse Event|3|||
48650041|NCT01939977|156570467|FG000|Overall Study|Lack of Efficacy|3|||
48650042|NCT01939977|156570468|FG001|Overall Study|Lack of Efficacy|0|||
48650043|NCT01939977|156570467|FG000|Overall Study|Physician Decision|1|||
48650044|NCT01939977|156570468|FG001|Overall Study|Physician Decision|1|||
48650045|NCT01939977|156570467|FG000|Overall Study|Withdrawal by Subject|0|||
48650046|NCT01939977|156570468|FG001|Overall Study|Withdrawal by Subject|2|||
48650047|NCT01939977|156570467|FG000|Overall Study|Did not meet inclusion criteria|1|||
48650048|NCT01939977|156570468|FG001|Overall Study|Did not meet inclusion criteria|0|||
48650049|NCT01939977|156570467|FG000|Overall Study|Did not receive study medication|0|||
48650050|NCT01939977|156570468|FG001|Overall Study|Did not receive study medication|1|||
48650051|NCT00577707|156570469|FG000|Overall Study|Withdrawal by Subject|3|||
48650052|NCT01262560|156570470|FG000|Overall Study|Protocol Violation|0|||
48650053|NCT01262560|156570471|FG001|Overall Study|Protocol Violation|1|||
48650054|NCT01262560|156570472|FG002|Overall Study|Protocol Violation|2|||
48650055|NCT00656058|156570473|FG000|Overall Study|Withdrawal by Subject|2|||
48650056|NCT00656058|156570473|FG000|Overall Study|Withdrawal by Subject|4|||
48650057|NCT02097719|156570475|FG000|Overall Study|Subject Withdrew Consent|1|||
48650058|NCT02097719|156570476|FG001|Overall Study|Subject Withdrew Consent|0|||
48752632|NCT00793598|156940035|FG000|Overall Study|Patient Request|0|||
48752633|NCT00793598|156940036|FG001|Overall Study|Patient Request|1|||
48331574|NCT01777932|155411524|FG000|Overall Study|Investigator decision|10|||
48331575|NCT01777932|155411524|FG000|Overall Study|Reimbursement limit|9|||
48331576|NCT01777932|155411524|FG000|Overall Study|Patient refused further treatment|10|||
48331577|NCT01159600|155411525|FG000|Overall Study|Not treated|0|||
48331578|NCT01159600|155411526|FG001|Overall Study|Not treated|0|||
48331579|NCT01159600|155411527|FG002|Overall Study|Not treated|1|||
48331580|NCT01159600|155411528|FG003|Overall Study|Not treated|0|||
48331581|NCT01159600|155411529|FG004|Overall Study|Not treated|0|||
48331582|NCT01159600|155411530|FG005|Overall Study|Not treated|1|||
48331583|NCT01159600|155411531|FG006|Overall Study|Not treated|2|||
48331584|NCT01159600|155411532|FG007|Overall Study|Not treated|2|||
48331585|NCT01159600|155411525|FG000|Overall Study|Adverse Event|7|||
48331586|NCT01159600|155411526|FG001|Overall Study|Adverse Event|2|||
48650059|NCT02097719|156570475|FG000|Overall Study|Lost to Follow-up|0|||
48650060|NCT02097719|156570476|FG001|Overall Study|Lost to Follow-up|1|||
48650061|NCT02097719|156570475|FG000|Overall Study|Adverse Event|2|||
48650062|NCT02097719|156570476|FG001|Overall Study|Adverse Event|0|||
48650063|NCT00861692|156570477|FG000|Overall Study|Death|6|||
48331587|NCT01159600|155411527|FG002|Overall Study|Adverse Event|5|||
48331588|NCT01159600|155411528|FG003|Overall Study|Adverse Event|1|||
48331589|NCT01159600|155411529|FG004|Overall Study|Adverse Event|8|||
48331590|NCT01159600|155411530|FG005|Overall Study|Adverse Event|6|||
48331591|NCT01159600|155411531|FG006|Overall Study|Adverse Event|7|||
48331592|NCT01159600|155411532|FG007|Overall Study|Adverse Event|5|||
48331593|NCT01159600|155411525|FG000|Overall Study|Lack of Efficacy|0|||
48331594|NCT01159600|155411526|FG001|Overall Study|Lack of Efficacy|0|||
48331595|NCT01159600|155411527|FG002|Overall Study|Lack of Efficacy|0|||
48331596|NCT01159600|155411528|FG003|Overall Study|Lack of Efficacy|0|||
48650064|NCT04262882|156570478|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
48650065|NCT04262882|156570479|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
48650066|NCT04262882|156570478|FG000|Overall Study|Lost to Follow-up|1|||
48650067|NCT04262882|156570479|FG001|Overall Study|Lost to Follow-up|0|||
48650068|NCT03292640|156570480|FG000|Overall Study|Withdrawal by Subject|17|||
48650069|NCT03292640|156570481|FG001|Overall Study|Withdrawal by Subject|16|||
48650070|NCT03292640|156570480|FG000|Overall Study|Adverse Event|20|||
48650071|NCT03292640|156570481|FG001|Overall Study|Adverse Event|2|||
48650072|NCT03292640|156570480|FG000|Overall Study|Lost to Follow-up|24|||
48650073|NCT03292640|156570481|FG001|Overall Study|Lost to Follow-up|24|||
48650074|NCT02597452|156570484|FG000|Overall Study|testing incomplete|30|||
48650075|NCT00107900|156570487|FG000|Overall Study|Adverse Event|3|||
48650076|NCT00107900|156570488|FG001|Overall Study|Adverse Event|2|||
48650077|NCT00107900|156570489|FG002|Overall Study|Adverse Event|10|||
48752634|NCT00793598|156940037|FG002|Overall Study|Patient Request|0|||
48752635|NCT00793598|156940038|FG003|Overall Study|Patient Request|0|||
48752636|NCT00793598|156940039|FG004|Overall Study|Patient Request|0|||
48752637|NCT00793598|156940040|FG005|Overall Study|Patient Request|0|||
48752638|NCT00793598|156940041|FG006|Overall Study|Patient Request|0|||
48752639|NCT00793598|156940042|FG007|Overall Study|Patient Request|0|||
48752640|NCT00793598|156940035|FG000|Overall Study|Protocol Violation|0|||
48752641|NCT00793598|156940036|FG001|Overall Study|Protocol Violation|0|||
48752642|NCT00793598|156940037|FG002|Overall Study|Protocol Violation|0|||
48752643|NCT00793598|156940038|FG003|Overall Study|Protocol Violation|0|||
48752644|NCT00793598|156940039|FG004|Overall Study|Protocol Violation|0|||
48752645|NCT00793598|156940040|FG005|Overall Study|Protocol Violation|0|||
48752646|NCT00793598|156940041|FG006|Overall Study|Protocol Violation|0|||
48752647|NCT00793598|156940042|FG007|Overall Study|Protocol Violation|1|||
48752648|NCT00793598|156940035|FG000|Overall Study|Subject not dosed|0|||
48752649|NCT00793598|156940036|FG001|Overall Study|Subject not dosed|0|||
48752650|NCT00793598|156940037|FG002|Overall Study|Subject not dosed|0|||
48752651|NCT00793598|156940038|FG003|Overall Study|Subject not dosed|0|||
48752652|NCT00793598|156940039|FG004|Overall Study|Subject not dosed|0|||
48752653|NCT00793598|156940040|FG005|Overall Study|Subject not dosed|1|||
48752654|NCT00793598|156940041|FG006|Overall Study|Subject not dosed|0|||
48752655|NCT00793598|156940042|FG007|Overall Study|Subject not dosed|0|||
48752656|NCT02239978|156940043|FG000|Overall Study|Withdrawal by Subject|2|||
48752657|NCT02239978|156940044|FG001|Overall Study|Withdrawal by Subject|0|||
48752658|NCT05255068|156940045|FG000|Overall Study|Lost to Follow-up|0|||
48752659|NCT05255068|156940046|FG001|Overall Study|Lost to Follow-up|1|||
48752660|NCT00290888|156940050|FG000|Overall Study|Physician Decision|3|||
48650078|NCT00107900|156570490|FG003|Overall Study|Adverse Event|3|||
48752661|NCT00290888|156940051|FG001|Overall Study|Physician Decision|1|||
48752662|NCT00540514|156940054|FG000|Overall Study|Still on treatment|3|||
48752663|NCT00540514|156940055|FG001|Overall Study|Still on treatment|0|||
48331597|NCT01159600|155411529|FG004|Overall Study|Lack of Efficacy|2|||
48331598|NCT01159600|155411530|FG005|Overall Study|Lack of Efficacy|0|||
48331599|NCT01159600|155411531|FG006|Overall Study|Lack of Efficacy|0|||
48331600|NCT01159600|155411532|FG007|Overall Study|Lack of Efficacy|1|||
48331601|NCT01159600|155411525|FG000|Overall Study|Non compliant with protocol|2|||
48331602|NCT01159600|155411526|FG001|Overall Study|Non compliant with protocol|1|||
48752664|NCT00540514|156940054|FG000|Overall Study|Unacceptable Toxicity|61|||
48650079|NCT00107900|156570491|FG004|Overall Study|Adverse Event|5|||
48650080|NCT00107900|156570492|FG005|Overall Study|Adverse Event|3|||
48650081|NCT00107900|156570487|FG000|Overall Study|Death|0|||
48650082|NCT00107900|156570488|FG001|Overall Study|Death|0|||
48650083|NCT00107900|156570489|FG002|Overall Study|Death|0|||
48650084|NCT00107900|156570490|FG003|Overall Study|Death|0|||
48650085|NCT00107900|156570491|FG004|Overall Study|Death|1|||
48650086|NCT00107900|156570492|FG005|Overall Study|Death|0|||
48650087|NCT00107900|156570487|FG000|Overall Study|Lost to Follow-up|4|||
48650088|NCT00107900|156570488|FG001|Overall Study|Lost to Follow-up|1|||
48650089|NCT00107900|156570489|FG002|Overall Study|Lost to Follow-up|3|||
48650090|NCT00107900|156570490|FG003|Overall Study|Lost to Follow-up|2|||
48331603|NCT01159600|155411527|FG002|Overall Study|Non compliant with protocol|0|||
48331604|NCT01159600|155411528|FG003|Overall Study|Non compliant with protocol|0|||
48331605|NCT01159600|155411529|FG004|Overall Study|Non compliant with protocol|2|||
48331606|NCT01159600|155411530|FG005|Overall Study|Non compliant with protocol|0|||
48331607|NCT01159600|155411531|FG006|Overall Study|Non compliant with protocol|2|||
48331608|NCT01159600|155411532|FG007|Overall Study|Non compliant with protocol|0|||
48331609|NCT01159600|155411525|FG000|Overall Study|Lost to Follow-up|2|||
48331610|NCT01159600|155411526|FG001|Overall Study|Lost to Follow-up|3|||
48331611|NCT01159600|155411527|FG002|Overall Study|Lost to Follow-up|4|||
48331612|NCT01159600|155411528|FG003|Overall Study|Lost to Follow-up|3|||
48331613|NCT01159600|155411529|FG004|Overall Study|Lost to Follow-up|3|||
48331614|NCT01159600|155411530|FG005|Overall Study|Lost to Follow-up|0|||
48331615|NCT01159600|155411531|FG006|Overall Study|Lost to Follow-up|3|||
48331616|NCT01159600|155411532|FG007|Overall Study|Lost to Follow-up|2|||
48331617|NCT01159600|155411525|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
48331618|NCT01159600|155411526|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
48650091|NCT00107900|156570491|FG004|Overall Study|Lost to Follow-up|5|||
48650092|NCT00107900|156570492|FG005|Overall Study|Lost to Follow-up|5|||
48331619|NCT01159600|155411527|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
48331620|NCT01159600|155411528|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
48331621|NCT01159600|155411529|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
48331622|NCT01159600|155411530|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
48331623|NCT01159600|155411531|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
48331624|NCT01159600|155411532|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
48331625|NCT01159600|155411525|FG000|Overall Study|Other reason not defined above|3|||
48331626|NCT01159600|155411526|FG001|Overall Study|Other reason not defined above|0|||
48331627|NCT01159600|155411527|FG002|Overall Study|Other reason not defined above|4|||
48331628|NCT01159600|155411528|FG003|Overall Study|Other reason not defined above|2|||
48331629|NCT01159600|155411529|FG004|Overall Study|Other reason not defined above|5|||
48331630|NCT01159600|155411530|FG005|Overall Study|Other reason not defined above|7|||
48331631|NCT01159600|155411531|FG006|Overall Study|Other reason not defined above|3|||
48331632|NCT01159600|155411532|FG007|Overall Study|Other reason not defined above|3|||
48331633|NCT00983294|155411533|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
48331634|NCT00983294|155411533|FG000|Colchicine With Azithromycin|Adverse Event|1|||
48331635|NCT00963924|155411534|FG000|Overall Study|Adverse Event|1|||
48331636|NCT00963924|155411535|FG001|Overall Study|Adverse Event|0|||
48331637|NCT00963924|155411534|FG000|Overall Study|Withdrawal by Subject|0|||
48331638|NCT00963924|155411535|FG001|Overall Study|Withdrawal by Subject|1|||
48331639|NCT00963924|155411534|FG000|Overall Study|Changed antipsychotic|0|||
48331640|NCT00963924|155411535|FG001|Overall Study|Changed antipsychotic|1|||
48331641|NCT00963924|155411534|FG000|Overall Study|Lost to Follow-up|0|||
48331642|NCT00963924|155411535|FG001|Overall Study|Lost to Follow-up|1|||
48331643|NCT00446095|155411536|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
48331644|NCT00446095|155411537|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
48331645|NCT00446095|155411538|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
48331646|NCT00446095|155411539|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
48331647|NCT00446095|155411540|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
48331648|NCT00446095|155411536|FG000|Phase II (8 Weeks)|Adverse Event|0|||
48650093|NCT00107900|156570487|FG000|Overall Study|Protocol Violation|1|||
48650094|NCT00107900|156570488|FG001|Overall Study|Protocol Violation|0|||
48752665|NCT00540514|156940055|FG001|Overall Study|Unacceptable Toxicity|62|||
48752666|NCT00540514|156940054|FG000|Overall Study|Adverse Event|20|||
48331649|NCT00446095|155411537|FG001|Phase II (8 Weeks)|Adverse Event|1|||
48331650|NCT00446095|155411538|FG002|Phase II (8 Weeks)|Adverse Event|1|||
48331651|NCT00446095|155411539|FG003|Phase II (8 Weeks)|Adverse Event|0|||
48331652|NCT00446095|155411540|FG004|Phase II (8 Weeks)|Adverse Event|0|||
48331653|NCT00446095|155411536|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
48331654|NCT00446095|155411537|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
48331655|NCT00446095|155411538|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
48331656|NCT00446095|155411539|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
48650095|NCT00107900|156570489|FG002|Overall Study|Protocol Violation|5|||
48650096|NCT00107900|156570490|FG003|Overall Study|Protocol Violation|5|||
48650097|NCT00107900|156570491|FG004|Overall Study|Protocol Violation|7|||
48650098|NCT00107900|156570492|FG005|Overall Study|Protocol Violation|0|||
48752667|NCT00540514|156940055|FG001|Overall Study|Adverse Event|24|||
48331657|NCT00446095|155411540|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
48752668|NCT00540514|156940054|FG000|Overall Study|Physician Decision|86|||
48752669|NCT00540514|156940055|FG001|Overall Study|Physician Decision|99|||
48752670|NCT00540514|156940054|FG000|Overall Study|Protocol Deviation|3|||
48331658|NCT00446095|155411536|FG000|Phase II (8 Weeks)|Physician Decision|1|||
48331659|NCT00446095|155411537|FG001|Phase II (8 Weeks)|Physician Decision|0|||
48331660|NCT00446095|155411538|FG002|Phase II (8 Weeks)|Physician Decision|0|||
48331661|NCT00446095|155411539|FG003|Phase II (8 Weeks)|Physician Decision|0|||
48331662|NCT00446095|155411540|FG004|Phase II (8 Weeks)|Physician Decision|0|||
48331663|NCT00446095|155411536|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
48331664|NCT00446095|155411537|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
48331665|NCT00446095|155411538|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
48650099|NCT00107900|156570487|FG000|Overall Study|Withdrawal by Subject|1|||
48650100|NCT00107900|156570488|FG001|Overall Study|Withdrawal by Subject|0|||
48650101|NCT00107900|156570489|FG002|Overall Study|Withdrawal by Subject|5|||
48650102|NCT00107900|156570490|FG003|Overall Study|Withdrawal by Subject|0|||
48650103|NCT00107900|156570491|FG004|Overall Study|Withdrawal by Subject|1|||
48650104|NCT00107900|156570492|FG005|Overall Study|Withdrawal by Subject|1|||
48650105|NCT00107900|156570487|FG000|Overall Study|Administrative Reasons|1|||
48650106|NCT00107900|156570488|FG001|Overall Study|Administrative Reasons|0|||
48650107|NCT00107900|156570489|FG002|Overall Study|Administrative Reasons|2|||
48650108|NCT00107900|156570490|FG003|Overall Study|Administrative Reasons|2|||
48650109|NCT00107900|156570491|FG004|Overall Study|Administrative Reasons|2|||
48650110|NCT00107900|156570492|FG005|Overall Study|Administrative Reasons|0|||
48650111|NCT02982772|156572939|FG000|Intervention|Lost to Follow-up|19|||
48650112|NCT02982772|156572940|FG001|Intervention|Lost to Follow-up|13|||
48650113|NCT02982772|156572939|FG000|1M Follow-Up|Lost to Follow-up|21|||
48650114|NCT02982772|156572940|FG001|1M Follow-Up|Lost to Follow-up|18|||
48650115|NCT02982772|156572939|FG000|3M Follow-Up|Lost to Follow-up|17|||
48650116|NCT02982772|156572940|FG001|3M Follow-Up|Lost to Follow-up|11|||
48650117|NCT02982772|156572939|FG000|6M Follow-Up|Lost to Follow-up|11|||
48650118|NCT02982772|156572940|FG001|6M Follow-Up|Lost to Follow-up|9|||
48650119|NCT02982772|156572939|FG000|12M Follow-Up|Lost to Follow-up|11|||
48650120|NCT02982772|156572940|FG001|12M Follow-Up|Lost to Follow-up|5|||
48650121|NCT00814580|156572941|FG000|Overall Study|Adverse Event|6|||
48650122|NCT00814580|156572942|FG001|Overall Study|Adverse Event|15|||
48650123|NCT00814580|156572941|FG000|Overall Study|Lack of Efficacy|18|||
48650124|NCT00814580|156572942|FG001|Overall Study|Lack of Efficacy|25|||
48650125|NCT00814580|156572941|FG000|Overall Study|Protocol Violation|2|||
48650126|NCT00814580|156572942|FG001|Overall Study|Protocol Violation|0|||
48650127|NCT00814580|156572941|FG000|Overall Study|Withdrawal by Subject|2|||
48650128|NCT00814580|156572942|FG001|Overall Study|Withdrawal by Subject|2|||
48650129|NCT00814580|156572941|FG000|Overall Study|Other|1|||
48650130|NCT00814580|156572942|FG001|Overall Study|Other|3|||
48650131|NCT00814580|156572941|FG000|Overall Study|Did Not Take Drug|2|||
48650132|NCT00814580|156572942|FG001|Overall Study|Did Not Take Drug|2|||
48650133|NCT02974140|156572943|FG000|Overall Study|Adverse Event|2|||
48650134|NCT02974140|156572943|FG000|Overall Study|Lost to Follow-up|1|||
48650135|NCT02974140|156572943|FG000|Overall Study|Study Terminated by Sponsor|36|||
48752671|NCT00540514|156940055|FG001|Overall Study|Protocol Deviation|4|||
48752672|NCT00540514|156940054|FG000|Overall Study|Lost to Follow-up|1|||
48752673|NCT00540514|156940055|FG001|Overall Study|Lost to Follow-up|1|||
48752674|NCT00540514|156940054|FG000|Overall Study|Withdrawal by Subject|65|||
48752675|NCT00540514|156940055|FG001|Overall Study|Withdrawal by Subject|67|||
48752676|NCT00540514|156940054|FG000|Overall Study|Excluded prior to treatment|7|||
48752677|NCT00540514|156940055|FG001|Overall Study|Excluded prior to treatment|7|||
48752678|NCT00540514|156940054|FG000|Overall Study|Paclitaxel not available|0|||
48752679|NCT00540514|156940055|FG001|Overall Study|Paclitaxel not available|2|||
48752680|NCT02329730|156940056|FG000|Overall Study|Protocol Violation|0|||
48752681|NCT02329730|156940057|FG001|Overall Study|Protocol Violation|0|||
48752682|NCT02329730|156940058|FG002|Overall Study|Protocol Violation|0|||
48752683|NCT02329730|156940059|FG003|Overall Study|Protocol Violation|0|||
48752684|NCT02329730|156940060|FG004|Overall Study|Protocol Violation|2|||
48331666|NCT00446095|155411539|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
48331667|NCT00446095|155411540|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
48650136|NCT01905943|156572944|FG000|Overall Study|Withdrawal of consent|90|||
48650137|NCT01905943|156572944|FG000|Overall Study|Lost to Follow-up|16|||
48650138|NCT01905943|156572944|FG000|Overall Study|Investigator discretion|7|||
48650139|NCT01905943|156572944|FG000|Overall Study|Death|186|||
48650140|NCT01905943|156572944|FG000|Overall Study|Adverse Event|3|||
48650141|NCT01905943|156572944|FG000|Overall Study|Other|12|||
48650142|NCT01238991|156572947|FG000|Overall Study|Adverse Event|1|||
48650143|NCT01238991|156572948|FG001|Overall Study|Adverse Event|0|||
48650144|NCT01238991|156572949|FG002|Overall Study|Adverse Event|3|||
48650145|NCT01238991|156572950|FG003|Overall Study|Adverse Event|1|||
48650146|NCT01238991|156572951|FG004|Overall Study|Adverse Event|1|||
48650147|NCT01238991|156572952|FG005|Overall Study|Adverse Event|0|||
48650148|NCT01238991|156572953|FG006|Overall Study|Adverse Event|1|||
48752685|NCT02329730|156940061|FG005|Overall Study|Protocol Violation|2|||
48650149|NCT01238991|156572954|FG007|Overall Study|Adverse Event|1|||
48650150|NCT01238991|156572955|FG008|Overall Study|Adverse Event|0|||
48650151|NCT01238991|156572956|FG009|Overall Study|Adverse Event|0|||
48650152|NCT01238991|156572947|FG000|Overall Study|Death|0|||
48650153|NCT01238991|156572948|FG001|Overall Study|Death|0|||
48650154|NCT01238991|156572949|FG002|Overall Study|Death|0|||
48331668|NCT00446095|155411536|FG000|Phase II (8 Weeks)|Ongoing|0|||
48331669|NCT00446095|155411537|FG001|Phase II (8 Weeks)|Ongoing|0|||
48650155|NCT01238991|156572950|FG003|Overall Study|Death|1|||
48650156|NCT01238991|156572951|FG004|Overall Study|Death|0|||
48650157|NCT01238991|156572952|FG005|Overall Study|Death|0|||
48650158|NCT01238991|156572953|FG006|Overall Study|Death|0|||
48650159|NCT01238991|156572954|FG007|Overall Study|Death|0|||
48650160|NCT01238991|156572955|FG008|Overall Study|Death|0|||
48650161|NCT01238991|156572956|FG009|Overall Study|Death|0|||
48650162|NCT01238991|156572947|FG000|Overall Study|Lack of Efficacy|0|||
48650163|NCT01238991|156572948|FG001|Overall Study|Lack of Efficacy|0|||
48650164|NCT01238991|156572949|FG002|Overall Study|Lack of Efficacy|1|||
48650165|NCT01238991|156572950|FG003|Overall Study|Lack of Efficacy|0|||
48650166|NCT01238991|156572951|FG004|Overall Study|Lack of Efficacy|0|||
48650167|NCT01238991|156572952|FG005|Overall Study|Lack of Efficacy|0|||
48650168|NCT01238991|156572953|FG006|Overall Study|Lack of Efficacy|0|||
48650169|NCT01238991|156572954|FG007|Overall Study|Lack of Efficacy|0|||
48650170|NCT01238991|156572955|FG008|Overall Study|Lack of Efficacy|1|||
48650171|NCT01238991|156572956|FG009|Overall Study|Lack of Efficacy|0|||
48650172|NCT01238991|156572947|FG000|Overall Study|Withdrawal by Subject|0|||
48331670|NCT00446095|155411538|FG002|Phase II (8 Weeks)|Ongoing|1|||
48331671|NCT00446095|155411539|FG003|Phase II (8 Weeks)|Ongoing|0|||
48331672|NCT00446095|155411540|FG004|Phase II (8 Weeks)|Ongoing|0|||
48650173|NCT01238991|156572948|FG001|Overall Study|Withdrawal by Subject|0|||
48650174|NCT01238991|156572949|FG002|Overall Study|Withdrawal by Subject|1|||
48650175|NCT01238991|156572950|FG003|Overall Study|Withdrawal by Subject|0|||
48650176|NCT01238991|156572951|FG004|Overall Study|Withdrawal by Subject|0|||
48650177|NCT01238991|156572952|FG005|Overall Study|Withdrawal by Subject|0|||
48650178|NCT01238991|156572953|FG006|Overall Study|Withdrawal by Subject|0|||
48650179|NCT01238991|156572954|FG007|Overall Study|Withdrawal by Subject|0|||
48650180|NCT01238991|156572955|FG008|Overall Study|Withdrawal by Subject|0|||
48650181|NCT01238991|156572956|FG009|Overall Study|Withdrawal by Subject|0|||
48650182|NCT01238991|156572947|FG000|Overall Study|Study Terminated by Sponsor|0|||
48650183|NCT01238991|156572948|FG001|Overall Study|Study Terminated by Sponsor|0|||
48650184|NCT01238991|156572949|FG002|Overall Study|Study Terminated by Sponsor|0|||
48650185|NCT01238991|156572950|FG003|Overall Study|Study Terminated by Sponsor|0|||
48650186|NCT01238991|156572951|FG004|Overall Study|Study Terminated by Sponsor|1|||
48650187|NCT01238991|156572952|FG005|Overall Study|Study Terminated by Sponsor|0|||
48650188|NCT01238991|156572953|FG006|Overall Study|Study Terminated by Sponsor|7|||
48650189|NCT01238991|156572954|FG007|Overall Study|Study Terminated by Sponsor|4|||
48650190|NCT01238991|156572955|FG008|Overall Study|Study Terminated by Sponsor|2|||
48650191|NCT01238991|156572956|FG009|Overall Study|Study Terminated by Sponsor|2|||
48650192|NCT01238991|156572947|FG000|Overall Study|Caregiver's request|0|||
48650193|NCT01238991|156572948|FG001|Overall Study|Caregiver's request|0|||
48650194|NCT01238991|156572949|FG002|Overall Study|Caregiver's request|0|||
48650195|NCT01238991|156572950|FG003|Overall Study|Caregiver's request|0|||
48650196|NCT01238991|156572951|FG004|Overall Study|Caregiver's request|0|||
48650197|NCT01238991|156572952|FG005|Overall Study|Caregiver's request|0|||
48752686|NCT02329730|156940062|FG006|Overall Study|Protocol Violation|0|||
48752687|NCT02329730|156940063|FG007|Overall Study|Protocol Violation|0|||
48331673|NCT00446095|155411536|FG000|Phase I (28 Days)|Adverse Event|0|||
48331674|NCT00446095|155411537|FG001|Phase I (28 Days)|Adverse Event|0|||
48331675|NCT00446095|155411538|FG002|Phase I (28 Days)|Adverse Event|0|||
48331676|NCT00446095|155411539|FG003|Phase I (28 Days)|Adverse Event|1|||
48331677|NCT00446095|155411540|FG004|Phase I (28 Days)|Adverse Event|0|||
48331678|NCT00446095|155411536|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
48331679|NCT00446095|155411537|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
48752688|NCT02329730|156940064|FG008|Overall Study|Protocol Violation|0|||
48331680|NCT00446095|155411538|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
48331681|NCT00446095|155411539|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
48650198|NCT01238991|156572953|FG006|Overall Study|Caregiver's request|0|||
48650199|NCT01238991|156572954|FG007|Overall Study|Caregiver's request|0|||
48650200|NCT01238991|156572955|FG008|Overall Study|Caregiver's request|1|||
48650201|NCT01238991|156572956|FG009|Overall Study|Caregiver's request|0|||
48650202|NCT01238991|156572947|FG000|Overall Study|Admission to a nursing home|1|||
48650203|NCT01238991|156572948|FG001|Overall Study|Admission to a nursing home|0|||
48650204|NCT01238991|156572949|FG002|Overall Study|Admission to a nursing home|1|||
48650205|NCT01238991|156572950|FG003|Overall Study|Admission to a nursing home|0|||
48650206|NCT01238991|156572951|FG004|Overall Study|Admission to a nursing home|0|||
48650207|NCT01238991|156572952|FG005|Overall Study|Admission to a nursing home|0|||
48650208|NCT01238991|156572953|FG006|Overall Study|Admission to a nursing home|0|||
48650209|NCT01238991|156572954|FG007|Overall Study|Admission to a nursing home|0|||
48650210|NCT01238991|156572955|FG008|Overall Study|Admission to a nursing home|0|||
48650211|NCT01238991|156572956|FG009|Overall Study|Admission to a nursing home|0|||
48650212|NCT02237001|156572957|FG000|Overall Study|Lost to Follow-up|2|||
48650213|NCT02237001|156572957|FG000|Overall Study|Withdrawal by Subject|1|||
48650214|NCT02237001|156572957|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
48650215|NCT02237001|156572957|FG000|Overall Study|Re-operation|4|||
48650216|NCT02237001|156572957|FG000|Overall Study|Incarceration|1|||
48650217|NCT01713582|156572958|FG000|Overall Study|Disease progression|3|||
48650218|NCT01713582|156572959|FG001|Overall Study|Disease progression|3|||
48650219|NCT01713582|156572960|FG002|Overall Study|Disease progression|3|||
48650220|NCT01713582|156572961|FG003|Overall Study|Disease progression|2|||
48650221|NCT01713582|156572962|FG004|Overall Study|Disease progression|3|||
48650222|NCT01713582|156572963|FG005|Overall Study|Disease progression|3|||
48650223|NCT01713582|156572964|FG006|Overall Study|Disease progression|3|||
48650224|NCT01713582|156572965|FG007|Overall Study|Disease progression|3|||
48650225|NCT01713582|156572966|FG008|Overall Study|Disease progression|3|||
48650226|NCT01713582|156572967|FG009|Overall Study|Disease progression|11|||
48650227|NCT01713582|156572968|FG010|Overall Study|Disease progression|10|||
48650228|NCT01713582|156572969|FG011|Overall Study|Disease progression|5|||
48650229|NCT01713582|156572970|FG012|Overall Study|Disease progression|3|||
48650230|NCT01713582|156572971|FG013|Overall Study|Disease progression|3|||
48650231|NCT01713582|156572972|FG014|Overall Study|Disease progression|6|||
48650232|NCT01713582|156572973|FG015|Overall Study|Disease progression|6|||
48650233|NCT01713582|156572974|FG016|Overall Study|Disease progression|5|||
48650234|NCT01713582|156572975|FG017|Overall Study|Disease progression|2|||
48650235|NCT01713582|156572976|FG018|Overall Study|Disease progression|3|||
48650236|NCT01713582|156572977|FG019|Overall Study|Disease progression|5|||
48650237|NCT01713582|156572978|FG020|Overall Study|Disease progression|15|||
48752689|NCT02329730|156940065|FG009|Overall Study|Protocol Violation|0|||
48752690|NCT02329730|156940066|FG010|Overall Study|Protocol Violation|0|||
48752691|NCT02329730|156940067|FG011|Overall Study|Protocol Violation|0|||
48752692|NCT02329730|156940056|FG000|Overall Study|Withdrawal by Subject|0|||
48752693|NCT02329730|156940057|FG001|Overall Study|Withdrawal by Subject|0|||
48752694|NCT02329730|156940058|FG002|Overall Study|Withdrawal by Subject|0|||
48752695|NCT02329730|156940059|FG003|Overall Study|Withdrawal by Subject|0|||
48752696|NCT02329730|156940060|FG004|Overall Study|Withdrawal by Subject|1|||
48650238|NCT01713582|156572958|FG000|Overall Study|Death|0|||
48650239|NCT01713582|156572959|FG001|Overall Study|Death|0|||
48650240|NCT01713582|156572960|FG002|Overall Study|Death|0|||
48650241|NCT01713582|156572961|FG003|Overall Study|Death|1|||
48650242|NCT01713582|156572962|FG004|Overall Study|Death|1|||
48650243|NCT01713582|156572963|FG005|Overall Study|Death|3|||
48650244|NCT01713582|156572964|FG006|Overall Study|Death|3|||
48650245|NCT01713582|156572965|FG007|Overall Study|Death|2|||
48650246|NCT01713582|156572966|FG008|Overall Study|Death|3|||
48650247|NCT01713582|156572967|FG009|Overall Study|Death|4|||
48428045|NCT02518620|155754794|FG001|Overall Study|Pregnancy|0|||
48650248|NCT01713582|156572968|FG010|Overall Study|Death|3|||
48650249|NCT01713582|156572969|FG011|Overall Study|Death|0|||
48650250|NCT01713582|156572970|FG012|Overall Study|Death|0|||
48650251|NCT01713582|156572971|FG013|Overall Study|Death|0|||
48650252|NCT01713582|156572972|FG014|Overall Study|Death|0|||
48650253|NCT01713582|156572973|FG015|Overall Study|Death|0|||
48650254|NCT01713582|156572974|FG016|Overall Study|Death|0|||
48650255|NCT01713582|156572975|FG017|Overall Study|Death|0|||
48650256|NCT01713582|156572976|FG018|Overall Study|Death|0|||
48650257|NCT01713582|156572977|FG019|Overall Study|Death|0|||
48650258|NCT01713582|156572978|FG020|Overall Study|Death|0|||
48752697|NCT02329730|156940061|FG005|Overall Study|Withdrawal by Subject|0|||
48752698|NCT02329730|156940062|FG006|Overall Study|Withdrawal by Subject|1|||
48752699|NCT02329730|156940063|FG007|Overall Study|Withdrawal by Subject|1|||
48752700|NCT02329730|156940064|FG008|Overall Study|Withdrawal by Subject|1|||
48752701|NCT02329730|156940065|FG009|Overall Study|Withdrawal by Subject|1|||
48752702|NCT02329730|156940066|FG010|Overall Study|Withdrawal by Subject|0|||
48752703|NCT02329730|156940067|FG011|Overall Study|Withdrawal by Subject|0|||
48752704|NCT02674529|156940076|FG000|Overall Study|Lost to Follow-up|1|||
48752705|NCT02674529|156940077|FG001|Overall Study|Lost to Follow-up|2|||
48752706|NCT02674529|156940076|FG000|Overall Study|Withdrawal by Subject|2|||
48650259|NCT01713582|156572958|FG000|Overall Study|Adverse event-related|0|||
48650260|NCT01713582|156572959|FG001|Overall Study|Adverse event-related|0|||
48650261|NCT01713582|156572960|FG002|Overall Study|Adverse event-related|0|||
48650262|NCT01713582|156572961|FG003|Overall Study|Adverse event-related|0|||
48650263|NCT01713582|156572962|FG004|Overall Study|Adverse event-related|0|||
48650264|NCT01713582|156572963|FG005|Overall Study|Adverse event-related|0|||
48650265|NCT01713582|156572964|FG006|Overall Study|Adverse event-related|0|||
48650266|NCT01713582|156572965|FG007|Overall Study|Adverse event-related|0|||
48650267|NCT01713582|156572966|FG008|Overall Study|Adverse event-related|0|||
48650268|NCT01713582|156572967|FG009|Overall Study|Adverse event-related|1|||
48650269|NCT01713582|156572968|FG010|Overall Study|Adverse event-related|1|||
48650270|NCT01713582|156572969|FG011|Overall Study|Adverse event-related|0|||
48650271|NCT01713582|156572970|FG012|Overall Study|Adverse event-related|0|||
48650272|NCT01713582|156572971|FG013|Overall Study|Adverse event-related|0|||
48650273|NCT01713582|156572972|FG014|Overall Study|Adverse event-related|0|||
48650274|NCT01713582|156572973|FG015|Overall Study|Adverse event-related|0|||
48650275|NCT01713582|156572974|FG016|Overall Study|Adverse event-related|0|||
48650276|NCT01713582|156572975|FG017|Overall Study|Adverse event-related|0|||
48650277|NCT01713582|156572976|FG018|Overall Study|Adverse event-related|1|||
48650278|NCT01713582|156572977|FG019|Overall Study|Adverse event-related|0|||
48650279|NCT01713582|156572978|FG020|Overall Study|Adverse event-related|0|||
48650280|NCT01713582|156572958|FG000|Overall Study|Adverse event-unrelated|0|||
48650281|NCT01713582|156572959|FG001|Overall Study|Adverse event-unrelated|0|||
48650282|NCT01713582|156572960|FG002|Overall Study|Adverse event-unrelated|0|||
48650283|NCT01713582|156572961|FG003|Overall Study|Adverse event-unrelated|0|||
48650284|NCT01713582|156572962|FG004|Overall Study|Adverse event-unrelated|0|||
48650285|NCT01713582|156572963|FG005|Overall Study|Adverse event-unrelated|1|||
48650286|NCT01713582|156572964|FG006|Overall Study|Adverse event-unrelated|1|||
48650287|NCT01713582|156572965|FG007|Overall Study|Adverse event-unrelated|1|||
48650288|NCT01713582|156572966|FG008|Overall Study|Adverse event-unrelated|0|||
48650289|NCT01713582|156572967|FG009|Overall Study|Adverse event-unrelated|0|||
48650290|NCT01713582|156572968|FG010|Overall Study|Adverse event-unrelated|0|||
48650291|NCT01713582|156572969|FG011|Overall Study|Adverse event-unrelated|0|||
48650292|NCT01713582|156572970|FG012|Overall Study|Adverse event-unrelated|0|||
48650293|NCT01713582|156572971|FG013|Overall Study|Adverse event-unrelated|1|||
48650294|NCT01713582|156572972|FG014|Overall Study|Adverse event-unrelated|1|||
48650295|NCT01713582|156572973|FG015|Overall Study|Adverse event-unrelated|0|||
48650296|NCT01713582|156572974|FG016|Overall Study|Adverse event-unrelated|0|||
48752707|NCT02674529|156940077|FG001|Overall Study|Withdrawal by Subject|1|||
48752708|NCT02674529|156940076|FG000|Overall Study|Physician Decision|0|||
48752709|NCT02674529|156940077|FG001|Overall Study|Physician Decision|1|||
48650297|NCT01713582|156572975|FG017|Overall Study|Adverse event-unrelated|0|||
48650298|NCT01713582|156572976|FG018|Overall Study|Adverse event-unrelated|0|||
48752710|NCT02674529|156940076|FG000|Overall Study|Protocol Violation|0|||
48650299|NCT01713582|156572977|FG019|Overall Study|Adverse event-unrelated|0|||
48650300|NCT01713582|156572978|FG020|Overall Study|Adverse event-unrelated|0|||
48650301|NCT01713582|156572958|FG000|Overall Study|Withdrawal of consent|0|||
48650302|NCT01713582|156572959|FG001|Overall Study|Withdrawal of consent|0|||
48650303|NCT01713582|156572960|FG002|Overall Study|Withdrawal of consent|1|||
48650304|NCT01713582|156572961|FG003|Overall Study|Withdrawal of consent|0|||
48650305|NCT01713582|156572962|FG004|Overall Study|Withdrawal of consent|0|||
48650306|NCT01713582|156572963|FG005|Overall Study|Withdrawal of consent|1|||
48650307|NCT01713582|156572964|FG006|Overall Study|Withdrawal of consent|0|||
48650308|NCT01713582|156572965|FG007|Overall Study|Withdrawal of consent|0|||
48650309|NCT01713582|156572966|FG008|Overall Study|Withdrawal of consent|0|||
48650310|NCT01713582|156572967|FG009|Overall Study|Withdrawal of consent|1|||
48650311|NCT01713582|156572968|FG010|Overall Study|Withdrawal of consent|0|||
48650312|NCT01713582|156572969|FG011|Overall Study|Withdrawal of consent|0|||
48650313|NCT01713582|156572970|FG012|Overall Study|Withdrawal of consent|0|||
48650314|NCT01713582|156572971|FG013|Overall Study|Withdrawal of consent|0|||
48650315|NCT01713582|156572972|FG014|Overall Study|Withdrawal of consent|0|||
48650316|NCT01713582|156572973|FG015|Overall Study|Withdrawal of consent|0|||
48650317|NCT01713582|156572974|FG016|Overall Study|Withdrawal of consent|0|||
48650318|NCT01713582|156572975|FG017|Overall Study|Withdrawal of consent|0|||
48650319|NCT01713582|156572976|FG018|Overall Study|Withdrawal of consent|1|||
48650320|NCT01713582|156572977|FG019|Overall Study|Withdrawal of consent|0|||
48650321|NCT01713582|156572978|FG020|Overall Study|Withdrawal of consent|0|||
48650322|NCT01713582|156572958|FG000|Overall Study|Lack of Efficacy|0|||
48650323|NCT01713582|156572959|FG001|Overall Study|Lack of Efficacy|0|||
48650324|NCT01713582|156572960|FG002|Overall Study|Lack of Efficacy|0|||
48650325|NCT01713582|156572961|FG003|Overall Study|Lack of Efficacy|0|||
48650326|NCT01713582|156572962|FG004|Overall Study|Lack of Efficacy|0|||
48650327|NCT01713582|156572963|FG005|Overall Study|Lack of Efficacy|0|||
48650328|NCT01713582|156572964|FG006|Overall Study|Lack of Efficacy|0|||
48650329|NCT01713582|156572965|FG007|Overall Study|Lack of Efficacy|0|||
48650330|NCT01713582|156572966|FG008|Overall Study|Lack of Efficacy|0|||
48650331|NCT01713582|156572967|FG009|Overall Study|Lack of Efficacy|1|||
48650332|NCT01713582|156572968|FG010|Overall Study|Lack of Efficacy|2|||
48650333|NCT01713582|156572969|FG011|Overall Study|Lack of Efficacy|0|||
48650334|NCT01713582|156572970|FG012|Overall Study|Lack of Efficacy|0|||
48650335|NCT01713582|156572971|FG013|Overall Study|Lack of Efficacy|0|||
48650336|NCT01713582|156572972|FG014|Overall Study|Lack of Efficacy|0|||
48650337|NCT01713582|156572973|FG015|Overall Study|Lack of Efficacy|0|||
48650338|NCT01713582|156572974|FG016|Overall Study|Lack of Efficacy|0|||
48650339|NCT01713582|156572975|FG017|Overall Study|Lack of Efficacy|0|||
48650340|NCT01713582|156572976|FG018|Overall Study|Lack of Efficacy|0|||
48650341|NCT01713582|156572977|FG019|Overall Study|Lack of Efficacy|0|||
48650342|NCT01713582|156572978|FG020|Overall Study|Lack of Efficacy|0|||
48650343|NCT01713582|156572958|FG000|Overall Study|Withdrawal by Subject|0|||
48650344|NCT01713582|156572959|FG001|Overall Study|Withdrawal by Subject|0|||
48650345|NCT01713582|156572960|FG002|Overall Study|Withdrawal by Subject|0|||
48752711|NCT02674529|156940077|FG001|Overall Study|Protocol Violation|1|||
48752712|NCT02891850|156940078|FG000|Overall Study|Adverse Event|3|||
48752713|NCT02891850|156940079|FG001|Overall Study|Adverse Event|0|||
48752714|NCT02891850|156940078|FG000|Overall Study|Death|0|||
48752715|NCT02891850|156940079|FG001|Overall Study|Death|4|||
48331682|NCT00446095|155411540|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
48331683|NCT03692871|155411541|FG000|Overall Study|Death|1|||
48331684|NCT03692871|155411542|FG001|Overall Study|Death|1|||
48331685|NCT03692871|155411541|FG000|Overall Study|Lost to Follow-up|24|||
48331686|NCT03692871|155411542|FG001|Overall Study|Lost to Follow-up|9|||
48331687|NCT03692871|155411541|FG000|Overall Study|Physician Decision|22|||
48331688|NCT03692871|155411542|FG001|Overall Study|Physician Decision|7|||
48331689|NCT03692871|155411541|FG000|Overall Study|Protocol Deviation|1|||
48331690|NCT03692871|155411542|FG001|Overall Study|Protocol Deviation|0|||
48650346|NCT01713582|156572961|FG003|Overall Study|Withdrawal by Subject|0|||
48650347|NCT01713582|156572962|FG004|Overall Study|Withdrawal by Subject|0|||
48650348|NCT01713582|156572963|FG005|Overall Study|Withdrawal by Subject|0|||
48331691|NCT03692871|155411541|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
48331692|NCT03692871|155411542|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
48331693|NCT02833948|155411543|FG000|Overall Study|Death|2|||
48650349|NCT01713582|156572964|FG006|Overall Study|Withdrawal by Subject|0|||
48650350|NCT01713582|156572965|FG007|Overall Study|Withdrawal by Subject|0|||
48650351|NCT01713582|156572966|FG008|Overall Study|Withdrawal by Subject|0|||
48650352|NCT01713582|156572967|FG009|Overall Study|Withdrawal by Subject|0|||
48650353|NCT01713582|156572968|FG010|Overall Study|Withdrawal by Subject|0|||
48331694|NCT02833948|155411544|FG001|Overall Study|Death|3|||
48650354|NCT01713582|156572969|FG011|Overall Study|Withdrawal by Subject|0|||
48650355|NCT01713582|156572970|FG012|Overall Study|Withdrawal by Subject|0|||
48650356|NCT01713582|156572971|FG013|Overall Study|Withdrawal by Subject|0|||
48650357|NCT01713582|156572972|FG014|Overall Study|Withdrawal by Subject|0|||
48752716|NCT02891850|156940078|FG000|Overall Study|Physician Decision|1|||
48752717|NCT02891850|156940079|FG001|Overall Study|Physician Decision|0|||
48752718|NCT02891850|156940078|FG000|Overall Study|Pregnancy|1|||
48752719|NCT02891850|156940079|FG001|Overall Study|Pregnancy|0|||
48650358|NCT01713582|156572973|FG015|Overall Study|Withdrawal by Subject|0|||
48650359|NCT01713582|156572974|FG016|Overall Study|Withdrawal by Subject|0|||
48650360|NCT01713582|156572975|FG017|Overall Study|Withdrawal by Subject|1|||
48650361|NCT01713582|156572976|FG018|Overall Study|Withdrawal by Subject|0|||
48650362|NCT01713582|156572977|FG019|Overall Study|Withdrawal by Subject|0|||
48650363|NCT01713582|156572978|FG020|Overall Study|Withdrawal by Subject|0|||
48650364|NCT01713582|156572958|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
48650365|NCT01713582|156572959|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
48650366|NCT01713582|156572960|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
48650367|NCT01713582|156572961|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
48650368|NCT01713582|156572962|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
48650369|NCT01713582|156572963|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
48650370|NCT01713582|156572964|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
48650371|NCT01713582|156572965|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
48752720|NCT02891850|156940078|FG000|Overall Study|Withdrawal by Subject|2|||
48752721|NCT02891850|156940079|FG001|Overall Study|Withdrawal by Subject|3|||
48752722|NCT02961751|156940088|FG000|Overall Study|Lost to Follow-up|11|||
48752723|NCT02961751|156940088|FG000|Overall Study|Physician Decision|2|||
48752724|NCT02961751|156940088|FG000|Overall Study|Not Eligible at Enrollment|1|||
48752725|NCT02961751|156940088|FG000|Overall Study|Protocol Violation|1|||
48752726|NCT02345850|156940089|FG000|Overall Study|Not transplanted|10|||
48752727|NCT02345850|156940090|FG001|Overall Study|Not transplanted|5|||
48752728|NCT02345850|156940091|FG002|Overall Study|Not transplanted|4|||
48752729|NCT02345850|156940089|FG000|Overall Study|Lost to Follow-up|2|||
48752730|NCT02345850|156940090|FG001|Overall Study|Lost to Follow-up|3|||
48752731|NCT02345850|156940091|FG002|Overall Study|Lost to Follow-up|2|||
48752732|NCT02345850|156940089|FG000|Overall Study|Withdrawal by Subject|1|||
48752733|NCT02345850|156940090|FG001|Overall Study|Withdrawal by Subject|0|||
48331695|NCT02833948|155411543|FG000|Overall Study|were not scanned|8|||
48331696|NCT02833948|155411544|FG001|Overall Study|were not scanned|13|||
48331697|NCT02833948|155411543|FG000|Overall Study|scans could not be evaluated|5|||
48331698|NCT02833948|155411544|FG001|Overall Study|scans could not be evaluated|2|||
48650372|NCT01713582|156572966|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
48650373|NCT01713582|156572967|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
48650374|NCT01713582|156572968|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
48650375|NCT01713582|156572969|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
48650376|NCT01713582|156572970|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
48650377|NCT01713582|156572971|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
48650378|NCT01713582|156572972|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
48650379|NCT01713582|156572973|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
48650380|NCT01713582|156572974|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
48650381|NCT01713582|156572975|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
48650382|NCT01713582|156572976|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
48650383|NCT01713582|156572977|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
48650384|NCT01713582|156572978|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
48650385|NCT01713582|156572958|FG000|Overall Study|Disease progression and adverse event|0|||
48650386|NCT01713582|156572959|FG001|Overall Study|Disease progression and adverse event|0|||
48650387|NCT01713582|156572960|FG002|Overall Study|Disease progression and adverse event|0|||
48650388|NCT01713582|156572961|FG003|Overall Study|Disease progression and adverse event|0|||
48650389|NCT01713582|156572962|FG004|Overall Study|Disease progression and adverse event|0|||
48650390|NCT01713582|156572963|FG005|Overall Study|Disease progression and adverse event|0|||
48650391|NCT01713582|156572964|FG006|Overall Study|Disease progression and adverse event|0|||
48650392|NCT01713582|156572965|FG007|Overall Study|Disease progression and adverse event|0|||
48650393|NCT01713582|156572966|FG008|Overall Study|Disease progression and adverse event|0|||
48650394|NCT01713582|156572967|FG009|Overall Study|Disease progression and adverse event|0|||
48650395|NCT01713582|156572968|FG010|Overall Study|Disease progression and adverse event|0|||
48650396|NCT01713582|156572969|FG011|Overall Study|Disease progression and adverse event|0|||
48650397|NCT01713582|156572970|FG012|Overall Study|Disease progression and adverse event|0|||
48752734|NCT02345850|156940091|FG002|Overall Study|Withdrawal by Subject|0|||
48331699|NCT01930188|155411545|FG000|Overall Study|unclassified|4|||
48331700|NCT01930188|155411546|FG001|Overall Study|unclassified|5|||
48650398|NCT01713582|156572971|FG013|Overall Study|Disease progression and adverse event|0|||
48650399|NCT01713582|156572972|FG014|Overall Study|Disease progression and adverse event|0|||
48650400|NCT01713582|156572973|FG015|Overall Study|Disease progression and adverse event|0|||
48752735|NCT02373202|156940092|FG000|Overall Study|Adverse Event|2|||
48752736|NCT02373202|156940093|FG001|Overall Study|Adverse Event|5|||
48752737|NCT02373202|156940094|FG002|Overall Study|Adverse Event|2|||
48752738|NCT02373202|156940095|FG003|Overall Study|Adverse Event|1|||
48650401|NCT01713582|156572974|FG016|Overall Study|Disease progression and adverse event|1|||
48650402|NCT01713582|156572975|FG017|Overall Study|Disease progression and adverse event|0|||
48650403|NCT01713582|156572976|FG018|Overall Study|Disease progression and adverse event|0|||
48650404|NCT01713582|156572977|FG019|Overall Study|Disease progression and adverse event|0|||
48650405|NCT01713582|156572978|FG020|Overall Study|Disease progression and adverse event|0|||
48650406|NCT00617084|156572979|FG000|Overall Study|Withdrawal by Subject|5|||
48650407|NCT00617084|156572980|FG001|Overall Study|Withdrawal by Subject|7|||
48650408|NCT00617084|156572979|FG000|Overall Study|Missed 12 Months visit|16|||
48650409|NCT00617084|156572980|FG001|Overall Study|Missed 12 Months visit|19|||
48650410|NCT03370419|156572982|FG000|Overall Study|Lost to Follow-up|16|||
48650411|NCT00809835|156572987|FG000|Overall Study|Lost to Follow-up|7|||
48650412|NCT00809835|156572988|FG001|Overall Study|Lost to Follow-up|6|||
48650413|NCT00809835|156572989|FG002|Overall Study|Lost to Follow-up|10|||
48650414|NCT00809835|156572990|FG003|Overall Study|Lost to Follow-up|2|||
48650415|NCT00809835|156572987|FG000|Overall Study|Withdrawal by Subject|1|||
48650416|NCT00809835|156572988|FG001|Overall Study|Withdrawal by Subject|1|||
48650417|NCT00809835|156572989|FG002|Overall Study|Withdrawal by Subject|1|||
48650418|NCT00809835|156572990|FG003|Overall Study|Withdrawal by Subject|0|||
48650419|NCT00956007|156572991|FG000|Overall Study|Protocol Violation|27|||
48650420|NCT00956007|156572992|FG001|Overall Study|Protocol Violation|23|||
48650421|NCT01681186|156572995|FG000|Washout Period From Second Intervention|Adverse Event|0|||
48650422|NCT01681186|156572996|FG001|Washout Period From Second Intervention|Adverse Event|0|||
48650423|NCT01681186|156572997|FG002|Washout Period From Second Intervention|Adverse Event|0|||
48650424|NCT01681186|156572998|FG003|Washout Period From Second Intervention|Adverse Event|0|||
48650425|NCT01681186|156572999|FG004|Washout Period From Second Intervention|Adverse Event|0|||
48650426|NCT01681186|156573000|FG005|Washout Period From Second Intervention|Adverse Event|0|||
48650427|NCT01681186|156573001|FG006|Washout Period From Second Intervention|Adverse Event|1|||
48650428|NCT01681186|156573002|FG007|Washout Period From Second Intervention|Adverse Event|0|||
48650429|NCT01681186|156572995|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
48650430|NCT01681186|156572996|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
48650431|NCT01681186|156572997|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
48650432|NCT01681186|156572998|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
48650433|NCT01681186|156572999|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
48650434|NCT01681186|156573000|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
48650435|NCT01681186|156573001|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
48650436|NCT01681186|156573002|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
48650437|NCT01681186|156572995|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
48650438|NCT01681186|156572996|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
48650439|NCT01681186|156572997|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
48650440|NCT01681186|156572998|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
48650441|NCT01681186|156572999|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
48650442|NCT01681186|156573000|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
48650443|NCT01681186|156573001|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
48650444|NCT01681186|156573002|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
48650445|NCT01681186|156572995|FG000|Fourth Intervention|Protocol Violation|0|||
48650446|NCT01681186|156572996|FG001|Fourth Intervention|Protocol Violation|0|||
48650447|NCT01681186|156572997|FG002|Fourth Intervention|Protocol Violation|0|||
48650448|NCT01681186|156572998|FG003|Fourth Intervention|Protocol Violation|0|||
48650449|NCT01681186|156572999|FG004|Fourth Intervention|Protocol Violation|0|||
48650450|NCT01681186|156573000|FG005|Fourth Intervention|Protocol Violation|0|||
48650451|NCT01681186|156573001|FG006|Fourth Intervention|Protocol Violation|0|||
48650452|NCT01681186|156573002|FG007|Fourth Intervention|Protocol Violation|1|||
48650453|NCT03333928|156573005|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
48650454|NCT03333928|156573006|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
48650455|NCT03333928|156573007|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
48650456|NCT03333928|156573005|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
48650457|NCT03333928|156573006|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
48650458|NCT03333928|156573007|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
48331701|NCT01930188|155411547|FG002|Overall Study|unclassified|3|||
48331702|NCT01930188|155411545|FG000|Overall Study|Missing follow-up information|2|||
48650459|NCT03333928|156573005|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
48650460|NCT03333928|156573006|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
48650461|NCT03333928|156573007|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
48650462|NCT03333928|156573005|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
48650463|NCT03333928|156573006|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
48650464|NCT03333928|156573007|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
48650465|NCT03333928|156573005|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
48752739|NCT02373202|156940092|FG000|Overall Study|Lack of Efficacy|0|||
48650466|NCT03333928|156573006|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
48650467|NCT03333928|156573007|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
48650468|NCT03333928|156573005|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
48650469|NCT03333928|156573006|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
48650470|NCT03333928|156573007|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
48650471|NCT03333928|156573005|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
48650472|NCT03333928|156573006|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
48650473|NCT03333928|156573007|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
48650474|NCT03333928|156573005|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
48650475|NCT03333928|156573006|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
48650476|NCT03333928|156573007|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
48650477|NCT02482298|156573012|FG000|Overall Study|Withdrawal by Subject|2|||
48752740|NCT02373202|156940093|FG001|Overall Study|Lack of Efficacy|0|||
48752741|NCT02373202|156940094|FG002|Overall Study|Lack of Efficacy|1|||
48752742|NCT02373202|156940095|FG003|Overall Study|Lack of Efficacy|0|||
48650478|NCT02482298|156573013|FG001|Overall Study|Withdrawal by Subject|1|||
48650479|NCT02482298|156573014|FG002|Overall Study|Withdrawal by Subject|2|||
48650480|NCT02482298|156573012|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
48752743|NCT02373202|156940092|FG000|Overall Study|Other|0|||
48752744|NCT02373202|156940093|FG001|Overall Study|Other|1|||
48752745|NCT02373202|156940094|FG002|Overall Study|Other|0|||
48752746|NCT02373202|156940095|FG003|Overall Study|Other|0|||
48752747|NCT02392247|156940096|FG000|Overall Study|Withdrawal by Subject|1|||
48752748|NCT02392247|156940096|FG000|Overall Study|Surgery cancelled; no data|1|||
48752749|NCT01411228|156940097|FG000|Overall Study|Lost to Follow-up|0|||
48752750|NCT01411228|156940098|FG001|Overall Study|Lost to Follow-up|0|||
48752751|NCT01411228|156940099|FG002|Overall Study|Lost to Follow-up|1|||
48752752|NCT01411228|156940097|FG000|Overall Study|Withdrawal by Subject|1|||
48752753|NCT01411228|156940098|FG001|Overall Study|Withdrawal by Subject|0|||
48752754|NCT01411228|156940099|FG002|Overall Study|Withdrawal by Subject|0|||
48752755|NCT03055260|156940104|FG000|Overall Study|Withdrawal by Subject|1|||
48752756|NCT03055260|156940105|FG001|Overall Study|Withdrawal by Subject|0|||
48752757|NCT00573469|156940106|FG000|Overall Study|Adverse Event|1|||
48752758|NCT00573469|156940107|FG001|Overall Study|Adverse Event|1|||
48752759|NCT00573469|156940108|FG002|Overall Study|Adverse Event|1|||
48752760|NCT00573469|156940106|FG000|Overall Study|Withdrawal by Subject|0|||
48752761|NCT00573469|156940107|FG001|Overall Study|Withdrawal by Subject|2|||
48752762|NCT00573469|156940108|FG002|Overall Study|Withdrawal by Subject|0|||
48752763|NCT00573469|156940106|FG000|Overall Study|Other|5|||
48752764|NCT00573469|156940107|FG001|Overall Study|Other|1|||
48752765|NCT00573469|156940108|FG002|Overall Study|Other|3|||
48752766|NCT02825992|156940109|FG000|Overall Study|Withdrawal by Subject|4|||
48752767|NCT02825992|156940109|FG000|Overall Study|Lost to Follow-up|2|||
48752768|NCT02825992|156940109|FG000|Overall Study|Procedure terminated|2|||
48752769|NCT03506815|156940110|FG000|Overall Study|Adverse Event|8|||
48752770|NCT03506815|156940111|FG001|Overall Study|Adverse Event|0|||
48752771|NCT03506815|156940110|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
48752772|NCT03506815|156940111|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
48752773|NCT03506815|156940110|FG000|Overall Study|Protocol Violation|1|||
48752774|NCT03506815|156940111|FG001|Overall Study|Protocol Violation|0|||
48752775|NCT03506815|156940110|FG000|Overall Study|Elective Surgery|1|||
48752776|NCT03506815|156940111|FG001|Overall Study|Elective Surgery|0|||
48752777|NCT03068130|156940115|FG000|Overall Study|Adverse Event|19|||
48752778|NCT03068130|156940115|FG000|Overall Study|Death|14|||
48752779|NCT03068130|156940115|FG000|Overall Study|Lost to Follow-up|4|||
48752780|NCT03068130|156940115|FG000|Overall Study|Withdrawal by Subject|26|||
48752781|NCT03068130|156940115|FG000|Overall Study|Administrative Reasons|3|||
48752782|NCT03068130|156940115|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
48752783|NCT03068130|156940115|FG000|Overall Study|Study terminated by sponsor|194|||
48752784|NCT04271605|156940127|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
48752785|NCT01438957|156940134|FG000|Overall Study|Physician Decision|1|||
48752786|NCT01438957|156940135|FG001|Overall Study|Physician Decision|1|||
48752787|NCT01438957|156940136|FG002|Overall Study|Physician Decision|0|||
48752788|NCT01438957|156940137|FG003|Overall Study|Physician Decision|1|||
48331703|NCT01930188|155411546|FG001|Overall Study|Missing follow-up information|2|||
48331704|NCT01930188|155411547|FG002|Overall Study|Missing follow-up information|3|||
48752789|NCT01438957|156940138|FG004|Overall Study|Physician Decision|0|||
48331705|NCT01930188|155411545|FG000|Overall Study|Lost to Follow-up|5|||
48331706|NCT01930188|155411546|FG001|Overall Study|Lost to Follow-up|2|||
48752790|NCT03138889|156940139|FG000|Overall Study|Withdrawal by Subject|5|||
48331707|NCT01930188|155411547|FG002|Overall Study|Lost to Follow-up|2|||
48331708|NCT01930188|155411545|FG000|Overall Study|Death|2|||
48331709|NCT01930188|155411546|FG001|Overall Study|Death|1|||
48331710|NCT01930188|155411547|FG002|Overall Study|Death|3|||
48331711|NCT01930188|155411545|FG000|Overall Study|Withdrawal by Subject|9|||
48331712|NCT01930188|155411546|FG001|Overall Study|Withdrawal by Subject|11|||
48331713|NCT01930188|155411547|FG002|Overall Study|Withdrawal by Subject|8|||
48331714|NCT02170207|155411548|FG000|Overall Study|Case report forms unavailable|5|||
48650481|NCT02482298|156573013|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
48650482|NCT02482298|156573014|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
48331715|NCT03122860|155411550|FG000|Overall Study|Discontinued Before Treatment|1|||
48331716|NCT03122860|155411551|FG001|Overall Study|Discontinued Before Treatment|1|||
48331717|NCT03122860|155411552|FG002|Overall Study|Discontinued Before Treatment|2|||
48331718|NCT03122860|155411553|FG003|Overall Study|Discontinued Before Treatment|0|||
48331719|NCT03122860|155411554|FG004|Overall Study|Discontinued Before Treatment|1|||
48331720|NCT03122860|155411555|FG005|Overall Study|Discontinued Before Treatment|0|||
48331721|NCT03122860|155411550|FG000|Overall Study|Adverse Event|1|||
48331722|NCT03122860|155411551|FG001|Overall Study|Adverse Event|0|||
48331723|NCT03122860|155411552|FG002|Overall Study|Adverse Event|1|||
48331724|NCT03122860|155411553|FG003|Overall Study|Adverse Event|1|||
48331725|NCT03122860|155411554|FG004|Overall Study|Adverse Event|0|||
48331726|NCT03122860|155411555|FG005|Overall Study|Adverse Event|0|||
48331727|NCT03122860|155411550|FG000|Overall Study|Lost to Follow-up|5|||
48331728|NCT03122860|155411551|FG001|Overall Study|Lost to Follow-up|2|||
48331729|NCT03122860|155411552|FG002|Overall Study|Lost to Follow-up|3|||
48331730|NCT03122860|155411553|FG003|Overall Study|Lost to Follow-up|3|||
48331731|NCT03122860|155411554|FG004|Overall Study|Lost to Follow-up|5|||
48331732|NCT03122860|155411555|FG005|Overall Study|Lost to Follow-up|4|||
48331733|NCT03122860|155411550|FG000|Overall Study|Subject Non-Compliance|0|||
48331734|NCT03122860|155411551|FG001|Overall Study|Subject Non-Compliance|0|||
48331735|NCT03122860|155411552|FG002|Overall Study|Subject Non-Compliance|1|||
48331736|NCT03122860|155411553|FG003|Overall Study|Subject Non-Compliance|0|||
48331737|NCT03122860|155411554|FG004|Overall Study|Subject Non-Compliance|0|||
48331738|NCT03122860|155411555|FG005|Overall Study|Subject Non-Compliance|0|||
48650483|NCT02482298|156573012|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
48650484|NCT02482298|156573013|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
48650485|NCT02482298|156573014|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
48650486|NCT02482298|156573012|FG000|Overall Study|Lost to Follow-up|0|||
48650487|NCT02482298|156573013|FG001|Overall Study|Lost to Follow-up|1|||
48650488|NCT02482298|156573014|FG002|Overall Study|Lost to Follow-up|0|||
48650489|NCT03053440|156573017|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
48650490|NCT03053440|156573018|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
48650491|NCT03053440|156573017|FG000|Overall Study|Death|18|||
48650492|NCT03053440|156573018|FG001|Overall Study|Death|14|||
48650493|NCT03053440|156573017|FG000|Overall Study|Withdrawal by Subject|9|||
48650494|NCT03053440|156573018|FG001|Overall Study|Withdrawal by Subject|8|||
48650495|NCT03053440|156573017|FG000|Overall Study|Lost to Follow-up|1|||
48650496|NCT03053440|156573018|FG001|Overall Study|Lost to Follow-up|0|||
48650497|NCT03053440|156573017|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
48650498|NCT03053440|156573018|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
48650499|NCT03053440|156573017|FG000|Overall Study|Physician Decision|2|||
48650500|NCT03053440|156573018|FG001|Overall Study|Physician Decision|1|||
48650501|NCT03053440|156573017|FG000|Overall Study|Participant Randomized but died before dosing|1|||
48650502|NCT03053440|156573018|FG001|Overall Study|Participant Randomized but died before dosing|0|||
48650503|NCT01188551|156573021|FG000|Overall Study|Pharmacy issues|1|||
48650504|NCT01188551|156573022|FG001|Overall Study|Pharmacy issues|0|||
48650505|NCT01188551|156573023|FG002|Overall Study|Pharmacy issues|0|||
48331739|NCT03122860|155411550|FG000|Overall Study|Withdrawal by Subject|3|||
48650506|NCT01188551|156573024|FG003|Overall Study|Pharmacy issues|0|||
48650507|NCT01436656|156573025|FG000|Dose Escalation|Death|1|||
48650508|NCT01436656|156573026|FG001|Dose Escalation|Death|3|||
48331740|NCT03122860|155411551|FG001|Overall Study|Withdrawal by Subject|2|||
48331741|NCT03122860|155411552|FG002|Overall Study|Withdrawal by Subject|5|||
48331742|NCT03122860|155411553|FG003|Overall Study|Withdrawal by Subject|7|||
48331743|NCT03122860|155411554|FG004|Overall Study|Withdrawal by Subject|9|||
48331744|NCT03122860|155411555|FG005|Overall Study|Withdrawal by Subject|8|||
48650509|NCT01436656|156573027|FG002|Dose Escalation|Death|1|||
48650510|NCT01436656|156573028|FG003|Dose Escalation|Death|0|||
48650511|NCT01436656|156573029|FG004|Dose Escalation|Death|2|||
48650512|NCT01436656|156573030|FG005|Dose Escalation|Death|1|||
48650513|NCT01436656|156573031|FG006|Dose Escalation|Death|1|||
48650514|NCT01436656|156573032|FG007|Dose Escalation|Death|1|||
48650515|NCT01436656|156573033|FG008|Dose Escalation|Death|1|||
48650516|NCT01436656|156573034|FG009|Dose Escalation|Death|0|||
48650517|NCT01436656|156573035|FG010|Dose Escalation|Death|0|||
48650518|NCT01436656|156573036|FG011|Dose Escalation|Death|0|||
48650519|NCT01436656|156573037|FG012|Dose Escalation|Death|0|||
48650520|NCT01436656|156573038|FG013|Dose Escalation|Death|0|||
48650521|NCT01436656|156573039|FG014|Dose Escalation|Death|0|||
48650522|NCT01436656|156573040|FG015|Dose Escalation|Death|0|||
48650523|NCT01436656|156573041|FG016|Dose Escalation|Death|0|||
48650524|NCT01436656|156573042|FG017|Dose Escalation|Death|0|||
48650525|NCT01436656|156573025|FG000|Dose Escalation|Protocol Violation|0|||
48650526|NCT01436656|156573026|FG001|Dose Escalation|Protocol Violation|0|||
48650527|NCT01436656|156573027|FG002|Dose Escalation|Protocol Violation|0|||
48650528|NCT01436656|156573028|FG003|Dose Escalation|Protocol Violation|0|||
48650529|NCT01436656|156573029|FG004|Dose Escalation|Protocol Violation|0|||
48650530|NCT01436656|156573030|FG005|Dose Escalation|Protocol Violation|1|||
48752791|NCT03138889|156940140|FG001|Overall Study|Withdrawal by Subject|5|||
48752792|NCT03138889|156940141|FG002|Overall Study|Withdrawal by Subject|0|||
48752793|NCT03138889|156940142|FG003|Overall Study|Withdrawal by Subject|2|||
48752794|NCT03138889|156940143|FG004|Overall Study|Withdrawal by Subject|1|||
48752795|NCT03138889|156940144|FG005|Overall Study|Withdrawal by Subject|3|||
48752796|NCT03138889|156940145|FG006|Overall Study|Withdrawal by Subject|0|||
48752797|NCT03138889|156940146|FG007|Overall Study|Withdrawal by Subject|1|||
48752798|NCT00936910|156940147|FG000|Overall Study|Lack of Efficacy|3|||
48752799|NCT00105482|156940148|FG000|Overall Study|Adverse Event|1|||
48331745|NCT02764320|155411556|FG000|Overall Study|Withdrawal by Subject|35|||
48331746|NCT02764320|155411557|FG001|Overall Study|Withdrawal by Subject|38|||
48331747|NCT02764320|155411556|FG000|Overall Study|Protocol Violation|11|||
48650531|NCT01436656|156573031|FG006|Dose Escalation|Protocol Violation|0|||
48650532|NCT01436656|156573032|FG007|Dose Escalation|Protocol Violation|0|||
48650533|NCT01436656|156573033|FG008|Dose Escalation|Protocol Violation|0|||
48650534|NCT01436656|156573034|FG009|Dose Escalation|Protocol Violation|0|||
48650535|NCT01436656|156573035|FG010|Dose Escalation|Protocol Violation|0|||
48650536|NCT01436656|156573036|FG011|Dose Escalation|Protocol Violation|0|||
48650537|NCT01436656|156573037|FG012|Dose Escalation|Protocol Violation|0|||
48650538|NCT01436656|156573038|FG013|Dose Escalation|Protocol Violation|0|||
48650539|NCT01436656|156573039|FG014|Dose Escalation|Protocol Violation|0|||
48650540|NCT01436656|156573040|FG015|Dose Escalation|Protocol Violation|0|||
48650541|NCT01436656|156573041|FG016|Dose Escalation|Protocol Violation|0|||
48650542|NCT01436656|156573042|FG017|Dose Escalation|Protocol Violation|0|||
48650543|NCT01436656|156573025|FG000|Dose Escalation|Withdrawal by Subject|0|||
48650544|NCT01436656|156573026|FG001|Dose Escalation|Withdrawal by Subject|0|||
48650545|NCT01436656|156573027|FG002|Dose Escalation|Withdrawal by Subject|0|||
48650546|NCT01436656|156573028|FG003|Dose Escalation|Withdrawal by Subject|0|||
48650547|NCT01436656|156573029|FG004|Dose Escalation|Withdrawal by Subject|1|||
48650548|NCT01436656|156573030|FG005|Dose Escalation|Withdrawal by Subject|0|||
48650549|NCT01436656|156573031|FG006|Dose Escalation|Withdrawal by Subject|0|||
48650550|NCT01436656|156573032|FG007|Dose Escalation|Withdrawal by Subject|2|||
48752800|NCT00105482|156940149|FG001|Overall Study|Adverse Event|1|||
48331748|NCT02764320|155411557|FG001|Overall Study|Protocol Violation|6|||
48331749|NCT02764320|155411556|FG000|Overall Study|Adverse Event|2|||
48331750|NCT02764320|155411557|FG001|Overall Study|Adverse Event|0|||
48331751|NCT02764320|155411556|FG000|Overall Study|Health Issues unable to continue|2|||
48331752|NCT02764320|155411557|FG001|Overall Study|Health Issues unable to continue|0|||
48331753|NCT02764320|155411556|FG000|Overall Study|Did not meet inclusion criteria|1|||
48331754|NCT02764320|155411557|FG001|Overall Study|Did not meet inclusion criteria|0|||
48331755|NCT02764320|155411556|FG000|Overall Study|Subject moved|0|||
48331756|NCT02764320|155411557|FG001|Overall Study|Subject moved|2|||
48331757|NCT02764320|155411556|FG000|Overall Study|Overused medication unavailable|0|||
48331758|NCT02764320|155411557|FG001|Overall Study|Overused medication unavailable|1|||
48331759|NCT02764320|155411556|FG000|Overall Study|Seeking care outside site|0|||
48331760|NCT02764320|155411557|FG001|Overall Study|Seeking care outside site|1|||
48752801|NCT00105482|156940148|FG000|Overall Study|Lost to Follow-up|26|||
48331761|NCT02764320|155411556|FG000|Overall Study|Technology barriers|0|||
48331762|NCT02764320|155411557|FG001|Overall Study|Technology barriers|1|||
48752802|NCT00105482|156940149|FG001|Overall Study|Lost to Follow-up|17|||
48752803|NCT00105482|156940148|FG000|Overall Study|Withdrawal by Subject|0|||
48331763|NCT04085614|155411565|FG000|Overall Study|Protocol Violation|9|||
48331764|NCT04085614|155411566|FG001|Overall Study|Protocol Violation|6|||
48650551|NCT01436656|156573033|FG008|Dose Escalation|Withdrawal by Subject|0|||
48650552|NCT01436656|156573034|FG009|Dose Escalation|Withdrawal by Subject|1|||
48650553|NCT01436656|156573035|FG010|Dose Escalation|Withdrawal by Subject|1|||
48650554|NCT01436656|156573036|FG011|Dose Escalation|Withdrawal by Subject|0|||
48650555|NCT01436656|156573037|FG012|Dose Escalation|Withdrawal by Subject|0|||
48650556|NCT01436656|156573038|FG013|Dose Escalation|Withdrawal by Subject|0|||
48650557|NCT01436656|156573039|FG014|Dose Escalation|Withdrawal by Subject|0|||
48650558|NCT01436656|156573040|FG015|Dose Escalation|Withdrawal by Subject|0|||
48650559|NCT01436656|156573041|FG016|Dose Escalation|Withdrawal by Subject|0|||
48650560|NCT01436656|156573042|FG017|Dose Escalation|Withdrawal by Subject|0|||
48650561|NCT01436656|156573025|FG000|Dose Escalation|Administrative problems|0|||
48650562|NCT01436656|156573026|FG001|Dose Escalation|Administrative problems|1|||
48650563|NCT01436656|156573027|FG002|Dose Escalation|Administrative problems|0|||
48650564|NCT01436656|156573028|FG003|Dose Escalation|Administrative problems|0|||
48650565|NCT01436656|156573029|FG004|Dose Escalation|Administrative problems|0|||
48650566|NCT01436656|156573030|FG005|Dose Escalation|Administrative problems|0|||
48650567|NCT01436656|156573031|FG006|Dose Escalation|Administrative problems|0|||
48650568|NCT01436656|156573032|FG007|Dose Escalation|Administrative problems|0|||
48650569|NCT01436656|156573033|FG008|Dose Escalation|Administrative problems|0|||
48650570|NCT01436656|156573034|FG009|Dose Escalation|Administrative problems|0|||
48650571|NCT01436656|156573035|FG010|Dose Escalation|Administrative problems|0|||
48650572|NCT01436656|156573036|FG011|Dose Escalation|Administrative problems|0|||
48650573|NCT01436656|156573037|FG012|Dose Escalation|Administrative problems|0|||
48650574|NCT01436656|156573038|FG013|Dose Escalation|Administrative problems|0|||
48650575|NCT01436656|156573039|FG014|Dose Escalation|Administrative problems|0|||
48650576|NCT01436656|156573040|FG015|Dose Escalation|Administrative problems|0|||
48650577|NCT01436656|156573041|FG016|Dose Escalation|Administrative problems|0|||
48650578|NCT01436656|156573042|FG017|Dose Escalation|Administrative problems|0|||
48650579|NCT01436656|156573025|FG000|Dose Escalation|Lost to Follow-up|1|||
48650580|NCT01436656|156573026|FG001|Dose Escalation|Lost to Follow-up|0|||
48650581|NCT01436656|156573027|FG002|Dose Escalation|Lost to Follow-up|0|||
48650582|NCT01436656|156573028|FG003|Dose Escalation|Lost to Follow-up|0|||
48650583|NCT01436656|156573029|FG004|Dose Escalation|Lost to Follow-up|1|||
48650584|NCT01436656|156573030|FG005|Dose Escalation|Lost to Follow-up|0|||
48650585|NCT01436656|156573031|FG006|Dose Escalation|Lost to Follow-up|0|||
48650586|NCT01436656|156573032|FG007|Dose Escalation|Lost to Follow-up|0|||
48650587|NCT01436656|156573033|FG008|Dose Escalation|Lost to Follow-up|0|||
48650588|NCT01436656|156573034|FG009|Dose Escalation|Lost to Follow-up|0|||
48650589|NCT01436656|156573035|FG010|Dose Escalation|Lost to Follow-up|0|||
48650590|NCT01436656|156573036|FG011|Dose Escalation|Lost to Follow-up|0|||
48650591|NCT01436656|156573037|FG012|Dose Escalation|Lost to Follow-up|0|||
48650592|NCT01436656|156573038|FG013|Dose Escalation|Lost to Follow-up|0|||
48752804|NCT00105482|156940149|FG001|Overall Study|Withdrawal by Subject|1|||
48752805|NCT00105482|156940148|FG000|Overall Study|Lost Interest|29|||
48752806|NCT00105482|156940149|FG001|Overall Study|Lost Interest|32|||
48752807|NCT00105482|156940148|FG000|Overall Study|Scheduling Conflict|2|||
48752808|NCT00105482|156940149|FG001|Overall Study|Scheduling Conflict|3|||
48752809|NCT00105482|156940148|FG000|Overall Study|Withdrawn by PI|1|||
48752810|NCT00105482|156940149|FG001|Overall Study|Withdrawn by PI|1|||
48752811|NCT04626297|156940151|FG000|Overall Study|Adverse Event|5|||
48752812|NCT04626297|156940152|FG001|Overall Study|Adverse Event|3|||
48650593|NCT01436656|156573039|FG014|Dose Escalation|Lost to Follow-up|0|||
48650594|NCT01436656|156573040|FG015|Dose Escalation|Lost to Follow-up|0|||
48650595|NCT01436656|156573041|FG016|Dose Escalation|Lost to Follow-up|0|||
48650596|NCT01436656|156573042|FG017|Dose Escalation|Lost to Follow-up|0|||
48650597|NCT01436656|156573025|FG000|Dose Escalation|New anti-cancer therapy|1|||
48650598|NCT01436656|156573026|FG001|Dose Escalation|New anti-cancer therapy|0|||
48650599|NCT01436656|156573027|FG002|Dose Escalation|New anti-cancer therapy|0|||
48650600|NCT01436656|156573028|FG003|Dose Escalation|New anti-cancer therapy|0|||
48650601|NCT01436656|156573029|FG004|Dose Escalation|New anti-cancer therapy|0|||
48650602|NCT01436656|156573030|FG005|Dose Escalation|New anti-cancer therapy|0|||
48650603|NCT01436656|156573031|FG006|Dose Escalation|New anti-cancer therapy|0|||
48650604|NCT01436656|156573032|FG007|Dose Escalation|New anti-cancer therapy|0|||
48650605|NCT01436656|156573033|FG008|Dose Escalation|New anti-cancer therapy|1|||
48650606|NCT01436656|156573034|FG009|Dose Escalation|New anti-cancer therapy|1|||
48650607|NCT01436656|156573035|FG010|Dose Escalation|New anti-cancer therapy|0|||
48650608|NCT01436656|156573036|FG011|Dose Escalation|New anti-cancer therapy|0|||
48650609|NCT01436656|156573037|FG012|Dose Escalation|New anti-cancer therapy|0|||
48650610|NCT01436656|156573038|FG013|Dose Escalation|New anti-cancer therapy|0|||
48650611|NCT01436656|156573039|FG014|Dose Escalation|New anti-cancer therapy|0|||
48650612|NCT01436656|156573040|FG015|Dose Escalation|New anti-cancer therapy|0|||
48650613|NCT01436656|156573041|FG016|Dose Escalation|New anti-cancer therapy|0|||
48650614|NCT01436656|156573042|FG017|Dose Escalation|New anti-cancer therapy|0|||
48650615|NCT01436656|156573025|FG000|Dose Expansion|Adverse Event|0|||
48650616|NCT01436656|156573026|FG001|Dose Expansion|Adverse Event|0|||
48650617|NCT01436656|156573027|FG002|Dose Expansion|Adverse Event|0|||
48650618|NCT01436656|156573028|FG003|Dose Expansion|Adverse Event|0|||
48650619|NCT01436656|156573029|FG004|Dose Expansion|Adverse Event|0|||
48650620|NCT01436656|156573030|FG005|Dose Expansion|Adverse Event|0|||
48650621|NCT01436656|156573031|FG006|Dose Expansion|Adverse Event|0|||
48650622|NCT01436656|156573032|FG007|Dose Expansion|Adverse Event|0|||
48650623|NCT01436656|156573033|FG008|Dose Expansion|Adverse Event|0|||
48650624|NCT01436656|156573034|FG009|Dose Expansion|Adverse Event|0|||
48650625|NCT01436656|156573035|FG010|Dose Expansion|Adverse Event|0|||
48650626|NCT01436656|156573036|FG011|Dose Expansion|Adverse Event|1|||
48650627|NCT01436656|156573037|FG012|Dose Expansion|Adverse Event|0|||
48650628|NCT01436656|156573038|FG013|Dose Expansion|Adverse Event|0|||
48650629|NCT01436656|156573039|FG014|Dose Expansion|Adverse Event|0|||
48650630|NCT01436656|156573040|FG015|Dose Expansion|Adverse Event|0|||
48752813|NCT04626297|156940151|FG000|Overall Study|Lost to Follow-up|7|||
48752814|NCT04626297|156940152|FG001|Overall Study|Lost to Follow-up|3|||
48650631|NCT01436656|156573041|FG016|Dose Expansion|Adverse Event|0|||
48331765|NCT01000649|155411571|FG000|Overall Study|Adverse Event|5|||
48331766|NCT01000649|155411572|FG001|Overall Study|Adverse Event|1|||
48331767|NCT01000649|155411573|FG002|Overall Study|Adverse Event|2|||
48331768|NCT01000649|155411574|FG003|Overall Study|Adverse Event|4|||
48331769|NCT01000649|155411571|FG000|Overall Study|Lost to Follow-up|0|||
48331770|NCT01000649|155411572|FG001|Overall Study|Lost to Follow-up|2|||
48331771|NCT01000649|155411573|FG002|Overall Study|Lost to Follow-up|0|||
48650632|NCT01436656|156573042|FG017|Dose Expansion|Adverse Event|0|||
48650633|NCT01436656|156573025|FG000|Dose Expansion|Withdrawal by Subject|0|||
48650634|NCT01436656|156573026|FG001|Dose Expansion|Withdrawal by Subject|0|||
48650635|NCT01436656|156573027|FG002|Dose Expansion|Withdrawal by Subject|0|||
48650636|NCT01436656|156573028|FG003|Dose Expansion|Withdrawal by Subject|0|||
48650637|NCT01436656|156573029|FG004|Dose Expansion|Withdrawal by Subject|0|||
48650638|NCT01436656|156573030|FG005|Dose Expansion|Withdrawal by Subject|0|||
48650639|NCT01436656|156573031|FG006|Dose Expansion|Withdrawal by Subject|0|||
48650640|NCT01436656|156573032|FG007|Dose Expansion|Withdrawal by Subject|0|||
48650641|NCT01436656|156573033|FG008|Dose Expansion|Withdrawal by Subject|0|||
48650642|NCT01436656|156573034|FG009|Dose Expansion|Withdrawal by Subject|0|||
48650643|NCT01436656|156573035|FG010|Dose Expansion|Withdrawal by Subject|0|||
48650644|NCT01436656|156573036|FG011|Dose Expansion|Withdrawal by Subject|1|||
48650645|NCT01436656|156573037|FG012|Dose Expansion|Withdrawal by Subject|3|||
48650646|NCT01436656|156573038|FG013|Dose Expansion|Withdrawal by Subject|1|||
48650647|NCT01436656|156573039|FG014|Dose Expansion|Withdrawal by Subject|2|||
48650648|NCT01436656|156573040|FG015|Dose Expansion|Withdrawal by Subject|0|||
48650649|NCT01436656|156573041|FG016|Dose Expansion|Withdrawal by Subject|1|||
48650650|NCT01436656|156573042|FG017|Dose Expansion|Withdrawal by Subject|1|||
48650651|NCT01436656|156573025|FG000|Dose Expansion|Death|0|||
48650652|NCT01436656|156573026|FG001|Dose Expansion|Death|0|||
48650653|NCT01436656|156573027|FG002|Dose Expansion|Death|0|||
48650654|NCT01436656|156573028|FG003|Dose Expansion|Death|0|||
48752815|NCT04626297|156940151|FG000|Overall Study|Protocol Violation|5|||
48752816|NCT04626297|156940152|FG001|Overall Study|Protocol Violation|1|||
48752817|NCT04626297|156940151|FG000|Overall Study|Withdrawal by Subject|20|||
48752818|NCT04626297|156940152|FG001|Overall Study|Withdrawal by Subject|6|||
48752819|NCT04626297|156940151|FG000|Overall Study|Sponsor decision|2|||
48752820|NCT04626297|156940152|FG001|Overall Study|Sponsor decision|1|||
48752821|NCT03462082|156940155|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752822|NCT03462082|156940156|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752823|NCT03462082|156940157|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752824|NCT03462082|156940158|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752825|NCT03462082|156940159|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752826|NCT03462082|156940160|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
48752827|NCT03462082|156940161|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
48752828|NCT03462082|156940162|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
48752829|NCT01979016|156940163|FG000|Overall Study|Withdrawal by Subject|2|||
48752830|NCT01979016|156940164|FG001|Overall Study|Withdrawal by Subject|0|||
48752831|NCT01979016|156940163|FG000|Overall Study|Adverse Event|0|||
48752832|NCT01979016|156940164|FG001|Overall Study|Adverse Event|1|||
48752833|NCT03998189|156940165|FG000|Overall Study|Lack of Efficacy|0|||
48752834|NCT03998189|156940166|FG001|Overall Study|Lack of Efficacy|1|||
48752835|NCT01442493|156940167|FG000|Overall Study|withdrawn from study|3|||
48752836|NCT01442493|156940168|FG001|Overall Study|withdrawn from study|2|||
48752837|NCT01750242|156940169|FG000|Overall Study|Unreadable Images|3|||
48752838|NCT02557646|156940171|FG000|Overall Study|Adverse Event|40|||
48752839|NCT02557646|156940171|FG000|Overall Study|Death|1|||
48752840|NCT02557646|156940171|FG000|Overall Study|Lack of Efficacy|186|||
48752841|NCT02557646|156940171|FG000|Overall Study|Withdrawal by Subject|18|||
48752842|NCT02557646|156940171|FG000|Overall Study|Lost to Follow-up|17|||
48752843|NCT02557646|156940171|FG000|Overall Study|Other|14|||
48752844|NCT00927784|156940183|FG000|Overall Study|Death|1|||
48752845|NCT00927784|156940184|FG001|Overall Study|Death|0|||
48752846|NCT00927784|156940183|FG000|Overall Study|Withdrawal by Subject|1|||
48752847|NCT00927784|156940184|FG001|Overall Study|Withdrawal by Subject|0|||
48752848|NCT02860169|156940185|FG000|Part A|Withdrawal by Subject|1|||
48752849|NCT02860169|156940185|FG000|Part A|Other (Screening failure)|6|||
48752850|NCT02860169|156940185|FG000|Part A|Other (Survey not completed)|3|||
48752851|NCT02860169|156940185|FG000|Part A|Other (did not completed consent)|1|||
48331772|NCT01000649|155411574|FG003|Overall Study|Lost to Follow-up|2|||
48331773|NCT00103857|155411579|FG000|54-Week Base Study|Adverse Event|12|||
48331774|NCT00103857|155411580|FG001|54-Week Base Study|Adverse Event|9|||
48331775|NCT00103857|155411581|FG002|54-Week Base Study|Adverse Event|11|||
48752852|NCT02860169|156940185|FG000|Part B|Other (Screening failure)|10|||
48331776|NCT00103857|155411582|FG003|54-Week Base Study|Adverse Event|6|||
48752853|NCT02860169|156940185|FG000|Part B|Withdrawal by Subject|1|||
48650655|NCT01436656|156573029|FG004|Dose Expansion|Death|0|||
48650656|NCT01436656|156573030|FG005|Dose Expansion|Death|0|||
48650657|NCT01436656|156573031|FG006|Dose Expansion|Death|0|||
48752854|NCT02860169|156940185|FG000|Part C|Other (Screening failure)|1|||
48331777|NCT00103857|155411583|FG004|54-Week Base Study|Adverse Event|5|||
48331778|NCT00103857|155411584|FG005|54-Week Base Study|Adverse Event|11|||
48331779|NCT00103857|155411585|FG006|54-Week Base Study|Adverse Event|3|||
48331780|NCT00103857|155411579|FG000|54-Week Base Study|Death|0|||
48331781|NCT00103857|155411580|FG001|54-Week Base Study|Death|0|||
48331782|NCT00103857|155411581|FG002|54-Week Base Study|Death|0|||
48331783|NCT00103857|155411582|FG003|54-Week Base Study|Death|0|||
48331784|NCT00103857|155411583|FG004|54-Week Base Study|Death|1|||
48331785|NCT00103857|155411584|FG005|54-Week Base Study|Death|1|||
48331786|NCT00103857|155411585|FG006|54-Week Base Study|Death|0|||
48331787|NCT00103857|155411579|FG000|54-Week Base Study|Lack of Efficacy|11|||
48331788|NCT00103857|155411580|FG001|54-Week Base Study|Lack of Efficacy|14|||
48331789|NCT00103857|155411581|FG002|54-Week Base Study|Lack of Efficacy|8|||
48331790|NCT00103857|155411582|FG003|54-Week Base Study|Lack of Efficacy|4|||
48331791|NCT00103857|155411583|FG004|54-Week Base Study|Lack of Efficacy|3|||
48331792|NCT00103857|155411584|FG005|54-Week Base Study|Lack of Efficacy|14|||
48331793|NCT00103857|155411585|FG006|54-Week Base Study|Lack of Efficacy|19|||
48331794|NCT00103857|155411579|FG000|54-Week Base Study|Lost to Follow-up|5|||
48331795|NCT00103857|155411580|FG001|54-Week Base Study|Lost to Follow-up|4|||
48331796|NCT00103857|155411581|FG002|54-Week Base Study|Lost to Follow-up|7|||
48331797|NCT00103857|155411582|FG003|54-Week Base Study|Lost to Follow-up|5|||
48331798|NCT00103857|155411583|FG004|54-Week Base Study|Lost to Follow-up|10|||
48331799|NCT00103857|155411584|FG005|54-Week Base Study|Lost to Follow-up|9|||
48331800|NCT00103857|155411585|FG006|54-Week Base Study|Lost to Follow-up|3|||
48331801|NCT00103857|155411579|FG000|54-Week Base Study|Physician Decision|1|||
48331802|NCT00103857|155411580|FG001|54-Week Base Study|Physician Decision|1|||
48331803|NCT00103857|155411581|FG002|54-Week Base Study|Physician Decision|0|||
48331804|NCT00103857|155411582|FG003|54-Week Base Study|Physician Decision|0|||
48331805|NCT00103857|155411583|FG004|54-Week Base Study|Physician Decision|1|||
48331806|NCT00103857|155411584|FG005|54-Week Base Study|Physician Decision|0|||
48331807|NCT00103857|155411585|FG006|54-Week Base Study|Physician Decision|0|||
48331808|NCT00103857|155411579|FG000|54-Week Base Study|Pregnancy|1|||
48331809|NCT00103857|155411580|FG001|54-Week Base Study|Pregnancy|0|||
48331810|NCT00103857|155411581|FG002|54-Week Base Study|Pregnancy|0|||
48331811|NCT00103857|155411582|FG003|54-Week Base Study|Pregnancy|0|||
48331812|NCT00103857|155411583|FG004|54-Week Base Study|Pregnancy|1|||
48331813|NCT00103857|155411584|FG005|54-Week Base Study|Pregnancy|0|||
48331814|NCT00103857|155411585|FG006|54-Week Base Study|Pregnancy|1|||
48331815|NCT00103857|155411579|FG000|54-Week Base Study|Protocol Violation|6|||
48331816|NCT00103857|155411580|FG001|54-Week Base Study|Protocol Violation|4|||
48331817|NCT00103857|155411581|FG002|54-Week Base Study|Protocol Violation|2|||
48331818|NCT00103857|155411582|FG003|54-Week Base Study|Protocol Violation|4|||
48331819|NCT00103857|155411583|FG004|54-Week Base Study|Protocol Violation|0|||
48331820|NCT00103857|155411584|FG005|54-Week Base Study|Protocol Violation|3|||
48331821|NCT00103857|155411585|FG006|54-Week Base Study|Protocol Violation|3|||
48331822|NCT00103857|155411579|FG000|54-Week Base Study|Withdrawal by Subject|17|||
48331823|NCT00103857|155411580|FG001|54-Week Base Study|Withdrawal by Subject|16|||
48331824|NCT00103857|155411581|FG002|54-Week Base Study|Withdrawal by Subject|16|||
48331825|NCT00103857|155411582|FG003|54-Week Base Study|Withdrawal by Subject|15|||
48331826|NCT00103857|155411583|FG004|54-Week Base Study|Withdrawal by Subject|10|||
48331827|NCT00103857|155411584|FG005|54-Week Base Study|Withdrawal by Subject|15|||
48331828|NCT00103857|155411585|FG006|54-Week Base Study|Withdrawal by Subject|4|||
48331829|NCT00103857|155411579|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
48331830|NCT00103857|155411580|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
48331831|NCT00103857|155411581|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
48331832|NCT00103857|155411582|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
48331833|NCT00103857|155411583|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
48331834|NCT00103857|155411584|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
48331835|NCT00103857|155411585|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
48331836|NCT00103857|155411579|FG000|54-Week Base Study|patient moved|0|||
48331837|NCT00103857|155411580|FG001|54-Week Base Study|patient moved|1|||
48331838|NCT00103857|155411581|FG002|54-Week Base Study|patient moved|1|||
48331839|NCT00103857|155411582|FG003|54-Week Base Study|patient moved|2|||
48331840|NCT00103857|155411583|FG004|54-Week Base Study|patient moved|3|||
48331841|NCT00103857|155411584|FG005|54-Week Base Study|patient moved|1|||
48331842|NCT00103857|155411585|FG006|54-Week Base Study|patient moved|0|||
48331843|NCT00103857|155411579|FG000|54-Week Base Study|non-compliance with study procedures|1|||
48331844|NCT00103857|155411580|FG001|54-Week Base Study|non-compliance with study procedures|2|||
48331845|NCT00103857|155411581|FG002|54-Week Base Study|non-compliance with study procedures|0|||
48331846|NCT00103857|155411582|FG003|54-Week Base Study|non-compliance with study procedures|0|||
48331847|NCT00103857|155411583|FG004|54-Week Base Study|non-compliance with study procedures|0|||
48331848|NCT00103857|155411584|FG005|54-Week Base Study|non-compliance with study procedures|2|||
48331849|NCT00103857|155411585|FG006|54-Week Base Study|non-compliance with study procedures|0|||
48331850|NCT00103857|155411579|FG000|54-Week Base Study|patient incarcerated|0|||
48331851|NCT00103857|155411580|FG001|54-Week Base Study|patient incarcerated|0|||
48331852|NCT00103857|155411581|FG002|54-Week Base Study|patient incarcerated|0|||
48331853|NCT00103857|155411582|FG003|54-Week Base Study|patient incarcerated|0|||
48331854|NCT00103857|155411583|FG004|54-Week Base Study|patient incarcerated|1|||
48331855|NCT00103857|155411584|FG005|54-Week Base Study|patient incarcerated|1|||
48331856|NCT00103857|155411585|FG006|54-Week Base Study|patient incarcerated|0|||
48331857|NCT00103857|155411579|FG000|54-Week Base Study|laboratory reporting error|0|||
48331858|NCT00103857|155411580|FG001|54-Week Base Study|laboratory reporting error|0|||
48331859|NCT00103857|155411581|FG002|54-Week Base Study|laboratory reporting error|0|||
48331860|NCT00103857|155411582|FG003|54-Week Base Study|laboratory reporting error|0|||
48331861|NCT00103857|155411583|FG004|54-Week Base Study|laboratory reporting error|1|||
48331862|NCT00103857|155411584|FG005|54-Week Base Study|laboratory reporting error|0|||
48331863|NCT00103857|155411585|FG006|54-Week Base Study|laboratory reporting error|0|||
48331864|NCT00103857|155411579|FG000|54-Week Base Study|site error|0|||
48331865|NCT00103857|155411580|FG001|54-Week Base Study|site error|0|||
48331866|NCT00103857|155411581|FG002|54-Week Base Study|site error|0|||
48331867|NCT00103857|155411582|FG003|54-Week Base Study|site error|0|||
48331868|NCT00103857|155411583|FG004|54-Week Base Study|site error|0|||
48331869|NCT00103857|155411584|FG005|54-Week Base Study|site error|1|||
48331870|NCT00103857|155411585|FG006|54-Week Base Study|site error|0|||
48331871|NCT00103857|155411579|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
48331872|NCT00103857|155411580|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
48331873|NCT00103857|155411581|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
48331874|NCT00103857|155411582|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
48331875|NCT00103857|155411583|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
48331876|NCT00103857|155411584|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
48331877|NCT00103857|155411585|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
48331878|NCT00103857|155411579|FG000|50-Week Extension Study|Adverse Event|2|||
48331879|NCT00103857|155411580|FG001|50-Week Extension Study|Adverse Event|3|||
48331880|NCT00103857|155411581|FG002|50-Week Extension Study|Adverse Event|2|||
48331881|NCT00103857|155411582|FG003|50-Week Extension Study|Adverse Event|0|||
48331882|NCT00103857|155411583|FG004|50-Week Extension Study|Adverse Event|1|||
48331883|NCT00103857|155411584|FG005|50-Week Extension Study|Adverse Event|1|||
48331884|NCT00103857|155411585|FG006|50-Week Extension Study|Adverse Event|0|||
48331885|NCT00103857|155411579|FG000|50-Week Extension Study|Death|0|||
48331886|NCT00103857|155411580|FG001|50-Week Extension Study|Death|0|||
48331887|NCT00103857|155411581|FG002|50-Week Extension Study|Death|0|||
48331888|NCT00103857|155411582|FG003|50-Week Extension Study|Death|1|||
48331889|NCT00103857|155411583|FG004|50-Week Extension Study|Death|0|||
48331890|NCT00103857|155411584|FG005|50-Week Extension Study|Death|1|||
48331891|NCT00103857|155411585|FG006|50-Week Extension Study|Death|0|||
48331892|NCT00103857|155411579|FG000|50-Week Extension Study|Lack of Efficacy|26|||
48331893|NCT00103857|155411580|FG001|50-Week Extension Study|Lack of Efficacy|15|||
48331894|NCT00103857|155411581|FG002|50-Week Extension Study|Lack of Efficacy|13|||
48331895|NCT00103857|155411582|FG003|50-Week Extension Study|Lack of Efficacy|16|||
48331896|NCT00103857|155411583|FG004|50-Week Extension Study|Lack of Efficacy|8|||
48331897|NCT00103857|155411584|FG005|50-Week Extension Study|Lack of Efficacy|8|||
48331898|NCT00103857|155411585|FG006|50-Week Extension Study|Lack of Efficacy|0|||
48331899|NCT00103857|155411579|FG000|50-Week Extension Study|Lost to Follow-up|4|||
48331900|NCT00103857|155411580|FG001|50-Week Extension Study|Lost to Follow-up|0|||
48331901|NCT00103857|155411581|FG002|50-Week Extension Study|Lost to Follow-up|1|||
48331902|NCT00103857|155411582|FG003|50-Week Extension Study|Lost to Follow-up|4|||
48331903|NCT00103857|155411583|FG004|50-Week Extension Study|Lost to Follow-up|3|||
48650658|NCT01436656|156573032|FG007|Dose Expansion|Death|0|||
48650659|NCT01436656|156573033|FG008|Dose Expansion|Death|0|||
48650660|NCT01436656|156573034|FG009|Dose Expansion|Death|0|||
48650661|NCT01436656|156573035|FG010|Dose Expansion|Death|0|||
48650662|NCT01436656|156573036|FG011|Dose Expansion|Death|0|||
48650663|NCT01436656|156573037|FG012|Dose Expansion|Death|1|||
48650664|NCT01436656|156573038|FG013|Dose Expansion|Death|0|||
48650665|NCT01436656|156573039|FG014|Dose Expansion|Death|3|||
48331904|NCT00103857|155411584|FG005|50-Week Extension Study|Lost to Follow-up|3|||
48331905|NCT00103857|155411585|FG006|50-Week Extension Study|Lost to Follow-up|0|||
48331906|NCT00103857|155411579|FG000|50-Week Extension Study|Physician Decision|0|||
48331907|NCT00103857|155411580|FG001|50-Week Extension Study|Physician Decision|1|||
48331908|NCT00103857|155411581|FG002|50-Week Extension Study|Physician Decision|1|||
48331909|NCT00103857|155411582|FG003|50-Week Extension Study|Physician Decision|0|||
48331910|NCT00103857|155411583|FG004|50-Week Extension Study|Physician Decision|0|||
48331911|NCT00103857|155411584|FG005|50-Week Extension Study|Physician Decision|0|||
48331912|NCT00103857|155411585|FG006|50-Week Extension Study|Physician Decision|0|||
48331913|NCT00103857|155411579|FG000|50-Week Extension Study|Pregnancy|0|||
48331914|NCT00103857|155411580|FG001|50-Week Extension Study|Pregnancy|0|||
48331915|NCT00103857|155411581|FG002|50-Week Extension Study|Pregnancy|1|||
48331916|NCT00103857|155411582|FG003|50-Week Extension Study|Pregnancy|0|||
48331917|NCT00103857|155411583|FG004|50-Week Extension Study|Pregnancy|1|||
48650666|NCT01436656|156573040|FG015|Dose Expansion|Death|0|||
48650667|NCT01436656|156573041|FG016|Dose Expansion|Death|3|||
48650668|NCT01436656|156573042|FG017|Dose Expansion|Death|3|||
48650669|NCT01436656|156573025|FG000|Dose Expansion|Lost to Follow-up|0|||
48650670|NCT01436656|156573026|FG001|Dose Expansion|Lost to Follow-up|0|||
48650671|NCT01436656|156573027|FG002|Dose Expansion|Lost to Follow-up|0|||
48650672|NCT01436656|156573028|FG003|Dose Expansion|Lost to Follow-up|0|||
48650673|NCT01436656|156573029|FG004|Dose Expansion|Lost to Follow-up|0|||
48650674|NCT01436656|156573030|FG005|Dose Expansion|Lost to Follow-up|0|||
48650675|NCT01436656|156573031|FG006|Dose Expansion|Lost to Follow-up|0|||
48650676|NCT01436656|156573032|FG007|Dose Expansion|Lost to Follow-up|0|||
48650677|NCT01436656|156573033|FG008|Dose Expansion|Lost to Follow-up|0|||
48650678|NCT01436656|156573034|FG009|Dose Expansion|Lost to Follow-up|0|||
48650679|NCT01436656|156573035|FG010|Dose Expansion|Lost to Follow-up|0|||
48331918|NCT00103857|155411584|FG005|50-Week Extension Study|Pregnancy|0|||
48331919|NCT00103857|155411585|FG006|50-Week Extension Study|Pregnancy|0|||
48331920|NCT00103857|155411579|FG000|50-Week Extension Study|Protocol Violation|1|||
48331921|NCT00103857|155411580|FG001|50-Week Extension Study|Protocol Violation|1|||
48331922|NCT00103857|155411581|FG002|50-Week Extension Study|Protocol Violation|1|||
48331923|NCT00103857|155411582|FG003|50-Week Extension Study|Protocol Violation|2|||
48331924|NCT00103857|155411583|FG004|50-Week Extension Study|Protocol Violation|0|||
48331925|NCT00103857|155411584|FG005|50-Week Extension Study|Protocol Violation|1|||
48331926|NCT00103857|155411585|FG006|50-Week Extension Study|Protocol Violation|0|||
48331927|NCT00103857|155411579|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
48331928|NCT00103857|155411580|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
48331929|NCT00103857|155411581|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
48331930|NCT00103857|155411582|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
48331931|NCT00103857|155411583|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
48331932|NCT00103857|155411584|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
48331933|NCT00103857|155411585|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
48331934|NCT00103857|155411579|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
48331935|NCT00103857|155411580|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
48331936|NCT00103857|155411581|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
48331937|NCT00103857|155411582|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
48331938|NCT00103857|155411583|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
48331939|NCT00103857|155411584|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
48331940|NCT00103857|155411585|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
48331941|NCT00103857|155411579|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
48331942|NCT00103857|155411580|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
48331943|NCT00103857|155411581|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
48331944|NCT00103857|155411582|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
48331945|NCT00103857|155411583|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
48331946|NCT00103857|155411584|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
48331947|NCT00103857|155411585|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
48331948|NCT00103857|155411579|FG000|50-Week Extension Study|patient moved|0|||
48650680|NCT01436656|156573036|FG011|Dose Expansion|Lost to Follow-up|0|||
48650681|NCT01436656|156573037|FG012|Dose Expansion|Lost to Follow-up|0|||
48650682|NCT01436656|156573038|FG013|Dose Expansion|Lost to Follow-up|0|||
48650683|NCT01436656|156573039|FG014|Dose Expansion|Lost to Follow-up|0|||
48650684|NCT01436656|156573040|FG015|Dose Expansion|Lost to Follow-up|0|||
48650685|NCT01436656|156573041|FG016|Dose Expansion|Lost to Follow-up|0|||
48650686|NCT01436656|156573042|FG017|Dose Expansion|Lost to Follow-up|3|||
48650687|NCT01436656|156573025|FG000|Dose Expansion|Disease progression|0|||
48650688|NCT01436656|156573026|FG001|Dose Expansion|Disease progression|0|||
48650689|NCT01436656|156573027|FG002|Dose Expansion|Disease progression|0|||
48650690|NCT01436656|156573028|FG003|Dose Expansion|Disease progression|0|||
48650691|NCT01436656|156573029|FG004|Dose Expansion|Disease progression|0|||
48650692|NCT01436656|156573030|FG005|Dose Expansion|Disease progression|0|||
48650693|NCT01436656|156573031|FG006|Dose Expansion|Disease progression|0|||
48650694|NCT01436656|156573032|FG007|Dose Expansion|Disease progression|0|||
48650695|NCT01436656|156573033|FG008|Dose Expansion|Disease progression|0|||
48650696|NCT01436656|156573034|FG009|Dose Expansion|Disease progression|0|||
48650697|NCT01436656|156573035|FG010|Dose Expansion|Disease progression|0|||
48650698|NCT01436656|156573036|FG011|Dose Expansion|Disease progression|3|||
48650699|NCT01436656|156573037|FG012|Dose Expansion|Disease progression|1|||
48650700|NCT01436656|156573038|FG013|Dose Expansion|Disease progression|0|||
48650701|NCT01436656|156573039|FG014|Dose Expansion|Disease progression|1|||
48650702|NCT01436656|156573040|FG015|Dose Expansion|Disease progression|0|||
48650703|NCT01436656|156573041|FG016|Dose Expansion|Disease progression|0|||
48650704|NCT01436656|156573042|FG017|Dose Expansion|Disease progression|1|||
48650705|NCT01436656|156573025|FG000|Dose Expansion|New cancer therapy|0|||
48650706|NCT01436656|156573026|FG001|Dose Expansion|New cancer therapy|0|||
48650707|NCT01436656|156573027|FG002|Dose Expansion|New cancer therapy|0|||
48650708|NCT01436656|156573028|FG003|Dose Expansion|New cancer therapy|0|||
48650709|NCT01436656|156573029|FG004|Dose Expansion|New cancer therapy|0|||
48650710|NCT01436656|156573030|FG005|Dose Expansion|New cancer therapy|0|||
48650711|NCT01436656|156573031|FG006|Dose Expansion|New cancer therapy|0|||
48650712|NCT01436656|156573032|FG007|Dose Expansion|New cancer therapy|0|||
48650713|NCT01436656|156573033|FG008|Dose Expansion|New cancer therapy|0|||
48650714|NCT01436656|156573034|FG009|Dose Expansion|New cancer therapy|0|||
48650715|NCT01436656|156573035|FG010|Dose Expansion|New cancer therapy|0|||
48650716|NCT01436656|156573036|FG011|Dose Expansion|New cancer therapy|1|||
48650717|NCT01436656|156573037|FG012|Dose Expansion|New cancer therapy|1|||
48650718|NCT01436656|156573038|FG013|Dose Expansion|New cancer therapy|0|||
48650719|NCT01436656|156573039|FG014|Dose Expansion|New cancer therapy|2|||
48650720|NCT01436656|156573040|FG015|Dose Expansion|New cancer therapy|0|||
48650721|NCT01436656|156573041|FG016|Dose Expansion|New cancer therapy|0|||
48650722|NCT01436656|156573042|FG017|Dose Expansion|New cancer therapy|0|||
48650723|NCT00391053|156573043|FG000|Overall Study|Serious Adverse Events|1|||
48650724|NCT00391053|156573044|FG001|Overall Study|Serious Adverse Events|0|||
48650725|NCT00391053|156573045|FG002|Overall Study|Serious Adverse Events|1|||
48650726|NCT00391053|156573046|FG003|Overall Study|Serious Adverse Events|4|||
48650727|NCT00391053|156573043|FG000|Overall Study|Protocol Violation|2|||
48650728|NCT00391053|156573044|FG001|Overall Study|Protocol Violation|0|||
48650729|NCT00391053|156573045|FG002|Overall Study|Protocol Violation|0|||
48650730|NCT00391053|156573046|FG003|Overall Study|Protocol Violation|0|||
48650731|NCT00391053|156573043|FG000|Overall Study|Lost to Follow-up|1|||
48650732|NCT00391053|156573044|FG001|Overall Study|Lost to Follow-up|0|||
48650733|NCT00391053|156573045|FG002|Overall Study|Lost to Follow-up|0|||
48650734|NCT00391053|156573046|FG003|Overall Study|Lost to Follow-up|5|||
48650735|NCT00391053|156573043|FG000|Overall Study|Withdrawal by Subject|5|||
48650736|NCT00391053|156573044|FG001|Overall Study|Withdrawal by Subject|1|||
48650737|NCT00391053|156573045|FG002|Overall Study|Withdrawal by Subject|1|||
48650738|NCT00391053|156573046|FG003|Overall Study|Withdrawal by Subject|1|||
48650739|NCT04644276|156573047|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
48650740|NCT04644276|156573048|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
48650741|NCT04644276|156573049|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
48650742|NCT03782259|156573052|FG000|Overall Study|Lost to Follow-up|1|||
48650743|NCT03782259|156573053|FG001|Overall Study|Lost to Follow-up|1|||
48650744|NCT03782259|156573052|FG000|Overall Study|Moved out of state|0|||
48650745|NCT03782259|156573053|FG001|Overall Study|Moved out of state|2|||
48650746|NCT03782259|156573052|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
48650747|NCT03782259|156573053|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
48752855|NCT03266094|156940191|FG000|Overall Study|Lost to Follow-up|1|||
48752856|NCT03266094|156940191|FG000|Overall Study|Withdrawal by Subject|1|||
48752857|NCT04128267|156940198|FG000|Overall Study|Withdrawal by Subject|6|||
48752858|NCT04128267|156940198|FG000|Overall Study|Death|2|||
48752859|NCT04128267|156940198|FG000|Overall Study|Disease progression|1|||
48752860|NCT04128267|156940198|FG000|Overall Study|Participant had other medical issues|4|||
48752861|NCT04128267|156940198|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
48752862|NCT00750204|156940199|FG000|Overall Study|study halted prematurely|1|||
48752863|NCT00750204|156940200|FG001|Overall Study|study halted prematurely|1|||
48752864|NCT01386554|156940209|FG000|Overall Study|Lost to Follow-up|0|||
48752865|NCT01386554|156940210|FG001|Overall Study|Lost to Follow-up|0|||
48752866|NCT01386554|156940211|FG002|Overall Study|Lost to Follow-up|1|||
48752867|NCT01386554|156940209|FG000|Overall Study|Adverse Event|2|||
48331949|NCT00103857|155411580|FG001|50-Week Extension Study|patient moved|0|||
48331950|NCT00103857|155411581|FG002|50-Week Extension Study|patient moved|1|||
48331951|NCT00103857|155411582|FG003|50-Week Extension Study|patient moved|2|||
48331952|NCT00103857|155411583|FG004|50-Week Extension Study|patient moved|0|||
48331953|NCT00103857|155411584|FG005|50-Week Extension Study|patient moved|0|||
48650748|NCT03782259|156573052|FG000|Overall Study|Subject discontinued intervention|1|||
48650749|NCT03782259|156573053|FG001|Overall Study|Subject discontinued intervention|0|||
48331954|NCT00103857|155411585|FG006|50-Week Extension Study|patient moved|0|||
48331955|NCT00103857|155411579|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
48331956|NCT00103857|155411580|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
48331957|NCT00103857|155411581|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
48331958|NCT00103857|155411582|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
48331959|NCT00103857|155411583|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
48331960|NCT00103857|155411584|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
48331961|NCT00103857|155411585|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
48331962|NCT00103857|155411579|FG000|50-Week Extension Study|reason unspecified|0|||
48331963|NCT00103857|155411580|FG001|50-Week Extension Study|reason unspecified|0|||
48331964|NCT00103857|155411581|FG002|50-Week Extension Study|reason unspecified|0|||
48650750|NCT01208324|156573054|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
48650751|NCT01208324|156573055|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
48650752|NCT01208324|156573056|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
48650753|NCT01208324|156573057|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
48650754|NCT05069597|156573058|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
48650755|NCT05069597|156573059|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
48650756|NCT03654040|156573060|FG000|Overall Study|Death|1|||
48650757|NCT03654040|156573061|FG001|Overall Study|Death|0|||
48650758|NCT03654040|156573060|FG000|Overall Study|Withdrawal by Subject|1|||
48650759|NCT03654040|156573061|FG001|Overall Study|Withdrawal by Subject|0|||
48650760|NCT03654040|156573060|FG000|Overall Study|Study terminated by sponsor|8|||
48650761|NCT03654040|156573061|FG001|Overall Study|Study terminated by sponsor|2|||
48650762|NCT03654040|156573060|FG000|Overall Study|Failure to initiate study therapy|2|||
48650763|NCT03654040|156573061|FG001|Overall Study|Failure to initiate study therapy|0|||
48650764|NCT03654040|156573060|FG000|Overall Study|Transplanted at another center|2|||
48650765|NCT03654040|156573061|FG001|Overall Study|Transplanted at another center|0|||
48650766|NCT03654040|156573060|FG000|Overall Study|Failure to meet eligibility criteria|14|||
48650767|NCT03654040|156573061|FG001|Overall Study|Failure to meet eligibility criteria|2|||
48650768|NCT03654040|156573060|FG000|Overall Study|No longer transplant candidate|1|||
48650769|NCT03654040|156573061|FG001|Overall Study|No longer transplant candidate|0|||
48650770|NCT03654040|156573060|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
48650771|NCT03654040|156573061|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
48650772|NCT03654040|156573060|FG000|Overall Study|Recipient ineligible|0|||
48650773|NCT03654040|156573061|FG001|Overall Study|Recipient ineligible|2|||
48650774|NCT03654040|156573060|FG000|Overall Study|Received deceased liver|0|||
48650775|NCT03654040|156573061|FG001|Overall Study|Received deceased liver|1|||
48650776|NCT01709110|156573062|FG000|Overall Study|Adverse Event|56|||
48650777|NCT01709110|156573063|FG001|Overall Study|Adverse Event|48|||
48650778|NCT01709110|156573062|FG000|Overall Study|Death|14|||
48650779|NCT01709110|156573063|FG001|Overall Study|Death|6|||
48650780|NCT01709110|156573062|FG000|Overall Study|Lost to Follow-up|7|||
48650781|NCT01709110|156573063|FG001|Overall Study|Lost to Follow-up|5|||
48650782|NCT01709110|156573062|FG000|Overall Study|Protocol Violation|4|||
48650783|NCT01709110|156573063|FG001|Overall Study|Protocol Violation|6|||
48650784|NCT01709110|156573062|FG000|Overall Study|Withdrawal by Subject|96|||
48650785|NCT01709110|156573063|FG001|Overall Study|Withdrawal by Subject|89|||
48650786|NCT01709110|156573062|FG000|Overall Study|Physician Decision|4|||
48650787|NCT01709110|156573063|FG001|Overall Study|Physician Decision|10|||
48650788|NCT01709110|156573062|FG000|Overall Study|Sponsor Decision|2|||
48650789|NCT01709110|156573063|FG001|Overall Study|Sponsor Decision|2|||
48650790|NCT01709110|156573062|FG000|Overall Study|Lack of Efficacy|1|||
48650791|NCT01709110|156573063|FG001|Overall Study|Lack of Efficacy|1|||
48650792|NCT01709110|156573062|FG000|Overall Study|Caregiver Decision|1|||
48650793|NCT01709110|156573063|FG001|Overall Study|Caregiver Decision|1|||
48650794|NCT02120781|156573066|FG000|Overall Study|Physician Decision|2|||
48650795|NCT02120781|156573067|FG001|Overall Study|Physician Decision|0|||
48650796|NCT02120781|156573066|FG000|Overall Study|Completion not documented|2|||
48650797|NCT02120781|156573067|FG001|Overall Study|Completion not documented|1|||
48650798|NCT02298868|156573068|FG000|Overall Study|Adverse Event|1|||
48650799|NCT02298868|156573068|FG000|Overall Study|Death|1|||
48650800|NCT02298868|156573068|FG000|Overall Study|Patient underwent transplant|1|||
48331965|NCT00103857|155411582|FG003|50-Week Extension Study|reason unspecified|0|||
48331966|NCT00103857|155411583|FG004|50-Week Extension Study|reason unspecified|1|||
48331967|NCT00103857|155411584|FG005|50-Week Extension Study|reason unspecified|0|||
48331968|NCT00103857|155411585|FG006|50-Week Extension Study|reason unspecified|0|||
48331969|NCT03166215|155411588|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
48331970|NCT03166215|155411589|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
48331971|NCT03166215|155411590|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
48331972|NCT03166215|155411588|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
48331973|NCT03166215|155411589|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
48331974|NCT03166215|155411590|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
48331975|NCT03652610|155411591|FG000|Overall Study|Lost to Follow-up|1|||
48331976|NCT03652610|155411592|FG001|Overall Study|Lost to Follow-up|0|||
48650801|NCT02831855|156573069|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
48650802|NCT02831855|156573070|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
48650803|NCT02831855|156573071|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
48650804|NCT02831855|156573069|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
48650805|NCT02831855|156573070|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
48650806|NCT02831855|156573071|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
48650807|NCT02831855|156573069|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
48650808|NCT02831855|156573070|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
48650809|NCT02831855|156573071|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
48650810|NCT02831855|156573069|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
48650811|NCT02831855|156573070|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
48650812|NCT02831855|156573071|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
48650813|NCT02831855|156573069|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
48650814|NCT02831855|156573070|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
48650815|NCT02831855|156573071|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
48650816|NCT02831855|156573069|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
48650817|NCT02831855|156573070|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
48650818|NCT02831855|156573071|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
48650819|NCT02831855|156573069|FG000|Open Label Phase (24 Weeks)|Other|4|||
48650820|NCT02831855|156573070|FG001|Open Label Phase (24 Weeks)|Other|0|||
48331977|NCT03652610|155411591|FG000|Overall Study|Withdrawal by Subject|3|||
48331978|NCT03652610|155411592|FG001|Overall Study|Withdrawal by Subject|5|||
48331979|NCT02707952|155411593|FG000|Overall Study|Adverse Event|1|||
48331980|NCT02707952|155411594|FG001|Overall Study|Adverse Event|0|||
48650821|NCT02831855|156573071|FG002|Open Label Phase (24 Weeks)|Other|0|||
48331981|NCT02707952|155411595|FG002|Overall Study|Adverse Event|0|||
48331982|NCT02707952|155411596|FG003|Overall Study|Adverse Event|0|||
48650822|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
48650823|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
48650824|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
48650825|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Death|0|||
48650826|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Death|0|||
48752868|NCT01386554|156940210|FG001|Overall Study|Adverse Event|5|||
48752869|NCT01386554|156940211|FG002|Overall Study|Adverse Event|2|||
48331983|NCT02707952|155411593|FG000|Overall Study|Lost to Follow-up|1|||
48331984|NCT02707952|155411594|FG001|Overall Study|Lost to Follow-up|0|||
48752870|NCT01386554|156940209|FG000|Overall Study|Progressive disease|1|||
48752871|NCT01386554|156940210|FG001|Overall Study|Progressive disease|2|||
48752872|NCT01386554|156940211|FG002|Overall Study|Progressive disease|2|||
48752873|NCT01386554|156940209|FG000|Overall Study|Administration of live vaccines|0|||
48752874|NCT01386554|156940210|FG001|Overall Study|Administration of live vaccines|1|||
48752875|NCT01386554|156940211|FG002|Overall Study|Administration of live vaccines|0|||
48752876|NCT01386554|156940209|FG000|Overall Study|Investigator discretion|0|||
48752877|NCT01386554|156940210|FG001|Overall Study|Investigator discretion|0|||
48650827|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Death|2|||
48650828|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
48650829|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
48650830|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
48650831|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
48650832|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
48650833|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
48650834|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
48650835|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
48650836|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
48650837|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Other|0|||
48650838|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Other|2|||
48650839|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Other|5|||
48650840|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
48650841|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
48650842|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
48650843|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
48650844|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
48650845|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
48650846|NCT02831855|156573069|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
48650847|NCT02831855|156573070|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
48650848|NCT02831855|156573071|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
48650849|NCT00075764|156573077|FG000|Overall Study|Adverse Event|5|||
48650850|NCT00075764|156573078|FG001|Overall Study|Adverse Event|12|||
48650851|NCT00075764|156573077|FG000|Overall Study|Death|4|||
48650852|NCT00075764|156573078|FG001|Overall Study|Death|8|||
48650853|NCT00075764|156573077|FG000|Overall Study|Withdrawal by Subject|28|||
48650854|NCT00075764|156573078|FG001|Overall Study|Withdrawal by Subject|18|||
48650855|NCT00075764|156573077|FG000|Overall Study|Progression|269|||
48650856|NCT00075764|156573078|FG001|Overall Study|Progression|274|||
48650857|NCT00075764|156573077|FG000|Overall Study|Still on treatment|8|||
48650858|NCT00075764|156573078|FG001|Overall Study|Still on treatment|15|||
48650859|NCT00075764|156573077|FG000|Overall Study|Delinquent|4|||
48650860|NCT00075764|156573078|FG001|Overall Study|Delinquent|2|||
48650861|NCT00075764|156573077|FG000|Overall Study|Not protocol specified|27|||
48650862|NCT00075764|156573078|FG001|Overall Study|Not protocol specified|19|||
48650863|NCT00075764|156573077|FG000|Overall Study|Under review|0|||
48650864|NCT00075764|156573078|FG001|Overall Study|Under review|1|||
48650865|NCT00194077|156573080|FG000|Overall Study|Lack of Efficacy|22|||
48650866|NCT00194077|156573081|FG001|Overall Study|Lack of Efficacy|29|||
48650867|NCT00194077|156573080|FG000|Overall Study|Study nonadherence|1|||
48650868|NCT00194077|156573081|FG001|Overall Study|Study nonadherence|0|||
48650869|NCT00194077|156573080|FG000|Overall Study|Withdrawal by Subject|1|||
48650870|NCT00194077|156573081|FG001|Overall Study|Withdrawal by Subject|1|||
48650871|NCT01309997|156573088|FG000|Overall Study|Adverse Event|1|||
48650872|NCT01309997|156573089|FG001|Overall Study|Adverse Event|0|||
48650873|NCT01309997|156573088|FG000|Overall Study|Death|1|||
48650874|NCT01309997|156573089|FG001|Overall Study|Death|3|||
48650875|NCT01309997|156573088|FG000|Overall Study|Lack of Efficacy|2|||
48752878|NCT01386554|156940211|FG002|Overall Study|Investigator discretion|1|||
48752879|NCT01386554|156940209|FG000|Overall Study|Reason not collected|0|||
48752880|NCT01386554|156940210|FG001|Overall Study|Reason not collected|1|||
48752881|NCT01386554|156940211|FG002|Overall Study|Reason not collected|0|||
48650876|NCT01309997|156573089|FG001|Overall Study|Lack of Efficacy|2|||
48650877|NCT01309997|156573088|FG000|Overall Study|Withdrawal by Subject|1|||
48650878|NCT01309997|156573089|FG001|Overall Study|Withdrawal by Subject|1|||
48650879|NCT00282087|156573090|FG000|Overall Study|Death|1|||
48650880|NCT01147250|156573096|FG000|Overall Study|Lost to Follow-up|14|||
48650881|NCT01147250|156573097|FG001|Overall Study|Lost to Follow-up|11|||
48650882|NCT01147250|156573096|FG000|Overall Study|Withdrawal by Subject|83|||
48650883|NCT01147250|156573097|FG001|Overall Study|Withdrawal by Subject|88|||
48650884|NCT01147250|156573096|FG000|Overall Study|Site termination by sponsor|13|||
48331985|NCT02707952|155411595|FG002|Overall Study|Lost to Follow-up|0|||
48650885|NCT01147250|156573097|FG001|Overall Study|Site termination by sponsor|5|||
48331986|NCT02707952|155411596|FG003|Overall Study|Lost to Follow-up|0|||
48331987|NCT02707952|155411593|FG000|Overall Study|Withdrawal by Subject|0|||
48331988|NCT02707952|155411594|FG001|Overall Study|Withdrawal by Subject|1|||
48331989|NCT02707952|155411595|FG002|Overall Study|Withdrawal by Subject|2|||
48331990|NCT02707952|155411596|FG003|Overall Study|Withdrawal by Subject|0|||
48331991|NCT04108858|155411597|FG000|Overall Study|Adverse Event|1|||
48331992|NCT01156675|155411600|FG000|Overall Study|Death|5|||
48331993|NCT01156675|155411601|FG001|Overall Study|Death|3|||
48331994|NCT01156675|155411602|FG002|Overall Study|Death|0|||
48331995|NCT01156675|155411600|FG000|Overall Study|No data|29|||
48331996|NCT01156675|155411601|FG001|Overall Study|No data|22|||
48331997|NCT01156675|155411602|FG002|Overall Study|No data|2|||
48331998|NCT00689351|155411609|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
48331999|NCT00689351|155411610|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
48332000|NCT00689351|155411609|FG000|Infant Series of Dosing|Adverse Event|1|||
48332001|NCT00689351|155411610|FG001|Infant Series of Dosing|Adverse Event|0|||
48332002|NCT00689351|155411609|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
48332003|NCT00689351|155411610|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
48332004|NCT00689351|155411609|FG000|After Infant Series|Parent/legal guardian request|1|||
48332005|NCT00689351|155411610|FG001|After Infant Series|Parent/legal guardian request|0|||
48332006|NCT03137459|155413457|FG000|2-month Assessment|Withdrawal by Subject|13|||
48332007|NCT03137459|155413458|FG001|2-month Assessment|Withdrawal by Subject|3|||
48332008|NCT03137459|155413457|FG000|2-month Assessment|Unable to reach|42|||
48332009|NCT03137459|155413458|FG001|2-month Assessment|Unable to reach|32|||
48332010|NCT03137459|155413457|FG000|2-month Assessment|Refused assessment|7|||
48332011|NCT03137459|155413458|FG001|2-month Assessment|Refused assessment|5|||
48650886|NCT01147250|156573096|FG000|Overall Study|Other than specified|0|||
48650887|NCT01147250|156573097|FG001|Overall Study|Other than specified|1|||
48650888|NCT00624468|156573098|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
48650889|NCT00624468|156573099|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
48650890|NCT00624468|156573100|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
48650891|NCT00624468|156573101|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
48650892|NCT00624468|156573098|FG000|Double-blind Period|Withdrew Prematurely|1|||
48650893|NCT00624468|156573099|FG001|Double-blind Period|Withdrew Prematurely|1|||
48650894|NCT00624468|156573100|FG002|Double-blind Period|Withdrew Prematurely|0|||
48650895|NCT00624468|156573101|FG003|Double-blind Period|Withdrew Prematurely|0|||
48650896|NCT00624468|156573098|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
48650897|NCT00624468|156573099|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
48650898|NCT00624468|156573100|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
48332012|NCT03137459|155413457|FG000|2-month Assessment|Acutely ill|6|||
48332013|NCT03137459|155413458|FG001|2-month Assessment|Acutely ill|2|||
48332014|NCT03137459|155413457|FG000|4-month Assessment|Death|4|||
48332015|NCT03137459|155413458|FG001|4-month Assessment|Death|2|||
48332016|NCT03137459|155413457|FG000|4-month Assessment|Withdrawal by Subject|4|||
48332017|NCT03137459|155413458|FG001|4-month Assessment|Withdrawal by Subject|2|||
48332018|NCT03137459|155413457|FG000|4-month Assessment|Unable to reach|44|||
48332019|NCT03137459|155413458|FG001|4-month Assessment|Unable to reach|29|||
48650899|NCT00624468|156573101|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
48650900|NCT00624468|156573098|FG000|Safety Follow-up (SFU) Period|Other|0|||
48650901|NCT00624468|156573099|FG001|Safety Follow-up (SFU) Period|Other|0|||
48650902|NCT00624468|156573100|FG002|Safety Follow-up (SFU) Period|Other|1|||
48650903|NCT00624468|156573101|FG003|Safety Follow-up (SFU) Period|Other|1|||
48650904|NCT02249091|156573102|FG000|Overall Study|Lack of Efficacy|8|||
48650905|NCT02249091|156573103|FG001|Overall Study|Lack of Efficacy|3|||
48650906|NCT02249091|156573102|FG000|Overall Study|Physician Decision|4|||
48650907|NCT02249091|156573103|FG001|Overall Study|Physician Decision|1|||
48332020|NCT03137459|155413457|FG000|4-month Assessment|Refused assessment|24|||
48332021|NCT03137459|155413458|FG001|4-month Assessment|Refused assessment|10|||
48650908|NCT02249091|156573102|FG000|Overall Study|Withdrawal by Subject|2|||
48650909|NCT02249091|156573103|FG001|Overall Study|Withdrawal by Subject|2|||
48650910|NCT02249091|156573102|FG000|Overall Study|Death|3|||
48650911|NCT02249091|156573103|FG001|Overall Study|Death|4|||
48650912|NCT02249091|156573102|FG000|Overall Study|Adverse Event|1|||
48650913|NCT02249091|156573103|FG001|Overall Study|Adverse Event|0|||
48650914|NCT02249091|156573102|FG000|Overall Study|Stable disease with following SCT|0|||
48650915|NCT02249091|156573103|FG001|Overall Study|Stable disease with following SCT|1|||
48332022|NCT03137459|155413457|FG000|4-month Assessment|Acutely ill|2|||
48332023|NCT03137459|155413458|FG001|4-month Assessment|Acutely ill|3|||
48332024|NCT03137459|155413457|FG000|6-months|Lost to Follow-up|14|||
48332025|NCT03137459|155413458|FG001|6-months|Lost to Follow-up|11|||
48650916|NCT02249091|156573102|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
48650917|NCT02249091|156573103|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
48332026|NCT03137459|155413457|FG000|6-months|Death|0|||
48650918|NCT02249091|156573102|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
48332027|NCT03137459|155413458|FG001|6-months|Death|2|||
48332028|NCT03137459|155413457|FG000|6-months|Refused assessment|6|||
48752882|NCT00733408|156942025|FG000|Overall Study|Adverse Event|4|||
48752883|NCT01134783|156942026|FG000|Overall Study|Pregnancy|16|||
48752884|NCT01134783|156942027|FG001|Overall Study|Pregnancy|8|||
48752885|NCT01134783|156942026|FG000|Overall Study|Withdrawal by Subject|15|||
48752886|NCT01134783|156942027|FG001|Overall Study|Withdrawal by Subject|9|||
48752887|NCT01134783|156942026|FG000|Overall Study|Lost to Follow-up|5|||
48752888|NCT01134783|156942027|FG001|Overall Study|Lost to Follow-up|20|||
48752889|NCT01581931|156942029|FG000|Washout|Adverse Event|0|||
48752890|NCT01581931|156942030|FG001|Washout|Adverse Event|1|||
48752891|NCT03291808|156942033|FG000|Overall Study|Lost to Follow-up|6|||
48752892|NCT03291808|156942033|FG000|Overall Study|Research burden|4|||
48752893|NCT00638378|156942034|FG000|Overall Study|Death|2|||
48752894|NCT00638378|156942034|FG000|Overall Study|Adverse Event|1|||
48752895|NCT00638378|156942034|FG000|Overall Study|Disease progression|15|||
48752896|NCT00638378|156942034|FG000|Overall Study|Physician Decision|4|||
48752897|NCT01852110|156942037|FG000|Overall Study|Adverse Event|12|||
48752898|NCT01852110|156942038|FG001|Overall Study|Adverse Event|5|||
48752899|NCT01852110|156942039|FG002|Overall Study|Adverse Event|0|||
48752900|NCT01852110|156942040|FG003|Overall Study|Adverse Event|0|||
48752901|NCT01852110|156942041|FG004|Overall Study|Adverse Event|0|||
48332029|NCT03137459|155413458|FG001|6-months|Refused assessment|3|||
48332030|NCT03137459|155413457|FG000|6-months|Acutely ill|1|||
48332031|NCT03137459|155413458|FG001|6-months|Acutely ill|1|||
48332032|NCT00985088|155413459|FG000|Overall Study|Serious Adverse Event|1|||
48332033|NCT00985088|155413460|FG001|Overall Study|Serious Adverse Event|1|||
48332034|NCT00985088|155413461|FG002|Overall Study|Serious Adverse Event|0|||
48332035|NCT00985088|155413462|FG003|Overall Study|Serious Adverse Event|0|||
48332036|NCT00985088|155413463|FG004|Overall Study|Serious Adverse Event|0|||
48332037|NCT00985088|155413464|FG005|Overall Study|Serious Adverse Event|0|||
48332038|NCT00985088|155413465|FG006|Overall Study|Serious Adverse Event|0|||
48332039|NCT00985088|155413466|FG007|Overall Study|Serious Adverse Event|1|||
48332040|NCT00985088|155413459|FG000|Overall Study|Adverse Event|0|||
48650919|NCT02249091|156573103|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
48650920|NCT02249091|156573102|FG000|Overall Study|Refractory AML|1|||
48650921|NCT02249091|156573103|FG001|Overall Study|Refractory AML|1|||
48650922|NCT00372619|156573104|FG000|Overall Study|Ineligible|0|||
48650923|NCT00372619|156573105|FG001|Overall Study|Ineligible|0|||
48650924|NCT00372619|156573106|FG002|Overall Study|Ineligible|0|||
48650925|NCT00372619|156573107|FG003|Overall Study|Ineligible|0|||
48650926|NCT00372619|156573108|FG004|Overall Study|Ineligible|0|||
48650927|NCT00372619|156573109|FG005|Overall Study|Ineligible|2|||
48650928|NCT00372619|156573110|FG006|Overall Study|Ineligible|0|||
48650929|NCT00372619|156573104|FG000|Overall Study|Inevaluable|0|||
48650930|NCT00372619|156573105|FG001|Overall Study|Inevaluable|0|||
48650931|NCT00372619|156573106|FG002|Overall Study|Inevaluable|0|||
48650932|NCT00372619|156573107|FG003|Overall Study|Inevaluable|0|||
48650933|NCT00372619|156573108|FG004|Overall Study|Inevaluable|0|||
48650934|NCT00372619|156573109|FG005|Overall Study|Inevaluable|1|||
48650935|NCT00372619|156573110|FG006|Overall Study|Inevaluable|0|||
48650936|NCT01901289|156573115|FG000|Overall Study|Death|32|||
48650937|NCT01901289|156573115|FG000|Overall Study|Lost to Follow-up|16|||
48650938|NCT01901289|156573115|FG000|Overall Study|Withdrawal by Subject|35|||
48650939|NCT01901289|156573115|FG000|Overall Study|Other type of endpoint met|2|||
48650940|NCT02595866|156573116|FG000|Overall Study|Adverse Event|2|||
48752902|NCT01852110|156942042|FG005|Overall Study|Adverse Event|0|||
48752903|NCT01852110|156942037|FG000|Overall Study|Lost to Follow-up|1|||
48332041|NCT00985088|155413460|FG001|Overall Study|Adverse Event|0|||
48332042|NCT00985088|155413461|FG002|Overall Study|Adverse Event|1|||
48332043|NCT00985088|155413462|FG003|Overall Study|Adverse Event|0|||
48332044|NCT00985088|155413463|FG004|Overall Study|Adverse Event|0|||
48332045|NCT00985088|155413464|FG005|Overall Study|Adverse Event|0|||
48650941|NCT02595866|156573117|FG001|Overall Study|Adverse Event|5|||
48650942|NCT02595866|156573116|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
48650943|NCT02595866|156573117|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
48650944|NCT02595866|156573116|FG000|Overall Study|Death|0|||
48752904|NCT01852110|156942038|FG001|Overall Study|Lost to Follow-up|3|||
48752905|NCT01852110|156942039|FG002|Overall Study|Lost to Follow-up|0|||
48752906|NCT01852110|156942040|FG003|Overall Study|Lost to Follow-up|0|||
48752907|NCT01852110|156942041|FG004|Overall Study|Lost to Follow-up|0|||
48752908|NCT01852110|156942042|FG005|Overall Study|Lost to Follow-up|0|||
48332046|NCT00985088|155413465|FG006|Overall Study|Adverse Event|0|||
48332047|NCT00985088|155413466|FG007|Overall Study|Adverse Event|0|||
48332048|NCT00985088|155413459|FG000|Overall Study|Withdrawal by Subject|4|||
48332049|NCT00985088|155413460|FG001|Overall Study|Withdrawal by Subject|0|||
48650945|NCT02595866|156573117|FG001|Overall Study|Death|1|||
48650946|NCT02595866|156573116|FG000|Overall Study|Incarceration|1|||
48650947|NCT02595866|156573117|FG001|Overall Study|Incarceration|0|||
48752909|NCT01852110|156942037|FG000|Overall Study|Non-compliance with Study Drug|2|||
48752910|NCT01852110|156942038|FG001|Overall Study|Non-compliance with Study Drug|1|||
48650948|NCT02595866|156573116|FG000|Overall Study|Lack of Efficacy|17|||
48650949|NCT02595866|156573117|FG001|Overall Study|Lack of Efficacy|7|||
48650950|NCT02595866|156573116|FG000|Overall Study|Physician Decision|4|||
48650951|NCT02595866|156573117|FG001|Overall Study|Physician Decision|3|||
48332050|NCT00985088|155413461|FG002|Overall Study|Withdrawal by Subject|0|||
48752911|NCT01852110|156942039|FG002|Overall Study|Non-compliance with Study Drug|0|||
48332051|NCT00985088|155413462|FG003|Overall Study|Withdrawal by Subject|1|||
48332052|NCT00985088|155413463|FG004|Overall Study|Withdrawal by Subject|3|||
48650952|NCT02595866|156573116|FG000|Overall Study|Switched to Alternative Treatment|1|||
48332053|NCT00985088|155413464|FG005|Overall Study|Withdrawal by Subject|2|||
48332054|NCT00985088|155413465|FG006|Overall Study|Withdrawal by Subject|1|||
48332055|NCT00985088|155413466|FG007|Overall Study|Withdrawal by Subject|2|||
48332056|NCT00985088|155413459|FG000|Overall Study|Migrated/moved from study area|0|||
48332057|NCT00985088|155413460|FG001|Overall Study|Migrated/moved from study area|0|||
48332058|NCT00985088|155413461|FG002|Overall Study|Migrated/moved from study area|1|||
48332059|NCT00985088|155413462|FG003|Overall Study|Migrated/moved from study area|0|||
48332060|NCT00985088|155413463|FG004|Overall Study|Migrated/moved from study area|0|||
48332061|NCT00985088|155413464|FG005|Overall Study|Migrated/moved from study area|0|||
48332062|NCT00985088|155413465|FG006|Overall Study|Migrated/moved from study area|0|||
48332063|NCT00985088|155413466|FG007|Overall Study|Migrated/moved from study area|1|||
48332064|NCT00985088|155413459|FG000|Overall Study|Lost to Follow-up|6|||
48332065|NCT00985088|155413460|FG001|Overall Study|Lost to Follow-up|1|||
48332066|NCT00985088|155413461|FG002|Overall Study|Lost to Follow-up|2|||
48332067|NCT00985088|155413462|FG003|Overall Study|Lost to Follow-up|6|||
48332068|NCT00985088|155413463|FG004|Overall Study|Lost to Follow-up|6|||
48332069|NCT00985088|155413464|FG005|Overall Study|Lost to Follow-up|5|||
48650953|NCT02595866|156573117|FG001|Overall Study|Switched to Alternative Treatment|0|||
48332070|NCT00985088|155413465|FG006|Overall Study|Lost to Follow-up|3|||
48332071|NCT00985088|155413466|FG007|Overall Study|Lost to Follow-up|2|||
48332072|NCT02232737|155413467|FG000|Overall Study|Lost to Follow-up|18|||
48332073|NCT02232737|155413468|FG001|Overall Study|Lost to Follow-up|28|||
48332074|NCT02232737|155413469|FG002|Overall Study|Lost to Follow-up|33|||
48332075|NCT02232737|155413467|FG000|Overall Study|Personal reasons|7|||
48332076|NCT02232737|155413468|FG001|Overall Study|Personal reasons|8|||
48332077|NCT02232737|155413469|FG002|Overall Study|Personal reasons|14|||
48332078|NCT02232737|155413467|FG000|Overall Study|Adverse Event|6|||
48332079|NCT02232737|155413468|FG001|Overall Study|Adverse Event|3|||
48332080|NCT02232737|155413469|FG002|Overall Study|Adverse Event|8|||
48332081|NCT02232737|155413467|FG000|Overall Study|Incarcerated|2|||
48332082|NCT02232737|155413468|FG001|Overall Study|Incarcerated|1|||
48332083|NCT02232737|155413469|FG002|Overall Study|Incarcerated|2|||
48332084|NCT02232737|155413467|FG000|Overall Study|Withdrawal by Subject|0|||
48332085|NCT02232737|155413468|FG001|Overall Study|Withdrawal by Subject|1|||
48332086|NCT02232737|155413469|FG002|Overall Study|Withdrawal by Subject|2|||
48332087|NCT02232737|155413467|FG000|Overall Study|Death|0|||
48332088|NCT02232737|155413468|FG001|Overall Study|Death|1|||
48332089|NCT02232737|155413469|FG002|Overall Study|Death|1|||
48332090|NCT02232737|155413467|FG000|Overall Study|Physician Decision|1|||
48332091|NCT02232737|155413468|FG001|Overall Study|Physician Decision|3|||
48332092|NCT02232737|155413469|FG002|Overall Study|Physician Decision|1|||
48332093|NCT02232737|155413467|FG000|Overall Study|Protocol Violation|1|||
48332094|NCT02232737|155413468|FG001|Overall Study|Protocol Violation|0|||
48332095|NCT02232737|155413469|FG002|Overall Study|Protocol Violation|1|||
48332096|NCT02232737|155413467|FG000|Overall Study|Reason unknown|1|||
48332097|NCT02232737|155413468|FG001|Overall Study|Reason unknown|0|||
48650954|NCT02595866|156573116|FG000|Overall Study|Study Terminated|0|||
48650955|NCT02595866|156573117|FG001|Overall Study|Study Terminated|4|||
48650956|NCT02595866|156573116|FG000|Overall Study|Withdrawal by Subject|6|||
48650957|NCT02595866|156573117|FG001|Overall Study|Withdrawal by Subject|1|||
48752912|NCT01852110|156942040|FG003|Overall Study|Non-compliance with Study Drug|0|||
48752913|NCT01852110|156942041|FG004|Overall Study|Non-compliance with Study Drug|0|||
48752914|NCT01852110|156942042|FG005|Overall Study|Non-compliance with Study Drug|0|||
48752915|NCT01852110|156942037|FG000|Overall Study|Physician Decision|1|||
48752916|NCT01852110|156942038|FG001|Overall Study|Physician Decision|0|||
48752917|NCT01852110|156942039|FG002|Overall Study|Physician Decision|0|||
48752918|NCT01852110|156942040|FG003|Overall Study|Physician Decision|0|||
48752919|NCT01852110|156942041|FG004|Overall Study|Physician Decision|0|||
48752920|NCT01852110|156942042|FG005|Overall Study|Physician Decision|0|||
48752921|NCT01852110|156942037|FG000|Overall Study|Protocol Violation|0|||
48332098|NCT02232737|155413469|FG002|Overall Study|Reason unknown|0|||
48332099|NCT00925548|155413479|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
48332100|NCT00925548|155413480|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
48332101|NCT02224755|155413487|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
48332102|NCT02224755|155413488|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
48332103|NCT02224755|155413487|FG000|Two Year Follow up Post-implant|Death|103|||
48332104|NCT02224755|155413488|FG001|Two Year Follow up Post-implant|Death|98|||
48752922|NCT01852110|156942038|FG001|Overall Study|Protocol Violation|1|||
48752923|NCT01852110|156942039|FG002|Overall Study|Protocol Violation|0|||
48332105|NCT02224755|155413487|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
48332106|NCT02224755|155413488|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
48332107|NCT02224755|155413487|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
48332108|NCT02224755|155413488|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
48332109|NCT02224755|155413487|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
48332110|NCT02224755|155413488|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
48332111|NCT02095145|155413489|FG000|Overall Study|Withdrawal by Subject|1|||
48332112|NCT02095145|155413490|FG001|Overall Study|Withdrawal by Subject|0|||
48332113|NCT00696241|155413496|FG000|Overall Study|Adverse Event|11|||
48332114|NCT00696241|155413497|FG001|Overall Study|Adverse Event|3|||
48332115|NCT00696241|155413498|FG002|Overall Study|Adverse Event|6|||
48332116|NCT00696241|155413499|FG003|Overall Study|Adverse Event|4|||
48332117|NCT00696241|155413500|FG004|Overall Study|Adverse Event|5|||
48332118|NCT00696241|155413496|FG000|Overall Study|Protocol Violation|1|||
48332119|NCT00696241|155413497|FG001|Overall Study|Protocol Violation|1|||
48332120|NCT00696241|155413498|FG002|Overall Study|Protocol Violation|2|||
48332121|NCT00696241|155413499|FG003|Overall Study|Protocol Violation|0|||
48332122|NCT00696241|155413500|FG004|Overall Study|Protocol Violation|3|||
48332123|NCT00696241|155413496|FG000|Overall Study|Lost to Follow-up|1|||
48332124|NCT00696241|155413497|FG001|Overall Study|Lost to Follow-up|4|||
48332125|NCT00696241|155413498|FG002|Overall Study|Lost to Follow-up|1|||
48332126|NCT00696241|155413499|FG003|Overall Study|Lost to Follow-up|2|||
48332127|NCT00696241|155413500|FG004|Overall Study|Lost to Follow-up|0|||
48332128|NCT00696241|155413496|FG000|Overall Study|Withdrawal by Subject|4|||
48332129|NCT00696241|155413497|FG001|Overall Study|Withdrawal by Subject|8|||
48332130|NCT00696241|155413498|FG002|Overall Study|Withdrawal by Subject|6|||
48332131|NCT00696241|155413499|FG003|Overall Study|Withdrawal by Subject|1|||
48332132|NCT00696241|155413500|FG004|Overall Study|Withdrawal by Subject|0|||
48332133|NCT00696241|155413496|FG000|Overall Study|Lack of Efficacy|1|||
48332134|NCT00696241|155413497|FG001|Overall Study|Lack of Efficacy|5|||
48332135|NCT00696241|155413498|FG002|Overall Study|Lack of Efficacy|4|||
48332136|NCT00696241|155413499|FG003|Overall Study|Lack of Efficacy|5|||
48332137|NCT00696241|155413500|FG004|Overall Study|Lack of Efficacy|3|||
48332138|NCT00696241|155413496|FG000|Overall Study|Other|6|||
48332139|NCT00696241|155413497|FG001|Overall Study|Other|1|||
48332140|NCT00696241|155413498|FG002|Overall Study|Other|5|||
48332141|NCT00696241|155413499|FG003|Overall Study|Other|2|||
48332142|NCT00696241|155413500|FG004|Overall Study|Other|1|||
48332143|NCT01613599|155413502|FG000|Overall Study|Death|9|||
48332144|NCT01613599|155413502|FG000|Overall Study|Lost to Follow-up|5|||
48332145|NCT01613599|155413502|FG000|Overall Study|Withdrawal by Subject|8|||
48650958|NCT00778336|156573118|FG000|Index Procedure-Discharge|Death|6|||
48650959|NCT00778336|156573119|FG001|Index Procedure-Discharge|Death|3|||
48650960|NCT00778336|156573120|FG002|Index Procedure-Discharge|Death|2|||
48650961|NCT00778336|156573121|FG003|Index Procedure-Discharge|Death|0|||
48650962|NCT00778336|156573118|FG000|3 Month Follow Up|Lost to Follow-up|15|||
48650963|NCT00778336|156573119|FG001|3 Month Follow Up|Lost to Follow-up|20|||
48752924|NCT01852110|156942040|FG003|Overall Study|Protocol Violation|0|||
48752925|NCT01852110|156942041|FG004|Overall Study|Protocol Violation|0|||
48752926|NCT01852110|156942042|FG005|Overall Study|Protocol Violation|0|||
48650964|NCT00778336|156573120|FG002|3 Month Follow Up|Lost to Follow-up|3|||
48752927|NCT01852110|156942037|FG000|Overall Study|Study Terminated by Sponsor|30|||
48752928|NCT01852110|156942038|FG001|Overall Study|Study Terminated by Sponsor|32|||
48752929|NCT01852110|156942039|FG002|Overall Study|Study Terminated by Sponsor|0|||
48752930|NCT01852110|156942040|FG003|Overall Study|Study Terminated by Sponsor|0|||
48752931|NCT01852110|156942041|FG004|Overall Study|Study Terminated by Sponsor|0|||
48650965|NCT00778336|156573121|FG003|3 Month Follow Up|Lost to Follow-up|0|||
48332146|NCT01613599|155413502|FG000|Overall Study|Reason not specified|3|||
48332147|NCT02102724|155413505|FG000|Overall Study|Lost to Follow-up|1|||
48332148|NCT02102724|155413506|FG001|Overall Study|Lost to Follow-up|0|||
48332149|NCT02102724|155413505|FG000|Overall Study|surgery for brain aneurysm|1|||
48332150|NCT02102724|155413506|FG001|Overall Study|surgery for brain aneurysm|1|||
48332151|NCT02924051|155413507|FG000|Overall Study|Withdrawal by Subject|1|||
48332152|NCT02924051|155413508|FG001|Overall Study|Withdrawal by Subject|9|||
48332153|NCT04749797|155413511|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
48332154|NCT04749797|155413512|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
48332155|NCT04749797|155413513|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
48332156|NCT00632736|155413514|FG000|Overall Study|Adverse Event|104|||
48332157|NCT00632736|155413514|FG000|Overall Study|Lost to Follow-up|15|||
48332158|NCT00632736|155413514|FG000|Overall Study|Protocol Violation|14|||
48332159|NCT00632736|155413514|FG000|Overall Study|Withdrawal by Subject|99|||
48752932|NCT01852110|156942042|FG005|Overall Study|Study Terminated by Sponsor|0|||
48752933|NCT01852110|156942037|FG000|Overall Study|Withdrawal by Subject|4|||
48332160|NCT00632736|155413514|FG000|Overall Study|Lack of Efficacy|5|||
48752934|NCT01852110|156942038|FG001|Overall Study|Withdrawal by Subject|4|||
48752935|NCT01852110|156942039|FG002|Overall Study|Withdrawal by Subject|0|||
48650966|NCT00778336|156573118|FG000|3 Month Follow Up|Death|8|||
48650967|NCT00778336|156573119|FG001|3 Month Follow Up|Death|3|||
48650968|NCT00778336|156573120|FG002|3 Month Follow Up|Death|2|||
48650969|NCT00778336|156573121|FG003|3 Month Follow Up|Death|0|||
48650970|NCT01437111|156573122|FG000|Overall Study|Adverse Event|2|||
48650971|NCT01437111|156573122|FG000|Overall Study|Withdrawal by Subject|4|||
48650972|NCT01437111|156573122|FG000|Overall Study|Not reported|5|||
48650973|NCT01437111|156573122|FG000|Overall Study|Physician Decision|1|||
48650974|NCT01437111|156573122|FG000|Overall Study|Lost to Follow-up|5|||
48650975|NCT01437111|156573122|FG000|Overall Study|Protocol Violation|1|||
48650976|NCT02342288|156573123|FG000|Overall Study|no protocol anesthesiologist available|3|||
48332161|NCT00632736|155413514|FG000|Overall Study|Sponsor terminated study|5|||
48332162|NCT00632736|155413514|FG000|Overall Study|Non-compliance|10|||
48332163|NCT00632736|155413514|FG000|Overall Study|Other|16|||
48332164|NCT01323790|155413515|FG000|Overall Study|Other|3|||
48332165|NCT01323790|155413516|FG001|Overall Study|Other|2|||
48332166|NCT01323790|155413517|FG002|Overall Study|Other|1|||
48332167|NCT01323790|155413515|FG000|Overall Study|Lost to Follow-up|11|||
48332168|NCT01323790|155413516|FG001|Overall Study|Lost to Follow-up|9|||
48332169|NCT01323790|155413517|FG002|Overall Study|Lost to Follow-up|9|||
48332170|NCT01323790|155413515|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
48332171|NCT01323790|155413516|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
48332172|NCT01323790|155413517|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
48332173|NCT01323790|155413515|FG000|Overall Study|Lack of Efficacy|3|||
48332174|NCT01323790|155413516|FG001|Overall Study|Lack of Efficacy|0|||
48332175|NCT01323790|155413517|FG002|Overall Study|Lack of Efficacy|3|||
48332176|NCT01323790|155413515|FG000|Overall Study|Adverse Event|11|||
48332177|NCT01323790|155413516|FG001|Overall Study|Adverse Event|24|||
48650977|NCT02342288|156573124|FG001|Overall Study|no protocol anesthesiologist available|2|||
48650978|NCT02342288|156573123|FG000|Overall Study|anesthesia leak in system|1|||
48650979|NCT02342288|156573124|FG001|Overall Study|anesthesia leak in system|0|||
48650980|NCT02342288|156573123|FG000|Overall Study|Withdrawal by Subject|1|||
48650981|NCT02342288|156573124|FG001|Overall Study|Withdrawal by Subject|0|||
48650982|NCT02342288|156573123|FG000|Overall Study|coordinator contaminated with blood|0|||
48650983|NCT02342288|156573124|FG001|Overall Study|coordinator contaminated with blood|1|||
48650984|NCT02342288|156573123|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
48650985|NCT02342288|156573124|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
48650986|NCT02342288|156573123|FG000|Overall Study|coordinator not available|0|||
48650987|NCT02342288|156573124|FG001|Overall Study|coordinator not available|2|||
48650988|NCT00191945|156573127|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
48650989|NCT00191945|156573128|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
48650990|NCT00191945|156573127|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
48650991|NCT00191945|156573128|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
48650992|NCT00191945|156573127|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
48650993|NCT00191945|156573128|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
48650994|NCT00191945|156573127|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
48650995|NCT00191945|156573128|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
48650996|NCT02308163|156573130|FG000|Overall Study|Not fulfill eligible criteria|1|||
48650997|NCT02308163|156573131|FG001|Overall Study|Not fulfill eligible criteria|2|||
48650998|NCT02308163|156573132|FG002|Overall Study|Not fulfill eligible criteria|0|||
48650999|NCT02308163|156573133|FG003|Overall Study|Not fulfill eligible criteria|1|||
48651000|NCT02308163|156573134|FG004|Overall Study|Not fulfill eligible criteria|1|||
48651001|NCT02308163|156573130|FG000|Overall Study|Adverse Event|9|||
48651002|NCT02308163|156573131|FG001|Overall Study|Adverse Event|5|||
48651003|NCT02308163|156573132|FG002|Overall Study|Adverse Event|2|||
48651004|NCT02308163|156573133|FG003|Overall Study|Adverse Event|2|||
48651005|NCT02308163|156573134|FG004|Overall Study|Adverse Event|11|||
48651006|NCT02308163|156573130|FG000|Overall Study|Lack of Efficacy|11|||
48651007|NCT02308163|156573131|FG001|Overall Study|Lack of Efficacy|3|||
48651008|NCT02308163|156573132|FG002|Overall Study|Lack of Efficacy|8|||
48651009|NCT02308163|156573133|FG003|Overall Study|Lack of Efficacy|4|||
48651010|NCT02308163|156573134|FG004|Overall Study|Lack of Efficacy|6|||
48332178|NCT01323790|155413517|FG002|Overall Study|Adverse Event|12|||
48332179|NCT01323790|155413515|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48332180|NCT01323790|155413516|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48332181|NCT01323790|155413517|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
48332182|NCT01323790|155413515|FG000|Overall Study|Withdrawal by Subject|23|||
48332183|NCT01323790|155413516|FG001|Overall Study|Withdrawal by Subject|20|||
48651011|NCT02308163|156573130|FG000|Overall Study|Withdrawal of consent|2|||
48651012|NCT02308163|156573131|FG001|Overall Study|Withdrawal of consent|3|||
48651013|NCT02308163|156573132|FG002|Overall Study|Withdrawal of consent|0|||
48651014|NCT02308163|156573133|FG003|Overall Study|Withdrawal of consent|2|||
48332184|NCT01323790|155413517|FG002|Overall Study|Withdrawal by Subject|13|||
48651015|NCT02308163|156573134|FG004|Overall Study|Withdrawal of consent|6|||
48332185|NCT01323790|155413515|FG000|Overall Study|Did Not Receive Treatment|2|||
48332186|NCT01323790|155413516|FG001|Overall Study|Did Not Receive Treatment|0|||
48651016|NCT02308163|156573130|FG000|Overall Study|Protocol Violation|3|||
48651017|NCT02308163|156573131|FG001|Overall Study|Protocol Violation|3|||
48651018|NCT02308163|156573132|FG002|Overall Study|Protocol Violation|3|||
48651019|NCT02308163|156573133|FG003|Overall Study|Protocol Violation|2|||
48651020|NCT02308163|156573134|FG004|Overall Study|Protocol Violation|5|||
48651021|NCT02308163|156573130|FG000|Overall Study|Lab data met discontinuation criteria|3|||
48651022|NCT02308163|156573131|FG001|Overall Study|Lab data met discontinuation criteria|0|||
48651023|NCT02308163|156573132|FG002|Overall Study|Lab data met discontinuation criteria|0|||
48651024|NCT02308163|156573133|FG003|Overall Study|Lab data met discontinuation criteria|2|||
48651025|NCT02308163|156573134|FG004|Overall Study|Lab data met discontinuation criteria|0|||
48651026|NCT02308163|156573130|FG000|Overall Study|Miscellaneous|2|||
48651027|NCT02308163|156573131|FG001|Overall Study|Miscellaneous|2|||
48651028|NCT02308163|156573132|FG002|Overall Study|Miscellaneous|1|||
48651029|NCT02308163|156573133|FG003|Overall Study|Miscellaneous|0|||
48651030|NCT02308163|156573134|FG004|Overall Study|Miscellaneous|5|||
48651031|NCT03802630|156573135|FG000|Overall Study|Study terminated by sponsor|130|||
48651032|NCT03802630|156573136|FG001|Overall Study|Study terminated by sponsor|134|||
48651033|NCT03802630|156573135|FG000|Overall Study|Subject decision|16|||
48651034|NCT03802630|156573136|FG001|Overall Study|Subject decision|9|||
48651035|NCT03802630|156573135|FG000|Overall Study|Adverse Event|3|||
48651036|NCT03802630|156573136|FG001|Overall Study|Adverse Event|1|||
48651037|NCT03802630|156573135|FG000|Overall Study|Lost to Follow-up|2|||
48651038|NCT03802630|156573136|FG001|Overall Study|Lost to Follow-up|2|||
48651039|NCT03802630|156573135|FG000|Overall Study|Physician Decision|2|||
48651040|NCT03802630|156573136|FG001|Overall Study|Physician Decision|0|||
48651041|NCT03802630|156573135|FG000|Overall Study|Death|0|||
48651042|NCT03802630|156573136|FG001|Overall Study|Death|2|||
48651043|NCT02016716|156573137|FG000|Overall Study|Withdrawal by Subject|5|||
48651044|NCT02016716|156573138|FG001|Overall Study|Withdrawal by Subject|5|||
48651045|NCT02016716|156573139|FG002|Overall Study|Withdrawal by Subject|5|||
48651046|NCT02016716|156573137|FG000|Overall Study|Protocol-specified Criteria|0|||
48651047|NCT02016716|156573138|FG001|Overall Study|Protocol-specified Criteria|1|||
48651048|NCT02016716|156573139|FG002|Overall Study|Protocol-specified Criteria|0|||
48651049|NCT02016716|156573137|FG000|Overall Study|Lost to Follow-up|1|||
48651050|NCT02016716|156573138|FG001|Overall Study|Lost to Follow-up|2|||
48651051|NCT02016716|156573139|FG002|Overall Study|Lost to Follow-up|1|||
48651052|NCT02248649|156573140|FG000|Overall Study|Death|7|||
48651053|NCT02248649|156573141|FG001|Overall Study|Death|11|||
48651054|NCT02248649|156573140|FG000|Overall Study|Lost to Follow-up|14|||
48651055|NCT02248649|156573141|FG001|Overall Study|Lost to Follow-up|10|||
48651056|NCT01802580|156573142|FG000|Overall Study|Physician Decision|1|||
48651057|NCT01802580|156573143|FG001|Overall Study|Physician Decision|0|||
48651058|NCT01802580|156573142|FG000|Overall Study|Protocol Violation|2|||
48651059|NCT01802580|156573143|FG001|Overall Study|Protocol Violation|0|||
48651060|NCT01802580|156573142|FG000|Overall Study|Withdrawal by Subject|5|||
48651061|NCT01802580|156573143|FG001|Overall Study|Withdrawal by Subject|6|||
48651062|NCT01802580|156573142|FG000|Overall Study|Other|1|||
48651063|NCT01802580|156573143|FG001|Overall Study|Other|3|||
48651064|NCT01802580|156573142|FG000|Overall Study|Lack of Efficacy|0|||
48651065|NCT01802580|156573143|FG001|Overall Study|Lack of Efficacy|2|||
48651066|NCT00082368|156573154|FG000|Overall Study|Not treated-pt had poor IV access|1|||
48651067|NCT01846299|156573155|FG000|Overall Study|Physician Decision|4|||
48651068|NCT01846299|156573156|FG001|Overall Study|Physician Decision|2|||
48651069|NCT01846299|156573155|FG000|Overall Study|Protocol deviation|1|||
48651070|NCT01846299|156573156|FG001|Overall Study|Protocol deviation|0|||
48651071|NCT01846299|156573155|FG000|Overall Study|Death|1|||
48651072|NCT01846299|156573156|FG001|Overall Study|Death|2|||
48651073|NCT01846299|156573155|FG000|Overall Study|Lost to Follow-up|3|||
48651074|NCT01846299|156573156|FG001|Overall Study|Lost to Follow-up|0|||
48651075|NCT01846299|156573155|FG000|Overall Study|Withdrawal by Subject|1|||
48651076|NCT01846299|156573156|FG001|Overall Study|Withdrawal by Subject|6|||
48651077|NCT01846299|156573155|FG000|Overall Study|Adverse Event|2|||
48651078|NCT01846299|156573156|FG001|Overall Study|Adverse Event|0|||
48651079|NCT02644096|156573157|FG000|Overall Study|Withdrawal by Subject|28|||
48651080|NCT02644096|156573158|FG001|Overall Study|Withdrawal by Subject|25|||
48651081|NCT02147197|156573159|FG000|Overall Study|Adverse Event|1|||
48651082|NCT02147197|156573160|FG001|Overall Study|Adverse Event|0|||
48651083|NCT02147197|156573161|FG002|Overall Study|Adverse Event|0|||
48752936|NCT01852110|156942040|FG003|Overall Study|Withdrawal by Subject|0|||
48752937|NCT01852110|156942041|FG004|Overall Study|Withdrawal by Subject|0|||
48332187|NCT01323790|155413517|FG002|Overall Study|Did Not Receive Treatment|1|||
48752938|NCT01852110|156942042|FG005|Overall Study|Withdrawal by Subject|0|||
48752939|NCT00793403|156942043|FG000|Overall Study|Other|73|||
48752940|NCT01338792|156942045|FG000|Overall Study|Adverse Event|2|||
48752941|NCT01338792|156942045|FG000|Overall Study|Death|1|||
48752942|NCT01338792|156942045|FG000|Overall Study|Withdrawal by Subject|1|||
48752943|NCT01652703|156942046|FG000|Overall Study|Withdrawal by Subject|0|||
48332188|NCT01323790|155413515|FG000|Overall Study|Severe non-compliance with protocol|2|||
48332189|NCT01323790|155413516|FG001|Overall Study|Severe non-compliance with protocol|2|||
48332190|NCT01323790|155413517|FG002|Overall Study|Severe non-compliance with protocol|2|||
48332191|NCT01855399|155413523|FG000|6 Month|Lost to Follow-up|12|||
48332192|NCT01855399|155413524|FG001|6 Month|Lost to Follow-up|9|||
48332193|NCT01855399|155413523|FG000|6 Month|Withdrawal by Subject|8|||
48332194|NCT01855399|155413524|FG001|6 Month|Withdrawal by Subject|6|||
48332195|NCT01855399|155413523|FG000|12 Month|Lost to Follow-up|7|||
48332196|NCT01855399|155413524|FG001|12 Month|Lost to Follow-up|11|||
48752944|NCT01652703|156942047|FG001|Overall Study|Withdrawal by Subject|1|||
48651084|NCT02147197|156573159|FG000|Overall Study|Withdrawal of Consent|4|||
48651085|NCT02147197|156573160|FG001|Overall Study|Withdrawal of Consent|3|||
48651086|NCT02147197|156573161|FG002|Overall Study|Withdrawal of Consent|2|||
48651087|NCT02147197|156573159|FG000|Overall Study|Lost to Follow-up|2|||
48651088|NCT02147197|156573160|FG001|Overall Study|Lost to Follow-up|3|||
48752945|NCT01652703|156942048|FG002|Overall Study|Withdrawal by Subject|3|||
48752946|NCT01652703|156942049|FG003|Overall Study|Withdrawal by Subject|1|||
48752947|NCT01652703|156942050|FG004|Overall Study|Withdrawal by Subject|0|||
48752948|NCT01652703|156942051|FG005|Overall Study|Withdrawal by Subject|1|||
48752949|NCT01652703|156942046|FG000|Overall Study|Other|0|||
48752950|NCT01652703|156942047|FG001|Overall Study|Other|0|||
48332197|NCT00871715|155413525|FG000|Overall Study|Withdrawal by Subject|6|||
48332198|NCT00871715|155413526|FG001|Overall Study|Withdrawal by Subject|10|||
48651089|NCT02147197|156573161|FG002|Overall Study|Lost to Follow-up|1|||
48651090|NCT02147197|156573159|FG000|Overall Study|Protocol Violation|1|||
48651091|NCT02147197|156573160|FG001|Overall Study|Protocol Violation|0|||
48651092|NCT02147197|156573161|FG002|Overall Study|Protocol Violation|3|||
48651093|NCT02147197|156573159|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48651094|NCT02147197|156573160|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48651095|NCT02147197|156573161|FG002|Overall Study|Other Miscellaneous Reasons|3|||
48651096|NCT01700959|156573162|FG000|Overall Study|Adverse Event|0|||
48651097|NCT01700959|156573163|FG001|Overall Study|Adverse Event|1|||
48651098|NCT01700959|156573164|FG002|Overall Study|Adverse Event|1|||
48651099|NCT01700959|156573165|FG003|Overall Study|Adverse Event|2|||
48651100|NCT01700959|156573166|FG004|Overall Study|Adverse Event|0|||
48651101|NCT01700959|156573167|FG005|Overall Study|Adverse Event|2|||
48651102|NCT01700959|156573162|FG000|Overall Study|Withdrawal by Subject|15|||
48651103|NCT01700959|156573163|FG001|Overall Study|Withdrawal by Subject|9|||
48651104|NCT01700959|156573164|FG002|Overall Study|Withdrawal by Subject|12|||
48651105|NCT01700959|156573165|FG003|Overall Study|Withdrawal by Subject|11|||
48651106|NCT01700959|156573166|FG004|Overall Study|Withdrawal by Subject|8|||
48651107|NCT01700959|156573167|FG005|Overall Study|Withdrawal by Subject|12|||
48651108|NCT01700959|156573162|FG000|Overall Study|Ineligible|2|||
48651109|NCT01700959|156573163|FG001|Overall Study|Ineligible|1|||
48651110|NCT01700959|156573164|FG002|Overall Study|Ineligible|2|||
48651111|NCT01700959|156573165|FG003|Overall Study|Ineligible|0|||
48651112|NCT01700959|156573166|FG004|Overall Study|Ineligible|0|||
48651113|NCT01700959|156573167|FG005|Overall Study|Ineligible|1|||
48651114|NCT01700959|156573162|FG000|Overall Study|Noncompliant|9|||
48651115|NCT01700959|156573163|FG001|Overall Study|Noncompliant|9|||
48752951|NCT01652703|156942048|FG002|Overall Study|Other|0|||
48752952|NCT01652703|156942049|FG003|Overall Study|Other|1|||
48332199|NCT00871715|155413527|FG002|Overall Study|Withdrawal by Subject|15|||
48332200|NCT00871715|155413525|FG000|Overall Study|Physician Decision|6|||
48332201|NCT00871715|155413526|FG001|Overall Study|Physician Decision|0|||
48332202|NCT00871715|155413527|FG002|Overall Study|Physician Decision|2|||
48332203|NCT00871715|155413525|FG000|Overall Study|Lost to Follow-up|3|||
48332204|NCT00871715|155413526|FG001|Overall Study|Lost to Follow-up|6|||
48332205|NCT00871715|155413527|FG002|Overall Study|Lost to Follow-up|9|||
48651116|NCT01700959|156573164|FG002|Overall Study|Noncompliant|17|||
48651117|NCT01700959|156573165|FG003|Overall Study|Noncompliant|18|||
48651118|NCT01700959|156573166|FG004|Overall Study|Noncompliant|15|||
48651119|NCT01700959|156573167|FG005|Overall Study|Noncompliant|9|||
48651120|NCT01700959|156573162|FG000|Overall Study|Side effects|1|||
48651121|NCT01700959|156573163|FG001|Overall Study|Side effects|4|||
48651122|NCT01700959|156573164|FG002|Overall Study|Side effects|8|||
48651123|NCT01700959|156573165|FG003|Overall Study|Side effects|4|||
48752953|NCT01652703|156942050|FG004|Overall Study|Other|1|||
48752954|NCT01652703|156942051|FG005|Overall Study|Other|1|||
48752955|NCT00903695|156942052|FG000|Overall Study|medical exclusion after 1st testing|1|||
48752956|NCT00903695|156942053|FG001|Overall Study|medical exclusion after 1st testing|0|||
48332206|NCT03015220|155413528|FG000|Overall Study|Withdrawal by Subject|3|||
48332207|NCT03015220|155413529|FG001|Overall Study|Withdrawal by Subject|2|||
48651124|NCT01700959|156573166|FG004|Overall Study|Side effects|4|||
48651125|NCT01700959|156573167|FG005|Overall Study|Side effects|1|||
48651126|NCT00810277|156574841|FG000|Overall Study|Adverse Event|1|||
48651127|NCT04472650|156574842|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
48332208|NCT03015220|155413530|FG002|Overall Study|Withdrawal by Subject|2|||
48332209|NCT03015220|155413531|FG003|Overall Study|Withdrawal by Subject|2|||
48332210|NCT03015220|155413528|FG000|Overall Study|Lost to Follow-up|0|||
48332211|NCT03015220|155413529|FG001|Overall Study|Lost to Follow-up|0|||
48332212|NCT03015220|155413530|FG002|Overall Study|Lost to Follow-up|1|||
48332213|NCT03015220|155413531|FG003|Overall Study|Lost to Follow-up|0|||
48332214|NCT00512902|155413532|FG000|Overall Study|Adverse Event|7|||
48332215|NCT00512902|155413532|FG000|Overall Study|Lost to Follow-up|1|||
48332216|NCT01794689|155413533|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
48752957|NCT00903695|156942052|FG000|Overall Study|lung cancer|1|||
48752958|NCT00903695|156942053|FG001|Overall Study|lung cancer|0|||
48752959|NCT00381095|156942055|FG000|Overall Study|Death|3|||
48752960|NCT00381095|156942056|FG001|Overall Study|Death|4|||
48752961|NCT00381095|156942055|FG000|Overall Study|Lack of Efficacy|2|||
48332217|NCT01794689|155413534|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
48332218|NCT01794689|155413535|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
48332219|NCT01794689|155413536|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
48332220|NCT01794689|155413533|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
48332221|NCT01794689|155413534|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
48332222|NCT01794689|155413535|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
48332223|NCT01794689|155413536|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
48332224|NCT01794689|155413533|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
48332225|NCT01794689|155413534|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
48332226|NCT01794689|155413535|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
48332227|NCT01794689|155413536|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
48332228|NCT01794689|155413533|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
48332229|NCT01794689|155413534|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
48332230|NCT01794689|155413535|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
48332231|NCT01794689|155413536|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
48332232|NCT01964547|155413551|FG000|Overall Study|Adverse Event|8|||
48332233|NCT01964547|155413552|FG001|Overall Study|Adverse Event|2|||
48332234|NCT01964547|155413551|FG000|Overall Study|Withdrawal by Subject|4|||
48332235|NCT01964547|155413552|FG001|Overall Study|Withdrawal by Subject|7|||
48332236|NCT01964547|155413551|FG000|Overall Study|Lost to Follow-up|0|||
48332237|NCT01964547|155413552|FG001|Overall Study|Lost to Follow-up|1|||
48651128|NCT04472650|156574843|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
48651129|NCT00559104|156574853|FG000|Overall Study|Lack of Efficacy|9|||
48651130|NCT00559104|156574854|FG001|Overall Study|Lack of Efficacy|0|||
48651131|NCT03107052|156574855|FG000|Overall Study|Adverse Event|6|||
48651132|NCT03107052|156574856|FG001|Overall Study|Adverse Event|1|||
48651133|NCT03107052|156574857|FG002|Overall Study|Adverse Event|2|||
48651134|NCT03107052|156574855|FG000|Overall Study|Withdrawal by Subject|9|||
48651135|NCT03107052|156574856|FG001|Overall Study|Withdrawal by Subject|5|||
48651136|NCT03107052|156574857|FG002|Overall Study|Withdrawal by Subject|8|||
48651137|NCT03107052|156574855|FG000|Overall Study|Protocol Violation|6|||
48752962|NCT00381095|156942056|FG001|Overall Study|Lack of Efficacy|4|||
48752963|NCT00381095|156942055|FG000|Overall Study|Other|2|||
48752964|NCT00381095|156942056|FG001|Overall Study|Other|2|||
48752965|NCT00381095|156942055|FG000|Overall Study|Protocol Violation|1|||
48752966|NCT00381095|156942056|FG001|Overall Study|Protocol Violation|1|||
48752967|NCT00381095|156942055|FG000|Overall Study|Withdrawal by Subject|3|||
48752968|NCT00381095|156942056|FG001|Overall Study|Withdrawal by Subject|3|||
48332238|NCT01964547|155413551|FG000|Overall Study|Withdrawal by Investigator|0|||
48332239|NCT01964547|155413552|FG001|Overall Study|Withdrawal by Investigator|1|||
48332240|NCT01115309|155413553|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
48332241|NCT01115309|155413553|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
48332242|NCT01115309|155413553|FG000|Long-term Follow-up|Lost to Follow-up|6|||
48332243|NCT01549951|155413554|FG000|Overall Study|Adverse Event|15|||
48332244|NCT01549951|155413554|FG000|Overall Study|Withdrawal by Subject|2|||
48332245|NCT01549951|155413554|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
48332246|NCT01549951|155413554|FG000|Overall Study|Progressive disease|29|||
48332247|NCT01549951|155413554|FG000|Overall Study|Symptomatic deterioration|1|||
48651138|NCT03107052|156574856|FG001|Overall Study|Protocol Violation|0|||
48752969|NCT00381095|156942055|FG000|Overall Study|Adverse Event|2|||
48332248|NCT01549951|155413554|FG000|Overall Study|Other|2|||
48332249|NCT02674399|155413555|FG000|Overall Study|Lost to Follow-up|2|||
48332250|NCT02674399|155413556|FG001|Overall Study|Lost to Follow-up|0|||
48332251|NCT01766206|155413557|FG000|Overall Study|Withdrawal by Subject|22|||
48651139|NCT03107052|156574857|FG002|Overall Study|Protocol Violation|3|||
48752970|NCT00381095|156942056|FG001|Overall Study|Adverse Event|7|||
48752971|NCT00754624|156942057|FG000|Overall Study|Adverse Event|16|||
48332252|NCT01766206|155413557|FG000|Overall Study|Lost to Follow-up|10|||
48332253|NCT01766206|155413557|FG000|Overall Study|Inappropriate enrollment|18|||
48332254|NCT01766206|155413557|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
48332255|NCT01313663|155413558|FG000|Overall Study|Study Closed/Terminated|2|||
48332256|NCT01313663|155413559|FG001|Overall Study|Study Closed/Terminated|4|||
48332257|NCT01313663|155413558|FG000|Overall Study|Lost to Follow-up|0|||
48332258|NCT01313663|155413559|FG001|Overall Study|Lost to Follow-up|1|||
48332259|NCT01313663|155413558|FG000|Overall Study|Physician Decision|0|||
48332260|NCT01313663|155413559|FG001|Overall Study|Physician Decision|2|||
48332261|NCT01313663|155413558|FG000|Overall Study|Withdrawal by Subject|2|||
48332262|NCT01313663|155413559|FG001|Overall Study|Withdrawal by Subject|1|||
48332263|NCT01229176|155413561|FG000|Overall Study|Withdrawal by Subject|0|||
48332264|NCT01229176|155413562|FG001|Overall Study|Withdrawal by Subject|0|||
48332265|NCT01229176|155413563|FG002|Overall Study|Withdrawal by Subject|0|||
48332266|NCT01229176|155413564|FG003|Overall Study|Withdrawal by Subject|1|||
48332267|NCT01229176|155413565|FG004|Overall Study|Withdrawal by Subject|1|||
48332268|NCT01229176|155413566|FG005|Overall Study|Withdrawal by Subject|1|||
48332269|NCT01229176|155413567|FG006|Overall Study|Withdrawal by Subject|0|||
48332270|NCT01229176|155413568|FG007|Overall Study|Withdrawal by Subject|1|||
48332271|NCT01229176|155413561|FG000|Overall Study|Lost to Follow-up|0|||
48332272|NCT01229176|155413562|FG001|Overall Study|Lost to Follow-up|3|||
48332273|NCT01229176|155413563|FG002|Overall Study|Lost to Follow-up|0|||
48332274|NCT01229176|155413564|FG003|Overall Study|Lost to Follow-up|0|||
48332275|NCT01229176|155413565|FG004|Overall Study|Lost to Follow-up|1|||
48332276|NCT01229176|155413566|FG005|Overall Study|Lost to Follow-up|1|||
48332277|NCT01229176|155413567|FG006|Overall Study|Lost to Follow-up|0|||
48332278|NCT01229176|155413568|FG007|Overall Study|Lost to Follow-up|2|||
48332279|NCT02138838|155413573|FG000|Overall Study|Study Closure|7|||
48332280|NCT02138838|155413574|FG001|Overall Study|Study Closure|6|||
48332281|NCT02138838|155413573|FG000|Overall Study|Withdrawal by Subject|1|||
48332282|NCT02138838|155413574|FG001|Overall Study|Withdrawal by Subject|5|||
48332283|NCT02106325|155413575|FG000|Phase 1|Lost to Follow-up|2|||
48332284|NCT02106325|155413576|FG001|Phase 1|Lost to Follow-up|2|||
48332285|NCT02106325|155413575|FG000|Phase 2|Lost to Follow-up|2|||
48332286|NCT02106325|155413576|FG001|Phase 2|Lost to Follow-up|3|||
48332287|NCT02106325|155413575|FG000|Phase 3|Lost to Follow-up|2|||
48332288|NCT02106325|155413576|FG001|Phase 3|Lost to Follow-up|1|||
48332289|NCT00824850|155413583|FG000|Overall Study|Withdrawal by Subject|0|||
48332290|NCT00824850|155413584|FG001|Overall Study|Withdrawal by Subject|1|||
48332291|NCT02367794|155413585|FG000|Overall Study|Death|252|||
48332292|NCT02367794|155413586|FG001|Overall Study|Death|245|||
48332293|NCT02367794|155413587|FG002|Overall Study|Death|243|||
48332294|NCT02367794|155413585|FG000|Overall Study|Lost to Follow-up|1|||
48332295|NCT02367794|155413586|FG001|Overall Study|Lost to Follow-up|2|||
48332296|NCT02367794|155413587|FG002|Overall Study|Lost to Follow-up|2|||
48332297|NCT02367794|155413585|FG000|Overall Study|Physician Decision|0|||
48332298|NCT02367794|155413586|FG001|Overall Study|Physician Decision|5|||
48332299|NCT02367794|155413587|FG002|Overall Study|Physician Decision|3|||
48332300|NCT02367794|155413585|FG000|Overall Study|Protocol Violation|1|||
48332301|NCT02367794|155413586|FG001|Overall Study|Protocol Violation|0|||
48332302|NCT02367794|155413587|FG002|Overall Study|Protocol Violation|1|||
48332303|NCT02367794|155413585|FG000|Overall Study|Withdrawal by Subject|25|||
48332304|NCT02367794|155413586|FG001|Overall Study|Withdrawal by Subject|12|||
48332305|NCT02367794|155413587|FG002|Overall Study|Withdrawal by Subject|20|||
48332306|NCT02367794|155413585|FG000|Overall Study|Brain metastasis|1|||
48332307|NCT02367794|155413586|FG001|Overall Study|Brain metastasis|0|||
48651140|NCT03107052|156574855|FG000|Overall Study|Lost to Follow-up|4|||
48651141|NCT03107052|156574856|FG001|Overall Study|Lost to Follow-up|0|||
48651142|NCT03107052|156574857|FG002|Overall Study|Lost to Follow-up|1|||
48651143|NCT03107052|156574855|FG000|Overall Study|Lack of Efficacy|23|||
48332308|NCT02367794|155413587|FG002|Overall Study|Brain metastasis|0|||
48332309|NCT02367794|155413585|FG000|Overall Study|Randomized in error|0|||
48332310|NCT02367794|155413586|FG001|Overall Study|Randomized in error|0|||
48332311|NCT02367794|155413587|FG002|Overall Study|Randomized in error|1|||
48332312|NCT02367794|155413585|FG000|Overall Study|Patient unable to receive carboplatin|0|||
48651144|NCT03107052|156574856|FG001|Overall Study|Lack of Efficacy|7|||
48332313|NCT02367794|155413586|FG001|Overall Study|Patient unable to receive carboplatin|0|||
48332314|NCT02367794|155413587|FG002|Overall Study|Patient unable to receive carboplatin|1|||
48651145|NCT03107052|156574857|FG002|Overall Study|Lack of Efficacy|4|||
48651146|NCT03107052|156574855|FG000|Overall Study|Other than specified|4|||
48651147|NCT03107052|156574856|FG001|Overall Study|Other than specified|2|||
48332315|NCT02367794|155413585|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
48332316|NCT02367794|155413586|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
48332317|NCT02367794|155413587|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
48332318|NCT02367794|155413585|FG000|Overall Study|Adverse Event|0|||
48332319|NCT02367794|155413586|FG001|Overall Study|Adverse Event|0|||
48332320|NCT02367794|155413587|FG002|Overall Study|Adverse Event|2|||
48332321|NCT02367794|155413585|FG000|Overall Study|Study Terminated By Sponsor|0|||
48651148|NCT03107052|156574857|FG002|Overall Study|Other than specified|0|||
48332322|NCT02367794|155413586|FG001|Overall Study|Study Terminated By Sponsor|1|||
48332323|NCT02367794|155413587|FG002|Overall Study|Study Terminated By Sponsor|1|||
48332324|NCT02367794|155413585|FG000|Overall Study|Moved to Roll-Over Study|0|||
48332325|NCT02367794|155413586|FG001|Overall Study|Moved to Roll-Over Study|15|||
48332326|NCT02367794|155413587|FG002|Overall Study|Moved to Roll-Over Study|13|||
48332327|NCT02367794|155413585|FG000|Overall Study|Sponsor Request|60|||
48332328|NCT02367794|155413586|FG001|Overall Study|Sponsor Request|57|||
48332329|NCT02367794|155413587|FG002|Overall Study|Sponsor Request|45|||
48332330|NCT02367794|155413585|FG000|Overall Study|Moved into PTAP Study|0|||
48332331|NCT02367794|155413586|FG001|Overall Study|Moved into PTAP Study|2|||
48332332|NCT02367794|155413587|FG002|Overall Study|Moved into PTAP Study|3|||
48332333|NCT02367794|155413585|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
48332334|NCT02367794|155413586|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
48332335|NCT02367794|155413587|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
48332336|NCT02367794|155413585|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
48332337|NCT02367794|155413586|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
48332338|NCT02367794|155413587|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
48332339|NCT02367794|155413585|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
48332340|NCT02367794|155413586|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
48332341|NCT02367794|155413587|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
48332342|NCT02367794|155413585|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
48651149|NCT03107052|156574855|FG000|Overall Study|Study terminated due to futility|67|||
48651150|NCT03107052|156574856|FG001|Overall Study|Study terminated due to futility|31|||
48651151|NCT03107052|156574857|FG002|Overall Study|Study terminated due to futility|23|||
48651152|NCT01734785|156574858|FG000|Open-Label Period|Adverse Event|0|||
48332343|NCT02367794|155413586|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
48383944|NCT04422990|155601507|FG001|Overall Study|Withdrawal by Subject|1|||
48651153|NCT01734785|156574859|FG001|Open-Label Period|Adverse Event|0|||
48651154|NCT01734785|156574860|FG002|Open-Label Period|Adverse Event|0|||
48651155|NCT01734785|156574861|FG003|Open-Label Period|Adverse Event|9|||
48651156|NCT01734785|156574858|FG000|Open-Label Period|Lack of Efficacy|0|||
48651157|NCT01734785|156574859|FG001|Open-Label Period|Lack of Efficacy|0|||
48651158|NCT01734785|156574860|FG002|Open-Label Period|Lack of Efficacy|0|||
48651159|NCT01734785|156574861|FG003|Open-Label Period|Lack of Efficacy|1|||
48651160|NCT01734785|156574858|FG000|Open-Label Period|Protocol Violation|0|||
48651161|NCT01734785|156574859|FG001|Open-Label Period|Protocol Violation|0|||
48651162|NCT01734785|156574860|FG002|Open-Label Period|Protocol Violation|0|||
48651163|NCT01734785|156574861|FG003|Open-Label Period|Protocol Violation|13|||
48651164|NCT01734785|156574858|FG000|Open-Label Period|Lost to Follow-up|0|||
48651165|NCT01734785|156574859|FG001|Open-Label Period|Lost to Follow-up|0|||
48651166|NCT01734785|156574860|FG002|Open-Label Period|Lost to Follow-up|0|||
48651167|NCT01734785|156574861|FG003|Open-Label Period|Lost to Follow-up|14|||
48651168|NCT01734785|156574858|FG000|Open-Label Period|Withdrawal by Subject|0|||
48651169|NCT01734785|156574859|FG001|Open-Label Period|Withdrawal by Subject|0|||
48651170|NCT01734785|156574860|FG002|Open-Label Period|Withdrawal by Subject|0|||
48651171|NCT01734785|156574861|FG003|Open-Label Period|Withdrawal by Subject|12|||
48651172|NCT01734785|156574858|FG000|Open-Label Period|Other Reasons|0|||
48651173|NCT01734785|156574859|FG001|Open-Label Period|Other Reasons|0|||
48651174|NCT01734785|156574860|FG002|Open-Label Period|Other Reasons|0|||
48651175|NCT01734785|156574861|FG003|Open-Label Period|Other Reasons|224|||
48651176|NCT01734785|156574858|FG000|Double-Blind Period|Adverse Event|0|||
48651177|NCT01734785|156574859|FG001|Double-Blind Period|Adverse Event|3|||
48651178|NCT01734785|156574860|FG002|Double-Blind Period|Adverse Event|2|||
48651179|NCT01734785|156574861|FG003|Double-Blind Period|Adverse Event|0|||
48651180|NCT01734785|156574858|FG000|Double-Blind Period|Lack of Efficacy|0|||
48651181|NCT01734785|156574859|FG001|Double-Blind Period|Lack of Efficacy|1|||
48651182|NCT01734785|156574860|FG002|Double-Blind Period|Lack of Efficacy|0|||
48651183|NCT01734785|156574861|FG003|Double-Blind Period|Lack of Efficacy|0|||
48651184|NCT01734785|156574858|FG000|Double-Blind Period|Protocol Violation|0|||
48651185|NCT01734785|156574859|FG001|Double-Blind Period|Protocol Violation|1|||
48651186|NCT01734785|156574860|FG002|Double-Blind Period|Protocol Violation|1|||
48651187|NCT01734785|156574861|FG003|Double-Blind Period|Protocol Violation|0|||
48651188|NCT01734785|156574858|FG000|Double-Blind Period|Lost to Follow-up|2|||
48651189|NCT01734785|156574859|FG001|Double-Blind Period|Lost to Follow-up|4|||
48651190|NCT01734785|156574860|FG002|Double-Blind Period|Lost to Follow-up|2|||
48651191|NCT01734785|156574861|FG003|Double-Blind Period|Lost to Follow-up|0|||
48651192|NCT01734785|156574858|FG000|Double-Blind Period|Withdrawal by Subject|2|||
48651193|NCT01734785|156574859|FG001|Double-Blind Period|Withdrawal by Subject|0|||
48651194|NCT01734785|156574860|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48651195|NCT01734785|156574861|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48651196|NCT01734785|156574858|FG000|Double-Blind Period|Not treated|1|||
48651197|NCT01734785|156574859|FG001|Double-Blind Period|Not treated|0|||
48651198|NCT01734785|156574860|FG002|Double-Blind Period|Not treated|0|||
48651199|NCT01734785|156574861|FG003|Double-Blind Period|Not treated|0|||
48332344|NCT02367794|155413587|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
48332345|NCT01828021|155413588|FG000|Overall Study|Adverse Event|5|||
48332346|NCT01828021|155413588|FG000|Overall Study|Lack of Efficacy|17|||
48332347|NCT01828021|155413588|FG000|Overall Study|Withdrawal by Subject|2|||
48332348|NCT01828021|155413588|FG000|Overall Study|Ileal obstruction, unrelated|1|||
48332349|NCT02010684|155413589|FG000|Overall Study|Lost to Follow-up|8|||
48332350|NCT02010684|155413590|FG001|Overall Study|Lost to Follow-up|18|||
48332351|NCT02010684|155413589|FG000|Overall Study|Withdrawal by Subject|4|||
48332352|NCT02010684|155413590|FG001|Overall Study|Withdrawal by Subject|5|||
48332353|NCT02009865|155413593|FG000|Overall Study|Adverse Event|0|||
48332354|NCT02009865|155413594|FG001|Overall Study|Adverse Event|2|||
48332355|NCT02009865|155413593|FG000|Overall Study|Protocol Violation|0|||
48332356|NCT02009865|155413594|FG001|Overall Study|Protocol Violation|2|||
48332357|NCT02009865|155413593|FG000|Overall Study|Withdrawal by Subject|1|||
48332358|NCT02009865|155413594|FG001|Overall Study|Withdrawal by Subject|1|||
48332359|NCT00990314|155413597|FG000|Overall Study|Death|2|||
48332360|NCT00990314|155413597|FG000|Overall Study|Adverse Event|2|||
48332361|NCT00990314|155413597|FG000|Overall Study|Withdrawal by Subject|3|||
48332362|NCT00990314|155413597|FG000|Overall Study|Non-Compliance|1|||
48332363|NCT00990314|155413597|FG000|Overall Study|Physician Decision|3|||
48332364|NCT00990314|155413597|FG000|Overall Study|Lack of Efficacy|1|||
48332365|NCT02935894|155413599|FG000|Overall Study|Subject dismissed|1|||
48332366|NCT01884571|155413604|FG000|Overall Study|Adverse Event|1|||
48332367|NCT01884571|155413604|FG000|Overall Study|Death|2|||
48332368|NCT01884571|155413604|FG000|Overall Study|Withdrawal by Subject|2|||
48332369|NCT01884571|155413604|FG000|Overall Study|Disease progression|3|||
48332370|NCT00091572|155413605|FG000|Overall Study|Lost to Follow-up|1|||
48332371|NCT00091572|155413606|FG001|Overall Study|Lost to Follow-up|1|||
48332372|NCT00091572|155413605|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
48332373|NCT00091572|155413606|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
48332374|NCT00091572|155413605|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
48332375|NCT00091572|155413606|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
48332376|NCT00091572|155413605|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
48332377|NCT00091572|155413606|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
48332378|NCT00091572|155413605|FG000|Overall Study|Other Reason|6|||
48332379|NCT00091572|155413606|FG001|Overall Study|Other Reason|13|||
48332380|NCT00091572|155413605|FG000|Overall Study|Ongoing (still on treatment)|8|||
48332381|NCT00091572|155413606|FG001|Overall Study|Ongoing (still on treatment)|12|||
48332382|NCT00091572|155413605|FG000|Overall Study|Major Protocol Violation|2|||
48332383|NCT00091572|155413606|FG001|Overall Study|Major Protocol Violation|0|||
48332384|NCT00091572|155413605|FG000|Overall Study|Toxicity (Related AE)|53|||
48332385|NCT00091572|155413606|FG001|Overall Study|Toxicity (Related AE)|9|||
48332386|NCT01634165|155413608|FG000|Period 2|Adverse Event|0|||
48332387|NCT01634165|155413609|FG001|Period 2|Adverse Event|1|||
48332388|NCT01634165|155413610|FG002|Period 2|Adverse Event|0|||
48332389|NCT01634165|155413611|FG003|Period 2|Adverse Event|0|||
48332390|NCT03070301|155413612|FG000|Overall Study|Progression of disease|16|||
48332391|NCT03070301|155413612|FG000|Overall Study|Physician Decision|3|||
48332392|NCT03070301|155413612|FG000|Overall Study|Withdrawal by Subject|1|||
48332393|NCT00731692|155414684|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
48332394|NCT00731692|155414685|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
48332395|NCT00731692|155414686|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
48332396|NCT00731692|155414684|FG000|Core Study (36 Months)|Physician Decision|1|||
48332397|NCT00731692|155414685|FG001|Core Study (36 Months)|Physician Decision|0|||
48332398|NCT00731692|155414686|FG002|Core Study (36 Months)|Physician Decision|2|||
48332399|NCT00731692|155414684|FG000|Core Study (36 Months)|Death|2|||
48332400|NCT00731692|155414685|FG001|Core Study (36 Months)|Death|1|||
48332401|NCT00731692|155414686|FG002|Core Study (36 Months)|Death|2|||
48332402|NCT00731692|155414684|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
48332403|NCT00731692|155414685|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
48332404|NCT00731692|155414686|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
48332405|NCT00731692|155414684|FG000|Core Study (36 Months)|Administrative|2|||
48332406|NCT00731692|155414685|FG001|Core Study (36 Months)|Administrative|2|||
48332407|NCT00731692|155414686|FG002|Core Study (36 Months)|Administrative|6|||
48651200|NCT00576628|156574865|FG000|Overall Study|Adverse Event|11|||
48332408|NCT00731692|155414684|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
48332409|NCT00731692|155414685|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
48651201|NCT00576628|156574865|FG000|Overall Study|Death|2|||
48651202|NCT00576628|156574865|FG000|Overall Study|Failure to return|1|||
48651203|NCT00576628|156574865|FG000|Overall Study|Refused Treatment|8|||
48332410|NCT00731692|155414686|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
48332411|NCT00731692|155414684|FG000|Core Study (36 Months)|Protocol Violation|4|||
48332412|NCT00731692|155414685|FG001|Core Study (36 Months)|Protocol Violation|5|||
48332413|NCT00731692|155414686|FG002|Core Study (36 Months)|Protocol Violation|8|||
48651204|NCT00576628|156574865|FG000|Overall Study|Pregnancy|1|||
48651205|NCT00576628|156574865|FG000|Overall Study|RBC transfusion|1|||
48752972|NCT00754624|156942057|FG000|Overall Study|Death|1|||
48332414|NCT00731692|155414684|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
48332415|NCT00731692|155414685|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
48332416|NCT00731692|155414686|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
48332417|NCT00731692|155414684|FG000|Core Study (36 Months)|Adverse Event|25|||
48332418|NCT00731692|155414685|FG001|Core Study (36 Months)|Adverse Event|28|||
48332419|NCT00731692|155414686|FG002|Core Study (36 Months)|Adverse Event|29|||
48332420|NCT00731692|155414684|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
48332421|NCT00731692|155414685|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
48332422|NCT00731692|155414686|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
48332423|NCT00731692|155414684|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
48332424|NCT00731692|155414685|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
48332425|NCT00731692|155414686|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
48332426|NCT00731692|155414684|FG000|Extension Phase|Abnormal test procedure|0|||
48332427|NCT00731692|155414685|FG001|Extension Phase|Abnormal test procedure|0|||
48332428|NCT00731692|155414686|FG002|Extension Phase|Abnormal test procedure|1|||
48332429|NCT00731692|155414684|FG000|Extension Phase|Abnormal lab values|0|||
48332430|NCT00731692|155414685|FG001|Extension Phase|Abnormal lab values|0|||
48332431|NCT00731692|155414686|FG002|Extension Phase|Abnormal lab values|1|||
48332432|NCT00731692|155414684|FG000|Extension Phase|Lost to Follow-up|0|||
48332433|NCT00731692|155414685|FG001|Extension Phase|Lost to Follow-up|1|||
48332434|NCT00731692|155414686|FG002|Extension Phase|Lost to Follow-up|4|||
48651206|NCT00576628|156574865|FG000|Overall Study|Progression of Kidney Disease|1|||
48651207|NCT00576628|156574865|FG000|Overall Study|Progression of Renal Failure|1|||
48651208|NCT00576628|156574865|FG000|Overall Study|The patient move into other town|1|||
48651209|NCT00576628|156574865|FG000|Overall Study|Transplantation|1|||
48651210|NCT00576628|156574865|FG000|Overall Study|Dialysis|15|||
48651211|NCT00570778|156574866|FG000|Overall Study|Protocol deviation|2|||
48651212|NCT00570778|156574867|FG001|Overall Study|Protocol deviation|1|||
48651213|NCT00570778|156574868|FG002|Overall Study|Protocol deviation|2|||
48651214|NCT00570778|156574869|FG003|Overall Study|Protocol deviation|2|||
48651215|NCT00570778|156574866|FG000|Overall Study|Adverse Event|0|||
48651216|NCT00570778|156574867|FG001|Overall Study|Adverse Event|1|||
48651217|NCT00570778|156574868|FG002|Overall Study|Adverse Event|4|||
48651218|NCT00570778|156574869|FG003|Overall Study|Adverse Event|1|||
48332435|NCT00731692|155414684|FG000|Extension Phase|Withdrawal by Subject|4|||
48332436|NCT00731692|155414685|FG001|Extension Phase|Withdrawal by Subject|5|||
48332437|NCT00731692|155414686|FG002|Extension Phase|Withdrawal by Subject|3|||
48332438|NCT00731692|155414684|FG000|Extension Phase|Adverse Event|1|||
48332439|NCT00731692|155414685|FG001|Extension Phase|Adverse Event|1|||
48332440|NCT00731692|155414686|FG002|Extension Phase|Adverse Event|15|||
48332441|NCT00458783|155414687|FG000|Overall Study|Protocol Violation|1228|||
48332442|NCT00458783|155414688|FG001|Overall Study|Protocol Violation|1220|||
48651219|NCT00570778|156574866|FG000|Overall Study|Subject withdrew consent|0|||
48651220|NCT00570778|156574867|FG001|Overall Study|Subject withdrew consent|1|||
48651221|NCT00570778|156574868|FG002|Overall Study|Subject withdrew consent|0|||
48651222|NCT00570778|156574869|FG003|Overall Study|Subject withdrew consent|1|||
48651223|NCT00570778|156574866|FG000|Overall Study|Abnormal test procedure|1|||
48651224|NCT00570778|156574867|FG001|Overall Study|Abnormal test procedure|0|||
48651225|NCT00570778|156574868|FG002|Overall Study|Abnormal test procedure|0|||
48651226|NCT00570778|156574869|FG003|Overall Study|Abnormal test procedure|0|||
48651227|NCT00570778|156574866|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48651228|NCT00570778|156574867|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48651229|NCT00570778|156574868|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48651230|NCT00570778|156574869|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48651231|NCT00570778|156574866|FG000|Overall Study|Lost to Follow-up|0|||
48651232|NCT00570778|156574867|FG001|Overall Study|Lost to Follow-up|0|||
48651233|NCT00570778|156574868|FG002|Overall Study|Lost to Follow-up|1|||
48651234|NCT00570778|156574869|FG003|Overall Study|Lost to Follow-up|0|||
48651235|NCT00570778|156574866|FG000|Overall Study|Subject no longer requires study drug|0|||
48651236|NCT00570778|156574867|FG001|Overall Study|Subject no longer requires study drug|1|||
48651237|NCT00570778|156574868|FG002|Overall Study|Subject no longer requires study drug|0|||
48651238|NCT00570778|156574869|FG003|Overall Study|Subject no longer requires study drug|0|||
48752973|NCT00754624|156942057|FG000|Overall Study|Physician Decision|8|||
48332443|NCT01737398|155414689|FG000|Overall Study|Adverse event or SAE|16|||
48332444|NCT01737398|155414690|FG001|Overall Study|Adverse event or SAE|1|||
48332445|NCT01737398|155414689|FG000|Overall Study|Stopping rule met|2|||
48332446|NCT01737398|155414690|FG001|Overall Study|Stopping rule met|1|||
48332447|NCT01737398|155414689|FG000|Overall Study|Voluntary withdrawal|2|||
48332448|NCT01737398|155414690|FG001|Overall Study|Voluntary withdrawal|3|||
48651239|NCT03650413|156574870|FG000|Overall Study|Adverse Event|1|||
48651240|NCT03650413|156574870|FG000|Overall Study|Lack of Efficacy|17|||
48752974|NCT00754624|156942057|FG000|Overall Study|Protocol Violation|1|||
48332449|NCT01737398|155414689|FG000|Overall Study|Ineligibility|1|||
48651241|NCT03650413|156574870|FG000|Overall Study|Other|9|||
48651242|NCT03650413|156574870|FG000|Overall Study|Physician Decision|2|||
48651243|NCT03650413|156574870|FG000|Overall Study|Study Terminated By Sponsor|16|||
48651244|NCT03650413|156574870|FG000|Overall Study|Withdrawal by Subject|16|||
48651245|NCT02516982|156574871|FG000|Overall Study|Called in to antenatal appointment|32|||
48651246|NCT02516982|156574872|FG001|Overall Study|Called in to antenatal appointment|35|||
48651247|NCT02516982|156574873|FG002|Overall Study|Called in to antenatal appointment|0|||
48651248|NCT02516982|156574874|FG003|Overall Study|Called in to antenatal appointment|0|||
48651249|NCT02516982|156574871|FG000|Overall Study|Withdrawal by Subject|0|||
48651250|NCT02516982|156574872|FG001|Overall Study|Withdrawal by Subject|0|||
48651251|NCT02516982|156574873|FG002|Overall Study|Withdrawal by Subject|1|||
48651252|NCT02516982|156574874|FG003|Overall Study|Withdrawal by Subject|2|||
48651253|NCT02516982|156574871|FG000|Overall Study|Protocol Violation|0|||
48651254|NCT02516982|156574872|FG001|Overall Study|Protocol Violation|0|||
48651255|NCT02516982|156574873|FG002|Overall Study|Protocol Violation|1|||
48752975|NCT00754624|156942057|FG000|Overall Study|Withdrawal by Subject|28|||
48752976|NCT00754624|156942057|FG000|Overall Study|Various|12|||
48752977|NCT00754624|156942057|FG000|Overall Study|Lost to Follow-up|3|||
48752978|NCT00720434|156942058|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
48752979|NCT00720434|156942059|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
48752980|NCT00720434|156942060|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
48752981|NCT00720434|156942061|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
48752982|NCT00720434|156942058|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
48752983|NCT00720434|156942059|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
48752984|NCT00720434|156942060|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
48752985|NCT00720434|156942061|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
48752986|NCT00720434|156942058|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
48752987|NCT00720434|156942059|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
48752988|NCT00720434|156942060|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
48752989|NCT00720434|156942061|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
48752990|NCT00720434|156942058|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
48752991|NCT00720434|156942059|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
48752992|NCT00720434|156942060|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
48752993|NCT00720434|156942061|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
48752994|NCT00720434|156942058|FG000|Open-Label Period (Week 5-72)|Other|4|||
48752995|NCT00720434|156942059|FG001|Open-Label Period (Week 5-72)|Other|3|||
48752996|NCT00720434|156942060|FG002|Open-Label Period (Week 5-72)|Other|3|||
48752997|NCT00720434|156942061|FG003|Open-Label Period (Week 5-72)|Other|2|||
48752998|NCT02425046|156942063|FG000|Overall Study|Lost to Follow-up|52|||
48752999|NCT02425046|156942064|FG001|Overall Study|Lost to Follow-up|50|||
48753000|NCT02425046|156942065|FG002|Overall Study|Lost to Follow-up|56|||
48753001|NCT02425046|156942063|FG000|Overall Study|Withdrawal by Subject|16|||
48753002|NCT02425046|156942064|FG001|Overall Study|Withdrawal by Subject|12|||
48753003|NCT02425046|156942065|FG002|Overall Study|Withdrawal by Subject|0|||
48753004|NCT01831544|156942066|FG000|Overall Study|Death|1|||
48753005|NCT01831544|156942066|FG000|Overall Study|Still on original MVAD device|2|||
48753006|NCT00931762|156942068|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
48753007|NCT00931762|156942068|FG000|Overall Study|Administrative Problems|5|||
48753008|NCT00931762|156942068|FG000|Overall Study|Death|1|||
48753009|NCT00931762|156942068|FG000|Overall Study|Disease Progression|3|||
48753010|NCT00931762|156942068|FG000|Overall Study|Adverse Event (s)|11|||
48753011|NCT00931762|156942068|FG000|Overall Study|Subject withdrew consent|13|||
48753012|NCT01320085|156942069|FG000|Overall Study|Disease Progression|26|||
48753013|NCT01320085|156942070|FG001|Overall Study|Disease Progression|93|||
48753014|NCT01320085|156942071|FG002|Overall Study|Disease Progression|17|||
48753015|NCT01320085|156942069|FG000|Overall Study|Adverse Event|12|||
48753016|NCT01320085|156942070|FG001|Overall Study|Adverse Event|20|||
48753017|NCT01320085|156942071|FG002|Overall Study|Adverse Event|5|||
48753018|NCT01320085|156942069|FG000|Overall Study|Withdrawal by Subject|2|||
48753019|NCT01320085|156942070|FG001|Overall Study|Withdrawal by Subject|4|||
48753020|NCT01320085|156942071|FG002|Overall Study|Withdrawal by Subject|1|||
48753021|NCT01320085|156942069|FG000|Overall Study|Protocol Deviation|1|||
48753022|NCT01320085|156942070|FG001|Overall Study|Protocol Deviation|0|||
48332450|NCT01737398|155414690|FG001|Overall Study|Ineligibility|0|||
48332451|NCT01737398|155414689|FG000|Overall Study|Liver transplant|1|||
48651256|NCT02516982|156574874|FG003|Overall Study|Protocol Violation|1|||
48651257|NCT02516982|156574871|FG000|Overall Study|Did not install the app|0|||
48651258|NCT02516982|156574872|FG001|Overall Study|Did not install the app|0|||
48651259|NCT02516982|156574873|FG002|Overall Study|Did not install the app|46|||
48753023|NCT01320085|156942071|FG002|Overall Study|Protocol Deviation|1|||
48753024|NCT01320085|156942069|FG000|Overall Study|Administrative problems|0|||
48332452|NCT01737398|155414690|FG001|Overall Study|Liver transplant|0|||
48651260|NCT02516982|156574874|FG003|Overall Study|Did not install the app|47|||
48651261|NCT02817594|156574877|FG000|Overall Study|Withdrawal by Subject|1|||
48753025|NCT01320085|156942070|FG001|Overall Study|Administrative problems|0|||
48753026|NCT01320085|156942071|FG002|Overall Study|Administrative problems|1|||
48753027|NCT03070782|156942076|FG000|Overall Study|Adverse Event|3|||
48753028|NCT03070782|156942077|FG001|Overall Study|Adverse Event|0|||
48753029|NCT03070782|156942078|FG002|Overall Study|Adverse Event|3|||
48753030|NCT03070782|156942079|FG003|Overall Study|Adverse Event|1|||
48753031|NCT03070782|156942080|FG004|Overall Study|Adverse Event|6|||
48753032|NCT03070782|156942081|FG005|Overall Study|Adverse Event|2|||
48753033|NCT03070782|156942076|FG000|Overall Study|Withdrawal by Subject|2|||
48753034|NCT03070782|156942077|FG001|Overall Study|Withdrawal by Subject|1|||
48753035|NCT03070782|156942078|FG002|Overall Study|Withdrawal by Subject|1|||
48753036|NCT03070782|156942079|FG003|Overall Study|Withdrawal by Subject|0|||
48753037|NCT03070782|156942080|FG004|Overall Study|Withdrawal by Subject|4|||
48753038|NCT03070782|156942081|FG005|Overall Study|Withdrawal by Subject|3|||
48753039|NCT03070782|156942076|FG000|Overall Study|Reason Not Specified|2|||
48753040|NCT03070782|156942077|FG001|Overall Study|Reason Not Specified|0|||
48753041|NCT03070782|156942078|FG002|Overall Study|Reason Not Specified|0|||
48753042|NCT03070782|156942079|FG003|Overall Study|Reason Not Specified|1|||
48753043|NCT03070782|156942080|FG004|Overall Study|Reason Not Specified|2|||
48753044|NCT03070782|156942081|FG005|Overall Study|Reason Not Specified|1|||
48753045|NCT03070782|156942076|FG000|Overall Study|Ineligibility|0|||
48753046|NCT03070782|156942077|FG001|Overall Study|Ineligibility|0|||
48753047|NCT03070782|156942078|FG002|Overall Study|Ineligibility|0|||
48753048|NCT03070782|156942079|FG003|Overall Study|Ineligibility|1|||
48753049|NCT03070782|156942080|FG004|Overall Study|Ineligibility|0|||
48753050|NCT03070782|156942081|FG005|Overall Study|Ineligibility|1|||
48753051|NCT03070782|156942076|FG000|Overall Study|Pregnancy|0|||
48753052|NCT03070782|156942077|FG001|Overall Study|Pregnancy|0|||
48753053|NCT03070782|156942078|FG002|Overall Study|Pregnancy|0|||
48753054|NCT03070782|156942079|FG003|Overall Study|Pregnancy|1|||
48753055|NCT03070782|156942080|FG004|Overall Study|Pregnancy|0|||
48753056|NCT03070782|156942081|FG005|Overall Study|Pregnancy|0|||
48753057|NCT03070782|156942076|FG000|Overall Study|Investigator Judgement|0|||
48753058|NCT03070782|156942077|FG001|Overall Study|Investigator Judgement|0|||
48753059|NCT03070782|156942078|FG002|Overall Study|Investigator Judgement|0|||
48753060|NCT03070782|156942079|FG003|Overall Study|Investigator Judgement|1|||
48753061|NCT03070782|156942080|FG004|Overall Study|Investigator Judgement|0|||
48753062|NCT03070782|156942081|FG005|Overall Study|Investigator Judgement|0|||
48753063|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
48753064|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
48332453|NCT01737398|155414689|FG000|Overall Study|Disease progression|2|||
48332454|NCT01737398|155414690|FG001|Overall Study|Disease progression|3|||
48332455|NCT01737398|155414689|FG000|Overall Study|Sponsor's decision|2|||
48332456|NCT01737398|155414690|FG001|Overall Study|Sponsor's decision|0|||
48332457|NCT02038049|155414692|FG000|Overall Study|Lost to Follow-up|1|||
48332458|NCT02038049|155414693|FG001|Overall Study|Lost to Follow-up|0|||
48332459|NCT04938453|155414694|FG000|Washout Period 1|Adverse Event|1|||
48332460|NCT04938453|155414695|FG001|Washout Period 1|Adverse Event|0|||
48332461|NCT04938453|155414694|FG000|Washout Period 1|Physician Decision|0|||
48332462|NCT04938453|155414695|FG001|Washout Period 1|Physician Decision|1|||
48332463|NCT02392507|155414696|FG000|Induction Regimen|Death|3|||
48332464|NCT02392507|155414696|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
48332465|NCT02392507|155414696|FG000|Induction Regimen|Physician Decision|1|||
48332466|NCT02392507|155414696|FG000|Induction Regimen|Withdrawal by Subject|2|||
48332467|NCT02392507|155414696|FG000|Maintenance Regimen|Death|1|||
48332468|NCT02392507|155414696|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
48332469|NCT00487240|155414697|FG000|Overall Study|Withdrawal by Subject|12|||
48651262|NCT02817594|156574877|FG000|Overall Study|Other|1|||
48651263|NCT02817594|156574877|FG000|Overall Study|Did Not Receive Treatment|1|||
48651264|NCT05332392|156574878|FG000|Overall Study|Did not meet inclusion criteria|25|||
48651265|NCT05332392|156574878|FG000|Overall Study|Principal Investigator's decision|17|||
48651266|NCT05332392|156574878|FG000|Overall Study|Adverse Event|1|||
48651267|NCT05332392|156574878|FG000|Overall Study|Subject's decision|1|||
48651268|NCT02314156|156574880|FG000|Overall Study|Adverse Event|1|||
48651269|NCT02314156|156574881|FG001|Overall Study|Adverse Event|0|||
48651270|NCT02314156|156574880|FG000|Overall Study|Withdrawal by Subject|1|||
48651271|NCT02314156|156574881|FG001|Overall Study|Withdrawal by Subject|0|||
48753065|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
48753066|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
48753067|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
48332470|NCT00487240|155414698|FG001|Overall Study|Withdrawal by Subject|6|||
48332471|NCT00487240|155414697|FG000|Overall Study|Lost to Follow-up|7|||
48332472|NCT00487240|155414698|FG001|Overall Study|Lost to Follow-up|6|||
48332473|NCT00487240|155414697|FG000|Overall Study|Adverse Event|0|||
48651272|NCT00066222|156574882|FG000|Overall Study|No protocol treatment received|1|||
48651273|NCT00405392|156574883|FG000|Overall Study|Adverse Event|15|||
48651274|NCT00405392|156574884|FG001|Overall Study|Adverse Event|14|||
48753068|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
48753069|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
48753070|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
48753071|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
48332474|NCT00487240|155414698|FG001|Overall Study|Adverse Event|4|||
48332475|NCT00487240|155414697|FG000|Overall Study|Protocol Violation|5|||
48332476|NCT00487240|155414698|FG001|Overall Study|Protocol Violation|5|||
48332477|NCT00487240|155414697|FG000|Overall Study|Entry Criteria Not Met|3|||
48332478|NCT00487240|155414698|FG001|Overall Study|Entry Criteria Not Met|4|||
48332479|NCT00487240|155414697|FG000|Overall Study|Sponsor Decision|2|||
48332480|NCT00487240|155414698|FG001|Overall Study|Sponsor Decision|1|||
48332481|NCT00487240|155414697|FG000|Overall Study|Physician Decision|2|||
48332482|NCT00487240|155414698|FG001|Overall Study|Physician Decision|0|||
48332483|NCT00578344|155414701|FG000|Overall Study|Insurance problems|1|||
48332484|NCT00578344|155414701|FG000|Overall Study|Graft failure|1|||
48332485|NCT03052517|155414702|FG000|Overall Study|Study Terminated By Sponsor|928|||
48332486|NCT03052517|155414703|FG001|Overall Study|Study Terminated By Sponsor|938|||
48332487|NCT03052517|155414704|FG002|Overall Study|Study Terminated By Sponsor|296|||
48332488|NCT03052517|155414702|FG000|Overall Study|Subject/Guardian Decision|50|||
48332489|NCT03052517|155414703|FG001|Overall Study|Subject/Guardian Decision|45|||
48332490|NCT03052517|155414704|FG002|Overall Study|Subject/Guardian Decision|22|||
48332491|NCT03052517|155414702|FG000|Overall Study|Lack of Efficacy|23|||
48332492|NCT03052517|155414703|FG001|Overall Study|Lack of Efficacy|14|||
48332493|NCT03052517|155414704|FG002|Overall Study|Lack of Efficacy|7|||
48332494|NCT03052517|155414702|FG000|Overall Study|Adverse Event|6|||
48651275|NCT00405392|156574883|FG000|Overall Study|Did not meet Eligibility criteria|7|||
48651276|NCT00405392|156574884|FG001|Overall Study|Did not meet Eligibility criteria|2|||
48651277|NCT00405392|156574883|FG000|Overall Study|Withdrawal by Subject|4|||
48651278|NCT00405392|156574884|FG001|Overall Study|Withdrawal by Subject|3|||
48651279|NCT00405392|156574883|FG000|Overall Study|Lost to Follow-up|1|||
48651280|NCT00405392|156574884|FG001|Overall Study|Lost to Follow-up|2|||
48651281|NCT00405392|156574883|FG000|Overall Study|Data missing|2|||
48332495|NCT03052517|155414703|FG001|Overall Study|Adverse Event|5|||
48651282|NCT00405392|156574884|FG001|Overall Study|Data missing|0|||
48651283|NCT00405392|156574883|FG000|Overall Study|Non-compliance|0|||
48651284|NCT00405392|156574884|FG001|Overall Study|Non-compliance|1|||
48651285|NCT00405392|156574883|FG000|Overall Study|Other|1|||
48651286|NCT00405392|156574884|FG001|Overall Study|Other|5|||
48332496|NCT03052517|155414704|FG002|Overall Study|Adverse Event|0|||
48651287|NCT02684617|156574885|FG000|Overall Study|Adverse Event|1|||
48651288|NCT02684617|156574886|FG001|Overall Study|Adverse Event|0|||
48651289|NCT02684617|156574887|FG002|Overall Study|Adverse Event|1|||
48651290|NCT02684617|156574885|FG000|Overall Study|Death|8|||
48651291|NCT02684617|156574886|FG001|Overall Study|Death|16|||
48651292|NCT02684617|156574887|FG002|Overall Study|Death|28|||
48651293|NCT02684617|156574885|FG000|Overall Study|Withdrawal by Subject|2|||
48651294|NCT02684617|156574886|FG001|Overall Study|Withdrawal by Subject|0|||
48651295|NCT02684617|156574887|FG002|Overall Study|Withdrawal by Subject|4|||
48651296|NCT02684617|156574885|FG000|Overall Study|Screen Failure|1|||
48651297|NCT02684617|156574886|FG001|Overall Study|Screen Failure|0|||
48651298|NCT02684617|156574887|FG002|Overall Study|Screen Failure|2|||
48651299|NCT02684617|156574885|FG000|Overall Study|Study Terminated by Sponsor|6|||
48651300|NCT02684617|156574886|FG001|Overall Study|Study Terminated by Sponsor|1|||
48651301|NCT02684617|156574887|FG002|Overall Study|Study Terminated by Sponsor|5|||
48651302|NCT00090779|156574890|FG000|Step 1|Withdrawal by Subject|4|||
48651303|NCT00090779|156574891|FG001|Step 1|Withdrawal by Subject|2|||
48651304|NCT00090779|156574890|FG000|Step 1|Lost to Follow-up|3|||
48651305|NCT00090779|156574891|FG001|Step 1|Lost to Follow-up|2|||
48651306|NCT00090779|156574890|FG000|Step 1|Death|0|||
48651307|NCT00090779|156574891|FG001|Step 1|Death|2|||
48651308|NCT00090779|156574890|FG000|Step 1|Physician Decision|1|||
48651309|NCT00090779|156574891|FG001|Step 1|Physician Decision|0|||
48651310|NCT00090779|156574890|FG000|Step 1|Pregnancy|1|||
48651311|NCT00090779|156574891|FG001|Step 1|Pregnancy|0|||
48651312|NCT00090779|156574890|FG000|Step 1|Non-compliance to study requirements|0|||
48651313|NCT00090779|156574891|FG001|Step 1|Non-compliance to study requirements|1|||
48651314|NCT00090779|156574890|FG000|Step 1|Subject relocated|2|||
48651315|NCT00090779|156574891|FG001|Step 1|Subject relocated|8|||
48332497|NCT03052517|155414702|FG000|Overall Study|Physician Decision|4|||
48332498|NCT03052517|155414703|FG001|Overall Study|Physician Decision|5|||
48651316|NCT00090779|156574890|FG000|Step 2|Off study per study closure|6|||
48651317|NCT00090779|156574891|FG001|Step 2|Off study per study closure|16|||
48332499|NCT03052517|155414704|FG002|Overall Study|Physician Decision|1|||
48332500|NCT03052517|155414702|FG000|Overall Study|Death|3|||
48332501|NCT03052517|155414703|FG001|Overall Study|Death|0|||
48332502|NCT03052517|155414704|FG002|Overall Study|Death|1|||
48332503|NCT03052517|155414702|FG000|Overall Study|Lost to Follow-up|2|||
48651318|NCT00090779|156574890|FG000|Step 2|Subject relocated|0|||
48651319|NCT00090779|156574891|FG001|Step 2|Subject relocated|1|||
48651320|NCT00090779|156574890|FG000|Step 2|Non-compliance to study requirements|0|||
48651321|NCT00090779|156574891|FG001|Step 2|Non-compliance to study requirements|1|||
48651322|NCT00090779|156574890|FG000|Step 3|Initiation of ART and off extended study|3|||
48651323|NCT00090779|156574891|FG001|Step 3|Initiation of ART and off extended study|2|||
48651324|NCT00090779|156574890|FG000|Step 3|Off extended study due to study closure|4|||
48753072|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
48753073|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
48753074|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
48753075|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
48753076|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
48753077|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
48753078|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
48753079|NCT03510884|156942088|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
48753080|NCT03510884|156942089|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
48753081|NCT03510884|156942090|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
48753082|NCT03510884|156942091|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
48651325|NCT00090779|156574891|FG001|Step 3|Off extended study due to study closure|3|||
48651326|NCT04075513|156574901|FG000|Overall Study|Withdrawal by Subject|2|||
48651327|NCT04075513|156574902|FG001|Overall Study|Withdrawal by Subject|2|||
48651328|NCT04075513|156574901|FG000|Overall Study|Lack of Efficacy|1|||
48753083|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
48753084|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
48753085|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
48753086|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
48753087|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
48753088|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
48753089|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
48753090|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
48753091|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
48753092|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
48753093|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
48753094|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
48753095|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
48753096|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
48753097|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
48753098|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
48753099|NCT03510884|156942088|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
48753100|NCT03510884|156942089|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
48753101|NCT03510884|156942090|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
48753102|NCT03510884|156942091|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
48753103|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753104|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753105|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753106|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753107|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753108|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
48753109|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
48753110|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48651329|NCT04075513|156574902|FG001|Overall Study|Lack of Efficacy|0|||
48651330|NCT04075513|156574901|FG000|Overall Study|Lost to Follow-up|4|||
48651331|NCT04075513|156574902|FG001|Overall Study|Lost to Follow-up|2|||
48651332|NCT04075513|156574901|FG000|Overall Study|Switch to insulin pump|1|||
48651333|NCT04075513|156574902|FG001|Overall Study|Switch to insulin pump|0|||
48651334|NCT01523743|156574907|FG000|Period 1|Adverse Event|1|||
48651335|NCT01523743|156574908|FG001|Period 1|Adverse Event|0|||
48651336|NCT01523743|156574907|FG000|Period 1|Withdrawal by Subject|6|||
48651337|NCT01523743|156574908|FG001|Period 1|Withdrawal by Subject|2|||
48651338|NCT01523743|156574907|FG000|Period 1|Lost to Follow-up|1|||
48651339|NCT01523743|156574908|FG001|Period 1|Lost to Follow-up|0|||
48651340|NCT01523743|156574907|FG000|Period 1|Lack of Efficacy|1|||
48651341|NCT01523743|156574908|FG001|Period 1|Lack of Efficacy|0|||
48651342|NCT01523743|156574907|FG000|Period 1|Felt unable to empty bladder|1|||
48651343|NCT01523743|156574908|FG001|Period 1|Felt unable to empty bladder|0|||
48651344|NCT01523743|156574907|FG000|Period 2|Withdrawal by Subject|0|||
48651345|NCT01523743|156574908|FG001|Period 2|Withdrawal by Subject|2|||
48651346|NCT01523743|156574907|FG000|Period 2|Adverse Event|1|||
48651347|NCT01523743|156574908|FG001|Period 2|Adverse Event|0|||
48651348|NCT04550832|156574911|FG000|Overall Study|Adverse Event|0|||
48651349|NCT04550832|156574912|FG001|Overall Study|Adverse Event|0|||
48651350|NCT04550832|156574913|FG002|Overall Study|Adverse Event|2|||
48651351|NCT04550832|156574914|FG003|Overall Study|Adverse Event|0|||
48651352|NCT04550832|156574915|FG004|Overall Study|Adverse Event|1|||
48651353|NCT02569476|156574917|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
48651354|NCT02569476|156574917|FG000|Overall Study|Death|33|||
48651355|NCT02569476|156574917|FG000|Overall Study|Withdrawal by Subject|9|||
48651356|NCT02569476|156574917|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
48651357|NCT02569476|156574917|FG000|Overall Study|Palliative care|1|||
48332504|NCT03052517|155414703|FG001|Overall Study|Lost to Follow-up|4|||
48332505|NCT03052517|155414704|FG002|Overall Study|Lost to Follow-up|0|||
48332506|NCT03052517|155414702|FG000|Overall Study|Pregnancy|1|||
48332507|NCT03052517|155414703|FG001|Overall Study|Pregnancy|0|||
48332508|NCT03052517|155414704|FG002|Overall Study|Pregnancy|1|||
48332509|NCT03052517|155414702|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
48332510|NCT03052517|155414703|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
48651358|NCT02569476|156574917|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
48651359|NCT02569476|156574917|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
48651360|NCT05420961|156574918|FG000|Overall Study|Withdrawal by Subject|2|||
48651361|NCT05420961|156574919|FG001|Overall Study|Withdrawal by Subject|1|||
48651362|NCT05420961|156574920|FG002|Overall Study|Withdrawal by Subject|1|||
48651363|NCT05420961|156574921|FG003|Overall Study|Withdrawal by Subject|0|||
48651364|NCT05420961|156574922|FG004|Overall Study|Withdrawal by Subject|0|||
48651365|NCT05420961|156574918|FG000|Overall Study|Lost to Follow-up|0|||
48651366|NCT05420961|156574919|FG001|Overall Study|Lost to Follow-up|0|||
48651367|NCT05420961|156574920|FG002|Overall Study|Lost to Follow-up|1|||
48332511|NCT03052517|155414704|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
48651368|NCT05420961|156574921|FG003|Overall Study|Lost to Follow-up|0|||
48651369|NCT05420961|156574922|FG004|Overall Study|Lost to Follow-up|0|||
48651370|NCT05420961|156574918|FG000|Overall Study|Randomized by mistake without study treatment|0|||
48651371|NCT05420961|156574919|FG001|Overall Study|Randomized by mistake without study treatment|0|||
48651372|NCT05420961|156574920|FG002|Overall Study|Randomized by mistake without study treatment|1|||
48651373|NCT05420961|156574921|FG003|Overall Study|Randomized by mistake without study treatment|0|||
48651374|NCT05420961|156574922|FG004|Overall Study|Randomized by mistake without study treatment|1|||
48651375|NCT03931382|156574923|FG000|Overall Study|Equipment malfunction|2|||
48651376|NCT03931382|156574924|FG001|Overall Study|Equipment malfunction|0|||
48651377|NCT03931382|156574925|FG002|Overall Study|Equipment malfunction|2|||
48651378|NCT03931382|156574923|FG000|Overall Study|Withdrawal by Subject|0|||
48651379|NCT03931382|156574924|FG001|Overall Study|Withdrawal by Subject|1|||
48651380|NCT03931382|156574925|FG002|Overall Study|Withdrawal by Subject|0|||
48651381|NCT01140867|156574931|FG000|Overall Study|Adverse Event|22|||
48651382|NCT01140867|156574931|FG000|Overall Study|Lack of Efficacy|3|||
48651383|NCT01140867|156574931|FG000|Overall Study|Lost to Follow-up|2|||
48651384|NCT01140867|156574931|FG000|Overall Study|Withdrawal by Subject|1|||
48651385|NCT01140867|156574931|FG000|Overall Study|Protocol Violation|1|||
48651386|NCT01140867|156574931|FG000|Overall Study|Uncooperative patient|2|||
48651387|NCT01140867|156574931|FG000|Overall Study|Medication Noncompliance|2|||
48651388|NCT03629223|156574932|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
48651389|NCT03629223|156574933|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
48651390|NCT03629223|156574934|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
48651391|NCT03629223|156574935|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
48651392|NCT03629223|156574936|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
48651393|NCT03629223|156574937|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
48651394|NCT03629223|156574932|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
48651395|NCT03629223|156574933|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
48651396|NCT03629223|156574934|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
48651397|NCT03629223|156574935|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
48651398|NCT03629223|156574936|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
48651399|NCT03629223|156574937|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
48651400|NCT03629223|156574932|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
48651401|NCT03629223|156574933|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
48651402|NCT03629223|156574934|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
48651403|NCT03629223|156574935|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
48651404|NCT03629223|156574936|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
48651405|NCT03629223|156574937|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
48651406|NCT03629223|156574932|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
48651407|NCT03629223|156574933|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
48651408|NCT03629223|156574934|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
48651409|NCT03629223|156574935|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
48651410|NCT03629223|156574936|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
48651411|NCT03629223|156574937|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
48332512|NCT03052517|155414702|FG000|Overall Study|Technical Problems|0|||
48332513|NCT03052517|155414703|FG001|Overall Study|Technical Problems|1|||
48332514|NCT03052517|155414704|FG002|Overall Study|Technical Problems|0|||
48651412|NCT03629223|156574932|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
48651413|NCT03629223|156574933|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
48753111|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753112|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753113|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753114|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753115|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
48753116|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
48753117|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753118|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753119|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753120|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753121|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753122|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
48753123|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
48753124|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753125|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753126|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753127|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753128|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753129|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
48753130|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
48753131|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
48753132|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
48753133|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
48753134|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
48753135|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
48753136|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
48753137|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
48753138|NCT01059825|156942100|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
48753139|NCT01059825|156942101|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
48753140|NCT01059825|156942102|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
48753141|NCT01059825|156942103|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
48753142|NCT01059825|156942104|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
48753143|NCT01059825|156942105|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
48753144|NCT01059825|156942106|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
48753145|NCT01059825|156942100|FG000|Treatment Period|Lost to Follow-up|2|||
48753146|NCT01059825|156942101|FG001|Treatment Period|Lost to Follow-up|1|||
48753147|NCT01059825|156942102|FG002|Treatment Period|Lost to Follow-up|0|||
48753148|NCT01059825|156942103|FG003|Treatment Period|Lost to Follow-up|1|||
48753149|NCT01059825|156942104|FG004|Treatment Period|Lost to Follow-up|2|||
48753150|NCT01059825|156942105|FG005|Treatment Period|Lost to Follow-up|0|||
48753151|NCT01059825|156942106|FG006|Treatment Period|Lost to Follow-up|0|||
48753152|NCT01059825|156942100|FG000|Treatment Period|Withdrawal by Subject|3|||
48753153|NCT01059825|156942101|FG001|Treatment Period|Withdrawal by Subject|0|||
48753154|NCT01059825|156942102|FG002|Treatment Period|Withdrawal by Subject|1|||
48753155|NCT01059825|156942103|FG003|Treatment Period|Withdrawal by Subject|5|||
48753156|NCT01059825|156942104|FG004|Treatment Period|Withdrawal by Subject|4|||
48753157|NCT01059825|156942105|FG005|Treatment Period|Withdrawal by Subject|1|||
48753158|NCT01059825|156942106|FG006|Treatment Period|Withdrawal by Subject|0|||
48753159|NCT01059825|156942100|FG000|Treatment Period|Other reason not specified|1|||
48753160|NCT01059825|156942101|FG001|Treatment Period|Other reason not specified|2|||
48753161|NCT01059825|156942102|FG002|Treatment Period|Other reason not specified|1|||
48651414|NCT03629223|156574934|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
48651415|NCT03629223|156574935|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
48651416|NCT03629223|156574936|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
48651417|NCT03629223|156574937|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
48651418|NCT01534351|156574938|FG000|Overall Study|Study Terminated Early|1|||
48651419|NCT01534351|156574939|FG001|Overall Study|Study Terminated Early|0|||
48651420|NCT01534351|156574940|FG002|Overall Study|Study Terminated Early|0|||
48651421|NCT03490292|156574941|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
48651422|NCT03490292|156574942|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
48651423|NCT03490292|156574941|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
48651424|NCT03490292|156574942|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
48651425|NCT03490292|156574941|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
48651426|NCT03490292|156574942|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
48651427|NCT03490292|156574941|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
48651428|NCT03490292|156574942|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
48651429|NCT03490292|156574941|FG000|1 Year Follow Up Post Last Dose|Death|1|||
48651430|NCT03490292|156574942|FG001|1 Year Follow Up Post Last Dose|Death|1|||
48753162|NCT01059825|156942103|FG003|Treatment Period|Other reason not specified|2|||
48753163|NCT01059825|156942104|FG004|Treatment Period|Other reason not specified|0|||
48753164|NCT01059825|156942105|FG005|Treatment Period|Other reason not specified|0|||
48753165|NCT01059825|156942106|FG006|Treatment Period|Other reason not specified|0|||
48753166|NCT01059825|156942100|FG000|Treatment Period|Protocol Violation|0|||
48753167|NCT01059825|156942101|FG001|Treatment Period|Protocol Violation|0|||
48753168|NCT01059825|156942102|FG002|Treatment Period|Protocol Violation|1|||
48753169|NCT01059825|156942103|FG003|Treatment Period|Protocol Violation|1|||
48753170|NCT01059825|156942104|FG004|Treatment Period|Protocol Violation|1|||
48753171|NCT01059825|156942105|FG005|Treatment Period|Protocol Violation|1|||
48753172|NCT01059825|156942106|FG006|Treatment Period|Protocol Violation|0|||
48753173|NCT01059825|156942100|FG000|Treatment Period|Adverse event related to study drug|1|||
48753174|NCT01059825|156942101|FG001|Treatment Period|Adverse event related to study drug|0|||
48332515|NCT00813709|155414714|FG000|Double Blind Period|Adverse Event|4|||
48332516|NCT00813709|155414715|FG001|Double Blind Period|Adverse Event|1|||
48332517|NCT00813709|155414716|FG002|Double Blind Period|Adverse Event|4|||
48332518|NCT00813709|155414717|FG003|Double Blind Period|Adverse Event|0|||
48332519|NCT00813709|155414718|FG004|Double Blind Period|Adverse Event|0|||
48332520|NCT00813709|155414719|FG005|Double Blind Period|Adverse Event|0|||
48332521|NCT00813709|155414714|FG000|Double Blind Period|Lost to Follow-up|3|||
48332522|NCT00813709|155414715|FG001|Double Blind Period|Lost to Follow-up|2|||
48332523|NCT00813709|155414716|FG002|Double Blind Period|Lost to Follow-up|2|||
48332524|NCT00813709|155414717|FG003|Double Blind Period|Lost to Follow-up|0|||
48332525|NCT00813709|155414718|FG004|Double Blind Period|Lost to Follow-up|0|||
48332526|NCT00813709|155414719|FG005|Double Blind Period|Lost to Follow-up|0|||
48332527|NCT00813709|155414714|FG000|Double Blind Period|Switched to open label phase|9|||
48332528|NCT00813709|155414715|FG001|Double Blind Period|Switched to open label phase|26|||
48332529|NCT00813709|155414716|FG002|Double Blind Period|Switched to open label phase|18|||
48332530|NCT00813709|155414717|FG003|Double Blind Period|Switched to open label phase|0|||
48332531|NCT00813709|155414718|FG004|Double Blind Period|Switched to open label phase|0|||
48651431|NCT03928418|156574943|FG000|Overall Study|Lost to Follow-up|5|||
48651432|NCT03928418|156574944|FG001|Overall Study|Lost to Follow-up|3|||
48651433|NCT03928418|156574945|FG002|Overall Study|Lost to Follow-up|5|||
48651434|NCT03928418|156574943|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
48651435|NCT03928418|156574944|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
48651436|NCT03928418|156574945|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
48651437|NCT04599803|156574946|FG000|Overall Study|Withdrawal by Subject|5|||
48651438|NCT04599803|156574946|FG000|Overall Study|Lost to Follow-up|26|||
48651439|NCT00395486|156574951|FG000|Overall Study|Adverse Event|1|||
48651440|NCT00395486|156574952|FG001|Overall Study|Adverse Event|2|||
48651441|NCT00395486|156574951|FG000|Overall Study|Withdrawal by Subject|5|||
48651442|NCT00395486|156574952|FG001|Overall Study|Withdrawal by Subject|2|||
48651443|NCT00395486|156574951|FG000|Overall Study|Lost to Follow-up|0|||
48651444|NCT00395486|156574952|FG001|Overall Study|Lost to Follow-up|1|||
48651445|NCT04731298|156574956|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
48651446|NCT04731298|156574957|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
48651447|NCT02455336|156574958|FG000|Overall Study|Withdrawal by Subject|0|||
48651448|NCT02455336|156574959|FG001|Overall Study|Withdrawal by Subject|2|||
48651449|NCT02455336|156574958|FG000|Overall Study|Adverse Event|3|||
48651450|NCT02455336|156574959|FG001|Overall Study|Adverse Event|0|||
48651451|NCT02455336|156574958|FG000|Overall Study|Non-responder to treatment|2|||
48651452|NCT02455336|156574959|FG001|Overall Study|Non-responder to treatment|0|||
48651453|NCT03594747|156574968|FG000|Overall Study|Death|78|||
48651454|NCT03594747|156574969|FG001|Overall Study|Death|86|||
48651455|NCT03594747|156574970|FG002|Overall Study|Death|87|||
48651456|NCT03594747|156574968|FG000|Overall Study|Withdrawal by Subject|5|||
48651457|NCT03594747|156574969|FG001|Overall Study|Withdrawal by Subject|2|||
48651458|NCT03594747|156574970|FG002|Overall Study|Withdrawal by Subject|11|||
48651459|NCT03594747|156574968|FG000|Overall Study|Lost to Follow-up|4|||
48651460|NCT03594747|156574969|FG001|Overall Study|Lost to Follow-up|1|||
48651461|NCT03594747|156574970|FG002|Overall Study|Lost to Follow-up|1|||
48651462|NCT03594747|156574968|FG000|Overall Study|Physician Decision|0|||
48651463|NCT03594747|156574969|FG001|Overall Study|Physician Decision|1|||
48651464|NCT03594747|156574970|FG002|Overall Study|Physician Decision|0|||
48651465|NCT03594747|156574968|FG000|Overall Study|Sponsor decision|23|||
48651466|NCT03594747|156574969|FG001|Overall Study|Sponsor decision|17|||
48651467|NCT03594747|156574970|FG002|Overall Study|Sponsor decision|16|||
48651468|NCT03594747|156574968|FG000|Overall Study|Did not meet inclusion criteria|0|||
48651469|NCT03594747|156574969|FG001|Overall Study|Did not meet inclusion criteria|0|||
48651470|NCT03594747|156574970|FG002|Overall Study|Did not meet inclusion criteria|1|||
48651471|NCT03594747|156574968|FG000|Overall Study|Transfer to long term extension study|10|||
48651472|NCT03594747|156574969|FG001|Overall Study|Transfer to long term extension study|12|||
48651473|NCT03594747|156574970|FG002|Overall Study|Transfer to long term extension study|5|||
48753175|NCT01059825|156942102|FG002|Treatment Period|Adverse event related to study drug|1|||
48753176|NCT01059825|156942103|FG003|Treatment Period|Adverse event related to study drug|1|||
48753177|NCT01059825|156942104|FG004|Treatment Period|Adverse event related to study drug|0|||
48753178|NCT01059825|156942105|FG005|Treatment Period|Adverse event related to study drug|0|||
48753179|NCT01059825|156942106|FG006|Treatment Period|Adverse event related to study drug|0|||
48753180|NCT01059825|156942100|FG000|Treatment Period|Insufficient clinical response|3|||
48753181|NCT01059825|156942101|FG001|Treatment Period|Insufficient clinical response|0|||
48753182|NCT01059825|156942102|FG002|Treatment Period|Insufficient clinical response|0|||
48753183|NCT01059825|156942103|FG003|Treatment Period|Insufficient clinical response|0|||
48753184|NCT01059825|156942104|FG004|Treatment Period|Insufficient clinical response|0|||
48753185|NCT01059825|156942105|FG005|Treatment Period|Insufficient clinical response|0|||
48753186|NCT01059825|156942106|FG006|Treatment Period|Insufficient clinical response|0|||
48753187|NCT01059825|156942100|FG000|Treatment Period|Adverse event not related to study drug|0|||
48753188|NCT01059825|156942101|FG001|Treatment Period|Adverse event not related to study drug|1|||
48753189|NCT01059825|156942102|FG002|Treatment Period|Adverse event not related to study drug|2|||
48753190|NCT01059825|156942103|FG003|Treatment Period|Adverse event not related to study drug|1|||
48753191|NCT01059825|156942104|FG004|Treatment Period|Adverse event not related to study drug|1|||
48332532|NCT00813709|155414719|FG005|Double Blind Period|Switched to open label phase|0|||
48332533|NCT00813709|155414714|FG000|Double Blind Period|Randomized but not treated|1|||
48332534|NCT00813709|155414715|FG001|Double Blind Period|Randomized but not treated|3|||
48332535|NCT00813709|155414716|FG002|Double Blind Period|Randomized but not treated|1|||
48332536|NCT00813709|155414717|FG003|Double Blind Period|Randomized but not treated|0|||
48332537|NCT00813709|155414718|FG004|Double Blind Period|Randomized but not treated|0|||
48332538|NCT00813709|155414719|FG005|Double Blind Period|Randomized but not treated|0|||
48332539|NCT00813709|155414714|FG000|Double Blind Period|Other|14|||
48332540|NCT00813709|155414715|FG001|Double Blind Period|Other|9|||
48332541|NCT00813709|155414716|FG002|Double Blind Period|Other|6|||
48332542|NCT00813709|155414717|FG003|Double Blind Period|Other|0|||
48332543|NCT00813709|155414718|FG004|Double Blind Period|Other|0|||
48332544|NCT00813709|155414719|FG005|Double Blind Period|Other|0|||
48332545|NCT00813709|155414714|FG000|Open Label Period|Adverse Event|0|||
48332546|NCT00813709|155414715|FG001|Open Label Period|Adverse Event|0|||
48332547|NCT00813709|155414716|FG002|Open Label Period|Adverse Event|0|||
48332548|NCT00813709|155414717|FG003|Open Label Period|Adverse Event|5|||
48332549|NCT00813709|155414718|FG004|Open Label Period|Adverse Event|4|||
48753192|NCT01059825|156942105|FG005|Treatment Period|Adverse event not related to study drug|1|||
48753193|NCT01059825|156942106|FG006|Treatment Period|Adverse event not related to study drug|0|||
48332550|NCT00813709|155414719|FG005|Open Label Period|Adverse Event|3|||
48332551|NCT00813709|155414714|FG000|Open Label Period|Lack of Efficacy|0|||
48332552|NCT00813709|155414715|FG001|Open Label Period|Lack of Efficacy|0|||
48332553|NCT00813709|155414716|FG002|Open Label Period|Lack of Efficacy|0|||
48332554|NCT00813709|155414717|FG003|Open Label Period|Lack of Efficacy|3|||
48332555|NCT00813709|155414718|FG004|Open Label Period|Lack of Efficacy|1|||
48332556|NCT00813709|155414719|FG005|Open Label Period|Lack of Efficacy|1|||
48332557|NCT00813709|155414714|FG000|Open Label Period|Randomized but not treated|0|||
48332558|NCT00813709|155414715|FG001|Open Label Period|Randomized but not treated|0|||
48332559|NCT00813709|155414716|FG002|Open Label Period|Randomized but not treated|0|||
48651474|NCT00005947|156574971|FG000|Overall Study|Death|54|||
48651475|NCT00005947|156574972|FG001|Overall Study|Death|40|||
48651476|NCT00005947|156574971|FG000|Overall Study|Patient Refused to Continue|2|||
48651477|NCT00005947|156574972|FG001|Overall Study|Patient Refused to Continue|1|||
48651478|NCT00005947|156574971|FG000|Overall Study|Site Closure|1|||
48651479|NCT00005947|156574972|FG001|Overall Study|Site Closure|0|||
48651480|NCT02265536|156574973|FG000|Overall Study|Adverse Event|1|||
48651481|NCT02265536|156574974|FG001|Overall Study|Adverse Event|0|||
48651482|NCT02265536|156574975|FG002|Overall Study|Adverse Event|0|||
48651483|NCT02265536|156574976|FG003|Overall Study|Adverse Event|0|||
48651484|NCT02265536|156574977|FG004|Overall Study|Adverse Event|1|||
48651485|NCT02265536|156574978|FG005|Overall Study|Adverse Event|0|||
48651486|NCT02265536|156574973|FG000|Overall Study|Physician Decision|0|||
48651487|NCT02265536|156574974|FG001|Overall Study|Physician Decision|0|||
48651488|NCT02265536|156574975|FG002|Overall Study|Physician Decision|0|||
48651489|NCT02265536|156574976|FG003|Overall Study|Physician Decision|0|||
48651490|NCT02265536|156574977|FG004|Overall Study|Physician Decision|2|||
48651491|NCT02265536|156574978|FG005|Overall Study|Physician Decision|0|||
48651492|NCT02265536|156574973|FG000|Overall Study|Withdrawal by Subject|0|||
48651493|NCT02265536|156574974|FG001|Overall Study|Withdrawal by Subject|3|||
48332560|NCT00813709|155414717|FG003|Open Label Period|Randomized but not treated|1|||
48651494|NCT02265536|156574975|FG002|Overall Study|Withdrawal by Subject|0|||
48651495|NCT02265536|156574976|FG003|Overall Study|Withdrawal by Subject|0|||
48651496|NCT02265536|156574977|FG004|Overall Study|Withdrawal by Subject|0|||
48651497|NCT02265536|156574978|FG005|Overall Study|Withdrawal by Subject|0|||
48332561|NCT00813709|155414718|FG004|Open Label Period|Randomized but not treated|0|||
48332562|NCT00813709|155414719|FG005|Open Label Period|Randomized but not treated|1|||
48332563|NCT00813709|155414714|FG000|Open Label Period|Other|0|||
48332564|NCT00813709|155414715|FG001|Open Label Period|Other|0|||
48332565|NCT00813709|155414716|FG002|Open Label Period|Other|0|||
48332566|NCT00813709|155414717|FG003|Open Label Period|Other|11|||
48332567|NCT00813709|155414718|FG004|Open Label Period|Other|5|||
48332568|NCT00813709|155414719|FG005|Open Label Period|Other|6|||
48332569|NCT00624377|155414720|FG000|Overall Study|Lost to Follow-up|355|||
48651498|NCT00349349|156574979|FG000|Overall Study|Adverse Event|5|||
48332570|NCT00624377|155414720|FG000|Overall Study|Withdrawal by Subject|100|||
48332571|NCT00624377|155414720|FG000|Overall Study|Adverse Event|14|||
48332572|NCT00624377|155414720|FG000|Overall Study|Other|91|||
48332573|NCT00624377|155414720|FG000|Overall Study|Non-evaluable population|84|||
48332574|NCT00088166|155414730|FG000|Overall Study|Adverse Event|11|||
48332575|NCT00088166|155414731|FG001|Overall Study|Adverse Event|9|||
48332576|NCT00088166|155414730|FG000|Overall Study|Death|3|||
48332577|NCT00088166|155414731|FG001|Overall Study|Death|1|||
48651499|NCT00349349|156574980|FG001|Overall Study|Adverse Event|6|||
48651500|NCT00349349|156574981|FG002|Overall Study|Adverse Event|2|||
48332578|NCT00088166|155414730|FG000|Overall Study|Lost to Follow-up|0|||
48332579|NCT00088166|155414731|FG001|Overall Study|Lost to Follow-up|1|||
48332580|NCT00088166|155414730|FG000|Overall Study|Physician Decision|4|||
48332581|NCT00088166|155414731|FG001|Overall Study|Physician Decision|1|||
48332582|NCT00088166|155414730|FG000|Overall Study|Protocol Violation|1|||
48332583|NCT00088166|155414731|FG001|Overall Study|Protocol Violation|5|||
48332584|NCT00088166|155414730|FG000|Overall Study|Patient deterioration|29|||
48332585|NCT00088166|155414731|FG001|Overall Study|Patient deterioration|39|||
48332586|NCT00088166|155414730|FG000|Overall Study|Withdrawal by Subject|5|||
48332587|NCT00088166|155414731|FG001|Overall Study|Withdrawal by Subject|5|||
48332588|NCT01976507|155414732|FG000|Overall Study|Adverse Event|6|||
48332589|NCT01976507|155414732|FG000|Overall Study|ablation not done, drug not given|1|||
48332590|NCT01722097|155414739|FG000|Overall Study|Patient sheets not returned|6|||
48332591|NCT01722097|155414740|FG001|Overall Study|Patient sheets not returned|5|||
48332592|NCT01757288|155414744|FG000|Overall Study|Consent withdrawal|0|||
48332593|NCT01757288|155414745|FG001|Overall Study|Consent withdrawal|4|||
48332594|NCT01757288|155414746|FG002|Overall Study|Consent withdrawal|4|||
48332595|NCT01757288|155414744|FG000|Overall Study|Patient off study, IRB hold.|0|||
48651501|NCT00349349|156574979|FG000|Overall Study|Withdrawal by Subject|5|||
48651502|NCT00349349|156574980|FG001|Overall Study|Withdrawal by Subject|2|||
48651503|NCT00349349|156574981|FG002|Overall Study|Withdrawal by Subject|1|||
48332596|NCT01757288|155414745|FG001|Overall Study|Patient off study, IRB hold.|0|||
48332597|NCT01757288|155414746|FG002|Overall Study|Patient off study, IRB hold.|1|||
48332598|NCT01757288|155414744|FG000|Overall Study|Patient death prior to starting treatment|0|||
48332599|NCT01757288|155414745|FG001|Overall Study|Patient death prior to starting treatment|0|||
48332600|NCT01757288|155414746|FG002|Overall Study|Patient death prior to starting treatment|1|||
48332601|NCT01757288|155414744|FG000|Overall Study|Wrong medication administered|0|||
48332602|NCT01757288|155414745|FG001|Overall Study|Wrong medication administered|1|||
48332603|NCT01757288|155414746|FG002|Overall Study|Wrong medication administered|0|||
48651504|NCT00349349|156574979|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
48651505|NCT00349349|156574980|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
48651506|NCT00349349|156574981|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
48651507|NCT00349349|156574979|FG000|Overall Study|Death|13|||
48651508|NCT00349349|156574980|FG001|Overall Study|Death|10|||
48651509|NCT00349349|156574981|FG002|Overall Study|Death|1|||
48651510|NCT00349349|156574979|FG000|Overall Study|Other Treatment Selected|2|||
48651511|NCT00349349|156574980|FG001|Overall Study|Other Treatment Selected|0|||
48651512|NCT00349349|156574981|FG002|Overall Study|Other Treatment Selected|0|||
48651513|NCT00349349|156574979|FG000|Overall Study|Participant Reduced General Condition|0|||
48651514|NCT00349349|156574980|FG001|Overall Study|Participant Reduced General Condition|1|||
48651515|NCT00349349|156574981|FG002|Overall Study|Participant Reduced General Condition|0|||
48651516|NCT00349349|156574979|FG000|Overall Study|Physician Decision|1|||
48651517|NCT00349349|156574980|FG001|Overall Study|Physician Decision|2|||
48651518|NCT00349349|156574981|FG002|Overall Study|Physician Decision|1|||
48651519|NCT00349349|156574979|FG000|Overall Study|No Response|0|||
48651520|NCT00349349|156574980|FG001|Overall Study|No Response|3|||
48651521|NCT00349349|156574981|FG002|Overall Study|No Response|0|||
48651522|NCT00349349|156574979|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
48651523|NCT00349349|156574980|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
48651524|NCT00349349|156574981|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
48651525|NCT03028415|156574982|FG000|Overall Study|Lost to Follow-up|6|||
48651526|NCT03028415|156574983|FG001|Overall Study|Lost to Follow-up|3|||
48332604|NCT01757288|155414744|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
48332605|NCT01757288|155414745|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
48332606|NCT01757288|155414746|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
48332607|NCT01757288|155414744|FG000|Overall Study|Not meeting protocol constraints|0|||
48332608|NCT01757288|155414745|FG001|Overall Study|Not meeting protocol constraints|1|||
48332609|NCT01757288|155414746|FG002|Overall Study|Not meeting protocol constraints|1|||
48332610|NCT01757288|155414744|FG000|Overall Study|Multiple missed appointments|0|||
48332611|NCT01757288|155414745|FG001|Overall Study|Multiple missed appointments|1|||
48332612|NCT01757288|155414746|FG002|Overall Study|Multiple missed appointments|0|||
48332613|NCT01757288|155414744|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
48332614|NCT01757288|155414745|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
48332615|NCT01757288|155414746|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
48332616|NCT01757288|155414744|FG000|Overall Study|>2 weeks treatment break|0|||
48332617|NCT01757288|155414745|FG001|Overall Study|>2 weeks treatment break|0|||
48332618|NCT01757288|155414746|FG002|Overall Study|>2 weeks treatment break|1|||
48332619|NCT02825550|155414747|FG000|Overall Study|Physician Decision|1|||
48332620|NCT04617847|155414748|FG000|Overall Study|Withdrawal by Subject|1|||
48332621|NCT04617847|155414749|FG001|Overall Study|Withdrawal by Subject|0|||
48332622|NCT04617847|155414748|FG000|Overall Study|Adverse Event|0|||
48332623|NCT04617847|155414749|FG001|Overall Study|Adverse Event|2|||
48332624|NCT04617847|155414748|FG000|Overall Study|Death|0|||
48332625|NCT04617847|155414749|FG001|Overall Study|Death|1|||
48332626|NCT04617847|155414748|FG000|Overall Study|Termination of Study by Sponsor|2|||
48332627|NCT04617847|155414749|FG001|Overall Study|Termination of Study by Sponsor|21|||
48332628|NCT00952523|155414750|FG000|Overall Study|Withdrawal by Subject|7|||
48332629|NCT00346398|155414753|FG000|Overall Study|Lost to Follow-up|3|||
48332630|NCT00346398|155414754|FG001|Overall Study|Lost to Follow-up|0|||
48332631|NCT00346398|155414753|FG000|Overall Study|Withdrawal by Subject|0|||
48332632|NCT00346398|155414754|FG001|Overall Study|Withdrawal by Subject|2|||
48332633|NCT02607956|155414757|FG000|Double-Blinded Phase|Withdrew Consent|17|||
48332634|NCT02607956|155414758|FG001|Double-Blinded Phase|Withdrew Consent|19|||
48332635|NCT02607956|155414759|FG002|Double-Blinded Phase|Withdrew Consent|0|||
48332636|NCT02607956|155414760|FG003|Double-Blinded Phase|Withdrew Consent|0|||
48332637|NCT02607956|155414757|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
48332638|NCT02607956|155414758|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
48332639|NCT02607956|155414759|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
48332640|NCT02607956|155414760|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
48332641|NCT02607956|155414757|FG000|Double-Blinded Phase|Randomized but never treated|7|||
48332642|NCT02607956|155414758|FG001|Double-Blinded Phase|Randomized but never treated|5|||
48332643|NCT02607956|155414759|FG002|Double-Blinded Phase|Randomized but never treated|0|||
48332644|NCT02607956|155414760|FG003|Double-Blinded Phase|Randomized but never treated|0|||
48332645|NCT02607956|155414757|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
48332646|NCT02607956|155414758|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
48332647|NCT02607956|155414759|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
48332648|NCT02607956|155414760|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
48332649|NCT02607956|155414757|FG000|Double-Blinded Phase|Death|4|||
48332650|NCT02607956|155414758|FG001|Double-Blinded Phase|Death|4|||
48332651|NCT02607956|155414759|FG002|Double-Blinded Phase|Death|0|||
48332652|NCT02607956|155414760|FG003|Double-Blinded Phase|Death|0|||
48332653|NCT02607956|155414757|FG000|Double-Blinded Phase|Adverse Event|4|||
48332654|NCT02607956|155414758|FG001|Double-Blinded Phase|Adverse Event|3|||
48332655|NCT02607956|155414759|FG002|Double-Blinded Phase|Adverse Event|0|||
48332656|NCT02607956|155414760|FG003|Double-Blinded Phase|Adverse Event|0|||
48332657|NCT02607956|155414757|FG000|Double-Blinded Phase|Protocol Violation|3|||
48332658|NCT02607956|155414758|FG001|Double-Blinded Phase|Protocol Violation|1|||
48332659|NCT02607956|155414759|FG002|Double-Blinded Phase|Protocol Violation|0|||
48332660|NCT02607956|155414760|FG003|Double-Blinded Phase|Protocol Violation|0|||
48332661|NCT02607956|155414757|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
48332662|NCT02607956|155414758|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
48332663|NCT02607956|155414759|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
48332664|NCT02607956|155414760|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
48332665|NCT02607956|155414757|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
48332666|NCT02607956|155414758|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
48651527|NCT03028415|156574982|FG000|Overall Study|Withdrawal by Subject|1|||
48651528|NCT03028415|156574983|FG001|Overall Study|Withdrawal by Subject|0|||
48332667|NCT02607956|155414759|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
48332668|NCT02607956|155414760|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
48332669|NCT02607956|155414757|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
48332670|NCT02607956|155414758|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
48332671|NCT02607956|155414759|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
48332672|NCT02607956|155414760|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
48332673|NCT02607956|155414757|FG000|Open-Label Extension Phase|Death|0|||
48332674|NCT02607956|155414758|FG001|Open-Label Extension Phase|Death|0|||
48332675|NCT02607956|155414759|FG002|Open-Label Extension Phase|Death|1|||
48332676|NCT02607956|155414760|FG003|Open-Label Extension Phase|Death|3|||
48332677|NCT02607956|155414757|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
48332678|NCT02607956|155414758|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
48332679|NCT02607956|155414759|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
48332680|NCT02607956|155414760|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
48332681|NCT02607956|155414757|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
48651529|NCT03028415|156574982|FG000|Overall Study|Discontinued due to COVID-19|1|||
48651530|NCT03028415|156574983|FG001|Overall Study|Discontinued due to COVID-19|0|||
48651531|NCT02907216|156574984|FG000|Overall Study|No benefit to be obtained by continuing|0|||
48651532|NCT02907216|156574985|FG001|Overall Study|No benefit to be obtained by continuing|1|||
48651533|NCT02907216|156574984|FG000|Overall Study|Withdrawal by Subject|1|||
48651534|NCT02907216|156574985|FG001|Overall Study|Withdrawal by Subject|0|||
48651535|NCT03734016|156574988|FG000|Overall Study|Participants Remaining in the Study|260|||
48651536|NCT03734016|156574989|FG001|Overall Study|Participants Remaining in the Study|240|||
48651537|NCT03734016|156574988|FG000|Overall Study|Death|48|||
48651538|NCT03734016|156574989|FG001|Overall Study|Death|60|||
48651539|NCT03734016|156574988|FG000|Overall Study|Withdrawal by Subject|14|||
48651540|NCT03734016|156574989|FG001|Overall Study|Withdrawal by Subject|16|||
48651541|NCT03734016|156574988|FG000|Overall Study|Physician Decision|0|||
48651542|NCT03734016|156574989|FG001|Overall Study|Physician Decision|7|||
48651543|NCT03734016|156574988|FG000|Overall Study|Lost to Follow-up|3|||
48651544|NCT03734016|156574989|FG001|Overall Study|Lost to Follow-up|1|||
48651545|NCT03734016|156574988|FG000|Overall Study|Adverse Event|2|||
48651546|NCT03734016|156574989|FG001|Overall Study|Adverse Event|1|||
48651547|NCT04601532|156574990|FG000|Overall Study|Lost to Follow-up|1|||
48651548|NCT04601532|156574991|FG001|Overall Study|Lost to Follow-up|2|||
48651549|NCT04601532|156574990|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
48651550|NCT04601532|156574991|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
48651551|NCT02485639|156574992|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
48651552|NCT02485639|156574992|FG000|Overall Study|Early termination|4|||
48651553|NCT02485639|156574992|FG000|Overall Study|Withdrawal by Subject|4|||
48651554|NCT03941964|156574993|FG000|Overall Study|Adverse Event|1|||
48651555|NCT03941964|156574994|FG001|Overall Study|Adverse Event|8|||
48651556|NCT03941964|156574993|FG000|Overall Study|Progressive disease|7|||
48651557|NCT03941964|156574994|FG001|Overall Study|Progressive disease|3|||
48651558|NCT03941964|156574993|FG000|Overall Study|Lack of Efficacy|0|||
48651559|NCT03941964|156574994|FG001|Overall Study|Lack of Efficacy|1|||
48651560|NCT03941964|156574993|FG000|Overall Study|Death|3|||
48651561|NCT03941964|156574994|FG001|Overall Study|Death|1|||
48651562|NCT03941964|156574993|FG000|Overall Study|Withdrew consent|1|||
48651563|NCT03941964|156574994|FG001|Overall Study|Withdrew consent|3|||
48651564|NCT03941964|156574993|FG000|Overall Study|Physician Decision|9|||
48651565|NCT03941964|156574994|FG001|Overall Study|Physician Decision|2|||
48651566|NCT03941964|156574993|FG000|Overall Study|Other, not specified|2|||
48651567|NCT03941964|156574994|FG001|Overall Study|Other, not specified|1|||
48651568|NCT01659996|156574997|FG000|Overall Study|Protocol Violation|3|||
48651569|NCT01659996|156574998|FG001|Overall Study|Protocol Violation|3|||
48651570|NCT01659996|156574999|FG002|Overall Study|Protocol Violation|3|||
48651571|NCT01659996|156574997|FG000|Overall Study|Lost to Follow-up|1|||
48651572|NCT01659996|156574998|FG001|Overall Study|Lost to Follow-up|3|||
48651573|NCT01659996|156574999|FG002|Overall Study|Lost to Follow-up|2|||
48651574|NCT01659996|156574997|FG000|Overall Study|Adverse Event|0|||
48651575|NCT01659996|156574998|FG001|Overall Study|Adverse Event|0|||
48651576|NCT01659996|156574999|FG002|Overall Study|Adverse Event|1|||
48651577|NCT01659996|156574997|FG000|Overall Study|Withdrawal by Subject|4|||
48651578|NCT01659996|156574998|FG001|Overall Study|Withdrawal by Subject|1|||
48651579|NCT01659996|156574999|FG002|Overall Study|Withdrawal by Subject|5|||
48651580|NCT03206918|156575000|FG000|Overall Study|Death|11|||
48651581|NCT03206918|156575000|FG000|Overall Study|Withdrawal by Subject|5|||
48651582|NCT03206918|156575000|FG000|Overall Study|Study terminated by sponsor|12|||
48651583|NCT03206918|156575000|FG000|Overall Study|Lost to Follow-up|3|||
48651584|NCT03206918|156575000|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
48651585|NCT01566149|156576041|FG000|Overall Study|Adverse Event|0|||
48651586|NCT01566149|156576042|FG001|Overall Study|Adverse Event|1|||
48332682|NCT02607956|155414758|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
48332683|NCT02607956|155414759|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
48332684|NCT02607956|155414760|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
48332685|NCT02607956|155414757|FG000|Open-Label Extension Phase|Protocol Violation|0|||
48332686|NCT02607956|155414758|FG001|Open-Label Extension Phase|Protocol Violation|0|||
48332687|NCT02607956|155414759|FG002|Open-Label Extension Phase|Protocol Violation|0|||
48332688|NCT02607956|155414760|FG003|Open-Label Extension Phase|Protocol Violation|2|||
48651587|NCT01566149|156576041|FG000|Overall Study|Non-compliance with study medication|2|||
48651588|NCT01566149|156576042|FG001|Overall Study|Non-compliance with study medication|0|||
48651589|NCT01566149|156576041|FG000|Overall Study|Protocol Violation|0|||
48651590|NCT01566149|156576042|FG001|Overall Study|Protocol Violation|1|||
48651591|NCT01566149|156576041|FG000|Overall Study|Withdrawal by Subject|1|||
48651592|NCT01566149|156576042|FG001|Overall Study|Withdrawal by Subject|0|||
48651593|NCT02222688|156576045|FG000|Overall Study|Withdrawal by Subject|0|||
48651594|NCT02222688|156576046|FG001|Overall Study|Withdrawal by Subject|0|||
48651595|NCT02222688|156576047|FG002|Overall Study|Withdrawal by Subject|0|||
48651596|NCT02222688|156576048|FG003|Overall Study|Withdrawal by Subject|2|||
48651597|NCT02222688|156576049|FG004|Overall Study|Withdrawal by Subject|1|||
48651598|NCT02222688|156576050|FG005|Overall Study|Withdrawal by Subject|0|||
48651599|NCT02222688|156576051|FG006|Overall Study|Withdrawal by Subject|1|||
48651600|NCT02222688|156576045|FG000|Overall Study|Disease progression|1|||
48651601|NCT02222688|156576046|FG001|Overall Study|Disease progression|0|||
48651602|NCT02222688|156576047|FG002|Overall Study|Disease progression|0|||
48651603|NCT02222688|156576048|FG003|Overall Study|Disease progression|0|||
48651604|NCT02222688|156576049|FG004|Overall Study|Disease progression|0|||
48651605|NCT02222688|156576050|FG005|Overall Study|Disease progression|0|||
48651606|NCT02222688|156576051|FG006|Overall Study|Disease progression|0|||
48651607|NCT03145064|156576054|FG000|Overall Study|Death|24|||
48651608|NCT03145064|156576054|FG000|Overall Study|Lost to Follow-up|3|||
48651609|NCT03145064|156576054|FG000|Overall Study|Withdrawal by Subject|6|||
48651610|NCT03145064|156576054|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
48651611|NCT03145064|156576054|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
48651612|NCT02543281|156576055|FG000|Overall Study|Lost to Follow-up|0|||
48651613|NCT02543281|156576056|FG001|Overall Study|Lost to Follow-up|0|||
48651614|NCT02543281|156576057|FG002|Overall Study|Lost to Follow-up|1|||
48651615|NCT01961297|156576058|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
48651616|NCT01961297|156576059|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
48651617|NCT02923830|156576060|FG000|Overall Study|Physician Decision|13|||
48651618|NCT02923830|156576061|FG001|Overall Study|Physician Decision|15|||
48651619|NCT00623233|156576062|FG000|Overall Study|Adverse Event|10|||
48651620|NCT00623233|156576062|FG000|Overall Study|Physician Decision|10|||
48753194|NCT00429273|156942107|FG000|Overall Study|Lost to Follow-up|1|||
48753195|NCT00429273|156942108|FG001|Overall Study|Lost to Follow-up|2|||
48753196|NCT00429273|156942109|FG002|Overall Study|Lost to Follow-up|2|||
48753197|NCT00429273|156942107|FG000|Overall Study|Physician Decision|6|||
48753198|NCT00429273|156942108|FG001|Overall Study|Physician Decision|5|||
48753199|NCT00429273|156942109|FG002|Overall Study|Physician Decision|5|||
48753200|NCT00429273|156942107|FG000|Overall Study|Adverse Event|1|||
48753201|NCT00429273|156942108|FG001|Overall Study|Adverse Event|1|||
48753202|NCT00429273|156942109|FG002|Overall Study|Adverse Event|2|||
48753203|NCT02259582|156942114|FG000|Overall Study|Physician Decision|0|||
48753204|NCT02259582|156942115|FG001|Overall Study|Physician Decision|1|||
48753205|NCT02259582|156942116|FG002|Overall Study|Physician Decision|0|||
48753206|NCT02259582|156942114|FG000|Overall Study|Death|0|||
48753207|NCT02259582|156942115|FG001|Overall Study|Death|0|||
48753208|NCT02259582|156942116|FG002|Overall Study|Death|1|||
48753209|NCT02259582|156942114|FG000|Overall Study|Adverse Event|1|||
48753210|NCT02259582|156942115|FG001|Overall Study|Adverse Event|0|||
48753211|NCT02259582|156942116|FG002|Overall Study|Adverse Event|1|||
48753212|NCT02259582|156942114|FG000|Overall Study|Withdrawal by Subject|0|||
48753213|NCT02259582|156942115|FG001|Overall Study|Withdrawal by Subject|0|||
48753214|NCT02259582|156942116|FG002|Overall Study|Withdrawal by Subject|1|||
48753215|NCT02259582|156942114|FG000|Overall Study|Disease progression|14|||
48753216|NCT02259582|156942115|FG001|Overall Study|Disease progression|15|||
48753217|NCT02259582|156942116|FG002|Overall Study|Disease progression|17|||
48753218|NCT02259582|156942114|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
48753219|NCT02259582|156942115|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
48753220|NCT02259582|156942116|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
48753221|NCT03585504|156942122|FG000|Overall Study|Lost to Follow-up|26|||
48753222|NCT03585504|156942123|FG001|Overall Study|Lost to Follow-up|29|||
48753223|NCT00617123|156942133|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
48753224|NCT00617123|156942134|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
48753225|NCT00617123|156942133|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
48753226|NCT00617123|156942134|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
48753227|NCT00617123|156942133|FG000|Referral Screening Period|Adverse Event|0|||
48753228|NCT00617123|156942134|FG001|Referral Screening Period|Adverse Event|1|||
48753229|NCT00617123|156942133|FG000|Study Treatment Period|Withdrawal by Subject|8|||
48753230|NCT00617123|156942134|FG001|Study Treatment Period|Withdrawal by Subject|12|||
48753231|NCT00617123|156942133|FG000|Study Treatment Period|Adverse Event|7|||
48651621|NCT00623233|156576062|FG000|Overall Study|Lost to Follow-up|1|||
48651622|NCT00623233|156576062|FG000|Overall Study|Withdrawal by Subject|3|||
48651623|NCT04908384|156576065|FG000|Overall Study|Lost to Follow-up|4|||
48651624|NCT04908384|156576066|FG001|Overall Study|Lost to Follow-up|4|||
48651625|NCT04908384|156576067|FG002|Overall Study|Lost to Follow-up|0|||
48753232|NCT00617123|156942134|FG001|Study Treatment Period|Adverse Event|3|||
48753233|NCT00617123|156942133|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
48753234|NCT00617123|156942134|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
48753235|NCT00617123|156942133|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
48753236|NCT00617123|156942134|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
48651626|NCT04908384|156576068|FG003|Overall Study|Lost to Follow-up|0|||
48651627|NCT00249808|156576069|FG000|Overall Study|Other|27|||
48753237|NCT02289898|156942135|FG000|Overall Study|Death|5|||
48651628|NCT00249808|156576069|FG000|Overall Study|Protocol Violation|3|||
48651629|NCT00249808|156576069|FG000|Overall Study|Lost to Follow-up|8|||
48332689|NCT02607956|155414757|FG000|Open-Label Extension Phase|Pregnancy|0|||
48332690|NCT02607956|155414758|FG001|Open-Label Extension Phase|Pregnancy|0|||
48332691|NCT02607956|155414759|FG002|Open-Label Extension Phase|Pregnancy|0|||
48332692|NCT02607956|155414760|FG003|Open-Label Extension Phase|Pregnancy|1|||
48651630|NCT00249808|156576069|FG000|Overall Study|Adverse Event|81|||
48651631|NCT00249808|156576069|FG000|Overall Study|Lack of Efficacy|52|||
48651632|NCT00249808|156576069|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
48651633|NCT01951586|156576070|FG000|Overall Study|Death|61|||
48651634|NCT01951586|156576071|FG001|Overall Study|Death|120|||
48651635|NCT01951586|156576070|FG000|Overall Study|Withdrawal by Subject|8|||
48651636|NCT01951586|156576071|FG001|Overall Study|Withdrawal by Subject|17|||
48651637|NCT01951586|156576070|FG000|Overall Study|Lost to Follow-up|0|||
48651638|NCT01951586|156576071|FG001|Overall Study|Lost to Follow-up|1|||
48651639|NCT01951586|156576070|FG000|Overall Study|Sponsor Decision|9|||
48651640|NCT01951586|156576071|FG001|Overall Study|Sponsor Decision|10|||
48651641|NCT00748618|156576074|FG000|Overall Study|Adverse Event|1|||
48651642|NCT00748618|156576075|FG001|Overall Study|Adverse Event|0|||
48651643|NCT05507567|156576076|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
48651644|NCT05507567|156576077|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
48651645|NCT05507567|156576078|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
48651646|NCT05507567|156576076|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
48651647|NCT05507567|156576077|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
48651648|NCT05507567|156576078|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
48332693|NCT00636168|155414761|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
48332694|NCT00636168|155414762|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
48332695|NCT00636168|155414761|FG000|Randomized to Study Drug|Adverse Event|1|||
48332696|NCT00636168|155414762|FG001|Randomized to Study Drug|Adverse Event|0|||
48332697|NCT00636168|155414761|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
48332698|NCT00636168|155414762|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
48651649|NCT05507567|156576076|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
48651650|NCT05507567|156576077|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
48651651|NCT05507567|156576078|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
48651652|NCT05507567|156576076|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
48651653|NCT05507567|156576077|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
48651654|NCT05507567|156576078|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
48651655|NCT03286543|156576081|FG000|Consented|Screen failure before randomization|2|||
48651656|NCT03286543|156576082|FG001|Consented|Screen failure before randomization|0|||
48651657|NCT03286543|156576083|FG002|Consented|Screen failure before randomization|0|||
48651658|NCT03286543|156576081|FG000|Consented|Screen failure before enrollment|4|||
48651659|NCT03286543|156576082|FG001|Consented|Screen failure before enrollment|0|||
48753238|NCT02289898|156942136|FG001|Overall Study|Death|4|||
48753239|NCT02289898|156942137|FG002|Overall Study|Death|3|||
48753240|NCT02289898|156942135|FG000|Overall Study|Physician Decision|2|||
48753241|NCT02289898|156942136|FG001|Overall Study|Physician Decision|5|||
48753242|NCT02289898|156942137|FG002|Overall Study|Physician Decision|2|||
48753243|NCT02289898|156942135|FG000|Overall Study|Withdrawal by Subject|0|||
48753244|NCT02289898|156942136|FG001|Overall Study|Withdrawal by Subject|4|||
48753245|NCT02289898|156942137|FG002|Overall Study|Withdrawal by Subject|1|||
48753246|NCT02289898|156942135|FG000|Overall Study|Adverse Event|3|||
48753247|NCT02289898|156942136|FG001|Overall Study|Adverse Event|5|||
48753248|NCT02289898|156942137|FG002|Overall Study|Adverse Event|5|||
48753249|NCT02289898|156942135|FG000|Overall Study|Disease progression|34|||
48753250|NCT02289898|156942136|FG001|Overall Study|Disease progression|28|||
48753251|NCT02289898|156942137|FG002|Overall Study|Disease progression|34|||
48753252|NCT02289898|156942135|FG000|Overall Study|Use of another anticancer therapy|0|||
48753253|NCT02289898|156942136|FG001|Overall Study|Use of another anticancer therapy|0|||
48753254|NCT02289898|156942137|FG002|Overall Study|Use of another anticancer therapy|1|||
48753255|NCT02289898|156942135|FG000|Overall Study|Other|8|||
48753256|NCT02289898|156942136|FG001|Overall Study|Other|7|||
48753257|NCT02289898|156942137|FG002|Overall Study|Other|10|||
48753258|NCT00885105|156942138|FG000|Overall Study|Withdrawal by Subject|0|||
48651660|NCT03286543|156576083|FG002|Consented|Screen failure before enrollment|0|||
48753259|NCT00885105|156942139|FG001|Overall Study|Withdrawal by Subject|8|||
48753260|NCT00885105|156942138|FG000|Overall Study|Adverse Event|1|||
48651661|NCT03286543|156576081|FG000|Consented|TKA cancelled after enrollment|1|||
48651662|NCT03286543|156576082|FG001|Consented|TKA cancelled after enrollment|0|||
48651663|NCT03286543|156576083|FG002|Consented|TKA cancelled after enrollment|0|||
48753261|NCT00885105|156942139|FG001|Overall Study|Adverse Event|0|||
48753262|NCT00885105|156942138|FG000|Overall Study|Protocol Violation|0|||
48753263|NCT00885105|156942139|FG001|Overall Study|Protocol Violation|2|||
48753264|NCT00166114|156942141|FG000|Overall Study|Protocol Violation|2|||
48753265|NCT00166114|156942142|FG001|Overall Study|Protocol Violation|1|||
48753266|NCT00166114|156942141|FG000|Overall Study|Withdrawal by Subject|10|||
48383945|NCT04422990|155601506|FG000|Overall Study|Travel|3|||
48651664|NCT03286543|156576081|FG000|Consented|Withdrawn from study|12|||
48651665|NCT03286543|156576082|FG001|Consented|Withdrawn from study|0|||
48651666|NCT03286543|156576083|FG002|Consented|Withdrawn from study|0|||
48332699|NCT00636168|155414761|FG000|Treated With Study Drug|Recurrence of disease|135|||
48651667|NCT03286543|156576081|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
48651668|NCT03286543|156576082|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
48651669|NCT03286543|156576083|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
48651670|NCT03286543|156576081|FG000|Study Enrollment|Withdrawn from study|0|||
48651671|NCT03286543|156576082|FG001|Study Enrollment|Withdrawn from study|6|||
48651672|NCT03286543|156576083|FG002|Study Enrollment|Withdrawn from study|6|||
48651673|NCT03850093|156576084|FG000|Overall Study|Withdrawal by Subject|1|||
48651674|NCT03850093|156576085|FG001|Overall Study|Withdrawal by Subject|0|||
48651675|NCT03850093|156576086|FG002|Overall Study|Withdrawal by Subject|2|||
48651676|NCT00438360|156576088|FG000|Overall Study|Adverse Event|6|||
48651677|NCT00438360|156576089|FG001|Overall Study|Adverse Event|1|||
48651678|NCT00438360|156576088|FG000|Overall Study|Lack of Efficacy|42|||
48651679|NCT00438360|156576089|FG001|Overall Study|Lack of Efficacy|27|||
48651680|NCT00438360|156576088|FG000|Overall Study|Other|24|||
48651681|NCT00438360|156576089|FG001|Overall Study|Other|15|||
48651682|NCT02752633|156576090|FG000|Overall Study|Withdrawal by Subject|1|||
48651683|NCT02277691|156576091|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
48651684|NCT02277691|156576091|FG000|Overall Study|Voluntary Withdrawal|7|||
48651685|NCT02277691|156576091|FG000|Overall Study|Lack of Efficacy|5|||
48651686|NCT02277691|156576091|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
48651687|NCT00070109|156576094|FG000|Overall Study|Death|1|||
48651688|NCT00070109|156576095|FG001|Overall Study|Death|1|||
48651689|NCT00070109|156576096|FG002|Overall Study|Death|0|||
48651690|NCT00070109|156576097|FG003|Overall Study|Death|0|||
48651691|NCT00070109|156576098|FG004|Overall Study|Death|1|||
48651692|NCT00070109|156576094|FG000|Overall Study|Lack of Efficacy|6|||
48651693|NCT00070109|156576095|FG001|Overall Study|Lack of Efficacy|4|||
48651694|NCT00070109|156576096|FG002|Overall Study|Lack of Efficacy|5|||
48651695|NCT00070109|156576097|FG003|Overall Study|Lack of Efficacy|15|||
48651696|NCT00070109|156576098|FG004|Overall Study|Lack of Efficacy|5|||
48651697|NCT00070109|156576094|FG000|Overall Study|Physician Decision|1|||
48651698|NCT00070109|156576095|FG001|Overall Study|Physician Decision|0|||
48651699|NCT00070109|156576096|FG002|Overall Study|Physician Decision|0|||
48651700|NCT00070109|156576097|FG003|Overall Study|Physician Decision|0|||
48651701|NCT00070109|156576098|FG004|Overall Study|Physician Decision|0|||
48651702|NCT00070109|156576094|FG000|Overall Study|Withdrawal by Subject|0|||
48383946|NCT04422990|155601507|FG001|Overall Study|Travel|0|||
48753267|NCT00166114|156942142|FG001|Overall Study|Withdrawal by Subject|4|||
48753268|NCT00166114|156942141|FG000|Overall Study|Adverse Event|2|||
48753269|NCT00166114|156942142|FG001|Overall Study|Adverse Event|1|||
48753270|NCT01074450|156942153|FG000|First Intervention|Emesis in Dosing Interval|0|||
48753271|NCT01074450|156942154|FG001|First Intervention|Emesis in Dosing Interval|2|||
48753272|NCT01074450|156942153|FG000|Second Intervention|Protocol Violation|1|||
48753273|NCT01074450|156942154|FG001|Second Intervention|Protocol Violation|0|||
48753274|NCT01074450|156942153|FG000|Second Intervention|Physician Decision|0|||
48753275|NCT01074450|156942154|FG001|Second Intervention|Physician Decision|1|||
48753276|NCT01574326|156942155|FG000|Overall Study|Randomized but not treated|0|||
48753277|NCT01574326|156942156|FG001|Overall Study|Randomized but not treated|1|||
48753278|NCT01574326|156942155|FG000|Overall Study|Withdrawal by Participant|2|||
48753279|NCT01574326|156942156|FG001|Overall Study|Withdrawal by Participant|4|||
48753280|NCT01574326|156942155|FG000|Overall Study|Physician Decision|5|||
48753281|NCT01574326|156942156|FG001|Overall Study|Physician Decision|3|||
48753282|NCT01574326|156942155|FG000|Overall Study|Adverse Event|1|||
48753283|NCT01574326|156942156|FG001|Overall Study|Adverse Event|3|||
48753284|NCT01574326|156942155|FG000|Overall Study|Other: Mainly kidney transplant|8|||
48753285|NCT01574326|156942156|FG001|Overall Study|Other: Mainly kidney transplant|8|||
48753286|NCT01195415|156942157|FG000|Overall Study|No repeat biopsy due to progression|2|||
48753287|NCT01585194|156942163|FG000|Overall Study|Withdrawal by Subject|1|||
48753288|NCT01585194|156942163|FG000|Overall Study|Physician Decision|2|||
48753289|NCT01585194|156942163|FG000|Overall Study|Lack of insurance|1|||
48753290|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
48753291|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
48753292|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
48753293|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
48753294|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
48753295|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
48753296|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
48753297|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
48753298|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
48753299|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
48332700|NCT00636168|155414762|FG001|Treated With Study Drug|Recurrence of disease|282|||
48332701|NCT00636168|155414761|FG000|Treated With Study Drug|Adverse Event|250|||
48332702|NCT00636168|155414762|FG001|Treated With Study Drug|Adverse Event|22|||
48332703|NCT00636168|155414761|FG000|Treated With Study Drug|Participant withdrew consent|16|||
48332704|NCT00636168|155414762|FG001|Treated With Study Drug|Participant withdrew consent|21|||
48332705|NCT00636168|155414761|FG000|Treated With Study Drug|Poor/non-compliance|1|||
48332706|NCT00636168|155414762|FG001|Treated With Study Drug|Poor/non-compliance|3|||
48332707|NCT00636168|155414761|FG000|Treated With Study Drug|Death|3|||
48332708|NCT00636168|155414762|FG001|Treated With Study Drug|Death|0|||
48332709|NCT00636168|155414761|FG000|Treated With Study Drug|Pregnancy|1|||
48332710|NCT00636168|155414762|FG001|Treated With Study Drug|Pregnancy|0|||
48332711|NCT00636168|155414761|FG000|Treated With Study Drug|No longer meets study criteria|1|||
48332712|NCT00636168|155414762|FG001|Treated With Study Drug|No longer meets study criteria|0|||
48332713|NCT00636168|155414761|FG000|Treated With Study Drug|Other reason|1|||
48332714|NCT00636168|155414762|FG001|Treated With Study Drug|Other reason|3|||
48332715|NCT00636168|155414761|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
48332716|NCT00636168|155414762|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
48332717|NCT00636168|155414761|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
48332718|NCT00636168|155414762|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
48332719|NCT00636168|155414761|FG000|Long Term Follow-Up|Death|8|||
48332720|NCT00636168|155414762|FG001|Long Term Follow-Up|Death|9|||
48332721|NCT02312258|155414764|FG000|Overall Study|Lost to Follow-up|8|||
48332722|NCT02312258|155414765|FG001|Overall Study|Lost to Follow-up|8|||
48332723|NCT02312258|155414764|FG000|Overall Study|Withdrawal by Patient|49|||
48332724|NCT02312258|155414765|FG001|Overall Study|Withdrawal by Patient|76|||
48332725|NCT02312258|155414764|FG000|Overall Study|Reason not Specified|107|||
48332726|NCT02312258|155414765|FG001|Overall Study|Reason not Specified|159|||
48651703|NCT00070109|156576095|FG001|Overall Study|Withdrawal by Subject|1|||
48651704|NCT00070109|156576096|FG002|Overall Study|Withdrawal by Subject|1|||
48651705|NCT00070109|156576097|FG003|Overall Study|Withdrawal by Subject|0|||
48651706|NCT00070109|156576098|FG004|Overall Study|Withdrawal by Subject|0|||
48651707|NCT00070109|156576094|FG000|Overall Study|Adverse Event|0|||
48651708|NCT00070109|156576095|FG001|Overall Study|Adverse Event|0|||
48651709|NCT00070109|156576096|FG002|Overall Study|Adverse Event|2|||
48651710|NCT00070109|156576097|FG003|Overall Study|Adverse Event|4|||
48753300|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
48753301|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
48753302|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
48753303|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
48753304|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
48753305|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
48332727|NCT02312258|155414764|FG000|Overall Study|Missing|2|||
48332728|NCT02312258|155414765|FG001|Overall Study|Missing|1|||
48332729|NCT02312258|155414764|FG000|Overall Study|Death|115|||
48332730|NCT02312258|155414765|FG001|Overall Study|Death|181|||
48753306|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
48753307|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
48753308|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
48753309|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
48753310|NCT01962207|156942164|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
48332731|NCT01681511|155414766|FG000|Overall Study|No Treatment Received|1|||
48332732|NCT01681511|155414767|FG001|Overall Study|No Treatment Received|3|||
48332733|NCT01681511|155414766|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
48332734|NCT01681511|155414767|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
48332735|NCT01681511|155414766|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
48332736|NCT01681511|155414767|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
48332737|NCT01681511|155414766|FG000|Overall Study|No Daily Urine Sample Collected|0|||
48332738|NCT01681511|155414767|FG001|Overall Study|No Daily Urine Sample Collected|1|||
48332739|NCT01681511|155414766|FG000|Overall Study|No post-catheter sample collected|11|||
48651711|NCT00070109|156576098|FG004|Overall Study|Adverse Event|2|||
48651712|NCT00070109|156576094|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
48651713|NCT00070109|156576095|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
48651714|NCT00070109|156576096|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
48651715|NCT00070109|156576097|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
48332740|NCT01681511|155414767|FG001|Overall Study|No post-catheter sample collected|4|||
48332741|NCT03060525|155414768|FG000|Overall Study|moved out of state|1|||
48332742|NCT03060525|155414769|FG001|Overall Study|moved out of state|1|||
48332743|NCT03060525|155414770|FG002|Overall Study|moved out of state|1|||
48332744|NCT03060525|155414771|FG003|Overall Study|moved out of state|1|||
48383947|NCT00764751|155601511|FG000|Overall Study|Adverse Event|1|||
48651716|NCT00070109|156576098|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
48651717|NCT01524224|156576105|FG000|Overall Study|Progressive Disease|1|||
48651718|NCT01524224|156576106|FG001|Overall Study|Progressive Disease|0|||
48651719|NCT01524224|156576107|FG002|Overall Study|Progressive Disease|2|||
48332745|NCT03060525|155414768|FG000|Overall Study|unable to meet time commitment required of study|2|||
48332746|NCT03060525|155414769|FG001|Overall Study|unable to meet time commitment required of study|3|||
48332747|NCT03060525|155414770|FG002|Overall Study|unable to meet time commitment required of study|3|||
48332748|NCT03060525|155414771|FG003|Overall Study|unable to meet time commitment required of study|1|||
48332749|NCT03060525|155414768|FG000|Overall Study|no longer interested in doing intervention|0|||
48332750|NCT03060525|155414769|FG001|Overall Study|no longer interested in doing intervention|0|||
48332751|NCT03060525|155414770|FG002|Overall Study|no longer interested in doing intervention|0|||
48332752|NCT03060525|155414771|FG003|Overall Study|no longer interested in doing intervention|1|||
48332753|NCT01429285|155414772|FG000|Overall Study|Protocol Violation|9|||
48332754|NCT01429285|155414773|FG001|Overall Study|Protocol Violation|4|||
48332755|NCT01429285|155414772|FG000|Overall Study|Missing Data|5|||
48332756|NCT01429285|155414773|FG001|Overall Study|Missing Data|3|||
48332757|NCT01429285|155414772|FG000|Overall Study|Erroneously Enrolled Twice|8|||
48332758|NCT01429285|155414773|FG001|Overall Study|Erroneously Enrolled Twice|2|||
48332759|NCT03560206|155414774|FG000|Overall Study|Lost to Follow-up|19|||
48332760|NCT03560206|155414775|FG001|Overall Study|Lost to Follow-up|11|||
48332761|NCT03560206|155414774|FG000|Overall Study|Withdrawal by Subject|2|||
48651720|NCT01524224|156576108|FG003|Overall Study|Progressive Disease|1|||
48651721|NCT01524224|156576109|FG004|Overall Study|Progressive Disease|2|||
48651722|NCT01524224|156576110|FG005|Overall Study|Progressive Disease|1|||
48651723|NCT01524224|156576111|FG006|Overall Study|Progressive Disease|1|||
48651724|NCT01524224|156576112|FG007|Overall Study|Progressive Disease|5|||
48651725|NCT01524224|156576105|FG000|Overall Study|Withdrawal by Subject|2|||
48332762|NCT03560206|155414775|FG001|Overall Study|Withdrawal by Subject|4|||
48332763|NCT03560206|155414774|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
48332764|NCT03560206|155414775|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
48332765|NCT03560206|155414774|FG000|Overall Study|Busy schedule|14|||
48332766|NCT03560206|155414775|FG001|Overall Study|Busy schedule|2|||
48332767|NCT03560206|155414774|FG000|Overall Study|patients' new health condition such as cancer|10|||
48332768|NCT03560206|155414775|FG001|Overall Study|patients' new health condition such as cancer|1|||
48332769|NCT02340806|155414779|FG000|Overall Study|Protocol Violation|2|||
48332770|NCT02340806|155414780|FG001|Overall Study|Protocol Violation|0|||
48332771|NCT02340806|155414779|FG000|Overall Study|epidural catheter replaced|2|||
48332772|NCT02340806|155414780|FG001|Overall Study|epidural catheter replaced|1|||
48332773|NCT02340806|155414779|FG000|Overall Study|history of chronic pain medication|1|||
48332774|NCT02340806|155414780|FG001|Overall Study|history of chronic pain medication|0|||
48332775|NCT02340806|155414779|FG000|Overall Study|re-dose < 90 min of CSE|1|||
48332776|NCT02340806|155414780|FG001|Overall Study|re-dose < 90 min of CSE|3|||
48332777|NCT01986348|155414781|FG000|Overall Study|Death|8|||
48332778|NCT01986348|155414782|FG001|Overall Study|Death|22|||
48332779|NCT01986348|155414783|FG002|Overall Study|Death|10|||
48332780|NCT01986348|155414784|FG003|Overall Study|Death|21|||
48332781|NCT01986348|155414781|FG000|Overall Study|Lost to Follow-up|0|||
48332782|NCT01986348|155414782|FG001|Overall Study|Lost to Follow-up|0|||
48332783|NCT01986348|155414783|FG002|Overall Study|Lost to Follow-up|0|||
48332784|NCT01986348|155414784|FG003|Overall Study|Lost to Follow-up|2|||
48332785|NCT01986348|155414781|FG000|Overall Study|Physician Decision|0|||
48332786|NCT01986348|155414782|FG001|Overall Study|Physician Decision|0|||
48332787|NCT01986348|155414783|FG002|Overall Study|Physician Decision|0|||
48332788|NCT01986348|155414784|FG003|Overall Study|Physician Decision|1|||
48332789|NCT01986348|155414781|FG000|Overall Study|Progressive Disease|0|||
48332790|NCT01986348|155414782|FG001|Overall Study|Progressive Disease|0|||
48332791|NCT01986348|155414783|FG002|Overall Study|Progressive Disease|2|||
48332792|NCT01986348|155414784|FG003|Overall Study|Progressive Disease|0|||
48332793|NCT01986348|155414781|FG000|Overall Study|Withdrawal by Participant|0|||
48332794|NCT01986348|155414782|FG001|Overall Study|Withdrawal by Participant|1|||
48332795|NCT01986348|155414783|FG002|Overall Study|Withdrawal by Participant|2|||
48651726|NCT01524224|156576106|FG001|Overall Study|Withdrawal by Subject|0|||
48651727|NCT01524224|156576107|FG002|Overall Study|Withdrawal by Subject|0|||
48651728|NCT01524224|156576108|FG003|Overall Study|Withdrawal by Subject|0|||
48651729|NCT01524224|156576109|FG004|Overall Study|Withdrawal by Subject|0|||
48753311|NCT01962207|156942165|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
48332796|NCT01986348|155414784|FG003|Overall Study|Withdrawal by Participant|1|||
48332797|NCT01986348|155414781|FG000|Overall Study|Study Terminated by Sponsor|0|||
48332798|NCT01986348|155414782|FG001|Overall Study|Study Terminated by Sponsor|0|||
48332799|NCT01986348|155414783|FG002|Overall Study|Study Terminated by Sponsor|0|||
48332800|NCT01986348|155414784|FG003|Overall Study|Study Terminated by Sponsor|3|||
48332801|NCT01986348|155414781|FG000|Overall Study|Other-unspecified|0|||
48332802|NCT01986348|155414782|FG001|Overall Study|Other-unspecified|1|||
48651730|NCT01524224|156576110|FG005|Overall Study|Withdrawal by Subject|0|||
48651731|NCT01524224|156576111|FG006|Overall Study|Withdrawal by Subject|2|||
48651732|NCT01524224|156576112|FG007|Overall Study|Withdrawal by Subject|0|||
48651733|NCT01524224|156576105|FG000|Overall Study|Adverse Event|0|||
48651734|NCT01524224|156576106|FG001|Overall Study|Adverse Event|1|||
48332803|NCT01986348|155414783|FG002|Overall Study|Other-unspecified|0|||
48651735|NCT01524224|156576107|FG002|Overall Study|Adverse Event|0|||
48651736|NCT01524224|156576108|FG003|Overall Study|Adverse Event|0|||
48651737|NCT01524224|156576109|FG004|Overall Study|Adverse Event|0|||
48651738|NCT01524224|156576110|FG005|Overall Study|Adverse Event|1|||
48651739|NCT01524224|156576111|FG006|Overall Study|Adverse Event|0|||
48651740|NCT01524224|156576112|FG007|Overall Study|Adverse Event|0|||
48651741|NCT01524224|156576105|FG000|Overall Study|Physician Decision|0|||
48651742|NCT01524224|156576106|FG001|Overall Study|Physician Decision|0|||
48651743|NCT01524224|156576107|FG002|Overall Study|Physician Decision|0|||
48651744|NCT01524224|156576108|FG003|Overall Study|Physician Decision|1|||
48332804|NCT01986348|155414784|FG003|Overall Study|Other-unspecified|2|||
48332805|NCT00853957|155414788|FG000|Overall Study|Adverse Event|9|||
48332806|NCT00853957|155414789|FG001|Overall Study|Adverse Event|3|||
48332807|NCT00853957|155414788|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48332808|NCT00853957|155414789|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48332809|NCT00853957|155414788|FG000|Overall Study|Subject withdrew consent|4|||
48332810|NCT00853957|155414789|FG001|Overall Study|Subject withdrew consent|5|||
48332811|NCT00853957|155414788|FG000|Overall Study|Lost to Follow-up|1|||
48332812|NCT00853957|155414789|FG001|Overall Study|Lost to Follow-up|6|||
48332813|NCT00853957|155414788|FG000|Overall Study|Protocol deviation|0|||
48332814|NCT00853957|155414789|FG001|Overall Study|Protocol deviation|3|||
48332815|NCT02332889|155414792|FG000|Overall Study|Physician Decision|1|||
48332816|NCT00451906|155415855|FG000|Overall Study|Adverse Event|515|||
48332817|NCT00451906|155415855|FG000|Overall Study|Lost to Follow-up|31|||
48332818|NCT00451906|155415855|FG000|Overall Study|Withdrawal by Subject|111|||
48332819|NCT00451906|155415855|FG000|Overall Study|Protocol Violation|21|||
48332820|NCT00451906|155415855|FG000|Overall Study|Progressive disease|1328|||
48651745|NCT01524224|156576109|FG004|Overall Study|Physician Decision|1|||
48651746|NCT01524224|156576110|FG005|Overall Study|Physician Decision|0|||
48753312|NCT01962207|156942166|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
48753313|NCT01962207|156942167|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
48753314|NCT02154490|156944178|FG000|Overall Study|No tissue submitted|23|||
48753315|NCT02154490|156944178|FG000|Overall Study|No biomarker results|167|||
48753316|NCT02154490|156944178|FG000|Overall Study|Not assigned to a sub-study|270|||
48753317|NCT02154490|156944178|FG000|Overall Study|Did not register to a sub-study|749|||
48753318|NCT01991067|156944179|FG000|Overall Study|Lost to Follow-up|6|||
48753319|NCT01991067|156944180|FG001|Overall Study|Lost to Follow-up|5|||
48753320|NCT02989194|156944187|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
48753321|NCT02989194|156944188|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
48753322|NCT02989194|156944189|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
48753323|NCT02989194|156944187|FG000|Overall Study|Lost to Follow-up|0|||
48753324|NCT02989194|156944188|FG001|Overall Study|Lost to Follow-up|1|||
48753325|NCT02989194|156944189|FG002|Overall Study|Lost to Follow-up|0|||
48753326|NCT02989194|156944187|FG000|Overall Study|Withdrawal by Subject|0|||
48753327|NCT02989194|156944188|FG001|Overall Study|Withdrawal by Subject|1|||
48753328|NCT02989194|156944189|FG002|Overall Study|Withdrawal by Subject|0|||
48753329|NCT00004978|156944190|FG000|Overall Study|Death|107|||
48753330|NCT00004978|156944191|FG001|Overall Study|Death|116|||
48753331|NCT00004978|156944190|FG000|Overall Study|Lost to Follow-up|101|||
48753332|NCT00004978|156944191|FG001|Overall Study|Lost to Follow-up|108|||
48753333|NCT00004978|156944190|FG000|Overall Study|Withdrawal by Subject|17|||
48753334|NCT00004978|156944191|FG001|Overall Study|Withdrawal by Subject|26|||
48753335|NCT00004978|156944190|FG000|Overall Study|site closure - not in analysis cohort|19|||
48753336|NCT00004978|156944191|FG001|Overall Study|site closure - not in analysis cohort|20|||
48753337|NCT02064868|156944192|FG000|Overall Study|Lost to Follow-up|14|||
48753338|NCT02064868|156944193|FG001|Overall Study|Lost to Follow-up|8|||
48753339|NCT02064868|156944192|FG000|Overall Study|Physician Decision|1|||
48753340|NCT02064868|156944193|FG001|Overall Study|Physician Decision|0|||
48753341|NCT02064868|156944192|FG000|Overall Study|Withdrawal by Subject|14|||
48753342|NCT02064868|156944193|FG001|Overall Study|Withdrawal by Subject|3|||
48753343|NCT02064868|156944192|FG000|Overall Study|Technical Problems or Missing|5|||
48753344|NCT02064868|156944193|FG001|Overall Study|Technical Problems or Missing|2|||
48753345|NCT00617773|156944196|FG000|Overall Study|Physician Decision|1|||
48753346|NCT00617773|156944196|FG000|Overall Study|Lack of compliance with the protocol|1|||
48332821|NCT00451906|155415855|FG000|Overall Study|Termination of the study|108|||
48753347|NCT00617773|156944196|FG000|Overall Study|Withdrawal by Subject|1|||
48753348|NCT00617773|156944196|FG000|Overall Study|Death|1|||
48753349|NCT00617773|156944196|FG000|Overall Study|Progressive disease|19|||
48332822|NCT00451906|155415855|FG000|Overall Study|Other Reasons|121|||
48332823|NCT00451906|155415855|FG000|Overall Study|Did not complete final visit|4|||
48332824|NCT04633200|155415857|FG000|Overall Study|Lost to Follow-up|3|||
48651747|NCT01524224|156576111|FG006|Overall Study|Physician Decision|0|||
48651748|NCT01524224|156576112|FG007|Overall Study|Physician Decision|1|||
48651749|NCT01524224|156576105|FG000|Overall Study|Sponsor Decision|0|||
48651750|NCT01524224|156576106|FG001|Overall Study|Sponsor Decision|0|||
48332825|NCT04633200|155415858|FG001|Overall Study|Lost to Follow-up|5|||
48651751|NCT01524224|156576107|FG002|Overall Study|Sponsor Decision|0|||
48332826|NCT02713594|155415859|FG000|Overall Study|Withdrawal by Subject|32|||
48332827|NCT02713594|155415860|FG001|Overall Study|Withdrawal by Subject|22|||
48332828|NCT02713594|155415859|FG000|Overall Study|Lost to Follow-up|358|||
48332829|NCT02713594|155415860|FG001|Overall Study|Lost to Follow-up|374|||
48332830|NCT03493282|155415861|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
48332831|NCT03493282|155415862|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
48332832|NCT03493282|155415863|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
48332833|NCT03493282|155415861|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
48332834|NCT03493282|155415862|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
48332835|NCT03493282|155415863|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
48332836|NCT00413283|155415865|FG000|Overall Study|Withdrawal by Subject|1|||
48332837|NCT00413283|155415866|FG001|Overall Study|Withdrawal by Subject|0|||
48332838|NCT00413283|155415867|FG002|Overall Study|Withdrawal by Subject|0|||
48332839|NCT00413283|155415868|FG003|Overall Study|Withdrawal by Subject|1|||
48332840|NCT00413283|155415865|FG000|Overall Study|Death|0|||
48332841|NCT00413283|155415866|FG001|Overall Study|Death|0|||
48332842|NCT00413283|155415867|FG002|Overall Study|Death|1|||
48332843|NCT00413283|155415868|FG003|Overall Study|Death|1|||
48332844|NCT00413283|155415865|FG000|Overall Study|Adverse Event|0|||
48332845|NCT00413283|155415866|FG001|Overall Study|Adverse Event|0|||
48332846|NCT00413283|155415867|FG002|Overall Study|Adverse Event|0|||
48332847|NCT00413283|155415868|FG003|Overall Study|Adverse Event|1|||
48332848|NCT00413283|155415865|FG000|Overall Study|Ineligibility determined|0|||
48332849|NCT00413283|155415866|FG001|Overall Study|Ineligibility determined|0|||
48332850|NCT00413283|155415867|FG002|Overall Study|Ineligibility determined|0|||
48332851|NCT00413283|155415868|FG003|Overall Study|Ineligibility determined|1|||
48332852|NCT00413283|155415865|FG000|Overall Study|Protocol deviation|0|||
48332853|NCT00413283|155415866|FG001|Overall Study|Protocol deviation|1|||
48332854|NCT00413283|155415867|FG002|Overall Study|Protocol deviation|0|||
48332855|NCT00413283|155415868|FG003|Overall Study|Protocol deviation|0|||
48332856|NCT00413283|155415865|FG000|Overall Study|Requirement for alternative therapy|0|||
48332857|NCT00413283|155415866|FG001|Overall Study|Requirement for alternative therapy|2|||
48332858|NCT00413283|155415867|FG002|Overall Study|Requirement for alternative therapy|0|||
48332859|NCT00413283|155415868|FG003|Overall Study|Requirement for alternative therapy|0|||
48332860|NCT00413283|155415865|FG000|Overall Study|Other|0|||
48332861|NCT00413283|155415866|FG001|Overall Study|Other|0|||
48332862|NCT00413283|155415867|FG002|Overall Study|Other|1|||
48332863|NCT00413283|155415868|FG003|Overall Study|Other|0|||
48332864|NCT02771366|155415869|FG000|Period 1|Withdrawal by Subject|0|||
48332865|NCT02771366|155415870|FG001|Period 1|Withdrawal by Subject|2|||
48332866|NCT02771366|155415869|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
48332867|NCT02771366|155415870|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
48332868|NCT02354417|155415871|FG000|Overall Study|Physician Decision|1|||
48332869|NCT04311983|155415877|FG000|Overall Study|Lost to Follow-up|421|||
48332870|NCT04311983|155415878|FG001|Overall Study|Lost to Follow-up|456|||
48332871|NCT04311983|155415877|FG000|Overall Study|Incomplete survey|7|||
48332872|NCT04311983|155415878|FG001|Overall Study|Incomplete survey|9|||
48332873|NCT04311983|155415877|FG000|Overall Study|Death|1|||
48332874|NCT04311983|155415878|FG001|Overall Study|Death|0|||
48332875|NCT01437540|155415879|FG000|Overall Study|Not listed below|7|||
48332876|NCT01437540|155415880|FG001|Overall Study|Not listed below|6|||
48332877|NCT01437540|155415879|FG000|Overall Study|COPD exacerbation|13|||
48651752|NCT01524224|156576108|FG003|Overall Study|Sponsor Decision|0|||
48651753|NCT01524224|156576109|FG004|Overall Study|Sponsor Decision|1|||
48651754|NCT01524224|156576110|FG005|Overall Study|Sponsor Decision|0|||
48651755|NCT01524224|156576111|FG006|Overall Study|Sponsor Decision|0|||
48651756|NCT01524224|156576112|FG007|Overall Study|Sponsor Decision|0|||
48651757|NCT05040971|156576119|FG000|Overall Study|Withdrawal by Subject|0|||
48651758|NCT05040971|156576120|FG001|Overall Study|Withdrawal by Subject|2|||
48651759|NCT05040971|156576119|FG000|Overall Study|Lost to Follow-up|8|||
48651760|NCT05040971|156576120|FG001|Overall Study|Lost to Follow-up|3|||
48651761|NCT05040971|156576119|FG000|Overall Study|Death|2|||
48651762|NCT05040971|156576120|FG001|Overall Study|Death|0|||
48651763|NCT00610857|156576122|FG000|Overall Study|Not evaluable for response|2|||
48651764|NCT02027311|156576126|FG000|Overall Study|Protocol Violation|3|||
48651765|NCT02027311|156576127|FG001|Overall Study|Protocol Violation|2|||
48651766|NCT00904670|156576128|FG000|Open Label Phase|Withdrawal by Subject|2|||
48332878|NCT01437540|155415880|FG001|Overall Study|COPD exacerbation|3|||
48332879|NCT01437540|155415879|FG000|Overall Study|Lost to Follow-up|3|||
48332880|NCT01437540|155415880|FG001|Overall Study|Lost to Follow-up|5|||
48332881|NCT01437540|155415879|FG000|Overall Study|Lack of Efficacy|23|||
48651767|NCT00904670|156576129|FG001|Open Label Phase|Withdrawal by Subject|0|||
48651768|NCT00904670|156576128|FG000|Open Label Phase|Adverse Event|2|||
48332882|NCT01437540|155415880|FG001|Overall Study|Lack of Efficacy|11|||
48332883|NCT01437540|155415879|FG000|Overall Study|Protocol Violation|24|||
48332884|NCT01437540|155415880|FG001|Overall Study|Protocol Violation|12|||
48332885|NCT01437540|155415879|FG000|Overall Study|Adverse Event|26|||
48651769|NCT00904670|156576129|FG001|Open Label Phase|Adverse Event|0|||
48651770|NCT00904670|156576128|FG000|Open Label Phase|Lack of Efficacy|1|||
48332886|NCT01437540|155415880|FG001|Overall Study|Adverse Event|13|||
48332887|NCT01437540|155415879|FG000|Overall Study|Withdrawal by Subject|31|||
48332888|NCT01437540|155415880|FG001|Overall Study|Withdrawal by Subject|15|||
48332889|NCT02889900|155415888|FG000|Overall Study|Adverse Event|11|||
48332890|NCT02889900|155415888|FG000|Overall Study|Condition under investigation worsened|32|||
48332891|NCT02889900|155415888|FG000|Overall Study|Other|5|||
48332892|NCT02889900|155415888|FG000|Overall Study|Withdrawal by Subject|7|||
48332893|NCT02889900|155415888|FG000|Overall Study|Not treated|2|||
48332894|NCT03316170|155415889|FG000|Overall Study|Death|1|||
48332895|NCT03316170|155415890|FG001|Overall Study|Death|0|||
48332896|NCT03316170|155415889|FG000|Overall Study|Lost to Follow-up|6|||
48332897|NCT03316170|155415890|FG001|Overall Study|Lost to Follow-up|7|||
48332898|NCT01416285|155415891|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
48332899|NCT01416285|155415892|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
48332900|NCT04328467|155415896|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
48332901|NCT04328467|155415897|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
48332902|NCT04328467|155415898|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
48332903|NCT01944774|155415902|FG000|Overall Study|Withdrawal by Subject|2|||
48332904|NCT01944774|155415903|FG001|Overall Study|Withdrawal by Subject|3|||
48332905|NCT01944774|155415904|FG002|Overall Study|Withdrawal by Subject|3|||
48332906|NCT01944774|155415902|FG000|Overall Study|Adverse Event|3|||
48332907|NCT01944774|155415903|FG001|Overall Study|Adverse Event|2|||
48332908|NCT01944774|155415904|FG002|Overall Study|Adverse Event|3|||
48332909|NCT01944774|155415902|FG000|Overall Study|Lack of Efficacy|1|||
48332910|NCT01944774|155415903|FG001|Overall Study|Lack of Efficacy|2|||
48332911|NCT01944774|155415904|FG002|Overall Study|Lack of Efficacy|2|||
48332912|NCT01944774|155415902|FG000|Overall Study|Lost to Follow-up|0|||
48332913|NCT01944774|155415903|FG001|Overall Study|Lost to Follow-up|1|||
48332914|NCT01944774|155415904|FG002|Overall Study|Lost to Follow-up|0|||
48332915|NCT00749944|155415905|FG000|Overall Study|Lost to Follow-up|2|||
48332916|NCT00749944|155415906|FG001|Overall Study|Lost to Follow-up|1|||
48332917|NCT00749944|155415905|FG000|Overall Study|Other|1|||
48332918|NCT00749944|155415906|FG001|Overall Study|Other|0|||
48332919|NCT00749944|155415905|FG000|Overall Study|Withdrawal by Subject|2|||
48332920|NCT00749944|155415906|FG001|Overall Study|Withdrawal by Subject|0|||
48332921|NCT00603798|155415915|FG000|Overall Study|Adverse Event|4|||
48332922|NCT00603798|155415916|FG001|Overall Study|Adverse Event|2|||
48332923|NCT00603798|155415917|FG002|Overall Study|Adverse Event|1|||
48332924|NCT00603798|155415915|FG000|Overall Study|Withdrawal by Subject|4|||
48332925|NCT00603798|155415916|FG001|Overall Study|Withdrawal by Subject|3|||
48332926|NCT00603798|155415917|FG002|Overall Study|Withdrawal by Subject|4|||
48332927|NCT00603798|155415915|FG000|Overall Study|Lost to Follow-up|1|||
48332928|NCT00603798|155415916|FG001|Overall Study|Lost to Follow-up|0|||
48332929|NCT00603798|155415917|FG002|Overall Study|Lost to Follow-up|1|||
48332930|NCT00603798|155415915|FG000|Overall Study|Non-compliance with study procedures|0|||
48332931|NCT00603798|155415916|FG001|Overall Study|Non-compliance with study procedures|1|||
48332932|NCT00603798|155415917|FG002|Overall Study|Non-compliance with study procedures|0|||
48332933|NCT00603798|155415915|FG000|Overall Study|Not due to AE|1|||
48332934|NCT00603798|155415916|FG001|Overall Study|Not due to AE|1|||
48332935|NCT00603798|155415917|FG002|Overall Study|Not due to AE|4|||
48332936|NCT04766996|155415918|FG000|Overall Study|Withdrawal by Subject|1|||
48332937|NCT04766996|155415919|FG001|Overall Study|Withdrawal by Subject|0|||
48332938|NCT04766996|155415920|FG002|Overall Study|Withdrawal by Subject|13|||
48332939|NCT03693989|155415923|FG000|Overall Study|Protocol Violation|3|||
48332940|NCT03693989|155415924|FG001|Overall Study|Protocol Violation|4|||
48332941|NCT01220999|155415925|FG000|Overall Study|Progressive disease|0|||
48332942|NCT01220999|155415926|FG001|Overall Study|Progressive disease|0|||
48332943|NCT01220999|155415927|FG002|Overall Study|Progressive disease|1|||
48332944|NCT01220999|155415928|FG003|Overall Study|Progressive disease|0|||
48332945|NCT01220999|155415929|FG004|Overall Study|Progressive disease|0|||
48332946|NCT02525744|155415932|FG000|Period 1|Physician Decision|0|||
48332947|NCT02525744|155415933|FG001|Period 1|Physician Decision|0|||
48332948|NCT02525744|155415934|FG002|Period 1|Physician Decision|1|||
48332949|NCT02525744|155415935|FG003|Period 1|Physician Decision|0|||
48332950|NCT02525744|155415932|FG000|Period 3|Adverse Event|0|||
48332951|NCT02525744|155415933|FG001|Period 3|Adverse Event|1|||
48332952|NCT02525744|155415934|FG002|Period 3|Adverse Event|0|||
48332953|NCT02525744|155415935|FG003|Period 3|Adverse Event|0|||
48332954|NCT02525744|155415932|FG000|Period 4|Withdrawal by Subject|1|||
48332955|NCT02525744|155415933|FG001|Period 4|Withdrawal by Subject|0|||
48332956|NCT02525744|155415934|FG002|Period 4|Withdrawal by Subject|0|||
48332957|NCT02525744|155415935|FG003|Period 4|Withdrawal by Subject|0|||
48332958|NCT02525744|155415932|FG000|Period 5|Physician Decision|1|||
48332959|NCT02525744|155415933|FG001|Period 5|Physician Decision|0|||
48332960|NCT02525744|155415934|FG002|Period 5|Physician Decision|0|||
48332961|NCT02525744|155415935|FG003|Period 5|Physician Decision|0|||
48332962|NCT04765046|155415936|FG000|Overall Study|Screen Failure|2|||
48332963|NCT04765046|155415936|FG000|Overall Study|Withdrawal by Subject|4|||
48332964|NCT04765046|155415936|FG000|Overall Study|Physician Decision|4|||
48332965|NCT04765046|155415936|FG000|Overall Study|Surgery Cancelled|8|||
48332966|NCT03150589|155415939|FG000|Overall Study|Withdrawal by Subject|16|||
48332967|NCT03150589|155415940|FG001|Overall Study|Withdrawal by Subject|9|||
48651771|NCT00904670|156576129|FG001|Open Label Phase|Lack of Efficacy|0|||
48651772|NCT00904670|156576128|FG000|Open Label Phase|Lost to Follow-up|1|||
48651773|NCT00904670|156576129|FG001|Open Label Phase|Lost to Follow-up|0|||
48651774|NCT04154293|156576131|FG000|Overall Study|Withdrawal by Subject|2|||
48651775|NCT04154293|156576132|FG001|Overall Study|Withdrawal by Subject|3|||
48651776|NCT04154293|156576133|FG002|Overall Study|Withdrawal by Subject|1|||
48651777|NCT04154293|156576131|FG000|Overall Study|Physician Decision|0|||
48651778|NCT04154293|156576132|FG001|Overall Study|Physician Decision|0|||
48651779|NCT04154293|156576133|FG002|Overall Study|Physician Decision|1|||
48651780|NCT00564902|156576136|FG000|Overall Study|Withdrawal by Subject|0|||
48651781|NCT00564902|156576137|FG001|Overall Study|Withdrawal by Subject|3|||
48651782|NCT00564902|156576138|FG002|Overall Study|Withdrawal by Subject|4|||
48651783|NCT00564902|156576136|FG000|Overall Study|Death|1|||
48651784|NCT00564902|156576137|FG001|Overall Study|Death|1|||
48651785|NCT00564902|156576138|FG002|Overall Study|Death|0|||
48651786|NCT03783442|156576139|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
48651787|NCT03783442|156576140|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
48651788|NCT03783442|156576139|FG000|Overall Study|Death|196|||
48651789|NCT03783442|156576140|FG001|Overall Study|Death|226|||
48651790|NCT03783442|156576139|FG000|Overall Study|Withdrawal by Subject|14|||
48651791|NCT03783442|156576140|FG001|Overall Study|Withdrawal by Subject|17|||
48651792|NCT03783442|156576139|FG000|Overall Study|Lost to Follow-up|2|||
48651793|NCT03783442|156576140|FG001|Overall Study|Lost to Follow-up|3|||
48651794|NCT01932372|156576141|FG000|Overall Study|Not meeting eligibility criteria|33|||
48651795|NCT01932372|156576142|FG001|Overall Study|Not meeting eligibility criteria|179|||
48651796|NCT04532294|156576143|FG000|Overall Study|Withdrawal by Subject|0|||
48651797|NCT04532294|156576144|FG001|Overall Study|Withdrawal by Subject|0|||
48651798|NCT04532294|156576145|FG002|Overall Study|Withdrawal by Subject|1|||
48753350|NCT00617773|156944196|FG000|Overall Study|Protocol Violation|1|||
48753351|NCT00418314|156944197|FG000|Overall Study|Withdrawal by Subject|1|||
48753352|NCT00418314|156944198|FG001|Overall Study|Withdrawal by Subject|2|||
48753353|NCT03824912|156944202|FG000|Overall Study|Lost to Follow-up|18|||
48753354|NCT03824912|156944203|FG001|Overall Study|Lost to Follow-up|15|||
48753355|NCT03824912|156944204|FG002|Overall Study|Lost to Follow-up|8|||
48753356|NCT03824912|156944202|FG000|Overall Study|Negative Baseline Culture Result|118|||
48753357|NCT03824912|156944203|FG001|Overall Study|Negative Baseline Culture Result|112|||
48753358|NCT03824912|156944204|FG002|Overall Study|Negative Baseline Culture Result|57|||
48753359|NCT03824912|156944202|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48753360|NCT03824912|156944203|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48753361|NCT03824912|156944204|FG002|Overall Study|Non-Compliance with Study Drug|1|||
48753362|NCT03824912|156944202|FG000|Overall Study|Protocol Violation|1|||
48753363|NCT03824912|156944203|FG001|Overall Study|Protocol Violation|4|||
48753364|NCT03824912|156944204|FG002|Overall Study|Protocol Violation|1|||
48753365|NCT03824912|156944202|FG000|Overall Study|Withdrawal by Subject|3|||
48753366|NCT03824912|156944203|FG001|Overall Study|Withdrawal by Subject|2|||
48753367|NCT03824912|156944204|FG002|Overall Study|Withdrawal by Subject|1|||
48753368|NCT03824912|156944202|FG000|Overall Study|Participation in another study|0|||
48753369|NCT03824912|156944203|FG001|Overall Study|Participation in another study|1|||
48753370|NCT03824912|156944204|FG002|Overall Study|Participation in another study|0|||
48753371|NCT01349803|156944205|FG000|Overall Study|Adverse Event|0|||
48753372|NCT01349803|156944206|FG001|Overall Study|Adverse Event|0|||
48753373|NCT01349803|156944207|FG002|Overall Study|Adverse Event|0|||
48753374|NCT01349803|156944208|FG003|Overall Study|Adverse Event|2|||
48753375|NCT01349803|156944205|FG000|Overall Study|Withdrawal by Subject|1|||
48753376|NCT01349803|156944206|FG001|Overall Study|Withdrawal by Subject|0|||
48753377|NCT01349803|156944207|FG002|Overall Study|Withdrawal by Subject|0|||
48753378|NCT01349803|156944208|FG003|Overall Study|Withdrawal by Subject|0|||
48753379|NCT01349803|156944205|FG000|Overall Study|Protocol-specified criteria|0|||
48753380|NCT01349803|156944206|FG001|Overall Study|Protocol-specified criteria|1|||
48332968|NCT03150589|155415939|FG000|Overall Study|Adverse Event|7|||
48651799|NCT04532294|156576143|FG000|Overall Study|Participants Not Dosed|0|||
48651800|NCT04532294|156576144|FG001|Overall Study|Participants Not Dosed|0|||
48651801|NCT04532294|156576145|FG002|Overall Study|Participants Not Dosed|2|||
48651802|NCT04382586|156576146|FG000|Overall Study|Death|3|||
48651803|NCT04382586|156576147|FG001|Overall Study|Death|4|||
48651804|NCT04382586|156576146|FG000|Overall Study|Lost to Follow-up|11|||
48651805|NCT04382586|156576147|FG001|Overall Study|Lost to Follow-up|8|||
48651806|NCT04382586|156576146|FG000|Overall Study|Withdrawal by Subject|3|||
48651807|NCT04382586|156576147|FG001|Overall Study|Withdrawal by Subject|1|||
48651808|NCT04382586|156576146|FG000|Overall Study|Physician Decision|0|||
48651809|NCT04382586|156576147|FG001|Overall Study|Physician Decision|3|||
48753381|NCT01349803|156944207|FG002|Overall Study|Protocol-specified criteria|3|||
48753382|NCT01349803|156944208|FG003|Overall Study|Protocol-specified criteria|0|||
48651810|NCT02438683|156576151|FG000|Overall Study|Adverse Event|1|||
48651811|NCT02438683|156576152|FG001|Overall Study|Adverse Event|0|||
48651812|NCT02438683|156576153|FG002|Overall Study|Adverse Event|0|||
48651813|NCT02438683|156576154|FG003|Overall Study|Adverse Event|0|||
48651814|NCT02438683|156576155|FG004|Overall Study|Adverse Event|0|||
48651815|NCT02438683|156576156|FG005|Overall Study|Adverse Event|0|||
48651816|NCT04621240|156576157|FG000|Overall Study|Withdrawal by Subject|36|||
48651817|NCT00830375|156576158|FG000|Overall Study|Lost to Follow-up|1|||
48651818|NCT03315793|156576160|FG000|Overall Study|Adverse Event|4|||
48651819|NCT03315793|156576161|FG001|Overall Study|Adverse Event|2|||
48651820|NCT03315793|156576160|FG000|Overall Study|Protocol Deviation|1|||
48651821|NCT03315793|156576161|FG001|Overall Study|Protocol Deviation|0|||
48651822|NCT03315793|156576160|FG000|Overall Study|Difficult for regular visit|0|||
48651823|NCT03315793|156576161|FG001|Overall Study|Difficult for regular visit|1|||
48651824|NCT04790279|156577825|FG000|Overall Study|Did not meet medication start criteria|27|||
48651825|NCT04790279|156577826|FG001|Overall Study|Did not meet medication start criteria|15|||
48651826|NCT04790279|156577825|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
48651827|NCT04790279|156577826|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
48651828|NCT04790279|156577825|FG000|Overall Study|Protocol Violation|8|||
48651829|NCT04790279|156577826|FG001|Overall Study|Protocol Violation|3|||
48753383|NCT01244906|156944209|FG000|Overall Study|Death|2|||
48753384|NCT01244906|156944209|FG000|Overall Study|Progression of disease post treatment|6|||
48753385|NCT03934931|156944210|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
48753386|NCT03934931|156944211|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
48753387|NCT03934931|156944212|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
48332969|NCT03150589|155415940|FG001|Overall Study|Adverse Event|6|||
48332970|NCT03150589|155415939|FG000|Overall Study|Protocol Violation|4|||
48332971|NCT03150589|155415940|FG001|Overall Study|Protocol Violation|3|||
48651830|NCT04790279|156577825|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
48651831|NCT04790279|156577826|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
48651832|NCT00316706|156577827|FG000|Overall Study|Lost to Follow-up|38|||
48332972|NCT03150589|155415939|FG000|Overall Study|Lost to Follow-up|3|||
48332973|NCT03150589|155415940|FG001|Overall Study|Lost to Follow-up|3|||
48332974|NCT03150589|155415939|FG000|Overall Study|Death|2|||
48332975|NCT03150589|155415940|FG001|Overall Study|Death|3|||
48332976|NCT03150589|155415939|FG000|Overall Study|IP non-compliance and other reasons|12|||
48332977|NCT03150589|155415940|FG001|Overall Study|IP non-compliance and other reasons|3|||
48332978|NCT01029925|155415941|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
48332979|NCT01029925|155415941|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
48332980|NCT01029925|155415941|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
48332981|NCT01020435|155415944|FG000|Overall Study|Lost to Follow-up|0|||
48332982|NCT01020435|155415945|FG001|Overall Study|Lost to Follow-up|1|||
48332983|NCT01916109|155415949|FG000|Overall Study|Withdrawal by Subject|1|||
48332984|NCT02006641|155415952|FG000|Overall Study|Withdrawal before treatment|2|||
48332985|NCT02006641|155415953|FG001|Overall Study|Withdrawal before treatment|5|||
48332986|NCT02006641|155415954|FG002|Overall Study|Withdrawal before treatment|3|||
48332987|NCT02006641|155415952|FG000|Overall Study|Adverse Event|15|||
48332988|NCT02006641|155415953|FG001|Overall Study|Adverse Event|11|||
48332989|NCT02006641|155415954|FG002|Overall Study|Adverse Event|15|||
48332990|NCT02006641|155415952|FG000|Overall Study|Protocol Violation|0|||
48332991|NCT02006641|155415953|FG001|Overall Study|Protocol Violation|2|||
48332992|NCT02006641|155415954|FG002|Overall Study|Protocol Violation|2|||
48651833|NCT00316706|156577828|FG001|Overall Study|Lost to Follow-up|48|||
48651834|NCT03640325|156577829|FG000|Overall Study|Withdrawal by Subject|4|||
48651835|NCT03640325|156577830|FG001|Overall Study|Withdrawal by Subject|1|||
48651836|NCT03640325|156577831|FG002|Overall Study|Withdrawal by Subject|0|||
48651837|NCT03640325|156577829|FG000|Overall Study|Lost to Follow-up|4|||
48753388|NCT00460408|156944213|FG000|Overall Study|Adverse Event|1|||
48753389|NCT00460408|156944214|FG001|Overall Study|Adverse Event|0|||
48753390|NCT00460408|156944215|FG002|Overall Study|Adverse Event|0|||
48753391|NCT00460408|156944216|FG003|Overall Study|Adverse Event|0|||
48332993|NCT02006641|155415952|FG000|Overall Study|Lost to Follow-up|0|||
48332994|NCT02006641|155415953|FG001|Overall Study|Lost to Follow-up|1|||
48332995|NCT02006641|155415954|FG002|Overall Study|Lost to Follow-up|0|||
48332996|NCT02006641|155415952|FG000|Overall Study|Withdrawal by Subject|7|||
48332997|NCT02006641|155415953|FG001|Overall Study|Withdrawal by Subject|12|||
48332998|NCT02006641|155415954|FG002|Overall Study|Withdrawal by Subject|11|||
48332999|NCT02006641|155415952|FG000|Overall Study|Other reason: patient didn't show up|1|||
48333000|NCT02006641|155415953|FG001|Overall Study|Other reason: patient didn't show up|0|||
48333001|NCT02006641|155415954|FG002|Overall Study|Other reason: patient didn't show up|0|||
48651838|NCT03640325|156577830|FG001|Overall Study|Lost to Follow-up|5|||
48651839|NCT03640325|156577831|FG002|Overall Study|Lost to Follow-up|21|||
48651840|NCT03640325|156577829|FG000|Overall Study|Death|5|||
48651841|NCT03640325|156577830|FG001|Overall Study|Death|5|||
48651842|NCT03640325|156577831|FG002|Overall Study|Death|0|||
48651843|NCT03493451|156577832|FG000|Overall Study|Death|11|||
48651844|NCT03493451|156577833|FG001|Overall Study|Death|26|||
48651845|NCT03493451|156577834|FG002|Overall Study|Death|3|||
48651846|NCT03493451|156577832|FG000|Overall Study|Lost to Follow-up|1|||
48651847|NCT03493451|156577833|FG001|Overall Study|Lost to Follow-up|4|||
48651848|NCT03493451|156577834|FG002|Overall Study|Lost to Follow-up|1|||
48651849|NCT03493451|156577832|FG000|Overall Study|Withdrawal by Subject|1|||
48651850|NCT03493451|156577833|FG001|Overall Study|Withdrawal by Subject|1|||
48651851|NCT03493451|156577834|FG002|Overall Study|Withdrawal by Subject|2|||
48651852|NCT03493451|156577832|FG000|Overall Study|Progressive Disease|1|||
48333002|NCT02006641|155415952|FG000|Overall Study|Other reason:patient didn't want to come|0|||
48333003|NCT02006641|155415953|FG001|Overall Study|Other reason:patient didn't want to come|0|||
48333004|NCT02006641|155415954|FG002|Overall Study|Other reason:patient didn't want to come|1|||
48333005|NCT02006641|155415952|FG000|Overall Study|Other reason: patient has moved|1|||
48333006|NCT02006641|155415953|FG001|Overall Study|Other reason: patient has moved|0|||
48333007|NCT02006641|155415954|FG002|Overall Study|Other reason: patient has moved|1|||
48651853|NCT03493451|156577833|FG001|Overall Study|Progressive Disease|0|||
48651854|NCT03493451|156577834|FG002|Overall Study|Progressive Disease|0|||
48651855|NCT03493451|156577832|FG000|Overall Study|Transferred to long term extension study|8|||
48651856|NCT03493451|156577833|FG001|Overall Study|Transferred to long term extension study|13|||
48651857|NCT03493451|156577834|FG002|Overall Study|Transferred to long term extension study|5|||
48651858|NCT01133756|156577835|FG000|Overall Study|Adverse Event|1|||
48651859|NCT01133756|156577836|FG001|Overall Study|Adverse Event|2|||
48651860|NCT01133756|156577837|FG002|Overall Study|Adverse Event|1|||
48651861|NCT01133756|156577835|FG000|Overall Study|Investigator Decision|1|||
48651862|NCT01133756|156577836|FG001|Overall Study|Investigator Decision|0|||
48651863|NCT01133756|156577837|FG002|Overall Study|Investigator Decision|0|||
48651864|NCT01133756|156577835|FG000|Overall Study|Withdrawal by Subject|0|||
48651865|NCT01133756|156577836|FG001|Overall Study|Withdrawal by Subject|1|||
48651866|NCT01133756|156577837|FG002|Overall Study|Withdrawal by Subject|0|||
48651867|NCT01133756|156577835|FG000|Overall Study|Progression of Disease|0|||
48651868|NCT01133756|156577836|FG001|Overall Study|Progression of Disease|0|||
48651869|NCT01133756|156577837|FG002|Overall Study|Progression of Disease|1|||
48651870|NCT03430843|156577840|FG000|Overall Study|Death|233|||
48651871|NCT03430843|156577841|FG001|Overall Study|Death|233|||
48651872|NCT03430843|156577840|FG000|Overall Study|Sponsor Decision|17|||
48651873|NCT03430843|156577841|FG001|Overall Study|Sponsor Decision|6|||
48651874|NCT03430843|156577840|FG000|Overall Study|Withdrawal by Subject|5|||
48651875|NCT03430843|156577841|FG001|Overall Study|Withdrawal by Subject|14|||
48651876|NCT03430843|156577840|FG000|Overall Study|Lost to Follow-up|1|||
48651877|NCT03430843|156577841|FG001|Overall Study|Lost to Follow-up|3|||
48651878|NCT03941873|156577842|FG000|Overall Study|Death|0|||
48651879|NCT03941873|156577843|FG001|Overall Study|Death|12|||
48651880|NCT03941873|156577844|FG002|Overall Study|Death|2|||
48651881|NCT03941873|156577845|FG003|Overall Study|Death|53|||
48651882|NCT03941873|156577842|FG000|Overall Study|Withdrawal by Subject|1|||
48651883|NCT03941873|156577843|FG001|Overall Study|Withdrawal by Subject|1|||
48651884|NCT03941873|156577844|FG002|Overall Study|Withdrawal by Subject|0|||
48651885|NCT03941873|156577845|FG003|Overall Study|Withdrawal by Subject|5|||
48651886|NCT03941873|156577842|FG000|Overall Study|Lost to Follow-up|1|||
48651887|NCT03941873|156577843|FG001|Overall Study|Lost to Follow-up|2|||
48651888|NCT03941873|156577844|FG002|Overall Study|Lost to Follow-up|0|||
48651889|NCT03941873|156577845|FG003|Overall Study|Lost to Follow-up|0|||
48651890|NCT03941873|156577842|FG000|Overall Study|Sponsor Decision|0|||
48651891|NCT03941873|156577843|FG001|Overall Study|Sponsor Decision|6|||
48651892|NCT03941873|156577844|FG002|Overall Study|Sponsor Decision|0|||
48651893|NCT03941873|156577845|FG003|Overall Study|Sponsor Decision|15|||
48651894|NCT03520920|156577853|FG000|Overall Study|Death|13|||
48651895|NCT03520920|156577854|FG001|Overall Study|Death|1|||
48753392|NCT00460408|156944213|FG000|Overall Study|Death|7|||
48753393|NCT00460408|156944214|FG001|Overall Study|Death|0|||
48753394|NCT00460408|156944215|FG002|Overall Study|Death|0|||
48753395|NCT00460408|156944216|FG003|Overall Study|Death|0|||
48753396|NCT00460408|156944213|FG000|Overall Study|Lost to Follow-up|11|||
48753397|NCT00460408|156944214|FG001|Overall Study|Lost to Follow-up|0|||
48753398|NCT00460408|156944215|FG002|Overall Study|Lost to Follow-up|1|||
48753399|NCT00460408|156944216|FG003|Overall Study|Lost to Follow-up|0|||
48753400|NCT00460408|156944213|FG000|Overall Study|Withdrawal by Subject|31|||
48753401|NCT00460408|156944214|FG001|Overall Study|Withdrawal by Subject|0|||
48753402|NCT00460408|156944215|FG002|Overall Study|Withdrawal by Subject|0|||
48753403|NCT00460408|156944216|FG003|Overall Study|Withdrawal by Subject|0|||
48333008|NCT02006641|155415952|FG000|Overall Study|Other reason: caregiver in hospital|0|||
48651896|NCT03520920|156577855|FG002|Overall Study|Death|0|||
48651897|NCT03520920|156577853|FG000|Overall Study|Withdrawal by Subject|2|||
48651898|NCT03520920|156577854|FG001|Overall Study|Withdrawal by Subject|1|||
48651899|NCT03520920|156577855|FG002|Overall Study|Withdrawal by Subject|0|||
48651900|NCT03520920|156577853|FG000|Overall Study|Study Terminated by the Sponsor|5|||
48753404|NCT00460408|156944213|FG000|Overall Study|Insufficient clinical response|5|||
48753405|NCT00460408|156944214|FG001|Overall Study|Insufficient clinical response|1|||
48651901|NCT03520920|156577854|FG001|Overall Study|Study Terminated by the Sponsor|14|||
48651902|NCT03520920|156577855|FG002|Overall Study|Study Terminated by the Sponsor|5|||
48651903|NCT04952597|156577859|FG000|Overall Study|Death|12|||
48651904|NCT04952597|156577860|FG001|Overall Study|Death|13|||
48651905|NCT04952597|156577861|FG002|Overall Study|Death|14|||
48651906|NCT04952597|156577859|FG000|Overall Study|Withdrawal by Subject|1|||
48651907|NCT04952597|156577860|FG001|Overall Study|Withdrawal by Subject|0|||
48651908|NCT04952597|156577861|FG002|Overall Study|Withdrawal by Subject|3|||
48651909|NCT04952597|156577859|FG000|Overall Study|Lost to Follow-up|0|||
48651910|NCT04952597|156577860|FG001|Overall Study|Lost to Follow-up|1|||
48651911|NCT04952597|156577861|FG002|Overall Study|Lost to Follow-up|1|||
48651912|NCT01092780|156577866|FG000|Washout Period 1|Adverse Event|0|||
48651913|NCT01092780|156577867|FG001|Washout Period 1|Adverse Event|1|||
48651914|NCT01092780|156577868|FG002|Washout Period 1|Adverse Event|0|||
48651915|NCT01092780|156577869|FG003|Washout Period 1|Adverse Event|0|||
48651916|NCT01092780|156577866|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
48651917|NCT01092780|156577867|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
48651918|NCT01092780|156577868|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
48651919|NCT01092780|156577869|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
48651920|NCT01092780|156577866|FG000|Washout Period 2|Adverse Event|0|||
48651921|NCT01092780|156577867|FG001|Washout Period 2|Adverse Event|1|||
48651922|NCT01092780|156577868|FG002|Washout Period 2|Adverse Event|1|||
48651923|NCT01092780|156577869|FG003|Washout Period 2|Adverse Event|0|||
48651924|NCT03994211|156577874|FG000|Core Phase|Adverse Event|0|||
48651925|NCT03994211|156577875|FG001|Core Phase|Adverse Event|1|||
48651926|NCT03994211|156577876|FG002|Core Phase|Adverse Event|0|||
48651927|NCT03994211|156577874|FG000|Extension Phase|Adverse Event|0|||
48651928|NCT03994211|156577875|FG001|Extension Phase|Adverse Event|0|||
48651929|NCT03994211|156577876|FG002|Extension Phase|Adverse Event|1|||
48651930|NCT03994211|156577874|FG000|Extension Phase|Physician Decision|0|||
48651931|NCT03994211|156577875|FG001|Extension Phase|Physician Decision|0|||
48651932|NCT03994211|156577876|FG002|Extension Phase|Physician Decision|1|||
48651933|NCT03994211|156577874|FG000|Extension Phase|Progressive Disease|0|||
48651934|NCT03994211|156577875|FG001|Extension Phase|Progressive Disease|0|||
48651935|NCT03994211|156577876|FG002|Extension Phase|Progressive Disease|20|||
48651936|NCT03994211|156577874|FG000|Extension Phase|Withdrawal by Subject|0|||
48651937|NCT03994211|156577875|FG001|Extension Phase|Withdrawal by Subject|0|||
48651938|NCT03994211|156577876|FG002|Extension Phase|Withdrawal by Subject|2|||
48651939|NCT01555073|156577881|FG000|Overall Study|Lost to Follow-up|1|||
48651940|NCT01555073|156577882|FG001|Overall Study|Lost to Follow-up|2|||
48651941|NCT01555073|156577883|FG002|Overall Study|Lost to Follow-up|0|||
48651942|NCT01555073|156577884|FG003|Overall Study|Lost to Follow-up|5|||
48651943|NCT01355679|156577885|FG000|Overall Study|benign tumor types found at biopsy|2|||
48651944|NCT01066104|156577886|FG000|Overall Study|Adverse Event|1|||
48651945|NCT01066104|156577887|FG001|Overall Study|Adverse Event|1|||
48651946|NCT01066104|156577886|FG000|Overall Study|Protocol Violation|1|||
48651947|NCT01066104|156577887|FG001|Overall Study|Protocol Violation|0|||
48651948|NCT04660552|156577888|FG000|Overall Study|Withdrawal by Subject|3|||
48651949|NCT04660552|156577889|FG001|Overall Study|Withdrawal by Subject|1|||
48651950|NCT00964002|156577894|FG000|Overall Study|Protocol Violation|8|||
48651951|NCT00271856|156577900|FG000|Overall Study|Withdrawal by Subject|1|||
48651952|NCT00271856|156577901|FG001|Overall Study|Withdrawal by Subject|7|||
48651953|NCT00271856|156577900|FG000|Overall Study|Lost to Follow-up|10|||
48651954|NCT00271856|156577901|FG001|Overall Study|Lost to Follow-up|11|||
48651955|NCT02091362|156577902|FG000|Period 1|Protocol Violation|1|||
48651956|NCT02091362|156577903|FG001|Period 1|Protocol Violation|0|||
48651957|NCT02091362|156577902|FG000|Period 1|Withdrawal by Subject|2|||
48651958|NCT02091362|156577903|FG001|Period 1|Withdrawal by Subject|3|||
48651959|NCT02091362|156577902|FG000|Period 1|Lost to Follow-up|0|||
48651960|NCT02091362|156577903|FG001|Period 1|Lost to Follow-up|1|||
48651961|NCT02091362|156577902|FG000|Period 1|Adverse Event|2|||
48651962|NCT02091362|156577903|FG001|Period 1|Adverse Event|0|||
48651963|NCT02091362|156577902|FG000|Wash-out|Lost to Follow-up|1|||
48651964|NCT02091362|156577903|FG001|Wash-out|Lost to Follow-up|1|||
48651965|NCT02091362|156577902|FG000|Wash-out|Withdrawal by Subject|0|||
48651966|NCT02091362|156577903|FG001|Wash-out|Withdrawal by Subject|2|||
48651967|NCT02091362|156577902|FG000|Period 2|Adverse Event|1|||
48651968|NCT02091362|156577903|FG001|Period 2|Adverse Event|0|||
48651969|NCT02091362|156577902|FG000|Period 2|Lost to Follow-up|0|||
48651970|NCT02091362|156577903|FG001|Period 2|Lost to Follow-up|1|||
48651971|NCT02091362|156577902|FG000|Period 2|Withdrawal by Subject|1|||
48651972|NCT02091362|156577903|FG001|Period 2|Withdrawal by Subject|1|||
48651973|NCT04004221|156577906|FG000|Overall Study|Death|89|||
48651974|NCT04004221|156577906|FG000|Overall Study|Withdrawal by Subject|5|||
48651975|NCT04004221|156577906|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
48651976|NCT04004221|156577906|FG000|Overall Study|Sponsor Decision|9|||
48651977|NCT04004221|156577906|FG000|Overall Study|Participant refused to enter LTE|1|||
48651978|NCT04470050|156577907|FG000|Double-blind Treatment Phase|Adverse Event|0|||
48651979|NCT04470050|156577908|FG001|Double-blind Treatment Phase|Adverse Event|0|||
48651980|NCT04470050|156577909|FG002|Double-blind Treatment Phase|Adverse Event|0|||
48651981|NCT04470050|156577910|FG003|Double-blind Treatment Phase|Adverse Event|1|||
48651982|NCT04470050|156577911|FG004|Double-blind Treatment Phase|Adverse Event|0|||
48651983|NCT04470050|156577912|FG005|Double-blind Treatment Phase|Adverse Event|0|||
48651984|NCT04470050|156577913|FG006|Double-blind Treatment Phase|Adverse Event|0|||
48651985|NCT04470050|156577907|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48651986|NCT04470050|156577908|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
48651987|NCT04470050|156577909|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
48651988|NCT04470050|156577910|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
48651989|NCT04470050|156577911|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
48651990|NCT04470050|156577912|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
48651991|NCT04470050|156577913|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
48651992|NCT04470050|156577907|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
48651993|NCT04470050|156577908|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
48651994|NCT04470050|156577909|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
48651995|NCT04470050|156577910|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
48651996|NCT04470050|156577911|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
48651997|NCT04470050|156577912|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
48651998|NCT04470050|156577913|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
48651999|NCT01581021|156577916|FG000|Overall Study|Lost to Follow-up|4|||
48652000|NCT01581021|156577917|FG001|Overall Study|Lost to Follow-up|6|||
48652001|NCT01581021|156577916|FG000|Overall Study|More than 2 hooks in thoracic|3|||
48652002|NCT01581021|156577917|FG001|Overall Study|More than 2 hooks in thoracic|0|||
48652003|NCT01581021|156577916|FG000|Overall Study|Neuromuscular|2|||
48652004|NCT01581021|156577917|FG001|Overall Study|Neuromuscular|1|||
48652005|NCT01581021|156577916|FG000|Overall Study|Not Randomized|1|||
48333009|NCT02006641|155415953|FG001|Overall Study|Other reason: caregiver in hospital|1|||
48333010|NCT02006641|155415954|FG002|Overall Study|Other reason: caregiver in hospital|0|||
48333011|NCT02006641|155415952|FG000|Overall Study|Other reason: patient's wife has died|0|||
48652006|NCT01581021|156577917|FG001|Overall Study|Not Randomized|2|||
48652007|NCT01581021|156577916|FG000|Overall Study|Lenke 6 Classification|0|||
48652008|NCT01581021|156577917|FG001|Overall Study|Lenke 6 Classification|1|||
48333012|NCT02006641|155415953|FG001|Overall Study|Other reason: patient's wife has died|0|||
48333013|NCT02006641|155415954|FG002|Overall Study|Other reason: patient's wife has died|1|||
48652009|NCT01581021|156577916|FG000|Overall Study|Lack of Efficacy|0|||
48652010|NCT01581021|156577917|FG001|Overall Study|Lack of Efficacy|1|||
48652011|NCT00613327|156577926|FG000|Overall Study|Adverse Event|38|||
48652012|NCT00613327|156577926|FG000|Overall Study|Lost to Follow-up|8|||
48652013|NCT00613327|156577926|FG000|Overall Study|Withdrawal by Subject|6|||
48383948|NCT00764751|155601512|FG001|Overall Study|Adverse Event|1|||
48652014|NCT00613327|156577926|FG000|Overall Study|Protocol Violation|2|||
48652015|NCT00613327|156577926|FG000|Overall Study|Other|47|||
48652016|NCT03028129|156577927|FG000|Overall Study|Adverse Event|13|||
48652017|NCT03028129|156577928|FG001|Overall Study|Adverse Event|2|||
48652018|NCT03028129|156577927|FG000|Overall Study|Lost to Follow-up|50|||
48652019|NCT03028129|156577928|FG001|Overall Study|Lost to Follow-up|38|||
48652020|NCT03028129|156577927|FG000|Overall Study|Physician Decision|0|||
48652021|NCT03028129|156577928|FG001|Overall Study|Physician Decision|1|||
48652022|NCT03028129|156577927|FG000|Overall Study|Protocol Violation|1|||
48652023|NCT03028129|156577928|FG001|Overall Study|Protocol Violation|1|||
48652024|NCT03028129|156577927|FG000|Overall Study|Withdrawal by Subject|62|||
48652025|NCT03028129|156577928|FG001|Overall Study|Withdrawal by Subject|45|||
48652026|NCT04222699|156577931|FG000|Overall Study|Lost to Follow-up|2|||
48333014|NCT02006641|155415952|FG000|Overall Study|Other reason: hospitalisation|0|||
48333015|NCT02006641|155415953|FG001|Overall Study|Other reason: hospitalisation|1|||
48333016|NCT02006641|155415954|FG002|Overall Study|Other reason: hospitalisation|0|||
48333017|NCT02006641|155415952|FG000|Overall Study|Other reason: caregiver impossibility|0|||
48333018|NCT02006641|155415953|FG001|Overall Study|Other reason: caregiver impossibility|0|||
48652027|NCT00700882|156577932|FG000|Overall Study|Never received treatment|6|||
48652028|NCT00700882|156577932|FG000|Overall Study|Ineligible|2|||
48652029|NCT00700882|156577932|FG000|Overall Study|No KIT mutation|51|||
48652030|NCT01076205|156577935|FG000|Overall Study|Adverse Drug Reaction|299|||
48652031|NCT01076205|156577935|FG000|Overall Study|Lack of Effectiveness|1423|||
48652032|NCT01076205|156577935|FG000|Overall Study|Other Reason|1075|||
48652033|NCT01076205|156577935|FG000|Overall Study|Unknown Reason|71|||
48652034|NCT01076205|156577935|FG000|Overall Study|Lost to Follow-up|3151|||
48652035|NCT00361231|156577936|FG000|Overall Study|Physician Decision|3|||
48652036|NCT00361231|156577936|FG000|Overall Study|Symptomatic deterioration|5|||
48652037|NCT00361231|156577936|FG000|Overall Study|Radiographic disease progression|16|||
48652038|NCT00361231|156577936|FG000|Overall Study|Withdrawal by Subject|4|||
48652039|NCT00361231|156577936|FG000|Overall Study|Adverse Event|6|||
48652040|NCT01030952|156577937|FG000|Overall Study|Protocol Violation|0|||
48652041|NCT01030952|156577938|FG001|Overall Study|Protocol Violation|1|||
48652042|NCT01030952|156577937|FG000|Overall Study|Informed consent withdrawal|1|||
48652043|NCT01030952|156577938|FG001|Overall Study|Informed consent withdrawal|0|||
48652044|NCT01030952|156577937|FG000|Overall Study|Lost to Follow-up|0|||
48652045|NCT01030952|156577938|FG001|Overall Study|Lost to Follow-up|1|||
48652046|NCT01030952|156577937|FG000|Overall Study|Unexplained|1|||
48652047|NCT01030952|156577938|FG001|Overall Study|Unexplained|1|||
48652048|NCT01732510|156577947|FG000|Overall Study|Adverse Event|0|||
48652049|NCT01732510|156577948|FG001|Overall Study|Adverse Event|1|||
48652050|NCT01732510|156577949|FG002|Overall Study|Adverse Event|1|||
48652051|NCT01732510|156577950|FG003|Overall Study|Adverse Event|0|||
48652052|NCT01732510|156577951|FG004|Overall Study|Adverse Event|0|||
48652053|NCT01732510|156577952|FG005|Overall Study|Adverse Event|0|||
48652054|NCT01732510|156577953|FG006|Overall Study|Adverse Event|1|||
48652055|NCT01732510|156577947|FG000|Overall Study|Protocol Violation|0|||
48652056|NCT01732510|156577948|FG001|Overall Study|Protocol Violation|0|||
48652057|NCT01732510|156577949|FG002|Overall Study|Protocol Violation|0|||
48652058|NCT01732510|156577950|FG003|Overall Study|Protocol Violation|1|||
48753406|NCT00460408|156944215|FG002|Overall Study|Insufficient clinical response|5|||
48753407|NCT00460408|156944216|FG003|Overall Study|Insufficient clinical response|0|||
48753408|NCT00460408|156944213|FG000|Overall Study|Other|12|||
48753409|NCT00460408|156944214|FG001|Overall Study|Other|2|||
48753410|NCT00460408|156944215|FG002|Overall Study|Other|0|||
48753411|NCT00460408|156944216|FG003|Overall Study|Other|0|||
48753412|NCT00865124|156944217|FG000|Overall Study|Physician Decision|2|||
48753413|NCT00865124|156944218|FG001|Overall Study|Physician Decision|1|||
48753414|NCT00865124|156944219|FG002|Overall Study|Physician Decision|0|||
48753415|NCT00865124|156944217|FG000|Overall Study|Withdrawn consent|2|||
48652059|NCT01732510|156577951|FG004|Overall Study|Protocol Violation|0|||
48652060|NCT01732510|156577952|FG005|Overall Study|Protocol Violation|0|||
48652061|NCT01732510|156577953|FG006|Overall Study|Protocol Violation|0|||
48753416|NCT00865124|156944218|FG001|Overall Study|Withdrawn consent|0|||
48753417|NCT00865124|156944219|FG002|Overall Study|Withdrawn consent|0|||
48753418|NCT01601626|156944220|FG000|Overall Study|Death|1|||
48753419|NCT01601626|156944221|FG001|Overall Study|Death|1|||
48753420|NCT01601626|156944222|FG002|Overall Study|Death|1|||
48753421|NCT01601626|156944220|FG000|Overall Study|Lost to Follow-up|1|||
48753422|NCT01601626|156944221|FG001|Overall Study|Lost to Follow-up|2|||
48333019|NCT02006641|155415954|FG002|Overall Study|Other reason: caregiver impossibility|1|||
48652062|NCT01732510|156577947|FG000|Overall Study|Withdrawal by Subject|1|||
48652063|NCT01732510|156577948|FG001|Overall Study|Withdrawal by Subject|3|||
48652064|NCT01732510|156577949|FG002|Overall Study|Withdrawal by Subject|2|||
48652065|NCT01732510|156577950|FG003|Overall Study|Withdrawal by Subject|1|||
48652066|NCT01732510|156577951|FG004|Overall Study|Withdrawal by Subject|5|||
48652067|NCT01732510|156577952|FG005|Overall Study|Withdrawal by Subject|0|||
48753423|NCT01601626|156944222|FG002|Overall Study|Lost to Follow-up|0|||
48753424|NCT01601626|156944220|FG000|Overall Study|Unable to Get to Clinic|0|||
48753425|NCT01601626|156944221|FG001|Overall Study|Unable to Get to Clinic|1|||
48753426|NCT01601626|156944222|FG002|Overall Study|Unable to Get to Clinic|0|||
48652068|NCT01732510|156577953|FG006|Overall Study|Withdrawal by Subject|1|||
48652069|NCT01732510|156577947|FG000|Overall Study|Lost to Follow-up|0|||
48652070|NCT01732510|156577948|FG001|Overall Study|Lost to Follow-up|0|||
48652071|NCT01732510|156577949|FG002|Overall Study|Lost to Follow-up|1|||
48652072|NCT01732510|156577950|FG003|Overall Study|Lost to Follow-up|1|||
48652073|NCT01732510|156577951|FG004|Overall Study|Lost to Follow-up|0|||
48333020|NCT02006641|155415952|FG000|Overall Study|Other reason: protocol non-compliance|0|||
48333021|NCT02006641|155415953|FG001|Overall Study|Other reason: protocol non-compliance|0|||
48333022|NCT02006641|155415954|FG002|Overall Study|Other reason: protocol non-compliance|1|||
48333023|NCT01670526|155415955|FG000|Overall Study|Withdrawal by Subject|3|||
48333024|NCT01670526|155415956|FG001|Overall Study|Withdrawal by Subject|1|||
48333025|NCT01670526|155415955|FG000|Overall Study|Lost to Follow-up|9|||
48333026|NCT01670526|155415956|FG001|Overall Study|Lost to Follow-up|5|||
48333027|NCT00537914|155415957|FG000|Overall Study|Death|1|||
48333028|NCT00537914|155415957|FG000|Overall Study|Adverse Event|7|||
48333029|NCT00537914|155415957|FG000|Overall Study|Treatment failure|10|||
48333030|NCT00537914|155415957|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
48333031|NCT00537914|155415957|FG000|Overall Study|Lost to Follow-up|19|||
48333032|NCT00537914|155415957|FG000|Overall Study|Withdrawal of informed consent|59|||
48333033|NCT01970527|155415958|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
48333034|NCT01970527|155415959|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
48333035|NCT01970527|155415958|FG000|Treatment|Disease progression|0|||
48333036|NCT01970527|155415959|FG001|Treatment|Disease progression|1|||
48333037|NCT01970527|155415958|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
48333038|NCT01970527|155415959|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
48333039|NCT01970527|155415958|FG000|Treatment|Death|0|||
48333040|NCT01970527|155415959|FG001|Treatment|Death|1|||
48333041|NCT01970527|155415958|FG000|Follow-up Clinic Visit|Disease progression|1|||
48333042|NCT01970527|155415959|FG001|Follow-up Clinic Visit|Disease progression|1|||
48333043|NCT01970527|155415958|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
48333044|NCT01970527|155415959|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
48333045|NCT01970527|155415958|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
48333046|NCT01970527|155415959|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
48333047|NCT00882050|155415964|FG000|Overall Study|Physician Decision|1|||
48333048|NCT00882050|155415965|FG001|Overall Study|Physician Decision|0|||
48333049|NCT00882050|155415966|FG002|Overall Study|Physician Decision|0|||
48333050|NCT01123200|155415967|FG000|Overall Study|Withdrawal by Subject|1|||
48333051|NCT01052714|155415968|FG000|Overall Study|Adverse Event|6|||
48333052|NCT01052714|155415969|FG001|Overall Study|Adverse Event|3|||
48333053|NCT01052714|155415970|FG002|Overall Study|Adverse Event|0|||
48333054|NCT01052714|155415968|FG000|Overall Study|Death|1|||
48333055|NCT01052714|155415969|FG001|Overall Study|Death|2|||
48333056|NCT01052714|155415970|FG002|Overall Study|Death|0|||
48333057|NCT01052714|155415968|FG000|Overall Study|Lost to Follow-up|2|||
48333058|NCT01052714|155415969|FG001|Overall Study|Lost to Follow-up|3|||
48333059|NCT01052714|155415970|FG002|Overall Study|Lost to Follow-up|0|||
48333060|NCT01052714|155415968|FG000|Overall Study|Physician Decision|9|||
48333061|NCT01052714|155415969|FG001|Overall Study|Physician Decision|9|||
48333062|NCT01052714|155415970|FG002|Overall Study|Physician Decision|1|||
48333063|NCT01052714|155415968|FG000|Overall Study|Withdrawal by Subject|7|||
48333064|NCT01052714|155415969|FG001|Overall Study|Withdrawal by Subject|12|||
48333065|NCT01052714|155415970|FG002|Overall Study|Withdrawal by Subject|1|||
48333066|NCT01517282|155415975|FG000|Overall Study|Consent withdrawn|0|||
48333067|NCT01517282|155415976|FG001|Overall Study|Consent withdrawn|1|||
48333068|NCT01517282|155415977|FG002|Overall Study|Consent withdrawn|1|||
48333069|NCT01517282|155415978|FG003|Overall Study|Consent withdrawn|1|||
48652074|NCT01732510|156577952|FG005|Overall Study|Lost to Follow-up|1|||
48652075|NCT01732510|156577953|FG006|Overall Study|Lost to Follow-up|0|||
48652076|NCT01732510|156577947|FG000|Overall Study|Physician Decision|0|||
48652077|NCT01732510|156577948|FG001|Overall Study|Physician Decision|1|||
48652078|NCT01732510|156577949|FG002|Overall Study|Physician Decision|0|||
48652079|NCT01732510|156577950|FG003|Overall Study|Physician Decision|0|||
48652080|NCT01732510|156577951|FG004|Overall Study|Physician Decision|0|||
48333070|NCT01517282|155415975|FG000|Overall Study|Physician Decision|1|||
48333071|NCT01517282|155415976|FG001|Overall Study|Physician Decision|0|||
48333072|NCT01517282|155415977|FG002|Overall Study|Physician Decision|0|||
48333073|NCT01517282|155415978|FG003|Overall Study|Physician Decision|0|||
48333074|NCT03242863|155415979|FG000|Study Week 1|Withdrawal by Subject|0|||
48333075|NCT03242863|155415980|FG001|Study Week 1|Withdrawal by Subject|1|||
48333076|NCT03242863|155415981|FG002|Study Week 1|Withdrawal by Subject|0|||
48333077|NCT03242863|155415982|FG003|Study Week 1|Withdrawal by Subject|0|||
48333078|NCT03242863|155415983|FG004|Study Week 1|Withdrawal by Subject|3|||
48333079|NCT03242863|155415984|FG005|Study Week 1|Withdrawal by Subject|0|||
48652081|NCT01732510|156577952|FG005|Overall Study|Physician Decision|0|||
48652082|NCT01732510|156577953|FG006|Overall Study|Physician Decision|0|||
48652083|NCT01732510|156577947|FG000|Overall Study|Pregnancy|0|||
48652084|NCT01732510|156577948|FG001|Overall Study|Pregnancy|0|||
48333080|NCT01945086|155415987|FG000|Overall Study|Withdrawal by Subject|1|||
48333081|NCT01945086|155415988|FG001|Overall Study|Withdrawal by Subject|0|||
48333082|NCT01945086|155415989|FG002|Overall Study|Withdrawal by Subject|1|||
48333083|NCT01945086|155415987|FG000|Overall Study|Adverse Event|0|||
48333084|NCT01945086|155415988|FG001|Overall Study|Adverse Event|0|||
48333085|NCT01945086|155415989|FG002|Overall Study|Adverse Event|1|||
48333086|NCT01186809|155415990|FG000|Overall Study|Death|30|||
48333087|NCT00383500|155415991|FG000|Overall Study|Withdrawal by Subject|8|||
48333088|NCT00383500|155415992|FG001|Overall Study|Withdrawal by Subject|3|||
48333089|NCT00383500|155415993|FG002|Overall Study|Withdrawal by Subject|0|||
48333090|NCT00383500|155415991|FG000|Overall Study|Lost to Follow-up|0|||
48333091|NCT00383500|155415992|FG001|Overall Study|Lost to Follow-up|0|||
48652085|NCT01732510|156577949|FG002|Overall Study|Pregnancy|0|||
48333092|NCT00383500|155415993|FG002|Overall Study|Lost to Follow-up|2|||
48333093|NCT02196259|155417606|FG000|Overall Study|Researcher choice|0|||
48333094|NCT02196259|155417607|FG001|Overall Study|Researcher choice|0|||
48333095|NCT02196259|155417608|FG002|Overall Study|Researcher choice|1|||
48333096|NCT02196259|155417606|FG000|Overall Study|Partial data analysis|0|||
48333097|NCT02196259|155417607|FG001|Overall Study|Partial data analysis|3|||
48333098|NCT02196259|155417608|FG002|Overall Study|Partial data analysis|0|||
48333099|NCT03823703|155417609|FG000|Overall Study|Sponsor request|0|||
48333100|NCT03823703|155417610|FG001|Overall Study|Sponsor request|3|||
48333101|NCT03823703|155417611|FG002|Overall Study|Sponsor request|4|||
48333102|NCT03823703|155417609|FG000|Overall Study|Adverse Event|3|||
48333103|NCT03823703|155417610|FG001|Overall Study|Adverse Event|1|||
48333104|NCT03823703|155417611|FG002|Overall Study|Adverse Event|0|||
48333105|NCT03823703|155417609|FG000|Overall Study|Withdrawal by Subject|0|||
48333106|NCT03823703|155417610|FG001|Overall Study|Withdrawal by Subject|1|||
48333107|NCT03823703|155417611|FG002|Overall Study|Withdrawal by Subject|0|||
48333108|NCT02710669|155417614|FG000|Overall Study|Physician Decision|2|||
48333109|NCT02710669|155417615|FG001|Overall Study|Physician Decision|1|||
48333110|NCT02710669|155417616|FG002|Overall Study|Physician Decision|0|||
48333111|NCT02710669|155417614|FG000|Overall Study|Institutional delays (including COVID)|2|||
48333112|NCT02710669|155417615|FG001|Overall Study|Institutional delays (including COVID)|2|||
48333113|NCT02710669|155417616|FG002|Overall Study|Institutional delays (including COVID)|0|||
48333114|NCT02710669|155417614|FG000|Overall Study|arrived in afib/aflutter|10|||
48333115|NCT02710669|155417615|FG001|Overall Study|arrived in afib/aflutter|8|||
48333116|NCT02710669|155417616|FG002|Overall Study|arrived in afib/aflutter|2|||
48333117|NCT04323800|155417619|FG000|Overall Study|Withdrawal by Subject|4|||
48333118|NCT04323800|155417620|FG001|Overall Study|Withdrawal by Subject|4|||
48333119|NCT04323800|155417619|FG000|Overall Study|Incomplete transfusion|1|||
48333120|NCT04323800|155417620|FG001|Overall Study|Incomplete transfusion|0|||
48333121|NCT04323800|155417619|FG000|Overall Study|Other|0|||
48333122|NCT04323800|155417620|FG001|Overall Study|Other|1|||
48333123|NCT04323800|155417619|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
48333124|NCT04323800|155417620|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
48333125|NCT00489554|155417621|FG000|Overall Study|Adverse Event|2|||
48333126|NCT00489554|155417621|FG000|Overall Study|Withdrawal by Subject|1|||
48333127|NCT00489554|155417621|FG000|Overall Study|Lost to Follow-up|1|||
48333128|NCT00443820|155417622|FG000|Overall Study|Adverse Event|1|||
48333129|NCT00443820|155417623|FG001|Overall Study|Adverse Event|1|||
48333130|NCT00443820|155417624|FG002|Overall Study|Adverse Event|0|||
48333131|NCT00443820|155417625|FG003|Overall Study|Adverse Event|0|||
48333132|NCT00443820|155417622|FG000|Overall Study|Lack of Efficacy|3|||
48333133|NCT00443820|155417623|FG001|Overall Study|Lack of Efficacy|2|||
48333134|NCT00443820|155417624|FG002|Overall Study|Lack of Efficacy|1|||
48333135|NCT00443820|155417625|FG003|Overall Study|Lack of Efficacy|1|||
48333136|NCT00443820|155417622|FG000|Overall Study|Protocol Violation|2|||
48333137|NCT00443820|155417623|FG001|Overall Study|Protocol Violation|1|||
48652086|NCT01732510|156577950|FG003|Overall Study|Pregnancy|1|||
48333138|NCT00443820|155417624|FG002|Overall Study|Protocol Violation|2|||
48333139|NCT00443820|155417625|FG003|Overall Study|Protocol Violation|1|||
48333140|NCT00443820|155417622|FG000|Overall Study|Withdrawal by Subject|6|||
48333141|NCT00443820|155417623|FG001|Overall Study|Withdrawal by Subject|7|||
48333142|NCT00443820|155417624|FG002|Overall Study|Withdrawal by Subject|8|||
48333143|NCT00443820|155417625|FG003|Overall Study|Withdrawal by Subject|9|||
48333144|NCT00443820|155417622|FG000|Overall Study|Lost to Follow-up|9|||
48652087|NCT01732510|156577951|FG004|Overall Study|Pregnancy|0|||
48652088|NCT01732510|156577952|FG005|Overall Study|Pregnancy|0|||
48333145|NCT00443820|155417623|FG001|Overall Study|Lost to Follow-up|8|||
48333146|NCT00443820|155417624|FG002|Overall Study|Lost to Follow-up|6|||
48333147|NCT00443820|155417625|FG003|Overall Study|Lost to Follow-up|5|||
48333148|NCT00443820|155417622|FG000|Overall Study|Administrative problems|0|||
48333149|NCT00443820|155417623|FG001|Overall Study|Administrative problems|0|||
48333150|NCT00443820|155417624|FG002|Overall Study|Administrative problems|0|||
48333151|NCT00443820|155417625|FG003|Overall Study|Administrative problems|1|||
48333152|NCT00443820|155417622|FG000|Overall Study|Death|0|||
48333153|NCT00443820|155417623|FG001|Overall Study|Death|0|||
48652089|NCT01732510|156577953|FG006|Overall Study|Pregnancy|0|||
48652090|NCT01732510|156577947|FG000|Overall Study|Study Terminated By Sponsor|0|||
48333154|NCT00443820|155417624|FG002|Overall Study|Death|1|||
48333155|NCT00443820|155417625|FG003|Overall Study|Death|0|||
48333156|NCT00671853|155417629|FG000|Overall Study|Lack of Efficacy|3|||
48333157|NCT00671853|155417630|FG001|Overall Study|Lack of Efficacy|7|||
48333158|NCT00671853|155417629|FG000|Overall Study|Adverse Event|7|||
48333159|NCT00671853|155417630|FG001|Overall Study|Adverse Event|1|||
48333160|NCT00671853|155417629|FG000|Overall Study|Withdrawal by Subject|1|||
48333161|NCT00671853|155417630|FG001|Overall Study|Withdrawal by Subject|5|||
48333162|NCT00671853|155417629|FG000|Overall Study|Lost to Follow-up|8|||
48333163|NCT00671853|155417630|FG001|Overall Study|Lost to Follow-up|8|||
48333164|NCT00671853|155417629|FG000|Overall Study|Physician Decision|0|||
48333165|NCT00671853|155417630|FG001|Overall Study|Physician Decision|2|||
48333166|NCT00671853|155417629|FG000|Overall Study|Non-adherence with study procedures|1|||
48333167|NCT00671853|155417630|FG001|Overall Study|Non-adherence with study procedures|4|||
48333168|NCT01802333|155417635|FG000|Overall Study|Ineligible|2|||
48333169|NCT01802333|155417636|FG001|Overall Study|Ineligible|6|||
48333170|NCT01802333|155417637|FG002|Overall Study|Ineligible|8|||
48333171|NCT01802333|155417635|FG000|Overall Study|Adverse Event|1|||
48333172|NCT01802333|155417636|FG001|Overall Study|Adverse Event|8|||
48333173|NCT01802333|155417637|FG002|Overall Study|Adverse Event|8|||
48333174|NCT01802333|155417635|FG000|Overall Study|Withdrawal by Subject|6|||
48333175|NCT01802333|155417636|FG001|Overall Study|Withdrawal by Subject|6|||
48652091|NCT01732510|156577948|FG001|Overall Study|Study Terminated By Sponsor|0|||
48652092|NCT01732510|156577949|FG002|Overall Study|Study Terminated By Sponsor|0|||
48652093|NCT01732510|156577950|FG003|Overall Study|Study Terminated By Sponsor|1|||
48652094|NCT01732510|156577951|FG004|Overall Study|Study Terminated By Sponsor|0|||
48652095|NCT01732510|156577952|FG005|Overall Study|Study Terminated By Sponsor|12|||
48652096|NCT01732510|156577953|FG006|Overall Study|Study Terminated By Sponsor|6|||
48333176|NCT01802333|155417637|FG002|Overall Study|Withdrawal by Subject|5|||
48333177|NCT01802333|155417635|FG000|Overall Study|Progression/relapse|1|||
48333178|NCT01802333|155417636|FG001|Overall Study|Progression/relapse|3|||
48333179|NCT01802333|155417637|FG002|Overall Study|Progression/relapse|0|||
48333180|NCT01802333|155417635|FG000|Overall Study|Death|7|||
48333181|NCT01802333|155417636|FG001|Overall Study|Death|14|||
48333182|NCT01802333|155417637|FG002|Overall Study|Death|13|||
48333183|NCT01802333|155417635|FG000|Overall Study|Other - not protocol specified|32|||
48333184|NCT01802333|155417636|FG001|Overall Study|Other - not protocol specified|22|||
48333185|NCT01802333|155417637|FG002|Overall Study|Other - not protocol specified|24|||
48333186|NCT01802333|155417635|FG000|Overall Study|Did not start treatment|0|||
48333187|NCT01802333|155417636|FG001|Overall Study|Did not start treatment|2|||
48333188|NCT01802333|155417637|FG002|Overall Study|Did not start treatment|5|||
48333189|NCT01393600|155417641|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
48333190|NCT01393600|155417642|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
48333191|NCT01393600|155417643|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
48333192|NCT01393600|155417644|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
48333193|NCT01393600|155417641|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
48333194|NCT01393600|155417642|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
48333195|NCT01393600|155417643|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
48333196|NCT01393600|155417644|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
48333197|NCT01393600|155417641|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
48333198|NCT01393600|155417642|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
48333199|NCT01393600|155417643|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
48333200|NCT01393600|155417644|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
48333201|NCT01393600|155417641|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
48333202|NCT01393600|155417642|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
48333203|NCT01393600|155417643|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
48333204|NCT01393600|155417644|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
48333205|NCT01393600|155417641|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
48333206|NCT01393600|155417642|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
48652097|NCT00313144|156577954|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
48652098|NCT00313144|156577954|FG000|Overall Study|Death|7|||
48652099|NCT00313144|156577954|FG000|Overall Study|Lost to Follow-up|5|||
48333207|NCT01393600|155417643|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
48333208|NCT01393600|155417644|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
48333209|NCT01393600|155417641|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
48333210|NCT01393600|155417642|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
48333211|NCT01393600|155417643|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
48333212|NCT01393600|155417644|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
48652100|NCT00313144|156577954|FG000|Overall Study|Withdrawal by Subject|4|||
48333213|NCT01393600|155417641|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
48333214|NCT01393600|155417642|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
48652101|NCT00313144|156577954|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
48652102|NCT00313144|156577954|FG000|Overall Study|Physician Decision|4|||
48652103|NCT00313144|156577954|FG000|Overall Study|Adverse event - transient|5|||
48652104|NCT00313144|156577954|FG000|Overall Study|Liver transplant|1|||
48652105|NCT00313144|156577954|FG000|Overall Study|Insurance (homecare provider) change|1|||
48428046|NCT02518620|155754793|FG000|Overall Study|Relocation|2|||
48652106|NCT00313144|156577954|FG000|Overall Study|Change to different product|1|||
48753427|NCT01601626|156944220|FG000|Overall Study|Withdrawal by Subject|0|||
48753428|NCT01601626|156944221|FG001|Overall Study|Withdrawal by Subject|1|||
48753429|NCT01601626|156944222|FG002|Overall Study|Withdrawal by Subject|1|||
48753430|NCT01601626|156944220|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
48652107|NCT00313144|156577954|FG000|Overall Study|Due to termination of the study|66|||
48652108|NCT02241733|156577972|FG000|Overall Study|Lost to Follow-up|9|||
48753431|NCT01601626|156944221|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
48753432|NCT01601626|156944222|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
48753433|NCT00545168|156944223|FG000|Overall Study|Lost to Follow-up|5|||
48753434|NCT00545168|156944224|FG001|Overall Study|Lost to Follow-up|5|||
48753435|NCT00545168|156944225|FG002|Overall Study|Lost to Follow-up|5|||
48753436|NCT00545168|156944223|FG000|Overall Study|Withdrawal by Subject|9|||
48753437|NCT00545168|156944224|FG001|Overall Study|Withdrawal by Subject|0|||
48333215|NCT01393600|155417643|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
48333216|NCT01393600|155417644|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
48333217|NCT02784834|155417645|FG000|Overall Study|Lack of Efficacy|1|||
48333218|NCT03884478|155417646|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
48333219|NCT03884478|155417647|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
48333220|NCT03884478|155417648|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
48333221|NCT03884478|155417646|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
48333222|NCT03884478|155417647|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
48333223|NCT03884478|155417648|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
48333224|NCT03884478|155417646|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
48333225|NCT03884478|155417647|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
48333226|NCT03884478|155417648|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
48333227|NCT03884478|155417646|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
48333228|NCT03884478|155417647|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
48333229|NCT03884478|155417648|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
48333230|NCT03265132|155417649|FG000|Overall Study|Adverse Event|0|||
48652109|NCT02241733|156577973|FG001|Overall Study|Lost to Follow-up|4|||
48652110|NCT02241733|156577972|FG000|Overall Study|Physician Decision|6|||
48652111|NCT02241733|156577973|FG001|Overall Study|Physician Decision|2|||
48652112|NCT02241733|156577972|FG000|Overall Study|Withdrawal by Subject|0|||
48652113|NCT02241733|156577973|FG001|Overall Study|Withdrawal by Subject|2|||
48652114|NCT02241733|156577972|FG000|Overall Study|Death|0|||
48652115|NCT02241733|156577973|FG001|Overall Study|Death|2|||
48652116|NCT02218697|156577974|FG000|Overall Study|Adverse Event|0|||
48652117|NCT02218697|156577975|FG001|Overall Study|Adverse Event|2|||
48652118|NCT02218697|156577974|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
48652119|NCT02218697|156577975|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
48652120|NCT02218697|156577974|FG000|Overall Study|Withdrawal by Subject|2|||
48333231|NCT03265132|155417650|FG001|Overall Study|Adverse Event|1|||
48333232|NCT03265132|155417649|FG000|Overall Study|Lack of Efficacy|0|||
48333233|NCT03265132|155417650|FG001|Overall Study|Lack of Efficacy|2|||
48333234|NCT03265132|155417649|FG000|Overall Study|Progressive disease|0|||
48333235|NCT03265132|155417650|FG001|Overall Study|Progressive disease|2|||
48333236|NCT03265132|155417649|FG000|Overall Study|Withdrawal by Subject|0|||
48333237|NCT03265132|155417650|FG001|Overall Study|Withdrawal by Subject|1|||
48333238|NCT01670877|155417654|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48333239|NCT01670877|155417655|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
48333240|NCT01670877|155417656|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48333241|NCT01670877|155417657|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48333242|NCT01670877|155417658|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48333243|NCT01670877|155417659|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
48333244|NCT01670877|155417654|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48333245|NCT01670877|155417655|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48333246|NCT01670877|155417656|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
48333247|NCT01670877|155417657|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48333248|NCT01670877|155417658|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48333249|NCT01670877|155417659|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
48333250|NCT01670877|155417654|FG000|Part I and Part 2|Grade 2 vomiting|0|||
48333251|NCT01670877|155417655|FG001|Part I and Part 2|Grade 2 vomiting|0|||
48333252|NCT01670877|155417656|FG002|Part I and Part 2|Grade 2 vomiting|0|||
48333253|NCT01670877|155417657|FG003|Part I and Part 2|Grade 2 vomiting|1|||
48333254|NCT01670877|155417658|FG004|Part I and Part 2|Grade 2 vomiting|0|||
48333255|NCT01670877|155417659|FG005|Part I and Part 2|Grade 2 vomiting|0|||
48333256|NCT01670877|155417654|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48753438|NCT00545168|156944225|FG002|Overall Study|Withdrawal by Subject|13|||
48753439|NCT00545168|156944223|FG000|Overall Study|Protocol Violation|1|||
48753440|NCT00545168|156944224|FG001|Overall Study|Protocol Violation|0|||
48753441|NCT00545168|156944225|FG002|Overall Study|Protocol Violation|1|||
48753442|NCT00545168|156944223|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
48753443|NCT00545168|156944224|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
48753444|NCT00545168|156944225|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
48753445|NCT02598076|156944226|FG000|Overall Study|Lost to Follow-up|2|||
48753446|NCT02598076|156944227|FG001|Overall Study|Lost to Follow-up|3|||
48753447|NCT03227029|156944228|FG000|Overall Study|Child Wheezed (no treatment)|0|||
48753448|NCT03227029|156944229|FG001|Overall Study|Child Wheezed (no treatment)|1|||
48753449|NCT03227029|156944230|FG002|Overall Study|Child Wheezed (no treatment)|0|||
48753450|NCT03227029|156944228|FG000|Overall Study|No post RSV season visit due to COVID|3|||
48753451|NCT03227029|156944229|FG001|Overall Study|No post RSV season visit due to COVID|3|||
48753452|NCT03227029|156944230|FG002|Overall Study|No post RSV season visit due to COVID|2|||
48333257|NCT01670877|155417655|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48333258|NCT01670877|155417656|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48333259|NCT01670877|155417657|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
48333260|NCT01670877|155417658|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48333261|NCT01670877|155417659|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
48333262|NCT01670877|155417654|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48333263|NCT01670877|155417655|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48333264|NCT01670877|155417656|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48333265|NCT01670877|155417657|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
48333266|NCT01670877|155417658|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48333267|NCT01670877|155417659|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
48333268|NCT00417885|155417660|FG000|Overall Study|Adverse Event|1|||
48333269|NCT00417885|155417660|FG000|Overall Study|Objective Progression or Relapse|3|||
48333270|NCT00417885|155417660|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
48333271|NCT04739306|155417661|FG000|Main Study Period|Adverse Event|6|||
48333272|NCT04739306|155417662|FG001|Main Study Period|Adverse Event|7|||
48333273|NCT04739306|155417661|FG000|Main Study Period|Lost to Follow-up|4|||
48333274|NCT04739306|155417662|FG001|Main Study Period|Lost to Follow-up|6|||
48333275|NCT04739306|155417661|FG000|Main Study Period|Physician Decision|1|||
48333276|NCT04739306|155417662|FG001|Main Study Period|Physician Decision|1|||
48333277|NCT04739306|155417661|FG000|Main Study Period|Withdrawal by Subject|8|||
48333278|NCT04739306|155417662|FG001|Main Study Period|Withdrawal by Subject|6|||
48333279|NCT04739306|155417661|FG000|Main Study Period|Protocol Violation|0|||
48333280|NCT04739306|155417662|FG001|Main Study Period|Protocol Violation|1|||
48333281|NCT04739306|155417661|FG000|Main Study Period|War in Ukraine|1|||
48333282|NCT04739306|155417662|FG001|Main Study Period|War in Ukraine|1|||
48753453|NCT03227029|156944228|FG000|Overall Study|Not able to get to clinic|0|||
48333283|NCT02037568|155417666|FG000|Overall Study|Withdrawal by Subject|17|||
48333284|NCT02037568|155417667|FG001|Overall Study|Withdrawal by Subject|24|||
48333285|NCT02037568|155417666|FG000|Overall Study|Lost to Follow-up|16|||
48333286|NCT02037568|155417667|FG001|Overall Study|Lost to Follow-up|13|||
48333287|NCT02037568|155417666|FG000|Overall Study|Screen Failure|3|||
48333288|NCT02037568|155417667|FG001|Overall Study|Screen Failure|1|||
48333289|NCT02037568|155417666|FG000|Overall Study|Patient did not receive transplant|0|||
48333290|NCT02037568|155417667|FG001|Overall Study|Patient did not receive transplant|1|||
48333291|NCT00096278|155417668|FG000|Overall Study|No follow-up data|15|||
48333292|NCT00096278|155417669|FG001|Overall Study|No follow-up data|18|||
48333293|NCT00096278|155417668|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
48333294|NCT00096278|155417669|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
48333295|NCT03875729|155417676|FG000|Overall Study|Adverse Event|0|||
48333296|NCT03875729|155417677|FG001|Overall Study|Adverse Event|5|||
48333297|NCT03875729|155417676|FG000|Overall Study|Withdrawal by Subject|8|||
48333298|NCT03875729|155417677|FG001|Overall Study|Withdrawal by Subject|11|||
48333299|NCT03875729|155417676|FG000|Overall Study|Pregnancy|0|||
48333300|NCT03875729|155417677|FG001|Overall Study|Pregnancy|1|||
48333301|NCT03875729|155417676|FG000|Overall Study|Lost to Follow-up|0|||
48333302|NCT03875729|155417677|FG001|Overall Study|Lost to Follow-up|5|||
48333303|NCT03875729|155417676|FG000|Overall Study|Personal reasons|2|||
48333304|NCT03875729|155417677|FG001|Overall Study|Personal reasons|0|||
48333305|NCT01405508|155417678|FG000|Overall Study|AE, non-serious non-fatal|1|||
48333306|NCT01405508|155417679|FG001|Overall Study|AE, non-serious non-fatal|1|||
48333307|NCT01405508|155417680|FG002|Overall Study|AE, non-serious non-fatal|0|||
48333308|NCT01405508|155417681|FG003|Overall Study|AE, non-serious non-fatal|0|||
48333309|NCT00476957|155417684|FG000|Overall Study|Lost to Follow-up|176|||
48333310|NCT00476957|155417685|FG001|Overall Study|Lost to Follow-up|193|||
48333311|NCT02516202|155417686|FG000|Overall Study|Withdrawal by Subject|1|||
48333312|NCT02516202|155417687|FG001|Overall Study|Withdrawal by Subject|0|||
48753454|NCT03227029|156944229|FG001|Overall Study|Not able to get to clinic|0|||
48333313|NCT02516202|155417688|FG002|Overall Study|Withdrawal by Subject|1|||
48333314|NCT02516202|155417686|FG000|Overall Study|Lost to Follow-up|1|||
48333315|NCT02516202|155417687|FG001|Overall Study|Lost to Follow-up|1|||
48753455|NCT03227029|156944230|FG002|Overall Study|Not able to get to clinic|1|||
48652121|NCT02218697|156577975|FG001|Overall Study|Withdrawal by Subject|3|||
48652122|NCT01974206|156577976|FG000|Overall Study|Did Not Take Study Drug|0|||
48652123|NCT01974206|156577977|FG001|Overall Study|Did Not Take Study Drug|1|||
48652124|NCT01974206|156577976|FG000|Overall Study|Physician Decision|1|||
48652125|NCT01974206|156577977|FG001|Overall Study|Physician Decision|0|||
48652126|NCT01974206|156577976|FG000|Overall Study|Withdrawal by Subject|3|||
48652127|NCT01974206|156577977|FG001|Overall Study|Withdrawal by Subject|0|||
48333316|NCT02516202|155417688|FG002|Overall Study|Lost to Follow-up|1|||
48333317|NCT02516202|155417686|FG000|Overall Study|Stopped Follow-up|0|||
48333318|NCT02516202|155417687|FG001|Overall Study|Stopped Follow-up|0|||
48333319|NCT02516202|155417688|FG002|Overall Study|Stopped Follow-up|1|||
48333320|NCT00529529|155417692|FG000|Overall Study|Adverse Event|12|||
48333321|NCT00529529|155417693|FG001|Overall Study|Adverse Event|17|||
48333322|NCT00529529|155417694|FG002|Overall Study|Adverse Event|8|||
48333323|NCT00529529|155417692|FG000|Overall Study|Subject withdrew consent|12|||
48333324|NCT00529529|155417693|FG001|Overall Study|Subject withdrew consent|9|||
48333325|NCT00529529|155417694|FG002|Overall Study|Subject withdrew consent|12|||
48652128|NCT01974206|156577976|FG000|Overall Study|Lost to Follow-up|1|||
48333326|NCT00529529|155417692|FG000|Overall Study|Protocol deviation|8|||
48333327|NCT00529529|155417693|FG001|Overall Study|Protocol deviation|12|||
48333328|NCT00529529|155417694|FG002|Overall Study|Protocol deviation|5|||
48333329|NCT00529529|155417692|FG000|Overall Study|Lost to Follow-up|5|||
48333330|NCT00529529|155417693|FG001|Overall Study|Lost to Follow-up|3|||
48333331|NCT00529529|155417694|FG002|Overall Study|Lost to Follow-up|1|||
48333332|NCT00529529|155417692|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48333333|NCT00529529|155417693|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48333334|NCT00529529|155417694|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48333335|NCT00529529|155417692|FG000|Overall Study|Death|2|||
48333336|NCT00529529|155417693|FG001|Overall Study|Death|0|||
48652129|NCT01974206|156577977|FG001|Overall Study|Lost to Follow-up|0|||
48652130|NCT01974206|156577976|FG000|Overall Study|Death|1|||
48652131|NCT01974206|156577977|FG001|Overall Study|Death|0|||
48652132|NCT05111002|156577978|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
48652133|NCT05111002|156577979|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
48652134|NCT05111002|156577978|FG000|Secondary Outcome|Lost to Follow-up|1|||
48652135|NCT05111002|156577979|FG001|Secondary Outcome|Lost to Follow-up|0|||
48652136|NCT04776720|156577986|FG000|Overall Study|COVID Related|4|||
48652137|NCT04776720|156577987|FG001|Overall Study|COVID Related|2|||
48652138|NCT04776720|156577986|FG000|Overall Study|Adverse Event|2|||
48652139|NCT04776720|156577987|FG001|Overall Study|Adverse Event|0|||
48652140|NCT04776720|156577986|FG000|Overall Study|Serious Adverse Event|0|||
48652141|NCT04776720|156577987|FG001|Overall Study|Serious Adverse Event|1|||
48652142|NCT04776720|156577986|FG000|Overall Study|Too Busy|3|||
48652143|NCT04776720|156577987|FG001|Overall Study|Too Busy|1|||
48753456|NCT03227029|156944228|FG000|Overall Study|Withdrawal by Subject|1|||
48753457|NCT03227029|156944229|FG001|Overall Study|Withdrawal by Subject|0|||
48753458|NCT03227029|156944230|FG002|Overall Study|Withdrawal by Subject|0|||
48753459|NCT03227029|156944228|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
48333337|NCT00529529|155417694|FG002|Overall Study|Death|0|||
48333338|NCT00529529|155417692|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48333339|NCT00529529|155417693|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48333340|NCT00529529|155417694|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48333341|NCT00529529|155417692|FG000|Overall Study|Administrative problems|1|||
48333342|NCT00529529|155417693|FG001|Overall Study|Administrative problems|0|||
48333343|NCT00529529|155417694|FG002|Overall Study|Administrative problems|3|||
48333344|NCT00409747|155417695|FG000|Overall Study|Withdrawal by Subject|1|||
48333345|NCT03979040|155417696|FG000|Overall Study|Withdrawal by Subject|24|||
48333346|NCT03979040|155417697|FG001|Overall Study|Withdrawal by Subject|32|||
48333347|NCT03979040|155417696|FG000|Overall Study|randomized but never started treatment|32|||
48333348|NCT03979040|155417697|FG001|Overall Study|randomized but never started treatment|39|||
48333349|NCT03979040|155417696|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
48333350|NCT03979040|155417697|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
48333351|NCT02691702|155417700|FG000|Overall Study|Adverse Event|1|||
48333352|NCT02691702|155417701|FG001|Overall Study|Adverse Event|0|||
48333353|NCT02691702|155417702|FG002|Overall Study|Adverse Event|0|||
48333354|NCT02691702|155417703|FG003|Overall Study|Adverse Event|0|||
48333355|NCT02691702|155417704|FG004|Overall Study|Adverse Event|0|||
48333356|NCT02691702|155417705|FG005|Overall Study|Adverse Event|0|||
48333357|NCT02691702|155417706|FG006|Overall Study|Adverse Event|0|||
48652144|NCT04776720|156577986|FG000|Overall Study|Lost to Follow-up|1|||
48652145|NCT04776720|156577987|FG001|Overall Study|Lost to Follow-up|2|||
48652146|NCT04776720|156577986|FG000|Overall Study|Family|2|||
48652147|NCT04776720|156577987|FG001|Overall Study|Family|2|||
48652148|NCT04776720|156577986|FG000|Overall Study|No remote technology access|0|||
48652149|NCT04776720|156577987|FG001|Overall Study|No remote technology access|1|||
48753460|NCT03227029|156944229|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
48652150|NCT04776720|156577986|FG000|Overall Study|Withdrawal by Subject|1|||
48652151|NCT04776720|156577987|FG001|Overall Study|Withdrawal by Subject|0|||
48652152|NCT04776720|156577986|FG000|Overall Study|Cannot tolerate intervention|1|||
48652153|NCT04776720|156577987|FG001|Overall Study|Cannot tolerate intervention|0|||
48652154|NCT04776720|156577986|FG000|Overall Study|Incomplete outcome data|6|||
48652155|NCT04776720|156577987|FG001|Overall Study|Incomplete outcome data|1|||
48652156|NCT02684058|156577990|FG000|Treatment Period|Progressive disease|4|||
48652157|NCT02684058|156577991|FG001|Treatment Period|Progressive disease|10|||
48652158|NCT02684058|156577992|FG002|Treatment Period|Progressive disease|19|||
48652159|NCT02684058|156577990|FG000|Treatment Period|Adverse Event|3|||
48652160|NCT02684058|156577991|FG001|Treatment Period|Adverse Event|8|||
48333358|NCT02691702|155417707|FG007|Overall Study|Adverse Event|0|||
48333359|NCT02691702|155417708|FG008|Overall Study|Adverse Event|1|||
48333360|NCT02691702|155417709|FG009|Overall Study|Adverse Event|0|||
48333361|NCT02691702|155417710|FG010|Overall Study|Adverse Event|1|||
48333362|NCT02691702|155417700|FG000|Overall Study|Lost to Follow-up|0|||
48333363|NCT02691702|155417701|FG001|Overall Study|Lost to Follow-up|0|||
48333364|NCT02691702|155417702|FG002|Overall Study|Lost to Follow-up|1|||
48333365|NCT02691702|155417703|FG003|Overall Study|Lost to Follow-up|0|||
48333366|NCT02691702|155417704|FG004|Overall Study|Lost to Follow-up|0|||
48333367|NCT02691702|155417705|FG005|Overall Study|Lost to Follow-up|2|||
48333368|NCT02691702|155417706|FG006|Overall Study|Lost to Follow-up|0|||
48333369|NCT02691702|155417707|FG007|Overall Study|Lost to Follow-up|0|||
48333370|NCT02691702|155417708|FG008|Overall Study|Lost to Follow-up|0|||
48333371|NCT02691702|155417709|FG009|Overall Study|Lost to Follow-up|0|||
48333372|NCT02691702|155417710|FG010|Overall Study|Lost to Follow-up|1|||
48333373|NCT02691702|155417700|FG000|Overall Study|Withdrawal by Subject|1|||
48333374|NCT02691702|155417701|FG001|Overall Study|Withdrawal by Subject|1|||
48333375|NCT02691702|155417702|FG002|Overall Study|Withdrawal by Subject|0|||
48333376|NCT02691702|155417703|FG003|Overall Study|Withdrawal by Subject|0|||
48333377|NCT02691702|155417704|FG004|Overall Study|Withdrawal by Subject|0|||
48333378|NCT02691702|155417705|FG005|Overall Study|Withdrawal by Subject|1|||
48652161|NCT02684058|156577992|FG002|Treatment Period|Adverse Event|1|||
48652162|NCT02684058|156577990|FG000|Treatment Period|Physician Decision|5|||
48652163|NCT02684058|156577991|FG001|Treatment Period|Physician Decision|1|||
48652164|NCT02684058|156577992|FG002|Treatment Period|Physician Decision|2|||
48652165|NCT02684058|156577990|FG000|Treatment Period|New therapy for study indication|1|||
48652166|NCT02684058|156577991|FG001|Treatment Period|New therapy for study indication|0|||
48652167|NCT02684058|156577992|FG002|Treatment Period|New therapy for study indication|0|||
48652168|NCT02684058|156577990|FG000|Treatment Period|Protocol deviation|0|||
48652169|NCT02684058|156577991|FG001|Treatment Period|Protocol deviation|1|||
48652170|NCT02684058|156577992|FG002|Treatment Period|Protocol deviation|0|||
48652171|NCT02684058|156577990|FG000|Treatment Period|Subject/guardian decision|4|||
48652172|NCT02684058|156577991|FG001|Treatment Period|Subject/guardian decision|3|||
48652173|NCT02684058|156577992|FG002|Treatment Period|Subject/guardian decision|0|||
48652174|NCT02684058|156577990|FG000|Treatment Period|Death|0|||
48652175|NCT02684058|156577991|FG001|Treatment Period|Death|0|||
48652176|NCT02684058|156577992|FG002|Treatment Period|Death|2|||
48652177|NCT02684058|156577990|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48652178|NCT02684058|156577991|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
48652179|NCT02684058|156577992|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48652180|NCT02684058|156577990|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
48652181|NCT02684058|156577991|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
48652182|NCT02684058|156577992|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
48652183|NCT02684058|156577990|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
48652184|NCT02684058|156577991|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
48652185|NCT02684058|156577992|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
48652186|NCT02684058|156577990|FG000|Post-treatment Efficacy Follow-up|Death|0|||
48652187|NCT02684058|156577991|FG001|Post-treatment Efficacy Follow-up|Death|0|||
48652188|NCT02684058|156577992|FG002|Post-treatment Efficacy Follow-up|Death|3|||
48652189|NCT02684058|156577990|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
48652190|NCT02684058|156577991|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
48652191|NCT02684058|156577992|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
48652192|NCT02684058|156577990|FG000|Post-treatment Survival Follow-up|Death|0|||
48652193|NCT02684058|156577991|FG001|Post-treatment Survival Follow-up|Death|0|||
48652194|NCT02684058|156577992|FG002|Post-treatment Survival Follow-up|Death|7|||
48652195|NCT02684058|156577990|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
48652196|NCT02684058|156577991|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
48652197|NCT02684058|156577992|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
48652198|NCT02684058|156577990|FG000|Crossover Treatment Period|Progressive disease|0|||
48652199|NCT02684058|156577991|FG001|Crossover Treatment Period|Progressive disease|1|||
48333379|NCT02691702|155417706|FG006|Overall Study|Withdrawal by Subject|2|||
48333380|NCT02691702|155417707|FG007|Overall Study|Withdrawal by Subject|0|||
48753461|NCT03227029|156944230|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
48753462|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
48753463|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
48753464|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
48753465|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
48753466|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
48753467|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
48753468|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
48753469|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
48753470|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
48753471|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
48753472|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
48753473|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
48753474|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
48753475|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
48753476|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
48753477|NCT01124422|156944231|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
48753478|NCT01124422|156944232|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
48753479|NCT01124422|156944233|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
48753480|NCT01124422|156944231|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
48586353|NCT01358578|156338934|FG004|Follow-up Period|Physician Decision|0|||
48586354|NCT01358578|156338935|FG005|Follow-up Period|Physician Decision|0|||
48586355|NCT05940077|156338936|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
48586356|NCT00388297|156338942|FG000|Overall Study|Lost to Follow-up|16|||
48586357|NCT00388297|156338943|FG001|Overall Study|Lost to Follow-up|12|||
48586358|NCT00388297|156338944|FG002|Overall Study|Lost to Follow-up|11|||
48586359|NCT00388297|156338945|FG003|Overall Study|Lost to Follow-up|8|||
48586360|NCT01636947|156338946|FG000|Overall Study|Not Treated|2|||
48586361|NCT01636947|156338947|FG001|Overall Study|Not Treated|2|||
48586362|NCT01636947|156338946|FG000|Overall Study|Lost to Follow-up|4|||
48586363|NCT01636947|156338947|FG001|Overall Study|Lost to Follow-up|0|||
48586364|NCT01636947|156338946|FG000|Overall Study|Protocol Violation|1|||
48586365|NCT01636947|156338947|FG001|Overall Study|Protocol Violation|1|||
48586366|NCT01636947|156338946|FG000|Overall Study|Withdrawal by Subject|3|||
48586367|NCT01636947|156338947|FG001|Overall Study|Withdrawal by Subject|3|||
48586368|NCT01636947|156338946|FG000|Overall Study|Adverse Event|1|||
48586369|NCT01636947|156338947|FG001|Overall Study|Adverse Event|1|||
48586370|NCT01636947|156338946|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
48586371|NCT01636947|156338947|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
48586372|NCT03605849|156338948|FG000|Overall Study|Adverse Event|20|||
48586373|NCT03605849|156338949|FG001|Overall Study|Adverse Event|21|||
48586374|NCT03605849|156338950|FG002|Overall Study|Adverse Event|29|||
48586375|NCT03605849|156338951|FG003|Overall Study|Adverse Event|11|||
48586376|NCT03605849|156338948|FG000|Overall Study|Lack of Efficacy|4|||
48586377|NCT03605849|156338949|FG001|Overall Study|Lack of Efficacy|7|||
48586378|NCT03605849|156338950|FG002|Overall Study|Lack of Efficacy|9|||
48586379|NCT03605849|156338951|FG003|Overall Study|Lack of Efficacy|2|||
48586380|NCT03605849|156338948|FG000|Overall Study|Lost to Follow-up|8|||
48586381|NCT03605849|156338949|FG001|Overall Study|Lost to Follow-up|8|||
48586382|NCT03605849|156338950|FG002|Overall Study|Lost to Follow-up|14|||
48586383|NCT03605849|156338951|FG003|Overall Study|Lost to Follow-up|11|||
48586384|NCT03605849|156338948|FG000|Overall Study|Non-compliance With IMP|6|||
48586385|NCT03605849|156338949|FG001|Overall Study|Non-compliance With IMP|5|||
48586386|NCT03605849|156338950|FG002|Overall Study|Non-compliance With IMP|2|||
48586387|NCT03605849|156338951|FG003|Overall Study|Non-compliance With IMP|1|||
48586388|NCT03605849|156338948|FG000|Overall Study|Protocol Deviation|1|||
48586389|NCT03605849|156338949|FG001|Overall Study|Protocol Deviation|2|||
48586390|NCT03605849|156338950|FG002|Overall Study|Protocol Deviation|1|||
48586391|NCT03605849|156338951|FG003|Overall Study|Protocol Deviation|3|||
48586392|NCT03605849|156338948|FG000|Overall Study|Withdrawal by Subject|33|||
48586393|NCT03605849|156338949|FG001|Overall Study|Withdrawal by Subject|28|||
48586394|NCT03605849|156338950|FG002|Overall Study|Withdrawal by Subject|30|||
48586395|NCT03605849|156338951|FG003|Overall Study|Withdrawal by Subject|28|||
48586396|NCT03605849|156338948|FG000|Overall Study|Site Terminated by Sponsor|0|||
48586397|NCT03605849|156338949|FG001|Overall Study|Site Terminated by Sponsor|0|||
48586398|NCT03605849|156338950|FG002|Overall Study|Site Terminated by Sponsor|0|||
48586399|NCT03605849|156338951|FG003|Overall Study|Site Terminated by Sponsor|1|||
48586400|NCT03605849|156338948|FG000|Overall Study|Physician Decision|2|||
48586401|NCT03605849|156338949|FG001|Overall Study|Physician Decision|1|||
48586402|NCT03605849|156338950|FG002|Overall Study|Physician Decision|2|||
48586403|NCT03605849|156338951|FG003|Overall Study|Physician Decision|1|||
48586404|NCT03605849|156338948|FG000|Overall Study|Enrolled, but not Treated|2|||
48586405|NCT03605849|156338949|FG001|Overall Study|Enrolled, but not Treated|2|||
48586406|NCT03605849|156338950|FG002|Overall Study|Enrolled, but not Treated|3|||
48586407|NCT03605849|156338951|FG003|Overall Study|Enrolled, but not Treated|2|||
48586408|NCT03605849|156338948|FG000|Overall Study|Other (COVID-19 Related)|0|||
48586409|NCT03605849|156338949|FG001|Overall Study|Other (COVID-19 Related)|1|||
48586410|NCT03605849|156338950|FG002|Overall Study|Other (COVID-19 Related)|1|||
48586411|NCT03605849|156338951|FG003|Overall Study|Other (COVID-19 Related)|0|||
48652200|NCT02684058|156577992|FG002|Crossover Treatment Period|Progressive disease|0|||
48652201|NCT00443053|156577993|FG000|Overall Study|Adverse Event|2|||
48652202|NCT00443053|156577994|FG001|Overall Study|Adverse Event|1|||
48652203|NCT00443053|156577993|FG000|Overall Study|Withdrawal by Subject|9|||
48652204|NCT00443053|156577994|FG001|Overall Study|Withdrawal by Subject|18|||
48652205|NCT00443053|156577993|FG000|Overall Study|Lost to Follow-up|4|||
48652206|NCT00443053|156577994|FG001|Overall Study|Lost to Follow-up|5|||
48652207|NCT00443053|156577993|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
48652208|NCT00443053|156577994|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
48652209|NCT00443053|156577993|FG000|Overall Study|Noncompliance|2|||
48652210|NCT00443053|156577994|FG001|Overall Study|Noncompliance|1|||
48652211|NCT00443053|156577993|FG000|Overall Study|Other|3|||
48652212|NCT00443053|156577994|FG001|Overall Study|Other|4|||
48652213|NCT00443053|156577993|FG000|Overall Study|Physician Decision|0|||
48652214|NCT00443053|156577994|FG001|Overall Study|Physician Decision|4|||
48652215|NCT00281099|156577995|FG000|Overall Study|Death|46|||
48652216|NCT00281099|156577996|FG001|Overall Study|Death|57|||
48652217|NCT00281099|156577995|FG000|Overall Study|Lost to Follow-up|10|||
48652218|NCT00281099|156577996|FG001|Overall Study|Lost to Follow-up|19|||
48652219|NCT00281099|156577995|FG000|Overall Study|Withdrawal by Subject|65|||
48652220|NCT00281099|156577996|FG001|Overall Study|Withdrawal by Subject|70|||
48652221|NCT00281099|156577995|FG000|Overall Study|Physician Decision|79|||
48652222|NCT00281099|156577996|FG001|Overall Study|Physician Decision|72|||
48652223|NCT00281099|156577995|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
48652224|NCT00281099|156577996|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
48652225|NCT02524275|156577997|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
48652226|NCT03763656|156577998|FG000|Overall Study|Physician Decision|1|||
48652227|NCT03763656|156577998|FG000|Overall Study|Protocol Violation|1|||
48652228|NCT03763656|156577998|FG000|Overall Study|Withdrawal by Subject|7|||
48652229|NCT02461290|156577999|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
48652230|NCT02461290|156577999|FG000|Overall Study|Lost to Follow-up|3|||
48652231|NCT00368745|156579429|FG000|Double-blind Treatment Period|Adverse Event|6|||
48652232|NCT00368745|156579430|FG001|Double-blind Treatment Period|Adverse Event|6|||
48652233|NCT00368745|156579429|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
48652234|NCT00368745|156579430|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
48652235|NCT00368745|156579429|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
48652236|NCT00368745|156579430|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
48652237|NCT00368745|156579429|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
48652238|NCT00368745|156579430|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
48652239|NCT00368745|156579429|FG000|Double-blind Treatment Period|Other|7|||
48652240|NCT00368745|156579430|FG001|Double-blind Treatment Period|Other|6|||
48652241|NCT00854724|156579431|FG000|First Intervention|Withdrawal by Subject|1|||
48652242|NCT00854724|156579432|FG001|First Intervention|Withdrawal by Subject|1|||
48652243|NCT00854724|156579431|FG000|Washout|Protocol Violation|1|||
48652244|NCT00854724|156579432|FG001|Washout|Protocol Violation|0|||
48652245|NCT00854724|156579431|FG000|Washout|Withdrawal by Subject|0|||
48652246|NCT00854724|156579432|FG001|Washout|Withdrawal by Subject|1|||
48652247|NCT00854724|156579431|FG000|Second Intervention|Protocol Violation|1|||
48652248|NCT00854724|156579432|FG001|Second Intervention|Protocol Violation|0|||
48652249|NCT00854724|156579431|FG000|Second Intervention|Physician Decision|0|||
48652250|NCT00854724|156579432|FG001|Second Intervention|Physician Decision|1|||
48652251|NCT02719691|156579435|FG000|Overall Study|Physician Decision|0|||
48652252|NCT02719691|156579436|FG001|Overall Study|Physician Decision|0|||
48652253|NCT02719691|156579437|FG002|Overall Study|Physician Decision|1|||
48652254|NCT02719691|156579438|FG003|Overall Study|Physician Decision|0|||
48652255|NCT02719691|156579439|FG004|Overall Study|Physician Decision|0|||
48652256|NCT02719691|156579440|FG005|Overall Study|Physician Decision|0|||
48652257|NCT02719691|156579441|FG006|Overall Study|Physician Decision|0|||
48652258|NCT02719691|156579435|FG000|Overall Study|Withdrawal by Subject|0|||
48652259|NCT02719691|156579436|FG001|Overall Study|Withdrawal by Subject|0|||
48652260|NCT02719691|156579437|FG002|Overall Study|Withdrawal by Subject|0|||
48652261|NCT02719691|156579438|FG003|Overall Study|Withdrawal by Subject|0|||
48652262|NCT02719691|156579439|FG004|Overall Study|Withdrawal by Subject|0|||
48652263|NCT02719691|156579440|FG005|Overall Study|Withdrawal by Subject|1|||
48652264|NCT02719691|156579441|FG006|Overall Study|Withdrawal by Subject|0|||
48652265|NCT02388165|156579455|FG000|Overall Study|Study terminated by sponsor|5|||
48652266|NCT02388165|156579456|FG001|Overall Study|Study terminated by sponsor|5|||
48652267|NCT02388165|156579455|FG000|Overall Study|Other|11|||
48586412|NCT03605849|156338948|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
48586413|NCT03605849|156338949|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
48333381|NCT02691702|155417708|FG008|Overall Study|Withdrawal by Subject|0|||
48333382|NCT02691702|155417709|FG009|Overall Study|Withdrawal by Subject|0|||
48333383|NCT02691702|155417710|FG010|Overall Study|Withdrawal by Subject|0|||
48333384|NCT02691702|155417700|FG000|Overall Study|Other|0|||
48652268|NCT02388165|156579456|FG001|Overall Study|Other|13|||
48652269|NCT02388165|156579455|FG000|Overall Study|No longer meet eligibility criteria|40|||
48652270|NCT02388165|156579456|FG001|Overall Study|No longer meet eligibility criteria|43|||
48652271|NCT02388165|156579455|FG000|Overall Study|Withdrawal of consent|31|||
48652272|NCT02388165|156579456|FG001|Overall Study|Withdrawal of consent|32|||
48652273|NCT02388165|156579455|FG000|Overall Study|Lost to Follow-up|19|||
48652274|NCT02388165|156579456|FG001|Overall Study|Lost to Follow-up|20|||
48652275|NCT02388165|156579455|FG000|Overall Study|Death|13|||
48652276|NCT02388165|156579456|FG001|Overall Study|Death|10|||
48652277|NCT02388165|156579455|FG000|Overall Study|Adverse Event|3|||
48652278|NCT02388165|156579456|FG001|Overall Study|Adverse Event|5|||
48652279|NCT02388165|156579455|FG000|Overall Study|Did not meet entrance criteria|5|||
48652280|NCT02388165|156579456|FG001|Overall Study|Did not meet entrance criteria|2|||
48652281|NCT04560816|156579457|FG000|Overall Study|Withdrawal by Subject|1|||
48652282|NCT04560816|156579458|FG001|Overall Study|Withdrawal by Subject|1|||
48652283|NCT04560816|156579459|FG002|Overall Study|Withdrawal by Subject|1|||
48333385|NCT02691702|155417701|FG001|Overall Study|Other|0|||
48333386|NCT02691702|155417702|FG002|Overall Study|Other|0|||
48333387|NCT02691702|155417703|FG003|Overall Study|Other|0|||
48333388|NCT02691702|155417704|FG004|Overall Study|Other|0|||
48333389|NCT02691702|155417705|FG005|Overall Study|Other|0|||
48333390|NCT02691702|155417706|FG006|Overall Study|Other|1|||
48333391|NCT02691702|155417707|FG007|Overall Study|Other|0|||
48333392|NCT02691702|155417708|FG008|Overall Study|Other|1|||
48333393|NCT02691702|155417709|FG009|Overall Study|Other|0|||
48333394|NCT02691702|155417710|FG010|Overall Study|Other|0|||
48333395|NCT02691702|155417700|FG000|Overall Study|Protocol Violation|0|||
48333396|NCT02691702|155417701|FG001|Overall Study|Protocol Violation|0|||
48333397|NCT02691702|155417702|FG002|Overall Study|Protocol Violation|0|||
48333398|NCT02691702|155417703|FG003|Overall Study|Protocol Violation|0|||
48333399|NCT02691702|155417704|FG004|Overall Study|Protocol Violation|0|||
48333400|NCT02691702|155417705|FG005|Overall Study|Protocol Violation|0|||
48333401|NCT02691702|155417706|FG006|Overall Study|Protocol Violation|0|||
48333402|NCT02691702|155417707|FG007|Overall Study|Protocol Violation|0|||
48333403|NCT02691702|155417708|FG008|Overall Study|Protocol Violation|0|||
48333404|NCT02691702|155417709|FG009|Overall Study|Protocol Violation|2|||
48333405|NCT02691702|155417710|FG010|Overall Study|Protocol Violation|0|||
48333406|NCT02279732|155417711|FG000|Overall Study|Death|23|||
48333407|NCT02279732|155417712|FG001|Overall Study|Death|20|||
48333408|NCT02279732|155417711|FG000|Overall Study|Disease Progression|13|||
48333409|NCT02279732|155417712|FG001|Overall Study|Disease Progression|3|||
48333410|NCT02279732|155417711|FG000|Overall Study|Withdrawal by Subject|2|||
48333411|NCT02279732|155417712|FG001|Overall Study|Withdrawal by Subject|7|||
48333412|NCT02279732|155417711|FG000|Overall Study|Adverse Event|1|||
48333413|NCT02279732|155417712|FG001|Overall Study|Adverse Event|2|||
48333414|NCT02279732|155417711|FG000|Overall Study|Administrative Reason By Sponsor|0|||
48333415|NCT02279732|155417712|FG001|Overall Study|Administrative Reason By Sponsor|2|||
48333416|NCT02279732|155417711|FG000|Overall Study|Study Drug Toxicity|2|||
48333417|NCT02279732|155417712|FG001|Overall Study|Study Drug Toxicity|0|||
48333418|NCT02279732|155417711|FG000|Overall Study|Lost to Follow-up|0|||
48333419|NCT02279732|155417712|FG001|Overall Study|Lost to Follow-up|1|||
48333420|NCT02279732|155417711|FG000|Overall Study|Maximum Clinical Benefit|1|||
48333421|NCT02279732|155417712|FG001|Overall Study|Maximum Clinical Benefit|0|||
48333422|NCT02279732|155417711|FG000|Overall Study|Subject Requested to Discontinue|0|||
48333423|NCT02279732|155417712|FG001|Overall Study|Subject Requested to Discontinue|1|||
48333424|NCT02279732|155417711|FG000|Overall Study|Other|53|||
48333425|NCT02279732|155417712|FG001|Overall Study|Other|67|||
48652284|NCT04560816|156579460|FG003|Overall Study|Withdrawal by Subject|0|||
48652285|NCT04560816|156579461|FG004|Overall Study|Withdrawal by Subject|3|||
48333426|NCT02279732|155417711|FG000|Overall Study|Other|3|||
48333427|NCT02279732|155417712|FG001|Overall Study|Other|3|||
48333428|NCT02203513|155417715|FG000|Overall Study|Refused further treatment|2|||
48333429|NCT02203513|155417716|FG001|Overall Study|Refused further treatment|0|||
48333430|NCT02203513|155417717|FG002|Overall Study|Refused further treatment|1|||
48333431|NCT02203513|155417718|FG003|Overall Study|Refused further treatment|0|||
48652286|NCT04560816|156579462|FG005|Overall Study|Withdrawal by Subject|0|||
48652287|NCT04560816|156579457|FG000|Overall Study|Lost to Follow-up|1|||
48652288|NCT04560816|156579458|FG001|Overall Study|Lost to Follow-up|0|||
48652289|NCT04560816|156579459|FG002|Overall Study|Lost to Follow-up|0|||
48652290|NCT04560816|156579460|FG003|Overall Study|Lost to Follow-up|0|||
48652291|NCT04560816|156579461|FG004|Overall Study|Lost to Follow-up|0|||
48333432|NCT02203513|155417719|FG004|Overall Study|Refused further treatment|0|||
48333433|NCT02203513|155417715|FG000|Overall Study|Switched to alternative treatment|3|||
48333434|NCT02203513|155417716|FG001|Overall Study|Switched to alternative treatment|4|||
48652292|NCT04560816|156579462|FG005|Overall Study|Lost to Follow-up|0|||
48652293|NCT04560816|156579457|FG000|Overall Study|Protocol Violation|1|||
48652294|NCT04560816|156579458|FG001|Overall Study|Protocol Violation|0|||
48652295|NCT04560816|156579459|FG002|Overall Study|Protocol Violation|0|||
48652296|NCT04560816|156579460|FG003|Overall Study|Protocol Violation|0|||
48652297|NCT04560816|156579461|FG004|Overall Study|Protocol Violation|0|||
48652298|NCT04560816|156579462|FG005|Overall Study|Protocol Violation|0|||
48586414|NCT03605849|156338950|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
48586415|NCT03605849|156338951|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
48586416|NCT00957424|156338952|FG000|Overall Study|Lost to Follow-up|19|||
48586417|NCT00957424|156338952|FG000|Overall Study|Protocol Violation|3|||
48586418|NCT00957424|156338952|FG000|Overall Study|Withdrawal by Subject|1|||
48586419|NCT02304380|156338953|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
48586420|NCT02304380|156338954|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
48586421|NCT02304380|156338955|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
48652299|NCT01532921|156579467|FG000|Overall Study|Death|3|||
48652300|NCT01532921|156579467|FG000|Overall Study|Withdrawal by Subject|2|||
48652301|NCT01532921|156579467|FG000|Overall Study|Lost to Follow-up|3|||
48652302|NCT01532921|156579467|FG000|Overall Study|Physician Decision|7|||
48652303|NCT01532921|156579467|FG000|Overall Study|Device was explanted during procedure|1|||
48652304|NCT03818607|156579468|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
48652305|NCT03818607|156579469|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
48652306|NCT03818607|156579468|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
48652307|NCT03818607|156579469|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
48652308|NCT03818607|156579468|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
48652309|NCT03818607|156579469|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
48652310|NCT00967694|156579470|FG000|Overall Study|Withdrawal by Subject|6|||
48652311|NCT01843673|156579471|FG000|Overall Study|Lack of Efficacy|2|||
48652312|NCT01843673|156579471|FG000|Overall Study|Withdrawal by Subject|4|||
48652313|NCT02321319|156579472|FG000|Overall Study|Product discontinued|5|||
48652314|NCT01703091|156579480|FG000|Overall Study|Adverse Event|5|||
48652315|NCT01703091|156579481|FG001|Overall Study|Adverse Event|3|||
48586422|NCT02304380|156338956|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
48586423|NCT02304380|156338957|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
48586424|NCT02304380|156338958|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
48586425|NCT01027897|156338961|FG000|Overall Study|Protocol Violation|1|||
48586426|NCT01027897|156338961|FG000|Overall Study|Withdrawal by Subject|1|||
48586427|NCT00312572|156338965|FG000|Overall Study|Adverse Event|10|||
48333435|NCT02203513|155417717|FG002|Overall Study|Switched to alternative treatment|0|||
48333436|NCT02203513|155417718|FG003|Overall Study|Switched to alternative treatment|0|||
48333437|NCT02203513|155417719|FG004|Overall Study|Switched to alternative treatment|4|||
48333438|NCT02203513|155417715|FG000|Overall Study|Did not receive investigational product (IP)|0|||
48333439|NCT02203513|155417716|FG001|Overall Study|Did not receive investigational product (IP)|1|||
48333440|NCT02203513|155417717|FG002|Overall Study|Did not receive investigational product (IP)|0|||
48333441|NCT02203513|155417718|FG003|Overall Study|Did not receive investigational product (IP)|0|||
48333442|NCT02203513|155417719|FG004|Overall Study|Did not receive investigational product (IP)|0|||
48333443|NCT02203513|155417715|FG000|Overall Study|Death (unrelated to study therapy)|1|||
48333444|NCT02203513|155417716|FG001|Overall Study|Death (unrelated to study therapy)|3|||
48333445|NCT02203513|155417717|FG002|Overall Study|Death (unrelated to study therapy)|1|||
48333446|NCT02203513|155417718|FG003|Overall Study|Death (unrelated to study therapy)|0|||
48333447|NCT02203513|155417719|FG004|Overall Study|Death (unrelated to study therapy)|2|||
48333448|NCT02203513|155417715|FG000|Overall Study|Lost to Follow-up|0|||
48333449|NCT02203513|155417716|FG001|Overall Study|Lost to Follow-up|0|||
48333450|NCT02203513|155417717|FG002|Overall Study|Lost to Follow-up|1|||
48333451|NCT02203513|155417718|FG003|Overall Study|Lost to Follow-up|1|||
48333452|NCT02203513|155417719|FG004|Overall Study|Lost to Follow-up|0|||
48333453|NCT01441596|155417720|FG000|Overall Study|Other reason not defined below|0|||
48333454|NCT01441596|155417721|FG001|Overall Study|Other reason not defined below|2|||
48333455|NCT01441596|155417722|FG002|Overall Study|Other reason not defined below|1|||
48333456|NCT01441596|155417720|FG000|Overall Study|Withdrawal by Subject|4|||
48333457|NCT01441596|155417721|FG001|Overall Study|Withdrawal by Subject|0|||
48333458|NCT01441596|155417722|FG002|Overall Study|Withdrawal by Subject|2|||
48333459|NCT01441596|155417720|FG000|Overall Study|Not treated|0|||
48333460|NCT01441596|155417721|FG001|Overall Study|Not treated|1|||
48333461|NCT01441596|155417722|FG002|Overall Study|Not treated|1|||
48333462|NCT03953079|155417723|FG000|Core Study|Withdrawal by Subject|1|||
48333463|NCT03953079|155417724|FG001|Core Study|Withdrawal by Subject|2|||
48333464|NCT03953079|155417725|FG002|Core Study|Withdrawal by Subject|1|||
48652316|NCT01703091|156579480|FG000|Overall Study|Physician Decision|2|||
48586428|NCT00312572|156338966|FG001|Overall Study|Adverse Event|16|||
48652317|NCT01703091|156579481|FG001|Overall Study|Physician Decision|1|||
48333465|NCT03953079|155417723|FG000|Core Study|COVID-19|0|||
48333466|NCT03953079|155417724|FG001|Core Study|COVID-19|1|||
48333467|NCT03953079|155417725|FG002|Core Study|COVID-19|0|||
48652318|NCT01703091|156579480|FG000|Overall Study|Withdrawal by Subject|1|||
48652319|NCT01703091|156579481|FG001|Overall Study|Withdrawal by Subject|0|||
48333468|NCT03953079|155417723|FG000|Core Study|Difficulties leaving the house|0|||
48333469|NCT03953079|155417724|FG001|Core Study|Difficulties leaving the house|1|||
48333470|NCT03953079|155417725|FG002|Core Study|Difficulties leaving the house|0|||
48333471|NCT03953079|155417723|FG000|Extension Study|Withdrawal by Subject|1|||
48333472|NCT03953079|155417724|FG001|Extension Study|Withdrawal by Subject|0|||
48333473|NCT03953079|155417725|FG002|Extension Study|Withdrawal by Subject|0|||
48333474|NCT03953079|155417723|FG000|Extension Study|Received Rescue Treatment|5|||
48333475|NCT03953079|155417724|FG001|Extension Study|Received Rescue Treatment|6|||
48333476|NCT03953079|155417725|FG002|Extension Study|Received Rescue Treatment|5|||
48333477|NCT02291549|155417726|FG000|Overall Study|Lost to Follow-up|1|||
48333478|NCT02291549|155417727|FG001|Overall Study|Lost to Follow-up|0|||
48333479|NCT02291549|155417726|FG000|Overall Study|Withdrawal by Subject|0|||
48333480|NCT02291549|155417727|FG001|Overall Study|Withdrawal by Subject|1|||
48333481|NCT03019289|155417728|FG000|Overall Study|Adverse Event|1|||
48333482|NCT03019289|155417729|FG001|Overall Study|Adverse Event|0|||
48333483|NCT03019289|155417730|FG002|Overall Study|Adverse Event|0|||
48333484|NCT03019289|155417731|FG003|Overall Study|Adverse Event|0|||
48333485|NCT03019289|155417732|FG004|Overall Study|Adverse Event|0|||
48333486|NCT03019289|155417733|FG005|Overall Study|Adverse Event|0|||
48333487|NCT03019289|155417734|FG006|Overall Study|Adverse Event|0|||
48333488|NCT03019289|155417735|FG007|Overall Study|Adverse Event|0|||
48333489|NCT03019289|155417736|FG008|Overall Study|Adverse Event|1|||
48333490|NCT03019289|155417728|FG000|Overall Study|Other|1|||
48333491|NCT03019289|155417729|FG001|Overall Study|Other|0|||
48333492|NCT03019289|155417730|FG002|Overall Study|Other|0|||
48333493|NCT03019289|155417731|FG003|Overall Study|Other|0|||
48333494|NCT03019289|155417732|FG004|Overall Study|Other|0|||
48333495|NCT03019289|155417733|FG005|Overall Study|Other|0|||
48333496|NCT03019289|155417734|FG006|Overall Study|Other|0|||
48333497|NCT03019289|155417735|FG007|Overall Study|Other|0|||
48333498|NCT03019289|155417736|FG008|Overall Study|Other|0|||
48333499|NCT00655824|155417738|FG000|Overall Study|Adverse Event|3|||
48333500|NCT00655824|155417738|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
48333501|NCT00655824|155417738|FG000|Overall Study|Protocol Violation|1|||
48333502|NCT00655824|155417738|FG000|Overall Study|Withdrawal by Subject|4|||
48333503|NCT00655824|155417738|FG000|Overall Study|Deterioration of Trial Disease|2|||
48333504|NCT00589628|155417739|FG000|Overall Study|Lost to Follow-up|0|||
48333505|NCT00589628|155417740|FG001|Overall Study|Lost to Follow-up|1|||
48333506|NCT02923349|155417741|FG000|Overall Study|Other|1|||
48333507|NCT02923349|155417742|FG001|Overall Study|Other|2|||
48333508|NCT02923349|155417743|FG002|Overall Study|Other|4|||
48333509|NCT02923349|155417744|FG003|Overall Study|Other|1|||
48333510|NCT02923349|155417745|FG004|Overall Study|Other|3|||
48333511|NCT02923349|155417746|FG005|Overall Study|Other|0|||
48333512|NCT02923349|155417747|FG006|Overall Study|Other|1|||
48333513|NCT02923349|155417741|FG000|Overall Study|Withdrawal by Subject|2|||
48333514|NCT02923349|155417742|FG001|Overall Study|Withdrawal by Subject|2|||
48333515|NCT02923349|155417743|FG002|Overall Study|Withdrawal by Subject|8|||
48333516|NCT02923349|155417744|FG003|Overall Study|Withdrawal by Subject|10|||
48333517|NCT02923349|155417745|FG004|Overall Study|Withdrawal by Subject|12|||
48333518|NCT02923349|155417746|FG005|Overall Study|Withdrawal by Subject|3|||
48333519|NCT02923349|155417747|FG006|Overall Study|Withdrawal by Subject|0|||
48333520|NCT02923349|155417741|FG000|Overall Study|Physician Decision|0|||
48333521|NCT02923349|155417742|FG001|Overall Study|Physician Decision|0|||
48333522|NCT02923349|155417743|FG002|Overall Study|Physician Decision|0|||
48333523|NCT02923349|155417744|FG003|Overall Study|Physician Decision|1|||
48333524|NCT02923349|155417745|FG004|Overall Study|Physician Decision|1|||
48652320|NCT01703091|156579480|FG000|Overall Study|Sponsor Decision|1|||
48652321|NCT01703091|156579481|FG001|Overall Study|Sponsor Decision|0|||
48652322|NCT00022763|156579482|FG000|Overall Study|Adverse Event|1|||
48652323|NCT00022763|156579483|FG001|Overall Study|Adverse Event|2|||
48333525|NCT02923349|155417746|FG005|Overall Study|Physician Decision|0|||
48333526|NCT02923349|155417747|FG006|Overall Study|Physician Decision|2|||
48333527|NCT02923349|155417741|FG000|Overall Study|Lost to Follow-up|0|||
48333528|NCT02923349|155417742|FG001|Overall Study|Lost to Follow-up|0|||
48333529|NCT02923349|155417743|FG002|Overall Study|Lost to Follow-up|3|||
48652324|NCT00022763|156579482|FG000|Overall Study|Injection Site Reactions|0|||
48652325|NCT00022763|156579483|FG001|Overall Study|Injection Site Reactions|2|||
48652326|NCT00022763|156579482|FG000|Overall Study|Death|0|||
48333530|NCT02923349|155417744|FG003|Overall Study|Lost to Follow-up|0|||
48333531|NCT02923349|155417745|FG004|Overall Study|Lost to Follow-up|1|||
48333532|NCT02923349|155417746|FG005|Overall Study|Lost to Follow-up|1|||
48333533|NCT02923349|155417747|FG006|Overall Study|Lost to Follow-up|0|||
48333534|NCT02923349|155417741|FG000|Overall Study|Death|1|||
48333535|NCT02923349|155417742|FG001|Overall Study|Death|0|||
48333536|NCT02923349|155417743|FG002|Overall Study|Death|2|||
48333537|NCT02923349|155417744|FG003|Overall Study|Death|4|||
48333538|NCT02923349|155417745|FG004|Overall Study|Death|2|||
48333539|NCT02923349|155417746|FG005|Overall Study|Death|3|||
48333540|NCT02923349|155417747|FG006|Overall Study|Death|0|||
48652327|NCT00022763|156579483|FG001|Overall Study|Death|1|||
48333541|NCT01334606|155417748|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
48333542|NCT00508144|155417749|FG000|Overall Study|Not eligible|6|||
48333543|NCT00508144|155417749|FG000|Overall Study|Death|5|||
48333544|NCT01294644|155417750|FG000|Overall Study|Adverse Event|2|||
48333545|NCT01294644|155417751|FG001|Overall Study|Adverse Event|0|||
48333546|NCT01294644|155417752|FG002|Overall Study|Adverse Event|1|||
48333547|NCT01294644|155417750|FG000|Overall Study|Withdrawal by Subject|3|||
48333548|NCT01294644|155417751|FG001|Overall Study|Withdrawal by Subject|7|||
48333549|NCT01294644|155417752|FG002|Overall Study|Withdrawal by Subject|4|||
48333550|NCT01294644|155417750|FG000|Overall Study|Lost to Follow-up|3|||
48333551|NCT01294644|155417751|FG001|Overall Study|Lost to Follow-up|2|||
48333552|NCT01294644|155417752|FG002|Overall Study|Lost to Follow-up|5|||
48333553|NCT01294644|155417750|FG000|Overall Study|Miscellaneous Reason|2|||
48333554|NCT01294644|155417751|FG001|Overall Study|Miscellaneous Reason|1|||
48333555|NCT01294644|155417752|FG002|Overall Study|Miscellaneous Reason|4|||
48333556|NCT02612285|155417757|FG000|Overall Study|Withdrawal by Subject|1|||
48333557|NCT03769090|155419372|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
48333558|NCT03769090|155419373|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
48383949|NCT00764751|155601511|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
48586429|NCT00312572|156338965|FG000|Overall Study|Lost to Follow-up|1|||
48586430|NCT00312572|156338966|FG001|Overall Study|Lost to Follow-up|1|||
48586431|NCT00312572|156338965|FG000|Overall Study|Administrative|4|||
48586432|NCT00312572|156338966|FG001|Overall Study|Administrative|2|||
48586433|NCT00312572|156338965|FG000|Overall Study|Lack of Efficacy|1|||
48586434|NCT00312572|156338966|FG001|Overall Study|Lack of Efficacy|2|||
48586435|NCT03597022|156338967|FG000|Overall Study|Premature termination of the study|7|||
48586436|NCT03597022|156338968|FG001|Overall Study|Premature termination of the study|7|||
48586437|NCT03597022|156338969|FG002|Overall Study|Premature termination of the study|8|||
48586438|NCT03597022|156338967|FG000|Overall Study|Serious adverse event|1|||
48586439|NCT03597022|156338968|FG001|Overall Study|Serious adverse event|1|||
48586440|NCT03597022|156338969|FG002|Overall Study|Serious adverse event|0|||
48586441|NCT05385224|156338974|FG000|Overall Study|Unable to swallow capsule|2|||
48586442|NCT05385224|156338974|FG000|Overall Study|Withdrawal by Subject|2|||
48586443|NCT05385224|156338974|FG000|Overall Study|Did not meet study criteria|1|||
48586444|NCT04150068|156338979|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
48586445|NCT04150068|156338980|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
48586446|NCT04150068|156338981|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
48586447|NCT04150068|156338979|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
48586448|NCT04150068|156338980|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
48333559|NCT03769090|155419374|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
48333560|NCT03769090|155419372|FG000|Overall Study|Withdrawal by Subject|52|||
48333561|NCT03769090|155419373|FG001|Overall Study|Withdrawal by Subject|62|||
48333562|NCT03769090|155419374|FG002|Overall Study|Withdrawal by Subject|74|||
48333563|NCT03769090|155419372|FG000|Overall Study|Death|4|||
48333564|NCT03769090|155419373|FG001|Overall Study|Death|2|||
48333565|NCT03769090|155419374|FG002|Overall Study|Death|2|||
48333566|NCT03769090|155419372|FG000|Overall Study|Adverse Event|7|||
48333567|NCT03769090|155419373|FG001|Overall Study|Adverse Event|7|||
48333568|NCT03769090|155419374|FG002|Overall Study|Adverse Event|8|||
48333569|NCT03769090|155419372|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
48333570|NCT03769090|155419373|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
48333571|NCT03769090|155419374|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
48333572|NCT03769090|155419372|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
48333573|NCT03769090|155419373|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
48333574|NCT03769090|155419374|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
48333575|NCT03769090|155419372|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
48333576|NCT03769090|155419373|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
48333577|NCT03769090|155419374|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
48333578|NCT03769090|155419372|FG000|Overall Study|Protocol Violation|5|||
48333579|NCT03769090|155419373|FG001|Overall Study|Protocol Violation|6|||
48333580|NCT03769090|155419374|FG002|Overall Study|Protocol Violation|8|||
48333581|NCT03769090|155419372|FG000|Overall Study|Pregnancy|1|||
48333582|NCT03769090|155419373|FG001|Overall Study|Pregnancy|0|||
48333583|NCT03769090|155419374|FG002|Overall Study|Pregnancy|3|||
48333584|NCT03769090|155419372|FG000|Overall Study|Lost to Follow-up|19|||
48333585|NCT03769090|155419373|FG001|Overall Study|Lost to Follow-up|25|||
48333586|NCT03769090|155419374|FG002|Overall Study|Lost to Follow-up|21|||
48333587|NCT03769090|155419372|FG000|Overall Study|Condition under investigation worsened|2|||
48333588|NCT03769090|155419373|FG001|Overall Study|Condition under investigation worsened|0|||
48333589|NCT03769090|155419374|FG002|Overall Study|Condition under investigation worsened|1|||
48333590|NCT03769090|155419372|FG000|Overall Study|Lack of Efficacy|1|||
48333591|NCT03769090|155419373|FG001|Overall Study|Lack of Efficacy|2|||
48333592|NCT03769090|155419374|FG002|Overall Study|Lack of Efficacy|2|||
48652328|NCT00022763|156579482|FG000|Overall Study|Lost to Follow-up|0|||
48333593|NCT03769090|155419372|FG000|Overall Study|Other reasons|8|||
48333594|NCT03769090|155419373|FG001|Overall Study|Other reasons|12|||
48333595|NCT03769090|155419374|FG002|Overall Study|Other reasons|15|||
48333596|NCT01970878|155419375|FG000|Overall Study|Withdrawal by Subject|11|||
48333597|NCT01970878|155419376|FG001|Overall Study|Withdrawal by Subject|10|||
48333598|NCT01970878|155419377|FG002|Overall Study|Withdrawal by Subject|14|||
48333599|NCT01970878|155419378|FG003|Overall Study|Withdrawal by Subject|7|||
48333600|NCT01970878|155419375|FG000|Overall Study|Lost to Follow-up|1|||
48333601|NCT01970878|155419376|FG001|Overall Study|Lost to Follow-up|3|||
48333602|NCT01970878|155419377|FG002|Overall Study|Lost to Follow-up|2|||
48333603|NCT01970878|155419378|FG003|Overall Study|Lost to Follow-up|4|||
48333604|NCT01970878|155419375|FG000|Overall Study|Administrative Reasons|1|||
48333605|NCT01970878|155419376|FG001|Overall Study|Administrative Reasons|0|||
48333606|NCT01970878|155419377|FG002|Overall Study|Administrative Reasons|0|||
48333607|NCT01970878|155419378|FG003|Overall Study|Administrative Reasons|4|||
48333608|NCT01970878|155419375|FG000|Overall Study|Lack of Efficacy|2|||
48333609|NCT01970878|155419376|FG001|Overall Study|Lack of Efficacy|1|||
48333610|NCT01970878|155419377|FG002|Overall Study|Lack of Efficacy|2|||
48333611|NCT01970878|155419378|FG003|Overall Study|Lack of Efficacy|0|||
48333612|NCT01970878|155419375|FG000|Overall Study|Adverse Event|12|||
48333613|NCT01970878|155419376|FG001|Overall Study|Adverse Event|7|||
48652329|NCT00022763|156579483|FG001|Overall Study|Lost to Follow-up|3|||
48652330|NCT00022763|156579482|FG000|Overall Study|Withdrawal by Subject|4|||
48652331|NCT00022763|156579483|FG001|Overall Study|Withdrawal by Subject|7|||
48652332|NCT00022763|156579482|FG000|Overall Study|Insufficient Therapy|1|||
48652333|NCT00022763|156579483|FG001|Overall Study|Insufficient Therapy|0|||
48652334|NCT00022763|156579482|FG000|Overall Study|Admin|3|||
48652335|NCT00022763|156579483|FG001|Overall Study|Admin|2|||
48652336|NCT02550288|156579484|FG000|Overall Study|Adverse Event|0|||
48652337|NCT02550288|156579485|FG001|Overall Study|Adverse Event|1|||
48333614|NCT01970878|155419377|FG002|Overall Study|Adverse Event|4|||
48333615|NCT01970878|155419378|FG003|Overall Study|Adverse Event|3|||
48333616|NCT01970878|155419375|FG000|Overall Study|Protocol Specified Criteria|10|||
48333617|NCT01970878|155419376|FG001|Overall Study|Protocol Specified Criteria|4|||
48652338|NCT02550288|156579486|FG002|Overall Study|Adverse Event|0|||
48652339|NCT02550288|156579487|FG003|Overall Study|Adverse Event|0|||
48333618|NCT01970878|155419377|FG002|Overall Study|Protocol Specified Criteria|3|||
48333619|NCT01970878|155419378|FG003|Overall Study|Protocol Specified Criteria|6|||
48333620|NCT01970878|155419375|FG000|Overall Study|Physician Decision|0|||
48333621|NCT01970878|155419376|FG001|Overall Study|Physician Decision|1|||
48333622|NCT01970878|155419377|FG002|Overall Study|Physician Decision|1|||
48586449|NCT04150068|156338981|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
48586450|NCT01618916|156338984|FG000|Overall Study|Adverse Event|1|||
48586451|NCT01618916|156338985|FG001|Overall Study|Adverse Event|0|||
48586452|NCT01618916|156338986|FG002|Overall Study|Adverse Event|0|||
48586453|NCT01618916|156338987|FG003|Overall Study|Adverse Event|0|||
48586454|NCT01618916|156338988|FG004|Overall Study|Adverse Event|0|||
48753481|NCT01124422|156944232|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
48753482|NCT01124422|156944233|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
48652340|NCT02550288|156579488|FG004|Overall Study|Adverse Event|0|||
48652341|NCT02550288|156579484|FG000|Overall Study|Physician Decision|0|||
48652342|NCT02550288|156579485|FG001|Overall Study|Physician Decision|0|||
48652343|NCT02550288|156579486|FG002|Overall Study|Physician Decision|0|||
48652344|NCT02550288|156579487|FG003|Overall Study|Physician Decision|1|||
48652345|NCT02550288|156579488|FG004|Overall Study|Physician Decision|0|||
48652346|NCT02550288|156579484|FG000|Overall Study|Protocol Violation|2|||
48652347|NCT02550288|156579485|FG001|Overall Study|Protocol Violation|2|||
48652348|NCT02550288|156579486|FG002|Overall Study|Protocol Violation|1|||
48652349|NCT02550288|156579487|FG003|Overall Study|Protocol Violation|0|||
48652350|NCT02550288|156579488|FG004|Overall Study|Protocol Violation|3|||
48652351|NCT02550288|156579484|FG000|Overall Study|Participant moved|0|||
48652352|NCT02550288|156579485|FG001|Overall Study|Participant moved|0|||
48652353|NCT02550288|156579486|FG002|Overall Study|Participant moved|0|||
48652354|NCT02550288|156579487|FG003|Overall Study|Participant moved|1|||
48652355|NCT02550288|156579488|FG004|Overall Study|Participant moved|0|||
48652356|NCT02550288|156579484|FG000|Overall Study|Withdrawal by Subject|0|||
48652357|NCT02550288|156579485|FG001|Overall Study|Withdrawal by Subject|0|||
48652358|NCT02550288|156579486|FG002|Overall Study|Withdrawal by Subject|0|||
48652359|NCT02550288|156579487|FG003|Overall Study|Withdrawal by Subject|1|||
48652360|NCT02550288|156579488|FG004|Overall Study|Withdrawal by Subject|0|||
48652361|NCT01296711|156579489|FG000|Overall Study|Adverse Event|3|||
48652362|NCT01296711|156579490|FG001|Overall Study|Adverse Event|1|||
48652363|NCT01296711|156579491|FG002|Overall Study|Adverse Event|4|||
48652364|NCT01296711|156579492|FG003|Overall Study|Adverse Event|3|||
48652365|NCT01296711|156579493|FG004|Overall Study|Adverse Event|1|||
48652366|NCT01296711|156579494|FG005|Overall Study|Adverse Event|6|||
48652367|NCT01296711|156579495|FG006|Overall Study|Adverse Event|11|||
48652368|NCT01296711|156579496|FG007|Overall Study|Adverse Event|3|||
48652369|NCT01296711|156579489|FG000|Overall Study|Lack of Efficacy|1|||
48652370|NCT01296711|156579490|FG001|Overall Study|Lack of Efficacy|4|||
48652371|NCT01296711|156579491|FG002|Overall Study|Lack of Efficacy|1|||
48652372|NCT01296711|156579492|FG003|Overall Study|Lack of Efficacy|1|||
48652373|NCT01296711|156579493|FG004|Overall Study|Lack of Efficacy|1|||
48652374|NCT01296711|156579494|FG005|Overall Study|Lack of Efficacy|0|||
48652375|NCT01296711|156579495|FG006|Overall Study|Lack of Efficacy|2|||
48652376|NCT01296711|156579496|FG007|Overall Study|Lack of Efficacy|3|||
48652377|NCT01296711|156579489|FG000|Overall Study|Lost to Follow-up|0|||
48652378|NCT01296711|156579490|FG001|Overall Study|Lost to Follow-up|0|||
48652379|NCT01296711|156579491|FG002|Overall Study|Lost to Follow-up|1|||
48652380|NCT01296711|156579492|FG003|Overall Study|Lost to Follow-up|1|||
48652381|NCT01296711|156579493|FG004|Overall Study|Lost to Follow-up|2|||
48652382|NCT01296711|156579494|FG005|Overall Study|Lost to Follow-up|0|||
48652383|NCT01296711|156579495|FG006|Overall Study|Lost to Follow-up|4|||
48652384|NCT01296711|156579496|FG007|Overall Study|Lost to Follow-up|2|||
48652385|NCT01296711|156579489|FG000|Overall Study|Protocol Violation|0|||
48652386|NCT01296711|156579490|FG001|Overall Study|Protocol Violation|0|||
48753483|NCT01124422|156944231|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
48753484|NCT01124422|156944232|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
48753485|NCT01124422|156944233|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
48753486|NCT01124422|156944231|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
48753487|NCT01124422|156944232|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
48652387|NCT01296711|156579491|FG002|Overall Study|Protocol Violation|0|||
48652388|NCT01296711|156579492|FG003|Overall Study|Protocol Violation|1|||
48652389|NCT01296711|156579493|FG004|Overall Study|Protocol Violation|1|||
48652390|NCT01296711|156579494|FG005|Overall Study|Protocol Violation|0|||
48652391|NCT01296711|156579495|FG006|Overall Study|Protocol Violation|0|||
48753488|NCT01124422|156944233|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
48753489|NCT01124422|156944231|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
48753490|NCT01124422|156944232|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
48586455|NCT01618916|156338989|FG005|Overall Study|Adverse Event|0|||
48586456|NCT01618916|156338984|FG000|Overall Study|Withdrawal by Subject|0|||
48586457|NCT01618916|156338985|FG001|Overall Study|Withdrawal by Subject|1|||
48586458|NCT01618916|156338986|FG002|Overall Study|Withdrawal by Subject|1|||
48586459|NCT01618916|156338987|FG003|Overall Study|Withdrawal by Subject|0|||
48586460|NCT01618916|156338988|FG004|Overall Study|Withdrawal by Subject|1|||
48586461|NCT01618916|156338989|FG005|Overall Study|Withdrawal by Subject|0|||
48586462|NCT01618916|156338984|FG000|Overall Study|Lost to Follow-up|1|||
48586463|NCT01618916|156338985|FG001|Overall Study|Lost to Follow-up|0|||
48333623|NCT01970878|155419378|FG003|Overall Study|Physician Decision|0|||
48333624|NCT01970878|155419375|FG000|Overall Study|No Completion Status|0|||
48333625|NCT01970878|155419376|FG001|Overall Study|No Completion Status|1|||
48652392|NCT01296711|156579496|FG007|Overall Study|Protocol Violation|0|||
48333626|NCT01970878|155419377|FG002|Overall Study|No Completion Status|0|||
48333627|NCT01970878|155419378|FG003|Overall Study|No Completion Status|0|||
48333628|NCT00670449|155419379|FG000|Overall Study|Adverse Event|6|||
48333629|NCT00670449|155419380|FG001|Overall Study|Adverse Event|2|||
48333630|NCT00670449|155419381|FG002|Overall Study|Adverse Event|8|||
48333631|NCT00670449|155419382|FG003|Overall Study|Adverse Event|5|||
48333632|NCT00670449|155419379|FG000|Overall Study|Protocol Deviation|1|||
48333633|NCT00670449|155419380|FG001|Overall Study|Protocol Deviation|2|||
48333634|NCT00670449|155419381|FG002|Overall Study|Protocol Deviation|0|||
48333635|NCT00670449|155419382|FG003|Overall Study|Protocol Deviation|1|||
48333636|NCT00670449|155419379|FG000|Overall Study|Administrative Problems|0|||
48333637|NCT00670449|155419380|FG001|Overall Study|Administrative Problems|2|||
48333638|NCT00670449|155419381|FG002|Overall Study|Administrative Problems|0|||
48333639|NCT00670449|155419382|FG003|Overall Study|Administrative Problems|1|||
48333640|NCT00670449|155419379|FG000|Overall Study|Subject Withdrew Consent|0|||
48333641|NCT00670449|155419380|FG001|Overall Study|Subject Withdrew Consent|2|||
48333642|NCT00670449|155419381|FG002|Overall Study|Subject Withdrew Consent|0|||
48333643|NCT00670449|155419382|FG003|Overall Study|Subject Withdrew Consent|1|||
48333644|NCT00670449|155419379|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
48333645|NCT00670449|155419380|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48333646|NCT00670449|155419381|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
48333647|NCT00670449|155419382|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48652393|NCT01296711|156579489|FG000|Overall Study|Withdrawal by Subject|4|||
48333648|NCT00670449|155419379|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
48333649|NCT00670449|155419380|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
48333650|NCT00670449|155419381|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
48333651|NCT00670449|155419382|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
48333652|NCT02660086|155419387|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
48333653|NCT02660086|155419388|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
48333654|NCT02660086|155419387|FG000|Overall Study- 12-month|Left full-time employment|12|||
48333655|NCT02660086|155419388|FG001|Overall Study- 12-month|Left full-time employment|20|||
48652394|NCT01296711|156579490|FG001|Overall Study|Withdrawal by Subject|2|||
48652395|NCT01296711|156579491|FG002|Overall Study|Withdrawal by Subject|2|||
48652396|NCT01296711|156579492|FG003|Overall Study|Withdrawal by Subject|1|||
48652397|NCT01296711|156579493|FG004|Overall Study|Withdrawal by Subject|1|||
48652398|NCT01296711|156579494|FG005|Overall Study|Withdrawal by Subject|1|||
48652399|NCT01296711|156579495|FG006|Overall Study|Withdrawal by Subject|2|||
48652400|NCT01296711|156579496|FG007|Overall Study|Withdrawal by Subject|1|||
48652401|NCT01296711|156579489|FG000|Overall Study|Study termination|8|||
48652402|NCT01296711|156579490|FG001|Overall Study|Study termination|1|||
48652403|NCT01296711|156579491|FG002|Overall Study|Study termination|5|||
48652404|NCT01296711|156579492|FG003|Overall Study|Study termination|4|||
48652405|NCT01296711|156579493|FG004|Overall Study|Study termination|4|||
48652406|NCT01296711|156579494|FG005|Overall Study|Study termination|4|||
48652407|NCT01296711|156579495|FG006|Overall Study|Study termination|8|||
48652408|NCT01296711|156579496|FG007|Overall Study|Study termination|10|||
48652409|NCT01296711|156579489|FG000|Overall Study|Continued elevated liver enzymes|0|||
48652410|NCT01296711|156579490|FG001|Overall Study|Continued elevated liver enzymes|0|||
48652411|NCT01296711|156579491|FG002|Overall Study|Continued elevated liver enzymes|0|||
48652412|NCT01296711|156579492|FG003|Overall Study|Continued elevated liver enzymes|1|||
48652413|NCT01296711|156579493|FG004|Overall Study|Continued elevated liver enzymes|0|||
48652414|NCT01296711|156579494|FG005|Overall Study|Continued elevated liver enzymes|0|||
48652415|NCT01296711|156579495|FG006|Overall Study|Continued elevated liver enzymes|0|||
48652416|NCT01296711|156579496|FG007|Overall Study|Continued elevated liver enzymes|0|||
48652417|NCT01296711|156579489|FG000|Overall Study|Methotrexate discontinued|0|||
48652418|NCT01296711|156579490|FG001|Overall Study|Methotrexate discontinued|0|||
48652419|NCT01296711|156579491|FG002|Overall Study|Methotrexate discontinued|0|||
48652420|NCT01296711|156579492|FG003|Overall Study|Methotrexate discontinued|1|||
48652421|NCT01296711|156579493|FG004|Overall Study|Methotrexate discontinued|0|||
48652422|NCT01296711|156579494|FG005|Overall Study|Methotrexate discontinued|0|||
48652423|NCT01296711|156579495|FG006|Overall Study|Methotrexate discontinued|0|||
48652424|NCT01296711|156579496|FG007|Overall Study|Methotrexate discontinued|0|||
48652425|NCT01296711|156579489|FG000|Overall Study|Investigator discretion|0|||
48652426|NCT01296711|156579490|FG001|Overall Study|Investigator discretion|0|||
48652427|NCT01296711|156579491|FG002|Overall Study|Investigator discretion|0|||
48652428|NCT01296711|156579492|FG003|Overall Study|Investigator discretion|0|||
48652429|NCT01296711|156579493|FG004|Overall Study|Investigator discretion|0|||
48652430|NCT01296711|156579494|FG005|Overall Study|Investigator discretion|0|||
48652431|NCT01296711|156579495|FG006|Overall Study|Investigator discretion|1|||
48753491|NCT01124422|156944233|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
48652432|NCT01296711|156579496|FG007|Overall Study|Investigator discretion|0|||
48652433|NCT01296711|156579489|FG000|Overall Study|Other|0|||
48652434|NCT01296711|156579490|FG001|Overall Study|Other|0|||
48652435|NCT01296711|156579491|FG002|Overall Study|Other|0|||
48652436|NCT01296711|156579492|FG003|Overall Study|Other|0|||
48652437|NCT01296711|156579493|FG004|Overall Study|Other|0|||
48652438|NCT01296711|156579494|FG005|Overall Study|Other|0|||
48652439|NCT01296711|156579495|FG006|Overall Study|Other|1|||
48652440|NCT01296711|156579496|FG007|Overall Study|Other|0|||
48652441|NCT01296711|156579489|FG000|Overall Study|Required restricted steroid injections|0|||
48652442|NCT01296711|156579490|FG001|Overall Study|Required restricted steroid injections|0|||
48652443|NCT01296711|156579491|FG002|Overall Study|Required restricted steroid injections|0|||
48652444|NCT01296711|156579492|FG003|Overall Study|Required restricted steroid injections|0|||
48652445|NCT01296711|156579493|FG004|Overall Study|Required restricted steroid injections|0|||
48652446|NCT01296711|156579494|FG005|Overall Study|Required restricted steroid injections|0|||
48652447|NCT01296711|156579495|FG006|Overall Study|Required restricted steroid injections|1|||
48652448|NCT01296711|156579496|FG007|Overall Study|Required restricted steroid injections|0|||
48652449|NCT01296711|156579489|FG000|Overall Study|Ongoing missed appointments|0|||
48652450|NCT01296711|156579490|FG001|Overall Study|Ongoing missed appointments|0|||
48652451|NCT01296711|156579491|FG002|Overall Study|Ongoing missed appointments|0|||
48652452|NCT01296711|156579492|FG003|Overall Study|Ongoing missed appointments|0|||
48652453|NCT01296711|156579493|FG004|Overall Study|Ongoing missed appointments|0|||
48652454|NCT01296711|156579494|FG005|Overall Study|Ongoing missed appointments|0|||
48652455|NCT01296711|156579495|FG006|Overall Study|Ongoing missed appointments|1|||
48652456|NCT01296711|156579496|FG007|Overall Study|Ongoing missed appointments|0|||
48652457|NCT01296711|156579489|FG000|Overall Study|Failure to comply with visits|0|||
48652458|NCT01296711|156579490|FG001|Overall Study|Failure to comply with visits|0|||
48652459|NCT01296711|156579491|FG002|Overall Study|Failure to comply with visits|0|||
48652460|NCT01296711|156579492|FG003|Overall Study|Failure to comply with visits|0|||
48652461|NCT01296711|156579493|FG004|Overall Study|Failure to comply with visits|0|||
48652462|NCT01296711|156579494|FG005|Overall Study|Failure to comply with visits|0|||
48652463|NCT01296711|156579495|FG006|Overall Study|Failure to comply with visits|0|||
48652464|NCT01296711|156579496|FG007|Overall Study|Failure to comply with visits|1|||
48652465|NCT01296711|156579489|FG000|Overall Study|Patient decision due to transport|0|||
48652466|NCT01296711|156579490|FG001|Overall Study|Patient decision due to transport|0|||
48652467|NCT01296711|156579491|FG002|Overall Study|Patient decision due to transport|0|||
48652468|NCT01296711|156579492|FG003|Overall Study|Patient decision due to transport|0|||
48652469|NCT01296711|156579493|FG004|Overall Study|Patient decision due to transport|0|||
48652470|NCT01296711|156579494|FG005|Overall Study|Patient decision due to transport|0|||
48652471|NCT01296711|156579495|FG006|Overall Study|Patient decision due to transport|0|||
48652472|NCT01296711|156579496|FG007|Overall Study|Patient decision due to transport|1|||
48652473|NCT03249909|156579499|FG000|Overall Study|Withdrawal by Subject|3|||
48652474|NCT03249909|156579500|FG001|Overall Study|Withdrawal by Subject|0|||
48652475|NCT03249909|156579501|FG002|Overall Study|Withdrawal by Subject|0|||
48652476|NCT03249909|156579499|FG000|Overall Study|Adverse Event|3|||
48753492|NCT03958955|156944236|FG000|Overall Study|Adverse Event|1|||
48753493|NCT03454893|156944237|FG000|Overall Study|Study Terminated by the Sponsor|5|||
48753494|NCT03454893|156944237|FG000|Overall Study|Did not pass screening|4|||
48753495|NCT01113801|156944238|FG000|Overall Study|Adverse Event|4|||
48753496|NCT01113801|156944239|FG001|Overall Study|Adverse Event|0|||
48753497|NCT01113801|156944240|FG002|Overall Study|Adverse Event|2|||
48753498|NCT01113801|156944241|FG003|Overall Study|Adverse Event|6|||
48753499|NCT01113801|156944238|FG000|Overall Study|Death|4|||
48753500|NCT01113801|156944239|FG001|Overall Study|Death|5|||
48753501|NCT01113801|156944240|FG002|Overall Study|Death|3|||
48753502|NCT01113801|156944241|FG003|Overall Study|Death|4|||
48753503|NCT01113801|156944238|FG000|Overall Study|Protocol Violation|0|||
48753504|NCT01113801|156944239|FG001|Overall Study|Protocol Violation|1|||
48753505|NCT01113801|156944240|FG002|Overall Study|Protocol Violation|0|||
48753506|NCT01113801|156944241|FG003|Overall Study|Protocol Violation|0|||
48753507|NCT01113801|156944238|FG000|Overall Study|Withdrawal by Subject|9|||
48753508|NCT01113801|156944239|FG001|Overall Study|Withdrawal by Subject|7|||
48753509|NCT01113801|156944240|FG002|Overall Study|Withdrawal by Subject|7|||
48753510|NCT01113801|156944241|FG003|Overall Study|Withdrawal by Subject|8|||
48753511|NCT01113801|156944238|FG000|Overall Study|Physician Decision|2|||
48652477|NCT03249909|156579500|FG001|Overall Study|Adverse Event|0|||
48652478|NCT03249909|156579501|FG002|Overall Study|Adverse Event|0|||
48652479|NCT03249909|156579499|FG000|Overall Study|Lost to Follow-up|0|||
48652480|NCT03249909|156579500|FG001|Overall Study|Lost to Follow-up|1|||
48652481|NCT03249909|156579501|FG002|Overall Study|Lost to Follow-up|0|||
48652482|NCT01035463|156579503|FG000|Overall Study|Adverse Event|0|||
48652483|NCT01035463|156579504|FG001|Overall Study|Adverse Event|0|||
48652484|NCT01035463|156579505|FG002|Overall Study|Adverse Event|4|||
48652485|NCT01035463|156579506|FG003|Overall Study|Adverse Event|1|||
48652486|NCT01035463|156579507|FG004|Overall Study|Adverse Event|5|||
48652487|NCT01035463|156579508|FG005|Overall Study|Adverse Event|7|||
48652488|NCT01035463|156579503|FG000|Overall Study|Withdrawal by Subject|0|||
48652489|NCT01035463|156579504|FG001|Overall Study|Withdrawal by Subject|2|||
48652490|NCT01035463|156579505|FG002|Overall Study|Withdrawal by Subject|1|||
48652491|NCT01035463|156579506|FG003|Overall Study|Withdrawal by Subject|0|||
48652492|NCT01035463|156579507|FG004|Overall Study|Withdrawal by Subject|1|||
48652493|NCT01035463|156579508|FG005|Overall Study|Withdrawal by Subject|4|||
48652494|NCT01035463|156579503|FG000|Overall Study|Disease progression|0|||
48652495|NCT01035463|156579504|FG001|Overall Study|Disease progression|0|||
48652496|NCT01035463|156579505|FG002|Overall Study|Disease progression|0|||
48652497|NCT01035463|156579506|FG003|Overall Study|Disease progression|0|||
48652498|NCT01035463|156579507|FG004|Overall Study|Disease progression|0|||
48652499|NCT01035463|156579508|FG005|Overall Study|Disease progression|3|||
48652500|NCT01035463|156579503|FG000|Overall Study|Other Malignancy|0|||
48652501|NCT01035463|156579504|FG001|Overall Study|Other Malignancy|0|||
48652502|NCT01035463|156579505|FG002|Overall Study|Other Malignancy|0|||
48753512|NCT01113801|156944239|FG001|Overall Study|Physician Decision|2|||
48753513|NCT01113801|156944240|FG002|Overall Study|Physician Decision|3|||
48753514|NCT01113801|156944241|FG003|Overall Study|Physician Decision|3|||
48753515|NCT01113801|156944238|FG000|Overall Study|Sponsor Decision|15|||
48753516|NCT01113801|156944239|FG001|Overall Study|Sponsor Decision|21|||
48753517|NCT01113801|156944240|FG002|Overall Study|Sponsor Decision|20|||
48652503|NCT01035463|156579506|FG003|Overall Study|Other Malignancy|0|||
48753518|NCT01113801|156944241|FG003|Overall Study|Sponsor Decision|15|||
48652504|NCT01035463|156579507|FG004|Overall Study|Other Malignancy|0|||
48652505|NCT01035463|156579508|FG005|Overall Study|Other Malignancy|2|||
48652506|NCT01035463|156579503|FG000|Overall Study|Other|0|||
48652507|NCT01035463|156579504|FG001|Overall Study|Other|0|||
48753519|NCT01113801|156944238|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
48753520|NCT01113801|156944239|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
48753521|NCT01113801|156944240|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
48753522|NCT01113801|156944241|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
48652508|NCT01035463|156579505|FG002|Overall Study|Other|0|||
48652509|NCT01035463|156579506|FG003|Overall Study|Other|1|||
48652510|NCT01035463|156579507|FG004|Overall Study|Other|0|||
48753523|NCT01949051|156944243|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
48333656|NCT02660086|155419387|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
48333657|NCT02660086|155419388|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
48333658|NCT02660086|155419387|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
48333659|NCT02660086|155419388|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
48333660|NCT02660086|155419387|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
48333661|NCT02660086|155419388|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
48333662|NCT02660086|155419387|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
48652511|NCT01035463|156579508|FG005|Overall Study|Other|2|||
48652512|NCT00313313|156579509|FG000|Overall Study|Lack of Efficacy|14|||
48652513|NCT00313313|156579510|FG001|Overall Study|Lack of Efficacy|9|||
48652514|NCT00313313|156579511|FG002|Overall Study|Lack of Efficacy|20|||
48652515|NCT00313313|156579509|FG000|Overall Study|Withdrawal of consent by subject|18|||
48652516|NCT00313313|156579510|FG001|Overall Study|Withdrawal of consent by subject|17|||
48652517|NCT00313313|156579511|FG002|Overall Study|Withdrawal of consent by subject|31|||
48652518|NCT00313313|156579509|FG000|Overall Study|Lost to Follow-up|10|||
48652519|NCT00313313|156579510|FG001|Overall Study|Lost to Follow-up|7|||
48652520|NCT00313313|156579511|FG002|Overall Study|Lost to Follow-up|9|||
48652521|NCT00313313|156579509|FG000|Overall Study|Adverse Event|15|||
48652522|NCT00313313|156579510|FG001|Overall Study|Adverse Event|16|||
48652523|NCT00313313|156579511|FG002|Overall Study|Adverse Event|12|||
48652524|NCT00313313|156579509|FG000|Overall Study|Physician Decision|2|||
48652525|NCT00313313|156579510|FG001|Overall Study|Physician Decision|6|||
48652526|NCT00313313|156579511|FG002|Overall Study|Physician Decision|4|||
48652527|NCT00313313|156579509|FG000|Overall Study|Poor/Noncompliance|3|||
48652528|NCT00313313|156579510|FG001|Overall Study|Poor/Noncompliance|6|||
48652529|NCT00313313|156579511|FG002|Overall Study|Poor/Noncompliance|2|||
48652530|NCT00313313|156579509|FG000|Overall Study|Pregnancy|1|||
48652531|NCT00313313|156579510|FG001|Overall Study|Pregnancy|2|||
48652532|NCT00313313|156579511|FG002|Overall Study|Pregnancy|0|||
48652533|NCT00313313|156579509|FG000|Overall Study|Death|0|||
48652534|NCT00313313|156579510|FG001|Overall Study|Death|0|||
48652535|NCT00313313|156579511|FG002|Overall Study|Death|2|||
48652536|NCT00313313|156579509|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
48652537|NCT00313313|156579510|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
48652538|NCT00313313|156579511|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
48652539|NCT03832322|156579520|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
48652540|NCT03832322|156579521|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
48652541|NCT01606176|156579523|FG000|Overall Study|Adverse Event|2|||
48652542|NCT01606176|156579524|FG001|Overall Study|Adverse Event|3|||
48652543|NCT01606176|156579523|FG000|Overall Study|Disease progression|1|||
48652544|NCT01606176|156579524|FG001|Overall Study|Disease progression|0|||
48652545|NCT01606176|156579523|FG000|Overall Study|Withdrawal by Subject|1|||
48652546|NCT01606176|156579524|FG001|Overall Study|Withdrawal by Subject|0|||
48652547|NCT01814397|156579531|FG000|Overall Study|Adverse Event|7|||
48652548|NCT01814397|156579531|FG000|Overall Study|Withdrawal by Subject|7|||
48652549|NCT03136497|156579534|FG000|Overall Study|Screen Failure|1|||
48652550|NCT03136497|156579535|FG001|Overall Study|Screen Failure|0|||
48652551|NCT03136497|156579536|FG002|Overall Study|Screen Failure|0|||
48652552|NCT02487654|156579537|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
48652553|NCT02487654|156579538|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
48753524|NCT01949051|156944244|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
48753525|NCT01949051|156944245|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
48753526|NCT01949051|156944246|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
48753527|NCT01949051|156944247|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
48753528|NCT01949051|156944248|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
48753529|NCT01949051|156944243|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
48753530|NCT01949051|156944244|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48753531|NCT01949051|156944245|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48753532|NCT01949051|156944246|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48753533|NCT01949051|156944247|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48753534|NCT01949051|156944248|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
48333663|NCT02660086|155419388|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
48428047|NCT02518620|155754794|FG001|Overall Study|Relocation|1|||
48652554|NCT02487654|156579537|FG000|Overall Study|Withdrawal by Subject|3|||
48652555|NCT02487654|156579538|FG001|Overall Study|Withdrawal by Subject|7|||
48652556|NCT00616018|156579540|FG000|Overall Study|Protocol Violation|3|||
48652557|NCT03718884|156579541|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
48753535|NCT01949051|156944243|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48753536|NCT01949051|156944244|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48753537|NCT01949051|156944245|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48652558|NCT03718884|156579542|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
48652559|NCT03718884|156579541|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
48652560|NCT03718884|156579542|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
48652561|NCT00350870|156579545|FG000|Overall Study|Withdrawal by Subject|21|||
48333664|NCT01377844|155419389|FG000|Overall Study|Withdrawal by Subject|25|||
48333665|NCT01377844|155419390|FG001|Overall Study|Withdrawal by Subject|28|||
48333666|NCT01377844|155419389|FG000|Overall Study|Protocol Violation|2|||
48333667|NCT01377844|155419390|FG001|Overall Study|Protocol Violation|3|||
48333668|NCT01377844|155419389|FG000|Overall Study|Adverse Event|3|||
48333669|NCT01377844|155419390|FG001|Overall Study|Adverse Event|0|||
48333670|NCT01377844|155419389|FG000|Overall Study|Physician Decision|6|||
48333671|NCT01377844|155419390|FG001|Overall Study|Physician Decision|3|||
48333672|NCT01377844|155419389|FG000|Overall Study|Study terminated by Sponsor|0|||
48333673|NCT01377844|155419390|FG001|Overall Study|Study terminated by Sponsor|1|||
48333674|NCT00307489|155419391|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
48333675|NCT00307489|155419392|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
48333676|NCT00307489|155419391|FG000|Baseline Through Week 48|Physician Decision|1|||
48333677|NCT00307489|155419392|FG001|Baseline Through Week 48|Physician Decision|0|||
48333678|NCT00307489|155419391|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
48333679|NCT00307489|155419392|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
48333680|NCT00307489|155419391|FG000|Week 48 Through Week 168|Adverse Event|1|||
48333681|NCT00307489|155419392|FG001|Week 48 Through Week 168|Adverse Event|0|||
48333682|NCT00307489|155419391|FG000|Week 48 Through Week 168|Physician Decision|1|||
48333683|NCT00307489|155419392|FG001|Week 48 Through Week 168|Physician Decision|0|||
48333684|NCT00307489|155419391|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
48333685|NCT00307489|155419392|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
48333686|NCT00307489|155419391|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
48333687|NCT00307489|155419392|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
48333688|NCT00307489|155419391|FG000|Week 48 Through Week 168|Death|0|||
48333689|NCT00307489|155419392|FG001|Week 48 Through Week 168|Death|1|||
48333690|NCT00307489|155419391|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
48333691|NCT00307489|155419392|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
48333692|NCT00307489|155419391|FG000|Week 48 Through Week 168|Seroconversion|1|||
48333693|NCT00307489|155419392|FG001|Week 48 Through Week 168|Seroconversion|0|||
48333694|NCT02708498|155419399|FG000|Overall Study|Death|20|||
48333695|NCT02708498|155419400|FG001|Overall Study|Death|19|||
48333696|NCT02708498|155419401|FG002|Overall Study|Death|0|||
48333697|NCT02708498|155419402|FG003|Overall Study|Death|0|||
48333698|NCT02708498|155419403|FG004|Overall Study|Death|1|||
48333699|NCT02708498|155419404|FG005|Overall Study|Death|0|||
48333700|NCT02708498|155419405|FG006|Overall Study|Death|0|||
48333701|NCT02708498|155419406|FG007|Overall Study|Death|0|||
48333702|NCT02708498|155419399|FG000|Overall Study|Unknown reason, missing data|0|||
48333703|NCT02708498|155419400|FG001|Overall Study|Unknown reason, missing data|0|||
48333704|NCT02708498|155419401|FG002|Overall Study|Unknown reason, missing data|62|||
48333705|NCT02708498|155419402|FG003|Overall Study|Unknown reason, missing data|51|||
48333706|NCT02708498|155419403|FG004|Overall Study|Unknown reason, missing data|195|||
48333707|NCT02708498|155419404|FG005|Overall Study|Unknown reason, missing data|132|||
48333708|NCT02708498|155419405|FG006|Overall Study|Unknown reason, missing data|0|||
48333709|NCT02708498|155419406|FG007|Overall Study|Unknown reason, missing data|0|||
48333710|NCT01381549|155419407|FG000|Overall Study|Ineligible: No organisms isolated|0|||
48333711|NCT01381549|155419408|FG001|Overall Study|Ineligible: No organisms isolated|0|||
48333712|NCT01381549|155419409|FG002|Overall Study|Ineligible: No organisms isolated|1|||
48333713|NCT03236779|155419410|FG000|Overall Study|Lost to Follow-up|13|||
48333714|NCT03236779|155419411|FG001|Overall Study|Lost to Follow-up|21|||
48333715|NCT02981953|155419412|FG000|Overall Study|Death|9|||
48333716|NCT02981953|155419412|FG000|Overall Study|Withdrawal by Subject|1|||
48333717|NCT02981953|155419412|FG000|Overall Study|Withdrawal to non-compliance|1|||
48333718|NCT00403845|155419415|FG000|Treatment Period 1|Subject withdrew consent|1|||
48333719|NCT00403845|155419416|FG001|Treatment Period 1|Subject withdrew consent|0|||
48333720|NCT00403845|155419417|FG002|Treatment Period 1|Subject withdrew consent|0|||
48333721|NCT00403845|155419418|FG003|Treatment Period 1|Subject withdrew consent|0|||
48333722|NCT00403845|155419415|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
48333723|NCT00403845|155419416|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
48333724|NCT00403845|155419417|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
48333725|NCT00403845|155419418|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
48333726|NCT00403845|155419415|FG000|Treatment Period 2|Subject withdrew consent|1|||
48333727|NCT00403845|155419416|FG001|Treatment Period 2|Subject withdrew consent|0|||
48333728|NCT00403845|155419417|FG002|Treatment Period 2|Subject withdrew consent|0|||
48333729|NCT00403845|155419418|FG003|Treatment Period 2|Subject withdrew consent|0|||
48333730|NCT00403845|155419415|FG000|Treatment Period 3|Subject withdrew consent|0|||
48333731|NCT00403845|155419416|FG001|Treatment Period 3|Subject withdrew consent|0|||
48333732|NCT00403845|155419417|FG002|Treatment Period 3|Subject withdrew consent|0|||
48333733|NCT00403845|155419418|FG003|Treatment Period 3|Subject withdrew consent|1|||
48333734|NCT00403845|155419415|FG000|Treatment Period 3|Adverse Event|0|||
48333735|NCT00403845|155419416|FG001|Treatment Period 3|Adverse Event|0|||
48652562|NCT00350870|156579546|FG001|Overall Study|Withdrawal by Subject|17|||
48652563|NCT00350870|156579547|FG002|Overall Study|Withdrawal by Subject|15|||
48333736|NCT00403845|155419417|FG002|Treatment Period 3|Adverse Event|0|||
48333737|NCT00403845|155419418|FG003|Treatment Period 3|Adverse Event|1|||
48333738|NCT00805792|155419419|FG000|Overall Study|Death|3|||
48333739|NCT00805792|155419419|FG000|Overall Study|Lost to Follow-up|2|||
48333740|NCT02935673|155419428|FG000|Overall Study|Adverse Event|0|||
48333741|NCT02935673|155419429|FG001|Overall Study|Adverse Event|1|||
48333742|NCT02935673|155419430|FG002|Overall Study|Adverse Event|0|||
48333743|NCT02935673|155419428|FG000|Overall Study|Withdrawal by Subject|1|||
48333744|NCT02935673|155419429|FG001|Overall Study|Withdrawal by Subject|2|||
48333745|NCT02935673|155419430|FG002|Overall Study|Withdrawal by Subject|0|||
48333746|NCT01640288|155419431|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
48333747|NCT01640288|155419432|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
48333748|NCT01640288|155419431|FG000|Overall Study|Screen Failure|20|||
48652564|NCT00350870|156579548|FG003|Overall Study|Withdrawal by Subject|14|||
48652565|NCT00350870|156579545|FG000|Overall Study|Physician Decision|1|||
48652566|NCT00350870|156579546|FG001|Overall Study|Physician Decision|0|||
48652567|NCT00350870|156579547|FG002|Overall Study|Physician Decision|1|||
48652568|NCT00350870|156579548|FG003|Overall Study|Physician Decision|1|||
48652569|NCT04730635|156579549|FG000|Overall Study|Lost to Follow-up|1|||
48652570|NCT04730635|156579550|FG001|Overall Study|Lost to Follow-up|0|||
48652571|NCT04730635|156579549|FG000|Overall Study|Withdrawal by Subject|0|||
48652572|NCT04730635|156579550|FG001|Overall Study|Withdrawal by Subject|1|||
48652573|NCT00516906|156579551|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
48652574|NCT00516906|156579552|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
48652575|NCT03268954|156579555|FG000|Overall Study|Ongoing|23|||
48652576|NCT03268954|156579556|FG001|Overall Study|Ongoing|31|||
48652577|NCT03268954|156579555|FG000|Overall Study|Adverse Event|53|||
48652578|NCT03268954|156579556|FG001|Overall Study|Adverse Event|62|||
48652579|NCT03268954|156579555|FG000|Overall Study|Withdrawal by Subject|25|||
48652580|NCT03268954|156579556|FG001|Overall Study|Withdrawal by Subject|16|||
48652581|NCT03268954|156579555|FG000|Overall Study|Progressive Disease|61|||
48652582|NCT03268954|156579556|FG001|Overall Study|Progressive Disease|48|||
48652583|NCT03268954|156579555|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
48652584|NCT03268954|156579556|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
48652585|NCT03268954|156579555|FG000|Overall Study|Reason not Specified|40|||
48652586|NCT03268954|156579556|FG001|Overall Study|Reason not Specified|40|||
48652587|NCT01108731|156579557|FG000|Overall Study|Withdrawal by Subject|1|||
48652588|NCT01108731|156579558|FG001|Overall Study|Withdrawal by Subject|1|||
48652589|NCT01108731|156579557|FG000|Overall Study|Adverse Event|3|||
48652590|NCT01108731|156579558|FG001|Overall Study|Adverse Event|3|||
48652591|NCT04209634|156579563|FG000|Overall Study|Ongoing|10|||
48652592|NCT00780143|156579564|FG000|Overall Study|Progressive disease|1|||
48652593|NCT00780143|156579564|FG000|Overall Study|Toxicity|1|||
48652594|NCT00780143|156579564|FG000|Overall Study|Adverse Event|1|||
48652595|NCT00583752|156579565|FG000|Overall Study|Lost to Follow-up|5|||
48652596|NCT00583752|156579566|FG001|Overall Study|Lost to Follow-up|5|||
48652597|NCT00875485|156581200|FG000|Challenge Dose Epoch|Pregnancy|1|||
48652598|NCT00875485|156581201|FG001|Challenge Dose Epoch|Pregnancy|0|||
48652599|NCT01132651|156581202|FG000|Overall Study|Lost to Follow-up|1|||
48652600|NCT01132651|156581203|FG001|Overall Study|Lost to Follow-up|1|||
48652601|NCT02482428|156581204|FG000|Overall Study|Lost to Follow-up|4|||
48652602|NCT02482428|156581205|FG001|Overall Study|Lost to Follow-up|9|||
48652603|NCT02482428|156581206|FG002|Overall Study|Lost to Follow-up|1|||
48652604|NCT02482428|156581207|FG003|Overall Study|Lost to Follow-up|2|||
48652605|NCT02482428|156581208|FG004|Overall Study|Lost to Follow-up|4|||
48652606|NCT02482428|156581204|FG000|Overall Study|Physician Decision|0|||
48652607|NCT02482428|156581205|FG001|Overall Study|Physician Decision|0|||
48652608|NCT02482428|156581206|FG002|Overall Study|Physician Decision|0|||
48652609|NCT02482428|156581207|FG003|Overall Study|Physician Decision|0|||
48652610|NCT02482428|156581208|FG004|Overall Study|Physician Decision|1|||
48652611|NCT02482428|156581204|FG000|Overall Study|protocol deviation|1|||
48652612|NCT02482428|156581205|FG001|Overall Study|protocol deviation|1|||
48652613|NCT02482428|156581206|FG002|Overall Study|protocol deviation|0|||
48652614|NCT02482428|156581207|FG003|Overall Study|protocol deviation|0|||
48652615|NCT02482428|156581208|FG004|Overall Study|protocol deviation|0|||
48652616|NCT02482428|156581204|FG000|Overall Study|subject/guardian decision|4|||
48652617|NCT02482428|156581205|FG001|Overall Study|subject/guardian decision|2|||
48652618|NCT02482428|156581206|FG002|Overall Study|subject/guardian decision|0|||
48652619|NCT02482428|156581207|FG003|Overall Study|subject/guardian decision|0|||
48652620|NCT02482428|156581208|FG004|Overall Study|subject/guardian decision|2|||
48652621|NCT01893411|156581209|FG000|Overall Study|Protocol Violation|1|||
48652622|NCT01893411|156581210|FG001|Overall Study|Protocol Violation|0|||
48333749|NCT01640288|155419432|FG001|Overall Study|Screen Failure|18|||
48333750|NCT01640288|155419431|FG000|Overall Study|Withdrawn by PI|5|||
48333751|NCT01640288|155419432|FG001|Overall Study|Withdrawn by PI|0|||
48333752|NCT01640288|155419431|FG000|Overall Study|Withdrawal by Subject|1|||
48333753|NCT01640288|155419432|FG001|Overall Study|Withdrawal by Subject|0|||
48333754|NCT02547974|155419441|FG000|Overall Study|Withdrawal by Subject|1|||
48753538|NCT01949051|156944246|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48753539|NCT01949051|156944247|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
48753540|NCT01949051|156944248|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
48753541|NCT01949051|156944243|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48753542|NCT01949051|156944244|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
48753543|NCT01949051|156944245|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48652623|NCT01893411|156581211|FG002|Overall Study|Protocol Violation|0|||
48652624|NCT01893411|156581209|FG000|Overall Study|Physician Decision|1|||
48652625|NCT01893411|156581210|FG001|Overall Study|Physician Decision|1|||
48652626|NCT01893411|156581211|FG002|Overall Study|Physician Decision|2|||
48652627|NCT01893411|156581209|FG000|Overall Study|Lack of Efficacy|2|||
48652628|NCT01893411|156581210|FG001|Overall Study|Lack of Efficacy|1|||
48652629|NCT01893411|156581211|FG002|Overall Study|Lack of Efficacy|0|||
48652630|NCT01893411|156581209|FG000|Overall Study|Other|3|||
48652631|NCT01893411|156581210|FG001|Overall Study|Other|1|||
48652632|NCT01893411|156581211|FG002|Overall Study|Other|3|||
48652633|NCT01893411|156581209|FG000|Overall Study|Adverse Event|1|||
48652634|NCT01893411|156581210|FG001|Overall Study|Adverse Event|0|||
48652635|NCT01893411|156581211|FG002|Overall Study|Adverse Event|0|||
48652636|NCT01893411|156581209|FG000|Overall Study|Withdrawal by Subject|7|||
48652637|NCT01893411|156581210|FG001|Overall Study|Withdrawal by Subject|4|||
48652638|NCT01893411|156581211|FG002|Overall Study|Withdrawal by Subject|3|||
48652639|NCT01893411|156581209|FG000|Overall Study|Lost to Follow-up|2|||
48652640|NCT01893411|156581210|FG001|Overall Study|Lost to Follow-up|0|||
48652641|NCT01893411|156581211|FG002|Overall Study|Lost to Follow-up|1|||
48652642|NCT02582814|156581213|FG000|Overall Study|Study-specific withdrawal criteria|1|||
48652643|NCT02582814|156581214|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48652644|NCT02582814|156581213|FG000|Overall Study|Withdrawal by Subject|4|||
48652645|NCT02582814|156581214|FG001|Overall Study|Withdrawal by Subject|3|||
48652646|NCT02582814|156581213|FG000|Overall Study|Adverse Event|4|||
48652647|NCT02582814|156581214|FG001|Overall Study|Adverse Event|4|||
48652648|NCT00443872|156581219|FG000|Overall Study|Protocol Violation|7|||
48652649|NCT00443872|156581219|FG000|Overall Study|Lost to Follow-up|2|||
48652650|NCT00443872|156581219|FG000|Overall Study|Adverse Event|8|||
48652651|NCT02789345|156581220|FG000|Overall Study|Adverse Event|0|||
48652652|NCT02789345|156581221|FG001|Overall Study|Adverse Event|0|||
48652653|NCT02789345|156581222|FG002|Overall Study|Adverse Event|1|||
48652654|NCT02789345|156581220|FG000|Overall Study|Death|0|||
48652655|NCT02789345|156581221|FG001|Overall Study|Death|0|||
48652656|NCT02789345|156581222|FG002|Overall Study|Death|1|||
48652657|NCT02789345|156581220|FG000|Overall Study|Physician Decision|2|||
48652658|NCT02789345|156581221|FG001|Overall Study|Physician Decision|0|||
48652659|NCT02789345|156581222|FG002|Overall Study|Physician Decision|1|||
48652660|NCT02789345|156581220|FG000|Overall Study|Progressive Disease|1|||
48652661|NCT02789345|156581221|FG001|Overall Study|Progressive Disease|3|||
48652662|NCT02789345|156581222|FG002|Overall Study|Progressive Disease|14|||
48652663|NCT00654745|156581224|FG000|Overall Study|Adverse Event|12|||
48652664|NCT00654745|156581224|FG000|Overall Study|Lost to Follow-up|7|||
48652665|NCT00654745|156581224|FG000|Overall Study|Protocol Violation|11|||
48652666|NCT00654745|156581224|FG000|Overall Study|Withdrawal by Subject|10|||
48652667|NCT00654745|156581224|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
48652668|NCT01200407|156581225|FG000|Overall Study|Lost to Follow-up|56|||
48652669|NCT01200407|156581225|FG000|Overall Study|Adverse Event|3|||
48652670|NCT01200407|156581225|FG000|Overall Study|Withdrawal by Subject|4|||
48652671|NCT01200407|156581225|FG000|Overall Study|Other|19|||
48652672|NCT03470194|156581228|FG000|Overall Study|Lost to Follow-up|11|||
48652673|NCT03470194|156581229|FG001|Overall Study|Lost to Follow-up|17|||
48652674|NCT00104416|156581230|FG000|Double-Blind Phase|Adverse Event|2|||
48652675|NCT00104416|156581231|FG001|Double-Blind Phase|Adverse Event|1|||
48652676|NCT00104416|156581232|FG002|Double-Blind Phase|Adverse Event|0|||
48652677|NCT00104416|156581233|FG003|Double-Blind Phase|Adverse Event|0|||
48652678|NCT00104416|156581234|FG004|Double-Blind Phase|Adverse Event|0|||
48652679|NCT00104416|156581230|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48333755|NCT02547974|155419442|FG001|Overall Study|Withdrawal by Subject|0|||
48333756|NCT02547974|155419443|FG002|Overall Study|Withdrawal by Subject|0|||
48333757|NCT02547974|155419444|FG003|Overall Study|Withdrawal by Subject|0|||
48333758|NCT02753075|155419445|FG000|Overall Study|Adverse Event|2|||
48333759|NCT02753075|155419446|FG001|Overall Study|Adverse Event|1|||
48333760|NCT02753075|155419447|FG002|Overall Study|Adverse Event|0|||
48333761|NCT02753075|155419445|FG000|Overall Study|Lost to Follow-up|2|||
48333762|NCT02753075|155419446|FG001|Overall Study|Lost to Follow-up|0|||
48333763|NCT02753075|155419447|FG002|Overall Study|Lost to Follow-up|0|||
48333764|NCT02753075|155419445|FG000|Overall Study|Withdrawal of Consent|1|||
48333765|NCT02753075|155419446|FG001|Overall Study|Withdrawal of Consent|1|||
48333766|NCT02753075|155419447|FG002|Overall Study|Withdrawal of Consent|3|||
48333767|NCT02753075|155419445|FG000|Overall Study|Physician Decision|3|||
48333768|NCT02753075|155419446|FG001|Overall Study|Physician Decision|1|||
48333769|NCT02753075|155419447|FG002|Overall Study|Physician Decision|0|||
48333770|NCT02109172|155419450|FG000|Overall Study|Withdrawal by Subject|1|||
48333771|NCT02109172|155419451|FG001|Overall Study|Withdrawal by Subject|0|||
48333772|NCT02109172|155419452|FG002|Overall Study|Withdrawal by Subject|0|||
48333773|NCT02109172|155419453|FG003|Overall Study|Withdrawal by Subject|1|||
48333774|NCT02109172|155419454|FG004|Overall Study|Withdrawal by Subject|0|||
48333775|NCT02109172|155419455|FG005|Overall Study|Withdrawal by Subject|0|||
48333776|NCT02109172|155419450|FG000|Overall Study|Adverse Event|0|||
48652680|NCT00104416|156581231|FG001|Double-Blind Phase|Lost to Follow-up|1|||
48652681|NCT00104416|156581232|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48652682|NCT00104416|156581233|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48652683|NCT00104416|156581234|FG004|Double-Blind Phase|Lost to Follow-up|0|||
48652684|NCT00104416|156581230|FG000|Double-Blind Phase|Protocol Violation|0|||
48652685|NCT00104416|156581231|FG001|Double-Blind Phase|Protocol Violation|1|||
48652686|NCT00104416|156581232|FG002|Double-Blind Phase|Protocol Violation|0|||
48652687|NCT00104416|156581233|FG003|Double-Blind Phase|Protocol Violation|0|||
48652688|NCT00104416|156581234|FG004|Double-Blind Phase|Protocol Violation|0|||
48652689|NCT00104416|156581230|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
48652690|NCT00104416|156581231|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
48652691|NCT00104416|156581232|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48652692|NCT00104416|156581233|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48652693|NCT00104416|156581234|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
48753544|NCT01949051|156944246|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48753545|NCT01949051|156944247|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48652694|NCT00104416|156581230|FG000|Double-Blind Phase|Pregnancy|1|||
48652695|NCT00104416|156581231|FG001|Double-Blind Phase|Pregnancy|0|||
48652696|NCT00104416|156581232|FG002|Double-Blind Phase|Pregnancy|0|||
48652697|NCT00104416|156581233|FG003|Double-Blind Phase|Pregnancy|0|||
48652698|NCT00104416|156581234|FG004|Double-Blind Phase|Pregnancy|0|||
48652699|NCT00104416|156581230|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
48652700|NCT00104416|156581231|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
48652701|NCT00104416|156581232|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
48652702|NCT00104416|156581233|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
48652703|NCT00104416|156581234|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
48652704|NCT00104416|156581230|FG000|Continuation Phase|Adverse Event|0|||
48652705|NCT00104416|156581231|FG001|Continuation Phase|Adverse Event|0|||
48652706|NCT00104416|156581232|FG002|Continuation Phase|Adverse Event|2|||
48652707|NCT00104416|156581233|FG003|Continuation Phase|Adverse Event|0|||
48652708|NCT00104416|156581234|FG004|Continuation Phase|Adverse Event|2|||
48652709|NCT00104416|156581230|FG000|Continuation Phase|Lost to Follow-up|0|||
48652710|NCT00104416|156581231|FG001|Continuation Phase|Lost to Follow-up|0|||
48652711|NCT00104416|156581232|FG002|Continuation Phase|Lost to Follow-up|1|||
48652712|NCT00104416|156581233|FG003|Continuation Phase|Lost to Follow-up|0|||
48652713|NCT00104416|156581234|FG004|Continuation Phase|Lost to Follow-up|1|||
48333777|NCT02109172|155419451|FG001|Overall Study|Adverse Event|0|||
48333778|NCT02109172|155419452|FG002|Overall Study|Adverse Event|1|||
48333779|NCT02109172|155419453|FG003|Overall Study|Adverse Event|0|||
48333780|NCT02109172|155419454|FG004|Overall Study|Adverse Event|0|||
48333781|NCT02109172|155419455|FG005|Overall Study|Adverse Event|1|||
48333782|NCT02109172|155419450|FG000|Overall Study|Death|0|||
48333783|NCT02109172|155419451|FG001|Overall Study|Death|0|||
48333784|NCT02109172|155419452|FG002|Overall Study|Death|0|||
48652714|NCT00104416|156581230|FG000|Continuation Phase|Withdrawal by Subject|0|||
48652715|NCT00104416|156581231|FG001|Continuation Phase|Withdrawal by Subject|0|||
48652716|NCT00104416|156581232|FG002|Continuation Phase|Withdrawal by Subject|2|||
48652717|NCT00104416|156581233|FG003|Continuation Phase|Withdrawal by Subject|1|||
48652718|NCT00104416|156581234|FG004|Continuation Phase|Withdrawal by Subject|1|||
48652719|NCT00104416|156581230|FG000|Continuation Phase|Pregnancy|0|||
48652720|NCT00104416|156581231|FG001|Continuation Phase|Pregnancy|0|||
48652721|NCT00104416|156581232|FG002|Continuation Phase|Pregnancy|1|||
48652722|NCT00104416|156581233|FG003|Continuation Phase|Pregnancy|1|||
48652723|NCT00104416|156581234|FG004|Continuation Phase|Pregnancy|0|||
48652724|NCT00104416|156581230|FG000|Continuation Phase|Non-compliance|0|||
48652725|NCT00104416|156581231|FG001|Continuation Phase|Non-compliance|0|||
48652726|NCT00104416|156581232|FG002|Continuation Phase|Non-compliance|0|||
48652727|NCT00104416|156581233|FG003|Continuation Phase|Non-compliance|0|||
48652728|NCT00104416|156581234|FG004|Continuation Phase|Non-compliance|1|||
48652729|NCT01450696|156581235|FG000|Overall Study|Never Treated|1|||
48652730|NCT01450696|156581236|FG001|Overall Study|Never Treated|1|||
48652731|NCT01450696|156581235|FG000|Overall Study|Death|77|||
48652732|NCT01450696|156581236|FG001|Overall Study|Death|84|||
48652733|NCT01450696|156581235|FG000|Overall Study|Lost to Follow-up|3|||
48652734|NCT01450696|156581236|FG001|Overall Study|Lost to Follow-up|3|||
48652735|NCT01450696|156581235|FG000|Overall Study|Non-Compliance|1|||
48652736|NCT01450696|156581236|FG001|Overall Study|Non-Compliance|0|||
48652737|NCT01450696|156581235|FG000|Overall Study|Withdrawal by Subject|13|||
48652738|NCT01450696|156581236|FG001|Overall Study|Withdrawal by Subject|2|||
48652739|NCT01450696|156581235|FG000|Overall Study|Study Terminated by Sponsor|53|||
48652740|NCT01450696|156581236|FG001|Overall Study|Study Terminated by Sponsor|58|||
48652741|NCT00152477|156581239|FG000|Chemotherapy Period|Adverse Event|9|||
48652742|NCT00152477|156581240|FG001|Chemotherapy Period|Adverse Event|4|||
48652743|NCT00152477|156581241|FG002|Chemotherapy Period|Adverse Event|5|||
48652744|NCT00152477|156581239|FG000|Chemotherapy Period|Death|1|||
48652745|NCT00152477|156581240|FG001|Chemotherapy Period|Death|3|||
48652746|NCT00152477|156581241|FG002|Chemotherapy Period|Death|3|||
48652747|NCT00152477|156581239|FG000|Chemotherapy Period|Lack of Efficacy|4|||
48652748|NCT00152477|156581240|FG001|Chemotherapy Period|Lack of Efficacy|5|||
48652749|NCT00152477|156581241|FG002|Chemotherapy Period|Lack of Efficacy|6|||
48652750|NCT00152477|156581239|FG000|Chemotherapy Period|Lost to Follow-up|1|||
48652751|NCT00152477|156581240|FG001|Chemotherapy Period|Lost to Follow-up|0|||
48652752|NCT00152477|156581241|FG002|Chemotherapy Period|Lost to Follow-up|1|||
48652753|NCT00152477|156581239|FG000|Chemotherapy Period|Protocol Violation|1|||
48652754|NCT00152477|156581240|FG001|Chemotherapy Period|Protocol Violation|1|||
48652755|NCT00152477|156581241|FG002|Chemotherapy Period|Protocol Violation|0|||
48652756|NCT00152477|156581239|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
48652757|NCT00152477|156581240|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
48652758|NCT00152477|156581241|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
48652759|NCT00152477|156581239|FG000|Chemotherapy Period|Progression of Disease|6|||
48652760|NCT00152477|156581240|FG001|Chemotherapy Period|Progression of Disease|8|||
48652761|NCT00152477|156581241|FG002|Chemotherapy Period|Progression of Disease|4|||
48652762|NCT00152477|156581239|FG000|Chemotherapy Period|Investigator decision|0|||
48652763|NCT00152477|156581240|FG001|Chemotherapy Period|Investigator decision|0|||
48652764|NCT00152477|156581241|FG002|Chemotherapy Period|Investigator decision|1|||
48652765|NCT00152477|156581239|FG000|Chemotherapy Period|Patient condition worsened|1|||
48652766|NCT00152477|156581240|FG001|Chemotherapy Period|Patient condition worsened|0|||
48652767|NCT00152477|156581241|FG002|Chemotherapy Period|Patient condition worsened|0|||
48652768|NCT00152477|156581239|FG000|Monotherapy Period|Adverse Event|1|||
48652769|NCT00152477|156581240|FG001|Monotherapy Period|Adverse Event|0|||
48652770|NCT00152477|156581241|FG002|Monotherapy Period|Adverse Event|5|||
48652771|NCT00152477|156581239|FG000|Monotherapy Period|Death|2|||
48652772|NCT00152477|156581240|FG001|Monotherapy Period|Death|0|||
48652773|NCT00152477|156581241|FG002|Monotherapy Period|Death|1|||
48652774|NCT00152477|156581239|FG000|Monotherapy Period|Lack of Efficacy|7|||
48652775|NCT00152477|156581240|FG001|Monotherapy Period|Lack of Efficacy|16|||
48652776|NCT00152477|156581241|FG002|Monotherapy Period|Lack of Efficacy|10|||
48652777|NCT00152477|156581239|FG000|Monotherapy Period|Protocol Violation|0|||
48652778|NCT00152477|156581240|FG001|Monotherapy Period|Protocol Violation|1|||
48652779|NCT00152477|156581241|FG002|Monotherapy Period|Protocol Violation|0|||
48652780|NCT00152477|156581239|FG000|Monotherapy Period|Withdrawal by Subject|0|||
48652781|NCT00152477|156581240|FG001|Monotherapy Period|Withdrawal by Subject|0|||
48652782|NCT00152477|156581241|FG002|Monotherapy Period|Withdrawal by Subject|4|||
48652783|NCT00152477|156581239|FG000|Monotherapy Period|Progression of Disease|5|||
48652784|NCT00152477|156581240|FG001|Monotherapy Period|Progression of Disease|11|||
48652785|NCT00152477|156581241|FG002|Monotherapy Period|Progression of Disease|12|||
48652786|NCT00152477|156581239|FG000|Monotherapy Period|Patient decision|0|||
48652787|NCT00152477|156581240|FG001|Monotherapy Period|Patient decision|1|||
48652788|NCT00152477|156581241|FG002|Monotherapy Period|Patient decision|1|||
48753546|NCT01949051|156944248|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
48753547|NCT01949051|156944243|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753548|NCT01949051|156944244|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753549|NCT01949051|156944245|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
48753550|NCT01949051|156944246|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753551|NCT01949051|156944247|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753552|NCT01949051|156944248|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
48753553|NCT01948050|156944249|FG000|Overall Study|Withdrawal by Subject|0|||
48753554|NCT01948050|156944250|FG001|Overall Study|Withdrawal by Subject|1|||
48333785|NCT02109172|155419453|FG003|Overall Study|Death|0|||
48333786|NCT02109172|155419454|FG004|Overall Study|Death|1|||
48333787|NCT02109172|155419455|FG005|Overall Study|Death|0|||
48333788|NCT02446015|155419456|FG000|Overall Study|Adverse Event|0|||
48333789|NCT02446015|155419457|FG001|Overall Study|Adverse Event|1|||
48333790|NCT02446015|155419456|FG000|Overall Study|Withdrawal by Subject|1|||
48333791|NCT02446015|155419457|FG001|Overall Study|Withdrawal by Subject|0|||
48333792|NCT02291861|155419468|FG000|Overall Study|Adverse Event|2|||
48333793|NCT02291861|155419469|FG001|Overall Study|Adverse Event|4|||
48333794|NCT02291861|155419470|FG002|Overall Study|Adverse Event|1|||
48333795|NCT02291861|155419471|FG003|Overall Study|Adverse Event|2|||
48333796|NCT02291861|155419468|FG000|Overall Study|Death|0|||
48333797|NCT02291861|155419469|FG001|Overall Study|Death|0|||
48333798|NCT02291861|155419470|FG002|Overall Study|Death|1|||
48333799|NCT02291861|155419471|FG003|Overall Study|Death|1|||
48333800|NCT02291861|155419468|FG000|Overall Study|Protocol Violation|1|||
48333801|NCT02291861|155419469|FG001|Overall Study|Protocol Violation|0|||
48333802|NCT02291861|155419470|FG002|Overall Study|Protocol Violation|0|||
48652789|NCT00152477|156581239|FG000|Monotherapy Period|Study personel decision|0|||
48652790|NCT00152477|156581240|FG001|Monotherapy Period|Study personel decision|0|||
48652791|NCT00152477|156581241|FG002|Monotherapy Period|Study personel decision|1|||
48652792|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652793|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
48652794|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652795|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652796|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652797|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
48652798|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
48652799|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
48652800|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48652801|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48652802|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48652803|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
48652804|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
48652805|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
48652806|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48652807|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48652808|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48652809|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
48652810|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
48652811|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
48652812|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
48652813|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
48652814|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
48652815|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
48652816|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652817|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
48652818|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652819|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652820|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652821|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
48652822|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
48652823|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
48652824|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
48652825|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
48753555|NCT01506479|156944252|FG000|Overall Study|Lost to Follow-up|1|||
48333803|NCT02291861|155419471|FG003|Overall Study|Protocol Violation|1|||
48333804|NCT02291861|155419468|FG000|Overall Study|Withdrawal by Subject|1|||
48333805|NCT02291861|155419469|FG001|Overall Study|Withdrawal by Subject|2|||
48333806|NCT02291861|155419470|FG002|Overall Study|Withdrawal by Subject|1|||
48333807|NCT02291861|155419471|FG003|Overall Study|Withdrawal by Subject|4|||
48652826|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
48652827|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
48652828|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652829|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
48652830|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652831|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652832|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652833|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
48652834|NCT03985943|156581242|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652835|NCT03985943|156581243|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
48652836|NCT03985943|156581244|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652837|NCT03985943|156581245|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652838|NCT03985943|156581246|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652839|NCT03985943|156581247|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
48652840|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48652841|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
48652842|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
48652843|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
48652844|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
48652845|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
48652846|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48652847|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
48652848|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
48652849|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
48652850|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
48652851|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
48652852|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
48652853|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
48652854|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
48652855|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
48652856|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
48652857|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
48652858|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48652859|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48652860|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
48652861|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
48652862|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
48652863|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
48652864|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
48652865|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
48652866|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
48652867|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
48652868|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
48652869|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
48652870|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
48652871|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
48652872|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
48652873|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
48652874|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
48652875|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
48652876|NCT03985943|156581242|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
48652877|NCT03985943|156581243|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
48652878|NCT03985943|156581244|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
48652879|NCT03985943|156581245|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
48652880|NCT03985943|156581246|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
48652881|NCT03985943|156581247|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
48652882|NCT04295681|156581253|FG000|Overall Study|Eligibility error|1|||
48652883|NCT04295681|156581254|FG001|Overall Study|Eligibility error|3|||
48652884|NCT03575065|156581255|FG000|Overall Study|Death|31|||
48652885|NCT03575065|156581256|FG001|Overall Study|Death|12|||
48652886|NCT03575065|156581255|FG000|Overall Study|Sponsor's Decision|28|||
48652887|NCT03575065|156581256|FG001|Overall Study|Sponsor's Decision|13|||
48652888|NCT03575065|156581255|FG000|Overall Study|Withdrawal by Subject|2|||
48652889|NCT03575065|156581256|FG001|Overall Study|Withdrawal by Subject|1|||
48652890|NCT03575065|156581255|FG000|Overall Study|Lost to Follow-up|1|||
48652891|NCT03575065|156581256|FG001|Overall Study|Lost to Follow-up|0|||
48652892|NCT02858440|156581257|FG000|Overall Study|Lost to Follow-up|3|||
48652893|NCT02858440|156581257|FG000|Overall Study|Protocol Violation|2|||
48652894|NCT02858440|156581257|FG000|Overall Study|Consent withdrawal|3|||
48652895|NCT02858440|156581257|FG000|Overall Study|Migrated/moved from study area|4|||
48652896|NCT01054560|156581259|FG000|Overall Study|Death|10|||
48652897|NCT01054560|156581260|FG001|Overall Study|Death|21|||
48652898|NCT01054560|156581259|FG000|Overall Study|Lost to Follow-up|2|||
48652899|NCT01054560|156581260|FG001|Overall Study|Lost to Follow-up|5|||
48652900|NCT01054560|156581259|FG000|Overall Study|Withdrawal by Subject|0|||
48652901|NCT01054560|156581260|FG001|Overall Study|Withdrawal by Subject|2|||
48652902|NCT01054560|156581259|FG000|Overall Study|Physician Decision|1|||
48652903|NCT01054560|156581260|FG001|Overall Study|Physician Decision|0|||
48652904|NCT01262638|156581261|FG000|Overall Study|Adverse Event|3|||
48652905|NCT01262638|156581262|FG001|Overall Study|Adverse Event|4|||
48652906|NCT01262638|156581263|FG002|Overall Study|Adverse Event|3|||
48652907|NCT01262638|156581264|FG003|Overall Study|Adverse Event|4|||
48652908|NCT01262638|156581261|FG000|Overall Study|Protocol Violation|1|||
48652909|NCT01262638|156581262|FG001|Overall Study|Protocol Violation|0|||
48652910|NCT01262638|156581263|FG002|Overall Study|Protocol Violation|0|||
48652911|NCT01262638|156581264|FG003|Overall Study|Protocol Violation|1|||
48652912|NCT01262638|156581261|FG000|Overall Study|Withdrawal by Subject|2|||
48652913|NCT01262638|156581262|FG001|Overall Study|Withdrawal by Subject|1|||
48652914|NCT01262638|156581263|FG002|Overall Study|Withdrawal by Subject|0|||
48652915|NCT01262638|156581264|FG003|Overall Study|Withdrawal by Subject|1|||
48652916|NCT01262638|156581261|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
48652917|NCT01262638|156581262|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
48652918|NCT01262638|156581263|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
48652919|NCT01262638|156581264|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
48652920|NCT01262638|156581261|FG000|Overall Study|Lost to Follow-up|1|||
48652921|NCT01262638|156581262|FG001|Overall Study|Lost to Follow-up|1|||
48652922|NCT01262638|156581263|FG002|Overall Study|Lost to Follow-up|1|||
48652923|NCT01262638|156581264|FG003|Overall Study|Lost to Follow-up|1|||
48652924|NCT01262638|156581261|FG000|Overall Study|Participant Went Out of Town|0|||
48652925|NCT01262638|156581262|FG001|Overall Study|Participant Went Out of Town|0|||
48652926|NCT01262638|156581263|FG002|Overall Study|Participant Went Out of Town|1|||
48652927|NCT01262638|156581264|FG003|Overall Study|Participant Went Out of Town|0|||
48652928|NCT00939029|156581267|FG000|Overall Study|Withdrawal by Subject|3|||
48652929|NCT00939029|156581268|FG001|Overall Study|Withdrawal by Subject|7|||
48652930|NCT00939029|156581267|FG000|Overall Study|Lost to Follow-up|3|||
48652931|NCT00939029|156581268|FG001|Overall Study|Lost to Follow-up|4|||
48753556|NCT01506479|156944253|FG001|Overall Study|Lost to Follow-up|2|||
48753557|NCT01506479|156944254|FG002|Overall Study|Lost to Follow-up|2|||
48753558|NCT01506479|156944252|FG000|Overall Study|Withdrawal by Subject|1|||
48753559|NCT01506479|156944253|FG001|Overall Study|Withdrawal by Subject|2|||
48652932|NCT00939029|156581267|FG000|Overall Study|Adverse Event|0|||
48652933|NCT00939029|156581268|FG001|Overall Study|Adverse Event|1|||
48652934|NCT00487942|156581269|FG000|Overall Study|Adverse Event|1|||
48652935|NCT00487942|156581270|FG001|Overall Study|Adverse Event|1|||
48652936|NCT00487942|156581271|FG002|Overall Study|Adverse Event|1|||
48652937|NCT00487942|156581272|FG003|Overall Study|Adverse Event|1|||
48652938|NCT00487942|156581269|FG000|Overall Study|Lost to Follow-up|1|||
48652939|NCT00487942|156581270|FG001|Overall Study|Lost to Follow-up|0|||
48652940|NCT00487942|156581271|FG002|Overall Study|Lost to Follow-up|0|||
48652941|NCT00487942|156581272|FG003|Overall Study|Lost to Follow-up|1|||
48652942|NCT00487942|156581269|FG000|Overall Study|Protocol Violation|1|||
48652943|NCT00487942|156581270|FG001|Overall Study|Protocol Violation|1|||
48652944|NCT00487942|156581271|FG002|Overall Study|Protocol Violation|0|||
48652945|NCT00487942|156581272|FG003|Overall Study|Protocol Violation|0|||
48652946|NCT00487942|156581269|FG000|Overall Study|Withdrawal by Subject|0|||
48652947|NCT00487942|156581270|FG001|Overall Study|Withdrawal by Subject|1|||
48652948|NCT00487942|156581271|FG002|Overall Study|Withdrawal by Subject|2|||
48652949|NCT00487942|156581272|FG003|Overall Study|Withdrawal by Subject|0|||
48652950|NCT00676520|156581273|FG000|Overall Study|Withdrawal by Subject|163|||
48652951|NCT00676520|156581273|FG000|Overall Study|Lost to Follow-up|162|||
48652952|NCT00676520|156581273|FG000|Overall Study|Death|159|||
48652953|NCT00676520|156581273|FG000|Overall Study|Physician Decision|20|||
48652954|NCT00676520|156581273|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
48652955|NCT00676520|156581273|FG000|Overall Study|Other Reason|18|||
48652956|NCT00889603|156581288|FG000|Overall Study|Adverse Event|7|||
48652957|NCT00889603|156581288|FG000|Overall Study|Death|3|||
48652958|NCT00889603|156581288|FG000|Overall Study|Lost to Follow-up|19|||
48652959|NCT00889603|156581288|FG000|Overall Study|No longer willing to participant in stud|4|||
48652960|NCT00889603|156581288|FG000|Overall Study|Other|4|||
48652961|NCT00851552|156581289|FG000|Overall Study|Death|2|||
48652962|NCT00851552|156581289|FG000|Overall Study|Adverse Event|1|||
48652963|NCT00851552|156581289|FG000|Overall Study|Disease Progression|4|||
48652964|NCT00177294|156581290|FG000|Overall Study|Withdrawal by Subject|7|||
48753560|NCT01506479|156944254|FG002|Overall Study|Withdrawal by Subject|1|||
48753561|NCT01506479|156944252|FG000|Overall Study|Missing assessment|1|||
48333808|NCT02291861|155419468|FG000|Overall Study|Noncompliance|1|||
48333809|NCT02291861|155419469|FG001|Overall Study|Noncompliance|1|||
48333810|NCT02291861|155419470|FG002|Overall Study|Noncompliance|2|||
48333811|NCT02291861|155419471|FG003|Overall Study|Noncompliance|1|||
48333812|NCT02291861|155419468|FG000|Overall Study|Lost to Follow-up|2|||
48333813|NCT02291861|155419469|FG001|Overall Study|Lost to Follow-up|1|||
48753562|NCT01506479|156944253|FG001|Overall Study|Missing assessment|0|||
48753563|NCT01506479|156944254|FG002|Overall Study|Missing assessment|0|||
48753564|NCT01506479|156944252|FG000|Overall Study|Adverse Event|0|||
48333814|NCT02291861|155419470|FG002|Overall Study|Lost to Follow-up|4|||
48333815|NCT02291861|155419471|FG003|Overall Study|Lost to Follow-up|0|||
48333816|NCT02291861|155419468|FG000|Overall Study|Other|0|||
48333817|NCT02291861|155419469|FG001|Overall Study|Other|0|||
48333818|NCT02291861|155419470|FG002|Overall Study|Other|0|||
48333819|NCT02291861|155419471|FG003|Overall Study|Other|1|||
48333820|NCT00476151|155419472|FG000|Overall Study|Adverse Event|0|||
48333821|NCT00476151|155419473|FG001|Overall Study|Adverse Event|2|||
48652965|NCT00177294|156581291|FG001|Overall Study|Withdrawal by Subject|5|||
48652966|NCT01813058|156581292|FG000|Overall Study|Withdrawal by Subject|5|||
48652967|NCT01813058|156581293|FG001|Overall Study|Withdrawal by Subject|4|||
48652968|NCT00675441|156581294|FG000|Overall Study|Withdrawal by Subject|2|||
48652969|NCT00675441|156581294|FG000|Overall Study|Death|1|||
48652970|NCT02993822|156581296|FG000|Overall Study|Lack of Efficacy|1|||
48652971|NCT02993822|156581297|FG001|Overall Study|Lack of Efficacy|1|||
48333822|NCT00476151|155419472|FG000|Overall Study|Protocol Violation|1|||
48333823|NCT00476151|155419473|FG001|Overall Study|Protocol Violation|3|||
48333824|NCT00476151|155419472|FG000|Overall Study|Withdrawal by Subject|2|||
48333825|NCT00476151|155419473|FG001|Overall Study|Withdrawal by Subject|0|||
48333826|NCT00476151|155419472|FG000|Overall Study|Physician Decision|0|||
48333827|NCT00476151|155419473|FG001|Overall Study|Physician Decision|2|||
48333828|NCT01767376|155419474|FG000|Overall Study|Lost to Follow-up|3|||
48333829|NCT01767376|155419475|FG001|Overall Study|Lost to Follow-up|2|||
48652972|NCT02993822|156581298|FG002|Overall Study|Lack of Efficacy|0|||
48652973|NCT02993822|156581299|FG003|Overall Study|Lack of Efficacy|0|||
48652974|NCT02993822|156581296|FG000|Overall Study|Protocol Violation|1|||
48652975|NCT02993822|156581297|FG001|Overall Study|Protocol Violation|0|||
48652976|NCT02993822|156581298|FG002|Overall Study|Protocol Violation|0|||
48652977|NCT02993822|156581299|FG003|Overall Study|Protocol Violation|0|||
48652978|NCT02993822|156581296|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
48652979|NCT02993822|156581297|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
48652980|NCT02993822|156581298|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
48652981|NCT02993822|156581299|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
48652982|NCT02993822|156581296|FG000|Overall Study|Adverse Event|3|||
48652983|NCT02993822|156581297|FG001|Overall Study|Adverse Event|1|||
48652984|NCT02993822|156581298|FG002|Overall Study|Adverse Event|7|||
48652985|NCT02993822|156581299|FG003|Overall Study|Adverse Event|0|||
48652986|NCT02993822|156581296|FG000|Overall Study|Withdrawal by Subject|4|||
48652987|NCT02993822|156581297|FG001|Overall Study|Withdrawal by Subject|2|||
48652988|NCT02993822|156581298|FG002|Overall Study|Withdrawal by Subject|2|||
48652989|NCT02993822|156581299|FG003|Overall Study|Withdrawal by Subject|3|||
48652990|NCT02993822|156581296|FG000|Overall Study|Lost to Follow-up|1|||
48652991|NCT02993822|156581297|FG001|Overall Study|Lost to Follow-up|0|||
48652992|NCT02993822|156581298|FG002|Overall Study|Lost to Follow-up|1|||
48652993|NCT02993822|156581299|FG003|Overall Study|Lost to Follow-up|0|||
48652994|NCT01694121|156581300|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
48652995|NCT01694121|156581301|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
48652996|NCT00431444|156581304|FG000|Overall Study|Protocol Violation|1|||
48652997|NCT00431444|156581305|FG001|Overall Study|Protocol Violation|4|||
48652998|NCT00431444|156581304|FG000|Overall Study|Adverse Event|2|||
48652999|NCT00431444|156581305|FG001|Overall Study|Adverse Event|1|||
48653000|NCT00431444|156581304|FG000|Overall Study|Withdrawal by Subject|1|||
48653001|NCT00431444|156581305|FG001|Overall Study|Withdrawal by Subject|1|||
48653002|NCT00431444|156581304|FG000|Overall Study|Lost to Follow-up|1|||
48653003|NCT00431444|156581305|FG001|Overall Study|Lost to Follow-up|0|||
48653004|NCT00431444|156581304|FG000|Overall Study|Administrative Problems|0|||
48653005|NCT00431444|156581305|FG001|Overall Study|Administrative Problems|1|||
48653006|NCT03213938|156581306|FG000|Overall Study|Lost to Follow-up|4|||
48653007|NCT03213938|156581307|FG001|Overall Study|Lost to Follow-up|3|||
48653008|NCT03213938|156581306|FG000|Overall Study|Lack of Efficacy|1|||
48653009|NCT03213938|156581307|FG001|Overall Study|Lack of Efficacy|0|||
48333830|NCT01767376|155419476|FG002|Overall Study|Lost to Follow-up|0|||
48333831|NCT01767376|155419474|FG000|Overall Study|Withdrawal by Subject|1|||
48653010|NCT03213938|156581306|FG000|Overall Study|Decline to participate|5|||
48653011|NCT03213938|156581307|FG001|Overall Study|Decline to participate|4|||
48753565|NCT01506479|156944253|FG001|Overall Study|Adverse Event|1|||
48333832|NCT01767376|155419475|FG001|Overall Study|Withdrawal by Subject|1|||
48333833|NCT01767376|155419476|FG002|Overall Study|Withdrawal by Subject|0|||
48333834|NCT01393964|155419477|FG000|Overall Study|Disease Progression|4|||
48333835|NCT01393964|155419478|FG001|Overall Study|Disease Progression|3|||
48653012|NCT03213938|156581306|FG000|Overall Study|Without reason|4|||
48653013|NCT03213938|156581307|FG001|Overall Study|Without reason|5|||
48653014|NCT04238481|156581310|FG000|Overall Study|Miscellaneous|0|||
48653015|NCT04238481|156581311|FG001|Overall Study|Miscellaneous|1|||
48653016|NCT04238481|156581312|FG002|Overall Study|Miscellaneous|0|||
48653017|NCT04238481|156581313|FG003|Overall Study|Miscellaneous|0|||
48653018|NCT01301066|156581319|FG000|Overall Study|Lost to Follow-up|5|||
48653019|NCT01301066|156581320|FG001|Overall Study|Lost to Follow-up|11|||
48653020|NCT01301066|156581319|FG000|Overall Study|Protocol Violation|8|||
48653021|NCT01301066|156581320|FG001|Overall Study|Protocol Violation|7|||
48653022|NCT01301066|156581319|FG000|Overall Study|Withdrawal by Subject|4|||
48653023|NCT01301066|156581320|FG001|Overall Study|Withdrawal by Subject|9|||
48653024|NCT01301066|156581319|FG000|Overall Study|Adverse Event|6|||
48653025|NCT01301066|156581320|FG001|Overall Study|Adverse Event|6|||
48653026|NCT01301066|156581319|FG000|Overall Study|Sponsor Decision|2|||
48653027|NCT01301066|156581320|FG001|Overall Study|Sponsor Decision|1|||
48653028|NCT01301066|156581319|FG000|Overall Study|Physician Decision|0|||
48653029|NCT01301066|156581320|FG001|Overall Study|Physician Decision|1|||
48653030|NCT01301066|156581319|FG000|Overall Study|Other|2|||
48653031|NCT01301066|156581320|FG001|Overall Study|Other|0|||
48653032|NCT02712983|156583240|FG000|Treatment Phase|Adverse Event|3|||
48653033|NCT02712983|156583241|FG001|Treatment Phase|Adverse Event|1|||
48653034|NCT02712983|156583242|FG002|Treatment Phase|Adverse Event|1|||
48653035|NCT02712983|156583243|FG003|Treatment Phase|Adverse Event|4|||
48653036|NCT02712983|156583244|FG004|Treatment Phase|Adverse Event|3|||
48653037|NCT02712983|156583245|FG005|Treatment Phase|Adverse Event|0|||
48653038|NCT02712983|156583246|FG006|Treatment Phase|Adverse Event|6|||
48653039|NCT02712983|156583247|FG007|Treatment Phase|Adverse Event|6|||
48653040|NCT02712983|156583248|FG008|Treatment Phase|Adverse Event|1|||
48653041|NCT02712983|156583240|FG000|Treatment Phase|Protocol Deviation|0|||
48653042|NCT02712983|156583241|FG001|Treatment Phase|Protocol Deviation|0|||
48653043|NCT02712983|156583242|FG002|Treatment Phase|Protocol Deviation|0|||
48653044|NCT02712983|156583243|FG003|Treatment Phase|Protocol Deviation|2|||
48653045|NCT02712983|156583244|FG004|Treatment Phase|Protocol Deviation|0|||
48653046|NCT02712983|156583245|FG005|Treatment Phase|Protocol Deviation|0|||
48653047|NCT02712983|156583246|FG006|Treatment Phase|Protocol Deviation|1|||
48653048|NCT02712983|156583247|FG007|Treatment Phase|Protocol Deviation|0|||
48653049|NCT02712983|156583248|FG008|Treatment Phase|Protocol Deviation|0|||
48653050|NCT02712983|156583240|FG000|Treatment Phase|Technical Problems|0|||
48653051|NCT02712983|156583241|FG001|Treatment Phase|Technical Problems|0|||
48653052|NCT02712983|156583242|FG002|Treatment Phase|Technical Problems|0|||
48653053|NCT02712983|156583243|FG003|Treatment Phase|Technical Problems|0|||
48653054|NCT02712983|156583244|FG004|Treatment Phase|Technical Problems|0|||
48653055|NCT02712983|156583245|FG005|Treatment Phase|Technical Problems|0|||
48653056|NCT02712983|156583246|FG006|Treatment Phase|Technical Problems|1|||
48653057|NCT02712983|156583247|FG007|Treatment Phase|Technical Problems|0|||
48653058|NCT02712983|156583248|FG008|Treatment Phase|Technical Problems|0|||
48653059|NCT02712983|156583240|FG000|Treatment Phase|Physician Decision|0|||
48653060|NCT02712983|156583241|FG001|Treatment Phase|Physician Decision|0|||
48653061|NCT02712983|156583242|FG002|Treatment Phase|Physician Decision|0|||
48653062|NCT02712983|156583243|FG003|Treatment Phase|Physician Decision|0|||
48653063|NCT02712983|156583244|FG004|Treatment Phase|Physician Decision|0|||
48653064|NCT02712983|156583245|FG005|Treatment Phase|Physician Decision|0|||
48653065|NCT02712983|156583246|FG006|Treatment Phase|Physician Decision|0|||
48653066|NCT02712983|156583247|FG007|Treatment Phase|Physician Decision|1|||
48653067|NCT02712983|156583248|FG008|Treatment Phase|Physician Decision|1|||
48653068|NCT02712983|156583240|FG000|Treatment Phase|Subject Decision|2|||
48653069|NCT02712983|156583241|FG001|Treatment Phase|Subject Decision|0|||
48653070|NCT02712983|156583242|FG002|Treatment Phase|Subject Decision|0|||
48653071|NCT02712983|156583243|FG003|Treatment Phase|Subject Decision|2|||
48653072|NCT02712983|156583244|FG004|Treatment Phase|Subject Decision|1|||
48653073|NCT02712983|156583245|FG005|Treatment Phase|Subject Decision|0|||
48653074|NCT02712983|156583246|FG006|Treatment Phase|Subject Decision|1|||
48653075|NCT02712983|156583247|FG007|Treatment Phase|Subject Decision|2|||
48653076|NCT02712983|156583248|FG008|Treatment Phase|Subject Decision|0|||
48653077|NCT02712983|156583240|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653078|NCT02712983|156583241|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
48653079|NCT02712983|156583242|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653080|NCT02712983|156583243|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653081|NCT02712983|156583244|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653082|NCT02712983|156583245|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653083|NCT02712983|156583246|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
48653084|NCT02712983|156583247|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
48653085|NCT02712983|156583248|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48653086|NCT02712983|156583240|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653087|NCT02712983|156583241|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48753566|NCT01506479|156944254|FG002|Overall Study|Adverse Event|0|||
48753567|NCT02005445|156944257|FG000|Overall Study|Dual study enrollment|0|||
48653088|NCT02712983|156583242|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653089|NCT02712983|156583243|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
48653090|NCT02712983|156583244|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48333836|NCT01393964|155419479|FG002|Overall Study|Disease Progression|5|||
48653091|NCT02712983|156583245|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653092|NCT02712983|156583246|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653093|NCT02712983|156583247|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48653094|NCT02712983|156583248|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
48333837|NCT01393964|155419477|FG000|Overall Study|Study drug toxicity|1|||
48333838|NCT01393964|155419478|FG001|Overall Study|Study drug toxicity|0|||
48653095|NCT02712983|156583240|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653096|NCT02712983|156583241|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653097|NCT02712983|156583242|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653098|NCT02712983|156583243|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653099|NCT02712983|156583244|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
48653100|NCT02712983|156583245|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
48653101|NCT02712983|156583246|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
48653102|NCT02712983|156583247|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
48653103|NCT02712983|156583248|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
48653104|NCT01340625|156583253|FG000|First Intervention|Adverse Event|1|||
48653105|NCT01340625|156583254|FG001|First Intervention|Adverse Event|0|||
48653106|NCT01340625|156583253|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
48653107|NCT01340625|156583254|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
48653108|NCT02290691|156583259|FG000|Overall Study|Noncompliance|0|||
48653109|NCT02290691|156583260|FG001|Overall Study|Noncompliance|1|||
48653110|NCT02290691|156583259|FG000|Overall Study|Withdrawal by Subject|1|||
48653111|NCT02290691|156583260|FG001|Overall Study|Withdrawal by Subject|1|||
48653112|NCT02290691|156583259|FG000|Overall Study|Lost to Follow-up|7|||
48653113|NCT02290691|156583260|FG001|Overall Study|Lost to Follow-up|7|||
48653114|NCT00566982|156583261|FG000|Overall Study|Adverse Event|6|||
48653115|NCT00566982|156583262|FG001|Overall Study|Adverse Event|48|||
48653116|NCT00566982|156583261|FG000|Overall Study|Withdrawal by Subject|1|||
48653117|NCT00566982|156583262|FG001|Overall Study|Withdrawal by Subject|14|||
48653118|NCT00566982|156583261|FG000|Overall Study|Protocol Violation|1|||
48653119|NCT00566982|156583262|FG001|Overall Study|Protocol Violation|4|||
48653120|NCT00566982|156583261|FG000|Overall Study|Lost to Follow-up|0|||
48653121|NCT00566982|156583262|FG001|Overall Study|Lost to Follow-up|1|||
48653122|NCT00566982|156583261|FG000|Overall Study|Other-family problems & doctor's request|0|||
48653123|NCT00566982|156583262|FG001|Overall Study|Other-family problems & doctor's request|2|||
48653124|NCT00336284|156583263|FG000|Overall Study|Death|52|||
48653125|NCT00336284|156583264|FG001|Overall Study|Death|26|||
48653126|NCT00336284|156583263|FG000|Overall Study|Lost to Follow-up|82|||
48653127|NCT00336284|156583264|FG001|Overall Study|Lost to Follow-up|61|||
48653128|NCT00336284|156583263|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
48653129|NCT00336284|156583264|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
48653130|NCT03530995|156583265|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
48653131|NCT03530995|156583266|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
48653132|NCT03530995|156583265|FG000|Part 1 Period 3|Protocol Violation|1|||
48653133|NCT03530995|156583266|FG001|Part 1 Period 3|Protocol Violation|0|||
48653134|NCT03530995|156583265|FG000|Part 1 Period 4|Physician Decision|1|||
48653135|NCT03530995|156583266|FG001|Part 1 Period 4|Physician Decision|0|||
48653136|NCT03530995|156583265|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
48753568|NCT02005445|156944258|FG001|Overall Study|Dual study enrollment|1|||
48753569|NCT01881776|156944262|FG000|Overall Study|Lost to Follow-up|1|||
48333839|NCT01393964|155419479|FG002|Overall Study|Study drug toxicity|0|||
48333840|NCT01393964|155419477|FG000|Overall Study|Withdrawal by Subject|0|||
48333841|NCT01393964|155419478|FG001|Overall Study|Withdrawal by Subject|0|||
48333842|NCT01393964|155419479|FG002|Overall Study|Withdrawal by Subject|1|||
48333843|NCT01393964|155419477|FG000|Overall Study|Adverse event unrelated to study drug|0|||
48333844|NCT01393964|155419478|FG001|Overall Study|Adverse event unrelated to study drug|3|||
48333845|NCT01393964|155419479|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48333846|NCT01393964|155419477|FG000|Overall Study|Subject request stop study treatment|0|||
48333847|NCT01393964|155419478|FG001|Overall Study|Subject request stop study treatment|1|||
48333848|NCT01393964|155419479|FG002|Overall Study|Subject request stop study treatment|0|||
48653137|NCT03530995|156583266|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
48653138|NCT00218634|156583267|FG000|Overall Study|Lost to Follow-up|8|||
48653139|NCT00218634|156583268|FG001|Overall Study|Lost to Follow-up|15|||
48653140|NCT05243745|156583269|FG000|Overall Study|Withdrawal by Subject|0|||
48653141|NCT05243745|156583270|FG001|Overall Study|Withdrawal by Subject|0|||
48653142|NCT05243745|156583271|FG002|Overall Study|Withdrawal by Subject|0|||
48653143|NCT05243745|156583272|FG003|Overall Study|Withdrawal by Subject|1|||
48333849|NCT01393964|155419477|FG000|Overall Study|Subject decided to move to transplant|1|||
48333850|NCT01393964|155419478|FG001|Overall Study|Subject decided to move to transplant|0|||
48333851|NCT01393964|155419479|FG002|Overall Study|Subject decided to move to transplant|0|||
48333852|NCT01393964|155419477|FG000|Overall Study|Subject switched to commercial supply|1|||
48333853|NCT01393964|155419478|FG001|Overall Study|Subject switched to commercial supply|0|||
48333854|NCT01393964|155419479|FG002|Overall Study|Subject switched to commercial supply|2|||
48333855|NCT01393964|155419477|FG000|Overall Study|Subject plateaued in terms of effect|1|||
48333856|NCT01393964|155419478|FG001|Overall Study|Subject plateaued in terms of effect|0|||
48333857|NCT01393964|155419479|FG002|Overall Study|Subject plateaued in terms of effect|0|||
48333858|NCT01393964|155419477|FG000|Overall Study|Investigator removed subject from study|0|||
48333859|NCT01393964|155419478|FG001|Overall Study|Investigator removed subject from study|1|||
48333860|NCT01393964|155419479|FG002|Overall Study|Investigator removed subject from study|0|||
48333861|NCT01393964|155419477|FG000|Overall Study|Subject converted to roll-over study|0|||
48333862|NCT01393964|155419478|FG001|Overall Study|Subject converted to roll-over study|1|||
48333863|NCT01393964|155419479|FG002|Overall Study|Subject converted to roll-over study|0|||
48333864|NCT01393964|155419477|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
48333865|NCT01393964|155419478|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
48333866|NCT01393964|155419479|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
48333867|NCT01322347|155419480|FG000|Overall Study|Adverse Event|7|||
48333868|NCT01322347|155419481|FG001|Overall Study|Adverse Event|2|||
48333869|NCT01322347|155419480|FG000|Overall Study|Death|5|||
48333870|NCT01322347|155419481|FG001|Overall Study|Death|3|||
48333871|NCT01322347|155419480|FG000|Overall Study|Physician Decision|2|||
48333872|NCT01322347|155419481|FG001|Overall Study|Physician Decision|1|||
48333873|NCT01322347|155419480|FG000|Overall Study|Protocol Violation|5|||
48333874|NCT01322347|155419481|FG001|Overall Study|Protocol Violation|2|||
48333875|NCT01322347|155419480|FG000|Overall Study|Withdrawal by Subject|1|||
48333876|NCT01322347|155419481|FG001|Overall Study|Withdrawal by Subject|4|||
48333877|NCT01322347|155419480|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
48333878|NCT01322347|155419481|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
48333879|NCT01322347|155419480|FG000|Overall Study|blood transfusion|5|||
48333880|NCT01322347|155419481|FG001|Overall Study|blood transfusion|5|||
48333881|NCT01322347|155419480|FG000|Overall Study|sponsor decision|1|||
48333882|NCT01322347|155419481|FG001|Overall Study|sponsor decision|3|||
48653144|NCT05243745|156583269|FG000|Overall Study|Unable to Attend Visit 6|0|||
48653145|NCT05243745|156583270|FG001|Overall Study|Unable to Attend Visit 6|0|||
48653146|NCT05243745|156583271|FG002|Overall Study|Unable to Attend Visit 6|1|||
48653147|NCT05243745|156583272|FG003|Overall Study|Unable to Attend Visit 6|0|||
48653148|NCT03037476|156583285|FG000|Overall Study|Lost to Follow-up|63|||
48653149|NCT03037476|156583286|FG001|Overall Study|Lost to Follow-up|46|||
48653150|NCT00327015|156583287|FG000|Overall Study|Lack of Efficacy|18|||
48653151|NCT00327015|156583288|FG001|Overall Study|Lack of Efficacy|18|||
48653152|NCT00327015|156583289|FG002|Overall Study|Lack of Efficacy|35|||
48653153|NCT00327015|156583290|FG003|Overall Study|Lack of Efficacy|29|||
48653154|NCT00327015|156583287|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
48653155|NCT00327015|156583288|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
48653156|NCT00327015|156583289|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
48653157|NCT00327015|156583290|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
48653158|NCT00327015|156583287|FG000|Overall Study|Lost to Follow-up|22|||
48653159|NCT00327015|156583288|FG001|Overall Study|Lost to Follow-up|23|||
48653160|NCT00327015|156583289|FG002|Overall Study|Lost to Follow-up|29|||
48653161|NCT00327015|156583290|FG003|Overall Study|Lost to Follow-up|22|||
48653162|NCT00327015|156583287|FG000|Overall Study|Adverse Event|14|||
48653163|NCT00327015|156583288|FG001|Overall Study|Adverse Event|10|||
48653164|NCT00327015|156583289|FG002|Overall Study|Adverse Event|14|||
48653165|NCT00327015|156583290|FG003|Overall Study|Adverse Event|14|||
48653166|NCT00327015|156583287|FG000|Overall Study|Subject no longer meets study criteria|4|||
48653167|NCT00327015|156583288|FG001|Overall Study|Subject no longer meets study criteria|2|||
48653168|NCT00327015|156583289|FG002|Overall Study|Subject no longer meets study criteria|8|||
48653169|NCT00327015|156583290|FG003|Overall Study|Subject no longer meets study criteria|7|||
48653170|NCT00327015|156583287|FG000|Overall Study|Poor/Noncompliance|11|||
48653171|NCT00327015|156583288|FG001|Overall Study|Poor/Noncompliance|8|||
48333883|NCT01322347|155419480|FG000|Overall Study|ineligible|6|||
48333884|NCT01322347|155419481|FG001|Overall Study|ineligible|3|||
48653172|NCT00327015|156583289|FG002|Overall Study|Poor/Noncompliance|4|||
48333885|NCT01322347|155419480|FG000|Overall Study|kidney transplant|3|||
48333886|NCT01322347|155419481|FG001|Overall Study|kidney transplant|1|||
48333887|NCT01322347|155419480|FG000|Overall Study|study drug withheld > 12 wks|0|||
48333888|NCT01322347|155419481|FG001|Overall Study|study drug withheld > 12 wks|1|||
48653173|NCT00327015|156583290|FG003|Overall Study|Poor/Noncompliance|5|||
48653174|NCT00327015|156583287|FG000|Overall Study|Physician Decision|0|||
48653175|NCT00327015|156583288|FG001|Overall Study|Physician Decision|1|||
48653176|NCT00327015|156583289|FG002|Overall Study|Physician Decision|3|||
48333889|NCT01322347|155419480|FG000|Overall Study|moved/changed dialysis|2|||
48653177|NCT00327015|156583290|FG003|Overall Study|Physician Decision|2|||
48653178|NCT00327015|156583287|FG000|Overall Study|Death|1|||
48653179|NCT00327015|156583288|FG001|Overall Study|Death|2|||
48653180|NCT00327015|156583289|FG002|Overall Study|Death|2|||
48653181|NCT00327015|156583290|FG003|Overall Study|Death|3|||
48653182|NCT00327015|156583287|FG000|Overall Study|Pregnancy|0|||
48653183|NCT00327015|156583288|FG001|Overall Study|Pregnancy|2|||
48653184|NCT00327015|156583289|FG002|Overall Study|Pregnancy|1|||
48653185|NCT00327015|156583290|FG003|Overall Study|Pregnancy|1|||
48653186|NCT00327015|156583287|FG000|Overall Study|Administrative Reason by Sponsor|1|||
48653187|NCT00327015|156583288|FG001|Overall Study|Administrative Reason by Sponsor|2|||
48653188|NCT00327015|156583289|FG002|Overall Study|Administrative Reason by Sponsor|2|||
48653189|NCT00327015|156583290|FG003|Overall Study|Administrative Reason by Sponsor|1|||
48653190|NCT01986231|156583294|FG000|Overall Study|Adverse Event|1|||
48653191|NCT00837265|156583295|FG000|Pilot Phase|Withdrawal by Subject|0|||
48653192|NCT00837265|156583296|FG001|Pilot Phase|Withdrawal by Subject|2|||
48653193|NCT00837265|156583297|FG002|Pilot Phase|Withdrawal by Subject|3|||
48653194|NCT00837265|156583298|FG003|Pilot Phase|Withdrawal by Subject|2|||
48653195|NCT00837265|156583299|FG004|Pilot Phase|Withdrawal by Subject|0|||
48653196|NCT00837265|156583300|FG005|Pilot Phase|Withdrawal by Subject|0|||
48653197|NCT00837265|156583301|FG006|Pilot Phase|Withdrawal by Subject|0|||
48653198|NCT00837265|156583295|FG000|Pilot Phase|Decision of the investigator|2|||
48653199|NCT00837265|156583296|FG001|Pilot Phase|Decision of the investigator|1|||
48753570|NCT01881776|156944263|FG001|Overall Study|Lost to Follow-up|2|||
48753571|NCT01881776|156944264|FG002|Overall Study|Lost to Follow-up|1|||
48753572|NCT01881776|156944262|FG000|Overall Study|Protocol Violation|0|||
48753573|NCT01881776|156944263|FG001|Overall Study|Protocol Violation|2|||
48753574|NCT01881776|156944264|FG002|Overall Study|Protocol Violation|1|||
48753575|NCT02320149|156944265|FG000|Overall Study|Adverse Event|3|||
48753576|NCT02320149|156944266|FG001|Overall Study|Adverse Event|7|||
48753577|NCT02320149|156944265|FG000|Overall Study|Withdrawal of Consent|28|||
48753578|NCT02320149|156944266|FG001|Overall Study|Withdrawal of Consent|32|||
48753579|NCT02320149|156944265|FG000|Overall Study|Lost to Follow-up|21|||
48753580|NCT02320149|156944266|FG001|Overall Study|Lost to Follow-up|34|||
48753581|NCT02320149|156944265|FG000|Overall Study|Protocol Violation|2|||
48753582|NCT02320149|156944266|FG001|Overall Study|Protocol Violation|1|||
48753583|NCT02320149|156944265|FG000|Overall Study|Noncompliance with Study Treatment|7|||
48753584|NCT02320149|156944266|FG001|Overall Study|Noncompliance with Study Treatment|2|||
48753585|NCT02320149|156944265|FG000|Overall Study|Lack of Efficacy|0|||
48753586|NCT02320149|156944266|FG001|Overall Study|Lack of Efficacy|1|||
48753587|NCT02320149|156944265|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48753588|NCT02320149|156944266|FG001|Overall Study|Other Miscellaneous Reasons|3|||
48753589|NCT00006903|156944268|FG000|Overall Study|Still receiving treatment|0|||
48753590|NCT00006903|156944269|FG001|Overall Study|Still receiving treatment|0|||
48753591|NCT00006903|156944270|FG002|Overall Study|Still receiving treatment|1|||
48753592|NCT00006903|156944268|FG000|Overall Study|Refused further treatment|0|||
48753593|NCT00006903|156944269|FG001|Overall Study|Refused further treatment|2|||
48753594|NCT00006903|156944270|FG002|Overall Study|Refused further treatment|1|||
48753595|NCT00006903|156944268|FG000|Overall Study|Adverse Event|0|||
48753596|NCT00006903|156944269|FG001|Overall Study|Adverse Event|0|||
48753597|NCT00006903|156944270|FG002|Overall Study|Adverse Event|1|||
48753598|NCT00006903|156944268|FG000|Overall Study|Death|0|||
48753599|NCT00006903|156944269|FG001|Overall Study|Death|1|||
48753600|NCT00006903|156944270|FG002|Overall Study|Death|0|||
48753601|NCT00006903|156944268|FG000|Overall Study|Patient never treated|0|||
48753602|NCT00006903|156944269|FG001|Overall Study|Patient never treated|0|||
48753603|NCT00006903|156944270|FG002|Overall Study|Patient never treated|1|||
48753604|NCT00006903|156944268|FG000|Overall Study|Ineligible|10|||
48653200|NCT00837265|156583297|FG002|Pilot Phase|Decision of the investigator|0|||
48653201|NCT00837265|156583298|FG003|Pilot Phase|Decision of the investigator|0|||
48653202|NCT00837265|156583299|FG004|Pilot Phase|Decision of the investigator|0|||
48753605|NCT00006903|156944269|FG001|Overall Study|Ineligible|1|||
48753606|NCT00006903|156944270|FG002|Overall Study|Ineligible|2|||
48753607|NCT02393547|156944271|FG000|Overall Study|Adverse Event|2|||
48653203|NCT00837265|156583300|FG005|Pilot Phase|Decision of the investigator|0|||
48653204|NCT00837265|156583301|FG006|Pilot Phase|Decision of the investigator|0|||
48753608|NCT02393547|156944271|FG000|Overall Study|Withdrawal by Subject|3|||
48753609|NCT02393547|156944271|FG000|Overall Study|Lost to Follow-up|1|||
48753610|NCT02707991|156944272|FG000|Overall Study|Protocol Violation|1|||
48753611|NCT02707991|156944273|FG001|Overall Study|Protocol Violation|0|||
48753612|NCT02707991|156944272|FG000|Overall Study|Became ineligible|0|||
48753613|NCT02707991|156944273|FG001|Overall Study|Became ineligible|1|||
48333890|NCT01322347|155419481|FG001|Overall Study|moved/changed dialysis|4|||
48333891|NCT00590759|155419484|FG000|Overall Study|Death|52|||
48333892|NCT00590759|155419484|FG000|Overall Study|Lost to Follow-up|28|||
48333893|NCT01109979|155419488|FG000|Overall Study|Physician Decision|2|||
48333894|NCT01109979|155419489|FG001|Overall Study|Physician Decision|0|||
48333895|NCT01109979|155419488|FG000|Overall Study|Withdrawal by Subject|0|||
48333896|NCT01109979|155419489|FG001|Overall Study|Withdrawal by Subject|1|||
48333897|NCT01494467|155419490|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
48333898|NCT01494467|155419491|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
48333899|NCT01494467|155419490|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
48333900|NCT01494467|155419491|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
48333901|NCT01494467|155419490|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
48333902|NCT01494467|155419491|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
48653205|NCT00837265|156583295|FG000|Pilot Phase|Adverse Event|1|||
48653206|NCT00837265|156583296|FG001|Pilot Phase|Adverse Event|0|||
48653207|NCT00837265|156583297|FG002|Pilot Phase|Adverse Event|0|||
48653208|NCT00837265|156583298|FG003|Pilot Phase|Adverse Event|0|||
48333903|NCT01494467|155419490|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
48333904|NCT01494467|155419491|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
48333905|NCT01494467|155419490|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
48333906|NCT01494467|155419491|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
48333907|NCT01494467|155419490|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
48653209|NCT00837265|156583299|FG004|Pilot Phase|Adverse Event|0|||
48653210|NCT00837265|156583300|FG005|Pilot Phase|Adverse Event|0|||
48653211|NCT00837265|156583301|FG006|Pilot Phase|Adverse Event|0|||
48653212|NCT00837265|156583295|FG000|Pilot Phase|Disease progression|0|||
48653213|NCT00837265|156583296|FG001|Pilot Phase|Disease progression|0|||
48653214|NCT00837265|156583297|FG002|Pilot Phase|Disease progression|0|||
48653215|NCT00837265|156583298|FG003|Pilot Phase|Disease progression|1|||
48653216|NCT00837265|156583299|FG004|Pilot Phase|Disease progression|0|||
48653217|NCT00837265|156583300|FG005|Pilot Phase|Disease progression|0|||
48653218|NCT00837265|156583301|FG006|Pilot Phase|Disease progression|0|||
48653219|NCT00837265|156583295|FG000|Pilot Phase|Participant left the city|0|||
48653220|NCT00837265|156583296|FG001|Pilot Phase|Participant left the city|0|||
48653221|NCT00837265|156583297|FG002|Pilot Phase|Participant left the city|0|||
48653222|NCT00837265|156583298|FG003|Pilot Phase|Participant left the city|1|||
48653223|NCT00837265|156583299|FG004|Pilot Phase|Participant left the city|0|||
48653224|NCT00837265|156583300|FG005|Pilot Phase|Participant left the city|0|||
48653225|NCT00837265|156583301|FG006|Pilot Phase|Participant left the city|0|||
48653226|NCT00837265|156583295|FG000|Main Phase|Withdrawal by Subject|0|||
48653227|NCT00837265|156583296|FG001|Main Phase|Withdrawal by Subject|0|||
48653228|NCT00837265|156583297|FG002|Main Phase|Withdrawal by Subject|0|||
48653229|NCT00837265|156583298|FG003|Main Phase|Withdrawal by Subject|0|||
48653230|NCT00837265|156583299|FG004|Main Phase|Withdrawal by Subject|4|||
48653231|NCT00837265|156583300|FG005|Main Phase|Withdrawal by Subject|2|||
48653232|NCT00837265|156583301|FG006|Main Phase|Withdrawal by Subject|1|||
48653233|NCT00837265|156583295|FG000|Main Phase|Decision of the investigator|0|||
48653234|NCT00837265|156583296|FG001|Main Phase|Decision of the investigator|0|||
48653235|NCT00837265|156583297|FG002|Main Phase|Decision of the investigator|0|||
48653236|NCT00837265|156583298|FG003|Main Phase|Decision of the investigator|0|||
48653237|NCT00837265|156583299|FG004|Main Phase|Decision of the investigator|0|||
48653238|NCT00837265|156583300|FG005|Main Phase|Decision of the investigator|2|||
48653239|NCT00837265|156583301|FG006|Main Phase|Decision of the investigator|1|||
48333908|NCT01494467|155419491|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
48333909|NCT01494467|155419490|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
48333910|NCT01494467|155419491|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
48333911|NCT01494467|155419490|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
48653240|NCT00837265|156583295|FG000|Main Phase|Adverse Event|0|||
48653241|NCT00837265|156583296|FG001|Main Phase|Adverse Event|0|||
48653242|NCT00837265|156583297|FG002|Main Phase|Adverse Event|0|||
48653243|NCT00837265|156583298|FG003|Main Phase|Adverse Event|0|||
48653244|NCT00837265|156583299|FG004|Main Phase|Adverse Event|0|||
48653245|NCT00837265|156583300|FG005|Main Phase|Adverse Event|1|||
48653246|NCT00837265|156583301|FG006|Main Phase|Adverse Event|0|||
48653247|NCT00837265|156583295|FG000|Main Phase|Death|0|||
48653248|NCT00837265|156583296|FG001|Main Phase|Death|0|||
48333912|NCT01494467|155419491|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
48333913|NCT01494467|155419490|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
48333914|NCT01494467|155419491|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
48653249|NCT00837265|156583297|FG002|Main Phase|Death|0|||
48653250|NCT00837265|156583298|FG003|Main Phase|Death|0|||
48653251|NCT00837265|156583299|FG004|Main Phase|Death|2|||
48653252|NCT00837265|156583300|FG005|Main Phase|Death|0|||
48333915|NCT01494467|155419490|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
48653253|NCT00837265|156583301|FG006|Main Phase|Death|1|||
48653254|NCT00837265|156583295|FG000|Main Phase|Lost to Follow-up|0|||
48653255|NCT00837265|156583296|FG001|Main Phase|Lost to Follow-up|0|||
48653256|NCT00837265|156583297|FG002|Main Phase|Lost to Follow-up|0|||
48653257|NCT00837265|156583298|FG003|Main Phase|Lost to Follow-up|0|||
48653258|NCT00837265|156583299|FG004|Main Phase|Lost to Follow-up|1|||
48653259|NCT00837265|156583300|FG005|Main Phase|Lost to Follow-up|0|||
48653260|NCT00837265|156583301|FG006|Main Phase|Lost to Follow-up|0|||
48653261|NCT00837265|156583295|FG000|Main Phase|Principal investigator resignation|0|||
48653262|NCT00837265|156583296|FG001|Main Phase|Principal investigator resignation|0|||
48653263|NCT00837265|156583297|FG002|Main Phase|Principal investigator resignation|0|||
48653264|NCT00837265|156583298|FG003|Main Phase|Principal investigator resignation|0|||
48653265|NCT00837265|156583299|FG004|Main Phase|Principal investigator resignation|2|||
48653266|NCT00837265|156583300|FG005|Main Phase|Principal investigator resignation|0|||
48653267|NCT00837265|156583301|FG006|Main Phase|Principal investigator resignation|0|||
48653268|NCT00837265|156583295|FG000|Main Phase|Participant's personal reason|0|||
48653269|NCT00837265|156583296|FG001|Main Phase|Participant's personal reason|0|||
48653270|NCT00837265|156583297|FG002|Main Phase|Participant's personal reason|0|||
48653271|NCT00837265|156583298|FG003|Main Phase|Participant's personal reason|0|||
48653272|NCT00837265|156583299|FG004|Main Phase|Participant's personal reason|1|||
48653273|NCT00837265|156583300|FG005|Main Phase|Participant's personal reason|0|||
48653274|NCT00837265|156583301|FG006|Main Phase|Participant's personal reason|0|||
48653275|NCT01110330|156583302|FG000|Overall Study|Adverse Event|0|||
48653276|NCT01110330|156583303|FG001|Overall Study|Adverse Event|4|||
48653277|NCT01110330|156583304|FG002|Overall Study|Adverse Event|3|||
48653278|NCT01110330|156583302|FG000|Overall Study|Lack of Efficacy|3|||
48653279|NCT01110330|156583303|FG001|Overall Study|Lack of Efficacy|1|||
48653280|NCT01110330|156583304|FG002|Overall Study|Lack of Efficacy|1|||
48653281|NCT01110330|156583302|FG000|Overall Study|Lost to Follow-up|9|||
48653282|NCT01110330|156583303|FG001|Overall Study|Lost to Follow-up|10|||
48653283|NCT01110330|156583304|FG002|Overall Study|Lost to Follow-up|15|||
48653284|NCT01110330|156583302|FG000|Overall Study|Physician Decision|0|||
48653285|NCT01110330|156583303|FG001|Overall Study|Physician Decision|1|||
48653286|NCT01110330|156583304|FG002|Overall Study|Physician Decision|0|||
48653287|NCT01110330|156583302|FG000|Overall Study|Protocol Violation|2|||
48653288|NCT01110330|156583303|FG001|Overall Study|Protocol Violation|0|||
48653289|NCT01110330|156583304|FG002|Overall Study|Protocol Violation|4|||
48653290|NCT01110330|156583302|FG000|Overall Study|Withdrawal by Subject|0|||
48653291|NCT01110330|156583303|FG001|Overall Study|Withdrawal by Subject|6|||
48653292|NCT01110330|156583304|FG002|Overall Study|Withdrawal by Subject|2|||
48653293|NCT01110330|156583302|FG000|Overall Study|Other|1|||
48653294|NCT01110330|156583303|FG001|Overall Study|Other|1|||
48653295|NCT01110330|156583304|FG002|Overall Study|Other|1|||
48653296|NCT03350035|156583321|FG000|Overall Study|Lack of Efficacy|2|||
48653297|NCT03350035|156583322|FG001|Overall Study|Lack of Efficacy|0|||
48653298|NCT03350035|156583323|FG002|Overall Study|Lack of Efficacy|0|||
48653299|NCT03350035|156583321|FG000|Overall Study|Subject discharged to hospice|0|||
48653300|NCT03350035|156583322|FG001|Overall Study|Subject discharged to hospice|0|||
48653301|NCT03350035|156583323|FG002|Overall Study|Subject discharged to hospice|1|||
48753614|NCT02205814|156944274|FG000|Overall Study|Lost to Follow-up|0|||
48753615|NCT02205814|156944275|FG001|Overall Study|Lost to Follow-up|0|||
48753616|NCT02205814|156944276|FG002|Overall Study|Lost to Follow-up|0|||
48753617|NCT02205814|156944277|FG003|Overall Study|Lost to Follow-up|1|||
48753618|NCT02205814|156944274|FG000|Overall Study|Lack of Efficacy|1|||
48753619|NCT02205814|156944275|FG001|Overall Study|Lack of Efficacy|0|||
48753620|NCT02205814|156944276|FG002|Overall Study|Lack of Efficacy|1|||
48753621|NCT02205814|156944277|FG003|Overall Study|Lack of Efficacy|1|||
48753622|NCT02205814|156944274|FG000|Overall Study|Physician Decision|0|||
48753623|NCT02205814|156944275|FG001|Overall Study|Physician Decision|0|||
48753624|NCT02205814|156944276|FG002|Overall Study|Physician Decision|1|||
48753625|NCT02205814|156944277|FG003|Overall Study|Physician Decision|0|||
48428048|NCT01518192|155754795|FG000|Overall Study|Lost to Follow-up|29|||
48653302|NCT04115748|156583328|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
48653303|NCT04115748|156583329|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
48653304|NCT04115748|156583330|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
48653305|NCT04115748|156583331|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
48653306|NCT04115748|156583332|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653307|NCT04115748|156583333|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653308|NCT04115748|156583334|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653309|NCT04115748|156583335|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653310|NCT04115748|156583336|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48753626|NCT02205814|156944274|FG000|Overall Study|Protocol Violation|1|||
48653311|NCT04115748|156583337|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
48653312|NCT04115748|156583328|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653313|NCT04115748|156583329|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653314|NCT04115748|156583330|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653315|NCT04115748|156583331|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
48333916|NCT01494467|155419491|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
48333917|NCT01494467|155419490|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
48653316|NCT04115748|156583332|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653317|NCT04115748|156583333|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653318|NCT04115748|156583334|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48333918|NCT01494467|155419491|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
48333919|NCT01494467|155419490|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
48333920|NCT01494467|155419491|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
48333921|NCT01494467|155419490|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
48333922|NCT01494467|155419491|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
48333923|NCT01494467|155419490|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
48653319|NCT04115748|156583335|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653320|NCT04115748|156583336|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653321|NCT04115748|156583337|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
48653322|NCT04115748|156583328|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
48653323|NCT04115748|156583329|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
48653324|NCT04115748|156583330|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
48653325|NCT04115748|156583331|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
48653326|NCT04115748|156583332|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
48653327|NCT04115748|156583333|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
48653328|NCT04115748|156583334|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
48653329|NCT04115748|156583335|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
48653330|NCT04115748|156583336|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
48653331|NCT04115748|156583337|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
48653332|NCT04115748|156583328|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653333|NCT04115748|156583329|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48333924|NCT01494467|155419491|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
48333925|NCT03136861|155419493|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
48333926|NCT03136861|155419494|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
48653334|NCT04115748|156583330|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48333927|NCT03136861|155419495|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48333928|NCT03136861|155419496|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48333929|NCT03136861|155419497|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48333930|NCT03136861|155419498|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48333931|NCT03136861|155419499|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
48333932|NCT03136861|155419493|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
48653335|NCT04115748|156583331|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653336|NCT04115748|156583332|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653337|NCT04115748|156583333|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653338|NCT04115748|156583334|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653339|NCT04115748|156583335|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48333933|NCT03136861|155419494|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
48333934|NCT03136861|155419495|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48333935|NCT03136861|155419496|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48333936|NCT03136861|155419497|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48333937|NCT03136861|155419498|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48333938|NCT03136861|155419499|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
48333939|NCT03136861|155419493|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
48333940|NCT03136861|155419494|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
48333941|NCT03136861|155419495|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48333942|NCT03136861|155419496|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48333943|NCT03136861|155419497|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48333944|NCT03136861|155419498|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48333945|NCT03136861|155419499|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
48653340|NCT04115748|156583336|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
48653341|NCT04115748|156583337|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
48653342|NCT03379259|156583338|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
48653343|NCT03379259|156583339|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
48653344|NCT03379259|156583340|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
48653345|NCT03379259|156583341|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
48753627|NCT02205814|156944275|FG001|Overall Study|Protocol Violation|0|||
48333946|NCT03136861|155419493|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48333947|NCT03136861|155419494|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
48333948|NCT03136861|155419495|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48333949|NCT03136861|155419496|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48333950|NCT03136861|155419497|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48333951|NCT03136861|155419498|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48333952|NCT03136861|155419499|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
48333953|NCT03136861|155419493|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
48333954|NCT03136861|155419494|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
48333955|NCT03136861|155419495|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48333956|NCT03136861|155419496|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48333957|NCT03136861|155419497|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48333958|NCT03136861|155419498|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48333959|NCT03136861|155419499|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
48333960|NCT03136861|155419493|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
48333961|NCT03136861|155419494|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
48333962|NCT03136861|155419495|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
48333963|NCT03136861|155419496|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
48333964|NCT03136861|155419497|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
48333965|NCT03136861|155419498|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
48333966|NCT03136861|155419499|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
48333967|NCT03136861|155419493|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48333968|NCT03136861|155419494|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48333969|NCT03136861|155419495|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
48333970|NCT03136861|155419496|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48753628|NCT02205814|156944276|FG002|Overall Study|Protocol Violation|0|||
48753629|NCT02205814|156944277|FG003|Overall Study|Protocol Violation|1|||
48753630|NCT02205814|156944274|FG000|Overall Study|Withdrawal by Subject|0|||
48753631|NCT02205814|156944275|FG001|Overall Study|Withdrawal by Subject|1|||
48753632|NCT02205814|156944276|FG002|Overall Study|Withdrawal by Subject|2|||
48753633|NCT02205814|156944277|FG003|Overall Study|Withdrawal by Subject|1|||
48753634|NCT02205814|156944274|FG000|Overall Study|not compliant with study procedures|0|||
48753635|NCT02205814|156944275|FG001|Overall Study|not compliant with study procedures|0|||
48753636|NCT02205814|156944276|FG002|Overall Study|not compliant with study procedures|1|||
48753637|NCT02205814|156944277|FG003|Overall Study|not compliant with study procedures|0|||
48753638|NCT03402386|156944280|FG000|Overall Study|Adverse Event|3|||
48753639|NCT03402386|156944280|FG000|Overall Study|Physician Decision|1|||
48753640|NCT03402386|156944280|FG000|Overall Study|Difficult to control Hb|2|||
48753641|NCT01996982|156944281|FG000|Overall Study|PI/team left institution|7|||
48753642|NCT03552198|156944282|FG000|Overall Study|Lost to Follow-up|42|||
48753643|NCT03552198|156944283|FG001|Overall Study|Lost to Follow-up|48|||
48333971|NCT03136861|155419497|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48333972|NCT03136861|155419498|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48333973|NCT03136861|155419499|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
48333974|NCT03136861|155419493|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48753644|NCT03552198|156944284|FG002|Overall Study|Lost to Follow-up|15|||
48753645|NCT03552198|156944285|FG003|Overall Study|Lost to Follow-up|19|||
48753646|NCT03552198|156944282|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
48753647|NCT03552198|156944283|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
48753648|NCT03552198|156944284|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
48753649|NCT03552198|156944285|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
48753650|NCT03552198|156944282|FG000|Overall Study|Did not receive air alerts|1|||
48586464|NCT01618916|156338986|FG002|Overall Study|Lost to Follow-up|0|||
48333975|NCT03136861|155419494|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48586465|NCT01618916|156338987|FG003|Overall Study|Lost to Follow-up|2|||
48586466|NCT01618916|156338988|FG004|Overall Study|Lost to Follow-up|0|||
48586467|NCT01618916|156338989|FG005|Overall Study|Lost to Follow-up|0|||
48586468|NCT01853696|156338990|FG000|Overall Study|Withdrawal by Subject|1|||
48586469|NCT01853696|156338991|FG001|Overall Study|Withdrawal by Subject|1|||
48586470|NCT01853696|156338990|FG000|Overall Study|Lost to Follow-up|5|||
48586471|NCT01853696|156338991|FG001|Overall Study|Lost to Follow-up|4|||
48586472|NCT04521114|156338992|FG000|Overall Study|Lost to Follow-up|1|||
48586473|NCT04521114|156338993|FG001|Overall Study|Lost to Follow-up|2|||
48586474|NCT04521114|156338994|FG002|Overall Study|Lost to Follow-up|0|||
48586475|NCT04521114|156338992|FG000|Overall Study|Withdrawal by Subject|1|||
48586476|NCT04521114|156338993|FG001|Overall Study|Withdrawal by Subject|2|||
48586477|NCT04521114|156338994|FG002|Overall Study|Withdrawal by Subject|2|||
48586478|NCT04521114|156338992|FG000|Overall Study|Adverse Event|1|||
48586479|NCT04521114|156338993|FG001|Overall Study|Adverse Event|0|||
48333976|NCT03136861|155419495|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
48753651|NCT03552198|156944283|FG001|Overall Study|Did not receive air alerts|0|||
48333977|NCT03136861|155419496|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48333978|NCT03136861|155419497|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48333979|NCT03136861|155419498|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48333980|NCT03136861|155419499|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
48333981|NCT00584909|155419500|FG000|Overall Study|Adverse Event|4|||
48333982|NCT03345407|155419501|FG000|Overall Study|Withdrawal by Subject|11|||
48333983|NCT03345407|155419502|FG001|Overall Study|Withdrawal by Subject|1|||
48333984|NCT03345407|155419503|FG002|Overall Study|Withdrawal by Subject|5|||
48333985|NCT03345407|155419504|FG003|Overall Study|Withdrawal by Subject|6|||
48333986|NCT03345407|155419505|FG004|Overall Study|Withdrawal by Subject|3|||
48333987|NCT03345407|155419506|FG005|Overall Study|Withdrawal by Subject|6|||
48333988|NCT03345407|155419507|FG006|Overall Study|Withdrawal by Subject|16|||
48333989|NCT03345407|155419501|FG000|Overall Study|Physician Decision|3|||
48333990|NCT03345407|155419502|FG001|Overall Study|Physician Decision|1|||
48333991|NCT03345407|155419503|FG002|Overall Study|Physician Decision|0|||
48333992|NCT03345407|155419504|FG003|Overall Study|Physician Decision|0|||
48333993|NCT03345407|155419505|FG004|Overall Study|Physician Decision|1|||
48333994|NCT03345407|155419506|FG005|Overall Study|Physician Decision|2|||
48333995|NCT03345407|155419507|FG006|Overall Study|Physician Decision|3|||
48333996|NCT03345407|155419501|FG000|Overall Study|Lost to Follow-up|2|||
48333997|NCT03345407|155419502|FG001|Overall Study|Lost to Follow-up|0|||
48333998|NCT03345407|155419503|FG002|Overall Study|Lost to Follow-up|1|||
48333999|NCT03345407|155419504|FG003|Overall Study|Lost to Follow-up|0|||
48334000|NCT03345407|155419505|FG004|Overall Study|Lost to Follow-up|1|||
48334001|NCT03345407|155419506|FG005|Overall Study|Lost to Follow-up|2|||
48334002|NCT03345407|155419507|FG006|Overall Study|Lost to Follow-up|3|||
48334003|NCT03345407|155419501|FG000|Overall Study|Protocol-defined stopping criteria|9|||
48334004|NCT03345407|155419502|FG001|Overall Study|Protocol-defined stopping criteria|0|||
48334005|NCT03345407|155419503|FG002|Overall Study|Protocol-defined stopping criteria|0|||
48334006|NCT03345407|155419504|FG003|Overall Study|Protocol-defined stopping criteria|0|||
48334007|NCT03345407|155419505|FG004|Overall Study|Protocol-defined stopping criteria|2|||
48334008|NCT03345407|155419506|FG005|Overall Study|Protocol-defined stopping criteria|1|||
48334009|NCT03345407|155419507|FG006|Overall Study|Protocol-defined stopping criteria|1|||
48334010|NCT03345407|155419501|FG000|Overall Study|Protocol Violation|2|||
48334011|NCT03345407|155419502|FG001|Overall Study|Protocol Violation|0|||
48334012|NCT03345407|155419503|FG002|Overall Study|Protocol Violation|0|||
48334013|NCT03345407|155419504|FG003|Overall Study|Protocol Violation|0|||
48334014|NCT03345407|155419505|FG004|Overall Study|Protocol Violation|1|||
48334015|NCT03345407|155419506|FG005|Overall Study|Protocol Violation|0|||
48334016|NCT03345407|155419507|FG006|Overall Study|Protocol Violation|3|||
48334017|NCT03345407|155419501|FG000|Overall Study|Lack of Efficacy|1|||
48334018|NCT03345407|155419502|FG001|Overall Study|Lack of Efficacy|1|||
48334019|NCT03345407|155419503|FG002|Overall Study|Lack of Efficacy|1|||
48334020|NCT03345407|155419504|FG003|Overall Study|Lack of Efficacy|1|||
48334021|NCT03345407|155419505|FG004|Overall Study|Lack of Efficacy|1|||
48586480|NCT04521114|156338994|FG002|Overall Study|Adverse Event|0|||
48586481|NCT04521114|156338992|FG000|Overall Study|Sponsor Wish|1|||
48586482|NCT04521114|156338993|FG001|Overall Study|Sponsor Wish|0|||
48586483|NCT04521114|156338994|FG002|Overall Study|Sponsor Wish|0|||
48586484|NCT04521114|156338992|FG000|Overall Study|Withdrawal of Consent|2|||
48753652|NCT03552198|156944284|FG002|Overall Study|Did not receive air alerts|0|||
48753653|NCT03552198|156944285|FG003|Overall Study|Did not receive air alerts|1|||
48753654|NCT02170051|156944286|FG000|Overall Study|Withdrawal by Subject|10|||
48586485|NCT04521114|156338993|FG001|Overall Study|Withdrawal of Consent|2|||
48586486|NCT04521114|156338994|FG002|Overall Study|Withdrawal of Consent|0|||
48586487|NCT01362517|156338995|FG000|Overall Study|Protocol Violation|1|||
48753655|NCT02170051|156944287|FG001|Overall Study|Withdrawal by Subject|10|||
48753656|NCT02170051|156944286|FG000|Overall Study|Lost to Follow-up|1|||
48753657|NCT02170051|156944287|FG001|Overall Study|Lost to Follow-up|3|||
48334022|NCT03345407|155419506|FG005|Overall Study|Lack of Efficacy|0|||
48334023|NCT03345407|155419507|FG006|Overall Study|Lack of Efficacy|3|||
48334024|NCT03345407|155419501|FG000|Overall Study|Adverse Event|4|||
48334025|NCT03345407|155419502|FG001|Overall Study|Adverse Event|0|||
48334026|NCT03345407|155419503|FG002|Overall Study|Adverse Event|5|||
48334027|NCT03345407|155419504|FG003|Overall Study|Adverse Event|4|||
48334028|NCT03345407|155419505|FG004|Overall Study|Adverse Event|6|||
48334029|NCT03345407|155419506|FG005|Overall Study|Adverse Event|5|||
48334030|NCT03345407|155419507|FG006|Overall Study|Adverse Event|16|||
48334031|NCT03262389|155419508|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
48334032|NCT03262389|155419508|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
48334033|NCT03262389|155419508|FG000|Overall Study|opted out of PET/MR|1|||
48586488|NCT01362517|156338995|FG000|Overall Study|Lost to Follow-up|1|||
48586489|NCT03004924|156338996|FG000|Overall Study|Adverse Event|6|||
48753658|NCT00881712|156944288|FG000|Overall Study|Death|1|||
48334034|NCT00113529|155419510|FG000|Overall Study|Adverse Event|4|||
48334035|NCT00113529|155419510|FG000|Overall Study|Lack of Efficacy|20|||
48334036|NCT00113529|155419510|FG000|Overall Study|Decision of sponsor|6|||
48334037|NCT00113529|155419510|FG000|Overall Study|Withdrawal by Subject|4|||
48334038|NCT02449902|155419514|FG000|Overall Study|Adverse Event|0|||
48334039|NCT02449902|155419515|FG001|Overall Study|Adverse Event|1|||
48334040|NCT02449902|155419514|FG000|Overall Study|Withdrawal by Subject|0|||
48334041|NCT02449902|155419515|FG001|Overall Study|Withdrawal by Subject|1|||
48334042|NCT02009332|155419516|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48334043|NCT02009332|155419517|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
48334044|NCT02009332|155419518|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48334045|NCT02009332|155419519|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48334046|NCT02009332|155419520|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48334047|NCT02009332|155419521|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
48334048|NCT02009332|155419516|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48334049|NCT02009332|155419517|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48334050|NCT02009332|155419518|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48334051|NCT02009332|155419519|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48334052|NCT02009332|155419520|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
48334053|NCT02009332|155419521|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
48334054|NCT02009332|155419516|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48334055|NCT02009332|155419517|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48334056|NCT02009332|155419518|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48334057|NCT02009332|155419519|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48334058|NCT02009332|155419520|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
48334059|NCT02009332|155419521|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
48334060|NCT01912599|155419522|FG000|Overall Study|Withdrawal by Subject|0|||
48334061|NCT01912599|155419523|FG001|Overall Study|Withdrawal by Subject|1|||
48753659|NCT00881712|156944289|FG001|Overall Study|Death|0|||
48753660|NCT00881712|156944290|FG002|Overall Study|Death|0|||
48753661|NCT00881712|156944288|FG000|Overall Study|Withdrawal by Subject|1|||
48753662|NCT00881712|156944289|FG001|Overall Study|Withdrawal by Subject|0|||
48753663|NCT00881712|156944290|FG002|Overall Study|Withdrawal by Subject|0|||
48753664|NCT01129960|156944291|FG000|Overall Study|Withdrawal by Subject|3|||
48753665|NCT01129960|156944292|FG001|Overall Study|Withdrawal by Subject|0|||
48753666|NCT01129960|156944293|FG002|Overall Study|Withdrawal by Subject|3|||
48753667|NCT01129960|156944294|FG003|Overall Study|Withdrawal by Subject|2|||
48753668|NCT01129960|156944291|FG000|Overall Study|Lack of Efficacy|1|||
48753669|NCT01129960|156944292|FG001|Overall Study|Lack of Efficacy|1|||
48753670|NCT01129960|156944293|FG002|Overall Study|Lack of Efficacy|1|||
48753671|NCT01129960|156944294|FG003|Overall Study|Lack of Efficacy|1|||
48753672|NCT01129960|156944291|FG000|Overall Study|Adverse Event|23|||
48753673|NCT01129960|156944292|FG001|Overall Study|Adverse Event|16|||
48753674|NCT01129960|156944293|FG002|Overall Study|Adverse Event|16|||
48753675|NCT01129960|156944294|FG003|Overall Study|Adverse Event|7|||
48753676|NCT01129960|156944291|FG000|Overall Study|Protocol Violation|1|||
48753677|NCT01129960|156944292|FG001|Overall Study|Protocol Violation|2|||
48753678|NCT01129960|156944293|FG002|Overall Study|Protocol Violation|3|||
48753679|NCT01129960|156944294|FG003|Overall Study|Protocol Violation|0|||
48753680|NCT01129960|156944291|FG000|Overall Study|Lost to Follow-up|0|||
48753681|NCT01129960|156944292|FG001|Overall Study|Lost to Follow-up|2|||
48753682|NCT01129960|156944293|FG002|Overall Study|Lost to Follow-up|3|||
48753683|NCT01129960|156944294|FG003|Overall Study|Lost to Follow-up|3|||
48753684|NCT01129960|156944291|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
48753685|NCT01129960|156944292|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
48753686|NCT01129960|156944293|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
48753687|NCT01129960|156944294|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
48753688|NCT01129960|156944291|FG000|Overall Study|Physician Decision|1|||
48334062|NCT00648895|155419524|FG000|Overall Study|Lack of Efficacy|0|||
48334063|NCT00648895|155419525|FG001|Overall Study|Lack of Efficacy|1|||
48334064|NCT01280721|155419526|FG000|Overall Study|Adverse Event|4|||
48334065|NCT01280721|155419526|FG000|Overall Study|Physician Decision|3|||
48334066|NCT01280721|155419526|FG000|Overall Study|Withdrawal by Subject|6|||
48334067|NCT01280721|155419526|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
48334068|NCT01280721|155419526|FG000|Overall Study|No tolerability for the lowest dose|2|||
48334069|NCT00795639|155419527|FG000|Overall Study|Death|1|||
48334070|NCT00795639|155419528|FG001|Overall Study|Death|6|||
48334071|NCT00795639|155419527|FG000|Overall Study|Withdrawal by Subject|1|||
48334072|NCT00795639|155419528|FG001|Overall Study|Withdrawal by Subject|3|||
48753689|NCT01129960|156944292|FG001|Overall Study|Physician Decision|0|||
48753690|NCT01129960|156944293|FG002|Overall Study|Physician Decision|0|||
48753691|NCT01129960|156944294|FG003|Overall Study|Physician Decision|0|||
48753692|NCT01129960|156944291|FG000|Overall Study|Pregnancy|1|||
48753693|NCT01129960|156944292|FG001|Overall Study|Pregnancy|0|||
48753694|NCT01129960|156944293|FG002|Overall Study|Pregnancy|0|||
48753695|NCT01129960|156944294|FG003|Overall Study|Pregnancy|0|||
48753696|NCT01605877|156944295|FG000|Overall Study|Withdrawal by Subject|1|||
48753697|NCT04533438|156944296|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
48753698|NCT04533438|156944297|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
48753699|NCT02547454|156944300|FG000|Overall Study|Due to hemodialysis|53|||
48753700|NCT02547454|156944300|FG000|Overall Study|Due to transplantation|1|||
48753701|NCT02547454|156944300|FG000|Overall Study|Due to no further need to treat|4|||
48753702|NCT02547454|156944300|FG000|Overall Study|Death|38|||
48753703|NCT02547454|156944300|FG000|Overall Study|Lost to Follow-up|26|||
48753704|NCT02547454|156944300|FG000|Overall Study|Other|39|||
48753705|NCT02547454|156944300|FG000|Overall Study|No data|11|||
48753706|NCT01339429|156944304|FG000|Overall Study|Withdrawal by Subject|1|||
48753707|NCT01339429|156944304|FG000|Overall Study|Physician Decision|3|||
48753708|NCT01085591|156944305|FG000|Overall Study|Adverse Event|0|||
48753709|NCT01085591|156944306|FG001|Overall Study|Adverse Event|1|||
48586490|NCT03004924|156338997|FG001|Overall Study|Adverse Event|5|||
48586491|NCT03004924|156338998|FG002|Overall Study|Adverse Event|10|||
48586492|NCT03004924|156338996|FG000|Overall Study|Protocol Violation|4|||
48334073|NCT00795639|155419527|FG000|Overall Study|Pregnancy|1|||
48334074|NCT00795639|155419528|FG001|Overall Study|Pregnancy|0|||
48334075|NCT00795639|155419527|FG000|Overall Study|Adverse Event|5|||
48334076|NCT00795639|155419528|FG001|Overall Study|Adverse Event|2|||
48586493|NCT03004924|156338997|FG001|Overall Study|Protocol Violation|0|||
48586494|NCT03004924|156338998|FG002|Overall Study|Protocol Violation|1|||
48586495|NCT03004924|156338996|FG000|Overall Study|Withdrawal by Subject|5|||
48586496|NCT03004924|156338997|FG001|Overall Study|Withdrawal by Subject|3|||
48586497|NCT03004924|156338998|FG002|Overall Study|Withdrawal by Subject|5|||
48753710|NCT01085591|156944307|FG002|Overall Study|Adverse Event|3|||
48753711|NCT01085591|156944305|FG000|Overall Study|Physician Decision|1|||
48753712|NCT01085591|156944306|FG001|Overall Study|Physician Decision|0|||
48753713|NCT01085591|156944307|FG002|Overall Study|Physician Decision|1|||
48753714|NCT01085591|156944305|FG000|Overall Study|Withdrawal by Subject|0|||
48753715|NCT01085591|156944306|FG001|Overall Study|Withdrawal by Subject|2|||
48753716|NCT01085591|156944307|FG002|Overall Study|Withdrawal by Subject|1|||
48753717|NCT01085591|156944305|FG000|Overall Study|Lost to Follow-up|0|||
48753718|NCT01085591|156944306|FG001|Overall Study|Lost to Follow-up|1|||
48753719|NCT01085591|156944307|FG002|Overall Study|Lost to Follow-up|1|||
48753720|NCT01085591|156944305|FG000|Overall Study|Protocol Violation|1|||
48753721|NCT01085591|156944306|FG001|Overall Study|Protocol Violation|1|||
48753722|NCT01085591|156944307|FG002|Overall Study|Protocol Violation|1|||
48753723|NCT01085591|156944305|FG000|Overall Study|Other|0|||
48753724|NCT01085591|156944306|FG001|Overall Study|Other|1|||
48753725|NCT01085591|156944307|FG002|Overall Study|Other|0|||
48753726|NCT01085591|156944305|FG000|Overall Study|Not Properly Consented|1|||
48753727|NCT01085591|156944306|FG001|Overall Study|Not Properly Consented|0|||
48753728|NCT01085591|156944307|FG002|Overall Study|Not Properly Consented|0|||
48753729|NCT01059799|156944308|FG000|Overall Study|Adverse Event|2|||
48753730|NCT01059799|156944309|FG001|Overall Study|Adverse Event|3|||
48753731|NCT01059799|156944308|FG000|Overall Study|Lack of Efficacy|1|||
48753732|NCT01059799|156944309|FG001|Overall Study|Lack of Efficacy|0|||
48753733|NCT01059799|156944308|FG000|Overall Study|Protocol Violation|3|||
48753734|NCT01059799|156944309|FG001|Overall Study|Protocol Violation|2|||
48753735|NCT01059799|156944308|FG000|Overall Study|Withdrawal criteria|13|||
48753736|NCT01059799|156944309|FG001|Overall Study|Withdrawal criteria|2|||
48753737|NCT01059799|156944308|FG000|Overall Study|Other|12|||
48753738|NCT01059799|156944309|FG001|Overall Study|Other|3|||
48753739|NCT02625259|156944312|FG000|First Intervention (Day 1)|Other|0|||
48753740|NCT02625259|156944313|FG001|First Intervention (Day 1)|Other|0|||
48753741|NCT02625259|156944314|FG002|First Intervention (Day 1)|Other|1|||
48753742|NCT02625259|156944315|FG003|First Intervention (Day 1)|Other|0|||
48334077|NCT00795639|155419527|FG000|Overall Study|Other|0|||
48334078|NCT00795639|155419528|FG001|Overall Study|Other|2|||
48334079|NCT00795639|155419527|FG000|Overall Study|Terminated by sponsor|13|||
48586498|NCT03004924|156338996|FG000|Overall Study|Lost to Follow-up|6|||
48586499|NCT03004924|156338997|FG001|Overall Study|Lost to Follow-up|1|||
48586500|NCT03004924|156338998|FG002|Overall Study|Lost to Follow-up|4|||
48334080|NCT00795639|155419528|FG001|Overall Study|Terminated by sponsor|12|||
48753743|NCT02625259|156944316|FG004|First Intervention (Day 1)|Other|0|||
48753744|NCT02625259|156944312|FG000|First Intervention (Day 1)|Adverse Event|2|||
48586501|NCT03004924|156338996|FG000|Overall Study|Lack of Efficacy|2|||
48753745|NCT02625259|156944313|FG001|First Intervention (Day 1)|Adverse Event|1|||
48753746|NCT02625259|156944314|FG002|First Intervention (Day 1)|Adverse Event|0|||
48753747|NCT02625259|156944315|FG003|First Intervention (Day 1)|Adverse Event|0|||
48753748|NCT02625259|156944316|FG004|First Intervention (Day 1)|Adverse Event|0|||
48753749|NCT02625259|156944312|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
48753750|NCT02625259|156944313|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
48753751|NCT02625259|156944314|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
48586502|NCT03004924|156338997|FG001|Overall Study|Lack of Efficacy|4|||
48586503|NCT03004924|156338998|FG002|Overall Study|Lack of Efficacy|2|||
48586504|NCT03004924|156338996|FG000|Overall Study|Physician Decision|1|||
48334081|NCT00795639|155419527|FG000|Overall Study|Randomized and not treated|0|||
48334082|NCT00795639|155419528|FG001|Overall Study|Randomized and not treated|1|||
48334083|NCT03349476|155419529|FG000|Overall Study|Physician Decision|3|||
48334084|NCT04930263|155419533|FG000|Overall Study|Withdrawal by Subject|3|||
48334085|NCT04930263|155419534|FG001|Overall Study|Withdrawal by Subject|5|||
48334086|NCT02245620|155420760|FG000|Overall Study|Physician Decision|1|||
48334087|NCT02245620|155420761|FG001|Overall Study|Physician Decision|1|||
48334088|NCT02511106|155420764|FG000|Overall Study|Lost to Follow-up|6|||
48334089|NCT02511106|155420765|FG001|Overall Study|Lost to Follow-up|4|||
48334090|NCT02511106|155420764|FG000|Overall Study|Withdrawal by Subject|24|||
48334091|NCT02511106|155420765|FG001|Overall Study|Withdrawal by Subject|21|||
48334092|NCT02511106|155420764|FG000|Overall Study|Death|42|||
48334093|NCT02511106|155420765|FG001|Overall Study|Death|82|||
48334094|NCT02511106|155420764|FG000|Overall Study|Ongoing study at data cut-off|3|||
48334095|NCT02511106|155420765|FG001|Overall Study|Ongoing study at data cut-off|2|||
48334096|NCT02511106|155420764|FG000|Overall Study|Without specified reason|3|||
48586505|NCT03004924|156338997|FG001|Overall Study|Physician Decision|0|||
48586506|NCT03004924|156338998|FG002|Overall Study|Physician Decision|1|||
48586507|NCT03004924|156338996|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48586508|NCT03004924|156338997|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48653346|NCT03379259|156583342|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
48653347|NCT03379259|156583343|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
48653348|NCT03379259|156583338|FG000|Overall Study|Death|0|||
48653349|NCT03379259|156583339|FG001|Overall Study|Death|1|||
48653350|NCT03379259|156583340|FG002|Overall Study|Death|2|||
48653351|NCT03379259|156583341|FG003|Overall Study|Death|1|||
48653352|NCT03379259|156583342|FG004|Overall Study|Death|4|||
48653353|NCT03379259|156583343|FG005|Overall Study|Death|2|||
48653354|NCT03379259|156583338|FG000|Overall Study|Withdrawal by Subject|0|||
48653355|NCT03379259|156583339|FG001|Overall Study|Withdrawal by Subject|0|||
48653356|NCT03379259|156583340|FG002|Overall Study|Withdrawal by Subject|1|||
48653357|NCT03379259|156583341|FG003|Overall Study|Withdrawal by Subject|0|||
48653358|NCT03379259|156583342|FG004|Overall Study|Withdrawal by Subject|2|||
48653359|NCT03379259|156583343|FG005|Overall Study|Withdrawal by Subject|0|||
48653360|NCT03379259|156583338|FG000|Overall Study|Study terminated by sponsor|0|||
48653361|NCT03379259|156583339|FG001|Overall Study|Study terminated by sponsor|0|||
48653362|NCT03379259|156583340|FG002|Overall Study|Study terminated by sponsor|0|||
48653363|NCT03379259|156583341|FG003|Overall Study|Study terminated by sponsor|1|||
48653364|NCT03379259|156583342|FG004|Overall Study|Study terminated by sponsor|1|||
48653365|NCT03379259|156583343|FG005|Overall Study|Study terminated by sponsor|4|||
48653366|NCT03379259|156583338|FG000|Overall Study|Disease progression|0|||
48334097|NCT02511106|155420765|FG001|Overall Study|Without specified reason|0|||
48334098|NCT01543204|155420769|FG000|Overall Study|Non-compliance|1|||
48334099|NCT01543204|155420769|FG000|Overall Study|Adverse Event|1|||
48334100|NCT01543204|155420769|FG000|Overall Study|Withdrawal by Subject|4|||
48334101|NCT01543204|155420769|FG000|Overall Study|Requirement for Alternative Therapy|1|||
48334102|NCT01543204|155420769|FG000|Overall Study|Lost to Follow-up|1|||
48586509|NCT03004924|156338998|FG002|Overall Study|Withdrawal by parent/guardian|2|||
48586510|NCT03004924|156338996|FG000|Overall Study|Screen Failure|1|||
48653367|NCT03379259|156583339|FG001|Overall Study|Disease progression|0|||
48653368|NCT03379259|156583340|FG002|Overall Study|Disease progression|0|||
48653369|NCT03379259|156583341|FG003|Overall Study|Disease progression|1|||
48653370|NCT03379259|156583342|FG004|Overall Study|Disease progression|0|||
48586511|NCT03004924|156338997|FG001|Overall Study|Screen Failure|0|||
48586512|NCT03004924|156338998|FG002|Overall Study|Screen Failure|0|||
48586513|NCT03004924|156338996|FG000|Overall Study|Pregnancy|0|||
48586514|NCT03004924|156338997|FG001|Overall Study|Pregnancy|1|||
48586515|NCT03004924|156338998|FG002|Overall Study|Pregnancy|0|||
48586516|NCT03004924|156338996|FG000|Overall Study|Terminated by Sponsor|0|||
48586517|NCT03004924|156338997|FG001|Overall Study|Terminated by Sponsor|0|||
48586518|NCT03004924|156338998|FG002|Overall Study|Terminated by Sponsor|1|||
48586519|NCT03004924|156338996|FG000|Overall Study|Missed Study Visit|0|||
48586520|NCT03004924|156338997|FG001|Overall Study|Missed Study Visit|0|||
48586521|NCT03004924|156338998|FG002|Overall Study|Missed Study Visit|2|||
48586522|NCT03004924|156338996|FG000|Overall Study|HSV1 Positive|1|||
48586523|NCT03004924|156338997|FG001|Overall Study|HSV1 Positive|0|||
48586524|NCT03004924|156338998|FG002|Overall Study|HSV1 Positive|0|||
48586525|NCT01167634|156338999|FG000|Overall Study|Lost to Follow-up|1|||
48586526|NCT01167634|156339000|FG001|Overall Study|Lost to Follow-up|3|||
48586527|NCT01167634|156339001|FG002|Overall Study|Lost to Follow-up|3|||
48586528|NCT01167634|156339002|FG003|Overall Study|Lost to Follow-up|4|||
48586529|NCT01167634|156338999|FG000|Overall Study|Withdrawal by Subject|1|||
48586530|NCT01167634|156339000|FG001|Overall Study|Withdrawal by Subject|1|||
48586531|NCT01167634|156339001|FG002|Overall Study|Withdrawal by Subject|0|||
48653371|NCT03379259|156583343|FG005|Overall Study|Disease progression|1|||
48653372|NCT03379259|156583338|FG000|Overall Study|Lost to Follow-up|0|||
48653373|NCT03379259|156583339|FG001|Overall Study|Lost to Follow-up|0|||
48653374|NCT03379259|156583340|FG002|Overall Study|Lost to Follow-up|0|||
48653375|NCT03379259|156583341|FG003|Overall Study|Lost to Follow-up|0|||
48653376|NCT03379259|156583342|FG004|Overall Study|Lost to Follow-up|1|||
48653377|NCT03379259|156583343|FG005|Overall Study|Lost to Follow-up|0|||
48653378|NCT03379259|156583338|FG000|Overall Study|Deteriorating condition|0|||
48653379|NCT03379259|156583339|FG001|Overall Study|Deteriorating condition|0|||
48653380|NCT03379259|156583340|FG002|Overall Study|Deteriorating condition|0|||
48653381|NCT03379259|156583341|FG003|Overall Study|Deteriorating condition|0|||
48653382|NCT03379259|156583342|FG004|Overall Study|Deteriorating condition|1|||
48653383|NCT03379259|156583343|FG005|Overall Study|Deteriorating condition|0|||
48653384|NCT00473668|156583344|FG000|Overall Study|Withdrawal by Subject|0|||
48653385|NCT00473668|156583345|FG001|Overall Study|Withdrawal by Subject|2|||
48653386|NCT00473668|156583346|FG002|Overall Study|Withdrawal by Subject|0|||
48653387|NCT00473668|156583344|FG000|Overall Study|Migrated/moved from study area|3|||
48653388|NCT00473668|156583345|FG001|Overall Study|Migrated/moved from study area|2|||
48653389|NCT00473668|156583346|FG002|Overall Study|Migrated/moved from study area|0|||
48653390|NCT00473668|156583344|FG000|Overall Study|Lost to Follow-up|0|||
48653391|NCT00473668|156583345|FG001|Overall Study|Lost to Follow-up|4|||
48653392|NCT00473668|156583346|FG002|Overall Study|Lost to Follow-up|6|||
48653393|NCT00473668|156583344|FG000|Overall Study|Other|2|||
48653394|NCT00473668|156583345|FG001|Overall Study|Other|3|||
48653395|NCT00473668|156583346|FG002|Overall Study|Other|4|||
48653396|NCT00984165|156583347|FG000|Overall Study|Death on study|2|||
48653397|NCT00984165|156583348|FG001|Overall Study|Death on study|0|||
48653398|NCT00984165|156583349|FG002|Overall Study|Death on study|0|||
48653399|NCT00984165|156583350|FG003|Overall Study|Death on study|0|||
48653400|NCT00984165|156583347|FG000|Overall Study|Disease progression on study|5|||
48653401|NCT00984165|156583348|FG001|Overall Study|Disease progression on study|1|||
48653402|NCT00984165|156583349|FG002|Overall Study|Disease progression on study|0|||
48653403|NCT00984165|156583350|FG003|Overall Study|Disease progression on study|0|||
48653404|NCT00984165|156583347|FG000|Overall Study|Death of recipient|0|||
48653405|NCT00984165|156583348|FG001|Overall Study|Death of recipient|0|||
48653406|NCT00984165|156583349|FG002|Overall Study|Death of recipient|0|||
48653407|NCT00984165|156583350|FG003|Overall Study|Death of recipient|1|||
48653408|NCT00984165|156583347|FG000|Overall Study|New protocol|0|||
48653409|NCT00984165|156583348|FG001|Overall Study|New protocol|0|||
48653410|NCT00984165|156583349|FG002|Overall Study|New protocol|0|||
48653411|NCT00984165|156583350|FG003|Overall Study|New protocol|1|||
48653412|NCT00984165|156583347|FG000|Overall Study|P+/donor pair removed from protocol|0|||
48653413|NCT00984165|156583348|FG001|Overall Study|P+/donor pair removed from protocol|0|||
48653414|NCT00984165|156583349|FG002|Overall Study|P+/donor pair removed from protocol|0|||
48653415|NCT00984165|156583350|FG003|Overall Study|P+/donor pair removed from protocol|1|||
48653416|NCT00984165|156583347|FG000|Overall Study|removed with a pair recipient|0|||
48653417|NCT00984165|156583348|FG001|Overall Study|removed with a pair recipient|0|||
48653418|NCT00984165|156583349|FG002|Overall Study|removed with a pair recipient|0|||
48653419|NCT00984165|156583350|FG003|Overall Study|removed with a pair recipient|1|||
48653420|NCT00633074|156583353|FG000|Overall Study|Adverse Event|1|||
48653421|NCT00633074|156583354|FG001|Overall Study|Adverse Event|0|||
48653422|NCT00365105|156583356|FG000|Overall Study|Protocol Violation|5|||
48653423|NCT00365105|156583357|FG001|Overall Study|Protocol Violation|8|||
48653424|NCT01463696|156583359|FG000|Overall Study|Adverse Event|0|||
48653425|NCT01463696|156583360|FG001|Overall Study|Adverse Event|1|||
48653426|NCT01463696|156583361|FG002|Overall Study|Adverse Event|0|||
48653427|NCT01463696|156583362|FG003|Overall Study|Adverse Event|2|||
48653428|NCT01463696|156583363|FG004|Overall Study|Adverse Event|0|||
48653429|NCT01463696|156583364|FG005|Overall Study|Adverse Event|1|||
48653430|NCT01463696|156583365|FG006|Overall Study|Adverse Event|3|||
48653431|NCT01463696|156583366|FG007|Overall Study|Adverse Event|2|||
48653432|NCT01463696|156583359|FG000|Overall Study|Lost to Follow-up|0|||
48653433|NCT01463696|156583360|FG001|Overall Study|Lost to Follow-up|0|||
48653434|NCT01463696|156583361|FG002|Overall Study|Lost to Follow-up|1|||
48653435|NCT01463696|156583362|FG003|Overall Study|Lost to Follow-up|0|||
48653436|NCT01463696|156583363|FG004|Overall Study|Lost to Follow-up|0|||
48653437|NCT01463696|156583364|FG005|Overall Study|Lost to Follow-up|0|||
48653438|NCT01463696|156583365|FG006|Overall Study|Lost to Follow-up|0|||
48653439|NCT01463696|156583366|FG007|Overall Study|Lost to Follow-up|0|||
48653440|NCT01463696|156583359|FG000|Overall Study|Progressive Disease|0|||
48653441|NCT01463696|156583360|FG001|Overall Study|Progressive Disease|1|||
48653442|NCT01463696|156583361|FG002|Overall Study|Progressive Disease|0|||
48653443|NCT01463696|156583362|FG003|Overall Study|Progressive Disease|1|||
48653444|NCT01463696|156583363|FG004|Overall Study|Progressive Disease|0|||
48653445|NCT01463696|156583364|FG005|Overall Study|Progressive Disease|1|||
48653446|NCT01463696|156583365|FG006|Overall Study|Progressive Disease|4|||
48653447|NCT01463696|156583366|FG007|Overall Study|Progressive Disease|2|||
48653448|NCT01463696|156583359|FG000|Overall Study|Withdrawal by Subject|0|||
48653449|NCT01463696|156583360|FG001|Overall Study|Withdrawal by Subject|0|||
48653450|NCT01463696|156583361|FG002|Overall Study|Withdrawal by Subject|0|||
48653451|NCT01463696|156583362|FG003|Overall Study|Withdrawal by Subject|1|||
48653452|NCT01463696|156583363|FG004|Overall Study|Withdrawal by Subject|1|||
48653453|NCT01463696|156583364|FG005|Overall Study|Withdrawal by Subject|1|||
48653454|NCT01463696|156583365|FG006|Overall Study|Withdrawal by Subject|2|||
48653455|NCT01463696|156583366|FG007|Overall Study|Withdrawal by Subject|0|||
48334103|NCT02721147|155420770|FG000|Overall Study|Lost to Follow-up|2|||
48334104|NCT02721147|155420771|FG001|Overall Study|Lost to Follow-up|0|||
48334105|NCT02721147|155420772|FG002|Overall Study|Lost to Follow-up|0|||
48334106|NCT02256553|155420775|FG000|Period I|Adverse Event|5|||
48334107|NCT02256553|155420775|FG000|Period I|Protocol Violation|1|||
48334108|NCT02256553|155420775|FG000|Period II|Adverse Event|1|||
48334109|NCT02256553|155420775|FG000|Period II|Subject Moved|1|||
48334110|NCT02256553|155420775|FG000|Period III|Adverse Event|3|||
48334111|NCT03326856|155420784|FG000|Overall Study|Lost to Follow-up|1|||
48334112|NCT03326856|155420785|FG001|Overall Study|Lost to Follow-up|1|||
48334113|NCT03326856|155420786|FG002|Overall Study|Lost to Follow-up|0|||
48334114|NCT03326856|155420787|FG003|Overall Study|Lost to Follow-up|0|||
48334115|NCT03326856|155420788|FG004|Overall Study|Lost to Follow-up|0|||
48334116|NCT00042939|155420789|FG000|Overall Study|Adverse Event|6|||
48653456|NCT01463696|156583359|FG000|Overall Study|Not Treated|0|||
48653457|NCT01463696|156583360|FG001|Overall Study|Not Treated|0|||
48653458|NCT01463696|156583361|FG002|Overall Study|Not Treated|0|||
48653459|NCT01463696|156583362|FG003|Overall Study|Not Treated|0|||
48653460|NCT01463696|156583363|FG004|Overall Study|Not Treated|0|||
48653461|NCT01463696|156583364|FG005|Overall Study|Not Treated|0|||
48653462|NCT01463696|156583365|FG006|Overall Study|Not Treated|1|||
48653463|NCT01463696|156583366|FG007|Overall Study|Not Treated|0|||
48653464|NCT00245050|156583367|FG000|Overall Study|Adverse Event|3|||
48334117|NCT00042939|155420790|FG001|Overall Study|Adverse Event|7|||
48334118|NCT00042939|155420789|FG000|Overall Study|Death|3|||
48334119|NCT00042939|155420790|FG001|Overall Study|Death|2|||
48334120|NCT00042939|155420789|FG000|Overall Study|Withdrawal by Subject|3|||
48653465|NCT00245050|156583368|FG001|Overall Study|Adverse Event|2|||
48334121|NCT00042939|155420790|FG001|Overall Study|Withdrawal by Subject|4|||
48334122|NCT00042939|155420789|FG000|Overall Study|Other disease|1|||
48334123|NCT00042939|155420790|FG001|Overall Study|Other disease|0|||
48334124|NCT00042939|155420789|FG000|Overall Study|Ineligible|2|||
48334125|NCT00042939|155420790|FG001|Overall Study|Ineligible|2|||
48334126|NCT00042939|155420789|FG000|Overall Study|Deterioration of health|3|||
48334127|NCT00042939|155420790|FG001|Overall Study|Deterioration of health|4|||
48334128|NCT00042939|155420789|FG000|Overall Study|QOL diminished|1|||
48334129|NCT00042939|155420790|FG001|Overall Study|QOL diminished|0|||
48334130|NCT00042939|155420789|FG000|Overall Study|Rising ca 19-9|1|||
48334131|NCT00042939|155420790|FG001|Overall Study|Rising ca 19-9|0|||
48334132|NCT00042939|155420789|FG000|Overall Study|Patient non-compliance|1|||
48334133|NCT00042939|155420790|FG001|Overall Study|Patient non-compliance|0|||
48334134|NCT00042939|155420789|FG000|Overall Study|Still on treatment|1|||
48334135|NCT00042939|155420790|FG001|Overall Study|Still on treatment|0|||
48653466|NCT00425698|156583369|FG000|Overall Study|Adverse Event|3|||
48653467|NCT00425698|156583370|FG001|Overall Study|Adverse Event|1|||
48653468|NCT00425698|156583369|FG000|Overall Study|Withdrawal by Subject|0|||
48653469|NCT00425698|156583370|FG001|Overall Study|Withdrawal by Subject|1|||
48653470|NCT02957747|156583374|FG000|Overall Study|Withdrawal by Subject|0|||
48653471|NCT02957747|156583375|FG001|Overall Study|Withdrawal by Subject|3|||
48653472|NCT02957747|156583374|FG000|Overall Study|Lost to Follow-up|10|||
48653473|NCT02957747|156583375|FG001|Overall Study|Lost to Follow-up|5|||
48653474|NCT03905265|156583376|FG000|Overall Study|Withdrawal by Subject|1|||
48653475|NCT03905265|156583377|FG001|Overall Study|Withdrawal by Subject|1|||
48653476|NCT03905265|156583378|FG002|Overall Study|Withdrawal by Subject|0|||
48653477|NCT03905265|156583379|FG003|Overall Study|Withdrawal by Subject|0|||
48653478|NCT01164891|156583381|FG000|Overall Study|Disease Progression|5|||
48653479|NCT01164891|156583381|FG000|Overall Study|Adverse Event|1|||
48653480|NCT03632993|156583382|FG000|Overall Study|Withdrawal by Subject|1|||
48653481|NCT03632993|156583383|FG001|Overall Study|Withdrawal by Subject|0|||
48653482|NCT03632993|156583384|FG002|Overall Study|Withdrawal by Subject|0|||
48653483|NCT03632993|156583385|FG003|Overall Study|Withdrawal by Subject|0|||
48653484|NCT03632993|156583386|FG004|Overall Study|Withdrawal by Subject|0|||
48334136|NCT00042939|155420789|FG000|Overall Study|Treatment break > 4 weeks|0|||
48334137|NCT00042939|155420790|FG001|Overall Study|Treatment break > 4 weeks|1|||
48334138|NCT00042939|155420789|FG000|Overall Study|Did not start treatment|2|||
48334139|NCT00042939|155420790|FG001|Overall Study|Did not start treatment|1|||
48334140|NCT00274287|155420791|FG000|Overall Study|Withdrawal by Subject|1|||
48334141|NCT00274287|155420791|FG000|Overall Study|subject non-compliance|1|||
48334142|NCT04421456|155420792|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
48334143|NCT04421456|155420793|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
48334144|NCT04421456|155420794|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
48653485|NCT03632993|156583387|FG005|Overall Study|Withdrawal by Subject|0|||
48653486|NCT03632993|156583388|FG006|Overall Study|Withdrawal by Subject|0|||
48653487|NCT03632993|156583389|FG007|Overall Study|Withdrawal by Subject|0|||
48653488|NCT03632993|156583390|FG008|Overall Study|Withdrawal by Subject|0|||
48653489|NCT03632993|156583391|FG009|Overall Study|Withdrawal by Subject|1|||
48653490|NCT03632993|156583382|FG000|Overall Study|Protocol Non-compliance|0|||
48653491|NCT03632993|156583383|FG001|Overall Study|Protocol Non-compliance|1|||
48653492|NCT03632993|156583384|FG002|Overall Study|Protocol Non-compliance|0|||
48653493|NCT03632993|156583385|FG003|Overall Study|Protocol Non-compliance|0|||
48653494|NCT03632993|156583386|FG004|Overall Study|Protocol Non-compliance|0|||
48653495|NCT03632993|156583387|FG005|Overall Study|Protocol Non-compliance|0|||
48653496|NCT03632993|156583388|FG006|Overall Study|Protocol Non-compliance|0|||
48653497|NCT03632993|156583389|FG007|Overall Study|Protocol Non-compliance|0|||
48653498|NCT03632993|156583390|FG008|Overall Study|Protocol Non-compliance|0|||
48653499|NCT03632993|156583391|FG009|Overall Study|Protocol Non-compliance|0|||
48653500|NCT03632993|156583382|FG000|Overall Study|Lost to Follow-up|0|||
48653501|NCT03632993|156583383|FG001|Overall Study|Lost to Follow-up|0|||
48653502|NCT03632993|156583384|FG002|Overall Study|Lost to Follow-up|0|||
48653503|NCT03632993|156583385|FG003|Overall Study|Lost to Follow-up|0|||
48653504|NCT03632993|156583386|FG004|Overall Study|Lost to Follow-up|0|||
48653505|NCT03632993|156583387|FG005|Overall Study|Lost to Follow-up|1|||
48653506|NCT03632993|156583388|FG006|Overall Study|Lost to Follow-up|0|||
48653507|NCT03632993|156583389|FG007|Overall Study|Lost to Follow-up|1|||
48653508|NCT03632993|156583390|FG008|Overall Study|Lost to Follow-up|0|||
48653509|NCT03632993|156583391|FG009|Overall Study|Lost to Follow-up|0|||
48653510|NCT03632993|156583382|FG000|Overall Study|Adverse Event|0|||
48653511|NCT03632993|156583383|FG001|Overall Study|Adverse Event|0|||
48653512|NCT03632993|156583384|FG002|Overall Study|Adverse Event|0|||
48653513|NCT03632993|156583385|FG003|Overall Study|Adverse Event|0|||
48653514|NCT03632993|156583386|FG004|Overall Study|Adverse Event|0|||
48653515|NCT03632993|156583387|FG005|Overall Study|Adverse Event|1|||
48653516|NCT03632993|156583388|FG006|Overall Study|Adverse Event|0|||
48653517|NCT03632993|156583389|FG007|Overall Study|Adverse Event|1|||
48653518|NCT03632993|156583390|FG008|Overall Study|Adverse Event|0|||
48653519|NCT03632993|156583391|FG009|Overall Study|Adverse Event|0|||
48653520|NCT03983382|156583392|FG000|Overall Study|Death|1|||
48653521|NCT03983382|156583392|FG000|Overall Study|Lost to Follow-up|3|||
48653522|NCT03983382|156583392|FG000|Overall Study|Physician Decision|2|||
48653523|NCT03983382|156583392|FG000|Overall Study|Withdrawal by Subject|10|||
48653524|NCT03983382|156583392|FG000|Overall Study|Change in cancer treatment|2|||
48653525|NCT02141399|156583393|FG000|Overall Study|Adverse Event|158|||
48653526|NCT02141399|156583393|FG000|Overall Study|Lack of Efficacy|62|||
48653527|NCT02141399|156583393|FG000|Overall Study|Lost to Follow-up|151|||
48653528|NCT02141399|156583393|FG000|Overall Study|Non-compliance with study drug|18|||
48653529|NCT02141399|156583393|FG000|Overall Study|Other|45|||
48653530|NCT02141399|156583393|FG000|Overall Study|Physician Decision|17|||
48653531|NCT02141399|156583393|FG000|Overall Study|Pregnancy|3|||
48653532|NCT02141399|156583393|FG000|Overall Study|Protocol Violation|38|||
48653533|NCT02141399|156583393|FG000|Overall Study|Withdrawal by Subject|238|||
48653534|NCT02141399|156583393|FG000|Overall Study|Failure to meet eligibility criteria|14|||
48653535|NCT00765037|156583396|FG000|Overall Study|Lost to Follow-up|5|||
48653536|NCT00765037|156583396|FG000|Overall Study|Adverse Event|1|||
48653537|NCT03070171|156583401|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
48653538|NCT03070171|156583402|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
48653539|NCT03070171|156583401|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
48653540|NCT03070171|156583402|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
48653541|NCT02851797|156583403|FG000|Overall Study|Withdrawal by Subject|4|||
48653542|NCT02851797|156583404|FG001|Overall Study|Withdrawal by Subject|2|||
48653543|NCT02851797|156583403|FG000|Overall Study|Adverse Event|3|||
48653544|NCT02851797|156583404|FG001|Overall Study|Adverse Event|0|||
48653545|NCT00958347|156583405|FG000|Overall Study|Death|43|||
48653546|NCT00958347|156583405|FG000|Overall Study|Withdrawal by Subject|23|||
48653547|NCT00958347|156583405|FG000|Overall Study|Lost to Follow-up|15|||
48653548|NCT00958347|156583405|FG000|Overall Study|revision/removal|10|||
48653549|NCT00958347|156583405|FG000|Overall Study|study termination|135|||
48653550|NCT00157196|156583406|FG000|Overall Study|Ongoing at data cut-off|9|||
48653551|NCT04091581|156583414|FG000|Overall Study|Lost to Follow-up|0|||
48653552|NCT04091581|156583415|FG001|Overall Study|Lost to Follow-up|1|||
48653553|NCT01271010|156586266|FG000|Overall Study|Reason not specified|11|||
48653554|NCT01271010|156586266|FG000|Overall Study|Start of new CLL therapy|1|||
48653555|NCT01271010|156586266|FG000|Overall Study|Protocol Violation|1|||
48653556|NCT01271010|156586266|FG000|Overall Study|Death|2|||
48653557|NCT01271010|156586266|FG000|Overall Study|Progression and relapse of disease|1|||
48653558|NCT01271010|156586266|FG000|Overall Study|Withdrawal by Subject|18|||
48653559|NCT01271010|156586266|FG000|Overall Study|Disease progression|27|||
48653560|NCT00948857|156586268|FG000|Overall Study|Lost to Follow-up|1|||
48653561|NCT00948857|156586269|FG001|Overall Study|Lost to Follow-up|0|||
48653562|NCT00734604|156586270|FG000|Overall Study|Adverse Event|0|||
48653563|NCT00734604|156586271|FG001|Overall Study|Adverse Event|2|||
48653564|NCT00734604|156586272|FG002|Overall Study|Adverse Event|0|||
48653565|NCT00734604|156586273|FG003|Overall Study|Adverse Event|2|||
48653566|NCT00734604|156586274|FG004|Overall Study|Adverse Event|1|||
48653567|NCT00734604|156586275|FG005|Overall Study|Adverse Event|1|||
48653568|NCT00734604|156586270|FG000|Overall Study|Serious Adverse Event|1|||
48653569|NCT00734604|156586271|FG001|Overall Study|Serious Adverse Event|0|||
48653570|NCT00734604|156586272|FG002|Overall Study|Serious Adverse Event|1|||
48653571|NCT00734604|156586273|FG003|Overall Study|Serious Adverse Event|2|||
48653572|NCT00734604|156586274|FG004|Overall Study|Serious Adverse Event|0|||
48653573|NCT00734604|156586275|FG005|Overall Study|Serious Adverse Event|1|||
48653574|NCT00734604|156586270|FG000|Overall Study|Lost to Follow-up|1|||
48653575|NCT00734604|156586271|FG001|Overall Study|Lost to Follow-up|2|||
48653576|NCT00734604|156586272|FG002|Overall Study|Lost to Follow-up|2|||
48653577|NCT00734604|156586273|FG003|Overall Study|Lost to Follow-up|4|||
48653578|NCT00734604|156586274|FG004|Overall Study|Lost to Follow-up|2|||
48653579|NCT00734604|156586275|FG005|Overall Study|Lost to Follow-up|3|||
48653580|NCT00734604|156586270|FG000|Overall Study|Physician Decision|0|||
48653581|NCT00734604|156586271|FG001|Overall Study|Physician Decision|1|||
48653582|NCT00734604|156586272|FG002|Overall Study|Physician Decision|1|||
48653583|NCT00734604|156586273|FG003|Overall Study|Physician Decision|0|||
48653584|NCT00734604|156586274|FG004|Overall Study|Physician Decision|0|||
48653585|NCT00734604|156586275|FG005|Overall Study|Physician Decision|0|||
48653586|NCT00734604|156586270|FG000|Overall Study|Protocol Violation|0|||
48653587|NCT00734604|156586271|FG001|Overall Study|Protocol Violation|2|||
48653588|NCT00734604|156586272|FG002|Overall Study|Protocol Violation|0|||
48653589|NCT00734604|156586273|FG003|Overall Study|Protocol Violation|0|||
48653590|NCT00734604|156586274|FG004|Overall Study|Protocol Violation|1|||
48653591|NCT00734604|156586275|FG005|Overall Study|Protocol Violation|0|||
48653592|NCT00734604|156586270|FG000|Overall Study|Sponsor Decision|1|||
48653593|NCT00734604|156586271|FG001|Overall Study|Sponsor Decision|2|||
48653594|NCT00734604|156586272|FG002|Overall Study|Sponsor Decision|1|||
48653595|NCT00734604|156586273|FG003|Overall Study|Sponsor Decision|0|||
48653596|NCT00734604|156586274|FG004|Overall Study|Sponsor Decision|2|||
48653597|NCT00734604|156586275|FG005|Overall Study|Sponsor Decision|0|||
48653598|NCT00734604|156586270|FG000|Overall Study|Withdrawal by Subject|0|||
48653599|NCT00734604|156586271|FG001|Overall Study|Withdrawal by Subject|2|||
48653600|NCT00734604|156586272|FG002|Overall Study|Withdrawal by Subject|0|||
48653601|NCT00734604|156586273|FG003|Overall Study|Withdrawal by Subject|1|||
48653602|NCT00734604|156586274|FG004|Overall Study|Withdrawal by Subject|2|||
48653603|NCT00734604|156586275|FG005|Overall Study|Withdrawal by Subject|1|||
48653604|NCT00734604|156586270|FG000|Overall Study|Lack of Efficacy|0|||
48653605|NCT00734604|156586271|FG001|Overall Study|Lack of Efficacy|1|||
48653606|NCT00734604|156586272|FG002|Overall Study|Lack of Efficacy|1|||
48653607|NCT00734604|156586273|FG003|Overall Study|Lack of Efficacy|0|||
48653608|NCT00734604|156586274|FG004|Overall Study|Lack of Efficacy|0|||
48653609|NCT00734604|156586275|FG005|Overall Study|Lack of Efficacy|0|||
48653610|NCT04308239|156586276|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
48653611|NCT04308239|156586277|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
48653612|NCT04308239|156586276|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
48653613|NCT04308239|156586277|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
48653614|NCT04308239|156586276|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
48653615|NCT04308239|156586277|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
48653616|NCT04308239|156586276|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
48653617|NCT04308239|156586277|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
48653618|NCT02141633|156586278|FG000|Overall Study|Physician Decision|1|||
48653619|NCT02141633|156586279|FG001|Overall Study|Physician Decision|0|||
48653620|NCT00176488|156586280|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
48653621|NCT01519791|156586281|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
48653622|NCT01519791|156586282|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
48653623|NCT01519791|156586281|FG000|Overall Study|Protocol Violation|6|||
48653624|NCT01519791|156586282|FG001|Overall Study|Protocol Violation|19|||
48653625|NCT01519791|156586281|FG000|Overall Study|Other Reason|87|||
48653626|NCT01519791|156586282|FG001|Overall Study|Other Reason|222|||
48653627|NCT01519791|156586281|FG000|Overall Study|subjects randomized in error|2|||
48653628|NCT01519791|156586282|FG001|Overall Study|subjects randomized in error|0|||
48653629|NCT01519791|156586281|FG000|Overall Study|Lack of Efficacy|16|||
48653630|NCT01519791|156586282|FG001|Overall Study|Lack of Efficacy|20|||
48653631|NCT01519791|156586281|FG000|Overall Study|SAE, non-fatal|6|||
48653632|NCT01519791|156586282|FG001|Overall Study|SAE, non-fatal|22|||
48653633|NCT01519791|156586281|FG000|Overall Study|AE, serious fatal|0|||
48653634|NCT01519791|156586282|FG001|Overall Study|AE, serious fatal|1|||
48653635|NCT01519791|156586281|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
48653636|NCT01519791|156586282|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
48753752|NCT02625259|156944315|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
48653637|NCT01519791|156586281|FG000|Overall Study|AE, non-serious non-fatal|12|||
48653638|NCT01519791|156586282|FG001|Overall Study|AE, non-serious non-fatal|31|||
48653639|NCT01519791|156586281|FG000|Overall Study|Withdrawal by Subject|15|||
48653640|NCT01519791|156586282|FG001|Overall Study|Withdrawal by Subject|37|||
48653641|NCT01519791|156586281|FG000|Overall Study|Lost to Follow-up|6|||
48653642|NCT01519791|156586282|FG001|Overall Study|Lost to Follow-up|14|||
48653643|NCT01751906|156586285|FG000|Overall Study|Lost to Follow-up|151|||
48653644|NCT01751906|156586286|FG001|Overall Study|Lost to Follow-up|68|||
48653645|NCT01751906|156586285|FG000|Overall Study|Withdrawal by Subject|22|||
48653646|NCT01751906|156586286|FG001|Overall Study|Withdrawal by Subject|18|||
48653647|NCT01751906|156586285|FG000|Overall Study|Physician Decision|5|||
48653648|NCT01751906|156586286|FG001|Overall Study|Physician Decision|2|||
48653649|NCT01751906|156586285|FG000|Overall Study|Death|84|||
48653650|NCT01751906|156586286|FG001|Overall Study|Death|43|||
48653651|NCT01751906|156586285|FG000|Overall Study|Denied on premises for follow-up by law|1|||
48653652|NCT01751906|156586286|FG001|Overall Study|Denied on premises for follow-up by law|0|||
48653653|NCT00328562|156586291|FG000|Overall Study|Disease progression|1|||
48653654|NCT00394251|156586295|FG000|Overall Study|Adverse Event|7|||
48334145|NCT04421456|155420792|FG000|Randomized Treatment Period|Adverse Event|0|||
48334146|NCT04421456|155420793|FG001|Randomized Treatment Period|Adverse Event|1|||
48334147|NCT04421456|155420794|FG002|Randomized Treatment Period|Adverse Event|0|||
48334148|NCT04421456|155420792|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
48334149|NCT04421456|155420793|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
48334150|NCT04421456|155420794|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
48334151|NCT04421456|155420792|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
48334152|NCT04421456|155420793|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
48334153|NCT04421456|155420794|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
48653655|NCT00394251|156586296|FG001|Overall Study|Adverse Event|5|||
48653656|NCT00394251|156586295|FG000|Overall Study|Unacceptable Toxicity|20|||
48653657|NCT00394251|156586296|FG001|Overall Study|Unacceptable Toxicity|18|||
48653658|NCT00394251|156586295|FG000|Overall Study|Physician Decision|1|||
48653659|NCT00394251|156586296|FG001|Overall Study|Physician Decision|1|||
48653660|NCT00394251|156586295|FG000|Overall Study|Protocol Violation|0|||
48653661|NCT00394251|156586296|FG001|Overall Study|Protocol Violation|1|||
48653662|NCT00394251|156586295|FG000|Overall Study|Withdrawal by Subject|7|||
48653663|NCT00394251|156586296|FG001|Overall Study|Withdrawal by Subject|11|||
48653664|NCT00394251|156586295|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
48653665|NCT00394251|156586296|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
48653666|NCT00705250|156586297|FG000|Overall Study|Withdrawal by Subject|1|||
48653667|NCT00705250|156586297|FG000|Overall Study|Patient died in car accident|1|||
48653668|NCT03206970|156586298|FG000|Overall Study|Death|21|||
48653669|NCT03206970|156586298|FG000|Overall Study|Withdrawal by Subject|13|||
48653670|NCT03206970|156586298|FG000|Overall Study|Lost to Follow-up|3|||
48653671|NCT03206970|156586298|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
48334154|NCT04421456|155420792|FG000|Randomized Treatment Period|Participant non-compliance|1|||
48334155|NCT04421456|155420793|FG001|Randomized Treatment Period|Participant non-compliance|1|||
48334156|NCT04421456|155420794|FG002|Randomized Treatment Period|Participant non-compliance|2|||
48334157|NCT04421456|155420792|FG000|Randomized Treatment Period|Other|0|||
48334158|NCT04421456|155420793|FG001|Randomized Treatment Period|Other|1|||
48334159|NCT04421456|155420794|FG002|Randomized Treatment Period|Other|3|||
48653672|NCT01576146|156586303|FG000|Extension Period 1|Adverse Event|2|||
48653673|NCT01576146|156586303|FG000|Extension Period 1|Death|2|||
48653674|NCT01576146|156586303|FG000|Extension Period 1|Physician Decision|2|||
48653675|NCT01576146|156586303|FG000|Extension Period 1|Withdrawal by Subject|1|||
48653676|NCT01576146|156586303|FG000|Extension Period 1|Lost to Follow-up|1|||
48653677|NCT01576146|156586303|FG000|Extension Period 1|Parathyroidectomy|1|||
48653678|NCT01576146|156586303|FG000|Extension Period 1|Renal Transplant|1|||
48653679|NCT01576146|156586303|FG000|Extension Period 2|Sponsor Decision|13|||
48753753|NCT02625259|156944316|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
48653680|NCT01576146|156586303|FG000|Extension Period 2|Death|1|||
48653681|NCT01576146|156586303|FG000|Extension Period 2|Adverse Event|1|||
48653682|NCT01576146|156586303|FG000|Extension Period 2|Renal Transplant|1|||
48653683|NCT01576146|156586303|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
48653684|NCT00413894|156586305|FG000|Overall Study|Withdrawal by Subject|10|||
48653685|NCT00413894|156586305|FG000|Overall Study|Administrative Reasons|1|||
48653686|NCT00413894|156586305|FG000|Overall Study|Hb <10 grams/deciliter|12|||
48653687|NCT00413894|156586305|FG000|Overall Study|Adverse Event|28|||
48653688|NCT00413894|156586305|FG000|Overall Study|Protocol Violation|11|||
48653689|NCT00413894|156586305|FG000|Overall Study|Other|18|||
48753754|NCT00661622|156944317|FG000|Overall Study|Protocol Violation|1|||
48753755|NCT00661622|156944318|FG001|Overall Study|Protocol Violation|0|||
48753756|NCT01905657|156944319|FG000|Overall Study|Adverse Event|23|||
48653690|NCT00316225|156586313|FG000|Overall Study|Adverse Event|2|||
48653691|NCT00316225|156586313|FG000|Overall Study|Physician Decision|3|||
48653692|NCT00316225|156586313|FG000|Overall Study|Progressive Disease|15|||
48653693|NCT00316225|156586313|FG000|Overall Study|Withdrawal by Subject|3|||
48334160|NCT00621842|155420795|FG000|Overall Study|Adverse Event|6|||
48653694|NCT00316225|156586313|FG000|Overall Study|Death|2|||
48653695|NCT01811485|156586314|FG000|Overall Study|Adverse Event|1|||
48653696|NCT01811485|156586315|FG001|Overall Study|Adverse Event|3|||
48753757|NCT01905657|156944320|FG001|Overall Study|Adverse Event|17|||
48653697|NCT01811485|156586316|FG002|Overall Study|Adverse Event|2|||
48653698|NCT01811485|156586314|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48653699|NCT01811485|156586315|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48653700|NCT01811485|156586316|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
48653701|NCT01811485|156586314|FG000|Overall Study|Administrative problems|1|||
48653702|NCT01811485|156586315|FG001|Overall Study|Administrative problems|0|||
48653703|NCT01811485|156586316|FG002|Overall Study|Administrative problems|0|||
48653704|NCT01811485|156586314|FG000|Overall Study|Protocol Deviation|0|||
48653705|NCT01811485|156586315|FG001|Overall Study|Protocol Deviation|1|||
48653706|NCT01811485|156586316|FG002|Overall Study|Protocol Deviation|0|||
48653707|NCT01545934|156586317|FG000|Overall Study|Withdrawal by Subject|4|||
48653708|NCT01545934|156586318|FG001|Overall Study|Withdrawal by Subject|3|||
48653709|NCT01545934|156586317|FG000|Overall Study|Lost to Follow-up|1|||
48653710|NCT01545934|156586318|FG001|Overall Study|Lost to Follow-up|0|||
48653711|NCT03654404|156586319|FG000|Overall Study|Death|1|||
48653712|NCT03654404|156586319|FG000|Overall Study|Lost to Follow-up|2|||
48653713|NCT03654404|156586319|FG000|Overall Study|Withdrawal by Subject|5|||
48653714|NCT03215758|156586327|FG000|Overall Study|Technical Problems|1|||
48653715|NCT03215758|156586328|FG001|Overall Study|Technical Problems|0|||
48653716|NCT03215758|156586327|FG000|Overall Study|Protocol deviation|0|||
48653717|NCT03215758|156586328|FG001|Overall Study|Protocol deviation|1|||
48653718|NCT03215758|156586327|FG000|Overall Study|Physician Decision|0|||
48653719|NCT03215758|156586328|FG001|Overall Study|Physician Decision|1|||
48653720|NCT03215758|156586327|FG000|Overall Study|Death|0|||
48653721|NCT03215758|156586328|FG001|Overall Study|Death|1|||
48653722|NCT03215758|156586327|FG000|Overall Study|Adverse Event|1|||
48653723|NCT03215758|156586328|FG001|Overall Study|Adverse Event|2|||
48653724|NCT03215758|156586327|FG000|Overall Study|Subject/Guardian Decision|3|||
48653725|NCT03215758|156586328|FG001|Overall Study|Subject/Guardian Decision|3|||
48653726|NCT04123093|156586329|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
48653727|NCT04123093|156586330|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
48653728|NCT04123093|156586329|FG000|Phase 2|Physician Decision|0|||
48653729|NCT04123093|156586330|FG001|Phase 2|Physician Decision|1|||
48653730|NCT04123093|156586329|FG000|Phase 2|Withdrawal by Subject|0|||
48653731|NCT04123093|156586330|FG001|Phase 2|Withdrawal by Subject|1|||
48653732|NCT00223808|156586332|FG000|Overall Study|<5 hrs therapy before discharge|3|||
48653733|NCT00223808|156586333|FG001|Overall Study|<5 hrs therapy before discharge|5|||
48653734|NCT00223808|156586334|FG002|Overall Study|<5 hrs therapy before discharge|5|||
48653735|NCT00606034|156586335|FG000|Overall Study|incarceration|1|||
48653736|NCT01205061|156586336|FG000|Overall Study|Adverse Event|4|||
48653737|NCT01205061|156586336|FG000|Overall Study|Withdrawal by Subject|11|||
48653738|NCT01205061|156586336|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
48653739|NCT01205061|156586336|FG000|Overall Study|Lost to Follow-up|9|||
48653740|NCT01205061|156586336|FG000|Overall Study|Other|1|||
48653741|NCT04537208|156586342|FG000|Overall Study|Adverse Event|0|||
48653742|NCT04537208|156586343|FG001|Overall Study|Adverse Event|0|||
48653743|NCT04537208|156586344|FG002|Overall Study|Adverse Event|0|||
48653744|NCT04537208|156586345|FG003|Overall Study|Adverse Event|0|||
48653745|NCT04537208|156586346|FG004|Overall Study|Adverse Event|0|||
48653746|NCT04537208|156586347|FG005|Overall Study|Adverse Event|0|||
48653747|NCT04537208|156586348|FG006|Overall Study|Adverse Event|0|||
48653748|NCT04537208|156586349|FG007|Overall Study|Adverse Event|0|||
48653749|NCT04537208|156586350|FG008|Overall Study|Adverse Event|1|||
48653750|NCT04537208|156586351|FG009|Overall Study|Adverse Event|0|||
48653751|NCT04537208|156586352|FG010|Overall Study|Adverse Event|0|||
48653752|NCT04537208|156586342|FG000|Overall Study|Protocol deviation|0|||
48653753|NCT04537208|156586343|FG001|Overall Study|Protocol deviation|0|||
48653754|NCT04537208|156586344|FG002|Overall Study|Protocol deviation|2|||
48653755|NCT04537208|156586345|FG003|Overall Study|Protocol deviation|0|||
48653756|NCT04537208|156586346|FG004|Overall Study|Protocol deviation|0|||
48653757|NCT04537208|156586347|FG005|Overall Study|Protocol deviation|2|||
48653758|NCT04537208|156586348|FG006|Overall Study|Protocol deviation|4|||
48653759|NCT04537208|156586349|FG007|Overall Study|Protocol deviation|0|||
48653760|NCT04537208|156586350|FG008|Overall Study|Protocol deviation|1|||
48653761|NCT04537208|156586351|FG009|Overall Study|Protocol deviation|0|||
48653762|NCT04537208|156586352|FG010|Overall Study|Protocol deviation|2|||
48653763|NCT04537208|156586342|FG000|Overall Study|Withdrawal by Subject|4|||
48653764|NCT04537208|156586343|FG001|Overall Study|Withdrawal by Subject|2|||
48653765|NCT04537208|156586344|FG002|Overall Study|Withdrawal by Subject|1|||
48653766|NCT04537208|156586345|FG003|Overall Study|Withdrawal by Subject|3|||
48653767|NCT04537208|156586346|FG004|Overall Study|Withdrawal by Subject|5|||
48653768|NCT04537208|156586347|FG005|Overall Study|Withdrawal by Subject|1|||
48653769|NCT04537208|156586348|FG006|Overall Study|Withdrawal by Subject|6|||
48653770|NCT04537208|156586349|FG007|Overall Study|Withdrawal by Subject|1|||
48653771|NCT04537208|156586350|FG008|Overall Study|Withdrawal by Subject|7|||
48334161|NCT00621842|155420795|FG000|Overall Study|Withdrawal by Subject|7|||
48334162|NCT00621842|155420795|FG000|Overall Study|Protocol Violation|4|||
48334163|NCT00621842|155420795|FG000|Overall Study|Lack of Efficacy|2|||
48334164|NCT02206607|155420797|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
48334165|NCT02206607|155420798|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
48334166|NCT02206607|155420799|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
48334167|NCT02206607|155420800|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
48334168|NCT02206607|155420801|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
48334169|NCT02206607|155420797|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
48334170|NCT02206607|155420798|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
48334171|NCT02206607|155420799|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
48334172|NCT02206607|155420800|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
48334173|NCT02206607|155420801|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
48334174|NCT02077374|155420810|FG000|Overall Study|Withdrawal by Subject|0|||
48334175|NCT02077374|155420811|FG001|Overall Study|Withdrawal by Subject|1|||
48334176|NCT02077374|155420810|FG000|Overall Study|Protocol Violation|0|||
48334177|NCT02077374|155420811|FG001|Overall Study|Protocol Violation|1|||
48653772|NCT04537208|156586351|FG009|Overall Study|Withdrawal by Subject|2|||
48653773|NCT04537208|156586352|FG010|Overall Study|Withdrawal by Subject|4|||
48653774|NCT04537208|156586342|FG000|Overall Study|Lost to Follow-up|4|||
48653775|NCT04537208|156586343|FG001|Overall Study|Lost to Follow-up|1|||
48653776|NCT04537208|156586344|FG002|Overall Study|Lost to Follow-up|3|||
48653777|NCT04537208|156586345|FG003|Overall Study|Lost to Follow-up|4|||
48653778|NCT04537208|156586346|FG004|Overall Study|Lost to Follow-up|3|||
48653779|NCT04537208|156586347|FG005|Overall Study|Lost to Follow-up|2|||
48653780|NCT04537208|156586348|FG006|Overall Study|Lost to Follow-up|3|||
48653781|NCT04537208|156586349|FG007|Overall Study|Lost to Follow-up|2|||
48653782|NCT04537208|156586350|FG008|Overall Study|Lost to Follow-up|7|||
48653783|NCT04537208|156586351|FG009|Overall Study|Lost to Follow-up|2|||
48653784|NCT04537208|156586352|FG010|Overall Study|Lost to Follow-up|2|||
48653785|NCT02323126|156586355|FG000|Overall Study|Patient / guardian decision|0|||
48653786|NCT02323126|156586356|FG001|Overall Study|Patient / guardian decision|1|||
48653787|NCT02323126|156586357|FG002|Overall Study|Patient / guardian decision|2|||
48653788|NCT02323126|156586355|FG000|Overall Study|Progressive disease|14|||
48653789|NCT02323126|156586356|FG001|Overall Study|Progressive disease|8|||
48653790|NCT02323126|156586357|FG002|Overall Study|Progressive disease|14|||
48653791|NCT02323126|156586355|FG000|Overall Study|Physician Decision|0|||
48653792|NCT02323126|156586356|FG001|Overall Study|Physician Decision|1|||
48653793|NCT02323126|156586357|FG002|Overall Study|Physician Decision|3|||
48653794|NCT02323126|156586355|FG000|Overall Study|Death|1|||
48653795|NCT02323126|156586356|FG001|Overall Study|Death|1|||
48653796|NCT02323126|156586357|FG002|Overall Study|Death|4|||
48653797|NCT02323126|156586355|FG000|Overall Study|Adverse Event|3|||
48653798|NCT02323126|156586356|FG001|Overall Study|Adverse Event|5|||
48653799|NCT02323126|156586357|FG002|Overall Study|Adverse Event|7|||
48653800|NCT00344318|156586366|FG000|Overall Study|Adverse Event|0|||
48653801|NCT00344318|156586367|FG001|Overall Study|Adverse Event|3|||
48653802|NCT00344318|156586368|FG002|Overall Study|Adverse Event|0|||
48653803|NCT00344318|156586369|FG003|Overall Study|Adverse Event|1|||
48653804|NCT00344318|156586366|FG000|Overall Study|Withdrawal by Subject|2|||
48653805|NCT00344318|156586367|FG001|Overall Study|Withdrawal by Subject|2|||
48653806|NCT00344318|156586368|FG002|Overall Study|Withdrawal by Subject|0|||
48653807|NCT00344318|156586369|FG003|Overall Study|Withdrawal by Subject|2|||
48653808|NCT00344318|156586366|FG000|Overall Study|Lost to Follow-up|2|||
48653809|NCT00344318|156586367|FG001|Overall Study|Lost to Follow-up|0|||
48653810|NCT00344318|156586368|FG002|Overall Study|Lost to Follow-up|1|||
48653811|NCT00344318|156586369|FG003|Overall Study|Lost to Follow-up|0|||
48653812|NCT01208961|156586370|FG000|High-Fat Period III|Protocol Violation|1|||
48653813|NCT01208961|156586371|FG001|High-Fat Period III|Protocol Violation|0|||
48653814|NCT00391430|156586372|FG000|Overall Study|Withdrawal by Subject|3|||
48653815|NCT00391430|156586373|FG001|Overall Study|Withdrawal by Subject|0|||
48653816|NCT00391430|156586374|FG002|Overall Study|Withdrawal by Subject|12|||
48653817|NCT02379988|156586377|FG000|Overall Study|Not eligible|1|||
48653818|NCT05479097|156586388|FG000|Overall Study|Withdrawal by Subject|2|||
48653819|NCT02095873|156586389|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48653820|NCT02095873|156586390|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48653821|NCT02095873|156586389|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
48653822|NCT02095873|156586390|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
48334178|NCT00316121|155420812|FG000|Overall Study|Death|1|||
48334179|NCT00316121|155420813|FG001|Overall Study|Death|0|||
48653823|NCT02095873|156586389|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
48653824|NCT02095873|156586390|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
48653825|NCT00211757|156586394|FG000|Overall Study|Withdrawal by Subject|1|||
48653826|NCT00211757|156586395|FG001|Overall Study|Withdrawal by Subject|1|||
48653827|NCT00211757|156586394|FG000|Overall Study|Lack of Efficacy|0|||
48653828|NCT00211757|156586395|FG001|Overall Study|Lack of Efficacy|1|||
48653829|NCT00322452|156586396|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48753758|NCT01905657|156944321|FG002|Overall Study|Adverse Event|18|||
48753759|NCT01905657|156944319|FG000|Overall Study|Clinical Progression|103|||
48653830|NCT00322452|156586397|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48653831|NCT00322452|156586396|FG000|Overall Study|Lost to Follow-up|5|||
48653832|NCT00322452|156586397|FG001|Overall Study|Lost to Follow-up|2|||
48653833|NCT00322452|156586396|FG000|Overall Study|Withdrawal by Subject|19|||
48753760|NCT01905657|156944320|FG001|Overall Study|Clinical Progression|78|||
48753761|NCT01905657|156944321|FG002|Overall Study|Clinical Progression|59|||
48753762|NCT01905657|156944319|FG000|Overall Study|Death|40|||
48753763|NCT01905657|156944320|FG001|Overall Study|Death|43|||
48753764|NCT01905657|156944321|FG002|Overall Study|Death|47|||
48753765|NCT01905657|156944319|FG000|Overall Study|Excluded Medication|13|||
48753766|NCT01905657|156944320|FG001|Overall Study|Excluded Medication|16|||
48334180|NCT00316121|155420812|FG000|Overall Study|Lost to Follow-up|14|||
48334181|NCT00316121|155420813|FG001|Overall Study|Lost to Follow-up|8|||
48334182|NCT00316121|155420812|FG000|Overall Study|Withdrawal by Subject|2|||
48334183|NCT00316121|155420813|FG001|Overall Study|Withdrawal by Subject|0|||
48334184|NCT00316121|155420812|FG000|Overall Study|Reason is missing|1|||
48334185|NCT00316121|155420813|FG001|Overall Study|Reason is missing|0|||
48334186|NCT00316121|155420812|FG000|Overall Study|Subject relocated|1|||
48334187|NCT00316121|155420813|FG001|Overall Study|Subject relocated|1|||
48334188|NCT00316121|155420812|FG000|Overall Study|Subject refused to return|1|||
48334189|NCT00316121|155420813|FG001|Overall Study|Subject refused to return|0|||
48334190|NCT00316121|155420812|FG000|Overall Study|Subject no show for visit x 3|1|||
48334191|NCT00316121|155420813|FG001|Overall Study|Subject no show for visit x 3|0|||
48334192|NCT00316121|155420812|FG000|Overall Study|Subject did not have 24 month visit|1|||
48334193|NCT00316121|155420813|FG001|Overall Study|Subject did not have 24 month visit|0|||
48653834|NCT00322452|156586397|FG001|Overall Study|Withdrawal by Subject|46|||
48653835|NCT00322452|156586396|FG000|Overall Study|Death|223|||
48653836|NCT00322452|156586397|FG001|Overall Study|Death|227|||
48653837|NCT00526656|156586398|FG000|Overall Study|Death|1|||
48653838|NCT00526656|156586398|FG000|Overall Study|Refused surgery|1|||
48653839|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Death|5|||
48653840|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Death|0|||
48653841|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Death|0|||
48653842|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
48653843|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
48653844|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
48653845|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
48653846|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
48653847|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
48653848|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
48653849|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
48653850|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
48653851|NCT01357161|156586401|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
48653852|NCT01357161|156586402|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
48653853|NCT01357161|156586403|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
48334194|NCT03989232|155420816|FG000|Overall Study|Lost to Follow-up|3|||
48334195|NCT03989232|155420817|FG001|Overall Study|Lost to Follow-up|10|||
48334196|NCT03989232|155420816|FG000|Overall Study|Withdrawal by Subject|6|||
48334197|NCT03989232|155420817|FG001|Overall Study|Withdrawal by Subject|6|||
48334198|NCT03989232|155420816|FG000|Overall Study|Death|1|||
48334199|NCT03989232|155420817|FG001|Overall Study|Death|2|||
48334200|NCT01989156|155420823|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
48334201|NCT01989156|155420824|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
48334202|NCT01989156|155420825|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
48334203|NCT01989156|155420823|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
48334204|NCT01989156|155420824|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
48334205|NCT01989156|155420825|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
48334206|NCT01989156|155420823|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
48334207|NCT01989156|155420824|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
48653854|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
48653855|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
48653856|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
48334208|NCT01989156|155420825|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
48334209|NCT01989156|155420823|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
48334210|NCT01989156|155420824|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
48334211|NCT01989156|155420825|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
48653857|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
48653858|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
48753767|NCT01905657|156944321|FG002|Overall Study|Excluded Medication|9|||
48753768|NCT01905657|156944319|FG000|Overall Study|Lost to Follow-up|1|||
48753769|NCT01905657|156944320|FG001|Overall Study|Lost to Follow-up|2|||
48334212|NCT01989156|155420823|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
48334213|NCT01989156|155420824|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
48334214|NCT01989156|155420825|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
48334215|NCT01989156|155420823|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
48334216|NCT01989156|155420824|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
48334217|NCT01989156|155420825|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
48334218|NCT01989156|155420823|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
48334219|NCT01989156|155420824|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
48334220|NCT01989156|155420825|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
48334221|NCT01989156|155420823|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
48334222|NCT01989156|155420824|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
48334223|NCT01989156|155420825|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
48334224|NCT00742560|155420827|FG000|Overall Study|Adverse Event|0|||
48334225|NCT00742560|155420828|FG001|Overall Study|Adverse Event|0|||
48334226|NCT00742560|155420829|FG002|Overall Study|Adverse Event|1|||
48334227|NCT00742560|155420830|FG003|Overall Study|Adverse Event|1|||
48334228|NCT00742560|155420831|FG004|Overall Study|Adverse Event|1|||
48334229|NCT00742560|155420827|FG000|Overall Study|Death|0|||
48334230|NCT00742560|155420828|FG001|Overall Study|Death|2|||
48334231|NCT00742560|155420829|FG002|Overall Study|Death|0|||
48753770|NCT01905657|156944321|FG002|Overall Study|Lost to Follow-up|1|||
48753771|NCT01905657|156944319|FG000|Overall Study|Physician Decision|5|||
48753772|NCT01905657|156944320|FG001|Overall Study|Physician Decision|8|||
48334232|NCT00742560|155420830|FG003|Overall Study|Death|2|||
48334233|NCT00742560|155420831|FG004|Overall Study|Death|3|||
48334234|NCT00742560|155420827|FG000|Overall Study|Subject's Decision|1|||
48334235|NCT00742560|155420828|FG001|Overall Study|Subject's Decision|0|||
48334236|NCT00742560|155420829|FG002|Overall Study|Subject's Decision|2|||
48334237|NCT00742560|155420830|FG003|Overall Study|Subject's Decision|3|||
48334238|NCT00742560|155420831|FG004|Overall Study|Subject's Decision|3|||
48334239|NCT00742560|155420827|FG000|Overall Study|Investigator's Decision|0|||
48334240|NCT00742560|155420828|FG001|Overall Study|Investigator's Decision|0|||
48334241|NCT00742560|155420829|FG002|Overall Study|Investigator's Decision|4|||
48334242|NCT00742560|155420830|FG003|Overall Study|Investigator's Decision|1|||
48334243|NCT00742560|155420831|FG004|Overall Study|Investigator's Decision|0|||
48334244|NCT00742560|155420827|FG000|Overall Study|Disease Progression|1|||
48334245|NCT00742560|155420828|FG001|Overall Study|Disease Progression|0|||
48334246|NCT00742560|155420829|FG002|Overall Study|Disease Progression|5|||
48334247|NCT00742560|155420830|FG003|Overall Study|Disease Progression|17|||
48334248|NCT00742560|155420831|FG004|Overall Study|Disease Progression|16|||
48334249|NCT00742560|155420827|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
48334250|NCT00742560|155420828|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
48334251|NCT00742560|155420829|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
48334252|NCT00742560|155420830|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
48334253|NCT00742560|155420831|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
48334254|NCT00742560|155420827|FG000|Overall Study|Other|0|||
48334255|NCT00742560|155420828|FG001|Overall Study|Other|1|||
48334256|NCT00742560|155420829|FG002|Overall Study|Other|8|||
48334257|NCT00742560|155420830|FG003|Overall Study|Other|9|||
48653859|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
48653860|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
48653861|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
48653862|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
48653863|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
48653864|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
48653865|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
48653866|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
48653867|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
48653868|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
48653869|NCT01357161|156586401|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
48653870|NCT01357161|156586402|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
48653871|NCT01357161|156586403|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
48653872|NCT02910401|156586404|FG000|Overall Study|Study closure Study closure|0|||
48653873|NCT02910401|156586405|FG001|Overall Study|Study closure Study closure|0|||
48653874|NCT02910401|156586406|FG002|Overall Study|Study closure Study closure|2|||
48334258|NCT00742560|155420831|FG004|Overall Study|Other|9|||
48334259|NCT00742560|155420827|FG000|Overall Study|MIssing|0|||
48334260|NCT00742560|155420828|FG001|Overall Study|MIssing|0|||
48334261|NCT00742560|155420829|FG002|Overall Study|MIssing|0|||
48334262|NCT00742560|155420830|FG003|Overall Study|MIssing|0|||
48334263|NCT00742560|155420831|FG004|Overall Study|MIssing|1|||
48653875|NCT02910401|156586404|FG000|Overall Study|Physician Decision|1|||
48653876|NCT02910401|156586405|FG001|Overall Study|Physician Decision|0|||
48753773|NCT01905657|156944321|FG002|Overall Study|Physician Decision|12|||
48753774|NCT01905657|156944319|FG000|Overall Study|Protocol Violation|2|||
48334264|NCT00658632|155420832|FG000|Overall Study|Adverse Event|13|||
48653877|NCT02910401|156586406|FG002|Overall Study|Physician Decision|0|||
48653878|NCT03300024|156586409|FG000|Overall Study|Physician Decision|4|||
48653879|NCT03300024|156586410|FG001|Overall Study|Physician Decision|6|||
48653880|NCT04065074|156586411|FG000|Overall Study|Adverse Event|1|||
48653881|NCT04065074|156586411|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
48753775|NCT01905657|156944320|FG001|Overall Study|Protocol Violation|1|||
48753776|NCT01905657|156944321|FG002|Overall Study|Protocol Violation|1|||
48653882|NCT01331837|156586412|FG000|Overall Study|Death|30|||
48653883|NCT01331837|156586413|FG001|Overall Study|Death|34|||
48653884|NCT01331837|156586412|FG000|Overall Study|Lost to Follow-up|3|||
48653885|NCT01331837|156586413|FG001|Overall Study|Lost to Follow-up|1|||
48653886|NCT01331837|156586412|FG000|Overall Study|Info not recorded|10|||
48653887|NCT01331837|156586413|FG001|Overall Study|Info not recorded|16|||
48653888|NCT01331837|156586412|FG000|Overall Study|Withdrawal by Subject|13|||
48653889|NCT01331837|156586413|FG001|Overall Study|Withdrawal by Subject|16|||
48653890|NCT00283803|156588051|FG000|Overall Study|Physician Decision|9|||
48653891|NCT00283803|156588051|FG000|Overall Study|Withdrawal by Subject|4|||
48653892|NCT01127607|156588052|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
48653893|NCT01127607|156588053|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
48653894|NCT01127607|156588052|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
48653895|NCT01127607|156588053|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
48653896|NCT03419897|156588054|FG000|Overall Study|Death|180|||
48653897|NCT03419897|156588054|FG000|Overall Study|Lost to Follow-up|1|||
48653898|NCT03419897|156588054|FG000|Overall Study|Withdrawal by Subject|6|||
48653899|NCT03419897|156588054|FG000|Overall Study|Sponsor Decision|61|||
48653900|NCT03419897|156588054|FG000|Overall Study|Physician Decision|1|||
48653901|NCT03062280|156588058|FG000|Overall Study|Adverse Event|1|||
48653902|NCT03062280|156588058|FG000|Overall Study|Death|1|||
48653903|NCT03062280|156588058|FG000|Overall Study|Fertility Treatment|2|||
48653904|NCT03062280|156588058|FG000|Overall Study|Physician Decision|2|||
48653905|NCT03062280|156588058|FG000|Overall Study|Pregnancy|5|||
48653906|NCT03062280|156588058|FG000|Overall Study|Withdrawal by Subject|11|||
48653907|NCT02003638|156588061|FG000|Overall Study|Withdrawal by Subject|1|||
48653908|NCT02003638|156588062|FG001|Overall Study|Withdrawal by Subject|0|||
48653909|NCT01289353|156588065|FG000|Overall Study|Lost to Follow-up|2|||
48653910|NCT02301546|156588068|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
48653911|NCT02301546|156588069|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
48653912|NCT02301546|156588068|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
48653913|NCT02301546|156588069|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
48753777|NCT01905657|156944319|FG000|Overall Study|Screen Failure|0|||
48753778|NCT01905657|156944320|FG001|Overall Study|Screen Failure|1|||
48753779|NCT01905657|156944321|FG002|Overall Study|Screen Failure|0|||
48753780|NCT01905657|156944319|FG000|Overall Study|Withdrawal by Subject|15|||
48753781|NCT01905657|156944320|FG001|Overall Study|Withdrawal by Subject|21|||
48753782|NCT01905657|156944321|FG002|Overall Study|Withdrawal by Subject|53|||
48753783|NCT01905657|156944319|FG000|Overall Study|Sponsor Decision|1|||
48753784|NCT01905657|156944320|FG001|Overall Study|Sponsor Decision|0|||
48753785|NCT01905657|156944321|FG002|Overall Study|Sponsor Decision|0|||
48753786|NCT04080297|156944322|FG000|Overall Study|Adverse Event|1|||
48753787|NCT04080297|156944323|FG001|Overall Study|Adverse Event|3|||
48753788|NCT04080297|156944322|FG000|Overall Study|concurrent illness|1|||
48334265|NCT00658632|155420833|FG001|Overall Study|Adverse Event|11|||
48334266|NCT00658632|155420832|FG000|Overall Study|Lost to Follow-up|25|||
48334267|NCT00658632|155420833|FG001|Overall Study|Lost to Follow-up|23|||
48334268|NCT00658632|155420832|FG000|Overall Study|Withdrawal by Subject|10|||
48334269|NCT00658632|155420833|FG001|Overall Study|Withdrawal by Subject|7|||
48334270|NCT00658632|155420832|FG000|Overall Study|Lack of Efficacy|0|||
48334271|NCT00658632|155420833|FG001|Overall Study|Lack of Efficacy|1|||
48334272|NCT00658632|155420832|FG000|Overall Study|Withdrawal of consent|8|||
48334273|NCT00658632|155420833|FG001|Overall Study|Withdrawal of consent|14|||
48334274|NCT00658632|155420832|FG000|Overall Study|Pregnancy|1|||
48653914|NCT02301546|156588068|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
48653915|NCT02301546|156588069|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
48653916|NCT02301546|156588068|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
48653917|NCT02301546|156588069|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
48653918|NCT02301546|156588068|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
48653919|NCT02301546|156588069|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
48653920|NCT02301546|156588068|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
48653921|NCT02301546|156588069|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
48653922|NCT02301546|156588068|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
48753789|NCT04080297|156944323|FG001|Overall Study|concurrent illness|0|||
48753790|NCT03915496|156944324|FG000|Overall Study|Adverse Event|2|||
48753791|NCT03915496|156944325|FG001|Overall Study|Adverse Event|1|||
48753792|NCT03915496|156944326|FG002|Overall Study|Adverse Event|2|||
48334275|NCT00658632|155420833|FG001|Overall Study|Pregnancy|1|||
48334276|NCT00658632|155420832|FG000|Overall Study|Other|7|||
48753793|NCT02663674|156944327|FG000|Overall Study|Lost to Follow-up|5|||
48653923|NCT02301546|156588069|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
48653924|NCT00433966|156588070|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
48653925|NCT00433966|156588071|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
48653926|NCT00433966|156588072|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
48653927|NCT00433966|156588073|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
48653928|NCT00433966|156588070|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
48653929|NCT00433966|156588071|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
48653930|NCT00433966|156588072|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
48653931|NCT00433966|156588073|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
48653932|NCT00433966|156588070|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
48653933|NCT00433966|156588071|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
48653934|NCT00433966|156588072|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
48653935|NCT00433966|156588073|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
48653936|NCT00433966|156588070|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
48653937|NCT00433966|156588071|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
48653938|NCT00433966|156588072|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
48653939|NCT00433966|156588073|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
48653940|NCT00433966|156588070|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
48653941|NCT00433966|156588071|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
48653942|NCT00433966|156588072|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
48653943|NCT00433966|156588073|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
48653944|NCT00853242|156588074|FG000|Overall Study|Adverse Event|0|||
48653945|NCT00853242|156588075|FG001|Overall Study|Adverse Event|1|||
48653946|NCT00853242|156588076|FG002|Overall Study|Adverse Event|1|||
48653947|NCT00853242|156588077|FG003|Overall Study|Adverse Event|0|||
48653948|NCT00853242|156588078|FG004|Overall Study|Adverse Event|3|||
48653949|NCT00853242|156588079|FG005|Overall Study|Adverse Event|1|||
48653950|NCT00853242|156588080|FG006|Overall Study|Adverse Event|1|||
48653951|NCT00853242|156588074|FG000|Overall Study|Noncompliant|0|||
48653952|NCT00853242|156588075|FG001|Overall Study|Noncompliant|0|||
48653953|NCT00853242|156588076|FG002|Overall Study|Noncompliant|0|||
48653954|NCT00853242|156588077|FG003|Overall Study|Noncompliant|0|||
48653955|NCT00853242|156588078|FG004|Overall Study|Noncompliant|1|||
48653956|NCT00853242|156588079|FG005|Overall Study|Noncompliant|0|||
48653957|NCT00853242|156588080|FG006|Overall Study|Noncompliant|0|||
48653958|NCT00853242|156588074|FG000|Overall Study|Withdrawal by Subject|1|||
48653959|NCT00853242|156588075|FG001|Overall Study|Withdrawal by Subject|2|||
48653960|NCT00853242|156588076|FG002|Overall Study|Withdrawal by Subject|0|||
48653961|NCT00853242|156588077|FG003|Overall Study|Withdrawal by Subject|4|||
48653962|NCT00853242|156588078|FG004|Overall Study|Withdrawal by Subject|0|||
48653963|NCT00853242|156588079|FG005|Overall Study|Withdrawal by Subject|0|||
48653964|NCT00853242|156588080|FG006|Overall Study|Withdrawal by Subject|2|||
48653965|NCT00853242|156588074|FG000|Overall Study|Other|2|||
48653966|NCT00853242|156588075|FG001|Overall Study|Other|0|||
48653967|NCT00853242|156588076|FG002|Overall Study|Other|2|||
48653968|NCT00853242|156588077|FG003|Overall Study|Other|0|||
48653969|NCT00853242|156588078|FG004|Overall Study|Other|0|||
48653970|NCT00853242|156588079|FG005|Overall Study|Other|1|||
48653971|NCT00853242|156588080|FG006|Overall Study|Other|2|||
48653972|NCT00441142|156588081|FG000|Overall Study|Adverse Event|2|||
48653973|NCT00441142|156588082|FG001|Overall Study|Adverse Event|3|||
48653974|NCT00441142|156588083|FG002|Overall Study|Adverse Event|3|||
48653975|NCT00441142|156588084|FG003|Overall Study|Adverse Event|22|||
48653976|NCT00441142|156588081|FG000|Overall Study|Lack of Efficacy|3|||
48653977|NCT00441142|156588082|FG001|Overall Study|Lack of Efficacy|3|||
48653978|NCT00441142|156588083|FG002|Overall Study|Lack of Efficacy|17|||
48653979|NCT00441142|156588084|FG003|Overall Study|Lack of Efficacy|32|||
48653980|NCT00441142|156588081|FG000|Overall Study|Withdrawal by Subject|0|||
48653981|NCT00441142|156588082|FG001|Overall Study|Withdrawal by Subject|0|||
48653982|NCT00441142|156588083|FG002|Overall Study|Withdrawal by Subject|2|||
48653983|NCT00441142|156588084|FG003|Overall Study|Withdrawal by Subject|10|||
48653984|NCT00441142|156588081|FG000|Overall Study|Patient still receiving active study tx|1|||
48653985|NCT00441142|156588082|FG001|Overall Study|Patient still receiving active study tx|0|||
48653986|NCT00441142|156588083|FG002|Overall Study|Patient still receiving active study tx|0|||
48653987|NCT00441142|156588084|FG003|Overall Study|Patient still receiving active study tx|2|||
48653988|NCT00441142|156588081|FG000|Overall Study|Physician Decision|0|||
48653989|NCT00441142|156588082|FG001|Overall Study|Physician Decision|1|||
48653990|NCT00441142|156588083|FG002|Overall Study|Physician Decision|0|||
48653991|NCT00441142|156588084|FG003|Overall Study|Physician Decision|1|||
48653992|NCT00441142|156588081|FG000|Overall Study|Death|0|||
48653993|NCT00441142|156588082|FG001|Overall Study|Death|0|||
48653994|NCT00441142|156588083|FG002|Overall Study|Death|0|||
48653995|NCT00441142|156588084|FG003|Overall Study|Death|1|||
48653996|NCT00338286|156588085|FG000|Overall Study|Withdrawal by Subject|50|||
48653997|NCT00338286|156588086|FG001|Overall Study|Withdrawal by Subject|54|||
48653998|NCT00338286|156588085|FG000|Overall Study|Lost to Follow-up|80|||
48653999|NCT00338286|156588086|FG001|Overall Study|Lost to Follow-up|66|||
48654000|NCT00338286|156588085|FG000|Overall Study|Other|103|||
48334277|NCT00658632|155420833|FG001|Overall Study|Other|8|||
48334278|NCT00237809|155420834|FG000|Overall Study|Lost to Follow-up|11|||
48334279|NCT00237809|155420835|FG001|Overall Study|Lost to Follow-up|10|||
48654001|NCT00338286|156588086|FG001|Overall Study|Other|93|||
48654002|NCT00716482|156588087|FG000|Overall Study|Lost to Follow-up|6|||
48654003|NCT00716482|156588087|FG000|Overall Study|Inadequate acquisition or analysis|50|||
48654004|NCT00716482|156588087|FG000|Overall Study|no pathology obtained|10|||
48654005|NCT00716482|156588087|FG000|Overall Study|technical/machine error|28|||
48654006|NCT00716482|156588087|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
48654007|NCT05286658|156588089|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
48654008|NCT05286658|156588089|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
48654009|NCT00632827|156588090|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
48654010|NCT00632827|156588090|FG000|Overall Study|Death|2|||
48654011|NCT00632827|156588090|FG000|Overall Study|Adverse Event|5|||
48654012|NCT00632827|156588090|FG000|Overall Study|Lost to Follow-up|1|||
48654013|NCT01126437|156588093|FG000|Overall Study|Not treated|11|||
48334280|NCT00237809|155420836|FG002|Overall Study|Lost to Follow-up|9|||
48334281|NCT00237809|155420837|FG003|Overall Study|Lost to Follow-up|9|||
48334282|NCT02132195|155420838|FG000|Initial Assignment|Relapsed|14|||
48334283|NCT02132195|155420839|FG001|Initial Assignment|Relapsed|0|||
48654014|NCT01126437|156588094|FG001|Overall Study|Not treated|18|||
48654015|NCT01126437|156588095|FG002|Overall Study|Not treated|19|||
48654016|NCT01126437|156588093|FG000|Overall Study|Sites with data irregularities/fraud|6|||
48654017|NCT01126437|156588094|FG001|Overall Study|Sites with data irregularities/fraud|6|||
48654018|NCT01126437|156588095|FG002|Overall Study|Sites with data irregularities/fraud|7|||
48654019|NCT01126437|156588093|FG000|Overall Study|Adverse Event|602|||
48654020|NCT01126437|156588094|FG001|Overall Study|Adverse Event|606|||
48654021|NCT01126437|156588095|FG002|Overall Study|Adverse Event|635|||
48654022|NCT01126437|156588093|FG000|Overall Study|Lack of Efficacy|65|||
48654023|NCT01126437|156588094|FG001|Overall Study|Lack of Efficacy|60|||
48654024|NCT01126437|156588095|FG002|Overall Study|Lack of Efficacy|59|||
48654025|NCT01126437|156588093|FG000|Overall Study|Protocol Violation|64|||
48654026|NCT01126437|156588094|FG001|Overall Study|Protocol Violation|66|||
48654027|NCT01126437|156588095|FG002|Overall Study|Protocol Violation|41|||
48654028|NCT01126437|156588093|FG000|Overall Study|Lost to Follow-up|52|||
48654029|NCT01126437|156588094|FG001|Overall Study|Lost to Follow-up|63|||
48654030|NCT01126437|156588095|FG002|Overall Study|Lost to Follow-up|55|||
48654031|NCT01126437|156588093|FG000|Overall Study|Withdrawal by Subject|331|||
48654032|NCT01126437|156588094|FG001|Overall Study|Withdrawal by Subject|335|||
48654033|NCT01126437|156588095|FG002|Overall Study|Withdrawal by Subject|319|||
48654034|NCT01126437|156588093|FG000|Overall Study|Other reason not specified|210|||
48654035|NCT01126437|156588094|FG001|Overall Study|Other reason not specified|176|||
48654036|NCT01126437|156588095|FG002|Overall Study|Other reason not specified|178|||
48654037|NCT02256384|156588098|FG000|Overall Study|Withdrawal by Subject|12|||
48654038|NCT02256384|156588098|FG000|Overall Study|Equipment not capturing data|2|||
48654039|NCT00842153|156588108|FG000|Overall Study|Adverse Event|0|||
48654040|NCT00842153|156588109|FG001|Overall Study|Adverse Event|1|||
48654041|NCT00842153|156588108|FG000|Overall Study|Lost to Follow-up|1|||
48654042|NCT00842153|156588109|FG001|Overall Study|Lost to Follow-up|2|||
48334284|NCT02132195|155420840|FG002|Initial Assignment|Relapsed|0|||
48334285|NCT02132195|155420838|FG000|Rescue Therapy|Relapsed|0|||
48334286|NCT02132195|155420839|FG001|Rescue Therapy|Relapsed|0|||
48334287|NCT02132195|155420840|FG002|Rescue Therapy|Relapsed|7|||
48334288|NCT02132195|155420838|FG000|Rescue Therapy|Physician Decision|0|||
48654043|NCT01071252|156588112|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
48334289|NCT02132195|155420839|FG001|Rescue Therapy|Physician Decision|0|||
48334290|NCT02132195|155420840|FG002|Rescue Therapy|Physician Decision|1|||
48334291|NCT02132195|155420838|FG000|Rescue Therapy|Withdrawal by Subject|0|||
48334292|NCT02132195|155420839|FG001|Rescue Therapy|Withdrawal by Subject|0|||
48654044|NCT01071252|156588113|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
48334293|NCT02132195|155420840|FG002|Rescue Therapy|Withdrawal by Subject|1|||
48654045|NCT01071252|156588114|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
48654046|NCT01071252|156588115|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
48654047|NCT01071252|156588116|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
48654048|NCT01071252|156588112|FG000|Overall Study|Withdrawal by Subject|8|||
48654049|NCT01071252|156588113|FG001|Overall Study|Withdrawal by Subject|2|||
48753794|NCT02663674|156944328|FG001|Overall Study|Lost to Follow-up|4|||
48654050|NCT01071252|156588114|FG002|Overall Study|Withdrawal by Subject|1|||
48753795|NCT02663674|156944327|FG000|Overall Study|Withdrawal by Subject|1|||
48654051|NCT01071252|156588115|FG003|Overall Study|Withdrawal by Subject|2|||
48753796|NCT02663674|156944328|FG001|Overall Study|Withdrawal by Subject|4|||
48334294|NCT02132195|155420838|FG000|Rescue Therapy|Adverse Event|0|||
48654052|NCT01071252|156588116|FG004|Overall Study|Withdrawal by Subject|3|||
48654053|NCT01071252|156588112|FG000|Overall Study|administrative problems|1|||
48654054|NCT01071252|156588113|FG001|Overall Study|administrative problems|1|||
48654055|NCT01071252|156588114|FG002|Overall Study|administrative problems|0|||
48654056|NCT01071252|156588115|FG003|Overall Study|administrative problems|2|||
48654057|NCT01071252|156588116|FG004|Overall Study|administrative problems|1|||
48654058|NCT01071252|156588112|FG000|Overall Study|Lost to Follow-up|1|||
48654059|NCT01071252|156588113|FG001|Overall Study|Lost to Follow-up|0|||
48654060|NCT01071252|156588114|FG002|Overall Study|Lost to Follow-up|1|||
48654061|NCT01071252|156588115|FG003|Overall Study|Lost to Follow-up|2|||
48654062|NCT01071252|156588116|FG004|Overall Study|Lost to Follow-up|0|||
48654063|NCT01071252|156588112|FG000|Overall Study|Adverse Event|1|||
48654064|NCT01071252|156588113|FG001|Overall Study|Adverse Event|1|||
48654065|NCT01071252|156588114|FG002|Overall Study|Adverse Event|0|||
48654066|NCT01071252|156588115|FG003|Overall Study|Adverse Event|1|||
48654067|NCT01071252|156588116|FG004|Overall Study|Adverse Event|0|||
48654068|NCT01071252|156588112|FG000|Overall Study|Death|0|||
48654069|NCT01071252|156588113|FG001|Overall Study|Death|0|||
48654070|NCT01071252|156588114|FG002|Overall Study|Death|0|||
48654071|NCT01071252|156588115|FG003|Overall Study|Death|0|||
48654072|NCT01071252|156588116|FG004|Overall Study|Death|1|||
48654073|NCT00712725|156588121|FG000|Overall Study|Adverse Event|1|||
48654074|NCT00712725|156588122|FG001|Overall Study|Adverse Event|0|||
48654075|NCT00712725|156588123|FG002|Overall Study|Adverse Event|0|||
48654076|NCT00712725|156588124|FG003|Overall Study|Adverse Event|1|||
48753797|NCT02663674|156944327|FG000|Overall Study|Physician Decision|1|||
48753798|NCT02663674|156944328|FG001|Overall Study|Physician Decision|1|||
48753799|NCT02663674|156944327|FG000|Overall Study|Other Event (Health Related)|0|||
48334295|NCT02132195|155420839|FG001|Rescue Therapy|Adverse Event|0|||
48334296|NCT02132195|155420840|FG002|Rescue Therapy|Adverse Event|2|||
48334297|NCT02058992|155420841|FG000|Overall Study|Lost to Follow-up|4|||
48753800|NCT02663674|156944328|FG001|Overall Study|Other Event (Health Related)|1|||
48334298|NCT02058992|155420841|FG000|Overall Study|Protocol Violation|92|||
48334299|NCT02058992|155420841|FG000|Overall Study|CRF Uncollected|20|||
48334300|NCT03503188|155420842|FG000|Overall Study|Non eligible in the sub study|0|||
48334301|NCT03503188|155420843|FG001|Overall Study|Non eligible in the sub study|1|||
48334302|NCT01287832|155420844|FG000|Overall Study|Adverse Event|1|||
48334303|NCT01287832|155420845|FG001|Overall Study|Adverse Event|0|||
48334304|NCT01287832|155420844|FG000|Overall Study|Death|0|||
48334305|NCT01287832|155420845|FG001|Overall Study|Death|1|||
48334306|NCT00818519|155420846|FG000|Overall Study|Adverse Event|2|||
48334307|NCT00818519|155420847|FG001|Overall Study|Adverse Event|2|||
48334308|NCT00818519|155420846|FG000|Overall Study|Lost to Follow-up|4|||
48334309|NCT00818519|155420847|FG001|Overall Study|Lost to Follow-up|6|||
48334310|NCT00818519|155420846|FG000|Overall Study|Protocol Violation|2|||
48334311|NCT00818519|155420847|FG001|Overall Study|Protocol Violation|1|||
48334312|NCT00818519|155420846|FG000|Overall Study|Pregnancy|0|||
48334313|NCT00818519|155420847|FG001|Overall Study|Pregnancy|1|||
48334314|NCT00818519|155420846|FG000|Overall Study|Withdrawal by Subject|4|||
48334315|NCT00818519|155420847|FG001|Overall Study|Withdrawal by Subject|9|||
48753801|NCT00512707|156944329|FG000|Overall Study|Lost to Follow-up|5|||
48753802|NCT00512707|156944330|FG001|Overall Study|Lost to Follow-up|11|||
48753803|NCT00512707|156944329|FG000|Overall Study|Developed skin irritation|2|||
48753804|NCT00512707|156944330|FG001|Overall Study|Developed skin irritation|1|||
48753805|NCT00512707|156944329|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
48753806|NCT00512707|156944330|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
48753807|NCT00512707|156944329|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
48753808|NCT00512707|156944330|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
48753809|NCT00848081|156946528|FG000|Overall Study|Adverse Event|6|||
48753810|NCT00848081|156946529|FG001|Overall Study|Adverse Event|7|||
48753811|NCT00848081|156946528|FG000|Overall Study|Protocol Violation|8|||
48753812|NCT00848081|156946529|FG001|Overall Study|Protocol Violation|5|||
48334316|NCT00818519|155420846|FG000|Overall Study|participant recovered completely|1|||
48334317|NCT00818519|155420847|FG001|Overall Study|participant recovered completely|0|||
48753813|NCT00848081|156946528|FG000|Overall Study|Lost to Follow-up|1|||
48753814|NCT00848081|156946529|FG001|Overall Study|Lost to Follow-up|0|||
48753815|NCT00848081|156946528|FG000|Overall Study|Physician Decision|0|||
48753816|NCT00848081|156946529|FG001|Overall Study|Physician Decision|3|||
48753817|NCT00848081|156946528|FG000|Overall Study|Withdrawal by Subject|5|||
48334318|NCT00818519|155420846|FG000|Overall Study|participant will leave for long tme|1|||
48334319|NCT00818519|155420847|FG001|Overall Study|participant will leave for long tme|0|||
48334320|NCT01755598|155420848|FG000|Overall Study|Other|109|||
48334321|NCT01755598|155420849|FG001|Overall Study|Other|109|||
48654077|NCT00712725|156588125|FG004|Overall Study|Adverse Event|0|||
48654078|NCT00712725|156588126|FG005|Overall Study|Adverse Event|0|||
48654079|NCT00712725|156588127|FG006|Overall Study|Adverse Event|0|||
48654080|NCT00712725|156588128|FG007|Overall Study|Adverse Event|0|||
48654081|NCT00712725|156588121|FG000|Overall Study|Lost to Follow-up|3|||
48753818|NCT00848081|156946529|FG001|Overall Study|Withdrawal by Subject|3|||
48334322|NCT01755598|155420848|FG000|Overall Study|Lost to Follow-up|32|||
48334323|NCT01755598|155420849|FG001|Overall Study|Lost to Follow-up|43|||
48334324|NCT01755598|155420848|FG000|Overall Study|Migrated/moved from study area|76|||
48334325|NCT01755598|155420849|FG001|Overall Study|Migrated/moved from study area|65|||
48334326|NCT01755598|155420848|FG000|Overall Study|Withdrawal by Subject|22|||
48334327|NCT01755598|155420849|FG001|Overall Study|Withdrawal by Subject|31|||
48334328|NCT01755598|155420848|FG000|Overall Study|Protocol Violation|7|||
48334329|NCT01755598|155420849|FG001|Overall Study|Protocol Violation|7|||
48334330|NCT01755598|155420848|FG000|Overall Study|Adverse Event|19|||
48334331|NCT01755598|155420849|FG001|Overall Study|Adverse Event|28|||
48334332|NCT03219216|155420852|FG000|Overall Study|Lost to Follow-up|0|||
48334333|NCT03219216|155420853|FG001|Overall Study|Lost to Follow-up|1|||
48334334|NCT02332824|155420854|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
48334335|NCT02332824|155420855|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48334336|NCT02332824|155420856|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
48334337|NCT02332824|155420857|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
48334338|NCT02332824|155420858|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
48334339|NCT02332824|155420859|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
48334340|NCT02332824|155420854|FG000|Overall Study|Voluntary Withdrawal|1|||
48334341|NCT02332824|155420855|FG001|Overall Study|Voluntary Withdrawal|0|||
48334342|NCT02332824|155420856|FG002|Overall Study|Voluntary Withdrawal|0|||
48334343|NCT02332824|155420857|FG003|Overall Study|Voluntary Withdrawal|0|||
48334344|NCT02332824|155420858|FG004|Overall Study|Voluntary Withdrawal|0|||
48334345|NCT02332824|155420859|FG005|Overall Study|Voluntary Withdrawal|0|||
48654082|NCT00712725|156588122|FG001|Overall Study|Lost to Follow-up|2|||
48654083|NCT00712725|156588123|FG002|Overall Study|Lost to Follow-up|1|||
48654084|NCT00712725|156588124|FG003|Overall Study|Lost to Follow-up|1|||
48654085|NCT00712725|156588125|FG004|Overall Study|Lost to Follow-up|2|||
48654086|NCT00712725|156588126|FG005|Overall Study|Lost to Follow-up|2|||
48654087|NCT00712725|156588127|FG006|Overall Study|Lost to Follow-up|3|||
48654088|NCT00712725|156588128|FG007|Overall Study|Lost to Follow-up|1|||
48654089|NCT00712725|156588121|FG000|Overall Study|Physician Decision|2|||
48654090|NCT00712725|156588122|FG001|Overall Study|Physician Decision|0|||
48334346|NCT02332824|155420854|FG000|Overall Study|Inconvenient schedule|1|||
48334347|NCT02332824|155420855|FG001|Overall Study|Inconvenient schedule|1|||
48654091|NCT00712725|156588123|FG002|Overall Study|Physician Decision|0|||
48654092|NCT00712725|156588124|FG003|Overall Study|Physician Decision|0|||
48654093|NCT00712725|156588125|FG004|Overall Study|Physician Decision|1|||
48654094|NCT00712725|156588126|FG005|Overall Study|Physician Decision|0|||
48654095|NCT00712725|156588127|FG006|Overall Study|Physician Decision|2|||
48654096|NCT00712725|156588128|FG007|Overall Study|Physician Decision|0|||
48654097|NCT00712725|156588121|FG000|Overall Study|Pregnancy|0|||
48654098|NCT00712725|156588122|FG001|Overall Study|Pregnancy|1|||
48654099|NCT00712725|156588123|FG002|Overall Study|Pregnancy|0|||
48654100|NCT00712725|156588124|FG003|Overall Study|Pregnancy|0|||
48654101|NCT00712725|156588125|FG004|Overall Study|Pregnancy|1|||
48654102|NCT00712725|156588126|FG005|Overall Study|Pregnancy|0|||
48654103|NCT00712725|156588127|FG006|Overall Study|Pregnancy|2|||
48654104|NCT00712725|156588128|FG007|Overall Study|Pregnancy|0|||
48753819|NCT02899988|156946533|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
48753820|NCT02899988|156946534|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
48753821|NCT02899988|156946535|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753822|NCT02899988|156946536|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753823|NCT02899988|156946537|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753824|NCT02899988|156946538|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753825|NCT02899988|156946539|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753826|NCT02899988|156946540|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753827|NCT02899988|156946541|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753828|NCT02899988|156946542|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753829|NCT02899988|156946543|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48753830|NCT02899988|156946533|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
48753831|NCT02899988|156946534|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
48753832|NCT02899988|156946535|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
48753833|NCT02899988|156946536|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
48753834|NCT02899988|156946537|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
48753835|NCT02899988|156946538|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
48753836|NCT02899988|156946539|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
48753837|NCT02899988|156946540|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
48654105|NCT00712725|156588121|FG000|Overall Study|Protocol Violation|2|||
48654106|NCT00712725|156588122|FG001|Overall Study|Protocol Violation|0|||
48654107|NCT00712725|156588123|FG002|Overall Study|Protocol Violation|1|||
48654108|NCT00712725|156588124|FG003|Overall Study|Protocol Violation|3|||
48654109|NCT00712725|156588125|FG004|Overall Study|Protocol Violation|2|||
48654110|NCT00712725|156588126|FG005|Overall Study|Protocol Violation|0|||
48654111|NCT00712725|156588127|FG006|Overall Study|Protocol Violation|1|||
48654112|NCT00712725|156588128|FG007|Overall Study|Protocol Violation|1|||
48654113|NCT00712725|156588121|FG000|Overall Study|Withdrawal by Subject|2|||
48654114|NCT00712725|156588122|FG001|Overall Study|Withdrawal by Subject|1|||
48654115|NCT00712725|156588123|FG002|Overall Study|Withdrawal by Subject|1|||
48654116|NCT00712725|156588124|FG003|Overall Study|Withdrawal by Subject|2|||
48654117|NCT00712725|156588125|FG004|Overall Study|Withdrawal by Subject|1|||
48654118|NCT00712725|156588126|FG005|Overall Study|Withdrawal by Subject|1|||
48654119|NCT00712725|156588127|FG006|Overall Study|Withdrawal by Subject|1|||
48654120|NCT00712725|156588128|FG007|Overall Study|Withdrawal by Subject|2|||
48654121|NCT00712725|156588121|FG000|Overall Study|Lack of Qualifying Event|16|||
48654122|NCT00712725|156588122|FG001|Overall Study|Lack of Qualifying Event|2|||
48654123|NCT00712725|156588123|FG002|Overall Study|Lack of Qualifying Event|6|||
48654124|NCT00712725|156588124|FG003|Overall Study|Lack of Qualifying Event|8|||
48654125|NCT00712725|156588125|FG004|Overall Study|Lack of Qualifying Event|11|||
48654126|NCT00712725|156588126|FG005|Overall Study|Lack of Qualifying Event|13|||
48654127|NCT00712725|156588127|FG006|Overall Study|Lack of Qualifying Event|11|||
48654128|NCT00712725|156588128|FG007|Overall Study|Lack of Qualifying Event|6|||
48654129|NCT00712725|156588121|FG000|Overall Study|Protocol Specified Criteria|3|||
48654130|NCT00712725|156588122|FG001|Overall Study|Protocol Specified Criteria|0|||
48654131|NCT00712725|156588123|FG002|Overall Study|Protocol Specified Criteria|1|||
48654132|NCT00712725|156588124|FG003|Overall Study|Protocol Specified Criteria|2|||
48654133|NCT00712725|156588125|FG004|Overall Study|Protocol Specified Criteria|1|||
48654134|NCT00712725|156588126|FG005|Overall Study|Protocol Specified Criteria|0|||
48654135|NCT00712725|156588127|FG006|Overall Study|Protocol Specified Criteria|2|||
48654136|NCT00712725|156588128|FG007|Overall Study|Protocol Specified Criteria|1|||
48654137|NCT02120300|156588129|FG000|Overall Study|Enrolled but Never Treated|2|||
48654138|NCT02120300|156588130|FG001|Overall Study|Enrolled but Never Treated|0|||
48654139|NCT02120300|156588131|FG002|Overall Study|Enrolled but Never Treated|0|||
48654140|NCT02120300|156588132|FG003|Overall Study|Enrolled but Never Treated|0|||
48654141|NCT02120300|156588129|FG000|Overall Study|Lack of Efficacy|0|||
48654142|NCT02120300|156588130|FG001|Overall Study|Lack of Efficacy|0|||
48654143|NCT02120300|156588131|FG002|Overall Study|Lack of Efficacy|0|||
48654144|NCT02120300|156588132|FG003|Overall Study|Lack of Efficacy|1|||
48654145|NCT02120300|156588129|FG000|Overall Study|Lost to Follow-up|1|||
48654146|NCT02120300|156588130|FG001|Overall Study|Lost to Follow-up|0|||
48334348|NCT02332824|155420856|FG002|Overall Study|Inconvenient schedule|0|||
48334349|NCT02332824|155420857|FG003|Overall Study|Inconvenient schedule|0|||
48334350|NCT02332824|155420858|FG004|Overall Study|Inconvenient schedule|0|||
48334351|NCT02332824|155420859|FG005|Overall Study|Inconvenient schedule|0|||
48334352|NCT02332824|155420854|FG000|Overall Study|Transfer|0|||
48334353|NCT02332824|155420855|FG001|Overall Study|Transfer|0|||
48334354|NCT02332824|155420856|FG002|Overall Study|Transfer|1|||
48334355|NCT02332824|155420857|FG003|Overall Study|Transfer|1|||
48334356|NCT02332824|155420858|FG004|Overall Study|Transfer|0|||
48334357|NCT02332824|155420859|FG005|Overall Study|Transfer|0|||
48334358|NCT00440037|155420860|FG000|Overall Study|Withdrawal by Subject|6|||
48334359|NCT00440037|155420860|FG000|Overall Study|Administrative decision|3|||
48334360|NCT00498797|155420861|FG000|Overall Study|Withdrawal by Subject|4|||
48334361|NCT00498797|155420862|FG001|Overall Study|Withdrawal by Subject|2|||
48334362|NCT00498797|155420861|FG000|Overall Study|Adverse Event|12|||
48334363|NCT00498797|155420862|FG001|Overall Study|Adverse Event|5|||
48334364|NCT00498797|155420861|FG000|Overall Study|Condition under investigation worsened|19|||
48654147|NCT02120300|156588131|FG002|Overall Study|Lost to Follow-up|0|||
48334365|NCT00498797|155420862|FG001|Overall Study|Condition under investigation worsened|21|||
48334366|NCT00498797|155420861|FG000|Overall Study|Other|3|||
48334367|NCT00498797|155420862|FG001|Overall Study|Other|1|||
48334368|NCT00321672|155420863|FG000|Overall Study|Withdrawal by Subject|5|||
48334369|NCT00321672|155420864|FG001|Overall Study|Withdrawal by Subject|1|||
48334370|NCT00321672|155420865|FG002|Overall Study|Withdrawal by Subject|2|||
48334371|NCT00321672|155420866|FG003|Overall Study|Withdrawal by Subject|0|||
48334372|NCT00321672|155420863|FG000|Overall Study|Noncompliance|1|||
48334373|NCT00321672|155420864|FG001|Overall Study|Noncompliance|2|||
48654148|NCT02120300|156588132|FG003|Overall Study|Lost to Follow-up|0|||
48654149|NCT01302834|156588133|FG000|Overall Study|Protocol Violation|17|||
48654150|NCT01302834|156588134|FG001|Overall Study|Protocol Violation|23|||
48654151|NCT01302834|156588133|FG000|Overall Study|HIV positive|1|||
48654152|NCT01302834|156588134|FG001|Overall Study|HIV positive|3|||
48654153|NCT02680041|156588142|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
48654154|NCT02680041|156588142|FG000|Overall Study|Lost to Follow-up|2|||
48654155|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
48654156|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
48654157|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
48654158|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
48654159|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
48654160|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
48654161|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
48654162|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
48654163|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
48654164|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
48654165|NCT01639339|156588148|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
48654166|NCT01639339|156588149|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
48654167|NCT01639339|156588148|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
48654168|NCT01639339|156588149|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
48654169|NCT01639339|156588148|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
48654170|NCT01639339|156588149|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
48654171|NCT01639339|156588148|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
48654172|NCT01639339|156588149|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
48654173|NCT01639339|156588148|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
48654174|NCT01639339|156588149|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
48654175|NCT00349921|156588150|FG000|First Spinal Injection|Physician Decision|1|||
48654176|NCT00349921|156588151|FG001|First Spinal Injection|Physician Decision|0|||
48654177|NCT00349921|156588152|FG002|First Spinal Injection|Physician Decision|0|||
48654178|NCT00349921|156588153|FG003|First Spinal Injection|Physician Decision|0|||
48654179|NCT00349921|156588150|FG000|First Spinal Injection|Adverse Event|0|||
48654180|NCT00349921|156588151|FG001|First Spinal Injection|Adverse Event|0|||
48654181|NCT00349921|156588152|FG002|First Spinal Injection|Adverse Event|1|||
48654182|NCT00349921|156588153|FG003|First Spinal Injection|Adverse Event|0|||
48654183|NCT05145322|156588156|FG000|Overall Study|Lost to Follow-up|4|||
48654184|NCT05145322|156588157|FG001|Overall Study|Lost to Follow-up|5|||
48654185|NCT01271712|156588158|FG000|Double Blind Treatment|Death|2|||
48654186|NCT01271712|156588159|FG001|Double Blind Treatment|Death|0|||
48654187|NCT01271712|156588158|FG000|Double Blind Treatment|Lack of Efficacy|1|||
48654188|NCT01271712|156588159|FG001|Double Blind Treatment|Lack of Efficacy|0|||
48654189|NCT01271712|156588158|FG000|Double Blind Treatment|Adverse Event|9|||
48654190|NCT01271712|156588159|FG001|Double Blind Treatment|Adverse Event|4|||
48654191|NCT01271712|156588158|FG000|Double Blind Treatment|Progressive disease|23|||
48654192|NCT01271712|156588159|FG001|Double Blind Treatment|Progressive disease|3|||
48654193|NCT01271712|156588158|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
48654194|NCT01271712|156588159|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
48334374|NCT00321672|155420865|FG002|Overall Study|Noncompliance|1|||
48334375|NCT00321672|155420866|FG003|Overall Study|Noncompliance|0|||
48334376|NCT00321672|155420863|FG000|Overall Study|Adverse Event|1|||
48334377|NCT00321672|155420864|FG001|Overall Study|Adverse Event|1|||
48334378|NCT00321672|155420865|FG002|Overall Study|Adverse Event|0|||
48334379|NCT00321672|155420866|FG003|Overall Study|Adverse Event|0|||
48334380|NCT00321672|155420863|FG000|Overall Study|Lack of Efficacy|1|||
48334381|NCT00321672|155420864|FG001|Overall Study|Lack of Efficacy|1|||
48334382|NCT00321672|155420865|FG002|Overall Study|Lack of Efficacy|0|||
48334383|NCT00321672|155420866|FG003|Overall Study|Lack of Efficacy|0|||
48334384|NCT00321672|155420863|FG000|Overall Study|Lost to Follow-up|2|||
48334385|NCT00321672|155420864|FG001|Overall Study|Lost to Follow-up|0|||
48334386|NCT00321672|155420865|FG002|Overall Study|Lost to Follow-up|4|||
48334387|NCT00321672|155420866|FG003|Overall Study|Lost to Follow-up|2|||
48334388|NCT00321672|155420863|FG000|Overall Study|Death|1|||
48334389|NCT00321672|155420864|FG001|Overall Study|Death|0|||
48334390|NCT00321672|155420865|FG002|Overall Study|Death|0|||
48334391|NCT00321672|155420866|FG003|Overall Study|Death|0|||
48334392|NCT00321672|155420863|FG000|Overall Study|Too far to travel for visits|1|||
48334393|NCT00321672|155420864|FG001|Overall Study|Too far to travel for visits|0|||
48334394|NCT00321672|155420865|FG002|Overall Study|Too far to travel for visits|0|||
48334395|NCT00321672|155420866|FG003|Overall Study|Too far to travel for visits|0|||
48334396|NCT00321672|155420863|FG000|Overall Study|Incarcerated|0|||
48334397|NCT00321672|155420864|FG001|Overall Study|Incarcerated|0|||
48334398|NCT00321672|155420865|FG002|Overall Study|Incarcerated|2|||
48334399|NCT00321672|155420866|FG003|Overall Study|Incarcerated|0|||
48654195|NCT01271712|156588158|FG000|Double Blind Treatment|Non compliance with study drug|2|||
48654196|NCT01271712|156588159|FG001|Double Blind Treatment|Non compliance with study drug|0|||
48654197|NCT01271712|156588158|FG000|Double Blind Treatment|receive no study drug|1|||
48654198|NCT01271712|156588159|FG001|Double Blind Treatment|receive no study drug|0|||
48334400|NCT00321672|155420863|FG000|Overall Study|Moved out of state|0|||
48334401|NCT00321672|155420864|FG001|Overall Study|Moved out of state|1|||
48334402|NCT00321672|155420865|FG002|Overall Study|Moved out of state|1|||
48654199|NCT01271712|156588158|FG000|Open Label Treatment|Death|6|||
48654200|NCT01271712|156588159|FG001|Open Label Treatment|Death|5|||
48654201|NCT01271712|156588158|FG000|Open Label Treatment|Withdrawal by Subject|6|||
48654202|NCT01271712|156588159|FG001|Open Label Treatment|Withdrawal by Subject|11|||
48654203|NCT01271712|156588158|FG000|Open Label Treatment|Physician Decision|2|||
48654204|NCT01271712|156588159|FG001|Open Label Treatment|Physician Decision|0|||
48654205|NCT01271712|156588158|FG000|Open Label Treatment|Adverse Event|14|||
48654206|NCT01271712|156588159|FG001|Open Label Treatment|Adverse Event|8|||
48654207|NCT01271712|156588158|FG000|Open Label Treatment|Progressive disease|59|||
48654208|NCT01271712|156588159|FG001|Open Label Treatment|Progressive disease|32|||
48654209|NCT01271712|156588158|FG000|Open Label Treatment|transferred to rollover study|1|||
48654210|NCT01271712|156588159|FG001|Open Label Treatment|transferred to rollover study|0|||
48654211|NCT01271712|156588158|FG000|Open Label Treatment|Non-compliance with study drug|1|||
48654212|NCT01271712|156588159|FG001|Open Label Treatment|Non-compliance with study drug|0|||
48654213|NCT01271712|156588158|FG000|Open Label Treatment|Protocol Violation|0|||
48654214|NCT01271712|156588159|FG001|Open Label Treatment|Protocol Violation|1|||
48654215|NCT01271712|156588158|FG000|Open Label Treatment|Switching to other therapy|2|||
48654216|NCT01271712|156588159|FG001|Open Label Treatment|Switching to other therapy|1|||
48654217|NCT01271712|156588158|FG000|Safety Follow-up|Death|11|||
48654218|NCT01271712|156588159|FG001|Safety Follow-up|Death|7|||
48654219|NCT01271712|156588158|FG000|Safety Follow-up|Withdrawal by Subject|4|||
48654220|NCT01271712|156588159|FG001|Safety Follow-up|Withdrawal by Subject|2|||
48654221|NCT01271712|156588158|FG000|Safety Follow-up|Protocol Violation|1|||
48654222|NCT01271712|156588159|FG001|Safety Follow-up|Protocol Violation|1|||
48654223|NCT01271712|156588158|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
48654224|NCT01271712|156588159|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
48654225|NCT01271712|156588158|FG000|Safety Follow-up|No follow-up|1|||
48654226|NCT01271712|156588159|FG001|Safety Follow-up|No follow-up|1|||
48654227|NCT01271712|156588158|FG000|Safety Follow-up|Progressive disease|1|||
48654228|NCT01271712|156588159|FG001|Safety Follow-up|Progressive disease|0|||
48334403|NCT00321672|155420866|FG003|Overall Study|Moved out of state|0|||
48334404|NCT00321672|155420863|FG000|Overall Study|Protocol Violation|0|||
48334405|NCT00321672|155420864|FG001|Overall Study|Protocol Violation|0|||
48654229|NCT01271712|156588158|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
48654230|NCT01271712|156588159|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
48654231|NCT01453205|156588162|FG000|Overall Study|Lost to Follow-up|3|||
48334406|NCT00321672|155420865|FG002|Overall Study|Protocol Violation|1|||
48654232|NCT01453205|156588163|FG001|Overall Study|Lost to Follow-up|0|||
48334407|NCT00321672|155420866|FG003|Overall Study|Protocol Violation|0|||
48334408|NCT00321672|155420863|FG000|Overall Study|Diagnosis of testicular cancer|0|||
48334409|NCT00321672|155420864|FG001|Overall Study|Diagnosis of testicular cancer|1|||
48654233|NCT01453205|156588164|FG002|Overall Study|Lost to Follow-up|1|||
48334410|NCT00321672|155420865|FG002|Overall Study|Diagnosis of testicular cancer|0|||
48654234|NCT01453205|156588162|FG000|Overall Study|Withdrawal by Subject|8|||
48654235|NCT01453205|156588163|FG001|Overall Study|Withdrawal by Subject|3|||
48654236|NCT01453205|156588164|FG002|Overall Study|Withdrawal by Subject|0|||
48654237|NCT01453205|156588162|FG000|Overall Study|Death|24|||
48654238|NCT01453205|156588163|FG001|Overall Study|Death|22|||
48654239|NCT01453205|156588164|FG002|Overall Study|Death|18|||
48654240|NCT01453205|156588162|FG000|Overall Study|Other|45|||
48654241|NCT01453205|156588163|FG001|Overall Study|Other|27|||
48654242|NCT01453205|156588164|FG002|Overall Study|Other|35|||
48334411|NCT00321672|155420866|FG003|Overall Study|Diagnosis of testicular cancer|0|||
48334412|NCT00321672|155420863|FG000|Overall Study|Extensive travel required for new job|0|||
48334413|NCT00321672|155420864|FG001|Overall Study|Extensive travel required for new job|1|||
48334414|NCT00321672|155420865|FG002|Overall Study|Extensive travel required for new job|0|||
48334415|NCT00321672|155420866|FG003|Overall Study|Extensive travel required for new job|0|||
48334416|NCT04222088|155420867|FG000|Overall Study|Lost to Follow-up|5|||
48334417|NCT04222088|155420868|FG001|Overall Study|Lost to Follow-up|1|||
48334418|NCT04222088|155420867|FG000|Overall Study|Withdrawal by Subject|4|||
48334419|NCT04222088|155420868|FG001|Overall Study|Withdrawal by Subject|0|||
48334420|NCT01071317|155420869|FG000|Overall Study|Lost to Follow-up|2|||
48334421|NCT01071317|155420870|FG001|Overall Study|Lost to Follow-up|2|||
48334422|NCT00936065|155420871|FG000|Overall Study|Adverse Event|1|||
48334423|NCT00936065|155420872|FG001|Overall Study|Adverse Event|0|||
48334424|NCT00936065|155420873|FG002|Overall Study|Adverse Event|1|||
48334425|NCT00936065|155420871|FG000|Overall Study|Lack of Efficacy|1|||
48334426|NCT00936065|155420872|FG001|Overall Study|Lack of Efficacy|0|||
48334427|NCT00936065|155420873|FG002|Overall Study|Lack of Efficacy|1|||
48334428|NCT00936065|155420871|FG000|Overall Study|Lost to Follow-up|1|||
48334429|NCT00936065|155420872|FG001|Overall Study|Lost to Follow-up|0|||
48334430|NCT00936065|155420873|FG002|Overall Study|Lost to Follow-up|0|||
48334431|NCT00936065|155420871|FG000|Overall Study|Protocol Violation|1|||
48334432|NCT00936065|155420872|FG001|Overall Study|Protocol Violation|2|||
48334433|NCT00936065|155420873|FG002|Overall Study|Protocol Violation|1|||
48334434|NCT00936065|155420871|FG000|Overall Study|Withdrawal by Subject|0|||
48654243|NCT04003207|156588166|FG000|Overall Study|Protocol Violation|1|||
48654244|NCT03635424|156588169|FG000|Overall Study|Adverse Event|1|||
48654245|NCT03635424|156588169|FG000|Overall Study|Death|1|||
48654246|NCT03635424|156588169|FG000|Overall Study|Device not implanted|1|||
48654247|NCT01352221|156588170|FG000|Double-blind Phase|Adverse Event|6|||
48654248|NCT01352221|156588171|FG001|Double-blind Phase|Adverse Event|4|||
48654249|NCT01352221|156588172|FG002|Double-blind Phase|Adverse Event|0|||
48654250|NCT01352221|156588173|FG003|Double-blind Phase|Adverse Event|0|||
48654251|NCT01352221|156588170|FG000|Double-blind Phase|Withdrawal by Subject|3|||
48654252|NCT01352221|156588171|FG001|Double-blind Phase|Withdrawal by Subject|5|||
48654253|NCT01352221|156588172|FG002|Double-blind Phase|Withdrawal by Subject|0|||
48654254|NCT01352221|156588173|FG003|Double-blind Phase|Withdrawal by Subject|0|||
48654255|NCT01352221|156588170|FG000|Double-blind Phase|Lost to Follow-up|0|||
48654256|NCT01352221|156588171|FG001|Double-blind Phase|Lost to Follow-up|1|||
48654257|NCT01352221|156588172|FG002|Double-blind Phase|Lost to Follow-up|0|||
48654258|NCT01352221|156588173|FG003|Double-blind Phase|Lost to Follow-up|0|||
48654259|NCT01352221|156588170|FG000|Double-blind Phase|Protocol Violation|0|||
48654260|NCT01352221|156588171|FG001|Double-blind Phase|Protocol Violation|1|||
48654261|NCT01352221|156588172|FG002|Double-blind Phase|Protocol Violation|0|||
48654262|NCT01352221|156588173|FG003|Double-blind Phase|Protocol Violation|0|||
48654263|NCT01352221|156588170|FG000|Open-label Phase|Physician Decision|0|||
48654264|NCT01352221|156588171|FG001|Open-label Phase|Physician Decision|0|||
48654265|NCT01352221|156588172|FG002|Open-label Phase|Physician Decision|2|||
48654266|NCT01352221|156588173|FG003|Open-label Phase|Physician Decision|1|||
48654267|NCT01352221|156588170|FG000|Open-label Phase|Pregnancy|0|||
48334435|NCT00936065|155420872|FG001|Overall Study|Withdrawal by Subject|2|||
48334436|NCT00936065|155420873|FG002|Overall Study|Withdrawal by Subject|4|||
48334437|NCT01207453|155420874|FG000|First Intervention|Adverse Event|2|||
48654268|NCT01352221|156588171|FG001|Open-label Phase|Pregnancy|0|||
48654269|NCT01352221|156588172|FG002|Open-label Phase|Pregnancy|1|||
48654270|NCT01352221|156588173|FG003|Open-label Phase|Pregnancy|0|||
48654271|NCT01352221|156588170|FG000|Open-label Phase|Adverse Event|0|||
48654272|NCT01352221|156588171|FG001|Open-label Phase|Adverse Event|0|||
48654273|NCT01352221|156588172|FG002|Open-label Phase|Adverse Event|8|||
48654274|NCT01352221|156588173|FG003|Open-label Phase|Adverse Event|4|||
48654275|NCT01352221|156588170|FG000|Open-label Phase|Withdrawal by Subject|0|||
48334438|NCT01207453|155420875|FG001|First Intervention|Adverse Event|1|||
48334439|NCT01207453|155420874|FG000|Washout|Adverse Event|1|||
48334440|NCT01207453|155420875|FG001|Washout|Adverse Event|0|||
48334441|NCT01207453|155420874|FG000|Washout|Lost to Follow-up|1|||
48654276|NCT01352221|156588171|FG001|Open-label Phase|Withdrawal by Subject|0|||
48654277|NCT01352221|156588172|FG002|Open-label Phase|Withdrawal by Subject|1|||
48654278|NCT01352221|156588173|FG003|Open-label Phase|Withdrawal by Subject|6|||
48334442|NCT01207453|155420875|FG001|Washout|Lost to Follow-up|0|||
48334443|NCT01207453|155420874|FG000|2nd Intervention|Adverse Event|1|||
48654279|NCT01352221|156588170|FG000|Open-label Phase|Worsening of IBD|0|||
48654280|NCT01352221|156588171|FG001|Open-label Phase|Worsening of IBD|0|||
48654281|NCT01352221|156588172|FG002|Open-label Phase|Worsening of IBD|1|||
48654282|NCT01352221|156588173|FG003|Open-label Phase|Worsening of IBD|0|||
48654283|NCT00079391|156588174|FG000|Overall Study|Withdrawal by Subject|1|||
48654284|NCT01691105|156588175|FG000|1 Month Follow-up|Lost to Follow-up|41|||
48654285|NCT01691105|156588176|FG001|1 Month Follow-up|Lost to Follow-up|38|||
48654286|NCT01691105|156588175|FG000|1 Month Follow-up|Death|2|||
48654287|NCT01691105|156588176|FG001|1 Month Follow-up|Death|3|||
48654288|NCT01691105|156588175|FG000|6 Month Follow-up|Lost to Follow-up|39|||
48654289|NCT01691105|156588176|FG001|6 Month Follow-up|Lost to Follow-up|58|||
48334444|NCT01207453|155420875|FG001|2nd Intervention|Adverse Event|2|||
48334445|NCT01207453|155420874|FG000|2nd Intervention|Lost to Follow-up|1|||
48334446|NCT01207453|155420875|FG001|2nd Intervention|Lost to Follow-up|0|||
48334447|NCT02144285|155420876|FG000|Overall Study|Withdrawal by Subject|0|||
48334448|NCT02144285|155420877|FG001|Overall Study|Withdrawal by Subject|0|||
48334449|NCT02144285|155420878|FG002|Overall Study|Withdrawal by Subject|0|||
48334450|NCT02144285|155420879|FG003|Overall Study|Withdrawal by Subject|0|||
48334451|NCT02144285|155420880|FG004|Overall Study|Withdrawal by Subject|1|||
48334452|NCT02144285|155420881|FG005|Overall Study|Withdrawal by Subject|0|||
48334453|NCT02144285|155420882|FG006|Overall Study|Withdrawal by Subject|0|||
48334454|NCT02144285|155420883|FG007|Overall Study|Withdrawal by Subject|0|||
48334455|NCT02144285|155420884|FG008|Overall Study|Withdrawal by Subject|0|||
48334456|NCT02144285|155420885|FG009|Overall Study|Withdrawal by Subject|0|||
48334457|NCT02135445|155420886|FG000|Overall Study|Lost to Follow-up|1|||
48334458|NCT02135445|155420887|FG001|Overall Study|Lost to Follow-up|0|||
48334459|NCT02135445|155420886|FG000|Overall Study|Withdrawal by Subject|1|||
48334460|NCT02135445|155420887|FG001|Overall Study|Withdrawal by Subject|0|||
48334461|NCT01185340|155422181|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
48334462|NCT01185340|155422182|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48334463|NCT01185340|155422183|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48654290|NCT01691105|156588175|FG000|6 Month Follow-up|Death|13|||
48654291|NCT01691105|156588176|FG001|6 Month Follow-up|Death|13|||
48654292|NCT01691105|156588175|FG000|12 Month Follow-up|Lost to Follow-up|50|||
48654293|NCT01691105|156588176|FG001|12 Month Follow-up|Lost to Follow-up|71|||
48334464|NCT01185340|155422184|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48334465|NCT01185340|155422181|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
48334466|NCT01185340|155422182|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48334467|NCT01185340|155422183|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48334468|NCT01185340|155422184|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48654294|NCT01691105|156588175|FG000|12 Month Follow-up|Death|22|||
48654295|NCT01691105|156588176|FG001|12 Month Follow-up|Death|30|||
48654296|NCT01691105|156588175|FG000|12 Month Biochemical Verification|Death|22|||
48654297|NCT01691105|156588176|FG001|12 Month Biochemical Verification|Death|30|||
48753838|NCT02899988|156946541|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
48654298|NCT01691105|156588175|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
48654299|NCT01691105|156588176|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
48654300|NCT01691105|156588175|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
48654301|NCT01691105|156588176|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
48654302|NCT03255967|156588177|FG000|Overall Study|Adverse Event|26|||
48654303|NCT03255967|156588178|FG001|Overall Study|Adverse Event|30|||
48654304|NCT03255967|156588177|FG000|Overall Study|Withdrawal by Subject|6|||
48654305|NCT03255967|156588178|FG001|Overall Study|Withdrawal by Subject|6|||
48654306|NCT03255967|156588177|FG000|Overall Study|Schedule conflict|6|||
48654307|NCT03255967|156588178|FG001|Overall Study|Schedule conflict|4|||
48654308|NCT03255967|156588177|FG000|Overall Study|POA did not sign consent form|2|||
48654309|NCT03255967|156588178|FG001|Overall Study|POA did not sign consent form|0|||
48654310|NCT02791516|156588179|FG000|Overall Study|Withdrawal by Subject|1|||
48654311|NCT02791516|156588180|FG001|Overall Study|Withdrawal by Subject|1|||
48654312|NCT01202188|156588181|FG000|Overall Study|Protocol deviation|14|||
48654313|NCT01202188|156588182|FG001|Overall Study|Protocol deviation|8|||
48654314|NCT01202188|156588183|FG002|Overall Study|Protocol deviation|12|||
48654315|NCT01202188|156588184|FG003|Overall Study|Protocol deviation|10|||
48654316|NCT01202188|156588185|FG004|Overall Study|Protocol deviation|11|||
48654317|NCT01202188|156588181|FG000|Overall Study|Subject withdrew consent|12|||
48654318|NCT01202188|156588182|FG001|Overall Study|Subject withdrew consent|13|||
48654319|NCT01202188|156588183|FG002|Overall Study|Subject withdrew consent|22|||
48654320|NCT01202188|156588184|FG003|Overall Study|Subject withdrew consent|11|||
48753839|NCT02899988|156946542|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
48334469|NCT01185340|155422181|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
48334470|NCT01185340|155422182|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48334471|NCT01185340|155422183|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48654321|NCT01202188|156588185|FG004|Overall Study|Subject withdrew consent|13|||
48654322|NCT01202188|156588181|FG000|Overall Study|Adverse Event|5|||
48334472|NCT01185340|155422184|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48334473|NCT01185340|155422181|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
48334474|NCT01185340|155422182|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48334475|NCT01185340|155422183|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48334476|NCT01185340|155422184|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48654323|NCT01202188|156588182|FG001|Overall Study|Adverse Event|23|||
48654324|NCT01202188|156588183|FG002|Overall Study|Adverse Event|13|||
48654325|NCT01202188|156588184|FG003|Overall Study|Adverse Event|10|||
48654326|NCT01202188|156588185|FG004|Overall Study|Adverse Event|10|||
48654327|NCT01202188|156588181|FG000|Overall Study|Administrative problems|3|||
48654328|NCT01202188|156588182|FG001|Overall Study|Administrative problems|2|||
48753840|NCT02899988|156946543|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
48753841|NCT02899988|156946533|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
48654329|NCT01202188|156588183|FG002|Overall Study|Administrative problems|1|||
48654330|NCT01202188|156588184|FG003|Overall Study|Administrative problems|1|||
48654331|NCT01202188|156588185|FG004|Overall Study|Administrative problems|2|||
48654332|NCT01202188|156588181|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48654333|NCT01202188|156588182|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48654334|NCT01202188|156588183|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48654335|NCT01202188|156588184|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
48654336|NCT01202188|156588185|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
48654337|NCT01202188|156588181|FG000|Overall Study|Lost to Follow-up|1|||
48654338|NCT01202188|156588182|FG001|Overall Study|Lost to Follow-up|1|||
48654339|NCT01202188|156588183|FG002|Overall Study|Lost to Follow-up|0|||
48654340|NCT01202188|156588184|FG003|Overall Study|Lost to Follow-up|4|||
48654341|NCT01202188|156588185|FG004|Overall Study|Lost to Follow-up|1|||
48654342|NCT01202188|156588181|FG000|Overall Study|Death|1|||
48654343|NCT01202188|156588182|FG001|Overall Study|Death|1|||
48654344|NCT01202188|156588183|FG002|Overall Study|Death|1|||
48654345|NCT01202188|156588184|FG003|Overall Study|Death|1|||
48654346|NCT01202188|156588185|FG004|Overall Study|Death|0|||
48654347|NCT01202188|156588181|FG000|Overall Study|Abnormal test procedure result (s)|0|||
48654348|NCT01202188|156588182|FG001|Overall Study|Abnormal test procedure result (s)|0|||
48654349|NCT01202188|156588183|FG002|Overall Study|Abnormal test procedure result (s)|2|||
48654350|NCT01202188|156588184|FG003|Overall Study|Abnormal test procedure result (s)|0|||
48654351|NCT01202188|156588185|FG004|Overall Study|Abnormal test procedure result (s)|0|||
48654352|NCT02701283|156588187|FG000|Overall Study|Death|25|||
48654353|NCT02701283|156588188|FG001|Overall Study|Death|29|||
48654354|NCT02701283|156588189|FG002|Overall Study|Death|19|||
48654355|NCT02701283|156588187|FG000|Overall Study|Lost to Follow-up|3|||
48654356|NCT02701283|156588188|FG001|Overall Study|Lost to Follow-up|8|||
48654357|NCT02701283|156588189|FG002|Overall Study|Lost to Follow-up|1|||
48654358|NCT02701283|156588187|FG000|Overall Study|Withdrawal by Subject|12|||
48654359|NCT02701283|156588188|FG001|Overall Study|Withdrawal by Subject|41|||
48654360|NCT02701283|156588189|FG002|Overall Study|Withdrawal by Subject|1|||
48654361|NCT02701283|156588187|FG000|Overall Study|Missed 2-year visit|22|||
48654362|NCT02701283|156588188|FG001|Overall Study|Missed 2-year visit|27|||
48654363|NCT02701283|156588189|FG002|Overall Study|Missed 2-year visit|0|||
48654364|NCT02701283|156588187|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
48654365|NCT02701283|156588188|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
48654366|NCT02701283|156588189|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
48654367|NCT04669262|156588190|FG000|Overall Study|Withdrawal by Subject|0|||
48654368|NCT04669262|156588191|FG001|Overall Study|Withdrawal by Subject|0|||
48654369|NCT04669262|156588192|FG002|Overall Study|Withdrawal by Subject|0|||
48654370|NCT04669262|156588193|FG003|Overall Study|Withdrawal by Subject|1|||
48654371|NCT04669262|156588190|FG000|Overall Study|Randomized but Not Treated|0|||
48654372|NCT04669262|156588191|FG001|Overall Study|Randomized but Not Treated|1|||
48654373|NCT04669262|156588192|FG002|Overall Study|Randomized but Not Treated|0|||
48654374|NCT04669262|156588193|FG003|Overall Study|Randomized but Not Treated|0|||
48654375|NCT05151445|156588194|FG000|Overall Study|Withdrawal by Subject|3|||
48654376|NCT01638013|156588195|FG000|Overall Study|Adverse Event|36|||
48654377|NCT01638013|156588196|FG001|Overall Study|Adverse Event|29|||
48654378|NCT01638013|156588197|FG002|Overall Study|Adverse Event|48|||
48654379|NCT01638013|156588195|FG000|Overall Study|Lack of Efficacy|39|||
48753842|NCT02899988|156946534|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
48753843|NCT02899988|156946535|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
48753844|NCT02899988|156946536|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
48753845|NCT02899988|156946537|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
48753846|NCT02899988|156946538|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
48753847|NCT02899988|156946539|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
48654380|NCT01638013|156588196|FG001|Overall Study|Lack of Efficacy|11|||
48654381|NCT01638013|156588197|FG002|Overall Study|Lack of Efficacy|14|||
48654382|NCT01638013|156588195|FG000|Overall Study|Protocol Violation|10|||
48654383|NCT01638013|156588196|FG001|Overall Study|Protocol Violation|7|||
48654384|NCT01638013|156588197|FG002|Overall Study|Protocol Violation|11|||
48654385|NCT01638013|156588195|FG000|Overall Study|Met discontinuation criteria|4|||
48654386|NCT01638013|156588196|FG001|Overall Study|Met discontinuation criteria|0|||
48654387|NCT01638013|156588197|FG002|Overall Study|Met discontinuation criteria|7|||
48654388|NCT01638013|156588195|FG000|Overall Study|Subject Lost to Follow up|1|||
48654389|NCT01638013|156588196|FG001|Overall Study|Subject Lost to Follow up|0|||
48753848|NCT02899988|156946540|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
48334477|NCT01185340|155422181|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
48334478|NCT01185340|155422182|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48654390|NCT01638013|156588197|FG002|Overall Study|Subject Lost to Follow up|1|||
48654391|NCT01638013|156588195|FG000|Overall Study|Miscellaneous|25|||
48753849|NCT02899988|156946541|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
48753850|NCT02899988|156946542|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
48753851|NCT02899988|156946543|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
48753852|NCT02899988|156946533|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
48753853|NCT02899988|156946534|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
48753854|NCT02899988|156946535|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
48753855|NCT02899988|156946536|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
48753856|NCT02899988|156946537|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
48753857|NCT02899988|156946538|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
48753858|NCT02899988|156946539|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
48753859|NCT02899988|156946540|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
48753860|NCT02899988|156946541|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
48753861|NCT02899988|156946542|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
48753862|NCT02899988|156946543|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
48753863|NCT02899988|156946533|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753864|NCT02899988|156946534|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753865|NCT02899988|156946535|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753866|NCT02899988|156946536|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753867|NCT02899988|156946537|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753868|NCT02899988|156946538|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
48753869|NCT02899988|156946539|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753870|NCT02899988|156946540|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
48753871|NCT02899988|156946541|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753872|NCT02899988|156946542|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753873|NCT02899988|156946543|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
48753874|NCT02899988|156946533|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753875|NCT02899988|156946534|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753876|NCT02899988|156946535|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753877|NCT02899988|156946536|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753878|NCT02899988|156946537|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
48753879|NCT02899988|156946538|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753880|NCT02899988|156946539|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
48753881|NCT02899988|156946540|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
48753882|NCT02899988|156946541|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
48753883|NCT02899988|156946542|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
48753884|NCT02899988|156946543|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
48654392|NCT01638013|156588196|FG001|Overall Study|Miscellaneous|19|||
48654393|NCT01638013|156588197|FG002|Overall Study|Miscellaneous|23|||
48654394|NCT01638013|156588195|FG000|Overall Study|Withdrawal of Consent|16|||
48654395|NCT01638013|156588196|FG001|Overall Study|Withdrawal of Consent|12|||
48654396|NCT01638013|156588197|FG002|Overall Study|Withdrawal of Consent|16|||
48654397|NCT01638013|156588195|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
48654398|NCT01638013|156588196|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
48654399|NCT01638013|156588197|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
48654400|NCT01457014|156588198|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
48654401|NCT01457014|156588199|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
48654402|NCT01457014|156588200|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
48654403|NCT01457014|156588201|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
48654404|NCT01457014|156588198|FG000|First Night|Withdrawal by Subject|3|||
48654405|NCT01457014|156588199|FG001|First Night|Withdrawal by Subject|0|||
48654406|NCT01457014|156588200|FG002|First Night|Withdrawal by Subject|0|||
48654407|NCT01457014|156588201|FG003|First Night|Withdrawal by Subject|0|||
48654408|NCT02438384|156588204|FG000|Overall Study|Lost to Follow-up|8|||
48753885|NCT01751867|156946544|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
48753886|NCT01751867|156946545|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
48753887|NCT01751867|156946544|FG000|Overall Study|Diease Progression|4|||
48753888|NCT01751867|156946545|FG001|Overall Study|Diease Progression|18|||
48334479|NCT01185340|155422183|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48428049|NCT01518192|155754796|FG001|Overall Study|Lost to Follow-up|26|||
48654409|NCT02438384|156588205|FG001|Overall Study|Lost to Follow-up|6|||
48654410|NCT02438384|156588206|FG002|Overall Study|Lost to Follow-up|4|||
48654411|NCT03319953|156588207|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
48654412|NCT03319953|156588208|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
48654413|NCT03319953|156588209|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
48654414|NCT03319953|156588210|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
48654415|NCT03319953|156588207|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
48753889|NCT01751867|156946544|FG000|Overall Study|Adverse Event|8|||
48753890|NCT01751867|156946545|FG001|Overall Study|Adverse Event|15|||
48753891|NCT01751867|156946544|FG000|Overall Study|Poor Compliance|0|||
48654416|NCT03319953|156588208|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
48753892|NCT01751867|156946545|FG001|Overall Study|Poor Compliance|5|||
48753893|NCT01751867|156946544|FG000|Overall Study|Withdrawal by Subject|3|||
48334480|NCT01185340|155422184|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48334481|NCT01185340|155422181|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
48654417|NCT03319953|156588209|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
48654418|NCT03319953|156588210|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
48654419|NCT04493424|156589697|FG000|Overall Study|Termination of the trial by the sponsor|89|||
48654420|NCT04493424|156589697|FG000|Overall Study|Withdrawal by Subject|9|||
48654421|NCT04493424|156589697|FG000|Overall Study|Lost to Follow-up|2|||
48654422|NCT04493424|156589697|FG000|Overall Study|Lack of Efficacy|3|||
48654423|NCT04493424|156589697|FG000|Overall Study|Adverse Event|5|||
48654424|NCT02920528|156589700|FG000|Overall Study|Incomplete Data|1|||
48654425|NCT02920528|156589701|FG001|Overall Study|Incomplete Data|1|||
48654426|NCT02920528|156589702|FG002|Overall Study|Incomplete Data|1|||
48654427|NCT02920528|156589700|FG000|Overall Study|Adverse Event|0|||
48654428|NCT02920528|156589701|FG001|Overall Study|Adverse Event|0|||
48654429|NCT02920528|156589702|FG002|Overall Study|Adverse Event|3|||
48654430|NCT02920528|156589700|FG000|Overall Study|Did not meet inclusion criteria|2|||
48654431|NCT02920528|156589701|FG001|Overall Study|Did not meet inclusion criteria|0|||
48654432|NCT02920528|156589702|FG002|Overall Study|Did not meet inclusion criteria|1|||
48654433|NCT03116828|156589703|FG000|Overall Study|Adverse Event|1|||
48654434|NCT03116828|156589704|FG001|Overall Study|Adverse Event|10|||
48654435|NCT03116828|156589703|FG000|Overall Study|Withdrawal by Subject|4|||
48654436|NCT03116828|156589704|FG001|Overall Study|Withdrawal by Subject|8|||
48654437|NCT03116828|156589703|FG000|Overall Study|OTHER|3|||
48654438|NCT03116828|156589704|FG001|Overall Study|OTHER|3|||
48654439|NCT02547038|156589706|FG000|Overall Study|Lost to Follow-up|3|||
48654440|NCT02547038|156589707|FG001|Overall Study|Lost to Follow-up|2|||
48654441|NCT04606199|156589709|FG000|Overall Study|Withdrawal by Subject|2|||
48654442|NCT05425732|156589710|FG000|Overall Study|Death|4|||
48654443|NCT05425732|156589711|FG001|Overall Study|Death|2|||
48654444|NCT05425732|156589712|FG002|Overall Study|Death|0|||
48654445|NCT05425732|156589713|FG003|Overall Study|Death|0|||
48654446|NCT05425732|156589710|FG000|Overall Study|Lost to Follow-up|10|||
48654447|NCT05425732|156589711|FG001|Overall Study|Lost to Follow-up|15|||
48654448|NCT05425732|156589712|FG002|Overall Study|Lost to Follow-up|5|||
48654449|NCT05425732|156589713|FG003|Overall Study|Lost to Follow-up|3|||
48654450|NCT05425732|156589710|FG000|Overall Study|Physician Decision|0|||
48654451|NCT05425732|156589711|FG001|Overall Study|Physician Decision|2|||
48654452|NCT05425732|156589712|FG002|Overall Study|Physician Decision|0|||
48654453|NCT05425732|156589713|FG003|Overall Study|Physician Decision|0|||
48654454|NCT05425732|156589710|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48654455|NCT05425732|156589711|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
48654456|NCT05425732|156589712|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48654457|NCT05425732|156589713|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48654458|NCT05425732|156589710|FG000|Overall Study|Withdrawal by Subject|4|||
48654459|NCT05425732|156589711|FG001|Overall Study|Withdrawal by Subject|8|||
48654460|NCT05425732|156589712|FG002|Overall Study|Withdrawal by Subject|1|||
48654461|NCT05425732|156589713|FG003|Overall Study|Withdrawal by Subject|1|||
48654462|NCT05425732|156589710|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
48654463|NCT05425732|156589711|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
48654464|NCT05425732|156589712|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
48654465|NCT05425732|156589713|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
48654466|NCT05935878|156589714|FG000|Overall Study|Death|1|||
48654467|NCT05935878|156589715|FG001|Overall Study|Death|2|||
48654468|NCT05935878|156589714|FG000|Overall Study|Withdrawal by Subject|5|||
48654469|NCT05935878|156589715|FG001|Overall Study|Withdrawal by Subject|5|||
48654470|NCT05935878|156589714|FG000|Overall Study|Revision of implant|1|||
48654471|NCT05935878|156589715|FG001|Overall Study|Revision of implant|1|||
48654472|NCT05935878|156589714|FG000|Overall Study|Mobile bearing dislocation|0|||
48654473|NCT05935878|156589715|FG001|Overall Study|Mobile bearing dislocation|1|||
48654474|NCT00306293|156589717|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
48654475|NCT00306293|156589718|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
48654476|NCT00306293|156589717|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
48654477|NCT00306293|156589718|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
48654478|NCT00306293|156589717|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
48654479|NCT00306293|156589718|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
48654480|NCT00306293|156589717|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
48654481|NCT00306293|156589718|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
48654482|NCT00306293|156589717|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
48654483|NCT00306293|156589718|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
48654484|NCT00306293|156589717|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
48654485|NCT00306293|156589718|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
48654486|NCT00306293|156589717|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
48654487|NCT00306293|156589718|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
48753894|NCT01751867|156946545|FG001|Overall Study|Withdrawal by Subject|1|||
48753895|NCT01751867|156946544|FG000|Overall Study|Physician Decision|4|||
48753896|NCT01751867|156946545|FG001|Overall Study|Physician Decision|7|||
48753897|NCT01751867|156946544|FG000|Overall Study|Protocol Violation|0|||
48753898|NCT01751867|156946545|FG001|Overall Study|Protocol Violation|2|||
48753899|NCT01751867|156946544|FG000|Overall Study|Death|0|||
48753900|NCT01751867|156946545|FG001|Overall Study|Death|5|||
48753901|NCT01751867|156946544|FG000|Overall Study|Other|11|||
48753902|NCT01751867|156946545|FG001|Overall Study|Other|37|||
48753903|NCT01751867|156946544|FG000|Overall Study|Randomized but not treated.|2|||
48753904|NCT01751867|156946545|FG001|Overall Study|Randomized but not treated.|1|||
48753905|NCT05620563|156946554|FG000|Overall Study|Adverse Event|3|||
48753906|NCT05620563|156946555|FG001|Overall Study|Adverse Event|1|||
48753907|NCT05620563|156946554|FG000|Overall Study|Lost to Follow-up|0|||
48753908|NCT05620563|156946555|FG001|Overall Study|Lost to Follow-up|2|||
48753909|NCT05620563|156946554|FG000|Overall Study|Protocol Deviation|1|||
48753910|NCT05620563|156946555|FG001|Overall Study|Protocol Deviation|2|||
48753911|NCT05620563|156946554|FG000|Overall Study|Withdrawal by Subject|3|||
48753912|NCT05620563|156946555|FG001|Overall Study|Withdrawal by Subject|3|||
48753913|NCT05620563|156946554|FG000|Overall Study|Physician Decision|0|||
48753914|NCT05620563|156946555|FG001|Overall Study|Physician Decision|1|||
48753915|NCT00411645|156946556|FG000|Overall Study|Consent Withdrawn|13|||
48753916|NCT00411645|156946557|FG001|Overall Study|Consent Withdrawn|22|||
48753917|NCT00411645|156946556|FG000|Overall Study|Death|56|||
48753918|NCT00411645|156946557|FG001|Overall Study|Death|135|||
48753919|NCT00411645|156946556|FG000|Overall Study|Investigator/Sponsor Decision|10|||
48753920|NCT00411645|156946557|FG001|Overall Study|Investigator/Sponsor Decision|7|||
48753921|NCT00411645|156946556|FG000|Overall Study|Lost to Follow-up|2|||
48753922|NCT00411645|156946557|FG001|Overall Study|Lost to Follow-up|0|||
48753923|NCT02289690|156946560|FG000|Overall Study|Adverse Event Related to Progression|0|||
48753924|NCT02289690|156946561|FG001|Overall Study|Adverse Event Related to Progression|1|||
48753925|NCT02289690|156946562|FG002|Overall Study|Adverse Event Related to Progression|1|||
48753926|NCT02289690|156946563|FG003|Overall Study|Adverse Event Related to Progression|0|||
48753927|NCT02289690|156946564|FG004|Overall Study|Adverse Event Related to Progression|1|||
48753928|NCT02289690|156946565|FG005|Overall Study|Adverse Event Related to Progression|0|||
48753929|NCT02289690|156946566|FG006|Overall Study|Adverse Event Related to Progression|1|||
48753930|NCT02289690|156946567|FG007|Overall Study|Adverse Event Related to Progression|0|||
48753931|NCT02289690|156946568|FG008|Overall Study|Adverse Event Related to Progression|0|||
48753932|NCT02289690|156946569|FG009|Overall Study|Adverse Event Related to Progression|0|||
48753933|NCT02289690|156946560|FG000|Overall Study|Withdrawal by Subject|1|||
48753934|NCT02289690|156946561|FG001|Overall Study|Withdrawal by Subject|0|||
48334482|NCT01185340|155422182|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48654488|NCT00306293|156589717|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
48654489|NCT00306293|156589718|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
48654490|NCT01892436|156589723|FG000|Overall Study|Withdrawal by Subject|8|||
48654491|NCT01892436|156589724|FG001|Overall Study|Withdrawal by Subject|15|||
48654492|NCT01892436|156589725|FG002|Overall Study|Withdrawal by Subject|4|||
48654493|NCT01892436|156589726|FG003|Overall Study|Withdrawal by Subject|4|||
48654494|NCT01892436|156589723|FG000|Overall Study|Death|1|||
48654495|NCT01892436|156589724|FG001|Overall Study|Death|1|||
48654496|NCT01892436|156589725|FG002|Overall Study|Death|0|||
48654497|NCT01892436|156589726|FG003|Overall Study|Death|0|||
48753935|NCT02289690|156946562|FG002|Overall Study|Withdrawal by Subject|0|||
48753936|NCT02289690|156946563|FG003|Overall Study|Withdrawal by Subject|0|||
48753937|NCT02289690|156946564|FG004|Overall Study|Withdrawal by Subject|1|||
48753938|NCT02289690|156946565|FG005|Overall Study|Withdrawal by Subject|1|||
48753939|NCT02289690|156946566|FG006|Overall Study|Withdrawal by Subject|0|||
48753940|NCT02289690|156946567|FG007|Overall Study|Withdrawal by Subject|0|||
48753941|NCT02289690|156946568|FG008|Overall Study|Withdrawal by Subject|4|||
48753942|NCT02289690|156946569|FG009|Overall Study|Withdrawal by Subject|2|||
48753943|NCT02289690|156946560|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
48334483|NCT01185340|155422183|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48334484|NCT01185340|155422184|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48334485|NCT01185340|155422181|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
48654498|NCT01892436|156589723|FG000|Overall Study|Physician Decision|2|||
48654499|NCT01892436|156589724|FG001|Overall Study|Physician Decision|1|||
48654500|NCT01892436|156589725|FG002|Overall Study|Physician Decision|0|||
48753944|NCT02289690|156946561|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
48753945|NCT02289690|156946562|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
48753946|NCT02289690|156946563|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
48753947|NCT02289690|156946564|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
48753948|NCT02289690|156946565|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
48753949|NCT02289690|156946566|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
48753950|NCT02289690|156946567|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
48753951|NCT02289690|156946568|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
48334486|NCT01185340|155422182|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48334487|NCT01185340|155422183|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48334488|NCT01185340|155422184|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48334489|NCT01185340|155422181|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
48334490|NCT01185340|155422182|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
48334491|NCT01185340|155422183|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
48334492|NCT01185340|155422184|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
48334493|NCT01185340|155422181|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
48334494|NCT01185340|155422182|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
48334495|NCT01185340|155422183|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
48334496|NCT01185340|155422184|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
48334497|NCT01185340|155422181|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
48334498|NCT01185340|155422182|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
48334499|NCT01185340|155422183|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
48654501|NCT01892436|156589726|FG003|Overall Study|Physician Decision|1|||
48654502|NCT01892436|156589723|FG000|Overall Study|Pregnancy|0|||
48654503|NCT01892436|156589724|FG001|Overall Study|Pregnancy|2|||
48654504|NCT01892436|156589725|FG002|Overall Study|Pregnancy|1|||
48654505|NCT01892436|156589726|FG003|Overall Study|Pregnancy|0|||
48654506|NCT01892436|156589723|FG000|Overall Study|Technical problems|2|||
48654507|NCT01892436|156589724|FG001|Overall Study|Technical problems|1|||
48654508|NCT01892436|156589725|FG002|Overall Study|Technical problems|1|||
48654509|NCT01892436|156589726|FG003|Overall Study|Technical problems|1|||
48654510|NCT01892436|156589723|FG000|Overall Study|Lack of Efficacy|1|||
48654511|NCT01892436|156589724|FG001|Overall Study|Lack of Efficacy|2|||
48654512|NCT01892436|156589725|FG002|Overall Study|Lack of Efficacy|2|||
48654513|NCT01892436|156589726|FG003|Overall Study|Lack of Efficacy|2|||
48654514|NCT01892436|156589723|FG000|Overall Study|Lost to Follow-up|1|||
48654515|NCT01892436|156589724|FG001|Overall Study|Lost to Follow-up|1|||
48654516|NCT01892436|156589725|FG002|Overall Study|Lost to Follow-up|1|||
48654517|NCT01892436|156589726|FG003|Overall Study|Lost to Follow-up|3|||
48654518|NCT01892436|156589723|FG000|Overall Study|non-compliance with treatment|1|||
48654519|NCT01892436|156589724|FG001|Overall Study|non-compliance with treatment|0|||
48654520|NCT01892436|156589725|FG002|Overall Study|non-compliance with treatment|0|||
48654521|NCT01892436|156589726|FG003|Overall Study|non-compliance with treatment|0|||
48654522|NCT01892436|156589723|FG000|Overall Study|Adverse Event|7|||
48654523|NCT01892436|156589724|FG001|Overall Study|Adverse Event|6|||
48654524|NCT01892436|156589725|FG002|Overall Study|Adverse Event|2|||
48654525|NCT01892436|156589726|FG003|Overall Study|Adverse Event|3|||
48654526|NCT00733291|156589727|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
48654527|NCT00733291|156589728|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
48654528|NCT00733291|156589729|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
48654529|NCT00733291|156589730|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
48654530|NCT05791565|156589732|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
48654531|NCT05791565|156589733|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
48654532|NCT01406938|156589734|FG000|Induction Period|Subject/guardian decision|6|||
48654533|NCT01406938|156589735|FG001|Induction Period|Subject/guardian decision|8|||
48654534|NCT01406938|156589736|FG002|Induction Period|Subject/guardian decision|0|||
48654535|NCT01406938|156589737|FG003|Induction Period|Subject/guardian decision|0|||
48654536|NCT01406938|156589738|FG004|Induction Period|Subject/guardian decision|0|||
48654537|NCT01406938|156589739|FG005|Induction Period|Subject/guardian decision|0|||
48654538|NCT01406938|156589734|FG000|Induction Period|Protocol deviation|1|||
48654539|NCT01406938|156589735|FG001|Induction Period|Protocol deviation|0|||
48654540|NCT01406938|156589736|FG002|Induction Period|Protocol deviation|0|||
48654541|NCT01406938|156589737|FG003|Induction Period|Protocol deviation|0|||
48654542|NCT01406938|156589738|FG004|Induction Period|Protocol deviation|0|||
48654543|NCT01406938|156589739|FG005|Induction Period|Protocol deviation|0|||
48654544|NCT01406938|156589734|FG000|Induction Period|Adverse Event|8|||
48654545|NCT01406938|156589735|FG001|Induction Period|Adverse Event|9|||
48654546|NCT01406938|156589736|FG002|Induction Period|Adverse Event|0|||
48654547|NCT01406938|156589737|FG003|Induction Period|Adverse Event|0|||
48654548|NCT01406938|156589738|FG004|Induction Period|Adverse Event|0|||
48654549|NCT01406938|156589739|FG005|Induction Period|Adverse Event|0|||
48654550|NCT01406938|156589734|FG000|Induction Period|Lack of Efficacy|1|||
48654551|NCT01406938|156589735|FG001|Induction Period|Lack of Efficacy|0|||
48654552|NCT01406938|156589736|FG002|Induction Period|Lack of Efficacy|0|||
48654553|NCT01406938|156589737|FG003|Induction Period|Lack of Efficacy|0|||
48654554|NCT01406938|156589738|FG004|Induction Period|Lack of Efficacy|0|||
48654555|NCT01406938|156589739|FG005|Induction Period|Lack of Efficacy|0|||
48654556|NCT01406938|156589734|FG000|Induction Period|Lost to Follow-up|2|||
48654557|NCT01406938|156589735|FG001|Induction Period|Lost to Follow-up|3|||
48654558|NCT01406938|156589736|FG002|Induction Period|Lost to Follow-up|0|||
48654559|NCT01406938|156589737|FG003|Induction Period|Lost to Follow-up|0|||
48654560|NCT01406938|156589738|FG004|Induction Period|Lost to Follow-up|0|||
48753952|NCT02289690|156946569|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
48753953|NCT02289690|156946560|FG000|Overall Study|Lost to Follow-up|0|||
48753954|NCT02289690|156946561|FG001|Overall Study|Lost to Follow-up|0|||
48753955|NCT02289690|156946562|FG002|Overall Study|Lost to Follow-up|0|||
48753956|NCT02289690|156946563|FG003|Overall Study|Lost to Follow-up|0|||
48753957|NCT02289690|156946564|FG004|Overall Study|Lost to Follow-up|0|||
48753958|NCT02289690|156946565|FG005|Overall Study|Lost to Follow-up|0|||
48753959|NCT02289690|156946566|FG006|Overall Study|Lost to Follow-up|0|||
48753960|NCT02289690|156946567|FG007|Overall Study|Lost to Follow-up|1|||
48753961|NCT02289690|156946568|FG008|Overall Study|Lost to Follow-up|0|||
48753962|NCT02289690|156946569|FG009|Overall Study|Lost to Follow-up|2|||
48753963|NCT02289690|156946560|FG000|Overall Study|Death|0|||
48753964|NCT02289690|156946561|FG001|Overall Study|Death|0|||
48753965|NCT02289690|156946562|FG002|Overall Study|Death|0|||
48753966|NCT02289690|156946563|FG003|Overall Study|Death|0|||
48753967|NCT02289690|156946564|FG004|Overall Study|Death|0|||
48753968|NCT02289690|156946565|FG005|Overall Study|Death|0|||
48753969|NCT02289690|156946566|FG006|Overall Study|Death|0|||
48753970|NCT02289690|156946567|FG007|Overall Study|Death|49|||
48753971|NCT02289690|156946568|FG008|Overall Study|Death|45|||
48753972|NCT02289690|156946569|FG009|Overall Study|Death|41|||
48753973|NCT02289690|156946560|FG000|Overall Study|Sponsor Discontinued Study|0|||
48753974|NCT02289690|156946561|FG001|Overall Study|Sponsor Discontinued Study|0|||
48753975|NCT02289690|156946562|FG002|Overall Study|Sponsor Discontinued Study|0|||
48753976|NCT02289690|156946563|FG003|Overall Study|Sponsor Discontinued Study|0|||
48753977|NCT02289690|156946564|FG004|Overall Study|Sponsor Discontinued Study|0|||
48753978|NCT02289690|156946565|FG005|Overall Study|Sponsor Discontinued Study|0|||
48753979|NCT02289690|156946566|FG006|Overall Study|Sponsor Discontinued Study|0|||
48753980|NCT02289690|156946567|FG007|Overall Study|Sponsor Discontinued Study|9|||
48753981|NCT02289690|156946568|FG008|Overall Study|Sponsor Discontinued Study|7|||
48654561|NCT01406938|156589739|FG005|Induction Period|Lost to Follow-up|0|||
48654562|NCT01406938|156589734|FG000|Maintenance Period|Adverse Event|0|||
48654563|NCT01406938|156589735|FG001|Maintenance Period|Adverse Event|0|||
48654564|NCT01406938|156589736|FG002|Maintenance Period|Adverse Event|2|||
48654565|NCT01406938|156589737|FG003|Maintenance Period|Adverse Event|8|||
48654566|NCT01406938|156589738|FG004|Maintenance Period|Adverse Event|4|||
48654567|NCT01406938|156589739|FG005|Maintenance Period|Adverse Event|2|||
48753982|NCT02289690|156946569|FG009|Overall Study|Sponsor Discontinued Study|15|||
48753983|NCT02289690|156946560|FG000|Overall Study|Other|0|||
48753984|NCT02289690|156946561|FG001|Overall Study|Other|0|||
48753985|NCT02289690|156946562|FG002|Overall Study|Other|0|||
48753986|NCT02289690|156946563|FG003|Overall Study|Other|1|||
48753987|NCT02289690|156946564|FG004|Overall Study|Other|1|||
48753988|NCT02289690|156946565|FG005|Overall Study|Other|0|||
48753989|NCT02289690|156946566|FG006|Overall Study|Other|1|||
48753990|NCT02289690|156946567|FG007|Overall Study|Other|2|||
48753991|NCT02289690|156946568|FG008|Overall Study|Other|3|||
48753992|NCT02289690|156946569|FG009|Overall Study|Other|1|||
48753993|NCT04273217|156946570|FG000|Overall Study|Lost to Follow-up|0|||
48753994|NCT04273217|156946571|FG001|Overall Study|Lost to Follow-up|0|||
48753995|NCT04273217|156946572|FG002|Overall Study|Lost to Follow-up|0|||
48753996|NCT04273217|156946573|FG003|Overall Study|Lost to Follow-up|0|||
48753997|NCT04273217|156946574|FG004|Overall Study|Lost to Follow-up|0|||
48753998|NCT04273217|156946575|FG005|Overall Study|Lost to Follow-up|1|||
48654568|NCT01406938|156589734|FG000|Maintenance Period|Death|0|||
48654569|NCT01406938|156589735|FG001|Maintenance Period|Death|0|||
48654570|NCT01406938|156589736|FG002|Maintenance Period|Death|0|||
48753999|NCT04273217|156946570|FG000|Overall Study|Participant non-compliance|0|||
48754000|NCT04273217|156946571|FG001|Overall Study|Participant non-compliance|0|||
48754001|NCT04273217|156946572|FG002|Overall Study|Participant non-compliance|0|||
48754002|NCT04273217|156946573|FG003|Overall Study|Participant non-compliance|0|||
48654571|NCT01406938|156589737|FG003|Maintenance Period|Death|0|||
48654572|NCT01406938|156589738|FG004|Maintenance Period|Death|1|||
48754003|NCT04273217|156946574|FG004|Overall Study|Participant non-compliance|1|||
48754004|NCT04273217|156946575|FG005|Overall Study|Participant non-compliance|0|||
48754005|NCT04273217|156946570|FG000|Overall Study|Positive urine drug screen|1|||
48754006|NCT04273217|156946571|FG001|Overall Study|Positive urine drug screen|0|||
48754007|NCT04273217|156946572|FG002|Overall Study|Positive urine drug screen|1|||
48654573|NCT01406938|156589739|FG005|Maintenance Period|Death|0|||
48654574|NCT01406938|156589734|FG000|Maintenance Period|Subject/guardian decision|0|||
48754008|NCT04273217|156946573|FG003|Overall Study|Positive urine drug screen|0|||
48754009|NCT04273217|156946574|FG004|Overall Study|Positive urine drug screen|0|||
48754010|NCT04273217|156946575|FG005|Overall Study|Positive urine drug screen|1|||
48754011|NCT00779467|156946578|FG000|Overall Study|Lack of Efficacy|11|||
48754012|NCT00779467|156946579|FG001|Overall Study|Lack of Efficacy|2|||
48754013|NCT00779467|156946580|FG002|Overall Study|Lack of Efficacy|6|||
48754014|NCT00779467|156946581|FG003|Overall Study|Lack of Efficacy|11|||
48754015|NCT00779467|156946578|FG000|Overall Study|failed inclusion criteria|3|||
48754016|NCT00779467|156946579|FG001|Overall Study|failed inclusion criteria|3|||
48754017|NCT00779467|156946580|FG002|Overall Study|failed inclusion criteria|1|||
48754018|NCT00779467|156946581|FG003|Overall Study|failed inclusion criteria|2|||
48654575|NCT01406938|156589735|FG001|Maintenance Period|Subject/guardian decision|0|||
48654576|NCT01406938|156589736|FG002|Maintenance Period|Subject/guardian decision|11|||
48654577|NCT01406938|156589737|FG003|Maintenance Period|Subject/guardian decision|7|||
48654578|NCT01406938|156589738|FG004|Maintenance Period|Subject/guardian decision|10|||
48654579|NCT01406938|156589739|FG005|Maintenance Period|Subject/guardian decision|7|||
48334500|NCT01185340|155422184|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
48334501|NCT01185340|155422181|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48334502|NCT01185340|155422182|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
48334503|NCT01185340|155422183|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48334504|NCT01185340|155422184|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
48334505|NCT01185340|155422181|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
48334506|NCT01185340|155422182|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48654580|NCT01406938|156589734|FG000|Maintenance Period|Protocol Violation|0|||
48654581|NCT01406938|156589735|FG001|Maintenance Period|Protocol Violation|0|||
48654582|NCT01406938|156589736|FG002|Maintenance Period|Protocol Violation|2|||
48654583|NCT01406938|156589737|FG003|Maintenance Period|Protocol Violation|2|||
48654584|NCT01406938|156589738|FG004|Maintenance Period|Protocol Violation|2|||
48654585|NCT01406938|156589739|FG005|Maintenance Period|Protocol Violation|2|||
48654586|NCT01406938|156589734|FG000|Maintenance Period|Pregnancy|0|||
48654587|NCT01406938|156589735|FG001|Maintenance Period|Pregnancy|0|||
48654588|NCT01406938|156589736|FG002|Maintenance Period|Pregnancy|0|||
48654589|NCT01406938|156589737|FG003|Maintenance Period|Pregnancy|0|||
48654590|NCT01406938|156589738|FG004|Maintenance Period|Pregnancy|1|||
48654591|NCT01406938|156589739|FG005|Maintenance Period|Pregnancy|0|||
48654592|NCT01406938|156589734|FG000|Maintenance Period|Lost to Follow-up|0|||
48654593|NCT01406938|156589735|FG001|Maintenance Period|Lost to Follow-up|0|||
48654594|NCT01406938|156589736|FG002|Maintenance Period|Lost to Follow-up|0|||
48654595|NCT01406938|156589737|FG003|Maintenance Period|Lost to Follow-up|0|||
48654596|NCT01406938|156589738|FG004|Maintenance Period|Lost to Follow-up|4|||
48654597|NCT01406938|156589739|FG005|Maintenance Period|Lost to Follow-up|0|||
48654598|NCT01406938|156589734|FG000|Maintenance Period|Lack of Efficacy|0|||
48654599|NCT01406938|156589735|FG001|Maintenance Period|Lack of Efficacy|0|||
48654600|NCT01406938|156589736|FG002|Maintenance Period|Lack of Efficacy|2|||
48654601|NCT01406938|156589737|FG003|Maintenance Period|Lack of Efficacy|1|||
48654602|NCT01406938|156589738|FG004|Maintenance Period|Lack of Efficacy|3|||
48654603|NCT01406938|156589739|FG005|Maintenance Period|Lack of Efficacy|5|||
48654604|NCT01406938|156589734|FG000|Follow up|Lack of Efficacy|3|||
48654605|NCT01406938|156589735|FG001|Follow up|Lack of Efficacy|2|||
48654606|NCT01406938|156589736|FG002|Follow up|Lack of Efficacy|1|||
48654607|NCT01406938|156589737|FG003|Follow up|Lack of Efficacy|0|||
48654608|NCT01406938|156589738|FG004|Follow up|Lack of Efficacy|0|||
48654609|NCT01406938|156589739|FG005|Follow up|Lack of Efficacy|0|||
48654610|NCT01406938|156589734|FG000|Follow up|Patient/guardian decision|4|||
48654611|NCT01406938|156589735|FG001|Follow up|Patient/guardian decision|2|||
48654612|NCT01406938|156589736|FG002|Follow up|Patient/guardian decision|4|||
48654613|NCT01406938|156589737|FG003|Follow up|Patient/guardian decision|2|||
48654614|NCT01406938|156589738|FG004|Follow up|Patient/guardian decision|4|||
48654615|NCT01406938|156589739|FG005|Follow up|Patient/guardian decision|1|||
48654616|NCT01406938|156589734|FG000|Follow up|Protocol Violation|0|||
48654617|NCT01406938|156589735|FG001|Follow up|Protocol Violation|0|||
48654618|NCT01406938|156589736|FG002|Follow up|Protocol Violation|1|||
48654619|NCT01406938|156589737|FG003|Follow up|Protocol Violation|0|||
48654620|NCT01406938|156589738|FG004|Follow up|Protocol Violation|0|||
48654621|NCT01406938|156589739|FG005|Follow up|Protocol Violation|0|||
48654622|NCT01406938|156589734|FG000|Follow up|Physician Decision|0|||
48654623|NCT01406938|156589735|FG001|Follow up|Physician Decision|0|||
48654624|NCT01406938|156589736|FG002|Follow up|Physician Decision|2|||
48654625|NCT01406938|156589737|FG003|Follow up|Physician Decision|0|||
48654626|NCT01406938|156589738|FG004|Follow up|Physician Decision|3|||
48654627|NCT01406938|156589739|FG005|Follow up|Physician Decision|1|||
48654628|NCT01406938|156589734|FG000|Follow up|Lost to Follow-up|1|||
48654629|NCT01406938|156589735|FG001|Follow up|Lost to Follow-up|1|||
48654630|NCT01406938|156589736|FG002|Follow up|Lost to Follow-up|0|||
48654631|NCT01406938|156589737|FG003|Follow up|Lost to Follow-up|1|||
48334507|NCT01185340|155422183|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
48654632|NCT01406938|156589738|FG004|Follow up|Lost to Follow-up|2|||
48654633|NCT01406938|156589739|FG005|Follow up|Lost to Follow-up|1|||
48654634|NCT00713349|156589740|FG000|Overall Study|Protocol Violation|1|||
48654635|NCT05260073|156589741|FG000|Overall Study|Physician Decision|1|||
48654636|NCT05260073|156589741|FG000|Overall Study|Withdrawal by Subject|6|||
48654637|NCT05260073|156589741|FG000|Overall Study|Lost to Follow-up|14|||
48654638|NCT01885208|156589743|FG000|Overall Study|Unclassified|32|||
48654639|NCT01885208|156589744|FG001|Overall Study|Unclassified|38|||
48654640|NCT02516098|156589747|FG000|Period 1|Protocol Violation|1|||
48654641|NCT02516098|156589748|FG001|Period 1|Protocol Violation|0|||
48654642|NCT02516098|156589747|FG000|Washout After Period 1|Adverse Event|0|||
48334508|NCT01185340|155422184|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48334509|NCT01185340|155422181|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
48334510|NCT01185340|155422182|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
48334511|NCT01185340|155422183|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
48334512|NCT01185340|155422184|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
48334513|NCT01185340|155422181|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48334514|NCT01185340|155422182|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48334515|NCT01185340|155422183|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
48334516|NCT01185340|155422184|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
48334517|NCT00587171|155422187|FG000|Overall Study|Lost to Follow-up|1|||
48334518|NCT00587171|155422188|FG001|Overall Study|Lost to Follow-up|1|||
48334519|NCT05005247|155422189|FG000|Overall Study|Withdrawal by Subject|0|||
48334520|NCT05005247|155422190|FG001|Overall Study|Withdrawal by Subject|1|||
48334521|NCT05005247|155422191|FG002|Overall Study|Withdrawal by Subject|0|||
48334522|NCT00608959|155422192|FG000|Part 1|Did not meet eligibility criteria|1|||
48334523|NCT00990184|155422194|FG000|Overall Study|Physician Decision|1|||
48334524|NCT00355784|155422195|FG000|Overall Study|Withdrawal by Subject|0|||
48334525|NCT00355784|155422196|FG001|Overall Study|Withdrawal by Subject|0|||
48334526|NCT00355784|155422197|FG002|Overall Study|Withdrawal by Subject|2|||
48334527|NCT01279447|155422201|FG000|Overall Study|Lost to Follow-up|3|||
48334528|NCT01279447|155422202|FG001|Overall Study|Lost to Follow-up|1|||
48334529|NCT01919489|155422203|FG000|Overall Study|Rejected the need of injections|4|||
48334530|NCT01919489|155422204|FG001|Overall Study|Rejected the need of injections|7|||
48334531|NCT01919489|155422203|FG000|Overall Study|Adverse Event|10|||
48334532|NCT01919489|155422204|FG001|Overall Study|Adverse Event|0|||
48334533|NCT01919489|155422203|FG000|Overall Study|Hospital readmission|2|||
48334534|NCT01919489|155422204|FG001|Overall Study|Hospital readmission|9|||
48334535|NCT01919489|155422203|FG000|Overall Study|Death|2|||
48334536|NCT01919489|155422204|FG001|Overall Study|Death|1|||
48334537|NCT01919489|155422203|FG000|Overall Study|Lost to Follow-up|38|||
48334538|NCT01919489|155422204|FG001|Overall Study|Lost to Follow-up|27|||
48334539|NCT01322386|155422205|FG000|Overall Study|Protocol Violation|0|||
48334540|NCT01322386|155422206|FG001|Overall Study|Protocol Violation|1|||
48334541|NCT01322386|155422205|FG000|Overall Study|Physician Decision|0|||
48334542|NCT01322386|155422206|FG001|Overall Study|Physician Decision|1|||
48334543|NCT03840993|155422212|FG000|Overall Study|Adverse Event|1|||
48334544|NCT03840993|155422213|FG001|Overall Study|Adverse Event|0|||
48334545|NCT03840993|155422212|FG000|Overall Study|Lost to Follow-up|4|||
48334546|NCT03840993|155422213|FG001|Overall Study|Lost to Follow-up|0|||
48654643|NCT02516098|156589748|FG001|Washout After Period 1|Adverse Event|1|||
48654644|NCT02516098|156589747|FG000|Period 2|Withdrawal by Subject|0|||
48654645|NCT02516098|156589748|FG001|Period 2|Withdrawal by Subject|1|||
48654646|NCT01126268|156589751|FG000|Overall Study|Adverse Event|1|||
48654647|NCT04026009|156589752|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48654648|NCT04026009|156589753|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48654649|NCT04026009|156589754|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
48654650|NCT04026009|156589755|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48654651|NCT04026009|156589756|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
48654652|NCT04026009|156589752|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
48654653|NCT04026009|156589753|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
48654654|NCT04026009|156589754|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
48654655|NCT04026009|156589755|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
48654656|NCT04026009|156589756|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
48654657|NCT03425006|156589757|FG000|Overall Study|Withdrawal by Subject|1|||
48654658|NCT03425006|156589757|FG000|Overall Study|Physician Decision|1|||
48654659|NCT03425006|156589757|FG000|Overall Study|Death|1|||
48654660|NCT00778375|156589766|FG000|Overall Study|Ineligible|3|||
48654661|NCT03333252|156589767|FG000|Overall Study|Adverse Event|10|||
48654662|NCT03333252|156589768|FG001|Overall Study|Adverse Event|6|||
48654663|NCT03333252|156589769|FG002|Overall Study|Adverse Event|5|||
48754019|NCT00779467|156946578|FG000|Overall Study|missing data|1|||
48754020|NCT00779467|156946579|FG001|Overall Study|missing data|0|||
48334547|NCT03840993|155422212|FG000|Overall Study|Physician Decision|0|||
48334548|NCT03840993|155422213|FG001|Overall Study|Physician Decision|1|||
48334549|NCT03840993|155422212|FG000|Overall Study|Pregnancy|0|||
48334550|NCT03840993|155422213|FG001|Overall Study|Pregnancy|1|||
48654664|NCT03333252|156589770|FG003|Overall Study|Adverse Event|2|||
48334551|NCT03840993|155422212|FG000|Overall Study|Withdrawal by Subject|1|||
48654665|NCT03333252|156589767|FG000|Overall Study|Death|1|||
48654666|NCT03333252|156589768|FG001|Overall Study|Death|3|||
48654667|NCT03333252|156589769|FG002|Overall Study|Death|0|||
48754021|NCT00779467|156946580|FG002|Overall Study|missing data|1|||
48334552|NCT03840993|155422213|FG001|Overall Study|Withdrawal by Subject|3|||
48334553|NCT03840993|155422212|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
48334554|NCT03840993|155422213|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
48754022|NCT00779467|156946581|FG003|Overall Study|missing data|4|||
48754023|NCT00779467|156946578|FG000|Overall Study|technical issue|0|||
48754024|NCT00779467|156946579|FG001|Overall Study|technical issue|0|||
48754025|NCT00779467|156946580|FG002|Overall Study|technical issue|2|||
48754026|NCT00779467|156946581|FG003|Overall Study|technical issue|1|||
48754027|NCT00779467|156946578|FG000|Overall Study|unavailable research staff|0|||
48754028|NCT00779467|156946579|FG001|Overall Study|unavailable research staff|0|||
48754029|NCT00779467|156946580|FG002|Overall Study|unavailable research staff|0|||
48754030|NCT00779467|156946581|FG003|Overall Study|unavailable research staff|1|||
48754031|NCT00390858|156946594|FG000|Overall Study|Adverse Event|6|||
48754032|NCT00390858|156946595|FG001|Overall Study|Adverse Event|2|||
48754033|NCT00390858|156946594|FG000|Overall Study|Lack of Efficacy|0|||
48754034|NCT00390858|156946595|FG001|Overall Study|Lack of Efficacy|1|||
48754035|NCT00390858|156946594|FG000|Overall Study|Withdrawal by Subject|3|||
48754036|NCT00390858|156946595|FG001|Overall Study|Withdrawal by Subject|4|||
48754037|NCT00450450|156946596|FG000|Overall Study|Death|1|||
48754038|NCT00450450|156946597|FG001|Overall Study|Death|3|||
48754039|NCT00450450|156946596|FG000|Overall Study|Relapse|2|||
48754040|NCT00450450|156946597|FG001|Overall Study|Relapse|0|||
48754041|NCT00450450|156946596|FG000|Overall Study|Missing Data|2|||
48754042|NCT00450450|156946597|FG001|Overall Study|Missing Data|0|||
48754043|NCT01314443|156946598|FG000|Overall Study|Withdrawal by Subject|2|||
48754044|NCT01314443|156946599|FG001|Overall Study|Withdrawal by Subject|1|||
48754045|NCT01314443|156946600|FG002|Overall Study|Withdrawal by Subject|1|||
48754046|NCT01314443|156946601|FG003|Overall Study|Withdrawal by Subject|1|||
48754047|NCT01314443|156946598|FG000|Overall Study|Protocol Violation|2|||
48754048|NCT01314443|156946599|FG001|Overall Study|Protocol Violation|2|||
48754049|NCT01314443|156946600|FG002|Overall Study|Protocol Violation|1|||
48754050|NCT01314443|156946601|FG003|Overall Study|Protocol Violation|1|||
48754051|NCT00759954|156946603|FG000|Overall Study|Personal reason|1|||
48754052|NCT00759954|156946604|FG001|Overall Study|Personal reason|0|||
48754053|NCT00759954|156946603|FG000|Overall Study|Adverse Event|1|||
48754054|NCT00759954|156946604|FG001|Overall Study|Adverse Event|2|||
48754055|NCT02875860|156946605|FG000|Overall Study|Withdrawal by Subject|0|||
48754056|NCT02875860|156946606|FG001|Overall Study|Withdrawal by Subject|1|||
48754057|NCT01156311|156946607|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
48754058|NCT01156311|156946608|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
48754059|NCT01156311|156946609|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
48754060|NCT01156311|156946610|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
48754061|NCT01156311|156946607|FG000|2-Month Monotherapy Period|Physician Decision|0|||
48754062|NCT01156311|156946608|FG001|2-Month Monotherapy Period|Physician Decision|1|||
48754063|NCT01156311|156946609|FG002|2-Month Monotherapy Period|Physician Decision|0|||
48754064|NCT01156311|156946610|FG003|2-Month Monotherapy Period|Physician Decision|0|||
48754065|NCT01156311|156946607|FG000|2-Month Monotherapy Period|Other|1|||
48754066|NCT01156311|156946608|FG001|2-Month Monotherapy Period|Other|0|||
48754067|NCT01156311|156946609|FG002|2-Month Monotherapy Period|Other|0|||
48754068|NCT01156311|156946610|FG003|2-Month Monotherapy Period|Other|0|||
48754069|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
48334555|NCT02213094|155422214|FG000|Overall Study|Adverse Event|1|||
48334556|NCT02213094|155422215|FG001|Overall Study|Adverse Event|0|||
48334557|NCT00441168|155422216|FG000|Treatment Period|Death|3|||
48334558|NCT00441168|155422217|FG001|Treatment Period|Death|0|||
48334559|NCT00441168|155422216|FG000|Treatment Period|Adverse Event|1|||
48654668|NCT03333252|156589770|FG003|Overall Study|Death|0|||
48654669|NCT03333252|156589767|FG000|Overall Study|Lack of Efficacy|8|||
48654670|NCT03333252|156589768|FG001|Overall Study|Lack of Efficacy|4|||
48654671|NCT03333252|156589769|FG002|Overall Study|Lack of Efficacy|0|||
48654672|NCT03333252|156589770|FG003|Overall Study|Lack of Efficacy|7|||
48654673|NCT03333252|156589767|FG000|Overall Study|Lost to Follow-up|0|||
48654674|NCT03333252|156589768|FG001|Overall Study|Lost to Follow-up|5|||
48654675|NCT03333252|156589769|FG002|Overall Study|Lost to Follow-up|9|||
48754070|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
48754071|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
48754072|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
48754073|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
48334560|NCT00441168|155422217|FG001|Treatment Period|Adverse Event|2|||
48334561|NCT00441168|155422216|FG000|Treatment Period|Progressive Disease|0|||
48654676|NCT03333252|156589770|FG003|Overall Study|Lost to Follow-up|3|||
48654677|NCT03333252|156589767|FG000|Overall Study|Withdrawal by Subject|14|||
48654678|NCT03333252|156589768|FG001|Overall Study|Withdrawal by Subject|24|||
48654679|NCT03333252|156589769|FG002|Overall Study|Withdrawal by Subject|11|||
48654680|NCT03333252|156589770|FG003|Overall Study|Withdrawal by Subject|17|||
48654681|NCT01106651|156589772|FG000|Overall Study|Adverse Event|17|||
48754074|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
48754075|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
48754076|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
48754077|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
48754078|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
48334562|NCT00441168|155422217|FG001|Treatment Period|Progressive Disease|2|||
48334563|NCT00441168|155422216|FG000|Treatment Period|Protocol Violation|0|||
48654682|NCT01106651|156589773|FG001|Overall Study|Adverse Event|9|||
48654683|NCT01106651|156589774|FG002|Overall Study|Adverse Event|23|||
48654684|NCT01106651|156589772|FG000|Overall Study|Lost to Follow-up|8|||
48654685|NCT01106651|156589773|FG001|Overall Study|Lost to Follow-up|2|||
48654686|NCT01106651|156589774|FG002|Overall Study|Lost to Follow-up|6|||
48654687|NCT01106651|156589772|FG000|Overall Study|Physician Decision|4|||
48654688|NCT01106651|156589773|FG001|Overall Study|Physician Decision|3|||
48654689|NCT01106651|156589774|FG002|Overall Study|Physician Decision|1|||
48654690|NCT01106651|156589772|FG000|Overall Study|Protocol Violation|1|||
48654691|NCT01106651|156589773|FG001|Overall Study|Protocol Violation|2|||
48654692|NCT01106651|156589774|FG002|Overall Study|Protocol Violation|1|||
48654693|NCT01106651|156589772|FG000|Overall Study|Withdrawal by Subject|14|||
48654694|NCT01106651|156589773|FG001|Overall Study|Withdrawal by Subject|7|||
48654695|NCT01106651|156589774|FG002|Overall Study|Withdrawal by Subject|4|||
48334564|NCT00441168|155422217|FG001|Treatment Period|Protocol Violation|1|||
48334565|NCT00441168|155422216|FG000|Treatment Period|Lost to Follow-up|0|||
48334566|NCT00441168|155422217|FG001|Treatment Period|Lost to Follow-up|1|||
48334567|NCT00441168|155422216|FG000|Treatment Period|Withdrawal by Subject|3|||
48334568|NCT00441168|155422217|FG001|Treatment Period|Withdrawal by Subject|0|||
48334569|NCT00441168|155422216|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
48334570|NCT00441168|155422217|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
48334571|NCT00441168|155422216|FG000|Treatment Period|refractory disease|1|||
48334572|NCT00441168|155422217|FG001|Treatment Period|refractory disease|0|||
48334573|NCT00441168|155422216|FG000|Follow-up Period|Death|3|||
48334574|NCT00441168|155422217|FG001|Follow-up Period|Death|0|||
48334575|NCT00441168|155422216|FG000|Follow-up Period|Lost to Follow-up|5|||
48334576|NCT00441168|155422217|FG001|Follow-up Period|Lost to Follow-up|6|||
48334577|NCT00441168|155422216|FG000|Follow-up Period|Withdrawal by Subject|3|||
48334578|NCT00441168|155422217|FG001|Follow-up Period|Withdrawal by Subject|0|||
48334579|NCT00441168|155422216|FG000|Follow-up Period|Other|1|||
48334580|NCT00441168|155422217|FG001|Follow-up Period|Other|3|||
48334581|NCT02097056|155422218|FG000|Overall Study|Protocol Violation|2|||
48334582|NCT02097056|155422218|FG000|Overall Study|Withdrawal by Subject|15|||
48334583|NCT02097056|155422218|FG000|Overall Study|Lost to Follow-up|2|||
48334584|NCT02097056|155422218|FG000|Overall Study|Adverse Event|37|||
48334585|NCT02097056|155422218|FG000|Overall Study|Other|2|||
48334586|NCT02604199|155422219|FG000|Overall Study|Pregnancy|0|||
48334587|NCT02604199|155422220|FG001|Overall Study|Pregnancy|0|||
48334588|NCT02604199|155422221|FG002|Overall Study|Pregnancy|0|||
48334589|NCT02604199|155422222|FG003|Overall Study|Pregnancy|1|||
48334590|NCT02604199|155422219|FG000|Overall Study|Study terminated by sponsor|0|||
48334591|NCT02604199|155422220|FG001|Overall Study|Study terminated by sponsor|2|||
48334592|NCT02604199|155422221|FG002|Overall Study|Study terminated by sponsor|0|||
48334593|NCT02604199|155422222|FG003|Overall Study|Study terminated by sponsor|2|||
48334594|NCT02604199|155422219|FG000|Overall Study|Withdrawal by Subject|0|||
48334595|NCT02604199|155422220|FG001|Overall Study|Withdrawal by Subject|1|||
48334596|NCT02604199|155422221|FG002|Overall Study|Withdrawal by Subject|0|||
48334597|NCT02604199|155422222|FG003|Overall Study|Withdrawal by Subject|0|||
48334598|NCT04474691|155422225|FG000|Overall Study|Withdrawal by Subject|9|||
48334599|NCT00134056|155422226|FG000|Randomization|Not eligible for assigned treatment|22|||
48334600|NCT00134056|155422227|FG001|Randomization|Not eligible for assigned treatment|20|||
48334601|NCT00134056|155422226|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
48334602|NCT00134056|155422227|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
48654696|NCT01106651|156589772|FG000|Overall Study|Noncompliance with study drug|1|||
48654697|NCT01106651|156589773|FG001|Overall Study|Noncompliance with study drug|0|||
48654698|NCT01106651|156589774|FG002|Overall Study|Noncompliance with study drug|2|||
48654699|NCT01106651|156589772|FG000|Overall Study|Other|34|||
48654700|NCT01106651|156589773|FG001|Overall Study|Other|31|||
48654701|NCT01106651|156589774|FG002|Overall Study|Other|21|||
48654702|NCT01106651|156589772|FG000|Overall Study|Death|0|||
48654703|NCT01106651|156589773|FG001|Overall Study|Death|3|||
48654704|NCT01106651|156589774|FG002|Overall Study|Death|0|||
48654705|NCT01779856|156589775|FG000|Overall Study|Withdrawal by Subject|15|||
48334603|NCT00134056|155422226|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
48334604|NCT00134056|155422227|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
48334605|NCT00134056|155422226|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
48334606|NCT00134056|155422227|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
48334607|NCT00134056|155422226|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
48334608|NCT00134056|155422227|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
48334609|NCT01426217|155422230|FG000|Overall Study|lost sample|8|||
48334610|NCT01426217|155422231|FG001|Overall Study|lost sample|14|||
48334611|NCT02555397|155422232|FG000|Overall Study|Withdrawal by Subject|1|||
48334612|NCT02555397|155422233|FG001|Overall Study|Withdrawal by Subject|0|||
48654706|NCT01779856|156589775|FG000|Overall Study|Death|3|||
48654707|NCT01779856|156589775|FG000|Overall Study|Physician Decision|1|||
48334613|NCT02555397|155422234|FG002|Overall Study|Withdrawal by Subject|0|||
48334614|NCT02555397|155422235|FG003|Overall Study|Withdrawal by Subject|0|||
48334615|NCT02555397|155422236|FG004|Overall Study|Withdrawal by Subject|0|||
48334616|NCT00617708|155422241|FG000|Overall Study|Adverse Event|0|||
48334617|NCT00617708|155422242|FG001|Overall Study|Adverse Event|6|||
48334618|NCT00617708|155422243|FG002|Overall Study|Adverse Event|9|||
48334619|NCT00617708|155422241|FG000|Overall Study|Withdrawal by Subject|1|||
48334620|NCT00617708|155422242|FG001|Overall Study|Withdrawal by Subject|1|||
48334621|NCT00617708|155422243|FG002|Overall Study|Withdrawal by Subject|7|||
48334622|NCT00617708|155422241|FG000|Overall Study|Death|0|||
48334623|NCT00617708|155422242|FG001|Overall Study|Death|6|||
48334624|NCT00617708|155422243|FG002|Overall Study|Death|5|||
48334625|NCT00617708|155422241|FG000|Overall Study|Progression/Relapse|7|||
48334626|NCT00617708|155422242|FG001|Overall Study|Progression/Relapse|40|||
48334627|NCT00617708|155422243|FG002|Overall Study|Progression/Relapse|36|||
48334628|NCT00617708|155422241|FG000|Overall Study|Not protocol specified|1|||
48334629|NCT00617708|155422242|FG001|Overall Study|Not protocol specified|4|||
48334630|NCT00617708|155422243|FG002|Overall Study|Not protocol specified|2|||
48334631|NCT00617708|155422241|FG000|Overall Study|Not eligible|1|||
48334632|NCT00617708|155422242|FG001|Overall Study|Not eligible|3|||
48334633|NCT00617708|155422243|FG002|Overall Study|Not eligible|5|||
48334634|NCT03747575|155422244|FG000|Overall Study|Withdrawal by Subject|6|||
48334635|NCT03747575|155422245|FG001|Overall Study|Withdrawal by Subject|3|||
48334636|NCT03747575|155422244|FG000|Overall Study|Lost to Follow-up|3|||
48334637|NCT03747575|155422245|FG001|Overall Study|Lost to Follow-up|3|||
48334638|NCT03747575|155422244|FG000|Overall Study|Adverse Event|0|||
48334639|NCT03747575|155422245|FG001|Overall Study|Adverse Event|1|||
48334640|NCT03615404|155422246|FG000|Overall Study|Death|1|||
48334641|NCT03615404|155422246|FG000|Overall Study|vaccine did not pass quality assurance|1|||
48334642|NCT00257556|155422247|FG000|Overall Study|Adverse Event|1|||
48334643|NCT00257556|155422248|FG001|Overall Study|Adverse Event|4|||
48334644|NCT00257556|155422247|FG000|Overall Study|Physician Decision|6|||
48334645|NCT00257556|155422248|FG001|Overall Study|Physician Decision|0|||
48334646|NCT00257556|155422247|FG000|Overall Study|Did not meet hCG criterion|3|||
48334647|NCT00257556|155422248|FG001|Overall Study|Did not meet hCG criterion|0|||
48334648|NCT00257556|155422247|FG000|Overall Study|other reason|4|||
48334649|NCT00257556|155422248|FG001|Overall Study|other reason|6|||
48334650|NCT01697956|155422249|FG000|Overall Study|Protocol Violation|1|||
48334651|NCT01697956|155422250|FG001|Overall Study|Protocol Violation|1|||
48334652|NCT00805441|155422251|FG000|Overall Study|Adverse Event|5|||
48334653|NCT00805441|155422252|FG001|Overall Study|Adverse Event|2|||
48334654|NCT00805441|155422251|FG000|Overall Study|Lack of Efficacy|0|||
48334655|NCT00805441|155422252|FG001|Overall Study|Lack of Efficacy|2|||
48334656|NCT00805441|155422251|FG000|Overall Study|Protocol Violation|4|||
48334657|NCT00805441|155422252|FG001|Overall Study|Protocol Violation|8|||
48334658|NCT00805441|155422251|FG000|Overall Study|Lost to Follow-up|10|||
48654708|NCT01779856|156589775|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
48334659|NCT00805441|155422252|FG001|Overall Study|Lost to Follow-up|13|||
48334660|NCT00805441|155422251|FG000|Overall Study|Withdrawal by Subject|15|||
48334661|NCT00805441|155422252|FG001|Overall Study|Withdrawal by Subject|9|||
48334662|NCT00805441|155422251|FG000|Overall Study|Physician Decision|0|||
48334663|NCT00805441|155422252|FG001|Overall Study|Physician Decision|1|||
48334664|NCT00805441|155422251|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
48334665|NCT00805441|155422252|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
48334666|NCT00141271|155422253|FG000|Overall Study|Adverse Event|31|||
48334667|NCT00141271|155422254|FG001|Overall Study|Adverse Event|19|||
48334668|NCT00141271|155422255|FG002|Overall Study|Adverse Event|17|||
48654709|NCT01779856|156589775|FG000|Overall Study|Delays in scheduling implant|1|||
48654710|NCT01779856|156589775|FG000|Overall Study|Subject ineligible for Implant|2|||
48654711|NCT03276026|156589785|FG000|Overall Study|Protocol Violation|1|||
48654712|NCT03276026|156589786|FG001|Overall Study|Protocol Violation|0|||
48654713|NCT02247011|156589787|FG000|Overall Study|Poor quality of radiological results|125|||
48654714|NCT01944098|156589790|FG000|Overall Study|Physician Decision|1|||
48654715|NCT01944098|156589791|FG001|Overall Study|Physician Decision|0|||
48654716|NCT00920387|156589792|FG000|Stage 1|Adverse Event|1|||
48654717|NCT00920387|156589793|FG001|Stage 1|Adverse Event|0|||
48654718|NCT00920387|156589794|FG002|Stage 1|Adverse Event|0|||
48654719|NCT00503581|156589795|FG000|Overall Study|Study closed|3|||
48654720|NCT00503581|156589796|FG001|Overall Study|Study closed|4|||
48654721|NCT00503581|156589797|FG002|Overall Study|Study closed|2|||
48654722|NCT00724854|156589798|FG000|Overall Study|Lack of Efficacy|187|||
48654723|NCT00724854|156589799|FG001|Overall Study|Lack of Efficacy|13|||
48654724|NCT00724854|156589798|FG000|Overall Study|Lost to Follow-up|87|||
48654725|NCT00724854|156589799|FG001|Overall Study|Lost to Follow-up|10|||
48334669|NCT00141271|155422253|FG000|Overall Study|Laboratory Abnormality|2|||
48334670|NCT00141271|155422254|FG001|Overall Study|Laboratory Abnormality|1|||
48334671|NCT00141271|155422255|FG002|Overall Study|Laboratory Abnormality|1|||
48334672|NCT00141271|155422253|FG000|Overall Study|Lack of Efficacy|7|||
48334673|NCT00141271|155422254|FG001|Overall Study|Lack of Efficacy|7|||
48654726|NCT00724854|156589798|FG000|Overall Study|Adverse Event|62|||
48334674|NCT00141271|155422255|FG002|Overall Study|Lack of Efficacy|3|||
48334675|NCT00141271|155422253|FG000|Overall Study|Lost to Follow-up|15|||
48334676|NCT00141271|155422254|FG001|Overall Study|Lost to Follow-up|15|||
48334677|NCT00141271|155422255|FG002|Overall Study|Lost to Follow-up|21|||
48334678|NCT00141271|155422253|FG000|Overall Study|Withdrawal by Subject|14|||
48334679|NCT00141271|155422254|FG001|Overall Study|Withdrawal by Subject|9|||
48334680|NCT00141271|155422255|FG002|Overall Study|Withdrawal by Subject|10|||
48334681|NCT00141271|155422253|FG000|Overall Study|Other|11|||
48334682|NCT00141271|155422254|FG001|Overall Study|Other|12|||
48334683|NCT00141271|155422255|FG002|Overall Study|Other|5|||
48334684|NCT04382053|155422262|FG000|Overall Study|Death|6|||
48334685|NCT04382053|155422263|FG001|Overall Study|Death|8|||
48334686|NCT04382053|155422262|FG000|Overall Study|Lost to Follow-up|0|||
48334687|NCT04382053|155422263|FG001|Overall Study|Lost to Follow-up|2|||
48334688|NCT04382053|155422262|FG000|Overall Study|Protocol Deviation|1|||
48334689|NCT04382053|155422263|FG001|Overall Study|Protocol Deviation|2|||
48334690|NCT04382053|155422262|FG000|Overall Study|Withdrawal by Subject|2|||
48334691|NCT04382053|155422263|FG001|Overall Study|Withdrawal by Subject|1|||
48654727|NCT00724854|156589799|FG001|Overall Study|Adverse Event|4|||
48654728|NCT00724854|156589798|FG000|Overall Study|Other|42|||
48654729|NCT00724854|156589799|FG001|Overall Study|Other|3|||
48654730|NCT00724854|156589798|FG000|Overall Study|Death|11|||
48654731|NCT00724854|156589799|FG001|Overall Study|Death|0|||
48654732|NCT00724854|156589798|FG000|Overall Study|Change of treatment|7|||
48654733|NCT00724854|156589799|FG001|Overall Study|Change of treatment|0|||
48654734|NCT00724854|156589798|FG000|Overall Study|Withdrawal by Subject|5|||
48654735|NCT00724854|156589799|FG001|Overall Study|Withdrawal by Subject|0|||
48654736|NCT00724854|156589798|FG000|Overall Study|Adverse event + lack of efficacy|2|||
48654737|NCT00724854|156589799|FG001|Overall Study|Adverse event + lack of efficacy|1|||
48654738|NCT01096368|156589800|FG000|Overall Study|Death|0|||
48654739|NCT01096368|156589801|FG001|Overall Study|Death|1|||
48654740|NCT01096368|156589802|FG002|Overall Study|Death|0|||
48654741|NCT01096368|156589803|FG003|Overall Study|Death|0|||
48654742|NCT01096368|156589804|FG004|Overall Study|Death|0|||
48654743|NCT01096368|156589800|FG000|Overall Study|Physician Decision|0|||
48654744|NCT01096368|156589801|FG001|Overall Study|Physician Decision|13|||
48654745|NCT01096368|156589802|FG002|Overall Study|Physician Decision|2|||
48654746|NCT01096368|156589803|FG003|Overall Study|Physician Decision|4|||
48654747|NCT01096368|156589804|FG004|Overall Study|Physician Decision|6|||
48654748|NCT01096368|156589800|FG000|Overall Study|Withdrawal by Subject|0|||
48654749|NCT01096368|156589801|FG001|Overall Study|Withdrawal by Subject|52|||
48654750|NCT01096368|156589802|FG002|Overall Study|Withdrawal by Subject|0|||
48654751|NCT01096368|156589803|FG003|Overall Study|Withdrawal by Subject|10|||
48654752|NCT01096368|156589804|FG004|Overall Study|Withdrawal by Subject|14|||
48754079|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
48754080|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
48754081|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
48754082|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
48754083|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
48754084|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
48754085|NCT01156311|156946607|FG000|6-month Add-on Therapy Period|Other|0|||
48754086|NCT01156311|156946608|FG001|6-month Add-on Therapy Period|Other|0|||
48754087|NCT01156311|156946609|FG002|6-month Add-on Therapy Period|Other|1|||
48754088|NCT01156311|156946610|FG003|6-month Add-on Therapy Period|Other|2|||
48754089|NCT00372112|156946621|FG000|Overall Study|Adverse Event|0|||
48754090|NCT00372112|156946622|FG001|Overall Study|Adverse Event|1|||
48754091|NCT00372112|156946623|FG002|Overall Study|Adverse Event|1|||
48754092|NCT00372112|156946624|FG003|Overall Study|Adverse Event|1|||
48754093|NCT00372112|156946621|FG000|Overall Study|Withdrawal by Subject|0|||
48754094|NCT00372112|156946622|FG001|Overall Study|Withdrawal by Subject|0|||
48754095|NCT00372112|156946623|FG002|Overall Study|Withdrawal by Subject|2|||
48754096|NCT00372112|156946624|FG003|Overall Study|Withdrawal by Subject|1|||
48754097|NCT00372112|156946621|FG000|Overall Study|Exacerbation|0|||
48334692|NCT00267865|155422273|FG000|Induction Treatment|Died before completing.|2|||
48334693|NCT00267865|155422273|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
48334694|NCT03686176|155422274|FG000|Overall Study|Procedure cancelled|1|||
48334695|NCT03686176|155422275|FG001|Overall Study|Procedure cancelled|0|||
48334696|NCT03686176|155422276|FG002|Overall Study|Procedure cancelled|0|||
48334697|NCT03686176|155422274|FG000|Overall Study|VR Malfunction|1|||
48654753|NCT01096368|156589800|FG000|Overall Study|Ineligible|0|||
48654754|NCT01096368|156589801|FG001|Overall Study|Ineligible|3|||
48654755|NCT01096368|156589802|FG002|Overall Study|Ineligible|2|||
48654756|NCT01096368|156589803|FG003|Overall Study|Ineligible|0|||
48654757|NCT01096368|156589804|FG004|Overall Study|Ineligible|25|||
48654758|NCT01096368|156589800|FG000|Overall Study|Did not start treatment|0|||
48654759|NCT01096368|156589801|FG001|Overall Study|Did not start treatment|4|||
48654760|NCT01096368|156589802|FG002|Overall Study|Did not start treatment|4|||
48754098|NCT00372112|156946622|FG001|Overall Study|Exacerbation|0|||
48334698|NCT03686176|155422275|FG001|Overall Study|VR Malfunction|0|||
48654761|NCT01096368|156589803|FG003|Overall Study|Did not start treatment|0|||
48654762|NCT01096368|156589804|FG004|Overall Study|Did not start treatment|0|||
48654763|NCT01096368|156589800|FG000|Overall Study|Progressive disease|0|||
48654764|NCT01096368|156589801|FG001|Overall Study|Progressive disease|6|||
48334699|NCT03686176|155422276|FG002|Overall Study|VR Malfunction|0|||
48334700|NCT00390806|155422282|FG000|Overall Study|Lost to Follow-up|7|||
48334701|NCT00390806|155422283|FG001|Overall Study|Lost to Follow-up|6|||
48334702|NCT00390806|155422282|FG000|Overall Study|Protocol Violation|2|||
48334703|NCT00390806|155422283|FG001|Overall Study|Protocol Violation|2|||
48334704|NCT00390806|155422282|FG000|Overall Study|Withdrawal by Subject|12|||
48334705|NCT00390806|155422283|FG001|Overall Study|Withdrawal by Subject|15|||
48334706|NCT00390806|155422282|FG000|Overall Study|Investigator Decision|4|||
48654765|NCT01096368|156589802|FG002|Overall Study|Progressive disease|0|||
48654766|NCT01096368|156589803|FG003|Overall Study|Progressive disease|10|||
48654767|NCT01096368|156589804|FG004|Overall Study|Progressive disease|3|||
48654768|NCT01096368|156589800|FG000|Overall Study|Other|0|||
48654769|NCT01096368|156589801|FG001|Overall Study|Other|0|||
48654770|NCT01096368|156589802|FG002|Overall Study|Other|1|||
48654771|NCT01096368|156589803|FG003|Overall Study|Other|0|||
48654772|NCT01096368|156589804|FG004|Overall Study|Other|0|||
48654773|NCT01096368|156589800|FG000|Overall Study|Treated with institutional review|0|||
48654774|NCT01096368|156589801|FG001|Overall Study|Treated with institutional review|0|||
48654775|NCT01096368|156589802|FG002|Overall Study|Treated with institutional review|0|||
48654776|NCT01096368|156589803|FG003|Overall Study|Treated with institutional review|0|||
48654777|NCT01096368|156589804|FG004|Overall Study|Treated with institutional review|1|||
48654778|NCT03070223|156589805|FG000|Overall Study|Lost to Follow-up|34|||
48654779|NCT03070223|156589806|FG001|Overall Study|Lost to Follow-up|27|||
48654780|NCT03070223|156589805|FG000|Overall Study|Withdrawal by Subject|12|||
48654781|NCT03070223|156589806|FG001|Overall Study|Withdrawal by Subject|22|||
48654782|NCT03070223|156589805|FG000|Overall Study|Protocol Violation|0|||
48654783|NCT03070223|156589806|FG001|Overall Study|Protocol Violation|1|||
48654784|NCT02566785|156589809|FG000|Overall Study|Lost to Follow-up|0|||
48654785|NCT02566785|156589810|FG001|Overall Study|Lost to Follow-up|2|||
48654786|NCT02566785|156589809|FG000|Overall Study|Worsening condition|1|||
48654787|NCT02566785|156589810|FG001|Overall Study|Worsening condition|1|||
48654788|NCT03219034|156589811|FG000|Overall Study|Lost to Follow-up|9|||
48654789|NCT03219034|156589812|FG001|Overall Study|Lost to Follow-up|13|||
48654790|NCT03219034|156589811|FG000|Overall Study|Additional dental work needed|1|||
48654791|NCT03219034|156589812|FG001|Overall Study|Additional dental work needed|0|||
48654792|NCT03219034|156589811|FG000|Overall Study|UPPP Surgery|1|||
48654793|NCT03219034|156589812|FG001|Overall Study|UPPP Surgery|0|||
48654794|NCT03219034|156589811|FG000|Overall Study|Dental sensitivity|0|||
48654795|NCT03219034|156589812|FG001|Overall Study|Dental sensitivity|1|||
48654796|NCT03219034|156589811|FG000|Overall Study|Death in family|0|||
48654797|NCT03219034|156589812|FG001|Overall Study|Death in family|1|||
48654798|NCT00118846|156589813|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
48654799|NCT00118846|156589814|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
48654800|NCT00118846|156589813|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
48654801|NCT00118846|156589814|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
48654802|NCT00118846|156589813|FG000|Overall Study|Physician Decision|1|||
48654803|NCT00118846|156589814|FG001|Overall Study|Physician Decision|0|||
48654804|NCT00118846|156589813|FG000|Overall Study|Medical condition|2|||
48654805|NCT00118846|156589814|FG001|Overall Study|Medical condition|2|||
48654806|NCT00118846|156589813|FG000|Overall Study|Lost to Follow-up|0|||
48654807|NCT00118846|156589814|FG001|Overall Study|Lost to Follow-up|2|||
48654808|NCT00118846|156589813|FG000|Overall Study|Personal reason|4|||
48654809|NCT00118846|156589814|FG001|Overall Study|Personal reason|5|||
48654810|NCT01597908|156589818|FG000|Randomized Phase|Death|217|||
48654811|NCT01597908|156589819|FG001|Randomized Phase|Death|238|||
48654812|NCT01597908|156589820|FG002|Randomized Phase|Death|0|||
48654813|NCT01597908|156589818|FG000|Randomized Phase|Sponsor Decision|93|||
48654814|NCT01597908|156589819|FG001|Randomized Phase|Sponsor Decision|39|||
48654815|NCT01597908|156589820|FG002|Randomized Phase|Sponsor Decision|0|||
48334707|NCT00390806|155422283|FG001|Overall Study|Investigator Decision|6|||
48334708|NCT00390806|155422282|FG000|Overall Study|Death|1|||
48654816|NCT01597908|156589818|FG000|Randomized Phase|Lost to Follow-up|9|||
48654817|NCT01597908|156589819|FG001|Randomized Phase|Lost to Follow-up|16|||
48654818|NCT01597908|156589820|FG002|Randomized Phase|Lost to Follow-up|0|||
48654819|NCT01597908|156589818|FG000|Randomized Phase|Physician Decision|6|||
48654820|NCT01597908|156589819|FG001|Randomized Phase|Physician Decision|3|||
48654821|NCT01597908|156589820|FG002|Randomized Phase|Physician Decision|0|||
48334709|NCT00390806|155422283|FG001|Overall Study|Death|0|||
48334710|NCT00390806|155422282|FG000|Overall Study|Physician Decision|0|||
48654822|NCT01597908|156589818|FG000|Randomized Phase|Withdrawal by Subject|26|||
48654823|NCT01597908|156589819|FG001|Randomized Phase|Withdrawal by Subject|22|||
48654824|NCT01597908|156589820|FG002|Randomized Phase|Withdrawal by Subject|0|||
48334711|NCT00390806|155422283|FG001|Overall Study|Physician Decision|1|||
48654825|NCT01597908|156589818|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
48654826|NCT01597908|156589819|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
48654827|NCT01597908|156589820|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
48654828|NCT01597908|156589818|FG000|Crossover Phase|Death|0|||
48654829|NCT01597908|156589819|FG001|Crossover Phase|Death|0|||
48654830|NCT01597908|156589820|FG002|Crossover Phase|Death|11|||
48654831|NCT01597908|156589818|FG000|Crossover Phase|Withdrawal by Subject|0|||
48334712|NCT00390806|155422282|FG000|Overall Study|Ongoing|4|||
48334713|NCT00390806|155422283|FG001|Overall Study|Ongoing|2|||
48334714|NCT02942771|155422284|FG000|Overall Study|Adverse Event|1|||
48334715|NCT02942771|155422285|FG001|Overall Study|Adverse Event|0|||
48334716|NCT02942771|155422286|FG002|Overall Study|Adverse Event|0|||
48334717|NCT02942771|155422287|FG003|Overall Study|Adverse Event|0|||
48334718|NCT02942771|155422288|FG004|Overall Study|Adverse Event|2|||
48334719|NCT02942771|155422284|FG000|Overall Study|Lost to Follow-up|1|||
48334720|NCT02942771|155422285|FG001|Overall Study|Lost to Follow-up|0|||
48334721|NCT02942771|155422286|FG002|Overall Study|Lost to Follow-up|0|||
48334722|NCT02942771|155422287|FG003|Overall Study|Lost to Follow-up|0|||
48334723|NCT02942771|155422288|FG004|Overall Study|Lost to Follow-up|0|||
48334724|NCT02942771|155422284|FG000|Overall Study|Withdrawal by Subject|1|||
48334725|NCT02942771|155422285|FG001|Overall Study|Withdrawal by Subject|0|||
48334726|NCT02942771|155422286|FG002|Overall Study|Withdrawal by Subject|0|||
48334727|NCT02942771|155422287|FG003|Overall Study|Withdrawal by Subject|0|||
48334728|NCT02942771|155422288|FG004|Overall Study|Withdrawal by Subject|2|||
48334729|NCT01199302|155422289|FG000|Overall Study|Adverse Event|1|||
48334730|NCT01199302|155422290|FG001|Overall Study|Adverse Event|1|||
48334731|NCT01199302|155422291|FG002|Overall Study|Adverse Event|2|||
48334732|NCT01199302|155422292|FG003|Overall Study|Adverse Event|0|||
48334733|NCT01199302|155422289|FG000|Overall Study|Withdrawal by Subject|2|||
48334734|NCT01199302|155422290|FG001|Overall Study|Withdrawal by Subject|2|||
48334735|NCT01199302|155422291|FG002|Overall Study|Withdrawal by Subject|3|||
48334736|NCT01199302|155422292|FG003|Overall Study|Withdrawal by Subject|0|||
48334737|NCT01199302|155422289|FG000|Overall Study|Disease Progression|3|||
48334738|NCT01199302|155422290|FG001|Overall Study|Disease Progression|4|||
48334739|NCT01199302|155422291|FG002|Overall Study|Disease Progression|4|||
48334740|NCT01199302|155422292|FG003|Overall Study|Disease Progression|2|||
48334741|NCT01199302|155422289|FG000|Overall Study|Study Termination|13|||
48334742|NCT01199302|155422290|FG001|Overall Study|Study Termination|8|||
48334743|NCT01199302|155422291|FG002|Overall Study|Study Termination|11|||
48334744|NCT01199302|155422292|FG003|Overall Study|Study Termination|9|||
48334745|NCT01199302|155422289|FG000|Overall Study|Lost to Follow-up|0|||
48334746|NCT01199302|155422290|FG001|Overall Study|Lost to Follow-up|1|||
48334747|NCT01199302|155422291|FG002|Overall Study|Lost to Follow-up|0|||
48334748|NCT01199302|155422292|FG003|Overall Study|Lost to Follow-up|0|||
48334749|NCT01199302|155422289|FG000|Overall Study|Other|1|||
48334750|NCT01199302|155422290|FG001|Overall Study|Other|0|||
48334751|NCT01199302|155422291|FG002|Overall Study|Other|0|||
48334752|NCT01199302|155422292|FG003|Overall Study|Other|0|||
48334753|NCT04212299|155422298|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
48334754|NCT00264576|155423948|FG000|Overall Study|Lost to Follow-up|1|||
48334755|NCT00264576|155423949|FG001|Overall Study|Lost to Follow-up|1|||
48334756|NCT01668355|155423952|FG000|Overall Study|Death|3|||
48334757|NCT01668355|155423953|FG001|Overall Study|Death|1|||
48654832|NCT01597908|156589819|FG001|Crossover Phase|Withdrawal by Subject|0|||
48654833|NCT01597908|156589820|FG002|Crossover Phase|Withdrawal by Subject|3|||
48654834|NCT01597908|156589818|FG000|Crossover Phase|Sponsor Decision|0|||
48654835|NCT01597908|156589819|FG001|Crossover Phase|Sponsor Decision|0|||
48654836|NCT01597908|156589820|FG002|Crossover Phase|Sponsor Decision|20|||
48654837|NCT01439971|156589825|FG000|Overall Study|Required number in cohort dosed|0|||
48654838|NCT01439971|156589826|FG001|Overall Study|Required number in cohort dosed|1|||
48654839|NCT01439971|156589827|FG002|Overall Study|Required number in cohort dosed|2|||
48654840|NCT01439971|156589828|FG003|Overall Study|Required number in cohort dosed|0|||
48654841|NCT01439971|156589829|FG004|Overall Study|Required number in cohort dosed|1|||
48654842|NCT01468233|156589830|FG000|Treatment Period 1|Adverse Event|5|||
48654843|NCT01468233|156589831|FG001|Treatment Period 1|Adverse Event|3|||
48334758|NCT01668355|155423952|FG000|Overall Study|Withdrawal by Subject|6|||
48334759|NCT01668355|155423953|FG001|Overall Study|Withdrawal by Subject|1|||
48334760|NCT01277302|155423954|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
48334761|NCT01277302|155423955|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
48334762|NCT01277302|155423956|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
48334763|NCT01277302|155423954|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
48334764|NCT01277302|155423955|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
48334765|NCT01277302|155423956|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
48654844|NCT01468233|156589832|FG002|Treatment Period 1|Adverse Event|0|||
48754099|NCT00372112|156946623|FG002|Overall Study|Exacerbation|0|||
48334766|NCT01277302|155423954|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
48334767|NCT01277302|155423955|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
48334768|NCT01277302|155423956|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
48334769|NCT01277302|155423954|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
48654845|NCT01468233|156589833|FG003|Treatment Period 1|Adverse Event|0|||
48334770|NCT01277302|155423955|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
48654846|NCT01468233|156589834|FG004|Treatment Period 1|Adverse Event|0|||
48654847|NCT01468233|156589835|FG005|Treatment Period 1|Adverse Event|0|||
48654848|NCT01468233|156589830|FG000|Treatment Period 1|Withdrawal by Subject|3|||
48654849|NCT01468233|156589831|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48654850|NCT01468233|156589832|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48654851|NCT01468233|156589833|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48654852|NCT01468233|156589834|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48654853|NCT01468233|156589835|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48654854|NCT01468233|156589830|FG000|Treatment Period 1|Lost to Follow-up|3|||
48654855|NCT01468233|156589831|FG001|Treatment Period 1|Lost to Follow-up|0|||
48654856|NCT01468233|156589832|FG002|Treatment Period 1|Lost to Follow-up|0|||
48654857|NCT01468233|156589833|FG003|Treatment Period 1|Lost to Follow-up|0|||
48654858|NCT01468233|156589834|FG004|Treatment Period 1|Lost to Follow-up|0|||
48654859|NCT01468233|156589835|FG005|Treatment Period 1|Lost to Follow-up|0|||
48334771|NCT01277302|155423956|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
48334772|NCT01277302|155423954|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
48334773|NCT01277302|155423955|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
48334774|NCT01277302|155423956|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
48334775|NCT01277302|155423954|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
48334776|NCT01277302|155423955|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
48334777|NCT01277302|155423956|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
48334778|NCT01277302|155423954|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
48654860|NCT01468233|156589830|FG000|Treatment Period 1|Other|1|||
48654861|NCT01468233|156589831|FG001|Treatment Period 1|Other|1|||
48654862|NCT01468233|156589832|FG002|Treatment Period 1|Other|0|||
48654863|NCT01468233|156589833|FG003|Treatment Period 1|Other|0|||
48654864|NCT01468233|156589834|FG004|Treatment Period 1|Other|0|||
48654865|NCT01468233|156589835|FG005|Treatment Period 1|Other|0|||
48654866|NCT01468233|156589830|FG000|Treatment Period 2|Adverse Event|0|||
48654867|NCT01468233|156589831|FG001|Treatment Period 2|Adverse Event|0|||
48654868|NCT01468233|156589832|FG002|Treatment Period 2|Adverse Event|3|||
48654869|NCT01468233|156589833|FG003|Treatment Period 2|Adverse Event|0|||
48654870|NCT01468233|156589834|FG004|Treatment Period 2|Adverse Event|2|||
48654871|NCT01468233|156589835|FG005|Treatment Period 2|Adverse Event|1|||
48654872|NCT01468233|156589830|FG000|Treatment Period 2|Lack of Efficacy|0|||
48654873|NCT01468233|156589831|FG001|Treatment Period 2|Lack of Efficacy|0|||
48654874|NCT01468233|156589832|FG002|Treatment Period 2|Lack of Efficacy|9|||
48654875|NCT01468233|156589833|FG003|Treatment Period 2|Lack of Efficacy|2|||
48654876|NCT01468233|156589834|FG004|Treatment Period 2|Lack of Efficacy|0|||
48654877|NCT01468233|156589835|FG005|Treatment Period 2|Lack of Efficacy|1|||
48654878|NCT01468233|156589830|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48654879|NCT01468233|156589831|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48654880|NCT01468233|156589832|FG002|Treatment Period 2|Withdrawal by Subject|9|||
48654881|NCT01468233|156589833|FG003|Treatment Period 2|Withdrawal by Subject|1|||
48654882|NCT01468233|156589834|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48654883|NCT01468233|156589835|FG005|Treatment Period 2|Withdrawal by Subject|1|||
48654884|NCT01468233|156589830|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
48654885|NCT01468233|156589831|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
48654886|NCT01468233|156589832|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
48654887|NCT01468233|156589833|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
48654888|NCT01468233|156589834|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
48654889|NCT01468233|156589835|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
48654890|NCT01468233|156589830|FG000|Treatment Period 2|Lost to Follow-up|0|||
48654891|NCT01468233|156589831|FG001|Treatment Period 2|Lost to Follow-up|0|||
48654892|NCT01468233|156589832|FG002|Treatment Period 2|Lost to Follow-up|3|||
48654893|NCT01468233|156589833|FG003|Treatment Period 2|Lost to Follow-up|0|||
48654894|NCT01468233|156589834|FG004|Treatment Period 2|Lost to Follow-up|2|||
48654895|NCT01468233|156589835|FG005|Treatment Period 2|Lost to Follow-up|0|||
48654896|NCT01468233|156589830|FG000|Treatment Period 2|Other|0|||
48654897|NCT01468233|156589831|FG001|Treatment Period 2|Other|0|||
48654898|NCT01468233|156589832|FG002|Treatment Period 2|Other|3|||
48654899|NCT01468233|156589833|FG003|Treatment Period 2|Other|0|||
48654900|NCT01468233|156589834|FG004|Treatment Period 2|Other|1|||
48654901|NCT01468233|156589835|FG005|Treatment Period 2|Other|0|||
48654902|NCT00578877|156589836|FG000|Overall Study|Lost to Follow-up|8|||
48334779|NCT01277302|155423955|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
48334780|NCT01277302|155423956|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
48654903|NCT00578877|156589837|FG001|Overall Study|Lost to Follow-up|10|||
48654904|NCT00578877|156589836|FG000|Overall Study|early discontinue|61|||
48654905|NCT00578877|156589837|FG001|Overall Study|early discontinue|101|||
48754100|NCT00372112|156946624|FG003|Overall Study|Exacerbation|1|||
48754101|NCT00372112|156946621|FG000|Overall Study|PR >240 at Visit 3|0|||
48754102|NCT00372112|156946622|FG001|Overall Study|PR >240 at Visit 3|0|||
48754103|NCT00372112|156946623|FG002|Overall Study|PR >240 at Visit 3|0|||
48754104|NCT00372112|156946624|FG003|Overall Study|PR >240 at Visit 3|1|||
48754105|NCT00372112|156946621|FG000|Overall Study|Hepatitis B|1|||
48754106|NCT00372112|156946622|FG001|Overall Study|Hepatitis B|0|||
48754107|NCT00372112|156946623|FG002|Overall Study|Hepatitis B|0|||
48754108|NCT00372112|156946624|FG003|Overall Study|Hepatitis B|0|||
48754109|NCT00372112|156946621|FG000|Overall Study|Other-protocol violation|0|||
48754110|NCT00372112|156946622|FG001|Overall Study|Other-protocol violation|0|||
48754111|NCT00372112|156946623|FG002|Overall Study|Other-protocol violation|1|||
48754112|NCT00372112|156946624|FG003|Overall Study|Other-protocol violation|0|||
48754113|NCT00429104|156946630|FG000|Overall Study|Protocol Violation|1|||
48754114|NCT00642460|156946631|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
48754115|NCT00642460|156946632|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
48754116|NCT00642460|156946633|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
48754117|NCT00642460|156946634|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
48754118|NCT00642460|156946635|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
48754119|NCT00642460|156946636|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
48754120|NCT00642460|156946631|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
48754121|NCT00642460|156946632|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48754122|NCT00642460|156946633|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48754123|NCT00642460|156946634|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48754124|NCT00642460|156946635|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48754125|NCT00642460|156946636|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
48334781|NCT01277302|155423954|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
48334782|NCT01277302|155423955|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
48654906|NCT00578877|156589836|FG000|Overall Study|did not provide follow-up data|12|||
48654907|NCT00578877|156589837|FG001|Overall Study|did not provide follow-up data|17|||
48654908|NCT00721578|156589841|FG000|Overall Study|Death|1|||
48654909|NCT00721578|156589842|FG001|Overall Study|Death|1|||
48654910|NCT00721578|156589841|FG000|Overall Study|Withdrawal by Subject|1|||
48654911|NCT00721578|156589842|FG001|Overall Study|Withdrawal by Subject|1|||
48334783|NCT01277302|155423956|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
48334784|NCT01277302|155423954|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
48334785|NCT01277302|155423955|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
48334786|NCT01277302|155423956|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
48334787|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48334788|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48334789|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48334790|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
48334791|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48334792|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
48334793|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
48334794|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
48654912|NCT00855933|156589843|FG000|Overall Study|Withdrawal by Subject|0|||
48654913|NCT00855933|156589844|FG001|Overall Study|Withdrawal by Subject|1|||
48654914|NCT03372460|156589845|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
48654915|NCT03372460|156589846|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
48654916|NCT02374814|156589847|FG000|Overall Study|Lost to Follow-up|1|||
48654917|NCT02374814|156589848|FG001|Overall Study|Lost to Follow-up|1|||
48654918|NCT02374814|156589849|FG002|Overall Study|Lost to Follow-up|0|||
48654919|NCT02374814|156589850|FG003|Overall Study|Lost to Follow-up|1|||
48654920|NCT02374814|156589851|FG004|Overall Study|Lost to Follow-up|0|||
48654921|NCT02374814|156589852|FG005|Overall Study|Lost to Follow-up|0|||
48654922|NCT02374814|156589847|FG000|Overall Study|Withdrawal by Subject|0|||
48654923|NCT02374814|156589848|FG001|Overall Study|Withdrawal by Subject|0|||
48654924|NCT02374814|156589849|FG002|Overall Study|Withdrawal by Subject|1|||
48754126|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
48754127|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
48754128|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
48754129|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
48334795|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
48334796|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
48654925|NCT02374814|156589850|FG003|Overall Study|Withdrawal by Subject|1|||
48654926|NCT02374814|156589851|FG004|Overall Study|Withdrawal by Subject|0|||
48754130|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
48754131|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
48754132|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Death|0|||
48754133|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Death|1|||
48754134|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Death|0|||
48754135|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Death|2|||
48334797|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
48654927|NCT02374814|156589852|FG005|Overall Study|Withdrawal by Subject|0|||
48654928|NCT02220855|156591383|FG000|Overall Study|Adverse Event|8|||
48654929|NCT02220855|156591383|FG000|Overall Study|Disease Progression|5|||
48654930|NCT02220855|156591383|FG000|Overall Study|Withdrawal by Subject|1|||
48654931|NCT00790868|156591384|FG000|Overall Study|Withdrawal by Subject|4|||
48654932|NCT00790868|156591385|FG001|Overall Study|Withdrawal by Subject|5|||
48754136|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Death|0|||
48654933|NCT00790868|156591384|FG000|Overall Study|Lost to Follow-up|2|||
48654934|NCT00790868|156591385|FG001|Overall Study|Lost to Follow-up|12|||
48754137|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Death|0|||
48754138|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
48754139|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
48334798|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
48334799|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48334800|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48334801|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
48334802|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48334803|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48334804|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
48334805|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
48334806|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
48334807|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
48334808|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
48334809|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
48334810|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
48334811|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
48334812|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
48334813|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
48334814|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
48654935|NCT02998203|156591386|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
48654936|NCT02998203|156591387|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
48654937|NCT02998203|156591386|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
48654938|NCT02998203|156591387|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
48654939|NCT00978380|156591388|FG000|Overall Study|Protocol Violation|2|||
48654940|NCT00978380|156591388|FG000|Overall Study|Withdrawal criteria|9|||
48654941|NCT00978380|156591388|FG000|Overall Study|Unclassified|8|||
48654942|NCT02199314|156591391|FG000|Overall Study|Withdrawal by Subject|6|||
48654943|NCT02199314|156591391|FG000|Overall Study|Physician Decision|10|||
48654944|NCT04187144|156591392|FG000|Overall Study|Lost to Follow-up|12|||
48654945|NCT04187144|156591393|FG001|Overall Study|Lost to Follow-up|11|||
48654946|NCT04187144|156591392|FG000|Overall Study|Withdrawal by Subject|20|||
48654947|NCT04187144|156591393|FG001|Overall Study|Withdrawal by Subject|18|||
48654948|NCT04187144|156591392|FG000|Overall Study|Adverse Event|19|||
48654949|NCT04187144|156591393|FG001|Overall Study|Adverse Event|4|||
48654950|NCT04187144|156591392|FG000|Overall Study|Physician Decision|5|||
48654951|NCT04187144|156591393|FG001|Overall Study|Physician Decision|3|||
48654952|NCT04187144|156591392|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
48654953|NCT04187144|156591393|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
48654954|NCT04187144|156591392|FG000|Overall Study|Protocol Deviation|1|||
48654955|NCT04187144|156591393|FG001|Overall Study|Protocol Deviation|4|||
48654956|NCT01044745|156591394|FG000|Overall Study|Ineiligible|2|||
48654957|NCT04848220|156591395|FG000|Overall Study|Unable to proceed to study procedure|0|||
48654958|NCT04848220|156591396|FG001|Overall Study|Unable to proceed to study procedure|1|||
48654959|NCT04848220|156591397|FG002|Overall Study|Unable to proceed to study procedure|0|||
48654960|NCT04848220|156591395|FG000|Overall Study|Fractional flow not significant|0|||
48654961|NCT04848220|156591396|FG001|Overall Study|Fractional flow not significant|1|||
48654962|NCT04848220|156591397|FG002|Overall Study|Fractional flow not significant|0|||
48654963|NCT02403817|156591398|FG000|Overall Study|Withdrawal by Subject|5|||
48654964|NCT02403817|156591399|FG001|Overall Study|Withdrawal by Subject|0|||
48654965|NCT00559845|156591406|FG000|Overall Study|Withdrew Consent|1|||
48654966|NCT00559845|156591406|FG000|Overall Study|Disease Progression|1|||
48654967|NCT00559845|156591406|FG000|Overall Study|Adverse Event|3|||
48654968|NCT00559845|156591406|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
48654969|NCT00559845|156591406|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
48654970|NCT02242435|156591409|FG000|Overall Study|Lost to Follow-up|3|||
48754140|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
48654971|NCT02242435|156591410|FG001|Overall Study|Lost to Follow-up|4|||
48654972|NCT02242435|156591409|FG000|Overall Study|Adverse Event|3|||
48654973|NCT02242435|156591410|FG001|Overall Study|Adverse Event|2|||
48654974|NCT02242435|156591409|FG000|Overall Study|Withdrawal by Subject|13|||
48654975|NCT02242435|156591410|FG001|Overall Study|Withdrawal by Subject|8|||
48654976|NCT02242435|156591409|FG000|Overall Study|Death|0|||
48654977|NCT02242435|156591410|FG001|Overall Study|Death|1|||
48334815|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
48654978|NCT02242435|156591409|FG000|Overall Study|Protocol Violation|1|||
48654979|NCT02242435|156591410|FG001|Overall Study|Protocol Violation|0|||
48334816|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
48334817|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
48334818|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
48334819|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
48334820|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
48334821|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
48334822|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
48654980|NCT02242435|156591409|FG000|Overall Study|Physician Decision|0|||
48654981|NCT02242435|156591410|FG001|Overall Study|Physician Decision|1|||
48654982|NCT03895086|156591413|FG000|Overall Study|Early termination study|1|||
48654983|NCT03895086|156591414|FG001|Overall Study|Early termination study|0|||
48654984|NCT00459875|156591415|FG000|Overall Study|Ineligible participant|1|||
48654985|NCT00459875|156591415|FG000|Overall Study|Adverse Event|2|||
48654986|NCT02513485|156591416|FG000|Overall Study|Adverse Event|1|||
48654987|NCT02513485|156591417|FG001|Overall Study|Adverse Event|0|||
48654988|NCT05289271|156591418|FG000|Overall Study|Mistakenly allocated, untreated|1|||
48654989|NCT05289271|156591419|FG001|Overall Study|Mistakenly allocated, untreated|0|||
48654990|NCT03764631|156591420|FG000|Overall Study|Personal Reasons|3|||
48654991|NCT03764631|156591421|FG001|Overall Study|Personal Reasons|2|||
48654992|NCT03764631|156591420|FG000|Overall Study|Switching Therapy|3|||
48654993|NCT03764631|156591421|FG001|Overall Study|Switching Therapy|3|||
48654994|NCT03764631|156591420|FG000|Overall Study|Adverse Event|0|||
48654995|NCT03764631|156591421|FG001|Overall Study|Adverse Event|1|||
48654996|NCT03764631|156591420|FG000|Overall Study|Lost to Follow-up|33|||
48654997|NCT03764631|156591421|FG001|Overall Study|Lost to Follow-up|41|||
48654998|NCT03764631|156591420|FG000|Overall Study|No data as study site was closed|2|||
48654999|NCT03764631|156591421|FG001|Overall Study|No data as study site was closed|6|||
48655000|NCT03299881|156591422|FG000|Overall Study|Study Termination|17|||
48655001|NCT03299881|156591423|FG001|Overall Study|Study Termination|13|||
48655002|NCT02974855|156591424|FG000|Overall Study|Adverse Event|0|||
48655003|NCT02974855|156591425|FG001|Overall Study|Adverse Event|1|||
48655004|NCT02974855|156591426|FG002|Overall Study|Adverse Event|0|||
48655005|NCT02974855|156591427|FG003|Overall Study|Adverse Event|1|||
48655006|NCT02447250|156591435|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
48655007|NCT02447250|156591435|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
48655008|NCT02447250|156591435|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
48655009|NCT01265563|156591436|FG000|Overall Study|Withdrawal by Subject|0|||
48655010|NCT01265563|156591437|FG001|Overall Study|Withdrawal by Subject|1|||
48655011|NCT01265563|156591438|FG002|Overall Study|Withdrawal by Subject|1|||
48655012|NCT01265563|156591439|FG003|Overall Study|Withdrawal by Subject|0|||
48655013|NCT01265563|156591440|FG004|Overall Study|Withdrawal by Subject|2|||
48655014|NCT00873041|156591441|FG000|Core Study|Adverse Event|2|||
48655015|NCT00873041|156591442|FG001|Core Study|Adverse Event|3|||
48655016|NCT00873041|156591443|FG002|Core Study|Adverse Event|1|||
48655017|NCT00873041|156591441|FG000|Core Study|Withdrawal by Subject|1|||
48655018|NCT00873041|156591442|FG001|Core Study|Withdrawal by Subject|2|||
48655019|NCT00873041|156591443|FG002|Core Study|Withdrawal by Subject|2|||
48655020|NCT00873041|156591441|FG000|Core Study|Lost to Follow-up|3|||
48655021|NCT00873041|156591442|FG001|Core Study|Lost to Follow-up|1|||
48655022|NCT00873041|156591443|FG002|Core Study|Lost to Follow-up|0|||
48655023|NCT00873041|156591441|FG000|Core Study|Abnormal laboratory value|0|||
48655024|NCT00873041|156591442|FG001|Core Study|Abnormal laboratory value|0|||
48655025|NCT00873041|156591443|FG002|Core Study|Abnormal laboratory value|1|||
48655026|NCT00873041|156591441|FG000|Core Study|Protocol deviation|1|||
48655027|NCT00873041|156591442|FG001|Core Study|Protocol deviation|0|||
48655028|NCT00873041|156591443|FG002|Core Study|Protocol deviation|1|||
48655029|NCT00873041|156591441|FG000|Extension Study|Adverse Event|1|||
48655030|NCT00873041|156591442|FG001|Extension Study|Adverse Event|0|||
48655031|NCT00873041|156591443|FG002|Extension Study|Adverse Event|1|||
48655032|NCT00873041|156591441|FG000|Extension Study|Administrative reasons|0|||
48428050|NCT01518192|155754797|FG002|Overall Study|Lost to Follow-up|35|||
48655033|NCT00873041|156591442|FG001|Extension Study|Administrative reasons|0|||
48655034|NCT00873041|156591443|FG002|Extension Study|Administrative reasons|1|||
48655035|NCT03655054|156591444|FG000|Overall Study|Lost to Follow-up|1|||
48655036|NCT00543803|156591445|FG000|Overall Study|Adverse Event|14|||
48655037|NCT00543803|156591445|FG000|Overall Study|Lack of Efficacy|22|||
48655038|NCT00543803|156591445|FG000|Overall Study|Lost to Follow-up|20|||
48655039|NCT00543803|156591445|FG000|Overall Study|Other|86|||
48655040|NCT03359785|156591452|FG000|Overall Study|Protocol Violation|0|||
48334823|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
48334824|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
48334825|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
48334826|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
48334827|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
48334828|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
48334829|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
48334830|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
48334831|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
48334832|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
48334833|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
48334834|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
48334835|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
48334836|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
48334837|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
48334838|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
48334839|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
48334840|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
48334841|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
48334842|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
48334843|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
48334844|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
48334845|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
48334846|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
48334847|NCT03395197|155423957|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
48334848|NCT03395197|155423958|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
48334849|NCT03395197|155423959|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
48334850|NCT03395197|155423960|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
48655041|NCT03359785|156591453|FG001|Overall Study|Protocol Violation|1|||
48655042|NCT03359785|156591454|FG002|Overall Study|Protocol Violation|0|||
48655043|NCT03359785|156591455|FG003|Overall Study|Protocol Violation|0|||
48655044|NCT03359785|156591452|FG000|Overall Study|Early study termination due to study pause|0|||
48655045|NCT03359785|156591453|FG001|Overall Study|Early study termination due to study pause|0|||
48655046|NCT03359785|156591454|FG002|Overall Study|Early study termination due to study pause|2|||
48655047|NCT03359785|156591455|FG003|Overall Study|Early study termination due to study pause|0|||
48655048|NCT03359785|156591452|FG000|Overall Study|Withdrawal by Subject|2|||
48655049|NCT03359785|156591453|FG001|Overall Study|Withdrawal by Subject|2|||
48655050|NCT03359785|156591454|FG002|Overall Study|Withdrawal by Subject|0|||
48655051|NCT03359785|156591455|FG003|Overall Study|Withdrawal by Subject|0|||
48655052|NCT00557310|156591456|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
48655053|NCT00557310|156591456|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
48655054|NCT00557310|156591456|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
48655055|NCT00557310|156591456|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
48655056|NCT00557310|156591456|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
48655057|NCT00557310|156591456|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
48655058|NCT04659174|156591459|FG000|Overall Study|Sponsor decision to discontinue study|0|||
48655059|NCT04659174|156591460|FG001|Overall Study|Sponsor decision to discontinue study|2|||
48655060|NCT04659174|156591459|FG000|Overall Study|Lost to Follow-up|9|||
48655061|NCT04659174|156591460|FG001|Overall Study|Lost to Follow-up|11|||
48655062|NCT04659174|156591459|FG000|Overall Study|Adverse Event|8|||
48655063|NCT04659174|156591460|FG001|Overall Study|Adverse Event|5|||
48655064|NCT04659174|156591459|FG000|Overall Study|Withdrawal by Subject|17|||
48655065|NCT04659174|156591460|FG001|Overall Study|Withdrawal by Subject|33|||
48655066|NCT04659174|156591459|FG000|Overall Study|Progressive disease|0|||
48655067|NCT04659174|156591460|FG001|Overall Study|Progressive disease|2|||
48655068|NCT04659174|156591459|FG000|Overall Study|Other reasons|0|||
48655069|NCT04659174|156591460|FG001|Overall Study|Other reasons|2|||
48655070|NCT04659174|156591459|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
48655071|NCT04659174|156591460|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
48655072|NCT04659174|156591459|FG000|Overall Study|Alcohol or illegal drug use|0|||
48655073|NCT04659174|156591460|FG001|Overall Study|Alcohol or illegal drug use|3|||
48655074|NCT04659174|156591459|FG000|Overall Study|Violation of entry criteria|1|||
48655075|NCT04659174|156591460|FG001|Overall Study|Violation of entry criteria|0|||
48655076|NCT04659174|156591459|FG000|Overall Study|Death|0|||
48655077|NCT04659174|156591460|FG001|Overall Study|Death|1|||
48655078|NCT03650803|156591461|FG000|Overall Study|Lost to Follow-up|6|||
48655079|NCT02839720|156591464|FG000|Overall Study|Adverse Event|2|||
48655080|NCT02839720|156591464|FG000|Overall Study|Non-compliance|2|||
48655081|NCT02839720|156591464|FG000|Overall Study|Intercurrent Illness|1|||
48655082|NCT02839720|156591464|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
48655083|NCT02649218|156591465|FG000|Overall Study|Adverse Event|8|||
48655084|NCT02649218|156591465|FG000|Overall Study|Lack of Efficacy|8|||
48655085|NCT02649218|156591465|FG000|Overall Study|Pregnancy|3|||
48655086|NCT02649218|156591465|FG000|Overall Study|Protocol Violation|3|||
48655087|NCT02649218|156591465|FG000|Overall Study|Physician Decision|1|||
48655088|NCT02649218|156591465|FG000|Overall Study|Withdrawal by Subject|2|||
48655089|NCT01451931|156591466|FG000|Overall Study|Lost to Follow-up|17|||
48655090|NCT01451931|156591467|FG001|Overall Study|Lost to Follow-up|36|||
48655091|NCT01451931|156591468|FG002|Overall Study|Lost to Follow-up|21|||
48655092|NCT01451931|156591466|FG000|Overall Study|Withdrawal by Subject|16|||
48655093|NCT01451931|156591467|FG001|Overall Study|Withdrawal by Subject|22|||
48655094|NCT01451931|156591468|FG002|Overall Study|Withdrawal by Subject|22|||
48655095|NCT05593913|156591469|FG000|Overall Study|Insufficient image quality|39|||
48655096|NCT04470908|156591470|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
48655097|NCT00957944|156591479|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
48655098|NCT00957944|156591480|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
48655099|NCT00027378|156591485|FG000|Overall Study|Physician Decision|0|||
48655100|NCT00027378|156591486|FG001|Overall Study|Physician Decision|3|||
48655101|NCT00294645|156591491|FG000|Overall Study|Death|10|||
48655102|NCT00294645|156591492|FG001|Overall Study|Death|18|||
48655103|NCT00294645|156591491|FG000|Overall Study|Lost to Follow-up|1|||
48655104|NCT00294645|156591492|FG001|Overall Study|Lost to Follow-up|10|||
48655105|NCT00294645|156591491|FG000|Overall Study|Withdrawal by Subject|18|||
48655106|NCT00294645|156591492|FG001|Overall Study|Withdrawal by Subject|34|||
48655107|NCT00294645|156591491|FG000|Overall Study|Physician Decision|15|||
48754141|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
48754142|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
48754143|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
48754144|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
48754145|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
48754146|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
48754147|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
48754148|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
48754149|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
48754150|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
48754151|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
48754152|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
48655108|NCT00294645|156591492|FG001|Overall Study|Physician Decision|20|||
48655109|NCT00294645|156591491|FG000|Overall Study|Other|4|||
48655110|NCT00294645|156591492|FG001|Overall Study|Other|10|||
48655111|NCT01330628|156591493|FG000|Overall Study|Death|2|||
48655112|NCT01330628|156591494|FG001|Overall Study|Death|3|||
48655113|NCT01330628|156591493|FG000|Overall Study|Lost to Follow-up|5|||
48655114|NCT01330628|156591494|FG001|Overall Study|Lost to Follow-up|6|||
48655115|NCT01330628|156591493|FG000|Overall Study|Adverse Event|44|||
48655116|NCT01330628|156591494|FG001|Overall Study|Adverse Event|25|||
48655117|NCT01330628|156591493|FG000|Overall Study|Withdrawn|18|||
48655118|NCT01330628|156591494|FG001|Overall Study|Withdrawn|6|||
48655119|NCT01330628|156591493|FG000|Overall Study|Didn't receive study treatment|1|||
48655120|NCT01330628|156591494|FG001|Overall Study|Didn't receive study treatment|0|||
48655121|NCT00812006|156591495|FG000|Overall Study|Lost to Follow-up|0|||
48655122|NCT00812006|156591496|FG001|Overall Study|Lost to Follow-up|0|||
48655123|NCT00812006|156591497|FG002|Overall Study|Lost to Follow-up|2|||
48655124|NCT00812006|156591495|FG000|Overall Study|Physician Decision|0|||
48655125|NCT00812006|156591496|FG001|Overall Study|Physician Decision|0|||
48655126|NCT00812006|156591497|FG002|Overall Study|Physician Decision|1|||
48655127|NCT00812006|156591495|FG000|Overall Study|Withdrawal by Subject|2|||
48655128|NCT00812006|156591496|FG001|Overall Study|Withdrawal by Subject|1|||
48655129|NCT00812006|156591497|FG002|Overall Study|Withdrawal by Subject|1|||
48655130|NCT00812006|156591495|FG000|Overall Study|Lack of Qualifying Event|4|||
48655131|NCT00812006|156591496|FG001|Overall Study|Lack of Qualifying Event|2|||
48655132|NCT00812006|156591497|FG002|Overall Study|Lack of Qualifying Event|2|||
48655133|NCT01795495|156591498|FG000|Overall Study|Protocol Violation|1|||
48655134|NCT01795495|156591499|FG001|Overall Study|Protocol Violation|0|||
48655135|NCT01795495|156591500|FG002|Overall Study|Protocol Violation|1|||
48655136|NCT01795495|156591498|FG000|Overall Study|Physician Decision|0|||
48655137|NCT01795495|156591499|FG001|Overall Study|Physician Decision|0|||
48655138|NCT01795495|156591500|FG002|Overall Study|Physician Decision|1|||
48655139|NCT00098748|156591501|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
48754153|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
48655140|NCT00098748|156591502|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
48655141|NCT00098748|156591503|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
48754154|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
48754155|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
48754156|NCT00642460|156946631|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48754157|NCT00642460|156946632|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48754158|NCT00642460|156946633|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48754159|NCT00642460|156946634|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
48754160|NCT00642460|156946635|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48754161|NCT00642460|156946636|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
48334851|NCT03395197|155423961|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
48334852|NCT03395197|155423962|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
48334853|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|Death|0|||
48334854|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|Death|0|||
48334855|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|Death|0|||
48334856|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|Death|0|||
48655142|NCT00098748|156591501|FG000|Received Study Treatment|Death|2|||
48655143|NCT00098748|156591502|FG001|Received Study Treatment|Death|1|||
48655144|NCT00098748|156591503|FG002|Received Study Treatment|Death|2|||
48655145|NCT00098748|156591501|FG000|Received Study Treatment|Adverse Event|1|||
48655146|NCT00098748|156591502|FG001|Received Study Treatment|Adverse Event|2|||
48655147|NCT00098748|156591503|FG002|Received Study Treatment|Adverse Event|5|||
48655148|NCT00098748|156591501|FG000|Received Study Treatment|Lack of Efficacy|40|||
48655149|NCT00098748|156591502|FG001|Received Study Treatment|Lack of Efficacy|27|||
48655150|NCT00098748|156591503|FG002|Received Study Treatment|Lack of Efficacy|27|||
48655151|NCT00098748|156591501|FG000|Received Study Treatment|Other|2|||
48655152|NCT00098748|156591502|FG001|Received Study Treatment|Other|2|||
48655153|NCT00098748|156591503|FG002|Received Study Treatment|Other|6|||
48655154|NCT00098748|156591501|FG000|Received Study Treatment|Subject defaulted|3|||
48655155|NCT00098748|156591502|FG001|Received Study Treatment|Subject defaulted|4|||
48655156|NCT00098748|156591503|FG002|Received Study Treatment|Subject defaulted|4|||
48655157|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
48655158|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
48655159|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
48655160|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
48655161|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
48655162|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
48655163|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
48655164|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
48655165|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
48655166|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
48655167|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
48655168|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
48655169|NCT00098748|156591501|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
48655170|NCT00098748|156591502|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
48655171|NCT00098748|156591503|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
48655172|NCT02305849|156591509|FG000|Overall Study|Adverse Event|10|||
48655173|NCT02305849|156591510|FG001|Overall Study|Adverse Event|12|||
48655174|NCT02305849|156591511|FG002|Overall Study|Adverse Event|7|||
48655175|NCT02305849|156591512|FG003|Overall Study|Adverse Event|3|||
48655176|NCT02305849|156591509|FG000|Overall Study|Lack of Efficacy|10|||
48655177|NCT02305849|156591510|FG001|Overall Study|Lack of Efficacy|6|||
48655178|NCT02305849|156591511|FG002|Overall Study|Lack of Efficacy|3|||
48655179|NCT02305849|156591512|FG003|Overall Study|Lack of Efficacy|9|||
48655180|NCT02305849|156591509|FG000|Overall Study|Withdrawal by Subject|2|||
48655181|NCT02305849|156591510|FG001|Overall Study|Withdrawal by Subject|2|||
48655182|NCT02305849|156591511|FG002|Overall Study|Withdrawal by Subject|1|||
48655183|NCT02305849|156591512|FG003|Overall Study|Withdrawal by Subject|4|||
48655184|NCT02305849|156591509|FG000|Overall Study|Lost to Follow-up|0|||
48655185|NCT02305849|156591510|FG001|Overall Study|Lost to Follow-up|2|||
48655186|NCT02305849|156591511|FG002|Overall Study|Lost to Follow-up|0|||
48655187|NCT02305849|156591512|FG003|Overall Study|Lost to Follow-up|0|||
48655188|NCT02305849|156591509|FG000|Overall Study|Protocol Violation|3|||
48655189|NCT02305849|156591510|FG001|Overall Study|Protocol Violation|2|||
48655190|NCT02305849|156591511|FG002|Overall Study|Protocol Violation|1|||
48655191|NCT02305849|156591512|FG003|Overall Study|Protocol Violation|1|||
48334857|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|Death|1|||
48334858|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|Death|4|||
48655192|NCT02305849|156591509|FG000|Overall Study|Lab data met discontinuation criteria|0|||
48655193|NCT02305849|156591510|FG001|Overall Study|Lab data met discontinuation criteria|1|||
48655194|NCT02305849|156591511|FG002|Overall Study|Lab data met discontinuation criteria|2|||
48655195|NCT02305849|156591512|FG003|Overall Study|Lab data met discontinuation criteria|1|||
48655196|NCT02305849|156591509|FG000|Overall Study|Miscellaneous|1|||
48334859|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
48655197|NCT02305849|156591510|FG001|Overall Study|Miscellaneous|2|||
48655198|NCT02305849|156591511|FG002|Overall Study|Miscellaneous|4|||
48655199|NCT02305849|156591512|FG003|Overall Study|Miscellaneous|1|||
48655200|NCT02305849|156591509|FG000|Overall Study|Not fulfill eligibility criteria|1|||
48655201|NCT02305849|156591510|FG001|Overall Study|Not fulfill eligibility criteria|1|||
48655202|NCT02305849|156591511|FG002|Overall Study|Not fulfill eligibility criteria|0|||
48655203|NCT02305849|156591512|FG003|Overall Study|Not fulfill eligibility criteria|0|||
48655204|NCT02557100|156593311|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
48655205|NCT02557100|156593312|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
48655206|NCT02557100|156593313|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
48655207|NCT02557100|156593311|FG000|Single Blind Treatment Period|Death|0|||
48655208|NCT02557100|156593312|FG001|Single Blind Treatment Period|Death|1|||
48655209|NCT02557100|156593313|FG002|Single Blind Treatment Period|Death|0|||
48655210|NCT02557100|156593311|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
48655211|NCT02557100|156593312|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
48655212|NCT02557100|156593313|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
48655213|NCT02557100|156593311|FG000|Single Blind Treatment Period|Adverse Event|0|||
48655214|NCT02557100|156593312|FG001|Single Blind Treatment Period|Adverse Event|1|||
48655215|NCT02557100|156593313|FG002|Single Blind Treatment Period|Adverse Event|0|||
48655216|NCT02557100|156593311|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
48655217|NCT02557100|156593312|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
48655218|NCT02557100|156593313|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
48655219|NCT02557100|156593311|FG000|Cumulative Abatacept Period|Other Reasons|0|||
48655220|NCT02557100|156593312|FG001|Cumulative Abatacept Period|Other Reasons|0|||
48655221|NCT02557100|156593313|FG002|Cumulative Abatacept Period|Other Reasons|1|||
48655222|NCT02557100|156593311|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
48655223|NCT02557100|156593312|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
48655224|NCT02557100|156593313|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
48655225|NCT02557100|156593311|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
48655226|NCT02557100|156593312|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
48655227|NCT02557100|156593313|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
48655228|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
48655229|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
48655230|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
48655231|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
48655232|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
48655233|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
48655234|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
48655235|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
48655236|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
48655237|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
48655238|NCT00510718|156593314|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
48655239|NCT00510718|156593315|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
48655240|NCT01089413|156593316|FG000|Overall Study|Lost to Follow-up|1|||
48655241|NCT01089413|156593316|FG000|Overall Study|Progressive Disease|93|||
48655242|NCT01089413|156593316|FG000|Overall Study|Participant Withdrew Consent|1|||
48655243|NCT01089413|156593316|FG000|Overall Study|Unacceptable Toxicity|12|||
48655244|NCT01089413|156593316|FG000|Overall Study|Death|10|||
48655245|NCT01089413|156593316|FG000|Overall Study|Metastasectomy|13|||
48655246|NCT01089413|156593316|FG000|Overall Study|Other|71|||
48655247|NCT02264665|156593319|FG000|Overall Study|Other|0|||
48655248|NCT02264665|156593320|FG001|Overall Study|Other|0|||
48655249|NCT02264665|156593321|FG002|Overall Study|Other|3|||
48655250|NCT02264665|156593322|FG003|Overall Study|Other|0|||
48655251|NCT02264665|156593323|FG004|Overall Study|Other|0|||
48655252|NCT02264665|156593324|FG005|Overall Study|Other|0|||
48754162|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
48754163|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
48754164|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
48754165|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
48754166|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
48334860|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
48334861|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
48428205|NCT02531373|155756499|FG001|Overall Study|Lack of Efficacy|0|||
48655253|NCT02264665|156593325|FG006|Overall Study|Other|0|||
48655254|NCT02264665|156593319|FG000|Overall Study|Death|9|||
48655255|NCT02264665|156593320|FG001|Overall Study|Death|8|||
48655256|NCT02264665|156593321|FG002|Overall Study|Death|13|||
48655257|NCT02264665|156593322|FG003|Overall Study|Death|5|||
48655258|NCT02264665|156593323|FG004|Overall Study|Death|0|||
48655259|NCT02264665|156593324|FG005|Overall Study|Death|0|||
48655260|NCT02264665|156593325|FG006|Overall Study|Death|1|||
48754167|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
48754168|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
48754169|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
48754170|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
48754171|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
48754172|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
48754173|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
48754174|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
48754175|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
48754176|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
48754177|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
48754178|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
48754179|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
48754180|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
48754181|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
48754182|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
48754183|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
48754184|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
48754185|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
48754186|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Other|0|||
48754187|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Other|0|||
48754188|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Other|0|||
48754189|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Other|0|||
48754190|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Other|2|||
48754191|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Other|2|||
48754192|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Death|0|||
48754193|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Death|0|||
48754194|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Death|0|||
48754195|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Death|0|||
48655261|NCT02264665|156593319|FG000|Overall Study|Lost to Follow-up|1|||
48655262|NCT02264665|156593320|FG001|Overall Study|Lost to Follow-up|0|||
48655263|NCT02264665|156593321|FG002|Overall Study|Lost to Follow-up|2|||
48655264|NCT02264665|156593322|FG003|Overall Study|Lost to Follow-up|1|||
48655265|NCT02264665|156593323|FG004|Overall Study|Lost to Follow-up|0|||
48655266|NCT02264665|156593324|FG005|Overall Study|Lost to Follow-up|0|||
48655267|NCT02264665|156593325|FG006|Overall Study|Lost to Follow-up|0|||
48655268|NCT02264665|156593319|FG000|Overall Study|Participant decision|0|||
48655269|NCT02264665|156593320|FG001|Overall Study|Participant decision|0|||
48655270|NCT02264665|156593321|FG002|Overall Study|Participant decision|0|||
48655271|NCT02264665|156593322|FG003|Overall Study|Participant decision|1|||
48655272|NCT02264665|156593323|FG004|Overall Study|Participant decision|0|||
48655273|NCT02264665|156593324|FG005|Overall Study|Participant decision|0|||
48655274|NCT02264665|156593325|FG006|Overall Study|Participant decision|0|||
48655275|NCT02264665|156593319|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
48655276|NCT02264665|156593320|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
48655277|NCT02264665|156593321|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
48655278|NCT02264665|156593322|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
48655279|NCT02264665|156593323|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
48655280|NCT02264665|156593324|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
48655281|NCT02264665|156593325|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
48655282|NCT02264665|156593319|FG000|Overall Study|Data Missing|0|||
48754196|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Death|0|||
48754197|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Death|3|||
48754198|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48754199|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48754200|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48754201|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48754202|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
48655283|NCT02264665|156593320|FG001|Overall Study|Data Missing|0|||
48655284|NCT02264665|156593321|FG002|Overall Study|Data Missing|1|||
48655285|NCT02264665|156593322|FG003|Overall Study|Data Missing|0|||
48655286|NCT02264665|156593323|FG004|Overall Study|Data Missing|0|||
48655287|NCT02264665|156593324|FG005|Overall Study|Data Missing|0|||
48655288|NCT02264665|156593325|FG006|Overall Study|Data Missing|0|||
48655289|NCT00470093|156593326|FG000|Overall Study|Adverse Event|2|||
48655290|NCT01667224|156593327|FG000|Overall Study|Withdrawal by Subject|3|||
48655291|NCT01667224|156593328|FG001|Overall Study|Withdrawal by Subject|1|||
48655292|NCT01667224|156593327|FG000|Overall Study|Protocol Violation|1|||
48655293|NCT01667224|156593328|FG001|Overall Study|Protocol Violation|1|||
48655294|NCT00962741|156593329|FG000|Overall Study|Failed to return|3|||
48655295|NCT00962741|156593329|FG000|Overall Study|Lost to Follow-up|2|||
48655296|NCT00962741|156593329|FG000|Overall Study|Withdrawal by Subject|1|||
48655297|NCT00962741|156593329|FG000|Overall Study|Lack of Efficacy|1|||
48655298|NCT00962741|156593329|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
48655299|NCT04225676|156593332|FG000|Overall Study|Physician Decision|1|||
48655300|NCT04225676|156593332|FG000|Overall Study|Lack of Efficacy|1|||
48655301|NCT04225676|156593332|FG000|Overall Study|Study terminated by sponsor|3|||
48655302|NCT01942161|156593333|FG000|Overall Study|Adverse Event|1|||
48655303|NCT01942161|156593334|FG001|Overall Study|Adverse Event|2|||
48655304|NCT01942161|156593335|FG002|Overall Study|Adverse Event|5|||
48655305|NCT01942161|156593333|FG000|Overall Study|Physician Decision|3|||
48655306|NCT01942161|156593334|FG001|Overall Study|Physician Decision|1|||
48655307|NCT01942161|156593335|FG002|Overall Study|Physician Decision|0|||
48655308|NCT01942161|156593333|FG000|Overall Study|Protocol Violation|1|||
48655309|NCT01942161|156593334|FG001|Overall Study|Protocol Violation|0|||
48655310|NCT01942161|156593335|FG002|Overall Study|Protocol Violation|0|||
48655311|NCT01942161|156593333|FG000|Overall Study|Withdrawal by Subject|3|||
48655312|NCT01942161|156593334|FG001|Overall Study|Withdrawal by Subject|3|||
48655313|NCT01942161|156593335|FG002|Overall Study|Withdrawal by Subject|1|||
48655314|NCT01814878|156593337|FG000|Overall Study|Adverse Event|16|||
48655315|NCT01814878|156593338|FG001|Overall Study|Adverse Event|5|||
48655316|NCT01814878|156593337|FG000|Overall Study|Withdrawal by Subject|20|||
48655317|NCT01814878|156593338|FG001|Overall Study|Withdrawal by Subject|16|||
48655318|NCT01814878|156593337|FG000|Overall Study|Protocol Violation|5|||
48655319|NCT01814878|156593338|FG001|Overall Study|Protocol Violation|5|||
48655320|NCT01814878|156593337|FG000|Overall Study|Physician Decision|3|||
48655321|NCT01814878|156593338|FG001|Overall Study|Physician Decision|1|||
48655322|NCT01814878|156593337|FG000|Overall Study|Screening failure (drop-out)|0|||
48655323|NCT01814878|156593338|FG001|Overall Study|Screening failure (drop-out)|3|||
48655324|NCT01814878|156593337|FG000|Overall Study|Other|2|||
48655325|NCT01814878|156593338|FG001|Overall Study|Other|0|||
48655326|NCT03645421|156593339|FG000|Overall Study|Adverse Event|0|||
48655327|NCT03645421|156593340|FG001|Overall Study|Adverse Event|0|||
48655328|NCT03645421|156593341|FG002|Overall Study|Adverse Event|4|||
48655329|NCT03645421|156593342|FG003|Overall Study|Adverse Event|1|||
48655330|NCT03645421|156593339|FG000|Overall Study|Withdrawal by patient|0|||
48655331|NCT03645421|156593340|FG001|Overall Study|Withdrawal by patient|0|||
48655332|NCT03645421|156593341|FG002|Overall Study|Withdrawal by patient|0|||
48655333|NCT03645421|156593342|FG003|Overall Study|Withdrawal by patient|3|||
48655334|NCT03645421|156593339|FG000|Overall Study|Study specific withdrawal criteria|0|||
48655335|NCT03645421|156593340|FG001|Overall Study|Study specific withdrawal criteria|0|||
48655336|NCT03645421|156593341|FG002|Overall Study|Study specific withdrawal criteria|1|||
48655337|NCT03645421|156593342|FG003|Overall Study|Study specific withdrawal criteria|0|||
48655338|NCT02379221|156593343|FG000|Overall Study|Lost to Follow-up|1|||
48655339|NCT01257568|156593344|FG000|Overall Study|Lost to Follow-up|2|||
48655340|NCT01257568|156593344|FG000|Overall Study|Withdrawal by Subject|6|||
48655341|NCT01257568|156593344|FG000|Overall Study|Terminated|1|||
48655342|NCT01257568|156593344|FG000|Overall Study|Component Revision|24|||
48655343|NCT02019108|156593345|FG000|Overall Study|Lost to Follow-up|5|||
48655344|NCT02019108|156593346|FG001|Overall Study|Lost to Follow-up|7|||
48655345|NCT01610557|156593347|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
48655346|NCT01610557|156593348|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
48655347|NCT01610557|156593349|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
48655348|NCT01610557|156593350|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
48754203|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
48754204|NCT00642460|156946631|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
48754205|NCT00642460|156946632|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
48428206|NCT02531373|155756500|FG002|Overall Study|Lack of Efficacy|0|||
48655349|NCT01610557|156593351|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
48655350|NCT01610557|156593347|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
48655351|NCT01610557|156593348|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
48655352|NCT01610557|156593349|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
48655353|NCT01610557|156593350|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
48655354|NCT01610557|156593351|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
48655355|NCT01549886|156593354|FG000|Overall Study|Sponsor's decision|2|||
48655356|NCT01549886|156593355|FG001|Overall Study|Sponsor's decision|3|||
48655357|NCT02039219|156593356|FG000|Treatment|Withdrawal by Subject|1|||
48655358|NCT02039219|156593357|FG001|Treatment|Withdrawal by Subject|0|||
48655359|NCT02039219|156593356|FG000|Treatment|Adverse Event|0|||
48655360|NCT02039219|156593357|FG001|Treatment|Adverse Event|1|||
48655361|NCT02039219|156593356|FG000|Treatment|Physician Decision|1|||
48334862|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
48334863|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
48334864|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
48334865|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48334866|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48334867|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48334868|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48334869|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
48334870|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
48334871|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
48334872|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
48334873|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
48334874|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
48334875|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
48334876|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
48334877|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
48334878|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
48334879|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
48334880|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
48334881|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
48334882|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
48334883|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
48334884|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
48334885|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
48655362|NCT02039219|156593357|FG001|Treatment|Physician Decision|0|||
48655363|NCT02039219|156593356|FG000|Treatment|Lost to Follow-up|0|||
48655364|NCT02039219|156593357|FG001|Treatment|Lost to Follow-up|1|||
48655365|NCT02039219|156593356|FG000|Treatment|Protocol Violation|1|||
48655366|NCT02039219|156593357|FG001|Treatment|Protocol Violation|0|||
48655367|NCT02039219|156593356|FG000|Treatment|Death|1|||
48655368|NCT02039219|156593357|FG001|Treatment|Death|0|||
48655369|NCT02039219|156593356|FG000|Follow up|Adverse Event|0|||
48655370|NCT02039219|156593357|FG001|Follow up|Adverse Event|1|||
48655371|NCT04098367|156593358|FG000|Overall Study|Adverse Event|0|||
48655372|NCT04098367|156593359|FG001|Overall Study|Adverse Event|0|||
48655373|NCT04098367|156593360|FG002|Overall Study|Adverse Event|1|||
48655374|NCT04098367|156593358|FG000|Overall Study|Lost to Follow-up|1|||
48655375|NCT04098367|156593359|FG001|Overall Study|Lost to Follow-up|5|||
48655376|NCT04098367|156593360|FG002|Overall Study|Lost to Follow-up|2|||
48655377|NCT04098367|156593358|FG000|Overall Study|Withdrawal by Subject|0|||
48655378|NCT04098367|156593359|FG001|Overall Study|Withdrawal by Subject|0|||
48655379|NCT04098367|156593360|FG002|Overall Study|Withdrawal by Subject|1|||
48655380|NCT04098367|156593358|FG000|Overall Study|Sick . Could not attend visit|1|||
48655381|NCT04098367|156593359|FG001|Overall Study|Sick . Could not attend visit|0|||
48655382|NCT04098367|156593360|FG002|Overall Study|Sick . Could not attend visit|0|||
48655383|NCT00129701|156593361|FG000|Overall Study|Withdrawal by Subject|33|||
48655384|NCT03576066|156593362|FG000|Overall Study|Noncompliance with study drug|0|||
48655385|NCT03576066|156593363|FG001|Overall Study|Noncompliance with study drug|1|||
48655386|NCT02750345|156593364|FG000|Intervention 1|Adverse Event|0|||
48655387|NCT02750345|156593365|FG001|Intervention 1|Adverse Event|0|||
48655388|NCT02750345|156593366|FG002|Intervention 1|Adverse Event|0|||
48655389|NCT02750345|156593367|FG003|Intervention 1|Adverse Event|0|||
48655390|NCT02750345|156593368|FG004|Intervention 1|Adverse Event|1|||
48655391|NCT02750345|156593369|FG005|Intervention 1|Adverse Event|0|||
48655392|NCT01474772|156593370|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
48655393|NCT01474772|156593371|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
48655394|NCT01474772|156593370|FG000|Period 1|AE not Related to Study Drug|1|||
48655395|NCT01474772|156593371|FG001|Period 1|AE not Related to Study Drug|0|||
48655396|NCT01474772|156593370|FG000|Period 1|Withdrawal by Subject|3|||
48655397|NCT01474772|156593371|FG001|Period 1|Withdrawal by Subject|1|||
48655398|NCT01474772|156593370|FG000|Period 1|Lost to Follow-up|1|||
48655399|NCT01474772|156593371|FG001|Period 1|Lost to Follow-up|0|||
48655400|NCT01474772|156593370|FG000|Period 1|Reason not Specified|1|||
48655401|NCT01474772|156593371|FG001|Period 1|Reason not Specified|1|||
48754206|NCT00642460|156946633|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
48655402|NCT01474772|156593370|FG000|Washout|AE not Related to Study Drug|2|||
48655403|NCT01474772|156593371|FG001|Washout|AE not Related to Study Drug|0|||
48655404|NCT01474772|156593370|FG000|Washout|Withdrawal by Subject|1|||
48754207|NCT00642460|156946634|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
48754208|NCT00642460|156946635|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
48754209|NCT00642460|156946636|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
48754210|NCT00726661|156946637|FG000|Overall Study|Lost to Follow-up|36|||
48754211|NCT00726661|156946638|FG001|Overall Study|Lost to Follow-up|11|||
48754212|NCT00726661|156946637|FG000|Overall Study|Withdrawal by Subject|17|||
48754213|NCT00726661|156946638|FG001|Overall Study|Withdrawal by Subject|13|||
48754214|NCT00726661|156946637|FG000|Overall Study|Trial terminated by sponsor|214|||
48655405|NCT01474772|156593371|FG001|Washout|Withdrawal by Subject|0|||
48655406|NCT01474772|156593370|FG000|Washout|Lost to Follow-up|0|||
48655407|NCT01474772|156593371|FG001|Washout|Lost to Follow-up|1|||
48655408|NCT01474772|156593370|FG000|Washout|Reason not Specified|0|||
48655409|NCT01474772|156593371|FG001|Washout|Reason not Specified|1|||
48655410|NCT01474772|156593370|FG000|Period 2|Death|0|||
48655411|NCT01474772|156593371|FG001|Period 2|Death|1|||
48655412|NCT01474772|156593370|FG000|Period 2|AE Related to Study Drug|0|||
48754215|NCT00726661|156946638|FG001|Overall Study|Trial terminated by sponsor|187|||
48334886|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
48334887|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
48334888|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
48334889|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
48655413|NCT01474772|156593371|FG001|Period 2|AE Related to Study Drug|1|||
48655414|NCT01474772|156593370|FG000|Period 2|AE not Related to Study Drug|4|||
48655415|NCT01474772|156593371|FG001|Period 2|AE not Related to Study Drug|1|||
48655416|NCT01474772|156593370|FG000|Period 2|Lack of Efficacy|1|||
48655417|NCT01474772|156593371|FG001|Period 2|Lack of Efficacy|0|||
48655418|NCT01474772|156593370|FG000|Period 2|Withdrawal by Subject|3|||
48655419|NCT01474772|156593371|FG001|Period 2|Withdrawal by Subject|4|||
48334890|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
48334891|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
48334892|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
48334893|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
48334894|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
48334895|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|Other|0|||
48334896|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|Other|0|||
48334897|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|Other|0|||
48334898|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|Other|0|||
48334899|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|Other|3|||
48334900|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|Other|3|||
48334901|NCT03395197|155423957|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
48334902|NCT03395197|155423958|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
48334903|NCT03395197|155423959|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
48334904|NCT03395197|155423960|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
48655420|NCT01474772|156593370|FG000|Period 2|Lost to Follow-up|1|||
48655421|NCT01474772|156593371|FG001|Period 2|Lost to Follow-up|1|||
48655422|NCT01474772|156593370|FG000|Period 2|Reason not Specified|0|||
48655423|NCT01474772|156593371|FG001|Period 2|Reason not Specified|2|||
48655424|NCT01474772|156593370|FG000|Follow-up|AE not Related to Study Drug|0|||
48655425|NCT01474772|156593371|FG001|Follow-up|AE not Related to Study Drug|1|||
48655426|NCT04484649|156593372|FG000|Overall Study|Lost to Follow-up|2|||
48655427|NCT04484649|156593373|FG001|Overall Study|Lost to Follow-up|1|||
48655428|NCT04484649|156593372|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
48655429|NCT04484649|156593373|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
48655430|NCT00730041|156593374|FG000|Overall Study|Lost to Follow-up|0|||
48655431|NCT00730041|156593375|FG001|Overall Study|Lost to Follow-up|2|||
48655432|NCT02570152|156593376|FG000|Overall Study|Protocol Violation|2|||
48655433|NCT02570152|156593376|FG000|Overall Study|Migrated/moved from study area|13|||
48655434|NCT04752566|156593378|FG000|Overall Study|Protocol Violation|0|||
48655435|NCT04752566|156593379|FG001|Overall Study|Protocol Violation|1|||
48655436|NCT04752566|156593378|FG000|Overall Study|Death|1|||
48655437|NCT04752566|156593379|FG001|Overall Study|Death|0|||
48655438|NCT04752566|156593378|FG000|Overall Study|Adverse Event|1|||
48655439|NCT04752566|156593379|FG001|Overall Study|Adverse Event|0|||
48655440|NCT04752566|156593378|FG000|Overall Study|Withdrawal by Subject|2|||
48655441|NCT04752566|156593379|FG001|Overall Study|Withdrawal by Subject|0|||
48334905|NCT03395197|155423961|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
48334906|NCT03395197|155423962|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
48655442|NCT04752566|156593378|FG000|Overall Study|Physician Decision|1|||
48754216|NCT00726661|156946637|FG000|Overall Study|Death|475|||
48754217|NCT00726661|156946638|FG001|Overall Study|Death|159|||
48754218|NCT00726661|156946637|FG000|Overall Study|Physician Decision|25|||
48655443|NCT04752566|156593379|FG001|Overall Study|Physician Decision|1|||
48655444|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
48655445|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
48334907|NCT04050722|155423963|FG000|Overall Study|Withdrawal by Subject|1|||
48334908|NCT04050722|155423964|FG001|Overall Study|Withdrawal by Subject|0|||
48334909|NCT04783389|155423965|FG000|Overall Study|Withdrawal by Subject|2|||
48334910|NCT04783389|155423966|FG001|Overall Study|Withdrawal by Subject|0|||
48334911|NCT04783389|155423967|FG002|Overall Study|Withdrawal by Subject|0|||
48334912|NCT04783389|155423965|FG000|Overall Study|Termination of Study by Sponsor|10|||
48334913|NCT04783389|155423966|FG001|Overall Study|Termination of Study by Sponsor|12|||
48334914|NCT04783389|155423967|FG002|Overall Study|Termination of Study by Sponsor|14|||
48334915|NCT02489799|155423970|FG000|Overall Study|Lost to Follow-up|4|||
48334916|NCT02489799|155423971|FG001|Overall Study|Lost to Follow-up|1|||
48334917|NCT02489799|155423970|FG000|Overall Study|Failure to Maintain Eligibility|4|||
48334918|NCT02489799|155423971|FG001|Overall Study|Failure to Maintain Eligibility|6|||
48655446|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
48655447|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
48655448|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
48655449|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
48655450|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
48655451|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
48655452|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
48655453|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
48655454|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
48655455|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
48655456|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
48655457|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
48655458|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
48655459|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
48655460|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
48655461|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655462|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655463|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655464|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655465|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655466|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655467|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655468|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655469|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655470|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655471|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655472|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655473|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
48655474|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
48334919|NCT02489799|155423970|FG000|Overall Study|Withdrawal by Subject|1|||
48334920|NCT02489799|155423971|FG001|Overall Study|Withdrawal by Subject|1|||
48655475|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
48655476|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
48655477|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
48655478|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
48655479|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
48655480|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
48655481|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
48655482|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
48655483|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
48655484|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
48655485|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
48655486|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
48655487|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
48655488|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
48655489|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
48655490|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
48655491|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
48655492|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
48655493|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
48655494|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
48655495|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
48334921|NCT02489799|155423970|FG000|Overall Study|Death|0|||
48655496|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
48655497|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
48655498|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
48655499|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
48655500|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
48655501|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
48655502|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
48334922|NCT02489799|155423971|FG001|Overall Study|Death|1|||
48334923|NCT01018992|155423972|FG000|Overall Study|Adverse Event|8|||
48334924|NCT01018992|155423973|FG001|Overall Study|Adverse Event|3|||
48334925|NCT01018992|155423972|FG000|Overall Study|Withdrawal by Subject|3|||
48334926|NCT01018992|155423973|FG001|Overall Study|Withdrawal by Subject|8|||
48334927|NCT01018992|155423972|FG000|Overall Study|Protocol Violation|0|||
48334928|NCT01018992|155423973|FG001|Overall Study|Protocol Violation|4|||
48334929|NCT01018992|155423972|FG000|Overall Study|Lost to Follow-up|5|||
48334930|NCT01018992|155423973|FG001|Overall Study|Lost to Follow-up|1|||
48334931|NCT03029585|155423974|FG000|Overall Study|Death|1|||
48334932|NCT03029585|155423975|FG001|Overall Study|Death|1|||
48334933|NCT03029585|155423974|FG000|Overall Study|Withdrawal by Subject|1|||
48334934|NCT03029585|155423975|FG001|Overall Study|Withdrawal by Subject|0|||
48334935|NCT02400749|155423976|FG000|Week 0 -16|Withdrawal by Subject|5|||
48334936|NCT02400749|155423977|FG001|Week 0 -16|Withdrawal by Subject|5|||
48334937|NCT02400749|155423976|FG000|Week 0 -16|Adverse Event|3|||
48334938|NCT02400749|155423977|FG001|Week 0 -16|Adverse Event|1|||
48334939|NCT02400749|155423976|FG000|Week 0 -16|Lost to Follow-up|2|||
48334940|NCT02400749|155423977|FG001|Week 0 -16|Lost to Follow-up|0|||
48334941|NCT02400749|155423976|FG000|Week 0 -16|Protocol Violation|1|||
48334942|NCT02400749|155423977|FG001|Week 0 -16|Protocol Violation|0|||
48334943|NCT02400749|155423976|FG000|Week 17 - 32|Withdrawal by Subject|3|||
48334944|NCT02400749|155423977|FG001|Week 17 - 32|Withdrawal by Subject|2|||
48334945|NCT02400749|155423976|FG000|Week 17 - 32|Adverse Event|2|||
48334946|NCT02400749|155423977|FG001|Week 17 - 32|Adverse Event|1|||
48334947|NCT04425252|155423980|FG000|Overall Study|Withdrawal by Subject|2|||
48334948|NCT04425252|155423981|FG001|Overall Study|Withdrawal by Subject|1|||
48334949|NCT04425252|155423980|FG000|Overall Study|Lost to Follow-up|1|||
48334950|NCT04425252|155423981|FG001|Overall Study|Lost to Follow-up|0|||
48334951|NCT04425252|155423980|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
48334952|NCT04425252|155423981|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
48334953|NCT03694210|155423983|FG000|Overall Study|Death|1|||
48334954|NCT03694210|155423983|FG000|Overall Study|Screen Failure|7|||
48334955|NCT01848483|155423984|FG000|Overall Study|Death|2|||
48334956|NCT01848483|155423985|FG001|Overall Study|Death|1|||
48334957|NCT01848483|155423984|FG000|Overall Study|Lost to Follow-up|6|||
48334958|NCT01848483|155423985|FG001|Overall Study|Lost to Follow-up|8|||
48334959|NCT01848483|155423984|FG000|Overall Study|Withdrawal by Subject|1|||
48334960|NCT01848483|155423985|FG001|Overall Study|Withdrawal by Subject|0|||
48334961|NCT01848483|155423984|FG000|Overall Study|Incarceration|2|||
48334962|NCT01848483|155423985|FG001|Overall Study|Incarceration|2|||
48334963|NCT03622580|155423989|FG000|Overall Study|Death|16|||
48334964|NCT03622580|155423990|FG001|Overall Study|Death|21|||
48334965|NCT03622580|155423991|FG002|Overall Study|Death|13|||
48334966|NCT03622580|155423989|FG000|Overall Study|Adverse Event|6|||
48334967|NCT03622580|155423990|FG001|Overall Study|Adverse Event|6|||
48334968|NCT03622580|155423991|FG002|Overall Study|Adverse Event|5|||
48334969|NCT03622580|155423989|FG000|Overall Study|Withdrawal by Subject|12|||
48334970|NCT03622580|155423990|FG001|Overall Study|Withdrawal by Subject|7|||
48334971|NCT03622580|155423991|FG002|Overall Study|Withdrawal by Subject|19|||
48334972|NCT03622580|155423989|FG000|Overall Study|Lost to Follow-up|12|||
48334973|NCT03622580|155423990|FG001|Overall Study|Lost to Follow-up|9|||
48334974|NCT03622580|155423991|FG002|Overall Study|Lost to Follow-up|9|||
48334975|NCT03622580|155423989|FG000|Overall Study|Protocol Violation|1|||
48334976|NCT03622580|155423990|FG001|Overall Study|Protocol Violation|0|||
48334977|NCT03622580|155423991|FG002|Overall Study|Protocol Violation|1|||
48334978|NCT03622580|155423989|FG000|Overall Study|Physician Decision|3|||
48334979|NCT03622580|155423990|FG001|Overall Study|Physician Decision|0|||
48334980|NCT03622580|155423991|FG002|Overall Study|Physician Decision|1|||
48334981|NCT03622580|155423989|FG000|Overall Study|Pregnancy|0|||
48334982|NCT03622580|155423990|FG001|Overall Study|Pregnancy|1|||
48655503|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
48655504|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
48655505|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
48655506|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
48655507|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
48655508|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48754219|NCT00726661|156946638|FG001|Overall Study|Physician Decision|13|||
48334983|NCT03622580|155423991|FG002|Overall Study|Pregnancy|0|||
48334984|NCT03622580|155423989|FG000|Overall Study|Lack of Efficacy|0|||
48334985|NCT03622580|155423990|FG001|Overall Study|Lack of Efficacy|0|||
48334986|NCT03622580|155423991|FG002|Overall Study|Lack of Efficacy|1|||
48334987|NCT03622580|155423989|FG000|Overall Study|Other|2|||
48334988|NCT03622580|155423990|FG001|Overall Study|Other|0|||
48334989|NCT03622580|155423991|FG002|Overall Study|Other|3|||
48334990|NCT01248715|155423994|FG000|Overall Study|Not influenza positive|501|||
48334991|NCT01248715|155423995|FG001|Overall Study|Not influenza positive|510|||
48334992|NCT02152384|155423998|FG000|Period 1|Withdrawal by Subject|0|||
48334993|NCT02152384|155423999|FG001|Period 1|Withdrawal by Subject|1|||
48334994|NCT02152384|155423998|FG000|Period 1|Adverse Event|1|||
48334995|NCT02152384|155423999|FG001|Period 1|Adverse Event|1|||
48334996|NCT01768572|155424003|FG000|Overall Study|Adverse Event|7|||
48334997|NCT01768572|155424004|FG001|Overall Study|Adverse Event|8|||
48334998|NCT01768572|155424005|FG002|Overall Study|Adverse Event|4|||
48655509|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48754220|NCT00726661|156946637|FG000|Overall Study|Other|47|||
48754221|NCT00726661|156946638|FG001|Overall Study|Other|35|||
48754222|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
48754223|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
48754224|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
48754225|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
48754226|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
48754227|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
48754228|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
48754229|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
48754230|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
48754231|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
48754232|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
48754233|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
48754234|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
48754235|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
48754236|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
48754237|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
48754238|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
48754239|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
48754240|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
48754241|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
48655510|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655511|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655512|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655513|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655514|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655515|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655516|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655517|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48754242|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
48754243|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
48754244|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
48754245|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
48754246|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
48754247|NCT01285310|156946639|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
48754248|NCT01285310|156946640|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
48754249|NCT01285310|156946641|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
48754250|NCT01285310|156946642|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
48754251|NCT01285310|156946643|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
48754252|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
48754253|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
48754254|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
48754255|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
48754256|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
48754257|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
48754258|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
48334999|NCT01768572|155424003|FG000|Overall Study|Lack of Efficacy|1|||
48335000|NCT01768572|155424004|FG001|Overall Study|Lack of Efficacy|3|||
48335001|NCT01768572|155424005|FG002|Overall Study|Lack of Efficacy|1|||
48335002|NCT01768572|155424003|FG000|Overall Study|Other, Not due to an adverse event|1|||
48655518|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
48655519|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
48655520|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
48655521|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
48655522|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
48754259|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
48335003|NCT01768572|155424004|FG001|Overall Study|Other, Not due to an adverse event|1|||
48655523|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655524|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48754260|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
48754261|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
48335004|NCT01768572|155424005|FG002|Overall Study|Other, Not due to an adverse event|1|||
48335005|NCT03602053|155424006|FG000|Overall Study|Withdrawal by Subject|7|||
48655525|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655526|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655527|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655528|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655529|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655530|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655531|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655532|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655533|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
48655534|NCT03831191|156593380|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
48335006|NCT03602053|155424007|FG001|Overall Study|Withdrawal by Subject|9|||
48335007|NCT03602053|155424008|FG002|Overall Study|Withdrawal by Subject|7|||
48335008|NCT03602053|155424006|FG000|Overall Study|Lost to Follow-up|5|||
48335009|NCT03602053|155424007|FG001|Overall Study|Lost to Follow-up|6|||
48335010|NCT03602053|155424008|FG002|Overall Study|Lost to Follow-up|0|||
48335011|NCT03602053|155424006|FG000|Overall Study|Protocol Violation|3|||
48335012|NCT03602053|155424007|FG001|Overall Study|Protocol Violation|0|||
48335013|NCT03602053|155424008|FG002|Overall Study|Protocol Violation|4|||
48335014|NCT03602053|155424006|FG000|Overall Study|Physician Decision|1|||
48335015|NCT03602053|155424007|FG001|Overall Study|Physician Decision|0|||
48335016|NCT03602053|155424008|FG002|Overall Study|Physician Decision|0|||
48335017|NCT03602053|155424006|FG000|Overall Study|migration|2|||
48335018|NCT03602053|155424007|FG001|Overall Study|migration|3|||
48335019|NCT03602053|155424008|FG002|Overall Study|migration|0|||
48335020|NCT03602053|155424006|FG000|Overall Study|Other|1|||
48335021|NCT03602053|155424007|FG001|Overall Study|Other|0|||
48335022|NCT03602053|155424008|FG002|Overall Study|Other|0|||
48335023|NCT01102426|155424014|FG000|Overall Study|Randomized but not treated|4|||
48335024|NCT01102426|155424015|FG001|Overall Study|Randomized but not treated|1|||
48335025|NCT01102426|155424014|FG000|Overall Study|Adverse Events (treatment-related)|15|||
48335026|NCT01102426|155424015|FG001|Overall Study|Adverse Events (treatment-related)|8|||
48335027|NCT01102426|155424014|FG000|Overall Study|Physician Decision|9|||
48335028|NCT01102426|155424015|FG001|Overall Study|Physician Decision|6|||
48335029|NCT01102426|155424014|FG000|Overall Study|Progressive Disease|85|||
48335030|NCT01102426|155424015|FG001|Overall Study|Progressive Disease|44|||
48335031|NCT01102426|155424014|FG000|Overall Study|Adverse Events (unrelated to|9|||
48754262|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
48335032|NCT01102426|155424015|FG001|Overall Study|Adverse Events (unrelated to|1|||
48335033|NCT01102426|155424014|FG000|Overall Study|Patient Refusal|24|||
48335034|NCT01102426|155424015|FG001|Overall Study|Patient Refusal|12|||
48335035|NCT01102426|155424014|FG000|Overall Study|Death (due to adverse events|0|||
48335036|NCT01102426|155424015|FG001|Overall Study|Death (due to adverse events|1|||
48335037|NCT01102426|155424014|FG000|Overall Study|Death (non-related to the study|19|||
48335038|NCT01102426|155424015|FG001|Overall Study|Death (non-related to the study|8|||
48335039|NCT01131325|155424016|FG000|Overall Study|Adverse Event|1|||
48335040|NCT01131325|155424016|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
48335041|NCT01540474|155424017|FG000|Vaccination Period|Lost to Follow-up|0|||
48335042|NCT01540474|155424018|FG001|Vaccination Period|Lost to Follow-up|1|||
48335043|NCT01540474|155424019|FG002|Vaccination Period|Lost to Follow-up|0|||
48335044|NCT01540474|155424020|FG003|Vaccination Period|Lost to Follow-up|0|||
48335045|NCT02005484|155424021|FG000|Overall Study|Death|1|||
48335046|NCT02005484|155424021|FG000|Overall Study|Disease progression|1|||
48655535|NCT03831191|156593381|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655536|NCT03831191|156593382|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655537|NCT03831191|156593383|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
48655538|NCT03831191|156593384|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655539|NCT03831191|156593385|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655540|NCT03831191|156593386|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655541|NCT03831191|156593387|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655542|NCT03831191|156593388|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655543|NCT03831191|156593389|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655544|NCT03831191|156593390|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655545|NCT03831191|156593391|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655546|NCT03831191|156593392|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655547|NCT03831191|156593393|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655548|NCT03831191|156593394|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
48655549|NCT03831191|156593380|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
48655550|NCT03831191|156593381|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
48655551|NCT03831191|156593382|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
48754263|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
48335047|NCT02005484|155424021|FG000|Overall Study|Changed to a Different Study|1|||
48335048|NCT02005484|155424021|FG000|Overall Study|Sponsor decision|1|||
48335049|NCT03557307|155424023|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
48335050|NCT03557307|155424023|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
48335051|NCT03557307|155424023|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
48335052|NCT03557307|155424023|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
48335053|NCT03557307|155424023|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
48335054|NCT03557307|155424023|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
48335055|NCT03557307|155424023|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
48335056|NCT03557307|155424023|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
48335057|NCT03557307|155424023|FG000|Period 2: Maintenance Phase|Death|3|||
48335058|NCT03557307|155424023|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
48335059|NCT03557307|155424023|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
48335060|NCT03557307|155424023|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
48335061|NCT03557307|155424023|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
48335062|NCT03557307|155424023|FG000|Period 2: Maintenance Phase|other|3|||
48335063|NCT01190436|155424024|FG000|Overall Study|Lost to Follow-up|35|||
48335064|NCT01190436|155424024|FG000|Overall Study|Other|4|||
48335065|NCT01535261|155424025|FG000|Overall Study|Physician Decision|8|||
48335066|NCT01535261|155424025|FG000|Overall Study|Protocol Violation|3|||
48655552|NCT03831191|156593383|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
48655553|NCT03831191|156593384|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
48655554|NCT03831191|156593385|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
48655555|NCT03831191|156593386|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
48655556|NCT03831191|156593387|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
48335067|NCT01535261|155424025|FG000|Overall Study|Death|5|||
48335068|NCT01535261|155424025|FG000|Overall Study|Lost to Follow-up|8|||
48335069|NCT01535261|155424025|FG000|Overall Study|Withdrawal by Subject|14|||
48655557|NCT03831191|156593388|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
48335070|NCT01535261|155424025|FG000|Overall Study|Adverse Event|12|||
48335071|NCT01180400|155424028|FG000|Overall Study|Withdrawal by Subject|5|||
48335072|NCT01180400|155424029|FG001|Overall Study|Withdrawal by Subject|6|||
48335073|NCT01180400|155424028|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48335074|NCT01180400|155424029|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
48335075|NCT01180400|155424028|FG000|Overall Study|Adverse Event|12|||
48335076|NCT01180400|155424029|FG001|Overall Study|Adverse Event|10|||
48335077|NCT01180400|155424028|FG000|Overall Study|Severe non-compliance to protocol|1|||
48335078|NCT01180400|155424029|FG001|Overall Study|Severe non-compliance to protocol|2|||
48335079|NCT01180400|155424028|FG000|Overall Study|Condition under investigation worsened|2|||
48335080|NCT01180400|155424029|FG001|Overall Study|Condition under investigation worsened|1|||
48335081|NCT01180400|155424028|FG000|Overall Study|Lack of Efficacy|2|||
48335082|NCT01180400|155424029|FG001|Overall Study|Lack of Efficacy|0|||
48335083|NCT01180400|155424028|FG000|Overall Study|Study-specific withdrawal criteria|1|||
48335084|NCT01180400|155424029|FG001|Overall Study|Study-specific withdrawal criteria|2|||
48335085|NCT01180400|155424028|FG000|Overall Study|Lost to Follow-up|2|||
48335086|NCT01180400|155424029|FG001|Overall Study|Lost to Follow-up|3|||
48335087|NCT01180400|155424028|FG000|Overall Study|Other|0|||
48335088|NCT01180400|155424029|FG001|Overall Study|Other|1|||
48335089|NCT00472082|155424030|FG000|Overall Study|Study prematurely terminated|5|||
48335090|NCT02727998|155424031|FG000|Overall Study|Lost to Follow-up|3|||
48335091|NCT02727998|155424032|FG001|Overall Study|Lost to Follow-up|3|||
48655558|NCT03831191|156593389|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
48655559|NCT03831191|156593390|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
48655560|NCT03831191|156593391|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
48655561|NCT03831191|156593392|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
48655562|NCT03831191|156593393|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
48655563|NCT03831191|156593394|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
48655564|NCT03831191|156593380|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655565|NCT03831191|156593381|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655566|NCT03831191|156593382|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655567|NCT03831191|156593383|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655568|NCT03831191|156593384|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655569|NCT03831191|156593385|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655570|NCT03831191|156593386|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655571|NCT03831191|156593387|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655572|NCT03831191|156593388|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655573|NCT03831191|156593389|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655574|NCT03831191|156593390|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655575|NCT03831191|156593391|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655576|NCT03831191|156593392|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655577|NCT03831191|156593393|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
48655578|NCT03831191|156593394|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
48335092|NCT02727998|155424031|FG000|Overall Study|Withdrawal by Subject|0|||
48335093|NCT02727998|155424032|FG001|Overall Study|Withdrawal by Subject|1|||
48655579|NCT03831191|156593380|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655580|NCT03831191|156593381|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655581|NCT03831191|156593382|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655582|NCT03831191|156593383|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655583|NCT03831191|156593384|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655584|NCT03831191|156593385|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655585|NCT03831191|156593386|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655586|NCT03831191|156593387|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655587|NCT03831191|156593388|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655588|NCT03831191|156593389|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655589|NCT03831191|156593390|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655590|NCT03831191|156593391|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48655591|NCT03831191|156593392|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48754264|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
48754265|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
48754266|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
48754267|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
48754268|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
48754269|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
48754270|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
48754271|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
48754272|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
48335094|NCT05104242|155424037|FG000|Overall Study|Withdrawal by Subject|1|||
48335095|NCT05104242|155424038|FG001|Overall Study|Withdrawal by Subject|5|||
48335096|NCT05104242|155424037|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
48335097|NCT05104242|155424038|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
48335098|NCT00442559|155424039|FG000|Overall Study|Lost to Follow-up|32|||
48335099|NCT00442559|155424040|FG001|Overall Study|Lost to Follow-up|34|||
48335100|NCT00442559|155424039|FG000|Overall Study|Protocol Violation|1|||
48335101|NCT00442559|155424040|FG001|Overall Study|Protocol Violation|1|||
48335102|NCT00442559|155424039|FG000|Overall Study|Withdrawal by Subject|1|||
48335103|NCT00442559|155424040|FG001|Overall Study|Withdrawal by Subject|0|||
48335104|NCT02588027|155424044|FG000|Overall Study|Withdrawal by Subject|1|||
48335105|NCT02588027|155424045|FG001|Overall Study|Withdrawal by Subject|3|||
48335106|NCT02588027|155424044|FG000|Overall Study|Protocol Violation|4|||
48335107|NCT02588027|155424045|FG001|Overall Study|Protocol Violation|1|||
48335108|NCT04189224|155424046|FG000|Period 2|Adverse Event|0|||
48335109|NCT04189224|155424047|FG001|Period 2|Adverse Event|1|||
48335110|NCT03562117|155424052|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
48335111|NCT03562117|155424053|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
48335112|NCT03562117|155424054|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
48335113|NCT03928821|155424055|FG000|Overall Study|Death|0|||
48335114|NCT03928821|155424056|FG001|Overall Study|Death|1|||
48335115|NCT03928821|155424057|FG002|Overall Study|Death|0|||
48335116|NCT03928821|155424058|FG003|Overall Study|Death|0|||
48335117|NCT03928821|155424055|FG000|Overall Study|Lost to Follow-up|0|||
48655592|NCT03831191|156593393|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
48335118|NCT03928821|155424056|FG001|Overall Study|Lost to Follow-up|2|||
48335119|NCT03928821|155424057|FG002|Overall Study|Lost to Follow-up|3|||
48655593|NCT03831191|156593394|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
48655594|NCT01471028|156593398|FG000|VTI-208|Adverse Event|39|||
48655595|NCT01471028|156593399|FG001|VTI-208|Adverse Event|41|||
48754273|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
48754274|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
48754275|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
48754276|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
48754277|NCT01285310|156946639|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
48335120|NCT03928821|155424058|FG003|Overall Study|Lost to Follow-up|0|||
48335121|NCT03928821|155424055|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48335122|NCT03928821|155424056|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48655596|NCT01471028|156593398|FG000|VTI-208|Withdrawal by Subject|0|||
48655597|NCT01471028|156593399|FG001|VTI-208|Withdrawal by Subject|2|||
48655598|NCT01471028|156593398|FG000|VTI-208|Lost to Follow-up|1|||
48655599|NCT01471028|156593399|FG001|VTI-208|Lost to Follow-up|1|||
48655600|NCT01471028|156593398|FG000|VTI-208E|Death|7|||
48655601|NCT01471028|156593399|FG001|VTI-208E|Death|10|||
48655602|NCT01471028|156593398|FG000|VTI-208E|Withdrawal by Subject|1|||
48754278|NCT01285310|156946640|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
48754279|NCT01285310|156946641|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
48335123|NCT03928821|155424057|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
48335124|NCT03928821|155424058|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
48655603|NCT01471028|156593399|FG001|VTI-208E|Withdrawal by Subject|0|||
48655604|NCT01471028|156593398|FG000|VTI-208E|Lost to Follow-up|0|||
48335125|NCT01911819|155424059|FG000|Overall Study|Adverse Event|0|||
48655605|NCT01471028|156593399|FG001|VTI-208E|Lost to Follow-up|2|||
48335126|NCT01911819|155424060|FG001|Overall Study|Adverse Event|1|||
48335127|NCT01911819|155424061|FG002|Overall Study|Adverse Event|0|||
48335128|NCT01911819|155424059|FG000|Overall Study|Withdrawal by Subject|1|||
48335129|NCT01911819|155424060|FG001|Overall Study|Withdrawal by Subject|1|||
48335130|NCT01911819|155424061|FG002|Overall Study|Withdrawal by Subject|0|||
48335131|NCT00595764|155424065|FG000|Overall Study|Protocol Violation|24|||
48335132|NCT00595764|155424066|FG001|Overall Study|Protocol Violation|19|||
48335133|NCT00595764|155424065|FG000|Overall Study|Missed Medication >1 week|10|||
48335134|NCT00595764|155424066|FG001|Overall Study|Missed Medication >1 week|17|||
48335135|NCT00595764|155424065|FG000|Overall Study|Missed 3 PM visits|1|||
48335136|NCT00595764|155424066|FG001|Overall Study|Missed 3 PM visits|7|||
48335137|NCT00595764|155424065|FG000|Overall Study|Withdrawal by Subject|4|||
48335138|NCT00595764|155424066|FG001|Overall Study|Withdrawal by Subject|0|||
48335139|NCT00905255|155424067|FG000|Overall Study|Adverse Event|7|||
48335140|NCT00905255|155424068|FG001|Overall Study|Adverse Event|5|||
48335141|NCT00905255|155424067|FG000|Overall Study|Withdrawal by Subject|5|||
48335142|NCT00905255|155424068|FG001|Overall Study|Withdrawal by Subject|4|||
48335143|NCT00905255|155424067|FG000|Overall Study|Familial and Personal Reasons|1|||
48335144|NCT00905255|155424068|FG001|Overall Study|Familial and Personal Reasons|0|||
48335145|NCT01528605|155424069|FG000|Overall Study|Lost to Follow-up|1|||
48335146|NCT01528605|155424070|FG001|Overall Study|Lost to Follow-up|0|||
48335147|NCT01528605|155424071|FG002|Overall Study|Lost to Follow-up|1|||
48335148|NCT01528605|155424072|FG003|Overall Study|Lost to Follow-up|1|||
48335149|NCT01528605|155424073|FG004|Overall Study|Lost to Follow-up|0|||
48335150|NCT01528605|155424074|FG005|Overall Study|Lost to Follow-up|0|||
48335151|NCT01528605|155424069|FG000|Overall Study|Death|1|||
48335152|NCT01528605|155424070|FG001|Overall Study|Death|0|||
48335153|NCT01528605|155424071|FG002|Overall Study|Death|0|||
48335154|NCT01528605|155424072|FG003|Overall Study|Death|0|||
48335155|NCT01528605|155424073|FG004|Overall Study|Death|0|||
48335156|NCT01528605|155424074|FG005|Overall Study|Death|0|||
48335157|NCT02389894|155424075|FG000|Overall Study|Death|4|||
48335158|NCT02389894|155424076|FG001|Overall Study|Death|5|||
48335159|NCT02389894|155424077|FG002|Overall Study|Death|3|||
48335160|NCT02389894|155424075|FG000|Overall Study|Withdrawal by Subject|2|||
48335161|NCT02389894|155424076|FG001|Overall Study|Withdrawal by Subject|4|||
48335162|NCT02389894|155424077|FG002|Overall Study|Withdrawal by Subject|5|||
48335163|NCT02389894|155424075|FG000|Overall Study|Lost to Follow-up|2|||
48335164|NCT02389894|155424076|FG001|Overall Study|Lost to Follow-up|1|||
48335165|NCT02389894|155424077|FG002|Overall Study|Lost to Follow-up|1|||
48335166|NCT02312245|155424078|FG000|Overall Study|Death|0|||
48335167|NCT02312245|155424079|FG001|Overall Study|Death|0|||
48335168|NCT02312245|155424080|FG002|Overall Study|Death|0|||
48335169|NCT02312245|155424081|FG003|Overall Study|Death|1|||
48335170|NCT02312245|155424078|FG000|Overall Study|Withdrawal by Subject|1|||
48335171|NCT02312245|155424079|FG001|Overall Study|Withdrawal by Subject|1|||
48335172|NCT02312245|155424080|FG002|Overall Study|Withdrawal by Subject|0|||
48335173|NCT02312245|155424081|FG003|Overall Study|Withdrawal by Subject|2|||
48335174|NCT02312245|155424078|FG000|Overall Study|Alternative Therapy|1|||
48335175|NCT02312245|155424079|FG001|Overall Study|Alternative Therapy|0|||
48335176|NCT02312245|155424080|FG002|Overall Study|Alternative Therapy|0|||
48335177|NCT02312245|155424081|FG003|Overall Study|Alternative Therapy|0|||
48335178|NCT02312245|155424078|FG000|Overall Study|Progression|0|||
48335179|NCT02312245|155424079|FG001|Overall Study|Progression|0|||
48335180|NCT02312245|155424080|FG002|Overall Study|Progression|0|||
48335181|NCT02312245|155424081|FG003|Overall Study|Progression|5|||
48335182|NCT02312245|155424078|FG000|Overall Study|Patient went to hospice|0|||
48335183|NCT02312245|155424079|FG001|Overall Study|Patient went to hospice|0|||
48335184|NCT02312245|155424080|FG002|Overall Study|Patient went to hospice|0|||
48335185|NCT02312245|155424081|FG003|Overall Study|Patient went to hospice|1|||
48335186|NCT02312245|155424078|FG000|Overall Study|Ineligible|1|||
48335187|NCT02312245|155424079|FG001|Overall Study|Ineligible|0|||
48335188|NCT02312245|155424080|FG002|Overall Study|Ineligible|0|||
48655606|NCT03077438|156593403|FG000|Overall Study|Protocol Violation|3|||
48655607|NCT03077438|156593404|FG001|Overall Study|Protocol Violation|5|||
48655608|NCT03077438|156593403|FG000|Overall Study|Withdrawal by Subject|3|||
48655609|NCT03077438|156593404|FG001|Overall Study|Withdrawal by Subject|6|||
48655610|NCT03077438|156593403|FG000|Overall Study|Lost to Follow-up|6|||
48655611|NCT03077438|156593404|FG001|Overall Study|Lost to Follow-up|3|||
48655612|NCT01685801|156593411|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
48655613|NCT01685801|156593412|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
48335189|NCT02312245|155424081|FG003|Overall Study|Ineligible|0|||
48335190|NCT02548585|155424084|FG000|Overall Study|Withdrawal by Subject|0|||
48335191|NCT02548585|155424085|FG001|Overall Study|Withdrawal by Subject|0|||
48335192|NCT02548585|155424086|FG002|Overall Study|Withdrawal by Subject|0|||
48335193|NCT02548585|155424087|FG003|Overall Study|Withdrawal by Subject|0|||
48335194|NCT02548585|155424088|FG004|Overall Study|Withdrawal by Subject|0|||
48655614|NCT01685801|156593413|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
48335195|NCT02548585|155424089|FG005|Overall Study|Withdrawal by Subject|1|||
48335196|NCT02548585|155424090|FG006|Overall Study|Withdrawal by Subject|0|||
48335197|NCT02548585|155424084|FG000|Overall Study|Lost to Follow-up|1|||
48335198|NCT02548585|155424085|FG001|Overall Study|Lost to Follow-up|0|||
48335199|NCT02548585|155424086|FG002|Overall Study|Lost to Follow-up|0|||
48335200|NCT02548585|155424087|FG003|Overall Study|Lost to Follow-up|0|||
48335201|NCT02548585|155424088|FG004|Overall Study|Lost to Follow-up|0|||
48335202|NCT02548585|155424089|FG005|Overall Study|Lost to Follow-up|0|||
48335203|NCT02548585|155424090|FG006|Overall Study|Lost to Follow-up|0|||
48335204|NCT02548585|155424084|FG000|Overall Study|Other|1|||
48335205|NCT02548585|155424085|FG001|Overall Study|Other|0|||
48335206|NCT02548585|155424086|FG002|Overall Study|Other|0|||
48335207|NCT02548585|155424087|FG003|Overall Study|Other|2|||
48335208|NCT02548585|155424088|FG004|Overall Study|Other|3|||
48335209|NCT02548585|155424089|FG005|Overall Study|Other|0|||
48335210|NCT02548585|155424090|FG006|Overall Study|Other|1|||
48655615|NCT01685801|156593414|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
48655616|NCT01685801|156593411|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
48655617|NCT01685801|156593412|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
48655618|NCT01685801|156593413|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
48655619|NCT01685801|156593414|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
48655620|NCT00666588|156593415|FG000|Overall Study|ineligible|2|||
48655621|NCT00666588|156593416|FG001|Overall Study|ineligible|0|||
48655622|NCT00666588|156593417|FG002|Overall Study|ineligible|0|||
48655623|NCT00666588|156593418|FG003|Overall Study|ineligible|2|||
48655624|NCT00666588|156593415|FG000|Overall Study|inevaluable|2|||
48655625|NCT00666588|156593416|FG001|Overall Study|inevaluable|0|||
48754280|NCT01285310|156946642|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
48754281|NCT01285310|156946643|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
48754282|NCT02733991|156946648|FG000|Overall Study|Adverse Event|1|||
48754283|NCT02733991|156946649|FG001|Overall Study|Adverse Event|0|||
48754284|NCT02733991|156946648|FG000|Overall Study|Withdrawal by Subject|0|||
48754285|NCT02733991|156946649|FG001|Overall Study|Withdrawal by Subject|5|||
48754286|NCT02485574|156946652|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
48754287|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
48754288|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
48754289|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
48754290|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
48754291|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
48754292|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
48754293|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
48754294|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
48754295|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
48754296|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
48754297|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Death|2|||
48754298|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Death|1|||
48754299|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Death|4|||
48754300|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Death|0|||
48754301|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Death|0|||
48754302|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
48754303|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
48754304|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
48754305|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
48754306|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
48754307|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Other Reason|1|||
48754308|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Other Reason|3|||
48754309|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Other Reason|2|||
48754310|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Other Reason|0|||
48754311|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Other Reason|0|||
48754312|NCT00555321|156946653|FG000|Treatment Phase up to 12-months|Never treated|2|||
48754313|NCT00555321|156946654|FG001|Treatment Phase up to 12-months|Never treated|3|||
48754314|NCT00555321|156946655|FG002|Treatment Phase up to 12-months|Never treated|1|||
48754315|NCT00555321|156946656|FG003|Treatment Phase up to 12-months|Never treated|0|||
48335211|NCT02548585|155424084|FG000|Overall Study|Randomized but not treated|0|||
48335212|NCT02548585|155424085|FG001|Overall Study|Randomized but not treated|0|||
48335213|NCT02548585|155424086|FG002|Overall Study|Randomized but not treated|0|||
48335214|NCT02548585|155424087|FG003|Overall Study|Randomized but not treated|0|||
48335215|NCT02548585|155424088|FG004|Overall Study|Randomized but not treated|0|||
48335216|NCT02548585|155424089|FG005|Overall Study|Randomized but not treated|1|||
48754316|NCT00555321|156946657|FG004|Treatment Phase up to 12-months|Never treated|4|||
48754317|NCT00555321|156946653|FG000|Long-term Extension Phase|Adverse Event|2|||
48754318|NCT00555321|156946654|FG001|Long-term Extension Phase|Adverse Event|5|||
48335217|NCT02548585|155424090|FG006|Overall Study|Randomized but not treated|0|||
48655626|NCT00666588|156593417|FG002|Overall Study|inevaluable|0|||
48335218|NCT00535626|155425223|FG000|Overall Study|Death|15|||
48335219|NCT00535626|155425223|FG000|Overall Study|Lost to Follow-up|29|||
48335220|NCT00535626|155425223|FG000|Overall Study|Withdrawal by Subject|20|||
48335221|NCT00535626|155425223|FG000|Overall Study|Removal/revision of study component|8|||
48335222|NCT00535626|155425223|FG000|Overall Study|Subject terminated|31|||
48335223|NCT00535626|155425223|FG000|Overall Study|Unable to return|2|||
48335224|NCT02121808|155425227|FG000|Overall Study|Technical problem|3|||
48335225|NCT01562275|155425228|FG000|Stage 1|Adverse Event|0|||
48335226|NCT01562275|155425229|FG001|Stage 1|Adverse Event|0|||
48335227|NCT01562275|155425230|FG002|Stage 1|Adverse Event|0|||
48335228|NCT01562275|155425231|FG003|Stage 1|Adverse Event|1|||
48335229|NCT01562275|155425232|FG004|Stage 1|Adverse Event|1|||
48335230|NCT01562275|155425233|FG005|Stage 1|Adverse Event|0|||
48335231|NCT01562275|155425234|FG006|Stage 1|Adverse Event|0|||
48335232|NCT01562275|155425235|FG007|Stage 1|Adverse Event|0|||
48335233|NCT01562275|155425236|FG008|Stage 1|Adverse Event|0|||
48335234|NCT01562275|155425237|FG009|Stage 1|Adverse Event|1|||
48335235|NCT01562275|155425238|FG010|Stage 1|Adverse Event|0|||
48335236|NCT01562275|155425239|FG011|Stage 1|Adverse Event|0|||
48335237|NCT01562275|155425240|FG012|Stage 1|Adverse Event|0|||
48335238|NCT01562275|155425228|FG000|Stage 1|Death|1|||
48655627|NCT00666588|156593418|FG003|Overall Study|inevaluable|0|||
48655628|NCT03466099|156593421|FG000|Overall Study|Adverse Event|1|||
48655629|NCT03466099|156593422|FG001|Overall Study|Adverse Event|1|||
48655630|NCT03466099|156593423|FG002|Overall Study|Adverse Event|1|||
48655631|NCT03466099|156593421|FG000|Overall Study|Withdrawal by Subject|2|||
48655632|NCT03466099|156593422|FG001|Overall Study|Withdrawal by Subject|3|||
48655633|NCT03466099|156593423|FG002|Overall Study|Withdrawal by Subject|1|||
48655634|NCT03466099|156593421|FG000|Overall Study|Use of rescue medication|8|||
48655635|NCT03466099|156593422|FG001|Overall Study|Use of rescue medication|9|||
48655636|NCT03466099|156593423|FG002|Overall Study|Use of rescue medication|13|||
48655637|NCT03466099|156593421|FG000|Overall Study|Rescued without meeting criteria|4|||
48655638|NCT03466099|156593422|FG001|Overall Study|Rescued without meeting criteria|1|||
48655639|NCT03466099|156593423|FG002|Overall Study|Rescued without meeting criteria|1|||
48655640|NCT03466099|156593421|FG000|Overall Study|Subject compliance|2|||
48655641|NCT03466099|156593422|FG001|Overall Study|Subject compliance|0|||
48655642|NCT03466099|156593423|FG002|Overall Study|Subject compliance|0|||
48655643|NCT03466099|156593421|FG000|Overall Study|Worsening disease|0|||
48655644|NCT03466099|156593422|FG001|Overall Study|Worsening disease|0|||
48754319|NCT00555321|156946655|FG002|Long-term Extension Phase|Adverse Event|2|||
48754320|NCT00555321|156946656|FG003|Long-term Extension Phase|Adverse Event|1|||
48754321|NCT00555321|156946657|FG004|Long-term Extension Phase|Adverse Event|0|||
48754322|NCT00555321|156946653|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
48754323|NCT00555321|156946654|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
48754324|NCT00555321|156946655|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
48754325|NCT00555321|156946656|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
48754326|NCT00555321|156946657|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
48754327|NCT00555321|156946653|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
48754328|NCT00555321|156946654|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
48754329|NCT00555321|156946655|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
48754330|NCT00555321|156946656|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
48754331|NCT00555321|156946657|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
48754332|NCT00555321|156946653|FG000|Long-term Extension Phase|Death|2|||
48754333|NCT00555321|156946654|FG001|Long-term Extension Phase|Death|0|||
48754334|NCT00555321|156946655|FG002|Long-term Extension Phase|Death|0|||
48754335|NCT00555321|156946656|FG003|Long-term Extension Phase|Death|3|||
48754336|NCT00555321|156946657|FG004|Long-term Extension Phase|Death|0|||
48754337|NCT00555321|156946653|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
48754338|NCT00555321|156946654|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
48335239|NCT01562275|155425229|FG001|Stage 1|Death|0|||
48335240|NCT01562275|155425230|FG002|Stage 1|Death|0|||
48335241|NCT01562275|155425231|FG003|Stage 1|Death|0|||
48335242|NCT01562275|155425232|FG004|Stage 1|Death|0|||
48335243|NCT01562275|155425233|FG005|Stage 1|Death|0|||
48335244|NCT01562275|155425234|FG006|Stage 1|Death|0|||
48335245|NCT01562275|155425235|FG007|Stage 1|Death|0|||
48335246|NCT01562275|155425236|FG008|Stage 1|Death|0|||
48754339|NCT00555321|156946655|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
48754340|NCT00555321|156946656|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
48335247|NCT01562275|155425237|FG009|Stage 1|Death|0|||
48655645|NCT03466099|156593423|FG002|Overall Study|Worsening disease|1|||
48754341|NCT00555321|156946657|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
48754342|NCT00555321|156946653|FG000|Long-term Extension Phase|Other Reason|1|||
48335248|NCT01562275|155425238|FG010|Stage 1|Death|0|||
48335249|NCT01562275|155425239|FG011|Stage 1|Death|0|||
48335250|NCT01562275|155425240|FG012|Stage 1|Death|0|||
48335251|NCT01562275|155425228|FG000|Stage 1|Non Compliance|0|||
48655646|NCT00385944|156593426|FG000|1st Maintenance Dose Period|Physician Decision|1|||
48655647|NCT00385944|156593427|FG001|1st Maintenance Dose Period|Physician Decision|0|||
48655648|NCT00385944|156593428|FG002|1st Maintenance Dose Period|Physician Decision|0|||
48655649|NCT00385944|156593426|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
48655650|NCT00385944|156593427|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
48655651|NCT00385944|156593428|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
48655652|NCT00385944|156593426|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
48655653|NCT00385944|156593427|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
48655654|NCT00385944|156593428|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
48655655|NCT00385944|156593426|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
48655656|NCT00385944|156593427|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
48655657|NCT00385944|156593428|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
48655658|NCT00054327|156593429|FG000|Overall Study|Engraftment failure|1|||
48655659|NCT00054327|156593430|FG001|Overall Study|Engraftment failure|0|||
48655660|NCT00054327|156593431|FG002|Overall Study|Engraftment failure|0|||
48655661|NCT00054327|156593432|FG003|Overall Study|Engraftment failure|0|||
48655662|NCT00054327|156593433|FG004|Overall Study|Engraftment failure|0|||
48655663|NCT00054327|156593434|FG005|Overall Study|Engraftment failure|0|||
48655664|NCT02231892|156593435|FG000|Overall Study|Lost to Follow-up|1|||
48655665|NCT02231892|156593436|FG001|Overall Study|Lost to Follow-up|0|||
48655666|NCT02231892|156593437|FG002|Overall Study|Lost to Follow-up|3|||
48655667|NCT02231892|156593435|FG000|Overall Study|Withdrawal by Subject|4|||
48655668|NCT02231892|156593436|FG001|Overall Study|Withdrawal by Subject|3|||
48655669|NCT02231892|156593437|FG002|Overall Study|Withdrawal by Subject|15|||
48655670|NCT02231892|156593435|FG000|Overall Study|Physician Decision|0|||
48655671|NCT02231892|156593436|FG001|Overall Study|Physician Decision|2|||
48655672|NCT02231892|156593437|FG002|Overall Study|Physician Decision|4|||
48655673|NCT02231892|156593435|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
48655674|NCT02231892|156593436|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
48655675|NCT02231892|156593437|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
48655676|NCT02231892|156593435|FG000|Overall Study|Participant motor threshold was >83%|0|||
48655677|NCT02231892|156593436|FG001|Overall Study|Participant motor threshold was >83%|0|||
48655678|NCT02231892|156593437|FG002|Overall Study|Participant motor threshold was >83%|9|||
48655679|NCT02231892|156593435|FG000|Overall Study|Could not find motor threshold|2|||
48754343|NCT00555321|156946654|FG001|Long-term Extension Phase|Other Reason|0|||
48335252|NCT01562275|155425229|FG001|Stage 1|Non Compliance|0|||
48335253|NCT01562275|155425230|FG002|Stage 1|Non Compliance|1|||
48335254|NCT01562275|155425231|FG003|Stage 1|Non Compliance|0|||
48655680|NCT02231892|156593436|FG001|Overall Study|Could not find motor threshold|0|||
48655681|NCT02231892|156593437|FG002|Overall Study|Could not find motor threshold|1|||
48655682|NCT02231892|156593435|FG000|Overall Study|Could not find reliable motor hotspot|0|||
48655683|NCT02231892|156593436|FG001|Overall Study|Could not find reliable motor hotspot|0|||
48754344|NCT00555321|156946655|FG002|Long-term Extension Phase|Other Reason|2|||
48335255|NCT01562275|155425232|FG004|Stage 1|Non Compliance|0|||
48655684|NCT02231892|156593437|FG002|Overall Study|Could not find reliable motor hotspot|1|||
48655685|NCT00290771|156593441|FG000|Overall Study|Disease progression|95|||
48655686|NCT00290771|156593442|FG001|Overall Study|Disease progression|73|||
48655687|NCT00290771|156593441|FG000|Overall Study|Death|11|||
48655688|NCT00290771|156593442|FG001|Overall Study|Death|10|||
48655689|NCT00290771|156593441|FG000|Overall Study|Adverse Event|12|||
48655690|NCT00290771|156593442|FG001|Overall Study|Adverse Event|6|||
48655691|NCT00290771|156593441|FG000|Overall Study|Withdrawal by Subject|5|||
48655692|NCT00290771|156593442|FG001|Overall Study|Withdrawal by Subject|6|||
48655693|NCT00290771|156593441|FG000|Overall Study|Administrative problems|2|||
48655694|NCT00290771|156593442|FG001|Overall Study|Administrative problems|1|||
48655695|NCT00290771|156593441|FG000|Overall Study|Protocol Violation|2|||
48655696|NCT00290771|156593442|FG001|Overall Study|Protocol Violation|0|||
48655697|NCT00290771|156593441|FG000|Overall Study|Lost to Follow-up|0|||
48655698|NCT00290771|156593442|FG001|Overall Study|Lost to Follow-up|1|||
48655699|NCT01895543|156593452|FG000|Overall Study|Withdrawal by Subject|43|||
48655700|NCT01895543|156593452|FG000|Overall Study|Lost to Follow-up|25|||
48655701|NCT01895543|156593452|FG000|Overall Study|Adverse Event|28|||
48655702|NCT01895543|156593452|FG000|Overall Study|Subject's substantial non-compliance|6|||
48655703|NCT01895543|156593452|FG000|Overall Study|Protocol Violation|1|||
48655704|NCT01895543|156593452|FG000|Overall Study|Physician Decision|2|||
48655705|NCT01895543|156593452|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
48655706|NCT04049266|156593457|FG000|Overall Study|Adverse Event|16|||
48655707|NCT04049266|156593458|FG001|Overall Study|Adverse Event|9|||
48655708|NCT04049266|156593457|FG000|Overall Study|Non-compliance with study drug|0|||
48655709|NCT04049266|156593458|FG001|Overall Study|Non-compliance with study drug|3|||
48655710|NCT04049266|156593457|FG000|Overall Study|Withdrawal by Subject|6|||
48335256|NCT01562275|155425233|FG005|Stage 1|Non Compliance|0|||
48335257|NCT01562275|155425234|FG006|Stage 1|Non Compliance|0|||
48655711|NCT04049266|156593458|FG001|Overall Study|Withdrawal by Subject|10|||
48655712|NCT04049266|156593457|FG000|Overall Study|Lost to Follow-up|2|||
48655713|NCT04049266|156593458|FG001|Overall Study|Lost to Follow-up|2|||
48335258|NCT01562275|155425235|FG007|Stage 1|Non Compliance|0|||
48754345|NCT00555321|156946656|FG003|Long-term Extension Phase|Other Reason|0|||
48655714|NCT04049266|156593457|FG000|Overall Study|Progressive disease|11|||
48754346|NCT00555321|156946657|FG004|Long-term Extension Phase|Other Reason|0|||
48754347|NCT04294472|156946660|FG000|Overall Study|Adverse Event|0|||
48754348|NCT04294472|156946661|FG001|Overall Study|Adverse Event|1|||
48754349|NCT04294472|156946662|FG002|Overall Study|Adverse Event|1|||
48754350|NCT04294472|156946660|FG000|Overall Study|Randomized but not treated|0|||
48754351|NCT04294472|156946661|FG001|Overall Study|Randomized but not treated|1|||
48754352|NCT04294472|156946662|FG002|Overall Study|Randomized but not treated|1|||
48754353|NCT00667368|156946665|FG000|Overall Study|Lost to Follow-up|176|||
48655715|NCT04049266|156593458|FG001|Overall Study|Progressive disease|2|||
48655716|NCT04049266|156593457|FG000|Overall Study|Physician Decision|1|||
48655717|NCT04049266|156593458|FG001|Overall Study|Physician Decision|0|||
48655718|NCT04049266|156593457|FG000|Overall Study|Patient moved out of state|1|||
48655719|NCT04049266|156593458|FG001|Overall Study|Patient moved out of state|0|||
48655720|NCT00404755|156593459|FG000|Phase I (Bupropion)|Adverse Event|3|||
48655721|NCT00404755|156593459|FG000|Phase I (Bupropion)|Other|1|||
48655722|NCT00404755|156593459|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
48655723|NCT00252694|156593460|FG000|Overall Study|Withdrawal by Subject|83|||
48655724|NCT00252694|156593461|FG001|Overall Study|Withdrawal by Subject|91|||
48655725|NCT00252694|156593460|FG000|Overall Study|Death|36|||
48655726|NCT00252694|156593461|FG001|Overall Study|Death|34|||
48655727|NCT00252694|156593460|FG000|Overall Study|Mostly Lost to Follow Up|8|||
48655728|NCT00252694|156593461|FG001|Overall Study|Mostly Lost to Follow Up|13|||
48655729|NCT00252694|156593460|FG000|Overall Study|Patient Moving|17|||
48655730|NCT00252694|156593461|FG001|Overall Study|Patient Moving|16|||
48655731|NCT00096226|156593463|FG000|Overall Study|Ineligible|2|||
48655732|NCT00096226|156593463|FG000|Overall Study|Protocol treatment not started|1|||
48655733|NCT04376684|156593464|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
48655734|NCT04376684|156593465|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
48655735|NCT04376684|156593466|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
48655736|NCT04376684|156593467|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
48655737|NCT04376684|156593464|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
48655738|NCT04376684|156593465|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
48655739|NCT04376684|156593466|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
48655740|NCT04376684|156593467|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
48655741|NCT04376684|156593464|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
48655742|NCT04376684|156593465|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
48655743|NCT04376684|156593466|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
48655744|NCT04376684|156593467|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
48655745|NCT04376684|156593464|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
48655746|NCT04376684|156593465|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
48655747|NCT04376684|156593466|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
48655748|NCT04376684|156593467|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
48655749|NCT04376684|156593464|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
48655750|NCT04376684|156593465|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
48655751|NCT04376684|156593466|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
48655752|NCT04376684|156593467|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
48655753|NCT04376684|156593464|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
48655754|NCT04376684|156593465|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
48655755|NCT04376684|156593466|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
48655756|NCT04376684|156593467|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
48655757|NCT04376684|156593464|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
48655758|NCT04376684|156593465|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
48655759|NCT04376684|156593466|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
48655760|NCT04376684|156593467|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
48754354|NCT00667368|156946666|FG001|Overall Study|Lost to Follow-up|155|||
48754355|NCT00667368|156946665|FG000|Overall Study|Discontinued early|24|||
48335259|NCT01562275|155425236|FG008|Stage 1|Non Compliance|0|||
48335260|NCT01562275|155425237|FG009|Stage 1|Non Compliance|0|||
48335261|NCT01562275|155425238|FG010|Stage 1|Non Compliance|0|||
48655761|NCT04173260|156593472|FG000|Overall Study|Early termination|4|||
48655762|NCT04644237|156593473|FG000|Overall Study|Death|3|||
48335262|NCT01562275|155425239|FG011|Stage 1|Non Compliance|0|||
48335263|NCT01562275|155425240|FG012|Stage 1|Non Compliance|0|||
48335264|NCT01562275|155425228|FG000|Stage 1|Physician Decision|0|||
48655763|NCT04644237|156593474|FG001|Overall Study|Death|2|||
48655764|NCT04644237|156593473|FG000|Overall Study|Adverse Event|15|||
48655765|NCT04644237|156593474|FG001|Overall Study|Adverse Event|12|||
48655766|NCT04644237|156593473|FG000|Overall Study|Progressive Disease|47|||
48655767|NCT04644237|156593474|FG001|Overall Study|Progressive Disease|19|||
48655768|NCT04644237|156593473|FG000|Overall Study|Clinical Progression|4|||
48655769|NCT04644237|156593474|FG001|Overall Study|Clinical Progression|1|||
48655770|NCT04644237|156593473|FG000|Overall Study|Withdrawal by Subject|1|||
48754356|NCT00667368|156946666|FG001|Overall Study|Discontinued early|17|||
48754357|NCT01957553|156946669|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
48335265|NCT01562275|155425229|FG001|Stage 1|Physician Decision|0|||
48655771|NCT04644237|156593474|FG001|Overall Study|Withdrawal by Subject|2|||
48655772|NCT04644237|156593473|FG000|Overall Study|Physician Decision|3|||
48655773|NCT04644237|156593474|FG001|Overall Study|Physician Decision|0|||
48655774|NCT04644237|156593473|FG000|Overall Study|Other|1|||
48655775|NCT04644237|156593474|FG001|Overall Study|Other|0|||
48655776|NCT04644237|156593473|FG000|Overall Study|Randomized but not Treated|1|||
48655777|NCT04644237|156593474|FG001|Overall Study|Randomized but not Treated|0|||
48655778|NCT00090233|156593476|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
48655779|NCT00090233|156593477|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
48655780|NCT00090233|156593476|FG000|Overall Study|Adverse Event|214|||
48655781|NCT00090233|156593477|FG001|Overall Study|Adverse Event|198|||
48655782|NCT00090233|156593476|FG000|Overall Study|Lost to Follow-up|68|||
48655783|NCT00090233|156593477|FG001|Overall Study|Lost to Follow-up|95|||
48655784|NCT00090233|156593476|FG000|Overall Study|Protocol Violation|960|||
48655785|NCT00090233|156593477|FG001|Overall Study|Protocol Violation|1022|||
48655786|NCT00090233|156593476|FG000|Overall Study|Withdrawal by Subject|182|||
48655787|NCT00090233|156593477|FG001|Overall Study|Withdrawal by Subject|211|||
48655788|NCT00090233|156593476|FG000|Overall Study|Moved|203|||
48655789|NCT00090233|156593477|FG001|Overall Study|Moved|189|||
48655790|NCT00090233|156593476|FG000|Overall Study|Other|1211|||
48754358|NCT01957553|156946670|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
48335266|NCT01562275|155425230|FG002|Stage 1|Physician Decision|0|||
48335267|NCT01562275|155425231|FG003|Stage 1|Physician Decision|0|||
48335268|NCT01562275|155425232|FG004|Stage 1|Physician Decision|1|||
48335269|NCT01562275|155425233|FG005|Stage 1|Physician Decision|0|||
48655791|NCT00090233|156593477|FG001|Overall Study|Other|1160|||
48655792|NCT00090233|156593476|FG000|Overall Study|Data not available at data cut-off point|1552|||
48655793|NCT00090233|156593477|FG001|Overall Study|Data not available at data cut-off point|1563|||
48655794|NCT01252186|156593478|FG000|Overall Study|Adverse Event|9|||
48655795|NCT01252186|156593479|FG001|Overall Study|Adverse Event|6|||
48655796|NCT01252186|156593480|FG002|Overall Study|Adverse Event|8|||
48655797|NCT01252186|156593478|FG000|Overall Study|Withdrawal by Subject|2|||
48655798|NCT01252186|156593479|FG001|Overall Study|Withdrawal by Subject|5|||
48655799|NCT01252186|156593480|FG002|Overall Study|Withdrawal by Subject|2|||
48655800|NCT01252186|156593478|FG000|Overall Study|Physician Decision|0|||
48655801|NCT01252186|156593479|FG001|Overall Study|Physician Decision|0|||
48655802|NCT01252186|156593480|FG002|Overall Study|Physician Decision|1|||
48655803|NCT01252186|156593478|FG000|Overall Study|Non-compliance|0|||
48655804|NCT01252186|156593479|FG001|Overall Study|Non-compliance|3|||
48655805|NCT01252186|156593480|FG002|Overall Study|Non-compliance|4|||
48655806|NCT01252186|156593478|FG000|Overall Study|Protocol Violation|0|||
48655807|NCT01252186|156593479|FG001|Overall Study|Protocol Violation|0|||
48655808|NCT01252186|156593480|FG002|Overall Study|Protocol Violation|1|||
48655809|NCT01252186|156593478|FG000|Overall Study|Pregnancy|2|||
48655810|NCT01252186|156593479|FG001|Overall Study|Pregnancy|2|||
48655811|NCT01252186|156593480|FG002|Overall Study|Pregnancy|0|||
48655812|NCT01252186|156593478|FG000|Overall Study|Sponsor Request|2|||
48655813|NCT01252186|156593479|FG001|Overall Study|Sponsor Request|1|||
48655814|NCT01252186|156593480|FG002|Overall Study|Sponsor Request|0|||
48655815|NCT01252186|156593478|FG000|Overall Study|Lost to Follow-up|10|||
48655816|NCT01252186|156593479|FG001|Overall Study|Lost to Follow-up|10|||
48655817|NCT01252186|156593480|FG002|Overall Study|Lost to Follow-up|11|||
48655818|NCT01252186|156593478|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
48655819|NCT01252186|156593479|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
48655820|NCT01252186|156593480|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
48655821|NCT00580034|156593482|FG000|Overall Study|Toxicity|10|||
48655822|NCT00580034|156593483|FG001|Overall Study|Toxicity|0|||
48655823|NCT03305081|156593484|FG000|Overall Study|Lost to Follow-up|10|||
48655824|NCT03305081|156593485|FG001|Overall Study|Lost to Follow-up|15|||
48655825|NCT02499900|156593486|FG000|Core Study Period|Other|1|||
48655826|NCT02499900|156593487|FG001|Core Study Period|Other|4|||
48754359|NCT01957553|156946669|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
48754360|NCT01957553|156946670|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
48655827|NCT02499900|156593486|FG000|Core Study Period|Lost to Follow-up|1|||
48655828|NCT02499900|156593487|FG001|Core Study Period|Lost to Follow-up|2|||
48754361|NCT01957553|156946669|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
48754362|NCT01957553|156946670|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
48335270|NCT01562275|155425234|FG006|Stage 1|Physician Decision|1|||
48335271|NCT01562275|155425235|FG007|Stage 1|Physician Decision|0|||
48655829|NCT02499900|156593486|FG000|Core Study Period|Per sponsor request|0|||
48655830|NCT02499900|156593487|FG001|Core Study Period|Per sponsor request|1|||
48655831|NCT02499900|156593486|FG000|Core Study Period|Pregnancy|1|||
48655832|NCT02499900|156593487|FG001|Core Study Period|Pregnancy|0|||
48655833|NCT02499900|156593486|FG000|Core Study Period|Protocol Violation|3|||
48655834|NCT02499900|156593487|FG001|Core Study Period|Protocol Violation|0|||
48655835|NCT02499900|156593486|FG000|Core Study Period|Withdrawal by Subject|11|||
48655836|NCT02499900|156593487|FG001|Core Study Period|Withdrawal by Subject|10|||
48655837|NCT02499900|156593486|FG000|Core Study Period|Adverse Event|18|||
48655838|NCT02499900|156593487|FG001|Core Study Period|Adverse Event|14|||
48754363|NCT01957553|156946669|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
48754364|NCT01957553|156946670|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
48754365|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
48335272|NCT01562275|155425236|FG008|Stage 1|Physician Decision|1|||
48655839|NCT02499900|156593486|FG000|Core Study Period|Death|0|||
48655840|NCT02499900|156593487|FG001|Core Study Period|Death|1|||
48655841|NCT02499900|156593486|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
48655842|NCT02499900|156593487|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
48655843|NCT02499900|156593486|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
48655844|NCT02499900|156593487|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
48655845|NCT02499900|156593486|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
48655846|NCT02499900|156593487|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
48655847|NCT02499900|156593486|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
48655848|NCT02499900|156593487|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
48655849|NCT02499900|156593486|FG000|Extension Study Period|Adverse Event|2|||
48655850|NCT02499900|156593487|FG001|Extension Study Period|Adverse Event|4|||
48655851|NCT02499900|156593486|FG000|Extension Study Period|Withdrawal by Subject|5|||
48655852|NCT02499900|156593487|FG001|Extension Study Period|Withdrawal by Subject|2|||
48655853|NCT02499900|156593486|FG000|Extension Study Period|Physician Decision|2|||
48655854|NCT02499900|156593487|FG001|Extension Study Period|Physician Decision|5|||
48655855|NCT02499900|156593486|FG000|Extension Study Period|Pregnancy|1|||
48655856|NCT02499900|156593487|FG001|Extension Study Period|Pregnancy|2|||
48655857|NCT02499900|156593486|FG000|Extension Study Period|Lost to Follow-up|2|||
48655858|NCT02499900|156593487|FG001|Extension Study Period|Lost to Follow-up|5|||
48655859|NCT02499900|156593486|FG000|Extension Study Period|Other|0|||
48655860|NCT02499900|156593487|FG001|Extension Study Period|Other|2|||
48655861|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
48655862|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
48655863|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
48655864|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
48655865|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
48655866|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
48655867|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
48655868|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
48655869|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
48655870|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
48655871|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
48655872|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
48655873|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
48655874|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
48655875|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
48655876|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
48655877|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
48655878|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
48655879|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
48655880|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
48655881|NCT03222973|156593488|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
48655882|NCT03222973|156593489|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
48655883|NCT03222973|156593490|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
48655884|NCT03222973|156593491|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
48655885|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
48655886|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
48655887|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
48655888|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
48655889|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
48655890|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
48655891|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
48655892|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
48655893|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
48655894|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
48655895|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
48655896|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
48655897|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
48655898|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
48655899|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
48655900|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
48655901|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
48655902|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
48655903|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
48655904|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
48655905|NCT03222973|156593488|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
48754366|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
48655906|NCT03222973|156593489|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
48655907|NCT03222973|156593490|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
48655908|NCT03222973|156593491|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
48655909|NCT04027049|156593494|FG000|Overall Study|Withdrawn by family|1|||
48655910|NCT04027049|156593495|FG001|Overall Study|Withdrawn by family|0|||
48754367|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
48754368|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
48754369|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
48754370|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
48754371|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
48754372|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
48754373|NCT01957553|156946669|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
48754374|NCT01957553|156946670|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
48754375|NCT04044716|156946671|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
48754376|NCT04044716|156946672|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
48754377|NCT04044716|156946673|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
48754378|NCT04044716|156946671|FG000|Overall Study|Lost to Follow-up|2|||
48754379|NCT04044716|156946672|FG001|Overall Study|Lost to Follow-up|3|||
48754380|NCT04044716|156946673|FG002|Overall Study|Lost to Follow-up|0|||
48754381|NCT02730455|156946674|FG000|Overall Study|Death|5|||
48754382|NCT02730455|156946675|FG001|Overall Study|Death|6|||
48754383|NCT02730455|156946676|FG002|Overall Study|Death|4|||
48754384|NCT02730455|156946674|FG000|Overall Study|Consent withdrawn|2|||
48754385|NCT02730455|156946675|FG001|Overall Study|Consent withdrawn|4|||
48754386|NCT02730455|156946676|FG002|Overall Study|Consent withdrawn|1|||
48754387|NCT02730455|156946674|FG000|Overall Study|Lost to Follow-up|3|||
48754388|NCT02730455|156946675|FG001|Overall Study|Lost to Follow-up|1|||
48754389|NCT02730455|156946676|FG002|Overall Study|Lost to Follow-up|4|||
48754390|NCT02730455|156946674|FG000|Overall Study|Other|1|||
48754391|NCT02730455|156946675|FG001|Overall Study|Other|1|||
48754392|NCT02730455|156946676|FG002|Overall Study|Other|2|||
48754393|NCT02730455|156946674|FG000|Overall Study|Other|2|||
48754394|NCT02730455|156946675|FG001|Overall Study|Other|2|||
48754395|NCT02730455|156946676|FG002|Overall Study|Other|0|||
48754396|NCT00737282|156946677|FG000|Overall Study|Study prematurely terminated|175|||
48754397|NCT00459108|156946682|FG000|Overall Study|Withdrawal by Subject|5|||
48754398|NCT00459108|156946682|FG000|Overall Study|Adverse Event|3|||
48754399|NCT00459108|156946682|FG000|Overall Study|Death|2|||
48754400|NCT00459108|156946682|FG000|Overall Study|Progression|1|||
48754401|NCT02743871|156946686|FG000|Overall Study|Lost to Follow-up|0|||
48754402|NCT02743871|156946687|FG001|Overall Study|Lost to Follow-up|0|||
48754403|NCT02743871|156946688|FG002|Overall Study|Lost to Follow-up|0|||
48335273|NCT01562275|155425237|FG009|Stage 1|Physician Decision|0|||
48335274|NCT01562275|155425238|FG010|Stage 1|Physician Decision|0|||
48335275|NCT01562275|155425239|FG011|Stage 1|Physician Decision|0|||
48335276|NCT01562275|155425240|FG012|Stage 1|Physician Decision|0|||
48335277|NCT01562275|155425228|FG000|Stage 1|Progression of Disease|2|||
48335278|NCT01562275|155425229|FG001|Stage 1|Progression of Disease|6|||
48335279|NCT01562275|155425230|FG002|Stage 1|Progression of Disease|2|||
48335280|NCT01562275|155425231|FG003|Stage 1|Progression of Disease|1|||
48335281|NCT01562275|155425232|FG004|Stage 1|Progression of Disease|2|||
48335282|NCT01562275|155425233|FG005|Stage 1|Progression of Disease|4|||
48335283|NCT01562275|155425234|FG006|Stage 1|Progression of Disease|1|||
48335284|NCT01562275|155425235|FG007|Stage 1|Progression of Disease|7|||
48335285|NCT01562275|155425236|FG008|Stage 1|Progression of Disease|2|||
48335286|NCT01562275|155425237|FG009|Stage 1|Progression of Disease|5|||
48335287|NCT01562275|155425238|FG010|Stage 1|Progression of Disease|3|||
48655911|NCT04027049|156593494|FG000|Overall Study|Participant safety|1|||
48655912|NCT04027049|156593495|FG001|Overall Study|Participant safety|0|||
48335288|NCT01562275|155425239|FG011|Stage 1|Progression of Disease|0|||
48335289|NCT01562275|155425240|FG012|Stage 1|Progression of Disease|0|||
48655913|NCT03746600|156593496|FG000|Overall Study|Withdrawal by Subject|3|||
48655914|NCT03746600|156593497|FG001|Overall Study|Withdrawal by Subject|3|||
48335290|NCT01562275|155425228|FG000|Stage 1|Withdrawal by Subject|0|||
48335291|NCT01562275|155425229|FG001|Stage 1|Withdrawal by Subject|1|||
48335292|NCT01562275|155425230|FG002|Stage 1|Withdrawal by Subject|0|||
48335293|NCT01562275|155425231|FG003|Stage 1|Withdrawal by Subject|2|||
48335294|NCT01562275|155425232|FG004|Stage 1|Withdrawal by Subject|0|||
48335295|NCT01562275|155425233|FG005|Stage 1|Withdrawal by Subject|0|||
48335296|NCT01562275|155425234|FG006|Stage 1|Withdrawal by Subject|1|||
48655915|NCT03746600|156593496|FG000|Overall Study|dismissed from study|1|||
48335297|NCT01562275|155425235|FG007|Stage 1|Withdrawal by Subject|0|||
48335298|NCT01562275|155425236|FG008|Stage 1|Withdrawal by Subject|0|||
48335299|NCT01562275|155425237|FG009|Stage 1|Withdrawal by Subject|1|||
48754404|NCT02743871|156946689|FG003|Overall Study|Lost to Follow-up|1|||
48754405|NCT02743871|156946690|FG004|Overall Study|Lost to Follow-up|0|||
48754406|NCT02743871|156946691|FG005|Overall Study|Lost to Follow-up|0|||
48335300|NCT01562275|155425238|FG010|Stage 1|Withdrawal by Subject|0|||
48335301|NCT01562275|155425239|FG011|Stage 1|Withdrawal by Subject|0|||
48655916|NCT03746600|156593497|FG001|Overall Study|dismissed from study|0|||
48335302|NCT01562275|155425240|FG012|Stage 1|Withdrawal by Subject|0|||
48335303|NCT01562275|155425228|FG000|Stage 2|Death|0|||
48335304|NCT01562275|155425229|FG001|Stage 2|Death|0|||
48655917|NCT03746600|156593496|FG000|Overall Study|Lost to Follow-up|1|||
48655918|NCT03746600|156593497|FG001|Overall Study|Lost to Follow-up|0|||
48655919|NCT04068519|156593498|FG000|Dose Verification|Death|15|||
48655920|NCT04068519|156593498|FG000|Dose Verification|Withdrawal by Subject|1|||
48655921|NCT04068519|156593498|FG000|Pharmacokinetic Sub-study|Death|35|||
48655922|NCT04068519|156593498|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
48655923|NCT04068519|156593498|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
48655924|NCT04068519|156593498|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
48655925|NCT04068519|156593498|FG000|Indication Expansion|Death|152|||
48655926|NCT04068519|156593498|FG000|Indication Expansion|Withdrawal by Subject|10|||
48655927|NCT04068519|156593498|FG000|Indication Expansion|Lost to Follow-up|7|||
48655928|NCT03280303|156595878|FG000|Overall Study|Death|505|||
48655929|NCT03280303|156595878|FG000|Overall Study|Study terminated by sponsor|383|||
48335305|NCT01562275|155425230|FG002|Stage 2|Death|0|||
48335306|NCT01562275|155425231|FG003|Stage 2|Death|0|||
48335307|NCT01562275|155425232|FG004|Stage 2|Death|0|||
48335308|NCT01562275|155425233|FG005|Stage 2|Death|0|||
48335309|NCT01562275|155425234|FG006|Stage 2|Death|0|||
48335310|NCT01562275|155425235|FG007|Stage 2|Death|0|||
48335311|NCT01562275|155425236|FG008|Stage 2|Death|0|||
48335312|NCT01562275|155425237|FG009|Stage 2|Death|0|||
48335313|NCT01562275|155425238|FG010|Stage 2|Death|0|||
48335314|NCT01562275|155425239|FG011|Stage 2|Death|2|||
48335315|NCT01562275|155425240|FG012|Stage 2|Death|1|||
48335316|NCT01562275|155425228|FG000|Stage 2|Progression of Disease|0|||
48335317|NCT01562275|155425229|FG001|Stage 2|Progression of Disease|0|||
48335318|NCT01562275|155425230|FG002|Stage 2|Progression of Disease|0|||
48335319|NCT01562275|155425231|FG003|Stage 2|Progression of Disease|0|||
48335320|NCT01562275|155425232|FG004|Stage 2|Progression of Disease|0|||
48335321|NCT01562275|155425233|FG005|Stage 2|Progression of Disease|0|||
48335322|NCT01562275|155425234|FG006|Stage 2|Progression of Disease|0|||
48335323|NCT01562275|155425235|FG007|Stage 2|Progression of Disease|0|||
48335324|NCT01562275|155425236|FG008|Stage 2|Progression of Disease|0|||
48335325|NCT01562275|155425237|FG009|Stage 2|Progression of Disease|0|||
48335326|NCT01562275|155425238|FG010|Stage 2|Progression of Disease|0|||
48335327|NCT01562275|155425239|FG011|Stage 2|Progression of Disease|12|||
48335328|NCT01562275|155425240|FG012|Stage 2|Progression of Disease|4|||
48335329|NCT00070707|155425241|FG000|Overall Study|Adverse Event|1|||
48335330|NCT00070707|155425242|FG001|Overall Study|Adverse Event|2|||
48335331|NCT00070707|155425241|FG000|Overall Study|Lack of Efficacy|4|||
48655930|NCT03280303|156595878|FG000|Overall Study|Other|148|||
48655931|NCT03280303|156595878|FG000|Overall Study|No longer willing to participate in study|101|||
48655932|NCT03280303|156595878|FG000|Overall Study|Lost to follow up|39|||
48655933|NCT03280303|156595878|FG000|Overall Study|Adverse Event|20|||
48655934|NCT01631747|156595879|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
48655935|NCT01631747|156595880|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
48655936|NCT01631747|156595879|FG000|Live Birth|Pregnancy Termination|1|||
48655937|NCT01631747|156595880|FG001|Live Birth|Pregnancy Termination|0|||
48335332|NCT00070707|155425242|FG001|Overall Study|Lack of Efficacy|1|||
48335333|NCT00070707|155425241|FG000|Overall Study|Protocol Violation|8|||
48335334|NCT00070707|155425242|FG001|Overall Study|Protocol Violation|4|||
48335335|NCT00070707|155425241|FG000|Overall Study|Unrelated to Study Medication|1|||
48335336|NCT00070707|155425242|FG001|Overall Study|Unrelated to Study Medication|0|||
48335337|NCT00647699|155425243|FG000|Overall Study|Lost to Follow-up|5|||
48335338|NCT00647699|155425244|FG001|Overall Study|Lost to Follow-up|4|||
48335339|NCT00647699|155425243|FG000|Overall Study|Withdrawal by Subject|3|||
48335340|NCT00647699|155425244|FG001|Overall Study|Withdrawal by Subject|8|||
48335341|NCT04909593|155425245|FG000|Overall Study|Withdrawal by Subject|1|||
48335342|NCT01241448|155425246|FG000|Overall Study|Adverse Event|1|||
48655938|NCT01631747|156595879|FG000|Live Birth|MIscarriage|2|||
48335343|NCT01241448|155425247|FG001|Overall Study|Adverse Event|0|||
48335344|NCT01241448|155425248|FG002|Overall Study|Adverse Event|2|||
48335345|NCT01241448|155425249|FG003|Overall Study|Adverse Event|2|||
48335346|NCT01241448|155425246|FG000|Overall Study|Lost to Follow-up|2|||
48335347|NCT01241448|155425247|FG001|Overall Study|Lost to Follow-up|1|||
48655939|NCT01631747|156595880|FG001|Live Birth|MIscarriage|0|||
48655940|NCT01631747|156595879|FG000|Live Birth|Stillbirth|1|||
48655941|NCT01631747|156595880|FG001|Live Birth|Stillbirth|1|||
48655942|NCT01631747|156595879|FG000|One Year Infant Outcomes|Patient Refused|13|||
48655943|NCT01631747|156595880|FG001|One Year Infant Outcomes|Patient Refused|9|||
48335348|NCT01241448|155425248|FG002|Overall Study|Lost to Follow-up|1|||
48655944|NCT00064259|156595881|FG000|Overall Study|Adverse Event|1|||
48335349|NCT01241448|155425249|FG003|Overall Study|Lost to Follow-up|1|||
48335350|NCT01241448|155425246|FG000|Overall Study|Physician Decision|0|||
48335351|NCT01241448|155425247|FG001|Overall Study|Physician Decision|2|||
48335352|NCT01241448|155425248|FG002|Overall Study|Physician Decision|0|||
48754407|NCT02743871|156946692|FG006|Overall Study|Lost to Follow-up|1|||
48754408|NCT02743871|156946693|FG007|Overall Study|Lost to Follow-up|0|||
48754409|NCT02743871|156946694|FG008|Overall Study|Lost to Follow-up|0|||
48754410|NCT02743871|156946695|FG009|Overall Study|Lost to Follow-up|0|||
48754411|NCT02743871|156946696|FG010|Overall Study|Lost to Follow-up|0|||
48754412|NCT02743871|156946697|FG011|Overall Study|Lost to Follow-up|2|||
48754413|NCT02743871|156946698|FG012|Overall Study|Lost to Follow-up|0|||
48754414|NCT02743871|156946699|FG013|Overall Study|Lost to Follow-up|0|||
48754415|NCT02743871|156946686|FG000|Overall Study|Withdrawal by Subject|0|||
48754416|NCT02743871|156946687|FG001|Overall Study|Withdrawal by Subject|0|||
48754417|NCT02743871|156946688|FG002|Overall Study|Withdrawal by Subject|0|||
48754418|NCT02743871|156946689|FG003|Overall Study|Withdrawal by Subject|0|||
48754419|NCT02743871|156946690|FG004|Overall Study|Withdrawal by Subject|0|||
48754420|NCT02743871|156946691|FG005|Overall Study|Withdrawal by Subject|0|||
48754421|NCT02743871|156946692|FG006|Overall Study|Withdrawal by Subject|0|||
48754422|NCT02743871|156946693|FG007|Overall Study|Withdrawal by Subject|0|||
48754423|NCT02743871|156946694|FG008|Overall Study|Withdrawal by Subject|0|||
48754424|NCT02743871|156946695|FG009|Overall Study|Withdrawal by Subject|0|||
48754425|NCT02743871|156946696|FG010|Overall Study|Withdrawal by Subject|1|||
48754426|NCT02743871|156946697|FG011|Overall Study|Withdrawal by Subject|0|||
48754427|NCT02743871|156946698|FG012|Overall Study|Withdrawal by Subject|12|||
48754428|NCT02743871|156946699|FG013|Overall Study|Withdrawal by Subject|6|||
48754429|NCT02743871|156946686|FG000|Overall Study|Adverse Event|1|||
48754430|NCT02743871|156946687|FG001|Overall Study|Adverse Event|0|||
48754431|NCT02743871|156946688|FG002|Overall Study|Adverse Event|0|||
48754432|NCT02743871|156946689|FG003|Overall Study|Adverse Event|0|||
48754433|NCT02743871|156946690|FG004|Overall Study|Adverse Event|0|||
48754434|NCT02743871|156946691|FG005|Overall Study|Adverse Event|0|||
48754435|NCT02743871|156946692|FG006|Overall Study|Adverse Event|0|||
48754436|NCT02743871|156946693|FG007|Overall Study|Adverse Event|0|||
48754437|NCT02743871|156946694|FG008|Overall Study|Adverse Event|0|||
48754438|NCT02743871|156946695|FG009|Overall Study|Adverse Event|0|||
48754439|NCT02743871|156946696|FG010|Overall Study|Adverse Event|0|||
48754440|NCT02743871|156946697|FG011|Overall Study|Adverse Event|0|||
48754441|NCT02743871|156946698|FG012|Overall Study|Adverse Event|0|||
48754442|NCT02743871|156946699|FG013|Overall Study|Adverse Event|0|||
48754443|NCT02743871|156946686|FG000|Overall Study|Other|0|||
48754444|NCT02743871|156946687|FG001|Overall Study|Other|0|||
48754445|NCT02743871|156946688|FG002|Overall Study|Other|0|||
48754446|NCT02743871|156946689|FG003|Overall Study|Other|0|||
48754447|NCT02743871|156946690|FG004|Overall Study|Other|0|||
48754448|NCT02743871|156946691|FG005|Overall Study|Other|0|||
48754449|NCT02743871|156946692|FG006|Overall Study|Other|0|||
48754450|NCT02743871|156946693|FG007|Overall Study|Other|0|||
48754451|NCT02743871|156946694|FG008|Overall Study|Other|0|||
48754452|NCT02743871|156946695|FG009|Overall Study|Other|0|||
48754453|NCT02743871|156946696|FG010|Overall Study|Other|0|||
48754454|NCT02743871|156946697|FG011|Overall Study|Other|1|||
48754455|NCT02743871|156946698|FG012|Overall Study|Other|1|||
48754456|NCT02743871|156946699|FG013|Overall Study|Other|1|||
48754457|NCT02743871|156946686|FG000|Overall Study|Protocol Violation|0|||
48754458|NCT02743871|156946687|FG001|Overall Study|Protocol Violation|0|||
48754459|NCT02743871|156946688|FG002|Overall Study|Protocol Violation|0|||
48754460|NCT02743871|156946689|FG003|Overall Study|Protocol Violation|0|||
48754461|NCT02743871|156946690|FG004|Overall Study|Protocol Violation|0|||
48754462|NCT02743871|156946691|FG005|Overall Study|Protocol Violation|0|||
48754463|NCT02743871|156946692|FG006|Overall Study|Protocol Violation|0|||
48335353|NCT01241448|155425249|FG003|Overall Study|Physician Decision|0|||
48335354|NCT01241448|155425246|FG000|Overall Study|Protocol Violation|10|||
48335355|NCT01241448|155425247|FG001|Overall Study|Protocol Violation|5|||
48335356|NCT01241448|155425248|FG002|Overall Study|Protocol Violation|3|||
48335357|NCT01241448|155425249|FG003|Overall Study|Protocol Violation|6|||
48335358|NCT01241448|155425246|FG000|Overall Study|Sponsor Decision|17|||
48335359|NCT01241448|155425247|FG001|Overall Study|Sponsor Decision|14|||
48754464|NCT02743871|156946693|FG007|Overall Study|Protocol Violation|0|||
48754465|NCT02743871|156946694|FG008|Overall Study|Protocol Violation|0|||
48754466|NCT02743871|156946695|FG009|Overall Study|Protocol Violation|0|||
48754467|NCT02743871|156946696|FG010|Overall Study|Protocol Violation|0|||
48754468|NCT02743871|156946697|FG011|Overall Study|Protocol Violation|0|||
48754469|NCT02743871|156946698|FG012|Overall Study|Protocol Violation|2|||
48754470|NCT02743871|156946699|FG013|Overall Study|Protocol Violation|0|||
48754471|NCT03194321|156946705|FG000|Overall Study|Withdrawal by Subject|1|||
48754472|NCT03194321|156946705|FG000|Overall Study|Lost to Follow-up|1|||
48754473|NCT03194321|156946705|FG000|Overall Study|Travel for Follow-up|1|||
48754474|NCT03241342|156946707|FG000|Overall Study|Adverse Event|5|||
48754475|NCT03241342|156946708|FG001|Overall Study|Adverse Event|8|||
48754476|NCT03241342|156946709|FG002|Overall Study|Adverse Event|4|||
48754477|NCT03241342|156946707|FG000|Overall Study|Lack of Efficacy|0|||
48754478|NCT03241342|156946708|FG001|Overall Study|Lack of Efficacy|0|||
48754479|NCT03241342|156946709|FG002|Overall Study|Lack of Efficacy|1|||
48754480|NCT03241342|156946707|FG000|Overall Study|noncompliance with study drug|2|||
48754481|NCT03241342|156946708|FG001|Overall Study|noncompliance with study drug|1|||
48754482|NCT03241342|156946709|FG002|Overall Study|noncompliance with study drug|1|||
48754483|NCT03241342|156946707|FG000|Overall Study|sponsor decision|0|||
48754484|NCT03241342|156946708|FG001|Overall Study|sponsor decision|1|||
48754485|NCT03241342|156946709|FG002|Overall Study|sponsor decision|2|||
48754486|NCT03241342|156946707|FG000|Overall Study|not reported|15|||
48754487|NCT03241342|156946708|FG001|Overall Study|not reported|21|||
48754488|NCT03241342|156946709|FG002|Overall Study|not reported|19|||
48754489|NCT01698801|156946712|FG000|Treatment Phase|Adverse Event|4|||
48754490|NCT01698801|156946712|FG000|Treatment Phase|Protocol Violation|1|||
48754491|NCT01698801|156946712|FG000|Treatment Phase|Other|4|||
48754492|NCT01698801|156946712|FG000|Treatment Phase|Withdrawal by Subject|1|||
48754493|NCT01698801|156946712|FG000|Treatment Phase|Disease progression|1|||
48754494|NCT01698801|156946712|FG000|Follow Up Phase|Withdrawal by Subject|1|||
48754495|NCT01698801|156946712|FG000|Follow Up Phase|Death|4|||
48754496|NCT01705652|156946713|FG000|Overall Study|Adverse Event|1|||
48754497|NCT01705652|156946714|FG001|Overall Study|Adverse Event|0|||
48754498|NCT01705652|156946713|FG000|Overall Study|Withdrawal by Subject|1|||
48754499|NCT01705652|156946714|FG001|Overall Study|Withdrawal by Subject|2|||
48754500|NCT01705652|156946713|FG000|Overall Study|non-compliance|1|||
48754501|NCT01705652|156946714|FG001|Overall Study|non-compliance|1|||
48754502|NCT00847704|156946716|FG000|Overall Study|Withdrawal by Subject|1|||
48754503|NCT03036072|156946717|FG000|Overall Study|Death|0|||
48754504|NCT03036072|156946718|FG001|Overall Study|Death|1|||
48754505|NCT03036072|156946717|FG000|Overall Study|Withdrawal by Subject|0|||
48754506|NCT03036072|156946718|FG001|Overall Study|Withdrawal by Subject|1|||
48754507|NCT03036072|156946717|FG000|Overall Study|Physician Decision|0|||
48754508|NCT03036072|156946718|FG001|Overall Study|Physician Decision|1|||
48335360|NCT01241448|155425248|FG002|Overall Study|Sponsor Decision|12|||
48335361|NCT01241448|155425249|FG003|Overall Study|Sponsor Decision|6|||
48335362|NCT01241448|155425246|FG000|Overall Study|Withdrawal by Subject|4|||
48335363|NCT01241448|155425247|FG001|Overall Study|Withdrawal by Subject|5|||
48335364|NCT01241448|155425248|FG002|Overall Study|Withdrawal by Subject|3|||
48335365|NCT01241448|155425249|FG003|Overall Study|Withdrawal by Subject|6|||
48335366|NCT01241448|155425246|FG000|Overall Study|Excluded due to data integrity issues|3|||
48335367|NCT01241448|155425247|FG001|Overall Study|Excluded due to data integrity issues|2|||
48335368|NCT01241448|155425248|FG002|Overall Study|Excluded due to data integrity issues|2|||
48335369|NCT01241448|155425249|FG003|Overall Study|Excluded due to data integrity issues|2|||
48655945|NCT00064259|156595882|FG001|Overall Study|Adverse Event|0|||
48655946|NCT00064259|156595883|FG002|Overall Study|Adverse Event|0|||
48655947|NCT00064259|156595884|FG003|Overall Study|Adverse Event|1|||
48655948|NCT01579565|156595885|FG000|Randomized|Adverse Event|1|||
48655949|NCT01579565|156595886|FG001|Randomized|Adverse Event|3|||
48655950|NCT01579565|156595885|FG000|Randomized|Withdrawal by Subject|3|||
48655951|NCT01579565|156595886|FG001|Randomized|Withdrawal by Subject|0|||
48655952|NCT01579565|156595885|FG000|Randomized|inadequate preoperative pupil dilation|0|||
48655953|NCT01579565|156595886|FG001|Randomized|inadequate preoperative pupil dilation|1|||
48655954|NCT01579565|156595885|FG000|Randomized|prohibited preoperative eating|1|||
48655955|NCT01579565|156595886|FG001|Randomized|prohibited preoperative eating|0|||
48754509|NCT02111850|156946719|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48335370|NCT02092285|155425250|FG000|Induction Phase|Adverse Event|7|||
48335371|NCT02092285|155425250|FG000|Induction Phase|Physician Decision|4|||
48655956|NCT01579565|156595885|FG000|Randomized|prohibited preoperative medication|0|||
48655957|NCT01579565|156595886|FG001|Randomized|prohibited preoperative medication|1|||
48655958|NCT01579565|156595885|FG000|Treated|Physician Decision|0|||
48655959|NCT01579565|156595886|FG001|Treated|Physician Decision|1|||
48655960|NCT01579565|156595885|FG000|Treated|Lost to Follow-up|2|||
48655961|NCT01579565|156595886|FG001|Treated|Lost to Follow-up|1|||
48655962|NCT01579565|156595885|FG000|Treated|declined to return for final visit|0|||
48655963|NCT01579565|156595886|FG001|Treated|declined to return for final visit|1|||
48655964|NCT01380535|156595887|FG000|Overall Study|Adverse Event|3|||
48655965|NCT01380535|156595888|FG001|Overall Study|Adverse Event|3|||
48655966|NCT01380535|156595887|FG000|Overall Study|Death|3|||
48335372|NCT02092285|155425250|FG000|Induction Phase|Pregnancy|1|||
48655967|NCT01380535|156595888|FG001|Overall Study|Death|0|||
48655968|NCT01380535|156595887|FG000|Overall Study|Study site closed|0|||
48335373|NCT02092285|155425250|FG000|Induction Phase|Relapse/Recurrence|7|||
48335374|NCT02092285|155425250|FG000|Induction Phase|Withdrawal by Subject|2|||
48335375|NCT02092285|155425250|FG000|Induction Phase|Lack of Efficacy|14|||
48655969|NCT01380535|156595888|FG001|Overall Study|Study site closed|5|||
48655970|NCT01380535|156595887|FG000|Overall Study|Withdrawal by Subject|1|||
48655971|NCT01380535|156595888|FG001|Overall Study|Withdrawal by Subject|2|||
48754510|NCT02111850|156946720|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754511|NCT02111850|156946721|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754512|NCT02111850|156946722|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754513|NCT02111850|156946723|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
48655972|NCT01380535|156595887|FG000|Overall Study|Protocol Violation|0|||
48655973|NCT01380535|156595888|FG001|Overall Study|Protocol Violation|2|||
48655974|NCT01380535|156595887|FG000|Overall Study|Lack of Efficacy|0|||
48655975|NCT01380535|156595888|FG001|Overall Study|Lack of Efficacy|3|||
48655976|NCT02954406|156595889|FG000|Overall Study|Adverse Event|0|||
48655977|NCT02954406|156595890|FG001|Overall Study|Adverse Event|1|||
48655978|NCT02954406|156595891|FG002|Overall Study|Adverse Event|0|||
48655979|NCT02954406|156595892|FG003|Overall Study|Adverse Event|0|||
48655980|NCT02954406|156595893|FG004|Overall Study|Adverse Event|1|||
48655981|NCT02954406|156595894|FG005|Overall Study|Adverse Event|0|||
48655982|NCT02954406|156595895|FG006|Overall Study|Adverse Event|0|||
48655983|NCT02954406|156595896|FG007|Overall Study|Adverse Event|0|||
48655984|NCT02954406|156595897|FG008|Overall Study|Adverse Event|1|||
48655985|NCT02954406|156595898|FG009|Overall Study|Adverse Event|1|||
48655986|NCT02954406|156595899|FG010|Overall Study|Adverse Event|0|||
48655987|NCT02954406|156595889|FG000|Overall Study|Progressive Disease|3|||
48335376|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
48655988|NCT02954406|156595890|FG001|Overall Study|Progressive Disease|4|||
48655989|NCT02954406|156595891|FG002|Overall Study|Progressive Disease|3|||
48655990|NCT02954406|156595892|FG003|Overall Study|Progressive Disease|4|||
48655991|NCT02954406|156595893|FG004|Overall Study|Progressive Disease|3|||
48655992|NCT02954406|156595894|FG005|Overall Study|Progressive Disease|3|||
48655993|NCT02954406|156595895|FG006|Overall Study|Progressive Disease|2|||
48655994|NCT02954406|156595896|FG007|Overall Study|Progressive Disease|2|||
48655995|NCT02954406|156595897|FG008|Overall Study|Progressive Disease|1|||
48655996|NCT02954406|156595898|FG009|Overall Study|Progressive Disease|1|||
48655997|NCT02954406|156595899|FG010|Overall Study|Progressive Disease|0|||
48655998|NCT02954406|156595889|FG000|Overall Study|Symptomatic Deterioration|0|||
48655999|NCT02954406|156595890|FG001|Overall Study|Symptomatic Deterioration|1|||
48656000|NCT02954406|156595891|FG002|Overall Study|Symptomatic Deterioration|0|||
48656001|NCT02954406|156595892|FG003|Overall Study|Symptomatic Deterioration|0|||
48656002|NCT02954406|156595893|FG004|Overall Study|Symptomatic Deterioration|0|||
48656003|NCT02954406|156595894|FG005|Overall Study|Symptomatic Deterioration|0|||
48656004|NCT02954406|156595895|FG006|Overall Study|Symptomatic Deterioration|0|||
48656005|NCT02954406|156595896|FG007|Overall Study|Symptomatic Deterioration|0|||
48656006|NCT02954406|156595897|FG008|Overall Study|Symptomatic Deterioration|0|||
48656007|NCT02954406|156595898|FG009|Overall Study|Symptomatic Deterioration|0|||
48656008|NCT02954406|156595899|FG010|Overall Study|Symptomatic Deterioration|0|||
48335377|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
48335378|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
48656009|NCT02954406|156595889|FG000|Overall Study|Death|0|||
48656010|NCT02954406|156595890|FG001|Overall Study|Death|0|||
48656011|NCT02954406|156595891|FG002|Overall Study|Death|0|||
48656012|NCT02954406|156595892|FG003|Overall Study|Death|0|||
48656013|NCT02954406|156595893|FG004|Overall Study|Death|1|||
48335379|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
48335380|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
48656014|NCT02954406|156595894|FG005|Overall Study|Death|0|||
48335381|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
48335382|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
48335383|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
48335384|NCT02092285|155425250|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
48335385|NCT00484198|155425251|FG000|Overall Study|Participant Withdrew Consent|12|||
48335386|NCT00484198|155425252|FG001|Overall Study|Participant Withdrew Consent|21|||
48335387|NCT00484198|155425253|FG002|Overall Study|Participant Withdrew Consent|47|||
48335388|NCT00484198|155425254|FG003|Overall Study|Participant Withdrew Consent|59|||
48656015|NCT02954406|156595895|FG006|Overall Study|Death|0|||
48656016|NCT02954406|156595896|FG007|Overall Study|Death|0|||
48656017|NCT02954406|156595897|FG008|Overall Study|Death|1|||
48656018|NCT02954406|156595898|FG009|Overall Study|Death|1|||
48335389|NCT00484198|155425251|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
48656019|NCT02954406|156595899|FG010|Overall Study|Death|0|||
48656020|NCT02954406|156595889|FG000|Overall Study|Reason Not Specified|0|||
48656021|NCT02954406|156595890|FG001|Overall Study|Reason Not Specified|0|||
48656022|NCT02954406|156595891|FG002|Overall Study|Reason Not Specified|3|||
48656023|NCT02954406|156595892|FG003|Overall Study|Reason Not Specified|2|||
48656024|NCT02954406|156595893|FG004|Overall Study|Reason Not Specified|2|||
48656025|NCT02954406|156595894|FG005|Overall Study|Reason Not Specified|0|||
48656026|NCT02954406|156595895|FG006|Overall Study|Reason Not Specified|1|||
48656027|NCT02954406|156595896|FG007|Overall Study|Reason Not Specified|0|||
48656028|NCT02954406|156595897|FG008|Overall Study|Reason Not Specified|1|||
48656029|NCT02954406|156595898|FG009|Overall Study|Reason Not Specified|0|||
48656030|NCT02954406|156595899|FG010|Overall Study|Reason Not Specified|0|||
48656031|NCT02867813|156595900|FG000|Overall Study|Withdrawal by Subject|57|||
48656032|NCT02867813|156595901|FG001|Overall Study|Withdrawal by Subject|56|||
48656033|NCT02867813|156595900|FG000|Overall Study|Decision by Sponsor|7|||
48656034|NCT02867813|156595901|FG001|Overall Study|Decision by Sponsor|7|||
48656035|NCT02867813|156595900|FG000|Overall Study|Lost to Follow-up|91|||
48335390|NCT00484198|155425252|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
48335391|NCT00484198|155425253|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
48335392|NCT00484198|155425254|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
48335393|NCT00484198|155425251|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
48335394|NCT00484198|155425252|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
48335395|NCT00484198|155425253|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
48335396|NCT00484198|155425254|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
48335397|NCT00484198|155425251|FG000|Overall Study|Adverse Event|3|||
48335398|NCT00484198|155425252|FG001|Overall Study|Adverse Event|11|||
48335399|NCT00484198|155425253|FG002|Overall Study|Adverse Event|32|||
48335400|NCT00484198|155425254|FG003|Overall Study|Adverse Event|31|||
48335401|NCT00484198|155425251|FG000|Overall Study|Protocol Violation|0|||
48335402|NCT00484198|155425252|FG001|Overall Study|Protocol Violation|5|||
48335403|NCT00484198|155425253|FG002|Overall Study|Protocol Violation|6|||
48335404|NCT00484198|155425254|FG003|Overall Study|Protocol Violation|8|||
48335405|NCT00484198|155425251|FG000|Overall Study|Other|7|||
48335406|NCT00484198|155425252|FG001|Overall Study|Other|10|||
48335407|NCT00484198|155425253|FG002|Overall Study|Other|31|||
48335408|NCT00484198|155425254|FG003|Overall Study|Other|28|||
48656036|NCT02867813|156595901|FG001|Overall Study|Lost to Follow-up|78|||
48656037|NCT02867813|156595900|FG000|Overall Study|Missing|2|||
48335409|NCT02163499|155425259|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
48335410|NCT02163499|155425259|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
48335411|NCT02163499|155425259|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
48335412|NCT02163499|155425259|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
48335413|NCT02163499|155425259|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
48335414|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
48335415|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
48335416|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
48335417|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
48335418|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
48335419|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
48335420|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
48335421|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
48335422|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
48335423|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Death|8|||
48335424|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
48335425|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
48335426|NCT02163499|155425259|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
48335427|NCT00668746|155425260|FG000|Overall Study|Lost to Follow-up|2|||
48335428|NCT00668746|155425261|FG001|Overall Study|Lost to Follow-up|1|||
48335429|NCT00080119|155425262|FG000|Overall Study|Discontinued because of study closure|0|||
48335430|NCT00080119|155425263|FG001|Overall Study|Discontinued because of study closure|0|||
48335431|NCT00080119|155425264|FG002|Overall Study|Discontinued because of study closure|130|||
48335432|NCT00080119|155425265|FG003|Overall Study|Discontinued because of study closure|141|||
48335433|NCT00080119|155425262|FG000|Overall Study|Unable to get to clinic|24|||
48335434|NCT00080119|155425263|FG001|Overall Study|Unable to get to clinic|24|||
48335435|NCT00080119|155425264|FG002|Overall Study|Unable to get to clinic|7|||
48335436|NCT00080119|155425265|FG003|Overall Study|Unable to get to clinic|1|||
48335437|NCT00080119|155425262|FG000|Overall Study|Consent withdrawn|13|||
48335438|NCT00080119|155425263|FG001|Overall Study|Consent withdrawn|17|||
48335439|NCT00080119|155425264|FG002|Overall Study|Consent withdrawn|4|||
48335440|NCT00080119|155425265|FG003|Overall Study|Consent withdrawn|6|||
48335441|NCT00080119|155425262|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
48335442|NCT00080119|155425263|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
48335443|NCT00080119|155425264|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
48335444|NCT00080119|155425265|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
48335445|NCT00080119|155425262|FG000|Overall Study|Lost to Follow-up|16|||
48656038|NCT02867813|156595901|FG001|Overall Study|Missing|1|||
48656039|NCT02867813|156595900|FG000|Overall Study|Death|294|||
48656040|NCT02867813|156595901|FG001|Overall Study|Death|268|||
48335446|NCT00080119|155425263|FG001|Overall Study|Lost to Follow-up|19|||
48335447|NCT00080119|155425264|FG002|Overall Study|Lost to Follow-up|19|||
48335448|NCT00080119|155425265|FG003|Overall Study|Lost to Follow-up|14|||
48335449|NCT00889863|155425266|FG000|Part I: Open Label|Death|1|||
48335450|NCT00889863|155425267|FG001|Part I: Open Label|Death|0|||
48335451|NCT00889863|155425266|FG000|Part I: Open Label|Adverse Event|4|||
48335452|NCT00889863|155425267|FG001|Part I: Open Label|Adverse Event|0|||
48335453|NCT00889863|155425266|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
48335454|NCT00889863|155425267|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
48335455|NCT00889863|155425266|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
48335456|NCT00889863|155425267|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
48335457|NCT00889863|155425266|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
48428207|NCT02531373|155756501|FG003|Overall Study|Lack of Efficacy|0|||
48335458|NCT00889863|155425267|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
48335459|NCT00889863|155425266|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
48335460|NCT00889863|155425267|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
48335461|NCT00889863|155425266|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
48335462|NCT00889863|155425267|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
48335463|NCT03344458|155425268|FG000|Overall Study|Physician Decision|1|||
48335464|NCT03344458|155425268|FG000|Overall Study|Withdrawal by Subject|16|||
48335465|NCT03344458|155425268|FG000|Overall Study|Other reasons|10|||
48335466|NCT03344458|155425268|FG000|Overall Study|Lost to Follow-up|9|||
48335467|NCT03344458|155425268|FG000|Overall Study|Protocol Violation|3|||
48335468|NCT02964234|155425269|FG000|Overall Study|Lost to Follow-up|22|||
48335469|NCT02964234|155425270|FG001|Overall Study|Lost to Follow-up|13|||
48335470|NCT03696342|155425271|FG000|Overall Study|Lost to Follow-up|1|||
48335471|NCT03696342|155425272|FG001|Overall Study|Lost to Follow-up|0|||
48335472|NCT01345253|155425273|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
48335473|NCT01345253|155425274|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
48335474|NCT01345253|155425273|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
48335475|NCT01345253|155425274|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
48335476|NCT01345253|155425273|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
48335477|NCT01345253|155425274|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
48335478|NCT01345253|155425273|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
48335479|NCT01345253|155425274|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
48335480|NCT01345253|155425273|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
48335481|NCT01345253|155425274|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
48335482|NCT01345253|155425273|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
48335483|NCT01345253|155425274|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
48335484|NCT01345253|155425273|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
48335485|NCT01345253|155425274|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
48335486|NCT01345253|155425273|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
48335487|NCT01345253|155425274|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
48335488|NCT01345253|155425273|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
48335489|NCT01345253|155425274|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
48335490|NCT01345253|155425273|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
48335491|NCT01345253|155425274|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
48335492|NCT01345253|155425273|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
48335493|NCT01345253|155425274|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
48335494|NCT01345253|155425273|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
48335495|NCT01345253|155425274|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
48335496|NCT01345253|155425273|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
48335497|NCT01345253|155425274|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
48335498|NCT01345253|155425273|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
48335499|NCT01345253|155425274|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
48335500|NCT01345253|155425273|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
48335501|NCT01345253|155425274|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
48335502|NCT00267956|155425275|FG000|Controlled Period|Adverse Event|4|||
48335503|NCT00267956|155425276|FG001|Controlled Period|Adverse Event|1|||
48335504|NCT00267956|155425277|FG002|Controlled Period|Adverse Event|0|||
48335505|NCT00267956|155425278|FG003|Controlled Period|Adverse Event|0|||
48335506|NCT00267956|155425275|FG000|Controlled Period|Lack of Efficacy|4|||
48335507|NCT00267956|155425276|FG001|Controlled Period|Lack of Efficacy|2|||
48335508|NCT00267956|155425277|FG002|Controlled Period|Lack of Efficacy|0|||
48335509|NCT00267956|155425278|FG003|Controlled Period|Lack of Efficacy|0|||
48335510|NCT00267956|155425275|FG000|Controlled Period|Lost to Follow-up|2|||
48335511|NCT00267956|155425276|FG001|Controlled Period|Lost to Follow-up|0|||
48335512|NCT00267956|155425277|FG002|Controlled Period|Lost to Follow-up|0|||
48335513|NCT00267956|155425278|FG003|Controlled Period|Lost to Follow-up|0|||
48335514|NCT00267956|155425275|FG000|Controlled Period|Withdrew consent|3|||
48335515|NCT00267956|155425276|FG001|Controlled Period|Withdrew consent|1|||
48335516|NCT00267956|155425277|FG002|Controlled Period|Withdrew consent|0|||
48335517|NCT00267956|155425278|FG003|Controlled Period|Withdrew consent|0|||
48335518|NCT00267956|155425275|FG000|After Controlled Period|Adverse Event|0|||
48335519|NCT00267956|155425276|FG001|After Controlled Period|Adverse Event|0|||
48335520|NCT00267956|155425277|FG002|After Controlled Period|Adverse Event|2|||
48335521|NCT00267956|155425278|FG003|After Controlled Period|Adverse Event|1|||
48335522|NCT00267956|155425275|FG000|After Controlled Period|Lack of Efficacy|0|||
48335523|NCT00267956|155425276|FG001|After Controlled Period|Lack of Efficacy|0|||
48335524|NCT00267956|155425277|FG002|After Controlled Period|Lack of Efficacy|1|||
48335525|NCT00267956|155425278|FG003|After Controlled Period|Lack of Efficacy|1|||
48383950|NCT00764751|155601512|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
48656041|NCT02578680|156595905|FG000|Overall Study|Death|329|||
48335526|NCT00267956|155425275|FG000|After Controlled Period|Lost to Follow-up|0|||
48335527|NCT00267956|155425276|FG001|After Controlled Period|Lost to Follow-up|0|||
48335528|NCT00267956|155425277|FG002|After Controlled Period|Lost to Follow-up|1|||
48335529|NCT00267956|155425278|FG003|After Controlled Period|Lost to Follow-up|0|||
48335530|NCT00267956|155425275|FG000|After Controlled Period|Withdrew consent|0|||
48335531|NCT00267956|155425276|FG001|After Controlled Period|Withdrew consent|0|||
48335532|NCT00267956|155425277|FG002|After Controlled Period|Withdrew consent|1|||
48335533|NCT00267956|155425278|FG003|After Controlled Period|Withdrew consent|0|||
48335534|NCT00460434|155425279|FG000|Overall Study|Lost to Follow-up|3|||
48335535|NCT00460434|155425280|FG001|Overall Study|Lost to Follow-up|7|||
48335536|NCT02092909|155425282|FG000|Overall Study|Adverse Event|0|||
48335537|NCT02092909|155425283|FG001|Overall Study|Adverse Event|0|||
48335538|NCT02092909|155425284|FG002|Overall Study|Adverse Event|4|||
48335539|NCT02092909|155425285|FG003|Overall Study|Adverse Event|2|||
48335540|NCT02092909|155425282|FG000|Overall Study|Lack of Efficacy|0|||
48335541|NCT02092909|155425283|FG001|Overall Study|Lack of Efficacy|2|||
48335542|NCT02092909|155425284|FG002|Overall Study|Lack of Efficacy|1|||
48335543|NCT02092909|155425285|FG003|Overall Study|Lack of Efficacy|0|||
48335544|NCT02092909|155425282|FG000|Overall Study|Withdrawal by Subject|0|||
48335545|NCT02092909|155425283|FG001|Overall Study|Withdrawal by Subject|0|||
48335546|NCT02092909|155425284|FG002|Overall Study|Withdrawal by Subject|2|||
48335547|NCT02092909|155425285|FG003|Overall Study|Withdrawal by Subject|1|||
48335548|NCT02092909|155425282|FG000|Overall Study|Study terminated by Sponsor|0|||
48335549|NCT02092909|155425283|FG001|Overall Study|Study terminated by Sponsor|0|||
48335550|NCT02092909|155425284|FG002|Overall Study|Study terminated by Sponsor|0|||
48335551|NCT02092909|155425285|FG003|Overall Study|Study terminated by Sponsor|2|||
48335552|NCT02092909|155425282|FG000|Overall Study|Miscellaneous|1|||
48335553|NCT02092909|155425283|FG001|Overall Study|Miscellaneous|1|||
48335554|NCT02092909|155425284|FG002|Overall Study|Miscellaneous|2|||
48335555|NCT02092909|155425285|FG003|Overall Study|Miscellaneous|1|||
48335556|NCT00821093|155425286|FG000|Overall Study|Adverse Event|20|||
48335557|NCT00821093|155425287|FG001|Overall Study|Adverse Event|12|||
48335558|NCT00821093|155425286|FG000|Overall Study|Withdrawal by Subject|9|||
48335559|NCT00821093|155425287|FG001|Overall Study|Withdrawal by Subject|13|||
48335560|NCT00821093|155425286|FG000|Overall Study|Lost to Follow-up|9|||
48335561|NCT00821093|155425287|FG001|Overall Study|Lost to Follow-up|3|||
48335562|NCT00821093|155425286|FG000|Overall Study|Protocol deviation|3|||
48335563|NCT00821093|155425287|FG001|Overall Study|Protocol deviation|6|||
48335564|NCT00821093|155425286|FG000|Overall Study|Abnormal laboratory value(s)|2|||
48335565|NCT00821093|155425287|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48335566|NCT00821093|155425286|FG000|Overall Study|Lack of Efficacy|2|||
48335567|NCT00821093|155425287|FG001|Overall Study|Lack of Efficacy|2|||
48335568|NCT00821093|155425286|FG000|Overall Study|Death|2|||
48335569|NCT00821093|155425287|FG001|Overall Study|Death|1|||
48335570|NCT00821093|155425286|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48335571|NCT00821093|155425287|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48335572|NCT00821093|155425286|FG000|Overall Study|Administrative problems|1|||
48335573|NCT00821093|155425287|FG001|Overall Study|Administrative problems|2|||
48335574|NCT01014013|155425288|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
48335575|NCT01014013|155425289|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
48656042|NCT02578680|156595906|FG001|Overall Study|Death|181|||
48656043|NCT02578680|156595905|FG000|Overall Study|Lost to Follow-up|3|||
48656044|NCT02578680|156595906|FG001|Overall Study|Lost to Follow-up|1|||
48656045|NCT02578680|156595905|FG000|Overall Study|Physician Decision|0|||
48656046|NCT02578680|156595906|FG001|Overall Study|Physician Decision|1|||
48656047|NCT02578680|156595905|FG000|Overall Study|Protocol Violation|1|||
48656048|NCT02578680|156595906|FG001|Overall Study|Protocol Violation|1|||
48656049|NCT02578680|156595905|FG000|Overall Study|Sponsor Decision|64|||
48656050|NCT02578680|156595906|FG001|Overall Study|Sponsor Decision|13|||
48656051|NCT02578680|156595905|FG000|Overall Study|Withdrawal by Subject|13|||
48656052|NCT02578680|156595906|FG001|Overall Study|Withdrawal by Subject|9|||
48656053|NCT00882583|156595907|FG000|Overall Study|Physician Decision|1|||
48656054|NCT00882583|156595908|FG001|Overall Study|Physician Decision|0|||
48656055|NCT00882583|156595907|FG000|Overall Study|Adverse Event|0|||
48656056|NCT00882583|156595908|FG001|Overall Study|Adverse Event|1|||
48656057|NCT00516893|156595916|FG000|Overall Study|Lost to Follow-up|4|||
48656058|NCT00516893|156595916|FG000|Overall Study|Adverse Event|3|||
48656059|NCT00516893|156595916|FG000|Overall Study|Withdrawal by Subject|2|||
48335576|NCT01014013|155425288|FG000|Overall Study|Clinical adverse experience|4|||
48335577|NCT01014013|155425289|FG001|Overall Study|Clinical adverse experience|2|||
48335578|NCT01014013|155425288|FG000|Overall Study|Laboratory adverse experience|1|||
48335579|NCT01014013|155425289|FG001|Overall Study|Laboratory adverse experience|1|||
48335580|NCT01014013|155425288|FG000|Overall Study|Protocol Violation|1|||
48335581|NCT01014013|155425289|FG001|Overall Study|Protocol Violation|3|||
48335582|NCT01014013|155425288|FG000|Overall Study|Withdrawal by Subject|7|||
48428208|NCT02531373|155756502|FG004|Overall Study|Lack of Efficacy|3|||
48656060|NCT00516893|156595916|FG000|Overall Study|Noncompliance|2|||
48656061|NCT00516893|156595916|FG000|Overall Study|Death|1|||
48656062|NCT00516893|156595916|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
48656063|NCT00516893|156595916|FG000|Overall Study|Relocated|1|||
48656064|NCT00516893|156595916|FG000|Overall Study|Pregnancy|1|||
48656065|NCT00516893|156595916|FG000|Overall Study|Received Medication From Another Study|1|||
48656066|NCT02596958|156595917|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
48656067|NCT02596958|156595917|FG000|Overall Study|Cancer Progression|441|||
48656068|NCT02596958|156595917|FG000|Overall Study|Death From Cancer|112|||
48656069|NCT02596958|156595917|FG000|Overall Study|Death From Other Cause|33|||
48656070|NCT02596958|156595917|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
48656071|NCT02596958|156595917|FG000|Overall Study|Administrative Reasons/Other|231|||
48656072|NCT02596958|156595917|FG000|Overall Study|Lost to Follow-up|33|||
48656073|NCT02596958|156595917|FG000|Overall Study|Missing|32|||
48656074|NCT02596958|156595917|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
48656075|NCT03596047|156595921|FG000|Overall Study|Withdrawal by Subject|7|||
48656076|NCT03596047|156595922|FG001|Overall Study|Withdrawal by Subject|4|||
48656077|NCT03596047|156595921|FG000|Overall Study|Lost to Follow-up|0|||
48656078|NCT03596047|156595922|FG001|Overall Study|Lost to Follow-up|2|||
48656079|NCT03727646|156595923|FG000|Overall Study|Adverse Event|1|||
48656080|NCT03727646|156595924|FG001|Overall Study|Adverse Event|0|||
48656081|NCT05659719|156595925|FG000|Overall Study|At sponsor's request|0|||
48656082|NCT05659719|156595926|FG001|Overall Study|At sponsor's request|0|||
48656083|NCT05659719|156595927|FG002|Overall Study|At sponsor's request|0|||
48656084|NCT05659719|156595928|FG003|Overall Study|At sponsor's request|95|||
48656085|NCT05659719|156595925|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
48656086|NCT05659719|156595926|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
48656087|NCT05659719|156595927|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
48656088|NCT05659719|156595928|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
48656089|NCT05659719|156595925|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
48656090|NCT05659719|156595926|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
48656091|NCT05659719|156595927|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
48754514|NCT02111850|156946724|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754515|NCT02111850|156946725|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48335583|NCT01014013|155425289|FG001|Overall Study|Withdrawal by Subject|4|||
48335584|NCT01014013|155425288|FG000|Overall Study|Clinical/microbiologic failure|1|||
48335585|NCT01014013|155425289|FG001|Overall Study|Clinical/microbiologic failure|2|||
48335586|NCT01014013|155425288|FG000|Overall Study|Pathogen culture = no growth|26|||
48335587|NCT01014013|155425289|FG001|Overall Study|Pathogen culture = no growth|34|||
48335588|NCT01014013|155425288|FG000|Overall Study|Negative urine culture|2|||
48335589|NCT01014013|155425289|FG001|Overall Study|Negative urine culture|0|||
48335590|NCT01014013|155425288|FG000|Overall Study|Pathogen resistant|7|||
48656092|NCT05659719|156595928|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
48656093|NCT05659719|156595925|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
48335591|NCT01014013|155425289|FG001|Overall Study|Pathogen resistant|4|||
48656094|NCT05659719|156595926|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
48656095|NCT05659719|156595927|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
48656096|NCT05659719|156595928|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
48656097|NCT05659719|156595925|FG000|Overall Study|Lost to Follow-up|0|||
48656098|NCT05659719|156595926|FG001|Overall Study|Lost to Follow-up|0|||
48656099|NCT05659719|156595927|FG002|Overall Study|Lost to Follow-up|0|||
48656100|NCT05659719|156595928|FG003|Overall Study|Lost to Follow-up|2|||
48656101|NCT05659719|156595925|FG000|Overall Study|Moved to another observational study|0|||
48656102|NCT05659719|156595926|FG001|Overall Study|Moved to another observational study|0|||
48656103|NCT05659719|156595927|FG002|Overall Study|Moved to another observational study|0|||
48656104|NCT05659719|156595928|FG003|Overall Study|Moved to another observational study|1|||
48656105|NCT05659719|156595925|FG000|Overall Study|The child was enrolled in an interventional study|0|||
48656106|NCT05659719|156595926|FG001|Overall Study|The child was enrolled in an interventional study|0|||
48656107|NCT05659719|156595927|FG002|Overall Study|The child was enrolled in an interventional study|0|||
48656108|NCT05659719|156595928|FG003|Overall Study|The child was enrolled in an interventional study|55|||
48656109|NCT05659719|156595925|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
48656110|NCT05659719|156595926|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
48656111|NCT05659719|156595927|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
48656112|NCT05659719|156595928|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
48656113|NCT05659719|156595925|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
48335592|NCT01014013|155425288|FG000|Overall Study|Physician Decision|0|||
48335593|NCT01014013|155425289|FG001|Overall Study|Physician Decision|1|||
48335594|NCT01014013|155425288|FG000|Overall Study|Another antibiotic therapy required|0|||
48335595|NCT01014013|155425289|FG001|Overall Study|Another antibiotic therapy required|1|||
48335596|NCT01014013|155425288|FG000|Overall Study|Appendectomy|1|||
48335597|NCT01014013|155425289|FG001|Overall Study|Appendectomy|0|||
48335598|NCT01014013|155425288|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
48335599|NCT01014013|155425289|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
48335600|NCT03031782|155425291|FG000|Treatment Period 1|Lack of Efficacy|3|||
48335601|NCT03031782|155425292|FG001|Treatment Period 1|Lack of Efficacy|0|||
48335602|NCT03031782|155425293|FG002|Treatment Period 1|Lack of Efficacy|0|||
48335603|NCT03031782|155425294|FG003|Treatment Period 1|Lack of Efficacy|0|||
48335604|NCT03031782|155425295|FG004|Treatment Period 1|Lack of Efficacy|0|||
48335605|NCT03031782|155425291|FG000|Treatment Period 2|Physician Decision|0|||
48335606|NCT03031782|155425292|FG001|Treatment Period 2|Physician Decision|1|||
48335607|NCT03031782|155425293|FG002|Treatment Period 2|Physician Decision|0|||
48335608|NCT03031782|155425294|FG003|Treatment Period 2|Physician Decision|0|||
48335609|NCT03031782|155425295|FG004|Treatment Period 2|Physician Decision|3|||
48335610|NCT03031782|155425291|FG000|Treatment Period 2|Lack of Efficacy|0|||
48335611|NCT03031782|155425292|FG001|Treatment Period 2|Lack of Efficacy|1|||
48335612|NCT03031782|155425293|FG002|Treatment Period 2|Lack of Efficacy|0|||
48754516|NCT02111850|156946726|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754517|NCT02111850|156946727|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754518|NCT02111850|156946728|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754519|NCT02111850|156946729|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
48754520|NCT04772755|156946730|FG000|Overall Study|Withdrawal by Subject|1|||
48754521|NCT04772755|156946731|FG001|Overall Study|Withdrawal by Subject|0|||
48754522|NCT04772755|156946730|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
48335613|NCT03031782|155425294|FG003|Treatment Period 2|Lack of Efficacy|0|||
48335614|NCT03031782|155425295|FG004|Treatment Period 2|Lack of Efficacy|1|||
48335615|NCT03031782|155425291|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48335616|NCT03031782|155425292|FG001|Treatment Period 2|Withdrawal by Subject|3|||
48335617|NCT03031782|155425293|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48335618|NCT03031782|155425294|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48335619|NCT03031782|155425295|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48335620|NCT03031782|155425291|FG000|Treatment Period 2|Adverse Event|0|||
48335621|NCT03031782|155425292|FG001|Treatment Period 2|Adverse Event|1|||
48335622|NCT03031782|155425293|FG002|Treatment Period 2|Adverse Event|2|||
48335623|NCT03031782|155425294|FG003|Treatment Period 2|Adverse Event|0|||
48754523|NCT04772755|156946731|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
48754524|NCT01189812|156946735|FG000|Overall Study|Withdrawal by Subject|2|||
48754525|NCT01189812|156946736|FG001|Overall Study|Withdrawal by Subject|3|||
48754526|NCT01189812|156946735|FG000|Overall Study|Adverse Event|1|||
48754527|NCT01189812|156946736|FG001|Overall Study|Adverse Event|0|||
48754528|NCT01189812|156946735|FG000|Overall Study|Out of Window|4|||
48335624|NCT03031782|155425295|FG004|Treatment Period 2|Adverse Event|0|||
48335625|NCT03031782|155425291|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48335626|NCT03031782|155425292|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48335627|NCT03031782|155425293|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48335628|NCT03031782|155425294|FG003|Treatment Period 3|Withdrawal by Subject|1|||
48335629|NCT03031782|155425295|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48335630|NCT00901459|155425296|FG000|Overall Study|Withdrawal by Subject|6|||
48656114|NCT05659719|156595926|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
48656115|NCT05659719|156595927|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
48656116|NCT05659719|156595928|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
48656117|NCT00185380|156595936|FG000|Overall Study|Adverse Event|41|||
48656118|NCT00185380|156595937|FG001|Overall Study|Adverse Event|43|||
48656119|NCT00185380|156595938|FG002|Overall Study|Adverse Event|48|||
48656120|NCT00185380|156595936|FG000|Overall Study|Lost to Follow-up|0|||
48656121|NCT00185380|156595937|FG001|Overall Study|Lost to Follow-up|4|||
48656122|NCT00185380|156595938|FG002|Overall Study|Lost to Follow-up|3|||
48656123|NCT00185380|156595936|FG000|Overall Study|Pregnancy|1|||
48656124|NCT00185380|156595937|FG001|Overall Study|Pregnancy|4|||
48656125|NCT00185380|156595938|FG002|Overall Study|Pregnancy|0|||
48656126|NCT00185380|156595936|FG000|Overall Study|Protocol Violation|2|||
48656127|NCT00185380|156595937|FG001|Overall Study|Protocol Violation|2|||
48656128|NCT00185380|156595938|FG002|Overall Study|Protocol Violation|1|||
48656129|NCT00185380|156595936|FG000|Overall Study|Withdrawal by Subject|1|||
48656130|NCT00185380|156595937|FG001|Overall Study|Withdrawal by Subject|2|||
48754529|NCT01189812|156946736|FG001|Overall Study|Out of Window|3|||
48335631|NCT00753896|155425297|FG000|Overall Study|Adverse Event|4|||
48335632|NCT00753896|155425297|FG000|Overall Study|Death|1|||
48335633|NCT00753896|155425297|FG000|Overall Study|Lost to Follow-up|2|||
48335634|NCT00753896|155425297|FG000|Overall Study|Protocol Violation|1|||
48428209|NCT02531373|155756503|FG005|Overall Study|Lack of Efficacy|2|||
48335635|NCT00753896|155425297|FG000|Overall Study|Withdrawal by Subject|4|||
48335636|NCT00753896|155425297|FG000|Overall Study|Entry Criteria Not Met|4|||
48335637|NCT01280656|155425298|FG000|Overall Study|Adverse Event|1|||
48335638|NCT01280656|155425299|FG001|Overall Study|Adverse Event|14|||
48335639|NCT01280656|155425300|FG002|Overall Study|Adverse Event|13|||
48335640|NCT01280656|155425298|FG000|Overall Study|Lack of Efficacy|1|||
48335641|NCT01280656|155425299|FG001|Overall Study|Lack of Efficacy|22|||
48335642|NCT01280656|155425300|FG002|Overall Study|Lack of Efficacy|38|||
48335643|NCT01280656|155425298|FG000|Overall Study|Treatment shortening (RGT)|0|||
48335644|NCT01280656|155425299|FG001|Overall Study|Treatment shortening (RGT)|4|||
48335645|NCT01280656|155425300|FG002|Overall Study|Treatment shortening (RGT)|5|||
48335646|NCT01280656|155425298|FG000|Overall Study|Other|1|||
48335647|NCT01280656|155425299|FG001|Overall Study|Other|7|||
48335648|NCT01280656|155425300|FG002|Overall Study|Other|7|||
48335649|NCT03906240|155425301|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
48335650|NCT03906240|155425302|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
48335651|NCT03906240|155425301|FG000|Overall Study|Lost to Follow-up|1|||
48335652|NCT03906240|155425302|FG001|Overall Study|Lost to Follow-up|0|||
48335653|NCT03906240|155425301|FG000|Overall Study|Withdrawal by Subject|0|||
48335654|NCT03906240|155425302|FG001|Overall Study|Withdrawal by Subject|1|||
48335655|NCT00157209|155425308|FG000|Overall Study|Ongoing at data cut-off|10|||
48335656|NCT00157209|155425309|FG001|Overall Study|Ongoing at data cut-off|0|||
48335657|NCT01721109|155425312|FG000|Overall Study|Lack of Efficacy|1|||
48335658|NCT01721109|155425312|FG000|Overall Study|Non- Compliance with Study Drug|3|||
48335659|NCT01721109|155425312|FG000|Overall Study|Withdrew Consent|1|||
48335660|NCT01721109|155425312|FG000|Overall Study|Lost to Follow-up|2|||
48335661|NCT01288729|155425323|FG000|Overall Study|Withdrawal by Subject|1|||
48335662|NCT01288729|155425324|FG001|Overall Study|Withdrawal by Subject|0|||
48335663|NCT02577315|155425327|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48335664|NCT02577315|155425328|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
48335665|NCT05522777|155426874|FG000|Overall Study|Lack of Efficacy|1|||
48335666|NCT05522777|155426874|FG000|Overall Study|Withdrawal by Subject|1|||
48335667|NCT04730271|155426875|FG000|Overall Study|Adverse Event|0|||
48335668|NCT04730271|155426876|FG001|Overall Study|Adverse Event|2|||
48335669|NCT04730271|155426875|FG000|Overall Study|Withdrawal by Subject|1|||
48656131|NCT00185380|156595938|FG002|Overall Study|Withdrawal by Subject|0|||
48656132|NCT00185380|156595936|FG000|Overall Study|Failed insertion|1|||
48656133|NCT00185380|156595937|FG001|Overall Study|Failed insertion|1|||
48656134|NCT00185380|156595938|FG002|Overall Study|Failed insertion|2|||
48656135|NCT00185380|156595936|FG000|Overall Study|Planned pregnancy|9|||
48656136|NCT00185380|156595937|FG001|Overall Study|Planned pregnancy|12|||
48656137|NCT00185380|156595938|FG002|Overall Study|Planned pregnancy|12|||
48656138|NCT00185380|156595936|FG000|Overall Study|No need for contraception|3|||
48656139|NCT00185380|156595937|FG001|Overall Study|No need for contraception|3|||
48656140|NCT00185380|156595938|FG002|Overall Study|No need for contraception|3|||
48656141|NCT00185380|156595936|FG000|Overall Study|Could not attend visits|2|||
48656142|NCT00185380|156595937|FG001|Overall Study|Could not attend visits|0|||
48656143|NCT00185380|156595938|FG002|Overall Study|Could not attend visits|4|||
48656144|NCT00185380|156595936|FG000|Overall Study|personal reason|6|||
48656145|NCT00185380|156595937|FG001|Overall Study|personal reason|1|||
48656146|NCT00185380|156595938|FG002|Overall Study|personal reason|1|||
48656147|NCT02589665|156595939|FG000|Induction Period|Did not receive drug|0|||
48656148|NCT02589665|156595940|FG001|Induction Period|Did not receive drug|0|||
48656149|NCT02589665|156595941|FG002|Induction Period|Did not receive drug|0|||
48656150|NCT02589665|156595942|FG003|Induction Period|Did not receive drug|1|||
48656151|NCT02589665|156595943|FG004|Induction Period|Did not receive drug|0|||
48656152|NCT02589665|156595944|FG005|Induction Period|Did not receive drug|0|||
48656153|NCT02589665|156595945|FG006|Induction Period|Did not receive drug|0|||
48656154|NCT02589665|156595946|FG007|Induction Period|Did not receive drug|0|||
48656155|NCT02589665|156595947|FG008|Induction Period|Did not receive drug|0|||
48656156|NCT02589665|156595948|FG009|Induction Period|Did not receive drug|0|||
48656157|NCT02589665|156595939|FG000|Induction Period|Adverse Event|3|||
48656158|NCT02589665|156595940|FG001|Induction Period|Adverse Event|0|||
48656159|NCT02589665|156595941|FG002|Induction Period|Adverse Event|2|||
48335670|NCT04730271|155426876|FG001|Overall Study|Withdrawal by Subject|1|||
48335671|NCT04730271|155426875|FG000|Overall Study|Protocol Violation|7|||
48335672|NCT04730271|155426876|FG001|Overall Study|Protocol Violation|13|||
48335673|NCT04730271|155426875|FG000|Overall Study|Lost to Follow-up|3|||
48335674|NCT04730271|155426876|FG001|Overall Study|Lost to Follow-up|3|||
48335675|NCT04730271|155426875|FG000|Overall Study|Death|1|||
48335676|NCT04730271|155426876|FG001|Overall Study|Death|0|||
48335677|NCT01732757|155426877|FG000|Overall Study|Lost to Follow-up|1|||
48335678|NCT01732757|155426878|FG001|Overall Study|Lost to Follow-up|0|||
48335679|NCT01732757|155426879|FG002|Overall Study|Lost to Follow-up|0|||
48656160|NCT02589665|156595942|FG003|Induction Period|Adverse Event|2|||
48656161|NCT02589665|156595943|FG004|Induction Period|Adverse Event|0|||
48656162|NCT02589665|156595944|FG005|Induction Period|Adverse Event|0|||
48335680|NCT01304940|155426885|FG000|Overall Study|not meet symptom severity requirement|3|||
48335681|NCT01304940|155426886|FG001|Overall Study|not meet symptom severity requirement|0|||
48335682|NCT00087516|155426887|FG000|Overall Study|Adverse Event|10|||
48335683|NCT00087516|155426888|FG001|Overall Study|Adverse Event|10|||
48335684|NCT00087516|155426889|FG002|Overall Study|Adverse Event|3|||
48335685|NCT00087516|155426890|FG003|Overall Study|Adverse Event|6|||
48335686|NCT00087516|155426887|FG000|Overall Study|Lack of Efficacy|82|||
48335687|NCT00087516|155426888|FG001|Overall Study|Lack of Efficacy|80|||
48335688|NCT00087516|155426889|FG002|Overall Study|Lack of Efficacy|39|||
48335689|NCT00087516|155426890|FG003|Overall Study|Lack of Efficacy|29|||
48335690|NCT00087516|155426887|FG000|Overall Study|Lost to Follow-up|8|||
48335691|NCT00087516|155426888|FG001|Overall Study|Lost to Follow-up|6|||
48335692|NCT00087516|155426889|FG002|Overall Study|Lost to Follow-up|5|||
48335693|NCT00087516|155426890|FG003|Overall Study|Lost to Follow-up|5|||
48335694|NCT00087516|155426887|FG000|Overall Study|Protocol Violation|4|||
48335695|NCT00087516|155426888|FG001|Overall Study|Protocol Violation|8|||
48335696|NCT00087516|155426889|FG002|Overall Study|Protocol Violation|3|||
48656163|NCT02589665|156595945|FG006|Induction Period|Adverse Event|0|||
48656164|NCT02589665|156595946|FG007|Induction Period|Adverse Event|0|||
48656165|NCT02589665|156595947|FG008|Induction Period|Adverse Event|0|||
48656166|NCT02589665|156595948|FG009|Induction Period|Adverse Event|0|||
48656167|NCT02589665|156595939|FG000|Induction Period|Withdrawal by Subject|0|||
48656168|NCT02589665|156595940|FG001|Induction Period|Withdrawal by Subject|1|||
48656169|NCT02589665|156595941|FG002|Induction Period|Withdrawal by Subject|0|||
48656170|NCT02589665|156595942|FG003|Induction Period|Withdrawal by Subject|1|||
48656171|NCT02589665|156595943|FG004|Induction Period|Withdrawal by Subject|0|||
48656172|NCT02589665|156595944|FG005|Induction Period|Withdrawal by Subject|0|||
48656173|NCT02589665|156595945|FG006|Induction Period|Withdrawal by Subject|0|||
48656174|NCT02589665|156595946|FG007|Induction Period|Withdrawal by Subject|0|||
48656175|NCT02589665|156595947|FG008|Induction Period|Withdrawal by Subject|0|||
48656176|NCT02589665|156595948|FG009|Induction Period|Withdrawal by Subject|0|||
48656177|NCT02589665|156595939|FG000|Induction Period|Protocol Violation|0|||
48656178|NCT02589665|156595940|FG001|Induction Period|Protocol Violation|1|||
48656179|NCT02589665|156595941|FG002|Induction Period|Protocol Violation|0|||
48656180|NCT02589665|156595942|FG003|Induction Period|Protocol Violation|0|||
48656181|NCT02589665|156595943|FG004|Induction Period|Protocol Violation|0|||
48656182|NCT02589665|156595944|FG005|Induction Period|Protocol Violation|0|||
48656183|NCT02589665|156595945|FG006|Induction Period|Protocol Violation|0|||
48656184|NCT02589665|156595946|FG007|Induction Period|Protocol Violation|0|||
48656185|NCT02589665|156595947|FG008|Induction Period|Protocol Violation|0|||
48656186|NCT02589665|156595948|FG009|Induction Period|Protocol Violation|0|||
48656187|NCT02589665|156595939|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656188|NCT02589665|156595940|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656189|NCT02589665|156595941|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656190|NCT02589665|156595942|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656191|NCT02589665|156595943|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
48656192|NCT02589665|156595944|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
48656193|NCT02589665|156595945|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
48656194|NCT02589665|156595946|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656195|NCT02589665|156595947|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656196|NCT02589665|156595948|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656197|NCT02589665|156595939|FG000|Maintenance Period|Withdrawal by Subject|0|||
48656198|NCT02589665|156595940|FG001|Maintenance Period|Withdrawal by Subject|0|||
48656199|NCT02589665|156595941|FG002|Maintenance Period|Withdrawal by Subject|0|||
48656200|NCT02589665|156595942|FG003|Maintenance Period|Withdrawal by Subject|0|||
48335697|NCT00087516|155426890|FG003|Overall Study|Protocol Violation|6|||
48656201|NCT02589665|156595943|FG004|Maintenance Period|Withdrawal by Subject|4|||
48656202|NCT02589665|156595944|FG005|Maintenance Period|Withdrawal by Subject|2|||
48656203|NCT02589665|156595945|FG006|Maintenance Period|Withdrawal by Subject|4|||
48656204|NCT02589665|156595946|FG007|Maintenance Period|Withdrawal by Subject|0|||
48656205|NCT02589665|156595947|FG008|Maintenance Period|Withdrawal by Subject|0|||
48656206|NCT02589665|156595948|FG009|Maintenance Period|Withdrawal by Subject|0|||
48656207|NCT02589665|156595939|FG000|Maintenance Period|Lack of Efficacy|0|||
48656208|NCT02589665|156595940|FG001|Maintenance Period|Lack of Efficacy|0|||
48656209|NCT02589665|156595941|FG002|Maintenance Period|Lack of Efficacy|0|||
48656210|NCT02589665|156595942|FG003|Maintenance Period|Lack of Efficacy|0|||
48656211|NCT02589665|156595943|FG004|Maintenance Period|Lack of Efficacy|2|||
48656212|NCT02589665|156595944|FG005|Maintenance Period|Lack of Efficacy|1|||
48335698|NCT00087516|155426887|FG000|Overall Study|Withdrawal by Subject|16|||
48335699|NCT00087516|155426888|FG001|Overall Study|Withdrawal by Subject|27|||
48656213|NCT02589665|156595945|FG006|Maintenance Period|Lack of Efficacy|0|||
48656214|NCT02589665|156595946|FG007|Maintenance Period|Lack of Efficacy|0|||
48656215|NCT02589665|156595947|FG008|Maintenance Period|Lack of Efficacy|0|||
48335700|NCT00087516|155426889|FG002|Overall Study|Withdrawal by Subject|11|||
48335701|NCT00087516|155426890|FG003|Overall Study|Withdrawal by Subject|12|||
48335702|NCT00087516|155426887|FG000|Overall Study|Site terminated|0|||
48335703|NCT00087516|155426888|FG001|Overall Study|Site terminated|2|||
48335704|NCT00087516|155426889|FG002|Overall Study|Site terminated|1|||
48335705|NCT00087516|155426890|FG003|Overall Study|Site terminated|0|||
48335706|NCT00087516|155426887|FG000|Overall Study|Protocol specified discontinuation|35|||
48335707|NCT00087516|155426888|FG001|Overall Study|Protocol specified discontinuation|33|||
48335708|NCT00087516|155426889|FG002|Overall Study|Protocol specified discontinuation|33|||
48335709|NCT00087516|155426890|FG003|Overall Study|Protocol specified discontinuation|26|||
48335710|NCT00087516|155426887|FG000|Overall Study|Patient moved|3|||
48335711|NCT00087516|155426888|FG001|Overall Study|Patient moved|2|||
48335712|NCT00087516|155426889|FG002|Overall Study|Patient moved|1|||
48335713|NCT00087516|155426890|FG003|Overall Study|Patient moved|0|||
48335714|NCT00087516|155426887|FG000|Overall Study|Patient was non-compliant|3|||
48335715|NCT00087516|155426888|FG001|Overall Study|Patient was non-compliant|1|||
48335716|NCT00087516|155426889|FG002|Overall Study|Patient was non-compliant|0|||
48335717|NCT00087516|155426890|FG003|Overall Study|Patient was non-compliant|0|||
48335718|NCT00087516|155426887|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
48335719|NCT00087516|155426888|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
48335720|NCT00087516|155426889|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
48335721|NCT00087516|155426890|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
48335722|NCT00087516|155426887|FG000|Overall Study|Other|0|||
48335723|NCT00087516|155426888|FG001|Overall Study|Other|0|||
48335724|NCT00087516|155426889|FG002|Overall Study|Other|1|||
48335725|NCT00087516|155426890|FG003|Overall Study|Other|0|||
48335726|NCT00409006|155426891|FG000|Overall Study|Death|15|||
48335727|NCT00409006|155426892|FG001|Overall Study|Death|6|||
48335728|NCT00409006|155426891|FG000|Overall Study|Lost to Follow-up|1|||
48335729|NCT00409006|155426892|FG001|Overall Study|Lost to Follow-up|2|||
48335730|NCT00409006|155426891|FG000|Overall Study|Withdrawal by Subject|3|||
48335731|NCT00409006|155426892|FG001|Overall Study|Withdrawal by Subject|2|||
48335732|NCT00409006|155426891|FG000|Overall Study|Physician Decision|1|||
48335733|NCT00409006|155426892|FG001|Overall Study|Physician Decision|2|||
48335734|NCT00278395|155426893|FG000|Overall Study|Adverse Event|2|||
48335735|NCT00278395|155426893|FG000|Overall Study|Nonevaluable|1|||
48656216|NCT02589665|156595948|FG009|Maintenance Period|Lack of Efficacy|0|||
48656217|NCT02589665|156595939|FG000|Maintenance Period|Adverse Event|0|||
48656218|NCT02589665|156595940|FG001|Maintenance Period|Adverse Event|0|||
48656219|NCT02589665|156595941|FG002|Maintenance Period|Adverse Event|0|||
48656220|NCT02589665|156595942|FG003|Maintenance Period|Adverse Event|0|||
48656221|NCT02589665|156595943|FG004|Maintenance Period|Adverse Event|0|||
48656222|NCT02589665|156595944|FG005|Maintenance Period|Adverse Event|0|||
48656223|NCT02589665|156595945|FG006|Maintenance Period|Adverse Event|2|||
48656224|NCT02589665|156595946|FG007|Maintenance Period|Adverse Event|0|||
48656225|NCT02589665|156595947|FG008|Maintenance Period|Adverse Event|0|||
48656226|NCT02589665|156595948|FG009|Maintenance Period|Adverse Event|0|||
48656227|NCT02589665|156595939|FG000|Maintenance Period|Lost to Follow-up|0|||
48656228|NCT02589665|156595940|FG001|Maintenance Period|Lost to Follow-up|0|||
48656229|NCT02589665|156595941|FG002|Maintenance Period|Lost to Follow-up|0|||
48656230|NCT02589665|156595942|FG003|Maintenance Period|Lost to Follow-up|0|||
48656231|NCT02589665|156595943|FG004|Maintenance Period|Lost to Follow-up|0|||
48656232|NCT02589665|156595944|FG005|Maintenance Period|Lost to Follow-up|1|||
48656233|NCT02589665|156595945|FG006|Maintenance Period|Lost to Follow-up|0|||
48656234|NCT02589665|156595946|FG007|Maintenance Period|Lost to Follow-up|0|||
48656235|NCT02589665|156595947|FG008|Maintenance Period|Lost to Follow-up|0|||
48656236|NCT02589665|156595948|FG009|Maintenance Period|Lost to Follow-up|0|||
48656237|NCT02589665|156595939|FG000|Maintenance Period|Physician Decision|0|||
48656238|NCT02589665|156595940|FG001|Maintenance Period|Physician Decision|0|||
48656239|NCT02589665|156595941|FG002|Maintenance Period|Physician Decision|0|||
48656240|NCT02589665|156595942|FG003|Maintenance Period|Physician Decision|0|||
48656241|NCT02589665|156595943|FG004|Maintenance Period|Physician Decision|0|||
48656242|NCT02589665|156595944|FG005|Maintenance Period|Physician Decision|1|||
48656243|NCT02589665|156595945|FG006|Maintenance Period|Physician Decision|0|||
48656244|NCT02589665|156595946|FG007|Maintenance Period|Physician Decision|0|||
48656245|NCT02589665|156595947|FG008|Maintenance Period|Physician Decision|0|||
48656246|NCT02589665|156595948|FG009|Maintenance Period|Physician Decision|0|||
48656247|NCT02589665|156595939|FG000|Maintenance Period|Reason Not Collected|0|||
48656248|NCT02589665|156595940|FG001|Maintenance Period|Reason Not Collected|0|||
48656249|NCT02589665|156595941|FG002|Maintenance Period|Reason Not Collected|0|||
48656250|NCT02589665|156595942|FG003|Maintenance Period|Reason Not Collected|0|||
48656251|NCT02589665|156595943|FG004|Maintenance Period|Reason Not Collected|0|||
48656252|NCT02589665|156595944|FG005|Maintenance Period|Reason Not Collected|1|||
48335736|NCT03928743|155426894|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
48335737|NCT03928743|155426895|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
48335738|NCT03928743|155426896|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
48656253|NCT02589665|156595945|FG006|Maintenance Period|Reason Not Collected|1|||
48335739|NCT03928743|155426894|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
48335740|NCT03928743|155426895|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
48335741|NCT03928743|155426896|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
48335742|NCT03928743|155426894|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
48335743|NCT03928743|155426895|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
48335744|NCT03928743|155426896|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
48335745|NCT03928743|155426894|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
48335746|NCT03928743|155426895|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
48335747|NCT03928743|155426896|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
48335748|NCT03928743|155426894|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
48335749|NCT03928743|155426895|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
48335750|NCT03928743|155426896|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
48335751|NCT03928743|155426894|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
48335752|NCT03928743|155426895|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
48335753|NCT03928743|155426896|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
48335754|NCT03928743|155426894|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
48335755|NCT03928743|155426895|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
48335756|NCT03928743|155426896|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
48335757|NCT03928743|155426894|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
48335758|NCT03928743|155426895|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
48335759|NCT03928743|155426896|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
48656254|NCT02589665|156595946|FG007|Maintenance Period|Reason Not Collected|0|||
48656255|NCT02589665|156595947|FG008|Maintenance Period|Reason Not Collected|0|||
48656256|NCT02589665|156595948|FG009|Maintenance Period|Reason Not Collected|0|||
48656257|NCT02589665|156595939|FG000|Induction Extension Period|Adverse Event|0|||
48656258|NCT02589665|156595940|FG001|Induction Extension Period|Adverse Event|0|||
48656259|NCT02589665|156595941|FG002|Induction Extension Period|Adverse Event|0|||
48656260|NCT02589665|156595942|FG003|Induction Extension Period|Adverse Event|0|||
48656261|NCT02589665|156595943|FG004|Induction Extension Period|Adverse Event|0|||
48656262|NCT02589665|156595944|FG005|Induction Extension Period|Adverse Event|0|||
48656263|NCT02589665|156595945|FG006|Induction Extension Period|Adverse Event|0|||
48656264|NCT02589665|156595946|FG007|Induction Extension Period|Adverse Event|0|||
48656265|NCT02589665|156595947|FG008|Induction Extension Period|Adverse Event|4|||
48656266|NCT02589665|156595948|FG009|Induction Extension Period|Adverse Event|0|||
48656267|NCT02589665|156595939|FG000|Induction Extension Period|Lack of Efficacy|0|||
48656268|NCT02589665|156595940|FG001|Induction Extension Period|Lack of Efficacy|0|||
48656269|NCT02589665|156595941|FG002|Induction Extension Period|Lack of Efficacy|0|||
48656270|NCT02589665|156595942|FG003|Induction Extension Period|Lack of Efficacy|0|||
48656271|NCT02589665|156595943|FG004|Induction Extension Period|Lack of Efficacy|0|||
48656272|NCT02589665|156595944|FG005|Induction Extension Period|Lack of Efficacy|0|||
48656273|NCT02589665|156595945|FG006|Induction Extension Period|Lack of Efficacy|0|||
48656274|NCT02589665|156595946|FG007|Induction Extension Period|Lack of Efficacy|0|||
48335760|NCT03928743|155426894|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
48656275|NCT02589665|156595947|FG008|Induction Extension Period|Lack of Efficacy|3|||
48656276|NCT02589665|156595948|FG009|Induction Extension Period|Lack of Efficacy|0|||
48656277|NCT02589665|156595939|FG000|Induction Extension Period|Withdrawal by Subject|0|||
48656278|NCT02589665|156595940|FG001|Induction Extension Period|Withdrawal by Subject|0|||
48656279|NCT02589665|156595941|FG002|Induction Extension Period|Withdrawal by Subject|0|||
48656280|NCT02589665|156595942|FG003|Induction Extension Period|Withdrawal by Subject|0|||
48656281|NCT02589665|156595943|FG004|Induction Extension Period|Withdrawal by Subject|0|||
48656282|NCT02589665|156595944|FG005|Induction Extension Period|Withdrawal by Subject|0|||
48656283|NCT02589665|156595945|FG006|Induction Extension Period|Withdrawal by Subject|0|||
48656284|NCT02589665|156595946|FG007|Induction Extension Period|Withdrawal by Subject|2|||
48656285|NCT02589665|156595947|FG008|Induction Extension Period|Withdrawal by Subject|3|||
48656286|NCT02589665|156595948|FG009|Induction Extension Period|Withdrawal by Subject|0|||
48656287|NCT02589665|156595939|FG000|Induction Extension Period|Physician Decision|0|||
48656288|NCT02589665|156595940|FG001|Induction Extension Period|Physician Decision|0|||
48656289|NCT02589665|156595941|FG002|Induction Extension Period|Physician Decision|0|||
48656290|NCT02589665|156595942|FG003|Induction Extension Period|Physician Decision|0|||
48656291|NCT02589665|156595943|FG004|Induction Extension Period|Physician Decision|0|||
48656292|NCT02589665|156595944|FG005|Induction Extension Period|Physician Decision|0|||
48656293|NCT02589665|156595945|FG006|Induction Extension Period|Physician Decision|0|||
48335761|NCT03928743|155426895|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
48656294|NCT02589665|156595946|FG007|Induction Extension Period|Physician Decision|0|||
48656295|NCT02589665|156595947|FG008|Induction Extension Period|Physician Decision|1|||
48656296|NCT02589665|156595948|FG009|Induction Extension Period|Physician Decision|0|||
48656297|NCT02589665|156595939|FG000|Induction Extension Period|Reason Not Collected|0|||
48656298|NCT02589665|156595940|FG001|Induction Extension Period|Reason Not Collected|0|||
48335762|NCT03928743|155426896|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
48335763|NCT03928743|155426894|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
48335764|NCT03928743|155426895|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
48335765|NCT03928743|155426896|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
48335766|NCT03928743|155426894|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
48335767|NCT03928743|155426895|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
48335768|NCT03928743|155426896|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
48335769|NCT04025762|155426897|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
48335770|NCT04025762|155426898|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
48335771|NCT04184622|155426905|FG000|Overall Study|Adverse Event|7|||
48335772|NCT04184622|155426906|FG001|Overall Study|Adverse Event|7|||
48335773|NCT04184622|155426907|FG002|Overall Study|Adverse Event|11|||
48335774|NCT04184622|155426908|FG003|Overall Study|Adverse Event|8|||
48335775|NCT04184622|155426905|FG000|Overall Study|Death|4|||
48335776|NCT04184622|155426906|FG001|Overall Study|Death|4|||
48335777|NCT04184622|155426907|FG002|Overall Study|Death|2|||
48335778|NCT04184622|155426908|FG003|Overall Study|Death|1|||
48335779|NCT04184622|155426905|FG000|Overall Study|Lost to Follow-up|41|||
48335780|NCT04184622|155426906|FG001|Overall Study|Lost to Follow-up|19|||
48335781|NCT04184622|155426907|FG002|Overall Study|Lost to Follow-up|20|||
48656299|NCT02589665|156595941|FG002|Induction Extension Period|Reason Not Collected|0|||
48656300|NCT02589665|156595942|FG003|Induction Extension Period|Reason Not Collected|0|||
48656301|NCT02589665|156595943|FG004|Induction Extension Period|Reason Not Collected|0|||
48656302|NCT02589665|156595944|FG005|Induction Extension Period|Reason Not Collected|0|||
48656303|NCT02589665|156595945|FG006|Induction Extension Period|Reason Not Collected|0|||
48656304|NCT02589665|156595946|FG007|Induction Extension Period|Reason Not Collected|0|||
48335782|NCT04184622|155426908|FG003|Overall Study|Lost to Follow-up|15|||
48335783|NCT04184622|155426905|FG000|Overall Study|Missing Weight at Week 72|1|||
48335784|NCT04184622|155426906|FG001|Overall Study|Missing Weight at Week 72|0|||
48335785|NCT04184622|155426907|FG002|Overall Study|Missing Weight at Week 72|1|||
48335786|NCT04184622|155426908|FG003|Overall Study|Missing Weight at Week 72|0|||
48335787|NCT04184622|155426905|FG000|Overall Study|Other - as reported by the investigator|22|||
48335788|NCT04184622|155426906|FG001|Overall Study|Other - as reported by the investigator|7|||
48335789|NCT04184622|155426907|FG002|Overall Study|Other - as reported by the investigator|5|||
48335790|NCT04184622|155426908|FG003|Overall Study|Other - as reported by the investigator|12|||
48335791|NCT04184622|155426905|FG000|Overall Study|Physician Decision|0|||
48335792|NCT04184622|155426906|FG001|Overall Study|Physician Decision|0|||
48335793|NCT04184622|155426907|FG002|Overall Study|Physician Decision|3|||
48335794|NCT04184622|155426908|FG003|Overall Study|Physician Decision|1|||
48335795|NCT04184622|155426905|FG000|Overall Study|Pregnancy|4|||
48335796|NCT04184622|155426906|FG001|Overall Study|Pregnancy|4|||
48335797|NCT04184622|155426907|FG002|Overall Study|Pregnancy|3|||
48335798|NCT04184622|155426908|FG003|Overall Study|Pregnancy|5|||
48335799|NCT04184622|155426905|FG000|Overall Study|Protocol Deviation|1|||
48335800|NCT04184622|155426906|FG001|Overall Study|Protocol Deviation|0|||
48335801|NCT04184622|155426907|FG002|Overall Study|Protocol Deviation|0|||
48335802|NCT04184622|155426908|FG003|Overall Study|Protocol Deviation|0|||
48335803|NCT04184622|155426905|FG000|Overall Study|Withdrawal by Subject|68|||
48335804|NCT04184622|155426906|FG001|Overall Study|Withdrawal by Subject|28|||
48335805|NCT04184622|155426907|FG002|Overall Study|Withdrawal by Subject|29|||
48335806|NCT04184622|155426908|FG003|Overall Study|Withdrawal by Subject|22|||
48335807|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
48335808|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
48335809|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
48335810|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
48335811|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Adverse Event|7|||
48656305|NCT02589665|156595947|FG008|Induction Extension Period|Reason Not Collected|1|||
48656306|NCT02589665|156595948|FG009|Induction Extension Period|Reason Not Collected|0|||
48656307|NCT02589665|156595939|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656308|NCT02589665|156595940|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656309|NCT02589665|156595941|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48335812|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Adverse Event|8|||
48335813|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Adverse Event|8|||
48335814|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Adverse Event|9|||
48335815|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
48656310|NCT02589665|156595942|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656311|NCT02589665|156595943|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48335816|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
48335817|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
48335818|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
48335819|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
48335820|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
48428210|NCT02531373|155756504|FG006|Overall Study|Lack of Efficacy|4|||
48335821|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
48335822|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
48335823|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Pregnancy|0|||
48335824|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Pregnancy|2|||
48335825|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Pregnancy|2|||
48335826|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Pregnancy|0|||
48335827|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Non-compliance|1|||
48335828|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Non-compliance|0|||
48335829|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Non-compliance|0|||
48335830|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Non-compliance|3|||
48335831|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Other|3|||
48335832|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Other|0|||
48335833|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Other|3|||
48335834|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Other|2|||
48335835|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
48335836|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
48335837|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
48335838|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
48335839|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
48335840|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
48335841|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
48335842|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
48335843|NCT02143713|155426910|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
48335844|NCT02143713|155426911|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
48335845|NCT02143713|155426912|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
48335846|NCT02143713|155426913|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
48335847|NCT02143713|155426910|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
48335848|NCT02143713|155426911|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
48335849|NCT02143713|155426912|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
48754530|NCT01189812|156946735|FG000|Overall Study|Moved out of State|1|||
48335850|NCT02143713|155426913|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
48335851|NCT02143713|155426910|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
48335852|NCT02143713|155426911|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
48335853|NCT02143713|155426912|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
48335854|NCT02143713|155426913|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
48335855|NCT02143713|155426910|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
48335856|NCT02143713|155426911|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
48335857|NCT02143713|155426912|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
48335858|NCT02143713|155426913|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
48335859|NCT02143713|155426910|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
48335860|NCT02143713|155426911|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
48335861|NCT02143713|155426912|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
48335862|NCT02143713|155426913|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
48335863|NCT02143713|155426910|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
48335864|NCT02143713|155426911|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
48335865|NCT02143713|155426912|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
48335866|NCT02143713|155426913|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
48335867|NCT02143713|155426910|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
48335868|NCT02143713|155426911|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
48335869|NCT02143713|155426912|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
48335870|NCT02143713|155426913|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
48335871|NCT01215253|155426915|FG000|Overall Study|Withdrawal by Subject|57|||
48335872|NCT01215253|155426916|FG001|Overall Study|Withdrawal by Subject|35|||
48335873|NCT01215253|155426915|FG000|Overall Study|Physician Decision|9|||
48335874|NCT01215253|155426916|FG001|Overall Study|Physician Decision|12|||
48335875|NCT01215253|155426915|FG000|Overall Study|Lost to Follow-up|6|||
48335876|NCT01215253|155426916|FG001|Overall Study|Lost to Follow-up|4|||
48335877|NCT01215253|155426915|FG000|Overall Study|Other|14|||
48335878|NCT01215253|155426916|FG001|Overall Study|Other|12|||
48335879|NCT01090739|155426917|FG000|Enrollment|Withdrawal by Subject|24|||
48335880|NCT01090739|155426917|FG000|Enrollment|Protocol Violation|14|||
48335881|NCT01090739|155426917|FG000|Enrollment|Lost to Follow-up|5|||
48335882|NCT01090739|155426917|FG000|Enrollment|Physician Decision|5|||
48335883|NCT01090739|155426917|FG000|Enrollment|Sponsor termination of site|4|||
48335884|NCT01090739|155426917|FG000|Enrollment|Study implant limit reached|2|||
48335885|NCT01090739|155426917|FG000|Enrollment|Adverse Event|1|||
48335886|NCT01090739|155426917|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
48335887|NCT01090739|155426917|FG000|12 Month Follow-up|Lost to Follow-up|1|||
48335888|NCT01090739|155426917|FG000|12 Month Follow-up|Physician Decision|1|||
48335889|NCT01090739|155426917|FG000|12 Month Follow-up|Death|1|||
48335890|NCT01090739|155426917|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
48335891|NCT01090739|155426917|FG000|24 Month Follow-up|Lost to Follow-up|1|||
48335892|NCT01090739|155426917|FG000|24 Month Follow-up|Death|1|||
48335893|NCT01090739|155426917|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
48335894|NCT01090739|155426917|FG000|36 Month Follow-up|Visit still pending|17|||
48335895|NCT03672188|155426918|FG000|Overall Study|Withdrawal by Subject|0|||
48335896|NCT03672188|155426919|FG001|Overall Study|Withdrawal by Subject|0|||
48335897|NCT03672188|155426920|FG002|Overall Study|Withdrawal by Subject|0|||
48335898|NCT03672188|155426921|FG003|Overall Study|Withdrawal by Subject|3|||
48335899|NCT03672188|155426922|FG004|Overall Study|Withdrawal by Subject|0|||
48335900|NCT03672188|155426923|FG005|Overall Study|Withdrawal by Subject|0|||
48335901|NCT03672188|155426924|FG006|Overall Study|Withdrawal by Subject|0|||
48335902|NCT03672188|155426925|FG007|Overall Study|Withdrawal by Subject|0|||
48335903|NCT03672188|155426926|FG008|Overall Study|Withdrawal by Subject|0|||
48335904|NCT03672188|155426927|FG009|Overall Study|Withdrawal by Subject|0|||
48335905|NCT03672188|155426928|FG010|Overall Study|Withdrawal by Subject|0|||
48335906|NCT03672188|155426929|FG011|Overall Study|Withdrawal by Subject|0|||
48335907|NCT03672188|155426930|FG012|Overall Study|Withdrawal by Subject|0|||
48335908|NCT03672188|155426931|FG013|Overall Study|Withdrawal by Subject|0|||
48335909|NCT03672188|155426932|FG014|Overall Study|Withdrawal by Subject|0|||
48335910|NCT03672188|155426918|FG000|Overall Study|Death|0|||
48335911|NCT03672188|155426919|FG001|Overall Study|Death|0|||
48335912|NCT03672188|155426920|FG002|Overall Study|Death|0|||
48335913|NCT03672188|155426921|FG003|Overall Study|Death|0|||
48335914|NCT03672188|155426922|FG004|Overall Study|Death|0|||
48335915|NCT03672188|155426923|FG005|Overall Study|Death|0|||
48335916|NCT03672188|155426924|FG006|Overall Study|Death|0|||
48335917|NCT03672188|155426925|FG007|Overall Study|Death|0|||
48335918|NCT03672188|155426926|FG008|Overall Study|Death|0|||
48335919|NCT03672188|155426927|FG009|Overall Study|Death|0|||
48335920|NCT03672188|155426928|FG010|Overall Study|Death|0|||
48335921|NCT03672188|155426929|FG011|Overall Study|Death|0|||
48335922|NCT03672188|155426930|FG012|Overall Study|Death|1|||
48335923|NCT03672188|155426931|FG013|Overall Study|Death|0|||
48335924|NCT03672188|155426932|FG014|Overall Study|Death|0|||
48335925|NCT03672188|155426918|FG000|Overall Study|Lost to Follow-up|0|||
48335926|NCT03672188|155426919|FG001|Overall Study|Lost to Follow-up|0|||
48656312|NCT02589665|156595944|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656313|NCT02589665|156595945|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656314|NCT02589665|156595946|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656315|NCT02589665|156595947|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
48656316|NCT02589665|156595948|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
48656317|NCT02589665|156595939|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
48335927|NCT03672188|155426920|FG002|Overall Study|Lost to Follow-up|1|||
48335928|NCT03672188|155426921|FG003|Overall Study|Lost to Follow-up|0|||
48335929|NCT03672188|155426922|FG004|Overall Study|Lost to Follow-up|0|||
48754531|NCT01189812|156946736|FG001|Overall Study|Moved out of State|2|||
48754532|NCT00001596|156948085|FG000|Overall Study|Death|1|||
48754533|NCT00001596|156948086|FG001|Overall Study|Death|0|||
48754534|NCT00001596|156948085|FG000|Overall Study|Withdrawal by Subject|3|||
48754535|NCT00001596|156948086|FG001|Overall Study|Withdrawal by Subject|1|||
48754536|NCT00001596|156948085|FG000|Overall Study|Study Termination|12|||
48754537|NCT00001596|156948086|FG001|Overall Study|Study Termination|9|||
48656318|NCT02589665|156595940|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
48656319|NCT02589665|156595941|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
48656320|NCT02589665|156595942|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
48656321|NCT02589665|156595943|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
48656322|NCT02589665|156595944|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
48656323|NCT02589665|156595945|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
48335930|NCT03672188|155426923|FG005|Overall Study|Lost to Follow-up|0|||
48335931|NCT03672188|155426924|FG006|Overall Study|Lost to Follow-up|0|||
48656324|NCT02589665|156595946|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
48335932|NCT03672188|155426925|FG007|Overall Study|Lost to Follow-up|0|||
48335933|NCT03672188|155426926|FG008|Overall Study|Lost to Follow-up|0|||
48335934|NCT03672188|155426927|FG009|Overall Study|Lost to Follow-up|0|||
48656325|NCT02589665|156595947|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
48335935|NCT03672188|155426928|FG010|Overall Study|Lost to Follow-up|0|||
48335936|NCT03672188|155426929|FG011|Overall Study|Lost to Follow-up|0|||
48335937|NCT03672188|155426930|FG012|Overall Study|Lost to Follow-up|0|||
48335938|NCT03672188|155426931|FG013|Overall Study|Lost to Follow-up|0|||
48335939|NCT03672188|155426932|FG014|Overall Study|Lost to Follow-up|0|||
48335940|NCT01714947|155426933|FG000|Part B|Progressive Disease|3|||
48335941|NCT01123356|155426934|FG000|Overall Study|Adverse Event|2|||
48335942|NCT01123356|155426934|FG000|Overall Study|Lack of Efficacy|4|||
48335943|NCT01123356|155426934|FG000|Overall Study|Withdrawal by Subject|1|||
48335944|NCT00402298|155426940|FG000|Overall Study|Withdrawal by Subject|1|||
48754538|NCT00001596|156948085|FG000|Overall Study|Adverse Event|1|||
48754539|NCT00001596|156948086|FG001|Overall Study|Adverse Event|0|||
48754540|NCT03562481|156948094|FG000|First Intervention|Lost to Follow-up|1|||
48754541|NCT03562481|156948095|FG001|First Intervention|Lost to Follow-up|0|||
48754542|NCT01327885|156948096|FG000|Overall Study|Disease progression-according to RECIST|173|||
48754543|NCT01327885|156948097|FG001|Overall Study|Disease progression-according to RECIST|165|||
48754544|NCT01327885|156948096|FG000|Overall Study|Clinical progression|24|||
48754545|NCT01327885|156948097|FG001|Overall Study|Clinical progression|27|||
48754546|NCT01327885|156948096|FG000|Overall Study|Adverse Event|14|||
48754547|NCT01327885|156948097|FG001|Overall Study|Adverse Event|10|||
48754548|NCT01327885|156948096|FG000|Overall Study|Subject choice|5|||
48335945|NCT00402298|155426941|FG001|Overall Study|Withdrawal by Subject|0|||
48335946|NCT02069379|155426942|FG000|Baseline Measurements|Lost to Follow-up|1|||
48335947|NCT02069379|155426943|FG001|Baseline Measurements|Lost to Follow-up|0|||
48335948|NCT02069379|155426944|FG002|Baseline Measurements|Lost to Follow-up|0|||
48335949|NCT02069379|155426945|FG003|Baseline Measurements|Lost to Follow-up|0|||
48335950|NCT02069379|155426942|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
48335951|NCT02069379|155426943|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
48335952|NCT02069379|155426944|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
48335953|NCT02069379|155426945|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
48335954|NCT02069379|155426942|FG000|First Treatment Arm|Lost to Follow-up|0|||
48335955|NCT02069379|155426943|FG001|First Treatment Arm|Lost to Follow-up|1|||
48335956|NCT02069379|155426944|FG002|First Treatment Arm|Lost to Follow-up|1|||
48335957|NCT02069379|155426945|FG003|First Treatment Arm|Lost to Follow-up|0|||
48335958|NCT02069379|155426942|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
48335959|NCT02069379|155426943|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
48335960|NCT02069379|155426944|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
48335961|NCT02069379|155426945|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
48335962|NCT02069379|155426942|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
48335963|NCT02069379|155426943|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
48335964|NCT02069379|155426944|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
48335965|NCT02069379|155426945|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
48335966|NCT02069379|155426942|FG000|Second Treatment Arm|Lost to Follow-up|0|||
48335967|NCT02069379|155426943|FG001|Second Treatment Arm|Lost to Follow-up|0|||
48335968|NCT02069379|155426944|FG002|Second Treatment Arm|Lost to Follow-up|1|||
48335969|NCT02069379|155426945|FG003|Second Treatment Arm|Lost to Follow-up|0|||
48335970|NCT01469819|155426946|FG000|Overall Study|Withdrawal by Subject|1|||
48335971|NCT01469819|155426946|FG000|Overall Study|Did not meet inclusionary criteria|2|||
48656326|NCT02589665|156595948|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
48656327|NCT02589665|156595939|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
48656328|NCT02589665|156595940|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
48656329|NCT02589665|156595941|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
48656330|NCT02589665|156595942|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
48656331|NCT02589665|156595943|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
48656332|NCT02589665|156595944|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
48656333|NCT02589665|156595945|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
48656334|NCT02589665|156595946|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
48656335|NCT02589665|156595947|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
48656336|NCT02589665|156595948|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
48656337|NCT02589665|156595939|FG000|Maintenance Extension Period|Adverse Event|0|||
48656338|NCT02589665|156595940|FG001|Maintenance Extension Period|Adverse Event|0|||
48656339|NCT02589665|156595941|FG002|Maintenance Extension Period|Adverse Event|0|||
48656340|NCT02589665|156595942|FG003|Maintenance Extension Period|Adverse Event|0|||
48656341|NCT02589665|156595943|FG004|Maintenance Extension Period|Adverse Event|0|||
48656342|NCT02589665|156595944|FG005|Maintenance Extension Period|Adverse Event|0|||
48656343|NCT02589665|156595945|FG006|Maintenance Extension Period|Adverse Event|0|||
48656344|NCT02589665|156595946|FG007|Maintenance Extension Period|Adverse Event|0|||
48656345|NCT02589665|156595947|FG008|Maintenance Extension Period|Adverse Event|0|||
48656346|NCT02589665|156595948|FG009|Maintenance Extension Period|Adverse Event|2|||
48656347|NCT02589665|156595939|FG000|Maintenance Extension Period|Non-responder|0|||
48656348|NCT02589665|156595940|FG001|Maintenance Extension Period|Non-responder|0|||
48656349|NCT02589665|156595941|FG002|Maintenance Extension Period|Non-responder|0|||
48656350|NCT02589665|156595942|FG003|Maintenance Extension Period|Non-responder|0|||
48656351|NCT02589665|156595943|FG004|Maintenance Extension Period|Non-responder|0|||
48656352|NCT02589665|156595944|FG005|Maintenance Extension Period|Non-responder|0|||
48656353|NCT02589665|156595945|FG006|Maintenance Extension Period|Non-responder|0|||
48754549|NCT01327885|156948097|FG001|Overall Study|Subject choice|10|||
48335972|NCT01469819|155426946|FG000|Overall Study|Could not swallow SmartPill|2|||
48335973|NCT01469819|155426946|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
48335974|NCT03209492|155426947|FG000|Overall Study|Case Report Forms Uncollected|5|||
48754550|NCT01327885|156948096|FG000|Overall Study|Other|8|||
48754551|NCT01327885|156948097|FG001|Overall Study|Other|6|||
48656354|NCT02589665|156595946|FG007|Maintenance Extension Period|Non-responder|0|||
48656355|NCT02589665|156595947|FG008|Maintenance Extension Period|Non-responder|0|||
48656356|NCT02589665|156595948|FG009|Maintenance Extension Period|Non-responder|1|||
48656357|NCT01443364|156595949|FG000|Overall Study|Lack of Efficacy|14|||
48656358|NCT01443364|156595949|FG000|Overall Study|Lost to Follow-up|3|||
48656359|NCT01443364|156595949|FG000|Overall Study|Withdrawal by Subject|5|||
48656360|NCT01443364|156595949|FG000|Overall Study|Other Reason|4|||
48656361|NCT01443364|156595949|FG000|Overall Study|SAE, non-fatal|6|||
48656362|NCT01443364|156595949|FG000|Overall Study|AE, non-serious non-fatal|8|||
48656363|NCT01443364|156595949|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48656364|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Adverse Event|76|||
48656365|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Adverse Event|0|||
48656366|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Adverse Event|0|||
48656367|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Death|3|||
48656368|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Death|0|||
48656369|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Death|0|||
48656370|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
48656371|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
48656372|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
48656373|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Physician Decision|9|||
48656374|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Physician Decision|0|||
48656375|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Physician Decision|0|||
48656376|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
48656377|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
48656378|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
48656379|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Disease progression|45|||
48656380|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Disease progression|0|||
48656381|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Disease progression|0|||
48656382|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
48656383|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
48656384|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
48656385|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
48754552|NCT01327885|156948096|FG000|Overall Study|Withdrawal of consent from study|3|||
48754553|NCT01327885|156948097|FG001|Overall Study|Withdrawal of consent from study|4|||
48656386|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
48754554|NCT01327885|156948096|FG000|Overall Study|Not treated|1|||
48754555|NCT01327885|156948097|FG001|Overall Study|Not treated|1|||
48754556|NCT01327885|156948096|FG000|Overall Study|Administrative decision|0|||
48754557|NCT01327885|156948097|FG001|Overall Study|Administrative decision|1|||
48754558|NCT02041286|156948098|FG000|Overall Study|Adverse Event|1|||
48754559|NCT00549302|156948103|FG000|Double-Blind|Death|2|||
48754560|NCT00549302|156948104|FG001|Double-Blind|Death|9|||
48754561|NCT00549302|156948105|FG002|Double-Blind|Death|0|||
48754562|NCT00549302|156948103|FG000|Double-Blind|Adverse Event|3|||
48754563|NCT00549302|156948104|FG001|Double-Blind|Adverse Event|16|||
48754564|NCT00549302|156948105|FG002|Double-Blind|Adverse Event|0|||
48754565|NCT00549302|156948103|FG000|Double-Blind|Withdrawal by Subject|3|||
48754566|NCT00549302|156948104|FG001|Double-Blind|Withdrawal by Subject|8|||
48754567|NCT00549302|156948105|FG002|Double-Blind|Withdrawal by Subject|0|||
48754568|NCT00549302|156948103|FG000|Double-Blind|Investigator Decision|1|||
48754569|NCT00549302|156948104|FG001|Double-Blind|Investigator Decision|5|||
48754570|NCT00549302|156948105|FG002|Double-Blind|Investigator Decision|0|||
48754571|NCT00549302|156948103|FG000|Double-Blind|Sponsor Decision|0|||
48754572|NCT00549302|156948104|FG001|Double-Blind|Sponsor Decision|1|||
48754573|NCT00549302|156948105|FG002|Double-Blind|Sponsor Decision|0|||
48754574|NCT00549302|156948103|FG000|Double-Blind|Lost to Follow-up|1|||
48754575|NCT00549302|156948104|FG001|Double-Blind|Lost to Follow-up|2|||
48754576|NCT00549302|156948105|FG002|Double-Blind|Lost to Follow-up|0|||
48754577|NCT00549302|156948103|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
48754578|NCT00549302|156948104|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
48754579|NCT00549302|156948105|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
48754580|NCT00549302|156948103|FG000|Double-Blind|New condition or starts new therapy|0|||
48754581|NCT00549302|156948104|FG001|Double-Blind|New condition or starts new therapy|2|||
48754582|NCT00549302|156948105|FG002|Double-Blind|New condition or starts new therapy|0|||
48754583|NCT00549302|156948103|FG000|Open-Label|Adverse Event|0|||
48754584|NCT00549302|156948104|FG001|Open-Label|Adverse Event|0|||
48754585|NCT00549302|156948105|FG002|Open-Label|Adverse Event|11|||
48754586|NCT00549302|156948103|FG000|Open-Label|Death|0|||
48754587|NCT00549302|156948104|FG001|Open-Label|Death|0|||
48754588|NCT00549302|156948105|FG002|Open-Label|Death|40|||
48754589|NCT00549302|156948103|FG000|Open-Label|Investigator Decision|0|||
48754590|NCT00549302|156948104|FG001|Open-Label|Investigator Decision|0|||
48754591|NCT00549302|156948105|FG002|Open-Label|Investigator Decision|5|||
48754592|NCT00549302|156948103|FG000|Open-Label|Lost to Follow-up|0|||
48754593|NCT00549302|156948104|FG001|Open-Label|Lost to Follow-up|0|||
48754594|NCT00549302|156948105|FG002|Open-Label|Lost to Follow-up|2|||
48335975|NCT00561678|155426948|FG000|Overall Study|Withdrawal by Subject|4|||
48335976|NCT00561678|155426949|FG001|Overall Study|Withdrawal by Subject|3|||
48335977|NCT00561678|155426948|FG000|Overall Study|surgery cancelled|1|||
48335978|NCT00561678|155426949|FG001|Overall Study|surgery cancelled|1|||
48335979|NCT00561678|155426948|FG000|Overall Study|surgery rescheduled to different site|2|||
48335980|NCT00561678|155426949|FG001|Overall Study|surgery rescheduled to different site|2|||
48335981|NCT00561678|155426948|FG000|Overall Study|anesthesia provider refusal|1|||
48335982|NCT00561678|155426949|FG001|Overall Study|anesthesia provider refusal|0|||
48335983|NCT01762345|155426950|FG000|Overall Study|Adverse Event|5|||
48335984|NCT01762345|155426950|FG000|Overall Study|Protocol Violation|2|||
48335985|NCT05072795|155426951|FG000|Overall Study|Lost to Follow-up|5|||
48335986|NCT01894620|155426956|FG000|Overall Study|Withdrawal by Subject|0|||
48335987|NCT01894620|155426957|FG001|Overall Study|Withdrawal by Subject|1|||
48335988|NCT02877680|155426958|FG000|Overall Study|Lost to Follow-up|1|||
48335989|NCT02877680|155426959|FG001|Overall Study|Lost to Follow-up|1|||
48335990|NCT01133678|155426960|FG000|Overall Study|Death|1|||
48335991|NCT01133678|155426961|FG001|Overall Study|Death|1|||
48335992|NCT05647304|155426962|FG000|Overall Study|Withdrawal by Subject|1|||
48335993|NCT05647304|155426963|FG001|Overall Study|Withdrawal by Subject|0|||
48335994|NCT00657709|155426970|FG000|Overall Study|AE or Death|7|||
48335995|NCT00657709|155426971|FG001|Overall Study|AE or Death|7|||
48335996|NCT00657709|155426972|FG002|Overall Study|AE or Death|6|||
48335997|NCT00657709|155426973|FG003|Overall Study|AE or Death|7|||
48335998|NCT00657709|155426974|FG004|Overall Study|AE or Death|1|||
48335999|NCT00657709|155426970|FG000|Overall Study|Withdrawal by Subject|7|||
48336000|NCT00657709|155426971|FG001|Overall Study|Withdrawal by Subject|15|||
48336001|NCT00657709|155426972|FG002|Overall Study|Withdrawal by Subject|15|||
48336002|NCT00657709|155426973|FG003|Overall Study|Withdrawal by Subject|5|||
48336003|NCT00657709|155426974|FG004|Overall Study|Withdrawal by Subject|9|||
48336004|NCT00657709|155426970|FG000|Overall Study|Lost to Follow-up|9|||
48336005|NCT00657709|155426971|FG001|Overall Study|Lost to Follow-up|9|||
48336006|NCT00657709|155426972|FG002|Overall Study|Lost to Follow-up|7|||
48336007|NCT00657709|155426973|FG003|Overall Study|Lost to Follow-up|1|||
48336008|NCT00657709|155426974|FG004|Overall Study|Lost to Follow-up|21|||
48336009|NCT00657709|155426970|FG000|Overall Study|Protocol Violation|0|||
48336010|NCT00657709|155426971|FG001|Overall Study|Protocol Violation|2|||
48336011|NCT00657709|155426972|FG002|Overall Study|Protocol Violation|0|||
48336012|NCT00657709|155426973|FG003|Overall Study|Protocol Violation|1|||
48336013|NCT00657709|155426974|FG004|Overall Study|Protocol Violation|2|||
48656387|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
48656388|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
48656389|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
48336014|NCT02305797|155426975|FG000|Overall Study|Adverse Event|11|||
48336015|NCT02305797|155426976|FG001|Overall Study|Adverse Event|2|||
48336016|NCT02305797|155426975|FG000|Overall Study|Withdrawal by Subject|9|||
48336017|NCT02305797|155426976|FG001|Overall Study|Withdrawal by Subject|10|||
48336018|NCT02305797|155426975|FG000|Overall Study|Lack of Efficacy|6|||
48656390|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
48656391|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
48656392|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
48656393|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
48656394|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
48656395|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
48656396|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
48656397|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
48656398|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
48656399|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
48656400|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
48656401|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
48656402|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
48656403|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
48656404|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
48656405|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
48656406|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
48656407|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
48656408|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
48656409|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Promotor request|1|||
48656410|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Promotor request|0|||
48754595|NCT00549302|156948103|FG000|Open-Label|Other|0|||
48336019|NCT02305797|155426976|FG001|Overall Study|Lack of Efficacy|0|||
48336020|NCT02305797|155426975|FG000|Overall Study|Lost to Follow-up|5|||
48336021|NCT02305797|155426976|FG001|Overall Study|Lost to Follow-up|11|||
48336022|NCT02305797|155426975|FG000|Overall Study|Pregnancy|0|||
48336023|NCT02305797|155426976|FG001|Overall Study|Pregnancy|2|||
48754596|NCT00549302|156948104|FG001|Open-Label|Other|0|||
48754597|NCT00549302|156948105|FG002|Open-Label|Other|3|||
48754598|NCT00549302|156948103|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
48754599|NCT00549302|156948104|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
48754600|NCT00549302|156948105|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
48754601|NCT00549302|156948103|FG000|Open-Label|Withdrawal by Subject|0|||
48754602|NCT00549302|156948104|FG001|Open-Label|Withdrawal by Subject|0|||
48754603|NCT00549302|156948105|FG002|Open-Label|Withdrawal by Subject|6|||
48754604|NCT02233309|156948109|FG000|Overall Study|Physician Decision|5|||
48754605|NCT02436889|156948113|FG000|Overall Study|No improvement in symptoms|1|||
48754606|NCT02436889|156948114|FG001|Overall Study|No improvement in symptoms|0|||
48754607|NCT02436889|156948113|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
48754608|NCT02436889|156948114|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
48754609|NCT01946425|156948122|FG000|Overall Study|Protocol Violation|1|||
48754610|NCT01946425|156948123|FG001|Overall Study|Protocol Violation|0|||
48754611|NCT01946425|156948122|FG000|Overall Study|Withdrawal by Subject|1|||
48754612|NCT01946425|156948123|FG001|Overall Study|Withdrawal by Subject|0|||
48754613|NCT00142584|156948124|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
48754614|NCT00142584|156948125|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
48754615|NCT00142584|156948124|FG000|Overall Study|Withdrawal by Subject|30|||
48754616|NCT00142584|156948125|FG001|Overall Study|Withdrawal by Subject|16|||
48754617|NCT00142584|156948124|FG000|Overall Study|Lost to Follow-up|22|||
48754618|NCT00142584|156948125|FG001|Overall Study|Lost to Follow-up|12|||
48754619|NCT00142584|156948124|FG000|Overall Study|Adverse Event|14|||
48754620|NCT00142584|156948125|FG001|Overall Study|Adverse Event|5|||
48754621|NCT00142584|156948124|FG000|Overall Study|Protocol Violation|4|||
48754622|NCT00142584|156948125|FG001|Overall Study|Protocol Violation|7|||
48754623|NCT00142584|156948124|FG000|Overall Study|Treatment Failure|2|||
48754624|NCT00142584|156948125|FG001|Overall Study|Treatment Failure|0|||
48754625|NCT02551731|156948126|FG000|Overall Study|Withdrawal by Subject|2|||
48754626|NCT01961323|156948127|FG000|Overall Study|Withdrawal by Subject|7|||
48754627|NCT01961323|156948127|FG000|Overall Study|Lost to Follow-up|8|||
48754628|NCT01961323|156948127|FG000|Overall Study|screen failure|34|||
48754629|NCT03336333|156948128|FG000|Overall Study|Remained on study at time of data cut-off|202|||
48754630|NCT03336333|156948129|FG001|Overall Study|Remained on study at time of data cut-off|219|||
48754631|NCT03336333|156948130|FG002|Overall Study|Remained on study at time of data cut-off|102|||
48754632|NCT03336333|156948128|FG000|Overall Study|Death|14|||
48754633|NCT03336333|156948129|FG001|Overall Study|Death|16|||
48754634|NCT03336333|156948130|FG002|Overall Study|Death|8|||
48754635|NCT03336333|156948128|FG000|Overall Study|Withdrawal by Subject|16|||
48754636|NCT03336333|156948129|FG001|Overall Study|Withdrawal by Subject|5|||
48754637|NCT03336333|156948130|FG002|Overall Study|Withdrawal by Subject|1|||
48754638|NCT03336333|156948128|FG000|Overall Study|Physician Decision|5|||
48754639|NCT03336333|156948129|FG001|Overall Study|Physician Decision|1|||
48754640|NCT03336333|156948130|FG002|Overall Study|Physician Decision|0|||
48754641|NCT03336333|156948128|FG000|Overall Study|Lost to Follow-up|1|||
48754642|NCT03336333|156948129|FG001|Overall Study|Lost to Follow-up|0|||
48754643|NCT03336333|156948130|FG002|Overall Study|Lost to Follow-up|0|||
48754644|NCT00770289|156948131|FG000|Overall Study|Other|6|||
48754645|NCT02377466|156948134|FG000|Overall Study|Other: Randomized and not treated|0|||
48754646|NCT02377466|156948135|FG001|Overall Study|Other: Randomized and not treated|2|||
48754647|NCT00137046|156948136|FG000|Overall Study|Death|2|||
48754648|NCT00137046|156948137|FG001|Overall Study|Death|1|||
48656411|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Promotor request|0|||
48656412|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
48656413|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
48656414|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
48656415|NCT01461928|156595951|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
48656416|NCT01461928|156595952|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
48656417|NCT01461928|156595953|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
48656418|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Death|3|||
48656419|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Death|0|||
48656420|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Death|0|||
48656421|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
48656422|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
48754649|NCT00137046|156948136|FG000|Overall Study|Adverse Event|16|||
48754650|NCT00137046|156948137|FG001|Overall Study|Adverse Event|5|||
48754651|NCT00137046|156948136|FG000|Overall Study|Laboratory Abnormality|2|||
48754652|NCT00137046|156948137|FG001|Overall Study|Laboratory Abnormality|0|||
48754653|NCT00137046|156948136|FG000|Overall Study|Lack of Efficacy|13|||
48754654|NCT00137046|156948137|FG001|Overall Study|Lack of Efficacy|1|||
48754655|NCT00137046|156948136|FG000|Overall Study|Lost to Follow-up|8|||
48754656|NCT00137046|156948137|FG001|Overall Study|Lost to Follow-up|24|||
48754657|NCT00137046|156948136|FG000|Overall Study|Other|23|||
48754658|NCT00137046|156948137|FG001|Overall Study|Other|19|||
48754659|NCT00137046|156948136|FG000|Overall Study|Withdrawal by Subject|33|||
48656423|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
48656424|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
48656425|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
48656426|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
48656427|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Diseases progression|91|||
48656428|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Diseases progression|0|||
48656429|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Diseases progression|0|||
48656430|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Adverse Event|70|||
48656431|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Adverse Event|0|||
48656432|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Adverse Event|0|||
48656433|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Physician Decision|9|||
48656434|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Physician Decision|0|||
48656435|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Physician Decision|0|||
48656436|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
48656437|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
48656438|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
48656439|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
48656440|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
48656441|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
48656442|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
48656443|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
48656444|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
48656445|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Not compliant|1|||
48656446|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Not compliant|0|||
48656447|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Not compliant|0|||
48656448|NCT01461928|156595951|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
48656449|NCT01461928|156595952|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
48656450|NCT01461928|156595953|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
48656451|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Adverse Event|0|||
48656452|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Adverse Event|2|||
48656453|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Adverse Event|0|||
48656454|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Death|0|||
48656455|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Death|10|||
48656456|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Death|8|||
48656457|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Physician Decision|0|||
48656458|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Physician Decision|0|||
48656459|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Physician Decision|4|||
48656460|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
48656461|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
48656462|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
48656463|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Moved to another town|0|||
48656464|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Moved to another town|1|||
48656465|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Moved to another town|0|||
48656466|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Disease progression|0|||
48656467|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Disease progression|0|||
48656468|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Disease progression|3|||
48656469|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
48656470|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
48656471|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
48656472|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
48656473|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
48656474|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
48656475|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
48656476|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
48656477|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
48656478|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
48656479|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
48656480|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
48656481|NCT01461928|156595951|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
48656482|NCT01461928|156595952|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
48656483|NCT01461928|156595953|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
48656484|NCT02150057|156595967|FG000|Overall Study|Lost to Follow-up|6|||
48656485|NCT02150057|156595968|FG001|Overall Study|Lost to Follow-up|4|||
48656486|NCT00664560|156595969|FG000|Overall Study|Adverse Event|19|||
48754660|NCT00137046|156948137|FG001|Overall Study|Withdrawal by Subject|42|||
48754661|NCT00137046|156948136|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
48754662|NCT00137046|156948137|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
48754663|NCT00137046|156948136|FG000|Overall Study|Withdrew prior to study treatment|1|||
48754664|NCT00137046|156948137|FG001|Overall Study|Withdrew prior to study treatment|1|||
48754665|NCT03187262|156948138|FG000|Induction|Lack of Efficacy|2|||
48754666|NCT03187262|156948138|FG000|Induction|Progressive Disease|4|||
48754667|NCT03187262|156948138|FG000|Consolidation|Progressive Disease|5|||
48754668|NCT00110149|156948139|FG000|Overall Study|Physician Decision|3|||
48754669|NCT00191789|156948142|FG000|Overall Study|Adverse Event|5|||
48754670|NCT00191789|156948142|FG000|Overall Study|Patient: Satisfactory Response|5|||
48754671|NCT00191789|156948142|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
48754672|NCT00191789|156948142|FG000|Overall Study|Withdrawal by Subject|4|||
48754673|NCT00191789|156948142|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
48754674|NCT00191789|156948142|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
48754675|NCT00191789|156948142|FG000|Overall Study|Death - Not Study-Drug Related|1|||
48754676|NCT03334448|156948145|FG000|Washout|Personal Reason|0|||
48754677|NCT03334448|156948146|FG001|Washout|Personal Reason|1|||
48754678|NCT03334448|156948147|FG002|Washout|Personal Reason|0|||
48754679|NCT03334448|156948148|FG003|Washout|Personal Reason|0|||
48754680|NCT03334448|156948145|FG000|Washout|Protocol Violation|0|||
48754681|NCT03334448|156948146|FG001|Washout|Protocol Violation|0|||
48754682|NCT03334448|156948147|FG002|Washout|Protocol Violation|0|||
48754683|NCT03334448|156948148|FG003|Washout|Protocol Violation|1|||
48754684|NCT02326025|156948149|FG000|Overall Study|Adverse Event|3|||
48754685|NCT02326025|156948150|FG001|Overall Study|Adverse Event|0|||
48754686|NCT02326025|156948149|FG000|Overall Study|Physician Decision|1|||
48754687|NCT02326025|156948150|FG001|Overall Study|Physician Decision|2|||
48754688|NCT02326025|156948149|FG000|Overall Study|Physician and Participant Decision|1|||
48754689|NCT02326025|156948150|FG001|Overall Study|Physician and Participant Decision|0|||
48754690|NCT02326025|156948149|FG000|Overall Study|Withdrawal by Subject|0|||
48754691|NCT02326025|156948150|FG001|Overall Study|Withdrawal by Subject|2|||
48754692|NCT02326025|156948149|FG000|Overall Study|Protocol Violation|0|||
48754693|NCT02326025|156948150|FG001|Overall Study|Protocol Violation|1|||
48754694|NCT00467259|156948151|FG000|Overall Study|Adverse Event|24|||
48754695|NCT00467259|156948152|FG001|Overall Study|Adverse Event|90|||
48754696|NCT00467259|156948151|FG000|Overall Study|Protocol Violation|1|||
48754697|NCT00467259|156948152|FG001|Overall Study|Protocol Violation|7|||
48754698|NCT00467259|156948151|FG000|Overall Study|Withdrawal by Subject|34|||
48754699|NCT00467259|156948152|FG001|Overall Study|Withdrawal by Subject|108|||
48754700|NCT00467259|156948151|FG000|Overall Study|Physician Decision|0|||
48754701|NCT00467259|156948152|FG001|Overall Study|Physician Decision|2|||
48754702|NCT00467259|156948151|FG000|Overall Study|Lost to Follow-up|14|||
48754703|NCT00467259|156948152|FG001|Overall Study|Lost to Follow-up|34|||
48754704|NCT00467259|156948151|FG000|Overall Study|Site Closed|2|||
48656487|NCT00664560|156595970|FG001|Overall Study|Adverse Event|16|||
48754705|NCT00467259|156948152|FG001|Overall Study|Site Closed|1|||
48754706|NCT03965962|156948155|FG000|Overall Study|Adverse Event|1|||
48754707|NCT03965962|156948156|FG001|Overall Study|Adverse Event|0|||
48754708|NCT03965962|156948157|FG002|Overall Study|Adverse Event|0|||
48754709|NCT03965962|156948158|FG003|Overall Study|Adverse Event|0|||
48754710|NCT03965962|156948155|FG000|Overall Study|Protocol Violation|21|||
48754711|NCT03965962|156948156|FG001|Overall Study|Protocol Violation|4|||
48336024|NCT02305797|155426975|FG000|Overall Study|Noncompliance|14|||
48754712|NCT03965962|156948157|FG002|Overall Study|Protocol Violation|10|||
48754713|NCT03965962|156948158|FG003|Overall Study|Protocol Violation|5|||
48754714|NCT03965962|156948155|FG000|Overall Study|Lost to Follow-up|0|||
48656488|NCT00664560|156595971|FG002|Overall Study|Adverse Event|7|||
48656489|NCT00664560|156595969|FG000|Overall Study|Withdrawal by Subject|9|||
48656490|NCT00664560|156595970|FG001|Overall Study|Withdrawal by Subject|13|||
48656491|NCT00664560|156595971|FG002|Overall Study|Withdrawal by Subject|7|||
48656492|NCT00664560|156595969|FG000|Overall Study|Lost to Follow-up|0|||
48656493|NCT00664560|156595970|FG001|Overall Study|Lost to Follow-up|2|||
48656494|NCT00664560|156595971|FG002|Overall Study|Lost to Follow-up|0|||
48656495|NCT00664560|156595969|FG000|Overall Study|Other|11|||
48656496|NCT00664560|156595970|FG001|Overall Study|Other|4|||
48656497|NCT00664560|156595971|FG002|Overall Study|Other|5|||
48656498|NCT05312632|156595972|FG000|Overall Study|Adverse Event|12|||
48656499|NCT05312632|156595972|FG000|Overall Study|Withdrawal by Subject|10|||
48656500|NCT05312632|156595972|FG000|Overall Study|Lack of Efficacy|4|||
48656501|NCT05312632|156595972|FG000|Overall Study|Non-compliance with study procedures|9|||
48656502|NCT05312632|156595972|FG000|Overall Study|Other|4|||
48656503|NCT01801436|156595975|FG000|Overall Study|Withdrawal by Subject|3|||
48656504|NCT01801436|156595975|FG000|Overall Study|Adverse Event|2|||
48656505|NCT01801436|156595975|FG000|Overall Study|Progressive disease|4|||
48656506|NCT04085458|156595978|FG000|Overall Study|Other|1|||
48656507|NCT04085458|156595978|FG000|Overall Study|Withdrawal by Subject|2|||
48656508|NCT04085458|156595978|FG000|Overall Study|Adverse Event|2|||
48656509|NCT01005316|156595983|FG000|Overall Study|Adverse Event|0|||
48656510|NCT01005316|156595984|FG001|Overall Study|Adverse Event|0|||
48656511|NCT01005316|156595985|FG002|Overall Study|Adverse Event|0|||
48656512|NCT01005316|156595986|FG003|Overall Study|Adverse Event|1|||
48656513|NCT01005316|156595983|FG000|Overall Study|Death|20|||
48656514|NCT01005316|156595984|FG001|Overall Study|Death|5|||
48656515|NCT01005316|156595985|FG002|Overall Study|Death|1|||
48656516|NCT01005316|156595986|FG003|Overall Study|Death|15|||
48656517|NCT01005316|156595983|FG000|Overall Study|Study Termination|5|||
48656518|NCT01005316|156595984|FG001|Overall Study|Study Termination|63|||
48656519|NCT01005316|156595985|FG002|Overall Study|Study Termination|9|||
48656520|NCT01005316|156595986|FG003|Overall Study|Study Termination|85|||
48656521|NCT01005316|156595983|FG000|Overall Study|Lost to Follow-up|1|||
48656522|NCT01005316|156595984|FG001|Overall Study|Lost to Follow-up|3|||
48656523|NCT01005316|156595985|FG002|Overall Study|Lost to Follow-up|0|||
48656524|NCT01005316|156595986|FG003|Overall Study|Lost to Follow-up|2|||
48656525|NCT01005316|156595983|FG000|Overall Study|Physician Decision|6|||
48656526|NCT01005316|156595984|FG001|Overall Study|Physician Decision|0|||
48656527|NCT01005316|156595985|FG002|Overall Study|Physician Decision|0|||
48656528|NCT01005316|156595986|FG003|Overall Study|Physician Decision|0|||
48656529|NCT01005316|156595983|FG000|Overall Study|Sponsor Decision|6|||
48656530|NCT01005316|156595984|FG001|Overall Study|Sponsor Decision|3|||
48656531|NCT01005316|156595985|FG002|Overall Study|Sponsor Decision|0|||
48656532|NCT01005316|156595986|FG003|Overall Study|Sponsor Decision|0|||
48656533|NCT01005316|156595983|FG000|Overall Study|Withdrawal by Subject|1|||
48656534|NCT01005316|156595984|FG001|Overall Study|Withdrawal by Subject|1|||
48656535|NCT01005316|156595985|FG002|Overall Study|Withdrawal by Subject|0|||
48656536|NCT01005316|156595986|FG003|Overall Study|Withdrawal by Subject|2|||
48656537|NCT01005316|156595983|FG000|Overall Study|Consented to Another Study|2|||
48656538|NCT01005316|156595984|FG001|Overall Study|Consented to Another Study|0|||
48656539|NCT01005316|156595985|FG002|Overall Study|Consented to Another Study|0|||
48656540|NCT01005316|156595986|FG003|Overall Study|Consented to Another Study|0|||
48656541|NCT01005316|156595983|FG000|Overall Study|Delisted|8|||
48656542|NCT01005316|156595984|FG001|Overall Study|Delisted|0|||
48656543|NCT01005316|156595985|FG002|Overall Study|Delisted|0|||
48656544|NCT01005316|156595986|FG003|Overall Study|Delisted|0|||
48656545|NCT01005316|156595983|FG000|Overall Study|Transferred Care|1|||
48656546|NCT01005316|156595984|FG001|Overall Study|Transferred Care|0|||
48656547|NCT01005316|156595985|FG002|Overall Study|Transferred Care|1|||
48656548|NCT01005316|156595986|FG003|Overall Study|Transferred Care|3|||
48656549|NCT01005316|156595983|FG000|Overall Study|Retransplanted|0|||
48656550|NCT01005316|156595984|FG001|Overall Study|Retransplanted|1|||
48656551|NCT01005316|156595985|FG002|Overall Study|Retransplanted|0|||
48656552|NCT01005316|156595986|FG003|Overall Study|Retransplanted|0|||
48656553|NCT00960011|156595987|FG000|Overall Study|Death|5|||
48656554|NCT00960011|156595988|FG001|Overall Study|Death|0|||
48656555|NCT00960011|156595987|FG000|Overall Study|Lost to Follow-up|6|||
48656556|NCT00960011|156595988|FG001|Overall Study|Lost to Follow-up|2|||
48656557|NCT01007435|156595992|FG000|Overall Study|Adverse Event|16|||
48656558|NCT01007435|156595993|FG001|Overall Study|Adverse Event|25|||
48336025|NCT02305797|155426976|FG001|Overall Study|Noncompliance|12|||
48656559|NCT01007435|156595994|FG002|Overall Study|Adverse Event|47|||
48656560|NCT01007435|156595995|FG003|Overall Study|Adverse Event|31|||
48656561|NCT01007435|156595992|FG000|Overall Study|Death|2|||
48656562|NCT01007435|156595993|FG001|Overall Study|Death|4|||
48656563|NCT01007435|156595994|FG002|Overall Study|Death|2|||
48656564|NCT01007435|156595995|FG003|Overall Study|Death|1|||
48656565|NCT01007435|156595992|FG000|Overall Study|Insufficient Therapeutic Response|21|||
48656566|NCT01007435|156595993|FG001|Overall Study|Insufficient Therapeutic Response|7|||
48656567|NCT01007435|156595994|FG002|Overall Study|Insufficient Therapeutic Response|2|||
48656568|NCT01007435|156595995|FG003|Overall Study|Insufficient Therapeutic Response|9|||
48656569|NCT01007435|156595992|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
48656570|NCT01007435|156595993|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
48656571|NCT01007435|156595994|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
48656572|NCT01007435|156595995|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
48656573|NCT01007435|156595992|FG000|Overall Study|Other Protocol Violation|2|||
48656574|NCT01007435|156595993|FG001|Overall Study|Other Protocol Violation|0|||
48656575|NCT01007435|156595994|FG002|Overall Study|Other Protocol Violation|1|||
48656576|NCT01007435|156595995|FG003|Overall Study|Other Protocol Violation|0|||
48656577|NCT01007435|156595992|FG000|Overall Study|Refused Treatment|13|||
48656578|NCT01007435|156595993|FG001|Overall Study|Refused Treatment|13|||
48656579|NCT01007435|156595994|FG002|Overall Study|Refused Treatment|5|||
48656580|NCT01007435|156595995|FG003|Overall Study|Refused Treatment|8|||
48656581|NCT01007435|156595992|FG000|Overall Study|Failure to Return|5|||
48656582|NCT01007435|156595993|FG001|Overall Study|Failure to Return|4|||
48656583|NCT01007435|156595994|FG002|Overall Study|Failure to Return|3|||
48656584|NCT01007435|156595995|FG003|Overall Study|Failure to Return|6|||
48656585|NCT01007435|156595992|FG000|Overall Study|Reason not Specified|1|||
48656586|NCT01007435|156595993|FG001|Overall Study|Reason not Specified|1|||
48656587|NCT01007435|156595994|FG002|Overall Study|Reason not Specified|2|||
48656588|NCT01007435|156595995|FG003|Overall Study|Reason not Specified|1|||
48656589|NCT01734395|156595996|FG000|Overall Study|Other|65|||
48656590|NCT01734395|156595996|FG000|Overall Study|Lost to Follow-up|287|||
48656591|NCT01734395|156595996|FG000|Overall Study|Lack of Efficacy|5|||
48656592|NCT01734395|156595996|FG000|Overall Study|Adverse Event|40|||
48656593|NCT01734395|156595996|FG000|Overall Study|Withdrawal by Subject|10|||
48656594|NCT01734395|156595996|FG000|Overall Study|Missing the reasons for not completed|3|||
48656595|NCT01190475|156595999|FG000|Overall Study|Withdrawal by Subject|0|||
48656596|NCT01190475|156596000|FG001|Overall Study|Withdrawal by Subject|0|||
48656597|NCT01190475|156596001|FG002|Overall Study|Withdrawal by Subject|1|||
48656598|NCT00624585|156596002|FG000|Overall Study|Death|3|||
48656599|NCT00624585|156596002|FG000|Overall Study|Disease Progression|6|||
48656600|NCT00624585|156596002|FG000|Overall Study|Adverse Event|3|||
48656601|NCT00113399|156596008|FG000|Overall Study|Death|1|||
48656602|NCT00113399|156596009|FG001|Overall Study|Death|1|||
48656603|NCT00113399|156596008|FG000|Overall Study|Withdrawal by Subject|1|||
48656604|NCT00113399|156596009|FG001|Overall Study|Withdrawal by Subject|2|||
48336026|NCT02305797|155426975|FG000|Overall Study|Reason not collected|0|||
48656605|NCT00113399|156596008|FG000|Overall Study|Complete Response|0|||
48656606|NCT00113399|156596009|FG001|Overall Study|Complete Response|1|||
48656607|NCT00113399|156596008|FG000|Overall Study|Other|0|||
48656608|NCT00113399|156596009|FG001|Overall Study|Other|1|||
48656609|NCT00396136|156596010|FG000|Overall Study|Death|43|||
48656610|NCT00396136|156596010|FG000|Overall Study|Withdrawal by Subject|59|||
48656611|NCT00396136|156596010|FG000|Overall Study|Lost to Follow-up|15|||
48336027|NCT02305797|155426976|FG001|Overall Study|Reason not collected|1|||
48336028|NCT00422162|155426978|FG000|Overall Study|Adverse Event|11|||
48336029|NCT00422162|155426979|FG001|Overall Study|Adverse Event|9|||
48336030|NCT00422162|155426978|FG000|Overall Study|Lack of Efficacy|4|||
48336031|NCT00422162|155426979|FG001|Overall Study|Lack of Efficacy|10|||
48336032|NCT00422162|155426978|FG000|Overall Study|Withdrawal by Subject|7|||
48336033|NCT00422162|155426979|FG001|Overall Study|Withdrawal by Subject|6|||
48336034|NCT00422162|155426978|FG000|Overall Study|Lost to Follow-up|1|||
48656612|NCT00396136|156596010|FG000|Overall Study|Study device explanted|8|||
48656613|NCT03350256|156596013|FG000|Overall Study|Inclusion/exclusion violation|4|||
48656614|NCT03350256|156596013|FG000|Overall Study|Recommended for other therapies|2|||
48656615|NCT03350256|156596013|FG000|Overall Study|Protocol Violation|3|||
48656616|NCT03350256|156596013|FG000|Overall Study|Non compliance|2|||
48656617|NCT03350256|156596013|FG000|Overall Study|Denial by insurance|1|||
48656618|NCT03350256|156596013|FG000|Overall Study|Adverse Event|2|||
48656619|NCT03350256|156596013|FG000|Overall Study|Trial failure|12|||
48656620|NCT03350256|156596013|FG000|Overall Study|Did not proceed to permanent implant|3|||
48656621|NCT03350256|156596013|FG000|Overall Study|Withdrawal by Subject|3|||
48656622|NCT03350256|156596013|FG000|Overall Study|Subject moving out of state|1|||
48656623|NCT03350256|156596013|FG000|Overall Study|Lost to Follow-up|1|||
48656624|NCT03350256|156596013|FG000|Overall Study|Lack of Efficacy|2|||
48656625|NCT01425359|156596014|FG000|Overall Study|Randomized but Not Treated|2|||
48656626|NCT01425359|156596015|FG001|Overall Study|Randomized but Not Treated|3|||
48656627|NCT01425359|156596014|FG000|Overall Study|Adverse Event|9|||
48656628|NCT01425359|156596015|FG001|Overall Study|Adverse Event|8|||
48656629|NCT01425359|156596014|FG000|Overall Study|Revascularization|0|||
48656630|NCT01425359|156596015|FG001|Overall Study|Revascularization|1|||
48656631|NCT01425359|156596014|FG000|Overall Study|Death|0|||
48656632|NCT01425359|156596015|FG001|Overall Study|Death|1|||
48656633|NCT01425359|156596014|FG000|Overall Study|Unsatisfactory Response|1|||
48656634|NCT01425359|156596015|FG001|Overall Study|Unsatisfactory Response|0|||
48656635|NCT01425359|156596014|FG000|Overall Study|Protocol Violation|1|||
48656636|NCT01425359|156596015|FG001|Overall Study|Protocol Violation|2|||
48656637|NCT01425359|156596014|FG000|Overall Study|Subject Withdrew Consent|1|||
48656638|NCT01425359|156596015|FG001|Overall Study|Subject Withdrew Consent|2|||
48656639|NCT01425359|156596014|FG000|Overall Study|Investigator's Discretion|2|||
48656640|NCT01425359|156596015|FG001|Overall Study|Investigator's Discretion|0|||
48656641|NCT01425359|156596014|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
48656642|NCT01425359|156596015|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
48656643|NCT03172325|156596018|FG000|Overall Study|Adverse Event|2|||
48656644|NCT03172325|156596019|FG001|Overall Study|Adverse Event|3|||
48656645|NCT03172325|156596018|FG000|Overall Study|Positive PPD|1|||
48656646|NCT03172325|156596019|FG001|Overall Study|Positive PPD|0|||
48656647|NCT03172325|156596018|FG000|Overall Study|Poor Compliance|1|||
48656648|NCT03172325|156596019|FG001|Overall Study|Poor Compliance|1|||
48656649|NCT04043234|156596020|FG000|Overall Study|Lost to Follow-up|1|||
48656650|NCT04043234|156596020|FG000|Overall Study|Withdrawal by Subject|1|||
48656651|NCT02135029|156596021|FG000|Overall Study|Adverse Event|2|||
48656652|NCT02135029|156596022|FG001|Overall Study|Adverse Event|2|||
48656653|NCT02135029|156596023|FG002|Overall Study|Adverse Event|2|||
48656654|NCT02135029|156596021|FG000|Overall Study|Lost to Follow-up|0|||
48656655|NCT02135029|156596022|FG001|Overall Study|Lost to Follow-up|1|||
48656656|NCT02135029|156596023|FG002|Overall Study|Lost to Follow-up|0|||
48656657|NCT02135029|156596021|FG000|Overall Study|Withdrawal by Subject|2|||
48656658|NCT02135029|156596022|FG001|Overall Study|Withdrawal by Subject|0|||
48656659|NCT02135029|156596023|FG002|Overall Study|Withdrawal by Subject|1|||
48656660|NCT02135029|156596021|FG000|Overall Study|Other|0|||
48656661|NCT02135029|156596022|FG001|Overall Study|Other|1|||
48656662|NCT02135029|156596023|FG002|Overall Study|Other|0|||
48656663|NCT02135029|156596021|FG000|Overall Study|Death|0|||
48656664|NCT02135029|156596022|FG001|Overall Study|Death|1|||
48656665|NCT02135029|156596023|FG002|Overall Study|Death|0|||
48656666|NCT00503776|156596026|FG000|Overall Study|Withdrawal by Subject|1|||
48656667|NCT00503776|156596027|FG001|Overall Study|Withdrawal by Subject|0|||
48656668|NCT00503776|156596028|FG002|Overall Study|Withdrawal by Subject|1|||
48656669|NCT00503776|156596029|FG003|Overall Study|Withdrawal by Subject|1|||
48656670|NCT00503776|156596026|FG000|Overall Study|Physician Decision|0|||
48656671|NCT00503776|156596027|FG001|Overall Study|Physician Decision|0|||
48656672|NCT00503776|156596028|FG002|Overall Study|Physician Decision|1|||
48656673|NCT00503776|156596029|FG003|Overall Study|Physician Decision|1|||
48656674|NCT02778555|156596030|FG000|Overall Study|Withdrawal by Subject|55|||
48656675|NCT02778555|156596031|FG001|Overall Study|Withdrawal by Subject|32|||
48656676|NCT02778555|156596032|FG002|Overall Study|Withdrawal by Subject|107|||
48656677|NCT03403361|156596033|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
48656678|NCT00107315|156596034|FG000|Overall Study|Disease Progression|9|||
48656679|NCT00107315|156596034|FG000|Overall Study|Adverse Event|4|||
48656680|NCT00107315|156596034|FG000|Overall Study|Withdrawal by Subject|2|||
48656681|NCT02901054|156596037|FG000|Overall Study|Physician Decision|1|||
48656682|NCT02901054|156596037|FG000|Overall Study|Withdrawal by Subject|3|||
48656683|NCT03006848|156596040|FG000|Overall Study|Adverse Event|1|||
48656684|NCT03006848|156596040|FG000|Overall Study|Physician Decision|1|||
48656685|NCT03006848|156596040|FG000|Overall Study|Lack of Efficacy|16|||
48656686|NCT00541866|156596041|FG000|Overall Study|Adverse Event|3|||
48656687|NCT00541866|156596042|FG001|Overall Study|Adverse Event|0|||
48656688|NCT00541866|156596043|FG002|Overall Study|Adverse Event|0|||
48656689|NCT00541866|156596044|FG003|Overall Study|Adverse Event|0|||
48656690|NCT00541866|156596045|FG004|Overall Study|Adverse Event|0|||
48656691|NCT00541866|156596041|FG000|Overall Study|Death|1|||
48656692|NCT00541866|156596042|FG001|Overall Study|Death|0|||
48656693|NCT00541866|156596043|FG002|Overall Study|Death|0|||
48656694|NCT00541866|156596044|FG003|Overall Study|Death|0|||
48656695|NCT00541866|156596045|FG004|Overall Study|Death|0|||
48656696|NCT00541866|156596041|FG000|Overall Study|Lack of Efficacy|19|||
48656697|NCT00541866|156596042|FG001|Overall Study|Lack of Efficacy|15|||
48656698|NCT00541866|156596043|FG002|Overall Study|Lack of Efficacy|10|||
48656699|NCT00541866|156596044|FG003|Overall Study|Lack of Efficacy|12|||
48656700|NCT00541866|156596045|FG004|Overall Study|Lack of Efficacy|14|||
48656701|NCT00541866|156596041|FG000|Overall Study|Not Reported or Other|11|||
48656702|NCT00541866|156596042|FG001|Overall Study|Not Reported or Other|3|||
48656703|NCT00541866|156596043|FG002|Overall Study|Not Reported or Other|3|||
48656704|NCT00541866|156596044|FG003|Overall Study|Not Reported or Other|3|||
48656705|NCT00541866|156596045|FG004|Overall Study|Not Reported or Other|1|||
48656706|NCT00541866|156596041|FG000|Overall Study|Physician Decision|0|||
48656707|NCT00541866|156596042|FG001|Overall Study|Physician Decision|0|||
48656708|NCT00541866|156596043|FG002|Overall Study|Physician Decision|2|||
48656709|NCT00541866|156596044|FG003|Overall Study|Physician Decision|1|||
48656710|NCT00541866|156596045|FG004|Overall Study|Physician Decision|0|||
48656711|NCT00522418|156596046|FG000|Overall Study|Local IRB Consent Violation|5|||
48656712|NCT00522418|156596047|FG001|Overall Study|Local IRB Consent Violation|5|||
48656713|NCT00522418|156596046|FG000|Overall Study|Early Study Termination|46|||
48656714|NCT00522418|156596047|FG001|Overall Study|Early Study Termination|47|||
48656715|NCT00522418|156596046|FG000|Overall Study|Noncompliance|2|||
48656716|NCT00522418|156596047|FG001|Overall Study|Noncompliance|2|||
48656717|NCT00522418|156596046|FG000|Overall Study|Reason Not Specified|3|||
48656718|NCT00522418|156596047|FG001|Overall Study|Reason Not Specified|1|||
48656719|NCT00522418|156596046|FG000|Overall Study|Consent Withdraw|1|||
48656720|NCT00522418|156596047|FG001|Overall Study|Consent Withdraw|2|||
48656721|NCT00522418|156596046|FG000|Overall Study|Lack of Efficacy|0|||
48656722|NCT00522418|156596047|FG001|Overall Study|Lack of Efficacy|1|||
48656723|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
48656724|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
48656725|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Death|0|||
48656726|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Death|0|||
48656727|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
48656728|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
48656729|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
48656730|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
48656731|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
48656732|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
48656733|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
48656734|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
48656735|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
48656736|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
48336035|NCT00422162|155426979|FG001|Overall Study|Lost to Follow-up|2|||
48656737|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
48656738|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
48656739|NCT00433160|156596052|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
48656740|NCT00433160|156596053|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
48656741|NCT00433160|156596052|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
48656742|NCT00433160|156596053|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
48656743|NCT00433160|156596052|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
48656744|NCT00433160|156596053|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
48656745|NCT00433160|156596052|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
48656746|NCT00433160|156596053|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
48656747|NCT00433160|156596052|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
48656748|NCT00433160|156596053|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
48656749|NCT00433160|156596052|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
48656750|NCT00433160|156596053|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
48656751|NCT00433160|156596052|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
48656752|NCT00433160|156596053|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
48656753|NCT00433160|156596052|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
48656754|NCT00433160|156596053|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
48656755|NCT00075725|156596054|FG000|Overall Study|Adverse Event|6|||
48656756|NCT00075725|156596055|FG001|Overall Study|Adverse Event|6|||
48656757|NCT00075725|156596056|FG002|Overall Study|Adverse Event|20|||
48656758|NCT00075725|156596057|FG003|Overall Study|Adverse Event|8|||
48656759|NCT00075725|156596058|FG004|Overall Study|Adverse Event|4|||
48656760|NCT00075725|156596059|FG005|Overall Study|Adverse Event|38|||
48656761|NCT00075725|156596060|FG006|Overall Study|Adverse Event|3|||
48656762|NCT00075725|156596061|FG007|Overall Study|Adverse Event|51|||
48656763|NCT00075725|156596062|FG008|Overall Study|Adverse Event|15|||
48656764|NCT00075725|156596063|FG009|Overall Study|Adverse Event|4|||
48656765|NCT00075725|156596064|FG010|Overall Study|Adverse Event|2|||
48656766|NCT00075725|156596065|FG011|Overall Study|Adverse Event|2|||
48656767|NCT00075725|156596054|FG000|Overall Study|Death|3|||
48656768|NCT00075725|156596055|FG001|Overall Study|Death|5|||
48656769|NCT00075725|156596056|FG002|Overall Study|Death|10|||
48656770|NCT00075725|156596057|FG003|Overall Study|Death|2|||
48656771|NCT00075725|156596058|FG004|Overall Study|Death|3|||
48656772|NCT00075725|156596059|FG005|Overall Study|Death|25|||
48656773|NCT00075725|156596060|FG006|Overall Study|Death|4|||
48656774|NCT00075725|156596061|FG007|Overall Study|Death|22|||
48656775|NCT00075725|156596062|FG008|Overall Study|Death|14|||
48336036|NCT00422162|155426978|FG000|Overall Study|Non-Compliant with Protocol|1|||
48656776|NCT00075725|156596063|FG009|Overall Study|Death|4|||
48656777|NCT00075725|156596064|FG010|Overall Study|Death|3|||
48656778|NCT00075725|156596065|FG011|Overall Study|Death|0|||
48656779|NCT00075725|156596054|FG000|Overall Study|Lost to Follow-up|1|||
48656780|NCT00075725|156596055|FG001|Overall Study|Lost to Follow-up|1|||
48336037|NCT00422162|155426979|FG001|Overall Study|Non-Compliant with Protocol|1|||
48656781|NCT00075725|156596056|FG002|Overall Study|Lost to Follow-up|4|||
48656782|NCT00075725|156596057|FG003|Overall Study|Lost to Follow-up|1|||
48656783|NCT00075725|156596058|FG004|Overall Study|Lost to Follow-up|0|||
48656784|NCT00075725|156596059|FG005|Overall Study|Lost to Follow-up|13|||
48656785|NCT00075725|156596060|FG006|Overall Study|Lost to Follow-up|2|||
48656786|NCT00075725|156596061|FG007|Overall Study|Lost to Follow-up|4|||
48656787|NCT00075725|156596062|FG008|Overall Study|Lost to Follow-up|1|||
48656788|NCT00075725|156596063|FG009|Overall Study|Lost to Follow-up|0|||
48656789|NCT00075725|156596064|FG010|Overall Study|Lost to Follow-up|0|||
48656790|NCT00075725|156596065|FG011|Overall Study|Lost to Follow-up|0|||
48656791|NCT00075725|156596054|FG000|Overall Study|Physician Decision|2|||
48656792|NCT00075725|156596055|FG001|Overall Study|Physician Decision|6|||
48656793|NCT00075725|156596056|FG002|Overall Study|Physician Decision|5|||
48656794|NCT00075725|156596057|FG003|Overall Study|Physician Decision|8|||
48656795|NCT00075725|156596058|FG004|Overall Study|Physician Decision|4|||
48656796|NCT00075725|156596059|FG005|Overall Study|Physician Decision|19|||
48656797|NCT00075725|156596060|FG006|Overall Study|Physician Decision|3|||
48656798|NCT00075725|156596061|FG007|Overall Study|Physician Decision|17|||
48656799|NCT00075725|156596062|FG008|Overall Study|Physician Decision|5|||
48656800|NCT00075725|156596063|FG009|Overall Study|Physician Decision|0|||
48656801|NCT00075725|156596064|FG010|Overall Study|Physician Decision|1|||
48656802|NCT00075725|156596065|FG011|Overall Study|Physician Decision|0|||
48656803|NCT00075725|156596054|FG000|Overall Study|Pregnancy|0|||
48656804|NCT00075725|156596055|FG001|Overall Study|Pregnancy|0|||
48656805|NCT00075725|156596056|FG002|Overall Study|Pregnancy|0|||
48656806|NCT00075725|156596057|FG003|Overall Study|Pregnancy|0|||
48656807|NCT00075725|156596058|FG004|Overall Study|Pregnancy|0|||
48656808|NCT00075725|156596059|FG005|Overall Study|Pregnancy|1|||
48656809|NCT00075725|156596060|FG006|Overall Study|Pregnancy|0|||
48754715|NCT03965962|156948156|FG001|Overall Study|Lost to Follow-up|1|||
48656810|NCT00075725|156596061|FG007|Overall Study|Pregnancy|1|||
48754716|NCT03965962|156948157|FG002|Overall Study|Lost to Follow-up|0|||
48754717|NCT03965962|156948158|FG003|Overall Study|Lost to Follow-up|0|||
48754718|NCT03965962|156948155|FG000|Overall Study|Withdrawal by Subject|3|||
48754719|NCT03965962|156948156|FG001|Overall Study|Withdrawal by Subject|0|||
48754720|NCT03965962|156948157|FG002|Overall Study|Withdrawal by Subject|0|||
48754721|NCT03965962|156948158|FG003|Overall Study|Withdrawal by Subject|1|||
48754722|NCT04285879|156948160|FG000|Overall Study|Lost to Follow-up|1|||
48754723|NCT04285879|156948161|FG001|Overall Study|Lost to Follow-up|8|||
48754724|NCT04285879|156948160|FG000|Overall Study|medical/surgical exclusion|16|||
48754725|NCT04285879|156948161|FG001|Overall Study|medical/surgical exclusion|0|||
48754726|NCT04900220|156948162|FG000|Overall Study|Lost to Follow-up|1|||
48336038|NCT00422162|155426978|FG000|Overall Study|Other|0|||
48336039|NCT00422162|155426979|FG001|Overall Study|Other|1|||
48336040|NCT00422162|155426978|FG000|Overall Study|Didn't Receive Treatment|0|||
48336041|NCT00422162|155426979|FG001|Overall Study|Didn't Receive Treatment|1|||
48336042|NCT02959866|155426980|FG000|Overall Study|Withdrawal by Subject|1|||
48336043|NCT03529942|155426981|FG000|Overall Study|Withdrawal by Subject|13|||
48336044|NCT03529942|155426981|FG000|Overall Study|Physician Decision|1|||
48336045|NCT03529942|155426981|FG000|Overall Study|Lost to Follow-up|7|||
48336046|NCT03529942|155426981|FG000|Overall Study|Needle inserted but no drug administered|1|||
48336047|NCT03529942|155426981|FG000|Overall Study|Personal reasons|1|||
48336048|NCT03647709|155426985|FG000|Overall Study|Lost to Follow-up|5|||
48336049|NCT03647709|155426985|FG000|Overall Study|Physician Decision|6|||
48336050|NCT03647709|155426985|FG000|Overall Study|Withdrawal by Subject|3|||
48656811|NCT00075725|156596062|FG008|Overall Study|Pregnancy|0|||
48656812|NCT00075725|156596063|FG009|Overall Study|Pregnancy|0|||
48656813|NCT00075725|156596064|FG010|Overall Study|Pregnancy|0|||
48656814|NCT00075725|156596065|FG011|Overall Study|Pregnancy|0|||
48656815|NCT00075725|156596054|FG000|Overall Study|Protocol Violation|1|||
48656816|NCT00075725|156596055|FG001|Overall Study|Protocol Violation|1|||
48656817|NCT00075725|156596056|FG002|Overall Study|Protocol Violation|0|||
48656818|NCT00075725|156596057|FG003|Overall Study|Protocol Violation|3|||
48656819|NCT00075725|156596058|FG004|Overall Study|Protocol Violation|3|||
48656820|NCT00075725|156596059|FG005|Overall Study|Protocol Violation|2|||
48656821|NCT00075725|156596060|FG006|Overall Study|Protocol Violation|1|||
48656822|NCT00075725|156596061|FG007|Overall Study|Protocol Violation|2|||
48656823|NCT00075725|156596062|FG008|Overall Study|Protocol Violation|3|||
48656824|NCT00075725|156596063|FG009|Overall Study|Protocol Violation|0|||
48656825|NCT00075725|156596064|FG010|Overall Study|Protocol Violation|0|||
48656826|NCT00075725|156596065|FG011|Overall Study|Protocol Violation|1|||
48336051|NCT03839355|155426986|FG000|Overall Study|Withdrawal by Subject|1|||
48656827|NCT00075725|156596054|FG000|Overall Study|Withdrawal by Subject|12|||
48656828|NCT00075725|156596055|FG001|Overall Study|Withdrawal by Subject|3|||
48656829|NCT00075725|156596056|FG002|Overall Study|Withdrawal by Subject|6|||
48336052|NCT03839355|155426987|FG001|Overall Study|Withdrawal by Subject|0|||
48336053|NCT01075815|155426995|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
48336054|NCT01075815|155426996|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
48656830|NCT00075725|156596057|FG003|Overall Study|Withdrawal by Subject|10|||
48656831|NCT00075725|156596058|FG004|Overall Study|Withdrawal by Subject|6|||
48656832|NCT00075725|156596059|FG005|Overall Study|Withdrawal by Subject|27|||
48656833|NCT00075725|156596060|FG006|Overall Study|Withdrawal by Subject|7|||
48656834|NCT00075725|156596061|FG007|Overall Study|Withdrawal by Subject|31|||
48656835|NCT00075725|156596062|FG008|Overall Study|Withdrawal by Subject|10|||
48656836|NCT00075725|156596063|FG009|Overall Study|Withdrawal by Subject|2|||
48754727|NCT04900220|156948163|FG001|Overall Study|Lost to Follow-up|1|||
48754728|NCT00877383|156948170|FG000|Overall Study|Adverse Event|13|||
48656837|NCT00075725|156596064|FG010|Overall Study|Withdrawal by Subject|0|||
48656838|NCT00075725|156596065|FG011|Overall Study|Withdrawal by Subject|0|||
48336055|NCT01075815|155426995|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
48336056|NCT01075815|155426996|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
48656839|NCT00075725|156596054|FG000|Overall Study|Disease Progression, all other reasons|17|||
48656840|NCT00075725|156596055|FG001|Overall Study|Disease Progression, all other reasons|5|||
48656841|NCT00075725|156596056|FG002|Overall Study|Disease Progression, all other reasons|33|||
48656842|NCT00075725|156596057|FG003|Overall Study|Disease Progression, all other reasons|6|||
48656843|NCT00075725|156596058|FG004|Overall Study|Disease Progression, all other reasons|21|||
48656844|NCT00075725|156596059|FG005|Overall Study|Disease Progression, all other reasons|59|||
48656845|NCT00075725|156596060|FG006|Overall Study|Disease Progression, all other reasons|20|||
48656846|NCT00075725|156596061|FG007|Overall Study|Disease Progression, all other reasons|46|||
48656847|NCT00075725|156596062|FG008|Overall Study|Disease Progression, all other reasons|21|||
48656848|NCT00075725|156596063|FG009|Overall Study|Disease Progression, all other reasons|4|||
48656849|NCT00075725|156596064|FG010|Overall Study|Disease Progression, all other reasons|0|||
48656850|NCT00075725|156596065|FG011|Overall Study|Disease Progression, all other reasons|5|||
48656851|NCT00075725|156596054|FG000|Overall Study|Patient off treatment|0|||
48656852|NCT00075725|156596055|FG001|Overall Study|Patient off treatment|0|||
48656853|NCT00075725|156596056|FG002|Overall Study|Patient off treatment|1|||
48656854|NCT00075725|156596057|FG003|Overall Study|Patient off treatment|2|||
48656855|NCT00075725|156596058|FG004|Overall Study|Patient off treatment|1|||
48656856|NCT00075725|156596059|FG005|Overall Study|Patient off treatment|0|||
48656857|NCT00075725|156596060|FG006|Overall Study|Patient off treatment|0|||
48656858|NCT00075725|156596061|FG007|Overall Study|Patient off treatment|2|||
48656859|NCT00075725|156596062|FG008|Overall Study|Patient off treatment|1|||
48656860|NCT00075725|156596063|FG009|Overall Study|Patient off treatment|0|||
48656861|NCT00075725|156596064|FG010|Overall Study|Patient off treatment|0|||
48656862|NCT00075725|156596065|FG011|Overall Study|Patient off treatment|0|||
48656863|NCT00075725|156596054|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
48656864|NCT00075725|156596055|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
48656865|NCT00075725|156596056|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
48656866|NCT00075725|156596057|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
48656867|NCT00075725|156596058|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
48656868|NCT00075725|156596059|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
48656869|NCT00075725|156596060|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
48656870|NCT00075725|156596061|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
48656871|NCT00075725|156596062|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
48656872|NCT00075725|156596063|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
48656873|NCT00075725|156596064|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
48656874|NCT00075725|156596065|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
48656875|NCT00075725|156596054|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
48656876|NCT00075725|156596055|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
48656877|NCT00075725|156596056|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
48656878|NCT00075725|156596057|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
48656879|NCT00075725|156596058|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
48656880|NCT00075725|156596059|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
48656881|NCT00075725|156596060|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
48656882|NCT00075725|156596061|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
48656883|NCT00075725|156596062|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
48656884|NCT00075725|156596063|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
48656885|NCT00075725|156596064|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
48656886|NCT00075725|156596065|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
48656887|NCT00075725|156596054|FG000|Overall Study|Pt non compliant with therapy|2|||
48656888|NCT00075725|156596055|FG001|Overall Study|Pt non compliant with therapy|1|||
48656889|NCT00075725|156596056|FG002|Overall Study|Pt non compliant with therapy|1|||
48656890|NCT00075725|156596057|FG003|Overall Study|Pt non compliant with therapy|0|||
48656891|NCT00075725|156596058|FG004|Overall Study|Pt non compliant with therapy|2|||
48656892|NCT00075725|156596059|FG005|Overall Study|Pt non compliant with therapy|14|||
48656893|NCT00075725|156596060|FG006|Overall Study|Pt non compliant with therapy|2|||
48656894|NCT00075725|156596061|FG007|Overall Study|Pt non compliant with therapy|5|||
48336057|NCT01075815|155426995|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
48656895|NCT00075725|156596062|FG008|Overall Study|Pt non compliant with therapy|3|||
48656896|NCT00075725|156596063|FG009|Overall Study|Pt non compliant with therapy|0|||
48656897|NCT00075725|156596064|FG010|Overall Study|Pt non compliant with therapy|0|||
48656898|NCT00075725|156596065|FG011|Overall Study|Pt non compliant with therapy|0|||
48656899|NCT00075725|156596054|FG000|Overall Study|Pt age out of range for treatment|0|||
48656900|NCT00075725|156596055|FG001|Overall Study|Pt age out of range for treatment|1|||
48656901|NCT00075725|156596056|FG002|Overall Study|Pt age out of range for treatment|0|||
48656902|NCT00075725|156596057|FG003|Overall Study|Pt age out of range for treatment|0|||
48656903|NCT00075725|156596058|FG004|Overall Study|Pt age out of range for treatment|0|||
48754729|NCT00877383|156948171|FG001|Overall Study|Adverse Event|14|||
48754730|NCT00877383|156948170|FG000|Overall Study|Lost to Follow-up|5|||
48754731|NCT00877383|156948171|FG001|Overall Study|Lost to Follow-up|3|||
48754732|NCT00877383|156948170|FG000|Overall Study|Subject withdrew consent|3|||
48754733|NCT00877383|156948171|FG001|Overall Study|Subject withdrew consent|12|||
48754734|NCT00877383|156948170|FG000|Overall Study|Subject no longer requires study drug|2|||
48754735|NCT00877383|156948171|FG001|Overall Study|Subject no longer requires study drug|0|||
48754736|NCT00877383|156948170|FG000|Overall Study|Administrative problems|2|||
48754737|NCT00877383|156948171|FG001|Overall Study|Administrative problems|0|||
48656904|NCT00075725|156596059|FG005|Overall Study|Pt age out of range for treatment|1|||
48656905|NCT00075725|156596060|FG006|Overall Study|Pt age out of range for treatment|0|||
48656906|NCT00075725|156596061|FG007|Overall Study|Pt age out of range for treatment|1|||
48656907|NCT00075725|156596062|FG008|Overall Study|Pt age out of range for treatment|0|||
48656908|NCT00075725|156596063|FG009|Overall Study|Pt age out of range for treatment|0|||
48656909|NCT00075725|156596064|FG010|Overall Study|Pt age out of range for treatment|0|||
48656910|NCT00075725|156596065|FG011|Overall Study|Pt age out of range for treatment|0|||
48656911|NCT00075725|156596054|FG000|Overall Study|Insurance issues|0|||
48656912|NCT00075725|156596055|FG001|Overall Study|Insurance issues|1|||
48656913|NCT00075725|156596056|FG002|Overall Study|Insurance issues|0|||
48656914|NCT00075725|156596057|FG003|Overall Study|Insurance issues|1|||
48656915|NCT00075725|156596058|FG004|Overall Study|Insurance issues|1|||
48656916|NCT00075725|156596059|FG005|Overall Study|Insurance issues|1|||
48656917|NCT00075725|156596060|FG006|Overall Study|Insurance issues|0|||
48754738|NCT00877383|156948170|FG000|Overall Study|Protocol deviation|2|||
48754739|NCT00877383|156948171|FG001|Overall Study|Protocol deviation|6|||
48754740|NCT00877383|156948170|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48754741|NCT00877383|156948171|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48754742|NCT00877383|156948170|FG000|Overall Study|Death|1|||
48754743|NCT00877383|156948171|FG001|Overall Study|Death|2|||
48754744|NCT03211416|156948172|FG000|Overall Study|Adverse Event|7|||
48754745|NCT03211416|156948172|FG000|Overall Study|Lack of Efficacy|2|||
48754746|NCT03211416|156948172|FG000|Overall Study|Physician Decision|1|||
48754747|NCT02669433|156948175|FG000|Overall Study|Protocol Violation|0|||
48754748|NCT02669433|156948176|FG001|Overall Study|Protocol Violation|4|||
48754749|NCT02669433|156948177|FG002|Overall Study|Protocol Violation|1|||
48754750|NCT02669433|156948175|FG000|Overall Study|Disease Progression|1|||
48754751|NCT02669433|156948176|FG001|Overall Study|Disease Progression|0|||
48754752|NCT02669433|156948177|FG002|Overall Study|Disease Progression|0|||
48754753|NCT02669433|156948175|FG000|Overall Study|Physician Decision|1|||
48656918|NCT00075725|156596061|FG007|Overall Study|Insurance issues|1|||
48754754|NCT02669433|156948176|FG001|Overall Study|Physician Decision|1|||
48754755|NCT02669433|156948177|FG002|Overall Study|Physician Decision|0|||
48754756|NCT02669433|156948175|FG000|Overall Study|Adverse Event|6|||
48754757|NCT02669433|156948176|FG001|Overall Study|Adverse Event|7|||
48656919|NCT00075725|156596062|FG008|Overall Study|Insurance issues|0|||
48656920|NCT00075725|156596063|FG009|Overall Study|Insurance issues|0|||
48656921|NCT00075725|156596064|FG010|Overall Study|Insurance issues|0|||
48656922|NCT00075725|156596065|FG011|Overall Study|Insurance issues|0|||
48656923|NCT00075725|156596054|FG000|Overall Study|MRD positive after extended ind|0|||
48656924|NCT00075725|156596055|FG001|Overall Study|MRD positive after extended ind|1|||
48754758|NCT02669433|156948177|FG002|Overall Study|Adverse Event|10|||
48754759|NCT02669433|156948175|FG000|Overall Study|Sponsor Termination|1|||
48754760|NCT02669433|156948176|FG001|Overall Study|Sponsor Termination|0|||
48754761|NCT02669433|156948177|FG002|Overall Study|Sponsor Termination|1|||
48754762|NCT02669433|156948175|FG000|Overall Study|Withdrawal by Subject|5|||
48754763|NCT02669433|156948176|FG001|Overall Study|Withdrawal by Subject|1|||
48754764|NCT02669433|156948177|FG002|Overall Study|Withdrawal by Subject|0|||
48656925|NCT00075725|156596056|FG002|Overall Study|MRD positive after extended ind|1|||
48656926|NCT00075725|156596057|FG003|Overall Study|MRD positive after extended ind|0|||
48656927|NCT00075725|156596058|FG004|Overall Study|MRD positive after extended ind|1|||
48656928|NCT00075725|156596059|FG005|Overall Study|MRD positive after extended ind|2|||
48656929|NCT00075725|156596060|FG006|Overall Study|MRD positive after extended ind|0|||
48656930|NCT00075725|156596061|FG007|Overall Study|MRD positive after extended ind|1|||
48656931|NCT00075725|156596062|FG008|Overall Study|MRD positive after extended ind|0|||
48754765|NCT02669433|156948175|FG000|Overall Study|Withdrawal by Caregiver|1|||
48754766|NCT02669433|156948176|FG001|Overall Study|Withdrawal by Caregiver|0|||
48754767|NCT02669433|156948177|FG002|Overall Study|Withdrawal by Caregiver|2|||
48656932|NCT00075725|156596063|FG009|Overall Study|MRD positive after extended ind|0|||
48754768|NCT02669433|156948175|FG000|Overall Study|Death|0|||
48754769|NCT02669433|156948176|FG001|Overall Study|Death|1|||
48754770|NCT02669433|156948177|FG002|Overall Study|Death|1|||
48754771|NCT01170091|156948178|FG000|Overall Study|Missing efficacy evaluation|3|||
48754772|NCT01170091|156948178|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
48656933|NCT00075725|156596064|FG010|Overall Study|MRD positive after extended ind|0|||
48754773|NCT03128892|156948179|FG000|Overall Study|Withdrawal by Subject|2|||
48336058|NCT01075815|155426996|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
48336059|NCT01699178|155426997|FG000|Overall Study|Adverse Event|1|||
48336060|NCT01699178|155426998|FG001|Overall Study|Adverse Event|5|||
48336061|NCT01699178|155426997|FG000|Overall Study|Lost to Follow-up|1|||
48336062|NCT01699178|155426998|FG001|Overall Study|Lost to Follow-up|6|||
48336063|NCT01699178|155426997|FG000|Overall Study|Non-compliance with Study Drug|3|||
48336064|NCT01699178|155426998|FG001|Overall Study|Non-compliance with Study Drug|1|||
48336065|NCT01699178|155426997|FG000|Overall Study|Physician Decision|1|||
48336066|NCT01699178|155426998|FG001|Overall Study|Physician Decision|0|||
48336067|NCT01699178|155426997|FG000|Overall Study|Withdrawal by Subject|4|||
48336068|NCT01699178|155426998|FG001|Overall Study|Withdrawal by Subject|12|||
48336069|NCT01699178|155426997|FG000|Overall Study|Hematocrit >54%|1|||
48336070|NCT01699178|155426998|FG001|Overall Study|Hematocrit >54%|1|||
48336071|NCT01699178|155426997|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
48336072|NCT01699178|155426998|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
48336073|NCT01699178|155426997|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
48336074|NCT01699178|155426998|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
48336075|NCT01261793|155426999|FG000|Overall Study|Lack of Efficacy|44|||
48336076|NCT01261793|155427000|FG001|Overall Study|Lack of Efficacy|37|||
48336077|NCT01261793|155427001|FG002|Overall Study|Lack of Efficacy|32|||
48336078|NCT01261793|155426999|FG000|Overall Study|Protocol Violation|3|||
48656934|NCT00075725|156596065|FG011|Overall Study|MRD positive after extended ind|0|||
48656935|NCT00075725|156596054|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
48656936|NCT00075725|156596055|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
48656937|NCT00075725|156596056|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
48656938|NCT00075725|156596057|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
48656939|NCT00075725|156596058|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
48656940|NCT00075725|156596059|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
48656941|NCT00075725|156596060|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
48656942|NCT00075725|156596061|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
48656943|NCT00075725|156596062|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
48656944|NCT00075725|156596063|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
48656945|NCT00075725|156596064|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
48656946|NCT00075725|156596065|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
48656947|NCT00075725|156596054|FG000|Overall Study|Inevaluable|1|||
48656948|NCT00075725|156596055|FG001|Overall Study|Inevaluable|1|||
48336079|NCT01261793|155427000|FG001|Overall Study|Protocol Violation|5|||
48336080|NCT01261793|155427001|FG002|Overall Study|Protocol Violation|6|||
48336081|NCT01261793|155426999|FG000|Overall Study|Lost to Follow-up|10|||
48336082|NCT01261793|155427000|FG001|Overall Study|Lost to Follow-up|3|||
48336083|NCT01261793|155427001|FG002|Overall Study|Lost to Follow-up|7|||
48336084|NCT01261793|155426999|FG000|Overall Study|Withdrawal by Subject|12|||
48336085|NCT01261793|155427000|FG001|Overall Study|Withdrawal by Subject|14|||
48336086|NCT01261793|155427001|FG002|Overall Study|Withdrawal by Subject|14|||
48336087|NCT01261793|155426999|FG000|Overall Study|Death|3|||
48336088|NCT01261793|155427000|FG001|Overall Study|Death|1|||
48336089|NCT01261793|155427001|FG002|Overall Study|Death|0|||
48336090|NCT01261793|155426999|FG000|Overall Study|Adverse Event|9|||
48336091|NCT01261793|155427000|FG001|Overall Study|Adverse Event|24|||
48336092|NCT01261793|155427001|FG002|Overall Study|Adverse Event|19|||
48336093|NCT01261793|155426999|FG000|Overall Study|Patient non-availability|1|||
48336094|NCT01261793|155427000|FG001|Overall Study|Patient non-availability|1|||
48336095|NCT01261793|155427001|FG002|Overall Study|Patient non-availability|1|||
48336096|NCT01261793|155426999|FG000|Overall Study|Suspected pregnancy|1|||
48336097|NCT01261793|155427000|FG001|Overall Study|Suspected pregnancy|1|||
48336098|NCT01261793|155427001|FG002|Overall Study|Suspected pregnancy|0|||
48656949|NCT00075725|156596056|FG002|Overall Study|Inevaluable|4|||
48656950|NCT00075725|156596057|FG003|Overall Study|Inevaluable|2|||
48656951|NCT00075725|156596058|FG004|Overall Study|Inevaluable|2|||
48656952|NCT00075725|156596059|FG005|Overall Study|Inevaluable|9|||
48656953|NCT00075725|156596060|FG006|Overall Study|Inevaluable|1|||
48656954|NCT00075725|156596061|FG007|Overall Study|Inevaluable|11|||
48336099|NCT01261793|155426999|FG000|Overall Study|Patient non-compliance|1|||
48336100|NCT01261793|155427000|FG001|Overall Study|Patient non-compliance|0|||
48656955|NCT00075725|156596062|FG008|Overall Study|Inevaluable|2|||
48656956|NCT00075725|156596063|FG009|Overall Study|Inevaluable|0|||
48656957|NCT00075725|156596064|FG010|Overall Study|Inevaluable|1|||
48656958|NCT00075725|156596065|FG011|Overall Study|Inevaluable|0|||
48754774|NCT03128892|156948179|FG000|Overall Study|Physician Decision|1|||
48336101|NCT01261793|155427001|FG002|Overall Study|Patient non-compliance|1|||
48336102|NCT01261793|155426999|FG000|Overall Study|Patient pregnant|1|||
48336103|NCT01261793|155427000|FG001|Overall Study|Patient pregnant|0|||
48336104|NCT01261793|155427001|FG002|Overall Study|Patient pregnant|0|||
48336105|NCT01261793|155426999|FG000|Overall Study|Outside the study area|0|||
48336106|NCT01261793|155427000|FG001|Overall Study|Outside the study area|2|||
48336107|NCT01261793|155427001|FG002|Overall Study|Outside the study area|1|||
48336108|NCT01261793|155426999|FG000|Overall Study|Lack of efficacy & patient not available|0|||
48754775|NCT01524692|156948182|FG000|Overall Study|Withdrawal by Subject|3|||
48754776|NCT00296374|156948184|FG000|Overall Study|Adverse Event|14|||
48754777|NCT00296374|156948185|FG001|Overall Study|Adverse Event|10|||
48754778|NCT00296374|156948186|FG002|Overall Study|Adverse Event|7|||
48336109|NCT01261793|155427000|FG001|Overall Study|Lack of efficacy & patient not available|1|||
48336110|NCT01261793|155427001|FG002|Overall Study|Lack of efficacy & patient not available|0|||
48586532|NCT01167634|156339002|FG003|Overall Study|Withdrawal by Subject|0|||
48586533|NCT00553358|156339003|FG000|Overall Study|Randomized but did not receive treatment|3|||
48586534|NCT00553358|156339004|FG001|Overall Study|Randomized but did not receive treatment|3|||
48586535|NCT00553358|156339005|FG002|Overall Study|Randomized but did not receive treatment|1|||
48586536|NCT00553358|156339003|FG000|Overall Study|Lost to Follow-up|22|||
48586537|NCT00553358|156339004|FG001|Overall Study|Lost to Follow-up|26|||
48586538|NCT00553358|156339005|FG002|Overall Study|Lost to Follow-up|18|||
48336111|NCT01261793|155426999|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
48336112|NCT01261793|155427000|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
48336113|NCT01261793|155427001|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
48336114|NCT01261793|155426999|FG000|Overall Study|Randomization error|0|||
48336115|NCT01261793|155427000|FG001|Overall Study|Randomization error|1|||
48336116|NCT01261793|155427001|FG002|Overall Study|Randomization error|0|||
48336117|NCT01261793|155426999|FG000|Overall Study|Patient unable to start IV line|0|||
48336118|NCT01261793|155427000|FG001|Overall Study|Patient unable to start IV line|0|||
48336119|NCT01261793|155427001|FG002|Overall Study|Patient unable to start IV line|1|||
48336120|NCT01196741|155427002|FG000|Overall Study|Disease progression|34|||
48336121|NCT01196741|155427003|FG001|Overall Study|Disease progression|14|||
48336122|NCT01196741|155427002|FG000|Overall Study|Adverse Event|10|||
48336123|NCT01196741|155427003|FG001|Overall Study|Adverse Event|6|||
48336124|NCT01196741|155427002|FG000|Overall Study|Serious Adverse Event|3|||
48336125|NCT01196741|155427003|FG001|Overall Study|Serious Adverse Event|1|||
48336126|NCT01196741|155427002|FG000|Overall Study|Dose limiting Adverse Event|2|||
48336127|NCT01196741|155427003|FG001|Overall Study|Dose limiting Adverse Event|1|||
48336128|NCT01196741|155427002|FG000|Overall Study|Withdrawal by Subject|3|||
48336129|NCT01196741|155427003|FG001|Overall Study|Withdrawal by Subject|0|||
48336130|NCT01196741|155427002|FG000|Overall Study|Other reason|3|||
48336131|NCT01196741|155427003|FG001|Overall Study|Other reason|3|||
48336132|NCT01196741|155427002|FG000|Overall Study|Other|3|||
48336133|NCT01196741|155427003|FG001|Overall Study|Other|2|||
48586539|NCT00553358|156339003|FG000|Overall Study|Withdrew completely|23|||
48336134|NCT01196741|155427002|FG000|Overall Study|Protocol Violation|2|||
48336135|NCT01196741|155427003|FG001|Overall Study|Protocol Violation|1|||
48336136|NCT01468597|155427004|FG000|Overall Study|Found ineligible|17|||
48336137|NCT01468597|155427004|FG000|Overall Study|concomitant valves|12|||
48586540|NCT00553358|156339004|FG001|Overall Study|Withdrew completely|33|||
48586541|NCT00553358|156339005|FG002|Overall Study|Withdrew completely|34|||
48586542|NCT00553358|156339003|FG000|Overall Study|Died during clinical follow-up|25|||
48586543|NCT00553358|156339004|FG001|Overall Study|Died during clinical follow-up|29|||
48586544|NCT00553358|156339005|FG002|Overall Study|Died during clinical follow-up|32|||
48586545|NCT00553358|156339003|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
48586546|NCT00553358|156339004|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
48586547|NCT00553358|156339005|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
48586548|NCT00553358|156339003|FG000|Overall Study|Died after clinical follow-up ended|1|||
48586549|NCT00553358|156339004|FG001|Overall Study|Died after clinical follow-up ended|2|||
48586550|NCT00553358|156339005|FG002|Overall Study|Died after clinical follow-up ended|0|||
48586551|NCT00553358|156339003|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
48586552|NCT00553358|156339004|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
48586553|NCT00553358|156339005|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
48586554|NCT00438256|156339008|FG000|Overall Study|Ineligible for Resection|2|||
48586555|NCT00438256|156339009|FG001|Overall Study|Ineligible for Resection|1|||
48586556|NCT00438256|156339010|FG002|Overall Study|Ineligible for Resection|1|||
48586557|NCT00438256|156339011|FG003|Overall Study|Ineligible for Resection|7|||
48586558|NCT00438256|156339008|FG000|Overall Study|Excluded final Diagnosis|0|||
48586559|NCT00438256|156339009|FG001|Overall Study|Excluded final Diagnosis|0|||
48586560|NCT00438256|156339010|FG002|Overall Study|Excluded final Diagnosis|0|||
48586561|NCT00438256|156339011|FG003|Overall Study|Excluded final Diagnosis|2|||
48586562|NCT01280682|156339015|FG000|Overall Study|Lost to Follow-up|0|||
48586563|NCT01280682|156339016|FG001|Overall Study|Lost to Follow-up|6|||
48586564|NCT01280682|156339015|FG000|Overall Study|Withdrawal by Subject|0|||
48586565|NCT01280682|156339016|FG001|Overall Study|Withdrawal by Subject|7|||
48586566|NCT02565706|156339025|FG000|Overall Study|Withdrawal by Subject|5|||
48586567|NCT02565706|156339026|FG001|Overall Study|Withdrawal by Subject|7|||
48586568|NCT02565706|156339027|FG002|Overall Study|Withdrawal by Subject|7|||
48586569|NCT02565706|156339028|FG003|Overall Study|Withdrawal by Subject|11|||
48336138|NCT01468597|155427004|FG000|Overall Study|off-pump CABG|1|||
48336139|NCT01468597|155427004|FG000|Overall Study|no platelet function data|5|||
48336140|NCT00603278|155427005|FG000|Overall Study|Lack of Efficacy|35|||
48336141|NCT00603278|155427006|FG001|Overall Study|Lack of Efficacy|10|||
48336142|NCT00603278|155427007|FG002|Overall Study|Lack of Efficacy|11|||
48336143|NCT00603278|155427008|FG003|Overall Study|Lack of Efficacy|8|||
48336144|NCT00603278|155427009|FG004|Overall Study|Lack of Efficacy|7|||
48336145|NCT00603278|155427010|FG005|Overall Study|Lack of Efficacy|14|||
48336146|NCT00603278|155427005|FG000|Overall Study|Adverse Event|0|||
48336147|NCT00603278|155427006|FG001|Overall Study|Adverse Event|3|||
48336148|NCT00603278|155427007|FG002|Overall Study|Adverse Event|1|||
48336149|NCT00603278|155427008|FG003|Overall Study|Adverse Event|0|||
48336150|NCT00603278|155427009|FG004|Overall Study|Adverse Event|2|||
48336151|NCT00603278|155427010|FG005|Overall Study|Adverse Event|1|||
48656959|NCT00075725|156596054|FG000|Overall Study|Other|4|||
48656960|NCT00075725|156596055|FG001|Overall Study|Other|2|||
48656961|NCT00075725|156596056|FG002|Overall Study|Other|1|||
48656962|NCT00075725|156596057|FG003|Overall Study|Other|1|||
48656963|NCT00075725|156596058|FG004|Overall Study|Other|1|||
48656964|NCT00075725|156596059|FG005|Overall Study|Other|4|||
48656965|NCT00075725|156596060|FG006|Overall Study|Other|2|||
48656966|NCT00075725|156596061|FG007|Overall Study|Other|9|||
48656967|NCT00075725|156596062|FG008|Overall Study|Other|2|||
48656968|NCT00075725|156596063|FG009|Overall Study|Other|1|||
48656969|NCT00075725|156596064|FG010|Overall Study|Other|0|||
48656970|NCT00075725|156596065|FG011|Overall Study|Other|3|||
48656971|NCT00075725|156596054|FG000|Overall Study|Pt trying to find a BM donor|0|||
48656972|NCT00075725|156596055|FG001|Overall Study|Pt trying to find a BM donor|1|||
48656973|NCT00075725|156596056|FG002|Overall Study|Pt trying to find a BM donor|0|||
48656974|NCT00075725|156596057|FG003|Overall Study|Pt trying to find a BM donor|0|||
48656975|NCT00075725|156596058|FG004|Overall Study|Pt trying to find a BM donor|0|||
48656976|NCT00075725|156596059|FG005|Overall Study|Pt trying to find a BM donor|0|||
48656977|NCT00075725|156596060|FG006|Overall Study|Pt trying to find a BM donor|0|||
48656978|NCT00075725|156596061|FG007|Overall Study|Pt trying to find a BM donor|0|||
48656979|NCT00075725|156596062|FG008|Overall Study|Pt trying to find a BM donor|0|||
48656980|NCT00075725|156596063|FG009|Overall Study|Pt trying to find a BM donor|0|||
48656981|NCT00075725|156596064|FG010|Overall Study|Pt trying to find a BM donor|0|||
48656982|NCT00075725|156596065|FG011|Overall Study|Pt trying to find a BM donor|0|||
48656983|NCT00075725|156596054|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
48656984|NCT00075725|156596055|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
48656985|NCT00075725|156596056|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
48656986|NCT00075725|156596057|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
48656987|NCT00075725|156596058|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
48656988|NCT00075725|156596059|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
48656989|NCT00075725|156596060|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
48656990|NCT00075725|156596061|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
48656991|NCT00075725|156596062|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
48656992|NCT00075725|156596063|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
48656993|NCT00075725|156596064|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
48656994|NCT00075725|156596065|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
48656995|NCT00075725|156596054|FG000|Overall Study|Unsuccessful institutional transfer|0|||
48656996|NCT00075725|156596055|FG001|Overall Study|Unsuccessful institutional transfer|0|||
48656997|NCT00075725|156596056|FG002|Overall Study|Unsuccessful institutional transfer|2|||
48656998|NCT00075725|156596057|FG003|Overall Study|Unsuccessful institutional transfer|0|||
48656999|NCT00075725|156596058|FG004|Overall Study|Unsuccessful institutional transfer|0|||
48657000|NCT00075725|156596059|FG005|Overall Study|Unsuccessful institutional transfer|0|||
48657001|NCT00075725|156596060|FG006|Overall Study|Unsuccessful institutional transfer|0|||
48657002|NCT00075725|156596061|FG007|Overall Study|Unsuccessful institutional transfer|0|||
48657003|NCT00075725|156596062|FG008|Overall Study|Unsuccessful institutional transfer|0|||
48657004|NCT00075725|156596063|FG009|Overall Study|Unsuccessful institutional transfer|1|||
48657005|NCT00075725|156596064|FG010|Overall Study|Unsuccessful institutional transfer|0|||
48657006|NCT00075725|156596065|FG011|Overall Study|Unsuccessful institutional transfer|0|||
48657007|NCT00075725|156596054|FG000|Overall Study|specimen(s) not submitted|0|||
48657008|NCT00075725|156596055|FG001|Overall Study|specimen(s) not submitted|0|||
48657009|NCT00075725|156596056|FG002|Overall Study|specimen(s) not submitted|2|||
48657010|NCT00075725|156596057|FG003|Overall Study|specimen(s) not submitted|0|||
48657011|NCT00075725|156596058|FG004|Overall Study|specimen(s) not submitted|0|||
48657012|NCT00075725|156596059|FG005|Overall Study|specimen(s) not submitted|0|||
48657013|NCT00075725|156596060|FG006|Overall Study|specimen(s) not submitted|0|||
48657014|NCT00075725|156596061|FG007|Overall Study|specimen(s) not submitted|0|||
48336152|NCT00603278|155427005|FG000|Overall Study|Withdrawal by Subject|2|||
48336153|NCT00603278|155427006|FG001|Overall Study|Withdrawal by Subject|3|||
48657015|NCT00075725|156596062|FG008|Overall Study|specimen(s) not submitted|0|||
48657016|NCT00075725|156596063|FG009|Overall Study|specimen(s) not submitted|0|||
48336154|NCT00603278|155427007|FG002|Overall Study|Withdrawal by Subject|1|||
48336155|NCT00603278|155427008|FG003|Overall Study|Withdrawal by Subject|2|||
48336156|NCT00603278|155427009|FG004|Overall Study|Withdrawal by Subject|1|||
48657017|NCT00075725|156596064|FG010|Overall Study|specimen(s) not submitted|0|||
48657018|NCT00075725|156596065|FG011|Overall Study|specimen(s) not submitted|0|||
48657019|NCT00075725|156596054|FG000|Overall Study|Pt went to transplant|0|||
48657020|NCT00075725|156596055|FG001|Overall Study|Pt went to transplant|0|||
48657021|NCT00075725|156596056|FG002|Overall Study|Pt went to transplant|0|||
48657022|NCT00075725|156596057|FG003|Overall Study|Pt went to transplant|1|||
48657023|NCT00075725|156596058|FG004|Overall Study|Pt went to transplant|0|||
48657024|NCT00075725|156596059|FG005|Overall Study|Pt went to transplant|1|||
48657025|NCT00075725|156596060|FG006|Overall Study|Pt went to transplant|0|||
48336157|NCT00603278|155427010|FG005|Overall Study|Withdrawal by Subject|2|||
48336158|NCT00603278|155427005|FG000|Overall Study|Protocol Violation|3|||
48336159|NCT00603278|155427006|FG001|Overall Study|Protocol Violation|0|||
48336160|NCT00603278|155427007|FG002|Overall Study|Protocol Violation|1|||
48336161|NCT00603278|155427008|FG003|Overall Study|Protocol Violation|1|||
48336162|NCT00603278|155427009|FG004|Overall Study|Protocol Violation|0|||
48336163|NCT00603278|155427010|FG005|Overall Study|Protocol Violation|1|||
48336164|NCT00603278|155427005|FG000|Overall Study|Physician Decision|0|||
48336165|NCT00603278|155427006|FG001|Overall Study|Physician Decision|1|||
48336166|NCT00603278|155427007|FG002|Overall Study|Physician Decision|0|||
48336167|NCT00603278|155427008|FG003|Overall Study|Physician Decision|0|||
48336168|NCT00603278|155427009|FG004|Overall Study|Physician Decision|2|||
48336169|NCT00603278|155427010|FG005|Overall Study|Physician Decision|1|||
48336170|NCT00603278|155427005|FG000|Overall Study|Lost to Follow-up|1|||
48336171|NCT00603278|155427006|FG001|Overall Study|Lost to Follow-up|0|||
48336172|NCT00603278|155427007|FG002|Overall Study|Lost to Follow-up|0|||
48336173|NCT00603278|155427008|FG003|Overall Study|Lost to Follow-up|0|||
48336174|NCT00603278|155427009|FG004|Overall Study|Lost to Follow-up|1|||
48336175|NCT00603278|155427010|FG005|Overall Study|Lost to Follow-up|0|||
48336176|NCT00448344|155427011|FG000|Overall Study|Lost to Follow-up|20|||
48336177|NCT00448344|155427012|FG001|Overall Study|Lost to Follow-up|22|||
48336178|NCT00448344|155427011|FG000|Overall Study|Withdrawal by Subject|6|||
48336179|NCT00448344|155427012|FG001|Overall Study|Withdrawal by Subject|8|||
48336180|NCT00448344|155427011|FG000|Overall Study|Death|3|||
48336181|NCT00448344|155427012|FG001|Overall Study|Death|4|||
48336182|NCT00448344|155427011|FG000|Overall Study|Physician Decision|1|||
48336183|NCT00448344|155427012|FG001|Overall Study|Physician Decision|2|||
48336184|NCT01760876|155427013|FG000|Overall Study|Non-cardiac death (head injury)|1|||
48336185|NCT01760876|155427013|FG000|Overall Study|Carcinoma of prostate|1|||
48336186|NCT01760876|155427013|FG000|Overall Study|Impaired renal function|1|||
48336187|NCT01760876|155427013|FG000|Overall Study|Major depression|1|||
48336188|NCT01760876|155427013|FG000|Overall Study|Very poor baseline OCT quality|2|||
48336189|NCT03689452|155427014|FG000|Overall Study|Lost to Follow-up|1|||
48336190|NCT03689452|155427015|FG001|Overall Study|Lost to Follow-up|1|||
48336191|NCT02676778|155427016|FG000|Overall Study|Disease Progression|7|||
48336192|NCT02676778|155427017|FG001|Overall Study|Disease Progression|3|||
48657026|NCT00075725|156596061|FG007|Overall Study|Pt went to transplant|0|||
48657027|NCT00075725|156596062|FG008|Overall Study|Pt went to transplant|0|||
48657028|NCT00075725|156596063|FG009|Overall Study|Pt went to transplant|0|||
48657029|NCT00075725|156596064|FG010|Overall Study|Pt went to transplant|0|||
48657030|NCT00075725|156596065|FG011|Overall Study|Pt went to transplant|0|||
48657031|NCT00075725|156596054|FG000|Overall Study|Pt received additional steroids|0|||
48657032|NCT00075725|156596055|FG001|Overall Study|Pt received additional steroids|0|||
48657033|NCT00075725|156596056|FG002|Overall Study|Pt received additional steroids|0|||
48657034|NCT00075725|156596057|FG003|Overall Study|Pt received additional steroids|1|||
48336193|NCT02676778|155427018|FG002|Overall Study|Disease Progression|1|||
48336194|NCT02676778|155427016|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
48336195|NCT02676778|155427017|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
48336196|NCT02676778|155427018|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
48336197|NCT02676778|155427016|FG000|Overall Study|Withdrawal by Subject|3|||
48336198|NCT02676778|155427017|FG001|Overall Study|Withdrawal by Subject|2|||
48336199|NCT02676778|155427018|FG002|Overall Study|Withdrawal by Subject|0|||
48657035|NCT00075725|156596058|FG004|Overall Study|Pt received additional steroids|0|||
48657036|NCT00075725|156596059|FG005|Overall Study|Pt received additional steroids|0|||
48336200|NCT02676778|155427016|FG000|Overall Study|Other|4|||
48336201|NCT02676778|155427017|FG001|Overall Study|Other|3|||
48657037|NCT00075725|156596060|FG006|Overall Study|Pt received additional steroids|0|||
48336202|NCT02676778|155427018|FG002|Overall Study|Other|0|||
48336203|NCT02676778|155427016|FG000|Overall Study|Adverse Event|2|||
48336204|NCT02676778|155427017|FG001|Overall Study|Adverse Event|3|||
48336205|NCT02676778|155427018|FG002|Overall Study|Adverse Event|0|||
48336206|NCT00788671|155428207|FG000|Overall Study|Death|2|||
48336207|NCT00788671|155428207|FG000|Overall Study|Unable to biopsy|1|||
48336208|NCT00788671|155428207|FG000|Overall Study|Withdrawal by Subject|4|||
48336209|NCT00788671|155428207|FG000|Overall Study|IUD expulsed|1|||
48336210|NCT00788671|155428207|FG000|Overall Study|Lost to follow up|2|||
48336211|NCT05487300|155428208|FG000|Overall Study|Withdrawal by Subject|1|||
48336212|NCT05487300|155428209|FG001|Overall Study|Withdrawal by Subject|0|||
48336213|NCT03020914|155428211|FG000|Overall Study|Surgery Cancelled|1|||
48336214|NCT03020914|155428212|FG001|Overall Study|Surgery Cancelled|0|||
48336215|NCT02880293|155428217|FG000|Overall Study|Inevaluable|5|||
48336216|NCT02659059|155428220|FG000|Overall Study|Other reasons|6|||
48336217|NCT02659059|155428221|FG001|Overall Study|Other reasons|1|||
48336218|NCT02659059|155428220|FG000|Overall Study|Disease Progression|143|||
48336219|NCT02659059|155428221|FG001|Overall Study|Disease Progression|16|||
48336220|NCT02659059|155428220|FG000|Overall Study|Study Drug toxicity|56|||
48336221|NCT02659059|155428221|FG001|Overall Study|Study Drug toxicity|9|||
48336222|NCT02659059|155428220|FG000|Overall Study|Death|3|||
48336223|NCT02659059|155428221|FG001|Overall Study|Death|1|||
48336224|NCT02659059|155428220|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
48657038|NCT00075725|156596061|FG007|Overall Study|Pt received additional steroids|0|||
48336225|NCT02659059|155428221|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
48336226|NCT02659059|155428220|FG000|Overall Study|Participant request to discontinue study treatment|5|||
48336227|NCT02659059|155428221|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48336228|NCT02659059|155428220|FG000|Overall Study|Participant withdrew consent|6|||
48336229|NCT02659059|155428221|FG001|Overall Study|Participant withdrew consent|1|||
48336230|NCT02830893|155428222|FG000|Overall Study|Relocation to out of the country|1|||
48336231|NCT02830893|155428223|FG001|Overall Study|Relocation to out of the country|0|||
48336232|NCT02830893|155428222|FG000|Overall Study|Lost to Follow-up|0|||
48336233|NCT02830893|155428223|FG001|Overall Study|Lost to Follow-up|2|||
48336234|NCT02830893|155428222|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
48336235|NCT02830893|155428223|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
48336236|NCT03976102|155428224|FG000|Overall Study|Withdrawal by Subject|4|||
48336237|NCT03976102|155428225|FG001|Overall Study|Withdrawal by Subject|4|||
48336238|NCT03976102|155428224|FG000|Overall Study|Adverse Event|2|||
48336239|NCT03976102|155428225|FG001|Overall Study|Adverse Event|4|||
48336240|NCT03976102|155428224|FG000|Overall Study|Not related to Covid-19|9|||
48336241|NCT03976102|155428225|FG001|Overall Study|Not related to Covid-19|13|||
48336242|NCT03976102|155428224|FG000|Overall Study|Lost to Follow-up|0|||
48336243|NCT03976102|155428225|FG001|Overall Study|Lost to Follow-up|2|||
48336244|NCT03976102|155428224|FG000|Overall Study|Death|3|||
48336245|NCT03976102|155428225|FG001|Overall Study|Death|2|||
48336246|NCT03976102|155428224|FG000|Overall Study|Physician Decision|1|||
48336247|NCT03976102|155428225|FG001|Overall Study|Physician Decision|1|||
48336248|NCT02014402|155428229|FG000|Overall Study|Adverse Event|1|||
48336249|NCT02014402|155428230|FG001|Overall Study|Adverse Event|0|||
48657039|NCT00075725|156596062|FG008|Overall Study|Pt received additional steroids|0|||
48657040|NCT00075725|156596063|FG009|Overall Study|Pt received additional steroids|0|||
48657041|NCT00075725|156596064|FG010|Overall Study|Pt received additional steroids|0|||
48657042|NCT00075725|156596065|FG011|Overall Study|Pt received additional steroids|0|||
48657043|NCT00075725|156596054|FG000|Overall Study|Pt relocated|0|||
48657044|NCT00075725|156596055|FG001|Overall Study|Pt relocated|0|||
48657045|NCT00075725|156596056|FG002|Overall Study|Pt relocated|0|||
48657046|NCT00075725|156596057|FG003|Overall Study|Pt relocated|2|||
48657047|NCT00075725|156596058|FG004|Overall Study|Pt relocated|0|||
48657048|NCT00075725|156596059|FG005|Overall Study|Pt relocated|1|||
48657049|NCT00075725|156596060|FG006|Overall Study|Pt relocated|1|||
48657050|NCT00075725|156596061|FG007|Overall Study|Pt relocated|2|||
48657051|NCT00075725|156596062|FG008|Overall Study|Pt relocated|1|||
48657052|NCT00075725|156596063|FG009|Overall Study|Pt relocated|0|||
48657053|NCT00075725|156596064|FG010|Overall Study|Pt relocated|0|||
48657054|NCT00075725|156596065|FG011|Overall Study|Pt relocated|0|||
48657055|NCT00075725|156596054|FG000|Overall Study|Institution Terminated|0|||
48336250|NCT02014402|155428231|FG002|Overall Study|Adverse Event|0|||
48336251|NCT02014402|155428232|FG003|Overall Study|Adverse Event|0|||
48336252|NCT02014402|155428229|FG000|Overall Study|Withdrawal by Subject|1|||
48336253|NCT02014402|155428230|FG001|Overall Study|Withdrawal by Subject|2|||
48657056|NCT00075725|156596055|FG001|Overall Study|Institution Terminated|0|||
48657057|NCT00075725|156596056|FG002|Overall Study|Institution Terminated|0|||
48657058|NCT00075725|156596057|FG003|Overall Study|Institution Terminated|0|||
48336254|NCT02014402|155428231|FG002|Overall Study|Withdrawal by Subject|2|||
48336255|NCT02014402|155428232|FG003|Overall Study|Withdrawal by Subject|1|||
48336256|NCT02014402|155428229|FG000|Overall Study|Subject did not have transportation|0|||
48336257|NCT02014402|155428230|FG001|Overall Study|Subject did not have transportation|1|||
48336258|NCT02014402|155428231|FG002|Overall Study|Subject did not have transportation|0|||
48336259|NCT02014402|155428232|FG003|Overall Study|Subject did not have transportation|0|||
48336260|NCT02014402|155428229|FG000|Overall Study|Lost to Follow-up|0|||
48336261|NCT02014402|155428230|FG001|Overall Study|Lost to Follow-up|0|||
48336262|NCT02014402|155428231|FG002|Overall Study|Lost to Follow-up|1|||
48657059|NCT00075725|156596058|FG004|Overall Study|Institution Terminated|1|||
48657060|NCT00075725|156596059|FG005|Overall Study|Institution Terminated|0|||
48657061|NCT00075725|156596060|FG006|Overall Study|Institution Terminated|0|||
48336263|NCT02014402|155428232|FG003|Overall Study|Lost to Follow-up|2|||
48336264|NCT01148017|155428233|FG000|Overall Study|Withdrawal by Subject|31|||
48336265|NCT01148017|155428234|FG001|Overall Study|Withdrawal by Subject|14|||
48336266|NCT01148017|155428235|FG002|Overall Study|Withdrawal by Subject|0|||
48336267|NCT01148017|155428236|FG003|Overall Study|Withdrawal by Subject|0|||
48336268|NCT01148017|155428233|FG000|Overall Study|Lost to Follow-up|23|||
48336269|NCT01148017|155428234|FG001|Overall Study|Lost to Follow-up|10|||
48336270|NCT01148017|155428235|FG002|Overall Study|Lost to Follow-up|0|||
48336271|NCT01148017|155428236|FG003|Overall Study|Lost to Follow-up|0|||
48336272|NCT01148017|155428233|FG000|Overall Study|Inappropriate enrollment|1|||
48336273|NCT01148017|155428234|FG001|Overall Study|Inappropriate enrollment|0|||
48336274|NCT01148017|155428235|FG002|Overall Study|Inappropriate enrollment|0|||
48336275|NCT01148017|155428236|FG003|Overall Study|Inappropriate enrollment|0|||
48336276|NCT01148017|155428233|FG000|Overall Study|Administrative reason|22|||
48336277|NCT01148017|155428234|FG001|Overall Study|Administrative reason|9|||
48336278|NCT01148017|155428235|FG002|Overall Study|Administrative reason|0|||
48336279|NCT01148017|155428236|FG003|Overall Study|Administrative reason|0|||
48336280|NCT01148017|155428233|FG000|Overall Study|Unable to classify|3|||
48336281|NCT01148017|155428234|FG001|Overall Study|Unable to classify|1|||
48336282|NCT01148017|155428235|FG002|Overall Study|Unable to classify|0|||
48336283|NCT01148017|155428236|FG003|Overall Study|Unable to classify|0|||
48336284|NCT00871494|155428238|FG000|Overall Study|Protocol Violation|5|||
48336285|NCT00871494|155428238|FG000|Overall Study|Lack of Efficacy|4|||
48336286|NCT00871494|155428238|FG000|Overall Study|Adverse Event|4|||
48336287|NCT00871494|155428238|FG000|Overall Study|Lost to Follow-up|1|||
48336288|NCT01074229|155428242|FG000|Overall Study|Lost to Follow-up|1|||
48336289|NCT01074229|155428243|FG001|Overall Study|Lost to Follow-up|0|||
48336290|NCT01074229|155428244|FG002|Overall Study|Lost to Follow-up|0|||
48336291|NCT01074229|155428242|FG000|Overall Study|Change to open surgical procedure|1|||
48336292|NCT01074229|155428243|FG001|Overall Study|Change to open surgical procedure|3|||
48336293|NCT01074229|155428244|FG002|Overall Study|Change to open surgical procedure|4|||
48336294|NCT01816165|155428245|FG000|Overall Study|Adverse Event|1|||
48336295|NCT01816165|155428246|FG001|Overall Study|Adverse Event|0|||
48336296|NCT01816165|155428247|FG002|Overall Study|Adverse Event|0|||
48336297|NCT01816165|155428248|FG003|Overall Study|Adverse Event|0|||
48336298|NCT01263223|155428251|FG000|Period 2|Withdrawal by Subject|0|||
48336299|NCT01263223|155428252|FG001|Period 2|Withdrawal by Subject|1|||
48336300|NCT01263223|155428251|FG000|7-day Follow-up|Withdrawal by Subject|0|||
48336301|NCT01263223|155428252|FG001|7-day Follow-up|Withdrawal by Subject|1|||
48336302|NCT01263223|155428251|FG000|7-day Follow-up|Lost to Follow-up|1|||
48336303|NCT01263223|155428252|FG001|7-day Follow-up|Lost to Follow-up|0|||
48336304|NCT02246647|155428253|FG000|Overall Study|Withdrawal by Subject|1|||
48336305|NCT02246647|155428254|FG001|Overall Study|Withdrawal by Subject|1|||
48336306|NCT02865083|155428260|FG000|Overall Study|Early Termination|3|||
48336307|NCT02865083|155428261|FG001|Overall Study|Early Termination|1|||
48336308|NCT04626128|155428262|FG000|Overall Study|Withdrawal by Subject|0|||
48336309|NCT04626128|155428263|FG001|Overall Study|Withdrawal by Subject|1|||
48336310|NCT04626128|155428264|FG002|Overall Study|Withdrawal by Subject|0|||
48336311|NCT04626128|155428265|FG003|Overall Study|Withdrawal by Subject|0|||
48336312|NCT02722278|155428266|FG000|Overall Study|Withdrawal by Subject|5|||
48336313|NCT02722278|155428267|FG001|Overall Study|Withdrawal by Subject|3|||
48336314|NCT02722278|155428266|FG000|Overall Study|Adverse Event|4|||
48336315|NCT02722278|155428267|FG001|Overall Study|Adverse Event|1|||
48336316|NCT02722278|155428266|FG000|Overall Study|Lost to Follow-up|2|||
48336317|NCT02722278|155428267|FG001|Overall Study|Lost to Follow-up|0|||
48336318|NCT02722278|155428266|FG000|Overall Study|Protocol Violation|1|||
48336319|NCT02722278|155428267|FG001|Overall Study|Protocol Violation|0|||
48336320|NCT02722278|155428266|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
48336321|NCT02722278|155428267|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
48336322|NCT02722278|155428266|FG000|Overall Study|Subject declined after tx assignment|0|||
48336323|NCT02722278|155428267|FG001|Overall Study|Subject declined after tx assignment|1|||
48336324|NCT02722278|155428266|FG000|Overall Study|Site closure not study related|0|||
48336325|NCT02722278|155428267|FG001|Overall Study|Site closure not study related|1|||
48336326|NCT02465866|155428268|FG000|Period 3|Withdrawal by Subject|0|||
48336327|NCT02465866|155428269|FG001|Period 3|Withdrawal by Subject|1|||
48336328|NCT02465866|155428270|FG002|Period 3|Withdrawal by Subject|0|||
48336329|NCT02465866|155428271|FG003|Period 3|Withdrawal by Subject|0|||
48336330|NCT04175392|155428272|FG000|Overall Study|Withdrawal by Subject|3|||
48336331|NCT04175392|155428273|FG001|Overall Study|Withdrawal by Subject|2|||
48336332|NCT03449979|155428274|FG000|Overall Study|Technical difficulty|0|||
48336333|NCT03449979|155428275|FG001|Overall Study|Technical difficulty|0|||
48336334|NCT03449979|155428276|FG002|Overall Study|Technical difficulty|0|||
48336335|NCT03449979|155428277|FG003|Overall Study|Technical difficulty|1|||
48336336|NCT00379210|155428278|FG000|Overall Study|Withdrawal by Subject|10|||
48336337|NCT00379210|155428279|FG001|Overall Study|Withdrawal by Subject|7|||
48336338|NCT02105688|155428280|FG000|Part A: Double-Blind|Adverse Event|1|||
48336339|NCT02105688|155428281|FG001|Part A: Double-Blind|Adverse Event|0|||
48336340|NCT02105688|155428280|FG000|Part A: Double-Blind|Death|0|||
48336341|NCT02105688|155428281|FG001|Part A: Double-Blind|Death|1|||
48336342|NCT02105688|155428280|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
48336343|NCT02105688|155428281|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
48336344|NCT02105688|155428280|FG000|Part A: Double-Blind|Physician Decision|0|||
48336345|NCT02105688|155428281|FG001|Part A: Double-Blind|Physician Decision|1|||
48336346|NCT02105688|155428280|FG000|Part A: Double-Blind|Status Unknown|0|||
48336347|NCT02105688|155428281|FG001|Part A: Double-Blind|Status Unknown|2|||
48336348|NCT02105688|155428280|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
48336349|NCT02105688|155428281|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
48336350|NCT02105688|155428280|FG000|Part B: Observational Follow-up|Death|2|||
48336351|NCT02105688|155428281|FG001|Part B: Observational Follow-up|Death|1|||
48336352|NCT02105688|155428280|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
48657062|NCT00075725|156596061|FG007|Overall Study|Institution Terminated|3|||
48657063|NCT00075725|156596062|FG008|Overall Study|Institution Terminated|0|||
48657064|NCT00075725|156596063|FG009|Overall Study|Institution Terminated|0|||
48657065|NCT00075725|156596064|FG010|Overall Study|Institution Terminated|0|||
48336353|NCT02105688|155428281|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
48336354|NCT02105688|155428280|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
48336355|NCT02105688|155428281|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
48336356|NCT02105688|155428280|FG000|Part B: Observational Follow-up|Physician Decision|3|||
48336357|NCT02105688|155428281|FG001|Part B: Observational Follow-up|Physician Decision|1|||
48657066|NCT00075725|156596065|FG011|Overall Study|Institution Terminated|0|||
48657067|NCT00075725|156596054|FG000|Overall Study|Study Closure|1|||
48657068|NCT00075725|156596055|FG001|Overall Study|Study Closure|0|||
48657069|NCT00075725|156596056|FG002|Overall Study|Study Closure|0|||
48657070|NCT00075725|156596057|FG003|Overall Study|Study Closure|0|||
48657071|NCT00075725|156596058|FG004|Overall Study|Study Closure|1|||
48657072|NCT00075725|156596059|FG005|Overall Study|Study Closure|3|||
48657073|NCT00075725|156596060|FG006|Overall Study|Study Closure|0|||
48657074|NCT00075725|156596061|FG007|Overall Study|Study Closure|1|||
48657075|NCT00075725|156596062|FG008|Overall Study|Study Closure|0|||
48657076|NCT00075725|156596063|FG009|Overall Study|Study Closure|0|||
48657077|NCT00075725|156596064|FG010|Overall Study|Study Closure|0|||
48657078|NCT00075725|156596065|FG011|Overall Study|Study Closure|0|||
48657079|NCT00075725|156596054|FG000|Overall Study|Other complications|0|||
48657080|NCT00075725|156596055|FG001|Overall Study|Other complications|0|||
48657081|NCT00075725|156596056|FG002|Overall Study|Other complications|0|||
48657082|NCT00075725|156596057|FG003|Overall Study|Other complications|0|||
48657083|NCT00075725|156596058|FG004|Overall Study|Other complications|0|||
48657084|NCT00075725|156596059|FG005|Overall Study|Other complications|1|||
48657085|NCT00075725|156596060|FG006|Overall Study|Other complications|0|||
48336358|NCT00700999|155428282|FG000|Overall Study|Lost to Follow-up|7|||
48657086|NCT00075725|156596061|FG007|Overall Study|Other complications|0|||
48657087|NCT00075725|156596062|FG008|Overall Study|Other complications|0|||
48657088|NCT00075725|156596063|FG009|Overall Study|Other complications|0|||
48657089|NCT00075725|156596064|FG010|Overall Study|Other complications|0|||
48657090|NCT00075725|156596065|FG011|Overall Study|Other complications|0|||
48657091|NCT00075725|156596054|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
48657092|NCT00075725|156596055|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
48657093|NCT00075725|156596056|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
48657094|NCT00075725|156596057|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
48657095|NCT00075725|156596058|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
48657096|NCT00075725|156596059|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
48657097|NCT00075725|156596060|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
48336359|NCT00700999|155428283|FG001|Overall Study|Lost to Follow-up|7|||
48336360|NCT00700999|155428282|FG000|Overall Study|Excluded - did not meet study criteria|0|||
48336361|NCT00700999|155428283|FG001|Overall Study|Excluded - did not meet study criteria|1|||
48336362|NCT00700999|155428282|FG000|Overall Study|Withdrawal by Subject|8|||
48336363|NCT00700999|155428283|FG001|Overall Study|Withdrawal by Subject|1|||
48336364|NCT04908488|155428284|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
48336365|NCT04908488|155428285|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
48336366|NCT04908488|155428284|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
48336367|NCT04908488|155428285|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
48336368|NCT03444155|155428286|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
48336369|NCT03444155|155428287|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
48336370|NCT02475733|155428294|FG000|Overall Study|Withdrawal by Subject|1|||
48336371|NCT02475733|155428295|FG001|Overall Study|Withdrawal by Subject|0|||
48336372|NCT02475733|155428294|FG000|Overall Study|Physician Decision|1|||
48336373|NCT02475733|155428295|FG001|Overall Study|Physician Decision|0|||
48336374|NCT01864200|155428296|FG000|Overall Study|Lost to Follow-up|1|||
48336375|NCT01864200|155428297|FG001|Overall Study|Lost to Follow-up|3|||
48336376|NCT01864200|155428296|FG000|Overall Study|Protocol Violation|1|||
48336377|NCT01864200|155428297|FG001|Overall Study|Protocol Violation|0|||
48336378|NCT00424476|155428298|FG000|Overall Study|Withdrawal by Subject|7|||
48336379|NCT00424476|155428299|FG001|Overall Study|Withdrawal by Subject|6|||
48336380|NCT00424476|155428300|FG002|Overall Study|Withdrawal by Subject|3|||
48336381|NCT00424476|155428298|FG000|Overall Study|Adverse Event|19|||
48336382|NCT00424476|155428299|FG001|Overall Study|Adverse Event|16|||
48336383|NCT00424476|155428300|FG002|Overall Study|Adverse Event|15|||
48336384|NCT00424476|155428298|FG000|Overall Study|Lack of Efficacy|16|||
48336385|NCT00424476|155428299|FG001|Overall Study|Lack of Efficacy|12|||
48336386|NCT00424476|155428300|FG002|Overall Study|Lack of Efficacy|12|||
48336387|NCT00424476|155428298|FG000|Overall Study|Lack of Compliance|1|||
48336388|NCT00424476|155428299|FG001|Overall Study|Lack of Compliance|1|||
48336389|NCT00424476|155428300|FG002|Overall Study|Lack of Compliance|1|||
48336390|NCT00424476|155428298|FG000|Overall Study|Lost to Follow-up|4|||
48336391|NCT00424476|155428299|FG001|Overall Study|Lost to Follow-up|6|||
48336392|NCT00424476|155428300|FG002|Overall Study|Lost to Follow-up|3|||
48336393|NCT00424476|155428298|FG000|Overall Study|Protocol Violation|7|||
48336394|NCT00424476|155428299|FG001|Overall Study|Protocol Violation|2|||
48336395|NCT00424476|155428300|FG002|Overall Study|Protocol Violation|3|||
48336396|NCT00424476|155428298|FG000|Overall Study|Physician Decision|3|||
48336397|NCT00424476|155428299|FG001|Overall Study|Physician Decision|2|||
48336398|NCT00424476|155428300|FG002|Overall Study|Physician Decision|3|||
48336399|NCT00424476|155428298|FG000|Overall Study|Other|4|||
48336400|NCT00424476|155428299|FG001|Overall Study|Other|3|||
48336401|NCT00424476|155428300|FG002|Overall Study|Other|9|||
48336402|NCT00848198|155428301|FG000|Overall Study|Incomplete Case Report Forms|15|||
48657098|NCT00075725|156596061|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
48336403|NCT02267746|155428302|FG000|Overall Study|Adverse Event|0|||
48336404|NCT02267746|155428303|FG001|Overall Study|Adverse Event|2|||
48336405|NCT02267746|155428304|FG002|Overall Study|Adverse Event|1|||
48336406|NCT02267746|155428302|FG000|Overall Study|Protocol Violation|8|||
48336407|NCT02267746|155428303|FG001|Overall Study|Protocol Violation|7|||
48336408|NCT02267746|155428304|FG002|Overall Study|Protocol Violation|3|||
48336409|NCT02267746|155428302|FG000|Overall Study|Lack of Efficacy|11|||
48336410|NCT02267746|155428303|FG001|Overall Study|Lack of Efficacy|11|||
48336411|NCT02267746|155428304|FG002|Overall Study|Lack of Efficacy|15|||
48336412|NCT02267746|155428302|FG000|Overall Study|Protocol Violation|1|||
48336413|NCT02267746|155428303|FG001|Overall Study|Protocol Violation|2|||
48336414|NCT02267746|155428304|FG002|Overall Study|Protocol Violation|1|||
48336415|NCT02267746|155428302|FG000|Overall Study|Miscellaneous|1|||
48336416|NCT02267746|155428303|FG001|Overall Study|Miscellaneous|0|||
48336417|NCT02267746|155428304|FG002|Overall Study|Miscellaneous|1|||
48336418|NCT04598776|155428305|FG000|Overall Study|Protocol Violation|5|||
48336419|NCT04598776|155428305|FG000|Overall Study|Physician Decision|4|||
48336420|NCT03873038|155428306|FG000|Part 2|Withdrawal by Subject|0|||
48336421|NCT03873038|155428307|FG001|Part 2|Withdrawal by Subject|0|||
48336422|NCT03873038|155428308|FG002|Part 2|Withdrawal by Subject|0|||
48336423|NCT03873038|155428309|FG003|Part 2|Withdrawal by Subject|0|||
48754779|NCT00296374|156948184|FG000|Overall Study|Withdrawal by Subject|3|||
48754780|NCT00296374|156948185|FG001|Overall Study|Withdrawal by Subject|5|||
48754781|NCT00296374|156948186|FG002|Overall Study|Withdrawal by Subject|11|||
48754782|NCT00296374|156948184|FG000|Overall Study|Incorrect enrollment|3|||
48754783|NCT00296374|156948185|FG001|Overall Study|Incorrect enrollment|3|||
48754784|NCT00296374|156948186|FG002|Overall Study|Incorrect enrollment|4|||
48754785|NCT00296374|156948184|FG000|Overall Study|Protocol Violation|1|||
48754786|NCT00296374|156948185|FG001|Overall Study|Protocol Violation|2|||
48754787|NCT00296374|156948186|FG002|Overall Study|Protocol Violation|3|||
48754788|NCT00296374|156948184|FG000|Overall Study|Lost to Follow-up|3|||
48336424|NCT03873038|155428310|FG004|Part 2|Withdrawal by Subject|0|||
48336425|NCT03873038|155428311|FG005|Part 2|Withdrawal by Subject|1|||
48336426|NCT03873038|155428306|FG000|Part 2|Unknon|0|||
48336427|NCT03873038|155428307|FG001|Part 2|Unknon|0|||
48336428|NCT03873038|155428308|FG002|Part 2|Unknon|0|||
48336429|NCT03873038|155428309|FG003|Part 2|Unknon|0|||
48336430|NCT03873038|155428310|FG004|Part 2|Unknon|1|||
48657099|NCT00075725|156596062|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
48657100|NCT00075725|156596063|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
48657101|NCT00075725|156596064|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
48657102|NCT00075725|156596065|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
48657103|NCT00075725|156596054|FG000|Overall Study|Pt incarcerated|0|||
48657104|NCT00075725|156596055|FG001|Overall Study|Pt incarcerated|0|||
48657105|NCT00075725|156596056|FG002|Overall Study|Pt incarcerated|0|||
48657106|NCT00075725|156596057|FG003|Overall Study|Pt incarcerated|0|||
48657107|NCT00075725|156596058|FG004|Overall Study|Pt incarcerated|0|||
48657108|NCT00075725|156596059|FG005|Overall Study|Pt incarcerated|0|||
48657109|NCT00075725|156596060|FG006|Overall Study|Pt incarcerated|0|||
48657110|NCT00075725|156596061|FG007|Overall Study|Pt incarcerated|1|||
48657111|NCT00075725|156596062|FG008|Overall Study|Pt incarcerated|0|||
48754789|NCT00296374|156948185|FG001|Overall Study|Lost to Follow-up|1|||
48754790|NCT00296374|156948186|FG002|Overall Study|Lost to Follow-up|1|||
48754791|NCT00296374|156948184|FG000|Overall Study|Relocated to another state|1|||
48754792|NCT00296374|156948185|FG001|Overall Study|Relocated to another state|0|||
48754793|NCT00296374|156948186|FG002|Overall Study|Relocated to another state|0|||
48754794|NCT00296374|156948184|FG000|Overall Study|Stopped drug before end of study visit|0|||
48754795|NCT00296374|156948185|FG001|Overall Study|Stopped drug before end of study visit|1|||
48754796|NCT00296374|156948186|FG002|Overall Study|Stopped drug before end of study visit|0|||
48754797|NCT00296374|156948184|FG000|Overall Study|Nephrologist introduced ACE|0|||
48754798|NCT00296374|156948185|FG001|Overall Study|Nephrologist introduced ACE|1|||
48754799|NCT00296374|156948186|FG002|Overall Study|Nephrologist introduced ACE|0|||
48754800|NCT00296374|156948184|FG000|Overall Study|Pregnancy|0|||
48754801|NCT00296374|156948185|FG001|Overall Study|Pregnancy|0|||
48754802|NCT00296374|156948186|FG002|Overall Study|Pregnancy|2|||
48754803|NCT00296374|156948184|FG000|Overall Study|Other|0|||
48754804|NCT00296374|156948185|FG001|Overall Study|Other|0|||
48336431|NCT03873038|155428311|FG005|Part 2|Unknon|0|||
48336432|NCT04743999|155428315|FG000|3-month Questionnaire|Death|1|||
48336433|NCT04743999|155428315|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
48336434|NCT04743999|155428315|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
48336435|NCT04743999|155428315|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
48336436|NCT05700851|155428316|FG000|Overall Study|Received a kidney transplant|1|||
48336437|NCT05700851|155428316|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
48754805|NCT00296374|156948186|FG002|Overall Study|Other|1|||
48754806|NCT01721330|156948187|FG000|Overall Study|Withdrawal by Subject|0|||
48754807|NCT01721330|156948188|FG001|Overall Study|Withdrawal by Subject|1|||
48754808|NCT00459667|156948197|FG000|Overall Study|Adverse Event|9|||
48754809|NCT00459667|156948198|FG001|Overall Study|Adverse Event|12|||
48336438|NCT05700851|155428316|FG000|Overall Study|Withdrawal by Subject|1|||
48336439|NCT02133131|155428317|FG000|Overall Study|Adverse Event|0|||
48336440|NCT02133131|155428318|FG001|Overall Study|Adverse Event|0|||
48336441|NCT02133131|155428319|FG002|Overall Study|Adverse Event|0|||
48336442|NCT02133131|155428320|FG003|Overall Study|Adverse Event|1|||
48336443|NCT02133131|155428321|FG004|Overall Study|Adverse Event|0|||
48336444|NCT02133131|155428322|FG005|Overall Study|Adverse Event|0|||
48336445|NCT02133131|155428323|FG006|Overall Study|Adverse Event|0|||
48336446|NCT02133131|155428317|FG000|Overall Study|Lost to Follow-up|1|||
48336447|NCT02133131|155428318|FG001|Overall Study|Lost to Follow-up|0|||
48336448|NCT02133131|155428319|FG002|Overall Study|Lost to Follow-up|0|||
48336449|NCT02133131|155428320|FG003|Overall Study|Lost to Follow-up|1|||
48336450|NCT02133131|155428321|FG004|Overall Study|Lost to Follow-up|0|||
48336451|NCT02133131|155428322|FG005|Overall Study|Lost to Follow-up|0|||
48657112|NCT00075725|156596063|FG009|Overall Study|Pt incarcerated|0|||
48657113|NCT00075725|156596064|FG010|Overall Study|Pt incarcerated|0|||
48657114|NCT00075725|156596065|FG011|Overall Study|Pt incarcerated|0|||
48657115|NCT01560637|156596066|FG000|Overall Study|Adverse Event|63|||
48657116|NCT01560637|156596066|FG000|Overall Study|Death|69|||
48657117|NCT01560637|156596066|FG000|Overall Study|Lost to Follow-up|8|||
48657118|NCT01560637|156596066|FG000|Overall Study|Protocol Violation|8|||
48657119|NCT01560637|156596066|FG000|Overall Study|Withdrawal by Subject|24|||
48657120|NCT01560637|156596066|FG000|Overall Study|Progressive Disease|20|||
48657121|NCT01560637|156596066|FG000|Overall Study|Other Reason Not Specified|6|||
48657122|NCT00072293|156596069|FG000|Overall Study|Lost to Follow-up|1|||
48657123|NCT00072293|156596070|FG001|Overall Study|Lost to Follow-up|1|||
48657124|NCT00072293|156596069|FG000|Overall Study|Withdrawal by Subject|0|||
48657125|NCT00072293|156596070|FG001|Overall Study|Withdrawal by Subject|1|||
48657126|NCT01166373|156596073|FG000|Overall Study|Lost to Follow-up|3|||
48657127|NCT01166373|156596074|FG001|Overall Study|Lost to Follow-up|2|||
48657128|NCT01166373|156596075|FG002|Overall Study|Lost to Follow-up|2|||
48657129|NCT01166373|156596076|FG003|Overall Study|Lost to Follow-up|2|||
48657130|NCT01166373|156596073|FG000|Overall Study|Withdrawal by Subject|1|||
48657131|NCT01166373|156596074|FG001|Overall Study|Withdrawal by Subject|2|||
48657132|NCT01166373|156596075|FG002|Overall Study|Withdrawal by Subject|2|||
48657133|NCT01166373|156596076|FG003|Overall Study|Withdrawal by Subject|3|||
48657134|NCT01166373|156596073|FG000|Overall Study|Physician Decision|1|||
48657135|NCT01166373|156596074|FG001|Overall Study|Physician Decision|0|||
48657136|NCT01166373|156596075|FG002|Overall Study|Physician Decision|0|||
48657137|NCT01166373|156596076|FG003|Overall Study|Physician Decision|0|||
48657138|NCT02752958|156596079|FG000|Overall Study|Adverse Event|3|||
48657139|NCT02752958|156596079|FG000|Overall Study|Lost to Follow-up|1|||
48657140|NCT02752958|156596079|FG000|Overall Study|Protocol Violation|1|||
48657141|NCT02752958|156596079|FG000|Overall Study|Withdrawal by Subject|2|||
48657142|NCT02752958|156596079|FG000|Overall Study|Other (Reason not specified)|2|||
48657143|NCT02214225|156596080|FG000|Overall Study|Lost to Follow-up|46|||
48657144|NCT02214225|156596081|FG001|Overall Study|Lost to Follow-up|18|||
48657145|NCT02214225|156596082|FG002|Overall Study|Lost to Follow-up|18|||
48657146|NCT02214225|156596080|FG000|Overall Study|Withdrawal by Subject|2|||
48657147|NCT02214225|156596081|FG001|Overall Study|Withdrawal by Subject|0|||
48657148|NCT02214225|156596082|FG002|Overall Study|Withdrawal by Subject|2|||
48657149|NCT02214225|156596080|FG000|Overall Study|Death|5|||
48657150|NCT02214225|156596081|FG001|Overall Study|Death|0|||
48657151|NCT02214225|156596082|FG002|Overall Study|Death|1|||
48657152|NCT02214225|156596080|FG000|Overall Study|randomized in error, not vaccinated|2|||
48657153|NCT02214225|156596081|FG001|Overall Study|randomized in error, not vaccinated|1|||
48657154|NCT02214225|156596082|FG002|Overall Study|randomized in error, not vaccinated|1|||
48657155|NCT00405964|156596083|FG000|Overall Study|Treatment Failure|17|||
48657156|NCT00405964|156596084|FG001|Overall Study|Treatment Failure|45|||
48657157|NCT00405964|156596083|FG000|Overall Study|Adverse Event|7|||
48657158|NCT00405964|156596084|FG001|Overall Study|Adverse Event|16|||
48657159|NCT00405964|156596083|FG000|Overall Study|Lost to Follow-up|5|||
48657160|NCT00405964|156596084|FG001|Overall Study|Lost to Follow-up|5|||
48657161|NCT00405964|156596083|FG000|Overall Study|Withdrawal by Subject|19|||
48657162|NCT00405964|156596084|FG001|Overall Study|Withdrawal by Subject|23|||
48657163|NCT00405964|156596083|FG000|Overall Study|Protocol Violation|11|||
48657164|NCT00405964|156596084|FG001|Overall Study|Protocol Violation|6|||
48657165|NCT01510145|156596089|FG000|Overall Study|Adverse Event|6|||
48657166|NCT01510145|156596089|FG000|Overall Study|Lost to Follow-up|5|||
48657167|NCT01510145|156596089|FG000|Overall Study|Withdrawal by Subject|6|||
48657168|NCT01510145|156596089|FG000|Overall Study|Relative reported subject withdrew|1|||
48657169|NCT01360398|156596090|FG000|Overall Study|Withdrawal by Subject|14|||
48657170|NCT01360398|156596090|FG000|Overall Study|Other|7|||
48657171|NCT01360398|156596090|FG000|Overall Study|Migrated/moved from study area|1|||
48657172|NCT03215927|156597641|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
48657173|NCT03215927|156597642|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
48657174|NCT03215927|156597641|FG000|Open Label Extension|Adverse Event|1|||
48657175|NCT03215927|156597642|FG001|Open Label Extension|Adverse Event|0|||
48657176|NCT03215927|156597641|FG000|Open Label Extension|Lack of Efficacy|1|||
48657177|NCT03215927|156597642|FG001|Open Label Extension|Lack of Efficacy|0|||
48657178|NCT03215927|156597641|FG000|Open Label Extension|Death|0|||
48657179|NCT03215927|156597642|FG001|Open Label Extension|Death|1|||
48657180|NCT02013206|156597643|FG000|Overall Study|Progressive disease (PD)|14|||
48657181|NCT02013206|156597644|FG001|Overall Study|Progressive disease (PD)|17|||
48657182|NCT02013206|156597643|FG000|Overall Study|Symptomatic deterioration|3|||
48657183|NCT02013206|156597644|FG001|Overall Study|Symptomatic deterioration|1|||
48657184|NCT02013206|156597643|FG000|Overall Study|Adverse Event|1|||
48657185|NCT02013206|156597644|FG001|Overall Study|Adverse Event|0|||
48657186|NCT02013206|156597643|FG000|Overall Study|Patient refusal|2|||
48657187|NCT02013206|156597644|FG001|Overall Study|Patient refusal|0|||
48657188|NCT02013206|156597643|FG000|Overall Study|Patient non-compliance|1|||
48657189|NCT02013206|156597644|FG001|Overall Study|Patient non-compliance|0|||
48657190|NCT02013206|156597643|FG000|Overall Study|Death|1|||
48657191|NCT02013206|156597644|FG001|Overall Study|Death|2|||
48657192|NCT02013206|156597643|FG000|Overall Study|Other reasons off treatment|5|||
48657193|NCT02013206|156597644|FG001|Overall Study|Other reasons off treatment|2|||
48657194|NCT00519376|156597658|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657195|NCT00519376|156597659|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657196|NCT00519376|156597660|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657197|NCT00519376|156597661|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657198|NCT00519376|156597662|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48336452|NCT02133131|155428323|FG006|Overall Study|Lost to Follow-up|0|||
48336453|NCT02133131|155428317|FG000|Overall Study|Status not recorded|4|||
48336454|NCT02133131|155428318|FG001|Overall Study|Status not recorded|5|||
48657199|NCT00519376|156597663|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657200|NCT00519376|156597664|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657201|NCT00519376|156597665|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657202|NCT00519376|156597666|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657203|NCT00519376|156597667|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657204|NCT00519376|156597668|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657205|NCT00519376|156597669|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657206|NCT00519376|156597670|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
48657207|NCT00519376|156597671|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657208|NCT00519376|156597672|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657209|NCT00519376|156597673|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
48657210|NCT00519376|156597658|FG000|Treatment Period 4|Lost to Follow-up|0|||
48657211|NCT00519376|156597659|FG001|Treatment Period 4|Lost to Follow-up|0|||
48657212|NCT00519376|156597660|FG002|Treatment Period 4|Lost to Follow-up|1|||
48657213|NCT00519376|156597661|FG003|Treatment Period 4|Lost to Follow-up|0|||
48657214|NCT00519376|156597662|FG004|Treatment Period 4|Lost to Follow-up|0|||
48657215|NCT00519376|156597663|FG005|Treatment Period 4|Lost to Follow-up|0|||
48657216|NCT00519376|156597664|FG006|Treatment Period 4|Lost to Follow-up|0|||
48657217|NCT00519376|156597665|FG007|Treatment Period 4|Lost to Follow-up|0|||
48657218|NCT00519376|156597666|FG008|Treatment Period 4|Lost to Follow-up|0|||
48657219|NCT00519376|156597667|FG009|Treatment Period 4|Lost to Follow-up|0|||
48657220|NCT00519376|156597668|FG010|Treatment Period 4|Lost to Follow-up|0|||
48336455|NCT02133131|155428319|FG002|Overall Study|Status not recorded|1|||
48336456|NCT02133131|155428320|FG003|Overall Study|Status not recorded|4|||
48657221|NCT00519376|156597669|FG011|Treatment Period 4|Lost to Follow-up|0|||
48657222|NCT00519376|156597670|FG012|Treatment Period 4|Lost to Follow-up|0|||
48657223|NCT00519376|156597671|FG013|Treatment Period 4|Lost to Follow-up|0|||
48657224|NCT00519376|156597672|FG014|Treatment Period 4|Lost to Follow-up|0|||
48657225|NCT00519376|156597673|FG015|Treatment Period 4|Lost to Follow-up|0|||
48657226|NCT00006164|156597674|FG000|Overall Study|Withdrew or lost to follow-up|70|||
48657227|NCT00006164|156597675|FG001|Overall Study|Withdrew or lost to follow-up|81|||
48657228|NCT00608023|156597676|FG000|Overall Study|Withdrawal by Subject|8|||
48657229|NCT00608023|156597677|FG001|Overall Study|Withdrawal by Subject|10|||
48657230|NCT00608023|156597678|FG002|Overall Study|Withdrawal by Subject|7|||
48657231|NCT00608023|156597676|FG000|Overall Study|Adverse Event|1|||
48657232|NCT00608023|156597677|FG001|Overall Study|Adverse Event|4|||
48657233|NCT00608023|156597678|FG002|Overall Study|Adverse Event|5|||
48657234|NCT00608023|156597676|FG000|Overall Study|Lost to Follow-up|2|||
48657235|NCT00608023|156597677|FG001|Overall Study|Lost to Follow-up|2|||
48754810|NCT00459667|156948199|FG002|Overall Study|Adverse Event|8|||
48754811|NCT00459667|156948197|FG000|Overall Study|Lost to Follow-up|5|||
48754812|NCT00459667|156948198|FG001|Overall Study|Lost to Follow-up|9|||
48754813|NCT00459667|156948199|FG002|Overall Study|Lost to Follow-up|3|||
48754814|NCT00459667|156948197|FG000|Overall Study|Pregnancy|1|||
48754815|NCT00459667|156948198|FG001|Overall Study|Pregnancy|1|||
48754816|NCT00459667|156948199|FG002|Overall Study|Pregnancy|1|||
48754817|NCT00459667|156948197|FG000|Overall Study|Protocol Violation|1|||
48754818|NCT00459667|156948198|FG001|Overall Study|Protocol Violation|0|||
48754819|NCT00459667|156948199|FG002|Overall Study|Protocol Violation|0|||
48754820|NCT00459667|156948197|FG000|Overall Study|Withdrawal by Subject|3|||
48754821|NCT00459667|156948198|FG001|Overall Study|Withdrawal by Subject|5|||
48754822|NCT00459667|156948199|FG002|Overall Study|Withdrawal by Subject|5|||
48754823|NCT00459667|156948197|FG000|Overall Study|Other disease modifying treatment|1|||
48754824|NCT00459667|156948198|FG001|Overall Study|Other disease modifying treatment|2|||
48754825|NCT00459667|156948199|FG002|Overall Study|Other disease modifying treatment|1|||
48754826|NCT00459667|156948197|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
48754827|NCT00459667|156948198|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
48754828|NCT00459667|156948199|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
48754829|NCT00459667|156948197|FG000|Overall Study|No treatment administered|6|||
48754830|NCT00459667|156948198|FG001|Overall Study|No treatment administered|3|||
48754831|NCT00459667|156948199|FG002|Overall Study|No treatment administered|1|||
48754832|NCT02671422|156948208|FG000|Overall Study|Lost to Follow-up|1|||
48754833|NCT02671422|156948208|FG000|Overall Study|Adverse Event|68|||
48754834|NCT02671422|156948208|FG000|Overall Study|Lack of Efficacy|1|||
48754835|NCT02671422|156948208|FG000|Overall Study|Lost to Follow-up|4|||
48754836|NCT02671422|156948208|FG000|Overall Study|Withdrawal by Subject|7|||
48754837|NCT02671422|156948208|FG000|Overall Study|Progressive Disease|156|||
48754838|NCT02671422|156948208|FG000|Overall Study|Worsening of Disease|4|||
48336457|NCT02133131|155428321|FG004|Overall Study|Status not recorded|0|||
48754839|NCT02671422|156948208|FG000|Overall Study|Sponsor decision|5|||
48754840|NCT02671422|156948208|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
48754841|NCT02671422|156948208|FG000|Overall Study|Not treated with Vargatef®|3|||
48754842|NCT02671422|156948208|FG000|Overall Study|Other not defined above|3|||
48754843|NCT02744391|156948209|FG000|Overall Study|Lost to Follow-up|9|||
48754844|NCT02744391|156948209|FG000|Overall Study|Physician Decision|2|||
48657236|NCT00608023|156597678|FG002|Overall Study|Lost to Follow-up|1|||
48657237|NCT00608023|156597676|FG000|Overall Study|Protocol Violation|1|||
48657238|NCT00608023|156597677|FG001|Overall Study|Protocol Violation|3|||
48657239|NCT00608023|156597678|FG002|Overall Study|Protocol Violation|1|||
48657240|NCT00608023|156597676|FG000|Overall Study|Unknown reason|0|||
48657241|NCT00608023|156597677|FG001|Overall Study|Unknown reason|3|||
48657242|NCT00608023|156597678|FG002|Overall Study|Unknown reason|0|||
48657243|NCT01681069|156597681|FG000|Overall Study|Withdrawal by Subject|4|||
48657244|NCT01681069|156597682|FG001|Overall Study|Withdrawal by Subject|5|||
48657245|NCT01681069|156597681|FG000|Overall Study|Protocol Violation|1|||
48657246|NCT01681069|156597682|FG001|Overall Study|Protocol Violation|1|||
48657247|NCT01681069|156597681|FG000|Overall Study|Adverse Event|0|||
48657248|NCT01681069|156597682|FG001|Overall Study|Adverse Event|1|||
48657249|NCT02743949|156597689|FG000|Overall Study|Adverse Event|0|||
48657250|NCT02743949|156597690|FG001|Overall Study|Adverse Event|0|||
48657251|NCT02743949|156597691|FG002|Overall Study|Adverse Event|2|||
48657252|NCT02743949|156597689|FG000|Overall Study|Significant Protocol Deviation|2|||
48657253|NCT02743949|156597690|FG001|Overall Study|Significant Protocol Deviation|0|||
48657254|NCT02743949|156597691|FG002|Overall Study|Significant Protocol Deviation|1|||
48657255|NCT02743949|156597689|FG000|Overall Study|Voluntary Withdrawal|2|||
48657256|NCT02743949|156597690|FG001|Overall Study|Voluntary Withdrawal|1|||
48657257|NCT02743949|156597691|FG002|Overall Study|Voluntary Withdrawal|0|||
48657258|NCT03389555|156597692|FG000|Overall Study|Protocol Violation|1|||
48657259|NCT03389555|156597693|FG001|Overall Study|Protocol Violation|3|||
48657260|NCT03389555|156597692|FG000|Overall Study|Death|1|||
48657261|NCT03389555|156597693|FG001|Overall Study|Death|0|||
48657262|NCT00920218|156597698|FG000|Overall Study|Serious Adverse Event|2|||
48657263|NCT00920218|156597699|FG001|Overall Study|Serious Adverse Event|0|||
48657264|NCT00920218|156597700|FG002|Overall Study|Serious Adverse Event|2|||
48657265|NCT00920218|156597701|FG003|Overall Study|Serious Adverse Event|1|||
48657266|NCT00920218|156597698|FG000|Overall Study|Withdrawal by Subject|0|||
48657267|NCT00920218|156597699|FG001|Overall Study|Withdrawal by Subject|3|||
48657268|NCT00920218|156597700|FG002|Overall Study|Withdrawal by Subject|2|||
48657269|NCT00920218|156597701|FG003|Overall Study|Withdrawal by Subject|0|||
48657270|NCT00920218|156597698|FG000|Overall Study|Migrated/moved from study area|0|||
48657271|NCT00920218|156597699|FG001|Overall Study|Migrated/moved from study area|0|||
48657272|NCT00920218|156597700|FG002|Overall Study|Migrated/moved from study area|1|||
48657273|NCT00920218|156597701|FG003|Overall Study|Migrated/moved from study area|0|||
48657274|NCT00920218|156597698|FG000|Overall Study|Lost to Follow-up|0|||
48657275|NCT00920218|156597699|FG001|Overall Study|Lost to Follow-up|1|||
48657276|NCT00920218|156597700|FG002|Overall Study|Lost to Follow-up|0|||
48657277|NCT00920218|156597701|FG003|Overall Study|Lost to Follow-up|3|||
48657278|NCT00920218|156597698|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
48657279|NCT00920218|156597699|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
48657280|NCT00920218|156597700|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
48657281|NCT00920218|156597701|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
48657282|NCT00920218|156597698|FG000|Overall Study|Other|0|||
48657283|NCT00920218|156597699|FG001|Overall Study|Other|0|||
48657284|NCT00920218|156597700|FG002|Overall Study|Other|1|||
48657285|NCT00920218|156597701|FG003|Overall Study|Other|0|||
48657286|NCT00923975|156597702|FG000|Overall Study|Did not meet inclusion criteria|1|||
48657287|NCT01328535|156597703|FG000|Overall Study|Ineligible|1|||
48657288|NCT04417218|156597704|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
48657289|NCT04417218|156597705|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
48657290|NCT03224507|156597706|FG000|Overall Study|Death|3|||
48657291|NCT03224507|156597707|FG001|Overall Study|Death|0|||
48657292|NCT03224507|156597706|FG000|Overall Study|Lack of Efficacy|6|||
48657293|NCT03224507|156597707|FG001|Overall Study|Lack of Efficacy|0|||
48657294|NCT03224507|156597706|FG000|Overall Study|Withdrawal by Subject|6|||
48657295|NCT03224507|156597707|FG001|Overall Study|Withdrawal by Subject|0|||
48657296|NCT00347438|156597710|FG000|Overall Study|Withdrawal by Subject|1|||
48657297|NCT00347438|156597710|FG000|Overall Study|Physician Decision|1|||
48657298|NCT00322023|156597711|FG000|Overall Study|various|0|||
48657299|NCT00322023|156597712|FG001|Overall Study|various|2|||
48657300|NCT00322023|156597713|FG002|Overall Study|various|6|||
48657301|NCT03327220|156597714|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
48657302|NCT03327220|156597715|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
48657303|NCT03327220|156597714|FG000|Overall Study|Investigator Decision|2|||
48657304|NCT03327220|156597715|FG001|Overall Study|Investigator Decision|0|||
48657305|NCT03327220|156597714|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
48657306|NCT03327220|156597715|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
48657307|NCT03327220|156597714|FG000|Overall Study|Fungal infection|1|||
48657308|NCT03327220|156597715|FG001|Overall Study|Fungal infection|0|||
48657309|NCT03327220|156597714|FG000|Overall Study|Discharged to Rehabilitation|0|||
48657310|NCT03327220|156597715|FG001|Overall Study|Discharged to Rehabilitation|1|||
48657311|NCT03327220|156597714|FG000|Overall Study|Missing|1|||
48657312|NCT03327220|156597715|FG001|Overall Study|Missing|0|||
48657313|NCT01177553|156597716|FG000|Overall Study|babies not yet 6 months of age|1|||
48657314|NCT01177553|156597717|FG001|Overall Study|babies not yet 6 months of age|0|||
48657315|NCT02534935|156597720|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
48657316|NCT02534935|156597721|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
48657317|NCT02534935|156597722|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
48657318|NCT02534935|156597720|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
48657319|NCT02534935|156597721|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
48657320|NCT02534935|156597722|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
48657321|NCT02534935|156597720|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
48657322|NCT02534935|156597721|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
48657323|NCT02534935|156597722|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
48657324|NCT02534935|156597720|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
48657325|NCT02534935|156597721|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
48657326|NCT02534935|156597722|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
48657327|NCT02534935|156597720|FG000|Stage 1: 24 Months|Adverse Event|0|||
48657328|NCT02534935|156597721|FG001|Stage 1: 24 Months|Adverse Event|2|||
48657329|NCT02534935|156597722|FG002|Stage 1: 24 Months|Adverse Event|0|||
48657330|NCT02534935|156597720|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
48657331|NCT02534935|156597721|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
48657332|NCT02534935|156597722|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
48657333|NCT02534935|156597720|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
48657334|NCT02534935|156597721|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
48657335|NCT02534935|156597722|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
48657336|NCT01239381|156597723|FG000|Overall Study|Protocol Violation|1|||
48657337|NCT01239381|156597723|FG000|Overall Study|Withdrawal by Subject|1|||
48657338|NCT01082874|156597724|FG000|Overall Study|Lost to Follow-up|10|||
48336458|NCT02133131|155428322|FG005|Overall Study|Status not recorded|0|||
48336459|NCT02133131|155428323|FG006|Overall Study|Status not recorded|0|||
48336460|NCT02133131|155428317|FG000|Overall Study|Ongoing in study|0|||
48336461|NCT02133131|155428318|FG001|Overall Study|Ongoing in study|0|||
48336462|NCT02133131|155428319|FG002|Overall Study|Ongoing in study|0|||
48336463|NCT02133131|155428320|FG003|Overall Study|Ongoing in study|0|||
48336464|NCT02133131|155428321|FG004|Overall Study|Ongoing in study|15|||
48336465|NCT02133131|155428322|FG005|Overall Study|Ongoing in study|14|||
48336466|NCT02133131|155428323|FG006|Overall Study|Ongoing in study|11|||
48336467|NCT02133131|155428317|FG000|Overall Study|Protocol Violation|0|||
48336468|NCT02133131|155428318|FG001|Overall Study|Protocol Violation|0|||
48336469|NCT02133131|155428319|FG002|Overall Study|Protocol Violation|0|||
48336470|NCT02133131|155428320|FG003|Overall Study|Protocol Violation|0|||
48336471|NCT02133131|155428321|FG004|Overall Study|Protocol Violation|0|||
48336472|NCT02133131|155428322|FG005|Overall Study|Protocol Violation|0|||
48336473|NCT02133131|155428323|FG006|Overall Study|Protocol Violation|1|||
48336474|NCT02481934|155428328|FG000|Overall Study|Death|2|||
48336475|NCT01399905|155428329|FG000|Overall Study|Withdrawal by Subject|1|||
48336476|NCT01399905|155428330|FG001|Overall Study|Withdrawal by Subject|1|||
48336477|NCT00732498|155428331|FG000|Overall Study|Ineligible|1|||
48336478|NCT00732498|155428331|FG000|Overall Study|Adverse Event|2|||
48336479|NCT00732498|155428331|FG000|Overall Study|Physician Decision|3|||
48336480|NCT03394508|155428332|FG000|Overall Study|Protocol Violation|0|||
48336481|NCT03394508|155428333|FG001|Overall Study|Protocol Violation|3|||
48336482|NCT03394508|155428332|FG000|Overall Study|Lost to Follow-up|1|||
48336483|NCT03394508|155428333|FG001|Overall Study|Lost to Follow-up|0|||
48657339|NCT01082874|156597725|FG001|Overall Study|Lost to Follow-up|10|||
48657340|NCT01082874|156597726|FG002|Overall Study|Lost to Follow-up|6|||
48657341|NCT01082874|156597727|FG003|Overall Study|Lost to Follow-up|10|||
48657342|NCT01082874|156597724|FG000|Overall Study|Withdrawal by Subject|1|||
48657343|NCT01082874|156597725|FG001|Overall Study|Withdrawal by Subject|2|||
48657344|NCT01082874|156597726|FG002|Overall Study|Withdrawal by Subject|5|||
48657345|NCT01082874|156597727|FG003|Overall Study|Withdrawal by Subject|3|||
48657346|NCT02442310|156597730|FG000|Overall Study|Adverse Event|2|||
48657347|NCT02442310|156597730|FG000|Overall Study|Withdrawal by Subject|1|||
48657348|NCT00695955|156597731|FG000|Cohort 1|Adverse Event|26|||
48657349|NCT00695955|156597731|FG000|Cohort 1|Protocol Violation|2|||
48657350|NCT00695955|156597731|FG000|Cohort 1|Lost to Follow-up|30|||
48657351|NCT00695955|156597731|FG000|Cohort 1|Withdrawal by Subject|25|||
48657352|NCT00695955|156597731|FG000|Cohort 1|Lack of Efficacy|3|||
48657353|NCT00695955|156597731|FG000|Cohort 1|Other|16|||
48657354|NCT00695955|156597731|FG000|Cohort 2|Adverse Event|24|||
48657355|NCT00695955|156597731|FG000|Cohort 2|Protocol Violation|5|||
48657356|NCT00695955|156597731|FG000|Cohort 2|Lost to Follow-up|38|||
48657357|NCT00695955|156597731|FG000|Cohort 2|Withdrawal by Subject|28|||
48657358|NCT00695955|156597731|FG000|Cohort 2|Lack of Efficacy|4|||
48657359|NCT00695955|156597731|FG000|Cohort 2|Other|5|||
48657360|NCT01972308|156597732|FG000|Overall Study|Withdrawal by Subject|0|||
48657361|NCT01972308|156597733|FG001|Overall Study|Withdrawal by Subject|1|||
48657362|NCT01972308|156597732|FG000|Overall Study|Lost to Follow-up|4|||
48657363|NCT01972308|156597733|FG001|Overall Study|Lost to Follow-up|6|||
48657364|NCT01972308|156597732|FG000|Overall Study|Death|4|||
48657365|NCT01972308|156597733|FG001|Overall Study|Death|1|||
48657366|NCT01562314|156597744|FG000|Overall Study|Adverse Event|10|||
48657367|NCT01562314|156597745|FG001|Overall Study|Adverse Event|5|||
48657368|NCT01562314|156597744|FG000|Overall Study|Met Withdrawal Criteria|3|||
48657369|NCT01562314|156597745|FG001|Overall Study|Met Withdrawal Criteria|2|||
48657370|NCT01562314|156597744|FG000|Overall Study|Withdrawal by Subject|0|||
48657371|NCT01562314|156597745|FG001|Overall Study|Withdrawal by Subject|1|||
48657372|NCT01703208|156597755|FG000|Overall Study|Death|61|||
48657373|NCT01703208|156597756|FG001|Overall Study|Death|48|||
48657374|NCT01703208|156597755|FG000|Overall Study|Lack of Efficacy|1|||
48657375|NCT01703208|156597756|FG001|Overall Study|Lack of Efficacy|2|||
48657376|NCT01703208|156597755|FG000|Overall Study|Lost to Follow-up|68|||
48657377|NCT01703208|156597756|FG001|Overall Study|Lost to Follow-up|62|||
48657378|NCT01703208|156597755|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48657379|NCT01703208|156597756|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48657380|NCT01703208|156597755|FG000|Overall Study|Excluded Medication|1|||
48657381|NCT01703208|156597756|FG001|Overall Study|Excluded Medication|2|||
48657382|NCT01703208|156597755|FG000|Overall Study|Site Discontinued Study Participation|23|||
48657383|NCT01703208|156597756|FG001|Overall Study|Site Discontinued Study Participation|27|||
48657384|NCT01703208|156597755|FG000|Overall Study|Physician Decision|11|||
48657385|NCT01703208|156597756|FG001|Overall Study|Physician Decision|13|||
48657386|NCT01703208|156597755|FG000|Overall Study|Progressive disease|2|||
48657387|NCT01703208|156597756|FG001|Overall Study|Progressive disease|2|||
48657388|NCT01703208|156597755|FG000|Overall Study|Protocol Violation|1|||
48657389|NCT01703208|156597756|FG001|Overall Study|Protocol Violation|1|||
48657390|NCT01703208|156597755|FG000|Overall Study|Study Terminated by Sponsor|1710|||
48657391|NCT01703208|156597756|FG001|Overall Study|Study Terminated by Sponsor|1716|||
48657392|NCT01703208|156597755|FG000|Overall Study|Withdrawal by Subject|205|||
48657393|NCT01703208|156597756|FG001|Overall Study|Withdrawal by Subject|209|||
48657394|NCT01703208|156597755|FG000|Overall Study|Adverse Event|14|||
48657395|NCT01703208|156597756|FG001|Overall Study|Adverse Event|19|||
48657396|NCT01703208|156597755|FG000|Overall Study|Technical Problems|0|||
48657397|NCT01703208|156597756|FG001|Overall Study|Technical Problems|1|||
48657398|NCT01703208|156597755|FG000|Overall Study|Protocol Deviation|2|||
48657399|NCT01703208|156597756|FG001|Overall Study|Protocol Deviation|0|||
48657400|NCT03194568|156597759|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
48657401|NCT01349322|156597760|FG000|Overall Study|Protocol Violation|45|||
48657402|NCT01349322|156597761|FG001|Overall Study|Protocol Violation|47|||
48657403|NCT00790647|156597766|FG000|Overall Study|Adverse Event|1|||
48657404|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
48657405|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
48657406|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
48657407|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
48657408|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
48657409|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
48657410|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
48657411|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
48657412|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
48657413|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
48657414|NCT00737568|156597767|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
48657415|NCT00737568|156597768|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
48657416|NCT00737568|156597767|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
48657417|NCT00737568|156597768|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
48657418|NCT00737568|156597767|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
48657419|NCT00737568|156597768|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
48754845|NCT02744391|156948209|FG000|Overall Study|Withdrawal by Subject|3|||
48754846|NCT02677987|156948211|FG000|Overall Study|Withdrawal by Subject|3|||
48754847|NCT02677987|156948212|FG001|Overall Study|Withdrawal by Subject|0|||
48754848|NCT02677987|156948211|FG000|Overall Study|Lost to Follow-up|1|||
48754849|NCT02677987|156948212|FG001|Overall Study|Lost to Follow-up|0|||
48754850|NCT04007094|156948213|FG000|Overall Study|Lost to Follow-up|1|||
48754851|NCT04007094|156948214|FG001|Overall Study|Lost to Follow-up|1|||
48754852|NCT02700815|156949680|FG000|Overall Study|Adverse Event|0|||
48754853|NCT02700815|156949681|FG001|Overall Study|Adverse Event|6|||
48754854|NCT02700815|156949682|FG002|Overall Study|Adverse Event|2|||
48754855|NCT02700815|156949683|FG003|Overall Study|Adverse Event|3|||
48754856|NCT02700815|156949680|FG000|Overall Study|Lack of Efficacy|0|||
48754857|NCT02700815|156949681|FG001|Overall Study|Lack of Efficacy|0|||
48754858|NCT02700815|156949682|FG002|Overall Study|Lack of Efficacy|1|||
48754859|NCT02700815|156949683|FG003|Overall Study|Lack of Efficacy|2|||
48657420|NCT00737568|156597767|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
48657421|NCT00737568|156597768|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
48657422|NCT03298984|156597769|FG000|Overall Study|Physician Decision|1|||
48657423|NCT03298984|156597770|FG001|Overall Study|Physician Decision|0|||
48657424|NCT03298984|156597771|FG002|Overall Study|Physician Decision|0|||
48657425|NCT03298984|156597772|FG003|Overall Study|Physician Decision|6|||
48657426|NCT03298984|156597769|FG000|Overall Study|Lack of Efficacy|0|||
48657427|NCT03298984|156597770|FG001|Overall Study|Lack of Efficacy|1|||
48657428|NCT03298984|156597771|FG002|Overall Study|Lack of Efficacy|1|||
48657429|NCT03298984|156597772|FG003|Overall Study|Lack of Efficacy|4|||
48657430|NCT03298984|156597769|FG000|Overall Study|Relapsed disease (following remission)|0|||
48657431|NCT03298984|156597770|FG001|Overall Study|Relapsed disease (following remission)|0|||
48657432|NCT03298984|156597771|FG002|Overall Study|Relapsed disease (following remission)|1|||
48657433|NCT03298984|156597772|FG003|Overall Study|Relapsed disease (following remission)|1|||
48657434|NCT03298984|156597769|FG000|Overall Study|Adverse Event|0|||
48657435|NCT03298984|156597770|FG001|Overall Study|Adverse Event|0|||
48657436|NCT03298984|156597771|FG002|Overall Study|Adverse Event|0|||
48657437|NCT03298984|156597772|FG003|Overall Study|Adverse Event|1|||
48657438|NCT03298984|156597769|FG000|Overall Study|Death|0|||
48657439|NCT03298984|156597770|FG001|Overall Study|Death|0|||
48657440|NCT03298984|156597771|FG002|Overall Study|Death|0|||
48657441|NCT03298984|156597772|FG003|Overall Study|Death|2|||
48657442|NCT03298984|156597769|FG000|Overall Study|Insurance Company Decision|0|||
48657443|NCT03298984|156597770|FG001|Overall Study|Insurance Company Decision|0|||
48657444|NCT03298984|156597771|FG002|Overall Study|Insurance Company Decision|0|||
48657445|NCT03298984|156597772|FG003|Overall Study|Insurance Company Decision|1|||
48657446|NCT00570037|156597779|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
48657447|NCT00570037|156597780|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
48657448|NCT01774253|156597781|FG000|Overall Study|Lack of Efficacy|4|||
48657449|NCT01774253|156597781|FG000|Overall Study|Physician Decision|2|||
48657450|NCT01774253|156597781|FG000|Overall Study|Withdrawal by Subject|2|||
48657451|NCT01774253|156597781|FG000|Overall Study|Death|1|||
48754860|NCT02700815|156949680|FG000|Overall Study|Lost to Follow-up|1|||
48754861|NCT02700815|156949681|FG001|Overall Study|Lost to Follow-up|0|||
48657452|NCT05426031|156597782|FG000|Overall Study|Circulatory Arrest|3|||
48657453|NCT05426031|156597783|FG001|Overall Study|Circulatory Arrest|2|||
48657454|NCT02080481|156597786|FG000|Overall Study|Never received a block.|1|||
48754862|NCT02700815|156949682|FG002|Overall Study|Lost to Follow-up|0|||
48754863|NCT02700815|156949683|FG003|Overall Study|Lost to Follow-up|1|||
48754864|NCT02700815|156949680|FG000|Overall Study|Refusal to continue medication|0|||
48754865|NCT02700815|156949681|FG001|Overall Study|Refusal to continue medication|1|||
48754866|NCT02700815|156949682|FG002|Overall Study|Refusal to continue medication|0|||
48754867|NCT02700815|156949683|FG003|Overall Study|Refusal to continue medication|1|||
48754868|NCT02700815|156949680|FG000|Overall Study|Withdrawal by Subject|0|||
48754869|NCT02700815|156949681|FG001|Overall Study|Withdrawal by Subject|0|||
48754870|NCT02700815|156949682|FG002|Overall Study|Withdrawal by Subject|1|||
48754871|NCT02700815|156949683|FG003|Overall Study|Withdrawal by Subject|0|||
48754872|NCT00856284|156949685|FG000|Overall Study|Hyperglycemic rescue|231|||
48754873|NCT00856284|156949686|FG001|Overall Study|Hyperglycemic rescue|201|||
48754874|NCT00856284|156949687|FG002|Overall Study|Hyperglycemic rescue|235|||
48754875|NCT00856284|156949685|FG000|Overall Study|Adverse Event|60|||
48754876|NCT00856284|156949686|FG001|Overall Study|Adverse Event|74|||
48754877|NCT00856284|156949687|FG002|Overall Study|Adverse Event|82|||
48754878|NCT00856284|156949685|FG000|Overall Study|Major protocol deviation|24|||
48754879|NCT00856284|156949686|FG001|Overall Study|Major protocol deviation|16|||
48754880|NCT00856284|156949687|FG002|Overall Study|Major protocol deviation|15|||
48754881|NCT00856284|156949685|FG000|Overall Study|Lost to Follow-up|20|||
48754882|NCT00856284|156949686|FG001|Overall Study|Lost to Follow-up|22|||
48754883|NCT00856284|156949687|FG002|Overall Study|Lost to Follow-up|28|||
48754884|NCT00856284|156949685|FG000|Overall Study|Voluntary withdrawal|48|||
48754885|NCT00856284|156949686|FG001|Overall Study|Voluntary withdrawal|52|||
48754886|NCT00856284|156949687|FG002|Overall Study|Voluntary withdrawal|62|||
48754887|NCT00856284|156949685|FG000|Overall Study|Pregnancy|1|||
48754888|NCT00856284|156949686|FG001|Overall Study|Pregnancy|2|||
48754889|NCT00856284|156949687|FG002|Overall Study|Pregnancy|0|||
48754890|NCT00856284|156949685|FG000|Overall Study|Investigator discretion|9|||
48754891|NCT00856284|156949686|FG001|Overall Study|Investigator discretion|8|||
48754892|NCT00856284|156949687|FG002|Overall Study|Investigator discretion|10|||
48754893|NCT00856284|156949685|FG000|Overall Study|Other|15|||
48754894|NCT00856284|156949686|FG001|Overall Study|Other|17|||
48754895|NCT00856284|156949687|FG002|Overall Study|Other|14|||
48754896|NCT00856284|156949685|FG000|Overall Study|Randomized in error|0|||
48754897|NCT00856284|156949686|FG001|Overall Study|Randomized in error|0|||
48754898|NCT00856284|156949687|FG002|Overall Study|Randomized in error|1|||
48754899|NCT03042533|156949693|FG000|Overall Study|MD left program|1|||
48754900|NCT03042533|156949694|FG001|Overall Study|MD left program|4|||
48336484|NCT00942188|155428334|FG000|Overall Study|Adverse Event|0|||
48336485|NCT00942188|155428335|FG001|Overall Study|Adverse Event|3|||
48657455|NCT02080481|156597787|FG001|Overall Study|Never received a block.|0|||
48657456|NCT02310230|156597793|FG000|Overall Study|Physician Decision|1|||
48657457|NCT02310230|156597794|FG001|Overall Study|Physician Decision|3|||
48657458|NCT02310230|156597793|FG000|Overall Study|monitor baseline taken after induction|2|||
48657459|NCT02310230|156597794|FG001|Overall Study|monitor baseline taken after induction|7|||
48657460|NCT02310230|156597793|FG000|Overall Study|Poor signal quality|5|||
48657461|NCT02310230|156597794|FG001|Overall Study|Poor signal quality|8|||
48657462|NCT02310230|156597793|FG000|Overall Study|Case cancelled|1|||
48657463|NCT02310230|156597794|FG001|Overall Study|Case cancelled|0|||
48657464|NCT00884039|156597795|FG000|Overall Study|Withdrawal by Subject|0|||
48657465|NCT00884039|156597796|FG001|Overall Study|Withdrawal by Subject|1|||
48657466|NCT00884039|156597795|FG000|Overall Study|Lack of Efficacy|2|||
48657467|NCT00884039|156597796|FG001|Overall Study|Lack of Efficacy|0|||
48657468|NCT02826421|156597797|FG000|Overall Study|Adverse Event|1|||
48657469|NCT02826421|156597798|FG001|Overall Study|Adverse Event|0|||
48657470|NCT02826421|156597799|FG002|Overall Study|Adverse Event|0|||
48657471|NCT02826421|156597800|FG003|Overall Study|Adverse Event|1|||
48657472|NCT02826421|156597797|FG000|Overall Study|Withdrawal by Subject|1|||
48657473|NCT02826421|156597798|FG001|Overall Study|Withdrawal by Subject|3|||
48657474|NCT02826421|156597799|FG002|Overall Study|Withdrawal by Subject|1|||
48657475|NCT02826421|156597800|FG003|Overall Study|Withdrawal by Subject|1|||
48657476|NCT02826421|156597797|FG000|Overall Study|Reason not given|1|||
48657477|NCT02826421|156597798|FG001|Overall Study|Reason not given|0|||
48657478|NCT02826421|156597799|FG002|Overall Study|Reason not given|1|||
48657479|NCT02826421|156597800|FG003|Overall Study|Reason not given|0|||
48657480|NCT01456195|156599787|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48657481|NCT01456195|156599788|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
48657482|NCT01456195|156599789|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
48657483|NCT01456195|156599787|FG000|Overall Study|Lost to Follow-up|3|||
48657484|NCT01456195|156599788|FG001|Overall Study|Lost to Follow-up|1|||
48754901|NCT03042533|156949695|FG002|Overall Study|MD left program|1|||
48754902|NCT02335489|156949698|FG000|Overall Study|Sponsor terminated study|4|||
48754903|NCT02335489|156949698|FG000|Overall Study|Lost to Follow-up|1|||
48657485|NCT01456195|156599789|FG002|Overall Study|Lost to Follow-up|3|||
48657486|NCT01456195|156599787|FG000|Overall Study|Voluntary Withdrawal|5|||
48657487|NCT01456195|156599788|FG001|Overall Study|Voluntary Withdrawal|3|||
48657488|NCT01456195|156599789|FG002|Overall Study|Voluntary Withdrawal|7|||
48657489|NCT01456195|156599787|FG000|Overall Study|Lack of Efficacy|0|||
48657490|NCT01456195|156599788|FG001|Overall Study|Lack of Efficacy|1|||
48657491|NCT01456195|156599789|FG002|Overall Study|Lack of Efficacy|0|||
48657492|NCT01456195|156599787|FG000|Overall Study|Other Reasons|2|||
48657493|NCT01456195|156599788|FG001|Overall Study|Other Reasons|1|||
48657494|NCT01456195|156599789|FG002|Overall Study|Other Reasons|3|||
48657495|NCT03300817|156599792|FG000|Overall Study|Withdrawal by Subject|1|||
48657496|NCT03300817|156599792|FG000|Overall Study|Adverse Event|1|||
48657497|NCT03300817|156599792|FG000|Overall Study|Subject Found to be Ineligible|2|||
48657498|NCT03842969|156599793|FG000|Overall Study|Participant declined follow-up visit|0|||
48657499|NCT03842969|156599794|FG001|Overall Study|Participant declined follow-up visit|1|||
48657500|NCT03842969|156599795|FG002|Overall Study|Participant declined follow-up visit|0|||
48657501|NCT03842969|156599793|FG000|Overall Study|Sponsor's decision|12|||
48657502|NCT03842969|156599794|FG001|Overall Study|Sponsor's decision|99|||
48657503|NCT03842969|156599795|FG002|Overall Study|Sponsor's decision|61|||
48657504|NCT03842969|156599793|FG000|Overall Study|Pregnancy|0|||
48657505|NCT03842969|156599794|FG001|Overall Study|Pregnancy|0|||
48657506|NCT03842969|156599795|FG002|Overall Study|Pregnancy|1|||
48657507|NCT03842969|156599793|FG000|Overall Study|Death|1|||
48657508|NCT03842969|156599794|FG001|Overall Study|Death|0|||
48657509|NCT03842969|156599795|FG002|Overall Study|Death|1|||
48657510|NCT03842969|156599793|FG000|Overall Study|Withdrawal by Subject|3|||
48657511|NCT03842969|156599794|FG001|Overall Study|Withdrawal by Subject|30|||
48657512|NCT03842969|156599795|FG002|Overall Study|Withdrawal by Subject|18|||
48657513|NCT03842969|156599793|FG000|Overall Study|Protocol Violation|1|||
48657514|NCT03842969|156599794|FG001|Overall Study|Protocol Violation|1|||
48657515|NCT03842969|156599795|FG002|Overall Study|Protocol Violation|0|||
48657516|NCT03842969|156599793|FG000|Overall Study|Physician Decision|0|||
48657517|NCT03842969|156599794|FG001|Overall Study|Physician Decision|3|||
48657518|NCT03842969|156599795|FG002|Overall Study|Physician Decision|0|||
48657519|NCT03842969|156599793|FG000|Overall Study|Lost to Follow-up|0|||
48657520|NCT03842969|156599794|FG001|Overall Study|Lost to Follow-up|2|||
48657521|NCT03842969|156599795|FG002|Overall Study|Lost to Follow-up|0|||
48657522|NCT03842969|156599793|FG000|Overall Study|Adverse Event|0|||
48657523|NCT03842969|156599794|FG001|Overall Study|Adverse Event|2|||
48657524|NCT03842969|156599795|FG002|Overall Study|Adverse Event|0|||
48657525|NCT00489424|156599797|FG000|Overall Study|Adverse Event|3|||
48657526|NCT00489424|156599798|FG001|Overall Study|Adverse Event|3|||
48657527|NCT00489424|156599799|FG002|Overall Study|Adverse Event|4|||
48657528|NCT00489424|156599797|FG000|Overall Study|Lack of Efficacy|1|||
48657529|NCT00489424|156599798|FG001|Overall Study|Lack of Efficacy|0|||
48657530|NCT00489424|156599799|FG002|Overall Study|Lack of Efficacy|0|||
48657531|NCT00489424|156599797|FG000|Overall Study|Administrative problems|0|||
48657532|NCT00489424|156599798|FG001|Overall Study|Administrative problems|2|||
48657533|NCT00489424|156599799|FG002|Overall Study|Administrative problems|1|||
48657534|NCT01468207|156599800|FG000|Treatment Period 1|Adverse Event|1|||
48657535|NCT01468207|156599801|FG001|Treatment Period 1|Adverse Event|0|||
48657536|NCT01468207|156599802|FG002|Treatment Period 1|Adverse Event|0|||
48657537|NCT01468207|156599803|FG003|Treatment Period 1|Adverse Event|0|||
48657538|NCT01468207|156599804|FG004|Treatment Period 1|Adverse Event|0|||
48657539|NCT01468207|156599805|FG005|Treatment Period 1|Adverse Event|0|||
48657540|NCT01468207|156599800|FG000|Treatment Period 1|Protocol Violation|1|||
48657541|NCT01468207|156599801|FG001|Treatment Period 1|Protocol Violation|1|||
48657542|NCT01468207|156599802|FG002|Treatment Period 1|Protocol Violation|0|||
48657543|NCT01468207|156599803|FG003|Treatment Period 1|Protocol Violation|0|||
48657544|NCT01468207|156599804|FG004|Treatment Period 1|Protocol Violation|0|||
48657545|NCT01468207|156599805|FG005|Treatment Period 1|Protocol Violation|0|||
48657546|NCT01468207|156599800|FG000|Treatment Period 1|Withdrawal by Subject|5|||
48657547|NCT01468207|156599801|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48657548|NCT01468207|156599802|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48657549|NCT01468207|156599803|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48657550|NCT01468207|156599804|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48657551|NCT01468207|156599805|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48657552|NCT01468207|156599800|FG000|Treatment Period 1|Lost to Follow-up|2|||
48657553|NCT01468207|156599801|FG001|Treatment Period 1|Lost to Follow-up|1|||
48657554|NCT01468207|156599802|FG002|Treatment Period 1|Lost to Follow-up|0|||
48657555|NCT01468207|156599803|FG003|Treatment Period 1|Lost to Follow-up|0|||
48657556|NCT01468207|156599804|FG004|Treatment Period 1|Lost to Follow-up|0|||
48657557|NCT01468207|156599805|FG005|Treatment Period 1|Lost to Follow-up|0|||
48657558|NCT01468207|156599800|FG000|Treatment Period 1|Other|0|||
48657559|NCT01468207|156599801|FG001|Treatment Period 1|Other|2|||
48754904|NCT02335489|156949698|FG000|Overall Study|Withdrawal by Subject|2|||
48657560|NCT01468207|156599802|FG002|Treatment Period 1|Other|0|||
48657561|NCT01468207|156599803|FG003|Treatment Period 1|Other|0|||
48657562|NCT01468207|156599804|FG004|Treatment Period 1|Other|0|||
48657563|NCT01468207|156599805|FG005|Treatment Period 1|Other|0|||
48657564|NCT01468207|156599800|FG000|Treatment Period 2|Adverse Event|0|||
48657565|NCT01468207|156599801|FG001|Treatment Period 2|Adverse Event|0|||
48657566|NCT01468207|156599802|FG002|Treatment Period 2|Adverse Event|6|||
48657567|NCT01468207|156599803|FG003|Treatment Period 2|Adverse Event|1|||
48657568|NCT01468207|156599804|FG004|Treatment Period 2|Adverse Event|2|||
48657569|NCT01468207|156599805|FG005|Treatment Period 2|Adverse Event|1|||
48657570|NCT01468207|156599800|FG000|Treatment Period 2|Lack of Efficacy|0|||
48657571|NCT01468207|156599801|FG001|Treatment Period 2|Lack of Efficacy|0|||
48657572|NCT01468207|156599802|FG002|Treatment Period 2|Lack of Efficacy|1|||
48657573|NCT01468207|156599803|FG003|Treatment Period 2|Lack of Efficacy|1|||
48657574|NCT01468207|156599804|FG004|Treatment Period 2|Lack of Efficacy|0|||
48657575|NCT01468207|156599805|FG005|Treatment Period 2|Lack of Efficacy|2|||
48657576|NCT01468207|156599800|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48657577|NCT01468207|156599801|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48657578|NCT01468207|156599802|FG002|Treatment Period 2|Withdrawal by Subject|5|||
48657579|NCT01468207|156599803|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48657580|NCT01468207|156599804|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48657581|NCT01468207|156599805|FG005|Treatment Period 2|Withdrawal by Subject|2|||
48657582|NCT01468207|156599800|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
48657583|NCT01468207|156599801|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
48657584|NCT01468207|156599802|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
48657585|NCT01468207|156599803|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
48657586|NCT01468207|156599804|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
48657587|NCT01468207|156599805|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
48657588|NCT01468207|156599800|FG000|Treatment Period 2|Lost to Follow-up|0|||
48657589|NCT01468207|156599801|FG001|Treatment Period 2|Lost to Follow-up|0|||
48657590|NCT01468207|156599802|FG002|Treatment Period 2|Lost to Follow-up|5|||
48657591|NCT01468207|156599803|FG003|Treatment Period 2|Lost to Follow-up|1|||
48657592|NCT01468207|156599804|FG004|Treatment Period 2|Lost to Follow-up|0|||
48657593|NCT01468207|156599805|FG005|Treatment Period 2|Lost to Follow-up|0|||
48657594|NCT01468207|156599800|FG000|Treatment Period 2|Other|0|||
48657595|NCT01468207|156599801|FG001|Treatment Period 2|Other|0|||
48657596|NCT01468207|156599802|FG002|Treatment Period 2|Other|5|||
48657597|NCT01468207|156599803|FG003|Treatment Period 2|Other|1|||
48657598|NCT01468207|156599804|FG004|Treatment Period 2|Other|1|||
48657599|NCT01468207|156599805|FG005|Treatment Period 2|Other|2|||
48657600|NCT02226562|156599819|FG000|Overall Study|Lost to Follow-up|0|||
48657601|NCT02226562|156599820|FG001|Overall Study|Lost to Follow-up|1|||
48657602|NCT01466660|156599821|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
48657603|NCT01466660|156599822|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
48657604|NCT01466660|156599821|FG000|Overall Study|Worsening of underlying cancer disease|5|||
48657605|NCT01466660|156599822|FG001|Overall Study|Worsening of underlying cancer disease|2|||
48657606|NCT01466660|156599821|FG000|Overall Study|Other adverse event|19|||
48657607|NCT01466660|156599822|FG001|Overall Study|Other adverse event|18|||
48657608|NCT01466660|156599821|FG000|Overall Study|Protocol Violation|2|||
48657609|NCT01466660|156599822|FG001|Overall Study|Protocol Violation|1|||
48657610|NCT01466660|156599821|FG000|Overall Study|Refused continuation of trial medication|4|||
48657611|NCT01466660|156599822|FG001|Overall Study|Refused continuation of trial medication|3|||
48657612|NCT01466660|156599821|FG000|Overall Study|Other reason not defined above|10|||
48657613|NCT01466660|156599822|FG001|Overall Study|Other reason not defined above|8|||
48657614|NCT03195660|156599823|FG000|Overall Study|The study was terminated|2|||
48657615|NCT01413100|156599824|FG000|Overall Study|Withdrawal by Subject|1|||
48657616|NCT02449889|156599825|FG000|Overall Study|Adverse Event|1|||
48657617|NCT02449889|156599826|FG001|Overall Study|Adverse Event|2|||
48657618|NCT02449889|156599827|FG002|Overall Study|Adverse Event|0|||
48657619|NCT02449889|156599825|FG000|Overall Study|Protocol Violation|0|||
48657620|NCT02449889|156599826|FG001|Overall Study|Protocol Violation|4|||
48657621|NCT02449889|156599827|FG002|Overall Study|Protocol Violation|1|||
48657622|NCT01257230|156599828|FG000|Overall Study|Not Treated|0|||
48657623|NCT01257230|156599829|FG001|Overall Study|Not Treated|0|||
48657624|NCT01257230|156599830|FG002|Overall Study|Not Treated|1|||
48657625|NCT01257230|156599828|FG000|Overall Study|Adverse Event|2|||
48657626|NCT01257230|156599829|FG001|Overall Study|Adverse Event|0|||
48657627|NCT01257230|156599830|FG002|Overall Study|Adverse Event|0|||
48657628|NCT01257230|156599828|FG000|Overall Study|Lack of Efficacy|0|||
48657629|NCT01257230|156599829|FG001|Overall Study|Lack of Efficacy|1|||
48657630|NCT01257230|156599830|FG002|Overall Study|Lack of Efficacy|0|||
48657631|NCT01257230|156599828|FG000|Overall Study|Protocol Violation|3|||
48657632|NCT01257230|156599829|FG001|Overall Study|Protocol Violation|0|||
48657633|NCT01257230|156599830|FG002|Overall Study|Protocol Violation|1|||
48754905|NCT02335489|156949698|FG000|Overall Study|Physician Decision|2|||
48657634|NCT01257230|156599828|FG000|Overall Study|Withdrawal by Subject|0|||
48657635|NCT01257230|156599829|FG001|Overall Study|Withdrawal by Subject|4|||
48657636|NCT01257230|156599830|FG002|Overall Study|Withdrawal by Subject|1|||
48657637|NCT01257230|156599828|FG000|Overall Study|Other reason not defined above|1|||
48657638|NCT01257230|156599829|FG001|Overall Study|Other reason not defined above|5|||
48657639|NCT01257230|156599830|FG002|Overall Study|Other reason not defined above|3|||
48754906|NCT02335489|156949698|FG000|Overall Study|Lack of Efficacy|1|||
48754907|NCT02564042|156949699|FG000|Overall Study|Adverse Event|4|||
48754908|NCT02564042|156949700|FG001|Overall Study|Adverse Event|4|||
48754909|NCT02564042|156949701|FG002|Overall Study|Adverse Event|3|||
48657640|NCT01369641|156599833|FG000|Overall Study|Withdrawal by Subject|1|||
48754910|NCT02564042|156949702|FG003|Overall Study|Adverse Event|0|||
48754911|NCT02564042|156949703|FG004|Overall Study|Adverse Event|0|||
48754912|NCT02564042|156949704|FG005|Overall Study|Adverse Event|1|||
48754913|NCT02564042|156949699|FG000|Overall Study|Lost to Follow-up|1|||
48754914|NCT02564042|156949700|FG001|Overall Study|Lost to Follow-up|1|||
48754915|NCT02564042|156949701|FG002|Overall Study|Lost to Follow-up|1|||
48754916|NCT02564042|156949702|FG003|Overall Study|Lost to Follow-up|0|||
48754917|NCT02564042|156949703|FG004|Overall Study|Lost to Follow-up|1|||
48754918|NCT02564042|156949704|FG005|Overall Study|Lost to Follow-up|1|||
48754919|NCT02564042|156949699|FG000|Overall Study|Physician Decision|1|||
48754920|NCT02564042|156949700|FG001|Overall Study|Physician Decision|0|||
48754921|NCT02564042|156949701|FG002|Overall Study|Physician Decision|0|||
48657641|NCT01973387|156599834|FG000|Overall Study|Adverse Event|14|||
48657642|NCT01973387|156599835|FG001|Overall Study|Adverse Event|4|||
48754922|NCT02564042|156949702|FG003|Overall Study|Physician Decision|1|||
48754923|NCT02564042|156949703|FG004|Overall Study|Physician Decision|0|||
48754924|NCT02564042|156949704|FG005|Overall Study|Physician Decision|0|||
48754925|NCT02564042|156949699|FG000|Overall Study|Withdrawal by Subject|5|||
48754926|NCT02564042|156949700|FG001|Overall Study|Withdrawal by Subject|3|||
48754927|NCT02564042|156949701|FG002|Overall Study|Withdrawal by Subject|2|||
48754928|NCT02564042|156949702|FG003|Overall Study|Withdrawal by Subject|2|||
48754929|NCT02564042|156949703|FG004|Overall Study|Withdrawal by Subject|10|||
48754930|NCT02564042|156949704|FG005|Overall Study|Withdrawal by Subject|12|||
48754931|NCT02743806|156949705|FG000|Overall Study|Adverse Event|9|||
48754932|NCT02743806|156949705|FG000|Overall Study|Lost to Follow-up|8|||
48754933|NCT02743806|156949705|FG000|Overall Study|Voluntary Withdrawal|54|||
48754934|NCT02743806|156949705|FG000|Overall Study|Study Termination|65|||
48754935|NCT02743806|156949705|FG000|Overall Study|Pregnancy|6|||
48754936|NCT02743806|156949705|FG000|Overall Study|No Longer Clinically Benefiting|27|||
48754937|NCT02743806|156949705|FG000|Overall Study|Reason Not Specified|12|||
48754938|NCT01349790|156949706|FG000|Overall Study|Investigator Judgement|3|||
48754939|NCT01349790|156949706|FG000|Overall Study|Death|2|||
48754940|NCT01349790|156949706|FG000|Overall Study|Withdrawal by Patient|2|||
48754941|NCT01349790|156949706|FG000|Overall Study|Adverse Event|1|||
48754942|NCT01349790|156949706|FG000|Overall Study|Lost to Follow-up|1|||
48754943|NCT02514447|156949707|FG000|Overall Study|Withdrawal by Subject|3|||
48754944|NCT02514447|156949708|FG001|Overall Study|Withdrawal by Subject|1|||
48754945|NCT02514447|156949709|FG002|Overall Study|Withdrawal by Subject|1|||
48754946|NCT02514447|156949710|FG003|Overall Study|Withdrawal by Subject|0|||
48754947|NCT02514447|156949711|FG004|Overall Study|Withdrawal by Subject|0|||
48754948|NCT02514447|156949712|FG005|Overall Study|Withdrawal by Subject|0|||
48336486|NCT00942188|155428336|FG002|Overall Study|Adverse Event|2|||
48336487|NCT00942188|155428337|FG003|Overall Study|Adverse Event|0|||
48657643|NCT01973387|156599834|FG000|Overall Study|Withdrawal by Subject|7|||
48657644|NCT01973387|156599835|FG001|Overall Study|Withdrawal by Subject|4|||
48754949|NCT02514447|156949713|FG006|Overall Study|Withdrawal by Subject|0|||
48754950|NCT02514447|156949714|FG007|Overall Study|Withdrawal by Subject|1|||
48754951|NCT02514447|156949715|FG008|Overall Study|Withdrawal by Subject|1|||
48754952|NCT02514447|156949707|FG000|Overall Study|Death|24|||
48336488|NCT00942188|155428334|FG000|Overall Study|Lack of Efficacy|0|||
48336489|NCT00942188|155428335|FG001|Overall Study|Lack of Efficacy|0|||
48336490|NCT00942188|155428336|FG002|Overall Study|Lack of Efficacy|0|||
48336491|NCT00942188|155428337|FG003|Overall Study|Lack of Efficacy|1|||
48336492|NCT00942188|155428334|FG000|Overall Study|Protocol Violation|1|||
48657645|NCT01973387|156599834|FG000|Overall Study|Study terminated by sponsor|63|||
48657646|NCT01973387|156599835|FG001|Overall Study|Study terminated by sponsor|0|||
48657647|NCT01973387|156599834|FG000|Overall Study|Progressive disease or relapse|16|||
48754953|NCT02514447|156949708|FG001|Overall Study|Death|28|||
48754954|NCT02514447|156949709|FG002|Overall Study|Death|29|||
48754955|NCT02514447|156949710|FG003|Overall Study|Death|0|||
48754956|NCT02514447|156949711|FG004|Overall Study|Death|3|||
48754957|NCT02514447|156949712|FG005|Overall Study|Death|4|||
48754958|NCT02514447|156949713|FG006|Overall Study|Death|8|||
48754959|NCT02514447|156949714|FG007|Overall Study|Death|6|||
48336493|NCT00942188|155428335|FG001|Overall Study|Protocol Violation|1|||
48336494|NCT00942188|155428336|FG002|Overall Study|Protocol Violation|0|||
48754960|NCT02514447|156949715|FG008|Overall Study|Death|5|||
48754961|NCT02514447|156949707|FG000|Overall Study|Lost to Follow-up|1|||
48754962|NCT02514447|156949708|FG001|Overall Study|Lost to Follow-up|0|||
48754963|NCT02514447|156949709|FG002|Overall Study|Lost to Follow-up|0|||
48754964|NCT02514447|156949710|FG003|Overall Study|Lost to Follow-up|0|||
48336495|NCT00942188|155428337|FG003|Overall Study|Protocol Violation|0|||
48657648|NCT01973387|156599835|FG001|Overall Study|Progressive disease or relapse|5|||
48754965|NCT02514447|156949711|FG004|Overall Study|Lost to Follow-up|0|||
48754966|NCT02514447|156949712|FG005|Overall Study|Lost to Follow-up|0|||
48754967|NCT02514447|156949713|FG006|Overall Study|Lost to Follow-up|0|||
48754968|NCT02514447|156949714|FG007|Overall Study|Lost to Follow-up|0|||
48754969|NCT02514447|156949715|FG008|Overall Study|Lost to Follow-up|1|||
48754970|NCT02514447|156949707|FG000|Overall Study|Sponsor Termination of Study|0|||
48754971|NCT02514447|156949708|FG001|Overall Study|Sponsor Termination of Study|1|||
48754972|NCT02514447|156949709|FG002|Overall Study|Sponsor Termination of Study|1|||
48754973|NCT02514447|156949710|FG003|Overall Study|Sponsor Termination of Study|0|||
48754974|NCT02514447|156949711|FG004|Overall Study|Sponsor Termination of Study|0|||
48754975|NCT02514447|156949712|FG005|Overall Study|Sponsor Termination of Study|0|||
48754976|NCT02514447|156949713|FG006|Overall Study|Sponsor Termination of Study|0|||
48754977|NCT02514447|156949714|FG007|Overall Study|Sponsor Termination of Study|0|||
48754978|NCT02514447|156949715|FG008|Overall Study|Sponsor Termination of Study|0|||
48754979|NCT02514447|156949707|FG000|Overall Study|Study completion per Investigator|1|||
48754980|NCT02514447|156949708|FG001|Overall Study|Study completion per Investigator|0|||
48754981|NCT02514447|156949709|FG002|Overall Study|Study completion per Investigator|1|||
48754982|NCT02514447|156949710|FG003|Overall Study|Study completion per Investigator|2|||
48754983|NCT02514447|156949711|FG004|Overall Study|Study completion per Investigator|0|||
48754984|NCT02514447|156949712|FG005|Overall Study|Study completion per Investigator|0|||
48657649|NCT01973387|156599834|FG000|Overall Study|Death|4|||
48657650|NCT01973387|156599835|FG001|Overall Study|Death|3|||
48657651|NCT01973387|156599834|FG000|Overall Study|Randomized, not treated|2|||
48657652|NCT01973387|156599835|FG001|Overall Study|Randomized, not treated|2|||
48657653|NCT02545517|156599836|FG000|Overall Study|Death|2|||
48657654|NCT02545517|156599837|FG001|Overall Study|Death|2|||
48657655|NCT02545517|156599838|FG002|Overall Study|Death|1|||
48657656|NCT02545517|156599836|FG000|Overall Study|Lost to Follow-up|14|||
48754985|NCT02514447|156949713|FG006|Overall Study|Study completion per Investigator|0|||
48754986|NCT02514447|156949714|FG007|Overall Study|Study completion per Investigator|0|||
48754987|NCT02514447|156949715|FG008|Overall Study|Study completion per Investigator|1|||
48336496|NCT00942188|155428334|FG000|Overall Study|Lost to Follow-up|2|||
48657657|NCT02545517|156599837|FG001|Overall Study|Lost to Follow-up|13|||
48657658|NCT02545517|156599838|FG002|Overall Study|Lost to Follow-up|17|||
48657659|NCT02545517|156599836|FG000|Overall Study|Protocol Violation|0|||
48657660|NCT02545517|156599837|FG001|Overall Study|Protocol Violation|1|||
48657661|NCT02545517|156599838|FG002|Overall Study|Protocol Violation|1|||
48657662|NCT02545517|156599836|FG000|Overall Study|Withdrawal by Subject|5|||
48657663|NCT02545517|156599837|FG001|Overall Study|Withdrawal by Subject|8|||
48657664|NCT02545517|156599838|FG002|Overall Study|Withdrawal by Subject|9|||
48657665|NCT02545517|156599836|FG000|Overall Study|Administrative reason|5|||
48657666|NCT02545517|156599837|FG001|Overall Study|Administrative reason|6|||
48657667|NCT02545517|156599838|FG002|Overall Study|Administrative reason|10|||
48657668|NCT02545517|156599836|FG000|Overall Study|Other|2|||
48657669|NCT02545517|156599837|FG001|Overall Study|Other|4|||
48657670|NCT02545517|156599838|FG002|Overall Study|Other|3|||
48657671|NCT01529515|156599841|FG000|TRANSITION PHASE|Adverse Event|16|||
48657672|NCT01529515|156599842|FG001|TRANSITION PHASE|Adverse Event|0|||
48657673|NCT01529515|156599843|FG002|TRANSITION PHASE|Adverse Event|0|||
48657674|NCT01529515|156599844|FG003|TRANSITION PHASE|Adverse Event|0|||
48657675|NCT01529515|156599841|FG000|TRANSITION PHASE|Death|1|||
48657676|NCT01529515|156599842|FG001|TRANSITION PHASE|Death|0|||
48657677|NCT01529515|156599843|FG002|TRANSITION PHASE|Death|0|||
48657678|NCT01529515|156599844|FG003|TRANSITION PHASE|Death|0|||
48657679|NCT01529515|156599841|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
48657680|NCT01529515|156599842|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
48657681|NCT01529515|156599843|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
48657682|NCT01529515|156599844|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
48657683|NCT01529515|156599841|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
48657684|NCT01529515|156599842|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
48657685|NCT01529515|156599843|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
48657686|NCT01529515|156599844|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
48657687|NCT01529515|156599841|FG000|TRANSITION PHASE|Protocol Violation|4|||
48657688|NCT01529515|156599842|FG001|TRANSITION PHASE|Protocol Violation|0|||
48657689|NCT01529515|156599843|FG002|TRANSITION PHASE|Protocol Violation|0|||
48754988|NCT01986985|156949721|FG000|Overall Study|Withdrawal by Subject|4|||
48754989|NCT01986985|156949721|FG000|Overall Study|Scan not completed due to malfunction|3|||
48754990|NCT00449540|156949723|FG000|Pretreatment Phase|No migraine experienced|66|||
48754991|NCT00449540|156949724|FG001|Pretreatment Phase|No migraine experienced|0|||
48336497|NCT00942188|155428335|FG001|Overall Study|Lost to Follow-up|1|||
48657690|NCT01529515|156599844|FG003|TRANSITION PHASE|Protocol Violation|0|||
48657691|NCT01529515|156599841|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
48657692|NCT01529515|156599842|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
48657693|NCT01529515|156599843|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
48657694|NCT01529515|156599844|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
48657695|NCT01529515|156599841|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
48657696|NCT01529515|156599842|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
48657697|NCT01529515|156599843|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
48657698|NCT01529515|156599844|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
48657699|NCT01529515|156599841|FG000|TRANSITION PHASE|Other|9|||
48657700|NCT01529515|156599842|FG001|TRANSITION PHASE|Other|0|||
48657701|NCT01529515|156599843|FG002|TRANSITION PHASE|Other|0|||
48657702|NCT01529515|156599844|FG003|TRANSITION PHASE|Other|0|||
48657703|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Adverse Event|0|||
48657704|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Adverse Event|10|||
48657705|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Adverse Event|0|||
48657706|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Adverse Event|0|||
48657707|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
48657708|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
48657709|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
48657710|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
48657711|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
48657712|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
48657713|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
48657714|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
48657715|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
48657716|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
48657717|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
48657718|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
48657719|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
48657720|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
48657721|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
48657722|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
48657723|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
48657724|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
48657725|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
48657726|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
48657727|NCT01529515|156599841|FG000|MAINTENANCE PHASE|Other|0|||
48657728|NCT01529515|156599842|FG001|MAINTENANCE PHASE|Other|10|||
48657729|NCT01529515|156599843|FG002|MAINTENANCE PHASE|Other|0|||
48657730|NCT01529515|156599844|FG003|MAINTENANCE PHASE|Other|0|||
48657731|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
48657732|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
48657733|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
48657734|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
48657735|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
48657736|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
48657737|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
48657738|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
48657739|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
48657740|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
48657741|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
48657742|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
48657743|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
48657744|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
48657745|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
48657746|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
48657747|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
48657748|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
48657749|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
48657750|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
48657751|NCT01529515|156599841|FG000|DOUBLE BLIND PHASE|Other|0|||
48657752|NCT01529515|156599842|FG001|DOUBLE BLIND PHASE|Other|0|||
48657753|NCT01529515|156599843|FG002|DOUBLE BLIND PHASE|Other|9|||
48657754|NCT01529515|156599844|FG003|DOUBLE BLIND PHASE|Other|2|||
48657755|NCT00688324|156599845|FG000|Overall Study|Withdrawal by Subject|2|||
48657756|NCT00688324|156599845|FG000|Overall Study|Physician Decision|5|||
48657757|NCT00688324|156599845|FG000|Overall Study|Lost to Follow-up|1|||
48657758|NCT01535599|156599852|FG000|Overall Study|Adverse Event|6|||
48657759|NCT01535599|156599853|FG001|Overall Study|Adverse Event|15|||
48657760|NCT01535599|156599852|FG000|Overall Study|Lost to Follow-up|3|||
48657761|NCT01535599|156599853|FG001|Overall Study|Lost to Follow-up|4|||
48657762|NCT01535599|156599852|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
48657763|NCT01535599|156599853|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
48657764|NCT01535599|156599852|FG000|Overall Study|Treatment Failure|33|||
48657765|NCT01535599|156599853|FG001|Overall Study|Treatment Failure|66|||
48657766|NCT01535599|156599852|FG000|Overall Study|BL Culture + for Group A Strep|0|||
48657767|NCT01535599|156599853|FG001|Overall Study|BL Culture + for Group A Strep|1|||
48657768|NCT01535599|156599852|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
48657769|NCT01535599|156599853|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
48657770|NCT01535599|156599852|FG000|Overall Study|Randomized in Error|2|||
48657771|NCT01535599|156599853|FG001|Overall Study|Randomized in Error|4|||
48657772|NCT01535599|156599852|FG000|Overall Study|Did not use product|1|||
48657773|NCT01535599|156599853|FG001|Overall Study|Did not use product|0|||
48657774|NCT01535599|156599852|FG000|Overall Study|Other|1|||
48657775|NCT01535599|156599853|FG001|Overall Study|Other|0|||
48657776|NCT01535599|156599852|FG000|Overall Study|Stopped medication|0|||
48657777|NCT01535599|156599853|FG001|Overall Study|Stopped medication|1|||
48657778|NCT01535599|156599852|FG000|Overall Study|Noncompliance|0|||
48657779|NCT01535599|156599853|FG001|Overall Study|Noncompliance|1|||
48657780|NCT01229254|156599854|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
48657781|NCT01229254|156599855|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
48657782|NCT01229254|156599856|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
48657783|NCT01229254|156599854|FG000|Overall Study|Adverse Event|4|||
48657784|NCT01229254|156599855|FG001|Overall Study|Adverse Event|5|||
48657785|NCT01229254|156599856|FG002|Overall Study|Adverse Event|3|||
48657786|NCT01229254|156599854|FG000|Overall Study|Lost to Follow-up|3|||
48657787|NCT01229254|156599855|FG001|Overall Study|Lost to Follow-up|0|||
48657788|NCT01229254|156599856|FG002|Overall Study|Lost to Follow-up|1|||
48657789|NCT01229254|156599854|FG000|Overall Study|Physician Decision|0|||
48657790|NCT01229254|156599855|FG001|Overall Study|Physician Decision|3|||
48657791|NCT01229254|156599856|FG002|Overall Study|Physician Decision|0|||
48657792|NCT01229254|156599854|FG000|Overall Study|Protocol Violation|4|||
48657793|NCT01229254|156599855|FG001|Overall Study|Protocol Violation|6|||
48657794|NCT01229254|156599856|FG002|Overall Study|Protocol Violation|5|||
48657795|NCT01229254|156599854|FG000|Overall Study|Withdrawal by Subject|1|||
48657796|NCT01229254|156599855|FG001|Overall Study|Withdrawal by Subject|0|||
48657797|NCT01229254|156599856|FG002|Overall Study|Withdrawal by Subject|1|||
48657798|NCT01229254|156599854|FG000|Overall Study|Non-compliance with Study Drug|0|||
48657799|NCT01229254|156599855|FG001|Overall Study|Non-compliance with Study Drug|1|||
48657800|NCT01229254|156599856|FG002|Overall Study|Non-compliance with Study Drug|1|||
48657801|NCT00791479|156599859|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657802|NCT00791479|156599860|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657803|NCT00791479|156599861|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657804|NCT00791479|156599862|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657805|NCT00791479|156599863|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
48657806|NCT00791479|156599864|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
48657807|NCT00791479|156599859|FG000|Overall Study|Adverse Event|0|||
48657808|NCT00791479|156599860|FG001|Overall Study|Adverse Event|1|||
48657809|NCT00791479|156599861|FG002|Overall Study|Adverse Event|0|||
48657810|NCT00791479|156599862|FG003|Overall Study|Adverse Event|2|||
48657811|NCT00791479|156599863|FG004|Overall Study|Adverse Event|0|||
48657812|NCT00791479|156599864|FG005|Overall Study|Adverse Event|1|||
48657813|NCT00791479|156599859|FG000|Overall Study|Lost to Follow-up|0|||
48657814|NCT00791479|156599860|FG001|Overall Study|Lost to Follow-up|1|||
48657815|NCT00791479|156599861|FG002|Overall Study|Lost to Follow-up|0|||
48657816|NCT00791479|156599862|FG003|Overall Study|Lost to Follow-up|0|||
48657817|NCT00791479|156599863|FG004|Overall Study|Lost to Follow-up|0|||
48657818|NCT00791479|156599864|FG005|Overall Study|Lost to Follow-up|1|||
48657819|NCT00791479|156599859|FG000|Overall Study|Protocol Violation|2|||
48657820|NCT00791479|156599860|FG001|Overall Study|Protocol Violation|1|||
48657821|NCT00791479|156599861|FG002|Overall Study|Protocol Violation|0|||
48336498|NCT00942188|155428336|FG002|Overall Study|Lost to Follow-up|2|||
48657822|NCT00791479|156599862|FG003|Overall Study|Protocol Violation|1|||
48336499|NCT00942188|155428337|FG003|Overall Study|Lost to Follow-up|0|||
48336500|NCT00942188|155428334|FG000|Overall Study|Withdrawal by Subject|1|||
48336501|NCT00942188|155428335|FG001|Overall Study|Withdrawal by Subject|3|||
48336502|NCT00942188|155428336|FG002|Overall Study|Withdrawal by Subject|4|||
48336503|NCT00942188|155428337|FG003|Overall Study|Withdrawal by Subject|2|||
48336504|NCT00942188|155428334|FG000|Overall Study|Physician Decision|0|||
48336505|NCT00942188|155428335|FG001|Overall Study|Physician Decision|0|||
48336506|NCT00942188|155428336|FG002|Overall Study|Physician Decision|1|||
48336507|NCT00942188|155428337|FG003|Overall Study|Physician Decision|0|||
48336508|NCT00942188|155428334|FG000|Overall Study|Sponsor Decision|0|||
48336509|NCT00942188|155428335|FG001|Overall Study|Sponsor Decision|2|||
48336510|NCT00942188|155428336|FG002|Overall Study|Sponsor Decision|0|||
48657823|NCT00791479|156599863|FG004|Overall Study|Protocol Violation|0|||
48657824|NCT00791479|156599864|FG005|Overall Study|Protocol Violation|0|||
48657825|NCT00791479|156599859|FG000|Overall Study|Withdrawal by Subject|0|||
48657826|NCT00791479|156599860|FG001|Overall Study|Withdrawal by Subject|0|||
48657827|NCT00791479|156599861|FG002|Overall Study|Withdrawal by Subject|0|||
48657828|NCT00791479|156599862|FG003|Overall Study|Withdrawal by Subject|1|||
48657829|NCT00791479|156599863|FG004|Overall Study|Withdrawal by Subject|0|||
48657830|NCT00791479|156599864|FG005|Overall Study|Withdrawal by Subject|1|||
48657831|NCT00244933|156599865|FG000|Overall Study|Not response evaluable|2|||
48657832|NCT00866047|156599866|FG000|Treatment Period|Progressive disease|13|||
48657833|NCT00866047|156599866|FG000|Treatment Period|Adverse Event|16|||
48657834|NCT00866047|156599866|FG000|Treatment Period|Physician Decision|14|||
48657835|NCT00866047|156599866|FG000|Treatment Period|Withdrawal by Subject|5|||
48657836|NCT00866047|156599866|FG000|Follow-up Period|Lost to Follow-up|5|||
48657837|NCT00515294|156599867|FG000|Overall Study|Lost to Follow-up|3|||
48657838|NCT00515294|156599868|FG001|Overall Study|Lost to Follow-up|2|||
48657839|NCT00515294|156599869|FG002|Overall Study|Lost to Follow-up|3|||
48657840|NCT00515294|156599870|FG003|Overall Study|Lost to Follow-up|1|||
48657841|NCT00515294|156599867|FG000|Overall Study|Driver simulator problems|1|||
48657842|NCT00515294|156599868|FG001|Overall Study|Driver simulator problems|1|||
48657843|NCT00515294|156599869|FG002|Overall Study|Driver simulator problems|1|||
48657844|NCT00515294|156599870|FG003|Overall Study|Driver simulator problems|3|||
48657845|NCT00515294|156599867|FG000|Overall Study|Caffeine amount inaccurate|5|||
48657846|NCT00515294|156599868|FG001|Overall Study|Caffeine amount inaccurate|0|||
48657847|NCT00515294|156599869|FG002|Overall Study|Caffeine amount inaccurate|7|||
48657848|NCT00515294|156599870|FG003|Overall Study|Caffeine amount inaccurate|0|||
48657849|NCT01610713|156599871|FG000|Overall Study|Adverse Event|3|||
48657850|NCT01610713|156599872|FG001|Overall Study|Adverse Event|0|||
48657851|NCT01610713|156599871|FG000|Overall Study|Lack of Efficacy|1|||
48657852|NCT01610713|156599872|FG001|Overall Study|Lack of Efficacy|0|||
48657853|NCT01610713|156599871|FG000|Overall Study|low mood and poor motivation|1|||
48657854|NCT01610713|156599872|FG001|Overall Study|low mood and poor motivation|0|||
48657855|NCT01610713|156599871|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
48657856|NCT01610713|156599872|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
48657857|NCT01610713|156599871|FG000|Overall Study|Lost to Follow-up|0|||
48657858|NCT01610713|156599872|FG001|Overall Study|Lost to Follow-up|1|||
48657859|NCT02324205|156599873|FG000|Overall Study|Withdrawal by Subject|37|||
48657860|NCT05427539|156599876|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
48657861|NCT05427539|156599877|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
48657862|NCT05427539|156599876|FG000|Period 1|Withdrawal by Subject|1|||
48657863|NCT05427539|156599877|FG001|Period 1|Withdrawal by Subject|0|||
48657864|NCT01774097|156599878|FG000|Overall Study|Withdrawal by Subject|1|||
48657865|NCT01774097|156599879|FG001|Overall Study|Withdrawal by Subject|1|||
48657866|NCT01774097|156599878|FG000|Overall Study|Adverse Event|1|||
48657867|NCT01774097|156599879|FG001|Overall Study|Adverse Event|1|||
48657868|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
48657869|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
48657870|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
48657871|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
48657872|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
48657873|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
48657874|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
48657875|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657876|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657877|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657878|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
48657879|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
48657880|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657881|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657882|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657883|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657884|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48657885|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
48754992|NCT00449540|156949725|FG002|Pretreatment Phase|No migraine experienced|0|||
48754993|NCT00449540|156949723|FG000|Treatment Phase|did not experience or treat migraine|0|||
48754994|NCT00449540|156949724|FG001|Treatment Phase|did not experience or treat migraine|20|||
48754995|NCT00449540|156949725|FG002|Treatment Phase|did not experience or treat migraine|17|||
48754996|NCT02865187|156949726|FG000|Overall Study|Lost to Follow-up|12|||
48754997|NCT02865187|156949727|FG001|Overall Study|Lost to Follow-up|7|||
48754998|NCT02865187|156949726|FG000|Overall Study|Adverse Event|1|||
48754999|NCT02865187|156949727|FG001|Overall Study|Adverse Event|0|||
48755000|NCT02268864|156949732|FG000|Overall Study|Withdrawal by Subject|2|||
48755001|NCT02268864|156949733|FG001|Overall Study|Withdrawal by Subject|0|||
48755002|NCT02268864|156949734|FG002|Overall Study|Withdrawal by Subject|0|||
48755003|NCT02268864|156949732|FG000|Overall Study|Death|0|||
48755004|NCT02268864|156949733|FG001|Overall Study|Death|1|||
48755005|NCT02268864|156949734|FG002|Overall Study|Death|0|||
48755006|NCT00533845|156949735|FG000|Overall Study|Physician Decision|1|||
48755007|NCT00533845|156949736|FG001|Overall Study|Physician Decision|0|||
48755008|NCT01288469|156949739|FG000|Overall Study|Adverse Event|4|||
48755009|NCT01288469|156949740|FG001|Overall Study|Adverse Event|1|||
48755010|NCT01288469|156949741|FG002|Overall Study|Adverse Event|1|||
48755011|NCT01288469|156949739|FG000|Overall Study|Poor compliance to protocol|0|||
48755012|NCT01288469|156949740|FG001|Overall Study|Poor compliance to protocol|1|||
48755013|NCT01288469|156949741|FG002|Overall Study|Poor compliance to protocol|0|||
48755014|NCT01288469|156949739|FG000|Overall Study|Participant Moved|1|||
48755015|NCT01288469|156949740|FG001|Overall Study|Participant Moved|0|||
48755016|NCT01288469|156949741|FG002|Overall Study|Participant Moved|0|||
48755017|NCT01288469|156949739|FG000|Overall Study|Consent withdrawn by subject|1|||
48755018|NCT01288469|156949740|FG001|Overall Study|Consent withdrawn by subject|1|||
48755019|NCT01288469|156949741|FG002|Overall Study|Consent withdrawn by subject|1|||
48755020|NCT01288469|156949739|FG000|Overall Study|Exclusion criteria finally met|1|||
48755021|NCT01288469|156949740|FG001|Overall Study|Exclusion criteria finally met|0|||
48755022|NCT01288469|156949741|FG002|Overall Study|Exclusion criteria finally met|0|||
48755023|NCT02107482|156949751|FG000|Overall Study|inconveinence|2|||
48755024|NCT02107482|156949751|FG000|Overall Study|Lost to Follow-up|1|||
48755025|NCT02107482|156949751|FG000|Overall Study|Lack of Efficacy|1|||
48755026|NCT02157298|156949757|FG000|Overall Study|Adverse Event|1|||
48755027|NCT02157298|156949758|FG001|Overall Study|Adverse Event|0|||
48755028|NCT02157298|156949757|FG000|Overall Study|Subject no longer meets study criteria|1|||
48755029|NCT02157298|156949758|FG001|Overall Study|Subject no longer meets study criteria|2|||
48755030|NCT02157298|156949757|FG000|Overall Study|Poor/Non-compliance|1|||
48755031|NCT02157298|156949758|FG001|Overall Study|Poor/Non-compliance|0|||
48755032|NCT02157298|156949757|FG000|Overall Study|Withdrawal by Subject|1|||
48755033|NCT02157298|156949758|FG001|Overall Study|Withdrawal by Subject|0|||
48755034|NCT03855280|156949759|FG000|Treatment Phase|Adverse Event|1|||
48755035|NCT03855280|156949759|FG000|Treatment Phase|Withdrawal by Subject|1|||
48755036|NCT03855280|156949759|FG000|Continuation Phase|Protocol Violation|1|||
48755037|NCT03855280|156949759|FG000|Continuation Phase|Adverse Event|1|||
48755038|NCT03855280|156949759|FG000|Continuation Phase|Sponsor Concluded Study|1|||
48755039|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
48755040|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
48755041|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
48755042|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
48755043|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|Death|7|||
48755044|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|Death|5|||
48755045|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
48755046|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
48755047|NCT02999854|156949760|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
48755048|NCT02999854|156949761|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
48755049|NCT02999854|156949760|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
48755050|NCT02999854|156949761|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
48755051|NCT02999854|156949760|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
48755052|NCT02999854|156949761|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
48755053|NCT02999854|156949760|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
48755054|NCT02999854|156949761|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
48755055|NCT04059094|156949762|FG000|Overall Study|Adverse Event|0|||
48755056|NCT04059094|156949763|FG001|Overall Study|Adverse Event|0|||
48755057|NCT04059094|156949764|FG002|Overall Study|Adverse Event|0|||
48755058|NCT04059094|156949765|FG003|Overall Study|Adverse Event|0|||
48336511|NCT00942188|155428337|FG003|Overall Study|Sponsor Decision|1|||
48755059|NCT04059094|156949766|FG004|Overall Study|Adverse Event|1|||
48755060|NCT04059094|156949762|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
48755061|NCT04059094|156949763|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
48336512|NCT05379400|155429485|FG000|Overall Study|Lost to Follow-up|1|||
48336513|NCT05379400|155429486|FG001|Overall Study|Lost to Follow-up|1|||
48657886|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
48755062|NCT04059094|156949764|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
48755063|NCT04059094|156949765|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
48755064|NCT04059094|156949766|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
48755065|NCT00461682|156949767|FG000|Overall Study|Protocol Violation|1|||
48755066|NCT02953314|156949775|FG000|Overall Study|Adverse Event|0|||
48755067|NCT02953314|156949776|FG001|Overall Study|Adverse Event|1|||
48755068|NCT02953314|156949775|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48755069|NCT02953314|156949776|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
48755070|NCT00818662|156949777|FG000|Overall Study|Adverse Event|5|||
48657887|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657888|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
48657889|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657890|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657891|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
48657892|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
48755071|NCT00818662|156949778|FG001|Overall Study|Adverse Event|14|||
48755072|NCT00818662|156949779|FG002|Overall Study|Adverse Event|4|||
48755073|NCT00818662|156949780|FG003|Overall Study|Adverse Event|3|||
48755074|NCT00818662|156949777|FG000|Overall Study|Withdrawal by Subject|5|||
48755075|NCT00818662|156949778|FG001|Overall Study|Withdrawal by Subject|4|||
48755076|NCT00818662|156949779|FG002|Overall Study|Withdrawal by Subject|2|||
48755077|NCT00818662|156949780|FG003|Overall Study|Withdrawal by Subject|2|||
48755078|NCT00818662|156949777|FG000|Overall Study|Death|1|||
48755079|NCT00818662|156949778|FG001|Overall Study|Death|3|||
48755080|NCT00818662|156949779|FG002|Overall Study|Death|0|||
48755081|NCT00818662|156949780|FG003|Overall Study|Death|0|||
48755082|NCT00818662|156949777|FG000|Overall Study|Physician Decision|1|||
48755083|NCT00818662|156949778|FG001|Overall Study|Physician Decision|0|||
48336514|NCT00215943|155429487|FG000|Overall Study|Disease Progression|3|||
48336515|NCT00215943|155429488|FG001|Overall Study|Disease Progression|5|||
48755084|NCT00818662|156949779|FG002|Overall Study|Physician Decision|0|||
48336516|NCT00215943|155429487|FG000|Overall Study|Alternate therapy|0|||
48336517|NCT00215943|155429488|FG001|Overall Study|Alternate therapy|1|||
48336518|NCT00215943|155429487|FG000|Overall Study|Adverse Event|3|||
48336519|NCT00215943|155429488|FG001|Overall Study|Adverse Event|6|||
48336520|NCT00215943|155429487|FG000|Overall Study|Other disease|0|||
48336521|NCT00215943|155429488|FG001|Overall Study|Other disease|1|||
48336522|NCT00215943|155429487|FG000|Overall Study|Other complications|3|||
48336523|NCT00215943|155429488|FG001|Overall Study|Other complications|1|||
48336524|NCT04999020|155429489|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
48336525|NCT04999020|155429490|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
48336526|NCT04999020|155429491|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
48336527|NCT04999020|155429492|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
48336528|NCT04999020|155429489|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
48336529|NCT04999020|155429490|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
48336530|NCT04999020|155429491|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
48336531|NCT04999020|155429492|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
48336532|NCT04999020|155429489|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
48336533|NCT04999020|155429490|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
48336534|NCT04999020|155429491|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
48336535|NCT04999020|155429492|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
48336536|NCT04999020|155429489|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48336537|NCT04999020|155429490|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48336538|NCT04999020|155429491|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
48336539|NCT04999020|155429492|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
48336540|NCT04999020|155429489|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
48336541|NCT04999020|155429490|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
48336542|NCT04999020|155429491|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
48336543|NCT04999020|155429492|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
48336544|NCT04999020|155429489|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
48336545|NCT04999020|155429490|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
48336546|NCT04999020|155429491|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
48336547|NCT04999020|155429492|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
48336548|NCT04999020|155429489|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
48336549|NCT04999020|155429490|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
48336550|NCT04999020|155429491|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
48755085|NCT00818662|156949780|FG003|Overall Study|Physician Decision|0|||
48755086|NCT00818662|156949777|FG000|Overall Study|Lost to Follow-up|0|||
48755087|NCT00818662|156949778|FG001|Overall Study|Lost to Follow-up|0|||
48657893|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657894|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657895|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657896|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657897|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657898|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657899|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657900|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657901|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657902|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657903|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
48657904|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657905|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657906|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
48657907|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657908|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657909|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657910|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657911|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657912|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657913|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657914|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657915|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657916|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657917|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657918|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657919|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657920|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657921|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
48657922|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657923|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657924|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
48657925|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657926|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657927|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657928|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657929|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657930|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657931|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657932|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657933|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657934|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657935|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657936|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657937|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657938|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657939|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
48657940|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657941|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657942|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657943|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657944|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657945|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657946|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657947|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657948|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657949|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657950|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
48657951|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657952|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657953|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657954|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657955|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657956|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48657957|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
48755088|NCT00818662|156949779|FG002|Overall Study|Lost to Follow-up|0|||
48755089|NCT00818662|156949780|FG003|Overall Study|Lost to Follow-up|1|||
48336551|NCT04999020|155429492|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
48336552|NCT04999020|155429489|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
48336553|NCT04999020|155429490|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
48336554|NCT04999020|155429491|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
48336555|NCT04999020|155429492|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
48336556|NCT01072149|155429493|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336557|NCT01072149|155429494|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336558|NCT01072149|155429495|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48336559|NCT01072149|155429496|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336560|NCT01072149|155429497|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336561|NCT01072149|155429498|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48755090|NCT00818662|156949777|FG000|Overall Study|Unwilling or Unable to Participate|4|||
48755091|NCT00818662|156949778|FG001|Overall Study|Unwilling or Unable to Participate|6|||
48657958|NCT03447314|156599881|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48755092|NCT00818662|156949779|FG002|Overall Study|Unwilling or Unable to Participate|2|||
48755093|NCT00818662|156949780|FG003|Overall Study|Unwilling or Unable to Participate|4|||
48755094|NCT00818662|156949777|FG000|Overall Study|Protocol Violation|1|||
48336562|NCT01072149|155429499|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336563|NCT01072149|155429500|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48657959|NCT03447314|156599882|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657960|NCT03447314|156599883|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48755095|NCT00818662|156949778|FG001|Overall Study|Protocol Violation|1|||
48755096|NCT00818662|156949779|FG002|Overall Study|Protocol Violation|0|||
48755097|NCT00818662|156949780|FG003|Overall Study|Protocol Violation|0|||
48755098|NCT00818662|156949777|FG000|Overall Study|Requires a Prohibited Medication|1|||
48755099|NCT00818662|156949778|FG001|Overall Study|Requires a Prohibited Medication|0|||
48755100|NCT00818662|156949779|FG002|Overall Study|Requires a Prohibited Medication|0|||
48755101|NCT00818662|156949780|FG003|Overall Study|Requires a Prohibited Medication|0|||
48755102|NCT00818662|156949777|FG000|Overall Study|Safety Risk|1|||
48755103|NCT00818662|156949778|FG001|Overall Study|Safety Risk|1|||
48755104|NCT00818662|156949779|FG002|Overall Study|Safety Risk|0|||
48755105|NCT00818662|156949780|FG003|Overall Study|Safety Risk|1|||
48755106|NCT00818662|156949777|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
48755107|NCT00818662|156949778|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
48755108|NCT00818662|156949779|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
48755109|NCT00818662|156949780|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
48755110|NCT00818662|156949777|FG000|Overall Study|Participant's health declined|0|||
48755111|NCT00818662|156949778|FG001|Overall Study|Participant's health declined|0|||
48755112|NCT00818662|156949779|FG002|Overall Study|Participant's health declined|0|||
48755113|NCT00818662|156949780|FG003|Overall Study|Participant's health declined|1|||
48755114|NCT00818662|156949777|FG000|Overall Study|Caregiver to pursue other treatment|0|||
48755115|NCT00818662|156949778|FG001|Overall Study|Caregiver to pursue other treatment|1|||
48755116|NCT00818662|156949779|FG002|Overall Study|Caregiver to pursue other treatment|0|||
48755117|NCT00818662|156949780|FG003|Overall Study|Caregiver to pursue other treatment|0|||
48755118|NCT00818662|156949777|FG000|Overall Study|Moving out of state|0|||
48755119|NCT00818662|156949778|FG001|Overall Study|Moving out of state|0|||
48336564|NCT01072149|155429501|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336565|NCT01072149|155429502|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336566|NCT01072149|155429503|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48755120|NCT00818662|156949779|FG002|Overall Study|Moving out of state|0|||
48755121|NCT00818662|156949780|FG003|Overall Study|Moving out of state|1|||
48755122|NCT00818662|156949777|FG000|Overall Study|Declined move to another study site|1|||
48336567|NCT01072149|155429504|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336568|NCT01072149|155429505|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336569|NCT01072149|155429506|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336570|NCT01072149|155429507|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336571|NCT01072149|155429508|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336572|NCT01072149|155429509|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336573|NCT01072149|155429510|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48336574|NCT01072149|155429493|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336575|NCT01072149|155429494|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336576|NCT01072149|155429495|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336577|NCT01072149|155429496|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336578|NCT01072149|155429497|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336579|NCT01072149|155429498|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336580|NCT01072149|155429499|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336581|NCT01072149|155429500|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336582|NCT01072149|155429501|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48657961|NCT03447314|156599884|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
48657962|NCT03447314|156599885|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657963|NCT03447314|156599886|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
48755123|NCT00818662|156949778|FG001|Overall Study|Declined move to another study site|0|||
48755124|NCT00818662|156949779|FG002|Overall Study|Declined move to another study site|0|||
48755125|NCT00818662|156949780|FG003|Overall Study|Declined move to another study site|0|||
48755126|NCT00818662|156949777|FG000|Overall Study|Change in living situation|0|||
48755127|NCT00818662|156949778|FG001|Overall Study|Change in living situation|0|||
48755128|NCT00818662|156949779|FG002|Overall Study|Change in living situation|0|||
48755129|NCT00818662|156949780|FG003|Overall Study|Change in living situation|1|||
48755130|NCT00818662|156949777|FG000|Overall Study|Study partner decision|0|||
48755131|NCT00818662|156949778|FG001|Overall Study|Study partner decision|0|||
48755132|NCT00818662|156949779|FG002|Overall Study|Study partner decision|0|||
48755133|NCT00818662|156949780|FG003|Overall Study|Study partner decision|1|||
48755134|NCT00818662|156949777|FG000|Overall Study|Admitted to long term nursing care|0|||
48755135|NCT00818662|156949778|FG001|Overall Study|Admitted to long term nursing care|1|||
48755136|NCT00818662|156949779|FG002|Overall Study|Admitted to long term nursing care|0|||
48755137|NCT00818662|156949780|FG003|Overall Study|Admitted to long term nursing care|0|||
48755138|NCT01722071|156949781|FG000|Overall Study|Protocol Violation|1|||
48755139|NCT01722071|156949782|FG001|Overall Study|Protocol Violation|0|||
48755140|NCT00656474|156949783|FG000|Overall Study|Other Reason|1|||
48755141|NCT01614067|156949785|FG000|Overall Study|Pregnancy|1|||
48755142|NCT01614067|156949786|FG001|Overall Study|Pregnancy|0|||
48755143|NCT01614067|156949785|FG000|Overall Study|Physician Decision|6|||
48755144|NCT01614067|156949786|FG001|Overall Study|Physician Decision|5|||
48755145|NCT01614067|156949785|FG000|Overall Study|Withdrawal by Subject|0|||
48755146|NCT01614067|156949786|FG001|Overall Study|Withdrawal by Subject|1|||
48755147|NCT01614067|156949785|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
48755148|NCT01614067|156949786|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
48755149|NCT03061331|156949790|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
48336583|NCT01072149|155429502|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48657964|NCT03447314|156599887|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657965|NCT03447314|156599888|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657966|NCT03447314|156599889|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657967|NCT03447314|156599890|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657968|NCT03447314|156599891|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657969|NCT03447314|156599892|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657970|NCT03447314|156599893|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657971|NCT03447314|156599894|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657972|NCT03447314|156599895|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657973|NCT03447314|156599896|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657974|NCT03447314|156599897|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657975|NCT03447314|156599898|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
48657976|NCT02152371|156599899|FG000|Overall Study|Adverse Event|6|||
48657977|NCT02152371|156599900|FG001|Overall Study|Adverse Event|2|||
48657978|NCT02152371|156599899|FG000|Overall Study|Withdrawal by Subject|3|||
48657979|NCT02152371|156599900|FG001|Overall Study|Withdrawal by Subject|7|||
48755150|NCT03061331|156949791|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
48755151|NCT02998840|156949792|FG000|Overall Study|Lost to Follow-up|1|||
48755152|NCT02998840|156949793|FG001|Overall Study|Lost to Follow-up|1|||
48755153|NCT02998840|156949794|FG002|Overall Study|Lost to Follow-up|2|||
48755154|NCT02998840|156949795|FG003|Overall Study|Lost to Follow-up|3|||
48755155|NCT02998840|156949792|FG000|Overall Study|Withdrawal by Subject|1|||
48755156|NCT02998840|156949793|FG001|Overall Study|Withdrawal by Subject|1|||
48336584|NCT01072149|155429503|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48657980|NCT02152371|156599899|FG000|Overall Study|Protocol Violation|2|||
48657981|NCT02152371|156599900|FG001|Overall Study|Protocol Violation|3|||
48657982|NCT02152371|156599899|FG000|Overall Study|Lost to Follow-up|1|||
48657983|NCT02152371|156599900|FG001|Overall Study|Lost to Follow-up|0|||
48657984|NCT02152371|156599899|FG000|Overall Study|Lack of Efficacy|0|||
48657985|NCT02152371|156599900|FG001|Overall Study|Lack of Efficacy|1|||
48657986|NCT02152371|156599899|FG000|Overall Study|Physician Decision|0|||
48657987|NCT02152371|156599900|FG001|Overall Study|Physician Decision|2|||
48657988|NCT02152371|156599899|FG000|Overall Study|Reason Not Given|0|||
48657989|NCT02152371|156599900|FG001|Overall Study|Reason Not Given|1|||
48657990|NCT02099344|156599902|FG000|Overall Study|Physician Decision|1|||
48657991|NCT02099344|156599903|FG001|Overall Study|Physician Decision|0|||
48657992|NCT02151981|156599906|FG000|Overall Study|Death|184|||
48657993|NCT02151981|156599907|FG001|Overall Study|Death|88|||
48657994|NCT02151981|156599906|FG000|Overall Study|Lost to Follow-up|7|||
48657995|NCT02151981|156599907|FG001|Overall Study|Lost to Follow-up|1|||
48657996|NCT02151981|156599906|FG000|Overall Study|Withdrawal by Subject|27|||
48657997|NCT02151981|156599907|FG001|Overall Study|Withdrawal by Subject|21|||
48657998|NCT02151981|156599906|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48657999|NCT02151981|156599907|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48658000|NCT02151981|156599906|FG000|Overall Study|Other reasons|1|||
48658001|NCT02151981|156599907|FG001|Overall Study|Other reasons|2|||
48658002|NCT03006458|156599913|FG000|First Intervention|Unsatisfied Vision|0|||
48658003|NCT03006458|156599914|FG001|First Intervention|Unsatisfied Vision|3|||
48658004|NCT01482169|156599915|FG000|Overall Study|Physician Decision|2|||
48658005|NCT00457821|156599921|FG000|Part 2|Withdrawal by Subject|0|||
48658006|NCT00457821|156599922|FG001|Part 2|Withdrawal by Subject|0|||
48658007|NCT00457821|156599923|FG002|Part 2|Withdrawal by Subject|0|||
48658008|NCT00457821|156599924|FG003|Part 2|Withdrawal by Subject|0|||
48658009|NCT00457821|156599925|FG004|Part 2|Withdrawal by Subject|0|||
48658010|NCT00457821|156599926|FG005|Part 2|Withdrawal by Subject|0|||
48658011|NCT00457821|156599927|FG006|Part 2|Withdrawal by Subject|0|||
48658012|NCT00457821|156599928|FG007|Part 2|Withdrawal by Subject|1|||
48658013|NCT00778258|156599929|FG000|Overall Study|Adverse Event|1|||
48658014|NCT00778258|156599930|FG001|Overall Study|Adverse Event|0|||
48658015|NCT00778258|156599931|FG002|Overall Study|Adverse Event|0|||
48658016|NCT00778258|156599932|FG003|Overall Study|Adverse Event|0|||
48658017|NCT00778258|156599933|FG004|Overall Study|Adverse Event|0|||
48658018|NCT00778258|156599934|FG005|Overall Study|Adverse Event|1|||
48658019|NCT00778258|156599935|FG006|Overall Study|Adverse Event|0|||
48658020|NCT00778258|156599936|FG007|Overall Study|Adverse Event|0|||
48658021|NCT00778258|156599937|FG008|Overall Study|Adverse Event|0|||
48658022|NCT00778258|156599929|FG000|Overall Study|Lost to Follow-up|0|||
48658023|NCT00778258|156599930|FG001|Overall Study|Lost to Follow-up|0|||
48658024|NCT00778258|156599931|FG002|Overall Study|Lost to Follow-up|2|||
48658025|NCT00778258|156599932|FG003|Overall Study|Lost to Follow-up|0|||
48658026|NCT00778258|156599933|FG004|Overall Study|Lost to Follow-up|0|||
48658027|NCT00778258|156599934|FG005|Overall Study|Lost to Follow-up|3|||
48658028|NCT00778258|156599935|FG006|Overall Study|Lost to Follow-up|2|||
48658029|NCT00778258|156599936|FG007|Overall Study|Lost to Follow-up|2|||
48658030|NCT00778258|156599937|FG008|Overall Study|Lost to Follow-up|0|||
48658031|NCT00778258|156599929|FG000|Overall Study|Withdrawal by Subject|6|||
48658032|NCT00778258|156599930|FG001|Overall Study|Withdrawal by Subject|2|||
48658033|NCT00778258|156599931|FG002|Overall Study|Withdrawal by Subject|8|||
48658034|NCT00778258|156599932|FG003|Overall Study|Withdrawal by Subject|2|||
48658035|NCT00778258|156599933|FG004|Overall Study|Withdrawal by Subject|0|||
48658036|NCT00778258|156599934|FG005|Overall Study|Withdrawal by Subject|6|||
48658037|NCT00778258|156599935|FG006|Overall Study|Withdrawal by Subject|12|||
48658038|NCT00778258|156599936|FG007|Overall Study|Withdrawal by Subject|12|||
48658039|NCT00778258|156599937|FG008|Overall Study|Withdrawal by Subject|4|||
48658040|NCT00778258|156599929|FG000|Overall Study|New Contraindication|0|||
48336585|NCT01072149|155429504|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48658041|NCT00778258|156599930|FG001|Overall Study|New Contraindication|0|||
48658042|NCT00778258|156599931|FG002|Overall Study|New Contraindication|0|||
48658043|NCT00778258|156599932|FG003|Overall Study|New Contraindication|0|||
48658044|NCT00778258|156599933|FG004|Overall Study|New Contraindication|0|||
48658045|NCT00778258|156599934|FG005|Overall Study|New Contraindication|0|||
48336586|NCT01072149|155429505|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336587|NCT01072149|155429506|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336588|NCT01072149|155429507|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48658046|NCT00778258|156599935|FG006|Overall Study|New Contraindication|0|||
48658047|NCT00778258|156599936|FG007|Overall Study|New Contraindication|1|||
48428211|NCT02531373|155756505|FG007|Overall Study|Lack of Efficacy|8|||
48658048|NCT00778258|156599937|FG008|Overall Study|New Contraindication|0|||
48658049|NCT00778258|156599929|FG000|Overall Study|Non-compliance|0|||
48658050|NCT00778258|156599930|FG001|Overall Study|Non-compliance|0|||
48658051|NCT00778258|156599931|FG002|Overall Study|Non-compliance|0|||
48336589|NCT01072149|155429508|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48336590|NCT01072149|155429509|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
48658052|NCT00778258|156599932|FG003|Overall Study|Non-compliance|1|||
48658053|NCT00778258|156599933|FG004|Overall Study|Non-compliance|0|||
48658054|NCT00778258|156599934|FG005|Overall Study|Non-compliance|0|||
48658055|NCT00778258|156599935|FG006|Overall Study|Non-compliance|0|||
48658056|NCT00778258|156599936|FG007|Overall Study|Non-compliance|0|||
48658057|NCT00778258|156599937|FG008|Overall Study|Non-compliance|0|||
48658058|NCT00778258|156599929|FG000|Overall Study|Other|0|||
48658059|NCT00778258|156599930|FG001|Overall Study|Other|0|||
48658060|NCT00778258|156599931|FG002|Overall Study|Other|0|||
48658061|NCT00778258|156599932|FG003|Overall Study|Other|0|||
48658062|NCT00778258|156599933|FG004|Overall Study|Other|0|||
48658063|NCT00778258|156599934|FG005|Overall Study|Other|0|||
48658064|NCT00778258|156599935|FG006|Overall Study|Other|1|||
48755157|NCT02998840|156949794|FG002|Overall Study|Withdrawal by Subject|0|||
48755158|NCT02998840|156949795|FG003|Overall Study|Withdrawal by Subject|1|||
48755159|NCT02998840|156949792|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
48755160|NCT02998840|156949793|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
48755161|NCT02998840|156949794|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
48755162|NCT02998840|156949795|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
48755163|NCT03338855|156949796|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
48336591|NCT01072149|155429510|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
48586570|NCT02565706|156339025|FG000|Overall Study|Lost to Follow-up|72|||
48586571|NCT02565706|156339026|FG001|Overall Study|Lost to Follow-up|75|||
48586572|NCT02565706|156339027|FG002|Overall Study|Lost to Follow-up|82|||
48586573|NCT02565706|156339028|FG003|Overall Study|Lost to Follow-up|74|||
48586574|NCT00934856|156339029|FG000|Feasibility Part|Progressive disease|4|||
48586575|NCT00934856|156339030|FG001|Feasibility Part|Progressive disease|4|||
48586576|NCT00934856|156339031|FG002|Feasibility Part|Progressive disease|2|||
48586577|NCT00934856|156339032|FG003|Feasibility Part|Progressive disease|3|||
48586578|NCT00934856|156339033|FG004|Feasibility Part|Progressive disease|0|||
48586579|NCT00934856|156339034|FG005|Feasibility Part|Progressive disease|0|||
48586580|NCT00934856|156339029|FG000|Feasibility Part|Physician Decision|0|||
48586581|NCT00934856|156339030|FG001|Feasibility Part|Physician Decision|0|||
48586582|NCT00934856|156339031|FG002|Feasibility Part|Physician Decision|1|||
48586583|NCT00934856|156339032|FG003|Feasibility Part|Physician Decision|0|||
48586584|NCT00934856|156339033|FG004|Feasibility Part|Physician Decision|0|||
48586585|NCT00934856|156339034|FG005|Feasibility Part|Physician Decision|0|||
48658065|NCT00778258|156599936|FG007|Overall Study|Other|0|||
48658066|NCT00778258|156599937|FG008|Overall Study|Other|0|||
48658067|NCT00096174|156599938|FG000|Overall Study|Lack of Efficacy|9|||
48658068|NCT00096174|156599938|FG000|Overall Study|Adverse Event|15|||
48658069|NCT00096174|156599938|FG000|Overall Study|Death|6|||
48658070|NCT00096174|156599938|FG000|Overall Study|Withdrawal by Subject|15|||
48586586|NCT00934856|156339029|FG000|Feasibility Part|Adverse Event|1|||
48586587|NCT00934856|156339030|FG001|Feasibility Part|Adverse Event|1|||
48586588|NCT00934856|156339031|FG002|Feasibility Part|Adverse Event|0|||
48586589|NCT00934856|156339032|FG003|Feasibility Part|Adverse Event|1|||
48586590|NCT00934856|156339033|FG004|Feasibility Part|Adverse Event|0|||
48586591|NCT00934856|156339034|FG005|Feasibility Part|Adverse Event|2|||
48586592|NCT00934856|156339029|FG000|Feasibility Part|Withdrawal by Subject|0|||
48336592|NCT01072149|155429493|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336593|NCT01072149|155429494|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336594|NCT01072149|155429495|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336595|NCT01072149|155429496|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336596|NCT01072149|155429497|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336597|NCT01072149|155429498|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336598|NCT01072149|155429499|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336599|NCT01072149|155429500|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336600|NCT01072149|155429501|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336601|NCT01072149|155429502|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336602|NCT01072149|155429503|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
48336603|NCT01072149|155429504|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336604|NCT01072149|155429505|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336605|NCT01072149|155429506|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336606|NCT01072149|155429507|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336607|NCT01072149|155429508|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336608|NCT01072149|155429509|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336609|NCT01072149|155429510|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48336610|NCT01072149|155429493|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336611|NCT01072149|155429494|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
48336612|NCT01072149|155429495|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336613|NCT01072149|155429496|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336614|NCT01072149|155429497|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336615|NCT01072149|155429498|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336616|NCT01072149|155429499|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336617|NCT01072149|155429500|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336618|NCT01072149|155429501|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336619|NCT01072149|155429502|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336620|NCT01072149|155429503|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336621|NCT01072149|155429504|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336622|NCT01072149|155429505|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336623|NCT01072149|155429506|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336624|NCT01072149|155429507|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336625|NCT01072149|155429508|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336626|NCT01072149|155429509|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336627|NCT01072149|155429510|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48336628|NCT01072149|155429493|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336629|NCT01072149|155429494|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48658071|NCT00096174|156599938|FG000|Overall Study|Not started protocol therapy|3|||
48336630|NCT01072149|155429495|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
48336631|NCT01072149|155429496|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336632|NCT01072149|155429497|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336633|NCT01072149|155429498|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48658072|NCT00096174|156599938|FG000|Overall Study|Ineligible|6|||
48658073|NCT00096174|156599938|FG000|Overall Study|other reason|8|||
48658074|NCT02136680|156599939|FG000|Overall Study|No Longer Interested|1|||
48658075|NCT02136680|156599940|FG001|Overall Study|No Longer Interested|1|||
48658076|NCT02136680|156599939|FG000|Overall Study|No longer receiving care at clinic|3|||
48658077|NCT02136680|156599940|FG001|Overall Study|No longer receiving care at clinic|5|||
48658078|NCT02136680|156599939|FG000|Overall Study|Moved away|5|||
48658079|NCT02136680|156599940|FG001|Overall Study|Moved away|4|||
48336634|NCT01072149|155429499|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48658080|NCT02136680|156599939|FG000|Overall Study|Unable to schedule|17|||
48658081|NCT02136680|156599940|FG001|Overall Study|Unable to schedule|16|||
48658082|NCT02136680|156599939|FG000|Overall Study|Study ended before interview due|6|||
48658083|NCT02136680|156599940|FG001|Overall Study|Study ended before interview due|3|||
48658084|NCT02182440|156599950|FG000|Overall Study|Adverse Event|0|||
48428212|NCT02531373|155756506|FG008|Overall Study|Lack of Efficacy|5|||
48586593|NCT00934856|156339030|FG001|Feasibility Part|Withdrawal by Subject|0|||
48658085|NCT02182440|156599951|FG001|Overall Study|Adverse Event|1|||
48586594|NCT00934856|156339031|FG002|Feasibility Part|Withdrawal by Subject|0|||
48586595|NCT00934856|156339032|FG003|Feasibility Part|Withdrawal by Subject|1|||
48586596|NCT00934856|156339033|FG004|Feasibility Part|Withdrawal by Subject|0|||
48658086|NCT02182440|156599952|FG002|Overall Study|Adverse Event|0|||
48658087|NCT02182440|156599953|FG003|Overall Study|Adverse Event|0|||
48658088|NCT02182440|156599950|FG000|Overall Study|Death|31|||
48658089|NCT02182440|156599951|FG001|Overall Study|Death|8|||
48658090|NCT02182440|156599952|FG002|Overall Study|Death|5|||
48658091|NCT02182440|156599953|FG003|Overall Study|Death|16|||
48658092|NCT02182440|156599950|FG000|Overall Study|Protocol Violation|0|||
48658093|NCT02182440|156599951|FG001|Overall Study|Protocol Violation|1|||
48586597|NCT00934856|156339034|FG005|Feasibility Part|Withdrawal by Subject|1|||
48586598|NCT00934856|156339029|FG000|Extension Part|Adverse Event|0|||
48586599|NCT00934856|156339030|FG001|Extension Part|Adverse Event|0|||
48586600|NCT00934856|156339031|FG002|Extension Part|Adverse Event|0|||
48658094|NCT02182440|156599952|FG002|Overall Study|Protocol Violation|0|||
48586601|NCT00934856|156339032|FG003|Extension Part|Adverse Event|1|||
48586602|NCT00934856|156339033|FG004|Extension Part|Adverse Event|4|||
48586603|NCT00934856|156339034|FG005|Extension Part|Adverse Event|4|||
48586604|NCT00934856|156339029|FG000|Extension Part|Progressive disease|0|||
48586605|NCT00934856|156339030|FG001|Extension Part|Progressive disease|0|||
48586606|NCT00934856|156339031|FG002|Extension Part|Progressive disease|0|||
48586607|NCT00934856|156339032|FG003|Extension Part|Progressive disease|1|||
48658095|NCT02182440|156599953|FG003|Overall Study|Protocol Violation|0|||
48658096|NCT02182440|156599950|FG000|Overall Study|Physician Decision|1|||
48658097|NCT02182440|156599951|FG001|Overall Study|Physician Decision|0|||
48658098|NCT02182440|156599952|FG002|Overall Study|Physician Decision|0|||
48658099|NCT02182440|156599953|FG003|Overall Study|Physician Decision|0|||
48658100|NCT02182440|156599950|FG000|Overall Study|Withdrawal by Subject|1|||
48658101|NCT02182440|156599951|FG001|Overall Study|Withdrawal by Subject|1|||
48658102|NCT02182440|156599952|FG002|Overall Study|Withdrawal by Subject|3|||
48658103|NCT02182440|156599953|FG003|Overall Study|Withdrawal by Subject|4|||
48658104|NCT02182440|156599950|FG000|Overall Study|different, e.g adm other hospital|12|||
48658105|NCT02182440|156599951|FG001|Overall Study|different, e.g adm other hospital|3|||
48658106|NCT02182440|156599952|FG002|Overall Study|different, e.g adm other hospital|3|||
48658107|NCT02182440|156599953|FG003|Overall Study|different, e.g adm other hospital|10|||
48658108|NCT00624819|156599954|FG000|Follow-up Period: Year 4|Parents decision|0|||
48658109|NCT00624819|156599955|FG001|Follow-up Period: Year 4|Parents decision|0|||
48658110|NCT00624819|156599956|FG002|Follow-up Period: Year 4|Parents decision|1|||
48658111|NCT00624819|156599957|FG003|Follow-up Period: Year 4|Parents decision|0|||
48658112|NCT00624819|156599954|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
48658113|NCT00624819|156599955|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
48658114|NCT00624819|156599956|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
48658115|NCT00624819|156599957|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
48658116|NCT02279719|156599958|FG000|Overall Study|Patients randomized but never treated|0|||
48658117|NCT02279719|156599959|FG001|Overall Study|Patients randomized but never treated|0|||
48658118|NCT02279719|156599960|FG002|Overall Study|Patients randomized but never treated|0|||
48658119|NCT02279719|156599961|FG003|Overall Study|Patients randomized but never treated|0|||
48658120|NCT02279719|156599962|FG004|Overall Study|Patients randomized but never treated|3|||
48586608|NCT00934856|156339033|FG004|Extension Part|Progressive disease|0|||
48586609|NCT00934856|156339034|FG005|Extension Part|Progressive disease|0|||
48658121|NCT02279719|156599963|FG005|Overall Study|Patients randomized but never treated|0|||
48428213|NCT02531373|155756498|FG000|Overall Study|Lost to Follow-up|0|||
48658122|NCT02279719|156599964|FG006|Overall Study|Patients randomized but never treated|3|||
48658123|NCT00737711|156601570|FG000|Overall Study|Adverse Event|2|||
48658124|NCT00737711|156601570|FG000|Overall Study|Death|8|||
48658125|NCT00737711|156601570|FG000|Overall Study|Failure to return|4|||
48586610|NCT00934856|156339029|FG000|Extension Part|Non-compliance with drug|0|||
48586611|NCT00934856|156339030|FG001|Extension Part|Non-compliance with drug|0|||
48586612|NCT00934856|156339031|FG002|Extension Part|Non-compliance with drug|0|||
48336635|NCT01072149|155429500|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336636|NCT01072149|155429501|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48586613|NCT00934856|156339032|FG003|Extension Part|Non-compliance with drug|0|||
48336637|NCT01072149|155429502|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48586614|NCT00934856|156339033|FG004|Extension Part|Non-compliance with drug|0|||
48586615|NCT00934856|156339034|FG005|Extension Part|Non-compliance with drug|1|||
48336638|NCT01072149|155429503|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48428214|NCT02531373|155756499|FG001|Overall Study|Lost to Follow-up|0|||
48586616|NCT01935700|156339036|FG000|Overall Study|Withdrawal by Subject|1|||
48586617|NCT01935700|156339037|FG001|Overall Study|Withdrawal by Subject|0|||
48586618|NCT01935700|156339036|FG000|Overall Study|Physician Decision|4|||
48586619|NCT01935700|156339037|FG001|Overall Study|Physician Decision|0|||
48586620|NCT02327013|156339038|FG000|Overall Study|Adverse Event|4|||
48586621|NCT02327013|156339039|FG001|Overall Study|Adverse Event|4|||
48586622|NCT02327013|156339040|FG002|Overall Study|Adverse Event|3|||
48586623|NCT02327013|156339041|FG003|Overall Study|Adverse Event|0|||
48586624|NCT02327013|156339042|FG004|Overall Study|Adverse Event|1|||
48586625|NCT02327013|156339038|FG000|Overall Study|Lack of Efficacy|2|||
48586626|NCT02327013|156339039|FG001|Overall Study|Lack of Efficacy|0|||
48586627|NCT02327013|156339040|FG002|Overall Study|Lack of Efficacy|5|||
48586628|NCT02327013|156339041|FG003|Overall Study|Lack of Efficacy|0|||
48586629|NCT02327013|156339042|FG004|Overall Study|Lack of Efficacy|1|||
48586630|NCT02327013|156339038|FG000|Overall Study|Non-compliance with IMP|1|||
48586631|NCT02327013|156339039|FG001|Overall Study|Non-compliance with IMP|2|||
48586632|NCT02327013|156339040|FG002|Overall Study|Non-compliance with IMP|7|||
48586633|NCT02327013|156339041|FG003|Overall Study|Non-compliance with IMP|0|||
48586634|NCT02327013|156339042|FG004|Overall Study|Non-compliance with IMP|0|||
48586635|NCT02327013|156339038|FG000|Overall Study|Withdrawal of Consent|1|||
48586636|NCT02327013|156339039|FG001|Overall Study|Withdrawal of Consent|0|||
48586637|NCT02327013|156339040|FG002|Overall Study|Withdrawal of Consent|3|||
48586638|NCT02327013|156339041|FG003|Overall Study|Withdrawal of Consent|0|||
48586639|NCT02327013|156339042|FG004|Overall Study|Withdrawal of Consent|0|||
48586640|NCT02327013|156339038|FG000|Overall Study|Lost to Follow-up|2|||
48586641|NCT02327013|156339039|FG001|Overall Study|Lost to Follow-up|4|||
48586642|NCT02327013|156339040|FG002|Overall Study|Lost to Follow-up|5|||
48586643|NCT02327013|156339041|FG003|Overall Study|Lost to Follow-up|0|||
48586644|NCT02327013|156339042|FG004|Overall Study|Lost to Follow-up|0|||
48586645|NCT02327013|156339038|FG000|Overall Study|Administrative or other reason(s)|1|||
48586646|NCT02327013|156339039|FG001|Overall Study|Administrative or other reason(s)|5|||
48586647|NCT02327013|156339040|FG002|Overall Study|Administrative or other reason(s)|11|||
48586648|NCT02327013|156339041|FG003|Overall Study|Administrative or other reason(s)|1|||
48586649|NCT02327013|156339042|FG004|Overall Study|Administrative or other reason(s)|1|||
48586650|NCT02327013|156339038|FG000|Overall Study|Protocol Violation|0|||
48586651|NCT02327013|156339039|FG001|Overall Study|Protocol Violation|0|||
48586652|NCT02327013|156339040|FG002|Overall Study|Protocol Violation|3|||
48586653|NCT02327013|156339041|FG003|Overall Study|Protocol Violation|0|||
48586654|NCT02327013|156339042|FG004|Overall Study|Protocol Violation|1|||
48586655|NCT02327013|156339038|FG000|Overall Study|Withdrawal before treatment|2|||
48586656|NCT02327013|156339039|FG001|Overall Study|Withdrawal before treatment|1|||
48586657|NCT02327013|156339040|FG002|Overall Study|Withdrawal before treatment|5|||
48586658|NCT02327013|156339041|FG003|Overall Study|Withdrawal before treatment|0|||
48586659|NCT02327013|156339042|FG004|Overall Study|Withdrawal before treatment|0|||
48586660|NCT00803205|156339046|FG000|Overall Study|Adverse Event|7|||
48586661|NCT00803205|156339047|FG001|Overall Study|Adverse Event|2|||
48586662|NCT00803205|156339046|FG000|Overall Study|Lost to Follow-up|1|||
48586663|NCT00803205|156339047|FG001|Overall Study|Lost to Follow-up|0|||
48586664|NCT00803205|156339046|FG000|Overall Study|Withdrawal by Subject|9|||
48586665|NCT00803205|156339047|FG001|Overall Study|Withdrawal by Subject|9|||
48586666|NCT00803205|156339046|FG000|Overall Study|Physician Decision|1|||
48586667|NCT00803205|156339047|FG001|Overall Study|Physician Decision|0|||
48586668|NCT00803205|156339046|FG000|Overall Study|Protocol Violation|1|||
48586669|NCT00803205|156339047|FG001|Overall Study|Protocol Violation|1|||
48586670|NCT00803205|156339046|FG000|Overall Study|Medical Monitor Decision|1|||
48586671|NCT00803205|156339047|FG001|Overall Study|Medical Monitor Decision|0|||
48586672|NCT00803205|156339046|FG000|Overall Study|Acquired a Lung Infection|0|||
48586673|NCT00803205|156339047|FG001|Overall Study|Acquired a Lung Infection|1|||
48586674|NCT00803205|156339046|FG000|Overall Study|Sponsor Decision|0|||
48586675|NCT00803205|156339047|FG001|Overall Study|Sponsor Decision|1|||
48586676|NCT02854605|156339048|FG000|Overall Study|Adverse Event|1|||
48586677|NCT02854605|156339049|FG001|Overall Study|Adverse Event|5|||
48586678|NCT02854605|156339050|FG002|Overall Study|Adverse Event|2|||
48586679|NCT02854605|156339048|FG000|Overall Study|Lost to Follow-up|0|||
48658126|NCT00737711|156601570|FG000|Overall Study|Protocol Violation|1|||
48658127|NCT00737711|156601570|FG000|Overall Study|Withdrawal by Subject|5|||
48658128|NCT00737711|156601570|FG000|Overall Study|Blood transfusion|6|||
48658129|NCT00737711|156601570|FG000|Overall Study|Other|5|||
48658130|NCT00420004|156601571|FG000|Overall Study|Adverse Event|4|||
48658131|NCT00420004|156601572|FG001|Overall Study|Adverse Event|1|||
48658132|NCT00420004|156601573|FG002|Overall Study|Adverse Event|1|||
48658133|NCT00420004|156601571|FG000|Overall Study|Lack of Efficacy|5|||
48586680|NCT02854605|156339049|FG001|Overall Study|Lost to Follow-up|2|||
48586681|NCT02854605|156339050|FG002|Overall Study|Lost to Follow-up|0|||
48586682|NCT02854605|156339048|FG000|Overall Study|Withdrew Consent|1|||
48586683|NCT02854605|156339049|FG001|Overall Study|Withdrew Consent|0|||
48586684|NCT02854605|156339050|FG002|Overall Study|Withdrew Consent|1|||
48586685|NCT02854605|156339048|FG000|Overall Study|Investigator's Discretion|1|||
48586686|NCT02854605|156339049|FG001|Overall Study|Investigator's Discretion|0|||
48586687|NCT02854605|156339050|FG002|Overall Study|Investigator's Discretion|0|||
48586688|NCT02854605|156339048|FG000|Overall Study|Protocol Violation|0|||
48586689|NCT02854605|156339049|FG001|Overall Study|Protocol Violation|0|||
48586690|NCT02854605|156339050|FG002|Overall Study|Protocol Violation|1|||
48586691|NCT01273155|156339055|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
48586692|NCT01273155|156339056|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
48586693|NCT01273155|156339057|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
48586694|NCT01273155|156339058|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
48586695|NCT01273155|156339059|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
48658134|NCT00420004|156601572|FG001|Overall Study|Lack of Efficacy|4|||
48658135|NCT00420004|156601573|FG002|Overall Study|Lack of Efficacy|1|||
48658136|NCT00420004|156601571|FG000|Overall Study|Lost to Follow-up|31|||
48658137|NCT00420004|156601572|FG001|Overall Study|Lost to Follow-up|12|||
48658138|NCT00420004|156601573|FG002|Overall Study|Lost to Follow-up|10|||
48658139|NCT00420004|156601571|FG000|Overall Study|Entry Criteria Not Met|0|||
48658140|NCT00420004|156601572|FG001|Overall Study|Entry Criteria Not Met|1|||
48658141|NCT00420004|156601573|FG002|Overall Study|Entry Criteria Not Met|0|||
48658142|NCT00420004|156601571|FG000|Overall Study|Physician Decision|14|||
48658143|NCT00420004|156601572|FG001|Overall Study|Physician Decision|4|||
48658144|NCT00420004|156601573|FG002|Overall Study|Physician Decision|2|||
48658145|NCT00420004|156601571|FG000|Overall Study|Protocol Violation|5|||
48658146|NCT00420004|156601572|FG001|Overall Study|Protocol Violation|4|||
48658147|NCT00420004|156601573|FG002|Overall Study|Protocol Violation|3|||
48658148|NCT00420004|156601571|FG000|Overall Study|Withdrawal by Subject|67|||
48658149|NCT00420004|156601572|FG001|Overall Study|Withdrawal by Subject|42|||
48658150|NCT00420004|156601573|FG002|Overall Study|Withdrawal by Subject|14|||
48658151|NCT00420004|156601571|FG000|Overall Study|Sponsor Decision|3|||
48658152|NCT00420004|156601572|FG001|Overall Study|Sponsor Decision|3|||
48658153|NCT00420004|156601573|FG002|Overall Study|Sponsor Decision|1|||
48658154|NCT00132691|156601579|FG000|Overall Study|Lost to Follow-up|5|||
48658155|NCT00132691|156601580|FG001|Overall Study|Lost to Follow-up|8|||
48658156|NCT00132691|156601579|FG000|Overall Study|Missed 2-year visit|4|||
48658157|NCT00132691|156601580|FG001|Overall Study|Missed 2-year visit|4|||
48658158|NCT00132691|156601579|FG000|Overall Study|Death|2|||
48658159|NCT00132691|156601580|FG001|Overall Study|Death|0|||
48658160|NCT01032291|156601587|FG000|Safety Lead-in|Adverse Event|1|||
48658161|NCT01032291|156601588|FG001|Safety Lead-in|Adverse Event|0|||
48658162|NCT01032291|156601589|FG002|Safety Lead-in|Adverse Event|0|||
48658163|NCT01032291|156601587|FG000|Safety Lead-in|Death|1|||
48658164|NCT01032291|156601588|FG001|Safety Lead-in|Death|0|||
48658165|NCT01032291|156601589|FG002|Safety Lead-in|Death|0|||
48658166|NCT01032291|156601587|FG000|Proof of Concept|Adverse Event|0|||
48658167|NCT01032291|156601588|FG001|Proof of Concept|Adverse Event|5|||
48658168|NCT01032291|156601589|FG002|Proof of Concept|Adverse Event|1|||
48658169|NCT01032291|156601587|FG000|Proof of Concept|Death|0|||
48658170|NCT01032291|156601588|FG001|Proof of Concept|Death|1|||
48658171|NCT01032291|156601589|FG002|Proof of Concept|Death|2|||
48658172|NCT01032291|156601587|FG000|Proof of Concept|Lack of Efficacy|0|||
48658173|NCT01032291|156601588|FG001|Proof of Concept|Lack of Efficacy|1|||
48658174|NCT01032291|156601589|FG002|Proof of Concept|Lack of Efficacy|0|||
48658175|NCT01032291|156601587|FG000|Proof of Concept|Never Received Study Drug|0|||
48658176|NCT01032291|156601588|FG001|Proof of Concept|Never Received Study Drug|1|||
48586696|NCT01273155|156339060|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
48586697|NCT01273155|156339061|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
48658177|NCT01032291|156601589|FG002|Proof of Concept|Never Received Study Drug|0|||
48658178|NCT00758264|156601593|FG000|Active Phase|Withdrawal by Subject|0|||
48658179|NCT00758264|156601594|FG001|Active Phase|Withdrawal by Subject|0|||
48658180|NCT00758264|156601595|FG002|Active Phase|Withdrawal by Subject|1|||
48658181|NCT00758264|156601593|FG000|Active Phase|Lost to Follow-up|1|||
48658182|NCT00758264|156601594|FG001|Active Phase|Lost to Follow-up|0|||
48658183|NCT00758264|156601595|FG002|Active Phase|Lost to Follow-up|0|||
48755164|NCT03338855|156949797|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
48755165|NCT01286012|156949802|FG000|Overall Study|Adverse Event|3|||
48658184|NCT00758264|156601593|FG000|Active Phase|Other|0|||
48755166|NCT01286012|156949803|FG001|Overall Study|Adverse Event|3|||
48755167|NCT01286012|156949802|FG000|Overall Study|Death|2|||
48755168|NCT01286012|156949803|FG001|Overall Study|Death|3|||
48755169|NCT01286012|156949802|FG000|Overall Study|Protocol Violation|1|||
48755170|NCT01286012|156949803|FG001|Overall Study|Protocol Violation|1|||
48755171|NCT01286012|156949802|FG000|Overall Study|Withdrawal by Subject|4|||
48755172|NCT01286012|156949803|FG001|Overall Study|Withdrawal by Subject|4|||
48755173|NCT01286012|156949802|FG000|Overall Study|Physician Decision|2|||
48755174|NCT01286012|156949803|FG001|Overall Study|Physician Decision|0|||
48755175|NCT01286012|156949802|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
48658185|NCT00758264|156601594|FG001|Active Phase|Other|0|||
48658186|NCT00758264|156601595|FG002|Active Phase|Other|4|||
48658187|NCT01988662|156601598|FG000|Overall Study|Subject/guardian decision|1|||
48658188|NCT01988662|156601599|FG001|Overall Study|Subject/guardian decision|1|||
48755176|NCT01286012|156949803|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
48336639|NCT01072149|155429504|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336640|NCT01072149|155429505|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336641|NCT01072149|155429506|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336642|NCT01072149|155429507|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336643|NCT01072149|155429508|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336644|NCT01072149|155429509|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48658189|NCT01988662|156601598|FG000|Overall Study|Adverse Event|3|||
48336645|NCT01072149|155429510|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
48336646|NCT01072149|155429493|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336647|NCT01072149|155429494|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336648|NCT01072149|155429495|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336649|NCT01072149|155429496|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336650|NCT01072149|155429497|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336651|NCT01072149|155429498|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336652|NCT01072149|155429499|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336653|NCT01072149|155429500|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
48336654|NCT01072149|155429501|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336655|NCT01072149|155429502|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336656|NCT01072149|155429503|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336657|NCT01072149|155429504|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336658|NCT01072149|155429505|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336659|NCT01072149|155429506|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336660|NCT01072149|155429507|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336661|NCT01072149|155429508|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336662|NCT01072149|155429509|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336663|NCT01072149|155429510|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
48336664|NCT01072149|155429493|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
48336665|NCT01072149|155429494|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
48336666|NCT01072149|155429495|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
48336667|NCT01072149|155429496|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
48336668|NCT01072149|155429497|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
48336669|NCT01072149|155429498|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
48336670|NCT01072149|155429499|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
48336671|NCT01072149|155429500|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
48336672|NCT01072149|155429501|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
48336673|NCT01072149|155429502|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
48336674|NCT01072149|155429503|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
48336675|NCT01072149|155429504|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
48658190|NCT01988662|156601599|FG001|Overall Study|Adverse Event|1|||
48658191|NCT01498575|156601602|FG000|Overall Sample|Withdrawal by Subject|60|||
48658192|NCT01498575|156601603|FG001|Overall Sample|Withdrawal by Subject|14|||
48658193|NCT01498575|156601602|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
48658194|NCT01498575|156601603|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
48658195|NCT01498575|156601602|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
48658196|NCT01498575|156601603|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
48658197|NCT00368836|156601604|FG000|Phase II|Screen Failure|1|||
48658198|NCT00368836|156601604|FG000|Phase II|Withdrawal by Subject|1|||
48658199|NCT00368836|156601604|FG000|Phase II|unable to collect blood and/or breath|17|||
48658200|NCT00368836|156601604|FG000|Phase II|Protocol Violation|2|||
48658201|NCT01345591|156601608|FG000|Overall Study|Lost to Follow-up|1|||
48658202|NCT01165320|156601609|FG000|Overall Study|Clinical adverse experience|2|||
48336676|NCT01072149|155429505|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
48658203|NCT01165320|156601610|FG001|Overall Study|Clinical adverse experience|1|||
48428215|NCT02531373|155756500|FG002|Overall Study|Lost to Follow-up|0|||
48658204|NCT01165320|156601611|FG002|Overall Study|Clinical adverse experience|0|||
48755177|NCT00511667|156949804|FG000|Overall Study|Adverse Event|1|||
48755178|NCT00511667|156949805|FG001|Overall Study|Adverse Event|0|||
48755179|NCT00511667|156949804|FG000|Overall Study|Protocol Violation|1|||
48755180|NCT00511667|156949805|FG001|Overall Study|Protocol Violation|1|||
48755181|NCT00511667|156949804|FG000|Overall Study|Withdrawal by Subject|2|||
48755182|NCT00511667|156949805|FG001|Overall Study|Withdrawal by Subject|0|||
48755183|NCT00511667|156949804|FG000|Overall Study|Site terminated|6|||
48755184|NCT00511667|156949805|FG001|Overall Study|Site terminated|1|||
48755185|NCT00511667|156949804|FG000|Overall Study|Other|2|||
48755186|NCT00511667|156949805|FG001|Overall Study|Other|1|||
48755187|NCT00643682|156949806|FG000|Overall Study|did not keep appointment|522|||
48658205|NCT01165320|156601609|FG000|Overall Study|Laboratory adverse experience|1|||
48658206|NCT01165320|156601610|FG001|Overall Study|Laboratory adverse experience|0|||
48658207|NCT01165320|156601611|FG002|Overall Study|Laboratory adverse experience|0|||
48658208|NCT01165320|156601609|FG000|Overall Study|Lack of Efficacy|0|||
48755188|NCT00643682|156949807|FG001|Overall Study|did not keep appointment|509|||
48755189|NCT01165554|156949810|FG000|Overall Study|Withdrawal by Subject|23|||
48755190|NCT00492115|156949811|FG000|Overall Study|Withdrawal by Subject|3|||
48755191|NCT00492115|156949812|FG001|Overall Study|Withdrawal by Subject|4|||
48755192|NCT02200445|156949814|FG000|Overall Study|Lack of Efficacy|1|||
48755193|NCT02200445|156949815|FG001|Overall Study|Lack of Efficacy|2|||
48755194|NCT02200445|156949816|FG002|Overall Study|Lack of Efficacy|2|||
48755195|NCT02200445|156949814|FG000|Overall Study|Adverse Event|0|||
48755196|NCT02200445|156949815|FG001|Overall Study|Adverse Event|2|||
48755197|NCT02200445|156949816|FG002|Overall Study|Adverse Event|0|||
48755198|NCT00323115|156949817|FG000|Vaccine Administration|Adverse Event|1|||
48755199|NCT00323115|156949817|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
48755200|NCT01252940|156949819|FG000|Main Study Phase|Randomized but not treated|4|||
48755201|NCT01252940|156949820|FG001|Main Study Phase|Randomized but not treated|2|||
48755202|NCT01252940|156949819|FG000|Main Study Phase|Adverse Event|3|||
48755203|NCT01252940|156949820|FG001|Main Study Phase|Adverse Event|1|||
48755204|NCT01252940|156949819|FG000|Main Study Phase|Lack of Efficacy|1|||
48755205|NCT01252940|156949820|FG001|Main Study Phase|Lack of Efficacy|0|||
48755206|NCT01252940|156949819|FG000|Main Study Phase|Lost to Follow-up|6|||
48755207|NCT01252940|156949820|FG001|Main Study Phase|Lost to Follow-up|1|||
48755208|NCT01252940|156949819|FG000|Main Study Phase|Physician Decision|1|||
48755209|NCT01252940|156949820|FG001|Main Study Phase|Physician Decision|0|||
48755210|NCT01252940|156949819|FG000|Main Study Phase|Protocol Violation|4|||
48755211|NCT01252940|156949820|FG001|Main Study Phase|Protocol Violation|2|||
48755212|NCT01252940|156949819|FG000|Main Study Phase|Withdrawal by Subject|6|||
48755213|NCT01252940|156949820|FG001|Main Study Phase|Withdrawal by Subject|5|||
48755214|NCT01252940|156949819|FG000|Main Study Phase|Subject Non-compliance|1|||
48658209|NCT01165320|156601610|FG001|Overall Study|Lack of Efficacy|2|||
48658210|NCT01165320|156601611|FG002|Overall Study|Lack of Efficacy|0|||
48755215|NCT01252940|156949820|FG001|Main Study Phase|Subject Non-compliance|1|||
48658211|NCT01165320|156601609|FG000|Overall Study|Reason unknown|0|||
48658212|NCT01165320|156601610|FG001|Overall Study|Reason unknown|1|||
48658213|NCT01165320|156601611|FG002|Overall Study|Reason unknown|0|||
48658214|NCT03515551|156601612|FG000|Overall Study|Death|4|||
48658215|NCT03515551|156601613|FG001|Overall Study|Death|1|||
48658216|NCT03515551|156601614|FG002|Overall Study|Death|2|||
48658217|NCT03515551|156601615|FG003|Overall Study|Death|2|||
48658218|NCT03515551|156601616|FG004|Overall Study|Death|2|||
48658219|NCT03515551|156601617|FG005|Overall Study|Death|4|||
48658220|NCT03515551|156601618|FG006|Overall Study|Death|1|||
48755216|NCT01252940|156949819|FG000|Extension Phase|Adverse Event|2|||
48755217|NCT01252940|156949820|FG001|Extension Phase|Adverse Event|1|||
48755218|NCT01252940|156949819|FG000|Extension Phase|Lack of Efficacy|1|||
48755219|NCT01252940|156949820|FG001|Extension Phase|Lack of Efficacy|0|||
48658221|NCT03515551|156601612|FG000|Overall Study|Lost to Follow-up|0|||
48658222|NCT03515551|156601613|FG001|Overall Study|Lost to Follow-up|0|||
48336677|NCT01072149|155429506|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
48658223|NCT03515551|156601614|FG002|Overall Study|Lost to Follow-up|1|||
48658224|NCT03515551|156601615|FG003|Overall Study|Lost to Follow-up|0|||
48336678|NCT01072149|155429507|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
48336679|NCT01072149|155429508|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
48336680|NCT01072149|155429509|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
48336681|NCT01072149|155429510|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
48658225|NCT03515551|156601616|FG004|Overall Study|Lost to Follow-up|0|||
48658226|NCT03515551|156601617|FG005|Overall Study|Lost to Follow-up|0|||
48658227|NCT03515551|156601618|FG006|Overall Study|Lost to Follow-up|0|||
48658228|NCT03515551|156601612|FG000|Overall Study|Withdrawal by Subject|0|||
48658229|NCT03515551|156601613|FG001|Overall Study|Withdrawal by Subject|1|||
48658230|NCT03515551|156601614|FG002|Overall Study|Withdrawal by Subject|0|||
48755220|NCT01252940|156949819|FG000|Extension Phase|Lost to Follow-up|5|||
48755221|NCT01252940|156949820|FG001|Extension Phase|Lost to Follow-up|0|||
48336682|NCT01072149|155429493|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48658231|NCT03515551|156601615|FG003|Overall Study|Withdrawal by Subject|0|||
48658232|NCT03515551|156601616|FG004|Overall Study|Withdrawal by Subject|0|||
48755222|NCT01252940|156949819|FG000|Extension Phase|Physician Decision|0|||
48755223|NCT01252940|156949820|FG001|Extension Phase|Physician Decision|1|||
48336683|NCT01072149|155429494|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336684|NCT01072149|155429495|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48658233|NCT03515551|156601617|FG005|Overall Study|Withdrawal by Subject|0|||
48336685|NCT01072149|155429496|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336686|NCT01072149|155429497|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336687|NCT01072149|155429498|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336688|NCT01072149|155429499|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336689|NCT01072149|155429500|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48658234|NCT03515551|156601618|FG006|Overall Study|Withdrawal by Subject|1|||
48658235|NCT03515551|156601612|FG000|Overall Study|Study ended by sponsor|0|||
48336690|NCT01072149|155429501|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336691|NCT01072149|155429502|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336692|NCT01072149|155429503|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336693|NCT01072149|155429504|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336694|NCT01072149|155429505|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336695|NCT01072149|155429506|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336696|NCT01072149|155429507|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336697|NCT01072149|155429508|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
48658236|NCT03515551|156601613|FG001|Overall Study|Study ended by sponsor|0|||
48658237|NCT03515551|156601614|FG002|Overall Study|Study ended by sponsor|2|||
48658238|NCT03515551|156601615|FG003|Overall Study|Study ended by sponsor|1|||
48658239|NCT03515551|156601616|FG004|Overall Study|Study ended by sponsor|3|||
48658240|NCT03515551|156601617|FG005|Overall Study|Study ended by sponsor|0|||
48658241|NCT03515551|156601618|FG006|Overall Study|Study ended by sponsor|3|||
48658242|NCT03515551|156601612|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658243|NCT03515551|156601613|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
48658244|NCT03515551|156601614|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658245|NCT03515551|156601615|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658246|NCT03515551|156601616|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658247|NCT03515551|156601617|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658248|NCT03515551|156601618|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
48658249|NCT03305419|156601619|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658250|NCT03305419|156601620|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
48658251|NCT03305419|156601621|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658252|NCT03305419|156601622|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658253|NCT03305419|156601623|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658254|NCT03305419|156601624|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658255|NCT03305419|156601625|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658256|NCT03305419|156601626|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
48658257|NCT03305419|156601619|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
48658258|NCT03305419|156601620|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658259|NCT03305419|156601621|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658260|NCT03305419|156601622|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658261|NCT03305419|156601623|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658262|NCT03305419|156601624|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658263|NCT03305419|156601625|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658264|NCT03305419|156601626|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
48658265|NCT03305419|156601619|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
48658266|NCT03305419|156601620|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658267|NCT03305419|156601621|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658268|NCT03305419|156601622|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658269|NCT03305419|156601623|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658270|NCT03305419|156601624|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658271|NCT03305419|156601625|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658272|NCT03305419|156601626|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
48658273|NCT03305419|156601619|FG000|Part B (14 Days)|Adverse Event|0|||
48658274|NCT03305419|156601620|FG001|Part B (14 Days)|Adverse Event|0|||
48658275|NCT03305419|156601621|FG002|Part B (14 Days)|Adverse Event|0|||
48658276|NCT03305419|156601622|FG003|Part B (14 Days)|Adverse Event|0|||
48658277|NCT03305419|156601623|FG004|Part B (14 Days)|Adverse Event|1|||
48658278|NCT03305419|156601624|FG005|Part B (14 Days)|Adverse Event|2|||
48658279|NCT03305419|156601625|FG006|Part B (14 Days)|Adverse Event|4|||
48658280|NCT03305419|156601626|FG007|Part B (14 Days)|Adverse Event|0|||
48658281|NCT03305419|156601619|FG000|Part B (14 Days)|Physician Decision|0|||
48658282|NCT03305419|156601620|FG001|Part B (14 Days)|Physician Decision|0|||
48658283|NCT03305419|156601621|FG002|Part B (14 Days)|Physician Decision|0|||
48658284|NCT03305419|156601622|FG003|Part B (14 Days)|Physician Decision|0|||
48755224|NCT01252940|156949819|FG000|Extension Phase|Subject Non-compliance|1|||
48658285|NCT03305419|156601623|FG004|Part B (14 Days)|Physician Decision|2|||
48336698|NCT01072149|155429509|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48336699|NCT01072149|155429510|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
48658286|NCT03305419|156601624|FG005|Part B (14 Days)|Physician Decision|8|||
48658287|NCT03305419|156601625|FG006|Part B (14 Days)|Physician Decision|1|||
48658288|NCT03305419|156601626|FG007|Part B (14 Days)|Physician Decision|0|||
48658289|NCT00075946|156601627|FG000|Overall Study|Path ineligible: undetermined histology|0|||
48658290|NCT00075946|156601628|FG001|Overall Study|Path ineligible: undetermined histology|0|||
48658291|NCT00075946|156601629|FG002|Overall Study|Path ineligible: undetermined histology|0|||
48658292|NCT00075946|156601630|FG003|Overall Study|Path ineligible: undetermined histology|0|||
48658293|NCT00075946|156601631|FG004|Overall Study|Path ineligible: undetermined histology|6|||
48658294|NCT00075946|156601627|FG000|Overall Study|Did not achieve response after induction|0|||
48658295|NCT00075946|156601628|FG001|Overall Study|Did not achieve response after induction|0|||
48658296|NCT00075946|156601629|FG002|Overall Study|Did not achieve response after induction|0|||
48658297|NCT00075946|156601630|FG003|Overall Study|Did not achieve response after induction|0|||
48658298|NCT00075946|156601631|FG004|Overall Study|Did not achieve response after induction|182|||
48658299|NCT00075946|156601627|FG000|Overall Study|Incorrectly randomized (no response)|5|||
48658300|NCT00075946|156601628|FG001|Overall Study|Incorrectly randomized (no response)|5|||
48658301|NCT00075946|156601629|FG002|Overall Study|Incorrectly randomized (no response)|5|||
48658302|NCT00075946|156601630|FG003|Overall Study|Incorrectly randomized (no response)|1|||
48658303|NCT00075946|156601631|FG004|Overall Study|Incorrectly randomized (no response)|0|||
48658304|NCT00075946|156601627|FG000|Overall Study|Adverse Event|2|||
48658305|NCT00075946|156601628|FG001|Overall Study|Adverse Event|10|||
48658306|NCT00075946|156601629|FG002|Overall Study|Adverse Event|0|||
48658307|NCT00075946|156601630|FG003|Overall Study|Adverse Event|2|||
48658308|NCT00075946|156601631|FG004|Overall Study|Adverse Event|0|||
48658309|NCT00075946|156601627|FG000|Overall Study|Death|0|||
48658310|NCT00075946|156601628|FG001|Overall Study|Death|1|||
48658311|NCT00075946|156601629|FG002|Overall Study|Death|0|||
48658312|NCT00075946|156601630|FG003|Overall Study|Death|0|||
48336700|NCT01072149|155429493|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
48336701|NCT01072149|155429494|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
48336702|NCT01072149|155429495|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
48336703|NCT01072149|155429496|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
48336704|NCT01072149|155429497|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
48336705|NCT01072149|155429498|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
48336706|NCT01072149|155429499|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
48336707|NCT01072149|155429500|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
48336708|NCT01072149|155429501|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
48336709|NCT01072149|155429502|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
48336710|NCT01072149|155429503|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
48336711|NCT01072149|155429504|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
48336712|NCT01072149|155429505|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
48336713|NCT01072149|155429506|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
48336714|NCT01072149|155429507|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
48336715|NCT01072149|155429508|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
48336716|NCT01072149|155429509|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
48336717|NCT01072149|155429510|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
48336718|NCT01072149|155429493|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336719|NCT01072149|155429494|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336720|NCT01072149|155429495|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336721|NCT01072149|155429496|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48658313|NCT00075946|156601631|FG004|Overall Study|Death|0|||
48658314|NCT00075946|156601627|FG000|Overall Study|Withdrawal by Subject|23|||
48658315|NCT00075946|156601628|FG001|Overall Study|Withdrawal by Subject|58|||
48658316|NCT00075946|156601629|FG002|Overall Study|Withdrawal by Subject|4|||
48658317|NCT00075946|156601630|FG003|Overall Study|Withdrawal by Subject|9|||
48658318|NCT00075946|156601631|FG004|Overall Study|Withdrawal by Subject|0|||
48658319|NCT00075946|156601627|FG000|Overall Study|Alternative therapy|16|||
48658320|NCT00075946|156601628|FG001|Overall Study|Alternative therapy|2|||
48658321|NCT00075946|156601629|FG002|Overall Study|Alternative therapy|5|||
48336722|NCT01072149|155429497|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336723|NCT01072149|155429498|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336724|NCT01072149|155429499|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336725|NCT01072149|155429500|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336726|NCT01072149|155429501|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48658322|NCT00075946|156601630|FG003|Overall Study|Alternative therapy|0|||
48658323|NCT00075946|156601631|FG004|Overall Study|Alternative therapy|0|||
48658324|NCT00075946|156601627|FG000|Overall Study|Other complicating disease|7|||
48658325|NCT00075946|156601628|FG001|Overall Study|Other complicating disease|13|||
48336727|NCT01072149|155429502|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48428216|NCT02531373|155756501|FG003|Overall Study|Lost to Follow-up|0|||
48658326|NCT00075946|156601629|FG002|Overall Study|Other complicating disease|1|||
48658327|NCT00075946|156601630|FG003|Overall Study|Other complicating disease|4|||
48658328|NCT00075946|156601631|FG004|Overall Study|Other complicating disease|0|||
48658329|NCT00075946|156601627|FG000|Overall Study|No response to retreatment|23|||
48658330|NCT00075946|156601628|FG001|Overall Study|No response to retreatment|0|||
48658331|NCT00075946|156601629|FG002|Overall Study|No response to retreatment|2|||
48658332|NCT00075946|156601630|FG003|Overall Study|No response to retreatment|0|||
48658333|NCT00075946|156601631|FG004|Overall Study|No response to retreatment|0|||
48658334|NCT00075946|156601627|FG000|Overall Study|Time to progression less than 6 months|15|||
48658335|NCT00075946|156601628|FG001|Overall Study|Time to progression less than 6 months|30|||
48658336|NCT00075946|156601629|FG002|Overall Study|Time to progression less than 6 months|8|||
48658337|NCT00075946|156601630|FG003|Overall Study|Time to progression less than 6 months|3|||
48658338|NCT00075946|156601631|FG004|Overall Study|Time to progression less than 6 months|0|||
48658339|NCT00075946|156601627|FG000|Overall Study|Other|57|||
48658340|NCT00075946|156601628|FG001|Overall Study|Other|32|||
48658341|NCT00075946|156601629|FG002|Overall Study|Other|3|||
48658342|NCT00075946|156601630|FG003|Overall Study|Other|11|||
48658343|NCT00075946|156601631|FG004|Overall Study|Other|0|||
48658344|NCT01923363|156601632|FG000|Overall Study|Protocol Violation|1|||
48658345|NCT00521599|156601633|FG000|Overall Study|Adverse Event|5|||
48658346|NCT00521599|156601634|FG001|Overall Study|Adverse Event|7|||
48658347|NCT00521599|156601635|FG002|Overall Study|Adverse Event|6|||
48658348|NCT00521599|156601633|FG000|Overall Study|Treatment Failure|8|||
48658349|NCT00521599|156601634|FG001|Overall Study|Treatment Failure|9|||
48658350|NCT00521599|156601635|FG002|Overall Study|Treatment Failure|22|||
48658351|NCT00521599|156601633|FG000|Overall Study|Lost to Follow-up|2|||
48658352|NCT00521599|156601634|FG001|Overall Study|Lost to Follow-up|1|||
48658353|NCT00521599|156601635|FG002|Overall Study|Lost to Follow-up|2|||
48658354|NCT00521599|156601633|FG000|Overall Study|Withdrawal by Subject|3|||
48658355|NCT00521599|156601634|FG001|Overall Study|Withdrawal by Subject|5|||
48658356|NCT00521599|156601635|FG002|Overall Study|Withdrawal by Subject|1|||
48658357|NCT00521599|156601633|FG000|Overall Study|Withdrawal by subject treatment related|3|||
48658358|NCT00521599|156601634|FG001|Overall Study|Withdrawal by subject treatment related|1|||
48658359|NCT00521599|156601635|FG002|Overall Study|Withdrawal by subject treatment related|2|||
48658360|NCT00521599|156601633|FG000|Overall Study|Protocol Violation|2|||
48658361|NCT00521599|156601634|FG001|Overall Study|Protocol Violation|4|||
48658362|NCT00521599|156601635|FG002|Overall Study|Protocol Violation|2|||
48658363|NCT00521599|156601633|FG000|Overall Study|Did not meet protocol eligibility|2|||
48658364|NCT00521599|156601634|FG001|Overall Study|Did not meet protocol eligibility|2|||
48658365|NCT00521599|156601635|FG002|Overall Study|Did not meet protocol eligibility|1|||
48658366|NCT02359045|156601639|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
48658367|NCT02359045|156601640|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48658368|NCT02359045|156601639|FG000|Overall Study|Lost to Follow-up|1|||
48658369|NCT02359045|156601640|FG001|Overall Study|Lost to Follow-up|1|||
48658370|NCT02359045|156601639|FG000|Overall Study|Adverse Event|0|||
48658371|NCT02359045|156601640|FG001|Overall Study|Adverse Event|1|||
48658372|NCT05704543|156601642|FG000|Overall Study|Withdrawal by Subject|1|||
48658373|NCT05704543|156601643|FG001|Overall Study|Withdrawal by Subject|1|||
48658374|NCT05704543|156601644|FG002|Overall Study|Withdrawal by Subject|0|||
48658375|NCT05704543|156601645|FG003|Overall Study|Withdrawal by Subject|2|||
48658376|NCT05704543|156601642|FG000|Overall Study|Lost to Follow-up|1|||
48658377|NCT05704543|156601643|FG001|Overall Study|Lost to Follow-up|2|||
48658378|NCT05704543|156601644|FG002|Overall Study|Lost to Follow-up|0|||
48658379|NCT05704543|156601645|FG003|Overall Study|Lost to Follow-up|0|||
48658380|NCT02780856|156601648|FG000|Overall Study|Lost to Follow-up|1|||
48658381|NCT04239222|156601649|FG000|Baseline|Withdrawal by Subject|0|||
48658382|NCT04239222|156601650|FG001|Baseline|Withdrawal by Subject|0|||
48658383|NCT04239222|156601651|FG002|Baseline|Withdrawal by Subject|1|||
48658384|NCT04239222|156601652|FG003|Baseline|Withdrawal by Subject|1|||
48658385|NCT04239222|156601649|FG000|First Foot Assignment|Withdrawal by Subject|0|||
48658386|NCT04239222|156601650|FG001|First Foot Assignment|Withdrawal by Subject|0|||
48658387|NCT04239222|156601651|FG002|First Foot Assignment|Withdrawal by Subject|1|||
48658388|NCT04239222|156601652|FG003|First Foot Assignment|Withdrawal by Subject|0|||
48658389|NCT04239222|156601649|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
48658390|NCT04239222|156601650|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
48658391|NCT04239222|156601651|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
48658392|NCT04239222|156601652|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
48658393|NCT05232864|156601655|FG000|Overall Study|Adverse Event|0|||
48658394|NCT05232864|156601656|FG001|Overall Study|Adverse Event|1|||
48658395|NCT05232864|156601655|FG000|Overall Study|Study terminated by sponsor|16|||
48658396|NCT05232864|156601656|FG001|Overall Study|Study terminated by sponsor|14|||
48658397|NCT05032690|156601658|FG000|Period 1|Adverse Event|0|||
48658398|NCT05032690|156601659|FG001|Period 1|Adverse Event|1|||
48658399|NCT05032690|156601660|FG002|Period 1|Adverse Event|0|||
48658400|NCT05032690|156601661|FG003|Period 1|Adverse Event|0|||
48658401|NCT05032690|156601658|FG000|Period 1|Withdrawal by Subject|1|||
48658402|NCT05032690|156601659|FG001|Period 1|Withdrawal by Subject|0|||
48658403|NCT05032690|156601660|FG002|Period 1|Withdrawal by Subject|0|||
48658404|NCT05032690|156601661|FG003|Period 1|Withdrawal by Subject|0|||
48658405|NCT05032690|156601658|FG000|Period 1|No longer meets eligibility criteria|0|||
48658406|NCT05032690|156601659|FG001|Period 1|No longer meets eligibility criteria|1|||
48658407|NCT05032690|156601660|FG002|Period 1|No longer meets eligibility criteria|0|||
48658408|NCT05032690|156601661|FG003|Period 1|No longer meets eligibility criteria|0|||
48658409|NCT05032690|156601658|FG000|Period 2|Adverse Event|1|||
48658410|NCT05032690|156601659|FG001|Period 2|Adverse Event|0|||
48658411|NCT05032690|156601660|FG002|Period 2|Adverse Event|0|||
48658412|NCT05032690|156601661|FG003|Period 2|Adverse Event|0|||
48658413|NCT05032690|156601658|FG000|Period 2|Withdrawal by Subject|0|||
48658414|NCT05032690|156601659|FG001|Period 2|Withdrawal by Subject|1|||
48658415|NCT05032690|156601660|FG002|Period 2|Withdrawal by Subject|0|||
48658416|NCT05032690|156601661|FG003|Period 2|Withdrawal by Subject|0|||
48658417|NCT05032690|156601658|FG000|Period 2|No longer meets eligibility criteria|0|||
48658418|NCT05032690|156601659|FG001|Period 2|No longer meets eligibility criteria|1|||
48658419|NCT05032690|156601660|FG002|Period 2|No longer meets eligibility criteria|0|||
48658420|NCT05032690|156601661|FG003|Period 2|No longer meets eligibility criteria|0|||
48658421|NCT05032690|156601658|FG000|Period 3|Adverse Event|0|||
48658422|NCT05032690|156601659|FG001|Period 3|Adverse Event|1|||
48658423|NCT05032690|156601660|FG002|Period 3|Adverse Event|0|||
48658424|NCT05032690|156601661|FG003|Period 3|Adverse Event|0|||
48658425|NCT00951080|156601664|FG000|Overall Study|Adverse Event|3|||
48658426|NCT00951080|156601665|FG001|Overall Study|Adverse Event|3|||
48658427|NCT00951080|156601664|FG000|Overall Study|Lost to Follow-up|0|||
48658428|NCT00951080|156601665|FG001|Overall Study|Lost to Follow-up|1|||
48658429|NCT00951080|156601664|FG000|Overall Study|Physician Decision|4|||
48658430|NCT00951080|156601665|FG001|Overall Study|Physician Decision|1|||
48658431|NCT00951080|156601664|FG000|Overall Study|Other|19|||
48658432|NCT00951080|156601665|FG001|Overall Study|Other|22|||
48658433|NCT01960998|156601666|FG000|Overall Study|Lost to Follow-up|3|||
48658434|NCT01960998|156601667|FG001|Overall Study|Lost to Follow-up|7|||
48658435|NCT01960998|156601666|FG000|Overall Study|Death|0|||
48658436|NCT01960998|156601667|FG001|Overall Study|Death|1|||
48658437|NCT01960998|156601666|FG000|Overall Study|Withdrawal by Subject|8|||
48658438|NCT01960998|156601667|FG001|Overall Study|Withdrawal by Subject|2|||
48755225|NCT01252940|156949820|FG001|Extension Phase|Subject Non-compliance|0|||
48755226|NCT01252940|156949819|FG000|Extension Phase|Withdrawal by Subject|1|||
48755227|NCT01252940|156949820|FG001|Extension Phase|Withdrawal by Subject|1|||
48755228|NCT01943292|156951199|FG000|Overall Study|Withdrawal by Subject|1|||
48755229|NCT01943292|156951200|FG001|Overall Study|Withdrawal by Subject|0|||
48755230|NCT01943292|156951201|FG002|Overall Study|Withdrawal by Subject|0|||
48755231|NCT00996216|156951202|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
48336728|NCT01072149|155429503|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336729|NCT01072149|155429504|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336730|NCT01072149|155429505|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
48336731|NCT01072149|155429506|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336732|NCT01072149|155429507|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336733|NCT01072149|155429508|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336734|NCT01072149|155429509|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336735|NCT01072149|155429510|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
48336736|NCT01072149|155429493|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336737|NCT01072149|155429494|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336738|NCT01072149|155429495|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
48336739|NCT01072149|155429496|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336740|NCT01072149|155429497|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336741|NCT01072149|155429498|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336742|NCT01072149|155429499|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336743|NCT01072149|155429500|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336744|NCT01072149|155429501|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336745|NCT01072149|155429502|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336746|NCT01072149|155429503|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336747|NCT01072149|155429504|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336748|NCT01072149|155429505|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336749|NCT01072149|155429506|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
48658439|NCT01960998|156601666|FG000|Overall Study|lost computer access|0|||
48658440|NCT01960998|156601667|FG001|Overall Study|lost computer access|1|||
48658441|NCT00759356|156601668|FG000|Overall Study|Adverse Event|0|||
48658442|NCT00759356|156601669|FG001|Overall Study|Adverse Event|1|||
48658443|NCT00759356|156601668|FG000|Overall Study|Withdrawal by Subject|0|||
48755232|NCT00996216|156951202|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
48755233|NCT00996216|156951202|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
48658444|NCT00759356|156601669|FG001|Overall Study|Withdrawal by Subject|2|||
48336750|NCT01072149|155429507|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48658445|NCT00759356|156601668|FG000|Overall Study|Subject was unable to return|1|||
48336751|NCT01072149|155429508|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48658446|NCT00759356|156601669|FG001|Overall Study|Subject was unable to return|0|||
48658447|NCT01713283|156601673|FG000|Overall Study|Lack of Efficacy|10|||
48658448|NCT01713283|156601674|FG001|Overall Study|Lack of Efficacy|2|||
48658449|NCT01713283|156601673|FG000|Overall Study|Lost to Follow-up|1|||
48658450|NCT01713283|156601674|FG001|Overall Study|Lost to Follow-up|1|||
48658451|NCT02585830|156601675|FG000|Overall Study|Withdrawal by Subject|3|||
48658452|NCT00585221|156601676|FG000|Overall Study|Protocol Violation|8|||
48658453|NCT02509052|156601677|FG000|Overall Study|Non compliance|0|||
48658454|NCT02509052|156601678|FG001|Overall Study|Non compliance|0|||
48658455|NCT02509052|156601679|FG002|Overall Study|Non compliance|1|||
48658456|NCT00835640|156601680|FG000|Second Intervention|Protocol Violation|1|||
48658457|NCT00835640|156601681|FG001|Second Intervention|Protocol Violation|0|||
48658458|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
48658459|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
48658460|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Death|1|||
48658461|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Death|0|||
48658462|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
48658463|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
48658464|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
48658465|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
48658466|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
48658467|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
48658468|NCT00350272|156601682|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
48658469|NCT00350272|156601683|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
48658470|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
48658471|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
48658472|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
48658473|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
48658474|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
48658475|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
48658476|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
48658477|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
48658478|NCT00350272|156601682|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
48658479|NCT00350272|156601683|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
48658480|NCT03349645|156601684|FG000|Overall Study|Sponsor Terminated Study|75|||
48658481|NCT03349645|156601684|FG000|Overall Study|Withdrawal by Subject|4|||
48658482|NCT03349645|156601684|FG000|Overall Study|Protocol Violation|1|||
48658483|NCT03349645|156601684|FG000|Overall Study|Other|2|||
48658484|NCT01939002|156601695|FG000|Overall Study|Adverse Event|13|||
48658485|NCT01939002|156601696|FG001|Overall Study|Adverse Event|13|||
48658486|NCT01939002|156601695|FG000|Overall Study|Withdrawal by Subject|5|||
48658487|NCT01939002|156601696|FG001|Overall Study|Withdrawal by Subject|3|||
48658488|NCT01939002|156601695|FG000|Overall Study|Other|1|||
48658489|NCT01939002|156601696|FG001|Overall Study|Other|2|||
48658490|NCT01133405|156601697|FG000|Period 1|Withdrawal by Subject|0|||
48658491|NCT01133405|156601698|FG001|Period 1|Withdrawal by Subject|1|||
48658492|NCT01133405|156601699|FG002|Period 1|Withdrawal by Subject|0|||
48658493|NCT01133405|156601700|FG003|Period 1|Withdrawal by Subject|1|||
48658494|NCT01133405|156601701|FG004|Period 1|Withdrawal by Subject|0|||
48658495|NCT01133405|156601702|FG005|Period 1|Withdrawal by Subject|1|||
48658496|NCT01133405|156601703|FG006|Period 1|Withdrawal by Subject|0|||
48658497|NCT01133405|156601704|FG007|Period 1|Withdrawal by Subject|0|||
48658498|NCT01133405|156601705|FG008|Period 1|Withdrawal by Subject|0|||
48658499|NCT01133405|156601706|FG009|Period 1|Withdrawal by Subject|0|||
48658500|NCT01133405|156601697|FG000|Period 1|Physician Decision|0|||
48658501|NCT01133405|156601698|FG001|Period 1|Physician Decision|0|||
48658502|NCT01133405|156601699|FG002|Period 1|Physician Decision|0|||
48658503|NCT01133405|156601700|FG003|Period 1|Physician Decision|1|||
48658504|NCT01133405|156601701|FG004|Period 1|Physician Decision|0|||
48658505|NCT01133405|156601702|FG005|Period 1|Physician Decision|0|||
48658506|NCT01133405|156601703|FG006|Period 1|Physician Decision|0|||
48658507|NCT01133405|156601704|FG007|Period 1|Physician Decision|0|||
48658508|NCT01133405|156601705|FG008|Period 1|Physician Decision|0|||
48658509|NCT01133405|156601706|FG009|Period 1|Physician Decision|0|||
48658510|NCT01133405|156601697|FG000|Period 1|Discontinued after randomization|1|||
48755234|NCT00842712|156951203|FG000|Safety Run-in Part|Adverse Event|0|||
48755235|NCT00842712|156951204|FG001|Safety Run-in Part|Adverse Event|1|||
48755236|NCT00842712|156951205|FG002|Safety Run-in Part|Adverse Event|0|||
48755237|NCT00842712|156951206|FG003|Safety Run-in Part|Adverse Event|0|||
48755238|NCT00842712|156951207|FG004|Safety Run-in Part|Adverse Event|0|||
48755239|NCT00842712|156951208|FG005|Safety Run-in Part|Adverse Event|0|||
48755240|NCT00842712|156951209|FG006|Safety Run-in Part|Adverse Event|0|||
48755241|NCT00842712|156951203|FG000|Safety Run-in Part|Progressive disease|3|||
48755242|NCT00842712|156951204|FG001|Safety Run-in Part|Progressive disease|1|||
48755243|NCT00842712|156951205|FG002|Safety Run-in Part|Progressive disease|0|||
48755244|NCT00842712|156951206|FG003|Safety Run-in Part|Progressive disease|1|||
48755245|NCT00842712|156951207|FG004|Safety Run-in Part|Progressive disease|0|||
48755246|NCT00842712|156951208|FG005|Safety Run-in Part|Progressive disease|0|||
48755247|NCT00842712|156951209|FG006|Safety Run-in Part|Progressive disease|0|||
48755248|NCT00842712|156951203|FG000|Randomized Part|Randomized but not treated|0|||
48755249|NCT00842712|156951204|FG001|Randomized Part|Randomized but not treated|0|||
48755250|NCT00842712|156951205|FG002|Randomized Part|Randomized but not treated|0|||
48755251|NCT00842712|156951206|FG003|Randomized Part|Randomized but not treated|0|||
48755252|NCT00842712|156951207|FG004|Randomized Part|Randomized but not treated|0|||
48755253|NCT00842712|156951208|FG005|Randomized Part|Randomized but not treated|1|||
48755254|NCT00842712|156951209|FG006|Randomized Part|Randomized but not treated|4|||
48755255|NCT00842712|156951203|FG000|Randomized Part|Ongoing at cut-off date|0|||
48755256|NCT00842712|156951204|FG001|Randomized Part|Ongoing at cut-off date|0|||
48755257|NCT00842712|156951205|FG002|Randomized Part|Ongoing at cut-off date|0|||
48755258|NCT00842712|156951206|FG003|Randomized Part|Ongoing at cut-off date|0|||
48755259|NCT00842712|156951207|FG004|Randomized Part|Ongoing at cut-off date|0|||
48658511|NCT01133405|156601698|FG001|Period 1|Discontinued after randomization|0|||
48658512|NCT01133405|156601699|FG002|Period 1|Discontinued after randomization|0|||
48658513|NCT01133405|156601700|FG003|Period 1|Discontinued after randomization|0|||
48658514|NCT01133405|156601701|FG004|Period 1|Discontinued after randomization|0|||
48658515|NCT01133405|156601702|FG005|Period 1|Discontinued after randomization|0|||
48658516|NCT01133405|156601703|FG006|Period 1|Discontinued after randomization|1|||
48658517|NCT01133405|156601704|FG007|Period 1|Discontinued after randomization|0|||
48658518|NCT01133405|156601705|FG008|Period 1|Discontinued after randomization|0|||
48658519|NCT01133405|156601706|FG009|Period 1|Discontinued after randomization|0|||
48658520|NCT01133405|156601697|FG000|Period 1|Received drug only in period 2|0|||
48658521|NCT01133405|156601698|FG001|Period 1|Received drug only in period 2|1|||
48658522|NCT01133405|156601699|FG002|Period 1|Received drug only in period 2|0|||
48658523|NCT01133405|156601700|FG003|Period 1|Received drug only in period 2|2|||
48658524|NCT01133405|156601701|FG004|Period 1|Received drug only in period 2|0|||
48755260|NCT00842712|156951208|FG005|Randomized Part|Ongoing at cut-off date|0|||
48755261|NCT00842712|156951209|FG006|Randomized Part|Ongoing at cut-off date|2|||
48755262|NCT04492618|156951214|FG000|Overall Study|Withdrawal by Subject|1|||
48755263|NCT02664441|156951215|FG000|Randomization|Withdrawal by Subject|0|||
48755264|NCT02664441|156951216|FG001|Randomization|Withdrawal by Subject|1|||
48755265|NCT02664441|156951215|FG000|36-week Randomized Trial|Adverse Event|2|||
48755266|NCT02664441|156951216|FG001|36-week Randomized Trial|Adverse Event|0|||
48755267|NCT02664441|156951215|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
48755268|NCT02664441|156951216|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
48658525|NCT01133405|156601702|FG005|Period 1|Received drug only in period 2|1|||
48658526|NCT01133405|156601703|FG006|Period 1|Received drug only in period 2|0|||
48658527|NCT01133405|156601704|FG007|Period 1|Received drug only in period 2|0|||
48755269|NCT02664441|156951215|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
48755270|NCT02664441|156951216|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
48755271|NCT02664441|156951215|FG000|18-week Open Label Extension|Adverse Event|1|||
48755272|NCT02664441|156951216|FG001|18-week Open Label Extension|Adverse Event|0|||
48755273|NCT02664441|156951215|FG000|18-week Open Label Extension|Physician Decision|1|||
48658528|NCT01133405|156601705|FG008|Period 1|Received drug only in period 2|0|||
48658529|NCT01133405|156601706|FG009|Period 1|Received drug only in period 2|0|||
48658530|NCT01133405|156601697|FG000|Period 1|Received drug only in period 3|0|||
48658531|NCT01133405|156601698|FG001|Period 1|Received drug only in period 3|1|||
48658532|NCT01133405|156601699|FG002|Period 1|Received drug only in period 3|1|||
48658533|NCT01133405|156601700|FG003|Period 1|Received drug only in period 3|0|||
48658534|NCT01133405|156601701|FG004|Period 1|Received drug only in period 3|0|||
48658535|NCT01133405|156601702|FG005|Period 1|Received drug only in period 3|0|||
48658536|NCT01133405|156601703|FG006|Period 1|Received drug only in period 3|0|||
48658537|NCT01133405|156601704|FG007|Period 1|Received drug only in period 3|0|||
48658538|NCT01133405|156601705|FG008|Period 1|Received drug only in period 3|0|||
48658539|NCT01133405|156601706|FG009|Period 1|Received drug only in period 3|0|||
48755274|NCT02664441|156951216|FG001|18-week Open Label Extension|Physician Decision|0|||
48755275|NCT02664441|156951215|FG000|18-week Open Label Extension|Death|1|||
48755276|NCT02664441|156951216|FG001|18-week Open Label Extension|Death|0|||
48755277|NCT02664441|156951215|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
48755278|NCT02664441|156951216|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
48755279|NCT01413191|156951217|FG000|Overall Study|Lost to Follow-up|5|||
48755280|NCT01413191|156951217|FG000|Overall Study|Disease Progression|5|||
48755281|NCT01413191|156951217|FG000|Overall Study|Death|1|||
48755282|NCT03654651|156951218|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
48658540|NCT01133405|156601697|FG000|Period 2|Adverse Event|0|||
48658541|NCT01133405|156601698|FG001|Period 2|Adverse Event|0|||
48658542|NCT01133405|156601699|FG002|Period 2|Adverse Event|1|||
48658543|NCT01133405|156601700|FG003|Period 2|Adverse Event|0|||
48658544|NCT01133405|156601701|FG004|Period 2|Adverse Event|0|||
48658545|NCT01133405|156601702|FG005|Period 2|Adverse Event|0|||
48658546|NCT01133405|156601703|FG006|Period 2|Adverse Event|0|||
48658547|NCT01133405|156601704|FG007|Period 2|Adverse Event|0|||
48658548|NCT01133405|156601705|FG008|Period 2|Adverse Event|0|||
48755283|NCT03654651|156951219|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
48755284|NCT03045328|156951220|FG000|Overall Study|Withdrawal by Subject|2|||
48658549|NCT01133405|156601706|FG009|Period 2|Adverse Event|0|||
48658550|NCT01133405|156601697|FG000|Period 2|Withdrawal by Subject|0|||
48658551|NCT01133405|156601698|FG001|Period 2|Withdrawal by Subject|0|||
48658552|NCT01133405|156601699|FG002|Period 2|Withdrawal by Subject|0|||
48658553|NCT01133405|156601700|FG003|Period 2|Withdrawal by Subject|1|||
48658554|NCT01133405|156601701|FG004|Period 2|Withdrawal by Subject|0|||
48658555|NCT01133405|156601702|FG005|Period 2|Withdrawal by Subject|1|||
48658556|NCT01133405|156601703|FG006|Period 2|Withdrawal by Subject|0|||
48658557|NCT01133405|156601704|FG007|Period 2|Withdrawal by Subject|0|||
48658558|NCT01133405|156601705|FG008|Period 2|Withdrawal by Subject|0|||
48658559|NCT01133405|156601706|FG009|Period 2|Withdrawal by Subject|0|||
48658560|NCT01133405|156601697|FG000|Period 2|Entry Criteria Not Met|0|||
48658561|NCT01133405|156601698|FG001|Period 2|Entry Criteria Not Met|1|||
48658562|NCT01133405|156601699|FG002|Period 2|Entry Criteria Not Met|0|||
48658563|NCT01133405|156601700|FG003|Period 2|Entry Criteria Not Met|0|||
48658564|NCT01133405|156601701|FG004|Period 2|Entry Criteria Not Met|0|||
48658565|NCT01133405|156601702|FG005|Period 2|Entry Criteria Not Met|0|||
48658566|NCT01133405|156601703|FG006|Period 2|Entry Criteria Not Met|0|||
48658567|NCT01133405|156601704|FG007|Period 2|Entry Criteria Not Met|0|||
48658568|NCT01133405|156601705|FG008|Period 2|Entry Criteria Not Met|0|||
48658569|NCT01133405|156601706|FG009|Period 2|Entry Criteria Not Met|0|||
48658570|NCT01133405|156601697|FG000|Period 2|Physician Decision|0|||
48658571|NCT01133405|156601698|FG001|Period 2|Physician Decision|0|||
48658572|NCT01133405|156601699|FG002|Period 2|Physician Decision|0|||
48658573|NCT01133405|156601700|FG003|Period 2|Physician Decision|0|||
48755285|NCT00715078|156951223|FG000|Overall Study|Death|29|||
48755286|NCT00715078|156951224|FG001|Overall Study|Death|36|||
48336752|NCT01072149|155429509|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336753|NCT01072149|155429510|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
48336754|NCT03904693|155429511|FG000|Overall Study|Death|0|||
48658574|NCT01133405|156601701|FG004|Period 2|Physician Decision|0|||
48658575|NCT01133405|156601702|FG005|Period 2|Physician Decision|1|||
48755287|NCT00715078|156951225|FG002|Overall Study|Death|36|||
48755288|NCT00715078|156951223|FG000|Overall Study|Withdrawal by Subject|1|||
48336755|NCT03904693|155429512|FG001|Overall Study|Death|0|||
48658576|NCT01133405|156601703|FG006|Period 2|Physician Decision|0|||
48658577|NCT01133405|156601704|FG007|Period 2|Physician Decision|0|||
48658578|NCT01133405|156601705|FG008|Period 2|Physician Decision|0|||
48658579|NCT01133405|156601706|FG009|Period 2|Physician Decision|0|||
48658580|NCT01865812|156601710|FG000|Primary Treatment Phase|Adverse Event|2|||
48658581|NCT01865812|156601711|FG001|Primary Treatment Phase|Adverse Event|0|||
48658582|NCT01865812|156601710|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
48658583|NCT01865812|156601711|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
48755289|NCT00715078|156951224|FG001|Overall Study|Withdrawal by Subject|0|||
48755290|NCT00715078|156951225|FG002|Overall Study|Withdrawal by Subject|1|||
48658584|NCT01865812|156601710|FG000|Long-term Safety Extension Phase|Pruritus|0|||
48658585|NCT01865812|156601711|FG001|Long-term Safety Extension Phase|Pruritus|3|||
48658586|NCT01865812|156601710|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
48658587|NCT01865812|156601711|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
48658588|NCT01865812|156601710|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
48658589|NCT01865812|156601711|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
48658590|NCT02692040|156601712|FG000|Overall Study|Protocol Violation|0|||
48658591|NCT02692040|156601713|FG001|Overall Study|Protocol Violation|0|||
48658592|NCT02692040|156601714|FG002|Overall Study|Protocol Violation|0|||
48658593|NCT02692040|156601715|FG003|Overall Study|Protocol Violation|0|||
48658594|NCT02692040|156601716|FG004|Overall Study|Protocol Violation|0|||
48658595|NCT02692040|156601717|FG005|Overall Study|Protocol Violation|0|||
48658596|NCT02692040|156601718|FG006|Overall Study|Protocol Violation|0|||
48336756|NCT03904693|155429513|FG002|Overall Study|Death|3|||
48336757|NCT03904693|155429511|FG000|Overall Study|Physician Decision|0|||
48336758|NCT03904693|155429512|FG001|Overall Study|Physician Decision|0|||
48336759|NCT03904693|155429513|FG002|Overall Study|Physician Decision|2|||
48336760|NCT03904693|155429511|FG000|Overall Study|Withdrawal by Subject|0|||
48336761|NCT03904693|155429512|FG001|Overall Study|Withdrawal by Subject|1|||
48336762|NCT03904693|155429513|FG002|Overall Study|Withdrawal by Subject|4|||
48336763|NCT00555620|155429518|FG000|Overall Study|Death|0|||
48336764|NCT00555620|155429519|FG001|Overall Study|Death|1|||
48336765|NCT00555620|155429520|FG002|Overall Study|Death|0|||
48336766|NCT00555620|155429521|FG003|Overall Study|Death|0|||
48336767|NCT00555620|155429522|FG004|Overall Study|Death|0|||
48336768|NCT00555620|155429523|FG005|Overall Study|Death|1|||
48336769|NCT00555620|155429518|FG000|Overall Study|Study terminated by sponsor|0|||
48336770|NCT00555620|155429519|FG001|Overall Study|Study terminated by sponsor|0|||
48336771|NCT00555620|155429520|FG002|Overall Study|Study terminated by sponsor|1|||
48336772|NCT00555620|155429521|FG003|Overall Study|Study terminated by sponsor|0|||
48336773|NCT00555620|155429522|FG004|Overall Study|Study terminated by sponsor|0|||
48336774|NCT00555620|155429523|FG005|Overall Study|Study terminated by sponsor|0|||
48336775|NCT00555620|155429518|FG000|Overall Study|Adverse Event|0|||
48336776|NCT00555620|155429519|FG001|Overall Study|Adverse Event|0|||
48336777|NCT00555620|155429520|FG002|Overall Study|Adverse Event|1|||
48336778|NCT00555620|155429521|FG003|Overall Study|Adverse Event|5|||
48336779|NCT00555620|155429522|FG004|Overall Study|Adverse Event|0|||
48658597|NCT02692040|156601719|FG007|Overall Study|Protocol Violation|0|||
48658598|NCT02692040|156601720|FG008|Overall Study|Protocol Violation|0|||
48658599|NCT02692040|156601721|FG009|Overall Study|Protocol Violation|0|||
48658600|NCT02692040|156601722|FG010|Overall Study|Protocol Violation|0|||
48658601|NCT02692040|156601723|FG011|Overall Study|Protocol Violation|0|||
48658602|NCT02692040|156601724|FG012|Overall Study|Protocol Violation|1|||
48658603|NCT02692040|156601725|FG013|Overall Study|Protocol Violation|0|||
48658604|NCT02692040|156601726|FG014|Overall Study|Protocol Violation|0|||
48658605|NCT02692040|156601727|FG015|Overall Study|Protocol Violation|0|||
48658606|NCT02692040|156601728|FG016|Overall Study|Protocol Violation|0|||
48658607|NCT02692040|156601712|FG000|Overall Study|Adverse Event|0|||
48658608|NCT02692040|156601713|FG001|Overall Study|Adverse Event|0|||
48658609|NCT02692040|156601714|FG002|Overall Study|Adverse Event|0|||
48658610|NCT02692040|156601715|FG003|Overall Study|Adverse Event|0|||
48658611|NCT02692040|156601716|FG004|Overall Study|Adverse Event|0|||
48658612|NCT02692040|156601717|FG005|Overall Study|Adverse Event|0|||
48658613|NCT02692040|156601718|FG006|Overall Study|Adverse Event|0|||
48658614|NCT02692040|156601719|FG007|Overall Study|Adverse Event|0|||
48658615|NCT02692040|156601720|FG008|Overall Study|Adverse Event|0|||
48658616|NCT02692040|156601721|FG009|Overall Study|Adverse Event|0|||
48658617|NCT02692040|156601722|FG010|Overall Study|Adverse Event|0|||
48658618|NCT02692040|156601723|FG011|Overall Study|Adverse Event|0|||
48658619|NCT02692040|156601724|FG012|Overall Study|Adverse Event|0|||
48658620|NCT02692040|156601725|FG013|Overall Study|Adverse Event|3|||
48658621|NCT02692040|156601726|FG014|Overall Study|Adverse Event|1|||
48658622|NCT02692040|156601727|FG015|Overall Study|Adverse Event|1|||
48658623|NCT02692040|156601728|FG016|Overall Study|Adverse Event|0|||
48336780|NCT00555620|155429523|FG005|Overall Study|Adverse Event|1|||
48658624|NCT02640625|156603664|FG000|Overall Study|Adverse Event|1|||
48658625|NCT02109432|156603665|FG000|Overall Study|Withdrawal by Subject|1|||
48658626|NCT01945216|156603667|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
48658627|NCT01945216|156603667|FG000|Overall Study|Protocol Violation|42|||
48658628|NCT01945216|156603667|FG000|Overall Study|CRF not assured by investigators|5|||
48658629|NCT02791191|156603668|FG000|Overall Study|Adverse Event|2|||
48336781|NCT00555620|155429518|FG000|Overall Study|Objective progression or relapse|6|||
48336782|NCT00555620|155429519|FG001|Overall Study|Objective progression or relapse|5|||
48336783|NCT00555620|155429520|FG002|Overall Study|Objective progression or relapse|12|||
48336784|NCT00555620|155429521|FG003|Overall Study|Objective progression or relapse|17|||
48658630|NCT02791191|156603669|FG001|Overall Study|Adverse Event|4|||
48658631|NCT02791191|156603670|FG002|Overall Study|Adverse Event|5|||
48658632|NCT02791191|156603668|FG000|Overall Study|Lack of Efficacy|0|||
48336785|NCT00555620|155429522|FG004|Overall Study|Objective progression or relapse|3|||
48336786|NCT00555620|155429523|FG005|Overall Study|Objective progression or relapse|16|||
48336787|NCT00555620|155429518|FG000|Overall Study|Participant refused treatment|0|||
48336788|NCT00555620|155429519|FG001|Overall Study|Participant refused treatment|1|||
48336789|NCT00555620|155429520|FG002|Overall Study|Participant refused treatment|1|||
48336790|NCT00555620|155429521|FG003|Overall Study|Participant refused treatment|0|||
48336791|NCT00555620|155429522|FG004|Overall Study|Participant refused treatment|0|||
48336792|NCT00555620|155429523|FG005|Overall Study|Participant refused treatment|1|||
48336793|NCT00555620|155429518|FG000|Overall Study|Other|0|||
48336794|NCT00555620|155429519|FG001|Overall Study|Other|0|||
48336795|NCT00555620|155429520|FG002|Overall Study|Other|0|||
48336796|NCT00555620|155429521|FG003|Overall Study|Other|1|||
48336797|NCT00555620|155429522|FG004|Overall Study|Other|0|||
48336798|NCT00555620|155429523|FG005|Overall Study|Other|3|||
48336799|NCT00396409|155429524|FG000|Period 1 - 2007|Adverse Event|0|||
48336800|NCT00396409|155429525|FG001|Period 1 - 2007|Adverse Event|1|||
48336801|NCT00396409|155429524|FG000|Period 1 - 2007|Lack of Efficacy|0|||
48336802|NCT00396409|155429525|FG001|Period 1 - 2007|Lack of Efficacy|1|||
48336803|NCT00396409|155429524|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
48336804|NCT00396409|155429525|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
48336805|NCT00396409|155429524|FG000|Period 1 - 2007|Lost to Follow-up|2|||
48336806|NCT00396409|155429525|FG001|Period 1 - 2007|Lost to Follow-up|3|||
48336807|NCT00396409|155429524|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
48336808|NCT00396409|155429525|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
48336809|NCT00396409|155429524|FG000|Period 2 - 2008|Protocol Violation|1|||
48336810|NCT00396409|155429525|FG001|Period 2 - 2008|Protocol Violation|0|||
48336811|NCT00396409|155429524|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
48336812|NCT00396409|155429525|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
48336813|NCT00396409|155429524|FG000|Period 2 - 2008|Lost to Follow-up|3|||
48336814|NCT00396409|155429525|FG001|Period 2 - 2008|Lost to Follow-up|1|||
48336815|NCT01320683|155429529|FG000|Overall Study|Positive antibody response|1|||
48336816|NCT01877720|155429530|FG000|Overall Study|Adverse Event|1|||
48336817|NCT01877720|155429531|FG001|Overall Study|Adverse Event|0|||
48336818|NCT00447499|155429532|FG000|Overall Study|Adverse Event|1|||
48336819|NCT00447499|155429532|FG000|Overall Study|Patient Decision|4|||
48336820|NCT00447499|155429532|FG000|Overall Study|Sponsor Decision|1|||
48336821|NCT00447499|155429532|FG000|Overall Study|Physician Decision|1|||
48336822|NCT03034772|155429535|FG000|Overall Study|Adverse Event|0|||
48336823|NCT03034772|155429536|FG001|Overall Study|Adverse Event|1|||
48336824|NCT03034772|155429535|FG000|Overall Study|Withdrawal by Subject|0|||
48336825|NCT03034772|155429536|FG001|Overall Study|Withdrawal by Subject|1|||
48336826|NCT03386344|155429538|FG000|Overall Study|Adverse Event|6|||
48336827|NCT03386344|155429539|FG001|Overall Study|Adverse Event|3|||
48336828|NCT03386344|155429540|FG002|Overall Study|Adverse Event|1|||
48336829|NCT03386344|155429538|FG000|Overall Study|Poor Compliance to Protocol|0|||
48336830|NCT03386344|155429539|FG001|Overall Study|Poor Compliance to Protocol|1|||
48336831|NCT03386344|155429540|FG002|Overall Study|Poor Compliance to Protocol|0|||
48336832|NCT03386344|155429538|FG000|Overall Study|Study Terminated by Sponsor|101|||
48336833|NCT03386344|155429539|FG001|Overall Study|Study Terminated by Sponsor|102|||
48336834|NCT03386344|155429540|FG002|Overall Study|Study Terminated by Sponsor|106|||
48336835|NCT03386344|155429538|FG000|Overall Study|Lost to Follow-up|3|||
48336836|NCT03386344|155429539|FG001|Overall Study|Lost to Follow-up|2|||
48336837|NCT03386344|155429540|FG002|Overall Study|Lost to Follow-up|1|||
48336838|NCT03386344|155429538|FG000|Overall Study|At the Participant's own Request|7|||
48336839|NCT03386344|155429539|FG001|Overall Study|At the Participant's own Request|7|||
48336840|NCT03386344|155429540|FG002|Overall Study|At the Participant's own Request|8|||
48336841|NCT03386344|155429538|FG000|Overall Study|Reason not Specified|0|||
48336842|NCT03386344|155429539|FG001|Overall Study|Reason not Specified|1|||
48336843|NCT03386344|155429540|FG002|Overall Study|Reason not Specified|0|||
48658633|NCT02791191|156603669|FG001|Overall Study|Lack of Efficacy|1|||
48658634|NCT02791191|156603670|FG002|Overall Study|Lack of Efficacy|0|||
48658635|NCT02791191|156603668|FG000|Overall Study|Study Drug Non-Compliance|0|||
48658636|NCT02791191|156603669|FG001|Overall Study|Study Drug Non-Compliance|2|||
48658637|NCT02791191|156603670|FG002|Overall Study|Study Drug Non-Compliance|0|||
48658638|NCT02791191|156603668|FG000|Overall Study|Site Closed by Sponsor|1|||
48658639|NCT02791191|156603669|FG001|Overall Study|Site Closed by Sponsor|1|||
48658640|NCT02791191|156603670|FG002|Overall Study|Site Closed by Sponsor|3|||
48658641|NCT02791191|156603668|FG000|Overall Study|Progressive Disease|1|||
48658642|NCT02791191|156603669|FG001|Overall Study|Progressive Disease|0|||
48658643|NCT02791191|156603670|FG002|Overall Study|Progressive Disease|0|||
48658644|NCT02791191|156603668|FG000|Overall Study|Study Terminated by Sponsor|29|||
48755291|NCT00715078|156951223|FG000|Overall Study|Unable to start due to disease prog.|0|||
48336844|NCT01525875|155429541|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
48336845|NCT01525875|155429542|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
48336846|NCT01525875|155429541|FG000|Open-label Period|Lost to Follow-up|0|||
48336847|NCT01525875|155429542|FG001|Open-label Period|Lost to Follow-up|2|||
48336848|NCT01106586|155429546|FG000|Overall Study|Adverse Event|9|||
48336849|NCT01106586|155429547|FG001|Overall Study|Adverse Event|15|||
48336850|NCT01106586|155429546|FG000|Overall Study|Death|1|||
48336851|NCT01106586|155429547|FG001|Overall Study|Death|3|||
48336852|NCT01106586|155429546|FG000|Overall Study|Pregnancy|2|||
48336853|NCT01106586|155429547|FG001|Overall Study|Pregnancy|2|||
48336854|NCT01106586|155429546|FG000|Overall Study|Lack of Efficacy|1|||
48336855|NCT01106586|155429547|FG001|Overall Study|Lack of Efficacy|0|||
48336856|NCT01106586|155429546|FG000|Overall Study|Investigator's Discretion|5|||
48336857|NCT01106586|155429547|FG001|Overall Study|Investigator's Discretion|8|||
48336858|NCT01106586|155429546|FG000|Overall Study|Withdrew Consent|18|||
48336859|NCT01106586|155429547|FG001|Overall Study|Withdrew Consent|30|||
48336860|NCT01106586|155429546|FG000|Overall Study|Lost to Follow-up|24|||
48336861|NCT01106586|155429547|FG001|Overall Study|Lost to Follow-up|20|||
48336862|NCT01106586|155429546|FG000|Overall Study|Participant Noncompliance|12|||
48336863|NCT01106586|155429547|FG001|Overall Study|Participant Noncompliance|10|||
48336864|NCT01106586|155429546|FG000|Overall Study|Protocol Violation|1|||
48336865|NCT01106586|155429547|FG001|Overall Study|Protocol Violation|0|||
48336866|NCT01106586|155429546|FG000|Overall Study|Participant Transferred to Another Study|212|||
48336867|NCT01106586|155429547|FG001|Overall Study|Participant Transferred to Another Study|197|||
48336868|NCT05274906|155429548|FG000|Overall Study|Withdrawal by Subject|2|||
48336869|NCT05274906|155429549|FG001|Overall Study|Withdrawal by Subject|1|||
48336870|NCT05265247|155429550|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
48336871|NCT05265247|155429551|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
48336872|NCT05265247|155429550|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
48336873|NCT05265247|155429551|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
48336874|NCT05265247|155429550|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
48336875|NCT05265247|155429551|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
48336876|NCT03508830|155429552|FG000|Overall Study|Withdrawal by Subject|3|||
48336877|NCT03508830|155429553|FG001|Overall Study|Withdrawal by Subject|4|||
48336878|NCT03508830|155429552|FG000|Overall Study|Physician Decision|2|||
48336879|NCT03508830|155429553|FG001|Overall Study|Physician Decision|2|||
48336880|NCT00748098|155429562|FG000|First Treatment Intervention Period|Adverse Event|1|||
48336881|NCT00748098|155429563|FG001|First Treatment Intervention Period|Adverse Event|1|||
48336882|NCT00748098|155429562|FG000|First Treatment Intervention Period|Protocol Violation|1|||
48336883|NCT00748098|155429563|FG001|First Treatment Intervention Period|Protocol Violation|0|||
48336884|NCT00748098|155429562|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
48336885|NCT00748098|155429563|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
48336886|NCT00748098|155429562|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
48336887|NCT00748098|155429563|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
48336888|NCT00748098|155429562|FG000|First Taper Period|Protocol Violation|1|||
48336889|NCT00748098|155429563|FG001|First Taper Period|Protocol Violation|0|||
48336890|NCT00748098|155429562|FG000|First Taper Period|Withdrawal by Subject|2|||
48336891|NCT00748098|155429563|FG001|First Taper Period|Withdrawal by Subject|0|||
48336892|NCT00748098|155429562|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
48336893|NCT00748098|155429563|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
48336894|NCT00748098|155429562|FG000|1-Week Washout Period|Adverse Event|0|||
48336895|NCT00748098|155429563|FG001|1-Week Washout Period|Adverse Event|1|||
48336896|NCT00748098|155429562|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
48336897|NCT00748098|155429563|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
48336898|NCT00748098|155429562|FG000|Second Treatment Intervention Period|Adverse Event|4|||
48336899|NCT00748098|155429563|FG001|Second Treatment Intervention Period|Adverse Event|1|||
48336900|NCT00748098|155429562|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
48336901|NCT00748098|155429563|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
48336902|NCT00748098|155429562|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
48336903|NCT00748098|155429563|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
48336904|NCT04380688|155429564|FG000|Overall Study|Death|2|||
48336905|NCT04380688|155429565|FG001|Overall Study|Death|2|||
48336906|NCT04380688|155429564|FG000|Overall Study|Lost to Follow-up|2|||
48336907|NCT04380688|155429565|FG001|Overall Study|Lost to Follow-up|4|||
48336908|NCT04380688|155429564|FG000|Overall Study|Withdrawal by Subject|3|||
48336909|NCT04380688|155429565|FG001|Overall Study|Withdrawal by Subject|3|||
48336910|NCT01078571|155429566|FG000|Overall Study|Adverse Event|36|||
48336911|NCT01078571|155429566|FG000|Overall Study|Lack of effectiveness|36|||
48336912|NCT01078571|155429566|FG000|Overall Study|Reason not reported|21|||
48336913|NCT01078571|155429566|FG000|Overall Study|Withdrawal by Subject|12|||
48336914|NCT01078571|155429566|FG000|Overall Study|Lost to Follow-up|8|||
48336915|NCT01078571|155429566|FG000|Overall Study|Protocol Violation|2|||
48336916|NCT02213458|155429576|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
48336917|NCT02213458|155429577|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
48336918|NCT02213458|155429576|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
48336919|NCT02213458|155429577|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
48336920|NCT02213458|155429576|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
48336921|NCT02213458|155429577|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
48336922|NCT02213458|155429576|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
48336923|NCT02213458|155429577|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
48336924|NCT02213458|155429576|FG000|Overall Study|Refused re-consent|6|||
48336925|NCT02213458|155429577|FG001|Overall Study|Refused re-consent|0|||
48336926|NCT02213458|155429576|FG000|Overall Study|Lost to Follow-up|2|||
48336927|NCT02213458|155429577|FG001|Overall Study|Lost to Follow-up|2|||
48336928|NCT02213458|155429576|FG000|Overall Study|Withdrawal by Subject|26|||
48336929|NCT02213458|155429577|FG001|Overall Study|Withdrawal by Subject|8|||
48336930|NCT01257698|155429578|FG000|Overall Study|Protocol Violation|4|||
48336931|NCT01257698|155429579|FG001|Overall Study|Protocol Violation|0|||
48336932|NCT00665392|155429590|FG000|Overall Study|not treated|1|||
48336933|NCT05287178|155429594|FG000|Overall Study|Lost to Follow-up|2|||
48336934|NCT01536795|155429595|FG000|Overall Study|Lost to Follow-up|0|||
48336935|NCT01536795|155429596|FG001|Overall Study|Lost to Follow-up|2|||
48336936|NCT01536795|155429595|FG000|Overall Study|Lack of Efficacy|1|||
48336937|NCT01536795|155429596|FG001|Overall Study|Lack of Efficacy|0|||
48336938|NCT00050167|155429598|FG000|Overall Study|not eligible not invasive|1|||
48336939|NCT00050167|155429599|FG001|Overall Study|not eligible not invasive|1|||
48336940|NCT00495612|155429601|FG000|Overall Study|Lost to Follow-up|1|||
48336941|NCT00495612|155429602|FG001|Overall Study|Lost to Follow-up|0|||
48336942|NCT00495612|155429601|FG000|Overall Study|Subject's Decision to Withdraw|3|||
48336943|NCT00495612|155429602|FG001|Overall Study|Subject's Decision to Withdraw|0|||
48336944|NCT03530345|155429606|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
48336945|NCT03530345|155429607|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
48336946|NCT03530345|155429606|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
48336947|NCT03530345|155429607|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
48336948|NCT03530345|155429606|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
48336949|NCT03530345|155429607|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
48658645|NCT02791191|156603669|FG001|Overall Study|Study Terminated by Sponsor|101|||
48658646|NCT02791191|156603670|FG002|Overall Study|Study Terminated by Sponsor|109|||
48658647|NCT02791191|156603668|FG000|Overall Study|Withdrawal by Subject|3|||
48658648|NCT02791191|156603669|FG001|Overall Study|Withdrawal by Subject|1|||
48658649|NCT02791191|156603670|FG002|Overall Study|Withdrawal by Subject|3|||
48658650|NCT02791191|156603668|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
48658651|NCT02791191|156603669|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
48658652|NCT02791191|156603670|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
48658653|NCT00782171|156603671|FG000|Overall Study|Lost to Follow-up|2|||
48658654|NCT00782171|156603672|FG001|Overall Study|Lost to Follow-up|2|||
48658655|NCT00782171|156603671|FG000|Overall Study|Withdrawal by Subject|2|||
48658656|NCT00782171|156603672|FG001|Overall Study|Withdrawal by Subject|1|||
48658657|NCT00782171|156603671|FG000|Overall Study|complications|3|||
48658658|NCT00782171|156603672|FG001|Overall Study|complications|1|||
48658659|NCT00782171|156603671|FG000|Overall Study|others|7|||
48658660|NCT00782171|156603672|FG001|Overall Study|others|9|||
48658661|NCT00782171|156603671|FG000|Overall Study|not eligible|8|||
48658662|NCT00782171|156603672|FG001|Overall Study|not eligible|6|||
48658663|NCT05032157|156603674|FG000|Overall Study|Adverse Event|12|||
48658664|NCT05032157|156603675|FG001|Overall Study|Adverse Event|7|||
48658665|NCT05032157|156603674|FG000|Overall Study|Pregnancy|0|||
48658666|NCT05032157|156603675|FG001|Overall Study|Pregnancy|2|||
48658667|NCT05032157|156603674|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48658668|NCT05032157|156603675|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
48658669|NCT05032157|156603674|FG000|Overall Study|Protocol Deviation|8|||
48658670|NCT05032157|156603675|FG001|Overall Study|Protocol Deviation|4|||
48658671|NCT05032157|156603674|FG000|Overall Study|Lost to Follow-up|1|||
48658672|NCT05032157|156603675|FG001|Overall Study|Lost to Follow-up|3|||
48658673|NCT05032157|156603674|FG000|Overall Study|Physician Decision|7|||
48336950|NCT03530345|155429606|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
48336951|NCT03530345|155429607|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
48658674|NCT05032157|156603675|FG001|Overall Study|Physician Decision|2|||
48658675|NCT05032157|156603674|FG000|Overall Study|Patient Decision|38|||
48658676|NCT05032157|156603675|FG001|Overall Study|Patient Decision|19|||
48658677|NCT01559259|156603679|FG000|Overall Study|Withdrawal by Subject|0|||
48658678|NCT01559259|156603680|FG001|Overall Study|Withdrawal by Subject|0|||
48658679|NCT01559259|156603681|FG002|Overall Study|Withdrawal by Subject|0|||
48658680|NCT01559259|156603682|FG003|Overall Study|Withdrawal by Subject|1|||
48658681|NCT01559259|156603683|FG004|Overall Study|Withdrawal by Subject|0|||
48658682|NCT01559259|156603679|FG000|Overall Study|Adverse Event|0|||
48658683|NCT01559259|156603680|FG001|Overall Study|Adverse Event|1|||
48658684|NCT01559259|156603681|FG002|Overall Study|Adverse Event|1|||
48755292|NCT00715078|156951224|FG001|Overall Study|Unable to start due to disease prog.|0|||
48658685|NCT01559259|156603682|FG003|Overall Study|Adverse Event|0|||
48658686|NCT01559259|156603683|FG004|Overall Study|Adverse Event|0|||
48658687|NCT04753658|156603684|FG000|Overall Study|Progressive disease|7|||
48658688|NCT04753658|156603684|FG000|Overall Study|Other|7|||
48658689|NCT04753658|156603684|FG000|Overall Study|Adverse Event|1|||
48658690|NCT00549900|156603688|FG000|Overall Study|Adverse Event|1|||
48658691|NCT01145352|156603693|FG000|Overall Study|Found to have been registered twice|6|||
48658692|NCT01145352|156603693|FG000|Overall Study|Treated before marketing approval|4|||
48658693|NCT01145352|156603693|FG000|Overall Study|Syringe formulation was used|1|||
48658694|NCT04984876|156603698|FG000|Overall Study|Subject decision|2|||
48658695|NCT04984876|156603699|FG001|Overall Study|Subject decision|10|||
48658696|NCT04984876|156603700|FG002|Overall Study|Subject decision|3|||
48658697|NCT04984876|156603701|FG003|Overall Study|Subject decision|3|||
48658698|NCT04984876|156603702|FG004|Overall Study|Subject decision|3|||
48658699|NCT04984876|156603703|FG005|Overall Study|Subject decision|0|||
48658700|NCT04984876|156603698|FG000|Overall Study|Guardian decision|0|||
48658701|NCT04984876|156603699|FG001|Overall Study|Guardian decision|1|||
48658702|NCT04984876|156603700|FG002|Overall Study|Guardian decision|0|||
48658703|NCT04984876|156603701|FG003|Overall Study|Guardian decision|2|||
48658704|NCT04984876|156603702|FG004|Overall Study|Guardian decision|0|||
48658705|NCT04984876|156603703|FG005|Overall Study|Guardian decision|1|||
48658706|NCT04984876|156603698|FG000|Overall Study|Lost to Follow-up|0|||
48658707|NCT04984876|156603699|FG001|Overall Study|Lost to Follow-up|0|||
48658708|NCT04984876|156603700|FG002|Overall Study|Lost to Follow-up|1|||
48658709|NCT04984876|156603701|FG003|Overall Study|Lost to Follow-up|1|||
48658710|NCT04984876|156603702|FG004|Overall Study|Lost to Follow-up|0|||
48658711|NCT04984876|156603703|FG005|Overall Study|Lost to Follow-up|0|||
48658712|NCT04984876|156603698|FG000|Overall Study|Physician Decision|1|||
48658713|NCT04984876|156603699|FG001|Overall Study|Physician Decision|0|||
48658714|NCT04984876|156603700|FG002|Overall Study|Physician Decision|0|||
48658715|NCT04984876|156603701|FG003|Overall Study|Physician Decision|1|||
48658716|NCT04984876|156603702|FG004|Overall Study|Physician Decision|0|||
48658717|NCT04984876|156603703|FG005|Overall Study|Physician Decision|0|||
48658718|NCT04984876|156603698|FG000|Overall Study|Adverse Event|0|||
48658719|NCT04984876|156603699|FG001|Overall Study|Adverse Event|0|||
48658720|NCT04984876|156603700|FG002|Overall Study|Adverse Event|1|||
48658721|NCT04984876|156603701|FG003|Overall Study|Adverse Event|0|||
48658722|NCT04984876|156603702|FG004|Overall Study|Adverse Event|0|||
48658723|NCT04984876|156603703|FG005|Overall Study|Adverse Event|0|||
48658724|NCT03457142|156603704|FG000|Overall Study|Death|1|||
48658725|NCT03392883|156603709|FG000|Overall Study|Lost to Follow-up|122|||
48658726|NCT03392883|156603710|FG001|Overall Study|Lost to Follow-up|13|||
48658727|NCT03392883|156603711|FG002|Overall Study|Lost to Follow-up|9|||
48658728|NCT03392883|156603709|FG000|Overall Study|Death|4|||
48658729|NCT03392883|156603710|FG001|Overall Study|Death|0|||
48658730|NCT03392883|156603711|FG002|Overall Study|Death|0|||
48658731|NCT03392883|156603709|FG000|Overall Study|Lack of Efficacy|29|||
48658732|NCT03392883|156603710|FG001|Overall Study|Lack of Efficacy|0|||
48658733|NCT03392883|156603711|FG002|Overall Study|Lack of Efficacy|0|||
48658734|NCT03392883|156603709|FG000|Overall Study|Withdrawal by Subject|180|||
48658735|NCT03392883|156603710|FG001|Overall Study|Withdrawal by Subject|0|||
48658736|NCT03392883|156603711|FG002|Overall Study|Withdrawal by Subject|0|||
48658737|NCT03392883|156603709|FG000|Overall Study|Adverse Event|1|||
48658738|NCT03392883|156603710|FG001|Overall Study|Adverse Event|0|||
48658739|NCT03392883|156603711|FG002|Overall Study|Adverse Event|0|||
48658740|NCT00090142|156603712|FG000|Treatment Period I|Lost to Follow-up|1|||
48658741|NCT00090142|156603713|FG001|Treatment Period I|Lost to Follow-up|2|||
48336952|NCT03406507|155429608|FG000|Extension Period|Lack of Efficacy|0|||
48336953|NCT03406507|155429609|FG001|Extension Period|Lack of Efficacy|1|||
48336954|NCT00663923|155429610|FG000|Overall Study|Lost to Follow-up|2|||
48658742|NCT00090142|156603712|FG000|Treatment Period I|Protocol Violation|2|||
48658743|NCT00090142|156603713|FG001|Treatment Period I|Protocol Violation|0|||
48658744|NCT00090142|156603712|FG000|Treatment Period I|Withdrawal by Subject|2|||
48658745|NCT00090142|156603713|FG001|Treatment Period I|Withdrawal by Subject|0|||
48658746|NCT00090142|156603712|FG000|Treatment Period I|Other|0|||
48658747|NCT00090142|156603713|FG001|Treatment Period I|Other|1|||
48658748|NCT00090142|156603712|FG000|Treatment Period II|Other|1|||
48658749|NCT00090142|156603713|FG001|Treatment Period II|Other|0|||
48658750|NCT02300558|156603714|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
48658751|NCT02300558|156603714|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
48336955|NCT02316171|155429611|FG000|Overall Study|difficulties with urinary catheter|1|||
48658752|NCT02300558|156603714|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
48658753|NCT02300558|156603714|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
48658754|NCT01846663|156603715|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
48658755|NCT01846663|156603716|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
48658756|NCT01846663|156603715|FG000|Overall Study|Withdrawal by Subject|1|||
48658757|NCT01846663|156603716|FG001|Overall Study|Withdrawal by Subject|0|||
48658758|NCT01846663|156603715|FG000|Overall Study|Adverse Event|1|||
48658759|NCT01846663|156603716|FG001|Overall Study|Adverse Event|2|||
48658760|NCT00813865|156603718|FG000|Overall Study|Failure to Respond|3|||
48658761|NCT00813865|156603718|FG000|Overall Study|Lost to Follow-up|3|||
48658762|NCT00813865|156603718|FG000|Overall Study|Withdrawal by Subject|1|||
48336956|NCT02316171|155429612|FG001|Overall Study|difficulties with urinary catheter|0|||
48336957|NCT02316171|155429613|FG002|Overall Study|difficulties with urinary catheter|0|||
48658763|NCT02754141|156603719|FG000|Overall Study|Disease progression|11|||
48658764|NCT02754141|156603720|FG001|Overall Study|Disease progression|7|||
48658765|NCT02754141|156603721|FG002|Overall Study|Disease progression|8|||
48658766|NCT02754141|156603722|FG003|Overall Study|Disease progression|5|||
48658767|NCT02754141|156603723|FG004|Overall Study|Disease progression|7|||
48658768|NCT02754141|156603724|FG005|Overall Study|Disease progression|7|||
48658769|NCT02754141|156603725|FG006|Overall Study|Disease progression|7|||
48658770|NCT02754141|156603726|FG007|Overall Study|Disease progression|6|||
48658771|NCT02754141|156603727|FG008|Overall Study|Disease progression|11|||
48658772|NCT02754141|156603728|FG009|Overall Study|Disease progression|16|||
48658773|NCT02754141|156603729|FG010|Overall Study|Disease progression|18|||
48658774|NCT02754141|156603730|FG011|Overall Study|Disease progression|13|||
48658775|NCT02754141|156603731|FG012|Overall Study|Disease progression|10|||
48658776|NCT02754141|156603732|FG013|Overall Study|Disease progression|12|||
48658777|NCT02754141|156603733|FG014|Overall Study|Disease progression|12|||
48658778|NCT02754141|156603734|FG015|Overall Study|Disease progression|14|||
48658779|NCT02754141|156603735|FG016|Overall Study|Disease progression|0|||
48658780|NCT02754141|156603736|FG017|Overall Study|Disease progression|1|||
48658781|NCT02754141|156603719|FG000|Overall Study|Study drug toxicity|1|||
48658782|NCT02754141|156603720|FG001|Overall Study|Study drug toxicity|1|||
48658783|NCT02754141|156603721|FG002|Overall Study|Study drug toxicity|0|||
48658784|NCT02754141|156603722|FG003|Overall Study|Study drug toxicity|0|||
48658785|NCT02754141|156603723|FG004|Overall Study|Study drug toxicity|0|||
48658786|NCT02754141|156603724|FG005|Overall Study|Study drug toxicity|0|||
48658787|NCT02754141|156603725|FG006|Overall Study|Study drug toxicity|0|||
48658788|NCT02754141|156603726|FG007|Overall Study|Study drug toxicity|0|||
48658789|NCT02754141|156603727|FG008|Overall Study|Study drug toxicity|0|||
48658790|NCT02754141|156603728|FG009|Overall Study|Study drug toxicity|0|||
48658791|NCT02754141|156603729|FG010|Overall Study|Study drug toxicity|2|||
48658792|NCT02754141|156603730|FG011|Overall Study|Study drug toxicity|1|||
48658793|NCT02754141|156603731|FG012|Overall Study|Study drug toxicity|1|||
48658794|NCT02754141|156603732|FG013|Overall Study|Study drug toxicity|0|||
48658795|NCT02754141|156603733|FG014|Overall Study|Study drug toxicity|0|||
48658796|NCT02754141|156603734|FG015|Overall Study|Study drug toxicity|0|||
48658797|NCT02754141|156603735|FG016|Overall Study|Study drug toxicity|0|||
48658798|NCT02754141|156603736|FG017|Overall Study|Study drug toxicity|0|||
48658799|NCT02754141|156603719|FG000|Overall Study|AE unrelated to study drug|1|||
48658800|NCT02754141|156603720|FG001|Overall Study|AE unrelated to study drug|1|||
48658801|NCT02754141|156603721|FG002|Overall Study|AE unrelated to study drug|0|||
48658802|NCT02754141|156603722|FG003|Overall Study|AE unrelated to study drug|1|||
48658803|NCT02754141|156603723|FG004|Overall Study|AE unrelated to study drug|3|||
48658804|NCT02754141|156603724|FG005|Overall Study|AE unrelated to study drug|2|||
48658805|NCT02754141|156603725|FG006|Overall Study|AE unrelated to study drug|1|||
48658806|NCT02754141|156603726|FG007|Overall Study|AE unrelated to study drug|0|||
48658807|NCT02754141|156603727|FG008|Overall Study|AE unrelated to study drug|0|||
48658808|NCT02754141|156603728|FG009|Overall Study|AE unrelated to study drug|0|||
48658809|NCT02754141|156603729|FG010|Overall Study|AE unrelated to study drug|0|||
48658810|NCT02754141|156603730|FG011|Overall Study|AE unrelated to study drug|0|||
48658811|NCT02754141|156603731|FG012|Overall Study|AE unrelated to study drug|0|||
48658812|NCT02754141|156603732|FG013|Overall Study|AE unrelated to study drug|0|||
48658813|NCT02754141|156603733|FG014|Overall Study|AE unrelated to study drug|0|||
48658814|NCT02754141|156603734|FG015|Overall Study|AE unrelated to study drug|0|||
48658815|NCT02754141|156603735|FG016|Overall Study|AE unrelated to study drug|0|||
48658816|NCT02754141|156603736|FG017|Overall Study|AE unrelated to study drug|0|||
48658817|NCT02754141|156603719|FG000|Overall Study|Request to discontinue|0|||
48658818|NCT02754141|156603720|FG001|Overall Study|Request to discontinue|0|||
48658819|NCT02754141|156603721|FG002|Overall Study|Request to discontinue|0|||
48658820|NCT02754141|156603722|FG003|Overall Study|Request to discontinue|0|||
48658821|NCT02754141|156603723|FG004|Overall Study|Request to discontinue|0|||
48658822|NCT02754141|156603724|FG005|Overall Study|Request to discontinue|0|||
48658823|NCT02754141|156603725|FG006|Overall Study|Request to discontinue|0|||
48658824|NCT02754141|156603726|FG007|Overall Study|Request to discontinue|0|||
48658825|NCT02754141|156603727|FG008|Overall Study|Request to discontinue|1|||
48658826|NCT02754141|156603728|FG009|Overall Study|Request to discontinue|0|||
48658827|NCT02754141|156603729|FG010|Overall Study|Request to discontinue|0|||
48658828|NCT02754141|156603730|FG011|Overall Study|Request to discontinue|0|||
48658829|NCT02754141|156603731|FG012|Overall Study|Request to discontinue|0|||
48658830|NCT02754141|156603732|FG013|Overall Study|Request to discontinue|1|||
48336958|NCT02316171|155429614|FG003|Overall Study|difficulties with urinary catheter|0|||
48336959|NCT04853394|155429615|FG000|Follow-up Interviews|Lost to Follow-up|22|||
48336960|NCT04853394|155429616|FG001|Follow-up Interviews|Lost to Follow-up|15|||
48336961|NCT01804140|155429617|FG000|Overall Study|No sampling or biopsy procedures done|114|||
48336962|NCT01524887|155429618|FG000|Overall Study|Withdrawal by Subject|6|||
48336963|NCT01524887|155429619|FG001|Overall Study|Withdrawal by Subject|2|||
48658831|NCT02754141|156603733|FG014|Overall Study|Request to discontinue|1|||
48658832|NCT02754141|156603734|FG015|Overall Study|Request to discontinue|0|||
48658833|NCT02754141|156603735|FG016|Overall Study|Request to discontinue|0|||
48658834|NCT02754141|156603736|FG017|Overall Study|Request to discontinue|0|||
48658835|NCT02754141|156603719|FG000|Overall Study|Withdrew consent|0|||
48658836|NCT02754141|156603720|FG001|Overall Study|Withdrew consent|0|||
48658837|NCT02754141|156603721|FG002|Overall Study|Withdrew consent|0|||
48658838|NCT02754141|156603722|FG003|Overall Study|Withdrew consent|0|||
48658839|NCT02754141|156603723|FG004|Overall Study|Withdrew consent|0|||
48658840|NCT02754141|156603724|FG005|Overall Study|Withdrew consent|0|||
48658841|NCT02754141|156603725|FG006|Overall Study|Withdrew consent|0|||
48658842|NCT02754141|156603726|FG007|Overall Study|Withdrew consent|0|||
48658843|NCT02754141|156603727|FG008|Overall Study|Withdrew consent|0|||
48658844|NCT02754141|156603728|FG009|Overall Study|Withdrew consent|1|||
48658845|NCT02754141|156603729|FG010|Overall Study|Withdrew consent|0|||
48658846|NCT02754141|156603730|FG011|Overall Study|Withdrew consent|0|||
48658847|NCT02754141|156603731|FG012|Overall Study|Withdrew consent|0|||
48658848|NCT02754141|156603732|FG013|Overall Study|Withdrew consent|0|||
48658849|NCT02754141|156603733|FG014|Overall Study|Withdrew consent|0|||
48658850|NCT02754141|156603734|FG015|Overall Study|Withdrew consent|0|||
48658851|NCT02754141|156603735|FG016|Overall Study|Withdrew consent|0|||
48658852|NCT02754141|156603736|FG017|Overall Study|Withdrew consent|0|||
48658853|NCT02754141|156603719|FG000|Overall Study|Maximum clinical benefit|0|||
48658854|NCT02754141|156603720|FG001|Overall Study|Maximum clinical benefit|0|||
48658855|NCT02754141|156603721|FG002|Overall Study|Maximum clinical benefit|0|||
48658856|NCT02754141|156603722|FG003|Overall Study|Maximum clinical benefit|1|||
48658857|NCT02754141|156603723|FG004|Overall Study|Maximum clinical benefit|0|||
48658858|NCT02754141|156603724|FG005|Overall Study|Maximum clinical benefit|0|||
48658859|NCT02754141|156603725|FG006|Overall Study|Maximum clinical benefit|0|||
48658860|NCT02754141|156603726|FG007|Overall Study|Maximum clinical benefit|0|||
48658861|NCT02754141|156603727|FG008|Overall Study|Maximum clinical benefit|0|||
48658862|NCT02754141|156603728|FG009|Overall Study|Maximum clinical benefit|0|||
48658863|NCT02754141|156603729|FG010|Overall Study|Maximum clinical benefit|0|||
48336964|NCT01524887|155429620|FG002|Overall Study|Withdrawal by Subject|3|||
48336965|NCT01524887|155429618|FG000|Overall Study|Adverse Event|5|||
48336966|NCT01524887|155429619|FG001|Overall Study|Adverse Event|1|||
48336967|NCT01524887|155429620|FG002|Overall Study|Adverse Event|1|||
48658864|NCT02754141|156603730|FG011|Overall Study|Maximum clinical benefit|0|||
48658865|NCT02754141|156603731|FG012|Overall Study|Maximum clinical benefit|0|||
48658866|NCT02754141|156603732|FG013|Overall Study|Maximum clinical benefit|0|||
48658867|NCT02754141|156603733|FG014|Overall Study|Maximum clinical benefit|0|||
48658868|NCT02754141|156603734|FG015|Overall Study|Maximum clinical benefit|0|||
48658869|NCT02754141|156603735|FG016|Overall Study|Maximum clinical benefit|0|||
48658870|NCT02754141|156603736|FG017|Overall Study|Maximum clinical benefit|0|||
48336968|NCT01524887|155429618|FG000|Overall Study|Protocol Violation|0|||
48336969|NCT01524887|155429619|FG001|Overall Study|Protocol Violation|0|||
48336970|NCT01524887|155429620|FG002|Overall Study|Protocol Violation|1|||
48336971|NCT01524887|155429618|FG000|Overall Study|Study termination|73|||
48336972|NCT01524887|155429619|FG001|Overall Study|Study termination|87|||
48336973|NCT01524887|155429620|FG002|Overall Study|Study termination|79|||
48336974|NCT01524887|155429618|FG000|Overall Study|Withdrawal by Caregiver|0|||
48336975|NCT01524887|155429619|FG001|Overall Study|Withdrawal by Caregiver|0|||
48336976|NCT01524887|155429620|FG002|Overall Study|Withdrawal by Caregiver|2|||
48336977|NCT01524887|155429618|FG000|Overall Study|Use of prohibited medication|1|||
48336978|NCT01524887|155429619|FG001|Overall Study|Use of prohibited medication|0|||
48336979|NCT01524887|155429620|FG002|Overall Study|Use of prohibited medication|0|||
48336980|NCT05006703|155431755|FG000|Overall Study|Withdrawal by Subject|1|||
48336981|NCT05006703|155431756|FG001|Overall Study|Withdrawal by Subject|0|||
48658871|NCT02754141|156603719|FG000|Overall Study|No longer meets study criteria|0|||
48658872|NCT02754141|156603720|FG001|Overall Study|No longer meets study criteria|0|||
48658873|NCT02754141|156603721|FG002|Overall Study|No longer meets study criteria|0|||
48658874|NCT02754141|156603722|FG003|Overall Study|No longer meets study criteria|1|||
48658875|NCT02754141|156603723|FG004|Overall Study|No longer meets study criteria|0|||
48336982|NCT05006703|155431755|FG000|Overall Study|Lost to Follow-up|13|||
48336983|NCT05006703|155431756|FG001|Overall Study|Lost to Follow-up|5|||
48658876|NCT02754141|156603724|FG005|Overall Study|No longer meets study criteria|0|||
48658877|NCT02754141|156603725|FG006|Overall Study|No longer meets study criteria|0|||
48658878|NCT02754141|156603726|FG007|Overall Study|No longer meets study criteria|0|||
48658879|NCT02754141|156603727|FG008|Overall Study|No longer meets study criteria|0|||
48658880|NCT02754141|156603728|FG009|Overall Study|No longer meets study criteria|0|||
48658881|NCT02754141|156603729|FG010|Overall Study|No longer meets study criteria|0|||
48658882|NCT02754141|156603730|FG011|Overall Study|No longer meets study criteria|0|||
48658883|NCT02754141|156603731|FG012|Overall Study|No longer meets study criteria|0|||
48658884|NCT02754141|156603732|FG013|Overall Study|No longer meets study criteria|0|||
48658885|NCT02754141|156603733|FG014|Overall Study|No longer meets study criteria|0|||
48658886|NCT02754141|156603734|FG015|Overall Study|No longer meets study criteria|0|||
48658887|NCT02754141|156603735|FG016|Overall Study|No longer meets study criteria|0|||
48658888|NCT02754141|156603736|FG017|Overall Study|No longer meets study criteria|0|||
48658889|NCT02754141|156603719|FG000|Overall Study|Other reasons|0|||
48658890|NCT02754141|156603720|FG001|Overall Study|Other reasons|0|||
48658891|NCT02754141|156603721|FG002|Overall Study|Other reasons|0|||
48658892|NCT02754141|156603722|FG003|Overall Study|Other reasons|0|||
48658893|NCT02754141|156603723|FG004|Overall Study|Other reasons|0|||
48658894|NCT02754141|156603724|FG005|Overall Study|Other reasons|0|||
48658895|NCT02754141|156603725|FG006|Overall Study|Other reasons|0|||
48658896|NCT02754141|156603726|FG007|Overall Study|Other reasons|1|||
48658897|NCT02754141|156603727|FG008|Overall Study|Other reasons|0|||
48658898|NCT02754141|156603728|FG009|Overall Study|Other reasons|0|||
48658899|NCT02754141|156603729|FG010|Overall Study|Other reasons|0|||
48658900|NCT02754141|156603730|FG011|Overall Study|Other reasons|0|||
48658901|NCT02754141|156603731|FG012|Overall Study|Other reasons|2|||
48658902|NCT02754141|156603732|FG013|Overall Study|Other reasons|0|||
48658903|NCT02754141|156603733|FG014|Overall Study|Other reasons|0|||
48658904|NCT02754141|156603734|FG015|Overall Study|Other reasons|0|||
48658905|NCT02754141|156603735|FG016|Overall Study|Other reasons|0|||
48658906|NCT02754141|156603736|FG017|Overall Study|Other reasons|0|||
48658907|NCT02754141|156603719|FG000|Overall Study|Completed treatment as per protocol|0|||
48658908|NCT02754141|156603720|FG001|Overall Study|Completed treatment as per protocol|1|||
48658909|NCT02754141|156603721|FG002|Overall Study|Completed treatment as per protocol|0|||
48658910|NCT02754141|156603722|FG003|Overall Study|Completed treatment as per protocol|0|||
48658911|NCT02754141|156603723|FG004|Overall Study|Completed treatment as per protocol|0|||
48658912|NCT02754141|156603724|FG005|Overall Study|Completed treatment as per protocol|0|||
48658913|NCT02754141|156603725|FG006|Overall Study|Completed treatment as per protocol|0|||
48658914|NCT02754141|156603726|FG007|Overall Study|Completed treatment as per protocol|0|||
48658915|NCT02754141|156603727|FG008|Overall Study|Completed treatment as per protocol|0|||
48658916|NCT02754141|156603728|FG009|Overall Study|Completed treatment as per protocol|0|||
48658917|NCT02754141|156603729|FG010|Overall Study|Completed treatment as per protocol|0|||
48658918|NCT02754141|156603730|FG011|Overall Study|Completed treatment as per protocol|0|||
48658919|NCT02754141|156603731|FG012|Overall Study|Completed treatment as per protocol|1|||
48658920|NCT02754141|156603732|FG013|Overall Study|Completed treatment as per protocol|0|||
48658921|NCT02754141|156603733|FG014|Overall Study|Completed treatment as per protocol|0|||
48658922|NCT02754141|156603734|FG015|Overall Study|Completed treatment as per protocol|0|||
48658923|NCT02754141|156603735|FG016|Overall Study|Completed treatment as per protocol|0|||
48658924|NCT02754141|156603736|FG017|Overall Study|Completed treatment as per protocol|0|||
48658925|NCT02754141|156603719|FG000|Overall Study|Not completing monotherapy|0|||
48658926|NCT02754141|156603720|FG001|Overall Study|Not completing monotherapy|0|||
48658927|NCT02754141|156603721|FG002|Overall Study|Not completing monotherapy|0|||
48658928|NCT02754141|156603722|FG003|Overall Study|Not completing monotherapy|0|||
48658929|NCT02754141|156603723|FG004|Overall Study|Not completing monotherapy|0|||
48658930|NCT02754141|156603724|FG005|Overall Study|Not completing monotherapy|0|||
48658931|NCT02754141|156603725|FG006|Overall Study|Not completing monotherapy|0|||
48658932|NCT02754141|156603726|FG007|Overall Study|Not completing monotherapy|0|||
48658933|NCT02754141|156603727|FG008|Overall Study|Not completing monotherapy|0|||
48658934|NCT02754141|156603728|FG009|Overall Study|Not completing monotherapy|0|||
48658935|NCT02754141|156603729|FG010|Overall Study|Not completing monotherapy|0|||
48658936|NCT02754141|156603730|FG011|Overall Study|Not completing monotherapy|0|||
48658937|NCT02754141|156603731|FG012|Overall Study|Not completing monotherapy|0|||
48658938|NCT02754141|156603732|FG013|Overall Study|Not completing monotherapy|1|||
48658939|NCT02754141|156603733|FG014|Overall Study|Not completing monotherapy|0|||
48658940|NCT02754141|156603734|FG015|Overall Study|Not completing monotherapy|0|||
48336984|NCT04049578|155431758|FG000|Overall Study|Physician Decision|1|||
48658941|NCT02754141|156603735|FG016|Overall Study|Not completing monotherapy|0|||
48658942|NCT02754141|156603736|FG017|Overall Study|Not completing monotherapy|0|||
48658943|NCT03031470|156603739|FG000|Overall Study|Adverse Event|3|||
48658944|NCT03031470|156603740|FG001|Overall Study|Adverse Event|0|||
48658945|NCT03031470|156603739|FG000|Overall Study|Death|3|||
48658946|NCT03031470|156603740|FG001|Overall Study|Death|1|||
48658947|NCT03031470|156603739|FG000|Overall Study|Lost to Follow-up|1|||
48658948|NCT03031470|156603740|FG001|Overall Study|Lost to Follow-up|1|||
48658949|NCT03031470|156603739|FG000|Overall Study|Withdrawal by Subject|1|||
48658950|NCT03031470|156603740|FG001|Overall Study|Withdrawal by Subject|0|||
48658951|NCT03031470|156603739|FG000|Overall Study|Protocol entry criteria not met|0|||
48658952|NCT03031470|156603740|FG001|Overall Study|Protocol entry criteria not met|1|||
48658953|NCT03031470|156603739|FG000|Overall Study|Cancel the operation|0|||
48658954|NCT03031470|156603740|FG001|Overall Study|Cancel the operation|1|||
48658955|NCT03505788|156603741|FG000|Overall Study|Lost to Follow-up|2|||
48658956|NCT03505788|156603742|FG001|Overall Study|Lost to Follow-up|1|||
48658957|NCT03505788|156603741|FG000|Overall Study|Withdrawal by Subject|1|||
48658958|NCT03505788|156603742|FG001|Overall Study|Withdrawal by Subject|3|||
48658959|NCT03505788|156603741|FG000|Overall Study|Physician Decision|0|||
48658960|NCT03505788|156603742|FG001|Overall Study|Physician Decision|1|||
48658961|NCT01421303|156603743|FG000|Overall Study|Lost to Follow-up|13|||
48658962|NCT01421303|156603743|FG000|Overall Study|Non compliance with study procedure|1|||
48658963|NCT01421303|156603743|FG000|Overall Study|Other|7|||
48336985|NCT02065895|155431759|FG000|Overall Study|Protocol Violation|1|||
48336986|NCT02065895|155431760|FG001|Overall Study|Protocol Violation|0|||
48336987|NCT02065895|155431761|FG002|Overall Study|Protocol Violation|0|||
48658964|NCT01421303|156603743|FG000|Overall Study|Withdrawal by Subject|1|||
48658965|NCT03960580|156603744|FG000|Overall Study|Adverse Event|2|||
48658966|NCT03960580|156603745|FG001|Overall Study|Adverse Event|1|||
48658967|NCT03960580|156603746|FG002|Overall Study|Adverse Event|1|||
48658968|NCT03960580|156603744|FG000|Overall Study|Lost to Follow-up|1|||
48658969|NCT03960580|156603745|FG001|Overall Study|Lost to Follow-up|0|||
48658970|NCT03960580|156603746|FG002|Overall Study|Lost to Follow-up|0|||
48658971|NCT03960580|156603744|FG000|Overall Study|Lack of Efficacy|2|||
48658972|NCT03960580|156603745|FG001|Overall Study|Lack of Efficacy|1|||
48658973|NCT03960580|156603746|FG002|Overall Study|Lack of Efficacy|0|||
48658974|NCT03960580|156603744|FG000|Overall Study|Protocol Violation|0|||
48658975|NCT03960580|156603745|FG001|Overall Study|Protocol Violation|0|||
48658976|NCT03960580|156603746|FG002|Overall Study|Protocol Violation|1|||
48658977|NCT03960580|156603744|FG000|Overall Study|Withdrawal by Subject|1|||
48336988|NCT02065895|155431762|FG003|Overall Study|Protocol Violation|1|||
48336989|NCT02065895|155431763|FG004|Overall Study|Protocol Violation|0|||
48336990|NCT02065895|155431764|FG005|Overall Study|Protocol Violation|0|||
48336991|NCT02065895|155431759|FG000|Overall Study|Scheduling conflicts|0|||
48336992|NCT02065895|155431760|FG001|Overall Study|Scheduling conflicts|1|||
48336993|NCT02065895|155431761|FG002|Overall Study|Scheduling conflicts|0|||
48336994|NCT02065895|155431762|FG003|Overall Study|Scheduling conflicts|0|||
48336995|NCT02065895|155431763|FG004|Overall Study|Scheduling conflicts|0|||
48336996|NCT02065895|155431764|FG005|Overall Study|Scheduling conflicts|0|||
48336997|NCT02011568|155431765|FG000|Overall Study|Withdrawal by Subject|8|||
48336998|NCT02011568|155431766|FG001|Overall Study|Withdrawal by Subject|10|||
48336999|NCT02011568|155431765|FG000|Overall Study|Physician Decision|1|||
48658978|NCT03960580|156603745|FG001|Overall Study|Withdrawal by Subject|1|||
48658979|NCT03960580|156603746|FG002|Overall Study|Withdrawal by Subject|1|||
48658980|NCT03960580|156603744|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
48658981|NCT03960580|156603745|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
48337000|NCT02011568|155431766|FG001|Overall Study|Physician Decision|3|||
48337001|NCT01807234|155431767|FG000|Overall Study|Lost to Follow-up|2|||
48337002|NCT01807234|155431768|FG001|Overall Study|Lost to Follow-up|5|||
48658982|NCT03960580|156603746|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
48658983|NCT04600076|156603747|FG000|Overall Study|Lost to Follow-up|3|||
48658984|NCT02701777|156603748|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
48658985|NCT02701777|156603749|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
48658986|NCT02701777|156603750|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
48658987|NCT02701777|156603751|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
48658988|NCT02701777|156603748|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
48658989|NCT02701777|156603749|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
48337003|NCT01807234|155431769|FG002|Overall Study|Lost to Follow-up|1|||
48337004|NCT01807234|155431770|FG003|Overall Study|Lost to Follow-up|1|||
48337005|NCT01807234|155431771|FG004|Overall Study|Lost to Follow-up|1|||
48337006|NCT01807234|155431772|FG005|Overall Study|Lost to Follow-up|2|||
48337007|NCT01807234|155431767|FG000|Overall Study|Withdrawal by Subject|3|||
48337008|NCT01807234|155431768|FG001|Overall Study|Withdrawal by Subject|1|||
48337009|NCT01807234|155431769|FG002|Overall Study|Withdrawal by Subject|1|||
48337010|NCT01807234|155431770|FG003|Overall Study|Withdrawal by Subject|1|||
48337011|NCT01807234|155431771|FG004|Overall Study|Withdrawal by Subject|2|||
48337012|NCT01807234|155431772|FG005|Overall Study|Withdrawal by Subject|1|||
48337013|NCT01807234|155431767|FG000|Overall Study|Lack of Efficacy|0|||
48337014|NCT01807234|155431768|FG001|Overall Study|Lack of Efficacy|0|||
48337015|NCT01807234|155431769|FG002|Overall Study|Lack of Efficacy|0|||
48337016|NCT01807234|155431770|FG003|Overall Study|Lack of Efficacy|0|||
48337017|NCT01807234|155431771|FG004|Overall Study|Lack of Efficacy|1|||
48337018|NCT01807234|155431772|FG005|Overall Study|Lack of Efficacy|1|||
48337019|NCT00538629|155431775|FG000|Overall Study|At subject's request|1|||
48337020|NCT00538629|155431775|FG000|Overall Study|Adverse Event|2|||
48337021|NCT00538629|155431775|FG000|Overall Study|Lack of Efficacy|12|||
48337022|NCT00538629|155431775|FG000|Overall Study|Lost to Follow-up|6|||
48337023|NCT00538629|155431775|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
48337024|NCT01587703|155431780|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
48337025|NCT01587703|155431781|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337026|NCT01587703|155431782|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337027|NCT01587703|155431783|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337028|NCT01587703|155431784|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337029|NCT01587703|155431785|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337030|NCT01587703|155431786|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337031|NCT01587703|155431787|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337032|NCT01587703|155431788|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337033|NCT01587703|155431789|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337034|NCT01587703|155431790|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337035|NCT01587703|155431791|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337036|NCT01587703|155431792|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337037|NCT01587703|155431793|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337038|NCT01587703|155431794|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337039|NCT01587703|155431795|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48658990|NCT02701777|156603750|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
48658991|NCT02701777|156603751|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
48658992|NCT01327053|156603752|FG000|Overall Study|Adverse Event|23|||
48658993|NCT01327053|156603753|FG001|Overall Study|Adverse Event|57|||
48755293|NCT00715078|156951225|FG002|Overall Study|Unable to start due to disease prog.|1|||
48658994|NCT01327053|156603752|FG000|Overall Study|Patient/guardian decision|11|||
48658995|NCT01327053|156603753|FG001|Overall Study|Patient/guardian decision|35|||
48658996|NCT01327053|156603752|FG000|Overall Study|Physician Decision|10|||
48658997|NCT01327053|156603753|FG001|Overall Study|Physician Decision|14|||
48658998|NCT01327053|156603752|FG000|Overall Study|Death|1|||
48658999|NCT01327053|156603753|FG001|Overall Study|Death|5|||
48755294|NCT00386776|156951226|FG000|Overall Study|Withdrawal by Subject|8|||
48755295|NCT00788151|156951227|FG000|Overall Study|Other adverse event|0|||
48755296|NCT00788151|156951228|FG001|Overall Study|Other adverse event|2|||
48755297|NCT00788151|156951227|FG000|Overall Study|Protocol Violation|0|||
48755298|NCT00788151|156951228|FG001|Overall Study|Protocol Violation|1|||
48755299|NCT00788151|156951227|FG000|Overall Study|Withdrawal by Subject|13|||
48755300|NCT00788151|156951228|FG001|Overall Study|Withdrawal by Subject|6|||
48755301|NCT00788151|156951227|FG000|Overall Study|Enrolled but not treated|1|||
48755302|NCT00788151|156951228|FG001|Overall Study|Enrolled but not treated|1|||
48755303|NCT00498602|156951234|FG000|Overall Study|Death|0|||
48755304|NCT00498602|156951235|FG001|Overall Study|Death|0|||
48755305|NCT00498602|156951236|FG002|Overall Study|Death|0|||
48755306|NCT00498602|156951237|FG003|Overall Study|Death|0|||
48337040|NCT01587703|155431796|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337041|NCT01587703|155431797|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48755307|NCT00498602|156951238|FG004|Overall Study|Death|0|||
48755308|NCT00498602|156951239|FG005|Overall Study|Death|1|||
48337042|NCT01587703|155431798|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
48337043|NCT01587703|155431780|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337044|NCT01587703|155431781|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337045|NCT01587703|155431782|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48659000|NCT01327053|156603752|FG000|Overall Study|Lost to Follow-up|2|||
48659001|NCT01327053|156603753|FG001|Overall Study|Lost to Follow-up|4|||
48755309|NCT00498602|156951240|FG006|Overall Study|Death|0|||
48659002|NCT01327053|156603752|FG000|Overall Study|Non-compliance with study treatment|0|||
48659003|NCT01327053|156603753|FG001|Overall Study|Non-compliance with study treatment|5|||
48659004|NCT01327053|156603752|FG000|Overall Study|Study terminated by Sponsor|1|||
48659005|NCT01327053|156603753|FG001|Overall Study|Study terminated by Sponsor|3|||
48659006|NCT01327053|156603752|FG000|Overall Study|Progressive disease|31|||
48659007|NCT01327053|156603753|FG001|Overall Study|Progressive disease|26|||
48659008|NCT01327053|156603752|FG000|Overall Study|Protocol Violation|0|||
48659009|NCT01327053|156603753|FG001|Overall Study|Protocol Violation|1|||
48659010|NCT01327053|156603752|FG000|Overall Study|Untreated|0|||
48659011|NCT01327053|156603753|FG001|Overall Study|Untreated|1|||
48659012|NCT01574157|156603754|FG000|Overall Study|Withdrawal by Subject|4|||
48659013|NCT01574157|156603755|FG001|Overall Study|Withdrawal by Subject|5|||
48659014|NCT01574157|156603754|FG000|Overall Study|Lost to Follow-up|0|||
48659015|NCT01574157|156603755|FG001|Overall Study|Lost to Follow-up|3|||
48659016|NCT02298179|156603756|FG000|Overall Study|Lost to Follow-up|0|||
48659017|NCT02298179|156603757|FG001|Overall Study|Lost to Follow-up|0|||
48659018|NCT02298179|156603758|FG002|Overall Study|Lost to Follow-up|1|||
48659019|NCT02298179|156603759|FG003|Overall Study|Lost to Follow-up|0|||
48659020|NCT02298179|156603760|FG004|Overall Study|Lost to Follow-up|0|||
48659021|NCT02298179|156603761|FG005|Overall Study|Lost to Follow-up|0|||
48659022|NCT02298179|156603762|FG006|Overall Study|Lost to Follow-up|0|||
48659023|NCT02298179|156603763|FG007|Overall Study|Lost to Follow-up|1|||
48659024|NCT02298179|156603764|FG008|Overall Study|Lost to Follow-up|0|||
48659025|NCT02298179|156603765|FG009|Overall Study|Lost to Follow-up|0|||
48659026|NCT02298179|156603766|FG010|Overall Study|Lost to Follow-up|0|||
48337046|NCT01587703|155431783|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48659027|NCT02298179|156603767|FG011|Overall Study|Lost to Follow-up|0|||
48659028|NCT01824823|156603775|FG000|Overall Study|Lack of Efficacy|1|||
48659029|NCT01824823|156603776|FG001|Overall Study|Lack of Efficacy|1|||
48659030|NCT01824823|156603775|FG000|Overall Study|Off-treatment reason not submitted|1|||
48659031|NCT01824823|156603776|FG001|Overall Study|Off-treatment reason not submitted|0|||
48659032|NCT01170065|156603787|FG000|Overall Study|Adverse Event|17|||
48659033|NCT01170065|156603788|FG001|Overall Study|Adverse Event|50|||
48659034|NCT01170065|156603789|FG002|Overall Study|Adverse Event|10|||
48659035|NCT01170065|156603787|FG000|Overall Study|Lost to Follow-up|1|||
48659036|NCT01170065|156603788|FG001|Overall Study|Lost to Follow-up|4|||
48659037|NCT01170065|156603789|FG002|Overall Study|Lost to Follow-up|1|||
48659038|NCT01170065|156603787|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
48659039|NCT01170065|156603788|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
48659040|NCT01170065|156603789|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
48659041|NCT01170065|156603787|FG000|Overall Study|Reason other than specified|3|||
48659042|NCT01170065|156603788|FG001|Overall Study|Reason other than specified|8|||
48659043|NCT01170065|156603789|FG002|Overall Study|Reason other than specified|3|||
48659044|NCT01170065|156603787|FG000|Overall Study|Ongoing after planned observation time|5|||
48659045|NCT01170065|156603788|FG001|Overall Study|Ongoing after planned observation time|26|||
48659046|NCT01170065|156603789|FG002|Overall Study|Ongoing after planned observation time|10|||
48659047|NCT01089023|156603790|FG000|Overall Study|Lost to Follow-up|3|||
48659048|NCT01089023|156603790|FG000|Overall Study|Adverse Event|1|||
48659049|NCT01089023|156603790|FG000|Overall Study|Withdrawal by Subject|1|||
48659050|NCT01089023|156603790|FG000|Overall Study|Protocol Violation|1|||
48659051|NCT01089023|156603790|FG000|Overall Study|Lack of Efficacy|1|||
48659052|NCT02323204|156603794|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
48659053|NCT02323204|156603795|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
48659054|NCT02323204|156603796|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
48337047|NCT01587703|155431784|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48659055|NCT02323204|156603797|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
48659056|NCT02323204|156603794|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
48337048|NCT01587703|155431785|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
48659057|NCT02323204|156603795|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
48659058|NCT02323204|156603796|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
48659059|NCT02323204|156603797|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
48659060|NCT02323204|156603794|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
48659061|NCT02323204|156603795|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
48337049|NCT01587703|155431786|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48659062|NCT02323204|156603796|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
48659063|NCT02323204|156603797|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
48659064|NCT02323204|156603794|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
48659065|NCT02323204|156603795|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
48659066|NCT02323204|156603796|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
48659067|NCT02323204|156603797|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
48659068|NCT02323204|156603794|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
48659069|NCT02323204|156603795|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
48659070|NCT02323204|156603796|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
48659071|NCT02323204|156603797|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
48659072|NCT02323204|156603794|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
48659073|NCT02323204|156603795|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
48659074|NCT02323204|156603796|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
48659075|NCT02323204|156603797|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
48659076|NCT02323204|156603794|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
48659077|NCT02323204|156603795|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
48659078|NCT02323204|156603796|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
48659079|NCT02323204|156603797|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
48659080|NCT02323204|156603794|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
48659081|NCT02323204|156603795|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
48659082|NCT02323204|156603796|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
48659083|NCT02323204|156603797|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
48659084|NCT02323204|156603794|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
48659085|NCT02323204|156603795|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
48659086|NCT02323204|156603796|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
48659087|NCT02323204|156603797|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
48659088|NCT03158012|156603799|FG000|Overall Study|Withdrawal by Subject|0|||
48659089|NCT03158012|156603800|FG001|Overall Study|Withdrawal by Subject|1|||
48659090|NCT02141490|156603808|FG000|Overall Study|Screening failures|4|||
48659091|NCT02141490|156603809|FG001|Overall Study|Screening failures|0|||
48659092|NCT02141490|156603810|FG002|Overall Study|Screening failures|0|||
48659093|NCT00191724|156605133|FG000|Overall Study|Adverse Event|0|||
48659094|NCT00191724|156605134|FG001|Overall Study|Adverse Event|0|||
48659095|NCT00191724|156605135|FG002|Overall Study|Adverse Event|1|||
48659096|NCT00191724|156605136|FG003|Overall Study|Adverse Event|0|||
48659097|NCT00191724|156605137|FG004|Overall Study|Adverse Event|0|||
48659098|NCT00191724|156605133|FG000|Overall Study|Lost to Follow-up|1|||
48659099|NCT00191724|156605134|FG001|Overall Study|Lost to Follow-up|1|||
48659100|NCT00191724|156605135|FG002|Overall Study|Lost to Follow-up|0|||
48659101|NCT00191724|156605136|FG003|Overall Study|Lost to Follow-up|2|||
48659102|NCT00191724|156605137|FG004|Overall Study|Lost to Follow-up|3|||
48659103|NCT00191724|156605133|FG000|Overall Study|Withdrawal by Subject|0|||
48659104|NCT00191724|156605134|FG001|Overall Study|Withdrawal by Subject|0|||
48659105|NCT00191724|156605135|FG002|Overall Study|Withdrawal by Subject|0|||
48337050|NCT01587703|155431787|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
48337051|NCT01587703|155431788|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337052|NCT01587703|155431789|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337053|NCT01587703|155431790|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337054|NCT01587703|155431791|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337055|NCT01587703|155431792|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337056|NCT01587703|155431793|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337057|NCT01587703|155431794|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337058|NCT01587703|155431795|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337059|NCT01587703|155431796|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337060|NCT01587703|155431797|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337061|NCT01587703|155431798|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
48337062|NCT01587703|155431780|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337063|NCT01587703|155431781|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337064|NCT01587703|155431782|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337065|NCT01587703|155431783|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337066|NCT01587703|155431784|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337067|NCT01587703|155431785|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337068|NCT01587703|155431786|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
48337069|NCT01587703|155431787|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337070|NCT01587703|155431788|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337071|NCT01587703|155431789|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337072|NCT01587703|155431790|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337073|NCT01587703|155431791|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337074|NCT01587703|155431792|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337075|NCT01587703|155431793|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337076|NCT01587703|155431794|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337077|NCT01587703|155431795|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337078|NCT01587703|155431796|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337079|NCT01587703|155431797|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337080|NCT01587703|155431798|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
48337081|NCT01587703|155431780|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
48337082|NCT01587703|155431781|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
48337083|NCT01587703|155431782|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
48428217|NCT02531373|155756502|FG004|Overall Study|Lost to Follow-up|0|||
48659106|NCT00191724|156605136|FG003|Overall Study|Withdrawal by Subject|1|||
48337084|NCT01587703|155431783|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
48337085|NCT01587703|155431784|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
48337086|NCT01587703|155431785|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
48337087|NCT01587703|155431786|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
48337088|NCT01587703|155431787|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
48337089|NCT01587703|155431788|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337090|NCT01587703|155431789|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337091|NCT01587703|155431790|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337092|NCT01587703|155431791|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337093|NCT01587703|155431792|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337094|NCT01587703|155431793|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337095|NCT01587703|155431794|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337096|NCT01587703|155431795|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337097|NCT01587703|155431796|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337098|NCT01587703|155431797|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337099|NCT01587703|155431798|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
48337100|NCT01587703|155431780|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337101|NCT01587703|155431781|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337102|NCT01587703|155431782|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337103|NCT01587703|155431783|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337104|NCT01587703|155431784|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337105|NCT01587703|155431785|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337106|NCT01587703|155431786|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337107|NCT01587703|155431787|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337108|NCT01587703|155431788|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
48337109|NCT01587703|155431789|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
48337110|NCT01587703|155431790|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
48337111|NCT01587703|155431791|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337112|NCT01587703|155431792|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337113|NCT01587703|155431793|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337114|NCT01587703|155431794|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337115|NCT01587703|155431795|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337116|NCT01587703|155431796|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337117|NCT01587703|155431797|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337118|NCT01587703|155431798|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
48337119|NCT01587703|155431780|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337120|NCT01587703|155431781|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337121|NCT01587703|155431782|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337122|NCT01587703|155431783|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337123|NCT01587703|155431784|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337124|NCT01587703|155431785|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337125|NCT01587703|155431786|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337126|NCT01587703|155431787|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337127|NCT01587703|155431788|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
48337128|NCT01587703|155431789|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337129|NCT01587703|155431790|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
48337130|NCT01587703|155431791|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337131|NCT01587703|155431792|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337132|NCT01587703|155431793|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337133|NCT01587703|155431794|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337134|NCT01587703|155431795|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337135|NCT01587703|155431796|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337136|NCT01587703|155431797|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337137|NCT01587703|155431798|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
48337138|NCT01587703|155431780|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337139|NCT01587703|155431781|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337140|NCT01587703|155431782|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337141|NCT01587703|155431783|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337142|NCT01587703|155431784|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337143|NCT01587703|155431785|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337144|NCT01587703|155431786|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337145|NCT01587703|155431787|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337146|NCT01587703|155431788|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337147|NCT01587703|155431789|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
48337148|NCT01587703|155431790|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
48337149|NCT01587703|155431791|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48428218|NCT02531373|155756503|FG005|Overall Study|Lost to Follow-up|2|||
48337150|NCT01587703|155431792|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337151|NCT01587703|155431793|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337152|NCT01587703|155431794|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48659107|NCT00191724|156605137|FG004|Overall Study|Withdrawal by Subject|0|||
48659108|NCT01772472|156605138|FG000|Overall Study|Death|56|||
48659109|NCT01772472|156605139|FG001|Overall Study|Death|42|||
48659110|NCT01772472|156605138|FG000|Overall Study|Physician Decision|1|||
48659111|NCT01772472|156605139|FG001|Overall Study|Physician Decision|3|||
48659112|NCT01772472|156605138|FG000|Overall Study|Other|5|||
48659113|NCT01772472|156605139|FG001|Overall Study|Other|5|||
48659114|NCT01772472|156605138|FG000|Overall Study|Lost to Follow-up|12|||
48659115|NCT01772472|156605139|FG001|Overall Study|Lost to Follow-up|8|||
48659116|NCT01772472|156605138|FG000|Overall Study|Withdrawal by Subject|72|||
48659117|NCT01772472|156605139|FG001|Overall Study|Withdrawal by Subject|50|||
48659118|NCT01772472|156605138|FG000|Overall Study|Ongoing|597|||
48659119|NCT01772472|156605139|FG001|Overall Study|Ongoing|635|||
48659120|NCT03334851|156605140|FG000|Overall Study|Other|0|||
48659121|NCT03334851|156605141|FG001|Overall Study|Other|0|||
48659122|NCT03334851|156605142|FG002|Overall Study|Other|0|||
48659123|NCT03334851|156605143|FG003|Overall Study|Other|0|||
48659124|NCT03334851|156605144|FG004|Overall Study|Other|0|||
48659125|NCT03334851|156605145|FG005|Overall Study|Other|0|||
48659126|NCT03334851|156605146|FG006|Overall Study|Other|0|||
48659127|NCT03334851|156605147|FG007|Overall Study|Other|1|||
48659128|NCT03334851|156605148|FG008|Overall Study|Other|0|||
48659129|NCT03334851|156605149|FG009|Overall Study|Other|0|||
48659130|NCT03334851|156605150|FG010|Overall Study|Other|0|||
48659131|NCT03334851|156605151|FG011|Overall Study|Other|0|||
48659132|NCT03334851|156605152|FG012|Overall Study|Other|0|||
48659133|NCT03334851|156605140|FG000|Overall Study|Adverse Event|0|||
48659134|NCT03334851|156605141|FG001|Overall Study|Adverse Event|0|||
48659135|NCT03334851|156605142|FG002|Overall Study|Adverse Event|0|||
48659136|NCT03334851|156605143|FG003|Overall Study|Adverse Event|0|||
48659137|NCT03334851|156605144|FG004|Overall Study|Adverse Event|0|||
48659138|NCT03334851|156605145|FG005|Overall Study|Adverse Event|0|||
48659139|NCT03334851|156605146|FG006|Overall Study|Adverse Event|0|||
48659140|NCT03334851|156605147|FG007|Overall Study|Adverse Event|1|||
48659141|NCT03334851|156605148|FG008|Overall Study|Adverse Event|0|||
48659142|NCT03334851|156605149|FG009|Overall Study|Adverse Event|0|||
48659143|NCT03334851|156605150|FG010|Overall Study|Adverse Event|0|||
48659144|NCT03334851|156605151|FG011|Overall Study|Adverse Event|0|||
48659145|NCT03334851|156605152|FG012|Overall Study|Adverse Event|0|||
48659146|NCT03334851|156605140|FG000|Overall Study|Withdrawal by Subject|0|||
48659147|NCT03334851|156605141|FG001|Overall Study|Withdrawal by Subject|0|||
48659148|NCT03334851|156605142|FG002|Overall Study|Withdrawal by Subject|0|||
48659149|NCT03334851|156605143|FG003|Overall Study|Withdrawal by Subject|0|||
48659150|NCT03334851|156605144|FG004|Overall Study|Withdrawal by Subject|0|||
48659151|NCT03334851|156605145|FG005|Overall Study|Withdrawal by Subject|0|||
48659152|NCT03334851|156605146|FG006|Overall Study|Withdrawal by Subject|0|||
48659153|NCT03334851|156605147|FG007|Overall Study|Withdrawal by Subject|0|||
48659154|NCT03334851|156605148|FG008|Overall Study|Withdrawal by Subject|0|||
48659155|NCT03334851|156605149|FG009|Overall Study|Withdrawal by Subject|0|||
48659156|NCT03334851|156605150|FG010|Overall Study|Withdrawal by Subject|1|||
48659157|NCT03334851|156605151|FG011|Overall Study|Withdrawal by Subject|0|||
48659158|NCT03334851|156605152|FG012|Overall Study|Withdrawal by Subject|1|||
48659159|NCT03334851|156605140|FG000|Overall Study|Lost to Follow-up|0|||
48659160|NCT03334851|156605141|FG001|Overall Study|Lost to Follow-up|0|||
48659161|NCT03334851|156605142|FG002|Overall Study|Lost to Follow-up|0|||
48659162|NCT03334851|156605143|FG003|Overall Study|Lost to Follow-up|0|||
48659163|NCT03334851|156605144|FG004|Overall Study|Lost to Follow-up|0|||
48659164|NCT03334851|156605145|FG005|Overall Study|Lost to Follow-up|0|||
48659165|NCT03334851|156605146|FG006|Overall Study|Lost to Follow-up|0|||
48659166|NCT03334851|156605147|FG007|Overall Study|Lost to Follow-up|0|||
48659167|NCT03334851|156605148|FG008|Overall Study|Lost to Follow-up|0|||
48337153|NCT01587703|155431795|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48659168|NCT03334851|156605149|FG009|Overall Study|Lost to Follow-up|0|||
48659169|NCT03334851|156605150|FG010|Overall Study|Lost to Follow-up|2|||
48659170|NCT03334851|156605151|FG011|Overall Study|Lost to Follow-up|1|||
48659171|NCT03334851|156605152|FG012|Overall Study|Lost to Follow-up|0|||
48659172|NCT00523705|156605153|FG000|Overall Study|No time for study.|0|||
48659173|NCT00523705|156605154|FG001|Overall Study|No time for study.|1|||
48659174|NCT00596154|156605155|FG000|Overall Study|Not Evaluable|2|||
48659175|NCT01534260|156605162|FG000|Overall Study|Adverse Event|1|||
48659176|NCT01534260|156605163|FG001|Overall Study|Adverse Event|8|||
48659177|NCT01534260|156605162|FG000|Overall Study|Death|2|||
48659178|NCT01534260|156605163|FG001|Overall Study|Death|0|||
48659179|NCT01534260|156605162|FG000|Overall Study|Lack of Efficacy|1|||
48659180|NCT01534260|156605163|FG001|Overall Study|Lack of Efficacy|1|||
48659181|NCT01534260|156605162|FG000|Overall Study|Withdrawal by Subject|1|||
48659182|NCT01534260|156605163|FG001|Overall Study|Withdrawal by Subject|3|||
48337154|NCT01587703|155431796|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337155|NCT01587703|155431797|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337156|NCT01587703|155431798|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
48337157|NCT01587703|155431780|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337158|NCT01587703|155431781|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337159|NCT01587703|155431782|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48659183|NCT01534260|156605162|FG000|Overall Study|Disease Progression|8|||
48659184|NCT01534260|156605163|FG001|Overall Study|Disease Progression|6|||
48659185|NCT01534260|156605162|FG000|Overall Study|Physician Decision|3|||
48659186|NCT01534260|156605163|FG001|Overall Study|Physician Decision|1|||
48659187|NCT01534260|156605162|FG000|Overall Study|No treatment, per protocol|0|||
48659188|NCT01534260|156605163|FG001|Overall Study|No treatment, per protocol|1|||
48659189|NCT00856206|156605168|FG000|Overall Study|Protocol Violation|6|||
48659190|NCT00856206|156605169|FG001|Overall Study|Protocol Violation|18|||
48659191|NCT00856206|156605168|FG000|Overall Study|Adverse Event|10|||
48659192|NCT00856206|156605169|FG001|Overall Study|Adverse Event|46|||
48659193|NCT00856206|156605168|FG000|Overall Study|Lack of Efficacy|1|||
48659194|NCT00856206|156605169|FG001|Overall Study|Lack of Efficacy|2|||
48659195|NCT00856206|156605168|FG000|Overall Study|Withdrawal by Subject|15|||
48659196|NCT00856206|156605169|FG001|Overall Study|Withdrawal by Subject|36|||
48659197|NCT00856206|156605168|FG000|Overall Study|Lost to Follow-up|13|||
48659198|NCT00856206|156605169|FG001|Overall Study|Lost to Follow-up|39|||
48659199|NCT00856206|156605168|FG000|Overall Study|Death|2|||
48659200|NCT00856206|156605169|FG001|Overall Study|Death|2|||
48659201|NCT00856206|156605168|FG000|Overall Study|Decision by the Sponsor|4|||
48659202|NCT00856206|156605169|FG001|Overall Study|Decision by the Sponsor|8|||
48659203|NCT00856206|156605168|FG000|Overall Study|Other than specified above|3|||
48659204|NCT00856206|156605169|FG001|Overall Study|Other than specified above|10|||
48659205|NCT04068181|156605170|FG000|Overall Study|Death|17|||
48659206|NCT04068181|156605171|FG001|Overall Study|Death|12|||
48659207|NCT04068181|156605172|FG002|Overall Study|Death|4|||
48659208|NCT04068181|156605173|FG003|Overall Study|Death|7|||
48659209|NCT04068181|156605170|FG000|Overall Study|Lost to Follow-up|1|||
48659210|NCT04068181|156605171|FG001|Overall Study|Lost to Follow-up|0|||
48659211|NCT04068181|156605172|FG002|Overall Study|Lost to Follow-up|0|||
48659212|NCT04068181|156605173|FG003|Overall Study|Lost to Follow-up|0|||
48659213|NCT04068181|156605170|FG000|Overall Study|Withdrawal of consent from study|3|||
48659214|NCT04068181|156605171|FG001|Overall Study|Withdrawal of consent from study|0|||
48659215|NCT04068181|156605172|FG002|Overall Study|Withdrawal of consent from study|0|||
48659216|NCT04068181|156605173|FG003|Overall Study|Withdrawal of consent from study|0|||
48659217|NCT01553149|156605174|FG000|Overall Study|Adverse Event|0|||
48659218|NCT01553149|156605175|FG001|Overall Study|Adverse Event|9|||
48659219|NCT01553149|156605174|FG000|Overall Study|Physician Decision|5|||
48659220|NCT01553149|156605175|FG001|Overall Study|Physician Decision|10|||
48659221|NCT01553149|156605174|FG000|Overall Study|Ineligible|0|||
48659222|NCT01553149|156605175|FG001|Overall Study|Ineligible|1|||
48659223|NCT00468676|156605176|FG000|Overall Study|Lost to Follow-up|14|||
48755310|NCT00498602|156951234|FG000|Overall Study|Lack of Efficacy|1|||
48755311|NCT00498602|156951235|FG001|Overall Study|Lack of Efficacy|0|||
48659224|NCT00468676|156605177|FG001|Overall Study|Lost to Follow-up|11|||
48659225|NCT00468676|156605176|FG000|Overall Study|Death|2|||
48755312|NCT00498602|156951236|FG002|Overall Study|Lack of Efficacy|0|||
48755313|NCT00498602|156951237|FG003|Overall Study|Lack of Efficacy|0|||
48755314|NCT00498602|156951238|FG004|Overall Study|Lack of Efficacy|0|||
48755315|NCT00498602|156951239|FG005|Overall Study|Lack of Efficacy|0|||
48755316|NCT00498602|156951240|FG006|Overall Study|Lack of Efficacy|0|||
48337160|NCT01587703|155431783|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48659226|NCT00468676|156605177|FG001|Overall Study|Death|1|||
48659227|NCT05100628|156605183|FG000|Overall Study|Progressive Disease|1|||
48659228|NCT05100628|156605184|FG001|Overall Study|Progressive Disease|0|||
48659229|NCT05100628|156605185|FG002|Overall Study|Progressive Disease|0|||
48659230|NCT05100628|156605186|FG003|Overall Study|Progressive Disease|0|||
48659231|NCT05100628|156605183|FG000|Overall Study|Study Terminated by Sponsor|0|||
48659232|NCT05100628|156605184|FG001|Overall Study|Study Terminated by Sponsor|0|||
48659233|NCT05100628|156605185|FG002|Overall Study|Study Terminated by Sponsor|3|||
48659234|NCT05100628|156605186|FG003|Overall Study|Study Terminated by Sponsor|0|||
48755317|NCT00498602|156951234|FG000|Overall Study|Lost to Follow-up|0|||
48337161|NCT01587703|155431784|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337162|NCT01587703|155431785|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337163|NCT01587703|155431786|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48428219|NCT02531373|155756504|FG006|Overall Study|Lost to Follow-up|2|||
48659235|NCT05100628|156605183|FG000|Overall Study|unkown|0|||
48659236|NCT05100628|156605184|FG001|Overall Study|unkown|1|||
48755318|NCT00498602|156951235|FG001|Overall Study|Lost to Follow-up|2|||
48755319|NCT00498602|156951236|FG002|Overall Study|Lost to Follow-up|0|||
48659237|NCT05100628|156605185|FG002|Overall Study|unkown|0|||
48659238|NCT05100628|156605186|FG003|Overall Study|unkown|0|||
48659239|NCT00068250|156605197|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
48659240|NCT00068250|156605198|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
48659241|NCT00068250|156605199|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
48659242|NCT00068250|156605200|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
48659243|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Death|1|||
48659244|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Death|1|||
48659245|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Death|0|||
48659246|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Death|0|||
48659247|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Death|1|||
48659248|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Death|0|||
48659249|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Death|0|||
48659250|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Death|0|||
48659251|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Death|0|||
48659252|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Death|0|||
48659253|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
48659254|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
48659255|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
48659256|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659257|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
48659258|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659259|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
48337164|NCT01587703|155431787|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337165|NCT01587703|155431788|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
48337166|NCT01587703|155431789|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337167|NCT01587703|155431790|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337168|NCT01587703|155431791|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337169|NCT01587703|155431792|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337170|NCT01587703|155431793|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337171|NCT01587703|155431794|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337172|NCT01587703|155431795|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337173|NCT01587703|155431796|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337174|NCT01587703|155431797|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337175|NCT01587703|155431798|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
48337176|NCT01587703|155431780|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337177|NCT01587703|155431781|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337178|NCT01587703|155431782|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337179|NCT01587703|155431783|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337180|NCT01587703|155431784|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337181|NCT01587703|155431785|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337182|NCT01587703|155431786|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337183|NCT01587703|155431787|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337184|NCT01587703|155431788|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337185|NCT01587703|155431789|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337186|NCT01587703|155431790|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337187|NCT01587703|155431791|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337188|NCT01587703|155431792|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337189|NCT01587703|155431793|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337190|NCT01587703|155431794|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337191|NCT01587703|155431795|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337192|NCT01587703|155431796|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337193|NCT01587703|155431797|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
48337194|NCT01587703|155431798|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
48337195|NCT01587703|155431780|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337196|NCT01587703|155431781|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337197|NCT01587703|155431782|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337198|NCT01587703|155431783|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337199|NCT01587703|155431784|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48659260|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659261|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659262|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
48659263|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659264|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659265|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659266|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659267|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
48659268|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659269|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48337200|NCT01587703|155431785|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48659270|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48337201|NCT01587703|155431786|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337202|NCT01587703|155431787|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337203|NCT01587703|155431788|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337204|NCT01587703|155431789|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337205|NCT01587703|155431790|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337206|NCT01587703|155431791|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337207|NCT01587703|155431792|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337208|NCT01587703|155431793|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337209|NCT01587703|155431794|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337210|NCT01587703|155431795|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337211|NCT01587703|155431796|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
48337212|NCT01587703|155431797|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
48659271|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659272|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
48659273|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
48659274|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659275|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659276|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659277|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659278|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659279|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659280|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659281|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659282|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
48659283|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
48659284|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659285|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659286|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
48659287|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
48659288|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659289|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659290|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659291|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659292|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
48659293|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
48659294|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659295|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659296|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
48659297|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659298|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659299|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659300|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659301|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659302|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
48659303|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
48659304|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
48659305|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
48659306|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
48659307|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
48659308|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659309|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659310|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659311|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659312|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
48659313|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
48659314|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
48659315|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
48659316|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659317|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
48659318|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659319|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659320|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48337213|NCT01587703|155431798|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
48337214|NCT01587703|155431780|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337215|NCT01587703|155431781|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337216|NCT01587703|155431782|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337217|NCT01587703|155431783|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337218|NCT01587703|155431784|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337219|NCT01587703|155431785|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337220|NCT01587703|155431786|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337221|NCT01587703|155431787|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337222|NCT01587703|155431788|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337223|NCT01587703|155431789|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337224|NCT01587703|155431790|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337225|NCT01587703|155431791|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337226|NCT01587703|155431792|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337227|NCT01587703|155431793|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337228|NCT01587703|155431794|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337229|NCT01587703|155431795|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
48337230|NCT01587703|155431796|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337231|NCT01587703|155431797|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337232|NCT01587703|155431798|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
48337233|NCT01587703|155431780|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337234|NCT01587703|155431781|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337235|NCT01587703|155431782|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337236|NCT01587703|155431783|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337237|NCT01587703|155431784|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337238|NCT01587703|155431785|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337239|NCT01587703|155431786|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337240|NCT01587703|155431787|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337241|NCT01587703|155431788|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337242|NCT01587703|155431789|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337243|NCT01587703|155431790|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337244|NCT01587703|155431791|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
48337245|NCT01587703|155431792|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337246|NCT01587703|155431793|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337247|NCT01587703|155431794|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
48337248|NCT01587703|155431795|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337249|NCT01587703|155431796|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337250|NCT01587703|155431797|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337251|NCT01587703|155431798|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
48337252|NCT01587703|155431780|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337253|NCT01587703|155431781|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337254|NCT01587703|155431782|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337255|NCT01587703|155431783|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337256|NCT01587703|155431784|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337257|NCT01587703|155431785|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337258|NCT01587703|155431786|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337259|NCT01587703|155431787|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337260|NCT01587703|155431788|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337261|NCT01587703|155431789|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337262|NCT01587703|155431790|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337263|NCT01587703|155431791|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
48337264|NCT01587703|155431792|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
48337265|NCT01587703|155431793|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
48337266|NCT01587703|155431794|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
48337267|NCT01587703|155431795|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
48337268|NCT01587703|155431796|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
48337269|NCT01587703|155431797|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337270|NCT01587703|155431798|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
48337271|NCT01587703|155431780|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337272|NCT01587703|155431781|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337273|NCT01587703|155431782|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337274|NCT01587703|155431783|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337275|NCT01587703|155431784|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337276|NCT01587703|155431785|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337277|NCT01587703|155431786|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
48659321|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659322|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659323|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
48337278|NCT01587703|155431787|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337279|NCT01587703|155431788|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337280|NCT01587703|155431789|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337281|NCT01587703|155431790|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337282|NCT01587703|155431791|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
48337283|NCT01587703|155431792|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
48337284|NCT01587703|155431793|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
48337285|NCT01587703|155431794|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
48337286|NCT01587703|155431795|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
48337287|NCT01587703|155431796|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
48337288|NCT01587703|155431797|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337289|NCT01587703|155431798|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
48337290|NCT01587703|155431780|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337291|NCT01587703|155431781|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337292|NCT01587703|155431782|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337293|NCT01587703|155431783|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337294|NCT01587703|155431784|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337295|NCT01587703|155431785|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48428220|NCT02531373|155756505|FG007|Overall Study|Lost to Follow-up|0|||
48659324|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659325|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659326|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
48659327|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
48659328|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659329|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659330|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659331|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659332|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
48659333|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659334|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659335|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659336|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659337|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659338|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659339|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659340|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659341|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48755320|NCT00498602|156951237|FG003|Overall Study|Lost to Follow-up|2|||
48755321|NCT00498602|156951238|FG004|Overall Study|Lost to Follow-up|0|||
48755322|NCT00498602|156951239|FG005|Overall Study|Lost to Follow-up|0|||
48755323|NCT00498602|156951240|FG006|Overall Study|Lost to Follow-up|0|||
48755324|NCT00498602|156951234|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
48755325|NCT00498602|156951235|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48755326|NCT00498602|156951236|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
48755327|NCT00498602|156951237|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
48755328|NCT00498602|156951238|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48755329|NCT00498602|156951239|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
48755330|NCT00498602|156951240|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48755331|NCT00498602|156951234|FG000|Overall Study|AE not related to Study Drug|1|||
48755332|NCT00498602|156951235|FG001|Overall Study|AE not related to Study Drug|3|||
48755333|NCT00498602|156951236|FG002|Overall Study|AE not related to Study Drug|0|||
48755334|NCT00498602|156951237|FG003|Overall Study|AE not related to Study Drug|0|||
48755335|NCT00498602|156951238|FG004|Overall Study|AE not related to Study Drug|2|||
48755336|NCT00498602|156951239|FG005|Overall Study|AE not related to Study Drug|2|||
48755337|NCT00498602|156951240|FG006|Overall Study|AE not related to Study Drug|1|||
48755338|NCT00498602|156951234|FG000|Overall Study|Caregiver Request|2|||
48755339|NCT00498602|156951235|FG001|Overall Study|Caregiver Request|2|||
48755340|NCT00498602|156951236|FG002|Overall Study|Caregiver Request|2|||
48755341|NCT00498602|156951237|FG003|Overall Study|Caregiver Request|0|||
48755342|NCT00498602|156951238|FG004|Overall Study|Caregiver Request|1|||
48755343|NCT00498602|156951239|FG005|Overall Study|Caregiver Request|2|||
48755344|NCT00498602|156951240|FG006|Overall Study|Caregiver Request|0|||
48755345|NCT00498602|156951234|FG000|Overall Study|Investigator Request|0|||
48337296|NCT01587703|155431786|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337297|NCT01587703|155431787|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337298|NCT01587703|155431788|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337299|NCT01587703|155431789|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337300|NCT01587703|155431790|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337301|NCT01587703|155431791|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
48337302|NCT01587703|155431792|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337303|NCT01587703|155431793|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337304|NCT01587703|155431794|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337305|NCT01587703|155431795|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337306|NCT01587703|155431796|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337307|NCT01587703|155431797|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337308|NCT01587703|155431798|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
48337309|NCT00828139|155431799|FG000|Overall Study|Adverse Event|8|||
48337310|NCT00828139|155431800|FG001|Overall Study|Adverse Event|1|||
48337311|NCT00828139|155431801|FG002|Overall Study|Adverse Event|10|||
48337312|NCT00828139|155431802|FG003|Overall Study|Adverse Event|5|||
48337313|NCT00828139|155431799|FG000|Overall Study|Death|2|||
48337314|NCT00828139|155431800|FG001|Overall Study|Death|1|||
48337315|NCT00828139|155431801|FG002|Overall Study|Death|0|||
48337316|NCT00828139|155431802|FG003|Overall Study|Death|2|||
48337317|NCT00828139|155431799|FG000|Overall Study|Refusal unrelated to toxicity|3|||
48337318|NCT00828139|155431800|FG001|Overall Study|Refusal unrelated to toxicity|4|||
48337319|NCT00828139|155431801|FG002|Overall Study|Refusal unrelated to toxicity|5|||
48659342|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659343|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659344|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659345|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
48659346|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659347|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
48659348|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659349|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659350|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659351|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659352|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659353|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
48659354|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
48659355|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
48659356|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
48659357|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
48659358|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659359|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659360|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659361|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659362|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
48659363|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659364|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659365|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659366|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
48659367|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
48659368|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659369|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659370|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659371|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659372|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659373|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659374|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48337320|NCT00828139|155431802|FG003|Overall Study|Refusal unrelated to toxicity|3|||
48337321|NCT00828139|155431799|FG000|Overall Study|Disease Progression|24|||
48337322|NCT00828139|155431800|FG001|Overall Study|Disease Progression|33|||
48337323|NCT00828139|155431801|FG002|Overall Study|Disease Progression|35|||
48337324|NCT00828139|155431802|FG003|Overall Study|Disease Progression|39|||
48337325|NCT00828139|155431799|FG000|Overall Study|Other|4|||
48337326|NCT00828139|155431800|FG001|Overall Study|Other|2|||
48337327|NCT00828139|155431801|FG002|Overall Study|Other|5|||
48337328|NCT00828139|155431802|FG003|Overall Study|Other|2|||
48337329|NCT01922102|155431803|FG000|Overall Study|Withdrawal by Subject|7|||
48337330|NCT01922102|155431804|FG001|Overall Study|Withdrawal by Subject|3|||
48337331|NCT01922102|155431805|FG002|Overall Study|Withdrawal by Subject|7|||
48337332|NCT01922102|155431803|FG000|Overall Study|Physician Decision|0|||
48337333|NCT01922102|155431804|FG001|Overall Study|Physician Decision|2|||
48337334|NCT01922102|155431805|FG002|Overall Study|Physician Decision|1|||
48337335|NCT01922102|155431803|FG000|Overall Study|Adverse Event|1|||
48337336|NCT01922102|155431804|FG001|Overall Study|Adverse Event|2|||
48337337|NCT01922102|155431805|FG002|Overall Study|Adverse Event|0|||
48337338|NCT01922102|155431803|FG000|Overall Study|Lost to Follow-up|1|||
48337339|NCT01922102|155431804|FG001|Overall Study|Lost to Follow-up|0|||
48337340|NCT01922102|155431805|FG002|Overall Study|Lost to Follow-up|0|||
48337341|NCT01922102|155431803|FG000|Overall Study|Administrative problems|0|||
48337342|NCT01922102|155431804|FG001|Overall Study|Administrative problems|2|||
48337343|NCT01922102|155431805|FG002|Overall Study|Administrative problems|0|||
48337344|NCT04271254|155431806|FG000|Overall Study|Withdrawal by Subject|3|||
48337345|NCT00930644|155431809|FG000|Overall Study|Withdrawal by Subject|4|||
48337346|NCT00930644|155431809|FG000|Overall Study|Physician Decision|2|||
48337347|NCT00930644|155431809|FG000|Overall Study|Death|1|||
48337348|NCT00930644|155431809|FG000|Overall Study|Adverse Event|16|||
48337349|NCT02660034|155431810|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
48337350|NCT02660034|155431811|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
48337351|NCT02660034|155431812|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
48337352|NCT02660034|155431813|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
48337353|NCT02660034|155431814|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
48337354|NCT02660034|155431815|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
48337355|NCT02660034|155431816|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
48337356|NCT02660034|155431817|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
48337357|NCT02660034|155431818|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
48337358|NCT02660034|155431819|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
48337359|NCT02660034|155431820|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
48337360|NCT02660034|155431821|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
48337361|NCT02660034|155431822|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
48337362|NCT02660034|155431823|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
48337363|NCT02660034|155431810|FG000|Overall Study|Progressive Disease (Clinical)|7|||
48337364|NCT02660034|155431811|FG001|Overall Study|Progressive Disease (Clinical)|8|||
48337365|NCT02660034|155431812|FG002|Overall Study|Progressive Disease (Clinical)|3|||
48337366|NCT02660034|155431813|FG003|Overall Study|Progressive Disease (Clinical)|9|||
48337367|NCT02660034|155431814|FG004|Overall Study|Progressive Disease (Clinical)|3|||
48337368|NCT02660034|155431815|FG005|Overall Study|Progressive Disease (Clinical)|0|||
48337369|NCT02660034|155431816|FG006|Overall Study|Progressive Disease (Clinical)|0|||
48337370|NCT02660034|155431817|FG007|Overall Study|Progressive Disease (Clinical)|0|||
48337371|NCT02660034|155431818|FG008|Overall Study|Progressive Disease (Clinical)|0|||
48337372|NCT02660034|155431819|FG009|Overall Study|Progressive Disease (Clinical)|0|||
48337373|NCT02660034|155431820|FG010|Overall Study|Progressive Disease (Clinical)|0|||
48337374|NCT02660034|155431821|FG011|Overall Study|Progressive Disease (Clinical)|0|||
48337375|NCT02660034|155431822|FG012|Overall Study|Progressive Disease (Clinical)|0|||
48337376|NCT02660034|155431823|FG013|Overall Study|Progressive Disease (Clinical)|0|||
48337377|NCT02660034|155431810|FG000|Overall Study|Lost to Follow-up|0|||
48337378|NCT02660034|155431811|FG001|Overall Study|Lost to Follow-up|0|||
48337379|NCT02660034|155431812|FG002|Overall Study|Lost to Follow-up|1|||
48337380|NCT02660034|155431813|FG003|Overall Study|Lost to Follow-up|1|||
48337381|NCT02660034|155431814|FG004|Overall Study|Lost to Follow-up|0|||
48337382|NCT02660034|155431815|FG005|Overall Study|Lost to Follow-up|0|||
48337383|NCT02660034|155431816|FG006|Overall Study|Lost to Follow-up|0|||
48337384|NCT02660034|155431817|FG007|Overall Study|Lost to Follow-up|0|||
48337385|NCT02660034|155431818|FG008|Overall Study|Lost to Follow-up|0|||
48337386|NCT02660034|155431819|FG009|Overall Study|Lost to Follow-up|1|||
48337387|NCT02660034|155431820|FG010|Overall Study|Lost to Follow-up|1|||
48337388|NCT02660034|155431821|FG011|Overall Study|Lost to Follow-up|1|||
48337389|NCT02660034|155431822|FG012|Overall Study|Lost to Follow-up|0|||
48337390|NCT02660034|155431823|FG013|Overall Study|Lost to Follow-up|0|||
48337391|NCT02660034|155431810|FG000|Overall Study|Participant moved into special access scheme|1|||
48337392|NCT02660034|155431811|FG001|Overall Study|Participant moved into special access scheme|2|||
48337393|NCT02660034|155431812|FG002|Overall Study|Participant moved into special access scheme|0|||
48337394|NCT02660034|155431813|FG003|Overall Study|Participant moved into special access scheme|0|||
48337395|NCT02660034|155431814|FG004|Overall Study|Participant moved into special access scheme|0|||
48337396|NCT02660034|155431815|FG005|Overall Study|Participant moved into special access scheme|0|||
48428221|NCT02531373|155756506|FG008|Overall Study|Lost to Follow-up|0|||
48659375|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659376|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659377|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659378|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659379|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659380|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48337397|NCT02660034|155431816|FG006|Overall Study|Participant moved into special access scheme|0|||
48337398|NCT02660034|155431817|FG007|Overall Study|Participant moved into special access scheme|0|||
48337399|NCT02660034|155431818|FG008|Overall Study|Participant moved into special access scheme|0|||
48337400|NCT02660034|155431819|FG009|Overall Study|Participant moved into special access scheme|0|||
48337401|NCT02660034|155431820|FG010|Overall Study|Participant moved into special access scheme|0|||
48337402|NCT02660034|155431821|FG011|Overall Study|Participant moved into special access scheme|0|||
48337403|NCT02660034|155431822|FG012|Overall Study|Participant moved into special access scheme|0|||
48337404|NCT02660034|155431823|FG013|Overall Study|Participant moved into special access scheme|0|||
48337405|NCT02660034|155431810|FG000|Overall Study|Adverse Event|1|||
48337406|NCT02660034|155431811|FG001|Overall Study|Adverse Event|0|||
48337407|NCT02660034|155431812|FG002|Overall Study|Adverse Event|0|||
48337408|NCT02660034|155431813|FG003|Overall Study|Adverse Event|0|||
48337409|NCT02660034|155431814|FG004|Overall Study|Adverse Event|0|||
48337410|NCT02660034|155431815|FG005|Overall Study|Adverse Event|0|||
48337411|NCT02660034|155431816|FG006|Overall Study|Adverse Event|0|||
48659381|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659382|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659383|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
48659384|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659385|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48337412|NCT02660034|155431817|FG007|Overall Study|Adverse Event|0|||
48337413|NCT02660034|155431818|FG008|Overall Study|Adverse Event|0|||
48337414|NCT02660034|155431819|FG009|Overall Study|Adverse Event|0|||
48337415|NCT02660034|155431820|FG010|Overall Study|Adverse Event|0|||
48337416|NCT02660034|155431821|FG011|Overall Study|Adverse Event|0|||
48337417|NCT02660034|155431822|FG012|Overall Study|Adverse Event|0|||
48337418|NCT02660034|155431823|FG013|Overall Study|Adverse Event|0|||
48337419|NCT02660034|155431810|FG000|Overall Study|Sponsor Decision|0|||
48337420|NCT02660034|155431811|FG001|Overall Study|Sponsor Decision|1|||
48337421|NCT02660034|155431812|FG002|Overall Study|Sponsor Decision|2|||
48337422|NCT02660034|155431813|FG003|Overall Study|Sponsor Decision|2|||
48337423|NCT02660034|155431814|FG004|Overall Study|Sponsor Decision|3|||
48337424|NCT02660034|155431815|FG005|Overall Study|Sponsor Decision|0|||
48337425|NCT02660034|155431816|FG006|Overall Study|Sponsor Decision|0|||
48337426|NCT02660034|155431817|FG007|Overall Study|Sponsor Decision|0|||
48337427|NCT02660034|155431818|FG008|Overall Study|Sponsor Decision|0|||
48337428|NCT02660034|155431819|FG009|Overall Study|Sponsor Decision|0|||
48659386|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48337429|NCT02660034|155431820|FG010|Overall Study|Sponsor Decision|0|||
48337430|NCT02660034|155431821|FG011|Overall Study|Sponsor Decision|0|||
48337431|NCT02660034|155431822|FG012|Overall Study|Sponsor Decision|0|||
48337432|NCT02660034|155431823|FG013|Overall Study|Sponsor Decision|1|||
48337433|NCT02660034|155431810|FG000|Overall Study|Withdrawal by Subject|0|||
48337434|NCT02660034|155431811|FG001|Overall Study|Withdrawal by Subject|0|||
48337435|NCT02660034|155431812|FG002|Overall Study|Withdrawal by Subject|0|||
48659387|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
48659388|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659389|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659390|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659391|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659392|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
48659393|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659394|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659395|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48692726|NCT04908683|156724585|FG001|Overall Study|Site Closure by Sponsor|3|||
48337436|NCT02660034|155431813|FG003|Overall Study|Withdrawal by Subject|0|||
48337437|NCT02660034|155431814|FG004|Overall Study|Withdrawal by Subject|0|||
48337438|NCT02660034|155431815|FG005|Overall Study|Withdrawal by Subject|0|||
48337439|NCT02660034|155431816|FG006|Overall Study|Withdrawal by Subject|1|||
48337440|NCT02660034|155431817|FG007|Overall Study|Withdrawal by Subject|1|||
48659396|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48337441|NCT02660034|155431818|FG008|Overall Study|Withdrawal by Subject|1|||
48337442|NCT02660034|155431819|FG009|Overall Study|Withdrawal by Subject|0|||
48337443|NCT02660034|155431820|FG010|Overall Study|Withdrawal by Subject|0|||
48659397|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
48659398|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659399|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659400|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659401|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659402|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659403|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659404|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
48659405|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659406|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659407|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
48659408|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659409|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659410|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48337444|NCT02660034|155431821|FG011|Overall Study|Withdrawal by Subject|1|||
48337445|NCT02660034|155431822|FG012|Overall Study|Withdrawal by Subject|2|||
48337446|NCT02660034|155431823|FG013|Overall Study|Withdrawal by Subject|0|||
48337447|NCT02660034|155431810|FG000|Overall Study|Death|0|||
48337448|NCT02660034|155431811|FG001|Overall Study|Death|0|||
48337449|NCT02660034|155431812|FG002|Overall Study|Death|0|||
48337450|NCT02660034|155431813|FG003|Overall Study|Death|0|||
48337451|NCT02660034|155431814|FG004|Overall Study|Death|0|||
48337452|NCT02660034|155431815|FG005|Overall Study|Death|13|||
48337453|NCT02660034|155431816|FG006|Overall Study|Death|14|||
48337454|NCT02660034|155431817|FG007|Overall Study|Death|10|||
48337455|NCT02660034|155431818|FG008|Overall Study|Death|9|||
48337456|NCT02660034|155431819|FG009|Overall Study|Death|21|||
48337457|NCT02660034|155431820|FG010|Overall Study|Death|17|||
48659411|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659412|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
48659413|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
48659414|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659415|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659416|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659417|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
48659418|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659419|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659420|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659421|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659422|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
48659423|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
48659424|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659425|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
48659426|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659427|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
48337458|NCT02660034|155431821|FG011|Overall Study|Death|15|||
48337459|NCT02660034|155431822|FG012|Overall Study|Death|18|||
48337460|NCT02660034|155431823|FG013|Overall Study|Death|7|||
48337461|NCT02660034|155431810|FG000|Overall Study|Physician Decision|0|||
48337462|NCT02660034|155431811|FG001|Overall Study|Physician Decision|0|||
48337463|NCT02660034|155431812|FG002|Overall Study|Physician Decision|0|||
48337464|NCT02660034|155431813|FG003|Overall Study|Physician Decision|0|||
48337465|NCT02660034|155431814|FG004|Overall Study|Physician Decision|0|||
48337466|NCT02660034|155431815|FG005|Overall Study|Physician Decision|0|||
48337467|NCT02660034|155431816|FG006|Overall Study|Physician Decision|0|||
48337468|NCT02660034|155431817|FG007|Overall Study|Physician Decision|0|||
48337469|NCT02660034|155431818|FG008|Overall Study|Physician Decision|0|||
48659428|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48337470|NCT02660034|155431819|FG009|Overall Study|Physician Decision|0|||
48337471|NCT02660034|155431820|FG010|Overall Study|Physician Decision|0|||
48337472|NCT02660034|155431821|FG011|Overall Study|Physician Decision|0|||
48337473|NCT02660034|155431822|FG012|Overall Study|Physician Decision|0|||
48337474|NCT02660034|155431823|FG013|Overall Study|Physician Decision|1|||
48337475|NCT02660034|155431810|FG000|Overall Study|Participants transferred to LTE|0|||
48337476|NCT02660034|155431811|FG001|Overall Study|Participants transferred to LTE|0|||
48337477|NCT02660034|155431812|FG002|Overall Study|Participants transferred to LTE|0|||
48337478|NCT02660034|155431813|FG003|Overall Study|Participants transferred to LTE|0|||
48337479|NCT02660034|155431814|FG004|Overall Study|Participants transferred to LTE|0|||
48337480|NCT02660034|155431815|FG005|Overall Study|Participants transferred to LTE|10|||
48337481|NCT02660034|155431816|FG006|Overall Study|Participants transferred to LTE|8|||
48337482|NCT02660034|155431817|FG007|Overall Study|Participants transferred to LTE|8|||
48337483|NCT02660034|155431818|FG008|Overall Study|Participants transferred to LTE|10|||
48337484|NCT02660034|155431819|FG009|Overall Study|Participants transferred to LTE|1|||
48337485|NCT02660034|155431820|FG010|Overall Study|Participants transferred to LTE|2|||
48337486|NCT02660034|155431821|FG011|Overall Study|Participants transferred to LTE|4|||
48659429|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659430|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659431|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659432|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
48659433|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Other|5|||
48659434|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Other|1|||
48659435|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Other|0|||
48659436|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Other|3|||
48659437|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Other|0|||
48659438|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Other|0|||
48659439|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Other|0|||
48659440|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Other|0|||
48659441|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Other|0|||
48659442|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Other|0|||
48659443|NCT03352557|156605209|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659444|NCT03352557|156605210|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659445|NCT03352557|156605211|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659446|NCT03352557|156605212|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659447|NCT03352557|156605213|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
48659448|NCT03352557|156605214|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659449|NCT03352557|156605215|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659450|NCT03352557|156605216|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659451|NCT03352557|156605217|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659452|NCT03352557|156605218|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
48659453|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Death|0|||
48659454|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Death|0|||
48659455|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Death|0|||
48337487|NCT02660034|155431822|FG012|Overall Study|Participants transferred to LTE|1|||
48337488|NCT02660034|155431823|FG013|Overall Study|Participants transferred to LTE|1|||
48337489|NCT04883541|155431824|FG000|Overall Study|Not attending regular yoga class|16|||
48337490|NCT04883541|155431825|FG001|Overall Study|Not attending regular yoga class|0|||
48337491|NCT04883541|155431824|FG000|Overall Study|Not attending the pregnancy school|0|||
48337492|NCT04883541|155431825|FG001|Overall Study|Not attending the pregnancy school|9|||
48337493|NCT02030847|155431829|FG000|Overall Study|Death|10|||
48337494|NCT02030847|155431829|FG000|Overall Study|Disease Progression|15|||
48337495|NCT02030847|155431829|FG000|Overall Study|New Cancer Therapy|8|||
48337496|NCT02030847|155431829|FG000|Overall Study|Physician Decision|3|||
48337497|NCT02030847|155431829|FG000|Overall Study|Withdrawal by Subject|1|||
48337498|NCT03184519|155431830|FG000|Overall Study|Lost to Follow-up|6|||
48337499|NCT03184519|155431830|FG000|Overall Study|Physician Decision|21|||
48337500|NCT04879823|155431831|FG000|Overall Study|Physician Decision|3|||
48337501|NCT04879823|155431832|FG001|Overall Study|Physician Decision|1|||
48337502|NCT04879823|155431831|FG000|Overall Study|Protocol Violation|2|||
48337503|NCT04879823|155431832|FG001|Overall Study|Protocol Violation|3|||
48337504|NCT04879823|155431831|FG000|Overall Study|Lost to Follow-up|43|||
48337505|NCT04879823|155431832|FG001|Overall Study|Lost to Follow-up|35|||
48337506|NCT01182285|155431837|FG000|First Intervention Week 1-10|Disease progression|1|||
48337507|NCT01182285|155431838|FG001|First Intervention Week 1-10|Disease progression|0|||
48337508|NCT01182285|155431839|FG002|First Intervention Week 1-10|Disease progression|0|||
48337509|NCT01182285|155431837|FG000|First Intervention Week 1-10|Adverse Event|1|||
48337510|NCT01182285|155431838|FG001|First Intervention Week 1-10|Adverse Event|0|||
48337511|NCT01182285|155431839|FG002|First Intervention Week 1-10|Adverse Event|0|||
48337512|NCT01182285|155431837|FG000|First Intervention Week 1-10|Non-compliance|1|||
48337513|NCT01182285|155431838|FG001|First Intervention Week 1-10|Non-compliance|0|||
48337514|NCT01182285|155431839|FG002|First Intervention Week 1-10|Non-compliance|0|||
48659456|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Death|0|||
48659457|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Death|0|||
48659458|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Death|1|||
48659459|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Death|0|||
48692727|NCT04908683|156724584|FG000|Overall Study|Adverse Event|21|||
48337515|NCT01182285|155431837|FG000|Third Intervention Week 11-52|Disease Progression|0|||
48337516|NCT01182285|155431838|FG001|Third Intervention Week 11-52|Disease Progression|0|||
48337517|NCT01182285|155431839|FG002|Third Intervention Week 11-52|Disease Progression|6|||
48337518|NCT01182285|155431837|FG000|Third Intervention Week 11-52|Other|0|||
48337519|NCT01182285|155431838|FG001|Third Intervention Week 11-52|Other|0|||
48337520|NCT01182285|155431839|FG002|Third Intervention Week 11-52|Other|2|||
48337521|NCT00841321|155431844|FG000|Overall Study|Lost to Follow-up|1|||
48337522|NCT00841321|155431845|FG001|Overall Study|Lost to Follow-up|1|||
48337523|NCT00841321|155431844|FG000|Overall Study|Adverse Event|0|||
48337524|NCT00841321|155431845|FG001|Overall Study|Adverse Event|2|||
48337525|NCT00248794|155431846|FG000|Overall Study|Lost to Follow-up|6|||
48337526|NCT00248794|155431847|FG001|Overall Study|Lost to Follow-up|8|||
48337527|NCT00248794|155431848|FG002|Overall Study|Lost to Follow-up|3|||
48337528|NCT01358175|155431849|FG000|Overall Study|Death|1|||
48337529|NCT01358175|155431850|FG001|Overall Study|Death|0|||
48337530|NCT01358175|155431851|FG002|Overall Study|Death|1|||
48337531|NCT01358175|155431849|FG000|Overall Study|Withdrawal by Subject|9|||
48337532|NCT01358175|155431850|FG001|Overall Study|Withdrawal by Subject|5|||
48337533|NCT01358175|155431851|FG002|Overall Study|Withdrawal by Subject|10|||
48337534|NCT01358175|155431849|FG000|Overall Study|Technical issues|0|||
48337535|NCT01358175|155431850|FG001|Overall Study|Technical issues|1|||
48337536|NCT01358175|155431851|FG002|Overall Study|Technical issues|0|||
48337537|NCT01358175|155431849|FG000|Overall Study|Pregnancy|0|||
48337538|NCT01358175|155431850|FG001|Overall Study|Pregnancy|1|||
48337539|NCT01358175|155431851|FG002|Overall Study|Pregnancy|0|||
48337540|NCT01358175|155431849|FG000|Overall Study|Physician Decision|1|||
48337541|NCT01358175|155431850|FG001|Overall Study|Physician Decision|0|||
48337542|NCT01358175|155431851|FG002|Overall Study|Physician Decision|0|||
48337543|NCT01358175|155431849|FG000|Overall Study|Non Compliance with Study Treatment|0|||
48337544|NCT01358175|155431850|FG001|Overall Study|Non Compliance with Study Treatment|1|||
48337545|NCT01358175|155431851|FG002|Overall Study|Non Compliance with Study Treatment|1|||
48337546|NCT01358175|155431849|FG000|Overall Study|Lost to Follow-up|1|||
48337547|NCT01358175|155431850|FG001|Overall Study|Lost to Follow-up|1|||
48337548|NCT01358175|155431851|FG002|Overall Study|Lost to Follow-up|3|||
48337549|NCT01358175|155431849|FG000|Overall Study|Lack of Efficacy|3|||
48337550|NCT01358175|155431850|FG001|Overall Study|Lack of Efficacy|8|||
48337551|NCT01358175|155431851|FG002|Overall Study|Lack of Efficacy|6|||
48337552|NCT01358175|155431849|FG000|Overall Study|Adverse Event|6|||
48337553|NCT01358175|155431850|FG001|Overall Study|Adverse Event|11|||
48337554|NCT01358175|155431851|FG002|Overall Study|Adverse Event|11|||
48337555|NCT00244751|155431876|FG000|Overall Study|Adverse Event|7|||
48337556|NCT00244751|155431877|FG001|Overall Study|Adverse Event|7|||
48337557|NCT00244751|155431878|FG002|Overall Study|Adverse Event|5|||
48337558|NCT00244751|155431876|FG000|Overall Study|Lost to Follow-up|0|||
48337559|NCT00244751|155431877|FG001|Overall Study|Lost to Follow-up|1|||
48337560|NCT00244751|155431878|FG002|Overall Study|Lost to Follow-up|0|||
48337561|NCT00244751|155431876|FG000|Overall Study|Protocol Violation|1|||
48337562|NCT00244751|155431877|FG001|Overall Study|Protocol Violation|0|||
48337563|NCT00244751|155431878|FG002|Overall Study|Protocol Violation|1|||
48337564|NCT00244751|155431876|FG000|Overall Study|Withdrawal by Subject|7|||
48337565|NCT00244751|155431877|FG001|Overall Study|Withdrawal by Subject|5|||
48337566|NCT00244751|155431878|FG002|Overall Study|Withdrawal by Subject|3|||
48337567|NCT00244751|155431876|FG000|Overall Study|Elevated liver enzymes|1|||
48337568|NCT00244751|155431877|FG001|Overall Study|Elevated liver enzymes|0|||
48337569|NCT00244751|155431878|FG002|Overall Study|Elevated liver enzymes|0|||
48337570|NCT00244751|155431876|FG000|Overall Study|Lack of compliance with protocol|0|||
48337571|NCT00244751|155431877|FG001|Overall Study|Lack of compliance with protocol|1|||
48337572|NCT00244751|155431878|FG002|Overall Study|Lack of compliance with protocol|0|||
48337573|NCT00244751|155431876|FG000|Overall Study|Safety reasons|0|||
48337574|NCT00244751|155431877|FG001|Overall Study|Safety reasons|1|||
48337575|NCT00244751|155431878|FG002|Overall Study|Safety reasons|0|||
48337576|NCT00244751|155431876|FG000|Overall Study|Participant randomized by mistake|0|||
48337577|NCT00244751|155431877|FG001|Overall Study|Participant randomized by mistake|0|||
48337578|NCT00244751|155431878|FG002|Overall Study|Participant randomized by mistake|1|||
48337579|NCT03651271|155431879|FG000|Overall Study|Death|4|||
48337580|NCT03651271|155431880|FG001|Overall Study|Death|37|||
48337581|NCT03651271|155431881|FG002|Overall Study|Death|0|||
48337582|NCT03651271|155431882|FG003|Overall Study|Death|2|||
48337583|NCT03651271|155431883|FG004|Overall Study|Death|6|||
48337584|NCT03651271|155431879|FG000|Overall Study|Lost to Follow-up|1|||
48337585|NCT03651271|155431880|FG001|Overall Study|Lost to Follow-up|5|||
48337586|NCT03651271|155431881|FG002|Overall Study|Lost to Follow-up|0|||
48337587|NCT03651271|155431882|FG003|Overall Study|Lost to Follow-up|1|||
48337588|NCT03651271|155431883|FG004|Overall Study|Lost to Follow-up|0|||
48337589|NCT03651271|155431879|FG000|Overall Study|Physician Decision|0|||
48337590|NCT03651271|155431880|FG001|Overall Study|Physician Decision|2|||
48337591|NCT03651271|155431881|FG002|Overall Study|Physician Decision|0|||
48337592|NCT03651271|155431882|FG003|Overall Study|Physician Decision|0|||
48337593|NCT03651271|155431883|FG004|Overall Study|Physician Decision|0|||
48337594|NCT03651271|155431879|FG000|Overall Study|Withdrawal by Subject|1|||
48337595|NCT03651271|155431880|FG001|Overall Study|Withdrawal by Subject|15|||
48337596|NCT03651271|155431881|FG002|Overall Study|Withdrawal by Subject|0|||
48337597|NCT03651271|155431882|FG003|Overall Study|Withdrawal by Subject|0|||
48337598|NCT03651271|155431883|FG004|Overall Study|Withdrawal by Subject|1|||
48337599|NCT03651271|155431879|FG000|Overall Study|Patient medically unable to continue|0|||
48337600|NCT03651271|155431880|FG001|Overall Study|Patient medically unable to continue|0|||
48337601|NCT03651271|155431881|FG002|Overall Study|Patient medically unable to continue|0|||
48337602|NCT03651271|155431882|FG003|Overall Study|Patient medically unable to continue|1|||
48337603|NCT03651271|155431883|FG004|Overall Study|Patient medically unable to continue|0|||
48337604|NCT02446912|155431884|FG000|Overall Study|Adverse Event|3|||
48337605|NCT02446912|155431885|FG001|Overall Study|Adverse Event|13|||
48337606|NCT02446912|155431886|FG002|Overall Study|Adverse Event|5|||
48337607|NCT02446912|155431884|FG000|Overall Study|Condition under investigation worsened|0|||
48337608|NCT02446912|155431885|FG001|Overall Study|Condition under investigation worsened|1|||
48337609|NCT02446912|155431886|FG002|Overall Study|Condition under investigation worsened|1|||
48337610|NCT02446912|155431884|FG000|Overall Study|Study-specific withdrawal criteria|1|||
48337611|NCT02446912|155431885|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48337612|NCT02446912|155431886|FG002|Overall Study|Study-specific withdrawal criteria|0|||
48337613|NCT02446912|155431884|FG000|Overall Study|Lack of Efficacy|1|||
48337614|NCT02446912|155431885|FG001|Overall Study|Lack of Efficacy|4|||
48337615|NCT02446912|155431886|FG002|Overall Study|Lack of Efficacy|7|||
48337616|NCT02446912|155431884|FG000|Overall Study|Lost to Follow-up|0|||
48337617|NCT02446912|155431885|FG001|Overall Study|Lost to Follow-up|0|||
48337618|NCT02446912|155431886|FG002|Overall Study|Lost to Follow-up|2|||
48337619|NCT02446912|155431884|FG000|Overall Study|Severe non-compliance to protocol|1|||
48337620|NCT02446912|155431885|FG001|Overall Study|Severe non-compliance to protocol|0|||
48659460|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Death|1|||
48337621|NCT02446912|155431886|FG002|Overall Study|Severe non-compliance to protocol|1|||
48659461|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Death|1|||
48659462|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Death|1|||
48659463|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659464|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48337622|NCT02446912|155431884|FG000|Overall Study|Withdrawal by Subject|10|||
48337623|NCT02446912|155431885|FG001|Overall Study|Withdrawal by Subject|15|||
48337624|NCT02446912|155431886|FG002|Overall Study|Withdrawal by Subject|15|||
48337625|NCT02446912|155431884|FG000|Overall Study|Miscellaneous|2|||
48337626|NCT02446912|155431885|FG001|Overall Study|Miscellaneous|2|||
48337627|NCT02446912|155431886|FG002|Overall Study|Miscellaneous|4|||
48337628|NCT01901302|155431887|FG000|Overall Study|Adverse Event|2|||
48337629|NCT01901302|155431888|FG001|Overall Study|Adverse Event|1|||
48337630|NCT01901302|155431887|FG000|Overall Study|Lack of Efficacy|0|||
48659465|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659466|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659467|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659468|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
48659469|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659470|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659471|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659472|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
48659473|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659474|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659475|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659476|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659477|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659478|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659479|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659480|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659481|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
48659482|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
48659483|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659484|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659485|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659486|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659487|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
48659488|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
48755346|NCT00498602|156951235|FG001|Overall Study|Investigator Request|0|||
48755347|NCT00498602|156951236|FG002|Overall Study|Investigator Request|1|||
48337631|NCT01901302|155431888|FG001|Overall Study|Lack of Efficacy|2|||
48337632|NCT01901302|155431887|FG000|Overall Study|Study Terminated by Sponsor|23|||
48337633|NCT01901302|155431888|FG001|Overall Study|Study Terminated by Sponsor|20|||
48337634|NCT01901302|155431887|FG000|Overall Study|Withdrawal by Subject|2|||
48337635|NCT01901302|155431888|FG001|Overall Study|Withdrawal by Subject|0|||
48337636|NCT00296504|155431889|FG000|Interim Analysis|Withdrawal by Subject|8|||
48428222|NCT02531373|155756498|FG000|Overall Study|Physician Decision|0|||
48659489|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
48659490|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
48337637|NCT00296504|155431890|FG001|Interim Analysis|Withdrawal by Subject|0|||
48659491|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
48659492|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
48659493|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659494|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659495|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659496|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659497|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659498|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
48659499|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
48659500|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
48659501|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
48659502|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
48659503|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659504|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659505|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659506|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659507|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659508|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659509|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659510|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48337638|NCT00296504|155431891|FG002|Interim Analysis|Withdrawal by Subject|12|||
48659511|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
48659512|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
48659513|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659514|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659515|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659516|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659517|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659518|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
48659519|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
48659520|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
48659521|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
48659522|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
48659523|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659524|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659525|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659526|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659527|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659528|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659529|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659530|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
48659531|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
48692728|NCT04908683|156724585|FG001|Overall Study|Adverse Event|11|||
48337639|NCT00296504|155431892|FG003|Interim Analysis|Withdrawal by Subject|0|||
48337640|NCT00296504|155431893|FG004|Interim Analysis|Withdrawal by Subject|5|||
48337641|NCT00296504|155431894|FG005|Interim Analysis|Withdrawal by Subject|5|||
48337642|NCT00296504|155431895|FG006|Interim Analysis|Withdrawal by Subject|9|||
48337643|NCT00296504|155431896|FG007|Interim Analysis|Withdrawal by Subject|3|||
48337644|NCT00296504|155431897|FG008|Interim Analysis|Withdrawal by Subject|0|||
48337645|NCT00296504|155431889|FG000|Interim Analysis|Lost to Follow-up|13|||
48337646|NCT00296504|155431890|FG001|Interim Analysis|Lost to Follow-up|3|||
48337647|NCT00296504|155431891|FG002|Interim Analysis|Lost to Follow-up|26|||
48337648|NCT00296504|155431892|FG003|Interim Analysis|Lost to Follow-up|8|||
48337649|NCT00296504|155431893|FG004|Interim Analysis|Lost to Follow-up|14|||
48337650|NCT00296504|155431894|FG005|Interim Analysis|Lost to Follow-up|4|||
48337651|NCT00296504|155431895|FG006|Interim Analysis|Lost to Follow-up|11|||
48337652|NCT00296504|155431896|FG007|Interim Analysis|Lost to Follow-up|4|||
48659532|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
48659533|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659534|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659535|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659536|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48337653|NCT00296504|155431897|FG008|Interim Analysis|Lost to Follow-up|0|||
48337654|NCT00296504|155431889|FG000|Interim Analysis|Clinical Progression|1|||
48337655|NCT00296504|155431890|FG001|Interim Analysis|Clinical Progression|0|||
48337656|NCT00296504|155431891|FG002|Interim Analysis|Clinical Progression|1|||
48659537|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659538|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659539|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659540|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
48659541|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659542|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
48659543|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659544|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659545|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659546|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659547|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659548|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659549|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659550|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
48659551|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659552|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
48659553|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659554|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659555|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659556|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659557|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659558|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659559|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659560|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
48659561|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
48659562|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
48659563|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659564|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659565|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659566|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659567|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659568|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
48659569|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659570|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659571|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
48659572|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
48659573|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659574|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659575|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659576|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659577|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659578|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659579|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659580|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659581|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
48659582|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
48659583|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48337657|NCT00296504|155431892|FG003|Interim Analysis|Clinical Progression|1|||
48659584|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659585|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659586|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659587|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659588|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659589|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659590|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
48659591|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
48659592|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
48659593|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659594|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659595|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659596|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659597|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659598|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659599|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659600|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
48659601|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
48659602|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
48659603|NCT03352557|156605209|FG000|LTE Period: Week 80 to Week 173|Other|0|||
48659604|NCT03352557|156605210|FG001|LTE Period: Week 80 to Week 173|Other|0|||
48659605|NCT03352557|156605211|FG002|LTE Period: Week 80 to Week 173|Other|0|||
48659606|NCT03352557|156605212|FG003|LTE Period: Week 80 to Week 173|Other|0|||
48659607|NCT03352557|156605213|FG004|LTE Period: Week 80 to Week 173|Other|0|||
48659608|NCT03352557|156605214|FG005|LTE Period: Week 80 to Week 173|Other|0|||
48659609|NCT03352557|156605215|FG006|LTE Period: Week 80 to Week 173|Other|0|||
48659610|NCT03352557|156605216|FG007|LTE Period: Week 80 to Week 173|Other|1|||
48659611|NCT03352557|156605217|FG008|LTE Period: Week 80 to Week 173|Other|0|||
48659612|NCT03352557|156605218|FG009|LTE Period: Week 80 to Week 173|Other|0|||
48659613|NCT00907803|156605219|FG000|Overall Study|Withdrawal of consent - long commute|1|||
48659614|NCT00907803|156605220|FG001|Overall Study|Withdrawal of consent - long commute|0|||
48659615|NCT00907803|156605221|FG002|Overall Study|Withdrawal of consent - long commute|0|||
48659616|NCT00907803|156605219|FG000|Overall Study|Adverse Event|2|||
48659617|NCT00907803|156605220|FG001|Overall Study|Adverse Event|0|||
48659618|NCT00907803|156605221|FG002|Overall Study|Adverse Event|0|||
48659619|NCT00907803|156605219|FG000|Overall Study|Withdrawal by Subject|0|||
48659620|NCT00907803|156605220|FG001|Overall Study|Withdrawal by Subject|1|||
48659621|NCT00907803|156605221|FG002|Overall Study|Withdrawal by Subject|0|||
48659622|NCT00907803|156605219|FG000|Overall Study|Lost to Follow-up|0|||
48659623|NCT00907803|156605220|FG001|Overall Study|Lost to Follow-up|1|||
48659624|NCT00907803|156605221|FG002|Overall Study|Lost to Follow-up|0|||
48659625|NCT00907803|156605219|FG000|Overall Study|Protocol Violation|0|||
48659626|NCT00907803|156605220|FG001|Overall Study|Protocol Violation|1|||
48337658|NCT00296504|155431893|FG004|Interim Analysis|Clinical Progression|0|||
48337659|NCT00296504|155431894|FG005|Interim Analysis|Clinical Progression|2|||
48337660|NCT00296504|155431895|FG006|Interim Analysis|Clinical Progression|1|||
48337661|NCT00296504|155431896|FG007|Interim Analysis|Clinical Progression|2|||
48337662|NCT00296504|155431897|FG008|Interim Analysis|Clinical Progression|0|||
48337663|NCT00296504|155431889|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
48337664|NCT00296504|155431890|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
48659627|NCT00907803|156605221|FG002|Overall Study|Protocol Violation|0|||
48659628|NCT00916058|156605226|FG000|Phase 1|Screen Failure|0|||
48659629|NCT00916058|156605227|FG001|Phase 1|Screen Failure|0|||
48659630|NCT00916058|156605228|FG002|Phase 1|Screen Failure|0|||
48659631|NCT00916058|156605229|FG003|Phase 1|Screen Failure|0|||
48659632|NCT00916058|156605230|FG004|Phase 1|Screen Failure|0|||
48659633|NCT00916058|156605231|FG005|Phase 1|Screen Failure|1|||
48659634|NCT00916058|156605232|FG006|Phase 1|Screen Failure|0|||
48659635|NCT00916058|156605226|FG000|Phase 2|Screen Failure|0|||
48659636|NCT00916058|156605227|FG001|Phase 2|Screen Failure|0|||
48659637|NCT00916058|156605228|FG002|Phase 2|Screen Failure|0|||
48659638|NCT00916058|156605229|FG003|Phase 2|Screen Failure|0|||
48659639|NCT00916058|156605230|FG004|Phase 2|Screen Failure|0|||
48659640|NCT00916058|156605231|FG005|Phase 2|Screen Failure|0|||
48659641|NCT00916058|156605232|FG006|Phase 2|Screen Failure|3|||
48659642|NCT03385265|156605234|FG000|Overall Study|Withdrawal by Subject|5|||
48659643|NCT03385265|156605235|FG001|Overall Study|Withdrawal by Subject|2|||
48659644|NCT03385265|156605236|FG002|Overall Study|Withdrawal by Subject|5|||
48659645|NCT03385265|156605237|FG003|Overall Study|Withdrawal by Subject|2|||
48659646|NCT00241631|156605238|FG000|Run in (2 Weeks)|Physician Decision|3|||
48659647|NCT00241631|156605239|FG001|Run in (2 Weeks)|Physician Decision|3|||
48659648|NCT00241631|156605238|FG000|Phase 1 (4 Weeks)|sore throat|1|||
48337665|NCT00296504|155431891|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
48659649|NCT00241631|156605239|FG001|Phase 1 (4 Weeks)|sore throat|0|||
48659650|NCT00241631|156605238|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
48659651|NCT00241631|156605239|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
48659652|NCT00241631|156605238|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
48659653|NCT00241631|156605239|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
48659654|NCT00241631|156605238|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
48659655|NCT00241631|156605239|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
48659656|NCT02437305|156605240|FG000|Overall Study|Lost to Follow-up|18|||
48337666|NCT00296504|155431892|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
48337667|NCT00296504|155431893|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
48337668|NCT00296504|155431894|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
48337669|NCT00296504|155431895|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
48337670|NCT00296504|155431896|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
48337671|NCT00296504|155431897|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
48337672|NCT00296504|155431889|FG000|Interim Analysis|Adverse Event|0|||
48337673|NCT00296504|155431890|FG001|Interim Analysis|Adverse Event|0|||
48337674|NCT00296504|155431891|FG002|Interim Analysis|Adverse Event|13|||
48337675|NCT00296504|155431892|FG003|Interim Analysis|Adverse Event|4|||
48337676|NCT00296504|155431893|FG004|Interim Analysis|Adverse Event|6|||
48337677|NCT00296504|155431894|FG005|Interim Analysis|Adverse Event|3|||
48337678|NCT00296504|155431895|FG006|Interim Analysis|Adverse Event|4|||
48337679|NCT00296504|155431896|FG007|Interim Analysis|Adverse Event|5|||
48337680|NCT00296504|155431897|FG008|Interim Analysis|Adverse Event|0|||
48337681|NCT00296504|155431889|FG000|Interim Analysis|Protocol Violation|0|||
48337682|NCT00296504|155431890|FG001|Interim Analysis|Protocol Violation|0|||
48337683|NCT00296504|155431891|FG002|Interim Analysis|Protocol Violation|2|||
48337684|NCT00296504|155431892|FG003|Interim Analysis|Protocol Violation|0|||
48337685|NCT00296504|155431893|FG004|Interim Analysis|Protocol Violation|1|||
48337686|NCT00296504|155431894|FG005|Interim Analysis|Protocol Violation|0|||
48337687|NCT00296504|155431895|FG006|Interim Analysis|Protocol Violation|0|||
48337688|NCT00296504|155431896|FG007|Interim Analysis|Protocol Violation|1|||
48337689|NCT00296504|155431897|FG008|Interim Analysis|Protocol Violation|0|||
48337690|NCT00296504|155431889|FG000|Interim Analysis|Insufficient CD4 Response|0|||
48337691|NCT00296504|155431890|FG001|Interim Analysis|Insufficient CD4 Response|0|||
48659657|NCT02437305|156605241|FG001|Overall Study|Lost to Follow-up|12|||
48659658|NCT01118520|156605242|FG000|Overall Study|AAA repair|9|||
48659659|NCT01118520|156605243|FG001|Overall Study|AAA repair|7|||
48659660|NCT01118520|156605244|FG002|Overall Study|AAA repair|9|||
48659661|NCT01118520|156605242|FG000|Overall Study|Adverse Event|3|||
48659662|NCT01118520|156605243|FG001|Overall Study|Adverse Event|3|||
48659663|NCT01118520|156605244|FG002|Overall Study|Adverse Event|3|||
48659664|NCT01118520|156605242|FG000|Overall Study|Withdrawal by Subject|8|||
48659665|NCT01118520|156605243|FG001|Overall Study|Withdrawal by Subject|13|||
48659666|NCT01118520|156605244|FG002|Overall Study|Withdrawal by Subject|8|||
48659667|NCT02439450|156605245|FG000|Overall Study|Adverse Event|4|||
48659668|NCT02439450|156605246|FG001|Overall Study|Adverse Event|1|||
48659669|NCT02439450|156605247|FG002|Overall Study|Adverse Event|0|||
48337692|NCT00296504|155431891|FG002|Interim Analysis|Insufficient CD4 Response|0|||
48337693|NCT00296504|155431892|FG003|Interim Analysis|Insufficient CD4 Response|0|||
48337694|NCT00296504|155431893|FG004|Interim Analysis|Insufficient CD4 Response|1|||
48337695|NCT00296504|155431894|FG005|Interim Analysis|Insufficient CD4 Response|1|||
48337696|NCT00296504|155431895|FG006|Interim Analysis|Insufficient CD4 Response|0|||
48337697|NCT00296504|155431896|FG007|Interim Analysis|Insufficient CD4 Response|0|||
48337698|NCT00296504|155431897|FG008|Interim Analysis|Insufficient CD4 Response|0|||
48337699|NCT00296504|155431889|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
48337700|NCT00296504|155431890|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
48337701|NCT00296504|155431891|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
48337702|NCT00296504|155431892|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
48337703|NCT00296504|155431893|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
48337704|NCT00296504|155431894|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
48337705|NCT00296504|155431895|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
48337706|NCT00296504|155431896|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
48337707|NCT00296504|155431897|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
48337708|NCT00296504|155431889|FG000|Interim Analysis|Pregnancy|4|||
48659670|NCT02439450|156605248|FG003|Overall Study|Adverse Event|0|||
48659671|NCT02439450|156605245|FG000|Overall Study|Withdrawal by Subject|1|||
48659672|NCT02439450|156605246|FG001|Overall Study|Withdrawal by Subject|2|||
48337709|NCT00296504|155431890|FG001|Interim Analysis|Pregnancy|1|||
48337710|NCT00296504|155431891|FG002|Interim Analysis|Pregnancy|4|||
48337711|NCT00296504|155431892|FG003|Interim Analysis|Pregnancy|2|||
48337712|NCT00296504|155431893|FG004|Interim Analysis|Pregnancy|0|||
48337713|NCT00296504|155431894|FG005|Interim Analysis|Pregnancy|1|||
48337714|NCT00296504|155431895|FG006|Interim Analysis|Pregnancy|1|||
48659673|NCT02439450|156605247|FG002|Overall Study|Withdrawal by Subject|0|||
48659674|NCT02439450|156605248|FG003|Overall Study|Withdrawal by Subject|0|||
48337715|NCT00296504|155431896|FG007|Interim Analysis|Pregnancy|1|||
48659675|NCT02439450|156605245|FG000|Overall Study|Death|3|||
48337716|NCT00296504|155431897|FG008|Interim Analysis|Pregnancy|0|||
48337717|NCT00296504|155431889|FG000|Interim Analysis|Death|1|||
48337718|NCT00296504|155431890|FG001|Interim Analysis|Death|0|||
48337719|NCT00296504|155431891|FG002|Interim Analysis|Death|3|||
48337720|NCT00296504|155431892|FG003|Interim Analysis|Death|0|||
48337721|NCT00296504|155431893|FG004|Interim Analysis|Death|0|||
48337722|NCT00296504|155431894|FG005|Interim Analysis|Death|0|||
48337723|NCT00296504|155431895|FG006|Interim Analysis|Death|0|||
48337724|NCT00296504|155431896|FG007|Interim Analysis|Death|0|||
48337725|NCT00296504|155431897|FG008|Interim Analysis|Death|0|||
48337726|NCT00296504|155431889|FG000|Interim Analysis|Participant Non-compliant|0|||
48337727|NCT00296504|155431890|FG001|Interim Analysis|Participant Non-compliant|1|||
48337728|NCT00296504|155431891|FG002|Interim Analysis|Participant Non-compliant|2|||
48337729|NCT00296504|155431892|FG003|Interim Analysis|Participant Non-compliant|1|||
48337730|NCT00296504|155431893|FG004|Interim Analysis|Participant Non-compliant|1|||
48337731|NCT00296504|155431894|FG005|Interim Analysis|Participant Non-compliant|3|||
48337732|NCT00296504|155431895|FG006|Interim Analysis|Participant Non-compliant|6|||
48337733|NCT00296504|155431896|FG007|Interim Analysis|Participant Non-compliant|2|||
48337734|NCT00296504|155431897|FG008|Interim Analysis|Participant Non-compliant|0|||
48337735|NCT00296504|155431889|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48337736|NCT00296504|155431890|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48337737|NCT00296504|155431891|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
48337738|NCT00296504|155431892|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48337739|NCT00296504|155431893|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48337740|NCT00296504|155431894|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
48337741|NCT00296504|155431895|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48337742|NCT00296504|155431896|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48337743|NCT00296504|155431897|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
48337744|NCT00296504|155431889|FG000|Interim Analysis|To Simplify Treatment|0|||
48337745|NCT00296504|155431890|FG001|Interim Analysis|To Simplify Treatment|0|||
48337746|NCT00296504|155431891|FG002|Interim Analysis|To Simplify Treatment|1|||
48337747|NCT00296504|155431892|FG003|Interim Analysis|To Simplify Treatment|0|||
48337748|NCT00296504|155431893|FG004|Interim Analysis|To Simplify Treatment|0|||
48337749|NCT00296504|155431894|FG005|Interim Analysis|To Simplify Treatment|0|||
48337750|NCT00296504|155431895|FG006|Interim Analysis|To Simplify Treatment|2|||
48337751|NCT00296504|155431896|FG007|Interim Analysis|To Simplify Treatment|0|||
48337752|NCT00296504|155431897|FG008|Interim Analysis|To Simplify Treatment|0|||
48337753|NCT00296504|155431889|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
48337754|NCT00296504|155431890|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
48337755|NCT00296504|155431891|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
48337756|NCT00296504|155431892|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
48337757|NCT00296504|155431893|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
48337758|NCT00296504|155431894|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
48337759|NCT00296504|155431895|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
48337760|NCT00296504|155431896|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
48337761|NCT00296504|155431897|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
48337762|NCT00296504|155431889|FG000|Interim Analysis|Participant Moved|1|||
48337763|NCT00296504|155431890|FG001|Interim Analysis|Participant Moved|0|||
48337764|NCT00296504|155431891|FG002|Interim Analysis|Participant Moved|1|||
48337765|NCT00296504|155431892|FG003|Interim Analysis|Participant Moved|0|||
48337766|NCT00296504|155431893|FG004|Interim Analysis|Participant Moved|0|||
48337767|NCT00296504|155431894|FG005|Interim Analysis|Participant Moved|1|||
48337768|NCT00296504|155431895|FG006|Interim Analysis|Participant Moved|1|||
48337769|NCT00296504|155431896|FG007|Interim Analysis|Participant Moved|0|||
48337770|NCT00296504|155431897|FG008|Interim Analysis|Participant Moved|0|||
48337771|NCT00296504|155431889|FG000|Interim Analysis|Participant Was Incarcerated|2|||
48337772|NCT00296504|155431890|FG001|Interim Analysis|Participant Was Incarcerated|0|||
48337773|NCT00296504|155431891|FG002|Interim Analysis|Participant Was Incarcerated|1|||
48337774|NCT00296504|155431892|FG003|Interim Analysis|Participant Was Incarcerated|0|||
48337775|NCT00296504|155431893|FG004|Interim Analysis|Participant Was Incarcerated|0|||
48337776|NCT00296504|155431894|FG005|Interim Analysis|Participant Was Incarcerated|0|||
48337777|NCT00296504|155431895|FG006|Interim Analysis|Participant Was Incarcerated|0|||
48337778|NCT00296504|155431896|FG007|Interim Analysis|Participant Was Incarcerated|0|||
48337779|NCT00296504|155431897|FG008|Interim Analysis|Participant Was Incarcerated|0|||
48337780|NCT00296504|155431889|FG000|Interim Analysis|Resistance to FPV|0|||
48337781|NCT00296504|155431890|FG001|Interim Analysis|Resistance to FPV|0|||
48337782|NCT00296504|155431891|FG002|Interim Analysis|Resistance to FPV|1|||
48337783|NCT00296504|155431892|FG003|Interim Analysis|Resistance to FPV|0|||
48337784|NCT00296504|155431893|FG004|Interim Analysis|Resistance to FPV|0|||
48337785|NCT00296504|155431894|FG005|Interim Analysis|Resistance to FPV|0|||
48337786|NCT00296504|155431895|FG006|Interim Analysis|Resistance to FPV|0|||
48337787|NCT00296504|155431896|FG007|Interim Analysis|Resistance to FPV|0|||
48337788|NCT00296504|155431897|FG008|Interim Analysis|Resistance to FPV|0|||
48659676|NCT02439450|156605246|FG001|Overall Study|Death|0|||
48659677|NCT02439450|156605247|FG002|Overall Study|Death|0|||
48659678|NCT02439450|156605248|FG003|Overall Study|Death|1|||
48659679|NCT02439450|156605245|FG000|Overall Study|Progressive Disease|18|||
48659680|NCT02439450|156605246|FG001|Overall Study|Progressive Disease|41|||
48659681|NCT02439450|156605247|FG002|Overall Study|Progressive Disease|2|||
48337789|NCT00296504|155431889|FG000|Interim Analysis|Physician Decision|0|||
48337790|NCT00296504|155431890|FG001|Interim Analysis|Physician Decision|0|||
48337791|NCT00296504|155431891|FG002|Interim Analysis|Physician Decision|1|||
48337792|NCT00296504|155431892|FG003|Interim Analysis|Physician Decision|0|||
48337793|NCT00296504|155431893|FG004|Interim Analysis|Physician Decision|0|||
48337794|NCT00296504|155431894|FG005|Interim Analysis|Physician Decision|0|||
48337795|NCT00296504|155431895|FG006|Interim Analysis|Physician Decision|0|||
48337796|NCT00296504|155431896|FG007|Interim Analysis|Physician Decision|0|||
48337797|NCT00296504|155431897|FG008|Interim Analysis|Physician Decision|0|||
48337798|NCT00296504|155431889|FG000|Interim Analysis|Principle Investigator Discretion|2|||
48337799|NCT00296504|155431890|FG001|Interim Analysis|Principle Investigator Discretion|0|||
48337800|NCT00296504|155431891|FG002|Interim Analysis|Principle Investigator Discretion|1|||
48337801|NCT00296504|155431892|FG003|Interim Analysis|Principle Investigator Discretion|1|||
48659682|NCT02439450|156605248|FG003|Overall Study|Progressive Disease|3|||
48659683|NCT02763254|156605249|FG000|Overall Study|Adverse Event|1|||
48659684|NCT01819129|156605250|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
48659685|NCT01819129|156605251|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
48659686|NCT01819129|156605250|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
48659687|NCT01819129|156605251|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
48659688|NCT01819129|156605250|FG000|Overall Study|Other, Subject moved out of the country|0|||
48659689|NCT01819129|156605251|FG001|Overall Study|Other, Subject moved out of the country|1|||
48659690|NCT01819129|156605250|FG000|Overall Study|Withdrawal by Subject|15|||
48659691|NCT01819129|156605251|FG001|Overall Study|Withdrawal by Subject|15|||
48659692|NCT01819129|156605250|FG000|Overall Study|Lost to Follow-up|5|||
48659693|NCT01819129|156605251|FG001|Overall Study|Lost to Follow-up|2|||
48659694|NCT01819129|156605250|FG000|Overall Study|Lack of Efficacy|0|||
48659695|NCT01819129|156605251|FG001|Overall Study|Lack of Efficacy|1|||
48659696|NCT01819129|156605250|FG000|Overall Study|Adverse Event|1|||
48659697|NCT01819129|156605251|FG001|Overall Study|Adverse Event|4|||
48659698|NCT01819129|156605250|FG000|Overall Study|Death|1|||
48659699|NCT01819129|156605251|FG001|Overall Study|Death|1|||
48659700|NCT01819129|156605250|FG000|Overall Study|Withdrawal Criteria|20|||
48659701|NCT01819129|156605251|FG001|Overall Study|Withdrawal Criteria|15|||
48659702|NCT01646645|156605257|FG000|Overall Study|No Treated|1|||
48659703|NCT01646645|156605257|FG000|Overall Study|Inevaluable Donor|29|||
48659704|NCT01874275|156605258|FG000|Overall Study|Lost to Follow-up|1|||
48659705|NCT01874275|156605259|FG001|Overall Study|Lost to Follow-up|0|||
48659706|NCT00066469|156605260|FG000|Overall Study|Death|3|||
48659707|NCT00066469|156605260|FG000|Overall Study|Lack of Efficacy|9|||
48659708|NCT00066469|156605260|FG000|Overall Study|Lost to Follow-up|1|||
48659709|NCT00066469|156605260|FG000|Overall Study|Physician Decision|1|||
48659710|NCT00066469|156605260|FG000|Overall Study|Withdrawal by Subject|1|||
48659711|NCT00066469|156605260|FG000|Overall Study|ineligible|1|||
48659712|NCT04070326|156605266|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
48659713|NCT04070326|156605267|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
48659714|NCT01886690|156605268|FG000|Overall Study|Protocol Violation|0|||
48659715|NCT01886690|156605269|FG001|Overall Study|Protocol Violation|1|||
48659716|NCT01886690|156605268|FG000|Overall Study|Personal Reasons|0|||
48659717|NCT01886690|156605269|FG001|Overall Study|Personal Reasons|1|||
48659718|NCT04096820|156605270|FG000|Overall Study|Did not return for intervention|2|||
48659719|NCT04096820|156605270|FG000|Overall Study|Death|1|||
48659720|NCT04941807|156605271|FG000|Overall Study|Lost to Follow-up|1|||
48755348|NCT00498602|156951237|FG003|Overall Study|Investigator Request|0|||
48755349|NCT00498602|156951238|FG004|Overall Study|Investigator Request|0|||
48755350|NCT00498602|156951239|FG005|Overall Study|Investigator Request|0|||
48755351|NCT00498602|156951240|FG006|Overall Study|Investigator Request|0|||
48755352|NCT00498602|156951234|FG000|Overall Study|Subject Request|3|||
48755353|NCT00498602|156951235|FG001|Overall Study|Subject Request|0|||
48755354|NCT00498602|156951236|FG002|Overall Study|Subject Request|1|||
48755355|NCT00498602|156951237|FG003|Overall Study|Subject Request|1|||
48659721|NCT04941807|156605272|FG001|Overall Study|Lost to Follow-up|1|||
48337802|NCT00296504|155431893|FG004|Interim Analysis|Principle Investigator Discretion|0|||
48337803|NCT00296504|155431894|FG005|Interim Analysis|Principle Investigator Discretion|0|||
48659722|NCT02725593|156605273|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
48337804|NCT00296504|155431895|FG006|Interim Analysis|Principle Investigator Discretion|0|||
48659723|NCT02725593|156605274|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
48659724|NCT02725593|156605273|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
48659725|NCT02725593|156605274|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
48755356|NCT00498602|156951238|FG004|Overall Study|Subject Request|1|||
48755357|NCT00498602|156951239|FG005|Overall Study|Subject Request|4|||
48337805|NCT00296504|155431896|FG007|Interim Analysis|Principle Investigator Discretion|0|||
48337806|NCT00296504|155431897|FG008|Interim Analysis|Principle Investigator Discretion|0|||
48337807|NCT00296504|155431889|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
48337808|NCT00296504|155431890|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
48337809|NCT00296504|155431891|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
48337810|NCT00296504|155431892|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
48337811|NCT00296504|155431893|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
48337812|NCT00296504|155431894|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
48337813|NCT00296504|155431895|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
48337814|NCT00296504|155431896|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
48337815|NCT00296504|155431897|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
48337816|NCT00296504|155431889|FG000|Interim Analysis|Non-adherence|2|||
48337817|NCT00296504|155431890|FG001|Interim Analysis|Non-adherence|0|||
48337818|NCT00296504|155431891|FG002|Interim Analysis|Non-adherence|0|||
48337819|NCT00296504|155431892|FG003|Interim Analysis|Non-adherence|0|||
48659726|NCT02725593|156605273|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
48659727|NCT02725593|156605274|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
48659728|NCT02725593|156605273|FG000|Long Term Extension|Withdrawal by Subject|1|||
48659729|NCT02725593|156605274|FG001|Long Term Extension|Withdrawal by Subject|3|||
48659730|NCT04199104|156607084|FG000|Overall Study|Death|148|||
48659731|NCT04199104|156607085|FG001|Overall Study|Death|134|||
48659732|NCT04199104|156607084|FG000|Overall Study|Lost to Follow-up|1|||
48659733|NCT04199104|156607085|FG001|Overall Study|Lost to Follow-up|1|||
48659734|NCT04199104|156607084|FG000|Overall Study|Withdrawal by Subject|4|||
48659735|NCT04199104|156607085|FG001|Overall Study|Withdrawal by Subject|4|||
48659736|NCT04199104|156607084|FG000|Overall Study|Participants Ongoing|103|||
48659737|NCT04199104|156607085|FG001|Overall Study|Participants Ongoing|116|||
48659738|NCT03724981|156607090|FG000|First Device|Protocol Violation|1|||
48659739|NCT03724981|156607091|FG001|First Device|Protocol Violation|1|||
48659740|NCT04817670|156607095|FG000|Overall Study|Withdrawal by Subject|1|||
48659741|NCT04817670|156607096|FG001|Overall Study|Withdrawal by Subject|0|||
48659742|NCT04817670|156607097|FG002|Overall Study|Withdrawal by Subject|0|||
48659743|NCT04817670|156607098|FG003|Overall Study|Withdrawal by Subject|0|||
48659744|NCT04817670|156607099|FG004|Overall Study|Withdrawal by Subject|0|||
48659745|NCT04817670|156607095|FG000|Overall Study|Lost to Follow-up|0|||
48337820|NCT00296504|155431893|FG004|Interim Analysis|Non-adherence|1|||
48659746|NCT04817670|156607096|FG001|Overall Study|Lost to Follow-up|0|||
48659747|NCT04817670|156607097|FG002|Overall Study|Lost to Follow-up|1|||
48659748|NCT04817670|156607098|FG003|Overall Study|Lost to Follow-up|0|||
48337821|NCT00296504|155431894|FG005|Interim Analysis|Non-adherence|0|||
48659749|NCT04817670|156607099|FG004|Overall Study|Lost to Follow-up|0|||
48659750|NCT03312907|156607100|FG000|Overall Study|Adverse Event|1|||
48659751|NCT03312907|156607101|FG001|Overall Study|Adverse Event|6|||
48659752|NCT03312907|156607102|FG002|Overall Study|Adverse Event|1|||
48337822|NCT00296504|155431895|FG006|Interim Analysis|Non-adherence|0|||
48659753|NCT03312907|156607100|FG000|Overall Study|Protocol Violation|2|||
48337823|NCT00296504|155431896|FG007|Interim Analysis|Non-adherence|1|||
48337824|NCT00296504|155431897|FG008|Interim Analysis|Non-adherence|0|||
48337825|NCT00296504|155431889|FG000|Interim Analysis|Site Closing|1|||
48337826|NCT00296504|155431890|FG001|Interim Analysis|Site Closing|0|||
48337827|NCT00296504|155431891|FG002|Interim Analysis|Site Closing|0|||
48337828|NCT00296504|155431892|FG003|Interim Analysis|Site Closing|0|||
48337829|NCT00296504|155431893|FG004|Interim Analysis|Site Closing|0|||
48337830|NCT00296504|155431894|FG005|Interim Analysis|Site Closing|1|||
48337831|NCT00296504|155431895|FG006|Interim Analysis|Site Closing|2|||
48337832|NCT00296504|155431896|FG007|Interim Analysis|Site Closing|0|||
48337833|NCT00296504|155431897|FG008|Interim Analysis|Site Closing|0|||
48659754|NCT03312907|156607101|FG001|Overall Study|Protocol Violation|3|||
48659755|NCT03312907|156607102|FG002|Overall Study|Protocol Violation|4|||
48659756|NCT03312907|156607100|FG000|Overall Study|Lost to Follow-up|2|||
48659757|NCT03312907|156607101|FG001|Overall Study|Lost to Follow-up|3|||
48659758|NCT03312907|156607102|FG002|Overall Study|Lost to Follow-up|2|||
48659759|NCT03312907|156607100|FG000|Overall Study|Physician Decision|3|||
48659760|NCT03312907|156607101|FG001|Overall Study|Physician Decision|4|||
48659761|NCT03312907|156607102|FG002|Overall Study|Physician Decision|2|||
48659762|NCT03312907|156607100|FG000|Overall Study|Withdrawal by Subject|9|||
48659763|NCT03312907|156607101|FG001|Overall Study|Withdrawal by Subject|14|||
48659764|NCT03312907|156607102|FG002|Overall Study|Withdrawal by Subject|10|||
48659765|NCT02358031|156607103|FG000|Overall Study|Death|253|||
48659766|NCT02358031|156607104|FG001|Overall Study|Death|237|||
48337834|NCT00296504|155431889|FG000|Interim Analysis|Lack of Personnel at Site|1|||
48337835|NCT00296504|155431890|FG001|Interim Analysis|Lack of Personnel at Site|0|||
48337836|NCT00296504|155431891|FG002|Interim Analysis|Lack of Personnel at Site|0|||
48337837|NCT00296504|155431892|FG003|Interim Analysis|Lack of Personnel at Site|0|||
48659767|NCT02358031|156607105|FG002|Overall Study|Death|266|||
48659768|NCT02358031|156607103|FG000|Overall Study|Lost to Follow-up|1|||
48659769|NCT02358031|156607104|FG001|Overall Study|Lost to Follow-up|1|||
48659770|NCT02358031|156607105|FG002|Overall Study|Lost to Follow-up|0|||
48659771|NCT02358031|156607103|FG000|Overall Study|Withdrawal by Subject|19|||
48659772|NCT02358031|156607104|FG001|Overall Study|Withdrawal by Subject|14|||
48659773|NCT02358031|156607105|FG002|Overall Study|Withdrawal by Subject|18|||
48659774|NCT02358031|156607103|FG000|Overall Study|Sponsor Decision|26|||
48659775|NCT02358031|156607104|FG001|Overall Study|Sponsor Decision|28|||
48659776|NCT02358031|156607105|FG002|Overall Study|Sponsor Decision|16|||
48659777|NCT05104697|156607109|FG000|Overall Study|Withdrawal by Subject|0|||
48659778|NCT05104697|156607110|FG001|Overall Study|Withdrawal by Subject|1|||
48659779|NCT04714320|156607111|FG000|Overall Study|Voluntary Withdrawal|4|||
48659780|NCT04714320|156607112|FG001|Overall Study|Voluntary Withdrawal|1|||
48659781|NCT04714320|156607113|FG002|Overall Study|Voluntary Withdrawal|2|||
48659782|NCT04714320|156607111|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
48659783|NCT04714320|156607112|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
48659784|NCT04714320|156607113|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
48659785|NCT04714320|156607111|FG000|Overall Study|Reason Not Specified|1|||
48659786|NCT04714320|156607112|FG001|Overall Study|Reason Not Specified|3|||
48659787|NCT04714320|156607113|FG002|Overall Study|Reason Not Specified|3|||
48659788|NCT05656911|156607114|FG000|Treatment Phase|Physician Decision|2|||
48659789|NCT05656911|156607115|FG001|Treatment Phase|Physician Decision|0|||
48659790|NCT05656911|156607114|FG000|Treatment Phase|Lack of Efficacy|6|||
48659791|NCT05656911|156607115|FG001|Treatment Phase|Lack of Efficacy|3|||
48659792|NCT05656911|156607114|FG000|Treatment Phase|Subject Decision|4|||
48659793|NCT05656911|156607115|FG001|Treatment Phase|Subject Decision|2|||
48659794|NCT05656911|156607114|FG000|Treatment Phase|Other Reasons|1|||
48659795|NCT05656911|156607115|FG001|Treatment Phase|Other Reasons|0|||
48337838|NCT00296504|155431893|FG004|Interim Analysis|Lack of Personnel at Site|0|||
48337839|NCT00296504|155431894|FG005|Interim Analysis|Lack of Personnel at Site|0|||
48337840|NCT00296504|155431895|FG006|Interim Analysis|Lack of Personnel at Site|0|||
48337841|NCT00296504|155431896|FG007|Interim Analysis|Lack of Personnel at Site|0|||
48659796|NCT05656911|156607114|FG000|Treatment Phase|Adverse Event|3|||
48659797|NCT05656911|156607115|FG001|Treatment Phase|Adverse Event|1|||
48659798|NCT05656911|156607114|FG000|Follow-up Phase|Subject Decision|0|||
48659799|NCT05656911|156607115|FG001|Follow-up Phase|Subject Decision|1|||
48659800|NCT05656911|156607114|FG000|Follow-up Phase|Missing|1|||
48659801|NCT05656911|156607115|FG001|Follow-up Phase|Missing|0|||
48659802|NCT00567580|156607117|FG000|Overall Study|Protocol Violation|28|||
48659803|NCT00567580|156607118|FG001|Overall Study|Protocol Violation|24|||
48659804|NCT00567580|156607119|FG002|Overall Study|Protocol Violation|24|||
48659805|NCT05030233|156607122|FG000|Overall Study|withdrawn for transfer|1|||
48659806|NCT05030233|156607123|FG001|Overall Study|withdrawn for transfer|0|||
48659807|NCT01159171|156607124|FG000|Overall Study|Adverse Event|11|||
48659808|NCT01159171|156607124|FG000|Overall Study|Progression of Disease|28|||
48659809|NCT01159171|156607124|FG000|Overall Study|Protocol Violation|1|||
48659810|NCT01159171|156607124|FG000|Overall Study|Need for Surgery|5|||
48659811|NCT01159171|156607124|FG000|Overall Study|Medical Decision|4|||
48659812|NCT01159171|156607124|FG000|Overall Study|Death|1|||
48659813|NCT00896363|156607125|FG000|Overall Study|Adverse Event|3|||
48659814|NCT00896363|156607126|FG001|Overall Study|Adverse Event|4|||
48659815|NCT00896363|156607127|FG002|Overall Study|Adverse Event|2|||
48659816|NCT00896363|156607125|FG000|Overall Study|Lack of Efficacy|0|||
48659817|NCT00896363|156607126|FG001|Overall Study|Lack of Efficacy|2|||
48659818|NCT00896363|156607127|FG002|Overall Study|Lack of Efficacy|1|||
48659819|NCT00896363|156607125|FG000|Overall Study|Withdrawal by Subject|3|||
48755358|NCT00498602|156951240|FG006|Overall Study|Subject Request|1|||
48755359|NCT00498602|156951234|FG000|Overall Study|Other|2|||
48755360|NCT00498602|156951235|FG001|Overall Study|Other|3|||
48755361|NCT00498602|156951236|FG002|Overall Study|Other|1|||
48755362|NCT00498602|156951237|FG003|Overall Study|Other|0|||
48755363|NCT00498602|156951238|FG004|Overall Study|Other|0|||
48755364|NCT00498602|156951239|FG005|Overall Study|Other|3|||
48755365|NCT00498602|156951240|FG006|Overall Study|Other|0|||
48755366|NCT00456521|156951242|FG000|Overall Study|Adverse Event|150|||
48755367|NCT00456521|156951243|FG001|Overall Study|Adverse Event|25|||
48755368|NCT00456521|156951242|FG000|Overall Study|Withdrawal by Subject|43|||
48659820|NCT00896363|156607126|FG001|Overall Study|Withdrawal by Subject|5|||
48659821|NCT00896363|156607127|FG002|Overall Study|Withdrawal by Subject|5|||
48659822|NCT02759107|156607128|FG000|Overall Study|Adverse Event|0|||
48659823|NCT02759107|156607129|FG001|Overall Study|Adverse Event|0|||
48659824|NCT02759107|156607130|FG002|Overall Study|Adverse Event|0|||
48659825|NCT02759107|156607131|FG003|Overall Study|Adverse Event|0|||
48755369|NCT00456521|156951243|FG001|Overall Study|Withdrawal by Subject|24|||
48755370|NCT00456521|156951242|FG000|Overall Study|Lost to Follow-up|22|||
48755371|NCT00456521|156951243|FG001|Overall Study|Lost to Follow-up|17|||
48659826|NCT02759107|156607132|FG004|Overall Study|Adverse Event|0|||
48659827|NCT02759107|156607133|FG005|Overall Study|Adverse Event|0|||
48659828|NCT02759107|156607134|FG006|Overall Study|Adverse Event|0|||
48659829|NCT02759107|156607135|FG007|Overall Study|Adverse Event|0|||
48755372|NCT00456521|156951242|FG000|Overall Study|Lack of Efficacy|3|||
48659830|NCT02759107|156607136|FG008|Overall Study|Adverse Event|0|||
48659831|NCT02759107|156607137|FG009|Overall Study|Adverse Event|0|||
48659832|NCT02759107|156607138|FG010|Overall Study|Adverse Event|0|||
48659833|NCT02759107|156607139|FG011|Overall Study|Adverse Event|0|||
48659834|NCT02759107|156607140|FG012|Overall Study|Adverse Event|2|||
48659835|NCT02759107|156607141|FG013|Overall Study|Adverse Event|0|||
48659836|NCT02759107|156607142|FG014|Overall Study|Adverse Event|0|||
48659837|NCT02759107|156607143|FG015|Overall Study|Adverse Event|1|||
48659838|NCT02759107|156607144|FG016|Overall Study|Adverse Event|0|||
48659839|NCT02759107|156607145|FG017|Overall Study|Adverse Event|2|||
48659840|NCT02759107|156607128|FG000|Overall Study|Scheduling Conflict|0|||
48659841|NCT02759107|156607129|FG001|Overall Study|Scheduling Conflict|0|||
48659842|NCT02759107|156607130|FG002|Overall Study|Scheduling Conflict|0|||
48659843|NCT02759107|156607131|FG003|Overall Study|Scheduling Conflict|0|||
48659844|NCT02759107|156607132|FG004|Overall Study|Scheduling Conflict|0|||
48659845|NCT02759107|156607133|FG005|Overall Study|Scheduling Conflict|0|||
48659846|NCT02759107|156607134|FG006|Overall Study|Scheduling Conflict|0|||
48659847|NCT02759107|156607135|FG007|Overall Study|Scheduling Conflict|0|||
48659848|NCT02759107|156607136|FG008|Overall Study|Scheduling Conflict|0|||
48659849|NCT02759107|156607137|FG009|Overall Study|Scheduling Conflict|1|||
48659850|NCT02759107|156607138|FG010|Overall Study|Scheduling Conflict|0|||
48659851|NCT02759107|156607139|FG011|Overall Study|Scheduling Conflict|0|||
48659852|NCT02759107|156607140|FG012|Overall Study|Scheduling Conflict|0|||
48659853|NCT02759107|156607141|FG013|Overall Study|Scheduling Conflict|0|||
48659854|NCT02759107|156607142|FG014|Overall Study|Scheduling Conflict|0|||
48659855|NCT02759107|156607143|FG015|Overall Study|Scheduling Conflict|0|||
48659856|NCT02759107|156607144|FG016|Overall Study|Scheduling Conflict|0|||
48659857|NCT02759107|156607145|FG017|Overall Study|Scheduling Conflict|0|||
48659858|NCT03095027|156607146|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
48659859|NCT03095027|156607147|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
48659860|NCT00591149|156607150|FG000|Overall Study|Adverse Event|4|||
48659861|NCT00591149|156607150|FG000|Overall Study|Withdrawal by Subject|1|||
48659862|NCT00539513|156607151|FG000|Overall Study|Withdrawal by Subject|2|||
48659863|NCT00539513|156607152|FG001|Overall Study|Withdrawal by Subject|1|||
48659864|NCT00539513|156607151|FG000|Overall Study|Lost to Follow-up|0|||
48659865|NCT00539513|156607152|FG001|Overall Study|Lost to Follow-up|1|||
48659866|NCT03920293|156607154|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
48659867|NCT03920293|156607155|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
48659868|NCT03920293|156607154|FG000|Randomized-Controlled Period|Physician Decision|1|||
48659869|NCT03920293|156607155|FG001|Randomized-Controlled Period|Physician Decision|2|||
48659870|NCT03920293|156607154|FG000|Randomized-Controlled Period|Adverse Event|0|||
48659871|NCT03920293|156607155|FG001|Randomized-Controlled Period|Adverse Event|2|||
48659872|NCT03920293|156607154|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
48659873|NCT03920293|156607155|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
48659874|NCT03920293|156607154|FG000|Randomized-Controlled Period|Death|2|||
48659875|NCT03920293|156607155|FG001|Randomized-Controlled Period|Death|0|||
48659876|NCT03920293|156607154|FG000|Randomized-Controlled Period|Protocol Violation|1|||
48659877|NCT03920293|156607155|FG001|Randomized-Controlled Period|Protocol Violation|0|||
48659878|NCT03920293|156607154|FG000|Randomized-Controlled Period|Noncompliance|1|||
48659879|NCT03920293|156607155|FG001|Randomized-Controlled Period|Noncompliance|0|||
48659880|NCT03920293|156607154|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
48659881|NCT03920293|156607155|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
48659882|NCT03920293|156607154|FG000|Open- Label Extension Period|Death|3|||
48659883|NCT03920293|156607155|FG001|Open- Label Extension Period|Death|3|||
48659884|NCT03920293|156607154|FG000|Open- Label Extension Period|Physician Decision|5|||
48659885|NCT03920293|156607155|FG001|Open- Label Extension Period|Physician Decision|3|||
48659886|NCT03920293|156607154|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
48659887|NCT03920293|156607155|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
48659888|NCT03524612|156607156|FG000|Overall Study|Lack of Efficacy|10|||
48659889|NCT03524612|156607156|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
48659890|NCT03524612|156607156|FG000|Overall Study|Adverse Event|10|||
48659891|NCT03524612|156607156|FG000|Overall Study|Withdrawal by Subject|7|||
48659892|NCT03524612|156607156|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
48659893|NCT03524612|156607156|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
48659894|NCT03524612|156607156|FG000|Overall Study|New therapy for study indication|6|||
48659895|NCT03524612|156607156|FG000|Overall Study|Death|3|||
48659896|NCT03524612|156607156|FG000|Overall Study|Lost to Follow-up|2|||
48659897|NCT03524612|156607156|FG000|Overall Study|Protocol Violation|1|||
48659898|NCT00744978|156607160|FG000|Period 1|Lost to Follow-up|1|||
48659899|NCT00744978|156607161|FG001|Period 1|Lost to Follow-up|0|||
48659900|NCT00744978|156607160|FG000|Period 1|Withdrawal by Subject|0|||
48659901|NCT00744978|156607161|FG001|Period 1|Withdrawal by Subject|2|||
48659902|NCT00744978|156607160|FG000|Period 1|Other|0|||
48659903|NCT00744978|156607161|FG001|Period 1|Other|2|||
48659904|NCT00744978|156607160|FG000|Period 1|Adverse Event|4|||
48659905|NCT00744978|156607161|FG001|Period 1|Adverse Event|0|||
48659906|NCT00744978|156607160|FG000|Period 1|Randomized but not Treated|1|||
48659907|NCT00744978|156607161|FG001|Period 1|Randomized but not Treated|1|||
48659908|NCT00744978|156607160|FG000|Period 2|Adverse Event|0|||
48659909|NCT00744978|156607161|FG001|Period 2|Adverse Event|1|||
48659910|NCT03770728|156607162|FG000|Overall Study|Adverse Event|1|||
48659911|NCT03770728|156607163|FG001|Overall Study|Adverse Event|0|||
48659912|NCT03770728|156607164|FG002|Overall Study|Adverse Event|1|||
48659913|NCT03770728|156607165|FG003|Overall Study|Adverse Event|0|||
48659914|NCT03770728|156607162|FG000|Overall Study|Poor compliance to protocol|0|||
48659915|NCT03770728|156607163|FG001|Overall Study|Poor compliance to protocol|0|||
48659916|NCT03770728|156607164|FG002|Overall Study|Poor compliance to protocol|1|||
48659917|NCT03770728|156607165|FG003|Overall Study|Poor compliance to protocol|0|||
48755373|NCT00456521|156951243|FG001|Overall Study|Lack of Efficacy|6|||
48659918|NCT03770728|156607162|FG000|Overall Study|Withdrawal by Subject|13|||
48659919|NCT03770728|156607163|FG001|Overall Study|Withdrawal by Subject|8|||
48659920|NCT03770728|156607164|FG002|Overall Study|Withdrawal by Subject|9|||
48659921|NCT03770728|156607165|FG003|Overall Study|Withdrawal by Subject|13|||
48755374|NCT00456521|156951242|FG000|Overall Study|Protocol Violation|4|||
48755375|NCT00456521|156951243|FG001|Overall Study|Protocol Violation|0|||
48755376|NCT00456521|156951242|FG000|Overall Study|Pregnancy|1|||
48659922|NCT03770728|156607162|FG000|Overall Study|Other than specified|24|||
48659923|NCT03770728|156607163|FG001|Overall Study|Other than specified|23|||
48659924|NCT03770728|156607164|FG002|Overall Study|Other than specified|21|||
48659925|NCT03770728|156607165|FG003|Overall Study|Other than specified|22|||
48659926|NCT03703817|156607166|FG000|Overall Study|Not meeting eligibility criteria|7|||
48659927|NCT03703817|156607167|FG001|Overall Study|Not meeting eligibility criteria|4|||
48659928|NCT04195438|156607168|FG000|Overall Study|Withdrawal by Subject|1|||
48659929|NCT00223977|156607169|FG000|Overall Study|Adverse Event|7|||
48659930|NCT00223977|156607170|FG001|Overall Study|Adverse Event|10|||
48659931|NCT00223977|156607171|FG002|Overall Study|Adverse Event|0|||
48659932|NCT00223977|156607169|FG000|Overall Study|Protocol Violation|0|||
48659933|NCT00223977|156607170|FG001|Overall Study|Protocol Violation|0|||
48337842|NCT00296504|155431897|FG008|Interim Analysis|Lack of Personnel at Site|0|||
48337843|NCT00296504|155431889|FG000|Interim Analysis|Missed Schedule Date|1|||
48337844|NCT00296504|155431890|FG001|Interim Analysis|Missed Schedule Date|0|||
48337845|NCT00296504|155431891|FG002|Interim Analysis|Missed Schedule Date|0|||
48337846|NCT00296504|155431892|FG003|Interim Analysis|Missed Schedule Date|0|||
48337847|NCT00296504|155431893|FG004|Interim Analysis|Missed Schedule Date|0|||
48337848|NCT00296504|155431894|FG005|Interim Analysis|Missed Schedule Date|0|||
48337849|NCT00296504|155431895|FG006|Interim Analysis|Missed Schedule Date|0|||
48337850|NCT00296504|155431896|FG007|Interim Analysis|Missed Schedule Date|0|||
48337851|NCT00296504|155431897|FG008|Interim Analysis|Missed Schedule Date|0|||
48337852|NCT00296504|155431889|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
48337853|NCT00296504|155431890|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
48337854|NCT00296504|155431891|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
48337855|NCT00296504|155431892|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
48659934|NCT00223977|156607171|FG002|Overall Study|Protocol Violation|1|||
48659935|NCT00223977|156607169|FG000|Overall Study|Withdrawal by Subject|1|||
48659936|NCT00223977|156607170|FG001|Overall Study|Withdrawal by Subject|1|||
48659937|NCT00223977|156607171|FG002|Overall Study|Withdrawal by Subject|2|||
48659938|NCT00223977|156607169|FG000|Overall Study|Other|1|||
48659939|NCT00223977|156607170|FG001|Overall Study|Other|0|||
48659940|NCT00223977|156607171|FG002|Overall Study|Other|0|||
48659941|NCT01920568|156607172|FG000|Overall Study|Adverse Event|27|||
48659942|NCT01920568|156607173|FG001|Overall Study|Adverse Event|8|||
48659943|NCT01920568|156607172|FG000|Overall Study|Protocol Violation|5|||
48659944|NCT01920568|156607173|FG001|Overall Study|Protocol Violation|3|||
48659945|NCT01920568|156607172|FG000|Overall Study|Lost to Follow-up|2|||
48659946|NCT01920568|156607173|FG001|Overall Study|Lost to Follow-up|2|||
48659947|NCT01920568|156607172|FG000|Overall Study|Physician Decision|13|||
48659948|NCT01920568|156607173|FG001|Overall Study|Physician Decision|4|||
48659949|NCT01920568|156607172|FG000|Overall Study|Withdrawal by Subject|79|||
48659950|NCT01920568|156607173|FG001|Overall Study|Withdrawal by Subject|55|||
48337856|NCT00296504|155431893|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
48659951|NCT01920568|156607172|FG000|Overall Study|Death due to disease progression|25|||
48659952|NCT01920568|156607173|FG001|Overall Study|Death due to disease progression|12|||
48659953|NCT00683917|156607176|FG000|Overall Study|Study prematurely terminated|10|||
48659954|NCT03199053|156607177|FG000|ST Period|Withdrawal by Subject|2|||
48659955|NCT03199053|156607178|FG001|ST Period|Withdrawal by Subject|4|||
48659956|NCT03199053|156607179|FG002|ST Period|Withdrawal by Subject|6|||
48755377|NCT00456521|156951243|FG001|Overall Study|Pregnancy|1|||
48659957|NCT03199053|156607177|FG000|ST Period|Withdrawal by parent/guardian|1|||
48659958|NCT03199053|156607178|FG001|ST Period|Withdrawal by parent/guardian|1|||
48659959|NCT03199053|156607179|FG002|ST Period|Withdrawal by parent/guardian|1|||
48659960|NCT03199053|156607177|FG000|ST Period|Lost to Follow-up|2|||
48337857|NCT00296504|155431894|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
48659961|NCT03199053|156607178|FG001|ST Period|Lost to Follow-up|0|||
48659962|NCT03199053|156607179|FG002|ST Period|Lost to Follow-up|1|||
48659963|NCT03199053|156607177|FG000|LT Period|Withdrawal by Subject|1|||
48659964|NCT03199053|156607178|FG001|LT Period|Withdrawal by Subject|3|||
48659965|NCT03199053|156607179|FG002|LT Period|Withdrawal by Subject|3|||
48659966|NCT03199053|156607177|FG000|LT Period|Withdrawal by parent/guardian|0|||
48659967|NCT03199053|156607178|FG001|LT Period|Withdrawal by parent/guardian|0|||
48659968|NCT03199053|156607179|FG002|LT Period|Withdrawal by parent/guardian|1|||
48659969|NCT03199053|156607177|FG000|LT Period|Lost to Follow-up|0|||
48659970|NCT03199053|156607178|FG001|LT Period|Lost to Follow-up|1|||
48659971|NCT03199053|156607179|FG002|LT Period|Lost to Follow-up|1|||
48659972|NCT03199053|156607177|FG000|LT Period|Miscellaneous|0|||
48659973|NCT03199053|156607178|FG001|LT Period|Miscellaneous|0|||
48659974|NCT03199053|156607179|FG002|LT Period|Miscellaneous|2|||
48659975|NCT03199053|156607177|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
48659976|NCT03199053|156607178|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
48659977|NCT03199053|156607179|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
48337858|NCT00296504|155431895|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
48337859|NCT00296504|155431896|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
48659978|NCT03199053|156607177|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
48659979|NCT03199053|156607178|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
48659980|NCT03199053|156607179|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
48659981|NCT03199053|156607177|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
48659982|NCT03199053|156607178|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
48659983|NCT03199053|156607179|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
48659984|NCT03199053|156607177|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
48659985|NCT03199053|156607178|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
48659986|NCT03199053|156607179|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
48659987|NCT01323270|156607180|FG000|Overall Study|Withdrawal by Subject|19|||
48659988|NCT01323270|156607181|FG001|Overall Study|Withdrawal by Subject|10|||
48659989|NCT01323270|156607180|FG000|Overall Study|Protocol Violation|9|||
48659990|NCT01323270|156607181|FG001|Overall Study|Protocol Violation|7|||
48659991|NCT01323270|156607180|FG000|Overall Study|Lost to Follow-up|4|||
48659992|NCT01323270|156607181|FG001|Overall Study|Lost to Follow-up|6|||
48659993|NCT01323270|156607180|FG000|Overall Study|Adverse Event|8|||
48659994|NCT01323270|156607181|FG001|Overall Study|Adverse Event|0|||
48659995|NCT01323270|156607180|FG000|Overall Study|Other|0|||
48659996|NCT01323270|156607181|FG001|Overall Study|Other|3|||
48659997|NCT01323270|156607180|FG000|Overall Study|Physician Decision|0|||
48659998|NCT01323270|156607181|FG001|Overall Study|Physician Decision|2|||
48659999|NCT01323270|156607180|FG000|Overall Study|Not eligible|1|||
48660000|NCT01323270|156607181|FG001|Overall Study|Not eligible|1|||
48660001|NCT01323270|156607180|FG000|Overall Study|Death|1|||
48660002|NCT01323270|156607181|FG001|Overall Study|Death|0|||
48660003|NCT01323270|156607180|FG000|Overall Study|Randomized, but not vaccinated|1|||
48660004|NCT01323270|156607181|FG001|Overall Study|Randomized, but not vaccinated|0|||
48660005|NCT02229214|156607183|FG000|Overall Study|Adverse Event|2|||
48660006|NCT02229214|156607184|FG001|Overall Study|Adverse Event|0|||
48660007|NCT02229214|156607183|FG000|Overall Study|Withdrawal by Subject|4|||
48660008|NCT02229214|156607184|FG001|Overall Study|Withdrawal by Subject|0|||
48660009|NCT00246025|156607185|FG000|Overall Study|Adverse Event|7|||
48660010|NCT00246025|156607186|FG001|Overall Study|Adverse Event|9|||
48660011|NCT00246025|156607187|FG002|Overall Study|Adverse Event|9|||
48660012|NCT00246025|156607188|FG003|Overall Study|Adverse Event|10|||
48660013|NCT00246025|156607185|FG000|Overall Study|Withdrawal by Subject|3|||
48660014|NCT00246025|156607186|FG001|Overall Study|Withdrawal by Subject|0|||
48660015|NCT00246025|156607187|FG002|Overall Study|Withdrawal by Subject|1|||
48660016|NCT00246025|156607188|FG003|Overall Study|Withdrawal by Subject|2|||
48660017|NCT00246025|156607185|FG000|Overall Study|unsuitable medical history was found|0|||
48660018|NCT00246025|156607186|FG001|Overall Study|unsuitable medical history was found|0|||
48660019|NCT00246025|156607187|FG002|Overall Study|unsuitable medical history was found|0|||
48660020|NCT00246025|156607188|FG003|Overall Study|unsuitable medical history was found|1|||
48660021|NCT00931723|156607189|FG000|Overall Study|Withdrawal by Subject|11|||
48660022|NCT00931723|156607190|FG001|Overall Study|Withdrawal by Subject|13|||
48660023|NCT00931723|156607189|FG000|Overall Study|Adverse Event|6|||
48660024|NCT00931723|156607190|FG001|Overall Study|Adverse Event|13|||
48660025|NCT00931723|156607189|FG000|Overall Study|Lithium found in blood|0|||
48660026|NCT00931723|156607190|FG001|Overall Study|Lithium found in blood|1|||
48660027|NCT00931723|156607189|FG000|Overall Study|Condition under investigation worsened|1|||
48660028|NCT00931723|156607190|FG001|Overall Study|Condition under investigation worsened|2|||
48660029|NCT00931723|156607189|FG000|Overall Study|Lost to Follow-up|1|||
48660030|NCT00931723|156607190|FG001|Overall Study|Lost to Follow-up|2|||
48660031|NCT00931723|156607189|FG000|Overall Study|Study-specific discontinuation criteria|1|||
48660032|NCT00931723|156607190|FG001|Overall Study|Study-specific discontinuation criteria|1|||
48660033|NCT00931723|156607189|FG000|Overall Study|Severe non-compliance to protocol|2|||
48337860|NCT00296504|155431897|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
48337861|NCT00296504|155431889|FG000|Interim Analysis|Participant Stopped|0|||
48337862|NCT00296504|155431890|FG001|Interim Analysis|Participant Stopped|0|||
48337863|NCT00296504|155431891|FG002|Interim Analysis|Participant Stopped|0|||
48337864|NCT00296504|155431892|FG003|Interim Analysis|Participant Stopped|0|||
48337865|NCT00296504|155431893|FG004|Interim Analysis|Participant Stopped|1|||
48337866|NCT00296504|155431894|FG005|Interim Analysis|Participant Stopped|0|||
48337867|NCT00296504|155431895|FG006|Interim Analysis|Participant Stopped|0|||
48337868|NCT00296504|155431896|FG007|Interim Analysis|Participant Stopped|0|||
48337869|NCT00296504|155431897|FG008|Interim Analysis|Participant Stopped|0|||
48337870|NCT00296504|155431889|FG000|Interim Analysis|Physician and Participant Decision|0|||
48337871|NCT00296504|155431890|FG001|Interim Analysis|Physician and Participant Decision|0|||
48337872|NCT00296504|155431891|FG002|Interim Analysis|Physician and Participant Decision|0|||
48337873|NCT00296504|155431892|FG003|Interim Analysis|Physician and Participant Decision|0|||
48337874|NCT00296504|155431893|FG004|Interim Analysis|Physician and Participant Decision|0|||
48337875|NCT00296504|155431894|FG005|Interim Analysis|Physician and Participant Decision|1|||
48337876|NCT00296504|155431895|FG006|Interim Analysis|Physician and Participant Decision|0|||
48337877|NCT00296504|155431896|FG007|Interim Analysis|Physician and Participant Decision|0|||
48337878|NCT00296504|155431897|FG008|Interim Analysis|Physician and Participant Decision|0|||
48337879|NCT00296504|155431889|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
48337880|NCT00296504|155431890|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
48337881|NCT00296504|155431891|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
48337882|NCT00296504|155431892|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
48337883|NCT00296504|155431893|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
48337884|NCT00296504|155431894|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
48337885|NCT00296504|155431895|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
48337886|NCT00296504|155431896|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
48337887|NCT00296504|155431897|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
48660034|NCT00931723|156607190|FG001|Overall Study|Severe non-compliance to protocol|0|||
48337888|NCT00296504|155431889|FG000|Interim Analysis|Study Ended|0|||
48337889|NCT00296504|155431890|FG001|Interim Analysis|Study Ended|0|||
48337890|NCT00296504|155431891|FG002|Interim Analysis|Study Ended|0|||
48337891|NCT00296504|155431892|FG003|Interim Analysis|Study Ended|0|||
48337892|NCT00296504|155431893|FG004|Interim Analysis|Study Ended|0|||
48337893|NCT00296504|155431894|FG005|Interim Analysis|Study Ended|0|||
48337894|NCT00296504|155431895|FG006|Interim Analysis|Study Ended|1|||
48337895|NCT00296504|155431896|FG007|Interim Analysis|Study Ended|0|||
48337896|NCT00296504|155431897|FG008|Interim Analysis|Study Ended|0|||
48337897|NCT00296504|155431889|FG000|Interim Analysis|Participant Needed Interferon|0|||
48337898|NCT00296504|155431890|FG001|Interim Analysis|Participant Needed Interferon|0|||
48337899|NCT00296504|155431891|FG002|Interim Analysis|Participant Needed Interferon|0|||
48660035|NCT00931723|156607189|FG000|Overall Study|Safety reasons|0|||
48660036|NCT00931723|156607190|FG001|Overall Study|Safety reasons|1|||
48660037|NCT00931723|156607189|FG000|Overall Study|Took prohibited concomitant medication|0|||
48660038|NCT00931723|156607190|FG001|Overall Study|Took prohibited concomitant medication|1|||
48660039|NCT00931723|156607189|FG000|Overall Study|Lack or insufficient theraputic response|2|||
48660040|NCT00931723|156607190|FG001|Overall Study|Lack or insufficient theraputic response|5|||
48660041|NCT00931723|156607189|FG000|Overall Study|Sponsor decision|1|||
48660042|NCT00931723|156607190|FG001|Overall Study|Sponsor decision|0|||
48660043|NCT00931723|156607189|FG000|Overall Study|Late hospital discharge|1|||
48660044|NCT00931723|156607190|FG001|Overall Study|Late hospital discharge|0|||
48660045|NCT01571284|156607193|FG000|Overall Study|Participant's decision|84|||
48660046|NCT01571284|156607193|FG000|Overall Study|Lost to Follow-up|3|||
48337900|NCT00296504|155431892|FG003|Interim Analysis|Participant Needed Interferon|0|||
48337901|NCT00296504|155431893|FG004|Interim Analysis|Participant Needed Interferon|0|||
48337902|NCT00296504|155431894|FG005|Interim Analysis|Participant Needed Interferon|0|||
48337903|NCT00296504|155431895|FG006|Interim Analysis|Participant Needed Interferon|0|||
48337904|NCT00296504|155431896|FG007|Interim Analysis|Participant Needed Interferon|1|||
48337905|NCT00296504|155431897|FG008|Interim Analysis|Participant Needed Interferon|0|||
48337906|NCT00296504|155431889|FG000|Interim Analysis|Ongoing|32|||
48337907|NCT00296504|155431890|FG001|Interim Analysis|Ongoing|12|||
48337908|NCT00296504|155431891|FG002|Interim Analysis|Ongoing|16|||
48337909|NCT00296504|155431892|FG003|Interim Analysis|Ongoing|22|||
48337910|NCT00296504|155431893|FG004|Interim Analysis|Ongoing|0|||
48337911|NCT00296504|155431894|FG005|Interim Analysis|Ongoing|0|||
48337912|NCT00296504|155431895|FG006|Interim Analysis|Ongoing|30|||
48660047|NCT01571284|156607193|FG000|Overall Study|Enrolled but not treated|2|||
48660048|NCT01571284|156607193|FG000|Overall Study|Other than specified above|80|||
48660049|NCT03510468|156607194|FG000|Overall Study|Lost to Follow-up|1|||
48660050|NCT03510468|156607194|FG000|Overall Study|Adverse Event|5|||
48660051|NCT03510468|156607194|FG000|Overall Study|Physician Decision|1|||
48660052|NCT03510468|156607194|FG000|Overall Study|non-compliant with treatment|2|||
48660053|NCT03510468|156607194|FG000|Overall Study|Missed visit|1|||
48660054|NCT03754582|156607197|FG000|Treatment Phase|Adverse Event|0|||
48660055|NCT03754582|156607198|FG001|Treatment Phase|Adverse Event|1|||
48660056|NCT03754582|156607199|FG002|Treatment Phase|Adverse Event|0|||
48660057|NCT03754582|156607197|FG000|Follow-up Phase|Other|0|||
48660058|NCT03754582|156607198|FG001|Follow-up Phase|Other|0|||
48660059|NCT03754582|156607199|FG002|Follow-up Phase|Other|1|||
48660060|NCT00435162|156607202|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
48660061|NCT00435162|156607203|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
48660062|NCT00435162|156607204|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
48660063|NCT00435162|156607205|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
48660064|NCT00435162|156607206|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
48660065|NCT00435162|156607207|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
48660066|NCT02460783|156607210|FG000|Overall Study|Withdrawal by Subject|1|||
48660067|NCT02460783|156607211|FG001|Overall Study|Withdrawal by Subject|3|||
48660068|NCT02460783|156607210|FG000|Overall Study|Lost to Follow-up|1|||
48660069|NCT02460783|156607211|FG001|Overall Study|Lost to Follow-up|1|||
48660070|NCT00394901|156607215|FG000|Baseline Phase|Protocol Violation|0|||
48660071|NCT00394901|156607216|FG001|Baseline Phase|Protocol Violation|0|||
48660072|NCT00394901|156607217|FG002|Baseline Phase|Protocol Violation|1|||
48660073|NCT00394901|156607218|FG003|Baseline Phase|Protocol Violation|0|||
48660074|NCT00394901|156607215|FG000|Double-blind Phase|Adverse Event|5|||
48660075|NCT00394901|156607216|FG001|Double-blind Phase|Adverse Event|7|||
48660076|NCT00394901|156607217|FG002|Double-blind Phase|Adverse Event|16|||
48660077|NCT00394901|156607218|FG003|Double-blind Phase|Adverse Event|20|||
48660078|NCT00394901|156607215|FG000|Double-blind Phase|Lack of Efficacy|6|||
48660079|NCT00394901|156607216|FG001|Double-blind Phase|Lack of Efficacy|4|||
48660080|NCT00394901|156607217|FG002|Double-blind Phase|Lack of Efficacy|1|||
48660081|NCT00394901|156607218|FG003|Double-blind Phase|Lack of Efficacy|3|||
48337913|NCT00296504|155431896|FG007|Interim Analysis|Ongoing|1|||
48660082|NCT00394901|156607215|FG000|Double-blind Phase|Withdrawal by Subject|2|||
48660083|NCT00394901|156607216|FG001|Double-blind Phase|Withdrawal by Subject|0|||
48660084|NCT00394901|156607217|FG002|Double-blind Phase|Withdrawal by Subject|0|||
48660085|NCT00394901|156607218|FG003|Double-blind Phase|Withdrawal by Subject|0|||
48337914|NCT00296504|155431897|FG008|Interim Analysis|Ongoing|0|||
48337915|NCT00296504|155431889|FG000|Final Analysis|Withdrawal by Subject|0|||
48660086|NCT00394901|156607215|FG000|Double-blind Phase|Lost to Follow-up|0|||
48660087|NCT00394901|156607216|FG001|Double-blind Phase|Lost to Follow-up|0|||
48337916|NCT00296504|155431890|FG001|Final Analysis|Withdrawal by Subject|0|||
48337917|NCT00296504|155431891|FG002|Final Analysis|Withdrawal by Subject|0|||
48337918|NCT00296504|155431892|FG003|Final Analysis|Withdrawal by Subject|0|||
48337919|NCT00296504|155431893|FG004|Final Analysis|Withdrawal by Subject|0|||
48337920|NCT00296504|155431894|FG005|Final Analysis|Withdrawal by Subject|0|||
48337921|NCT00296504|155431895|FG006|Final Analysis|Withdrawal by Subject|0|||
48660088|NCT00394901|156607217|FG002|Double-blind Phase|Lost to Follow-up|0|||
48660089|NCT00394901|156607218|FG003|Double-blind Phase|Lost to Follow-up|1|||
48660090|NCT00394901|156607215|FG000|Double-blind Phase|Protocol Violation|0|||
48660091|NCT00394901|156607216|FG001|Double-blind Phase|Protocol Violation|0|||
48660092|NCT00394901|156607217|FG002|Double-blind Phase|Protocol Violation|0|||
48660093|NCT00394901|156607218|FG003|Double-blind Phase|Protocol Violation|1|||
48660094|NCT00394901|156607215|FG000|Double-blind Phase|Death|1|||
48660095|NCT00394901|156607216|FG001|Double-blind Phase|Death|0|||
48660096|NCT00394901|156607217|FG002|Double-blind Phase|Death|0|||
48660097|NCT00394901|156607218|FG003|Double-blind Phase|Death|0|||
48660098|NCT00394901|156607215|FG000|Double-blind Phase|Subject's Personal Reason|1|||
48660099|NCT00394901|156607216|FG001|Double-blind Phase|Subject's Personal Reason|0|||
48660100|NCT00394901|156607217|FG002|Double-blind Phase|Subject's Personal Reason|0|||
48660101|NCT00394901|156607218|FG003|Double-blind Phase|Subject's Personal Reason|1|||
48660102|NCT00394901|156607215|FG000|Double-blind Phase|Lack of Compliance|0|||
48660103|NCT00394901|156607216|FG001|Double-blind Phase|Lack of Compliance|3|||
48660104|NCT00394901|156607217|FG002|Double-blind Phase|Lack of Compliance|0|||
48660105|NCT00394901|156607218|FG003|Double-blind Phase|Lack of Compliance|0|||
48660106|NCT00394901|156607215|FG000|Double-blind Phase|Entry into another study was found|0|||
48660107|NCT00394901|156607216|FG001|Double-blind Phase|Entry into another study was found|0|||
48660108|NCT00394901|156607217|FG002|Double-blind Phase|Entry into another study was found|1|||
48660109|NCT00394901|156607218|FG003|Double-blind Phase|Entry into another study was found|0|||
48660110|NCT00394901|156607215|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
48660111|NCT00394901|156607216|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
48660112|NCT00394901|156607217|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
48660113|NCT00394901|156607218|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
48660114|NCT05028517|156607219|FG000|Overall Study|Lost to Follow-up|13|||
48660115|NCT05028517|156607220|FG001|Overall Study|Lost to Follow-up|20|||
48660116|NCT05028517|156607221|FG002|Overall Study|Lost to Follow-up|12|||
48660117|NCT05028517|156607219|FG000|Overall Study|Withdrawal by Subject|0|||
48660118|NCT05028517|156607220|FG001|Overall Study|Withdrawal by Subject|0|||
48660119|NCT05028517|156607221|FG002|Overall Study|Withdrawal by Subject|1|||
48660120|NCT03651895|156608630|FG000|First Drug Assignment|Adverse Event|4|||
48660121|NCT03651895|156608631|FG001|First Drug Assignment|Adverse Event|5|||
48660122|NCT03651895|156608630|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
48660123|NCT03651895|156608631|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
48660124|NCT04920084|156608634|FG000|Overall Study|Adverse Event|1|||
48660125|NCT04920084|156608634|FG000|Overall Study|Lost to Follow-up|2|||
48660126|NCT04920084|156608634|FG000|Overall Study|Withdrawal by Subject|2|||
48660127|NCT04896476|156608635|FG000|Overall Study|Withdrawal by Subject|1|||
48660128|NCT04896476|156608635|FG000|Overall Study|Lost to Follow-up|2|||
48660129|NCT02903368|156608637|FG000|Part 1|Adverse Event|3|||
48660130|NCT02903368|156608638|FG001|Part 1|Adverse Event|0|||
48660131|NCT02903368|156608639|FG002|Part 1|Adverse Event|0|||
48660132|NCT02903368|156608640|FG003|Part 1|Adverse Event|0|||
48660133|NCT02903368|156608637|FG000|Part 1|Withdrawal by Subject|1|||
48660134|NCT02903368|156608638|FG001|Part 1|Withdrawal by Subject|0|||
48660135|NCT02903368|156608639|FG002|Part 1|Withdrawal by Subject|0|||
48660136|NCT02903368|156608640|FG003|Part 1|Withdrawal by Subject|0|||
48660137|NCT02903368|156608637|FG000|Part 2|Adverse Event|0|||
48660138|NCT02903368|156608638|FG001|Part 2|Adverse Event|0|||
48660139|NCT02903368|156608639|FG002|Part 2|Adverse Event|5|||
48337922|NCT00296504|155431896|FG007|Final Analysis|Withdrawal by Subject|0|||
48337923|NCT00296504|155431897|FG008|Final Analysis|Withdrawal by Subject|1|||
48337924|NCT00296504|155431889|FG000|Final Analysis|Lost to Follow-up|0|||
48337925|NCT00296504|155431890|FG001|Final Analysis|Lost to Follow-up|0|||
48337926|NCT00296504|155431891|FG002|Final Analysis|Lost to Follow-up|0|||
48337927|NCT00296504|155431892|FG003|Final Analysis|Lost to Follow-up|0|||
48337928|NCT00296504|155431893|FG004|Final Analysis|Lost to Follow-up|0|||
48337929|NCT00296504|155431894|FG005|Final Analysis|Lost to Follow-up|0|||
48337930|NCT00296504|155431895|FG006|Final Analysis|Lost to Follow-up|0|||
48337931|NCT00296504|155431896|FG007|Final Analysis|Lost to Follow-up|0|||
48337932|NCT00296504|155431897|FG008|Final Analysis|Lost to Follow-up|5|||
48337933|NCT00296504|155431889|FG000|Final Analysis|Insufficient Viral Load Response|0|||
48337934|NCT00296504|155431890|FG001|Final Analysis|Insufficient Viral Load Response|0|||
48337935|NCT00296504|155431891|FG002|Final Analysis|Insufficient Viral Load Response|0|||
48337936|NCT00296504|155431892|FG003|Final Analysis|Insufficient Viral Load Response|0|||
48337937|NCT00296504|155431893|FG004|Final Analysis|Insufficient Viral Load Response|0|||
48337938|NCT00296504|155431894|FG005|Final Analysis|Insufficient Viral Load Response|0|||
48337939|NCT00296504|155431895|FG006|Final Analysis|Insufficient Viral Load Response|0|||
48337940|NCT00296504|155431896|FG007|Final Analysis|Insufficient Viral Load Response|0|||
48337941|NCT00296504|155431897|FG008|Final Analysis|Insufficient Viral Load Response|6|||
48337942|NCT00296504|155431889|FG000|Final Analysis|Adverse Event|0|||
48337943|NCT00296504|155431890|FG001|Final Analysis|Adverse Event|0|||
48337944|NCT00296504|155431891|FG002|Final Analysis|Adverse Event|0|||
48337945|NCT00296504|155431892|FG003|Final Analysis|Adverse Event|0|||
48337946|NCT00296504|155431893|FG004|Final Analysis|Adverse Event|0|||
48337947|NCT00296504|155431894|FG005|Final Analysis|Adverse Event|0|||
48337948|NCT00296504|155431895|FG006|Final Analysis|Adverse Event|0|||
48337949|NCT00296504|155431896|FG007|Final Analysis|Adverse Event|0|||
48337950|NCT00296504|155431897|FG008|Final Analysis|Adverse Event|2|||
48337951|NCT00296504|155431889|FG000|Final Analysis|Pregnancy|0|||
48337952|NCT00296504|155431890|FG001|Final Analysis|Pregnancy|0|||
48337953|NCT00296504|155431891|FG002|Final Analysis|Pregnancy|0|||
48337954|NCT00296504|155431892|FG003|Final Analysis|Pregnancy|0|||
48337955|NCT00296504|155431893|FG004|Final Analysis|Pregnancy|0|||
48337956|NCT00296504|155431894|FG005|Final Analysis|Pregnancy|0|||
48337957|NCT00296504|155431895|FG006|Final Analysis|Pregnancy|0|||
48337958|NCT00296504|155431896|FG007|Final Analysis|Pregnancy|0|||
48337959|NCT00296504|155431897|FG008|Final Analysis|Pregnancy|4|||
48337960|NCT00296504|155431889|FG000|Final Analysis|Tuberculosis|0|||
48337961|NCT00296504|155431890|FG001|Final Analysis|Tuberculosis|0|||
48337962|NCT00296504|155431891|FG002|Final Analysis|Tuberculosis|0|||
48337963|NCT00296504|155431892|FG003|Final Analysis|Tuberculosis|0|||
48337964|NCT00296504|155431893|FG004|Final Analysis|Tuberculosis|0|||
48337965|NCT00296504|155431894|FG005|Final Analysis|Tuberculosis|0|||
48337966|NCT00296504|155431895|FG006|Final Analysis|Tuberculosis|0|||
48337967|NCT00296504|155431896|FG007|Final Analysis|Tuberculosis|0|||
48337968|NCT00296504|155431897|FG008|Final Analysis|Tuberculosis|1|||
48337969|NCT00296504|155431889|FG000|Final Analysis|Participant Moved to Another Country|0|||
48337970|NCT00296504|155431890|FG001|Final Analysis|Participant Moved to Another Country|0|||
48337971|NCT00296504|155431891|FG002|Final Analysis|Participant Moved to Another Country|0|||
48337972|NCT00296504|155431892|FG003|Final Analysis|Participant Moved to Another Country|0|||
48337973|NCT00296504|155431893|FG004|Final Analysis|Participant Moved to Another Country|0|||
48337974|NCT00296504|155431894|FG005|Final Analysis|Participant Moved to Another Country|0|||
48337975|NCT00296504|155431895|FG006|Final Analysis|Participant Moved to Another Country|0|||
48337976|NCT00296504|155431896|FG007|Final Analysis|Participant Moved to Another Country|0|||
48337977|NCT00296504|155431897|FG008|Final Analysis|Participant Moved to Another Country|1|||
48337978|NCT00296504|155431889|FG000|Final Analysis|Poor Adherence|0|||
48660140|NCT02903368|156608640|FG003|Part 2|Adverse Event|0|||
48660141|NCT02903368|156608637|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
48337979|NCT00296504|155431890|FG001|Final Analysis|Poor Adherence|0|||
48660142|NCT02903368|156608638|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
48660143|NCT02903368|156608639|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
48660144|NCT02903368|156608640|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
48660145|NCT02903368|156608637|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
48660146|NCT02903368|156608638|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
48660147|NCT02903368|156608639|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
48660148|NCT02903368|156608640|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
48660149|NCT02903368|156608637|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
48660150|NCT02903368|156608638|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
48660151|NCT02903368|156608639|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
48660152|NCT02903368|156608640|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
48660153|NCT05948670|156608641|FG000|Overall Study|Protocol Violation|6|||
48660154|NCT05948670|156608642|FG001|Overall Study|Protocol Violation|8|||
48660155|NCT05948670|156608641|FG000|Overall Study|Withdrawal by Subject|0|||
48660156|NCT05948670|156608642|FG001|Overall Study|Withdrawal by Subject|1|||
48660157|NCT02576535|156608643|FG000|Overall Study|Withdrawal by Subject|2|||
48660158|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
48660159|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
48660160|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
48660161|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
48660162|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
48660163|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
48660164|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
48660165|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660166|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
48660167|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660168|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660169|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660170|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660171|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
48660172|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660173|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
48660174|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
48660175|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660176|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660177|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660178|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
48660179|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
48660180|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660181|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660182|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660183|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660184|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660185|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
48660186|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660187|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
48660188|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660189|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660190|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660191|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660192|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
48660193|NCT02962895|156608644|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660194|NCT02962895|156608645|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660195|NCT02962895|156608646|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660196|NCT02962895|156608647|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
48660197|NCT02962895|156608648|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660198|NCT02962895|156608649|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660199|NCT02962895|156608650|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
48660200|NCT02962895|156608644|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48337980|NCT00296504|155431891|FG002|Final Analysis|Poor Adherence|0|||
48337981|NCT00296504|155431892|FG003|Final Analysis|Poor Adherence|0|||
48337982|NCT00296504|155431893|FG004|Final Analysis|Poor Adherence|0|||
48660201|NCT02962895|156608645|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48692729|NCT04908683|156724584|FG000|Overall Study|Death|101|||
48337983|NCT00296504|155431894|FG005|Final Analysis|Poor Adherence|0|||
48337984|NCT00296504|155431895|FG006|Final Analysis|Poor Adherence|0|||
48660202|NCT02962895|156608646|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48660203|NCT02962895|156608647|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48660204|NCT02962895|156608648|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48660205|NCT02962895|156608649|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
48660206|NCT02962895|156608650|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
48660207|NCT02962895|156608644|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660208|NCT02962895|156608645|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660209|NCT02962895|156608646|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660210|NCT02962895|156608647|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660211|NCT02962895|156608648|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
48660212|NCT02962895|156608649|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
48660213|NCT02962895|156608650|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
48660214|NCT02962895|156608644|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660215|NCT02962895|156608645|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660216|NCT02962895|156608646|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660217|NCT02962895|156608647|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660218|NCT02962895|156608648|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660219|NCT02962895|156608649|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
48660220|NCT02962895|156608650|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
48660221|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48337985|NCT00296504|155431896|FG007|Final Analysis|Poor Adherence|0|||
48337986|NCT00296504|155431897|FG008|Final Analysis|Poor Adherence|1|||
48337987|NCT02038803|155431901|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
48337988|NCT02038803|155431901|FG000|Overall Study|Lost to Follow-up|1|||
48337989|NCT04754594|155431902|FG000|Blinded Period|Withdrawal by Subject|4|||
48337990|NCT04754594|155431903|FG001|Blinded Period|Withdrawal by Subject|9|||
48337991|NCT04754594|155431904|FG002|Blinded Period|Withdrawal by Subject|0|||
48337992|NCT04754594|155431905|FG003|Blinded Period|Withdrawal by Subject|0|||
48337993|NCT04754594|155431902|FG000|Blinded Period|Protocol Violation|2|||
48337994|NCT04754594|155431903|FG001|Blinded Period|Protocol Violation|2|||
48337995|NCT04754594|155431904|FG002|Blinded Period|Protocol Violation|0|||
48337996|NCT04754594|155431905|FG003|Blinded Period|Protocol Violation|0|||
48337997|NCT04754594|155431902|FG000|Blinded Period|Lost to Follow-up|1|||
48337998|NCT04754594|155431903|FG001|Blinded Period|Lost to Follow-up|1|||
48337999|NCT04754594|155431904|FG002|Blinded Period|Lost to Follow-up|0|||
48338000|NCT04754594|155431905|FG003|Blinded Period|Lost to Follow-up|0|||
48338001|NCT04754594|155431902|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
48338002|NCT04754594|155431903|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
48338003|NCT04754594|155431904|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
48338004|NCT04754594|155431905|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
48660222|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
48660223|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660224|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660225|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660226|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660227|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
48660228|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660229|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660230|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660231|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660232|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
48660233|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660234|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
48660235|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660236|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660237|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660238|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660239|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
48660240|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660241|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
48660242|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
48660243|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
48660244|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
48660245|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
48660246|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
48660247|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
48660248|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
48660249|NCT02962895|156608644|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
48660250|NCT02962895|156608645|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
48660251|NCT02962895|156608646|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
48660252|NCT02962895|156608647|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
48660253|NCT02962895|156608648|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
48660254|NCT02962895|156608649|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
48660255|NCT02962895|156608650|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
48660256|NCT04509674|156608651|FG000|Overall Study|Not treated|33|||
48338005|NCT04754594|155431902|FG000|Unblinded Period|Withdrawal by Subject|6|||
48338006|NCT04754594|155431903|FG001|Unblinded Period|Withdrawal by Subject|8|||
48338007|NCT04754594|155431904|FG002|Unblinded Period|Withdrawal by Subject|0|||
48338008|NCT04754594|155431905|FG003|Unblinded Period|Withdrawal by Subject|0|||
48660257|NCT04509674|156608652|FG001|Overall Study|Not treated|26|||
48660258|NCT04509674|156608651|FG000|Overall Study|Protocol Violation|9|||
48660259|NCT04509674|156608652|FG001|Overall Study|Protocol Violation|10|||
48660260|NCT04509674|156608651|FG000|Overall Study|Lost to Follow-up|31|||
48660261|NCT04509674|156608652|FG001|Overall Study|Lost to Follow-up|39|||
48660262|NCT04509674|156608651|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
48660263|NCT04509674|156608652|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
48660264|NCT04509674|156608651|FG000|Overall Study|Adverse event, serious fatal event|11|||
48660265|NCT04509674|156608652|FG001|Overall Study|Adverse event, serious fatal event|4|||
48660266|NCT04509674|156608651|FG000|Overall Study|Adverse event, non-fatal event|107|||
48660267|NCT04509674|156608652|FG001|Overall Study|Adverse event, non-fatal event|118|||
48660268|NCT04509674|156608651|FG000|Overall Study|Other reason than listed|106|||
48660269|NCT04509674|156608652|FG001|Overall Study|Other reason than listed|95|||
48660270|NCT00888329|156608654|FG000|Overall Study|Physician Decision|6|||
48660271|NCT00888329|156608655|FG001|Overall Study|Physician Decision|9|||
48660272|NCT03519971|156608656|FG000|Overall Study|Death|142|||
48660273|NCT03519971|156608657|FG001|Overall Study|Death|69|||
48338009|NCT04754594|155431902|FG000|Unblinded Period|Lost to Follow-up|5|||
48338010|NCT04754594|155431903|FG001|Unblinded Period|Lost to Follow-up|3|||
48338011|NCT04754594|155431904|FG002|Unblinded Period|Lost to Follow-up|0|||
48660274|NCT03519971|156608656|FG000|Overall Study|Lost to Follow-up|0|||
48338012|NCT04754594|155431905|FG003|Unblinded Period|Lost to Follow-up|0|||
48660275|NCT03519971|156608657|FG001|Overall Study|Lost to Follow-up|1|||
48660276|NCT03519971|156608656|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
48660277|NCT03519971|156608657|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
48660278|NCT03519971|156608656|FG000|Overall Study|Withdrawal by Subject|3|||
48660279|NCT03519971|156608657|FG001|Overall Study|Withdrawal by Subject|2|||
48660280|NCT03519971|156608656|FG000|Overall Study|Other|1|||
48660281|NCT03519971|156608657|FG001|Overall Study|Other|0|||
48338013|NCT04754594|155431902|FG000|Unblinded Period|Protocol Violation|2|||
48338014|NCT04754594|155431903|FG001|Unblinded Period|Protocol Violation|4|||
48338015|NCT04754594|155431904|FG002|Unblinded Period|Protocol Violation|0|||
48660282|NCT01208662|156608658|FG000|Induction and Consolidation|Disease Progression|23|||
48660283|NCT01208662|156608659|FG001|Induction and Consolidation|Disease Progression|13|||
48660284|NCT01208662|156608660|FG002|Induction and Consolidation|Disease Progression|0|||
48660285|NCT01208662|156608658|FG000|Induction and Consolidation|Adverse Event|16|||
48660286|NCT01208662|156608659|FG001|Induction and Consolidation|Adverse Event|18|||
48660287|NCT01208662|156608660|FG002|Induction and Consolidation|Adverse Event|2|||
48660288|NCT01208662|156608658|FG000|Induction and Consolidation|MD or Participant Decision|16|||
48660289|NCT01208662|156608659|FG001|Induction and Consolidation|MD or Participant Decision|34|||
48660290|NCT01208662|156608660|FG002|Induction and Consolidation|MD or Participant Decision|4|||
48660291|NCT01208662|156608658|FG000|Induction and Consolidation|Death|1|||
48660292|NCT01208662|156608659|FG001|Induction and Consolidation|Death|3|||
48755378|NCT00456521|156951242|FG000|Overall Study|Drug non-compliance, moved, other|26|||
48755379|NCT00456521|156951243|FG001|Overall Study|Drug non-compliance, moved, other|11|||
48660293|NCT01208662|156608660|FG002|Induction and Consolidation|Death|1|||
48660294|NCT01208662|156608658|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
48660295|NCT01208662|156608659|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
48338016|NCT04754594|155431905|FG003|Unblinded Period|Protocol Violation|0|||
48338017|NCT04754594|155431902|FG000|Unblinded Period|Other|3|||
48338018|NCT04754594|155431903|FG001|Unblinded Period|Other|0|||
48338019|NCT04754594|155431904|FG002|Unblinded Period|Other|0|||
48338020|NCT04754594|155431905|FG003|Unblinded Period|Other|0|||
48338021|NCT04754594|155431902|FG000|Infant Participants|Withdrawal by Subject|0|||
48338022|NCT04754594|155431903|FG001|Infant Participants|Withdrawal by Subject|0|||
48338023|NCT04754594|155431904|FG002|Infant Participants|Withdrawal by Subject|9|||
48338024|NCT04754594|155431905|FG003|Infant Participants|Withdrawal by Subject|17|||
48338025|NCT04754594|155431902|FG000|Infant Participants|Lost to Follow-up|0|||
48338026|NCT04754594|155431903|FG001|Infant Participants|Lost to Follow-up|0|||
48338027|NCT04754594|155431904|FG002|Infant Participants|Lost to Follow-up|4|||
48338028|NCT04754594|155431905|FG003|Infant Participants|Lost to Follow-up|10|||
48338029|NCT04754594|155431902|FG000|Infant Participants|Death|0|||
48338030|NCT04754594|155431903|FG001|Infant Participants|Death|0|||
48338031|NCT04754594|155431904|FG002|Infant Participants|Death|1|||
48338032|NCT04754594|155431905|FG003|Infant Participants|Death|1|||
48338033|NCT04754594|155431902|FG000|Infant Participants|Other|0|||
48660296|NCT01208662|156608660|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
48755380|NCT03779204|156951244|FG000|Overall Study|Lost to Follow-up|2|||
48755381|NCT03779204|156951245|FG001|Overall Study|Lost to Follow-up|0|||
48755382|NCT00558025|156951248|FG000|Overall Study|Adverse Event|1|||
48755383|NCT00558025|156951249|FG001|Overall Study|Adverse Event|1|||
48755384|NCT00558025|156951248|FG000|Overall Study|Withdrawal by Subject|2|||
48755385|NCT00558025|156951249|FG001|Overall Study|Withdrawal by Subject|2|||
48755386|NCT00558025|156951248|FG000|Overall Study|Protocol Violation|1|||
48755387|NCT00558025|156951249|FG001|Overall Study|Protocol Violation|0|||
48755388|NCT02288559|156951250|FG000|Overall Study|Adverse Event|1|||
48755389|NCT02288559|156951251|FG001|Overall Study|Adverse Event|1|||
48755390|NCT02288559|156951252|FG002|Overall Study|Adverse Event|5|||
48755391|NCT02288559|156951253|FG003|Overall Study|Adverse Event|0|||
48755392|NCT02288559|156951250|FG000|Overall Study|Death|0|||
48755393|NCT02288559|156951251|FG001|Overall Study|Death|0|||
48338034|NCT04754594|155431903|FG001|Infant Participants|Other|0|||
48338035|NCT04754594|155431904|FG002|Infant Participants|Other|1|||
48338036|NCT04754594|155431905|FG003|Infant Participants|Other|1|||
48338037|NCT06016127|155431906|FG000|Overall Study|Withdrawal by Subject|4|||
48338038|NCT06016127|155431907|FG001|Overall Study|Withdrawal by Subject|3|||
48660297|NCT01208662|156608658|FG000|Maintenance|Disease Progression|156|||
48660298|NCT01208662|156608659|FG001|Maintenance|Disease Progression|102|||
48755394|NCT02288559|156951252|FG002|Overall Study|Death|1|||
48755395|NCT02288559|156951253|FG003|Overall Study|Death|0|||
48338039|NCT02632045|155431912|FG000|Overall Study|Withdrawal by Subject|1|||
48338040|NCT02632045|155431913|FG001|Overall Study|Withdrawal by Subject|2|||
48338041|NCT05564052|155431914|FG000|Overall Study|Withdrawal by Subject|0|||
48338042|NCT05564052|155431915|FG001|Overall Study|Withdrawal by Subject|0|||
48338043|NCT05564052|155431916|FG002|Overall Study|Withdrawal by Subject|0|||
48338044|NCT05564052|155431917|FG003|Overall Study|Withdrawal by Subject|1|||
48338045|NCT05564052|155431914|FG000|Overall Study|Ongoing|8|||
48338046|NCT05564052|155431915|FG001|Overall Study|Ongoing|5|||
48338047|NCT05564052|155431916|FG002|Overall Study|Ongoing|4|||
48338048|NCT05564052|155431917|FG003|Overall Study|Ongoing|1|||
48660299|NCT01208662|156608660|FG002|Maintenance|Disease Progression|0|||
48660300|NCT01208662|156608658|FG000|Maintenance|Adverse Event|12|||
48660301|NCT01208662|156608659|FG001|Maintenance|Adverse Event|28|||
48660302|NCT01208662|156608660|FG002|Maintenance|Adverse Event|0|||
48660303|NCT01208662|156608658|FG000|Maintenance|MD or Participant Decision|24|||
48660304|NCT01208662|156608659|FG001|Maintenance|MD or Participant Decision|36|||
48660305|NCT01208662|156608660|FG002|Maintenance|MD or Participant Decision|0|||
48660306|NCT01208662|156608658|FG000|Maintenance|Death|0|||
48660307|NCT01208662|156608659|FG001|Maintenance|Death|3|||
48660308|NCT01208662|156608660|FG002|Maintenance|Death|0|||
48660309|NCT01208662|156608658|FG000|Maintenance|Discontinued for other reasons|21|||
48660310|NCT01208662|156608659|FG001|Maintenance|Discontinued for other reasons|31|||
48660311|NCT01208662|156608660|FG002|Maintenance|Discontinued for other reasons|0|||
48660312|NCT01208662|156608658|FG000|Maintenance|Still on Treatment|78|||
48660313|NCT01208662|156608659|FG001|Maintenance|Still on Treatment|89|||
48660314|NCT01208662|156608660|FG002|Maintenance|Still on Treatment|0|||
48660315|NCT04795167|156608661|FG000|Overall Study|Death|1|||
48660316|NCT04795167|156608662|FG001|Overall Study|Death|18|||
48660317|NCT04795167|156608663|FG002|Overall Study|Death|1|||
48660318|NCT04795167|156608661|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
48660319|NCT04795167|156608662|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
48660320|NCT04795167|156608663|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
48660321|NCT04039113|156608664|FG000|Overall Study|Withdrawal by Subject|8|||
48660322|NCT04039113|156608665|FG001|Overall Study|Withdrawal by Subject|11|||
48660323|NCT04039113|156608664|FG000|Overall Study|Lost to Follow-up|1|||
48660324|NCT04039113|156608665|FG001|Overall Study|Lost to Follow-up|1|||
48660325|NCT04039113|156608664|FG000|Overall Study|Adverse Event|2|||
48660326|NCT04039113|156608665|FG001|Overall Study|Adverse Event|2|||
48660327|NCT04039113|156608664|FG000|Overall Study|Death|2|||
48660328|NCT04039113|156608665|FG001|Overall Study|Death|4|||
48660329|NCT04039113|156608664|FG000|Overall Study|Site Closure|6|||
48660330|NCT04039113|156608665|FG001|Overall Study|Site Closure|0|||
48660331|NCT04039113|156608664|FG000|Overall Study|Failure to meet randomisation criteria|4|||
48660332|NCT04039113|156608665|FG001|Overall Study|Failure to meet randomisation criteria|0|||
48338049|NCT03340766|155431918|FG000|Overall Study|Withdrawal by Subject|2|||
48338050|NCT03340766|155431919|FG001|Overall Study|Withdrawal by Subject|1|||
48338051|NCT03340766|155431920|FG002|Overall Study|Withdrawal by Subject|3|||
48338052|NCT03340766|155431918|FG000|Overall Study|Lost to Follow-up|0|||
48338053|NCT03340766|155431919|FG001|Overall Study|Lost to Follow-up|0|||
48338054|NCT03340766|155431920|FG002|Overall Study|Lost to Follow-up|1|||
48338055|NCT03340766|155431918|FG000|Overall Study|Death|6|||
48338056|NCT03340766|155431919|FG001|Overall Study|Death|7|||
48338057|NCT03340766|155431920|FG002|Overall Study|Death|4|||
48338058|NCT02268526|155431921|FG000|Overall Study|Adverse Event|0|||
48338059|NCT02268526|155431922|FG001|Overall Study|Adverse Event|2|||
48338060|NCT02268526|155431923|FG002|Overall Study|Adverse Event|1|||
48338061|NCT02268526|155431921|FG000|Overall Study|Death|1|||
48338062|NCT02268526|155431922|FG001|Overall Study|Death|11|||
48338063|NCT02268526|155431923|FG002|Overall Study|Death|0|||
48338064|NCT02268526|155431921|FG000|Overall Study|protocol deviation|0|||
48338065|NCT02268526|155431922|FG001|Overall Study|protocol deviation|1|||
48338066|NCT02268526|155431923|FG002|Overall Study|protocol deviation|0|||
48338067|NCT02268526|155431921|FG000|Overall Study|Physician Decision|0|||
48660333|NCT04826471|156608666|FG000|Overall Study|Lost to Follow-up|2|||
48660334|NCT04826471|156608666|FG000|Overall Study|Protocol Violation|3|||
48660335|NCT04826471|156608666|FG000|Overall Study|Withdrawal by Subject|1|||
48660336|NCT01864018|156608668|FG000|Overall Study|Ineligible|3|||
48660337|NCT01864018|156608669|FG001|Overall Study|Ineligible|1|||
48660338|NCT00645528|156608670|FG000|Overall Study|Did not show up for Visit 2|7|||
48338068|NCT02268526|155431922|FG001|Overall Study|Physician Decision|0|||
48338069|NCT02268526|155431923|FG002|Overall Study|Physician Decision|1|||
48338070|NCT02268526|155431921|FG000|Overall Study|Subject/guardian decision|0|||
48338071|NCT02268526|155431922|FG001|Overall Study|Subject/guardian decision|7|||
48338072|NCT02268526|155431923|FG002|Overall Study|Subject/guardian decision|3|||
48660339|NCT04132518|156608671|FG000|Overall Study|Prematurely withdrawn from the study|0|||
48338073|NCT00596960|155431924|FG000|Overall Study|Death|1|||
48338074|NCT00596960|155431925|FG001|Overall Study|Death|2|||
48660340|NCT04132518|156608672|FG001|Overall Study|Prematurely withdrawn from the study|9|||
48692730|NCT04908683|156724585|FG001|Overall Study|Death|61|||
48338075|NCT00596960|155431924|FG000|Overall Study|Lost to Follow-up|6|||
48692731|NCT04908683|156724584|FG000|Overall Study|Sponsor's decision|14398|||
48692732|NCT04908683|156724585|FG001|Overall Study|Sponsor's decision|7205|||
48338076|NCT00596960|155431925|FG001|Overall Study|Lost to Follow-up|5|||
48660341|NCT04132518|156608673|FG002|Overall Study|Prematurely withdrawn from the study|1|||
48660342|NCT04863248|156608674|FG000|Overall Study|Sponsor Terminated|4|||
48660343|NCT04863248|156608675|FG001|Overall Study|Sponsor Terminated|1|||
48660344|NCT04863248|156608674|FG000|Overall Study|Death|0|||
48660345|NCT04863248|156608675|FG001|Overall Study|Death|1|||
48660346|NCT04863248|156608674|FG000|Overall Study|Withdrawal by Subject|0|||
48660347|NCT04863248|156608675|FG001|Overall Study|Withdrawal by Subject|1|||
48660348|NCT05205161|156608681|FG000|Overall Study|Study terminated by sponsor|3|||
48660349|NCT05205161|156608682|FG001|Overall Study|Study terminated by sponsor|3|||
48660350|NCT05205161|156608683|FG002|Overall Study|Study terminated by sponsor|1|||
48660351|NCT03263923|156608686|FG000|Overall Study|Withdrawal by Subject|10|||
48660352|NCT03263923|156608687|FG001|Overall Study|Withdrawal by Subject|8|||
48660353|NCT03263923|156608686|FG000|Overall Study|Lost to Follow-up|15|||
48660354|NCT03263923|156608687|FG001|Overall Study|Lost to Follow-up|13|||
48660355|NCT03362931|156608689|FG000|Overall Study|Adverse Event|1|||
48660356|NCT03362931|156608689|FG000|Overall Study|Death|2|||
48660357|NCT02927925|156608696|FG000|Overall Study|Death|16|||
48338077|NCT00596960|155431924|FG000|Overall Study|Withdrawal by Subject|1|||
48660358|NCT02927925|156608696|FG000|Overall Study|Physician Decision|1|||
48660359|NCT02927925|156608696|FG000|Overall Study|Withdrawal by Subject|11|||
48660360|NCT02927925|156608696|FG000|Overall Study|Other|3|||
48660361|NCT02927925|156608696|FG000|Overall Study|Disease progression at clinical cutoff|1|||
48338078|NCT00596960|155431925|FG001|Overall Study|Withdrawal by Subject|0|||
48660362|NCT00969761|156608697|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
48660363|NCT00969761|156608698|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660364|NCT00969761|156608699|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660365|NCT00969761|156608700|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
48338079|NCT00596960|155431924|FG000|Overall Study|Incarcerated|2|||
48338080|NCT00596960|155431925|FG001|Overall Study|Incarcerated|0|||
48338081|NCT00596960|155431924|FG000|Overall Study|Physician Decision|1|||
48338082|NCT00596960|155431925|FG001|Overall Study|Physician Decision|0|||
48338083|NCT00596960|155431924|FG000|Overall Study|Protocol Violation|0|||
48338084|NCT00596960|155431925|FG001|Overall Study|Protocol Violation|1|||
48338085|NCT00596960|155431924|FG000|Overall Study|No alcohol use data|0|||
48338086|NCT00596960|155431925|FG001|Overall Study|No alcohol use data|1|||
48338087|NCT01770509|155431932|FG000|Overall Study|Injury|0|||
48338088|NCT01770509|155431933|FG001|Overall Study|Injury|1|||
48660366|NCT00969761|156608701|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660367|NCT00969761|156608702|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660368|NCT00969761|156608703|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660369|NCT00969761|156608704|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660370|NCT00969761|156608705|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
48660371|NCT00969761|156608706|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
48660372|NCT00969761|156608707|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660373|NCT00969761|156608708|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
48660374|NCT00969761|156608697|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660375|NCT00969761|156608698|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660376|NCT00969761|156608699|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
48660377|NCT00969761|156608700|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660378|NCT00969761|156608701|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660379|NCT00969761|156608702|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660380|NCT00969761|156608703|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660381|NCT00969761|156608704|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660382|NCT00969761|156608705|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660383|NCT00969761|156608706|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660384|NCT00969761|156608707|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660385|NCT00969761|156608708|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
48660386|NCT00969761|156608697|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660387|NCT00969761|156608698|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660388|NCT00969761|156608699|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
48660389|NCT00969761|156608700|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660390|NCT00969761|156608701|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660391|NCT00969761|156608702|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660392|NCT00969761|156608703|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660393|NCT00969761|156608704|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660394|NCT00969761|156608705|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660395|NCT00969761|156608706|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660396|NCT00969761|156608707|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660397|NCT00969761|156608708|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
48660398|NCT00969761|156608697|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660399|NCT00969761|156608698|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660400|NCT00969761|156608699|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660401|NCT00969761|156608700|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660402|NCT00969761|156608701|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660403|NCT00969761|156608702|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660404|NCT00969761|156608703|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660405|NCT00969761|156608704|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660406|NCT00969761|156608705|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
48660407|NCT00969761|156608706|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660408|NCT00969761|156608707|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660409|NCT00969761|156608708|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
48660410|NCT00969761|156608697|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
48660411|NCT00969761|156608698|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48660412|NCT00969761|156608699|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
48660413|NCT00969761|156608700|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48660414|NCT00969761|156608701|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
48660415|NCT00969761|156608702|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48692733|NCT04908683|156724584|FG000|Overall Study|Other|92|||
48338089|NCT01770509|155431932|FG000|Overall Study|Lost to Follow-up|1|||
48338090|NCT01770509|155431933|FG001|Overall Study|Lost to Follow-up|2|||
48338091|NCT02066389|155431935|FG000|Overall Study|Adverse Event|1|||
48338092|NCT02066389|155431936|FG001|Overall Study|Adverse Event|1|||
48338093|NCT02066389|155431937|FG002|Overall Study|Adverse Event|1|||
48660416|NCT00969761|156608703|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48338094|NCT02066389|155431938|FG003|Overall Study|Adverse Event|1|||
48338095|NCT02066389|155431939|FG004|Overall Study|Adverse Event|5|||
48338096|NCT02066389|155431940|FG005|Overall Study|Adverse Event|1|||
48338097|NCT02066389|155431935|FG000|Overall Study|Withdrawal by Subject|4|||
48338098|NCT02066389|155431936|FG001|Overall Study|Withdrawal by Subject|0|||
48338099|NCT02066389|155431937|FG002|Overall Study|Withdrawal by Subject|5|||
48338100|NCT02066389|155431938|FG003|Overall Study|Withdrawal by Subject|1|||
48338101|NCT02066389|155431939|FG004|Overall Study|Withdrawal by Subject|1|||
48338102|NCT02066389|155431940|FG005|Overall Study|Withdrawal by Subject|2|||
48338103|NCT02066389|155431935|FG000|Overall Study|Lost to Follow-up|0|||
48660417|NCT00969761|156608704|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
48660418|NCT00969761|156608705|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
48660419|NCT00969761|156608706|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
48660420|NCT00969761|156608707|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48660421|NCT00969761|156608708|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
48660422|NCT00969761|156608697|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660423|NCT00969761|156608698|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660424|NCT00969761|156608699|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660425|NCT00969761|156608700|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
48660426|NCT00969761|156608701|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
48660427|NCT00969761|156608702|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660428|NCT00969761|156608703|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660429|NCT00969761|156608704|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660430|NCT00969761|156608705|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
48660431|NCT00969761|156608706|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660432|NCT00969761|156608707|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660433|NCT00969761|156608708|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
48660434|NCT01643850|156608711|FG000|Overall Study|Withdrawal by Subject|0|||
48660435|NCT01643850|156608712|FG001|Overall Study|Withdrawal by Subject|0|||
48660436|NCT01643850|156608713|FG002|Overall Study|Withdrawal by Subject|0|||
48660437|NCT01643850|156608714|FG003|Overall Study|Withdrawal by Subject|0|||
48660438|NCT01643850|156608715|FG004|Overall Study|Withdrawal by Subject|1|||
48660439|NCT01643850|156608716|FG005|Overall Study|Withdrawal by Subject|0|||
48660440|NCT01643850|156608717|FG006|Overall Study|Withdrawal by Subject|0|||
48660441|NCT01643850|156608718|FG007|Overall Study|Withdrawal by Subject|0|||
48660442|NCT01643850|156608719|FG008|Overall Study|Withdrawal by Subject|0|||
48660443|NCT01643850|156608711|FG000|Overall Study|Lost to Follow-up|0|||
48660444|NCT01643850|156608712|FG001|Overall Study|Lost to Follow-up|0|||
48660445|NCT01643850|156608713|FG002|Overall Study|Lost to Follow-up|0|||
48660446|NCT01643850|156608714|FG003|Overall Study|Lost to Follow-up|0|||
48660447|NCT01643850|156608715|FG004|Overall Study|Lost to Follow-up|0|||
48660448|NCT01643850|156608716|FG005|Overall Study|Lost to Follow-up|0|||
48660449|NCT01643850|156608717|FG006|Overall Study|Lost to Follow-up|1|||
48660450|NCT01643850|156608718|FG007|Overall Study|Lost to Follow-up|0|||
48660451|NCT01643850|156608719|FG008|Overall Study|Lost to Follow-up|1|||
48660452|NCT01643850|156608711|FG000|Overall Study|Adverse Event|0|||
48660453|NCT01643850|156608712|FG001|Overall Study|Adverse Event|0|||
48660454|NCT01643850|156608713|FG002|Overall Study|Adverse Event|0|||
48660455|NCT01643850|156608714|FG003|Overall Study|Adverse Event|0|||
48660456|NCT01643850|156608715|FG004|Overall Study|Adverse Event|1|||
48660457|NCT01643850|156608716|FG005|Overall Study|Adverse Event|0|||
48660458|NCT01643850|156608717|FG006|Overall Study|Adverse Event|0|||
48660459|NCT01643850|156608718|FG007|Overall Study|Adverse Event|0|||
48660460|NCT01643850|156608719|FG008|Overall Study|Adverse Event|0|||
48660461|NCT01643850|156608711|FG000|Overall Study|Administrative Problems|0|||
48338104|NCT02066389|155431936|FG001|Overall Study|Lost to Follow-up|0|||
48338105|NCT02066389|155431937|FG002|Overall Study|Lost to Follow-up|0|||
48338106|NCT02066389|155431938|FG003|Overall Study|Lost to Follow-up|1|||
48338107|NCT02066389|155431939|FG004|Overall Study|Lost to Follow-up|1|||
48338108|NCT02066389|155431940|FG005|Overall Study|Lost to Follow-up|1|||
48338109|NCT02066389|155431935|FG000|Overall Study|Randomized in Error|0|||
48338110|NCT02066389|155431936|FG001|Overall Study|Randomized in Error|0|||
48338111|NCT02066389|155431937|FG002|Overall Study|Randomized in Error|0|||
48338112|NCT02066389|155431938|FG003|Overall Study|Randomized in Error|0|||
48338113|NCT02066389|155431939|FG004|Overall Study|Randomized in Error|0|||
48338114|NCT02066389|155431940|FG005|Overall Study|Randomized in Error|1|||
48338115|NCT00832650|155431941|FG000|Overall Study|Randomized but not treated|0|||
48338116|NCT00832650|155431942|FG001|Overall Study|Randomized but not treated|0|||
48338117|NCT00832650|155431943|FG002|Overall Study|Randomized but not treated|1|||
48338118|NCT02374476|155431944|FG000|VT Induced Ablation|Screening Failures|36|||
48338119|NCT02374476|155431945|FG001|VT Induced Ablation|Screening Failures|0|||
48338120|NCT02374476|155431946|FG002|VT Induced Ablation|Screening Failures|0|||
48338121|NCT02374476|155431944|FG000|Arm Assignment|Withdrawal by Subject|0|||
48338122|NCT02374476|155431945|FG001|Arm Assignment|Withdrawal by Subject|0|||
48338123|NCT02374476|155431946|FG002|Arm Assignment|Withdrawal by Subject|1|||
48338124|NCT05431543|155431947|FG000|Overall Study|Medical History|1|||
48338125|NCT05431543|155431948|FG001|Overall Study|Medical History|0|||
48338126|NCT05431543|155431949|FG002|Overall Study|Medical History|0|||
48338127|NCT03356145|155431950|FG000|Overall Study|Withdrawal by Subject|2|||
48338128|NCT03356145|155431951|FG001|Overall Study|Withdrawal by Subject|1|||
48338129|NCT03356145|155431950|FG000|Overall Study|Did not meet inclusion criteria|1|||
48338130|NCT03356145|155431951|FG001|Overall Study|Did not meet inclusion criteria|0|||
48338131|NCT04242498|155431952|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
48338132|NCT04242498|155431953|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
48338133|NCT04242498|155431954|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
48338134|NCT04242498|155431955|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48338135|NCT04242498|155431956|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48660462|NCT01643850|156608712|FG001|Overall Study|Administrative Problems|0|||
48660463|NCT01643850|156608713|FG002|Overall Study|Administrative Problems|1|||
48660464|NCT01643850|156608714|FG003|Overall Study|Administrative Problems|0|||
48338136|NCT04242498|155431957|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48338137|NCT04242498|155431958|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
48338138|NCT04242498|155431952|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48338139|NCT04242498|155431953|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48338140|NCT04242498|155431954|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
48338141|NCT04242498|155431955|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48338142|NCT04242498|155431956|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48338143|NCT04242498|155431957|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48338144|NCT04242498|155431958|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
48338145|NCT04242498|155431952|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
48338146|NCT04242498|155431953|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48338147|NCT04242498|155431954|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
48660465|NCT01643850|156608715|FG004|Overall Study|Administrative Problems|1|||
48660466|NCT01643850|156608716|FG005|Overall Study|Administrative Problems|0|||
48660467|NCT01643850|156608717|FG006|Overall Study|Administrative Problems|0|||
48660468|NCT01643850|156608718|FG007|Overall Study|Administrative Problems|0|||
48660469|NCT01643850|156608719|FG008|Overall Study|Administrative Problems|0|||
48660470|NCT00772369|156608722|FG000|Overall Study|Did not return record release form|1|||
48338148|NCT04242498|155431955|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48660471|NCT02446418|156608723|FG000|Overall Study|Adverse Event|4|||
48660472|NCT02446418|156608724|FG001|Overall Study|Adverse Event|8|||
48660473|NCT02446418|156608723|FG000|Overall Study|Physician Decision|5|||
48660474|NCT02446418|156608724|FG001|Overall Study|Physician Decision|1|||
48660475|NCT02446418|156608723|FG000|Overall Study|Withdrawal by Subject|3|||
48660476|NCT02446418|156608724|FG001|Overall Study|Withdrawal by Subject|3|||
48660477|NCT02446418|156608723|FG000|Overall Study|Lost to Follow-up|2|||
48338149|NCT04242498|155431956|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48338150|NCT04242498|155431957|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48338151|NCT04242498|155431958|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
48660478|NCT02446418|156608724|FG001|Overall Study|Lost to Follow-up|2|||
48660479|NCT02446418|156608723|FG000|Overall Study|Protocol Violation|1|||
48660480|NCT02446418|156608724|FG001|Overall Study|Protocol Violation|2|||
48660481|NCT02446418|156608723|FG000|Overall Study|Lack of Efficacy|2|||
48660482|NCT02446418|156608724|FG001|Overall Study|Lack of Efficacy|0|||
48660483|NCT02446418|156608723|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
48660484|NCT02446418|156608724|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
48660485|NCT02210221|156608730|FG000|Overall Study|Lack of Efficacy|7|||
48660486|NCT02210221|156608730|FG000|Overall Study|Withdrawal by Subject|43|||
48660487|NCT01866423|156608731|FG000|Overall Study|Lack of Efficacy|3|||
48660488|NCT01866423|156608731|FG000|Overall Study|Sponsor Decision|1|||
48660489|NCT01174004|156608738|FG000|Overall Study|Adverse Event|2|||
48660490|NCT01174004|156608739|FG001|Overall Study|Adverse Event|10|||
48660491|NCT01174004|156608738|FG000|Overall Study|Withdrawal by Subject|2|||
48660492|NCT01174004|156608739|FG001|Overall Study|Withdrawal by Subject|3|||
48660493|NCT01174004|156608738|FG000|Overall Study|At Discretion of Sponsor|2|||
48660494|NCT01174004|156608739|FG001|Overall Study|At Discretion of Sponsor|2|||
48660495|NCT01174004|156608738|FG000|Overall Study|Protocol Violation|0|||
48660496|NCT01174004|156608739|FG001|Overall Study|Protocol Violation|1|||
48660497|NCT01174004|156608738|FG000|Overall Study|Physician Decision|1|||
48660498|NCT01174004|156608739|FG001|Overall Study|Physician Decision|0|||
48660499|NCT03481660|156609479|FG000|Overall Study|Adverse Event|5|||
48660500|NCT03481660|156609480|FG001|Overall Study|Adverse Event|4|||
48660501|NCT03481660|156609479|FG000|Overall Study|Death|13|||
48660502|NCT03481660|156609480|FG001|Overall Study|Death|9|||
48660503|NCT03481660|156609479|FG000|Overall Study|Lost to Follow-up|2|||
48660504|NCT03481660|156609480|FG001|Overall Study|Lost to Follow-up|2|||
48660505|NCT03481660|156609479|FG000|Overall Study|Physician Decision|2|||
48660506|NCT03481660|156609480|FG001|Overall Study|Physician Decision|3|||
48660507|NCT03481660|156609479|FG000|Overall Study|Withdrawal by Subject|14|||
48660508|NCT03481660|156609480|FG001|Overall Study|Withdrawal by Subject|7|||
48660509|NCT04755660|156609487|FG000|Overall Study|Lost to Follow-up|1|||
48660510|NCT04755660|156609488|FG001|Overall Study|Lost to Follow-up|1|||
48660511|NCT04755660|156609489|FG002|Overall Study|Lost to Follow-up|0|||
48660512|NCT04755660|156609487|FG000|Overall Study|Withdrawal by Subject|0|||
48660513|NCT04755660|156609488|FG001|Overall Study|Withdrawal by Subject|1|||
48660514|NCT04755660|156609489|FG002|Overall Study|Withdrawal by Subject|1|||
48660515|NCT04755660|156609487|FG000|Overall Study|Physician Decision|0|||
48660516|NCT04755660|156609488|FG001|Overall Study|Physician Decision|0|||
48660517|NCT04755660|156609489|FG002|Overall Study|Physician Decision|1|||
48660518|NCT03245736|156609505|FG000|Overall Study|Adverse Event|1|||
48660519|NCT03245736|156609505|FG000|Overall Study|Progressive Disease|4|||
48660520|NCT05438602|156609506|FG000|Treatment (15 Days)|Adverse Event|2|||
48660521|NCT05438602|156609507|FG001|Treatment (15 Days)|Adverse Event|1|||
48660522|NCT05438602|156609508|FG002|Treatment (15 Days)|Adverse Event|3|||
48660523|NCT05438602|156609506|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
48660524|NCT05438602|156609507|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
48660525|NCT05438602|156609508|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
48660526|NCT05438602|156609506|FG000|Treatment (15 Days)|Other|0|||
48660527|NCT05438602|156609507|FG001|Treatment (15 Days)|Other|0|||
48660528|NCT05438602|156609508|FG002|Treatment (15 Days)|Other|1|||
48660529|NCT05438602|156609506|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
48660530|NCT05438602|156609507|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
48660531|NCT05438602|156609508|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
48660532|NCT05438602|156609506|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
48660533|NCT05438602|156609507|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
48338152|NCT04242498|155431952|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
48338153|NCT04242498|155431953|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48338154|NCT04242498|155431954|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
48338155|NCT04242498|155431955|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48338156|NCT04242498|155431956|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48338157|NCT04242498|155431957|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48338158|NCT04242498|155431958|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
48338159|NCT04242498|155431952|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
48338160|NCT04242498|155431953|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
48338161|NCT04242498|155431954|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
48338162|NCT04242498|155431955|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48338163|NCT04242498|155431956|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48338164|NCT04242498|155431957|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48338165|NCT04242498|155431958|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
48660534|NCT05438602|156609508|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
48660535|NCT05438602|156609506|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
48660536|NCT05438602|156609507|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
48660537|NCT05438602|156609508|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
48660538|NCT05438602|156609506|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
48660539|NCT05438602|156609507|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
48660540|NCT05438602|156609508|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
48660541|NCT05438602|156609506|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
48660542|NCT05438602|156609507|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
48660543|NCT05438602|156609508|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
48660544|NCT05438602|156609506|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
48660545|NCT05438602|156609507|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
48660546|NCT05438602|156609508|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
48660547|NCT05438602|156609506|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
48338166|NCT04242498|155431952|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48338167|NCT04242498|155431953|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48338168|NCT04242498|155431954|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
48660548|NCT05438602|156609507|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
48660549|NCT05438602|156609508|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
48660550|NCT05275010|156609509|FG000|Overall Study|Reason Not Specified|4|||
48660551|NCT05275010|156609510|FG001|Overall Study|Reason Not Specified|1|||
48660552|NCT05275010|156609509|FG000|Overall Study|Withdrawal by Subject|1|||
48338169|NCT04242498|155431955|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48660553|NCT05275010|156609510|FG001|Overall Study|Withdrawal by Subject|0|||
48660554|NCT05275010|156609509|FG000|Overall Study|Lost to Follow-up|0|||
48660555|NCT05275010|156609510|FG001|Overall Study|Lost to Follow-up|1|||
48660556|NCT04059406|156609518|FG000|Overall Study|Early Treatment Termination|5|||
48660557|NCT04059406|156609519|FG001|Overall Study|Early Treatment Termination|5|||
48660558|NCT04059406|156609520|FG002|Overall Study|Early Treatment Termination|15|||
48660559|NCT04727554|156609523|FG000|Overall Study|Lost to Follow-up|0|||
48660560|NCT04727554|156609524|FG001|Overall Study|Lost to Follow-up|1|||
48660561|NCT04727554|156609523|FG000|Overall Study|Death|2|||
48660562|NCT04727554|156609524|FG001|Overall Study|Death|6|||
48660563|NCT04727554|156609523|FG000|Overall Study|Withdrawal by Subject|1|||
48660564|NCT04727554|156609524|FG001|Overall Study|Withdrawal by Subject|0|||
48660565|NCT03272828|156609527|FG000|Overall Study|Lost to Follow-up|7|||
48755396|NCT02288559|156951250|FG000|Overall Study|Lost to Follow-up|0|||
48755397|NCT02288559|156951251|FG001|Overall Study|Lost to Follow-up|0|||
48755398|NCT02288559|156951252|FG002|Overall Study|Lost to Follow-up|0|||
48660566|NCT03272828|156609528|FG001|Overall Study|Lost to Follow-up|7|||
48660567|NCT03272828|156609527|FG000|Overall Study|Withdrawal by Subject|2|||
48660568|NCT03272828|156609528|FG001|Overall Study|Withdrawal by Subject|0|||
48660569|NCT03272828|156609527|FG000|Overall Study|Deceased|1|||
48755399|NCT02288559|156951253|FG003|Overall Study|Lost to Follow-up|1|||
48660570|NCT03272828|156609528|FG001|Overall Study|Deceased|1|||
48660571|NCT03272828|156609527|FG000|Overall Study|Failed implant|1|||
48660572|NCT03272828|156609528|FG001|Overall Study|Failed implant|2|||
48660573|NCT03822468|156609532|FG000|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|110|||
48660574|NCT03822468|156609533|FG001|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|107|||
48660575|NCT03822468|156609532|FG000|Treatment Period|Progressive disease|50|||
48660576|NCT03822468|156609533|FG001|Treatment Period|Progressive disease|51|||
48755400|NCT02288559|156951250|FG000|Overall Study|Withdrawal by Subject|0|||
48755401|NCT02288559|156951251|FG001|Overall Study|Withdrawal by Subject|0|||
48660577|NCT03822468|156609532|FG000|Treatment Period|Adverse Event|16|||
48660578|NCT03822468|156609533|FG001|Treatment Period|Adverse Event|18|||
48660579|NCT03822468|156609532|FG000|Treatment Period|Patient decision|4|||
48660580|NCT03822468|156609533|FG001|Treatment Period|Patient decision|5|||
48660581|NCT03822468|156609532|FG000|Treatment Period|Physician Decision|4|||
48660582|NCT03822468|156609533|FG001|Treatment Period|Physician Decision|5|||
48660583|NCT03822468|156609532|FG000|Treatment Period|Protocol deviation|2|||
48660584|NCT03822468|156609533|FG001|Treatment Period|Protocol deviation|1|||
48660585|NCT03822468|156609532|FG000|Treatment Period|Death|1|||
48660586|NCT03822468|156609533|FG001|Treatment Period|Death|1|||
48660587|NCT03822468|156609532|FG000|Treatment Period|Lost to Follow-up|1|||
48660588|NCT03822468|156609533|FG001|Treatment Period|Lost to Follow-up|0|||
48660589|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|12|||
48660590|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|13|||
48660591|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Progressive disease|3|||
48660592|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
48660593|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Patient decision|3|||
48660594|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Patient decision|1|||
48660595|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Death|1|||
48660596|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Death|0|||
48660597|NCT03822468|156609532|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
48338170|NCT04242498|155431956|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48338171|NCT04242498|155431957|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48338172|NCT04242498|155431958|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
48660598|NCT03822468|156609533|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
48660599|NCT03580356|156609534|FG000|Treatment Period|Withdrawal by Subject|13|||
48660600|NCT03580356|156609535|FG001|Treatment Period|Withdrawal by Subject|0|||
48660601|NCT03580356|156609536|FG002|Treatment Period|Withdrawal by Subject|13|||
48660602|NCT03580356|156609537|FG003|Treatment Period|Withdrawal by Subject|1|||
48660603|NCT03580356|156609538|FG004|Treatment Period|Withdrawal by Subject|17|||
48660604|NCT03580356|156609539|FG005|Treatment Period|Withdrawal by Subject|0|||
48660605|NCT03580356|156609540|FG006|Treatment Period|Withdrawal by Subject|5|||
48660606|NCT03580356|156609541|FG007|Treatment Period|Withdrawal by Subject|0|||
48660607|NCT03580356|156609534|FG000|Treatment Period|Adverse Event|10|||
48660608|NCT03580356|156609535|FG001|Treatment Period|Adverse Event|0|||
48660609|NCT03580356|156609536|FG002|Treatment Period|Adverse Event|13|||
48660610|NCT03580356|156609537|FG003|Treatment Period|Adverse Event|0|||
48660611|NCT03580356|156609538|FG004|Treatment Period|Adverse Event|5|||
48660612|NCT03580356|156609539|FG005|Treatment Period|Adverse Event|0|||
48660613|NCT03580356|156609540|FG006|Treatment Period|Adverse Event|8|||
48338173|NCT04242498|155431952|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48338174|NCT04242498|155431953|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48338175|NCT04242498|155431954|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
48338176|NCT04242498|155431955|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48338177|NCT04242498|155431956|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48338178|NCT04242498|155431957|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48338179|NCT04242498|155431958|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
48338180|NCT04242498|155431952|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48338181|NCT04242498|155431953|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
48338182|NCT04242498|155431954|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
48660614|NCT03580356|156609541|FG007|Treatment Period|Adverse Event|0|||
48660615|NCT03580356|156609534|FG000|Treatment Period|Protocol Violation|5|||
48660616|NCT03580356|156609535|FG001|Treatment Period|Protocol Violation|0|||
48660617|NCT03580356|156609536|FG002|Treatment Period|Protocol Violation|6|||
48660618|NCT03580356|156609537|FG003|Treatment Period|Protocol Violation|1|||
48660619|NCT03580356|156609538|FG004|Treatment Period|Protocol Violation|9|||
48338183|NCT04242498|155431955|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48660620|NCT03580356|156609539|FG005|Treatment Period|Protocol Violation|1|||
48660621|NCT03580356|156609540|FG006|Treatment Period|Protocol Violation|1|||
48660622|NCT03580356|156609541|FG007|Treatment Period|Protocol Violation|0|||
48660623|NCT03580356|156609534|FG000|Treatment Period|Lack of Efficacy|6|||
48660624|NCT03580356|156609535|FG001|Treatment Period|Lack of Efficacy|0|||
48660625|NCT03580356|156609536|FG002|Treatment Period|Lack of Efficacy|2|||
48660626|NCT03580356|156609537|FG003|Treatment Period|Lack of Efficacy|0|||
48660627|NCT03580356|156609538|FG004|Treatment Period|Lack of Efficacy|3|||
48660628|NCT03580356|156609539|FG005|Treatment Period|Lack of Efficacy|0|||
48660629|NCT03580356|156609540|FG006|Treatment Period|Lack of Efficacy|3|||
48660630|NCT03580356|156609541|FG007|Treatment Period|Lack of Efficacy|0|||
48660631|NCT03580356|156609534|FG000|Treatment Period|Pregnancy|1|||
48660632|NCT03580356|156609535|FG001|Treatment Period|Pregnancy|0|||
48660633|NCT03580356|156609536|FG002|Treatment Period|Pregnancy|7|||
48660634|NCT03580356|156609537|FG003|Treatment Period|Pregnancy|0|||
48660635|NCT03580356|156609538|FG004|Treatment Period|Pregnancy|2|||
48660636|NCT03580356|156609539|FG005|Treatment Period|Pregnancy|0|||
48660637|NCT03580356|156609540|FG006|Treatment Period|Pregnancy|1|||
48660638|NCT03580356|156609541|FG007|Treatment Period|Pregnancy|0|||
48660639|NCT03580356|156609534|FG000|Treatment Period|Physician Decision|2|||
48660640|NCT03580356|156609535|FG001|Treatment Period|Physician Decision|0|||
48660641|NCT03580356|156609536|FG002|Treatment Period|Physician Decision|1|||
48660642|NCT03580356|156609537|FG003|Treatment Period|Physician Decision|0|||
48660643|NCT03580356|156609538|FG004|Treatment Period|Physician Decision|4|||
48660644|NCT03580356|156609539|FG005|Treatment Period|Physician Decision|0|||
48660645|NCT03580356|156609540|FG006|Treatment Period|Physician Decision|2|||
48660646|NCT03580356|156609541|FG007|Treatment Period|Physician Decision|0|||
48660647|NCT03580356|156609534|FG000|Treatment Period|Lost to Follow-up|1|||
48660648|NCT03580356|156609535|FG001|Treatment Period|Lost to Follow-up|1|||
48660649|NCT03580356|156609536|FG002|Treatment Period|Lost to Follow-up|1|||
48660650|NCT03580356|156609537|FG003|Treatment Period|Lost to Follow-up|0|||
48660651|NCT03580356|156609538|FG004|Treatment Period|Lost to Follow-up|3|||
48660652|NCT03580356|156609539|FG005|Treatment Period|Lost to Follow-up|0|||
48660653|NCT03580356|156609540|FG006|Treatment Period|Lost to Follow-up|1|||
48660654|NCT03580356|156609541|FG007|Treatment Period|Lost to Follow-up|0|||
48660655|NCT03580356|156609534|FG000|Treatment Period|Death|0|||
48660656|NCT03580356|156609535|FG001|Treatment Period|Death|0|||
48660657|NCT03580356|156609536|FG002|Treatment Period|Death|1|||
48660658|NCT03580356|156609537|FG003|Treatment Period|Death|0|||
48660659|NCT03580356|156609538|FG004|Treatment Period|Death|0|||
48660660|NCT03580356|156609539|FG005|Treatment Period|Death|0|||
48660661|NCT03580356|156609540|FG006|Treatment Period|Death|0|||
48660662|NCT03580356|156609541|FG007|Treatment Period|Death|0|||
48660663|NCT03580356|156609534|FG000|Treatment Period|Technical problems|0|||
48755402|NCT02288559|156951252|FG002|Overall Study|Withdrawal by Subject|2|||
48660664|NCT03580356|156609535|FG001|Treatment Period|Technical problems|0|||
48660665|NCT03580356|156609536|FG002|Treatment Period|Technical problems|0|||
48660666|NCT03580356|156609537|FG003|Treatment Period|Technical problems|0|||
48660667|NCT03580356|156609538|FG004|Treatment Period|Technical problems|1|||
48660668|NCT03580356|156609539|FG005|Treatment Period|Technical problems|0|||
48755403|NCT02288559|156951253|FG003|Overall Study|Withdrawal by Subject|1|||
48755404|NCT02288559|156951250|FG000|Overall Study|Reason Not Specified|0|||
48755405|NCT02288559|156951251|FG001|Overall Study|Reason Not Specified|0|||
48755406|NCT02288559|156951252|FG002|Overall Study|Reason Not Specified|3|||
48755407|NCT02288559|156951253|FG003|Overall Study|Reason Not Specified|0|||
48755408|NCT01782859|156951255|FG000|Overall Study|Protocol Violation|6|||
48755409|NCT01782859|156951256|FG001|Overall Study|Protocol Violation|6|||
48755410|NCT01782859|156951255|FG000|Overall Study|Withdrawal by Subject|0|||
48755411|NCT01782859|156951256|FG001|Overall Study|Withdrawal by Subject|1|||
48755412|NCT01907815|156951259|FG000|Overall Study|Withdrawal by Subject|1|||
48755413|NCT01907815|156951260|FG001|Overall Study|Withdrawal by Subject|0|||
48755414|NCT00143403|156951263|FG000|Overall Study|Adverse Event|3|||
48755415|NCT00143403|156951264|FG001|Overall Study|Adverse Event|8|||
48660669|NCT03580356|156609540|FG006|Treatment Period|Technical problems|0|||
48660670|NCT03580356|156609541|FG007|Treatment Period|Technical problems|0|||
48660671|NCT03580356|156609534|FG000|Treatment Period|Misrandomized, no treatment|0|||
48755416|NCT00143403|156951263|FG000|Overall Study|Death|1|||
48660672|NCT03580356|156609535|FG001|Treatment Period|Misrandomized, no treatment|0|||
48660673|NCT03580356|156609536|FG002|Treatment Period|Misrandomized, no treatment|1|||
48660674|NCT03580356|156609537|FG003|Treatment Period|Misrandomized, no treatment|0|||
48755417|NCT00143403|156951264|FG001|Overall Study|Death|0|||
48755418|NCT00143403|156951263|FG000|Overall Study|Withdrawal by Subject|3|||
48338184|NCT04242498|155431956|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48338185|NCT04242498|155431957|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48338186|NCT04242498|155431958|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
48338187|NCT04242498|155431952|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48338188|NCT04242498|155431953|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48338189|NCT04242498|155431954|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48338190|NCT04242498|155431955|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
48338191|NCT04242498|155431956|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
48338192|NCT04242498|155431957|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
48338193|NCT04242498|155431958|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
48338194|NCT04242498|155431952|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48338195|NCT04242498|155431953|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48338196|NCT04242498|155431954|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48338197|NCT04242498|155431955|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
48338198|NCT04242498|155431956|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
48338199|NCT04242498|155431957|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
48338200|NCT04242498|155431958|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
48338201|NCT04242498|155431952|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48338202|NCT04242498|155431953|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48338203|NCT04242498|155431954|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48660675|NCT03580356|156609538|FG004|Treatment Period|Misrandomized, no treatment|2|||
48660676|NCT03580356|156609539|FG005|Treatment Period|Misrandomized, no treatment|0|||
48660677|NCT03580356|156609540|FG006|Treatment Period|Misrandomized, no treatment|0|||
48660678|NCT03580356|156609541|FG007|Treatment Period|Misrandomized, no treatment|0|||
48660679|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
48660680|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
48660681|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
48660682|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
48660683|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
48660684|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
48660685|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
48660686|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
48660687|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
48660688|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48660689|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
48660690|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48660691|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
48660692|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48660693|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48755419|NCT00143403|156951264|FG001|Overall Study|Withdrawal by Subject|12|||
48755420|NCT00143403|156951263|FG000|Overall Study|Relapse|15|||
48755421|NCT00143403|156951264|FG001|Overall Study|Relapse|7|||
48755422|NCT00143403|156951263|FG000|Overall Study|Protocol Violation|2|||
48755423|NCT00143403|156951264|FG001|Overall Study|Protocol Violation|2|||
48755424|NCT00143403|156951263|FG000|Overall Study|specified by site|4|||
48755425|NCT00143403|156951264|FG001|Overall Study|specified by site|9|||
48755426|NCT00143403|156951263|FG000|Overall Study|Randomized Not Treated|7|||
48755427|NCT00143403|156951264|FG001|Overall Study|Randomized Not Treated|8|||
48755428|NCT00005937|156951265|FG000|Overall Study|Lack of Efficacy|5|||
48755429|NCT00742001|156951266|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
48755430|NCT00742001|156951267|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
48338204|NCT04242498|155431955|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48338205|NCT04242498|155431956|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
48338206|NCT04242498|155431957|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
48338207|NCT04242498|155431958|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
48338208|NCT04242498|155431952|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48338209|NCT04242498|155431953|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48338210|NCT04242498|155431954|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
48338211|NCT04242498|155431955|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
48338212|NCT04242498|155431956|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
48338213|NCT04242498|155431957|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
48338214|NCT04242498|155431958|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
48338215|NCT04242498|155431952|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48660694|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
48660695|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
48755431|NCT00742001|156951268|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
48338216|NCT04242498|155431953|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48338217|NCT04242498|155431954|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
48338218|NCT04242498|155431955|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
48338219|NCT04242498|155431956|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
48338220|NCT04242498|155431957|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
48338221|NCT04242498|155431958|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
48338222|NCT04242498|155431952|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48338223|NCT04242498|155431953|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48338224|NCT04242498|155431954|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48338225|NCT04242498|155431955|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48338226|NCT04242498|155431956|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
48338227|NCT04242498|155431957|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48338228|NCT04242498|155431958|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
48338229|NCT04242498|155431952|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48338230|NCT04242498|155431953|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48338231|NCT04242498|155431954|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48660696|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
48660697|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
48660698|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
48660699|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
48338232|NCT04242498|155431955|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48338233|NCT04242498|155431956|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48338234|NCT04242498|155431957|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
48338235|NCT04242498|155431958|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
48338236|NCT04242498|155431952|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48338237|NCT04242498|155431953|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48338238|NCT04242498|155431954|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48338239|NCT04242498|155431955|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48338240|NCT04242498|155431956|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
48338241|NCT04242498|155431957|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
48338242|NCT04242498|155431958|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
48338253|NCT03849300|155431961|FG000|Overall Study|move out to different area|1|||
48338254|NCT03849300|155431962|FG001|Overall Study|move out to different area|3|||
48660700|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
48660701|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
48660702|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
48660703|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660704|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660705|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
48660706|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660707|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
48660708|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660709|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48660710|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
48692734|NCT04908683|156724585|FG001|Overall Study|Other|50|||
48692735|NCT04908683|156724584|FG000|Overall Study|Randomized not vaccinated|108|||
48692736|NCT04908683|156724585|FG001|Overall Study|Randomized not vaccinated|52|||
48692737|NCT02542865|156724586|FG000|Overall Study|Identified as screen failure|1|||
48692738|NCT02542865|156724587|FG001|Overall Study|Identified as screen failure|0|||
48692739|NCT02542865|156724586|FG000|Overall Study|Withdrawal by Subject|16|||
48692740|NCT02542865|156724587|FG001|Overall Study|Withdrawal by Subject|0|||
48692741|NCT01339689|156724588|FG000|Overall Study|Adverse Event|1|||
48692742|NCT01339689|156724589|FG001|Overall Study|Adverse Event|2|||
48660711|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
48660712|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
48660713|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
48660714|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
48660715|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
48660716|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
48660717|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
48660718|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
48660719|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
48660720|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
48660721|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
48660722|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
48660723|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
48660724|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
48660725|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
48660726|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
48660727|NCT03580356|156609534|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
48660728|NCT03580356|156609535|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
48660729|NCT03580356|156609536|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
48660730|NCT03580356|156609537|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
48660731|NCT03580356|156609538|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
48660732|NCT03580356|156609539|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
48660733|NCT03580356|156609540|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
48660734|NCT03580356|156609541|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
48660735|NCT01080768|156609542|FG000|Overall Study|Protocol Deviation|2|||
48660736|NCT01080768|156609543|FG001|Overall Study|Protocol Deviation|1|||
48660737|NCT04181788|156609544|FG000|TREATMENT|Adverse Event|0|||
48660738|NCT04181788|156609545|FG001|TREATMENT|Adverse Event|2|||
48660739|NCT04181788|156609546|FG002|TREATMENT|Adverse Event|1|||
48660740|NCT04181788|156609547|FG003|TREATMENT|Adverse Event|0|||
48660741|NCT04181788|156609548|FG004|TREATMENT|Adverse Event|1|||
48660742|NCT04181788|156609549|FG005|TREATMENT|Adverse Event|3|||
48660743|NCT04181788|156609544|FG000|TREATMENT|Death|0|||
48660744|NCT04181788|156609545|FG001|TREATMENT|Death|0|||
48660745|NCT04181788|156609546|FG002|TREATMENT|Death|0|||
48660746|NCT04181788|156609547|FG003|TREATMENT|Death|0|||
48660747|NCT04181788|156609548|FG004|TREATMENT|Death|8|||
48660748|NCT04181788|156609549|FG005|TREATMENT|Death|8|||
48660749|NCT04181788|156609544|FG000|TREATMENT|Physician Decision|0|||
48660750|NCT04181788|156609545|FG001|TREATMENT|Physician Decision|0|||
48660751|NCT04181788|156609546|FG002|TREATMENT|Physician Decision|0|||
48660752|NCT04181788|156609547|FG003|TREATMENT|Physician Decision|0|||
48660753|NCT04181788|156609548|FG004|TREATMENT|Physician Decision|0|||
48660754|NCT04181788|156609549|FG005|TREATMENT|Physician Decision|1|||
48660755|NCT04181788|156609544|FG000|TREATMENT|Progressive disease|3|||
48660756|NCT04181788|156609545|FG001|TREATMENT|Progressive disease|3|||
48660757|NCT04181788|156609546|FG002|TREATMENT|Progressive disease|5|||
48660758|NCT04181788|156609547|FG003|TREATMENT|Progressive disease|7|||
48660759|NCT04181788|156609548|FG004|TREATMENT|Progressive disease|20|||
48660760|NCT04181788|156609549|FG005|TREATMENT|Progressive disease|38|||
48660761|NCT04181788|156609544|FG000|TREATMENT|Global deterioration of health status|0|||
48660762|NCT04181788|156609545|FG001|TREATMENT|Global deterioration of health status|2|||
48660763|NCT04181788|156609546|FG002|TREATMENT|Global deterioration of health status|0|||
48660764|NCT04181788|156609547|FG003|TREATMENT|Global deterioration of health status|0|||
48660765|NCT04181788|156609548|FG004|TREATMENT|Global deterioration of health status|2|||
48660766|NCT04181788|156609549|FG005|TREATMENT|Global deterioration of health status|8|||
48660767|NCT04181788|156609544|FG000|TREATMENT|Withdrawal by Subject|1|||
48660768|NCT04181788|156609545|FG001|TREATMENT|Withdrawal by Subject|2|||
48660769|NCT04181788|156609546|FG002|TREATMENT|Withdrawal by Subject|0|||
48338255|NCT03849300|155431963|FG002|Overall Study|move out to different area|1|||
48338256|NCT03849300|155431964|FG003|Overall Study|move out to different area|4|||
48660770|NCT04181788|156609547|FG003|TREATMENT|Withdrawal by Subject|0|||
48660771|NCT04181788|156609548|FG004|TREATMENT|Withdrawal by Subject|3|||
48660772|NCT04181788|156609549|FG005|TREATMENT|Withdrawal by Subject|5|||
48660773|NCT04181788|156609544|FG000|TREATMENT|Other unspecified|0|||
48660774|NCT04181788|156609545|FG001|TREATMENT|Other unspecified|0|||
48660775|NCT04181788|156609546|FG002|TREATMENT|Other unspecified|0|||
48660776|NCT04181788|156609547|FG003|TREATMENT|Other unspecified|0|||
48660777|NCT04181788|156609548|FG004|TREATMENT|Other unspecified|0|||
48660778|NCT04181788|156609549|FG005|TREATMENT|Other unspecified|2|||
48660779|NCT04181788|156609544|FG000|TREATMENT|Ongoing|0|||
48660780|NCT04181788|156609545|FG001|TREATMENT|Ongoing|3|||
48660781|NCT04181788|156609546|FG002|TREATMENT|Ongoing|0|||
48660782|NCT04181788|156609547|FG003|TREATMENT|Ongoing|5|||
48660783|NCT04181788|156609548|FG004|TREATMENT|Ongoing|7|||
48660784|NCT04181788|156609549|FG005|TREATMENT|Ongoing|15|||
48660785|NCT04181788|156609544|FG000|FOLLOW-UP|Death|0|||
48660786|NCT04181788|156609545|FG001|FOLLOW-UP|Death|0|||
48338257|NCT03849300|155431961|FG000|Overall Study|scheduling/transportation conflict|4|||
48338258|NCT03849300|155431962|FG001|Overall Study|scheduling/transportation conflict|4|||
48338259|NCT03849300|155431963|FG002|Overall Study|scheduling/transportation conflict|3|||
48338260|NCT03849300|155431964|FG003|Overall Study|scheduling/transportation conflict|2|||
48338261|NCT02962076|155431965|FG000|Overall Study|MHED tracer not available|5|||
48338262|NCT02962076|155431965|FG000|Overall Study|Protocol Violation|1|||
48338263|NCT02962076|155431965|FG000|Overall Study|Physician Decision|1|||
48338264|NCT01786551|155431969|FG000|Overall Study|Participant withdrew consent|2|||
48338265|NCT00547300|155431970|FG000|Overall Study|Study was Administratively Terminated|25|||
48338266|NCT00547300|155431971|FG001|Overall Study|Study was Administratively Terminated|24|||
48338267|NCT00547300|155431970|FG000|Overall Study|Did not Meet Entry Criteria|0|||
48338268|NCT00547300|155431971|FG001|Overall Study|Did not Meet Entry Criteria|2|||
48338269|NCT00755716|155433383|FG000|Overall Study|Adverse Event|1|||
48338270|NCT00755716|155433384|FG001|Overall Study|Adverse Event|4|||
48338271|NCT00755716|155433385|FG002|Overall Study|Adverse Event|1|||
48338272|NCT00755716|155433383|FG000|Overall Study|Lack of Efficacy|2|||
48338273|NCT00755716|155433384|FG001|Overall Study|Lack of Efficacy|0|||
48338274|NCT00755716|155433385|FG002|Overall Study|Lack of Efficacy|0|||
48338275|NCT00755716|155433383|FG000|Overall Study|Lost to Follow-up|5|||
48338276|NCT00755716|155433384|FG001|Overall Study|Lost to Follow-up|3|||
48338277|NCT00755716|155433385|FG002|Overall Study|Lost to Follow-up|1|||
48338278|NCT00755716|155433383|FG000|Overall Study|work schedule issues|0|||
48660787|NCT04181788|156609546|FG002|FOLLOW-UP|Death|1|||
48660788|NCT04181788|156609547|FG003|FOLLOW-UP|Death|2|||
48338279|NCT00755716|155433384|FG001|Overall Study|work schedule issues|1|||
48338280|NCT00755716|155433385|FG002|Overall Study|work schedule issues|1|||
48338281|NCT03786783|155433388|FG000|Overall Study|Death|1|||
48338282|NCT03786783|155433388|FG000|Overall Study|Physician Decision|6|||
48338283|NCT03786783|155433388|FG000|Overall Study|Withdrawal by Subject|2|||
48338284|NCT03786783|155433388|FG000|Overall Study|Disease Progression|7|||
48338285|NCT03786783|155433388|FG000|Overall Study|Patient/Parent Refusal|4|||
48338286|NCT03332589|155433389|FG000|Overall Study|Lack of Efficacy|2|||
48338287|NCT03332589|155433390|FG001|Overall Study|Lack of Efficacy|0|||
48338288|NCT03332589|155433391|FG002|Overall Study|Lack of Efficacy|0|||
48338289|NCT03332589|155433389|FG000|Overall Study|Adverse Event|1|||
48338290|NCT03332589|155433390|FG001|Overall Study|Adverse Event|0|||
48338291|NCT03332589|155433391|FG002|Overall Study|Adverse Event|0|||
48338292|NCT03332589|155433389|FG000|Overall Study|Death|1|||
48338293|NCT03332589|155433390|FG001|Overall Study|Death|0|||
48338294|NCT03332589|155433391|FG002|Overall Study|Death|0|||
48338295|NCT00108355|155433392|FG000|Overall Study|Peritonitis at index paracentesis|1|||
48338296|NCT00108355|155433393|FG001|Overall Study|Peritonitis at index paracentesis|1|||
48338297|NCT00108355|155433392|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
48338298|NCT00108355|155433393|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
48338299|NCT02164578|155433394|FG000|Treatment Period|Withdrawal by Subject|3|||
48338300|NCT02164578|155433395|FG001|Treatment Period|Withdrawal by Subject|3|||
48338301|NCT02164578|155433394|FG000|Treatment Period|Adverse Event|13|||
48338302|NCT02164578|155433395|FG001|Treatment Period|Adverse Event|6|||
48338303|NCT02164578|155433394|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
48338304|NCT02164578|155433395|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
48338305|NCT02164578|155433394|FG000|Treatment Period|Protocol Violation|0|||
48338306|NCT02164578|155433395|FG001|Treatment Period|Protocol Violation|2|||
48338307|NCT02164578|155433394|FG000|Extension Period|Withdrawal by Subject|2|||
48338308|NCT02164578|155433395|FG001|Extension Period|Withdrawal by Subject|0|||
48338309|NCT02164578|155433394|FG000|Extension Period|Adverse Event|4|||
48338310|NCT02164578|155433395|FG001|Extension Period|Adverse Event|0|||
48338311|NCT02164578|155433394|FG000|Extension Period|Expiry of study medication|1|||
48338312|NCT02164578|155433395|FG001|Extension Period|Expiry of study medication|0|||
48338313|NCT02164578|155433394|FG000|Extension Period|Protocol Violation|0|||
48338314|NCT02164578|155433395|FG001|Extension Period|Protocol Violation|1|||
48660789|NCT04181788|156609548|FG004|FOLLOW-UP|Death|8|||
48660790|NCT04181788|156609549|FG005|FOLLOW-UP|Death|20|||
48660791|NCT04181788|156609544|FG000|FOLLOW-UP|Lost to Follow-up|0|||
48660792|NCT04181788|156609545|FG001|FOLLOW-UP|Lost to Follow-up|0|||
48660793|NCT04181788|156609546|FG002|FOLLOW-UP|Lost to Follow-up|0|||
48660794|NCT04181788|156609547|FG003|FOLLOW-UP|Lost to Follow-up|0|||
48660795|NCT04181788|156609548|FG004|FOLLOW-UP|Lost to Follow-up|0|||
48755432|NCT01348347|156951271|FG000|Overall Study|Withdrawal by Subject|1|||
48338315|NCT02136797|155433396|FG000|Overall Study|Not Treated|8|||
48338316|NCT01863368|155433397|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
48338317|NCT01863368|155433398|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
48338318|NCT01863368|155433397|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
48338319|NCT01863368|155433398|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
48338320|NCT01863368|155433397|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
48660796|NCT04181788|156609549|FG005|FOLLOW-UP|Lost to Follow-up|2|||
48755433|NCT01348347|156951272|FG001|Overall Study|Withdrawal by Subject|1|||
48660797|NCT04181788|156609544|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
48338321|NCT01863368|155433398|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
48338322|NCT01863368|155433397|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
48338323|NCT01863368|155433398|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
48660798|NCT04181788|156609545|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
48660799|NCT04181788|156609546|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
48660800|NCT04181788|156609547|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
48660801|NCT04181788|156609548|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
48660802|NCT04181788|156609549|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
48660803|NCT04181788|156609544|FG000|FOLLOW-UP|Other unspecified|0|||
48660804|NCT04181788|156609545|FG001|FOLLOW-UP|Other unspecified|1|||
48660805|NCT04181788|156609546|FG002|FOLLOW-UP|Other unspecified|0|||
48660806|NCT04181788|156609547|FG003|FOLLOW-UP|Other unspecified|0|||
48660807|NCT04181788|156609548|FG004|FOLLOW-UP|Other unspecified|0|||
48660808|NCT04181788|156609549|FG005|FOLLOW-UP|Other unspecified|3|||
48660809|NCT04181788|156609544|FG000|FOLLOW-UP|Ongoing|0|||
48660810|NCT04181788|156609545|FG001|FOLLOW-UP|Ongoing|0|||
48660811|NCT04181788|156609546|FG002|FOLLOW-UP|Ongoing|1|||
48660812|NCT04181788|156609547|FG003|FOLLOW-UP|Ongoing|3|||
48660813|NCT04181788|156609548|FG004|FOLLOW-UP|Ongoing|2|||
48660814|NCT04181788|156609549|FG005|FOLLOW-UP|Ongoing|2|||
48338324|NCT01863368|155433397|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
48338325|NCT01863368|155433398|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
48338326|NCT01863368|155433397|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
48338327|NCT01863368|155433398|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
48338328|NCT00304278|155433399|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
48338329|NCT00304278|155433399|FG000|Overall Study|PT had medical condition preventing TX|1|||
48338330|NCT02854436|155433400|FG000|Overall Study|Adverse Event|1|||
48338331|NCT02854436|155433400|FG000|Overall Study|Death|208|||
48338332|NCT02854436|155433400|FG000|Overall Study|Lost to Follow-up|5|||
48338333|NCT02854436|155433400|FG000|Overall Study|Withdrawal by Subject|24|||
48338334|NCT02854436|155433400|FG000|Overall Study|Other|45|||
48338335|NCT02854436|155433400|FG000|Overall Study|Physician Decision|6|||
48338336|NCT01975701|155433401|FG000|Overall Study|Lost to Follow-up|1|||
48338337|NCT01975701|155433401|FG000|Overall Study|Death|23|||
48338338|NCT01975701|155433401|FG000|Overall Study|Physician Decision|1|||
48338339|NCT01655498|155433402|FG000|Overall Study|Unrelated health issue|2|||
48338340|NCT01655498|155433402|FG000|Overall Study|Protocol Violation|2|||
48338341|NCT01655498|155433402|FG000|Overall Study|Withdrawal by Subject|1|||
48338342|NCT03409276|155433403|FG000|Overall Study|Withdrawal by Subject|0|||
48338343|NCT03409276|155433404|FG001|Overall Study|Withdrawal by Subject|0|||
48338344|NCT03409276|155433405|FG002|Overall Study|Withdrawal by Subject|0|||
48338345|NCT03409276|155433406|FG003|Overall Study|Withdrawal by Subject|0|||
48338346|NCT03409276|155433407|FG004|Overall Study|Withdrawal by Subject|1|||
48338347|NCT03409276|155433403|FG000|Overall Study|Lost to Follow-up|0|||
48338348|NCT03409276|155433404|FG001|Overall Study|Lost to Follow-up|0|||
48338349|NCT03409276|155433405|FG002|Overall Study|Lost to Follow-up|0|||
48338350|NCT03409276|155433406|FG003|Overall Study|Lost to Follow-up|2|||
48338351|NCT03409276|155433407|FG004|Overall Study|Lost to Follow-up|2|||
48338352|NCT03605745|155433412|FG000|Overall Study|Study was terminated for business reasons|47|||
48338353|NCT02543294|155433413|FG000|Overall Study|Lost to Follow-up|3|||
48338354|NCT02543294|155433413|FG000|Overall Study|Physician Decision|2|||
48338355|NCT02543294|155433413|FG000|Overall Study|Withdrawal by Subject|7|||
48338356|NCT01038128|155433414|FG000|Overall Study|Lack of Efficacy|1|||
48338357|NCT01038128|155433414|FG000|Overall Study|Lost to Follow-up|1|||
48338358|NCT01038128|155433414|FG000|Overall Study|Withdrawal by Subject|2|||
48660815|NCT02456636|156611034|FG000|Overall Study|Death|0|||
48660816|NCT02456636|156611035|FG001|Overall Study|Death|3|||
48660817|NCT02456636|156611036|FG002|Overall Study|Death|0|||
48660818|NCT02456636|156611034|FG000|Overall Study|Pregnancy|1|||
48660819|NCT02456636|156611035|FG001|Overall Study|Pregnancy|3|||
48660820|NCT02456636|156611036|FG002|Overall Study|Pregnancy|5|||
48660821|NCT02456636|156611034|FG000|Overall Study|Physician Decision|4|||
48660822|NCT02456636|156611035|FG001|Overall Study|Physician Decision|5|||
48660823|NCT02456636|156611036|FG002|Overall Study|Physician Decision|4|||
48660824|NCT02456636|156611034|FG000|Overall Study|Withdrawal by Subject|13|||
48660825|NCT02456636|156611035|FG001|Overall Study|Withdrawal by Subject|14|||
48660826|NCT02456636|156611036|FG002|Overall Study|Withdrawal by Subject|16|||
48338359|NCT03761849|155433415|FG000|Overall Study|transferred to OpenLabelExtension|35|||
48338360|NCT03761849|155433416|FG001|Overall Study|transferred to OpenLabelExtension|34|||
48660827|NCT02456636|156611034|FG000|Overall Study|Lost to Follow-up|50|||
48660828|NCT02456636|156611035|FG001|Overall Study|Lost to Follow-up|44|||
48338361|NCT03761849|155433417|FG002|Overall Study|transferred to OpenLabelExtension|36|||
48338362|NCT03761849|155433418|FG003|Overall Study|transferred to OpenLabelExtension|0|||
48338363|NCT03761849|155433419|FG004|Overall Study|transferred to OpenLabelExtension|0|||
48338364|NCT03761849|155433420|FG005|Overall Study|transferred to OpenLabelExtension|0|||
48338365|NCT03761849|155433415|FG000|Overall Study|Adverse Event|1|||
48338366|NCT03761849|155433416|FG001|Overall Study|Adverse Event|0|||
48660829|NCT02456636|156611036|FG002|Overall Study|Lost to Follow-up|50|||
48660830|NCT03555981|156611037|FG000|Overall Study|Lost to Follow-up|0|||
48660831|NCT03555981|156611038|FG001|Overall Study|Lost to Follow-up|2|||
48660832|NCT00585546|156611044|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
48660833|NCT00585546|156611044|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
48660834|NCT01626118|156611045|FG000|Overall Study|Lack of Efficacy|1|||
48660835|NCT01626118|156611046|FG001|Overall Study|Lack of Efficacy|0|||
48660836|NCT01626118|156611047|FG002|Overall Study|Lack of Efficacy|1|||
48660837|NCT01626118|156611048|FG003|Overall Study|Lack of Efficacy|3|||
48660838|NCT01626118|156611045|FG000|Overall Study|Lost to Follow-up|1|||
48660839|NCT01626118|156611046|FG001|Overall Study|Lost to Follow-up|0|||
48660840|NCT01626118|156611047|FG002|Overall Study|Lost to Follow-up|0|||
48660841|NCT01626118|156611048|FG003|Overall Study|Lost to Follow-up|0|||
48660842|NCT01626118|156611045|FG000|Overall Study|Adverse Event|0|||
48660843|NCT01626118|156611046|FG001|Overall Study|Adverse Event|1|||
48660844|NCT01626118|156611047|FG002|Overall Study|Adverse Event|1|||
48660845|NCT01626118|156611048|FG003|Overall Study|Adverse Event|0|||
48660846|NCT01626118|156611045|FG000|Overall Study|Investigator Decision|0|||
48660847|NCT01626118|156611046|FG001|Overall Study|Investigator Decision|1|||
48660848|NCT01626118|156611047|FG002|Overall Study|Investigator Decision|0|||
48660849|NCT01626118|156611048|FG003|Overall Study|Investigator Decision|0|||
48660850|NCT03344549|156611055|FG000|Overall Study|Withdrawal by Subject|3|||
48660851|NCT03344549|156611056|FG001|Overall Study|Withdrawal by Subject|2|||
48660852|NCT03344549|156611055|FG000|Overall Study|Dialysis|2|||
48660853|NCT03344549|156611056|FG001|Overall Study|Dialysis|0|||
48660854|NCT03344549|156611055|FG000|Overall Study|Cancer|1|||
48660855|NCT03344549|156611056|FG001|Overall Study|Cancer|0|||
48660856|NCT03344549|156611055|FG000|Overall Study|Lack of electronic device|1|||
48660857|NCT03344549|156611056|FG001|Overall Study|Lack of electronic device|0|||
48338367|NCT03761849|155433417|FG002|Overall Study|Adverse Event|0|||
48338368|NCT03761849|155433418|FG003|Overall Study|Adverse Event|0|||
48338369|NCT03761849|155433419|FG004|Overall Study|Adverse Event|2|||
48338370|NCT03761849|155433420|FG005|Overall Study|Adverse Event|3|||
48660858|NCT03344549|156611055|FG000|Overall Study|Transportation difficulty|0|||
48338371|NCT03761849|155433415|FG000|Overall Study|Withdrawal by Subject|0|||
48338372|NCT03761849|155433416|FG001|Overall Study|Withdrawal by Subject|0|||
48338373|NCT03761849|155433417|FG002|Overall Study|Withdrawal by Subject|0|||
48338374|NCT03761849|155433418|FG003|Overall Study|Withdrawal by Subject|41|||
48338375|NCT03761849|155433419|FG004|Overall Study|Withdrawal by Subject|43|||
48660859|NCT03344549|156611056|FG001|Overall Study|Transportation difficulty|13|||
48660860|NCT04686084|156611057|FG000|Overall Study|Lost to Follow-up|1|||
48660861|NCT04065841|156611058|FG000|Overall Study|Adverse Event|4|||
48660862|NCT04065841|156611059|FG001|Overall Study|Adverse Event|2|||
48660863|NCT04065841|156611060|FG002|Overall Study|Adverse Event|10|||
48660864|NCT04065841|156611061|FG003|Overall Study|Adverse Event|1|||
48338376|NCT03761849|155433420|FG005|Overall Study|Withdrawal by Subject|35|||
48338377|NCT03761849|155433415|FG000|Overall Study|Lost to Follow-up|0|||
48338378|NCT03761849|155433416|FG001|Overall Study|Lost to Follow-up|1|||
48338379|NCT03761849|155433417|FG002|Overall Study|Lost to Follow-up|0|||
48338380|NCT03761849|155433418|FG003|Overall Study|Lost to Follow-up|2|||
48338381|NCT03761849|155433419|FG004|Overall Study|Lost to Follow-up|4|||
48338382|NCT03761849|155433420|FG005|Overall Study|Lost to Follow-up|5|||
48338383|NCT03761849|155433415|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
48338384|NCT03761849|155433416|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
48338385|NCT03761849|155433417|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
48338386|NCT03761849|155433418|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
48338387|NCT03761849|155433419|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
48338388|NCT03761849|155433420|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
48338389|NCT03761849|155433415|FG000|Overall Study|Physician Decision|0|||
48338390|NCT03761849|155433416|FG001|Overall Study|Physician Decision|0|||
48338391|NCT03761849|155433417|FG002|Overall Study|Physician Decision|0|||
48338392|NCT03761849|155433418|FG003|Overall Study|Physician Decision|1|||
48338393|NCT03761849|155433419|FG004|Overall Study|Physician Decision|4|||
48338394|NCT03761849|155433420|FG005|Overall Study|Physician Decision|4|||
48338395|NCT03761849|155433415|FG000|Overall Study|Death|0|||
48338396|NCT03761849|155433416|FG001|Overall Study|Death|0|||
48338397|NCT03761849|155433417|FG002|Overall Study|Death|0|||
48338398|NCT03761849|155433418|FG003|Overall Study|Death|1|||
48338399|NCT03761849|155433419|FG004|Overall Study|Death|1|||
48338400|NCT03761849|155433420|FG005|Overall Study|Death|3|||
48338401|NCT03761849|155433415|FG000|Overall Study|Protocol Violation|0|||
48338402|NCT03761849|155433416|FG001|Overall Study|Protocol Violation|0|||
48338403|NCT03761849|155433417|FG002|Overall Study|Protocol Violation|0|||
48338404|NCT03761849|155433418|FG003|Overall Study|Protocol Violation|2|||
48338405|NCT03761849|155433419|FG004|Overall Study|Protocol Violation|2|||
48338406|NCT03761849|155433420|FG005|Overall Study|Protocol Violation|1|||
48338407|NCT03761849|155433415|FG000|Overall Study|Participant could not come to site|0|||
48660865|NCT04065841|156611058|FG000|Overall Study|Lost to Follow-up|1|||
48660866|NCT04065841|156611059|FG001|Overall Study|Lost to Follow-up|2|||
48660867|NCT04065841|156611060|FG002|Overall Study|Lost to Follow-up|2|||
48660868|NCT04065841|156611061|FG003|Overall Study|Lost to Follow-up|2|||
48660869|NCT04065841|156611058|FG000|Overall Study|Physician Decision|1|||
48660870|NCT04065841|156611059|FG001|Overall Study|Physician Decision|0|||
48660871|NCT04065841|156611060|FG002|Overall Study|Physician Decision|0|||
48660872|NCT04065841|156611061|FG003|Overall Study|Physician Decision|0|||
48660873|NCT04065841|156611058|FG000|Overall Study|Protocol Violation|0|||
48660874|NCT04065841|156611059|FG001|Overall Study|Protocol Violation|1|||
48660875|NCT04065841|156611060|FG002|Overall Study|Protocol Violation|0|||
48660876|NCT04065841|156611061|FG003|Overall Study|Protocol Violation|0|||
48660877|NCT04065841|156611058|FG000|Overall Study|Study terminated by Sponsor|22|||
48660878|NCT04065841|156611059|FG001|Overall Study|Study terminated by Sponsor|16|||
48660879|NCT04065841|156611060|FG002|Overall Study|Study terminated by Sponsor|28|||
48660880|NCT04065841|156611061|FG003|Overall Study|Study terminated by Sponsor|17|||
48660881|NCT04065841|156611058|FG000|Overall Study|Withdrawal by Subject|1|||
48660882|NCT04065841|156611059|FG001|Overall Study|Withdrawal by Subject|1|||
48660883|NCT04065841|156611060|FG002|Overall Study|Withdrawal by Subject|2|||
48660884|NCT04065841|156611061|FG003|Overall Study|Withdrawal by Subject|0|||
48660885|NCT02210689|156611062|FG000|Overall Study|Withdrawal by Subject|7|||
48660886|NCT02210689|156611063|FG001|Overall Study|Withdrawal by Subject|4|||
48660887|NCT02210689|156611064|FG002|Overall Study|Withdrawal by Subject|2|||
48660888|NCT02210689|156611062|FG000|Overall Study|Adverse Event|0|||
48660889|NCT02210689|156611063|FG001|Overall Study|Adverse Event|1|||
48660890|NCT02210689|156611064|FG002|Overall Study|Adverse Event|0|||
48660891|NCT02210689|156611062|FG000|Overall Study|Protocol Violation|1|||
48660892|NCT02210689|156611063|FG001|Overall Study|Protocol Violation|0|||
48660893|NCT02210689|156611064|FG002|Overall Study|Protocol Violation|0|||
48660894|NCT02210689|156611062|FG000|Overall Study|Lost to Follow-up|11|||
48660895|NCT02210689|156611063|FG001|Overall Study|Lost to Follow-up|9|||
48660896|NCT02210689|156611064|FG002|Overall Study|Lost to Follow-up|5|||
48660897|NCT02210689|156611062|FG000|Overall Study|Pregnancy|0|||
48660898|NCT02210689|156611063|FG001|Overall Study|Pregnancy|1|||
48660899|NCT02210689|156611064|FG002|Overall Study|Pregnancy|0|||
48660900|NCT02210689|156611062|FG000|Overall Study|Lack of Efficacy|0|||
48660901|NCT02210689|156611063|FG001|Overall Study|Lack of Efficacy|1|||
48660902|NCT02210689|156611064|FG002|Overall Study|Lack of Efficacy|5|||
48660903|NCT02210689|156611062|FG000|Overall Study|Prohibited medication|2|||
48660904|NCT02210689|156611063|FG001|Overall Study|Prohibited medication|8|||
48660905|NCT02210689|156611064|FG002|Overall Study|Prohibited medication|1|||
48660906|NCT02210689|156611062|FG000|Overall Study|Negative Nugent score at baseline|6|||
48660907|NCT02210689|156611063|FG001|Overall Study|Negative Nugent score at baseline|2|||
48660908|NCT02210689|156611064|FG002|Overall Study|Negative Nugent score at baseline|2|||
48660909|NCT02210689|156611062|FG000|Overall Study|Other|25|||
48660910|NCT02210689|156611063|FG001|Overall Study|Other|21|||
48660911|NCT02210689|156611064|FG002|Overall Study|Other|8|||
48660912|NCT02365467|156611065|FG000|Overall Study|Death|3|||
48660913|NCT02186652|156611066|FG000|Overall Study|Lost to Follow-up|2|||
48660914|NCT02186652|156611067|FG001|Overall Study|Lost to Follow-up|0|||
48660915|NCT02928029|156611068|FG000|Overall Study|Withdrawal by Subject|0|||
48660916|NCT02928029|156611069|FG001|Overall Study|Withdrawal by Subject|1|||
48660917|NCT02928029|156611068|FG000|Overall Study|Radiological progression|1|||
48660918|NCT02928029|156611069|FG001|Overall Study|Radiological progression|0|||
48660919|NCT02928029|156611068|FG000|Overall Study|Clinical progression|1|||
48660920|NCT02928029|156611069|FG001|Overall Study|Clinical progression|2|||
48660921|NCT02928029|156611068|FG000|Overall Study|AE not related to clinical progression|1|||
48660922|NCT02928029|156611069|FG001|Overall Study|AE not related to clinical progression|1|||
48660923|NCT00613925|156611070|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
48660924|NCT00613925|156611071|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
48660925|NCT01467427|156611072|FG000|Overall Study|Withdrawal by Subject|1|||
48660926|NCT01467427|156611073|FG001|Overall Study|Withdrawal by Subject|0|||
48660927|NCT01467427|156611072|FG000|Overall Study|Not continuing in extension phase|0|||
48660928|NCT01467427|156611073|FG001|Overall Study|Not continuing in extension phase|2|||
48660929|NCT01467427|156611072|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
48660930|NCT01467427|156611073|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
48660931|NCT01467427|156611072|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
48660932|NCT01467427|156611073|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
48660933|NCT01467427|156611072|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
48660934|NCT01467427|156611073|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
48660935|NCT01467427|156611072|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
48660936|NCT01467427|156611073|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
48660937|NCT03881696|156611074|FG000|Overall Study|Adverse Event|2|||
48660938|NCT03881696|156611075|FG001|Overall Study|Adverse Event|0|||
48660939|NCT03881696|156611074|FG000|Overall Study|Withdrawal by Subject|2|||
48660940|NCT03881696|156611075|FG001|Overall Study|Withdrawal by Subject|0|||
48660941|NCT03881696|156611074|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
48660942|NCT03881696|156611075|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
48660943|NCT03881696|156611074|FG000|Overall Study|Failure to meet continuation criteria|1|||
48660944|NCT03881696|156611075|FG001|Overall Study|Failure to meet continuation criteria|0|||
48660945|NCT01818258|156611076|FG000|Overall Study|Death|3|||
48660946|NCT01818258|156611077|FG001|Overall Study|Death|0|||
48660947|NCT01818258|156611076|FG000|Overall Study|Withdrawal by Subject|0|||
48660948|NCT01818258|156611077|FG001|Overall Study|Withdrawal by Subject|1|||
48660949|NCT01818258|156611076|FG000|Overall Study|Lost to Follow-up|0|||
48660950|NCT01818258|156611077|FG001|Overall Study|Lost to Follow-up|1|||
48660951|NCT01818258|156611076|FG000|Overall Study|Unable to Travel to Clinic|0|||
48660952|NCT01818258|156611077|FG001|Overall Study|Unable to Travel to Clinic|1|||
48660953|NCT05299723|156611078|FG000|Overall Study|Withdrawal by Subject|0|||
48660954|NCT05299723|156611079|FG001|Overall Study|Withdrawal by Subject|2|||
48660955|NCT05299723|156611080|FG002|Overall Study|Withdrawal by Subject|0|||
48660956|NCT02606422|156611081|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
48660957|NCT02606422|156611082|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
48660958|NCT02606422|156611081|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
48660959|NCT02606422|156611082|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
48660960|NCT02606422|156611081|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
48660961|NCT02606422|156611082|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
48660962|NCT02606422|156611081|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
48660963|NCT02606422|156611082|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
48660964|NCT02891681|156611083|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
48660965|NCT02891681|156611084|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
48660966|NCT02891681|156611085|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
48660967|NCT02891681|156611083|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
48660968|NCT02891681|156611084|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
48660969|NCT02891681|156611085|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
48660970|NCT02891681|156611083|FG000|Overall Study|Taken off study after first imaging appointment|1|||
48660971|NCT02891681|156611084|FG001|Overall Study|Taken off study after first imaging appointment|0|||
48660972|NCT02891681|156611085|FG002|Overall Study|Taken off study after first imaging appointment|0|||
48660973|NCT02685748|156611090|FG000|Overall Study|Withdrawal by Subject|3|||
48660974|NCT02685748|156611091|FG001|Overall Study|Withdrawal by Subject|2|||
48660975|NCT03500172|156611092|FG000|Period 1: Baseline Randomization|Death|0|||
48660976|NCT03500172|156611093|FG001|Period 1: Baseline Randomization|Death|0|||
48660977|NCT03500172|156611094|FG002|Period 1: Baseline Randomization|Death|0|||
48660978|NCT03500172|156611095|FG003|Period 1: Baseline Randomization|Death|0|||
48660979|NCT03500172|156611096|FG004|Period 1: Baseline Randomization|Death|0|||
48660980|NCT03500172|156611097|FG005|Period 1: Baseline Randomization|Death|0|||
48660981|NCT03500172|156611098|FG006|Period 1: Baseline Randomization|Death|0|||
48338408|NCT03761849|155433416|FG001|Overall Study|Participant could not come to site|0|||
48660982|NCT03500172|156611099|FG007|Period 1: Baseline Randomization|Death|0|||
48660983|NCT03500172|156611100|FG008|Period 1: Baseline Randomization|Death|0|||
48660984|NCT03500172|156611101|FG009|Period 1: Baseline Randomization|Death|2|||
48660985|NCT03500172|156611102|FG010|Period 1: Baseline Randomization|Death|0|||
48660986|NCT03500172|156611092|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
48755434|NCT01348347|156951273|FG002|Overall Study|Withdrawal by Subject|1|||
48755435|NCT01348347|156951271|FG000|Overall Study|Progressive disease|2|||
48755436|NCT01348347|156951272|FG001|Overall Study|Progressive disease|5|||
48755437|NCT01348347|156951273|FG002|Overall Study|Progressive disease|5|||
48755438|NCT02763189|156951274|FG000|Overall Study|Device failure|0|||
48755439|NCT02763189|156951275|FG001|Overall Study|Device failure|2|||
48755440|NCT01018186|156951276|FG000|2-week Run-in Period|Protocol Violation|1|||
48755441|NCT01018186|156951277|FG001|2-week Run-in Period|Protocol Violation|0|||
48755442|NCT01018186|156951278|FG002|2-week Run-in Period|Protocol Violation|0|||
48755443|NCT01018186|156951279|FG003|2-week Run-in Period|Protocol Violation|0|||
48755444|NCT01018186|156951276|FG000|2-week Run-in Period|Lost to Follow-up|2|||
48755445|NCT01018186|156951277|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48755446|NCT01018186|156951278|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48755447|NCT01018186|156951279|FG003|2-week Run-in Period|Lost to Follow-up|0|||
48755448|NCT01018186|156951276|FG000|2-week Run-in Period|Physician Decision|3|||
48755449|NCT01018186|156951277|FG001|2-week Run-in Period|Physician Decision|0|||
48755450|NCT01018186|156951278|FG002|2-week Run-in Period|Physician Decision|0|||
48755451|NCT01018186|156951279|FG003|2-week Run-in Period|Physician Decision|0|||
48755452|NCT01018186|156951276|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
48755453|NCT01018186|156951277|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48755454|NCT01018186|156951278|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48755455|NCT01018186|156951279|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
48755456|NCT01018186|156951276|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
48755457|NCT01018186|156951277|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48755458|NCT01018186|156951278|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48755459|NCT01018186|156951279|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48755460|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
48755461|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
48755462|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
48755463|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
48755464|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
48755465|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
48338409|NCT03761849|155433417|FG002|Overall Study|Participant could not come to site|0|||
48338410|NCT03761849|155433418|FG003|Overall Study|Participant could not come to site|0|||
48338411|NCT03761849|155433419|FG004|Overall Study|Participant could not come to site|1|||
48338412|NCT03761849|155433420|FG005|Overall Study|Participant could not come to site|0|||
48338413|NCT03761849|155433415|FG000|Overall Study|SF- safety Finding|0|||
48338414|NCT03761849|155433416|FG001|Overall Study|SF- safety Finding|0|||
48660987|NCT03500172|156611093|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
48660988|NCT03500172|156611094|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
48660989|NCT03500172|156611095|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
48660990|NCT03500172|156611096|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
48660991|NCT03500172|156611097|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
48660992|NCT03500172|156611098|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
48660993|NCT03500172|156611099|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
48660994|NCT03500172|156611100|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
48660995|NCT03500172|156611101|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
48660996|NCT03500172|156611102|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
48660997|NCT03500172|156611092|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
48660998|NCT03500172|156611093|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
48660999|NCT03500172|156611094|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
48661000|NCT03500172|156611095|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
48661001|NCT03500172|156611096|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
48661002|NCT03500172|156611097|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
48661003|NCT03500172|156611098|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
48661004|NCT03500172|156611099|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
48661005|NCT03500172|156611100|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
48661006|NCT03500172|156611101|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
48661007|NCT03500172|156611102|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
48661008|NCT03500172|156611092|FG000|Period 2: Re-Randomization|Death|0|||
48661009|NCT03500172|156611093|FG001|Period 2: Re-Randomization|Death|0|||
48661010|NCT03500172|156611094|FG002|Period 2: Re-Randomization|Death|0|||
48661011|NCT03500172|156611095|FG003|Period 2: Re-Randomization|Death|4|||
48661012|NCT03500172|156611096|FG004|Period 2: Re-Randomization|Death|2|||
48661013|NCT03500172|156611097|FG005|Period 2: Re-Randomization|Death|0|||
48661014|NCT03500172|156611098|FG006|Period 2: Re-Randomization|Death|5|||
48661015|NCT03500172|156611099|FG007|Period 2: Re-Randomization|Death|2|||
48661016|NCT03500172|156611100|FG008|Period 2: Re-Randomization|Death|0|||
48661017|NCT03500172|156611101|FG009|Period 2: Re-Randomization|Death|0|||
48661018|NCT03500172|156611102|FG010|Period 2: Re-Randomization|Death|0|||
48661019|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
48661020|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
48661021|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
48661022|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
48661023|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
48661024|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
48661025|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
48661026|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
48661027|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
48661028|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
48661029|NCT03549871|156611103|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
48661030|NCT03549871|156611104|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
48661031|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
48661032|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
48755466|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
48755467|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
48755468|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
48338415|NCT03761849|155433417|FG002|Overall Study|SF- safety Finding|0|||
48338416|NCT03761849|155433418|FG003|Overall Study|SF- safety Finding|0|||
48338417|NCT03761849|155433419|FG004|Overall Study|SF- safety Finding|0|||
48338418|NCT03761849|155433420|FG005|Overall Study|SF- safety Finding|1|||
48338419|NCT03761849|155433415|FG000|Overall Study|Patient did not attend visit|0|||
48338420|NCT03761849|155433416|FG001|Overall Study|Patient did not attend visit|0|||
48338421|NCT03761849|155433417|FG002|Overall Study|Patient did not attend visit|0|||
48338422|NCT03761849|155433418|FG003|Overall Study|Patient did not attend visit|0|||
48338423|NCT03761849|155433419|FG004|Overall Study|Patient did not attend visit|0|||
48338424|NCT03761849|155433420|FG005|Overall Study|Patient did not attend visit|1|||
48338425|NCT00988429|155433427|FG000|Overall Study|Adverse Event|9|||
48338426|NCT00988429|155433428|FG001|Overall Study|Adverse Event|21|||
48338427|NCT00988429|155433429|FG002|Overall Study|Adverse Event|45|||
48338428|NCT00988429|155433427|FG000|Overall Study|Lack of Efficacy|0|||
48338429|NCT00988429|155433428|FG001|Overall Study|Lack of Efficacy|0|||
48338430|NCT00988429|155433429|FG002|Overall Study|Lack of Efficacy|1|||
48661033|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
48661034|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
48661035|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
48661036|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
48661037|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
48661038|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
48661039|NCT03549871|156611103|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
48661040|NCT03549871|156611104|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
48661041|NCT04439201|156611111|FG000|Overall Study|Ineligible|2|||
48661042|NCT04439201|156611111|FG000|Overall Study|Never start protocol therapy|1|||
48661043|NCT04439201|156611111|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
48661044|NCT04439201|156611111|FG000|Overall Study|Mutation status not confirmed|4|||
48661045|NCT04439201|156611111|FG000|Overall Study|Adverse Event|1|||
48661046|NCT04439201|156611111|FG000|Overall Study|Death|7|||
48661047|NCT04439201|156611111|FG000|Overall Study|Withdrawal by Subject|2|||
48661048|NCT04439201|156611111|FG000|Overall Study|Disease progression|20|||
48661049|NCT04439201|156611111|FG000|Overall Study|Alternative therapy|1|||
48661050|NCT04439201|156611111|FG000|Overall Study|Physician Decision|1|||
48661051|NCT02118766|156611112|FG000|Overall Study|Adverse Event|7|||
48661052|NCT02118766|156611113|FG001|Overall Study|Adverse Event|2|||
48661053|NCT02118766|156611112|FG000|Overall Study|Withdrawal by Subject|3|||
48661054|NCT02118766|156611113|FG001|Overall Study|Withdrawal by Subject|6|||
48661055|NCT02118766|156611112|FG000|Overall Study|Lost to Follow-up|5|||
48661056|NCT02118766|156611113|FG001|Overall Study|Lost to Follow-up|4|||
48661057|NCT02118766|156611112|FG000|Overall Study|Withdrawal by parent/guardian|12|||
48661058|NCT02118766|156611113|FG001|Overall Study|Withdrawal by parent/guardian|18|||
48661059|NCT02118766|156611112|FG000|Overall Study|Other|3|||
48661060|NCT02118766|156611113|FG001|Overall Study|Other|1|||
48661061|NCT02403635|156611114|FG000|Overall Study|Not eligible|9|||
48661062|NCT02240368|156611117|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
48661063|NCT02240368|156611118|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
48661064|NCT02240368|156611119|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
48661065|NCT02240368|156611117|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
48661066|NCT02240368|156611118|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
48661067|NCT02240368|156611119|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
48661068|NCT03946124|156611120|FG000|Overall Study|Withdrawal by Subject|19|||
48661069|NCT02334683|156611127|FG000|First 12 Week Period|Lost to Follow-up|1|||
48661070|NCT02334683|156611128|FG001|First 12 Week Period|Lost to Follow-up|0|||
48661071|NCT02334683|156611127|FG000|Second 12 Week Period|Adverse Event|0|||
48661072|NCT02334683|156611128|FG001|Second 12 Week Period|Adverse Event|1|||
48661073|NCT00871117|156611129|FG000|Overall Study|Lost to Follow-up|5|||
48661074|NCT00871117|156611130|FG001|Overall Study|Lost to Follow-up|6|||
48661075|NCT00871117|156611129|FG000|Overall Study|Other|0|||
48338431|NCT00988429|155433427|FG000|Overall Study|Non-Compliance with Study Drug|5|||
48338432|NCT00988429|155433428|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48661076|NCT00871117|156611130|FG001|Overall Study|Other|4|||
48338433|NCT00988429|155433429|FG002|Overall Study|Non-Compliance with Study Drug|3|||
48338434|NCT00988429|155433427|FG000|Overall Study|Physician Decision|1|||
48338435|NCT00988429|155433428|FG001|Overall Study|Physician Decision|0|||
48338436|NCT00988429|155433429|FG002|Overall Study|Physician Decision|3|||
48338437|NCT00988429|155433427|FG000|Overall Study|Pregnancy|2|||
48338438|NCT00988429|155433428|FG001|Overall Study|Pregnancy|1|||
48661077|NCT01218100|156611131|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
48661078|NCT01218100|156611132|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
48661079|NCT01218100|156611133|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
48661080|NCT01218100|156611134|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
48661081|NCT01218100|156611131|FG000|Overall Study|Adverse Event|4|||
48661082|NCT01218100|156611132|FG001|Overall Study|Adverse Event|6|||
48338439|NCT00988429|155433429|FG002|Overall Study|Pregnancy|0|||
48338440|NCT00988429|155433427|FG000|Overall Study|Protocol Violation|4|||
48338441|NCT00988429|155433428|FG001|Overall Study|Protocol Violation|3|||
48338442|NCT00988429|155433429|FG002|Overall Study|Protocol Violation|3|||
48338443|NCT00988429|155433427|FG000|Overall Study|Withdrawal by Subject|7|||
48338444|NCT00988429|155433428|FG001|Overall Study|Withdrawal by Subject|7|||
48338445|NCT00988429|155433429|FG002|Overall Study|Withdrawal by Subject|12|||
48338446|NCT00988429|155433427|FG000|Overall Study|Administrative Reasons|1|||
48338447|NCT00988429|155433428|FG001|Overall Study|Administrative Reasons|2|||
48338448|NCT00988429|155433429|FG002|Overall Study|Administrative Reasons|1|||
48338449|NCT00988429|155433427|FG000|Overall Study|other reasons|8|||
48338450|NCT00988429|155433428|FG001|Overall Study|other reasons|8|||
48338451|NCT00988429|155433429|FG002|Overall Study|other reasons|1|||
48338452|NCT04454125|155433430|FG000|Overall Study|Lost to Follow-up|0|||
48661083|NCT01218100|156611133|FG002|Overall Study|Adverse Event|6|||
48661084|NCT01218100|156611134|FG003|Overall Study|Adverse Event|7|||
48661085|NCT01218100|156611131|FG000|Overall Study|Lack of Efficacy|9|||
48661086|NCT01218100|156611132|FG001|Overall Study|Lack of Efficacy|6|||
48661087|NCT01218100|156611133|FG002|Overall Study|Lack of Efficacy|5|||
48661088|NCT01218100|156611134|FG003|Overall Study|Lack of Efficacy|12|||
48661089|NCT01218100|156611131|FG000|Overall Study|Protocol Violation|0|||
48661090|NCT01218100|156611132|FG001|Overall Study|Protocol Violation|0|||
48661091|NCT01218100|156611133|FG002|Overall Study|Protocol Violation|1|||
48661092|NCT01218100|156611134|FG003|Overall Study|Protocol Violation|1|||
48661093|NCT01218100|156611131|FG000|Overall Study|Withdrawal by Subject|5|||
48661094|NCT01218100|156611132|FG001|Overall Study|Withdrawal by Subject|2|||
48661095|NCT01218100|156611133|FG002|Overall Study|Withdrawal by Subject|6|||
48661096|NCT01218100|156611134|FG003|Overall Study|Withdrawal by Subject|7|||
48661097|NCT01218100|156611131|FG000|Overall Study|Lost to Follow-up|3|||
48661098|NCT01218100|156611132|FG001|Overall Study|Lost to Follow-up|8|||
48661099|NCT01218100|156611133|FG002|Overall Study|Lost to Follow-up|2|||
48661100|NCT01218100|156611134|FG003|Overall Study|Lost to Follow-up|1|||
48661101|NCT01218100|156611131|FG000|Overall Study|Other Reason|2|||
48661102|NCT01218100|156611132|FG001|Overall Study|Other Reason|2|||
48661103|NCT01218100|156611133|FG002|Overall Study|Other Reason|6|||
48661104|NCT01218100|156611134|FG003|Overall Study|Other Reason|4|||
48661105|NCT03730961|156611153|FG000|Overall Study|Adverse Event|0|||
48661106|NCT03730961|156611154|FG001|Overall Study|Adverse Event|1|||
48661107|NCT01767493|156611157|FG000|Overall Study|screen failures|3|||
48661108|NCT01457950|156611158|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
48661109|NCT01457950|156611159|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
48661110|NCT01457950|156611160|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
48661111|NCT01457950|156611161|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
48661112|NCT01457950|156611158|FG000|Double-Blind Phase|Protocol Violation|2|||
48661113|NCT01457950|156611159|FG001|Double-Blind Phase|Protocol Violation|1|||
48661114|NCT01457950|156611160|FG002|Double-Blind Phase|Protocol Violation|0|||
48661115|NCT01457950|156611161|FG003|Double-Blind Phase|Protocol Violation|0|||
48661116|NCT01457950|156611158|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
48661117|NCT01457950|156611159|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
48661118|NCT01457950|156611160|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48661119|NCT01457950|156611161|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48661120|NCT01457950|156611158|FG000|Open-Label Phase|Adverse Event|0|||
48661121|NCT01457950|156611159|FG001|Open-Label Phase|Adverse Event|0|||
48661122|NCT01457950|156611160|FG002|Open-Label Phase|Adverse Event|0|||
48661123|NCT01457950|156611161|FG003|Open-Label Phase|Adverse Event|1|||
48661124|NCT01457950|156611158|FG000|Open-Label Phase|Protocol Violation|0|||
48661125|NCT01457950|156611159|FG001|Open-Label Phase|Protocol Violation|0|||
48661126|NCT01457950|156611160|FG002|Open-Label Phase|Protocol Violation|0|||
48661127|NCT01457950|156611161|FG003|Open-Label Phase|Protocol Violation|1|||
48661128|NCT01457950|156611158|FG000|Open-Label Phase|Withdrawal by Subject|0|||
48755469|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
48755470|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
48755471|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
48755472|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
48755473|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
48755474|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
48755475|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
48755476|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
48755477|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
48755478|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
48755479|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
48755480|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
48755481|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
48755482|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
48755483|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
48338453|NCT04454125|155433431|FG001|Overall Study|Lost to Follow-up|1|||
48338454|NCT00331799|155433437|FG000|Overall Study|Withdrawal by Subject|2|||
48338455|NCT00331799|155433437|FG000|Overall Study|Sedation|1|||
48338456|NCT05203822|155433438|FG000|Overall Study|Adverse Event|1|||
48338457|NCT05203822|155433438|FG000|Overall Study|Withdrawal by Subject|1|||
48661129|NCT01457950|156611159|FG001|Open-Label Phase|Withdrawal by Subject|0|||
48661130|NCT01457950|156611160|FG002|Open-Label Phase|Withdrawal by Subject|2|||
48661131|NCT01457950|156611161|FG003|Open-Label Phase|Withdrawal by Subject|0|||
48661132|NCT03593681|156611162|FG000|Overall Study|Inadequate sample collected|12|||
48661133|NCT03593681|156611162|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
48661134|NCT03593681|156611162|FG000|Overall Study|Protocol Violation|3|||
48661135|NCT03593681|156611162|FG000|Overall Study|Withdrawal by Subject|3|||
48661136|NCT03593681|156611162|FG000|Overall Study|Procedure not attempted|3|||
48661137|NCT03593681|156611162|FG000|Overall Study|Adverse Event|2|||
48661138|NCT03593681|156611162|FG000|Overall Study|Physician Decision|1|||
48661139|NCT00717522|156611163|FG000|Overall Study|Disease Progression|5|||
48661140|NCT00717522|156611163|FG000|Overall Study|Adverse Event|1|||
48755484|NCT01018186|156951276|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48755485|NCT01018186|156951277|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
48755486|NCT01018186|156951278|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
48755487|NCT01018186|156951279|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
48755488|NCT01414075|156951284|FG000|Overall Study|Adverse Event|1|||
48338458|NCT01129011|155433444|FG000|Overall Study|Adverse Event|20|||
48338459|NCT01129011|155433445|FG001|Overall Study|Adverse Event|30|||
48661141|NCT00717522|156611163|FG000|Overall Study|Death|1|||
48661142|NCT01166958|156611164|FG000|Overall Study|Withdrawal by Subject|1|||
48338460|NCT01129011|155433444|FG000|Overall Study|Withdrawal by Subject|24|||
48338461|NCT01129011|155433445|FG001|Overall Study|Withdrawal by Subject|8|||
48338462|NCT01129011|155433444|FG000|Overall Study|Lost to Follow-up|6|||
48338463|NCT01129011|155433445|FG001|Overall Study|Lost to Follow-up|7|||
48338464|NCT01129011|155433444|FG000|Overall Study|Duodenal Ulcer|2|||
48338465|NCT01129011|155433445|FG001|Overall Study|Duodenal Ulcer|8|||
48338466|NCT01129011|155433444|FG000|Overall Study|misc|7|||
48661143|NCT01166958|156611165|FG001|Overall Study|Withdrawal by Subject|0|||
48661144|NCT02185014|156611170|FG000|Overall Study|Adverse Event|18|||
48661145|NCT02185014|156611170|FG000|Overall Study|Withdrew Consent|8|||
48661146|NCT02185014|156611170|FG000|Overall Study|Lost to Follow-up|4|||
48661147|NCT02185014|156611170|FG000|Overall Study|Lack of Efficacy|14|||
48661148|NCT02185014|156611170|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
48661149|NCT02185014|156611170|FG000|Overall Study|Subject Noncompliance|1|||
48661150|NCT02185014|156611170|FG000|Overall Study|Other|4|||
48661151|NCT01140568|156611175|FG000|Overall Study|disease progression|31|||
48661152|NCT01140568|156611175|FG000|Overall Study|Withdrawal by Subject|1|||
48661153|NCT01140568|156611175|FG000|Overall Study|Screen Fail|4|||
48661154|NCT03618628|156611176|FG000|Overall Study|Death|1|||
48661155|NCT03618628|156611176|FG000|Overall Study|Lost to Follow-up|1|||
48661156|NCT00493636|156611177|FG000|Overall Study|Withdrawal by Subject|1|||
48661157|NCT00493636|156611178|FG001|Overall Study|Withdrawal by Subject|0|||
48661158|NCT00493636|156611177|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
48661159|NCT00493636|156611178|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
48661160|NCT00493636|156611177|FG000|Overall Study|Mis-randomization|1|||
48661161|NCT00493636|156611178|FG001|Overall Study|Mis-randomization|1|||
48661162|NCT01741532|156611179|FG000|Overall Study|Adverse Event|4|||
48661163|NCT01741532|156611180|FG001|Overall Study|Adverse Event|0|||
48338467|NCT01129011|155433445|FG001|Overall Study|misc|4|||
48338468|NCT02498418|155433451|FG000|Overall Study|Lack of Efficacy|0|||
48338469|NCT02498418|155433452|FG001|Overall Study|Lack of Efficacy|0|||
48338470|NCT02498418|155433453|FG002|Overall Study|Lack of Efficacy|1|||
48338471|NCT02498418|155433451|FG000|Overall Study|Withdrawal by Subject|2|||
48338472|NCT02498418|155433452|FG001|Overall Study|Withdrawal by Subject|0|||
48338473|NCT02498418|155433453|FG002|Overall Study|Withdrawal by Subject|3|||
48338474|NCT02498418|155433451|FG000|Overall Study|Lost to Follow-up|0|||
48661164|NCT01741532|156611179|FG000|Overall Study|Withdrawal by Subject|1|||
48661165|NCT01741532|156611180|FG001|Overall Study|Withdrawal by Subject|1|||
48661166|NCT01741532|156611179|FG000|Overall Study|Protocol Violation|0|||
48661167|NCT01741532|156611180|FG001|Overall Study|Protocol Violation|1|||
48661168|NCT01741532|156611179|FG000|Overall Study|Worsening of the disease|3|||
48338475|NCT02498418|155433452|FG001|Overall Study|Lost to Follow-up|1|||
48338476|NCT02498418|155433453|FG002|Overall Study|Lost to Follow-up|1|||
48338477|NCT02498418|155433451|FG000|Overall Study|Participant taken prohibited medication|0|||
48338478|NCT02498418|155433452|FG001|Overall Study|Participant taken prohibited medication|1|||
48338479|NCT02498418|155433453|FG002|Overall Study|Participant taken prohibited medication|1|||
48661169|NCT01741532|156611180|FG001|Overall Study|Worsening of the disease|1|||
48661170|NCT01741532|156611179|FG000|Overall Study|Sponsor decision|1|||
48661171|NCT01741532|156611180|FG001|Overall Study|Sponsor decision|0|||
48661172|NCT01741532|156611179|FG000|Overall Study|Medical event|1|||
48661173|NCT01741532|156611180|FG001|Overall Study|Medical event|0|||
48661174|NCT01453946|156611181|FG000|Overall Study|Did not receive drug for the taper phase|1|||
48661175|NCT01453946|156611181|FG000|Overall Study|Protocol Violation|2|||
48661176|NCT01453946|156611181|FG000|Overall Study|Lack of Efficacy|3|||
48661177|NCT01453946|156611181|FG000|Overall Study|Adverse Event|3|||
48661178|NCT03352453|156611182|FG000|Overall Study|Miscellaneous Reasons|1|||
48661179|NCT03352453|156611183|FG001|Overall Study|Miscellaneous Reasons|2|||
48661180|NCT03352453|156611182|FG000|Overall Study|Lack of Efficacy|1|||
48661181|NCT03352453|156611183|FG001|Overall Study|Lack of Efficacy|0|||
48661182|NCT03352453|156611182|FG000|Overall Study|Withdrawal by Subject|8|||
48661183|NCT03352453|156611183|FG001|Overall Study|Withdrawal by Subject|14|||
48661184|NCT03352453|156611182|FG000|Overall Study|Study Terminated by Sponsor|2|||
48661185|NCT03352453|156611183|FG001|Overall Study|Study Terminated by Sponsor|1|||
48338480|NCT00449033|155433454|FG000|Treatment Period|Adverse Event|117|||
48338481|NCT00449033|155433455|FG001|Treatment Period|Adverse Event|83|||
48338482|NCT00449033|155433454|FG000|Treatment Period|Death|21|||
48338483|NCT00449033|155433455|FG001|Treatment Period|Death|12|||
48338484|NCT00449033|155433454|FG000|Treatment Period|Lost to Follow-up|0|||
48661186|NCT03352453|156611182|FG000|Overall Study|Protocol Deviation|1|||
48661187|NCT03352453|156611183|FG001|Overall Study|Protocol Deviation|0|||
48661188|NCT03352453|156611182|FG000|Overall Study|Lost to Follow-up|7|||
48661189|NCT03352453|156611183|FG001|Overall Study|Lost to Follow-up|6|||
48338485|NCT00449033|155433455|FG001|Treatment Period|Lost to Follow-up|2|||
48338486|NCT00449033|155433454|FG000|Treatment Period|Physician Decision|4|||
48338487|NCT00449033|155433455|FG001|Treatment Period|Physician Decision|5|||
48338488|NCT00449033|155433454|FG000|Treatment Period|Protocol Violation|8|||
48338489|NCT00449033|155433455|FG001|Treatment Period|Protocol Violation|7|||
48338490|NCT00449033|155433454|FG000|Treatment Period|Disease Progression|231|||
48338491|NCT00449033|155433455|FG001|Treatment Period|Disease Progression|288|||
48338492|NCT00449033|155433454|FG000|Treatment Period|Consent Withdrawn|36|||
48661190|NCT03352453|156611182|FG000|Overall Study|Adverse Event|2|||
48661191|NCT03352453|156611183|FG001|Overall Study|Adverse Event|9|||
48338493|NCT00449033|155433455|FG001|Treatment Period|Consent Withdrawn|20|||
48338494|NCT00449033|155433454|FG000|Treatment Period|Amended Protocol Criteria|22|||
48661192|NCT03158272|156611186|FG000|Overall Study|Disease progression|3|||
48661193|NCT03158272|156611187|FG001|Overall Study|Disease progression|3|||
48661194|NCT03158272|156611188|FG002|Overall Study|Disease progression|4|||
48661195|NCT03158272|156611189|FG003|Overall Study|Disease progression|6|||
48661196|NCT03158272|156611186|FG000|Overall Study|Death|0|||
48661197|NCT03158272|156611187|FG001|Overall Study|Death|0|||
48661198|NCT03158272|156611188|FG002|Overall Study|Death|1|||
48661199|NCT03158272|156611189|FG003|Overall Study|Death|0|||
48661200|NCT03158272|156611186|FG000|Overall Study|Other reasons|0|||
48661201|NCT03158272|156611187|FG001|Overall Study|Other reasons|0|||
48661202|NCT03158272|156611188|FG002|Overall Study|Other reasons|1|||
48661203|NCT03158272|156611189|FG003|Overall Study|Other reasons|0|||
48661204|NCT03158272|156611186|FG000|Overall Study|Adverse event unrelated to the drug|0|||
48661205|NCT03158272|156611187|FG001|Overall Study|Adverse event unrelated to the drug|1|||
48661206|NCT03158272|156611188|FG002|Overall Study|Adverse event unrelated to the drug|0|||
48661207|NCT03158272|156611189|FG003|Overall Study|Adverse event unrelated to the drug|0|||
48661208|NCT03089944|156611190|FG000|Overall Study|Lost to Follow-up|8|||
48661209|NCT03089944|156611190|FG000|Overall Study|Withdrew Consent|2|||
48661210|NCT03089944|156611190|FG000|Overall Study|Adverse Event|1|||
48661211|NCT03089944|156611190|FG000|Overall Study|Other|1|||
48661212|NCT04294225|156612417|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
48661213|NCT04294225|156612417|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
48661214|NCT04294225|156612417|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
48661215|NCT04294225|156612417|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
48661216|NCT04294225|156612417|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
48661217|NCT01691885|156612420|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
48661218|NCT01691885|156612421|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
48661219|NCT01691885|156612420|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
48661220|NCT01691885|156612421|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
48661221|NCT00590824|156612437|FG000|Overall Study|Disease could not be resected|0|||
48661222|NCT00590824|156612438|FG001|Overall Study|Disease could not be resected|2|||
48661223|NCT00590824|156612439|FG002|Overall Study|Disease could not be resected|1|||
48661224|NCT00590824|156612440|FG003|Overall Study|Disease could not be resected|0|||
48661225|NCT00590824|156612437|FG000|Overall Study|Adverse Event|0|||
48661226|NCT00590824|156612438|FG001|Overall Study|Adverse Event|0|||
48338495|NCT00449033|155433455|FG001|Treatment Period|Amended Protocol Criteria|18|||
48338496|NCT00449033|155433454|FG000|Treatment Period|Non-compliance|7|||
48661227|NCT00590824|156612439|FG002|Overall Study|Adverse Event|0|||
48661228|NCT00590824|156612440|FG003|Overall Study|Adverse Event|1|||
48661229|NCT05048342|156612441|FG000|Overall Study|Adverse Event|1|||
48661230|NCT05048342|156612441|FG000|Overall Study|Subject decision|2|||
48661231|NCT01175356|156612442|FG000|Overall Study|Death|1|||
48661232|NCT01175356|156612442|FG000|Overall Study|Lack of Efficacy|12|||
48661233|NCT01175356|156612442|FG000|Overall Study|Lost to Follow-up|1|||
48661234|NCT01175356|156612442|FG000|Overall Study|Physician Decision|23|||
48338497|NCT00449033|155433455|FG001|Treatment Period|Non-compliance|8|||
48338498|NCT00449033|155433454|FG000|Treatment Period|Second Malignancy|0|||
48338499|NCT00449033|155433455|FG001|Treatment Period|Second Malignancy|1|||
48338500|NCT00449033|155433454|FG000|Treatment Period|Reason Missing|0|||
48338501|NCT00449033|155433455|FG001|Treatment Period|Reason Missing|4|||
48338502|NCT00449033|155433454|FG000|Treatment Period|Treatment Ongoing|6|||
48338503|NCT00449033|155433455|FG001|Treatment Period|Treatment Ongoing|4|||
48338504|NCT00449033|155433454|FG000|Follow-up Period|Death|299|||
48338505|NCT00449033|155433455|FG001|Follow-up Period|Death|311|||
48338506|NCT00449033|155433454|FG000|Follow-up Period|Lost to Follow-up|6|||
48338507|NCT00449033|155433455|FG001|Follow-up Period|Lost to Follow-up|10|||
48661235|NCT01175356|156612442|FG000|Overall Study|Ineligible|1|||
48661236|NCT01175356|156612442|FG000|Overall Study|Treatment Slot Not Available|18|||
48661237|NCT01175356|156612442|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
48661238|NCT01175356|156612442|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
48661239|NCT01175356|156612442|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
48661240|NCT01175356|156612442|FG000|Overall Study|Inadequate stem cell for transplant|1|||
48661241|NCT01175356|156612442|FG000|Overall Study|Initiation other tx prior to completion|9|||
48661242|NCT03020199|156612443|FG000|Treatment Period|Adverse Event|0|||
48661243|NCT03020199|156612444|FG001|Treatment Period|Adverse Event|2|||
48661244|NCT03020199|156612443|FG000|Treatment Period|Lack of Efficacy|1|||
48661245|NCT03020199|156612444|FG001|Treatment Period|Lack of Efficacy|6|||
48661246|NCT03020199|156612443|FG000|Treatment Period|Lost to Follow-up|1|||
48661247|NCT03020199|156612444|FG001|Treatment Period|Lost to Follow-up|6|||
48661248|NCT03020199|156612443|FG000|Treatment Period|Physician Decision|0|||
48661249|NCT03020199|156612444|FG001|Treatment Period|Physician Decision|1|||
48661250|NCT03020199|156612443|FG000|Treatment Period|Subject/guardian decision|8|||
48661251|NCT03020199|156612444|FG001|Treatment Period|Subject/guardian decision|15|||
48661252|NCT03020199|156612443|FG000|Treatment Period|Subjects not treated|3|||
48661253|NCT03020199|156612444|FG001|Treatment Period|Subjects not treated|4|||
48661254|NCT03020199|156612443|FG000|Follow-up Period|Disease relapse|32|||
48661255|NCT03020199|156612444|FG001|Follow-up Period|Disease relapse|7|||
48661256|NCT03020199|156612443|FG000|Follow-up Period|Lack of Efficacy|1|||
48661257|NCT03020199|156612444|FG001|Follow-up Period|Lack of Efficacy|2|||
48661258|NCT03020199|156612443|FG000|Follow-up Period|Lost to Follow-up|4|||
48661259|NCT03020199|156612444|FG001|Follow-up Period|Lost to Follow-up|6|||
48661260|NCT03020199|156612443|FG000|Follow-up Period|Physician Decision|2|||
48661261|NCT03020199|156612444|FG001|Follow-up Period|Physician Decision|2|||
48661262|NCT03020199|156612443|FG000|Follow-up Period|Protocol Violation|1|||
48661263|NCT03020199|156612444|FG001|Follow-up Period|Protocol Violation|2|||
48661264|NCT03020199|156612443|FG000|Follow-up Period|Study terminated by Sponsor|6|||
48661265|NCT03020199|156612444|FG001|Follow-up Period|Study terminated by Sponsor|3|||
48661266|NCT03020199|156612443|FG000|Follow-up Period|Subject/guardian decision|14|||
48661267|NCT03020199|156612444|FG001|Follow-up Period|Subject/guardian decision|9|||
48661268|NCT05234632|156612445|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
48661269|NCT05234632|156612446|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
48661270|NCT05234632|156612445|FG000|Overall Study|Withdrawal by Subject|2|||
48661271|NCT05234632|156612446|FG001|Overall Study|Withdrawal by Subject|0|||
48661272|NCT05234632|156612445|FG000|Overall Study|Adverse Event|0|||
48661273|NCT05234632|156612446|FG001|Overall Study|Adverse Event|4|||
48661274|NCT05234632|156612445|FG000|Overall Study|Physician Decision|1|||
48661275|NCT05234632|156612446|FG001|Overall Study|Physician Decision|1|||
48661276|NCT05234632|156612445|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
48661277|NCT05234632|156612446|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
48661278|NCT05234632|156612445|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
48661279|NCT05234632|156612446|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
48661280|NCT01778049|156612447|FG000|Open Label Treatment Period|Adverse Event|5|||
48661281|NCT01778049|156612448|FG001|Open Label Treatment Period|Adverse Event|15|||
48755489|NCT01414075|156951285|FG001|Overall Study|Adverse Event|0|||
48755490|NCT01414075|156951286|FG002|Overall Study|Adverse Event|1|||
48755491|NCT01414075|156951287|FG003|Overall Study|Adverse Event|0|||
48755492|NCT01414075|156951284|FG000|Overall Study|Death|1|||
48755493|NCT01414075|156951285|FG001|Overall Study|Death|0|||
48755494|NCT01414075|156951286|FG002|Overall Study|Death|0|||
48755495|NCT01414075|156951287|FG003|Overall Study|Death|1|||
48755496|NCT01414075|156951284|FG000|Overall Study|Withdrawal by Subject|0|||
48755497|NCT01414075|156951285|FG001|Overall Study|Withdrawal by Subject|0|||
48755498|NCT01414075|156951286|FG002|Overall Study|Withdrawal by Subject|0|||
48755499|NCT01414075|156951287|FG003|Overall Study|Withdrawal by Subject|1|||
48755500|NCT01414075|156951284|FG000|Overall Study|Other than specified|1|||
48755501|NCT01414075|156951285|FG001|Overall Study|Other than specified|0|||
48755502|NCT01414075|156951286|FG002|Overall Study|Other than specified|1|||
48755503|NCT01414075|156951287|FG003|Overall Study|Other than specified|0|||
48755504|NCT03235154|156951290|FG000|Overall Study|Withdrawal by Subject|1|||
48755505|NCT03235154|156951290|FG000|Overall Study|Adverse Event|1|||
48338508|NCT00449033|155433454|FG000|Follow-up Period|Reason Missing|120|||
48338509|NCT00449033|155433455|FG001|Follow-up Period|Reason Missing|113|||
48338510|NCT04393779|155433456|FG000|Overall Study|Death|1|||
48338511|NCT04393779|155433456|FG000|Overall Study|Device reintervention or explant|4|||
48338512|NCT01648699|155433460|FG000|Overall Study|Death|1|||
48338513|NCT01648699|155433460|FG000|Overall Study|Lost to Follow-up|2|||
48338514|NCT01648699|155433460|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
48338515|NCT02116582|155433462|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
48338516|NCT02116582|155433462|FG000|Overall Study|Adverse Event|22|||
48338517|NCT02116582|155433462|FG000|Overall Study|Death|9|||
48338518|NCT02116582|155433462|FG000|Overall Study|Progressive Disease|148|||
48338519|NCT02116582|155433462|FG000|Overall Study|Protocol Violation|3|||
48338520|NCT02116582|155433462|FG000|Overall Study|Withdrawal by Subject|8|||
48338521|NCT02116582|155433462|FG000|Overall Study|Other: Miscellaneous|11|||
48338522|NCT02116582|155433462|FG000|Overall Study|Lost to Follow-up|1|||
48338523|NCT02116582|155433462|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
48338524|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
48338525|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
48338526|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
48338527|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Other|1|||
48338528|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Other|0|||
48338529|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Other|0|||
48338530|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Physician Decision|3|||
48338531|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Physician Decision|0|||
48338532|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Physician Decision|0|||
48338533|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
48338534|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
48338535|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
48338536|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
48338537|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
48338538|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
48338539|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Adverse Event|18|||
48338540|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Adverse Event|0|||
48338541|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Adverse Event|0|||
48338542|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
48338543|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
48338544|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
48338545|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
48338546|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
48338547|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
48338548|NCT03030599|155433472|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
48338549|NCT03030599|155433473|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
48338550|NCT03030599|155433474|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
48338551|NCT03030599|155433472|FG000|Stable Dose|Protocol deviation|3|||
48338552|NCT03030599|155433473|FG001|Stable Dose|Protocol deviation|0|||
48338553|NCT03030599|155433474|FG002|Stable Dose|Protocol deviation|0|||
48338554|NCT03030599|155433472|FG000|Stable Dose|Adverse Event|1|||
48338555|NCT03030599|155433473|FG001|Stable Dose|Adverse Event|0|||
48338556|NCT03030599|155433474|FG002|Stable Dose|Adverse Event|0|||
48338557|NCT03030599|155433472|FG000|Stable Dose|Lost to Follow-up|1|||
48338558|NCT03030599|155433473|FG001|Stable Dose|Lost to Follow-up|0|||
48338559|NCT03030599|155433474|FG002|Stable Dose|Lost to Follow-up|0|||
48661282|NCT01778049|156612449|FG002|Open Label Treatment Period|Adverse Event|0|||
48338560|NCT03030599|155433472|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
48338561|NCT03030599|155433473|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
48338562|NCT03030599|155433474|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
48338563|NCT03030599|155433472|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
48338564|NCT03030599|155433473|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
48338565|NCT03030599|155433474|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
48338566|NCT03030599|155433472|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
48338567|NCT03030599|155433473|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
48661283|NCT01778049|156612450|FG003|Open Label Treatment Period|Adverse Event|0|||
48661284|NCT01778049|156612451|FG004|Open Label Treatment Period|Adverse Event|0|||
48661285|NCT01778049|156612452|FG005|Open Label Treatment Period|Adverse Event|0|||
48661286|NCT01778049|156612447|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
48338568|NCT03030599|155433474|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
48338569|NCT03030599|155433472|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
48338570|NCT03030599|155433473|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
48338571|NCT03030599|155433474|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
48338572|NCT03030599|155433472|FG000|Open-label Extension|Adverse Event|3|||
48338573|NCT03030599|155433473|FG001|Open-label Extension|Adverse Event|0|||
48338574|NCT03030599|155433474|FG002|Open-label Extension|Adverse Event|0|||
48338575|NCT03030599|155433472|FG000|Open-label Extension|Lost to Follow-up|2|||
48338576|NCT03030599|155433473|FG001|Open-label Extension|Lost to Follow-up|0|||
48338577|NCT03030599|155433474|FG002|Open-label Extension|Lost to Follow-up|0|||
48338578|NCT03030599|155433472|FG000|Open-label Extension|Lack of Efficacy|1|||
48338579|NCT03030599|155433473|FG001|Open-label Extension|Lack of Efficacy|0|||
48338580|NCT03030599|155433474|FG002|Open-label Extension|Lack of Efficacy|0|||
48338581|NCT03030599|155433472|FG000|Open-label Extension|Other Reason|1|||
48338582|NCT03030599|155433473|FG001|Open-label Extension|Other Reason|0|||
48338583|NCT03030599|155433474|FG002|Open-label Extension|Other Reason|0|||
48338584|NCT02784535|155433481|FG000|Overall Study|Adverse Event|1|||
48338585|NCT02784535|155433482|FG001|Overall Study|Adverse Event|0|||
48338586|NCT02784535|155433481|FG000|Overall Study|Withdrawal by Subject|0|||
48338587|NCT02784535|155433482|FG001|Overall Study|Withdrawal by Subject|1|||
48338588|NCT02784535|155433481|FG000|Overall Study|Physician Decision|0|||
48338589|NCT02784535|155433482|FG001|Overall Study|Physician Decision|1|||
48338590|NCT00914732|155433484|FG000|Overall Study|Lost to Follow-up|6|||
48338591|NCT00914732|155433485|FG001|Overall Study|Lost to Follow-up|7|||
48338592|NCT00914732|155433486|FG002|Overall Study|Lost to Follow-up|9|||
48338593|NCT00914732|155433484|FG000|Overall Study|Withdrawal by Subject|3|||
48338594|NCT00914732|155433485|FG001|Overall Study|Withdrawal by Subject|0|||
48338595|NCT00914732|155433486|FG002|Overall Study|Withdrawal by Subject|2|||
48338596|NCT00914732|155433484|FG000|Overall Study|Adverse Event|1|||
48338597|NCT00914732|155433485|FG001|Overall Study|Adverse Event|0|||
48338598|NCT00914732|155433486|FG002|Overall Study|Adverse Event|0|||
48338599|NCT03740919|155433487|FG000|Lead-in Period|Lost to Follow-up|1|||
48661287|NCT01778049|156612448|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
48661288|NCT01778049|156612449|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
48661289|NCT01778049|156612450|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
48661290|NCT01778049|156612451|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
48661291|NCT01778049|156612452|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
48338600|NCT03740919|155433488|FG001|Lead-in Period|Lost to Follow-up|0|||
48338601|NCT03740919|155433489|FG002|Lead-in Period|Lost to Follow-up|0|||
48338602|NCT03740919|155433490|FG003|Lead-in Period|Lost to Follow-up|0|||
48338603|NCT03740919|155433487|FG000|Lead-in Period|Physician Decision|2|||
48338604|NCT03740919|155433488|FG001|Lead-in Period|Physician Decision|0|||
48338605|NCT03740919|155433489|FG002|Lead-in Period|Physician Decision|0|||
48338606|NCT03740919|155433490|FG003|Lead-in Period|Physician Decision|0|||
48338607|NCT03740919|155433487|FG000|Lead-in Period|Protocol Violation|1|||
48338608|NCT03740919|155433488|FG001|Lead-in Period|Protocol Violation|0|||
48338609|NCT03740919|155433489|FG002|Lead-in Period|Protocol Violation|0|||
48338610|NCT03740919|155433490|FG003|Lead-in Period|Protocol Violation|0|||
48338611|NCT03740919|155433487|FG000|Lead-in Period|Withdrawal by Subject|10|||
48338612|NCT03740919|155433488|FG001|Lead-in Period|Withdrawal by Subject|0|||
48338613|NCT03740919|155433489|FG002|Lead-in Period|Withdrawal by Subject|0|||
48338614|NCT03740919|155433490|FG003|Lead-in Period|Withdrawal by Subject|0|||
48338615|NCT03740919|155433487|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
48661292|NCT01778049|156612447|FG000|Open Label Treatment Period|Protocol Violation|5|||
48661293|NCT01778049|156612448|FG001|Open Label Treatment Period|Protocol Violation|5|||
48661294|NCT01778049|156612449|FG002|Open Label Treatment Period|Protocol Violation|0|||
48661295|NCT01778049|156612450|FG003|Open Label Treatment Period|Protocol Violation|0|||
48661296|NCT01778049|156612451|FG004|Open Label Treatment Period|Protocol Violation|0|||
48661297|NCT01778049|156612452|FG005|Open Label Treatment Period|Protocol Violation|0|||
48661298|NCT01778049|156612447|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
48661299|NCT01778049|156612448|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
48661300|NCT01778049|156612449|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
48661301|NCT01778049|156612450|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
48661302|NCT01778049|156612451|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
48661303|NCT01778049|156612452|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
48661304|NCT01778049|156612447|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
48661305|NCT01778049|156612448|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
48661306|NCT01778049|156612449|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
48661307|NCT01778049|156612450|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
48661308|NCT01778049|156612451|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
48338616|NCT03740919|155433488|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
48338617|NCT03740919|155433489|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
48338618|NCT03740919|155433490|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
48338619|NCT03740919|155433487|FG000|Lead-in Period|Study Task Too Burdensome|1|||
48338620|NCT03740919|155433488|FG001|Lead-in Period|Study Task Too Burdensome|0|||
48338621|NCT03740919|155433489|FG002|Lead-in Period|Study Task Too Burdensome|0|||
48338622|NCT03740919|155433490|FG003|Lead-in Period|Study Task Too Burdensome|0|||
48338623|NCT03740919|155433487|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
48661309|NCT01778049|156612452|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
48661310|NCT01778049|156612447|FG000|Open Label Treatment Period|Not treated|2|||
48692743|NCT01339689|156724588|FG000|Overall Study|Lost to Follow-up|9|||
48661311|NCT01778049|156612448|FG001|Open Label Treatment Period|Not treated|1|||
48661312|NCT01778049|156612449|FG002|Open Label Treatment Period|Not treated|0|||
48661313|NCT01778049|156612450|FG003|Open Label Treatment Period|Not treated|0|||
48661314|NCT01778049|156612451|FG004|Open Label Treatment Period|Not treated|0|||
48661315|NCT01778049|156612452|FG005|Open Label Treatment Period|Not treated|0|||
48661316|NCT01778049|156612447|FG000|Open Label Treatment Period|Other reason not defined above|77|||
48661317|NCT01778049|156612448|FG001|Open Label Treatment Period|Other reason not defined above|94|||
48661318|NCT01778049|156612449|FG002|Open Label Treatment Period|Other reason not defined above|0|||
48661319|NCT01778049|156612450|FG003|Open Label Treatment Period|Other reason not defined above|0|||
48661320|NCT01778049|156612451|FG004|Open Label Treatment Period|Other reason not defined above|0|||
48661321|NCT01778049|156612452|FG005|Open Label Treatment Period|Other reason not defined above|0|||
48661322|NCT01778049|156612447|FG000|Double Blind Treatment Period|Adverse Event|0|||
48661323|NCT01778049|156612448|FG001|Double Blind Treatment Period|Adverse Event|0|||
48661324|NCT01778049|156612449|FG002|Double Blind Treatment Period|Adverse Event|4|||
48661325|NCT01778049|156612450|FG003|Double Blind Treatment Period|Adverse Event|5|||
48661326|NCT01778049|156612451|FG004|Double Blind Treatment Period|Adverse Event|3|||
48661327|NCT01778049|156612452|FG005|Double Blind Treatment Period|Adverse Event|2|||
48661328|NCT01778049|156612447|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
48661329|NCT01778049|156612448|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
48661330|NCT01778049|156612449|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
48661331|NCT01778049|156612450|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
48661332|NCT01778049|156612451|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
48661333|NCT01778049|156612452|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
48661334|NCT01778049|156612447|FG000|Double Blind Treatment Period|Protocol Violation|0|||
48661335|NCT01778049|156612448|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48661336|NCT01778049|156612449|FG002|Double Blind Treatment Period|Protocol Violation|2|||
48661337|NCT01778049|156612450|FG003|Double Blind Treatment Period|Protocol Violation|0|||
48338624|NCT03740919|155433488|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
48338625|NCT03740919|155433489|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
48338626|NCT03740919|155433490|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
48338627|NCT03740919|155433487|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
48338628|NCT03740919|155433488|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
48338629|NCT03740919|155433489|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
48338630|NCT03740919|155433490|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
48338631|NCT03740919|155433487|FG000|Treatment Period|Adverse Event|0|||
48338632|NCT03740919|155433488|FG001|Treatment Period|Adverse Event|0|||
48338633|NCT03740919|155433489|FG002|Treatment Period|Adverse Event|2|||
48338634|NCT03740919|155433490|FG003|Treatment Period|Adverse Event|0|||
48338635|NCT03740919|155433487|FG000|Treatment Period|Protocol Violation|0|||
48338636|NCT03740919|155433488|FG001|Treatment Period|Protocol Violation|1|||
48338637|NCT03740919|155433489|FG002|Treatment Period|Protocol Violation|0|||
48338638|NCT03740919|155433490|FG003|Treatment Period|Protocol Violation|0|||
48338639|NCT03740919|155433487|FG000|Treatment Period|Withdrawal by Subject|0|||
48338640|NCT03740919|155433488|FG001|Treatment Period|Withdrawal by Subject|7|||
48338641|NCT03740919|155433489|FG002|Treatment Period|Withdrawal by Subject|6|||
48338642|NCT03740919|155433490|FG003|Treatment Period|Withdrawal by Subject|2|||
48338643|NCT03740919|155433487|FG000|Treatment Period|Terminated by Sponsor|0|||
48338644|NCT03740919|155433488|FG001|Treatment Period|Terminated by Sponsor|1|||
48338645|NCT03740919|155433489|FG002|Treatment Period|Terminated by Sponsor|0|||
48338646|NCT03740919|155433490|FG003|Treatment Period|Terminated by Sponsor|0|||
48338647|NCT03740919|155433487|FG000|Treatment Period|Issue with Insulin Pump|0|||
48338648|NCT03740919|155433488|FG001|Treatment Period|Issue with Insulin Pump|1|||
48338649|NCT03740919|155433489|FG002|Treatment Period|Issue with Insulin Pump|0|||
48338650|NCT03740919|155433490|FG003|Treatment Period|Issue with Insulin Pump|0|||
48338651|NCT03740919|155433487|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
48338652|NCT03740919|155433488|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
48338653|NCT03740919|155433489|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
48661338|NCT01778049|156612451|FG004|Double Blind Treatment Period|Protocol Violation|0|||
48661339|NCT01778049|156612452|FG005|Double Blind Treatment Period|Protocol Violation|0|||
48661340|NCT01778049|156612447|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
48661341|NCT01778049|156612448|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48661342|NCT01778049|156612449|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
48338654|NCT03740919|155433490|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
48338655|NCT03740919|155433487|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
48338656|NCT03740919|155433488|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
48338657|NCT03740919|155433489|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
48338658|NCT03740919|155433490|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
48661343|NCT01778049|156612450|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
48661344|NCT01778049|156612451|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
48661345|NCT01778049|156612452|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
48692744|NCT01339689|156724589|FG001|Overall Study|Lost to Follow-up|3|||
48338659|NCT03740919|155433487|FG000|Treatment Period|Not Completing Diary|0|||
48338660|NCT03740919|155433488|FG001|Treatment Period|Not Completing Diary|0|||
48338661|NCT03740919|155433489|FG002|Treatment Period|Not Completing Diary|1|||
48338662|NCT03740919|155433490|FG003|Treatment Period|Not Completing Diary|0|||
48338663|NCT03740919|155433487|FG000|Treatment Period|Insulin Painful to Participant|0|||
48338664|NCT03740919|155433488|FG001|Treatment Period|Insulin Painful to Participant|0|||
48338665|NCT03740919|155433489|FG002|Treatment Period|Insulin Painful to Participant|1|||
48338666|NCT03740919|155433490|FG003|Treatment Period|Insulin Painful to Participant|0|||
48338667|NCT02335242|155433491|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
48338668|NCT02335242|155433492|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
48338669|NCT02335242|155433491|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
48338670|NCT02335242|155433492|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
48338671|NCT02335242|155433491|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
48338672|NCT02335242|155433492|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
48338673|NCT04839289|155433494|FG000|Overall Study|Withdrawal by Subject|1|||
48338674|NCT04839289|155433495|FG001|Overall Study|Withdrawal by Subject|0|||
48338675|NCT02418819|155433496|FG000|Overall Study|Adverse Event|0|||
48338676|NCT02418819|155433497|FG001|Overall Study|Adverse Event|0|||
48338677|NCT02418819|155433498|FG002|Overall Study|Adverse Event|1|||
48338678|NCT02418819|155433499|FG003|Overall Study|Adverse Event|0|||
48338679|NCT02418819|155433496|FG000|Overall Study|Lost to Follow-up|1|||
48338680|NCT02418819|155433497|FG001|Overall Study|Lost to Follow-up|0|||
48338681|NCT02418819|155433498|FG002|Overall Study|Lost to Follow-up|0|||
48338682|NCT02418819|155433499|FG003|Overall Study|Lost to Follow-up|0|||
48338683|NCT02418819|155433496|FG000|Overall Study|No longer meets eligibility criteria|0|||
48338684|NCT02418819|155433497|FG001|Overall Study|No longer meets eligibility criteria|0|||
48338685|NCT02418819|155433498|FG002|Overall Study|No longer meets eligibility criteria|1|||
48338686|NCT02418819|155433499|FG003|Overall Study|No longer meets eligibility criteria|0|||
48338687|NCT02418819|155433496|FG000|Overall Study|No longer willing to participate|0|||
48338688|NCT02418819|155433497|FG001|Overall Study|No longer willing to participate|0|||
48338689|NCT02418819|155433498|FG002|Overall Study|No longer willing to participate|2|||
48755506|NCT03235154|156951290|FG000|Overall Study|Lost to Follow-up|2|||
48755507|NCT01922089|156951291|FG000|Overall Study|Adverse Event|18|||
48755508|NCT01922089|156951292|FG001|Overall Study|Adverse Event|13|||
48755509|NCT01922089|156951291|FG000|Overall Study|Protocol Deviation|10|||
48755510|NCT01922089|156951292|FG001|Overall Study|Protocol Deviation|7|||
48755511|NCT01922089|156951291|FG000|Overall Study|Withdrawal by Subject|3|||
48755512|NCT01922089|156951292|FG001|Overall Study|Withdrawal by Subject|4|||
48755513|NCT01922089|156951291|FG000|Overall Study|administrative problems|4|||
48755514|NCT01922089|156951292|FG001|Overall Study|administrative problems|1|||
48755515|NCT01922089|156951291|FG000|Overall Study|Physician Decision|2|||
48755516|NCT01922089|156951292|FG001|Overall Study|Physician Decision|3|||
48755517|NCT01922089|156951291|FG000|Overall Study|Death|2|||
48755518|NCT01922089|156951292|FG001|Overall Study|Death|1|||
48755519|NCT01922089|156951291|FG000|Overall Study|Lost to Follow-up|0|||
48755520|NCT01922089|156951292|FG001|Overall Study|Lost to Follow-up|1|||
48755521|NCT04200456|156951293|FG000|Overall Study|Physician Decision|0|||
48755522|NCT04200456|156951294|FG001|Overall Study|Physician Decision|1|||
48755523|NCT04200456|156951293|FG000|Overall Study|Withdrawal by Subject|2|||
48755524|NCT04200456|156951294|FG001|Overall Study|Withdrawal by Subject|2|||
48755525|NCT04200456|156951293|FG000|Overall Study|Lack of Efficacy|1|||
48755526|NCT04200456|156951294|FG001|Overall Study|Lack of Efficacy|1|||
48338690|NCT02418819|155433499|FG003|Overall Study|No longer willing to participate|1|||
48338691|NCT00676663|155433500|FG000|Overall Study|Death|43|||
48338692|NCT00676663|155433501|FG001|Overall Study|Death|27|||
48338693|NCT00676663|155433500|FG000|Overall Study|Withdrew Consent|1|||
48338694|NCT00676663|155433501|FG001|Overall Study|Withdrew Consent|8|||
48338695|NCT00676663|155433500|FG000|Overall Study|Lost to Follow-up|1|||
48338696|NCT00676663|155433501|FG001|Overall Study|Lost to Follow-up|3|||
48661346|NCT01778049|156612447|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
48661347|NCT01778049|156612448|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
48661348|NCT01778049|156612449|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
48661349|NCT01778049|156612450|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
48661350|NCT01778049|156612451|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
48661351|NCT01778049|156612452|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
48661352|NCT01778049|156612447|FG000|Double Blind Treatment Period|Not treated|0|||
48661353|NCT01778049|156612448|FG001|Double Blind Treatment Period|Not treated|0|||
48755527|NCT04200456|156951293|FG000|Overall Study|Adverse event, non-fatal|0|||
48338697|NCT03640754|155433505|FG000|Overall Study|Withdrawal by Subject|1|||
48338698|NCT03640754|155433506|FG001|Overall Study|Withdrawal by Subject|0|||
48338699|NCT03640754|155433505|FG000|Overall Study|Lost to Follow-up|0|||
48338700|NCT03640754|155433506|FG001|Overall Study|Lost to Follow-up|1|||
48428223|NCT02531373|155756499|FG001|Overall Study|Physician Decision|0|||
48755528|NCT04200456|156951294|FG001|Overall Study|Adverse event, non-fatal|1|||
48755529|NCT04200456|156951293|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
48338701|NCT04435522|155433509|FG000|Overall Study|Withdrawal by Subject|2|||
48338702|NCT02799745|155433510|FG000|Overall Study|Participant moved out of state|1|||
48338703|NCT02799745|155433511|FG001|Overall Study|Participant moved out of state|0|||
48338704|NCT02799745|155433510|FG000|Overall Study|Discontinued due to planned surgery|1|||
48338705|NCT02799745|155433511|FG001|Overall Study|Discontinued due to planned surgery|0|||
48338706|NCT02799745|155433510|FG000|Overall Study|Withdrawal by Subject|16|||
48338707|NCT02799745|155433511|FG001|Overall Study|Withdrawal by Subject|25|||
48338708|NCT02799745|155433510|FG000|Overall Study|Protocol Deviation|4|||
48338709|NCT02799745|155433511|FG001|Overall Study|Protocol Deviation|5|||
48338710|NCT02799745|155433510|FG000|Overall Study|Progressive Disease|28|||
48338711|NCT02799745|155433511|FG001|Overall Study|Progressive Disease|38|||
48338712|NCT02799745|155433510|FG000|Overall Study|Lost to Follow-up|3|||
48338713|NCT02799745|155433511|FG001|Overall Study|Lost to Follow-up|2|||
48338714|NCT02799745|155433510|FG000|Overall Study|Death|3|||
48338715|NCT02799745|155433511|FG001|Overall Study|Death|0|||
48338716|NCT02799745|155433510|FG000|Overall Study|Adverse Event|0|||
48338717|NCT02799745|155433511|FG001|Overall Study|Adverse Event|1|||
48338718|NCT04853238|155433512|FG000|Overall Study|Death|4|||
48338719|NCT04853238|155433513|FG001|Overall Study|Death|0|||
48338720|NCT04853238|155433514|FG002|Overall Study|Death|2|||
48338721|NCT04853238|155433512|FG000|Overall Study|Lost to Follow-up|16|||
48338722|NCT04853238|155433513|FG001|Overall Study|Lost to Follow-up|2|||
48338723|NCT04853238|155433514|FG002|Overall Study|Lost to Follow-up|37|||
48338724|NCT04853238|155433512|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
48338725|NCT04853238|155433513|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
48338726|NCT04853238|155433514|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
48661354|NCT01778049|156612449|FG002|Double Blind Treatment Period|Not treated|0|||
48661355|NCT01778049|156612450|FG003|Double Blind Treatment Period|Not treated|2|||
48661356|NCT01778049|156612451|FG004|Double Blind Treatment Period|Not treated|2|||
48661357|NCT01778049|156612452|FG005|Double Blind Treatment Period|Not treated|0|||
48661358|NCT01778049|156612447|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
48661359|NCT01778049|156612448|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
48661360|NCT01778049|156612449|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
48661361|NCT01778049|156612450|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
48661362|NCT01778049|156612451|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
48661363|NCT01778049|156612452|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
48661364|NCT00496197|156612453|FG000|Overall Study|Discontinued study due to death|43|||
48661365|NCT00496197|156612453|FG000|Overall Study|Adverse Event|13|||
48661366|NCT00496197|156612453|FG000|Overall Study|Does not meet entrance criteria|5|||
48661367|NCT00496197|156612453|FG000|Overall Study|Insufficient clinical response|3|||
48661368|NCT00496197|156612453|FG000|Overall Study|Insufficient bacteriological response|10|||
48661369|NCT00496197|156612453|FG000|Overall Study|Lost to Follow-up|11|||
48661370|NCT00496197|156612453|FG000|Overall Study|Withdrawal by Subject|11|||
48661371|NCT00496197|156612453|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
48661372|NCT00496197|156612453|FG000|Overall Study|Other|14|||
48661373|NCT00496197|156612453|FG000|Overall Study|Protocol Violation|8|||
48661374|NCT03773133|156612454|FG000|Overall Study|Screen Failure|8|||
48661375|NCT01344538|156612455|FG000|Overall Study|Adverse Event|1|||
48661376|NCT01344538|156612456|FG001|Overall Study|Adverse Event|1|||
48661377|NCT01344538|156612455|FG000|Overall Study|Lost to Follow-up|1|||
48661378|NCT01344538|156612456|FG001|Overall Study|Lost to Follow-up|0|||
48661379|NCT04564027|156612458|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
48661380|NCT04564027|156612459|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
48661381|NCT04564027|156612460|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
48661382|NCT04564027|156612461|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
48661383|NCT02509039|156612465|FG000|Overall Study|Adverse Event|0|||
48338727|NCT04853238|155433512|FG000|Overall Study|Withdrawal by Subject|6|||
48338728|NCT04853238|155433513|FG001|Overall Study|Withdrawal by Subject|0|||
48338729|NCT04853238|155433514|FG002|Overall Study|Withdrawal by Subject|21|||
48338730|NCT04853238|155433512|FG000|Overall Study|Physician Decision|0|||
48338731|NCT04853238|155433513|FG001|Overall Study|Physician Decision|0|||
48338732|NCT04853238|155433514|FG002|Overall Study|Physician Decision|2|||
48338733|NCT04853238|155433512|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
48338734|NCT04853238|155433513|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
48338735|NCT04853238|155433514|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
48338736|NCT02294461|155433515|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
48338737|NCT02294461|155433516|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
48661384|NCT02509039|156612466|FG001|Overall Study|Adverse Event|1|||
48661385|NCT02509039|156612467|FG002|Overall Study|Adverse Event|1|||
48338738|NCT02294461|155433515|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
48338739|NCT02294461|155433516|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
48338740|NCT02294461|155433515|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
48338741|NCT02294461|155433516|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
48338742|NCT02294461|155433515|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
48338743|NCT02294461|155433516|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
48338744|NCT02294461|155433515|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
48338745|NCT02294461|155433516|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
48338746|NCT02294461|155433515|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
48338747|NCT02294461|155433516|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
48338748|NCT02294461|155433515|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
48338749|NCT02294461|155433516|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
48338750|NCT02294461|155433515|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
48338751|NCT02294461|155433516|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
48338752|NCT02294461|155433515|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
48338753|NCT02294461|155433516|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
48338754|NCT02294461|155433515|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
48338755|NCT02294461|155433516|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
48338756|NCT02294461|155433515|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
48338757|NCT02294461|155433516|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
48338758|NCT02294461|155433515|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
48338759|NCT02294461|155433516|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
48338760|NCT02294461|155433515|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
48338761|NCT02294461|155433516|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
48338762|NCT02294461|155433515|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
48338763|NCT02294461|155433516|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
48338764|NCT02294461|155433515|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
48338765|NCT02294461|155433516|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
48338766|NCT00747149|155434715|FG000|Overall Study|Adverse Event|0|||
48338767|NCT00747149|155434716|FG001|Overall Study|Adverse Event|15|||
48338768|NCT00747149|155434715|FG000|Overall Study|Lost to Follow-up|0|||
48338769|NCT00747149|155434716|FG001|Overall Study|Lost to Follow-up|10|||
48338770|NCT00747149|155434715|FG000|Overall Study|Withdrawal by Subject|0|||
48338771|NCT00747149|155434716|FG001|Overall Study|Withdrawal by Subject|6|||
48338772|NCT00747149|155434715|FG000|Overall Study|Did not receive treatment|0|||
48338773|NCT00747149|155434716|FG001|Overall Study|Did not receive treatment|1|||
48338774|NCT00747149|155434715|FG000|Overall Study|Incorrect enrollment|0|||
48338775|NCT00747149|155434716|FG001|Overall Study|Incorrect enrollment|6|||
48338776|NCT00747149|155434715|FG000|Overall Study|Severe non-compliance to protocol|0|||
48338777|NCT00747149|155434716|FG001|Overall Study|Severe non-compliance to protocol|1|||
48338778|NCT00747149|155434715|FG000|Overall Study|Not reported|1|||
48338779|NCT00747149|155434716|FG001|Overall Study|Not reported|4|||
48338780|NCT01799993|155434717|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
48338781|NCT01799993|155434718|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
48338782|NCT01799993|155434717|FG000|Overall Study|Death|61|||
48338783|NCT01799993|155434718|FG001|Overall Study|Death|45|||
48338784|NCT01799993|155434717|FG000|Overall Study|Withdrawal by Subject|23|||
48338785|NCT01799993|155434718|FG001|Overall Study|Withdrawal by Subject|24|||
48338786|NCT01799993|155434717|FG000|Overall Study|Lost to Follow-up|5|||
48338787|NCT01799993|155434718|FG001|Overall Study|Lost to Follow-up|8|||
48338788|NCT01799993|155434717|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
48338789|NCT01799993|155434718|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
48661386|NCT02509039|156612468|FG003|Overall Study|Adverse Event|1|||
48661387|NCT02509039|156612465|FG000|Overall Study|Withdrawal by Subject|0|||
48338790|NCT01799993|155434717|FG000|Overall Study|Protocol driven decision point|0|||
48338791|NCT01799993|155434718|FG001|Overall Study|Protocol driven decision point|3|||
48338792|NCT01799993|155434717|FG000|Overall Study|Protocol Violation|1|||
48338793|NCT01799993|155434718|FG001|Overall Study|Protocol Violation|1|||
48338794|NCT01799993|155434717|FG000|Overall Study|Deterioration of general conditions|2|||
48338795|NCT01799993|155434718|FG001|Overall Study|Deterioration of general conditions|0|||
48338796|NCT01799993|155434717|FG000|Overall Study|Screen failure|0|||
48661388|NCT02509039|156612466|FG001|Overall Study|Withdrawal by Subject|0|||
48338797|NCT01799993|155434718|FG001|Overall Study|Screen failure|1|||
48338798|NCT01799993|155434717|FG000|Overall Study|Adverse Event|1|||
48338799|NCT01799993|155434718|FG001|Overall Study|Adverse Event|0|||
48338800|NCT01799993|155434717|FG000|Overall Study|Lack of Efficacy|1|||
48338801|NCT01799993|155434718|FG001|Overall Study|Lack of Efficacy|0|||
48338802|NCT01799993|155434717|FG000|Overall Study|Recovery|0|||
48338803|NCT01799993|155434718|FG001|Overall Study|Recovery|1|||
48338804|NCT01799993|155434717|FG000|Overall Study|Logistical difficulties|1|||
48338805|NCT01799993|155434718|FG001|Overall Study|Logistical difficulties|0|||
48338806|NCT01799993|155434717|FG000|Overall Study|Protocol deviation|1|||
48338807|NCT01799993|155434718|FG001|Overall Study|Protocol deviation|0|||
48338808|NCT01799993|155434717|FG000|Overall Study|Non-compliance with medical device|1|||
48338809|NCT01799993|155434718|FG001|Overall Study|Non-compliance with medical device|0|||
48338810|NCT01799993|155434717|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48338811|NCT01799993|155434718|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48338812|NCT01799993|155434717|FG000|Overall Study|Other|1|||
48338813|NCT01799993|155434718|FG001|Overall Study|Other|0|||
48338814|NCT01799993|155434717|FG000|Overall Study|Subject didn't return for follow-up|0|||
48338815|NCT01799993|155434718|FG001|Overall Study|Subject didn't return for follow-up|1|||
48338816|NCT05361304|155434722|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
48338817|NCT05361304|155434723|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
48338818|NCT05361304|155434722|FG000|Overall Study|COVID-19 Related|1|||
48338819|NCT05361304|155434723|FG001|Overall Study|COVID-19 Related|2|||
48338820|NCT05361304|155434722|FG000|Overall Study|Withdrawal by Subject|1|||
48338821|NCT05361304|155434723|FG001|Overall Study|Withdrawal by Subject|0|||
48338822|NCT02409732|155434724|FG000|Overall Study|Withdrawal by Subject|4|||
48338823|NCT02409732|155434724|FG000|Overall Study|Lost to Follow-up|2|||
48338824|NCT03320941|155434725|FG000|Overall Study|subject/guardian decision|0|||
48338825|NCT03320941|155434726|FG001|Overall Study|subject/guardian decision|0|||
48338826|NCT03320941|155434727|FG002|Overall Study|subject/guardian decision|0|||
48338827|NCT03320941|155434728|FG003|Overall Study|subject/guardian decision|1|||
48338828|NCT03320941|155434729|FG004|Overall Study|subject/guardian decision|0|||
48338829|NCT00376259|155434730|FG000|Overall Study|Sponsor request - study termination|21|||
48338830|NCT00376259|155434731|FG001|Overall Study|Sponsor request - study termination|21|||
48338831|NCT00376259|155434730|FG000|Overall Study|Patient request|1|||
48338832|NCT00376259|155434731|FG001|Overall Study|Patient request|0|||
48338833|NCT03960437|155434734|FG000|Overall Study|Removed by PI|4|||
48338834|NCT03960437|155434734|FG000|Overall Study|Lost to Follow-up|2|||
48338835|NCT03960437|155434734|FG000|Overall Study|Withdrawal by Subject|1|||
48338836|NCT03960437|155434734|FG000|Overall Study|Death|2|||
48338837|NCT01636258|155434740|FG000|Overall Study|Lost to Follow-up|1|||
48338838|NCT01636258|155434741|FG001|Overall Study|Lost to Follow-up|0|||
48338839|NCT03614923|155434742|FG000|Overall Study|Withdrawal by Subject|2|||
48338840|NCT03614923|155434743|FG001|Overall Study|Withdrawal by Subject|1|||
48338841|NCT03614923|155434744|FG002|Overall Study|Withdrawal by Subject|1|||
48338842|NCT03614923|155434742|FG000|Overall Study|Adverse Event|0|||
48338843|NCT03614923|155434743|FG001|Overall Study|Adverse Event|2|||
48338844|NCT03614923|155434744|FG002|Overall Study|Adverse Event|1|||
48338845|NCT03614923|155434742|FG000|Overall Study|Lost to Follow-up|1|||
48338846|NCT03614923|155434743|FG001|Overall Study|Lost to Follow-up|0|||
48338847|NCT03614923|155434744|FG002|Overall Study|Lost to Follow-up|1|||
48338848|NCT03614923|155434742|FG000|Overall Study|Lack of Efficacy|2|||
48338849|NCT03614923|155434743|FG001|Overall Study|Lack of Efficacy|0|||
48338850|NCT03614923|155434744|FG002|Overall Study|Lack of Efficacy|1|||
48338851|NCT03614923|155434742|FG000|Overall Study|Non-compliance|0|||
48338852|NCT03614923|155434743|FG001|Overall Study|Non-compliance|1|||
48338853|NCT03614923|155434744|FG002|Overall Study|Non-compliance|0|||
48338854|NCT03614923|155434742|FG000|Overall Study|Other|0|||
48338855|NCT03614923|155434743|FG001|Overall Study|Other|1|||
48338856|NCT03614923|155434744|FG002|Overall Study|Other|1|||
48338857|NCT03360071|155434745|FG000|Overall Study|Lost to Follow-up|1|||
48338858|NCT03360071|155434746|FG001|Overall Study|Lost to Follow-up|0|||
48338859|NCT02798861|155434747|FG000|Overall Study|Lost to Follow-up|22|||
48338860|NCT02798861|155434747|FG000|Overall Study|Withdrawal by Subject|1|||
48338861|NCT00946088|155434748|FG000|Overall Study|Withdrawal by Subject|0|||
48338862|NCT00946088|155434749|FG001|Overall Study|Withdrawal by Subject|1|||
48338863|NCT01882088|155434750|FG000|Overall Study|Intolerance of esophageal manometry|1|||
48338864|NCT01882088|155434750|FG000|Overall Study|no possibility to place the catheter|1|||
48338865|NCT01882088|155434750|FG000|Overall Study|Protocol Violation|1|||
48338866|NCT01882088|155434750|FG000|Overall Study|inadequate pH-impedance tracings|2|||
48338867|NCT03436797|155434757|FG000|Main Study|Withdrawal by Subject|2|||
48338868|NCT03436797|155434757|FG000|Main Study|Adverse Event|4|||
48338869|NCT03436797|155434757|FG000|Main Study|Lost to Follow-up|1|||
48338870|NCT03436797|155434757|FG000|Main Study|Death|1|||
48338871|NCT03436797|155434757|FG000|Main Study|Non-Specific|2|||
48338872|NCT03436797|155434757|FG000|Extended Dosing|Patient decision|1|||
48338873|NCT01077284|155434760|FG000|Overall Study|Adverse Event|2|||
48338874|NCT01077284|155434761|FG001|Overall Study|Adverse Event|0|||
48338875|NCT01077284|155434762|FG002|Overall Study|Adverse Event|1|||
48338876|NCT01077284|155434760|FG000|Overall Study|Lost to Follow-up|1|||
48338877|NCT01077284|155434761|FG001|Overall Study|Lost to Follow-up|2|||
48338878|NCT01077284|155434762|FG002|Overall Study|Lost to Follow-up|0|||
48338879|NCT01077284|155434760|FG000|Overall Study|Withdrawal by Subject|2|||
48338880|NCT01077284|155434761|FG001|Overall Study|Withdrawal by Subject|3|||
48338881|NCT01077284|155434762|FG002|Overall Study|Withdrawal by Subject|1|||
48338882|NCT01077284|155434760|FG000|Overall Study|Other|0|||
48338883|NCT01077284|155434761|FG001|Overall Study|Other|0|||
48338884|NCT01077284|155434762|FG002|Overall Study|Other|1|||
48338885|NCT02023099|155434763|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
48338886|NCT02023099|155434764|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
48338887|NCT02023099|155434765|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
48338888|NCT02023099|155434763|FG000|Overall Study|Withdrawn Consent|3|||
48338889|NCT02023099|155434764|FG001|Overall Study|Withdrawn Consent|0|||
48338890|NCT02023099|155434765|FG002|Overall Study|Withdrawn Consent|1|||
48338891|NCT02023099|155434763|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
48338892|NCT02023099|155434764|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
48338893|NCT02023099|155434765|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
48338894|NCT02632747|155434766|FG000|Wash-out Period|Adverse Event|1|||
48338895|NCT02632747|155434767|FG001|Wash-out Period|Adverse Event|0|||
48338896|NCT00730925|155434768|FG000|Overall Study|Progressive Disease|21|||
48338897|NCT00730925|155434768|FG000|Overall Study|Dose reducing Event|2|||
48338898|NCT00730925|155434768|FG000|Overall Study|Other Averse Event|7|||
48338899|NCT00730925|155434768|FG000|Overall Study|Protocol Violation|1|||
48338900|NCT00730925|155434768|FG000|Overall Study|Withdrawal by Subject|1|||
48338901|NCT00730925|155434768|FG000|Overall Study|Switch to combination therapy|8|||
48338902|NCT00730925|155434768|FG000|Overall Study|Other|1|||
48338903|NCT03481725|155434769|FG000|Overall Study|Withdrawal by Subject|1|||
48338904|NCT03481725|155434770|FG001|Overall Study|Withdrawal by Subject|0|||
48338905|NCT00472199|155434774|FG000|Overall Study|Adverse Event|19|||
48338906|NCT00472199|155434775|FG001|Overall Study|Adverse Event|23|||
48338907|NCT00472199|155434774|FG000|Overall Study|Lack of Efficacy|4|||
48338908|NCT00472199|155434775|FG001|Overall Study|Lack of Efficacy|25|||
48338909|NCT00472199|155434774|FG000|Overall Study|Lost to Follow-up|2|||
48338910|NCT00472199|155434775|FG001|Overall Study|Lost to Follow-up|4|||
48338911|NCT00472199|155434774|FG000|Overall Study|Protocol Violation|3|||
48338912|NCT00472199|155434775|FG001|Overall Study|Protocol Violation|2|||
48338913|NCT00472199|155434774|FG000|Overall Study|Withdrawal by Subject|6|||
48338914|NCT00472199|155434775|FG001|Overall Study|Withdrawal by Subject|5|||
48338915|NCT00472199|155434774|FG000|Overall Study|personal reason|0|||
48661389|NCT02509039|156612467|FG002|Overall Study|Withdrawal by Subject|1|||
48661390|NCT02509039|156612468|FG003|Overall Study|Withdrawal by Subject|0|||
48661391|NCT02509039|156612465|FG000|Overall Study|Progressive disease|2|||
48661392|NCT02509039|156612466|FG001|Overall Study|Progressive disease|2|||
48661393|NCT02509039|156612467|FG002|Overall Study|Progressive disease|1|||
48661394|NCT02509039|156612468|FG003|Overall Study|Progressive disease|5|||
48661395|NCT02509039|156612465|FG000|Overall Study|Study terminated by Sponsor|1|||
48338916|NCT00472199|155434775|FG001|Overall Study|personal reason|1|||
48338917|NCT00472199|155434774|FG000|Overall Study|patient was asymptomatic|1|||
48661396|NCT02509039|156612466|FG001|Overall Study|Study terminated by Sponsor|0|||
48661397|NCT02509039|156612467|FG002|Overall Study|Study terminated by Sponsor|0|||
48661398|NCT02509039|156612468|FG003|Overall Study|Study terminated by Sponsor|0|||
48661399|NCT04979897|156612471|FG000|Overall Study|Death|1|||
48661400|NCT04979897|156612472|FG001|Overall Study|Death|8|||
48661401|NCT04979897|156612471|FG000|Overall Study|Lost to Follow-up|111|||
48661402|NCT04979897|156612472|FG001|Overall Study|Lost to Follow-up|56|||
48661403|NCT04979897|156612471|FG000|Overall Study|Withdrawal by Subject|7|||
48661404|NCT04979897|156612472|FG001|Overall Study|Withdrawal by Subject|2|||
48661405|NCT03943550|156612475|FG000|Overall Study|Adverse Event|0|||
48661406|NCT03943550|156612476|FG001|Overall Study|Adverse Event|0|||
48661407|NCT03943550|156612477|FG002|Overall Study|Adverse Event|1|||
48661408|NCT03943550|156612475|FG000|Overall Study|Lost to Follow-up|0|||
48661409|NCT03943550|156612476|FG001|Overall Study|Lost to Follow-up|0|||
48661410|NCT03943550|156612477|FG002|Overall Study|Lost to Follow-up|1|||
48661411|NCT03943550|156612475|FG000|Overall Study|Progressive Disease|0|||
48661412|NCT03943550|156612476|FG001|Overall Study|Progressive Disease|0|||
48338918|NCT00472199|155434775|FG001|Overall Study|patient was asymptomatic|0|||
48338919|NCT01107912|155434776|FG000|Period 1|Adverse Event|0|||
48338920|NCT01107912|155434777|FG001|Period 1|Adverse Event|0|||
48338921|NCT01107912|155434778|FG002|Period 1|Adverse Event|0|||
48661413|NCT03943550|156612477|FG002|Overall Study|Progressive Disease|2|||
48338922|NCT01107912|155434779|FG003|Period 1|Adverse Event|0|||
48661414|NCT03943550|156612475|FG000|Overall Study|Participant Moved Out of the Country|0|||
48661415|NCT03943550|156612476|FG001|Overall Study|Participant Moved Out of the Country|1|||
48338923|NCT01107912|155434780|FG004|Period 1|Adverse Event|2|||
48338924|NCT01107912|155434781|FG005|Period 1|Adverse Event|0|||
48338925|NCT01107912|155434776|FG000|Period 1|Physician Decision|0|||
48661416|NCT03943550|156612477|FG002|Overall Study|Participant Moved Out of the Country|0|||
48661417|NCT03664674|156612482|FG000|Overall Study|Adverse Event|1|||
48661418|NCT03664674|156612483|FG001|Overall Study|Adverse Event|1|||
48661419|NCT03664674|156612482|FG000|Overall Study|Physician Decision|0|||
48661420|NCT03664674|156612483|FG001|Overall Study|Physician Decision|1|||
48661421|NCT03664674|156612482|FG000|Overall Study|Withdrawal by Subject|2|||
48661422|NCT03664674|156612483|FG001|Overall Study|Withdrawal by Subject|0|||
48755530|NCT04200456|156951294|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
48755531|NCT01867021|156951298|FG000|Overall Study|Adverse Event|0|||
48755532|NCT01867021|156951299|FG001|Overall Study|Adverse Event|1|||
48755533|NCT01867021|156951298|FG000|Overall Study|Not Eligible|0|||
48661423|NCT00592852|156612484|FG000|Overall Study|Non-compliance|1|||
48661424|NCT00592852|156612484|FG000|Overall Study|Adverse Event|3|||
48661425|NCT00592852|156612484|FG000|Overall Study|Found ineligible|1|||
48661426|NCT00592852|156612484|FG000|Overall Study|Withdrawal by Subject|1|||
48661427|NCT04422561|156612485|FG000|Overall Study|Lost to Follow-up|25|||
48661428|NCT04422561|156612486|FG001|Overall Study|Lost to Follow-up|11|||
48661429|NCT03834519|156612491|FG000|Overall Study|Lost to Follow-up|2|||
48661430|NCT03834519|156612492|FG001|Overall Study|Lost to Follow-up|1|||
48661431|NCT03834519|156612491|FG000|Overall Study|Withdrawal by Subject|5|||
48661432|NCT03834519|156612492|FG001|Overall Study|Withdrawal by Subject|8|||
48661433|NCT03834519|156612491|FG000|Overall Study|Death|368|||
48661434|NCT03834519|156612492|FG001|Overall Study|Death|174|||
48661435|NCT03834519|156612491|FG000|Overall Study|Physician Decision|5|||
48661436|NCT03834519|156612492|FG001|Overall Study|Physician Decision|1|||
48661437|NCT03834519|156612491|FG000|Overall Study|Sponsor decision|149|||
48661438|NCT03834519|156612492|FG001|Overall Study|Sponsor decision|80|||
48661439|NCT01071200|156612504|FG000|Overall Study|Lack of ovarian response|1|||
48661440|NCT01071200|156612505|FG001|Overall Study|Lack of ovarian response|1|||
48661441|NCT01071200|156612504|FG000|Overall Study|No fertilization|4|||
48661442|NCT01071200|156612505|FG001|Overall Study|No fertilization|0|||
48661443|NCT01071200|156612504|FG000|Overall Study|No oocytes retrieved|1|||
48338926|NCT01107912|155434777|FG001|Period 1|Physician Decision|0|||
48338927|NCT01107912|155434778|FG002|Period 1|Physician Decision|0|||
48338928|NCT01107912|155434779|FG003|Period 1|Physician Decision|0|||
48338929|NCT01107912|155434780|FG004|Period 1|Physician Decision|1|||
48338930|NCT01107912|155434781|FG005|Period 1|Physician Decision|0|||
48338931|NCT01107912|155434776|FG000|Period 1|Withdrawal by Subject|1|||
48338932|NCT01107912|155434777|FG001|Period 1|Withdrawal by Subject|0|||
48338933|NCT01107912|155434778|FG002|Period 1|Withdrawal by Subject|0|||
48338934|NCT01107912|155434779|FG003|Period 1|Withdrawal by Subject|0|||
48338935|NCT01107912|155434780|FG004|Period 1|Withdrawal by Subject|0|||
48338936|NCT01107912|155434781|FG005|Period 1|Withdrawal by Subject|0|||
48338937|NCT01107912|155434776|FG000|Period 2|Physician Decision|0|||
48338938|NCT01107912|155434777|FG001|Period 2|Physician Decision|0|||
48338939|NCT01107912|155434778|FG002|Period 2|Physician Decision|1|||
48338940|NCT01107912|155434779|FG003|Period 2|Physician Decision|0|||
48338941|NCT01107912|155434780|FG004|Period 2|Physician Decision|0|||
48338942|NCT01107912|155434781|FG005|Period 2|Physician Decision|0|||
48661444|NCT01071200|156612505|FG001|Overall Study|No oocytes retrieved|1|||
48661445|NCT01071200|156612504|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
48661446|NCT01071200|156612505|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
48661447|NCT01071200|156612504|FG000|Overall Study|No viable embryos|0|||
48661448|NCT01071200|156612505|FG001|Overall Study|No viable embryos|1|||
48661449|NCT01146652|156612506|FG000|Overall Study|Adverse Event|506|||
48661450|NCT01146652|156612507|FG001|Overall Study|Adverse Event|15|||
48661451|NCT01146652|156612506|FG000|Overall Study|Lack of Efficacy|91|||
48661452|NCT01146652|156612507|FG001|Overall Study|Lack of Efficacy|7|||
48661453|NCT01146652|156612506|FG000|Overall Study|Poor compliance to protocol|38|||
48661454|NCT01146652|156612507|FG001|Overall Study|Poor compliance to protocol|1|||
48661455|NCT01146652|156612506|FG000|Overall Study|Other unspecified reasons|314|||
48661456|NCT01146652|156612507|FG001|Overall Study|Other unspecified reasons|22|||
48661457|NCT01146652|156612506|FG000|Overall Study|Enrolled but not treated|2|||
48661458|NCT01146652|156612507|FG001|Overall Study|Enrolled but not treated|0|||
48661459|NCT03440918|156612513|FG000|Overall Study|Protocol Violation|0|||
48661460|NCT03440918|156612514|FG001|Overall Study|Protocol Violation|16|||
48661461|NCT02046226|156612515|FG000|Overall Study|Lost to Follow-up|7|||
48755534|NCT01867021|156951299|FG001|Overall Study|Not Eligible|1|||
48755535|NCT01867021|156951298|FG000|Overall Study|Death|1|||
48755536|NCT01867021|156951299|FG001|Overall Study|Death|0|||
48755537|NCT01867021|156951298|FG000|Overall Study|Lost to Follow-up|0|||
48755538|NCT01867021|156951299|FG001|Overall Study|Lost to Follow-up|2|||
48755539|NCT01867021|156951298|FG000|Overall Study|Withdrawal by Subject|1|||
48755540|NCT01867021|156951299|FG001|Overall Study|Withdrawal by Subject|6|||
48338943|NCT01107912|155434776|FG000|Period 3|Adverse Event|0|||
48661462|NCT01390779|156612516|FG000|Overall Study|Physician Decision|1|||
48661463|NCT01665430|156612520|FG000|Overall Study|Adverse Event|1|||
48755541|NCT00619801|156951300|FG000|Overall Study|Lack of Efficacy|0|||
48338944|NCT01107912|155434777|FG001|Period 3|Adverse Event|1|||
48338945|NCT01107912|155434778|FG002|Period 3|Adverse Event|1|||
48755542|NCT00619801|156951301|FG001|Overall Study|Lack of Efficacy|1|||
48661464|NCT01665430|156612520|FG000|Overall Study|Withdrawal by Subject|6|||
48661465|NCT01665430|156612520|FG000|Overall Study|Other Unspecified|2|||
48661466|NCT00168103|156612521|FG000|Overall Study|Withdrawal by Subject|1|||
48661467|NCT00168103|156612522|FG001|Overall Study|Withdrawal by Subject|2|||
48661468|NCT00168103|156612523|FG002|Overall Study|Withdrawal by Subject|1|||
48661469|NCT00168103|156612524|FG003|Overall Study|Withdrawal by Subject|0|||
48661470|NCT00168103|156612521|FG000|Overall Study|Lost to Follow-up|1|||
48661471|NCT00168103|156612522|FG001|Overall Study|Lost to Follow-up|3|||
48661472|NCT00168103|156612523|FG002|Overall Study|Lost to Follow-up|0|||
48661473|NCT00168103|156612524|FG003|Overall Study|Lost to Follow-up|0|||
48661474|NCT02981407|156612529|FG000|Overall Study|Withdrawal by Subject|2|||
48661475|NCT02981407|156612530|FG001|Overall Study|Withdrawal by Subject|0|||
48661476|NCT00536874|156612533|FG000|Overall Study|Adverse Event|1|||
48661477|NCT00536874|156612533|FG000|Overall Study|Death|2|||
48661478|NCT00536874|156612533|FG000|Overall Study|Withdrawal by Subject|1|||
48661479|NCT00610441|156612534|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
48661480|NCT00610441|156612535|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
48661481|NCT00610441|156612536|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
48661482|NCT00610441|156612537|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
48661483|NCT00610441|156612534|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
48661484|NCT00610441|156612535|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
48661485|NCT00610441|156612536|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
48661486|NCT00610441|156612537|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
48661487|NCT00610441|156612534|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
48661488|NCT00610441|156612535|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
48661489|NCT00610441|156612536|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
48661490|NCT00610441|156612537|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
48661491|NCT00610441|156612534|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
48661492|NCT00610441|156612535|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
48661493|NCT00610441|156612536|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
48661494|NCT00610441|156612537|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
48661495|NCT00610441|156612534|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
48661496|NCT00610441|156612535|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
48661497|NCT00610441|156612536|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
48338946|NCT01107912|155434779|FG003|Period 3|Adverse Event|0|||
48338947|NCT01107912|155434780|FG004|Period 3|Adverse Event|0|||
48338948|NCT01107912|155434781|FG005|Period 3|Adverse Event|0|||
48338949|NCT01107912|155434776|FG000|Period 3|Withdrawal by Subject|0|||
48338950|NCT01107912|155434777|FG001|Period 3|Withdrawal by Subject|0|||
48338951|NCT01107912|155434778|FG002|Period 3|Withdrawal by Subject|0|||
48338952|NCT01107912|155434779|FG003|Period 3|Withdrawal by Subject|1|||
48338953|NCT01107912|155434780|FG004|Period 3|Withdrawal by Subject|0|||
48338954|NCT01107912|155434781|FG005|Period 3|Withdrawal by Subject|0|||
48338955|NCT01601821|155434782|FG000|Overall Study|Death|2|||
48338956|NCT01601821|155434783|FG001|Overall Study|Death|5|||
48338957|NCT01601821|155434782|FG000|Overall Study|Protocol Violation|2|||
48338958|NCT01601821|155434783|FG001|Overall Study|Protocol Violation|2|||
48338959|NCT01601821|155434782|FG000|Overall Study|Lost to Follow-up|6|||
48338960|NCT01601821|155434783|FG001|Overall Study|Lost to Follow-up|14|||
48338961|NCT01601821|155434782|FG000|Overall Study|Withdrawal by Subject|1|||
48338962|NCT01601821|155434783|FG001|Overall Study|Withdrawal by Subject|0|||
48338963|NCT01601821|155434782|FG000|Overall Study|Graft Loss|6|||
48338964|NCT01601821|155434783|FG001|Overall Study|Graft Loss|6|||
48661498|NCT00610441|156612537|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
48661499|NCT00610441|156612534|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
48338965|NCT01601821|155434782|FG000|Overall Study|Study Events|7|||
48338966|NCT01601821|155434783|FG001|Overall Study|Study Events|1|||
48661500|NCT00610441|156612535|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
48338967|NCT01601821|155434782|FG000|Overall Study|Other|5|||
48338968|NCT01601821|155434783|FG001|Overall Study|Other|1|||
48661501|NCT00610441|156612536|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
48661502|NCT00610441|156612537|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
48661503|NCT00610441|156612534|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
48661504|NCT00610441|156612535|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
48338969|NCT04736602|155434784|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
48338970|NCT04736602|155434784|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
48661505|NCT00610441|156612536|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
48661506|NCT00610441|156612537|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
48661507|NCT00610441|156612534|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
48661508|NCT00610441|156612535|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
48661509|NCT00610441|156612536|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
48661510|NCT00610441|156612537|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
48661511|NCT00610441|156612534|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
48661512|NCT00610441|156612535|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
48661513|NCT00610441|156612536|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
48661514|NCT00610441|156612537|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
48661515|NCT00787930|156612546|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
48661516|NCT05985044|156614093|FG000|Overall Study|Death|6|||
48661517|NCT05985044|156614093|FG000|Overall Study|Lost to Follow-up|4|||
48661518|NCT05985044|156614093|FG000|Overall Study|Incapacitation|3|||
48661519|NCT05985044|156614093|FG000|Overall Study|Withdrawal by Subject|2|||
48661520|NCT00511433|156614094|FG000|Overall Study|Adverse Event|5|||
48661521|NCT00511433|156614095|FG001|Overall Study|Adverse Event|0|||
48661522|NCT00511433|156614094|FG000|Overall Study|Other Reason|1|||
48661523|NCT00511433|156614095|FG001|Overall Study|Other Reason|1|||
48661524|NCT02723006|156614096|FG000|Overall Study|Withdrawal by Subject|0|||
48661525|NCT02723006|156614097|FG001|Overall Study|Withdrawal by Subject|1|||
48661526|NCT02723006|156614098|FG002|Overall Study|Withdrawal by Subject|1|||
48661527|NCT02723006|156614096|FG000|Overall Study|Study Terminated by Sponsor|1|||
48661528|NCT02723006|156614097|FG001|Overall Study|Study Terminated by Sponsor|6|||
48661529|NCT02723006|156614098|FG002|Overall Study|Study Terminated by Sponsor|6|||
48661530|NCT00496483|156614099|FG000|Overall Study|Not dosed|9|||
48661531|NCT00496483|156614099|FG000|Overall Study|Adverse Event|2|||
48661532|NCT00496483|156614099|FG000|Overall Study|Lack of Efficacy|1|||
48661533|NCT01448824|156614100|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661534|NCT01448824|156614101|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661535|NCT01448824|156614102|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661536|NCT01448824|156614103|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661537|NCT01448824|156614104|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661538|NCT01448824|156614105|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661539|NCT01448824|156614106|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
48661540|NCT01448824|156614107|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
48661541|NCT01448824|156614100|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661542|NCT01448824|156614101|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661543|NCT01448824|156614102|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661544|NCT01448824|156614103|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
48661545|NCT01448824|156614104|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
48661546|NCT01448824|156614105|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
48661547|NCT01448824|156614106|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661548|NCT01448824|156614107|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
48661549|NCT01448824|156614100|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661550|NCT01448824|156614101|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661551|NCT01448824|156614102|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661552|NCT01448824|156614103|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661553|NCT01448824|156614104|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661554|NCT01448824|156614105|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
48661555|NCT01448824|156614106|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661556|NCT01448824|156614107|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
48661557|NCT01448824|156614100|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
48661558|NCT01448824|156614101|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
48661559|NCT01448824|156614102|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
48661560|NCT01448824|156614103|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
48661561|NCT01448824|156614104|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
48661562|NCT01448824|156614105|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
48661563|NCT01448824|156614106|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
48661564|NCT01448824|156614107|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
48338971|NCT01124916|155434790|FG000|Overall Study|Lost to Follow-up|3|||
48661565|NCT01448824|156614100|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48338972|NCT01124916|155434791|FG001|Overall Study|Lost to Follow-up|2|||
48338973|NCT00428441|155434796|FG000|Overall Study|Lost to Follow-up|1|||
48338974|NCT02205476|155434798|FG000|Overall Study|Study termination by Sponsor|7|||
48661566|NCT01448824|156614101|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661567|NCT01448824|156614102|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661568|NCT01448824|156614103|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48755543|NCT00619801|156951300|FG000|Overall Study|Withdrawal by Subject|1|||
48338975|NCT02205476|155434799|FG001|Overall Study|Study termination by Sponsor|3|||
48661569|NCT01448824|156614104|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661570|NCT01448824|156614105|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661571|NCT01448824|156614106|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
48661572|NCT01448824|156614107|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
48661573|NCT01448824|156614100|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661574|NCT01448824|156614101|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661575|NCT01448824|156614102|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661576|NCT01448824|156614103|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661577|NCT01448824|156614104|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661578|NCT01448824|156614105|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661579|NCT01448824|156614106|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
48661580|NCT01448824|156614107|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
48661581|NCT01448824|156614100|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661582|NCT01448824|156614101|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661583|NCT01448824|156614102|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661584|NCT01448824|156614103|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661585|NCT01448824|156614104|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661586|NCT01448824|156614105|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661587|NCT01448824|156614106|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
48661588|NCT01448824|156614107|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
48661589|NCT01448824|156614100|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661590|NCT01448824|156614101|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661591|NCT01448824|156614102|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661592|NCT01448824|156614103|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661593|NCT01448824|156614104|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661594|NCT01448824|156614105|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661595|NCT01448824|156614106|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
48661596|NCT01448824|156614107|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
48661597|NCT04883645|156614108|FG000|Overall Study|Death|1|||
48661598|NCT03948763|156614109|FG000|Overall Study|Sponsor's decision|0|||
48661599|NCT03948763|156614110|FG001|Overall Study|Sponsor's decision|2|||
48661600|NCT03948763|156614111|FG002|Overall Study|Sponsor's decision|6|||
48661601|NCT03948763|156614112|FG003|Overall Study|Sponsor's decision|4|||
48661602|NCT03948763|156614113|FG004|Overall Study|Sponsor's decision|0|||
48661603|NCT03948763|156614109|FG000|Overall Study|Physician Decision|0|||
48661604|NCT03948763|156614110|FG001|Overall Study|Physician Decision|0|||
48661605|NCT03948763|156614111|FG002|Overall Study|Physician Decision|1|||
48661606|NCT03948763|156614112|FG003|Overall Study|Physician Decision|0|||
48661607|NCT03948763|156614113|FG004|Overall Study|Physician Decision|0|||
48661608|NCT03948763|156614109|FG000|Overall Study|Lost to Follow-up|0|||
48661609|NCT03948763|156614110|FG001|Overall Study|Lost to Follow-up|0|||
48661610|NCT03948763|156614111|FG002|Overall Study|Lost to Follow-up|0|||
48661611|NCT03948763|156614112|FG003|Overall Study|Lost to Follow-up|0|||
48661612|NCT03948763|156614113|FG004|Overall Study|Lost to Follow-up|1|||
48661613|NCT03948763|156614109|FG000|Overall Study|Death|2|||
48661614|NCT03948763|156614110|FG001|Overall Study|Death|12|||
48661615|NCT03948763|156614111|FG002|Overall Study|Death|13|||
48661616|NCT03948763|156614112|FG003|Overall Study|Death|10|||
48661617|NCT03948763|156614113|FG004|Overall Study|Death|11|||
48661618|NCT03948763|156614109|FG000|Overall Study|Withdrawal by Subject|1|||
48661619|NCT03948763|156614110|FG001|Overall Study|Withdrawal by Subject|1|||
48661620|NCT03948763|156614111|FG002|Overall Study|Withdrawal by Subject|0|||
48661621|NCT03948763|156614112|FG003|Overall Study|Withdrawal by Subject|2|||
48661622|NCT03948763|156614113|FG004|Overall Study|Withdrawal by Subject|4|||
48661623|NCT00789581|156614114|FG000|AC Therapy|Adverse Event|2|||
48661624|NCT00789581|156614115|FG001|AC Therapy|Adverse Event|3|||
48661625|NCT00789581|156614114|FG000|AC Therapy|Withdrawal by Subject|4|||
48661626|NCT00789581|156614115|FG001|AC Therapy|Withdrawal by Subject|7|||
48661627|NCT00789581|156614114|FG000|AC Therapy|Disease recurrence|3|||
48661628|NCT00789581|156614115|FG001|AC Therapy|Disease recurrence|1|||
48661629|NCT00789581|156614114|FG000|AC Therapy|Intercurrent Illness|1|||
48661630|NCT00789581|156614115|FG001|AC Therapy|Intercurrent Illness|0|||
48661631|NCT00789581|156614114|FG000|AC Therapy|Never Treated|1|||
48661632|NCT00789581|156614115|FG001|AC Therapy|Never Treated|4|||
48661633|NCT00789581|156614114|FG000|AC Therapy|Other|0|||
48661634|NCT00789581|156614115|FG001|AC Therapy|Other|2|||
48661635|NCT00789581|156614114|FG000|Adjuvant Therapy|Never treated|2|||
48661636|NCT00789581|156614115|FG001|Adjuvant Therapy|Never treated|2|||
48661637|NCT00789581|156614114|FG000|Adjuvant Therapy|Adverse Event|20|||
48661638|NCT00789581|156614115|FG001|Adjuvant Therapy|Adverse Event|44|||
48661639|NCT00789581|156614114|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
48661640|NCT00789581|156614115|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
48661641|NCT00789581|156614114|FG000|Adjuvant Therapy|Disease recurrence|2|||
48661642|NCT00789581|156614115|FG001|Adjuvant Therapy|Disease recurrence|1|||
48661643|NCT00789581|156614114|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
48661644|NCT00789581|156614115|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
48661645|NCT00789581|156614114|FG000|Adjuvant Therapy|Protocol Violation|1|||
48661646|NCT00789581|156614115|FG001|Adjuvant Therapy|Protocol Violation|1|||
48661647|NCT00789581|156614114|FG000|Adjuvant Therapy|Other|0|||
48661648|NCT00789581|156614115|FG001|Adjuvant Therapy|Other|1|||
48661649|NCT04229992|156614120|FG000|Overall Study|Withdrawal by Subject|0|||
48661650|NCT04229992|156614121|FG001|Overall Study|Withdrawal by Subject|2|||
48338976|NCT04908800|155434800|FG000|Overall Study|Adverse Event|0|||
48661651|NCT04229992|156614122|FG002|Overall Study|Withdrawal by Subject|1|||
48661652|NCT04229992|156614123|FG003|Overall Study|Withdrawal by Subject|1|||
48661653|NCT04229992|156614120|FG000|Overall Study|Adverse Event|1|||
48661654|NCT04229992|156614121|FG001|Overall Study|Adverse Event|1|||
48661655|NCT04229992|156614122|FG002|Overall Study|Adverse Event|3|||
48661656|NCT04229992|156614123|FG003|Overall Study|Adverse Event|1|||
48661657|NCT04229992|156614120|FG000|Overall Study|Lost to Follow-up|0|||
48661658|NCT04229992|156614121|FG001|Overall Study|Lost to Follow-up|0|||
48661659|NCT04229992|156614122|FG002|Overall Study|Lost to Follow-up|0|||
48661660|NCT04229992|156614123|FG003|Overall Study|Lost to Follow-up|1|||
48661661|NCT04533347|156614130|FG000|Overall Study|Adverse Event|1|||
48661662|NCT04533347|156614131|FG001|Overall Study|Adverse Event|2|||
48661663|NCT04533347|156614130|FG000|Overall Study|Lost to Follow-up|2|||
48661664|NCT04533347|156614131|FG001|Overall Study|Lost to Follow-up|0|||
48661665|NCT04533347|156614130|FG000|Overall Study|Withdrawal by Subject|1|||
48661666|NCT04533347|156614131|FG001|Overall Study|Withdrawal by Subject|0|||
48661667|NCT01573442|156614137|FG000|Overall Study|Cancels|9|||
48661668|NCT01573442|156614138|FG001|Overall Study|Cancels|10|||
48661669|NCT04391894|156614141|FG000|Overall Study|Adverse Event|1|||
48661670|NCT04391894|156614142|FG001|Overall Study|Adverse Event|1|||
48661671|NCT04391894|156614143|FG002|Overall Study|Adverse Event|1|||
48661672|NCT04391894|156614144|FG003|Overall Study|Adverse Event|1|||
48661673|NCT04391894|156614145|FG004|Overall Study|Adverse Event|1|||
48661674|NCT04391894|156614141|FG000|Overall Study|Lost to Follow-up|1|||
48661675|NCT04391894|156614142|FG001|Overall Study|Lost to Follow-up|0|||
48661676|NCT04391894|156614143|FG002|Overall Study|Lost to Follow-up|0|||
48661677|NCT04391894|156614144|FG003|Overall Study|Lost to Follow-up|0|||
48661678|NCT04391894|156614145|FG004|Overall Study|Lost to Follow-up|0|||
48661679|NCT04391894|156614141|FG000|Overall Study|Protocol Violation|0|||
48661680|NCT04391894|156614142|FG001|Overall Study|Protocol Violation|0|||
48661681|NCT04391894|156614143|FG002|Overall Study|Protocol Violation|0|||
48661682|NCT04391894|156614144|FG003|Overall Study|Protocol Violation|1|||
48661683|NCT04391894|156614145|FG004|Overall Study|Protocol Violation|0|||
48661684|NCT04391894|156614141|FG000|Overall Study|Withdrawal by Subject|2|||
48661685|NCT04391894|156614142|FG001|Overall Study|Withdrawal by Subject|0|||
48661686|NCT04391894|156614143|FG002|Overall Study|Withdrawal by Subject|3|||
48661687|NCT04391894|156614144|FG003|Overall Study|Withdrawal by Subject|0|||
48661688|NCT04391894|156614145|FG004|Overall Study|Withdrawal by Subject|1|||
48661689|NCT04391894|156614141|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
48661690|NCT04391894|156614142|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
48661691|NCT04391894|156614143|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
48661692|NCT04391894|156614144|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
48661693|NCT04391894|156614145|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
48661694|NCT03766009|156614146|FG000|Usual Care|Death|0|||
48661695|NCT03766009|156614147|FG001|Usual Care|Death|0|||
48661696|NCT03766009|156614148|FG002|Usual Care|Death|0|||
48661697|NCT03766009|156614149|FG003|Usual Care|Death|1|||
48661698|NCT03766009|156614150|FG004|Usual Care|Death|0|||
48661699|NCT03766009|156614151|FG005|Usual Care|Death|0|||
48661700|NCT03766009|156614146|FG000|Usual Care|Lost to Follow-up|0|||
48338977|NCT04908800|155434801|FG001|Overall Study|Adverse Event|0|||
48338978|NCT04908800|155434802|FG002|Overall Study|Adverse Event|0|||
48661701|NCT03766009|156614147|FG001|Usual Care|Lost to Follow-up|0|||
48661702|NCT03766009|156614148|FG002|Usual Care|Lost to Follow-up|0|||
48338979|NCT04908800|155434803|FG003|Overall Study|Adverse Event|0|||
48338980|NCT04908800|155434804|FG004|Overall Study|Adverse Event|0|||
48661703|NCT03766009|156614149|FG003|Usual Care|Lost to Follow-up|1|||
48661704|NCT03766009|156614150|FG004|Usual Care|Lost to Follow-up|0|||
48661705|NCT03766009|156614151|FG005|Usual Care|Lost to Follow-up|0|||
48661706|NCT03766009|156614146|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
48661707|NCT03766009|156614147|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
48661708|NCT03766009|156614148|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
48661709|NCT03766009|156614149|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
48338981|NCT04908800|155434805|FG005|Overall Study|Adverse Event|0|||
48338982|NCT04908800|155434806|FG006|Overall Study|Adverse Event|0|||
48661710|NCT03766009|156614150|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
48661711|NCT03766009|156614151|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
48661712|NCT03766009|156614146|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
48692745|NCT01339689|156724588|FG000|Overall Study|Withdrawal by Subject|3|||
48661713|NCT03766009|156614147|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
48661714|NCT03766009|156614148|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
48661715|NCT03766009|156614149|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
48661716|NCT03766009|156614150|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
48661717|NCT03766009|156614151|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
48661718|NCT03766009|156614146|FG000|Usual Care|No treatment or declined surgery|0|||
48661719|NCT03766009|156614147|FG001|Usual Care|No treatment or declined surgery|0|||
48661720|NCT03766009|156614148|FG002|Usual Care|No treatment or declined surgery|0|||
48661721|NCT03766009|156614149|FG003|Usual Care|No treatment or declined surgery|2|||
48661722|NCT03766009|156614150|FG004|Usual Care|No treatment or declined surgery|0|||
48661723|NCT03766009|156614151|FG005|Usual Care|No treatment or declined surgery|0|||
48661724|NCT03766009|156614146|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
48661725|NCT03766009|156614147|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
48661726|NCT03766009|156614148|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
48661727|NCT03766009|156614149|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
48661728|NCT03766009|156614150|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
48661729|NCT03766009|156614151|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
48661730|NCT03766009|156614146|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661731|NCT03766009|156614147|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
48661732|NCT03766009|156614148|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661733|NCT03766009|156614149|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661734|NCT03766009|156614150|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661735|NCT03766009|156614151|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
48661736|NCT03766009|156614146|FG000|Usual Care|Ineligible|0|||
48661737|NCT03766009|156614147|FG001|Usual Care|Ineligible|1|||
48661738|NCT03766009|156614148|FG002|Usual Care|Ineligible|0|||
48755544|NCT00619801|156951301|FG001|Overall Study|Withdrawal by Subject|1|||
48755545|NCT00619801|156951300|FG000|Overall Study|Loss of efficacy|0|||
48755546|NCT00619801|156951301|FG001|Overall Study|Loss of efficacy|1|||
48755547|NCT02196558|156951304|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
48755548|NCT02196558|156951305|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
48755549|NCT02196558|156951306|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
48755550|NCT02196558|156951304|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
48755551|NCT02196558|156951305|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
48755552|NCT02196558|156951306|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
48755553|NCT02196558|156951304|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
48755554|NCT02196558|156951305|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
48755555|NCT02196558|156951306|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
48755556|NCT02196558|156951304|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
48755557|NCT02196558|156951305|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
48755558|NCT02196558|156951306|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
48755559|NCT02196558|156951304|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
48755560|NCT02196558|156951305|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
48755561|NCT02196558|156951306|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
48755562|NCT00396591|156951314|FG000|Overall Study|Disease Progression|13|||
48755563|NCT00396591|156951314|FG000|Overall Study|Adverse Event|2|||
48755564|NCT00396591|156951314|FG000|Overall Study|Participant request|1|||
48755565|NCT03406104|156951315|FG000|Overall Study|Lost to Follow-up|2|||
48755566|NCT03406104|156951315|FG000|Overall Study|Withdrawal by Subject|2|||
48755567|NCT03406104|156951315|FG000|Overall Study|due to Covid patient did not want to travel|1|||
48755568|NCT03406104|156951315|FG000|Overall Study|Death|2|||
48755569|NCT01013701|156951316|FG000|Overall Study|study prematurely terminated|7|||
48755570|NCT00556712|156951317|FG000|Overall Study|Adverse Event|7|||
48755571|NCT00556712|156951318|FG001|Overall Study|Adverse Event|19|||
48755572|NCT00556712|156951317|FG000|Overall Study|Death|5|||
48755573|NCT00556712|156951318|FG001|Overall Study|Death|10|||
48755574|NCT00556712|156951317|FG000|Overall Study|Progressive Disease|383|||
48755575|NCT00556712|156951318|FG001|Overall Study|Progressive Disease|320|||
48755576|NCT00556712|156951317|FG000|Overall Study|Protocol Violation|3|||
48755577|NCT00556712|156951318|FG001|Overall Study|Protocol Violation|2|||
48755578|NCT00556712|156951317|FG000|Overall Study|Refused Treatment|17|||
48755579|NCT00556712|156951318|FG001|Overall Study|Refused Treatment|16|||
48755580|NCT00556712|156951317|FG000|Overall Study|Failure to Return|2|||
48755581|NCT00556712|156951318|FG001|Overall Study|Failure to Return|3|||
48755582|NCT00556712|156951317|FG000|Overall Study|Other|2|||
48755583|NCT00556712|156951318|FG001|Overall Study|Other|2|||
48755584|NCT00556712|156951317|FG000|Overall Study|Ongoing at Data Cutoff|32|||
48755585|NCT00556712|156951318|FG001|Overall Study|Ongoing at Data Cutoff|66|||
48755586|NCT01361464|156951319|FG000|Overall Study|Death|1|||
48755587|NCT01361464|156951319|FG000|Overall Study|Withdrawal by Subject|2|||
48661739|NCT03766009|156614149|FG003|Usual Care|Ineligible|0|||
48661740|NCT03766009|156614150|FG004|Usual Care|Ineligible|0|||
48661741|NCT03766009|156614151|FG005|Usual Care|Ineligible|0|||
48661742|NCT03766009|156614146|FG000|Usual Care|Other: Staff turnover|0|||
48661743|NCT03766009|156614147|FG001|Usual Care|Other: Staff turnover|0|||
48755588|NCT04501666|156951322|FG000|Overall Study|Physician Decision|0|||
48755589|NCT04501666|156951323|FG001|Overall Study|Physician Decision|1|||
48755590|NCT04501666|156951322|FG000|Overall Study|Adverse Event|12|||
48755591|NCT04501666|156951323|FG001|Overall Study|Adverse Event|4|||
48755592|NCT04501666|156951322|FG000|Overall Study|Subject's request|10|||
48755593|NCT04501666|156951323|FG001|Overall Study|Subject's request|6|||
48755594|NCT04501666|156951322|FG000|Overall Study|Protocol Deviation|2|||
48755595|NCT04501666|156951323|FG001|Overall Study|Protocol Deviation|1|||
48755596|NCT04501666|156951322|FG000|Overall Study|Other-- site permanently closing|0|||
48755597|NCT04501666|156951323|FG001|Overall Study|Other-- site permanently closing|1|||
48755598|NCT04690751|156951324|FG000|Overall Study|Protocol Violation|0|||
48755599|NCT04690751|156951325|FG001|Overall Study|Protocol Violation|1|||
48755600|NCT04690751|156951326|FG002|Overall Study|Protocol Violation|0|||
48755601|NCT04690751|156951327|FG003|Overall Study|Protocol Violation|1|||
48755602|NCT04690751|156951328|FG004|Overall Study|Protocol Violation|2|||
48755603|NCT04690751|156951329|FG005|Overall Study|Protocol Violation|0|||
48755604|NCT04690751|156951324|FG000|Overall Study|Adverse Event|0|||
48755605|NCT04690751|156951325|FG001|Overall Study|Adverse Event|0|||
48755606|NCT04690751|156951326|FG002|Overall Study|Adverse Event|1|||
48755607|NCT04690751|156951327|FG003|Overall Study|Adverse Event|0|||
48755608|NCT04690751|156951328|FG004|Overall Study|Adverse Event|0|||
48661744|NCT03766009|156614148|FG002|Usual Care|Other: Staff turnover|0|||
48661745|NCT03766009|156614149|FG003|Usual Care|Other: Staff turnover|0|||
48661746|NCT03766009|156614150|FG004|Usual Care|Other: Staff turnover|0|||
48661747|NCT03766009|156614151|FG005|Usual Care|Other: Staff turnover|2|||
48755609|NCT04690751|156951329|FG005|Overall Study|Adverse Event|0|||
48661748|NCT02737436|156614154|FG000|Washout Period|Lost to Follow-up|5|||
48661749|NCT02737436|156614155|FG001|Washout Period|Lost to Follow-up|11|||
48661750|NCT02737436|156614154|FG000|Data Analysis|Scanning data problems|5|||
48661751|NCT02737436|156614155|FG001|Data Analysis|Scanning data problems|8|||
48661752|NCT01069861|156614157|FG000|Overall Study|Death|1|||
48661753|NCT01069861|156614157|FG000|Overall Study|Adverse Event|1|||
48661754|NCT01069861|156614157|FG000|Overall Study|Did not meet entrance criteria|1|||
48661755|NCT03781414|156614160|FG000|Overall Study|Study terminated by sponsor|39|||
48661756|NCT03781414|156614161|FG001|Overall Study|Study terminated by sponsor|34|||
48661757|NCT03781414|156614162|FG002|Overall Study|Study terminated by sponsor|25|||
48661758|NCT03781414|156614160|FG000|Overall Study|Adverse Event|3|||
48661759|NCT03781414|156614161|FG001|Overall Study|Adverse Event|6|||
48661760|NCT03781414|156614162|FG002|Overall Study|Adverse Event|3|||
48661761|NCT03781414|156614160|FG000|Overall Study|Physician Decision|2|||
48661762|NCT03781414|156614161|FG001|Overall Study|Physician Decision|0|||
48661763|NCT03781414|156614162|FG002|Overall Study|Physician Decision|1|||
48661764|NCT03781414|156614160|FG000|Overall Study|Withdrawal by Subject|2|||
48661765|NCT03781414|156614161|FG001|Overall Study|Withdrawal by Subject|3|||
48661766|NCT03781414|156614162|FG002|Overall Study|Withdrawal by Subject|3|||
48661767|NCT03781414|156614160|FG000|Overall Study|Death|1|||
48661768|NCT03781414|156614161|FG001|Overall Study|Death|4|||
48661769|NCT03781414|156614162|FG002|Overall Study|Death|0|||
48661770|NCT03781414|156614160|FG000|Overall Study|Lost to Follow-up|1|||
48661771|NCT03781414|156614161|FG001|Overall Study|Lost to Follow-up|1|||
48661772|NCT03781414|156614162|FG002|Overall Study|Lost to Follow-up|0|||
48661773|NCT04568603|156614163|FG000|Overall Study|Physician Decision|1|||
48661774|NCT02841579|156614164|FG000|Overall Study|Death|1|||
48661775|NCT02841579|156614164|FG000|Overall Study|Adverse Event|1|||
48661776|NCT02841579|156614164|FG000|Overall Study|Lack of Efficacy|9|||
48661777|NCT03622112|156614165|FG000|Overall Study|Withdrawal by Subject|6|||
48661778|NCT03622112|156614166|FG001|Overall Study|Withdrawal by Subject|2|||
48661779|NCT03622112|156614167|FG002|Overall Study|Withdrawal by Subject|4|||
48661780|NCT03622112|156614168|FG003|Overall Study|Withdrawal by Subject|2|||
48661781|NCT03622112|156614169|FG004|Overall Study|Withdrawal by Subject|1|||
48661782|NCT03622112|156614170|FG005|Overall Study|Withdrawal by Subject|2|||
48661783|NCT03622112|156614171|FG006|Overall Study|Withdrawal by Subject|2|||
48661784|NCT03622112|156614165|FG000|Overall Study|Death|0|||
48661785|NCT03622112|156614166|FG001|Overall Study|Death|0|||
48661786|NCT03622112|156614167|FG002|Overall Study|Death|0|||
48661787|NCT03622112|156614168|FG003|Overall Study|Death|1|||
48661788|NCT03622112|156614169|FG004|Overall Study|Death|0|||
48661789|NCT03622112|156614170|FG005|Overall Study|Death|0|||
48755610|NCT04690751|156951324|FG000|Overall Study|Positive urine drug screen test|0|||
48755611|NCT04690751|156951325|FG001|Overall Study|Positive urine drug screen test|0|||
48755612|NCT04690751|156951326|FG002|Overall Study|Positive urine drug screen test|0|||
48755613|NCT04690751|156951327|FG003|Overall Study|Positive urine drug screen test|0|||
48755614|NCT04690751|156951328|FG004|Overall Study|Positive urine drug screen test|1|||
48661790|NCT03622112|156614171|FG006|Overall Study|Death|0|||
48661791|NCT03622112|156614165|FG000|Overall Study|Lost to Follow-up|1|||
48661792|NCT03622112|156614166|FG001|Overall Study|Lost to Follow-up|1|||
48661793|NCT03622112|156614167|FG002|Overall Study|Lost to Follow-up|0|||
48661794|NCT03622112|156614168|FG003|Overall Study|Lost to Follow-up|0|||
48661795|NCT03622112|156614169|FG004|Overall Study|Lost to Follow-up|0|||
48661796|NCT03622112|156614170|FG005|Overall Study|Lost to Follow-up|0|||
48661797|NCT03622112|156614171|FG006|Overall Study|Lost to Follow-up|0|||
48661798|NCT03622112|156614165|FG000|Overall Study|Study-specific withdrawal criteria|10|||
48661799|NCT03622112|156614166|FG001|Overall Study|Study-specific withdrawal criteria|8|||
48661800|NCT03622112|156614167|FG002|Overall Study|Study-specific withdrawal criteria|7|||
48661801|NCT03622112|156614168|FG003|Overall Study|Study-specific withdrawal criteria|6|||
48661802|NCT03622112|156614169|FG004|Overall Study|Study-specific withdrawal criteria|4|||
48661803|NCT03622112|156614170|FG005|Overall Study|Study-specific withdrawal criteria|18|||
48661804|NCT03622112|156614171|FG006|Overall Study|Study-specific withdrawal criteria|4|||
48661805|NCT03622112|156614165|FG000|Overall Study|Protocol Violation|2|||
48661806|NCT03622112|156614166|FG001|Overall Study|Protocol Violation|0|||
48661807|NCT03622112|156614167|FG002|Overall Study|Protocol Violation|1|||
48661808|NCT03622112|156614168|FG003|Overall Study|Protocol Violation|1|||
48661809|NCT03622112|156614169|FG004|Overall Study|Protocol Violation|0|||
48661810|NCT03622112|156614170|FG005|Overall Study|Protocol Violation|0|||
48661811|NCT03622112|156614171|FG006|Overall Study|Protocol Violation|0|||
48661812|NCT03622112|156614165|FG000|Overall Study|Adverse Event|6|||
48661813|NCT03622112|156614166|FG001|Overall Study|Adverse Event|8|||
48661814|NCT03622112|156614167|FG002|Overall Study|Adverse Event|4|||
48661815|NCT03622112|156614168|FG003|Overall Study|Adverse Event|11|||
48661816|NCT03622112|156614169|FG004|Overall Study|Adverse Event|4|||
48661817|NCT03622112|156614170|FG005|Overall Study|Adverse Event|20|||
48661818|NCT03622112|156614171|FG006|Overall Study|Adverse Event|2|||
48661819|NCT03622112|156614165|FG000|Overall Study|Reason not specified|0|||
48755615|NCT04690751|156951329|FG005|Overall Study|Positive urine drug screen test|0|||
48755616|NCT02289079|156951330|FG000|Overall Study|Physician Decision|2|||
48755617|NCT02289079|156951331|FG001|Overall Study|Physician Decision|0|||
48755618|NCT02289079|156951330|FG000|Overall Study|Lost to Follow-up|0|||
48755619|NCT02289079|156951331|FG001|Overall Study|Lost to Follow-up|1|||
48755620|NCT00680043|156951332|FG000|Overall Study|Withdrawal by Subject|1|||
48755621|NCT00680043|156951333|FG001|Overall Study|Withdrawal by Subject|0|||
48755622|NCT00680043|156951334|FG002|Overall Study|Withdrawal by Subject|0|||
48755623|NCT00680043|156951332|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
48755624|NCT00680043|156951333|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
48755625|NCT00680043|156951334|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
48755626|NCT00680043|156951332|FG000|Overall Study|Renal Transplant|1|||
48755627|NCT00680043|156951333|FG001|Overall Study|Renal Transplant|0|||
48755628|NCT00680043|156951334|FG002|Overall Study|Renal Transplant|4|||
48755629|NCT03559257|156951336|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
48755630|NCT03559257|156951337|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
48755631|NCT03559257|156951336|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48755632|NCT03559257|156951337|FG001|Double Blind Treatment Period|Protocol Violation|4|||
48755633|NCT03559257|156951336|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
48755634|NCT03559257|156951337|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
48755635|NCT03559257|156951336|FG000|Double Blind Treatment Period|Adverse Event|0|||
48755636|NCT03559257|156951337|FG001|Double Blind Treatment Period|Adverse Event|1|||
48755637|NCT03559257|156951336|FG000|Double Blind Treatment Period|Screen Failure|0|||
48755638|NCT03559257|156951337|FG001|Double Blind Treatment Period|Screen Failure|1|||
48755639|NCT03559257|156951336|FG000|Open-label Treatment Period|Adverse Event|1|||
48755640|NCT03559257|156951337|FG001|Open-label Treatment Period|Adverse Event|4|||
48755641|NCT03559257|156951336|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
48755642|NCT03559257|156951337|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
48755643|NCT03559257|156951336|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
48661820|NCT03622112|156614166|FG001|Overall Study|Reason not specified|1|||
48661821|NCT03622112|156614167|FG002|Overall Study|Reason not specified|0|||
48661822|NCT03622112|156614168|FG003|Overall Study|Reason not specified|1|||
48661823|NCT03622112|156614169|FG004|Overall Study|Reason not specified|1|||
48661824|NCT03622112|156614170|FG005|Overall Study|Reason not specified|2|||
48661825|NCT03622112|156614171|FG006|Overall Study|Reason not specified|1|||
48661826|NCT01155466|156614172|FG000|Overall Study|Adverse Event|13|||
48661827|NCT01155466|156614173|FG001|Overall Study|Adverse Event|15|||
48755644|NCT03559257|156951337|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
48755645|NCT03559257|156951336|FG000|Open-label Treatment Period|Protocol Violation|2|||
48755646|NCT03559257|156951337|FG001|Open-label Treatment Period|Protocol Violation|0|||
48755647|NCT03559257|156951336|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
48755648|NCT03559257|156951337|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
48755649|NCT03559257|156951336|FG000|Open-label Treatment Period|Physician Decision|0|||
48755650|NCT03559257|156951337|FG001|Open-label Treatment Period|Physician Decision|1|||
48661828|NCT01155466|156614174|FG002|Overall Study|Adverse Event|6|||
48661829|NCT01155466|156614175|FG003|Overall Study|Adverse Event|17|||
48755651|NCT01026792|156951341|FG000|Overall Study|Protocol Violation|1|||
48755652|NCT00399360|156951344|FG000|Overall Study|Lost to Follow-up|2|||
48755653|NCT00399360|156951345|FG001|Overall Study|Lost to Follow-up|1|||
48755654|NCT00399360|156951346|FG002|Overall Study|Lost to Follow-up|2|||
48755655|NCT00399360|156951347|FG003|Overall Study|Lost to Follow-up|4|||
48755656|NCT00399360|156951344|FG000|Overall Study|Adverse Event|0|||
48755657|NCT00399360|156951345|FG001|Overall Study|Adverse Event|0|||
48755658|NCT00399360|156951346|FG002|Overall Study|Adverse Event|1|||
48755659|NCT00399360|156951347|FG003|Overall Study|Adverse Event|0|||
48755660|NCT00399360|156951344|FG000|Overall Study|Withdrawal by Subject|0|||
48755661|NCT00399360|156951345|FG001|Overall Study|Withdrawal by Subject|2|||
48755662|NCT00399360|156951346|FG002|Overall Study|Withdrawal by Subject|0|||
48755663|NCT00399360|156951347|FG003|Overall Study|Withdrawal by Subject|2|||
48755664|NCT03564145|156951348|FG000|Overall Study|Adverse Event|4|||
48755665|NCT03564145|156951348|FG000|Overall Study|Lost to Follow-up|21|||
48755666|NCT03564145|156951348|FG000|Overall Study|Protocol Violation|2|||
48755667|NCT03564145|156951348|FG000|Overall Study|Withdrawal by Subject|48|||
48755668|NCT03564145|156951348|FG000|Overall Study|Study Terminated by Sponsor|146|||
48755669|NCT03564145|156951348|FG000|Overall Study|Physician Decision|1|||
48755670|NCT03564145|156951348|FG000|Overall Study|Other Than Specified|1|||
48755671|NCT03564145|156951348|FG000|Overall Study|Pregnancy|1|||
48755672|NCT02446990|156951354|FG000|Overall Study|Death|485|||
48755673|NCT02446990|156951355|FG001|Overall Study|Death|458|||
48755674|NCT02446990|156951354|FG000|Overall Study|Lost to Follow-up|3|||
48755675|NCT02446990|156951355|FG001|Overall Study|Lost to Follow-up|1|||
48755676|NCT02446990|156951354|FG000|Overall Study|Physician Decision|1|||
48755677|NCT02446990|156951355|FG001|Overall Study|Physician Decision|0|||
48755678|NCT02446990|156951354|FG000|Overall Study|Withdrawal by Subject|231|||
48755679|NCT02446990|156951355|FG001|Overall Study|Withdrawal by Subject|199|||
48755680|NCT01064401|156951356|FG000|Overall Study|Adverse Event|47|||
48755681|NCT01064401|156951357|FG001|Overall Study|Adverse Event|56|||
48755682|NCT01064401|156951356|FG000|Overall Study|Lack of Efficacy|46|||
48755683|NCT01064401|156951357|FG001|Overall Study|Lack of Efficacy|23|||
48755684|NCT01064401|156951356|FG000|Overall Study|Lost to Follow-up|12|||
48755685|NCT01064401|156951357|FG001|Overall Study|Lost to Follow-up|9|||
48755686|NCT01064401|156951356|FG000|Overall Study|Consent Withdrawn|98|||
48755687|NCT01064401|156951357|FG001|Overall Study|Consent Withdrawn|80|||
48755688|NCT01064401|156951356|FG000|Overall Study|Investigator Decision|4|||
48755689|NCT01064401|156951357|FG001|Overall Study|Investigator Decision|6|||
48755690|NCT01064401|156951356|FG000|Overall Study|Death|4|||
48755691|NCT01064401|156951357|FG001|Overall Study|Death|0|||
48755692|NCT01064401|156951356|FG000|Overall Study|Pregnancy|4|||
48755693|NCT01064401|156951357|FG001|Overall Study|Pregnancy|7|||
48755694|NCT01064401|156951356|FG000|Overall Study|Noncompliance|7|||
48755695|NCT01064401|156951357|FG001|Overall Study|Noncompliance|8|||
48661830|NCT01155466|156614176|FG004|Overall Study|Adverse Event|18|||
48661831|NCT01155466|156614172|FG000|Overall Study|Lost to Follow-up|0|||
48661832|NCT01155466|156614173|FG001|Overall Study|Lost to Follow-up|0|||
48661833|NCT01155466|156614174|FG002|Overall Study|Lost to Follow-up|0|||
48661834|NCT01155466|156614175|FG003|Overall Study|Lost to Follow-up|0|||
48661835|NCT01155466|156614176|FG004|Overall Study|Lost to Follow-up|2|||
48661836|NCT01155466|156614172|FG000|Overall Study|Withdrawal by Subject|7|||
48755696|NCT01064401|156951356|FG000|Overall Study|Site Closure|4|||
48755697|NCT01064401|156951357|FG001|Overall Study|Site Closure|5|||
48755698|NCT01064401|156951356|FG000|Overall Study|Other|2|||
48755699|NCT01064401|156951357|FG001|Overall Study|Other|1|||
48755700|NCT04977583|156954147|FG000|Overall Study|Lost to Follow-up|8|||
48755701|NCT04977583|156954148|FG001|Overall Study|Lost to Follow-up|4|||
48755702|NCT04977583|156954149|FG002|Overall Study|Lost to Follow-up|13|||
48755703|NCT04977583|156954147|FG000|Overall Study|Withdrawal by Subject|3|||
48755704|NCT04977583|156954148|FG001|Overall Study|Withdrawal by Subject|2|||
48755705|NCT04977583|156954149|FG002|Overall Study|Withdrawal by Subject|1|||
48755706|NCT01572909|156954150|FG000|Overall Study|Adverse Event|7|||
48755707|NCT01572909|156954151|FG001|Overall Study|Adverse Event|2|||
48755708|NCT01572909|156954150|FG000|Overall Study|Death|3|||
48755709|NCT01572909|156954151|FG001|Overall Study|Death|1|||
48755710|NCT01572909|156954150|FG000|Overall Study|Lost to Follow-up|8|||
48755711|NCT01572909|156954151|FG001|Overall Study|Lost to Follow-up|7|||
48755712|NCT01572909|156954150|FG000|Overall Study|Physician Decision|1|||
48755713|NCT01572909|156954151|FG001|Overall Study|Physician Decision|1|||
48661837|NCT01155466|156614173|FG001|Overall Study|Withdrawal by Subject|5|||
48338983|NCT04908800|155434807|FG007|Overall Study|Adverse Event|0|||
48338984|NCT04908800|155434808|FG008|Overall Study|Adverse Event|0|||
48338985|NCT04908800|155434809|FG009|Overall Study|Adverse Event|0|||
48338986|NCT04908800|155434810|FG010|Overall Study|Adverse Event|1|||
48338987|NCT04908800|155434811|FG011|Overall Study|Adverse Event|0|||
48338988|NCT04908800|155434812|FG012|Overall Study|Adverse Event|0|||
48338989|NCT01348763|155434814|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
48338990|NCT01348763|155434814|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
48338991|NCT03214198|155434821|FG000|Overall Study|Case Report Forms Uncollected|18|||
48338992|NCT03214198|155434821|FG000|Overall Study|Protocol Deviation|18|||
48338993|NCT00919061|155434831|FG000|Overall Study|Adverse Event|1|||
48338994|NCT00919061|155434831|FG000|Overall Study|Withdrawal by Subject|1|||
48338995|NCT00308113|155434834|FG000|Overall Study|Protocol closure|0|||
48338996|NCT00308113|155434835|FG001|Overall Study|Protocol closure|0|||
48338997|NCT00308113|155434836|FG002|Overall Study|Protocol closure|0|||
48338998|NCT00308113|155434837|FG003|Overall Study|Protocol closure|1|||
48338999|NCT04944784|155434841|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
48339000|NCT04944784|155434842|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
48339001|NCT04944784|155434843|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
48339002|NCT04944784|155434844|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
48339003|NCT04944784|155434841|FG000|Double-blind Period|Adverse Event|20|||
48661838|NCT01155466|156614174|FG002|Overall Study|Withdrawal by Subject|9|||
48661839|NCT01155466|156614175|FG003|Overall Study|Withdrawal by Subject|4|||
48661840|NCT01155466|156614176|FG004|Overall Study|Withdrawal by Subject|4|||
48661841|NCT01155466|156614172|FG000|Overall Study|Protocol Violation|0|||
48661842|NCT01155466|156614173|FG001|Overall Study|Protocol Violation|0|||
48661843|NCT01155466|156614174|FG002|Overall Study|Protocol Violation|2|||
48661844|NCT01155466|156614175|FG003|Overall Study|Protocol Violation|0|||
48661845|NCT01155466|156614176|FG004|Overall Study|Protocol Violation|1|||
48661846|NCT01155466|156614172|FG000|Overall Study|Administrative|0|||
48661847|NCT01155466|156614173|FG001|Overall Study|Administrative|3|||
48661848|NCT01155466|156614174|FG002|Overall Study|Administrative|0|||
48661849|NCT01155466|156614175|FG003|Overall Study|Administrative|0|||
48661850|NCT01155466|156614176|FG004|Overall Study|Administrative|0|||
48339004|NCT04944784|155434842|FG001|Double-blind Period|Adverse Event|4|||
48339005|NCT04944784|155434843|FG002|Double-blind Period|Adverse Event|0|||
48339006|NCT04944784|155434844|FG003|Double-blind Period|Adverse Event|0|||
48339007|NCT04944784|155434841|FG000|Double-blind Period|Withdrawal by Subject|15|||
48339008|NCT04944784|155434842|FG001|Double-blind Period|Withdrawal by Subject|4|||
48339009|NCT04944784|155434843|FG002|Double-blind Period|Withdrawal by Subject|0|||
48339010|NCT04944784|155434844|FG003|Double-blind Period|Withdrawal by Subject|0|||
48339011|NCT04944784|155434841|FG000|Double-blind Period|Death|7|||
48339012|NCT04944784|155434842|FG001|Double-blind Period|Death|2|||
48339013|NCT04944784|155434843|FG002|Double-blind Period|Death|0|||
48661851|NCT01155466|156614172|FG000|Overall Study|Randomized not treated|2|||
48661852|NCT01155466|156614173|FG001|Overall Study|Randomized not treated|2|||
48661853|NCT01155466|156614174|FG002|Overall Study|Randomized not treated|3|||
48661854|NCT01155466|156614175|FG003|Overall Study|Randomized not treated|0|||
48661855|NCT01155466|156614176|FG004|Overall Study|Randomized not treated|2|||
48661856|NCT02174523|156614179|FG000|Overall Study|Withdrawal by Subject|1|||
48661857|NCT02174523|156614180|FG001|Overall Study|Withdrawal by Subject|0|||
48661858|NCT03640052|156614181|FG000|Overall Study|Lost to Follow-up|0|||
48661859|NCT03640052|156614182|FG001|Overall Study|Lost to Follow-up|1|||
48661860|NCT03640052|156614183|FG002|Overall Study|Lost to Follow-up|0|||
48661861|NCT03640052|156614184|FG003|Overall Study|Lost to Follow-up|0|||
48661862|NCT03640052|156614185|FG004|Overall Study|Lost to Follow-up|0|||
48661863|NCT00230282|156614186|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
48661864|NCT00230282|156614186|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
48661865|NCT00230282|156614186|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
48661866|NCT00230282|156614186|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
48661867|NCT03431350|156614187|FG000|Overall Study|ONGOING|0|||
48661868|NCT03431350|156614188|FG001|Overall Study|ONGOING|0|||
48661869|NCT03431350|156614189|FG002|Overall Study|ONGOING|2|||
48661870|NCT03431350|156614190|FG003|Overall Study|ONGOING|0|||
48661871|NCT03431350|156614191|FG004|Overall Study|ONGOING|1|||
48661872|NCT03431350|156614192|FG005|Overall Study|ONGOING|3|||
48661873|NCT03431350|156614193|FG006|Overall Study|ONGOING|0|||
48661874|NCT03431350|156614194|FG007|Overall Study|ONGOING|1|||
48661875|NCT03431350|156614195|FG008|Overall Study|ONGOING|3|||
48661876|NCT03431350|156614196|FG009|Overall Study|ONGOING|4|||
48661877|NCT03431350|156614197|FG010|Overall Study|ONGOING|2|||
48661878|NCT03431350|156614198|FG011|Overall Study|ONGOING|1|||
48661879|NCT03431350|156614187|FG000|Overall Study|Death|6|||
48661880|NCT03431350|156614188|FG001|Overall Study|Death|5|||
48661881|NCT03431350|156614189|FG002|Overall Study|Death|18|||
48661882|NCT03431350|156614190|FG003|Overall Study|Death|7|||
48661883|NCT03431350|156614191|FG004|Overall Study|Death|4|||
48661884|NCT03431350|156614192|FG005|Overall Study|Death|3|||
48661885|NCT03431350|156614193|FG006|Overall Study|Death|2|||
48339014|NCT04944784|155434844|FG003|Double-blind Period|Death|0|||
48339015|NCT04944784|155434841|FG000|Double-blind Period|Physician Decision|2|||
48339016|NCT04944784|155434842|FG001|Double-blind Period|Physician Decision|1|||
48339017|NCT04944784|155434843|FG002|Double-blind Period|Physician Decision|0|||
48339018|NCT04944784|155434844|FG003|Double-blind Period|Physician Decision|0|||
48339019|NCT04944784|155434841|FG000|Double-blind Period|Lack of Efficacy|0|||
48339020|NCT04944784|155434842|FG001|Double-blind Period|Lack of Efficacy|1|||
48339021|NCT04944784|155434843|FG002|Double-blind Period|Lack of Efficacy|0|||
48339022|NCT04944784|155434844|FG003|Double-blind Period|Lack of Efficacy|0|||
48339023|NCT04944784|155434841|FG000|Double-blind Period|Sponsor Request|2|||
48339024|NCT04944784|155434842|FG001|Double-blind Period|Sponsor Request|1|||
48339025|NCT04944784|155434843|FG002|Double-blind Period|Sponsor Request|0|||
48339026|NCT04944784|155434844|FG003|Double-blind Period|Sponsor Request|0|||
48339027|NCT04944784|155434841|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
48339028|NCT04944784|155434842|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
48339029|NCT04944784|155434843|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
48339030|NCT04944784|155434844|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
48339031|NCT04944784|155434841|FG000|Double-blind Period|Participant Choice|1|||
48339032|NCT04944784|155434842|FG001|Double-blind Period|Participant Choice|1|||
48339033|NCT04944784|155434843|FG002|Double-blind Period|Participant Choice|0|||
48339034|NCT04944784|155434844|FG003|Double-blind Period|Participant Choice|0|||
48339035|NCT04944784|155434841|FG000|Double-blind Period|Progressive Disease|2|||
48661886|NCT03431350|156614194|FG007|Overall Study|Death|0|||
48661887|NCT03431350|156614195|FG008|Overall Study|Death|0|||
48661888|NCT03431350|156614196|FG009|Overall Study|Death|0|||
48661889|NCT03431350|156614197|FG010|Overall Study|Death|4|||
48661890|NCT03431350|156614198|FG011|Overall Study|Death|0|||
48661891|NCT03431350|156614187|FG000|Overall Study|Lost to Follow-up|0|||
48661892|NCT03431350|156614188|FG001|Overall Study|Lost to Follow-up|1|||
48661893|NCT03431350|156614189|FG002|Overall Study|Lost to Follow-up|0|||
48661894|NCT03431350|156614190|FG003|Overall Study|Lost to Follow-up|0|||
48661895|NCT03431350|156614191|FG004|Overall Study|Lost to Follow-up|0|||
48339036|NCT04944784|155434842|FG001|Double-blind Period|Progressive Disease|2|||
48339037|NCT04944784|155434843|FG002|Double-blind Period|Progressive Disease|0|||
48339038|NCT04944784|155434844|FG003|Double-blind Period|Progressive Disease|0|||
48339039|NCT04944784|155434841|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
48339040|NCT04944784|155434842|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
48339041|NCT04944784|155434843|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
48339042|NCT04944784|155434844|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
48339043|NCT04944784|155434841|FG000|Active Drug Period|Adverse Event|0|||
48339044|NCT04944784|155434842|FG001|Active Drug Period|Adverse Event|0|||
48339045|NCT04944784|155434843|FG002|Active Drug Period|Adverse Event|3|||
48339046|NCT04944784|155434844|FG003|Active Drug Period|Adverse Event|6|||
48339047|NCT04944784|155434841|FG000|Active Drug Period|Withdrawal by Subject|0|||
48339048|NCT04944784|155434842|FG001|Active Drug Period|Withdrawal by Subject|0|||
48339049|NCT04944784|155434843|FG002|Active Drug Period|Withdrawal by Subject|4|||
48339050|NCT04944784|155434844|FG003|Active Drug Period|Withdrawal by Subject|7|||
48339051|NCT04944784|155434841|FG000|Active Drug Period|Death|0|||
48339052|NCT04944784|155434842|FG001|Active Drug Period|Death|0|||
48661896|NCT03431350|156614192|FG005|Overall Study|Lost to Follow-up|0|||
48661897|NCT03431350|156614193|FG006|Overall Study|Lost to Follow-up|0|||
48339053|NCT04944784|155434843|FG002|Active Drug Period|Death|3|||
48339054|NCT04944784|155434844|FG003|Active Drug Period|Death|4|||
48339055|NCT04944784|155434841|FG000|Active Drug Period|Lack of Efficacy|0|||
48339056|NCT04944784|155434842|FG001|Active Drug Period|Lack of Efficacy|0|||
48339057|NCT04944784|155434843|FG002|Active Drug Period|Lack of Efficacy|2|||
48661898|NCT03431350|156614194|FG007|Overall Study|Lost to Follow-up|0|||
48339058|NCT04944784|155434844|FG003|Active Drug Period|Lack of Efficacy|2|||
48661899|NCT03431350|156614195|FG008|Overall Study|Lost to Follow-up|0|||
48661900|NCT03431350|156614196|FG009|Overall Study|Lost to Follow-up|0|||
48661901|NCT03431350|156614197|FG010|Overall Study|Lost to Follow-up|0|||
48661902|NCT03431350|156614198|FG011|Overall Study|Lost to Follow-up|0|||
48661903|NCT03431350|156614187|FG000|Overall Study|Withdrawal by Subject|0|||
48661904|NCT03431350|156614188|FG001|Overall Study|Withdrawal by Subject|0|||
48661905|NCT03431350|156614189|FG002|Overall Study|Withdrawal by Subject|0|||
48661906|NCT03431350|156614190|FG003|Overall Study|Withdrawal by Subject|1|||
48661907|NCT03431350|156614191|FG004|Overall Study|Withdrawal by Subject|1|||
48661908|NCT03431350|156614192|FG005|Overall Study|Withdrawal by Subject|1|||
48661909|NCT03431350|156614193|FG006|Overall Study|Withdrawal by Subject|0|||
48661910|NCT03431350|156614194|FG007|Overall Study|Withdrawal by Subject|0|||
48661911|NCT03431350|156614195|FG008|Overall Study|Withdrawal by Subject|0|||
48661912|NCT03431350|156614196|FG009|Overall Study|Withdrawal by Subject|2|||
48661913|NCT03431350|156614197|FG010|Overall Study|Withdrawal by Subject|0|||
48661914|NCT03431350|156614198|FG011|Overall Study|Withdrawal by Subject|1|||
48339059|NCT04944784|155434841|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
48661915|NCT03431350|156614187|FG000|Overall Study|Other|0|||
48661916|NCT03431350|156614188|FG001|Overall Study|Other|0|||
48661917|NCT03431350|156614189|FG002|Overall Study|Other|1|||
48661918|NCT03431350|156614190|FG003|Overall Study|Other|3|||
48661919|NCT03431350|156614191|FG004|Overall Study|Other|2|||
48661920|NCT03431350|156614192|FG005|Overall Study|Other|2|||
48661921|NCT03431350|156614193|FG006|Overall Study|Other|4|||
48661922|NCT03431350|156614194|FG007|Overall Study|Other|0|||
48661923|NCT03431350|156614195|FG008|Overall Study|Other|14|||
48661924|NCT03431350|156614196|FG009|Overall Study|Other|11|||
48661925|NCT03431350|156614197|FG010|Overall Study|Other|11|||
48661926|NCT03431350|156614198|FG011|Overall Study|Other|15|||
48661927|NCT04706273|156614200|FG000|Overall Study|Withdrawal by Subject|27|||
48661928|NCT04706273|156614200|FG000|Overall Study|Physician Decision|1|||
48661929|NCT04706273|156614200|FG000|Overall Study|Lost to Follow-up|42|||
48661930|NCT04706273|156614200|FG000|Overall Study|Death|85|||
48661931|NCT04706273|156614200|FG000|Overall Study|Amputation that removes study device|2|||
48661932|NCT04706273|156614200|FG000|Overall Study|Surgical bypass|3|||
48661933|NCT04706273|156614200|FG000|Overall Study|Changing hospital|23|||
48661934|NCT04706273|156614200|FG000|Overall Study|Unable to attend hospital|2|||
48661935|NCT01438853|156614204|FG000|Overall Study|Death|0|||
48661936|NCT01438853|156614205|FG001|Overall Study|Death|0|||
48661937|NCT01438853|156614206|FG002|Overall Study|Death|0|||
48661938|NCT01438853|156614207|FG003|Overall Study|Death|1|||
48661939|NCT01438853|156614204|FG000|Overall Study|Withdrawal by Subject|0|||
48661940|NCT01438853|156614205|FG001|Overall Study|Withdrawal by Subject|0|||
48661941|NCT01438853|156614206|FG002|Overall Study|Withdrawal by Subject|1|||
48661942|NCT01438853|156614207|FG003|Overall Study|Withdrawal by Subject|0|||
48661943|NCT02624050|156614208|FG000|Overall Study|Physician Decision|4|||
48661944|NCT02624050|156614209|FG001|Overall Study|Physician Decision|0|||
48661945|NCT02624050|156614208|FG000|Overall Study|Protocol Violation|2|||
48661946|NCT02624050|156614209|FG001|Overall Study|Protocol Violation|0|||
48661947|NCT01904149|156614210|FG000|Overall Study|Adverse Event|3|||
48661948|NCT01904149|156614211|FG001|Overall Study|Adverse Event|4|||
48661949|NCT01904149|156614212|FG002|Overall Study|Adverse Event|0|||
48661950|NCT01904149|156614213|FG003|Overall Study|Adverse Event|1|||
48661951|NCT01904149|156614214|FG004|Overall Study|Adverse Event|1|||
48661952|NCT01904149|156614215|FG005|Overall Study|Adverse Event|2|||
48661953|NCT01904149|156614210|FG000|Overall Study|Lack of Efficacy|0|||
48661954|NCT01904149|156614211|FG001|Overall Study|Lack of Efficacy|3|||
48755714|NCT01572909|156954150|FG000|Overall Study|Technical Issues|1|||
48755715|NCT01572909|156954151|FG001|Overall Study|Technical Issues|0|||
48755716|NCT01572909|156954150|FG000|Overall Study|Withdrawal by Subject|12|||
48755717|NCT01572909|156954151|FG001|Overall Study|Withdrawal by Subject|11|||
48755718|NCT01572909|156954150|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
48755719|NCT01572909|156954151|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
48755720|NCT00410046|156954152|FG000|Overall Study|Adverse Event|3|||
48755721|NCT00410046|156954152|FG000|Overall Study|Withdrawal by Subject|1|||
48755722|NCT00410046|156954152|FG000|Overall Study|Lost to Follow-up|1|||
48755723|NCT01059786|156954153|FG000|Overall Study|Did not receive 6 cycles.|0|||
48755724|NCT01059786|156954154|FG001|Overall Study|Did not receive 6 cycles.|0|||
48755725|NCT01059786|156954155|FG002|Overall Study|Did not receive 6 cycles.|4|||
48755726|NCT01059786|156954156|FG003|Overall Study|Did not receive 6 cycles.|1|||
48755727|NCT01059786|156954157|FG004|Overall Study|Did not receive 6 cycles.|0|||
48755728|NCT05286307|156954164|FG000|Overall Study|Incomplete outcome assessments|2|||
48755729|NCT05286307|156954165|FG001|Overall Study|Incomplete outcome assessments|1|||
48755730|NCT05286307|156954164|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
48755731|NCT05286307|156954165|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
48755732|NCT05286307|156954164|FG000|Overall Study|Lost to follow up at 6 months|25|||
48755733|NCT05286307|156954165|FG001|Overall Study|Lost to follow up at 6 months|35|||
48755734|NCT05286307|156954164|FG000|Overall Study|Study medication not available|1|||
48755735|NCT05286307|156954165|FG001|Overall Study|Study medication not available|1|||
48755736|NCT00613938|156954166|FG000|Overall Study|Withdrawal by Subject|2|||
48755737|NCT00613938|156954167|FG001|Overall Study|Withdrawal by Subject|4|||
48755738|NCT00613938|156954168|FG002|Overall Study|Withdrawal by Subject|9|||
48755739|NCT00613938|156954169|FG003|Overall Study|Withdrawal by Subject|9|||
48755740|NCT00613938|156954166|FG000|Overall Study|Adverse Event|1|||
48755741|NCT00613938|156954167|FG001|Overall Study|Adverse Event|4|||
48755742|NCT00613938|156954168|FG002|Overall Study|Adverse Event|8|||
48755743|NCT00613938|156954169|FG003|Overall Study|Adverse Event|5|||
48755744|NCT00613938|156954166|FG000|Overall Study|Lack of Efficacy|16|||
48755745|NCT00613938|156954167|FG001|Overall Study|Lack of Efficacy|18|||
48755746|NCT00613938|156954168|FG002|Overall Study|Lack of Efficacy|5|||
48755747|NCT00613938|156954169|FG003|Overall Study|Lack of Efficacy|9|||
48755748|NCT00613938|156954166|FG000|Overall Study|Other|1|||
48755749|NCT00613938|156954167|FG001|Overall Study|Other|2|||
48755750|NCT00613938|156954168|FG002|Overall Study|Other|1|||
48755751|NCT00613938|156954169|FG003|Overall Study|Other|3|||
48755752|NCT00224055|156954176|FG000|Overall Study|Adverse Event|9|||
48755753|NCT00224055|156954177|FG001|Overall Study|Adverse Event|3|||
48661955|NCT01904149|156614212|FG002|Overall Study|Lack of Efficacy|1|||
48661956|NCT01904149|156614213|FG003|Overall Study|Lack of Efficacy|3|||
48661957|NCT01904149|156614214|FG004|Overall Study|Lack of Efficacy|3|||
48755754|NCT00224055|156954176|FG000|Overall Study|Lost to Follow-up|1|||
48755755|NCT00224055|156954177|FG001|Overall Study|Lost to Follow-up|2|||
48755756|NCT00224055|156954176|FG000|Overall Study|Protocol Violation|1|||
48755757|NCT00224055|156954177|FG001|Overall Study|Protocol Violation|1|||
48755758|NCT00224055|156954176|FG000|Overall Study|Inclusion Violation|3|||
48755759|NCT00224055|156954177|FG001|Overall Study|Inclusion Violation|6|||
48755760|NCT00224055|156954176|FG000|Overall Study|Withdrawal by Subject|0|||
48661958|NCT01904149|156614215|FG005|Overall Study|Lack of Efficacy|1|||
48661959|NCT01904149|156614210|FG000|Overall Study|Withdrawal by Subject|1|||
48661960|NCT01904149|156614211|FG001|Overall Study|Withdrawal by Subject|3|||
48661961|NCT01904149|156614212|FG002|Overall Study|Withdrawal by Subject|1|||
48661962|NCT01904149|156614213|FG003|Overall Study|Withdrawal by Subject|0|||
48661963|NCT01904149|156614214|FG004|Overall Study|Withdrawal by Subject|1|||
48661964|NCT01904149|156614215|FG005|Overall Study|Withdrawal by Subject|0|||
48661965|NCT01904149|156614210|FG000|Overall Study|Protocol Violation|0|||
48661966|NCT01904149|156614211|FG001|Overall Study|Protocol Violation|1|||
48661967|NCT01904149|156614212|FG002|Overall Study|Protocol Violation|0|||
48661968|NCT01904149|156614213|FG003|Overall Study|Protocol Violation|0|||
48661969|NCT01904149|156614214|FG004|Overall Study|Protocol Violation|0|||
48661970|NCT01904149|156614215|FG005|Overall Study|Protocol Violation|0|||
48661971|NCT01904149|156614210|FG000|Overall Study|non compliance with study drug|1|||
48661972|NCT01904149|156614211|FG001|Overall Study|non compliance with study drug|0|||
48661973|NCT01904149|156614212|FG002|Overall Study|non compliance with study drug|0|||
48755761|NCT00224055|156954177|FG001|Overall Study|Withdrawal by Subject|2|||
48755762|NCT00224055|156954176|FG000|Overall Study|Other|1|||
48755763|NCT00224055|156954177|FG001|Overall Study|Other|0|||
48755764|NCT01752907|156954186|FG000|Overall Study|Withdrawal by Subject|4|||
48661974|NCT01904149|156614213|FG003|Overall Study|non compliance with study drug|0|||
48661975|NCT01904149|156614214|FG004|Overall Study|non compliance with study drug|0|||
48661976|NCT01904149|156614215|FG005|Overall Study|non compliance with study drug|0|||
48661977|NCT01598753|156614216|FG000|Overall Study|Adverse Event|1|||
48661978|NCT01598753|156614217|FG001|Overall Study|Adverse Event|9|||
48661979|NCT01598753|156614218|FG002|Overall Study|Adverse Event|1|||
48661980|NCT01598753|156614219|FG003|Overall Study|Adverse Event|7|||
48661981|NCT01598753|156614216|FG000|Overall Study|Lost to Follow-up|4|||
48661982|NCT01598753|156614217|FG001|Overall Study|Lost to Follow-up|3|||
48661983|NCT01598753|156614218|FG002|Overall Study|Lost to Follow-up|7|||
48755765|NCT01752907|156954187|FG001|Overall Study|Withdrawal by Subject|10|||
48755766|NCT01752907|156954186|FG000|Overall Study|Lost to Follow-up|2|||
48755767|NCT01752907|156954187|FG001|Overall Study|Lost to Follow-up|1|||
48755768|NCT01752907|156954186|FG000|Overall Study|Decision by Sponsor|6|||
48755769|NCT01752907|156954187|FG001|Overall Study|Decision by Sponsor|9|||
48755770|NCT00696696|156954188|FG000|Overall Study|Adverse Event|5|||
48755771|NCT00696696|156954188|FG000|Overall Study|Withdrawal by Subject|8|||
48755772|NCT00696696|156954188|FG000|Overall Study|Physician Decision|2|||
48755773|NCT00696696|156954188|FG000|Overall Study|Death|3|||
48755774|NCT02642614|156954189|FG000|Overall Study|Adverse Event|1|||
48755775|NCT02642614|156954190|FG001|Overall Study|Adverse Event|1|||
48755776|NCT02642614|156954191|FG002|Overall Study|Adverse Event|2|||
48755777|NCT02642614|156954192|FG003|Overall Study|Adverse Event|2|||
48755778|NCT02642614|156954189|FG000|Overall Study|Lost to Follow-up|1|||
48755779|NCT02642614|156954190|FG001|Overall Study|Lost to Follow-up|0|||
48755780|NCT02642614|156954191|FG002|Overall Study|Lost to Follow-up|0|||
48755781|NCT02642614|156954192|FG003|Overall Study|Lost to Follow-up|0|||
48755782|NCT02642614|156954189|FG000|Overall Study|Withdrawal by Subject|1|||
48755783|NCT02642614|156954190|FG001|Overall Study|Withdrawal by Subject|1|||
48755784|NCT02642614|156954191|FG002|Overall Study|Withdrawal by Subject|0|||
48755785|NCT02642614|156954192|FG003|Overall Study|Withdrawal by Subject|0|||
48755786|NCT02450903|156954193|FG000|Overall Study|Adverse Event|3|||
48755787|NCT02450903|156954193|FG000|Overall Study|Progressive disease|15|||
48755788|NCT02450903|156954193|FG000|Overall Study|Switched to commercial drug|1|||
48755789|NCT02450903|156954193|FG000|Overall Study|Subject/guardian decision|1|||
48755790|NCT02279173|156954194|FG000|Overall Study|Protocol-specified Criteria|67|||
48755791|NCT02279173|156954194|FG000|Overall Study|Withdrawal by Subject|20|||
48755792|NCT02279173|156954194|FG000|Overall Study|Decision by Sponsor|4|||
48755793|NCT02279173|156954194|FG000|Overall Study|Lost to Follow-up|3|||
48755794|NCT00464087|156954197|FG000|Overall Study|No PCI per inclusion criteria|0|||
48755795|NCT00464087|156954198|FG001|Overall Study|No PCI per inclusion criteria|0|||
48755796|NCT00464087|156954199|FG002|Overall Study|No PCI per inclusion criteria|29|||
48755797|NCT03316131|156954200|FG000|Treatment Period 2|Protocol deviation|1|||
48661984|NCT01598753|156614219|FG003|Overall Study|Lost to Follow-up|5|||
48661985|NCT01598753|156614216|FG000|Overall Study|Physician Decision|0|||
48661986|NCT01598753|156614217|FG001|Overall Study|Physician Decision|1|||
48755798|NCT03316131|156954201|FG001|Treatment Period 2|Protocol deviation|0|||
48755799|NCT01409564|156954202|FG000|Overall Study|low medication compliance|4|||
48339060|NCT04944784|155434842|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
48339061|NCT04944784|155434843|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
48661987|NCT01598753|156614218|FG002|Overall Study|Physician Decision|0|||
48661988|NCT01598753|156614219|FG003|Overall Study|Physician Decision|2|||
48661989|NCT01598753|156614216|FG000|Overall Study|Withdrawal by Subject|7|||
48661990|NCT01598753|156614217|FG001|Overall Study|Withdrawal by Subject|2|||
48661991|NCT01598753|156614218|FG002|Overall Study|Withdrawal by Subject|0|||
48661992|NCT01598753|156614219|FG003|Overall Study|Withdrawal by Subject|1|||
48661993|NCT00953524|156614220|FG000|Overall Study|Adverse Event|2|||
48661994|NCT00953524|156614221|FG001|Overall Study|Adverse Event|0|||
48661995|NCT00953524|156614222|FG002|Overall Study|Adverse Event|1|||
48661996|NCT00953524|156614223|FG003|Overall Study|Adverse Event|2|||
48661997|NCT00953524|156614220|FG000|Overall Study|Protocol Violation|18|||
48661998|NCT00953524|156614221|FG001|Overall Study|Protocol Violation|10|||
48661999|NCT00953524|156614222|FG002|Overall Study|Protocol Violation|11|||
48662000|NCT00953524|156614223|FG003|Overall Study|Protocol Violation|6|||
48662001|NCT00953524|156614220|FG000|Overall Study|Lost to Follow-up|0|||
48662002|NCT00953524|156614221|FG001|Overall Study|Lost to Follow-up|1|||
48662003|NCT00953524|156614222|FG002|Overall Study|Lost to Follow-up|1|||
48662004|NCT00953524|156614223|FG003|Overall Study|Lost to Follow-up|0|||
48662005|NCT00953524|156614220|FG000|Overall Study|Withdrawal by Subject|2|||
48662006|NCT00953524|156614221|FG001|Overall Study|Withdrawal by Subject|4|||
48662007|NCT00953524|156614222|FG002|Overall Study|Withdrawal by Subject|1|||
48662008|NCT00953524|156614223|FG003|Overall Study|Withdrawal by Subject|0|||
48662009|NCT01371643|156614224|FG000|Overall Study|Withdrawal by Subject|3|||
48662010|NCT01371643|156614225|FG001|Overall Study|Withdrawal by Subject|0|||
48662011|NCT02699450|156614226|FG000|Overall Study|Death|2|||
48662012|NCT02699450|156614227|FG001|Overall Study|Death|1|||
48662013|NCT02699450|156614228|FG002|Overall Study|Death|2|||
48662014|NCT02699450|156614226|FG000|Overall Study|Met Criteria for Study Exit|0|||
48662015|NCT02699450|156614227|FG001|Overall Study|Met Criteria for Study Exit|0|||
48662016|NCT02699450|156614228|FG002|Overall Study|Met Criteria for Study Exit|1|||
48662017|NCT02699450|156614226|FG000|Overall Study|Protocol Violation|4|||
48662018|NCT02699450|156614227|FG001|Overall Study|Protocol Violation|3|||
48662019|NCT02699450|156614228|FG002|Overall Study|Protocol Violation|5|||
48662020|NCT02699450|156614226|FG000|Overall Study|Lost to Follow-up|3|||
48662021|NCT02699450|156614227|FG001|Overall Study|Lost to Follow-up|0|||
48662022|NCT02699450|156614228|FG002|Overall Study|Lost to Follow-up|5|||
48662023|NCT02699450|156614226|FG000|Overall Study|Physician Decision|2|||
48662024|NCT02699450|156614227|FG001|Overall Study|Physician Decision|0|||
48662025|NCT02699450|156614228|FG002|Overall Study|Physician Decision|0|||
48662026|NCT02699450|156614226|FG000|Overall Study|Withdrawal by Subject|3|||
48662027|NCT02699450|156614227|FG001|Overall Study|Withdrawal by Subject|1|||
48662028|NCT02699450|156614228|FG002|Overall Study|Withdrawal by Subject|2|||
48662029|NCT02699450|156614226|FG000|Overall Study|Adverse Event|1|||
48662030|NCT02699450|156614227|FG001|Overall Study|Adverse Event|0|||
48662031|NCT02699450|156614228|FG002|Overall Study|Adverse Event|0|||
48662032|NCT00033540|156614229|FG000|Overall Study|Adverse Event|14|||
48662033|NCT00033540|156614229|FG000|Overall Study|Death|1|||
48662034|NCT00033540|156614229|FG000|Overall Study|Progression|26|||
48662035|NCT00033540|156614229|FG000|Overall Study|Withdrawal by Subject|6|||
48662036|NCT00033540|156614229|FG000|Overall Study|Other|5|||
48755800|NCT01409564|156954203|FG001|Overall Study|low medication compliance|3|||
48755801|NCT01409564|156954202|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
48755802|NCT01409564|156954203|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
48755803|NCT00592839|156954204|FG000|Overall Study|Withdrawal by Subject|1|||
48755804|NCT00592839|156954205|FG001|Overall Study|Withdrawal by Subject|1|||
48755805|NCT00592839|156954206|FG002|Overall Study|Withdrawal by Subject|3|||
48755806|NCT00592839|156954204|FG000|Overall Study|Protocol Violation|1|||
48755807|NCT00592839|156954205|FG001|Overall Study|Protocol Violation|1|||
48428224|NCT02531373|155756500|FG002|Overall Study|Physician Decision|0|||
48662037|NCT00033540|156614229|FG000|Overall Study|Ineligible|3|||
48662038|NCT00033540|156614229|FG000|Overall Study|Never received treatment|2|||
48662039|NCT00042432|156614232|FG000|Overall Study|Adverse Event|4|||
48662040|NCT00042432|156614233|FG001|Overall Study|Adverse Event|1|||
48662041|NCT00042432|156614232|FG000|Overall Study|Withdrawal by Subject|1|||
48755808|NCT00592839|156954206|FG002|Overall Study|Protocol Violation|2|||
48662042|NCT00042432|156614233|FG001|Overall Study|Withdrawal by Subject|3|||
48662043|NCT00042432|156614232|FG000|Overall Study|Death|0|||
48662044|NCT00042432|156614233|FG001|Overall Study|Death|2|||
48662045|NCT00042432|156614232|FG000|Overall Study|Ineligibility determined|1|||
48662046|NCT00042432|156614233|FG001|Overall Study|Ineligibility determined|0|||
48662047|NCT00042432|156614232|FG000|Overall Study|Initiation of maintenance dialysis|1|||
48662048|NCT00042432|156614233|FG001|Overall Study|Initiation of maintenance dialysis|1|||
48662049|NCT00042432|156614232|FG000|Overall Study|Other|2|||
48662050|NCT00042432|156614233|FG001|Overall Study|Other|0|||
48662051|NCT02653495|156614238|FG000|Overall Study|Lost to Follow-up|2|||
48662052|NCT02653495|156614239|FG001|Overall Study|Lost to Follow-up|0|||
48662053|NCT02653495|156614238|FG000|Overall Study|Screening Failure|10|||
48662054|NCT02653495|156614239|FG001|Overall Study|Screening Failure|0|||
48662055|NCT02256267|156614240|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
48662056|NCT02256267|156614240|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
48662059|NCT02908685|156615787|FG000|Part 1 OLE|Withdrawal by Subject|0|||
48662060|NCT02908685|156615788|FG001|Part 1 OLE|Withdrawal by Subject|0|||
48662061|NCT02908685|156615789|FG002|Part 1 OLE|Withdrawal by Subject|0|||
48662062|NCT02908685|156615790|FG003|Part 1 OLE|Withdrawal by Subject|0|||
48662063|NCT02908685|156615791|FG004|Part 1 OLE|Withdrawal by Subject|0|||
48662064|NCT02908685|156615792|FG005|Part 1 OLE|Withdrawal by Subject|0|||
48662065|NCT02908685|156615793|FG006|Part 1 OLE|Withdrawal by Subject|0|||
48662066|NCT02908685|156615794|FG007|Part 1 OLE|Withdrawal by Subject|0|||
48662067|NCT02908685|156615795|FG008|Part 1 OLE|Withdrawal by Subject|0|||
48662068|NCT02908685|156615796|FG009|Part 1 OLE|Withdrawal by Subject|0|||
48662069|NCT02908685|156615797|FG010|Part 1 OLE|Withdrawal by Subject|2|||
48662070|NCT02908685|156615798|FG011|Part 1 OLE|Withdrawal by Subject|1|||
48662071|NCT02908685|156615799|FG012|Part 1 OLE|Withdrawal by Subject|0|||
48662072|NCT02908685|156615800|FG013|Part 1 OLE|Withdrawal by Subject|0|||
48662073|NCT02908685|156615787|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662074|NCT02908685|156615788|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662075|NCT02908685|156615789|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662076|NCT02908685|156615790|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662077|NCT02908685|156615791|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662078|NCT02908685|156615792|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662079|NCT02908685|156615793|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662080|NCT02908685|156615794|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662081|NCT02908685|156615795|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662082|NCT02908685|156615796|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662083|NCT02908685|156615797|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662084|NCT02908685|156615798|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
48662085|NCT02908685|156615799|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
48662086|NCT02908685|156615800|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
48662087|NCT02908685|156615787|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662088|NCT02908685|156615788|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662089|NCT02908685|156615789|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662090|NCT02908685|156615790|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662091|NCT02908685|156615791|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662092|NCT02908685|156615792|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662093|NCT02908685|156615793|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662094|NCT02908685|156615794|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662095|NCT02908685|156615795|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662096|NCT02908685|156615796|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662097|NCT02908685|156615797|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662098|NCT02908685|156615798|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662099|NCT02908685|156615799|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
48662100|NCT02908685|156615800|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
48662101|NCT02908685|156615787|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662102|NCT02908685|156615788|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662103|NCT02908685|156615789|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662104|NCT02908685|156615790|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662105|NCT02908685|156615791|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662106|NCT02908685|156615792|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662107|NCT02908685|156615793|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48339062|NCT04944784|155434844|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
48339063|NCT04944784|155434841|FG000|Active Drug Period|Participant Choice|0|||
48339064|NCT04944784|155434842|FG001|Active Drug Period|Participant Choice|0|||
48339065|NCT04944784|155434843|FG002|Active Drug Period|Participant Choice|0|||
48339066|NCT04944784|155434844|FG003|Active Drug Period|Participant Choice|1|||
48339067|NCT04944784|155434841|FG000|Active Drug Period|Progressive Disease|0|||
48339068|NCT04944784|155434842|FG001|Active Drug Period|Progressive Disease|0|||
48339069|NCT04944784|155434843|FG002|Active Drug Period|Progressive Disease|4|||
48339070|NCT04944784|155434844|FG003|Active Drug Period|Progressive Disease|4|||
48755809|NCT00592839|156954204|FG000|Overall Study|Adverse Event|0|||
48755810|NCT00592839|156954205|FG001|Overall Study|Adverse Event|1|||
48755811|NCT00592839|156954206|FG002|Overall Study|Adverse Event|0|||
48755812|NCT00592839|156954204|FG000|Overall Study|Lost to Follow-up|0|||
48755813|NCT00592839|156954205|FG001|Overall Study|Lost to Follow-up|1|||
48755814|NCT00592839|156954206|FG002|Overall Study|Lost to Follow-up|1|||
48755815|NCT02511184|156954207|FG000|Overall Study|Death|1|||
48755816|NCT02511184|156954208|FG001|Overall Study|Death|0|||
48755817|NCT02511184|156954207|FG000|Overall Study|Lost to Follow-up|0|||
48755818|NCT02511184|156954208|FG001|Overall Study|Lost to Follow-up|1|||
48755819|NCT02511184|156954207|FG000|Overall Study|Study terminated by sponsor|1|||
48755820|NCT02511184|156954208|FG001|Overall Study|Study terminated by sponsor|5|||
48755821|NCT02511184|156954207|FG000|Overall Study|Withdrawal by Subject|0|||
48755822|NCT02511184|156954208|FG001|Overall Study|Withdrawal by Subject|1|||
48755823|NCT00157950|156954211|FG000|Overall Study|Death|1|||
48755824|NCT00157950|156954212|FG001|Overall Study|Death|0|||
48755825|NCT01529346|156954213|FG000|Overall Study|Lost to Follow-up|2|||
48755826|NCT01529346|156954214|FG001|Overall Study|Lost to Follow-up|0|||
48755827|NCT01529346|156954215|FG002|Overall Study|Lost to Follow-up|1|||
48755828|NCT01529346|156954216|FG003|Overall Study|Lost to Follow-up|0|||
48755829|NCT01529346|156954217|FG004|Overall Study|Lost to Follow-up|0|||
48755830|NCT01529346|156954213|FG000|Overall Study|Other|0|||
48755831|NCT01529346|156954214|FG001|Overall Study|Other|1|||
48755832|NCT01529346|156954215|FG002|Overall Study|Other|1|||
48755833|NCT01529346|156954216|FG003|Overall Study|Other|0|||
48755834|NCT01529346|156954217|FG004|Overall Study|Other|0|||
48755835|NCT02554812|156954230|FG000|Overall Study|Adverse Event|2|||
48755836|NCT02554812|156954231|FG001|Overall Study|Adverse Event|5|||
48755837|NCT02554812|156954232|FG002|Overall Study|Adverse Event|3|||
48755838|NCT02554812|156954233|FG003|Overall Study|Adverse Event|0|||
48755839|NCT02554812|156954234|FG004|Overall Study|Adverse Event|5|||
48755840|NCT02554812|156954235|FG005|Overall Study|Adverse Event|0|||
48755841|NCT02554812|156954236|FG006|Overall Study|Adverse Event|1|||
48755842|NCT02554812|156954237|FG007|Overall Study|Adverse Event|6|||
48755843|NCT02554812|156954238|FG008|Overall Study|Adverse Event|2|||
48755844|NCT02554812|156954239|FG009|Overall Study|Adverse Event|2|||
48755845|NCT02554812|156954240|FG010|Overall Study|Adverse Event|1|||
48755846|NCT02554812|156954241|FG011|Overall Study|Adverse Event|2|||
48755847|NCT02554812|156954242|FG012|Overall Study|Adverse Event|0|||
48755848|NCT02554812|156954243|FG013|Overall Study|Adverse Event|3|||
48755849|NCT02554812|156954244|FG014|Overall Study|Adverse Event|2|||
48755850|NCT02554812|156954245|FG015|Overall Study|Adverse Event|1|||
48755851|NCT02554812|156954246|FG016|Overall Study|Adverse Event|0|||
48755852|NCT02554812|156954247|FG017|Overall Study|Adverse Event|1|||
48755853|NCT02554812|156954248|FG018|Overall Study|Adverse Event|0|||
48755854|NCT02554812|156954249|FG019|Overall Study|Adverse Event|0|||
48755855|NCT02554812|156954250|FG020|Overall Study|Adverse Event|0|||
48755856|NCT02554812|156954251|FG021|Overall Study|Adverse Event|2|||
48755857|NCT02554812|156954252|FG022|Overall Study|Adverse Event|1|||
48755858|NCT02554812|156954253|FG023|Overall Study|Adverse Event|1|||
48755859|NCT02554812|156954254|FG024|Overall Study|Adverse Event|1|||
48755860|NCT02554812|156954255|FG025|Overall Study|Adverse Event|2|||
48755861|NCT02554812|156954256|FG026|Overall Study|Adverse Event|1|||
48755862|NCT02554812|156954230|FG000|Overall Study|Death|1|||
48755863|NCT02554812|156954231|FG001|Overall Study|Death|2|||
48755864|NCT02554812|156954232|FG002|Overall Study|Death|2|||
48755865|NCT02554812|156954233|FG003|Overall Study|Death|2|||
48755866|NCT02554812|156954234|FG004|Overall Study|Death|0|||
48755867|NCT02554812|156954235|FG005|Overall Study|Death|1|||
48755868|NCT02554812|156954236|FG006|Overall Study|Death|1|||
48755869|NCT02554812|156954237|FG007|Overall Study|Death|1|||
48755870|NCT02554812|156954238|FG008|Overall Study|Death|0|||
48755871|NCT02554812|156954239|FG009|Overall Study|Death|0|||
48755872|NCT02554812|156954240|FG010|Overall Study|Death|0|||
48755873|NCT02554812|156954241|FG011|Overall Study|Death|0|||
48755874|NCT02554812|156954242|FG012|Overall Study|Death|0|||
48755875|NCT02554812|156954243|FG013|Overall Study|Death|0|||
48755876|NCT02554812|156954244|FG014|Overall Study|Death|1|||
48755877|NCT02554812|156954245|FG015|Overall Study|Death|1|||
48755878|NCT02554812|156954246|FG016|Overall Study|Death|1|||
48755879|NCT02554812|156954247|FG017|Overall Study|Death|0|||
48755880|NCT02554812|156954248|FG018|Overall Study|Death|1|||
48755881|NCT02554812|156954249|FG019|Overall Study|Death|2|||
48755882|NCT02554812|156954250|FG020|Overall Study|Death|0|||
48339071|NCT04944784|155434841|FG000|Active Drug Period|Lost to Follow-up|0|||
48339072|NCT04944784|155434842|FG001|Active Drug Period|Lost to Follow-up|0|||
48339073|NCT04944784|155434843|FG002|Active Drug Period|Lost to Follow-up|0|||
48339074|NCT04944784|155434844|FG003|Active Drug Period|Lost to Follow-up|1|||
48339075|NCT04130061|155434845|FG000|Overall Study|OR team forgot to request membrane|1|||
48339076|NCT04130061|155434846|FG001|Overall Study|OR team forgot to request membrane|0|||
48339077|NCT01537120|155436457|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
48339078|NCT01537120|155436457|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
48339079|NCT02392429|155436458|FG000|Screening|Screen failure|15|||
48339080|NCT02392429|155436458|FG000|Enrolled Participants|Ineligible due to disease|3|||
48662108|NCT02908685|156615794|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662109|NCT02908685|156615795|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662110|NCT02908685|156615796|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662111|NCT02908685|156615797|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662112|NCT02908685|156615798|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662113|NCT02908685|156615799|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
48662114|NCT02908685|156615800|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
48662115|NCT02908685|156615787|FG000|Part 2 OLE: > Month 24|Death|0|||
48662116|NCT02908685|156615788|FG001|Part 2 OLE: > Month 24|Death|0|||
48662117|NCT02908685|156615789|FG002|Part 2 OLE: > Month 24|Death|0|||
48662118|NCT02908685|156615790|FG003|Part 2 OLE: > Month 24|Death|0|||
48662119|NCT02908685|156615791|FG004|Part 2 OLE: > Month 24|Death|0|||
48662120|NCT02908685|156615792|FG005|Part 2 OLE: > Month 24|Death|0|||
48662121|NCT02908685|156615793|FG006|Part 2 OLE: > Month 24|Death|0|||
48662122|NCT02908685|156615794|FG007|Part 2 OLE: > Month 24|Death|0|||
48662123|NCT02908685|156615795|FG008|Part 2 OLE: > Month 24|Death|0|||
48662124|NCT02908685|156615796|FG009|Part 2 OLE: > Month 24|Death|0|||
48662125|NCT02908685|156615797|FG010|Part 2 OLE: > Month 24|Death|0|||
48662126|NCT02908685|156615798|FG011|Part 2 OLE: > Month 24|Death|0|||
48662127|NCT02908685|156615799|FG012|Part 2 OLE: > Month 24|Death|1|||
48662128|NCT02908685|156615800|FG013|Part 2 OLE: > Month 24|Death|0|||
48662129|NCT02908685|156615787|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
48662130|NCT02908685|156615788|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
48662131|NCT02908685|156615789|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
48662132|NCT02908685|156615790|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
48662133|NCT02908685|156615791|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
48662134|NCT02908685|156615792|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
48662135|NCT02908685|156615793|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
48662136|NCT02908685|156615794|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
48662137|NCT02908685|156615795|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
48662138|NCT02908685|156615796|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
48662139|NCT02908685|156615797|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
48662140|NCT02908685|156615798|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
48662141|NCT02908685|156615799|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
48662142|NCT02908685|156615800|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
48662143|NCT02908685|156615787|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662144|NCT02908685|156615788|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662145|NCT02908685|156615789|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662146|NCT02908685|156615790|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662147|NCT02908685|156615791|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662148|NCT02908685|156615792|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662149|NCT02908685|156615793|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662150|NCT02908685|156615794|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662151|NCT02908685|156615795|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662152|NCT02908685|156615796|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662153|NCT02908685|156615797|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662154|NCT02908685|156615798|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
48662155|NCT02908685|156615799|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
48662156|NCT02908685|156615800|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
48662157|NCT00983515|156615801|FG000|Ritonavir Alone|liver panel out of range|6|||
48662158|NCT00983515|156615801|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
48662159|NCT01730339|156615803|FG000|Overall Study|Withdrawal by Subject|3|||
48662160|NCT01730339|156615804|FG001|Overall Study|Withdrawal by Subject|2|||
48662161|NCT01730339|156615803|FG000|Overall Study|Lost to Follow-up|1|||
48662162|NCT01730339|156615804|FG001|Overall Study|Lost to Follow-up|1|||
48662163|NCT01730339|156615803|FG000|Overall Study|Un-specified|1|||
48662164|NCT01730339|156615804|FG001|Overall Study|Un-specified|0|||
48662165|NCT03733028|156615808|FG000|Overall Study|Study was stopped by PI|1|||
48662166|NCT03733028|156615809|FG001|Overall Study|Study was stopped by PI|2|||
48662167|NCT04569136|156615810|FG000|Overall Study|Lost to Follow-up|2|||
48339081|NCT02392429|155436458|FG000|Enrolled Participants|Withdrawal by Subject|4|||
48662168|NCT04569136|156615811|FG001|Overall Study|Lost to Follow-up|0|||
48662169|NCT04569136|156615812|FG002|Overall Study|Lost to Follow-up|1|||
48662170|NCT02116530|156615815|FG000|Overall Study|Withdrawal by Subject|1|||
48662171|NCT02116530|156615816|FG001|Overall Study|Withdrawal by Subject|2|||
48662172|NCT02116530|156615815|FG000|Overall Study|Adverse Event|4|||
48662173|NCT02116530|156615816|FG001|Overall Study|Adverse Event|0|||
48662174|NCT02116530|156615815|FG000|Overall Study|Physician Decision|1|||
48662175|NCT02116530|156615816|FG001|Overall Study|Physician Decision|0|||
48662176|NCT02116530|156615815|FG000|Overall Study|Lost to Follow-up|1|||
48662177|NCT02116530|156615816|FG001|Overall Study|Lost to Follow-up|0|||
48662178|NCT02116530|156615815|FG000|Overall Study|Other Medical Problems|2|||
48662179|NCT02116530|156615816|FG001|Overall Study|Other Medical Problems|2|||
48662180|NCT02233738|156615821|FG000|Overall Study|Lost to Follow-up|5|||
48662181|NCT02233738|156615822|FG001|Overall Study|Lost to Follow-up|12|||
48755883|NCT02554812|156954251|FG021|Overall Study|Death|1|||
48755884|NCT02554812|156954252|FG022|Overall Study|Death|1|||
48755885|NCT02554812|156954253|FG023|Overall Study|Death|0|||
48755886|NCT02554812|156954254|FG024|Overall Study|Death|0|||
48755887|NCT02554812|156954255|FG025|Overall Study|Death|0|||
48755888|NCT02554812|156954256|FG026|Overall Study|Death|0|||
48755889|NCT02554812|156954230|FG000|Overall Study|Lost to Follow-up|0|||
48755890|NCT02554812|156954231|FG001|Overall Study|Lost to Follow-up|1|||
48755891|NCT02554812|156954232|FG002|Overall Study|Lost to Follow-up|0|||
48755892|NCT02554812|156954233|FG003|Overall Study|Lost to Follow-up|0|||
48755893|NCT02554812|156954234|FG004|Overall Study|Lost to Follow-up|0|||
48755894|NCT02554812|156954235|FG005|Overall Study|Lost to Follow-up|0|||
48755895|NCT02554812|156954236|FG006|Overall Study|Lost to Follow-up|0|||
48755896|NCT02554812|156954237|FG007|Overall Study|Lost to Follow-up|0|||
48755897|NCT02554812|156954238|FG008|Overall Study|Lost to Follow-up|0|||
48755898|NCT02554812|156954239|FG009|Overall Study|Lost to Follow-up|0|||
48755899|NCT02554812|156954240|FG010|Overall Study|Lost to Follow-up|0|||
48755900|NCT02554812|156954241|FG011|Overall Study|Lost to Follow-up|0|||
48755901|NCT02554812|156954242|FG012|Overall Study|Lost to Follow-up|0|||
48755902|NCT02554812|156954243|FG013|Overall Study|Lost to Follow-up|0|||
48755903|NCT02554812|156954244|FG014|Overall Study|Lost to Follow-up|0|||
48755904|NCT02554812|156954245|FG015|Overall Study|Lost to Follow-up|0|||
48339082|NCT02392429|155436458|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
48339083|NCT02392429|155436458|FG000|Evaluable|Death|5|||
48339084|NCT02392429|155436458|FG000|Evaluable|Withdrawal by Subject|1|||
48339085|NCT02392429|155436458|FG000|Evaluable|Adverse Event|1|||
48339086|NCT02392429|155436458|FG000|Evaluable|remission bone marrow biopsy|3|||
48339087|NCT01503515|155436460|FG000|Overall Study|Adverse Event|4|||
48339088|NCT01503515|155436461|FG001|Overall Study|Adverse Event|5|||
48662182|NCT02233738|156615821|FG000|Overall Study|Death|0|||
48662183|NCT02233738|156615822|FG001|Overall Study|Death|1|||
48662184|NCT02233738|156615821|FG000|Overall Study|Withdrawal by Subject|0|||
48662185|NCT02233738|156615822|FG001|Overall Study|Withdrawal by Subject|1|||
48662186|NCT02233738|156615821|FG000|Overall Study|Did not return after Baseline|3|||
48662187|NCT02233738|156615822|FG001|Overall Study|Did not return after Baseline|2|||
48662188|NCT03028480|156615823|FG000|Overall Study|No revisit after the first prescription date|2|||
48662189|NCT03028480|156615823|FG000|Overall Study|Did not use the drug|1|||
48662190|NCT03028480|156615823|FG000|Overall Study|Violation of the enrollment deadline|10|||
48662191|NCT03028480|156615823|FG000|Overall Study|Case report forms were not collected|21|||
48339089|NCT01503515|155436460|FG000|Overall Study|Death|0|||
48339090|NCT01503515|155436461|FG001|Overall Study|Death|1|||
48339091|NCT01503515|155436460|FG000|Overall Study|Physician Decision|14|||
48662192|NCT01062841|156615825|FG000|Overall Study|Indwelling Device Removed|41|||
48662193|NCT01062841|156615826|FG001|Overall Study|Indwelling Device Removed|48|||
48662194|NCT01062841|156615825|FG000|Overall Study|Death|3|||
48662195|NCT01062841|156615826|FG001|Overall Study|Death|5|||
48662196|NCT01062841|156615825|FG000|Overall Study|Withdrawal by Subject|2|||
48662197|NCT01062841|156615826|FG001|Overall Study|Withdrawal by Subject|0|||
48339092|NCT01503515|155436461|FG001|Overall Study|Physician Decision|23|||
48662198|NCT01062841|156615825|FG000|Overall Study|Withdrawal by Study|3|||
48662199|NCT01062841|156615826|FG001|Overall Study|Withdrawal by Study|0|||
48755905|NCT02554812|156954246|FG016|Overall Study|Lost to Follow-up|0|||
48755906|NCT02554812|156954247|FG017|Overall Study|Lost to Follow-up|0|||
48755907|NCT02554812|156954248|FG018|Overall Study|Lost to Follow-up|0|||
48755908|NCT02554812|156954249|FG019|Overall Study|Lost to Follow-up|0|||
48662200|NCT02046174|156615827|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
48662201|NCT02046174|156615828|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
48662202|NCT01367704|156615832|FG000|Overall Study|Lost to Follow-up|47|||
48662203|NCT01367704|156615833|FG001|Overall Study|Lost to Follow-up|161|||
48755909|NCT02554812|156954250|FG020|Overall Study|Lost to Follow-up|0|||
48755910|NCT02554812|156954251|FG021|Overall Study|Lost to Follow-up|0|||
48755911|NCT02554812|156954252|FG022|Overall Study|Lost to Follow-up|0|||
48339093|NCT01503515|155436460|FG000|Overall Study|Withdrawal by Subject|0|||
48339094|NCT01503515|155436461|FG001|Overall Study|Withdrawal by Subject|1|||
48662204|NCT03220581|156615834|FG000|Overall Study|Withdrawal by Subject|0|||
48755912|NCT02554812|156954253|FG023|Overall Study|Lost to Follow-up|0|||
48755913|NCT02554812|156954254|FG024|Overall Study|Lost to Follow-up|0|||
48339095|NCT01503515|155436460|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
48339096|NCT01503515|155436461|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
48339097|NCT01503515|155436460|FG000|Overall Study|Ineligible|1|||
48339098|NCT01503515|155436461|FG001|Overall Study|Ineligible|1|||
48662205|NCT03220581|156615835|FG001|Overall Study|Withdrawal by Subject|1|||
48662206|NCT03220581|156615834|FG000|Overall Study|Lost to Follow-up|3|||
48662207|NCT03220581|156615835|FG001|Overall Study|Lost to Follow-up|6|||
48662208|NCT03831880|156615839|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
48662209|NCT03831880|156615840|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
48662210|NCT03831880|156615839|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
48662211|NCT03831880|156615840|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
48662212|NCT03958656|156615841|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
48662213|NCT03958656|156615842|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
48662214|NCT03958656|156615843|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
48339099|NCT02101554|155436462|FG000|Overall Study|Protocol Violation|0|||
48339100|NCT02101554|155436463|FG001|Overall Study|Protocol Violation|1|||
48339101|NCT02101554|155436464|FG002|Overall Study|Protocol Violation|0|||
48339102|NCT02101554|155436462|FG000|Overall Study|Insufficient Clinical Response|0|||
48339103|NCT02101554|155436463|FG001|Overall Study|Insufficient Clinical Response|2|||
48339104|NCT02101554|155436464|FG002|Overall Study|Insufficient Clinical Response|0|||
48339105|NCT02101554|155436462|FG000|Overall Study|Adverse Event|2|||
48339106|NCT02101554|155436463|FG001|Overall Study|Adverse Event|1|||
48339107|NCT02101554|155436464|FG002|Overall Study|Adverse Event|1|||
48339108|NCT02101554|155436462|FG000|Overall Study|Lost to Follow-up|0|||
48339109|NCT02101554|155436463|FG001|Overall Study|Lost to Follow-up|1|||
48339110|NCT02101554|155436464|FG002|Overall Study|Lost to Follow-up|0|||
48662215|NCT03958656|156615844|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
48662216|NCT03958656|156615841|FG000|Overall Study|No longer meets eligibility criteria|0|||
48662217|NCT03958656|156615842|FG001|Overall Study|No longer meets eligibility criteria|0|||
48662218|NCT03958656|156615843|FG002|Overall Study|No longer meets eligibility criteria|1|||
48662219|NCT03958656|156615844|FG003|Overall Study|No longer meets eligibility criteria|0|||
48662220|NCT03958656|156615841|FG000|Overall Study|Started anti-cancer treatment|0|||
48662221|NCT03958656|156615842|FG001|Overall Study|Started anti-cancer treatment|0|||
48662222|NCT03958656|156615843|FG002|Overall Study|Started anti-cancer treatment|1|||
48662223|NCT03958656|156615844|FG003|Overall Study|Started anti-cancer treatment|0|||
48662224|NCT04346108|156615845|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
48662225|NCT04346108|156615846|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
48662226|NCT04346108|156615847|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
48662227|NCT04346108|156615845|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
48662228|NCT04346108|156615846|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
48662229|NCT04346108|156615847|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
48662230|NCT00694096|156615848|FG000|Overall Study|Withdrawal by Subject|5|||
48662231|NCT03023826|156615849|FG000|Period 1|Withdrawal by Subject|0|||
48662232|NCT03023826|156615850|FG001|Period 1|Withdrawal by Subject|0|||
48662233|NCT03023826|156615851|FG002|Period 1|Withdrawal by Subject|0|||
48662234|NCT03023826|156615852|FG003|Period 1|Withdrawal by Subject|0|||
48339111|NCT02101554|155436462|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
48339112|NCT02101554|155436463|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
48339113|NCT02101554|155436464|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
48339114|NCT00092456|155436465|FG000|Overall Study|Adverse Event|0|||
48339115|NCT00092456|155436466|FG001|Overall Study|Adverse Event|0|||
48339116|NCT00092456|155436467|FG002|Overall Study|Adverse Event|1|||
48339117|NCT00092456|155436468|FG003|Overall Study|Adverse Event|1|||
48339118|NCT00092456|155436465|FG000|Overall Study|Lost to Follow-up|2|||
48339119|NCT00092456|155436466|FG001|Overall Study|Lost to Follow-up|2|||
48339120|NCT00092456|155436467|FG002|Overall Study|Lost to Follow-up|1|||
48339121|NCT00092456|155436468|FG003|Overall Study|Lost to Follow-up|2|||
48339122|NCT00092456|155436465|FG000|Overall Study|Protocol Violation|5|||
48339123|NCT00092456|155436466|FG001|Overall Study|Protocol Violation|7|||
48662235|NCT03023826|156615853|FG004|Period 1|Withdrawal by Subject|1|||
48339124|NCT00092456|155436467|FG002|Overall Study|Protocol Violation|8|||
48662236|NCT03023826|156615854|FG005|Period 1|Withdrawal by Subject|0|||
48755914|NCT02554812|156954255|FG025|Overall Study|Lost to Follow-up|0|||
48755915|NCT02554812|156954256|FG026|Overall Study|Lost to Follow-up|0|||
48339125|NCT00092456|155436468|FG003|Overall Study|Protocol Violation|6|||
48339126|NCT00092456|155436465|FG000|Overall Study|Withdrawal by Subject|13|||
48339127|NCT00092456|155436466|FG001|Overall Study|Withdrawal by Subject|5|||
48339128|NCT00092456|155436467|FG002|Overall Study|Withdrawal by Subject|16|||
48339129|NCT00092456|155436468|FG003|Overall Study|Withdrawal by Subject|6|||
48339130|NCT00092456|155436465|FG000|Overall Study|Moved|1|||
48339131|NCT00092456|155436466|FG001|Overall Study|Moved|1|||
48339132|NCT00092456|155436467|FG002|Overall Study|Moved|0|||
48339133|NCT00092456|155436468|FG003|Overall Study|Moved|1|||
48662237|NCT02142283|156615855|FG000|Overall Study|Death|20|||
48339134|NCT00092456|155436465|FG000|Overall Study|Other|4|||
48339135|NCT00092456|155436466|FG001|Overall Study|Other|2|||
48339136|NCT00092456|155436467|FG002|Overall Study|Other|3|||
48339137|NCT00092456|155436468|FG003|Overall Study|Other|0|||
48339138|NCT02762500|155436469|FG000|Overall Study|Lack of Efficacy|1|||
48339139|NCT02762500|155436470|FG001|Overall Study|Lack of Efficacy|0|||
48339140|NCT02762500|155436469|FG000|Overall Study|Withdrawal by Subject|1|||
48339141|NCT02762500|155436470|FG001|Overall Study|Withdrawal by Subject|1|||
48339142|NCT02762500|155436469|FG000|Overall Study|Adverse Event|0|||
48339143|NCT02762500|155436470|FG001|Overall Study|Adverse Event|2|||
48339144|NCT01350102|155436471|FG000|Overall Study|Adverse Event|0|||
48339145|NCT01350102|155436472|FG001|Overall Study|Adverse Event|0|||
48339146|NCT01350102|155436473|FG002|Overall Study|Adverse Event|1|||
48339147|NCT01350102|155436474|FG003|Overall Study|Adverse Event|0|||
48339148|NCT03924193|155436480|FG000|Overall Study|Adverse Event|10|||
48339149|NCT03924193|155436481|FG001|Overall Study|Adverse Event|0|||
48339150|NCT03924193|155436482|FG002|Overall Study|Adverse Event|10|||
48339151|NCT03924193|155436480|FG000|Overall Study|Withdrawal by Subject|5|||
48339152|NCT03924193|155436481|FG001|Overall Study|Withdrawal by Subject|10|||
48339153|NCT03924193|155436482|FG002|Overall Study|Withdrawal by Subject|2|||
48339154|NCT04523571|155436483|FG000|Received 2 Doses|Withdrawal by Subject|0|||
48339155|NCT04523571|155436484|FG001|Received 2 Doses|Withdrawal by Subject|0|||
48339156|NCT04523571|155436485|FG002|Received 2 Doses|Withdrawal by Subject|0|||
48339157|NCT04523571|155436486|FG003|Received 2 Doses|Withdrawal by Subject|1|||
48339158|NCT04523571|155436487|FG004|Received 2 Doses|Withdrawal by Subject|1|||
48339159|NCT04523571|155436488|FG005|Received 2 Doses|Withdrawal by Subject|0|||
48339160|NCT04523571|155436483|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
48339161|NCT04523571|155436484|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
48339162|NCT04523571|155436485|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
48339163|NCT04523571|155436486|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
48339164|NCT04523571|155436487|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
48339165|NCT04523571|155436488|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
48339166|NCT04523571|155436483|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48339167|NCT04523571|155436484|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48339168|NCT04523571|155436485|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48339169|NCT04523571|155436486|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48339170|NCT04523571|155436487|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
48339171|NCT04523571|155436488|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
48339172|NCT04523571|155436483|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
48339173|NCT04523571|155436484|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
48339174|NCT04523571|155436485|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
48339175|NCT04523571|155436486|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
48339176|NCT04523571|155436487|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
48339177|NCT04523571|155436488|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
48339178|NCT00228813|155436489|FG000|Overall Study|Death|4|||
48339179|NCT03469258|155436490|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
48339180|NCT00839306|155436494|FG000|Overall Study|Adverse Event|3|||
48339181|NCT00839306|155436495|FG001|Overall Study|Adverse Event|5|||
48662238|NCT02142283|156615856|FG001|Overall Study|Death|18|||
48339182|NCT00839306|155436494|FG000|Overall Study|Lost to Follow-up|6|||
48339183|NCT00839306|155436495|FG001|Overall Study|Lost to Follow-up|9|||
48339184|NCT00839306|155436494|FG000|Overall Study|Withdrawal by Subject|5|||
48339185|NCT00839306|155436495|FG001|Overall Study|Withdrawal by Subject|7|||
48339186|NCT00839306|155436494|FG000|Overall Study|Lack of Efficacy|5|||
48339187|NCT00839306|155436495|FG001|Overall Study|Lack of Efficacy|4|||
48339188|NCT00839306|155436494|FG000|Overall Study|Other|6|||
48339189|NCT00839306|155436495|FG001|Overall Study|Other|18|||
48339190|NCT01234675|155436496|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
48339191|NCT01234675|155436497|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
48339192|NCT01234675|155436496|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
48339193|NCT01234675|155436497|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
48339194|NCT00857311|155436498|FG000|Overall Study|Lost to Follow-up|1|||
48339195|NCT00857311|155436499|FG001|Overall Study|Lost to Follow-up|0|||
48339196|NCT00857311|155436500|FG002|Overall Study|Lost to Follow-up|0|||
48339197|NCT00857311|155436501|FG003|Overall Study|Lost to Follow-up|0|||
48339198|NCT00759681|155436504|FG000|Overall Study|Death|2|||
48339199|NCT00759681|155436505|FG001|Overall Study|Death|5|||
48339200|NCT00759681|155436504|FG000|Overall Study|Lost to Follow-up|8|||
48339201|NCT00759681|155436505|FG001|Overall Study|Lost to Follow-up|5|||
48339202|NCT00147745|155436516|FG000|Overall Study|Withdrawal by Subject|1|||
48339203|NCT00147745|155436517|FG001|Overall Study|Withdrawal by Subject|0|||
48339204|NCT00147745|155436518|FG002|Overall Study|Withdrawal by Subject|0|||
48339205|NCT01379521|155436519|FG000|Overall Study -Treatment Period|Adverse Event|3|||
48339206|NCT01379521|155436520|FG001|Overall Study -Treatment Period|Adverse Event|0|||
48339207|NCT01379521|155436519|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
48339208|NCT01379521|155436520|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
48339209|NCT01379521|155436519|FG000|Overall Study -Treatment Period|Disease Progression|23|||
48339210|NCT01379521|155436520|FG001|Overall Study -Treatment Period|Disease Progression|22|||
48339211|NCT01379521|155436519|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
48339212|NCT01379521|155436520|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
48339213|NCT01379521|155436519|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
48339214|NCT01379521|155436520|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
48339215|NCT01379521|155436519|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
48339216|NCT01379521|155436520|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
48339217|NCT01379521|155436519|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
48339218|NCT01379521|155436520|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
48339219|NCT01379521|155436519|FG000|Overall Study -Treatment Period|Death|2|||
48339220|NCT01379521|155436520|FG001|Overall Study -Treatment Period|Death|1|||
48339221|NCT01379521|155436519|FG000|Post-Treatment Evaluations|Disease Progression|22|||
48339222|NCT01379521|155436520|FG001|Post-Treatment Evaluations|Disease Progression|20|||
48339223|NCT01379521|155436519|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
48339224|NCT01379521|155436520|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
48339225|NCT01379521|155436519|FG000|Post-Treatment Evaluations|Death|1|||
48339226|NCT01379521|155436520|FG001|Post-Treatment Evaluations|Death|0|||
48339227|NCT01757171|155436521|FG000|Overall Study|Adverse Event|5|||
48339228|NCT01757171|155436522|FG001|Overall Study|Adverse Event|1|||
48339229|NCT01757171|155436521|FG000|Overall Study|Disease Progression|1|||
48339230|NCT01757171|155436522|FG001|Overall Study|Disease Progression|0|||
48339231|NCT01757171|155436521|FG000|Overall Study|Hospitalization|1|||
48339232|NCT01757171|155436522|FG001|Overall Study|Hospitalization|0|||
48339233|NCT01757171|155436521|FG000|Overall Study|ECOG decline|1|||
48662239|NCT02142283|156615855|FG000|Overall Study|Withdrawal by Subject|1|||
48662240|NCT02142283|156615856|FG001|Overall Study|Withdrawal by Subject|3|||
48662241|NCT00747344|156615857|FG000|Controlled Period|Adverse Event|3|||
48662242|NCT00747344|156615858|FG001|Controlled Period|Adverse Event|0|||
48662243|NCT00747344|156615859|FG002|Controlled Period|Adverse Event|0|||
48662244|NCT00747344|156615860|FG003|Controlled Period|Adverse Event|0|||
48662245|NCT00747344|156615857|FG000|Controlled Period|Lack of Efficacy|2|||
48662246|NCT00747344|156615858|FG001|Controlled Period|Lack of Efficacy|1|||
48662247|NCT00747344|156615859|FG002|Controlled Period|Lack of Efficacy|0|||
48662248|NCT00747344|156615860|FG003|Controlled Period|Lack of Efficacy|0|||
48662249|NCT00747344|156615857|FG000|Controlled Period|Other|0|||
48662250|NCT00747344|156615858|FG001|Controlled Period|Other|3|||
48662251|NCT00747344|156615859|FG002|Controlled Period|Other|0|||
48755916|NCT02554812|156954230|FG000|Overall Study|Global deterioration of health status|4|||
48339234|NCT01757171|155436522|FG001|Overall Study|ECOG decline|0|||
48339235|NCT03708744|155436526|FG000|Overall Study|Withdrawal by Subject|0|||
48662252|NCT00747344|156615860|FG003|Controlled Period|Other|0|||
48662253|NCT00747344|156615857|FG000|After Controlled Period|Adverse Event|0|||
48662254|NCT00747344|156615858|FG001|After Controlled Period|Adverse Event|0|||
48662255|NCT00747344|156615859|FG002|After Controlled Period|Adverse Event|0|||
48339236|NCT03708744|155436527|FG001|Overall Study|Withdrawal by Subject|0|||
48339237|NCT03708744|155436528|FG002|Overall Study|Withdrawal by Subject|1|||
48339238|NCT03708744|155436529|FG003|Overall Study|Withdrawal by Subject|0|||
48339239|NCT02812706|155436530|FG000|Phase 1|Adverse Event|0|||
48339240|NCT02812706|155436531|FG001|Phase 1|Adverse Event|2|||
48339241|NCT02812706|155436532|FG002|Phase 1|Adverse Event|0|||
48339242|NCT02812706|155436530|FG000|Phase 1|Progressive disease|3|||
48339243|NCT02812706|155436531|FG001|Phase 1|Progressive disease|3|||
48339244|NCT02812706|155436532|FG002|Phase 1|Progressive disease|0|||
48662256|NCT00747344|156615860|FG003|After Controlled Period|Adverse Event|1|||
48662257|NCT00765882|156615861|FG000|Overall Study|Adverse Event|10|||
48662258|NCT00765882|156615862|FG001|Overall Study|Adverse Event|21|||
48662259|NCT00765882|156615863|FG002|Overall Study|Adverse Event|20|||
48662260|NCT00765882|156615861|FG000|Overall Study|Lack of Efficacy|4|||
48662261|NCT00765882|156615862|FG001|Overall Study|Lack of Efficacy|0|||
48662262|NCT00765882|156615863|FG002|Overall Study|Lack of Efficacy|1|||
48662263|NCT00765882|156615861|FG000|Overall Study|Protocol Violation|4|||
48662264|NCT00765882|156615862|FG001|Overall Study|Protocol Violation|3|||
48339245|NCT02812706|155436530|FG000|Phase 2|Adverse Event|0|||
48339246|NCT02812706|155436531|FG001|Phase 2|Adverse Event|0|||
48339247|NCT02812706|155436532|FG002|Phase 2|Adverse Event|2|||
48339248|NCT02812706|155436530|FG000|Phase 2|Progressive disease|0|||
48339249|NCT02812706|155436531|FG001|Phase 2|Progressive disease|0|||
48339250|NCT02812706|155436532|FG002|Phase 2|Progressive disease|22|||
48339251|NCT02812706|155436530|FG000|Phase 2|Other-Unspecified|0|||
48339252|NCT02812706|155436531|FG001|Phase 2|Other-Unspecified|0|||
48339253|NCT02812706|155436532|FG002|Phase 2|Other-Unspecified|4|||
48339254|NCT03751280|155436541|FG000|Overall Study|Adverse Event|0|||
48339255|NCT03751280|155436542|FG001|Overall Study|Adverse Event|1|||
48339256|NCT03751280|155436541|FG000|Overall Study|Lost to Follow-up|3|||
48339257|NCT03751280|155436542|FG001|Overall Study|Lost to Follow-up|5|||
48339258|NCT03751280|155436541|FG000|Overall Study|Physician Decision|0|||
48339259|NCT03751280|155436542|FG001|Overall Study|Physician Decision|2|||
48339260|NCT03751280|155436541|FG000|Overall Study|Protocol Violation|0|||
48339261|NCT03751280|155436542|FG001|Overall Study|Protocol Violation|2|||
48339262|NCT03751280|155436541|FG000|Overall Study|Withdrawal by Subject|5|||
48339263|NCT03751280|155436542|FG001|Overall Study|Withdrawal by Subject|2|||
48339264|NCT00139659|155436551|FG000|Overall Study|Adverse Event|12|||
48339265|NCT00139659|155436552|FG001|Overall Study|Adverse Event|1|||
48339266|NCT00139659|155436551|FG000|Overall Study|Lack of Efficacy|1|||
48339267|NCT00139659|155436552|FG001|Overall Study|Lack of Efficacy|1|||
48339268|NCT00139659|155436551|FG000|Overall Study|Lost to Follow-up|7|||
48339269|NCT00139659|155436552|FG001|Overall Study|Lost to Follow-up|3|||
48339270|NCT00139659|155436551|FG000|Overall Study|Reason not Specified|6|||
48339271|NCT00139659|155436552|FG001|Overall Study|Reason not Specified|3|||
48662265|NCT00765882|156615863|FG002|Overall Study|Protocol Violation|1|||
48662266|NCT00765882|156615861|FG000|Overall Study|Withdrawal by Subject|2|||
48662267|NCT00765882|156615862|FG001|Overall Study|Withdrawal by Subject|6|||
48662268|NCT00765882|156615863|FG002|Overall Study|Withdrawal by Subject|6|||
48662269|NCT00765882|156615861|FG000|Overall Study|Lost to Follow-up|1|||
48662270|NCT00765882|156615862|FG001|Overall Study|Lost to Follow-up|9|||
48662271|NCT00765882|156615863|FG002|Overall Study|Lost to Follow-up|6|||
48662272|NCT00765882|156615861|FG000|Overall Study|Other Reason|3|||
48662273|NCT00765882|156615862|FG001|Overall Study|Other Reason|1|||
48339272|NCT00139659|155436551|FG000|Overall Study|Withdrawal by Subject|14|||
48339273|NCT00139659|155436552|FG001|Overall Study|Withdrawal by Subject|10|||
48339274|NCT02625922|155436553|FG000|Overall Study|Non-availability of IMP|1|||
48339275|NCT02625922|155436554|FG001|Overall Study|Non-availability of IMP|1|||
48339276|NCT02625922|155436553|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
48339277|NCT02625922|155436554|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
48339278|NCT01047306|155436557|FG000|Overall Study|Withdrawal by Subject|2|||
48339279|NCT01047306|155436558|FG001|Overall Study|Withdrawal by Subject|0|||
48339280|NCT01047306|155436557|FG000|Overall Study|Lost to Follow-up|1|||
48339281|NCT01047306|155436558|FG001|Overall Study|Lost to Follow-up|0|||
48339282|NCT01527500|155436559|FG000|Part A|Administrative|11|||
48339283|NCT01527500|155436560|FG001|Part A|Administrative|7|||
48339284|NCT01527500|155436559|FG000|Part A|Adverse Event|4|||
48662274|NCT00765882|156615863|FG002|Overall Study|Other Reason|2|||
48339285|NCT01527500|155436560|FG001|Part A|Adverse Event|2|||
48339286|NCT01527500|155436559|FG000|Part A|Death|4|||
48339287|NCT01527500|155436560|FG001|Part A|Death|1|||
48339288|NCT01527500|155436559|FG000|Part A|Lost to Follow-up|0|||
48662275|NCT03249935|156615870|FG000|Overall Study|Discharged from facility early|36|||
48662276|NCT03249935|156615870|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
48662277|NCT03249935|156615870|FG000|Overall Study|Protocol Violation|5|||
48662278|NCT01669421|156615871|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
48339289|NCT01527500|155436560|FG001|Part A|Lost to Follow-up|1|||
48662279|NCT01669421|156615871|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
48339290|NCT01527500|155436559|FG000|Part A|Protocol Deviation|9|||
48339291|NCT01527500|155436560|FG001|Part A|Protocol Deviation|2|||
48339292|NCT01527500|155436559|FG000|Part A|Withdrawal by Subject|2|||
48339293|NCT01527500|155436560|FG001|Part A|Withdrawal by Subject|0|||
48339294|NCT01527500|155436559|FG000|Part B|Adverse Event|1|||
48339295|NCT01527500|155436560|FG001|Part B|Adverse Event|0|||
48662280|NCT01799239|156615872|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
48662281|NCT01799239|156615873|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
48662282|NCT01799239|156615872|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
48662283|NCT01799239|156615873|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
48662284|NCT01799239|156615872|FG000|Period 1 (7 Days)|Protocol Violation|0|||
48662285|NCT01799239|156615873|FG001|Period 1 (7 Days)|Protocol Violation|1|||
48662286|NCT01799239|156615872|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
48662287|NCT01799239|156615873|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
48662288|NCT01799239|156615872|FG000|Period 2 (7 Days)|Protocol Violation|1|||
48662289|NCT01799239|156615873|FG001|Period 2 (7 Days)|Protocol Violation|0|||
48662290|NCT01561755|156615874|FG000|Overall Study|Lost to Follow-up|0|||
48662291|NCT01561755|156615875|FG001|Overall Study|Lost to Follow-up|1|||
48662292|NCT01605227|156615876|FG000|Overall Study|Did not receive study treatment|2|||
48662293|NCT01605227|156615877|FG001|Overall Study|Did not receive study treatment|3|||
48662294|NCT01605227|156615876|FG000|Overall Study|Adverse Event|228|||
48662295|NCT01605227|156615877|FG001|Overall Study|Adverse Event|42|||
48662296|NCT01605227|156615876|FG000|Overall Study|Progressive Disease|132|||
48339296|NCT00850993|155436561|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
48339297|NCT00850993|155436562|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
48339298|NCT00850993|155436563|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
48339299|NCT00850993|155436564|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
48339300|NCT01023022|155436566|FG000|Overall Study|Death|5|||
48339301|NCT01023022|155436566|FG000|Overall Study|Lost to Follow-up|7|||
48339302|NCT01023022|155436566|FG000|Overall Study|due to technical issues|2|||
48339303|NCT03023878|155436567|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
48339304|NCT03023878|155436567|FG000|Pre-Study Run-In Period|Death|1|||
48339305|NCT03023878|155436567|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
48339306|NCT03023878|155436567|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
48339307|NCT03023878|155436567|FG000|Treatment Period|Disease Progression|1|||
48339308|NCT03023878|155436567|FG000|Treatment Period|Withdrawal by Subject|1|||
48339309|NCT03023878|155436567|FG000|Treatment Period|Adverse Event|1|||
48339310|NCT03023878|155436567|FG000|Long Term Follow-Up Period|Death|2|||
48339311|NCT01812837|155436568|FG000|Overall Study|Lost to Follow-up|1|||
48339312|NCT01812837|155436569|FG001|Overall Study|Lost to Follow-up|1|||
48339313|NCT01812837|155436570|FG002|Overall Study|Lost to Follow-up|0|||
48339314|NCT01812837|155436568|FG000|Overall Study|Protocol Violation|1|||
48339315|NCT01812837|155436569|FG001|Overall Study|Protocol Violation|0|||
48339316|NCT01812837|155436570|FG002|Overall Study|Protocol Violation|0|||
48339317|NCT03779334|155436571|FG000|Overall Study|Withdrawal by Subject|3|||
48339318|NCT03779334|155436572|FG001|Overall Study|Withdrawal by Subject|0|||
48339319|NCT03779334|155436573|FG002|Overall Study|Withdrawal by Subject|0|||
48339320|NCT03779334|155436571|FG000|Overall Study|Ongoing in Study|5|||
48339321|NCT03779334|155436572|FG001|Overall Study|Ongoing in Study|13|||
48339322|NCT03779334|155436573|FG002|Overall Study|Ongoing in Study|5|||
48339323|NCT02849509|155436574|FG000|Overall Study|Worsening of disease under study|1|||
48339324|NCT02849509|155436575|FG001|Overall Study|Worsening of disease under study|1|||
48339325|NCT02849509|155436576|FG002|Overall Study|Worsening of disease under study|1|||
48339326|NCT02849509|155436574|FG000|Overall Study|Worsening of other pre-existing disease|0|||
48339327|NCT02849509|155436575|FG001|Overall Study|Worsening of other pre-existing disease|1|||
48339328|NCT02849509|155436576|FG002|Overall Study|Worsening of other pre-existing disease|2|||
48339329|NCT02849509|155436574|FG000|Overall Study|Other adverse event|36|||
48339330|NCT02849509|155436575|FG001|Overall Study|Other adverse event|41|||
48339331|NCT02849509|155436576|FG002|Overall Study|Other adverse event|8|||
48339332|NCT02849509|155436574|FG000|Overall Study|Withdrawal by Subject|6|||
48339333|NCT02849509|155436575|FG001|Overall Study|Withdrawal by Subject|17|||
48339334|NCT02849509|155436576|FG002|Overall Study|Withdrawal by Subject|12|||
48339335|NCT02849509|155436574|FG000|Overall Study|Lost to Follow-up|27|||
48339336|NCT02849509|155436575|FG001|Overall Study|Lost to Follow-up|67|||
48339337|NCT02849509|155436576|FG002|Overall Study|Lost to Follow-up|36|||
48339338|NCT02849509|155436574|FG000|Overall Study|Other, reason not specified|14|||
48339339|NCT02849509|155436575|FG001|Overall Study|Other, reason not specified|29|||
48662297|NCT01605227|156615877|FG001|Overall Study|Progressive Disease|128|||
48662298|NCT01605227|156615876|FG000|Overall Study|Clinical Deterioration|227|||
48662299|NCT01605227|156615877|FG001|Overall Study|Clinical Deterioration|133|||
48662300|NCT01605227|156615876|FG000|Overall Study|Lost to Follow-up|1|||
48339340|NCT02849509|155436576|FG002|Overall Study|Other, reason not specified|25|||
48662301|NCT01605227|156615877|FG001|Overall Study|Lost to Follow-up|0|||
48662302|NCT01605227|156615876|FG000|Overall Study|Protocol Violation|1|||
48339341|NCT02849509|155436574|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
48339342|NCT02849509|155436575|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
48339343|NCT02849509|155436576|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
48339344|NCT00577096|155436577|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
48339345|NCT00577096|155436578|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
48662303|NCT01605227|156615877|FG001|Overall Study|Protocol Violation|0|||
48662304|NCT01605227|156615876|FG000|Overall Study|Physician Decision|9|||
48662305|NCT01605227|156615877|FG001|Overall Study|Physician Decision|7|||
48662306|NCT01605227|156615876|FG000|Overall Study|Withdrawal by Subject|18|||
48662307|NCT01605227|156615877|FG001|Overall Study|Withdrawal by Subject|14|||
48662308|NCT01605227|156615876|FG000|Overall Study|Sponsor Decision|2|||
48662309|NCT01605227|156615877|FG001|Overall Study|Sponsor Decision|0|||
48662310|NCT01605227|156615876|FG000|Overall Study|Started New Therapy|1|||
48662311|NCT01605227|156615877|FG001|Overall Study|Started New Therapy|0|||
48662312|NCT01605227|156615876|FG000|Overall Study|Subject Decision|0|||
48339346|NCT00577096|155436577|FG000|Short Term Participation|Withdrawal by Subject|3|||
48339347|NCT00577096|155436578|FG001|Short Term Participation|Withdrawal by Subject|5|||
48339348|NCT00577096|155436577|FG000|Short Term Participation|Death|1|||
48339349|NCT00577096|155436578|FG001|Short Term Participation|Death|1|||
48339350|NCT00794573|155436580|FG000|Overall Study|Death|3|||
48339351|NCT00794573|155436581|FG001|Overall Study|Death|0|||
48339352|NCT00794573|155436580|FG000|Overall Study|Withdrawal by Subject|9|||
48339353|NCT00794573|155436581|FG001|Overall Study|Withdrawal by Subject|12|||
48339354|NCT00794573|155436580|FG000|Overall Study|Lost to Follow-up|26|||
48339355|NCT00794573|155436581|FG001|Overall Study|Lost to Follow-up|33|||
48339356|NCT04582864|155436586|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
48339357|NCT04582864|155436586|FG000|Overall Study|Death|1|||
48339358|NCT04374253|155436587|FG000|Overall Study|Adverse Event|0|||
48339359|NCT04374253|155436588|FG001|Overall Study|Adverse Event|26|||
48339360|NCT04374253|155436589|FG002|Overall Study|Adverse Event|2|||
48339361|NCT04374253|155436590|FG003|Overall Study|Adverse Event|12|||
48339362|NCT04374253|155436587|FG000|Overall Study|Study terminated by sponsor|13|||
48339363|NCT04374253|155436588|FG001|Overall Study|Study terminated by sponsor|593|||
48339364|NCT04374253|155436589|FG002|Overall Study|Study terminated by sponsor|21|||
48339365|NCT04374253|155436590|FG003|Overall Study|Study terminated by sponsor|567|||
48339366|NCT04374253|155436587|FG000|Overall Study|Withdrawal by Subject|0|||
48339367|NCT04374253|155436588|FG001|Overall Study|Withdrawal by Subject|55|||
48339368|NCT04374253|155436589|FG002|Overall Study|Withdrawal by Subject|3|||
48339369|NCT04374253|155436590|FG003|Overall Study|Withdrawal by Subject|40|||
48339370|NCT04374253|155436587|FG000|Overall Study|Physician Decision|1|||
48339371|NCT04374253|155436588|FG001|Overall Study|Physician Decision|10|||
48339372|NCT04374253|155436589|FG002|Overall Study|Physician Decision|1|||
48339373|NCT04374253|155436590|FG003|Overall Study|Physician Decision|10|||
48339374|NCT04374253|155436587|FG000|Overall Study|Protocol Violation|0|||
48339375|NCT04374253|155436588|FG001|Overall Study|Protocol Violation|0|||
48339376|NCT04374253|155436589|FG002|Overall Study|Protocol Violation|0|||
48339377|NCT04374253|155436590|FG003|Overall Study|Protocol Violation|2|||
48339378|NCT04374253|155436587|FG000|Overall Study|Death|0|||
48339379|NCT04374253|155436588|FG001|Overall Study|Death|3|||
48339380|NCT04374253|155436589|FG002|Overall Study|Death|1|||
48339381|NCT04374253|155436590|FG003|Overall Study|Death|1|||
48339382|NCT04374253|155436587|FG000|Overall Study|Lack of Efficacy|0|||
48339383|NCT04374253|155436588|FG001|Overall Study|Lack of Efficacy|0|||
48339384|NCT04374253|155436589|FG002|Overall Study|Lack of Efficacy|0|||
48339385|NCT04374253|155436590|FG003|Overall Study|Lack of Efficacy|1|||
48339386|NCT04374253|155436587|FG000|Overall Study|Lost to Follow-up|1|||
48339387|NCT04374253|155436588|FG001|Overall Study|Lost to Follow-up|1|||
48339388|NCT04374253|155436589|FG002|Overall Study|Lost to Follow-up|0|||
48339389|NCT04374253|155436590|FG003|Overall Study|Lost to Follow-up|2|||
48339390|NCT04374253|155436587|FG000|Overall Study|Reason Not Specified|0|||
48339391|NCT04374253|155436588|FG001|Overall Study|Reason Not Specified|8|||
48339392|NCT04374253|155436589|FG002|Overall Study|Reason Not Specified|0|||
48339393|NCT04374253|155436590|FG003|Overall Study|Reason Not Specified|8|||
48339394|NCT01482819|155436591|FG000|Overall Study|Lost to Follow-up|2|||
48339395|NCT01544153|155436596|FG000|Overall Study|Under 18|0|||
48339396|NCT01544153|155436597|FG001|Overall Study|Under 18|1|||
48339397|NCT01544153|155436598|FG002|Overall Study|Under 18|0|||
48339398|NCT01544153|155436599|FG003|Overall Study|Under 18|0|||
48662313|NCT01605227|156615877|FG001|Overall Study|Subject Decision|1|||
48662314|NCT01605227|156615876|FG000|Overall Study|Dose Held >6 weeks|0|||
48339399|NCT01544153|155436596|FG000|Overall Study|Non-smoker|0|||
48339400|NCT01544153|155436597|FG001|Overall Study|Non-smoker|0|||
48339401|NCT01544153|155436598|FG002|Overall Study|Non-smoker|1|||
48339402|NCT01544153|155436599|FG003|Overall Study|Non-smoker|0|||
48662315|NCT01605227|156615877|FG001|Overall Study|Dose Held >6 weeks|1|||
48339403|NCT00276016|155436600|FG000|Intervention 1|Withdrawal by Subject|0|||
48339404|NCT00276016|155436601|FG001|Intervention 1|Withdrawal by Subject|1|||
48662316|NCT04209114|156615878|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
48662317|NCT04209114|156615879|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
48339405|NCT00276016|155436602|FG002|Intervention 1|Withdrawal by Subject|0|||
48339406|NCT00276016|155436603|FG003|Intervention 1|Withdrawal by Subject|0|||
48339407|NCT00276016|155436604|FG004|Intervention 1|Withdrawal by Subject|0|||
48339408|NCT00276016|155436605|FG005|Intervention 1|Withdrawal by Subject|0|||
48339409|NCT00417989|155436606|FG000|Overall Study|Withdrawal by Subject|13|||
48339410|NCT00417989|155436607|FG001|Overall Study|Withdrawal by Subject|13|||
48339411|NCT00417989|155436606|FG000|Overall Study|Lost to Follow-up|1|||
48755917|NCT02554812|156954231|FG001|Overall Study|Global deterioration of health status|3|||
48755918|NCT02554812|156954232|FG002|Overall Study|Global deterioration of health status|3|||
48755919|NCT02554812|156954233|FG003|Overall Study|Global deterioration of health status|2|||
48755920|NCT02554812|156954234|FG004|Overall Study|Global deterioration of health status|5|||
48755921|NCT02554812|156954235|FG005|Overall Study|Global deterioration of health status|0|||
48755922|NCT02554812|156954236|FG006|Overall Study|Global deterioration of health status|2|||
48755923|NCT02554812|156954237|FG007|Overall Study|Global deterioration of health status|1|||
48755924|NCT02554812|156954238|FG008|Overall Study|Global deterioration of health status|1|||
48755925|NCT02554812|156954239|FG009|Overall Study|Global deterioration of health status|1|||
48755926|NCT02554812|156954240|FG010|Overall Study|Global deterioration of health status|2|||
48755927|NCT02554812|156954241|FG011|Overall Study|Global deterioration of health status|1|||
48755928|NCT02554812|156954242|FG012|Overall Study|Global deterioration of health status|0|||
48755929|NCT02554812|156954243|FG013|Overall Study|Global deterioration of health status|0|||
48755930|NCT02554812|156954244|FG014|Overall Study|Global deterioration of health status|0|||
48755931|NCT02554812|156954245|FG015|Overall Study|Global deterioration of health status|1|||
48755932|NCT02554812|156954246|FG016|Overall Study|Global deterioration of health status|0|||
48755933|NCT02554812|156954247|FG017|Overall Study|Global deterioration of health status|0|||
48755934|NCT02554812|156954248|FG018|Overall Study|Global deterioration of health status|0|||
48755935|NCT02554812|156954249|FG019|Overall Study|Global deterioration of health status|0|||
48755936|NCT02554812|156954250|FG020|Overall Study|Global deterioration of health status|0|||
48755937|NCT02554812|156954251|FG021|Overall Study|Global deterioration of health status|0|||
48755938|NCT02554812|156954252|FG022|Overall Study|Global deterioration of health status|0|||
48755939|NCT02554812|156954253|FG023|Overall Study|Global deterioration of health status|0|||
48662318|NCT04209114|156615880|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
48662319|NCT04209114|156615878|FG000|Pre-Treatment Phase|Other reasons|0|||
48662320|NCT04209114|156615879|FG001|Pre-Treatment Phase|Other reasons|0|||
48662321|NCT04209114|156615880|FG002|Pre-Treatment Phase|Other reasons|1|||
48662322|NCT04209114|156615878|FG000|Pre-Treatment Phase|Death|0|||
48662323|NCT04209114|156615879|FG001|Pre-Treatment Phase|Death|0|||
48755940|NCT02554812|156954254|FG024|Overall Study|Global deterioration of health status|0|||
48755941|NCT02554812|156954255|FG025|Overall Study|Global deterioration of health status|0|||
48755942|NCT02554812|156954256|FG026|Overall Study|Global deterioration of health status|0|||
48339412|NCT00417989|155436607|FG001|Overall Study|Lost to Follow-up|6|||
48662324|NCT04209114|156615880|FG002|Pre-Treatment Phase|Death|1|||
48662325|NCT04209114|156615878|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
48662326|NCT04209114|156615879|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
48662327|NCT04209114|156615880|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
48662328|NCT04209114|156615878|FG000|Treatment Phase|Other reasons|5|||
48662329|NCT04209114|156615879|FG001|Treatment Phase|Other reasons|3|||
48662330|NCT04209114|156615880|FG002|Treatment Phase|Other reasons|0|||
48662331|NCT04209114|156615878|FG000|Treatment Phase|Lost to Follow-up|1|||
48662332|NCT04209114|156615879|FG001|Treatment Phase|Lost to Follow-up|0|||
48662333|NCT04209114|156615880|FG002|Treatment Phase|Lost to Follow-up|0|||
48662334|NCT04209114|156615878|FG000|Treatment Phase|Participant withdrew consent|1|||
48662335|NCT04209114|156615879|FG001|Treatment Phase|Participant withdrew consent|0|||
48662336|NCT04209114|156615880|FG002|Treatment Phase|Participant withdrew consent|0|||
48662337|NCT04209114|156615878|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
48662338|NCT04209114|156615879|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
48662339|NCT04209114|156615880|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
48662340|NCT04209114|156615878|FG000|Treatment Phase|Death|4|||
48662341|NCT04209114|156615879|FG001|Treatment Phase|Death|1|||
48662342|NCT04209114|156615880|FG002|Treatment Phase|Death|0|||
48662343|NCT04209114|156615878|FG000|Treatment Phase|Study drug toxicity|4|||
48662344|NCT04209114|156615879|FG001|Treatment Phase|Study drug toxicity|6|||
48662345|NCT04209114|156615880|FG002|Treatment Phase|Study drug toxicity|0|||
48662346|NCT04209114|156615878|FG000|Treatment Phase|Disease progression|6|||
48662347|NCT04209114|156615879|FG001|Treatment Phase|Disease progression|9|||
48662348|NCT04209114|156615880|FG002|Treatment Phase|Disease progression|0|||
48662349|NCT02813668|156615881|FG000|Overall Study|Death|4|||
48662350|NCT02813668|156615881|FG000|Overall Study|Lost to Follow-up|509|||
48662351|NCT02813668|156615881|FG000|Overall Study|Withdrawal by Subject|148|||
48662352|NCT02813668|156615881|FG000|Overall Study|No longer at worksite|85|||
48662353|NCT02813668|156615881|FG000|Overall Study|Medical reasons not related to the study|4|||
48662354|NCT03366103|156615882|FG000|Overall Study|Disease Progression|3|||
48662355|NCT03366103|156615883|FG001|Overall Study|Disease Progression|1|||
48662356|NCT03366103|156615884|FG002|Overall Study|Disease Progression|0|||
48662357|NCT03366103|156615882|FG000|Overall Study|Adverse Event|0|||
48662358|NCT03366103|156615883|FG001|Overall Study|Adverse Event|1|||
48662359|NCT03366103|156615884|FG002|Overall Study|Adverse Event|0|||
48662360|NCT01028716|156615886|FG000|Overall Study|Physician Decision|1|||
48662361|NCT02549352|156615887|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
48662362|NCT02549352|156615888|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
48339413|NCT00417989|155436606|FG000|Overall Study|Protocol Violation|1|||
48339414|NCT00417989|155436607|FG001|Overall Study|Protocol Violation|0|||
48339415|NCT00417989|155436606|FG000|Overall Study|Death|0|||
48339416|NCT00417989|155436607|FG001|Overall Study|Death|1|||
48339417|NCT00417989|155436606|FG000|Overall Study|Physician Decision|5|||
48339418|NCT00417989|155436607|FG001|Overall Study|Physician Decision|2|||
48339419|NCT01636778|155436608|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
48662363|NCT02549352|156615887|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
48662364|NCT02549352|156615888|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
48662365|NCT02549352|156615887|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
48662366|NCT02549352|156615888|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
48662367|NCT02549352|156615887|FG000|12-month Follow-up|Withdrawal by Subject|4|||
48662368|NCT02549352|156615888|FG001|12-month Follow-up|Withdrawal by Subject|5|||
48662369|NCT02549352|156615887|FG000|12-month Follow-up|Lost to Follow-up|3|||
48662370|NCT02549352|156615888|FG001|12-month Follow-up|Lost to Follow-up|2|||
48339420|NCT01636778|155436609|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
48339421|NCT01636778|155436610|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
48339422|NCT01636778|155436608|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
48662371|NCT02549352|156615887|FG000|12-month Follow-up|Death|0|||
48662372|NCT02549352|156615888|FG001|12-month Follow-up|Death|1|||
48662373|NCT02549352|156615887|FG000|12-month Follow-up|Protocol Violation|0|||
48662374|NCT02549352|156615888|FG001|12-month Follow-up|Protocol Violation|1|||
48662375|NCT02549352|156615887|FG000|12-month Follow-up|Other|1|||
48662376|NCT02549352|156615888|FG001|12-month Follow-up|Other|3|||
48662377|NCT02818036|156615889|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
48662378|NCT02818036|156615890|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
48755943|NCT02554812|156954230|FG000|Overall Study|Progressive disease|20|||
48755944|NCT02554812|156954231|FG001|Overall Study|Progressive disease|16|||
48755945|NCT02554812|156954232|FG002|Overall Study|Progressive disease|19|||
48755946|NCT02554812|156954233|FG003|Overall Study|Progressive disease|18|||
48755947|NCT02554812|156954234|FG004|Overall Study|Progressive disease|21|||
48755948|NCT02554812|156954235|FG005|Overall Study|Progressive disease|15|||
48755949|NCT02554812|156954236|FG006|Overall Study|Progressive disease|6|||
48755950|NCT02554812|156954237|FG007|Overall Study|Progressive disease|13|||
48755951|NCT02554812|156954238|FG008|Overall Study|Progressive disease|6|||
48755952|NCT02554812|156954239|FG009|Overall Study|Progressive disease|6|||
48755953|NCT02554812|156954240|FG010|Overall Study|Progressive disease|8|||
48755954|NCT02554812|156954241|FG011|Overall Study|Progressive disease|8|||
48755955|NCT02554812|156954242|FG012|Overall Study|Progressive disease|6|||
48662379|NCT02818036|156615889|FG000|Overall Study|Withdrawal by Subject|1|||
48662380|NCT02818036|156615890|FG001|Overall Study|Withdrawal by Subject|0|||
48662381|NCT01154283|156615891|FG000|0-6 Weeks|Withdrawal by Subject|7|||
48662382|NCT01154283|156615892|FG001|0-6 Weeks|Withdrawal by Subject|2|||
48662383|NCT01154283|156615891|FG000|0-6 Weeks|Death|0|||
48662384|NCT01154283|156615892|FG001|0-6 Weeks|Death|1|||
48662385|NCT01154283|156615891|FG000|7-12 Weeks|Death|1|||
48662386|NCT01154283|156615892|FG001|7-12 Weeks|Death|0|||
48339423|NCT01636778|155436609|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
48662387|NCT01154283|156615891|FG000|7-12 Weeks|Withdrawal by Subject|0|||
48662388|NCT01154283|156615892|FG001|7-12 Weeks|Withdrawal by Subject|1|||
48662389|NCT01816906|156615893|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
48662390|NCT01816906|156615894|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
48662391|NCT01816906|156615893|FG000|Six Months|Lost to Follow-up|14|||
48662392|NCT01816906|156615894|FG001|Six Months|Lost to Follow-up|16|||
48662393|NCT01816906|156615893|FG000|12 Months|Adverse Event|2|||
48662394|NCT01816906|156615894|FG001|12 Months|Adverse Event|2|||
48662395|NCT01816906|156615893|FG000|12 Months|Death|0|||
48662396|NCT01816906|156615894|FG001|12 Months|Death|2|||
48662397|NCT01816906|156615893|FG000|12 Months|Lost to Follow-up|2|||
48662398|NCT01816906|156615894|FG001|12 Months|Lost to Follow-up|1|||
48755956|NCT02554812|156954243|FG013|Overall Study|Progressive disease|10|||
48755957|NCT02554812|156954244|FG014|Overall Study|Progressive disease|20|||
48755958|NCT02554812|156954245|FG015|Overall Study|Progressive disease|6|||
48428225|NCT02531373|155756501|FG003|Overall Study|Physician Decision|0|||
48662399|NCT00869050|156615895|FG000|Overall Study|Screen Failure|3|||
48662400|NCT02966795|156615898|FG000|Overall Study|Patient Left the Country|0|||
48662401|NCT02966795|156615899|FG001|Overall Study|Patient Left the Country|1|||
48662402|NCT01515475|156615900|FG000|Overall Study|Lost to Follow-up|20|||
48662403|NCT01515475|156615901|FG001|Overall Study|Lost to Follow-up|15|||
48662404|NCT01515475|156615902|FG002|Overall Study|Lost to Follow-up|12|||
48662405|NCT01515475|156615903|FG003|Overall Study|Lost to Follow-up|12|||
48662406|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
48662407|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
48662408|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
48755959|NCT02554812|156954246|FG016|Overall Study|Progressive disease|3|||
48755960|NCT02554812|156954247|FG017|Overall Study|Progressive disease|3|||
48755961|NCT02554812|156954248|FG018|Overall Study|Progressive disease|11|||
48662409|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
48662410|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
48662411|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
48662412|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
48662413|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
48662414|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
48662415|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
48662416|NCT01352741|156615904|FG000|Open-label Tapentadol Titration Period|Other|4|||
48662417|NCT01352741|156615905|FG001|Open-label Tapentadol Titration Period|Other|0|||
48662418|NCT01352741|156615904|FG000|Double-blind Comparative Period|Protocol Violation|2|||
48339424|NCT01636778|155436610|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
48339425|NCT01636778|155436608|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
48339426|NCT01636778|155436609|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
48339427|NCT01636778|155436610|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
48339428|NCT01636778|155436608|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
48339429|NCT01636778|155436609|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
48339430|NCT01636778|155436610|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
48339431|NCT01636778|155436608|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
48339432|NCT01636778|155436609|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
48339433|NCT01636778|155436610|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
48339434|NCT01636778|155436608|FG000|Follow-up Period After Part 2|Other|0|||
48339435|NCT01636778|155436609|FG001|Follow-up Period After Part 2|Other|0|||
48339436|NCT01636778|155436610|FG002|Follow-up Period After Part 2|Other|1|||
48339437|NCT01636778|155436608|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
48339438|NCT01636778|155436609|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
48339439|NCT01636778|155436610|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
48339440|NCT01636778|155436608|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
48339441|NCT01636778|155436609|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
48339442|NCT01636778|155436610|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
48339443|NCT02473913|155436613|FG000|Overall Study|Lost to Follow-up|3|||
48339444|NCT02473913|155436614|FG001|Overall Study|Lost to Follow-up|3|||
48339445|NCT00884793|155436615|FG000|Overall Study|Withdrawal by Subject|1|||
48339446|NCT03302559|155436618|FG000|Overall Study|Adverse Event|2|||
48339447|NCT03302559|155436618|FG000|Overall Study|Lost to Follow-up|1|||
48339448|NCT03302559|155436618|FG000|Overall Study|Withdrew Consent|3|||
48339449|NCT00714688|155436619|FG000|Overall Study|Lack of Efficacy|14|||
48339450|NCT00714688|155436620|FG001|Overall Study|Lack of Efficacy|1|||
48339451|NCT00714688|155436621|FG002|Overall Study|Lack of Efficacy|4|||
48339452|NCT00714688|155436619|FG000|Overall Study|Withdrawal by Subject|4|||
48339453|NCT00714688|155436620|FG001|Overall Study|Withdrawal by Subject|3|||
48339454|NCT00714688|155436621|FG002|Overall Study|Withdrawal by Subject|3|||
48339455|NCT00714688|155436619|FG000|Overall Study|Lost to Follow-up|5|||
48339456|NCT00714688|155436620|FG001|Overall Study|Lost to Follow-up|2|||
48339457|NCT00714688|155436621|FG002|Overall Study|Lost to Follow-up|0|||
48339458|NCT00714688|155436619|FG000|Overall Study|Adverse Event|2|||
48339459|NCT00714688|155436620|FG001|Overall Study|Adverse Event|15|||
48339460|NCT00714688|155436621|FG002|Overall Study|Adverse Event|19|||
48339461|NCT00714688|155436619|FG000|Overall Study|Subject Non-compliant|3|||
48339462|NCT00714688|155436620|FG001|Overall Study|Subject Non-compliant|5|||
48339463|NCT00714688|155436621|FG002|Overall Study|Subject Non-compliant|5|||
48662419|NCT01352741|156615905|FG001|Double-blind Comparative Period|Protocol Violation|0|||
48662420|NCT01352741|156615904|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
48662421|NCT01352741|156615905|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
48662422|NCT01352741|156615904|FG000|Double-blind Comparative Period|Adverse Event|16|||
48662423|NCT01352741|156615905|FG001|Double-blind Comparative Period|Adverse Event|17|||
48339464|NCT00714688|155436619|FG000|Overall Study|Ineligible to Continue the Study|0|||
48339465|NCT00714688|155436620|FG001|Overall Study|Ineligible to Continue the Study|1|||
48339466|NCT00714688|155436621|FG002|Overall Study|Ineligible to Continue the Study|1|||
48339467|NCT00714688|155436619|FG000|Overall Study|Sponsor's Decision|0|||
48339468|NCT00714688|155436620|FG001|Overall Study|Sponsor's Decision|2|||
48339469|NCT00714688|155436621|FG002|Overall Study|Sponsor's Decision|0|||
48339470|NCT00714688|155436619|FG000|Overall Study|Other|1|||
48339471|NCT00714688|155436620|FG001|Overall Study|Other|6|||
48339472|NCT00714688|155436621|FG002|Overall Study|Other|5|||
48339473|NCT04150250|155436622|FG000|Overall Study|Lost to Follow-up|0|||
48339474|NCT04150250|155436623|FG001|Overall Study|Lost to Follow-up|2|||
48339475|NCT02154516|155436624|FG000|Overall Study|Withdrawal by Subject|0|||
48662424|NCT01352741|156615904|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
48662425|NCT01352741|156615905|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
48662426|NCT01352741|156615904|FG000|Double-blind Comparative Period|Death|0|||
48662427|NCT01352741|156615905|FG001|Double-blind Comparative Period|Death|1|||
48339476|NCT02154516|155436625|FG001|Overall Study|Withdrawal by Subject|1|||
48339477|NCT02154516|155436624|FG000|Overall Study|Lost to Follow-up|1|||
48339478|NCT02154516|155436625|FG001|Overall Study|Lost to Follow-up|0|||
48339479|NCT02154516|155436624|FG000|Overall Study|Removal/revision of device|1|||
48339480|NCT02154516|155436625|FG001|Overall Study|Removal/revision of device|0|||
48339481|NCT02154516|155436624|FG000|Overall Study|Death|2|||
48339482|NCT02154516|155436625|FG001|Overall Study|Death|1|||
48339483|NCT04267393|155436626|FG000|Randomization|Adverse Event|1|||
48339484|NCT04267393|155436627|FG001|Randomization|Adverse Event|0|||
48339485|NCT04267393|155436628|FG002|Randomization|Adverse Event|0|||
48339486|NCT04267393|155436626|FG000|Randomization|Administrative Reasons by Sponsor|0|||
48339487|NCT04267393|155436627|FG001|Randomization|Administrative Reasons by Sponsor|1|||
48662428|NCT01352741|156615904|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
48662429|NCT01352741|156615905|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
48339488|NCT04267393|155436628|FG002|Randomization|Administrative Reasons by Sponsor|0|||
48662430|NCT01352741|156615904|FG000|Double-blind Comparative Period|Other|1|||
48662431|NCT01352741|156615905|FG001|Double-blind Comparative Period|Other|2|||
48339489|NCT04267393|155436626|FG000|Treatment Period|Adverse Event|0|||
48339490|NCT04267393|155436627|FG001|Treatment Period|Adverse Event|2|||
48339491|NCT04267393|155436628|FG002|Treatment Period|Adverse Event|3|||
48339492|NCT04267393|155436626|FG000|Treatment Period|Participant Withdrew Consent|0|||
48339493|NCT04267393|155436627|FG001|Treatment Period|Participant Withdrew Consent|0|||
48339494|NCT04267393|155436628|FG002|Treatment Period|Participant Withdrew Consent|1|||
48339495|NCT04267393|155436626|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
48339496|NCT04267393|155436627|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
48339497|NCT04267393|155436628|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
48339498|NCT02056873|155436629|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
48339499|NCT02556918|155438796|FG000|Overall Study|Protocol Violation|5|||
48339500|NCT02556918|155438797|FG001|Overall Study|Protocol Violation|6|||
48339501|NCT02556918|155438796|FG000|Overall Study|Withdrawal by Subject|4|||
48339502|NCT02556918|155438797|FG001|Overall Study|Withdrawal by Subject|4|||
48339503|NCT02081196|155438798|FG000|Overall Study|Lost to Follow-up|1|||
48339504|NCT01276509|155438799|FG000|Overall Study|Adverse Event|9|||
48339505|NCT01276509|155438800|FG001|Overall Study|Adverse Event|8|||
48339506|NCT01276509|155438801|FG002|Overall Study|Adverse Event|4|||
48339507|NCT01276509|155438802|FG003|Overall Study|Adverse Event|3|||
48339508|NCT01276509|155438799|FG000|Overall Study|Lack of Efficacy|2|||
48339509|NCT01276509|155438800|FG001|Overall Study|Lack of Efficacy|1|||
48339510|NCT01276509|155438801|FG002|Overall Study|Lack of Efficacy|1|||
48339511|NCT01276509|155438802|FG003|Overall Study|Lack of Efficacy|2|||
48339512|NCT01276509|155438799|FG000|Overall Study|Pregnancy|1|||
48339513|NCT01276509|155438800|FG001|Overall Study|Pregnancy|0|||
48662432|NCT01352741|156615904|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
48662433|NCT01352741|156615905|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
48662434|NCT01352741|156615904|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
48662435|NCT01352741|156615905|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
48339514|NCT01276509|155438801|FG002|Overall Study|Pregnancy|0|||
48339515|NCT01276509|155438802|FG003|Overall Study|Pregnancy|0|||
48339516|NCT01276509|155438799|FG000|Overall Study|Withdrawal by Subject|1|||
48339517|NCT01276509|155438800|FG001|Overall Study|Withdrawal by Subject|2|||
48339518|NCT01276509|155438801|FG002|Overall Study|Withdrawal by Subject|0|||
48339519|NCT01276509|155438802|FG003|Overall Study|Withdrawal by Subject|0|||
48339520|NCT01276509|155438799|FG000|Overall Study|Other|0|||
48339521|NCT01276509|155438800|FG001|Overall Study|Other|1|||
48339522|NCT01276509|155438801|FG002|Overall Study|Other|0|||
48339523|NCT01276509|155438802|FG003|Overall Study|Other|0|||
48339524|NCT01020487|155438803|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
48339525|NCT01020487|155438804|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
48662436|NCT01352741|156615904|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
48662437|NCT01352741|156615905|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
48662438|NCT01352741|156615904|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
48662439|NCT01352741|156615905|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
48662440|NCT02463032|156615909|FG000|Overall Study|Lack of Efficacy|61|||
48662441|NCT02463032|156615910|FG001|Overall Study|Lack of Efficacy|50|||
48662442|NCT02463032|156615909|FG000|Overall Study|Death|8|||
48662443|NCT02463032|156615910|FG001|Overall Study|Death|8|||
48662444|NCT02463032|156615909|FG000|Overall Study|Adverse Event|2|||
48662445|NCT02463032|156615910|FG001|Overall Study|Adverse Event|6|||
48662446|NCT00846040|156615911|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
48662447|NCT00846040|156615912|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
48662448|NCT00846040|156615913|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
48662449|NCT00846040|156615911|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
48662450|NCT00846040|156615912|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
48662451|NCT00846040|156615913|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
48662452|NCT02153346|156615914|FG000|Overall Study|Lost to Follow-up|11|||
48662453|NCT01710527|156615915|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
48662454|NCT01710527|156615916|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
48662455|NCT02635347|156615917|FG000|Overall Study|Failed screening|20|||
48662456|NCT02635347|156615918|FG001|Overall Study|Failed screening|7|||
48662457|NCT00546260|156615919|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
48662458|NCT00546260|156615920|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
48662459|NCT01688921|156615923|FG000|Overall Study|Lost to Follow-up|7|||
48662460|NCT01688921|156615924|FG001|Overall Study|Lost to Follow-up|13|||
48662461|NCT01688921|156615923|FG000|Overall Study|Physician Decision|6|||
48662462|NCT01688921|156615924|FG001|Overall Study|Physician Decision|1|||
48339526|NCT01020487|155438805|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
48662463|NCT01688921|156615923|FG000|Overall Study|Protocol Violation|0|||
48662464|NCT01688921|156615924|FG001|Overall Study|Protocol Violation|1|||
48755962|NCT02554812|156954249|FG019|Overall Study|Progressive disease|7|||
48755963|NCT02554812|156954250|FG020|Overall Study|Progressive disease|11|||
48755964|NCT02554812|156954251|FG021|Overall Study|Progressive disease|6|||
48755965|NCT02554812|156954252|FG022|Overall Study|Progressive disease|9|||
48755966|NCT02554812|156954253|FG023|Overall Study|Progressive disease|9|||
48755967|NCT02554812|156954254|FG024|Overall Study|Progressive disease|4|||
48755968|NCT02554812|156954255|FG025|Overall Study|Progressive disease|5|||
48755969|NCT02554812|156954256|FG026|Overall Study|Progressive disease|5|||
48755970|NCT02554812|156954230|FG000|Overall Study|Other|0|||
48662465|NCT01688921|156615923|FG000|Overall Study|informed consent|3|||
48662466|NCT01688921|156615924|FG001|Overall Study|informed consent|0|||
48662467|NCT00197145|156617592|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
48662468|NCT00197145|156617593|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
48662469|NCT00197145|156617592|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
48755971|NCT02554812|156954231|FG001|Overall Study|Other|0|||
48755972|NCT02554812|156954232|FG002|Overall Study|Other|2|||
48755973|NCT02554812|156954233|FG003|Overall Study|Other|3|||
48755974|NCT02554812|156954234|FG004|Overall Study|Other|2|||
48755975|NCT02554812|156954235|FG005|Overall Study|Other|1|||
48755976|NCT02554812|156954236|FG006|Overall Study|Other|0|||
48755977|NCT02554812|156954237|FG007|Overall Study|Other|0|||
48339527|NCT01020487|155438803|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
48339528|NCT01020487|155438804|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
48339529|NCT01020487|155438805|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
48339530|NCT01020487|155438803|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
48662470|NCT00197145|156617593|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
48662471|NCT00197145|156617592|FG000|Period 1: Randomized Treatment Phase|Other|2|||
48662472|NCT00197145|156617593|FG001|Period 1: Randomized Treatment Phase|Other|2|||
48662473|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
48662474|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
48662475|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
48662476|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
48662477|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
48662478|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
48662479|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
48662480|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
48662481|NCT00197145|156617592|FG000|Period 2 : Open Label Phase|Other|1|||
48662482|NCT00197145|156617593|FG001|Period 2 : Open Label Phase|Other|0|||
48662483|NCT01691014|156617596|FG000|Overall Study|Premature Termination|1|||
48662484|NCT01691014|156617597|FG001|Overall Study|Premature Termination|6|||
48662485|NCT01691014|156617598|FG002|Overall Study|Premature Termination|0|||
48662486|NCT01691014|156617599|FG003|Overall Study|Premature Termination|3|||
48662487|NCT01691014|156617596|FG000|Overall Study|Other|0|||
48662488|NCT01691014|156617597|FG001|Overall Study|Other|0|||
48662489|NCT01691014|156617598|FG002|Overall Study|Other|2|||
48662490|NCT01691014|156617599|FG003|Overall Study|Other|0|||
48662491|NCT01691014|156617596|FG000|Overall Study|Withdrawal by Subject|0|||
48662492|NCT01691014|156617597|FG001|Overall Study|Withdrawal by Subject|1|||
48662493|NCT01691014|156617598|FG002|Overall Study|Withdrawal by Subject|1|||
48662494|NCT01691014|156617599|FG003|Overall Study|Withdrawal by Subject|1|||
48662495|NCT01691014|156617596|FG000|Overall Study|Adverse Event|0|||
48662496|NCT01691014|156617597|FG001|Overall Study|Adverse Event|5|||
48662497|NCT01691014|156617598|FG002|Overall Study|Adverse Event|1|||
48662498|NCT01691014|156617599|FG003|Overall Study|Adverse Event|1|||
48662499|NCT01691014|156617596|FG000|Overall Study|Lack of Efficacy|2|||
48662500|NCT01691014|156617597|FG001|Overall Study|Lack of Efficacy|3|||
48662501|NCT01691014|156617598|FG002|Overall Study|Lack of Efficacy|7|||
48662502|NCT01691014|156617599|FG003|Overall Study|Lack of Efficacy|0|||
48662503|NCT02370537|156617600|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
48662504|NCT02370537|156617601|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
48662505|NCT02370537|156617602|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
48662506|NCT02370537|156617600|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
48339531|NCT01020487|155438804|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
48662507|NCT02370537|156617601|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
48662508|NCT02370537|156617602|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
48662509|NCT02370537|156617600|FG000|Part B|Not randomised to receive treatment|1|||
48662510|NCT02370537|156617601|FG001|Part B|Not randomised to receive treatment|2|||
48662511|NCT02370537|156617602|FG002|Part B|Not randomised to receive treatment|259|||
48662512|NCT02370537|156617600|FG000|Part B|Withdrawal by Subject|0|||
48662513|NCT02370537|156617601|FG001|Part B|Withdrawal by Subject|1|||
48755978|NCT02554812|156954238|FG008|Overall Study|Other|1|||
48755979|NCT02554812|156954239|FG009|Overall Study|Other|1|||
48755980|NCT02554812|156954240|FG010|Overall Study|Other|0|||
48755981|NCT02554812|156954241|FG011|Overall Study|Other|0|||
48755982|NCT02554812|156954242|FG012|Overall Study|Other|1|||
48662514|NCT02370537|156617602|FG002|Part B|Withdrawal by Subject|0|||
48662515|NCT01718743|156617603|FG000|Overall Study|Physician Decision|7|||
48662516|NCT01718743|156617603|FG000|Overall Study|Withdrawal by Subject|14|||
48662517|NCT01718743|156617603|FG000|Overall Study|Progressive Disease|22|||
48662518|NCT01718743|156617603|FG000|Overall Study|Toxicity|1|||
48662519|NCT01718743|156617603|FG000|Overall Study|Malignancy|1|||
48662520|NCT00642174|156617605|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
48662521|NCT00642174|156617606|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
48662522|NCT02526524|156617619|FG000|Overall Study|Withdrawal by Subject|3|||
48662523|NCT02526524|156617620|FG001|Overall Study|Withdrawal by Subject|3|||
48662524|NCT02526524|156617621|FG002|Overall Study|Withdrawal by Subject|6|||
48662525|NCT02526524|156617622|FG003|Overall Study|Withdrawal by Subject|1|||
48662526|NCT02526524|156617623|FG004|Overall Study|Withdrawal by Subject|9|||
48662527|NCT02526524|156617624|FG005|Overall Study|Withdrawal by Subject|5|||
48755983|NCT02554812|156954243|FG013|Overall Study|Other|0|||
48755984|NCT02554812|156954244|FG014|Overall Study|Other|1|||
48755985|NCT02554812|156954245|FG015|Overall Study|Other|0|||
48755986|NCT02554812|156954246|FG016|Overall Study|Other|0|||
48755987|NCT02554812|156954247|FG017|Overall Study|Other|0|||
48755988|NCT02554812|156954248|FG018|Overall Study|Other|0|||
48755989|NCT02554812|156954249|FG019|Overall Study|Other|0|||
48755990|NCT02554812|156954250|FG020|Overall Study|Other|0|||
48755991|NCT02554812|156954251|FG021|Overall Study|Other|2|||
48755992|NCT02554812|156954252|FG022|Overall Study|Other|0|||
48755993|NCT02554812|156954253|FG023|Overall Study|Other|0|||
48755994|NCT02554812|156954254|FG024|Overall Study|Other|0|||
48755995|NCT02554812|156954255|FG025|Overall Study|Other|0|||
48755996|NCT02554812|156954256|FG026|Overall Study|Other|0|||
48755997|NCT02554812|156954230|FG000|Overall Study|Withdrawal by Subject|1|||
48755998|NCT02554812|156954231|FG001|Overall Study|Withdrawal by Subject|0|||
48755999|NCT02554812|156954232|FG002|Overall Study|Withdrawal by Subject|0|||
48756000|NCT02554812|156954233|FG003|Overall Study|Withdrawal by Subject|2|||
48756001|NCT02554812|156954234|FG004|Overall Study|Withdrawal by Subject|2|||
48756002|NCT02554812|156954235|FG005|Overall Study|Withdrawal by Subject|3|||
48756003|NCT02554812|156954236|FG006|Overall Study|Withdrawal by Subject|0|||
48756004|NCT02554812|156954237|FG007|Overall Study|Withdrawal by Subject|0|||
48756005|NCT02554812|156954238|FG008|Overall Study|Withdrawal by Subject|1|||
48756006|NCT02554812|156954239|FG009|Overall Study|Withdrawal by Subject|1|||
48756007|NCT02554812|156954240|FG010|Overall Study|Withdrawal by Subject|0|||
48756008|NCT02554812|156954241|FG011|Overall Study|Withdrawal by Subject|1|||
48756009|NCT02554812|156954242|FG012|Overall Study|Withdrawal by Subject|1|||
48756010|NCT02554812|156954243|FG013|Overall Study|Withdrawal by Subject|1|||
48756011|NCT02554812|156954244|FG014|Overall Study|Withdrawal by Subject|1|||
48756012|NCT02554812|156954245|FG015|Overall Study|Withdrawal by Subject|1|||
48756013|NCT02554812|156954246|FG016|Overall Study|Withdrawal by Subject|3|||
48756014|NCT02554812|156954247|FG017|Overall Study|Withdrawal by Subject|1|||
48756015|NCT02554812|156954248|FG018|Overall Study|Withdrawal by Subject|0|||
48756016|NCT02554812|156954249|FG019|Overall Study|Withdrawal by Subject|2|||
48662528|NCT02526524|156617619|FG000|Overall Study|Adverse Event|3|||
48662529|NCT02526524|156617620|FG001|Overall Study|Adverse Event|2|||
48662530|NCT02526524|156617621|FG002|Overall Study|Adverse Event|4|||
48662531|NCT02526524|156617622|FG003|Overall Study|Adverse Event|2|||
48662532|NCT02526524|156617623|FG004|Overall Study|Adverse Event|6|||
48662533|NCT02526524|156617624|FG005|Overall Study|Adverse Event|8|||
48662534|NCT02526524|156617619|FG000|Overall Study|Lost to Follow-up|2|||
48662535|NCT02526524|156617620|FG001|Overall Study|Lost to Follow-up|3|||
48662536|NCT02526524|156617621|FG002|Overall Study|Lost to Follow-up|8|||
48662537|NCT02526524|156617622|FG003|Overall Study|Lost to Follow-up|1|||
48662538|NCT02526524|156617623|FG004|Overall Study|Lost to Follow-up|2|||
48662539|NCT02526524|156617624|FG005|Overall Study|Lost to Follow-up|5|||
48756017|NCT02554812|156954250|FG020|Overall Study|Withdrawal by Subject|0|||
48756018|NCT02554812|156954251|FG021|Overall Study|Withdrawal by Subject|1|||
48756019|NCT02554812|156954252|FG022|Overall Study|Withdrawal by Subject|0|||
48756020|NCT02554812|156954253|FG023|Overall Study|Withdrawal by Subject|1|||
48756021|NCT02554812|156954254|FG024|Overall Study|Withdrawal by Subject|0|||
48756022|NCT02554812|156954255|FG025|Overall Study|Withdrawal by Subject|0|||
48756023|NCT02554812|156954256|FG026|Overall Study|Withdrawal by Subject|1|||
48662540|NCT02526524|156617619|FG000|Overall Study|Protocol Violation|3|||
48662541|NCT02526524|156617620|FG001|Overall Study|Protocol Violation|1|||
48662542|NCT02526524|156617621|FG002|Overall Study|Protocol Violation|5|||
48662543|NCT02526524|156617622|FG003|Overall Study|Protocol Violation|3|||
48662544|NCT02526524|156617623|FG004|Overall Study|Protocol Violation|4|||
48662545|NCT02526524|156617624|FG005|Overall Study|Protocol Violation|3|||
48756024|NCT02554812|156954230|FG000|Overall Study|Physician Decision|1|||
48756025|NCT02554812|156954231|FG001|Overall Study|Physician Decision|0|||
48756026|NCT02554812|156954232|FG002|Overall Study|Physician Decision|0|||
48756027|NCT02554812|156954233|FG003|Overall Study|Physician Decision|1|||
48756028|NCT02554812|156954234|FG004|Overall Study|Physician Decision|0|||
48756029|NCT02554812|156954235|FG005|Overall Study|Physician Decision|1|||
48756030|NCT02554812|156954236|FG006|Overall Study|Physician Decision|0|||
48756031|NCT02554812|156954237|FG007|Overall Study|Physician Decision|0|||
48756032|NCT02554812|156954238|FG008|Overall Study|Physician Decision|0|||
48756033|NCT02554812|156954239|FG009|Overall Study|Physician Decision|0|||
48756034|NCT02554812|156954240|FG010|Overall Study|Physician Decision|1|||
48756035|NCT02554812|156954241|FG011|Overall Study|Physician Decision|0|||
48756036|NCT02554812|156954242|FG012|Overall Study|Physician Decision|0|||
48756037|NCT02554812|156954243|FG013|Overall Study|Physician Decision|0|||
48756038|NCT02554812|156954244|FG014|Overall Study|Physician Decision|0|||
48756039|NCT02554812|156954245|FG015|Overall Study|Physician Decision|0|||
48339532|NCT01020487|155438805|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
48339533|NCT01020487|155438803|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
48339534|NCT01020487|155438804|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
48662546|NCT02526524|156617619|FG000|Overall Study|Loss of Glucose Control|0|||
48756040|NCT02554812|156954246|FG016|Overall Study|Physician Decision|1|||
48339535|NCT01020487|155438805|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
48339536|NCT01020487|155438803|FG000|Part 2 Open-label Period|Adverse Event|0|||
48339537|NCT01020487|155438804|FG001|Part 2 Open-label Period|Adverse Event|4|||
48339538|NCT01020487|155438805|FG002|Part 2 Open-label Period|Adverse Event|1|||
48339539|NCT03050372|155438806|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
48339540|NCT03050372|155438807|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
48339541|NCT03050372|155438806|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
48339542|NCT03050372|155438807|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
48339543|NCT01945593|155438810|FG000|Overall Study|Adverse Event|0|||
48339544|NCT01945593|155438811|FG001|Overall Study|Adverse Event|0|||
48339545|NCT01945593|155438812|FG002|Overall Study|Adverse Event|0|||
48339546|NCT01945593|155438813|FG003|Overall Study|Adverse Event|5|||
48339547|NCT01945593|155438810|FG000|Overall Study|Physician Decision|0|||
48339548|NCT01945593|155438811|FG001|Overall Study|Physician Decision|0|||
48339549|NCT01945593|155438812|FG002|Overall Study|Physician Decision|1|||
48339550|NCT01945593|155438813|FG003|Overall Study|Physician Decision|1|||
48339551|NCT01945593|155438810|FG000|Overall Study|Withdrawal by Subject|0|||
48339552|NCT01945593|155438811|FG001|Overall Study|Withdrawal by Subject|2|||
48339553|NCT01945593|155438812|FG002|Overall Study|Withdrawal by Subject|0|||
48339554|NCT01945593|155438813|FG003|Overall Study|Withdrawal by Subject|4|||
48339555|NCT01945593|155438810|FG000|Overall Study|Protocol Violation|0|||
48339556|NCT01945593|155438811|FG001|Overall Study|Protocol Violation|2|||
48339557|NCT01945593|155438812|FG002|Overall Study|Protocol Violation|1|||
48339558|NCT01945593|155438813|FG003|Overall Study|Protocol Violation|3|||
48339559|NCT01945593|155438810|FG000|Overall Study|Death|0|||
48662547|NCT02526524|156617620|FG001|Overall Study|Loss of Glucose Control|0|||
48662548|NCT02526524|156617621|FG002|Overall Study|Loss of Glucose Control|3|||
48339560|NCT01945593|155438811|FG001|Overall Study|Death|0|||
48339561|NCT01945593|155438812|FG002|Overall Study|Death|1|||
48339562|NCT01945593|155438813|FG003|Overall Study|Death|0|||
48339563|NCT01945593|155438810|FG000|Overall Study|Other: Terminated|0|||
48339564|NCT01945593|155438811|FG001|Overall Study|Other: Terminated|0|||
48339565|NCT01945593|155438812|FG002|Overall Study|Other: Terminated|0|||
48339566|NCT01945593|155438813|FG003|Overall Study|Other: Terminated|1|||
48339567|NCT01945593|155438810|FG000|Overall Study|Other: Surgical Procedure|0|||
48339568|NCT01945593|155438811|FG001|Overall Study|Other: Surgical Procedure|2|||
48339569|NCT01945593|155438812|FG002|Overall Study|Other: Surgical Procedure|0|||
48339570|NCT01945593|155438813|FG003|Overall Study|Other: Surgical Procedure|6|||
48662549|NCT02526524|156617622|FG003|Overall Study|Loss of Glucose Control|0|||
48662550|NCT02526524|156617623|FG004|Overall Study|Loss of Glucose Control|2|||
48662551|NCT02526524|156617624|FG005|Overall Study|Loss of Glucose Control|0|||
48662552|NCT02526524|156617619|FG000|Overall Study|Physician Decision|0|||
48662553|NCT02526524|156617620|FG001|Overall Study|Physician Decision|0|||
48662554|NCT02526524|156617621|FG002|Overall Study|Physician Decision|0|||
48662555|NCT02526524|156617622|FG003|Overall Study|Physician Decision|0|||
48662556|NCT02526524|156617623|FG004|Overall Study|Physician Decision|1|||
48662557|NCT02526524|156617624|FG005|Overall Study|Physician Decision|0|||
48662558|NCT02526524|156617619|FG000|Overall Study|Sponsor Decision|1|||
48662559|NCT02526524|156617620|FG001|Overall Study|Sponsor Decision|0|||
48662560|NCT02526524|156617621|FG002|Overall Study|Sponsor Decision|0|||
48662561|NCT02526524|156617622|FG003|Overall Study|Sponsor Decision|0|||
48339571|NCT01945593|155438810|FG000|Overall Study|Other: Screen Failure|0|||
48339572|NCT01945593|155438811|FG001|Overall Study|Other: Screen Failure|2|||
48339573|NCT01945593|155438812|FG002|Overall Study|Other: Screen Failure|0|||
48339574|NCT01945593|155438813|FG003|Overall Study|Other: Screen Failure|0|||
48339575|NCT01375777|155438818|FG000|Overall Study|Withdrawal by Subject|0|||
48662562|NCT02526524|156617623|FG004|Overall Study|Sponsor Decision|0|||
48662563|NCT02526524|156617624|FG005|Overall Study|Sponsor Decision|0|||
48662564|NCT02281955|156617628|FG000|Overall Study|Death|1|||
48662565|NCT00445939|156617636|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
48662566|NCT00445939|156617637|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
48756041|NCT02554812|156954247|FG017|Overall Study|Physician Decision|1|||
48756042|NCT02554812|156954248|FG018|Overall Study|Physician Decision|0|||
48756043|NCT02554812|156954249|FG019|Overall Study|Physician Decision|1|||
48756044|NCT02554812|156954250|FG020|Overall Study|Physician Decision|1|||
48756045|NCT02554812|156954251|FG021|Overall Study|Physician Decision|0|||
48756046|NCT02554812|156954252|FG022|Overall Study|Physician Decision|1|||
48756047|NCT02554812|156954253|FG023|Overall Study|Physician Decision|0|||
48756048|NCT02554812|156954254|FG024|Overall Study|Physician Decision|0|||
48756049|NCT02554812|156954255|FG025|Overall Study|Physician Decision|0|||
48756050|NCT02554812|156954256|FG026|Overall Study|Physician Decision|0|||
48756051|NCT02554812|156954230|FG000|Overall Study|Study terminated by sponsor|0|||
48756052|NCT02554812|156954231|FG001|Overall Study|Study terminated by sponsor|0|||
48756053|NCT02554812|156954232|FG002|Overall Study|Study terminated by sponsor|0|||
48756054|NCT02554812|156954233|FG003|Overall Study|Study terminated by sponsor|0|||
48756055|NCT02554812|156954234|FG004|Overall Study|Study terminated by sponsor|0|||
48756056|NCT02554812|156954235|FG005|Overall Study|Study terminated by sponsor|0|||
48756057|NCT02554812|156954236|FG006|Overall Study|Study terminated by sponsor|0|||
48756058|NCT02554812|156954237|FG007|Overall Study|Study terminated by sponsor|0|||
48756059|NCT02554812|156954238|FG008|Overall Study|Study terminated by sponsor|0|||
48756060|NCT02554812|156954239|FG009|Overall Study|Study terminated by sponsor|0|||
48756061|NCT02554812|156954240|FG010|Overall Study|Study terminated by sponsor|0|||
48756062|NCT02554812|156954241|FG011|Overall Study|Study terminated by sponsor|0|||
48756063|NCT02554812|156954242|FG012|Overall Study|Study terminated by sponsor|0|||
48756064|NCT02554812|156954243|FG013|Overall Study|Study terminated by sponsor|0|||
48756065|NCT02554812|156954244|FG014|Overall Study|Study terminated by sponsor|0|||
48756066|NCT02554812|156954245|FG015|Overall Study|Study terminated by sponsor|0|||
48756067|NCT02554812|156954246|FG016|Overall Study|Study terminated by sponsor|0|||
48756068|NCT02554812|156954247|FG017|Overall Study|Study terminated by sponsor|0|||
48756069|NCT02554812|156954248|FG018|Overall Study|Study terminated by sponsor|0|||
48756070|NCT02554812|156954249|FG019|Overall Study|Study terminated by sponsor|0|||
48756071|NCT02554812|156954250|FG020|Overall Study|Study terminated by sponsor|0|||
48756072|NCT02554812|156954251|FG021|Overall Study|Study terminated by sponsor|0|||
48756073|NCT02554812|156954252|FG022|Overall Study|Study terminated by sponsor|0|||
48756074|NCT02554812|156954253|FG023|Overall Study|Study terminated by sponsor|0|||
48756075|NCT02554812|156954254|FG024|Overall Study|Study terminated by sponsor|1|||
48756076|NCT02554812|156954255|FG025|Overall Study|Study terminated by sponsor|0|||
48756077|NCT02554812|156954256|FG026|Overall Study|Study terminated by sponsor|0|||
48756078|NCT02554812|156954230|FG000|Overall Study|No longer meets eligibility criteria|0|||
48756079|NCT02554812|156954231|FG001|Overall Study|No longer meets eligibility criteria|1|||
48756080|NCT02554812|156954232|FG002|Overall Study|No longer meets eligibility criteria|0|||
48756081|NCT02554812|156954233|FG003|Overall Study|No longer meets eligibility criteria|0|||
48756082|NCT02554812|156954234|FG004|Overall Study|No longer meets eligibility criteria|0|||
48756083|NCT02554812|156954235|FG005|Overall Study|No longer meets eligibility criteria|0|||
48756084|NCT02554812|156954236|FG006|Overall Study|No longer meets eligibility criteria|0|||
48756085|NCT02554812|156954237|FG007|Overall Study|No longer meets eligibility criteria|0|||
48756086|NCT02554812|156954238|FG008|Overall Study|No longer meets eligibility criteria|0|||
48756087|NCT02554812|156954239|FG009|Overall Study|No longer meets eligibility criteria|0|||
48756088|NCT02554812|156954240|FG010|Overall Study|No longer meets eligibility criteria|0|||
48756089|NCT02554812|156954241|FG011|Overall Study|No longer meets eligibility criteria|0|||
48756090|NCT02554812|156954242|FG012|Overall Study|No longer meets eligibility criteria|0|||
48756091|NCT02554812|156954243|FG013|Overall Study|No longer meets eligibility criteria|0|||
48756092|NCT02554812|156954244|FG014|Overall Study|No longer meets eligibility criteria|0|||
48756093|NCT02554812|156954245|FG015|Overall Study|No longer meets eligibility criteria|0|||
48756094|NCT02554812|156954246|FG016|Overall Study|No longer meets eligibility criteria|0|||
48756095|NCT02554812|156954247|FG017|Overall Study|No longer meets eligibility criteria|0|||
48756096|NCT02554812|156954248|FG018|Overall Study|No longer meets eligibility criteria|0|||
48756097|NCT02554812|156954249|FG019|Overall Study|No longer meets eligibility criteria|0|||
48756098|NCT02554812|156954250|FG020|Overall Study|No longer meets eligibility criteria|0|||
48756099|NCT02554812|156954251|FG021|Overall Study|No longer meets eligibility criteria|0|||
48756100|NCT02554812|156954252|FG022|Overall Study|No longer meets eligibility criteria|0|||
48339576|NCT01375777|155438819|FG001|Overall Study|Withdrawal by Subject|2|||
48339577|NCT01375777|155438820|FG002|Overall Study|Withdrawal by Subject|1|||
48339578|NCT01375777|155438821|FG003|Overall Study|Withdrawal by Subject|0|||
48339579|NCT01375777|155438822|FG004|Overall Study|Withdrawal by Subject|1|||
48339580|NCT01375777|155438823|FG005|Overall Study|Withdrawal by Subject|1|||
48339581|NCT01375777|155438824|FG006|Overall Study|Withdrawal by Subject|1|||
48756101|NCT02554812|156954253|FG023|Overall Study|No longer meets eligibility criteria|0|||
48756102|NCT02554812|156954254|FG024|Overall Study|No longer meets eligibility criteria|0|||
48756103|NCT02554812|156954255|FG025|Overall Study|No longer meets eligibility criteria|0|||
48756104|NCT02554812|156954256|FG026|Overall Study|No longer meets eligibility criteria|0|||
48756105|NCT03342690|156954257|FG000|Overall Study|Missing Information|9|||
48756106|NCT03342690|156954257|FG000|Overall Study|Protocol Violation|16|||
48756107|NCT01500629|156954258|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
48339582|NCT01375777|155438825|FG007|Overall Study|Withdrawal by Subject|2|||
48756108|NCT01500629|156954259|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
48756109|NCT00588848|156954260|FG000|Overall Study|Physician Decision|0|||
48756110|NCT00588848|156954261|FG001|Overall Study|Physician Decision|3|||
48756111|NCT02064894|156954264|FG000|Overall Study|Withdrawal by Subject|43|||
48756112|NCT02064894|156954265|FG001|Overall Study|Withdrawal by Subject|102|||
48756113|NCT02064894|156954266|FG002|Overall Study|Withdrawal by Subject|115|||
48756114|NCT02902965|156954270|FG000|Overall Study|Withdrawal by Subject|10|||
48756115|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
48339583|NCT01375777|155438826|FG008|Overall Study|Withdrawal by Subject|1|||
48339584|NCT01375777|155438818|FG000|Overall Study|Lost to Follow-up|1|||
48339585|NCT01375777|155438819|FG001|Overall Study|Lost to Follow-up|0|||
48339586|NCT01375777|155438820|FG002|Overall Study|Lost to Follow-up|0|||
48339587|NCT01375777|155438821|FG003|Overall Study|Lost to Follow-up|0|||
48662567|NCT00445939|156617638|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
48662568|NCT00445939|156617639|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
48662569|NCT00445939|156617636|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
48662570|NCT00445939|156617637|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
48662571|NCT00445939|156617638|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
48662572|NCT00445939|156617639|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
48662573|NCT03812185|156617640|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
48662574|NCT00006046|156617641|FG000|Overall Study|Adverse Event|3|||
48662575|NCT00006046|156617642|FG001|Overall Study|Adverse Event|0|||
48662576|NCT00006046|156617643|FG002|Overall Study|Adverse Event|0|||
48662577|NCT00006046|156617644|FG003|Overall Study|Adverse Event|0|||
48662578|NCT00006046|156617645|FG004|Overall Study|Adverse Event|0|||
48662579|NCT00006046|156617641|FG000|Overall Study|Disease Progression|2|||
48662580|NCT00006046|156617642|FG001|Overall Study|Disease Progression|0|||
48662581|NCT00006046|156617643|FG002|Overall Study|Disease Progression|0|||
48662582|NCT00006046|156617644|FG003|Overall Study|Disease Progression|0|||
48662583|NCT00006046|156617645|FG004|Overall Study|Disease Progression|0|||
48662584|NCT03176472|156617646|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
48662585|NCT03176472|156617647|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
48662586|NCT03176472|156617646|FG000|Double Blind Treatment Period|Adverse Event|0|||
48662587|NCT03176472|156617647|FG001|Double Blind Treatment Period|Adverse Event|5|||
48662588|NCT03176472|156617646|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
48662589|NCT03176472|156617647|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48662590|NCT03176472|156617646|FG000|Double Blind Treatment Period|Physician Decision|0|||
48662591|NCT03176472|156617647|FG001|Double Blind Treatment Period|Physician Decision|1|||
48662592|NCT03176472|156617646|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48662593|NCT03176472|156617647|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48662594|NCT03176472|156617646|FG000|Double Blind Treatment Period|Not Provided|1|||
48662595|NCT03176472|156617647|FG001|Double Blind Treatment Period|Not Provided|0|||
48662596|NCT03176472|156617646|FG000|Open Label Extension|Withdrawal by Subject|3|||
48662597|NCT03176472|156617647|FG001|Open Label Extension|Withdrawal by Subject|4|||
48662598|NCT03176472|156617646|FG000|Open Label Extension|Adverse Event|2|||
48662599|NCT03176472|156617647|FG001|Open Label Extension|Adverse Event|4|||
48662600|NCT03176472|156617646|FG000|Open Label Extension|Lost to Follow-up|1|||
48662601|NCT03176472|156617647|FG001|Open Label Extension|Lost to Follow-up|2|||
48662602|NCT03176472|156617646|FG000|Open Label Extension|Protocol Violation|0|||
48662603|NCT03176472|156617647|FG001|Open Label Extension|Protocol Violation|1|||
48662604|NCT03176472|156617646|FG000|Open Label Extension|Not Provided|2|||
48662605|NCT03176472|156617647|FG001|Open Label Extension|Not Provided|1|||
48662606|NCT00996281|156617648|FG000|Overall Study|Adverse Event|75|||
48662607|NCT00996281|156617649|FG001|Overall Study|Adverse Event|37|||
48662608|NCT00996281|156617648|FG000|Overall Study|Major Protocol Deviation|6|||
48662609|NCT00996281|156617649|FG001|Overall Study|Major Protocol Deviation|7|||
48662610|NCT00996281|156617648|FG000|Overall Study|Lost to Follow-up|14|||
48339588|NCT01375777|155438822|FG004|Overall Study|Lost to Follow-up|0|||
48339589|NCT01375777|155438823|FG005|Overall Study|Lost to Follow-up|0|||
48339590|NCT01375777|155438824|FG006|Overall Study|Lost to Follow-up|1|||
48662611|NCT00996281|156617649|FG001|Overall Study|Lost to Follow-up|16|||
48756116|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
48756117|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
48756118|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
48339591|NCT01375777|155438825|FG007|Overall Study|Lost to Follow-up|0|||
48339592|NCT01375777|155438826|FG008|Overall Study|Lost to Follow-up|0|||
48339593|NCT01375777|155438818|FG000|Overall Study|Other|1|||
48662612|NCT00996281|156617648|FG000|Overall Study|Withdrawal by Subject|31|||
48662613|NCT00996281|156617649|FG001|Overall Study|Withdrawal by Subject|20|||
48662614|NCT00996281|156617648|FG000|Overall Study|Lack of Efficacy|0|||
48662615|NCT00996281|156617649|FG001|Overall Study|Lack of Efficacy|2|||
48662616|NCT00996281|156617648|FG000|Overall Study|Other|5|||
48662617|NCT00996281|156617649|FG001|Overall Study|Other|7|||
48662618|NCT01187446|156617650|FG000|Overall Study|Patient started non-protocol therapy|0|||
48662619|NCT01187446|156617651|FG001|Overall Study|Patient started non-protocol therapy|1|||
48662620|NCT01007123|156617652|FG000|Overall Study|Adverse Event|3|||
48756119|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
48756120|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
48756121|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
48756122|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
48756123|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
48756124|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
48756125|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
48756126|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
48756127|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
48756128|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
48662621|NCT01007123|156617653|FG001|Overall Study|Adverse Event|4|||
48662622|NCT01007123|156617654|FG002|Overall Study|Adverse Event|7|||
48662623|NCT01007123|156617655|FG003|Overall Study|Adverse Event|1|||
48662624|NCT01007123|156617652|FG000|Overall Study|Lack of Efficacy|1|||
48662625|NCT01007123|156617653|FG001|Overall Study|Lack of Efficacy|0|||
48662626|NCT01007123|156617654|FG002|Overall Study|Lack of Efficacy|1|||
48662627|NCT01007123|156617655|FG003|Overall Study|Lack of Efficacy|4|||
48662628|NCT01007123|156617652|FG000|Overall Study|Protocol Violation|1|||
48662629|NCT01007123|156617653|FG001|Overall Study|Protocol Violation|1|||
48662630|NCT01007123|156617654|FG002|Overall Study|Protocol Violation|2|||
48662631|NCT01007123|156617655|FG003|Overall Study|Protocol Violation|1|||
48662632|NCT01007123|156617652|FG000|Overall Study|Withdrawal by Subject|1|||
48662633|NCT01007123|156617653|FG001|Overall Study|Withdrawal by Subject|0|||
48662634|NCT01007123|156617654|FG002|Overall Study|Withdrawal by Subject|1|||
48662635|NCT01007123|156617655|FG003|Overall Study|Withdrawal by Subject|0|||
48662636|NCT01007123|156617652|FG000|Overall Study|Lost to Follow-up|0|||
48662637|NCT01007123|156617653|FG001|Overall Study|Lost to Follow-up|1|||
48662638|NCT01007123|156617654|FG002|Overall Study|Lost to Follow-up|0|||
48662639|NCT01007123|156617655|FG003|Overall Study|Lost to Follow-up|0|||
48662640|NCT00524589|156617656|FG000|Overall Study|Withdrawal by Subject|2|||
48662641|NCT00524589|156617656|FG000|Overall Study|Disease Progression|16|||
48662642|NCT04299464|156617670|FG000|Overall Study|Adverse Event|1|||
48662643|NCT04299464|156617671|FG001|Overall Study|Adverse Event|0|||
48662644|NCT04299464|156617672|FG002|Overall Study|Adverse Event|2|||
48662645|NCT04299464|156617670|FG000|Overall Study|Non-compliance with Study Drug|1|||
48662646|NCT04299464|156617671|FG001|Overall Study|Non-compliance with Study Drug|0|||
48662647|NCT04299464|156617672|FG002|Overall Study|Non-compliance with Study Drug|0|||
48662648|NCT04299464|156617670|FG000|Overall Study|Reason not Specified|0|||
48662649|NCT04299464|156617671|FG001|Overall Study|Reason not Specified|1|||
48662650|NCT04299464|156617672|FG002|Overall Study|Reason not Specified|3|||
48662651|NCT04299464|156617670|FG000|Overall Study|Physician Decision|0|||
48662652|NCT04299464|156617671|FG001|Overall Study|Physician Decision|1|||
48662653|NCT04299464|156617672|FG002|Overall Study|Physician Decision|1|||
48662654|NCT04299464|156617670|FG000|Overall Study|Withdrawal by Subject|0|||
48662655|NCT04299464|156617671|FG001|Overall Study|Withdrawal by Subject|2|||
48662656|NCT04299464|156617672|FG002|Overall Study|Withdrawal by Subject|1|||
48662657|NCT00937404|156617675|FG000|Overall Study|Protocol Violation|1|||
48662658|NCT00937404|156617675|FG000|Overall Study|Withdrawal by Subject|1|||
48662659|NCT03894969|156617676|FG000|Overall Study|Adverse Event|0|||
48662660|NCT03894969|156617677|FG001|Overall Study|Adverse Event|2|||
48662661|NCT03894969|156617678|FG002|Overall Study|Adverse Event|0|||
48662662|NCT03894969|156617679|FG003|Overall Study|Adverse Event|1|||
48662663|NCT03894969|156617680|FG004|Overall Study|Adverse Event|2|||
48662664|NCT03894969|156617676|FG000|Overall Study|Lost to Follow-up|3|||
48662665|NCT03894969|156617677|FG001|Overall Study|Lost to Follow-up|1|||
48662666|NCT03894969|156617678|FG002|Overall Study|Lost to Follow-up|1|||
48662667|NCT03894969|156617679|FG003|Overall Study|Lost to Follow-up|0|||
48662668|NCT03894969|156617680|FG004|Overall Study|Lost to Follow-up|0|||
48662669|NCT03894969|156617676|FG000|Overall Study|Withdrawal by Subject|2|||
48662670|NCT03894969|156617677|FG001|Overall Study|Withdrawal by Subject|1|||
48662671|NCT03894969|156617678|FG002|Overall Study|Withdrawal by Subject|3|||
48662672|NCT03894969|156617679|FG003|Overall Study|Withdrawal by Subject|4|||
48662673|NCT03894969|156617680|FG004|Overall Study|Withdrawal by Subject|8|||
48662674|NCT03894969|156617676|FG000|Overall Study|Other|0|||
48662675|NCT03894969|156617677|FG001|Overall Study|Other|0|||
48662676|NCT03894969|156617678|FG002|Overall Study|Other|0|||
48662677|NCT03894969|156617679|FG003|Overall Study|Other|0|||
48662678|NCT03894969|156617680|FG004|Overall Study|Other|3|||
48339594|NCT01375777|155438819|FG001|Overall Study|Other|1|||
48339595|NCT01375777|155438820|FG002|Overall Study|Other|0|||
48339596|NCT01375777|155438821|FG003|Overall Study|Other|0|||
48339597|NCT01375777|155438822|FG004|Overall Study|Other|0|||
48339598|NCT01375777|155438823|FG005|Overall Study|Other|0|||
48339599|NCT01375777|155438824|FG006|Overall Study|Other|0|||
48339600|NCT01375777|155438825|FG007|Overall Study|Other|0|||
48662679|NCT03894969|156617676|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
48662680|NCT03894969|156617677|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
48662681|NCT03894969|156617678|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
48662682|NCT03894969|156617679|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
48662683|NCT03894969|156617680|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
48662684|NCT03894969|156617676|FG000|Overall Study|Solicited Adverse Event|0|||
48662685|NCT03894969|156617677|FG001|Overall Study|Solicited Adverse Event|1|||
48662686|NCT03894969|156617678|FG002|Overall Study|Solicited Adverse Event|0|||
48662687|NCT03894969|156617679|FG003|Overall Study|Solicited Adverse Event|0|||
48662688|NCT03894969|156617680|FG004|Overall Study|Solicited Adverse Event|0|||
48662689|NCT03834506|156617683|FG000|Overall Study|Death|336|||
48662690|NCT03834506|156617684|FG001|Overall Study|Death|326|||
48662691|NCT03834506|156617683|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48662692|NCT03834506|156617684|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48662693|NCT03834506|156617683|FG000|Overall Study|Withdrawal by Subject|10|||
48662694|NCT03834506|156617684|FG001|Overall Study|Withdrawal by Subject|8|||
48662695|NCT03834506|156617683|FG000|Overall Study|Sponsor decision|165|||
48662696|NCT03834506|156617684|FG001|Overall Study|Sponsor decision|178|||
48662697|NCT03834506|156617683|FG000|Overall Study|Physician Decision|3|||
48662698|NCT03834506|156617684|FG001|Overall Study|Physician Decision|1|||
48662699|NCT03834506|156617683|FG000|Overall Study|Lost to Follow-up|0|||
48662700|NCT03834506|156617684|FG001|Overall Study|Lost to Follow-up|1|||
48662701|NCT03054350|156617691|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
48662702|NCT03054350|156617692|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
48662703|NCT03054350|156617693|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
48662704|NCT03054350|156617694|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
48662705|NCT03054350|156617695|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
48662706|NCT03054350|156617696|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
48662707|NCT03054350|156617691|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662708|NCT03054350|156617692|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662709|NCT03054350|156617693|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
48662710|NCT03054350|156617694|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662711|NCT03054350|156617695|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662712|NCT03054350|156617696|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
48662713|NCT03054350|156617691|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
48662714|NCT03054350|156617692|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
48662715|NCT03054350|156617693|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
48662716|NCT03054350|156617694|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
48662717|NCT03054350|156617695|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
48662718|NCT03054350|156617696|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
48662719|NCT03054350|156617691|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662720|NCT03054350|156617692|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662721|NCT03054350|156617693|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
48662722|NCT03054350|156617694|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662723|NCT03054350|156617695|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662724|NCT03054350|156617696|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
48662725|NCT00867087|156617701|FG000|Overall Study|Other|1|||
48662726|NCT00867087|156617701|FG000|Overall Study|Withdrawal by Subject|4|||
48662727|NCT00867087|156617701|FG000|Overall Study|Death|37|||
48662728|NCT01238835|156617704|FG000|Overall Study|Death|124|||
48662729|NCT01238835|156617704|FG000|Overall Study|Withdrawal by Subject|9|||
48662730|NCT01238835|156617704|FG000|Overall Study|Lost to Follow-up|1|||
48662731|NCT01238835|156617704|FG000|Overall Study|Site early discontinuation|2|||
48339601|NCT01375777|155438826|FG008|Overall Study|Other|1|||
48339602|NCT01090076|155438827|FG000|Overall Study|Death|1|||
48339603|NCT01090076|155438828|FG001|Overall Study|Death|1|||
48339604|NCT01090076|155438827|FG000|Overall Study|Withdrawal by Subject|0|||
48339605|NCT01090076|155438828|FG001|Overall Study|Withdrawal by Subject|1|||
48662732|NCT00293709|156617705|FG000|Overall Study|Other|47|||
48662733|NCT02088073|156617706|FG000|Acute Phase|Withdrawal by Subject|5|||
48339606|NCT00473512|155438830|FG000|Period 1 (Phase 1)|Adverse Event|0|||
48662734|NCT02088073|156617707|FG001|Acute Phase|Withdrawal by Subject|0|||
48662735|NCT02088073|156617708|FG002|Acute Phase|Withdrawal by Subject|0|||
48339607|NCT00473512|155438831|FG001|Period 1 (Phase 1)|Adverse Event|0|||
48339608|NCT00473512|155438832|FG002|Period 1 (Phase 1)|Adverse Event|0|||
48662736|NCT02088073|156617709|FG003|Acute Phase|Withdrawal by Subject|0|||
48662737|NCT02088073|156617710|FG004|Acute Phase|Withdrawal by Subject|0|||
48662738|NCT02088073|156617706|FG000|Acute Phase|Hyperkalemia|2|||
48662739|NCT02088073|156617707|FG001|Acute Phase|Hyperkalemia|0|||
48662740|NCT02088073|156617708|FG002|Acute Phase|Hyperkalemia|0|||
48662741|NCT02088073|156617709|FG003|Acute Phase|Hyperkalemia|0|||
48756129|NCT00293254|156954271|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
48756130|NCT00293254|156954272|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
48756131|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
48756132|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
48756133|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Death|4|||
48756134|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Death|1|||
48756135|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
48756136|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
48756137|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
48756138|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
48756139|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
48756140|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
48662742|NCT02088073|156617710|FG004|Acute Phase|Hyperkalemia|0|||
48662743|NCT02088073|156617706|FG000|Maintanance Phase|Withdrawal by Subject|0|||
48662744|NCT02088073|156617707|FG001|Maintanance Phase|Withdrawal by Subject|2|||
48756141|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
48662745|NCT02088073|156617708|FG002|Maintanance Phase|Withdrawal by Subject|0|||
48662746|NCT02088073|156617709|FG003|Maintanance Phase|Withdrawal by Subject|0|||
48662747|NCT02088073|156617710|FG004|Maintanance Phase|Withdrawal by Subject|0|||
48662748|NCT02088073|156617706|FG000|Maintanance Phase|Adverse Event|0|||
48662749|NCT02088073|156617707|FG001|Maintanance Phase|Adverse Event|0|||
48662750|NCT02088073|156617708|FG002|Maintanance Phase|Adverse Event|3|||
48662751|NCT02088073|156617709|FG003|Maintanance Phase|Adverse Event|0|||
48662752|NCT02088073|156617710|FG004|Maintanance Phase|Adverse Event|1|||
48662753|NCT02088073|156617706|FG000|Maintanance Phase|Physician Decision|0|||
48662754|NCT02088073|156617707|FG001|Maintanance Phase|Physician Decision|0|||
48662755|NCT02088073|156617708|FG002|Maintanance Phase|Physician Decision|0|||
48662756|NCT02088073|156617709|FG003|Maintanance Phase|Physician Decision|0|||
48756142|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
48756143|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
48756144|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
48756145|NCT00293254|156954271|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
48756146|NCT00293254|156954272|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
48756147|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
48756148|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
48756149|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
48756150|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
48756151|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
48756152|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
48662757|NCT02088073|156617710|FG004|Maintanance Phase|Physician Decision|1|||
48662758|NCT02088073|156617706|FG000|Maintanance Phase|Sponsor's decision|0|||
48756153|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
48756154|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
48756155|NCT00293254|156954271|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
48756156|NCT00293254|156954272|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
48756157|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
48756158|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
48756159|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
48756160|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
48756161|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
48756162|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
48756163|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
48756164|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
48756165|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
48756166|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
48756167|NCT00293254|156954271|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
48756168|NCT00293254|156954272|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
48756169|NCT01963403|156954273|FG000|Overall Study|Lost to Follow-up|2|||
48756170|NCT01963403|156954274|FG001|Overall Study|Lost to Follow-up|3|||
48756171|NCT01963403|156954273|FG000|Overall Study|Implant removal|0|||
48756172|NCT01963403|156954274|FG001|Overall Study|Implant removal|1|||
48756173|NCT00589914|156954276|FG000|Overall Study|Adverse Event|19|||
48756174|NCT00589914|156954277|FG001|Overall Study|Adverse Event|10|||
48756175|NCT00589914|156954276|FG000|Overall Study|Death|2|||
48756176|NCT00589914|156954277|FG001|Overall Study|Death|0|||
48756177|NCT00589914|156954276|FG000|Overall Study|Lack of Efficacy|40|||
48756178|NCT00589914|156954277|FG001|Overall Study|Lack of Efficacy|43|||
48756179|NCT00589914|156954276|FG000|Overall Study|Lost to Follow-up|11|||
48756180|NCT00589914|156954277|FG001|Overall Study|Lost to Follow-up|18|||
48756181|NCT00589914|156954276|FG000|Overall Study|Pregnancy|1|||
48756182|NCT00589914|156954277|FG001|Overall Study|Pregnancy|0|||
48756183|NCT00589914|156954276|FG000|Overall Study|Withdrawal by Subject|55|||
48756184|NCT00589914|156954277|FG001|Overall Study|Withdrawal by Subject|49|||
48756185|NCT00589914|156954276|FG000|Overall Study|Other|22|||
48756186|NCT00589914|156954277|FG001|Overall Study|Other|17|||
48756187|NCT04483011|156954278|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
48756188|NCT04483011|156954279|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
48756189|NCT00799487|156954280|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
48756190|NCT00799487|156954281|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
48756191|NCT00799487|156954282|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
48756192|NCT00799487|156954280|FG000|Dose Adjustment Period|Adverse Event|2|||
48756193|NCT00799487|156954281|FG001|Dose Adjustment Period|Adverse Event|0|||
48756194|NCT00799487|156954282|FG002|Dose Adjustment Period|Adverse Event|0|||
48756195|NCT00799487|156954280|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
48756196|NCT00799487|156954281|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
48756197|NCT00799487|156954282|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
48756198|NCT00799487|156954280|FG000|Dose Adjustment Period|Investigator Discretion|2|||
48756199|NCT00799487|156954281|FG001|Dose Adjustment Period|Investigator Discretion|0|||
48756200|NCT00799487|156954282|FG002|Dose Adjustment Period|Investigator Discretion|0|||
48756201|NCT00799487|156954280|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
48339609|NCT00473512|155438833|FG003|Period 1 (Phase 1)|Adverse Event|5|||
48756202|NCT00799487|156954281|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
48756203|NCT00799487|156954282|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
48756204|NCT00799487|156954280|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
48756205|NCT00799487|156954281|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
48756206|NCT00799487|156954282|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
48756207|NCT00799487|156954280|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
48756208|NCT00799487|156954281|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
48756209|NCT00799487|156954282|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
48339610|NCT00473512|155438834|FG004|Period 1 (Phase 1)|Adverse Event|0|||
48339611|NCT00473512|155438830|FG000|Period 1 (Phase 1)|Death|0|||
48339612|NCT00473512|155438831|FG001|Period 1 (Phase 1)|Death|0|||
48339613|NCT00473512|155438832|FG002|Period 1 (Phase 1)|Death|0|||
48339614|NCT00473512|155438833|FG003|Period 1 (Phase 1)|Death|1|||
48339615|NCT00473512|155438834|FG004|Period 1 (Phase 1)|Death|0|||
48756210|NCT00799487|156954280|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
48339616|NCT00473512|155438830|FG000|Period 1 (Phase 1)|Disease Progression|1|||
48756211|NCT00799487|156954281|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
48756212|NCT00799487|156954282|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
48756213|NCT00799487|156954280|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
48756214|NCT00799487|156954281|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
48756215|NCT00799487|156954282|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
48339617|NCT00473512|155438831|FG001|Period 1 (Phase 1)|Disease Progression|1|||
48662759|NCT02088073|156617707|FG001|Maintanance Phase|Sponsor's decision|2|||
48662760|NCT02088073|156617708|FG002|Maintanance Phase|Sponsor's decision|0|||
48662761|NCT02088073|156617709|FG003|Maintanance Phase|Sponsor's decision|2|||
48662762|NCT02088073|156617710|FG004|Maintanance Phase|Sponsor's decision|1|||
48662763|NCT02088073|156617706|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
48662764|NCT02088073|156617707|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
48756216|NCT00799487|156954280|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
48756217|NCT00799487|156954281|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
48756218|NCT00799487|156954282|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
48756219|NCT00799487|156954280|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
48756220|NCT00799487|156954281|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
48756221|NCT00799487|156954282|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
48756222|NCT00799487|156954280|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
48756223|NCT00799487|156954281|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
48756224|NCT00799487|156954282|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
48756225|NCT04481750|156954283|FG000|Period 1 (Fasted)|Adverse Event|0|||
48756226|NCT04481750|156954284|FG001|Period 1 (Fasted)|Adverse Event|0|||
48756227|NCT04481750|156954285|FG002|Period 1 (Fasted)|Adverse Event|1|||
48756228|NCT04481750|156954286|FG003|Period 1 (Fasted)|Adverse Event|0|||
48756229|NCT04481750|156954287|FG004|Period 1 (Fasted)|Adverse Event|0|||
48756230|NCT04481750|156954288|FG005|Period 1 (Fasted)|Adverse Event|0|||
48756231|NCT04481750|156954289|FG006|Period 1 (Fasted)|Adverse Event|0|||
48756232|NCT04481750|156954290|FG007|Period 1 (Fasted)|Adverse Event|0|||
48756233|NCT04481750|156954291|FG008|Period 1 (Fasted)|Adverse Event|0|||
48756234|NCT04481750|156954292|FG009|Period 1 (Fasted)|Adverse Event|0|||
48756235|NCT04481750|156954293|FG010|Period 1 (Fasted)|Adverse Event|0|||
48756236|NCT03263442|156954294|FG000|Inpatient Phase|Death|1|||
48756237|NCT03263442|156954295|FG001|Inpatient Phase|Death|0|||
48339618|NCT00473512|155438832|FG002|Period 1 (Phase 1)|Disease Progression|0|||
48339619|NCT00473512|155438833|FG003|Period 1 (Phase 1)|Disease Progression|10|||
48339620|NCT00473512|155438834|FG004|Period 1 (Phase 1)|Disease Progression|1|||
48339621|NCT00473512|155438830|FG000|Period 1 (Phase 1)|Other|0|||
48339622|NCT00473512|155438831|FG001|Period 1 (Phase 1)|Other|0|||
48339623|NCT00473512|155438832|FG002|Period 1 (Phase 1)|Other|0|||
48339624|NCT00473512|155438833|FG003|Period 1 (Phase 1)|Other|1|||
48339625|NCT00473512|155438834|FG004|Period 1 (Phase 1)|Other|0|||
48339626|NCT00473512|155438830|FG000|Period 2 (Phase 2)|Adverse Event|0|||
48339627|NCT00473512|155438831|FG001|Period 2 (Phase 2)|Adverse Event|0|||
48339628|NCT00473512|155438832|FG002|Period 2 (Phase 2)|Adverse Event|0|||
48339629|NCT00473512|155438833|FG003|Period 2 (Phase 2)|Adverse Event|1|||
48662765|NCT02088073|156617708|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
48662766|NCT02088073|156617709|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
48662767|NCT02088073|156617710|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
48662768|NCT02088073|156617706|FG000|Maintanance Phase|Miscellaneous|0|||
48662769|NCT02088073|156617707|FG001|Maintanance Phase|Miscellaneous|2|||
48662770|NCT02088073|156617708|FG002|Maintanance Phase|Miscellaneous|1|||
48662771|NCT02088073|156617709|FG003|Maintanance Phase|Miscellaneous|2|||
48662772|NCT02088073|156617710|FG004|Maintanance Phase|Miscellaneous|1|||
48662773|NCT02088073|156617706|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
48662774|NCT02088073|156617707|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
48662775|NCT02088073|156617708|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
48662776|NCT02088073|156617709|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
48662777|NCT02088073|156617710|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
48662778|NCT02088073|156617706|FG000|Maintanance Phase|Subject compliance|0|||
48662779|NCT02088073|156617707|FG001|Maintanance Phase|Subject compliance|1|||
48662780|NCT02088073|156617708|FG002|Maintanance Phase|Subject compliance|0|||
48662781|NCT02088073|156617709|FG003|Maintanance Phase|Subject compliance|0|||
48662782|NCT02088073|156617710|FG004|Maintanance Phase|Subject compliance|0|||
48662783|NCT04612842|156617713|FG000|Overall Study|Lost to Follow-up|20|||
48662784|NCT04612842|156617714|FG001|Overall Study|Lost to Follow-up|11|||
48662785|NCT04612842|156617713|FG000|Overall Study|Withdrawal by Subject|26|||
48662786|NCT04612842|156617714|FG001|Overall Study|Withdrawal by Subject|15|||
48756238|NCT03263442|156954294|FG000|Inpatient Phase|Withdrawal by Subject|1|||
48756239|NCT03263442|156954295|FG001|Inpatient Phase|Withdrawal by Subject|0|||
48756240|NCT03263442|156954294|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
48339630|NCT00473512|155438834|FG004|Period 2 (Phase 2)|Adverse Event|0|||
48339631|NCT00473512|155438830|FG000|Period 2 (Phase 2)|Death|0|||
48339632|NCT00473512|155438831|FG001|Period 2 (Phase 2)|Death|0|||
48662787|NCT04612842|156617713|FG000|Overall Study|Death|2|||
48662788|NCT04612842|156617714|FG001|Overall Study|Death|2|||
48662789|NCT02419131|156617715|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
48662790|NCT02419131|156617716|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
48756241|NCT03263442|156954295|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
48339633|NCT00473512|155438832|FG002|Period 2 (Phase 2)|Death|0|||
48662791|NCT02419131|156617717|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
48339634|NCT00473512|155438833|FG003|Period 2 (Phase 2)|Death|1|||
48339635|NCT00473512|155438834|FG004|Period 2 (Phase 2)|Death|1|||
48339636|NCT00473512|155438830|FG000|Period 2 (Phase 2)|Disease Progression|0|||
48339637|NCT00473512|155438831|FG001|Period 2 (Phase 2)|Disease Progression|2|||
48339638|NCT00473512|155438832|FG002|Period 2 (Phase 2)|Disease Progression|2|||
48339639|NCT00473512|155438833|FG003|Period 2 (Phase 2)|Disease Progression|17|||
48339640|NCT00473512|155438834|FG004|Period 2 (Phase 2)|Disease Progression|1|||
48339641|NCT00473512|155438830|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
48339642|NCT00473512|155438831|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
48339643|NCT00473512|155438832|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
48662792|NCT02419131|156617715|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
48662793|NCT02419131|156617716|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
48662794|NCT02419131|156617717|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
48662795|NCT03762616|156617718|FG000|Overall Study|Protocol Violation|2|||
48662796|NCT04465877|156617719|FG000|Overall Study|Noncompliant with study requirements|0|||
48662797|NCT04465877|156617720|FG001|Overall Study|Noncompliant with study requirements|0|||
48662798|NCT04465877|156617721|FG002|Overall Study|Noncompliant with study requirements|1|||
48662799|NCT04465877|156617722|FG003|Overall Study|Noncompliant with study requirements|0|||
48339644|NCT00473512|155438833|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
48339645|NCT00473512|155438834|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
48339646|NCT00473512|155438830|FG000|Period 2 (Phase 2)|Other|1|||
48339647|NCT00473512|155438831|FG001|Period 2 (Phase 2)|Other|0|||
48339648|NCT00473512|155438832|FG002|Period 2 (Phase 2)|Other|0|||
48339649|NCT00473512|155438833|FG003|Period 2 (Phase 2)|Other|3|||
48339650|NCT00473512|155438834|FG004|Period 2 (Phase 2)|Other|0|||
48339651|NCT01870999|155438835|FG000|Overall Study|Adverse Event|0|||
48339652|NCT01870999|155438836|FG001|Overall Study|Adverse Event|4|||
48339653|NCT01870999|155438837|FG002|Overall Study|Adverse Event|1|||
48339654|NCT01870999|155438835|FG000|Overall Study|Subject met withdrawal criteria|3|||
48339655|NCT01870999|155438836|FG001|Overall Study|Subject met withdrawal criteria|2|||
48339656|NCT01870999|155438837|FG002|Overall Study|Subject met withdrawal criteria|0|||
48339657|NCT01870999|155438835|FG000|Overall Study|Subject withdrawn by Investigator|1|||
48339658|NCT01870999|155438836|FG001|Overall Study|Subject withdrawn by Investigator|0|||
48339659|NCT01870999|155438837|FG002|Overall Study|Subject withdrawn by Investigator|0|||
48756242|NCT03263442|156954294|FG000|1-month Follow-Up|Lost to Follow-up|1|||
48756243|NCT03263442|156954295|FG001|1-month Follow-Up|Lost to Follow-up|0|||
48339660|NCT01870999|155438835|FG000|Overall Study|Withdrawal by Subject|0|||
48339661|NCT01870999|155438836|FG001|Overall Study|Withdrawal by Subject|2|||
48339662|NCT01870999|155438837|FG002|Overall Study|Withdrawal by Subject|5|||
48756244|NCT03263442|156954294|FG000|3-month Follow-Up|Lost to Follow-up|1|||
48756245|NCT03263442|156954295|FG001|3-month Follow-Up|Lost to Follow-up|3|||
48756246|NCT03263442|156954294|FG000|6-month Follow-Up|Lost to Follow-up|2|||
48756247|NCT03263442|156954295|FG001|6-month Follow-Up|Lost to Follow-up|2|||
48756248|NCT03804879|156954296|FG000|Overall Study|Adverse Event|3|||
48756249|NCT03804879|156954297|FG001|Overall Study|Adverse Event|0|||
48756250|NCT03804879|156954296|FG000|Overall Study|Study Terminated By Sponsor|10|||
48756251|NCT03804879|156954297|FG001|Overall Study|Study Terminated By Sponsor|12|||
48756252|NCT03804879|156954296|FG000|Overall Study|Withdrawal by Subject|3|||
48756253|NCT03804879|156954297|FG001|Overall Study|Withdrawal by Subject|1|||
48756254|NCT01585428|156954298|FG000|Overall Study|Death during treatment|1|||
48756255|NCT01585428|156954299|FG001|Overall Study|Death during treatment|0|||
48339663|NCT01870999|155438835|FG000|Overall Study|Protocol Violation|0|||
48339664|NCT01870999|155438836|FG001|Overall Study|Protocol Violation|0|||
48339665|NCT01870999|155438837|FG002|Overall Study|Protocol Violation|1|||
48339666|NCT03441789|155438839|FG000|Overall Study|Withdrawal by Subject|1|||
48339667|NCT03441789|155438840|FG001|Overall Study|Withdrawal by Subject|1|||
48339668|NCT03441789|155438839|FG000|Overall Study|Adverse Event|0|||
48339669|NCT03441789|155438840|FG001|Overall Study|Adverse Event|1|||
48756256|NCT01084174|156954300|FG000|Overall Study|gastrointestinal symptoms|1|||
48756257|NCT01084174|156954301|FG001|Overall Study|gastrointestinal symptoms|1|||
48756258|NCT01084174|156954300|FG000|Overall Study|Eosinophilic esophagitis|0|||
48756259|NCT01084174|156954301|FG001|Overall Study|Eosinophilic esophagitis|1|||
48756260|NCT01084174|156954300|FG000|Overall Study|Anaphylaxis|0|||
48339670|NCT03441789|155438839|FG000|Overall Study|Protocol Violation|0|||
48339671|NCT03441789|155438840|FG001|Overall Study|Protocol Violation|1|||
48339672|NCT03441789|155438839|FG000|Overall Study|Lost to Follow-up|0|||
48339673|NCT03441789|155438840|FG001|Overall Study|Lost to Follow-up|1|||
48662800|NCT01396265|156617723|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
48662801|NCT02118597|156617724|FG000|Overall Study|Sponsor terminated the study|14|||
48662802|NCT02118597|156617724|FG000|Overall Study|Serious Adverse Event|1|||
48662803|NCT02118597|156617724|FG000|Overall Study|Investigator's decision|1|||
48756261|NCT01084174|156954301|FG001|Overall Study|Anaphylaxis|1|||
48339674|NCT01113541|155438841|FG000|Overall Study|Withdrawal by Subject|1|||
48339675|NCT01113541|155438841|FG000|Overall Study|Protocol Violation|1|||
48339676|NCT01113541|155438841|FG000|Overall Study|Study Terminated by Sponsor|7|||
48339677|NCT01113541|155438841|FG000|Overall Study|Adverse Event|4|||
48756262|NCT01084174|156954300|FG000|Overall Study|Participant noncompliance|0|||
48756263|NCT01084174|156954301|FG001|Overall Study|Participant noncompliance|1|||
48756264|NCT01034462|156954302|FG000|Overall Study|Adverse Event|7|||
48756265|NCT01034462|156954303|FG001|Overall Study|Adverse Event|17|||
48756266|NCT01034462|156954302|FG000|Overall Study|Lack of Efficacy|4|||
48756267|NCT01034462|156954303|FG001|Overall Study|Lack of Efficacy|4|||
48756268|NCT01034462|156954302|FG000|Overall Study|Protocol Violation|10|||
48756269|NCT01034462|156954303|FG001|Overall Study|Protocol Violation|7|||
48756270|NCT01034462|156954302|FG000|Overall Study|Withdrawal by Subject|9|||
48756271|NCT01034462|156954303|FG001|Overall Study|Withdrawal by Subject|8|||
48339678|NCT03745651|155438842|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
48339679|NCT03745651|155438843|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
48339680|NCT03745651|155438844|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48339681|NCT03745651|155438845|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48339682|NCT03745651|155438846|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48339683|NCT03745651|155438847|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48662804|NCT03444766|156617725|FG000|Overall Study|Other Reasons|2|||
48662805|NCT03444766|156617725|FG000|Overall Study|Participant Withdrew Consent|5|||
48662806|NCT03444766|156617725|FG000|Overall Study|Lost to Follow-up|2|||
48662807|NCT03444766|156617725|FG000|Overall Study|Death|2|||
48662808|NCT03444766|156617725|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
48662809|NCT03444766|156617725|FG000|Overall Study|Disease Progression|49|||
48662810|NCT02275117|156617728|FG000|Overall Study|Adverse Event|0|||
48662811|NCT02275117|156617729|FG001|Overall Study|Adverse Event|0|||
48662812|NCT02275117|156617730|FG002|Overall Study|Adverse Event|0|||
48339684|NCT03745651|155438848|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
48339685|NCT03745651|155438842|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
48339686|NCT03745651|155438843|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
48339687|NCT03745651|155438844|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
48339688|NCT03745651|155438845|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48339689|NCT03745651|155438846|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48339690|NCT03745651|155438847|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48662813|NCT02275117|156617731|FG003|Overall Study|Adverse Event|0|||
48662814|NCT02275117|156617732|FG004|Overall Study|Adverse Event|1|||
48662815|NCT02275117|156617728|FG000|Overall Study|Lack of Efficacy|6|||
48662816|NCT02275117|156617729|FG001|Overall Study|Lack of Efficacy|7|||
48662817|NCT02275117|156617730|FG002|Overall Study|Lack of Efficacy|5|||
48662818|NCT02275117|156617731|FG003|Overall Study|Lack of Efficacy|2|||
48662819|NCT02275117|156617732|FG004|Overall Study|Lack of Efficacy|10|||
48662820|NCT02275117|156617728|FG000|Overall Study|Lost to Follow-up|11|||
48662821|NCT02275117|156617729|FG001|Overall Study|Lost to Follow-up|16|||
48662822|NCT02275117|156617730|FG002|Overall Study|Lost to Follow-up|15|||
48662823|NCT02275117|156617731|FG003|Overall Study|Lost to Follow-up|16|||
48662824|NCT02275117|156617732|FG004|Overall Study|Lost to Follow-up|8|||
48662825|NCT02275117|156617728|FG000|Overall Study|Physician Decision|0|||
48662826|NCT02275117|156617729|FG001|Overall Study|Physician Decision|1|||
48662827|NCT02275117|156617730|FG002|Overall Study|Physician Decision|1|||
48662828|NCT02275117|156617731|FG003|Overall Study|Physician Decision|0|||
48662829|NCT02275117|156617732|FG004|Overall Study|Physician Decision|1|||
48662830|NCT02275117|156617728|FG000|Overall Study|Protocol Violation|1|||
48662831|NCT02275117|156617729|FG001|Overall Study|Protocol Violation|0|||
48662832|NCT02275117|156617730|FG002|Overall Study|Protocol Violation|1|||
48662833|NCT02275117|156617731|FG003|Overall Study|Protocol Violation|1|||
48662834|NCT02275117|156617732|FG004|Overall Study|Protocol Violation|0|||
48662835|NCT02275117|156617728|FG000|Overall Study|Withdrawal by Subject|6|||
48662836|NCT02275117|156617729|FG001|Overall Study|Withdrawal by Subject|4|||
48662837|NCT02275117|156617730|FG002|Overall Study|Withdrawal by Subject|7|||
48662838|NCT02275117|156617731|FG003|Overall Study|Withdrawal by Subject|3|||
48756272|NCT01034462|156954302|FG000|Overall Study|Lost to Follow-up|14|||
48756273|NCT01034462|156954303|FG001|Overall Study|Lost to Follow-up|16|||
48756274|NCT01034462|156954302|FG000|Overall Study|Other reasons|1|||
48339691|NCT03745651|155438848|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48662839|NCT02275117|156617732|FG004|Overall Study|Withdrawal by Subject|3|||
48756275|NCT01034462|156954303|FG001|Overall Study|Other reasons|2|||
48756276|NCT00708162|156954306|FG000|Randomized Phase|Randomized but Not Treated|7|||
48339692|NCT03745651|155438842|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
48339693|NCT03745651|155438843|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48339694|NCT03745651|155438844|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
48662840|NCT02275117|156617728|FG000|Overall Study|Terminated by Sponsor|4|||
48662841|NCT02275117|156617729|FG001|Overall Study|Terminated by Sponsor|4|||
48662842|NCT02275117|156617730|FG002|Overall Study|Terminated by Sponsor|4|||
48662843|NCT02275117|156617731|FG003|Overall Study|Terminated by Sponsor|6|||
48662844|NCT02275117|156617732|FG004|Overall Study|Terminated by Sponsor|4|||
48662845|NCT02275117|156617728|FG000|Overall Study|Worsening of Study Indication|0|||
48756277|NCT00708162|156954307|FG001|Randomized Phase|Randomized but Not Treated|5|||
48756278|NCT00708162|156954306|FG000|Randomized Phase|Participant Noncompliance|40|||
48756279|NCT00708162|156954307|FG001|Randomized Phase|Participant Noncompliance|32|||
48756280|NCT00708162|156954306|FG000|Randomized Phase|Lost to Follow-up|34|||
48756281|NCT00708162|156954307|FG001|Randomized Phase|Lost to Follow-up|34|||
48756282|NCT00708162|156954306|FG000|Randomized Phase|Withdrew Consent|31|||
48756283|NCT00708162|156954307|FG001|Randomized Phase|Withdrew Consent|22|||
48756284|NCT00708162|156954306|FG000|Randomized Phase|Lack of Efficacy|14|||
48756285|NCT00708162|156954307|FG001|Randomized Phase|Lack of Efficacy|19|||
48756286|NCT00708162|156954306|FG000|Randomized Phase|Protocol Violation|10|||
48756287|NCT00708162|156954307|FG001|Randomized Phase|Protocol Violation|11|||
48756288|NCT00708162|156954306|FG000|Randomized Phase|Adverse Event|8|||
48756289|NCT00708162|156954307|FG001|Randomized Phase|Adverse Event|12|||
48756290|NCT00708162|156954306|FG000|Randomized Phase|Investigator's Discretion|7|||
48756291|NCT00708162|156954307|FG001|Randomized Phase|Investigator's Discretion|10|||
48756292|NCT00708162|156954306|FG000|Randomized Phase|Death|2|||
48756293|NCT00708162|156954307|FG001|Randomized Phase|Death|9|||
48756294|NCT00708162|156954306|FG000|Randomized Phase|Pregnancy|3|||
48756295|NCT00708162|156954307|FG001|Randomized Phase|Pregnancy|0|||
48756296|NCT00708162|156954306|FG000|Open-Label Phase|Lost to Follow-up|10|||
48756297|NCT00708162|156954307|FG001|Open-Label Phase|Lost to Follow-up|8|||
48756298|NCT00708162|156954306|FG000|Open-Label Phase|Withdrew Consent|12|||
48756299|NCT00708162|156954307|FG001|Open-Label Phase|Withdrew Consent|6|||
48756300|NCT00708162|156954306|FG000|Open-Label Phase|Participant Noncompliance|7|||
48756301|NCT00708162|156954307|FG001|Open-Label Phase|Participant Noncompliance|7|||
48756302|NCT00708162|156954306|FG000|Open-Label Phase|Lack of Efficacy|7|||
48756303|NCT00708162|156954307|FG001|Open-Label Phase|Lack of Efficacy|4|||
48756304|NCT00708162|156954306|FG000|Open-Label Phase|Investigator's Discretion|3|||
48756305|NCT00708162|156954307|FG001|Open-Label Phase|Investigator's Discretion|2|||
48756306|NCT00708162|156954306|FG000|Open-Label Phase|Death|3|||
48756307|NCT00708162|156954307|FG001|Open-Label Phase|Death|1|||
48756308|NCT00708162|156954306|FG000|Open-Label Phase|Adverse Event|1|||
48756309|NCT00708162|156954307|FG001|Open-Label Phase|Adverse Event|2|||
48756310|NCT00708162|156954306|FG000|Open-Label Phase|Other|1|||
48756311|NCT00708162|156954307|FG001|Open-Label Phase|Other|0|||
48756312|NCT00503009|156954308|FG000|Overall Study|Protocol Violation|1|||
48756313|NCT00503009|156954309|FG001|Overall Study|Protocol Violation|0|||
48756314|NCT00503009|156954310|FG002|Overall Study|Protocol Violation|1|||
48756315|NCT00503009|156954308|FG000|Overall Study|Withdrawal by Subject|0|||
48756316|NCT00503009|156954309|FG001|Overall Study|Withdrawal by Subject|1|||
48756317|NCT00503009|156954310|FG002|Overall Study|Withdrawal by Subject|1|||
48756318|NCT00503009|156954308|FG000|Overall Study|Physician Decision|0|||
48756319|NCT00503009|156954309|FG001|Overall Study|Physician Decision|1|||
48756320|NCT00503009|156954310|FG002|Overall Study|Physician Decision|1|||
48756321|NCT00065507|156954311|FG000|Overall Study|Death|16|||
48756322|NCT00065507|156954312|FG001|Overall Study|Death|17|||
48756323|NCT00065507|156954311|FG000|Overall Study|Adverse Event|4|||
48756324|NCT00065507|156954312|FG001|Overall Study|Adverse Event|3|||
48339695|NCT03745651|155438845|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48339696|NCT03745651|155438846|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48662846|NCT02275117|156617729|FG001|Overall Study|Worsening of Study Indication|1|||
48662847|NCT02275117|156617730|FG002|Overall Study|Worsening of Study Indication|2|||
48662848|NCT02275117|156617731|FG003|Overall Study|Worsening of Study Indication|0|||
48662849|NCT02275117|156617732|FG004|Overall Study|Worsening of Study Indication|0|||
48662850|NCT02275117|156617728|FG000|Overall Study|Study Burden|5|||
48662851|NCT02275117|156617729|FG001|Overall Study|Study Burden|4|||
48662852|NCT02275117|156617730|FG002|Overall Study|Study Burden|7|||
48662853|NCT02275117|156617731|FG003|Overall Study|Study Burden|5|||
48662854|NCT02275117|156617732|FG004|Overall Study|Study Burden|7|||
48662855|NCT02275117|156617728|FG000|Overall Study|Other|1|||
48662856|NCT02275117|156617729|FG001|Overall Study|Other|0|||
48662857|NCT02275117|156617730|FG002|Overall Study|Other|0|||
48662858|NCT02275117|156617731|FG003|Overall Study|Other|0|||
48662859|NCT02275117|156617732|FG004|Overall Study|Other|2|||
48662860|NCT04508751|156617734|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
48662861|NCT04508751|156617735|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
48662862|NCT04508751|156617736|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
48662863|NCT02014480|156617737|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48662864|NCT02014480|156617738|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48756325|NCT00065507|156954311|FG000|Overall Study|Lack of Efficacy|0|||
48756326|NCT00065507|156954312|FG001|Overall Study|Lack of Efficacy|6|||
48756327|NCT00065507|156954311|FG000|Overall Study|Poor/Non-compliance|3|||
48756328|NCT00065507|156954312|FG001|Overall Study|Poor/Non-compliance|2|||
48756329|NCT00065507|156954311|FG000|Overall Study|Lost to Follow-up|3|||
48756330|NCT00065507|156954312|FG001|Overall Study|Lost to Follow-up|0|||
48756331|NCT00065507|156954311|FG000|Overall Study|Subject Withdrew Consent|2|||
48756332|NCT00065507|156954312|FG001|Overall Study|Subject Withdrew Consent|1|||
48756333|NCT00065507|156954311|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
48756334|NCT00065507|156954312|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
48756335|NCT01846507|156954316|FG000|Overall Study|Lost to Follow-up|4|||
48756336|NCT01846507|156954316|FG000|Overall Study|Protocol Violation|1|||
48756337|NCT01846507|156954316|FG000|Overall Study|Missing data|2|||
48756338|NCT01741701|156954322|FG000|Overall Study|Adverse Event|5|||
48756339|NCT01741701|156954323|FG001|Overall Study|Adverse Event|1|||
48756340|NCT01741701|156954322|FG000|Overall Study|Withdrawal by Subject|0|||
48756341|NCT01741701|156954323|FG001|Overall Study|Withdrawal by Subject|1|||
48756342|NCT00487747|156954324|FG000|Overall Study|Adverse Event|1|||
48756343|NCT00487747|156954324|FG000|Overall Study|Lost to Follow-up|9|||
48756344|NCT00487747|156954324|FG000|Overall Study|Lack of Efficacy|1|||
48756345|NCT03108027|156954325|FG000|Period 1|Subject/Guardian Decision|0|||
48756346|NCT03108027|156954326|FG001|Period 1|Subject/Guardian Decision|0|||
48662865|NCT02014480|156617739|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
48662866|NCT02014480|156617740|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48662867|NCT02014480|156617741|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48662868|NCT02014480|156617742|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48662869|NCT02014480|156617737|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48662870|NCT02014480|156617738|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48662871|NCT02014480|156617739|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48662872|NCT02014480|156617740|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
48662873|NCT02014480|156617741|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48662874|NCT02014480|156617742|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48662875|NCT02014480|156617737|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662876|NCT02014480|156617738|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662877|NCT02014480|156617739|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
48662878|NCT02014480|156617740|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662879|NCT02014480|156617741|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662880|NCT02014480|156617742|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
48662881|NCT02014480|156617737|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48662882|NCT02014480|156617738|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48662883|NCT02014480|156617739|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
48662884|NCT02014480|156617740|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48662885|NCT02014480|156617741|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48662886|NCT02014480|156617742|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48662887|NCT02014480|156617737|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48662888|NCT02014480|156617738|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
48662889|NCT02014480|156617739|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48662890|NCT02014480|156617740|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48662891|NCT02014480|156617741|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48756347|NCT03108027|156954327|FG002|Period 1|Subject/Guardian Decision|0|||
48756348|NCT03108027|156954328|FG003|Period 1|Subject/Guardian Decision|2|||
48756349|NCT03108027|156954329|FG004|Period 1|Subject/Guardian Decision|0|||
48756350|NCT03108027|156954330|FG005|Period 1|Subject/Guardian Decision|0|||
48756351|NCT03108027|156954325|FG000|Period 3|Adverse Event|0|||
48756352|NCT03108027|156954326|FG001|Period 3|Adverse Event|1|||
48756353|NCT03108027|156954327|FG002|Period 3|Adverse Event|0|||
48756354|NCT03108027|156954328|FG003|Period 3|Adverse Event|0|||
48756355|NCT03108027|156954329|FG004|Period 3|Adverse Event|0|||
48756356|NCT03108027|156954330|FG005|Period 3|Adverse Event|0|||
48756357|NCT02069366|156954331|FG000|Overall Study|Lost to Follow-up|0|||
48756358|NCT02069366|156954332|FG001|Overall Study|Lost to Follow-up|0|||
48339697|NCT03745651|155438847|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48662892|NCT02014480|156617742|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
48662893|NCT02014480|156617737|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
48662894|NCT02014480|156617738|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
48662895|NCT02014480|156617739|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
48662896|NCT02014480|156617740|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
48662897|NCT02014480|156617741|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
48662898|NCT02014480|156617742|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
48662899|NCT02014480|156617737|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48662900|NCT02014480|156617738|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48339698|NCT03745651|155438848|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
48662901|NCT02014480|156617739|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48756359|NCT02069366|156954333|FG002|Overall Study|Lost to Follow-up|1|||
48756360|NCT02069366|156954334|FG003|Overall Study|Lost to Follow-up|0|||
48428226|NCT02531373|155756502|FG004|Overall Study|Physician Decision|2|||
48662902|NCT02014480|156617740|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48662903|NCT02014480|156617741|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48756361|NCT02069366|156954335|FG004|Overall Study|Lost to Follow-up|0|||
48756362|NCT02069366|156954336|FG005|Overall Study|Lost to Follow-up|2|||
48756363|NCT02069366|156954331|FG000|Overall Study|Protocol Violation|0|||
48662904|NCT02014480|156617742|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
48662905|NCT03294135|156617743|FG000|Overall Study|Serious Adverse Event|1|||
48662906|NCT03294135|156617744|FG001|Overall Study|Serious Adverse Event|0|||
48662907|NCT03294135|156617745|FG002|Overall Study|Serious Adverse Event|0|||
48662908|NCT03294135|156617743|FG000|Overall Study|Lost to Follow-up|1|||
48662909|NCT03294135|156617744|FG001|Overall Study|Lost to Follow-up|0|||
48662910|NCT03294135|156617745|FG002|Overall Study|Lost to Follow-up|1|||
48662911|NCT03294135|156617743|FG000|Overall Study|Withdrawal by Subject|0|||
48662912|NCT03294135|156617744|FG001|Overall Study|Withdrawal by Subject|0|||
48662913|NCT03294135|156617745|FG002|Overall Study|Withdrawal by Subject|1|||
48662914|NCT03294135|156617743|FG000|Overall Study|Other|2|||
48662915|NCT03294135|156617744|FG001|Overall Study|Other|0|||
48662916|NCT03294135|156617745|FG002|Overall Study|Other|0|||
48662917|NCT01095653|156617746|FG000|Overall Study|Lack of Efficacy|3|||
48662918|NCT01095653|156617747|FG001|Overall Study|Lack of Efficacy|0|||
48662919|NCT01095653|156617748|FG002|Overall Study|Lack of Efficacy|0|||
48662920|NCT01095653|156617746|FG000|Overall Study|Adverse Event|1|||
48662921|NCT01095653|156617747|FG001|Overall Study|Adverse Event|4|||
48662922|NCT01095653|156617748|FG002|Overall Study|Adverse Event|4|||
48662923|NCT01095653|156617746|FG000|Overall Study|Lost to Follow-up|1|||
48662924|NCT01095653|156617747|FG001|Overall Study|Lost to Follow-up|0|||
48662925|NCT01095653|156617748|FG002|Overall Study|Lost to Follow-up|4|||
48662926|NCT01095653|156617746|FG000|Overall Study|Withdrawal by Subject|4|||
48662927|NCT01095653|156617747|FG001|Overall Study|Withdrawal by Subject|5|||
48662928|NCT01095653|156617748|FG002|Overall Study|Withdrawal by Subject|3|||
48662929|NCT01095653|156617746|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
48662930|NCT01095653|156617747|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
48662931|NCT01095653|156617748|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
48662932|NCT00853125|156617752|FG000|Overall Study|Study participant's donor was CMV +|1|||
48662933|NCT04662073|156617758|FG000|Overall Study|Withdrawal by Subject|1|||
48662934|NCT04662073|156617759|FG001|Overall Study|Withdrawal by Subject|0|||
48662935|NCT01813721|156617760|FG000|Overall Study|Ineligibility determined|63|||
48662936|NCT01813721|156617760|FG000|Overall Study|Withdrawal by Subject|1|||
48662937|NCT01133275|156617761|FG000|Overall Study|Withdrawal by Subject|1|||
48662938|NCT01133275|156617761|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
48662939|NCT00495521|156617762|FG000|Overall Study|Physician Decision|0|||
48662940|NCT00495521|156617763|FG001|Overall Study|Physician Decision|1|||
48662941|NCT00276094|156617764|FG000|Overall Study|Adverse Event|15|||
48662942|NCT00276094|156617765|FG001|Overall Study|Adverse Event|13|||
48662943|NCT00276094|156617766|FG002|Overall Study|Adverse Event|11|||
48662944|NCT00276094|156617764|FG000|Overall Study|Withdrawal by Subject|14|||
48662945|NCT00276094|156617765|FG001|Overall Study|Withdrawal by Subject|14|||
48662946|NCT00276094|156617766|FG002|Overall Study|Withdrawal by Subject|12|||
48662947|NCT00276094|156617764|FG000|Overall Study|Protocol Violation|16|||
48662948|NCT00276094|156617765|FG001|Overall Study|Protocol Violation|7|||
48662949|NCT00276094|156617766|FG002|Overall Study|Protocol Violation|10|||
48662950|NCT00276094|156617764|FG000|Overall Study|Lost to Follow-up|8|||
48662951|NCT00276094|156617765|FG001|Overall Study|Lost to Follow-up|6|||
48662952|NCT00276094|156617766|FG002|Overall Study|Lost to Follow-up|4|||
48662953|NCT00276094|156617764|FG000|Overall Study|Other-Subject moved out of country|1|||
48662954|NCT00276094|156617765|FG001|Overall Study|Other-Subject moved out of country|0|||
48662955|NCT00276094|156617766|FG002|Overall Study|Other-Subject moved out of country|0|||
48662956|NCT00276094|156617764|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
48662957|NCT00276094|156617765|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
48662958|NCT00276094|156617766|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
48662959|NCT00276094|156617764|FG000|Overall Study|Other-Lack of efficacy|1|||
48662960|NCT00276094|156617765|FG001|Overall Study|Other-Lack of efficacy|0|||
48662961|NCT00276094|156617766|FG002|Overall Study|Other-Lack of efficacy|0|||
48662962|NCT00276094|156617764|FG000|Overall Study|Other-Refused follow-up visit|1|||
48662963|NCT00276094|156617765|FG001|Overall Study|Other-Refused follow-up visit|0|||
48662964|NCT00276094|156617766|FG002|Overall Study|Other-Refused follow-up visit|0|||
48662965|NCT00276094|156617764|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
48662966|NCT00276094|156617765|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
48662967|NCT00276094|156617766|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
48662968|NCT00276094|156617764|FG000|Overall Study|Other-Relocation|0|||
48662969|NCT00276094|156617765|FG001|Overall Study|Other-Relocation|1|||
48662970|NCT00276094|156617766|FG002|Overall Study|Other-Relocation|0|||
48662971|NCT00276094|156617764|FG000|Overall Study|Other-Study medication lost|0|||
48662972|NCT00276094|156617765|FG001|Overall Study|Other-Study medication lost|0|||
48662973|NCT00276094|156617766|FG002|Overall Study|Other-Study medication lost|1|||
48662974|NCT01999218|156617767|FG000|Overall Study|Hyperglycemia|18|||
48662975|NCT01999218|156617768|FG001|Overall Study|Hyperglycemia|17|||
48662976|NCT01999218|156617769|FG002|Overall Study|Hyperglycemia|17|||
48662977|NCT01999218|156617767|FG000|Overall Study|Lack of Efficacy|1|||
48662978|NCT01999218|156617768|FG001|Overall Study|Lack of Efficacy|0|||
48662979|NCT01999218|156617769|FG002|Overall Study|Lack of Efficacy|1|||
48662980|NCT01999218|156617767|FG000|Overall Study|Lost to Follow-up|22|||
48339699|NCT03745651|155438842|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48339700|NCT03745651|155438843|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
48662981|NCT01999218|156617768|FG001|Overall Study|Lost to Follow-up|17|||
48662982|NCT01999218|156617769|FG002|Overall Study|Lost to Follow-up|18|||
48662983|NCT01999218|156617767|FG000|Overall Study|Non-Compliance With Study Drug|6|||
48662984|NCT01999218|156617768|FG001|Overall Study|Non-Compliance With Study Drug|4|||
48662985|NCT01999218|156617769|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48662986|NCT01999218|156617767|FG000|Overall Study|Physician Decision|1|||
48662987|NCT01999218|156617768|FG001|Overall Study|Physician Decision|4|||
48662988|NCT01999218|156617769|FG002|Overall Study|Physician Decision|6|||
48662989|NCT01999218|156617767|FG000|Overall Study|Protocol Violation|4|||
48662990|NCT01999218|156617768|FG001|Overall Study|Protocol Violation|5|||
48662991|NCT01999218|156617769|FG002|Overall Study|Protocol Violation|4|||
48662992|NCT01999218|156617767|FG000|Overall Study|Screen failure|0|||
48662993|NCT01999218|156617768|FG001|Overall Study|Screen failure|1|||
48662994|NCT01999218|156617769|FG002|Overall Study|Screen failure|0|||
48662995|NCT01999218|156617767|FG000|Overall Study|Study Terminated By Sponsor|7|||
48662996|NCT01999218|156617768|FG001|Overall Study|Study Terminated By Sponsor|5|||
48662997|NCT01999218|156617769|FG002|Overall Study|Study Terminated By Sponsor|12|||
48662998|NCT01999218|156617767|FG000|Overall Study|Participant moves|2|||
48662999|NCT01999218|156617768|FG001|Overall Study|Participant moves|5|||
48663000|NCT01999218|156617769|FG002|Overall Study|Participant moves|3|||
48663001|NCT01999218|156617767|FG000|Overall Study|Withdrawal by Subject|28|||
48663002|NCT01999218|156617768|FG001|Overall Study|Withdrawal by Subject|29|||
48663003|NCT01999218|156617769|FG002|Overall Study|Withdrawal by Subject|34|||
48663004|NCT01999218|156617767|FG000|Overall Study|Creatinine/eGFR|0|||
48663005|NCT01999218|156617768|FG001|Overall Study|Creatinine/eGFR|0|||
48663006|NCT01999218|156617769|FG002|Overall Study|Creatinine/eGFR|1|||
48663007|NCT01999218|156617767|FG000|Overall Study|Death|7|||
48663008|NCT01999218|156617768|FG001|Overall Study|Death|1|||
48663009|NCT01999218|156617769|FG002|Overall Study|Death|2|||
48663010|NCT01999218|156617767|FG000|Overall Study|Excluded Medication|1|||
48663011|NCT01999218|156617768|FG001|Overall Study|Excluded Medication|1|||
48663012|NCT01999218|156617769|FG002|Overall Study|Excluded Medication|2|||
48663013|NCT01999218|156617767|FG000|Overall Study|Adverse Event|9|||
48663014|NCT01999218|156617768|FG001|Overall Study|Adverse Event|7|||
48663015|NCT01999218|156617769|FG002|Overall Study|Adverse Event|7|||
48663016|NCT01999218|156617767|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
48663017|NCT01999218|156617768|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
48663018|NCT01999218|156617769|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
48663019|NCT02967692|156619477|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
48663020|NCT02967692|156619478|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
48663021|NCT02967692|156619479|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
48663022|NCT02967692|156619480|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
48663023|NCT02967692|156619477|FG000|Overall Study|Progressive disease|3|||
48663024|NCT02967692|156619478|FG001|Overall Study|Progressive disease|15|||
48663025|NCT02967692|156619479|FG002|Overall Study|Progressive disease|99|||
48663026|NCT02967692|156619480|FG003|Overall Study|Progressive disease|128|||
48663027|NCT02967692|156619477|FG000|Overall Study|Subject/guardian decision|1|||
48663028|NCT02967692|156619478|FG001|Overall Study|Subject/guardian decision|1|||
48663029|NCT02967692|156619479|FG002|Overall Study|Subject/guardian decision|6|||
48663030|NCT02967692|156619480|FG003|Overall Study|Subject/guardian decision|13|||
48663031|NCT02967692|156619477|FG000|Overall Study|Death|0|||
48663032|NCT02967692|156619478|FG001|Overall Study|Death|1|||
48663033|NCT02967692|156619479|FG002|Overall Study|Death|10|||
48663034|NCT02967692|156619480|FG003|Overall Study|Death|9|||
48663035|NCT02967692|156619477|FG000|Overall Study|Protocol deviation|1|||
48663036|NCT02967692|156619478|FG001|Overall Study|Protocol deviation|0|||
48663037|NCT02967692|156619479|FG002|Overall Study|Protocol deviation|1|||
48663038|NCT02967692|156619480|FG003|Overall Study|Protocol deviation|1|||
48663039|NCT02967692|156619477|FG000|Overall Study|Lost to Follow-up|0|||
48663040|NCT02967692|156619478|FG001|Overall Study|Lost to Follow-up|0|||
48663041|NCT02967692|156619479|FG002|Overall Study|Lost to Follow-up|1|||
48663042|NCT02967692|156619480|FG003|Overall Study|Lost to Follow-up|0|||
48663043|NCT02967692|156619477|FG000|Overall Study|Physician Decision|0|||
48663044|NCT02967692|156619478|FG001|Overall Study|Physician Decision|0|||
48663045|NCT02967692|156619479|FG002|Overall Study|Physician Decision|13|||
48663046|NCT02967692|156619480|FG003|Overall Study|Physician Decision|9|||
48663047|NCT02967692|156619477|FG000|Overall Study|Adverse Event|1|||
48663048|NCT02967692|156619478|FG001|Overall Study|Adverse Event|9|||
48663049|NCT02967692|156619479|FG002|Overall Study|Adverse Event|51|||
48663050|NCT02967692|156619480|FG003|Overall Study|Adverse Event|23|||
48692746|NCT01339689|156724589|FG001|Overall Study|Withdrawal by Subject|0|||
48692747|NCT01339689|156724588|FG000|Overall Study|Noncompliance|1|||
48339701|NCT03745651|155438844|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48339702|NCT03745651|155438845|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48339703|NCT03745651|155438846|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48756364|NCT02069366|156954332|FG001|Overall Study|Protocol Violation|0|||
48756365|NCT02069366|156954333|FG002|Overall Study|Protocol Violation|1|||
48756366|NCT02069366|156954334|FG003|Overall Study|Protocol Violation|0|||
48756367|NCT02069366|156954335|FG004|Overall Study|Protocol Violation|0|||
48756368|NCT02069366|156954336|FG005|Overall Study|Protocol Violation|0|||
48756369|NCT02069366|156954331|FG000|Overall Study|Withdrawal by Subject|1|||
48756370|NCT02069366|156954332|FG001|Overall Study|Withdrawal by Subject|0|||
48756371|NCT02069366|156954333|FG002|Overall Study|Withdrawal by Subject|1|||
48756372|NCT02069366|156954334|FG003|Overall Study|Withdrawal by Subject|2|||
48756373|NCT02069366|156954335|FG004|Overall Study|Withdrawal by Subject|0|||
48756374|NCT02069366|156954336|FG005|Overall Study|Withdrawal by Subject|0|||
48756375|NCT00268996|156954338|FG000|Overall Study|Adverse Event|11|||
48756376|NCT00268996|156954339|FG001|Overall Study|Adverse Event|7|||
48756377|NCT00268996|156954338|FG000|Overall Study|Lost to Follow-up|3|||
48339704|NCT03745651|155438847|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48339705|NCT03745651|155438848|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
48339706|NCT03745651|155438842|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
48663051|NCT01967823|156619481|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
48663052|NCT03283098|156619482|FG000|Overall Study|Withdrawal by Subject|0|||
48756378|NCT00268996|156954339|FG001|Overall Study|Lost to Follow-up|1|||
48756379|NCT00268996|156954338|FG000|Overall Study|Withdrawal by Subject|5|||
48756380|NCT00268996|156954339|FG001|Overall Study|Withdrawal by Subject|11|||
48756381|NCT00268996|156954338|FG000|Overall Study|Non-compliance|1|||
48756382|NCT00268996|156954339|FG001|Overall Study|Non-compliance|0|||
48756383|NCT00268996|156954338|FG000|Overall Study|Other|1|||
48756384|NCT00268996|156954339|FG001|Overall Study|Other|1|||
48756385|NCT00330616|156954340|FG000|Overall Study|Adverse Event|13|||
48339707|NCT03745651|155438843|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
48339708|NCT03745651|155438844|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
48339709|NCT03745651|155438845|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48339710|NCT03745651|155438846|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48339711|NCT03745651|155438847|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48339712|NCT03745651|155438848|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48339713|NCT03745651|155438842|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
48339714|NCT03745651|155438843|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
48339715|NCT03745651|155438844|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
48339716|NCT03745651|155438845|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
48339717|NCT03745651|155438846|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
48339718|NCT03745651|155438847|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
48339719|NCT03745651|155438848|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
48339720|NCT03745651|155438842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48339721|NCT03745651|155438843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48339722|NCT03745651|155438844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48339723|NCT03745651|155438845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48339724|NCT03745651|155438846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48339725|NCT03745651|155438847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
48339726|NCT03745651|155438848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
48339727|NCT03745651|155438842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48339728|NCT03745651|155438843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48339729|NCT03745651|155438844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48339730|NCT03745651|155438845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
48339731|NCT03745651|155438846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48663053|NCT03283098|156619483|FG001|Overall Study|Withdrawal by Subject|1|||
48663054|NCT00711113|156619484|FG000|Overall Study|Lost to Follow-up|9|||
48663055|NCT00711113|156619484|FG000|Overall Study|Implant lost|2|||
48663056|NCT00693017|156619495|FG000|Overall Study|Sponsor Decision|2|||
48663057|NCT00693017|156619496|FG001|Overall Study|Sponsor Decision|1|||
48663058|NCT00693017|156619495|FG000|Overall Study|Death|0|||
48663059|NCT00693017|156619496|FG001|Overall Study|Death|1|||
48663060|NCT00642369|156619499|FG000|Overall Study|Adverse Event|2|||
48663061|NCT00642369|156619500|FG001|Overall Study|Adverse Event|3|||
48663062|NCT00642369|156619499|FG000|Overall Study|Withdrawal by Subject|1|||
48663063|NCT00642369|156619500|FG001|Overall Study|Withdrawal by Subject|0|||
48663064|NCT00642369|156619499|FG000|Overall Study|misdiagnosis|0|||
48663065|NCT00642369|156619500|FG001|Overall Study|misdiagnosis|1|||
48663066|NCT00642369|156619499|FG000|Overall Study|Lack of Efficacy|2|||
48756386|NCT00330616|156954340|FG000|Overall Study|Lack of Efficacy|1|||
48756387|NCT00330616|156954340|FG000|Overall Study|Lost to Follow-up|2|||
48756388|NCT00330616|156954340|FG000|Overall Study|Withdrawal by Subject|4|||
48756389|NCT00330616|156954340|FG000|Overall Study|Other|1|||
48756390|NCT00730912|156954343|FG000|Overall Study|Discontinued|0|||
48756391|NCT00730912|156954344|FG001|Overall Study|Discontinued|0|||
48756392|NCT00730912|156954345|FG002|Overall Study|Discontinued|1|||
48756393|NCT00732615|156954346|FG000|Overall Study|Withdrawal by Subject|3|||
48663067|NCT00642369|156619500|FG001|Overall Study|Lack of Efficacy|2|||
48663068|NCT00847665|156619501|FG000|Overall Study|Withdrawal by Subject|1|||
48663069|NCT00847665|156619502|FG001|Overall Study|Withdrawal by Subject|0|||
48663070|NCT02536300|156619506|FG000|Overall Study|Investigator's Discretion|17|||
48663071|NCT02536300|156619507|FG001|Overall Study|Investigator's Discretion|11|||
48663072|NCT02536300|156619508|FG002|Overall Study|Investigator's Discretion|2|||
48663073|NCT02536300|156619506|FG000|Overall Study|Progressive Disease|11|||
48663074|NCT02536300|156619507|FG001|Overall Study|Progressive Disease|7|||
48663075|NCT02536300|156619508|FG002|Overall Study|Progressive Disease|6|||
48663076|NCT02536300|156619506|FG000|Overall Study|Study Terminated by Sponsor|6|||
48663077|NCT02536300|156619507|FG001|Overall Study|Study Terminated by Sponsor|4|||
48663078|NCT02536300|156619508|FG002|Overall Study|Study Terminated by Sponsor|7|||
48663079|NCT02536300|156619506|FG000|Overall Study|Death|7|||
48663080|NCT02536300|156619507|FG001|Overall Study|Death|0|||
48663081|NCT02536300|156619508|FG002|Overall Study|Death|5|||
48663082|NCT02536300|156619506|FG000|Overall Study|Withdrew Consent|4|||
48663083|NCT02536300|156619507|FG001|Overall Study|Withdrew Consent|2|||
48663084|NCT02536300|156619508|FG002|Overall Study|Withdrew Consent|0|||
48663085|NCT02536300|156619506|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
48663086|NCT02536300|156619507|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
48663087|NCT02536300|156619508|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
48663088|NCT02536300|156619506|FG000|Overall Study|Enrolled but Never Treated|0|||
48663089|NCT02536300|156619507|FG001|Overall Study|Enrolled but Never Treated|0|||
48663090|NCT02536300|156619508|FG002|Overall Study|Enrolled but Never Treated|1|||
48663091|NCT02536300|156619506|FG000|Overall Study|Non-compliance With Study Drug|1|||
48663092|NCT02536300|156619507|FG001|Overall Study|Non-compliance With Study Drug|0|||
48663093|NCT02536300|156619508|FG002|Overall Study|Non-compliance With Study Drug|0|||
48663094|NCT02536300|156619506|FG000|Overall Study|Protocol Violation|0|||
48663095|NCT02536300|156619507|FG001|Overall Study|Protocol Violation|1|||
48663096|NCT02536300|156619508|FG002|Overall Study|Protocol Violation|0|||
48663097|NCT01779869|156619509|FG000|Overall Study|Physician Decision|2|||
48663098|NCT02435680|156619511|FG000|Overall Study|Physician Decision|3|||
48663099|NCT02435680|156619512|FG001|Overall Study|Physician Decision|0|||
48663100|NCT02435680|156619513|FG002|Overall Study|Physician Decision|0|||
48663101|NCT02435680|156619511|FG000|Overall Study|subject / guardian decision|0|||
48663102|NCT02435680|156619512|FG001|Overall Study|subject / guardian decision|3|||
48756394|NCT00732615|156954347|FG001|Overall Study|Withdrawal by Subject|1|||
48756395|NCT00732615|156954346|FG000|Overall Study|Lost to Follow-up|0|||
48756396|NCT00732615|156954347|FG001|Overall Study|Lost to Follow-up|1|||
48663103|NCT02435680|156619513|FG002|Overall Study|subject / guardian decision|2|||
48663104|NCT02435680|156619511|FG000|Overall Study|Adverse Event|8|||
48663105|NCT02435680|156619512|FG001|Overall Study|Adverse Event|3|||
48663106|NCT02435680|156619513|FG002|Overall Study|Adverse Event|2|||
48663107|NCT02435680|156619511|FG000|Overall Study|progressive disease|10|||
48663108|NCT02435680|156619512|FG001|Overall Study|progressive disease|7|||
48663109|NCT02435680|156619513|FG002|Overall Study|progressive disease|11|||
48663110|NCT02435680|156619511|FG000|Overall Study|not treated|0|||
48663111|NCT02435680|156619512|FG001|Overall Study|not treated|0|||
48663112|NCT02435680|156619513|FG002|Overall Study|not treated|1|||
48663113|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
48663114|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
48663115|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
48663116|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
48756397|NCT00732615|156954346|FG000|Overall Study|Adverse Event|0|||
48663117|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
48756398|NCT00732615|156954347|FG001|Overall Study|Adverse Event|2|||
48756399|NCT00732615|156954346|FG000|Overall Study|Physician Decision|3|||
48663118|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
48663119|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
48663120|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
48663121|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
48663122|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
48663123|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
48663124|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
48663125|NCT01632241|156619514|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
48663126|NCT01632241|156619515|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
48663127|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
48663128|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
48663129|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
48663130|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
48663131|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
48663132|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
48663133|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
48663134|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
48663135|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
48663136|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
48663137|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
48663138|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
48663139|NCT01632241|156619514|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
48663140|NCT01632241|156619515|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
48663141|NCT04490109|156619516|FG000|Overall Study|Lost to Follow-up|3|||
48663142|NCT04490109|156619517|FG001|Overall Study|Lost to Follow-up|10|||
48663143|NCT04490109|156619518|FG002|Overall Study|Lost to Follow-up|4|||
48663144|NCT04490109|156619516|FG000|Overall Study|Withdrawal by Subject|8|||
48663145|NCT04490109|156619517|FG001|Overall Study|Withdrawal by Subject|6|||
48663146|NCT04490109|156619518|FG002|Overall Study|Withdrawal by Subject|9|||
48663147|NCT04490109|156619516|FG000|Overall Study|Physician Decision|0|||
48663148|NCT04490109|156619517|FG001|Overall Study|Physician Decision|2|||
48663149|NCT04490109|156619518|FG002|Overall Study|Physician Decision|3|||
48663150|NCT04490109|156619516|FG000|Overall Study|Adverse Event|2|||
48663151|NCT04490109|156619517|FG001|Overall Study|Adverse Event|1|||
48663152|NCT04490109|156619518|FG002|Overall Study|Adverse Event|0|||
48663153|NCT04490109|156619516|FG000|Overall Study|Significant Non-Compliance|2|||
48663154|NCT04490109|156619517|FG001|Overall Study|Significant Non-Compliance|4|||
48663155|NCT04490109|156619518|FG002|Overall Study|Significant Non-Compliance|4|||
48663156|NCT04490109|156619516|FG000|Overall Study|Significant Clinical Event|0|||
48663157|NCT04490109|156619517|FG001|Overall Study|Significant Clinical Event|1|||
48663158|NCT04490109|156619518|FG002|Overall Study|Significant Clinical Event|0|||
48663159|NCT04490109|156619516|FG000|Overall Study|Other Reason|4|||
48663160|NCT04490109|156619517|FG001|Overall Study|Other Reason|1|||
48663161|NCT04490109|156619518|FG002|Overall Study|Other Reason|1|||
48663162|NCT02851407|156619519|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48663163|NCT02851407|156619520|FG001|Overall Study|Withdrawal by parent/guardian|7|||
48663164|NCT02851407|156619519|FG000|Overall Study|Protocol deviation|0|||
48663165|NCT02851407|156619520|FG001|Overall Study|Protocol deviation|1|||
48663166|NCT02851407|156619519|FG000|Overall Study|Transferred to another hospital to continue|1|||
48663167|NCT02851407|156619520|FG001|Overall Study|Transferred to another hospital to continue|0|||
48663168|NCT02851407|156619519|FG000|Overall Study|Other Death|30|||
48663169|NCT02851407|156619520|FG001|Overall Study|Other Death|20|||
48663170|NCT02851407|156619519|FG000|Overall Study|Adverse event, serious fatal|6|||
48663171|NCT02851407|156619520|FG001|Overall Study|Adverse event, serious fatal|8|||
48663172|NCT02851407|156619519|FG000|Overall Study|Consent withdrawn by participant|5|||
48663173|NCT02851407|156619520|FG001|Overall Study|Consent withdrawn by participant|3|||
48663174|NCT02851407|156619519|FG000|Overall Study|Screen failure|2|||
48663175|NCT02851407|156619520|FG001|Overall Study|Screen failure|1|||
48663176|NCT02851407|156619519|FG000|Overall Study|Disease relapse|9|||
48663177|NCT02851407|156619520|FG001|Overall Study|Disease relapse|6|||
48663178|NCT02851407|156619519|FG000|Overall Study|Physician Decision|7|||
48663179|NCT02851407|156619520|FG001|Overall Study|Physician Decision|6|||
48663180|NCT02851407|156619519|FG000|Overall Study|Transferred to hospital closer to home|0|||
48663181|NCT02851407|156619520|FG001|Overall Study|Transferred to hospital closer to home|1|||
48663182|NCT02851407|156619519|FG000|Overall Study|Enrolled in an investigational study|0|||
48663183|NCT02851407|156619520|FG001|Overall Study|Enrolled in an investigational study|1|||
48663184|NCT02851407|156619519|FG000|Overall Study|Early recovery|1|||
48663185|NCT02851407|156619520|FG001|Overall Study|Early recovery|0|||
48663186|NCT02851407|156619519|FG000|Overall Study|Adverse event, non-fatal|7|||
48428227|NCT02531373|155756503|FG005|Overall Study|Physician Decision|1|||
48663187|NCT02851407|156619520|FG001|Overall Study|Adverse event, non-fatal|5|||
48663188|NCT02851407|156619519|FG000|Overall Study|Lost to Follow-up|0|||
48663189|NCT02851407|156619520|FG001|Overall Study|Lost to Follow-up|2|||
48663190|NCT00235391|156619523|FG000|Overall Study|Adverse Event|4|||
48663191|NCT00235391|156619524|FG001|Overall Study|Adverse Event|5|||
48663192|NCT00235391|156619525|FG002|Overall Study|Adverse Event|10|||
48663193|NCT00235391|156619526|FG003|Overall Study|Adverse Event|72|||
48663194|NCT00235391|156619527|FG004|Overall Study|Adverse Event|5|||
48663195|NCT00235391|156619528|FG005|Overall Study|Adverse Event|2|||
48663196|NCT00235391|156619523|FG000|Overall Study|Abnormal laboratory value(s)|3|||
48663197|NCT00235391|156619524|FG001|Overall Study|Abnormal laboratory value(s)|5|||
48663198|NCT00235391|156619525|FG002|Overall Study|Abnormal laboratory value(s)|4|||
48663199|NCT00235391|156619526|FG003|Overall Study|Abnormal laboratory value(s)|27|||
48663200|NCT00235391|156619527|FG004|Overall Study|Abnormal laboratory value(s)|1|||
48663201|NCT00235391|156619528|FG005|Overall Study|Abnormal laboratory value(s)|2|||
48663202|NCT00235391|156619523|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48663203|NCT00235391|156619524|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48663204|NCT00235391|156619525|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48663205|NCT00235391|156619526|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
48663206|NCT00235391|156619527|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
48663207|NCT00235391|156619528|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
48339732|NCT03745651|155438847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
48339733|NCT03745651|155438848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
48339734|NCT03745651|155438842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48339735|NCT03745651|155438843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48339736|NCT03745651|155438844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48339737|NCT03745651|155438845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
48339738|NCT03745651|155438846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
48339739|NCT03745651|155438847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
48339740|NCT03745651|155438848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
48339741|NCT03745651|155438842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48339742|NCT03745651|155438843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48339743|NCT03745651|155438844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48339744|NCT03745651|155438845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
48339745|NCT03745651|155438846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
48339746|NCT03745651|155438847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
48339747|NCT03745651|155438848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
48339748|NCT03745651|155438842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48339749|NCT03745651|155438843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48339750|NCT03745651|155438844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48339751|NCT03745651|155438845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
48339752|NCT03745651|155438846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48339753|NCT03745651|155438847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
48339754|NCT03745651|155438848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
48339755|NCT03745651|155438842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48339756|NCT03745651|155438843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48339757|NCT03745651|155438844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48339758|NCT03745651|155438845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48339759|NCT03745651|155438846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48339760|NCT03745651|155438847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
48339761|NCT03745651|155438848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
48339762|NCT03745651|155438842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48339763|NCT03745651|155438843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48339764|NCT03745651|155438844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48339765|NCT03745651|155438845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
48339766|NCT03745651|155438846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
48339767|NCT03745651|155438847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
48339768|NCT03745651|155438848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
48339769|NCT03745651|155438842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
48663208|NCT00235391|156619523|FG000|Overall Study|Condition no longer requires treatment|3|||
48663209|NCT00235391|156619524|FG001|Overall Study|Condition no longer requires treatment|0|||
48339770|NCT03745651|155438843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
48339771|NCT03745651|155438844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
48339772|NCT03745651|155438845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
48339773|NCT03745651|155438846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
48339774|NCT03745651|155438847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
48339775|NCT03745651|155438848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
48339776|NCT04175834|155438849|FG000|Overall Study|Withdrawal by Subject|1|||
48339777|NCT04175834|155438850|FG001|Overall Study|Withdrawal by Subject|0|||
48663210|NCT00235391|156619525|FG002|Overall Study|Condition no longer requires treatment|0|||
48692748|NCT01339689|156724589|FG001|Overall Study|Noncompliance|0|||
48692749|NCT01339689|156724588|FG000|Overall Study|Relocated out of area|0|||
48692750|NCT01339689|156724589|FG001|Overall Study|Relocated out of area|1|||
48692751|NCT01339689|156724588|FG000|Overall Study|Other|2|||
48692752|NCT01339689|156724589|FG001|Overall Study|Other|2|||
48692753|NCT01339689|156724588|FG000|Overall Study|multiple reasons|1|||
48692754|NCT01339689|156724589|FG001|Overall Study|multiple reasons|1|||
48692755|NCT01469221|156724590|FG000|Double Blind Phase|Protocol Violation|1|||
48692756|NCT01469221|156724591|FG001|Double Blind Phase|Protocol Violation|0|||
48339778|NCT03029234|155438851|FG000|Overall Study|Sponsor Decision|1|||
48339779|NCT03029234|155438851|FG000|Overall Study|Withdrawal by Subject|5|||
48339780|NCT03029234|155438851|FG000|Overall Study|Death|91|||
48663211|NCT00235391|156619526|FG003|Overall Study|Condition no longer requires treatment|11|||
48339781|NCT03029234|155438851|FG000|Overall Study|Lost to Follow-up|2|||
48339782|NCT01745380|155438852|FG000|Overall Study|Lost to Follow-up|1|||
48339783|NCT01745380|155438853|FG001|Overall Study|Lost to Follow-up|0|||
48339784|NCT01745380|155438852|FG000|Overall Study|Lack of Efficacy|0|||
48339785|NCT01745380|155438853|FG001|Overall Study|Lack of Efficacy|1|||
48663212|NCT00235391|156619527|FG004|Overall Study|Condition no longer requires treatment|1|||
48663213|NCT00235391|156619528|FG005|Overall Study|Condition no longer requires treatment|0|||
48339786|NCT01514864|155438858|FG000|Overall Study|Disease progression|7|||
48339787|NCT01514864|155438859|FG001|Overall Study|Disease progression|5|||
48339788|NCT01514864|155438858|FG000|Overall Study|Study drug toxicity|2|||
48339789|NCT01514864|155438859|FG001|Overall Study|Study drug toxicity|0|||
48339790|NCT01114217|155438862|FG000|Overall Study|Adverse Event|5|||
48339791|NCT01114217|155438863|FG001|Overall Study|Adverse Event|3|||
48339792|NCT01114217|155438862|FG000|Overall Study|Lost to Follow-up|17|||
48339793|NCT01114217|155438863|FG001|Overall Study|Lost to Follow-up|33|||
48339794|NCT01114217|155438862|FG000|Overall Study|Withdrawal by Subject|21|||
48339795|NCT01114217|155438863|FG001|Overall Study|Withdrawal by Subject|28|||
48339796|NCT01114217|155438862|FG000|Overall Study|Other-Clerical Error|3|||
48339797|NCT01114217|155438863|FG001|Overall Study|Other-Clerical Error|0|||
48339798|NCT01114217|155438862|FG000|Overall Study|Other-Early termination|6|||
48339799|NCT01114217|155438863|FG001|Overall Study|Other-Early termination|10|||
48339800|NCT01114217|155438862|FG000|Overall Study|Other-Procedure|1|||
48663214|NCT00235391|156619523|FG000|Overall Study|Protocol deviation|0|||
48663215|NCT00235391|156619524|FG001|Overall Study|Protocol deviation|0|||
48663216|NCT00235391|156619525|FG002|Overall Study|Protocol deviation|1|||
48663217|NCT00235391|156619526|FG003|Overall Study|Protocol deviation|11|||
48663218|NCT00235391|156619527|FG004|Overall Study|Protocol deviation|0|||
48663219|NCT00235391|156619528|FG005|Overall Study|Protocol deviation|0|||
48663220|NCT00235391|156619523|FG000|Overall Study|Withdrawal by Subject|2|||
48663221|NCT00235391|156619524|FG001|Overall Study|Withdrawal by Subject|3|||
48663222|NCT00235391|156619525|FG002|Overall Study|Withdrawal by Subject|3|||
48663223|NCT00235391|156619526|FG003|Overall Study|Withdrawal by Subject|61|||
48663224|NCT00235391|156619527|FG004|Overall Study|Withdrawal by Subject|5|||
48663225|NCT00235391|156619528|FG005|Overall Study|Withdrawal by Subject|0|||
48663226|NCT00235391|156619523|FG000|Overall Study|Lost to Follow-up|0|||
48663227|NCT00235391|156619524|FG001|Overall Study|Lost to Follow-up|3|||
48663228|NCT00235391|156619525|FG002|Overall Study|Lost to Follow-up|3|||
48663229|NCT00235391|156619526|FG003|Overall Study|Lost to Follow-up|16|||
48663230|NCT00235391|156619527|FG004|Overall Study|Lost to Follow-up|0|||
48663231|NCT00235391|156619528|FG005|Overall Study|Lost to Follow-up|0|||
48663232|NCT00235391|156619523|FG000|Overall Study|Administrative problems|0|||
48663233|NCT00235391|156619524|FG001|Overall Study|Administrative problems|0|||
48663234|NCT00235391|156619525|FG002|Overall Study|Administrative problems|0|||
48663235|NCT00235391|156619526|FG003|Overall Study|Administrative problems|1|||
48339801|NCT01114217|155438863|FG001|Overall Study|Other-Procedure|1|||
48339802|NCT01114217|155438862|FG000|Overall Study|Other-Pregnancy|2|||
48663236|NCT00235391|156619527|FG004|Overall Study|Administrative problems|0|||
48663237|NCT00235391|156619528|FG005|Overall Study|Administrative problems|0|||
48663238|NCT00235391|156619523|FG000|Overall Study|Death|0|||
48663239|NCT00235391|156619524|FG001|Overall Study|Death|0|||
48663240|NCT00235391|156619525|FG002|Overall Study|Death|1|||
48663241|NCT00235391|156619526|FG003|Overall Study|Death|4|||
48663242|NCT00235391|156619527|FG004|Overall Study|Death|0|||
48663243|NCT00235391|156619528|FG005|Overall Study|Death|0|||
48663244|NCT02098369|156619529|FG000|Overall Study|Withdrawal by Subject|1|||
48663245|NCT02098369|156619530|FG001|Overall Study|Withdrawal by Subject|5|||
48663246|NCT02098369|156619531|FG002|Overall Study|Withdrawal by Subject|0|||
48663247|NCT02098369|156619529|FG000|Overall Study|Lost to Follow-up|5|||
48663248|NCT02098369|156619530|FG001|Overall Study|Lost to Follow-up|1|||
48663249|NCT02098369|156619531|FG002|Overall Study|Lost to Follow-up|3|||
48663250|NCT02098369|156619529|FG000|Overall Study|Death|1|||
48663251|NCT02098369|156619530|FG001|Overall Study|Death|1|||
48663252|NCT02098369|156619531|FG002|Overall Study|Death|1|||
48663253|NCT02098369|156619529|FG000|Overall Study|Other|0|||
48663254|NCT02098369|156619530|FG001|Overall Study|Other|2|||
48663255|NCT02098369|156619531|FG002|Overall Study|Other|1|||
48663256|NCT03276052|156619533|FG000|Overall Study|Withdrawal by Subject|5|||
48663257|NCT03276052|156619533|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
48663258|NCT03784846|156619534|FG000|Pre-COVID Study|Lost to Follow-up|3|||
48663259|NCT03784846|156619535|FG001|Pre-COVID Study|Lost to Follow-up|3|||
48663260|NCT03784846|156619536|FG002|Pre-COVID Study|Lost to Follow-up|2|||
48663261|NCT03784846|156619534|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
48663262|NCT03784846|156619535|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
48663263|NCT03784846|156619536|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
48663264|NCT03784846|156619534|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
48663265|NCT03784846|156619535|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
48663266|NCT03784846|156619536|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
48663267|NCT03784846|156619534|FG000|Post-COVID Study|Lost to Follow-up|3|||
48663268|NCT03784846|156619535|FG001|Post-COVID Study|Lost to Follow-up|5|||
48663269|NCT03784846|156619536|FG002|Post-COVID Study|Lost to Follow-up|1|||
48663270|NCT03784846|156619534|FG000|Post-COVID Study|Withdrawal by Subject|1|||
48663271|NCT03784846|156619535|FG001|Post-COVID Study|Withdrawal by Subject|2|||
48663272|NCT03784846|156619536|FG002|Post-COVID Study|Withdrawal by Subject|0|||
48663273|NCT00554619|156619537|FG000|Overall Study|Adverse Event|1|||
48663274|NCT00554619|156619537|FG000|Overall Study|Physician Decision|1|||
48663275|NCT00554619|156619537|FG000|Overall Study|Liver Function Test Abnormality|1|||
48663276|NCT04224272|156619538|FG000|Part 1 - Dose Finding|Death|4|||
48663277|NCT04224272|156619538|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
48663278|NCT04224272|156619538|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
48663279|NCT04224272|156619538|FG000|Part 2 - Dose Expansion|Death|10|||
48663280|NCT04224272|156619538|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
48663281|NCT03242772|156619539|FG000|Overall Study|Lost to Follow-up|2|||
48663282|NCT03242772|156619540|FG001|Overall Study|Lost to Follow-up|0|||
48663283|NCT03242772|156619539|FG000|Overall Study|Physician Decision|0|||
48663284|NCT03242772|156619540|FG001|Overall Study|Physician Decision|1|||
48663285|NCT03242772|156619539|FG000|Overall Study|Withdrawal by Subject|1|||
48663286|NCT03242772|156619540|FG001|Overall Study|Withdrawal by Subject|0|||
48663287|NCT04677660|156619543|FG000|Overall Study|Lost to Follow-up|0|||
48663288|NCT04677660|156619544|FG001|Overall Study|Lost to Follow-up|2|||
48663289|NCT04677660|156619543|FG000|Overall Study|Withdrawal by Subject|0|||
48663290|NCT04677660|156619544|FG001|Overall Study|Withdrawal by Subject|1|||
48663291|NCT04677660|156619543|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
48663292|NCT04677660|156619544|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
48756400|NCT00732615|156954347|FG001|Overall Study|Physician Decision|0|||
48756401|NCT00732615|156954346|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
48756402|NCT00732615|156954347|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
48756403|NCT03566823|156954348|FG000|Overall Study|Lack of Efficacy|0|||
48756404|NCT03566823|156954349|FG001|Overall Study|Lack of Efficacy|1|||
48756405|NCT03566823|156954350|FG002|Overall Study|Lack of Efficacy|0|||
48756406|NCT03566823|156954348|FG000|Overall Study|Withdrawal by Subject|1|||
48339803|NCT01114217|155438863|FG001|Overall Study|Other-Pregnancy|4|||
48428228|NCT02531373|155756504|FG006|Overall Study|Physician Decision|0|||
48663293|NCT03060512|156619545|FG000|Overall Study|Adverse Event|4|||
48663294|NCT03060512|156619546|FG001|Overall Study|Adverse Event|6|||
48663295|NCT03060512|156619545|FG000|Overall Study|Lost to Follow-up|1|||
48663296|NCT03060512|156619546|FG001|Overall Study|Lost to Follow-up|1|||
48663297|NCT03060512|156619545|FG000|Overall Study|Withdrawal by Subject|1|||
48663298|NCT03060512|156619546|FG001|Overall Study|Withdrawal by Subject|0|||
48663299|NCT03060512|156619545|FG000|Overall Study|Non-compliance with study medication|1|||
48663300|NCT03060512|156619546|FG001|Overall Study|Non-compliance with study medication|2|||
48663301|NCT02785458|156619547|FG000|1 Month|Withdrawal by Subject|2|||
48663302|NCT02785458|156619548|FG001|1 Month|Withdrawal by Subject|1|||
48663303|NCT02785458|156619547|FG000|1 Month|Lost to Follow-up|38|||
48663304|NCT02785458|156619548|FG001|1 Month|Lost to Follow-up|31|||
48663305|NCT02785458|156619547|FG000|1 Month|Deemed Ineligible|1|||
48663306|NCT02785458|156619548|FG001|1 Month|Deemed Ineligible|0|||
48663307|NCT02785458|156619547|FG000|1 Month|Completed Evaluation by Baseline|42|||
48663308|NCT02785458|156619548|FG001|1 Month|Completed Evaluation by Baseline|39|||
48663309|NCT02785458|156619547|FG000|1 Month|Partial Interview|0|||
48663310|NCT02785458|156619548|FG001|1 Month|Partial Interview|4|||
48663311|NCT02785458|156619547|FG000|3 Months|Withdrawal by Subject|3|||
48663312|NCT02785458|156619548|FG001|3 Months|Withdrawal by Subject|1|||
48663313|NCT02785458|156619547|FG000|3 Months|Lost to Follow-up|25|||
48663314|NCT02785458|156619548|FG001|3 Months|Lost to Follow-up|21|||
48663315|NCT02785458|156619547|FG000|3 Months|Completed Evaluation at 1 Month|100|||
48663316|NCT02785458|156619548|FG001|3 Months|Completed Evaluation at 1 Month|89|||
48663317|NCT00089986|156619549|FG000|Overall Study|Adverse Event|6|||
48756407|NCT03566823|156954349|FG001|Overall Study|Withdrawal by Subject|2|||
48756408|NCT03566823|156954350|FG002|Overall Study|Withdrawal by Subject|0|||
48756409|NCT03566823|156954348|FG000|Overall Study|Adverse Event|1|||
48756410|NCT03566823|156954349|FG001|Overall Study|Adverse Event|0|||
48756411|NCT03566823|156954350|FG002|Overall Study|Adverse Event|2|||
48756412|NCT01528254|156954351|FG000|Overall Study|Administrative problems|96|||
48756413|NCT01528254|156954352|FG001|Overall Study|Administrative problems|94|||
48756414|NCT01528254|156954351|FG000|Overall Study|Adverse Event|28|||
48756415|NCT01528254|156954352|FG001|Overall Study|Adverse Event|44|||
48756416|NCT01528254|156954351|FG000|Overall Study|Lost to Follow-up|17|||
48663318|NCT00089986|156619550|FG001|Overall Study|Adverse Event|9|||
48663319|NCT00089986|156619551|FG002|Overall Study|Adverse Event|6|||
48663320|NCT00089986|156619549|FG000|Overall Study|Lost to Follow-up|3|||
48663321|NCT00089986|156619550|FG001|Overall Study|Lost to Follow-up|1|||
48756417|NCT01528254|156954352|FG001|Overall Study|Lost to Follow-up|24|||
48756418|NCT01528254|156954351|FG000|Overall Study|Death|13|||
48756419|NCT01528254|156954352|FG001|Overall Study|Death|9|||
48756420|NCT01528254|156954351|FG000|Overall Study|Protocol deviation|9|||
48756421|NCT01528254|156954352|FG001|Overall Study|Protocol deviation|19|||
48756422|NCT01528254|156954351|FG000|Overall Study|New therapy for study indication|8|||
48756423|NCT01528254|156954352|FG001|Overall Study|New therapy for study indication|6|||
48756424|NCT01528254|156954351|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
48756425|NCT01528254|156954352|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48756426|NCT01528254|156954351|FG000|Overall Study|Withdrawal by Subject|5|||
48756427|NCT01528254|156954352|FG001|Overall Study|Withdrawal by Subject|4|||
48756428|NCT01528254|156954351|FG000|Overall Study|Abnormal laboratory value(s)|3|||
48756429|NCT01528254|156954352|FG001|Overall Study|Abnormal laboratory value(s)|7|||
48756430|NCT01528254|156954351|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48756431|NCT01528254|156954352|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48756432|NCT01528254|156954351|FG000|Overall Study|No longer requires study drug|1|||
48756433|NCT01528254|156954352|FG001|Overall Study|No longer requires study drug|1|||
48756434|NCT00748033|156954353|FG000|Overall Study|Adverse Event|0|||
48756435|NCT00748033|156954354|FG001|Overall Study|Adverse Event|1|||
48756436|NCT01344161|156954355|FG000|Overall Study|Lost to Follow-up|4|||
48663322|NCT00089986|156619551|FG002|Overall Study|Lost to Follow-up|1|||
48663323|NCT00089986|156619549|FG000|Overall Study|Protocol Violation|0|||
48663324|NCT00089986|156619550|FG001|Overall Study|Protocol Violation|1|||
48756437|NCT01344161|156954356|FG001|Overall Study|Lost to Follow-up|1|||
48756438|NCT01344161|156954355|FG000|Overall Study|Pregnancy|0|||
48756439|NCT01344161|156954356|FG001|Overall Study|Pregnancy|1|||
48756440|NCT01344161|156954355|FG000|Overall Study|Protocol Violation|1|||
48756441|NCT01344161|156954356|FG001|Overall Study|Protocol Violation|1|||
48756442|NCT02496533|156954357|FG000|Overall Study|Lack of data on outcome|3|||
48756443|NCT02496533|156954358|FG001|Overall Study|Lack of data on outcome|0|||
48756444|NCT02496533|156954357|FG000|Overall Study|Patient did not complete all measures|0|||
48756445|NCT02496533|156954358|FG001|Overall Study|Patient did not complete all measures|4|||
48756446|NCT02496533|156954357|FG000|Overall Study|Late for radiologic testing|0|||
48756447|NCT02496533|156954358|FG001|Overall Study|Late for radiologic testing|2|||
48756448|NCT03021265|156954359|FG000|Overall Study|Adverse Event|29|||
48756449|NCT03021265|156954359|FG000|Overall Study|Lack of Efficacy|3|||
48756450|NCT03021265|156954359|FG000|Overall Study|Improved|17|||
48756451|NCT03021265|156954359|FG000|Overall Study|Lost to Follow-up|67|||
48756452|NCT03021265|156954359|FG000|Overall Study|No reason given|2|||
48663325|NCT00089986|156619551|FG002|Overall Study|Protocol Violation|0|||
48756453|NCT03021265|156954359|FG000|Overall Study|No visit since the first visit|4|||
48756454|NCT02484729|156954360|FG000|Overall Study|Failure of IntelliCap Error|0|||
48756455|NCT02484729|156954361|FG001|Overall Study|Failure of IntelliCap Error|0|||
48756456|NCT02484729|156954362|FG002|Overall Study|Failure of IntelliCap Error|0|||
48756457|NCT02484729|156954363|FG003|Overall Study|Failure of IntelliCap Error|0|||
48756458|NCT02484729|156954364|FG004|Overall Study|Failure of IntelliCap Error|0|||
48663326|NCT00089986|156619549|FG000|Overall Study|Patient transferred to another hospital|2|||
48663327|NCT00089986|156619550|FG001|Overall Study|Patient transferred to another hospital|1|||
48663328|NCT00089986|156619551|FG002|Overall Study|Patient transferred to another hospital|0|||
48756459|NCT02484729|156954365|FG005|Overall Study|Failure of IntelliCap Error|0|||
48756460|NCT02484729|156954366|FG006|Overall Study|Failure of IntelliCap Error|0|||
48756461|NCT02484729|156954367|FG007|Overall Study|Failure of IntelliCap Error|0|||
48756462|NCT02484729|156954368|FG008|Overall Study|Failure of IntelliCap Error|0|||
48756463|NCT02484729|156954369|FG009|Overall Study|Failure of IntelliCap Error|1|||
48756464|NCT02738450|156954370|FG000|Overall Study|Withdrawal by Subject|0|||
48756465|NCT02738450|156954371|FG001|Overall Study|Withdrawal by Subject|2|||
48756466|NCT02738450|156954372|FG002|Overall Study|Withdrawal by Subject|0|||
48756467|NCT02626520|156954374|FG000|Overall Study|Physician Decision|1|||
48756468|NCT02626520|156954375|FG001|Overall Study|Physician Decision|1|||
48756469|NCT02626520|156954374|FG000|Overall Study|Adverse Event|0|||
48756470|NCT02626520|156954375|FG001|Overall Study|Adverse Event|4|||
48756471|NCT02626520|156954374|FG000|Overall Study|Lack of Efficacy|0|||
48756472|NCT02626520|156954375|FG001|Overall Study|Lack of Efficacy|2|||
48756473|NCT02626520|156954374|FG000|Overall Study|Did not start protocol therapy|0|||
48756474|NCT02626520|156954375|FG001|Overall Study|Did not start protocol therapy|2|||
48756475|NCT02626520|156954374|FG000|Overall Study|Study terminated|0|||
48756476|NCT02626520|156954375|FG001|Overall Study|Study terminated|1|||
48756477|NCT01082965|156954376|FG000|Overall Study|Protocol Violation|0|||
48756478|NCT01082965|156954377|FG001|Overall Study|Protocol Violation|1|||
48756479|NCT01082965|156954376|FG000|Overall Study|Other|1|||
48756480|NCT01082965|156954377|FG001|Overall Study|Other|1|||
48756481|NCT04350788|156954385|FG000|Overall Study|Lost to Follow-up|6|||
48756482|NCT04350788|156954386|FG001|Overall Study|Lost to Follow-up|2|||
48663329|NCT00089986|156619549|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
48663330|NCT00089986|156619550|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
48663331|NCT00089986|156619551|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
48663332|NCT00089986|156619549|FG000|Overall Study|Hemohlobin stopping rule|0|||
48663333|NCT00089986|156619550|FG001|Overall Study|Hemohlobin stopping rule|1|||
48663334|NCT00089986|156619551|FG002|Overall Study|Hemohlobin stopping rule|0|||
48663335|NCT00089986|156619549|FG000|Overall Study|Investigator decision to withdrew|0|||
48663336|NCT00089986|156619550|FG001|Overall Study|Investigator decision to withdrew|1|||
48663337|NCT00089986|156619551|FG002|Overall Study|Investigator decision to withdrew|0|||
48663338|NCT00089986|156619549|FG000|Overall Study|Enrollment in another study|0|||
48663339|NCT00089986|156619550|FG001|Overall Study|Enrollment in another study|1|||
48663340|NCT00089986|156619551|FG002|Overall Study|Enrollment in another study|0|||
48663341|NCT00089986|156619549|FG000|Overall Study|Family decision|0|||
48663342|NCT00089986|156619550|FG001|Overall Study|Family decision|1|||
48663343|NCT00089986|156619551|FG002|Overall Study|Family decision|0|||
48663344|NCT00089986|156619549|FG000|Overall Study|Do not resuscitate (DNR)|0|||
48663345|NCT00089986|156619550|FG001|Overall Study|Do not resuscitate (DNR)|0|||
48663346|NCT00089986|156619551|FG002|Overall Study|Do not resuscitate (DNR)|1|||
48663347|NCT00089986|156619549|FG000|Overall Study|Withdrawal by Subject|3|||
48663348|NCT00089986|156619550|FG001|Overall Study|Withdrawal by Subject|6|||
48663349|NCT00089986|156619551|FG002|Overall Study|Withdrawal by Subject|2|||
48663350|NCT02825420|156619552|FG000|Overall Study|Death|30|||
48663351|NCT02825420|156619553|FG001|Overall Study|Death|12|||
48663352|NCT02825420|156619552|FG000|Overall Study|Progressive disease|6|||
48663353|NCT02825420|156619553|FG001|Overall Study|Progressive disease|1|||
48663354|NCT02825420|156619552|FG000|Overall Study|Lost to Follow-up|2|||
48663355|NCT02825420|156619553|FG001|Overall Study|Lost to Follow-up|2|||
48663356|NCT02825420|156619552|FG000|Overall Study|Withdrawal by Subject|1|||
48756483|NCT04350788|156954385|FG000|Overall Study|Withdrawal by Subject|2|||
48756484|NCT04350788|156954386|FG001|Overall Study|Withdrawal by Subject|4|||
48756485|NCT04350788|156954385|FG000|Overall Study|Protocol Violation|4|||
48756486|NCT04350788|156954386|FG001|Overall Study|Protocol Violation|0|||
48663357|NCT02825420|156619553|FG001|Overall Study|Withdrawal by Subject|1|||
48663358|NCT02825420|156619552|FG000|Overall Study|Protocol amendment not signed|1|||
48663359|NCT02825420|156619553|FG001|Overall Study|Protocol amendment not signed|1|||
48663360|NCT02825420|156619552|FG000|Overall Study|Physician Decision|1|||
48663361|NCT02825420|156619553|FG001|Overall Study|Physician Decision|0|||
48663362|NCT02825420|156619552|FG000|Overall Study|Did not receive PLD|2|||
48756487|NCT00524368|156956111|FG000|Overall Study|Adverse Event|10|||
48756488|NCT00524368|156956112|FG001|Overall Study|Adverse Event|12|||
48756489|NCT00524368|156956111|FG000|Overall Study|Lost to Follow-up|9|||
48756490|NCT00524368|156956112|FG001|Overall Study|Lost to Follow-up|13|||
48663363|NCT02825420|156619553|FG001|Overall Study|Did not receive PLD|0|||
48663364|NCT00413920|156619554|FG000|Overall Study|Adverse Event|9|||
48663365|NCT00413920|156619555|FG001|Overall Study|Adverse Event|11|||
48663366|NCT00413920|156619554|FG000|Overall Study|Lack of Efficacy|11|||
48663367|NCT00413920|156619555|FG001|Overall Study|Lack of Efficacy|9|||
48663368|NCT00413920|156619554|FG000|Overall Study|Death|3|||
48663369|NCT00413920|156619555|FG001|Overall Study|Death|5|||
48663370|NCT00413920|156619554|FG000|Overall Study|Graft Loss|5|||
48663371|NCT00413920|156619555|FG001|Overall Study|Graft Loss|3|||
48663372|NCT02434354|156619556|FG000|Overall Study|screen fail|3|||
48663373|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
48663374|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
48663375|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
48663376|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
48663377|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
48663378|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
48756491|NCT00524368|156956111|FG000|Overall Study|Withdrawal by Subject|4|||
48756492|NCT00524368|156956112|FG001|Overall Study|Withdrawal by Subject|5|||
48663379|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
48663380|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
48663381|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
48663382|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
48663383|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
48663384|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
48663385|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Adverse Event|1|||
48663386|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Adverse Event|0|||
48663387|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Adverse Event|2|||
48663388|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Adverse Event|0|||
48756493|NCT00524368|156956111|FG000|Overall Study|Non-compliant|8|||
48756494|NCT00524368|156956112|FG001|Overall Study|Non-compliant|9|||
48663389|NCT01185964|156619557|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
48663390|NCT01185964|156619558|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
48663391|NCT01185964|156619559|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
48663392|NCT01185964|156619560|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
48663393|NCT01185964|156619557|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
48663394|NCT01185964|156619558|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
48663395|NCT01185964|156619559|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
48663396|NCT01185964|156619560|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
48663397|NCT01185964|156619557|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
48663398|NCT01185964|156619558|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
48663399|NCT01185964|156619559|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
48663400|NCT01185964|156619560|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
48663401|NCT01185964|156619557|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
48663402|NCT01185964|156619558|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
48663403|NCT01185964|156619559|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
48663404|NCT01185964|156619560|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
48663405|NCT01852825|156619561|FG000|Overall Study|Withdrawal by Subject|2|||
48663406|NCT01852825|156619562|FG001|Overall Study|Withdrawal by Subject|0|||
48663407|NCT01852825|156619563|FG002|Overall Study|Withdrawal by Subject|0|||
48663408|NCT03351114|156619573|FG000|Overall Study|Withdrawal by Subject|1|||
48663409|NCT01479595|156619585|FG000|Overall Study|Protocol deviation|0|||
48663410|NCT01479595|156619586|FG001|Overall Study|Protocol deviation|1|||
48663411|NCT01479595|156619585|FG000|Overall Study|Adverse Event|2|||
48663412|NCT01479595|156619586|FG001|Overall Study|Adverse Event|1|||
48663413|NCT01628367|156619587|FG000|Overall Study|Adverse Event|1|||
48663414|NCT01628367|156619588|FG001|Overall Study|Adverse Event|0|||
48663415|NCT02726880|156619593|FG000|Overall Study|Withdrawal by Subject|2|||
48756495|NCT00524368|156956111|FG000|Overall Study|Reached a Virologic Endpoint|3|||
48756496|NCT00524368|156956112|FG001|Overall Study|Reached a Virologic Endpoint|2|||
48756497|NCT00524368|156956111|FG000|Overall Study|Sponsor's Decision|2|||
48663416|NCT02726880|156619594|FG001|Overall Study|Withdrawal by Subject|0|||
48663417|NCT02726880|156619593|FG000|Overall Study|Lost to Follow-up|1|||
48663418|NCT02726880|156619594|FG001|Overall Study|Lost to Follow-up|3|||
48663419|NCT00966719|156619595|FG000|Overall Study|Lost to Follow-up|6|||
48663420|NCT00966719|156619596|FG001|Overall Study|Lost to Follow-up|11|||
48663421|NCT02741570|156619599|FG000|Pre-Treatment Period|Other reasons|0|||
48663422|NCT02741570|156619600|FG001|Pre-Treatment Period|Other reasons|3|||
48663423|NCT02741570|156619599|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
48663424|NCT02741570|156619600|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
48663425|NCT02741570|156619599|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
48663426|NCT02741570|156619600|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
48663427|NCT02741570|156619599|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
48756498|NCT00524368|156956112|FG001|Overall Study|Sponsor's Decision|0|||
48339804|NCT01114217|155438862|FG000|Overall Study|Other-Protocol Violation|1|||
48339805|NCT01114217|155438863|FG001|Overall Study|Other-Protocol Violation|3|||
48339806|NCT01114217|155438862|FG000|Overall Study|Other-Lack of Efficacy|1|||
48339807|NCT01114217|155438863|FG001|Overall Study|Other-Lack of Efficacy|0|||
48339808|NCT01114217|155438862|FG000|Overall Study|Other-Non Compliance|2|||
48339809|NCT01114217|155438863|FG001|Overall Study|Other-Non Compliance|0|||
48339810|NCT01114217|155438862|FG000|Overall Study|Other-Physician Decision|1|||
48339811|NCT01114217|155438863|FG001|Overall Study|Other-Physician Decision|1|||
48339812|NCT01114217|155438862|FG000|Overall Study|Other-Sponsor Decision|10|||
48339813|NCT01114217|155438863|FG001|Overall Study|Other-Sponsor Decision|12|||
48339814|NCT01114217|155438862|FG000|Overall Study|Other-Study Termination|0|||
48339815|NCT01114217|155438863|FG001|Overall Study|Other-Study Termination|1|||
48339816|NCT01114217|155438862|FG000|Overall Study|Other-Study Withdrawn|1|||
48339817|NCT01114217|155438863|FG001|Overall Study|Other-Study Withdrawn|1|||
48339818|NCT01114217|155438862|FG000|Overall Study|Other-Site Stopped Communicating|2|||
48339819|NCT01114217|155438863|FG001|Overall Study|Other-Site Stopped Communicating|0|||
48339820|NCT01114217|155438862|FG000|Overall Study|Other-Lost to Follow-up|1|||
48663428|NCT02741570|156619600|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
48663429|NCT02741570|156619599|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
48663430|NCT02741570|156619600|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
48663431|NCT02741570|156619599|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
48663432|NCT02741570|156619600|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
48663433|NCT02741570|156619599|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
48663434|NCT02741570|156619600|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48663435|NCT02741570|156619599|FG000|Pre-Treatment Period|Death|0|||
48663436|NCT02741570|156619600|FG001|Pre-Treatment Period|Death|1|||
48663437|NCT02741570|156619599|FG000|Pre-Treatment Period|Disease progression|0|||
48663438|NCT02741570|156619600|FG001|Pre-Treatment Period|Disease progression|1|||
48663439|NCT02741570|156619599|FG000|Treatment Period|Other reasons|47|||
48663440|NCT02741570|156619600|FG001|Treatment Period|Other reasons|12|||
48663441|NCT02741570|156619599|FG000|Treatment Period|Poor/non-compliance|0|||
48663442|NCT02741570|156619600|FG001|Treatment Period|Poor/non-compliance|2|||
48663443|NCT02741570|156619599|FG000|Treatment Period|Maximum clinical benefit|4|||
48663444|NCT02741570|156619600|FG001|Treatment Period|Maximum clinical benefit|6|||
48663445|NCT02741570|156619599|FG000|Treatment Period|Lost to Follow-up|1|||
48663446|NCT02741570|156619600|FG001|Treatment Period|Lost to Follow-up|3|||
48663447|NCT02741570|156619599|FG000|Treatment Period|Participant withdrew consent|9|||
48663448|NCT02741570|156619600|FG001|Treatment Period|Participant withdrew consent|13|||
48663449|NCT02741570|156619599|FG000|Treatment Period|Participant request to discontinue treatment|8|||
48663450|NCT02741570|156619600|FG001|Treatment Period|Participant request to discontinue treatment|23|||
48663451|NCT02741570|156619599|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
48663452|NCT02741570|156619600|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
48663453|NCT02741570|156619599|FG000|Treatment Period|Death|9|||
48663454|NCT02741570|156619600|FG001|Treatment Period|Death|7|||
48663455|NCT02741570|156619599|FG000|Treatment Period|Study drug toxicity|55|||
48663456|NCT02741570|156619600|FG001|Treatment Period|Study drug toxicity|47|||
48663457|NCT02741570|156619599|FG000|Treatment Period|Disease progression|294|||
48663458|NCT02741570|156619600|FG001|Treatment Period|Disease progression|301|||
48663459|NCT02741570|156619599|FG000|Treatment Period|Administrative reason by sponsor|0|||
48663460|NCT02741570|156619600|FG001|Treatment Period|Administrative reason by sponsor|1|||
48663461|NCT02581930|156619602|FG000|Overall Study|Withdrawal by Subject|1|||
48663462|NCT02581930|156619602|FG000|Overall Study|patient declined further treatment|1|||
48663463|NCT01822535|156619604|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
48663464|NCT01822535|156619605|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
48663465|NCT01822535|156619604|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
48663466|NCT01822535|156619605|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
48663467|NCT01822535|156619604|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
48663468|NCT01822535|156619605|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
48339821|NCT01114217|155438863|FG001|Overall Study|Other-Lost to Follow-up|0|||
48339822|NCT01114217|155438862|FG000|Overall Study|Other-Withdrawal by Subject|1|||
48339823|NCT01114217|155438863|FG001|Overall Study|Other-Withdrawal by Subject|1|||
48339824|NCT01369147|155438864|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
48428229|NCT02531373|155756505|FG007|Overall Study|Physician Decision|0|||
48663469|NCT02278614|156619606|FG000|Overall Study|Withdrawal by Subject|3|||
48663470|NCT02278614|156619607|FG001|Overall Study|Withdrawal by Subject|5|||
48663471|NCT02278614|156619606|FG000|Overall Study|Adverse Event|1|||
48663472|NCT02278614|156619607|FG001|Overall Study|Adverse Event|0|||
48663473|NCT02278614|156619606|FG000|Overall Study|left eye was not eligible|1|||
48663474|NCT02278614|156619607|FG001|Overall Study|left eye was not eligible|0|||
48663475|NCT04384107|156619608|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
48663476|NCT04384107|156619609|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
48756499|NCT00524368|156956111|FG000|Overall Study|Ineligible to Continue the study|2|||
48663477|NCT04384107|156619608|FG000|Overall Study|Lost to Follow-up|1|||
48663478|NCT04384107|156619609|FG001|Overall Study|Lost to Follow-up|0|||
48663479|NCT00525824|156619610|FG000|Overall Study|Adverse Event|7|||
48663480|NCT00525824|156619611|FG001|Overall Study|Adverse Event|11|||
48663481|NCT00525824|156619612|FG002|Overall Study|Adverse Event|6|||
48663482|NCT00525824|156619613|FG003|Overall Study|Adverse Event|7|||
48663483|NCT00525824|156619610|FG000|Overall Study|Withdrawal by Subject|5|||
48663484|NCT00525824|156619611|FG001|Overall Study|Withdrawal by Subject|9|||
48663485|NCT00525824|156619612|FG002|Overall Study|Withdrawal by Subject|3|||
48663486|NCT00525824|156619613|FG003|Overall Study|Withdrawal by Subject|4|||
48663487|NCT00525824|156619610|FG000|Overall Study|Lost to Follow-up|4|||
48663488|NCT00525824|156619611|FG001|Overall Study|Lost to Follow-up|2|||
48663489|NCT00525824|156619612|FG002|Overall Study|Lost to Follow-up|4|||
48663490|NCT00525824|156619613|FG003|Overall Study|Lost to Follow-up|0|||
48663491|NCT00525824|156619610|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
48663492|NCT00525824|156619611|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
48663493|NCT00525824|156619612|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
48663494|NCT00525824|156619613|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
48663495|NCT00525824|156619610|FG000|Overall Study|Severe non-compliance|0|||
48663496|NCT00525824|156619611|FG001|Overall Study|Severe non-compliance|1|||
48663497|NCT00525824|156619612|FG002|Overall Study|Severe non-compliance|1|||
48663498|NCT00525824|156619613|FG003|Overall Study|Severe non-compliance|1|||
48663499|NCT00525824|156619610|FG000|Overall Study|Safety reasons|1|||
48663500|NCT00525824|156619611|FG001|Overall Study|Safety reasons|0|||
48663501|NCT00525824|156619612|FG002|Overall Study|Safety reasons|1|||
48663502|NCT00525824|156619613|FG003|Overall Study|Safety reasons|0|||
48663503|NCT00525824|156619610|FG000|Overall Study|Other|1|||
48663504|NCT00525824|156619611|FG001|Overall Study|Other|3|||
48663505|NCT00525824|156619612|FG002|Overall Study|Other|3|||
48663506|NCT00525824|156619613|FG003|Overall Study|Other|1|||
48663507|NCT02366767|156619616|FG000|Overall Study|left for home after 1 day at camp|1|||
48663508|NCT02366767|156619617|FG001|Overall Study|left for home after 1 day at camp|0|||
48663509|NCT05599451|156621213|FG000|Overall Study|Not randomized|11|||
48663510|NCT05599451|156621214|FG001|Overall Study|Not randomized|0|||
48663511|NCT05599451|156621215|FG002|Overall Study|Not randomized|0|||
48663512|NCT05599451|156621216|FG003|Overall Study|Not randomized|0|||
48663513|NCT05599451|156621217|FG004|Overall Study|Not randomized|0|||
48663514|NCT05599451|156621213|FG000|Overall Study|Physician Decision|0|||
48663515|NCT05599451|156621214|FG001|Overall Study|Physician Decision|0|||
48663516|NCT05599451|156621215|FG002|Overall Study|Physician Decision|0|||
48663517|NCT05599451|156621216|FG003|Overall Study|Physician Decision|1|||
48663518|NCT05599451|156621217|FG004|Overall Study|Physician Decision|0|||
48663519|NCT01740089|156621218|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
48663520|NCT01740089|156621219|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
48663521|NCT01740089|156621220|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
48663522|NCT01740089|156621218|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
48663523|NCT01740089|156621219|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
48663524|NCT01740089|156621220|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
48663525|NCT01740089|156621218|FG000|After 12 Weeks|Lack of Efficacy|3|||
48663526|NCT01740089|156621219|FG001|After 12 Weeks|Lack of Efficacy|1|||
48663527|NCT01740089|156621220|FG002|After 12 Weeks|Lack of Efficacy|4|||
48663528|NCT01740089|156621218|FG000|After 12 Weeks|Adverse Event|2|||
48663529|NCT01740089|156621219|FG001|After 12 Weeks|Adverse Event|0|||
48663530|NCT01740089|156621220|FG002|After 12 Weeks|Adverse Event|5|||
48663531|NCT01740089|156621218|FG000|After 12 Weeks|Protocol Violation|1|||
48663532|NCT01740089|156621219|FG001|After 12 Weeks|Protocol Violation|1|||
48663533|NCT01740089|156621220|FG002|After 12 Weeks|Protocol Violation|1|||
48663534|NCT01740089|156621218|FG000|After 12 Weeks|Withdrawal by Subject|1|||
48663535|NCT01740089|156621219|FG001|After 12 Weeks|Withdrawal by Subject|1|||
48663536|NCT01740089|156621220|FG002|After 12 Weeks|Withdrawal by Subject|1|||
48663537|NCT03372551|156621221|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
48756500|NCT00524368|156956112|FG001|Overall Study|Ineligible to Continue the study|5|||
48756501|NCT00524368|156956111|FG000|Overall Study|Other|3|||
48756502|NCT00524368|156956112|FG001|Overall Study|Other|2|||
48663538|NCT03372551|156621222|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
48663539|NCT04258995|156621223|FG000|Overall Study|Lost to Follow-up|1|||
48663540|NCT04258995|156621224|FG001|Overall Study|Lost to Follow-up|1|||
48663541|NCT03100539|156621225|FG000|Overall Study|Lost to Follow-up|60|||
48663542|NCT03100539|156621226|FG001|Overall Study|Lost to Follow-up|54|||
48663543|NCT03100539|156621227|FG002|Overall Study|Lost to Follow-up|17|||
48663544|NCT03100539|156621225|FG000|Overall Study|Uncollected|8|||
48663545|NCT03100539|156621226|FG001|Overall Study|Uncollected|8|||
48663546|NCT03100539|156621227|FG002|Overall Study|Uncollected|0|||
48663547|NCT03100539|156621225|FG000|Overall Study|Ally Health|0|||
48663548|NCT03100539|156621226|FG001|Overall Study|Ally Health|0|||
48663549|NCT03100539|156621227|FG002|Overall Study|Ally Health|3|||
48663550|NCT03100539|156621225|FG000|Overall Study|Disinterest|0|||
48663551|NCT03100539|156621226|FG001|Overall Study|Disinterest|0|||
48756503|NCT00180414|156956118|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
48339825|NCT01369147|155438865|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
48339826|NCT01369147|155438866|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
48339827|NCT02592434|155438869|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
48339828|NCT02592434|155438870|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
48339829|NCT02592434|155438871|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
48339830|NCT02592434|155438869|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
48339831|NCT02592434|155438870|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
48339832|NCT02592434|155438871|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
48339833|NCT02592434|155438869|FG000|Open-Label Phase (18 Weeks)|Other|3|||
48339834|NCT02592434|155438870|FG001|Open-Label Phase (18 Weeks)|Other|0|||
48339835|NCT02592434|155438871|FG002|Open-Label Phase (18 Weeks)|Other|0|||
48339836|NCT02592434|155438869|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
48339837|NCT02592434|155438870|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
48339838|NCT02592434|155438871|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
48339839|NCT02592434|155438869|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
48339840|NCT02592434|155438870|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
48339841|NCT02592434|155438871|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
48339842|NCT02592434|155438869|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
48339843|NCT02592434|155438870|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
48339844|NCT02592434|155438871|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
48339845|NCT02592434|155438869|FG000|Double Blind Phase (26 Weeks)|Other|0|||
48339846|NCT02592434|155438870|FG001|Double Blind Phase (26 Weeks)|Other|1|||
48339847|NCT02592434|155438871|FG002|Double Blind Phase (26 Weeks)|Other|0|||
48339848|NCT02592434|155438869|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
48339849|NCT02592434|155438870|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
48663552|NCT03100539|156621227|FG002|Overall Study|Disinterest|22|||
48339850|NCT02592434|155438871|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
48339851|NCT02592434|155438869|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
48339852|NCT02592434|155438870|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
48339853|NCT02592434|155438871|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
48663553|NCT03100539|156621225|FG000|Overall Study|Veteran Health|0|||
48663554|NCT03100539|156621226|FG001|Overall Study|Veteran Health|0|||
48663555|NCT03100539|156621227|FG002|Overall Study|Veteran Health|8|||
48663556|NCT03100539|156621225|FG000|Overall Study|Moved|0|||
48663557|NCT03100539|156621226|FG001|Overall Study|Moved|0|||
48663558|NCT03100539|156621227|FG002|Overall Study|Moved|1|||
48663559|NCT03100539|156621225|FG000|Overall Study|Scheduling Conflicts|0|||
48663560|NCT03100539|156621226|FG001|Overall Study|Scheduling Conflicts|0|||
48663561|NCT03100539|156621227|FG002|Overall Study|Scheduling Conflicts|12|||
48663562|NCT04511702|156621228|FG000|Overall Study|Lost to Follow-up|3|||
48663563|NCT04511702|156621229|FG001|Overall Study|Lost to Follow-up|0|||
48663564|NCT04511702|156621230|FG002|Overall Study|Lost to Follow-up|4|||
48663565|NCT04511702|156621228|FG000|Overall Study|Withdrawal by Subject|17|||
48663566|NCT04511702|156621229|FG001|Overall Study|Withdrawal by Subject|1|||
48663567|NCT04511702|156621230|FG002|Overall Study|Withdrawal by Subject|8|||
48663568|NCT03356977|156621234|FG000|Overall Study|Lost to Follow-up|3|||
48663569|NCT03356977|156621234|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48663570|NCT01728077|156621239|FG000|Overall Study|Lack of Efficacy|3|||
48663571|NCT01728077|156621240|FG001|Overall Study|Lack of Efficacy|1|||
48663572|NCT01728077|156621239|FG000|Overall Study|Lost to Follow-up|1|||
48663573|NCT01728077|156621240|FG001|Overall Study|Lost to Follow-up|0|||
48663574|NCT01728077|156621239|FG000|Overall Study|Subject choice|2|||
48663575|NCT01728077|156621240|FG001|Overall Study|Subject choice|3|||
48663576|NCT01728077|156621239|FG000|Overall Study|Death|0|||
48339854|NCT02592434|155438869|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
48339855|NCT02592434|155438870|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
48339856|NCT02592434|155438871|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
48339857|NCT02379078|155438872|FG000|Overall Study|Lost to Follow-up|33|||
48339858|NCT02379078|155438873|FG001|Overall Study|Lost to Follow-up|30|||
48339859|NCT02379078|155438872|FG000|Overall Study|Withdrawal by Subject|6|||
48339860|NCT02379078|155438873|FG001|Overall Study|Withdrawal by Subject|5|||
48339861|NCT03794609|155438874|FG000|Overall Study|Other|10|||
48339862|NCT03794609|155438874|FG000|Overall Study|Withdrawal by Subject|66|||
48339863|NCT03794609|155438874|FG000|Overall Study|The child is enrolled in an interventional study|70|||
48663577|NCT01728077|156621240|FG001|Overall Study|Death|1|||
48663578|NCT01728077|156621239|FG000|Overall Study|Patient moving|1|||
48663579|NCT01728077|156621240|FG001|Overall Study|Patient moving|0|||
48663580|NCT01728077|156621239|FG000|Overall Study|Non compliance|1|||
48663581|NCT01728077|156621240|FG001|Overall Study|Non compliance|0|||
48663582|NCT00378599|156621244|FG000|Overall Study|Adverse Event|38|||
48663583|NCT00378599|156621244|FG000|Overall Study|Protocol Violation|2|||
48663584|NCT00378599|156621244|FG000|Overall Study|Treatment failure|7|||
48663585|NCT00378599|156621244|FG000|Overall Study|Withdrawal by Subject|5|||
48663586|NCT00489736|156621245|FG000|Overall Study|Lack of Efficacy|53|||
48663587|NCT00489736|156621246|FG001|Overall Study|Lack of Efficacy|14|||
48663588|NCT00489736|156621245|FG000|Overall Study|Adverse Event|32|||
48663589|NCT00489736|156621246|FG001|Overall Study|Adverse Event|45|||
48663590|NCT00489736|156621245|FG000|Overall Study|Poor compliance|6|||
48663591|NCT00489736|156621246|FG001|Overall Study|Poor compliance|2|||
48663592|NCT00489736|156621245|FG000|Overall Study|Not coded/ Not pre-specified|5|||
48663593|NCT00489736|156621246|FG001|Overall Study|Not coded/ Not pre-specified|8|||
48663594|NCT05368103|156621247|FG000|Overall Study|Withdrawal by Subject|4|||
48663595|NCT05368103|156621247|FG000|Overall Study|Lost to Follow-up|1|||
48663596|NCT05368103|156621247|FG000|Overall Study|Lack of Efficacy|3|||
48663597|NCT00320255|156621248|FG000|Overall Study|Lack of Efficacy|1|||
48663598|NCT00320255|156621249|FG001|Overall Study|Lack of Efficacy|0|||
48663599|NCT00320255|156621250|FG002|Overall Study|Lack of Efficacy|0|||
48663600|NCT00320255|156621251|FG003|Overall Study|Lack of Efficacy|0|||
48663601|NCT00320255|156621252|FG004|Overall Study|Lack of Efficacy|0|||
48663602|NCT00320255|156621253|FG005|Overall Study|Lack of Efficacy|0|||
48663603|NCT00320255|156621248|FG000|Overall Study|Adverse Event|5|||
48663604|NCT00320255|156621249|FG001|Overall Study|Adverse Event|2|||
48663605|NCT00320255|156621250|FG002|Overall Study|Adverse Event|3|||
48663606|NCT00320255|156621251|FG003|Overall Study|Adverse Event|2|||
48663607|NCT00320255|156621252|FG004|Overall Study|Adverse Event|0|||
48663608|NCT00320255|156621253|FG005|Overall Study|Adverse Event|0|||
48663609|NCT00320255|156621248|FG000|Overall Study|Withdrawal by Subject|1|||
48663610|NCT00320255|156621249|FG001|Overall Study|Withdrawal by Subject|2|||
48663611|NCT00320255|156621250|FG002|Overall Study|Withdrawal by Subject|2|||
48663612|NCT00320255|156621251|FG003|Overall Study|Withdrawal by Subject|4|||
48663613|NCT00320255|156621252|FG004|Overall Study|Withdrawal by Subject|0|||
48663614|NCT00320255|156621253|FG005|Overall Study|Withdrawal by Subject|0|||
48663615|NCT00320255|156621248|FG000|Overall Study|Poor compliance/noncompliance|1|||
48663616|NCT00320255|156621249|FG001|Overall Study|Poor compliance/noncompliance|1|||
48663617|NCT00320255|156621250|FG002|Overall Study|Poor compliance/noncompliance|0|||
48663618|NCT00320255|156621251|FG003|Overall Study|Poor compliance/noncompliance|1|||
48756504|NCT00180414|156956119|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
48756505|NCT03641651|156956124|FG000|Overall Study|organizational issues at one study site|1|||
48756506|NCT03010254|156956125|FG000|Overall Study|Adverse Event|0|||
48756507|NCT03010254|156956126|FG001|Overall Study|Adverse Event|1|||
48756508|NCT03010254|156956125|FG000|Overall Study|Lost to Follow-up|4|||
48756509|NCT03010254|156956126|FG001|Overall Study|Lost to Follow-up|0|||
48756510|NCT03010254|156956125|FG000|Overall Study|Withdrawal by Subject|1|||
48756511|NCT03010254|156956126|FG001|Overall Study|Withdrawal by Subject|1|||
48756512|NCT03010254|156956125|FG000|Overall Study|Other|2|||
48756513|NCT03010254|156956126|FG001|Overall Study|Other|3|||
48756514|NCT03909295|156956127|FG000|Overall Study|Adverse Event|2|||
48756515|NCT03909295|156956127|FG000|Overall Study|Study terminated by sponsor|50|||
48756516|NCT01702454|156956130|FG000|Overall Study|Consent withdrawal|0|||
48756517|NCT01702454|156956131|FG001|Overall Study|Consent withdrawal|1|||
48756518|NCT01702454|156956130|FG000|Overall Study|Migrated/moved from study area|0|||
48756519|NCT01702454|156956131|FG001|Overall Study|Migrated/moved from study area|1|||
48756520|NCT01702454|156956130|FG000|Overall Study|Lost to Follow-up|3|||
48756521|NCT01702454|156956131|FG001|Overall Study|Lost to Follow-up|6|||
48756522|NCT00710710|156956132|FG000|Overall Study|Consent withdrawn|2|||
48756523|NCT00710710|156956133|FG001|Overall Study|Consent withdrawn|2|||
48756524|NCT00710710|156956132|FG000|Overall Study|Protocol Violation|0|||
48756525|NCT00710710|156956133|FG001|Overall Study|Protocol Violation|1|||
48756526|NCT00710710|156956132|FG000|Overall Study|Adverse Event|3|||
48756527|NCT00710710|156956133|FG001|Overall Study|Adverse Event|3|||
48756528|NCT00710710|156956132|FG000|Overall Study|Progressive disease|40|||
48756529|NCT00710710|156956133|FG001|Overall Study|Progressive disease|38|||
48756530|NCT01313767|156956136|FG000|Overall Study|Adverse Event|1|||
48756531|NCT01313767|156956137|FG001|Overall Study|Adverse Event|0|||
48663619|NCT00320255|156621252|FG004|Overall Study|Poor compliance/noncompliance|0|||
48663620|NCT00320255|156621253|FG005|Overall Study|Poor compliance/noncompliance|0|||
48663621|NCT00320255|156621248|FG000|Overall Study|No longer meets study criteria|0|||
48663622|NCT00320255|156621249|FG001|Overall Study|No longer meets study criteria|0|||
48663623|NCT00320255|156621250|FG002|Overall Study|No longer meets study criteria|0|||
48663624|NCT00320255|156621251|FG003|Overall Study|No longer meets study criteria|1|||
48663625|NCT00320255|156621252|FG004|Overall Study|No longer meets study criteria|0|||
48663626|NCT00320255|156621253|FG005|Overall Study|No longer meets study criteria|0|||
48663627|NCT00320255|156621248|FG000|Overall Study|Other|3|||
48663628|NCT00320255|156621249|FG001|Overall Study|Other|2|||
48663629|NCT00320255|156621250|FG002|Overall Study|Other|1|||
48663630|NCT00320255|156621251|FG003|Overall Study|Other|0|||
48663631|NCT00320255|156621252|FG004|Overall Study|Other|0|||
48663632|NCT00320255|156621253|FG005|Overall Study|Other|0|||
48663633|NCT00543296|156621254|FG000|Overall Study|Physician Decision|7|||
48663634|NCT00367744|156621260|FG000|Overall Study|Lost to Follow-up|4|||
48663635|NCT00367744|156621261|FG001|Overall Study|Lost to Follow-up|5|||
48663636|NCT01703117|156621262|FG000|Overall Study|Adverse Event|4|||
48663637|NCT01703117|156621263|FG001|Overall Study|Adverse Event|3|||
48663638|NCT01703117|156621262|FG000|Overall Study|Withdrawal by Subject|0|||
48663639|NCT01703117|156621263|FG001|Overall Study|Withdrawal by Subject|1|||
48663640|NCT01340937|156621266|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
48663641|NCT01340937|156621267|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
48663642|NCT01340937|156621268|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
48663643|NCT01340937|156621269|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
48663644|NCT01340937|156621266|FG000|Period 1: Infant Series|Adverse Event|0|||
48663645|NCT01340937|156621267|FG001|Period 1: Infant Series|Adverse Event|1|||
48663646|NCT01340937|156621268|FG002|Period 1: Infant Series|Adverse Event|4|||
48663647|NCT01340937|156621269|FG003|Period 1: Infant Series|Adverse Event|0|||
48663648|NCT01340937|156621266|FG000|Period 1: Infant Series|Death|2|||
48663649|NCT01340937|156621267|FG001|Period 1: Infant Series|Death|0|||
48663650|NCT01340937|156621268|FG002|Period 1: Infant Series|Death|2|||
48663651|NCT01340937|156621269|FG003|Period 1: Infant Series|Death|0|||
48663652|NCT01340937|156621266|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
48663653|NCT01340937|156621267|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
48663654|NCT01340937|156621268|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
48663655|NCT01340937|156621269|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
48663656|NCT01340937|156621266|FG000|Period 1: Infant Series|Physician Decision|2|||
48663657|NCT01340937|156621267|FG001|Period 1: Infant Series|Physician Decision|3|||
48663658|NCT01340937|156621268|FG002|Period 1: Infant Series|Physician Decision|1|||
48663659|NCT01340937|156621269|FG003|Period 1: Infant Series|Physician Decision|0|||
48663660|NCT01340937|156621266|FG000|Period 1: Infant Series|Protocol Violation|1|||
48663661|NCT01340937|156621267|FG001|Period 1: Infant Series|Protocol Violation|4|||
48663662|NCT01340937|156621268|FG002|Period 1: Infant Series|Protocol Violation|4|||
48663663|NCT01340937|156621269|FG003|Period 1: Infant Series|Protocol Violation|3|||
48756532|NCT01313767|156956136|FG000|Overall Study|Lost to Follow-up|1|||
48756533|NCT01313767|156956137|FG001|Overall Study|Lost to Follow-up|0|||
48756534|NCT01313767|156956136|FG000|Overall Study|Withdrawal by Subject|2|||
48663664|NCT01340937|156621266|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
48663665|NCT01340937|156621267|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
48663666|NCT01340937|156621268|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
48663667|NCT01340937|156621269|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
48663668|NCT01340937|156621266|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
48756535|NCT01313767|156956137|FG001|Overall Study|Withdrawal by Subject|1|||
48756536|NCT01313767|156956136|FG000|Overall Study|Protocol Violation|3|||
48756537|NCT01313767|156956137|FG001|Overall Study|Protocol Violation|1|||
48339864|NCT03794609|155438874|FG000|Overall Study|Inclusion/exclusion criteria|8|||
48339865|NCT03794609|155438874|FG000|Overall Study|At sponsor's request|151|||
48339866|NCT03794609|155438874|FG000|Overall Study|Physician Decision|1|||
48756538|NCT02904512|156956138|FG000|Overall Study|Withdrawal by Subject|1|||
48756539|NCT02904512|156956139|FG001|Overall Study|Withdrawal by Subject|0|||
48756540|NCT02904512|156956138|FG000|Overall Study|Transferred to ICU|1|||
48756541|NCT02904512|156956139|FG001|Overall Study|Transferred to ICU|0|||
48756542|NCT02904512|156956138|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
48756543|NCT02904512|156956139|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
48756544|NCT02485301|156956140|FG000|Overall Study|Serious Adverse Events|2|||
48756545|NCT02485301|156956141|FG001|Overall Study|Serious Adverse Events|1|||
48756546|NCT02485301|156956140|FG000|Overall Study|Protocol Violation|0|||
48756547|NCT02485301|156956141|FG001|Overall Study|Protocol Violation|1|||
48756548|NCT02485301|156956140|FG000|Overall Study|Withdrawal by Subject|6|||
48756549|NCT02485301|156956141|FG001|Overall Study|Withdrawal by Subject|7|||
48756550|NCT02485301|156956140|FG000|Overall Study|Migrated/moved from study area|10|||
48756551|NCT02485301|156956141|FG001|Overall Study|Migrated/moved from study area|19|||
48756552|NCT02485301|156956140|FG000|Overall Study|Lost to Follow-up|17|||
48756553|NCT02485301|156956141|FG001|Overall Study|Lost to Follow-up|17|||
48756554|NCT02485301|156956140|FG000|Overall Study|Other|3|||
48756555|NCT02485301|156956141|FG001|Overall Study|Other|4|||
48756556|NCT02282020|156956142|FG000|Overall Study|Objective Disease Progression|128|||
48756557|NCT02282020|156956143|FG001|Overall Study|Objective Disease Progression|30|||
48756558|NCT02282020|156956142|FG000|Overall Study|Adverse Event|18|||
48756559|NCT02282020|156956143|FG001|Overall Study|Adverse Event|15|||
48756560|NCT02282020|156956142|FG000|Overall Study|Withdrawal by Subject|7|||
48756561|NCT02282020|156956143|FG001|Overall Study|Withdrawal by Subject|10|||
48756562|NCT02282020|156956142|FG000|Overall Study|Miscellaneous|5|||
48756563|NCT02282020|156956143|FG001|Overall Study|Miscellaneous|19|||
48756564|NCT02282020|156956142|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
48756565|NCT02282020|156956143|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
48756566|NCT02282020|156956142|FG000|Overall Study|Developed Discontinuation Criteria|0|||
48756567|NCT02282020|156956143|FG001|Overall Study|Developed Discontinuation Criteria|2|||
48756568|NCT02282020|156956142|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
48756569|NCT02282020|156956143|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
48756570|NCT00475176|156956144|FG000|Overall Study|Adverse Event|2|||
48756571|NCT00475176|156956144|FG000|Overall Study|Withdrawal by Subject|1|||
48756572|NCT00475176|156956144|FG000|Overall Study|Protocol Violation|1|||
48756573|NCT01594125|156956146|FG000|Overall Study|Withdrawal by Subject|1|||
48756574|NCT01594125|156956147|FG001|Overall Study|Withdrawal by Subject|0|||
48756575|NCT01594125|156956148|FG002|Overall Study|Withdrawal by Subject|0|||
48756576|NCT01594125|156956149|FG003|Overall Study|Withdrawal by Subject|1|||
48756577|NCT01594125|156956150|FG004|Overall Study|Withdrawal by Subject|0|||
48756578|NCT01594125|156956146|FG000|Overall Study|Progressive Disease|3|||
48339867|NCT03794609|155438874|FG000|Overall Study|Lost to Follow-up|5|||
48339868|NCT01323309|155438876|FG000|Overall Study|Death|9|||
48339869|NCT01323309|155438877|FG001|Overall Study|Death|15|||
48339870|NCT01323309|155438878|FG002|Overall Study|Death|5|||
48339871|NCT01323309|155438876|FG000|Overall Study|Lost to Follow-up|11|||
48339872|NCT01323309|155438877|FG001|Overall Study|Lost to Follow-up|14|||
48339873|NCT01323309|155438878|FG002|Overall Study|Lost to Follow-up|24|||
48339874|NCT01323309|155438876|FG000|Overall Study|Withdrawal by Subject|14|||
48663669|NCT01340937|156621267|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
48663670|NCT01340937|156621268|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
48663671|NCT01340937|156621269|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
48663672|NCT01340937|156621266|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
48756579|NCT01594125|156956147|FG001|Overall Study|Progressive Disease|12|||
48339875|NCT01323309|155438877|FG001|Overall Study|Withdrawal by Subject|14|||
48339876|NCT01323309|155438878|FG002|Overall Study|Withdrawal by Subject|18|||
48663673|NCT01340937|156621267|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
48756580|NCT01594125|156956148|FG002|Overall Study|Progressive Disease|3|||
48756581|NCT01594125|156956149|FG003|Overall Study|Progressive Disease|3|||
48756582|NCT01594125|156956150|FG004|Overall Study|Progressive Disease|7|||
48756583|NCT03635957|156956153|FG000|Run-In Period|Lost to Follow-up|1|||
48756584|NCT03635957|156956153|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
48756585|NCT01549392|156956154|FG000|Overall Study|Withdrawal by Subject|1|||
48339877|NCT01323309|155438876|FG000|Overall Study|Disease progression|5|||
48339878|NCT01323309|155438877|FG001|Overall Study|Disease progression|11|||
48756586|NCT01549392|156956155|FG001|Overall Study|Withdrawal by Subject|0|||
48756587|NCT00227903|156956157|FG000|Overall Study|Withdrawal by Subject|2|||
48756588|NCT00227903|156956158|FG001|Overall Study|Withdrawal by Subject|5|||
48756589|NCT00227903|156956157|FG000|Overall Study|Subject moved out of area|1|||
48756590|NCT00227903|156956158|FG001|Overall Study|Subject moved out of area|2|||
48756591|NCT00227903|156956157|FG000|Overall Study|Lost to Follow-up|1|||
48756592|NCT00227903|156956158|FG001|Overall Study|Lost to Follow-up|3|||
48756593|NCT00227903|156956157|FG000|Overall Study|Miscarriage|1|||
48756594|NCT00227903|156956158|FG001|Overall Study|Miscarriage|0|||
48756595|NCT01103284|156956159|FG000|Overall Study|Death|2|||
48756596|NCT01103284|156956160|FG001|Overall Study|Death|0|||
48756597|NCT01103284|156956159|FG000|Overall Study|Lost to Follow-up|9|||
48663674|NCT01340937|156621268|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
48663675|NCT01340937|156621269|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
48663676|NCT01340937|156621266|FG000|Period 2: Interim Period|Adverse Event|1|||
48663677|NCT01340937|156621267|FG001|Period 2: Interim Period|Adverse Event|0|||
48663678|NCT01340937|156621268|FG002|Period 2: Interim Period|Adverse Event|1|||
48663679|NCT01340937|156621269|FG003|Period 2: Interim Period|Adverse Event|0|||
48663680|NCT01340937|156621266|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
48663681|NCT01340937|156621267|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
48663682|NCT01340937|156621268|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
48663683|NCT01340937|156621269|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
48663684|NCT01340937|156621266|FG000|Period 2: Interim Period|Physician Decision|0|||
48663685|NCT01340937|156621267|FG001|Period 2: Interim Period|Physician Decision|1|||
48663686|NCT01340937|156621268|FG002|Period 2: Interim Period|Physician Decision|1|||
48663687|NCT01340937|156621269|FG003|Period 2: Interim Period|Physician Decision|0|||
48663688|NCT01340937|156621266|FG000|Period 2: Interim Period|Protocol Violation|5|||
48663689|NCT01340937|156621267|FG001|Period 2: Interim Period|Protocol Violation|3|||
48663690|NCT01340937|156621268|FG002|Period 2: Interim Period|Protocol Violation|6|||
48663691|NCT01340937|156621269|FG003|Period 2: Interim Period|Protocol Violation|3|||
48663692|NCT01340937|156621266|FG000|Period 2: Interim Period|Technical problems|4|||
48663693|NCT01340937|156621267|FG001|Period 2: Interim Period|Technical problems|4|||
48663694|NCT01340937|156621268|FG002|Period 2: Interim Period|Technical problems|6|||
48663695|NCT01340937|156621269|FG003|Period 2: Interim Period|Technical problems|3|||
48663696|NCT01340937|156621266|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
48663697|NCT01340937|156621267|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
48663698|NCT01340937|156621268|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
48663699|NCT01340937|156621269|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
48663700|NCT01340937|156621266|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
48663701|NCT01340937|156621267|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
48663702|NCT01340937|156621268|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
48663703|NCT01340937|156621269|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
48663704|NCT01340937|156621266|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
48663705|NCT01340937|156621267|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
48663706|NCT01340937|156621268|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
48663707|NCT01340937|156621269|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
48663708|NCT01340937|156621266|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
48756598|NCT01103284|156956160|FG001|Overall Study|Lost to Follow-up|10|||
48756599|NCT01103284|156956159|FG000|Overall Study|Pregnancy|3|||
48756600|NCT01103284|156956160|FG001|Overall Study|Pregnancy|1|||
48663709|NCT01340937|156621267|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
48756601|NCT01103284|156956159|FG000|Overall Study|Protocol Violation|12|||
48756602|NCT01103284|156956160|FG001|Overall Study|Protocol Violation|5|||
48756603|NCT01103284|156956159|FG000|Overall Study|Adverse Event|0|||
48339879|NCT01323309|155438878|FG002|Overall Study|Disease progression|4|||
48339880|NCT03048058|155438879|FG000|Overall Study|Lost to Follow-up|4|||
48339881|NCT03048058|155438880|FG001|Overall Study|Lost to Follow-up|0|||
48339882|NCT03048058|155438879|FG000|Overall Study|Withdrawal by Subject|0|||
48339883|NCT03048058|155438880|FG001|Overall Study|Withdrawal by Subject|4|||
48339884|NCT01622088|155438889|FG000|Overall Study|Adverse Event|20|||
48339885|NCT01622088|155438889|FG000|Overall Study|Lost to Follow-up|1|||
48339886|NCT01622088|155438889|FG000|Overall Study|Withdrawal by Subject|20|||
48339887|NCT01622088|155438889|FG000|Overall Study|Investigator Decision|1|||
48339888|NCT01622088|155438889|FG000|Overall Study|Death|53|||
48339889|NCT01622088|155438889|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
48339890|NCT04362176|155438891|FG000|Overall Study|Lost to Follow-up|5|||
48663710|NCT01340937|156621268|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
48663711|NCT01340937|156621269|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
48663712|NCT00794365|156621270|FG000|Overall Study|Lost to Follow-up|38|||
48663713|NCT00794365|156621270|FG000|Overall Study|Other|17|||
48663714|NCT00794365|156621270|FG000|Overall Study|Poor Compliance|11|||
48663715|NCT00794365|156621270|FG000|Overall Study|Adverse Event|10|||
48663716|NCT00794365|156621270|FG000|Overall Study|Lack of Efficacy|3|||
48663717|NCT04584346|156621277|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
48663718|NCT04584346|156621278|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
48663719|NCT03538444|156621279|FG000|Overall Study|opioid withdrawal|1|||
48663720|NCT03538444|156621280|FG001|Overall Study|opioid withdrawal|0|||
48663721|NCT00350623|156621283|FG000|Overall Study|Lost to Follow-up|8|||
48663722|NCT00350623|156621284|FG001|Overall Study|Lost to Follow-up|3|||
48663723|NCT00350623|156621285|FG002|Overall Study|Lost to Follow-up|4|||
48663724|NCT00350623|156621283|FG000|Overall Study|Withdrawal by Subject|0|||
48663725|NCT00350623|156621284|FG001|Overall Study|Withdrawal by Subject|1|||
48663726|NCT00350623|156621285|FG002|Overall Study|Withdrawal by Subject|1|||
48663727|NCT00350623|156621283|FG000|Overall Study|patient traveling outside the country|0|||
48663728|NCT00350623|156621284|FG001|Overall Study|patient traveling outside the country|0|||
48663729|NCT00350623|156621285|FG002|Overall Study|patient traveling outside the country|1|||
48663730|NCT01666119|156621290|FG000|Overall Study|Adverse Event|6|||
48663731|NCT01666119|156621290|FG000|Overall Study|Withdrawal by Subject|16|||
48663732|NCT01666119|156621290|FG000|Overall Study|Lost to Follow-up|7|||
48663733|NCT01666119|156621290|FG000|Overall Study|non compliance with study medication, pa|18|||
48663734|NCT01666119|156621290|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
48663735|NCT02437409|156621301|FG000|Overall Study|Withdrawal by Subject|3|||
48663736|NCT02437409|156621301|FG000|Overall Study|Screening failure|12|||
48663737|NCT01777542|156621302|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
48663738|NCT01777542|156621303|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
48663739|NCT01133626|156621304|FG000|Overall Study|Adverse Event|0|||
48663740|NCT01133626|156621305|FG001|Overall Study|Adverse Event|1|||
48663741|NCT01133626|156621306|FG002|Overall Study|Adverse Event|0|||
48663742|NCT01133626|156621304|FG000|Overall Study|Withdrawal by Subject|1|||
48663743|NCT01133626|156621305|FG001|Overall Study|Withdrawal by Subject|2|||
48663744|NCT01133626|156621306|FG002|Overall Study|Withdrawal by Subject|2|||
48663745|NCT01133626|156621304|FG000|Overall Study|Other|0|||
48663746|NCT01133626|156621305|FG001|Overall Study|Other|2|||
48663747|NCT01133626|156621306|FG002|Overall Study|Other|0|||
48663748|NCT00520013|156621309|FG000|Overall Study|Withdrawal by Subject|0|||
48663749|NCT00520013|156621310|FG001|Overall Study|Withdrawal by Subject|0|||
48663750|NCT00520013|156621311|FG002|Overall Study|Withdrawal by Subject|1|||
48663751|NCT00520013|156621309|FG000|Overall Study|Adverse Event|2|||
48663752|NCT00520013|156621310|FG001|Overall Study|Adverse Event|10|||
48663753|NCT00520013|156621311|FG002|Overall Study|Adverse Event|7|||
48756604|NCT01103284|156956160|FG001|Overall Study|Adverse Event|5|||
48756605|NCT01103284|156956159|FG000|Overall Study|Withdrawal by Subject|14|||
48756606|NCT01103284|156956160|FG001|Overall Study|Withdrawal by Subject|18|||
48756607|NCT01103284|156956159|FG000|Overall Study|Dermal Hypersensitivity|0|||
48756608|NCT01103284|156956160|FG001|Overall Study|Dermal Hypersensitivity|1|||
48756609|NCT01103284|156956159|FG000|Overall Study|Termination by the Sponsor|0|||
48756610|NCT01103284|156956160|FG001|Overall Study|Termination by the Sponsor|1|||
48756611|NCT01103284|156956159|FG000|Overall Study|Not described|2|||
48756612|NCT01103284|156956160|FG001|Overall Study|Not described|1|||
48756613|NCT01103284|156956159|FG000|Overall Study|Missing CRF entries for study completion|0|||
48663754|NCT00520013|156621309|FG000|Overall Study|Progressive Disease|7|||
48663755|NCT00520013|156621310|FG001|Overall Study|Progressive Disease|3|||
48663756|NCT00520013|156621311|FG002|Overall Study|Progressive Disease|0|||
48756614|NCT01103284|156956160|FG001|Overall Study|Missing CRF entries for study completion|2|||
48756615|NCT03226392|156956165|FG000|Overall Study|Protocol Deviation|1|||
48756616|NCT03226392|156956166|FG001|Overall Study|Protocol Deviation|0|||
48339891|NCT04362176|155438892|FG001|Overall Study|Lost to Follow-up|8|||
48339892|NCT04362176|155438891|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
48663757|NCT00520013|156621309|FG000|Overall Study|Clinical Progression|3|||
48663758|NCT00520013|156621310|FG001|Overall Study|Clinical Progression|1|||
48756617|NCT03226392|156956165|FG000|Overall Study|Physician Decision|1|||
48663759|NCT00520013|156621311|FG002|Overall Study|Clinical Progression|0|||
48663760|NCT00520013|156621309|FG000|Overall Study|Death|0|||
48663761|NCT00520013|156621310|FG001|Overall Study|Death|1|||
48663762|NCT00520013|156621311|FG002|Overall Study|Death|0|||
48663763|NCT00520013|156621309|FG000|Overall Study|Physician Decision|0|||
48663764|NCT00520013|156621310|FG001|Overall Study|Physician Decision|0|||
48663765|NCT00520013|156621311|FG002|Overall Study|Physician Decision|3|||
48663766|NCT02788201|156621312|FG000|Overall Study|Death|1|||
48663767|NCT02788201|156621313|FG001|Overall Study|Death|1|||
48663768|NCT02788201|156621314|FG002|Overall Study|Death|1|||
48663769|NCT02788201|156621315|FG003|Overall Study|Death|1|||
48663770|NCT02788201|156621316|FG004|Overall Study|Death|0|||
48663771|NCT02788201|156621317|FG005|Overall Study|Death|1|||
48663772|NCT02788201|156621312|FG000|Overall Study|Ineligible|0|||
48663773|NCT02788201|156621313|FG001|Overall Study|Ineligible|0|||
48663774|NCT02788201|156621314|FG002|Overall Study|Ineligible|0|||
48339893|NCT04362176|155438892|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
48339894|NCT05878522|155438898|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339895|NCT05878522|155438899|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339896|NCT05878522|155438900|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339897|NCT05878522|155438901|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339898|NCT05878522|155438902|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339899|NCT05878522|155438903|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339900|NCT05878522|155438904|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339901|NCT05878522|155438905|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339902|NCT05878522|155438906|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
48339903|NCT05878522|155438907|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339904|NCT05878522|155438908|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48339905|NCT05878522|155438909|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
48663775|NCT02788201|156621315|FG003|Overall Study|Ineligible|0|||
48663776|NCT02788201|156621316|FG004|Overall Study|Ineligible|0|||
48663777|NCT02788201|156621317|FG005|Overall Study|Ineligible|1|||
48663778|NCT02788201|156621312|FG000|Overall Study|Withdrawal by Subject|0|||
48663779|NCT02788201|156621313|FG001|Overall Study|Withdrawal by Subject|0|||
48663780|NCT02788201|156621314|FG002|Overall Study|Withdrawal by Subject|0|||
48663781|NCT02788201|156621315|FG003|Overall Study|Withdrawal by Subject|0|||
48663782|NCT02788201|156621316|FG004|Overall Study|Withdrawal by Subject|0|||
48663783|NCT02788201|156621317|FG005|Overall Study|Withdrawal by Subject|1|||
48663784|NCT00824005|156621318|FG000|Overall Study|Death|0|||
48663785|NCT00824005|156621319|FG001|Overall Study|Death|1|||
48663786|NCT00824005|156621318|FG000|Overall Study|Lost to Follow-up|0|||
48339906|NCT05878522|155438898|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
48339907|NCT05878522|155438899|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48339908|NCT05878522|155438900|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48339909|NCT05878522|155438901|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48339910|NCT05878522|155438902|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48663787|NCT00824005|156621319|FG001|Overall Study|Lost to Follow-up|1|||
48339911|NCT05878522|155438903|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48339912|NCT05878522|155438904|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48663788|NCT01510184|156621320|FG000|Overall Study|Sponsor discretion|28|||
48756618|NCT03226392|156956166|FG001|Overall Study|Physician Decision|0|||
48663789|NCT01510184|156621321|FG001|Overall Study|Sponsor discretion|28|||
48663790|NCT01510184|156621320|FG000|Overall Study|Death|1|||
48663791|NCT01510184|156621321|FG001|Overall Study|Death|2|||
48756619|NCT03226392|156956165|FG000|Overall Study|Lost to Follow-up|1|||
48756620|NCT03226392|156956166|FG001|Overall Study|Lost to Follow-up|0|||
48756621|NCT03226392|156956165|FG000|Overall Study|Adverse Event|1|||
48756622|NCT03226392|156956166|FG001|Overall Study|Adverse Event|0|||
48756623|NCT03226392|156956165|FG000|Overall Study|Technical Problems|0|||
48756624|NCT03226392|156956166|FG001|Overall Study|Technical Problems|2|||
48756625|NCT03226392|156956165|FG000|Overall Study|Subject/Guardian Decision|7|||
48756626|NCT03226392|156956166|FG001|Overall Study|Subject/Guardian Decision|6|||
48756627|NCT03414424|156956167|FG000|Overall Study|Screened out after consent|0|||
48756628|NCT03414424|156956168|FG001|Overall Study|Screened out after consent|2|||
48756629|NCT03414424|156956167|FG000|Overall Study|Lost to Follow-up|0|||
48663792|NCT01510184|156621320|FG000|Overall Study|Withdrawal by Subject|1|||
48663793|NCT01510184|156621321|FG001|Overall Study|Withdrawal by Subject|4|||
48663794|NCT01510184|156621320|FG000|Overall Study|Other|0|||
48663795|NCT01510184|156621321|FG001|Overall Study|Other|1|||
48756630|NCT03414424|156956168|FG001|Overall Study|Lost to Follow-up|1|||
48756631|NCT02728895|156956169|FG000|Overall Study|Other|1|||
48756632|NCT02728895|156956170|FG001|Overall Study|Other|2|||
48756633|NCT02728895|156956169|FG000|Overall Study|Withdrawal by Subject|0|||
48756634|NCT02728895|156956170|FG001|Overall Study|Withdrawal by Subject|3|||
48756635|NCT03527966|156956173|FG000|Overall Study|Lost to Follow-up|3|||
48756636|NCT03527966|156956174|FG001|Overall Study|Lost to Follow-up|0|||
48756637|NCT00937157|156956175|FG000|Overall Study|Pregnancy|1|||
48756638|NCT00937157|156956175|FG000|Overall Study|Lost to Follow-up|3|||
48756639|NCT03303079|156956176|FG000|Overall Study|Adverse Event|0|||
48756640|NCT03303079|156956177|FG001|Overall Study|Adverse Event|1|||
48756641|NCT03303079|156956178|FG002|Overall Study|Adverse Event|3|||
48756642|NCT03303079|156956176|FG000|Overall Study|Protocol Violation|5|||
48756643|NCT03303079|156956177|FG001|Overall Study|Protocol Violation|4|||
48756644|NCT03303079|156956178|FG002|Overall Study|Protocol Violation|7|||
48756645|NCT03303079|156956176|FG000|Overall Study|Withdrawal by Subject|2|||
48756646|NCT03303079|156956177|FG001|Overall Study|Withdrawal by Subject|4|||
48756647|NCT03303079|156956178|FG002|Overall Study|Withdrawal by Subject|2|||
48756648|NCT03303079|156956176|FG000|Overall Study|Other than specified|0|||
48756649|NCT03303079|156956177|FG001|Overall Study|Other than specified|2|||
48756650|NCT03303079|156956178|FG002|Overall Study|Other than specified|0|||
48756651|NCT01111149|156956179|FG000|Overall Study|Protocol Violation|1|||
48756652|NCT01111149|156956180|FG001|Overall Study|Protocol Violation|1|||
48663796|NCT01143051|156621322|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
48663797|NCT01143051|156621323|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
48663798|NCT01143051|156621324|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
48663799|NCT01143051|156621325|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
48663800|NCT01143051|156621326|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
48663801|NCT01143051|156621327|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
48663802|NCT01143051|156621322|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
48663803|NCT01143051|156621323|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
48663804|NCT01143051|156621324|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
48663805|NCT01143051|156621325|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
48663806|NCT01143051|156621326|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
48663807|NCT01143051|156621327|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
48663808|NCT02836873|156621328|FG000|Overall Study|Protocol Violation|0|||
48663809|NCT02836873|156621329|FG001|Overall Study|Protocol Violation|1|||
48663810|NCT02836873|156621328|FG000|Overall Study|Adverse Event|1|||
48663811|NCT02836873|156621329|FG001|Overall Study|Adverse Event|4|||
48663812|NCT02836873|156621328|FG000|Overall Study|Withdrawal by Subject|2|||
48663813|NCT02836873|156621329|FG001|Overall Study|Withdrawal by Subject|2|||
48663814|NCT02836873|156621328|FG000|Overall Study|Lost to Follow-up|1|||
48663815|NCT02836873|156621329|FG001|Overall Study|Lost to Follow-up|3|||
48663816|NCT02836873|156621328|FG000|Overall Study|Physician Decision|0|||
48663817|NCT02836873|156621329|FG001|Overall Study|Physician Decision|1|||
48663818|NCT02836873|156621328|FG000|Overall Study|Other|1|||
48663819|NCT02836873|156621329|FG001|Overall Study|Other|0|||
48663820|NCT02594098|156621334|FG000|Overall Study|Lack of Efficacy|17|||
48663821|NCT02594098|156621335|FG001|Overall Study|Lack of Efficacy|6|||
48756653|NCT01111149|156956181|FG002|Overall Study|Protocol Violation|2|||
48663822|NCT02594098|156621334|FG000|Overall Study|Withdrawal by Subject|1|||
48663823|NCT02594098|156621335|FG001|Overall Study|Withdrawal by Subject|3|||
48663824|NCT02594098|156621334|FG000|Overall Study|Terminated participation|6|||
48663825|NCT02594098|156621335|FG001|Overall Study|Terminated participation|2|||
48663826|NCT02594098|156621334|FG000|Overall Study|Seek alternative treatment|2|||
48663827|NCT02594098|156621335|FG001|Overall Study|Seek alternative treatment|1|||
48663828|NCT02594098|156621334|FG000|Overall Study|Other|0|||
48663829|NCT02594098|156621335|FG001|Overall Study|Other|1|||
48663830|NCT01996592|156621336|FG000|Overall Study|no response to text/no diary entry|32|||
48663831|NCT01996592|156621336|FG000|Overall Study|change in surgical date|4|||
48663832|NCT01996592|156621336|FG000|Overall Study|Withdrawal by Subject|5|||
48663833|NCT01996592|156621336|FG000|Overall Study|change in mode of delivery|4|||
48663834|NCT03532932|156621337|FG000|Overall Study|Protocol Deviation|33|||
48663835|NCT03532932|156621338|FG001|Overall Study|Protocol Deviation|31|||
48663836|NCT03532932|156621337|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
48339913|NCT05878522|155438905|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48339914|NCT05878522|155438906|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48663837|NCT03532932|156621338|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
48663838|NCT03532932|156621337|FG000|Overall Study|Withdrawal by Subject|2|||
48663839|NCT03532932|156621338|FG001|Overall Study|Withdrawal by Subject|0|||
48663840|NCT03532932|156621337|FG000|Overall Study|Lost to Follow-up|15|||
48663841|NCT03532932|156621338|FG001|Overall Study|Lost to Follow-up|9|||
48339915|NCT05878522|155438907|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
48663842|NCT03532932|156621337|FG000|Overall Study|Adverse Event|4|||
48663843|NCT03532932|156621338|FG001|Overall Study|Adverse Event|3|||
48663844|NCT03532932|156621337|FG000|Overall Study|Death|0|||
48663845|NCT03532932|156621338|FG001|Overall Study|Death|2|||
48663846|NCT03532932|156621337|FG000|Overall Study|Other|11|||
48663847|NCT03532932|156621338|FG001|Overall Study|Other|16|||
48663848|NCT02255565|156621339|FG000|Overall Study|Withdrawal by Subject|0|||
48663849|NCT02255565|156621340|FG001|Overall Study|Withdrawal by Subject|1|||
48663850|NCT02255565|156621341|FG002|Overall Study|Withdrawal by Subject|0|||
48663851|NCT01344629|156621348|FG000|Crossover Period 2|Withdrawal by Subject|0|||
48663852|NCT01344629|156621349|FG001|Crossover Period 2|Withdrawal by Subject|1|||
48663853|NCT02782325|156621353|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
48663854|NCT02782325|156621354|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
48663855|NCT02782325|156621355|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
48663856|NCT02782325|156621353|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
48663857|NCT02782325|156621354|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
48663858|NCT02782325|156621355|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
48663859|NCT02242981|156621373|FG000|Overall Study|Withdrawal by Subject|1|||
48663860|NCT00303446|156623142|FG000|Overall Study|Withdrawal by Subject|2|||
48663861|NCT00303446|156623143|FG001|Overall Study|Withdrawal by Subject|2|||
48663862|NCT00303446|156623142|FG000|Overall Study|Death|0|||
48663863|NCT00303446|156623143|FG001|Overall Study|Death|1|||
48663864|NCT00303446|156623142|FG000|Overall Study|Physician Decision|0|||
48663865|NCT00303446|156623143|FG001|Overall Study|Physician Decision|1|||
48663866|NCT03002818|156623144|FG000|Overall Study|Decision of the investigator|1|||
48663867|NCT01739933|156623151|FG000|Overall Study|Death|89|||
48663868|NCT01739933|156623152|FG001|Overall Study|Death|86|||
48663869|NCT01739933|156623151|FG000|Overall Study|Withdrawal by Subject|10|||
48756654|NCT01111149|156956179|FG000|Overall Study|Withdrawal by Subject|1|||
48756655|NCT01111149|156956180|FG001|Overall Study|Withdrawal by Subject|0|||
48756656|NCT01111149|156956181|FG002|Overall Study|Withdrawal by Subject|2|||
48756657|NCT01110707|156956182|FG000|Overall Study|Protocol Violation|0|||
48756658|NCT01110707|156956183|FG001|Overall Study|Protocol Violation|3|||
48756659|NCT01998633|156956184|FG000|Overall Study|Death|1|||
48756660|NCT03315208|156956185|FG000|Overall Study|Lost to Follow-up|11|||
48756661|NCT03315208|156956186|FG001|Overall Study|Lost to Follow-up|6|||
48756662|NCT03315208|156956185|FG000|Overall Study|Withdrawal by Subject|2|||
48756663|NCT03315208|156956186|FG001|Overall Study|Withdrawal by Subject|0|||
48756664|NCT02746874|156956190|FG000|Overall Study|Withdrawal by Subject|0|||
48756665|NCT02746874|156956191|FG001|Overall Study|Withdrawal by Subject|1|||
48756666|NCT02746874|156956190|FG000|Overall Study|Surgery Date Changed|0|||
48756667|NCT02746874|156956191|FG001|Overall Study|Surgery Date Changed|2|||
48756668|NCT02255981|156956192|FG000|Overall Study|Lost to Follow-up|3|||
48756669|NCT02255981|156956192|FG000|Overall Study|Withdrawal by Subject|1|||
48756670|NCT02278263|156956196|FG000|Overall Study|Protocol Violation|7|||
48756671|NCT02278263|156956197|FG001|Overall Study|Protocol Violation|0|||
48756672|NCT02278263|156956198|FG002|Overall Study|Protocol Violation|9|||
48756673|NCT00022633|156956199|FG000|Overall Study|Adverse Event|11|||
48756674|NCT00022633|156956200|FG001|Overall Study|Adverse Event|1|||
48756675|NCT00022633|156956199|FG000|Overall Study|Refusal unrelated to adverse event|1|||
48756676|NCT00022633|156956200|FG001|Overall Study|Refusal unrelated to adverse event|0|||
48756677|NCT00022633|156956199|FG000|Overall Study|Progression/relapse|9|||
48663870|NCT01739933|156623152|FG001|Overall Study|Withdrawal by Subject|8|||
48663871|NCT01739933|156623151|FG000|Overall Study|Lost to Follow-up|3|||
48663872|NCT01739933|156623152|FG001|Overall Study|Lost to Follow-up|10|||
48663873|NCT01739933|156623151|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
48663874|NCT01739933|156623152|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
48663875|NCT02251717|156623153|FG000|Overall Study|Adverse Event|0|||
48663876|NCT02251717|156623154|FG001|Overall Study|Adverse Event|1|||
48663877|NCT02251717|156623153|FG000|Overall Study|Withdrew Consent|1|||
48663878|NCT02251717|156623154|FG001|Overall Study|Withdrew Consent|0|||
48663879|NCT02688088|156623159|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
48663880|NCT02688088|156623160|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
48663881|NCT02688088|156623161|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
48663882|NCT02688088|156623162|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
48663883|NCT02688088|156623163|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
48663884|NCT02688088|156623159|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
48663885|NCT02688088|156623160|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
48663886|NCT02688088|156623161|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
48756678|NCT00022633|156956200|FG001|Overall Study|Progression/relapse|2|||
48756679|NCT00022633|156956199|FG000|Overall Study|Death|4|||
48663887|NCT02688088|156623162|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
48663888|NCT02688088|156623163|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
48663889|NCT02688088|156623159|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
48756680|NCT00022633|156956200|FG001|Overall Study|Death|0|||
48756681|NCT00022633|156956199|FG000|Overall Study|Other - not protocol specified|3|||
48756682|NCT00022633|156956200|FG001|Overall Study|Other - not protocol specified|2|||
48756683|NCT00022633|156956199|FG000|Overall Study|Ineligible|4|||
48663890|NCT02688088|156623160|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
48663891|NCT02688088|156623161|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
48663892|NCT02688088|156623162|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
48663893|NCT02688088|156623163|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
48663894|NCT02688088|156623159|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
48663895|NCT02688088|156623160|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
48756684|NCT00022633|156956200|FG001|Overall Study|Ineligible|0|||
48756685|NCT00674661|156956205|FG000|Overall Study|Other|5|||
48756686|NCT00674661|156956206|FG001|Overall Study|Other|7|||
48756687|NCT00674661|156956205|FG000|Overall Study|Lost to Follow-up|6|||
48756688|NCT00674661|156956206|FG001|Overall Study|Lost to Follow-up|3|||
48756689|NCT00674661|156956205|FG000|Overall Study|Withdrawal by Subject|0|||
48756690|NCT00674661|156956206|FG001|Overall Study|Withdrawal by Subject|5|||
48756691|NCT02410954|156956212|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
48756692|NCT02410954|156956213|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
48756693|NCT02410954|156956212|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
48756694|NCT02410954|156956213|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
48756695|NCT02452398|156956217|FG000|Overall Study|Adverse Event|1|||
48756696|NCT02452398|156956217|FG000|Overall Study|Lost to Follow-up|28|||
48663896|NCT02688088|156623161|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
48663897|NCT02688088|156623162|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
48663898|NCT02688088|156623163|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
48663899|NCT02688088|156623159|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
48663900|NCT02688088|156623160|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
48663901|NCT02688088|156623161|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
48663902|NCT02688088|156623162|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
48663903|NCT02688088|156623163|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
48663904|NCT02688088|156623159|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
48663905|NCT02688088|156623160|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
48663906|NCT02688088|156623161|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
48663907|NCT02688088|156623162|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
48663908|NCT02688088|156623163|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
48663909|NCT02688088|156623159|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
48663910|NCT02688088|156623160|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
48663911|NCT02688088|156623161|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
48663912|NCT02688088|156623162|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
48663913|NCT02688088|156623163|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
48663914|NCT02688088|156623159|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
48663915|NCT02688088|156623160|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
48663916|NCT02688088|156623161|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
48663917|NCT02688088|156623162|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
48663918|NCT02688088|156623163|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
48663919|NCT02688088|156623159|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
48663920|NCT02688088|156623160|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
48663921|NCT02688088|156623161|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
48663922|NCT02688088|156623162|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
48663923|NCT02688088|156623163|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
48756697|NCT02452398|156956217|FG000|Overall Study|Physician Decision|2|||
48756698|NCT02452398|156956217|FG000|Overall Study|Withdrawal by Subject|6|||
48756699|NCT02452398|156956217|FG000|Overall Study|Moved away|4|||
48756700|NCT01333059|156956218|FG000|Overall Study|Physician Decision|3|||
48756701|NCT01333059|156956219|FG001|Overall Study|Physician Decision|3|||
48756702|NCT01333059|156956218|FG000|Overall Study|Protocol Violation|3|||
48756703|NCT01333059|156956219|FG001|Overall Study|Protocol Violation|0|||
48756704|NCT00450333|156956220|FG000|Overall Study|Study terminated|47|||
48756705|NCT00450333|156956221|FG001|Overall Study|Study terminated|54|||
48756706|NCT00450333|156956222|FG002|Overall Study|Study terminated|16|||
48756707|NCT00450333|156956223|FG003|Overall Study|Study terminated|21|||
48339916|NCT05878522|155438908|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48339917|NCT05878522|155438909|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
48663924|NCT04021524|156623169|FG000|Overall Study|Change in surgical intervention|0|||
48663925|NCT04021524|156623170|FG001|Overall Study|Change in surgical intervention|1|||
48663926|NCT01921218|156623171|FG000|Overall Study|Death|2|||
48756708|NCT00450333|156956220|FG000|Overall Study|Adverse Event|1|||
48756709|NCT00450333|156956221|FG001|Overall Study|Adverse Event|7|||
48756710|NCT00450333|156956222|FG002|Overall Study|Adverse Event|2|||
48756711|NCT00450333|156956223|FG003|Overall Study|Adverse Event|2|||
48756712|NCT00450333|156956220|FG000|Overall Study|Protocol Violation|1|||
48756713|NCT00450333|156956221|FG001|Overall Study|Protocol Violation|0|||
48756714|NCT00450333|156956222|FG002|Overall Study|Protocol Violation|1|||
48756715|NCT00450333|156956223|FG003|Overall Study|Protocol Violation|0|||
48756716|NCT00450333|156956220|FG000|Overall Study|Withdrawal by Subject|1|||
48756717|NCT00450333|156956221|FG001|Overall Study|Withdrawal by Subject|0|||
48756718|NCT00450333|156956222|FG002|Overall Study|Withdrawal by Subject|3|||
48756719|NCT00450333|156956223|FG003|Overall Study|Withdrawal by Subject|0|||
48756720|NCT00450333|156956220|FG000|Overall Study|Kidney transplant|1|||
48756721|NCT00450333|156956221|FG001|Overall Study|Kidney transplant|0|||
48756722|NCT00450333|156956222|FG002|Overall Study|Kidney transplant|1|||
48756723|NCT00450333|156956223|FG003|Overall Study|Kidney transplant|3|||
48756724|NCT00450333|156956220|FG000|Overall Study|Death|3|||
48756725|NCT00450333|156956221|FG001|Overall Study|Death|2|||
48756726|NCT00450333|156956222|FG002|Overall Study|Death|2|||
48339918|NCT05878522|155438898|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339919|NCT05878522|155438899|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
48663927|NCT01921218|156623172|FG001|Overall Study|Death|1|||
48663928|NCT01921218|156623171|FG000|Overall Study|Withdrawal by Subject|0|||
48339920|NCT05878522|155438900|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339921|NCT05878522|155438901|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
48339922|NCT05878522|155438902|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339923|NCT05878522|155438903|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339924|NCT05878522|155438904|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339925|NCT05878522|155438905|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339926|NCT05878522|155438906|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339927|NCT05878522|155438907|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339928|NCT05878522|155438908|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48339929|NCT05878522|155438909|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
48663929|NCT01921218|156623172|FG001|Overall Study|Withdrawal by Subject|2|||
48339930|NCT05878522|155438898|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339931|NCT05878522|155438899|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339932|NCT05878522|155438900|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339933|NCT05878522|155438901|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339934|NCT05878522|155438902|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
48339935|NCT05878522|155438903|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339936|NCT05878522|155438904|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339937|NCT05878522|155438905|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339938|NCT05878522|155438906|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339939|NCT05878522|155438907|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339940|NCT05878522|155438908|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339941|NCT05878522|155438909|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
48339942|NCT03861078|155438910|FG000|Overall Study|COVID-19 shut down|4|||
48339943|NCT03861078|155438910|FG000|Overall Study|Lost to Follow-up|1|||
48339944|NCT03861078|155438910|FG000|Overall Study|Protocol Violation|2|||
48339945|NCT03861078|155438910|FG000|Overall Study|lack of venous access|1|||
48339946|NCT00975130|155438911|FG000|Study Part 1|Adverse Event|150|||
48339947|NCT00975130|155438912|FG001|Study Part 1|Adverse Event|0|||
48339948|NCT00975130|155438913|FG002|Study Part 1|Adverse Event|0|||
48339949|NCT00975130|155438911|FG000|Study Part 1|Lost to Follow-up|19|||
48339950|NCT00975130|155438912|FG001|Study Part 1|Lost to Follow-up|0|||
48339951|NCT00975130|155438913|FG002|Study Part 1|Lost to Follow-up|0|||
48339952|NCT00975130|155438911|FG000|Study Part 1|Withdrawal by Subject|61|||
48339953|NCT00975130|155438912|FG001|Study Part 1|Withdrawal by Subject|0|||
48339954|NCT00975130|155438913|FG002|Study Part 1|Withdrawal by Subject|0|||
48339955|NCT00975130|155438911|FG000|Study Part 1|Protocol Violation|13|||
48339956|NCT00975130|155438912|FG001|Study Part 1|Protocol Violation|0|||
48339957|NCT00975130|155438913|FG002|Study Part 1|Protocol Violation|0|||
48339958|NCT00975130|155438911|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
48339959|NCT00975130|155438912|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
48663930|NCT01921218|156623171|FG000|Overall Study|Kidney transplant|1|||
48663931|NCT01921218|156623172|FG001|Overall Study|Kidney transplant|1|||
48756727|NCT00450333|156956223|FG003|Overall Study|Death|2|||
48756728|NCT03473808|156956227|FG000|Overall Study|Withdrawal by Subject|1|||
48756729|NCT04814433|156956231|FG000|Overall Study|Survey not returned|4|||
48756730|NCT04814433|156956232|FG001|Overall Study|Survey not returned|8|||
48756731|NCT04814433|156956233|FG002|Overall Study|Survey not returned|4|||
48756732|NCT04814433|156956234|FG003|Overall Study|Survey not returned|5|||
48756733|NCT00513474|156956235|FG000|Overall Study|Death|6|||
48756734|NCT00513474|156956236|FG001|Overall Study|Death|9|||
48339960|NCT00975130|155438913|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
48339961|NCT00975130|155438911|FG000|Study Part 1|Administrative|4|||
48339962|NCT00975130|155438912|FG001|Study Part 1|Administrative|0|||
48339963|NCT00975130|155438913|FG002|Study Part 1|Administrative|0|||
48663932|NCT00354107|156623173|FG000|Overall Study|Adverse Event|2|||
48663933|NCT00354107|156623173|FG000|Overall Study|Physician Decision|2|||
48663934|NCT00354107|156623173|FG000|Overall Study|Withdrawal by Subject|1|||
48663935|NCT02838901|156623181|FG000|Overall Study|Withdrawal by Subject|1|||
48339964|NCT00975130|155438911|FG000|Study Part 1|Withdrew Consent|24|||
48339965|NCT00975130|155438912|FG001|Study Part 1|Withdrew Consent|0|||
48339966|NCT00975130|155438913|FG002|Study Part 1|Withdrew Consent|0|||
48339967|NCT00975130|155438911|FG000|Study Part 2|Adverse Event|0|||
48339968|NCT00975130|155438912|FG001|Study Part 2|Adverse Event|14|||
48339969|NCT00975130|155438913|FG002|Study Part 2|Adverse Event|7|||
48339970|NCT00975130|155438911|FG000|Study Part 2|Lost to Follow-up|0|||
48339971|NCT00975130|155438912|FG001|Study Part 2|Lost to Follow-up|0|||
48339972|NCT00975130|155438913|FG002|Study Part 2|Lost to Follow-up|1|||
48339973|NCT00975130|155438911|FG000|Study Part 2|Withdrawal by Subject|0|||
48339974|NCT00975130|155438912|FG001|Study Part 2|Withdrawal by Subject|13|||
48339975|NCT00975130|155438913|FG002|Study Part 2|Withdrawal by Subject|5|||
48339976|NCT00975130|155438911|FG000|Study Part 2|Withdrew Consent|0|||
48339977|NCT00975130|155438912|FG001|Study Part 2|Withdrew Consent|6|||
48339978|NCT00975130|155438913|FG002|Study Part 2|Withdrew Consent|2|||
48339979|NCT00975130|155438911|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
48663936|NCT02838901|156623182|FG001|Overall Study|Withdrawal by Subject|1|||
48663937|NCT02838901|156623181|FG000|Overall Study|Lost to Follow-up|1|||
48663938|NCT02838901|156623182|FG001|Overall Study|Lost to Follow-up|1|||
48663939|NCT00076336|156623183|FG000|Overall Study|Death|13|||
48663940|NCT00076336|156623184|FG001|Overall Study|Death|17|||
48663941|NCT00076336|156623183|FG000|Overall Study|Adverse Event|4|||
48663942|NCT00076336|156623184|FG001|Overall Study|Adverse Event|4|||
48663943|NCT00076336|156623183|FG000|Overall Study|Lost to Follow-up|4|||
48663944|NCT00076336|156623184|FG001|Overall Study|Lost to Follow-up|4|||
48663945|NCT00076336|156623183|FG000|Overall Study|Non-Compliance|2|||
48663946|NCT00076336|156623184|FG001|Overall Study|Non-Compliance|0|||
48663947|NCT00076336|156623183|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
48663948|NCT00076336|156623184|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
48663949|NCT00076336|156623183|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
48663950|NCT00076336|156623184|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
48663951|NCT00076336|156623183|FG000|Overall Study|Liver Transplantation|3|||
48663952|NCT00076336|156623184|FG001|Overall Study|Liver Transplantation|3|||
48663953|NCT00076336|156623183|FG000|Overall Study|Virologic Breakthrough|14|||
48663954|NCT00076336|156623184|FG001|Overall Study|Virologic Breakthrough|16|||
48663955|NCT00076336|156623183|FG000|Overall Study|Treatment failure|4|||
48663956|NCT00076336|156623184|FG001|Overall Study|Treatment failure|5|||
48663957|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
48663958|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
48663959|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
48663960|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
48663961|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
48663962|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
48663963|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
48663964|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
48663965|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
48663966|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
48663967|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Other|1|||
48663968|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Other|1|||
48663969|NCT02075047|156623185|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
48663970|NCT02075047|156623186|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
48663971|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
48663972|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
48663973|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
48663974|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
48663975|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
48663976|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
48663977|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
48663978|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
48663979|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
48663980|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
48663981|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Other|1|||
48663982|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Other|2|||
48663983|NCT02075047|156623185|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
48663984|NCT02075047|156623186|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
48663985|NCT01156389|156623189|FG000|Overall Study|Elevated liver enzymes|4|||
48663986|NCT01156389|156623190|FG001|Overall Study|Elevated liver enzymes|0|||
48663987|NCT01156389|156623189|FG000|Overall Study|Vomiting|0|||
48663988|NCT01156389|156623190|FG001|Overall Study|Vomiting|1|||
48663989|NCT04126564|156623191|FG000|Overall Study|Withdrawal by Subject|0|||
48663990|NCT04126564|156623192|FG001|Overall Study|Withdrawal by Subject|2|||
48339980|NCT00975130|155438912|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
48339981|NCT00975130|155438913|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
48339982|NCT00975130|155438911|FG000|Study Part 2|Administrative|0|||
48756735|NCT00513474|156956235|FG000|Overall Study|Participant Withdrew Consent|1|||
48756736|NCT00513474|156956236|FG001|Overall Study|Participant Withdrew Consent|0|||
48756737|NCT01686633|156956237|FG000|Overall Study|Lack of Efficacy|33|||
48756738|NCT01686633|156956238|FG001|Overall Study|Lack of Efficacy|13|||
48756739|NCT01686633|156956239|FG002|Overall Study|Lack of Efficacy|11|||
48756740|NCT01686633|156956237|FG000|Overall Study|Withdrawal by Subject|8|||
48756741|NCT01686633|156956238|FG001|Overall Study|Withdrawal by Subject|8|||
48756742|NCT01686633|156956239|FG002|Overall Study|Withdrawal by Subject|5|||
48756743|NCT01686633|156956237|FG000|Overall Study|Physician Decision|3|||
48756744|NCT01686633|156956238|FG001|Overall Study|Physician Decision|4|||
48756745|NCT01686633|156956239|FG002|Overall Study|Physician Decision|4|||
48756746|NCT01686633|156956237|FG000|Overall Study|Adverse Event|4|||
48756747|NCT01686633|156956238|FG001|Overall Study|Adverse Event|3|||
48756748|NCT01686633|156956239|FG002|Overall Study|Adverse Event|3|||
48756749|NCT01686633|156956237|FG000|Overall Study|Protocol Violation|2|||
48756750|NCT01686633|156956238|FG001|Overall Study|Protocol Violation|3|||
48756751|NCT01686633|156956239|FG002|Overall Study|Protocol Violation|0|||
48756752|NCT01686633|156956237|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
48756753|NCT01686633|156956238|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
48756754|NCT01686633|156956239|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
48756755|NCT01686633|156956237|FG000|Overall Study|Lost to Follow-up|0|||
48756756|NCT01686633|156956238|FG001|Overall Study|Lost to Follow-up|1|||
48756757|NCT01686633|156956239|FG002|Overall Study|Lost to Follow-up|1|||
48756758|NCT02045797|156956240|FG000|Overall Study|Adverse Event|3|||
48756759|NCT02045797|156956241|FG001|Overall Study|Adverse Event|1|||
48756760|NCT02045797|156956242|FG002|Overall Study|Adverse Event|0|||
48756761|NCT02045797|156956240|FG000|Overall Study|Lack of Efficacy|1|||
48756762|NCT02045797|156956241|FG001|Overall Study|Lack of Efficacy|0|||
48756763|NCT02045797|156956242|FG002|Overall Study|Lack of Efficacy|0|||
48756764|NCT02045797|156956240|FG000|Overall Study|Lost to Follow-up|2|||
48756765|NCT02045797|156956241|FG001|Overall Study|Lost to Follow-up|3|||
48756766|NCT02045797|156956242|FG002|Overall Study|Lost to Follow-up|1|||
48756767|NCT02045797|156956240|FG000|Overall Study|Physician Decision|0|||
48756768|NCT02045797|156956241|FG001|Overall Study|Physician Decision|1|||
48756769|NCT02045797|156956242|FG002|Overall Study|Physician Decision|0|||
48756770|NCT02045797|156956240|FG000|Overall Study|Withdrawal by Subject|1|||
48756771|NCT02045797|156956241|FG001|Overall Study|Withdrawal by Subject|2|||
48756772|NCT02045797|156956242|FG002|Overall Study|Withdrawal by Subject|0|||
48756773|NCT02738151|156956243|FG000|Overall Study|Randomized but not treated|4|||
48756774|NCT02738151|156956244|FG001|Overall Study|Randomized but not treated|1|||
48756775|NCT02738151|156956243|FG000|Overall Study|Adverse Event|4|||
48756776|NCT02738151|156956244|FG001|Overall Study|Adverse Event|5|||
48756777|NCT02738151|156956243|FG000|Overall Study|Hypoglycemia|0|||
48756778|NCT02738151|156956244|FG001|Overall Study|Hypoglycemia|1|||
48756779|NCT02738151|156956243|FG000|Overall Study|Poor Compliance to Protocol|4|||
48756780|NCT02738151|156956244|FG001|Overall Study|Poor Compliance to Protocol|3|||
48756781|NCT02738151|156956243|FG000|Overall Study|Other than specified above|11|||
48756782|NCT02738151|156956244|FG001|Overall Study|Other than specified above|21|||
48756783|NCT03649711|156956245|FG000|Overall Study|Adverse Event|0|||
48756784|NCT03649711|156956246|FG001|Overall Study|Adverse Event|1|||
48756785|NCT03649711|156956247|FG002|Overall Study|Adverse Event|0|||
48756786|NCT03649711|156956245|FG000|Overall Study|Kidney Transplant|1|||
48756787|NCT03649711|156956246|FG001|Overall Study|Kidney Transplant|0|||
48663991|NCT04126564|156623191|FG000|Overall Study|Lost to Follow-up|0|||
48663992|NCT04126564|156623192|FG001|Overall Study|Lost to Follow-up|1|||
48663993|NCT00445848|156623193|FG000|Overall Study|Adverse Event|14|||
48663994|NCT00445848|156623193|FG000|Overall Study|Withdrawal by Subject|4|||
48663995|NCT00445848|156623193|FG000|Overall Study|Progression|62|||
48663996|NCT00445848|156623193|FG000|Overall Study|Other-Not protocol specified|5|||
48663997|NCT01920893|156623194|FG000|Overall Study|Adverse Event|5|||
48663998|NCT01920893|156623195|FG001|Overall Study|Adverse Event|2|||
48663999|NCT01920893|156623194|FG000|Overall Study|Lack of Efficacy|2|||
48664000|NCT01920893|156623195|FG001|Overall Study|Lack of Efficacy|0|||
48664001|NCT00159913|156623196|FG000|Overall Study|Adverse Event|1|||
48756788|NCT03649711|156956247|FG002|Overall Study|Kidney Transplant|0|||
48756789|NCT01988103|156958101|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
48756790|NCT01988103|156958102|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
48756791|NCT01988103|156958103|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
48756792|NCT01988103|156958104|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
48756793|NCT01988103|156958105|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
48756794|NCT01988103|156958101|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
48756795|NCT01988103|156958102|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
48756796|NCT01988103|156958103|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
48664002|NCT00159913|156623197|FG001|Overall Study|Adverse Event|0|||
48756797|NCT01988103|156958104|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
48756798|NCT01988103|156958105|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
48664003|NCT00159913|156623198|FG002|Overall Study|Adverse Event|1|||
48664004|NCT00159913|156623199|FG003|Overall Study|Adverse Event|0|||
48664005|NCT00159913|156623196|FG000|Overall Study|Withdrawal by Subject|0|||
48664006|NCT00159913|156623197|FG001|Overall Study|Withdrawal by Subject|0|||
48756799|NCT01988103|156958101|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
48756800|NCT01988103|156958102|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
48756801|NCT01988103|156958103|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
48756802|NCT01988103|156958104|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
48756803|NCT01988103|156958105|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
48756804|NCT01988103|156958101|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
48756805|NCT01988103|156958102|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
48756806|NCT01988103|156958103|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
48756807|NCT01988103|156958104|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
48756808|NCT01988103|156958105|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
48756809|NCT01988103|156958101|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
48756810|NCT01988103|156958102|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
48756811|NCT01988103|156958103|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
48756812|NCT01988103|156958104|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
48756813|NCT01988103|156958105|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
48756814|NCT01988103|156958101|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
48756815|NCT01988103|156958102|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
48756816|NCT01988103|156958103|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
48756817|NCT01988103|156958104|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
48756818|NCT01988103|156958105|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
48756819|NCT01988103|156958101|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
48756820|NCT01988103|156958102|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
48756821|NCT01988103|156958103|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
48756822|NCT01988103|156958104|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
48756823|NCT01988103|156958105|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
48756824|NCT04166435|156958106|FG000|Overall Study|2 patients ineligible for response|2|||
48756825|NCT00267046|156958107|FG000|Overall Study|Disease progression|4|||
48756826|NCT00267046|156958108|FG001|Overall Study|Disease progression|2|||
48756827|NCT00267046|156958107|FG000|Overall Study|Chemotoxicity|2|||
48756828|NCT00267046|156958108|FG001|Overall Study|Chemotoxicity|0|||
48756829|NCT00267046|156958107|FG000|Overall Study|Open-label palifermin|2|||
48756830|NCT00267046|156958108|FG001|Overall Study|Open-label palifermin|7|||
48756831|NCT00267046|156958107|FG000|Overall Study|Surgery|3|||
48756832|NCT00267046|156958108|FG001|Overall Study|Surgery|1|||
48756833|NCT00267046|156958107|FG000|Overall Study|Withdrawal by Subject|1|||
48756834|NCT00267046|156958108|FG001|Overall Study|Withdrawal by Subject|0|||
48756835|NCT00267046|156958107|FG000|Overall Study|Radiation|0|||
48756836|NCT00267046|156958108|FG001|Overall Study|Radiation|1|||
48756837|NCT02066233|156958111|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
48756838|NCT02066233|156958112|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
48756839|NCT00103142|156958113|FG000|Overall Study|Adverse Event|1|||
48664007|NCT00159913|156623198|FG002|Overall Study|Withdrawal by Subject|0|||
48664008|NCT00159913|156623199|FG003|Overall Study|Withdrawal by Subject|1|||
48664009|NCT00159913|156623196|FG000|Overall Study|Lost to Follow-up|0|||
48756840|NCT00103142|156958114|FG001|Overall Study|Adverse Event|0|||
48756841|NCT00103142|156958113|FG000|Overall Study|Progression of disease|2|||
48756842|NCT00103142|156958114|FG001|Overall Study|Progression of disease|1|||
48664010|NCT00159913|156623197|FG001|Overall Study|Lost to Follow-up|0|||
48664011|NCT00159913|156623198|FG002|Overall Study|Lost to Follow-up|0|||
48664012|NCT00159913|156623199|FG003|Overall Study|Lost to Follow-up|1|||
48756843|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Death|3|||
48756844|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Death|2|||
48756845|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Death|4|||
48756846|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Death|3|||
48756847|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Death|0|||
48756848|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Death|0|||
48756849|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
48756850|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
48756851|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
48756852|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
48756853|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
48756854|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
48756855|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
48756856|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756857|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756858|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756859|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756860|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
48756861|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
48756862|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
48756863|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
48756864|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
48756865|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
48756866|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
48756867|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
48756868|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
48664013|NCT00159913|156623196|FG000|Overall Study|Protocol Violation|1|||
48664014|NCT00159913|156623197|FG001|Overall Study|Protocol Violation|0|||
48664015|NCT00159913|156623198|FG002|Overall Study|Protocol Violation|1|||
48664016|NCT00159913|156623199|FG003|Overall Study|Protocol Violation|0|||
48664017|NCT01081301|156623200|FG000|Overall Study|Bereaved|3|||
48664018|NCT01081301|156623200|FG000|Overall Study|Too busy|5|||
48664019|NCT01081301|156623200|FG000|Overall Study|Patient too ill|2|||
48664020|NCT01081301|156623200|FG000|Overall Study|Lost to Follow-up|4|||
48664021|NCT01765426|156623201|FG000|Overall Study|Lost to Follow-up|0|||
48664022|NCT01765426|156623202|FG001|Overall Study|Lost to Follow-up|1|||
48756869|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
48339983|NCT00975130|155438912|FG001|Study Part 2|Administrative|1|||
48339984|NCT00975130|155438913|FG002|Study Part 2|Administrative|0|||
48339985|NCT00975130|155438911|FG000|Study Part 2|Protocol Violation|0|||
48339986|NCT00975130|155438912|FG001|Study Part 2|Protocol Violation|0|||
48339987|NCT00975130|155438913|FG002|Study Part 2|Protocol Violation|1|||
48339988|NCT00240097|155438914|FG000|Part I|Adverse Event|1|||
48339989|NCT00240097|155438914|FG000|Part I|Death|1|||
48339990|NCT00240097|155438914|FG000|Part I|histology|1|||
48339991|NCT00240097|155438914|FG000|Part I|unevaluable|1|||
48339992|NCT00240097|155438914|FG000|Part II|did not continue from Part I|23|||
48339993|NCT03613454|155438915|FG000|Overall Study|Protocol Violation|1|||
48339994|NCT03613454|155438916|FG001|Overall Study|Protocol Violation|0|||
48664023|NCT01765426|156623203|FG002|Overall Study|Lost to Follow-up|0|||
48664024|NCT01765426|156623204|FG003|Overall Study|Lost to Follow-up|0|||
48664025|NCT00989235|156623205|FG000|Overall Study|Death|0|||
48664026|NCT00989235|156623206|FG001|Overall Study|Death|1|||
48664027|NCT00989235|156623205|FG000|Overall Study|Adverse Event|0|||
48664028|NCT00989235|156623206|FG001|Overall Study|Adverse Event|1|||
48664029|NCT00989235|156623205|FG000|Overall Study|Lack of Efficacy|1|||
48664030|NCT00989235|156623206|FG001|Overall Study|Lack of Efficacy|0|||
48664031|NCT00989235|156623205|FG000|Overall Study|Withdrawal of Consent|1|||
48664032|NCT00989235|156623206|FG001|Overall Study|Withdrawal of Consent|1|||
48664033|NCT00989235|156623205|FG000|Overall Study|Desire to Become Pregnant|1|||
48664034|NCT00989235|156623206|FG001|Overall Study|Desire to Become Pregnant|0|||
48664035|NCT00989235|156623205|FG000|Overall Study|Randomized by Mistake|0|||
48664036|NCT00989235|156623206|FG001|Overall Study|Randomized by Mistake|2|||
48664037|NCT00989235|156623205|FG000|Overall Study|Lost to Follow-up|0|||
48339995|NCT03613454|155438915|FG000|Overall Study|Protocol Violation|0|||
48664038|NCT00989235|156623206|FG001|Overall Study|Lost to Follow-up|1|||
48664039|NCT00545532|156623207|FG000|Overall Study|Withdrawal by Subject|1|||
48664040|NCT00545532|156623208|FG001|Overall Study|Withdrawal by Subject|3|||
48664041|NCT00545532|156623207|FG000|Overall Study|Lost to Follow-up|5|||
48664042|NCT00545532|156623208|FG001|Overall Study|Lost to Follow-up|6|||
48339996|NCT03613454|155438916|FG001|Overall Study|Protocol Violation|1|||
48339997|NCT01332318|155438920|FG000|Overall Study|Adverse Event|0|||
48339998|NCT01332318|155438921|FG001|Overall Study|Adverse Event|3|||
48664043|NCT00545532|156623207|FG000|Overall Study|Death|0|||
48664044|NCT00545532|156623208|FG001|Overall Study|Death|1|||
48664045|NCT02680574|156623214|FG000|Overall Study|Death|137|||
48756870|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
48756871|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
48756872|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
48756873|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
48756874|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
48756875|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
48756876|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
48756877|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
48756878|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
48756879|NCT02432846|156958115|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48756880|NCT02432846|156958116|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48756881|NCT02432846|156958117|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
48756882|NCT02432846|156958118|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48339999|NCT01332318|155438922|FG002|Overall Study|Adverse Event|0|||
48340000|NCT01332318|155438923|FG003|Overall Study|Adverse Event|0|||
48340001|NCT01332318|155438920|FG000|Overall Study|Withdrawal by Subject|1|||
48340002|NCT01332318|155438921|FG001|Overall Study|Withdrawal by Subject|1|||
48340003|NCT01332318|155438922|FG002|Overall Study|Withdrawal by Subject|0|||
48340004|NCT01332318|155438923|FG003|Overall Study|Withdrawal by Subject|1|||
48340005|NCT01332318|155438920|FG000|Overall Study|Protocol Violation|1|||
48340006|NCT01332318|155438921|FG001|Overall Study|Protocol Violation|0|||
48340007|NCT01332318|155438922|FG002|Overall Study|Protocol Violation|1|||
48340008|NCT01332318|155438923|FG003|Overall Study|Protocol Violation|1|||
48340009|NCT01721759|155438924|FG000|Treatment Period|Disease Progression|85|||
48756883|NCT02432846|156958119|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48756884|NCT02432846|156958120|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
48340010|NCT01721759|155438924|FG000|Treatment Period|Study drug toxicity|14|||
48340011|NCT01721759|155438924|FG000|Treatment Period|Death|1|||
48340012|NCT01721759|155438924|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
48340013|NCT01721759|155438924|FG000|Treatment Period|Participant request to withdraw|3|||
48340014|NCT01721759|155438924|FG000|Treatment Period|Other Reasons|3|||
48340015|NCT01721759|155438924|FG000|End of Study Period|Participant Withdrew Consent|5|||
48340016|NCT01721759|155438924|FG000|End of Study Period|Death|101|||
48340017|NCT01721759|155438924|FG000|End of Study Period|Lost to Follow-up|1|||
48664046|NCT02680574|156623215|FG001|Overall Study|Death|137|||
48664047|NCT02680574|156623214|FG000|Overall Study|Withdrawal by Subject|17|||
48664048|NCT02680574|156623215|FG001|Overall Study|Withdrawal by Subject|9|||
48664049|NCT02680574|156623214|FG000|Overall Study|Lost to Follow-up|4|||
48664050|NCT02680574|156623215|FG001|Overall Study|Lost to Follow-up|6|||
48664051|NCT01514240|156623216|FG000|Overall Study|Adverse Event|4|||
48664052|NCT01514240|156623217|FG001|Overall Study|Adverse Event|4|||
48664053|NCT01514240|156623216|FG000|Overall Study|Subject Decision|2|||
48664054|NCT01514240|156623217|FG001|Overall Study|Subject Decision|7|||
48664055|NCT01286987|156623222|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
48664056|NCT01286987|156623223|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
48664057|NCT01286987|156623224|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
48664058|NCT01286987|156623225|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
48664059|NCT01286987|156623226|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
48664060|NCT01286987|156623227|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
48664061|NCT01286987|156623228|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
48340018|NCT01721759|155438924|FG000|End of Study Period|Other Reasons|10|||
48340019|NCT00464737|155438925|FG000|Overall Study|Adverse Event|12|||
48340020|NCT00464737|155438926|FG001|Overall Study|Adverse Event|17|||
48340021|NCT00464737|155438927|FG002|Overall Study|Adverse Event|33|||
48756885|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
48756886|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
48340022|NCT00464737|155438925|FG000|Overall Study|Lack of Efficacy|7|||
48340023|NCT00464737|155438926|FG001|Overall Study|Lack of Efficacy|7|||
48340024|NCT00464737|155438927|FG002|Overall Study|Lack of Efficacy|4|||
48340025|NCT00464737|155438925|FG000|Overall Study|Withdrawal by Subject|5|||
48340026|NCT00464737|155438926|FG001|Overall Study|Withdrawal by Subject|3|||
48340027|NCT00464737|155438927|FG002|Overall Study|Withdrawal by Subject|5|||
48340028|NCT00464737|155438925|FG000|Overall Study|Protocol Violation|1|||
48664062|NCT01286987|156623229|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
48664063|NCT01286987|156623230|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
48340029|NCT00464737|155438926|FG001|Overall Study|Protocol Violation|1|||
48664064|NCT01286987|156623231|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
48664065|NCT01286987|156623232|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
48340030|NCT00464737|155438927|FG002|Overall Study|Protocol Violation|5|||
48340031|NCT00464737|155438925|FG000|Overall Study|Non-compliance|0|||
48340032|NCT00464737|155438926|FG001|Overall Study|Non-compliance|1|||
48340033|NCT00464737|155438927|FG002|Overall Study|Non-compliance|1|||
48340034|NCT00464737|155438925|FG000|Overall Study|Lost to Follow-up|5|||
48340035|NCT00464737|155438926|FG001|Overall Study|Lost to Follow-up|2|||
48664066|NCT01286987|156623233|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
48664067|NCT01286987|156623234|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
48664068|NCT01286987|156623235|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
48664069|NCT01286987|156623236|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
48664070|NCT01286987|156623222|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
48664071|NCT01286987|156623223|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
48664072|NCT01286987|156623224|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
48664073|NCT01286987|156623225|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
48756887|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
48756888|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
48756889|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
48756890|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
48664074|NCT01286987|156623226|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
48664075|NCT01286987|156623227|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
48664076|NCT01286987|156623228|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
48664077|NCT01286987|156623229|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
48664078|NCT01286987|156623230|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
48664079|NCT01286987|156623231|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
48664080|NCT01286987|156623232|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
48664081|NCT01286987|156623233|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
48664082|NCT01286987|156623234|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
48340036|NCT00464737|155438927|FG002|Overall Study|Lost to Follow-up|5|||
48340037|NCT00464737|155438925|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
48340038|NCT00464737|155438926|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
48340039|NCT00464737|155438927|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
48340040|NCT00464737|155438925|FG000|Overall Study|Other: Subject left town; family illness|1|||
48340041|NCT00464737|155438926|FG001|Overall Study|Other: Subject left town; family illness|0|||
48340042|NCT00464737|155438927|FG002|Overall Study|Other: Subject left town; family illness|0|||
48340043|NCT00464737|155438925|FG000|Overall Study|Other: Study demands too great|0|||
48340044|NCT00464737|155438926|FG001|Overall Study|Other: Study demands too great|1|||
48340045|NCT00464737|155438927|FG002|Overall Study|Other: Study demands too great|0|||
48340046|NCT00464737|155438925|FG000|Overall Study|Other: Personal family reasons|0|||
48340047|NCT00464737|155438926|FG001|Overall Study|Other: Personal family reasons|0|||
48340048|NCT00464737|155438927|FG002|Overall Study|Other: Personal family reasons|1|||
48340049|NCT00464737|155438925|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
48340050|NCT00464737|155438926|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
48340051|NCT00464737|155438927|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
48340052|NCT00580047|155438928|FG000|Overall Study|Lost to Follow-up|1|||
48340053|NCT00580047|155438929|FG001|Overall Study|Lost to Follow-up|1|||
48340054|NCT00580047|155438930|FG002|Overall Study|Lost to Follow-up|0|||
48340055|NCT00580047|155438928|FG000|Overall Study|Withdrawal by Subject|1|||
48664083|NCT01286987|156623235|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
48664084|NCT01286987|156623236|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
48756891|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
48756892|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
48340056|NCT00580047|155438929|FG001|Overall Study|Withdrawal by Subject|1|||
48340057|NCT00580047|155438930|FG002|Overall Study|Withdrawal by Subject|2|||
48340058|NCT00580047|155438928|FG000|Overall Study|Withdrawal by Subject|1|||
48340059|NCT00580047|155438929|FG001|Overall Study|Withdrawal by Subject|0|||
48340060|NCT00580047|155438930|FG002|Overall Study|Withdrawal by Subject|0|||
48340061|NCT02820298|155438931|FG000|Overall Study|Withdrawal by Subject|0|||
48664085|NCT01286987|156623222|FG000|Part 1: Dose Escalation|Physician Decision|0|||
48664086|NCT01286987|156623223|FG001|Part 1: Dose Escalation|Physician Decision|0|||
48340062|NCT02820298|155438932|FG001|Overall Study|Withdrawal by Subject|1|||
48664087|NCT01286987|156623224|FG002|Part 1: Dose Escalation|Physician Decision|0|||
48664088|NCT01286987|156623225|FG003|Part 1: Dose Escalation|Physician Decision|0|||
48664089|NCT01286987|156623226|FG004|Part 1: Dose Escalation|Physician Decision|1|||
48664090|NCT01286987|156623227|FG005|Part 1: Dose Escalation|Physician Decision|0|||
48664091|NCT01286987|156623228|FG006|Part 1: Dose Escalation|Physician Decision|0|||
48664092|NCT01286987|156623229|FG007|Part 1: Dose Escalation|Physician Decision|0|||
48664093|NCT01286987|156623230|FG008|Part 1: Dose Escalation|Physician Decision|0|||
48664094|NCT01286987|156623231|FG009|Part 1: Dose Escalation|Physician Decision|0|||
48664095|NCT01286987|156623232|FG010|Part 1: Dose Escalation|Physician Decision|0|||
48664096|NCT01286987|156623233|FG011|Part 1: Dose Escalation|Physician Decision|0|||
48340063|NCT02820298|155438931|FG000|Overall Study|Physician Decision|1|||
48664097|NCT01286987|156623234|FG012|Part 1: Dose Escalation|Physician Decision|0|||
48664098|NCT01286987|156623235|FG013|Part 1: Dose Escalation|Physician Decision|0|||
48664099|NCT01286987|156623236|FG014|Part 1: Dose Escalation|Physician Decision|0|||
48664100|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Death|0|||
48664101|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Death|0|||
48664102|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Death|0|||
48664103|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Death|0|||
48664104|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Death|0|||
48664105|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Death|0|||
48664106|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Death|0|||
48664107|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Death|0|||
48664108|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Death|0|||
48664109|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Death|0|||
48664110|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Death|0|||
48664111|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Death|0|||
48664112|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Death|1|||
48756893|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
48756894|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
48664113|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Death|1|||
48664114|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Death|0|||
48756895|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
48340064|NCT02820298|155438932|FG001|Overall Study|Physician Decision|0|||
48340065|NCT02820298|155438931|FG000|Overall Study|Protocol Violation|0|||
48340066|NCT02820298|155438932|FG001|Overall Study|Protocol Violation|1|||
48340067|NCT00702520|155438933|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
48340068|NCT00702520|155438934|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
48340069|NCT00702520|155438935|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
48756896|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
48340070|NCT00702520|155438936|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
48340071|NCT00702520|155438933|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
48664115|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Physician Decision|0|||
48664116|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Physician Decision|0|||
48664117|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Physician Decision|0|||
48664118|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Physician Decision|0|||
48664119|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Physician Decision|0|||
48664120|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Physician Decision|0|||
48664121|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Physician Decision|0|||
48664122|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Physician Decision|0|||
48664123|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Physician Decision|0|||
48756897|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756898|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756899|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756900|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756901|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
48756902|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
48756903|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
48756904|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
48756905|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
48756906|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
48340072|NCT00702520|155438934|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
48340073|NCT00702520|155438935|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
48340074|NCT00702520|155438936|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
48340075|NCT00702520|155438933|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
48340076|NCT00702520|155438934|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
48340077|NCT00702520|155438935|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
48340078|NCT00702520|155438936|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
48340079|NCT02188784|155438937|FG000|Overall Study|Death|3|||
48340080|NCT02188784|155438938|FG001|Overall Study|Death|1|||
48340081|NCT02188784|155438937|FG000|Overall Study|Lost to Follow-up|1|||
48340082|NCT02188784|155438938|FG001|Overall Study|Lost to Follow-up|0|||
48340083|NCT02188784|155438937|FG000|Overall Study|Withdrawal by Subject|3|||
48340084|NCT02188784|155438938|FG001|Overall Study|Withdrawal by Subject|9|||
48340085|NCT02188784|155438937|FG000|Overall Study|Physician Decision|2|||
48340086|NCT02188784|155438938|FG001|Overall Study|Physician Decision|3|||
48756907|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
48756908|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
48340087|NCT05041439|155438939|FG000|Overall Study|Withdrawal by Subject|1|||
48340088|NCT05041439|155438940|FG001|Overall Study|Withdrawal by Subject|1|||
48340089|NCT05041439|155438939|FG000|Overall Study|Death|1|||
48756909|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
48340090|NCT05041439|155438940|FG001|Overall Study|Death|0|||
48340091|NCT04295499|155438941|FG000|Overall Study|moving out of state|1|||
48340092|NCT04295499|155438942|FG001|Overall Study|moving out of state|0|||
48664124|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Physician Decision|0|||
48664125|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Physician Decision|1|||
48664126|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Physician Decision|1|||
48664127|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Physician Decision|0|||
48664128|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Physician Decision|1|||
48664129|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Physician Decision|0|||
48664130|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Other|0|||
48664131|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Other|0|||
48664132|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Other|0|||
48664133|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Other|0|||
48664134|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Other|0|||
48664135|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Other|0|||
48664136|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Other|0|||
48664137|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Other|0|||
48664138|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Other|0|||
48664139|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Other|0|||
48664140|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Other|0|||
48664141|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Other|0|||
48664142|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Other|0|||
48664143|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Other|1|||
48664144|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Other|0|||
48664145|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
48664146|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
48340093|NCT04295499|155438941|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
48340094|NCT04295499|155438942|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
48340095|NCT01021683|155438946|FG000|Overall Study|Lack of Efficacy|12|||
48340096|NCT01021683|155438946|FG000|Overall Study|Recovery of neutrophil count|51|||
48340097|NCT01021683|155438946|FG000|Overall Study|Other|8|||
48340098|NCT01374971|155438949|FG000|Overall Study|Withdrawal by Subject|1|||
48340099|NCT01876823|155438956|FG000|Overall Study|Withdrawal by Subject|5|||
48340100|NCT01876823|155438956|FG000|Overall Study|Physician Decision|2|||
48340101|NCT01876823|155438956|FG000|Overall Study|Patients moved|2|||
48340102|NCT02965599|155438959|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
48340103|NCT02965599|155438960|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
48340104|NCT00170950|155438961|FG000|Overall Study|Death|236|||
48340105|NCT00170950|155438962|FG001|Overall Study|Death|274|||
48340106|NCT00170950|155438961|FG000|Overall Study|Withdrawal by Subject|496|||
48340107|NCT00170950|155438962|FG001|Overall Study|Withdrawal by Subject|498|||
48340108|NCT00170950|155438961|FG000|Overall Study|Lost to Follow-up|134|||
48340109|NCT00170950|155438962|FG001|Overall Study|Lost to Follow-up|115|||
48340110|NCT00170950|155438961|FG000|Overall Study|Missing|2|||
48340111|NCT00170950|155438962|FG001|Overall Study|Missing|1|||
48340112|NCT00170950|155438961|FG000|Overall Study|Termination Data Not Recorded|17|||
48340113|NCT00170950|155438962|FG001|Overall Study|Termination Data Not Recorded|22|||
48340114|NCT05294328|155438967|FG000|Overall Study|Adverse Event|1|||
48340115|NCT05294328|155438968|FG001|Overall Study|Adverse Event|0|||
48340116|NCT05294328|155438969|FG002|Overall Study|Adverse Event|0|||
48340117|NCT05294328|155438967|FG000|Overall Study|Physician Decision|1|||
48340118|NCT05294328|155438968|FG001|Overall Study|Physician Decision|1|||
48340119|NCT05294328|155438969|FG002|Overall Study|Physician Decision|0|||
48340120|NCT05294328|155438967|FG000|Overall Study|Withdrawal by Subject|0|||
48340121|NCT05294328|155438968|FG001|Overall Study|Withdrawal by Subject|2|||
48340122|NCT05294328|155438969|FG002|Overall Study|Withdrawal by Subject|1|||
48340123|NCT05294328|155438967|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
48340124|NCT05294328|155438968|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
48340125|NCT05294328|155438969|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
48340126|NCT00489489|155440457|FG000|Overall Study|Not treated due to protocol violation|0|||
48340127|NCT00489489|155440458|FG001|Overall Study|Not treated due to protocol violation|1|||
48340128|NCT00489489|155440459|FG002|Overall Study|Not treated due to protocol violation|1|||
48340129|NCT00489489|155440457|FG000|Overall Study|Adverse Event|1|||
48340130|NCT00489489|155440458|FG001|Overall Study|Adverse Event|1|||
48664147|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
48664148|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
48664149|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
48664150|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
48664151|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
48664152|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
48756910|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
48756911|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
48756912|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
48756913|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
48756914|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
48756915|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
48756916|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
48756917|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
48340131|NCT00489489|155440459|FG002|Overall Study|Adverse Event|1|||
48340132|NCT00489489|155440457|FG000|Overall Study|Protocol Violation|1|||
48340133|NCT00489489|155440458|FG001|Overall Study|Protocol Violation|0|||
48340134|NCT00489489|155440459|FG002|Overall Study|Protocol Violation|1|||
48340135|NCT00489489|155440457|FG000|Overall Study|Progressive disease|0|||
48340136|NCT00489489|155440458|FG001|Overall Study|Progressive disease|1|||
48340137|NCT00489489|155440459|FG002|Overall Study|Progressive disease|0|||
48664153|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
48664154|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
48664155|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
48664156|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
48664157|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
48664158|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
48664159|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
48664160|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
48664161|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
48664162|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
48664163|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
48664164|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
48664165|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
48664166|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
48664167|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
48664168|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
48664169|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
48664170|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
48664171|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
48664172|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
48340138|NCT00489489|155440457|FG000|Overall Study|Participant did not wish to continue|1|||
48340139|NCT00489489|155440458|FG001|Overall Study|Participant did not wish to continue|1|||
48340140|NCT00489489|155440459|FG002|Overall Study|Participant did not wish to continue|0|||
48340141|NCT00489489|155440457|FG000|Overall Study|Other than above|0|||
48340142|NCT00489489|155440458|FG001|Overall Study|Other than above|1|||
48340143|NCT00489489|155440459|FG002|Overall Study|Other than above|0|||
48340144|NCT05066230|155440460|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
48340145|NCT05066230|155440461|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
48340146|NCT05066230|155440460|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
48340147|NCT05066230|155440461|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
48340148|NCT05066230|155440460|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
48340149|NCT05066230|155440461|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
48340150|NCT05066230|155440460|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
48340151|NCT05066230|155440461|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
48664173|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
48664174|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
48664175|NCT01286987|156623222|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664176|NCT01286987|156623223|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664177|NCT01286987|156623224|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664178|NCT01286987|156623225|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664179|NCT01286987|156623226|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664180|NCT01286987|156623227|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664181|NCT01286987|156623228|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664182|NCT01286987|156623229|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664183|NCT01286987|156623230|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664184|NCT01286987|156623231|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664185|NCT01286987|156623232|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
48664186|NCT01286987|156623233|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664187|NCT01286987|156623234|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664188|NCT01286987|156623235|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664189|NCT01286987|156623236|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
48664190|NCT02961790|156623239|FG000|Overall Study|Canceled|4|||
48664191|NCT02961790|156623240|FG001|Overall Study|Canceled|5|||
48664192|NCT02961790|156623241|FG002|Overall Study|Canceled|1|||
48664193|NCT02961790|156623242|FG003|Overall Study|Canceled|4|||
48664194|NCT02961790|156623239|FG000|Overall Study|without baseline data|4|||
48664195|NCT02961790|156623240|FG001|Overall Study|without baseline data|0|||
48664196|NCT02961790|156623241|FG002|Overall Study|without baseline data|1|||
48664197|NCT02961790|156623242|FG003|Overall Study|without baseline data|0|||
48664198|NCT02961790|156623239|FG000|Overall Study|without post baseline data|7|||
48664199|NCT02961790|156623240|FG001|Overall Study|without post baseline data|6|||
48664200|NCT02961790|156623241|FG002|Overall Study|without post baseline data|4|||
48664201|NCT02961790|156623242|FG003|Overall Study|without post baseline data|1|||
48664202|NCT00711802|156623246|FG000|Overall Study|Not treated (no further detail)|2|||
48664203|NCT00711802|156623247|FG001|Overall Study|Not treated (no further detail)|1|||
48664204|NCT00711802|156623248|FG002|Overall Study|Not treated (no further detail)|2|||
48664205|NCT00711802|156623249|FG003|Overall Study|Not treated (no further detail)|0|||
48664206|NCT00711802|156623250|FG004|Overall Study|Not treated (no further detail)|2|||
48664207|NCT00711802|156623251|FG005|Overall Study|Not treated (no further detail)|0|||
48664208|NCT00711802|156623252|FG006|Overall Study|Not treated (no further detail)|0|||
48664209|NCT00711802|156623253|FG007|Overall Study|Not treated (no further detail)|0|||
48664210|NCT00711802|156623246|FG000|Overall Study|Adverse Event|0|||
48664211|NCT00711802|156623247|FG001|Overall Study|Adverse Event|0|||
48664212|NCT00711802|156623248|FG002|Overall Study|Adverse Event|0|||
48664213|NCT00711802|156623249|FG003|Overall Study|Adverse Event|0|||
48664214|NCT00711802|156623250|FG004|Overall Study|Adverse Event|1|||
48664215|NCT00711802|156623251|FG005|Overall Study|Adverse Event|1|||
48664216|NCT00711802|156623252|FG006|Overall Study|Adverse Event|0|||
48664217|NCT00711802|156623253|FG007|Overall Study|Adverse Event|0|||
48664218|NCT00711802|156623246|FG000|Overall Study|Microbiological failure|0|||
48664219|NCT00711802|156623247|FG001|Overall Study|Microbiological failure|1|||
48664220|NCT00711802|156623248|FG002|Overall Study|Microbiological failure|0|||
48664221|NCT00711802|156623249|FG003|Overall Study|Microbiological failure|0|||
48664222|NCT00711802|156623250|FG004|Overall Study|Microbiological failure|0|||
48756918|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
48756919|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
48756920|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
48340152|NCT05066230|155440460|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
48340153|NCT05066230|155440461|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
48340154|NCT05066230|155440460|FG000|After Week 48|Adverse Event|1|||
48340155|NCT05066230|155440461|FG001|After Week 48|Adverse Event|0|||
48340156|NCT05066230|155440460|FG000|After Week 48|Non-compliance with study schedule|1|||
48340157|NCT05066230|155440461|FG001|After Week 48|Non-compliance with study schedule|0|||
48340158|NCT05066230|155440460|FG000|After Week 48|Withdrawal by Subject|0|||
48340159|NCT05066230|155440461|FG001|After Week 48|Withdrawal by Subject|1|||
48340160|NCT05066230|155440460|FG000|After Week 48|Lost to Follow-up|3|||
48340161|NCT05066230|155440461|FG001|After Week 48|Lost to Follow-up|3|||
48340162|NCT05066230|155440460|FG000|After Week 48|Sponsor Request|115|||
48340163|NCT05066230|155440461|FG001|After Week 48|Sponsor Request|111|||
48664223|NCT00711802|156623251|FG005|Overall Study|Microbiological failure|1|||
48340164|NCT02507297|155440462|FG000|Overall Study|Withdrawal by Subject|1|||
48664224|NCT00711802|156623252|FG006|Overall Study|Microbiological failure|0|||
48664225|NCT00711802|156623253|FG007|Overall Study|Microbiological failure|0|||
48664226|NCT00711802|156623246|FG000|Overall Study|Protocol Violation|0|||
48664227|NCT00711802|156623247|FG001|Overall Study|Protocol Violation|0|||
48664228|NCT00711802|156623248|FG002|Overall Study|Protocol Violation|0|||
48664229|NCT00711802|156623249|FG003|Overall Study|Protocol Violation|1|||
48664230|NCT00711802|156623250|FG004|Overall Study|Protocol Violation|0|||
48664231|NCT00711802|156623251|FG005|Overall Study|Protocol Violation|0|||
48664232|NCT00711802|156623252|FG006|Overall Study|Protocol Violation|0|||
48664233|NCT00711802|156623253|FG007|Overall Study|Protocol Violation|0|||
48340165|NCT02507297|155440463|FG001|Overall Study|Withdrawal by Subject|0|||
48340166|NCT02507297|155440462|FG000|Overall Study|Lost to Follow-up|0|||
48340167|NCT02507297|155440463|FG001|Overall Study|Lost to Follow-up|1|||
48340168|NCT00515112|155440468|FG000|Overall Study|Death|0|||
48340169|NCT00515112|155440469|FG001|Overall Study|Death|1|||
48664234|NCT00711802|156623246|FG000|Overall Study|Physician Decision|0|||
48664235|NCT00711802|156623247|FG001|Overall Study|Physician Decision|2|||
48664236|NCT00711802|156623248|FG002|Overall Study|Physician Decision|0|||
48664237|NCT00711802|156623249|FG003|Overall Study|Physician Decision|0|||
48664238|NCT00711802|156623250|FG004|Overall Study|Physician Decision|0|||
48756921|NCT02432846|156958115|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48756922|NCT02432846|156958116|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48756923|NCT02432846|156958117|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48340170|NCT00515112|155440468|FG000|Overall Study|The study was terminated|3|||
48340171|NCT00515112|155440469|FG001|Overall Study|The study was terminated|2|||
48340172|NCT01825785|155440470|FG000|Overall Study|Adverse Event|0|||
48340173|NCT01825785|155440471|FG001|Overall Study|Adverse Event|0|||
48340174|NCT01825785|155440472|FG002|Overall Study|Adverse Event|0|||
48756924|NCT02432846|156958118|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48756925|NCT02432846|156958119|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
48756926|NCT02432846|156958120|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
48756927|NCT02769247|156958121|FG000|Overall Study|Withdrawal by Subject|1|||
48756928|NCT02769247|156958122|FG001|Overall Study|Withdrawal by Subject|0|||
48756929|NCT02769247|156958123|FG002|Overall Study|Withdrawal by Subject|0|||
48756930|NCT02769247|156958124|FG003|Overall Study|Withdrawal by Subject|1|||
48756931|NCT02769247|156958121|FG000|Overall Study|Protocol Violation|0|||
48756932|NCT02769247|156958122|FG001|Overall Study|Protocol Violation|0|||
48340175|NCT01825785|155440473|FG003|Overall Study|Adverse Event|0|||
48340176|NCT01825785|155440474|FG004|Overall Study|Adverse Event|1|||
48340177|NCT01825785|155440475|FG005|Overall Study|Adverse Event|0|||
48340178|NCT01825785|155440476|FG006|Overall Study|Adverse Event|0|||
48340179|NCT01825785|155440470|FG000|Overall Study|Withdrawal by Subject|0|||
48340180|NCT01825785|155440471|FG001|Overall Study|Withdrawal by Subject|0|||
48340181|NCT01825785|155440472|FG002|Overall Study|Withdrawal by Subject|0|||
48664239|NCT00711802|156623251|FG005|Overall Study|Physician Decision|0|||
48664240|NCT00711802|156623252|FG006|Overall Study|Physician Decision|0|||
48756933|NCT02769247|156958123|FG002|Overall Study|Protocol Violation|1|||
48756934|NCT02769247|156958124|FG003|Overall Study|Protocol Violation|0|||
48756935|NCT02769247|156958121|FG000|Overall Study|Physician Decision|1|||
48756936|NCT02769247|156958122|FG001|Overall Study|Physician Decision|0|||
48756937|NCT02769247|156958123|FG002|Overall Study|Physician Decision|0|||
48340182|NCT01825785|155440473|FG003|Overall Study|Withdrawal by Subject|0|||
48340183|NCT01825785|155440474|FG004|Overall Study|Withdrawal by Subject|1|||
48340184|NCT01825785|155440475|FG005|Overall Study|Withdrawal by Subject|1|||
48340185|NCT01825785|155440476|FG006|Overall Study|Withdrawal by Subject|0|||
48340186|NCT00246129|155440479|FG000|Overall Study|Lost to Follow-up|1|||
48340187|NCT00246129|155440480|FG001|Overall Study|Lost to Follow-up|0|||
48664241|NCT00711802|156623253|FG007|Overall Study|Physician Decision|0|||
48664242|NCT00711802|156623246|FG000|Overall Study|Withdrawal by Subject|0|||
48340188|NCT00246129|155440479|FG000|Overall Study|Death|2|||
48340189|NCT00246129|155440480|FG001|Overall Study|Death|1|||
48340190|NCT00246129|155440479|FG000|Overall Study|suffered primary non-function|1|||
48664243|NCT00711802|156623247|FG001|Overall Study|Withdrawal by Subject|1|||
48340191|NCT00246129|155440480|FG001|Overall Study|suffered primary non-function|0|||
48340192|NCT00246129|155440479|FG000|Overall Study|grafts failed|3|||
48340193|NCT00246129|155440480|FG001|Overall Study|grafts failed|1|||
48340194|NCT03740737|155440483|FG000|Overall Study|Protocol deviation|13|||
48340195|NCT03740737|155440484|FG001|Overall Study|Protocol deviation|0|||
48340196|NCT03740737|155440483|FG000|Overall Study|Adverse Event|2|||
48340197|NCT03740737|155440484|FG001|Overall Study|Adverse Event|0|||
48340198|NCT03740737|155440483|FG000|Overall Study|Lost to Follow-up|1|||
48340199|NCT03740737|155440484|FG001|Overall Study|Lost to Follow-up|0|||
48664244|NCT00711802|156623248|FG002|Overall Study|Withdrawal by Subject|0|||
48664245|NCT00711802|156623249|FG003|Overall Study|Withdrawal by Subject|1|||
48664246|NCT00711802|156623250|FG004|Overall Study|Withdrawal by Subject|0|||
48664247|NCT00711802|156623251|FG005|Overall Study|Withdrawal by Subject|0|||
48664248|NCT00711802|156623252|FG006|Overall Study|Withdrawal by Subject|0|||
48664249|NCT00711802|156623253|FG007|Overall Study|Withdrawal by Subject|0|||
48664250|NCT00711802|156623246|FG000|Overall Study|Lost to Follow-up|0|||
48664251|NCT00711802|156623247|FG001|Overall Study|Lost to Follow-up|0|||
48664252|NCT00711802|156623248|FG002|Overall Study|Lost to Follow-up|3|||
48664253|NCT00711802|156623249|FG003|Overall Study|Lost to Follow-up|1|||
48664254|NCT00711802|156623250|FG004|Overall Study|Lost to Follow-up|10|||
48664255|NCT00711802|156623251|FG005|Overall Study|Lost to Follow-up|6|||
48756938|NCT02769247|156958124|FG003|Overall Study|Physician Decision|0|||
48756939|NCT02426892|156958127|FG000|Overall Study|Adverse Event|2|||
48756940|NCT02426892|156958127|FG000|Overall Study|Lack of Efficacy|17|||
48756941|NCT02426892|156958127|FG000|Overall Study|Withdrawal by Subject|1|||
48756942|NCT00227305|156958128|FG000|Overall Study|Adverse Event|40|||
48756943|NCT00227305|156958128|FG000|Overall Study|Withdrawal by Subject|42|||
48756944|NCT00227305|156958128|FG000|Overall Study|Lost to Follow-up|33|||
48756945|NCT00227305|156958128|FG000|Overall Study|Study specific discontinuation|13|||
48756946|NCT00227305|156958128|FG000|Overall Study|MOVED OUT OF AREA|3|||
48756947|NCT00227305|156958128|FG000|Overall Study|Lack of Efficacy|7|||
48756948|NCT00227305|156958128|FG000|Overall Study|Physician Decision|3|||
48756949|NCT00227305|156958128|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
48756950|NCT00227305|156958128|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
48756951|NCT00227305|156958128|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
48756952|NCT02118012|156958129|FG000|Overall Study|Adverse Event|0|||
48756953|NCT02118012|156958130|FG001|Overall Study|Adverse Event|1|||
48756954|NCT02118012|156958129|FG000|Overall Study|Physician Decision|0|||
48756955|NCT02118012|156958130|FG001|Overall Study|Physician Decision|1|||
48756956|NCT03325075|156958134|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
48756957|NCT03325075|156958135|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
48756958|NCT03325075|156958136|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
48756959|NCT03325075|156958137|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
48756960|NCT03325075|156958134|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
48756961|NCT03325075|156958135|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
48756962|NCT03325075|156958136|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
48756963|NCT03325075|156958137|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
48756964|NCT03325075|156958134|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
48756965|NCT03325075|156958135|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
48756966|NCT03325075|156958136|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
48756967|NCT03325075|156958137|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
48756968|NCT02659631|156958140|FG000|Overall Study|Lost to Follow-up|0|||
48756969|NCT02659631|156958141|FG001|Overall Study|Lost to Follow-up|0|||
48756970|NCT02659631|156958142|FG002|Overall Study|Lost to Follow-up|2|||
48756971|NCT02659631|156958143|FG003|Overall Study|Lost to Follow-up|0|||
48756972|NCT02659631|156958144|FG004|Overall Study|Lost to Follow-up|0|||
48756973|NCT02659631|156958145|FG005|Overall Study|Lost to Follow-up|1|||
48340200|NCT03740737|155440483|FG000|Overall Study|Randomization failure|1|||
48664256|NCT00711802|156623252|FG006|Overall Study|Lost to Follow-up|4|||
48756974|NCT02659631|156958146|FG006|Overall Study|Lost to Follow-up|0|||
48756975|NCT02659631|156958147|FG007|Overall Study|Lost to Follow-up|0|||
48756976|NCT02659631|156958148|FG008|Overall Study|Lost to Follow-up|0|||
48756977|NCT02659631|156958149|FG009|Overall Study|Lost to Follow-up|0|||
48756978|NCT02659631|156958140|FG000|Overall Study|Withdrawal prior to treatment|0|||
48756979|NCT02659631|156958141|FG001|Overall Study|Withdrawal prior to treatment|0|||
48756980|NCT02659631|156958142|FG002|Overall Study|Withdrawal prior to treatment|0|||
48756981|NCT02659631|156958143|FG003|Overall Study|Withdrawal prior to treatment|0|||
48340201|NCT03740737|155440484|FG001|Overall Study|Randomization failure|0|||
48340202|NCT03740737|155440483|FG000|Overall Study|Participant withdrew consent|1|||
48340203|NCT03740737|155440484|FG001|Overall Study|Participant withdrew consent|0|||
48664257|NCT00711802|156623253|FG007|Overall Study|Lost to Follow-up|2|||
48664258|NCT00711802|156623246|FG000|Overall Study|Reason not reported|0|||
48340204|NCT03740737|155440483|FG000|Overall Study|Participant withdrew from trial|2|||
48340205|NCT03740737|155440484|FG001|Overall Study|Participant withdrew from trial|1|||
48340206|NCT00507429|155440485|FG000|Treatment Phase|Disease Progression|12|||
48340207|NCT00507429|155440486|FG001|Treatment Phase|Disease Progression|5|||
48340208|NCT00507429|155440485|FG000|Treatment Phase|Adverse Event|12|||
48340209|NCT00507429|155440486|FG001|Treatment Phase|Adverse Event|5|||
48340210|NCT00507429|155440485|FG000|Treatment Phase|Withdrawal by Subject|3|||
48340211|NCT00507429|155440486|FG001|Treatment Phase|Withdrawal by Subject|3|||
48340212|NCT00507429|155440485|FG000|Treatment Phase|Physician Decision|4|||
48340213|NCT00507429|155440486|FG001|Treatment Phase|Physician Decision|2|||
48340214|NCT00507429|155440485|FG000|Treatment Phase|Other|6|||
48340215|NCT00507429|155440486|FG001|Treatment Phase|Other|3|||
48340216|NCT00507429|155440485|FG000|Maintenance Phase|Progressive Disease|14|||
48340217|NCT00507429|155440486|FG001|Maintenance Phase|Progressive Disease|0|||
48340218|NCT02889809|155440495|FG000|Overall Study|Withdrawal by Subject|30|||
48340219|NCT02889809|155440496|FG001|Overall Study|Withdrawal by Subject|21|||
48340220|NCT02889809|155440495|FG000|Overall Study|Lost to Follow-up|1|||
48340221|NCT02889809|155440496|FG001|Overall Study|Lost to Follow-up|1|||
48340222|NCT02889809|155440495|FG000|Overall Study|Site Closed|12|||
48340223|NCT02889809|155440496|FG001|Overall Study|Site Closed|11|||
48756982|NCT02659631|156958144|FG004|Overall Study|Withdrawal prior to treatment|1|||
48756983|NCT02659631|156958145|FG005|Overall Study|Withdrawal prior to treatment|0|||
48756984|NCT02659631|156958146|FG006|Overall Study|Withdrawal prior to treatment|0|||
48756985|NCT02659631|156958147|FG007|Overall Study|Withdrawal prior to treatment|0|||
48756986|NCT02659631|156958148|FG008|Overall Study|Withdrawal prior to treatment|0|||
48756987|NCT02659631|156958149|FG009|Overall Study|Withdrawal prior to treatment|0|||
48756988|NCT02659631|156958140|FG000|Overall Study|Participant refused further follow-up|0|||
48756989|NCT02659631|156958141|FG001|Overall Study|Participant refused further follow-up|0|||
48756990|NCT02659631|156958142|FG002|Overall Study|Participant refused further follow-up|0|||
48756991|NCT02659631|156958143|FG003|Overall Study|Participant refused further follow-up|1|||
48756992|NCT02659631|156958144|FG004|Overall Study|Participant refused further follow-up|0|||
48756993|NCT02659631|156958145|FG005|Overall Study|Participant refused further follow-up|0|||
48756994|NCT02659631|156958146|FG006|Overall Study|Participant refused further follow-up|0|||
48756995|NCT02659631|156958147|FG007|Overall Study|Participant refused further follow-up|0|||
48756996|NCT02659631|156958148|FG008|Overall Study|Participant refused further follow-up|1|||
48756997|NCT02659631|156958149|FG009|Overall Study|Participant refused further follow-up|0|||
48756998|NCT02659631|156958140|FG000|Overall Study|Death (follow-up phase)|1|||
48756999|NCT02659631|156958141|FG001|Overall Study|Death (follow-up phase)|2|||
48757000|NCT02659631|156958142|FG002|Overall Study|Death (follow-up phase)|1|||
48757001|NCT02659631|156958143|FG003|Overall Study|Death (follow-up phase)|1|||
48340224|NCT01753323|155440500|FG000|Overall Study|Lack of Efficacy|0|||
48340225|NCT01753323|155440501|FG001|Overall Study|Lack of Efficacy|0|||
48757002|NCT02659631|156958144|FG004|Overall Study|Death (follow-up phase)|3|||
48757003|NCT02659631|156958145|FG005|Overall Study|Death (follow-up phase)|2|||
48757004|NCT02659631|156958146|FG006|Overall Study|Death (follow-up phase)|0|||
48340226|NCT01753323|155440502|FG002|Overall Study|Lack of Efficacy|8|||
48340227|NCT01753323|155440500|FG000|Overall Study|Protocol deviation|1|||
48340228|NCT01753323|155440501|FG001|Overall Study|Protocol deviation|0|||
48340229|NCT01753323|155440502|FG002|Overall Study|Protocol deviation|0|||
48340230|NCT01753323|155440500|FG000|Overall Study|Adverse Event|0|||
48340231|NCT01753323|155440501|FG001|Overall Study|Adverse Event|0|||
48340232|NCT01753323|155440502|FG002|Overall Study|Adverse Event|1|||
48340233|NCT00774306|155440506|FG000|Overall Study|Adverse Event|3|||
48340234|NCT00774306|155440507|FG001|Overall Study|Adverse Event|0|||
48340235|NCT00774306|155440508|FG002|Overall Study|Adverse Event|0|||
48340236|NCT00774306|155440509|FG003|Overall Study|Adverse Event|0|||
48340237|NCT00774306|155440506|FG000|Overall Study|Protocol Violation|2|||
48340238|NCT00774306|155440507|FG001|Overall Study|Protocol Violation|0|||
48340239|NCT00774306|155440508|FG002|Overall Study|Protocol Violation|3|||
48340240|NCT00774306|155440509|FG003|Overall Study|Protocol Violation|0|||
48340241|NCT00774306|155440506|FG000|Overall Study|Withdrawal by Subject|6|||
48340242|NCT00774306|155440507|FG001|Overall Study|Withdrawal by Subject|1|||
48340243|NCT00774306|155440508|FG002|Overall Study|Withdrawal by Subject|1|||
48340244|NCT00774306|155440509|FG003|Overall Study|Withdrawal by Subject|0|||
48340245|NCT00774306|155440506|FG000|Overall Study|Lost to Follow-up|6|||
48340246|NCT00774306|155440507|FG001|Overall Study|Lost to Follow-up|0|||
48340247|NCT00774306|155440508|FG002|Overall Study|Lost to Follow-up|4|||
48340248|NCT00774306|155440509|FG003|Overall Study|Lost to Follow-up|5|||
48340249|NCT00774306|155440506|FG000|Overall Study|Death|1|||
48340250|NCT00774306|155440507|FG001|Overall Study|Death|1|||
48340251|NCT00774306|155440508|FG002|Overall Study|Death|0|||
48340252|NCT00774306|155440509|FG003|Overall Study|Death|0|||
48340253|NCT01012999|155440516|FG000|Overall Study|Protocol Violation|1|||
48340254|NCT01136733|155440517|FG000|Phase 1b|Adverse Event|0|||
48340255|NCT01136733|155440518|FG001|Phase 1b|Adverse Event|3|||
48340256|NCT01136733|155440519|FG002|Phase 1b|Adverse Event|1|||
48340257|NCT01136733|155440520|FG003|Phase 1b|Adverse Event|0|||
48340258|NCT01136733|155440521|FG004|Phase 1b|Adverse Event|0|||
48340259|NCT01136733|155440522|FG005|Phase 1b|Adverse Event|0|||
48340260|NCT01136733|155440523|FG006|Phase 1b|Adverse Event|0|||
48340261|NCT01136733|155440517|FG000|Phase 1b|Participant Choice|0|||
48340262|NCT01136733|155440518|FG001|Phase 1b|Participant Choice|0|||
48664259|NCT00711802|156623247|FG001|Overall Study|Reason not reported|1|||
48664260|NCT00711802|156623248|FG002|Overall Study|Reason not reported|1|||
48340263|NCT01136733|155440519|FG002|Phase 1b|Participant Choice|1|||
48340264|NCT01136733|155440520|FG003|Phase 1b|Participant Choice|0|||
48340265|NCT01136733|155440521|FG004|Phase 1b|Participant Choice|0|||
48340266|NCT01136733|155440522|FG005|Phase 1b|Participant Choice|0|||
48340267|NCT01136733|155440523|FG006|Phase 1b|Participant Choice|0|||
48340268|NCT01136733|155440517|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
48340269|NCT01136733|155440518|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
48340270|NCT01136733|155440519|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
48340271|NCT01136733|155440520|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
48664261|NCT00711802|156623249|FG003|Overall Study|Reason not reported|0|||
48664262|NCT00711802|156623250|FG004|Overall Study|Reason not reported|1|||
48664263|NCT00711802|156623251|FG005|Overall Study|Reason not reported|0|||
48664264|NCT00711802|156623252|FG006|Overall Study|Reason not reported|1|||
48664265|NCT00711802|156623253|FG007|Overall Study|Reason not reported|0|||
48664266|NCT02370095|156623254|FG000|Overall Study|Withdrawal by Subject|0|||
48664267|NCT02370095|156623255|FG001|Overall Study|Withdrawal by Subject|1|||
48664268|NCT00900146|156623256|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
48340272|NCT01136733|155440521|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
48340273|NCT01136733|155440522|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
48340274|NCT01136733|155440523|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
48664269|NCT00900146|156623257|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
48664270|NCT00900146|156623258|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
48664271|NCT00900146|156623259|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
48340275|NCT01136733|155440517|FG000|Phase 1b|Clinical Progression|1|||
48340276|NCT01136733|155440518|FG001|Phase 1b|Clinical Progression|1|||
48340277|NCT01136733|155440519|FG002|Phase 1b|Clinical Progression|0|||
48340278|NCT01136733|155440520|FG003|Phase 1b|Clinical Progression|0|||
48340279|NCT01136733|155440521|FG004|Phase 1b|Clinical Progression|0|||
48340280|NCT01136733|155440522|FG005|Phase 1b|Clinical Progression|0|||
48340281|NCT01136733|155440523|FG006|Phase 1b|Clinical Progression|0|||
48664272|NCT00900146|156623260|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
48664273|NCT00900146|156623256|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
48664274|NCT00900146|156623257|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
48664275|NCT00900146|156623258|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
48664276|NCT00900146|156623259|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
48664277|NCT00900146|156623260|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
48664278|NCT00900146|156623256|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
48664279|NCT00900146|156623257|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
48664280|NCT00900146|156623258|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
48664281|NCT00900146|156623259|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
48664282|NCT00900146|156623260|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
48664283|NCT00900146|156623256|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
48664284|NCT00900146|156623257|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
48664285|NCT00900146|156623258|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
48664286|NCT00900146|156623259|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
48664287|NCT00900146|156623260|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
48340282|NCT01136733|155440517|FG000|Phase 2|Disease Progression|0|||
48664288|NCT00900146|156623256|FG000|Intermediate: Period III|Lost to Follow-up|2|||
48664289|NCT00900146|156623257|FG001|Intermediate: Period III|Lost to Follow-up|0|||
48664290|NCT00900146|156623258|FG002|Intermediate: Period III|Lost to Follow-up|0|||
48664291|NCT00900146|156623259|FG003|Intermediate: Period III|Lost to Follow-up|0|||
48664292|NCT00900146|156623260|FG004|Intermediate: Period III|Lost to Follow-up|1|||
48664293|NCT00900146|156623256|FG000|Intermediate: Period III|Administrative problems|85|||
48664294|NCT00900146|156623257|FG001|Intermediate: Period III|Administrative problems|92|||
48664295|NCT00900146|156623258|FG002|Intermediate: Period III|Administrative problems|84|||
48664296|NCT00900146|156623259|FG003|Intermediate: Period III|Administrative problems|90|||
48664297|NCT00900146|156623260|FG004|Intermediate: Period III|Administrative problems|163|||
48664298|NCT01129882|156623265|FG000|Overall Study|Adverse Event|39|||
48664299|NCT01129882|156623265|FG000|Overall Study|Death|6|||
48664300|NCT01129882|156623265|FG000|Overall Study|Lack of Efficacy|5|||
48340283|NCT01136733|155440518|FG001|Phase 2|Disease Progression|0|||
48340284|NCT01136733|155440519|FG002|Phase 2|Disease Progression|0|||
48340285|NCT01136733|155440520|FG003|Phase 2|Disease Progression|0|||
48340286|NCT01136733|155440521|FG004|Phase 2|Disease Progression|30|||
48340287|NCT01136733|155440522|FG005|Phase 2|Disease Progression|32|||
48340288|NCT01136733|155440523|FG006|Phase 2|Disease Progression|38|||
48340289|NCT01136733|155440517|FG000|Phase 2|Adverse Event|0|||
48340290|NCT01136733|155440518|FG001|Phase 2|Adverse Event|0|||
48340291|NCT01136733|155440519|FG002|Phase 2|Adverse Event|0|||
48340292|NCT01136733|155440520|FG003|Phase 2|Adverse Event|0|||
48340293|NCT01136733|155440521|FG004|Phase 2|Adverse Event|11|||
48340294|NCT01136733|155440522|FG005|Phase 2|Adverse Event|13|||
48340295|NCT01136733|155440523|FG006|Phase 2|Adverse Event|5|||
48340296|NCT01136733|155440517|FG000|Phase 2|Participant Choice|0|||
48664301|NCT01129882|156623265|FG000|Overall Study|Lost to Follow-up|13|||
48664302|NCT01129882|156623265|FG000|Overall Study|Physician Decision|27|||
48664303|NCT01129882|156623265|FG000|Overall Study|Protocol Deviation|3|||
48664304|NCT01129882|156623265|FG000|Overall Study|Withdrawal Criteria Met|19|||
48664305|NCT01129882|156623265|FG000|Overall Study|Trial Termination by Sponsor|6|||
48664306|NCT01129882|156623265|FG000|Overall Study|Withdrawal by Subject|160|||
48664307|NCT00355342|156623266|FG000|Overall Study|Adverse Event|13|||
48664308|NCT00355342|156623267|FG001|Overall Study|Adverse Event|15|||
48664309|NCT00355342|156623266|FG000|Overall Study|Lost to Follow-up|4|||
48664310|NCT00355342|156623267|FG001|Overall Study|Lost to Follow-up|2|||
48664311|NCT00355342|156623266|FG000|Overall Study|Withdrawal by Subject|14|||
48664312|NCT00355342|156623267|FG001|Overall Study|Withdrawal by Subject|11|||
48664313|NCT00355342|156623266|FG000|Overall Study|Sponsor terminated study|2|||
48664314|NCT00355342|156623267|FG001|Overall Study|Sponsor terminated study|2|||
48664315|NCT00355342|156623266|FG000|Overall Study|Overcompliant-PI discretion|1|||
48664316|NCT00355342|156623267|FG001|Overall Study|Overcompliant-PI discretion|0|||
48664317|NCT00355342|156623266|FG000|Overall Study|Use of prohibited medication|1|||
48664318|NCT00355342|156623267|FG001|Overall Study|Use of prohibited medication|0|||
48664319|NCT00355342|156623266|FG000|Overall Study|COPD exacerbation|1|||
48664320|NCT00355342|156623267|FG001|Overall Study|COPD exacerbation|1|||
48664321|NCT00355342|156623266|FG000|Overall Study|Dispensed wrong study drug kit|1|||
48664322|NCT00355342|156623267|FG001|Overall Study|Dispensed wrong study drug kit|0|||
48664323|NCT00355342|156623266|FG000|Overall Study|Non-compliance with Dexa scans|1|||
48664324|NCT00355342|156623267|FG001|Overall Study|Non-compliance with Dexa scans|0|||
48664325|NCT00355342|156623266|FG000|Overall Study|Withdrawal by participant and physician|1|||
48664326|NCT00355342|156623267|FG001|Overall Study|Withdrawal by participant and physician|0|||
48664327|NCT00355342|156623266|FG000|Overall Study|Participant relocated|0|||
48340297|NCT01136733|155440518|FG001|Phase 2|Participant Choice|0|||
48340298|NCT01136733|155440519|FG002|Phase 2|Participant Choice|0|||
48340299|NCT01136733|155440520|FG003|Phase 2|Participant Choice|0|||
48340300|NCT01136733|155440521|FG004|Phase 2|Participant Choice|3|||
48757005|NCT02659631|156958147|FG007|Overall Study|Death (follow-up phase)|3|||
48757006|NCT02659631|156958148|FG008|Overall Study|Death (follow-up phase)|1|||
48757007|NCT02659631|156958149|FG009|Overall Study|Death (follow-up phase)|0|||
48757008|NCT02659631|156958140|FG000|Overall Study|Death (treatment phase)|0|||
48757009|NCT02659631|156958141|FG001|Overall Study|Death (treatment phase)|0|||
48757010|NCT02659631|156958142|FG002|Overall Study|Death (treatment phase)|0|||
48757011|NCT02659631|156958143|FG003|Overall Study|Death (treatment phase)|0|||
48757012|NCT02659631|156958144|FG004|Overall Study|Death (treatment phase)|1|||
48757013|NCT02659631|156958145|FG005|Overall Study|Death (treatment phase)|0|||
48757014|NCT02659631|156958146|FG006|Overall Study|Death (treatment phase)|1|||
48757015|NCT02659631|156958147|FG007|Overall Study|Death (treatment phase)|0|||
48757016|NCT02659631|156958148|FG008|Overall Study|Death (treatment phase)|0|||
48757017|NCT02659631|156958149|FG009|Overall Study|Death (treatment phase)|0|||
48757018|NCT00495170|156958150|FG000|Overall Study|Lost to Follow-up|9|||
48757019|NCT00495170|156958150|FG000|Overall Study|Withdrawal by Subject|3|||
48757020|NCT00495170|156958150|FG000|Overall Study|Inappropriate staging|8|||
48757021|NCT01408914|156958153|FG000|Overall Study|Could not complete tx in protocol period|5|||
48757022|NCT01408914|156958154|FG001|Overall Study|Could not complete tx in protocol period|5|||
48664328|NCT00355342|156623267|FG001|Overall Study|Participant relocated|1|||
48664329|NCT00355342|156623266|FG000|Overall Study|Participant discontinued study drug|0|||
48664330|NCT00355342|156623267|FG001|Overall Study|Participant discontinued study drug|1|||
48664331|NCT00355342|156623266|FG000|Overall Study|Study management|0|||
48664332|NCT00355342|156623267|FG001|Overall Study|Study management|1|||
48664333|NCT00355342|156623266|FG000|Overall Study|Protocol Violation|0|||
48664334|NCT00355342|156623267|FG001|Overall Study|Protocol Violation|1|||
48664335|NCT00355342|156623266|FG000|Overall Study|Use of protocol excluded medication|0|||
48664336|NCT00355342|156623267|FG001|Overall Study|Use of protocol excluded medication|1|||
48664337|NCT02436408|156623268|FG000|Overall Study|Death|1|||
48664338|NCT02649855|156623269|FG000|Overall Study|Refused further treatment|2|||
48664339|NCT02649855|156623270|FG001|Overall Study|Refused further treatment|1|||
48664340|NCT02649855|156623271|FG002|Overall Study|Refused further treatment|1|||
48664341|NCT02649855|156623269|FG000|Overall Study|Withdrew consent|0|||
48664342|NCT02649855|156623270|FG001|Overall Study|Withdrew consent|1|||
48664343|NCT02649855|156623271|FG002|Overall Study|Withdrew consent|0|||
48664344|NCT02649855|156623269|FG000|Overall Study|Switched to alternative treatment|0|||
48664345|NCT02649855|156623270|FG001|Overall Study|Switched to alternative treatment|1|||
48664346|NCT02649855|156623271|FG002|Overall Study|Switched to alternative treatment|1|||
48664347|NCT02649855|156623269|FG000|Overall Study|Principal investigator discretion|0|||
48664348|NCT02649855|156623270|FG001|Overall Study|Principal investigator discretion|1|||
48664349|NCT02649855|156623271|FG002|Overall Study|Principal investigator discretion|1|||
48664350|NCT02649855|156623269|FG000|Overall Study|No treatment, per protocol|1|||
48664351|NCT02649855|156623270|FG001|Overall Study|No treatment, per protocol|0|||
48664352|NCT02649855|156623271|FG002|Overall Study|No treatment, per protocol|0|||
48664353|NCT02649855|156623269|FG000|Overall Study|Initiate new treatment|1|||
48664354|NCT02649855|156623270|FG001|Overall Study|Initiate new treatment|0|||
48664355|NCT02649855|156623271|FG002|Overall Study|Initiate new treatment|0|||
48664356|NCT03777917|156623275|FG000|Overall Study|Withdrawal by Subject|1|||
48664357|NCT03777917|156623276|FG001|Overall Study|Withdrawal by Subject|0|||
48664358|NCT03777917|156623275|FG000|Overall Study|Physician Decision|1|||
48664359|NCT03777917|156623276|FG001|Overall Study|Physician Decision|0|||
48664360|NCT03777917|156623275|FG000|Overall Study|Lost to Follow-up|6|||
48664361|NCT03777917|156623276|FG001|Overall Study|Lost to Follow-up|2|||
48664362|NCT03777917|156623275|FG000|Overall Study|Other|1|||
48664363|NCT03777917|156623276|FG001|Overall Study|Other|0|||
48664364|NCT01287221|156623278|FG000|Overall Study|Lack of Perceived Benefit|1|||
48664365|NCT01287221|156623279|FG001|Overall Study|Lack of Perceived Benefit|1|||
48664366|NCT01287221|156623278|FG000|Overall Study|Adverse Event|3|||
48664367|NCT01287221|156623279|FG001|Overall Study|Adverse Event|3|||
48664368|NCT01287221|156623278|FG000|Overall Study|Withdrawal by Subject|0|||
48757023|NCT01408914|156958155|FG002|Overall Study|Could not complete tx in protocol period|6|||
48757024|NCT01408914|156958153|FG000|Overall Study|Lost to Follow-up|4|||
48757025|NCT01408914|156958154|FG001|Overall Study|Lost to Follow-up|1|||
48757026|NCT01408914|156958155|FG002|Overall Study|Lost to Follow-up|2|||
48757027|NCT01408914|156958153|FG000|Overall Study|Physician Decision|1|||
48664369|NCT01287221|156623279|FG001|Overall Study|Withdrawal by Subject|1|||
48664370|NCT03515941|156623284|FG000|Overall Study|Adverse Event|1|||
48664371|NCT03515941|156623285|FG001|Overall Study|Adverse Event|0|||
48664372|NCT00283868|156623286|FG000|Overall Study|Lost to Follow-up|7|||
48664373|NCT00283868|156623287|FG001|Overall Study|Lost to Follow-up|8|||
48664374|NCT00353873|156623288|FG000|Overall Study|Protocol Violation|1|||
48664375|NCT00353873|156623289|FG001|Overall Study|Protocol Violation|2|||
48664376|NCT00353873|156623288|FG000|Overall Study|Exacerbation|1|||
48664377|NCT00353873|156623289|FG001|Overall Study|Exacerbation|0|||
48664378|NCT00353873|156623288|FG000|Overall Study|Adverse Event|1|||
48664379|NCT00353873|156623289|FG001|Overall Study|Adverse Event|0|||
48664380|NCT00353873|156623288|FG000|Overall Study|Physician Decision|2|||
48664381|NCT00353873|156623289|FG001|Overall Study|Physician Decision|0|||
48664382|NCT00353873|156623288|FG000|Overall Study|Withdrawal by Subject|1|||
48664383|NCT00353873|156623289|FG001|Overall Study|Withdrawal by Subject|1|||
48664384|NCT02743780|156623294|FG000|Part 3 (7 Days)|Adverse Event|0|||
48664385|NCT02743780|156623295|FG001|Part 3 (7 Days)|Adverse Event|0|||
48664386|NCT02743780|156623296|FG002|Part 3 (7 Days)|Adverse Event|1|||
48664387|NCT02743780|156623297|FG003|Part 3 (7 Days)|Adverse Event|0|||
48664388|NCT02743780|156623298|FG004|Part 3 (7 Days)|Adverse Event|0|||
48664389|NCT01294462|156623299|FG000|Overall Study|Lost to Follow-up|1|||
48664390|NCT01294462|156623300|FG001|Overall Study|Lost to Follow-up|0|||
48664391|NCT01294462|156623299|FG000|Overall Study|Withdrawal by Subject|65|||
48664392|NCT01294462|156623300|FG001|Overall Study|Withdrawal by Subject|63|||
48664393|NCT00953680|156623303|FG000|Period 1|Withdrawal by Subject|0|||
48664394|NCT00953680|156623304|FG001|Period 1|Withdrawal by Subject|1|||
48664395|NCT01873729|156623305|FG000|Overall Study|Withdrawal by Subject|1|||
48664396|NCT02312219|156623307|FG000|Overall Study|Withdrawal by Subject|1|||
48664397|NCT02312219|156623308|FG001|Overall Study|Withdrawal by Subject|2|||
48664398|NCT02312219|156623307|FG000|Overall Study|could not schedule imaging in time|0|||
48664399|NCT02312219|156623308|FG001|Overall Study|could not schedule imaging in time|2|||
48664400|NCT02312219|156623307|FG000|Overall Study|Other|0|||
48664401|NCT02312219|156623308|FG001|Overall Study|Other|1|||
48664402|NCT02312219|156623307|FG000|Overall Study|Not randomized. Ineligible|0|||
48664403|NCT02312219|156623308|FG001|Overall Study|Not randomized. Ineligible|1|||
48664404|NCT03553498|156623310|FG000|Overall Study|Missing primary outcome|1|||
48664405|NCT03553498|156623311|FG001|Overall Study|Missing primary outcome|2|||
48664406|NCT02226198|156625078|FG000|Lead-in Phase|Protocol Violation|1|||
48664407|NCT02226198|156625079|FG001|Lead-in Phase|Protocol Violation|0|||
48664408|NCT02226198|156625080|FG002|Lead-in Phase|Protocol Violation|0|||
48664409|NCT02226198|156625078|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
48664410|NCT02226198|156625079|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
48664411|NCT02226198|156625080|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
48664412|NCT02744612|156625082|FG000|Overall Study|Withdrawal by Subject|0|||
48664413|NCT02744612|156625083|FG001|Overall Study|Withdrawal by Subject|2|||
48664414|NCT00871923|156625086|FG000|Overall Study|Death|1|||
48664415|NCT00871923|156625086|FG000|Overall Study|Withdrawal by Subject|1|||
48664416|NCT01952665|156625090|FG000|Overall Study|Physician Decision|3|||
48664417|NCT01952665|156625091|FG001|Overall Study|Physician Decision|2|||
48664418|NCT01952665|156625090|FG000|Overall Study|Lost to Follow-up|1|||
48664419|NCT01952665|156625091|FG001|Overall Study|Lost to Follow-up|2|||
48664420|NCT01952665|156625090|FG000|Overall Study|Adverse Event|2|||
48664421|NCT01952665|156625091|FG001|Overall Study|Adverse Event|1|||
48664422|NCT01952665|156625090|FG000|Overall Study|Protocol Violation|0|||
48664423|NCT01952665|156625091|FG001|Overall Study|Protocol Violation|1|||
48664424|NCT01463111|156625103|FG000|Overall Study|Withdrawal by Subject|2|||
48664425|NCT01463111|156625103|FG000|Overall Study|Lost to Follow-up|5|||
48664426|NCT01463111|156625103|FG000|Overall Study|Physician Decision|2|||
48664427|NCT04143217|156625104|FG000|Overall Study|Withdrawal by Subject|42|||
48664428|NCT04143217|156625104|FG000|Overall Study|Adverse Event|29|||
48664429|NCT04143217|156625104|FG000|Overall Study|Lost to Follow-up|29|||
48664430|NCT04143217|156625104|FG000|Overall Study|Lack of Efficacy|15|||
48664431|NCT04143217|156625104|FG000|Overall Study|Physician Decision|1|||
48664432|NCT04143217|156625104|FG000|Overall Study|Non-Compliance With Study Drug|6|||
48664433|NCT04143217|156625104|FG000|Overall Study|Other, Multiple Categories|11|||
48664434|NCT01962987|156625106|FG000|Overall Study|Adverse Event|4|||
48664435|NCT01962987|156625107|FG001|Overall Study|Adverse Event|4|||
48664436|NCT01962987|156625108|FG002|Overall Study|Adverse Event|0|||
48664437|NCT01962987|156625106|FG000|Overall Study|Lost to Follow-up|0|||
48664438|NCT01962987|156625107|FG001|Overall Study|Lost to Follow-up|0|||
48664439|NCT01962987|156625108|FG002|Overall Study|Lost to Follow-up|1|||
48664440|NCT01962987|156625106|FG000|Overall Study|Non compliance with dosing requirements|4|||
48664441|NCT01962987|156625107|FG001|Overall Study|Non compliance with dosing requirements|2|||
48757028|NCT01408914|156958154|FG001|Overall Study|Physician Decision|1|||
48757029|NCT01408914|156958155|FG002|Overall Study|Physician Decision|0|||
48757030|NCT01408914|156958153|FG000|Overall Study|Withdrawal by Subject|1|||
48757031|NCT01408914|156958154|FG001|Overall Study|Withdrawal by Subject|0|||
48757032|NCT01408914|156958155|FG002|Overall Study|Withdrawal by Subject|1|||
48757033|NCT01408914|156958153|FG000|Overall Study|Moved out of study jurisdiction|1|||
48757034|NCT01408914|156958154|FG001|Overall Study|Moved out of study jurisdiction|1|||
48757035|NCT01408914|156958155|FG002|Overall Study|Moved out of study jurisdiction|0|||
48757036|NCT01408914|156958153|FG000|Overall Study|Late exclusion|0|||
48757037|NCT01408914|156958154|FG001|Overall Study|Late exclusion|3|||
48757038|NCT01408914|156958155|FG002|Overall Study|Late exclusion|3|||
48757039|NCT01408914|156958153|FG000|Overall Study|Change in local TB/HIV norms|0|||
48757040|NCT01408914|156958154|FG001|Overall Study|Change in local TB/HIV norms|1|||
48757041|NCT01408914|156958155|FG002|Overall Study|Change in local TB/HIV norms|1|||
48757042|NCT00137423|156958156|FG000|Overall Study|Adverse Event|7|||
48757043|NCT00137423|156958157|FG001|Overall Study|Adverse Event|9|||
48757044|NCT00137423|156958156|FG000|Overall Study|consent withdrawn|1|||
48757045|NCT00137423|156958157|FG001|Overall Study|consent withdrawn|1|||
48757046|NCT00137423|156958156|FG000|Overall Study|Lack of Efficacy|31|||
48757047|NCT00137423|156958157|FG001|Overall Study|Lack of Efficacy|33|||
48757048|NCT00137423|156958156|FG000|Overall Study|Death|0|||
48757049|NCT00137423|156958157|FG001|Overall Study|Death|1|||
48757050|NCT01928329|156958158|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
48757051|NCT01928329|156958159|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
48757052|NCT01928329|156958158|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
48757053|NCT01928329|156958159|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
48757054|NCT01928329|156958158|FG000|Overall Study|Adverse Event|5|||
48757055|NCT01928329|156958159|FG001|Overall Study|Adverse Event|3|||
48757056|NCT01928329|156958158|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
48757057|NCT01928329|156958159|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
48757058|NCT01928329|156958158|FG000|Overall Study|Withdrawal by Subject|1|||
48757059|NCT01928329|156958159|FG001|Overall Study|Withdrawal by Subject|5|||
48757060|NCT01928329|156958158|FG000|Overall Study|Physician Decision|1|||
48757061|NCT01928329|156958159|FG001|Overall Study|Physician Decision|1|||
48757062|NCT01119131|156958164|FG000|Overall Study|Adverse Event|1|||
48757063|NCT01119131|156958165|FG001|Overall Study|Adverse Event|1|||
48757064|NCT01119131|156958166|FG002|Overall Study|Adverse Event|1|||
48757065|NCT01119131|156958164|FG000|Overall Study|Non-Compliance|1|||
48757066|NCT01119131|156958165|FG001|Overall Study|Non-Compliance|0|||
48757067|NCT01119131|156958166|FG002|Overall Study|Non-Compliance|4|||
48757068|NCT01119131|156958164|FG000|Overall Study|Physician Decision|0|||
48757069|NCT01119131|156958165|FG001|Overall Study|Physician Decision|0|||
48757070|NCT01119131|156958166|FG002|Overall Study|Physician Decision|1|||
48757071|NCT00909389|156958170|FG000|Overall Study|Adverse Event|6|||
48757072|NCT00909389|156958170|FG000|Overall Study|Death|4|||
48757073|NCT00909389|156958170|FG000|Overall Study|Poor Compliance|16|||
48757074|NCT00909389|156958170|FG000|Overall Study|Lost to Follow-up|4|||
48757075|NCT00909389|156958170|FG000|Overall Study|No Information|103|||
48757076|NCT00003492|156958171|FG000|Overall Study|Not evaluable|6|||
48664442|NCT01962987|156625108|FG002|Overall Study|Non compliance with dosing requirements|0|||
48664443|NCT01962987|156625106|FG000|Overall Study|Miscellaneous|1|||
48664444|NCT01962987|156625107|FG001|Overall Study|Miscellaneous|9|||
48664445|NCT01962987|156625108|FG002|Overall Study|Miscellaneous|2|||
48664446|NCT01962987|156625106|FG000|Overall Study|Restricted medication|5|||
48664447|NCT01962987|156625107|FG001|Overall Study|Restricted medication|1|||
48664448|NCT01962987|156625108|FG002|Overall Study|Restricted medication|1|||
48757077|NCT00597766|156958174|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
48757078|NCT00597766|156958175|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
48757079|NCT00597766|156958176|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
48757080|NCT00597766|156958174|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
48757081|NCT00597766|156958175|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
48757082|NCT00597766|156958176|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
48757083|NCT02733367|156958177|FG000|Overall Study|Withdrawal by Subject|6|||
48757084|NCT01166763|156958178|FG000|Overall Study|Withdrawal by Subject|3|||
48664449|NCT01962987|156625106|FG000|Overall Study|Serious Adverse Event|1|||
48757085|NCT01909479|156958179|FG000|From Baseline to Week 26|Adverse Event|3|||
48757086|NCT01909479|156958180|FG001|From Baseline to Week 26|Adverse Event|2|||
48757087|NCT01909479|156958179|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
48664450|NCT01962987|156625107|FG001|Overall Study|Serious Adverse Event|0|||
48757088|NCT01909479|156958180|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
48757089|NCT01909479|156958179|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
48757090|NCT01909479|156958180|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
48757091|NCT01909479|156958179|FG000|26 - 52 Weeks|Adverse Event|0|||
48757092|NCT01909479|156958180|FG001|26 - 52 Weeks|Adverse Event|1|||
48757093|NCT01909479|156958179|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
48757094|NCT01909479|156958180|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
48757095|NCT01909479|156958179|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
48757096|NCT01909479|156958180|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
48757097|NCT01909479|156958179|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
48757098|NCT01909479|156958180|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
48757099|NCT01909479|156958179|FG000|52 Weeks to End of Study|Adverse Event|2|||
48757100|NCT01909479|156958180|FG001|52 Weeks to End of Study|Adverse Event|1|||
48757101|NCT01909479|156958179|FG000|52 Weeks to End of Study|Death|0|||
48757102|NCT01909479|156958180|FG001|52 Weeks to End of Study|Death|1|||
48757103|NCT01909479|156958179|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
48757104|NCT01909479|156958180|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
48757105|NCT01909479|156958179|FG000|52 Weeks to End of Study|Protocol Violation|1|||
48757106|NCT01909479|156958180|FG001|52 Weeks to End of Study|Protocol Violation|0|||
48757107|NCT01909479|156958179|FG000|52 Weeks to End of Study|Progressive disease|1|||
48757108|NCT01909479|156958180|FG001|52 Weeks to End of Study|Progressive disease|1|||
48757109|NCT01909479|156958179|FG000|52 Weeks to End of Study|Personal reasons|2|||
48757110|NCT01909479|156958180|FG001|52 Weeks to End of Study|Personal reasons|1|||
48757111|NCT01909479|156958179|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
48757112|NCT01909479|156958180|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
48757113|NCT01909479|156958179|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
48757114|NCT01909479|156958180|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
48757115|NCT01909479|156958179|FG000|52 Weeks to End of Study|Lack of contact|1|||
48757116|NCT01909479|156958180|FG001|52 Weeks to End of Study|Lack of contact|0|||
48757117|NCT01909479|156958179|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
48757118|NCT01909479|156958180|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
48757119|NCT01909479|156958179|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
48757120|NCT01909479|156958180|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
48757121|NCT04446377|156958181|FG000|Overall Study|Withdrawal by Subject|6|||
48757122|NCT04446377|156958182|FG001|Overall Study|Withdrawal by Subject|1|||
48757123|NCT04446377|156958181|FG000|Overall Study|Physician Decision|1|||
48757124|NCT04446377|156958182|FG001|Overall Study|Physician Decision|1|||
48757125|NCT04446377|156958181|FG000|Overall Study|Lost to Follow-up|0|||
48757126|NCT04446377|156958182|FG001|Overall Study|Lost to Follow-up|2|||
48757127|NCT04446377|156958181|FG000|Overall Study|Not eligible|0|||
48757128|NCT04446377|156958182|FG001|Overall Study|Not eligible|1|||
48757129|NCT03557151|156958184|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
48757130|NCT03557151|156958185|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
48757131|NCT03557151|156958184|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
48757132|NCT03557151|156958185|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
48757133|NCT03557151|156958184|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
48757134|NCT03557151|156958185|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
48757135|NCT00840294|156958186|FG000|Overall Study|Withdrawal by Subject|2|||
48757136|NCT00840294|156958187|FG001|Overall Study|Withdrawal by Subject|1|||
48757137|NCT00840294|156958186|FG000|Overall Study|Protocol Violation|1|||
48757138|NCT00840294|156958187|FG001|Overall Study|Protocol Violation|3|||
48757139|NCT00840294|156958186|FG000|Overall Study|Illness|0|||
48757140|NCT00840294|156958187|FG001|Overall Study|Illness|1|||
48757141|NCT04256785|156958190|FG000|Overall Study|Adverse Event|8|||
48757142|NCT04256785|156958191|FG001|Overall Study|Adverse Event|6|||
48757143|NCT04256785|156958190|FG000|Overall Study|Lack of Efficacy|3|||
48757144|NCT04256785|156958191|FG001|Overall Study|Lack of Efficacy|4|||
48757145|NCT04256785|156958190|FG000|Overall Study|Lost to Follow-up|7|||
48757146|NCT04256785|156958191|FG001|Overall Study|Lost to Follow-up|7|||
48757147|NCT04256785|156958190|FG000|Overall Study|Protocol Violation|1|||
48757148|NCT04256785|156958191|FG001|Overall Study|Protocol Violation|0|||
48757149|NCT04256785|156958190|FG000|Overall Study|Withdrawal by Subject|4|||
48757150|NCT04256785|156958191|FG001|Overall Study|Withdrawal by Subject|1|||
48757151|NCT04256785|156958190|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
48757152|NCT04256785|156958191|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
48757153|NCT03721276|156958192|FG000|Overall Study|Lost to Follow-up|5|||
48340301|NCT01136733|155440522|FG005|Phase 2|Participant Choice|0|||
48757154|NCT03721276|156958193|FG001|Overall Study|Lost to Follow-up|3|||
48757155|NCT03721276|156958192|FG000|Overall Study|Adverse Event|0|||
48757156|NCT03721276|156958193|FG001|Overall Study|Adverse Event|1|||
48757157|NCT03358290|156958194|FG000|Overall Study|Study discontinued by Sponsor|0|||
48757158|NCT03358290|156958195|FG001|Overall Study|Study discontinued by Sponsor|1|||
48757159|NCT03358290|156958196|FG002|Overall Study|Study discontinued by Sponsor|1|||
48757160|NCT03358290|156958197|FG003|Overall Study|Study discontinued by Sponsor|0|||
48757161|NCT03358290|156958198|FG004|Overall Study|Study discontinued by Sponsor|0|||
48757162|NCT03358290|156958194|FG000|Overall Study|Adverse Event|0|||
48757163|NCT03358290|156958195|FG001|Overall Study|Adverse Event|0|||
48340302|NCT01136733|155440523|FG006|Phase 2|Participant Choice|1|||
48340303|NCT01136733|155440517|FG000|Phase 2|Administrative-Withdrew Consent|0|||
48340304|NCT01136733|155440518|FG001|Phase 2|Administrative-Withdrew Consent|0|||
48340305|NCT01136733|155440519|FG002|Phase 2|Administrative-Withdrew Consent|0|||
48340306|NCT01136733|155440520|FG003|Phase 2|Administrative-Withdrew Consent|0|||
48340307|NCT01136733|155440521|FG004|Phase 2|Administrative-Withdrew Consent|1|||
48340308|NCT01136733|155440522|FG005|Phase 2|Administrative-Withdrew Consent|0|||
48340309|NCT01136733|155440523|FG006|Phase 2|Administrative-Withdrew Consent|0|||
48340310|NCT01136733|155440517|FG000|Phase 2|Other|0|||
48340311|NCT01136733|155440518|FG001|Phase 2|Other|0|||
48340312|NCT01136733|155440519|FG002|Phase 2|Other|0|||
48340313|NCT01136733|155440520|FG003|Phase 2|Other|0|||
48340314|NCT01136733|155440521|FG004|Phase 2|Other|6|||
48340315|NCT01136733|155440522|FG005|Phase 2|Other|7|||
48340316|NCT01136733|155440523|FG006|Phase 2|Other|6|||
48340317|NCT01703988|155440524|FG000|Overall Study|Investigator Judgment|0|||
48340318|NCT01703988|155440525|FG001|Overall Study|Investigator Judgment|0|||
48340319|NCT01703988|155440526|FG002|Overall Study|Investigator Judgment|0|||
48340320|NCT01703988|155440527|FG003|Overall Study|Investigator Judgment|1|||
48664451|NCT01962987|156625108|FG002|Overall Study|Serious Adverse Event|0|||
48664452|NCT01962987|156625106|FG000|Overall Study|Withdrawal by Subject|11|||
48664453|NCT01962987|156625107|FG001|Overall Study|Withdrawal by Subject|10|||
48664454|NCT01962987|156625108|FG002|Overall Study|Withdrawal by Subject|6|||
48664455|NCT01962987|156625106|FG000|Overall Study|Randomized in Error|4|||
48757164|NCT03358290|156958196|FG002|Overall Study|Adverse Event|1|||
48757165|NCT03358290|156958197|FG003|Overall Study|Adverse Event|2|||
48757166|NCT03358290|156958198|FG004|Overall Study|Adverse Event|0|||
48757167|NCT03358290|156958194|FG000|Overall Study|Withdrawal by Subject|0|||
48757168|NCT03358290|156958195|FG001|Overall Study|Withdrawal by Subject|0|||
48757169|NCT03358290|156958196|FG002|Overall Study|Withdrawal by Subject|0|||
48757170|NCT03358290|156958197|FG003|Overall Study|Withdrawal by Subject|0|||
48757171|NCT03358290|156958198|FG004|Overall Study|Withdrawal by Subject|1|||
48757172|NCT00416078|156958199|FG000|Overall Study|Death|3|||
48757173|NCT00416078|156958200|FG001|Overall Study|Death|4|||
48757174|NCT00416078|156958199|FG000|Overall Study|Withdrawal by Subject|3|||
48757175|NCT00416078|156958200|FG001|Overall Study|Withdrawal by Subject|2|||
48757176|NCT00416078|156958199|FG000|Overall Study|Physician Decision|1|||
48757177|NCT00416078|156958200|FG001|Overall Study|Physician Decision|0|||
48757178|NCT00416078|156958199|FG000|Overall Study|Lost to Follow-up|4|||
48757179|NCT00416078|156958200|FG001|Overall Study|Lost to Follow-up|2|||
48757180|NCT01829230|156958201|FG000|Overall Study|Protocol Violation|0|||
48757181|NCT01829230|156958202|FG001|Overall Study|Protocol Violation|2|||
48757182|NCT01829230|156958201|FG000|Overall Study|Withdrawal by Subject|0|||
48757183|NCT01829230|156958202|FG001|Overall Study|Withdrawal by Subject|1|||
48757184|NCT01829230|156958201|FG000|Overall Study|Lost to Follow-up|1|||
48664456|NCT01962987|156625107|FG001|Overall Study|Randomized in Error|2|||
48757185|NCT01829230|156958202|FG001|Overall Study|Lost to Follow-up|1|||
48340321|NCT04057937|155440533|FG000|Placebo-controlled Phase|Adverse Event|3|||
48664457|NCT01962987|156625108|FG002|Overall Study|Randomized in Error|2|||
48664458|NCT03361189|156625117|FG000|Overall Study|Received heart transplant|1|||
48664459|NCT03361189|156625118|FG001|Overall Study|Received heart transplant|0|||
48664460|NCT03361189|156625117|FG000|Overall Study|Pacemake replacement|0|||
48664461|NCT03361189|156625118|FG001|Overall Study|Pacemake replacement|1|||
48664462|NCT01338610|156625132|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
48664463|NCT01338610|156625133|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
48664464|NCT01338610|156625134|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
48664465|NCT01338610|156625132|FG000|Overall Study|Protocol Violation|1|||
48664466|NCT01338610|156625133|FG001|Overall Study|Protocol Violation|0|||
48664467|NCT01338610|156625134|FG002|Overall Study|Protocol Violation|1|||
48664468|NCT01338610|156625132|FG000|Overall Study|Adverse Event|3|||
48664469|NCT01338610|156625133|FG001|Overall Study|Adverse Event|0|||
48664470|NCT01338610|156625134|FG002|Overall Study|Adverse Event|0|||
48664471|NCT00171925|156625135|FG000|Overall Study|Adverse Event|10|||
48664472|NCT00171925|156625136|FG001|Overall Study|Adverse Event|6|||
48664473|NCT00171925|156625135|FG000|Overall Study|Protocol Violation|1|||
48664474|NCT00171925|156625136|FG001|Overall Study|Protocol Violation|1|||
48664475|NCT00171925|156625135|FG000|Overall Study|Withdrawal by Subject|6|||
48664476|NCT00171925|156625136|FG001|Overall Study|Withdrawal by Subject|9|||
48664477|NCT00171925|156625135|FG000|Overall Study|Lost to Follow-up|2|||
48664478|NCT00171925|156625136|FG001|Overall Study|Lost to Follow-up|2|||
48664479|NCT00171925|156625135|FG000|Overall Study|Administrative problems|10|||
48664480|NCT00171925|156625136|FG001|Overall Study|Administrative problems|11|||
48664481|NCT00171925|156625135|FG000|Overall Study|Death|1|||
48664482|NCT00171925|156625136|FG001|Overall Study|Death|2|||
48664483|NCT02590562|156625143|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
48664484|NCT00977938|156625146|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
48664485|NCT00977938|156625147|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
48664486|NCT00977938|156625148|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
48664487|NCT00977938|156625149|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
48664488|NCT00977938|156625146|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
48664489|NCT00977938|156625147|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
48757186|NCT00969150|156958203|FG000|Overall Study|Adverse Event|4|||
48757187|NCT00969150|156958204|FG001|Overall Study|Adverse Event|14|||
48757188|NCT00969150|156958203|FG000|Overall Study|Lack of Efficacy|1|||
48757189|NCT00969150|156958204|FG001|Overall Study|Lack of Efficacy|1|||
48340322|NCT04057937|155440534|FG001|Placebo-controlled Phase|Adverse Event|0|||
48664490|NCT00977938|156625148|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
48664491|NCT00977938|156625149|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
48664492|NCT00977938|156625146|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
48664493|NCT00977938|156625147|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
48664494|NCT00977938|156625148|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
48664495|NCT00977938|156625149|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
48664496|NCT00977938|156625146|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
48757190|NCT00969150|156958203|FG000|Overall Study|Protocol Violation|9|||
48757191|NCT00969150|156958204|FG001|Overall Study|Protocol Violation|12|||
48340323|NCT04057937|155440533|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
48340324|NCT04057937|155440534|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
48340325|NCT04057937|155440533|FG000|Active-treatment Phase|Pregnancy|0|||
48340326|NCT04057937|155440534|FG001|Active-treatment Phase|Pregnancy|1|||
48340327|NCT04057937|155440533|FG000|Active-treatment Phase|Physician Decision|0|||
48664497|NCT00977938|156625147|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
48664498|NCT00977938|156625148|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
48664499|NCT00977938|156625149|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
48664500|NCT00977938|156625146|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
48664501|NCT00977938|156625147|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
48664502|NCT00977938|156625148|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
48664503|NCT00977938|156625149|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
48664504|NCT00977938|156625146|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
48664505|NCT00977938|156625147|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
48664506|NCT00977938|156625148|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
48664507|NCT00977938|156625149|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
48664508|NCT02498067|156625150|FG000|Overall Study|Lost to Follow-up|22|||
48664509|NCT02498067|156625150|FG000|Overall Study|Did not meet inclusion criteria|11|||
48664510|NCT01697462|156625151|FG000|Overall Study|Disease Progression|1|||
48664511|NCT01697462|156625151|FG000|Overall Study|Adverse Event|6|||
48664512|NCT01697462|156625151|FG000|Overall Study|Lost to Follow-up|21|||
48664513|NCT01697462|156625151|FG000|Overall Study|Withdrawal by Subject|12|||
48664514|NCT01697462|156625151|FG000|Overall Study|Investigator Decision|21|||
48664515|NCT01697462|156625151|FG000|Overall Study|Death|1|||
48664516|NCT01697462|156625151|FG000|Overall Study|Other|10|||
48664517|NCT01697462|156625151|FG000|Overall Study|Missing|5|||
48664518|NCT00598078|156625152|FG000|Period 2 (Day 2)|Adverse Event|1|||
48664519|NCT00598078|156625153|FG001|Period 2 (Day 2)|Adverse Event|0|||
48664520|NCT02387164|156625154|FG000|Overall Study|Lost to Follow-up|2|||
48664521|NCT02387164|156625155|FG001|Overall Study|Lost to Follow-up|0|||
48664522|NCT02387164|156625154|FG000|Overall Study|Diagnosed|1|||
48664523|NCT02387164|156625155|FG001|Overall Study|Diagnosed|2|||
48664524|NCT02370641|156625158|FG000|Overall Study|dropped study|4|||
48664525|NCT02370641|156625159|FG001|Overall Study|dropped study|2|||
48664526|NCT02133664|156625161|FG000|Overall Study|Lost to Follow-up|2|||
48664527|NCT02133664|156625162|FG001|Overall Study|Lost to Follow-up|1|||
48664528|NCT02133664|156625161|FG000|Overall Study|Adverse Event|3|||
48664529|NCT02133664|156625162|FG001|Overall Study|Adverse Event|6|||
48664530|NCT01253265|156625163|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
48664531|NCT01253265|156625164|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
48664532|NCT01253265|156625165|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
48664533|NCT01253265|156625166|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
48664534|NCT01253265|156625167|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
48664535|NCT01253265|156625163|FG000|Overall Study|Withdrawal by Subject|0|||
48664536|NCT01253265|156625164|FG001|Overall Study|Withdrawal by Subject|0|||
48664537|NCT01253265|156625165|FG002|Overall Study|Withdrawal by Subject|0|||
48664538|NCT01253265|156625166|FG003|Overall Study|Withdrawal by Subject|0|||
48664539|NCT01253265|156625167|FG004|Overall Study|Withdrawal by Subject|1|||
48664540|NCT00541099|156625168|FG000|Overall Study|Ineligible|3|||
48664541|NCT02956850|156625169|FG000|Overall Study|Withdrawal by Subject|0|||
48664542|NCT02956850|156625170|FG001|Overall Study|Withdrawal by Subject|0|||
48664543|NCT02956850|156625171|FG002|Overall Study|Withdrawal by Subject|0|||
48664544|NCT02956850|156625172|FG003|Overall Study|Withdrawal by Subject|0|||
48664545|NCT02956850|156625173|FG004|Overall Study|Withdrawal by Subject|0|||
48664546|NCT02956850|156625174|FG005|Overall Study|Withdrawal by Subject|0|||
48664547|NCT02956850|156625175|FG006|Overall Study|Withdrawal by Subject|0|||
48664548|NCT02956850|156625176|FG007|Overall Study|Withdrawal by Subject|0|||
48664549|NCT02956850|156625177|FG008|Overall Study|Withdrawal by Subject|0|||
48664550|NCT02956850|156625178|FG009|Overall Study|Withdrawal by Subject|0|||
48664551|NCT02956850|156625179|FG010|Overall Study|Withdrawal by Subject|0|||
48664552|NCT02956850|156625180|FG011|Overall Study|Withdrawal by Subject|0|||
48664553|NCT02956850|156625181|FG012|Overall Study|Withdrawal by Subject|0|||
48664554|NCT02956850|156625182|FG013|Overall Study|Withdrawal by Subject|0|||
48664555|NCT02956850|156625183|FG014|Overall Study|Withdrawal by Subject|0|||
48664556|NCT02956850|156625184|FG015|Overall Study|Withdrawal by Subject|0|||
48664557|NCT02956850|156625185|FG016|Overall Study|Withdrawal by Subject|0|||
48664558|NCT02956850|156625186|FG017|Overall Study|Withdrawal by Subject|1|||
48664559|NCT00392808|156625187|FG000|Overall Study|Lost to Follow-up|3|||
48340328|NCT04057937|155440534|FG001|Active-treatment Phase|Physician Decision|1|||
48664560|NCT00392808|156625188|FG001|Overall Study|Lost to Follow-up|2|||
48664561|NCT00392808|156625189|FG002|Overall Study|Lost to Follow-up|1|||
48664562|NCT00392808|156625190|FG003|Overall Study|Lost to Follow-up|2|||
48664563|NCT00392808|156625187|FG000|Overall Study|Unable to withdraw blood|3|||
48664564|NCT00392808|156625188|FG001|Overall Study|Unable to withdraw blood|1|||
48664565|NCT00392808|156625189|FG002|Overall Study|Unable to withdraw blood|1|||
48757192|NCT00969150|156958203|FG000|Overall Study|Withdrawal by Subject|13|||
48757193|NCT00969150|156958204|FG001|Overall Study|Withdrawal by Subject|9|||
48757194|NCT00969150|156958203|FG000|Overall Study|Lost to Follow-up|5|||
48757195|NCT00969150|156958204|FG001|Overall Study|Lost to Follow-up|4|||
48757196|NCT00969150|156958203|FG000|Overall Study|Other reasons|1|||
48757197|NCT00969150|156958204|FG001|Overall Study|Other reasons|0|||
48757198|NCT00391274|156958205|FG000|Overall Study|Death Due to Study Disease|55|||
48757199|NCT00391274|156958206|FG001|Overall Study|Death Due to Study Disease|45|||
48757200|NCT00391274|156958205|FG000|Overall Study|Lost to Follow-up|0|||
48757201|NCT00391274|156958206|FG001|Overall Study|Lost to Follow-up|3|||
48757202|NCT00391274|156958205|FG000|Overall Study|Physician Decision|4|||
48757203|NCT00391274|156958206|FG001|Overall Study|Physician Decision|2|||
48757204|NCT00391274|156958205|FG000|Overall Study|Withdrawal by Subject|0|||
48757205|NCT00391274|156958206|FG001|Overall Study|Withdrawal by Subject|3|||
48757206|NCT00391274|156958205|FG000|Overall Study|Death Due to Adverse Event|1|||
48757207|NCT00391274|156958206|FG001|Overall Study|Death Due to Adverse Event|3|||
48757208|NCT00391274|156958205|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
48757209|NCT00391274|156958206|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
48757210|NCT00391274|156958205|FG000|Overall Study|Death Not Study Related|0|||
48757211|NCT00391274|156958206|FG001|Overall Study|Death Not Study Related|1|||
48757212|NCT01106898|156958209|FG000|Overall Study|Adverse Event|6|||
48757213|NCT01338493|156958210|FG000|Enrolled|Withdrawal by Subject|1|||
48757214|NCT01338493|156958210|FG000|Enrolled|Patient not implanted|4|||
48757215|NCT01338493|156958210|FG000|Discharge|Death|1|||
48757216|NCT01338493|156958210|FG000|Discharge|Missed visit|1|||
48757217|NCT01338493|156958210|FG000|6 Months Follow up|Lost to Follow-up|11|||
48757218|NCT01338493|156958210|FG000|6 Months Follow up|Missed visit|8|||
48757219|NCT01338493|156958210|FG000|12 Months Follow up|Lost to Follow-up|9|||
48757220|NCT01472081|156958211|FG000|Overall Study|Continuing treatment at time of analysis|1|||
48757221|NCT01472081|156958212|FG001|Overall Study|Continuing treatment at time of analysis|4|||
48757222|NCT01472081|156958213|FG002|Overall Study|Continuing treatment at time of analysis|1|||
48757223|NCT01472081|156958214|FG003|Overall Study|Continuing treatment at time of analysis|8|||
48757224|NCT01472081|156958215|FG004|Overall Study|Continuing treatment at time of analysis|9|||
48757225|NCT01472081|156958216|FG005|Overall Study|Continuing treatment at time of analysis|0|||
48757226|NCT01472081|156958211|FG000|Overall Study|Disease Progression|4|||
48757227|NCT01472081|156958212|FG001|Overall Study|Disease Progression|10|||
48757228|NCT01472081|156958213|FG002|Overall Study|Disease Progression|12|||
48757229|NCT01472081|156958214|FG003|Overall Study|Disease Progression|31|||
48757230|NCT01472081|156958215|FG004|Overall Study|Disease Progression|22|||
48664566|NCT00392808|156625190|FG003|Overall Study|Unable to withdraw blood|2|||
48664567|NCT01416441|156625193|FG000|Overall Study|Lost to Follow-up|5|||
48664568|NCT01416441|156625193|FG000|Overall Study|Adverse Event|6|||
48664569|NCT01416441|156625193|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
48664570|NCT01416441|156625193|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
48664571|NCT01416441|156625193|FG000|Overall Study|Investigator Withdrew Subject|2|||
48664572|NCT01416441|156625193|FG000|Overall Study|Subject Withdrew Consent|12|||
48664573|NCT01416441|156625193|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
48664574|NCT01945775|156625194|FG000|Overall Study|Death|214|||
48757231|NCT01472081|156958216|FG005|Overall Study|Disease Progression|3|||
48757232|NCT01472081|156958211|FG000|Overall Study|Study drug toxicity|2|||
48757233|NCT01472081|156958212|FG001|Overall Study|Study drug toxicity|9|||
48757234|NCT01472081|156958213|FG002|Overall Study|Study drug toxicity|4|||
48757235|NCT01472081|156958214|FG003|Overall Study|Study drug toxicity|6|||
48757236|NCT01472081|156958215|FG004|Overall Study|Study drug toxicity|13|||
48757237|NCT01472081|156958216|FG005|Overall Study|Study drug toxicity|2|||
48757238|NCT01472081|156958211|FG000|Overall Study|Death|0|||
48757239|NCT01472081|156958212|FG001|Overall Study|Death|0|||
48757240|NCT01472081|156958213|FG002|Overall Study|Death|0|||
48757241|NCT01472081|156958214|FG003|Overall Study|Death|0|||
48757242|NCT01472081|156958215|FG004|Overall Study|Death|1|||
48757243|NCT01472081|156958216|FG005|Overall Study|Death|0|||
48757244|NCT01472081|156958211|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
48757245|NCT01472081|156958212|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
48340329|NCT00005908|155440538|FG000|Overall Study|Withdrawal by Subject|1|||
48340330|NCT00005908|155440539|FG001|Overall Study|Withdrawal by Subject|0|||
48340331|NCT01268488|155440540|FG000|Overall Study|Adverse Event|3|||
48340332|NCT01268488|155440540|FG000|Overall Study|Physician Decision|2|||
48340333|NCT00938041|155440543|FG000|Overall Study|Lost to Follow-up|6|||
48340334|NCT00938041|155440543|FG000|Overall Study|Received Alternative Therapy|1|||
48340335|NCT00938041|155440543|FG000|Overall Study|Progressive Disease|5|||
48340336|NCT00938041|155440543|FG000|Overall Study|Death|12|||
48340337|NCT00938041|155440543|FG000|Overall Study|Adrenal Insufficiency|3|||
48340338|NCT00404547|155440544|FG000|Overall Study|Adverse Event|39|||
48340339|NCT00404547|155440545|FG001|Overall Study|Adverse Event|6|||
48340340|NCT00404547|155440544|FG000|Overall Study|Withdrawal by Subject|19|||
48340341|NCT00404547|155440545|FG001|Overall Study|Withdrawal by Subject|2|||
48340342|NCT00404547|155440544|FG000|Overall Study|Protocol Violation|0|||
48340343|NCT00404547|155440545|FG001|Overall Study|Protocol Violation|1|||
48340344|NCT00404547|155440544|FG000|Overall Study|Lost to Follow-up|20|||
48757246|NCT01472081|156958213|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
48664575|NCT01945775|156625195|FG001|Overall Study|Death|98|||
48664576|NCT01945775|156625194|FG000|Overall Study|Lost to Follow-up|12|||
48664577|NCT01945775|156625195|FG001|Overall Study|Lost to Follow-up|7|||
48664578|NCT01945775|156625194|FG000|Overall Study|Withdrawal by Subject|11|||
48664579|NCT01945775|156625195|FG001|Overall Study|Withdrawal by Subject|21|||
48664580|NCT01945775|156625194|FG000|Overall Study|Other|50|||
48664581|NCT01945775|156625195|FG001|Overall Study|Other|18|||
48664582|NCT01420627|156625196|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
48664583|NCT00787137|156625198|FG000|Overall Study|Study Termination|0|||
48664584|NCT00787137|156625199|FG001|Overall Study|Study Termination|0|||
48664585|NCT00787137|156625200|FG002|Overall Study|Study Termination|1|||
48664586|NCT03464422|156625201|FG000|Overall Study|Lost to Follow-up|2|||
48757247|NCT01472081|156958214|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
48757248|NCT01472081|156958215|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
48340345|NCT00404547|155440545|FG001|Overall Study|Lost to Follow-up|9|||
48340346|NCT00404547|155440544|FG000|Overall Study|Lack of compliance|5|||
48340347|NCT00404547|155440545|FG001|Overall Study|Lack of compliance|1|||
48340348|NCT00404547|155440544|FG000|Overall Study|Other|4|||
48340349|NCT00404547|155440545|FG001|Overall Study|Other|0|||
48340350|NCT00404547|155440544|FG000|Overall Study|Reason not stated|3|||
48340351|NCT00404547|155440545|FG001|Overall Study|Reason not stated|6|||
48340352|NCT06080438|155440550|FG000|Overall Study|Lost to Follow-up|2|||
48340353|NCT04543942|155440551|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
48340354|NCT04543942|155440552|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
48340355|NCT04543942|155440551|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
48340356|NCT04543942|155440552|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
48340357|NCT02522299|155440553|FG000|Overall Study|Adverse Event|2|||
48664587|NCT03464422|156625201|FG000|Overall Study|Withdrawal by Subject|2|||
48757249|NCT01472081|156958216|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
48757250|NCT01472081|156958211|FG000|Overall Study|Withdrawal by Subject|0|||
48757251|NCT01472081|156958212|FG001|Overall Study|Withdrawal by Subject|0|||
48757252|NCT01472081|156958213|FG002|Overall Study|Withdrawal by Subject|0|||
48757253|NCT01472081|156958214|FG003|Overall Study|Withdrawal by Subject|0|||
48340358|NCT02522299|155440554|FG001|Overall Study|Adverse Event|0|||
48664588|NCT03353922|156625203|FG000|Overall Study|Withdrawal by Subject|1|||
48664589|NCT03353922|156625204|FG001|Overall Study|Withdrawal by Subject|0|||
48664590|NCT03353922|156625205|FG002|Overall Study|Withdrawal by Subject|1|||
48664591|NCT03353922|156625206|FG003|Overall Study|Withdrawal by Subject|1|||
48664592|NCT03353922|156625207|FG004|Overall Study|Withdrawal by Subject|0|||
48664593|NCT03353922|156625208|FG005|Overall Study|Withdrawal by Subject|0|||
48664594|NCT03353922|156625203|FG000|Overall Study|Adverse Event|0|||
48664595|NCT03353922|156625204|FG001|Overall Study|Adverse Event|1|||
48664596|NCT03353922|156625205|FG002|Overall Study|Adverse Event|0|||
48664597|NCT03353922|156625206|FG003|Overall Study|Adverse Event|0|||
48664598|NCT03353922|156625207|FG004|Overall Study|Adverse Event|0|||
48664599|NCT03353922|156625208|FG005|Overall Study|Adverse Event|0|||
48664600|NCT00868530|156625209|FG000|Overall Study|Adverse Event|3|||
48340359|NCT02522299|155440553|FG000|Overall Study|Physician Decision|0|||
48340360|NCT02522299|155440554|FG001|Overall Study|Physician Decision|1|||
48340361|NCT02522299|155440553|FG000|Overall Study|Withdrawal by Subject|2|||
48340362|NCT02522299|155440554|FG001|Overall Study|Withdrawal by Subject|0|||
48664601|NCT00868530|156625209|FG000|Overall Study|Lost to Follow-up|1|||
48664602|NCT00886119|156625210|FG000|Period 1|Did not meet inclusion criteria|1|||
48757254|NCT01472081|156958215|FG004|Overall Study|Withdrawal by Subject|0|||
48757255|NCT01472081|156958216|FG005|Overall Study|Withdrawal by Subject|1|||
48340363|NCT01446042|155440555|FG000|Overall Study|Withdrawal by Subject|12|||
48340364|NCT01446042|155440556|FG001|Overall Study|Withdrawal by Subject|2|||
48340365|NCT01446042|155440557|FG002|Overall Study|Withdrawal by Subject|4|||
48664603|NCT00886119|156625211|FG001|Period 1|Did not meet inclusion criteria|0|||
48664604|NCT01902888|156625212|FG000|Overall Study|Study Terminated|3|||
48664605|NCT02616393|156625216|FG000|Overall Study|Death|5|||
48340366|NCT01446042|155440555|FG000|Overall Study|Adverse Event|1|||
48340367|NCT01446042|155440556|FG001|Overall Study|Adverse Event|0|||
48340368|NCT01446042|155440557|FG002|Overall Study|Adverse Event|4|||
48340369|NCT01446042|155440555|FG000|Overall Study|Lost to Follow-up|5|||
48340370|NCT01446042|155440556|FG001|Overall Study|Lost to Follow-up|0|||
48340371|NCT01446042|155440557|FG002|Overall Study|Lost to Follow-up|0|||
48340372|NCT01446042|155440555|FG000|Overall Study|Other reasons|2|||
48340373|NCT01446042|155440556|FG001|Overall Study|Other reasons|1|||
48340374|NCT01446042|155440557|FG002|Overall Study|Other reasons|1|||
48340375|NCT00910871|155440558|FG000|Overall Study|Adverse Event|5|||
48340376|NCT00910871|155440558|FG000|Overall Study|Death|12|||
48340377|NCT00910871|155440558|FG000|Overall Study|Lost to Follow-up|8|||
48340378|NCT00910871|155440558|FG000|Overall Study|Protocol Violation|11|||
48340379|NCT00910871|155440558|FG000|Overall Study|Withdrawal by Subject|12|||
48340380|NCT00910871|155440558|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
48340381|NCT00910871|155440558|FG000|Overall Study|Undefined|1|||
48340382|NCT02359552|155440559|FG000|Overall Study|Lost to Follow-up|3|||
48340383|NCT02359552|155440560|FG001|Overall Study|Lost to Follow-up|4|||
48340384|NCT02573883|155440561|FG000|Six Month Follow Up|Lost to Follow-up|1|||
48340385|NCT02573883|155440562|FG001|Six Month Follow Up|Lost to Follow-up|0|||
48340386|NCT02573883|155440563|FG002|Six Month Follow Up|Lost to Follow-up|0|||
48340387|NCT02573883|155440564|FG003|Six Month Follow Up|Lost to Follow-up|0|||
48340388|NCT02573883|155440561|FG000|One Year Follow Up|Lost to Follow-up|2|||
48340389|NCT02573883|155440562|FG001|One Year Follow Up|Lost to Follow-up|1|||
48340390|NCT02573883|155440563|FG002|One Year Follow Up|Lost to Follow-up|0|||
48340391|NCT02573883|155440564|FG003|One Year Follow Up|Lost to Follow-up|0|||
48340392|NCT00607789|155440565|FG000|Overall Study|Adverse Event|3|||
48340393|NCT00607789|155440566|FG001|Overall Study|Adverse Event|0|||
48340394|NCT00607789|155440565|FG000|Overall Study|Lack of Efficacy|0|||
48340395|NCT00607789|155440566|FG001|Overall Study|Lack of Efficacy|1|||
48340396|NCT00607789|155440565|FG000|Overall Study|Inadequate adherence|3|||
48340397|NCT00607789|155440566|FG001|Overall Study|Inadequate adherence|0|||
48340398|NCT00607789|155440565|FG000|Overall Study|Lost to Follow-up|0|||
48340399|NCT00607789|155440566|FG001|Overall Study|Lost to Follow-up|5|||
48340400|NCT00607789|155440565|FG000|Overall Study|Withdrawal by Subject|1|||
48340401|NCT00607789|155440566|FG001|Overall Study|Withdrawal by Subject|0|||
48340402|NCT01313299|155440568|FG000|Overall Study|Adverse Event|3|||
48340403|NCT01313299|155440569|FG001|Overall Study|Adverse Event|1|||
48340404|NCT01313299|155440570|FG002|Overall Study|Adverse Event|1|||
48340405|NCT01313299|155440568|FG000|Overall Study|Lost to Follow-up|1|||
48340406|NCT01313299|155440569|FG001|Overall Study|Lost to Follow-up|0|||
48340407|NCT01313299|155440570|FG002|Overall Study|Lost to Follow-up|0|||
48340408|NCT01313299|155440568|FG000|Overall Study|Protocol Violation|2|||
48340409|NCT01313299|155440569|FG001|Overall Study|Protocol Violation|0|||
48340410|NCT01313299|155440570|FG002|Overall Study|Protocol Violation|0|||
48340411|NCT01313299|155440568|FG000|Overall Study|Withdrawal by Subject|1|||
48340412|NCT01313299|155440569|FG001|Overall Study|Withdrawal by Subject|0|||
48340413|NCT01313299|155440570|FG002|Overall Study|Withdrawal by Subject|2|||
48340414|NCT01313299|155440568|FG000|Overall Study|Family reason and moved out of state|0|||
48340415|NCT01313299|155440569|FG001|Overall Study|Family reason and moved out of state|2|||
48340416|NCT01313299|155440570|FG002|Overall Study|Family reason and moved out of state|0|||
48340417|NCT01313299|155440568|FG000|Overall Study|Lack of subject compliance|0|||
48340418|NCT01313299|155440569|FG001|Overall Study|Lack of subject compliance|0|||
48340419|NCT01313299|155440570|FG002|Overall Study|Lack of subject compliance|1|||
48340420|NCT04089332|155440572|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
48340421|NCT04089332|155440572|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
48340422|NCT04089332|155440572|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
48340423|NCT02971683|155440582|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
48340424|NCT02971683|155440583|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
48340425|NCT02971683|155440582|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
48340426|NCT02971683|155440583|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
48340427|NCT02971683|155440582|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
48340428|NCT02971683|155440583|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
48340429|NCT02971683|155440582|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
48340430|NCT02971683|155440583|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
48340431|NCT02971683|155440582|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
48664606|NCT02616393|156625217|FG001|Overall Study|Death|12|||
48664607|NCT02616393|156625218|FG002|Overall Study|Death|1|||
48664608|NCT02616393|156625216|FG000|Overall Study|Termination by Sponsor|4|||
48664609|NCT02616393|156625217|FG001|Overall Study|Termination by Sponsor|5|||
48664610|NCT02616393|156625218|FG002|Overall Study|Termination by Sponsor|2|||
48664611|NCT02616393|156625216|FG000|Overall Study|Other|3|||
48664612|NCT02616393|156625217|FG001|Overall Study|Other|0|||
48664613|NCT02616393|156625218|FG002|Overall Study|Other|0|||
48664614|NCT02616393|156625216|FG000|Overall Study|Withdrawal by Subject|1|||
48664615|NCT02616393|156625217|FG001|Overall Study|Withdrawal by Subject|1|||
48664616|NCT02616393|156625218|FG002|Overall Study|Withdrawal by Subject|0|||
48664617|NCT02616393|156625216|FG000|Overall Study|Lost to Follow-up|0|||
48664618|NCT02616393|156625217|FG001|Overall Study|Lost to Follow-up|2|||
48664619|NCT02616393|156625218|FG002|Overall Study|Lost to Follow-up|0|||
48664620|NCT01460407|156625219|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
48664621|NCT01460407|156625220|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
48664622|NCT00526110|156625231|FG000|Overall Study|Adverse Event|2|||
48664623|NCT00526110|156625232|FG001|Overall Study|Adverse Event|9|||
48664624|NCT00526110|156625231|FG000|Overall Study|Disease Progression|0|||
48664625|NCT00526110|156625232|FG001|Overall Study|Disease Progression|19|||
48664626|NCT00526110|156625231|FG000|Overall Study|Maximal Response|0|||
48664627|NCT00526110|156625232|FG001|Overall Study|Maximal Response|6|||
48664628|NCT00526110|156625231|FG000|Overall Study|Withdrawal by Subject|0|||
48664629|NCT00526110|156625232|FG001|Overall Study|Withdrawal by Subject|2|||
48664630|NCT00526110|156625231|FG000|Overall Study|Poor Tolerance|0|||
48664631|NCT00526110|156625232|FG001|Overall Study|Poor Tolerance|5|||
48664632|NCT01011933|156625233|FG000|Overall Study|Wrong cell type|1|||
48664633|NCT01011933|156625233|FG000|Overall Study|Improper pre-protocol Rx|1|||
48664634|NCT01011933|156625233|FG000|Overall Study|Inadequate pathology|1|||
48664635|NCT01011933|156625233|FG000|Overall Study|Never treated|1|||
48664636|NCT01439074|156625236|FG000|Overall Study|Lost to Follow-up|3|||
48664637|NCT01439074|156625237|FG001|Overall Study|Lost to Follow-up|4|||
48664638|NCT01439074|156625236|FG000|Overall Study|Subject shedding|1|||
48664639|NCT01439074|156625237|FG001|Overall Study|Subject shedding|0|||
48664640|NCT01439074|156625236|FG000|Overall Study|Withdrawal by Subject|1|||
48664641|NCT01439074|156625237|FG001|Overall Study|Withdrawal by Subject|5|||
48664642|NCT01439074|156625236|FG000|Overall Study|Other|4|||
48664643|NCT01439074|156625237|FG001|Overall Study|Other|4|||
48664644|NCT02193087|156625238|FG000|Overall Study|Adverse Event|2|||
48664645|NCT02193087|156625239|FG001|Overall Study|Adverse Event|0|||
48664646|NCT02193087|156625240|FG002|Overall Study|Adverse Event|0|||
48664647|NCT02193087|156625241|FG003|Overall Study|Adverse Event|11|||
48664648|NCT02193087|156625238|FG000|Overall Study|Lost to Follow-up|14|||
48664649|NCT02193087|156625239|FG001|Overall Study|Lost to Follow-up|6|||
48664650|NCT02193087|156625240|FG002|Overall Study|Lost to Follow-up|4|||
48664651|NCT02193087|156625241|FG003|Overall Study|Lost to Follow-up|37|||
48664652|NCT02193087|156625238|FG000|Overall Study|Protocol Violation|2|||
48664653|NCT02193087|156625239|FG001|Overall Study|Protocol Violation|0|||
48664654|NCT02193087|156625240|FG002|Overall Study|Protocol Violation|1|||
48664655|NCT02193087|156625241|FG003|Overall Study|Protocol Violation|2|||
48664656|NCT02193087|156625238|FG000|Overall Study|Withdrawal by Subject|10|||
48664657|NCT02193087|156625239|FG001|Overall Study|Withdrawal by Subject|3|||
48664658|NCT02193087|156625240|FG002|Overall Study|Withdrawal by Subject|1|||
48664659|NCT02193087|156625241|FG003|Overall Study|Withdrawal by Subject|19|||
48664660|NCT02193087|156625238|FG000|Overall Study|Other Reason Not Specified|7|||
48664661|NCT02193087|156625239|FG001|Overall Study|Other Reason Not Specified|2|||
48664662|NCT02193087|156625240|FG002|Overall Study|Other Reason Not Specified|1|||
48664663|NCT02193087|156625241|FG003|Overall Study|Other Reason Not Specified|9|||
48664664|NCT02193087|156625238|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
48664665|NCT02193087|156625239|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
48664666|NCT02193087|156625240|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
48664667|NCT02193087|156625241|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
48664668|NCT01100567|156625242|FG000|Overall Study|Withdrawal by Subject|5|||
48664669|NCT01100567|156625243|FG001|Overall Study|Withdrawal by Subject|8|||
48664670|NCT01100567|156625242|FG000|Overall Study|Early Hospital Discharge|6|||
48664671|NCT01100567|156625243|FG001|Overall Study|Early Hospital Discharge|4|||
48664672|NCT01100567|156625242|FG000|Overall Study|Lost to Follow-up|1|||
48757256|NCT01472081|156958211|FG000|Overall Study|Poor/non-compliance|0|||
48757257|NCT01472081|156958212|FG001|Overall Study|Poor/non-compliance|0|||
48757258|NCT01472081|156958213|FG002|Overall Study|Poor/non-compliance|1|||
48757259|NCT01472081|156958214|FG003|Overall Study|Poor/non-compliance|0|||
48757260|NCT01472081|156958215|FG004|Overall Study|Poor/non-compliance|1|||
48757261|NCT01472081|156958216|FG005|Overall Study|Poor/non-compliance|0|||
48757262|NCT01472081|156958211|FG000|Overall Study|No longer meets study criteria|0|||
48757263|NCT01472081|156958212|FG001|Overall Study|No longer meets study criteria|0|||
48757264|NCT01472081|156958213|FG002|Overall Study|No longer meets study criteria|1|||
48757265|NCT01472081|156958214|FG003|Overall Study|No longer meets study criteria|0|||
48757266|NCT01472081|156958215|FG004|Overall Study|No longer meets study criteria|0|||
48757267|NCT01472081|156958216|FG005|Overall Study|No longer meets study criteria|0|||
48757268|NCT01472081|156958211|FG000|Overall Study|Subject request to discontinue treatment|0|||
48757269|NCT01472081|156958212|FG001|Overall Study|Subject request to discontinue treatment|3|||
48757270|NCT01472081|156958213|FG002|Overall Study|Subject request to discontinue treatment|1|||
48757271|NCT01472081|156958214|FG003|Overall Study|Subject request to discontinue treatment|1|||
48757272|NCT01472081|156958215|FG004|Overall Study|Subject request to discontinue treatment|0|||
48757273|NCT01472081|156958216|FG005|Overall Study|Subject request to discontinue treatment|0|||
48757274|NCT00541034|156958218|FG000|Overall Study|Non-Compliance|3|||
48757275|NCT00975481|156958221|FG000|Second Intervention Period|Adverse Event|2|||
48757276|NCT00975481|156958222|FG001|Second Intervention Period|Adverse Event|1|||
48757277|NCT00975481|156958223|FG002|Second Intervention Period|Adverse Event|0|||
48757278|NCT00975481|156958224|FG003|Second Intervention Period|Adverse Event|0|||
48757279|NCT00975481|156958225|FG004|Second Intervention Period|Adverse Event|0|||
48757280|NCT00975481|156958226|FG005|Second Intervention Period|Adverse Event|0|||
48757281|NCT00975481|156958221|FG000|Second Intervention Period|Withdrawal by Subject|0|||
48757282|NCT00975481|156958222|FG001|Second Intervention Period|Withdrawal by Subject|0|||
48757283|NCT00975481|156958223|FG002|Second Intervention Period|Withdrawal by Subject|1|||
48757284|NCT00975481|156958224|FG003|Second Intervention Period|Withdrawal by Subject|0|||
48757285|NCT00975481|156958225|FG004|Second Intervention Period|Withdrawal by Subject|0|||
48757286|NCT00975481|156958226|FG005|Second Intervention Period|Withdrawal by Subject|0|||
48757287|NCT00975481|156958221|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
48757288|NCT00975481|156958222|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
48757289|NCT00975481|156958223|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
48757290|NCT00975481|156958224|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
48757291|NCT00975481|156958225|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
48757292|NCT00975481|156958226|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
48757293|NCT00975481|156958221|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
48757294|NCT00975481|156958222|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
48757295|NCT00975481|156958223|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
48757296|NCT00975481|156958224|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
48757297|NCT00975481|156958225|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
48757298|NCT00975481|156958226|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
48757299|NCT00056407|156958227|FG000|Overall Study|Adverse Event|282|||
48757300|NCT00056407|156958228|FG001|Overall Study|Adverse Event|364|||
48757301|NCT00056407|156958227|FG000|Overall Study|Withdrawal by Subject|377|||
48757302|NCT00056407|156958228|FG001|Overall Study|Withdrawal by Subject|361|||
48757303|NCT00056407|156958227|FG000|Overall Study|Lost to Follow-up|123|||
48757304|NCT00056407|156958228|FG001|Overall Study|Lost to Follow-up|113|||
48757305|NCT00056407|156958227|FG000|Overall Study|Protocol Violation|104|||
48757306|NCT00056407|156958228|FG001|Overall Study|Protocol Violation|95|||
48757307|NCT00056407|156958227|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
48757308|NCT00056407|156958228|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
48757309|NCT00056407|156958227|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
48757310|NCT00056407|156958228|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
48664673|NCT01100567|156625243|FG001|Overall Study|Lost to Follow-up|2|||
48664674|NCT01100567|156625242|FG000|Overall Study|Physician Decision|0|||
48664675|NCT01100567|156625243|FG001|Overall Study|Physician Decision|1|||
48664676|NCT01100567|156625242|FG000|Overall Study|Deemed ineligible after consent|0|||
48664677|NCT01100567|156625243|FG001|Overall Study|Deemed ineligible after consent|1|||
48664678|NCT01498185|156625245|FG000|Overall Study|Adverse Event|0|||
48664679|NCT01498185|156625246|FG001|Overall Study|Adverse Event|0|||
48664680|NCT01498185|156625247|FG002|Overall Study|Adverse Event|0|||
48664681|NCT01498185|156625248|FG003|Overall Study|Adverse Event|1|||
48664682|NCT01498185|156625249|FG004|Overall Study|Adverse Event|0|||
48664683|NCT01498185|156625245|FG000|Overall Study|Withdrawal by Subject|1|||
48664684|NCT01498185|156625246|FG001|Overall Study|Withdrawal by Subject|1|||
48664685|NCT01498185|156625247|FG002|Overall Study|Withdrawal by Subject|0|||
48664686|NCT01498185|156625248|FG003|Overall Study|Withdrawal by Subject|2|||
48664687|NCT01498185|156625249|FG004|Overall Study|Withdrawal by Subject|1|||
48664688|NCT01498185|156625245|FG000|Overall Study|No longer met criteria, etc|0|||
48340432|NCT02971683|155440583|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
48340433|NCT02971683|155440582|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
48340434|NCT02971683|155440583|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
48340435|NCT02971683|155440582|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
48340436|NCT02971683|155440583|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
48340437|NCT02971683|155440582|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
48340438|NCT02971683|155440583|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
48340439|NCT02971683|155440582|FG000|Open-Label|Lost to Follow-up|1|||
48340440|NCT02971683|155440583|FG001|Open-Label|Lost to Follow-up|0|||
48340441|NCT02971683|155440582|FG000|Open-Label|Participants withdrew consent|0|||
48340442|NCT02971683|155440583|FG001|Open-Label|Participants withdrew consent|2|||
48340443|NCT02971683|155440582|FG000|Open-Label|Participant request to discontinue study treatment|1|||
48340444|NCT02971683|155440583|FG001|Open-Label|Participant request to discontinue study treatment|0|||
48340445|NCT02971683|155440582|FG000|Open-Label|Lack of Efficacy|2|||
48340446|NCT02971683|155440583|FG001|Open-Label|Lack of Efficacy|0|||
48340447|NCT02971683|155440582|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
48340448|NCT02971683|155440583|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
48340449|NCT02971683|155440582|FG000|Long-Term Open Label|Participant withdrew consent|1|||
48340450|NCT02971683|155440583|FG001|Long-Term Open Label|Participant withdrew consent|0|||
48340451|NCT02971683|155440582|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
48340452|NCT02971683|155440583|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
48340453|NCT02971683|155440582|FG000|Long-Term Open Label|Adverse Event|1|||
48340454|NCT02971683|155440583|FG001|Long-Term Open Label|Adverse Event|2|||
48340455|NCT02971683|155440582|FG000|Long-Term Open Label|Lack of Efficacy|1|||
48340456|NCT02971683|155440583|FG001|Long-Term Open Label|Lack of Efficacy|1|||
48340457|NCT02963922|155440584|FG000|Overall Study|Adverse Event|15|||
48340458|NCT02963922|155440585|FG001|Overall Study|Adverse Event|6|||
48340459|NCT02963922|155440584|FG000|Overall Study|Protocol deviation|6|||
48340460|NCT02963922|155440585|FG001|Overall Study|Protocol deviation|6|||
48340461|NCT02963922|155440584|FG000|Overall Study|Lack of Efficacy|1|||
48340462|NCT02963922|155440585|FG001|Overall Study|Lack of Efficacy|1|||
48340463|NCT02963922|155440584|FG000|Overall Study|Lost to Follow-up|2|||
48340464|NCT02963922|155440585|FG001|Overall Study|Lost to Follow-up|3|||
48340465|NCT02963922|155440584|FG000|Overall Study|Other|8|||
48340466|NCT02963922|155440585|FG001|Overall Study|Other|14|||
48340467|NCT00500539|155440586|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
48340468|NCT00500539|155440586|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
48340469|NCT00500539|155440586|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
48340470|NCT00500539|155440586|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
48340471|NCT00500539|155440586|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
48340472|NCT00500539|155440586|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
48340473|NCT00500539|155440586|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
48340474|NCT00500539|155440586|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
48340475|NCT00500539|155440586|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
48340476|NCT00500539|155440586|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
48340477|NCT00500539|155440586|FG000|Follow-up Period (16 Weeks)|Death|1|||
48340478|NCT00500539|155440586|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
48340479|NCT00500539|155440586|FG000|Follow-up Period (16 Weeks)|Missing|3|||
48340480|NCT04872101|155442198|FG000|Overall Study|Withdrawal by Subject|10|||
48340481|NCT04872101|155442199|FG001|Overall Study|Withdrawal by Subject|16|||
48340482|NCT04872101|155442198|FG000|Overall Study|Lack of Efficacy|6|||
48340483|NCT04872101|155442199|FG001|Overall Study|Lack of Efficacy|14|||
48340484|NCT04872101|155442198|FG000|Overall Study|Adverse Event|1|||
48340485|NCT04872101|155442199|FG001|Overall Study|Adverse Event|6|||
48340486|NCT04872101|155442198|FG000|Overall Study|Lost to Follow-up|2|||
48340487|NCT04872101|155442199|FG001|Overall Study|Lost to Follow-up|1|||
48664689|NCT01498185|156625246|FG001|Overall Study|No longer met criteria, etc|0|||
48664690|NCT01498185|156625247|FG002|Overall Study|No longer met criteria, etc|0|||
48664691|NCT01498185|156625248|FG003|Overall Study|No longer met criteria, etc|0|||
48664692|NCT01498185|156625249|FG004|Overall Study|No longer met criteria, etc|2|||
48664693|NCT02608450|156625252|FG000|Overall Study|Lost to Follow-up|39|||
48664694|NCT02608450|156625253|FG001|Overall Study|Lost to Follow-up|32|||
48664695|NCT02608450|156625252|FG000|Overall Study|Withdrawal by Subject|21|||
48664696|NCT02608450|156625253|FG001|Overall Study|Withdrawal by Subject|15|||
48664697|NCT02608450|156625252|FG000|Overall Study|Adverse Event|3|||
48664698|NCT02608450|156625253|FG001|Overall Study|Adverse Event|6|||
48664699|NCT02608450|156625252|FG000|Overall Study|Withdrawal by parent|2|||
48664700|NCT02608450|156625253|FG001|Overall Study|Withdrawal by parent|3|||
48664701|NCT02608450|156625252|FG000|Overall Study|Lack of Efficacy|0|||
48664702|NCT02608450|156625253|FG001|Overall Study|Lack of Efficacy|3|||
48664703|NCT02608450|156625252|FG000|Overall Study|Noncompliance with study drug|0|||
48664704|NCT02608450|156625253|FG001|Overall Study|Noncompliance with study drug|2|||
48664705|NCT02608450|156625252|FG000|Overall Study|Physician Decision|0|||
48664706|NCT02608450|156625253|FG001|Overall Study|Physician Decision|1|||
48664707|NCT02608450|156625252|FG000|Overall Study|Pregnancy|0|||
48664708|NCT02608450|156625253|FG001|Overall Study|Pregnancy|1|||
48664709|NCT02608450|156625252|FG000|Overall Study|Progressive disease|1|||
48664710|NCT02608450|156625253|FG001|Overall Study|Progressive disease|0|||
48664711|NCT02608450|156625252|FG000|Overall Study|Multiple reasons|0|||
48664712|NCT02608450|156625253|FG001|Overall Study|Multiple reasons|2|||
48664713|NCT00276614|156625258|FG000|Overall Study|Progression of disease under study|3|||
48757311|NCT00056407|156958227|FG000|Overall Study|Missing|25|||
48757312|NCT00056407|156958228|FG001|Overall Study|Missing|34|||
48757313|NCT03251079|156958229|FG000|Overall Study|Withdrawal by Subject|1|||
48757314|NCT01428453|156958230|FG000|Overall Study|Adverse Event|2|||
48757315|NCT01428453|156958231|FG001|Overall Study|Adverse Event|7|||
48757316|NCT01428453|156958230|FG000|Overall Study|Protocol Violation|1|||
48757317|NCT01428453|156958231|FG001|Overall Study|Protocol Violation|0|||
48757318|NCT01428453|156958230|FG000|Overall Study|Lost to Follow-up|0|||
48757319|NCT01428453|156958231|FG001|Overall Study|Lost to Follow-up|1|||
48757320|NCT01428453|156958230|FG000|Overall Study|Withdrawal by Subject|3|||
48757321|NCT01428453|156958231|FG001|Overall Study|Withdrawal by Subject|1|||
48757322|NCT01996709|156958236|FG000|Overall Study|Withdrawal by Subject|1|||
48757323|NCT01996709|156958237|FG001|Overall Study|Withdrawal by Subject|0|||
48757324|NCT01996709|156958236|FG000|Overall Study|Lost to Follow-up|3|||
48757325|NCT01996709|156958237|FG001|Overall Study|Lost to Follow-up|0|||
48757326|NCT01996709|156958236|FG000|Overall Study|Subject Non-Compliant|1|||
48757327|NCT01996709|156958237|FG001|Overall Study|Subject Non-Compliant|0|||
48757328|NCT01996709|156958236|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
48757329|NCT01996709|156958237|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
48757330|NCT05517382|156958240|FG000|Overall Study|Lost to Follow-up|0|||
48757331|NCT05517382|156958241|FG001|Overall Study|Lost to Follow-up|1|||
48757332|NCT02677922|156958248|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
48757333|NCT02677922|156958249|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
48664714|NCT02449018|156625259|FG000|Overall Study|Abnormal laboratory value|0|||
48664715|NCT02449018|156625260|FG001|Overall Study|Abnormal laboratory value|1|||
48664716|NCT02449018|156625259|FG000|Overall Study|Administrative problems|1|||
48664717|NCT02449018|156625260|FG001|Overall Study|Administrative problems|0|||
48664718|NCT02449018|156625259|FG000|Overall Study|Adverse Event|5|||
48340488|NCT04872101|155442198|FG000|Overall Study|Pregnancy|2|||
48340489|NCT04872101|155442199|FG001|Overall Study|Pregnancy|0|||
48340490|NCT04872101|155442198|FG000|Overall Study|Prohibited Medication|1|||
48340491|NCT04872101|155442199|FG001|Overall Study|Prohibited Medication|0|||
48340492|NCT04872101|155442198|FG000|Overall Study|Not dosed|1|||
48340493|NCT04872101|155442199|FG001|Overall Study|Not dosed|0|||
48340494|NCT01838499|155442200|FG000|Overall Study|Protocol Violation|0|||
48340495|NCT01838499|155442201|FG001|Overall Study|Protocol Violation|1|||
48340496|NCT01838499|155442200|FG000|Overall Study|Lost to Follow-up|2|||
48340497|NCT01838499|155442201|FG001|Overall Study|Lost to Follow-up|4|||
48340498|NCT01838499|155442200|FG000|Overall Study|Lack of Efficacy|1|||
48340499|NCT01838499|155442201|FG001|Overall Study|Lack of Efficacy|2|||
48340500|NCT01838499|155442200|FG000|Overall Study|Adverse Event|2|||
48340501|NCT01838499|155442201|FG001|Overall Study|Adverse Event|1|||
48340502|NCT01838499|155442200|FG000|Overall Study|Withdrawal by Subject|19|||
48340503|NCT01838499|155442201|FG001|Overall Study|Withdrawal by Subject|9|||
48340504|NCT01193283|155442202|FG000|Overall Study|Death|1|||
48340505|NCT02368691|155442203|FG000|Overall Study|Death|13|||
48340506|NCT02368691|155442203|FG000|Overall Study|Lack of Efficacy|15|||
48340507|NCT02368691|155442203|FG000|Overall Study|Physician Decision|4|||
48340508|NCT01654289|155442204|FG000|Overall Study|Withdrawal by Subject|10|||
48340509|NCT01654289|155442205|FG001|Overall Study|Withdrawal by Subject|8|||
48340510|NCT01654289|155442206|FG002|Overall Study|Withdrawal by Subject|5|||
48340511|NCT01654289|155442204|FG000|Overall Study|Withdrew from intervention only|17|||
48340512|NCT01654289|155442205|FG001|Overall Study|Withdrew from intervention only|20|||
48340513|NCT01654289|155442206|FG002|Overall Study|Withdrew from intervention only|0|||
48340514|NCT04194541|155442207|FG000|Day 1 Through 13|Lost to Follow-up|3|||
48340515|NCT04194541|155442207|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
48340516|NCT04194541|155442207|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
48340517|NCT01103141|155442208|FG000|Overall Study|Death|0|||
48340518|NCT01103141|155442209|FG001|Overall Study|Death|1|||
48340519|NCT01103141|155442208|FG000|Overall Study|Lost to Follow-up|2|||
48340520|NCT01103141|155442209|FG001|Overall Study|Lost to Follow-up|1|||
48340521|NCT01403805|155442210|FG000|Overall Study|Withdrawal by Subject|0|||
48340522|NCT01403805|155442211|FG001|Overall Study|Withdrawal by Subject|4|||
48340523|NCT01403805|155442210|FG000|Overall Study|Lost to Follow-up|0|||
48340524|NCT01403805|155442211|FG001|Overall Study|Lost to Follow-up|2|||
48340525|NCT01403805|155442210|FG000|Overall Study|Death|0|||
48340526|NCT01403805|155442211|FG001|Overall Study|Death|1|||
48340527|NCT01695993|155442212|FG000|Overall Study|Lost to Follow-up|2|||
48340528|NCT01695993|155442213|FG001|Overall Study|Lost to Follow-up|1|||
48340529|NCT01695993|155442214|FG002|Overall Study|Lost to Follow-up|3|||
48340530|NCT01695993|155442212|FG000|Overall Study|Withdrawal by Subject|2|||
48340531|NCT01695993|155442213|FG001|Overall Study|Withdrawal by Subject|2|||
48340532|NCT01695993|155442214|FG002|Overall Study|Withdrawal by Subject|2|||
48340533|NCT01695993|155442212|FG000|Overall Study|To ill to continue|1|||
48340534|NCT01695993|155442213|FG001|Overall Study|To ill to continue|2|||
48340535|NCT01695993|155442214|FG002|Overall Study|To ill to continue|0|||
48340536|NCT01695993|155442212|FG000|Overall Study|Changed Medical Facility|0|||
48340537|NCT01695993|155442213|FG001|Overall Study|Changed Medical Facility|0|||
48340538|NCT01695993|155442214|FG002|Overall Study|Changed Medical Facility|1|||
48340539|NCT01732627|155442215|FG000|Overall Study|Withdrawal by Subject|1|||
48340540|NCT01732627|155442216|FG001|Overall Study|Withdrawal by Subject|0|||
48340541|NCT02029521|155442217|FG000|Overall Study|Protocol Violation|1|||
48340542|NCT02029521|155442218|FG001|Overall Study|Protocol Violation|0|||
48340543|NCT02029521|155442217|FG000|Overall Study|Withdrawal by Subject|1|||
48340544|NCT02029521|155442218|FG001|Overall Study|Withdrawal by Subject|1|||
48340545|NCT01026103|155442226|FG000|Overall Study|Physician Decision|1|||
48340546|NCT01026103|155442226|FG000|Overall Study|did not receive study device bc of error|1|||
48340547|NCT00762502|155442227|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
48340548|NCT00762502|155442228|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
48664719|NCT02449018|156625260|FG001|Overall Study|Adverse Event|1|||
48664720|NCT02449018|156625259|FG000|Overall Study|Protocol deviation|4|||
48664721|NCT02449018|156625260|FG001|Overall Study|Protocol deviation|0|||
48340549|NCT00762502|155442229|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
48340550|NCT00762502|155442227|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
48340551|NCT00762502|155442228|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
48340552|NCT00762502|155442229|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
48340553|NCT00762502|155442227|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
48340554|NCT00762502|155442228|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
48340555|NCT00762502|155442229|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
48340556|NCT02504502|155442230|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
48757334|NCT02677922|156958250|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
48757335|NCT02677922|156958251|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
48757336|NCT02677922|156958252|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
48757337|NCT02677922|156958253|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
48757338|NCT02677922|156958248|FG000|Treatment Period|Adverse Event|0|||
48757339|NCT02677922|156958249|FG001|Treatment Period|Adverse Event|0|||
48757340|NCT02677922|156958250|FG002|Treatment Period|Adverse Event|1|||
48757341|NCT02677922|156958251|FG003|Treatment Period|Adverse Event|3|||
48757342|NCT02677922|156958252|FG004|Treatment Period|Adverse Event|5|||
48757343|NCT02677922|156958253|FG005|Treatment Period|Adverse Event|2|||
48757344|NCT02677922|156958248|FG000|Treatment Period|Progressive Disease|1|||
48757345|NCT02677922|156958249|FG001|Treatment Period|Progressive Disease|1|||
48757346|NCT02677922|156958250|FG002|Treatment Period|Progressive Disease|0|||
48757347|NCT02677922|156958251|FG003|Treatment Period|Progressive Disease|0|||
48757348|NCT02677922|156958252|FG004|Treatment Period|Progressive Disease|8|||
48757349|NCT02677922|156958253|FG005|Treatment Period|Progressive Disease|7|||
48757350|NCT02677922|156958248|FG000|Treatment Period|Lack of Efficacy|0|||
48757351|NCT02677922|156958249|FG001|Treatment Period|Lack of Efficacy|0|||
48757352|NCT02677922|156958250|FG002|Treatment Period|Lack of Efficacy|0|||
48757353|NCT02677922|156958251|FG003|Treatment Period|Lack of Efficacy|1|||
48757354|NCT02677922|156958252|FG004|Treatment Period|Lack of Efficacy|1|||
48757355|NCT02677922|156958253|FG005|Treatment Period|Lack of Efficacy|6|||
48757356|NCT02677922|156958248|FG000|Treatment Period|Withdrawal by Subject|0|||
48757357|NCT02677922|156958249|FG001|Treatment Period|Withdrawal by Subject|0|||
48757358|NCT02677922|156958250|FG002|Treatment Period|Withdrawal by Subject|1|||
48757359|NCT02677922|156958251|FG003|Treatment Period|Withdrawal by Subject|3|||
48757360|NCT02677922|156958252|FG004|Treatment Period|Withdrawal by Subject|5|||
48757361|NCT02677922|156958253|FG005|Treatment Period|Withdrawal by Subject|5|||
48757362|NCT02677922|156958248|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
48757363|NCT02677922|156958249|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
48757364|NCT02677922|156958250|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
48757365|NCT02677922|156958251|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
48757366|NCT02677922|156958252|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
48757367|NCT02677922|156958253|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
48340557|NCT02504502|155442231|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
48664722|NCT02449018|156625259|FG000|Overall Study|Patient decision|2|||
48664723|NCT02449018|156625260|FG001|Overall Study|Patient decision|0|||
48664724|NCT01288612|156626902|FG000|Overall Study|Unable to contact|11|||
48664725|NCT01288612|156626903|FG001|Overall Study|Unable to contact|16|||
48664726|NCT01288612|156626904|FG002|Overall Study|Unable to contact|20|||
48664727|NCT01288612|156626902|FG000|Overall Study|Declined|78|||
48664728|NCT01288612|156626903|FG001|Overall Study|Declined|63|||
48664729|NCT01288612|156626904|FG002|Overall Study|Declined|62|||
48664730|NCT01288612|156626902|FG000|Overall Study|Unable to intubate|0|||
48664731|NCT01288612|156626903|FG001|Overall Study|Unable to intubate|3|||
48664732|NCT01288612|156626904|FG002|Overall Study|Unable to intubate|0|||
48664733|NCT00428220|156626905|FG000|Overall Study|Participant died|8|||
48664734|NCT00428220|156626905|FG000|Overall Study|Global deterioration of health status|7|||
48664735|NCT00428220|156626905|FG000|Overall Study|Lost to Follow-up|4|||
48664736|NCT00428220|156626905|FG000|Overall Study|Objective progression or relapse|123|||
48664737|NCT00428220|156626905|FG000|Overall Study|Participant refused continued treatment|7|||
48664738|NCT00428220|156626905|FG000|Overall Study|Adverse Event|51|||
48664739|NCT00428220|156626905|FG000|Overall Study|Other|23|||
48664740|NCT01328041|156626907|FG000|Overall Study|Adverse Event|7|||
48664741|NCT01328041|156626907|FG000|Overall Study|Lack of Efficacy|27|||
48664742|NCT01328041|156626907|FG000|Overall Study|Protocol Violation|7|||
48664743|NCT01328041|156626907|FG000|Overall Study|Lost to Follow-up|7|||
48664744|NCT01328041|156626907|FG000|Overall Study|Physician Decision|2|||
48664745|NCT01328041|156626907|FG000|Overall Study|Withdrawal by Subject|7|||
48664746|NCT01460719|156626911|FG000|Overall Study|Adverse Event|1|||
48664747|NCT01460719|156626911|FG000|Overall Study|Withdrawal by Subject|1|||
48757368|NCT02677922|156958248|FG000|Treatment Period|Disease Relapse|0|||
48757369|NCT02677922|156958249|FG001|Treatment Period|Disease Relapse|0|||
48757370|NCT02677922|156958250|FG002|Treatment Period|Disease Relapse|0|||
48664748|NCT00823212|156626912|FG000|Overall Study|Death|8|||
48664749|NCT00823212|156626913|FG001|Overall Study|Death|10|||
48664750|NCT00823212|156626912|FG000|Overall Study|Withdrawal by Subject|6|||
48664751|NCT00823212|156626913|FG001|Overall Study|Withdrawal by Subject|1|||
48664752|NCT00823212|156626912|FG000|Overall Study|Incarcerated|0|||
48664753|NCT00823212|156626913|FG001|Overall Study|Incarcerated|1|||
48664754|NCT00823212|156626912|FG000|Overall Study|Missed 12-month visit|21|||
48757371|NCT02677922|156958251|FG003|Treatment Period|Disease Relapse|3|||
48757372|NCT02677922|156958252|FG004|Treatment Period|Disease Relapse|6|||
48757373|NCT02677922|156958253|FG005|Treatment Period|Disease Relapse|1|||
48757374|NCT02677922|156958248|FG000|Treatment Period|Allogeneic HSCT|1|||
48757375|NCT02677922|156958249|FG001|Treatment Period|Allogeneic HSCT|0|||
48757376|NCT02677922|156958250|FG002|Treatment Period|Allogeneic HSCT|0|||
48340558|NCT02504502|155442230|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
48664755|NCT00823212|156626913|FG001|Overall Study|Missed 12-month visit|21|||
48664756|NCT00149994|156626914|FG000|Overall Study|Administrative problems:|1|||
48340559|NCT02504502|155442231|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
48757377|NCT02677922|156958251|FG003|Treatment Period|Allogeneic HSCT|1|||
48757378|NCT02677922|156958252|FG004|Treatment Period|Allogeneic HSCT|4|||
48757379|NCT02677922|156958253|FG005|Treatment Period|Allogeneic HSCT|1|||
48757380|NCT02677922|156958248|FG000|Treatment Period|Other Reasons|0|||
48757381|NCT02677922|156958249|FG001|Treatment Period|Other Reasons|0|||
48757382|NCT02677922|156958250|FG002|Treatment Period|Other Reasons|0|||
48757383|NCT02677922|156958251|FG003|Treatment Period|Other Reasons|1|||
48757384|NCT02677922|156958252|FG004|Treatment Period|Other Reasons|3|||
48757385|NCT02677922|156958253|FG005|Treatment Period|Other Reasons|5|||
48757386|NCT02677922|156958248|FG000|Treatment Period|Death|0|||
48757387|NCT02677922|156958249|FG001|Treatment Period|Death|0|||
48757388|NCT02677922|156958250|FG002|Treatment Period|Death|0|||
48757389|NCT02677922|156958251|FG003|Treatment Period|Death|0|||
48757390|NCT02677922|156958252|FG004|Treatment Period|Death|12|||
48757391|NCT02677922|156958253|FG005|Treatment Period|Death|1|||
48757392|NCT02677922|156958248|FG000|Treatment Period|Non-compliance with Study Drug|0|||
48757393|NCT02677922|156958249|FG001|Treatment Period|Non-compliance with Study Drug|0|||
48757394|NCT02677922|156958250|FG002|Treatment Period|Non-compliance with Study Drug|0|||
48757395|NCT02677922|156958251|FG003|Treatment Period|Non-compliance with Study Drug|0|||
48757396|NCT02677922|156958252|FG004|Treatment Period|Non-compliance with Study Drug|1|||
48757397|NCT02677922|156958253|FG005|Treatment Period|Non-compliance with Study Drug|0|||
48757398|NCT02677922|156958248|FG000|Treatment Period|Physician Decision|0|||
48757399|NCT02677922|156958249|FG001|Treatment Period|Physician Decision|0|||
48757400|NCT02677922|156958250|FG002|Treatment Period|Physician Decision|0|||
48340560|NCT03042559|155442232|FG000|Overall Study|drop out|1|||
48340561|NCT03042559|155442233|FG001|Overall Study|drop out|1|||
48340562|NCT02744898|155442237|FG000|Overall Study|Progressive Disease|2|||
48757401|NCT02677922|156958251|FG003|Treatment Period|Physician Decision|0|||
48340563|NCT02744898|155442237|FG000|Overall Study|Physician Decision|1|||
48340564|NCT02744898|155442237|FG000|Overall Study|Toxicity|1|||
48340565|NCT03802513|155442244|FG000|Overall Study|Lost to Follow-up|1|||
48340566|NCT01190228|155442245|FG000|Overall Study|Protocol Violation|4|||
48340567|NCT01190228|155442246|FG001|Overall Study|Protocol Violation|0|||
48340568|NCT01190228|155442247|FG002|Overall Study|Protocol Violation|0|||
48664757|NCT00149994|156626915|FG001|Overall Study|Administrative problems:|0|||
48664758|NCT00149994|156626914|FG000|Overall Study|Protocol Violation|0|||
48664759|NCT00149994|156626915|FG001|Overall Study|Protocol Violation|1|||
48664760|NCT00098722|156626916|FG000|Double Blind Phase|Adverse Event|7|||
48664761|NCT00098722|156626917|FG001|Double Blind Phase|Adverse Event|7|||
48664762|NCT00098722|156626918|FG002|Double Blind Phase|Adverse Event|3|||
48664763|NCT00098722|156626919|FG003|Double Blind Phase|Adverse Event|0|||
48664764|NCT00098722|156626920|FG004|Double Blind Phase|Adverse Event|0|||
48664765|NCT00098722|156626921|FG005|Double Blind Phase|Adverse Event|0|||
48664766|NCT00098722|156626922|FG006|Double Blind Phase|Adverse Event|0|||
48664767|NCT00098722|156626916|FG000|Double Blind Phase|Death|2|||
48664768|NCT00098722|156626917|FG001|Double Blind Phase|Death|5|||
48664769|NCT00098722|156626918|FG002|Double Blind Phase|Death|0|||
48664770|NCT00098722|156626919|FG003|Double Blind Phase|Death|0|||
48664771|NCT00098722|156626920|FG004|Double Blind Phase|Death|0|||
48664772|NCT00098722|156626921|FG005|Double Blind Phase|Death|0|||
48664773|NCT00098722|156626922|FG006|Double Blind Phase|Death|0|||
48664774|NCT00098722|156626916|FG000|Double Blind Phase|Lack of Efficacy|21|||
48664775|NCT00098722|156626917|FG001|Double Blind Phase|Lack of Efficacy|23|||
48757402|NCT02677922|156958252|FG004|Treatment Period|Physician Decision|0|||
48757403|NCT02677922|156958253|FG005|Treatment Period|Physician Decision|1|||
48757404|NCT02677922|156958248|FG000|Treatment Period|Symptomatic Deterioration|0|||
48340569|NCT01190228|155442245|FG000|Overall Study|Withdrawal by Subject|1|||
48340570|NCT01190228|155442246|FG001|Overall Study|Withdrawal by Subject|0|||
48340571|NCT01190228|155442247|FG002|Overall Study|Withdrawal by Subject|0|||
48340572|NCT03120949|155442248|FG000|Overall Study|randomized in error|1|||
48664776|NCT00098722|156626918|FG002|Double Blind Phase|Lack of Efficacy|15|||
48664777|NCT00098722|156626919|FG003|Double Blind Phase|Lack of Efficacy|0|||
48664778|NCT00098722|156626920|FG004|Double Blind Phase|Lack of Efficacy|0|||
48664779|NCT00098722|156626921|FG005|Double Blind Phase|Lack of Efficacy|0|||
48664780|NCT00098722|156626922|FG006|Double Blind Phase|Lack of Efficacy|0|||
48664781|NCT00098722|156626916|FG000|Double Blind Phase|Participant defaulted|16|||
48664782|NCT00098722|156626917|FG001|Double Blind Phase|Participant defaulted|11|||
48664783|NCT00098722|156626918|FG002|Double Blind Phase|Participant defaulted|9|||
48757405|NCT02677922|156958249|FG001|Treatment Period|Symptomatic Deterioration|0|||
48757406|NCT02677922|156958250|FG002|Treatment Period|Symptomatic Deterioration|0|||
48757407|NCT02677922|156958251|FG003|Treatment Period|Symptomatic Deterioration|0|||
48757408|NCT02677922|156958252|FG004|Treatment Period|Symptomatic Deterioration|1|||
48340573|NCT03120949|155442249|FG001|Overall Study|randomized in error|0|||
48664784|NCT00098722|156626919|FG003|Double Blind Phase|Participant defaulted|0|||
48340574|NCT03120949|155442248|FG000|Overall Study|Death|13|||
48340575|NCT03120949|155442249|FG001|Overall Study|Death|13|||
48340576|NCT03120949|155442248|FG000|Overall Study|Lost to Follow-up|23|||
48340577|NCT03120949|155442249|FG001|Overall Study|Lost to Follow-up|13|||
48340578|NCT03120949|155442248|FG000|Overall Study|Withdrawal by Subject|139|||
48340579|NCT03120949|155442249|FG001|Overall Study|Withdrawal by Subject|124|||
48340580|NCT03120949|155442248|FG000|Overall Study|Covid-19|43|||
48340581|NCT03120949|155442249|FG001|Overall Study|Covid-19|34|||
48340582|NCT03120949|155442248|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
48340583|NCT03120949|155442249|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
48340584|NCT03120949|155442248|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
48340585|NCT03120949|155442249|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
48340586|NCT03120949|155442248|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
48340587|NCT03120949|155442249|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
48340588|NCT03120949|155442248|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
48664785|NCT00098722|156626920|FG004|Double Blind Phase|Participant defaulted|0|||
48340589|NCT03120949|155442249|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
48340590|NCT03120949|155442248|FG000|Overall Study|Site was closed|2|||
48340591|NCT03120949|155442249|FG001|Overall Study|Site was closed|3|||
48340592|NCT03120949|155442248|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
48340593|NCT03120949|155442249|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
48340594|NCT03120949|155442248|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
48340595|NCT03120949|155442249|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
48340596|NCT03120949|155442248|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
48340597|NCT03120949|155442249|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
48340598|NCT03120949|155442248|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
48340599|NCT03120949|155442249|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
48340600|NCT03120949|155442248|FG000|Overall Study|Other: Adverse Event|0|||
48340601|NCT03120949|155442249|FG001|Overall Study|Other: Adverse Event|1|||
48340602|NCT03120949|155442248|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
48340603|NCT03120949|155442249|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
48340604|NCT03120949|155442248|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
48340605|NCT03120949|155442249|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
48340606|NCT03120949|155442248|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
48340607|NCT03120949|155442249|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
48340608|NCT03120949|155442248|FG000|Overall Study|Personal Reasons|0|||
48340609|NCT03120949|155442249|FG001|Overall Study|Personal Reasons|1|||
48340610|NCT03120949|155442248|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
48340611|NCT03120949|155442249|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
48340612|NCT03120949|155442248|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
48340613|NCT03120949|155442249|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
48340614|NCT03120949|155442248|FG000|Overall Study|Compliance With Medication|0|||
48340615|NCT03120949|155442249|FG001|Overall Study|Compliance With Medication|1|||
48340616|NCT03120949|155442248|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
48340617|NCT03120949|155442249|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
48340618|NCT03120949|155442248|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
48340619|NCT03120949|155442249|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
48340620|NCT03120949|155442248|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
48340621|NCT03120949|155442249|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
48340622|NCT00348283|155442251|FG000|Induction|Adverse Event|0|||
48340623|NCT00348283|155442252|FG001|Induction|Adverse Event|2|||
48340624|NCT00348283|155442251|FG000|Induction|Protocol Violation|0|||
48664786|NCT00098722|156626921|FG005|Double Blind Phase|Participant defaulted|0|||
48664787|NCT00098722|156626922|FG006|Double Blind Phase|Participant defaulted|0|||
48664788|NCT00098722|156626916|FG000|Double Blind Phase|Pregnancy|1|||
48664789|NCT00098722|156626917|FG001|Double Blind Phase|Pregnancy|0|||
48664790|NCT00098722|156626918|FG002|Double Blind Phase|Pregnancy|0|||
48664791|NCT00098722|156626919|FG003|Double Blind Phase|Pregnancy|0|||
48664792|NCT00098722|156626920|FG004|Double Blind Phase|Pregnancy|0|||
48664793|NCT00098722|156626921|FG005|Double Blind Phase|Pregnancy|0|||
48664794|NCT00098722|156626922|FG006|Double Blind Phase|Pregnancy|0|||
48757409|NCT02677922|156958253|FG005|Treatment Period|Symptomatic Deterioration|0|||
48757410|NCT01782664|156958262|FG000|Overall Study|Adverse Event|2|||
48757411|NCT01782664|156958263|FG001|Overall Study|Adverse Event|2|||
48757412|NCT01782664|156958264|FG002|Overall Study|Adverse Event|2|||
48757413|NCT01782664|156958265|FG003|Overall Study|Adverse Event|2|||
48757414|NCT01782664|156958266|FG004|Overall Study|Adverse Event|0|||
48757415|NCT01782664|156958267|FG005|Overall Study|Adverse Event|0|||
48757416|NCT01782664|156958262|FG000|Overall Study|Lack of Efficacy|2|||
48757417|NCT01782664|156958263|FG001|Overall Study|Lack of Efficacy|0|||
48757418|NCT01782664|156958264|FG002|Overall Study|Lack of Efficacy|2|||
48757419|NCT01782664|156958265|FG003|Overall Study|Lack of Efficacy|2|||
48757420|NCT01782664|156958266|FG004|Overall Study|Lack of Efficacy|0|||
48757421|NCT01782664|156958267|FG005|Overall Study|Lack of Efficacy|0|||
48757422|NCT01782664|156958262|FG000|Overall Study|Protocol Violation|0|||
48757423|NCT01782664|156958263|FG001|Overall Study|Protocol Violation|1|||
48757424|NCT01782664|156958264|FG002|Overall Study|Protocol Violation|0|||
48757425|NCT01782664|156958265|FG003|Overall Study|Protocol Violation|1|||
48757426|NCT01782664|156958266|FG004|Overall Study|Protocol Violation|0|||
48757427|NCT01782664|156958267|FG005|Overall Study|Protocol Violation|0|||
48757428|NCT01782664|156958262|FG000|Overall Study|Withdrawal by Subject|2|||
48757429|NCT01782664|156958263|FG001|Overall Study|Withdrawal by Subject|2|||
48340625|NCT00348283|155442252|FG001|Induction|Protocol Violation|4|||
48664795|NCT00098722|156626916|FG000|Double Blind Phase|Randomized, not treated|4|||
48664796|NCT00098722|156626917|FG001|Double Blind Phase|Randomized, not treated|3|||
48664797|NCT00098722|156626918|FG002|Double Blind Phase|Randomized, not treated|3|||
48664798|NCT00098722|156626919|FG003|Double Blind Phase|Randomized, not treated|0|||
48664799|NCT00098722|156626920|FG004|Double Blind Phase|Randomized, not treated|0|||
48664800|NCT00098722|156626921|FG005|Double Blind Phase|Randomized, not treated|0|||
48664801|NCT00098722|156626922|FG006|Double Blind Phase|Randomized, not treated|0|||
48664802|NCT00098722|156626916|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
48664803|NCT00098722|156626917|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
48664804|NCT00098722|156626918|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
48664805|NCT00098722|156626919|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
48664806|NCT00098722|156626920|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
48664807|NCT00098722|156626921|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
48664808|NCT00098722|156626922|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
48664809|NCT00098722|156626916|FG000|Double Blind Phase|Other|7|||
48664810|NCT00098722|156626917|FG001|Double Blind Phase|Other|8|||
48664811|NCT00098722|156626918|FG002|Double Blind Phase|Other|7|||
48664812|NCT00098722|156626919|FG003|Double Blind Phase|Other|0|||
48664813|NCT00098722|156626920|FG004|Double Blind Phase|Other|0|||
48664814|NCT00098722|156626921|FG005|Double Blind Phase|Other|0|||
48664815|NCT00098722|156626922|FG006|Double Blind Phase|Other|0|||
48664816|NCT00098722|156626916|FG000|Open Label Phase|Adverse Event|0|||
48664817|NCT00098722|156626917|FG001|Open Label Phase|Adverse Event|0|||
48664818|NCT00098722|156626918|FG002|Open Label Phase|Adverse Event|0|||
48664819|NCT00098722|156626919|FG003|Open Label Phase|Adverse Event|5|||
48664820|NCT00098722|156626920|FG004|Open Label Phase|Adverse Event|0|||
48664821|NCT00098722|156626921|FG005|Open Label Phase|Adverse Event|0|||
48664822|NCT00098722|156626922|FG006|Open Label Phase|Adverse Event|0|||
48664823|NCT00098722|156626916|FG000|Open Label Phase|Death|0|||
48664824|NCT00098722|156626917|FG001|Open Label Phase|Death|0|||
48664825|NCT00098722|156626918|FG002|Open Label Phase|Death|0|||
48664826|NCT00098722|156626919|FG003|Open Label Phase|Death|2|||
48664827|NCT00098722|156626920|FG004|Open Label Phase|Death|0|||
48757430|NCT01782664|156958264|FG002|Overall Study|Withdrawal by Subject|0|||
48757431|NCT01782664|156958265|FG003|Overall Study|Withdrawal by Subject|0|||
48757432|NCT01782664|156958266|FG004|Overall Study|Withdrawal by Subject|0|||
48757433|NCT01782664|156958267|FG005|Overall Study|Withdrawal by Subject|0|||
48664828|NCT00098722|156626921|FG005|Open Label Phase|Death|0|||
48664829|NCT00098722|156626922|FG006|Open Label Phase|Death|0|||
48664830|NCT00098722|156626916|FG000|Open Label Phase|Lack of Efficacy|0|||
48664831|NCT00098722|156626917|FG001|Open Label Phase|Lack of Efficacy|0|||
48664832|NCT00098722|156626918|FG002|Open Label Phase|Lack of Efficacy|0|||
48664833|NCT00098722|156626919|FG003|Open Label Phase|Lack of Efficacy|8|||
48664834|NCT00098722|156626920|FG004|Open Label Phase|Lack of Efficacy|0|||
48664835|NCT00098722|156626921|FG005|Open Label Phase|Lack of Efficacy|0|||
48664836|NCT00098722|156626922|FG006|Open Label Phase|Lack of Efficacy|0|||
48664837|NCT00098722|156626916|FG000|Open Label Phase|Pregnancy|0|||
48757434|NCT00529542|156958268|FG000|Overall Study|Withdrawal by Subject|1|||
48340626|NCT00348283|155442251|FG000|Double Blind|Adverse Event|2|||
48340627|NCT00348283|155442252|FG001|Double Blind|Adverse Event|5|||
48340628|NCT00348283|155442251|FG000|Double Blind|Withdrawal by Subject|1|||
48340629|NCT00348283|155442252|FG001|Double Blind|Withdrawal by Subject|1|||
48664838|NCT00098722|156626917|FG001|Open Label Phase|Pregnancy|0|||
48664839|NCT00098722|156626918|FG002|Open Label Phase|Pregnancy|0|||
48664840|NCT00098722|156626919|FG003|Open Label Phase|Pregnancy|1|||
48664841|NCT00098722|156626920|FG004|Open Label Phase|Pregnancy|0|||
48664842|NCT00098722|156626921|FG005|Open Label Phase|Pregnancy|0|||
48340630|NCT00348283|155442251|FG000|Double Blind|Protocol Violation|0|||
48340631|NCT00348283|155442252|FG001|Double Blind|Protocol Violation|1|||
48340632|NCT00348283|155442251|FG000|Double Blind|Lack of Efficacy|2|||
48340633|NCT00348283|155442252|FG001|Double Blind|Lack of Efficacy|2|||
48340634|NCT00348283|155442251|FG000|Double Blind|Pregnancy|0|||
48340635|NCT00348283|155442252|FG001|Double Blind|Pregnancy|1|||
48340636|NCT00348283|155442251|FG000|Open Label|Adverse Event|0|||
48340637|NCT00348283|155442252|FG001|Open Label|Adverse Event|8|||
48340638|NCT00348283|155442251|FG000|Open Label|Withdrawal by Subject|0|||
48340639|NCT00348283|155442252|FG001|Open Label|Withdrawal by Subject|4|||
48340640|NCT00348283|155442251|FG000|Open Label|Lost to Follow-up|0|||
48340641|NCT00348283|155442252|FG001|Open Label|Lost to Follow-up|1|||
48340642|NCT00348283|155442251|FG000|Open Label|Lack of Efficacy|0|||
48340643|NCT00348283|155442252|FG001|Open Label|Lack of Efficacy|13|||
48340644|NCT00348283|155442251|FG000|Open Label|Administrative reasons|0|||
48340645|NCT00348283|155442252|FG001|Open Label|Administrative reasons|5|||
48340646|NCT00348283|155442251|FG000|Open Label|Subject moved to the United States|0|||
48340647|NCT00348283|155442252|FG001|Open Label|Subject moved to the United States|1|||
48340648|NCT00348283|155442251|FG000|Open Label|Pregnancy|0|||
48340649|NCT00348283|155442252|FG001|Open Label|Pregnancy|1|||
48340650|NCT00348283|155442251|FG000|Open Label|Sponsor decision|0|||
48664843|NCT00098722|156626922|FG006|Open Label Phase|Pregnancy|0|||
48664844|NCT00098722|156626916|FG000|Open Label Phase|Participant defaulted|0|||
48664845|NCT00098722|156626917|FG001|Open Label Phase|Participant defaulted|0|||
48664846|NCT00098722|156626918|FG002|Open Label Phase|Participant defaulted|0|||
48664847|NCT00098722|156626919|FG003|Open Label Phase|Participant defaulted|18|||
48664848|NCT00098722|156626920|FG004|Open Label Phase|Participant defaulted|0|||
48664849|NCT00098722|156626921|FG005|Open Label Phase|Participant defaulted|0|||
48340651|NCT00348283|155442252|FG001|Open Label|Sponsor decision|1|||
48340652|NCT03873714|155442253|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
48340653|NCT01247922|155442254|FG000|Overall Study|Disease progression|4|||
48340654|NCT05740371|155442257|FG000|Overall Study|Death|1|||
48340655|NCT00985621|155442272|FG000|Overall Study|Adverse Event|2|||
48340656|NCT00985621|155442273|FG001|Overall Study|Adverse Event|3|||
48340657|NCT00985621|155442274|FG002|Overall Study|Adverse Event|4|||
48340658|NCT00985621|155442275|FG003|Overall Study|Adverse Event|16|||
48340659|NCT00985621|155442272|FG000|Overall Study|Lack of Efficacy|10|||
48340660|NCT00985621|155442273|FG001|Overall Study|Lack of Efficacy|6|||
48340661|NCT00985621|155442274|FG002|Overall Study|Lack of Efficacy|5|||
48340662|NCT00985621|155442275|FG003|Overall Study|Lack of Efficacy|12|||
48664850|NCT00098722|156626922|FG006|Open Label Phase|Participant defaulted|0|||
48664851|NCT00098722|156626916|FG000|Open Label Phase|Ongoing at cut-off date|0|||
48664852|NCT00098722|156626917|FG001|Open Label Phase|Ongoing at cut-off date|0|||
48664853|NCT00098722|156626918|FG002|Open Label Phase|Ongoing at cut-off date|0|||
48664854|NCT00098722|156626919|FG003|Open Label Phase|Ongoing at cut-off date|220|||
48664855|NCT00098722|156626920|FG004|Open Label Phase|Ongoing at cut-off date|50|||
48664856|NCT00098722|156626921|FG005|Open Label Phase|Ongoing at cut-off date|0|||
48664857|NCT00098722|156626922|FG006|Open Label Phase|Ongoing at cut-off date|0|||
48664858|NCT00098722|156626916|FG000|Open Label Phase|Other|0|||
48664859|NCT00098722|156626917|FG001|Open Label Phase|Other|0|||
48340663|NCT00985621|155442272|FG000|Overall Study|Lost to Follow-up|2|||
48340664|NCT00985621|155442273|FG001|Overall Study|Lost to Follow-up|3|||
48340665|NCT00985621|155442274|FG002|Overall Study|Lost to Follow-up|4|||
48340666|NCT00985621|155442275|FG003|Overall Study|Lost to Follow-up|4|||
48340667|NCT00985621|155442272|FG000|Overall Study|Study Terminated by Sponsor|89|||
48340668|NCT00985621|155442273|FG001|Overall Study|Study Terminated by Sponsor|108|||
48340669|NCT00985621|155442274|FG002|Overall Study|Study Terminated by Sponsor|99|||
48340670|NCT00985621|155442275|FG003|Overall Study|Study Terminated by Sponsor|92|||
48340671|NCT00985621|155442272|FG000|Overall Study|Protocol Violation|1|||
48340672|NCT00985621|155442273|FG001|Overall Study|Protocol Violation|1|||
48340673|NCT00985621|155442274|FG002|Overall Study|Protocol Violation|1|||
48664860|NCT00098722|156626918|FG002|Open Label Phase|Other|0|||
48340674|NCT00985621|155442275|FG003|Overall Study|Protocol Violation|0|||
48340675|NCT00985621|155442272|FG000|Overall Study|Withdrawal by Subject|8|||
48664861|NCT00098722|156626919|FG003|Open Label Phase|Other|18|||
48664862|NCT00098722|156626920|FG004|Open Label Phase|Other|0|||
48664863|NCT00098722|156626921|FG005|Open Label Phase|Other|0|||
48664864|NCT00098722|156626922|FG006|Open Label Phase|Other|0|||
48340676|NCT00985621|155442273|FG001|Overall Study|Withdrawal by Subject|10|||
48664865|NCT00098722|156626916|FG000|Observation Phase|Death|0|||
48664866|NCT00098722|156626917|FG001|Observation Phase|Death|0|||
48340677|NCT00985621|155442274|FG002|Overall Study|Withdrawal by Subject|8|||
48340678|NCT00985621|155442275|FG003|Overall Study|Withdrawal by Subject|12|||
48340679|NCT00985621|155442272|FG000|Overall Study|Other|1|||
48340680|NCT00985621|155442273|FG001|Overall Study|Other|0|||
48340681|NCT00985621|155442274|FG002|Overall Study|Other|0|||
48340682|NCT00985621|155442275|FG003|Overall Study|Other|0|||
48340683|NCT00985621|155442272|FG000|Overall Study|Randomized but not Treated|1|||
48340684|NCT00985621|155442273|FG001|Overall Study|Randomized but not Treated|0|||
48340685|NCT00985621|155442274|FG002|Overall Study|Randomized but not Treated|2|||
48340686|NCT00985621|155442275|FG003|Overall Study|Randomized but not Treated|1|||
48340687|NCT01774929|155442279|FG000|Overall Study|Adverse Event|3|||
48340688|NCT02040532|155442280|FG000|Overall Study|Lost to Follow-up|1|||
48340689|NCT02040532|155442280|FG000|Overall Study|Physician Decision|4|||
48340690|NCT02040532|155442280|FG000|Overall Study|Adverse Event|4|||
48340691|NCT02040532|155442280|FG000|Overall Study|Withdrawal by Subject|3|||
48340692|NCT00145496|155442286|FG000|Overall Study|Adverse Event|42|||
48340693|NCT00145496|155442287|FG001|Overall Study|Adverse Event|30|||
48340694|NCT00145496|155442286|FG000|Overall Study|Lack of Efficacy|12|||
48340695|NCT00145496|155442287|FG001|Overall Study|Lack of Efficacy|7|||
48340696|NCT00145496|155442286|FG000|Overall Study|Withdrawal by Subject|32|||
48340697|NCT00145496|155442287|FG001|Overall Study|Withdrawal by Subject|26|||
48340698|NCT00145496|155442286|FG000|Overall Study|Lost to Follow-up|12|||
48340699|NCT00145496|155442287|FG001|Overall Study|Lost to Follow-up|5|||
48340700|NCT00145496|155442286|FG000|Overall Study|Other|25|||
48340701|NCT00145496|155442287|FG001|Overall Study|Other|13|||
48340702|NCT01780584|155442288|FG000|Overall Study|Death|1|||
48340703|NCT01780584|155442289|FG001|Overall Study|Death|0|||
48340704|NCT01780584|155442290|FG002|Overall Study|Death|1|||
48340705|NCT01780584|155442288|FG000|Overall Study|Adverse Event|0|||
48340706|NCT01780584|155442289|FG001|Overall Study|Adverse Event|1|||
48340707|NCT01780584|155442290|FG002|Overall Study|Adverse Event|0|||
48340708|NCT01780584|155442288|FG000|Overall Study|Protocol Violation|0|||
48340709|NCT01780584|155442289|FG001|Overall Study|Protocol Violation|0|||
48340710|NCT01780584|155442290|FG002|Overall Study|Protocol Violation|1|||
48340711|NCT00562484|155442291|FG000|Overall Study|Adverse Event|6|||
48340712|NCT00562484|155442292|FG001|Overall Study|Adverse Event|1|||
48340713|NCT00562484|155442291|FG000|Overall Study|Protocol Violation|11|||
48340714|NCT00562484|155442292|FG001|Overall Study|Protocol Violation|2|||
48340715|NCT00562484|155442291|FG000|Overall Study|Withdrawal by Subject|12|||
48340716|NCT00562484|155442292|FG001|Overall Study|Withdrawal by Subject|9|||
48340717|NCT00562484|155442291|FG000|Overall Study|Moved away from the study area|20|||
48340718|NCT00562484|155442292|FG001|Overall Study|Moved away from the study area|9|||
48340719|NCT00562484|155442291|FG000|Overall Study|Lost to Follow-up|132|||
48340720|NCT00562484|155442292|FG001|Overall Study|Lost to Follow-up|71|||
48340721|NCT00562484|155442291|FG000|Overall Study|Reason not provided or not specified|25|||
48340722|NCT00562484|155442292|FG001|Overall Study|Reason not provided or not specified|12|||
48340723|NCT00525915|155442295|FG000|Overall Study|Non-Compliance|0|||
48340724|NCT00525915|155442296|FG001|Overall Study|Non-Compliance|1|||
48340725|NCT00525915|155442295|FG000|Overall Study|Disease Progression|5|||
48340726|NCT00525915|155442296|FG001|Overall Study|Disease Progression|6|||
48340727|NCT00525915|155442295|FG000|Overall Study|Withdrawal by Subject|1|||
48340728|NCT00525915|155442296|FG001|Overall Study|Withdrawal by Subject|0|||
48340729|NCT00525915|155442295|FG000|Overall Study|Refused Surgery|1|||
48340730|NCT00525915|155442296|FG001|Overall Study|Refused Surgery|2|||
48340731|NCT00525915|155442295|FG000|Overall Study|Unrelated illness|1|||
48340732|NCT00525915|155442296|FG001|Overall Study|Unrelated illness|0|||
48340733|NCT01204775|155442299|FG000|Overall Study|Poor/non-compliance|0|||
48340734|NCT01204775|155442300|FG001|Overall Study|Poor/non-compliance|1|||
48340735|NCT01204775|155442299|FG000|Overall Study|Withdrawal by Subject|1|||
48340736|NCT01204775|155442300|FG001|Overall Study|Withdrawal by Subject|0|||
48340737|NCT03169530|155442301|FG000|Overall Study|Study ended by NIH|15|||
48340738|NCT03169530|155442302|FG001|Overall Study|Study ended by NIH|17|||
48340739|NCT04783519|155442303|FG000|Overall Study|Withdrawal by Subject|2|||
48340740|NCT04783519|155442304|FG001|Overall Study|Withdrawal by Subject|7|||
48340741|NCT04783519|155442305|FG002|Overall Study|Withdrawal by Subject|3|||
48340742|NCT04783519|155442303|FG000|Overall Study|Lost to Follow-up|9|||
48340743|NCT04783519|155442304|FG001|Overall Study|Lost to Follow-up|7|||
48340744|NCT04783519|155442305|FG002|Overall Study|Lost to Follow-up|6|||
48340745|NCT01032200|155442306|FG000|Overall Study|Death|1|||
48340746|NCT01032200|155442307|FG001|Overall Study|Death|1|||
48340747|NCT01032200|155442306|FG000|Overall Study|Withdrawal by Subject|1|||
48340748|NCT01032200|155442307|FG001|Overall Study|Withdrawal by Subject|3|||
48340749|NCT01032200|155442306|FG000|Overall Study|Toxicity|0|||
48340750|NCT01032200|155442307|FG001|Overall Study|Toxicity|2|||
48340751|NCT01032200|155442306|FG000|Overall Study|Progression|1|||
48340752|NCT01032200|155442307|FG001|Overall Study|Progression|0|||
48340753|NCT01032200|155442306|FG000|Overall Study|Multiple|1|||
48340754|NCT01032200|155442307|FG001|Overall Study|Multiple|1|||
48340755|NCT01568112|155442311|FG000|Overall Study|Randomized But Not Treated|0|||
48340756|NCT01568112|155442312|FG001|Overall Study|Randomized But Not Treated|1|||
48340757|NCT01568112|155442313|FG002|Overall Study|Randomized But Not Treated|0|||
48340758|NCT01568112|155442314|FG003|Overall Study|Randomized But Not Treated|0|||
48340759|NCT01568112|155442311|FG000|Overall Study|Withdrew due to Adverse Event|2|||
48664867|NCT00098722|156626918|FG002|Observation Phase|Death|0|||
48664868|NCT00098722|156626919|FG003|Observation Phase|Death|0|||
48664869|NCT00098722|156626920|FG004|Observation Phase|Death|0|||
48664870|NCT00098722|156626921|FG005|Observation Phase|Death|5|||
48664871|NCT00098722|156626922|FG006|Observation Phase|Death|3|||
48664872|NCT00098722|156626916|FG000|Observation Phase|Lack of Efficacy|0|||
48664873|NCT00098722|156626917|FG001|Observation Phase|Lack of Efficacy|0|||
48664874|NCT00098722|156626918|FG002|Observation Phase|Lack of Efficacy|0|||
48664875|NCT00098722|156626919|FG003|Observation Phase|Lack of Efficacy|0|||
48340760|NCT01568112|155442312|FG001|Overall Study|Withdrew due to Adverse Event|4|||
48340761|NCT01568112|155442313|FG002|Overall Study|Withdrew due to Adverse Event|6|||
48340762|NCT01568112|155442314|FG003|Overall Study|Withdrew due to Adverse Event|3|||
48340763|NCT01568112|155442311|FG000|Overall Study|Lost to Follow-up|0|||
48340764|NCT01568112|155442312|FG001|Overall Study|Lost to Follow-up|0|||
48340765|NCT01568112|155442313|FG002|Overall Study|Lost to Follow-up|0|||
48340766|NCT01568112|155442314|FG003|Overall Study|Lost to Follow-up|1|||
48340767|NCT01568112|155442311|FG000|Overall Study|Withdrawal by Subject|2|||
48340768|NCT01568112|155442312|FG001|Overall Study|Withdrawal by Subject|3|||
48340769|NCT01568112|155442313|FG002|Overall Study|Withdrawal by Subject|0|||
48340770|NCT01568112|155442314|FG003|Overall Study|Withdrawal by Subject|7|||
48340771|NCT01568112|155442311|FG000|Overall Study|Withdrawal by Physician|1|||
48340772|NCT01568112|155442312|FG001|Overall Study|Withdrawal by Physician|0|||
48340773|NCT01568112|155442313|FG002|Overall Study|Withdrawal by Physician|1|||
48340774|NCT01568112|155442314|FG003|Overall Study|Withdrawal by Physician|1|||
48340775|NCT00645099|155442315|FG000|Overall Study|Lack of Efficacy|15|||
48340776|NCT00645099|155442316|FG001|Overall Study|Lack of Efficacy|6|||
48340777|NCT00645099|155442315|FG000|Overall Study|Withdrawal by Subject|30|||
48340778|NCT00645099|155442316|FG001|Overall Study|Withdrawal by Subject|22|||
48340779|NCT00645099|155442315|FG000|Overall Study|Lost to Follow-up|6|||
48340780|NCT00645099|155442316|FG001|Overall Study|Lost to Follow-up|4|||
48340781|NCT00645099|155442315|FG000|Overall Study|Adverse Event|11|||
48340782|NCT00645099|155442316|FG001|Overall Study|Adverse Event|5|||
48340783|NCT00645099|155442315|FG000|Overall Study|Other|9|||
48340784|NCT00645099|155442316|FG001|Overall Study|Other|5|||
48340785|NCT04372186|155442318|FG000|Overall Study|Death|24|||
48340786|NCT04372186|155442319|FG001|Overall Study|Death|11|||
48340787|NCT04372186|155442318|FG000|Overall Study|Transferred to a different facility for care|0|||
48340788|NCT04372186|155442319|FG001|Overall Study|Transferred to a different facility for care|2|||
48340789|NCT02785900|155442320|FG000|Overall Study|Study Termination by Sponsor|64|||
48664876|NCT00098722|156626920|FG004|Observation Phase|Lack of Efficacy|0|||
48664877|NCT00098722|156626921|FG005|Observation Phase|Lack of Efficacy|2|||
48664878|NCT00098722|156626922|FG006|Observation Phase|Lack of Efficacy|0|||
48664879|NCT00098722|156626916|FG000|Observation Phase|Participant defaulted|0|||
48664880|NCT00098722|156626917|FG001|Observation Phase|Participant defaulted|0|||
48664881|NCT00098722|156626918|FG002|Observation Phase|Participant defaulted|0|||
48664882|NCT00098722|156626919|FG003|Observation Phase|Participant defaulted|0|||
48664883|NCT00098722|156626920|FG004|Observation Phase|Participant defaulted|0|||
48664884|NCT00098722|156626921|FG005|Observation Phase|Participant defaulted|17|||
48664885|NCT00098722|156626922|FG006|Observation Phase|Participant defaulted|4|||
48664886|NCT00098722|156626916|FG000|Observation Phase|Other|0|||
48664887|NCT00098722|156626917|FG001|Observation Phase|Other|0|||
48757435|NCT00529542|156958269|FG001|Overall Study|Withdrawal by Subject|0|||
48340790|NCT02785900|155442321|FG001|Overall Study|Study Termination by Sponsor|81|||
48340791|NCT02785900|155442320|FG000|Overall Study|Death|46|||
48340792|NCT02785900|155442321|FG001|Overall Study|Death|32|||
48340793|NCT02785900|155442320|FG000|Overall Study|Withdrawal by Subject|4|||
48340794|NCT02785900|155442321|FG001|Overall Study|Withdrawal by Subject|8|||
48340795|NCT02785900|155442320|FG000|Overall Study|Physician Decision|3|||
48340796|NCT02785900|155442321|FG001|Overall Study|Physician Decision|2|||
48340797|NCT01808144|155442322|FG000|Overall Study|Death|1|||
48340798|NCT01808144|155442323|FG001|Overall Study|Death|0|||
48340799|NCT01808144|155442322|FG000|Overall Study|Withdrawal by Subject|16|||
48340800|NCT01808144|155442323|FG001|Overall Study|Withdrawal by Subject|23|||
48664888|NCT00098722|156626918|FG002|Observation Phase|Other|0|||
48664889|NCT00098722|156626919|FG003|Observation Phase|Other|0|||
48340801|NCT01808144|155442322|FG000|Overall Study|Lost to Follow-up|6|||
48340802|NCT01808144|155442323|FG001|Overall Study|Lost to Follow-up|3|||
48340803|NCT01808144|155442322|FG000|Overall Study|Protocol Violation|6|||
48340804|NCT01808144|155442323|FG001|Overall Study|Protocol Violation|6|||
48664890|NCT00098722|156626920|FG004|Observation Phase|Other|0|||
48664891|NCT00098722|156626921|FG005|Observation Phase|Other|21|||
48664892|NCT00098722|156626922|FG006|Observation Phase|Other|10|||
48664893|NCT00934947|156626923|FG000|Overall Study|Adverse Event|0|||
48664894|NCT00934947|156626924|FG001|Overall Study|Adverse Event|2|||
48664895|NCT01342965|156626925|FG000|Overall Study|Death|58|||
48664896|NCT01342965|156626926|FG001|Overall Study|Death|57|||
48664897|NCT01342965|156626925|FG000|Overall Study|Lost to Follow-up|5|||
48664898|NCT01342965|156626926|FG001|Overall Study|Lost to Follow-up|3|||
48664899|NCT01342965|156626925|FG000|Overall Study|Other Reasons- Unspecified|44|||
48664900|NCT01342965|156626926|FG001|Overall Study|Other Reasons- Unspecified|38|||
48664901|NCT01342965|156626925|FG000|Overall Study|Withdrawal by Subject|2|||
48664902|NCT01342965|156626926|FG001|Overall Study|Withdrawal by Subject|9|||
48664903|NCT00623545|156626927|FG000|Overall Study|Adverse Event|6|||
48757436|NCT00529542|156958268|FG000|Overall Study|Lost to Follow-up|0|||
48757437|NCT00529542|156958269|FG001|Overall Study|Lost to Follow-up|1|||
48757438|NCT00501293|156960714|FG000|Optimization Period|Enrolled in error|1|||
48757439|NCT00501293|156960715|FG001|Optimization Period|Enrolled in error|0|||
48757440|NCT00501293|156960714|FG000|Maintenance Period|Withdrawal by Subject|14|||
48757441|NCT00501293|156960715|FG001|Maintenance Period|Withdrawal by Subject|13|||
48757442|NCT00501293|156960714|FG000|Maintenance Period|Lost to Follow-up|12|||
48340805|NCT01808144|155442322|FG000|Overall Study|Gout flare|0|||
48664904|NCT00623545|156626927|FG000|Overall Study|Withdrawal by Subject|4|||
48664905|NCT01804582|156626929|FG000|Overall Study|Lost to Follow-up|47|||
48664906|NCT01804582|156626930|FG001|Overall Study|Lost to Follow-up|56|||
48664907|NCT01804582|156626929|FG000|Overall Study|Physician Decision|2|||
48664908|NCT01804582|156626930|FG001|Overall Study|Physician Decision|0|||
48664909|NCT00919867|156626931|FG000|First Intervention|Withdrawal by Subject|0|||
48757443|NCT00501293|156960715|FG001|Maintenance Period|Lost to Follow-up|7|||
48664910|NCT00919867|156626932|FG001|First Intervention|Withdrawal by Subject|0|||
48664911|NCT00919867|156626933|FG002|First Intervention|Withdrawal by Subject|1|||
48664912|NCT00919867|156626934|FG003|First Intervention|Withdrawal by Subject|0|||
48664913|NCT00919867|156626935|FG004|First Intervention|Withdrawal by Subject|0|||
48664914|NCT00919867|156626936|FG005|First Intervention|Withdrawal by Subject|0|||
48664915|NCT00919867|156626931|FG000|First Intervention|Physician Decision|0|||
48664916|NCT00919867|156626932|FG001|First Intervention|Physician Decision|0|||
48664917|NCT00919867|156626933|FG002|First Intervention|Physician Decision|0|||
48664918|NCT00919867|156626934|FG003|First Intervention|Physician Decision|0|||
48664919|NCT00919867|156626935|FG004|First Intervention|Physician Decision|0|||
48664920|NCT00919867|156626936|FG005|First Intervention|Physician Decision|1|||
48664921|NCT04962230|156626937|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
48664922|NCT04962230|156626937|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
48757444|NCT00501293|156960714|FG000|Maintenance Period|Adverse Event|6|||
48757445|NCT00501293|156960715|FG001|Maintenance Period|Adverse Event|6|||
48340806|NCT01808144|155442323|FG001|Overall Study|Gout flare|1|||
48664923|NCT02969590|156626938|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
48664924|NCT02969590|156626939|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
48664925|NCT02969590|156626940|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
48664926|NCT01149486|156626941|FG000|First Intervention|Adverse Event|0|||
48664927|NCT01149486|156626942|FG001|First Intervention|Adverse Event|1|||
48664928|NCT03630302|156626946|FG000|Surgery|hardware issue prevented LFP recordings|1|||
48664929|NCT03630302|156626946|FG000|3 Month Visit|Adverse Event|2|||
48664930|NCT03630302|156626946|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
48664931|NCT00681564|156626947|FG000|Overall Study|Lost to Follow-up|6|||
48664932|NCT00681564|156626948|FG001|Overall Study|Lost to Follow-up|6|||
48664933|NCT00681564|156626947|FG000|Overall Study|Withdrawal by Subject|0|||
48664934|NCT00681564|156626948|FG001|Overall Study|Withdrawal by Subject|1|||
48664935|NCT00681564|156626947|FG000|Overall Study|Death|0|||
48664936|NCT00681564|156626948|FG001|Overall Study|Death|1|||
48664937|NCT01135914|156626949|FG000|Overall Study|Withdrawal by Subject|1|||
48664938|NCT01135914|156626950|FG001|Overall Study|Withdrawal by Subject|3|||
48664939|NCT01135914|156626951|FG002|Overall Study|Withdrawal by Subject|6|||
48664940|NCT01135914|156626949|FG000|Overall Study|Lost to Follow-up|1|||
48664941|NCT01135914|156626950|FG001|Overall Study|Lost to Follow-up|0|||
48340807|NCT01808144|155442322|FG000|Overall Study|Adverse Event|11|||
48340808|NCT01808144|155442323|FG001|Overall Study|Adverse Event|15|||
48340809|NCT00230971|155442327|FG000|Randomization|No study drug administered|3|||
48340810|NCT00230971|155442328|FG001|Randomization|No study drug administered|3|||
48340811|NCT00230971|155442327|FG000|Baseline Participants|Lost to Follow-up|5|||
48340812|NCT00230971|155442328|FG001|Baseline Participants|Lost to Follow-up|12|||
48340813|NCT00230971|155442327|FG000|Baseline Participants|Death|6|||
48340814|NCT00230971|155442328|FG001|Baseline Participants|Death|5|||
48340815|NCT00230971|155442327|FG000|Baseline Participants|Withdrawal by Subject|7|||
48340816|NCT00230971|155442328|FG001|Baseline Participants|Withdrawal by Subject|1|||
48340817|NCT00230971|155442327|FG000|Baseline Participants|Adverse Event|1|||
48340818|NCT00230971|155442328|FG001|Baseline Participants|Adverse Event|0|||
48340819|NCT00230971|155442327|FG000|Baseline Participants|No bacteria observed|1|||
48340820|NCT00230971|155442328|FG001|Baseline Participants|No bacteria observed|0|||
48340821|NCT00230971|155442327|FG000|Baseline Participants|Failure to return|1|||
48340822|NCT00230971|155442328|FG001|Baseline Participants|Failure to return|1|||
48340823|NCT00230971|155442327|FG000|Baseline Participants|Reintervention|1|||
48340824|NCT00230971|155442328|FG001|Baseline Participants|Reintervention|0|||
48340825|NCT03749616|155442329|FG000|Overall Study|Lost to Follow-up|4|||
48340826|NCT03749616|155442330|FG001|Overall Study|Lost to Follow-up|7|||
48340827|NCT03749616|155442329|FG000|Overall Study|Screen Failure|1|||
48340828|NCT03749616|155442330|FG001|Overall Study|Screen Failure|1|||
48340829|NCT03749616|155442329|FG000|Overall Study|Withdrawal by Subject|2|||
48340830|NCT03749616|155442330|FG001|Overall Study|Withdrawal by Subject|0|||
48340831|NCT04491136|155442334|FG000|Overall Study|Patient withdraw informed consent|9|||
48340832|NCT04491136|155442334|FG000|Overall Study|Adverse Event|2|||
48340833|NCT04491136|155442334|FG000|Overall Study|Death|3|||
48340834|NCT04491136|155442334|FG000|Overall Study|Lost to Follow-up|3|||
48340835|NCT04491136|155442334|FG000|Overall Study|Physician Decision|45|||
48340836|NCT04491136|155442334|FG000|Overall Study|sponsor terminated the study early|16|||
48340837|NCT04491136|155442334|FG000|Overall Study|Patient/guardian's decision|1|||
48340838|NCT00705614|155444135|FG000|Initial Intervention|Adverse Event|40|||
48340839|NCT00705614|155444136|FG001|Initial Intervention|Adverse Event|21|||
48340840|NCT00705614|155444135|FG000|Initial Intervention|Lost to Follow-up|310|||
48340841|NCT00705614|155444136|FG001|Initial Intervention|Lost to Follow-up|191|||
48340842|NCT00705614|155444135|FG000|Initial Intervention|Withdrawal by Subject|114|||
48340843|NCT00705614|155444136|FG001|Initial Intervention|Withdrawal by Subject|71|||
48340844|NCT00705614|155444135|FG000|Initial Intervention|Administrative Reason|51|||
48340845|NCT00705614|155444136|FG001|Initial Intervention|Administrative Reason|38|||
48340846|NCT00705614|155444135|FG000|Initial Intervention|Status completion unknown|3|||
48340847|NCT00705614|155444136|FG001|Initial Intervention|Status completion unknown|0|||
48340848|NCT00705614|155444135|FG000|Switch to Remicade|Adverse Event|0|||
48340849|NCT00705614|155444136|FG001|Switch to Remicade|Adverse Event|5|||
48340850|NCT00705614|155444135|FG000|Switch to Remicade|Lost to Follow-up|0|||
48664942|NCT01135914|156626951|FG002|Overall Study|Lost to Follow-up|1|||
48664943|NCT01135914|156626949|FG000|Overall Study|Protocol Violation|0|||
48664944|NCT01135914|156626950|FG001|Overall Study|Protocol Violation|0|||
48664945|NCT01135914|156626951|FG002|Overall Study|Protocol Violation|3|||
48664946|NCT01135914|156626949|FG000|Overall Study|Lack of Efficacy|2|||
48664947|NCT01135914|156626950|FG001|Overall Study|Lack of Efficacy|1|||
48664948|NCT01135914|156626951|FG002|Overall Study|Lack of Efficacy|10|||
48664949|NCT01135914|156626949|FG000|Overall Study|Adverse Event|0|||
48340851|NCT00705614|155444136|FG001|Switch to Remicade|Lost to Follow-up|23|||
48340852|NCT00705614|155444135|FG000|Switch to Remicade|Withdrawal by Subject|0|||
48340853|NCT00705614|155444136|FG001|Switch to Remicade|Withdrawal by Subject|12|||
48340854|NCT00705614|155444135|FG000|Switch to Remicade|Administrative Reason|0|||
48340855|NCT00705614|155444136|FG001|Switch to Remicade|Administrative Reason|9|||
48664950|NCT01135914|156626950|FG001|Overall Study|Adverse Event|1|||
48664951|NCT01135914|156626951|FG002|Overall Study|Adverse Event|2|||
48664952|NCT02078102|156626952|FG000|Overall Study|Adverse Event|1|||
48664953|NCT02078102|156626953|FG001|Overall Study|Adverse Event|0|||
48664954|NCT02078102|156626952|FG000|Overall Study|Withdrawal by Subject|1|||
48664955|NCT02078102|156626953|FG001|Overall Study|Withdrawal by Subject|0|||
48664956|NCT02078102|156626952|FG000|Overall Study|Physician Decision|0|||
48664957|NCT02078102|156626953|FG001|Overall Study|Physician Decision|1|||
48664958|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
48664959|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
48664960|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
48664961|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
48664962|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
48664963|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
48340856|NCT02878590|155444137|FG000|Overall Study|Withdrawal by Subject|2|||
48340857|NCT01730118|155444138|FG000|Dose Escalation|Death on study|5|||
48340858|NCT01730118|155444139|FG001|Dose Escalation|Death on study|7|||
48664964|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
48664965|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
48664966|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
48664967|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
48757446|NCT00501293|156960714|FG000|Maintenance Period|Protocol Violation|2|||
48757447|NCT00501293|156960715|FG001|Maintenance Period|Protocol Violation|1|||
48757448|NCT00501293|156960714|FG000|Maintenance Period|Lack of Efficacy|4|||
48757449|NCT00501293|156960715|FG001|Maintenance Period|Lack of Efficacy|1|||
48664968|NCT03906656|156626958|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
48664969|NCT03906656|156626959|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
48757450|NCT00501293|156960714|FG000|Maintenance Period|Noncompliant with study medication|5|||
48757451|NCT00501293|156960715|FG001|Maintenance Period|Noncompliant with study medication|0|||
48757452|NCT00501293|156960714|FG000|Maintenance Period|Went into rehabilitation|1|||
48757453|NCT00501293|156960715|FG001|Maintenance Period|Went into rehabilitation|0|||
48757454|NCT00501293|156960714|FG000|Maintenance Period|Would not wear patch|1|||
48757455|NCT00501293|156960715|FG001|Maintenance Period|Would not wear patch|0|||
48757456|NCT00501293|156960714|FG000|Maintenance Period|Application site reaction|1|||
48757457|NCT00501293|156960715|FG001|Maintenance Period|Application site reaction|0|||
48757458|NCT01164956|156960718|FG000|Overall Study|Side Effects|1|||
48757459|NCT01164956|156960719|FG001|Overall Study|Side Effects|0|||
48340859|NCT01730118|155444140|FG002|Dose Escalation|Death on study|2|||
48340860|NCT01730118|155444141|FG003|Dose Escalation|Death on study|6|||
48340861|NCT01730118|155444142|FG004|Dose Escalation|Death on study|0|||
48340862|NCT01730118|155444143|FG005|Dose Escalation|Death on study|0|||
48340863|NCT01730118|155444144|FG006|Dose Escalation|Death on study|0|||
48340864|NCT01730118|155444138|FG000|Dose Escalation|Died before treatment|0|||
48340865|NCT01730118|155444139|FG001|Dose Escalation|Died before treatment|0|||
48340866|NCT01730118|155444140|FG002|Dose Escalation|Died before treatment|0|||
48664970|NCT03906656|156626958|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
48664971|NCT03906656|156626959|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
48664972|NCT03906656|156626958|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
48664973|NCT03906656|156626959|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
48664974|NCT03906656|156626958|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
48757460|NCT01164956|156960720|FG002|Overall Study|Side Effects|1|||
48664975|NCT03906656|156626959|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
48664976|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
48664977|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
48664978|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
48664979|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
48664980|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
48664981|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
48664982|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
48664983|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
48664984|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
48664985|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
48664986|NCT03906656|156626958|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
48664987|NCT03906656|156626959|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
48664988|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
48664989|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
48664990|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
48664991|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
48664992|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Death|2|||
48664993|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Death|0|||
48664994|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
48664995|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
48664996|NCT03906656|156626958|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
48664997|NCT03906656|156626959|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
48664998|NCT00882908|156626960|FG000|Overall Study|Adverse Event|0|||
48664999|NCT00882908|156626961|FG001|Overall Study|Adverse Event|0|||
48665000|NCT00882908|156626962|FG002|Overall Study|Adverse Event|1|||
48665001|NCT00882908|156626963|FG003|Overall Study|Adverse Event|0|||
48665002|NCT00882908|156626964|FG004|Overall Study|Adverse Event|1|||
48665003|NCT00882908|156626960|FG000|Overall Study|Lost to Follow-up|3|||
48665004|NCT00882908|156626961|FG001|Overall Study|Lost to Follow-up|5|||
48665005|NCT00882908|156626962|FG002|Overall Study|Lost to Follow-up|3|||
48665006|NCT00882908|156626963|FG003|Overall Study|Lost to Follow-up|1|||
48665007|NCT00882908|156626964|FG004|Overall Study|Lost to Follow-up|2|||
48665008|NCT00882908|156626960|FG000|Overall Study|Protocol Violation|0|||
48665009|NCT00882908|156626961|FG001|Overall Study|Protocol Violation|1|||
48665010|NCT00882908|156626962|FG002|Overall Study|Protocol Violation|0|||
48665011|NCT00882908|156626963|FG003|Overall Study|Protocol Violation|0|||
48665012|NCT00882908|156626964|FG004|Overall Study|Protocol Violation|0|||
48665013|NCT00882908|156626960|FG000|Overall Study|Withdrawal by Subject|0|||
48665014|NCT00882908|156626961|FG001|Overall Study|Withdrawal by Subject|0|||
48665015|NCT00882908|156626962|FG002|Overall Study|Withdrawal by Subject|3|||
48665016|NCT00882908|156626963|FG003|Overall Study|Withdrawal by Subject|5|||
48665017|NCT00882908|156626964|FG004|Overall Study|Withdrawal by Subject|2|||
48665018|NCT00882908|156626960|FG000|Overall Study|Subject reached a virologic endpoint|0|||
48665019|NCT00882908|156626961|FG001|Overall Study|Subject reached a virologic endpoint|0|||
48665020|NCT00882908|156626962|FG002|Overall Study|Subject reached a virologic endpoint|0|||
48665021|NCT00882908|156626963|FG003|Overall Study|Subject reached a virologic endpoint|0|||
48665022|NCT00882908|156626964|FG004|Overall Study|Subject reached a virologic endpoint|1|||
48340867|NCT01730118|155444141|FG003|Dose Escalation|Died before treatment|0|||
48340868|NCT01730118|155444142|FG004|Dose Escalation|Died before treatment|0|||
48665023|NCT00882908|156626960|FG000|Overall Study|Study terminated in error|0|||
48665024|NCT00882908|156626961|FG001|Overall Study|Study terminated in error|0|||
48665025|NCT00882908|156626962|FG002|Overall Study|Study terminated in error|0|||
48665026|NCT00882908|156626963|FG003|Overall Study|Study terminated in error|1|||
48665027|NCT00882908|156626964|FG004|Overall Study|Study terminated in error|0|||
48665028|NCT02130986|156626965|FG000|Overall Study|Withdrawal by Subject|4|||
48340869|NCT01730118|155444143|FG005|Dose Escalation|Died before treatment|0|||
48340870|NCT01730118|155444144|FG006|Dose Escalation|Died before treatment|1|||
48428230|NCT02531373|155756506|FG008|Overall Study|Physician Decision|0|||
48665029|NCT02130986|156626966|FG001|Overall Study|Withdrawal by Subject|4|||
48665030|NCT02130986|156626965|FG000|Overall Study|Lost to Follow-up|151|||
48665031|NCT02130986|156626966|FG001|Overall Study|Lost to Follow-up|160|||
48665032|NCT02689076|156626967|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
48665033|NCT02689076|156626968|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
48665034|NCT02689076|156626969|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
48665035|NCT02689076|156626967|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
48665036|NCT02689076|156626968|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
48665037|NCT02689076|156626969|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
48665038|NCT02689076|156626967|FG000|Overall Study|Did not have an HIE match|2|||
48665039|NCT02689076|156626968|FG001|Overall Study|Did not have an HIE match|0|||
48665040|NCT02689076|156626969|FG002|Overall Study|Did not have an HIE match|0|||
48665041|NCT02689076|156626967|FG000|Overall Study|Death during non-VA encounter|2|||
48665042|NCT02689076|156626968|FG001|Overall Study|Death during non-VA encounter|5|||
48665043|NCT02689076|156626969|FG002|Overall Study|Death during non-VA encounter|0|||
48665044|NCT02689076|156626967|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
48665045|NCT02689076|156626968|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
48665046|NCT02689076|156626969|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
48665047|NCT02689076|156626967|FG000|Overall Study|Participant no longer active in VA system|1|||
48665048|NCT02689076|156626968|FG001|Overall Study|Participant no longer active in VA system|0|||
48665049|NCT02689076|156626969|FG002|Overall Study|Participant no longer active in VA system|0|||
48665050|NCT02689076|156626967|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
48665051|NCT02689076|156626968|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
48665052|NCT02689076|156626969|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
48665053|NCT00320372|156626974|FG000|Overall Study|Physician Decision|4|||
48665054|NCT00320372|156626975|FG001|Overall Study|Physician Decision|7|||
48665055|NCT00320372|156626974|FG000|Overall Study|Death|7|||
48665056|NCT00320372|156626975|FG001|Overall Study|Death|8|||
48665057|NCT00320372|156626974|FG000|Overall Study|Withdrawal by Subject|55|||
48340871|NCT01730118|155444138|FG000|Dose Escalation|Chose to start a different treatment|1|||
48340872|NCT01730118|155444139|FG001|Dose Escalation|Chose to start a different treatment|0|||
48340873|NCT01730118|155444140|FG002|Dose Escalation|Chose to start a different treatment|0|||
48340874|NCT01730118|155444141|FG003|Dose Escalation|Chose to start a different treatment|0|||
48340875|NCT01730118|155444142|FG004|Dose Escalation|Chose to start a different treatment|0|||
48340876|NCT01730118|155444143|FG005|Dose Escalation|Chose to start a different treatment|0|||
48340877|NCT01730118|155444144|FG006|Dose Escalation|Chose to start a different treatment|0|||
48665058|NCT00320372|156626975|FG001|Overall Study|Withdrawal by Subject|37|||
48665059|NCT00320372|156626974|FG000|Overall Study|Non-Compliance|40|||
48665060|NCT00320372|156626975|FG001|Overall Study|Non-Compliance|39|||
48665061|NCT00320372|156626974|FG000|Overall Study|Did not Meet (I/E)|3|||
48665062|NCT00320372|156626975|FG001|Overall Study|Did not Meet (I/E)|1|||
48665063|NCT00320372|156626974|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
48665064|NCT00320372|156626975|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
48340878|NCT01730118|155444138|FG000|Dose Escalation|Withdrawal by Subject|0|||
48665065|NCT00106691|156626985|FG000|Overall Study|Adverse Event|60|||
48665066|NCT00106691|156626986|FG001|Overall Study|Adverse Event|64|||
48665067|NCT00106691|156626985|FG000|Overall Study|Lost to Follow-up|23|||
48665068|NCT00106691|156626986|FG001|Overall Study|Lost to Follow-up|18|||
48665069|NCT00106691|156626985|FG000|Overall Study|Physician Decision|18|||
48665070|NCT00106691|156626986|FG001|Overall Study|Physician Decision|21|||
48665071|NCT00106691|156626985|FG000|Overall Study|Protocol Violation|13|||
48665072|NCT00106691|156626986|FG001|Overall Study|Protocol Violation|18|||
48665073|NCT00106691|156626985|FG000|Overall Study|Withdrawal by Subject|75|||
48665074|NCT00106691|156626986|FG001|Overall Study|Withdrawal by Subject|70|||
48665075|NCT00106691|156626985|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
48665076|NCT00106691|156626986|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
48665077|NCT00106691|156626985|FG000|Overall Study|QTc>480|3|||
48665078|NCT00106691|156626986|FG001|Overall Study|QTc>480|1|||
48665079|NCT00106691|156626985|FG000|Overall Study|mililtary deployment|2|||
48665080|NCT00106691|156626986|FG001|Overall Study|mililtary deployment|0|||
48665081|NCT00106691|156626985|FG000|Overall Study|Study Site Closing/PI Moved|1|||
48757461|NCT00967798|156960721|FG000|Overall Study|Withdrawal by Subject|5|||
48340879|NCT01730118|155444139|FG001|Dose Escalation|Withdrawal by Subject|0|||
48665082|NCT00106691|156626986|FG001|Overall Study|Study Site Closing/PI Moved|2|||
48665083|NCT00106691|156626985|FG000|Overall Study|Cardiologist recommendation|1|||
48665084|NCT00106691|156626986|FG001|Overall Study|Cardiologist recommendation|0|||
48665085|NCT00106691|156626985|FG000|Overall Study|Pt. moved to another state|1|||
48340880|NCT01730118|155444140|FG002|Dose Escalation|Withdrawal by Subject|1|||
48340881|NCT01730118|155444141|FG003|Dose Escalation|Withdrawal by Subject|0|||
48757462|NCT00967798|156960722|FG001|Overall Study|Withdrawal by Subject|2|||
48757463|NCT00967798|156960721|FG000|Overall Study|Lost to Follow-up|4|||
48757464|NCT00967798|156960722|FG001|Overall Study|Lost to Follow-up|1|||
48757465|NCT00531050|156960725|FG000|Part 1: Period 1|Adverse Event|0|||
48757466|NCT00531050|156960726|FG001|Part 1: Period 1|Adverse Event|1|||
48757467|NCT00531050|156960727|FG002|Part 1: Period 1|Adverse Event|0|||
48757468|NCT00531050|156960728|FG003|Part 1: Period 1|Adverse Event|0|||
48757469|NCT00531050|156960729|FG004|Part 1: Period 1|Adverse Event|0|||
48757470|NCT00531050|156960730|FG005|Part 1: Period 1|Adverse Event|0|||
48757471|NCT00531050|156960725|FG000|Part 1: Period 1|Protocol Deviation|0|||
48757472|NCT00531050|156960726|FG001|Part 1: Period 1|Protocol Deviation|0|||
48757473|NCT00531050|156960727|FG002|Part 1: Period 1|Protocol Deviation|0|||
48757474|NCT00531050|156960728|FG003|Part 1: Period 1|Protocol Deviation|1|||
48757475|NCT00531050|156960729|FG004|Part 1: Period 1|Protocol Deviation|0|||
48757476|NCT00531050|156960730|FG005|Part 1: Period 1|Protocol Deviation|0|||
48757477|NCT00531050|156960725|FG000|Part 1: Period 3|Adverse Event|1|||
48757478|NCT00531050|156960726|FG001|Part 1: Period 3|Adverse Event|0|||
48757479|NCT00531050|156960727|FG002|Part 1: Period 3|Adverse Event|0|||
48757480|NCT00531050|156960728|FG003|Part 1: Period 3|Adverse Event|0|||
48757481|NCT00531050|156960729|FG004|Part 1: Period 3|Adverse Event|0|||
48757482|NCT00531050|156960730|FG005|Part 1: Period 3|Adverse Event|0|||
48757483|NCT00531050|156960725|FG000|Part 2: Period 1|Adverse Event|0|||
48665086|NCT00106691|156626986|FG001|Overall Study|Pt. moved to another state|0|||
48665087|NCT00106691|156626985|FG000|Overall Study|Taking exclusionary avodart|1|||
48665088|NCT00106691|156626986|FG001|Overall Study|Taking exclusionary avodart|0|||
48665089|NCT00106691|156626985|FG000|Overall Study|Not able to discontinue plavix|0|||
48665090|NCT00106691|156626986|FG001|Overall Study|Not able to discontinue plavix|1|||
48757484|NCT00531050|156960726|FG001|Part 2: Period 1|Adverse Event|0|||
48757485|NCT00531050|156960727|FG002|Part 2: Period 1|Adverse Event|0|||
48757486|NCT00531050|156960728|FG003|Part 2: Period 1|Adverse Event|0|||
48757487|NCT00531050|156960729|FG004|Part 2: Period 1|Adverse Event|0|||
48757488|NCT00531050|156960730|FG005|Part 2: Period 1|Adverse Event|1|||
48757489|NCT00531050|156960725|FG000|Part 2: Period 3|Abnormal test procedure|1|||
48757490|NCT00531050|156960726|FG001|Part 2: Period 3|Abnormal test procedure|0|||
48757491|NCT00531050|156960727|FG002|Part 2: Period 3|Abnormal test procedure|0|||
48757492|NCT00531050|156960728|FG003|Part 2: Period 3|Abnormal test procedure|0|||
48757493|NCT00531050|156960729|FG004|Part 2: Period 3|Abnormal test procedure|0|||
48757494|NCT00531050|156960730|FG005|Part 2: Period 3|Abnormal test procedure|1|||
48757495|NCT00232817|156960731|FG000|Overall Study|Protocol Violation|2|||
48757496|NCT00232817|156960732|FG001|Overall Study|Protocol Violation|1|||
48757497|NCT03518073|156960733|FG000|Overall Study|Adverse Event|2|||
48757498|NCT03518073|156960734|FG001|Overall Study|Adverse Event|4|||
48757499|NCT03518073|156960735|FG002|Overall Study|Adverse Event|2|||
48757500|NCT03518073|156960733|FG000|Overall Study|Death|2|||
48757501|NCT03518073|156960734|FG001|Overall Study|Death|1|||
48757502|NCT03518073|156960735|FG002|Overall Study|Death|3|||
48665091|NCT02761694|156626987|FG000|Overall Study|Lack of Efficacy|0|||
48665092|NCT02761694|156626988|FG001|Overall Study|Lack of Efficacy|0|||
48665093|NCT02761694|156626989|FG002|Overall Study|Lack of Efficacy|0|||
48665094|NCT02761694|156626990|FG003|Overall Study|Lack of Efficacy|0|||
48665095|NCT02761694|156626991|FG004|Overall Study|Lack of Efficacy|0|||
48665096|NCT02761694|156626992|FG005|Overall Study|Lack of Efficacy|0|||
48665097|NCT02761694|156626993|FG006|Overall Study|Lack of Efficacy|6|||
48665098|NCT02761694|156626994|FG007|Overall Study|Lack of Efficacy|0|||
48665099|NCT02761694|156626995|FG008|Overall Study|Lack of Efficacy|0|||
48665100|NCT02761694|156626996|FG009|Overall Study|Lack of Efficacy|1|||
48665101|NCT02761694|156626997|FG010|Overall Study|Lack of Efficacy|1|||
48665102|NCT02761694|156626998|FG011|Overall Study|Lack of Efficacy|4|||
48665103|NCT02761694|156626987|FG000|Overall Study|Death|0|||
48665104|NCT02761694|156626988|FG001|Overall Study|Death|0|||
48665105|NCT02761694|156626989|FG002|Overall Study|Death|0|||
48665106|NCT02761694|156626990|FG003|Overall Study|Death|0|||
48757503|NCT03518073|156960733|FG000|Overall Study|Lost to Follow-up|1|||
48757504|NCT03518073|156960734|FG001|Overall Study|Lost to Follow-up|0|||
48757505|NCT03518073|156960735|FG002|Overall Study|Lost to Follow-up|1|||
48757506|NCT03518073|156960733|FG000|Overall Study|Physician Decision|5|||
48757507|NCT03518073|156960734|FG001|Overall Study|Physician Decision|0|||
48757508|NCT03518073|156960735|FG002|Overall Study|Physician Decision|2|||
48757509|NCT03518073|156960733|FG000|Overall Study|Progressive disease|1|||
48757510|NCT03518073|156960734|FG001|Overall Study|Progressive disease|1|||
48665107|NCT02761694|156626991|FG004|Overall Study|Death|0|||
48665108|NCT02761694|156626992|FG005|Overall Study|Death|0|||
48665109|NCT02761694|156626993|FG006|Overall Study|Death|2|||
48665110|NCT02761694|156626994|FG007|Overall Study|Death|0|||
48665111|NCT02761694|156626995|FG008|Overall Study|Death|2|||
48665112|NCT02761694|156626996|FG009|Overall Study|Death|2|||
48665113|NCT02761694|156626997|FG010|Overall Study|Death|1|||
48665114|NCT02761694|156626998|FG011|Overall Study|Death|0|||
48757511|NCT03518073|156960735|FG002|Overall Study|Progressive disease|1|||
48757512|NCT03518073|156960733|FG000|Overall Study|Protocol Violation|1|||
48665115|NCT02761694|156626987|FG000|Overall Study|Physician Decision|0|||
48665116|NCT02761694|156626988|FG001|Overall Study|Physician Decision|0|||
48665117|NCT02761694|156626989|FG002|Overall Study|Physician Decision|0|||
48665118|NCT02761694|156626990|FG003|Overall Study|Physician Decision|0|||
48665119|NCT02761694|156626991|FG004|Overall Study|Physician Decision|0|||
48665120|NCT02761694|156626992|FG005|Overall Study|Physician Decision|0|||
48665121|NCT02761694|156626993|FG006|Overall Study|Physician Decision|1|||
48665122|NCT02761694|156626994|FG007|Overall Study|Physician Decision|0|||
48665123|NCT02761694|156626995|FG008|Overall Study|Physician Decision|0|||
48665124|NCT02761694|156626996|FG009|Overall Study|Physician Decision|0|||
48665125|NCT02761694|156626997|FG010|Overall Study|Physician Decision|0|||
48665126|NCT02761694|156626998|FG011|Overall Study|Physician Decision|0|||
48665127|NCT02761694|156626987|FG000|Overall Study|Withdrawal by Subject|0|||
48665128|NCT02761694|156626988|FG001|Overall Study|Withdrawal by Subject|0|||
48665129|NCT02761694|156626989|FG002|Overall Study|Withdrawal by Subject|0|||
48665130|NCT02761694|156626990|FG003|Overall Study|Withdrawal by Subject|1|||
48665131|NCT02761694|156626991|FG004|Overall Study|Withdrawal by Subject|0|||
48665132|NCT02761694|156626992|FG005|Overall Study|Withdrawal by Subject|0|||
48665133|NCT02761694|156626993|FG006|Overall Study|Withdrawal by Subject|4|||
48665134|NCT02761694|156626994|FG007|Overall Study|Withdrawal by Subject|0|||
48665135|NCT02761694|156626995|FG008|Overall Study|Withdrawal by Subject|2|||
48665136|NCT02761694|156626996|FG009|Overall Study|Withdrawal by Subject|1|||
48665137|NCT02761694|156626997|FG010|Overall Study|Withdrawal by Subject|0|||
48665138|NCT02761694|156626998|FG011|Overall Study|Withdrawal by Subject|0|||
48665139|NCT02761694|156626987|FG000|Overall Study|Lost to Follow-up|0|||
48757513|NCT03518073|156960734|FG001|Overall Study|Protocol Violation|0|||
48340882|NCT01730118|155444142|FG004|Dose Escalation|Withdrawal by Subject|0|||
48340883|NCT01730118|155444143|FG005|Dose Escalation|Withdrawal by Subject|0|||
48340884|NCT01730118|155444144|FG006|Dose Escalation|Withdrawal by Subject|0|||
48340885|NCT01730118|155444138|FG000|Dose Escalation|Disease progression prior to treatment|0|||
48340886|NCT01730118|155444139|FG001|Dose Escalation|Disease progression prior to treatment|0|||
48340887|NCT01730118|155444140|FG002|Dose Escalation|Disease progression prior to treatment|0|||
48340888|NCT01730118|155444141|FG003|Dose Escalation|Disease progression prior to treatment|0|||
48665140|NCT02761694|156626988|FG001|Overall Study|Lost to Follow-up|0|||
48665141|NCT02761694|156626989|FG002|Overall Study|Lost to Follow-up|0|||
48665142|NCT02761694|156626990|FG003|Overall Study|Lost to Follow-up|0|||
48665143|NCT02761694|156626991|FG004|Overall Study|Lost to Follow-up|0|||
48665144|NCT02761694|156626992|FG005|Overall Study|Lost to Follow-up|0|||
48665145|NCT02761694|156626993|FG006|Overall Study|Lost to Follow-up|1|||
48665146|NCT02761694|156626994|FG007|Overall Study|Lost to Follow-up|0|||
48665147|NCT02761694|156626995|FG008|Overall Study|Lost to Follow-up|0|||
48665148|NCT02761694|156626996|FG009|Overall Study|Lost to Follow-up|0|||
48665149|NCT02761694|156626997|FG010|Overall Study|Lost to Follow-up|0|||
48665150|NCT02761694|156626998|FG011|Overall Study|Lost to Follow-up|1|||
48665151|NCT02761694|156626987|FG000|Overall Study|Adverse Event|0|||
48665152|NCT02761694|156626988|FG001|Overall Study|Adverse Event|0|||
48665153|NCT02761694|156626989|FG002|Overall Study|Adverse Event|0|||
48665154|NCT02761694|156626990|FG003|Overall Study|Adverse Event|0|||
48665155|NCT02761694|156626991|FG004|Overall Study|Adverse Event|0|||
48757514|NCT03518073|156960735|FG002|Overall Study|Protocol Violation|0|||
48757515|NCT03518073|156960733|FG000|Overall Study|Withdrawal by Subject|30|||
48757516|NCT03518073|156960734|FG001|Overall Study|Withdrawal by Subject|34|||
48757517|NCT03518073|156960735|FG002|Overall Study|Withdrawal by Subject|29|||
48340889|NCT01730118|155444142|FG004|Dose Escalation|Disease progression prior to treatment|0|||
48340890|NCT01730118|155444143|FG005|Dose Escalation|Disease progression prior to treatment|0|||
48340891|NCT01730118|155444144|FG006|Dose Escalation|Disease progression prior to treatment|1|||
48340892|NCT01730118|155444138|FG000|Dose Expansion|Death|0|||
48340893|NCT01730118|155444139|FG001|Dose Expansion|Death|0|||
48340894|NCT01730118|155444140|FG002|Dose Expansion|Death|0|||
48340895|NCT01730118|155444141|FG003|Dose Expansion|Death|0|||
48665156|NCT02761694|156626992|FG005|Overall Study|Adverse Event|0|||
48665157|NCT02761694|156626993|FG006|Overall Study|Adverse Event|1|||
48665158|NCT02761694|156626994|FG007|Overall Study|Adverse Event|0|||
48665159|NCT02761694|156626995|FG008|Overall Study|Adverse Event|1|||
48665160|NCT02761694|156626996|FG009|Overall Study|Adverse Event|0|||
48665161|NCT02761694|156626997|FG010|Overall Study|Adverse Event|0|||
48665162|NCT02761694|156626998|FG011|Overall Study|Adverse Event|1|||
48757518|NCT03518073|156960733|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
48340896|NCT01730118|155444142|FG004|Dose Expansion|Death|1|||
48340897|NCT01730118|155444143|FG005|Dose Expansion|Death|0|||
48665163|NCT02761694|156626987|FG000|Overall Study|Other|4|||
48665164|NCT02761694|156626988|FG001|Overall Study|Other|4|||
48665165|NCT02761694|156626989|FG002|Overall Study|Other|1|||
48665166|NCT02761694|156626990|FG003|Overall Study|Other|2|||
48665167|NCT02761694|156626991|FG004|Overall Study|Other|3|||
48665168|NCT02761694|156626992|FG005|Overall Study|Other|3|||
48665169|NCT02761694|156626993|FG006|Overall Study|Other|18|||
48665170|NCT02761694|156626994|FG007|Overall Study|Other|8|||
48665171|NCT02761694|156626995|FG008|Overall Study|Other|0|||
48665172|NCT02761694|156626996|FG009|Overall Study|Other|1|||
48665173|NCT02761694|156626997|FG010|Overall Study|Other|1|||
48665174|NCT02761694|156626998|FG011|Overall Study|Other|0|||
48665175|NCT00787202|156626999|FG000|Overall Study|Adverse Event|3|||
48665176|NCT00787202|156627000|FG001|Overall Study|Adverse Event|2|||
48665177|NCT00787202|156627001|FG002|Overall Study|Adverse Event|0|||
48665178|NCT00787202|156627002|FG003|Overall Study|Adverse Event|0|||
48665179|NCT00787202|156627003|FG004|Overall Study|Adverse Event|2|||
48665180|NCT00787202|156626999|FG000|Overall Study|Lack of Efficacy|5|||
48665181|NCT00787202|156627000|FG001|Overall Study|Lack of Efficacy|6|||
48665182|NCT00787202|156627001|FG002|Overall Study|Lack of Efficacy|5|||
48665183|NCT00787202|156627002|FG003|Overall Study|Lack of Efficacy|2|||
48665184|NCT00787202|156627003|FG004|Overall Study|Lack of Efficacy|1|||
48665185|NCT00787202|156626999|FG000|Overall Study|Lost to Follow-up|1|||
48665186|NCT00787202|156627000|FG001|Overall Study|Lost to Follow-up|0|||
48665187|NCT00787202|156627001|FG002|Overall Study|Lost to Follow-up|0|||
48665188|NCT00787202|156627002|FG003|Overall Study|Lost to Follow-up|0|||
48665189|NCT00787202|156627003|FG004|Overall Study|Lost to Follow-up|0|||
48665190|NCT00787202|156626999|FG000|Overall Study|Withdrawal by Subject|2|||
48665191|NCT00787202|156627000|FG001|Overall Study|Withdrawal by Subject|2|||
48665192|NCT00787202|156627001|FG002|Overall Study|Withdrawal by Subject|2|||
48665193|NCT00787202|156627002|FG003|Overall Study|Withdrawal by Subject|0|||
48665194|NCT00787202|156627003|FG004|Overall Study|Withdrawal by Subject|0|||
48665195|NCT00787202|156626999|FG000|Overall Study|Protocol Violation|2|||
48665196|NCT00787202|156627000|FG001|Overall Study|Protocol Violation|1|||
48665197|NCT00787202|156627001|FG002|Overall Study|Protocol Violation|0|||
48665198|NCT00787202|156627002|FG003|Overall Study|Protocol Violation|0|||
48665199|NCT00787202|156627003|FG004|Overall Study|Protocol Violation|1|||
48665200|NCT00787202|156626999|FG000|Overall Study|Randomized, not treated|1|||
48665201|NCT00787202|156627000|FG001|Overall Study|Randomized, not treated|0|||
48665202|NCT00787202|156627001|FG002|Overall Study|Randomized, not treated|0|||
48665203|NCT00787202|156627002|FG003|Overall Study|Randomized, not treated|0|||
48665204|NCT00787202|156627003|FG004|Overall Study|Randomized, not treated|0|||
48665205|NCT01442064|156627004|FG000|Overall Study|Adverse Event|2|||
48665206|NCT01442064|156627005|FG001|Overall Study|Adverse Event|2|||
48665207|NCT01442064|156627006|FG002|Overall Study|Adverse Event|2|||
48665208|NCT01442064|156627007|FG003|Overall Study|Adverse Event|1|||
48665209|NCT01442064|156627008|FG004|Overall Study|Adverse Event|2|||
48665210|NCT01442064|156627009|FG005|Overall Study|Adverse Event|0|||
48665211|NCT01442064|156627004|FG000|Overall Study|Death|0|||
48665212|NCT01442064|156627005|FG001|Overall Study|Death|1|||
48665213|NCT01442064|156627006|FG002|Overall Study|Death|3|||
48665214|NCT01442064|156627007|FG003|Overall Study|Death|3|||
48665215|NCT01442064|156627008|FG004|Overall Study|Death|1|||
48340898|NCT01730118|155444144|FG006|Dose Expansion|Death|0|||
48340899|NCT01730118|155444138|FG000|Dose Expansion|Other medical condition|0|||
48340900|NCT01730118|155444139|FG001|Dose Expansion|Other medical condition|0|||
48665216|NCT01442064|156627009|FG005|Overall Study|Death|3|||
48665217|NCT01442064|156627004|FG000|Overall Study|Lost to Follow-up|5|||
48665218|NCT01442064|156627005|FG001|Overall Study|Lost to Follow-up|5|||
48340901|NCT01730118|155444140|FG002|Dose Expansion|Other medical condition|0|||
48665219|NCT01442064|156627006|FG002|Overall Study|Lost to Follow-up|1|||
48665220|NCT01442064|156627007|FG003|Overall Study|Lost to Follow-up|1|||
48665221|NCT01442064|156627008|FG004|Overall Study|Lost to Follow-up|3|||
48665222|NCT01442064|156627009|FG005|Overall Study|Lost to Follow-up|3|||
48665223|NCT01442064|156627004|FG000|Overall Study|Physician Decision|1|||
48665224|NCT01442064|156627005|FG001|Overall Study|Physician Decision|1|||
48665225|NCT01442064|156627006|FG002|Overall Study|Physician Decision|2|||
48665226|NCT01442064|156627007|FG003|Overall Study|Physician Decision|3|||
48665227|NCT01442064|156627008|FG004|Overall Study|Physician Decision|3|||
48665228|NCT01442064|156627009|FG005|Overall Study|Physician Decision|1|||
48665229|NCT01442064|156627004|FG000|Overall Study|Withdrawal by Subject|6|||
48665230|NCT01442064|156627005|FG001|Overall Study|Withdrawal by Subject|3|||
48665231|NCT01442064|156627006|FG002|Overall Study|Withdrawal by Subject|2|||
48665232|NCT01442064|156627007|FG003|Overall Study|Withdrawal by Subject|2|||
48340902|NCT01730118|155444141|FG003|Dose Expansion|Other medical condition|0|||
48665233|NCT01442064|156627008|FG004|Overall Study|Withdrawal by Subject|2|||
48665234|NCT01442064|156627009|FG005|Overall Study|Withdrawal by Subject|1|||
48665235|NCT01442064|156627004|FG000|Overall Study|Sponsor decision|82|||
48665236|NCT01442064|156627005|FG001|Overall Study|Sponsor decision|88|||
48665237|NCT01442064|156627006|FG002|Overall Study|Sponsor decision|92|||
48665238|NCT01442064|156627007|FG003|Overall Study|Sponsor decision|88|||
48665239|NCT01442064|156627008|FG004|Overall Study|Sponsor decision|95|||
48665240|NCT01442064|156627009|FG005|Overall Study|Sponsor decision|87|||
48665241|NCT01442064|156627004|FG000|Overall Study|Subject non-compliance|0|||
48665242|NCT01442064|156627005|FG001|Overall Study|Subject non-compliance|0|||
48340903|NCT01730118|155444142|FG004|Dose Expansion|Other medical condition|1|||
48665243|NCT01442064|156627006|FG002|Overall Study|Subject non-compliance|0|||
48665244|NCT01442064|156627007|FG003|Overall Study|Subject non-compliance|0|||
48665245|NCT01442064|156627008|FG004|Overall Study|Subject non-compliance|0|||
48757519|NCT03518073|156960734|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
48757520|NCT03518073|156960735|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
48665246|NCT01442064|156627009|FG005|Overall Study|Subject non-compliance|2|||
48665247|NCT01442064|156627004|FG000|Overall Study|Condition mandated other intervention|1|||
48665248|NCT01442064|156627005|FG001|Overall Study|Condition mandated other intervention|1|||
48665249|NCT01442064|156627006|FG002|Overall Study|Condition mandated other intervention|2|||
48665250|NCT01442064|156627007|FG003|Overall Study|Condition mandated other intervention|0|||
48665251|NCT01442064|156627008|FG004|Overall Study|Condition mandated other intervention|0|||
48665252|NCT01442064|156627009|FG005|Overall Study|Condition mandated other intervention|2|||
48665253|NCT01269385|156627010|FG000|Overall Study|Adverse Event|1|||
48665254|NCT01269385|156627011|FG001|Overall Study|Adverse Event|1|||
48665255|NCT01269385|156627012|FG002|Overall Study|Adverse Event|0|||
48665256|NCT01269385|156627013|FG003|Overall Study|Adverse Event|0|||
48665257|NCT01958021|156627014|FG000|Overall Study|Progressive disease|87|||
48665258|NCT01958021|156627015|FG001|Overall Study|Progressive disease|146|||
48665259|NCT01958021|156627014|FG000|Overall Study|Adverse Event|25|||
48665260|NCT01958021|156627015|FG001|Overall Study|Adverse Event|7|||
48665261|NCT01958021|156627014|FG000|Overall Study|Subject/guardian decision|12|||
48665262|NCT01958021|156627015|FG001|Overall Study|Subject/guardian decision|13|||
48665263|NCT01958021|156627014|FG000|Overall Study|Physician Decision|10|||
48665264|NCT01958021|156627015|FG001|Overall Study|Physician Decision|13|||
48665265|NCT01958021|156627014|FG000|Overall Study|Protocol Violation|3|||
48665266|NCT01958021|156627015|FG001|Overall Study|Protocol Violation|1|||
48665267|NCT01958021|156627014|FG000|Overall Study|Death|2|||
48665268|NCT01958021|156627015|FG001|Overall Study|Death|0|||
48665269|NCT03242018|156627016|FG000|Overall Study|Adverse Event|7|||
48665270|NCT03242018|156627017|FG001|Overall Study|Adverse Event|7|||
48665271|NCT03242018|156627018|FG002|Overall Study|Adverse Event|6|||
48665272|NCT03242018|156627016|FG000|Overall Study|Lost to Follow-up|2|||
48665273|NCT03242018|156627017|FG001|Overall Study|Lost to Follow-up|2|||
48665274|NCT03242018|156627018|FG002|Overall Study|Lost to Follow-up|2|||
48665275|NCT03242018|156627016|FG000|Overall Study|At the Participant's Own Request|5|||
48665276|NCT03242018|156627017|FG001|Overall Study|At the Participant's Own Request|1|||
48665277|NCT03242018|156627018|FG002|Overall Study|At the Participant's Own Request|4|||
48665278|NCT03242018|156627016|FG000|Overall Study|Reason Not Specified|3|||
48665279|NCT03242018|156627017|FG001|Overall Study|Reason Not Specified|4|||
48665280|NCT03242018|156627018|FG002|Overall Study|Reason Not Specified|1|||
48665281|NCT03242018|156627016|FG000|Overall Study|Study Terminated by Sponsor|1|||
48665282|NCT03242018|156627017|FG001|Overall Study|Study Terminated by Sponsor|0|||
48665283|NCT03242018|156627018|FG002|Overall Study|Study Terminated by Sponsor|1|||
48665284|NCT00946322|156627019|FG000|Pre-treatment|participant failure to follow up|1|||
48665285|NCT00946322|156627019|FG000|Post-treatment|participant failure to follow up|2|||
48665286|NCT00687609|156627020|FG000|Overall Study|Physician Decision|1|||
48665287|NCT00687609|156627020|FG000|Overall Study|Withdrawal by Subject|2|||
48665288|NCT01617447|156627021|FG000|Overall Study|Adverse Event|0|||
48665289|NCT01617447|156627022|FG001|Overall Study|Adverse Event|1|||
48665290|NCT01617447|156627021|FG000|Overall Study|Physician Decision|0|||
48665291|NCT01617447|156627022|FG001|Overall Study|Physician Decision|2|||
48665292|NCT02713529|156627023|FG000|Overall Study|Withdrawal by Subject|3|||
48665293|NCT02713529|156627024|FG001|Overall Study|Withdrawal by Subject|1|||
48665294|NCT02713529|156627025|FG002|Overall Study|Withdrawal by Subject|4|||
48665295|NCT02713529|156627026|FG003|Overall Study|Withdrawal by Subject|2|||
48665296|NCT02713529|156627027|FG004|Overall Study|Withdrawal by Subject|0|||
48757521|NCT03518073|156960733|FG000|Overall Study|Covid-19|1|||
48757522|NCT03518073|156960734|FG001|Overall Study|Covid-19|2|||
48757523|NCT03518073|156960735|FG002|Overall Study|Covid-19|1|||
48757524|NCT02169739|156960737|FG000|Overall Study|Lost to Follow-up|0|||
48757525|NCT02169739|156960738|FG001|Overall Study|Lost to Follow-up|4|||
48757526|NCT01484873|156960739|FG000|Overall Study|Withdrawal by Subject|2|||
48757527|NCT01356966|156960740|FG000|Overall Study|Withdrawal by Subject|1|||
48757528|NCT01356966|156960741|FG001|Overall Study|Withdrawal by Subject|2|||
48757529|NCT01356966|156960740|FG000|Overall Study|Physician Decision|1|||
48757530|NCT01356966|156960741|FG001|Overall Study|Physician Decision|0|||
48757531|NCT01647282|156960742|FG000|Overall Study|Physician Decision|7|||
48757532|NCT01647282|156960743|FG001|Overall Study|Physician Decision|5|||
48757533|NCT01475331|156960744|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
48757534|NCT01475331|156960745|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
48757535|NCT01475331|156960744|FG000|Overall Study|excessive main duct communication|1|||
48757536|NCT01475331|156960745|FG001|Overall Study|excessive main duct communication|1|||
48757537|NCT01475331|156960744|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
48757538|NCT01475331|156960745|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
48757539|NCT01475331|156960744|FG000|Overall Study|Sign of malignancy during the procedure|2|||
48757540|NCT01475331|156960745|FG001|Overall Study|Sign of malignancy during the procedure|0|||
48665297|NCT02713529|156627028|FG005|Overall Study|Withdrawal by Subject|1|||
48665298|NCT02713529|156627029|FG006|Overall Study|Withdrawal by Subject|1|||
48665299|NCT02713529|156627023|FG000|Overall Study|Lost to Follow-up|1|||
48665300|NCT02713529|156627024|FG001|Overall Study|Lost to Follow-up|0|||
48665301|NCT02713529|156627025|FG002|Overall Study|Lost to Follow-up|1|||
48665302|NCT02713529|156627026|FG003|Overall Study|Lost to Follow-up|0|||
48665303|NCT02713529|156627027|FG004|Overall Study|Lost to Follow-up|0|||
48665304|NCT02713529|156627028|FG005|Overall Study|Lost to Follow-up|0|||
48665305|NCT02713529|156627029|FG006|Overall Study|Lost to Follow-up|0|||
48665306|NCT02713529|156627023|FG000|Overall Study|Death|3|||
48665307|NCT02713529|156627024|FG001|Overall Study|Death|3|||
48665308|NCT02713529|156627025|FG002|Overall Study|Death|26|||
48665309|NCT02713529|156627026|FG003|Overall Study|Death|27|||
48665310|NCT02713529|156627027|FG004|Overall Study|Death|3|||
48665311|NCT02713529|156627028|FG005|Overall Study|Death|13|||
48665312|NCT02713529|156627029|FG006|Overall Study|Death|3|||
48665313|NCT00477269|156627030|FG000|Core Study|Adverse Event|6|||
48665314|NCT00477269|156627031|FG001|Core Study|Adverse Event|4|||
48757541|NCT01475331|156960744|FG000|Overall Study|cyst found to be prohibitively small|0|||
48757542|NCT01475331|156960745|FG001|Overall Study|cyst found to be prohibitively small|1|||
48757543|NCT01525550|156960746|FG000|Overall Study|Lost to Follow-up|8|||
48757544|NCT01525550|156960747|FG001|Overall Study|Lost to Follow-up|2|||
48757545|NCT01525550|156960746|FG000|Overall Study|Death|19|||
48757546|NCT01525550|156960747|FG001|Overall Study|Death|28|||
48757547|NCT01525550|156960746|FG000|Overall Study|Other|0|||
48757548|NCT01525550|156960747|FG001|Overall Study|Other|4|||
48757549|NCT01525550|156960746|FG000|Overall Study|Sponsor's Decision|30|||
48757550|NCT01525550|156960747|FG001|Overall Study|Sponsor's Decision|11|||
48757551|NCT01525550|156960746|FG000|Overall Study|Withdrawal by Subject|4|||
48757552|NCT01525550|156960747|FG001|Overall Study|Withdrawal by Subject|0|||
48757553|NCT02345811|156960748|FG000|First Intervention|Withdrawal by Subject|1|||
48757554|NCT02345811|156960749|FG001|First Intervention|Withdrawal by Subject|1|||
48757555|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
48757556|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
48757557|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
48757558|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
48757559|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
48757560|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
48757561|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
48757562|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
48757563|NCT01541969|156960750|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
48757564|NCT01541969|156960751|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
48757565|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
48757566|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
48757567|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
48757568|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
48757569|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
48757570|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
48757571|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
48757572|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
48757573|NCT01541969|156960750|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
48757574|NCT01541969|156960751|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
48757575|NCT03480750|156960753|FG000|Overall Study|Withdrawal by Subject|0|||
48757576|NCT03480750|156960754|FG001|Overall Study|Withdrawal by Subject|1|||
48757577|NCT03480750|156960755|FG002|Overall Study|Withdrawal by Subject|0|||
48757578|NCT03480750|156960756|FG003|Overall Study|Withdrawal by Subject|0|||
48665315|NCT00477269|156627032|FG002|Core Study|Adverse Event|0|||
48665316|NCT00477269|156627030|FG000|Core Study|Death|3|||
48665317|NCT00477269|156627031|FG001|Core Study|Death|3|||
48665318|NCT00477269|156627032|FG002|Core Study|Death|0|||
48665319|NCT00477269|156627030|FG000|Core Study|Withdrawn Consent|0|||
48665320|NCT00477269|156627031|FG001|Core Study|Withdrawn Consent|1|||
48665321|NCT00477269|156627032|FG002|Core Study|Withdrawn Consent|0|||
48665322|NCT00477269|156627030|FG000|Open Label Extension|Adverse Event|0|||
48665323|NCT00477269|156627031|FG001|Open Label Extension|Adverse Event|0|||
48665324|NCT00477269|156627032|FG002|Open Label Extension|Adverse Event|4|||
48665325|NCT00477269|156627030|FG000|Open Label Extension|Abnormal laboratory values|0|||
48665326|NCT00477269|156627031|FG001|Open Label Extension|Abnormal laboratory values|0|||
48665327|NCT00477269|156627032|FG002|Open Label Extension|Abnormal laboratory values|1|||
48665328|NCT00477269|156627030|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
48757579|NCT03480750|156960757|FG004|Overall Study|Withdrawal by Subject|0|||
48757580|NCT03480750|156960758|FG005|Overall Study|Withdrawal by Subject|0|||
48665329|NCT00477269|156627031|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
48665330|NCT00477269|156627032|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
48757581|NCT03480750|156960753|FG000|Overall Study|The interruption in Trientine shippment|0|||
48665331|NCT00477269|156627030|FG000|Open Label Extension|Adminiatrative problems|0|||
48757582|NCT03480750|156960754|FG001|Overall Study|The interruption in Trientine shippment|0|||
48757583|NCT03480750|156960755|FG002|Overall Study|The interruption in Trientine shippment|0|||
48757584|NCT03480750|156960756|FG003|Overall Study|The interruption in Trientine shippment|0|||
48757585|NCT03480750|156960757|FG004|Overall Study|The interruption in Trientine shippment|0|||
48757586|NCT03480750|156960758|FG005|Overall Study|The interruption in Trientine shippment|1|||
48757587|NCT00518323|156960762|FG000|Overall Study|Lack of Efficacy|14|||
48757588|NCT00518323|156960763|FG001|Overall Study|Lack of Efficacy|2|||
48757589|NCT00518323|156960764|FG002|Overall Study|Lack of Efficacy|4|||
48757590|NCT00518323|156960765|FG003|Overall Study|Lack of Efficacy|20|||
48757591|NCT00518323|156960762|FG000|Overall Study|Withdrawal by Subject|1|||
48757592|NCT00518323|156960763|FG001|Overall Study|Withdrawal by Subject|2|||
48757593|NCT00518323|156960764|FG002|Overall Study|Withdrawal by Subject|4|||
48757594|NCT00518323|156960765|FG003|Overall Study|Withdrawal by Subject|2|||
48757595|NCT00518323|156960762|FG000|Overall Study|Lost to Follow-up|0|||
48757596|NCT00518323|156960763|FG001|Overall Study|Lost to Follow-up|2|||
48757597|NCT00518323|156960764|FG002|Overall Study|Lost to Follow-up|1|||
48757598|NCT00518323|156960765|FG003|Overall Study|Lost to Follow-up|3|||
48757599|NCT00518323|156960762|FG000|Overall Study|Adverse Event|1|||
48757600|NCT00518323|156960763|FG001|Overall Study|Adverse Event|1|||
48757601|NCT00518323|156960764|FG002|Overall Study|Adverse Event|1|||
48757602|NCT00518323|156960765|FG003|Overall Study|Adverse Event|0|||
48757603|NCT00518323|156960762|FG000|Overall Study|Prohibited medication and others|3|||
48757604|NCT00518323|156960763|FG001|Overall Study|Prohibited medication and others|1|||
48757605|NCT00518323|156960764|FG002|Overall Study|Prohibited medication and others|1|||
48757606|NCT00518323|156960765|FG003|Overall Study|Prohibited medication and others|0|||
48757607|NCT00356369|156960766|FG000|Active Phase|Withdrawal by Subject|2|||
48665332|NCT00477269|156627031|FG001|Open Label Extension|Adminiatrative problems|0|||
48757608|NCT00356369|156960767|FG001|Active Phase|Withdrawal by Subject|1|||
48665333|NCT00477269|156627032|FG002|Open Label Extension|Adminiatrative problems|2|||
48665334|NCT00477269|156627030|FG000|Open Label Extension|Death|0|||
48665335|NCT00477269|156627031|FG001|Open Label Extension|Death|0|||
48665336|NCT00477269|156627032|FG002|Open Label Extension|Death|4|||
48665337|NCT01565564|156627045|FG000|Overall Study|Lost to Follow-up|5|||
48665338|NCT01565564|156627046|FG001|Overall Study|Lost to Follow-up|1|||
48665339|NCT03759041|156627047|FG000|Overall Study|Withdrawal by Subject|4|||
48665340|NCT03759041|156627048|FG001|Overall Study|Withdrawal by Subject|10|||
48665341|NCT03759041|156627049|FG002|Overall Study|Withdrawal by Subject|10|||
48665342|NCT03759041|156627047|FG000|Overall Study|Adverse Event|1|||
48665343|NCT03759041|156627048|FG001|Overall Study|Adverse Event|3|||
48665344|NCT03759041|156627049|FG002|Overall Study|Adverse Event|4|||
48665345|NCT03759041|156627047|FG000|Overall Study|Lack of Efficacy|0|||
48665346|NCT03759041|156627048|FG001|Overall Study|Lack of Efficacy|0|||
48665347|NCT03759041|156627049|FG002|Overall Study|Lack of Efficacy|1|||
48665348|NCT03759041|156627047|FG000|Overall Study|Study Terminated by Sponsor|15|||
48665349|NCT03759041|156627048|FG001|Overall Study|Study Terminated by Sponsor|16|||
48665350|NCT03759041|156627049|FG002|Overall Study|Study Terminated by Sponsor|10|||
48665351|NCT03759041|156627047|FG000|Overall Study|Other reason for discontinuation|0|||
48665352|NCT03759041|156627048|FG001|Overall Study|Other reason for discontinuation|2|||
48665353|NCT03759041|156627049|FG002|Overall Study|Other reason for discontinuation|1|||
48665354|NCT03759041|156627047|FG000|Overall Study|Lost to Follow-up|7|||
48665355|NCT03759041|156627048|FG001|Overall Study|Lost to Follow-up|2|||
48665356|NCT03759041|156627049|FG002|Overall Study|Lost to Follow-up|2|||
48665357|NCT03759041|156627047|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
48665358|NCT03759041|156627048|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
48665359|NCT03759041|156627049|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
48665360|NCT03831945|156627052|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
48665361|NCT03831945|156627053|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
48665362|NCT03831945|156627052|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
48665363|NCT03831945|156627053|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
48665364|NCT03831945|156627052|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
48665365|NCT03831945|156627053|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
48665366|NCT00806442|156627054|FG000|Overall Study|Lost to Follow-up|3|||
48665367|NCT00806442|156627055|FG001|Overall Study|Lost to Follow-up|2|||
48665368|NCT00806442|156627054|FG000|Overall Study|Withdrawal by Subject|1|||
48665369|NCT00806442|156627055|FG001|Overall Study|Withdrawal by Subject|5|||
48665370|NCT01522404|156627060|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
48665371|NCT01522404|156627061|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
48757609|NCT00255047|156960789|FG000|Overall Study|Serious Adverse Events|2|||
48757610|NCT00255047|156960790|FG001|Overall Study|Serious Adverse Events|1|||
48757611|NCT00255047|156960791|FG002|Overall Study|Serious Adverse Events|2|||
48665372|NCT01522404|156627060|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
48665373|NCT01522404|156627061|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
48665374|NCT01522404|156627060|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
48665375|NCT01522404|156627061|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
48665376|NCT03734029|156627064|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
48665377|NCT03734029|156627065|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
48665378|NCT03734029|156627064|FG000|Overall Study|Adverse Event|60|||
48665379|NCT03734029|156627065|FG001|Overall Study|Adverse Event|14|||
48665380|NCT03734029|156627064|FG000|Overall Study|Withdrawal by Subject|12|||
48665381|NCT03734029|156627065|FG001|Overall Study|Withdrawal by Subject|11|||
48665382|NCT03734029|156627064|FG000|Overall Study|Clinical progression by investigator|10|||
48665383|NCT03734029|156627065|FG001|Overall Study|Clinical progression by investigator|8|||
48665384|NCT03734029|156627064|FG000|Overall Study|Death|5|||
48665385|NCT03734029|156627065|FG001|Overall Study|Death|2|||
48665386|NCT03734029|156627064|FG000|Overall Study|Physician Decision|4|||
48665387|NCT03734029|156627065|FG001|Overall Study|Physician Decision|3|||
48665388|NCT03734029|156627064|FG000|Overall Study|Other|2|||
48665389|NCT03734029|156627065|FG001|Overall Study|Other|0|||
48665390|NCT03734029|156627064|FG000|Overall Study|Lost to Follow-up|0|||
48665391|NCT03734029|156627065|FG001|Overall Study|Lost to Follow-up|1|||
48665392|NCT03734029|156627064|FG000|Overall Study|Randomized, but not treated|2|||
48665393|NCT03734029|156627065|FG001|Overall Study|Randomized, but not treated|12|||
48665394|NCT03582813|156627066|FG000|Overall Study|Lost to Follow-up|18|||
48665395|NCT03582813|156627067|FG001|Overall Study|Lost to Follow-up|21|||
48665396|NCT03582813|156627066|FG000|Overall Study|Withdrawal by Subject|1|||
48665397|NCT03582813|156627067|FG001|Overall Study|Withdrawal by Subject|0|||
48665398|NCT02739321|156627084|FG000|Overall Study|Lack of Efficacy|1|||
48665399|NCT02739321|156627085|FG001|Overall Study|Lack of Efficacy|1|||
48665400|NCT02739321|156627084|FG000|Overall Study|Lost to Follow-up|1|||
48665401|NCT02739321|156627085|FG001|Overall Study|Lost to Follow-up|1|||
48665402|NCT02739321|156627084|FG000|Overall Study|Withdrawal by Subject|1|||
48665403|NCT02739321|156627085|FG001|Overall Study|Withdrawal by Subject|2|||
48665404|NCT01440517|156628450|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
48665405|NCT01537081|156628451|FG000|Overall Study|Adverse Event|5|||
48665406|NCT01537081|156628452|FG001|Overall Study|Adverse Event|2|||
48665407|NCT01537081|156628453|FG002|Overall Study|Adverse Event|2|||
48665408|NCT01537081|156628451|FG000|Overall Study|Lack of Efficacy|2|||
48665409|NCT01537081|156628452|FG001|Overall Study|Lack of Efficacy|1|||
48665410|NCT01537081|156628453|FG002|Overall Study|Lack of Efficacy|0|||
48665411|NCT01537081|156628451|FG000|Overall Study|Lost to Follow-up|17|||
48665412|NCT01537081|156628452|FG001|Overall Study|Lost to Follow-up|15|||
48665413|NCT01537081|156628453|FG002|Overall Study|Lost to Follow-up|9|||
48665414|NCT01537081|156628451|FG000|Overall Study|Protocol Violation|3|||
48665415|NCT01537081|156628452|FG001|Overall Study|Protocol Violation|2|||
48665416|NCT01537081|156628453|FG002|Overall Study|Protocol Violation|2|||
48665417|NCT01537081|156628451|FG000|Overall Study|Withdrawal by Subject|6|||
48665418|NCT01537081|156628452|FG001|Overall Study|Withdrawal by Subject|11|||
48665419|NCT01537081|156628453|FG002|Overall Study|Withdrawal by Subject|3|||
48665420|NCT01537081|156628451|FG000|Overall Study|Physician Decision|5|||
48665421|NCT01537081|156628452|FG001|Overall Study|Physician Decision|6|||
48665422|NCT01537081|156628453|FG002|Overall Study|Physician Decision|0|||
48340904|NCT01730118|155444143|FG005|Dose Expansion|Other medical condition|0|||
48340905|NCT01730118|155444144|FG006|Dose Expansion|Other medical condition|0|||
48340906|NCT01730118|155444138|FG000|Dose Expansion|Withdrawal by Subject|0|||
48340907|NCT01730118|155444139|FG001|Dose Expansion|Withdrawal by Subject|0|||
48340908|NCT01730118|155444140|FG002|Dose Expansion|Withdrawal by Subject|0|||
48340909|NCT01730118|155444141|FG003|Dose Expansion|Withdrawal by Subject|0|||
48340910|NCT01730118|155444142|FG004|Dose Expansion|Withdrawal by Subject|1|||
48340911|NCT01730118|155444143|FG005|Dose Expansion|Withdrawal by Subject|0|||
48340912|NCT01730118|155444144|FG006|Dose Expansion|Withdrawal by Subject|0|||
48340913|NCT01730118|155444138|FG000|Dose Expansion|Disease progression|0|||
48340914|NCT01730118|155444139|FG001|Dose Expansion|Disease progression|0|||
48340915|NCT01730118|155444140|FG002|Dose Expansion|Disease progression|0|||
48340916|NCT01730118|155444141|FG003|Dose Expansion|Disease progression|0|||
48340917|NCT01730118|155444142|FG004|Dose Expansion|Disease progression|0|||
48340918|NCT01730118|155444143|FG005|Dose Expansion|Disease progression|1|||
48665423|NCT01537081|156628451|FG000|Overall Study|Sponsor decision|0|||
48665424|NCT01537081|156628452|FG001|Overall Study|Sponsor decision|1|||
48665425|NCT01537081|156628453|FG002|Overall Study|Sponsor decision|0|||
48665426|NCT01537081|156628451|FG000|Overall Study|Assigned but never dosed|1|||
48665427|NCT01537081|156628452|FG001|Overall Study|Assigned but never dosed|0|||
48665428|NCT01537081|156628453|FG002|Overall Study|Assigned but never dosed|0|||
48665429|NCT03285958|156628456|FG000|Overall Study|Lost to Follow-up|1|||
48665430|NCT03285958|156628457|FG001|Overall Study|Lost to Follow-up|1|||
48665431|NCT03285958|156628456|FG000|Overall Study|Withdrawal by Subject|1|||
48665432|NCT03285958|156628457|FG001|Overall Study|Withdrawal by Subject|0|||
48340919|NCT01730118|155444144|FG006|Dose Expansion|Disease progression|0|||
48340920|NCT01730118|155444138|FG000|Dose Expansion|Inability to return|0|||
48340921|NCT01730118|155444139|FG001|Dose Expansion|Inability to return|0|||
48340922|NCT01730118|155444140|FG002|Dose Expansion|Inability to return|0|||
48340923|NCT01730118|155444141|FG003|Dose Expansion|Inability to return|0|||
48665433|NCT03285958|156628456|FG000|Overall Study|Not able to attend required orientation|3|||
48665434|NCT03285958|156628457|FG001|Overall Study|Not able to attend required orientation|0|||
48665435|NCT03405935|156628458|FG000|Overall Study|Adverse Event|3|||
48665436|NCT03405935|156628458|FG000|Overall Study|Death|2|||
48665437|NCT03405935|156628458|FG000|Overall Study|Withdrawal by Subject|1|||
48665438|NCT03405935|156628458|FG000|Overall Study|Lost to Follow-up|2|||
48665439|NCT03383783|156628465|FG000|Overall Study|Withdrawal by Subject|2|||
48665440|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
48665441|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
48665442|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
48665443|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
48665444|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
48665445|NCT01224821|156628466|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
48665446|NCT01224821|156628466|FG000|Long-Term Follow-Up|Death|2|||
48665447|NCT01224821|156628466|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
48665448|NCT01170598|156628467|FG000|Overall Study|Withdrawal by Subject|1|||
48665449|NCT01170598|156628467|FG000|Overall Study|Death|3|||
48665450|NCT01170598|156628467|FG000|Overall Study|Lost to Follow-up|1|||
48665451|NCT01170598|156628467|FG000|Overall Study|Refused|1|||
48665452|NCT03761394|156628472|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
48665453|NCT03761394|156628473|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
48665454|NCT03761394|156628474|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
48665455|NCT03761394|156628475|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
48665456|NCT03761394|156628472|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
48665457|NCT03761394|156628473|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
48665458|NCT03761394|156628474|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
48757612|NCT00255047|156960792|FG003|Overall Study|Serious Adverse Events|1|||
48665459|NCT03761394|156628475|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
48665460|NCT03761394|156628472|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
48665461|NCT03761394|156628473|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
48665462|NCT03761394|156628474|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
48665463|NCT03761394|156628475|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
48665464|NCT03761394|156628472|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
48665465|NCT03761394|156628473|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
48665466|NCT03761394|156628474|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
48665467|NCT03761394|156628475|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
48665468|NCT01145053|156628476|FG000|Overall Study|Adverse Event|22|||
48665469|NCT01145053|156628476|FG000|Overall Study|Lost to Follow-up|28|||
48665470|NCT01145053|156628476|FG000|Overall Study|Withdrawal by Subject|25|||
48665471|NCT01145053|156628476|FG000|Overall Study|Other|18|||
48665472|NCT01891344|156628490|FG000|Overall Study|Ongoing|6|||
48665473|NCT01891344|156628491|FG001|Overall Study|Ongoing|2|||
48340924|NCT01730118|155444142|FG004|Dose Expansion|Inability to return|0|||
48340925|NCT01730118|155444143|FG005|Dose Expansion|Inability to return|1|||
48340926|NCT01730118|155444144|FG006|Dose Expansion|Inability to return|0|||
48340927|NCT01730118|155444138|FG000|Dose Expansion|Physician Decision|0|||
48340928|NCT01730118|155444139|FG001|Dose Expansion|Physician Decision|0|||
48340929|NCT01730118|155444140|FG002|Dose Expansion|Physician Decision|0|||
48340930|NCT01730118|155444141|FG003|Dose Expansion|Physician Decision|0|||
48340931|NCT01730118|155444142|FG004|Dose Expansion|Physician Decision|0|||
48340932|NCT01730118|155444143|FG005|Dose Expansion|Physician Decision|1|||
48340933|NCT01730118|155444144|FG006|Dose Expansion|Physician Decision|0|||
48340934|NCT00961298|155444145|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
48340935|NCT00961298|155444145|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
48340936|NCT00961298|155444145|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
48340937|NCT04044352|155444146|FG000|Overall Study|Lost to Follow-up|9|||
48340938|NCT04044352|155444146|FG000|Overall Study|Withdrawal by Subject|2|||
48340939|NCT03840200|155444150|FG000|Overall Study|Death|6|||
48340940|NCT03840200|155444151|FG001|Overall Study|Death|3|||
48340941|NCT03840200|155444152|FG002|Overall Study|Death|6|||
48340942|NCT03840200|155444153|FG003|Overall Study|Death|10|||
48340943|NCT03840200|155444150|FG000|Overall Study|Reason Not Specified|2|||
48340944|NCT03840200|155444151|FG001|Overall Study|Reason Not Specified|2|||
48340945|NCT03840200|155444152|FG002|Overall Study|Reason Not Specified|1|||
48340946|NCT03840200|155444153|FG003|Overall Study|Reason Not Specified|15|||
48340947|NCT03840200|155444150|FG000|Overall Study|Physician Decision|0|||
48340948|NCT03840200|155444151|FG001|Overall Study|Physician Decision|0|||
48340949|NCT03840200|155444152|FG002|Overall Study|Physician Decision|0|||
48340950|NCT03840200|155444153|FG003|Overall Study|Physician Decision|2|||
48340951|NCT03840200|155444150|FG000|Overall Study|Progressive Disease|0|||
48340952|NCT03840200|155444151|FG001|Overall Study|Progressive Disease|0|||
48340953|NCT03840200|155444152|FG002|Overall Study|Progressive Disease|0|||
48340954|NCT03840200|155444153|FG003|Overall Study|Progressive Disease|1|||
48340955|NCT03840200|155444150|FG000|Overall Study|Withdrawal by Subject|0|||
48340956|NCT03840200|155444151|FG001|Overall Study|Withdrawal by Subject|1|||
48340957|NCT03840200|155444152|FG002|Overall Study|Withdrawal by Subject|0|||
48340958|NCT03840200|155444153|FG003|Overall Study|Withdrawal by Subject|2|||
48340959|NCT03722485|155444158|FG000|Overall Study|Withdrawal by Subject|1|||
48340960|NCT03722485|155444159|FG001|Overall Study|Withdrawal by Subject|0|||
48340961|NCT03722485|155444158|FG000|Overall Study|Adverse Event|0|||
48340962|NCT03722485|155444159|FG001|Overall Study|Adverse Event|2|||
48665474|NCT01891344|156628492|FG002|Overall Study|Ongoing|0|||
48665475|NCT01891344|156628493|FG003|Overall Study|Ongoing|1|||
48340963|NCT03722485|155444158|FG000|Overall Study|subject discharged prior to study completion|1|||
48340964|NCT03722485|155444159|FG001|Overall Study|subject discharged prior to study completion|5|||
48340965|NCT03722485|155444158|FG000|Overall Study|eligibility criteria not met|2|||
48340966|NCT03722485|155444159|FG001|Overall Study|eligibility criteria not met|0|||
48340967|NCT03087851|155444162|FG000|Overall Study|Withdraw on medical grounds|0|||
48665476|NCT01891344|156628494|FG004|Overall Study|Ongoing|4|||
48665477|NCT01891344|156628495|FG005|Overall Study|Ongoing|1|||
48757613|NCT00255047|156960789|FG000|Overall Study|Adverse Event|0|||
48340968|NCT03087851|155444163|FG001|Overall Study|Withdraw on medical grounds|1|||
48340969|NCT03087851|155444164|FG002|Overall Study|Withdraw on medical grounds|2|||
48340970|NCT03997409|155444165|FG000|Overall Study|Protocol Violation|1|||
48665478|NCT01891344|156628496|FG006|Overall Study|Ongoing|0|||
48665479|NCT01891344|156628497|FG007|Overall Study|Ongoing|0|||
48665480|NCT01414205|156628503|FG000|Overall Study|Death|5|||
48665481|NCT01414205|156628504|FG001|Overall Study|Death|1|||
48665482|NCT01414205|156628503|FG000|Overall Study|Lost to Follow-up|1|||
48665483|NCT01414205|156628504|FG001|Overall Study|Lost to Follow-up|4|||
48665484|NCT01414205|156628503|FG000|Overall Study|Physician Decision|0|||
48665485|NCT01414205|156628504|FG001|Overall Study|Physician Decision|1|||
48665486|NCT01414205|156628503|FG000|Overall Study|Randomized but not Treated|1|||
48665487|NCT01414205|156628504|FG001|Overall Study|Randomized but not Treated|1|||
48665488|NCT00054691|156628506|FG000|Overall Study|Unmeasurable Disease|2|||
48665489|NCT00054691|156628506|FG000|Overall Study|Noncompliant|1|||
48665490|NCT02914548|156628507|FG000|Overall Study|Adverse Event|15|||
48665491|NCT02914548|156628508|FG001|Overall Study|Adverse Event|7|||
48665492|NCT02914548|156628509|FG002|Overall Study|Adverse Event|15|||
48757614|NCT00255047|156960790|FG001|Overall Study|Adverse Event|3|||
48757615|NCT00255047|156960791|FG002|Overall Study|Adverse Event|2|||
48757616|NCT00255047|156960792|FG003|Overall Study|Adverse Event|1|||
48757617|NCT00255047|156960789|FG000|Overall Study|Protocol Violation|13|||
48757618|NCT00255047|156960790|FG001|Overall Study|Protocol Violation|13|||
48757619|NCT00255047|156960791|FG002|Overall Study|Protocol Violation|16|||
48757620|NCT00255047|156960792|FG003|Overall Study|Protocol Violation|20|||
48757621|NCT00255047|156960789|FG000|Overall Study|Lost to Follow-up|9|||
48757622|NCT00255047|156960790|FG001|Overall Study|Lost to Follow-up|8|||
48757623|NCT00255047|156960791|FG002|Overall Study|Lost to Follow-up|5|||
48757624|NCT00255047|156960792|FG003|Overall Study|Lost to Follow-up|6|||
48757625|NCT00255047|156960789|FG000|Overall Study|Withdrawal by Subject|24|||
48757626|NCT00255047|156960790|FG001|Overall Study|Withdrawal by Subject|23|||
48757627|NCT00255047|156960791|FG002|Overall Study|Withdrawal by Subject|25|||
48757628|NCT00255047|156960792|FG003|Overall Study|Withdrawal by Subject|18|||
48757629|NCT00811473|156960793|FG000|Overall Study|Adverse Event|3|||
48757630|NCT00811473|156960794|FG001|Overall Study|Adverse Event|12|||
48757631|NCT00811473|156960793|FG000|Overall Study|Lost to Follow-up|5|||
48757632|NCT00811473|156960794|FG001|Overall Study|Lost to Follow-up|1|||
48757633|NCT00811473|156960793|FG000|Overall Study|Withdrawal by Subject|2|||
48757634|NCT00811473|156960794|FG001|Overall Study|Withdrawal by Subject|4|||
48757635|NCT00811473|156960793|FG000|Overall Study|Severe non-compliance to protocol|2|||
48757636|NCT00811473|156960794|FG001|Overall Study|Severe non-compliance to protocol|4|||
48757637|NCT00811473|156960793|FG000|Overall Study|Lack of therapeutic response|4|||
48757638|NCT00811473|156960794|FG001|Overall Study|Lack of therapeutic response|1|||
48757639|NCT00811473|156960793|FG000|Overall Study|Condition under investigation worsened|1|||
48757640|NCT00811473|156960794|FG001|Overall Study|Condition under investigation worsened|3|||
48757641|NCT00811473|156960793|FG000|Overall Study|Other 2|4|||
48757642|NCT00811473|156960794|FG001|Overall Study|Other 2|1|||
48757643|NCT00811473|156960793|FG000|Overall Study|Incorrect Enrollment|1|||
48757644|NCT00811473|156960794|FG001|Overall Study|Incorrect Enrollment|0|||
48757645|NCT00811473|156960793|FG000|Overall Study|Safety Reasons|1|||
48757646|NCT00811473|156960794|FG001|Overall Study|Safety Reasons|0|||
48757647|NCT04053023|156960800|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
48757648|NCT04053023|156960801|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
48757649|NCT00383149|156960802|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
48757650|NCT00383149|156960802|FG000|Overall Study|Death|2|||
48757651|NCT00383149|156960802|FG000|Overall Study|Disease Progression|38|||
48757652|NCT00383149|156960802|FG000|Overall Study|Lost to Follow-up|1|||
48757653|NCT00383149|156960802|FG000|Overall Study|Other|1|||
48757654|NCT00383149|156960802|FG000|Overall Study|Study Drug Toxicity|4|||
48757655|NCT00383149|156960802|FG000|Overall Study|Request to Discontinue Treatment|4|||
48757656|NCT00383149|156960802|FG000|Overall Study|Participant Withdrew Consent|1|||
48757657|NCT01558752|156960811|FG000|Overall Study|Physician Decision|2|||
48665493|NCT02914548|156628507|FG000|Overall Study|Physician Decision|2|||
48665494|NCT02914548|156628508|FG001|Overall Study|Physician Decision|2|||
48665495|NCT02914548|156628509|FG002|Overall Study|Physician Decision|0|||
48665496|NCT02914548|156628507|FG000|Overall Study|Protocol Violation|1|||
48665497|NCT02914548|156628508|FG001|Overall Study|Protocol Violation|0|||
48665498|NCT02914548|156628509|FG002|Overall Study|Protocol Violation|0|||
48665499|NCT02914548|156628507|FG000|Overall Study|Withdrawal by Subject|3|||
48665500|NCT02914548|156628508|FG001|Overall Study|Withdrawal by Subject|4|||
48665501|NCT02914548|156628509|FG002|Overall Study|Withdrawal by Subject|4|||
48665502|NCT02914548|156628507|FG000|Overall Study|>40% of body surface area|0|||
48757658|NCT01558752|156960812|FG001|Overall Study|Physician Decision|0|||
48757659|NCT00553150|156960815|FG000|Overall Study|Withdrawal by Subject|0|||
48757660|NCT00553150|156960816|FG001|Overall Study|Withdrawal by Subject|0|||
48340971|NCT03997409|155444166|FG001|Overall Study|Protocol Violation|1|||
48340972|NCT03997409|155444167|FG002|Overall Study|Protocol Violation|0|||
48340973|NCT03997409|155444165|FG000|Overall Study|Withdrawal by Subject|3|||
48340974|NCT03997409|155444166|FG001|Overall Study|Withdrawal by Subject|0|||
48340975|NCT03997409|155444167|FG002|Overall Study|Withdrawal by Subject|0|||
48340976|NCT03997409|155444165|FG000|Overall Study|Lost to Follow-up|0|||
48340977|NCT03997409|155444166|FG001|Overall Study|Lost to Follow-up|0|||
48340978|NCT03997409|155444167|FG002|Overall Study|Lost to Follow-up|1|||
48340979|NCT00511147|155444170|FG000|Overall Study|Withdrawal by Subject|1|||
48340980|NCT00511147|155444170|FG000|Overall Study|Disease progression|5|||
48340981|NCT00511147|155444170|FG000|Overall Study|Required platelet transfusion|1|||
48340982|NCT00116584|155444181|FG000|Overall Study|Withdrawal by Subject|1|||
48340983|NCT00116584|155444182|FG001|Overall Study|Withdrawal by Subject|0|||
48340984|NCT00116584|155444181|FG000|Overall Study|Protocol Violation|1|||
48340985|NCT00116584|155444182|FG001|Overall Study|Protocol Violation|1|||
48340986|NCT00809783|155444183|FG000|Overall Study|Death|1|||
48340987|NCT00809783|155444184|FG001|Overall Study|Death|0|||
48340988|NCT00809783|155444185|FG002|Overall Study|Death|0|||
48340989|NCT00809783|155444183|FG000|Overall Study|Adverse Event|34|||
48340990|NCT00809783|155444184|FG001|Overall Study|Adverse Event|52|||
48340991|NCT00809783|155444185|FG002|Overall Study|Adverse Event|71|||
48340992|NCT00809783|155444183|FG000|Overall Study|Lack of Efficacy|39|||
48340993|NCT00809783|155444184|FG001|Overall Study|Lack of Efficacy|52|||
48340994|NCT00809783|155444185|FG002|Overall Study|Lack of Efficacy|63|||
48340995|NCT00809783|155444183|FG000|Overall Study|Lost to Follow-up|0|||
48340996|NCT00809783|155444184|FG001|Overall Study|Lost to Follow-up|3|||
48340997|NCT00809783|155444185|FG002|Overall Study|Lost to Follow-up|4|||
48340998|NCT00809783|155444183|FG000|Overall Study|Withdrawal by Subject|47|||
48340999|NCT00809783|155444184|FG001|Overall Study|Withdrawal by Subject|72|||
48341000|NCT00809783|155444185|FG002|Overall Study|Withdrawal by Subject|64|||
48341001|NCT00809783|155444183|FG000|Overall Study|Protocol Violation|2|||
48341002|NCT00809783|155444184|FG001|Overall Study|Protocol Violation|6|||
48757661|NCT00553150|156960817|FG002|Overall Study|Withdrawal by Subject|0|||
48757662|NCT00553150|156960818|FG003|Overall Study|Withdrawal by Subject|2|||
48757663|NCT00553150|156960815|FG000|Overall Study|Protocol Violation|0|||
48757664|NCT00553150|156960816|FG001|Overall Study|Protocol Violation|0|||
48757665|NCT00553150|156960817|FG002|Overall Study|Protocol Violation|0|||
48757666|NCT00553150|156960818|FG003|Overall Study|Protocol Violation|1|||
48757667|NCT00553150|156960815|FG000|Overall Study|Ineligible|0|||
48757668|NCT00553150|156960816|FG001|Overall Study|Ineligible|0|||
48757669|NCT00553150|156960817|FG002|Overall Study|Ineligible|0|||
48757670|NCT00553150|156960818|FG003|Overall Study|Ineligible|1|||
48757671|NCT01980875|156960819|FG000|Overall Study|Withdrew Consent|1|||
48757672|NCT01980875|156960820|FG001|Overall Study|Withdrew Consent|1|||
48757673|NCT01980875|156960821|FG002|Overall Study|Withdrew Consent|1|||
48757674|NCT01980875|156960819|FG000|Overall Study|Study Terminated by Sponsor|7|||
48757675|NCT01980875|156960820|FG001|Overall Study|Study Terminated by Sponsor|24|||
48757676|NCT01980875|156960821|FG002|Overall Study|Study Terminated by Sponsor|22|||
48757677|NCT01980875|156960819|FG000|Overall Study|Lost to Follow-up|0|||
48757678|NCT01980875|156960820|FG001|Overall Study|Lost to Follow-up|0|||
48757679|NCT01980875|156960821|FG002|Overall Study|Lost to Follow-up|1|||
48341003|NCT00809783|155444185|FG002|Overall Study|Protocol Violation|5|||
48341004|NCT00809783|155444183|FG000|Overall Study|Randomized, but not treated|3|||
48341005|NCT00809783|155444184|FG001|Overall Study|Randomized, but not treated|0|||
48341006|NCT00809783|155444185|FG002|Overall Study|Randomized, but not treated|2|||
48341007|NCT00809783|155444183|FG000|Overall Study|Study Terminated by Sponsor|378|||
48341008|NCT00809783|155444184|FG001|Overall Study|Study Terminated by Sponsor|626|||
48341009|NCT00809783|155444185|FG002|Overall Study|Study Terminated by Sponsor|565|||
48757680|NCT00665847|156960822|FG000|Overall Study|Adverse Event|8|||
48757681|NCT00665847|156960822|FG000|Overall Study|Withdrawal by Subject|2|||
48757682|NCT00665847|156960822|FG000|Overall Study|Subject non-compliant|8|||
48757683|NCT00665847|156960822|FG000|Overall Study|Subject reached a virologic endpoint|4|||
48757684|NCT00665847|156960822|FG000|Overall Study|Resistance to TMC125|1|||
48757685|NCT00665847|156960822|FG000|Overall Study|Subject ineligible to continue the trial|1|||
48665503|NCT02914548|156628508|FG001|Overall Study|>40% of body surface area|1|||
48665504|NCT02914548|156628509|FG002|Overall Study|>40% of body surface area|1|||
48665505|NCT00260065|156628510|FG000|Overall Study|Progressive Disease|22|||
48665506|NCT00260065|156628510|FG000|Overall Study|Adverse Event|17|||
48665507|NCT00260065|156628510|FG000|Overall Study|Death|13|||
48665508|NCT00260065|156628510|FG000|Overall Study|Withdrawal by Subject|13|||
48665509|NCT00260065|156628510|FG000|Overall Study|Physician Decision|19|||
48665510|NCT00260065|156628510|FG000|Overall Study|Not otherwise specified|8|||
48665511|NCT00260065|156628510|FG000|Overall Study|Medication Noncompliance|1|||
48665512|NCT02847858|156628511|FG000|Overall Study|Lost to Follow-up|401|||
48665513|NCT02847858|156628512|FG001|Overall Study|Lost to Follow-up|269|||
48665514|NCT01036529|156628513|FG000|Overall Study|Adverse Event|0|||
48665515|NCT01036529|156628514|FG001|Overall Study|Adverse Event|1|||
48665516|NCT01036529|156628513|FG000|Overall Study|Lost to Follow-up|0|||
48665517|NCT01036529|156628514|FG001|Overall Study|Lost to Follow-up|1|||
48665518|NCT01036529|156628513|FG000|Overall Study|Physician Decision|1|||
48665519|NCT01036529|156628514|FG001|Overall Study|Physician Decision|0|||
48665520|NCT01036529|156628513|FG000|Overall Study|Withdrawal by Subject|1|||
48665521|NCT01036529|156628514|FG001|Overall Study|Withdrawal by Subject|1|||
48665522|NCT01036529|156628513|FG000|Overall Study|Sponsor study termination|11|||
48665523|NCT01036529|156628514|FG001|Overall Study|Sponsor study termination|12|||
48665524|NCT03968159|156628524|FG000|Overall Study|Adverse Event|4|||
48757686|NCT00665847|156960822|FG000|Overall Study|Switch to Commercial Medication|1|||
48757687|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Adverse Event|82|||
48757688|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Death|6|||
48665525|NCT03968159|156628525|FG001|Overall Study|Adverse Event|4|||
48665526|NCT03968159|156628524|FG000|Overall Study|Lost to Follow-up|1|||
48665527|NCT03968159|156628525|FG001|Overall Study|Lost to Follow-up|1|||
48665528|NCT03968159|156628524|FG000|Overall Study|Use of prohibited medication|0|||
48665529|NCT03968159|156628525|FG001|Overall Study|Use of prohibited medication|1|||
48665530|NCT03968159|156628524|FG000|Overall Study|Protocol Violation|2|||
48665531|NCT03968159|156628525|FG001|Overall Study|Protocol Violation|2|||
48665532|NCT03968159|156628524|FG000|Overall Study|Withdrawal by Subject|4|||
48665533|NCT03968159|156628525|FG001|Overall Study|Withdrawal by Subject|6|||
48665534|NCT03968159|156628524|FG000|Overall Study|Lack of Efficacy|0|||
48665535|NCT03968159|156628525|FG001|Overall Study|Lack of Efficacy|1|||
48665536|NCT03968159|156628524|FG000|Overall Study|Not further specified|2|||
48665537|NCT03968159|156628525|FG001|Overall Study|Not further specified|0|||
48665538|NCT00581828|156628527|FG000|Overall Study|Protocol Violation|1|||
48665539|NCT00160199|156628529|FG000|Overall Study|Adverse Event|5|||
48665540|NCT00160199|156628530|FG001|Overall Study|Adverse Event|14|||
48665541|NCT00160199|156628529|FG000|Overall Study|Lack of Efficacy|0|||
48665542|NCT00160199|156628530|FG001|Overall Study|Lack of Efficacy|1|||
48665543|NCT00160199|156628529|FG000|Overall Study|Lost to Follow-up|7|||
48665544|NCT00160199|156628530|FG001|Overall Study|Lost to Follow-up|7|||
48665545|NCT00160199|156628529|FG000|Overall Study|Withdrawal by Subject|4|||
48665546|NCT00160199|156628530|FG001|Overall Study|Withdrawal by Subject|6|||
48665547|NCT00160199|156628529|FG000|Overall Study|Administrative|0|||
48665548|NCT00160199|156628530|FG001|Overall Study|Administrative|1|||
48757689|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
48757690|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
48757691|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
48757692|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
48757693|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
48757694|NCT00195676|156960831|FG000|Period O - Open-label Treatment|Other reasons|68|||
48757695|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
48757696|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
48757697|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
48757698|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
48757699|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
48757700|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
48757701|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
48757702|NCT00195676|156960831|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
48757703|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
48757704|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
48757705|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
48757706|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
48757707|NCT00195676|156960831|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
48757708|NCT03447990|156960832|FG000|Overall Study|Withdrawal by Subject|0|||
48757709|NCT03447990|156960833|FG001|Overall Study|Withdrawal by Subject|0|||
48757710|NCT03447990|156960834|FG002|Overall Study|Withdrawal by Subject|0|||
48757711|NCT03447990|156960835|FG003|Overall Study|Withdrawal by Subject|0|||
48757712|NCT03447990|156960836|FG004|Overall Study|Withdrawal by Subject|0|||
48757713|NCT03447990|156960837|FG005|Overall Study|Withdrawal by Subject|0|||
48757714|NCT03447990|156960838|FG006|Overall Study|Withdrawal by Subject|1|||
48757715|NCT00535223|156960840|FG000|Overall Study|Withdrawal by Subject|4|||
48757716|NCT00535223|156960841|FG001|Overall Study|Withdrawal by Subject|1|||
48757717|NCT00616655|156960842|FG000|Overall Study|Adverse Event|10|||
48757718|NCT00616655|156960843|FG001|Overall Study|Adverse Event|7|||
48757719|NCT00616655|156960844|FG002|Overall Study|Adverse Event|12|||
48757720|NCT00616655|156960842|FG000|Overall Study|Lack of Efficacy|5|||
48757721|NCT00616655|156960843|FG001|Overall Study|Lack of Efficacy|5|||
48757722|NCT00616655|156960844|FG002|Overall Study|Lack of Efficacy|5|||
48757723|NCT00616655|156960842|FG000|Overall Study|Lost to Follow-up|3|||
48757724|NCT00616655|156960843|FG001|Overall Study|Lost to Follow-up|12|||
48757725|NCT00616655|156960844|FG002|Overall Study|Lost to Follow-up|10|||
48757726|NCT00616655|156960842|FG000|Overall Study|Protocol Violation|2|||
48757727|NCT00616655|156960843|FG001|Overall Study|Protocol Violation|4|||
48757728|NCT00616655|156960844|FG002|Overall Study|Protocol Violation|3|||
48757729|NCT00616655|156960842|FG000|Overall Study|Withdrawal by Subject|9|||
48757730|NCT00616655|156960843|FG001|Overall Study|Withdrawal by Subject|7|||
48665549|NCT00160199|156628529|FG000|Overall Study|Protocol Violation|8|||
48665550|NCT00160199|156628530|FG001|Overall Study|Protocol Violation|8|||
48665551|NCT00434759|156628531|FG000|Overall Study|Lack of Efficacy|5|||
48665552|NCT00434759|156628532|FG001|Overall Study|Lack of Efficacy|4|||
48665553|NCT00434759|156628531|FG000|Overall Study|Withdrawal by Subject|17|||
48665554|NCT00434759|156628532|FG001|Overall Study|Withdrawal by Subject|1|||
48665555|NCT00434759|156628531|FG000|Overall Study|family affairs|2|||
48665556|NCT00434759|156628532|FG001|Overall Study|family affairs|0|||
48665557|NCT00875056|156628534|FG000|Overall Study|Adverse Event|6|||
48665558|NCT00875056|156628535|FG001|Overall Study|Adverse Event|1|||
48665559|NCT00875056|156628536|FG002|Overall Study|Adverse Event|2|||
48665560|NCT00875056|156628534|FG000|Overall Study|Progressive Disease|14|||
48665561|NCT00875056|156628535|FG001|Overall Study|Progressive Disease|8|||
48665562|NCT00875056|156628536|FG002|Overall Study|Progressive Disease|3|||
48665563|NCT00875056|156628534|FG000|Overall Study|Withdrawal by Subject|3|||
48665564|NCT00875056|156628535|FG001|Overall Study|Withdrawal by Subject|0|||
48665565|NCT00875056|156628536|FG002|Overall Study|Withdrawal by Subject|1|||
48665566|NCT01300819|156628537|FG000|Overall Study|Adverse Event|9|||
48665567|NCT01300819|156628538|FG001|Overall Study|Adverse Event|27|||
48665568|NCT01300819|156628537|FG000|Overall Study|Lack of Efficacy|2|||
48665569|NCT01300819|156628538|FG001|Overall Study|Lack of Efficacy|1|||
48665570|NCT01300819|156628537|FG000|Overall Study|Withdrawal by Subject|10|||
48665571|NCT01300819|156628538|FG001|Overall Study|Withdrawal by Subject|12|||
48665572|NCT01300819|156628537|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
48665573|NCT01300819|156628538|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
48665574|NCT01300819|156628537|FG000|Overall Study|Refusal to down titrate study drug|0|||
48665575|NCT01300819|156628538|FG001|Overall Study|Refusal to down titrate study drug|1|||
48757731|NCT00616655|156960844|FG002|Overall Study|Withdrawal by Subject|11|||
48757732|NCT00616655|156960842|FG000|Overall Study|Does not meet in/ex criteria|0|||
48665576|NCT01300819|156628537|FG000|Overall Study|Administrative reason|0|||
48665577|NCT01300819|156628538|FG001|Overall Study|Administrative reason|1|||
48757733|NCT00616655|156960843|FG001|Overall Study|Does not meet in/ex criteria|0|||
48757734|NCT00616655|156960844|FG002|Overall Study|Does not meet in/ex criteria|2|||
48757735|NCT00616655|156960842|FG000|Overall Study|Other|6|||
48757736|NCT00616655|156960843|FG001|Overall Study|Other|6|||
48757737|NCT00616655|156960844|FG002|Overall Study|Other|5|||
48757738|NCT03761147|156960847|FG000|Overall Study|Withdrawal by Subject|6|||
48665578|NCT01300819|156628537|FG000|Overall Study|Safety follow up not done by mistake|0|||
48665579|NCT01300819|156628538|FG001|Overall Study|Safety follow up not done by mistake|1|||
48665580|NCT01300819|156628537|FG000|Overall Study|Follow up call was not done|1|||
48665581|NCT01300819|156628538|FG001|Overall Study|Follow up call was not done|0|||
48665582|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
48665583|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
48665584|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
48665585|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
48665586|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
48665587|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
48665588|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48665589|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48665590|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
48665591|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
48665592|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
48665593|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
48665594|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
48665595|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
48665596|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
48665597|NCT00554099|156628541|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
48665598|NCT00554099|156628542|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
48665599|NCT00554099|156628543|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
48341010|NCT00809783|155444183|FG000|Overall Study|Other|21|||
48341011|NCT00809783|155444184|FG001|Overall Study|Other|21|||
48341012|NCT00809783|155444185|FG002|Overall Study|Other|16|||
48341013|NCT00126555|155444186|FG000|Overall Study|Withdrawal by Subject|1|||
48341014|NCT00126555|155444186|FG000|Overall Study|Adverse Event|2|||
48341015|NCT00126555|155444186|FG000|Overall Study|Progressive Disease|3|||
48341016|NCT03314233|155444196|FG000|Overall Study|No longer eligible at time of delivery|1|||
48341017|NCT01838447|155444197|FG000|Overall Study|Change in surgical plan|1|||
48665600|NCT00554099|156628541|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
48665601|NCT00554099|156628542|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
48665602|NCT00554099|156628543|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
48665603|NCT00554099|156628541|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
48665604|NCT00554099|156628542|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
48665605|NCT00554099|156628543|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
48665606|NCT00554099|156628541|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
48665607|NCT00554099|156628542|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
48665608|NCT00554099|156628543|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
48665609|NCT02075632|156628547|FG000|Overall Study|Adverse Event|1|||
48665610|NCT02075632|156628548|FG001|Overall Study|Adverse Event|1|||
48665611|NCT02075632|156628547|FG000|Overall Study|Lost to Follow-up|0|||
48665612|NCT02075632|156628548|FG001|Overall Study|Lost to Follow-up|3|||
48665613|NCT02075632|156628547|FG000|Overall Study|Withdrawal by Subject|0|||
48665614|NCT02075632|156628548|FG001|Overall Study|Withdrawal by Subject|1|||
48665615|NCT00791557|156628549|FG000|Overall Study|Adverse Event|1|||
48665616|NCT02573246|156628552|FG000|Overall Study|Lost to Follow-up|2|||
48665617|NCT02573246|156628553|FG001|Overall Study|Lost to Follow-up|0|||
48341018|NCT01838447|155444198|FG001|Overall Study|Change in surgical plan|2|||
48665618|NCT02573246|156628554|FG002|Overall Study|Lost to Follow-up|0|||
48665619|NCT02573246|156628555|FG003|Overall Study|Lost to Follow-up|0|||
48665620|NCT02573246|156628556|FG004|Overall Study|Lost to Follow-up|1|||
48665621|NCT02573246|156628552|FG000|Overall Study|Withdrawal by Subject|0|||
48665622|NCT02573246|156628553|FG001|Overall Study|Withdrawal by Subject|0|||
48665623|NCT02573246|156628554|FG002|Overall Study|Withdrawal by Subject|0|||
48665624|NCT02573246|156628555|FG003|Overall Study|Withdrawal by Subject|0|||
48665625|NCT02573246|156628556|FG004|Overall Study|Withdrawal by Subject|1|||
48665626|NCT02573246|156628552|FG000|Overall Study|Physician Decision|1|||
48665627|NCT02573246|156628553|FG001|Overall Study|Physician Decision|1|||
48665628|NCT02573246|156628554|FG002|Overall Study|Physician Decision|3|||
48665629|NCT02573246|156628555|FG003|Overall Study|Physician Decision|2|||
48757739|NCT03761147|156960848|FG001|Overall Study|Withdrawal by Subject|1|||
48757740|NCT03761147|156960847|FG000|Overall Study|Adverse Event|1|||
48341019|NCT01838447|155444197|FG000|Overall Study|Withdrawal by Subject|1|||
48341020|NCT01838447|155444198|FG001|Overall Study|Withdrawal by Subject|1|||
48341021|NCT02490878|155444199|FG000|Overall Study|deemed ineligible|0|||
48341022|NCT02490878|155444200|FG001|Overall Study|deemed ineligible|1|||
48341023|NCT02490878|155444199|FG000|Overall Study|progression prior to treatment|0|||
48341024|NCT02490878|155444200|FG001|Overall Study|progression prior to treatment|1|||
48665630|NCT02573246|156628556|FG004|Overall Study|Physician Decision|2|||
48665631|NCT03002623|156628557|FG000|Overall Study|Lost to Follow-up|1|||
48341025|NCT02490878|155444199|FG000|Overall Study|only submitted baseline QOL|0|||
48341026|NCT02490878|155444200|FG001|Overall Study|only submitted baseline QOL|1|||
48341027|NCT01183013|155444203|FG000|Overall Study|Adverse Event|6|||
48665632|NCT03002623|156628558|FG001|Overall Study|Lost to Follow-up|0|||
48665633|NCT03002623|156628557|FG000|Overall Study|Physician Decision|1|||
48665634|NCT03002623|156628558|FG001|Overall Study|Physician Decision|1|||
48665635|NCT00657371|156628563|FG000|Overall Study|Poor bowel preparation|15|||
48757741|NCT03761147|156960848|FG001|Overall Study|Adverse Event|3|||
48757742|NCT03630120|156960849|FG000|Overall Study|Disease progression|0|||
48757743|NCT03630120|156960850|FG001|Overall Study|Disease progression|1|||
48757744|NCT03630120|156960851|FG002|Overall Study|Disease progression|1|||
48757745|NCT03630120|156960852|FG003|Overall Study|Disease progression|1|||
48757746|NCT01826487|156960853|FG000|Overall Study|Adverse Event|1|||
48757747|NCT01826487|156960854|FG001|Overall Study|Adverse Event|1|||
48757748|NCT01826487|156960853|FG000|Overall Study|Lost to Follow-up|1|||
48757749|NCT01826487|156960854|FG001|Overall Study|Lost to Follow-up|0|||
48757750|NCT01826487|156960853|FG000|Overall Study|Withdrawal by Subject|1|||
48757751|NCT01826487|156960854|FG001|Overall Study|Withdrawal by Subject|3|||
48757752|NCT01826487|156960853|FG000|Overall Study|Protocol Violation|1|||
48757753|NCT01826487|156960854|FG001|Overall Study|Protocol Violation|1|||
48757754|NCT01408030|156960855|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
48757755|NCT01408030|156960856|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
48757756|NCT01408030|156960857|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
48757757|NCT01408030|156960858|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
48757758|NCT01408030|156960855|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
48757759|NCT01408030|156960856|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
48757760|NCT01408030|156960857|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
48757761|NCT01408030|156960858|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
48757762|NCT01408030|156960855|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
48757763|NCT01408030|156960856|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
48757764|NCT01408030|156960857|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
48757765|NCT01408030|156960858|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
48757766|NCT01408030|156960855|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
48757767|NCT01408030|156960856|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
48757768|NCT01408030|156960857|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
48757769|NCT01408030|156960858|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
48757770|NCT01408030|156960855|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
48757771|NCT01408030|156960856|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
48757772|NCT01408030|156960857|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
48757773|NCT01408030|156960858|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
48757774|NCT01408030|156960855|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
48757775|NCT01408030|156960856|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
48757776|NCT01408030|156960857|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
48757777|NCT01408030|156960858|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
48757778|NCT01408030|156960855|FG000|Observation Phase (Off Drug)|Other|1|||
48757779|NCT01408030|156960856|FG001|Observation Phase (Off Drug)|Other|1|||
48757780|NCT01408030|156960857|FG002|Observation Phase (Off Drug)|Other|1|||
48757781|NCT01408030|156960858|FG003|Observation Phase (Off Drug)|Other|1|||
48757782|NCT00423150|156960860|FG000|Overall Study|Adverse Event|11|||
48757783|NCT00423150|156960860|FG000|Overall Study|Progression of disease being studied|69|||
48757784|NCT00423150|156960860|FG000|Overall Study|Withdrawal by Subject|1|||
48757785|NCT00423150|156960860|FG000|Overall Study|Non-compliance with protocol|1|||
48341028|NCT01183013|155444204|FG001|Overall Study|Adverse Event|8|||
48665636|NCT00657371|156628563|FG000|Overall Study|Unable to intubate the cecum|5|||
48665637|NCT00657371|156628563|FG000|Overall Study|Protocol Violation|2|||
48665638|NCT00657371|156628563|FG000|Overall Study|Device- related reasons|13|||
48665639|NCT00657371|156628563|FG000|Overall Study|Pre-existing medical condition|4|||
48665640|NCT04342689|156628564|FG000|Overall Study|Withdrawal by Subject|32|||
48665641|NCT04342689|156628565|FG001|Overall Study|Withdrawal by Subject|33|||
48665642|NCT04342689|156628564|FG000|Overall Study|Lost to Follow-up|10|||
48341029|NCT01183013|155444205|FG002|Overall Study|Adverse Event|5|||
48665643|NCT04342689|156628565|FG001|Overall Study|Lost to Follow-up|12|||
48665644|NCT00844805|156628566|FG000|Treatment Phase|Adverse Event|5|||
48665645|NCT00844805|156628567|FG001|Treatment Phase|Adverse Event|1|||
48665646|NCT00844805|156628568|FG002|Treatment Phase|Adverse Event|0|||
48665647|NCT00844805|156628569|FG003|Treatment Phase|Adverse Event|0|||
48757786|NCT00423150|156960860|FG000|Overall Study|Administrative|4|||
48341030|NCT01183013|155444206|FG003|Overall Study|Adverse Event|5|||
48665648|NCT00844805|156628566|FG000|Treatment Phase|Withdrawal by Subject|3|||
48665649|NCT00844805|156628567|FG001|Treatment Phase|Withdrawal by Subject|4|||
48665650|NCT00844805|156628568|FG002|Treatment Phase|Withdrawal by Subject|0|||
48665651|NCT00844805|156628569|FG003|Treatment Phase|Withdrawal by Subject|0|||
48665652|NCT00844805|156628566|FG000|Treatment Phase|Noncompliance With Protocol|1|||
48665653|NCT00844805|156628567|FG001|Treatment Phase|Noncompliance With Protocol|0|||
48665654|NCT00844805|156628568|FG002|Treatment Phase|Noncompliance With Protocol|0|||
48665655|NCT00844805|156628569|FG003|Treatment Phase|Noncompliance With Protocol|0|||
48665656|NCT00844805|156628566|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
48665657|NCT00844805|156628567|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
48665658|NCT00844805|156628568|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
48665659|NCT00844805|156628569|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
48665660|NCT00844805|156628566|FG000|Follow-Up Phase|Adverse Event|0|||
48665661|NCT00844805|156628567|FG001|Follow-Up Phase|Adverse Event|0|||
48665662|NCT00844805|156628568|FG002|Follow-Up Phase|Adverse Event|1|||
48665663|NCT00844805|156628569|FG003|Follow-Up Phase|Adverse Event|0|||
48665664|NCT00844805|156628566|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
48665665|NCT00844805|156628567|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
48665666|NCT00844805|156628568|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
48757787|NCT03204305|156960862|FG000|Overall Study|Lost to Follow-up|6|||
48757788|NCT03204305|156960863|FG001|Overall Study|Lost to Follow-up|4|||
48757789|NCT03204305|156960864|FG002|Overall Study|Lost to Follow-up|0|||
48757790|NCT03204305|156960865|FG003|Overall Study|Lost to Follow-up|0|||
48665667|NCT00844805|156628569|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
48665668|NCT00844805|156628566|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
48665669|NCT00844805|156628567|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
48757791|NCT03204305|156960862|FG000|Overall Study|Physician Decision|1|||
48757792|NCT03204305|156960863|FG001|Overall Study|Physician Decision|0|||
48757793|NCT03204305|156960864|FG002|Overall Study|Physician Decision|0|||
48757794|NCT03204305|156960865|FG003|Overall Study|Physician Decision|0|||
48757795|NCT03204305|156960862|FG000|Overall Study|failure to place arterial line|2|||
48341031|NCT01183013|155444207|FG004|Overall Study|Adverse Event|10|||
48341032|NCT01183013|155444208|FG005|Overall Study|Adverse Event|10|||
48665670|NCT00844805|156628568|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
48341033|NCT01183013|155444209|FG006|Overall Study|Adverse Event|6|||
48341034|NCT01183013|155444203|FG000|Overall Study|Lack of Efficacy|3|||
48341035|NCT01183013|155444204|FG001|Overall Study|Lack of Efficacy|2|||
48665671|NCT00844805|156628569|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
48665672|NCT00844805|156628566|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
48665673|NCT00844805|156628567|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
48665674|NCT00844805|156628568|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
48665675|NCT00844805|156628569|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
48665676|NCT00844805|156628566|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
48665677|NCT00844805|156628567|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
48665678|NCT00844805|156628568|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
48665679|NCT00844805|156628569|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
48665680|NCT01167907|156628576|FG000|Overall Study|Protocol Violation|1|||
48665681|NCT01167907|156628577|FG001|Overall Study|Protocol Violation|0|||
48665682|NCT01167907|156628576|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
48665683|NCT01167907|156628577|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
48757796|NCT03204305|156960863|FG001|Overall Study|failure to place arterial line|1|||
48757797|NCT03204305|156960864|FG002|Overall Study|failure to place arterial line|0|||
48757798|NCT03204305|156960865|FG003|Overall Study|failure to place arterial line|0|||
48341036|NCT01183013|155444205|FG002|Overall Study|Lack of Efficacy|1|||
48341037|NCT01183013|155444206|FG003|Overall Study|Lack of Efficacy|2|||
48665684|NCT00857948|156628578|FG000|Overall Study|Withdrawal by Subject|2|||
48665685|NCT00857948|156628579|FG001|Overall Study|Withdrawal by Subject|0|||
48665686|NCT00857948|156628580|FG002|Overall Study|Withdrawal by Subject|0|||
48665687|NCT00857948|156628581|FG003|Overall Study|Withdrawal by Subject|0|||
48665688|NCT00857948|156628578|FG000|Overall Study|Protocol Violation|1|||
48665689|NCT00857948|156628579|FG001|Overall Study|Protocol Violation|0|||
48665690|NCT00857948|156628580|FG002|Overall Study|Protocol Violation|1|||
48665691|NCT00857948|156628581|FG003|Overall Study|Protocol Violation|0|||
48665692|NCT03077698|156628585|FG000|Progestin Monotherapy|Stable Disease|8|||
48665693|NCT03077698|156628586|FG001|Progestin Monotherapy|Stable Disease|0|||
48665694|NCT03077698|156628585|FG000|Progestin Monotherapy|Adverse Event|1|||
48665695|NCT03077698|156628586|FG001|Progestin Monotherapy|Adverse Event|0|||
48665696|NCT03077698|156628585|FG000|Progestin Monotherapy|Death|1|||
48665697|NCT03077698|156628586|FG001|Progestin Monotherapy|Death|0|||
48665698|NCT03077698|156628585|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
48665699|NCT03077698|156628586|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
48665700|NCT03077698|156628585|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
48665701|NCT03077698|156628586|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
48665702|NCT03077698|156628585|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
48665703|NCT03077698|156628586|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
48665704|NCT03077698|156628585|FG000|Safety Follow Up|Withdrawal by Subject|2|||
48665705|NCT03077698|156628586|FG001|Safety Follow Up|Withdrawal by Subject|1|||
48665706|NCT03077698|156628585|FG000|Safety Follow Up|Transfer of care to hospice|1|||
48665707|NCT03077698|156628586|FG001|Safety Follow Up|Transfer of care to hospice|0|||
48665708|NCT04135859|156628590|FG000|Overall Study|Withdrawal by Subject|1|||
48665709|NCT04135859|156628591|FG001|Overall Study|Withdrawal by Subject|0|||
48665710|NCT04135859|156628590|FG000|Overall Study|Withdrawal due to screening failure|1|||
48665711|NCT04135859|156628591|FG001|Overall Study|Withdrawal due to screening failure|2|||
48665712|NCT04135859|156628590|FG000|Overall Study|Did not complete stress test|3|||
48665713|NCT04135859|156628591|FG001|Overall Study|Did not complete stress test|3|||
48665714|NCT04135859|156628590|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
48665715|NCT04135859|156628591|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
48665716|NCT00613080|156628592|FG000|Overall Study|Ineligible / no protocol treatment|11|||
48665717|NCT01066780|156628593|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
48665718|NCT01066780|156628594|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
48665719|NCT01241760|156628597|FG000|Overall Study|Adverse Event|1|||
48665720|NCT01241760|156628598|FG001|Overall Study|Adverse Event|0|||
48665721|NCT01241760|156628597|FG000|Overall Study|Lost to Follow-up|18|||
48665722|NCT01241760|156628598|FG001|Overall Study|Lost to Follow-up|22|||
48665723|NCT01241760|156628597|FG000|Overall Study|Withdrawal by Subject|13|||
48665724|NCT01241760|156628598|FG001|Overall Study|Withdrawal by Subject|13|||
48665725|NCT01241760|156628597|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
48665726|NCT01241760|156628598|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
48665727|NCT01241760|156628597|FG000|Overall Study|Other|1|||
48665728|NCT01241760|156628598|FG001|Overall Study|Other|1|||
48665729|NCT03697993|156628599|FG000|Overall Study|Became Ineligible after Enrollment|1|||
48665730|NCT03697993|156628600|FG001|Overall Study|Became Ineligible after Enrollment|3|||
48665731|NCT03697993|156628599|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
48665732|NCT03697993|156628600|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
48665733|NCT03697993|156628599|FG000|Overall Study|Lost to Follow-up|3|||
48665734|NCT03697993|156628600|FG001|Overall Study|Lost to Follow-up|0|||
48665735|NCT03697993|156628599|FG000|Overall Study|Physician Decision|4|||
48665736|NCT03697993|156628600|FG001|Overall Study|Physician Decision|0|||
48665737|NCT03697993|156628599|FG000|Overall Study|Initial Urine Culture Negative|0|||
48665738|NCT03697993|156628600|FG001|Overall Study|Initial Urine Culture Negative|1|||
48665739|NCT02279498|156628613|FG000|Overall Study|Adverse Event|3|||
48665740|NCT02279498|156628614|FG001|Overall Study|Adverse Event|0|||
48665741|NCT02279498|156628613|FG000|Overall Study|Lack of Efficacy|4|||
48665742|NCT02279498|156628614|FG001|Overall Study|Lack of Efficacy|0|||
48665743|NCT02279498|156628613|FG000|Overall Study|Lost to Follow-up|0|||
48665744|NCT02279498|156628614|FG001|Overall Study|Lost to Follow-up|1|||
48665745|NCT02279498|156628613|FG000|Overall Study|Withdrawal by Subject|9|||
48665746|NCT02279498|156628614|FG001|Overall Study|Withdrawal by Subject|2|||
48665747|NCT02279498|156628613|FG000|Overall Study|Undefined|2|||
48665748|NCT02279498|156628614|FG001|Overall Study|Undefined|1|||
48665749|NCT04284813|156628615|FG000|Overall Study|Withdrawal by Subject|1|||
48665750|NCT02525094|156628616|FG000|Overall Study|Lost to Follow-up|2|||
48665751|NCT02525094|156628617|FG001|Overall Study|Lost to Follow-up|1|||
48665752|NCT02525094|156628616|FG000|Overall Study|Withdrawal by Subject|5|||
48665753|NCT02525094|156628617|FG001|Overall Study|Withdrawal by Subject|6|||
48665754|NCT02525094|156628616|FG000|Overall Study|Not Treated|1|||
48665755|NCT02525094|156628617|FG001|Overall Study|Not Treated|1|||
48341038|NCT01183013|155444207|FG004|Overall Study|Lack of Efficacy|1|||
48665756|NCT01591863|156628618|FG000|Overall Study|Adverse Event|3|||
48341039|NCT01183013|155444208|FG005|Overall Study|Lack of Efficacy|2|||
48341040|NCT01183013|155444209|FG006|Overall Study|Lack of Efficacy|0|||
48341041|NCT01183013|155444203|FG000|Overall Study|Protocol Violation|5|||
48341042|NCT01183013|155444204|FG001|Overall Study|Protocol Violation|2|||
48341043|NCT01183013|155444205|FG002|Overall Study|Protocol Violation|4|||
48341044|NCT01183013|155444206|FG003|Overall Study|Protocol Violation|0|||
48341045|NCT01183013|155444207|FG004|Overall Study|Protocol Violation|4|||
48341046|NCT01183013|155444208|FG005|Overall Study|Protocol Violation|3|||
48341047|NCT01183013|155444209|FG006|Overall Study|Protocol Violation|3|||
48341048|NCT01183013|155444203|FG000|Overall Study|Lost to Follow-up|7|||
48341049|NCT01183013|155444204|FG001|Overall Study|Lost to Follow-up|3|||
48665757|NCT01591863|156628618|FG000|Overall Study|Withdrawal by Subject|1|||
48665758|NCT01591863|156628618|FG000|Overall Study|recurrence|9|||
48665759|NCT01591863|156628618|FG000|Overall Study|Lack of Efficacy|1|||
48665760|NCT00969436|156628620|FG000|Overall Study|Protocol Violation|1|||
48665761|NCT00969436|156628621|FG001|Overall Study|Protocol Violation|3|||
48665762|NCT00969436|156628622|FG002|Overall Study|Protocol Violation|0|||
48665763|NCT00969436|156628620|FG000|Overall Study|Migrated/moved from study area|12|||
48665764|NCT00969436|156628621|FG001|Overall Study|Migrated/moved from study area|10|||
48665765|NCT00969436|156628622|FG002|Overall Study|Migrated/moved from study area|2|||
48665766|NCT00969436|156628620|FG000|Overall Study|Father - serious health problem|0|||
48665767|NCT00969436|156628621|FG001|Overall Study|Father - serious health problem|0|||
48665768|NCT00969436|156628622|FG002|Overall Study|Father - serious health problem|1|||
48665769|NCT00969436|156628620|FG000|Overall Study|Parents personal problem|0|||
48665770|NCT00969436|156628621|FG001|Overall Study|Parents personal problem|0|||
48665771|NCT00969436|156628622|FG002|Overall Study|Parents personal problem|1|||
48665772|NCT00969436|156628620|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
48665773|NCT00969436|156628621|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
48665774|NCT00969436|156628622|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
48665775|NCT00969436|156628620|FG000|Overall Study|Withdrawal by Subject|3|||
48665776|NCT00969436|156628621|FG001|Overall Study|Withdrawal by Subject|0|||
48665777|NCT00969436|156628622|FG002|Overall Study|Withdrawal by Subject|2|||
48665778|NCT00969436|156628620|FG000|Overall Study|Lost to Follow-up|8|||
48665779|NCT00969436|156628621|FG001|Overall Study|Lost to Follow-up|8|||
48665780|NCT00969436|156628622|FG002|Overall Study|Lost to Follow-up|5|||
48665781|NCT00831701|156628625|FG000|Overall Study|Withdrawal by Subject|2|||
48665782|NCT00831701|156628626|FG001|Overall Study|Withdrawal by Subject|0|||
48665783|NCT00831701|156628625|FG000|Overall Study|Stone expulsion before first medication|2|||
48665784|NCT00831701|156628626|FG001|Overall Study|Stone expulsion before first medication|2|||
48665785|NCT00831701|156628625|FG000|Overall Study|Lost to Follow-up|1|||
48665786|NCT00831701|156628626|FG001|Overall Study|Lost to Follow-up|3|||
48665787|NCT00262847|156630056|FG000|Overall Study|Disease Progression|309|||
48665788|NCT00262847|156630057|FG001|Overall Study|Disease Progression|274|||
48665789|NCT00262847|156630058|FG002|Overall Study|Disease Progression|195|||
48665790|NCT00262847|156630056|FG000|Overall Study|Patient Refusal|41|||
48665791|NCT00262847|156630057|FG001|Overall Study|Patient Refusal|52|||
48665792|NCT00262847|156630058|FG002|Overall Study|Patient Refusal|47|||
48665793|NCT00262847|156630056|FG000|Overall Study|Adverse Event|74|||
48665794|NCT00262847|156630057|FG001|Overall Study|Adverse Event|88|||
48665795|NCT00262847|156630058|FG002|Overall Study|Adverse Event|108|||
48665796|NCT00262847|156630056|FG000|Overall Study|Death|8|||
48665797|NCT00262847|156630057|FG001|Overall Study|Death|8|||
48665798|NCT00262847|156630058|FG002|Overall Study|Death|11|||
48665799|NCT00262847|156630056|FG000|Overall Study|Concomitant disease|3|||
48665800|NCT00262847|156630057|FG001|Overall Study|Concomitant disease|2|||
48665801|NCT00262847|156630058|FG002|Overall Study|Concomitant disease|4|||
48665802|NCT00262847|156630056|FG000|Overall Study|Other Reasons|79|||
48665803|NCT00262847|156630057|FG001|Overall Study|Other Reasons|88|||
48665804|NCT00262847|156630058|FG002|Overall Study|Other Reasons|27|||
48665805|NCT00262847|156630056|FG000|Overall Study|Did not receive study treatment|4|||
48665806|NCT00262847|156630057|FG001|Overall Study|Did not receive study treatment|1|||
48665807|NCT00262847|156630058|FG002|Overall Study|Did not receive study treatment|4|||
48665808|NCT02091284|156630059|FG000|Overall Study|Withdrawal by Subject|2|||
48665809|NCT02091284|156630060|FG001|Overall Study|Withdrawal by Subject|1|||
48665810|NCT02091284|156630059|FG000|Overall Study|unreliable data|1|||
48665811|NCT02091284|156630060|FG001|Overall Study|unreliable data|0|||
48665812|NCT03627065|156630067|FG000|Overall Study|Study Terminated by sponsor|1|||
48665813|NCT03627065|156630067|FG000|Overall Study|Withdrawal by Subject|2|||
48665814|NCT02804750|156630068|FG000|Period 1|Adverse Event|0|||
48665815|NCT02804750|156630069|FG001|Period 1|Adverse Event|2|||
48665816|NCT02804750|156630068|FG000|Period 1|Withdrawal by Subject|0|||
48665817|NCT02804750|156630069|FG001|Period 1|Withdrawal by Subject|1|||
48665818|NCT02804750|156630068|FG000|Period 2|Adverse Event|1|||
48665819|NCT02804750|156630069|FG001|Period 2|Adverse Event|0|||
48665820|NCT02804750|156630068|FG000|Period 3|Adverse Event|0|||
48665821|NCT02804750|156630069|FG001|Period 3|Adverse Event|2|||
48665822|NCT02804750|156630068|FG000|Period 4|Adverse Event|0|||
48665823|NCT02804750|156630069|FG001|Period 4|Adverse Event|5|||
48665824|NCT03602885|156630070|FG000|Overall Study|Lost to Follow-up|3|||
48757799|NCT03204305|156960862|FG000|Overall Study|Withdrawal by Subject|2|||
48757800|NCT03204305|156960863|FG001|Overall Study|Withdrawal by Subject|0|||
48757801|NCT03204305|156960864|FG002|Overall Study|Withdrawal by Subject|0|||
48757802|NCT03204305|156960865|FG003|Overall Study|Withdrawal by Subject|0|||
48757803|NCT00455429|156960866|FG000|Overall Study|Study Terminated by Sponsor|0|||
48757804|NCT00455429|156960867|FG001|Overall Study|Study Terminated by Sponsor|0|||
48757805|NCT00455429|156960868|FG002|Overall Study|Study Terminated by Sponsor|0|||
48757806|NCT00455429|156960869|FG003|Overall Study|Study Terminated by Sponsor|3|||
48757807|NCT00455429|156960866|FG000|Overall Study|Lost to Follow-up|1|||
48757808|NCT00455429|156960867|FG001|Overall Study|Lost to Follow-up|0|||
48757809|NCT00455429|156960868|FG002|Overall Study|Lost to Follow-up|0|||
48757810|NCT00455429|156960869|FG003|Overall Study|Lost to Follow-up|3|||
48757811|NCT00455429|156960866|FG000|Overall Study|Withdrawal by Subject|0|||
48665825|NCT03602885|156630071|FG001|Overall Study|Lost to Follow-up|0|||
48665826|NCT02046070|156630072|FG000|Overall Study|Progressive Disease|18|||
48665827|NCT02046070|156630073|FG001|Overall Study|Progressive Disease|11|||
48665828|NCT02046070|156630074|FG002|Overall Study|Progressive Disease|40|||
48665829|NCT02046070|156630072|FG000|Overall Study|Adverse Event|8|||
48665830|NCT02046070|156630073|FG001|Overall Study|Adverse Event|10|||
48665831|NCT02046070|156630074|FG002|Overall Study|Adverse Event|17|||
48665832|NCT02046070|156630072|FG000|Overall Study|Withdrawal by Subject|1|||
48665833|NCT02046070|156630073|FG001|Overall Study|Withdrawal by Subject|2|||
48665834|NCT02046070|156630074|FG002|Overall Study|Withdrawal by Subject|6|||
48665835|NCT02046070|156630072|FG000|Overall Study|Study Terminated by Sponsor|1|||
48665836|NCT02046070|156630073|FG001|Overall Study|Study Terminated by Sponsor|1|||
48665837|NCT02046070|156630074|FG002|Overall Study|Study Terminated by Sponsor|1|||
48665838|NCT02046070|156630072|FG000|Overall Study|Reason not Specified|4|||
48665839|NCT02046070|156630073|FG001|Overall Study|Reason not Specified|4|||
48665840|NCT02046070|156630074|FG002|Overall Study|Reason not Specified|6|||
48665841|NCT01974752|156630078|FG000|Overall Study|Death|33|||
48665842|NCT01974752|156630079|FG001|Overall Study|Death|11|||
48665843|NCT01974752|156630078|FG000|Overall Study|Lost to Follow-up|2|||
48665844|NCT01974752|156630079|FG001|Overall Study|Lost to Follow-up|0|||
48665845|NCT01974752|156630078|FG000|Overall Study|Withdrawal by Subject|2|||
48665846|NCT01974752|156630079|FG001|Overall Study|Withdrawal by Subject|3|||
48665847|NCT01974752|156630078|FG000|Overall Study|Other Eligibility Criteria|0|||
48665848|NCT01974752|156630079|FG001|Overall Study|Other Eligibility Criteria|1|||
48665849|NCT00330928|156630080|FG000|Overall Study|Lost to Follow-up|6|||
48757812|NCT00455429|156960867|FG001|Overall Study|Withdrawal by Subject|1|||
48757813|NCT00455429|156960868|FG002|Overall Study|Withdrawal by Subject|1|||
48757814|NCT00455429|156960869|FG003|Overall Study|Withdrawal by Subject|0|||
48757815|NCT00455429|156960866|FG000|Overall Study|Lack of Efficacy|0|||
48757816|NCT00455429|156960867|FG001|Overall Study|Lack of Efficacy|1|||
48757817|NCT00455429|156960868|FG002|Overall Study|Lack of Efficacy|0|||
48757818|NCT00455429|156960869|FG003|Overall Study|Lack of Efficacy|1|||
48757819|NCT00455429|156960866|FG000|Overall Study|Adverse Event|0|||
48757820|NCT00455429|156960867|FG001|Overall Study|Adverse Event|1|||
48757821|NCT00455429|156960868|FG002|Overall Study|Adverse Event|0|||
48341050|NCT01183013|155444205|FG002|Overall Study|Lost to Follow-up|4|||
48341051|NCT01183013|155444206|FG003|Overall Study|Lost to Follow-up|3|||
48341052|NCT01183013|155444207|FG004|Overall Study|Lost to Follow-up|2|||
48341053|NCT01183013|155444208|FG005|Overall Study|Lost to Follow-up|6|||
48341054|NCT01183013|155444209|FG006|Overall Study|Lost to Follow-up|5|||
48341055|NCT01183013|155444203|FG000|Overall Study|Withdrawal by Subject|9|||
48341056|NCT01183013|155444204|FG001|Overall Study|Withdrawal by Subject|13|||
48341057|NCT01183013|155444205|FG002|Overall Study|Withdrawal by Subject|10|||
48341058|NCT01183013|155444206|FG003|Overall Study|Withdrawal by Subject|8|||
48341059|NCT01183013|155444207|FG004|Overall Study|Withdrawal by Subject|7|||
48341060|NCT01183013|155444208|FG005|Overall Study|Withdrawal by Subject|9|||
48341061|NCT01183013|155444209|FG006|Overall Study|Withdrawal by Subject|10|||
48665850|NCT00330928|156630080|FG000|Overall Study|Physician Decision|9|||
48665851|NCT00330928|156630080|FG000|Overall Study|Death|1|||
48665852|NCT00330928|156630080|FG000|Overall Study|IVUS could not be performed.|1|||
48665853|NCT01998893|156630081|FG000|Overall Study|Adverse Event|2|||
48757822|NCT00455429|156960869|FG003|Overall Study|Adverse Event|3|||
48757823|NCT00455429|156960866|FG000|Overall Study|Randomly assigned but not treated|0|||
48757824|NCT00455429|156960867|FG001|Overall Study|Randomly assigned but not treated|0|||
48341062|NCT01183013|155444203|FG000|Overall Study|Reasons other than stated above|15|||
48341063|NCT01183013|155444204|FG001|Overall Study|Reasons other than stated above|11|||
48341064|NCT01183013|155444205|FG002|Overall Study|Reasons other than stated above|17|||
48341065|NCT01183013|155444206|FG003|Overall Study|Reasons other than stated above|12|||
48341066|NCT01183013|155444207|FG004|Overall Study|Reasons other than stated above|12|||
48341067|NCT01183013|155444208|FG005|Overall Study|Reasons other than stated above|15|||
48665854|NCT01998893|156630081|FG000|Overall Study|Death|1|||
48665855|NCT01998893|156630081|FG000|Overall Study|Lost to Follow-up|8|||
48665856|NCT01998893|156630081|FG000|Overall Study|Physician Decision|2|||
48665857|NCT01998893|156630081|FG000|Overall Study|Protocol Violation|2|||
48341068|NCT01183013|155444209|FG006|Overall Study|Reasons other than stated above|13|||
48341069|NCT02402465|155444213|FG000|Overall Study|Withdrawal by Subject|0|||
48341070|NCT02402465|155444214|FG001|Overall Study|Withdrawal by Subject|0|||
48341071|NCT02402465|155444215|FG002|Overall Study|Withdrawal by Subject|0|||
48341072|NCT02402465|155444216|FG003|Overall Study|Withdrawal by Subject|0|||
48341073|NCT02402465|155444217|FG004|Overall Study|Withdrawal by Subject|0|||
48341074|NCT02402465|155444218|FG005|Overall Study|Withdrawal by Subject|1|||
48341075|NCT02402465|155444213|FG000|Overall Study|Lost to Follow-up|0|||
48341076|NCT02402465|155444214|FG001|Overall Study|Lost to Follow-up|1|||
48341077|NCT02402465|155444215|FG002|Overall Study|Lost to Follow-up|0|||
48341078|NCT02402465|155444216|FG003|Overall Study|Lost to Follow-up|0|||
48341079|NCT02402465|155444217|FG004|Overall Study|Lost to Follow-up|1|||
48665858|NCT01998893|156630081|FG000|Overall Study|Withdrawal by Subject|1|||
48665859|NCT01998893|156630081|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
48665860|NCT04676867|156630087|FG000|Overall Study|Screen failure|0|||
48665861|NCT04676867|156630088|FG001|Overall Study|Screen failure|0|||
48665862|NCT04676867|156630089|FG002|Overall Study|Screen failure|6|||
48665863|NCT04676867|156630090|FG003|Overall Study|Screen failure|2|||
48665864|NCT04676867|156630087|FG000|Overall Study|Death|0|||
48665865|NCT04676867|156630088|FG001|Overall Study|Death|0|||
48665866|NCT04676867|156630089|FG002|Overall Study|Death|1|||
48665867|NCT04676867|156630090|FG003|Overall Study|Death|0|||
48665868|NCT04676867|156630087|FG000|Overall Study|Withdrawal by Subject|2|||
48665869|NCT04676867|156630088|FG001|Overall Study|Withdrawal by Subject|2|||
48665870|NCT04676867|156630089|FG002|Overall Study|Withdrawal by Subject|4|||
48665871|NCT04676867|156630090|FG003|Overall Study|Withdrawal by Subject|4|||
48665872|NCT04676867|156630087|FG000|Overall Study|Lost to Follow-up|1|||
48665873|NCT04676867|156630088|FG001|Overall Study|Lost to Follow-up|0|||
48341080|NCT02402465|155444218|FG005|Overall Study|Lost to Follow-up|0|||
48341081|NCT02720081|155444219|FG000|Overall Study|Adverse Event|0|||
48341082|NCT02720081|155444220|FG001|Overall Study|Adverse Event|3|||
48341083|NCT02720081|155444219|FG000|Overall Study|Protocol Violation|4|||
48341084|NCT02720081|155444220|FG001|Overall Study|Protocol Violation|1|||
48341085|NCT02845375|155444221|FG000|Overall Study|upper airway obstruction|1|||
48341086|NCT02845375|155444222|FG001|Overall Study|upper airway obstruction|2|||
48341087|NCT02845375|155444223|FG002|Overall Study|upper airway obstruction|1|||
48341088|NCT01177137|155444224|FG000|Overall Study|Withdrawal by Subject|10|||
48341089|NCT01177137|155444225|FG001|Overall Study|Withdrawal by Subject|10|||
48341090|NCT01177137|155444226|FG002|Overall Study|Withdrawal by Subject|2|||
48341091|NCT02720198|155444227|FG000|Overall Study|Withdrawal by Subject|0|||
48341092|NCT02720198|155444228|FG001|Overall Study|Withdrawal by Subject|1|||
48665874|NCT04676867|156630089|FG002|Overall Study|Lost to Follow-up|0|||
48665875|NCT04676867|156630090|FG003|Overall Study|Lost to Follow-up|0|||
48665876|NCT02231762|156630100|FG000|Combination Phase|Adverse Event|10|||
48665877|NCT02231762|156630101|FG001|Combination Phase|Adverse Event|0|||
48665878|NCT02231762|156630102|FG002|Combination Phase|Adverse Event|0|||
48665879|NCT02231762|156630103|FG003|Combination Phase|Adverse Event|0|||
48665880|NCT02231762|156630100|FG000|Combination Phase|Withdrawal by Subject|2|||
48665881|NCT02231762|156630101|FG001|Combination Phase|Withdrawal by Subject|0|||
48665882|NCT02231762|156630102|FG002|Combination Phase|Withdrawal by Subject|0|||
48665883|NCT02231762|156630103|FG003|Combination Phase|Withdrawal by Subject|0|||
48341093|NCT04468633|155444231|FG000|Overall Study|Withdrawal by Subject|4|||
48341094|NCT04468633|155444232|FG001|Overall Study|Withdrawal by Subject|0|||
48341095|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
48341096|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
48341097|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
48665884|NCT02231762|156630100|FG000|Combination Phase|Disease Progression|6|||
48665885|NCT02231762|156630101|FG001|Combination Phase|Disease Progression|0|||
48341098|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
48341099|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Death|0|||
48341100|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Death|0|||
48341101|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Death|1|||
48341102|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Death|0|||
48341103|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
48341104|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
48341105|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
48341106|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
48341107|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
48341108|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
48341109|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
48341110|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
48665886|NCT02231762|156630102|FG002|Combination Phase|Disease Progression|0|||
48665887|NCT02231762|156630103|FG003|Combination Phase|Disease Progression|0|||
48665888|NCT02231762|156630100|FG000|Combination Phase|Did not meet inclusion criteria|1|||
48665889|NCT02231762|156630101|FG001|Combination Phase|Did not meet inclusion criteria|0|||
48665890|NCT02231762|156630102|FG002|Combination Phase|Did not meet inclusion criteria|0|||
48665891|NCT02231762|156630103|FG003|Combination Phase|Did not meet inclusion criteria|0|||
48757825|NCT00455429|156960868|FG002|Overall Study|Randomly assigned but not treated|0|||
48757826|NCT00455429|156960869|FG003|Overall Study|Randomly assigned but not treated|2|||
48757827|NCT00455429|156960866|FG000|Overall Study|Personal Reason|1|||
48757828|NCT00455429|156960867|FG001|Overall Study|Personal Reason|0|||
48757829|NCT00455429|156960868|FG002|Overall Study|Personal Reason|0|||
48757830|NCT00455429|156960869|FG003|Overall Study|Personal Reason|0|||
48757831|NCT00455429|156960866|FG000|Overall Study|Non-compliance|0|||
48757832|NCT00455429|156960867|FG001|Overall Study|Non-compliance|0|||
48757833|NCT00455429|156960868|FG002|Overall Study|Non-compliance|0|||
48757834|NCT00455429|156960869|FG003|Overall Study|Non-compliance|1|||
48757835|NCT00455429|156960866|FG000|Overall Study|Other|0|||
48757836|NCT00455429|156960867|FG001|Overall Study|Other|2|||
48757837|NCT00455429|156960868|FG002|Overall Study|Other|0|||
48757838|NCT00455429|156960869|FG003|Overall Study|Other|1|||
48757839|NCT01603459|156960872|FG000|Overall Study|Adverse Event|5|||
48757840|NCT01603459|156960872|FG000|Overall Study|Withdrawal by Subject|5|||
48757841|NCT01603459|156960872|FG000|Overall Study|Lost to Follow-up|3|||
48757842|NCT01603459|156960872|FG000|Overall Study|Predefined discontinuation criteria|3|||
48341111|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
48757843|NCT01603459|156960872|FG000|Overall Study|Non-compliance|1|||
48757844|NCT01603459|156960872|FG000|Overall Study|Administrative reason|1|||
48757845|NCT02335099|156960873|FG000|Treatment|Withdrawal by Subject|1|||
48757846|NCT02335099|156960874|FG001|Treatment|Withdrawal by Subject|3|||
48341112|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
48341113|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
48341114|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
48341115|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
48341116|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
48341117|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
48341118|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
48341119|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
48341120|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
48341121|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
48341122|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
48341123|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Other|2|||
48341124|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Other|0|||
48341125|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Other|0|||
48341126|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Other|0|||
48341127|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
48341128|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
48341129|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
48341130|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
48341131|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
48341132|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
48341133|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
48341134|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
48341135|NCT03845517|155444233|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
48341136|NCT03845517|155444234|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
48341137|NCT03845517|155444235|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
48341138|NCT03845517|155444236|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
48341139|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
48341140|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
48341141|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
48341142|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
48341143|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Death|0|||
48341144|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Death|0|||
48341145|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Death|1|||
48341146|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Death|1|||
48341147|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
48341148|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
48341149|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
48341150|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
48341151|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
48341152|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
48665892|NCT02231762|156630100|FG000|Combination Phase|Protocol Violation|1|||
48665893|NCT02231762|156630101|FG001|Combination Phase|Protocol Violation|0|||
48665894|NCT02231762|156630102|FG002|Combination Phase|Protocol Violation|0|||
48665895|NCT02231762|156630103|FG003|Combination Phase|Protocol Violation|0|||
48665896|NCT02231762|156630100|FG000|Maintenance Phase|Disease progression|0|||
48665897|NCT02231762|156630101|FG001|Maintenance Phase|Disease progression|3|||
48665898|NCT02231762|156630102|FG002|Maintenance Phase|Disease progression|4|||
48665899|NCT02231762|156630103|FG003|Maintenance Phase|Disease progression|3|||
48665900|NCT02231762|156630100|FG000|Maintenance Phase|Adverse Event|0|||
48665901|NCT02231762|156630101|FG001|Maintenance Phase|Adverse Event|0|||
48665902|NCT02231762|156630102|FG002|Maintenance Phase|Adverse Event|1|||
48665903|NCT02231762|156630103|FG003|Maintenance Phase|Adverse Event|2|||
48665904|NCT03987932|156630107|FG000|Overall Study|Lost to Follow-up|2|||
48665905|NCT03987932|156630108|FG001|Overall Study|Lost to Follow-up|1|||
48341153|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
48341154|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
48341155|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
48341156|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
48341157|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
48341158|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
48341159|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Other|1|||
48341160|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Other|0|||
48341161|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Other|1|||
48341162|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Other|0|||
48341163|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
48341164|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
48341165|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
48428231|NCT02531373|155756498|FG000|Overall Study|Protocol Violation|0|||
48665906|NCT03987932|156630109|FG002|Overall Study|Lost to Follow-up|1|||
48665907|NCT03987932|156630107|FG000|Overall Study|Non-study related elective surgery|0|||
48665908|NCT03987932|156630108|FG001|Overall Study|Non-study related elective surgery|0|||
48665909|NCT03987932|156630109|FG002|Overall Study|Non-study related elective surgery|1|||
48341166|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
48341167|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
48341168|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
48341169|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
48341170|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
48341171|NCT03845517|155444233|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
48341172|NCT03845517|155444234|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
48665910|NCT03093974|156630112|FG000|Overall Study|Withdrawal by Subject|32|||
48665911|NCT03093974|156630113|FG001|Overall Study|Withdrawal by Subject|27|||
48665912|NCT03093974|156630112|FG000|Overall Study|Adverse Event|17|||
48665913|NCT03093974|156630113|FG001|Overall Study|Adverse Event|24|||
48665914|NCT03093974|156630112|FG000|Overall Study|Death|0|||
48665915|NCT03093974|156630113|FG001|Overall Study|Death|1|||
48665916|NCT03093974|156630112|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48665917|NCT03093974|156630113|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48665918|NCT03093974|156630112|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
48665919|NCT03093974|156630113|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
48665920|NCT03093974|156630112|FG000|Overall Study|Lost to Follow-up|0|||
48665921|NCT03093974|156630113|FG001|Overall Study|Lost to Follow-up|1|||
48665922|NCT03093974|156630112|FG000|Overall Study|Other|1|||
48665923|NCT03093974|156630113|FG001|Overall Study|Other|2|||
48665924|NCT00810901|156630117|FG000|Overall Study|Lost to Follow-up|88|||
48665925|NCT00810901|156630118|FG001|Overall Study|Lost to Follow-up|58|||
48665926|NCT00343915|156630121|FG000|Primary Study|Withdrawal by Subject|1|||
48665927|NCT00343915|156630122|FG001|Primary Study|Withdrawal by Subject|0|||
48665928|NCT00343915|156630121|FG000|Primary Study|Lost to Follow-up|2|||
48665929|NCT00343915|156630122|FG001|Primary Study|Lost to Follow-up|3|||
48665930|NCT00343915|156630121|FG000|Primary Study|Other|1|||
48665931|NCT00343915|156630122|FG001|Primary Study|Other|0|||
48665932|NCT01667562|156630123|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
48665933|NCT01667562|156630124|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
48665934|NCT01667562|156630123|FG000|Erlotinib Phase|Lost to Follow-up|0|||
48665935|NCT01667562|156630124|FG001|Erlotinib Phase|Lost to Follow-up|1|||
48665936|NCT01667562|156630123|FG000|Erlotinib Phase|Adverse Event|0|||
48757847|NCT02335099|156960873|FG000|Treatment|Lost to Follow-up|2|||
48757848|NCT02335099|156960874|FG001|Treatment|Lost to Follow-up|0|||
48757849|NCT02335099|156960873|FG000|Treatment|Death|1|||
48757850|NCT02335099|156960874|FG001|Treatment|Death|0|||
48757851|NCT02335099|156960873|FG000|Treatment|Adverse Event|1|||
48757852|NCT02335099|156960874|FG001|Treatment|Adverse Event|2|||
48757853|NCT02335099|156960873|FG000|Follow-up|Death|0|||
48757854|NCT02335099|156960874|FG001|Follow-up|Death|1|||
48757855|NCT00075582|156960875|FG000|Overall Study|Adverse Event|3|||
48757856|NCT00075582|156960876|FG001|Overall Study|Adverse Event|1|||
48757857|NCT00075582|156960875|FG000|Overall Study|Lack of Efficacy|4|||
48757858|NCT00075582|156960876|FG001|Overall Study|Lack of Efficacy|8|||
48757859|NCT00075582|156960875|FG000|Overall Study|Physician Decision|5|||
48757860|NCT00075582|156960876|FG001|Overall Study|Physician Decision|8|||
48757861|NCT00075582|156960875|FG000|Overall Study|Withdrawal by Subject|2|||
48757862|NCT00075582|156960876|FG001|Overall Study|Withdrawal by Subject|2|||
48757863|NCT00075582|156960875|FG000|Overall Study|Ineligible for study|36|||
48757864|NCT00075582|156960876|FG001|Overall Study|Ineligible for study|16|||
48757865|NCT02154581|156960877|FG000|Overall Study|Lost to Follow-up|7|||
48757866|NCT02154581|156960878|FG001|Overall Study|Lost to Follow-up|8|||
48757867|NCT01641692|156960879|FG000|Treatment Period 1|Adverse Event|1|||
48757868|NCT01641692|156960880|FG001|Treatment Period 1|Adverse Event|0|||
48757869|NCT01641692|156960881|FG002|Treatment Period 1|Adverse Event|0|||
48757870|NCT01641692|156960882|FG003|Treatment Period 1|Adverse Event|0|||
48757871|NCT01641692|156960883|FG004|Treatment Period 1|Adverse Event|0|||
48757872|NCT01641692|156960884|FG005|Treatment Period 1|Adverse Event|0|||
48757873|NCT01641692|156960885|FG006|Treatment Period 1|Adverse Event|0|||
48757874|NCT01641692|156960886|FG007|Treatment Period 1|Adverse Event|0|||
48757875|NCT01641692|156960879|FG000|Treatment Period 1|Lack of Efficacy|0|||
48757876|NCT01641692|156960880|FG001|Treatment Period 1|Lack of Efficacy|0|||
48757877|NCT01641692|156960881|FG002|Treatment Period 1|Lack of Efficacy|0|||
48757878|NCT01641692|156960882|FG003|Treatment Period 1|Lack of Efficacy|0|||
48757879|NCT01641692|156960883|FG004|Treatment Period 1|Lack of Efficacy|0|||
48757880|NCT01641692|156960884|FG005|Treatment Period 1|Lack of Efficacy|0|||
48757881|NCT01641692|156960885|FG006|Treatment Period 1|Lack of Efficacy|0|||
48665937|NCT01667562|156630124|FG001|Erlotinib Phase|Adverse Event|1|||
48665938|NCT01667562|156630123|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
48665939|NCT01667562|156630124|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
48665940|NCT01853072|156630126|FG000|Overall Study|Adverse event prior to treatment|0|||
48665941|NCT01853072|156630127|FG001|Overall Study|Adverse event prior to treatment|1|||
48665942|NCT01853072|156630126|FG000|Overall Study|Adverse Event|0|||
48757882|NCT01641692|156960886|FG007|Treatment Period 1|Lack of Efficacy|1|||
48757883|NCT01641692|156960879|FG000|Treatment Period 1|Protocol Violation|1|||
48757884|NCT01641692|156960880|FG001|Treatment Period 1|Protocol Violation|0|||
48665943|NCT01853072|156630127|FG001|Overall Study|Adverse Event|3|||
48665944|NCT01853072|156630126|FG000|Overall Study|Death|1|||
48341173|NCT03845517|155444235|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
48341174|NCT03845517|155444236|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
48341175|NCT01498445|155444237|FG000|Overall Study|Lack of Efficacy|0|||
48341176|NCT01498445|155444238|FG001|Overall Study|Lack of Efficacy|0|||
48341177|NCT01498445|155444239|FG002|Overall Study|Lack of Efficacy|1|||
48341178|NCT01498445|155444240|FG003|Overall Study|Lack of Efficacy|2|||
48341179|NCT01498445|155444241|FG004|Overall Study|Lack of Efficacy|0|||
48341180|NCT01498445|155444242|FG005|Overall Study|Lack of Efficacy|0|||
48341181|NCT01498445|155444237|FG000|Overall Study|Screen Failure|0|||
48341182|NCT01498445|155444238|FG001|Overall Study|Screen Failure|0|||
48341183|NCT01498445|155444239|FG002|Overall Study|Screen Failure|0|||
48665945|NCT01853072|156630127|FG001|Overall Study|Death|4|||
48665946|NCT01853072|156630126|FG000|Overall Study|Lost to Follow-up|0|||
48665947|NCT01853072|156630127|FG001|Overall Study|Lost to Follow-up|3|||
48665948|NCT01853072|156630126|FG000|Overall Study|Non-compliance with study drug|0|||
48665949|NCT01853072|156630127|FG001|Overall Study|Non-compliance with study drug|1|||
48665950|NCT01853072|156630126|FG000|Overall Study|Physician Decision|1|||
48665951|NCT01853072|156630127|FG001|Overall Study|Physician Decision|1|||
48665952|NCT01853072|156630126|FG000|Overall Study|Withdrawal by Subject|1|||
48665953|NCT01853072|156630127|FG001|Overall Study|Withdrawal by Subject|2|||
48665954|NCT01853072|156630126|FG000|Overall Study|Reason not specified|9|||
48665955|NCT01853072|156630127|FG001|Overall Study|Reason not specified|6|||
48665956|NCT01527383|156630128|FG000|Overall Study|Adverse Event|5|||
48665957|NCT01527383|156630129|FG001|Overall Study|Adverse Event|0|||
48665958|NCT01527383|156630128|FG000|Overall Study|Lost to Follow-up|3|||
48665959|NCT01527383|156630129|FG001|Overall Study|Lost to Follow-up|0|||
48665960|NCT01527383|156630128|FG000|Overall Study|Physician Decision|2|||
48665961|NCT01527383|156630129|FG001|Overall Study|Physician Decision|0|||
48665962|NCT01527383|156630128|FG000|Overall Study|Pregnancy|1|||
48665963|NCT01527383|156630129|FG001|Overall Study|Pregnancy|0|||
48665964|NCT01527383|156630128|FG000|Overall Study|Protocol Violation|1|||
48665965|NCT01527383|156630129|FG001|Overall Study|Protocol Violation|0|||
48665966|NCT01527383|156630128|FG000|Overall Study|Screen failure|1|||
48665967|NCT01527383|156630129|FG001|Overall Study|Screen failure|0|||
48665968|NCT01527383|156630128|FG000|Overall Study|Participant moved|0|||
48665969|NCT01527383|156630129|FG001|Overall Study|Participant moved|1|||
48665970|NCT01527383|156630128|FG000|Overall Study|Withdrawal by Subject|2|||
48665971|NCT01527383|156630129|FG001|Overall Study|Withdrawal by Subject|3|||
48665972|NCT01304329|156630130|FG000|Third Intervention (3 Days)|Adverse Event|0|||
48665973|NCT01304329|156630131|FG001|Third Intervention (3 Days)|Adverse Event|1|||
48665974|NCT01304329|156630132|FG002|Third Intervention (3 Days)|Adverse Event|0|||
48665975|NCT01304329|156630133|FG003|Third Intervention (3 Days)|Adverse Event|0|||
48341184|NCT01498445|155444240|FG003|Overall Study|Screen Failure|0|||
48341185|NCT01498445|155444241|FG004|Overall Study|Screen Failure|1|||
48341186|NCT01498445|155444242|FG005|Overall Study|Screen Failure|1|||
48665976|NCT01304329|156630134|FG004|Third Intervention (3 Days)|Adverse Event|0|||
48665977|NCT01304329|156630135|FG005|Third Intervention (3 Days)|Adverse Event|0|||
48665978|NCT01444027|156630137|FG000|Overall Study|Withdrawal by Subject|4|||
48665979|NCT01444027|156630138|FG001|Overall Study|Withdrawal by Subject|10|||
48665980|NCT01444027|156630139|FG002|Overall Study|Withdrawal by Subject|24|||
48665981|NCT01444027|156630137|FG000|Overall Study|Lost to Follow-up|26|||
48665982|NCT01444027|156630138|FG001|Overall Study|Lost to Follow-up|20|||
48665983|NCT01444027|156630139|FG002|Overall Study|Lost to Follow-up|14|||
48665984|NCT00657150|156630140|FG000|Overall Study|Adverse Event|19|||
48665985|NCT00657150|156630141|FG001|Overall Study|Adverse Event|10|||
48665986|NCT00657150|156630140|FG000|Overall Study|Non-compliant with protocol|5|||
48665987|NCT00657150|156630141|FG001|Overall Study|Non-compliant with protocol|9|||
48665988|NCT00657150|156630140|FG000|Overall Study|Lost to Follow-up|2|||
48665989|NCT00657150|156630141|FG001|Overall Study|Lost to Follow-up|0|||
48665990|NCT00657150|156630140|FG000|Overall Study|Withdrawal by Subject|51|||
48665991|NCT00657150|156630141|FG001|Overall Study|Withdrawal by Subject|36|||
48665992|NCT00657150|156630140|FG000|Overall Study|Other|38|||
48665993|NCT00657150|156630141|FG001|Overall Study|Other|38|||
48665994|NCT00657150|156630140|FG000|Treatment|Adverse Event|60|||
48665995|NCT00657150|156630141|FG001|Treatment|Adverse Event|53|||
48665996|NCT00657150|156630140|FG000|Treatment|Non-compliant with protocol|10|||
48665997|NCT00657150|156630141|FG001|Treatment|Non-compliant with protocol|9|||
48665998|NCT00657150|156630140|FG000|Treatment|Lost to Follow-up|1|||
48665999|NCT00657150|156630141|FG001|Treatment|Lost to Follow-up|0|||
48666000|NCT00657150|156630140|FG000|Treatment|Withdrawal by Subject|23|||
48666001|NCT00657150|156630141|FG001|Treatment|Withdrawal by Subject|20|||
48666002|NCT00657150|156630140|FG000|Treatment|Other|13|||
48666003|NCT00657150|156630141|FG001|Treatment|Other|15|||
48666004|NCT00432744|156630142|FG000|Months 0-6|Withdrawal by Subject|4|||
48666005|NCT00432744|156630143|FG001|Months 0-6|Withdrawal by Subject|4|||
48666006|NCT00432744|156630142|FG000|Months 0-6|Too disabled to score|1|||
48666007|NCT00432744|156630143|FG001|Months 0-6|Too disabled to score|0|||
48666008|NCT00432744|156630142|FG000|Months 7 - 12|Withdrawal by Subject|1|||
48666009|NCT00432744|156630143|FG001|Months 7 - 12|Withdrawal by Subject|0|||
48666010|NCT00432744|156630142|FG000|Months 7 - 12|Too disabled to score|0|||
48666011|NCT00432744|156630143|FG001|Months 7 - 12|Too disabled to score|1|||
48666012|NCT00468845|156630144|FG000|Overall Study|Adverse Event|9|||
48666013|NCT00468845|156630145|FG001|Overall Study|Adverse Event|14|||
48666014|NCT00468845|156630146|FG002|Overall Study|Adverse Event|11|||
48666015|NCT00468845|156630144|FG000|Overall Study|Lost to Follow-up|2|||
48666016|NCT00468845|156630145|FG001|Overall Study|Lost to Follow-up|1|||
48666017|NCT00468845|156630146|FG002|Overall Study|Lost to Follow-up|2|||
48666018|NCT00468845|156630144|FG000|Overall Study|Other|4|||
48666019|NCT00468845|156630145|FG001|Overall Study|Other|9|||
48666020|NCT00468845|156630146|FG002|Overall Study|Other|5|||
48666021|NCT00468845|156630144|FG000|Overall Study|No longer willing to participate|5|||
48666022|NCT00468845|156630145|FG001|Overall Study|No longer willing to participate|6|||
48666023|NCT00468845|156630146|FG002|Overall Study|No longer willing to participate|10|||
48666024|NCT00468845|156630144|FG000|Overall Study|Randomized, not treated|1|||
48666025|NCT00468845|156630145|FG001|Overall Study|Randomized, not treated|4|||
48666026|NCT00468845|156630146|FG002|Overall Study|Randomized, not treated|2|||
48666027|NCT02513823|156630148|FG000|Overall Study|Lost to Follow-up|4|||
48666028|NCT02513823|156630148|FG000|Overall Study|Physician Decision|1|||
48666029|NCT00740714|156630149|FG000|Overall Study|Withdrawal by Subject|17|||
48666030|NCT00740714|156630150|FG001|Overall Study|Withdrawal by Subject|19|||
48666031|NCT00740714|156630151|FG002|Overall Study|Withdrawal by Subject|29|||
48666032|NCT03344640|156630152|FG000|Overall Study|Adverse Event|1|||
48666033|NCT03344640|156630153|FG001|Overall Study|Adverse Event|0|||
48666034|NCT03344640|156630152|FG000|Overall Study|Physician Decision|1|||
48666035|NCT03344640|156630153|FG001|Overall Study|Physician Decision|1|||
48666036|NCT03344640|156630152|FG000|Overall Study|Withdrawal by Subject|1|||
48666037|NCT03344640|156630153|FG001|Overall Study|Withdrawal by Subject|2|||
48666038|NCT03344640|156630152|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
48666039|NCT03344640|156630153|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
48666040|NCT00259298|156630154|FG000|Overall Study|Withdrawal by Subject|1|||
48666041|NCT00259298|156630154|FG000|Overall Study|Physician Decision|2|||
48666042|NCT01400243|156630155|FG000|Overall Study|Protocol Violation|8|||
48666043|NCT01400243|156630156|FG001|Overall Study|Protocol Violation|11|||
48666044|NCT00815191|156630158|FG000|Overall Study|Protocol Violation|1|||
48666045|NCT00815191|156630159|FG001|Overall Study|Protocol Violation|1|||
48666046|NCT02226549|156630160|FG000|Overall Study|Randomized but Never Treated|1|||
48666047|NCT02226549|156630161|FG001|Overall Study|Randomized but Never Treated|0|||
48666048|NCT02226549|156630160|FG000|Overall Study|Lost to Follow-up|0|||
48666049|NCT02226549|156630161|FG001|Overall Study|Lost to Follow-up|1|||
48666050|NCT04316741|156630163|FG000|Baseline Enrollment|Lost to Follow-up|1|||
48666051|NCT04316741|156630164|FG001|Baseline Enrollment|Lost to Follow-up|1|||
48666052|NCT04316741|156630163|FG000|Immediate Post-Test|Lost to Follow-up|5|||
48666053|NCT04316741|156630164|FG001|Immediate Post-Test|Lost to Follow-up|1|||
48666054|NCT04316741|156630163|FG000|1-month Post-test|Lost to Follow-up|7|||
48666055|NCT04316741|156630164|FG001|1-month Post-test|Lost to Follow-up|2|||
48666056|NCT04316741|156630163|FG000|3-month Follow-up|Lost to Follow-up|10|||
48666057|NCT04316741|156630164|FG001|3-month Follow-up|Lost to Follow-up|2|||
48666058|NCT02356887|156630173|FG000|Overall Study|poor compliance|2|||
48666059|NCT01839656|156630177|FG000|Overall Study|Withdrawal by Subject|1|||
48666060|NCT01839656|156630178|FG001|Overall Study|Withdrawal by Subject|1|||
48666061|NCT01839656|156630177|FG000|Overall Study|Adverse event, serious fatal|1|||
48666062|NCT01839656|156630178|FG001|Overall Study|Adverse event, serious fatal|4|||
48757885|NCT01641692|156960881|FG002|Treatment Period 1|Protocol Violation|0|||
48757886|NCT01641692|156960882|FG003|Treatment Period 1|Protocol Violation|0|||
48757887|NCT01641692|156960883|FG004|Treatment Period 1|Protocol Violation|2|||
48757888|NCT01641692|156960884|FG005|Treatment Period 1|Protocol Violation|0|||
48757889|NCT01641692|156960885|FG006|Treatment Period 1|Protocol Violation|0|||
48757890|NCT01641692|156960886|FG007|Treatment Period 1|Protocol Violation|0|||
48757891|NCT01641692|156960879|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757892|NCT01641692|156960880|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757893|NCT01641692|156960881|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757894|NCT01641692|156960882|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757895|NCT01641692|156960883|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
48757896|NCT01641692|156960884|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757897|NCT01641692|156960885|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
48757898|NCT01641692|156960886|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
48757899|NCT01641692|156960879|FG000|Treatment Period 1|Lost to Follow-up|0|||
48757900|NCT01641692|156960880|FG001|Treatment Period 1|Lost to Follow-up|0|||
48757901|NCT01641692|156960881|FG002|Treatment Period 1|Lost to Follow-up|1|||
48757902|NCT01641692|156960882|FG003|Treatment Period 1|Lost to Follow-up|0|||
48757903|NCT01641692|156960883|FG004|Treatment Period 1|Lost to Follow-up|0|||
48757904|NCT01641692|156960884|FG005|Treatment Period 1|Lost to Follow-up|0|||
48757905|NCT01641692|156960885|FG006|Treatment Period 1|Lost to Follow-up|0|||
48757906|NCT01641692|156960886|FG007|Treatment Period 1|Lost to Follow-up|0|||
48757907|NCT01641692|156960879|FG000|Treatment Period 1|Physician Decision|0|||
48757908|NCT01641692|156960880|FG001|Treatment Period 1|Physician Decision|0|||
48757909|NCT01641692|156960881|FG002|Treatment Period 1|Physician Decision|0|||
48757910|NCT01641692|156960882|FG003|Treatment Period 1|Physician Decision|0|||
48757911|NCT01641692|156960883|FG004|Treatment Period 1|Physician Decision|1|||
48757912|NCT01641692|156960884|FG005|Treatment Period 1|Physician Decision|0|||
48757913|NCT01641692|156960885|FG006|Treatment Period 1|Physician Decision|0|||
48757914|NCT01641692|156960886|FG007|Treatment Period 1|Physician Decision|0|||
48757915|NCT01641692|156960879|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48757916|NCT01641692|156960880|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48757917|NCT01641692|156960881|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48757918|NCT01641692|156960882|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48666063|NCT01839656|156630177|FG000|Overall Study|Early study closure|0|||
48666064|NCT01839656|156630178|FG001|Overall Study|Early study closure|11|||
48666065|NCT01839656|156630177|FG000|Overall Study|Adverse Event|1|||
48666066|NCT01839656|156630178|FG001|Overall Study|Adverse Event|0|||
48666067|NCT02535416|156630181|FG000|Overall Study|Family bereavement overseas|1|||
48666068|NCT02535416|156630182|FG001|Overall Study|Family bereavement overseas|0|||
48341187|NCT01061775|155444243|FG000|Overall Study|Physician Decision|2|||
48341188|NCT01061775|155444243|FG000|Overall Study|Lost to Follow-up|1|||
48341189|NCT00784277|155444246|FG000|IR Treatment|Adverse Event|4|||
48341190|NCT00784277|155444247|FG001|IR Treatment|Adverse Event|8|||
48341191|NCT00784277|155444248|FG002|IR Treatment|Adverse Event|19|||
48341192|NCT00784277|155444249|FG003|IR Treatment|Adverse Event|35|||
48341193|NCT00784277|155444250|FG004|IR Treatment|Adverse Event|0|||
48341194|NCT00784277|155444251|FG005|IR Treatment|Adverse Event|0|||
48341195|NCT00784277|155444252|FG006|IR Treatment|Adverse Event|0|||
48341196|NCT00784277|155444246|FG000|IR Treatment|Lack of Efficacy|4|||
48341197|NCT00784277|155444247|FG001|IR Treatment|Lack of Efficacy|4|||
48341198|NCT00784277|155444248|FG002|IR Treatment|Lack of Efficacy|1|||
48341199|NCT00784277|155444249|FG003|IR Treatment|Lack of Efficacy|0|||
48341200|NCT00784277|155444250|FG004|IR Treatment|Lack of Efficacy|0|||
48341201|NCT00784277|155444251|FG005|IR Treatment|Lack of Efficacy|0|||
48341202|NCT00784277|155444252|FG006|IR Treatment|Lack of Efficacy|0|||
48341203|NCT00784277|155444246|FG000|IR Treatment|Lost to Follow-up|1|||
48341204|NCT00784277|155444247|FG001|IR Treatment|Lost to Follow-up|0|||
48341205|NCT00784277|155444248|FG002|IR Treatment|Lost to Follow-up|1|||
48341206|NCT00784277|155444249|FG003|IR Treatment|Lost to Follow-up|0|||
48341207|NCT00784277|155444250|FG004|IR Treatment|Lost to Follow-up|0|||
48341208|NCT00784277|155444251|FG005|IR Treatment|Lost to Follow-up|0|||
48341209|NCT00784277|155444252|FG006|IR Treatment|Lost to Follow-up|0|||
48341210|NCT00784277|155444246|FG000|IR Treatment|Withdrawal by Subject|5|||
48341211|NCT00784277|155444247|FG001|IR Treatment|Withdrawal by Subject|1|||
48666069|NCT02535416|156630183|FG002|Overall Study|Family bereavement overseas|0|||
48666070|NCT02535416|156630184|FG003|Overall Study|Family bereavement overseas|0|||
48666071|NCT02535416|156630185|FG004|Overall Study|Family bereavement overseas|0|||
48666072|NCT02535416|156630186|FG005|Overall Study|Family bereavement overseas|0|||
48666073|NCT02535416|156630187|FG006|Overall Study|Family bereavement overseas|0|||
48666074|NCT02535416|156630188|FG007|Overall Study|Family bereavement overseas|0|||
48666075|NCT02535416|156630189|FG008|Overall Study|Family bereavement overseas|0|||
48666076|NCT02920957|156630190|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
48666077|NCT02920957|156630191|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
48666078|NCT02920957|156630190|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
48666079|NCT02920957|156630191|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
48666080|NCT02920957|156630190|FG000|First Intervention : 1 Month|Adverse Event|1|||
48666081|NCT02920957|156630191|FG001|First Intervention : 1 Month|Adverse Event|0|||
48666082|NCT02920957|156630190|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
48666083|NCT02920957|156630191|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
48666084|NCT01711866|156630196|FG000|Overall Study|Noncompliant|3|||
48666085|NCT01711866|156630196|FG000|Overall Study|Withdrawal by Subject|3|||
48666086|NCT01711866|156630196|FG000|Overall Study|Adverse Event|2|||
48666087|NCT02290938|156630197|FG000|Overall Study|Lost to Follow-up|14|||
48666088|NCT02290938|156630198|FG001|Overall Study|Lost to Follow-up|43|||
48666089|NCT02558400|156630199|FG000|Overall Study|Adverse Event|47|||
48666090|NCT02558400|156630200|FG001|Overall Study|Adverse Event|53|||
48666091|NCT02558400|156630201|FG002|Overall Study|Adverse Event|4|||
48666092|NCT02558400|156630199|FG000|Overall Study|Withdrawal by Subject|13|||
48666093|NCT02558400|156630200|FG001|Overall Study|Withdrawal by Subject|9|||
48666094|NCT02558400|156630201|FG002|Overall Study|Withdrawal by Subject|8|||
48666095|NCT02558400|156630199|FG000|Overall Study|Non-Compliant|0|||
48666096|NCT02558400|156630200|FG001|Overall Study|Non-Compliant|1|||
48666097|NCT02558400|156630201|FG002|Overall Study|Non-Compliant|3|||
48666098|NCT02558400|156630199|FG000|Overall Study|Lost to Follow-up|5|||
48666099|NCT02558400|156630200|FG001|Overall Study|Lost to Follow-up|5|||
48666100|NCT02558400|156630201|FG002|Overall Study|Lost to Follow-up|4|||
48666101|NCT02558400|156630199|FG000|Overall Study|Lack of Efficacy|0|||
48666102|NCT02558400|156630200|FG001|Overall Study|Lack of Efficacy|13|||
48666103|NCT02558400|156630201|FG002|Overall Study|Lack of Efficacy|1|||
48757919|NCT01641692|156960883|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48757920|NCT01641692|156960884|FG005|Treatment Period 1|Withdrawal by Subject|2|||
48341212|NCT00784277|155444248|FG002|IR Treatment|Withdrawal by Subject|4|||
48341213|NCT00784277|155444249|FG003|IR Treatment|Withdrawal by Subject|6|||
48341214|NCT00784277|155444250|FG004|IR Treatment|Withdrawal by Subject|0|||
48341215|NCT00784277|155444251|FG005|IR Treatment|Withdrawal by Subject|0|||
48666104|NCT02558400|156630199|FG000|Overall Study|Disallowed Concurrent Medication|6|||
48666105|NCT02558400|156630200|FG001|Overall Study|Disallowed Concurrent Medication|7|||
48666106|NCT02558400|156630201|FG002|Overall Study|Disallowed Concurrent Medication|5|||
48757921|NCT01641692|156960885|FG006|Treatment Period 1|Withdrawal by Subject|0|||
48757922|NCT01641692|156960886|FG007|Treatment Period 1|Withdrawal by Subject|1|||
48666107|NCT02558400|156630199|FG000|Overall Study|Physician Decision|2|||
48666108|NCT02558400|156630200|FG001|Overall Study|Physician Decision|2|||
48666109|NCT02558400|156630201|FG002|Overall Study|Physician Decision|0|||
48341216|NCT00784277|155444252|FG006|IR Treatment|Withdrawal by Subject|0|||
48666110|NCT02558400|156630199|FG000|Overall Study|Protocol Violation|6|||
48666111|NCT02558400|156630200|FG001|Overall Study|Protocol Violation|3|||
48666112|NCT02558400|156630201|FG002|Overall Study|Protocol Violation|8|||
48666113|NCT02558400|156630199|FG000|Overall Study|Death|0|||
48666114|NCT02558400|156630200|FG001|Overall Study|Death|1|||
48666115|NCT02558400|156630201|FG002|Overall Study|Death|0|||
48666116|NCT02558400|156630199|FG000|Overall Study|Ineligible for the study|0|||
48666117|NCT02558400|156630200|FG001|Overall Study|Ineligible for the study|2|||
48666118|NCT02558400|156630201|FG002|Overall Study|Ineligible for the study|0|||
48666119|NCT00456599|156630202|FG000|Overall Study|Non-compliance|1|||
48666120|NCT00456599|156630202|FG000|Overall Study|Withdrawal by Subject|2|||
48666121|NCT03187834|156632348|FG000|Overall Study|Lost to Follow-up|0|||
48341217|NCT00784277|155444246|FG000|IR Treatment|Resolution Of Pain|0|||
48341218|NCT00784277|155444247|FG001|IR Treatment|Resolution Of Pain|1|||
48341219|NCT00784277|155444248|FG002|IR Treatment|Resolution Of Pain|0|||
48341220|NCT00784277|155444249|FG003|IR Treatment|Resolution Of Pain|0|||
48341221|NCT00784277|155444250|FG004|IR Treatment|Resolution Of Pain|0|||
48341222|NCT00784277|155444251|FG005|IR Treatment|Resolution Of Pain|0|||
48341223|NCT00784277|155444252|FG006|IR Treatment|Resolution Of Pain|0|||
48341224|NCT00784277|155444246|FG000|IR Treatment|Other|2|||
48341225|NCT00784277|155444247|FG001|IR Treatment|Other|3|||
48341226|NCT00784277|155444248|FG002|IR Treatment|Other|3|||
48341227|NCT00784277|155444249|FG003|IR Treatment|Other|2|||
48341228|NCT00784277|155444250|FG004|IR Treatment|Other|0|||
48341229|NCT00784277|155444251|FG005|IR Treatment|Other|0|||
48341230|NCT00784277|155444252|FG006|IR Treatment|Other|0|||
48341231|NCT00784277|155444246|FG000|ER Treatment|Adverse Event|0|||
48341232|NCT00784277|155444247|FG001|ER Treatment|Adverse Event|0|||
48341233|NCT00784277|155444248|FG002|ER Treatment|Adverse Event|0|||
48341234|NCT00784277|155444249|FG003|ER Treatment|Adverse Event|0|||
48341235|NCT00784277|155444250|FG004|ER Treatment|Adverse Event|1|||
48341236|NCT00784277|155444251|FG005|ER Treatment|Adverse Event|7|||
48341237|NCT00784277|155444252|FG006|ER Treatment|Adverse Event|7|||
48341238|NCT00784277|155444246|FG000|ER Treatment|Lack of Efficacy|0|||
48341239|NCT00784277|155444247|FG001|ER Treatment|Lack of Efficacy|0|||
48341240|NCT00784277|155444248|FG002|ER Treatment|Lack of Efficacy|0|||
48341241|NCT00784277|155444249|FG003|ER Treatment|Lack of Efficacy|0|||
48341242|NCT00784277|155444250|FG004|ER Treatment|Lack of Efficacy|3|||
48341243|NCT00784277|155444251|FG005|ER Treatment|Lack of Efficacy|4|||
48341244|NCT00784277|155444252|FG006|ER Treatment|Lack of Efficacy|0|||
48341245|NCT00784277|155444246|FG000|ER Treatment|Lost to Follow-up|0|||
48341246|NCT00784277|155444247|FG001|ER Treatment|Lost to Follow-up|0|||
48666122|NCT03187834|156632349|FG001|Overall Study|Lost to Follow-up|1|||
48341247|NCT00784277|155444248|FG002|ER Treatment|Lost to Follow-up|0|||
48666123|NCT03187834|156632350|FG002|Overall Study|Lost to Follow-up|2|||
48341248|NCT00784277|155444249|FG003|ER Treatment|Lost to Follow-up|0|||
48666124|NCT03187834|156632351|FG003|Overall Study|Lost to Follow-up|2|||
48666125|NCT03187834|156632348|FG000|Overall Study|Had invalid anthropometric measurements|5|||
48666126|NCT03187834|156632349|FG001|Overall Study|Had invalid anthropometric measurements|3|||
48666127|NCT03187834|156632350|FG002|Overall Study|Had invalid anthropometric measurements|4|||
48666128|NCT03187834|156632351|FG003|Overall Study|Had invalid anthropometric measurements|2|||
48666129|NCT00316693|156632352|FG000|Overall Study|Adverse Event|6|||
48666130|NCT00316693|156632353|FG001|Overall Study|Adverse Event|1|||
48666131|NCT00316693|156632352|FG000|Overall Study|Protocol Violation|1|||
48666132|NCT00316693|156632353|FG001|Overall Study|Protocol Violation|0|||
48666133|NCT00316693|156632352|FG000|Overall Study|Withdrawal by Subject|6|||
48666134|NCT00316693|156632353|FG001|Overall Study|Withdrawal by Subject|6|||
48666135|NCT00316693|156632352|FG000|Overall Study|Lost to Follow-up|26|||
48666136|NCT00316693|156632353|FG001|Overall Study|Lost to Follow-up|34|||
48666137|NCT00316693|156632352|FG000|Overall Study|Other|38|||
48666138|NCT00316693|156632353|FG001|Overall Study|Other|44|||
48666139|NCT00240110|156632354|FG000|Overall Study|Lost to Follow-up|6|||
48666140|NCT00240110|156632355|FG001|Overall Study|Lost to Follow-up|7|||
48666141|NCT02982018|156632356|FG000|Overall Study|Incorrect Lens Dispensed|1|||
48666142|NCT02982018|156632357|FG001|Overall Study|Incorrect Lens Dispensed|0|||
48666143|NCT02982018|156632356|FG000|Overall Study|Protocol Violation|1|||
48666144|NCT02982018|156632357|FG001|Overall Study|Protocol Violation|1|||
48666145|NCT02982018|156632356|FG000|Overall Study|Adverse Event|1|||
48666146|NCT02982018|156632357|FG001|Overall Study|Adverse Event|1|||
48666147|NCT02982018|156632356|FG000|Overall Study|Lens Discomfort|2|||
48666148|NCT02982018|156632357|FG001|Overall Study|Lens Discomfort|0|||
48666149|NCT02982018|156632356|FG000|Overall Study|Withdrawal by Subject|0|||
48666150|NCT02982018|156632357|FG001|Overall Study|Withdrawal by Subject|1|||
48666151|NCT00583791|156632358|FG000|Overall Study|Other|67|||
48666152|NCT00583791|156632358|FG000|Overall Study|Death|6|||
48666153|NCT03899064|156632359|FG000|Overall Study|Lost to Follow-up|1|||
48666154|NCT03899064|156632359|FG000|Overall Study|Protocol Violation|2|||
48666155|NCT03899064|156632359|FG000|Overall Study|Withdrawal by Subject|2|||
48666156|NCT03899064|156632359|FG000|Overall Study|Other|2|||
48341249|NCT00784277|155444250|FG004|ER Treatment|Lost to Follow-up|0|||
48341250|NCT00784277|155444251|FG005|ER Treatment|Lost to Follow-up|2|||
48341251|NCT00784277|155444252|FG006|ER Treatment|Lost to Follow-up|0|||
48341252|NCT00784277|155444246|FG000|ER Treatment|Withdrawal by Subject|0|||
48341253|NCT00784277|155444247|FG001|ER Treatment|Withdrawal by Subject|0|||
48341254|NCT00784277|155444248|FG002|ER Treatment|Withdrawal by Subject|0|||
48341255|NCT00784277|155444249|FG003|ER Treatment|Withdrawal by Subject|0|||
48341256|NCT00784277|155444250|FG004|ER Treatment|Withdrawal by Subject|2|||
48341257|NCT00784277|155444251|FG005|ER Treatment|Withdrawal by Subject|5|||
48341258|NCT00784277|155444252|FG006|ER Treatment|Withdrawal by Subject|3|||
48341259|NCT00784277|155444246|FG000|ER Treatment|Study Medication Non-Compliant|0|||
48341260|NCT00784277|155444247|FG001|ER Treatment|Study Medication Non-Compliant|0|||
48341261|NCT00784277|155444248|FG002|ER Treatment|Study Medication Non-Compliant|0|||
48341262|NCT00784277|155444249|FG003|ER Treatment|Study Medication Non-Compliant|0|||
48341263|NCT00784277|155444250|FG004|ER Treatment|Study Medication Non-Compliant|2|||
48341264|NCT00784277|155444251|FG005|ER Treatment|Study Medication Non-Compliant|3|||
48341265|NCT00784277|155444252|FG006|ER Treatment|Study Medication Non-Compliant|3|||
48341266|NCT00784277|155444246|FG000|ER Treatment|Other|0|||
48341267|NCT00784277|155444247|FG001|ER Treatment|Other|0|||
48341268|NCT00784277|155444248|FG002|ER Treatment|Other|0|||
48341269|NCT00784277|155444249|FG003|ER Treatment|Other|0|||
48341270|NCT00784277|155444250|FG004|ER Treatment|Other|1|||
48341271|NCT00784277|155444251|FG005|ER Treatment|Other|3|||
48341272|NCT00784277|155444252|FG006|ER Treatment|Other|2|||
48341273|NCT00203502|155444255|FG000|Overall Study|Death|1|||
48341274|NCT01951105|155444256|FG000|Overall Study|Adverse Event|0|||
48341275|NCT01951105|155444257|FG001|Overall Study|Adverse Event|5|||
48341276|NCT01951105|155444258|FG002|Overall Study|Adverse Event|0|||
48341277|NCT01951105|155444256|FG000|Overall Study|Lost to Follow-up|0|||
48341278|NCT01951105|155444257|FG001|Overall Study|Lost to Follow-up|1|||
48341279|NCT01951105|155444258|FG002|Overall Study|Lost to Follow-up|0|||
48341280|NCT01951105|155444256|FG000|Overall Study|Protocol Violation|1|||
48341281|NCT01951105|155444257|FG001|Overall Study|Protocol Violation|1|||
48341282|NCT01951105|155444258|FG002|Overall Study|Protocol Violation|1|||
48341283|NCT01951105|155444256|FG000|Overall Study|Withdrawal by Subject|0|||
48341284|NCT01951105|155444257|FG001|Overall Study|Withdrawal by Subject|3|||
48341285|NCT01951105|155444258|FG002|Overall Study|Withdrawal by Subject|1|||
48341286|NCT01075100|155444267|FG000|Overall Study|Adverse Event|15|||
48341287|NCT01075100|155444268|FG001|Overall Study|Adverse Event|18|||
48341288|NCT01075100|155444267|FG000|Overall Study|Patient Request|4|||
48341289|NCT01075100|155444268|FG001|Overall Study|Patient Request|4|||
48341290|NCT01075100|155444267|FG000|Overall Study|Investigator Request|2|||
48341291|NCT01075100|155444268|FG001|Overall Study|Investigator Request|1|||
48341292|NCT01075100|155444267|FG000|Overall Study|Disease Progression|25|||
48341293|NCT01075100|155444268|FG001|Overall Study|Disease Progression|29|||
48341294|NCT01075100|155444267|FG000|Overall Study|Other|3|||
48341295|NCT01075100|155444268|FG001|Overall Study|Other|1|||
48341296|NCT03303521|155444269|FG000|Overall Study|Withdrawal by Subject|2|||
48341297|NCT03303521|155444270|FG001|Overall Study|Withdrawal by Subject|0|||
48341298|NCT03303521|155444269|FG000|Overall Study|Death|1|||
48666157|NCT01606787|156632362|FG000|Overall Study|Withdrawal by Subject|4|||
48666158|NCT01606787|156632363|FG001|Overall Study|Withdrawal by Subject|5|||
48666159|NCT01606787|156632362|FG000|Overall Study|Surgery canceled|0|||
48666160|NCT01606787|156632363|FG001|Overall Study|Surgery canceled|2|||
48666161|NCT02080260|156632364|FG000|Overall Study|Death|18|||
48666162|NCT02080260|156632364|FG000|Overall Study|Withdrawal by Subject|1|||
48341299|NCT03303521|155444270|FG001|Overall Study|Death|0|||
48341300|NCT03303521|155444269|FG000|Overall Study|Kidney transplantation|0|||
48341301|NCT03303521|155444270|FG001|Overall Study|Kidney transplantation|1|||
48341302|NCT03303521|155444269|FG000|Overall Study|Investigational product discontinuation|0|||
48341303|NCT03303521|155444270|FG001|Overall Study|Investigational product discontinuation|1|||
48341304|NCT03303521|155444269|FG000|Overall Study|Transferred to non-study dialysis center|1|||
48341305|NCT03303521|155444270|FG001|Overall Study|Transferred to non-study dialysis center|0|||
48341306|NCT03303521|155444269|FG000|Overall Study|Non-comliance to study protocol|0|||
48341307|NCT03303521|155444270|FG001|Overall Study|Non-comliance to study protocol|1|||
48341308|NCT03303521|155444269|FG000|Overall Study|Adverse Event|1|||
48341309|NCT03303521|155444270|FG001|Overall Study|Adverse Event|0|||
48341310|NCT00191984|155444271|FG000|Overall Study|Disease Progression|21|||
48341311|NCT00191984|155444271|FG000|Overall Study|Adverse Event|4|||
48341312|NCT00191984|155444271|FG000|Overall Study|Death|2|||
48341313|NCT00191984|155444271|FG000|Overall Study|Entry Criteria Exclusion|1|||
48341314|NCT00191984|155444271|FG000|Overall Study|Withdrawal by Subject|7|||
48341315|NCT00191984|155444271|FG000|Overall Study|Physician Decision|4|||
48341316|NCT02642159|155444272|FG000|Overall Study|Randomized but not treated|1|||
48341317|NCT02642159|155444273|FG001|Overall Study|Randomized but not treated|0|||
48341318|NCT02642159|155444272|FG000|Overall Study|Adverse Event|10|||
48666163|NCT02650128|156632367|FG000|Overall Study|Death|2|||
48666164|NCT01231321|156632372|FG000|Overall Study|Adverse Event|3|||
48666165|NCT01231321|156632372|FG000|Overall Study|Lack of Efficacy|2|||
48666166|NCT00908115|156632373|FG000|Overall Study|Other|14|||
48666167|NCT02654236|156632374|FG000|Overall Study|Withdrawal by Subject|0|||
48666168|NCT02654236|156632375|FG001|Overall Study|Withdrawal by Subject|0|||
48666169|NCT02654236|156632376|FG002|Overall Study|Withdrawal by Subject|2|||
48666170|NCT00798317|156632377|FG000|Overall Study|Physician Decision|0|||
48666171|NCT00798317|156632378|FG001|Overall Study|Physician Decision|1|||
48666172|NCT00798317|156632377|FG000|Overall Study|Withdrawal by Subject|5|||
48666173|NCT00798317|156632378|FG001|Overall Study|Withdrawal by Subject|4|||
48666174|NCT00798317|156632377|FG000|Overall Study|Lost to Follow-up|2|||
48666175|NCT00798317|156632378|FG001|Overall Study|Lost to Follow-up|2|||
48666176|NCT00798317|156632377|FG000|Overall Study|Adverse Event|2|||
48666177|NCT00798317|156632378|FG001|Overall Study|Adverse Event|0|||
48666178|NCT00798317|156632377|FG000|Overall Study|Death|1|||
48666179|NCT00798317|156632378|FG001|Overall Study|Death|0|||
48666180|NCT00416715|156632381|FG000|Overall Study|Not evaluable for joint aches|7|||
48666181|NCT00416715|156632381|FG000|Overall Study|Vitamin D levels not evaluable|8|||
48666182|NCT01930890|156632382|FG000|Overall Study|Study Termination|14|||
48666183|NCT01930890|156632383|FG001|Overall Study|Study Termination|28|||
48666184|NCT01930890|156632384|FG002|Overall Study|Study Termination|13|||
48666185|NCT01930890|156632385|FG003|Overall Study|Study Termination|25|||
48666186|NCT01930890|156632382|FG000|Overall Study|Death|0|||
48666187|NCT01930890|156632383|FG001|Overall Study|Death|0|||
48666188|NCT01930890|156632384|FG002|Overall Study|Death|0|||
48341319|NCT02642159|155444273|FG001|Overall Study|Adverse Event|4|||
48341320|NCT02642159|155444272|FG000|Overall Study|Withdrawal by Subject|9|||
48341321|NCT02642159|155444273|FG001|Overall Study|Withdrawal by Subject|1|||
48341322|NCT02642159|155444272|FG000|Overall Study|Poor compliance to study protocol|1|||
48341323|NCT02642159|155444273|FG001|Overall Study|Poor compliance to study protocol|0|||
48341324|NCT02642159|155444272|FG000|Overall Study|Other than specified above|10|||
48341325|NCT02642159|155444273|FG001|Overall Study|Other than specified above|3|||
48341326|NCT02567227|155444274|FG000|9 Weeks|Adverse Event|5|||
48341327|NCT02567227|155444275|FG001|9 Weeks|Adverse Event|5|||
48341328|NCT02567227|155444274|FG000|9 Weeks|Withdrawal by Subject|18|||
48341329|NCT02567227|155444275|FG001|9 Weeks|Withdrawal by Subject|8|||
48341330|NCT02567227|155444274|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
48341331|NCT02567227|155444275|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
48341332|NCT02567227|155444274|FG000|6 Month|Death|2|||
48341333|NCT02567227|155444275|FG001|6 Month|Death|0|||
48341334|NCT02567227|155444274|FG000|6 Month|Lost to Follow-up|43|||
48341335|NCT02567227|155444275|FG001|6 Month|Lost to Follow-up|40|||
48341336|NCT02567227|155444274|FG000|12 Months|Lost to Follow-up|31|||
48341337|NCT02567227|155444275|FG001|12 Months|Lost to Follow-up|32|||
48341338|NCT02567227|155444274|FG000|12 Months|Death|0|||
48341339|NCT02567227|155444275|FG001|12 Months|Death|2|||
48341340|NCT02131155|155444276|FG000|Overall Study|Adverse Event|1|||
48341341|NCT02131155|155444277|FG001|Overall Study|Adverse Event|0|||
48341342|NCT02131155|155444276|FG000|Overall Study|Treatment completed|1|||
48341343|NCT02131155|155444277|FG001|Overall Study|Treatment completed|0|||
48341344|NCT02131155|155444276|FG000|Overall Study|Primary tumour recurrence|2|||
48666189|NCT01930890|156632385|FG003|Overall Study|Death|1|||
48666190|NCT01930890|156632382|FG000|Overall Study|Investigator Decision|0|||
48341345|NCT02131155|155444277|FG001|Overall Study|Primary tumour recurrence|1|||
48341346|NCT02131155|155444276|FG000|Overall Study|Refused to continue study medication|1|||
48341347|NCT02131155|155444277|FG001|Overall Study|Refused to continue study medication|0|||
48341348|NCT02131155|155444276|FG000|Overall Study|Study early termination|20|||
48341349|NCT02131155|155444277|FG001|Overall Study|Study early termination|10|||
48341350|NCT01887418|155444278|FG000|Overall Study|Travelling difficulties|0|||
48341351|NCT01887418|155444279|FG001|Overall Study|Travelling difficulties|0|||
48666191|NCT01930890|156632383|FG001|Overall Study|Investigator Decision|1|||
48666192|NCT01930890|156632384|FG002|Overall Study|Investigator Decision|0|||
48666193|NCT01930890|156632385|FG003|Overall Study|Investigator Decision|0|||
48666194|NCT01930890|156632382|FG000|Overall Study|Consent Withdrawn|0|||
48666195|NCT01930890|156632383|FG001|Overall Study|Consent Withdrawn|3|||
48666196|NCT01930890|156632384|FG002|Overall Study|Consent Withdrawn|0|||
48666197|NCT01930890|156632385|FG003|Overall Study|Consent Withdrawn|1|||
48666198|NCT01930890|156632382|FG000|Overall Study|Adverse Event|0|||
48666199|NCT01930890|156632383|FG001|Overall Study|Adverse Event|1|||
48666200|NCT01930890|156632384|FG002|Overall Study|Adverse Event|0|||
48666201|NCT01930890|156632385|FG003|Overall Study|Adverse Event|0|||
48666202|NCT04035564|156632386|FG000|Overall Study|Protocol Violation|1|||
48666203|NCT04035564|156632387|FG001|Overall Study|Protocol Violation|2|||
48666204|NCT04035564|156632386|FG000|Overall Study|No laboratory available|2|||
48666205|NCT04035564|156632387|FG001|Overall Study|No laboratory available|2|||
48666206|NCT04035564|156632386|FG000|Overall Study|Guardian declined consent|1|||
48666207|NCT04035564|156632387|FG001|Overall Study|Guardian declined consent|2|||
48666208|NCT03421743|156632400|FG000|Overall Study|Lack of Efficacy|1|||
48666209|NCT03421743|156632401|FG001|Overall Study|Lack of Efficacy|0|||
48666210|NCT03421743|156632400|FG000|Overall Study|Adverse Event|2|||
48757923|NCT01641692|156960879|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
48757924|NCT01641692|156960880|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757925|NCT01641692|156960881|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48341352|NCT01887418|155444280|FG002|Overall Study|Travelling difficulties|1|||
48341353|NCT00084747|155444281|FG000|Overall Study|Relapsed|8|||
48341354|NCT00084747|155444281|FG000|Overall Study|Death|3|||
48341355|NCT00084747|155444281|FG000|Overall Study|Withdrawal by Subject|2|||
48341356|NCT02382406|155444282|FG000|Study Treatment|Disease Progression|8|||
48341357|NCT02382406|155444283|FG001|Study Treatment|Disease Progression|0|||
48666211|NCT03421743|156632401|FG001|Overall Study|Adverse Event|1|||
48666212|NCT03421743|156632400|FG000|Overall Study|Withdrawal by Subject|0|||
48666213|NCT03421743|156632401|FG001|Overall Study|Withdrawal by Subject|1|||
48666214|NCT00431951|156632402|FG000|Overall Study|Inability to follow study procedures|1|||
48666215|NCT00431951|156632403|FG001|Overall Study|Inability to follow study procedures|0|||
48666216|NCT00431951|156632404|FG002|Overall Study|Inability to follow study procedures|1|||
48666217|NCT00431951|156632405|FG003|Overall Study|Inability to follow study procedures|2|||
48666218|NCT00431951|156632402|FG000|Overall Study|Lost to Follow-up|0|||
48666219|NCT00431951|156632403|FG001|Overall Study|Lost to Follow-up|1|||
48666220|NCT00431951|156632404|FG002|Overall Study|Lost to Follow-up|0|||
48666221|NCT00431951|156632405|FG003|Overall Study|Lost to Follow-up|0|||
48666222|NCT00431951|156632402|FG000|Overall Study|Withdrawal by Subject|0|||
48666223|NCT00431951|156632403|FG001|Overall Study|Withdrawal by Subject|1|||
48666224|NCT00431951|156632404|FG002|Overall Study|Withdrawal by Subject|0|||
48666225|NCT00431951|156632405|FG003|Overall Study|Withdrawal by Subject|0|||
48666226|NCT00431951|156632402|FG000|Overall Study|Adverse Event|0|||
48666227|NCT00431951|156632403|FG001|Overall Study|Adverse Event|0|||
48666228|NCT00431951|156632404|FG002|Overall Study|Adverse Event|1|||
48666229|NCT00431951|156632405|FG003|Overall Study|Adverse Event|0|||
48341358|NCT02382406|155444284|FG002|Study Treatment|Disease Progression|20|||
48666230|NCT00700102|156632409|FG000|Overall Study|Died|394|||
48666231|NCT00700102|156632410|FG001|Overall Study|Died|385|||
48666232|NCT00700102|156632409|FG000|Overall Study|Lost to Follow-up|8|||
48666233|NCT00700102|156632410|FG001|Overall Study|Lost to Follow-up|10|||
48666234|NCT01299571|156632411|FG000|Overall Study|Protocol Violation|107|||
48666235|NCT02525939|156632412|FG000|Overall Study|Lost to Follow-up|27|||
48666236|NCT02525939|156632413|FG001|Overall Study|Lost to Follow-up|24|||
48666237|NCT02525939|156632412|FG000|Overall Study|Physician Decision|0|||
48666238|NCT02525939|156632413|FG001|Overall Study|Physician Decision|1|||
48666239|NCT02525939|156632412|FG000|Overall Study|Withdrawal by Subject|24|||
48666240|NCT02525939|156632413|FG001|Overall Study|Withdrawal by Subject|39|||
48666241|NCT02525939|156632412|FG000|Overall Study|Death|180|||
48666242|NCT02525939|156632413|FG001|Overall Study|Death|179|||
48666243|NCT05590000|156632414|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
48666244|NCT00762996|156632415|FG000|Period One|Protocol Violation|0|||
48666245|NCT00762996|156632416|FG001|Period One|Protocol Violation|0|||
48666246|NCT00762996|156632417|FG002|Period One|Protocol Violation|1|||
48666247|NCT00762996|156632418|FG003|Period One|Protocol Violation|0|||
48666248|NCT00762996|156632415|FG000|Period One|ineligible|0|||
48666249|NCT00762996|156632416|FG001|Period One|ineligible|0|||
48666250|NCT00762996|156632417|FG002|Period One|ineligible|1|||
48666251|NCT00762996|156632418|FG003|Period One|ineligible|1|||
48666252|NCT00762996|156632415|FG000|Period One|Adverse Event|0|||
48666253|NCT00762996|156632416|FG001|Period One|Adverse Event|0|||
48666254|NCT00762996|156632417|FG002|Period One|Adverse Event|1|||
48666255|NCT00762996|156632418|FG003|Period One|Adverse Event|0|||
48666256|NCT00762996|156632415|FG000|Period One|Withdrawal by Subject|0|||
48666257|NCT00762996|156632416|FG001|Period One|Withdrawal by Subject|0|||
48666258|NCT00762996|156632417|FG002|Period One|Withdrawal by Subject|1|||
48666259|NCT00762996|156632418|FG003|Period One|Withdrawal by Subject|0|||
48666260|NCT04063787|156632419|FG000|Overall Study|Inadequate Doppler data|4|||
48666261|NCT04063787|156632419|FG000|Overall Study|Lost to Follow-up|2|||
48666262|NCT04063787|156632419|FG000|Overall Study|Death|3|||
48757926|NCT01641692|156960882|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48341359|NCT02382406|155444282|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
48341360|NCT02382406|155444283|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
48341361|NCT02382406|155444284|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
48341362|NCT02382406|155444282|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
48341363|NCT02382406|155444283|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
48666263|NCT00849875|156632421|FG000|Overall Study|Death|28|||
48666264|NCT00849875|156632421|FG000|Overall Study|Ongoing (unknown completion status)|11|||
48666265|NCT00849875|156632421|FG000|Overall Study|Others|6|||
48666266|NCT00849875|156632421|FG000|Overall Study|Lost to Follow-up|2|||
48666267|NCT00086502|156632422|FG000|Overall Study|Adverse Event|11|||
48666268|NCT00086502|156632423|FG001|Overall Study|Adverse Event|2|||
48666269|NCT00086502|156632422|FG000|Overall Study|Lack of Efficacy|0|||
48666270|NCT00086502|156632423|FG001|Overall Study|Lack of Efficacy|2|||
48666271|NCT00086502|156632422|FG000|Overall Study|Lost to Follow-up|3|||
48666272|NCT00086502|156632423|FG001|Overall Study|Lost to Follow-up|1|||
48666273|NCT00086502|156632422|FG000|Overall Study|Physician Decision|1|||
48666274|NCT00086502|156632423|FG001|Overall Study|Physician Decision|1|||
48757927|NCT01641692|156960883|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757928|NCT01641692|156960884|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757929|NCT01641692|156960885|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757930|NCT01641692|156960886|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
48757931|NCT01641692|156960879|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757932|NCT01641692|156960880|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757933|NCT01641692|156960881|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757934|NCT01641692|156960882|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757935|NCT01641692|156960883|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757936|NCT01641692|156960884|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757937|NCT01641692|156960885|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
48757938|NCT01641692|156960886|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48757939|NCT01641692|156960879|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
48757940|NCT01641692|156960880|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757941|NCT01641692|156960881|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
48757942|NCT01641692|156960882|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
48757943|NCT01641692|156960883|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
48757944|NCT01641692|156960884|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48666275|NCT00086502|156632422|FG000|Overall Study|Pregnancy|0|||
48666276|NCT00086502|156632423|FG001|Overall Study|Pregnancy|1|||
48666277|NCT00086502|156632422|FG000|Overall Study|Protocol Violation|3|||
48666278|NCT00086502|156632423|FG001|Overall Study|Protocol Violation|3|||
48666279|NCT00086502|156632422|FG000|Overall Study|Withdrawal by Subject|5|||
48666280|NCT00086502|156632423|FG001|Overall Study|Withdrawal by Subject|6|||
48666281|NCT00086502|156632422|FG000|Overall Study|Patient Moved|1|||
48666282|NCT00086502|156632423|FG001|Overall Study|Patient Moved|1|||
48666283|NCT00086502|156632422|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
48666284|NCT00086502|156632423|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
48666285|NCT00086502|156632422|FG000|Overall Study|Patient Accidentally Unblinded|1|||
48666286|NCT00086502|156632423|FG001|Overall Study|Patient Accidentally Unblinded|0|||
48666287|NCT01842581|156632425|FG000|Overall Study|Adverse Event|6|||
48666288|NCT01842581|156632426|FG001|Overall Study|Adverse Event|4|||
48666289|NCT01842581|156632425|FG000|Overall Study|HE breakthrough|26|||
48666290|NCT01842581|156632426|FG001|Overall Study|HE breakthrough|13|||
48666291|NCT01842581|156632425|FG000|Overall Study|Liver transplant|2|||
48666292|NCT01842581|156632426|FG001|Overall Study|Liver transplant|0|||
48666293|NCT01842581|156632425|FG000|Overall Study|Lost to Follow-up|2|||
48666294|NCT01842581|156632426|FG001|Overall Study|Lost to Follow-up|5|||
48757945|NCT01641692|156960885|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757946|NCT01641692|156960886|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
48757947|NCT01641692|156960879|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48757948|NCT01641692|156960880|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48757949|NCT01641692|156960881|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48341364|NCT02382406|155444284|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
48341365|NCT02382406|155444282|FG000|Study Treatment|symptomatic deterioration|1|||
48341366|NCT02382406|155444283|FG001|Study Treatment|symptomatic deterioration|0|||
48341367|NCT02382406|155444284|FG002|Study Treatment|symptomatic deterioration|1|||
48341368|NCT02382406|155444282|FG000|Study Treatment|Death|0|||
48341369|NCT02382406|155444283|FG001|Study Treatment|Death|0|||
48341370|NCT02382406|155444284|FG002|Study Treatment|Death|2|||
48341371|NCT02382406|155444282|FG000|Follow up|Death|11|||
48341372|NCT02382406|155444283|FG001|Follow up|Death|0|||
48341373|NCT02382406|155444284|FG002|Follow up|Death|19|||
48341374|NCT02382406|155444282|FG000|Follow up|Symptomatic deterioration|1|||
48341375|NCT02382406|155444283|FG001|Follow up|Symptomatic deterioration|0|||
48341376|NCT02382406|155444284|FG002|Follow up|Symptomatic deterioration|1|||
48341377|NCT02382406|155444282|FG000|Follow up|Patient Refused Follow-up|1|||
48341378|NCT02382406|155444283|FG001|Follow up|Patient Refused Follow-up|0|||
48341379|NCT02382406|155444284|FG002|Follow up|Patient Refused Follow-up|0|||
48341380|NCT02382406|155444282|FG000|Follow up|Study Terminated|1|||
48341381|NCT02382406|155444283|FG001|Follow up|Study Terminated|0|||
48341382|NCT02382406|155444284|FG002|Follow up|Study Terminated|8|||
48341383|NCT02382406|155444282|FG000|Follow up|Withdrawal by Subject|0|||
48341384|NCT02382406|155444283|FG001|Follow up|Withdrawal by Subject|0|||
48341385|NCT02382406|155444284|FG002|Follow up|Withdrawal by Subject|2|||
48341386|NCT02350127|155444285|FG000|4-Month Assessment|Withdrawal by Subject|10|||
48341387|NCT02350127|155444286|FG001|4-Month Assessment|Withdrawal by Subject|9|||
48666295|NCT01842581|156632425|FG000|Overall Study|Withdrawal by Subject|5|||
48666296|NCT01842581|156632426|FG001|Overall Study|Withdrawal by Subject|7|||
48666297|NCT01842581|156632425|FG000|Overall Study|Other than specified|3|||
48666298|NCT01842581|156632426|FG001|Overall Study|Other than specified|1|||
48666299|NCT01995552|156632427|FG000|Overall Study|Protocol Violation|1|||
48666300|NCT01995552|156632427|FG000|Overall Study|Lack of Efficacy|15|||
48666301|NCT01995552|156632427|FG000|Overall Study|Death|1|||
48666302|NCT02068118|156632430|FG000|18-month Comparative Study Period|Death|90|||
48666303|NCT02068118|156632431|FG001|18-month Comparative Study Period|Death|97|||
48666304|NCT02068118|156632430|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
48666305|NCT02068118|156632431|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
48666306|NCT02068118|156632430|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
48666307|NCT02068118|156632431|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
48666308|NCT02068118|156632430|FG000|18-month Comparative Study Period|Heart transplant|9|||
48666309|NCT02068118|156632431|FG001|18-month Comparative Study Period|Heart transplant|15|||
48666310|NCT02068118|156632430|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
48666311|NCT02068118|156632431|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
48666312|NCT02068118|156632430|FG000|18-month Comparative Study Period|Hemiplegia|0|||
48666313|NCT02068118|156632431|FG001|18-month Comparative Study Period|Hemiplegia|1|||
48666314|NCT02068118|156632430|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
48666315|NCT02068118|156632431|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
48666316|NCT02068118|156632430|FG000|18-month Comparative Study Period|Move|0|||
48666317|NCT02068118|156632431|FG001|18-month Comparative Study Period|Move|1|||
48666318|NCT02068118|156632430|FG000|18-month Comparative Study Period|Hearing loss|0|||
48666319|NCT02068118|156632431|FG001|18-month Comparative Study Period|Hearing loss|1|||
48666320|NCT02068118|156632430|FG000|Extension Period|Death|0|||
48666321|NCT02068118|156632431|FG001|Extension Period|Death|2|||
48666322|NCT02068118|156632430|FG000|Extension Period|Withdrawal by Subject|1|||
48666323|NCT02068118|156632431|FG001|Extension Period|Withdrawal by Subject|0|||
48666324|NCT02068118|156632430|FG000|Extension Period|Heart transplant|1|||
48666325|NCT02068118|156632431|FG001|Extension Period|Heart transplant|0|||
48666326|NCT02068118|156632430|FG000|Extension Period|Wrong device use|0|||
48666327|NCT02068118|156632431|FG001|Extension Period|Wrong device use|1|||
48666328|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
48666329|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
48666330|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
48666331|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
48666332|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
48666333|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
48666334|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
48666335|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
48666336|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
48666337|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
48666338|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
48666339|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
48341388|NCT02350127|155444285|FG000|4-Month Assessment|Death|1|||
48666340|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
48341389|NCT02350127|155444286|FG001|4-Month Assessment|Death|0|||
48341390|NCT02350127|155444285|FG000|8-Month Assessment|Death|1|||
48341391|NCT02350127|155444286|FG001|8-Month Assessment|Death|1|||
48666341|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
48666342|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
48666343|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
48666344|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
48666345|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
48666346|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
48666347|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
48666348|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
48666349|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
48666350|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
48666351|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
48666352|NCT00624780|156632432|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
48666353|NCT00624780|156632433|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
48666354|NCT00624780|156632434|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
48666355|NCT00624780|156632435|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
48666356|NCT00624780|156632436|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
48666357|NCT00624780|156632437|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
48666358|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
48666359|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
48666360|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
48666361|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
48666362|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
48666363|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
48666364|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
48666365|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
48666366|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
48666367|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
48666368|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
48666369|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
48666370|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
48666371|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
48666372|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
48666373|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
48666374|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
48666375|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
48666376|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
48666377|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
48666378|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
48666379|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
48666380|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
48666381|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
48666382|NCT00624780|156632432|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
48666383|NCT00624780|156632433|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
48666384|NCT00624780|156632434|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
48666385|NCT00624780|156632435|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
48666386|NCT00624780|156632436|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
48666387|NCT00624780|156632437|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
48666388|NCT00624780|156632432|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
48666389|NCT00624780|156632433|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
48666390|NCT00624780|156632434|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
48666391|NCT00624780|156632435|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
48666392|NCT00624780|156632436|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
48666393|NCT00624780|156632437|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
48666394|NCT00624780|156632432|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
48666395|NCT00624780|156632433|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666396|NCT00624780|156632434|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666397|NCT00624780|156632435|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666398|NCT00624780|156632436|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666399|NCT00624780|156632437|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
48666400|NCT00624780|156632432|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666401|NCT00624780|156632433|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666402|NCT00624780|156632434|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
48666403|NCT00624780|156632435|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666404|NCT00624780|156632436|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666405|NCT00624780|156632437|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
48666406|NCT00624780|156632432|FG000|Follow-up (Week 26)|Death|0|||
48666407|NCT00624780|156632433|FG001|Follow-up (Week 26)|Death|0|||
48341392|NCT02350127|155444285|FG000|8-Month Assessment|Withdrawal by Subject|5|||
48341393|NCT02350127|155444286|FG001|8-Month Assessment|Withdrawal by Subject|8|||
48341394|NCT00460577|155444287|FG000|Overall Study|Protocol Violation|2|||
48341395|NCT00460577|155444288|FG001|Overall Study|Protocol Violation|6|||
48341396|NCT00776984|155444289|FG000|Overall Study|Adverse Event|8|||
48341397|NCT00776984|155444290|FG001|Overall Study|Adverse Event|2|||
48341398|NCT00776984|155444289|FG000|Overall Study|Protocol Violation|4|||
48341399|NCT00776984|155444290|FG001|Overall Study|Protocol Violation|2|||
48341400|NCT00776984|155444289|FG000|Overall Study|Lost to Follow-up|2|||
48666408|NCT00624780|156632434|FG002|Follow-up (Week 26)|Death|1|||
48666409|NCT00624780|156632435|FG003|Follow-up (Week 26)|Death|0|||
48666410|NCT00624780|156632436|FG004|Follow-up (Week 26)|Death|0|||
48666411|NCT00624780|156632437|FG005|Follow-up (Week 26)|Death|0|||
48666412|NCT00624780|156632432|FG000|Follow-up (Week 26)|Adverse Event|0|||
48666413|NCT00624780|156632433|FG001|Follow-up (Week 26)|Adverse Event|0|||
48666414|NCT00624780|156632434|FG002|Follow-up (Week 26)|Adverse Event|0|||
48666415|NCT00624780|156632435|FG003|Follow-up (Week 26)|Adverse Event|0|||
48666416|NCT00624780|156632436|FG004|Follow-up (Week 26)|Adverse Event|1|||
48666417|NCT00624780|156632437|FG005|Follow-up (Week 26)|Adverse Event|0|||
48666418|NCT00624780|156632432|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
48666419|NCT00624780|156632433|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
48666420|NCT00624780|156632434|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
48666421|NCT00624780|156632435|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
48341401|NCT00776984|155444290|FG001|Overall Study|Lost to Follow-up|0|||
48341402|NCT00776984|155444289|FG000|Overall Study|Withdrawal by Subject|12|||
48341403|NCT00776984|155444290|FG001|Overall Study|Withdrawal by Subject|7|||
48341404|NCT00776984|155444289|FG000|Overall Study|Lack of Efficacy|0|||
48341405|NCT00776984|155444290|FG001|Overall Study|Lack of Efficacy|1|||
48341406|NCT00776984|155444289|FG000|Overall Study|Other|5|||
48341407|NCT00776984|155444290|FG001|Overall Study|Other|9|||
48341408|NCT00274846|155444298|FG000|Overall Study|Did not receive adequate NK cells|1|||
48341409|NCT02282917|155444299|FG000|Overall Study|Withdrawal by Subject|1|||
48341410|NCT02282917|155444299|FG000|Overall Study|Screen Failure/Not Eligible|1|||
48341411|NCT02809677|155444302|FG000|Overall Study|Withdrawal by Subject|8|||
48341412|NCT02256488|155444303|FG000|Overall Study|Lost to Follow-up|6|||
48341413|NCT02256488|155444304|FG001|Overall Study|Lost to Follow-up|6|||
48341414|NCT02256488|155444305|FG002|Overall Study|Lost to Follow-up|9|||
48666422|NCT00624780|156632436|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
48666423|NCT00624780|156632437|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
48666424|NCT00624780|156632432|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
48666425|NCT00624780|156632433|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666426|NCT00624780|156632434|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666427|NCT00624780|156632435|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666428|NCT00624780|156632436|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666429|NCT00624780|156632437|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
48666430|NCT00624780|156632432|FG000|Follow-up (Week 26)|Other|1|||
48666431|NCT00624780|156632433|FG001|Follow-up (Week 26)|Other|1|||
48666432|NCT00624780|156632434|FG002|Follow-up (Week 26)|Other|0|||
48666433|NCT00624780|156632435|FG003|Follow-up (Week 26)|Other|0|||
48666434|NCT00624780|156632436|FG004|Follow-up (Week 26)|Other|0|||
48666435|NCT00624780|156632437|FG005|Follow-up (Week 26)|Other|0|||
48757950|NCT01641692|156960882|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48341415|NCT02256488|155444306|FG003|Overall Study|Lost to Follow-up|3|||
48666436|NCT03757130|156632442|FG000|Overall Study|Lost to Follow-up|0|||
48666437|NCT03757130|156632443|FG001|Overall Study|Lost to Follow-up|0|||
48341416|NCT02256488|155444303|FG000|Overall Study|OTHER|1|||
48341417|NCT02256488|155444304|FG001|Overall Study|OTHER|0|||
48341418|NCT02256488|155444305|FG002|Overall Study|OTHER|1|||
48666438|NCT03757130|156632444|FG002|Overall Study|Lost to Follow-up|0|||
48666439|NCT03757130|156632445|FG003|Overall Study|Lost to Follow-up|1|||
48757951|NCT01641692|156960883|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48341419|NCT02256488|155444306|FG003|Overall Study|OTHER|1|||
48666440|NCT03757130|156632446|FG004|Overall Study|Lost to Follow-up|0|||
48666441|NCT03757130|156632447|FG005|Overall Study|Lost to Follow-up|0|||
48666442|NCT03757130|156632448|FG006|Overall Study|Lost to Follow-up|0|||
48666443|NCT03757130|156632449|FG007|Overall Study|Lost to Follow-up|1|||
48341420|NCT02256488|155444303|FG000|Overall Study|Withdrawal by Subject|1|||
48341421|NCT02256488|155444304|FG001|Overall Study|Withdrawal by Subject|0|||
48341422|NCT02256488|155444305|FG002|Overall Study|Withdrawal by Subject|0|||
48666444|NCT03757130|156632442|FG000|Overall Study|Withdrawal by Subject|0|||
48666445|NCT03757130|156632443|FG001|Overall Study|Withdrawal by Subject|0|||
48757952|NCT01641692|156960884|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48757953|NCT01641692|156960885|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48757954|NCT01641692|156960886|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48757955|NCT01641692|156960879|FG000|Treatment Period 2|Lack of Efficacy|1|||
48757956|NCT01641692|156960880|FG001|Treatment Period 2|Lack of Efficacy|0|||
48757957|NCT01641692|156960881|FG002|Treatment Period 2|Lack of Efficacy|0|||
48757958|NCT01641692|156960882|FG003|Treatment Period 2|Lack of Efficacy|0|||
48757959|NCT01641692|156960883|FG004|Treatment Period 2|Lack of Efficacy|0|||
48666446|NCT03757130|156632444|FG002|Overall Study|Withdrawal by Subject|0|||
48666447|NCT03757130|156632445|FG003|Overall Study|Withdrawal by Subject|0|||
48666448|NCT03757130|156632446|FG004|Overall Study|Withdrawal by Subject|0|||
48666449|NCT03757130|156632447|FG005|Overall Study|Withdrawal by Subject|0|||
48666450|NCT03757130|156632448|FG006|Overall Study|Withdrawal by Subject|1|||
48666451|NCT03757130|156632449|FG007|Overall Study|Withdrawal by Subject|0|||
48666452|NCT02360293|156632450|FG000|Overall Study|Lost to Follow-up|73|||
48666453|NCT02360293|156632451|FG001|Overall Study|Lost to Follow-up|95|||
48666454|NCT02360293|156632450|FG000|Overall Study|Withdrawal by Subject|2|||
48666455|NCT02360293|156632451|FG001|Overall Study|Withdrawal by Subject|1|||
48666456|NCT02360293|156632450|FG000|Overall Study|Excluded|1|||
48666457|NCT02360293|156632451|FG001|Overall Study|Excluded|0|||
48666458|NCT00475865|156632452|FG000|Overall Study|Adverse Event|0|||
48666459|NCT00475865|156632453|FG001|Overall Study|Adverse Event|3|||
48666460|NCT00475865|156632454|FG002|Overall Study|Adverse Event|4|||
48666461|NCT00475865|156632452|FG000|Overall Study|Lack of Efficacy|1|||
48666462|NCT00475865|156632453|FG001|Overall Study|Lack of Efficacy|0|||
48666463|NCT00475865|156632454|FG002|Overall Study|Lack of Efficacy|0|||
48666464|NCT00475865|156632452|FG000|Overall Study|Progressive disease|0|||
48666465|NCT00475865|156632453|FG001|Overall Study|Progressive disease|1|||
48666466|NCT00475865|156632454|FG002|Overall Study|Progressive disease|2|||
48666467|NCT00475865|156632452|FG000|Overall Study|Participant did not wish to continue|1|||
48666468|NCT00475865|156632453|FG001|Overall Study|Participant did not wish to continue|0|||
48666469|NCT00475865|156632454|FG002|Overall Study|Participant did not wish to continue|0|||
48666470|NCT00475865|156632452|FG000|Overall Study|Other than above|0|||
48666471|NCT00475865|156632453|FG001|Overall Study|Other than above|1|||
48666472|NCT00475865|156632454|FG002|Overall Study|Other than above|0|||
48666473|NCT00612508|156632455|FG000|Overall Study|Withdrawal by Subject|3|||
48666474|NCT00612508|156632456|FG001|Overall Study|Withdrawal by Subject|4|||
48666475|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
48666476|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
48666477|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
48666478|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
48666479|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
48666480|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
48666481|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
48666482|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
48666483|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
48666484|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
48757960|NCT01641692|156960884|FG005|Treatment Period 2|Lack of Efficacy|0|||
48757961|NCT01641692|156960885|FG006|Treatment Period 2|Lack of Efficacy|0|||
48757962|NCT01641692|156960886|FG007|Treatment Period 2|Lack of Efficacy|0|||
48757963|NCT01641692|156960879|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
48757964|NCT01641692|156960880|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757965|NCT01641692|156960881|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757966|NCT01641692|156960882|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48341423|NCT02256488|155444306|FG003|Overall Study|Withdrawal by Subject|2|||
48341424|NCT00734851|155444311|FG000|Overall Study|Withdrawal by Subject|2|||
48666485|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
48666486|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
48666487|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
48666488|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
48341425|NCT00734851|155444311|FG000|Overall Study|Lost to Follow-up|1|||
48666489|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
48666490|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
48666491|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
48666492|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
48666493|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
48666494|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
48666495|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
48666496|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
48666497|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
48666498|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
48666499|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
48666500|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
48666501|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
48666502|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
48666503|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
48666504|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
48666505|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
48341426|NCT00734851|155444311|FG000|Overall Study|Physician Decision|18|||
48666506|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
48666507|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
48666508|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
48666509|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
48666510|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
48666511|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
48666512|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
48666513|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
48666514|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
48666515|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
48666516|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
48666517|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
48666518|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
48666519|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
48666520|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
48666521|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
48666522|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
48666523|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
48666524|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
48341427|NCT01294358|155444316|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
48341428|NCT01294358|155444317|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
48341429|NCT01294358|155444318|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
48341430|NCT01294358|155444319|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
48341431|NCT01294358|155444320|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
48341432|NCT01294358|155444316|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
48341433|NCT01294358|155444317|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
48341434|NCT01294358|155444318|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
48341435|NCT01294358|155444319|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
48341436|NCT01294358|155444320|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
48341437|NCT01294358|155444316|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
48341438|NCT01294358|155444317|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
48341439|NCT01294358|155444318|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
48341440|NCT01294358|155444319|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
48341441|NCT01294358|155444320|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
48341442|NCT01294358|155444316|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
48341443|NCT01294358|155444317|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
48341444|NCT01294358|155444318|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
48341445|NCT01294358|155444319|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
48341446|NCT01294358|155444320|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
48341447|NCT00990821|155444324|FG000|Overall Study|Withdrawal by Subject|0|||
48341448|NCT00990821|155444325|FG001|Overall Study|Withdrawal by Subject|2|||
48341449|NCT00990821|155444326|FG002|Overall Study|Withdrawal by Subject|0|||
48666525|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
48666526|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
48666527|NCT02008357|156632457|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
48757967|NCT01641692|156960883|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757968|NCT01641692|156960884|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757969|NCT01641692|156960885|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757970|NCT01641692|156960886|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
48757971|NCT01641692|156960879|FG000|Treatment Period 2|Lost to Follow-up|0|||
48757972|NCT01641692|156960880|FG001|Treatment Period 2|Lost to Follow-up|0|||
48757973|NCT01641692|156960881|FG002|Treatment Period 2|Lost to Follow-up|0|||
48757974|NCT01641692|156960882|FG003|Treatment Period 2|Lost to Follow-up|0|||
48757975|NCT01641692|156960883|FG004|Treatment Period 2|Lost to Follow-up|0|||
48757976|NCT01641692|156960884|FG005|Treatment Period 2|Lost to Follow-up|1|||
48757977|NCT01641692|156960885|FG006|Treatment Period 2|Lost to Follow-up|0|||
48757978|NCT01641692|156960886|FG007|Treatment Period 2|Lost to Follow-up|0|||
48757979|NCT01641692|156960879|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48757980|NCT01641692|156960880|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48757981|NCT01641692|156960881|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48666528|NCT02008357|156632458|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
48666529|NCT02008357|156632457|FG000|Open-label Extension Period|Adverse Event|8|||
48666530|NCT02008357|156632458|FG001|Open-label Extension Period|Adverse Event|7|||
48666531|NCT02008357|156632457|FG000|Open-label Extension Period|Death|7|||
48666532|NCT02008357|156632458|FG001|Open-label Extension Period|Death|4|||
48666533|NCT02008357|156632457|FG000|Open-label Extension Period|Lack of Efficacy|9|||
48666534|NCT02008357|156632458|FG001|Open-label Extension Period|Lack of Efficacy|5|||
48666535|NCT02008357|156632457|FG000|Open-label Extension Period|Lost to Follow-up|2|||
48757982|NCT01641692|156960882|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48757983|NCT01641692|156960883|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48341450|NCT00990821|155444327|FG003|Overall Study|Withdrawal by Subject|0|||
48666536|NCT02008357|156632458|FG001|Open-label Extension Period|Lost to Follow-up|2|||
48666537|NCT02008357|156632457|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
48666538|NCT02008357|156632458|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
48666539|NCT02008357|156632457|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
48757984|NCT01641692|156960884|FG005|Treatment Period 2|Withdrawal by Subject|1|||
48757985|NCT01641692|156960885|FG006|Treatment Period 2|Withdrawal by Subject|0|||
48757986|NCT01641692|156960886|FG007|Treatment Period 2|Withdrawal by Subject|1|||
48757987|NCT01641692|156960879|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757988|NCT01641692|156960880|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48341451|NCT00990821|155444328|FG004|Overall Study|Withdrawal by Subject|3|||
48341452|NCT00990821|155444329|FG005|Overall Study|Withdrawal by Subject|3|||
48341453|NCT00990821|155444330|FG006|Overall Study|Withdrawal by Subject|1|||
48341454|NCT00990821|155444331|FG007|Overall Study|Withdrawal by Subject|0|||
48341455|NCT00990821|155444332|FG008|Overall Study|Withdrawal by Subject|0|||
48341456|NCT00990821|155444333|FG009|Overall Study|Withdrawal by Subject|1|||
48341457|NCT00990821|155444334|FG010|Overall Study|Withdrawal by Subject|3|||
48341458|NCT00990821|155444335|FG011|Overall Study|Withdrawal by Subject|5|||
48341459|NCT00990821|155444336|FG012|Overall Study|Withdrawal by Subject|2|||
48341460|NCT00990821|155444337|FG013|Overall Study|Withdrawal by Subject|1|||
48341461|NCT02273180|155444338|FG000|Overall Study|Adverse Event|2|||
48341462|NCT02273180|155444339|FG001|Overall Study|Adverse Event|2|||
48341463|NCT02273180|155444338|FG000|Overall Study|Lack of Efficacy|1|||
48341464|NCT02273180|155444339|FG001|Overall Study|Lack of Efficacy|0|||
48341465|NCT02273180|155444338|FG000|Overall Study|Protocol Violation|1|||
48341466|NCT02273180|155444339|FG001|Overall Study|Protocol Violation|7|||
48341467|NCT02273180|155444338|FG000|Overall Study|Randomized but not treated|1|||
48341468|NCT02273180|155444339|FG001|Overall Study|Randomized but not treated|0|||
48341469|NCT02273180|155444338|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
48341470|NCT02273180|155444339|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
48341471|NCT02273180|155444338|FG000|Overall Study|Other than specified above|21|||
48341472|NCT02273180|155444339|FG001|Overall Study|Other than specified above|10|||
48341473|NCT04369664|155445895|FG000|Overall Study|Physician Decision|1|||
48666540|NCT02008357|156632458|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
48666541|NCT02008357|156632457|FG000|Open-label Extension Period|Safety Risk|2|||
48666542|NCT02008357|156632458|FG001|Open-label Extension Period|Safety Risk|1|||
48666543|NCT02008357|156632457|FG000|Open-label Extension Period|Non-Compliance|0|||
48666544|NCT02008357|156632458|FG001|Open-label Extension Period|Non-Compliance|1|||
48666545|NCT02008357|156632457|FG000|Open-label Extension Period|Investigator Recommendation|0|||
48666546|NCT02008357|156632458|FG001|Open-label Extension Period|Investigator Recommendation|1|||
48666547|NCT02008357|156632457|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
48666548|NCT02008357|156632458|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
48666549|NCT02008357|156632457|FG000|Open-label Extension Period|Coordinating Center Request|2|||
48666550|NCT02008357|156632458|FG001|Open-label Extension Period|Coordinating Center Request|4|||
48666551|NCT02008357|156632457|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
48666552|NCT02008357|156632458|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
48666553|NCT02008357|156632457|FG000|Open-label Extension Period|Study Ended|20|||
48666554|NCT02008357|156632458|FG001|Open-label Extension Period|Study Ended|25|||
48666555|NCT02008357|156632457|FG000|Open-label Extension Period|Personal Reasons|0|||
48666556|NCT02008357|156632458|FG001|Open-label Extension Period|Personal Reasons|1|||
48666557|NCT02008357|156632457|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
48666558|NCT02008357|156632458|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
48666559|NCT02008357|156632457|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
48666560|NCT02008357|156632458|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
48666561|NCT02008357|156632457|FG000|Open-label Extension Period|Other|2|||
48666562|NCT02008357|156632458|FG001|Open-label Extension Period|Other|0|||
48666563|NCT02365285|156632459|FG000|Overall Study|Physician Decision|0|||
48666564|NCT02365285|156632460|FG001|Overall Study|Physician Decision|1|||
48666565|NCT02365285|156632461|FG002|Overall Study|Physician Decision|1|||
48666566|NCT02365285|156632462|FG003|Overall Study|Physician Decision|0|||
48666567|NCT02365285|156632459|FG000|Overall Study|Adverse Event|0|||
48666568|NCT02365285|156632460|FG001|Overall Study|Adverse Event|0|||
48666569|NCT02365285|156632461|FG002|Overall Study|Adverse Event|0|||
48666570|NCT02365285|156632462|FG003|Overall Study|Adverse Event|2|||
48666571|NCT00490022|156632464|FG000|Overall Study|Adverse Event|0|||
48757989|NCT01641692|156960881|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757990|NCT01641692|156960882|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757991|NCT01641692|156960883|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
48757992|NCT01641692|156960884|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757993|NCT01641692|156960885|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
48757994|NCT01641692|156960886|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
48757995|NCT01641692|156960879|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48757996|NCT01641692|156960880|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48757997|NCT01641692|156960881|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48757998|NCT01641692|156960882|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48757999|NCT01641692|156960883|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48758000|NCT01641692|156960884|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48758001|NCT01641692|156960885|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48758002|NCT01641692|156960886|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48758003|NCT01641692|156960879|FG000|Treatment Period 3|Adverse Event|0|||
48758004|NCT01641692|156960880|FG001|Treatment Period 3|Adverse Event|0|||
48758005|NCT01641692|156960881|FG002|Treatment Period 3|Adverse Event|0|||
48758006|NCT01641692|156960882|FG003|Treatment Period 3|Adverse Event|0|||
48758007|NCT01641692|156960883|FG004|Treatment Period 3|Adverse Event|0|||
48758008|NCT01641692|156960884|FG005|Treatment Period 3|Adverse Event|0|||
48758009|NCT01641692|156960885|FG006|Treatment Period 3|Adverse Event|1|||
48758010|NCT01641692|156960886|FG007|Treatment Period 3|Adverse Event|0|||
48758011|NCT01641692|156960879|FG000|Treatment Period 3|Protocol Violation|0|||
48758012|NCT01641692|156960880|FG001|Treatment Period 3|Protocol Violation|0|||
48758013|NCT01641692|156960881|FG002|Treatment Period 3|Protocol Violation|1|||
48758014|NCT01641692|156960882|FG003|Treatment Period 3|Protocol Violation|0|||
48758015|NCT01641692|156960883|FG004|Treatment Period 3|Protocol Violation|0|||
48758016|NCT01641692|156960884|FG005|Treatment Period 3|Protocol Violation|0|||
48758017|NCT01641692|156960885|FG006|Treatment Period 3|Protocol Violation|0|||
48758018|NCT01641692|156960886|FG007|Treatment Period 3|Protocol Violation|0|||
48758019|NCT01641692|156960879|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758020|NCT01641692|156960880|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758021|NCT01641692|156960881|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758022|NCT01641692|156960882|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758023|NCT01641692|156960883|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758024|NCT01641692|156960884|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48758025|NCT01641692|156960885|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
48758026|NCT01641692|156960886|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
48341474|NCT04369664|155445896|FG001|Overall Study|Physician Decision|0|||
48341475|NCT05244226|155445902|FG000|Overall Study|Adverse Event|1|||
48341476|NCT05244226|155445903|FG001|Overall Study|Adverse Event|0|||
48341477|NCT05244226|155445904|FG002|Overall Study|Adverse Event|0|||
48341478|NCT05244226|155445902|FG000|Overall Study|Lost to Follow-up|0|||
48341479|NCT05244226|155445903|FG001|Overall Study|Lost to Follow-up|0|||
48341480|NCT05244226|155445904|FG002|Overall Study|Lost to Follow-up|1|||
48666572|NCT00490022|156632465|FG001|Overall Study|Adverse Event|2|||
48666573|NCT00490022|156632464|FG000|Overall Study|Withdrawal by Subject|1|||
48666574|NCT00490022|156632465|FG001|Overall Study|Withdrawal by Subject|0|||
48666575|NCT00490022|156632464|FG000|Overall Study|Subject failed to disclose concommitant|0|||
48666576|NCT00490022|156632465|FG001|Overall Study|Subject failed to disclose concommitant|1|||
48666577|NCT02124772|156632466|FG000|Overall Study|Lack of Efficacy|2|||
48666578|NCT02124772|156632467|FG001|Overall Study|Lack of Efficacy|0|||
48666579|NCT02124772|156632468|FG002|Overall Study|Lack of Efficacy|0|||
48666580|NCT02124772|156632469|FG003|Overall Study|Lack of Efficacy|1|||
48666581|NCT02124772|156632470|FG004|Overall Study|Lack of Efficacy|2|||
48666582|NCT02124772|156632471|FG005|Overall Study|Lack of Efficacy|3|||
48666583|NCT02124772|156632472|FG006|Overall Study|Lack of Efficacy|0|||
48666584|NCT02124772|156632473|FG007|Overall Study|Lack of Efficacy|2|||
48666585|NCT02124772|156632474|FG008|Overall Study|Lack of Efficacy|0|||
48666586|NCT02124772|156632475|FG009|Overall Study|Lack of Efficacy|1|||
48666587|NCT02124772|156632476|FG010|Overall Study|Lack of Efficacy|0|||
48666588|NCT02124772|156632477|FG011|Overall Study|Lack of Efficacy|0|||
48666589|NCT02124772|156632478|FG012|Overall Study|Lack of Efficacy|1|||
48666590|NCT02124772|156632466|FG000|Overall Study|Adverse Event|1|||
48666591|NCT02124772|156632467|FG001|Overall Study|Adverse Event|4|||
48666592|NCT02124772|156632468|FG002|Overall Study|Adverse Event|1|||
48666593|NCT02124772|156632469|FG003|Overall Study|Adverse Event|5|||
48666594|NCT02124772|156632470|FG004|Overall Study|Adverse Event|2|||
48666595|NCT02124772|156632471|FG005|Overall Study|Adverse Event|1|||
48666596|NCT02124772|156632472|FG006|Overall Study|Adverse Event|1|||
48666597|NCT02124772|156632473|FG007|Overall Study|Adverse Event|5|||
48666598|NCT02124772|156632474|FG008|Overall Study|Adverse Event|0|||
48666599|NCT02124772|156632475|FG009|Overall Study|Adverse Event|3|||
48666600|NCT02124772|156632476|FG010|Overall Study|Adverse Event|1|||
48666601|NCT02124772|156632477|FG011|Overall Study|Adverse Event|3|||
48666602|NCT02124772|156632478|FG012|Overall Study|Adverse Event|1|||
48666603|NCT02124772|156632466|FG000|Overall Study|Withdrawal consent|0|||
48666604|NCT02124772|156632467|FG001|Overall Study|Withdrawal consent|1|||
48666605|NCT02124772|156632468|FG002|Overall Study|Withdrawal consent|1|||
48666606|NCT02124772|156632469|FG003|Overall Study|Withdrawal consent|1|||
48666607|NCT02124772|156632470|FG004|Overall Study|Withdrawal consent|0|||
48666608|NCT02124772|156632471|FG005|Overall Study|Withdrawal consent|1|||
48666609|NCT02124772|156632472|FG006|Overall Study|Withdrawal consent|1|||
48341481|NCT05244226|155445902|FG000|Overall Study|Protocol Violation|0|||
48341482|NCT05244226|155445903|FG001|Overall Study|Protocol Violation|2|||
48341483|NCT05244226|155445904|FG002|Overall Study|Protocol Violation|2|||
48341484|NCT02679079|155445907|FG000|Overall Study|Adverse Event|2|||
48341485|NCT02679079|155445908|FG001|Overall Study|Adverse Event|0|||
48666610|NCT02124772|156632473|FG007|Overall Study|Withdrawal consent|0|||
48666611|NCT02124772|156632474|FG008|Overall Study|Withdrawal consent|0|||
48666612|NCT02124772|156632475|FG009|Overall Study|Withdrawal consent|1|||
48666613|NCT02124772|156632476|FG010|Overall Study|Withdrawal consent|0|||
48666614|NCT02124772|156632477|FG011|Overall Study|Withdrawal consent|1|||
48666615|NCT02124772|156632478|FG012|Overall Study|Withdrawal consent|0|||
48666616|NCT02124772|156632466|FG000|Overall Study|Investigator discretion|0|||
48666617|NCT02124772|156632467|FG001|Overall Study|Investigator discretion|2|||
48666618|NCT02124772|156632468|FG002|Overall Study|Investigator discretion|2|||
48666619|NCT02124772|156632469|FG003|Overall Study|Investigator discretion|1|||
48666620|NCT02124772|156632470|FG004|Overall Study|Investigator discretion|1|||
48666621|NCT02124772|156632471|FG005|Overall Study|Investigator discretion|0|||
48341486|NCT02679079|155445909|FG002|Overall Study|Adverse Event|2|||
48666622|NCT02124772|156632472|FG006|Overall Study|Investigator discretion|1|||
48666623|NCT02124772|156632473|FG007|Overall Study|Investigator discretion|0|||
48666624|NCT02124772|156632474|FG008|Overall Study|Investigator discretion|0|||
48666625|NCT02124772|156632475|FG009|Overall Study|Investigator discretion|1|||
48666626|NCT02124772|156632476|FG010|Overall Study|Investigator discretion|0|||
48666627|NCT02124772|156632477|FG011|Overall Study|Investigator discretion|1|||
48341487|NCT02679079|155445907|FG000|Overall Study|Protocol Violation|0|||
48341488|NCT02679079|155445908|FG001|Overall Study|Protocol Violation|1|||
48341489|NCT02679079|155445909|FG002|Overall Study|Protocol Violation|0|||
48666628|NCT02124772|156632478|FG012|Overall Study|Investigator discretion|0|||
48666629|NCT02124772|156632466|FG000|Overall Study|Progressive disease|0|||
48666630|NCT02124772|156632467|FG001|Overall Study|Progressive disease|0|||
48666631|NCT02124772|156632468|FG002|Overall Study|Progressive disease|0|||
48666632|NCT02124772|156632469|FG003|Overall Study|Progressive disease|0|||
48666633|NCT02124772|156632470|FG004|Overall Study|Progressive disease|0|||
48666634|NCT02124772|156632471|FG005|Overall Study|Progressive disease|0|||
48666635|NCT02124772|156632472|FG006|Overall Study|Progressive disease|1|||
48666636|NCT02124772|156632473|FG007|Overall Study|Progressive disease|1|||
48666637|NCT02124772|156632474|FG008|Overall Study|Progressive disease|0|||
48666638|NCT02124772|156632475|FG009|Overall Study|Progressive disease|0|||
48666639|NCT02124772|156632476|FG010|Overall Study|Progressive disease|0|||
48666640|NCT02124772|156632477|FG011|Overall Study|Progressive disease|0|||
48666641|NCT02124772|156632478|FG012|Overall Study|Progressive disease|0|||
48666642|NCT02124772|156632466|FG000|Overall Study|Other|0|||
48666643|NCT02124772|156632467|FG001|Overall Study|Other|7|||
48758027|NCT01641692|156960879|FG000|Treatment Period 3|Lost to Follow-up|0|||
48758028|NCT01641692|156960880|FG001|Treatment Period 3|Lost to Follow-up|1|||
48758029|NCT01641692|156960881|FG002|Treatment Period 3|Lost to Follow-up|0|||
48758030|NCT01641692|156960882|FG003|Treatment Period 3|Lost to Follow-up|0|||
48758031|NCT01641692|156960883|FG004|Treatment Period 3|Lost to Follow-up|0|||
48758032|NCT01641692|156960884|FG005|Treatment Period 3|Lost to Follow-up|0|||
48666644|NCT02124772|156632468|FG002|Overall Study|Other|2|||
48666645|NCT02124772|156632469|FG003|Overall Study|Other|5|||
48666646|NCT02124772|156632470|FG004|Overall Study|Other|4|||
48666647|NCT02124772|156632471|FG005|Overall Study|Other|3|||
48666648|NCT02124772|156632472|FG006|Overall Study|Other|4|||
48666649|NCT02124772|156632473|FG007|Overall Study|Other|1|||
48666650|NCT02124772|156632474|FG008|Overall Study|Other|1|||
48666651|NCT02124772|156632475|FG009|Overall Study|Other|1|||
48666652|NCT02124772|156632476|FG010|Overall Study|Other|1|||
48758033|NCT01641692|156960885|FG006|Treatment Period 3|Lost to Follow-up|0|||
48758034|NCT01641692|156960886|FG007|Treatment Period 3|Lost to Follow-up|0|||
48758035|NCT01641692|156960879|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758036|NCT01641692|156960880|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758037|NCT01641692|156960881|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758038|NCT01641692|156960882|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758039|NCT01641692|156960883|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758040|NCT01641692|156960884|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
48758041|NCT01641692|156960885|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758042|NCT01641692|156960886|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
48758043|NCT01641692|156960879|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48758044|NCT01641692|156960880|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
48758045|NCT01641692|156960881|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48341490|NCT02679079|155445907|FG000|Overall Study|Withdrawal by Subject|2|||
48341491|NCT02679079|155445908|FG001|Overall Study|Withdrawal by Subject|1|||
48341492|NCT02679079|155445909|FG002|Overall Study|Withdrawal by Subject|0|||
48341493|NCT00443755|155445912|FG000|Overall Study|Withdrawal by Subject|2|||
48341494|NCT00443755|155445913|FG001|Overall Study|Withdrawal by Subject|1|||
48341495|NCT00377312|155445914|FG000|Overall Study|Adverse Event|1|||
48758046|NCT01641692|156960882|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48758047|NCT01641692|156960883|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
48758048|NCT01641692|156960884|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48758049|NCT01641692|156960885|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
48758050|NCT01641692|156960886|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
48758051|NCT01166178|156960887|FG000|Overall Study|Withdrawal by Subject|1|||
48758052|NCT01166178|156960888|FG001|Overall Study|Withdrawal by Subject|0|||
48758053|NCT01166178|156960887|FG000|Overall Study|Study was terminated|20|||
48666653|NCT02124772|156632477|FG011|Overall Study|Other|1|||
48666654|NCT02124772|156632478|FG012|Overall Study|Other|0|||
48666655|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
48758054|NCT01166178|156960888|FG001|Overall Study|Study was terminated|8|||
48758055|NCT00679263|156960891|FG000|Visit 2/Dose 1|Adverse Event|1|||
48341496|NCT00377312|155445915|FG001|Overall Study|Adverse Event|1|||
48341497|NCT00762723|155445917|FG000|Overall Study|Study Terminated slow enrollement|5|||
48666656|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
48666657|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
48341498|NCT00762723|155445918|FG001|Overall Study|Study Terminated slow enrollement|5|||
48666658|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
48666659|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
48666660|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
48666661|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
48666662|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
48666663|NCT02636946|156632479|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
48666664|NCT02636946|156632480|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
48666665|NCT02636946|156632479|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
48666666|NCT02636946|156632480|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
48666667|NCT02358044|156632483|FG000|Overall Study|Adverse Event|0|||
48666668|NCT02358044|156632484|FG001|Overall Study|Adverse Event|1|||
48666669|NCT02358044|156632483|FG000|Overall Study|Lost to Follow-up|2|||
48666670|NCT02358044|156632484|FG001|Overall Study|Lost to Follow-up|1|||
48758056|NCT00679263|156960892|FG001|Visit 2/Dose 1|Adverse Event|0|||
48758057|NCT00679263|156960893|FG002|Visit 2/Dose 1|Adverse Event|0|||
48666671|NCT02358044|156632483|FG000|Overall Study|Physician Decision|0|||
48666672|NCT02358044|156632484|FG001|Overall Study|Physician Decision|1|||
48666673|NCT02358044|156632483|FG000|Overall Study|Withdrawal by Subject|0|||
48758058|NCT00679263|156960891|FG000|Visit 2/Dose 1|subject not compliance|1|||
48758059|NCT00679263|156960892|FG001|Visit 2/Dose 1|subject not compliance|1|||
48758060|NCT00679263|156960893|FG002|Visit 2/Dose 1|subject not compliance|0|||
48758061|NCT03144674|156960894|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
48758062|NCT03144674|156960895|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
48758063|NCT03144674|156960896|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
48758064|NCT03144674|156960897|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
48758065|NCT03144674|156960894|FG000|Overall Study|Death|3|||
48758066|NCT03144674|156960895|FG001|Overall Study|Death|1|||
48666674|NCT02358044|156632484|FG001|Overall Study|Withdrawal by Subject|4|||
48758067|NCT03144674|156960896|FG002|Overall Study|Death|1|||
48758068|NCT03144674|156960897|FG003|Overall Study|Death|10|||
48758069|NCT03144674|156960894|FG000|Overall Study|Lost to Follow-up|0|||
48666675|NCT01636713|156632485|FG000|Overall Study|Adverse Event|16|||
48666676|NCT01636713|156632486|FG001|Overall Study|Adverse Event|16|||
48666677|NCT01636713|156632487|FG002|Overall Study|Adverse Event|7|||
48666678|NCT01636713|156632485|FG000|Overall Study|Lack of Efficacy|6|||
48666679|NCT01636713|156632486|FG001|Overall Study|Lack of Efficacy|6|||
48666680|NCT01636713|156632487|FG002|Overall Study|Lack of Efficacy|2|||
48666681|NCT01636713|156632485|FG000|Overall Study|Protocol Violation|3|||
48666682|NCT01636713|156632486|FG001|Overall Study|Protocol Violation|0|||
48666683|NCT01636713|156632487|FG002|Overall Study|Protocol Violation|1|||
48666684|NCT01636713|156632485|FG000|Overall Study|Lost to Follow-up|0|||
48666685|NCT01636713|156632486|FG001|Overall Study|Lost to Follow-up|0|||
48666686|NCT01636713|156632487|FG002|Overall Study|Lost to Follow-up|1|||
48666687|NCT01636713|156632485|FG000|Overall Study|Withdrawal by Subject|5|||
48666688|NCT01636713|156632486|FG001|Overall Study|Withdrawal by Subject|4|||
48666689|NCT01636713|156632487|FG002|Overall Study|Withdrawal by Subject|8|||
48666690|NCT01636713|156632485|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
48666691|NCT01636713|156632486|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
48666692|NCT01636713|156632487|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
48666693|NCT03780959|156632488|FG000|Part 1|Adverse Event|1|||
48666694|NCT03780959|156632489|FG001|Part 1|Adverse Event|0|||
48666695|NCT03780959|156632490|FG002|Part 1|Adverse Event|0|||
48666696|NCT03780959|156632488|FG000|Part 1|Withdrawal by Subject|1|||
48666697|NCT03780959|156632489|FG001|Part 1|Withdrawal by Subject|0|||
48758070|NCT03144674|156960895|FG001|Overall Study|Lost to Follow-up|1|||
48758071|NCT03144674|156960896|FG002|Overall Study|Lost to Follow-up|1|||
48758072|NCT03144674|156960897|FG003|Overall Study|Lost to Follow-up|1|||
48758073|NCT03144674|156960894|FG000|Overall Study|Withdrawal by Participant|0|||
48758074|NCT03144674|156960895|FG001|Overall Study|Withdrawal by Participant|0|||
48666698|NCT03780959|156632490|FG002|Part 1|Withdrawal by Subject|0|||
48666699|NCT03780959|156632488|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
48666700|NCT03780959|156632489|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
48666701|NCT03780959|156632490|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
48666702|NCT03780959|156632488|FG000|Part 1|Response Status|2|||
48666703|NCT03780959|156632489|FG001|Part 1|Response Status|0|||
48666704|NCT03780959|156632490|FG002|Part 1|Response Status|0|||
48666705|NCT03780959|156632488|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
48666706|NCT03780959|156632489|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
48666707|NCT03780959|156632490|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
48666708|NCT03780959|156632488|FG000|Part 2|Response Status|0|||
48758075|NCT03144674|156960896|FG002|Overall Study|Withdrawal by Participant|0|||
48758076|NCT03144674|156960897|FG003|Overall Study|Withdrawal by Participant|3|||
48758077|NCT03144674|156960894|FG000|Overall Study|Reason not Specified|0|||
48758078|NCT03144674|156960895|FG001|Overall Study|Reason not Specified|0|||
48666709|NCT03780959|156632489|FG001|Part 2|Response Status|18|||
48666710|NCT03780959|156632490|FG002|Part 2|Response Status|6|||
48666711|NCT04493684|156632491|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
48666712|NCT04493684|156632492|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666713|NCT04493684|156632493|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
48666714|NCT04493684|156632494|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48758079|NCT03144674|156960896|FG002|Overall Study|Reason not Specified|2|||
48758080|NCT03144674|156960897|FG003|Overall Study|Reason not Specified|4|||
48758081|NCT02075658|156960898|FG000|Overall Study|Physician Decision|2|||
48758082|NCT02075658|156960899|FG001|Overall Study|Physician Decision|2|||
48758083|NCT02946047|156960909|FG000|Overall Study|Adverse Event|1|||
48758084|NCT02946047|156960910|FG001|Overall Study|Adverse Event|0|||
48666715|NCT04493684|156632495|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666716|NCT04493684|156632496|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
48758085|NCT02946047|156960911|FG002|Overall Study|Adverse Event|0|||
48341499|NCT00762723|155445919|FG002|Overall Study|Study Terminated slow enrollement|3|||
48666717|NCT04493684|156632497|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666718|NCT04493684|156632498|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666719|NCT04493684|156632499|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666720|NCT04493684|156632500|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666721|NCT04493684|156632501|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666722|NCT04493684|156632502|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666723|NCT04493684|156632503|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666724|NCT04493684|156632504|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666725|NCT04493684|156632505|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666726|NCT04493684|156632506|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666727|NCT04493684|156632507|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
48666728|NCT04493684|156632491|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
48666729|NCT04493684|156632492|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666730|NCT04493684|156632493|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48758086|NCT02946047|156960912|FG003|Overall Study|Adverse Event|0|||
48758087|NCT01894581|156960913|FG000|Overall Study|Withdrawal by Subject|2|||
48758088|NCT01894581|156960914|FG001|Overall Study|Withdrawal by Subject|3|||
48758089|NCT01894581|156960913|FG000|Overall Study|Screen Failure|3|||
48758090|NCT01894581|156960914|FG001|Overall Study|Screen Failure|4|||
48758091|NCT01502423|156960915|FG000|Overall Study|Withdrawal by Subject|0|||
48758092|NCT01502423|156960916|FG001|Overall Study|Withdrawal by Subject|1|||
48758093|NCT03045081|156962689|FG000|Overall Study|Withdrawal by Subject|6|||
48758094|NCT03045081|156962690|FG001|Overall Study|Withdrawal by Subject|11|||
48758095|NCT02699554|156962691|FG000|Overall Study|Lost to Follow-up|9|||
48758096|NCT00100815|156962697|FG000|Overall Study|Progression|24|||
48758097|NCT00100815|156962697|FG000|Overall Study|Adverse Event|18|||
48758098|NCT00100815|156962697|FG000|Overall Study|Death|4|||
48666731|NCT04493684|156632494|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666732|NCT04493684|156632495|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666733|NCT04493684|156632496|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666734|NCT04493684|156632497|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666735|NCT04493684|156632498|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666736|NCT04493684|156632499|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666737|NCT04493684|156632500|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666738|NCT04493684|156632501|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666739|NCT04493684|156632502|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666740|NCT04493684|156632503|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666741|NCT04493684|156632504|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666742|NCT04493684|156632505|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666743|NCT04493684|156632506|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666744|NCT04493684|156632507|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
48666745|NCT04493684|156632491|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666746|NCT04493684|156632492|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666747|NCT04493684|156632493|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666748|NCT04493684|156632494|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666749|NCT04493684|156632495|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666750|NCT04493684|156632496|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666751|NCT04493684|156632497|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
48666752|NCT04493684|156632498|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666753|NCT04493684|156632499|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666754|NCT04493684|156632500|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666755|NCT04493684|156632501|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666756|NCT04493684|156632502|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666757|NCT04493684|156632503|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666758|NCT04493684|156632504|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666759|NCT04493684|156632505|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666760|NCT04493684|156632506|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666761|NCT04493684|156632507|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
48666762|NCT04493684|156632491|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
48666763|NCT04493684|156632492|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666764|NCT04493684|156632493|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666765|NCT04493684|156632494|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666766|NCT04493684|156632495|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666767|NCT04493684|156632496|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666768|NCT04493684|156632497|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666769|NCT04493684|156632498|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666770|NCT04493684|156632499|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666771|NCT04493684|156632500|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666772|NCT04493684|156632501|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666773|NCT04493684|156632502|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666774|NCT04493684|156632503|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666775|NCT04493684|156632504|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666776|NCT04493684|156632505|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666777|NCT04493684|156632506|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666778|NCT04493684|156632507|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
48666779|NCT04493684|156632491|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666780|NCT04493684|156632492|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666781|NCT04493684|156632493|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666782|NCT04493684|156632494|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666783|NCT04493684|156632495|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666784|NCT04493684|156632496|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
48666785|NCT04493684|156632497|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666786|NCT04493684|156632498|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666787|NCT04493684|156632499|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666788|NCT04493684|156632500|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666789|NCT04493684|156632501|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666790|NCT04493684|156632502|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666791|NCT04493684|156632503|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666792|NCT04493684|156632504|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666793|NCT04493684|156632505|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666794|NCT04493684|156632506|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666795|NCT04493684|156632507|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
48666796|NCT04493684|156632491|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666797|NCT04493684|156632492|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666798|NCT04493684|156632493|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48341500|NCT00627523|155445920|FG000|Overall Study|Lack of Efficacy|1|||
48341501|NCT00627523|155445921|FG001|Overall Study|Lack of Efficacy|0|||
48341502|NCT00627523|155445920|FG000|Overall Study|Withdrawal by Subject|0|||
48341503|NCT00627523|155445921|FG001|Overall Study|Withdrawal by Subject|2|||
48341504|NCT00627523|155445920|FG000|Overall Study|Other|1|||
48341505|NCT00627523|155445921|FG001|Overall Study|Other|0|||
48341506|NCT00678899|155445922|FG000|Overall Study|Adverse Event|1|||
48341507|NCT04385849|155445923|FG000|Overall Study|Lost to Follow-up|1|||
48341508|NCT04385849|155445924|FG001|Overall Study|Lost to Follow-up|0|||
48341509|NCT05878990|155445925|FG000|Overall Study|Lost to Follow-up|7|||
48341510|NCT05878990|155445925|FG000|Overall Study|Withdrawal by Subject|1|||
48341511|NCT03341312|155445926|FG000|Period 1|Withdrawal by Subject|0|||
48341512|NCT03341312|155445927|FG001|Period 1|Withdrawal by Subject|1|||
48341513|NCT03341312|155445928|FG002|Period 1|Withdrawal by Subject|0|||
48341514|NCT03341312|155445929|FG003|Period 1|Withdrawal by Subject|0|||
48341515|NCT01812707|155445931|FG000|Overall Study|Adverse Event|0|||
48341516|NCT01812707|155445932|FG001|Overall Study|Adverse Event|0|||
48341517|NCT01812707|155445933|FG002|Overall Study|Adverse Event|0|||
48341518|NCT01812707|155445934|FG003|Overall Study|Adverse Event|2|||
48341519|NCT01812707|155445931|FG000|Overall Study|Poor compliance to protocol|1|||
48341520|NCT01812707|155445932|FG001|Overall Study|Poor compliance to protocol|0|||
48341521|NCT01812707|155445933|FG002|Overall Study|Poor compliance to protocol|0|||
48341522|NCT01812707|155445934|FG003|Overall Study|Poor compliance to protocol|0|||
48341523|NCT01812707|155445931|FG000|Overall Study|Consent withdrawn by participant|1|||
48341524|NCT01812707|155445932|FG001|Overall Study|Consent withdrawn by participant|0|||
48341525|NCT01812707|155445933|FG002|Overall Study|Consent withdrawn by participant|0|||
48341526|NCT01812707|155445934|FG003|Overall Study|Consent withdrawn by participant|0|||
48666799|NCT04493684|156632494|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666800|NCT04493684|156632495|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666801|NCT04493684|156632496|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666802|NCT04493684|156632497|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666803|NCT04493684|156632498|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666804|NCT04493684|156632499|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666805|NCT04493684|156632500|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48341527|NCT02339506|155445941|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
48341528|NCT02339506|155445942|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
48341529|NCT02339506|155445941|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
48341530|NCT02339506|155445942|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
48341531|NCT00609245|155445943|FG000|Overall Study|Adverse Event|1|||
48341532|NCT01066897|155445944|FG000|Overall Study|Withdrawal by Subject|1|||
48666806|NCT04493684|156632501|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48758099|NCT00100815|156962697|FG000|Overall Study|Other|3|||
48758100|NCT02877082|156962698|FG000|Overall Study|Trial was closed early|5|||
48758101|NCT00849381|156962699|FG000|Overall Study|Adverse Event|1|||
48758102|NCT00849381|156962699|FG000|Overall Study|Lost to Follow-up|129|||
48758103|NCT00849381|156962699|FG000|Overall Study|Protocol Violation|5|||
48758104|NCT00849381|156962699|FG000|Overall Study|Withdrawal by Subject|6|||
48758105|NCT00849381|156962699|FG000|Overall Study|Other|4|||
48758106|NCT03970733|156962700|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
48758107|NCT03970733|156962701|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
48758108|NCT03970733|156962702|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
48758109|NCT03970733|156962703|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
48758110|NCT03970733|156962704|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
48341533|NCT01066897|155445945|FG001|Overall Study|Withdrawal by Subject|0|||
48341534|NCT01066897|155445944|FG000|Overall Study|stopped study after developing the flu.|1|||
48341535|NCT01066897|155445945|FG001|Overall Study|stopped study after developing the flu.|0|||
48341536|NCT01697592|155445948|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
48341537|NCT01697592|155445949|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48666807|NCT04493684|156632502|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
48666808|NCT04493684|156632503|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666809|NCT04493684|156632504|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666810|NCT04493684|156632505|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666811|NCT04493684|156632506|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666812|NCT04493684|156632507|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
48666813|NCT04493684|156632491|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666814|NCT04493684|156632492|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666815|NCT04493684|156632493|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666816|NCT04493684|156632494|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666817|NCT04493684|156632495|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666818|NCT04493684|156632496|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666819|NCT04493684|156632497|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666820|NCT04493684|156632498|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666821|NCT04493684|156632499|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666822|NCT04493684|156632500|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666823|NCT04493684|156632501|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666824|NCT04493684|156632502|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666825|NCT04493684|156632503|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666826|NCT04493684|156632504|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666827|NCT04493684|156632505|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666828|NCT04493684|156632506|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
48666829|NCT04493684|156632507|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
48666830|NCT04493684|156632491|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666831|NCT04493684|156632492|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666832|NCT04493684|156632493|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666833|NCT04493684|156632494|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666834|NCT04493684|156632495|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666835|NCT04493684|156632496|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666836|NCT04493684|156632497|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666837|NCT04493684|156632498|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666838|NCT04493684|156632499|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666839|NCT04493684|156632500|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666840|NCT04493684|156632501|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666841|NCT04493684|156632502|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666842|NCT04493684|156632503|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666843|NCT04493684|156632504|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48758111|NCT03970733|156962700|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
48758112|NCT03970733|156962701|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
48758113|NCT03970733|156962702|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
48341538|NCT01697592|155445950|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48666844|NCT04493684|156632505|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666845|NCT04493684|156632506|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
48666846|NCT04493684|156632507|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
48666847|NCT03691779|156632517|FG000|Part B (24 Weeks)|Adverse Event|0|||
48666848|NCT03691779|156632518|FG001|Part B (24 Weeks)|Adverse Event|1|||
48758114|NCT03970733|156962703|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
48758115|NCT03970733|156962704|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
48758116|NCT03970733|156962700|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
48758117|NCT03970733|156962701|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
48758118|NCT03970733|156962702|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
48758119|NCT03970733|156962703|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
48758120|NCT03970733|156962704|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
48758121|NCT03970733|156962700|FG000|Main Study Phase (18 Months)|Other|1|||
48758122|NCT03970733|156962701|FG001|Main Study Phase (18 Months)|Other|1|||
48758123|NCT03970733|156962702|FG002|Main Study Phase (18 Months)|Other|0|||
48758124|NCT03970733|156962703|FG003|Main Study Phase (18 Months)|Other|0|||
48758125|NCT03970733|156962704|FG004|Main Study Phase (18 Months)|Other|0|||
48758126|NCT03970733|156962700|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
48758127|NCT03970733|156962701|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
48758128|NCT03970733|156962702|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
48758129|NCT03970733|156962703|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
48758130|NCT03970733|156962704|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
48758131|NCT00723892|156962707|FG000|Overall Study|Participant not tracked|33|||
48758132|NCT00723892|156962708|FG001|Overall Study|Participant not tracked|35|||
48758133|NCT00723892|156962707|FG000|Overall Study|Virological criterion|24|||
48758134|NCT00723892|156962708|FG001|Overall Study|Virological criterion|9|||
48758135|NCT00723892|156962707|FG000|Overall Study|Withdrawal by Subject|6|||
48758136|NCT00723892|156962708|FG001|Overall Study|Withdrawal by Subject|9|||
48758137|NCT00723892|156962707|FG000|Overall Study|End planned|11|||
48758138|NCT00723892|156962708|FG001|Overall Study|End planned|7|||
48758139|NCT00723892|156962707|FG000|Overall Study|Bad tolerance|5|||
48758140|NCT00723892|156962708|FG001|Overall Study|Bad tolerance|5|||
48758141|NCT00723892|156962707|FG000|Overall Study|Multiple reasons|17|||
48758142|NCT00723892|156962708|FG001|Overall Study|Multiple reasons|12|||
48341539|NCT01697592|155445951|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48341540|NCT01697592|155445952|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48666849|NCT03691779|156632517|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
48666850|NCT03691779|156632518|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
48666851|NCT00203021|156634072|FG000|Overall Study|Death|4|||
48666852|NCT00203021|156634073|FG001|Overall Study|Death|1|||
48666853|NCT00203021|156634072|FG000|Overall Study|Adverse Event|10|||
48666854|NCT00203021|156634073|FG001|Overall Study|Adverse Event|5|||
48666855|NCT00203021|156634072|FG000|Overall Study|Withdrawal by Subject|45|||
48666856|NCT00203021|156634073|FG001|Overall Study|Withdrawal by Subject|48|||
48666857|NCT00203021|156634072|FG000|Overall Study|Lost to Follow-up|9|||
48666858|NCT00203021|156634073|FG001|Overall Study|Lost to Follow-up|7|||
48666859|NCT00203021|156634072|FG000|Overall Study|Other than specified|11|||
48666860|NCT00203021|156634073|FG001|Overall Study|Other than specified|16|||
48666861|NCT00996801|156634075|FG000|Overall Study|Adverse Event|6|||
48666862|NCT00996801|156634076|FG001|Overall Study|Adverse Event|4|||
48666863|NCT00996801|156634077|FG002|Overall Study|Adverse Event|12|||
48666864|NCT00996801|156634078|FG003|Overall Study|Adverse Event|17|||
48666865|NCT00996801|156634079|FG004|Overall Study|Adverse Event|31|||
48666866|NCT00996801|156634080|FG005|Overall Study|Adverse Event|3|||
48666867|NCT00996801|156634075|FG000|Overall Study|Lack of Efficacy|3|||
48666868|NCT00996801|156634076|FG001|Overall Study|Lack of Efficacy|0|||
48666869|NCT00996801|156634077|FG002|Overall Study|Lack of Efficacy|1|||
48666870|NCT00996801|156634078|FG003|Overall Study|Lack of Efficacy|3|||
48666871|NCT00996801|156634079|FG004|Overall Study|Lack of Efficacy|0|||
48666872|NCT00996801|156634080|FG005|Overall Study|Lack of Efficacy|1|||
48666873|NCT00996801|156634075|FG000|Overall Study|Lost to Follow-up|0|||
48666874|NCT00996801|156634076|FG001|Overall Study|Lost to Follow-up|0|||
48666875|NCT00996801|156634077|FG002|Overall Study|Lost to Follow-up|0|||
48341541|NCT01697592|155445953|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48341542|NCT01697592|155445954|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48341543|NCT01697592|155445955|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48666876|NCT00996801|156634078|FG003|Overall Study|Lost to Follow-up|3|||
48758143|NCT00723892|156962707|FG000|Overall Study|Other|6|||
48758144|NCT00723892|156962708|FG001|Overall Study|Other|3|||
48758145|NCT00723892|156962707|FG000|Overall Study|Study end|1|||
48758146|NCT00723892|156962708|FG001|Overall Study|Study end|3|||
48341544|NCT01697592|155445956|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48341545|NCT01697592|155445957|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
48341546|NCT01697592|155445948|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48341547|NCT01697592|155445949|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48341548|NCT01697592|155445950|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48666877|NCT00996801|156634079|FG004|Overall Study|Lost to Follow-up|3|||
48758147|NCT00723892|156962707|FG000|Overall Study|Weight loss|1|||
48758148|NCT00723892|156962708|FG001|Overall Study|Weight loss|3|||
48758149|NCT00723892|156962707|FG000|Overall Study|Alcohol abuse|0|||
48666878|NCT00996801|156634080|FG005|Overall Study|Lost to Follow-up|2|||
48666879|NCT00996801|156634075|FG000|Overall Study|Physician Decision|0|||
48666880|NCT00996801|156634076|FG001|Overall Study|Physician Decision|0|||
48666881|NCT00996801|156634077|FG002|Overall Study|Physician Decision|0|||
48666882|NCT00996801|156634078|FG003|Overall Study|Physician Decision|1|||
48666883|NCT00996801|156634079|FG004|Overall Study|Physician Decision|0|||
48666884|NCT00996801|156634080|FG005|Overall Study|Physician Decision|0|||
48666885|NCT00996801|156634075|FG000|Overall Study|Progressive Disease|0|||
48666886|NCT00996801|156634076|FG001|Overall Study|Progressive Disease|1|||
48666887|NCT00996801|156634077|FG002|Overall Study|Progressive Disease|0|||
48666888|NCT00996801|156634078|FG003|Overall Study|Progressive Disease|0|||
48666889|NCT00996801|156634079|FG004|Overall Study|Progressive Disease|0|||
48666890|NCT00996801|156634080|FG005|Overall Study|Progressive Disease|0|||
48666891|NCT00996801|156634075|FG000|Overall Study|Protocol Violation|3|||
48666892|NCT00996801|156634076|FG001|Overall Study|Protocol Violation|4|||
48666893|NCT00996801|156634077|FG002|Overall Study|Protocol Violation|1|||
48666894|NCT00996801|156634078|FG003|Overall Study|Protocol Violation|2|||
48666895|NCT00996801|156634079|FG004|Overall Study|Protocol Violation|3|||
48666896|NCT00996801|156634080|FG005|Overall Study|Protocol Violation|4|||
48666897|NCT00996801|156634075|FG000|Overall Study|Study Terminated by Sponsor|0|||
48666898|NCT00996801|156634076|FG001|Overall Study|Study Terminated by Sponsor|1|||
48666899|NCT00996801|156634077|FG002|Overall Study|Study Terminated by Sponsor|0|||
48666900|NCT00996801|156634078|FG003|Overall Study|Study Terminated by Sponsor|0|||
48666901|NCT00996801|156634079|FG004|Overall Study|Study Terminated by Sponsor|46|||
48666902|NCT00996801|156634080|FG005|Overall Study|Study Terminated by Sponsor|0|||
48666903|NCT00996801|156634075|FG000|Overall Study|Withdrawal by Subject|8|||
48666904|NCT00996801|156634076|FG001|Overall Study|Withdrawal by Subject|6|||
48666905|NCT00996801|156634077|FG002|Overall Study|Withdrawal by Subject|9|||
48666906|NCT00996801|156634078|FG003|Overall Study|Withdrawal by Subject|5|||
48666907|NCT00996801|156634079|FG004|Overall Study|Withdrawal by Subject|5|||
48666908|NCT00996801|156634080|FG005|Overall Study|Withdrawal by Subject|9|||
48666909|NCT01688739|156634081|FG000|Overall Study|Administrative Decision|1|||
48666910|NCT01688739|156634082|FG001|Overall Study|Administrative Decision|0|||
48666911|NCT01688739|156634083|FG002|Overall Study|Administrative Decision|0|||
48666912|NCT01688739|156634084|FG003|Overall Study|Administrative Decision|0|||
48666913|NCT01688739|156634085|FG004|Overall Study|Administrative Decision|0|||
48666914|NCT01688739|156634086|FG005|Overall Study|Administrative Decision|0|||
48666915|NCT01688739|156634087|FG006|Overall Study|Administrative Decision|0|||
48666916|NCT01688739|156634088|FG007|Overall Study|Administrative Decision|0|||
48666917|NCT01688739|156634089|FG008|Overall Study|Administrative Decision|0|||
48666918|NCT01688739|156634090|FG009|Overall Study|Administrative Decision|0|||
48666919|NCT00289198|156634091|FG000|Overall Study|Adverse Event|0|||
48666920|NCT00289198|156634092|FG001|Overall Study|Adverse Event|2|||
48666921|NCT00289198|156634091|FG000|Overall Study|Protocol Violation|2|||
48666922|NCT00289198|156634092|FG001|Overall Study|Protocol Violation|1|||
48666923|NCT00289198|156634091|FG000|Overall Study|Withdrawal by Subject|4|||
48666924|NCT00289198|156634092|FG001|Overall Study|Withdrawal by Subject|1|||
48666925|NCT00289198|156634091|FG000|Overall Study|Lack of Efficacy|2|||
48666926|NCT00289198|156634092|FG001|Overall Study|Lack of Efficacy|0|||
48666927|NCT00289198|156634091|FG000|Overall Study|Other: Low compliance|0|||
48666928|NCT00289198|156634092|FG001|Overall Study|Other: Low compliance|1|||
48666929|NCT00289198|156634091|FG000|Overall Study|Other: Physician's decision|0|||
48666930|NCT00289198|156634092|FG001|Overall Study|Other: Physician's decision|1|||
48666931|NCT00289198|156634091|FG000|Overall Study|Other: Unable to attend on schedule|2|||
48341549|NCT01697592|155445951|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48341550|NCT01697592|155445952|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48341551|NCT01697592|155445953|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
48666932|NCT00289198|156634092|FG001|Overall Study|Other: Unable to attend on schedule|1|||
48666933|NCT00289198|156634091|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
48666934|NCT00289198|156634092|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
48666935|NCT00289198|156634091|FG000|Overall Study|Other: Impossible to come on visit|0|||
48666936|NCT00289198|156634092|FG001|Overall Study|Other: Impossible to come on visit|1|||
48666937|NCT01655381|156634095|FG000|Overall Study|Investigator Decision|1|||
48666938|NCT01655381|156634095|FG000|Overall Study|Moved to Another City|1|||
48666939|NCT01655381|156634095|FG000|Overall Study|Insufficient Treatment Response|1|||
48666940|NCT00046930|156634096|FG000|Overall Study|Ineligible|12|||
48666941|NCT00046930|156634097|FG001|Overall Study|Ineligible|4|||
48666942|NCT02119156|156634098|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
48666943|NCT02119156|156634099|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
48666944|NCT02119156|156634100|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
48666945|NCT02119156|156634098|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
48666946|NCT02119156|156634099|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
48666947|NCT02119156|156634100|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
48666948|NCT02119156|156634098|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
48341552|NCT01697592|155445954|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48341553|NCT01697592|155445955|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48666949|NCT02119156|156634099|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
48758150|NCT00723892|156962708|FG001|Overall Study|Alcohol abuse|1|||
48758151|NCT00723892|156962707|FG000|Overall Study|Intercurrent infection|2|||
48758152|NCT00723892|156962708|FG001|Overall Study|Intercurrent infection|0|||
48341554|NCT01697592|155445956|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48666950|NCT02119156|156634100|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
48666951|NCT02119156|156634098|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
48666952|NCT02119156|156634099|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
48666953|NCT02119156|156634100|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
48666954|NCT02119156|156634098|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
48666955|NCT02119156|156634099|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
48666956|NCT02119156|156634100|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
48666957|NCT02469415|156634101|FG000|Overall Study|Withdrawal by Subject|1|||
48666958|NCT02469415|156634101|FG000|Overall Study|Investigational agent placed on hold|2|||
48666959|NCT03554772|156634104|FG000|Overall Study|Lost to Follow-up|0|||
48666960|NCT03554772|156634105|FG001|Overall Study|Lost to Follow-up|0|||
48666961|NCT03554772|156634106|FG002|Overall Study|Lost to Follow-up|0|||
48666962|NCT03554772|156634107|FG003|Overall Study|Lost to Follow-up|2|||
48666963|NCT01994863|156634108|FG000|Period 1|Adverse Event|4|||
48666964|NCT01994863|156634109|FG001|Period 1|Adverse Event|0|||
48666965|NCT01994863|156634108|FG000|Period 1|Withdrawal by Subject|1|||
48666966|NCT01994863|156634109|FG001|Period 1|Withdrawal by Subject|0|||
48666967|NCT01994863|156634108|FG000|Period 1|Trial stopped by sponsor|1|||
48666968|NCT01994863|156634109|FG001|Period 1|Trial stopped by sponsor|3|||
48666969|NCT01994863|156634108|FG000|Period 1|Lack of Efficacy|1|||
48666970|NCT01994863|156634109|FG001|Period 1|Lack of Efficacy|0|||
48666971|NCT01994863|156634108|FG000|Period 2|Adverse Event|0|||
48666972|NCT01994863|156634109|FG001|Period 2|Adverse Event|1|||
48666973|NCT01994863|156634108|FG000|Period 2|Lack of Efficacy|0|||
48666974|NCT01994863|156634109|FG001|Period 2|Lack of Efficacy|2|||
48666975|NCT01994863|156634108|FG000|Period 2|Withdrawal by Subject|1|||
48666976|NCT01994863|156634109|FG001|Period 2|Withdrawal by Subject|1|||
48666977|NCT05136898|156634110|FG000|Overall Study|Adverse Event|2|||
48666978|NCT01009346|156634115|FG000|Overall Study|Adverse Event|4|||
48666979|NCT03271047|156634118|FG000|Phase 1b: Dose Finding Period|Death|8|||
48666980|NCT03271047|156634119|FG001|Phase 1b: Dose Finding Period|Death|8|||
48666981|NCT03271047|156634120|FG002|Phase 1b: Dose Finding Period|Death|0|||
48666982|NCT03271047|156634121|FG003|Phase 1b: Dose Finding Period|Death|0|||
48666983|NCT03271047|156634118|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
48666984|NCT03271047|156634119|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
48666985|NCT03271047|156634120|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
48666986|NCT03271047|156634121|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
48666987|NCT03271047|156634118|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
48666988|NCT03271047|156634119|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
48666989|NCT03271047|156634120|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
48666990|NCT03271047|156634121|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
48666991|NCT03271047|156634118|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
48666992|NCT03271047|156634119|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
48666993|NCT03271047|156634120|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
48666994|NCT03271047|156634121|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
48666995|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Other|0|||
48666996|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Other|0|||
48666997|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Other|0|||
48666998|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Other|1|||
48666999|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Death|0|||
48667000|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Death|0|||
48667001|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Death|20|||
48667002|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Death|21|||
48667003|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
48667004|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
48341555|NCT01697592|155445957|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
48341556|NCT01697592|155445948|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
48341557|NCT01697592|155445949|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48341558|NCT01697592|155445950|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48341559|NCT01697592|155445951|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48341560|NCT01697592|155445952|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48341561|NCT01697592|155445953|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48341562|NCT01697592|155445954|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48341563|NCT01697592|155445955|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48341564|NCT01697592|155445956|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48341565|NCT01697592|155445957|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
48667005|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
48758153|NCT00723892|156962707|FG000|Overall Study|Drug addiction|1|||
48758154|NCT00723892|156962708|FG001|Overall Study|Drug addiction|0|||
48428232|NCT02531373|155756499|FG001|Overall Study|Protocol Violation|0|||
48667006|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
48667007|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
48667008|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
48667009|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
48667010|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
48667011|NCT03271047|156634118|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
48667012|NCT03271047|156634119|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
48667013|NCT03271047|156634120|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
48667014|NCT03271047|156634121|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
48667015|NCT01100528|156634122|FG000|Overall Study|Death|1|||
48667016|NCT01100528|156634122|FG000|Overall Study|Withdrawal by Subject|2|||
48667017|NCT03374202|156634123|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
48667018|NCT03374202|156634124|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
48667019|NCT03374202|156634125|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
48667020|NCT03374202|156634123|FG000|Five Year Long Term Follow Up|Death|0|||
48667021|NCT03374202|156634124|FG001|Five Year Long Term Follow Up|Death|1|||
48667022|NCT03374202|156634125|FG002|Five Year Long Term Follow Up|Death|0|||
48667023|NCT05291936|156634126|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
48667024|NCT05291936|156634127|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
48667025|NCT05291936|156634126|FG000|Period 1|Withdrew Consent during study|1|||
48667026|NCT05291936|156634127|FG001|Period 1|Withdrew Consent during study|0|||
48667027|NCT05291936|156634126|FG000|Period 2|Adverse Event|0|||
48667028|NCT05291936|156634127|FG001|Period 2|Adverse Event|1|||
48667029|NCT05291936|156634126|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
48667030|NCT05291936|156634127|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
48667031|NCT00693472|156634131|FG000|Part 1|Adverse Event|1|||
48667032|NCT00693472|156634132|FG001|Part 1|Adverse Event|1|||
48667033|NCT00693472|156634133|FG002|Part 1|Adverse Event|0|||
48667034|NCT00693472|156634134|FG003|Part 1|Adverse Event|0|||
48667035|NCT00693472|156634131|FG000|Part 1|Lost to Follow-up|0|||
48667036|NCT00693472|156634132|FG001|Part 1|Lost to Follow-up|1|||
48667037|NCT00693472|156634133|FG002|Part 1|Lost to Follow-up|0|||
48667038|NCT00693472|156634134|FG003|Part 1|Lost to Follow-up|0|||
48667039|NCT00693472|156634131|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
48667040|NCT00693472|156634132|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
48667041|NCT00693472|156634133|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
48667042|NCT00693472|156634134|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
48667043|NCT00693472|156634131|FG000|Part 2|Adverse Event|0|||
48667044|NCT00693472|156634132|FG001|Part 2|Adverse Event|0|||
48667045|NCT00693472|156634133|FG002|Part 2|Adverse Event|1|||
48667046|NCT00693472|156634134|FG003|Part 2|Adverse Event|0|||
48667047|NCT00693472|156634131|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
48667048|NCT00693472|156634132|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
48667049|NCT00693472|156634133|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
48667050|NCT00693472|156634134|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
48667051|NCT01038713|156634135|FG000|Overall Study|Patient to hospice|1|||
48667052|NCT01038713|156634136|FG001|Overall Study|Patient to hospice|1|||
48667053|NCT01038713|156634137|FG002|Overall Study|Patient to hospice|1|||
48667054|NCT01038713|156634135|FG000|Overall Study|Lost to Follow-up|3|||
48667055|NCT01038713|156634136|FG001|Overall Study|Lost to Follow-up|0|||
48667056|NCT01038713|156634137|FG002|Overall Study|Lost to Follow-up|0|||
48667057|NCT01038713|156634135|FG000|Overall Study|Neuroendocrine Tumor|0|||
48667058|NCT01038713|156634136|FG001|Overall Study|Neuroendocrine Tumor|1|||
48667059|NCT01038713|156634137|FG002|Overall Study|Neuroendocrine Tumor|0|||
48341566|NCT01697592|155445948|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48341567|NCT01697592|155445949|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48341568|NCT01697592|155445950|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48341569|NCT01697592|155445951|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48758155|NCT03060447|156962709|FG000|Overall Study|Withdrawal by Subject|2|||
48758156|NCT03060447|156962710|FG001|Overall Study|Withdrawal by Subject|0|||
48341570|NCT01697592|155445952|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48341571|NCT01697592|155445953|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48667060|NCT01038713|156634135|FG000|Overall Study|died from PEP|0|||
48667061|NCT01038713|156634136|FG001|Overall Study|died from PEP|1|||
48667062|NCT01038713|156634137|FG002|Overall Study|died from PEP|0|||
48667063|NCT01038713|156634135|FG000|Overall Study|Autoimmune Pancreatitis|1|||
48667064|NCT01038713|156634136|FG001|Overall Study|Autoimmune Pancreatitis|0|||
48667065|NCT01038713|156634137|FG002|Overall Study|Autoimmune Pancreatitis|0|||
48667066|NCT00461305|156634140|FG000|Treatment|Adverse Event|26|||
48667067|NCT00461305|156634141|FG001|Treatment|Adverse Event|3|||
48667068|NCT00461305|156634140|FG000|Treatment|Lost to Follow-up|4|||
48667069|NCT00461305|156634141|FG001|Treatment|Lost to Follow-up|2|||
48667070|NCT00461305|156634140|FG000|Treatment|Protocol Violation|13|||
48667071|NCT00461305|156634141|FG001|Treatment|Protocol Violation|2|||
48667072|NCT00461305|156634140|FG000|Treatment|Withdrawal by Subject|48|||
48667073|NCT00461305|156634141|FG001|Treatment|Withdrawal by Subject|2|||
48667074|NCT00461305|156634140|FG000|Treatment|Never dispensed|5|||
48667075|NCT00461305|156634141|FG001|Treatment|Never dispensed|0|||
48667076|NCT00461305|156634140|FG000|Treatment|Study drug not taken|1|||
48667077|NCT00461305|156634141|FG001|Treatment|Study drug not taken|0|||
48667078|NCT00461305|156634140|FG000|Treatment|Partially missing diary|2|||
48667079|NCT00461305|156634141|FG001|Treatment|Partially missing diary|0|||
48667080|NCT00461305|156634140|FG000|Treatment|Other (missing drug etc)|2|||
48667081|NCT00461305|156634141|FG001|Treatment|Other (missing drug etc)|0|||
48667082|NCT00461305|156634140|FG000|Continued Treatment|Adverse Event|26|||
48667083|NCT00461305|156634141|FG001|Continued Treatment|Adverse Event|0|||
48667084|NCT00461305|156634140|FG000|Continued Treatment|Lost to Follow-up|4|||
48667085|NCT00461305|156634141|FG001|Continued Treatment|Lost to Follow-up|0|||
48667086|NCT00461305|156634140|FG000|Continued Treatment|Protocol Violation|13|||
48667087|NCT00461305|156634141|FG001|Continued Treatment|Protocol Violation|0|||
48667088|NCT00461305|156634140|FG000|Continued Treatment|Withdrawal by Subject|48|||
48667089|NCT00461305|156634141|FG001|Continued Treatment|Withdrawal by Subject|0|||
48758157|NCT01870583|156962711|FG000|Overall Study|Protocol Violation|0|||
48758158|NCT01870583|156962712|FG001|Overall Study|Protocol Violation|5|||
48758159|NCT01870583|156962713|FG002|Overall Study|Protocol Violation|3|||
48758160|NCT01870583|156962711|FG000|Overall Study|Lost to Follow-up|11|||
48758161|NCT01870583|156962712|FG001|Overall Study|Lost to Follow-up|13|||
48758162|NCT01870583|156962713|FG002|Overall Study|Lost to Follow-up|5|||
48758163|NCT01770379|156962718|FG000|Overall Study|Technical issues|1|||
48758164|NCT01770379|156962719|FG001|Overall Study|Technical issues|0|||
48758165|NCT01770379|156962720|FG002|Overall Study|Technical issues|0|||
48758166|NCT01770379|156962718|FG000|Overall Study|Withdrawal by Subject|7|||
48758167|NCT01770379|156962719|FG001|Overall Study|Withdrawal by Subject|10|||
48758168|NCT01770379|156962720|FG002|Overall Study|Withdrawal by Subject|7|||
48758169|NCT01770379|156962718|FG000|Overall Study|study terminated by sponsor|22|||
48758170|NCT01770379|156962719|FG001|Overall Study|study terminated by sponsor|23|||
48758171|NCT01770379|156962720|FG002|Overall Study|study terminated by sponsor|22|||
48758172|NCT01770379|156962718|FG000|Overall Study|Protocol Violation|0|||
48758173|NCT01770379|156962719|FG001|Overall Study|Protocol Violation|1|||
48667090|NCT00461305|156634140|FG000|Continued Treatment|Partially missing diary|2|||
48758174|NCT01770379|156962720|FG002|Overall Study|Protocol Violation|1|||
48758175|NCT01770379|156962718|FG000|Overall Study|Physician Decision|0|||
48758176|NCT01770379|156962719|FG001|Overall Study|Physician Decision|1|||
48758177|NCT01770379|156962720|FG002|Overall Study|Physician Decision|2|||
48758178|NCT01770379|156962718|FG000|Overall Study|Lost to Follow-up|0|||
48758179|NCT01770379|156962719|FG001|Overall Study|Lost to Follow-up|0|||
48758180|NCT01770379|156962720|FG002|Overall Study|Lost to Follow-up|2|||
48758181|NCT01770379|156962718|FG000|Overall Study|Lack of Efficacy|8|||
48758182|NCT01770379|156962719|FG001|Overall Study|Lack of Efficacy|6|||
48758183|NCT01770379|156962720|FG002|Overall Study|Lack of Efficacy|6|||
48758184|NCT01770379|156962718|FG000|Overall Study|Adverse Event|1|||
48758185|NCT01770379|156962719|FG001|Overall Study|Adverse Event|3|||
48758186|NCT01770379|156962720|FG002|Overall Study|Adverse Event|2|||
48758187|NCT00311623|156962723|FG000|Overall Study|Physician Decision|0|||
48758188|NCT00311623|156962724|FG001|Overall Study|Physician Decision|0|||
48758189|NCT00311623|156962725|FG002|Overall Study|Physician Decision|2|||
48758190|NCT01912287|156962726|FG000|Overall Study|Ineligible|1|||
48758191|NCT01912287|156962727|FG001|Overall Study|Ineligible|0|||
48758192|NCT01912287|156962728|FG002|Overall Study|Ineligible|1|||
48758193|NCT01912287|156962726|FG000|Overall Study|No-show|0|||
48758194|NCT01912287|156962727|FG001|Overall Study|No-show|0|||
48758195|NCT01912287|156962728|FG002|Overall Study|No-show|1|||
48758196|NCT01912287|156962726|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
48758197|NCT01912287|156962727|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
48758198|NCT01912287|156962728|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
48758199|NCT01912287|156962726|FG000|Overall Study|Felt treatment no longer needed|0|||
48758200|NCT01912287|156962727|FG001|Overall Study|Felt treatment no longer needed|1|||
48758201|NCT01912287|156962728|FG002|Overall Study|Felt treatment no longer needed|0|||
48758202|NCT01912287|156962726|FG000|Overall Study|Life circumstances|4|||
48758203|NCT01912287|156962727|FG001|Overall Study|Life circumstances|2|||
48758204|NCT01912287|156962728|FG002|Overall Study|Life circumstances|0|||
48341572|NCT01697592|155445954|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48341573|NCT01697592|155445955|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48667091|NCT00461305|156634141|FG001|Continued Treatment|Partially missing diary|0|||
48667092|NCT00461305|156634140|FG000|Continued Treatment|Other (missing drug etc)|2|||
48667093|NCT00461305|156634141|FG001|Continued Treatment|Other (missing drug etc)|0|||
48667094|NCT01048866|156634142|FG000|Overall Study|Adverse Event|1|||
48667095|NCT01048866|156634143|FG001|Overall Study|Adverse Event|0|||
48667096|NCT01048866|156634142|FG000|Overall Study|Protocol Violation|1|||
48667097|NCT01048866|156634143|FG001|Overall Study|Protocol Violation|0|||
48667098|NCT01048866|156634142|FG000|Overall Study|Physician Decision|1|||
48667099|NCT01048866|156634143|FG001|Overall Study|Physician Decision|0|||
48667100|NCT01048866|156634142|FG000|Overall Study|Withdrawal by Subject|0|||
48667101|NCT01048866|156634143|FG001|Overall Study|Withdrawal by Subject|2|||
48667102|NCT01048866|156634142|FG000|Overall Study|Lost to Follow-up|0|||
48667103|NCT01048866|156634143|FG001|Overall Study|Lost to Follow-up|2|||
48667104|NCT01048866|156634142|FG000|Overall Study|Other|1|||
48667105|NCT01048866|156634143|FG001|Overall Study|Other|1|||
48667106|NCT00907296|156634146|FG000|Overall Study|Ineligibility Determined|1|||
48667107|NCT00907296|156634147|FG001|Overall Study|Ineligibility Determined|0|||
48667108|NCT00907296|156634148|FG002|Overall Study|Ineligibility Determined|0|||
48667109|NCT00907296|156634149|FG003|Overall Study|Ineligibility Determined|1|||
48667110|NCT00907296|156634150|FG004|Overall Study|Ineligibility Determined|0|||
48667111|NCT00907296|156634151|FG005|Overall Study|Ineligibility Determined|0|||
48667112|NCT00907296|156634152|FG006|Overall Study|Ineligibility Determined|0|||
48667113|NCT00907296|156634153|FG007|Overall Study|Ineligibility Determined|1|||
48667114|NCT00907296|156634154|FG008|Overall Study|Ineligibility Determined|0|||
48667115|NCT00907296|156634155|FG009|Overall Study|Ineligibility Determined|0|||
48667116|NCT00907296|156634146|FG000|Overall Study|Protocol Deviation|0|||
48667117|NCT00907296|156634147|FG001|Overall Study|Protocol Deviation|1|||
48758205|NCT01912287|156962726|FG000|Overall Study|Lost Interest|1|||
48758206|NCT01912287|156962727|FG001|Overall Study|Lost Interest|0|||
48758207|NCT01912287|156962728|FG002|Overall Study|Lost Interest|0|||
48758208|NCT01912287|156962726|FG000|Overall Study|Uknown reason - subject drop out|5|||
48758209|NCT01912287|156962727|FG001|Overall Study|Uknown reason - subject drop out|7|||
48341574|NCT01697592|155445956|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
48341575|NCT01697592|155445957|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
48341576|NCT01697592|155445948|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48667118|NCT00907296|156634148|FG002|Overall Study|Protocol Deviation|0|||
48667119|NCT00907296|156634149|FG003|Overall Study|Protocol Deviation|0|||
48667120|NCT00907296|156634150|FG004|Overall Study|Protocol Deviation|0|||
48667121|NCT00907296|156634151|FG005|Overall Study|Protocol Deviation|0|||
48667122|NCT00907296|156634152|FG006|Overall Study|Protocol Deviation|0|||
48758210|NCT01912287|156962728|FG002|Overall Study|Uknown reason - subject drop out|3|||
48758211|NCT01912287|156962726|FG000|Overall Study|Missed Assesment|1|||
48758212|NCT01912287|156962727|FG001|Overall Study|Missed Assesment|1|||
48758213|NCT01912287|156962728|FG002|Overall Study|Missed Assesment|1|||
48758214|NCT01912287|156962726|FG000|Overall Study|Scheduling/change in availability|17|||
48758215|NCT01912287|156962727|FG001|Overall Study|Scheduling/change in availability|10|||
48758216|NCT01912287|156962728|FG002|Overall Study|Scheduling/change in availability|8|||
48758217|NCT03103919|156962729|FG000|Overall Study|Adverse Event|2|||
48758218|NCT03103919|156962730|FG001|Overall Study|Adverse Event|2|||
48758219|NCT04984993|156962731|FG000|Overall Study|Withdrawal by Subject|8|||
48758220|NCT04984993|156962732|FG001|Overall Study|Withdrawal by Subject|2|||
48758221|NCT04984993|156962731|FG000|Overall Study|Lost to Follow-up|2|||
48758222|NCT04984993|156962732|FG001|Overall Study|Lost to Follow-up|2|||
48758223|NCT04984993|156962731|FG000|Overall Study|Both patients moved to another country|4|||
48758224|NCT04984993|156962732|FG001|Overall Study|Both patients moved to another country|0|||
48758225|NCT04577118|156962735|FG000|Overall Study|Withdrawal by Subject|4|||
48758226|NCT02710045|156962737|FG000|Overall Study|Death|1|||
48758227|NCT02710045|156962738|FG001|Overall Study|Death|2|||
48758228|NCT02710045|156962739|FG002|Overall Study|Death|0|||
48758229|NCT02710045|156962737|FG000|Overall Study|Withdrawal by Subject|6|||
48758230|NCT02710045|156962738|FG001|Overall Study|Withdrawal by Subject|6|||
48758231|NCT02710045|156962739|FG002|Overall Study|Withdrawal by Subject|2|||
48758232|NCT02710045|156962737|FG000|Overall Study|Protocol Violation|1|||
48758233|NCT02710045|156962738|FG001|Overall Study|Protocol Violation|2|||
48758234|NCT02710045|156962739|FG002|Overall Study|Protocol Violation|3|||
48758235|NCT02710045|156962737|FG000|Overall Study|Lost to Follow-up|3|||
48667123|NCT00907296|156634153|FG007|Overall Study|Protocol Deviation|0|||
48667124|NCT00907296|156634154|FG008|Overall Study|Protocol Deviation|0|||
48667125|NCT00907296|156634155|FG009|Overall Study|Protocol Deviation|0|||
48667126|NCT00907296|156634146|FG000|Overall Study|Noncompliance|1|||
48667127|NCT00907296|156634147|FG001|Overall Study|Noncompliance|1|||
48667128|NCT00907296|156634148|FG002|Overall Study|Noncompliance|1|||
48667129|NCT00907296|156634149|FG003|Overall Study|Noncompliance|0|||
48667130|NCT00907296|156634150|FG004|Overall Study|Noncompliance|0|||
48758236|NCT02710045|156962738|FG001|Overall Study|Lost to Follow-up|6|||
48758237|NCT02710045|156962739|FG002|Overall Study|Lost to Follow-up|7|||
48758238|NCT02710045|156962737|FG000|Overall Study|Physician Decision|0|||
48758239|NCT02710045|156962738|FG001|Overall Study|Physician Decision|0|||
48758240|NCT02710045|156962739|FG002|Overall Study|Physician Decision|1|||
48758241|NCT02710045|156962737|FG000|Overall Study|Poor Attendance|0|||
48758242|NCT02710045|156962738|FG001|Overall Study|Poor Attendance|1|||
48758243|NCT02710045|156962739|FG002|Overall Study|Poor Attendance|0|||
48758244|NCT01359449|156962740|FG000|Overall Study|Lost to Follow-up|1|||
48758245|NCT01359449|156962741|FG001|Overall Study|Lost to Follow-up|0|||
48758246|NCT01359449|156962740|FG000|Overall Study|Protocol Violation|0|||
48758247|NCT01359449|156962741|FG001|Overall Study|Protocol Violation|2|||
48667131|NCT00907296|156634151|FG005|Overall Study|Noncompliance|1|||
48667132|NCT00907296|156634152|FG006|Overall Study|Noncompliance|0|||
48667133|NCT00907296|156634153|FG007|Overall Study|Noncompliance|2|||
48667134|NCT00907296|156634154|FG008|Overall Study|Noncompliance|0|||
48667135|NCT00907296|156634155|FG009|Overall Study|Noncompliance|0|||
48667136|NCT00907296|156634146|FG000|Overall Study|Adverse Event|2|||
48667137|NCT00907296|156634147|FG001|Overall Study|Adverse Event|0|||
48667138|NCT00907296|156634148|FG002|Overall Study|Adverse Event|0|||
48667139|NCT00907296|156634149|FG003|Overall Study|Adverse Event|0|||
48667140|NCT00907296|156634150|FG004|Overall Study|Adverse Event|0|||
48667141|NCT00907296|156634151|FG005|Overall Study|Adverse Event|0|||
48667142|NCT00907296|156634152|FG006|Overall Study|Adverse Event|1|||
48667143|NCT00907296|156634153|FG007|Overall Study|Adverse Event|0|||
48667144|NCT00907296|156634154|FG008|Overall Study|Adverse Event|0|||
48667145|NCT00907296|156634155|FG009|Overall Study|Adverse Event|1|||
48667146|NCT00907296|156634146|FG000|Overall Study|Withdrawal by Subject|7|||
48667147|NCT00907296|156634147|FG001|Overall Study|Withdrawal by Subject|2|||
48667148|NCT00907296|156634148|FG002|Overall Study|Withdrawal by Subject|1|||
48667149|NCT00907296|156634149|FG003|Overall Study|Withdrawal by Subject|1|||
48758248|NCT01359449|156962740|FG000|Overall Study|Withdrawal by Subject|3|||
48758249|NCT01359449|156962741|FG001|Overall Study|Withdrawal by Subject|2|||
48758250|NCT03178773|156962746|FG000|Overall Study|Death|0|||
48758251|NCT03178773|156962747|FG001|Overall Study|Death|1|||
48758252|NCT03178773|156962746|FG000|Overall Study|Lost to Follow-up|29|||
48758253|NCT03178773|156962747|FG001|Overall Study|Lost to Follow-up|25|||
48758254|NCT03178773|156962746|FG000|Overall Study|Withdrawal by Subject|10|||
48758255|NCT03178773|156962747|FG001|Overall Study|Withdrawal by Subject|14|||
48758256|NCT01382446|156962748|FG000|Overall Study|Withdrawal by Subject|0|||
48758257|NCT01382446|156962749|FG001|Overall Study|Withdrawal by Subject|1|||
48667150|NCT00907296|156634150|FG004|Overall Study|Withdrawal by Subject|1|||
48667151|NCT00907296|156634151|FG005|Overall Study|Withdrawal by Subject|5|||
48758258|NCT01382446|156962748|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
48341577|NCT01697592|155445949|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
48341578|NCT01697592|155445950|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
48341579|NCT01697592|155445951|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
48341580|NCT01697592|155445952|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48341581|NCT01697592|155445953|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48341582|NCT01697592|155445954|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
48341583|NCT01697592|155445955|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48341584|NCT01697592|155445956|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
48341585|NCT01697592|155445957|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
48341586|NCT01697592|155445948|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
48341587|NCT01697592|155445949|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48341588|NCT01697592|155445950|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48341589|NCT01697592|155445951|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
48341590|NCT01697592|155445952|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48341591|NCT01697592|155445953|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48341592|NCT01697592|155445954|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48341593|NCT01697592|155445955|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48341594|NCT01697592|155445956|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48341595|NCT01697592|155445957|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
48341596|NCT01697592|155445948|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
48341597|NCT01697592|155445949|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48341598|NCT01697592|155445950|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48341599|NCT01697592|155445951|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48341600|NCT01697592|155445952|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48667152|NCT00907296|156634152|FG006|Overall Study|Withdrawal by Subject|3|||
48667153|NCT00907296|156634153|FG007|Overall Study|Withdrawal by Subject|2|||
48667154|NCT00907296|156634154|FG008|Overall Study|Withdrawal by Subject|4|||
48667155|NCT00907296|156634155|FG009|Overall Study|Withdrawal by Subject|2|||
48667156|NCT00907296|156634146|FG000|Overall Study|Lost to Follow-up|9|||
48667157|NCT00907296|156634147|FG001|Overall Study|Lost to Follow-up|1|||
48667158|NCT00907296|156634148|FG002|Overall Study|Lost to Follow-up|0|||
48667159|NCT00907296|156634149|FG003|Overall Study|Lost to Follow-up|2|||
48667160|NCT00907296|156634150|FG004|Overall Study|Lost to Follow-up|0|||
48667161|NCT00907296|156634151|FG005|Overall Study|Lost to Follow-up|3|||
48667162|NCT00907296|156634152|FG006|Overall Study|Lost to Follow-up|2|||
48667163|NCT00907296|156634153|FG007|Overall Study|Lost to Follow-up|2|||
48667164|NCT00907296|156634154|FG008|Overall Study|Lost to Follow-up|0|||
48667165|NCT00907296|156634155|FG009|Overall Study|Lost to Follow-up|4|||
48667166|NCT02395055|156634156|FG000|Overall Study|Withdrawal by Subject|7|||
48667167|NCT02395055|156634157|FG001|Overall Study|Withdrawal by Subject|3|||
48667168|NCT00707746|156634158|FG000|Treatment Period|Adverse Event|2|||
48667169|NCT00707746|156634159|FG001|Treatment Period|Adverse Event|4|||
48667170|NCT00707746|156634158|FG000|Treatment Period|Ineligibility|0|||
48667171|NCT00707746|156634159|FG001|Treatment Period|Ineligibility|1|||
48667172|NCT02392403|156634160|FG000|Overall Study|Adverse Event|1|||
48667173|NCT02392403|156634160|FG000|Overall Study|Death|1|||
48667174|NCT02392403|156634160|FG000|Overall Study|Withdrawal by Subject|1|||
48667175|NCT01219933|156634162|FG000|Overall Study|Adverse Event|8|||
48667176|NCT01219933|156634162|FG000|Overall Study|No LDA reached|5|||
48667177|NCT01219933|156634162|FG000|Overall Study|No LDA maintained|7|||
48341601|NCT01697592|155445953|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
48341602|NCT01697592|155445954|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48341603|NCT01697592|155445955|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
48341604|NCT01697592|155445956|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48341605|NCT01697592|155445957|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
48341606|NCT01697592|155445948|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
48341607|NCT01697592|155445949|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
48341608|NCT01697592|155445950|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
48341609|NCT01697592|155445951|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
48341610|NCT01697592|155445952|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
48667178|NCT01219933|156634162|FG000|Overall Study|Lost to Follow-up|3|||
48667179|NCT01219933|156634162|FG000|Overall Study|GC free|1|||
48758259|NCT01382446|156962749|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
48758260|NCT00483379|156962751|FG000|Treatment Period|Adverse Event|1|||
48341611|NCT01697592|155445953|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
48341612|NCT01697592|155445954|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
48341613|NCT01697592|155445955|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
48341614|NCT01697592|155445956|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
48341615|NCT01697592|155445957|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
48341616|NCT03568708|155445958|FG000|Overall Study|Withdrawal by Subject|1|||
48428233|NCT02531373|155756500|FG002|Overall Study|Protocol Violation|0|||
48667180|NCT01219933|156634162|FG000|Overall Study|Withdrawal by Subject|5|||
48667181|NCT01219933|156634162|FG000|Overall Study|Protocol Violation|8|||
48667182|NCT01219933|156634162|FG000|Overall Study|Lack of Efficacy|1|||
48758261|NCT00483379|156962752|FG001|Treatment Period|Adverse Event|0|||
48758262|NCT00483379|156962751|FG000|Treatment Period|Withdrawal by Subject|1|||
48758263|NCT00483379|156962752|FG001|Treatment Period|Withdrawal by Subject|0|||
48758264|NCT00514540|156962753|FG000|First-Line Chemo|Withdrawal by Subject|1|||
48758265|NCT00514540|156962753|FG000|First-Line Chemo|Protocol Violation|7|||
48758266|NCT00514540|156962753|FG000|Second-Line|Physician/Patient Decision|31|||
48758267|NCT00422591|156962754|FG000|Overall Study|Physician Decision|4|||
48758268|NCT00422591|156962754|FG000|Overall Study|Withdrawal by Subject|2|||
48758269|NCT04210310|156962755|FG000|Overall Study|Lost to Follow-up|32|||
48758270|NCT04210310|156962756|FG001|Overall Study|Lost to Follow-up|1|||
48758271|NCT00680745|156962760|FG000|Overall Study|Withdrawal by Subject|8|||
48758272|NCT00680745|156962761|FG001|Overall Study|Withdrawal by Subject|3|||
48758273|NCT00680745|156962762|FG002|Overall Study|Withdrawal by Subject|2|||
48758274|NCT00680745|156962763|FG003|Overall Study|Withdrawal by Subject|8|||
48758275|NCT00680745|156962760|FG000|Overall Study|Lost to Follow-up|0|||
48758276|NCT00680745|156962761|FG001|Overall Study|Lost to Follow-up|1|||
48758277|NCT00680745|156962762|FG002|Overall Study|Lost to Follow-up|1|||
48758278|NCT00680745|156962763|FG003|Overall Study|Lost to Follow-up|0|||
48758279|NCT00680745|156962760|FG000|Overall Study|Death|1|||
48758280|NCT00680745|156962761|FG001|Overall Study|Death|0|||
48758281|NCT00680745|156962762|FG002|Overall Study|Death|1|||
48758282|NCT00680745|156962763|FG003|Overall Study|Death|0|||
48758283|NCT00680745|156962760|FG000|Overall Study|Adverse Event|5|||
48758284|NCT00680745|156962761|FG001|Overall Study|Adverse Event|3|||
48667183|NCT00316888|156634163|FG000|Overall Study|Adverse Event|4|||
48667184|NCT00316888|156634164|FG001|Overall Study|Adverse Event|5|||
48667185|NCT00316888|156634163|FG000|Overall Study|Withdrawal by Subject|2|||
48667186|NCT00316888|156634164|FG001|Overall Study|Withdrawal by Subject|2|||
48667187|NCT00316888|156634163|FG000|Overall Study|Not start protocol therapy|0|||
48667188|NCT00316888|156634164|FG001|Overall Study|Not start protocol therapy|1|||
48667189|NCT05239221|156634165|FG000|Overall Study|Adverse Event|0|||
48667190|NCT05239221|156634166|FG001|Overall Study|Adverse Event|0|||
48667191|NCT05239221|156634167|FG002|Overall Study|Adverse Event|0|||
48667192|NCT05239221|156634168|FG003|Overall Study|Adverse Event|0|||
48667193|NCT05239221|156634169|FG004|Overall Study|Adverse Event|0|||
48667194|NCT05239221|156634170|FG005|Overall Study|Adverse Event|0|||
48667195|NCT05239221|156634171|FG006|Overall Study|Adverse Event|1|||
48667196|NCT05239221|156634172|FG007|Overall Study|Adverse Event|0|||
48667197|NCT05239221|156634173|FG008|Overall Study|Adverse Event|0|||
48667198|NCT05239221|156634174|FG009|Overall Study|Adverse Event|0|||
48667199|NCT05239221|156634175|FG010|Overall Study|Adverse Event|1|||
48667200|NCT05239221|156634176|FG011|Overall Study|Adverse Event|1|||
48667201|NCT05239221|156634177|FG012|Overall Study|Adverse Event|0|||
48758285|NCT00680745|156962762|FG002|Overall Study|Adverse Event|3|||
48758286|NCT00680745|156962763|FG003|Overall Study|Adverse Event|3|||
48758287|NCT00680745|156962760|FG000|Overall Study|Poor/Non-compliance|0|||
48758288|NCT00680745|156962761|FG001|Overall Study|Poor/Non-compliance|3|||
48758289|NCT00680745|156962762|FG002|Overall Study|Poor/Non-compliance|0|||
48758290|NCT00680745|156962763|FG003|Overall Study|Poor/Non-compliance|0|||
48758291|NCT00680745|156962760|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
48758292|NCT00680745|156962761|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
48758293|NCT00680745|156962762|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
48341617|NCT03568708|155445959|FG001|Overall Study|Withdrawal by Subject|1|||
48341618|NCT03568708|155445958|FG000|Overall Study|Lost to Follow-up|0|||
48341619|NCT03568708|155445959|FG001|Overall Study|Lost to Follow-up|1|||
48341620|NCT01126879|155445960|FG000|Overall Study|Progressive Disease|3|||
48341621|NCT01126879|155445961|FG001|Overall Study|Progressive Disease|1|||
48341622|NCT01126879|155445960|FG000|Overall Study|Withdrawal by Subject|1|||
48341623|NCT01126879|155445961|FG001|Overall Study|Withdrawal by Subject|0|||
48341624|NCT01126879|155445960|FG000|Overall Study|Adverse Event|0|||
48341625|NCT01126879|155445961|FG001|Overall Study|Adverse Event|1|||
48341626|NCT01126879|155445960|FG000|Overall Study|Physician Decision|1|||
48341627|NCT01126879|155445961|FG001|Overall Study|Physician Decision|0|||
48341628|NCT05109117|155445962|FG000|Overall Study|Lost to Follow-up|1|||
48341629|NCT05109117|155445962|FG000|Overall Study|Discontinued for non-compliance|1|||
48341630|NCT01107353|155445965|FG000|Overall Study|Positive Drug Screen|1|||
48341631|NCT01107353|155445966|FG001|Overall Study|Positive Drug Screen|0|||
48341632|NCT02544113|155445971|FG000|Overall Study|Death|3|||
48341633|NCT02544113|155445972|FG001|Overall Study|Death|4|||
48341634|NCT00168805|155445973|FG000|Overall Study|Adverse Event|7|||
48341635|NCT00168805|155445974|FG001|Overall Study|Adverse Event|11|||
48341636|NCT00168805|155445975|FG002|Overall Study|Adverse Event|16|||
48341637|NCT00168805|155445973|FG000|Overall Study|Protocol Violation|12|||
48341638|NCT00168805|155445974|FG001|Overall Study|Protocol Violation|11|||
48341639|NCT00168805|155445975|FG002|Overall Study|Protocol Violation|8|||
48341640|NCT00168805|155445973|FG000|Overall Study|Lost to Follow-up|12|||
48341641|NCT00168805|155445974|FG001|Overall Study|Lost to Follow-up|17|||
48341642|NCT00168805|155445975|FG002|Overall Study|Lost to Follow-up|11|||
48341643|NCT00168805|155445973|FG000|Overall Study|Withdrawal by Subject|16|||
48341644|NCT00168805|155445974|FG001|Overall Study|Withdrawal by Subject|18|||
48341645|NCT00168805|155445975|FG002|Overall Study|Withdrawal by Subject|21|||
48341646|NCT00168805|155445973|FG000|Overall Study|Other|24|||
48341647|NCT00168805|155445974|FG001|Overall Study|Other|21|||
48341648|NCT00168805|155445975|FG002|Overall Study|Other|22|||
48341649|NCT00168805|155445973|FG000|Treatment|Adverse Event|25|||
48341650|NCT00168805|155445974|FG001|Treatment|Adverse Event|26|||
48341651|NCT00168805|155445975|FG002|Treatment|Adverse Event|32|||
48341652|NCT00168805|155445973|FG000|Treatment|Protocol Violation|3|||
48341653|NCT00168805|155445974|FG001|Treatment|Protocol Violation|5|||
48341654|NCT00168805|155445975|FG002|Treatment|Protocol Violation|5|||
48341655|NCT00168805|155445973|FG000|Treatment|Withdrawal by Subject|3|||
48341656|NCT00168805|155445974|FG001|Treatment|Withdrawal by Subject|7|||
48341657|NCT00168805|155445975|FG002|Treatment|Withdrawal by Subject|8|||
48341658|NCT00168805|155445973|FG000|Treatment|Other|18|||
48341659|NCT00168805|155445974|FG001|Treatment|Other|18|||
48341660|NCT00168805|155445975|FG002|Treatment|Other|17|||
48341661|NCT01837719|155445978|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
48341662|NCT01837719|155445978|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
48341663|NCT01878253|155445981|FG000|Overall Study|Death|1|||
48341664|NCT01878253|155445981|FG000|Overall Study|SIdus System Removal|3|||
48341665|NCT01878253|155445981|FG000|Overall Study|Withdrawal by Subject|1|||
48341666|NCT01878253|155445981|FG000|Overall Study|Lost to Follow-up|2|||
48341667|NCT01878253|155445981|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
48341668|NCT02391116|155445982|FG000|Treatment|Withdrawal by Subject|1|||
48341669|NCT02391116|155445982|FG000|Treatment|Protocol Violation|1|||
48341670|NCT02391116|155445982|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
48341671|NCT02391116|155445982|FG000|Treatment|AE with Clinical PD|3|||
48341672|NCT02391116|155445982|FG000|Safety Follow-up|Adverse Event|1|||
48341673|NCT02391116|155445982|FG000|Safety Follow-up|Withdrawal by Subject|4|||
48341674|NCT02391116|155445982|FG000|Safety Follow-up|Switching to Other Therapy|4|||
48341675|NCT02391116|155445982|FG000|Safety Follow-up|No Follow Up|1|||
48341676|NCT02391116|155445982|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
48341677|NCT02391116|155445982|FG000|Active Follow-up|Withdrawal by Subject|1|||
48341678|NCT02391116|155445982|FG000|Active Follow-up|Switching to Other Therapy|2|||
48341679|NCT02391116|155445982|FG000|Survival Follow-up|Withdrawal by Subject|3|||
48341680|NCT02391116|155445982|FG000|Survival Follow-up|Switching to Other Therapy|1|||
48341681|NCT03078751|155445984|FG000|Overall Study|Adverse Event|4|||
48341682|NCT03078751|155445985|FG001|Overall Study|Adverse Event|0|||
48341683|NCT03078751|155445984|FG000|Overall Study|Physician Decision|1|||
48341684|NCT03078751|155445985|FG001|Overall Study|Physician Decision|0|||
48341685|NCT03078751|155445984|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
48341686|NCT03078751|155445985|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
48341687|NCT03078751|155445984|FG000|Overall Study|Subject/guardian decision|8|||
48341688|NCT03078751|155445985|FG001|Overall Study|Subject/guardian decision|1|||
48341689|NCT03078751|155445984|FG000|Overall Study|Untreated|0|||
48341690|NCT03078751|155445985|FG001|Overall Study|Untreated|4|||
48341691|NCT02515097|155445991|FG000|Overall Study|Lost to Follow-up|4|||
48341692|NCT02515097|155445992|FG001|Overall Study|Lost to Follow-up|2|||
48341693|NCT02515097|155445991|FG000|Overall Study|Withdrawal by Subject|1|||
48341694|NCT02515097|155445992|FG001|Overall Study|Withdrawal by Subject|3|||
48341695|NCT02515097|155445991|FG000|Overall Study|Adverse Event|2|||
48341696|NCT02515097|155445992|FG001|Overall Study|Adverse Event|1|||
48341697|NCT00424177|155446002|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
48341698|NCT00424177|155446002|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
48341699|NCT00424177|155446002|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
48341700|NCT00424177|155446002|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
48341701|NCT00424177|155446002|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
48341702|NCT00424177|155446002|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
48341703|NCT00424177|155446002|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
48341704|NCT00424177|155446002|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
48341705|NCT00424177|155446002|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
48341706|NCT00424177|155446002|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
48341707|NCT04088136|155446003|FG000|Overall Study|Withdrawal by Subject|5|||
48341708|NCT04088136|155446004|FG001|Overall Study|Withdrawal by Subject|0|||
48341709|NCT04088136|155446003|FG000|Overall Study|Lack of Efficacy|0|||
48341710|NCT04088136|155446004|FG001|Overall Study|Lack of Efficacy|1|||
48341711|NCT01177228|155446005|FG000|Overall Study|Positive tuberculosis test|0|||
48341712|NCT01177228|155446006|FG001|Overall Study|Positive tuberculosis test|1|||
48341713|NCT01177228|155446007|FG002|Overall Study|Positive tuberculosis test|0|||
48341714|NCT01177228|155446008|FG003|Overall Study|Positive tuberculosis test|0|||
48341715|NCT01177228|155446005|FG000|Overall Study|Worsening disease activity|1|||
48341716|NCT01177228|155446006|FG001|Overall Study|Worsening disease activity|0|||
48341717|NCT01177228|155446007|FG002|Overall Study|Worsening disease activity|0|||
48341718|NCT01177228|155446008|FG003|Overall Study|Worsening disease activity|0|||
48341719|NCT01177228|155446005|FG000|Overall Study|Withdrawal by Subject|0|||
48341720|NCT01177228|155446006|FG001|Overall Study|Withdrawal by Subject|1|||
48341721|NCT01177228|155446007|FG002|Overall Study|Withdrawal by Subject|0|||
48341722|NCT01177228|155446008|FG003|Overall Study|Withdrawal by Subject|0|||
48341723|NCT00655668|155446009|FG000|Overall Study|Adverse Event|6|||
48341724|NCT00655668|155446009|FG000|Overall Study|Death|5|||
48341725|NCT00655668|155446009|FG000|Overall Study|Disease Progression|27|||
48341726|NCT00655668|155446009|FG000|Overall Study|Study Terminated|9|||
48341727|NCT00655668|155446009|FG000|Overall Study|Other|1|||
48341728|NCT00655668|155446009|FG000|Overall Study|New Lymphoma Treatment Started|4|||
48341729|NCT00655668|155446009|FG000|Overall Study|Withdrawal by Subject|2|||
48341730|NCT00006436|155446014|FG000|Overall Study|Refused further treatment|2|||
48341731|NCT00006436|155446014|FG000|Overall Study|Declined to participate (before treatment started)|1|||
48341732|NCT00316589|155446015|FG000|Overall Study|Withdrawal by Subject|0|||
48341733|NCT00316589|155446016|FG001|Overall Study|Withdrawal by Subject|5|||
48341734|NCT00316589|155446017|FG002|Overall Study|Withdrawal by Subject|0|||
48667202|NCT05239221|156634178|FG013|Overall Study|Adverse Event|0|||
48341735|NCT00316589|155446018|FG003|Overall Study|Withdrawal by Subject|1|||
48341736|NCT00316589|155446015|FG000|Overall Study|Subject unwilling/unable to comply|0|||
48341737|NCT00316589|155446016|FG001|Overall Study|Subject unwilling/unable to comply|6|||
48341738|NCT00316589|155446017|FG002|Overall Study|Subject unwilling/unable to comply|0|||
48341739|NCT00316589|155446018|FG003|Overall Study|Subject unwilling/unable to comply|2|||
48341740|NCT00316589|155446015|FG000|Overall Study|Adverse Event|1|||
48667203|NCT05239221|156634179|FG014|Overall Study|Adverse Event|0|||
48341741|NCT00316589|155446016|FG001|Overall Study|Adverse Event|0|||
48341742|NCT00316589|155446017|FG002|Overall Study|Adverse Event|0|||
48341743|NCT00316589|155446018|FG003|Overall Study|Adverse Event|1|||
48341744|NCT00316589|155446015|FG000|Overall Study|Physician Decision|0|||
48341745|NCT00316589|155446016|FG001|Overall Study|Physician Decision|1|||
48667204|NCT05239221|156634180|FG015|Overall Study|Adverse Event|0|||
48667205|NCT05239221|156634165|FG000|Overall Study|Withdrawal by Subject|0|||
48667206|NCT05239221|156634166|FG001|Overall Study|Withdrawal by Subject|0|||
48667207|NCT05239221|156634167|FG002|Overall Study|Withdrawal by Subject|0|||
48667208|NCT05239221|156634168|FG003|Overall Study|Withdrawal by Subject|0|||
48667209|NCT05239221|156634169|FG004|Overall Study|Withdrawal by Subject|0|||
48667210|NCT05239221|156634170|FG005|Overall Study|Withdrawal by Subject|0|||
48667211|NCT05239221|156634171|FG006|Overall Study|Withdrawal by Subject|0|||
48667212|NCT05239221|156634172|FG007|Overall Study|Withdrawal by Subject|0|||
48667213|NCT05239221|156634173|FG008|Overall Study|Withdrawal by Subject|0|||
48667214|NCT05239221|156634174|FG009|Overall Study|Withdrawal by Subject|0|||
48667215|NCT05239221|156634175|FG010|Overall Study|Withdrawal by Subject|1|||
48667216|NCT05239221|156634176|FG011|Overall Study|Withdrawal by Subject|0|||
48667217|NCT05239221|156634177|FG012|Overall Study|Withdrawal by Subject|0|||
48667218|NCT05239221|156634178|FG013|Overall Study|Withdrawal by Subject|0|||
48667219|NCT05239221|156634179|FG014|Overall Study|Withdrawal by Subject|0|||
48667220|NCT05239221|156634180|FG015|Overall Study|Withdrawal by Subject|1|||
48667221|NCT00652899|156634181|FG000|Overall Study|Death|1|||
48667222|NCT00652899|156634181|FG000|Overall Study|Treating physician decision|1|||
48341746|NCT00316589|155446017|FG002|Overall Study|Physician Decision|0|||
48341747|NCT00316589|155446018|FG003|Overall Study|Physician Decision|0|||
48341748|NCT00316589|155446015|FG000|Overall Study|Other reason|0|||
48341749|NCT00316589|155446016|FG001|Overall Study|Other reason|12|||
48341750|NCT00316589|155446017|FG002|Overall Study|Other reason|1|||
48341751|NCT00316589|155446018|FG003|Overall Study|Other reason|1|||
48341752|NCT00443599|155446021|FG000|Overall Study|Physician Decision|2|||
48341753|NCT00443599|155446022|FG001|Overall Study|Physician Decision|1|||
48341754|NCT00443599|155446021|FG000|Overall Study|Death|1|||
48341755|NCT00443599|155446022|FG001|Overall Study|Death|1|||
48341756|NCT00443599|155446021|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
48341757|NCT00443599|155446022|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
48341758|NCT01064856|155446023|FG000|Double-blind (DB) Period|Adverse Event|1|||
48341759|NCT01064856|155446024|FG001|Double-blind (DB) Period|Adverse Event|0|||
48341760|NCT01064856|155446025|FG002|Double-blind (DB) Period|Adverse Event|0|||
48341761|NCT01064856|155446026|FG003|Double-blind (DB) Period|Adverse Event|0|||
48341762|NCT01064856|155446023|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
48341763|NCT01064856|155446024|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
48341764|NCT01064856|155446025|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
48341765|NCT01064856|155446026|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
48341766|NCT01064856|155446023|FG000|Open-label (OL) Period|Adverse Event|0|||
48341767|NCT01064856|155446024|FG001|Open-label (OL) Period|Adverse Event|0|||
48341768|NCT01064856|155446025|FG002|Open-label (OL) Period|Adverse Event|12|||
48341769|NCT01064856|155446026|FG003|Open-label (OL) Period|Adverse Event|6|||
48341770|NCT01064856|155446023|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
48341771|NCT01064856|155446024|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
48341772|NCT01064856|155446025|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
48341773|NCT01064856|155446026|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
48341774|NCT01064856|155446023|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
48341775|NCT01064856|155446024|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
48341776|NCT01064856|155446025|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
48341777|NCT01064856|155446026|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
48341778|NCT01064856|155446023|FG000|Open-label (OL) Period|Other|0|||
48341779|NCT01064856|155446024|FG001|Open-label (OL) Period|Other|0|||
48341780|NCT01064856|155446025|FG002|Open-label (OL) Period|Other|7|||
48341781|NCT01064856|155446026|FG003|Open-label (OL) Period|Other|7|||
48341782|NCT01894256|155446027|FG000|Part A|Adverse Event|0|||
48341783|NCT01894256|155446028|FG001|Part A|Adverse Event|1|||
48341784|NCT01894256|155446029|FG002|Part A|Adverse Event|0|||
48341785|NCT01894256|155446027|FG000|Part B|Death|0|||
48341786|NCT01894256|155446028|FG001|Part B|Death|1|||
48341787|NCT01894256|155446029|FG002|Part B|Death|1|||
48341788|NCT01894256|155446027|FG000|Part B|Withdrawal by Subject|0|||
48341789|NCT01894256|155446028|FG001|Part B|Withdrawal by Subject|1|||
48341790|NCT01894256|155446029|FG002|Part B|Withdrawal by Subject|0|||
48341791|NCT01894256|155446027|FG000|Part B|Lack of Efficacy|15|||
48667223|NCT03461406|156634182|FG000|Overall Study|Death|1|||
48667224|NCT03461406|156634183|FG001|Overall Study|Death|2|||
48341792|NCT01894256|155446028|FG001|Part B|Lack of Efficacy|12|||
48341793|NCT01894256|155446029|FG002|Part B|Lack of Efficacy|13|||
48341794|NCT03036124|155446030|FG000|Overall Study|Lost to Follow-up|0|||
48341795|NCT03036124|155446031|FG001|Overall Study|Lost to Follow-up|2|||
48341796|NCT03036124|155446030|FG000|Overall Study|Withdrawal by Subject|5|||
48341797|NCT03036124|155446031|FG001|Overall Study|Withdrawal by Subject|4|||
48341798|NCT01283971|155446032|FG000|Overall Study|Adverse Event|3|||
48341799|NCT01283971|155446033|FG001|Overall Study|Adverse Event|5|||
48667225|NCT03461406|156634182|FG000|Overall Study|Consent Withdrawn by Participant|0|||
48667226|NCT03461406|156634183|FG001|Overall Study|Consent Withdrawn by Participant|1|||
48667227|NCT03461406|156634182|FG000|Overall Study|Screen Failure|3|||
48428234|NCT02531373|155756501|FG003|Overall Study|Protocol Violation|0|||
48341800|NCT01283971|155446032|FG000|Overall Study|Insufficient therapeutic responses|3|||
48667228|NCT03461406|156634183|FG001|Overall Study|Screen Failure|1|||
48667229|NCT03461406|156634182|FG000|Overall Study|Reason not Specified|1|||
48667230|NCT03461406|156634183|FG001|Overall Study|Reason not Specified|3|||
48667231|NCT03461406|156634182|FG000|Overall Study|Lost to Follow-up|3|||
48667232|NCT03461406|156634183|FG001|Overall Study|Lost to Follow-up|0|||
48667233|NCT02639338|156634184|FG000|Overall Study|Lost to Follow-up|2|||
48667234|NCT02639338|156634185|FG001|Overall Study|Lost to Follow-up|2|||
48667235|NCT02639338|156634184|FG000|Overall Study|Withdrew Consent|1|||
48667236|NCT02639338|156634185|FG001|Overall Study|Withdrew Consent|2|||
48667237|NCT02639338|156634184|FG000|Overall Study|Death|1|||
48667238|NCT02639338|156634185|FG001|Overall Study|Death|0|||
48667239|NCT02639338|156634184|FG000|Overall Study|Randomized but Not Treated|0|||
48667240|NCT02639338|156634185|FG001|Overall Study|Randomized but Not Treated|1|||
48341801|NCT01283971|155446033|FG001|Overall Study|Insufficient therapeutic responses|3|||
48341802|NCT01283971|155446032|FG000|Overall Study|Protocol Violation|5|||
48667241|NCT02715726|156634189|FG000|Overall Study|Adverse Event|2|||
48667242|NCT02715726|156634190|FG001|Overall Study|Adverse Event|6|||
48667243|NCT02715726|156634189|FG000|Overall Study|Protocol Violation|1|||
48667244|NCT02715726|156634190|FG001|Overall Study|Protocol Violation|0|||
48667245|NCT02715726|156634189|FG000|Overall Study|Death|2|||
48667246|NCT02715726|156634190|FG001|Overall Study|Death|1|||
48667247|NCT02715726|156634189|FG000|Overall Study|Participant moved|1|||
48758294|NCT00680745|156962763|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
48758295|NCT00680745|156962760|FG000|Overall Study|False Treatment|0|||
48758296|NCT00680745|156962761|FG001|Overall Study|False Treatment|1|||
48758297|NCT00680745|156962762|FG002|Overall Study|False Treatment|3|||
48758298|NCT00680745|156962763|FG003|Overall Study|False Treatment|0|||
48667248|NCT02715726|156634190|FG001|Overall Study|Participant moved|3|||
48667249|NCT02715726|156634189|FG000|Overall Study|Other than specified above|11|||
48667250|NCT02715726|156634190|FG001|Overall Study|Other than specified above|15|||
48667251|NCT02715726|156634189|FG000|Overall Study|Randomized but not treated|1|||
48667252|NCT02715726|156634190|FG001|Overall Study|Randomized but not treated|2|||
48758299|NCT01574612|156962764|FG000|Overall Study|Adverse Event|3|||
48758300|NCT01574612|156962764|FG000|Overall Study|non compliant with drug|2|||
48758301|NCT01574612|156962764|FG000|Overall Study|Withdrawal by Subject|1|||
48758302|NCT01574612|156962764|FG000|Overall Study|Lost to Follow-up|2|||
48758303|NCT02604212|156962766|FG000|Overall Study|Study Terminated by Sponsor|2|||
48758304|NCT02604212|156962767|FG001|Overall Study|Study Terminated by Sponsor|1|||
48758305|NCT02604212|156962768|FG002|Overall Study|Study Terminated by Sponsor|3|||
48758306|NCT02604212|156962769|FG003|Overall Study|Study Terminated by Sponsor|3|||
48758307|NCT02604212|156962766|FG000|Overall Study|Withdrawal by Subject|0|||
48758308|NCT02604212|156962767|FG001|Overall Study|Withdrawal by Subject|0|||
48758309|NCT02604212|156962768|FG002|Overall Study|Withdrawal by Subject|1|||
48758310|NCT02604212|156962769|FG003|Overall Study|Withdrawal by Subject|0|||
48758311|NCT01892501|156962774|FG000|Overall Study|Protocol Violation|2|||
48758312|NCT01892501|156962774|FG000|Overall Study|Puncture not carried out|9|||
48758313|NCT01892501|156962774|FG000|Overall Study|Radiological monitoring not carried out|5|||
48758314|NCT01892501|156962774|FG000|Overall Study|Non-contributory histological result|12|||
48758315|NCT04339296|156962778|FG000|Overall Study|Refuse to participate after allocation|1|||
48758316|NCT04339296|156962779|FG001|Overall Study|Refuse to participate after allocation|1|||
48758317|NCT04339296|156962778|FG000|Overall Study|Withdrew after completion of baseline|2|||
48758318|NCT04339296|156962779|FG001|Overall Study|Withdrew after completion of baseline|1|||
48667253|NCT01565941|156634191|FG000|Overall Study|Withdrawn by parent/guardian|3|||
48667254|NCT01565941|156634192|FG001|Overall Study|Withdrawn by parent/guardian|2|||
48758319|NCT04339296|156962778|FG000|Overall Study|Lost to Follow-up|0|||
48341803|NCT01283971|155446033|FG001|Overall Study|Protocol Violation|1|||
48667255|NCT01565941|156634191|FG000|Overall Study|Randomized; did not receive intevention|8|||
48667256|NCT01565941|156634192|FG001|Overall Study|Randomized; did not receive intevention|2|||
48667257|NCT03541187|156634195|FG000|Overall Study|Lost to Follow-up|2|||
48667258|NCT03541187|156634196|FG001|Overall Study|Lost to Follow-up|6|||
48667259|NCT03541187|156634195|FG000|Overall Study|Pregnancy|0|||
48667260|NCT03541187|156634196|FG001|Overall Study|Pregnancy|1|||
48667261|NCT03541187|156634195|FG000|Overall Study|Withdrawal by Subject|6|||
48667262|NCT03541187|156634196|FG001|Overall Study|Withdrawal by Subject|2|||
48758320|NCT04339296|156962779|FG001|Overall Study|Lost to Follow-up|4|||
48758321|NCT04339296|156962778|FG000|Overall Study|Discontinued intervention|5|||
48758322|NCT04339296|156962779|FG001|Overall Study|Discontinued intervention|3|||
48667263|NCT03541187|156634195|FG000|Overall Study|Moved out of town|1|||
48667264|NCT03541187|156634196|FG001|Overall Study|Moved out of town|0|||
48667265|NCT03541187|156634195|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
48667266|NCT03541187|156634196|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
48667267|NCT03541187|156634195|FG000|Overall Study|Did not meet randomization criteria|1|||
48667268|NCT03541187|156634196|FG001|Overall Study|Did not meet randomization criteria|1|||
48667269|NCT03541187|156634195|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
48667270|NCT03541187|156634196|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
48667271|NCT03541187|156634195|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
48758323|NCT03311659|156962780|FG000|Overall Study|Protocol Violation|1|||
48758324|NCT03492216|156962785|FG000|Overall Study|Death|1|||
48758325|NCT03492216|156962786|FG001|Overall Study|Death|0|||
48758326|NCT03492216|156962787|FG002|Overall Study|Death|4|||
48758327|NCT03492216|156962788|FG003|Overall Study|Death|0|||
48758328|NCT03492216|156962785|FG000|Overall Study|Withdrawal by Subject|5|||
48758329|NCT03492216|156962786|FG001|Overall Study|Withdrawal by Subject|3|||
48758330|NCT03492216|156962787|FG002|Overall Study|Withdrawal by Subject|1|||
48758331|NCT03492216|156962788|FG003|Overall Study|Withdrawal by Subject|1|||
48758332|NCT03492216|156962785|FG000|Overall Study|Lost to Follow-up|9|||
48758333|NCT03492216|156962786|FG001|Overall Study|Lost to Follow-up|2|||
48758334|NCT03492216|156962787|FG002|Overall Study|Lost to Follow-up|7|||
48758335|NCT03492216|156962788|FG003|Overall Study|Lost to Follow-up|8|||
48758336|NCT03492216|156962785|FG000|Overall Study|Moved|5|||
48758337|NCT03492216|156962786|FG001|Overall Study|Moved|3|||
48758338|NCT03492216|156962787|FG002|Overall Study|Moved|3|||
48758339|NCT03492216|156962788|FG003|Overall Study|Moved|5|||
48758340|NCT03492216|156962785|FG000|Overall Study|Too ill|0|||
48758341|NCT03492216|156962786|FG001|Overall Study|Too ill|1|||
48758342|NCT03492216|156962787|FG002|Overall Study|Too ill|0|||
48758343|NCT03492216|156962788|FG003|Overall Study|Too ill|0|||
48758344|NCT03492216|156962785|FG000|Overall Study|Incarcerated|0|||
48758345|NCT03492216|156962786|FG001|Overall Study|Incarcerated|0|||
48758346|NCT03492216|156962787|FG002|Overall Study|Incarcerated|2|||
48758347|NCT03492216|156962788|FG003|Overall Study|Incarcerated|0|||
48758348|NCT02810392|156962790|FG000|Overall Study|Subject too ill to continue|1|||
48758349|NCT02810392|156962791|FG001|Overall Study|Subject too ill to continue|0|||
48758350|NCT02810392|156962790|FG000|Overall Study|COVID 19 research restrictions|0|||
48758351|NCT02810392|156962791|FG001|Overall Study|COVID 19 research restrictions|1|||
48758352|NCT00453544|156962792|FG000|Overall Study|Withdrawal by Subject|1|||
48758353|NCT00453544|156962793|FG001|Overall Study|Withdrawal by Subject|0|||
48341804|NCT01283971|155446032|FG000|Overall Study|Refused treatment|3|||
48341805|NCT01283971|155446033|FG001|Overall Study|Refused treatment|1|||
48341806|NCT01283971|155446032|FG000|Overall Study|Failure to return|0|||
48341807|NCT01283971|155446033|FG001|Overall Study|Failure to return|1|||
48341808|NCT01283971|155446032|FG000|Overall Study|Administrative reasons|1|||
48341809|NCT01283971|155446033|FG001|Overall Study|Administrative reasons|1|||
48341810|NCT01946529|155446035|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
48341811|NCT01946529|155446036|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
48341812|NCT01946529|155446037|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
48341813|NCT01946529|155446035|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
48341814|NCT01946529|155446036|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
48341815|NCT01946529|155446037|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
48341816|NCT03049306|155446038|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
48341817|NCT03049306|155446039|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
48341818|NCT03151551|155446041|FG000|Open-Label Treatment Period|Adverse Event|0|||
48667272|NCT03541187|156634196|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
48667273|NCT00973102|156634197|FG000|Overall Study|Protocol Violation|1|||
48667274|NCT00973102|156634198|FG001|Overall Study|Protocol Violation|0|||
48667275|NCT00973102|156634197|FG000|Overall Study|Prisoner|0|||
48667276|NCT00973102|156634198|FG001|Overall Study|Prisoner|1|||
48667277|NCT03099148|156634199|FG000|Wash-out|scheduling conflict|0|||
48667278|NCT03099148|156634200|FG001|Wash-out|scheduling conflict|1|||
48667279|NCT03099148|156634201|FG002|Wash-out|scheduling conflict|0|||
48667280|NCT03099148|156634202|FG003|Wash-out|scheduling conflict|0|||
48667281|NCT03099148|156634199|FG000|Wash-out|Adverse Event|0|||
48667282|NCT03099148|156634200|FG001|Wash-out|Adverse Event|1|||
48667283|NCT03099148|156634201|FG002|Wash-out|Adverse Event|0|||
48667284|NCT03099148|156634202|FG003|Wash-out|Adverse Event|0|||
48667285|NCT03474081|156634208|FG000|Overall Study|Adverse Event|6|||
48667286|NCT03474081|156634209|FG001|Overall Study|Adverse Event|3|||
48667287|NCT03474081|156634208|FG000|Overall Study|Lost to Follow-up|2|||
48341819|NCT03151551|155446042|FG001|Open-Label Treatment Period|Adverse Event|2|||
48341820|NCT03151551|155446041|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
48341821|NCT03151551|155446042|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
48341822|NCT03151551|155446041|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
48341823|NCT03151551|155446042|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
48341824|NCT03151551|155446041|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
48341825|NCT03151551|155446042|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
48341826|NCT03151551|155446041|FG000|Open-Label Treatment Period|Physician Decision|3|||
48341827|NCT03151551|155446042|FG001|Open-Label Treatment Period|Physician Decision|0|||
48341828|NCT03151551|155446041|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
48341829|NCT03151551|155446042|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
48341830|NCT03151551|155446041|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
48341831|NCT03151551|155446042|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
48341832|NCT03151551|155446041|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
48341833|NCT03151551|155446042|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48341834|NCT03151551|155446041|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
48341835|NCT03151551|155446042|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
48341836|NCT03151551|155446041|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
48341837|NCT03151551|155446042|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
48341838|NCT00711555|155447608|FG000|Overall Study|Adverse Event|3|||
48667288|NCT03474081|156634209|FG001|Overall Study|Lost to Follow-up|1|||
48667289|NCT03474081|156634208|FG000|Overall Study|Physician Decision|3|||
48667290|NCT03474081|156634209|FG001|Overall Study|Physician Decision|2|||
48667291|NCT03474081|156634208|FG000|Overall Study|Withdrawal by Subject|5|||
48667292|NCT03474081|156634209|FG001|Overall Study|Withdrawal by Subject|7|||
48667293|NCT03474081|156634208|FG000|Overall Study|Investigator site closed|1|||
48667294|NCT03474081|156634209|FG001|Overall Study|Investigator site closed|0|||
48667295|NCT02210091|156634211|FG000|Overall Study|Physician Decision|0|||
48667296|NCT02210091|156634212|FG001|Overall Study|Physician Decision|1|||
48341839|NCT00676195|155447609|FG000|Overall Study|Lost to Follow-up|1|||
48341840|NCT00676195|155447609|FG000|Overall Study|Adverse Event|1|||
48341841|NCT00676195|155447609|FG000|Overall Study|Physician Decision|1|||
48341842|NCT03675308|155447612|FG000|Overall Study|Adverse Event|3|||
48341843|NCT03675308|155447613|FG001|Overall Study|Adverse Event|2|||
48667297|NCT02210091|156634211|FG000|Overall Study|Withdrawal by Sponsor|0|||
48341844|NCT03675308|155447612|FG000|Overall Study|Withdrawal by Subject|6|||
48341845|NCT03675308|155447613|FG001|Overall Study|Withdrawal by Subject|4|||
48341846|NCT03675308|155447612|FG000|Overall Study|Lost to Follow-up|3|||
48667298|NCT02210091|156634212|FG001|Overall Study|Withdrawal by Sponsor|1|||
48667299|NCT03159104|156634213|FG000|Overall Study|Violation of inclusion criteria|1|||
48667300|NCT03159104|156634214|FG001|Overall Study|Violation of inclusion criteria|2|||
48341847|NCT03675308|155447613|FG001|Overall Study|Lost to Follow-up|0|||
48667301|NCT01638559|156634215|FG000|Overall Study|Lost to Follow-up|1|||
48667302|NCT01638559|156634215|FG000|Overall Study|Withdrawal by Subject|1|||
48341848|NCT03675308|155447612|FG000|Overall Study|Lack of Efficacy|1|||
48341849|NCT03675308|155447613|FG001|Overall Study|Lack of Efficacy|1|||
48341850|NCT03675308|155447612|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
48341851|NCT03675308|155447613|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
48341852|NCT03675308|155447612|FG000|Overall Study|Other|0|||
48341853|NCT03675308|155447613|FG001|Overall Study|Other|1|||
48341854|NCT03721978|155447614|FG000|Overall Study|Withdrawal by Subject|6|||
48341855|NCT03721978|155447615|FG001|Overall Study|Withdrawal by Subject|1|||
48341856|NCT03721978|155447614|FG000|Overall Study|Adverse Event|1|||
48341857|NCT03721978|155447615|FG001|Overall Study|Adverse Event|1|||
48341858|NCT03721978|155447614|FG000|Overall Study|Progressive Disease|1|||
48341859|NCT03721978|155447615|FG001|Overall Study|Progressive Disease|0|||
48341860|NCT03721978|155447614|FG000|Overall Study|Lost to Follow-up|5|||
48341861|NCT03721978|155447615|FG001|Overall Study|Lost to Follow-up|1|||
48341862|NCT03721978|155447614|FG000|Overall Study|Reason not Specified|0|||
48341863|NCT03721978|155447615|FG001|Overall Study|Reason not Specified|2|||
48341864|NCT02388932|155447620|FG000|Overall Study|Death|1|||
48341865|NCT01902381|155447621|FG000|Overall Study|Withdrawal by Subject|1|||
48667303|NCT01638559|156634215|FG000|Overall Study|Subject declined to travel for biopsy|1|||
48341866|NCT04250883|155447622|FG000|Overall Study|Lost to Follow-up|1|||
48341867|NCT04250883|155447623|FG001|Overall Study|Lost to Follow-up|0|||
48341868|NCT00837096|155447625|FG000|Overall Study|Physician Decision|1|||
48341869|NCT00837096|155447626|FG001|Overall Study|Physician Decision|1|||
48341870|NCT00837096|155447625|FG000|Overall Study|Not reported|9|||
48341871|NCT00837096|155447626|FG001|Overall Study|Not reported|8|||
48341872|NCT04620733|155447627|FG000|Overall Study|Adverse Event|4|||
48667304|NCT01545050|156634219|FG000|Overall Study|Lack of Efficacy|0|||
48667305|NCT01545050|156634220|FG001|Overall Study|Lack of Efficacy|0|||
48667306|NCT01545050|156634221|FG002|Overall Study|Lack of Efficacy|0|||
48667307|NCT01545050|156634222|FG003|Overall Study|Lack of Efficacy|3|||
48667308|NCT01545050|156634223|FG004|Overall Study|Lack of Efficacy|2|||
48667309|NCT01545050|156634219|FG000|Overall Study|Adverse Event|1|||
48667310|NCT01545050|156634220|FG001|Overall Study|Adverse Event|1|||
48667311|NCT01545050|156634221|FG002|Overall Study|Adverse Event|2|||
48667312|NCT01545050|156634222|FG003|Overall Study|Adverse Event|2|||
48667313|NCT01545050|156634223|FG004|Overall Study|Adverse Event|0|||
48341873|NCT04620733|155447628|FG001|Overall Study|Adverse Event|3|||
48341874|NCT04620733|155447627|FG000|Overall Study|Withdrawal by Subject|2|||
48341875|NCT04620733|155447628|FG001|Overall Study|Withdrawal by Subject|5|||
48341876|NCT04620733|155447627|FG000|Overall Study|Lost to Follow-up|1|||
48341877|NCT04620733|155447628|FG001|Overall Study|Lost to Follow-up|1|||
48341878|NCT04620733|155447627|FG000|Overall Study|Protocol Deviation|1|||
48341879|NCT04620733|155447628|FG001|Overall Study|Protocol Deviation|1|||
48341880|NCT04620733|155447627|FG000|Overall Study|Reason Not Specified|0|||
48341881|NCT04620733|155447628|FG001|Overall Study|Reason Not Specified|1|||
48341882|NCT05335005|155447629|FG000|Overall Study|Lost to Follow-up|1|||
48341883|NCT02123797|155447640|FG000|Baseline Intervention|Death|9|||
48341884|NCT02123797|155447641|FG001|Baseline Intervention|Death|16|||
48341885|NCT02123797|155447642|FG002|Baseline Intervention|Death|0|||
48341886|NCT02123797|155447643|FG003|Baseline Intervention|Death|0|||
48341887|NCT02123797|155447644|FG004|Baseline Intervention|Death|0|||
48341888|NCT02123797|155447640|FG000|Baseline Intervention|Withdrawal by Subject|2|||
48341889|NCT02123797|155447641|FG001|Baseline Intervention|Withdrawal by Subject|8|||
48667314|NCT01545050|156634219|FG000|Overall Study|Discontinued study treatment|1|||
48667315|NCT01545050|156634220|FG001|Overall Study|Discontinued study treatment|0|||
48667316|NCT01545050|156634221|FG002|Overall Study|Discontinued study treatment|0|||
48667317|NCT01545050|156634222|FG003|Overall Study|Discontinued study treatment|0|||
48667318|NCT01545050|156634223|FG004|Overall Study|Discontinued study treatment|0|||
48667319|NCT01545050|156634219|FG000|Overall Study|Withdrawal by Subject|1|||
48341890|NCT02123797|155447642|FG002|Baseline Intervention|Withdrawal by Subject|0|||
48341891|NCT02123797|155447643|FG003|Baseline Intervention|Withdrawal by Subject|0|||
48667320|NCT01545050|156634220|FG001|Overall Study|Withdrawal by Subject|0|||
48667321|NCT01545050|156634221|FG002|Overall Study|Withdrawal by Subject|0|||
48667322|NCT01545050|156634222|FG003|Overall Study|Withdrawal by Subject|2|||
48341892|NCT02123797|155447644|FG004|Baseline Intervention|Withdrawal by Subject|0|||
48341893|NCT02123797|155447640|FG000|Baseline Intervention|Relocation|2|||
48341894|NCT02123797|155447641|FG001|Baseline Intervention|Relocation|0|||
48341895|NCT02123797|155447642|FG002|Baseline Intervention|Relocation|0|||
48341896|NCT02123797|155447643|FG003|Baseline Intervention|Relocation|0|||
48341897|NCT02123797|155447644|FG004|Baseline Intervention|Relocation|0|||
48341898|NCT02123797|155447640|FG000|Baseline Intervention|Out of window for initial survey|6|||
48341899|NCT02123797|155447641|FG001|Baseline Intervention|Out of window for initial survey|13|||
48341900|NCT02123797|155447642|FG002|Baseline Intervention|Out of window for initial survey|0|||
48667323|NCT01545050|156634223|FG004|Overall Study|Withdrawal by Subject|1|||
48667324|NCT01545050|156634219|FG000|Overall Study|Participant no longer meets study criteria|0|||
48667325|NCT01545050|156634220|FG001|Overall Study|Participant no longer meets study criteria|2|||
48341901|NCT02123797|155447643|FG003|Baseline Intervention|Out of window for initial survey|0|||
48341902|NCT02123797|155447644|FG004|Baseline Intervention|Out of window for initial survey|0|||
48341903|NCT02123797|155447640|FG000|Baseline Intervention|Lost to Follow-up|0|||
48758354|NCT00453544|156962794|FG002|Overall Study|Withdrawal by Subject|0|||
48758355|NCT00453544|156962795|FG003|Overall Study|Withdrawal by Subject|0|||
48758356|NCT00453544|156962792|FG000|Overall Study|Primary outcome measure not completed|1|||
48758357|NCT00453544|156962793|FG001|Overall Study|Primary outcome measure not completed|1|||
48758358|NCT00453544|156962794|FG002|Overall Study|Primary outcome measure not completed|0|||
48758359|NCT00453544|156962795|FG003|Overall Study|Primary outcome measure not completed|1|||
48758360|NCT02457910|156962796|FG000|Overall Study|Withdrawal by Subject|0|||
48758361|NCT02457910|156962797|FG001|Overall Study|Withdrawal by Subject|0|||
48758362|NCT02457910|156962798|FG002|Overall Study|Withdrawal by Subject|0|||
48758363|NCT02457910|156962799|FG003|Overall Study|Withdrawal by Subject|0|||
48341904|NCT02123797|155447641|FG001|Baseline Intervention|Lost to Follow-up|5|||
48341905|NCT02123797|155447642|FG002|Baseline Intervention|Lost to Follow-up|0|||
48341906|NCT02123797|155447643|FG003|Baseline Intervention|Lost to Follow-up|0|||
48341907|NCT02123797|155447644|FG004|Baseline Intervention|Lost to Follow-up|0|||
48341908|NCT02123797|155447640|FG000|Baseline Intervention|Other Disease|3|||
48341909|NCT02123797|155447641|FG001|Baseline Intervention|Other Disease|0|||
48341910|NCT02123797|155447642|FG002|Baseline Intervention|Other Disease|0|||
48341911|NCT02123797|155447643|FG003|Baseline Intervention|Other Disease|0|||
48341912|NCT02123797|155447644|FG004|Baseline Intervention|Other Disease|0|||
48341913|NCT02123797|155447640|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
48341914|NCT02123797|155447641|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
48341915|NCT02123797|155447642|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
48341916|NCT02123797|155447643|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
48341917|NCT02123797|155447644|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
48341918|NCT02123797|155447640|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
48341919|NCT02123797|155447641|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
48341920|NCT02123797|155447642|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
48341921|NCT02123797|155447643|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
48341922|NCT02123797|155447644|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
48341923|NCT02123797|155447640|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
48341924|NCT02123797|155447641|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
48341925|NCT02123797|155447642|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48341926|NCT02123797|155447643|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48341927|NCT02123797|155447644|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48341928|NCT02123797|155447640|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
48341929|NCT02123797|155447641|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
48341930|NCT02123797|155447642|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
48341931|NCT02123797|155447643|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
48341932|NCT02123797|155447644|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
48341933|NCT02123797|155447640|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
48341934|NCT02123797|155447641|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
48341935|NCT02123797|155447642|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
48341936|NCT02123797|155447643|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
48341937|NCT02123797|155447644|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
48341938|NCT02123797|155447640|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
48341939|NCT02123797|155447641|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
48341940|NCT02123797|155447642|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
48341941|NCT02123797|155447643|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
48341942|NCT02123797|155447644|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
48341943|NCT02123797|155447640|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
48341944|NCT02123797|155447641|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
48341945|NCT02123797|155447642|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
48341946|NCT02123797|155447643|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
48341947|NCT02123797|155447644|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
48341948|NCT02123797|155447640|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
48341949|NCT02123797|155447641|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
48341950|NCT02123797|155447642|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48341951|NCT02123797|155447643|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48341952|NCT02123797|155447644|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
48758364|NCT02457910|156962800|FG004|Overall Study|Withdrawal by Subject|0|||
48341953|NCT02123797|155447640|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
48341954|NCT02123797|155447641|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
48341955|NCT02123797|155447642|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
48341956|NCT02123797|155447643|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
48341957|NCT02123797|155447644|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
48667326|NCT01545050|156634221|FG002|Overall Study|Participant no longer meets study criteria|0|||
48667327|NCT01545050|156634222|FG003|Overall Study|Participant no longer meets study criteria|0|||
48667328|NCT01545050|156634223|FG004|Overall Study|Participant no longer meets study criteria|1|||
48667329|NCT01545050|156634219|FG000|Overall Study|Administrative reason by sponsor|4|||
48667330|NCT01545050|156634220|FG001|Overall Study|Administrative reason by sponsor|2|||
48667331|NCT01545050|156634221|FG002|Overall Study|Administrative reason by sponsor|3|||
48667332|NCT01545050|156634222|FG003|Overall Study|Administrative reason by sponsor|5|||
48667333|NCT01545050|156634223|FG004|Overall Study|Administrative reason by sponsor|5|||
48667334|NCT02540291|156634224|FG000|Overall Study|Death|7|||
48667335|NCT02540291|156634225|FG001|Overall Study|Death|7|||
48667336|NCT02540291|156634226|FG002|Overall Study|Death|5|||
48667337|NCT02540291|156634227|FG003|Overall Study|Death|7|||
48667338|NCT02540291|156634224|FG000|Overall Study|Lost to Follow-up|0|||
48667339|NCT02540291|156634225|FG001|Overall Study|Lost to Follow-up|0|||
48667340|NCT02540291|156634226|FG002|Overall Study|Lost to Follow-up|1|||
48667341|NCT02540291|156634227|FG003|Overall Study|Lost to Follow-up|0|||
48667342|NCT02540291|156634224|FG000|Overall Study|Withdrawal Of Consent|0|||
48667343|NCT02540291|156634225|FG001|Overall Study|Withdrawal Of Consent|1|||
48667344|NCT02540291|156634226|FG002|Overall Study|Withdrawal Of Consent|0|||
48667345|NCT02540291|156634227|FG003|Overall Study|Withdrawal Of Consent|0|||
48667346|NCT02540291|156634224|FG000|Overall Study|Study Terminated By Sponsor|1|||
48667347|NCT02540291|156634225|FG001|Overall Study|Study Terminated By Sponsor|0|||
48667348|NCT02540291|156634226|FG002|Overall Study|Study Terminated By Sponsor|0|||
48667349|NCT02540291|156634227|FG003|Overall Study|Study Terminated By Sponsor|0|||
48667350|NCT02540291|156634224|FG000|Overall Study|Other|0|||
48667351|NCT02540291|156634225|FG001|Overall Study|Other|0|||
48667352|NCT02540291|156634226|FG002|Overall Study|Other|1|||
48667353|NCT02540291|156634227|FG003|Overall Study|Other|0|||
48667354|NCT00279812|156634228|FG000|Overall Study|Protocol Violation|1|||
48667355|NCT00279812|156634229|FG001|Overall Study|Protocol Violation|1|||
48667356|NCT00279812|156634230|FG002|Overall Study|Protocol Violation|0|||
48667357|NCT00279812|156634231|FG003|Overall Study|Protocol Violation|0|||
48667358|NCT00279812|156634232|FG004|Overall Study|Protocol Violation|1|||
48667359|NCT00279812|156634233|FG005|Overall Study|Protocol Violation|0|||
48341958|NCT02775214|155447647|FG000|Overall Study|Withdrawal by Subject|2|||
48341959|NCT02775214|155447648|FG001|Overall Study|Withdrawal by Subject|0|||
48341960|NCT02706834|155447649|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48341961|NCT02706834|155447650|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48341962|NCT02706834|155447651|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48341963|NCT02706834|155447652|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
48341964|NCT02706834|155447653|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
48341965|NCT02706834|155447654|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
48341966|NCT02706834|155447655|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
48667360|NCT00279812|156634228|FG000|Overall Study|Withdrawal by Subject|0|||
48667361|NCT00279812|156634229|FG001|Overall Study|Withdrawal by Subject|4|||
48667362|NCT00279812|156634230|FG002|Overall Study|Withdrawal by Subject|2|||
48667363|NCT00279812|156634231|FG003|Overall Study|Withdrawal by Subject|0|||
48667364|NCT00279812|156634232|FG004|Overall Study|Withdrawal by Subject|0|||
48667365|NCT00279812|156634233|FG005|Overall Study|Withdrawal by Subject|0|||
48667366|NCT00279812|156634228|FG000|Overall Study|Adverse Event|0|||
48667367|NCT00279812|156634229|FG001|Overall Study|Adverse Event|1|||
48667368|NCT00279812|156634230|FG002|Overall Study|Adverse Event|1|||
48667369|NCT00279812|156634231|FG003|Overall Study|Adverse Event|0|||
48667370|NCT00279812|156634232|FG004|Overall Study|Adverse Event|2|||
48341967|NCT02706834|155447656|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
48667371|NCT00279812|156634233|FG005|Overall Study|Adverse Event|1|||
48667372|NCT01350115|156635467|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
48341968|NCT02706834|155447657|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
48341969|NCT02706834|155447658|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
48667373|NCT01350115|156635468|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
48667374|NCT01350115|156635467|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
48667375|NCT01350115|156635468|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
48667376|NCT01350115|156635467|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
48667377|NCT01350115|156635468|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
48667378|NCT02210832|156635470|FG000|Overall Study|Pregnancy termination .|3|||
48667379|NCT02210832|156635471|FG001|Overall Study|Pregnancy termination .|4|||
48667380|NCT02210832|156635472|FG002|Overall Study|Pregnancy termination .|1|||
48667381|NCT02210832|156635470|FG000|Overall Study|Lost to Follow-up|26|||
48667382|NCT02210832|156635471|FG001|Overall Study|Lost to Follow-up|32|||
48667383|NCT02210832|156635472|FG002|Overall Study|Lost to Follow-up|17|||
48667384|NCT01596335|156635473|FG000|Overall Study|exacerbation of primary disease|5|||
48667385|NCT01596335|156635474|FG001|Overall Study|exacerbation of primary disease|9|||
48667386|NCT04524455|156635475|FG000|Overall Study|Death|3|||
48667387|NCT04524455|156635476|FG001|Overall Study|Death|3|||
48667388|NCT04524455|156635475|FG000|Overall Study|Decision by Sponsor|0|||
48758365|NCT02457910|156962801|FG005|Overall Study|Withdrawal by Subject|1|||
48758366|NCT02457910|156962796|FG000|Overall Study|Adverse Event|0|||
48758367|NCT02457910|156962797|FG001|Overall Study|Adverse Event|2|||
48758368|NCT02457910|156962798|FG002|Overall Study|Adverse Event|1|||
48758369|NCT02457910|156962799|FG003|Overall Study|Adverse Event|1|||
48758370|NCT02457910|156962800|FG004|Overall Study|Adverse Event|1|||
48758371|NCT02457910|156962801|FG005|Overall Study|Adverse Event|3|||
48758372|NCT02457910|156962796|FG000|Overall Study|Disease progression|3|||
48758373|NCT02457910|156962797|FG001|Overall Study|Disease progression|3|||
48758374|NCT02457910|156962798|FG002|Overall Study|Disease progression|1|||
48667389|NCT04524455|156635476|FG001|Overall Study|Decision by Sponsor|2|||
48667390|NCT04524455|156635475|FG000|Overall Study|Withdrawal of Consent From Study|1|||
48667391|NCT04524455|156635476|FG001|Overall Study|Withdrawal of Consent From Study|0|||
48667392|NCT04524455|156635475|FG000|Overall Study|Lost to Follow-up|0|||
48667393|NCT04524455|156635476|FG001|Overall Study|Lost to Follow-up|1|||
48667394|NCT01519674|156635492|FG000|Overall Study|Adverse Event|3|||
48667395|NCT01519674|156635493|FG001|Overall Study|Adverse Event|3|||
48667396|NCT01519674|156635494|FG002|Overall Study|Adverse Event|0|||
48667397|NCT01519674|156635492|FG000|Overall Study|Lack of Efficacy|1|||
48667398|NCT01519674|156635493|FG001|Overall Study|Lack of Efficacy|1|||
48667399|NCT01519674|156635494|FG002|Overall Study|Lack of Efficacy|1|||
48667400|NCT01519674|156635492|FG000|Overall Study|Protocol Violation|0|||
48667401|NCT01519674|156635493|FG001|Overall Study|Protocol Violation|3|||
48667402|NCT01519674|156635494|FG002|Overall Study|Protocol Violation|1|||
48667403|NCT01519674|156635492|FG000|Overall Study|Withdrawal Criteria|7|||
48667404|NCT01519674|156635493|FG001|Overall Study|Withdrawal Criteria|2|||
48667405|NCT01519674|156635494|FG002|Overall Study|Withdrawal Criteria|7|||
48667406|NCT01519674|156635492|FG000|Overall Study|Unsclassified|10|||
48667407|NCT01519674|156635493|FG001|Overall Study|Unsclassified|4|||
48667408|NCT01519674|156635494|FG002|Overall Study|Unsclassified|3|||
48667409|NCT01610596|156635495|FG000|Overall Study|Lost to Follow-up|0|||
48667410|NCT01610596|156635496|FG001|Overall Study|Lost to Follow-up|1|||
48667411|NCT02317809|156635497|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
48667412|NCT02317809|156635498|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
48667413|NCT02317809|156635497|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
48667414|NCT02317809|156635498|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
48667415|NCT01114360|156635499|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
48667416|NCT01114360|156635500|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
48667417|NCT01646203|156635501|FG000|Overall Study|Adverse Event|2|||
48667418|NCT01646203|156635502|FG001|Overall Study|Adverse Event|0|||
48758375|NCT02457910|156962799|FG003|Overall Study|Disease progression|1|||
48758376|NCT02457910|156962800|FG004|Overall Study|Disease progression|4|||
48758377|NCT02457910|156962801|FG005|Overall Study|Disease progression|6|||
48758378|NCT02457910|156962796|FG000|Overall Study|Other complicating illness|0|||
48667419|NCT01646203|156635503|FG002|Overall Study|Adverse Event|1|||
48667420|NCT01646203|156635501|FG000|Overall Study|Withdrawal by Subject|0|||
48667421|NCT01646203|156635502|FG001|Overall Study|Withdrawal by Subject|1|||
48667422|NCT01646203|156635503|FG002|Overall Study|Withdrawal by Subject|0|||
48667423|NCT01646203|156635501|FG000|Overall Study|Physician's Decision|0|||
48667424|NCT01646203|156635502|FG001|Overall Study|Physician's Decision|1|||
48667425|NCT01646203|156635503|FG002|Overall Study|Physician's Decision|0|||
48667426|NCT03458702|156635504|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
48667427|NCT03458702|156635505|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
48667428|NCT03458702|156635504|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
48667429|NCT03458702|156635505|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
48667430|NCT02120365|156635510|FG000|Overall Study|Withdrawal by Subject|0|||
48667431|NCT02120365|156635511|FG001|Overall Study|Withdrawal by Subject|0|||
48667432|NCT02120365|156635512|FG002|Overall Study|Withdrawal by Subject|2|||
48667433|NCT02120365|156635513|FG003|Overall Study|Withdrawal by Subject|4|||
48667434|NCT02120365|156635514|FG004|Overall Study|Withdrawal by Subject|0|||
48667435|NCT02120365|156635515|FG005|Overall Study|Withdrawal by Subject|2|||
48667436|NCT02410824|156635517|FG000|First Intervention (One Week)|Headache|0|||
48667437|NCT02410824|156635518|FG001|First Intervention (One Week)|Headache|1|||
48667438|NCT01920152|156635519|FG000|Overall Study|Withdrawal by Subject|1|||
48667439|NCT01920152|156635520|FG001|Overall Study|Withdrawal by Subject|2|||
48667440|NCT00746733|156635521|FG000|Second Intervention|Adverse Event|1|||
48667441|NCT00746733|156635522|FG001|Second Intervention|Adverse Event|0|||
48667442|NCT00746733|156635521|FG000|Third Intervention|Withdrawal by Subject|1|||
48667443|NCT00746733|156635522|FG001|Third Intervention|Withdrawal by Subject|1|||
48667444|NCT01287195|156635523|FG000|Overall Study|Withdrawal by Subject|2|||
48758379|NCT02457910|156962797|FG001|Overall Study|Other complicating illness|0|||
48758380|NCT02457910|156962798|FG002|Overall Study|Other complicating illness|0|||
48758381|NCT02457910|156962799|FG003|Overall Study|Other complicating illness|0|||
48758382|NCT02457910|156962800|FG004|Overall Study|Other complicating illness|0|||
48758383|NCT02457910|156962801|FG005|Overall Study|Other complicating illness|1|||
48428235|NCT02531373|155756502|FG004|Overall Study|Protocol Violation|0|||
48758384|NCT02457910|156962796|FG000|Overall Study|Death|0|||
48758385|NCT02457910|156962797|FG001|Overall Study|Death|0|||
48758386|NCT02457910|156962798|FG002|Overall Study|Death|1|||
48758387|NCT02457910|156962799|FG003|Overall Study|Death|0|||
48758388|NCT02457910|156962800|FG004|Overall Study|Death|0|||
48758389|NCT02457910|156962801|FG005|Overall Study|Death|0|||
48758390|NCT00362115|156962802|FG000|Overall Study|Adverse Event|0|||
48758391|NCT00362115|156962803|FG001|Overall Study|Adverse Event|1|||
48758392|NCT00362115|156962804|FG002|Overall Study|Adverse Event|1|||
48758393|NCT00362115|156962805|FG003|Overall Study|Adverse Event|1|||
48758394|NCT00362115|156962806|FG004|Overall Study|Adverse Event|2|||
48667445|NCT01319721|156635527|FG000|Overall Study|Lost to Follow-up|1|||
48667446|NCT01319721|156635528|FG001|Overall Study|Lost to Follow-up|6|||
48667447|NCT00334282|156635529|FG000|Overall Study|Lost to Follow-up|11|||
48667448|NCT00334282|156635530|FG001|Overall Study|Lost to Follow-up|5|||
48667449|NCT00334282|156635529|FG000|Overall Study|Withdrawal by Subject|17|||
48667450|NCT00334282|156635530|FG001|Overall Study|Withdrawal by Subject|3|||
48667451|NCT00334282|156635529|FG000|Overall Study|Death|194|||
48667452|NCT00334282|156635530|FG001|Overall Study|Death|100|||
48667453|NCT00837876|156635531|FG000|Overall Study|Death|2|||
48667454|NCT00837876|156635531|FG000|Overall Study|Adverse Event|7|||
48667455|NCT00837876|156635531|FG000|Overall Study|Physician Decision|1|||
48667456|NCT00837876|156635531|FG000|Overall Study|Withdrawal by Subject|3|||
48667457|NCT00837876|156635531|FG000|Overall Study|disease progression|24|||
48667458|NCT01116427|156635532|FG000|Core Phase|Adverse Event|0|||
48667459|NCT01116427|156635533|FG001|Core Phase|Adverse Event|1|||
48667460|NCT01116427|156635532|FG000|Core Phase|Lost to Follow-up|1|||
48667461|NCT01116427|156635533|FG001|Core Phase|Lost to Follow-up|0|||
48667462|NCT01116427|156635532|FG000|Core Phase|Withdrawal by Subject|3|||
48667463|NCT01116427|156635533|FG001|Core Phase|Withdrawal by Subject|0|||
48667464|NCT01116427|156635532|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
48667465|NCT01116427|156635533|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
48667466|NCT01116427|156635532|FG000|Extension Phase|Adverse Event|1|||
48667467|NCT01116427|156635533|FG001|Extension Phase|Adverse Event|1|||
48667468|NCT01116427|156635532|FG000|Extension Phase|Lost to Follow-up|2|||
48667469|NCT01116427|156635533|FG001|Extension Phase|Lost to Follow-up|0|||
48667470|NCT01116427|156635532|FG000|Extension Phase|Withdrawal by Subject|5|||
48667471|NCT01116427|156635533|FG001|Extension Phase|Withdrawal by Subject|1|||
48667472|NCT01116427|156635532|FG000|Extension Phase|Not using appropriate birth control|1|||
48667473|NCT01116427|156635533|FG001|Extension Phase|Not using appropriate birth control|0|||
48667474|NCT00453973|156635534|FG000|Overall Study|Adverse Event|4|||
48667475|NCT00453973|156635535|FG001|Overall Study|Adverse Event|9|||
48667476|NCT00453973|156635534|FG000|Overall Study|Withdrawal by Subject|7|||
48667477|NCT00453973|156635535|FG001|Overall Study|Withdrawal by Subject|6|||
48667478|NCT00453973|156635534|FG000|Overall Study|PI Decision|0|||
48667479|NCT00453973|156635535|FG001|Overall Study|PI Decision|2|||
48667480|NCT00453973|156635534|FG000|Overall Study|Relocation|1|||
48667481|NCT00453973|156635535|FG001|Overall Study|Relocation|0|||
48667482|NCT00453973|156635534|FG000|Overall Study|Renal transplant|1|||
48667483|NCT00453973|156635535|FG001|Overall Study|Renal transplant|1|||
48667484|NCT00453973|156635534|FG000|Overall Study|Site closed by sponsor|3|||
48667485|NCT00453973|156635535|FG001|Overall Study|Site closed by sponsor|0|||
48667486|NCT00453973|156635534|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
48667487|NCT00453973|156635535|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
48667488|NCT01969500|156635536|FG000|Overall Study|Death|0|||
48667489|NCT01969500|156635537|FG001|Overall Study|Death|1|||
48667490|NCT01969500|156635536|FG000|Overall Study|extended hospitalization|1|||
48667491|NCT01969500|156635537|FG001|Overall Study|extended hospitalization|1|||
48667492|NCT01439126|156635540|FG000|Overall Study|Adverse Event|2|||
48667493|NCT01439126|156635541|FG001|Overall Study|Adverse Event|0|||
48667494|NCT01439126|156635540|FG000|Overall Study|Withdrawal by Subject|5|||
48667495|NCT01439126|156635541|FG001|Overall Study|Withdrawal by Subject|21|||
48667496|NCT01439126|156635540|FG000|Overall Study|Protocol Violation|6|||
48667497|NCT01439126|156635541|FG001|Overall Study|Protocol Violation|4|||
48667498|NCT01439126|156635540|FG000|Overall Study|Lost to Follow-up|6|||
48667499|NCT01439126|156635541|FG001|Overall Study|Lost to Follow-up|3|||
48758395|NCT00362115|156962807|FG005|Overall Study|Adverse Event|2|||
48758396|NCT00362115|156962808|FG006|Overall Study|Adverse Event|1|||
48758397|NCT00362115|156962802|FG000|Overall Study|Protocol Violation|0|||
48428236|NCT02531373|155756503|FG005|Overall Study|Protocol Violation|1|||
48667500|NCT01439126|156635540|FG000|Overall Study|Other-Use of prohibited treatment|0|||
48667501|NCT01439126|156635541|FG001|Overall Study|Other-Use of prohibited treatment|2|||
48667502|NCT01439126|156635540|FG000|Overall Study|Other-Miscellaneous|12|||
48667503|NCT01439126|156635541|FG001|Overall Study|Other-Miscellaneous|12|||
48667504|NCT02576860|156635549|FG000|Overall Study|Adverse Event|6|||
48667505|NCT02576860|156635550|FG001|Overall Study|Adverse Event|6|||
48667506|NCT02576860|156635549|FG000|Overall Study|Lost to Follow-up|5|||
48667507|NCT02576860|156635550|FG001|Overall Study|Lost to Follow-up|7|||
48667508|NCT02576860|156635549|FG000|Overall Study|Physician Decision|0|||
48758398|NCT00362115|156962803|FG001|Overall Study|Protocol Violation|0|||
48667509|NCT02576860|156635550|FG001|Overall Study|Physician Decision|1|||
48667510|NCT02576860|156635549|FG000|Overall Study|Protocol Violation|0|||
48667511|NCT02576860|156635550|FG001|Overall Study|Protocol Violation|2|||
48667512|NCT02576860|156635549|FG000|Overall Study|Withdrawal by Subject|13|||
48667513|NCT02576860|156635550|FG001|Overall Study|Withdrawal by Subject|8|||
48667514|NCT02576860|156635549|FG000|Overall Study|Disallowed medication|1|||
48667515|NCT02576860|156635550|FG001|Overall Study|Disallowed medication|0|||
48667516|NCT00780273|156635551|FG000|Overall Study|Death|1|||
48667517|NCT00780273|156635551|FG000|Overall Study|Lost to Follow-up|1|||
48667518|NCT02827500|156635552|FG000|Overall Study|Death|7|||
48667519|NCT02827500|156635553|FG001|Overall Study|Death|3|||
48667520|NCT02827500|156635552|FG000|Overall Study|Lost to Follow-up|1|||
48667521|NCT02827500|156635553|FG001|Overall Study|Lost to Follow-up|1|||
48667522|NCT02827500|156635552|FG000|Overall Study|Withdrawal by Subject|3|||
48667523|NCT02827500|156635553|FG001|Overall Study|Withdrawal by Subject|1|||
48667524|NCT02827500|156635552|FG000|Overall Study|Missing primary endpoint data|3|||
48667525|NCT02827500|156635553|FG001|Overall Study|Missing primary endpoint data|1|||
48667526|NCT02827500|156635552|FG000|Overall Study|Other|5|||
48667527|NCT02827500|156635553|FG001|Overall Study|Other|1|||
48667528|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
48667529|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
48667530|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
48667531|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
48667532|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
48667533|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
48667534|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
48667535|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
48667536|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
48667537|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
48667538|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
48667539|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
48667540|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
48667541|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
48667542|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
48667543|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
48667544|NCT03689244|156635554|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
48667545|NCT03689244|156635555|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
48667546|NCT03689244|156635556|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
48667547|NCT03689244|156635557|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
48667548|NCT03689244|156635554|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
48667549|NCT03689244|156635555|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
48667550|NCT03689244|156635556|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
48667551|NCT03689244|156635557|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
48667552|NCT03689244|156635554|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
48667553|NCT03689244|156635555|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
48667554|NCT03689244|156635556|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
48667555|NCT03689244|156635557|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
48667556|NCT03689244|156635554|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
48667557|NCT03689244|156635555|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
48667558|NCT03689244|156635556|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
48667559|NCT03689244|156635557|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
48667560|NCT01541917|156635558|FG000|Overall Study|Lost to Follow-up|2|||
48667561|NCT01541917|156635559|FG001|Overall Study|Lost to Follow-up|2|||
48667562|NCT01541917|156635558|FG000|Overall Study|Withdrawal by Subject|13|||
48667563|NCT01541917|156635559|FG001|Overall Study|Withdrawal by Subject|7|||
48667564|NCT03263780|156635560|FG000|Overall Study|Withdrawal by Subject|3|||
48667565|NCT03263780|156635560|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
48667566|NCT01739803|156635561|FG000|Overall Study|Lost to Follow-up|9|||
48667567|NCT01739803|156635562|FG001|Overall Study|Lost to Follow-up|6|||
48667568|NCT03426631|156635565|FG000|Overall Study|Lost to Follow-up|0|||
48667569|NCT03426631|156635566|FG001|Overall Study|Lost to Follow-up|1|||
48667570|NCT02698371|156635591|FG000|All Participants Flow|Lost to Follow-up|3|||
48667571|NCT02698371|156635591|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
48667572|NCT02698371|156635591|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
48667573|NCT02698371|156635591|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
48667574|NCT02698371|156635591|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
48667575|NCT02698371|156635591|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
48667576|NCT02698371|156635591|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
48667577|NCT00267150|156635592|FG000|Overall Study|Adverse Event|1|||
48667578|NCT01561963|156635595|FG000|Overall Study|Adverse Event|1|||
48667579|NCT00424190|156635597|FG000|Overall Study|Withdrew consent|3|||
48758399|NCT00362115|156962804|FG002|Overall Study|Protocol Violation|0|||
48758400|NCT00362115|156962805|FG003|Overall Study|Protocol Violation|0|||
48758401|NCT00362115|156962806|FG004|Overall Study|Protocol Violation|0|||
48758402|NCT00362115|156962807|FG005|Overall Study|Protocol Violation|1|||
48758403|NCT00362115|156962808|FG006|Overall Study|Protocol Violation|0|||
48758404|NCT00362115|156962802|FG000|Overall Study|Lost to Follow-up|0|||
48758405|NCT00362115|156962803|FG001|Overall Study|Lost to Follow-up|1|||
48758406|NCT00362115|156962804|FG002|Overall Study|Lost to Follow-up|0|||
48667580|NCT00424190|156635598|FG001|Overall Study|Withdrew consent|4|||
48667581|NCT00424190|156635597|FG000|Overall Study|Death|3|||
48667582|NCT00424190|156635598|FG001|Overall Study|Death|0|||
48667583|NCT00424190|156635597|FG000|Overall Study|Noncompliance|1|||
48667584|NCT00424190|156635598|FG001|Overall Study|Noncompliance|2|||
48667585|NCT00424190|156635597|FG000|Overall Study|Request of sponsor or investigator|0|||
48667586|NCT00424190|156635598|FG001|Overall Study|Request of sponsor or investigator|2|||
48667587|NCT00424190|156635597|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
48667588|NCT00424190|156635598|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
48667589|NCT00424190|156635597|FG000|Overall Study|Other|15|||
48667590|NCT00424190|156635598|FG001|Overall Study|Other|21|||
48667591|NCT02598128|156635602|FG000|Period A: Days -7 to -1|Adverse Event|1|||
48667592|NCT02598128|156635603|FG001|Period A: Days -7 to -1|Adverse Event|0|||
48667593|NCT02598128|156635604|FG002|Period A: Days -7 to -1|Adverse Event|0|||
48667594|NCT02598128|156635605|FG003|Period A: Days -7 to -1|Adverse Event|0|||
48667595|NCT01595581|156635610|FG000|Overall Study|Withdrawal by Subject|1|||
48667596|NCT01595581|156635611|FG001|Overall Study|Withdrawal by Subject|0|||
48667597|NCT02383433|156635612|FG000|Overall Study|Disease progression|2|||
48667598|NCT01278407|156637431|FG000|Confirmatory Phase|Adverse Event|5|||
48667599|NCT01278407|156637432|FG001|Confirmatory Phase|Adverse Event|10|||
48667600|NCT01278407|156637433|FG002|Confirmatory Phase|Adverse Event|1|||
48758407|NCT00362115|156962805|FG003|Overall Study|Lost to Follow-up|0|||
48758408|NCT00362115|156962806|FG004|Overall Study|Lost to Follow-up|2|||
48758409|NCT00362115|156962807|FG005|Overall Study|Lost to Follow-up|0|||
48758410|NCT00362115|156962808|FG006|Overall Study|Lost to Follow-up|1|||
48758411|NCT00362115|156962802|FG000|Overall Study|Withdrawal by Subject|1|||
48758412|NCT00362115|156962803|FG001|Overall Study|Withdrawal by Subject|3|||
48758413|NCT00362115|156962804|FG002|Overall Study|Withdrawal by Subject|1|||
48758414|NCT00362115|156962805|FG003|Overall Study|Withdrawal by Subject|0|||
48758415|NCT00362115|156962806|FG004|Overall Study|Withdrawal by Subject|1|||
48758416|NCT00362115|156962807|FG005|Overall Study|Withdrawal by Subject|3|||
48758417|NCT00362115|156962808|FG006|Overall Study|Withdrawal by Subject|4|||
48758418|NCT00362115|156962802|FG000|Overall Study|Lack of Efficacy|1|||
48758419|NCT00362115|156962803|FG001|Overall Study|Lack of Efficacy|0|||
48758420|NCT00362115|156962804|FG002|Overall Study|Lack of Efficacy|5|||
48758421|NCT00362115|156962805|FG003|Overall Study|Lack of Efficacy|2|||
48758422|NCT00362115|156962806|FG004|Overall Study|Lack of Efficacy|2|||
48758423|NCT00362115|156962807|FG005|Overall Study|Lack of Efficacy|0|||
48667601|NCT01278407|156637434|FG003|Confirmatory Phase|Adverse Event|0|||
48667602|NCT01278407|156637435|FG004|Confirmatory Phase|Adverse Event|0|||
48667603|NCT01278407|156637431|FG000|Confirmatory Phase|Participant's Choice|3|||
48667604|NCT01278407|156637432|FG001|Confirmatory Phase|Participant's Choice|5|||
48667605|NCT01278407|156637433|FG002|Confirmatory Phase|Participant's Choice|3|||
48667606|NCT01278407|156637434|FG003|Confirmatory Phase|Participant's Choice|0|||
48667607|NCT01278407|156637435|FG004|Confirmatory Phase|Participant's Choice|0|||
48667608|NCT01278407|156637431|FG000|Confirmatory Phase|Other|1|||
48667609|NCT01278407|156637432|FG001|Confirmatory Phase|Other|1|||
48667610|NCT01278407|156637433|FG002|Confirmatory Phase|Other|2|||
48667611|NCT01278407|156637434|FG003|Confirmatory Phase|Other|0|||
48667612|NCT01278407|156637435|FG004|Confirmatory Phase|Other|0|||
48667613|NCT01278407|156637431|FG000|Extension Phase|Adverse Event|0|||
48667614|NCT01278407|156637432|FG001|Extension Phase|Adverse Event|0|||
48667615|NCT01278407|156637433|FG002|Extension Phase|Adverse Event|0|||
48667616|NCT01278407|156637434|FG003|Extension Phase|Adverse Event|7|||
48667617|NCT01278407|156637435|FG004|Extension Phase|Adverse Event|16|||
48667618|NCT01278407|156637431|FG000|Extension Phase|Participant's Choice|0|||
48667619|NCT01278407|156637432|FG001|Extension Phase|Participant's Choice|0|||
48667620|NCT01278407|156637433|FG002|Extension Phase|Participant's Choice|0|||
48667621|NCT01278407|156637434|FG003|Extension Phase|Participant's Choice|4|||
48758424|NCT00362115|156962808|FG006|Overall Study|Lack of Efficacy|3|||
48758425|NCT00362115|156962802|FG000|Overall Study|Physician Decision|0|||
48758426|NCT00362115|156962803|FG001|Overall Study|Physician Decision|0|||
48758427|NCT00362115|156962804|FG002|Overall Study|Physician Decision|0|||
48758428|NCT00362115|156962805|FG003|Overall Study|Physician Decision|0|||
48758429|NCT00362115|156962806|FG004|Overall Study|Physician Decision|0|||
48667622|NCT01278407|156637435|FG004|Extension Phase|Participant's Choice|11|||
48667623|NCT01278407|156637431|FG000|Extension Phase|Other|0|||
48667624|NCT01278407|156637432|FG001|Extension Phase|Other|0|||
48667625|NCT01278407|156637433|FG002|Extension Phase|Other|0|||
48758430|NCT00362115|156962807|FG005|Overall Study|Physician Decision|0|||
48758431|NCT00362115|156962808|FG006|Overall Study|Physician Decision|3|||
48667626|NCT01278407|156637434|FG003|Extension Phase|Other|1|||
48667627|NCT01278407|156637435|FG004|Extension Phase|Other|3|||
48667628|NCT02753127|156637442|FG000|Overall Study|Lost to Follow-up|13|||
48758432|NCT00362115|156962802|FG000|Overall Study|Other|0|||
48758433|NCT00362115|156962803|FG001|Overall Study|Other|1|||
48758434|NCT00362115|156962804|FG002|Overall Study|Other|0|||
48758435|NCT00362115|156962805|FG003|Overall Study|Other|1|||
48758436|NCT00362115|156962806|FG004|Overall Study|Other|0|||
48758437|NCT00362115|156962807|FG005|Overall Study|Other|1|||
48758438|NCT00362115|156962808|FG006|Overall Study|Other|0|||
48341970|NCT02706834|155447659|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
48341971|NCT02706834|155447649|FG000|Overall Study|Lost to Follow-up|0|||
48667629|NCT02753127|156637443|FG001|Overall Study|Lost to Follow-up|11|||
48667630|NCT02753127|156637442|FG000|Overall Study|Withdrawal by Subject|37|||
48667631|NCT02753127|156637443|FG001|Overall Study|Withdrawal by Subject|47|||
48667632|NCT02753127|156637442|FG000|Overall Study|Other|3|||
48667633|NCT02753127|156637443|FG001|Overall Study|Other|8|||
48667634|NCT02753127|156637442|FG000|Overall Study|Hospice|0|||
48667635|NCT02753127|156637443|FG001|Overall Study|Hospice|2|||
48667636|NCT02351349|156637444|FG000|Overall Study|Withdrawal by Subject|2|||
48667637|NCT02351349|156637445|FG001|Overall Study|Withdrawal by Subject|3|||
48667638|NCT02981524|156637446|FG000|Overall Study|Progressive Disease|14|||
48667639|NCT02981524|156637446|FG000|Overall Study|Death (unrelated)|1|||
48667640|NCT02981524|156637446|FG000|Overall Study|Treatment Related Toxicity|1|||
48667641|NCT02981524|156637446|FG000|Overall Study|Withdrawal by Subject|1|||
48667642|NCT00186537|156637450|FG000|Overall Study|Withdrawal by Subject|4|||
48667643|NCT00186537|156637451|FG001|Overall Study|Withdrawal by Subject|0|||
48667644|NCT00186537|156637452|FG002|Overall Study|Withdrawal by Subject|3|||
48667645|NCT00186537|156637450|FG000|Overall Study|ALT > 1.5 x ULN|3|||
48667646|NCT00186537|156637451|FG001|Overall Study|ALT > 1.5 x ULN|0|||
48667647|NCT00186537|156637452|FG002|Overall Study|ALT > 1.5 x ULN|0|||
48667648|NCT03684304|156637453|FG000|Overall Study|Lost to Follow-up|19|||
48667649|NCT03684304|156637454|FG001|Overall Study|Lost to Follow-up|17|||
48667650|NCT00385723|156637456|FG000|Overall Study|Lost to Follow-up|1|||
48667651|NCT00385723|156637457|FG001|Overall Study|Lost to Follow-up|1|||
48667652|NCT00385723|156637458|FG002|Overall Study|Lost to Follow-up|0|||
48667653|NCT00385723|156637456|FG000|Overall Study|Withdrawal by Subject|1|||
48667654|NCT00385723|156637457|FG001|Overall Study|Withdrawal by Subject|0|||
48667655|NCT00385723|156637458|FG002|Overall Study|Withdrawal by Subject|2|||
48667656|NCT01484834|156637459|FG000|Overall Study|Lost to Follow-up|5|||
48667657|NCT01484834|156637460|FG001|Overall Study|Lost to Follow-up|8|||
48667658|NCT01484834|156637461|FG002|Overall Study|Lost to Follow-up|1|||
48667659|NCT01484834|156637462|FG003|Overall Study|Lost to Follow-up|4|||
48667660|NCT03455829|156637463|FG000|Overall Study|Death|2|||
48667661|NCT03455829|156637464|FG001|Overall Study|Death|3|||
48667662|NCT03455829|156637465|FG002|Overall Study|Death|2|||
48667663|NCT03455829|156637466|FG003|Overall Study|Death|4|||
48667664|NCT03455829|156637467|FG004|Overall Study|Death|2|||
48758439|NCT01387347|156962809|FG000|Overall Study|Lost to Follow-up|2|||
48667665|NCT03455829|156637463|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
48667666|NCT03455829|156637464|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
48667667|NCT03455829|156637465|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
48667668|NCT03455829|156637466|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
48667669|NCT03455829|156637467|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
48667670|NCT03455829|156637463|FG000|Overall Study|Disease progression|0|||
48667671|NCT03455829|156637464|FG001|Overall Study|Disease progression|0|||
48667672|NCT03455829|156637465|FG002|Overall Study|Disease progression|0|||
48667673|NCT03455829|156637466|FG003|Overall Study|Disease progression|1|||
48667674|NCT03455829|156637467|FG004|Overall Study|Disease progression|1|||
48667675|NCT00673881|156637468|FG000|Overall Study|Withdrawal by Subject|1|||
48667676|NCT01719003|156637469|FG000|Overall Study|Non compliant with protocol|1|||
48758440|NCT01387347|156962810|FG001|Overall Study|Lost to Follow-up|1|||
48341972|NCT02706834|155447650|FG001|Overall Study|Lost to Follow-up|0|||
48667677|NCT01719003|156637470|FG001|Overall Study|Non compliant with protocol|1|||
48667678|NCT01719003|156637471|FG002|Overall Study|Non compliant with protocol|0|||
48667679|NCT01719003|156637472|FG003|Overall Study|Non compliant with protocol|1|||
48667680|NCT01719003|156637473|FG004|Overall Study|Non compliant with protocol|2|||
48667681|NCT01719003|156637474|FG005|Overall Study|Non compliant with protocol|1|||
48758441|NCT03605303|156962814|FG000|Period 1|Study Terminated|2|||
48341973|NCT02706834|155447651|FG002|Overall Study|Lost to Follow-up|1|||
48341974|NCT02706834|155447652|FG003|Overall Study|Lost to Follow-up|0|||
48667682|NCT01719003|156637475|FG006|Overall Study|Non compliant with protocol|2|||
48667683|NCT01719003|156637476|FG007|Overall Study|Non compliant with protocol|3|||
48667684|NCT01719003|156637477|FG008|Overall Study|Non compliant with protocol|0|||
48667685|NCT01719003|156637469|FG000|Overall Study|Adverse Event|6|||
48667686|NCT01719003|156637470|FG001|Overall Study|Adverse Event|5|||
48667687|NCT01719003|156637471|FG002|Overall Study|Adverse Event|4|||
48758442|NCT03605303|156962815|FG001|Period 1|Study Terminated|1|||
48758443|NCT02153112|156962816|FG000|Overall Study|Adverse Event|0|||
48758444|NCT02153112|156962817|FG001|Overall Study|Adverse Event|0|||
48758445|NCT02153112|156962818|FG002|Overall Study|Adverse Event|1|||
48758446|NCT02153112|156962819|FG003|Overall Study|Adverse Event|0|||
48758447|NCT02153112|156962820|FG004|Overall Study|Adverse Event|0|||
48758448|NCT02153112|156962821|FG005|Overall Study|Adverse Event|0|||
48758449|NCT02153112|156962822|FG006|Overall Study|Adverse Event|0|||
48758450|NCT02153112|156962823|FG007|Overall Study|Adverse Event|0|||
48758451|NCT02153112|156962824|FG008|Overall Study|Adverse Event|0|||
48758452|NCT02153112|156962825|FG009|Overall Study|Adverse Event|0|||
48758453|NCT02153112|156962816|FG000|Overall Study|Lost to Follow-up|1|||
48758454|NCT02153112|156962817|FG001|Overall Study|Lost to Follow-up|1|||
48758455|NCT02153112|156962818|FG002|Overall Study|Lost to Follow-up|0|||
48758456|NCT02153112|156962819|FG003|Overall Study|Lost to Follow-up|0|||
48758457|NCT02153112|156962820|FG004|Overall Study|Lost to Follow-up|2|||
48341975|NCT02706834|155447653|FG004|Overall Study|Lost to Follow-up|0|||
48341976|NCT02706834|155447654|FG005|Overall Study|Lost to Follow-up|0|||
48341977|NCT02706834|155447655|FG006|Overall Study|Lost to Follow-up|0|||
48341978|NCT02706834|155447656|FG007|Overall Study|Lost to Follow-up|0|||
48341979|NCT02706834|155447657|FG008|Overall Study|Lost to Follow-up|0|||
48341980|NCT02706834|155447658|FG009|Overall Study|Lost to Follow-up|0|||
48341981|NCT02706834|155447659|FG010|Overall Study|Lost to Follow-up|0|||
48341982|NCT02706834|155447649|FG000|Overall Study|Voluntary Withdrawal|1|||
48341983|NCT02706834|155447650|FG001|Overall Study|Voluntary Withdrawal|0|||
48341984|NCT02706834|155447651|FG002|Overall Study|Voluntary Withdrawal|0|||
48341985|NCT02706834|155447652|FG003|Overall Study|Voluntary Withdrawal|0|||
48341986|NCT02706834|155447653|FG004|Overall Study|Voluntary Withdrawal|0|||
48341987|NCT02706834|155447654|FG005|Overall Study|Voluntary Withdrawal|0|||
48341988|NCT02706834|155447655|FG006|Overall Study|Voluntary Withdrawal|0|||
48341989|NCT02706834|155447656|FG007|Overall Study|Voluntary Withdrawal|0|||
48341990|NCT02706834|155447657|FG008|Overall Study|Voluntary Withdrawal|0|||
48341991|NCT02706834|155447658|FG009|Overall Study|Voluntary Withdrawal|1|||
48341992|NCT02706834|155447659|FG010|Overall Study|Voluntary Withdrawal|0|||
48341993|NCT02706834|155447649|FG000|Overall Study|Other Reason Not Specified|1|||
48341994|NCT02706834|155447650|FG001|Overall Study|Other Reason Not Specified|0|||
48341995|NCT02706834|155447651|FG002|Overall Study|Other Reason Not Specified|0|||
48667688|NCT01719003|156637472|FG003|Overall Study|Adverse Event|3|||
48667689|NCT01719003|156637473|FG004|Overall Study|Adverse Event|4|||
48667690|NCT01719003|156637474|FG005|Overall Study|Adverse Event|3|||
48667691|NCT01719003|156637475|FG006|Overall Study|Adverse Event|6|||
48667692|NCT01719003|156637476|FG007|Overall Study|Adverse Event|5|||
48667693|NCT01719003|156637477|FG008|Overall Study|Adverse Event|0|||
48667694|NCT01719003|156637469|FG000|Overall Study|Lost to Follow-up|0|||
48667695|NCT01719003|156637470|FG001|Overall Study|Lost to Follow-up|6|||
48667696|NCT01719003|156637471|FG002|Overall Study|Lost to Follow-up|7|||
48667697|NCT01719003|156637472|FG003|Overall Study|Lost to Follow-up|2|||
48667698|NCT01719003|156637473|FG004|Overall Study|Lost to Follow-up|3|||
48667699|NCT01719003|156637474|FG005|Overall Study|Lost to Follow-up|4|||
48667700|NCT01719003|156637475|FG006|Overall Study|Lost to Follow-up|3|||
48667701|NCT01719003|156637476|FG007|Overall Study|Lost to Follow-up|2|||
48758458|NCT02153112|156962821|FG005|Overall Study|Lost to Follow-up|1|||
48758459|NCT02153112|156962822|FG006|Overall Study|Lost to Follow-up|1|||
48758460|NCT02153112|156962823|FG007|Overall Study|Lost to Follow-up|0|||
48758461|NCT02153112|156962824|FG008|Overall Study|Lost to Follow-up|1|||
48341996|NCT02706834|155447652|FG003|Overall Study|Other Reason Not Specified|0|||
48341997|NCT02706834|155447653|FG004|Overall Study|Other Reason Not Specified|1|||
48341998|NCT02706834|155447654|FG005|Overall Study|Other Reason Not Specified|0|||
48341999|NCT02706834|155447655|FG006|Overall Study|Other Reason Not Specified|0|||
48342000|NCT02706834|155447656|FG007|Overall Study|Other Reason Not Specified|0|||
48342001|NCT02706834|155447657|FG008|Overall Study|Other Reason Not Specified|0|||
48342002|NCT02706834|155447658|FG009|Overall Study|Other Reason Not Specified|0|||
48342003|NCT02706834|155447659|FG010|Overall Study|Other Reason Not Specified|0|||
48342004|NCT02815735|155447660|FG000|First Intervention (4 Weeks)|Discomfort|1|||
48667702|NCT01719003|156637477|FG008|Overall Study|Lost to Follow-up|2|||
48342005|NCT02815735|155447661|FG001|First Intervention (4 Weeks)|Discomfort|0|||
48342006|NCT02815735|155447660|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
48342007|NCT02815735|155447661|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
48667703|NCT01719003|156637469|FG000|Overall Study|Refusal to continue, not due to AE|2|||
48667704|NCT01719003|156637470|FG001|Overall Study|Refusal to continue, not due to AE|5|||
48758462|NCT02153112|156962825|FG009|Overall Study|Lost to Follow-up|1|||
48758463|NCT02153112|156962816|FG000|Overall Study|Withdrawal by Subject|3|||
48758464|NCT02153112|156962817|FG001|Overall Study|Withdrawal by Subject|1|||
48342008|NCT02815735|155447660|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
48342009|NCT02815735|155447661|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
48342010|NCT02815735|155447660|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
48342011|NCT02815735|155447661|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
48667705|NCT01719003|156637471|FG002|Overall Study|Refusal to continue, not due to AE|4|||
48342012|NCT00382408|155447662|FG000|Overall Study|Did not meet protocol requirement|3|||
48342013|NCT00382408|155447663|FG001|Overall Study|Did not meet protocol requirement|3|||
48342014|NCT00382408|155447662|FG000|Overall Study|Protocol Violation|2|||
48667706|NCT01719003|156637472|FG003|Overall Study|Refusal to continue, not due to AE|4|||
48667707|NCT01719003|156637473|FG004|Overall Study|Refusal to continue, not due to AE|4|||
48667708|NCT01719003|156637474|FG005|Overall Study|Refusal to continue, not due to AE|3|||
48667709|NCT01719003|156637475|FG006|Overall Study|Refusal to continue, not due to AE|8|||
48667710|NCT01719003|156637476|FG007|Overall Study|Refusal to continue, not due to AE|7|||
48667711|NCT01719003|156637477|FG008|Overall Study|Refusal to continue, not due to AE|1|||
48667712|NCT01719003|156637469|FG000|Overall Study|Reason other than those specified|0|||
48667713|NCT01719003|156637470|FG001|Overall Study|Reason other than those specified|0|||
48667714|NCT01719003|156637471|FG002|Overall Study|Reason other than those specified|2|||
48667715|NCT01719003|156637472|FG003|Overall Study|Reason other than those specified|3|||
48667716|NCT01719003|156637473|FG004|Overall Study|Reason other than those specified|4|||
48667717|NCT01719003|156637474|FG005|Overall Study|Reason other than those specified|1|||
48667718|NCT01719003|156637475|FG006|Overall Study|Reason other than those specified|0|||
48667719|NCT01719003|156637476|FG007|Overall Study|Reason other than those specified|3|||
48667720|NCT01719003|156637477|FG008|Overall Study|Reason other than those specified|1|||
48667721|NCT01719003|156637469|FG000|Overall Study|Lack of Efficacy|0|||
48667722|NCT01719003|156637470|FG001|Overall Study|Lack of Efficacy|0|||
48667723|NCT01719003|156637471|FG002|Overall Study|Lack of Efficacy|0|||
48667724|NCT01719003|156637472|FG003|Overall Study|Lack of Efficacy|0|||
48667725|NCT01719003|156637473|FG004|Overall Study|Lack of Efficacy|0|||
48667726|NCT01719003|156637474|FG005|Overall Study|Lack of Efficacy|0|||
48667727|NCT01719003|156637475|FG006|Overall Study|Lack of Efficacy|1|||
48667728|NCT01719003|156637476|FG007|Overall Study|Lack of Efficacy|0|||
48667729|NCT01719003|156637477|FG008|Overall Study|Lack of Efficacy|0|||
48667730|NCT03283150|156637482|FG000|Overall Study|Withdrawal by Subject|6|||
48667731|NCT03283150|156637483|FG001|Overall Study|Withdrawal by Subject|0|||
48667732|NCT03283150|156637484|FG002|Overall Study|Withdrawal by Subject|0|||
48667733|NCT01143896|156637485|FG000|Overall Study|Did not complete Baseline Interview|5|||
48667734|NCT01143896|156637486|FG001|Overall Study|Did not complete Baseline Interview|4|||
48667735|NCT01143896|156637485|FG000|Overall Study|Lost to Follow-up|18|||
48667736|NCT01143896|156637486|FG001|Overall Study|Lost to Follow-up|13|||
48667737|NCT01143896|156637485|FG000|Overall Study|Withdrawal by Subject|13|||
48667738|NCT01143896|156637486|FG001|Overall Study|Withdrawal by Subject|5|||
48667739|NCT01143896|156637485|FG000|Overall Study|Death|6|||
48667740|NCT01143896|156637486|FG001|Overall Study|Death|3|||
48667741|NCT02084238|156637489|FG000|Overall Study|Lost to Follow-up|2|||
48758465|NCT02153112|156962818|FG002|Overall Study|Withdrawal by Subject|2|||
48342015|NCT00382408|155447663|FG001|Overall Study|Protocol Violation|2|||
48667742|NCT04375397|156637492|FG000|Overall Study|Death|1|||
48667743|NCT04375397|156637493|FG001|Overall Study|Death|1|||
48667744|NCT04375397|156637492|FG000|Overall Study|Withdrew consent|2|||
48667745|NCT04375397|156637493|FG001|Overall Study|Withdrew consent|0|||
48667746|NCT04375397|156637492|FG000|Overall Study|Lost to Follow-up|6|||
48667747|NCT04375397|156637493|FG001|Overall Study|Lost to Follow-up|4|||
48667748|NCT04375397|156637492|FG000|Overall Study|Other, not specified|0|||
48667749|NCT04375397|156637493|FG001|Overall Study|Other, not specified|1|||
48667750|NCT03412604|156637494|FG000|Overall Study|Withdrawal by Subject|1|||
48667751|NCT05545644|156637496|FG000|Overall Study|Lost to Follow-up|4|||
48667752|NCT05545644|156637497|FG001|Overall Study|Lost to Follow-up|3|||
48667753|NCT03242252|156637498|FG000|Overall Study|At the Participant's own Request|18|||
48667754|NCT03242252|156637499|FG001|Overall Study|At the Participant's own Request|10|||
48667755|NCT03242252|156637500|FG002|Overall Study|At the Participant's own Request|15|||
48667756|NCT03242252|156637498|FG000|Overall Study|Adverse Event|8|||
48667757|NCT03242252|156637499|FG001|Overall Study|Adverse Event|6|||
48667758|NCT03242252|156637500|FG002|Overall Study|Adverse Event|9|||
48667759|NCT03242252|156637498|FG000|Overall Study|Poor Compliance to Protocol|0|||
48667760|NCT03242252|156637499|FG001|Overall Study|Poor Compliance to Protocol|2|||
48667761|NCT03242252|156637500|FG002|Overall Study|Poor Compliance to Protocol|3|||
48667762|NCT03242252|156637498|FG000|Overall Study|Study Terminated by Sponsor|1|||
48758466|NCT02153112|156962819|FG003|Overall Study|Withdrawal by Subject|2|||
48758467|NCT02153112|156962820|FG004|Overall Study|Withdrawal by Subject|1|||
48667763|NCT03242252|156637499|FG001|Overall Study|Study Terminated by Sponsor|0|||
48667764|NCT03242252|156637500|FG002|Overall Study|Study Terminated by Sponsor|0|||
48667765|NCT03242252|156637498|FG000|Overall Study|Reason not Specified|4|||
48667766|NCT03242252|156637499|FG001|Overall Study|Reason not Specified|4|||
48667767|NCT03242252|156637500|FG002|Overall Study|Reason not Specified|1|||
48667768|NCT03242252|156637498|FG000|Overall Study|Lost to Follow-up|5|||
48667769|NCT03242252|156637499|FG001|Overall Study|Lost to Follow-up|1|||
48667770|NCT03242252|156637500|FG002|Overall Study|Lost to Follow-up|4|||
48667771|NCT00993499|156637507|FG000|Run-in Period (8 Days)|Adverse Event|0|||
48667772|NCT00993499|156637508|FG001|Run-in Period (8 Days)|Adverse Event|1|||
48667773|NCT00993499|156637509|FG002|Run-in Period (8 Days)|Adverse Event|0|||
48667774|NCT00993499|156637510|FG003|Run-in Period (8 Days)|Adverse Event|0|||
48667775|NCT00993499|156637511|FG004|Run-in Period (8 Days)|Adverse Event|0|||
48667776|NCT00993499|156637512|FG005|Run-in Period (8 Days)|Adverse Event|0|||
48667777|NCT00993499|156637507|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
48667778|NCT00993499|156637508|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667779|NCT00993499|156637509|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667780|NCT00993499|156637510|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667781|NCT00993499|156637511|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667782|NCT00993499|156637512|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
48667783|NCT00993499|156637507|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
48667784|NCT00993499|156637508|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
48667785|NCT00993499|156637509|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
48667786|NCT00993499|156637510|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
48667787|NCT00993499|156637511|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
48667788|NCT00993499|156637512|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
48667789|NCT00993499|156637507|FG000|Run-in Period (8 Days)|Progressive disease|0|||
48667790|NCT00993499|156637508|FG001|Run-in Period (8 Days)|Progressive disease|1|||
48667791|NCT00993499|156637509|FG002|Run-in Period (8 Days)|Progressive disease|1|||
48667792|NCT00993499|156637510|FG003|Run-in Period (8 Days)|Progressive disease|0|||
48667793|NCT00993499|156637511|FG004|Run-in Period (8 Days)|Progressive disease|0|||
48667794|NCT00993499|156637512|FG005|Run-in Period (8 Days)|Progressive disease|0|||
48667795|NCT00993499|156637507|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
48667796|NCT00993499|156637508|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
48667797|NCT00993499|156637509|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
48667798|NCT00993499|156637510|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
48667799|NCT00993499|156637511|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
48667800|NCT00993499|156637512|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
48667801|NCT00993499|156637507|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
48667802|NCT00993499|156637508|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
48667803|NCT00993499|156637509|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
48758468|NCT02153112|156962821|FG005|Overall Study|Withdrawal by Subject|1|||
48758469|NCT02153112|156962822|FG006|Overall Study|Withdrawal by Subject|7|||
48758470|NCT02153112|156962823|FG007|Overall Study|Withdrawal by Subject|2|||
48758471|NCT02153112|156962824|FG008|Overall Study|Withdrawal by Subject|13|||
48758472|NCT02153112|156962825|FG009|Overall Study|Withdrawal by Subject|12|||
48758473|NCT02153112|156962816|FG000|Overall Study|Reason not Specified|0|||
48758474|NCT02153112|156962817|FG001|Overall Study|Reason not Specified|0|||
48758475|NCT02153112|156962818|FG002|Overall Study|Reason not Specified|0|||
48758476|NCT02153112|156962819|FG003|Overall Study|Reason not Specified|0|||
48758477|NCT02153112|156962820|FG004|Overall Study|Reason not Specified|0|||
48758478|NCT02153112|156962821|FG005|Overall Study|Reason not Specified|0|||
48758479|NCT02153112|156962822|FG006|Overall Study|Reason not Specified|0|||
48758480|NCT02153112|156962823|FG007|Overall Study|Reason not Specified|0|||
48758481|NCT02153112|156962824|FG008|Overall Study|Reason not Specified|1|||
48758482|NCT02153112|156962825|FG009|Overall Study|Reason not Specified|1|||
48758483|NCT00309842|156962826|FG000|Overall Study|Lost to Follow-up|1|||
48758484|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
48758485|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
48758486|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
48758487|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
48758488|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
48758489|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
48758490|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
48758491|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
48758492|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
48758493|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
48758494|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
48758495|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
48342016|NCT00382408|155447662|FG000|Overall Study|Physician Decision|1|||
48342017|NCT00382408|155447663|FG001|Overall Study|Physician Decision|0|||
48342018|NCT00382408|155447662|FG000|Overall Study|Withdrawal by Subject|17|||
48342019|NCT00382408|155447663|FG001|Overall Study|Withdrawal by Subject|6|||
48342020|NCT00382408|155447662|FG000|Overall Study|Pregnancy|2|||
48342021|NCT00382408|155447663|FG001|Overall Study|Pregnancy|0|||
48342022|NCT00382408|155447662|FG000|Overall Study|Lost to Follow-up|19|||
48342023|NCT00382408|155447663|FG001|Overall Study|Lost to Follow-up|8|||
48342024|NCT00382408|155447662|FG000|Overall Study|Other|100|||
48342025|NCT00382408|155447663|FG001|Overall Study|Other|35|||
48342026|NCT00352053|155447664|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
48342027|NCT00352053|155447665|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
48342028|NCT00352053|155447664|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
48342029|NCT00352053|155447665|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
48342030|NCT00352053|155447664|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
48342031|NCT00352053|155447665|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
48342032|NCT00352053|155447664|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
48342033|NCT00352053|155447665|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
48342034|NCT00352053|155447664|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
48342035|NCT00352053|155447665|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
48342036|NCT00352053|155447664|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
48342037|NCT00352053|155447665|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
48342038|NCT00352053|155447664|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
48342039|NCT00352053|155447665|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
48342040|NCT00352053|155447664|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
48342041|NCT00352053|155447665|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
48342042|NCT00352053|155447664|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
48342043|NCT00352053|155447665|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
48342044|NCT00352053|155447664|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
48758496|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
48758497|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
48342045|NCT00352053|155447665|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
48342046|NCT00352053|155447664|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
48342047|NCT00352053|155447665|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
48342048|NCT00352053|155447664|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
48342049|NCT00352053|155447665|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
48342050|NCT00352053|155447664|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
48342051|NCT00352053|155447665|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
48342052|NCT04121741|155447666|FG000|Overall Study|Protocol Violation|1|||
48342053|NCT04121741|155447667|FG001|Overall Study|Protocol Violation|0|||
48758498|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
48342054|NCT04121741|155447668|FG002|Overall Study|Protocol Violation|0|||
48342055|NCT04121741|155447669|FG003|Overall Study|Protocol Violation|0|||
48342056|NCT04121741|155447670|FG004|Overall Study|Protocol Violation|0|||
48342057|NCT04121741|155447671|FG005|Overall Study|Protocol Violation|0|||
48342058|NCT03853746|155447672|FG000|Overall Study|Withdrawal by Subject|1|||
48342059|NCT01572493|155447673|FG000|Overall Study|Physician Decision|1|||
48342060|NCT01572493|155447674|FG001|Overall Study|Physician Decision|0|||
48342061|NCT01572493|155447675|FG002|Overall Study|Physician Decision|0|||
48342062|NCT01572493|155447676|FG003|Overall Study|Physician Decision|0|||
48342063|NCT01572493|155447677|FG004|Overall Study|Physician Decision|0|||
48342064|NCT01572493|155447678|FG005|Overall Study|Physician Decision|0|||
48342065|NCT01572493|155447679|FG006|Overall Study|Physician Decision|0|||
48342066|NCT01572493|155447680|FG007|Overall Study|Physician Decision|0|||
48342067|NCT01572493|155447681|FG008|Overall Study|Physician Decision|0|||
48342068|NCT01572493|155447673|FG000|Overall Study|Switched to alternative treatment|0|||
48342069|NCT01572493|155447674|FG001|Overall Study|Switched to alternative treatment|1|||
48342070|NCT01572493|155447675|FG002|Overall Study|Switched to alternative treatment|2|||
48342071|NCT01572493|155447676|FG003|Overall Study|Switched to alternative treatment|1|||
48342072|NCT01572493|155447677|FG004|Overall Study|Switched to alternative treatment|2|||
48342073|NCT01572493|155447678|FG005|Overall Study|Switched to alternative treatment|0|||
48342074|NCT01572493|155447679|FG006|Overall Study|Switched to alternative treatment|2|||
48342075|NCT01572493|155447680|FG007|Overall Study|Switched to alternative treatment|0|||
48342076|NCT01572493|155447681|FG008|Overall Study|Switched to alternative treatment|2|||
48342077|NCT01572493|155447673|FG000|Overall Study|Death|0|||
48342078|NCT01572493|155447674|FG001|Overall Study|Death|0|||
48342079|NCT01572493|155447675|FG002|Overall Study|Death|0|||
48342080|NCT01572493|155447676|FG003|Overall Study|Death|1|||
48342081|NCT01572493|155447677|FG004|Overall Study|Death|0|||
48342082|NCT01572493|155447678|FG005|Overall Study|Death|1|||
48342083|NCT01572493|155447679|FG006|Overall Study|Death|0|||
48342084|NCT01572493|155447680|FG007|Overall Study|Death|0|||
48342085|NCT01572493|155447681|FG008|Overall Study|Death|0|||
48342086|NCT01572493|155447673|FG000|Overall Study|Adverse Event|0|||
48342087|NCT01572493|155447674|FG001|Overall Study|Adverse Event|0|||
48342088|NCT01572493|155447675|FG002|Overall Study|Adverse Event|0|||
48342089|NCT01572493|155447676|FG003|Overall Study|Adverse Event|0|||
48342090|NCT01572493|155447677|FG004|Overall Study|Adverse Event|0|||
48342091|NCT01572493|155447678|FG005|Overall Study|Adverse Event|0|||
48342092|NCT01572493|155447679|FG006|Overall Study|Adverse Event|1|||
48342093|NCT01572493|155447680|FG007|Overall Study|Adverse Event|0|||
48342094|NCT01572493|155447681|FG008|Overall Study|Adverse Event|0|||
48342095|NCT04203199|155447682|FG000|First Intervention Period|Lost to Follow-up|0|||
48342096|NCT04203199|155447683|FG001|First Intervention Period|Lost to Follow-up|1|||
48342097|NCT04203199|155447682|FG000|Second Intervention Period|Medication change|1|||
48342098|NCT04203199|155447683|FG001|Second Intervention Period|Medication change|0|||
48342099|NCT01631825|155447684|FG000|Overall Study|Adverse Event|42|||
48342100|NCT01631825|155447684|FG000|Overall Study|Lack of Efficacy|7|||
48342101|NCT01631825|155447684|FG000|Overall Study|Withdrawal by Subject|9|||
48342102|NCT01631825|155447684|FG000|Overall Study|Protocol Violation|4|||
48342103|NCT01631825|155447684|FG000|Overall Study|Discontinuation criteria|1|||
48342104|NCT01631825|155447684|FG000|Overall Study|Physician Decision|2|||
48342105|NCT02110225|155447685|FG000|Overall Study|Lost to Follow-up|0|||
48342106|NCT02110225|155447686|FG001|Overall Study|Lost to Follow-up|1|||
48342107|NCT02110225|155447687|FG002|Overall Study|Lost to Follow-up|0|||
48342108|NCT02176018|155447688|FG000|Overall Study|Adverse Event|0|||
48342109|NCT02176018|155447689|FG001|Overall Study|Adverse Event|2|||
48342110|NCT02176018|155447688|FG000|Overall Study|Lost to Follow-up|3|||
48342111|NCT02176018|155447689|FG001|Overall Study|Lost to Follow-up|1|||
48342112|NCT02176018|155447688|FG000|Overall Study|Protocol Violation|1|||
48342113|NCT02176018|155447689|FG001|Overall Study|Protocol Violation|1|||
48342114|NCT02176018|155447688|FG000|Overall Study|Withdrawal by Subject|1|||
48342115|NCT02176018|155447689|FG001|Overall Study|Withdrawal by Subject|2|||
48342116|NCT02068352|155447690|FG000|Overall Study|Lost to Follow-up|0|||
48342117|NCT02068352|155447691|FG001|Overall Study|Lost to Follow-up|2|||
48342118|NCT02068352|155447692|FG002|Overall Study|Lost to Follow-up|0|||
48758499|NCT00561080|156962827|FG000|Vaccination Period (up to Month 4)|Other|0|||
48758500|NCT00561080|156962828|FG001|Vaccination Period (up to Month 4)|Other|2|||
48758501|NCT00561080|156962829|FG002|Vaccination Period (up to Month 4)|Other|1|||
48758502|NCT00561080|156962827|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
48758503|NCT00561080|156962828|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
48758504|NCT00561080|156962829|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
48758505|NCT00561080|156962827|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
48758506|NCT00561080|156962828|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
48758507|NCT00561080|156962829|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
48758508|NCT00561080|156962827|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
48758509|NCT00561080|156962828|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
48758510|NCT00561080|156962829|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
48758511|NCT00561080|156962827|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
48758512|NCT00561080|156962828|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
48758513|NCT00561080|156962829|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
48758514|NCT03519347|156962834|FG000|Interventional Crossover Period 1|Death|0|||
48758515|NCT03519347|156962835|FG001|Interventional Crossover Period 1|Death|0|||
48758516|NCT03519347|156962836|FG002|Interventional Crossover Period 1|Death|0|||
48758517|NCT03519347|156962837|FG003|Interventional Crossover Period 1|Death|1|||
48758518|NCT00982488|156964571|FG000|Overall Study|Administrative reason by sponsor|81|||
48758519|NCT00982488|156964572|FG001|Overall Study|Administrative reason by sponsor|3|||
48758520|NCT00982488|156964573|FG002|Overall Study|Administrative reason by sponsor|11|||
48758521|NCT00982488|156964574|FG003|Overall Study|Administrative reason by sponsor|0|||
48758522|NCT00982488|156964575|FG004|Overall Study|Administrative reason by sponsor|0|||
48758523|NCT00982488|156964571|FG000|Overall Study|Adverse event unrelated to study drug|5|||
48758524|NCT00982488|156964572|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48758525|NCT00982488|156964573|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48758526|NCT00982488|156964574|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48758527|NCT00982488|156964575|FG004|Overall Study|Adverse event unrelated to study drug|0|||
48758528|NCT00982488|156964571|FG000|Overall Study|Death|11|||
48758529|NCT00982488|156964572|FG001|Overall Study|Death|0|||
48758530|NCT00982488|156964573|FG002|Overall Study|Death|2|||
48758531|NCT00982488|156964574|FG003|Overall Study|Death|0|||
48758532|NCT00982488|156964575|FG004|Overall Study|Death|0|||
48758533|NCT00982488|156964571|FG000|Overall Study|Disease progression|30|||
48758534|NCT00982488|156964572|FG001|Overall Study|Disease progression|5|||
48758535|NCT00982488|156964573|FG002|Overall Study|Disease progression|10|||
48758536|NCT00982488|156964574|FG003|Overall Study|Disease progression|1|||
48758537|NCT00982488|156964575|FG004|Overall Study|Disease progression|1|||
48758538|NCT00982488|156964571|FG000|Overall Study|Lost to Follow-up|1|||
48758539|NCT00982488|156964572|FG001|Overall Study|Lost to Follow-up|0|||
48758540|NCT00982488|156964573|FG002|Overall Study|Lost to Follow-up|0|||
48758541|NCT00982488|156964574|FG003|Overall Study|Lost to Follow-up|0|||
48758542|NCT00982488|156964575|FG004|Overall Study|Lost to Follow-up|0|||
48758543|NCT00982488|156964571|FG000|Overall Study|Maximum clinical benefit|1|||
48758544|NCT00982488|156964572|FG001|Overall Study|Maximum clinical benefit|1|||
48758545|NCT00982488|156964573|FG002|Overall Study|Maximum clinical benefit|1|||
48758546|NCT00982488|156964574|FG003|Overall Study|Maximum clinical benefit|0|||
48758547|NCT00982488|156964575|FG004|Overall Study|Maximum clinical benefit|0|||
48758548|NCT00982488|156964571|FG000|Overall Study|Other|15|||
48758549|NCT00982488|156964572|FG001|Overall Study|Other|1|||
48758550|NCT00982488|156964573|FG002|Overall Study|Other|3|||
48758551|NCT00982488|156964574|FG003|Overall Study|Other|1|||
48758552|NCT00982488|156964575|FG004|Overall Study|Other|0|||
48758553|NCT00982488|156964571|FG000|Overall Study|Poor compliance/noncompliance|0|||
48758554|NCT00982488|156964572|FG001|Overall Study|Poor compliance/noncompliance|1|||
48758555|NCT00982488|156964573|FG002|Overall Study|Poor compliance/noncompliance|0|||
48758556|NCT00982488|156964574|FG003|Overall Study|Poor compliance/noncompliance|0|||
48758557|NCT00982488|156964575|FG004|Overall Study|Poor compliance/noncompliance|0|||
48758558|NCT00982488|156964571|FG000|Overall Study|Stem cell transplant|2|||
48758559|NCT00982488|156964572|FG001|Overall Study|Stem cell transplant|0|||
48758560|NCT00982488|156964573|FG002|Overall Study|Stem cell transplant|0|||
48758561|NCT00982488|156964574|FG003|Overall Study|Stem cell transplant|1|||
48758562|NCT00982488|156964575|FG004|Overall Study|Stem cell transplant|0|||
48758563|NCT00982488|156964571|FG000|Overall Study|Study drug toxicity|34|||
48758564|NCT00982488|156964572|FG001|Overall Study|Study drug toxicity|1|||
48758565|NCT00982488|156964573|FG002|Overall Study|Study drug toxicity|6|||
48758566|NCT00982488|156964574|FG003|Overall Study|Study drug toxicity|0|||
48758567|NCT00982488|156964575|FG004|Overall Study|Study drug toxicity|0|||
48758568|NCT00982488|156964571|FG000|Overall Study|Withdrawal by Subject|5|||
48758569|NCT00982488|156964572|FG001|Overall Study|Withdrawal by Subject|1|||
48758570|NCT00982488|156964573|FG002|Overall Study|Withdrawal by Subject|1|||
48758571|NCT00982488|156964574|FG003|Overall Study|Withdrawal by Subject|0|||
48758572|NCT00982488|156964575|FG004|Overall Study|Withdrawal by Subject|0|||
48758573|NCT00463346|156964576|FG000|Overall Study|Withdrawal by Subject|3|||
48667804|NCT00993499|156637510|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
48667805|NCT00993499|156637511|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
48667806|NCT00993499|156637512|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
48667807|NCT00993499|156637507|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
48667808|NCT00993499|156637508|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
48667809|NCT00993499|156637509|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
48667810|NCT00993499|156637510|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
48667811|NCT00993499|156637511|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
48667812|NCT00993499|156637512|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
48667813|NCT00993499|156637507|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667814|NCT00993499|156637508|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667815|NCT00993499|156637509|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
48667816|NCT00993499|156637510|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667817|NCT00993499|156637511|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667818|NCT00993499|156637512|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
48667819|NCT00993499|156637507|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667820|NCT00993499|156637508|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
48667821|NCT00993499|156637509|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667822|NCT00993499|156637510|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667823|NCT00993499|156637511|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667824|NCT00993499|156637512|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
48667825|NCT00993499|156637507|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
48667826|NCT00993499|156637508|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
48667827|NCT00993499|156637509|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
48667828|NCT00993499|156637510|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
48667829|NCT00993499|156637511|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
48667830|NCT00993499|156637512|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
48667831|NCT00993499|156637507|FG000|Discontinued After Starting Course 3|DLT|1|||
48667832|NCT00993499|156637508|FG001|Discontinued After Starting Course 3|DLT|0|||
48667833|NCT00993499|156637509|FG002|Discontinued After Starting Course 3|DLT|2|||
48667834|NCT00993499|156637510|FG003|Discontinued After Starting Course 3|DLT|1|||
48667835|NCT00993499|156637511|FG004|Discontinued After Starting Course 3|DLT|0|||
48667836|NCT00993499|156637512|FG005|Discontinued After Starting Course 3|DLT|0|||
48667837|NCT00993499|156637507|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
48667838|NCT00993499|156637508|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
48667839|NCT00993499|156637509|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
48667840|NCT00993499|156637510|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
48667841|NCT00993499|156637511|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
48667842|NCT00993499|156637512|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
48667843|NCT02759315|156637513|FG000|Overall Study|Adverse Event|0|||
48667844|NCT02759315|156637514|FG001|Overall Study|Adverse Event|0|||
48667845|NCT02759315|156637515|FG002|Overall Study|Adverse Event|0|||
48667846|NCT02759315|156637516|FG003|Overall Study|Adverse Event|1|||
48667847|NCT02759315|156637517|FG004|Overall Study|Adverse Event|0|||
48667848|NCT02759315|156637513|FG000|Overall Study|Death|0|||
48667849|NCT02759315|156637514|FG001|Overall Study|Death|0|||
48667850|NCT02759315|156637515|FG002|Overall Study|Death|1|||
48667851|NCT02759315|156637516|FG003|Overall Study|Death|0|||
48667852|NCT02759315|156637517|FG004|Overall Study|Death|0|||
48667853|NCT02759315|156637513|FG000|Overall Study|Lost to Follow-up|2|||
48667854|NCT02759315|156637514|FG001|Overall Study|Lost to Follow-up|0|||
48667855|NCT02759315|156637515|FG002|Overall Study|Lost to Follow-up|4|||
48667856|NCT02759315|156637516|FG003|Overall Study|Lost to Follow-up|0|||
48667857|NCT02759315|156637517|FG004|Overall Study|Lost to Follow-up|0|||
48667858|NCT02759315|156637513|FG000|Overall Study|Protocol Violation|0|||
48667859|NCT02759315|156637514|FG001|Overall Study|Protocol Violation|1|||
48667860|NCT02759315|156637515|FG002|Overall Study|Protocol Violation|0|||
48667861|NCT02759315|156637516|FG003|Overall Study|Protocol Violation|0|||
48667862|NCT02759315|156637517|FG004|Overall Study|Protocol Violation|0|||
48667863|NCT02759315|156637513|FG000|Overall Study|Study terminated prior to completion|2|||
48667864|NCT02759315|156637514|FG001|Overall Study|Study terminated prior to completion|0|||
48667865|NCT02759315|156637515|FG002|Overall Study|Study terminated prior to completion|5|||
48667866|NCT02759315|156637516|FG003|Overall Study|Study terminated prior to completion|0|||
48667867|NCT02759315|156637517|FG004|Overall Study|Study terminated prior to completion|1|||
48667868|NCT00870194|156637523|FG000|Overall Study|Adverse Event|10|||
48667869|NCT00870194|156637524|FG001|Overall Study|Adverse Event|5|||
48667870|NCT00870194|156637523|FG000|Overall Study|Lack of Efficacy|0|||
48667871|NCT00870194|156637524|FG001|Overall Study|Lack of Efficacy|1|||
48667872|NCT00870194|156637523|FG000|Overall Study|Lost to Follow-up|2|||
48667873|NCT00870194|156637524|FG001|Overall Study|Lost to Follow-up|0|||
48667874|NCT00870194|156637523|FG000|Overall Study|Physician Decision|3|||
48667875|NCT00870194|156637524|FG001|Overall Study|Physician Decision|1|||
48667876|NCT00870194|156637523|FG000|Overall Study|Protocol Violation|3|||
48667877|NCT00870194|156637524|FG001|Overall Study|Protocol Violation|3|||
48667878|NCT00870194|156637523|FG000|Overall Study|Entry Criteria Not Met|1|||
48667879|NCT00870194|156637524|FG001|Overall Study|Entry Criteria Not Met|2|||
48667880|NCT00870194|156637523|FG000|Overall Study|Subject Decision|7|||
48667881|NCT00870194|156637524|FG001|Overall Study|Subject Decision|2|||
48342119|NCT02068352|155447690|FG000|Overall Study|Adverse Event|4|||
48342120|NCT02068352|155447691|FG001|Overall Study|Adverse Event|2|||
48342121|NCT02068352|155447692|FG002|Overall Study|Adverse Event|7|||
48342122|NCT02068352|155447690|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
48342123|NCT02068352|155447691|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
48342124|NCT02068352|155447692|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
48667882|NCT00162266|156637525|FG000|Double-Blind Period|Adverse Event|5|||
48667883|NCT00162266|156637526|FG001|Double-Blind Period|Adverse Event|9|||
48667884|NCT00162266|156637527|FG002|Double-Blind Period|Adverse Event|11|||
48667885|NCT00162266|156637528|FG003|Double-Blind Period|Adverse Event|0|||
48667886|NCT00162266|156637525|FG000|Double-Blind Period|Death|0|||
48342125|NCT02068352|155447690|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
48342126|NCT02068352|155447691|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
48342127|NCT02068352|155447692|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
48342128|NCT02068352|155447690|FG000|Overall Study|Protocol Deviation|0|||
48667887|NCT00162266|156637526|FG001|Double-Blind Period|Death|1|||
48667888|NCT00162266|156637527|FG002|Double-Blind Period|Death|0|||
48667889|NCT00162266|156637528|FG003|Double-Blind Period|Death|0|||
48667890|NCT00162266|156637525|FG000|Double-Blind Period|Lost to Follow-up|1|||
48667891|NCT00162266|156637526|FG001|Double-Blind Period|Lost to Follow-up|2|||
48667892|NCT00162266|156637527|FG002|Double-Blind Period|Lost to Follow-up|0|||
48667893|NCT00162266|156637528|FG003|Double-Blind Period|Lost to Follow-up|0|||
48667894|NCT00162266|156637525|FG000|Double-Blind Period|Other Reason|1|||
48667895|NCT00162266|156637526|FG001|Double-Blind Period|Other Reason|0|||
48667896|NCT00162266|156637527|FG002|Double-Blind Period|Other Reason|1|||
48667897|NCT00162266|156637528|FG003|Double-Blind Period|Other Reason|0|||
48667898|NCT00162266|156637525|FG000|Double-Blind Period|Lack of Efficacy|13|||
48667899|NCT00162266|156637526|FG001|Double-Blind Period|Lack of Efficacy|17|||
48667900|NCT00162266|156637527|FG002|Double-Blind Period|Lack of Efficacy|30|||
48667901|NCT00162266|156637528|FG003|Double-Blind Period|Lack of Efficacy|0|||
48667902|NCT00162266|156637525|FG000|Double-Blind Period|Withdrawal by Subject|5|||
48667903|NCT00162266|156637526|FG001|Double-Blind Period|Withdrawal by Subject|2|||
48667904|NCT00162266|156637527|FG002|Double-Blind Period|Withdrawal by Subject|6|||
48667905|NCT00162266|156637528|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48667906|NCT00162266|156637525|FG000|Open-Label Period|Death|0|||
48342129|NCT02068352|155447691|FG001|Overall Study|Protocol Deviation|0|||
48342130|NCT02068352|155447692|FG002|Overall Study|Protocol Deviation|1|||
48342131|NCT05153499|155447693|FG000|Overall Study|Withdrawal by Subject|1|||
48342132|NCT05153499|155447694|FG001|Overall Study|Withdrawal by Subject|0|||
48342133|NCT05153499|155447693|FG000|Overall Study|Clinical Hold|1|||
48342134|NCT05153499|155447694|FG001|Overall Study|Clinical Hold|0|||
48342135|NCT05153499|155447693|FG000|Overall Study|Study Termination|6|||
48342136|NCT05153499|155447694|FG001|Overall Study|Study Termination|5|||
48342137|NCT01116440|155447695|FG000|Treatment|Withdrawal by Subject|2|||
48342138|NCT01116440|155447696|FG001|Treatment|Withdrawal by Subject|2|||
48342139|NCT01116440|155447695|FG000|Treatment|Lost to Follow-up|1|||
48342140|NCT01116440|155447696|FG001|Treatment|Lost to Follow-up|1|||
48667907|NCT00162266|156637526|FG001|Open-Label Period|Death|0|||
48667908|NCT00162266|156637527|FG002|Open-Label Period|Death|0|||
48667909|NCT00162266|156637528|FG003|Open-Label Period|Death|7|||
48342141|NCT01116440|155447695|FG000|Treatment|Protocol Violation|0|||
48342142|NCT01116440|155447696|FG001|Treatment|Protocol Violation|2|||
48342143|NCT01116440|155447695|FG000|Treatment|Lack of Efficacy|0|||
48342144|NCT01116440|155447696|FG001|Treatment|Lack of Efficacy|1|||
48667910|NCT00162266|156637525|FG000|Open-Label Period|Adverse Event|0|||
48667911|NCT00162266|156637526|FG001|Open-Label Period|Adverse Event|0|||
48667912|NCT00162266|156637527|FG002|Open-Label Period|Adverse Event|0|||
48667913|NCT00162266|156637528|FG003|Open-Label Period|Adverse Event|46|||
48667914|NCT00162266|156637525|FG000|Open-Label Period|Lack of Efficacy|0|||
48667915|NCT00162266|156637526|FG001|Open-Label Period|Lack of Efficacy|0|||
48667916|NCT00162266|156637527|FG002|Open-Label Period|Lack of Efficacy|0|||
48667917|NCT00162266|156637528|FG003|Open-Label Period|Lack of Efficacy|26|||
48667918|NCT00162266|156637525|FG000|Open-Label Period|Lost to Follow-up|0|||
48342145|NCT01116440|155447695|FG000|Treatment|Adverse Event|0|||
48342146|NCT01116440|155447696|FG001|Treatment|Adverse Event|1|||
48667919|NCT00162266|156637526|FG001|Open-Label Period|Lost to Follow-up|0|||
48667920|NCT00162266|156637527|FG002|Open-Label Period|Lost to Follow-up|0|||
48667921|NCT00162266|156637528|FG003|Open-Label Period|Lost to Follow-up|3|||
48667922|NCT00162266|156637525|FG000|Open-Label Period|Withdrawal by Subject|0|||
48667923|NCT00162266|156637526|FG001|Open-Label Period|Withdrawal by Subject|0|||
48667924|NCT00162266|156637527|FG002|Open-Label Period|Withdrawal by Subject|0|||
48667925|NCT00162266|156637528|FG003|Open-Label Period|Withdrawal by Subject|31|||
48667926|NCT00162266|156637525|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
48667927|NCT00162266|156637526|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
48667928|NCT00162266|156637527|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
48667929|NCT00162266|156637528|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
48667930|NCT00162266|156637525|FG000|Open-Label Period|Other Reasons|0|||
48667931|NCT00162266|156637526|FG001|Open-Label Period|Other Reasons|0|||
48667932|NCT00162266|156637527|FG002|Open-Label Period|Other Reasons|0|||
48667933|NCT00162266|156637528|FG003|Open-Label Period|Other Reasons|15|||
48667934|NCT01754194|156637531|FG000|Overall Study|Lost to Follow-up|39|||
48667935|NCT01754194|156637532|FG001|Overall Study|Lost to Follow-up|14|||
48667936|NCT01754194|156637531|FG000|Overall Study|Withdrawal by Subject|4|||
48667937|NCT01754194|156637532|FG001|Overall Study|Withdrawal by Subject|5|||
48667938|NCT01754194|156637531|FG000|Overall Study|Other|9|||
48667939|NCT01754194|156637532|FG001|Overall Study|Other|8|||
48667940|NCT01896271|156637533|FG000|Overall Study|Physician Decision|10|||
48667941|NCT02322190|156637534|FG000|Overall Study|Death on study|1|||
48667942|NCT02322190|156637535|FG001|Overall Study|Death on study|0|||
48667943|NCT02776033|156637539|FG000|Overall Study|Withdrawal by Subject|0|||
48667944|NCT02776033|156637540|FG001|Overall Study|Withdrawal by Subject|0|||
48667945|NCT02776033|156637541|FG002|Overall Study|Withdrawal by Subject|2|||
48667946|NCT02776033|156637539|FG000|Overall Study|Physician Decision|2|||
48667947|NCT02776033|156637540|FG001|Overall Study|Physician Decision|0|||
48667948|NCT02776033|156637541|FG002|Overall Study|Physician Decision|0|||
48667949|NCT02776033|156637539|FG000|Overall Study|Lost to Follow-up|1|||
48667950|NCT02776033|156637540|FG001|Overall Study|Lost to Follow-up|0|||
48667951|NCT02776033|156637541|FG002|Overall Study|Lost to Follow-up|0|||
48667952|NCT02776033|156637539|FG000|Overall Study|Adverse Event|1|||
48667953|NCT02776033|156637540|FG001|Overall Study|Adverse Event|2|||
48667954|NCT02776033|156637541|FG002|Overall Study|Adverse Event|0|||
48667955|NCT03149003|156637542|FG000|Overall Study|Randomized but not treated|0|||
48667956|NCT03149003|156637543|FG001|Overall Study|Randomized but not treated|1|||
48667957|NCT03149003|156637544|FG002|Overall Study|Randomized but not treated|18|||
48667958|NCT01685983|156637545|FG000|Overall Study|Adverse Event|7|||
48667959|NCT01685983|156637545|FG000|Overall Study|Death|1|||
48667960|NCT01685983|156637545|FG000|Overall Study|Withdrawal by Subject|19|||
48667961|NCT01685983|156637545|FG000|Overall Study|Protocol Violation|2|||
48667962|NCT01685983|156637545|FG000|Overall Study|Physician Decision|13|||
48667963|NCT01685983|156637545|FG000|Overall Study|Other|7|||
48667964|NCT01685983|156637545|FG000|Overall Study|Progressive Disease|32|||
48667965|NCT01685983|156637545|FG000|Overall Study|Noncompliance with Study Drug|1|||
48667966|NCT00582738|156637547|FG000|Overall Study|Administrative Problems|7|||
48667967|NCT00582738|156637548|FG001|Overall Study|Administrative Problems|8|||
48667968|NCT00582738|156637547|FG000|Overall Study|Adverse Event|0|||
48667969|NCT00582738|156637548|FG001|Overall Study|Adverse Event|5|||
48667970|NCT00582738|156637547|FG000|Overall Study|Graft Lost|0|||
48667971|NCT00582738|156637548|FG001|Overall Study|Graft Lost|1|||
48667972|NCT00582738|156637547|FG000|Overall Study|Other|1|||
48667973|NCT00582738|156637548|FG001|Overall Study|Other|0|||
48667974|NCT00582738|156637547|FG000|Overall Study|Protocol Violation|1|||
48667975|NCT00582738|156637548|FG001|Overall Study|Protocol Violation|1|||
48667976|NCT00582738|156637547|FG000|Overall Study|Withdrawal by Subject|0|||
48667977|NCT00582738|156637548|FG001|Overall Study|Withdrawal by Subject|3|||
48667978|NCT04047420|156637549|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
48667979|NCT04047420|156637549|FG000|Washout Period|Refused Participation|2|||
48667980|NCT02012686|156637553|FG000|Overall Study|muscle contraction|0|||
48667981|NCT02012686|156637554|FG001|Overall Study|muscle contraction|1|||
48667982|NCT02012686|156637553|FG000|Overall Study|electrocardiography monitoring noise|0|||
48667983|NCT02012686|156637554|FG001|Overall Study|electrocardiography monitoring noise|1|||
48667984|NCT04912895|156637555|FG000|Overall Study|Unable to provide specimen|2|||
48667985|NCT04912895|156637556|FG001|Overall Study|Unable to provide specimen|0|||
48667986|NCT04912895|156637557|FG002|Overall Study|Unable to provide specimen|0|||
48667987|NCT01703065|156637558|FG000|Overall Study|Lack of Efficacy|1|||
48758574|NCT00463346|156964577|FG001|Overall Study|Withdrawal by Subject|3|||
48758575|NCT00488345|156964587|FG000|Overall Study|Adverse Event|0|||
48758576|NCT00488345|156964588|FG001|Overall Study|Adverse Event|1|||
48758577|NCT00488345|156964589|FG002|Overall Study|Adverse Event|1|||
48758578|NCT00488345|156964587|FG000|Overall Study|Unable to administer antibiotics at home|0|||
48758579|NCT00488345|156964588|FG001|Overall Study|Unable to administer antibiotics at home|1|||
48758580|NCT00488345|156964589|FG002|Overall Study|Unable to administer antibiotics at home|0|||
48758581|NCT00488345|156964587|FG000|Overall Study|Institutional Review Board review|0|||
48758582|NCT00488345|156964588|FG001|Overall Study|Institutional Review Board review|0|||
48758583|NCT00488345|156964589|FG002|Overall Study|Institutional Review Board review|1|||
48758584|NCT00488345|156964587|FG000|Overall Study|Surgical team recommendation|0|||
48758585|NCT00488345|156964588|FG001|Overall Study|Surgical team recommendation|1|||
48758586|NCT00488345|156964589|FG002|Overall Study|Surgical team recommendation|0|||
48758587|NCT00488345|156964587|FG000|Overall Study|Parent/legal guardian request|0|||
48758588|NCT00488345|156964588|FG001|Overall Study|Parent/legal guardian request|1|||
48342147|NCT01116440|155447695|FG000|Withdrawal|Withdrawal by Subject|0|||
48342148|NCT01116440|155447696|FG001|Withdrawal|Withdrawal by Subject|1|||
48342149|NCT01116440|155447695|FG000|Withdrawal|Lost to Follow-up|0|||
48342150|NCT01116440|155447696|FG001|Withdrawal|Lost to Follow-up|1|||
48342151|NCT01116440|155447695|FG000|Follow-up|Lost to Follow-up|0|||
48342152|NCT01116440|155447696|FG001|Follow-up|Lost to Follow-up|1|||
48342153|NCT01116440|155447695|FG000|Follow-up|Withdrawal by Subject|0|||
48342154|NCT01116440|155447696|FG001|Follow-up|Withdrawal by Subject|1|||
48342155|NCT05600036|155447697|FG000|Overall Study|Adverse Event|0|||
48342156|NCT05600036|155447698|FG001|Overall Study|Adverse Event|2|||
48342157|NCT05600036|155447699|FG002|Overall Study|Adverse Event|1|||
48342158|NCT05600036|155447700|FG003|Overall Study|Adverse Event|0|||
48342159|NCT05600036|155447701|FG004|Overall Study|Adverse Event|1|||
48342160|NCT05600036|155447702|FG005|Overall Study|Adverse Event|0|||
48342161|NCT05600036|155447697|FG000|Overall Study|Lost to Follow-up|0|||
48667988|NCT01703065|156637559|FG001|Overall Study|Lack of Efficacy|0|||
48667989|NCT03262116|156637560|FG000|Overall Study|Physician Decision|0|||
48667990|NCT03262116|156637561|FG001|Overall Study|Physician Decision|2|||
48667991|NCT03262116|156637562|FG002|Overall Study|Physician Decision|1|||
48667992|NCT03262116|156637563|FG003|Overall Study|Physician Decision|1|||
48667993|NCT03262116|156637564|FG004|Overall Study|Physician Decision|1|||
48667994|NCT03262116|156637565|FG005|Overall Study|Physician Decision|2|||
48667995|NCT03022981|156637568|FG000|Overall Study|Adverse Event|0|||
48667996|NCT03022981|156637569|FG001|Overall Study|Adverse Event|1|||
48667997|NCT03022981|156637570|FG002|Overall Study|Adverse Event|0|||
48667998|NCT03022981|156637568|FG000|Overall Study|Investigator's Discretion|0|||
48667999|NCT03022981|156637569|FG001|Overall Study|Investigator's Discretion|1|||
48668000|NCT03022981|156637570|FG002|Overall Study|Investigator's Discretion|2|||
48668001|NCT03022981|156637568|FG000|Overall Study|Lost to Follow-up|6|||
48668002|NCT03022981|156637569|FG001|Overall Study|Lost to Follow-up|2|||
48758589|NCT00488345|156964589|FG002|Overall Study|Parent/legal guardian request|1|||
48758590|NCT03182829|156964591|FG000|Overall Study|Protocol Violation|12|||
48758591|NCT03182829|156964592|FG001|Overall Study|Protocol Violation|12|||
48758592|NCT03182829|156964591|FG000|Overall Study|Other|4|||
48668003|NCT03022981|156637570|FG002|Overall Study|Lost to Follow-up|1|||
48668004|NCT03022981|156637568|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48668005|NCT03022981|156637569|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48758593|NCT03182829|156964592|FG001|Overall Study|Other|3|||
48758594|NCT00254540|156964593|FG000|Overall Study|Adverse Event|6|||
48758595|NCT00254540|156964594|FG001|Overall Study|Adverse Event|7|||
48758596|NCT00254540|156964593|FG000|Overall Study|Lack of Efficacy|13|||
48758597|NCT00254540|156964594|FG001|Overall Study|Lack of Efficacy|13|||
48758598|NCT00254540|156964593|FG000|Overall Study|Death|0|||
48758599|NCT00254540|156964594|FG001|Overall Study|Death|1|||
48758600|NCT00254540|156964593|FG000|Overall Study|Laboratory Test Abnormality|0|||
48758601|NCT00254540|156964594|FG001|Overall Study|Laboratory Test Abnormality|1|||
48758602|NCT00249444|156964595|FG000|Overall Study|Lost to Follow-up|2|||
48758603|NCT00249444|156964596|FG001|Overall Study|Lost to Follow-up|2|||
48758604|NCT00249444|156964595|FG000|Overall Study|non-compliant|9|||
48758605|NCT00249444|156964596|FG001|Overall Study|non-compliant|11|||
48758606|NCT00249444|156964595|FG000|Overall Study|Adverse Event|1|||
48758607|NCT00249444|156964596|FG001|Overall Study|Adverse Event|1|||
48758608|NCT00249444|156964595|FG000|Overall Study|life event|0|||
48758609|NCT00249444|156964596|FG001|Overall Study|life event|1|||
48758610|NCT00412854|156964599|FG000|Overall Study|Withdrawn due to adverse events|1|||
48758611|NCT00412854|156964600|FG001|Overall Study|Withdrawn due to adverse events|5|||
48758612|NCT00412854|156964599|FG000|Overall Study|Withdrawn for other reasons|13|||
48758613|NCT00412854|156964600|FG001|Overall Study|Withdrawn for other reasons|11|||
48668006|NCT03022981|156637570|FG002|Overall Study|Non-Compliance With Study Drug|2|||
48668007|NCT03022981|156637568|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
48668008|NCT03022981|156637569|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
48668009|NCT03022981|156637570|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
48668010|NCT00654004|156637574|FG000|Overall Study|Lost to Follow-up|1|||
48668011|NCT00654004|156637575|FG001|Overall Study|Lost to Follow-up|0|||
48668012|NCT01378429|156637576|FG000|Overall Study|Noncompliance with study drug|1|||
48668013|NCT01378429|156637577|FG001|Overall Study|Noncompliance with study drug|0|||
48668014|NCT02241187|156637578|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
48668015|NCT01490294|156637579|FG000|Overall Study|Prematurely discontinuation|4|||
48668016|NCT01490294|156637580|FG001|Overall Study|Prematurely discontinuation|0|||
48668017|NCT01490294|156637581|FG002|Overall Study|Prematurely discontinuation|1|||
48668018|NCT01490294|156637582|FG003|Overall Study|Prematurely discontinuation|1|||
48668019|NCT01490294|156637579|FG000|Overall Study|Adverse Event|1|||
48668020|NCT01490294|156637580|FG001|Overall Study|Adverse Event|0|||
48668021|NCT01490294|156637581|FG002|Overall Study|Adverse Event|0|||
48668022|NCT01490294|156637582|FG003|Overall Study|Adverse Event|0|||
48668023|NCT02404649|156637592|FG000|Overall Study|Adverse Event|1|||
48668024|NCT02404649|156637593|FG001|Overall Study|Adverse Event|2|||
48668025|NCT00330668|156637594|FG000|BID Dosing Period|Adverse Event|1|||
48668026|NCT00330668|156637594|FG000|BID Dosing Period|Lost to Follow-up|7|||
48668027|NCT00330668|156637594|FG000|BID Dosing Period|Non-Compliance|5|||
48668028|NCT00330668|156637594|FG000|BID Dosing Period|Withdrawal by Subject|19|||
48668029|NCT00330668|156637594|FG000|BID Dosing Period|Sponsor's decision|1|||
48668030|NCT00330668|156637594|FG000|BID Dosing Period|Other|3|||
48668031|NCT00330668|156637594|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
48668032|NCT00330668|156637594|FG000|QD Dosing Period|Other|1|||
48668033|NCT00330668|156637594|FG000|QD Dosing Period|Withdrawal by Subject|1|||
48668034|NCT00330668|156637594|FG000|QD Dosing Period|Lost to Follow-up|2|||
48692757|NCT01469221|156724592|FG002|Double Blind Phase|Protocol Violation|0|||
48692758|NCT01469221|156724590|FG000|Double Blind Phase|Physician Decision|1|||
48692759|NCT01469221|156724591|FG001|Double Blind Phase|Physician Decision|1|||
48692760|NCT01469221|156724592|FG002|Double Blind Phase|Physician Decision|0|||
48692761|NCT01469221|156724590|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
48692762|NCT01469221|156724591|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
48692763|NCT01469221|156724592|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
48692764|NCT03988608|156724593|FG000|Overall Study|Adverse Event|1|||
48692765|NCT03988608|156724593|FG000|Overall Study|Lost to Follow-up|1|||
48692766|NCT03988608|156724593|FG000|Overall Study|Withdrawal by Subject|3|||
48692767|NCT03988608|156724593|FG000|Overall Study|Death|1|||
48692768|NCT02140047|156724594|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48758614|NCT01710033|156964601|FG000|Stage 2|Adverse Event|0|||
48758615|NCT01710033|156964602|FG001|Stage 2|Adverse Event|0|||
48758616|NCT01710033|156964603|FG002|Stage 2|Adverse Event|0|||
48692769|NCT02140047|156724595|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48692770|NCT02140047|156724596|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48758617|NCT01710033|156964604|FG003|Stage 2|Adverse Event|0|||
48758618|NCT01710033|156964605|FG004|Stage 2|Adverse Event|1|||
48758619|NCT02085785|156964608|FG000|Overall Study|Withdrawal by Subject|2|||
48758620|NCT02085785|156964609|FG001|Overall Study|Withdrawal by Subject|1|||
48758621|NCT02085785|156964608|FG000|Overall Study|Lost to Follow-up|0|||
48692771|NCT00333775|156724599|FG000|Overall Study|Death|144|||
48692772|NCT00333775|156724600|FG001|Overall Study|Death|149|||
48692773|NCT00333775|156724601|FG002|Overall Study|Death|143|||
48692774|NCT00333775|156724599|FG000|Overall Study|In Follow-up When Study Stopped|87|||
48758622|NCT02085785|156964609|FG001|Overall Study|Lost to Follow-up|1|||
48758623|NCT02772081|156964610|FG000|Overall Study|Physician Decision|1|||
48758624|NCT02772081|156964611|FG001|Overall Study|Physician Decision|1|||
48758625|NCT02772081|156964610|FG000|Overall Study|Death|1|||
48758626|NCT02772081|156964611|FG001|Overall Study|Death|1|||
48758627|NCT00469092|156964615|FG000|Overall Study|Adverse Event|5|||
48758628|NCT00469092|156964616|FG001|Overall Study|Adverse Event|4|||
48758629|NCT00469092|156964615|FG000|Overall Study|Lack of Efficacy|1|||
48758630|NCT00469092|156964616|FG001|Overall Study|Lack of Efficacy|0|||
48758631|NCT00469092|156964615|FG000|Overall Study|Lost to Follow-up|1|||
48758632|NCT00469092|156964616|FG001|Overall Study|Lost to Follow-up|2|||
48758633|NCT00469092|156964615|FG000|Overall Study|Protocol Violation|3|||
48758634|NCT00469092|156964616|FG001|Overall Study|Protocol Violation|3|||
48758635|NCT00469092|156964615|FG000|Overall Study|Withdrawal by Subject|4|||
48758636|NCT00469092|156964616|FG001|Overall Study|Withdrawal by Subject|4|||
48758637|NCT00469092|156964615|FG000|Overall Study|Withdrawal Criteria|3|||
48758638|NCT00469092|156964616|FG001|Overall Study|Withdrawal Criteria|4|||
48758639|NCT00469092|156964615|FG000|Overall Study|Incorrectly Randomised|4|||
48758640|NCT00469092|156964616|FG001|Overall Study|Incorrectly Randomised|3|||
48758641|NCT00469092|156964615|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
48758642|NCT00469092|156964616|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
48758643|NCT00469092|156964615|FG000|Overall Study|Use of lipid lowering drug|1|||
48758644|NCT00469092|156964616|FG001|Overall Study|Use of lipid lowering drug|0|||
48758645|NCT00469092|156964615|FG000|Overall Study|Hypoglycaemic Episodes|1|||
48758646|NCT00469092|156964616|FG001|Overall Study|Hypoglycaemic Episodes|1|||
48758647|NCT00469092|156964615|FG000|Overall Study|Abnormal lab value|1|||
48758648|NCT00469092|156964616|FG001|Overall Study|Abnormal lab value|0|||
48758649|NCT00469092|156964615|FG000|Overall Study|Use of Corticosteroid|1|||
48758650|NCT00469092|156964616|FG001|Overall Study|Use of Corticosteroid|0|||
48758651|NCT02024867|156964617|FG000|Overall Study|Protocol Violation|3|||
48342162|NCT05600036|155447698|FG001|Overall Study|Lost to Follow-up|2|||
48342163|NCT05600036|155447699|FG002|Overall Study|Lost to Follow-up|1|||
48342164|NCT05600036|155447700|FG003|Overall Study|Lost to Follow-up|1|||
48342165|NCT05600036|155447701|FG004|Overall Study|Lost to Follow-up|0|||
48758652|NCT02024867|156964618|FG001|Overall Study|Protocol Violation|3|||
48758653|NCT02024867|156964617|FG000|Overall Study|Lost to Follow-up|6|||
48758654|NCT02024867|156964618|FG001|Overall Study|Lost to Follow-up|4|||
48758655|NCT02063854|156964619|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
48342166|NCT05600036|155447702|FG005|Overall Study|Lost to Follow-up|0|||
48342167|NCT05600036|155447697|FG000|Overall Study|Protocol Violation|0|||
48342168|NCT05600036|155447698|FG001|Overall Study|Protocol Violation|0|||
48342169|NCT05600036|155447699|FG002|Overall Study|Protocol Violation|2|||
48342170|NCT05600036|155447700|FG003|Overall Study|Protocol Violation|0|||
48668035|NCT00387647|156639045|FG000|Overall Study|Death|18|||
48758656|NCT02063854|156964620|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
48758657|NCT02063854|156964621|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
48758658|NCT02063854|156964622|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
48758659|NCT02063854|156964623|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
48758660|NCT02063854|156964624|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
48758661|NCT02063854|156964625|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
48758662|NCT02063854|156964619|FG000|Overall Study|Major Protocol Deviation|0|||
48342171|NCT05600036|155447701|FG004|Overall Study|Protocol Violation|0|||
48342172|NCT05600036|155447702|FG005|Overall Study|Protocol Violation|0|||
48342173|NCT05600036|155447697|FG000|Overall Study|Withdrawal by Subject|0|||
48342174|NCT05600036|155447698|FG001|Overall Study|Withdrawal by Subject|1|||
48342175|NCT05600036|155447699|FG002|Overall Study|Withdrawal by Subject|2|||
48668036|NCT04030247|156639046|FG000|Overall Study|Withdrawal by Subject|4|||
48668037|NCT04030247|156639046|FG000|Overall Study|Lost to Follow-up|13|||
48668038|NCT00840060|156639047|FG000|Overall Study|Withdrawal by Subject|1|||
48668039|NCT00840060|156639048|FG001|Overall Study|Withdrawal by Subject|0|||
48668040|NCT00840060|156639047|FG000|Overall Study|Change in emotional/behavioral status|0|||
48668041|NCT00840060|156639048|FG001|Overall Study|Change in emotional/behavioral status|1|||
48668042|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
48668043|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
48668044|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
48758663|NCT02063854|156964620|FG001|Overall Study|Major Protocol Deviation|0|||
48758664|NCT02063854|156964621|FG002|Overall Study|Major Protocol Deviation|3|||
48758665|NCT02063854|156964622|FG003|Overall Study|Major Protocol Deviation|0|||
48342176|NCT05600036|155447700|FG003|Overall Study|Withdrawal by Subject|0|||
48668045|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
48758666|NCT02063854|156964623|FG004|Overall Study|Major Protocol Deviation|0|||
48758667|NCT02063854|156964624|FG005|Overall Study|Major Protocol Deviation|0|||
48758668|NCT02063854|156964625|FG006|Overall Study|Major Protocol Deviation|0|||
48758669|NCT02063854|156964619|FG000|Overall Study|Voluntary Withdrawal|2|||
48758670|NCT02063854|156964620|FG001|Overall Study|Voluntary Withdrawal|0|||
48758671|NCT02063854|156964621|FG002|Overall Study|Voluntary Withdrawal|8|||
48668046|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
48758672|NCT02063854|156964622|FG003|Overall Study|Voluntary Withdrawal|1|||
48758673|NCT02063854|156964623|FG004|Overall Study|Voluntary Withdrawal|3|||
48758674|NCT02063854|156964624|FG005|Overall Study|Voluntary Withdrawal|6|||
48758675|NCT02063854|156964625|FG006|Overall Study|Voluntary Withdrawal|1|||
48758676|NCT02063854|156964619|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
48758677|NCT02063854|156964620|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
48342177|NCT05600036|155447701|FG004|Overall Study|Withdrawal by Subject|3|||
48342178|NCT05600036|155447702|FG005|Overall Study|Withdrawal by Subject|5|||
48342179|NCT05600036|155447697|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48758678|NCT02063854|156964621|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
48758679|NCT02063854|156964622|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
48758680|NCT02063854|156964623|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
48758681|NCT02063854|156964624|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
48758682|NCT02063854|156964625|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
48758683|NCT02063854|156964619|FG000|Overall Study|Reason Not Specified|1|||
48758684|NCT02063854|156964620|FG001|Overall Study|Reason Not Specified|0|||
48758685|NCT02063854|156964621|FG002|Overall Study|Reason Not Specified|0|||
48758686|NCT02063854|156964622|FG003|Overall Study|Reason Not Specified|0|||
48758687|NCT02063854|156964623|FG004|Overall Study|Reason Not Specified|0|||
48758688|NCT02063854|156964624|FG005|Overall Study|Reason Not Specified|0|||
48758689|NCT02063854|156964625|FG006|Overall Study|Reason Not Specified|0|||
48758690|NCT02063854|156964619|FG000|Overall Study|Did Not Receive Study Drug|0|||
48758691|NCT02063854|156964620|FG001|Overall Study|Did Not Receive Study Drug|0|||
48758692|NCT02063854|156964621|FG002|Overall Study|Did Not Receive Study Drug|0|||
48758693|NCT02063854|156964622|FG003|Overall Study|Did Not Receive Study Drug|0|||
48758694|NCT02063854|156964623|FG004|Overall Study|Did Not Receive Study Drug|0|||
48758695|NCT02063854|156964624|FG005|Overall Study|Did Not Receive Study Drug|1|||
48758696|NCT02063854|156964625|FG006|Overall Study|Did Not Receive Study Drug|0|||
48758697|NCT02436356|156964626|FG000|Overall Study|Excluded by MRI Screening|0|||
48758698|NCT02436356|156964627|FG001|Overall Study|Excluded by MRI Screening|0|||
48758699|NCT02436356|156964628|FG002|Overall Study|Excluded by MRI Screening|2|||
48758700|NCT02436356|156964626|FG000|Overall Study|Lost to Follow-up|0|||
48758701|NCT02436356|156964627|FG001|Overall Study|Lost to Follow-up|1|||
48758702|NCT02436356|156964628|FG002|Overall Study|Lost to Follow-up|0|||
48758703|NCT02436356|156964626|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
48758704|NCT02436356|156964627|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
48758705|NCT02436356|156964628|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
48758706|NCT02436356|156964626|FG000|Overall Study|Excluded due to other medical conditions|3|||
48758707|NCT02436356|156964627|FG001|Overall Study|Excluded due to other medical conditions|0|||
48758708|NCT02436356|156964628|FG002|Overall Study|Excluded due to other medical conditions|0|||
48758709|NCT02436356|156964626|FG000|Overall Study|Withdrawal by Subject|1|||
48758710|NCT02436356|156964627|FG001|Overall Study|Withdrawal by Subject|0|||
48758711|NCT02436356|156964628|FG002|Overall Study|Withdrawal by Subject|0|||
48758712|NCT01462084|156964629|FG000|Overall Study|Withdrawal by Subject|1|||
48758713|NCT01462084|156964630|FG001|Overall Study|Withdrawal by Subject|0|||
48758714|NCT01462084|156964629|FG000|Overall Study|Protocol Violation|1|||
48758715|NCT01462084|156964630|FG001|Overall Study|Protocol Violation|1|||
48758716|NCT02611778|156964631|FG000|Overall Study|Withdrawal by Subject|2|||
48758717|NCT02611778|156964632|FG001|Overall Study|Withdrawal by Subject|8|||
48758718|NCT02611778|156964631|FG000|Overall Study|Adverse Event|1|||
48758719|NCT02611778|156964632|FG001|Overall Study|Adverse Event|2|||
48758720|NCT02611778|156964631|FG000|Overall Study|Death|2|||
48758721|NCT02611778|156964632|FG001|Overall Study|Death|1|||
48758722|NCT02611778|156964631|FG000|Overall Study|Protocol Violation|1|||
48758723|NCT02611778|156964632|FG001|Overall Study|Protocol Violation|0|||
48758724|NCT02611778|156964631|FG000|Overall Study|Lost to Follow-up|3|||
48758725|NCT02611778|156964632|FG001|Overall Study|Lost to Follow-up|1|||
48758726|NCT02611778|156964631|FG000|Overall Study|Need for alternative treatment|1|||
48758727|NCT02611778|156964632|FG001|Overall Study|Need for alternative treatment|0|||
48758728|NCT02611778|156964631|FG000|Overall Study|Other Reason|2|||
48758729|NCT02611778|156964632|FG001|Overall Study|Other Reason|1|||
48758730|NCT00810407|156964633|FG000|Overall Study|Protocol Violation|3|||
48758731|NCT00810407|156964633|FG000|Overall Study|No Visit After First Day of Treatment|3|||
48758732|NCT02864251|156964637|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
48428237|NCT02531373|155756504|FG006|Overall Study|Protocol Violation|1|||
48758733|NCT02864251|156964638|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
48758734|NCT02864251|156964639|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
48758735|NCT02864251|156964637|FG000|Pre-Treatment|Withdrawal by Participant|0|||
48758736|NCT02864251|156964638|FG001|Pre-Treatment|Withdrawal by Participant|0|||
48758737|NCT02864251|156964639|FG002|Pre-Treatment|Withdrawal by Participant|4|||
48758738|NCT02864251|156964637|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
48758739|NCT02864251|156964638|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
48758740|NCT02864251|156964639|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
48758741|NCT02864251|156964637|FG000|Pre-Treatment|Other Reasons|0|||
48758742|NCT02864251|156964638|FG001|Pre-Treatment|Other Reasons|1|||
48758743|NCT02864251|156964639|FG002|Pre-Treatment|Other Reasons|1|||
48758744|NCT02864251|156964637|FG000|Treatment|Disease Progression|109|||
48758745|NCT02864251|156964638|FG001|Treatment|Disease Progression|52|||
48758746|NCT02864251|156964639|FG002|Treatment|Disease Progression|101|||
48758747|NCT02864251|156964637|FG000|Treatment|Study Drug Toxicity|9|||
48758748|NCT02864251|156964638|FG001|Treatment|Study Drug Toxicity|4|||
48758749|NCT02864251|156964639|FG002|Treatment|Study Drug Toxicity|10|||
48758750|NCT02864251|156964637|FG000|Treatment|Death|0|||
48758751|NCT02864251|156964638|FG001|Treatment|Death|2|||
48758752|NCT02864251|156964639|FG002|Treatment|Death|3|||
48758753|NCT02864251|156964637|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
48668047|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
48668048|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
48668049|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
48668050|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
48668051|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
48668052|NCT01263015|156639049|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
48668053|NCT01263015|156639050|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
48668054|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
48668055|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
48668056|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
48668057|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
48668058|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
48668059|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
48668060|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
48668061|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
48668062|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
48668063|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
48668064|NCT01263015|156639049|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
48668065|NCT01263015|156639050|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
48668066|NCT03131596|156639051|FG000|Overall Study|Protocol Violation|3|||
48668067|NCT03131596|156639052|FG001|Overall Study|Protocol Violation|3|||
48668068|NCT03131596|156639051|FG000|Overall Study|Lost to Follow-up|3|||
48668069|NCT03131596|156639052|FG001|Overall Study|Lost to Follow-up|0|||
48668070|NCT00509093|156639055|FG000|Overall Study|Adverse Event|10|||
48668071|NCT00509093|156639055|FG000|Overall Study|Disease Progression|9|||
48668072|NCT00509093|156639055|FG000|Overall Study|Transformed into MDS|1|||
48668073|NCT00509093|156639055|FG000|Overall Study|Withdrawal by Subject|3|||
48668074|NCT00509093|156639055|FG000|Overall Study|Physician Decision|1|||
48668075|NCT03204890|156639059|FG000|Overall Study|Withdrawal by Subject|1|||
48668076|NCT01176565|156639060|FG000|Overall Study|Lost to Follow-up|12|||
48668077|NCT01176565|156639061|FG001|Overall Study|Lost to Follow-up|16|||
48668078|NCT01176565|156639060|FG000|Overall Study|Withdrawal by Subject|7|||
48668079|NCT01176565|156639061|FG001|Overall Study|Withdrawal by Subject|1|||
48668080|NCT01176565|156639060|FG000|Overall Study|Not Analyzed (any other reason)|1|||
48668081|NCT01176565|156639061|FG001|Overall Study|Not Analyzed (any other reason)|2|||
48668082|NCT03369431|156639063|FG000|Overall Study|Lost to Follow-up|1|||
48668083|NCT03369431|156639064|FG001|Overall Study|Lost to Follow-up|3|||
48668084|NCT03369431|156639063|FG000|Overall Study|Withdrawal by Subject|2|||
48668085|NCT03369431|156639064|FG001|Overall Study|Withdrawal by Subject|3|||
48668086|NCT03369431|156639063|FG000|Overall Study|Protocol Violation|1|||
48668087|NCT03369431|156639064|FG001|Overall Study|Protocol Violation|1|||
48668088|NCT02212678|156639065|FG000|Overall Study|Adverse Event|1|||
48668089|NCT01635764|156639066|FG000|Overall Study|Adverse Event|46|||
48668090|NCT01635764|156639066|FG000|Overall Study|Lack of Efficacy|76|||
48668091|NCT01635764|156639066|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
48758754|NCT02864251|156964638|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
48758755|NCT02864251|156964639|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
48758756|NCT02864251|156964637|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
48342180|NCT05600036|155447698|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48668092|NCT01635764|156639066|FG000|Overall Study|Protocol Deviation|1|||
48668093|NCT01635764|156639066|FG000|Overall Study|Withdrew Consent|67|||
48668094|NCT01635764|156639066|FG000|Overall Study|Lost to Follow-up|53|||
48342181|NCT05600036|155447699|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48342182|NCT05600036|155447700|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
48342183|NCT05600036|155447701|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48342184|NCT05600036|155447702|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
48342185|NCT05600036|155447697|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48342186|NCT05600036|155447698|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
48342187|NCT05600036|155447699|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48342188|NCT05600036|155447700|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48342189|NCT05600036|155447701|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48342190|NCT05600036|155447702|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
48342191|NCT05600036|155447697|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48668095|NCT01635764|156639066|FG000|Overall Study|Other|28|||
48342192|NCT05600036|155447698|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48342193|NCT05600036|155447699|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48342194|NCT05600036|155447700|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
48342195|NCT05600036|155447701|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48342196|NCT05600036|155447702|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
48342197|NCT02262364|155447703|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
48342198|NCT00396097|155447705|FG000|Overall Study|Withdrawal by Subject|17|||
48342199|NCT00396097|155447706|FG001|Overall Study|Withdrawal by Subject|17|||
48342200|NCT00396097|155447705|FG000|Overall Study|Lost to Follow-up|4|||
48342201|NCT00396097|155447706|FG001|Overall Study|Lost to Follow-up|9|||
48342202|NCT00396097|155447705|FG000|Overall Study|Other|3|||
48342203|NCT00396097|155447706|FG001|Overall Study|Other|5|||
48342204|NCT00396097|155447705|FG000|Overall Study|Protocol Violation|0|||
48342205|NCT00396097|155447706|FG001|Overall Study|Protocol Violation|6|||
48342206|NCT00396097|155447705|FG000|Overall Study|Adverse Event|1|||
48342207|NCT00396097|155447706|FG001|Overall Study|Adverse Event|5|||
48342208|NCT00396097|155447705|FG000|Overall Study|Insufficient Clinical Response|1|||
48342209|NCT00396097|155447706|FG001|Overall Study|Insufficient Clinical Response|4|||
48342210|NCT03785210|155447707|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
48342211|NCT03785210|155447708|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
48342212|NCT02005029|155447709|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
48342213|NCT02005029|155447710|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
48342214|NCT03334747|155447711|FG000|Treatment Phase|Technical problems|0|||
48342215|NCT03334747|155447712|FG001|Treatment Phase|Technical problems|0|||
48342216|NCT03334747|155447713|FG002|Treatment Phase|Technical problems|0|||
48342217|NCT03334747|155447714|FG003|Treatment Phase|Technical problems|0|||
48342218|NCT03334747|155447715|FG004|Treatment Phase|Technical problems|1|||
48342219|NCT03334747|155447716|FG005|Treatment Phase|Technical problems|0|||
48342220|NCT03334747|155447717|FG006|Treatment Phase|Technical problems|0|||
48342221|NCT03334747|155447718|FG007|Treatment Phase|Technical problems|0|||
48342222|NCT03334747|155447719|FG008|Treatment Phase|Technical problems|0|||
48342223|NCT03334747|155447711|FG000|Treatment Phase|Subject/guardian decision|1|||
48668096|NCT00933244|156639067|FG000|Overall Study|Withdrawal by Subject|5|||
48668097|NCT00933244|156639068|FG001|Overall Study|Withdrawal by Subject|1|||
48668098|NCT00933244|156639069|FG002|Overall Study|Withdrawal by Subject|3|||
48342224|NCT03334747|155447712|FG001|Treatment Phase|Subject/guardian decision|0|||
48342225|NCT03334747|155447713|FG002|Treatment Phase|Subject/guardian decision|0|||
48342226|NCT03334747|155447714|FG003|Treatment Phase|Subject/guardian decision|0|||
48342227|NCT03334747|155447715|FG004|Treatment Phase|Subject/guardian decision|0|||
48342228|NCT03334747|155447716|FG005|Treatment Phase|Subject/guardian decision|1|||
48342229|NCT03334747|155447717|FG006|Treatment Phase|Subject/guardian decision|0|||
48342230|NCT03334747|155447718|FG007|Treatment Phase|Subject/guardian decision|0|||
48342231|NCT03334747|155447719|FG008|Treatment Phase|Subject/guardian decision|0|||
48342232|NCT03334747|155447711|FG000|Follow-Up Phase|Subject/guardian decision|0|||
48342233|NCT03334747|155447712|FG001|Follow-Up Phase|Subject/guardian decision|0|||
48342234|NCT03334747|155447713|FG002|Follow-Up Phase|Subject/guardian decision|0|||
48342235|NCT03334747|155447714|FG003|Follow-Up Phase|Subject/guardian decision|0|||
48342236|NCT03334747|155447715|FG004|Follow-Up Phase|Subject/guardian decision|0|||
48668099|NCT02258529|156639070|FG000|Overall Study|Study Terminated by Sponsor|9|||
48668100|NCT02258529|156639070|FG000|Overall Study|Adverse Event|1|||
48668101|NCT01318070|156639072|FG000|Overall Study|Adverse Event|1|||
48342237|NCT03334747|155447716|FG005|Follow-Up Phase|Subject/guardian decision|0|||
48342238|NCT03334747|155447717|FG006|Follow-Up Phase|Subject/guardian decision|1|||
48342239|NCT03334747|155447718|FG007|Follow-Up Phase|Subject/guardian decision|0|||
48342240|NCT03334747|155447719|FG008|Follow-Up Phase|Subject/guardian decision|1|||
48342241|NCT02137239|155447722|FG000|Overall Study|Discontinued Study Treatment|0|||
48342242|NCT02137239|155447723|FG001|Overall Study|Discontinued Study Treatment|3|||
48758757|NCT02864251|156964638|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
48758758|NCT02864251|156964639|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
48758759|NCT02864251|156964637|FG000|Treatment|Withdrawal by Participant|8|||
48758760|NCT02864251|156964638|FG001|Treatment|Withdrawal by Participant|5|||
48758761|NCT02864251|156964639|FG002|Treatment|Withdrawal by Participant|13|||
48758762|NCT02864251|156964637|FG000|Treatment|Maximum Clinical Benefit|1|||
48758763|NCT02864251|156964638|FG001|Treatment|Maximum Clinical Benefit|0|||
48758764|NCT02864251|156964639|FG002|Treatment|Maximum Clinical Benefit|1|||
48758765|NCT02864251|156964637|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
48758766|NCT02864251|156964638|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
48758767|NCT02864251|156964639|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
48758768|NCT02864251|156964637|FG000|Treatment|Other Reasons|1|||
48758769|NCT02864251|156964638|FG001|Treatment|Other Reasons|1|||
48758770|NCT02864251|156964639|FG002|Treatment|Other Reasons|4|||
48758771|NCT02864251|156964637|FG000|Treatment|Administrative Reason by Sponsor|1|||
48758772|NCT02864251|156964638|FG001|Treatment|Administrative Reason by Sponsor|0|||
48668102|NCT01318070|156639073|FG001|Overall Study|Adverse Event|1|||
48668103|NCT01318070|156639074|FG002|Overall Study|Adverse Event|5|||
48668104|NCT01318070|156639072|FG000|Overall Study|Withdrawal by Subject|0|||
48668105|NCT01318070|156639073|FG001|Overall Study|Withdrawal by Subject|1|||
48668106|NCT01318070|156639074|FG002|Overall Study|Withdrawal by Subject|1|||
48668107|NCT01318070|156639072|FG000|Overall Study|Lack of Efficacy|0|||
48668108|NCT01318070|156639073|FG001|Overall Study|Lack of Efficacy|0|||
48668109|NCT01318070|156639074|FG002|Overall Study|Lack of Efficacy|1|||
48668110|NCT01318070|156639072|FG000|Overall Study|Principal Investigator Discretion|1|||
48668111|NCT01318070|156639073|FG001|Overall Study|Principal Investigator Discretion|0|||
48668112|NCT01318070|156639074|FG002|Overall Study|Principal Investigator Discretion|0|||
48668113|NCT00391391|156639075|FG000|Overall Study|Adverse Event|0|||
48758773|NCT02864251|156964639|FG002|Treatment|Administrative Reason by Sponsor|0|||
48758774|NCT00276159|156964641|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
48758775|NCT02617511|156964650|FG000|Overall Study|Withdrawal by Subject|1|||
48342243|NCT02137239|155447722|FG000|Overall Study|Withdrew Consent|1|||
48668114|NCT00391391|156639076|FG001|Overall Study|Adverse Event|0|||
48668115|NCT00391391|156639077|FG002|Overall Study|Adverse Event|0|||
48758776|NCT02617511|156964651|FG001|Overall Study|Withdrawal by Subject|0|||
48758777|NCT00171223|156964652|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
48758778|NCT00171223|156964653|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
48758779|NCT00171223|156964654|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
48758780|NCT00171223|156964652|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
48758781|NCT00171223|156964653|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
48758782|NCT00171223|156964654|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
48758783|NCT00171223|156964652|FG000|Overall Study|Abnormal Procedure|1|||
48758784|NCT00171223|156964653|FG001|Overall Study|Abnormal Procedure|0|||
48758785|NCT00171223|156964654|FG002|Overall Study|Abnormal Procedure|0|||
48758786|NCT00171223|156964652|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
48758787|NCT00171223|156964653|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
48758788|NCT00171223|156964654|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
48758789|NCT00171223|156964652|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
48758790|NCT00171223|156964653|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
48758791|NCT00171223|156964654|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
48758792|NCT00171223|156964652|FG000|Overall Study|Protocol Violation|2|||
48758793|NCT00171223|156964653|FG001|Overall Study|Protocol Violation|2|||
48758794|NCT00171223|156964654|FG002|Overall Study|Protocol Violation|3|||
48342244|NCT02137239|155447723|FG001|Overall Study|Withdrew Consent|1|||
48342245|NCT02137239|155447722|FG000|Overall Study|Adverse Event|2|||
48758795|NCT00171223|156964652|FG000|Overall Study|Participant Withdrew Consent|12|||
48758796|NCT00171223|156964653|FG001|Overall Study|Participant Withdrew Consent|21|||
48342246|NCT02137239|155447723|FG001|Overall Study|Adverse Event|2|||
48758797|NCT00171223|156964654|FG002|Overall Study|Participant Withdrew Consent|15|||
48758798|NCT00171223|156964652|FG000|Overall Study|Lost to Follow-up|5|||
48758799|NCT00171223|156964653|FG001|Overall Study|Lost to Follow-up|2|||
48758800|NCT00171223|156964654|FG002|Overall Study|Lost to Follow-up|3|||
48758801|NCT00171223|156964652|FG000|Overall Study|Administrative Problems|4|||
48758802|NCT00171223|156964653|FG001|Overall Study|Administrative Problems|7|||
48758803|NCT00171223|156964654|FG002|Overall Study|Administrative Problems|6|||
48758804|NCT00171223|156964652|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
48758805|NCT00171223|156964653|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
48758806|NCT00171223|156964654|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
48758807|NCT00171223|156964652|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
48758808|NCT00171223|156964653|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
48758809|NCT00171223|156964654|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
48758810|NCT02188589|156964660|FG000|Overall Study|Withdrawal by Subject|5|||
48758811|NCT00894322|156964661|FG000|Overall Study|Withdrawal by Subject|1|||
48758812|NCT00894322|156964662|FG001|Overall Study|Withdrawal by Subject|0|||
48758813|NCT00894322|156964663|FG002|Overall Study|Withdrawal by Subject|0|||
48758814|NCT01519960|156964669|FG000|Overall Study|Withdrawal from the study|26|||
48758815|NCT01519960|156964670|FG001|Overall Study|Withdrawal from the study|22|||
48758816|NCT01519960|156964671|FG002|Overall Study|Withdrawal from the study|5|||
48758817|NCT02951156|156964672|FG000|Overall Study|Death|3|||
48758818|NCT02951156|156964673|FG001|Overall Study|Death|8|||
48758819|NCT02951156|156964674|FG002|Overall Study|Death|5|||
48758820|NCT02951156|156964672|FG000|Overall Study|Progressive disease|1|||
48758821|NCT02951156|156964673|FG001|Overall Study|Progressive disease|0|||
48758822|NCT02951156|156964674|FG002|Overall Study|Progressive disease|1|||
48758823|NCT02951156|156964672|FG000|Overall Study|Withdrawal by Subject|0|||
48758824|NCT02951156|156964673|FG001|Overall Study|Withdrawal by Subject|0|||
48758825|NCT02951156|156964674|FG002|Overall Study|Withdrawal by Subject|1|||
48758826|NCT02951156|156964672|FG000|Overall Study|Study terminated by sponsor|0|||
48758827|NCT02951156|156964673|FG001|Overall Study|Study terminated by sponsor|0|||
48758828|NCT02951156|156964674|FG002|Overall Study|Study terminated by sponsor|1|||
48758829|NCT02951156|156964672|FG000|Overall Study|Other|5|||
48758830|NCT02951156|156964673|FG001|Overall Study|Other|1|||
48758831|NCT02951156|156964674|FG002|Overall Study|Other|2|||
48758832|NCT00378209|156964677|FG000|Overall Study|Progressive disease|11|||
48758833|NCT00378209|156964677|FG000|Overall Study|Adverse Event|3|||
48758834|NCT00378209|156964677|FG000|Overall Study|Initiation of non-protocol therapy|3|||
48758835|NCT00378209|156964677|FG000|Overall Study|Physician Decision|3|||
48758836|NCT00378209|156964677|FG000|Overall Study|Death|1|||
48758837|NCT00378209|156964677|FG000|Overall Study|Treatment delay|1|||
48668116|NCT00391391|156639078|FG003|Overall Study|Adverse Event|1|||
48668117|NCT00391391|156639075|FG000|Overall Study|Lost to Follow-up|1|||
48758838|NCT00744627|156964678|FG000|Overall Study|Adverse Event|6|||
48758839|NCT00744627|156964679|FG001|Overall Study|Adverse Event|9|||
48758840|NCT00744627|156964678|FG000|Overall Study|Lack of Efficacy|7|||
48758841|NCT00744627|156964679|FG001|Overall Study|Lack of Efficacy|3|||
48668118|NCT00391391|156639076|FG001|Overall Study|Lost to Follow-up|3|||
48668119|NCT00391391|156639077|FG002|Overall Study|Lost to Follow-up|7|||
48668120|NCT00391391|156639078|FG003|Overall Study|Lost to Follow-up|4|||
48668121|NCT00391391|156639075|FG000|Overall Study|Protocol Violation|2|||
48668122|NCT00391391|156639076|FG001|Overall Study|Protocol Violation|3|||
48668123|NCT00391391|156639077|FG002|Overall Study|Protocol Violation|6|||
48668124|NCT00391391|156639078|FG003|Overall Study|Protocol Violation|7|||
48668125|NCT00391391|156639075|FG000|Overall Study|Withdrawal by Subject|6|||
48668126|NCT00391391|156639076|FG001|Overall Study|Withdrawal by Subject|4|||
48668127|NCT00391391|156639077|FG002|Overall Study|Withdrawal by Subject|10|||
48668128|NCT00391391|156639078|FG003|Overall Study|Withdrawal by Subject|7|||
48668129|NCT01533922|156639079|FG000|Overall Study|Adverse Event|5|||
48668130|NCT01533922|156639080|FG001|Overall Study|Adverse Event|8|||
48668131|NCT01533922|156639081|FG002|Overall Study|Adverse Event|6|||
48758842|NCT00744627|156964678|FG000|Overall Study|Noncompliance|0|||
48668132|NCT01533922|156639082|FG003|Overall Study|Adverse Event|3|||
48668133|NCT01533922|156639083|FG004|Overall Study|Adverse Event|4|||
48668134|NCT01533922|156639079|FG000|Overall Study|Lack of Efficacy|0|||
48668135|NCT01533922|156639080|FG001|Overall Study|Lack of Efficacy|0|||
48668136|NCT01533922|156639081|FG002|Overall Study|Lack of Efficacy|1|||
48758843|NCT00744627|156964679|FG001|Overall Study|Noncompliance|1|||
48758844|NCT00744627|156964678|FG000|Overall Study|Protocol Deviations|0|||
48668137|NCT01533922|156639082|FG003|Overall Study|Lack of Efficacy|0|||
48668138|NCT01533922|156639083|FG004|Overall Study|Lack of Efficacy|0|||
48668139|NCT01533922|156639079|FG000|Overall Study|Protocol Violation|0|||
48668140|NCT01533922|156639080|FG001|Overall Study|Protocol Violation|3|||
48668141|NCT01533922|156639081|FG002|Overall Study|Protocol Violation|0|||
48758845|NCT00744627|156964679|FG001|Overall Study|Protocol Deviations|2|||
48758846|NCT00744627|156964678|FG000|Overall Study|Voluntary Withdrawal|9|||
48758847|NCT00744627|156964679|FG001|Overall Study|Voluntary Withdrawal|6|||
48758848|NCT00744627|156964678|FG000|Overall Study|Lost to Follow-up|2|||
48758849|NCT00744627|156964679|FG001|Overall Study|Lost to Follow-up|1|||
48758850|NCT00744627|156964678|FG000|Overall Study|Other|1|||
48758851|NCT00744627|156964679|FG001|Overall Study|Other|0|||
48758852|NCT00768300|156964680|FG000|Overall Study|Randomized but not treated|1|||
48758853|NCT00768300|156964681|FG001|Overall Study|Randomized but not treated|1|||
48758854|NCT00768300|156964680|FG000|Overall Study|Adverse Event|10|||
48758855|NCT00768300|156964681|FG001|Overall Study|Adverse Event|2|||
48758856|NCT00768300|156964680|FG000|Overall Study|Protocol Violation|6|||
48758857|NCT00768300|156964681|FG001|Overall Study|Protocol Violation|1|||
48758858|NCT00768300|156964680|FG000|Overall Study|Withdrawal by Subject|13|||
48758859|NCT00768300|156964681|FG001|Overall Study|Withdrawal by Subject|7|||
48758860|NCT00768300|156964680|FG000|Overall Study|Physician Decision|2|||
48758861|NCT00768300|156964681|FG001|Overall Study|Physician Decision|3|||
48758862|NCT00768300|156964680|FG000|Overall Study|Study discontinued by Sponsor|271|||
48758863|NCT00768300|156964681|FG001|Overall Study|Study discontinued by Sponsor|140|||
48758864|NCT00768300|156964680|FG000|Overall Study|Death|21|||
48758865|NCT00768300|156964681|FG001|Overall Study|Death|5|||
48758866|NCT00768300|156964680|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
48758867|NCT00768300|156964681|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
48758868|NCT00768300|156964680|FG000|Overall Study|Screen failure following randomization|1|||
48758869|NCT00768300|156964681|FG001|Overall Study|Screen failure following randomization|0|||
48758870|NCT00768300|156964680|FG000|Overall Study|Received lung transplant|1|||
48758871|NCT00768300|156964681|FG001|Overall Study|Received lung transplant|1|||
48668142|NCT01533922|156639082|FG003|Overall Study|Protocol Violation|0|||
48668143|NCT01533922|156639083|FG004|Overall Study|Protocol Violation|1|||
48668144|NCT01533922|156639079|FG000|Overall Study|Withdrawal by Subject|3|||
48668145|NCT01533922|156639080|FG001|Overall Study|Withdrawal by Subject|1|||
48668146|NCT01533922|156639081|FG002|Overall Study|Withdrawal by Subject|2|||
48668147|NCT01533922|156639082|FG003|Overall Study|Withdrawal by Subject|2|||
48668148|NCT01533922|156639083|FG004|Overall Study|Withdrawal by Subject|1|||
48668149|NCT01533922|156639079|FG000|Overall Study|Other reason not defined above|2|||
48668150|NCT01533922|156639080|FG001|Overall Study|Other reason not defined above|0|||
48668151|NCT01533922|156639081|FG002|Overall Study|Other reason not defined above|1|||
48668152|NCT01533922|156639082|FG003|Overall Study|Other reason not defined above|0|||
48668153|NCT01533922|156639083|FG004|Overall Study|Other reason not defined above|0|||
48668154|NCT00930969|156639084|FG000|Overall Study|Death|5|||
48668155|NCT00930969|156639084|FG000|Overall Study|Lost to Follow-up|1|||
48668156|NCT00930969|156639084|FG000|Overall Study|Physician Decision|13|||
48668157|NCT00930969|156639084|FG000|Overall Study|Withdrawal by Subject|19|||
48668158|NCT02876328|156639085|FG000|Overall Study|Death|2|||
48668159|NCT02876328|156639086|FG001|Overall Study|Death|1|||
48668160|NCT02876328|156639087|FG002|Overall Study|Death|3|||
48668161|NCT02876328|156639088|FG003|Overall Study|Death|0|||
48668162|NCT02876328|156639089|FG004|Overall Study|Death|0|||
48668163|NCT02876328|156639090|FG005|Overall Study|Death|0|||
48668164|NCT02876328|156639091|FG006|Overall Study|Death|1|||
48758872|NCT00768300|156964680|FG000|Overall Study|Lost to Follow-up|0|||
48758873|NCT00768300|156964681|FG001|Overall Study|Lost to Follow-up|1|||
48758874|NCT00768300|156964680|FG000|Overall Study|Began prohibited concomitant medication|0|||
48758875|NCT00768300|156964681|FG001|Overall Study|Began prohibited concomitant medication|1|||
48758876|NCT00768300|156964680|FG000|Overall Study|Treated but never dosed with Study drug|1|||
48668165|NCT02876328|156639092|FG007|Overall Study|Death|3|||
48668166|NCT02876328|156639093|FG008|Overall Study|Death|0|||
48668167|NCT02876328|156639094|FG009|Overall Study|Death|1|||
48668168|NCT02876328|156639095|FG010|Overall Study|Death|1|||
48668169|NCT02876328|156639096|FG011|Overall Study|Death|0|||
48668170|NCT02876328|156639097|FG012|Overall Study|Death|0|||
48668171|NCT02876328|156639098|FG013|Overall Study|Death|0|||
48668172|NCT02876328|156639099|FG014|Overall Study|Death|0|||
48668173|NCT02876328|156639100|FG015|Overall Study|Death|0|||
48758877|NCT00768300|156964681|FG001|Overall Study|Treated but never dosed with Study drug|0|||
48758878|NCT00768300|156964680|FG000|Overall Study|Missing data|1|||
48758879|NCT00768300|156964681|FG001|Overall Study|Missing data|0|||
48758880|NCT01374087|156964690|FG000|Overall Study|Adverse Event|1|||
48758881|NCT01374087|156964691|FG001|Overall Study|Adverse Event|0|||
48758882|NCT01374087|156964690|FG000|Overall Study|Disease progression|2|||
48758883|NCT01374087|156964691|FG001|Overall Study|Disease progression|2|||
48758884|NCT01374087|156964690|FG000|Overall Study|Study discontinued|13|||
48758885|NCT01374087|156964691|FG001|Overall Study|Study discontinued|13|||
48758886|NCT00624052|156964697|FG000|Overall Study|Adverse Event|7|||
48758887|NCT00624052|156964698|FG001|Overall Study|Adverse Event|6|||
48758888|NCT00624052|156964699|FG002|Overall Study|Adverse Event|0|||
48758889|NCT00624052|156964700|FG003|Overall Study|Adverse Event|3|||
48758890|NCT00624052|156964697|FG000|Overall Study|Lack of Efficacy|1|||
48758891|NCT00624052|156964698|FG001|Overall Study|Lack of Efficacy|1|||
48668174|NCT02876328|156639101|FG016|Overall Study|Death|1|||
48668175|NCT02876328|156639102|FG017|Overall Study|Death|1|||
48668176|NCT02876328|156639103|FG018|Overall Study|Death|0|||
48668177|NCT02876328|156639104|FG019|Overall Study|Death|0|||
48668178|NCT02876328|156639105|FG020|Overall Study|Death|0|||
48668179|NCT02876328|156639106|FG021|Overall Study|Death|1|||
48668180|NCT02876328|156639107|FG022|Overall Study|Death|0|||
48668181|NCT02876328|156639108|FG023|Overall Study|Death|0|||
48668182|NCT02876328|156639085|FG000|Overall Study|Withdrawal by Subject|0|||
48668183|NCT02876328|156639086|FG001|Overall Study|Withdrawal by Subject|2|||
48668184|NCT02876328|156639087|FG002|Overall Study|Withdrawal by Subject|3|||
48668185|NCT02876328|156639088|FG003|Overall Study|Withdrawal by Subject|3|||
48668186|NCT02876328|156639089|FG004|Overall Study|Withdrawal by Subject|0|||
48668187|NCT02876328|156639090|FG005|Overall Study|Withdrawal by Subject|1|||
48668188|NCT02876328|156639091|FG006|Overall Study|Withdrawal by Subject|0|||
48668189|NCT02876328|156639092|FG007|Overall Study|Withdrawal by Subject|1|||
48668190|NCT02876328|156639093|FG008|Overall Study|Withdrawal by Subject|1|||
48668191|NCT02876328|156639094|FG009|Overall Study|Withdrawal by Subject|2|||
48668192|NCT02876328|156639095|FG010|Overall Study|Withdrawal by Subject|0|||
48668193|NCT02876328|156639096|FG011|Overall Study|Withdrawal by Subject|0|||
48668194|NCT02876328|156639097|FG012|Overall Study|Withdrawal by Subject|0|||
48668195|NCT02876328|156639098|FG013|Overall Study|Withdrawal by Subject|0|||
48668196|NCT02876328|156639099|FG014|Overall Study|Withdrawal by Subject|0|||
48668197|NCT02876328|156639100|FG015|Overall Study|Withdrawal by Subject|0|||
48668198|NCT02876328|156639101|FG016|Overall Study|Withdrawal by Subject|1|||
48668199|NCT02876328|156639102|FG017|Overall Study|Withdrawal by Subject|3|||
48668200|NCT02876328|156639103|FG018|Overall Study|Withdrawal by Subject|0|||
48668201|NCT02876328|156639104|FG019|Overall Study|Withdrawal by Subject|0|||
48668202|NCT02876328|156639105|FG020|Overall Study|Withdrawal by Subject|1|||
48668203|NCT02876328|156639106|FG021|Overall Study|Withdrawal by Subject|0|||
48668204|NCT02876328|156639107|FG022|Overall Study|Withdrawal by Subject|0|||
48668205|NCT02876328|156639108|FG023|Overall Study|Withdrawal by Subject|0|||
48668206|NCT02876328|156639085|FG000|Overall Study|Missed 12 Month Visit|15|||
48668207|NCT02876328|156639086|FG001|Overall Study|Missed 12 Month Visit|10|||
48668208|NCT02876328|156639087|FG002|Overall Study|Missed 12 Month Visit|11|||
48668209|NCT02876328|156639088|FG003|Overall Study|Missed 12 Month Visit|6|||
48668210|NCT02876328|156639089|FG004|Overall Study|Missed 12 Month Visit|10|||
48758892|NCT00624052|156964699|FG002|Overall Study|Lack of Efficacy|0|||
48758893|NCT00624052|156964700|FG003|Overall Study|Lack of Efficacy|0|||
48668211|NCT02876328|156639090|FG005|Overall Study|Missed 12 Month Visit|14|||
48668212|NCT02876328|156639091|FG006|Overall Study|Missed 12 Month Visit|3|||
48668213|NCT02876328|156639092|FG007|Overall Study|Missed 12 Month Visit|8|||
48668214|NCT02876328|156639093|FG008|Overall Study|Missed 12 Month Visit|9|||
48668215|NCT02876328|156639094|FG009|Overall Study|Missed 12 Month Visit|5|||
48668216|NCT02876328|156639095|FG010|Overall Study|Missed 12 Month Visit|4|||
48668217|NCT02876328|156639096|FG011|Overall Study|Missed 12 Month Visit|1|||
48668218|NCT02876328|156639097|FG012|Overall Study|Missed 12 Month Visit|5|||
48668219|NCT02876328|156639098|FG013|Overall Study|Missed 12 Month Visit|4|||
48668220|NCT02876328|156639099|FG014|Overall Study|Missed 12 Month Visit|4|||
48668221|NCT02876328|156639100|FG015|Overall Study|Missed 12 Month Visit|4|||
48668222|NCT02876328|156639101|FG016|Overall Study|Missed 12 Month Visit|3|||
48342247|NCT01072396|155447724|FG000|Period One|Adverse Event|1|||
48668223|NCT02876328|156639102|FG017|Overall Study|Missed 12 Month Visit|6|||
48668224|NCT02876328|156639103|FG018|Overall Study|Missed 12 Month Visit|2|||
48668225|NCT02876328|156639104|FG019|Overall Study|Missed 12 Month Visit|2|||
48758894|NCT00624052|156964697|FG000|Overall Study|Lost to Follow-up|2|||
48758895|NCT00624052|156964698|FG001|Overall Study|Lost to Follow-up|3|||
48758896|NCT00624052|156964699|FG002|Overall Study|Lost to Follow-up|1|||
48668226|NCT02876328|156639105|FG020|Overall Study|Missed 12 Month Visit|11|||
48758897|NCT00624052|156964700|FG003|Overall Study|Lost to Follow-up|0|||
48758898|NCT00624052|156964697|FG000|Overall Study|Non compliant with the protocol|2|||
48758899|NCT00624052|156964698|FG001|Overall Study|Non compliant with the protocol|1|||
48758900|NCT00624052|156964699|FG002|Overall Study|Non compliant with the protocol|1|||
48758901|NCT00624052|156964700|FG003|Overall Study|Non compliant with the protocol|1|||
48758902|NCT00624052|156964697|FG000|Overall Study|Consent withdrawn|3|||
48758903|NCT00624052|156964698|FG001|Overall Study|Consent withdrawn|1|||
48758904|NCT00624052|156964699|FG002|Overall Study|Consent withdrawn|1|||
48758905|NCT00624052|156964700|FG003|Overall Study|Consent withdrawn|0|||
48758906|NCT00624052|156964697|FG000|Overall Study|Changed job/ran out if meds|0|||
48758907|NCT00624052|156964698|FG001|Overall Study|Changed job/ran out if meds|2|||
48758908|NCT00624052|156964699|FG002|Overall Study|Changed job/ran out if meds|0|||
48758909|NCT00624052|156964700|FG003|Overall Study|Changed job/ran out if meds|0|||
48758910|NCT00946712|156964701|FG000|Overall Study|Adverse Event|118|||
48342248|NCT01072396|155447725|FG001|Period One|Adverse Event|1|||
48342249|NCT01072396|155447724|FG000|Period One|Protocol Violation|2|||
48668227|NCT02876328|156639106|FG021|Overall Study|Missed 12 Month Visit|7|||
48668228|NCT02876328|156639107|FG022|Overall Study|Missed 12 Month Visit|1|||
48668229|NCT02876328|156639108|FG023|Overall Study|Missed 12 Month Visit|0|||
48668230|NCT02712424|156639109|FG000|Overall Study|Lost to Follow-up|34|||
48668231|NCT02712424|156639110|FG001|Overall Study|Lost to Follow-up|32|||
48668232|NCT01443130|156639111|FG000|Overall Study|Lost to Follow-up|44|||
48668233|NCT01443130|156639112|FG001|Overall Study|Lost to Follow-up|42|||
48668234|NCT01443130|156639113|FG002|Overall Study|Lost to Follow-up|50|||
48668235|NCT01443130|156639114|FG003|Overall Study|Lost to Follow-up|23|||
48668236|NCT01443130|156639115|FG004|Overall Study|Lost to Follow-up|25|||
48668237|NCT01443130|156639116|FG005|Overall Study|Lost to Follow-up|21|||
48668238|NCT01443130|156639111|FG000|Overall Study|Death|0|||
48668239|NCT01443130|156639112|FG001|Overall Study|Death|1|||
48668240|NCT01443130|156639113|FG002|Overall Study|Death|0|||
48668241|NCT01443130|156639114|FG003|Overall Study|Death|7|||
48668242|NCT01443130|156639115|FG004|Overall Study|Death|10|||
48668243|NCT01443130|156639116|FG005|Overall Study|Death|8|||
48668244|NCT01443130|156639111|FG000|Overall Study|Adverse Event|2|||
48668245|NCT01443130|156639112|FG001|Overall Study|Adverse Event|1|||
48668246|NCT01443130|156639113|FG002|Overall Study|Adverse Event|1|||
48668247|NCT01443130|156639114|FG003|Overall Study|Adverse Event|0|||
48668248|NCT01443130|156639115|FG004|Overall Study|Adverse Event|0|||
48668249|NCT01443130|156639116|FG005|Overall Study|Adverse Event|0|||
48668250|NCT01443130|156639111|FG000|Overall Study|Protocol Violation|2|||
48668251|NCT01443130|156639112|FG001|Overall Study|Protocol Violation|1|||
48668252|NCT01443130|156639113|FG002|Overall Study|Protocol Violation|3|||
48668253|NCT01443130|156639114|FG003|Overall Study|Protocol Violation|2|||
48668254|NCT01443130|156639115|FG004|Overall Study|Protocol Violation|2|||
48668255|NCT01443130|156639116|FG005|Overall Study|Protocol Violation|3|||
48668256|NCT01443130|156639111|FG000|Overall Study|Withdrawal by Subject|15|||
48668257|NCT01443130|156639112|FG001|Overall Study|Withdrawal by Subject|14|||
48668258|NCT01443130|156639113|FG002|Overall Study|Withdrawal by Subject|12|||
48668259|NCT01443130|156639114|FG003|Overall Study|Withdrawal by Subject|7|||
48668260|NCT01443130|156639115|FG004|Overall Study|Withdrawal by Subject|7|||
48668261|NCT01443130|156639116|FG005|Overall Study|Withdrawal by Subject|2|||
48342250|NCT01072396|155447725|FG001|Period One|Protocol Violation|1|||
48342251|NCT01072396|155447724|FG000|Period One|Withdrawal by Subject|2|||
48342252|NCT01072396|155447725|FG001|Period One|Withdrawal by Subject|0|||
48342253|NCT01072396|155447724|FG000|Washout Period|Missing termination information|0|||
48342254|NCT01072396|155447725|FG001|Washout Period|Missing termination information|1|||
48342255|NCT01072396|155447724|FG000|Period Two|Adverse Event|0|||
48342256|NCT01072396|155447725|FG001|Period Two|Adverse Event|3|||
48342257|NCT01072396|155447724|FG000|Period Two|Lost to Follow-up|1|||
48668262|NCT01443130|156639111|FG000|Overall Study|Death of Subject's Infant|5|||
48668263|NCT01443130|156639112|FG001|Overall Study|Death of Subject's Infant|10|||
48668264|NCT01443130|156639113|FG002|Overall Study|Death of Subject's Infant|11|||
48342258|NCT01072396|155447725|FG001|Period Two|Lost to Follow-up|0|||
48342259|NCT01475370|155447734|FG000|Overall Study|Exacerbation of primary disease|2|||
48668265|NCT01443130|156639114|FG003|Overall Study|Death of Subject's Infant|0|||
48668266|NCT01443130|156639115|FG004|Overall Study|Death of Subject's Infant|0|||
48668267|NCT01443130|156639116|FG005|Overall Study|Death of Subject's Infant|0|||
48668268|NCT00364533|156639117|FG000|Overall Study|Adverse Event|8|||
48668269|NCT00364533|156639118|FG001|Overall Study|Adverse Event|7|||
48668270|NCT00364533|156639119|FG002|Overall Study|Adverse Event|15|||
48668271|NCT00364533|156639120|FG003|Overall Study|Adverse Event|5|||
48668272|NCT00364533|156639121|FG004|Overall Study|Adverse Event|2|||
48668273|NCT00364533|156639117|FG000|Overall Study|Withdrawal by Subject|4|||
48668274|NCT00364533|156639118|FG001|Overall Study|Withdrawal by Subject|8|||
48668275|NCT00364533|156639119|FG002|Overall Study|Withdrawal by Subject|6|||
48668276|NCT00364533|156639120|FG003|Overall Study|Withdrawal by Subject|6|||
48668277|NCT00364533|156639121|FG004|Overall Study|Withdrawal by Subject|6|||
48758911|NCT00946712|156964702|FG001|Overall Study|Adverse Event|124|||
48758912|NCT00946712|156964701|FG000|Overall Study|Disease progression|308|||
48668278|NCT00364533|156639117|FG000|Overall Study|Lack of Efficacy|22|||
48668279|NCT00364533|156639118|FG001|Overall Study|Lack of Efficacy|22|||
48668280|NCT00364533|156639119|FG002|Overall Study|Lack of Efficacy|21|||
48668281|NCT00364533|156639120|FG003|Overall Study|Lack of Efficacy|17|||
48668282|NCT00364533|156639121|FG004|Overall Study|Lack of Efficacy|42|||
48668283|NCT00364533|156639117|FG000|Overall Study|Subject discharged from hospital|4|||
48668284|NCT00364533|156639118|FG001|Overall Study|Subject discharged from hospital|1|||
48668285|NCT00364533|156639119|FG002|Overall Study|Subject discharged from hospital|2|||
48668286|NCT00364533|156639120|FG003|Overall Study|Subject discharged from hospital|3|||
48668287|NCT00364533|156639121|FG004|Overall Study|Subject discharged from hospital|1|||
48668288|NCT00364533|156639117|FG000|Overall Study|Variations in drug compliance|2|||
48758913|NCT00946712|156964702|FG001|Overall Study|Disease progression|404|||
48758914|NCT00946712|156964701|FG000|Overall Study|Death|21|||
48758915|NCT00946712|156964702|FG001|Overall Study|Death|22|||
48758916|NCT00946712|156964701|FG000|Overall Study|No treatment given|25|||
48758917|NCT00946712|156964702|FG001|Overall Study|No treatment given|29|||
48758918|NCT00946712|156964701|FG000|Overall Study|Other reasons|61|||
48758919|NCT00946712|156964702|FG001|Overall Study|Other reasons|73|||
48758920|NCT00946712|156964701|FG000|Overall Study|On Treatment|0|||
48758921|NCT00946712|156964702|FG001|Overall Study|On Treatment|4|||
48758922|NCT00946712|156964701|FG000|Overall Study|Ineligible|14|||
48758923|NCT00946712|156964702|FG001|Overall Study|Ineligible|6|||
48758924|NCT00853723|156964703|FG000|Overall Study|Adverse Event|3|||
48758925|NCT00853723|156964704|FG001|Overall Study|Adverse Event|4|||
48758926|NCT00853723|156964705|FG002|Overall Study|Adverse Event|1|||
48758927|NCT00853723|156964703|FG000|Overall Study|Withdrawal by Subject|2|||
48758928|NCT00853723|156964704|FG001|Overall Study|Withdrawal by Subject|1|||
48758929|NCT00853723|156964705|FG002|Overall Study|Withdrawal by Subject|0|||
48758930|NCT00853723|156964703|FG000|Overall Study|Protocol Violation|1|||
48758931|NCT00853723|156964704|FG001|Overall Study|Protocol Violation|2|||
48758932|NCT00853723|156964705|FG002|Overall Study|Protocol Violation|1|||
48758933|NCT05778786|156964706|FG000|Period 1|COVID-19 Related|3|||
48758934|NCT05778786|156964707|FG001|Period 1|COVID-19 Related|3|||
48758935|NCT05778786|156964706|FG000|Period 1|Withdrew Consent during Study|1|||
48758936|NCT05778786|156964707|FG001|Period 1|Withdrew Consent during Study|0|||
48758937|NCT05778786|156964706|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
48758938|NCT05778786|156964707|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
48758939|NCT05778786|156964706|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
48758940|NCT05778786|156964707|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
48758941|NCT01173718|156964708|FG000|Overall Study|Death|17|||
48758942|NCT01173718|156964708|FG000|Overall Study|Abandonment of study graft|27|||
48758943|NCT02406651|156964709|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
48758944|NCT03158051|156964716|FG000|Overall Study|Lost to Follow-up|41|||
48758945|NCT03158051|156964717|FG001|Overall Study|Lost to Follow-up|47|||
48758946|NCT03158051|156964716|FG000|Overall Study|Physician Decision|6|||
48758947|NCT03158051|156964717|FG001|Overall Study|Physician Decision|7|||
48758948|NCT03158051|156964716|FG000|Overall Study|Withdrawal by Subject|24|||
48342260|NCT01475370|155447735|FG001|Overall Study|Exacerbation of primary disease|2|||
48342261|NCT01475370|155447736|FG002|Overall Study|Exacerbation of primary disease|2|||
48342262|NCT01475370|155447734|FG000|Overall Study|Study drug administration difficult|0|||
48342263|NCT01475370|155447735|FG001|Overall Study|Study drug administration difficult|1|||
48342264|NCT01475370|155447736|FG002|Overall Study|Study drug administration difficult|1|||
48342265|NCT01475370|155447734|FG000|Overall Study|Other than specified|1|||
48342266|NCT01475370|155447735|FG001|Overall Study|Other than specified|0|||
48342267|NCT01475370|155447736|FG002|Overall Study|Other than specified|0|||
48342268|NCT05177770|155447739|FG000|Overall Study|Death|4|||
48342269|NCT05177770|155447739|FG000|Overall Study|Withdrawal by Subject|1|||
48342270|NCT05177770|155447739|FG000|Overall Study|Adverse Event prior to dosing|1|||
48342271|NCT03325608|155447742|FG000|Overall Study|Lost to Follow-up|23|||
48342272|NCT03325608|155447743|FG001|Overall Study|Lost to Follow-up|23|||
48342273|NCT03325608|155447744|FG002|Overall Study|Lost to Follow-up|30|||
48342274|NCT03325608|155447745|FG003|Overall Study|Lost to Follow-up|30|||
48342275|NCT03325608|155447742|FG000|Overall Study|Death of Caregiver|0|||
48342276|NCT03325608|155447743|FG001|Overall Study|Death of Caregiver|0|||
48342277|NCT03325608|155447744|FG002|Overall Study|Death of Caregiver|2|||
48342278|NCT03325608|155447745|FG003|Overall Study|Death of Caregiver|2|||
48342279|NCT03325608|155447742|FG000|Overall Study|Death of Care Recipient|34|||
48342280|NCT03325608|155447743|FG001|Overall Study|Death of Care Recipient|34|||
48342281|NCT03325608|155447744|FG002|Overall Study|Death of Care Recipient|28|||
48342282|NCT03325608|155447745|FG003|Overall Study|Death of Care Recipient|28|||
48342283|NCT03325608|155447742|FG000|Overall Study|Withdrawal by Subject|49|||
48342284|NCT03325608|155447743|FG001|Overall Study|Withdrawal by Subject|49|||
48342285|NCT03325608|155447744|FG002|Overall Study|Withdrawal by Subject|35|||
48342286|NCT03325608|155447745|FG003|Overall Study|Withdrawal by Subject|35|||
48342287|NCT03325608|155447742|FG000|Overall Study|Ineligible|7|||
48342288|NCT03325608|155447743|FG001|Overall Study|Ineligible|7|||
48342289|NCT03325608|155447744|FG002|Overall Study|Ineligible|5|||
48342290|NCT03325608|155447745|FG003|Overall Study|Ineligible|5|||
48342291|NCT00760877|155449153|FG000|Overall Study|Protocol Violation|1|||
48342292|NCT00760877|155449154|FG001|Overall Study|Protocol Violation|0|||
48342293|NCT00760877|155449153|FG000|Overall Study|Non-compliance with protocol treatment|2|||
48342294|NCT00760877|155449154|FG001|Overall Study|Non-compliance with protocol treatment|1|||
48342295|NCT00760877|155449153|FG000|Overall Study|Pregnancy|1|||
48342296|NCT00760877|155449154|FG001|Overall Study|Pregnancy|4|||
48342297|NCT00760877|155449153|FG000|Overall Study|Death|2|||
48342298|NCT00760877|155449154|FG001|Overall Study|Death|1|||
48342299|NCT00760877|155449153|FG000|Overall Study|Withdrawal by Subject|7|||
48342300|NCT00760877|155449154|FG001|Overall Study|Withdrawal by Subject|3|||
48342301|NCT00760877|155449153|FG000|Overall Study|Adverse Event|19|||
48342302|NCT00760877|155449154|FG001|Overall Study|Adverse Event|12|||
48342303|NCT00760877|155449153|FG000|Overall Study|Participant diagnosed with AML|0|||
48342304|NCT00760877|155449154|FG001|Overall Study|Participant diagnosed with AML|1|||
48342305|NCT00760877|155449153|FG000|Overall Study|Participant not eligible to cross-over|0|||
48342306|NCT00760877|155449154|FG001|Overall Study|Participant not eligible to cross-over|1|||
48342307|NCT00760877|155449153|FG000|Overall Study|Physician Decision|1|||
48342308|NCT00760877|155449154|FG001|Overall Study|Physician Decision|2|||
48342309|NCT00760877|155449153|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
48342310|NCT00760877|155449154|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
48342311|NCT00760877|155449153|FG000|Overall Study|Treatment failure|1|||
48342312|NCT00760877|155449154|FG001|Overall Study|Treatment failure|0|||
48342313|NCT04413149|155449157|FG000|Overall Study|Death|10|||
48342314|NCT04413149|155449158|FG001|Overall Study|Death|5|||
48342315|NCT04413149|155449157|FG000|Overall Study|Lung transplantation|1|||
48342316|NCT04413149|155449158|FG001|Overall Study|Lung transplantation|0|||
48342317|NCT02661490|155449163|FG000|Overall Study|Lost to Follow-up|0|||
48342318|NCT02661490|155449164|FG001|Overall Study|Lost to Follow-up|1|||
48758949|NCT03158051|156964717|FG001|Overall Study|Withdrawal by Subject|15|||
48342319|NCT02661490|155449165|FG002|Overall Study|Lost to Follow-up|0|||
48342320|NCT02661490|155449166|FG003|Overall Study|Lost to Follow-up|0|||
48342321|NCT02661490|155449167|FG004|Overall Study|Lost to Follow-up|2|||
48758950|NCT03158051|156964716|FG000|Overall Study|Death|0|||
48758951|NCT03158051|156964717|FG001|Overall Study|Death|1|||
48758952|NCT02892760|156966295|FG000|Overall Study|Withdrawal by Subject|3|||
48758953|NCT02673489|156966296|FG000|Treatment Period|Lost to Follow-up|3|||
48758954|NCT02673489|156966297|FG001|Treatment Period|Lost to Follow-up|0|||
48758955|NCT02673489|156966296|FG000|Treatment Period|Participant request to discontinue|1|||
48758956|NCT02673489|156966297|FG001|Treatment Period|Participant request to discontinue|1|||
48342322|NCT02661490|155449163|FG000|Overall Study|Withdrawal by Subject|2|||
48342323|NCT02661490|155449164|FG001|Overall Study|Withdrawal by Subject|0|||
48342324|NCT02661490|155449165|FG002|Overall Study|Withdrawal by Subject|2|||
48342325|NCT02661490|155449166|FG003|Overall Study|Withdrawal by Subject|0|||
48342326|NCT02661490|155449167|FG004|Overall Study|Withdrawal by Subject|0|||
48342327|NCT02661490|155449163|FG000|Overall Study|Death|1|||
48758957|NCT02673489|156966296|FG000|Treatment Period|Participant moved to another province|1|||
48758958|NCT02673489|156966297|FG001|Treatment Period|Participant moved to another province|0|||
48342328|NCT02661490|155449164|FG001|Overall Study|Death|1|||
48342329|NCT02661490|155449165|FG002|Overall Study|Death|0|||
48342330|NCT02661490|155449166|FG003|Overall Study|Death|1|||
48342331|NCT02661490|155449167|FG004|Overall Study|Death|0|||
48342332|NCT02661490|155449163|FG000|Overall Study|Reason not Specified|0|||
48342333|NCT02661490|155449164|FG001|Overall Study|Reason not Specified|0|||
48342334|NCT02661490|155449165|FG002|Overall Study|Reason not Specified|0|||
48342335|NCT02661490|155449166|FG003|Overall Study|Reason not Specified|0|||
48342336|NCT02661490|155449167|FG004|Overall Study|Reason not Specified|1|||
48342337|NCT02600897|155449168|FG000|Overall Study|Death|1|||
48342338|NCT02600897|155449169|FG001|Overall Study|Death|2|||
48342339|NCT02600897|155449170|FG002|Overall Study|Death|1|||
48342340|NCT02600897|155449171|FG003|Overall Study|Death|2|||
48342341|NCT02600897|155449172|FG004|Overall Study|Death|3|||
48342342|NCT02600897|155449173|FG005|Overall Study|Death|2|||
48342343|NCT02600897|155449174|FG006|Overall Study|Death|10|||
48342344|NCT02600897|155449175|FG007|Overall Study|Death|7|||
48758959|NCT02673489|156966296|FG000|Treatment Period|Participant was incarcerated|0|||
48758960|NCT02673489|156966297|FG001|Treatment Period|Participant was incarcerated|1|||
48758961|NCT02673489|156966296|FG000|Treatment Period|Adverse Event|0|||
48758962|NCT02673489|156966297|FG001|Treatment Period|Adverse Event|1|||
48758963|NCT02673489|156966296|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
48758964|NCT02673489|156966297|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
48758965|NCT02673489|156966296|FG000|Follow Up Period|Unable to return for follow-up|0|||
48758966|NCT02673489|156966297|FG001|Follow Up Period|Unable to return for follow-up|1|||
48758967|NCT00773292|156966298|FG000|Treatment 48 Weeks|Adverse Event|1|||
48758968|NCT00773292|156966298|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
48758969|NCT00202644|156966301|FG000|Overall Study|Adverse Event|12|||
48758970|NCT00202644|156966302|FG001|Overall Study|Adverse Event|13|||
48758971|NCT00202644|156966301|FG000|Overall Study|Withdrawal by Subject|8|||
48758972|NCT00202644|156966302|FG001|Overall Study|Withdrawal by Subject|6|||
48758973|NCT00202644|156966301|FG000|Overall Study|Lack of Efficacy|6|||
48758974|NCT00202644|156966302|FG001|Overall Study|Lack of Efficacy|6|||
48758975|NCT00202644|156966301|FG000|Overall Study|Lost to Follow-up|0|||
48758976|NCT00202644|156966302|FG001|Overall Study|Lost to Follow-up|1|||
48758977|NCT00202644|156966301|FG000|Overall Study|Other|9|||
48758978|NCT00202644|156966302|FG001|Overall Study|Other|1|||
48668289|NCT00364533|156639118|FG001|Overall Study|Variations in drug compliance|1|||
48668290|NCT00364533|156639119|FG002|Overall Study|Variations in drug compliance|1|||
48668291|NCT00364533|156639120|FG003|Overall Study|Variations in drug compliance|0|||
48668292|NCT00364533|156639121|FG004|Overall Study|Variations in drug compliance|0|||
48668293|NCT00364533|156639117|FG000|Overall Study|Non-compliance|1|||
48668294|NCT00364533|156639118|FG001|Overall Study|Non-compliance|0|||
48758979|NCT02057198|156966303|FG000|Overall Study|Death|0|||
48758980|NCT02057198|156966304|FG001|Overall Study|Death|0|||
48342345|NCT02600897|155449176|FG008|Overall Study|Death|20|||
48342346|NCT02600897|155449168|FG000|Overall Study|Lost to Follow-up|1|||
48342347|NCT02600897|155449169|FG001|Overall Study|Lost to Follow-up|0|||
48342348|NCT02600897|155449170|FG002|Overall Study|Lost to Follow-up|0|||
48342349|NCT02600897|155449171|FG003|Overall Study|Lost to Follow-up|0|||
48342350|NCT02600897|155449172|FG004|Overall Study|Lost to Follow-up|0|||
48342351|NCT02600897|155449173|FG005|Overall Study|Lost to Follow-up|0|||
48342352|NCT02600897|155449174|FG006|Overall Study|Lost to Follow-up|0|||
48342353|NCT02600897|155449175|FG007|Overall Study|Lost to Follow-up|1|||
48342354|NCT02600897|155449176|FG008|Overall Study|Lost to Follow-up|0|||
48342355|NCT02600897|155449168|FG000|Overall Study|Withdrawal by Subject|0|||
48342356|NCT02600897|155449169|FG001|Overall Study|Withdrawal by Subject|0|||
48342357|NCT02600897|155449170|FG002|Overall Study|Withdrawal by Subject|0|||
48342358|NCT02600897|155449171|FG003|Overall Study|Withdrawal by Subject|0|||
48342359|NCT02600897|155449172|FG004|Overall Study|Withdrawal by Subject|0|||
48342360|NCT02600897|155449173|FG005|Overall Study|Withdrawal by Subject|0|||
48342361|NCT02600897|155449174|FG006|Overall Study|Withdrawal by Subject|0|||
48342362|NCT02600897|155449175|FG007|Overall Study|Withdrawal by Subject|4|||
48342363|NCT02600897|155449176|FG008|Overall Study|Withdrawal by Subject|2|||
48342364|NCT02600897|155449168|FG000|Overall Study|Reason Not Specified|0|||
48342365|NCT02600897|155449169|FG001|Overall Study|Reason Not Specified|0|||
48342366|NCT02600897|155449170|FG002|Overall Study|Reason Not Specified|0|||
48342367|NCT02600897|155449171|FG003|Overall Study|Reason Not Specified|0|||
48342368|NCT02600897|155449172|FG004|Overall Study|Reason Not Specified|0|||
48342369|NCT02600897|155449173|FG005|Overall Study|Reason Not Specified|0|||
48428238|NCT02531373|155756505|FG007|Overall Study|Protocol Violation|0|||
48668295|NCT00364533|156639119|FG002|Overall Study|Non-compliance|0|||
48668296|NCT00364533|156639120|FG003|Overall Study|Non-compliance|0|||
48758981|NCT02057198|156966305|FG002|Overall Study|Death|1|||
48758982|NCT02057198|156966303|FG000|Overall Study|Discharged early; lost to followup|0|||
48758983|NCT02057198|156966304|FG001|Overall Study|Discharged early; lost to followup|1|||
48758984|NCT02057198|156966305|FG002|Overall Study|Discharged early; lost to followup|0|||
48758985|NCT00350636|156966306|FG000|Overall Study|Adverse Event|19|||
48758986|NCT00350636|156966307|FG001|Overall Study|Adverse Event|13|||
48758987|NCT00350636|156966306|FG000|Overall Study|Protocol Violation|1|||
48758988|NCT00350636|156966307|FG001|Overall Study|Protocol Violation|3|||
48758989|NCT00350636|156966306|FG000|Overall Study|Withdrawal by Subject|13|||
48758990|NCT00350636|156966307|FG001|Overall Study|Withdrawal by Subject|17|||
48758991|NCT00350636|156966306|FG000|Overall Study|Lost to Follow-up|9|||
48758992|NCT00350636|156966307|FG001|Overall Study|Lost to Follow-up|8|||
48758993|NCT00350636|156966306|FG000|Overall Study|Physician Decision|0|||
48758994|NCT00350636|156966307|FG001|Overall Study|Physician Decision|2|||
48758995|NCT00350636|156966306|FG000|Overall Study|Other|1|||
48758996|NCT00350636|156966307|FG001|Overall Study|Other|2|||
48758997|NCT02750592|156966308|FG000|Overall Study|Adverse Event|3|||
48758998|NCT02750592|156966308|FG000|Overall Study|Lack of Efficacy|2|||
48758999|NCT00453921|156966314|FG000|Overall Study|Withdrawal by Subject|1|||
48759000|NCT00453921|156966315|FG001|Overall Study|Withdrawal by Subject|1|||
48759001|NCT00453921|156966316|FG002|Overall Study|Withdrawal by Subject|1|||
48759002|NCT00453921|156966317|FG003|Overall Study|Withdrawal by Subject|1|||
48759003|NCT00453921|156966314|FG000|Overall Study|Lost to Follow-up|0|||
48759004|NCT00453921|156966315|FG001|Overall Study|Lost to Follow-up|0|||
48759005|NCT00453921|156966316|FG002|Overall Study|Lost to Follow-up|1|||
48759006|NCT00453921|156966317|FG003|Overall Study|Lost to Follow-up|0|||
48759007|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
48759008|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
48759009|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
48759010|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
48668297|NCT00364533|156639121|FG004|Overall Study|Non-compliance|0|||
48668298|NCT00364533|156639117|FG000|Overall Study|Protocol Violation|1|||
48668299|NCT00364533|156639118|FG001|Overall Study|Protocol Violation|1|||
48668300|NCT00364533|156639119|FG002|Overall Study|Protocol Violation|0|||
48668301|NCT00364533|156639120|FG003|Overall Study|Protocol Violation|0|||
48668302|NCT00364533|156639121|FG004|Overall Study|Protocol Violation|0|||
48668303|NCT03157583|156639122|FG000|Overall Study|Other (did not meet study criteria)|1|||
48668304|NCT01814670|156639123|FG000|Overall Study|Protocol Violation|12|||
48668305|NCT01943552|156639128|FG000|Overall Study|Adverse Event|3|||
48668306|NCT01943552|156639129|FG001|Overall Study|Adverse Event|2|||
48668307|NCT01943552|156639128|FG000|Overall Study|Withdrawal by Subject|6|||
48668308|NCT01943552|156639129|FG001|Overall Study|Withdrawal by Subject|6|||
48759011|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
48759012|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
48759013|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
48759014|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
48759015|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Other|4|||
48759016|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Other|1|||
48759017|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
48759018|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
48759019|NCT00303498|156966318|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
48759020|NCT00303498|156966319|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
48759021|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
48759022|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
48759023|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Death|1|||
48759024|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Death|0|||
48759025|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
48759026|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
48759027|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
48759028|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
48759029|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
48759030|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
48759031|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
48759032|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
48759033|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Other|1|||
48759034|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Other|0|||
48759035|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
48759036|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
48759037|NCT00303498|156966318|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
48668309|NCT01943552|156639128|FG000|Overall Study|Other Reasons|16|||
48668310|NCT01943552|156639129|FG001|Overall Study|Other Reasons|17|||
48668311|NCT00117793|156639130|FG000|Overall Study|Withdrawal by Subject|12|||
48668312|NCT01475162|156639131|FG000|Overall Study|Physician Decision|1|||
48668313|NCT01475162|156639131|FG000|Overall Study|Death|10|||
48668314|NCT01475162|156639131|FG000|Overall Study|Study closed for safety|3|||
48668315|NCT02565810|156639133|FG000|Overall Study|Withdrawal by Subject|1|||
48668316|NCT01827332|156639136|FG000|Overall Study|Lost to Follow-up|2|||
48668317|NCT01827332|156639137|FG001|Overall Study|Lost to Follow-up|1|||
48668318|NCT00490139|156639138|FG000|Overall Study|Death|106|||
48668319|NCT00490139|156639139|FG001|Overall Study|Death|119|||
48668320|NCT00490139|156639140|FG002|Overall Study|Death|168|||
48668321|NCT00490139|156639141|FG003|Overall Study|Death|135|||
48668322|NCT00490139|156639138|FG000|Overall Study|Lost to Follow-up|56|||
48668323|NCT00490139|156639139|FG001|Overall Study|Lost to Follow-up|46|||
48668324|NCT00490139|156639140|FG002|Overall Study|Lost to Follow-up|58|||
48668325|NCT00490139|156639141|FG003|Overall Study|Lost to Follow-up|56|||
48668326|NCT00490139|156639138|FG000|Overall Study|Participant Withdrew Consent|146|||
48668327|NCT00490139|156639139|FG001|Overall Study|Participant Withdrew Consent|110|||
48668328|NCT00490139|156639140|FG002|Overall Study|Participant Withdrew Consent|208|||
48668329|NCT00490139|156639141|FG003|Overall Study|Participant Withdrew Consent|116|||
48668330|NCT02049138|156639144|FG000|Overall Study|Adverse Event|46|||
48668331|NCT02049138|156639145|FG001|Overall Study|Adverse Event|25|||
48668332|NCT02049138|156639146|FG002|Overall Study|Adverse Event|1|||
48668333|NCT02049138|156639144|FG000|Overall Study|Withdrawal by Subject|57|||
48668334|NCT02049138|156639145|FG001|Overall Study|Withdrawal by Subject|21|||
48668335|NCT02049138|156639146|FG002|Overall Study|Withdrawal by Subject|5|||
48759038|NCT00303498|156966319|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
48759039|NCT01394523|156966320|FG000|Overall Study|Unable to place block|1|||
48759040|NCT01394523|156966321|FG001|Overall Study|Unable to place block|0|||
48759041|NCT01394523|156966322|FG002|Overall Study|Unable to place block|0|||
48759042|NCT04741074|156966323|FG000|Overall Study|Withdrawal by Subject|1|||
48759043|NCT04741074|156966324|FG001|Overall Study|Withdrawal by Subject|1|||
48759044|NCT04741074|156966323|FG000|Overall Study|Study terminated prematurely|1|||
48759045|NCT04741074|156966324|FG001|Overall Study|Study terminated prematurely|0|||
48759046|NCT02632552|156966325|FG000|Overall Study|Lost to Follow-up|14|||
48759047|NCT02632552|156966326|FG001|Overall Study|Lost to Follow-up|8|||
48759048|NCT02632552|156966325|FG000|Overall Study|Withdrawal by Subject|2|||
48759049|NCT02632552|156966326|FG001|Overall Study|Withdrawal by Subject|0|||
48759050|NCT02632552|156966325|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
48759051|NCT02632552|156966326|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
48759052|NCT03538158|156966334|FG000|Overall Study|Lost to Follow-up|13|||
48759053|NCT03538158|156966335|FG001|Overall Study|Lost to Follow-up|7|||
48759054|NCT03538158|156966334|FG000|Overall Study|Withdrawal by Subject|2|||
48759055|NCT03538158|156966335|FG001|Overall Study|Withdrawal by Subject|1|||
48759056|NCT00405587|156966336|FG000|Overall Study|Death|0|||
48759057|NCT00405587|156966337|FG001|Overall Study|Death|0|||
48759058|NCT00405587|156966338|FG002|Overall Study|Death|0|||
48759059|NCT00405587|156966339|FG003|Overall Study|Death|1|||
48759060|NCT00405587|156966336|FG000|Overall Study|Disease Progression|22|||
48759061|NCT00405587|156966337|FG001|Overall Study|Disease Progression|23|||
48759062|NCT00405587|156966338|FG002|Overall Study|Disease Progression|21|||
48759063|NCT00405587|156966339|FG003|Overall Study|Disease Progression|17|||
48759064|NCT00405587|156966336|FG000|Overall Study|Physician Decision|3|||
48759065|NCT00405587|156966337|FG001|Overall Study|Physician Decision|2|||
48759066|NCT00405587|156966338|FG002|Overall Study|Physician Decision|0|||
48759067|NCT00405587|156966339|FG003|Overall Study|Physician Decision|0|||
48759068|NCT00405587|156966336|FG000|Overall Study|Adverse Event|1|||
48759069|NCT00405587|156966337|FG001|Overall Study|Adverse Event|0|||
48759070|NCT00405587|156966338|FG002|Overall Study|Adverse Event|0|||
48759071|NCT00405587|156966339|FG003|Overall Study|Adverse Event|0|||
48759072|NCT00405587|156966336|FG000|Overall Study|Lost to Follow-up|0|||
48759073|NCT00405587|156966337|FG001|Overall Study|Lost to Follow-up|1|||
48759074|NCT00405587|156966338|FG002|Overall Study|Lost to Follow-up|1|||
48759075|NCT00405587|156966339|FG003|Overall Study|Lost to Follow-up|0|||
48759076|NCT00405587|156966336|FG000|Overall Study|Radiation induced necrosis|0|||
48759077|NCT00405587|156966337|FG001|Overall Study|Radiation induced necrosis|1|||
48759078|NCT00405587|156966338|FG002|Overall Study|Radiation induced necrosis|0|||
48759079|NCT00405587|156966339|FG003|Overall Study|Radiation induced necrosis|0|||
48759080|NCT00405587|156966336|FG000|Overall Study|Withdrawal by Subject|0|||
48759081|NCT00405587|156966337|FG001|Overall Study|Withdrawal by Subject|0|||
48759082|NCT00405587|156966338|FG002|Overall Study|Withdrawal by Subject|0|||
48759083|NCT00405587|156966339|FG003|Overall Study|Withdrawal by Subject|2|||
48759084|NCT00405587|156966336|FG000|Overall Study|Participant not dosed|0|||
48759085|NCT00405587|156966337|FG001|Overall Study|Participant not dosed|1|||
48759086|NCT00405587|156966338|FG002|Overall Study|Participant not dosed|0|||
48668336|NCT02049138|156639144|FG000|Overall Study|Lost to Follow-up|18|||
48668337|NCT02049138|156639145|FG001|Overall Study|Lost to Follow-up|5|||
48668338|NCT02049138|156639146|FG002|Overall Study|Lost to Follow-up|1|||
48668339|NCT02049138|156639144|FG000|Overall Study|Lack of Efficacy|10|||
48759087|NCT00405587|156966339|FG003|Overall Study|Participant not dosed|0|||
48759088|NCT00507442|156966340|FG000|Overall Study|Adverse Event|8|||
48759089|NCT00507442|156966341|FG001|Overall Study|Adverse Event|11|||
48759090|NCT00507442|156966342|FG002|Overall Study|Adverse Event|4|||
48759091|NCT00507442|156966343|FG003|Overall Study|Adverse Event|1|||
48759092|NCT00507442|156966340|FG000|Overall Study|Protocol Violation|0|||
48759093|NCT00507442|156966341|FG001|Overall Study|Protocol Violation|1|||
48759094|NCT00507442|156966342|FG002|Overall Study|Protocol Violation|0|||
48759095|NCT00507442|156966343|FG003|Overall Study|Protocol Violation|0|||
48759096|NCT00507442|156966340|FG000|Overall Study|Lost to Follow-up|0|||
48759097|NCT00507442|156966341|FG001|Overall Study|Lost to Follow-up|0|||
48759098|NCT00507442|156966342|FG002|Overall Study|Lost to Follow-up|1|||
48759099|NCT00507442|156966343|FG003|Overall Study|Lost to Follow-up|0|||
48668340|NCT02049138|156639145|FG001|Overall Study|Lack of Efficacy|26|||
48668341|NCT02049138|156639146|FG002|Overall Study|Lack of Efficacy|1|||
48668342|NCT02049138|156639144|FG000|Overall Study|Non-Compliance|15|||
48668343|NCT02049138|156639145|FG001|Overall Study|Non-Compliance|6|||
48668344|NCT02049138|156639146|FG002|Overall Study|Non-Compliance|0|||
48668345|NCT02049138|156639144|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
48668346|NCT02049138|156639145|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
48668347|NCT02049138|156639146|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
48668348|NCT02049138|156639144|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
48668349|NCT02049138|156639145|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
48668350|NCT02049138|156639146|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
48668351|NCT02049138|156639144|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
48668352|NCT02049138|156639145|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
48668353|NCT02049138|156639146|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
48759100|NCT00507442|156966340|FG000|Overall Study|Physician Decision|0|||
48759101|NCT00507442|156966341|FG001|Overall Study|Physician Decision|2|||
48759102|NCT00507442|156966342|FG002|Overall Study|Physician Decision|4|||
48668354|NCT02049138|156639144|FG000|Overall Study|Other|15|||
48668355|NCT02049138|156639145|FG001|Overall Study|Other|13|||
48668356|NCT02049138|156639146|FG002|Overall Study|Other|0|||
48759103|NCT00507442|156966343|FG003|Overall Study|Physician Decision|1|||
48759104|NCT00507442|156966340|FG000|Overall Study|Progressive Disease|2|||
48759105|NCT00507442|156966341|FG001|Overall Study|Progressive Disease|4|||
48759106|NCT00507442|156966342|FG002|Overall Study|Progressive Disease|2|||
48342370|NCT02600897|155449174|FG006|Overall Study|Reason Not Specified|0|||
48342371|NCT02600897|155449175|FG007|Overall Study|Reason Not Specified|0|||
48342372|NCT02600897|155449176|FG008|Overall Study|Reason Not Specified|1|||
48342373|NCT03322514|155449177|FG000|Overall Study|Withdrawal by Subject|1|||
48342374|NCT03322514|155449178|FG001|Overall Study|Withdrawal by Subject|1|||
48342375|NCT02093897|155449182|FG000|Overall Study|Physician Decision|1|||
48342376|NCT02093897|155449182|FG000|Overall Study|Planned age group closure - no's reached|17|||
48342377|NCT02093897|155449182|FG000|Overall Study|Adverse event, non-fatal|1|||
48342378|NCT00946998|155449183|FG000|Overall Study|Exited prior to first outcome assessment|5|||
48342379|NCT00946998|155449184|FG001|Overall Study|Exited prior to first outcome assessment|3|||
48342380|NCT04774237|155449189|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
48342381|NCT04774237|155449190|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
48342382|NCT04774237|155449191|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
48342383|NCT04774237|155449192|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
48342384|NCT04774237|155449193|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
48342385|NCT04774237|155449194|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
48342386|NCT00111839|155449195|FG000|Overall Study|Disease Progression|30|||
48342387|NCT00111839|155449196|FG001|Overall Study|Disease Progression|33|||
48342388|NCT00111839|155449197|FG002|Overall Study|Disease Progression|33|||
48342389|NCT00111839|155449195|FG000|Overall Study|Adverse Event|5|||
48342390|NCT00111839|155449196|FG001|Overall Study|Adverse Event|3|||
48342391|NCT00111839|155449197|FG002|Overall Study|Adverse Event|1|||
48342392|NCT00111839|155449195|FG000|Overall Study|Protocol Violation|2|||
48342393|NCT00111839|155449196|FG001|Overall Study|Protocol Violation|4|||
48668357|NCT02049138|156639144|FG000|Overall Study|Missing|0|||
48668358|NCT02049138|156639145|FG001|Overall Study|Missing|1|||
48342394|NCT00111839|155449197|FG002|Overall Study|Protocol Violation|2|||
48342395|NCT00111839|155449195|FG000|Overall Study|Death|1|||
48342396|NCT00111839|155449196|FG001|Overall Study|Death|1|||
48342397|NCT00111839|155449197|FG002|Overall Study|Death|6|||
48668359|NCT02049138|156639146|FG002|Overall Study|Missing|0|||
48668360|NCT02428413|156639147|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
48668361|NCT02428413|156639148|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
48668362|NCT02428413|156639147|FG000|Overall Study|Protocol Violation|1|||
48668363|NCT02428413|156639148|FG001|Overall Study|Protocol Violation|2|||
48668364|NCT02428413|156639147|FG000|Overall Study|Case Cancelled|2|||
48668365|NCT02428413|156639148|FG001|Overall Study|Case Cancelled|0|||
48668366|NCT02428413|156639147|FG000|Overall Study|Missed Cases|1|||
48668367|NCT02428413|156639148|FG001|Overall Study|Missed Cases|2|||
48668368|NCT02428413|156639147|FG000|Overall Study|Nurse Refusal|1|||
48668369|NCT02428413|156639148|FG001|Overall Study|Nurse Refusal|0|||
48668370|NCT00661388|156639149|FG000|Overall Study|Adverse Event|14|||
48668371|NCT00661388|156639149|FG000|Overall Study|Protocol Violation|7|||
48668372|NCT00661388|156639149|FG000|Overall Study|Renal transplantation|1|||
48668373|NCT00661388|156639149|FG000|Overall Study|Dialysis initiation|1|||
48668374|NCT00661388|156639149|FG000|Overall Study|Administrative reasons|1|||
48668375|NCT00413374|156639150|FG000|Overall Study|Ineligible due to screening criteria.|3|||
48668376|NCT00413374|156639151|FG001|Overall Study|Ineligible due to screening criteria.|0|||
48668377|NCT00413374|156639150|FG000|Overall Study|Adverse Event|1|||
48668378|NCT00413374|156639151|FG001|Overall Study|Adverse Event|0|||
48668379|NCT00413374|156639150|FG000|Overall Study|Lost to Follow-up|1|||
48668380|NCT00413374|156639151|FG001|Overall Study|Lost to Follow-up|0|||
48668381|NCT00413374|156639150|FG000|Overall Study|Surgery|1|||
48668382|NCT00413374|156639151|FG001|Overall Study|Surgery|0|||
48668383|NCT00552760|156639152|FG000|Overall Study|Adverse Event|3|||
48668384|NCT00552760|156639153|FG001|Overall Study|Adverse Event|5|||
48668385|NCT00552760|156639152|FG000|Overall Study|Relapsed- Depressed Event|10|||
48668386|NCT00552760|156639153|FG001|Overall Study|Relapsed- Depressed Event|16|||
48668387|NCT00552760|156639152|FG000|Overall Study|Relapse- Manic Event|3|||
48668388|NCT00552760|156639153|FG001|Overall Study|Relapse- Manic Event|3|||
48668389|NCT00552760|156639152|FG000|Overall Study|Relapsed- Mixed Event|3|||
48668390|NCT00552760|156639153|FG001|Overall Study|Relapsed- Mixed Event|5|||
48668391|NCT00552760|156639152|FG000|Overall Study|Protocol Violation|0|||
48668392|NCT00552760|156639153|FG001|Overall Study|Protocol Violation|1|||
48668393|NCT00552760|156639152|FG000|Overall Study|Lost to Follow-up|1|||
48668394|NCT00552760|156639153|FG001|Overall Study|Lost to Follow-up|1|||
48668395|NCT00552760|156639152|FG000|Overall Study|Non-compliance|1|||
48668396|NCT00552760|156639153|FG001|Overall Study|Non-compliance|1|||
48668397|NCT00552760|156639152|FG000|Overall Study|Medical Condition|1|||
48668398|NCT00552760|156639153|FG001|Overall Study|Medical Condition|1|||
48668399|NCT00552760|156639152|FG000|Overall Study|Withdrawal by Subject|3|||
48668400|NCT00552760|156639153|FG001|Overall Study|Withdrawal by Subject|0|||
48342398|NCT00111839|155449195|FG000|Overall Study|Withdrawal by Subject|2|||
48342399|NCT00111839|155449196|FG001|Overall Study|Withdrawal by Subject|2|||
48342400|NCT00111839|155449197|FG002|Overall Study|Withdrawal by Subject|2|||
48342401|NCT00111839|155449195|FG000|Overall Study|Lost to Follow-up|1|||
48668401|NCT00552760|156639152|FG000|Overall Study|Medication Change|1|||
48668402|NCT00552760|156639153|FG001|Overall Study|Medication Change|0|||
48342402|NCT00111839|155449196|FG001|Overall Study|Lost to Follow-up|0|||
48342403|NCT00111839|155449197|FG002|Overall Study|Lost to Follow-up|0|||
48342404|NCT00111839|155449195|FG000|Overall Study|Logistical Constraint|1|||
48342405|NCT00111839|155449196|FG001|Overall Study|Logistical Constraint|0|||
48342406|NCT00111839|155449197|FG002|Overall Study|Logistical Constraint|0|||
48342407|NCT00111839|155449195|FG000|Overall Study|Other|6|||
48342408|NCT00111839|155449196|FG001|Overall Study|Other|3|||
48668403|NCT00199888|156639154|FG000|Overall Study|Lost to Follow-up|1|||
48668404|NCT05219669|156639157|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668405|NCT05219669|156639158|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668406|NCT05219669|156639159|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
48668407|NCT05219669|156639160|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668408|NCT05219669|156639161|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668409|NCT05219669|156639162|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
48668410|NCT03134183|156639163|FG000|Overall Study|Withdrawal by Subject|1|||
48668411|NCT03134183|156639164|FG001|Overall Study|Withdrawal by Subject|1|||
48668412|NCT02177838|156639165|FG000|Overall Study|Withdrawal by Subject|1|||
48668413|NCT02177838|156639165|FG000|Overall Study|Physician Decision|1|||
48668414|NCT02177838|156639165|FG000|Overall Study|Death|1|||
48668415|NCT02621073|156639166|FG000|Overall Study|Lost to Follow-up|0|||
48668416|NCT02621073|156639167|FG001|Overall Study|Lost to Follow-up|1|||
48668417|NCT02621073|156639166|FG000|Overall Study|Physician Decision|3|||
48668418|NCT02621073|156639167|FG001|Overall Study|Physician Decision|2|||
48668419|NCT00495755|156639168|FG000|Overall Study|Adverse Event|3|||
48668420|NCT00454649|156639171|FG000|Overall Study|Lack of Efficacy|2|||
48668421|NCT00454649|156639172|FG001|Overall Study|Lack of Efficacy|2|||
48668422|NCT00454649|156639173|FG002|Overall Study|Lack of Efficacy|10|||
48668423|NCT00454649|156639174|FG003|Overall Study|Lack of Efficacy|3|||
48668424|NCT00454649|156639175|FG004|Overall Study|Lack of Efficacy|0|||
48668425|NCT00454649|156639176|FG005|Overall Study|Lack of Efficacy|4|||
48668426|NCT00454649|156639177|FG006|Overall Study|Lack of Efficacy|5|||
48668427|NCT00454649|156639178|FG007|Overall Study|Lack of Efficacy|13|||
48668428|NCT00454649|156639179|FG008|Overall Study|Lack of Efficacy|10|||
48668429|NCT00454649|156639180|FG009|Overall Study|Lack of Efficacy|2|||
48342409|NCT00111839|155449197|FG002|Overall Study|Other|3|||
48668430|NCT00454649|156639171|FG000|Overall Study|Adverse Event|0|||
48668431|NCT00454649|156639172|FG001|Overall Study|Adverse Event|1|||
48668432|NCT00454649|156639173|FG002|Overall Study|Adverse Event|3|||
48759107|NCT00507442|156966343|FG003|Overall Study|Progressive Disease|0|||
48759108|NCT00507442|156966340|FG000|Overall Study|Withdrawal by Subject|4|||
48759109|NCT00507442|156966341|FG001|Overall Study|Withdrawal by Subject|4|||
48759110|NCT00507442|156966342|FG002|Overall Study|Withdrawal by Subject|2|||
48759111|NCT00507442|156966343|FG003|Overall Study|Withdrawal by Subject|1|||
48759112|NCT00507442|156966340|FG000|Overall Study|Other|2|||
48759113|NCT00507442|156966341|FG001|Overall Study|Other|5|||
48759114|NCT00507442|156966342|FG002|Overall Study|Other|2|||
48759115|NCT00507442|156966343|FG003|Overall Study|Other|2|||
48759116|NCT00695396|156966344|FG000|Overall Study|Study Closed Prematurely|5|||
48759117|NCT00695396|156966345|FG001|Overall Study|Study Closed Prematurely|6|||
48668433|NCT00454649|156639174|FG003|Overall Study|Adverse Event|0|||
48668434|NCT00454649|156639175|FG004|Overall Study|Adverse Event|1|||
48668435|NCT00454649|156639176|FG005|Overall Study|Adverse Event|2|||
48668436|NCT00454649|156639177|FG006|Overall Study|Adverse Event|3|||
48668437|NCT00454649|156639178|FG007|Overall Study|Adverse Event|4|||
48668438|NCT00454649|156639179|FG008|Overall Study|Adverse Event|6|||
48668439|NCT00454649|156639180|FG009|Overall Study|Adverse Event|2|||
48668440|NCT00454649|156639171|FG000|Overall Study|Lost to Follow-up|0|||
48668441|NCT00454649|156639172|FG001|Overall Study|Lost to Follow-up|0|||
48668442|NCT00454649|156639173|FG002|Overall Study|Lost to Follow-up|1|||
48668443|NCT00454649|156639174|FG003|Overall Study|Lost to Follow-up|0|||
48668444|NCT00454649|156639175|FG004|Overall Study|Lost to Follow-up|0|||
48668445|NCT00454649|156639176|FG005|Overall Study|Lost to Follow-up|0|||
48668446|NCT00454649|156639177|FG006|Overall Study|Lost to Follow-up|1|||
48668447|NCT00454649|156639178|FG007|Overall Study|Lost to Follow-up|0|||
48668448|NCT00454649|156639179|FG008|Overall Study|Lost to Follow-up|0|||
48668449|NCT00454649|156639180|FG009|Overall Study|Lost to Follow-up|0|||
48668450|NCT00454649|156639171|FG000|Overall Study|Other|1|||
48668451|NCT00454649|156639172|FG001|Overall Study|Other|1|||
48668452|NCT00454649|156639173|FG002|Overall Study|Other|5|||
48668453|NCT00454649|156639174|FG003|Overall Study|Other|3|||
48668454|NCT00454649|156639175|FG004|Overall Study|Other|0|||
48668455|NCT00454649|156639176|FG005|Overall Study|Other|0|||
48668456|NCT00454649|156639177|FG006|Overall Study|Other|0|||
48668457|NCT00454649|156639178|FG007|Overall Study|Other|0|||
48668458|NCT00454649|156639179|FG008|Overall Study|Other|3|||
48668459|NCT00454649|156639180|FG009|Overall Study|Other|1|||
48668460|NCT00454649|156639171|FG000|Overall Study|Withdrawal by Subject|0|||
48668461|NCT00454649|156639172|FG001|Overall Study|Withdrawal by Subject|0|||
48668462|NCT00454649|156639173|FG002|Overall Study|Withdrawal by Subject|0|||
48668463|NCT00454649|156639174|FG003|Overall Study|Withdrawal by Subject|0|||
48668464|NCT00454649|156639175|FG004|Overall Study|Withdrawal by Subject|0|||
48668465|NCT00454649|156639176|FG005|Overall Study|Withdrawal by Subject|1|||
48668466|NCT00454649|156639177|FG006|Overall Study|Withdrawal by Subject|0|||
48668467|NCT00454649|156639178|FG007|Overall Study|Withdrawal by Subject|2|||
48668468|NCT00454649|156639179|FG008|Overall Study|Withdrawal by Subject|1|||
48668469|NCT00454649|156639180|FG009|Overall Study|Withdrawal by Subject|0|||
48668470|NCT02745535|156639182|FG000|Overall Study|Death|1|||
48668471|NCT02745535|156639182|FG000|Overall Study|Adverse Event|3|||
48668472|NCT02745535|156639182|FG000|Overall Study|Lost to Follow-up|2|||
48668473|NCT00459537|156639185|FG000|Overall Study|Adverse Event|1|||
48668474|NCT00459537|156639186|FG001|Overall Study|Adverse Event|6|||
48668475|NCT00459537|156639185|FG000|Overall Study|Lack of Efficacy|10|||
48668476|NCT00459537|156639186|FG001|Overall Study|Lack of Efficacy|11|||
48759118|NCT00695396|156966346|FG002|Overall Study|Study Closed Prematurely|8|||
48759119|NCT00695396|156966344|FG000|Overall Study|Withdrawal by Subject|2|||
48759120|NCT00695396|156966345|FG001|Overall Study|Withdrawal by Subject|2|||
48759121|NCT00695396|156966346|FG002|Overall Study|Withdrawal by Subject|0|||
48759122|NCT01086540|156966347|FG000|Overall Study|Death|3|||
48668477|NCT00459537|156639185|FG000|Overall Study|Withdrawal by Subject|20|||
48668478|NCT00459537|156639186|FG001|Overall Study|Withdrawal by Subject|26|||
48668479|NCT00459537|156639185|FG000|Overall Study|Lost to Follow-up|27|||
48668480|NCT00459537|156639186|FG001|Overall Study|Lost to Follow-up|30|||
48668481|NCT00459537|156639185|FG000|Overall Study|Administrative problems|3|||
48668482|NCT00459537|156639186|FG001|Overall Study|Administrative problems|0|||
48668483|NCT00459537|156639185|FG000|Overall Study|Protocol Violation|4|||
48668484|NCT00459537|156639186|FG001|Overall Study|Protocol Violation|3|||
48668485|NCT00459537|156639185|FG000|Overall Study|Missing|1|||
48668486|NCT00459537|156639186|FG001|Overall Study|Missing|0|||
48668487|NCT00637572|156639189|FG000|Overall Study|Adverse Event|1|||
48759123|NCT01086540|156966348|FG001|Overall Study|Death|1|||
48668488|NCT00637572|156639190|FG001|Overall Study|Adverse Event|2|||
48668489|NCT00637572|156639189|FG000|Overall Study|Death|0|||
48668490|NCT00637572|156639190|FG001|Overall Study|Death|1|||
48668491|NCT00637572|156639189|FG000|Overall Study|Lost to Follow-up|0|||
48668492|NCT00637572|156639190|FG001|Overall Study|Lost to Follow-up|1|||
48668493|NCT00637572|156639189|FG000|Overall Study|Physician Decision|1|||
48668494|NCT00637572|156639190|FG001|Overall Study|Physician Decision|1|||
48668495|NCT00637572|156639189|FG000|Overall Study|Withdrawal by Subject|0|||
48668496|NCT00637572|156639190|FG001|Overall Study|Withdrawal by Subject|2|||
48668497|NCT00637572|156639189|FG000|Overall Study|Illicit Drug Use|1|||
48668498|NCT00637572|156639190|FG001|Overall Study|Illicit Drug Use|0|||
48668499|NCT00896649|156639191|FG000|Overall Study|Physician Decision|1|||
48668500|NCT00896649|156639191|FG000|Overall Study|Pregnancy|1|||
48668501|NCT00896649|156639191|FG000|Overall Study|missing documentation|1|||
48668502|NCT00896649|156639191|FG000|Overall Study|technical difficulties|2|||
48668503|NCT04033068|156639192|FG000|Overall Study|Withdrawal by Subject|0|||
48668504|NCT04033068|156639193|FG001|Overall Study|Withdrawal by Subject|0|||
48668505|NCT04033068|156639194|FG002|Overall Study|Withdrawal by Subject|1|||
48668506|NCT04033068|156639195|FG003|Overall Study|Withdrawal by Subject|0|||
48668507|NCT04033068|156639192|FG000|Overall Study|Lost to Follow-up|0|||
48668508|NCT04033068|156639193|FG001|Overall Study|Lost to Follow-up|1|||
48668509|NCT04033068|156639194|FG002|Overall Study|Lost to Follow-up|0|||
48668510|NCT04033068|156639195|FG003|Overall Study|Lost to Follow-up|0|||
48668511|NCT04033068|156639192|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
48668512|NCT04033068|156639193|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
48668513|NCT04033068|156639194|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
48668514|NCT04033068|156639195|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
48668515|NCT01075984|156639196|FG000|Treatment Phase|Adverse Event|0|||
48668516|NCT01075984|156639197|FG001|Treatment Phase|Adverse Event|1|||
48668517|NCT01075984|156639198|FG002|Treatment Phase|Adverse Event|3|||
48668518|NCT01075984|156639199|FG003|Treatment Phase|Adverse Event|7|||
48668519|NCT01075984|156639200|FG004|Treatment Phase|Adverse Event|35|||
48668520|NCT01075984|156639196|FG000|Treatment Phase|Protocol Violation|0|||
48668521|NCT01075984|156639197|FG001|Treatment Phase|Protocol Violation|0|||
48668522|NCT01075984|156639198|FG002|Treatment Phase|Protocol Violation|1|||
48668523|NCT01075984|156639199|FG003|Treatment Phase|Protocol Violation|0|||
48668524|NCT01075984|156639200|FG004|Treatment Phase|Protocol Violation|3|||
48668525|NCT01075984|156639196|FG000|Treatment Phase|Withdrawal by Subject|0|||
48668526|NCT01075984|156639197|FG001|Treatment Phase|Withdrawal by Subject|0|||
48668527|NCT01075984|156639198|FG002|Treatment Phase|Withdrawal by Subject|2|||
48668528|NCT01075984|156639199|FG003|Treatment Phase|Withdrawal by Subject|0|||
48668529|NCT01075984|156639200|FG004|Treatment Phase|Withdrawal by Subject|15|||
48668530|NCT01075984|156639196|FG000|Treatment Phase|Treatment Failure|0|||
48668531|NCT01075984|156639197|FG001|Treatment Phase|Treatment Failure|0|||
48668532|NCT01075984|156639198|FG002|Treatment Phase|Treatment Failure|1|||
48668533|NCT01075984|156639199|FG003|Treatment Phase|Treatment Failure|0|||
48668534|NCT01075984|156639200|FG004|Treatment Phase|Treatment Failure|5|||
48668535|NCT01075984|156639196|FG000|Treatment Phase|Progression of disease|0|||
48668536|NCT01075984|156639197|FG001|Treatment Phase|Progression of disease|0|||
48668537|NCT01075984|156639198|FG002|Treatment Phase|Progression of disease|0|||
48668538|NCT01075984|156639199|FG003|Treatment Phase|Progression of disease|0|||
48668539|NCT01075984|156639200|FG004|Treatment Phase|Progression of disease|2|||
48668540|NCT01075984|156639196|FG000|Follow-up Phase|Protocol Violation|0|||
48668541|NCT01075984|156639197|FG001|Follow-up Phase|Protocol Violation|0|||
48668542|NCT01075984|156639198|FG002|Follow-up Phase|Protocol Violation|1|||
48668543|NCT01075984|156639199|FG003|Follow-up Phase|Protocol Violation|0|||
48668544|NCT01075984|156639200|FG004|Follow-up Phase|Protocol Violation|3|||
48668545|NCT01075984|156639196|FG000|Follow-up Phase|Adverse Event|0|||
48668546|NCT01075984|156639197|FG001|Follow-up Phase|Adverse Event|0|||
48668547|NCT01075984|156639198|FG002|Follow-up Phase|Adverse Event|0|||
48668548|NCT01075984|156639199|FG003|Follow-up Phase|Adverse Event|2|||
48668549|NCT01075984|156639200|FG004|Follow-up Phase|Adverse Event|27|||
48668550|NCT01075984|156639196|FG000|Follow-up Phase|Administrative|0|||
48668551|NCT01075984|156639197|FG001|Follow-up Phase|Administrative|0|||
48668552|NCT01075984|156639198|FG002|Follow-up Phase|Administrative|0|||
48668553|NCT01075984|156639199|FG003|Follow-up Phase|Administrative|0|||
48668554|NCT01075984|156639200|FG004|Follow-up Phase|Administrative|1|||
48668555|NCT01075984|156639196|FG000|Follow-up Phase|Withdrawal by Subject|0|||
48668556|NCT01075984|156639197|FG001|Follow-up Phase|Withdrawal by Subject|0|||
48668557|NCT01075984|156639198|FG002|Follow-up Phase|Withdrawal by Subject|0|||
48668558|NCT01075984|156639199|FG003|Follow-up Phase|Withdrawal by Subject|0|||
48668559|NCT01075984|156639200|FG004|Follow-up Phase|Withdrawal by Subject|10|||
48668560|NCT01075984|156639196|FG000|Follow-up Phase|Progression of disease|0|||
48668561|NCT01075984|156639197|FG001|Follow-up Phase|Progression of disease|0|||
48668562|NCT01075984|156639198|FG002|Follow-up Phase|Progression of disease|0|||
48668563|NCT01075984|156639199|FG003|Follow-up Phase|Progression of disease|0|||
48668564|NCT01075984|156639200|FG004|Follow-up Phase|Progression of disease|2|||
48668565|NCT01075984|156639196|FG000|Follow-up Phase|Treatment failure|0|||
48668566|NCT01075984|156639197|FG001|Follow-up Phase|Treatment failure|0|||
48668567|NCT01075984|156639198|FG002|Follow-up Phase|Treatment failure|0|||
48668568|NCT01075984|156639199|FG003|Follow-up Phase|Treatment failure|0|||
48668569|NCT01075984|156639200|FG004|Follow-up Phase|Treatment failure|4|||
48668570|NCT04232215|156639207|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48668571|NCT04232215|156639208|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
48668572|NCT02440789|156639212|FG000|Overall Study|Withdrawal by Subject|3|||
48668573|NCT02440789|156639212|FG000|Overall Study|Not willing to adhere to reqs|1|||
48668574|NCT01806064|156641329|FG000|Overall Study|Randomized Not Enrolled|0|||
48668575|NCT01806064|156641330|FG001|Overall Study|Randomized Not Enrolled|0|||
48668576|NCT01806064|156641331|FG002|Overall Study|Randomized Not Enrolled|0|||
48668577|NCT01806064|156641332|FG003|Overall Study|Randomized Not Enrolled|1|||
48668578|NCT01806064|156641333|FG004|Overall Study|Randomized Not Enrolled|2|||
48668579|NCT02559414|156641335|FG000|Overall Study|Lost to Follow-up|0|||
48668580|NCT02559414|156641336|FG001|Overall Study|Lost to Follow-up|1|||
48668581|NCT02559414|156641337|FG002|Overall Study|Lost to Follow-up|0|||
48668582|NCT02559414|156641335|FG000|Overall Study|Withdrawal by Subject|1|||
48668583|NCT02559414|156641336|FG001|Overall Study|Withdrawal by Subject|0|||
48668584|NCT02559414|156641337|FG002|Overall Study|Withdrawal by Subject|1|||
48668585|NCT02559414|156641335|FG000|Overall Study|Other|0|||
48668586|NCT02559414|156641336|FG001|Overall Study|Other|1|||
48668587|NCT02559414|156641337|FG002|Overall Study|Other|1|||
48668588|NCT00440310|156641345|FG000|Overall Study|Lost to Follow-up|4|||
48668589|NCT00440310|156641346|FG001|Overall Study|Lost to Follow-up|5|||
48668590|NCT00440310|156641345|FG000|Overall Study|Protocol Violation|0|||
48668591|NCT00440310|156641346|FG001|Overall Study|Protocol Violation|1|||
48668592|NCT00440310|156641345|FG000|Overall Study|Withdrawal by Subject|15|||
48668593|NCT00440310|156641346|FG001|Overall Study|Withdrawal by Subject|14|||
48668594|NCT00440310|156641345|FG000|Overall Study|No Reply at EOS|7|||
48668595|NCT00440310|156641346|FG001|Overall Study|No Reply at EOS|7|||
48668596|NCT00440310|156641345|FG000|Overall Study|Other|1|||
48668597|NCT00440310|156641346|FG001|Overall Study|Other|0|||
48668598|NCT00440310|156641345|FG000|Overall Study|Status Unknown|1|||
48428239|NCT02531373|155756506|FG008|Overall Study|Protocol Violation|1|||
48668599|NCT00440310|156641346|FG001|Overall Study|Status Unknown|3|||
48668600|NCT00680368|156641347|FG000|Overall Study|not supervised, not eligible|15|||
48668601|NCT01300351|156641348|FG000|Overall Study|Did not receive treatment|2|||
48668602|NCT01300351|156641349|FG001|Overall Study|Did not receive treatment|0|||
48668603|NCT01300351|156641348|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
48668604|NCT01300351|156641349|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
48668605|NCT01300351|156641348|FG000|Overall Study|Lost to Follow-up|0|||
48668606|NCT01300351|156641349|FG001|Overall Study|Lost to Follow-up|1|||
48668607|NCT01300351|156641348|FG000|Overall Study|Adverse Event|0|||
48668608|NCT01300351|156641349|FG001|Overall Study|Adverse Event|4|||
48668609|NCT01300351|156641348|FG000|Overall Study|Withdrawal by Subject|7|||
48668610|NCT01300351|156641349|FG001|Overall Study|Withdrawal by Subject|10|||
48668611|NCT02677844|156641350|FG000|Period 3|Withdrawal by Subject|0|||
48668612|NCT02677844|156641351|FG001|Period 3|Withdrawal by Subject|0|||
48668613|NCT02677844|156641352|FG002|Period 3|Withdrawal by Subject|0|||
48668614|NCT02677844|156641353|FG003|Period 3|Withdrawal by Subject|1|||
48668615|NCT02677844|156641354|FG004|Period 3|Withdrawal by Subject|0|||
48668616|NCT02677844|156641355|FG005|Period 3|Withdrawal by Subject|0|||
48668617|NCT02677844|156641356|FG006|Period 3|Withdrawal by Subject|0|||
48668618|NCT02230683|156641357|FG000|Overall Study|Adverse Event|1|||
48668619|NCT00096018|156641359|FG000|Overall Study|Became Ineligible (not treated)|0|||
48668620|NCT00096018|156641360|FG001|Overall Study|Became Ineligible (not treated)|3|||
48668621|NCT00096018|156641359|FG000|Overall Study|Miscellaneous (not treated)|0|||
48668622|NCT00096018|156641360|FG001|Overall Study|Miscellaneous (not treated)|2|||
48668623|NCT00096018|156641359|FG000|Overall Study|Adverse Event|0|||
48668624|NCT00096018|156641360|FG001|Overall Study|Adverse Event|5|||
48668625|NCT00096018|156641359|FG000|Overall Study|Death|0|||
48668626|NCT00096018|156641360|FG001|Overall Study|Death|1|||
48668627|NCT00096018|156641359|FG000|Overall Study|Withdrawal by Subject|0|||
48668628|NCT00096018|156641360|FG001|Overall Study|Withdrawal by Subject|2|||
48668629|NCT00096018|156641359|FG000|Overall Study|Miscellaneous|2|||
48668630|NCT00096018|156641360|FG001|Overall Study|Miscellaneous|1|||
48668631|NCT02266875|156641361|FG000|Overall Study|Withdrawal by Subject|9|||
48668632|NCT02266875|156641362|FG001|Overall Study|Withdrawal by Subject|0|||
48668633|NCT02266875|156641361|FG000|Overall Study|Lost to Follow-up|2|||
48668634|NCT02266875|156641362|FG001|Overall Study|Lost to Follow-up|0|||
48668635|NCT01554514|156641365|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
48668636|NCT01554514|156641365|FG000|Overall Study|Physician Decision|1|||
48668637|NCT01030874|156641366|FG000|Overall Study|Withdrawal by Subject|1|||
48668638|NCT01030874|156641367|FG001|Overall Study|Withdrawal by Subject|0|||
48668639|NCT01030874|156641366|FG000|Overall Study|Discharged in first 2 weeks|17|||
48668640|NCT01030874|156641367|FG001|Overall Study|Discharged in first 2 weeks|16|||
48668641|NCT02299076|156641368|FG000|Overall Study|Fraudulent Entries|20|||
48668642|NCT02299076|156641369|FG001|Overall Study|Fraudulent Entries|14|||
48668643|NCT00549770|156641370|FG000|Overall Study|Protocol deviation|1|||
48668644|NCT00549770|156641371|FG001|Overall Study|Protocol deviation|1|||
48668645|NCT00549770|156641372|FG002|Overall Study|Protocol deviation|1|||
48668646|NCT00549770|156641373|FG003|Overall Study|Protocol deviation|2|||
48668647|NCT00549770|156641374|FG004|Overall Study|Protocol deviation|2|||
48668648|NCT00549770|156641375|FG005|Overall Study|Protocol deviation|2|||
48668649|NCT00549770|156641376|FG006|Overall Study|Protocol deviation|1|||
48668650|NCT00549770|156641377|FG007|Overall Study|Protocol deviation|2|||
48668651|NCT00549770|156641370|FG000|Overall Study|Administrative problems|0|||
48668652|NCT00549770|156641371|FG001|Overall Study|Administrative problems|1|||
48668653|NCT00549770|156641372|FG002|Overall Study|Administrative problems|0|||
48668654|NCT00549770|156641373|FG003|Overall Study|Administrative problems|0|||
48668655|NCT00549770|156641374|FG004|Overall Study|Administrative problems|0|||
48668656|NCT00549770|156641375|FG005|Overall Study|Administrative problems|0|||
48668657|NCT00549770|156641376|FG006|Overall Study|Administrative problems|0|||
48668658|NCT00549770|156641377|FG007|Overall Study|Administrative problems|1|||
48668659|NCT00549770|156641370|FG000|Overall Study|Lost to Follow-up|0|||
48668660|NCT00549770|156641371|FG001|Overall Study|Lost to Follow-up|0|||
48668661|NCT00549770|156641372|FG002|Overall Study|Lost to Follow-up|2|||
48668662|NCT00549770|156641373|FG003|Overall Study|Lost to Follow-up|2|||
48668663|NCT00549770|156641374|FG004|Overall Study|Lost to Follow-up|3|||
48668664|NCT00549770|156641375|FG005|Overall Study|Lost to Follow-up|2|||
48668665|NCT00549770|156641376|FG006|Overall Study|Lost to Follow-up|0|||
48668666|NCT00549770|156641377|FG007|Overall Study|Lost to Follow-up|0|||
48668667|NCT00549770|156641370|FG000|Overall Study|Withdrawal by Subject|4|||
48668668|NCT00549770|156641371|FG001|Overall Study|Withdrawal by Subject|6|||
48668669|NCT00549770|156641372|FG002|Overall Study|Withdrawal by Subject|4|||
48668670|NCT00549770|156641373|FG003|Overall Study|Withdrawal by Subject|5|||
48668671|NCT00549770|156641374|FG004|Overall Study|Withdrawal by Subject|6|||
48668672|NCT00549770|156641375|FG005|Overall Study|Withdrawal by Subject|6|||
48668673|NCT00549770|156641376|FG006|Overall Study|Withdrawal by Subject|4|||
48668674|NCT00549770|156641377|FG007|Overall Study|Withdrawal by Subject|9|||
48668675|NCT00549770|156641370|FG000|Overall Study|Lack of Efficacy|1|||
48668676|NCT00549770|156641371|FG001|Overall Study|Lack of Efficacy|0|||
48668677|NCT00549770|156641372|FG002|Overall Study|Lack of Efficacy|2|||
48668678|NCT00549770|156641373|FG003|Overall Study|Lack of Efficacy|3|||
48668679|NCT00549770|156641374|FG004|Overall Study|Lack of Efficacy|5|||
48668680|NCT00549770|156641375|FG005|Overall Study|Lack of Efficacy|1|||
48668681|NCT00549770|156641376|FG006|Overall Study|Lack of Efficacy|3|||
48668682|NCT00549770|156641377|FG007|Overall Study|Lack of Efficacy|8|||
48668683|NCT00549770|156641370|FG000|Overall Study|Abnormal test procedure results|0|||
48668684|NCT00549770|156641371|FG001|Overall Study|Abnormal test procedure results|0|||
48668685|NCT00549770|156641372|FG002|Overall Study|Abnormal test procedure results|0|||
48668686|NCT00549770|156641373|FG003|Overall Study|Abnormal test procedure results|2|||
48668687|NCT00549770|156641374|FG004|Overall Study|Abnormal test procedure results|0|||
48668688|NCT00549770|156641375|FG005|Overall Study|Abnormal test procedure results|1|||
48668689|NCT00549770|156641376|FG006|Overall Study|Abnormal test procedure results|1|||
48668690|NCT00549770|156641377|FG007|Overall Study|Abnormal test procedure results|1|||
48668691|NCT00549770|156641370|FG000|Overall Study|Abnormal laboratory values|0|||
48668692|NCT00549770|156641371|FG001|Overall Study|Abnormal laboratory values|0|||
48668693|NCT00549770|156641372|FG002|Overall Study|Abnormal laboratory values|0|||
48668694|NCT00549770|156641373|FG003|Overall Study|Abnormal laboratory values|0|||
48668695|NCT00549770|156641374|FG004|Overall Study|Abnormal laboratory values|0|||
48668696|NCT00549770|156641375|FG005|Overall Study|Abnormal laboratory values|1|||
48668697|NCT00549770|156641376|FG006|Overall Study|Abnormal laboratory values|0|||
48668698|NCT00549770|156641377|FG007|Overall Study|Abnormal laboratory values|0|||
48668699|NCT00549770|156641370|FG000|Overall Study|Adverse Event|1|||
48668700|NCT00549770|156641371|FG001|Overall Study|Adverse Event|3|||
48668701|NCT00549770|156641372|FG002|Overall Study|Adverse Event|1|||
48668702|NCT00549770|156641373|FG003|Overall Study|Adverse Event|2|||
48668703|NCT00549770|156641374|FG004|Overall Study|Adverse Event|1|||
48668704|NCT00549770|156641375|FG005|Overall Study|Adverse Event|0|||
48759124|NCT01086540|156966347|FG000|Overall Study|Physician Decision|2|||
48759125|NCT01086540|156966348|FG001|Overall Study|Physician Decision|1|||
48759126|NCT01086540|156966347|FG000|Overall Study|Addition of new therapy for PAH|1|||
48759127|NCT01086540|156966348|FG001|Overall Study|Addition of new therapy for PAH|0|||
48759128|NCT00333866|156966351|FG000|Overall Study|Adverse Event|23|||
48759129|NCT00333866|156966352|FG001|Overall Study|Adverse Event|37|||
48759130|NCT00333866|156966353|FG002|Overall Study|Adverse Event|38|||
48759131|NCT00333866|156966354|FG003|Overall Study|Adverse Event|47|||
48759132|NCT00333866|156966351|FG000|Overall Study|Other|3|||
48759133|NCT00333866|156966352|FG001|Overall Study|Other|2|||
48759134|NCT00333866|156966353|FG002|Overall Study|Other|2|||
48759135|NCT00333866|156966354|FG003|Overall Study|Other|2|||
48759136|NCT00333866|156966351|FG000|Overall Study|Lack of Efficacy|8|||
48759137|NCT00333866|156966352|FG001|Overall Study|Lack of Efficacy|6|||
48759138|NCT00333866|156966353|FG002|Overall Study|Lack of Efficacy|3|||
48759139|NCT00333866|156966354|FG003|Overall Study|Lack of Efficacy|5|||
48759140|NCT00333866|156966351|FG000|Overall Study|Lost to Follow-up|1|||
48759141|NCT00333866|156966352|FG001|Overall Study|Lost to Follow-up|2|||
48759142|NCT00333866|156966353|FG002|Overall Study|Lost to Follow-up|2|||
48759143|NCT00333866|156966354|FG003|Overall Study|Lost to Follow-up|2|||
48759144|NCT00333866|156966351|FG000|Overall Study|Withdrawal by Subject|8|||
48759145|NCT00333866|156966352|FG001|Overall Study|Withdrawal by Subject|14|||
48759146|NCT00333866|156966353|FG002|Overall Study|Withdrawal by Subject|4|||
48759147|NCT00333866|156966354|FG003|Overall Study|Withdrawal by Subject|9|||
48759148|NCT00333866|156966351|FG000|Overall Study|Randomized but not Treated|5|||
48759149|NCT00333866|156966352|FG001|Overall Study|Randomized but not Treated|3|||
48759150|NCT00333866|156966353|FG002|Overall Study|Randomized but not Treated|2|||
48668705|NCT00549770|156641376|FG006|Overall Study|Adverse Event|5|||
48668706|NCT00549770|156641377|FG007|Overall Study|Adverse Event|4|||
48668707|NCT00357656|156641382|FG000|Overall Study|Other, No surgery performed|0|||
48668708|NCT00357656|156641383|FG001|Overall Study|Other, No surgery performed|3|||
48668709|NCT00685373|156641386|FG000|Overall Study|Adverse Event|3|||
48668710|NCT00685373|156641386|FG000|Overall Study|Withdrawal by Subject|5|||
48668711|NCT00685373|156641386|FG000|Overall Study|Lack of Efficacy|3|||
48668712|NCT00685373|156641386|FG000|Overall Study|Condition no longer requires study drug|1|||
48668713|NCT00685373|156641386|FG000|Overall Study|Lost to Follow-up|2|||
48759151|NCT00333866|156966354|FG003|Overall Study|Randomized but not Treated|1|||
48759152|NCT02956486|156966355|FG000|Core Phase|Adverse Event|51|||
48759153|NCT02956486|156966356|FG001|Core Phase|Adverse Event|88|||
48759154|NCT02956486|156966357|FG002|Core Phase|Adverse Event|0|||
48759155|NCT02956486|156966355|FG000|Core Phase|Lost to Follow-up|8|||
48668714|NCT00685373|156641386|FG000|Overall Study|Protocol Violation|1|||
48668715|NCT02758301|156641387|FG000|Overall Study|Death|12|||
48668716|NCT02758301|156641388|FG001|Overall Study|Death|0|||
48668717|NCT02758301|156641387|FG000|Overall Study|Physician Decision|10|||
48759156|NCT02956486|156966356|FG001|Core Phase|Lost to Follow-up|6|||
48759157|NCT02956486|156966357|FG002|Core Phase|Lost to Follow-up|0|||
48759158|NCT02956486|156966355|FG000|Core Phase|Inadequate therapeutic effect|4|||
48668718|NCT02758301|156641388|FG001|Overall Study|Physician Decision|1|||
48668719|NCT02758301|156641387|FG000|Overall Study|Withdrawal by Subject|5|||
48668720|NCT02758301|156641388|FG001|Overall Study|Withdrawal by Subject|6|||
48342410|NCT00111839|155449195|FG000|Overall Study|Randomized but Not Treated|0|||
48342411|NCT00111839|155449196|FG001|Overall Study|Randomized but Not Treated|0|||
48342412|NCT00111839|155449197|FG002|Overall Study|Randomized but Not Treated|2|||
48342413|NCT02186015|155449203|FG000|Overall Study|Physician Decision|1|||
48342414|NCT02186015|155449204|FG001|Overall Study|Physician Decision|0|||
48342415|NCT00907517|155449205|FG000|Overall Study|Progressive Disease|3|||
48668721|NCT02758301|156641387|FG000|Overall Study|Lost to Follow-up|7|||
48668722|NCT02758301|156641388|FG001|Overall Study|Lost to Follow-up|0|||
48668723|NCT02758301|156641387|FG000|Overall Study|Protocol Violation|0|||
48668724|NCT02758301|156641388|FG001|Overall Study|Protocol Violation|1|||
48668725|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
48342416|NCT00907517|155449206|FG001|Overall Study|Progressive Disease|3|||
48342417|NCT00907517|155449207|FG002|Overall Study|Progressive Disease|4|||
48342418|NCT00907517|155449208|FG003|Overall Study|Progressive Disease|4|||
48342419|NCT00907517|155449209|FG004|Overall Study|Progressive Disease|4|||
48342420|NCT00907517|155449205|FG000|Overall Study|Symptomatic Deterioration|0|||
48342421|NCT00907517|155449206|FG001|Overall Study|Symptomatic Deterioration|0|||
48342422|NCT00907517|155449207|FG002|Overall Study|Symptomatic Deterioration|0|||
48342423|NCT00907517|155449208|FG003|Overall Study|Symptomatic Deterioration|0|||
48668726|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
48668727|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
48668728|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
48668729|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
48668730|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
48668731|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
48668732|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
48668733|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
48668734|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
48668735|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
48668736|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
48668737|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
48668738|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
48668739|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
48759159|NCT02956486|156966356|FG001|Core Phase|Inadequate therapeutic effect|5|||
48759160|NCT02956486|156966357|FG002|Core Phase|Inadequate therapeutic effect|0|||
48759161|NCT02956486|156966355|FG000|Core Phase|Withdrawal by Subject|101|||
48759162|NCT02956486|156966356|FG001|Core Phase|Withdrawal by Subject|104|||
48759163|NCT02956486|156966357|FG002|Core Phase|Withdrawal by Subject|0|||
48759164|NCT02956486|156966355|FG000|Core Phase|Study terminated by sponsor|888|||
48668740|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
48668741|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
48668742|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
48668743|NCT01302054|156641389|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
48668744|NCT01302054|156641390|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
48668745|NCT01302054|156641391|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
48668746|NCT01302054|156641389|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
48668747|NCT01302054|156641390|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
48668748|NCT01302054|156641391|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
48668749|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48668750|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
48668751|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
48668752|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48668753|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
48668754|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48668755|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48668756|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
48668757|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
48668758|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
48668759|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
48668760|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
48668761|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48668762|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
48668763|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
48668764|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
48668765|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
48759165|NCT02956486|156966356|FG001|Core Phase|Study terminated by sponsor|848|||
48759166|NCT02956486|156966357|FG002|Core Phase|Study terminated by sponsor|0|||
48759167|NCT02956486|156966355|FG000|Core Phase|Other|27|||
48759168|NCT02956486|156966356|FG001|Core Phase|Other|18|||
48759169|NCT02956486|156966357|FG002|Core Phase|Other|0|||
48759170|NCT02956486|156966355|FG000|Core Phase|Not treated|0|||
48759171|NCT02956486|156966356|FG001|Core Phase|Not treated|3|||
48668766|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
48668767|NCT01302054|156641389|FG000|Double-Blind Treatment Phase|Other|0|||
48668768|NCT01302054|156641390|FG001|Double-Blind Treatment Phase|Other|4|||
48668769|NCT01302054|156641391|FG002|Double-Blind Treatment Phase|Other|9|||
48668770|NCT02713867|156641392|FG000|Randomization|Other Reason|2|||
48759172|NCT02956486|156966357|FG002|Core Phase|Not treated|0|||
48759173|NCT02956486|156966355|FG000|Extension Phase|Adverse Event|0|||
48759174|NCT02956486|156966356|FG001|Extension Phase|Adverse Event|0|||
48759175|NCT02956486|156966357|FG002|Extension Phase|Adverse Event|2|||
48668771|NCT02713867|156641393|FG001|Randomization|Other Reason|1|||
48668772|NCT02713867|156641392|FG000|Randomization|Participant Withdrew consent|0|||
48668773|NCT02713867|156641393|FG001|Randomization|Participant Withdrew consent|2|||
48668774|NCT02713867|156641392|FG000|Treatment Period|Other Reasons|22|||
48668775|NCT02713867|156641393|FG001|Treatment Period|Other Reasons|28|||
48668776|NCT02713867|156641392|FG000|Treatment Period|Administrative reason by sponsor|21|||
48668777|NCT02713867|156641393|FG001|Treatment Period|Administrative reason by sponsor|16|||
48668778|NCT02713867|156641392|FG000|Treatment Period|No longer meets study criteria|2|||
48668779|NCT02713867|156641393|FG001|Treatment Period|No longer meets study criteria|1|||
48668780|NCT02713867|156641392|FG000|Treatment Period|Poor/Non Compliance|1|||
48668781|NCT02713867|156641393|FG001|Treatment Period|Poor/Non Compliance|0|||
48668782|NCT02713867|156641392|FG000|Treatment Period|Maximum Clinical Benefit|5|||
48668783|NCT02713867|156641393|FG001|Treatment Period|Maximum Clinical Benefit|6|||
48668784|NCT02713867|156641392|FG000|Treatment Period|Withdrew consent|3|||
48668785|NCT02713867|156641393|FG001|Treatment Period|Withdrew consent|6|||
48668786|NCT02713867|156641392|FG000|Treatment Period|Requested to Discontinue|8|||
48668787|NCT02713867|156641393|FG001|Treatment Period|Requested to Discontinue|8|||
48668788|NCT02713867|156641392|FG000|Treatment Period|AE unrelated to Study Drug|11|||
48668789|NCT02713867|156641393|FG001|Treatment Period|AE unrelated to Study Drug|10|||
48668790|NCT02713867|156641392|FG000|Treatment Period|Death|7|||
48668791|NCT02713867|156641393|FG001|Treatment Period|Death|3|||
48668792|NCT02713867|156641392|FG000|Treatment Period|Study Drug Toxicity|16|||
48668793|NCT02713867|156641393|FG001|Treatment Period|Study Drug Toxicity|19|||
48668794|NCT02713867|156641392|FG000|Treatment Period|Disease Progression|82|||
48668795|NCT02713867|156641393|FG001|Treatment Period|Disease Progression|83|||
48668796|NCT02855944|156641396|FG000|Period 1: Treatment|Ongoing|14|||
48668797|NCT02855944|156641397|FG001|Period 1: Treatment|Ongoing|0|||
48668798|NCT02855944|156641396|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
48668799|NCT02855944|156641397|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
48668800|NCT02855944|156641396|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
48668801|NCT02855944|156641397|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
48668802|NCT02250664|156641398|FG000|Overall Study|Lost to Follow-up|18|||
48668803|NCT02250664|156641399|FG001|Overall Study|Lost to Follow-up|28|||
48668804|NCT02250664|156641400|FG002|Overall Study|Lost to Follow-up|33|||
48668805|NCT02250664|156641398|FG000|Overall Study|Personal Reasons|7|||
48668806|NCT02250664|156641399|FG001|Overall Study|Personal Reasons|8|||
48668807|NCT02250664|156641400|FG002|Overall Study|Personal Reasons|14|||
48668808|NCT02250664|156641398|FG000|Overall Study|Adverse Event|6|||
48668809|NCT02250664|156641399|FG001|Overall Study|Adverse Event|3|||
48668810|NCT02250664|156641400|FG002|Overall Study|Adverse Event|8|||
48668811|NCT02250664|156641398|FG000|Overall Study|Incarcerated|2|||
48668812|NCT02250664|156641399|FG001|Overall Study|Incarcerated|1|||
48668813|NCT02250664|156641400|FG002|Overall Study|Incarcerated|2|||
48668814|NCT02250664|156641398|FG000|Overall Study|Withdrawal by Subject|0|||
48668815|NCT02250664|156641399|FG001|Overall Study|Withdrawal by Subject|1|||
48668816|NCT02250664|156641400|FG002|Overall Study|Withdrawal by Subject|2|||
48668817|NCT02250664|156641398|FG000|Overall Study|Death|0|||
48668818|NCT02250664|156641399|FG001|Overall Study|Death|1|||
48668819|NCT02250664|156641400|FG002|Overall Study|Death|1|||
48668820|NCT02250664|156641398|FG000|Overall Study|Physician Decision|1|||
48668821|NCT02250664|156641399|FG001|Overall Study|Physician Decision|3|||
48668822|NCT02250664|156641400|FG002|Overall Study|Physician Decision|1|||
48668823|NCT02250664|156641398|FG000|Overall Study|Protocol Violation|1|||
48668824|NCT02250664|156641399|FG001|Overall Study|Protocol Violation|0|||
48668825|NCT02250664|156641400|FG002|Overall Study|Protocol Violation|1|||
48668826|NCT02250664|156641398|FG000|Overall Study|Reason unknown|1|||
48668827|NCT02250664|156641399|FG001|Overall Study|Reason unknown|0|||
48668828|NCT02250664|156641400|FG002|Overall Study|Reason unknown|0|||
48668829|NCT01369680|156641401|FG000|Overall Study|Lost to Follow-up|0|||
48668830|NCT01369680|156641402|FG001|Overall Study|Lost to Follow-up|0|||
48668831|NCT01369680|156641403|FG002|Overall Study|Lost to Follow-up|1|||
48668832|NCT01369680|156641404|FG003|Overall Study|Lost to Follow-up|2|||
48668833|NCT02391961|156641405|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
48668834|NCT02391961|156641406|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
48668835|NCT02391961|156641405|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
48668836|NCT02391961|156641406|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
48668837|NCT02391961|156641405|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48668838|NCT02391961|156641406|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48668839|NCT00514020|156641407|FG000|Overall Study|Adverse Event|6|||
48668840|NCT00514020|156641407|FG000|Overall Study|Withdrawal by Subject|3|||
48668841|NCT00514020|156641407|FG000|Overall Study|Physician Decision|1|||
48668842|NCT00514020|156641407|FG000|Overall Study|disease progression|9|||
48668843|NCT00514020|156641407|FG000|Overall Study|other complicating disease|2|||
48668844|NCT00514020|156641407|FG000|Overall Study|patient went to radiation treatment|1|||
48668845|NCT00514020|156641407|FG000|Overall Study|"patients moved to the no tx group"|6|||
48668846|NCT02308488|156641411|FG000|Overall Study|Withdrawal by Subject|2|||
48668847|NCT02723175|156641412|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
48668848|NCT02723175|156641413|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
48668849|NCT02723175|156641412|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
48668850|NCT02723175|156641413|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
48668851|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
48668852|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
48668853|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
48668854|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
48668855|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
48668856|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
48668857|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668858|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668859|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668860|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668861|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
48668862|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
48668863|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
48668864|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
48668865|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668866|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
48668867|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
48668868|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668869|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668870|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48759176|NCT02956486|156966355|FG000|Extension Phase|Study terminated by sponsor|0|||
48759177|NCT02956486|156966356|FG001|Extension Phase|Study terminated by sponsor|0|||
48759178|NCT02956486|156966357|FG002|Extension Phase|Study terminated by sponsor|16|||
48759179|NCT02956486|156966355|FG000|Extension Phase|Not Treated|0|||
48759180|NCT02956486|156966356|FG001|Extension Phase|Not Treated|0|||
48759181|NCT02956486|156966357|FG002|Extension Phase|Not Treated|1|||
48759182|NCT00720057|156966358|FG000|Overall Study|Lost to Follow-up|0|||
48759183|NCT00720057|156966359|FG001|Overall Study|Lost to Follow-up|2|||
48759184|NCT00720057|156966358|FG000|Overall Study|Protocol Violation|1|||
48759185|NCT00720057|156966359|FG001|Overall Study|Protocol Violation|0|||
48759186|NCT00720057|156966358|FG000|Overall Study|Withdrawal by Subject|0|||
48759187|NCT00720057|156966359|FG001|Overall Study|Withdrawal by Subject|1|||
48759188|NCT02062879|156966372|FG000|Overall Study|Withdrawal by Subject|4|||
48759189|NCT02062879|156966373|FG001|Overall Study|Withdrawal by Subject|1|||
48759190|NCT00322842|156966374|FG000|Overall Study|Withdrawal by Subject|0|||
48759191|NCT00322842|156966375|FG001|Overall Study|Withdrawal by Subject|1|||
48759192|NCT00322842|156966374|FG000|Overall Study|Lost to Follow-up|0|||
48759193|NCT00322842|156966375|FG001|Overall Study|Lost to Follow-up|1|||
48759194|NCT00322842|156966374|FG000|Overall Study|Refused transplant|1|||
48342424|NCT00907517|155449209|FG004|Overall Study|Symptomatic Deterioration|1|||
48759195|NCT00322842|156966375|FG001|Overall Study|Refused transplant|0|||
48759196|NCT00322842|156966374|FG000|Overall Study|Death|1|||
48759197|NCT00322842|156966375|FG001|Overall Study|Death|0|||
48668871|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668872|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
48668873|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668874|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
48668875|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
48668876|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
48668877|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
48668878|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
48668879|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668880|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668881|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48759198|NCT01412021|156966376|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
48759199|NCT01412021|156966376|FG000|Overall Study|Treatment Prior to Approval|3|||
48759200|NCT01412021|156966376|FG000|Overall Study|Transferred to Other Hospital|9|||
48759201|NCT02221284|156966377|FG000|Overall Study|Case Report Forms Uncollected|56|||
48759202|NCT02221284|156966377|FG000|Overall Study|Protocol Deviation|5|||
48759203|NCT01466387|156966378|FG000|Overall Study|Adverse Event|0|||
48759204|NCT01466387|156966379|FG001|Overall Study|Adverse Event|0|||
48759205|NCT01466387|156966380|FG002|Overall Study|Adverse Event|1|||
48759206|NCT01466387|156966381|FG003|Overall Study|Adverse Event|1|||
48759207|NCT01466387|156966382|FG004|Overall Study|Adverse Event|0|||
48759208|NCT01466387|156966383|FG005|Overall Study|Adverse Event|0|||
48759209|NCT01466387|156966378|FG000|Overall Study|Lost to Follow-up|0|||
48759210|NCT01466387|156966379|FG001|Overall Study|Lost to Follow-up|0|||
48759211|NCT01466387|156966380|FG002|Overall Study|Lost to Follow-up|0|||
48759212|NCT01466387|156966381|FG003|Overall Study|Lost to Follow-up|0|||
48759213|NCT01466387|156966382|FG004|Overall Study|Lost to Follow-up|0|||
48759214|NCT01466387|156966383|FG005|Overall Study|Lost to Follow-up|1|||
48759215|NCT01466387|156966378|FG000|Overall Study|Protocol Violation|1|||
48759216|NCT01466387|156966379|FG001|Overall Study|Protocol Violation|0|||
48759217|NCT01466387|156966380|FG002|Overall Study|Protocol Violation|0|||
48759218|NCT01466387|156966381|FG003|Overall Study|Protocol Violation|1|||
48759219|NCT01466387|156966382|FG004|Overall Study|Protocol Violation|0|||
48759220|NCT01466387|156966383|FG005|Overall Study|Protocol Violation|0|||
48759221|NCT01675128|156966384|FG000|Overall Study|Disease progression on study|1|||
48759222|NCT01675128|156966385|FG001|Overall Study|Disease progression on study|1|||
48759223|NCT01675128|156966386|FG002|Overall Study|Disease progression on study|1|||
48759224|NCT01675128|156966384|FG000|Overall Study|Refused further treatment|1|||
48759225|NCT01675128|156966385|FG001|Overall Study|Refused further treatment|0|||
48759226|NCT01675128|156966386|FG002|Overall Study|Refused further treatment|0|||
48759227|NCT01675128|156966384|FG000|Overall Study|Pulmonary complication; off study|0|||
48759228|NCT01675128|156966385|FG001|Overall Study|Pulmonary complication; off study|1|||
48759229|NCT01675128|156966386|FG002|Overall Study|Pulmonary complication; off study|0|||
48759230|NCT00945009|156966387|FG000|Overall Study|Lack of Efficacy|10|||
48759231|NCT00945009|156966388|FG001|Overall Study|Lack of Efficacy|0|||
48759232|NCT00945009|156966389|FG002|Overall Study|Lack of Efficacy|0|||
48759233|NCT00945009|156966387|FG000|Overall Study|Physician Decision|21|||
48759234|NCT00945009|156966388|FG001|Overall Study|Physician Decision|4|||
48759235|NCT00945009|156966389|FG002|Overall Study|Physician Decision|3|||
48759236|NCT00945009|156966387|FG000|Overall Study|Protocol Violation|6|||
48759237|NCT00945009|156966388|FG001|Overall Study|Protocol Violation|1|||
48759238|NCT00945009|156966389|FG002|Overall Study|Protocol Violation|0|||
48759239|NCT00945009|156966387|FG000|Overall Study|Withdrawal by Subject|1|||
48759240|NCT00945009|156966388|FG001|Overall Study|Withdrawal by Subject|0|||
48759241|NCT00945009|156966389|FG002|Overall Study|Withdrawal by Subject|0|||
48759242|NCT00945009|156966387|FG000|Overall Study|Ineligible|6|||
48759243|NCT00945009|156966388|FG001|Overall Study|Ineligible|1|||
48759244|NCT00945009|156966389|FG002|Overall Study|Ineligible|0|||
48759245|NCT00945009|156966387|FG000|Overall Study|Inevaluable|0|||
48759246|NCT00945009|156966388|FG001|Overall Study|Inevaluable|1|||
48759247|NCT00945009|156966389|FG002|Overall Study|Inevaluable|0|||
48759248|NCT00945009|156966387|FG000|Overall Study|Refusal of further protocol|1|||
48759249|NCT00945009|156966388|FG001|Overall Study|Refusal of further protocol|0|||
48759250|NCT00945009|156966389|FG002|Overall Study|Refusal of further protocol|0|||
48759251|NCT00832585|156966390|FG000|Overall Study|Withdrawal by Subject|1|||
48759252|NCT00832585|156966390|FG000|Overall Study|Lost to Follow-up|1|||
48759253|NCT03560531|156966391|FG000|Overall Study|Death|4|||
48759254|NCT03560531|156966392|FG001|Overall Study|Death|1|||
48759255|NCT03560531|156966393|FG002|Overall Study|Death|1|||
48759256|NCT03560531|156966394|FG003|Overall Study|Death|2|||
48759257|NCT03560531|156966395|FG004|Overall Study|Death|6|||
48759258|NCT03560531|156966396|FG005|Overall Study|Death|1|||
48759259|NCT03560531|156966397|FG006|Overall Study|Death|4|||
48759260|NCT03560531|156966398|FG007|Overall Study|Death|8|||
48759261|NCT03560531|156966399|FG008|Overall Study|Death|1|||
48759262|NCT03560531|156966400|FG009|Overall Study|Death|3|||
48759263|NCT03560531|156966401|FG010|Overall Study|Death|2|||
48759264|NCT03560531|156966402|FG011|Overall Study|Death|0|||
48759265|NCT03560531|156966403|FG012|Overall Study|Death|4|||
48759266|NCT03560531|156966404|FG013|Overall Study|Death|1|||
48759267|NCT03560531|156966391|FG000|Overall Study|Lost to Follow-up|1|||
48759268|NCT03560531|156966392|FG001|Overall Study|Lost to Follow-up|1|||
48759269|NCT03560531|156966393|FG002|Overall Study|Lost to Follow-up|0|||
48759270|NCT03560531|156966394|FG003|Overall Study|Lost to Follow-up|0|||
48759271|NCT03560531|156966395|FG004|Overall Study|Lost to Follow-up|0|||
48759272|NCT03560531|156966396|FG005|Overall Study|Lost to Follow-up|0|||
48759273|NCT03560531|156966397|FG006|Overall Study|Lost to Follow-up|1|||
48759274|NCT03560531|156966398|FG007|Overall Study|Lost to Follow-up|0|||
48759275|NCT03560531|156966399|FG008|Overall Study|Lost to Follow-up|0|||
48759276|NCT03560531|156966400|FG009|Overall Study|Lost to Follow-up|0|||
48759277|NCT03560531|156966401|FG010|Overall Study|Lost to Follow-up|0|||
48759278|NCT03560531|156966402|FG011|Overall Study|Lost to Follow-up|0|||
48759279|NCT03560531|156966403|FG012|Overall Study|Lost to Follow-up|0|||
48759280|NCT03560531|156966404|FG013|Overall Study|Lost to Follow-up|0|||
48759281|NCT03560531|156966391|FG000|Overall Study|Withdrawal by Subject|1|||
48759282|NCT03560531|156966392|FG001|Overall Study|Withdrawal by Subject|0|||
48759283|NCT03560531|156966393|FG002|Overall Study|Withdrawal by Subject|0|||
48759284|NCT03560531|156966394|FG003|Overall Study|Withdrawal by Subject|0|||
48759285|NCT03560531|156966395|FG004|Overall Study|Withdrawal by Subject|0|||
48759286|NCT03560531|156966396|FG005|Overall Study|Withdrawal by Subject|0|||
48428846|NCT04549168|155758999|FG000|Randomization Phase|Adverse Event|0|||
48759287|NCT03560531|156966397|FG006|Overall Study|Withdrawal by Subject|0|||
48759288|NCT03560531|156966398|FG007|Overall Study|Withdrawal by Subject|3|||
48759289|NCT03560531|156966399|FG008|Overall Study|Withdrawal by Subject|2|||
48759290|NCT03560531|156966400|FG009|Overall Study|Withdrawal by Subject|0|||
48759291|NCT03560531|156966401|FG010|Overall Study|Withdrawal by Subject|0|||
48759292|NCT03560531|156966402|FG011|Overall Study|Withdrawal by Subject|0|||
48759293|NCT03560531|156966403|FG012|Overall Study|Withdrawal by Subject|2|||
48759294|NCT03560531|156966404|FG013|Overall Study|Withdrawal by Subject|0|||
48759295|NCT03560531|156966391|FG000|Overall Study|Study end per-protocol|1|||
48759296|NCT03560531|156966392|FG001|Overall Study|Study end per-protocol|1|||
48759297|NCT03560531|156966393|FG002|Overall Study|Study end per-protocol|2|||
48759298|NCT03560531|156966394|FG003|Overall Study|Study end per-protocol|0|||
48759299|NCT03560531|156966395|FG004|Overall Study|Study end per-protocol|1|||
48759300|NCT03560531|156966396|FG005|Overall Study|Study end per-protocol|0|||
48759301|NCT03560531|156966397|FG006|Overall Study|Study end per-protocol|0|||
48759302|NCT03560531|156966398|FG007|Overall Study|Study end per-protocol|0|||
48759303|NCT03560531|156966399|FG008|Overall Study|Study end per-protocol|0|||
48759304|NCT03560531|156966400|FG009|Overall Study|Study end per-protocol|0|||
48759305|NCT03560531|156966401|FG010|Overall Study|Study end per-protocol|0|||
48759306|NCT03560531|156966402|FG011|Overall Study|Study end per-protocol|0|||
48759307|NCT03560531|156966403|FG012|Overall Study|Study end per-protocol|0|||
48759308|NCT03560531|156966404|FG013|Overall Study|Study end per-protocol|0|||
48759309|NCT03560531|156966391|FG000|Overall Study|Early study termination by sponsor|9|||
48759310|NCT03560531|156966392|FG001|Overall Study|Early study termination by sponsor|0|||
48759311|NCT03560531|156966393|FG002|Overall Study|Early study termination by sponsor|0|||
48759312|NCT03560531|156966394|FG003|Overall Study|Early study termination by sponsor|4|||
48759313|NCT03560531|156966395|FG004|Overall Study|Early study termination by sponsor|8|||
48759314|NCT03560531|156966396|FG005|Overall Study|Early study termination by sponsor|2|||
48759315|NCT03560531|156966397|FG006|Overall Study|Early study termination by sponsor|5|||
48759316|NCT03560531|156966398|FG007|Overall Study|Early study termination by sponsor|64|||
48759317|NCT03560531|156966399|FG008|Overall Study|Early study termination by sponsor|7|||
48759318|NCT03560531|156966400|FG009|Overall Study|Early study termination by sponsor|2|||
48759319|NCT03560531|156966401|FG010|Overall Study|Early study termination by sponsor|16|||
48759320|NCT03560531|156966402|FG011|Overall Study|Early study termination by sponsor|2|||
48759321|NCT03560531|156966403|FG012|Overall Study|Early study termination by sponsor|6|||
48759322|NCT03560531|156966404|FG013|Overall Study|Early study termination by sponsor|2|||
48759323|NCT01474876|156966410|FG000|Overall Study|Adverse Event|11|||
48759324|NCT01474876|156966411|FG001|Overall Study|Adverse Event|5|||
48759325|NCT01474876|156966412|FG002|Overall Study|Adverse Event|0|||
48759326|NCT01474876|156966410|FG000|Overall Study|Serious Adverse Event|2|||
48759327|NCT01474876|156966411|FG001|Overall Study|Serious Adverse Event|3|||
48759328|NCT01474876|156966412|FG002|Overall Study|Serious Adverse Event|0|||
48759329|NCT01474876|156966410|FG000|Overall Study|Lost to Follow-up|5|||
48759330|NCT01474876|156966411|FG001|Overall Study|Lost to Follow-up|4|||
48759331|NCT01474876|156966412|FG002|Overall Study|Lost to Follow-up|0|||
48759332|NCT01474876|156966410|FG000|Overall Study|Investigator's decision|28|||
48759333|NCT01474876|156966411|FG001|Overall Study|Investigator's decision|6|||
48759334|NCT01474876|156966412|FG002|Overall Study|Investigator's decision|0|||
48759335|NCT01474876|156966410|FG000|Overall Study|Patient's request|19|||
48759336|NCT01474876|156966411|FG001|Overall Study|Patient's request|5|||
48759337|NCT01474876|156966412|FG002|Overall Study|Patient's request|0|||
48759338|NCT01474876|156966410|FG000|Overall Study|Investigator's decision and pt request|1|||
48759339|NCT01474876|156966411|FG001|Overall Study|Investigator's decision and pt request|0|||
48759340|NCT01474876|156966412|FG002|Overall Study|Investigator's decision and pt request|0|||
48759341|NCT03839212|156966415|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
48759342|NCT01765153|156966420|FG000|Training Phase 1|Format of intervention differed|1|||
48759343|NCT01765153|156966421|FG001|Training Phase 1|Format of intervention differed|0|||
48759344|NCT01765153|156966420|FG000|Training Phase 1|Poor participation in intervention|0|||
48428847|NCT04549168|155759000|FG001|Randomization Phase|Adverse Event|0|||
48759345|NCT01765153|156966421|FG001|Training Phase 1|Poor participation in intervention|1|||
48759346|NCT01765153|156966420|FG000|Rest Phase 1|Withdrawal by Subject|0|||
48759347|NCT01765153|156966421|FG001|Rest Phase 1|Withdrawal by Subject|1|||
48759348|NCT01765153|156966420|FG000|Training Phase 2|Withdrawal by Subject|0|||
48759349|NCT01765153|156966421|FG001|Training Phase 2|Withdrawal by Subject|1|||
48759350|NCT01765153|156966420|FG000|Rest Phase 2|Lost to Follow-up|2|||
48759351|NCT01765153|156966421|FG001|Rest Phase 2|Lost to Follow-up|1|||
48759352|NCT02005250|156966422|FG000|Overall Study|Lost to Follow-up|15|||
48759353|NCT02005250|156966423|FG001|Overall Study|Lost to Follow-up|5|||
48759354|NCT02588833|156966424|FG000|Part 1|Withdrawal by Subject|1|||
48759355|NCT02588833|156966425|FG001|Part 1|Withdrawal by Subject|0|||
48759356|NCT02588833|156966424|FG000|Part 2A|Physician Decision|0|||
48759357|NCT02588833|156966425|FG001|Part 2A|Physician Decision|1|||
48759358|NCT02588833|156966424|FG000|Part 2A|Withdrawal by Subject|0|||
48759359|NCT02588833|156966425|FG001|Part 2A|Withdrawal by Subject|1|||
48428848|NCT04549168|155759001|FG002|Randomization Phase|Adverse Event|1|||
48668882|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668883|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
48668884|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
48668885|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
48668886|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
48668887|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668888|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
48668889|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
48668890|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668891|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668892|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668893|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668894|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
48668895|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668896|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668897|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
48668898|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668899|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668900|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
48668901|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668902|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668903|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668904|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668905|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
48668906|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
48759360|NCT02588833|156966424|FG000|Part 2B|Adverse Event|0|||
48759361|NCT02588833|156966425|FG001|Part 2B|Adverse Event|1|||
48759362|NCT02588833|156966424|FG000|Part 2C|Adverse Event|0|||
48759363|NCT02588833|156966425|FG001|Part 2C|Adverse Event|1|||
48759364|NCT02588833|156966424|FG000|Part 2C|Withdrawal by Subject|0|||
48759365|NCT02588833|156966425|FG001|Part 2C|Withdrawal by Subject|1|||
48759366|NCT02588833|156966424|FG000|Part 3 (Safety Follow-up)|Other|0|||
48759367|NCT02588833|156966425|FG001|Part 3 (Safety Follow-up)|Other|2|||
48759368|NCT01077804|156966427|FG000|Overall Study|Unreachable|102|||
48759369|NCT01077804|156966427|FG000|Overall Study|Refused to continue|79|||
48759370|NCT01077804|156966427|FG000|Overall Study|Other|18|||
48759371|NCT02921776|156966428|FG000|Overall Study|patient deterioration, fatigue|2|||
48759372|NCT02921776|156966429|FG001|Overall Study|patient deterioration, fatigue|6|||
48759373|NCT02921776|156966430|FG002|Overall Study|patient deterioration, fatigue|0|||
48668907|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668908|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48759374|NCT02921776|156966431|FG003|Overall Study|patient deterioration, fatigue|0|||
48759375|NCT02921776|156966432|FG004|Overall Study|patient deterioration, fatigue|0|||
48759376|NCT02921776|156966433|FG005|Overall Study|patient deterioration, fatigue|0|||
48759377|NCT02921776|156966434|FG006|Overall Study|patient deterioration, fatigue|0|||
48759378|NCT02921776|156966435|FG007|Overall Study|patient deterioration, fatigue|0|||
48759379|NCT02921776|156966428|FG000|Overall Study|Withdrawal by Subject|0|||
48759380|NCT02921776|156966429|FG001|Overall Study|Withdrawal by Subject|2|||
48759381|NCT02921776|156966430|FG002|Overall Study|Withdrawal by Subject|0|||
48759382|NCT02921776|156966431|FG003|Overall Study|Withdrawal by Subject|1|||
48759383|NCT02921776|156966432|FG004|Overall Study|Withdrawal by Subject|1|||
48759384|NCT02921776|156966433|FG005|Overall Study|Withdrawal by Subject|0|||
48759385|NCT02921776|156966434|FG006|Overall Study|Withdrawal by Subject|8|||
48759386|NCT02921776|156966435|FG007|Overall Study|Withdrawal by Subject|1|||
48759387|NCT02921776|156966428|FG000|Overall Study|Death|0|||
48759388|NCT02921776|156966429|FG001|Overall Study|Death|0|||
48759389|NCT02921776|156966430|FG002|Overall Study|Death|0|||
48759390|NCT02921776|156966431|FG003|Overall Study|Death|2|||
48759391|NCT02921776|156966432|FG004|Overall Study|Death|0|||
48759392|NCT02921776|156966433|FG005|Overall Study|Death|0|||
48759393|NCT02921776|156966434|FG006|Overall Study|Death|0|||
48759394|NCT02921776|156966435|FG007|Overall Study|Death|0|||
48759395|NCT02921776|156966428|FG000|Overall Study|extubation or early discharge|0|||
48759396|NCT02921776|156966429|FG001|Overall Study|extubation or early discharge|0|||
48759397|NCT02921776|156966430|FG002|Overall Study|extubation or early discharge|0|||
48759398|NCT02921776|156966431|FG003|Overall Study|extubation or early discharge|5|||
48428849|NCT04549168|155758999|FG000|Randomization Phase|Other|0|||
48668909|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668910|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668911|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668912|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668913|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668914|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668915|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668916|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
48668917|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668918|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668919|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
48668920|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668921|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668922|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668923|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668924|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668925|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668926|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668927|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
48668928|NCT02914561|156641418|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
48668929|NCT02914561|156641419|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668930|NCT02914561|156641420|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
48668931|NCT02914561|156641421|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
48668932|NCT02914561|156641422|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
48668933|NCT02914561|156641423|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
48668934|NCT02914561|156641424|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668935|NCT02914561|156641425|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48342425|NCT01732926|155449214|FG000|Overall Study|Study Terminated by Sponsor|168|||
48342426|NCT01732926|155449215|FG001|Overall Study|Study Terminated by Sponsor|80|||
48342427|NCT01732926|155449214|FG000|Overall Study|Withdrawal by Subject|46|||
48342428|NCT01732926|155449215|FG001|Overall Study|Withdrawal by Subject|8|||
48342429|NCT01732926|155449214|FG000|Overall Study|Physician Decision|24|||
48342430|NCT01732926|155449215|FG001|Overall Study|Physician Decision|11|||
48342431|NCT01732926|155449214|FG000|Overall Study|Other Reason|21|||
48342432|NCT01732926|155449215|FG001|Overall Study|Other Reason|4|||
48342433|NCT01732926|155449214|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
48342434|NCT01732926|155449215|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
48342435|NCT01732926|155449214|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
48342436|NCT01732926|155449215|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
48342437|NCT00187135|155449216|FG000|Visit One|Withdrawal by Subject|1|||
48342438|NCT00187135|155449217|FG001|Visit One|Withdrawal by Subject|0|||
48342439|NCT00187135|155449218|FG002|Visit One|Withdrawal by Subject|0|||
48342440|NCT00187135|155449219|FG003|Visit One|Withdrawal by Subject|0|||
48342441|NCT00187135|155449220|FG004|Visit One|Withdrawal by Subject|0|||
48342442|NCT00187135|155449221|FG005|Visit One|Withdrawal by Subject|1|||
48342443|NCT00187135|155449216|FG000|Visit One|Physician Decision|3|||
48342444|NCT00187135|155449217|FG001|Visit One|Physician Decision|1|||
48342445|NCT00187135|155449218|FG002|Visit One|Physician Decision|0|||
48342446|NCT00187135|155449219|FG003|Visit One|Physician Decision|0|||
48342447|NCT00187135|155449220|FG004|Visit One|Physician Decision|0|||
48342448|NCT00187135|155449221|FG005|Visit One|Physician Decision|1|||
48342449|NCT00187135|155449216|FG000|Visit Two|Death|0|||
48342450|NCT00187135|155449217|FG001|Visit Two|Death|0|||
48342451|NCT00187135|155449218|FG002|Visit Two|Death|0|||
48342452|NCT00187135|155449219|FG003|Visit Two|Death|1|||
48342453|NCT00187135|155449220|FG004|Visit Two|Death|0|||
48342454|NCT00187135|155449221|FG005|Visit Two|Death|1|||
48342455|NCT00187135|155449216|FG000|Visit Two|Physician Decision|1|||
48342456|NCT00187135|155449217|FG001|Visit Two|Physician Decision|0|||
48342457|NCT00187135|155449218|FG002|Visit Two|Physician Decision|0|||
48668936|NCT02914561|156641426|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668937|NCT02914561|156641427|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668938|NCT02914561|156641428|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
48668939|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668940|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668941|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668942|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668943|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668944|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
48668945|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
48668946|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
48668947|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
48668948|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
48668949|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
48668950|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668951|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668952|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668953|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668954|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668955|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
48668956|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
48668957|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
48668958|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
48668959|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
48668960|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
48668961|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668962|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668963|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668964|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668965|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668966|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
48668967|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
48668968|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
48668969|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
48668970|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
48668971|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
48668972|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668973|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668974|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668975|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668976|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668977|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668978|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
48668979|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668980|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
48668981|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
48668982|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
48668983|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668984|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668985|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668986|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668987|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48342458|NCT00187135|155449219|FG003|Visit Two|Physician Decision|0|||
48342459|NCT00187135|155449220|FG004|Visit Two|Physician Decision|0|||
48342460|NCT00187135|155449221|FG005|Visit Two|Physician Decision|0|||
48342461|NCT00187135|155449216|FG000|Visit Two|Withdrawal by Subject|1|||
48342462|NCT00187135|155449217|FG001|Visit Two|Withdrawal by Subject|1|||
48668988|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668989|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
48668990|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
48668991|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
48668992|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
48668993|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
48668994|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668995|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668996|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668997|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668998|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48668999|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48669000|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
48669001|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48669002|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
48669003|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48669004|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
48669005|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669006|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669007|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669008|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669009|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669010|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669011|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669012|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669013|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
48669014|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48759399|NCT02921776|156966432|FG004|Overall Study|extubation or early discharge|5|||
48759400|NCT02921776|156966433|FG005|Overall Study|extubation or early discharge|0|||
48759401|NCT02921776|156966434|FG006|Overall Study|extubation or early discharge|0|||
48759402|NCT02921776|156966435|FG007|Overall Study|extubation or early discharge|0|||
48759403|NCT02921776|156966428|FG000|Overall Study|Lost to Follow-up|0|||
48759404|NCT02921776|156966429|FG001|Overall Study|Lost to Follow-up|0|||
48759405|NCT02921776|156966430|FG002|Overall Study|Lost to Follow-up|0|||
48759406|NCT02921776|156966431|FG003|Overall Study|Lost to Follow-up|0|||
48759407|NCT02921776|156966432|FG004|Overall Study|Lost to Follow-up|0|||
48759408|NCT02921776|156966433|FG005|Overall Study|Lost to Follow-up|2|||
48759409|NCT02921776|156966434|FG006|Overall Study|Lost to Follow-up|3|||
48759410|NCT02921776|156966435|FG007|Overall Study|Lost to Follow-up|6|||
48759411|NCT00567892|156966436|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759412|NCT00567892|156966437|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759413|NCT00567892|156966438|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
48759414|NCT00567892|156966439|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
48759415|NCT00567892|156966436|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759416|NCT00567892|156966437|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759417|NCT00567892|156966438|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
48759418|NCT00567892|156966439|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
48759419|NCT02762266|156967926|FG000|Overall Study|Physician Decision|2|||
48759420|NCT02762266|156967927|FG001|Overall Study|Physician Decision|0|||
48759421|NCT01404325|156967930|FG000|Overall Study|Lost to Follow-up|1|||
48759422|NCT01404325|156967931|FG001|Overall Study|Lost to Follow-up|0|||
48759423|NCT01404325|156967930|FG000|Overall Study|Death|2|||
48759424|NCT01404325|156967931|FG001|Overall Study|Death|0|||
48759425|NCT01404325|156967930|FG000|Overall Study|Graft loss/Retransplantation|1|||
48759426|NCT01404325|156967931|FG001|Overall Study|Graft loss/Retransplantation|0|||
48759427|NCT01404325|156967930|FG000|Overall Study|non-specified reason|0|||
48759428|NCT01404325|156967931|FG001|Overall Study|non-specified reason|2|||
48759429|NCT00623727|156967932|FG000|Double Blind (DB)|Adverse Event|1|||
48759430|NCT00623727|156967933|FG001|Double Blind (DB)|Adverse Event|3|||
48759431|NCT00623727|156967932|FG000|Double Blind (DB)|Physician Decision|0|||
48669015|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
48669016|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669017|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48759432|NCT00623727|156967933|FG001|Double Blind (DB)|Physician Decision|1|||
48759433|NCT00623727|156967932|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
48759434|NCT00623727|156967933|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
48759435|NCT00623727|156967932|FG000|Double Blind (DB)|Lack of Efficacy|2|||
48669018|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669019|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669020|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669021|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669022|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
48669023|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669024|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669025|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669026|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
48669027|NCT02914561|156641418|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669028|NCT02914561|156641419|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669029|NCT02914561|156641420|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669030|NCT02914561|156641421|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669031|NCT02914561|156641422|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669032|NCT02914561|156641423|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669033|NCT02914561|156641424|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669034|NCT02914561|156641425|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
48669035|NCT02914561|156641426|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
48669036|NCT02914561|156641427|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
48669037|NCT02914561|156641428|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
48669038|NCT01300455|156641429|FG000|Washout|Withdrawal by Subject|1|||
48669039|NCT01300455|156641430|FG001|Washout|Withdrawal by Subject|0|||
48669040|NCT02528357|156641433|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669041|NCT02528357|156641434|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
48669042|NCT02528357|156641435|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669043|NCT02528357|156641436|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669044|NCT02528357|156641437|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669045|NCT02528357|156641438|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669046|NCT02528357|156641439|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669047|NCT02528357|156641440|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669048|NCT02528357|156641441|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669049|NCT02528357|156641442|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669050|NCT02528357|156641443|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669051|NCT02528357|156641444|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669052|NCT02528357|156641445|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669053|NCT02528357|156641446|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669054|NCT02528357|156641447|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669055|NCT02528357|156641448|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669056|NCT02528357|156641449|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669057|NCT02528357|156641450|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669058|NCT02528357|156641451|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
48669059|NCT02528357|156641433|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669060|NCT02528357|156641434|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669061|NCT02528357|156641435|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669062|NCT02528357|156641436|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
48669063|NCT02528357|156641437|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669064|NCT02528357|156641438|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
48669065|NCT02528357|156641439|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669066|NCT02528357|156641440|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
48669067|NCT02528357|156641441|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48342463|NCT00187135|155449218|FG002|Visit Two|Withdrawal by Subject|1|||
48669068|NCT02528357|156641442|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669069|NCT02528357|156641443|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669070|NCT02528357|156641444|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669071|NCT02528357|156641445|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669072|NCT02528357|156641446|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669073|NCT02528357|156641447|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669074|NCT02528357|156641448|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669075|NCT02528357|156641449|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669076|NCT02528357|156641450|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669077|NCT02528357|156641451|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
48669078|NCT02528357|156641433|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669079|NCT02528357|156641434|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669080|NCT02528357|156641435|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
48669081|NCT02528357|156641436|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669082|NCT02528357|156641437|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
48669083|NCT02528357|156641438|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669084|NCT02528357|156641439|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
48669085|NCT02528357|156641440|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
48669086|NCT02528357|156641441|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669087|NCT02528357|156641442|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669088|NCT02528357|156641443|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669089|NCT02528357|156641444|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669090|NCT02528357|156641445|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669091|NCT02528357|156641446|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669092|NCT02528357|156641447|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669093|NCT02528357|156641448|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669094|NCT02528357|156641449|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669095|NCT02528357|156641450|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669096|NCT02528357|156641451|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
48669097|NCT02528357|156641433|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669098|NCT02528357|156641434|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669099|NCT02528357|156641435|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669100|NCT02528357|156641436|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669101|NCT02528357|156641437|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669102|NCT02528357|156641438|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669103|NCT02528357|156641439|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669104|NCT02528357|156641440|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669105|NCT02528357|156641441|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669106|NCT02528357|156641442|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669107|NCT02528357|156641443|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669108|NCT02528357|156641444|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669109|NCT02528357|156641445|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669110|NCT02528357|156641446|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669111|NCT02528357|156641447|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669112|NCT02528357|156641448|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669113|NCT02528357|156641449|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669114|NCT02528357|156641450|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669115|NCT02528357|156641451|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669116|NCT02528357|156641433|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669117|NCT02528357|156641434|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669118|NCT02528357|156641435|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669119|NCT02528357|156641436|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669120|NCT02528357|156641437|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48759436|NCT00623727|156967933|FG001|Double Blind (DB)|Lack of Efficacy|2|||
48759437|NCT00623727|156967932|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
48759438|NCT00623727|156967933|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
48759439|NCT00623727|156967932|FG000|Double Blind (DB)|Lost to Follow-up|1|||
48759440|NCT00623727|156967933|FG001|Double Blind (DB)|Lost to Follow-up|1|||
48759441|NCT00623727|156967932|FG000|Double Blind (DB)|Protocol Violation|2|||
48759442|NCT00623727|156967933|FG001|Double Blind (DB)|Protocol Violation|2|||
48759443|NCT00623727|156967932|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
48669121|NCT02528357|156641438|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669122|NCT02528357|156641439|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669123|NCT02528357|156641440|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669124|NCT02528357|156641441|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669125|NCT02528357|156641442|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669126|NCT02528357|156641443|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669127|NCT02528357|156641444|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669128|NCT02528357|156641445|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669129|NCT02528357|156641446|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
48669130|NCT02528357|156641447|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
48669131|NCT02528357|156641448|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669132|NCT02528357|156641449|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669133|NCT02528357|156641450|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669134|NCT02528357|156641451|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
48669135|NCT02528357|156641433|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669136|NCT02528357|156641434|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669137|NCT02528357|156641435|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669138|NCT02528357|156641436|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669139|NCT02528357|156641437|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669140|NCT02528357|156641438|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669141|NCT02528357|156641439|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669142|NCT02528357|156641440|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669143|NCT02528357|156641441|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669144|NCT02528357|156641442|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669145|NCT02528357|156641443|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669146|NCT02528357|156641444|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669147|NCT02528357|156641445|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669148|NCT02528357|156641446|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
48669149|NCT02528357|156641447|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669150|NCT02528357|156641448|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669151|NCT02528357|156641449|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669152|NCT02528357|156641450|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669153|NCT02528357|156641451|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
48669154|NCT02528357|156641433|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669155|NCT02528357|156641434|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669156|NCT02528357|156641435|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669157|NCT02528357|156641436|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669158|NCT02528357|156641437|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669159|NCT02528357|156641438|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669160|NCT02528357|156641439|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669161|NCT02528357|156641440|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669162|NCT02528357|156641441|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669163|NCT02528357|156641442|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669164|NCT02528357|156641443|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
48669165|NCT02528357|156641444|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669166|NCT02528357|156641445|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
48669167|NCT02528357|156641446|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
48669168|NCT02528357|156641447|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
48669169|NCT02528357|156641448|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669170|NCT02528357|156641449|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669171|NCT02528357|156641450|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669172|NCT02528357|156641451|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
48669173|NCT02528357|156641433|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669174|NCT02528357|156641434|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669175|NCT02528357|156641435|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669176|NCT02528357|156641436|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669177|NCT02528357|156641437|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669178|NCT02528357|156641438|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669179|NCT02528357|156641439|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48692775|NCT00333775|156724600|FG001|Overall Study|In Follow-up When Study Stopped|92|||
48669180|NCT02528357|156641440|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669181|NCT02528357|156641441|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669182|NCT02528357|156641442|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669183|NCT02528357|156641443|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669184|NCT02528357|156641444|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
48669185|NCT02528357|156641445|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
48669186|NCT02528357|156641446|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669187|NCT02528357|156641447|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48669188|NCT02528357|156641448|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669189|NCT02528357|156641449|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669190|NCT02528357|156641450|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669191|NCT02528357|156641451|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669192|NCT02528357|156641433|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669193|NCT02528357|156641434|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669194|NCT02528357|156641435|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669195|NCT02528357|156641436|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669196|NCT02528357|156641437|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669197|NCT02528357|156641438|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669198|NCT02528357|156641439|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669199|NCT02528357|156641440|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669200|NCT02528357|156641441|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669201|NCT02528357|156641442|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669202|NCT02528357|156641443|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669203|NCT02528357|156641444|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669204|NCT02528357|156641445|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669205|NCT02528357|156641446|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669206|NCT02528357|156641447|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669207|NCT02528357|156641448|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669208|NCT02528357|156641449|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
48669209|NCT02528357|156641450|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669210|NCT02528357|156641451|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
48669211|NCT02528357|156641433|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669212|NCT02528357|156641434|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669213|NCT02528357|156641435|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669214|NCT02528357|156641436|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669215|NCT02528357|156641437|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669216|NCT02528357|156641438|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669217|NCT02528357|156641439|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669218|NCT02528357|156641440|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669219|NCT02528357|156641441|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669220|NCT02528357|156641442|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669221|NCT02528357|156641443|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669222|NCT02528357|156641444|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669223|NCT02528357|156641445|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669224|NCT02528357|156641446|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669225|NCT02528357|156641447|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669226|NCT02528357|156641448|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
48669227|NCT02528357|156641449|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
48692776|NCT00333775|156724601|FG002|Overall Study|In Follow-up When Study Stopped|96|||
48692777|NCT00333775|156724599|FG000|Overall Study|Lost to Follow-up|10|||
48692778|NCT00333775|156724600|FG001|Overall Study|Lost to Follow-up|7|||
48692779|NCT00333775|156724601|FG002|Overall Study|Lost to Follow-up|8|||
48692780|NCT03110315|156724603|FG000|Overall Study|Withdrawal by Subject|1|||
48692781|NCT03110315|156724604|FG001|Overall Study|Withdrawal by Subject|0|||
48692782|NCT01188772|156724610|FG000|Overall Study|Randomized but Not Treated|0|||
48692783|NCT01188772|156724611|FG001|Overall Study|Randomized but Not Treated|1|||
48669228|NCT02528357|156641450|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
48669229|NCT02528357|156641451|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
48669230|NCT01455220|156641456|FG000|Overall Study|screen fail|30|||
48669231|NCT02438813|156641459|FG000|Overall Study|Patient Decision|59|||
48669232|NCT02438813|156641459|FG000|Overall Study|Patient Lost to Follow-Up|137|||
48669233|NCT02438813|156641459|FG000|Overall Study|Study Ended by Sponsor|80|||
48669234|NCT02438813|156641459|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
48669235|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
48669236|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
48669237|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
48669238|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
48669239|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
48669240|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
48669241|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
48669242|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
48669243|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
48669244|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
48669245|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
48669246|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
48759444|NCT00623727|156967933|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
48759445|NCT00623727|156967932|FG000|Open Label Follow-up|Study termination|0|||
48759446|NCT00623727|156967933|FG001|Open Label Follow-up|Study termination|6|||
48759447|NCT00623727|156967932|FG000|Open Label Follow-up|Participant convenience|0|||
48759448|NCT00623727|156967933|FG001|Open Label Follow-up|Participant convenience|1|||
48759449|NCT01199289|156967934|FG000|Overall Study|Ineligibility determined|2|||
48759450|NCT01199289|156967935|FG001|Overall Study|Ineligibility determined|1|||
48759451|NCT01199289|156967936|FG002|Overall Study|Ineligibility determined|0|||
48759452|NCT01199289|156967937|FG003|Overall Study|Ineligibility determined|0|||
48759453|NCT01199289|156967934|FG000|Overall Study|Protocol Violation|1|||
48759454|NCT01199289|156967935|FG001|Overall Study|Protocol Violation|0|||
48759455|NCT01199289|156967936|FG002|Overall Study|Protocol Violation|0|||
48759456|NCT01199289|156967937|FG003|Overall Study|Protocol Violation|1|||
48759457|NCT01199289|156967934|FG000|Overall Study|Noncompliance|1|||
48759458|NCT01199289|156967935|FG001|Overall Study|Noncompliance|0|||
48759459|NCT01199289|156967936|FG002|Overall Study|Noncompliance|2|||
48759460|NCT01199289|156967937|FG003|Overall Study|Noncompliance|0|||
48759461|NCT01199289|156967934|FG000|Overall Study|Adverse Event|0|||
48759462|NCT01199289|156967935|FG001|Overall Study|Adverse Event|3|||
48759463|NCT01199289|156967936|FG002|Overall Study|Adverse Event|1|||
48759464|NCT01199289|156967937|FG003|Overall Study|Adverse Event|4|||
48759465|NCT01199289|156967934|FG000|Overall Study|Full consent withdrawn|2|||
48759466|NCT01199289|156967935|FG001|Overall Study|Full consent withdrawn|2|||
48759467|NCT01199289|156967936|FG002|Overall Study|Full consent withdrawn|2|||
48759468|NCT01199289|156967937|FG003|Overall Study|Full consent withdrawn|3|||
48759469|NCT01199289|156967934|FG000|Overall Study|Administrative decision|0|||
48759470|NCT01199289|156967935|FG001|Overall Study|Administrative decision|0|||
48759471|NCT01199289|156967936|FG002|Overall Study|Administrative decision|0|||
48759472|NCT01199289|156967937|FG003|Overall Study|Administrative decision|1|||
48759473|NCT01199289|156967934|FG000|Overall Study|Lost to Follow-up|0|||
48759474|NCT01199289|156967935|FG001|Overall Study|Lost to Follow-up|0|||
48759475|NCT01199289|156967936|FG002|Overall Study|Lost to Follow-up|0|||
48759476|NCT01199289|156967937|FG003|Overall Study|Lost to Follow-up|1|||
48759477|NCT01199289|156967934|FG000|Overall Study|Protocol-specified criteria|3|||
48759478|NCT01199289|156967935|FG001|Overall Study|Protocol-specified criteria|0|||
48759479|NCT01199289|156967936|FG002|Overall Study|Protocol-specified criteria|0|||
48759480|NCT01199289|156967937|FG003|Overall Study|Protocol-specified criteria|1|||
48759481|NCT01199289|156967934|FG000|Overall Study|Pregnancy|0|||
48759482|NCT01199289|156967935|FG001|Overall Study|Pregnancy|1|||
48759483|NCT01199289|156967936|FG002|Overall Study|Pregnancy|0|||
48759484|NCT01199289|156967937|FG003|Overall Study|Pregnancy|1|||
48759485|NCT02636868|156967938|FG000|Overall Study|Death|0|||
48759486|NCT02636868|156967939|FG001|Overall Study|Death|1|||
48759487|NCT02636868|156967940|FG002|Overall Study|Death|2|||
48759488|NCT02141282|156967941|FG000|Overall Study|Adverse event, not related to progression|8|||
48759489|NCT02141282|156967942|FG001|Overall Study|Adverse event, not related to progression|1|||
48759490|NCT02141282|156967943|FG002|Overall Study|Adverse event, not related to progression|3|||
48759491|NCT02141282|156967944|FG003|Overall Study|Adverse event, not related to progression|1|||
48759492|NCT02141282|156967941|FG000|Overall Study|Adverse event, related to progression|1|||
48759493|NCT02141282|156967942|FG001|Overall Study|Adverse event, related to progression|0|||
48759494|NCT02141282|156967943|FG002|Overall Study|Adverse event, related to progression|2|||
48759495|NCT02141282|156967944|FG003|Overall Study|Adverse event, related to progression|0|||
48759496|NCT02141282|156967941|FG000|Overall Study|COVID-19 infection|1|||
48759497|NCT02141282|156967942|FG001|Overall Study|COVID-19 infection|0|||
48759498|NCT02141282|156967943|FG002|Overall Study|COVID-19 infection|0|||
48759499|NCT02141282|156967944|FG003|Overall Study|COVID-19 infection|0|||
48759500|NCT02141282|156967941|FG000|Overall Study|Lost to Follow-up|0|||
48759501|NCT02141282|156967942|FG001|Overall Study|Lost to Follow-up|0|||
48759502|NCT02141282|156967943|FG002|Overall Study|Lost to Follow-up|4|||
48759503|NCT02141282|156967944|FG003|Overall Study|Lost to Follow-up|2|||
48759504|NCT02141282|156967941|FG000|Overall Study|Other, not specified|14|||
48759505|NCT02141282|156967942|FG001|Overall Study|Other, not specified|11|||
48759506|NCT02141282|156967943|FG002|Overall Study|Other, not specified|23|||
48759507|NCT02141282|156967944|FG003|Overall Study|Other, not specified|9|||
48759508|NCT02141282|156967941|FG000|Overall Study|Progressive disease, Richter's|4|||
48759509|NCT02141282|156967942|FG001|Overall Study|Progressive disease, Richter's|1|||
48759510|NCT02141282|156967943|FG002|Overall Study|Progressive disease, Richter's|1|||
48759511|NCT02141282|156967944|FG003|Overall Study|Progressive disease, Richter's|1|||
48759512|NCT02141282|156967941|FG000|Overall Study|Progressive disease per protocol|12|||
48759513|NCT02141282|156967942|FG001|Overall Study|Progressive disease per protocol|7|||
48759514|NCT02141282|156967943|FG002|Overall Study|Progressive disease per protocol|9|||
48759515|NCT02141282|156967944|FG003|Overall Study|Progressive disease per protocol|2|||
48759516|NCT02141282|156967941|FG000|Overall Study|Stem cell transplant|1|||
48669247|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
48669248|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
48669249|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
48669250|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
48669251|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
48759517|NCT02141282|156967942|FG001|Overall Study|Stem cell transplant|0|||
48759518|NCT02141282|156967943|FG002|Overall Study|Stem cell transplant|1|||
48759519|NCT02141282|156967944|FG003|Overall Study|Stem cell transplant|0|||
48759520|NCT02141282|156967941|FG000|Overall Study|Study terminated by Sponsor|0|||
48759521|NCT02141282|156967942|FG001|Overall Study|Study terminated by Sponsor|1|||
48759522|NCT02141282|156967943|FG002|Overall Study|Study terminated by Sponsor|0|||
48759523|NCT02141282|156967944|FG003|Overall Study|Study terminated by Sponsor|0|||
48759524|NCT02141282|156967941|FG000|Overall Study|Subject non-compliance|0|||
48759525|NCT02141282|156967942|FG001|Overall Study|Subject non-compliance|0|||
48759526|NCT02141282|156967943|FG002|Overall Study|Subject non-compliance|1|||
48759527|NCT02141282|156967944|FG003|Overall Study|Subject non-compliance|0|||
48759528|NCT02141282|156967941|FG000|Overall Study|Withdrew consent|2|||
48759529|NCT02141282|156967942|FG001|Overall Study|Withdrew consent|0|||
48759530|NCT02141282|156967943|FG002|Overall Study|Withdrew consent|4|||
48759531|NCT02141282|156967944|FG003|Overall Study|Withdrew consent|0|||
48759532|NCT03312933|156967945|FG000|Overall Study|Protocol Violation|15|||
48759533|NCT03312933|156967945|FG000|Overall Study|Lost to Follow-up|36|||
48759534|NCT03312933|156967945|FG000|Overall Study|Withdrawal by Subject|3|||
48759535|NCT02068443|156967946|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48759536|NCT02068443|156967947|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
48759537|NCT02068443|156967948|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
48759538|NCT02068443|156967946|FG000|Overall Study|Voluntary Withdrawal|4|||
48759539|NCT02068443|156967947|FG001|Overall Study|Voluntary Withdrawal|0|||
48759540|NCT02068443|156967948|FG002|Overall Study|Voluntary Withdrawal|1|||
48759541|NCT02068443|156967946|FG000|Overall Study|Lack of Efficacy|2|||
48759542|NCT02068443|156967947|FG001|Overall Study|Lack of Efficacy|1|||
48759543|NCT02068443|156967948|FG002|Overall Study|Lack of Efficacy|0|||
48759544|NCT02068443|156967946|FG000|Overall Study|Other Reason Not Specified|1|||
48759545|NCT02068443|156967947|FG001|Overall Study|Other Reason Not Specified|0|||
48759546|NCT02068443|156967948|FG002|Overall Study|Other Reason Not Specified|0|||
48759547|NCT01986855|156967949|FG000|Overall Study|Adverse Event|1|||
48759548|NCT01986855|156967950|FG001|Overall Study|Adverse Event|0|||
48759549|NCT01986855|156967951|FG002|Overall Study|Adverse Event|0|||
48669252|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
48669253|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
48669254|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
48669255|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
48669256|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
48669257|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
48669258|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
48669259|NCT01672866|156641464|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
48759550|NCT01986855|156967949|FG000|Overall Study|Death|3|||
48759551|NCT01986855|156967950|FG001|Overall Study|Death|4|||
48759552|NCT01986855|156967951|FG002|Overall Study|Death|4|||
48759553|NCT01986855|156967949|FG000|Overall Study|Lost to Follow-up|2|||
48759554|NCT01986855|156967950|FG001|Overall Study|Lost to Follow-up|1|||
48759555|NCT01986855|156967951|FG002|Overall Study|Lost to Follow-up|0|||
48759556|NCT01986855|156967949|FG000|Overall Study|Screen Failure|0|||
48759557|NCT01986855|156967950|FG001|Overall Study|Screen Failure|1|||
48759558|NCT01986855|156967951|FG002|Overall Study|Screen Failure|0|||
48759559|NCT01986855|156967949|FG000|Overall Study|Participant Moved|0|||
48759560|NCT01986855|156967950|FG001|Overall Study|Participant Moved|0|||
48759561|NCT01986855|156967951|FG002|Overall Study|Participant Moved|2|||
48669260|NCT01672866|156641465|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
48669261|NCT01672866|156641466|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
48669262|NCT01672866|156641464|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
48669263|NCT01672866|156641465|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
48669264|NCT01672866|156641466|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
48669265|NCT01672866|156641464|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
48669266|NCT01672866|156641465|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
48669267|NCT01672866|156641466|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
48669268|NCT01672866|156641464|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
48669269|NCT01672866|156641465|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
48669270|NCT01672866|156641466|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
48669271|NCT01672866|156641464|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
48669272|NCT01672866|156641465|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
48669273|NCT01672866|156641466|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
48669274|NCT01459913|156641467|FG000|Overall Study|Adverse Event|0|||
48669275|NCT01459913|156641468|FG001|Overall Study|Adverse Event|0|||
48669276|NCT01459913|156641469|FG002|Overall Study|Adverse Event|0|||
48669277|NCT01459913|156641470|FG003|Overall Study|Adverse Event|3|||
48669278|NCT01459913|156641467|FG000|Overall Study|Withdrawal by Subject|4|||
48669279|NCT01459913|156641468|FG001|Overall Study|Withdrawal by Subject|0|||
48669280|NCT01459913|156641469|FG002|Overall Study|Withdrawal by Subject|0|||
48669281|NCT01459913|156641470|FG003|Overall Study|Withdrawal by Subject|5|||
48669282|NCT01459913|156641467|FG000|Overall Study|Lost to Follow-up|7|||
48669283|NCT01459913|156641468|FG001|Overall Study|Lost to Follow-up|4|||
48669284|NCT01459913|156641469|FG002|Overall Study|Lost to Follow-up|1|||
48669285|NCT01459913|156641470|FG003|Overall Study|Lost to Follow-up|8|||
48669286|NCT01459913|156641467|FG000|Overall Study|Death|0|||
48669287|NCT01459913|156641468|FG001|Overall Study|Death|0|||
48669288|NCT01459913|156641469|FG002|Overall Study|Death|0|||
48669289|NCT01459913|156641470|FG003|Overall Study|Death|1|||
48669290|NCT01459913|156641467|FG000|Overall Study|Non- Compliance|0|||
48669291|NCT01459913|156641468|FG001|Overall Study|Non- Compliance|0|||
48669292|NCT01459913|156641469|FG002|Overall Study|Non- Compliance|0|||
48669293|NCT01459913|156641470|FG003|Overall Study|Non- Compliance|3|||
48669294|NCT01459913|156641467|FG000|Overall Study|Physician Decision|0|||
48669295|NCT01459913|156641468|FG001|Overall Study|Physician Decision|1|||
48669296|NCT01459913|156641469|FG002|Overall Study|Physician Decision|0|||
48669297|NCT01459913|156641470|FG003|Overall Study|Physician Decision|0|||
48669298|NCT01459913|156641467|FG000|Overall Study|Study Terminated by Sponsor|30|||
48669299|NCT01459913|156641468|FG001|Overall Study|Study Terminated by Sponsor|15|||
48669300|NCT01459913|156641469|FG002|Overall Study|Study Terminated by Sponsor|9|||
48669301|NCT01459913|156641470|FG003|Overall Study|Study Terminated by Sponsor|11|||
48669302|NCT01459913|156641467|FG000|Overall Study|Other|0|||
48669303|NCT01459913|156641468|FG001|Overall Study|Other|0|||
48669304|NCT01459913|156641469|FG002|Overall Study|Other|3|||
48669305|NCT01459913|156641470|FG003|Overall Study|Other|1|||
48669306|NCT01459913|156641467|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
48669307|NCT01459913|156641468|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
48669308|NCT01459913|156641469|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
48669309|NCT01459913|156641470|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
48669310|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
48669311|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
48669312|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
48669313|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
48669314|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
48669315|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
48669316|NCT01389323|156641471|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
48669317|NCT01389323|156641471|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
48669318|NCT01389323|156641471|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
48669319|NCT01389323|156641471|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
48669320|NCT01389323|156641471|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
48669321|NCT01064687|156641474|FG000|Overall Study|Adverse Event|9|||
48669322|NCT01064687|156641475|FG001|Overall Study|Adverse Event|4|||
48669323|NCT01064687|156641476|FG002|Overall Study|Adverse Event|10|||
48669324|NCT01064687|156641477|FG003|Overall Study|Adverse Event|3|||
48669325|NCT01064687|156641474|FG000|Overall Study|Death|1|||
48669326|NCT01064687|156641475|FG001|Overall Study|Death|1|||
48669327|NCT01064687|156641476|FG002|Overall Study|Death|0|||
48669328|NCT01064687|156641477|FG003|Overall Study|Death|0|||
48669329|NCT01064687|156641474|FG000|Overall Study|Entry Criteria Not Met|3|||
48669330|NCT01064687|156641475|FG001|Overall Study|Entry Criteria Not Met|0|||
48669331|NCT01064687|156641476|FG002|Overall Study|Entry Criteria Not Met|0|||
48669332|NCT01064687|156641477|FG003|Overall Study|Entry Criteria Not Met|0|||
48669333|NCT01064687|156641474|FG000|Overall Study|Lack of Efficacy|1|||
48759562|NCT01986855|156967949|FG000|Overall Study|Withdrawal by Subject|7|||
48759563|NCT01986855|156967950|FG001|Overall Study|Withdrawal by Subject|8|||
48759564|NCT01986855|156967951|FG002|Overall Study|Withdrawal by Subject|5|||
48759565|NCT00664742|156967952|FG000|Overall Study|Withdrawn due to adverse events|3|||
48759566|NCT00664742|156967952|FG000|Overall Study|Withdrawal by Subject|31|||
48759567|NCT00664742|156967952|FG000|Overall Study|Lost to Follow-up|92|||
48669334|NCT01064687|156641475|FG001|Overall Study|Lack of Efficacy|0|||
48669335|NCT01064687|156641476|FG002|Overall Study|Lack of Efficacy|2|||
48669336|NCT01064687|156641477|FG003|Overall Study|Lack of Efficacy|3|||
48669337|NCT01064687|156641474|FG000|Overall Study|Lost to Follow-up|7|||
48669338|NCT01064687|156641475|FG001|Overall Study|Lost to Follow-up|10|||
48669339|NCT01064687|156641476|FG002|Overall Study|Lost to Follow-up|13|||
48669340|NCT01064687|156641477|FG003|Overall Study|Lost to Follow-up|5|||
48669341|NCT01064687|156641474|FG000|Overall Study|Physician Decision|2|||
48669342|NCT01064687|156641475|FG001|Overall Study|Physician Decision|2|||
48669343|NCT01064687|156641476|FG002|Overall Study|Physician Decision|0|||
48759568|NCT03745937|156967953|FG000|Overall Study|Withdrawal by Subject|0|||
48759569|NCT03745937|156967954|FG001|Overall Study|Withdrawal by Subject|0|||
48759570|NCT03745937|156967955|FG002|Overall Study|Withdrawal by Subject|0|||
48759571|NCT03745937|156967956|FG003|Overall Study|Withdrawal by Subject|1|||
48759572|NCT03745937|156967953|FG000|Overall Study|Not-specifed|0|||
48759573|NCT03745937|156967954|FG001|Overall Study|Not-specifed|1|||
48759574|NCT03745937|156967955|FG002|Overall Study|Not-specifed|0|||
48759575|NCT03745937|156967956|FG003|Overall Study|Not-specifed|1|||
48759576|NCT00156533|156967960|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
48759577|NCT00156533|156967961|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
48759578|NCT00156533|156967962|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
48759579|NCT00156533|156967963|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
48759580|NCT00156533|156967960|FG000|Overall Study|Withdrawal by Subject|1|||
48759581|NCT00156533|156967961|FG001|Overall Study|Withdrawal by Subject|0|||
48759582|NCT00156533|156967962|FG002|Overall Study|Withdrawal by Subject|0|||
48669344|NCT01064687|156641477|FG003|Overall Study|Physician Decision|0|||
48669345|NCT01064687|156641474|FG000|Overall Study|Protocol Violation|1|||
48669346|NCT01064687|156641475|FG001|Overall Study|Protocol Violation|1|||
48669347|NCT01064687|156641476|FG002|Overall Study|Protocol Violation|0|||
48669348|NCT01064687|156641477|FG003|Overall Study|Protocol Violation|1|||
48669349|NCT01064687|156641474|FG000|Overall Study|Sponsor Decision|0|||
48669350|NCT01064687|156641475|FG001|Overall Study|Sponsor Decision|0|||
48669351|NCT01064687|156641476|FG002|Overall Study|Sponsor Decision|3|||
48669352|NCT01064687|156641477|FG003|Overall Study|Sponsor Decision|0|||
48669353|NCT01064687|156641474|FG000|Overall Study|Withdrawal by Subject|9|||
48669354|NCT01064687|156641475|FG001|Overall Study|Withdrawal by Subject|7|||
48669355|NCT01064687|156641476|FG002|Overall Study|Withdrawal by Subject|12|||
48669356|NCT01064687|156641477|FG003|Overall Study|Withdrawal by Subject|5|||
48759583|NCT00156533|156967963|FG003|Overall Study|Withdrawal by Subject|1|||
48759584|NCT00156533|156967960|FG000|Overall Study|Failed Screening|1|||
48669357|NCT01064687|156641474|FG000|Overall Study|Treatment Noncompliance|1|||
48669358|NCT01064687|156641475|FG001|Overall Study|Treatment Noncompliance|1|||
48669359|NCT01064687|156641476|FG002|Overall Study|Treatment Noncompliance|1|||
48669360|NCT01064687|156641477|FG003|Overall Study|Treatment Noncompliance|0|||
48669361|NCT00619489|156641478|FG000|Overall Study|Adverse Event|0|||
48669362|NCT00619489|156641479|FG001|Overall Study|Adverse Event|7|||
48669363|NCT00619489|156641478|FG000|Overall Study|Withdrawal by Subject|1|||
48669364|NCT00619489|156641479|FG001|Overall Study|Withdrawal by Subject|1|||
48759585|NCT00156533|156967961|FG001|Overall Study|Failed Screening|0|||
48759586|NCT00156533|156967962|FG002|Overall Study|Failed Screening|1|||
48759587|NCT00156533|156967963|FG003|Overall Study|Failed Screening|1|||
48759588|NCT00082355|156967964|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
48669365|NCT00619489|156641478|FG000|Overall Study|Lack of Efficacy|0|||
48669366|NCT00619489|156641479|FG001|Overall Study|Lack of Efficacy|11|||
48669367|NCT00619489|156641478|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
48669368|NCT00619489|156641479|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
48669369|NCT02966015|156641480|FG000|Inclusion Visit|did not answer questionnaire|8|||
48669370|NCT02966015|156641481|FG001|Inclusion Visit|did not answer questionnaire|3|||
48669371|NCT00845065|156641483|FG000|Overall Study|Adverse Event|3|||
48669372|NCT00845065|156641484|FG001|Overall Study|Adverse Event|23|||
48669373|NCT00845065|156641483|FG000|Overall Study|Lack of Efficacy|43|||
48669374|NCT00845065|156641484|FG001|Overall Study|Lack of Efficacy|21|||
48669375|NCT00845065|156641483|FG000|Overall Study|Non-Medical Reasons|1|||
48669376|NCT00845065|156641484|FG001|Overall Study|Non-Medical Reasons|11|||
48669377|NCT01977690|156641485|FG000|Overall Study|Withdrawal by Subject|0|||
48669378|NCT01977690|156641486|FG001|Overall Study|Withdrawal by Subject|4|||
48669379|NCT02644356|156641489|FG000|Overall Study|Withdrawal by Subject|2|||
48669380|NCT01291277|156641490|FG000|Overall Study|Death|2|||
48669381|NCT01291277|156641491|FG001|Overall Study|Death|2|||
48669382|NCT01291277|156641490|FG000|Overall Study|Lost to Follow-up|3|||
48669383|NCT01291277|156641491|FG001|Overall Study|Lost to Follow-up|1|||
48669384|NCT01831817|156641492|FG000|Overall Study|Lost to Follow-up|1|||
48669385|NCT01831817|156641493|FG001|Overall Study|Lost to Follow-up|0|||
48669386|NCT01831817|156641494|FG002|Overall Study|Lost to Follow-up|0|||
48759589|NCT00082355|156967964|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
48759590|NCT00082355|156967964|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
48759591|NCT01254227|156967965|FG000|Overall Study|Withdrawal by Subject|6|||
48759592|NCT01254227|156967965|FG000|Overall Study|Lost to Follow-up|6|||
48759593|NCT01254227|156967965|FG000|Overall Study|Adverse Event|5|||
48759594|NCT01254227|156967965|FG000|Overall Study|Abnormal test procedure result|5|||
48759595|NCT01254227|156967965|FG000|Overall Study|Administrative problems|2|||
48759596|NCT01254227|156967965|FG000|Overall Study|Death|1|||
48759597|NCT01254227|156967965|FG000|Overall Study|Protocol deviation|1|||
48759598|NCT01485640|156967966|FG000|Overall Study|Adverse Event|10|||
48759599|NCT01485640|156967966|FG000|Overall Study|Lack of Efficacy|2|||
48759600|NCT01485640|156967966|FG000|Overall Study|Protocol Violation|1|||
48759601|NCT01485640|156967966|FG000|Overall Study|Withdrawal by Subject|14|||
48759602|NCT01485640|156967966|FG000|Overall Study|Terminated by Sponsor|95|||
48759603|NCT03020407|156967967|FG000|Overall Study|Withdrawal by Subject|2|||
48759604|NCT03020407|156967968|FG001|Overall Study|Withdrawal by Subject|1|||
48759605|NCT03020407|156967967|FG000|Overall Study|Lost to Follow-up|2|||
48759606|NCT03020407|156967968|FG001|Overall Study|Lost to Follow-up|3|||
48759607|NCT03020407|156967967|FG000|Overall Study|Protocol Violation|0|||
48759608|NCT03020407|156967968|FG001|Overall Study|Protocol Violation|1|||
48759609|NCT00708643|156967969|FG000|Overall Study|Adverse Event|0|||
48759610|NCT00708643|156967970|FG001|Overall Study|Adverse Event|1|||
48759611|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
48759612|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
48759613|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
48759614|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
48759615|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
48759616|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
48759617|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
48759618|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
48759619|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
48759620|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
48759621|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
48759622|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
48759623|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
48759624|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
48759625|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
48759626|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
48759627|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
48759628|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
48759629|NCT00887354|156967972|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
48759630|NCT00887354|156967973|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
48759631|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
48759632|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
48759633|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
48759634|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
48759635|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
48669387|NCT01831817|156641495|FG003|Overall Study|Lost to Follow-up|0|||
48669388|NCT01831817|156641492|FG000|Overall Study|Withdrawl of Consent|3|||
48669389|NCT01831817|156641493|FG001|Overall Study|Withdrawl of Consent|0|||
48669390|NCT01831817|156641494|FG002|Overall Study|Withdrawl of Consent|0|||
48669391|NCT01831817|156641495|FG003|Overall Study|Withdrawl of Consent|0|||
48669392|NCT03684694|156641504|FG000|Phase 1|Withdrawal by Subject|1|||
48669393|NCT03684694|156641505|FG001|Phase 1|Withdrawal by Subject|0|||
48669394|NCT03684694|156641506|FG002|Phase 1|Withdrawal by Subject|0|||
48669395|NCT03684694|156641507|FG003|Phase 1|Withdrawal by Subject|0|||
48669396|NCT03684694|156641508|FG004|Phase 1|Withdrawal by Subject|0|||
48669397|NCT03684694|156641509|FG005|Phase 1|Withdrawal by Subject|0|||
48669398|NCT03684694|156641504|FG000|Phase 1|Investigator/Sponsor Decision|12|||
48669399|NCT03684694|156641505|FG001|Phase 1|Investigator/Sponsor Decision|2|||
48669400|NCT03684694|156641506|FG002|Phase 1|Investigator/Sponsor Decision|1|||
48669401|NCT03684694|156641507|FG003|Phase 1|Investigator/Sponsor Decision|0|||
48669402|NCT03684694|156641508|FG004|Phase 1|Investigator/Sponsor Decision|0|||
48669403|NCT03684694|156641509|FG005|Phase 1|Investigator/Sponsor Decision|0|||
48669404|NCT03684694|156641504|FG000|Phase 1|Death|24|||
48669405|NCT03684694|156641505|FG001|Phase 1|Death|0|||
48669406|NCT03684694|156641506|FG002|Phase 1|Death|3|||
48669407|NCT03684694|156641507|FG003|Phase 1|Death|0|||
48669408|NCT03684694|156641508|FG004|Phase 1|Death|0|||
48669409|NCT03684694|156641509|FG005|Phase 1|Death|0|||
48669410|NCT03684694|156641504|FG000|Phase 1|Lost to Follow-up|0|||
48669411|NCT03684694|156641505|FG001|Phase 1|Lost to Follow-up|0|||
48669412|NCT03684694|156641506|FG002|Phase 1|Lost to Follow-up|1|||
48669413|NCT03684694|156641507|FG003|Phase 1|Lost to Follow-up|0|||
48669414|NCT03684694|156641508|FG004|Phase 1|Lost to Follow-up|0|||
48669415|NCT03684694|156641509|FG005|Phase 1|Lost to Follow-up|0|||
48669416|NCT03684694|156641504|FG000|Phase 1|Miscellaneous|0|||
48759636|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
48759637|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
48759638|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
48759639|NCT00887354|156967972|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
48759640|NCT00887354|156967973|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
48759641|NCT00665353|156967976|FG000|Study Step 1|Adverse Event|1|||
48759642|NCT00665353|156967976|FG000|Study Step 1|Withdrawal by Subject|2|||
48759643|NCT00665353|156967976|FG000|Study Step 2|Lost to Follow-up|2|||
48759644|NCT00665353|156967976|FG000|Study Step 2|Lack of Efficacy|12|||
48759645|NCT01012622|156967977|FG000|Overall Study|Withdrawal by Subject|6|||
48759646|NCT01012622|156967977|FG000|Overall Study|Lost to Follow-up|5|||
48759647|NCT01012622|156967977|FG000|Overall Study|Adverse Event|7|||
48759648|NCT01012622|156967977|FG000|Overall Study|non-compliance with the drug|9|||
48759649|NCT01012622|156967977|FG000|Overall Study|Other|1|||
48759650|NCT01012622|156967977|FG000|Overall Study|screening failure|1|||
48759651|NCT01012622|156967977|FG000|Overall Study|withdrawal of consent by a parent|2|||
48759652|NCT04532099|156967978|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
48759653|NCT04532099|156967979|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
48759654|NCT04532099|156967980|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
48759655|NCT03724812|156967981|FG000|Overall Study|Missed Visit|1|||
48759656|NCT03724812|156967981|FG000|Overall Study|Death|2|||
48759657|NCT03724812|156967981|FG000|Overall Study|Withdrawal by Subject|1|||
48759658|NCT04461015|156967987|FG000|Overall Study|IV access lost during the study|0|||
48759659|NCT04461015|156967988|FG001|Overall Study|IV access lost during the study|1|||
48669417|NCT03684694|156641505|FG001|Phase 1|Miscellaneous|1|||
48669418|NCT03684694|156641506|FG002|Phase 1|Miscellaneous|0|||
48669419|NCT03684694|156641507|FG003|Phase 1|Miscellaneous|0|||
48669420|NCT03684694|156641508|FG004|Phase 1|Miscellaneous|0|||
48669421|NCT03684694|156641509|FG005|Phase 1|Miscellaneous|0|||
48669422|NCT03684694|156641504|FG000|Phase 2|Withdrawal by Subject|0|||
48669423|NCT03684694|156641505|FG001|Phase 2|Withdrawal by Subject|0|||
48669424|NCT03684694|156641506|FG002|Phase 2|Withdrawal by Subject|0|||
48669425|NCT03684694|156641507|FG003|Phase 2|Withdrawal by Subject|0|||
48669426|NCT03684694|156641508|FG004|Phase 2|Withdrawal by Subject|0|||
48669427|NCT03684694|156641509|FG005|Phase 2|Withdrawal by Subject|1|||
48669428|NCT03684694|156641504|FG000|Phase 2|Investigator/Sponsor Decision|0|||
48669429|NCT03684694|156641505|FG001|Phase 2|Investigator/Sponsor Decision|0|||
48669430|NCT03684694|156641506|FG002|Phase 2|Investigator/Sponsor Decision|0|||
48669431|NCT03684694|156641507|FG003|Phase 2|Investigator/Sponsor Decision|17|||
48669432|NCT03684694|156641508|FG004|Phase 2|Investigator/Sponsor Decision|16|||
48669433|NCT03684694|156641509|FG005|Phase 2|Investigator/Sponsor Decision|6|||
48669434|NCT03684694|156641504|FG000|Phase 2|Death|0|||
48759660|NCT04461015|156967987|FG000|Overall Study|Withdrawal by Subject|0|||
48759661|NCT04461015|156967988|FG001|Overall Study|Withdrawal by Subject|1|||
48759662|NCT02150954|156967989|FG000|Overall Study|Protocol Violation|1|||
48759663|NCT02150954|156967990|FG001|Overall Study|Protocol Violation|0|||
48759664|NCT02631850|156967991|FG000|Treatment Period|Lost to Follow-up|0|||
48759665|NCT02631850|156967992|FG001|Treatment Period|Lost to Follow-up|1|||
48759666|NCT02631850|156967993|FG002|Treatment Period|Lost to Follow-up|0|||
48759667|NCT02631850|156967994|FG003|Treatment Period|Lost to Follow-up|0|||
48759668|NCT02631850|156967991|FG000|Treatment Period|Protocol Violation|1|||
48759669|NCT02631850|156967992|FG001|Treatment Period|Protocol Violation|0|||
48759670|NCT02631850|156967993|FG002|Treatment Period|Protocol Violation|0|||
48759671|NCT02631850|156967994|FG003|Treatment Period|Protocol Violation|0|||
48759672|NCT02631850|156967991|FG000|Treatment Period|Withdrawal by Subject|0|||
48759673|NCT02631850|156967992|FG001|Treatment Period|Withdrawal by Subject|5|||
48759674|NCT02631850|156967993|FG002|Treatment Period|Withdrawal by Subject|2|||
48759675|NCT02631850|156967994|FG003|Treatment Period|Withdrawal by Subject|2|||
48759676|NCT02631850|156967991|FG000|Treatment Period|Adverse Event|1|||
48759677|NCT02631850|156967992|FG001|Treatment Period|Adverse Event|0|||
48759678|NCT02631850|156967993|FG002|Treatment Period|Adverse Event|2|||
48759679|NCT02631850|156967994|FG003|Treatment Period|Adverse Event|3|||
48759680|NCT02631850|156967991|FG000|Treatment Period|Family medical issue|1|||
48759681|NCT02631850|156967992|FG001|Treatment Period|Family medical issue|0|||
48759682|NCT02631850|156967993|FG002|Treatment Period|Family medical issue|0|||
48759683|NCT02631850|156967994|FG003|Treatment Period|Family medical issue|0|||
48759684|NCT02631850|156967991|FG000|6 Month Follow up|Lost to Follow-up|5|||
48759685|NCT02631850|156967992|FG001|6 Month Follow up|Lost to Follow-up|8|||
48759686|NCT02631850|156967993|FG002|6 Month Follow up|Lost to Follow-up|3|||
48759687|NCT02631850|156967994|FG003|6 Month Follow up|Lost to Follow-up|5|||
48759688|NCT02631850|156967991|FG000|6 Month Follow up|Withdrawal by Subject|1|||
48759689|NCT02631850|156967992|FG001|6 Month Follow up|Withdrawal by Subject|0|||
48759690|NCT02631850|156967993|FG002|6 Month Follow up|Withdrawal by Subject|0|||
48759691|NCT02631850|156967994|FG003|6 Month Follow up|Withdrawal by Subject|2|||
48759692|NCT02631850|156967991|FG000|6 Month Follow up|Adverse Event|1|||
48759693|NCT02631850|156967992|FG001|6 Month Follow up|Adverse Event|4|||
48759694|NCT02631850|156967993|FG002|6 Month Follow up|Adverse Event|1|||
48759695|NCT02631850|156967994|FG003|6 Month Follow up|Adverse Event|3|||
48759696|NCT02631850|156967991|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
48759697|NCT02631850|156967992|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
48759698|NCT02631850|156967993|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
48759699|NCT02631850|156967994|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
48759700|NCT03287804|156967995|FG000|Overall Study|Death|1|||
48669435|NCT03684694|156641505|FG001|Phase 2|Death|0|||
48669436|NCT03684694|156641506|FG002|Phase 2|Death|0|||
48669437|NCT03684694|156641507|FG003|Phase 2|Death|28|||
48342464|NCT00187135|155449219|FG003|Visit Two|Withdrawal by Subject|0|||
48669438|NCT03684694|156641508|FG004|Phase 2|Death|14|||
48669439|NCT03684694|156641509|FG005|Phase 2|Death|3|||
48669440|NCT03684694|156641504|FG000|Phase 2|Lost to Follow-up|0|||
48669441|NCT03684694|156641505|FG001|Phase 2|Lost to Follow-up|0|||
48669442|NCT03684694|156641506|FG002|Phase 2|Lost to Follow-up|0|||
48669443|NCT03684694|156641507|FG003|Phase 2|Lost to Follow-up|1|||
48669444|NCT03684694|156641508|FG004|Phase 2|Lost to Follow-up|0|||
48669445|NCT03684694|156641509|FG005|Phase 2|Lost to Follow-up|0|||
48669446|NCT03684694|156641504|FG000|Phase 2|Miscellaneous|0|||
48669447|NCT03684694|156641505|FG001|Phase 2|Miscellaneous|0|||
48669448|NCT03684694|156641506|FG002|Phase 2|Miscellaneous|0|||
48669449|NCT03684694|156641507|FG003|Phase 2|Miscellaneous|3|||
48669450|NCT03684694|156641508|FG004|Phase 2|Miscellaneous|0|||
48669451|NCT03684694|156641509|FG005|Phase 2|Miscellaneous|0|||
48669452|NCT03529110|156643160|FG000|Overall Study|Progressive Disease|66|||
48669453|NCT03529110|156643161|FG001|Overall Study|Progressive Disease|158|||
48669454|NCT03529110|156643160|FG000|Overall Study|Clinical Progression|4|||
48669455|NCT03529110|156643161|FG001|Overall Study|Clinical Progression|12|||
48669456|NCT03529110|156643160|FG000|Overall Study|Adverse Event|35|||
48669457|NCT03529110|156643161|FG001|Overall Study|Adverse Event|17|||
48669458|NCT03529110|156643160|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
48669459|NCT03529110|156643161|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
48669460|NCT03529110|156643160|FG000|Overall Study|Lack of Efficacy|3|||
48669461|NCT03529110|156643161|FG001|Overall Study|Lack of Efficacy|3|||
48669462|NCT03529110|156643160|FG000|Overall Study|Physician Decision|2|||
48669463|NCT03529110|156643161|FG001|Overall Study|Physician Decision|8|||
48669464|NCT03529110|156643160|FG000|Overall Study|Miscellaneous|2|||
48669465|NCT03529110|156643161|FG001|Overall Study|Miscellaneous|5|||
48669466|NCT02191605|156643162|FG000|Overall Study|Lost to Follow-up|9|||
48669467|NCT02191605|156643163|FG001|Overall Study|Lost to Follow-up|4|||
48669468|NCT02191605|156643164|FG002|Overall Study|Lost to Follow-up|7|||
48669469|NCT02191605|156643165|FG003|Overall Study|Lost to Follow-up|3|||
48669470|NCT02191605|156643166|FG004|Overall Study|Lost to Follow-up|4|||
48669471|NCT03323736|156643171|FG000|Overall Study|Screen Failure|14|||
48669472|NCT03323736|156643172|FG001|Overall Study|Screen Failure|9|||
48669473|NCT03323736|156643173|FG002|Overall Study|Screen Failure|1|||
48669474|NCT03323736|156643171|FG000|Overall Study|Withdrawal Before Treatment|3|||
48669475|NCT03323736|156643172|FG001|Overall Study|Withdrawal Before Treatment|1|||
48669476|NCT03323736|156643173|FG002|Overall Study|Withdrawal Before Treatment|1|||
48669477|NCT03323736|156643171|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
48669478|NCT03323736|156643172|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
48669479|NCT03323736|156643173|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
48669480|NCT02017522|156643174|FG000|Overall Study|Withdrawal by Subject|1|||
48669481|NCT02455076|156643175|FG000|Inpatient|Withdrawal by Subject|1|||
48669482|NCT02455076|156643176|FG001|Inpatient|Withdrawal by Subject|0|||
48669483|NCT02455076|156643177|FG002|Inpatient|Withdrawal by Subject|0|||
48669484|NCT02455076|156643178|FG003|Inpatient|Withdrawal by Subject|0|||
48669485|NCT02455076|156643179|FG004|Inpatient|Withdrawal by Subject|0|||
48669486|NCT02455076|156643175|FG000|Inpatient|Discharged <24 h after admission|0|||
48669487|NCT02455076|156643176|FG001|Inpatient|Discharged <24 h after admission|1|||
48669488|NCT02455076|156643177|FG002|Inpatient|Discharged <24 h after admission|0|||
48669489|NCT02455076|156643178|FG003|Inpatient|Discharged <24 h after admission|0|||
48669490|NCT02455076|156643179|FG004|Inpatient|Discharged <24 h after admission|0|||
48669491|NCT02455076|156643175|FG000|Inpatient|Adverse Event|3|||
48669492|NCT02455076|156643176|FG001|Inpatient|Adverse Event|0|||
48669493|NCT02455076|156643177|FG002|Inpatient|Adverse Event|0|||
48669494|NCT02455076|156643178|FG003|Inpatient|Adverse Event|0|||
48669495|NCT02455076|156643179|FG004|Inpatient|Adverse Event|0|||
48669496|NCT02455076|156643175|FG000|Outpatient|Adverse Event|0|||
48669497|NCT02455076|156643176|FG001|Outpatient|Adverse Event|0|||
48669498|NCT02455076|156643177|FG002|Outpatient|Adverse Event|0|||
48669499|NCT02455076|156643178|FG003|Outpatient|Adverse Event|5|||
48669500|NCT02455076|156643179|FG004|Outpatient|Adverse Event|0|||
48669501|NCT02455076|156643175|FG000|Outpatient|Lost to Follow-up|0|||
48669502|NCT02455076|156643176|FG001|Outpatient|Lost to Follow-up|0|||
48669503|NCT02455076|156643177|FG002|Outpatient|Lost to Follow-up|0|||
48669504|NCT02455076|156643178|FG003|Outpatient|Lost to Follow-up|1|||
48669505|NCT02455076|156643179|FG004|Outpatient|Lost to Follow-up|12|||
48669506|NCT03002311|156643180|FG000|Overall Study|Lost to Follow-up|13|||
48669507|NCT03002311|156643181|FG001|Overall Study|Lost to Follow-up|26|||
48669508|NCT03002311|156643180|FG000|Overall Study|Referral provider called to schedule app|3|||
48669509|NCT03002311|156643181|FG001|Overall Study|Referral provider called to schedule app|3|||
48669510|NCT03002311|156643180|FG000|Overall Study|Physician Decision|3|||
48669511|NCT03002311|156643181|FG001|Overall Study|Physician Decision|1|||
48669512|NCT00940485|156643182|FG000|Overall Study|HBeAb positive at Baseline|3|||
48669513|NCT00940485|156643183|FG001|Overall Study|HBeAb positive at Baseline|2|||
48669514|NCT00940485|156643182|FG000|Overall Study|Lost to Follow-up|2|||
48669515|NCT00940485|156643183|FG001|Overall Study|Lost to Follow-up|3|||
48669516|NCT00940485|156643182|FG000|Overall Study|Adverse Event|8|||
48669517|NCT00940485|156643183|FG001|Overall Study|Adverse Event|0|||
48669518|NCT00940485|156643182|FG000|Overall Study|Withdrawal by Subject|1|||
48669519|NCT00940485|156643183|FG001|Overall Study|Withdrawal by Subject|1|||
48669520|NCT00940485|156643182|FG000|Overall Study|Others|1|||
48669521|NCT00940485|156643183|FG001|Overall Study|Others|1|||
48669522|NCT00286221|156643188|FG000|Overall Study|Protocol Violation|2|||
48669523|NCT00286221|156643189|FG001|Overall Study|Protocol Violation|1|||
48669524|NCT00286221|156643190|FG002|Overall Study|Protocol Violation|6|||
48669525|NCT00286221|156643191|FG003|Overall Study|Protocol Violation|4|||
48669526|NCT00286221|156643188|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
48669527|NCT00286221|156643189|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
48669528|NCT00286221|156643190|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
48669529|NCT00286221|156643191|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
48669530|NCT00286221|156643188|FG000|Overall Study|Inability to trigger PCA|2|||
48669531|NCT00286221|156643189|FG001|Overall Study|Inability to trigger PCA|0|||
48669532|NCT00286221|156643190|FG002|Overall Study|Inability to trigger PCA|0|||
48669533|NCT00286221|156643191|FG003|Overall Study|Inability to trigger PCA|0|||
48669534|NCT00286221|156643188|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
48669535|NCT00286221|156643189|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
48669536|NCT00286221|156643190|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
48669537|NCT00286221|156643191|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
48669538|NCT02648217|156643192|FG000|Overall Study|Adverse Event|0|||
48669539|NCT02648217|156643193|FG001|Overall Study|Adverse Event|1|||
48669540|NCT02648217|156643192|FG000|Overall Study|Lost to Follow-up|1|||
48669541|NCT02648217|156643193|FG001|Overall Study|Lost to Follow-up|1|||
48669542|NCT02648217|156643192|FG000|Overall Study|Withdrawal by Subject|4|||
48669543|NCT02648217|156643193|FG001|Overall Study|Withdrawal by Subject|3|||
48669544|NCT02648217|156643192|FG000|Overall Study|Unclassified|5|||
48669545|NCT02648217|156643193|FG001|Overall Study|Unclassified|0|||
48669546|NCT00548717|156643194|FG000|Overall Study|Death|5|||
48669547|NCT00548717|156643195|FG001|Overall Study|Death|2|||
48669548|NCT00548717|156643194|FG000|Overall Study|Relapse|3|||
48669549|NCT00548717|156643195|FG001|Overall Study|Relapse|0|||
48669550|NCT00548717|156643194|FG000|Overall Study|Alternative treatment for GVHD|1|||
48669551|NCT00548717|156643195|FG001|Overall Study|Alternative treatment for GVHD|0|||
48669552|NCT02642965|156643196|FG000|Overall Study|Lack of Efficacy|4|||
48669553|NCT02642965|156643196|FG000|Overall Study|Physician Decision|9|||
48669554|NCT02809053|156643197|FG000|Overall Study|Death|0|||
48669555|NCT02809053|156643198|FG001|Overall Study|Death|1|||
48669556|NCT02809053|156643197|FG000|Overall Study|Lost to Follow-up|3|||
48669557|NCT02809053|156643198|FG001|Overall Study|Lost to Follow-up|1|||
48669558|NCT02809053|156643197|FG000|Overall Study|Withdrawal by Subject|2|||
48669559|NCT02809053|156643198|FG001|Overall Study|Withdrawal by Subject|3|||
48669560|NCT02809053|156643197|FG000|Overall Study|Disease Progression|2|||
48669561|NCT02809053|156643198|FG001|Overall Study|Disease Progression|1|||
48669562|NCT02445573|156643201|FG000|Overall Study|Withdrawal by Subject|1|||
48669563|NCT02445573|156643202|FG001|Overall Study|Withdrawal by Subject|1|||
48669564|NCT02445573|156643201|FG000|Overall Study|Lost to Follow-up|0|||
48669565|NCT02445573|156643202|FG001|Overall Study|Lost to Follow-up|1|||
48669566|NCT00290498|156643203|FG000|Overall Study|Death|2|||
48669567|NCT00290498|156643204|FG001|Overall Study|Death|0|||
48669568|NCT00290498|156643203|FG000|Overall Study|Physician Decision|1|||
48669569|NCT00290498|156643204|FG001|Overall Study|Physician Decision|0|||
48669570|NCT00290498|156643203|FG000|Overall Study|Withdrawal by Subject|1|||
48669571|NCT00290498|156643204|FG001|Overall Study|Withdrawal by Subject|0|||
48759701|NCT03287804|156967995|FG000|Overall Study|Physician Decision|2|||
48759702|NCT03287804|156967995|FG000|Overall Study|Progressive disease|8|||
48759703|NCT01046682|156967997|FG000|Overall Study|Adverse Event|2|||
48759704|NCT01046682|156967998|FG001|Overall Study|Adverse Event|0|||
48759705|NCT00326950|156967999|FG000|Overall Study|Progressive Disease|1|||
48759706|NCT00949325|156968008|FG000|Overall Study|Adverse Event|0|||
48759707|NCT00949325|156968009|FG001|Overall Study|Adverse Event|2|||
48759708|NCT00949325|156968010|FG002|Overall Study|Adverse Event|0|||
48759709|NCT00451321|156968011|FG000|Overall Study|Lost to Follow-up|3|||
48759710|NCT00451321|156968012|FG001|Overall Study|Lost to Follow-up|3|||
48759711|NCT00451321|156968013|FG002|Overall Study|Lost to Follow-up|1|||
48759712|NCT00451321|156968014|FG003|Overall Study|Lost to Follow-up|3|||
48759713|NCT00451321|156968015|FG004|Overall Study|Lost to Follow-up|0|||
48759714|NCT00451321|156968016|FG005|Overall Study|Lost to Follow-up|1|||
48759715|NCT00451321|156968017|FG006|Overall Study|Lost to Follow-up|0|||
48759716|NCT00451321|156968018|FG007|Overall Study|Lost to Follow-up|0|||
48759717|NCT00451321|156968011|FG000|Overall Study|Withdrawal by Subject|3|||
48669572|NCT00290498|156643203|FG000|Overall Study|Ineligible|3|||
48669573|NCT00290498|156643204|FG001|Overall Study|Ineligible|0|||
48669574|NCT00290498|156643203|FG000|Overall Study|Non-Compliance|1|||
48669575|NCT00290498|156643204|FG001|Overall Study|Non-Compliance|0|||
48669576|NCT01716104|156643207|FG000|Overall Study|Do not meet inclusion criteria|6|||
48669577|NCT01716104|156643208|FG001|Overall Study|Do not meet inclusion criteria|7|||
48669578|NCT00635089|156643213|FG000|Overall Study|Adverse Event|7|||
48669579|NCT00635089|156643213|FG000|Overall Study|Lack of Efficacy|28|||
48669580|NCT00635089|156643213|FG000|Overall Study|Protocol Deviation|4|||
48669581|NCT00635089|156643213|FG000|Overall Study|Lost to Follow-up|8|||
48669582|NCT00635089|156643213|FG000|Overall Study|Other|31|||
48669583|NCT00975143|156643218|FG000|Overall Study|Adverse Event|19|||
48669584|NCT00975143|156643219|FG001|Overall Study|Adverse Event|15|||
48669585|NCT00975143|156643218|FG000|Overall Study|Withdrawal by Subject|15|||
48669586|NCT00975143|156643219|FG001|Overall Study|Withdrawal by Subject|15|||
48669587|NCT00975143|156643218|FG000|Overall Study|Lost to Follow-up|20|||
48669588|NCT00975143|156643219|FG001|Overall Study|Lost to Follow-up|16|||
48669589|NCT00975143|156643218|FG000|Overall Study|Non-compliance|5|||
48669590|NCT00975143|156643219|FG001|Overall Study|Non-compliance|8|||
48669591|NCT00975143|156643218|FG000|Overall Study|Physician Decision|1|||
48759718|NCT00451321|156968012|FG001|Overall Study|Withdrawal by Subject|1|||
48759719|NCT00451321|156968013|FG002|Overall Study|Withdrawal by Subject|0|||
48759720|NCT00451321|156968014|FG003|Overall Study|Withdrawal by Subject|4|||
48669592|NCT00975143|156643219|FG001|Overall Study|Physician Decision|2|||
48669593|NCT00975143|156643218|FG000|Overall Study|Details not available|10|||
48669594|NCT00975143|156643219|FG001|Overall Study|Details not available|4|||
48669595|NCT01283542|156643220|FG000|Main Phase|Acute or progressive vision loss|1|||
48669596|NCT01283542|156643220|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
48669597|NCT01283542|156643220|FG000|Main Phase|abnormal laboratory values|5|||
48669598|NCT01283542|156643220|FG000|Extension Phase|Physician Decision|1|||
48669599|NCT01283542|156643220|FG000|Extension Phase|Adverse Event|1|||
48669600|NCT01283542|156643220|FG000|Extension Phase|Administrative problems|1|||
48669601|NCT05059977|156643221|FG000|Overall Study|Withdrawal by Subject|0|||
48669602|NCT05059977|156643222|FG001|Overall Study|Withdrawal by Subject|0|||
48669603|NCT05059977|156643223|FG002|Overall Study|Withdrawal by Subject|1|||
48669604|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
48669605|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
48669606|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
48669607|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
48669608|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
48669609|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
48759721|NCT00451321|156968015|FG004|Overall Study|Withdrawal by Subject|0|||
48759722|NCT00451321|156968016|FG005|Overall Study|Withdrawal by Subject|0|||
48759723|NCT00451321|156968017|FG006|Overall Study|Withdrawal by Subject|0|||
48759724|NCT00451321|156968018|FG007|Overall Study|Withdrawal by Subject|0|||
48759725|NCT00451321|156968011|FG000|Overall Study|Study closed/terminated|1|||
48759726|NCT00451321|156968012|FG001|Overall Study|Study closed/terminated|1|||
48759727|NCT00451321|156968013|FG002|Overall Study|Study closed/terminated|17|||
48759728|NCT00451321|156968014|FG003|Overall Study|Study closed/terminated|5|||
48759729|NCT00451321|156968015|FG004|Overall Study|Study closed/terminated|7|||
48759730|NCT00451321|156968016|FG005|Overall Study|Study closed/terminated|7|||
48759731|NCT00451321|156968017|FG006|Overall Study|Study closed/terminated|5|||
48759732|NCT00451321|156968018|FG007|Overall Study|Study closed/terminated|3|||
48759733|NCT00451321|156968011|FG000|Overall Study|Sponsor decision to amend protocol|0|||
48759734|NCT00451321|156968012|FG001|Overall Study|Sponsor decision to amend protocol|0|||
48759735|NCT00451321|156968013|FG002|Overall Study|Sponsor decision to amend protocol|0|||
48759736|NCT00451321|156968014|FG003|Overall Study|Sponsor decision to amend protocol|0|||
48759737|NCT00451321|156968015|FG004|Overall Study|Sponsor decision to amend protocol|0|||
48759738|NCT00451321|156968016|FG005|Overall Study|Sponsor decision to amend protocol|1|||
48759739|NCT00451321|156968017|FG006|Overall Study|Sponsor decision to amend protocol|1|||
48759740|NCT00451321|156968018|FG007|Overall Study|Sponsor decision to amend protocol|3|||
48759741|NCT02064166|156968019|FG000|Overall Study|Adverse Event|1|||
48759742|NCT02064166|156968020|FG001|Overall Study|Adverse Event|0|||
48759743|NCT00993291|156968021|FG000|Overall Study|Withdrawal by Subject|1|||
48759744|NCT00149747|156968022|FG000|Overall Study|Death|1|||
48759745|NCT00149747|156968023|FG001|Overall Study|Death|0|||
48759746|NCT00149747|156968022|FG000|Overall Study|Withdrawal by Subject|3|||
48759747|NCT00149747|156968023|FG001|Overall Study|Withdrawal by Subject|3|||
48759748|NCT00271609|156968024|FG000|Overall Study|Adverse Event|11|||
48759749|NCT00271609|156968025|FG001|Overall Study|Adverse Event|3|||
48759750|NCT00271609|156968024|FG000|Overall Study|Withdrawal by Subject|2|||
48759751|NCT00271609|156968025|FG001|Overall Study|Withdrawal by Subject|0|||
48759752|NCT03051607|156968026|FG000|Overall Study|Adverse Event|66|||
48759753|NCT02039674|156968027|FG000|Overall Study|Adverse Event|0|||
48759754|NCT02039674|156968028|FG001|Overall Study|Adverse Event|0|||
48759755|NCT02039674|156968029|FG002|Overall Study|Adverse Event|0|||
48759756|NCT02039674|156968030|FG003|Overall Study|Adverse Event|1|||
48759757|NCT02039674|156968031|FG004|Overall Study|Adverse Event|0|||
48759758|NCT02039674|156968032|FG005|Overall Study|Adverse Event|0|||
48759759|NCT02039674|156968033|FG006|Overall Study|Adverse Event|0|||
48759760|NCT02039674|156968034|FG007|Overall Study|Adverse Event|0|||
48759761|NCT02039674|156968035|FG008|Overall Study|Adverse Event|2|||
48759762|NCT02039674|156968036|FG009|Overall Study|Adverse Event|1|||
48759763|NCT02039674|156968037|FG010|Overall Study|Adverse Event|0|||
48759764|NCT02039674|156968038|FG011|Overall Study|Adverse Event|2|||
48759765|NCT02039674|156968039|FG012|Overall Study|Adverse Event|3|||
48759766|NCT02039674|156968040|FG013|Overall Study|Adverse Event|1|||
48759767|NCT02039674|156968027|FG000|Overall Study|Death|2|||
48759768|NCT02039674|156968028|FG001|Overall Study|Death|0|||
48759769|NCT02039674|156968029|FG002|Overall Study|Death|2|||
48759770|NCT02039674|156968030|FG003|Overall Study|Death|3|||
48759771|NCT02039674|156968031|FG004|Overall Study|Death|0|||
48759772|NCT02039674|156968032|FG005|Overall Study|Death|0|||
48759773|NCT02039674|156968033|FG006|Overall Study|Death|1|||
48759774|NCT02039674|156968034|FG007|Overall Study|Death|0|||
48759775|NCT02039674|156968035|FG008|Overall Study|Death|2|||
48759776|NCT02039674|156968036|FG009|Overall Study|Death|0|||
48759777|NCT02039674|156968037|FG010|Overall Study|Death|1|||
48759778|NCT02039674|156968038|FG011|Overall Study|Death|3|||
48759779|NCT02039674|156968039|FG012|Overall Study|Death|2|||
48759780|NCT02039674|156968040|FG013|Overall Study|Death|8|||
48759781|NCT02039674|156968027|FG000|Overall Study|Excluded Medication|1|||
48759782|NCT02039674|156968028|FG001|Overall Study|Excluded Medication|1|||
48759783|NCT02039674|156968029|FG002|Overall Study|Excluded Medication|0|||
48759784|NCT02039674|156968030|FG003|Overall Study|Excluded Medication|1|||
48759785|NCT02039674|156968031|FG004|Overall Study|Excluded Medication|0|||
48759786|NCT02039674|156968032|FG005|Overall Study|Excluded Medication|1|||
48759787|NCT02039674|156968033|FG006|Overall Study|Excluded Medication|0|||
48759788|NCT02039674|156968034|FG007|Overall Study|Excluded Medication|0|||
48759789|NCT02039674|156968035|FG008|Overall Study|Excluded Medication|2|||
48669610|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
48759790|NCT02039674|156968036|FG009|Overall Study|Excluded Medication|3|||
48759791|NCT02039674|156968037|FG010|Overall Study|Excluded Medication|5|||
48759792|NCT02039674|156968038|FG011|Overall Study|Excluded Medication|6|||
48759793|NCT02039674|156968039|FG012|Overall Study|Excluded Medication|8|||
48759794|NCT02039674|156968040|FG013|Overall Study|Excluded Medication|3|||
48759795|NCT02039674|156968027|FG000|Overall Study|Lost to Follow-up|0|||
48759796|NCT02039674|156968028|FG001|Overall Study|Lost to Follow-up|0|||
48759797|NCT02039674|156968029|FG002|Overall Study|Lost to Follow-up|0|||
48759798|NCT02039674|156968030|FG003|Overall Study|Lost to Follow-up|0|||
48759799|NCT02039674|156968031|FG004|Overall Study|Lost to Follow-up|1|||
48759800|NCT02039674|156968032|FG005|Overall Study|Lost to Follow-up|1|||
48669611|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
48669612|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
48669613|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
48669614|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
48669615|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
48669616|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
48669617|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
48669618|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
48759801|NCT02039674|156968033|FG006|Overall Study|Lost to Follow-up|0|||
48669619|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
48669620|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
48669621|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
48759802|NCT02039674|156968034|FG007|Overall Study|Lost to Follow-up|0|||
48759803|NCT02039674|156968035|FG008|Overall Study|Lost to Follow-up|0|||
48759804|NCT02039674|156968036|FG009|Overall Study|Lost to Follow-up|0|||
48759805|NCT02039674|156968037|FG010|Overall Study|Lost to Follow-up|0|||
48669622|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
48669623|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
48759806|NCT02039674|156968038|FG011|Overall Study|Lost to Follow-up|2|||
48759807|NCT02039674|156968039|FG012|Overall Study|Lost to Follow-up|2|||
48759808|NCT02039674|156968040|FG013|Overall Study|Lost to Follow-up|1|||
48669624|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
48669625|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
48669626|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
48669627|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
48669628|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
48669629|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
48669630|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
48669631|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
48669632|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
48669633|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
48669634|NCT00121641|156643229|FG000|24-week Short-term Treatment Period|Other Reason|1|||
48669635|NCT00121641|156643230|FG001|24-week Short-term Treatment Period|Other Reason|0|||
48669636|NCT00121641|156643231|FG002|24-week Short-term Treatment Period|Other Reason|0|||
48669637|NCT00121641|156643232|FG003|24-week Short-term Treatment Period|Other Reason|0|||
48669638|NCT00121641|156643233|FG004|24-week Short-term Treatment Period|Other Reason|0|||
48669639|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
48759809|NCT02039674|156968027|FG000|Overall Study|Physician Decision|0|||
48759810|NCT02039674|156968028|FG001|Overall Study|Physician Decision|0|||
48759811|NCT02039674|156968029|FG002|Overall Study|Physician Decision|0|||
48759812|NCT02039674|156968030|FG003|Overall Study|Physician Decision|0|||
48759813|NCT02039674|156968031|FG004|Overall Study|Physician Decision|0|||
48759814|NCT02039674|156968032|FG005|Overall Study|Physician Decision|0|||
48759815|NCT02039674|156968033|FG006|Overall Study|Physician Decision|0|||
48759816|NCT02039674|156968034|FG007|Overall Study|Physician Decision|0|||
48759817|NCT02039674|156968035|FG008|Overall Study|Physician Decision|0|||
48759818|NCT02039674|156968036|FG009|Overall Study|Physician Decision|0|||
48759819|NCT02039674|156968037|FG010|Overall Study|Physician Decision|0|||
48759820|NCT02039674|156968038|FG011|Overall Study|Physician Decision|1|||
48759821|NCT02039674|156968039|FG012|Overall Study|Physician Decision|1|||
48759822|NCT02039674|156968040|FG013|Overall Study|Physician Decision|0|||
48759823|NCT02039674|156968027|FG000|Overall Study|Progressive Disease|8|||
48759824|NCT02039674|156968028|FG001|Overall Study|Progressive Disease|8|||
48759825|NCT02039674|156968029|FG002|Overall Study|Progressive Disease|6|||
48759826|NCT02039674|156968030|FG003|Overall Study|Progressive Disease|7|||
48759827|NCT02039674|156968031|FG004|Overall Study|Progressive Disease|9|||
48759828|NCT02039674|156968032|FG005|Overall Study|Progressive Disease|10|||
48759829|NCT02039674|156968033|FG006|Overall Study|Progressive Disease|1|||
48759830|NCT02039674|156968034|FG007|Overall Study|Progressive Disease|3|||
48759831|NCT02039674|156968035|FG008|Overall Study|Progressive Disease|6|||
48759832|NCT02039674|156968036|FG009|Overall Study|Progressive Disease|4|||
48759833|NCT02039674|156968037|FG010|Overall Study|Progressive Disease|0|||
48759834|NCT02039674|156968038|FG011|Overall Study|Progressive Disease|34|||
48759835|NCT02039674|156968039|FG012|Overall Study|Progressive Disease|34|||
48759836|NCT02039674|156968040|FG013|Overall Study|Progressive Disease|18|||
48759837|NCT02039674|156968027|FG000|Overall Study|Withdrawal by Subject|1|||
48759838|NCT02039674|156968028|FG001|Overall Study|Withdrawal by Subject|2|||
48759839|NCT02039674|156968029|FG002|Overall Study|Withdrawal by Subject|3|||
48759840|NCT02039674|156968030|FG003|Overall Study|Withdrawal by Subject|0|||
48759841|NCT02039674|156968031|FG004|Overall Study|Withdrawal by Subject|1|||
48759842|NCT02039674|156968032|FG005|Overall Study|Withdrawal by Subject|0|||
48759843|NCT02039674|156968033|FG006|Overall Study|Withdrawal by Subject|0|||
48759844|NCT02039674|156968034|FG007|Overall Study|Withdrawal by Subject|0|||
48759845|NCT02039674|156968035|FG008|Overall Study|Withdrawal by Subject|0|||
48759846|NCT02039674|156968036|FG009|Overall Study|Withdrawal by Subject|1|||
48759847|NCT02039674|156968037|FG010|Overall Study|Withdrawal by Subject|1|||
48759848|NCT02039674|156968038|FG011|Overall Study|Withdrawal by Subject|4|||
48759849|NCT02039674|156968039|FG012|Overall Study|Withdrawal by Subject|6|||
48759850|NCT02039674|156968040|FG013|Overall Study|Withdrawal by Subject|2|||
48759851|NCT02039674|156968027|FG000|Overall Study|Clinical Progression|0|||
48759852|NCT02039674|156968028|FG001|Overall Study|Clinical Progression|0|||
48759853|NCT02039674|156968029|FG002|Overall Study|Clinical Progression|0|||
48759854|NCT02039674|156968030|FG003|Overall Study|Clinical Progression|0|||
48759855|NCT02039674|156968031|FG004|Overall Study|Clinical Progression|0|||
48759856|NCT02039674|156968032|FG005|Overall Study|Clinical Progression|0|||
48759857|NCT02039674|156968033|FG006|Overall Study|Clinical Progression|1|||
48759858|NCT02039674|156968034|FG007|Overall Study|Clinical Progression|0|||
48759859|NCT02039674|156968035|FG008|Overall Study|Clinical Progression|0|||
48669640|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
48669641|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
48669642|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
48669643|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
48759860|NCT02039674|156968036|FG009|Overall Study|Clinical Progression|0|||
48669644|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
48669645|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
48669646|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
48669647|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
48669648|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
48669649|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
48669650|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
48669651|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
48669652|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
48759861|NCT02039674|156968037|FG010|Overall Study|Clinical Progression|0|||
48669653|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
48669654|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
48669655|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
48669656|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
48669657|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
48759862|NCT02039674|156968038|FG011|Overall Study|Clinical Progression|0|||
48759863|NCT02039674|156968039|FG012|Overall Study|Clinical Progression|1|||
48759864|NCT02039674|156968040|FG013|Overall Study|Clinical Progression|0|||
48759865|NCT02039674|156968027|FG000|Overall Study|Sponsor Decision|1|||
48759866|NCT02039674|156968028|FG001|Overall Study|Sponsor Decision|1|||
48759867|NCT02039674|156968029|FG002|Overall Study|Sponsor Decision|1|||
48759868|NCT02039674|156968030|FG003|Overall Study|Sponsor Decision|1|||
48759869|NCT02039674|156968031|FG004|Overall Study|Sponsor Decision|1|||
48759870|NCT02039674|156968032|FG005|Overall Study|Sponsor Decision|0|||
48759871|NCT02039674|156968033|FG006|Overall Study|Sponsor Decision|0|||
48759872|NCT02039674|156968034|FG007|Overall Study|Sponsor Decision|0|||
48669658|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
48669659|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
48669660|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
48669661|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
48669662|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
48669663|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
48759873|NCT02039674|156968035|FG008|Overall Study|Sponsor Decision|0|||
48759874|NCT02039674|156968036|FG009|Overall Study|Sponsor Decision|3|||
48759875|NCT02039674|156968037|FG010|Overall Study|Sponsor Decision|0|||
48669664|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
48759876|NCT02039674|156968038|FG011|Overall Study|Sponsor Decision|8|||
48759877|NCT02039674|156968039|FG012|Overall Study|Sponsor Decision|5|||
48759878|NCT02039674|156968040|FG013|Overall Study|Sponsor Decision|0|||
48759879|NCT02039674|156968027|FG000|Overall Study|Other|0|||
48759880|NCT02039674|156968028|FG001|Overall Study|Other|0|||
48759881|NCT02039674|156968029|FG002|Overall Study|Other|0|||
48759882|NCT02039674|156968030|FG003|Overall Study|Other|0|||
48759883|NCT02039674|156968031|FG004|Overall Study|Other|0|||
48759884|NCT02039674|156968032|FG005|Overall Study|Other|0|||
48759885|NCT02039674|156968033|FG006|Overall Study|Other|0|||
48759886|NCT02039674|156968034|FG007|Overall Study|Other|0|||
48759887|NCT02039674|156968035|FG008|Overall Study|Other|0|||
48759888|NCT02039674|156968036|FG009|Overall Study|Other|0|||
48759889|NCT02039674|156968037|FG010|Overall Study|Other|0|||
48759890|NCT02039674|156968038|FG011|Overall Study|Other|0|||
48759891|NCT02039674|156968039|FG012|Overall Study|Other|1|||
48759892|NCT02039674|156968040|FG013|Overall Study|Other|0|||
48759893|NCT02136576|156968047|FG000|Overall Study|Lost to Follow-up|2|||
48759894|NCT02136576|156968048|FG001|Overall Study|Lost to Follow-up|0|||
48759895|NCT02136576|156968049|FG002|Overall Study|Lost to Follow-up|0|||
48759896|NCT01092182|156968058|FG000|Overall Study|Death|0|||
48759897|NCT01092182|156968059|FG001|Overall Study|Death|5|||
48759898|NCT01092182|156968060|FG002|Overall Study|Death|3|||
48759899|NCT01092182|156968058|FG000|Overall Study|participant safety|1|||
48759900|NCT01092182|156968059|FG001|Overall Study|participant safety|2|||
48759901|NCT01092182|156968060|FG002|Overall Study|participant safety|0|||
48759902|NCT01092182|156968058|FG000|Overall Study|Physician Decision|0|||
48759903|NCT01092182|156968059|FG001|Overall Study|Physician Decision|6|||
48759904|NCT01092182|156968060|FG002|Overall Study|Physician Decision|0|||
48759905|NCT01092182|156968058|FG000|Overall Study|Did not meet criteria|0|||
48759906|NCT01092182|156968059|FG001|Overall Study|Did not meet criteria|0|||
48759907|NCT01092182|156968060|FG002|Overall Study|Did not meet criteria|25|||
48759908|NCT01092182|156968058|FG000|Overall Study|Non-compliance|0|||
48759909|NCT01092182|156968059|FG001|Overall Study|Non-compliance|3|||
48759910|NCT01092182|156968060|FG002|Overall Study|Non-compliance|0|||
48759911|NCT01092182|156968058|FG000|Overall Study|Participant refused follow-up|0|||
48759912|NCT01092182|156968059|FG001|Overall Study|Participant refused follow-up|2|||
48759913|NCT01092182|156968060|FG002|Overall Study|Participant refused follow-up|0|||
48759914|NCT01951157|156968061|FG000|Overall Study|Progressive Disease|12|||
48759915|NCT01951157|156968062|FG001|Overall Study|Progressive Disease|13|||
48759916|NCT01951157|156968063|FG002|Overall Study|Progressive Disease|10|||
48759917|NCT01951157|156968061|FG000|Overall Study|Treatment-unrelated AE|1|||
48759918|NCT01951157|156968062|FG001|Overall Study|Treatment-unrelated AE|0|||
48669665|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
48669666|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
48669667|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
48759919|NCT01951157|156968063|FG002|Overall Study|Treatment-unrelated AE|3|||
48759920|NCT01951157|156968061|FG000|Overall Study|Study Termination|0|||
48759921|NCT01951157|156968062|FG001|Overall Study|Study Termination|0|||
48759922|NCT01951157|156968063|FG002|Overall Study|Study Termination|1|||
48759923|NCT01951157|156968061|FG000|Overall Study|Physician Decision|5|||
48759924|NCT01951157|156968062|FG001|Overall Study|Physician Decision|3|||
48759925|NCT01951157|156968063|FG002|Overall Study|Physician Decision|2|||
48759926|NCT01951157|156968061|FG000|Overall Study|Non-treatmentrelated death|2|||
48759927|NCT01951157|156968062|FG001|Overall Study|Non-treatmentrelated death|2|||
48759928|NCT01951157|156968063|FG002|Overall Study|Non-treatmentrelated death|2|||
48759929|NCT01951157|156968061|FG000|Overall Study|No treated|0|||
48759930|NCT01951157|156968062|FG001|Overall Study|No treated|1|||
48759931|NCT01951157|156968063|FG002|Overall Study|No treated|0|||
48759932|NCT01951157|156968061|FG000|Overall Study|Treatment-related AE|2|||
48759933|NCT01951157|156968062|FG001|Overall Study|Treatment-related AE|0|||
48759934|NCT01951157|156968063|FG002|Overall Study|Treatment-related AE|4|||
48759935|NCT01951157|156968061|FG000|Overall Study|Consent withdrawn by subject|0|||
48759936|NCT01951157|156968062|FG001|Overall Study|Consent withdrawn by subject|1|||
48759937|NCT01951157|156968063|FG002|Overall Study|Consent withdrawn by subject|3|||
48759938|NCT01951157|156968061|FG000|Overall Study|Treatment-related death|0|||
48759939|NCT01951157|156968062|FG001|Overall Study|Treatment-related death|2|||
48759940|NCT01951157|156968063|FG002|Overall Study|Treatment-related death|0|||
48669668|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
48669669|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
48669670|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
48669671|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
48669672|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
48669673|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
48669674|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
48669675|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
48669676|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
48669677|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
48669678|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
48669679|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Death|0|||
48669680|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Death|0|||
48669681|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Death|0|||
48669682|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Death|1|||
48669683|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Death|0|||
48669684|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Missing|0|||
48669685|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Missing|0|||
48669686|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Missing|1|||
48669687|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Missing|0|||
48759941|NCT01712854|156968064|FG000|Overall Study|Physician Decision|1|||
48759942|NCT00238121|156968067|FG000|Overall Study|Withdrawal by Subject|1|||
48759943|NCT00238121|156968068|FG001|Overall Study|Withdrawal by Subject|1|||
48759944|NCT00238121|156968067|FG000|Overall Study|Adverse Event|2|||
48759945|NCT00238121|156968068|FG001|Overall Study|Adverse Event|1|||
48669688|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Missing|0|||
48669689|NCT00121641|156643229|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
48669690|NCT00121641|156643230|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
48669691|NCT00121641|156643231|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
48759946|NCT02587065|156968069|FG000|Overall Study|Adverse Event|14|||
48759947|NCT02587065|156968069|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
48759948|NCT02587065|156968069|FG000|Overall Study|Non-adherence to the Protocol|3|||
48759949|NCT02587065|156968069|FG000|Overall Study|Discontinuation of Study Medication|2|||
48759950|NCT02587065|156968069|FG000|Overall Study|Reason not Specified|3|||
48759951|NCT02447081|156968072|FG000|Overall Study|Death|161|||
48759952|NCT02447081|156968072|FG000|Overall Study|Lost to Follow-up|36|||
48759953|NCT02447081|156968072|FG000|Overall Study|Visit not completed|17|||
48759954|NCT02447081|156968072|FG000|Overall Study|unsuccessful implant procedure|10|||
48759955|NCT02867709|156968073|FG000|Treatment Period|Adverse Event|1|||
48759956|NCT02867709|156968074|FG001|Treatment Period|Adverse Event|1|||
48759957|NCT02867709|156968075|FG002|Treatment Period|Adverse Event|2|||
48759958|NCT02867709|156968073|FG000|Treatment Period|Withdrawal of Consent|7|||
48759959|NCT02867709|156968074|FG001|Treatment Period|Withdrawal of Consent|9|||
48759960|NCT02867709|156968075|FG002|Treatment Period|Withdrawal of Consent|8|||
48759961|NCT02867709|156968073|FG000|Treatment Period|Lost to Follow-up|17|||
48759962|NCT02867709|156968074|FG001|Treatment Period|Lost to Follow-up|20|||
48759963|NCT02867709|156968075|FG002|Treatment Period|Lost to Follow-up|20|||
48759964|NCT02867709|156968073|FG000|Treatment Period|Lack of Qualifying Event|42|||
48759965|NCT02867709|156968074|FG001|Treatment Period|Lack of Qualifying Event|55|||
48759966|NCT02867709|156968075|FG002|Treatment Period|Lack of Qualifying Event|42|||
48759967|NCT02867709|156968073|FG000|Treatment Period|Protocol Violation|3|||
48759968|NCT02867709|156968074|FG001|Treatment Period|Protocol Violation|2|||
48759969|NCT02867709|156968075|FG002|Treatment Period|Protocol Violation|3|||
48759970|NCT02867709|156968073|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
48759971|NCT02867709|156968074|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
48759972|NCT02867709|156968075|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
48759973|NCT02867709|156968073|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
48759974|NCT02867709|156968074|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
48759975|NCT02867709|156968075|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
48759976|NCT02867709|156968073|FG000|Safety Follow-up Period|Pregnancy|0|||
48759977|NCT02867709|156968074|FG001|Safety Follow-up Period|Pregnancy|1|||
48759978|NCT02867709|156968075|FG002|Safety Follow-up Period|Pregnancy|0|||
48759979|NCT02867709|156968073|FG000|Safety Follow-up Period|Protocol Violation|0|||
48759980|NCT02867709|156968074|FG001|Safety Follow-up Period|Protocol Violation|1|||
48759981|NCT02867709|156968075|FG002|Safety Follow-up Period|Protocol Violation|1|||
48759982|NCT01848756|156968076|FG000|Overall Study|Adverse Event|1|||
48759983|NCT01848756|156968076|FG000|Overall Study|Withdrawal by Subject|1|||
48759984|NCT01848756|156968076|FG000|Overall Study|Enrolled in Error|1|||
48759985|NCT01042236|156970018|FG000|Treatment Period 1|Adverse Event|0|||
48759986|NCT01042236|156970019|FG001|Treatment Period 1|Adverse Event|1|||
48759987|NCT01042236|156970020|FG002|Treatment Period 1|Adverse Event|0|||
48759988|NCT01042236|156970021|FG003|Treatment Period 1|Adverse Event|0|||
48759989|NCT01042236|156970022|FG004|Treatment Period 1|Adverse Event|1|||
48759990|NCT01042236|156970023|FG005|Treatment Period 1|Adverse Event|0|||
48759991|NCT01042236|156970018|FG000|Treatment Period 3|Adverse Event|0|||
48759992|NCT01042236|156970019|FG001|Treatment Period 3|Adverse Event|0|||
48759993|NCT01042236|156970020|FG002|Treatment Period 3|Adverse Event|0|||
48759994|NCT01042236|156970021|FG003|Treatment Period 3|Adverse Event|1|||
48759995|NCT01042236|156970022|FG004|Treatment Period 3|Adverse Event|0|||
48759996|NCT01042236|156970023|FG005|Treatment Period 3|Adverse Event|0|||
48759997|NCT01042236|156970018|FG000|Treatment Period 3|Protocol Violation|0|||
48759998|NCT01042236|156970019|FG001|Treatment Period 3|Protocol Violation|0|||
48759999|NCT01042236|156970020|FG002|Treatment Period 3|Protocol Violation|0|||
48760000|NCT01042236|156970021|FG003|Treatment Period 3|Protocol Violation|1|||
48760001|NCT01042236|156970022|FG004|Treatment Period 3|Protocol Violation|0|||
48760002|NCT01042236|156970023|FG005|Treatment Period 3|Protocol Violation|0|||
48760003|NCT02981342|156970027|FG000|Overall Study|Adverse Event|0|||
48760004|NCT02981342|156970028|FG001|Overall Study|Adverse Event|0|||
48760005|NCT02981342|156970029|FG002|Overall Study|Adverse Event|0|||
48760006|NCT02981342|156970030|FG003|Overall Study|Adverse Event|1|||
48760007|NCT02981342|156970027|FG000|Overall Study|Death|0|||
48669692|NCT00121641|156643232|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
48669693|NCT00121641|156643233|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
48669694|NCT02096263|156643236|FG000|Overall Study|Adverse Event|1|||
48669695|NCT02096263|156643237|FG001|Overall Study|Adverse Event|0|||
48669696|NCT02096263|156643238|FG002|Overall Study|Adverse Event|1|||
48669697|NCT02096263|156643236|FG000|Overall Study|Lost to Follow-up|14|||
48669698|NCT02096263|156643237|FG001|Overall Study|Lost to Follow-up|18|||
48669699|NCT02096263|156643238|FG002|Overall Study|Lost to Follow-up|15|||
48760008|NCT02981342|156970028|FG001|Overall Study|Death|9|||
48760009|NCT02981342|156970029|FG002|Overall Study|Death|9|||
48760010|NCT02981342|156970030|FG003|Overall Study|Death|4|||
48760011|NCT02981342|156970027|FG000|Overall Study|Withdrawal by Subject|0|||
48760012|NCT02981342|156970028|FG001|Overall Study|Withdrawal by Subject|0|||
48760013|NCT02981342|156970029|FG002|Overall Study|Withdrawal by Subject|3|||
48760014|NCT02981342|156970030|FG003|Overall Study|Withdrawal by Subject|1|||
48760015|NCT02981342|156970027|FG000|Overall Study|Study closed by sponsor|0|||
48760016|NCT02981342|156970028|FG001|Overall Study|Study closed by sponsor|0|||
48760017|NCT02981342|156970029|FG002|Overall Study|Study closed by sponsor|1|||
48760018|NCT02981342|156970030|FG003|Overall Study|Study closed by sponsor|1|||
48760019|NCT02981342|156970027|FG000|Overall Study|Randomized, Never Treated|0|||
48760020|NCT02981342|156970028|FG001|Overall Study|Randomized, Never Treated|1|||
48760021|NCT02981342|156970029|FG002|Overall Study|Randomized, Never Treated|0|||
48760022|NCT02981342|156970030|FG003|Overall Study|Randomized, Never Treated|7|||
48760023|NCT02981342|156970027|FG000|Overall Study|Lost to Follow-up|0|||
48760024|NCT02981342|156970028|FG001|Overall Study|Lost to Follow-up|1|||
48760025|NCT02981342|156970029|FG002|Overall Study|Lost to Follow-up|0|||
48760026|NCT02981342|156970030|FG003|Overall Study|Lost to Follow-up|0|||
48760027|NCT01372501|156970031|FG000|Overall Study|Adverse Event|4|||
48760028|NCT01372501|156970031|FG000|Overall Study|Device migration|1|||
48760029|NCT00462761|156970032|FG000|Overall Study|Adverse Event|6|||
48760030|NCT00462761|156970032|FG000|Overall Study|Withdrawal by Subject|9|||
48760031|NCT00462761|156970032|FG000|Overall Study|Physician Decision|5|||
48760032|NCT00462761|156970032|FG000|Overall Study|Disease progression|43|||
48760033|NCT00462761|156970032|FG000|Overall Study|Death|12|||
48760034|NCT00462761|156970032|FG000|Overall Study|Other|1|||
48760035|NCT01365507|156970033|FG000|Overall Study|Withdrawal Criteria|8|||
48760036|NCT01365507|156970034|FG001|Overall Study|Withdrawal Criteria|5|||
48760037|NCT01365507|156970033|FG000|Overall Study|Unclassified|1|||
48760038|NCT01365507|156970034|FG001|Overall Study|Unclassified|4|||
48760039|NCT01466348|156970037|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
48760040|NCT01466348|156970038|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
48760041|NCT02489344|156970039|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
48760042|NCT02489344|156970039|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
48760043|NCT02489344|156970039|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
48760044|NCT02489344|156970039|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
48760045|NCT01139450|156970050|FG000|Overall Study|Withdrawal by Subject|7|||
48760046|NCT01139450|156970051|FG001|Overall Study|Withdrawal by Subject|10|||
48760047|NCT01139450|156970052|FG002|Overall Study|Withdrawal by Subject|13|||
48760048|NCT01139450|156970050|FG000|Overall Study|Lack of Efficacy|3|||
48760049|NCT01139450|156970051|FG001|Overall Study|Lack of Efficacy|1|||
48760050|NCT01139450|156970052|FG002|Overall Study|Lack of Efficacy|8|||
48760051|NCT01139450|156970050|FG000|Overall Study|Protocol Violation|6|||
48760052|NCT01139450|156970051|FG001|Overall Study|Protocol Violation|5|||
48760053|NCT01139450|156970052|FG002|Overall Study|Protocol Violation|2|||
48669700|NCT02096263|156643236|FG000|Overall Study|Other|7|||
48669701|NCT02096263|156643237|FG001|Overall Study|Other|9|||
48669702|NCT02096263|156643238|FG002|Overall Study|Other|6|||
48669703|NCT02096263|156643236|FG000|Overall Study|Sponsor study termination|0|||
48669704|NCT02096263|156643237|FG001|Overall Study|Sponsor study termination|0|||
48669705|NCT02096263|156643238|FG002|Overall Study|Sponsor study termination|1|||
48669706|NCT02096263|156643236|FG000|Overall Study|Protocol Violation|7|||
48669707|NCT02096263|156643237|FG001|Overall Study|Protocol Violation|2|||
48669708|NCT02096263|156643238|FG002|Overall Study|Protocol Violation|8|||
48669709|NCT02096263|156643236|FG000|Overall Study|Withdrawal by Subject|5|||
48669710|NCT02096263|156643237|FG001|Overall Study|Withdrawal by Subject|7|||
48669711|NCT02096263|156643238|FG002|Overall Study|Withdrawal by Subject|8|||
48669712|NCT03322423|156643239|FG000|Period 1|Subject no longer eligible|0|||
48669713|NCT03322423|156643240|FG001|Period 1|Subject no longer eligible|1|||
48669714|NCT03322423|156643239|FG000|Period 1|Withdrawal by Subject|0|||
48669715|NCT03322423|156643240|FG001|Period 1|Withdrawal by Subject|1|||
48669716|NCT03322423|156643239|FG000|Period 1|Incorrect Lens Dispensed|1|||
48760054|NCT01139450|156970050|FG000|Overall Study|Lost to Follow-up|9|||
48760055|NCT01139450|156970051|FG001|Overall Study|Lost to Follow-up|7|||
48760056|NCT01139450|156970052|FG002|Overall Study|Lost to Follow-up|11|||
48760057|NCT01139450|156970050|FG000|Overall Study|Administrative|0|||
48760058|NCT01139450|156970051|FG001|Overall Study|Administrative|0|||
48760059|NCT01139450|156970052|FG002|Overall Study|Administrative|1|||
48760060|NCT01139450|156970050|FG000|Overall Study|Adverse Event|2|||
48669717|NCT03322423|156643240|FG001|Period 1|Incorrect Lens Dispensed|0|||
48669718|NCT03322423|156643239|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
48669719|NCT03322423|156643240|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
48760061|NCT01139450|156970051|FG001|Overall Study|Adverse Event|2|||
48760062|NCT01139450|156970052|FG002|Overall Study|Adverse Event|3|||
48760063|NCT00605475|156970058|FG000|Overall Study|Abnormal Laboratory Values|0|||
48760064|NCT00605475|156970059|FG001|Overall Study|Abnormal Laboratory Values|0|||
48760065|NCT00605475|156970060|FG002|Overall Study|Abnormal Laboratory Values|0|||
48669720|NCT03322423|156643239|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
48669721|NCT03322423|156643240|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
48669722|NCT03322423|156643239|FG000|Period 2|Protocol Violation|1|||
48669723|NCT03322423|156643240|FG001|Period 2|Protocol Violation|0|||
48669724|NCT03322423|156643239|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
48669725|NCT03322423|156643240|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
48669726|NCT01264770|156643241|FG000|Overall Study|Not reported|0|||
48669727|NCT01264770|156643242|FG001|Overall Study|Not reported|0|||
48669728|NCT01264770|156643243|FG002|Overall Study|Not reported|1|||
48669729|NCT01264770|156643244|FG003|Overall Study|Not reported|0|||
48669730|NCT01264770|156643245|FG004|Overall Study|Not reported|0|||
48669731|NCT01264770|156643246|FG005|Overall Study|Not reported|0|||
48669732|NCT01264770|156643241|FG000|Overall Study|e.g., change in circumstances|8|||
48669733|NCT01264770|156643242|FG001|Overall Study|e.g., change in circumstances|3|||
48669734|NCT01264770|156643243|FG002|Overall Study|e.g., change in circumstances|3|||
48669735|NCT01264770|156643244|FG003|Overall Study|e.g., change in circumstances|3|||
48669736|NCT01264770|156643245|FG004|Overall Study|e.g., change in circumstances|4|||
48669737|NCT01264770|156643246|FG005|Overall Study|e.g., change in circumstances|4|||
48669738|NCT01264770|156643241|FG000|Overall Study|Severe non-compliance to protocol|0|||
48669739|NCT01264770|156643242|FG001|Overall Study|Severe non-compliance to protocol|0|||
48669740|NCT01264770|156643243|FG002|Overall Study|Severe non-compliance to protocol|1|||
48669741|NCT01264770|156643244|FG003|Overall Study|Severe non-compliance to protocol|1|||
48669742|NCT01264770|156643245|FG004|Overall Study|Severe non-compliance to protocol|0|||
48669743|NCT01264770|156643246|FG005|Overall Study|Severe non-compliance to protocol|0|||
48669744|NCT01264770|156643241|FG000|Overall Study|Lack of therapeutic response|1|||
48669745|NCT01264770|156643242|FG001|Overall Study|Lack of therapeutic response|0|||
48669746|NCT01264770|156643243|FG002|Overall Study|Lack of therapeutic response|2|||
48669747|NCT01264770|156643244|FG003|Overall Study|Lack of therapeutic response|1|||
48669748|NCT01264770|156643245|FG004|Overall Study|Lack of therapeutic response|1|||
48669749|NCT01264770|156643246|FG005|Overall Study|Lack of therapeutic response|0|||
48669750|NCT01264770|156643241|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
48669751|NCT01264770|156643242|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
48669752|NCT01264770|156643243|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
48669753|NCT01264770|156643244|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
48669754|NCT01264770|156643245|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
48669755|NCT01264770|156643246|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
48669756|NCT01264770|156643241|FG000|Overall Study|Lost to Follow-up|0|||
48669757|NCT01264770|156643242|FG001|Overall Study|Lost to Follow-up|0|||
48669758|NCT01264770|156643243|FG002|Overall Study|Lost to Follow-up|1|||
48669759|NCT01264770|156643244|FG003|Overall Study|Lost to Follow-up|1|||
48669760|NCT01264770|156643245|FG004|Overall Study|Lost to Follow-up|0|||
48669761|NCT01264770|156643246|FG005|Overall Study|Lost to Follow-up|0|||
48669762|NCT01264770|156643241|FG000|Overall Study|Adverse Event|7|||
48669763|NCT01264770|156643242|FG001|Overall Study|Adverse Event|7|||
48669764|NCT01264770|156643243|FG002|Overall Study|Adverse Event|8|||
48669765|NCT01264770|156643244|FG003|Overall Study|Adverse Event|0|||
48669766|NCT01264770|156643245|FG004|Overall Study|Adverse Event|2|||
48669767|NCT01264770|156643246|FG005|Overall Study|Adverse Event|1|||
48669768|NCT01985360|156643249|FG000|Overall Study|Withdrawal by Subject|4|||
48669769|NCT01985360|156643250|FG001|Overall Study|Withdrawal by Subject|0|||
48669770|NCT01985360|156643249|FG000|Overall Study|Lost to Follow-up|5|||
48669771|NCT01985360|156643250|FG001|Overall Study|Lost to Follow-up|3|||
48669772|NCT02976103|156643251|FG000|Overall Study|Withdrawal by Subject|1|||
48669773|NCT02976103|156643252|FG001|Overall Study|Withdrawal by Subject|0|||
48669774|NCT02976103|156643251|FG000|Overall Study|Lost to Follow-up|12|||
48669775|NCT02976103|156643252|FG001|Overall Study|Lost to Follow-up|8|||
48669776|NCT02683668|156643256|FG000|Period 2|Withdrawal by Subject|0|||
48669777|NCT02683668|156643257|FG001|Period 2|Withdrawal by Subject|1|||
48669778|NCT02683668|156643258|FG002|Period 2|Withdrawal by Subject|0|||
48669779|NCT02544373|156643261|FG000|Overall Study|Lost to Follow-up|5|||
48669780|NCT02544373|156643262|FG001|Overall Study|Lost to Follow-up|3|||
48669781|NCT02544373|156643261|FG000|Overall Study|Withdrawal by Subject|8|||
48669782|NCT02544373|156643262|FG001|Overall Study|Withdrawal by Subject|2|||
48669783|NCT02117349|156643263|FG000|Overall Study|Withdrawal by Subject|1|||
48669784|NCT02117349|156643264|FG001|Overall Study|Withdrawal by Subject|0|||
48669785|NCT02117349|156643263|FG000|Overall Study|Lost to Follow-up|1|||
48669786|NCT02117349|156643264|FG001|Overall Study|Lost to Follow-up|1|||
48669787|NCT02117349|156643263|FG000|Overall Study|Death|1|||
48669788|NCT02117349|156643264|FG001|Overall Study|Death|0|||
48669789|NCT02265796|156643265|FG000|Overall Study|Death|1|||
48669790|NCT02265796|156643266|FG001|Overall Study|Death|0|||
48669791|NCT02265796|156643265|FG000|Overall Study|started on excluded medication|1|||
48669792|NCT02265796|156643266|FG001|Overall Study|started on excluded medication|0|||
48669793|NCT02265796|156643265|FG000|Overall Study|Withdrawal by Subject|1|||
48669794|NCT02265796|156643266|FG001|Overall Study|Withdrawal by Subject|1|||
48669795|NCT04023682|156643268|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
48669796|NCT00897390|156643271|FG000|Overall Study|Adverse Event|2|||
48669797|NCT00897390|156643271|FG000|Overall Study|No Longer Met Study Criteria|1|||
48669798|NCT00897390|156643271|FG000|Overall Study|Personal Reasons|1|||
48669799|NCT00897390|156643271|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
48669800|NCT00958217|156643277|FG000|Overall Study|Death|2|||
48669801|NCT00958217|156643278|FG001|Overall Study|Death|1|||
48669802|NCT00958217|156643277|FG000|Overall Study|Withdrawal by Subject|4|||
48669803|NCT00958217|156643278|FG001|Overall Study|Withdrawal by Subject|3|||
48669804|NCT00958217|156643277|FG000|Overall Study|Lost to Follow-up|17|||
48669805|NCT00958217|156643278|FG001|Overall Study|Lost to Follow-up|19|||
48669806|NCT00958217|156643277|FG000|Overall Study|Moved out of area|1|||
48669807|NCT00958217|156643278|FG001|Overall Study|Moved out of area|1|||
48669808|NCT00958217|156643277|FG000|Overall Study|Inpatient hospitalization|0|||
48669809|NCT00958217|156643278|FG001|Overall Study|Inpatient hospitalization|1|||
48669810|NCT04349033|156643280|FG000|Overall Study|Lost to Follow-up|3|||
48669811|NCT04349033|156643281|FG001|Overall Study|Lost to Follow-up|1|||
48669812|NCT04349033|156643282|FG002|Overall Study|Lost to Follow-up|1|||
48669813|NCT00324233|156643288|FG000|First Period|unable to insert catheter|1|||
48669814|NCT00324233|156643289|FG001|First Period|unable to insert catheter|0|||
48669815|NCT00324233|156643288|FG000|Second Period|unable to insert catheter|1|||
48669816|NCT00324233|156643289|FG001|Second Period|unable to insert catheter|1|||
48669817|NCT00324233|156643288|FG000|Second Period|Protocol Violation|4|||
48669818|NCT00324233|156643289|FG001|Second Period|Protocol Violation|6|||
48669819|NCT01972789|156643290|FG000|Overall Study|Adverse Event|11|||
48669820|NCT01972789|156643291|FG001|Overall Study|Adverse Event|4|||
48669821|NCT01972789|156643290|FG000|Overall Study|Subject withdrew consent|14|||
48669822|NCT01972789|156643291|FG001|Overall Study|Subject withdrew consent|12|||
48669823|NCT01972789|156643290|FG000|Overall Study|Lost to Follow-up|4|||
48669824|NCT01972789|156643291|FG001|Overall Study|Lost to Follow-up|7|||
48669825|NCT01972789|156643290|FG000|Overall Study|Death|7|||
48669826|NCT01972789|156643291|FG001|Overall Study|Death|5|||
48669827|NCT01972789|156643290|FG000|Overall Study|Protocol deviation|1|||
48669828|NCT01972789|156643291|FG001|Overall Study|Protocol deviation|0|||
48669829|NCT01972789|156643290|FG000|Overall Study|Physician Decision|3|||
48669830|NCT01972789|156643291|FG001|Overall Study|Physician Decision|2|||
48669831|NCT02198235|156643292|FG000|Overall Study|Lost to Follow-up|3|||
48669832|NCT02198235|156643293|FG001|Overall Study|Lost to Follow-up|2|||
48669833|NCT02198235|156643294|FG002|Overall Study|Lost to Follow-up|2|||
48669834|NCT03442296|156643296|FG000|3 Month Follow-up|Death|3|||
48669835|NCT03442296|156643297|FG001|3 Month Follow-up|Death|1|||
48669836|NCT03442296|156643296|FG000|3 Month Follow-up|Lost to Follow-up|1|||
48669837|NCT03442296|156643297|FG001|3 Month Follow-up|Lost to Follow-up|1|||
48669838|NCT03442296|156643296|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
48669839|NCT03442296|156643297|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
48669840|NCT03442296|156643296|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
48669841|NCT03442296|156643297|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
48669842|NCT03442296|156643296|FG000|12 Month Follow-up|Incomplete measurement|1|||
48669843|NCT03442296|156643297|FG001|12 Month Follow-up|Incomplete measurement|1|||
48669844|NCT00718770|156643298|FG000|Overall Study|Adverse Event|1|||
48669845|NCT00718770|156643298|FG000|Overall Study|Lack of Efficacy|1|||
48669846|NCT00718770|156643298|FG000|Overall Study|Lack of Efficacy|1|||
48669847|NCT00718770|156643298|FG000|Overall Study|Adverse Event|1|||
48669848|NCT00718770|156643298|FG000|Overall Study|Lack of Efficacy|1|||
48669849|NCT00718770|156643298|FG000|Overall Study|Adverse Event|1|||
48669850|NCT00718770|156643298|FG000|Overall Study|Lack of Efficacy|1|||
48669851|NCT00718770|156643298|FG000|Overall Study|Adverse Event|1|||
48669852|NCT00042666|156643299|FG000|Overall Study|Adverse Event|2|||
48669853|NCT00042666|156643299|FG000|Overall Study|Death|4|||
48669854|NCT00042666|156643299|FG000|Overall Study|Protocol Violation|1|||
48669855|NCT00042666|156643299|FG000|Overall Study|Participant/Physician Perception|1|||
48669856|NCT00042666|156643299|FG000|Overall Study|Progressive Disease|41|||
48669857|NCT00042666|156643299|FG000|Overall Study|Other|1|||
48669858|NCT00042666|156643299|FG000|Overall Study|Other|4|||
48669859|NCT02516228|156643302|FG000|Overall Study|Lost to Follow-up|1|||
48669860|NCT02516228|156643302|FG000|Overall Study|Withdrawal by Subject|1|||
48669861|NCT02516228|156643302|FG000|Overall Study|Physician Decision|1|||
48669862|NCT00727558|156643305|FG000|Overall Study|Lens issue|0|||
48669863|NCT00727558|156643306|FG001|Overall Study|Lens issue|1|||
48669864|NCT00727558|156643305|FG000|Overall Study|Adverse Event|0|||
48669865|NCT00727558|156643306|FG001|Overall Study|Adverse Event|1|||
48669866|NCT00727558|156643305|FG000|Overall Study|Subject unable to return for follow-up|1|||
48669867|NCT00727558|156643306|FG001|Overall Study|Subject unable to return for follow-up|1|||
48669868|NCT00727558|156643305|FG000|Overall Study|Lost to Follow-up|1|||
48669869|NCT00727558|156643306|FG001|Overall Study|Lost to Follow-up|0|||
48669870|NCT02478255|156643311|FG000|Overall Study|Physician Decision|6|||
48669871|NCT02478255|156643312|FG001|Overall Study|Physician Decision|0|||
48669872|NCT02478255|156643311|FG000|Overall Study|Withdrawal by Subject|2|||
48669873|NCT02478255|156643312|FG001|Overall Study|Withdrawal by Subject|0|||
48669874|NCT00664326|156644710|FG000|Overall Study|Adverse Event|14|||
48669875|NCT00664326|156644710|FG000|Overall Study|Noncompliance with study medication|3|||
48669876|NCT00664326|156644710|FG000|Overall Study|Withdrawal by Subject|1|||
48669877|NCT00664326|156644710|FG000|Overall Study|Physician Decision|1|||
48669878|NCT00664326|156644710|FG000|Overall Study|Other Reasons|3|||
48669879|NCT00664326|156644710|FG000|Overall Study|Death|2|||
48669880|NCT00664326|156644710|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
48669881|NCT05079477|156644711|FG000|Overall Study|Lost to Follow-up|2|||
48669882|NCT05079477|156644712|FG001|Overall Study|Lost to Follow-up|0|||
48669883|NCT05079477|156644711|FG000|Overall Study|Withdrawal by Subject|1|||
48669884|NCT05079477|156644712|FG001|Overall Study|Withdrawal by Subject|0|||
48669885|NCT05079477|156644711|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
48669886|NCT05079477|156644712|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
48669887|NCT05079477|156644711|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
48669888|NCT05079477|156644712|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
48669889|NCT04732949|156644713|FG000|Overall Study|Withdrawal by Subject|23|||
48669890|NCT04732949|156644714|FG001|Overall Study|Withdrawal by Subject|27|||
48669891|NCT04732949|156644713|FG000|Overall Study|Protocol Violation|0|||
48669892|NCT04732949|156644714|FG001|Overall Study|Protocol Violation|1|||
48669893|NCT04732949|156644713|FG000|Overall Study|Non-compliance|0|||
48669894|NCT04732949|156644714|FG001|Overall Study|Non-compliance|2|||
48669895|NCT04732949|156644713|FG000|Overall Study|Physician Decision|2|||
48669896|NCT04732949|156644714|FG001|Overall Study|Physician Decision|1|||
48669897|NCT04732949|156644713|FG000|Overall Study|Serious adverse event (Fatal)|16|||
48669898|NCT04732949|156644714|FG001|Overall Study|Serious adverse event (Fatal)|18|||
48760066|NCT00605475|156970061|FG003|Overall Study|Abnormal Laboratory Values|0|||
48760067|NCT00605475|156970062|FG004|Overall Study|Abnormal Laboratory Values|0|||
48760068|NCT00605475|156970063|FG005|Overall Study|Abnormal Laboratory Values|0|||
48760069|NCT00605475|156970064|FG006|Overall Study|Abnormal Laboratory Values|0|||
48760070|NCT00605475|156970065|FG007|Overall Study|Abnormal Laboratory Values|0|||
48760071|NCT00605475|156970066|FG008|Overall Study|Abnormal Laboratory Values|1|||
48760072|NCT00605475|156970067|FG009|Overall Study|Abnormal Laboratory Values|0|||
48669899|NCT04732949|156644713|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
48760073|NCT00605475|156970058|FG000|Overall Study|Administrative problems|0|||
48760074|NCT00605475|156970059|FG001|Overall Study|Administrative problems|0|||
48760075|NCT00605475|156970060|FG002|Overall Study|Administrative problems|0|||
48760076|NCT00605475|156970061|FG003|Overall Study|Administrative problems|0|||
48760077|NCT00605475|156970062|FG004|Overall Study|Administrative problems|0|||
48760078|NCT00605475|156970063|FG005|Overall Study|Administrative problems|0|||
48760079|NCT00605475|156970064|FG006|Overall Study|Administrative problems|1|||
48760080|NCT00605475|156970065|FG007|Overall Study|Administrative problems|0|||
48760081|NCT00605475|156970066|FG008|Overall Study|Administrative problems|0|||
48760082|NCT00605475|156970067|FG009|Overall Study|Administrative problems|0|||
48760083|NCT00605475|156970058|FG000|Overall Study|Lost to Follow-up|0|||
48669900|NCT04732949|156644714|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
48669901|NCT04732949|156644713|FG000|Overall Study|Non-serious adverse event|1|||
48669902|NCT04732949|156644714|FG001|Overall Study|Non-serious adverse event|3|||
48669903|NCT04732949|156644713|FG000|Overall Study|Lost to Follow-up|26|||
48669904|NCT04732949|156644714|FG001|Overall Study|Lost to Follow-up|27|||
48669905|NCT04732949|156644713|FG000|Overall Study|Other|6|||
48669906|NCT04732949|156644714|FG001|Overall Study|Other|3|||
48669907|NCT02771626|156644716|FG000|Overall Study|Adverse Event|1|||
48669908|NCT02771626|156644717|FG001|Overall Study|Adverse Event|5|||
48669909|NCT02771626|156644718|FG002|Overall Study|Adverse Event|3|||
48669910|NCT02771626|156644719|FG003|Overall Study|Adverse Event|0|||
48669911|NCT02771626|156644720|FG004|Overall Study|Adverse Event|1|||
48669912|NCT02771626|156644721|FG005|Overall Study|Adverse Event|1|||
48669913|NCT02771626|156644716|FG000|Overall Study|Radiologic Disease Progression|6|||
48669914|NCT02771626|156644717|FG001|Overall Study|Radiologic Disease Progression|13|||
48669915|NCT02771626|156644718|FG002|Overall Study|Radiologic Disease Progression|10|||
48669916|NCT02771626|156644719|FG003|Overall Study|Radiologic Disease Progression|7|||
48669917|NCT02771626|156644720|FG004|Overall Study|Radiologic Disease Progression|28|||
48669918|NCT02771626|156644721|FG005|Overall Study|Radiologic Disease Progression|15|||
48669919|NCT02771626|156644716|FG000|Overall Study|Symptomatic Deterioration|0|||
48669920|NCT02771626|156644717|FG001|Overall Study|Symptomatic Deterioration|4|||
48669921|NCT02771626|156644718|FG002|Overall Study|Symptomatic Deterioration|2|||
48669922|NCT02771626|156644719|FG003|Overall Study|Symptomatic Deterioration|0|||
48669923|NCT02771626|156644720|FG004|Overall Study|Symptomatic Deterioration|5|||
48760084|NCT00605475|156970059|FG001|Overall Study|Lost to Follow-up|0|||
48760085|NCT00605475|156970060|FG002|Overall Study|Lost to Follow-up|0|||
48760086|NCT00605475|156970061|FG003|Overall Study|Lost to Follow-up|0|||
48760087|NCT00605475|156970062|FG004|Overall Study|Lost to Follow-up|0|||
48669924|NCT02771626|156644721|FG005|Overall Study|Symptomatic Deterioration|2|||
48669925|NCT02771626|156644716|FG000|Overall Study|Participant Request|0|||
48669926|NCT02771626|156644717|FG001|Overall Study|Participant Request|1|||
48669927|NCT02771626|156644718|FG002|Overall Study|Participant Request|0|||
48669928|NCT02771626|156644719|FG003|Overall Study|Participant Request|2|||
48669929|NCT02771626|156644720|FG004|Overall Study|Participant Request|0|||
48669930|NCT02771626|156644721|FG005|Overall Study|Participant Request|1|||
48669931|NCT02771626|156644716|FG000|Overall Study|Investigator Decision|0|||
48669932|NCT02771626|156644717|FG001|Overall Study|Investigator Decision|1|||
48669933|NCT02771626|156644718|FG002|Overall Study|Investigator Decision|0|||
48669934|NCT02771626|156644719|FG003|Overall Study|Investigator Decision|0|||
48669935|NCT02771626|156644720|FG004|Overall Study|Investigator Decision|1|||
48669936|NCT02771626|156644721|FG005|Overall Study|Investigator Decision|0|||
48669937|NCT02771626|156644716|FG000|Overall Study|Study Termination by Sponsor|0|||
48669938|NCT02771626|156644717|FG001|Overall Study|Study Termination by Sponsor|2|||
48669939|NCT02771626|156644718|FG002|Overall Study|Study Termination by Sponsor|1|||
48669940|NCT02771626|156644719|FG003|Overall Study|Study Termination by Sponsor|0|||
48669941|NCT02771626|156644720|FG004|Overall Study|Study Termination by Sponsor|1|||
48669942|NCT02771626|156644721|FG005|Overall Study|Study Termination by Sponsor|0|||
48669943|NCT02771626|156644716|FG000|Overall Study|Informed Consent Withdrawn|0|||
48669944|NCT02771626|156644717|FG001|Overall Study|Informed Consent Withdrawn|0|||
48669945|NCT02771626|156644718|FG002|Overall Study|Informed Consent Withdrawn|1|||
48669946|NCT02771626|156644719|FG003|Overall Study|Informed Consent Withdrawn|0|||
48669947|NCT02771626|156644720|FG004|Overall Study|Informed Consent Withdrawn|1|||
48669948|NCT02771626|156644721|FG005|Overall Study|Informed Consent Withdrawn|1|||
48669949|NCT02771626|156644716|FG000|Overall Study|Other, Not Specified|1|||
48669950|NCT02771626|156644717|FG001|Overall Study|Other, Not Specified|0|||
48669951|NCT02771626|156644718|FG002|Overall Study|Other, Not Specified|0|||
48669952|NCT02771626|156644719|FG003|Overall Study|Other, Not Specified|0|||
48669953|NCT02771626|156644720|FG004|Overall Study|Other, Not Specified|0|||
48669954|NCT02771626|156644721|FG005|Overall Study|Other, Not Specified|1|||
48669955|NCT04094584|156644722|FG000|Overall Study|No interest in study|88|||
48669956|NCT04094584|156644722|FG000|Overall Study|Unwilling to undergo screening tests|36|||
48669957|NCT04094584|156644722|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
48669958|NCT04094584|156644722|FG000|Overall Study|Opioid use|7|||
48669959|NCT04094584|156644722|FG000|Overall Study|Need for major surgery in study period|4|||
48669960|NCT04094584|156644722|FG000|Overall Study|eligible but declined enrollment|4|||
48692784|NCT01188772|156724612|FG002|Overall Study|Randomized but Not Treated|0|||
48692785|NCT01188772|156724613|FG003|Overall Study|Randomized but Not Treated|0|||
48692786|NCT01188772|156724610|FG000|Overall Study|Adverse Event|0|||
48692787|NCT01188772|156724611|FG001|Overall Study|Adverse Event|1|||
48692788|NCT01188772|156724612|FG002|Overall Study|Adverse Event|2|||
48692789|NCT01188772|156724613|FG003|Overall Study|Adverse Event|0|||
48692790|NCT01188772|156724610|FG000|Overall Study|Lost to Follow-up|4|||
48692791|NCT01188772|156724611|FG001|Overall Study|Lost to Follow-up|1|||
48692792|NCT01188772|156724612|FG002|Overall Study|Lost to Follow-up|1|||
48692793|NCT01188772|156724613|FG003|Overall Study|Lost to Follow-up|1|||
48692794|NCT01188772|156724610|FG000|Overall Study|Non-responder|0|||
48692795|NCT01188772|156724611|FG001|Overall Study|Non-responder|0|||
48692796|NCT01188772|156724612|FG002|Overall Study|Non-responder|3|||
48692797|NCT01188772|156724613|FG003|Overall Study|Non-responder|0|||
48692798|NCT01188772|156724610|FG000|Overall Study|Physician Decision|0|||
48692799|NCT01188772|156724611|FG001|Overall Study|Physician Decision|0|||
48692800|NCT01188772|156724612|FG002|Overall Study|Physician Decision|1|||
48692801|NCT01188772|156724613|FG003|Overall Study|Physician Decision|0|||
48692802|NCT01188772|156724610|FG000|Overall Study|Terminated by Sponsor|0|||
48692803|NCT01188772|156724611|FG001|Overall Study|Terminated by Sponsor|0|||
48692804|NCT01188772|156724612|FG002|Overall Study|Terminated by Sponsor|1|||
48692805|NCT01188772|156724613|FG003|Overall Study|Terminated by Sponsor|0|||
48692806|NCT01188772|156724610|FG000|Overall Study|Treatment Failure|0|||
48692807|NCT01188772|156724611|FG001|Overall Study|Treatment Failure|0|||
48692808|NCT01188772|156724612|FG002|Overall Study|Treatment Failure|1|||
48692809|NCT01188772|156724613|FG003|Overall Study|Treatment Failure|0|||
48692810|NCT01188772|156724610|FG000|Overall Study|Virologic Failure|1|||
48692811|NCT01188772|156724611|FG001|Overall Study|Virologic Failure|0|||
48760088|NCT00605475|156970063|FG005|Overall Study|Lost to Follow-up|0|||
48760089|NCT00605475|156970064|FG006|Overall Study|Lost to Follow-up|0|||
48760090|NCT00605475|156970065|FG007|Overall Study|Lost to Follow-up|0|||
48760091|NCT00605475|156970066|FG008|Overall Study|Lost to Follow-up|1|||
48760092|NCT00605475|156970067|FG009|Overall Study|Lost to Follow-up|1|||
48760093|NCT00605475|156970058|FG000|Overall Study|Protocol Violation|0|||
48760094|NCT00605475|156970059|FG001|Overall Study|Protocol Violation|0|||
48760095|NCT00605475|156970060|FG002|Overall Study|Protocol Violation|0|||
48760096|NCT00605475|156970061|FG003|Overall Study|Protocol Violation|0|||
48760097|NCT00605475|156970062|FG004|Overall Study|Protocol Violation|1|||
48760098|NCT00605475|156970063|FG005|Overall Study|Protocol Violation|0|||
48760099|NCT00605475|156970064|FG006|Overall Study|Protocol Violation|0|||
48760100|NCT00605475|156970065|FG007|Overall Study|Protocol Violation|0|||
48760101|NCT00605475|156970066|FG008|Overall Study|Protocol Violation|0|||
48760102|NCT00605475|156970067|FG009|Overall Study|Protocol Violation|0|||
48760103|NCT00605475|156970058|FG000|Overall Study|Withdrawal by Subject|0|||
48669961|NCT04094584|156644722|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
48760104|NCT00605475|156970059|FG001|Overall Study|Withdrawal by Subject|0|||
48669962|NCT04094584|156644722|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
48669963|NCT04094584|156644722|FG000|Overall Study|Lost to Follow-up|3|||
48669964|NCT04094584|156644722|FG000|Overall Study|Withdrawal by Subject|2|||
48669965|NCT00300365|156644723|FG000|Overall Study|Lost to Follow-up|1|||
48669966|NCT00300365|156644724|FG001|Overall Study|Lost to Follow-up|0|||
48669967|NCT00300365|156644723|FG000|Overall Study|Physician Decision|2|||
48669968|NCT00300365|156644724|FG001|Overall Study|Physician Decision|0|||
48669969|NCT00300365|156644723|FG000|Overall Study|Withdrawal by Subject|1|||
48669970|NCT00300365|156644724|FG001|Overall Study|Withdrawal by Subject|0|||
48669971|NCT00300365|156644723|FG000|Overall Study|Adverse Event|0|||
48669972|NCT00300365|156644724|FG001|Overall Study|Adverse Event|2|||
48669973|NCT02717130|156644725|FG000|Overall Study|Withdrawal by Subject|1|||
48760105|NCT00605475|156970060|FG002|Overall Study|Withdrawal by Subject|0|||
48760106|NCT00605475|156970061|FG003|Overall Study|Withdrawal by Subject|0|||
48760107|NCT00605475|156970062|FG004|Overall Study|Withdrawal by Subject|0|||
48760108|NCT00605475|156970063|FG005|Overall Study|Withdrawal by Subject|2|||
48760109|NCT00605475|156970064|FG006|Overall Study|Withdrawal by Subject|0|||
48760110|NCT00605475|156970065|FG007|Overall Study|Withdrawal by Subject|0|||
48760111|NCT00605475|156970066|FG008|Overall Study|Withdrawal by Subject|0|||
48760112|NCT00605475|156970067|FG009|Overall Study|Withdrawal by Subject|1|||
48760113|NCT02357901|156970071|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
48760114|NCT02357901|156970072|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
48760115|NCT02357901|156970073|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
48669974|NCT02717130|156644725|FG000|Overall Study|Adverse Event|1|||
48760116|NCT02357901|156970074|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
48760117|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
48760118|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
48760119|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
48760120|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
48760121|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
48669975|NCT02717130|156644725|FG000|Overall Study|Physician Decision|1|||
48669976|NCT02717130|156644725|FG000|Overall Study|Study Closure|4|||
48669977|NCT00530920|156644728|FG000|Overall Study|Randomized but not treated|0|||
48669978|NCT00530920|156644729|FG001|Overall Study|Randomized but not treated|2|||
48669979|NCT00530920|156644730|FG002|Overall Study|Randomized but not treated|0|||
48669980|NCT00530920|156644728|FG000|Overall Study|Adverse Event|0|||
48669981|NCT00530920|156644729|FG001|Overall Study|Adverse Event|0|||
48669982|NCT00530920|156644730|FG002|Overall Study|Adverse Event|3|||
48669983|NCT00530920|156644728|FG000|Overall Study|Withdrawal by Subject|0|||
48669984|NCT00530920|156644729|FG001|Overall Study|Withdrawal by Subject|0|||
48669985|NCT00530920|156644730|FG002|Overall Study|Withdrawal by Subject|1|||
48669986|NCT03688555|156644731|FG000|Treatment Period|Adverse Event|0|||
48669987|NCT03688555|156644732|FG001|Treatment Period|Adverse Event|0|||
48669988|NCT03688555|156644733|FG002|Treatment Period|Adverse Event|1|||
48669989|NCT02900170|156644735|FG000|Overall Study|Lost to Follow-up|8|||
48669990|NCT01600053|156644738|FG000|Overall Study|Adverse Event|2|||
48669991|NCT01600053|156644738|FG000|Overall Study|trial will not meet the interim endpoint|9|||
48669992|NCT01177969|156644741|FG000|Overall Study|Protocol Violation|2|||
48669993|NCT01177969|156644742|FG001|Overall Study|Protocol Violation|1|||
48669994|NCT01177969|156644741|FG000|Overall Study|Withdrawal by Subject|1|||
48669995|NCT01177969|156644742|FG001|Overall Study|Withdrawal by Subject|2|||
48669996|NCT02421601|156644743|FG000|Overall Study|Adverse Event|4|||
48669997|NCT02421601|156644743|FG000|Overall Study|Lack of Efficacy|5|||
48669998|NCT02421601|156644743|FG000|Overall Study|Physician Decision|1|||
48669999|NCT02421601|156644743|FG000|Overall Study|Withdrawal by Subject|31|||
48670000|NCT02421601|156644743|FG000|Overall Study|Others|41|||
48670001|NCT00581360|156644745|FG000|Overall Study|Withdrawal by Subject|1|||
48670002|NCT00257660|156644747|FG000|Overall Study|Lack of Efficacy|5|||
48670003|NCT00257660|156644748|FG001|Overall Study|Lack of Efficacy|23|||
48670004|NCT00257660|156644747|FG000|Overall Study|Withdrawal by Subject|2|||
48670005|NCT00257660|156644748|FG001|Overall Study|Withdrawal by Subject|0|||
48670006|NCT00257660|156644747|FG000|Overall Study|Lost to Follow-up|1|||
48670007|NCT00257660|156644748|FG001|Overall Study|Lost to Follow-up|0|||
48586698|NCT01273155|156339055|FG000|Overall Study|Change in liver function/no longer eval.|0|||
48586699|NCT01273155|156339056|FG001|Overall Study|Change in liver function/no longer eval.|1|||
48586700|NCT01273155|156339057|FG002|Overall Study|Change in liver function/no longer eval.|0|||
48586701|NCT01273155|156339058|FG003|Overall Study|Change in liver function/no longer eval.|0|||
48586702|NCT01273155|156339059|FG004|Overall Study|Change in liver function/no longer eval.|1|||
48586703|NCT01273155|156339060|FG005|Overall Study|Change in liver function/no longer eval.|0|||
48586704|NCT01273155|156339061|FG006|Overall Study|Change in liver function/no longer eval.|0|||
48586705|NCT01273155|156339055|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
48586706|NCT01273155|156339056|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
48586707|NCT01273155|156339057|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
48586708|NCT01273155|156339058|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
48586709|NCT01273155|156339059|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
48586710|NCT01273155|156339060|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
48586711|NCT01273155|156339061|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
48586712|NCT01273155|156339055|FG000|Overall Study|Died during Cycle 1|0|||
48586713|NCT01273155|156339056|FG001|Overall Study|Died during Cycle 1|0|||
48586714|NCT01273155|156339057|FG002|Overall Study|Died during Cycle 1|1|||
48586715|NCT01273155|156339058|FG003|Overall Study|Died during Cycle 1|1|||
48586716|NCT01273155|156339059|FG004|Overall Study|Died during Cycle 1|0|||
48586717|NCT01273155|156339060|FG005|Overall Study|Died during Cycle 1|2|||
48586718|NCT01273155|156339061|FG006|Overall Study|Died during Cycle 1|2|||
48586719|NCT01273155|156339055|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
48586720|NCT01273155|156339056|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
48586721|NCT01273155|156339057|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
48586722|NCT01273155|156339058|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
48586723|NCT01273155|156339059|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
48586724|NCT01273155|156339060|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
48586725|NCT01273155|156339061|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
48586726|NCT01606202|156339062|FG000|Overall Study|Adverse Event|5|||
48586727|NCT01606202|156339063|FG001|Overall Study|Adverse Event|0|||
48586728|NCT01606202|156339062|FG000|Overall Study|Withdrawal by Subject|2|||
48586729|NCT01606202|156339063|FG001|Overall Study|Withdrawal by Subject|1|||
48586730|NCT01606202|156339062|FG000|Overall Study|Personal problems|0|||
48586731|NCT01606202|156339063|FG001|Overall Study|Personal problems|1|||
48586732|NCT01606202|156339062|FG000|Overall Study|Problems with administration|0|||
48586733|NCT01606202|156339063|FG001|Overall Study|Problems with administration|1|||
48586734|NCT00380718|156339064|FG000|Overall Study|Adverse Event|1|||
48586735|NCT00380718|156339064|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
48586736|NCT05020366|156339066|FG000|Overall Study|Lost to Follow-up|2|||
48586737|NCT05020366|156339067|FG001|Overall Study|Lost to Follow-up|0|||
48586738|NCT05020366|156339066|FG000|Overall Study|Withdrawal by Subject|2|||
48586739|NCT05020366|156339067|FG001|Overall Study|Withdrawal by Subject|0|||
48586740|NCT00483704|156339069|FG000|Randomization|Withdrawal by Subject|19|||
48586741|NCT00483704|156339070|FG001|Randomization|Withdrawal by Subject|28|||
48586742|NCT00483704|156339071|FG002|Randomization|Withdrawal by Subject|18|||
48586743|NCT00483704|156339069|FG000|Randomization|Protocol Violation|14|||
48586744|NCT00483704|156339070|FG001|Randomization|Protocol Violation|25|||
48586745|NCT00483704|156339071|FG002|Randomization|Protocol Violation|22|||
48586746|NCT00483704|156339069|FG000|Randomization|Lost to Follow-up|14|||
48586747|NCT00483704|156339070|FG001|Randomization|Lost to Follow-up|14|||
48586748|NCT00483704|156339071|FG002|Randomization|Lost to Follow-up|19|||
48586749|NCT00483704|156339069|FG000|Randomization|Pregnancy|1|||
48586750|NCT00483704|156339070|FG001|Randomization|Pregnancy|0|||
48586751|NCT00483704|156339071|FG002|Randomization|Pregnancy|0|||
48586752|NCT00483704|156339069|FG000|Randomization|Physician Decision|2|||
48586753|NCT00483704|156339070|FG001|Randomization|Physician Decision|4|||
48586754|NCT00483704|156339071|FG002|Randomization|Physician Decision|0|||
48586755|NCT00483704|156339069|FG000|Randomization|Progressive disease|0|||
48670008|NCT00257660|156644747|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
48670009|NCT00257660|156644748|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
48670010|NCT00257660|156644747|FG000|Overall Study|No longer wanted to do blood draws|1|||
48670011|NCT00257660|156644748|FG001|Overall Study|No longer wanted to do blood draws|0|||
48670012|NCT00491608|156644749|FG000|Overall Study|Death|2|||
48670013|NCT00491608|156644749|FG000|Overall Study|Withdrawal by Subject|1|||
48670014|NCT02925741|156644750|FG000|Overall Study|Withdrawal by Subject|11|||
48670015|NCT02925741|156644751|FG001|Overall Study|Withdrawal by Subject|0|||
48670016|NCT00025155|156644752|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
48670017|NCT00025155|156644752|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
48670018|NCT05086510|156644755|FG000|Overall Study|Lost to Follow-up|0|||
48670019|NCT05086510|156644756|FG001|Overall Study|Lost to Follow-up|2|||
48670020|NCT05086510|156644755|FG000|Overall Study|Death|0|||
48670021|NCT05086510|156644756|FG001|Overall Study|Death|2|||
48670022|NCT00587847|156644762|FG000|Overall Study|Lack of Efficacy|5|||
48670023|NCT00587847|156644762|FG000|Overall Study|Adverse Event|2|||
48670024|NCT00343382|156644763|FG000|Overall Study|Adverse Event|2|||
48670025|NCT00343382|156644764|FG001|Overall Study|Adverse Event|10|||
48670026|NCT00343382|156644765|FG002|Overall Study|Adverse Event|7|||
48670027|NCT00343382|156644763|FG000|Overall Study|Withdrawal by Subject|1|||
48670028|NCT00343382|156644764|FG001|Overall Study|Withdrawal by Subject|2|||
48670029|NCT00343382|156644765|FG002|Overall Study|Withdrawal by Subject|6|||
48670030|NCT00343382|156644763|FG000|Overall Study|Other Reason Not Specified|1|||
48670031|NCT00343382|156644764|FG001|Overall Study|Other Reason Not Specified|2|||
48670032|NCT00343382|156644765|FG002|Overall Study|Other Reason Not Specified|4|||
48670033|NCT04032080|156644766|FG000|Overall Study|Death|6|||
48670034|NCT04881747|156644767|FG000|Period 2 Washout|Adverse Event|1|||
48670035|NCT04881747|156644768|FG001|Period 2 Washout|Adverse Event|0|||
48670036|NCT04881747|156644769|FG002|Period 2 Washout|Adverse Event|0|||
48670037|NCT04881747|156644770|FG003|Period 2 Washout|Adverse Event|0|||
48670038|NCT04881747|156644771|FG004|Period 2 Washout|Adverse Event|1|||
48670039|NCT04881747|156644772|FG005|Period 2 Washout|Adverse Event|0|||
48670040|NCT04881747|156644767|FG000|Period 2 Washout|Withdrawal by Subject|1|||
48670041|NCT04881747|156644768|FG001|Period 2 Washout|Withdrawal by Subject|0|||
48670042|NCT04881747|156644769|FG002|Period 2 Washout|Withdrawal by Subject|0|||
48670043|NCT04881747|156644770|FG003|Period 2 Washout|Withdrawal by Subject|1|||
48670044|NCT04881747|156644771|FG004|Period 2 Washout|Withdrawal by Subject|0|||
48670045|NCT04881747|156644772|FG005|Period 2 Washout|Withdrawal by Subject|0|||
48670046|NCT03332160|156644773|FG000|Overall Study|Withdrawal by Subject|1|||
48670047|NCT03332160|156644774|FG001|Overall Study|Withdrawal by Subject|1|||
48670048|NCT03332160|156644773|FG000|Overall Study|Adverse Event|0|||
48670049|NCT03332160|156644774|FG001|Overall Study|Adverse Event|1|||
48670050|NCT03332160|156644773|FG000|Overall Study|Developed Exclusion Criteria|0|||
48670051|NCT03332160|156644774|FG001|Overall Study|Developed Exclusion Criteria|1|||
48670052|NCT03332160|156644773|FG000|Overall Study|Non-adherence to treatment|0|||
48670053|NCT03332160|156644774|FG001|Overall Study|Non-adherence to treatment|2|||
48670054|NCT00409344|156644775|FG000|Overall Study|no enrollment|0|||
48670055|NCT00409344|156644776|FG001|Overall Study|no enrollment|0|||
48670056|NCT00351273|156644778|FG000|Overall Study|Lost to Follow-up|1|||
48670057|NCT00351273|156644779|FG001|Overall Study|Lost to Follow-up|2|||
48670058|NCT00351273|156644780|FG002|Overall Study|Lost to Follow-up|5|||
48670059|NCT03869333|156644783|FG000|Overall Study|Lost to Follow-up|1|||
48670060|NCT03869333|156644784|FG001|Overall Study|Lost to Follow-up|0|||
48670061|NCT03869333|156644785|FG002|Overall Study|Lost to Follow-up|0|||
48670062|NCT03869333|156644786|FG003|Overall Study|Lost to Follow-up|0|||
48670063|NCT03869333|156644783|FG000|Overall Study|Pregnancy|1|||
48760122|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
48670064|NCT03869333|156644784|FG001|Overall Study|Pregnancy|0|||
48670065|NCT03869333|156644785|FG002|Overall Study|Pregnancy|0|||
48670066|NCT03869333|156644786|FG003|Overall Study|Pregnancy|0|||
48760123|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
48760124|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
48760125|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
48760126|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
48760127|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
48760128|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
48760129|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
48760130|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
48760131|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
48760132|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
48342465|NCT00187135|155449220|FG004|Visit Two|Withdrawal by Subject|1|||
48670067|NCT03869333|156644783|FG000|Overall Study|Physician Decision|0|||
48670068|NCT03869333|156644784|FG001|Overall Study|Physician Decision|1|||
48670069|NCT03869333|156644785|FG002|Overall Study|Physician Decision|0|||
48670070|NCT03869333|156644786|FG003|Overall Study|Physician Decision|0|||
48670071|NCT04208087|156644789|FG000|Overall Study|Adverse Event|1|||
48670072|NCT04208087|156644790|FG001|Overall Study|Adverse Event|0|||
48670073|NCT04208087|156644791|FG002|Overall Study|Adverse Event|0|||
48670074|NCT04208087|156644792|FG003|Overall Study|Adverse Event|0|||
48670075|NCT04208087|156644793|FG004|Overall Study|Adverse Event|0|||
48670076|NCT04208087|156644789|FG000|Overall Study|Withdrawal by Subject|0|||
48670077|NCT04208087|156644790|FG001|Overall Study|Withdrawal by Subject|0|||
48760133|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
48760134|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
48760135|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
48760136|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
48760137|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
48760138|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
48760139|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
48760140|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
48760141|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
48760142|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
48760143|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
48760144|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
48760145|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
48760146|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
48760147|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
48760148|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
48760149|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
48760150|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
48760151|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
48760152|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
48760153|NCT02357901|156970071|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
48760154|NCT02357901|156970072|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
48760155|NCT02357901|156970073|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
48760156|NCT02357901|156970074|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
48760157|NCT00413192|156970082|FG000|Overall Study|Disease progression|26|||
48760158|NCT00413192|156970083|FG001|Overall Study|Disease progression|31|||
48760159|NCT00413192|156970084|FG002|Overall Study|Disease progression|16|||
48760160|NCT00413192|156970085|FG003|Overall Study|Disease progression|25|||
48760161|NCT00413192|156970082|FG000|Overall Study|Toxicity|3|||
48760162|NCT00413192|156970083|FG001|Overall Study|Toxicity|2|||
48760163|NCT00413192|156970084|FG002|Overall Study|Toxicity|2|||
48760164|NCT00413192|156970085|FG003|Overall Study|Toxicity|2|||
48760165|NCT00413192|156970082|FG000|Overall Study|Withdrawal by Subject|3|||
48760166|NCT00413192|156970083|FG001|Overall Study|Withdrawal by Subject|5|||
48760167|NCT00413192|156970084|FG002|Overall Study|Withdrawal by Subject|0|||
48760168|NCT00413192|156970085|FG003|Overall Study|Withdrawal by Subject|1|||
48760169|NCT00413192|156970082|FG000|Overall Study|Intercurrent illness|0|||
48760170|NCT00413192|156970083|FG001|Overall Study|Intercurrent illness|0|||
48760171|NCT00413192|156970084|FG002|Overall Study|Intercurrent illness|0|||
48760172|NCT00413192|156970085|FG003|Overall Study|Intercurrent illness|1|||
48760173|NCT00413192|156970082|FG000|Overall Study|Intercurrent death|0|||
48760174|NCT00413192|156970083|FG001|Overall Study|Intercurrent death|1|||
48760175|NCT00413192|156970084|FG002|Overall Study|Intercurrent death|0|||
48760176|NCT00413192|156970085|FG003|Overall Study|Intercurrent death|0|||
48760177|NCT00413192|156970082|FG000|Overall Study|Other|5|||
48760178|NCT00413192|156970083|FG001|Overall Study|Other|1|||
48760179|NCT00413192|156970084|FG002|Overall Study|Other|1|||
48760180|NCT00413192|156970085|FG003|Overall Study|Other|2|||
48760181|NCT00413192|156970082|FG000|Overall Study|Not treated|0|||
48760182|NCT00413192|156970083|FG001|Overall Study|Not treated|0|||
48760183|NCT00413192|156970084|FG002|Overall Study|Not treated|0|||
48760184|NCT00413192|156970085|FG003|Overall Study|Not treated|1|||
48760185|NCT00278954|156970090|FG000|Overall Study|Adverse Event|3|||
48760186|NCT00278954|156970090|FG000|Overall Study|Lost to Follow-up|1|||
48760187|NCT00278954|156970090|FG000|Overall Study|Withdrawal by Subject|1|||
48760188|NCT01454570|156970095|FG000|Overall Study|Withdrawal by Subject|2|||
48760189|NCT01454570|156970095|FG000|Overall Study|Screen Failure|7|||
48760190|NCT00772707|156970096|FG000|Overall Study|Withdrawn|3|||
48760191|NCT00885755|156970098|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
48760192|NCT00885755|156970099|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
48760193|NCT00885755|156970100|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
48760194|NCT00885755|156970098|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
48760195|NCT00885755|156970099|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
48760196|NCT00885755|156970100|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
48760197|NCT00885755|156970098|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
48760198|NCT00885755|156970099|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
48760199|NCT00885755|156970100|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
48760200|NCT00885755|156970098|FG000|Part I: Trastuzumab+Taxane|Death|0|||
48760201|NCT00885755|156970099|FG001|Part I: Trastuzumab+Taxane|Death|0|||
48760202|NCT00885755|156970100|FG002|Part I: Trastuzumab+Taxane|Death|1|||
48760203|NCT00885755|156970098|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
48670078|NCT04208087|156644791|FG002|Overall Study|Withdrawal by Subject|1|||
48670079|NCT04208087|156644792|FG003|Overall Study|Withdrawal by Subject|0|||
48760204|NCT00885755|156970099|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
48760205|NCT00885755|156970100|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
48760206|NCT01266460|156970101|FG000|Overall Study|Adverse Event|3|||
48760207|NCT01266460|156970101|FG000|Overall Study|Withdrawal by Subject|5|||
48760208|NCT01266460|156970101|FG000|Overall Study|Disease Progression|18|||
48760209|NCT01266460|156970101|FG000|Overall Study|Not otherwise specified|8|||
48760210|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
48760211|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
48760212|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
48760213|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
48760214|NCT01589445|156970102|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
48760215|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
48760216|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
48760217|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
48760218|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
48760219|NCT01589445|156970102|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
48760220|NCT01050257|156970117|FG000|Overall Study|Adverse Event|4|||
48760221|NCT01050257|156970118|FG001|Overall Study|Adverse Event|4|||
48760222|NCT01050257|156970119|FG002|Overall Study|Adverse Event|2|||
48760223|NCT01050257|156970117|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
48670080|NCT04208087|156644793|FG004|Overall Study|Withdrawal by Subject|0|||
48670081|NCT04208087|156644789|FG000|Overall Study|Other|0|||
48670082|NCT04208087|156644790|FG001|Overall Study|Other|0|||
48670083|NCT04208087|156644791|FG002|Overall Study|Other|0|||
48670084|NCT04208087|156644792|FG003|Overall Study|Other|0|||
48670085|NCT04208087|156644793|FG004|Overall Study|Other|1|||
48670086|NCT01198509|156644794|FG000|Overall Study|Withdrawal by Subject|1|||
48760224|NCT01050257|156970118|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
48670087|NCT01198509|156644795|FG001|Overall Study|Withdrawal by Subject|0|||
48670088|NCT01198509|156644796|FG002|Overall Study|Withdrawal by Subject|0|||
48760225|NCT01050257|156970119|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
48760226|NCT01050257|156970117|FG000|Overall Study|Withdrawal by Subject|0|||
48760227|NCT01050257|156970118|FG001|Overall Study|Withdrawal by Subject|3|||
48760228|NCT01050257|156970119|FG002|Overall Study|Withdrawal by Subject|0|||
48760229|NCT01050257|156970117|FG000|Overall Study|No reason specified|0|||
48760230|NCT01050257|156970118|FG001|Overall Study|No reason specified|0|||
48760231|NCT01050257|156970119|FG002|Overall Study|No reason specified|2|||
48760232|NCT01050257|156970117|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
48760233|NCT01050257|156970118|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
48760234|NCT01050257|156970119|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
48760235|NCT01050257|156970117|FG000|Overall Study|Violation criteria|0|||
48760236|NCT01050257|156970118|FG001|Overall Study|Violation criteria|1|||
48760237|NCT01050257|156970119|FG002|Overall Study|Violation criteria|0|||
48760238|NCT01050257|156970117|FG000|Overall Study|Failure to return|0|||
48760239|NCT01050257|156970118|FG001|Overall Study|Failure to return|2|||
48670089|NCT01198509|156644797|FG003|Overall Study|Withdrawal by Subject|0|||
48670090|NCT01198509|156644798|FG004|Overall Study|Withdrawal by Subject|0|||
48670091|NCT01198509|156644799|FG005|Overall Study|Withdrawal by Subject|0|||
48670092|NCT02228096|156644805|FG000|Overall Study|Study terminated by Sponsor|24|||
48670093|NCT02228096|156644805|FG000|Overall Study|Lack of Efficacy|18|||
48670094|NCT02228096|156644805|FG000|Overall Study|Death|12|||
48670095|NCT02228096|156644805|FG000|Overall Study|Physician Decision|3|||
48670096|NCT02228096|156644805|FG000|Overall Study|Subject/guardian decision|2|||
48670097|NCT02228096|156644805|FG000|Overall Study|New therapy for study indication|1|||
48670098|NCT02228096|156644805|FG000|Overall Study|Enrolled, not infused|11|||
48670099|NCT01969721|156644807|FG000|Overall Study|Adverse Event|3|||
48670100|NCT01969721|156644808|FG001|Overall Study|Adverse Event|8|||
48670101|NCT01969721|156644809|FG002|Overall Study|Adverse Event|3|||
48670102|NCT01969721|156644810|FG003|Overall Study|Adverse Event|2|||
48670103|NCT01969721|156644807|FG000|Overall Study|Lack of Efficacy|0|||
48670104|NCT01969721|156644808|FG001|Overall Study|Lack of Efficacy|0|||
48670105|NCT01969721|156644809|FG002|Overall Study|Lack of Efficacy|1|||
48670106|NCT01969721|156644810|FG003|Overall Study|Lack of Efficacy|0|||
48670107|NCT01969721|156644807|FG000|Overall Study|Non compliant with protocol|1|||
48670108|NCT01969721|156644808|FG001|Overall Study|Non compliant with protocol|1|||
48670109|NCT01969721|156644809|FG002|Overall Study|Non compliant with protocol|0|||
48670110|NCT01969721|156644810|FG003|Overall Study|Non compliant with protocol|2|||
48670111|NCT01969721|156644807|FG000|Overall Study|Other not defined above|0|||
48670112|NCT01969721|156644808|FG001|Overall Study|Other not defined above|2|||
48670113|NCT01969721|156644809|FG002|Overall Study|Other not defined above|0|||
48670114|NCT01969721|156644810|FG003|Overall Study|Other not defined above|0|||
48670115|NCT01969721|156644807|FG000|Overall Study|Discontinued during washout periods.|0|||
48670116|NCT01969721|156644808|FG001|Overall Study|Discontinued during washout periods.|1|||
48670117|NCT01969721|156644809|FG002|Overall Study|Discontinued during washout periods.|1|||
48670118|NCT01969721|156644810|FG003|Overall Study|Discontinued during washout periods.|2|||
48670119|NCT00558272|156644811|FG000|Overall Study|Adverse Event|10|||
48670120|NCT00558272|156644812|FG001|Overall Study|Adverse Event|0|||
48670121|NCT00558272|156644811|FG000|Overall Study|Death|1|||
48670122|NCT00558272|156644812|FG001|Overall Study|Death|0|||
48670123|NCT00558272|156644811|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
48670124|NCT00558272|156644812|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
48670125|NCT00558272|156644811|FG000|Overall Study|AZ study team decision|0|||
48670126|NCT00558272|156644812|FG001|Overall Study|AZ study team decision|1|||
48670127|NCT00558272|156644811|FG000|Overall Study|Incorrectly enrolled|1|||
48670128|NCT00558272|156644812|FG001|Overall Study|Incorrectly enrolled|0|||
48670129|NCT00558272|156644811|FG000|Overall Study|Withdrawal by Subject|0|||
48670130|NCT00558272|156644812|FG001|Overall Study|Withdrawal by Subject|1|||
48670131|NCT00952614|156644813|FG000|Overall Study|Death|3|||
48670132|NCT00952614|156644813|FG000|Overall Study|Lost to Follow-up|3|||
48670133|NCT00952614|156644813|FG000|Overall Study|other reason|1|||
48670134|NCT00849108|156644817|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
48760240|NCT01050257|156970119|FG002|Overall Study|Failure to return|0|||
48670135|NCT00849108|156644818|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
48670136|NCT00849108|156644817|FG000|Cohort 2 Efficacy|Adverse Event|0|||
48670137|NCT00849108|156644818|FG001|Cohort 2 Efficacy|Adverse Event|1|||
48670138|NCT00849108|156644817|FG000|Cohort 2 Efficacy|Other|0|||
48670139|NCT00849108|156644818|FG001|Cohort 2 Efficacy|Other|9|||
48670140|NCT02963701|156644819|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
48670141|NCT02963701|156644820|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
48760241|NCT01050257|156970117|FG000|Overall Study|Death|0|||
48760242|NCT01050257|156970118|FG001|Overall Study|Death|0|||
48760243|NCT01050257|156970119|FG002|Overall Study|Death|1|||
48760244|NCT00278109|156970121|FG000|Overall Study|Adverse Event|3|||
48670142|NCT03480009|156644821|FG000|Overall Study|Lost to Follow-up|4|||
48670143|NCT03480009|156644822|FG001|Overall Study|Lost to Follow-up|5|||
48670144|NCT03480009|156644823|FG002|Overall Study|Lost to Follow-up|4|||
48670145|NCT03480009|156644824|FG003|Overall Study|Lost to Follow-up|0|||
48670146|NCT04496453|156644826|FG000|Overall Study|Lost to Follow-up|6|||
48670147|NCT02456857|156644831|FG000|Overall Study|Disease Progression|4|||
48670148|NCT01220180|156644832|FG000|Overall Study|Lost to Follow-up|76|||
48670149|NCT01220180|156644832|FG000|Overall Study|Other|72|||
48670150|NCT01220180|156644832|FG000|Overall Study|Adverse Event|35|||
48670151|NCT01220180|156644832|FG000|Overall Study|Lack of Efficacy|22|||
48670152|NCT01220180|156644832|FG000|Overall Study|Death|1|||
48670153|NCT01220180|156644832|FG000|Overall Study|Randomized but not treated|1|||
48670154|NCT02262754|156644835|FG000|Overall Study|Adverse Event|3|||
48670155|NCT02262754|156644836|FG001|Overall Study|Adverse Event|4|||
48670156|NCT02262754|156644837|FG002|Overall Study|Adverse Event|0|||
48670157|NCT02262754|156644835|FG000|Overall Study|Lack of Efficacy|2|||
48670158|NCT02262754|156644836|FG001|Overall Study|Lack of Efficacy|0|||
48670159|NCT02262754|156644837|FG002|Overall Study|Lack of Efficacy|1|||
48670160|NCT02262754|156644835|FG000|Overall Study|Lost to Follow-up|0|||
48670161|NCT02262754|156644836|FG001|Overall Study|Lost to Follow-up|0|||
48670162|NCT02262754|156644837|FG002|Overall Study|Lost to Follow-up|1|||
48670163|NCT02262754|156644835|FG000|Overall Study|No longer meets eligibility criteria|0|||
48670164|NCT02262754|156644836|FG001|Overall Study|No longer meets eligibility criteria|1|||
48670165|NCT02262754|156644837|FG002|Overall Study|No longer meets eligibility criteria|0|||
48670166|NCT02262754|156644835|FG000|Overall Study|Study terminated by sponsor|5|||
48670167|NCT02262754|156644836|FG001|Overall Study|Study terminated by sponsor|4|||
48670168|NCT02262754|156644837|FG002|Overall Study|Study terminated by sponsor|4|||
48670169|NCT02262754|156644835|FG000|Overall Study|Protocol Violation|1|||
48670170|NCT02262754|156644836|FG001|Overall Study|Protocol Violation|0|||
48670171|NCT02262754|156644837|FG002|Overall Study|Protocol Violation|0|||
48670172|NCT02262754|156644835|FG000|Overall Study|Withdrawal by Subject|1|||
48670173|NCT02262754|156644836|FG001|Overall Study|Withdrawal by Subject|0|||
48670174|NCT02262754|156644837|FG002|Overall Study|Withdrawal by Subject|1|||
48670175|NCT02262754|156644835|FG000|Overall Study|Other|4|||
48670176|NCT02262754|156644836|FG001|Overall Study|Other|0|||
48670177|NCT02262754|156644837|FG002|Overall Study|Other|2|||
48670178|NCT05327361|156644838|FG000|Overall Study|Lost to Follow-up|4|||
48670179|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
48670180|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
48670181|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
48670182|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
48670183|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
48670184|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
48670185|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
48670186|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
48670187|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Death|0|||
48670188|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Death|1|||
48670189|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
48670190|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
48670191|NCT03281304|156644839|FG000|Treatment Phase (up to 42 Months)|Other|0|||
48670192|NCT03281304|156644840|FG001|Treatment Phase (up to 42 Months)|Other|2|||
48670193|NCT03281304|156644839|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
48760245|NCT00278109|156970121|FG000|Overall Study|social circumstances|1|||
48760246|NCT00613015|156970123|FG000|Overall Study|Lost to Follow-up|0|||
48760247|NCT00613015|156970124|FG001|Overall Study|Lost to Follow-up|1|||
48760248|NCT00613015|156970125|FG002|Overall Study|Lost to Follow-up|3|||
48760249|NCT00613015|156970126|FG003|Overall Study|Lost to Follow-up|3|||
48760250|NCT00613015|156970127|FG004|Overall Study|Lost to Follow-up|2|||
48760251|NCT00613015|156970128|FG005|Overall Study|Lost to Follow-up|3|||
48760252|NCT02205333|156970129|FG000|Overall Study|Death|5|||
48760253|NCT02205333|156970130|FG001|Overall Study|Death|6|||
48760254|NCT02205333|156970131|FG002|Overall Study|Death|2|||
48760255|NCT02205333|156970132|FG003|Overall Study|Death|6|||
48760256|NCT02205333|156970133|FG004|Overall Study|Death|5|||
48760257|NCT02205333|156970134|FG005|Overall Study|Death|3|||
48760258|NCT02205333|156970135|FG006|Overall Study|Death|3|||
48760259|NCT02205333|156970136|FG007|Overall Study|Death|2|||
48760260|NCT02205333|156970137|FG008|Overall Study|Death|0|||
48760261|NCT02205333|156970129|FG000|Overall Study|Withdrawal by Subject|1|||
48760262|NCT02205333|156970130|FG001|Overall Study|Withdrawal by Subject|0|||
48760263|NCT02205333|156970131|FG002|Overall Study|Withdrawal by Subject|0|||
48760264|NCT02205333|156970132|FG003|Overall Study|Withdrawal by Subject|1|||
48760265|NCT02205333|156970133|FG004|Overall Study|Withdrawal by Subject|0|||
48760266|NCT02205333|156970134|FG005|Overall Study|Withdrawal by Subject|0|||
48760267|NCT02205333|156970135|FG006|Overall Study|Withdrawal by Subject|2|||
48760268|NCT02205333|156970136|FG007|Overall Study|Withdrawal by Subject|0|||
48760269|NCT02205333|156970137|FG008|Overall Study|Withdrawal by Subject|0|||
48760270|NCT00454987|156970138|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
48760271|NCT00454987|156970139|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
48760272|NCT00454987|156970140|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
48670194|NCT03281304|156644840|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
48670195|NCT00626405|156644841|FG000|Overall Study|Deemed Ineligible|1|||
48670196|NCT00626405|156644842|FG001|Overall Study|Deemed Ineligible|0|||
48670197|NCT00626405|156644841|FG000|Overall Study|Withdrawal by Subject|0|||
48670198|NCT00626405|156644842|FG001|Overall Study|Withdrawal by Subject|1|||
48670199|NCT04046250|156644843|FG000|Overall Study|Death|0|||
48670200|NCT04046250|156644844|FG001|Overall Study|Death|1|||
48670201|NCT04046250|156644843|FG000|Overall Study|Withdrawal by Subject|3|||
48670202|NCT04046250|156644844|FG001|Overall Study|Withdrawal by Subject|3|||
48670203|NCT00566254|156644849|FG000|Overall Study|Adverse Event|3|||
48670204|NCT00566254|156644850|FG001|Overall Study|Adverse Event|1|||
48670205|NCT00566254|156644849|FG000|Overall Study|Protocol Violation|1|||
48670206|NCT00566254|156644850|FG001|Overall Study|Protocol Violation|3|||
48670207|NCT00566254|156644849|FG000|Overall Study|Withdrawal by Subject|1|||
48670208|NCT00566254|156644850|FG001|Overall Study|Withdrawal by Subject|2|||
48670209|NCT00566254|156644849|FG000|Overall Study|Lack of Efficacy|5|||
48670210|NCT00566254|156644850|FG001|Overall Study|Lack of Efficacy|6|||
48670211|NCT00566254|156644849|FG000|Overall Study|Other|0|||
48670212|NCT00566254|156644850|FG001|Overall Study|Other|2|||
48670213|NCT00758589|156646444|FG000|Overall Study|Adverse Event|3|||
48670214|NCT00758589|156646445|FG001|Overall Study|Adverse Event|2|||
48670215|NCT00758589|156646446|FG002|Overall Study|Adverse Event|5|||
48670216|NCT00758589|156646447|FG003|Overall Study|Adverse Event|4|||
48670217|NCT00758589|156646444|FG000|Overall Study|Withdrawal by Subject|0|||
48670218|NCT00758589|156646445|FG001|Overall Study|Withdrawal by Subject|1|||
48670219|NCT00758589|156646446|FG002|Overall Study|Withdrawal by Subject|1|||
48670220|NCT00758589|156646447|FG003|Overall Study|Withdrawal by Subject|1|||
48670221|NCT00758589|156646444|FG000|Overall Study|Palm stopped to work|0|||
48670222|NCT00758589|156646445|FG001|Overall Study|Palm stopped to work|0|||
48670223|NCT00758589|156646446|FG002|Overall Study|Palm stopped to work|0|||
48670224|NCT00758589|156646447|FG003|Overall Study|Palm stopped to work|1|||
48670225|NCT01825941|156646448|FG000|Overall Study|Lost to Follow-up|4|||
48670226|NCT01825941|156646449|FG001|Overall Study|Lost to Follow-up|1|||
48670227|NCT03966885|156646450|FG000|Overall Study|Death|1|||
48670228|NCT03966885|156646451|FG001|Overall Study|Death|0|||
48670229|NCT03966885|156646450|FG000|Overall Study|Lost to Follow-up|1|||
48670230|NCT03966885|156646451|FG001|Overall Study|Lost to Follow-up|2|||
48670231|NCT03966885|156646450|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
48670232|NCT03966885|156646451|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
48670233|NCT03966885|156646450|FG000|Overall Study|Moved from study area.|0|||
48670234|NCT03966885|156646451|FG001|Overall Study|Moved from study area.|2|||
48670235|NCT02032407|156646452|FG000|Overall Study|Lost to Follow-up|2|||
48670236|NCT02032407|156646452|FG000|Overall Study|Pregnancy|1|||
48670237|NCT02032407|156646452|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48670238|NCT00734071|156646454|FG000|Overall Study|Adverse Event|4|||
48670239|NCT00734071|156646455|FG001|Overall Study|Adverse Event|3|||
48670240|NCT00734071|156646454|FG000|Overall Study|Lack of Efficacy|3|||
48670241|NCT00734071|156646455|FG001|Overall Study|Lack of Efficacy|1|||
48670242|NCT00734071|156646454|FG000|Overall Study|Noncompliance|2|||
48670243|NCT00734071|156646455|FG001|Overall Study|Noncompliance|2|||
48670244|NCT00734071|156646454|FG000|Overall Study|Protocol Deviations|3|||
48670245|NCT00734071|156646455|FG001|Overall Study|Protocol Deviations|4|||
48670246|NCT00734071|156646454|FG000|Overall Study|Voluntary Withdrawal|9|||
48670247|NCT00734071|156646455|FG001|Overall Study|Voluntary Withdrawal|7|||
48342466|NCT00187135|155449221|FG005|Visit Two|Withdrawal by Subject|1|||
48670248|NCT00734071|156646454|FG000|Overall Study|Lost to Follow-up|16|||
48670249|NCT00734071|156646455|FG001|Overall Study|Lost to Follow-up|8|||
48670250|NCT00734071|156646454|FG000|Overall Study|Other|1|||
48670251|NCT00734071|156646455|FG001|Overall Study|Other|2|||
48670252|NCT00541346|156646456|FG000|Follow-up|Adverse Event|1|||
48692812|NCT01188772|156724612|FG002|Overall Study|Virologic Failure|0|||
48670253|NCT03559699|156646457|FG000|Overall Study|Withdrawal by Subject|6|||
48670254|NCT03559699|156646457|FG000|Overall Study|Lost to Follow-up|1|||
48670255|NCT00471887|156646458|FG000|Overall Study|Adverse Event|9|||
48670256|NCT01062061|156646467|FG000|Overall Study|Enrolled more than once|2|||
48670257|NCT01062061|156646467|FG000|Overall Study|Investigated before study start|13|||
48670258|NCT01062061|156646467|FG000|Overall Study|Outside chief indications|10|||
48670259|NCT01062061|156646467|FG000|Overall Study|Failed to meet inclusion criteria|2|||
48670260|NCT00771615|156646470|FG000|Overall Study|Withdrawal by Subject|0|||
48670261|NCT00771615|156646471|FG001|Overall Study|Withdrawal by Subject|1|||
48670262|NCT00771615|156646472|FG002|Overall Study|Withdrawal by Subject|0|||
48670263|NCT00771615|156646473|FG003|Overall Study|Withdrawal by Subject|0|||
48670264|NCT00771615|156646474|FG004|Overall Study|Withdrawal by Subject|0|||
48670265|NCT00771615|156646475|FG005|Overall Study|Withdrawal by Subject|0|||
48670266|NCT00771615|156646476|FG006|Overall Study|Withdrawal by Subject|0|||
48670267|NCT00771615|156646477|FG007|Overall Study|Withdrawal by Subject|1|||
48670268|NCT00771615|156646478|FG008|Overall Study|Withdrawal by Subject|0|||
48670269|NCT00771615|156646470|FG000|Overall Study|Lost to Follow-up|1|||
48670270|NCT00771615|156646471|FG001|Overall Study|Lost to Follow-up|1|||
48670271|NCT00771615|156646472|FG002|Overall Study|Lost to Follow-up|1|||
48670272|NCT00771615|156646473|FG003|Overall Study|Lost to Follow-up|1|||
48670273|NCT00771615|156646474|FG004|Overall Study|Lost to Follow-up|0|||
48670274|NCT00771615|156646475|FG005|Overall Study|Lost to Follow-up|1|||
48670275|NCT00771615|156646476|FG006|Overall Study|Lost to Follow-up|1|||
48670276|NCT00771615|156646477|FG007|Overall Study|Lost to Follow-up|0|||
48670277|NCT00771615|156646478|FG008|Overall Study|Lost to Follow-up|0|||
48670278|NCT00689793|156646479|FG000|Overall Study|Lost to Follow-up|4|||
48670279|NCT00689793|156646480|FG001|Overall Study|Lost to Follow-up|5|||
48670280|NCT03779503|156646482|FG000|First Intervention|Adverse Event|0|||
48670281|NCT03779503|156646483|FG001|First Intervention|Adverse Event|1|||
48670282|NCT03779503|156646482|FG000|First Intervention|Withdrawal by Subject|1|||
48670283|NCT03779503|156646483|FG001|First Intervention|Withdrawal by Subject|0|||
48670284|NCT02066415|156646484|FG000|Overall Study|Decision by Sponsor|5|||
48670285|NCT02066415|156646485|FG001|Overall Study|Decision by Sponsor|4|||
48670286|NCT02066415|156646486|FG002|Overall Study|Decision by Sponsor|2|||
48670287|NCT02066415|156646484|FG000|Overall Study|Withdrawal by Subject|9|||
48670288|NCT02066415|156646485|FG001|Overall Study|Withdrawal by Subject|1|||
48760273|NCT00454987|156970138|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
48760274|NCT00454987|156970139|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
48760275|NCT00454987|156970140|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
48760276|NCT00454987|156970138|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
48760277|NCT00454987|156970139|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
48760278|NCT00454987|156970140|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
48760279|NCT01476696|156970141|FG000|Overall Study|Sponsor decision|2|||
48760280|NCT01476696|156970142|FG001|Overall Study|Sponsor decision|1|||
48670289|NCT02066415|156646486|FG002|Overall Study|Withdrawal by Subject|4|||
48670290|NCT02066415|156646484|FG000|Overall Study|Lost to Follow-up|7|||
48670291|NCT02066415|156646485|FG001|Overall Study|Lost to Follow-up|2|||
48342467|NCT00187135|155449216|FG000|Visit Two|Study Discontinued|3|||
48670292|NCT02066415|156646486|FG002|Overall Study|Lost to Follow-up|2|||
48670293|NCT02634606|156646488|FG000|Overall Study|unable to obtain the drug at start|13|||
48670294|NCT04957758|156646493|FG000|Overall Study|Adverse Event|1|||
48670295|NCT04957758|156646494|FG001|Overall Study|Adverse Event|0|||
48670296|NCT04957758|156646493|FG000|Overall Study|Lost to Follow-up|0|||
48670297|NCT04957758|156646494|FG001|Overall Study|Lost to Follow-up|2|||
48670298|NCT04957758|156646493|FG000|Overall Study|Withdrawal by Subject|4|||
48670299|NCT04957758|156646494|FG001|Overall Study|Withdrawal by Subject|2|||
48670300|NCT04957758|156646493|FG000|Overall Study|Protocol Violation|0|||
48670301|NCT04957758|156646494|FG001|Overall Study|Protocol Violation|1|||
48670302|NCT02066129|156646497|FG000|Overall Study|Lost to Follow-up|13|||
48670303|NCT02066129|156646498|FG001|Overall Study|Lost to Follow-up|12|||
48670304|NCT02066129|156646497|FG000|Overall Study|Withdrawal by Subject|7|||
48670305|NCT02066129|156646498|FG001|Overall Study|Withdrawal by Subject|10|||
48670306|NCT02066129|156646497|FG000|Overall Study|Lack of Efficacy|8|||
48670307|NCT02066129|156646498|FG001|Overall Study|Lack of Efficacy|10|||
48670308|NCT02066129|156646497|FG000|Overall Study|Physician Decision|1|||
48670309|NCT02066129|156646498|FG001|Overall Study|Physician Decision|1|||
48670310|NCT00847015|156646502|FG000|Overall Study|Withdrawal by Subject|1|||
48670311|NCT00847015|156646502|FG000|Overall Study|declined any surgery|1|||
48670312|NCT00847015|156646502|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
48670313|NCT03230292|156646505|FG000|Overall Study|Adverse Event|1|||
48670314|NCT03230292|156646505|FG000|Overall Study|Protocol Violation|1|||
48670315|NCT03230292|156646505|FG000|Overall Study|Lost to Follow-up|1|||
48670316|NCT03230292|156646505|FG000|Overall Study|Withdrawal by Subject|3|||
48670317|NCT00908037|156646508|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670318|NCT00908037|156646509|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670319|NCT00908037|156646510|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670320|NCT00908037|156646511|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670321|NCT00908037|156646512|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
48670322|NCT00908037|156646513|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670323|NCT00908037|156646514|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
48670324|NCT00908037|156646515|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670325|NCT00908037|156646516|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
48670326|NCT00908037|156646517|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670327|NCT00908037|156646518|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670328|NCT00908037|156646519|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
48670329|NCT00908037|156646508|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670330|NCT00908037|156646509|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670331|NCT00908037|156646510|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670332|NCT00908037|156646511|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670333|NCT00908037|156646512|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
48670334|NCT00908037|156646513|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670335|NCT00908037|156646514|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670336|NCT00908037|156646515|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670337|NCT00908037|156646516|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
48670338|NCT00908037|156646517|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670339|NCT00908037|156646518|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670340|NCT00908037|156646519|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
48670341|NCT00908037|156646508|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670342|NCT00908037|156646509|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670343|NCT00908037|156646510|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670344|NCT00908037|156646511|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
48670345|NCT00908037|156646512|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670346|NCT00908037|156646513|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670347|NCT00908037|156646514|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
48670348|NCT00908037|156646515|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670349|NCT00908037|156646516|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670350|NCT00908037|156646517|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670351|NCT00908037|156646518|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670352|NCT00908037|156646519|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
48670353|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670354|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670355|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670356|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670357|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670358|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670359|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670360|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670361|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670362|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670363|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
48670364|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
48670365|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670366|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670367|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670368|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670369|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670370|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670371|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670372|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48760281|NCT01476696|156970143|FG002|Overall Study|Sponsor decision|0|||
48760282|NCT01476696|156970141|FG000|Overall Study|Withdrawal by Subject|1|||
48760283|NCT01476696|156970142|FG001|Overall Study|Withdrawal by Subject|0|||
48760284|NCT01476696|156970143|FG002|Overall Study|Withdrawal by Subject|0|||
48760285|NCT01179477|156970146|FG000|Overall Study|Death|542|||
48760286|NCT01179477|156970146|FG000|Overall Study|Unsuccessful implant|80|||
48760287|NCT01179477|156970146|FG000|Overall Study|Non-death withdrawal|438|||
48760288|NCT01179477|156970146|FG000|Overall Study|Did not complete final visit|27|||
48760289|NCT00071760|156970148|FG000|Overall Study|Adverse Event|2|||
48760290|NCT00071760|156970149|FG001|Overall Study|Adverse Event|1|||
48760291|NCT00071760|156970148|FG000|Overall Study|Lost to Follow-up|0|||
48760292|NCT00071760|156970149|FG001|Overall Study|Lost to Follow-up|3|||
48760293|NCT00071760|156970148|FG000|Overall Study|Protocol Violation|1|||
48760294|NCT00071760|156970149|FG001|Overall Study|Protocol Violation|0|||
48760295|NCT00071760|156970148|FG000|Overall Study|Withdrawal by Subject|0|||
48760296|NCT00071760|156970149|FG001|Overall Study|Withdrawal by Subject|1|||
48670373|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670374|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
48670375|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
48670376|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
48670377|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670378|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670379|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670380|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670381|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670382|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48760297|NCT00071760|156970148|FG000|Overall Study|Insufficient Viral Load Response|1|||
48760298|NCT00071760|156970149|FG001|Overall Study|Insufficient Viral Load Response|1|||
48760299|NCT00071760|156970148|FG000|Overall Study|Lack of availability of RTV|1|||
48760300|NCT00071760|156970149|FG001|Overall Study|Lack of availability of RTV|0|||
48760301|NCT00071760|156970148|FG000|Overall Study|Physician Decision|2|||
48760302|NCT00071760|156970149|FG001|Overall Study|Physician Decision|1|||
48760303|NCT00071760|156970148|FG000|Overall Study|Relocation|0|||
48760304|NCT00071760|156970149|FG001|Overall Study|Relocation|1|||
48760305|NCT01994629|156970155|FG000|Overall Study|Withdrawal by Subject|1|||
48760306|NCT01994629|156970156|FG001|Overall Study|Withdrawal by Subject|0|||
48760307|NCT01994629|156970155|FG000|Overall Study|Lost to Follow-up|0|||
48760308|NCT01994629|156970156|FG001|Overall Study|Lost to Follow-up|3|||
48760309|NCT04120974|156970157|FG000|Overall Study|Death|1|||
48760310|NCT04120974|156970157|FG000|Overall Study|Physician Decision|1|||
48670383|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48760311|NCT04120974|156970157|FG000|Overall Study|Lost to Follow-up|6|||
48670384|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670385|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670386|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
48670387|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670388|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
48670389|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670390|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670391|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670392|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670393|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670394|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670395|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670396|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670397|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670398|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670399|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
48670400|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
48670401|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670402|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670403|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670404|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670405|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670406|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670407|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670408|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670409|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670410|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
48760312|NCT03424265|156970158|FG000|Overall Study|screening failure|1|||
48760313|NCT03424265|156970159|FG001|Overall Study|screening failure|0|||
48760314|NCT03424265|156970158|FG000|Overall Study|Withdrawal by Subject|0|||
48760315|NCT03424265|156970159|FG001|Overall Study|Withdrawal by Subject|2|||
48760316|NCT03089606|156970160|FG000|Overall Study|Progression after Cycle 1|1|||
48760317|NCT00335972|156970161|FG000|Overall Study|not given treatments|0|||
48760318|NCT00335972|156970162|FG001|Overall Study|not given treatments|3|||
48760319|NCT01846611|156970163|FG000|Overall Study|Lost to Follow-up|4|||
48760320|NCT01846611|156970164|FG001|Overall Study|Lost to Follow-up|6|||
48760321|NCT01846611|156970163|FG000|Overall Study|Withdrawal by Subject|15|||
48760322|NCT01846611|156970164|FG001|Overall Study|Withdrawal by Subject|19|||
48760323|NCT01846611|156970163|FG000|Overall Study|Other|19|||
48760324|NCT01846611|156970164|FG001|Overall Study|Other|18|||
48760325|NCT01505868|156970166|FG000|Overall Study|Withdrawal by Subject|1|||
48760326|NCT01505868|156970167|FG001|Overall Study|Withdrawal by Subject|0|||
48760327|NCT01505868|156970168|FG002|Overall Study|Withdrawal by Subject|0|||
48760328|NCT01505868|156970169|FG003|Overall Study|Withdrawal by Subject|0|||
48760329|NCT01505868|156970170|FG004|Overall Study|Withdrawal by Subject|0|||
48760330|NCT03341533|156970175|FG000|Overall Study|Withdrawal by Subject|1|||
48760331|NCT03341533|156970176|FG001|Overall Study|Withdrawal by Subject|1|||
48760332|NCT03341533|156970175|FG000|Overall Study|Not eligible after randomization|2|||
48760333|NCT03341533|156970176|FG001|Overall Study|Not eligible after randomization|1|||
48760334|NCT02882854|156970177|FG000|Overall Study|Lost to Follow-up|1|||
48760335|NCT02882854|156970178|FG001|Overall Study|Lost to Follow-up|2|||
48670411|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670412|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
48670413|NCT00908037|156646508|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670414|NCT00908037|156646509|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670415|NCT00908037|156646510|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670416|NCT00908037|156646511|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670417|NCT00908037|156646512|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670418|NCT00908037|156646513|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670419|NCT00908037|156646514|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670420|NCT00908037|156646515|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670421|NCT00908037|156646516|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670422|NCT00908037|156646517|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670423|NCT00908037|156646518|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
48670424|NCT00908037|156646519|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
48670425|NCT01147900|156646520|FG000|At Year 10|Lost to Follow-up|0|||
48670426|NCT01147900|156646521|FG001|At Year 10|Lost to Follow-up|1|||
48670427|NCT01147900|156646522|FG002|At Year 10|Lost to Follow-up|0|||
48670428|NCT03443427|156646523|FG000|Overall Study|Adverse Event|2|||
48670429|NCT03443427|156646524|FG001|Overall Study|Adverse Event|3|||
48670430|NCT03443427|156646523|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
48670431|NCT03443427|156646524|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
48670432|NCT03443427|156646523|FG000|Overall Study|Other|4|||
48670433|NCT03443427|156646524|FG001|Overall Study|Other|6|||
48670434|NCT01732913|156646529|FG000|Overall Study|Study Terminated by Sponsor|105|||
48670435|NCT01732913|156646530|FG001|Overall Study|Study Terminated by Sponsor|55|||
48670436|NCT01732913|156646529|FG000|Overall Study|Withdrawal by Subject|27|||
48670437|NCT01732913|156646530|FG001|Overall Study|Withdrawal by Subject|4|||
48670438|NCT01732913|156646529|FG000|Overall Study|Physician Decision|14|||
48670439|NCT01732913|156646530|FG001|Overall Study|Physician Decision|7|||
48670440|NCT01732913|156646529|FG000|Overall Study|Other|7|||
48670441|NCT01732913|156646530|FG001|Overall Study|Other|1|||
48670442|NCT01732913|156646529|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
48670443|NCT01732913|156646530|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
48670444|NCT01792518|156646531|FG000|Overall Study|Adverse Event|3|||
48670445|NCT01792518|156646532|FG001|Overall Study|Adverse Event|4|||
48670446|NCT01792518|156646531|FG000|Overall Study|Protocol Violation|0|||
48670447|NCT01792518|156646532|FG001|Overall Study|Protocol Violation|1|||
48670448|NCT01792518|156646531|FG000|Overall Study|Lost to Follow-up|3|||
48670449|NCT01792518|156646532|FG001|Overall Study|Lost to Follow-up|1|||
48670450|NCT01792518|156646531|FG000|Overall Study|Withdrawal by Subject|2|||
48670451|NCT01792518|156646532|FG001|Overall Study|Withdrawal by Subject|0|||
48670452|NCT01792518|156646531|FG000|Overall Study|Other Reason|0|||
48670453|NCT01792518|156646532|FG001|Overall Study|Other Reason|1|||
48670454|NCT03233438|156646535|FG000|Overall Study|Lost to Follow-up|4|||
48670455|NCT03233438|156646536|FG001|Overall Study|Lost to Follow-up|9|||
48670456|NCT03233438|156646535|FG000|Overall Study|Withdrawal by Subject|2|||
48670457|NCT03233438|156646536|FG001|Overall Study|Withdrawal by Subject|1|||
48670458|NCT03233438|156646535|FG000|Overall Study|No recording of dalbavancin|0|||
48670459|NCT03233438|156646536|FG001|Overall Study|No recording of dalbavancin|1|||
48670460|NCT02613169|156646539|FG000|Overall Study|Withdrawal by Subject|4|||
48670461|NCT02613169|156646540|FG001|Overall Study|Withdrawal by Subject|1|||
48760336|NCT02882854|156970177|FG000|Overall Study|Physician Decision|0|||
48760337|NCT02882854|156970178|FG001|Overall Study|Physician Decision|1|||
48760338|NCT02197806|156970181|FG000|Overall Study|Adverse Event|0|||
48760339|NCT02197806|156970182|FG001|Overall Study|Adverse Event|1|||
48670462|NCT02613169|156646539|FG000|Overall Study|Lost to Follow-up|0|||
48670463|NCT02613169|156646540|FG001|Overall Study|Lost to Follow-up|5|||
48670464|NCT02613169|156646539|FG000|Overall Study|HIV|0|||
48670465|NCT02613169|156646540|FG001|Overall Study|HIV|2|||
48670466|NCT02613169|156646539|FG000|Overall Study|No TB infection endpoint|14|||
48670467|NCT02613169|156646540|FG001|Overall Study|No TB infection endpoint|9|||
48670468|NCT02337725|156646542|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
48670469|NCT02337725|156646543|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
48760340|NCT02197806|156970183|FG002|Overall Study|Adverse Event|0|||
48760341|NCT02197806|156970184|FG003|Overall Study|Adverse Event|1|||
48760342|NCT03774433|156970191|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
48760343|NCT01288287|156970198|FG000|Overall Study|Lost to Follow-up|8|||
48760344|NCT01288287|156970198|FG000|Overall Study|Withdrawal by Subject|4|||
48760345|NCT01288287|156970198|FG000|Overall Study|Lack of Efficacy|13|||
48760346|NCT01288287|156970198|FG000|Overall Study|Other Reason|13|||
48670470|NCT02337725|156646542|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
48760347|NCT01288287|156970198|FG000|Overall Study|Unknown Reason|1|||
48760348|NCT01288287|156970198|FG000|Overall Study|Unknown Status|7|||
48760349|NCT01581307|156970199|FG000|Overall Study|Withdrawal by Subject|1|||
48760350|NCT00878709|156970200|FG000|Overall Study|Withdrawal by Subject|197|||
48760351|NCT00878709|156970201|FG001|Overall Study|Withdrawal by Subject|120|||
48760352|NCT00878709|156970200|FG000|Overall Study|Lost to Follow-up|35|||
48760353|NCT00878709|156970201|FG001|Overall Study|Lost to Follow-up|33|||
48760354|NCT00878709|156970200|FG000|Overall Study|Other Reasons|93|||
48670471|NCT02337725|156646543|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
48670472|NCT02337725|156646542|FG000|Overall Study|Major Protocol Deviation|0|||
48670473|NCT02337725|156646543|FG001|Overall Study|Major Protocol Deviation|1|||
48670474|NCT02337725|156646542|FG000|Overall Study|Voluntary Withdrawal|14|||
48670475|NCT02337725|156646543|FG001|Overall Study|Voluntary Withdrawal|3|||
48670476|NCT02337725|156646542|FG000|Overall Study|Lack of Efficacy|4|||
48670477|NCT02337725|156646543|FG001|Overall Study|Lack of Efficacy|0|||
48670478|NCT00084656|156646544|FG000|Overall Study|Other reasons|0|||
48670479|NCT00084656|156646545|FG001|Overall Study|Other reasons|12|||
48670480|NCT00084656|156646546|FG002|Overall Study|Other reasons|11|||
48670481|NCT00084656|156646544|FG000|Overall Study|Withdrawal by Subject|15|||
48760355|NCT00878709|156970201|FG001|Overall Study|Other Reasons|84|||
48760356|NCT02268786|156970202|FG000|Overall Study|No Euploid Embryos available|42|||
48670482|NCT00084656|156646545|FG001|Overall Study|Withdrawal by Subject|4|||
48760357|NCT02268786|156970203|FG001|Overall Study|No Euploid Embryos available|0|||
48670483|NCT00084656|156646546|FG002|Overall Study|Withdrawal by Subject|4|||
48760358|NCT02268786|156970202|FG000|Overall Study|Withdrawal by Subject|7|||
48670484|NCT00084656|156646544|FG000|Overall Study|Disease relapse|0|||
48670485|NCT00084656|156646545|FG001|Overall Study|Disease relapse|9|||
48670486|NCT00084656|156646546|FG002|Overall Study|Disease relapse|10|||
48670487|NCT00084656|156646544|FG000|Overall Study|Disease progression|9|||
48670488|NCT00084656|156646545|FG001|Overall Study|Disease progression|0|||
48670489|NCT00084656|156646546|FG002|Overall Study|Disease progression|0|||
48670490|NCT00084656|156646544|FG000|Overall Study|Lost to Follow-up|1|||
48670491|NCT00084656|156646545|FG001|Overall Study|Lost to Follow-up|0|||
48670492|NCT00084656|156646546|FG002|Overall Study|Lost to Follow-up|1|||
48670493|NCT02772978|156646547|FG000|Overall Study|Withdrawal by Subject|1|||
48670494|NCT02772978|156646548|FG001|Overall Study|Withdrawal by Subject|1|||
48670495|NCT00576576|156646552|FG000|Overall Study|Lost to Follow-up|6|||
48670496|NCT00576576|156646552|FG000|Overall Study|Protocol Violation|1|||
48670497|NCT03135210|156646553|FG000|Overall Study|Death|0|||
48670498|NCT03135210|156646554|FG001|Overall Study|Death|1|||
48670499|NCT01751776|156646555|FG000|Overall Study|Adverse Event|0|||
48670500|NCT01751776|156646556|FG001|Overall Study|Adverse Event|0|||
48670501|NCT01751776|156646557|FG002|Overall Study|Adverse Event|0|||
48670502|NCT01751776|156646558|FG003|Overall Study|Adverse Event|0|||
48670503|NCT01751776|156646559|FG004|Overall Study|Adverse Event|0|||
48670504|NCT01751776|156646560|FG005|Overall Study|Adverse Event|0|||
48670505|NCT01751776|156646561|FG006|Overall Study|Adverse Event|4|||
48670506|NCT01751776|156646562|FG007|Overall Study|Adverse Event|2|||
48670507|NCT01751776|156646555|FG000|Overall Study|Consent withdrawn|0|||
48670508|NCT01751776|156646556|FG001|Overall Study|Consent withdrawn|0|||
48670509|NCT01751776|156646557|FG002|Overall Study|Consent withdrawn|0|||
48670510|NCT01751776|156646558|FG003|Overall Study|Consent withdrawn|0|||
48670511|NCT01751776|156646559|FG004|Overall Study|Consent withdrawn|0|||
48670512|NCT01751776|156646560|FG005|Overall Study|Consent withdrawn|0|||
48670513|NCT01751776|156646561|FG006|Overall Study|Consent withdrawn|0|||
48670514|NCT01751776|156646562|FG007|Overall Study|Consent withdrawn|1|||
48670515|NCT01751776|156646555|FG000|Overall Study|Other reason not specified above|0|||
48670516|NCT01751776|156646556|FG001|Overall Study|Other reason not specified above|0|||
48670517|NCT01751776|156646557|FG002|Overall Study|Other reason not specified above|0|||
48670518|NCT01751776|156646558|FG003|Overall Study|Other reason not specified above|0|||
48670519|NCT01751776|156646559|FG004|Overall Study|Other reason not specified above|0|||
48670520|NCT01751776|156646560|FG005|Overall Study|Other reason not specified above|0|||
48670521|NCT01751776|156646561|FG006|Overall Study|Other reason not specified above|0|||
48670522|NCT01751776|156646562|FG007|Overall Study|Other reason not specified above|1|||
48670523|NCT00160654|156646563|FG000|Overall Study|Adverse Event|14|||
48670524|NCT00160654|156646563|FG000|Overall Study|Lack of Efficacy|4|||
48670525|NCT00160654|156646563|FG000|Overall Study|Lost to Follow-up|2|||
48670526|NCT00160654|156646563|FG000|Overall Study|Intake of expired drug|7|||
48670527|NCT00160654|156646563|FG000|Overall Study|Psychological trauma|1|||
48670528|NCT00160654|156646563|FG000|Overall Study|Sponsor decision|1|||
48670529|NCT00160654|156646563|FG000|Overall Study|Patient met exclusion criteria|1|||
48670530|NCT00160654|156646563|FG000|Overall Study|Patient decision|1|||
48670531|NCT00160654|156646563|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
48670532|NCT00160654|156646563|FG000|Overall Study|Met exclusion criteria|1|||
48670533|NCT00590577|156646564|FG000|Overall Study|Lack of Efficacy|31|||
48670534|NCT00590577|156646565|FG001|Overall Study|Lack of Efficacy|28|||
48670535|NCT00590577|156646566|FG002|Overall Study|Lack of Efficacy|23|||
48670536|NCT00590577|156646567|FG003|Overall Study|Lack of Efficacy|45|||
48670537|NCT00590577|156646564|FG000|Overall Study|Withdrawal by Subject|23|||
48670538|NCT00590577|156646565|FG001|Overall Study|Withdrawal by Subject|28|||
48670539|NCT00590577|156646566|FG002|Overall Study|Withdrawal by Subject|30|||
48670540|NCT00590577|156646567|FG003|Overall Study|Withdrawal by Subject|26|||
48670541|NCT00590577|156646564|FG000|Overall Study|Adverse Event|10|||
48670542|NCT00590577|156646565|FG001|Overall Study|Adverse Event|10|||
48670543|NCT00590577|156646566|FG002|Overall Study|Adverse Event|13|||
48670544|NCT00590577|156646567|FG003|Overall Study|Adverse Event|11|||
48670545|NCT00590577|156646564|FG000|Overall Study|Lost to Follow-up|12|||
48670546|NCT00590577|156646565|FG001|Overall Study|Lost to Follow-up|6|||
48670547|NCT00590577|156646566|FG002|Overall Study|Lost to Follow-up|6|||
48670548|NCT00590577|156646567|FG003|Overall Study|Lost to Follow-up|9|||
48670549|NCT00590577|156646564|FG000|Overall Study|Pregnancy|0|||
48760359|NCT02268786|156970203|FG001|Overall Study|Withdrawal by Subject|14|||
48760360|NCT02268786|156970202|FG000|Overall Study|Thaw Failure|6|||
48760361|NCT02268786|156970203|FG001|Overall Study|Thaw Failure|4|||
48760362|NCT02268786|156970202|FG000|Overall Study|Protocol Violation|1|||
48760363|NCT02268786|156970203|FG001|Overall Study|Protocol Violation|0|||
48760364|NCT04251221|156970204|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
48760365|NCT04251221|156970205|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
48760366|NCT02068222|156970209|FG000|Overall Study|Lost to Follow-up|1|||
48760367|NCT00531232|156972205|FG000|Overall Study|Investigator decision|0|||
48760368|NCT00531232|156972206|FG001|Overall Study|Investigator decision|0|||
48760369|NCT00531232|156972207|FG002|Overall Study|Investigator decision|4|||
48760370|NCT00531232|156972205|FG000|Overall Study|Participants refused further treatment|0|||
48760371|NCT00531232|156972206|FG001|Overall Study|Participants refused further treatment|1|||
48760372|NCT00531232|156972207|FG002|Overall Study|Participants refused further treatment|2|||
48760373|NCT00531232|156972205|FG000|Overall Study|Adverse events (AEs)|1|||
48760374|NCT00531232|156972206|FG001|Overall Study|Adverse events (AEs)|2|||
48760375|NCT00531232|156972207|FG002|Overall Study|Adverse events (AEs)|2|||
48760376|NCT00531232|156972205|FG000|Overall Study|Treatment failure|1|||
48760377|NCT00531232|156972206|FG001|Overall Study|Treatment failure|3|||
48760378|NCT00531232|156972207|FG002|Overall Study|Treatment failure|7|||
48760379|NCT00531232|156972205|FG000|Overall Study|Disease recurrence|0|||
48760380|NCT00531232|156972206|FG001|Overall Study|Disease recurrence|0|||
48760381|NCT00531232|156972207|FG002|Overall Study|Disease recurrence|1|||
48760382|NCT00531232|156972205|FG000|Overall Study|Deceased|2|||
48760383|NCT00531232|156972206|FG001|Overall Study|Deceased|2|||
48760384|NCT00531232|156972207|FG002|Overall Study|Deceased|2|||
48760385|NCT00531232|156972205|FG000|Overall Study|Withdrawal by Subject|0|||
48760386|NCT00531232|156972206|FG001|Overall Study|Withdrawal by Subject|1|||
48760387|NCT00531232|156972207|FG002|Overall Study|Withdrawal by Subject|2|||
48760388|NCT00531232|156972205|FG000|Overall Study|Other|0|||
48670550|NCT00590577|156646565|FG001|Overall Study|Pregnancy|1|||
48670551|NCT00590577|156646566|FG002|Overall Study|Pregnancy|0|||
48670552|NCT00590577|156646567|FG003|Overall Study|Pregnancy|0|||
48670553|NCT00590577|156646564|FG000|Overall Study|Various reasons|1|||
48670554|NCT00590577|156646565|FG001|Overall Study|Various reasons|3|||
48670555|NCT00590577|156646566|FG002|Overall Study|Various reasons|1|||
48670556|NCT00590577|156646567|FG003|Overall Study|Various reasons|2|||
48670557|NCT02477553|156646572|FG000|Overall Study|Screening up-to-date|12|||
48670558|NCT02477553|156646573|FG001|Overall Study|Screening up-to-date|13|||
48670559|NCT02477553|156646572|FG000|Overall Study|No MD visit|1|||
48670560|NCT02477553|156646573|FG001|Overall Study|No MD visit|1|||
48670561|NCT02477553|156646572|FG000|Overall Study|Workup consistent w/CRC|1|||
48670562|NCT02477553|156646573|FG001|Overall Study|Workup consistent w/CRC|1|||
48670563|NCT02477553|156646572|FG000|Overall Study|Technical issues with intervention|2|||
48670564|NCT02477553|156646573|FG001|Overall Study|Technical issues with intervention|0|||
48670565|NCT02477553|156646572|FG000|Overall Study|Elevated risk for CRC|2|||
48670566|NCT02477553|156646573|FG001|Overall Study|Elevated risk for CRC|2|||
48670567|NCT02477553|156646572|FG000|Overall Study|MD advised against screening|1|||
48670568|NCT02477553|156646573|FG001|Overall Study|MD advised against screening|3|||
48670569|NCT02477553|156646572|FG000|Overall Study|patient deceased|1|||
48670570|NCT02477553|156646573|FG001|Overall Study|patient deceased|0|||
48670571|NCT01345682|156646574|FG000|Overall Study|Progressive disease per RECIST|226|||
48670572|NCT01345682|156646575|FG001|Overall Study|Progressive disease per RECIST|93|||
48670573|NCT01345682|156646574|FG000|Overall Study|Worsening of underlying cancer disease|23|||
48670574|NCT01345682|156646575|FG001|Overall Study|Worsening of underlying cancer disease|12|||
48670575|NCT01345682|156646574|FG000|Overall Study|Adverse Event|51|||
48670576|NCT01345682|156646575|FG001|Overall Study|Adverse Event|41|||
48670577|NCT01345682|156646574|FG000|Overall Study|Non-compliance with protocol|0|||
48670578|NCT01345682|156646575|FG001|Overall Study|Non-compliance with protocol|1|||
48670579|NCT01345682|156646574|FG000|Overall Study|Lost to Follow-up|0|||
48670580|NCT01345682|156646575|FG001|Overall Study|Lost to Follow-up|1|||
48670581|NCT01345682|156646574|FG000|Overall Study|Refused to continue trial medication|16|||
48670582|NCT01345682|156646575|FG001|Overall Study|Refused to continue trial medication|9|||
48670583|NCT01345682|156646574|FG000|Overall Study|Not treated|2|||
48670584|NCT01345682|156646575|FG001|Overall Study|Not treated|1|||
48760389|NCT00531232|156972206|FG001|Overall Study|Other|0|||
48342468|NCT00187135|155449217|FG001|Visit Two|Study Discontinued|2|||
48670585|NCT01345682|156646574|FG000|Overall Study|Reason other than those specified above|4|||
48670586|NCT01345682|156646575|FG001|Overall Study|Reason other than those specified above|3|||
48670587|NCT05098509|156646576|FG000|Overall Study|Withdrawal by Subject|0|||
48670588|NCT05098509|156646577|FG001|Overall Study|Withdrawal by Subject|0|||
48670589|NCT05098509|156646578|FG002|Overall Study|Withdrawal by Subject|1|||
48670590|NCT05098509|156646579|FG003|Overall Study|Withdrawal by Subject|0|||
48760390|NCT00531232|156972207|FG002|Overall Study|Other|5|||
48760391|NCT00939809|156972208|FG000|Overall Study|Adverse Event|2|||
48760392|NCT00939809|156972208|FG000|Overall Study|Death|1|||
48760393|NCT04779489|156972209|FG000|Overall Study|Physician Decision|1|||
48670591|NCT05098509|156646576|FG000|Overall Study|Early study termination|1|||
48670592|NCT05098509|156646577|FG001|Overall Study|Early study termination|1|||
48670593|NCT05098509|156646578|FG002|Overall Study|Early study termination|1|||
48670594|NCT05098509|156646579|FG003|Overall Study|Early study termination|0|||
48670595|NCT00483002|156646586|FG000|Overall Study|Adverse Event|68|||
48670596|NCT00483002|156646586|FG000|Overall Study|Lack of Efficacy|555|||
48670597|NCT00483002|156646586|FG000|Overall Study|Lost to Follow-up|962|||
48670598|NCT00483002|156646586|FG000|Overall Study|Other|2|||
48670599|NCT00483002|156646586|FG000|Overall Study|Other|967|||
48670600|NCT03834220|156646593|FG000|Overall Study|Adverse Event|1|||
48670601|NCT03834220|156646594|FG001|Overall Study|Adverse Event|0|||
48670602|NCT03834220|156646595|FG002|Overall Study|Adverse Event|0|||
48670603|NCT03834220|156646593|FG000|Overall Study|Death|8|||
48670604|NCT03834220|156646594|FG001|Overall Study|Death|1|||
48670605|NCT03834220|156646595|FG002|Overall Study|Death|17|||
48670606|NCT03834220|156646593|FG000|Overall Study|Reason not Specified|9|||
48670607|NCT03834220|156646594|FG001|Overall Study|Reason not Specified|0|||
48670608|NCT03834220|156646595|FG002|Overall Study|Reason not Specified|6|||
48670609|NCT03834220|156646593|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
48670610|NCT03834220|156646594|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
48670611|NCT03834220|156646595|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
48670612|NCT03834220|156646593|FG000|Overall Study|Withdrawal of Consent|2|||
48670613|NCT03834220|156646594|FG001|Overall Study|Withdrawal of Consent|2|||
48670614|NCT03834220|156646595|FG002|Overall Study|Withdrawal of Consent|2|||
48670615|NCT00527332|156646603|FG000|Overall Study|Protocol Violation|4|||
48670616|NCT00527332|156646604|FG001|Overall Study|Protocol Violation|8|||
48670617|NCT00527332|156646603|FG000|Overall Study|Withdrew consent|5|||
48670618|NCT00527332|156646604|FG001|Overall Study|Withdrew consent|1|||
48670619|NCT02666105|156646605|FG000|Overall Study|Death|1|||
48670620|NCT00852241|156646607|FG000|Overall Study|Physician Decision|18|||
48670621|NCT03369236|156646608|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
48670622|NCT03369236|156646609|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
48670623|NCT03369236|156646608|FG000|Open-label Extension Period|Lack of Efficacy|2|||
48670624|NCT03369236|156646609|FG001|Open-label Extension Period|Lack of Efficacy|1|||
48670625|NCT03369236|156646608|FG000|Open-label Extension Period|Adverse Event|0|||
48670626|NCT03369236|156646609|FG001|Open-label Extension Period|Adverse Event|1|||
48670627|NCT03369236|156646608|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
48670628|NCT03369236|156646609|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
48670629|NCT05320393|156648214|FG000|Overall Study|Withdrawal by Subject|1|||
48760394|NCT00503308|156972212|FG000|Overall Study|Protocol Violation|2|||
48760395|NCT00503308|156972213|FG001|Overall Study|Protocol Violation|1|||
48760396|NCT03232281|156972214|FG000|Overall Study|Adverse Event|1|||
48760397|NCT03232281|156972215|FG001|Overall Study|Adverse Event|1|||
48670630|NCT05320393|156648215|FG001|Overall Study|Withdrawal by Subject|0|||
48670631|NCT05320393|156648216|FG002|Overall Study|Withdrawal by Subject|2|||
48760398|NCT03232281|156972214|FG000|Overall Study|Withdrawal by Subject|5|||
48760399|NCT03232281|156972215|FG001|Overall Study|Withdrawal by Subject|4|||
48760400|NCT03232281|156972214|FG000|Overall Study|Protocol Deviation|1|||
48760401|NCT03232281|156972215|FG001|Overall Study|Protocol Deviation|1|||
48760402|NCT02522286|156972217|FG000|Overall Study|Withdrawal by Subject|3|||
48760403|NCT02522286|156972218|FG001|Overall Study|Withdrawal by Subject|0|||
48760404|NCT02522286|156972219|FG002|Overall Study|Withdrawal by Subject|0|||
48760405|NCT02522286|156972220|FG003|Overall Study|Withdrawal by Subject|3|||
48760406|NCT01132482|156972225|FG000|Overall Study|Adverse Event|1|||
48760407|NCT01132482|156972226|FG001|Overall Study|Adverse Event|0|||
48760408|NCT02189473|156972227|FG000|Overall Study|Death|22|||
48760409|NCT02189473|156972228|FG001|Overall Study|Death|23|||
48760410|NCT02189473|156972227|FG000|Overall Study|Lost to Follow-up|1|||
48760411|NCT02189473|156972228|FG001|Overall Study|Lost to Follow-up|2|||
48760412|NCT01998737|156972229|FG000|Overall Study|Corrupted database|23|||
48760413|NCT01998737|156972230|FG001|Overall Study|Corrupted database|0|||
48760414|NCT01955161|156972231|FG000|Overall Study|Withdrawal before treatment|2|||
48760415|NCT01955161|156972232|FG001|Overall Study|Withdrawal before treatment|0|||
48760416|NCT01955161|156972233|FG002|Overall Study|Withdrawal before treatment|1|||
48760417|NCT01955161|156972231|FG000|Overall Study|Adverse Event|10|||
48760418|NCT01955161|156972232|FG001|Overall Study|Adverse Event|14|||
48760419|NCT01955161|156972233|FG002|Overall Study|Adverse Event|15|||
48760420|NCT01955161|156972231|FG000|Overall Study|Death|1|||
48670632|NCT05320393|156648214|FG000|Overall Study|Lost to Follow-up|1|||
48670633|NCT05320393|156648215|FG001|Overall Study|Lost to Follow-up|2|||
48670634|NCT05320393|156648216|FG002|Overall Study|Lost to Follow-up|1|||
48670635|NCT05320393|156648214|FG000|Overall Study|Moved; too much driving|0|||
48670636|NCT05320393|156648215|FG001|Overall Study|Moved; too much driving|0|||
48760421|NCT01955161|156972232|FG001|Overall Study|Death|1|||
48760422|NCT01955161|156972233|FG002|Overall Study|Death|3|||
48760423|NCT01955161|156972231|FG000|Overall Study|Withdrawal by Subject|9|||
48760424|NCT01955161|156972232|FG001|Overall Study|Withdrawal by Subject|8|||
48760425|NCT01955161|156972233|FG002|Overall Study|Withdrawal by Subject|12|||
48760426|NCT01955161|156972231|FG000|Overall Study|Protocol Violation|2|||
48760427|NCT01955161|156972232|FG001|Overall Study|Protocol Violation|0|||
48760428|NCT01955161|156972233|FG002|Overall Study|Protocol Violation|0|||
48760429|NCT01955161|156972231|FG000|Overall Study|Other reason: physician decision|0|||
48760430|NCT01955161|156972232|FG001|Overall Study|Other reason: physician decision|1|||
48760431|NCT01955161|156972233|FG002|Overall Study|Other reason: physician decision|1|||
48760432|NCT01955161|156972231|FG000|Overall Study|Other reason: disallowed medication|1|||
48760433|NCT01955161|156972232|FG001|Overall Study|Other reason: disallowed medication|0|||
48760434|NCT01955161|156972233|FG002|Overall Study|Other reason: disallowed medication|1|||
48760435|NCT01955161|156972231|FG000|Overall Study|Other reason: caregiver unavailable|1|||
48760436|NCT01955161|156972232|FG001|Overall Study|Other reason: caregiver unavailable|0|||
48760437|NCT01955161|156972233|FG002|Overall Study|Other reason: caregiver unavailable|0|||
48760438|NCT01955161|156972231|FG000|Overall Study|Other reason: moved to nursing home|0|||
48760439|NCT01955161|156972232|FG001|Overall Study|Other reason: moved to nursing home|1|||
48760440|NCT01955161|156972233|FG002|Overall Study|Other reason: moved to nursing home|0|||
48760441|NCT01955161|156972231|FG000|Overall Study|Other reason: insufficient compliance|0|||
48760442|NCT01955161|156972232|FG001|Overall Study|Other reason: insufficient compliance|0|||
48760443|NCT01955161|156972233|FG002|Overall Study|Other reason: insufficient compliance|1|||
48760444|NCT01955161|156972231|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
48760445|NCT01955161|156972232|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
48760446|NCT01955161|156972233|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
48760447|NCT01955161|156972231|FG000|Overall Study|Other reason: patient's will|0|||
48760448|NCT01955161|156972232|FG001|Overall Study|Other reason: patient's will|0|||
48760449|NCT01955161|156972233|FG002|Overall Study|Other reason: patient's will|1|||
48760450|NCT01614990|156972234|FG000|Overall Study|Protocol Violation|1|||
48760451|NCT01614990|156972235|FG001|Overall Study|Protocol Violation|1|||
48760452|NCT01172847|156972236|FG000|Overall Study|Withdrawal by Subject|3|||
48760453|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
48760454|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
48760455|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
48760456|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
48760457|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
48760458|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
48760459|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
48760460|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
48760461|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
48760462|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
48760463|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
48760464|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
48760465|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
48760466|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
48760467|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
48760468|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
48760469|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
48760470|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
48760471|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
48760472|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
48760473|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
48760474|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
48760475|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
48760476|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
48760477|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
48760478|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
48760479|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
48760480|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
48760481|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
48760482|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
48760483|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
48760484|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
48760485|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
48760486|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
48760487|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
48760488|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
48760489|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
48760490|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
48670637|NCT05320393|156648216|FG002|Overall Study|Moved; too much driving|2|||
48670638|NCT05320393|156648214|FG000|Overall Study|Did not receive treatment|0|||
48670639|NCT05320393|156648215|FG001|Overall Study|Did not receive treatment|0|||
48670640|NCT05320393|156648216|FG002|Overall Study|Did not receive treatment|1|||
48670641|NCT04969198|156648217|FG000|Overall Study|Withdrawal by Subject|20|||
48670642|NCT04969198|156648217|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
48670643|NCT04969198|156648217|FG000|Overall Study|Lost to Follow-up|20|||
48670644|NCT01272869|156648218|FG000|Period 2 (14 Days)|Adverse Event|1|||
48670645|NCT01272869|156648219|FG001|Period 2 (14 Days)|Adverse Event|0|||
48670646|NCT00490776|156648220|FG000|Overall Study|Withdrawal by Subject|1|||
48670647|NCT00490776|156648220|FG000|Overall Study|Administrative Problems|1|||
48670648|NCT00490776|156648220|FG000|Overall Study|Death|1|||
48670649|NCT00490776|156648220|FG000|Overall Study|New Cancer Therapy|1|||
48670650|NCT00490776|156648220|FG000|Overall Study|Disease Progression|5|||
48670651|NCT00308074|156648221|FG000|Overall Study|Withdrawal by Subject|1|||
48670652|NCT01424566|156648222|FG000|Single-blind Treatment|Adverse Event|71|||
48670653|NCT01424566|156648223|FG001|Single-blind Treatment|Adverse Event|0|||
48670654|NCT01424566|156648224|FG002|Single-blind Treatment|Adverse Event|0|||
48670655|NCT01424566|156648222|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
48670656|NCT01424566|156648223|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
48670657|NCT01424566|156648224|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
48670658|NCT01424566|156648222|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
48670659|NCT01424566|156648223|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
48670660|NCT01424566|156648224|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
48670661|NCT01424566|156648222|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
48670662|NCT01424566|156648223|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
48670663|NCT01424566|156648224|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
48670664|NCT01424566|156648222|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
48670665|NCT01424566|156648223|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
48670666|NCT01424566|156648224|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
48670667|NCT01424566|156648222|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
48670668|NCT01424566|156648223|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
48670669|NCT01424566|156648224|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
48670670|NCT01424566|156648222|FG000|Double-blind Treatment|Adverse Event|0|||
48670671|NCT01424566|156648223|FG001|Double-blind Treatment|Adverse Event|21|||
48670672|NCT01424566|156648224|FG002|Double-blind Treatment|Adverse Event|13|||
48670673|NCT01424566|156648222|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
48670674|NCT01424566|156648223|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
48670675|NCT01424566|156648224|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
48670676|NCT01424566|156648222|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
48670677|NCT01424566|156648223|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
48670678|NCT01424566|156648224|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
48670679|NCT01424566|156648222|FG000|Double-blind Treatment|Lack of Efficacy|0|||
48670680|NCT01424566|156648223|FG001|Double-blind Treatment|Lack of Efficacy|1|||
48670681|NCT01424566|156648224|FG002|Double-blind Treatment|Lack of Efficacy|1|||
48670682|NCT03883113|156648225|FG000|Overall Study|Physician Decision|4|||
48670683|NCT03883113|156648226|FG001|Overall Study|Physician Decision|2|||
48670684|NCT03883113|156648225|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
48670685|NCT03883113|156648226|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
48670686|NCT03883113|156648225|FG000|Overall Study|Pregnancy|1|||
48670687|NCT03883113|156648226|FG001|Overall Study|Pregnancy|0|||
48670688|NCT03883113|156648225|FG000|Overall Study|Adverse Event|0|||
48670689|NCT03883113|156648226|FG001|Overall Study|Adverse Event|1|||
48670690|NCT03883113|156648225|FG000|Overall Study|Withdrawal by Subject|1|||
48670691|NCT03883113|156648226|FG001|Overall Study|Withdrawal by Subject|2|||
48670692|NCT03883113|156648225|FG000|Overall Study|Lost to Follow-up|1|||
48670693|NCT03883113|156648226|FG001|Overall Study|Lost to Follow-up|0|||
48670694|NCT03689712|156648227|FG000|Overall Study|Adverse Event|1|||
48670695|NCT03689712|156648228|FG001|Overall Study|Adverse Event|0|||
48670696|NCT03689712|156648227|FG000|Overall Study|Death|20|||
48670697|NCT03689712|156648228|FG001|Overall Study|Death|10|||
48670698|NCT03689712|156648227|FG000|Overall Study|Lost to Follow-up|6|||
48670699|NCT03689712|156648228|FG001|Overall Study|Lost to Follow-up|6|||
48670700|NCT03689712|156648227|FG000|Overall Study|Other|1|||
48670701|NCT03689712|156648228|FG001|Overall Study|Other|0|||
48670702|NCT03689712|156648227|FG000|Overall Study|Patient Non-Compliance|0|||
48670703|NCT03689712|156648228|FG001|Overall Study|Patient Non-Compliance|1|||
48670704|NCT03689712|156648227|FG000|Overall Study|Withdrawal by Subject|20|||
48670705|NCT03689712|156648228|FG001|Overall Study|Withdrawal by Subject|4|||
48692813|NCT01188772|156724613|FG003|Overall Study|Virologic Failure|0|||
48760491|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
48760492|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
48760493|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
48760494|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
48760495|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
48760496|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
48760497|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
48760498|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
48760499|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
48760500|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
48760501|NCT03720470|156972237|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760502|NCT03720470|156972238|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760503|NCT03720470|156972239|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760504|NCT03720470|156972240|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760505|NCT03720470|156972241|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
48760506|NCT03720470|156972242|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
48760507|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
48760508|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
48760509|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
48760510|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
48670706|NCT03689712|156648227|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
48760511|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
48760512|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
48760513|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760514|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760515|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
48760516|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760517|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760518|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
48760519|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
48760520|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
48760521|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
48760522|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
48760523|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
48760524|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
48760525|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48670707|NCT03689712|156648228|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
48670708|NCT03689712|156648227|FG000|Overall Study|Randomized but not Treated|13|||
48670709|NCT03689712|156648228|FG001|Overall Study|Randomized but not Treated|7|||
48670710|NCT03689712|156648227|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
48670711|NCT03689712|156648228|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
48670712|NCT03266172|156648234|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
48670713|NCT03266172|156648235|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
48670714|NCT03266172|156648236|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
48670715|NCT03266172|156648234|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
48670716|NCT03266172|156648235|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
48670717|NCT03266172|156648236|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
48670718|NCT03266172|156648234|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
48670719|NCT03266172|156648235|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
48670720|NCT03266172|156648236|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
48670721|NCT03266172|156648234|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
48670722|NCT03266172|156648235|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
48670723|NCT03266172|156648236|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
48670724|NCT03266172|156648234|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
48670725|NCT03266172|156648235|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
48670726|NCT03266172|156648236|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
48670727|NCT03266172|156648234|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
48760526|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48670728|NCT03266172|156648235|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
48670729|NCT03266172|156648236|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
48670730|NCT00864851|156648237|FG000|Overall Study|Withdrawal by Subject|0|||
48670731|NCT00864851|156648238|FG001|Overall Study|Withdrawal by Subject|1|||
48670732|NCT00864851|156648239|FG002|Overall Study|Withdrawal by Subject|0|||
48670733|NCT00864851|156648237|FG000|Overall Study|Physician Decision|1|||
48670734|NCT00864851|156648238|FG001|Overall Study|Physician Decision|0|||
48670735|NCT00864851|156648239|FG002|Overall Study|Physician Decision|0|||
48670736|NCT00864851|156648237|FG000|Overall Study|Death|1|||
48670737|NCT00864851|156648238|FG001|Overall Study|Death|0|||
48670738|NCT00864851|156648239|FG002|Overall Study|Death|0|||
48670739|NCT00864851|156648237|FG000|Overall Study|Patient uncooperative|1|||
48670740|NCT00864851|156648238|FG001|Overall Study|Patient uncooperative|0|||
48670741|NCT00864851|156648239|FG002|Overall Study|Patient uncooperative|0|||
48670742|NCT00413010|156648240|FG000|Overall Study|Adverse Event|8|||
48670743|NCT00413010|156648241|FG001|Overall Study|Adverse Event|4|||
48670744|NCT00413010|156648240|FG000|Overall Study|Laboratory abnormality|0|||
48670745|NCT00413010|156648241|FG001|Overall Study|Laboratory abnormality|2|||
48670746|NCT00413010|156648240|FG000|Overall Study|Lack of Efficacy|0|||
48670747|NCT00413010|156648241|FG001|Overall Study|Lack of Efficacy|3|||
48670748|NCT00413010|156648240|FG000|Overall Study|Lost to Follow-up|3|||
48670749|NCT00413010|156648241|FG001|Overall Study|Lost to Follow-up|0|||
48670750|NCT00413010|156648240|FG000|Overall Study|Withdrawal by Subject|7|||
48670751|NCT00413010|156648241|FG001|Overall Study|Withdrawal by Subject|2|||
48670752|NCT00413010|156648240|FG000|Overall Study|Due to termination of the study|54|||
48670753|NCT00413010|156648241|FG001|Overall Study|Due to termination of the study|52|||
48670754|NCT00443781|156648242|FG000|Overall Study|Lost to Follow-up|10|||
48670755|NCT00443781|156648242|FG000|Overall Study|Physician Decision|2|||
48670756|NCT00443781|156648242|FG000|Overall Study|Protocol Violation|1|||
48670757|NCT00443781|156648242|FG000|Overall Study|Withdrawal by Subject|6|||
48670758|NCT00443781|156648242|FG000|Overall Study|Unable to comply with study follow up|2|||
48670759|NCT00443781|156648242|FG000|Overall Study|Investigator terminated participation|1|||
48670760|NCT00443781|156648242|FG000|Overall Study|Insurance not covered|2|||
48670761|NCT00443781|156648242|FG000|Overall Study|PD/FAD not done|1|||
48670762|NCT00430937|156648243|FG000|Overall Study|Adverse Event|3|||
48670763|NCT00430937|156648244|FG001|Overall Study|Adverse Event|8|||
48670764|NCT00430937|156648243|FG000|Overall Study|Death|0|||
48670765|NCT00430937|156648244|FG001|Overall Study|Death|1|||
48670766|NCT00430937|156648243|FG000|Overall Study|Lost to Follow-up|6|||
48670767|NCT00430937|156648244|FG001|Overall Study|Lost to Follow-up|6|||
48670768|NCT00430937|156648243|FG000|Overall Study|Withdrawal by Subject|5|||
48670769|NCT00430937|156648244|FG001|Overall Study|Withdrawal by Subject|2|||
48670770|NCT00430937|156648243|FG000|Overall Study|Protocol Violation|3|||
48670771|NCT00430937|156648244|FG001|Overall Study|Protocol Violation|2|||
48670772|NCT00430937|156648243|FG000|Overall Study|Lack of Efficacy|6|||
48670773|NCT00430937|156648244|FG001|Overall Study|Lack of Efficacy|5|||
48670774|NCT00430937|156648243|FG000|Overall Study|Inappropriate enrollment|2|||
48670775|NCT00430937|156648244|FG001|Overall Study|Inappropriate enrollment|1|||
48670776|NCT00430937|156648243|FG000|Overall Study|Administrative reasons|1|||
48670777|NCT00430937|156648244|FG001|Overall Study|Administrative reasons|0|||
48670778|NCT00430937|156648243|FG000|Overall Study|Protocol discontinuation criteria met|1|||
48670779|NCT00430937|156648244|FG001|Overall Study|Protocol discontinuation criteria met|2|||
48670780|NCT00430937|156648243|FG000|Overall Study|Unable to classify|0|||
48670781|NCT00430937|156648244|FG001|Overall Study|Unable to classify|1|||
48670782|NCT01659255|156648245|FG000|Overall Study|Adverse Event|0|||
48670783|NCT01659255|156648246|FG001|Overall Study|Adverse Event|0|||
48670784|NCT01659255|156648247|FG002|Overall Study|Adverse Event|0|||
48670785|NCT01659255|156648248|FG003|Overall Study|Adverse Event|0|||
48670786|NCT01659255|156648249|FG004|Overall Study|Adverse Event|0|||
48670787|NCT01659255|156648250|FG005|Overall Study|Adverse Event|1|||
48670788|NCT01659255|156648251|FG006|Overall Study|Adverse Event|1|||
48670789|NCT01659255|156648252|FG007|Overall Study|Adverse Event|0|||
48670790|NCT01659255|156648253|FG008|Overall Study|Adverse Event|0|||
48670791|NCT01659255|156648254|FG009|Overall Study|Adverse Event|1|||
48670792|NCT01659255|156648255|FG010|Overall Study|Adverse Event|0|||
48670793|NCT01659255|156648256|FG011|Overall Study|Adverse Event|1|||
48670794|NCT01659255|156648257|FG012|Overall Study|Adverse Event|0|||
48670795|NCT01659255|156648258|FG013|Overall Study|Adverse Event|2|||
48670796|NCT01659255|156648259|FG014|Overall Study|Adverse Event|0|||
48670797|NCT01659255|156648260|FG015|Overall Study|Adverse Event|1|||
48670798|NCT01659255|156648261|FG016|Overall Study|Adverse Event|0|||
48670799|NCT01659255|156648245|FG000|Overall Study|Death|0|||
48670800|NCT01659255|156648246|FG001|Overall Study|Death|1|||
48342469|NCT00187135|155449218|FG002|Visit Two|Study Discontinued|1|||
48670801|NCT01659255|156648247|FG002|Overall Study|Death|0|||
48670802|NCT01659255|156648248|FG003|Overall Study|Death|0|||
48670803|NCT01659255|156648249|FG004|Overall Study|Death|0|||
48670804|NCT01659255|156648250|FG005|Overall Study|Death|0|||
48670805|NCT01659255|156648251|FG006|Overall Study|Death|0|||
48342470|NCT00187135|155449219|FG003|Visit Two|Study Discontinued|7|||
48342471|NCT00187135|155449220|FG004|Visit Two|Study Discontinued|5|||
48342472|NCT00187135|155449221|FG005|Visit Two|Study Discontinued|6|||
48342473|NCT00187135|155449216|FG000|Visit Three|Death|0|||
48342474|NCT00187135|155449217|FG001|Visit Three|Death|0|||
48342475|NCT00187135|155449218|FG002|Visit Three|Death|1|||
48342476|NCT00187135|155449219|FG003|Visit Three|Death|0|||
48342477|NCT00187135|155449220|FG004|Visit Three|Death|1|||
48342478|NCT00187135|155449221|FG005|Visit Three|Death|0|||
48342479|NCT00187135|155449216|FG000|Visit Three|Withdrawal by Subject|0|||
48342480|NCT00187135|155449217|FG001|Visit Three|Withdrawal by Subject|1|||
48342481|NCT00187135|155449218|FG002|Visit Three|Withdrawal by Subject|1|||
48342482|NCT00187135|155449219|FG003|Visit Three|Withdrawal by Subject|2|||
48342483|NCT00187135|155449220|FG004|Visit Three|Withdrawal by Subject|0|||
48342484|NCT00187135|155449221|FG005|Visit Three|Withdrawal by Subject|0|||
48342485|NCT00187135|155449216|FG000|Visit Three|Study Discontinued|7|||
48342486|NCT00187135|155449217|FG001|Visit Three|Study Discontinued|6|||
48342487|NCT00187135|155449218|FG002|Visit Three|Study Discontinued|7|||
48342488|NCT00187135|155449219|FG003|Visit Three|Study Discontinued|7|||
48342489|NCT00187135|155449220|FG004|Visit Three|Study Discontinued|7|||
48342490|NCT00187135|155449221|FG005|Visit Three|Study Discontinued|6|||
48342491|NCT04748445|155449224|FG000|Overall Study|No longer met eligibility criteria|12|||
48342492|NCT04748445|155449224|FG000|Overall Study|Other|36|||
48342493|NCT04748445|155449224|FG000|Overall Study|Withdrawal by Subject|553|||
48342494|NCT04748445|155449224|FG000|Overall Study|Lost to Follow-up|30|||
48342495|NCT03635775|155449226|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
48342496|NCT03635775|155449227|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
48342497|NCT03635775|155449228|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
48342498|NCT03635775|155449229|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
48342499|NCT00105521|155449230|FG000|Overall Study|Other|1|||
48342500|NCT00105521|155449231|FG001|Overall Study|Other|1|||
48342501|NCT00105521|155449232|FG002|Overall Study|Other|2|||
48342502|NCT00105521|155449233|FG003|Overall Study|Other|0|||
48342503|NCT00105521|155449230|FG000|Overall Study|Adverse Event|10|||
48342504|NCT00105521|155449231|FG001|Overall Study|Adverse Event|4|||
48342505|NCT00105521|155449232|FG002|Overall Study|Adverse Event|10|||
48342506|NCT00105521|155449233|FG003|Overall Study|Adverse Event|8|||
48342507|NCT00105521|155449230|FG000|Overall Study|Withdrawal by Subject|1|||
48342508|NCT00105521|155449231|FG001|Overall Study|Withdrawal by Subject|0|||
48342509|NCT00105521|155449232|FG002|Overall Study|Withdrawal by Subject|1|||
48342510|NCT00105521|155449233|FG003|Overall Study|Withdrawal by Subject|4|||
48342511|NCT00105521|155449230|FG000|Overall Study|Lack of Efficacy|0|||
48342512|NCT00105521|155449231|FG001|Overall Study|Lack of Efficacy|0|||
48342513|NCT00105521|155449232|FG002|Overall Study|Lack of Efficacy|0|||
48342514|NCT00105521|155449233|FG003|Overall Study|Lack of Efficacy|1|||
48342515|NCT00105521|155449230|FG000|Overall Study|Protocol Violation|3|||
48342516|NCT00105521|155449231|FG001|Overall Study|Protocol Violation|5|||
48342517|NCT00105521|155449232|FG002|Overall Study|Protocol Violation|4|||
48342518|NCT00105521|155449233|FG003|Overall Study|Protocol Violation|4|||
48342519|NCT00105521|155449230|FG000|Overall Study|Lost to Follow-up|0|||
48670806|NCT01659255|156648252|FG007|Overall Study|Death|1|||
48670807|NCT01659255|156648253|FG008|Overall Study|Death|1|||
48670808|NCT01659255|156648254|FG009|Overall Study|Death|0|||
48670809|NCT01659255|156648255|FG010|Overall Study|Death|0|||
48342520|NCT00105521|155449231|FG001|Overall Study|Lost to Follow-up|1|||
48342521|NCT00105521|155449232|FG002|Overall Study|Lost to Follow-up|0|||
48342522|NCT00105521|155449233|FG003|Overall Study|Lost to Follow-up|0|||
48342523|NCT01536535|155449234|FG000|Overall Study|Withdrawal by Subject|10|||
48342524|NCT01536535|155449235|FG001|Overall Study|Withdrawal by Subject|5|||
48342525|NCT01536535|155449234|FG000|Overall Study|Lost to Follow-up|4|||
48670810|NCT01659255|156648256|FG011|Overall Study|Death|0|||
48670811|NCT01659255|156648257|FG012|Overall Study|Death|1|||
48670812|NCT01659255|156648258|FG013|Overall Study|Death|1|||
48670813|NCT01659255|156648259|FG014|Overall Study|Death|2|||
48670814|NCT01659255|156648260|FG015|Overall Study|Death|1|||
48670815|NCT01659255|156648261|FG016|Overall Study|Death|0|||
48670816|NCT01659255|156648245|FG000|Overall Study|Progressive Disease|2|||
48670817|NCT01659255|156648246|FG001|Overall Study|Progressive Disease|0|||
48670818|NCT01659255|156648247|FG002|Overall Study|Progressive Disease|0|||
48670819|NCT01659255|156648248|FG003|Overall Study|Progressive Disease|0|||
48670820|NCT01659255|156648249|FG004|Overall Study|Progressive Disease|0|||
48670821|NCT01659255|156648250|FG005|Overall Study|Progressive Disease|0|||
48670822|NCT01659255|156648251|FG006|Overall Study|Progressive Disease|0|||
48670823|NCT01659255|156648252|FG007|Overall Study|Progressive Disease|1|||
48670824|NCT01659255|156648253|FG008|Overall Study|Progressive Disease|0|||
48670825|NCT01659255|156648254|FG009|Overall Study|Progressive Disease|2|||
48670826|NCT01659255|156648255|FG010|Overall Study|Progressive Disease|2|||
48670827|NCT01659255|156648256|FG011|Overall Study|Progressive Disease|3|||
48670828|NCT01659255|156648257|FG012|Overall Study|Progressive Disease|5|||
48670829|NCT01659255|156648258|FG013|Overall Study|Progressive Disease|13|||
48670830|NCT01659255|156648259|FG014|Overall Study|Progressive Disease|6|||
48670831|NCT01659255|156648260|FG015|Overall Study|Progressive Disease|2|||
48670832|NCT01659255|156648261|FG016|Overall Study|Progressive Disease|3|||
48342526|NCT01536535|155449235|FG001|Overall Study|Lost to Follow-up|6|||
48342527|NCT01536535|155449234|FG000|Overall Study|Physician Decision|1|||
48342528|NCT01536535|155449235|FG001|Overall Study|Physician Decision|1|||
48342529|NCT01536535|155449234|FG000|Overall Study|Participant moved|0|||
48342530|NCT01536535|155449235|FG001|Overall Study|Participant moved|1|||
48342531|NCT01485991|155449238|FG000|Overall Study|Adverse Event|0|||
48342532|NCT01485991|155449239|FG001|Overall Study|Adverse Event|4|||
48342533|NCT01485991|155449238|FG000|Overall Study|Lost to Follow-up|13|||
48342534|NCT01485991|155449239|FG001|Overall Study|Lost to Follow-up|10|||
48342535|NCT01485991|155449238|FG000|Overall Study|Withdrawal by Subject|13|||
48342536|NCT01485991|155449239|FG001|Overall Study|Withdrawal by Subject|20|||
48342537|NCT01485991|155449238|FG000|Overall Study|randomized but not treated|6|||
48342538|NCT01485991|155449239|FG001|Overall Study|randomized but not treated|2|||
48342539|NCT02538471|155449240|FG000|Overall Study|Progression of disease|2|||
48342540|NCT01675050|155449241|FG000|Period One Treatment|Withdrawal by Subject|1|||
48342541|NCT01675050|155449242|FG001|Period One Treatment|Withdrawal by Subject|0|||
48342542|NCT02025985|155449243|FG000|Overall Study|Consent withdrawn|0|||
48342543|NCT02025985|155449244|FG001|Overall Study|Consent withdrawn|0|||
48342544|NCT02025985|155449245|FG002|Overall Study|Consent withdrawn|1|||
48342545|NCT02025985|155449246|FG003|Overall Study|Consent withdrawn|0|||
48342546|NCT02025985|155449247|FG004|Overall Study|Consent withdrawn|0|||
48342547|NCT02025985|155449243|FG000|Overall Study|Termination of study by Sponsor|4|||
48342548|NCT02025985|155449244|FG001|Overall Study|Termination of study by Sponsor|3|||
48342549|NCT02025985|155449245|FG002|Overall Study|Termination of study by Sponsor|1|||
48342550|NCT02025985|155449246|FG003|Overall Study|Termination of study by Sponsor|1|||
48342551|NCT02025985|155449247|FG004|Overall Study|Termination of study by Sponsor|3|||
48342552|NCT02025985|155449243|FG000|Overall Study|Death|21|||
48342553|NCT02025985|155449244|FG001|Overall Study|Death|20|||
48342554|NCT02025985|155449245|FG002|Overall Study|Death|23|||
48342555|NCT02025985|155449246|FG003|Overall Study|Death|20|||
48342556|NCT02025985|155449247|FG004|Overall Study|Death|17|||
48342557|NCT00527514|155449248|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
48342558|NCT00527514|155449248|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
48342559|NCT00527514|155449248|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
48342560|NCT00527514|155449248|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
48342561|NCT00527514|155449248|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
48342562|NCT00527514|155449248|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
48342563|NCT00527514|155449248|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
48342564|NCT03041701|155449250|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
48342565|NCT03041701|155449251|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
48342566|NCT03041701|155449252|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
48342567|NCT03041701|155449250|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
48342568|NCT03041701|155449251|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
48342569|NCT03041701|155449252|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
48342570|NCT03410108|155449254|FG000|Overall Study|Ongoing|41|||
48342571|NCT03410108|155449254|FG000|Overall Study|Adverse Event|4|||
48670833|NCT01659255|156648245|FG000|Overall Study|Withdrew Consent|0|||
48670834|NCT01659255|156648246|FG001|Overall Study|Withdrew Consent|0|||
48670835|NCT01659255|156648247|FG002|Overall Study|Withdrew Consent|0|||
48670836|NCT01659255|156648248|FG003|Overall Study|Withdrew Consent|0|||
48342572|NCT03410108|155449254|FG000|Overall Study|Progressive Disease|58|||
48342573|NCT03410108|155449254|FG000|Overall Study|Withdrawal by Subject|1|||
48342574|NCT02161185|155449255|FG000|Treatment Phase|Administrative/Other|7|||
48342575|NCT03575572|155449256|FG000|Overall Study|Withdrawal by Subject|2|||
48342576|NCT03575572|155449256|FG000|Overall Study|Physician Decision|2|||
48670837|NCT01659255|156648249|FG004|Overall Study|Withdrew Consent|0|||
48670838|NCT01659255|156648250|FG005|Overall Study|Withdrew Consent|0|||
48342577|NCT02162771|155449257|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
48670839|NCT01659255|156648251|FG006|Overall Study|Withdrew Consent|0|||
48342578|NCT02162771|155449258|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
48342579|NCT02162771|155449257|FG000|Core Study Period (Part 2)|Adverse Event|4|||
48342580|NCT02162771|155449258|FG001|Core Study Period (Part 2)|Adverse Event|1|||
48670840|NCT01659255|156648252|FG007|Overall Study|Withdrew Consent|0|||
48342581|NCT02162771|155449257|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
48342582|NCT02162771|155449258|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
48342583|NCT02162771|155449257|FG000|Core Study Period (Part 2)|Physician Decision|0|||
48342584|NCT02162771|155449258|FG001|Core Study Period (Part 2)|Physician Decision|2|||
48342585|NCT02162771|155449257|FG000|Core Study Period (Part 2)|Death|1|||
48342586|NCT02162771|155449258|FG001|Core Study Period (Part 2)|Death|0|||
48342587|NCT02162771|155449257|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
48342588|NCT02162771|155449258|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
48342589|NCT02162771|155449257|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
48342590|NCT02162771|155449258|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
48342591|NCT02162771|155449257|FG000|Maintenance Study Period (Part 2)|Death|2|||
48342592|NCT02162771|155449258|FG001|Maintenance Study Period (Part 2)|Death|1|||
48342593|NCT02162771|155449257|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
48342594|NCT02162771|155449258|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
48342595|NCT02162771|155449257|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
48342596|NCT02162771|155449258|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
48342597|NCT02162771|155449257|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
48342598|NCT02162771|155449258|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
48342599|NCT01287416|155449264|FG000|Pre-post Training|Withdrawal by Subject|17|||
48342600|NCT01287416|155449265|FG001|Pre-post Training|Withdrawal by Subject|24|||
48342601|NCT01287416|155449264|FG000|Pre-post Training|Lost to Follow-up|5|||
48342602|NCT01287416|155449265|FG001|Pre-post Training|Lost to Follow-up|1|||
48670841|NCT01659255|156648253|FG008|Overall Study|Withdrew Consent|0|||
48670842|NCT01659255|156648254|FG009|Overall Study|Withdrew Consent|0|||
48670843|NCT01659255|156648255|FG010|Overall Study|Withdrew Consent|1|||
48670844|NCT01659255|156648256|FG011|Overall Study|Withdrew Consent|0|||
48670845|NCT01659255|156648257|FG012|Overall Study|Withdrew Consent|0|||
48670846|NCT01659255|156648258|FG013|Overall Study|Withdrew Consent|1|||
48670847|NCT01659255|156648259|FG014|Overall Study|Withdrew Consent|0|||
48670848|NCT01659255|156648260|FG015|Overall Study|Withdrew Consent|0|||
48670849|NCT01659255|156648261|FG016|Overall Study|Withdrew Consent|0|||
48670850|NCT01659255|156648245|FG000|Overall Study|Investigator Decision|0|||
48670851|NCT01659255|156648246|FG001|Overall Study|Investigator Decision|0|||
48670852|NCT01659255|156648247|FG002|Overall Study|Investigator Decision|0|||
48670853|NCT01659255|156648248|FG003|Overall Study|Investigator Decision|0|||
48670854|NCT01659255|156648249|FG004|Overall Study|Investigator Decision|0|||
48670855|NCT01659255|156648250|FG005|Overall Study|Investigator Decision|0|||
48670856|NCT01659255|156648251|FG006|Overall Study|Investigator Decision|0|||
48670857|NCT01659255|156648252|FG007|Overall Study|Investigator Decision|0|||
48670858|NCT01659255|156648253|FG008|Overall Study|Investigator Decision|0|||
48670859|NCT01659255|156648254|FG009|Overall Study|Investigator Decision|0|||
48670860|NCT01659255|156648255|FG010|Overall Study|Investigator Decision|0|||
48670861|NCT01659255|156648256|FG011|Overall Study|Investigator Decision|0|||
48670862|NCT01659255|156648257|FG012|Overall Study|Investigator Decision|1|||
48670863|NCT01659255|156648258|FG013|Overall Study|Investigator Decision|1|||
48760527|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48342603|NCT01287416|155449264|FG000|6 Month Follow-up|Lost to Follow-up|3|||
48342604|NCT01287416|155449265|FG001|6 Month Follow-up|Lost to Follow-up|2|||
48342605|NCT02864342|155449268|FG000|Overall Study|Eligibility Criteria Deviation|2|||
48342606|NCT02864342|155449269|FG001|Overall Study|Eligibility Criteria Deviation|3|||
48342607|NCT02864342|155449268|FG000|Overall Study|Withdrawal by Subject|4|||
48670864|NCT01659255|156648259|FG014|Overall Study|Investigator Decision|0|||
48760528|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48760529|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
48760530|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
48760531|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760532|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760533|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
48760534|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760535|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760536|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
48760537|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
48760538|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
48760539|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
48760540|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
48342608|NCT02864342|155449269|FG001|Overall Study|Withdrawal by Subject|2|||
48342609|NCT02864342|155449268|FG000|Overall Study|Device Technology Issue|6|||
48342610|NCT02864342|155449269|FG001|Overall Study|Device Technology Issue|7|||
48670865|NCT01659255|156648260|FG015|Overall Study|Investigator Decision|0|||
48670866|NCT01659255|156648261|FG016|Overall Study|Investigator Decision|0|||
48670867|NCT01659255|156648245|FG000|Overall Study|Sponsor's Decision|0|||
48670868|NCT01659255|156648246|FG001|Overall Study|Sponsor's Decision|0|||
48670869|NCT01659255|156648247|FG002|Overall Study|Sponsor's Decision|0|||
48760541|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
48760542|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
48760543|NCT03720470|156972237|FG000|Treatment Period: Final 4 Weeks|Other|0|||
48760544|NCT03720470|156972238|FG001|Treatment Period: Final 4 Weeks|Other|1|||
48760545|NCT03720470|156972239|FG002|Treatment Period: Final 4 Weeks|Other|0|||
48760546|NCT03720470|156972240|FG003|Treatment Period: Final 4 Weeks|Other|2|||
48760547|NCT03720470|156972241|FG004|Treatment Period: Final 4 Weeks|Other|1|||
48760548|NCT03720470|156972242|FG005|Treatment Period: Final 4 Weeks|Other|0|||
48760549|NCT01163279|156972244|FG000|Overall Study|Withdrawal by Subject|2|||
48760550|NCT01163279|156972245|FG001|Overall Study|Withdrawal by Subject|0|||
48760551|NCT02411292|156972246|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
48760552|NCT02411292|156972246|FG000|Overall Study|Death|2|||
48760553|NCT02411292|156972246|FG000|Overall Study|Lost to Follow-up|3|||
48760554|NCT02784821|156972247|FG000|Overall Study|Death|0|||
48342611|NCT02864342|155449268|FG000|Overall Study|Death|0|||
48342612|NCT02864342|155449269|FG001|Overall Study|Death|1|||
48342613|NCT02864342|155449268|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
48342614|NCT02864342|155449269|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
48342615|NCT02864342|155449268|FG000|Overall Study|Lost to Follow-up|1|||
48342616|NCT02864342|155449269|FG001|Overall Study|Lost to Follow-up|5|||
48342617|NCT02864342|155449268|FG000|Overall Study|Lost Device|1|||
48342618|NCT02864342|155449269|FG001|Overall Study|Lost Device|0|||
48342619|NCT02864342|155449268|FG000|Overall Study|Adverse Event|1|||
48342620|NCT02864342|155449269|FG001|Overall Study|Adverse Event|0|||
48342621|NCT02391545|155449276|FG000|Overall Study|Death|0|||
48342622|NCT02391545|155449277|FG001|Overall Study|Death|2|||
48342623|NCT02391545|155449276|FG000|Overall Study|Lost to Follow-up|0|||
48342624|NCT02391545|155449277|FG001|Overall Study|Lost to Follow-up|1|||
48342625|NCT02391545|155449276|FG000|Overall Study|Termination of study by sponsor|20|||
48342626|NCT02391545|155449277|FG001|Overall Study|Termination of study by sponsor|20|||
48342627|NCT02391545|155449276|FG000|Overall Study|Withdrawal by Subject|0|||
48342628|NCT02391545|155449277|FG001|Overall Study|Withdrawal by Subject|1|||
48342629|NCT02391545|155449276|FG000|Overall Study|Other Reasons|6|||
48342630|NCT02391545|155449277|FG001|Overall Study|Other Reasons|4|||
48670870|NCT01659255|156648248|FG003|Overall Study|Sponsor's Decision|0|||
48342631|NCT03213691|155449282|FG000|Overall Study|Adverse Event|2|||
48342632|NCT03213691|155449282|FG000|Overall Study|Death|3|||
48342633|NCT03213691|155449282|FG000|Overall Study|Physician Decision|1|||
48342634|NCT03213691|155449282|FG000|Overall Study|Progressive Disease|14|||
48342635|NCT03213691|155449282|FG000|Overall Study|Ineligible|1|||
48342636|NCT03816332|155449283|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
48670871|NCT01659255|156648249|FG004|Overall Study|Sponsor's Decision|0|||
48670872|NCT01659255|156648250|FG005|Overall Study|Sponsor's Decision|0|||
48670873|NCT01659255|156648251|FG006|Overall Study|Sponsor's Decision|1|||
48670874|NCT01659255|156648252|FG007|Overall Study|Sponsor's Decision|0|||
48670875|NCT01659255|156648253|FG008|Overall Study|Sponsor's Decision|0|||
48670876|NCT01659255|156648254|FG009|Overall Study|Sponsor's Decision|0|||
48670877|NCT01659255|156648255|FG010|Overall Study|Sponsor's Decision|0|||
48670878|NCT01659255|156648256|FG011|Overall Study|Sponsor's Decision|0|||
48670879|NCT01659255|156648257|FG012|Overall Study|Sponsor's Decision|0|||
48670880|NCT01659255|156648258|FG013|Overall Study|Sponsor's Decision|0|||
48670881|NCT01659255|156648259|FG014|Overall Study|Sponsor's Decision|0|||
48670882|NCT01659255|156648260|FG015|Overall Study|Sponsor's Decision|0|||
48670883|NCT01659255|156648261|FG016|Overall Study|Sponsor's Decision|0|||
48670884|NCT01659255|156648245|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670885|NCT01659255|156648246|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670886|NCT01659255|156648247|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670887|NCT01659255|156648248|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670888|NCT01659255|156648249|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670889|NCT01659255|156648250|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670890|NCT01659255|156648251|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670891|NCT01659255|156648252|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670892|NCT01659255|156648253|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670893|NCT01659255|156648254|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670894|NCT01659255|156648255|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670895|NCT01659255|156648256|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670896|NCT01659255|156648257|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670897|NCT01659255|156648258|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670898|NCT01659255|156648259|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670899|NCT01659255|156648260|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
48760555|NCT02784821|156972248|FG001|Overall Study|Death|5|||
48760556|NCT02784821|156972249|FG002|Overall Study|Death|4|||
48760557|NCT02784821|156972250|FG003|Overall Study|Death|5|||
48342637|NCT03816332|155449283|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
48670900|NCT01659255|156648261|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
48670901|NCT01659255|156648245|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
48670902|NCT01659255|156648246|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
48670903|NCT01659255|156648247|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
48670904|NCT01659255|156648248|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
48670905|NCT01659255|156648249|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
48670906|NCT01659255|156648250|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
48670907|NCT01659255|156648251|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
48670908|NCT01659255|156648252|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
48670909|NCT01659255|156648253|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
48670910|NCT01659255|156648254|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
48670911|NCT01659255|156648255|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
48670912|NCT01659255|156648256|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
48670913|NCT01659255|156648257|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
48670914|NCT01659255|156648258|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
48670915|NCT01659255|156648259|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
48670916|NCT01659255|156648260|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
48670917|NCT01659255|156648261|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
48670918|NCT02006069|156648262|FG000|Overall Study|MPP other programming|239|||
48670919|NCT02006069|156648263|FG001|Overall Study|MPP other programming|0|||
48670920|NCT02006069|156648262|FG000|Overall Study|RV only pacing|0|||
48670921|NCT02006069|156648263|FG001|Overall Study|RV only pacing|3|||
48670922|NCT02989805|156648264|FG000|Overall Study|invalid consent|6|||
48670923|NCT02989805|156648265|FG001|Overall Study|invalid consent|4|||
48670924|NCT02760810|156648273|FG000|Overall Study|Protocol Violation|1|||
48670925|NCT01581619|156648274|FG000|Overall Study|Withdrawal by Subject|1|||
48670926|NCT01581619|156648274|FG000|Overall Study|Lost to Follow-up|1|||
48670927|NCT01639755|156648275|FG000|Overall Study|Study Ongoing|15|||
48670928|NCT01639755|156648275|FG000|Overall Study|Patient had device explantation|4|||
48670929|NCT03847909|156648277|FG000|Overall Study|Withdrawal by Subject|1|||
48670930|NCT03847909|156648278|FG001|Overall Study|Withdrawal by Subject|1|||
48670931|NCT03629912|156648279|FG000|Overall Study|Lost to Follow-up|19|||
48670932|NCT03629912|156648280|FG001|Overall Study|Lost to Follow-up|7|||
48670933|NCT03629912|156648281|FG002|Overall Study|Lost to Follow-up|5|||
48670934|NCT03629912|156648282|FG003|Overall Study|Lost to Follow-up|1|||
48670935|NCT03629912|156648279|FG000|Overall Study|Withdrawal by Subject|6|||
48670936|NCT03629912|156648280|FG001|Overall Study|Withdrawal by Subject|0|||
48670937|NCT03629912|156648281|FG002|Overall Study|Withdrawal by Subject|1|||
48670938|NCT03629912|156648282|FG003|Overall Study|Withdrawal by Subject|2|||
48670939|NCT03629912|156648279|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
48670940|NCT03629912|156648280|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
48670941|NCT03629912|156648281|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
48670942|NCT03629912|156648282|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
48760558|NCT02794103|156972251|FG000|Overall Study|Loss to follow up due to high sedation|3|||
48760559|NCT01881230|156972269|FG000|Overall Study|Death|2|||
48760560|NCT01881230|156972270|FG001|Overall Study|Death|0|||
48760561|NCT01881230|156972271|FG002|Overall Study|Death|1|||
48760562|NCT01881230|156972269|FG000|Overall Study|Adverse Event|9|||
48760563|NCT01881230|156972270|FG001|Overall Study|Adverse Event|13|||
48760564|NCT01881230|156972271|FG002|Overall Study|Adverse Event|12|||
48760565|NCT01881230|156972269|FG000|Overall Study|Progressive Disease|31|||
48760566|NCT01881230|156972270|FG001|Overall Study|Progressive Disease|35|||
48760567|NCT01881230|156972271|FG002|Overall Study|Progressive Disease|36|||
48760568|NCT01881230|156972269|FG000|Overall Study|Symptomatic Deterioration|3|||
48760569|NCT01881230|156972270|FG001|Overall Study|Symptomatic Deterioration|3|||
48760570|NCT01881230|156972271|FG002|Overall Study|Symptomatic Deterioration|1|||
48760571|NCT01881230|156972269|FG000|Overall Study|Withdrawal by Subject|6|||
48760572|NCT01881230|156972270|FG001|Overall Study|Withdrawal by Subject|4|||
48760573|NCT01881230|156972271|FG002|Overall Study|Withdrawal by Subject|6|||
48760574|NCT01881230|156972269|FG000|Overall Study|Physician Decision|4|||
48670943|NCT03629912|156648279|FG000|Overall Study|Death|1|||
48670944|NCT03629912|156648280|FG001|Overall Study|Death|0|||
48670945|NCT03629912|156648281|FG002|Overall Study|Death|0|||
48760575|NCT01881230|156972270|FG001|Overall Study|Physician Decision|3|||
48670946|NCT03629912|156648282|FG003|Overall Study|Death|0|||
48670947|NCT00869401|156648283|FG000|Overall Study|Withdrawal by Subject|0|||
48670948|NCT00869401|156648284|FG001|Overall Study|Withdrawal by Subject|0|||
48760576|NCT01881230|156972271|FG002|Overall Study|Physician Decision|6|||
48670949|NCT00869401|156648285|FG002|Overall Study|Withdrawal by Subject|0|||
48670950|NCT00869401|156648286|FG003|Overall Study|Withdrawal by Subject|5|||
48760577|NCT01881230|156972269|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48342638|NCT00853021|155449287|FG000|Overall Study|Adverse Event|2|||
48760578|NCT01881230|156972270|FG001|Overall Study|Non-Compliance with Study Drug|2|||
48760579|NCT01881230|156972271|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48342639|NCT00853021|155449287|FG000|Overall Study|Withdrawal by Subject|2|||
48342640|NCT00853021|155449287|FG000|Overall Study|Death|1|||
48342641|NCT04088500|155449291|FG000|Overall Study|Reason unknown|1|||
48342642|NCT04088500|155449291|FG000|Overall Study|Participant withdrew consent|1|||
48342643|NCT04088500|155449291|FG000|Overall Study|Disease progression|3|||
48342644|NCT00981578|155449292|FG000|Overall Study|Death|1|||
48342645|NCT00981578|155449292|FG000|Overall Study|Withdrawal by Subject|2|||
48342646|NCT01502371|155449297|FG000|Overall Study|Withdrawal by Subject|1|||
48342647|NCT01502371|155449298|FG001|Overall Study|Withdrawal by Subject|2|||
48342648|NCT01502371|155449299|FG002|Overall Study|Withdrawal by Subject|1|||
48342649|NCT01502371|155449300|FG003|Overall Study|Withdrawal by Subject|1|||
48342650|NCT01502371|155449301|FG004|Overall Study|Withdrawal by Subject|1|||
48342651|NCT01502371|155449297|FG000|Overall Study|Adverse Event|2|||
48342652|NCT01502371|155449298|FG001|Overall Study|Adverse Event|1|||
48342653|NCT01502371|155449299|FG002|Overall Study|Adverse Event|0|||
48342654|NCT01502371|155449300|FG003|Overall Study|Adverse Event|4|||
48342655|NCT01502371|155449301|FG004|Overall Study|Adverse Event|3|||
48342656|NCT01502371|155449297|FG000|Overall Study|Treatment Failure|22|||
48342657|NCT01502371|155449298|FG001|Overall Study|Treatment Failure|20|||
48342658|NCT01502371|155449299|FG002|Overall Study|Treatment Failure|12|||
48342659|NCT01502371|155449300|FG003|Overall Study|Treatment Failure|19|||
48342660|NCT01502371|155449301|FG004|Overall Study|Treatment Failure|30|||
48342661|NCT01502371|155449297|FG000|Overall Study|Lack of Efficacy|3|||
48342662|NCT01502371|155449298|FG001|Overall Study|Lack of Efficacy|3|||
48342663|NCT01502371|155449299|FG002|Overall Study|Lack of Efficacy|2|||
48342664|NCT01502371|155449300|FG003|Overall Study|Lack of Efficacy|2|||
48342665|NCT01502371|155449301|FG004|Overall Study|Lack of Efficacy|4|||
48342666|NCT01502371|155449297|FG000|Overall Study|Physician Decision|3|||
48342667|NCT01502371|155449298|FG001|Overall Study|Physician Decision|0|||
48342668|NCT01502371|155449299|FG002|Overall Study|Physician Decision|0|||
48342669|NCT01502371|155449300|FG003|Overall Study|Physician Decision|0|||
48342670|NCT01502371|155449301|FG004|Overall Study|Physician Decision|1|||
48342671|NCT01502371|155449297|FG000|Overall Study|Noncompliance with Study Drug|0|||
48342672|NCT01502371|155449298|FG001|Overall Study|Noncompliance with Study Drug|0|||
48342673|NCT01502371|155449299|FG002|Overall Study|Noncompliance with Study Drug|1|||
48342674|NCT01502371|155449300|FG003|Overall Study|Noncompliance with Study Drug|2|||
48342675|NCT01502371|155449301|FG004|Overall Study|Noncompliance with Study Drug|1|||
48342676|NCT01502371|155449297|FG000|Overall Study|Technical Problems|1|||
48342677|NCT01502371|155449298|FG001|Overall Study|Technical Problems|0|||
48342678|NCT01502371|155449299|FG002|Overall Study|Technical Problems|2|||
48342679|NCT01502371|155449300|FG003|Overall Study|Technical Problems|4|||
48342680|NCT01502371|155449301|FG004|Overall Study|Technical Problems|1|||
48342681|NCT01502371|155449297|FG000|Overall Study|Protocol Violation|9|||
48342682|NCT01502371|155449298|FG001|Overall Study|Protocol Violation|5|||
48342683|NCT01502371|155449299|FG002|Overall Study|Protocol Violation|6|||
48342684|NCT01502371|155449300|FG003|Overall Study|Protocol Violation|5|||
48342685|NCT01502371|155449301|FG004|Overall Study|Protocol Violation|10|||
48342686|NCT01502371|155449297|FG000|Overall Study|Excluded Medication|0|||
48342687|NCT01502371|155449298|FG001|Overall Study|Excluded Medication|1|||
48342688|NCT01502371|155449299|FG002|Overall Study|Excluded Medication|1|||
48342689|NCT01502371|155449300|FG003|Overall Study|Excluded Medication|0|||
48342690|NCT01502371|155449301|FG004|Overall Study|Excluded Medication|1|||
48342691|NCT00509925|155449302|FG000|Overall Study|Personal reasons|0|||
48342692|NCT00509925|155449303|FG001|Overall Study|Personal reasons|1|||
48342693|NCT00497198|155449304|FG000|Overall Study|Adverse Event|4|||
48342694|NCT00497198|155449305|FG001|Overall Study|Adverse Event|2|||
48342695|NCT00497198|155449304|FG000|Overall Study|Physician Decision|1|||
48342696|NCT00497198|155449305|FG001|Overall Study|Physician Decision|2|||
48342697|NCT00497198|155449304|FG000|Overall Study|Withdrawal by Subject|0|||
48342698|NCT00497198|155449305|FG001|Overall Study|Withdrawal by Subject|1|||
48342699|NCT01190449|155449306|FG000|Overall Study|Ineligible|0|||
48342700|NCT01190449|155449307|FG001|Overall Study|Ineligible|4|||
48342701|NCT03326193|155449313|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
48342702|NCT03326193|155449313|FG000|Overall Study|Death|19|||
48342703|NCT03326193|155449313|FG000|Overall Study|Withdrawal by Subject|8|||
48342704|NCT03662659|155449324|FG000|Pre-treatment|Participant no longer met study criteria|1|||
48342705|NCT03662659|155449325|FG001|Pre-treatment|Participant no longer met study criteria|1|||
48342706|NCT03662659|155449324|FG000|Pre-treatment|Other reasons|1|||
48342707|NCT03662659|155449325|FG001|Pre-treatment|Other reasons|0|||
48342708|NCT03662659|155449324|FG000|Treatment|Completed Treatment|0|||
48342709|NCT03662659|155449325|FG001|Treatment|Completed Treatment|2|||
48342710|NCT03662659|155449324|FG000|Treatment|Disease Progression|85|||
48342711|NCT03662659|155449325|FG001|Treatment|Disease Progression|97|||
48670951|NCT00869401|156648287|FG004|Overall Study|Withdrawal by Subject|3|||
48342712|NCT03662659|155449324|FG000|Treatment|Study Drug Toxicity|19|||
48342713|NCT03662659|155449325|FG001|Treatment|Study Drug Toxicity|9|||
48342714|NCT03662659|155449324|FG000|Treatment|Death|11|||
48342715|NCT03662659|155449325|FG001|Treatment|Death|9|||
48342716|NCT03662659|155449324|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
48342717|NCT03662659|155449325|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
48342718|NCT03662659|155449324|FG000|Treatment|Withdrawal by Subject|1|||
48342719|NCT03662659|155449325|FG001|Treatment|Withdrawal by Subject|1|||
48342720|NCT03662659|155449324|FG000|Treatment|Poor/Non-compliance|1|||
48342721|NCT03662659|155449325|FG001|Treatment|Poor/Non-compliance|0|||
48342722|NCT03662659|155449324|FG000|Treatment|Participant no longer meets study criteria|1|||
48342723|NCT03662659|155449325|FG001|Treatment|Participant no longer meets study criteria|0|||
48342724|NCT03662659|155449324|FG000|Treatment|Other reasons|10|||
48342725|NCT03662659|155449325|FG001|Treatment|Other reasons|8|||
48342726|NCT03662659|155449324|FG000|Treatment|Administrative reasons by sponsor|1|||
48342727|NCT03662659|155449325|FG001|Treatment|Administrative reasons by sponsor|0|||
48342728|NCT03662659|155449324|FG000|Treatment|maximum clinical benefit|0|||
48342729|NCT03662659|155449325|FG001|Treatment|maximum clinical benefit|2|||
48342730|NCT04490915|155450382|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
48342731|NCT04490915|155450383|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
48342732|NCT04490915|155450382|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48342733|NCT04490915|155450383|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48342734|NCT04490915|155450382|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48342735|NCT04490915|155450383|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
48342736|NCT04490915|155450382|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
48342737|NCT04490915|155450383|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
48342738|NCT04490915|155450382|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
48342739|NCT04490915|155450383|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
48342740|NCT04490915|155450382|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
48342741|NCT04490915|155450383|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
48342742|NCT04490915|155450382|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
48342743|NCT04490915|155450383|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
48342744|NCT03456076|155450384|FG000|Overall Study|Withdrawal by Subject|5|||
48342745|NCT03456076|155450385|FG001|Overall Study|Withdrawal by Subject|9|||
48342746|NCT03456076|155450384|FG000|Overall Study|Protocol deviation|0|||
48342747|NCT03456076|155450385|FG001|Overall Study|Protocol deviation|1|||
48342748|NCT03456076|155450384|FG000|Overall Study|Lost to Follow-up|0|||
48342749|NCT03456076|155450385|FG001|Overall Study|Lost to Follow-up|1|||
48342750|NCT03456076|155450384|FG000|Overall Study|Death|2|||
48342751|NCT03456076|155450385|FG001|Overall Study|Death|5|||
48342752|NCT03456076|155450384|FG000|Overall Study|Study ongoing|123|||
48342753|NCT03456076|155450385|FG001|Overall Study|Study ongoing|111|||
48342754|NCT03319719|155450393|FG000|Overall Study|Lost to Follow-up|1|||
48342755|NCT01960114|155450394|FG000|Overall Study|Adverse Event|1|||
48342756|NCT01960114|155450395|FG001|Overall Study|Adverse Event|0|||
48342757|NCT01960114|155450394|FG000|Overall Study|Could not swallow study medication|0|||
48342758|NCT01960114|155450395|FG001|Overall Study|Could not swallow study medication|1|||
48342759|NCT02253147|155450396|FG000|Overall Study|Protocol Violation|30|||
48342760|NCT02253147|155450396|FG000|Overall Study|Did not consent to study extension|9|||
48342761|NCT02253147|155450396|FG000|Overall Study|Conditional re-treatment at W52|5|||
48342762|NCT02253147|155450396|FG000|Overall Study|Lost to Follow-up|2|||
48342763|NCT02253147|155450396|FG000|Overall Study|Withdrawal by Subject|1|||
48342764|NCT01685047|155450397|FG000|Overall Study|Withdrawal by Subject|20|||
48342765|NCT01685047|155450397|FG000|Overall Study|Death|26|||
48342766|NCT01685047|155450397|FG000|Overall Study|Lost to Follow-up|8|||
48342767|NCT01685047|155450397|FG000|Overall Study|Physician Decision|25|||
48342768|NCT01685047|155450397|FG000|Overall Study|Adverse Event|5|||
48342769|NCT01685047|155450397|FG000|Overall Study|patient withdrawn by sponsor|1|||
48342770|NCT01533181|155450398|FG000|Overall Study|Disease progression pre-active treatment|0|||
48342771|NCT01533181|155450399|FG001|Overall Study|Disease progression pre-active treatment|1|||
48342772|NCT01533181|155450398|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
48342773|NCT01533181|155450399|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
48342774|NCT02847637|155450400|FG000|Overall Study|Withdrawal by Subject|0|||
48342775|NCT02847637|155450401|FG001|Overall Study|Withdrawal by Subject|1|||
48342776|NCT02847637|155450402|FG002|Overall Study|Withdrawal by Subject|1|||
48342777|NCT02847637|155450403|FG003|Overall Study|Withdrawal by Subject|0|||
48670952|NCT02175368|156648288|FG000|Overall Study|Lost to Follow-up|1|||
48670953|NCT00903331|156648289|FG000|Overall Study|Death|4|||
48670954|NCT00903331|156648290|FG001|Overall Study|Death|8|||
48670955|NCT00903331|156648289|FG000|Overall Study|Withdrawal of consent|1|||
48342778|NCT02847637|155450400|FG000|Overall Study|Lost to Follow-up|1|||
48342779|NCT02847637|155450401|FG001|Overall Study|Lost to Follow-up|1|||
48342780|NCT02847637|155450402|FG002|Overall Study|Lost to Follow-up|0|||
48342781|NCT02847637|155450403|FG003|Overall Study|Lost to Follow-up|0|||
48342782|NCT02469077|155450404|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
48342783|NCT02469077|155450405|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
48342784|NCT02469077|155450404|FG000|Post Randomization/Intervention Period|Relocated|1|||
48342785|NCT02469077|155450405|FG001|Post Randomization/Intervention Period|Relocated|1|||
48428850|NCT04549168|155759000|FG001|Randomization Phase|Other|2|||
48670956|NCT00903331|156648290|FG001|Overall Study|Withdrawal of consent|8|||
48342786|NCT02469077|155450404|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
48342787|NCT02469077|155450405|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
48342788|NCT02469077|155450404|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
48342789|NCT02469077|155450405|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
48342790|NCT02995733|155450406|FG000|Overall Study|Study site closed|9|||
48342791|NCT02995733|155450407|FG001|Overall Study|Study site closed|10|||
48342792|NCT02995733|155450406|FG000|Overall Study|Death|3|||
48342793|NCT02995733|155450407|FG001|Overall Study|Death|4|||
48342794|NCT02995733|155450406|FG000|Overall Study|Withdrawal by Subject|6|||
48342795|NCT02995733|155450407|FG001|Overall Study|Withdrawal by Subject|2|||
48342796|NCT02995733|155450406|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
48342797|NCT02995733|155450407|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
48342798|NCT02995733|155450406|FG000|Overall Study|Lost to Follow-up|48|||
48342799|NCT02995733|155450407|FG001|Overall Study|Lost to Follow-up|37|||
48342800|NCT02995733|155450406|FG000|Overall Study|Other|0|||
48342801|NCT02995733|155450407|FG001|Overall Study|Other|1|||
48342802|NCT01284634|155450408|FG000|Overall Study|Adverse Event|1|||
48342803|NCT01284634|155450409|FG001|Overall Study|Adverse Event|0|||
48342804|NCT01284634|155450410|FG002|Overall Study|Adverse Event|2|||
48342805|NCT01284634|155450411|FG003|Overall Study|Adverse Event|1|||
48342806|NCT04806451|155450413|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
48342807|NCT04806451|155450414|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
48342808|NCT04806451|155450413|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
48342809|NCT04806451|155450414|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
48342810|NCT04806451|155450413|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
48342811|NCT04806451|155450414|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
48342812|NCT03503162|155450415|FG000|Overall Study|did not meet eligibility|1|||
48342813|NCT02442349|155450418|FG000|Overall Study|Death|95|||
48342814|NCT02442349|155450418|FG000|Overall Study|Withdrawal by Subject|27|||
48342815|NCT02442349|155450418|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
48342816|NCT02442349|155450418|FG000|Overall Study|Lost to Follow-up|1|||
48342817|NCT01544309|155450419|FG000|Overall Study|Withdrawal by Subject|12|||
48342818|NCT01544309|155450420|FG001|Overall Study|Withdrawal by Subject|7|||
48342819|NCT01544309|155450419|FG000|Overall Study|Protocol Violation|2|||
48342820|NCT01544309|155450420|FG001|Overall Study|Protocol Violation|1|||
48342821|NCT01544309|155450419|FG000|Overall Study|Physician Decision|4|||
48342822|NCT01544309|155450420|FG001|Overall Study|Physician Decision|1|||
48342823|NCT01544309|155450419|FG000|Overall Study|Not performed pre-dose examination|1|||
48670957|NCT00903331|156648289|FG000|Overall Study|Lung transplant|0|||
48670958|NCT00903331|156648290|FG001|Overall Study|Lung transplant|2|||
48670959|NCT00249613|156648291|FG000|12 Month Follow-up|Death|1|||
48670960|NCT00249613|156648292|FG001|12 Month Follow-up|Death|1|||
48670961|NCT00249613|156648291|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
48670962|NCT00249613|156648292|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
48670963|NCT00249613|156648291|FG000|12 Month Follow-up|Lost to Follow-up|10|||
48670964|NCT00249613|156648292|FG001|12 Month Follow-up|Lost to Follow-up|8|||
48670965|NCT02437084|156648293|FG000|Overall Study|Withdrawal by Subject|2|||
48670966|NCT02437084|156648293|FG000|Overall Study|Physician Decision|1|||
48670967|NCT00884832|156648294|FG000|Overall Study|Withdrawal by Subject|0|||
48670968|NCT00884832|156648295|FG001|Overall Study|Withdrawal by Subject|1|||
48670969|NCT01571453|156648296|FG000|Overall Study|Adverse Event|14|||
48670970|NCT01571453|156648297|FG001|Overall Study|Adverse Event|32|||
48670971|NCT01571453|156648296|FG000|Overall Study|Lack of Efficacy|8|||
48670972|NCT01571453|156648297|FG001|Overall Study|Lack of Efficacy|3|||
48670973|NCT01571453|156648296|FG000|Overall Study|Non-compliance|2|||
48670974|NCT01571453|156648297|FG001|Overall Study|Non-compliance|4|||
48670975|NCT01571453|156648296|FG000|Overall Study|Protocol Violation|1|||
48670976|NCT01571453|156648297|FG001|Overall Study|Protocol Violation|5|||
48670977|NCT01571453|156648296|FG000|Overall Study|Withdrawal of consent|5|||
48670978|NCT01571453|156648297|FG001|Overall Study|Withdrawal of consent|13|||
48342824|NCT01544309|155450420|FG001|Overall Study|Not performed pre-dose examination|2|||
48342825|NCT01544309|155450419|FG000|Overall Study|Administered prohibit prior medication|1|||
48342826|NCT01544309|155450420|FG001|Overall Study|Administered prohibit prior medication|0|||
48342827|NCT01424189|155450427|FG000|Overall Study|Adverse Event|1|||
48342828|NCT01424189|155450428|FG001|Overall Study|Adverse Event|0|||
48342829|NCT01424189|155450427|FG000|Overall Study|Lost to Follow-up|4|||
48342830|NCT01424189|155450428|FG001|Overall Study|Lost to Follow-up|1|||
48342831|NCT01424189|155450427|FG000|Overall Study|Withdrawal by Subject|4|||
48342832|NCT01424189|155450428|FG001|Overall Study|Withdrawal by Subject|4|||
48342833|NCT01424189|155450427|FG000|Overall Study|Subject moved|1|||
48342834|NCT01424189|155450428|FG001|Overall Study|Subject moved|0|||
48342835|NCT01424189|155450427|FG000|Overall Study|Death|3|||
48342836|NCT01424189|155450428|FG001|Overall Study|Death|1|||
48342837|NCT04688086|155450429|FG000|Overall Study|Lost to Follow-up|164|||
48342838|NCT04688086|155450429|FG000|Overall Study|Imaging error;|64|||
48342839|NCT00728884|155450432|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
48342840|NCT00728884|155450432|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
48342841|NCT03915951|155450433|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
48342842|NCT03915951|155450434|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
48342843|NCT03915951|155450433|FG000|Overall Study|Adverse Event|12|||
48342844|NCT03915951|155450434|FG001|Overall Study|Adverse Event|6|||
48342845|NCT03915951|155450433|FG000|Overall Study|Disease progression (radiological)|17|||
48342846|NCT03915951|155450434|FG001|Overall Study|Disease progression (radiological)|15|||
48342847|NCT03915951|155450433|FG000|Overall Study|Disease progression (clinical)|4|||
48342848|NCT03915951|155450434|FG001|Overall Study|Disease progression (clinical)|1|||
48342849|NCT03915951|155450433|FG000|Overall Study|Patient decision|0|||
48342850|NCT03915951|155450434|FG001|Overall Study|Patient decision|4|||
48342851|NCT03915951|155450433|FG000|Overall Study|Investigator decision|0|||
48342852|NCT03915951|155450434|FG001|Overall Study|Investigator decision|1|||
48342853|NCT03915951|155450433|FG000|Overall Study|Consent withdrawn|1|||
48342854|NCT03915951|155450434|FG001|Overall Study|Consent withdrawn|1|||
48342855|NCT03915951|155450433|FG000|Overall Study|Death|0|||
48342856|NCT03915951|155450434|FG001|Overall Study|Death|3|||
48342857|NCT01329419|155450435|FG000|Overall Study|Protocol Violation|235|||
48342858|NCT01592383|155450443|FG000|Overall Study|Adverse Event|1|||
48342859|NCT02930837|155450444|FG000|Overall Study|Adverse Event|6|||
48342860|NCT02930837|155450444|FG000|Overall Study|Lost to Follow-up|5|||
48342861|NCT02930837|155450444|FG000|Overall Study|Withdrawal by Subject|1|||
48342862|NCT04167085|155450445|FG000|Baseline|Withdrawal by Subject|2|||
48342863|NCT04167085|155450446|FG001|Baseline|Withdrawal by Subject|1|||
48342864|NCT04167085|155450445|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
48342865|NCT04167085|155450446|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
48342866|NCT02998918|155450447|FG000|Overall Study|Withdrawal by Subject|1|||
48342867|NCT02998918|155450448|FG001|Overall Study|Withdrawal by Subject|0|||
48342868|NCT05970861|155450464|FG000|Overall Study|Physician Decision|4|||
48342869|NCT05970861|155450465|FG001|Overall Study|Physician Decision|4|||
48342870|NCT05970861|155450464|FG000|Overall Study|Lost to Follow-up|4|||
48342871|NCT05970861|155450465|FG001|Overall Study|Lost to Follow-up|3|||
48342872|NCT01679613|155450466|FG000|Overall Study|other than stated above|0|||
48342873|NCT01679613|155450467|FG001|Overall Study|other than stated above|1|||
48342874|NCT01679613|155450468|FG002|Overall Study|other than stated above|2|||
48342875|NCT01679613|155450469|FG003|Overall Study|other than stated above|2|||
48342876|NCT03282799|155450472|FG000|Overall Study|Pregnancy|1|||
48342877|NCT03282799|155450473|FG001|Overall Study|Pregnancy|0|||
48342878|NCT03282799|155450472|FG000|Overall Study|Physician Decision|1|||
48342879|NCT03282799|155450473|FG001|Overall Study|Physician Decision|0|||
48586756|NCT00483704|156339070|FG001|Randomization|Progressive disease|0|||
48586757|NCT00483704|156339071|FG002|Randomization|Progressive disease|1|||
48342882|NCT05451693|155450476|FG000|Overall Study|Withdrawal by Subject|1|||
48342883|NCT05451693|155450477|FG001|Overall Study|Withdrawal by Subject|1|||
48342884|NCT05129501|155450480|FG000|Overall Study|Lost to Follow-up|54|||
48342885|NCT05129501|155450481|FG001|Overall Study|Lost to Follow-up|41|||
48342886|NCT04572997|155451473|FG000|Overall Study|Adverse Event|1|||
48342887|NCT01904019|155451474|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
48342888|NCT01904019|155451474|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
48342889|NCT01904019|155451474|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
48342890|NCT01904019|155451474|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
48342891|NCT01904019|155451474|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
48342892|NCT01904019|155451474|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
48342893|NCT00814632|155451475|FG000|Overall Study|Lack of Efficacy|2|||
48342894|NCT00733226|155451478|FG000|Overall Study|Withdrawal by Subject|1|||
48342895|NCT00733226|155451479|FG001|Overall Study|Withdrawal by Subject|0|||
48342896|NCT00733226|155451478|FG000|Overall Study|Lost to Follow-up|2|||
48342897|NCT00733226|155451479|FG001|Overall Study|Lost to Follow-up|0|||
48342898|NCT00733226|155451478|FG000|Overall Study|moved to another place|2|||
48342899|NCT00733226|155451479|FG001|Overall Study|moved to another place|0|||
48342900|NCT03438188|155451480|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
48342901|NCT03438188|155451481|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
48342902|NCT03438188|155451482|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
48342903|NCT03438188|155451480|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
48342904|NCT03438188|155451481|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
48342905|NCT03438188|155451482|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
48342906|NCT03438188|155451480|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
48342907|NCT03438188|155451481|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
48342908|NCT03438188|155451482|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
48342909|NCT03438188|155451480|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
48342910|NCT03438188|155451481|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
48342911|NCT03438188|155451482|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
48342912|NCT03438188|155451480|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
48586758|NCT00483704|156339069|FG000|Randomization|Lack of qualifying migraines|21|||
48760580|NCT01881230|156972269|FG000|Overall Study|Given Commercially Available Drug|0|||
48760581|NCT01881230|156972270|FG001|Overall Study|Given Commercially Available Drug|0|||
48760582|NCT01881230|156972271|FG002|Overall Study|Given Commercially Available Drug|2|||
48760583|NCT01881230|156972269|FG000|Overall Study|Protocol Violation|1|||
48760584|NCT01881230|156972270|FG001|Overall Study|Protocol Violation|1|||
48760585|NCT01881230|156972271|FG002|Overall Study|Protocol Violation|0|||
48760586|NCT01881230|156972269|FG000|Overall Study|Miscellaneous|3|||
48760587|NCT01881230|156972270|FG001|Overall Study|Miscellaneous|3|||
48760588|NCT01881230|156972271|FG002|Overall Study|Miscellaneous|0|||
48760589|NCT01881230|156972269|FG000|Overall Study|Untreated: Other|0|||
48342913|NCT03438188|155451481|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
48342914|NCT03438188|155451482|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
48342915|NCT00451555|155451483|FG000|Overall Study|Protocol Violation|2|||
48342916|NCT00451555|155451484|FG001|Overall Study|Protocol Violation|2|||
48342917|NCT00451555|155451483|FG000|Overall Study|Adverse Event|3|||
48342918|NCT00451555|155451484|FG001|Overall Study|Adverse Event|1|||
48342919|NCT00451555|155451483|FG000|Overall Study|Withdrawal by Subject|6|||
48342920|NCT00451555|155451484|FG001|Overall Study|Withdrawal by Subject|0|||
48342921|NCT00451555|155451483|FG000|Overall Study|Physician Decision|2|||
48342922|NCT00451555|155451484|FG001|Overall Study|Physician Decision|1|||
48342923|NCT03468218|155451485|FG000|Overall Study|Adverse Event|5|||
48342924|NCT03468218|155451485|FG000|Overall Study|Progressive Disease|16|||
48342925|NCT03468218|155451485|FG000|Overall Study|Death|1|||
48342926|NCT03468218|155451485|FG000|Overall Study|Alternate therapy|1|||
48342927|NCT03468218|155451485|FG000|Overall Study|Withdrawal by Subject|2|||
48342928|NCT06247488|155451487|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
48342929|NCT06247488|155451488|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48760590|NCT01881230|156972270|FG001|Overall Study|Untreated: Other|0|||
48760591|NCT01881230|156972271|FG002|Overall Study|Untreated: Other|1|||
48760592|NCT01881230|156972269|FG000|Overall Study|Untreated: Death|0|||
48760593|NCT01881230|156972270|FG001|Overall Study|Untreated: Death|0|||
48760594|NCT01881230|156972271|FG002|Overall Study|Untreated: Death|1|||
48760595|NCT01881230|156972269|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
48760596|NCT01881230|156972270|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
48760597|NCT01881230|156972271|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
48760598|NCT02232425|156972272|FG000|Overall Study|Lost to Follow-up|6|||
48760599|NCT02232425|156972273|FG001|Overall Study|Lost to Follow-up|2|||
48760600|NCT02232425|156972272|FG000|Overall Study|Adverse Event|2|||
48760601|NCT02232425|156972273|FG001|Overall Study|Adverse Event|0|||
48760602|NCT02232425|156972272|FG000|Overall Study|Withdrawal by Subject|5|||
48760603|NCT02232425|156972273|FG001|Overall Study|Withdrawal by Subject|6|||
48760604|NCT02232425|156972272|FG000|Overall Study|Lack of Efficacy|1|||
48760605|NCT02232425|156972273|FG001|Overall Study|Lack of Efficacy|0|||
48760606|NCT02917031|156972274|FG000|Overall Study|Reason not specified|7|||
48760607|NCT02917031|156972275|FG001|Overall Study|Reason not specified|5|||
48760608|NCT02917031|156972276|FG002|Overall Study|Reason not specified|6|||
48760609|NCT02917031|156972274|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
48760610|NCT02917031|156972275|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
48760611|NCT02917031|156972276|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
48760612|NCT02917031|156972274|FG000|Overall Study|Withdrawal by Subject|3|||
48760613|NCT02917031|156972275|FG001|Overall Study|Withdrawal by Subject|3|||
48760614|NCT02917031|156972276|FG002|Overall Study|Withdrawal by Subject|0|||
48342930|NCT06247488|155451489|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48342931|NCT06247488|155451490|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48342932|NCT06247488|155451491|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48670979|NCT01571453|156648296|FG000|Overall Study|Lost to Follow-up|4|||
48670980|NCT01571453|156648297|FG001|Overall Study|Lost to Follow-up|2|||
48670981|NCT01571453|156648296|FG000|Overall Study|Administrative or other reason(s)|4|||
48670982|NCT01571453|156648297|FG001|Overall Study|Administrative or other reason(s)|3|||
48670983|NCT02453555|156648298|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
48670984|NCT02453555|156648299|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
48670985|NCT02453555|156648300|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
48670986|NCT02453555|156648301|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
48670987|NCT02453555|156648302|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
48760615|NCT02917031|156972274|FG000|Overall Study|Physician Decision|1|||
48760616|NCT02917031|156972275|FG001|Overall Study|Physician Decision|0|||
48760617|NCT02917031|156972276|FG002|Overall Study|Physician Decision|0|||
48760618|NCT02917031|156972274|FG000|Overall Study|Adverse Event|4|||
48760619|NCT02917031|156972275|FG001|Overall Study|Adverse Event|1|||
48342933|NCT06247488|155451492|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
48342934|NCT06247488|155451487|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48342935|NCT06247488|155451488|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48342936|NCT06247488|155451489|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48760620|NCT02917031|156972276|FG002|Overall Study|Adverse Event|5|||
48342937|NCT06247488|155451490|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
48342938|NCT06247488|155451491|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48342939|NCT06247488|155451492|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
48342940|NCT06247488|155451487|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
48342941|NCT06247488|155451488|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48342942|NCT06247488|155451489|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48342943|NCT06247488|155451490|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48342944|NCT06247488|155451491|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48342945|NCT06247488|155451492|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
48342946|NCT06247488|155451487|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48342947|NCT06247488|155451488|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48342948|NCT06247488|155451489|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48342949|NCT06247488|155451490|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
48342950|NCT06247488|155451491|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48342951|NCT06247488|155451492|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
48342952|NCT06247488|155451487|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48342953|NCT06247488|155451488|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48342954|NCT06247488|155451489|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48342955|NCT06247488|155451490|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48342956|NCT06247488|155451491|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
48342957|NCT06247488|155451492|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
48342958|NCT06247488|155451487|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
48342959|NCT06247488|155451488|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
48342960|NCT06247488|155451489|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
48342961|NCT06247488|155451490|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
48342962|NCT06247488|155451491|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
48342963|NCT06247488|155451492|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
48342964|NCT06247488|155451487|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48342965|NCT06247488|155451488|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48342966|NCT06247488|155451489|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48342967|NCT06247488|155451490|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48342968|NCT06247488|155451491|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
48342969|NCT06247488|155451492|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
48342970|NCT01040403|155451493|FG000|Overall Study|Adverse Event|10|||
48342971|NCT01040403|155451493|FG000|Overall Study|Protocol Violation|2|||
48342972|NCT01040403|155451493|FG000|Overall Study|Lost to Follow-up|1|||
48342973|NCT01040403|155451493|FG000|Overall Study|Not treated|1|||
48342974|NCT01040403|155451493|FG000|Overall Study|Other reason not defined above|6|||
48342975|NCT00317603|155451494|FG000|Overall Study|Progressive Disease|3|||
48342976|NCT01732588|155451495|FG000|First Intervention (7 Days)|Adverse Event|0|||
48342977|NCT01732588|155451496|FG001|First Intervention (7 Days)|Adverse Event|1|||
48342978|NCT01732588|155451497|FG002|First Intervention (7 Days)|Adverse Event|0|||
48342979|NCT00439647|155451498|FG000|Overall Study|Withdrawal by Subject|25|||
48342980|NCT00439647|155451499|FG001|Overall Study|Withdrawal by Subject|22|||
48342981|NCT00439647|155451498|FG000|Overall Study|Death|15|||
48342982|NCT00439647|155451499|FG001|Overall Study|Death|18|||
48342983|NCT00439647|155451498|FG000|Overall Study|Adverse Event|11|||
48342984|NCT00439647|155451499|FG001|Overall Study|Adverse Event|11|||
48342985|NCT00439647|155451498|FG000|Overall Study|Lost to Follow-up|4|||
48342986|NCT00439647|155451499|FG001|Overall Study|Lost to Follow-up|12|||
48342987|NCT00439647|155451498|FG000|Overall Study|Protocol Violation|3|||
48342988|NCT00439647|155451499|FG001|Overall Study|Protocol Violation|4|||
48342989|NCT00439647|155451498|FG000|Overall Study|Lack of Efficacy|0|||
48342990|NCT00439647|155451499|FG001|Overall Study|Lack of Efficacy|4|||
48342991|NCT00570921|155451500|FG000|Overall Study|Protocol Violation|1|||
48670988|NCT02453555|156648303|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
48670989|NCT02453555|156648298|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
48670990|NCT02453555|156648299|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48670991|NCT02453555|156648300|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48342992|NCT00570921|155451500|FG000|Overall Study|Physician Decision|1|||
48670992|NCT02453555|156648301|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48670993|NCT02453555|156648302|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48670994|NCT02453555|156648303|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
48670995|NCT02453555|156648298|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
48342993|NCT04772313|155451501|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
48342994|NCT04772313|155451501|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
48342995|NCT00588341|155451503|FG000|Overall Study|Withdrawal by Subject|3|||
48342996|NCT00588341|155451503|FG000|Overall Study|Not treated due to metastatic disease|1|||
48342997|NCT00588341|155451503|FG000|Overall Study|Patient ineligible|1|||
48342998|NCT04473222|155451504|FG000|Overall Study|Lost to Follow-up|13|||
48342999|NCT04473222|155451505|FG001|Overall Study|Lost to Follow-up|13|||
48343000|NCT04473222|155451504|FG000|Overall Study|Withdrawal by Subject|0|||
48670996|NCT02453555|156648299|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
48670997|NCT02453555|156648300|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48670998|NCT02453555|156648301|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48670999|NCT02453555|156648302|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48671000|NCT02453555|156648303|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48671001|NCT02453555|156648298|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
48671002|NCT02453555|156648299|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
48671003|NCT02453555|156648300|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
48671004|NCT02453555|156648301|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
48671005|NCT02453555|156648302|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
48671006|NCT02453555|156648303|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
48671007|NCT02453555|156648298|FG000|Extension Period|Adverse Event|0|||
48671008|NCT02453555|156648299|FG001|Extension Period|Adverse Event|0|||
48671009|NCT02453555|156648300|FG002|Extension Period|Adverse Event|1|||
48671010|NCT02453555|156648301|FG003|Extension Period|Adverse Event|2|||
48671011|NCT02453555|156648302|FG004|Extension Period|Adverse Event|1|||
48671012|NCT02453555|156648303|FG005|Extension Period|Adverse Event|1|||
48671013|NCT02453555|156648298|FG000|Extension Period|Protocol Violation|0|||
48671014|NCT02453555|156648299|FG001|Extension Period|Protocol Violation|0|||
48671015|NCT02453555|156648300|FG002|Extension Period|Protocol Violation|1|||
48671016|NCT02453555|156648301|FG003|Extension Period|Protocol Violation|0|||
48671017|NCT02453555|156648302|FG004|Extension Period|Protocol Violation|0|||
48671018|NCT02453555|156648303|FG005|Extension Period|Protocol Violation|0|||
48671019|NCT02453555|156648298|FG000|Extension Period|Withdrawal by Subject|0|||
48671020|NCT02453555|156648299|FG001|Extension Period|Withdrawal by Subject|0|||
48671021|NCT02453555|156648300|FG002|Extension Period|Withdrawal by Subject|1|||
48671022|NCT02453555|156648301|FG003|Extension Period|Withdrawal by Subject|0|||
48671023|NCT02453555|156648302|FG004|Extension Period|Withdrawal by Subject|0|||
48671024|NCT02453555|156648303|FG005|Extension Period|Withdrawal by Subject|0|||
48671025|NCT00444067|156648308|FG000|Overall Study|Lost to Follow-up|0|||
48671026|NCT00444067|156648309|FG001|Overall Study|Lost to Follow-up|1|||
48671027|NCT00500760|156648314|FG000|Overall Study|Death|32|||
48671028|NCT00500760|156648315|FG001|Overall Study|Death|15|||
48671029|NCT00500760|156648314|FG000|Overall Study|Withdrawal by Subject|5|||
48671030|NCT00500760|156648315|FG001|Overall Study|Withdrawal by Subject|7|||
48671031|NCT00500760|156648314|FG000|Overall Study|Administrative decision|2|||
48671032|NCT00500760|156648315|FG001|Overall Study|Administrative decision|0|||
48671033|NCT00500760|156648314|FG000|Overall Study|Lost to Follow-up|3|||
48671034|NCT00500760|156648315|FG001|Overall Study|Lost to Follow-up|0|||
48671035|NCT00500760|156648314|FG000|Overall Study|Other|1|||
48671036|NCT00500760|156648315|FG001|Overall Study|Other|2|||
48671037|NCT00710385|156648317|FG000|Overall Study|Did not qualify|1|||
48671038|NCT00710385|156648317|FG000|Overall Study|Withdrawal by Subject|1|||
48671039|NCT00710385|156648317|FG000|Overall Study|Undisclosed back pain|1|||
48671040|NCT00710385|156648317|FG000|Overall Study|Physician Decision|1|||
48671041|NCT00710385|156648317|FG000|Overall Study|Undisclosed excessive methadone use|1|||
48671042|NCT00129961|156648318|FG000|Overall Study|Adverse Event|1|||
48671043|NCT00129961|156648319|FG001|Overall Study|Adverse Event|0|||
48671044|NCT00129961|156648318|FG000|Overall Study|Death|1|||
48671045|NCT00129961|156648319|FG001|Overall Study|Death|1|||
48671046|NCT00129961|156648318|FG000|Overall Study|Withdrawal by Sponsor|14|||
48671047|NCT00129961|156648319|FG001|Overall Study|Withdrawal by Sponsor|20|||
48671048|NCT00129961|156648318|FG000|Overall Study|Physician Decision|1|||
48671049|NCT00129961|156648319|FG001|Overall Study|Physician Decision|0|||
48671050|NCT00129961|156648318|FG000|Overall Study|Withdrawal by Subject|2|||
48671051|NCT00129961|156648319|FG001|Overall Study|Withdrawal by Subject|1|||
48671052|NCT00129961|156648318|FG000|Overall Study|Missing Record|0|||
48671053|NCT00129961|156648319|FG001|Overall Study|Missing Record|1|||
48671054|NCT01600092|156648320|FG000|Overall Study|Adverse Event|2|||
48671055|NCT01600092|156648321|FG001|Overall Study|Adverse Event|0|||
48671056|NCT01600092|156648320|FG000|Overall Study|Lost to Follow-up|4|||
48671057|NCT01600092|156648321|FG001|Overall Study|Lost to Follow-up|6|||
48671058|NCT01600092|156648320|FG000|Overall Study|Withdrawal by parent/guardian|8|||
48671059|NCT01600092|156648321|FG001|Overall Study|Withdrawal by parent/guardian|6|||
48671060|NCT01600092|156648320|FG000|Overall Study|Physician Decision|1|||
48671061|NCT01600092|156648321|FG001|Overall Study|Physician Decision|1|||
48671062|NCT01600092|156648320|FG000|Overall Study|Randomized but not vaccinated|3|||
48671063|NCT01600092|156648321|FG001|Overall Study|Randomized but not vaccinated|3|||
48671064|NCT04598269|156648322|FG000|Overall Study|Adverse Event|0|||
48671065|NCT04598269|156648323|FG001|Overall Study|Adverse Event|3|||
48671066|NCT04598269|156648322|FG000|Overall Study|Withdrawal by Subject|1|||
48671067|NCT04598269|156648323|FG001|Overall Study|Withdrawal by Subject|4|||
48671068|NCT04598269|156648322|FG000|Overall Study|Lost to Follow-up|1|||
48671069|NCT04598269|156648323|FG001|Overall Study|Lost to Follow-up|0|||
48671070|NCT04598269|156648322|FG000|Overall Study|Not Treated|2|||
48671071|NCT04598269|156648323|FG001|Overall Study|Not Treated|0|||
48671072|NCT03550404|156648324|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
48671073|NCT03550404|156648325|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
48671074|NCT03550404|156648326|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
48671075|NCT03550404|156648324|FG000|Phase 2|Vacated position|1|||
48671076|NCT03550404|156648325|FG001|Phase 2|Vacated position|0|||
48671077|NCT03550404|156648326|FG002|Phase 2|Vacated position|0|||
48671078|NCT02925728|156648327|FG000|Overall Study|Death|3|||
48671079|NCT02925728|156648328|FG001|Overall Study|Death|5|||
48671080|NCT02925728|156648327|FG000|Overall Study|Physician Decision|1|||
48671081|NCT02925728|156648328|FG001|Overall Study|Physician Decision|0|||
48671082|NCT02925728|156648327|FG000|Overall Study|Withdrawal by Subject|1|||
48671083|NCT02925728|156648328|FG001|Overall Study|Withdrawal by Subject|0|||
48671084|NCT02102399|156648329|FG000|Overall Study|Withdrawal by Subject|6|||
48671085|NCT02102399|156648330|FG001|Overall Study|Withdrawal by Subject|4|||
48671086|NCT03652675|156648331|FG000|Overall Study|Lost to Follow-up|4|||
48671087|NCT03652675|156648332|FG001|Overall Study|Lost to Follow-up|4|||
48671088|NCT00086411|156648333|FG000|Overall Study|Lost to Follow-up|11|||
48671089|NCT00086411|156648334|FG001|Overall Study|Lost to Follow-up|11|||
48671090|NCT00086411|156648335|FG002|Overall Study|Lost to Follow-up|13|||
48671091|NCT00086411|156648336|FG003|Overall Study|Lost to Follow-up|12|||
48671092|NCT01704456|156648337|FG000|Overall Study|Lost to Follow-up|8|||
48671093|NCT01704456|156648338|FG001|Overall Study|Lost to Follow-up|14|||
48671094|NCT03596450|156648339|FG000|Overall Study|Death|9|||
48671095|NCT03596450|156648340|FG001|Overall Study|Death|9|||
48671096|NCT03596450|156648339|FG000|Overall Study|Protocol Violation|18|||
48671097|NCT03596450|156648340|FG001|Overall Study|Protocol Violation|26|||
48671098|NCT03596450|156648339|FG000|Overall Study|Lost to Follow-up|50|||
48343001|NCT04473222|155451505|FG001|Overall Study|Withdrawal by Subject|1|||
48671099|NCT03596450|156648340|FG001|Overall Study|Lost to Follow-up|56|||
48671100|NCT03596450|156648339|FG000|Overall Study|Adverse Event|14|||
48671101|NCT03596450|156648340|FG001|Overall Study|Adverse Event|7|||
48671102|NCT03596450|156648339|FG000|Overall Study|Withdrawal by Subject|38|||
48671103|NCT03596450|156648340|FG001|Overall Study|Withdrawal by Subject|36|||
48671104|NCT03596450|156648339|FG000|Overall Study|Accidentally Randomized|2|||
48671105|NCT03596450|156648340|FG001|Overall Study|Accidentally Randomized|0|||
48671106|NCT03596450|156648339|FG000|Overall Study|Other reasons|48|||
48671107|NCT03596450|156648340|FG001|Overall Study|Other reasons|53|||
48671108|NCT03596450|156648339|FG000|Overall Study|Pregnancy|2|||
48671109|NCT03596450|156648340|FG001|Overall Study|Pregnancy|0|||
48671110|NCT00447122|156648341|FG000|Overall Study|worsening medical condition -came off|0|||
48671111|NCT00447122|156648342|FG001|Overall Study|worsening medical condition -came off|1|||
48671112|NCT00447122|156648343|FG002|Overall Study|worsening medical condition -came off|0|||
48671113|NCT00447122|156648344|FG003|Overall Study|worsening medical condition -came off|0|||
48671114|NCT00915551|156648345|FG000|Overall Study|Withdrawal by Subject|0|||
48671115|NCT00915551|156648346|FG001|Overall Study|Withdrawal by Subject|1|||
48671116|NCT01274429|156648349|FG000|Overall Study|Study closed do to lack of funding|5|||
48671117|NCT00830180|156648350|FG000|Overall Study|Adverse Event|6|||
48671118|NCT00830180|156648350|FG000|Overall Study|Death|11|||
48671119|NCT00830180|156648350|FG000|Overall Study|Insufficient clinical response|1|||
48671120|NCT00830180|156648350|FG000|Overall Study|Withdrawal by Subject|5|||
48671121|NCT00830180|156648350|FG000|Overall Study|Progressive disease|2|||
48671122|NCT00830180|156648350|FG000|Overall Study|Other - Unspecified|1|||
48671123|NCT00629798|156648351|FG000|Overall Study|Not Treated|4|||
48343002|NCT04473222|155451504|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
48671124|NCT04384523|156648352|FG000|Overall Study|Lost to Follow-up|0|||
48671125|NCT04384523|156648353|FG001|Overall Study|Lost to Follow-up|0|||
48343003|NCT04473222|155451505|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
48343004|NCT01670188|155451506|FG000|Overall Study|Death|0|||
48343005|NCT01670188|155451507|FG001|Overall Study|Death|1|||
48343006|NCT01954771|155451508|FG000|Overall Study|Missing HbA1c of end-point|1|||
48343007|NCT01954771|155451509|FG001|Overall Study|Missing HbA1c of end-point|1|||
48671126|NCT04384523|156648354|FG002|Overall Study|Lost to Follow-up|0|||
48671127|NCT04384523|156648355|FG003|Overall Study|Lost to Follow-up|0|||
48671128|NCT04384523|156648356|FG004|Overall Study|Lost to Follow-up|0|||
48671129|NCT04384523|156648357|FG005|Overall Study|Lost to Follow-up|1|||
48671130|NCT04384523|156648352|FG000|Overall Study|Protocol Violation|0|||
48671131|NCT04384523|156648353|FG001|Overall Study|Protocol Violation|1|||
48671132|NCT04384523|156648354|FG002|Overall Study|Protocol Violation|0|||
48760621|NCT02917031|156972274|FG000|Overall Study|Death|2|||
48760622|NCT02917031|156972275|FG001|Overall Study|Death|3|||
48760623|NCT02917031|156972276|FG002|Overall Study|Death|4|||
48760624|NCT01465022|156972277|FG000|Overall Study|Lost to Follow-up|15|||
48760625|NCT01465022|156972278|FG001|Overall Study|Lost to Follow-up|14|||
48760626|NCT01465022|156972279|FG002|Overall Study|Lost to Follow-up|0|||
48671133|NCT04384523|156648355|FG003|Overall Study|Protocol Violation|0|||
48671134|NCT04384523|156648356|FG004|Overall Study|Protocol Violation|0|||
48671135|NCT04384523|156648357|FG005|Overall Study|Protocol Violation|0|||
48671136|NCT04384523|156648352|FG000|Overall Study|Withdrawal by Subject|1|||
48671137|NCT04384523|156648353|FG001|Overall Study|Withdrawal by Subject|0|||
48671138|NCT04384523|156648354|FG002|Overall Study|Withdrawal by Subject|0|||
48671139|NCT04384523|156648355|FG003|Overall Study|Withdrawal by Subject|0|||
48671140|NCT04384523|156648356|FG004|Overall Study|Withdrawal by Subject|0|||
48671141|NCT04384523|156648357|FG005|Overall Study|Withdrawal by Subject|0|||
48671142|NCT02554981|156648362|FG000|Overall Study|Adverse Event|1|||
48671143|NCT02554981|156648362|FG000|Overall Study|Administrative Reasons|1|||
48671144|NCT02554981|156648362|FG000|Overall Study|Other Miscellaneous Reasons|3|||
48671145|NCT01174173|156648363|FG000|Overall Study|drug-drug interaction|1|||
48671146|NCT03597061|156648364|FG000|Overall Study|Lost to Follow-up|1|||
48671147|NCT03597061|156648365|FG001|Overall Study|Lost to Follow-up|0|||
48671148|NCT03597061|156648364|FG000|Overall Study|Protocol Violation|0|||
48760627|NCT01465022|156972277|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
48760628|NCT01465022|156972278|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
48760629|NCT01465022|156972279|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
48760630|NCT01465022|156972277|FG000|Overall Study|Not Randomized|0|||
48760631|NCT01465022|156972278|FG001|Overall Study|Not Randomized|0|||
48760632|NCT01465022|156972279|FG002|Overall Study|Not Randomized|70|||
48760633|NCT01327300|156972280|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
48760634|NCT01327300|156972281|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
48760635|NCT03739112|156972282|FG000|Overall Study|Adverse Event|2|||
48760636|NCT03739112|156972283|FG001|Overall Study|Adverse Event|2|||
48760637|NCT03739112|156972282|FG000|Overall Study|Withdrawal by Subject|38|||
48760638|NCT03739112|156972283|FG001|Overall Study|Withdrawal by Subject|19|||
48760639|NCT03739112|156972282|FG000|Overall Study|Lost to Follow-up|31|||
48760640|NCT03739112|156972283|FG001|Overall Study|Lost to Follow-up|33|||
48760641|NCT03739112|156972282|FG000|Overall Study|Protocol Deviation|12|||
48760642|NCT03739112|156972283|FG001|Overall Study|Protocol Deviation|9|||
48760643|NCT03739112|156972282|FG000|Overall Study|Physician Decision|1|||
48760644|NCT03739112|156972283|FG001|Overall Study|Physician Decision|0|||
48760645|NCT03739112|156972282|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
48760646|NCT03739112|156972283|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
48760647|NCT03739112|156972282|FG000|Overall Study|Site went on hold|65|||
48760648|NCT03739112|156972283|FG001|Overall Study|Site went on hold|67|||
48760649|NCT03739112|156972282|FG000|Overall Study|Other than specified|8|||
48760650|NCT03739112|156972283|FG001|Overall Study|Other than specified|5|||
48760651|NCT03739112|156972282|FG000|Overall Study|Randomized but not vaccinated|31|||
48760652|NCT03739112|156972283|FG001|Overall Study|Randomized but not vaccinated|25|||
48760653|NCT02618434|156972286|FG000|Overall Study|Withdrawal by Subject|0|||
48760654|NCT02618434|156972287|FG001|Overall Study|Withdrawal by Subject|2|||
48760655|NCT02618434|156972288|FG002|Overall Study|Withdrawal by Subject|3|||
48760656|NCT02618434|156972286|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
48760657|NCT02618434|156972287|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
48760658|NCT02618434|156972288|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
48760659|NCT02618434|156972286|FG000|Overall Study|Lost to Follow-up|3|||
48760660|NCT02618434|156972287|FG001|Overall Study|Lost to Follow-up|1|||
48760661|NCT02618434|156972288|FG002|Overall Study|Lost to Follow-up|3|||
48760662|NCT02618434|156972286|FG000|Overall Study|Adverse Event|1|||
48760663|NCT02618434|156972287|FG001|Overall Study|Adverse Event|0|||
48760664|NCT02618434|156972288|FG002|Overall Study|Adverse Event|12|||
48343008|NCT01954771|155451510|FG002|Overall Study|Missing HbA1c of end-point|0|||
48343009|NCT01954771|155451508|FG000|Overall Study|Missing CGMS of end-point|1|||
48671149|NCT03597061|156648365|FG001|Overall Study|Protocol Violation|1|||
48671150|NCT02160145|156648366|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
48343010|NCT01954771|155451509|FG001|Overall Study|Missing CGMS of end-point|1|||
48343011|NCT01954771|155451510|FG002|Overall Study|Missing CGMS of end-point|0|||
48343012|NCT01954771|155451508|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
48343013|NCT01954771|155451509|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
48343014|NCT01954771|155451510|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
48343015|NCT00385697|155451515|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
48343016|NCT00385697|155451516|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
48343017|NCT00385697|155451517|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
48343018|NCT00385697|155451518|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
48343019|NCT00385697|155451519|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
48760665|NCT02618434|156972286|FG000|Overall Study|Physician Decision|0|||
48760666|NCT02618434|156972287|FG001|Overall Study|Physician Decision|1|||
48760667|NCT02618434|156972288|FG002|Overall Study|Physician Decision|0|||
48760668|NCT02618434|156972286|FG000|Overall Study|Protocol Violation|0|||
48760669|NCT02618434|156972287|FG001|Overall Study|Protocol Violation|0|||
48760670|NCT02618434|156972288|FG002|Overall Study|Protocol Violation|1|||
48760671|NCT02618434|156972286|FG000|Overall Study|Other, Multiple categories|1|||
48760672|NCT02618434|156972287|FG001|Overall Study|Other, Multiple categories|1|||
48760673|NCT02618434|156972288|FG002|Overall Study|Other, Multiple categories|1|||
48760674|NCT00644969|156972294|FG000|Treatment Phase|Randomized, not treated|1|||
48760675|NCT00644969|156972295|FG001|Treatment Phase|Randomized, not treated|0|||
48343020|NCT00385697|155451515|FG000|Open-label Segment 1|Lost to Follow-up|1|||
48671151|NCT02160145|156648367|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
48343021|NCT00385697|155451516|FG001|Open-label Segment 1|Lost to Follow-up|0|||
48343022|NCT00385697|155451517|FG002|Open-label Segment 1|Lost to Follow-up|0|||
48343023|NCT00385697|155451518|FG003|Open-label Segment 1|Lost to Follow-up|0|||
48343024|NCT00385697|155451519|FG004|Open-label Segment 1|Lost to Follow-up|0|||
48343025|NCT00385697|155451515|FG000|Double-blind Segment 2|Adverse Event|0|||
48343026|NCT00385697|155451516|FG001|Double-blind Segment 2|Adverse Event|3|||
48343027|NCT00385697|155451517|FG002|Double-blind Segment 2|Adverse Event|1|||
48343028|NCT00385697|155451518|FG003|Double-blind Segment 2|Adverse Event|0|||
48343029|NCT00385697|155451519|FG004|Double-blind Segment 2|Adverse Event|0|||
48343030|NCT00385697|155451515|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
48343031|NCT00385697|155451516|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
48343032|NCT00385697|155451517|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
48343033|NCT00385697|155451518|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
48343034|NCT00385697|155451519|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
48343035|NCT00385697|155451515|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
48343036|NCT00385697|155451516|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
48343037|NCT00385697|155451517|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
48343038|NCT00385697|155451518|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
48343039|NCT00385697|155451519|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
48343040|NCT00385697|155451515|FG000|Double-blind Segment 2|Other|0|||
48343041|NCT00385697|155451516|FG001|Double-blind Segment 2|Other|2|||
48343042|NCT00385697|155451517|FG002|Double-blind Segment 2|Other|0|||
48671152|NCT02160145|156648368|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
48671153|NCT02160145|156648366|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
48671154|NCT02160145|156648367|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
48671155|NCT02160145|156648368|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
48671156|NCT02160145|156648366|FG000|Randomized Double-blind Period|Subject decision|0|||
48671157|NCT02160145|156648367|FG001|Randomized Double-blind Period|Subject decision|21|||
48671158|NCT02160145|156648368|FG002|Randomized Double-blind Period|Subject decision|20|||
48671159|NCT02160145|156648366|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
48671160|NCT02160145|156648367|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
48671161|NCT02160145|156648368|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
48671162|NCT02160145|156648366|FG000|Randomized Double-blind Period|Physician Decision|0|||
48671163|NCT02160145|156648367|FG001|Randomized Double-blind Period|Physician Decision|7|||
48671164|NCT02160145|156648368|FG002|Randomized Double-blind Period|Physician Decision|5|||
48671165|NCT00375518|156648369|FG000|Overall Study|Withdrawal by Subject|2|||
48671166|NCT00375518|156648370|FG001|Overall Study|Withdrawal by Subject|10|||
48671167|NCT00375518|156648369|FG000|Overall Study|Patient Not Treated|6|||
48671168|NCT00375518|156648370|FG001|Overall Study|Patient Not Treated|6|||
48671169|NCT00375518|156648369|FG000|Overall Study|Death|0|||
48671170|NCT00375518|156648370|FG001|Overall Study|Death|1|||
48671171|NCT03755661|156648373|FG000|Overall Study|Lost to Follow-up|1|||
48760676|NCT00644969|156972294|FG000|Treatment Phase|Adverse Event|3|||
48760677|NCT00644969|156972295|FG001|Treatment Phase|Adverse Event|0|||
48343043|NCT00385697|155451518|FG003|Double-blind Segment 2|Other|0|||
48343044|NCT00385697|155451519|FG004|Double-blind Segment 2|Other|0|||
48343045|NCT00745121|155451522|FG000|Overall Study|Death|3|||
48343046|NCT00745121|155451523|FG001|Overall Study|Death|0|||
48343047|NCT00745121|155451522|FG000|Overall Study|Adverse Event|1|||
48343048|NCT00745121|155451523|FG001|Overall Study|Adverse Event|0|||
48343049|NCT00745121|155451522|FG000|Overall Study|Lost to Follow-up|1|||
48343050|NCT00745121|155451523|FG001|Overall Study|Lost to Follow-up|0|||
48343051|NCT00745121|155451522|FG000|Overall Study|Withdrawal by Subject|4|||
48343052|NCT00745121|155451523|FG001|Overall Study|Withdrawal by Subject|2|||
48343053|NCT00510783|155451536|FG000|Overall Study|Lost to Follow-up|29|||
48343054|NCT00510783|155451537|FG001|Overall Study|Lost to Follow-up|25|||
48343055|NCT00510783|155451536|FG000|Overall Study|Withdrawal by Subject|2|||
48343056|NCT00510783|155451537|FG001|Overall Study|Withdrawal by Subject|3|||
48343057|NCT00510783|155451536|FG000|Overall Study|Protocol Violation|0|||
48343058|NCT00510783|155451537|FG001|Overall Study|Protocol Violation|1|||
48343059|NCT00819013|155451540|FG000|Overall Study|Not meeting continuing study eligibility|2|||
48671172|NCT03755661|156648374|FG001|Overall Study|Lost to Follow-up|0|||
48671173|NCT01264419|156648375|FG000|Overall Study|Lost to Follow-up|3|||
48671174|NCT03959982|156650472|FG000|Overall Study|Withdrawal by Subject|1|||
48671175|NCT03959982|156650473|FG001|Overall Study|Withdrawal by Subject|0|||
48671176|NCT03959982|156650472|FG000|Overall Study|Physician Decision|2|||
48671177|NCT03959982|156650473|FG001|Overall Study|Physician Decision|0|||
48671178|NCT03959982|156650472|FG000|Overall Study|Lost to Follow-up|1|||
48671179|NCT03959982|156650473|FG001|Overall Study|Lost to Follow-up|0|||
48343060|NCT00819013|155451541|FG001|Overall Study|Not meeting continuing study eligibility|1|||
48428851|NCT04549168|155759001|FG002|Randomization Phase|Other|0|||
48671180|NCT01309269|156650474|FG000|Overall Study|Adverse Event|56|||
48671181|NCT01309269|156650474|FG000|Overall Study|Withdrawal by Subject|25|||
48671182|NCT01309269|156650474|FG000|Overall Study|Lack of Acceptance|15|||
48671183|NCT01309269|156650474|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
48671184|NCT01309269|156650474|FG000|Overall Study|Kidney Transplant|25|||
48671185|NCT01309269|156650474|FG000|Overall Study|Administrative Problems|141|||
48671186|NCT01309269|156650474|FG000|Overall Study|Other|256|||
48671187|NCT01309269|156650474|FG000|Overall Study|Other|1|||
48671188|NCT01309269|156650474|FG000|Overall Study|Study Completion Data Not Recorded|95|||
48671189|NCT01309269|156650474|FG000|Overall Study|Enrolled but not Treated|107|||
48671190|NCT00528996|156650475|FG000|Overall Study|Other reasons than listing|6|||
48671191|NCT00528996|156650476|FG001|Overall Study|Other reasons than listing|7|||
48671192|NCT00528996|156650477|FG002|Overall Study|Other reasons than listing|14|||
48671193|NCT00528996|156650478|FG003|Overall Study|Other reasons than listing|11|||
48671194|NCT00528996|156650479|FG004|Overall Study|Other reasons than listing|5|||
48671195|NCT00528996|156650475|FG000|Overall Study|Refused continue medication|16|||
48671196|NCT00528996|156650476|FG001|Overall Study|Refused continue medication|0|||
48671197|NCT00528996|156650477|FG002|Overall Study|Refused continue medication|3|||
48671198|NCT00528996|156650478|FG003|Overall Study|Refused continue medication|3|||
48671199|NCT00528996|156650479|FG004|Overall Study|Refused continue medication|6|||
48671200|NCT00528996|156650475|FG000|Overall Study|Lost to Follow-up|2|||
48671201|NCT00528996|156650476|FG001|Overall Study|Lost to Follow-up|0|||
48671202|NCT00528996|156650477|FG002|Overall Study|Lost to Follow-up|4|||
48671203|NCT00528996|156650478|FG003|Overall Study|Lost to Follow-up|1|||
48671204|NCT00528996|156650479|FG004|Overall Study|Lost to Follow-up|3|||
48671205|NCT00528996|156650475|FG000|Overall Study|Protocol Violation|1|||
48671206|NCT00528996|156650476|FG001|Overall Study|Protocol Violation|2|||
48671207|NCT00528996|156650477|FG002|Overall Study|Protocol Violation|3|||
48671208|NCT00528996|156650478|FG003|Overall Study|Protocol Violation|3|||
48671209|NCT00528996|156650479|FG004|Overall Study|Protocol Violation|2|||
48671210|NCT00528996|156650475|FG000|Overall Study|Lack of Efficacy|7|||
48671211|NCT00528996|156650476|FG001|Overall Study|Lack of Efficacy|2|||
48671212|NCT00528996|156650477|FG002|Overall Study|Lack of Efficacy|1|||
48671213|NCT00528996|156650478|FG003|Overall Study|Lack of Efficacy|3|||
48671214|NCT00528996|156650479|FG004|Overall Study|Lack of Efficacy|3|||
48671215|NCT00528996|156650475|FG000|Overall Study|Adverse Event|32|||
48671216|NCT00528996|156650476|FG001|Overall Study|Adverse Event|13|||
48671217|NCT00528996|156650477|FG002|Overall Study|Adverse Event|18|||
48671218|NCT00528996|156650478|FG003|Overall Study|Adverse Event|29|||
48671219|NCT00528996|156650479|FG004|Overall Study|Adverse Event|18|||
48671220|NCT00837759|156650480|FG000|Overall Study|Protocol Violation|3|||
48671221|NCT00837759|156650480|FG000|Overall Study|Lost to Follow-up|1|||
48671222|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Adverse Event|3|||
48671223|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Adverse Event|0|||
48671224|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
48671225|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
48671226|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Physician Decision|1|||
48671227|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Physician Decision|0|||
48671228|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
48671229|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
48671230|NCT02081599|156650481|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
48671231|NCT02081599|156650482|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
48671232|NCT02081599|156650481|FG000|Period 1：Double-blind Period|stopping criteria|1|||
48671233|NCT02081599|156650482|FG001|Period 1：Double-blind Period|stopping criteria|0|||
48671234|NCT02081599|156650481|FG000|Period 2：Open-label Period|Adverse Event|1|||
48671235|NCT02081599|156650482|FG001|Period 2：Open-label Period|Adverse Event|0|||
48671236|NCT02081599|156650481|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
48671237|NCT02081599|156650482|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
48671238|NCT02081599|156650481|FG000|Period 2：Open-label Period|Physician Decision|1|||
48671239|NCT02081599|156650482|FG001|Period 2：Open-label Period|Physician Decision|0|||
48671240|NCT02081599|156650481|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
48671241|NCT02081599|156650482|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
48671242|NCT01103063|156650483|FG000|Overall Study|Adverse Event|3|||
48671243|NCT01103063|156650484|FG001|Overall Study|Adverse Event|1|||
48671244|NCT01103063|156650483|FG000|Overall Study|Lost to Follow-up|68|||
48671245|NCT01103063|156650484|FG001|Overall Study|Lost to Follow-up|51|||
48671246|NCT01103063|156650483|FG000|Overall Study|Withdrawal by Subject|60|||
48671247|NCT01103063|156650484|FG001|Overall Study|Withdrawal by Subject|15|||
48671248|NCT01103063|156650483|FG000|Overall Study|Other|16|||
48671249|NCT01103063|156650484|FG001|Overall Study|Other|11|||
48671250|NCT01103063|156650483|FG000|Overall Study|Protocol Violation|1|||
48671251|NCT01103063|156650484|FG001|Overall Study|Protocol Violation|0|||
48671252|NCT01103063|156650483|FG000|Overall Study|Study terminated by Sponsor|326|||
48671253|NCT01103063|156650484|FG001|Overall Study|Study terminated by Sponsor|342|||
48671254|NCT01103063|156650483|FG000|Overall Study|Death|3|||
48671255|NCT01103063|156650484|FG001|Overall Study|Death|1|||
48671256|NCT03320330|156650485|FG000|Overall Study|Lack of Efficacy|5|||
48343061|NCT00819013|155451542|FG002|Overall Study|Not meeting continuing study eligibility|2|||
48343062|NCT00819013|155451543|FG003|Overall Study|Not meeting continuing study eligibility|1|||
48343063|NCT00819013|155451540|FG000|Overall Study|Adverse Event|0|||
48343064|NCT00819013|155451541|FG001|Overall Study|Adverse Event|0|||
48343065|NCT00819013|155451542|FG002|Overall Study|Adverse Event|1|||
48343066|NCT00819013|155451543|FG003|Overall Study|Adverse Event|0|||
48343067|NCT00819013|155451540|FG000|Overall Study|Withdrawal by Subject|1|||
48343068|NCT00819013|155451541|FG001|Overall Study|Withdrawal by Subject|0|||
48343069|NCT00819013|155451542|FG002|Overall Study|Withdrawal by Subject|1|||
48343070|NCT00819013|155451543|FG003|Overall Study|Withdrawal by Subject|0|||
48343071|NCT00819013|155451540|FG000|Overall Study|Lost to Follow-up|0|||
48343072|NCT00819013|155451541|FG001|Overall Study|Lost to Follow-up|0|||
48343073|NCT00819013|155451542|FG002|Overall Study|Lost to Follow-up|1|||
48343074|NCT00819013|155451543|FG003|Overall Study|Lost to Follow-up|2|||
48343075|NCT00819013|155451540|FG000|Overall Study|Death|0|||
48343076|NCT00819013|155451541|FG001|Overall Study|Death|0|||
48343077|NCT00819013|155451542|FG002|Overall Study|Death|0|||
48343078|NCT00819013|155451543|FG003|Overall Study|Death|1|||
48343079|NCT02553460|155451544|FG000|Overall Study|Death|3|||
48343080|NCT02553460|155451544|FG000|Overall Study|Withdrawal by Subject|1|||
48343081|NCT02553460|155451544|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
48343082|NCT02553460|155451544|FG000|Overall Study|Relapse or Transplant|14|||
48343083|NCT02553460|155451544|FG000|Overall Study|No response to treatment|2|||
48343084|NCT02553460|155451544|FG000|Overall Study|CAR T cells|2|||
48343085|NCT04137367|155451551|FG000|Overall Study|Lost to Follow-up|8|||
48343086|NCT04137367|155451552|FG001|Overall Study|Lost to Follow-up|6|||
48343087|NCT04137367|155451553|FG002|Overall Study|Lost to Follow-up|4|||
48343088|NCT02714257|155451554|FG000|Overall Study|Withdrawal by Subject|6|||
48343089|NCT02714257|155451555|FG001|Overall Study|Withdrawal by Subject|11|||
48343090|NCT02714257|155451554|FG000|Overall Study|Death|3|||
48343091|NCT02714257|155451555|FG001|Overall Study|Death|4|||
48343092|NCT02714257|155451554|FG000|Overall Study|Lost to Follow-up|1|||
48343093|NCT02714257|155451555|FG001|Overall Study|Lost to Follow-up|6|||
48343094|NCT01024036|155451557|FG000|Blinded Treatment|Adverse Event|1|||
48343095|NCT01024036|155451558|FG001|Blinded Treatment|Adverse Event|1|||
48343096|NCT01024036|155451557|FG000|Blinded Treatment|Lack of Efficacy|16|||
48343097|NCT01024036|155451558|FG001|Blinded Treatment|Lack of Efficacy|14|||
48343098|NCT01024036|155451557|FG000|Blinded Treatment|Physician Decision|1|||
48343099|NCT01024036|155451558|FG001|Blinded Treatment|Physician Decision|0|||
48343100|NCT01024036|155451557|FG000|Blinded Treatment|Death|0|||
48343101|NCT01024036|155451558|FG001|Blinded Treatment|Death|2|||
48343102|NCT01024036|155451557|FG000|Blinded Treatment|Withdrawal by Subject|4|||
48343103|NCT01024036|155451558|FG001|Blinded Treatment|Withdrawal by Subject|3|||
48343104|NCT01024036|155451557|FG000|Unblinded Treatment|Adverse Event|0|||
48343105|NCT01024036|155451558|FG001|Unblinded Treatment|Adverse Event|1|||
48343106|NCT01024036|155451557|FG000|Unblinded Treatment|Lack of Efficacy|0|||
48343107|NCT01024036|155451558|FG001|Unblinded Treatment|Lack of Efficacy|2|||
48343108|NCT01024036|155451557|FG000|Follow-Up Period|Lost to Follow-up|1|||
48343109|NCT01024036|155451558|FG001|Follow-Up Period|Lost to Follow-up|1|||
48343110|NCT01024036|155451557|FG000|Follow-Up Period|Withdrawal by Subject|0|||
48343111|NCT01024036|155451558|FG001|Follow-Up Period|Withdrawal by Subject|1|||
48343112|NCT01024036|155451557|FG000|Follow-Up Period|Adverse Event|4|||
48343113|NCT01024036|155451558|FG001|Follow-Up Period|Adverse Event|1|||
48343114|NCT04206384|155451559|FG000|Overall Study|Withdrawal by Subject|8|||
48343115|NCT04206384|155451559|FG000|Overall Study|Adverse Event|2|||
48343116|NCT04159805|155451562|FG000|Overall Study|Withdrawal by Subject|0|||
48343117|NCT04159805|155451563|FG001|Overall Study|Withdrawal by Subject|2|||
48343118|NCT04159805|155451564|FG002|Overall Study|Withdrawal by Subject|2|||
48343119|NCT02250183|155452231|FG000|Overall Study|Withdrawal by Subject|2|||
48343120|NCT02250183|155452231|FG000|Overall Study|Adverse Event|5|||
48343121|NCT02250183|155452231|FG000|Overall Study|Lost to Follow-up|1|||
48343122|NCT03746483|155452232|FG000|Overall Study|Adverse Event|0|||
48343123|NCT03746483|155452233|FG001|Overall Study|Adverse Event|1|||
48343124|NCT03746483|155452232|FG000|Overall Study|Lack of Efficacy|3|||
48343125|NCT03746483|155452233|FG001|Overall Study|Lack of Efficacy|2|||
48343126|NCT03746483|155452232|FG000|Overall Study|Lost to Follow-up|1|||
48343127|NCT03746483|155452233|FG001|Overall Study|Lost to Follow-up|0|||
48343128|NCT03746483|155452232|FG000|Overall Study|Protocol Violation|2|||
48343129|NCT03746483|155452233|FG001|Overall Study|Protocol Violation|0|||
48343130|NCT01951261|155452234|FG000|Overall Study|Death|1|||
48343131|NCT01951261|155452235|FG001|Overall Study|Death|0|||
48343132|NCT01951261|155452234|FG000|Overall Study|Lost to Follow-up|4|||
48343133|NCT01951261|155452235|FG001|Overall Study|Lost to Follow-up|3|||
48343134|NCT01951261|155452234|FG000|Overall Study|Protocol Violation|4|||
48343135|NCT01951261|155452235|FG001|Overall Study|Protocol Violation|3|||
48343136|NCT01924806|155452236|FG000|Overall Study|Physician Decision|2|||
48343137|NCT01924806|155452237|FG001|Overall Study|Physician Decision|1|||
48343138|NCT00578318|155452239|FG000|Overall Study|Lost to Follow-up|2|||
48343139|NCT00578318|155452240|FG001|Overall Study|Lost to Follow-up|0|||
48343140|NCT00578318|155452239|FG000|Overall Study|Physician Decision|1|||
48343141|NCT00578318|155452240|FG001|Overall Study|Physician Decision|0|||
48343142|NCT00475735|155452241|FG000|Treatment Period 1|Adverse Event|2|||
48343143|NCT00475735|155452242|FG001|Treatment Period 1|Adverse Event|0|||
48343144|NCT00475735|155452243|FG002|Treatment Period 1|Adverse Event|0|||
48343145|NCT00475735|155452244|FG003|Treatment Period 1|Adverse Event|0|||
48343146|NCT00475735|155452245|FG004|Treatment Period 1|Adverse Event|0|||
48343147|NCT00475735|155452246|FG005|Treatment Period 1|Adverse Event|0|||
48343148|NCT00475735|155452241|FG000|Treatment Period 1|Lack of Efficacy|1|||
48343149|NCT00475735|155452242|FG001|Treatment Period 1|Lack of Efficacy|0|||
48343150|NCT00475735|155452243|FG002|Treatment Period 1|Lack of Efficacy|0|||
48343151|NCT00475735|155452244|FG003|Treatment Period 1|Lack of Efficacy|0|||
48343152|NCT00475735|155452245|FG004|Treatment Period 1|Lack of Efficacy|0|||
48343153|NCT00475735|155452246|FG005|Treatment Period 1|Lack of Efficacy|0|||
48343154|NCT00475735|155452241|FG000|Treatment Period 1|Lost to Follow-up|0|||
48343155|NCT00475735|155452242|FG001|Treatment Period 1|Lost to Follow-up|0|||
48343156|NCT00475735|155452243|FG002|Treatment Period 1|Lost to Follow-up|0|||
48343157|NCT00475735|155452244|FG003|Treatment Period 1|Lost to Follow-up|0|||
48343158|NCT00475735|155452245|FG004|Treatment Period 1|Lost to Follow-up|0|||
48343159|NCT00475735|155452246|FG005|Treatment Period 1|Lost to Follow-up|1|||
48343160|NCT00475735|155452241|FG000|Treatment Period 1|Protocol Violation|0|||
48343161|NCT00475735|155452242|FG001|Treatment Period 1|Protocol Violation|0|||
48343162|NCT00475735|155452243|FG002|Treatment Period 1|Protocol Violation|0|||
48343163|NCT00475735|155452244|FG003|Treatment Period 1|Protocol Violation|1|||
48343164|NCT00475735|155452245|FG004|Treatment Period 1|Protocol Violation|0|||
48343165|NCT00475735|155452246|FG005|Treatment Period 1|Protocol Violation|0|||
48343166|NCT00475735|155452241|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48343167|NCT00475735|155452242|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48343168|NCT00475735|155452243|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48343169|NCT00475735|155452244|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48343170|NCT00475735|155452245|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48343171|NCT00475735|155452246|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48343172|NCT00475735|155452241|FG000|Treatment Period 1|DC due to AE but continuing|0|||
48343173|NCT00475735|155452242|FG001|Treatment Period 1|DC due to AE but continuing|0|||
48343174|NCT00475735|155452243|FG002|Treatment Period 1|DC due to AE but continuing|0|||
48343175|NCT00475735|155452244|FG003|Treatment Period 1|DC due to AE but continuing|1|||
48343176|NCT00475735|155452245|FG004|Treatment Period 1|DC due to AE but continuing|2|||
48671257|NCT03320330|156650486|FG001|Overall Study|Lack of Efficacy|5|||
48671258|NCT03320330|156650487|FG002|Overall Study|Lack of Efficacy|14|||
48671259|NCT03320330|156650485|FG000|Overall Study|Physician Decision|1|||
48671260|NCT03320330|156650486|FG001|Overall Study|Physician Decision|0|||
48671261|NCT03320330|156650487|FG002|Overall Study|Physician Decision|0|||
48671262|NCT00031460|156650488|FG000|Overall Study|Lost to Follow-up|0|||
48671263|NCT00031460|156650489|FG001|Overall Study|Lost to Follow-up|1|||
48343177|NCT00475735|155452246|FG005|Treatment Period 1|DC due to AE but continuing|2|||
48343178|NCT00475735|155452241|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48343179|NCT00475735|155452242|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
48343180|NCT00475735|155452243|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48343181|NCT00475735|155452244|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48343182|NCT00475735|155452245|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48343183|NCT00475735|155452246|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
48343184|NCT00475735|155452241|FG000|Treatment Washout|Lost to Follow-up|0|||
48343185|NCT00475735|155452242|FG001|Treatment Washout|Lost to Follow-up|1|||
48343186|NCT00475735|155452243|FG002|Treatment Washout|Lost to Follow-up|0|||
48343187|NCT00475735|155452244|FG003|Treatment Washout|Lost to Follow-up|0|||
48343188|NCT00475735|155452245|FG004|Treatment Washout|Lost to Follow-up|0|||
48343189|NCT00475735|155452246|FG005|Treatment Washout|Lost to Follow-up|0|||
48343190|NCT00475735|155452241|FG000|Treatment Washout|Protocol Violation|0|||
48343191|NCT00475735|155452242|FG001|Treatment Washout|Protocol Violation|1|||
48343192|NCT00475735|155452243|FG002|Treatment Washout|Protocol Violation|0|||
48343193|NCT00475735|155452244|FG003|Treatment Washout|Protocol Violation|0|||
48343194|NCT00475735|155452245|FG004|Treatment Washout|Protocol Violation|0|||
48343195|NCT00475735|155452246|FG005|Treatment Washout|Protocol Violation|0|||
48671264|NCT00031460|156650488|FG000|Overall Study|Withdrawal by Subject|1|||
48671265|NCT00031460|156650489|FG001|Overall Study|Withdrawal by Subject|1|||
48671266|NCT00031460|156650488|FG000|Overall Study|Non-Compliant|1|||
48343196|NCT00475735|155452241|FG000|Treatment Period 2|Adverse Event|0|||
48343197|NCT00475735|155452242|FG001|Treatment Period 2|Adverse Event|1|||
48343198|NCT00475735|155452243|FG002|Treatment Period 2|Adverse Event|0|||
48343199|NCT00475735|155452244|FG003|Treatment Period 2|Adverse Event|2|||
48343200|NCT00475735|155452245|FG004|Treatment Period 2|Adverse Event|0|||
48343201|NCT00475735|155452246|FG005|Treatment Period 2|Adverse Event|0|||
48343202|NCT00475735|155452241|FG000|Treatment Period 2|Lack of Efficacy|0|||
48343203|NCT00475735|155452242|FG001|Treatment Period 2|Lack of Efficacy|0|||
48343204|NCT00475735|155452243|FG002|Treatment Period 2|Lack of Efficacy|0|||
48343205|NCT00475735|155452244|FG003|Treatment Period 2|Lack of Efficacy|0|||
48343206|NCT00475735|155452245|FG004|Treatment Period 2|Lack of Efficacy|0|||
48671267|NCT00031460|156650489|FG001|Overall Study|Non-Compliant|1|||
48671268|NCT00031460|156650488|FG000|Overall Study|Death|0|||
48671269|NCT00031460|156650489|FG001|Overall Study|Death|1|||
48343207|NCT00475735|155452246|FG005|Treatment Period 2|Lack of Efficacy|1|||
48343208|NCT00475735|155452241|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48343209|NCT00475735|155452242|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48343210|NCT00475735|155452243|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48343211|NCT00475735|155452244|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48343212|NCT00475735|155452245|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48343213|NCT00475735|155452246|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48343214|NCT03132753|155452249|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
48343215|NCT03132753|155452250|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
48343216|NCT03132753|155452249|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
48343217|NCT03132753|155452250|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
48343218|NCT01747629|155452253|FG000|Overall Study|Adverse Event|1|||
48343219|NCT01747629|155452254|FG001|Overall Study|Adverse Event|2|||
48343220|NCT01747629|155452253|FG000|Overall Study|Withdrawal by Subject|2|||
48343221|NCT01747629|155452254|FG001|Overall Study|Withdrawal by Subject|2|||
48343222|NCT01747629|155452253|FG000|Overall Study|Noncompliance|1|||
48343223|NCT01747629|155452254|FG001|Overall Study|Noncompliance|1|||
48343224|NCT01747629|155452253|FG000|Overall Study|Inclusion criteria not met|1|||
48343225|NCT01747629|155452254|FG001|Overall Study|Inclusion criteria not met|0|||
48343226|NCT01747629|155452253|FG000|Overall Study|Not treated|1|||
48343227|NCT01747629|155452254|FG001|Overall Study|Not treated|0|||
48343228|NCT01747629|155452253|FG000|Overall Study|Other|2|||
48343229|NCT01747629|155452254|FG001|Overall Study|Other|1|||
48343230|NCT03045302|155452255|FG000|Overall Study|Pre-treatment adverse event|1|||
48343231|NCT01395914|155452256|FG000|Overall Study|Unrelated to study drug AE|6|||
48343232|NCT01395914|155452257|FG001|Overall Study|Unrelated to study drug AE|1|||
48343233|NCT01395914|155452256|FG000|Overall Study|Death|23|||
48343234|NCT01395914|155452257|FG001|Overall Study|Death|17|||
48343235|NCT01395914|155452256|FG000|Overall Study|Other|9|||
48343236|NCT01395914|155452257|FG001|Overall Study|Other|3|||
48343237|NCT01395914|155452256|FG000|Overall Study|Withdrawal by patient|27|||
48343238|NCT01395914|155452257|FG001|Overall Study|Withdrawal by patient|14|||
48343239|NCT01395914|155452256|FG000|Overall Study|Study drug-related AE|1|||
48343240|NCT01395914|155452257|FG001|Overall Study|Study drug-related AE|0|||
48343241|NCT01395914|155452256|FG000|Overall Study|Lost to Follow-up|6|||
48343242|NCT01395914|155452257|FG001|Overall Study|Lost to Follow-up|2|||
48343243|NCT04414397|155452258|FG000|Control Period|Withdrawal by Subject|2|||
48343244|NCT04414397|155452259|FG001|Control Period|Withdrawal by Subject|2|||
48343245|NCT04414397|155452258|FG000|Control Period|Lost to Follow-up|0|||
48343246|NCT04414397|155452259|FG001|Control Period|Lost to Follow-up|4|||
48343247|NCT04414397|155452258|FG000|Control Period|Protocol deviation|0|||
48343248|NCT04414397|155452259|FG001|Control Period|Protocol deviation|1|||
48343249|NCT04414397|155452258|FG000|Post-Control Period|Withdrawal by Subject|3|||
48671270|NCT00031460|156650488|FG000|Overall Study|Reactivation of Disease|5|||
48671271|NCT00031460|156650489|FG001|Overall Study|Reactivation of Disease|9|||
48671272|NCT00031460|156650488|FG000|Overall Study|Disruption of blinded drug supply|2|||
48671273|NCT00031460|156650489|FG001|Overall Study|Disruption of blinded drug supply|0|||
48671274|NCT00031460|156650488|FG000|Overall Study|Confirmed unevaluable|0|||
48671275|NCT00031460|156650489|FG001|Overall Study|Confirmed unevaluable|1|||
48671276|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
48671277|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
48671278|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
48671279|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
48671280|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
48671281|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
48671282|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
48760678|NCT00644969|156972294|FG000|Treatment Phase|Withdrawal by Subject|4|||
48343250|NCT04414397|155452259|FG001|Post-Control Period|Withdrawal by Subject|6|||
48671283|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
48760679|NCT00644969|156972295|FG001|Treatment Phase|Withdrawal by Subject|0|||
48760680|NCT00644969|156972294|FG000|Treatment Phase|Lost to Follow-up|2|||
48760681|NCT00644969|156972295|FG001|Treatment Phase|Lost to Follow-up|2|||
48760682|NCT00644969|156972294|FG000|Treatment Phase|Other|4|||
48760683|NCT00644969|156972295|FG001|Treatment Phase|Other|1|||
48760684|NCT00644969|156972294|FG000|Post Treatment Phase|Death|1|||
48760685|NCT00644969|156972295|FG001|Post Treatment Phase|Death|0|||
48760686|NCT00644969|156972294|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
48760687|NCT00644969|156972295|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
48760688|NCT00644969|156972294|FG000|Post Treatment Phase|Lost to Follow-up|4|||
48343251|NCT04414397|155452258|FG000|Post-Control Period|Lost to Follow-up|4|||
48343252|NCT04414397|155452259|FG001|Post-Control Period|Lost to Follow-up|9|||
48343253|NCT04414397|155452258|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
48343254|NCT04414397|155452259|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
48343255|NCT04414397|155452258|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
48343256|NCT04414397|155452259|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
48760689|NCT00644969|156972295|FG001|Post Treatment Phase|Lost to Follow-up|1|||
48671284|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
48671285|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
48671286|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
48671287|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
48671288|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
48671289|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
48671290|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
48671291|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
48671292|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
48671293|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
48671294|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
48671295|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
48671296|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
48671297|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
48671298|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
48760690|NCT00644969|156972294|FG000|Post Treatment Phase|Other|1|||
48760691|NCT00644969|156972295|FG001|Post Treatment Phase|Other|0|||
48760692|NCT00697515|156972296|FG000|Dose Optimization Period|Adverse Event|4|||
48760693|NCT00697515|156972297|FG001|Dose Optimization Period|Adverse Event|0|||
48760694|NCT00697515|156972296|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
48760695|NCT00697515|156972297|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
48760696|NCT00697515|156972296|FG000|Dose Optimization Period|Lost to Follow-up|2|||
48760697|NCT00697515|156972297|FG001|Dose Optimization Period|Lost to Follow-up|0|||
48760698|NCT00697515|156972296|FG000|Dose Optimization Period|sponsor request|2|||
48760699|NCT00697515|156972297|FG001|Dose Optimization Period|sponsor request|0|||
48760700|NCT00697515|156972296|FG000|Dose Optimization Period|called to active duty|1|||
48760701|NCT00697515|156972297|FG001|Dose Optimization Period|called to active duty|0|||
48760702|NCT00697515|156972296|FG000|Dose Optimization Period|elevated QTc|1|||
48760703|NCT00697515|156972297|FG001|Dose Optimization Period|elevated QTc|0|||
48760704|NCT00697515|156972296|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
48760705|NCT00697515|156972297|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
48671299|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
48671300|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
48671301|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
48671302|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
48671303|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
48671304|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
48671305|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
48671306|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
48671307|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
48671308|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
48343257|NCT01920178|155452260|FG000|Overall Study|Lost to Follow-up|2|||
48343258|NCT01920178|155452261|FG001|Overall Study|Lost to Follow-up|1|||
48343259|NCT01020747|155452262|FG000|Overall Study|Withdrawal by Subject|1|||
48343260|NCT03028012|155452263|FG000|Overall Study|Lost to Follow-up|2|||
48343261|NCT03028012|155452264|FG001|Overall Study|Lost to Follow-up|3|||
48343262|NCT03028012|155452265|FG002|Overall Study|Lost to Follow-up|3|||
48343263|NCT03209973|155452272|FG000|Overall Study|Withdrawal by Subject|7|||
48343264|NCT03209973|155452272|FG000|Overall Study|Lost to Follow-up|2|||
48343265|NCT03209973|155452272|FG000|Overall Study|Death|8|||
48343266|NCT03209973|155452272|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
48343267|NCT03209973|155452272|FG000|Overall Study|Sponsor Decision|18|||
48343268|NCT03209973|155452272|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
48343269|NCT03209973|155452272|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
48343270|NCT04778397|155452275|FG000|Overall Study|Death|59|||
48343271|NCT04778397|155452276|FG001|Overall Study|Death|54|||
48343272|NCT04778397|155452277|FG002|Overall Study|Death|11|||
48343273|NCT04778397|155452278|FG003|Overall Study|Death|9|||
48343274|NCT04778397|155452275|FG000|Overall Study|Study Terminated by Sponsor|34|||
48343275|NCT04778397|155452276|FG001|Overall Study|Study Terminated by Sponsor|42|||
48343276|NCT04778397|155452277|FG002|Overall Study|Study Terminated by Sponsor|15|||
48343277|NCT04778397|155452278|FG003|Overall Study|Study Terminated by Sponsor|12|||
48343278|NCT04778397|155452275|FG000|Overall Study|Withdrew Consent|5|||
48343279|NCT04778397|155452276|FG001|Overall Study|Withdrew Consent|4|||
48343280|NCT04778397|155452277|FG002|Overall Study|Withdrew Consent|1|||
48343281|NCT04778397|155452278|FG003|Overall Study|Withdrew Consent|1|||
48343282|NCT04778397|155452275|FG000|Overall Study|Reason Not Specified|1|||
48343283|NCT04778397|155452276|FG001|Overall Study|Reason Not Specified|3|||
48343284|NCT04778397|155452277|FG002|Overall Study|Reason Not Specified|0|||
48343285|NCT04778397|155452278|FG003|Overall Study|Reason Not Specified|2|||
48343286|NCT04778397|155452275|FG000|Overall Study|Lost to Follow-up|2|||
48343287|NCT04778397|155452276|FG001|Overall Study|Lost to Follow-up|1|||
48343288|NCT04778397|155452277|FG002|Overall Study|Lost to Follow-up|0|||
48343289|NCT04778397|155452278|FG003|Overall Study|Lost to Follow-up|1|||
48343290|NCT03512288|155452279|FG000|Overall Study|Adverse Event|1|||
48671309|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
48671310|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
48343291|NCT03512288|155452280|FG001|Overall Study|Adverse Event|0|||
48343292|NCT03512288|155452279|FG000|Overall Study|Lost to Follow-up|12|||
48343293|NCT03512288|155452280|FG001|Overall Study|Lost to Follow-up|15|||
48343294|NCT03512288|155452279|FG000|Overall Study|Physician Decision|0|||
48343295|NCT03512288|155452280|FG001|Overall Study|Physician Decision|2|||
48343296|NCT03512288|155452279|FG000|Overall Study|Protocol Violation|6|||
48343297|NCT03512288|155452280|FG001|Overall Study|Protocol Violation|4|||
48343298|NCT03512288|155452279|FG000|Overall Study|Medication error without associated adverse event|1|||
48343299|NCT03512288|155452280|FG001|Overall Study|Medication error without associated adverse event|0|||
48343300|NCT03512288|155452279|FG000|Overall Study|No longer met eligibility criteria|5|||
48343301|NCT03512288|155452280|FG001|Overall Study|No longer met eligibility criteria|2|||
48343302|NCT03512288|155452279|FG000|Overall Study|Withdrawal by parent/guardian|14|||
48671311|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
48671312|NCT02198794|156650490|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
48671313|NCT02198794|156650491|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
48671314|NCT02198794|156650492|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
48671315|NCT02198794|156650493|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
48671316|NCT02198794|156650490|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
48671317|NCT02198794|156650491|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
48760706|NCT00697515|156972296|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
48343303|NCT03512288|155452280|FG001|Overall Study|Withdrawal by parent/guardian|18|||
48343304|NCT03512288|155452279|FG000|Overall Study|Other|1|||
48343305|NCT03512288|155452280|FG001|Overall Study|Other|1|||
48343306|NCT03512288|155452279|FG000|Overall Study|Randomized but not treated|1|||
48343307|NCT03512288|155452280|FG001|Overall Study|Randomized but not treated|1|||
48343308|NCT01221948|155452281|FG000|Overall Study|Physician Decision|5|||
48343309|NCT01221948|155452281|FG000|Overall Study|Withdrawal by Subject|2|||
48343310|NCT01221948|155452281|FG000|Overall Study|not disclosed|2|||
48343311|NCT01221948|155452281|FG000|Overall Study|Death|1|||
48343312|NCT01221948|155452281|FG000|Overall Study|Protocol Violation|4|||
48343313|NCT02865135|155452282|FG000|Overall Study|Death|0|||
48343314|NCT02865135|155452283|FG001|Overall Study|Death|1|||
48343315|NCT02865135|155452284|FG002|Overall Study|Death|0|||
48343316|NCT02865135|155452282|FG000|Overall Study|Progression|6|||
48343317|NCT02865135|155452283|FG001|Overall Study|Progression|2|||
48343318|NCT02865135|155452284|FG002|Overall Study|Progression|2|||
48343319|NCT02212197|155452286|FG000|Overall Study|Need for radiotherapy|1|||
48343320|NCT02212197|155452287|FG001|Overall Study|Need for radiotherapy|0|||
48343321|NCT02212197|155452288|FG002|Overall Study|Need for radiotherapy|0|||
48343322|NCT01208870|155452289|FG000|Overall Study|Lost to Follow-up|2|||
48343323|NCT01208870|155452290|FG001|Overall Study|Lost to Follow-up|8|||
48343324|NCT01077622|155452291|FG000|Overall Study|Physician Decision|2|||
48343325|NCT01077622|155452291|FG000|Overall Study|Withdrawal by Subject|1|||
48343326|NCT02551692|155452294|FG000|Overall Study|Lost to Follow-up|0|||
48343327|NCT02551692|155452295|FG001|Overall Study|Lost to Follow-up|1|||
48343328|NCT02551692|155452296|FG002|Overall Study|Lost to Follow-up|4|||
48343329|NCT02551692|155452294|FG000|Overall Study|Withdrawal by Subject|1|||
48343330|NCT02551692|155452295|FG001|Overall Study|Withdrawal by Subject|0|||
48343331|NCT02551692|155452296|FG002|Overall Study|Withdrawal by Subject|1|||
48343332|NCT05172232|155452302|FG000|Overall Study|Lost to Follow-up|3|||
48343333|NCT00727259|155452303|FG000|Overall Study|Not all questionnaires completed|1055|||
48343334|NCT01207492|155452306|FG000|Overall Study|Still on study|1|||
48343335|NCT01207492|155452306|FG000|Overall Study|Withdrawal by Subject|9|||
48343336|NCT01207492|155452306|FG000|Overall Study|Physician Decision|1|||
48343337|NCT01207492|155452306|FG000|Overall Study|Progressive disease|3|||
48343338|NCT01207492|155452306|FG000|Overall Study|Toxicity|1|||
48343339|NCT01772147|155453810|FG000|Overall Study|Adverse Event|13|||
48343340|NCT01772147|155453811|FG001|Overall Study|Adverse Event|10|||
48343341|NCT01772147|155453812|FG002|Overall Study|Adverse Event|6|||
48343342|NCT01772147|155453810|FG000|Overall Study|Withdrew Consent|7|||
48343343|NCT01772147|155453811|FG001|Overall Study|Withdrew Consent|8|||
48343344|NCT01772147|155453812|FG002|Overall Study|Withdrew Consent|4|||
48343345|NCT01772147|155453810|FG000|Overall Study|Lost to Follow-up|1|||
48343346|NCT01772147|155453811|FG001|Overall Study|Lost to Follow-up|0|||
48343347|NCT01772147|155453812|FG002|Overall Study|Lost to Follow-up|1|||
48343348|NCT01772147|155453810|FG000|Overall Study|Protocol Deviation|2|||
48343349|NCT01772147|155453811|FG001|Overall Study|Protocol Deviation|1|||
48343350|NCT01772147|155453812|FG002|Overall Study|Protocol Deviation|1|||
48343351|NCT01772147|155453810|FG000|Overall Study|Lack of Efficacy|8|||
48343352|NCT01772147|155453811|FG001|Overall Study|Lack of Efficacy|6|||
48343353|NCT01772147|155453812|FG002|Overall Study|Lack of Efficacy|6|||
48343354|NCT01002547|155453813|FG000|Overall Study|Withdrawal by Subject|4|||
48343355|NCT01002547|155453814|FG001|Overall Study|Withdrawal by Subject|0|||
48343356|NCT01002547|155453815|FG002|Overall Study|Withdrawal by Subject|5|||
48343357|NCT01002547|155453813|FG000|Overall Study|Lost to Follow-up|2|||
48343358|NCT01002547|155453814|FG001|Overall Study|Lost to Follow-up|1|||
48343359|NCT01002547|155453815|FG002|Overall Study|Lost to Follow-up|1|||
48343360|NCT01002547|155453813|FG000|Overall Study|Physician Decision|1|||
48343361|NCT01002547|155453814|FG001|Overall Study|Physician Decision|0|||
48343362|NCT01002547|155453815|FG002|Overall Study|Physician Decision|0|||
48343363|NCT01002547|155453813|FG000|Overall Study|Death|0|||
48343364|NCT01002547|155453814|FG001|Overall Study|Death|2|||
48343365|NCT01002547|155453815|FG002|Overall Study|Death|2|||
48343366|NCT01002547|155453813|FG000|Overall Study|Adverse Event|1|||
48343367|NCT01002547|155453814|FG001|Overall Study|Adverse Event|0|||
48343368|NCT01002547|155453815|FG002|Overall Study|Adverse Event|0|||
48343369|NCT02859558|155453819|FG000|Step 1|Not Eligible|0|||
48343370|NCT02859558|155453820|FG001|Step 1|Not Eligible|0|||
48343371|NCT02859558|155453821|FG002|Step 1|Not Eligible|0|||
48343372|NCT02859558|155453822|FG003|Step 1|Not Eligible|0|||
48343373|NCT02859558|155453823|FG004|Step 1|Not Eligible|3|||
48343374|NCT02859558|155453819|FG000|Step 1|Lost to Follow-up|1|||
48671318|NCT02198794|156650492|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
48671319|NCT02198794|156650493|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
48671320|NCT02198794|156650490|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
48671321|NCT02198794|156650491|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
48671322|NCT02198794|156650492|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
48671323|NCT02198794|156650493|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
48343375|NCT02859558|155453820|FG001|Step 1|Lost to Follow-up|3|||
48343376|NCT02859558|155453821|FG002|Step 1|Lost to Follow-up|3|||
48343377|NCT02859558|155453822|FG003|Step 1|Lost to Follow-up|0|||
48343378|NCT02859558|155453823|FG004|Step 1|Lost to Follow-up|0|||
48343379|NCT02859558|155453819|FG000|Step 1|Did Not Return to Clinic|2|||
48343380|NCT02859558|155453820|FG001|Step 1|Did Not Return to Clinic|3|||
48343381|NCT02859558|155453821|FG002|Step 1|Did Not Return to Clinic|4|||
48343382|NCT02859558|155453822|FG003|Step 1|Did Not Return to Clinic|0|||
48343383|NCT02859558|155453823|FG004|Step 1|Did Not Return to Clinic|0|||
48343384|NCT02859558|155453819|FG000|Step 1|Moved|0|||
48343385|NCT02859558|155453820|FG001|Step 1|Moved|1|||
48671324|NCT02198794|156650490|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
48671325|NCT02198794|156650491|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
48671326|NCT02198794|156650492|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
48671327|NCT02198794|156650493|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
48671328|NCT02198794|156650490|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
48671329|NCT02198794|156650491|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
48671330|NCT02198794|156650492|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
48343386|NCT02859558|155453821|FG002|Step 1|Moved|1|||
48343387|NCT02859558|155453822|FG003|Step 1|Moved|0|||
48343388|NCT02859558|155453823|FG004|Step 1|Moved|0|||
48343389|NCT02859558|155453819|FG000|Step 1|Withdrawal By Participant|1|||
48343390|NCT02859558|155453820|FG001|Step 1|Withdrawal By Participant|2|||
48343391|NCT02859558|155453821|FG002|Step 1|Withdrawal By Participant|1|||
48343392|NCT02859558|155453822|FG003|Step 1|Withdrawal By Participant|0|||
48343393|NCT02859558|155453823|FG004|Step 1|Withdrawal By Participant|0|||
48343394|NCT02859558|155453819|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
48343395|NCT02859558|155453820|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
48343396|NCT02859558|155453821|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
48343397|NCT02859558|155453822|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
48671331|NCT02198794|156650493|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
48671332|NCT02198794|156650490|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
48671333|NCT02198794|156650491|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
48671334|NCT02198794|156650492|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
48671335|NCT02198794|156650493|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
48671336|NCT02905006|156650496|FG000|Overall Study|Adverse Event|1|||
48671337|NCT02905006|156650497|FG001|Overall Study|Adverse Event|1|||
48671338|NCT02905006|156650498|FG002|Overall Study|Adverse Event|1|||
48671339|NCT02905006|156650499|FG003|Overall Study|Adverse Event|1|||
48671340|NCT02905006|156650500|FG004|Overall Study|Adverse Event|0|||
48671341|NCT02905006|156650501|FG005|Overall Study|Adverse Event|1|||
48671342|NCT02905006|156650496|FG000|Overall Study|Lack of Efficacy|1|||
48671343|NCT02905006|156650497|FG001|Overall Study|Lack of Efficacy|0|||
48671344|NCT02905006|156650498|FG002|Overall Study|Lack of Efficacy|0|||
48671345|NCT02905006|156650499|FG003|Overall Study|Lack of Efficacy|0|||
48671346|NCT02905006|156650500|FG004|Overall Study|Lack of Efficacy|0|||
48671347|NCT02905006|156650501|FG005|Overall Study|Lack of Efficacy|0|||
48671348|NCT02905006|156650496|FG000|Overall Study|Protocol Violation|2|||
48671349|NCT02905006|156650497|FG001|Overall Study|Protocol Violation|0|||
48671350|NCT02905006|156650498|FG002|Overall Study|Protocol Violation|0|||
48671351|NCT02905006|156650499|FG003|Overall Study|Protocol Violation|0|||
48671352|NCT02905006|156650500|FG004|Overall Study|Protocol Violation|0|||
48671353|NCT02905006|156650501|FG005|Overall Study|Protocol Violation|0|||
48671354|NCT02905006|156650496|FG000|Overall Study|Lost to Follow-up|0|||
48671355|NCT02905006|156650497|FG001|Overall Study|Lost to Follow-up|0|||
48671356|NCT02905006|156650498|FG002|Overall Study|Lost to Follow-up|0|||
48671357|NCT02905006|156650499|FG003|Overall Study|Lost to Follow-up|1|||
48343398|NCT02859558|155453823|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
48343399|NCT02859558|155453819|FG000|Step 1|Incarceration|0|||
48671358|NCT02905006|156650500|FG004|Overall Study|Lost to Follow-up|1|||
48671359|NCT02905006|156650501|FG005|Overall Study|Lost to Follow-up|0|||
48671360|NCT02905006|156650496|FG000|Overall Study|Withdrawal by Subject|0|||
48671361|NCT02905006|156650497|FG001|Overall Study|Withdrawal by Subject|0|||
48671362|NCT02905006|156650498|FG002|Overall Study|Withdrawal by Subject|1|||
48671363|NCT02905006|156650499|FG003|Overall Study|Withdrawal by Subject|1|||
48671364|NCT02905006|156650500|FG004|Overall Study|Withdrawal by Subject|0|||
48671365|NCT02905006|156650501|FG005|Overall Study|Withdrawal by Subject|1|||
48671366|NCT02905006|156650496|FG000|Overall Study|Screening exclusion criteria met|1|||
48671367|NCT02905006|156650497|FG001|Overall Study|Screening exclusion criteria met|0|||
48671368|NCT02905006|156650498|FG002|Overall Study|Screening exclusion criteria met|0|||
48671369|NCT02905006|156650499|FG003|Overall Study|Screening exclusion criteria met|0|||
48671370|NCT02905006|156650500|FG004|Overall Study|Screening exclusion criteria met|0|||
48671371|NCT02905006|156650501|FG005|Overall Study|Screening exclusion criteria met|0|||
48671372|NCT02905006|156650496|FG000|Overall Study|Lab withdrawal criterion met|0|||
48671373|NCT02905006|156650497|FG001|Overall Study|Lab withdrawal criterion met|1|||
48671374|NCT02905006|156650498|FG002|Overall Study|Lab withdrawal criterion met|2|||
48671375|NCT02905006|156650499|FG003|Overall Study|Lab withdrawal criterion met|2|||
48671376|NCT02905006|156650500|FG004|Overall Study|Lab withdrawal criterion met|2|||
48671377|NCT02905006|156650501|FG005|Overall Study|Lab withdrawal criterion met|1|||
48671378|NCT02905006|156650496|FG000|Overall Study|Positive for Tuberculosis|0|||
48671379|NCT02905006|156650497|FG001|Overall Study|Positive for Tuberculosis|1|||
48671380|NCT02905006|156650498|FG002|Overall Study|Positive for Tuberculosis|0|||
48671381|NCT02905006|156650499|FG003|Overall Study|Positive for Tuberculosis|0|||
48671382|NCT02905006|156650500|FG004|Overall Study|Positive for Tuberculosis|0|||
48671383|NCT02905006|156650501|FG005|Overall Study|Positive for Tuberculosis|0|||
48671384|NCT02905006|156650496|FG000|Overall Study|Subject positive for Hep B|0|||
48671385|NCT02905006|156650497|FG001|Overall Study|Subject positive for Hep B|0|||
48671386|NCT02905006|156650498|FG002|Overall Study|Subject positive for Hep B|1|||
48671387|NCT02905006|156650499|FG003|Overall Study|Subject positive for Hep B|0|||
48671388|NCT02905006|156650500|FG004|Overall Study|Subject positive for Hep B|0|||
48671389|NCT02905006|156650501|FG005|Overall Study|Subject positive for Hep B|0|||
48671390|NCT02905006|156650496|FG000|Overall Study|Patient moved abroad|0|||
48760707|NCT00697515|156972297|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
48760708|NCT00697515|156972296|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
48760709|NCT00697515|156972297|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
48760710|NCT00697515|156972296|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
48760711|NCT00697515|156972297|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
48760712|NCT02389998|156972298|FG000|Overall Study|car accident|1|||
48760713|NCT02389998|156972299|FG001|Overall Study|car accident|0|||
48760714|NCT03045887|156972300|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
48760715|NCT03045887|156972301|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760716|NCT03045887|156972302|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760717|NCT03045887|156972303|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760718|NCT03045887|156972304|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760719|NCT03045887|156972305|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760720|NCT03045887|156972306|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760721|NCT03045887|156972307|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760722|NCT03045887|156972308|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760723|NCT03045887|156972309|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
48760724|NCT03045887|156972300|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760725|NCT03045887|156972301|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48671391|NCT02905006|156650497|FG001|Overall Study|Patient moved abroad|0|||
48671392|NCT02905006|156650498|FG002|Overall Study|Patient moved abroad|0|||
48671393|NCT02905006|156650499|FG003|Overall Study|Patient moved abroad|1|||
48671394|NCT02905006|156650500|FG004|Overall Study|Patient moved abroad|0|||
48671395|NCT02905006|156650501|FG005|Overall Study|Patient moved abroad|0|||
48671396|NCT02905006|156650496|FG000|Overall Study|Patient randomized by mistake|0|||
48671397|NCT02905006|156650497|FG001|Overall Study|Patient randomized by mistake|0|||
48671398|NCT02905006|156650498|FG002|Overall Study|Patient randomized by mistake|0|||
48671399|NCT02905006|156650499|FG003|Overall Study|Patient randomized by mistake|0|||
48671400|NCT02905006|156650500|FG004|Overall Study|Patient randomized by mistake|0|||
48671401|NCT02905006|156650501|FG005|Overall Study|Patient randomized by mistake|1|||
48671402|NCT01939366|156650502|FG000|Overall Study|Adverse Event|8|||
48671403|NCT01939366|156650503|FG001|Overall Study|Adverse Event|17|||
48671404|NCT01939366|156650504|FG002|Overall Study|Adverse Event|30|||
48343400|NCT02859558|155453820|FG001|Step 1|Incarceration|1|||
48671405|NCT01939366|156650505|FG003|Overall Study|Adverse Event|8|||
48671406|NCT01939366|156650506|FG004|Overall Study|Adverse Event|5|||
48671407|NCT01939366|156650502|FG000|Overall Study|Lack of Efficacy|2|||
48671408|NCT01939366|156650503|FG001|Overall Study|Lack of Efficacy|1|||
48671409|NCT01939366|156650504|FG002|Overall Study|Lack of Efficacy|1|||
48343401|NCT02859558|155453821|FG002|Step 1|Incarceration|0|||
48343402|NCT02859558|155453822|FG003|Step 1|Incarceration|0|||
48343403|NCT02859558|155453823|FG004|Step 1|Incarceration|0|||
48671410|NCT01939366|156650505|FG003|Overall Study|Lack of Efficacy|1|||
48671411|NCT01939366|156650506|FG004|Overall Study|Lack of Efficacy|3|||
48671412|NCT01939366|156650502|FG000|Overall Study|Lost to Follow-up|1|||
48671413|NCT01939366|156650503|FG001|Overall Study|Lost to Follow-up|1|||
48343404|NCT02859558|155453819|FG000|Step 1|Non-Adherence to Study Drug|2|||
48343405|NCT02859558|155453820|FG001|Step 1|Non-Adherence to Study Drug|0|||
48343406|NCT02859558|155453821|FG002|Step 1|Non-Adherence to Study Drug|1|||
48343407|NCT02859558|155453822|FG003|Step 1|Non-Adherence to Study Drug|0|||
48343408|NCT02859558|155453823|FG004|Step 1|Non-Adherence to Study Drug|0|||
48343409|NCT02859558|155453819|FG000|Step 1|Non-Adherence to Study Requirements|3|||
48343410|NCT02859558|155453820|FG001|Step 1|Non-Adherence to Study Requirements|1|||
48343411|NCT02859558|155453821|FG002|Step 1|Non-Adherence to Study Requirements|0|||
48343412|NCT02859558|155453822|FG003|Step 1|Non-Adherence to Study Requirements|0|||
48343413|NCT02859558|155453823|FG004|Step 1|Non-Adherence to Study Requirements|0|||
48671414|NCT01939366|156650504|FG002|Overall Study|Lost to Follow-up|0|||
48671415|NCT01939366|156650505|FG003|Overall Study|Lost to Follow-up|0|||
48671416|NCT01939366|156650506|FG004|Overall Study|Lost to Follow-up|0|||
48671417|NCT01939366|156650502|FG000|Overall Study|Withdrawal by Subject|1|||
48671418|NCT01939366|156650503|FG001|Overall Study|Withdrawal by Subject|0|||
48671419|NCT01939366|156650504|FG002|Overall Study|Withdrawal by Subject|2|||
48671420|NCT01939366|156650505|FG003|Overall Study|Withdrawal by Subject|2|||
48671421|NCT01939366|156650506|FG004|Overall Study|Withdrawal by Subject|3|||
48671422|NCT01939366|156650502|FG000|Overall Study|Inclusion criteria not met|0|||
48671423|NCT01939366|156650503|FG001|Overall Study|Inclusion criteria not met|1|||
48671424|NCT01939366|156650504|FG002|Overall Study|Inclusion criteria not met|1|||
48671425|NCT01939366|156650505|FG003|Overall Study|Inclusion criteria not met|0|||
48671426|NCT01939366|156650506|FG004|Overall Study|Inclusion criteria not met|1|||
48671427|NCT01939366|156650502|FG000|Overall Study|Other|0|||
48671428|NCT01939366|156650503|FG001|Overall Study|Other|0|||
48671429|NCT01939366|156650504|FG002|Overall Study|Other|2|||
48671430|NCT01939366|156650505|FG003|Overall Study|Other|2|||
48671431|NCT01939366|156650506|FG004|Overall Study|Other|1|||
48671432|NCT01939366|156650502|FG000|Overall Study|Protocol Violation|0|||
48671433|NCT01939366|156650503|FG001|Overall Study|Protocol Violation|0|||
48671434|NCT01939366|156650504|FG002|Overall Study|Protocol Violation|0|||
48671435|NCT01939366|156650505|FG003|Overall Study|Protocol Violation|1|||
48671436|NCT01939366|156650506|FG004|Overall Study|Protocol Violation|0|||
48671437|NCT01939366|156650502|FG000|Overall Study|Sponsor decision|0|||
48671438|NCT01939366|156650503|FG001|Overall Study|Sponsor decision|0|||
48671439|NCT01939366|156650504|FG002|Overall Study|Sponsor decision|0|||
48343414|NCT02859558|155453819|FG000|Step 1|Virologic Failure|2|||
48671440|NCT01939366|156650505|FG003|Overall Study|Sponsor decision|0|||
48671441|NCT01939366|156650506|FG004|Overall Study|Sponsor decision|2|||
48343415|NCT02859558|155453820|FG001|Step 1|Virologic Failure|1|||
48343416|NCT02859558|155453821|FG002|Step 1|Virologic Failure|1|||
48343417|NCT02859558|155453822|FG003|Step 1|Virologic Failure|0|||
48343418|NCT02859558|155453823|FG004|Step 1|Virologic Failure|0|||
48343419|NCT02859558|155453819|FG000|Step 2|Active On Study|23|||
48343420|NCT02859558|155453820|FG001|Step 2|Active On Study|38|||
48343421|NCT02859558|155453821|FG002|Step 2|Active On Study|20|||
48343422|NCT02859558|155453822|FG003|Step 2|Active On Study|0|||
48343423|NCT02859558|155453823|FG004|Step 2|Active On Study|0|||
48343424|NCT02859558|155453819|FG000|Step 2|Did Not Return to Clinic|2|||
48343425|NCT02859558|155453820|FG001|Step 2|Did Not Return to Clinic|0|||
48343426|NCT02859558|155453821|FG002|Step 2|Did Not Return to Clinic|0|||
48343427|NCT02859558|155453822|FG003|Step 2|Did Not Return to Clinic|0|||
48343428|NCT02859558|155453823|FG004|Step 2|Did Not Return to Clinic|0|||
48343429|NCT02859558|155453819|FG000|Step 2|Unexpected Closure of Site|0|||
48343430|NCT02859558|155453820|FG001|Step 2|Unexpected Closure of Site|1|||
48343431|NCT02859558|155453821|FG002|Step 2|Unexpected Closure of Site|1|||
48343432|NCT02859558|155453822|FG003|Step 2|Unexpected Closure of Site|0|||
48343433|NCT02859558|155453823|FG004|Step 2|Unexpected Closure of Site|0|||
48343434|NCT00925288|155453824|FG000|Overall Study|Lost to Follow-up|9|||
48343435|NCT00925288|155453825|FG001|Overall Study|Lost to Follow-up|7|||
48343436|NCT00434577|155453828|FG000|Months 0-3|Serious Adverse Event|0|||
48343437|NCT00434577|155453829|FG001|Months 0-3|Serious Adverse Event|0|||
48343438|NCT00434577|155453830|FG002|Months 0-3|Serious Adverse Event|1|||
48343439|NCT00434577|155453831|FG003|Months 0-3|Serious Adverse Event|0|||
48343440|NCT00434577|155453832|FG004|Months 0-3|Serious Adverse Event|0|||
48343441|NCT00434577|155453828|FG000|Months 0-3|Adverse Event|0|||
48343442|NCT00434577|155453829|FG001|Months 0-3|Adverse Event|1|||
48343443|NCT00434577|155453830|FG002|Months 0-3|Adverse Event|1|||
48343444|NCT00434577|155453831|FG003|Months 0-3|Adverse Event|0|||
48343445|NCT00434577|155453832|FG004|Months 0-3|Adverse Event|0|||
48343446|NCT00434577|155453828|FG000|Months 0-3|Lost to Follow-up|0|||
48343447|NCT00434577|155453829|FG001|Months 0-3|Lost to Follow-up|0|||
48343448|NCT00434577|155453830|FG002|Months 0-3|Lost to Follow-up|0|||
48343449|NCT00434577|155453831|FG003|Months 0-3|Lost to Follow-up|0|||
48343450|NCT00434577|155453832|FG004|Months 0-3|Lost to Follow-up|2|||
48343451|NCT00434577|155453828|FG000|Months 0-3|Protocol Violation|1|||
48343452|NCT00434577|155453829|FG001|Months 0-3|Protocol Violation|0|||
48343453|NCT00434577|155453830|FG002|Months 0-3|Protocol Violation|1|||
48343454|NCT00434577|155453831|FG003|Months 0-3|Protocol Violation|0|||
48343455|NCT00434577|155453832|FG004|Months 0-3|Protocol Violation|0|||
48343456|NCT00434577|155453828|FG000|Months 0-3|Withdrawal by Subject|2|||
48343457|NCT00434577|155453829|FG001|Months 0-3|Withdrawal by Subject|1|||
48343458|NCT00434577|155453830|FG002|Months 0-3|Withdrawal by Subject|1|||
48343459|NCT00434577|155453831|FG003|Months 0-3|Withdrawal by Subject|1|||
48343460|NCT00434577|155453832|FG004|Months 0-3|Withdrawal by Subject|1|||
48343461|NCT01967719|155453833|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
48343462|NCT01967719|155453834|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
48671442|NCT01939366|156650502|FG000|Overall Study|GCP non-compliance at site|2|||
48671443|NCT01939366|156650503|FG001|Overall Study|GCP non-compliance at site|3|||
48671444|NCT01939366|156650504|FG002|Overall Study|GCP non-compliance at site|2|||
48671445|NCT01939366|156650505|FG003|Overall Study|GCP non-compliance at site|3|||
48671446|NCT01939366|156650506|FG004|Overall Study|GCP non-compliance at site|3|||
48671447|NCT02853435|156650507|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48671448|NCT02853435|156650508|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48343463|NCT01967719|155453835|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
48343464|NCT01967719|155453836|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
48343465|NCT01967719|155453833|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
48343466|NCT01967719|155453834|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
48343467|NCT01967719|155453835|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
48343468|NCT01967719|155453836|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
48671449|NCT02853435|156650509|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48343469|NCT02329223|155453837|FG000|Overall Study|Withdrawal by Subject|1|||
48343470|NCT02329223|155453838|FG001|Overall Study|Withdrawal by Subject|2|||
48343471|NCT02329223|155453839|FG002|Overall Study|Withdrawal by Subject|5|||
48343472|NCT02329223|155453837|FG000|Overall Study|Physician Decision|0|||
48343473|NCT02329223|155453838|FG001|Overall Study|Physician Decision|0|||
48343474|NCT02329223|155453839|FG002|Overall Study|Physician Decision|1|||
48343475|NCT02329223|155453837|FG000|Overall Study|Adverse Event|0|||
48343476|NCT02329223|155453838|FG001|Overall Study|Adverse Event|1|||
48343477|NCT02329223|155453839|FG002|Overall Study|Adverse Event|0|||
48343478|NCT01232569|155453840|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
48343479|NCT01232569|155453841|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
48343480|NCT01232569|155453842|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48343481|NCT01232569|155453843|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
48343482|NCT01232569|155453840|FG000|Double-blind Treatment Period|Escape|2|||
48343483|NCT01232569|155453841|FG001|Double-blind Treatment Period|Escape|2|||
48343484|NCT01232569|155453842|FG002|Double-blind Treatment Period|Escape|0|||
48343485|NCT01232569|155453843|FG003|Double-blind Treatment Period|Escape|0|||
48343486|NCT01232569|155453840|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
48343487|NCT01232569|155453841|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
48343488|NCT01232569|155453842|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
48343489|NCT01232569|155453843|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
48343490|NCT01232569|155453840|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
48343491|NCT01232569|155453841|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
48343492|NCT01232569|155453842|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
48343493|NCT01232569|155453843|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
48343494|NCT01232569|155453840|FG000|Double-blind Treatment Period|Physician Decision|1|||
48343495|NCT01232569|155453841|FG001|Double-blind Treatment Period|Physician Decision|0|||
48343496|NCT01232569|155453842|FG002|Double-blind Treatment Period|Physician Decision|0|||
48343497|NCT01232569|155453843|FG003|Double-blind Treatment Period|Physician Decision|0|||
48343498|NCT01232569|155453840|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
48343499|NCT01232569|155453841|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
48343500|NCT01232569|155453842|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
48343501|NCT01232569|155453843|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
48343502|NCT01232569|155453840|FG000|Double-blind Treatment Period|Death|2|||
48343503|NCT01232569|155453841|FG001|Double-blind Treatment Period|Death|0|||
48343504|NCT01232569|155453842|FG002|Double-blind Treatment Period|Death|0|||
48343505|NCT01232569|155453843|FG003|Double-blind Treatment Period|Death|0|||
48343506|NCT00651937|155453844|FG000|Overall Study|Withdrawal by Subject|4|||
48343507|NCT00651937|155453845|FG001|Overall Study|Withdrawal by Subject|1|||
48343508|NCT00506922|155453855|FG000|Overall Study|Physician Decision|0|||
48343509|NCT00506922|155453856|FG001|Overall Study|Physician Decision|0|||
48343510|NCT00506922|155453857|FG002|Overall Study|Physician Decision|0|||
48343511|NCT00506922|155453858|FG003|Overall Study|Physician Decision|2|||
48343512|NCT00506922|155453859|FG004|Overall Study|Physician Decision|0|||
48343513|NCT00506922|155453855|FG000|Overall Study|Withdrawal by Subject|0|||
48671450|NCT02853435|156650510|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48671451|NCT02853435|156650511|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
48671452|NCT02853435|156650512|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
48671453|NCT03199391|156650513|FG000|Overall Study|Death|1|||
48671454|NCT03199391|156650513|FG000|Overall Study|Lost to Follow-up|3|||
48671455|NCT03199391|156650513|FG000|Overall Study|Adverse Event|2|||
48671456|NCT03199391|156650513|FG000|Overall Study|Withdrawal by Subject|10|||
48671457|NCT01267175|156650515|FG000|Overall Study|Withdrawal by Subject|1|||
48671458|NCT01267175|156650515|FG000|Overall Study|Lost to Follow-up|1|||
48671459|NCT01966445|156650516|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48671460|NCT01966445|156650517|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48671461|NCT01966445|156650518|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48343514|NCT00506922|155453856|FG001|Overall Study|Withdrawal by Subject|0|||
48343515|NCT00506922|155453857|FG002|Overall Study|Withdrawal by Subject|0|||
48343516|NCT00506922|155453858|FG003|Overall Study|Withdrawal by Subject|0|||
48343517|NCT00506922|155453859|FG004|Overall Study|Withdrawal by Subject|1|||
48343518|NCT04816708|155453860|FG000|Overall Study|Lost to Follow-up|10|||
48343519|NCT04816708|155453861|FG001|Overall Study|Lost to Follow-up|4|||
48343520|NCT03226106|155453863|FG000|Overall Study|Withdrawal by Subject|2|||
48343521|NCT03226106|155453864|FG001|Overall Study|Withdrawal by Subject|0|||
48343522|NCT03226106|155453863|FG000|Overall Study|Adverse Event|1|||
48343523|NCT03226106|155453864|FG001|Overall Study|Adverse Event|0|||
48343524|NCT03226106|155453863|FG000|Overall Study|Lost to Follow-up|2|||
48343525|NCT03226106|155453864|FG001|Overall Study|Lost to Follow-up|0|||
48343526|NCT01084239|155453865|FG000|28-Day Follow-up|Lost to Follow-up|4|||
48429207|NCT00912015|155760323|FG003|Overall Study|Lack of Efficacy|0|||
48343527|NCT01084239|155453866|FG001|28-Day Follow-up|Lost to Follow-up|9|||
48343528|NCT00550771|155453867|FG000|Overall Study|Adverse Event|11|||
48343529|NCT00550771|155453868|FG001|Overall Study|Adverse Event|3|||
48343530|NCT00550771|155453867|FG000|Overall Study|Discontinued for study-related reasons|0|||
48343531|NCT00550771|155453868|FG001|Overall Study|Discontinued for study-related reasons|1|||
48343532|NCT00550771|155453867|FG000|Overall Study|Physician Decision|2|||
48671462|NCT01966445|156650519|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
48671463|NCT01966445|156650520|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48671464|NCT01966445|156650521|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
48671465|NCT01966445|156650522|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
48671466|NCT01966445|156650516|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
48671467|NCT01966445|156650517|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
48671468|NCT01966445|156650518|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
48671469|NCT01966445|156650519|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
48671470|NCT01966445|156650520|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
48671471|NCT01966445|156650521|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
48343533|NCT00550771|155453868|FG001|Overall Study|Physician Decision|0|||
48343534|NCT00550771|155453867|FG000|Overall Study|Withdrawal by Subject|0|||
48343535|NCT00550771|155453868|FG001|Overall Study|Withdrawal by Subject|1|||
48343536|NCT00550771|155453867|FG000|Overall Study|Protocol Violation|4|||
48343537|NCT00550771|155453868|FG001|Overall Study|Protocol Violation|5|||
48343538|NCT02229396|155453872|FG000|Overall Study|Adverse Event|6|||
48343539|NCT02229396|155453873|FG001|Overall Study|Adverse Event|12|||
48343540|NCT02229396|155453874|FG002|Overall Study|Adverse Event|12|||
48343541|NCT02229396|155453872|FG000|Overall Study|Death|2|||
48671472|NCT01966445|156650522|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
48671473|NCT01966445|156650516|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
48671474|NCT01966445|156650517|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
48671475|NCT01966445|156650518|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
48671476|NCT01966445|156650519|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
48671477|NCT01966445|156650520|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
48671478|NCT01966445|156650521|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
48671479|NCT01966445|156650522|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
48671480|NCT01966445|156650516|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48760726|NCT03045887|156972302|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48343542|NCT02229396|155453873|FG001|Overall Study|Death|3|||
48343543|NCT02229396|155453874|FG002|Overall Study|Death|1|||
48343544|NCT02229396|155453872|FG000|Overall Study|Lost to Follow-up|14|||
48343545|NCT02229396|155453873|FG001|Overall Study|Lost to Follow-up|14|||
48343546|NCT02229396|155453874|FG002|Overall Study|Lost to Follow-up|21|||
48343547|NCT02229396|155453872|FG000|Overall Study|Protocol Violation|2|||
48343548|NCT02229396|155453873|FG001|Overall Study|Protocol Violation|1|||
48343549|NCT02229396|155453874|FG002|Overall Study|Protocol Violation|0|||
48343550|NCT02229396|155453872|FG000|Overall Study|Patient Incorrectly Randomized|0|||
48343551|NCT02229396|155453873|FG001|Overall Study|Patient Incorrectly Randomized|0|||
48343552|NCT02229396|155453874|FG002|Overall Study|Patient Incorrectly Randomized|1|||
48343553|NCT02229396|155453872|FG000|Overall Study|Other|10|||
48343554|NCT02229396|155453873|FG001|Overall Study|Other|18|||
48343555|NCT02229396|155453874|FG002|Overall Study|Other|15|||
48343556|NCT02229396|155453872|FG000|Overall Study|Withdrawal by Subject|42|||
48343557|NCT02229396|155453873|FG001|Overall Study|Withdrawal by Subject|28|||
48343558|NCT02229396|155453874|FG002|Overall Study|Withdrawal by Subject|41|||
48343559|NCT02229396|155453872|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
48343560|NCT02229396|155453873|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
48343561|NCT02229396|155453874|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
48343562|NCT02229396|155453872|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
48343563|NCT02229396|155453873|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
48343564|NCT02229396|155453874|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
48343565|NCT05006417|155453875|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
48343566|NCT03681353|155453878|FG000|Overall Study|Lost to Follow-up|2|||
48343567|NCT03681353|155453878|FG000|Overall Study|Withdrawal by Subject|3|||
48343568|NCT03681353|155453878|FG000|Overall Study|withdrawn by PI|2|||
48343569|NCT00726388|155453879|FG000|Overall Study|Withdrawal by Subject|5|||
48343570|NCT00726388|155453879|FG000|Overall Study|Adverse Event|3|||
48343571|NCT00726388|155453879|FG000|Overall Study|Lost to Follow-up|10|||
48343572|NCT00726388|155453879|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
48343573|NCT00726388|155453879|FG000|Overall Study|Other|5|||
48429285|NCT01958671|155760337|FG000|Overall Study|Participant moved|0|||
48343574|NCT00726388|155453879|FG000|Overall Study|Enrolled, Not Treated|79|||
48343575|NCT01011049|155453882|FG000|Overall Study|Protocol Violation|0|||
48343576|NCT01011049|155453883|FG001|Overall Study|Protocol Violation|0|||
48343577|NCT01011049|155453884|FG002|Overall Study|Protocol Violation|2|||
48343578|NCT01011049|155453885|FG003|Overall Study|Protocol Violation|0|||
48343579|NCT01011049|155453882|FG000|Overall Study|Lost to Follow-up|1|||
48343580|NCT01011049|155453883|FG001|Overall Study|Lost to Follow-up|2|||
48343581|NCT01011049|155453884|FG002|Overall Study|Lost to Follow-up|1|||
48671481|NCT01966445|156650517|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671482|NCT01966445|156650518|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671483|NCT01966445|156650519|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671484|NCT01966445|156650520|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671485|NCT01966445|156650521|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
48671486|NCT01966445|156650522|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
48671487|NCT01966445|156650516|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671488|NCT01966445|156650517|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671489|NCT01966445|156650518|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671490|NCT01966445|156650519|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671491|NCT01966445|156650520|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671492|NCT01966445|156650521|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
48671493|NCT01966445|156650522|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
48671494|NCT01141478|156650526|FG000|Overall Study|Withdrawal by Subject|1|||
48671495|NCT01141478|156650527|FG001|Overall Study|Withdrawal by Subject|1|||
48671496|NCT00902174|156650528|FG000|Overall Study|Adverse Event|27|||
48671497|NCT00902174|156650529|FG001|Overall Study|Adverse Event|7|||
48671498|NCT00902174|156650528|FG000|Overall Study|Lack of Efficacy|1|||
48671499|NCT00902174|156650529|FG001|Overall Study|Lack of Efficacy|5|||
48671500|NCT00902174|156650528|FG000|Overall Study|Death|2|||
48671501|NCT00902174|156650529|FG001|Overall Study|Death|2|||
48671502|NCT00902174|156650528|FG000|Overall Study|Withdrawal by Subject|2|||
48671503|NCT00902174|156650529|FG001|Overall Study|Withdrawal by Subject|1|||
48671504|NCT00902174|156650528|FG000|Overall Study|Abnormal labs|1|||
48671505|NCT00902174|156650529|FG001|Overall Study|Abnormal labs|1|||
48671506|NCT00902174|156650528|FG000|Overall Study|Protocol Violation|1|||
48671507|NCT00902174|156650529|FG001|Overall Study|Protocol Violation|1|||
48671508|NCT00902174|156650528|FG000|Overall Study|Administration problem|0|||
48671509|NCT00902174|156650529|FG001|Overall Study|Administration problem|1|||
48671510|NCT03006887|156650533|FG000|Overall Study|Adverse Event|1|||
48671511|NCT00462748|156650534|FG000|Overall Study|Adverse Event|7|||
48671512|NCT00462748|156650535|FG001|Overall Study|Adverse Event|5|||
48671513|NCT00462748|156650536|FG002|Overall Study|Adverse Event|9|||
48671514|NCT00462748|156650534|FG000|Overall Study|Protocol Violation|0|||
48671515|NCT00462748|156650535|FG001|Overall Study|Protocol Violation|2|||
48671516|NCT00462748|156650536|FG002|Overall Study|Protocol Violation|1|||
48671517|NCT00462748|156650534|FG000|Overall Study|Withdrew consent|3|||
48671518|NCT00462748|156650535|FG001|Overall Study|Withdrew consent|3|||
48671519|NCT00462748|156650536|FG002|Overall Study|Withdrew consent|0|||
48671520|NCT00462748|156650534|FG000|Overall Study|Lost to Follow-up|1|||
48671521|NCT00462748|156650535|FG001|Overall Study|Lost to Follow-up|1|||
48671522|NCT00462748|156650536|FG002|Overall Study|Lost to Follow-up|1|||
48671523|NCT00462748|156650534|FG000|Overall Study|Discontinued after 41 days Rx|1|||
48671524|NCT00462748|156650535|FG001|Overall Study|Discontinued after 41 days Rx|0|||
48671525|NCT00462748|156650536|FG002|Overall Study|Discontinued after 41 days Rx|0|||
48671526|NCT01818492|156650537|FG000|Overall Study|Adverse Event|2|||
48671527|NCT01818492|156650537|FG000|Overall Study|Death|3|||
48760727|NCT03045887|156972303|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
48760728|NCT03045887|156972304|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760729|NCT03045887|156972305|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760730|NCT03045887|156972306|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760731|NCT03045887|156972307|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760732|NCT03045887|156972308|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760733|NCT03045887|156972309|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
48760734|NCT03045887|156972300|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
48760735|NCT03045887|156972301|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
48760736|NCT03045887|156972302|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
48760737|NCT03045887|156972303|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
48760738|NCT03045887|156972304|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
48671528|NCT01818492|156650537|FG000|Overall Study|Withdrawal by Subject|1|||
48760739|NCT03045887|156972305|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
48343582|NCT01011049|155453885|FG003|Overall Study|Lost to Follow-up|0|||
48343583|NCT01011049|155453882|FG000|Overall Study|Withdrawal by Subject|0|||
48671529|NCT01818492|156650537|FG000|Overall Study|Additional therapy when not allowed PP|4|||
48671530|NCT00082381|156650538|FG000|Overall Study|Adverse Event|27|||
48671531|NCT00082381|156650539|FG001|Overall Study|Adverse Event|2|||
48671532|NCT00082381|156650538|FG000|Overall Study|Lost to Follow-up|5|||
48671533|NCT00082381|156650539|FG001|Overall Study|Lost to Follow-up|7|||
48671534|NCT00082381|156650538|FG000|Overall Study|Patient Decision|8|||
48671535|NCT00082381|156650539|FG001|Overall Study|Patient Decision|4|||
48671536|NCT00082381|156650538|FG000|Overall Study|Physician Decision|1|||
48671537|NCT00082381|156650539|FG001|Overall Study|Physician Decision|2|||
48671538|NCT00082381|156650538|FG000|Overall Study|Protocol Violation|10|||
48671539|NCT00082381|156650539|FG001|Overall Study|Protocol Violation|11|||
48671540|NCT00082381|156650538|FG000|Overall Study|Loss of Glucose Control|4|||
48671541|NCT00082381|156650539|FG001|Overall Study|Loss of Glucose Control|0|||
48671542|NCT04109976|156650540|FG000|Overall Study|Withdrawal by Subject|1|||
48671543|NCT04109976|156650541|FG001|Overall Study|Withdrawal by Subject|0|||
48671544|NCT01438177|156650542|FG000|Overall Study|Withdrawal by Subject|1|||
48671545|NCT01438177|156650542|FG000|Overall Study|Initiation of new therapy|1|||
48671546|NCT00619099|156650545|FG000|Overall Study|Progressive Disease|7|||
48671547|NCT00619099|156650546|FG001|Overall Study|Progressive Disease|5|||
48671548|NCT00619099|156650545|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
48671549|NCT00619099|156650546|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
48671550|NCT00619099|156650545|FG000|Overall Study|Adverse Event|4|||
48671551|NCT00619099|156650546|FG001|Overall Study|Adverse Event|3|||
48671552|NCT00619099|156650545|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
48671553|NCT00619099|156650546|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
48671554|NCT00619099|156650545|FG000|Overall Study|Withdrawal by Subject|10|||
48671555|NCT00619099|156650546|FG001|Overall Study|Withdrawal by Subject|2|||
48671556|NCT00619099|156650545|FG000|Overall Study|Physician Decision|9|||
48671557|NCT00619099|156650546|FG001|Overall Study|Physician Decision|6|||
48671558|NCT00885482|156650547|FG000|Overall Study|Pregnancy|1|||
48671559|NCT00885482|156650547|FG000|Overall Study|Lack of Efficacy|1|||
48671560|NCT00885482|156650547|FG000|Overall Study|Death|1|||
48671561|NCT00885482|156650547|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
48671562|NCT00129467|156650548|FG000|Received Intervention|Death|1|||
48671563|NCT00129467|156650549|FG001|Received Intervention|Death|1|||
48671564|NCT00129467|156650548|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
48671565|NCT00129467|156650549|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
48671566|NCT00129467|156650548|FG000|Received Intervention|Delirium|2|||
48671567|NCT00129467|156650549|FG001|Received Intervention|Delirium|0|||
48671568|NCT00129467|156650548|FG000|Received Intervention|Withdrawal by Subject|1|||
48671569|NCT00129467|156650549|FG001|Received Intervention|Withdrawal by Subject|0|||
48671570|NCT00129467|156650548|FG000|Received Intervention|Nausea|1|||
48671571|NCT00129467|156650549|FG001|Received Intervention|Nausea|0|||
48671572|NCT00129467|156650548|FG000|Received Intervention|Intolerance to citalopram|0|||
48671573|NCT00129467|156650549|FG001|Received Intervention|Intolerance to citalopram|1|||
48671574|NCT00129467|156650548|FG000|Received Intervention|Dizzyness, fatigue|0|||
48671575|NCT00129467|156650549|FG001|Received Intervention|Dizzyness, fatigue|1|||
48671576|NCT00129467|156650548|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
48671577|NCT00129467|156650549|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
48671578|NCT00129467|156650548|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
48671579|NCT00129467|156650549|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
48671580|NCT00694304|156650550|FG000|Overall Study|Adverse Event|42|||
48671581|NCT00694304|156650550|FG000|Overall Study|Lack of Efficacy|35|||
48671582|NCT00694304|156650550|FG000|Overall Study|Non-compliance With Study Product|16|||
48671583|NCT00694304|156650550|FG000|Overall Study|Protocol Violation|6|||
48671584|NCT00694304|156650550|FG000|Overall Study|Withdrawal of Consent|61|||
48671585|NCT00694304|156650550|FG000|Overall Study|Lost to Follow-up|15|||
48343584|NCT01011049|155453883|FG001|Overall Study|Withdrawal by Subject|0|||
48343585|NCT01011049|155453884|FG002|Overall Study|Withdrawal by Subject|1|||
48343586|NCT01011049|155453885|FG003|Overall Study|Withdrawal by Subject|0|||
48343587|NCT02435381|155453887|FG000|Overall Study|Lost to Follow-up|2|||
48343588|NCT02435381|155453888|FG001|Overall Study|Lost to Follow-up|1|||
48671586|NCT00694304|156650550|FG000|Overall Study|Administrative or Other Reasons|32|||
48671587|NCT00778895|156650551|FG000|Active Phase|Adverse Event|3|||
48671588|NCT00778895|156650552|FG001|Active Phase|Adverse Event|1|||
48671589|NCT00778895|156650553|FG002|Active Phase|Adverse Event|0|||
48671590|NCT00778895|156650551|FG000|Active Phase|Withdrawal by Subject|1|||
48671591|NCT00778895|156650552|FG001|Active Phase|Withdrawal by Subject|4|||
48671592|NCT00778895|156650553|FG002|Active Phase|Withdrawal by Subject|0|||
48760740|NCT03045887|156972306|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
48343589|NCT01145417|155453889|FG000|Overall Study|Death|1|||
48343590|NCT01145417|155453890|FG001|Overall Study|Death|0|||
48343591|NCT01145417|155453889|FG000|Overall Study|Lost to Follow-up|2|||
48671593|NCT00778895|156650551|FG000|Active Phase|Lost to Follow-up|1|||
48671594|NCT00778895|156650552|FG001|Active Phase|Lost to Follow-up|1|||
48671595|NCT00778895|156650553|FG002|Active Phase|Lost to Follow-up|0|||
48671596|NCT00778895|156650551|FG000|Active Phase|Other|2|||
48760741|NCT03045887|156972307|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
48343592|NCT01145417|155453890|FG001|Overall Study|Lost to Follow-up|1|||
48343593|NCT01145417|155453889|FG000|Overall Study|Withdrawal by Subject|1|||
48671597|NCT00778895|156650552|FG001|Active Phase|Other|0|||
48671598|NCT00778895|156650553|FG002|Active Phase|Other|0|||
48671599|NCT00778895|156650551|FG000|ESFU Phase|Adverse Event|2|||
48671600|NCT00778895|156650552|FG001|ESFU Phase|Adverse Event|1|||
48671601|NCT00778895|156650553|FG002|ESFU Phase|Adverse Event|0|||
48671602|NCT00778895|156650551|FG000|ESFU Phase|Withdrawal by Subject|1|||
48671603|NCT00778895|156650552|FG001|ESFU Phase|Withdrawal by Subject|4|||
48671604|NCT00778895|156650553|FG002|ESFU Phase|Withdrawal by Subject|0|||
48671605|NCT00778895|156650551|FG000|ESFU Phase|Lost to Follow-up|6|||
48671606|NCT00778895|156650552|FG001|ESFU Phase|Lost to Follow-up|7|||
48671607|NCT00778895|156650553|FG002|ESFU Phase|Lost to Follow-up|2|||
48671608|NCT00778895|156650551|FG000|ESFU Phase|Other|2|||
48671609|NCT00778895|156650552|FG001|ESFU Phase|Other|0|||
48671610|NCT00778895|156650553|FG002|ESFU Phase|Other|0|||
48671611|NCT01927055|156650557|FG000|Open-label|Adverse Event|6|||
48671612|NCT01927055|156650558|FG001|Open-label|Adverse Event|0|||
48671613|NCT01927055|156650559|FG002|Open-label|Adverse Event|0|||
48760742|NCT03045887|156972308|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
48760743|NCT03045887|156972309|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
48343594|NCT01145417|155453890|FG001|Overall Study|Withdrawal by Subject|2|||
48343595|NCT01145417|155453889|FG000|Overall Study|Pregnancy|1|||
48343596|NCT01145417|155453890|FG001|Overall Study|Pregnancy|0|||
48343597|NCT01145417|155453889|FG000|Overall Study|Adverse Event|0|||
48343598|NCT01145417|155453890|FG001|Overall Study|Adverse Event|1|||
48343599|NCT01145417|155453889|FG000|Overall Study|Study terminated by sponsor|35|||
48343600|NCT01145417|155453890|FG001|Overall Study|Study terminated by sponsor|43|||
48671614|NCT01927055|156650557|FG000|Open-label|Withdrawal by Subject|1|||
48671615|NCT01927055|156650558|FG001|Open-label|Withdrawal by Subject|0|||
48671616|NCT01927055|156650559|FG002|Open-label|Withdrawal by Subject|0|||
48671617|NCT01927055|156650557|FG000|Open-label|Study Stopped|4|||
48671618|NCT01927055|156650558|FG001|Open-label|Study Stopped|0|||
48671619|NCT01927055|156650559|FG002|Open-label|Study Stopped|0|||
48671620|NCT01927055|156650557|FG000|Open-label|Supine Hypertension|4|||
48671621|NCT01927055|156650558|FG001|Open-label|Supine Hypertension|0|||
48671622|NCT01927055|156650559|FG002|Open-label|Supine Hypertension|0|||
48671623|NCT01927055|156650557|FG000|Open-label|Difficulty attending study visits|1|||
48671624|NCT01927055|156650558|FG001|Open-label|Difficulty attending study visits|0|||
48671625|NCT01927055|156650559|FG002|Open-label|Difficulty attending study visits|0|||
48671626|NCT01927055|156650557|FG000|Double-Blind|Adverse Event|0|||
48671627|NCT01927055|156650558|FG001|Double-Blind|Adverse Event|1|||
48671628|NCT01927055|156650559|FG002|Double-Blind|Adverse Event|1|||
48671629|NCT01927055|156650557|FG000|Double-Blind|Protocol Violation|0|||
48671630|NCT01927055|156650558|FG001|Double-Blind|Protocol Violation|0|||
48671631|NCT01927055|156650559|FG002|Double-Blind|Protocol Violation|1|||
48671632|NCT01927055|156650557|FG000|Double-Blind|Withdrawal by Subject|0|||
48671633|NCT01927055|156650558|FG001|Double-Blind|Withdrawal by Subject|2|||
48671634|NCT01927055|156650559|FG002|Double-Blind|Withdrawal by Subject|3|||
48671635|NCT01927055|156650557|FG000|Double-Blind|Study Stopped|0|||
48671636|NCT01927055|156650558|FG001|Double-Blind|Study Stopped|7|||
48671637|NCT01927055|156650559|FG002|Double-Blind|Study Stopped|7|||
48671638|NCT01927055|156650557|FG000|Double-Blind|Supine Hypertension|0|||
48671639|NCT01927055|156650558|FG001|Double-Blind|Supine Hypertension|0|||
48671640|NCT01927055|156650559|FG002|Double-Blind|Supine Hypertension|1|||
48671641|NCT01927055|156650557|FG000|Double-Blind|Extended Vacation|0|||
48671642|NCT01927055|156650558|FG001|Double-Blind|Extended Vacation|1|||
48671643|NCT01927055|156650559|FG002|Double-Blind|Extended Vacation|0|||
48760744|NCT03045887|156972300|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48343601|NCT01145417|155453889|FG000|Overall Study|Other|1|||
48343602|NCT01145417|155453890|FG001|Overall Study|Other|0|||
48343603|NCT02396758|155453892|FG000|Overall Study|Withdrawal by Subject|2|||
48671644|NCT01424228|156650560|FG000|Overall Study|Withdrawal by Subject|27|||
48671645|NCT01424228|156650561|FG001|Overall Study|Withdrawal by Subject|11|||
48343604|NCT02396758|155453893|FG001|Overall Study|Withdrawal by Subject|0|||
48343605|NCT02396758|155453894|FG002|Overall Study|Withdrawal by Subject|0|||
48343606|NCT02396758|155453895|FG003|Overall Study|Withdrawal by Subject|1|||
48343607|NCT02396758|155453892|FG000|Overall Study|Lost to Follow-up|8|||
48671646|NCT01424228|156650560|FG000|Overall Study|Adverse Event|10|||
48343608|NCT02396758|155453893|FG001|Overall Study|Lost to Follow-up|5|||
48343609|NCT02396758|155453894|FG002|Overall Study|Lost to Follow-up|3|||
48671647|NCT01424228|156650561|FG001|Overall Study|Adverse Event|14|||
48671648|NCT01424228|156650560|FG000|Overall Study|Sponsor's decision|9|||
48671649|NCT01424228|156650561|FG001|Overall Study|Sponsor's decision|12|||
48671650|NCT01424228|156650560|FG000|Overall Study|Lack of Efficacy|5|||
48671651|NCT01424228|156650561|FG001|Overall Study|Lack of Efficacy|7|||
48671652|NCT01424228|156650560|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
48671653|NCT01424228|156650561|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
48671654|NCT01424228|156650560|FG000|Overall Study|Non-compliance|2|||
48671655|NCT01424228|156650561|FG001|Overall Study|Non-compliance|0|||
48671656|NCT01424228|156650560|FG000|Overall Study|Worsening of symptoms|1|||
48671657|NCT01424228|156650561|FG001|Overall Study|Worsening of symptoms|0|||
48671658|NCT01424228|156650560|FG000|Overall Study|Unplanned journey|0|||
48671659|NCT01424228|156650561|FG001|Overall Study|Unplanned journey|1|||
48671660|NCT00499746|156650568|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
48671661|NCT00499746|156650568|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
48671662|NCT00499746|156650568|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
48671663|NCT00499746|156650568|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
48671664|NCT02273960|156650569|FG000|Short Term Period|Lost to Follow-up|1|||
48671665|NCT02273960|156650570|FG001|Short Term Period|Lost to Follow-up|0|||
48671666|NCT02273960|156650571|FG002|Short Term Period|Lost to Follow-up|0|||
48671667|NCT02273960|156650572|FG003|Short Term Period|Lost to Follow-up|0|||
48671668|NCT02273960|156650569|FG000|Short Term Period|Lack of Efficacy|0|||
48671669|NCT02273960|156650570|FG001|Short Term Period|Lack of Efficacy|0|||
48671670|NCT02273960|156650571|FG002|Short Term Period|Lack of Efficacy|0|||
48671671|NCT02273960|156650572|FG003|Short Term Period|Lack of Efficacy|1|||
48671672|NCT02273960|156650569|FG000|Short Term Period|ST complete, not entering LTE|4|||
48671673|NCT02273960|156650570|FG001|Short Term Period|ST complete, not entering LTE|6|||
48671674|NCT02273960|156650571|FG002|Short Term Period|ST complete, not entering LTE|4|||
48671675|NCT02273960|156650572|FG003|Short Term Period|ST complete, not entering LTE|5|||
48671676|NCT02273960|156650569|FG000|Long Term Extension|Death|0|||
48671677|NCT02273960|156650570|FG001|Long Term Extension|Death|0|||
48671678|NCT02273960|156650571|FG002|Long Term Extension|Death|0|||
48671679|NCT02273960|156650572|FG003|Long Term Extension|Death|1|||
48671680|NCT01624090|156650573|FG000|Overall Study|DLT, taken off therapy|0|||
48671681|NCT01624090|156650574|FG001|Overall Study|DLT, taken off therapy|1|||
48671682|NCT01624090|156650575|FG002|Overall Study|DLT, taken off therapy|0|||
48671683|NCT01624090|156650576|FG003|Overall Study|DLT, taken off therapy|0|||
48671684|NCT01624090|156650573|FG000|Overall Study|Withdrew prior to treatment|0|||
48671685|NCT01624090|156650574|FG001|Overall Study|Withdrew prior to treatment|1|||
48671686|NCT01624090|156650575|FG002|Overall Study|Withdrew prior to treatment|0|||
48671687|NCT01624090|156650576|FG003|Overall Study|Withdrew prior to treatment|0|||
48671688|NCT01624090|156650573|FG000|Overall Study|Died on study|0|||
48671689|NCT01624090|156650574|FG001|Overall Study|Died on study|0|||
48671690|NCT01624090|156650575|FG002|Overall Study|Died on study|2|||
48671691|NCT01624090|156650576|FG003|Overall Study|Died on study|0|||
48671692|NCT01624090|156650573|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
48671693|NCT01624090|156650574|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
48671694|NCT01624090|156650575|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
48671695|NCT01624090|156650576|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
48671696|NCT01624090|156650573|FG000|Overall Study|Dose escalated|0|||
48671697|NCT01624090|156650574|FG001|Overall Study|Dose escalated|0|||
48671698|NCT01624090|156650575|FG002|Overall Study|Dose escalated|3|||
48671699|NCT01624090|156650576|FG003|Overall Study|Dose escalated|0|||
48671700|NCT00772109|156650577|FG000|Overall Study|Serious adverse event|1|||
48760745|NCT03045887|156972301|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48343610|NCT02396758|155453895|FG003|Overall Study|Lost to Follow-up|3|||
48343611|NCT02396758|155453892|FG000|Overall Study|Death|1|||
48343612|NCT02396758|155453893|FG001|Overall Study|Death|1|||
48343613|NCT02396758|155453894|FG002|Overall Study|Death|0|||
48343614|NCT02396758|155453895|FG003|Overall Study|Death|1|||
48343615|NCT02396758|155453892|FG000|Overall Study|Randomized but not treated|1|||
48343616|NCT02396758|155453893|FG001|Overall Study|Randomized but not treated|0|||
48671701|NCT00772109|156650578|FG001|Overall Study|Serious adverse event|0|||
48671702|NCT00772109|156650579|FG002|Overall Study|Serious adverse event|1|||
48760746|NCT03045887|156972302|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
48671703|NCT00772109|156650580|FG003|Overall Study|Serious adverse event|0|||
48671704|NCT00772109|156650577|FG000|Overall Study|Protocol Violation|5|||
48671705|NCT00772109|156650578|FG001|Overall Study|Protocol Violation|8|||
48760747|NCT03045887|156972303|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
48760748|NCT03045887|156972304|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760749|NCT03045887|156972305|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760750|NCT03045887|156972306|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760751|NCT03045887|156972307|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760752|NCT03045887|156972308|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48760753|NCT03045887|156972309|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
48343617|NCT02396758|155453894|FG002|Overall Study|Randomized but not treated|1|||
48671706|NCT00772109|156650579|FG002|Overall Study|Protocol Violation|7|||
48671707|NCT00772109|156650580|FG003|Overall Study|Protocol Violation|6|||
48343618|NCT02396758|155453895|FG003|Overall Study|Randomized but not treated|0|||
48343619|NCT00666835|155453897|FG000|Overall Study|Withdrawal by Subject|5|||
48343620|NCT00666835|155453898|FG001|Overall Study|Withdrawal by Subject|2|||
48343621|NCT00666835|155453897|FG000|Overall Study|Lack of Efficacy|0|||
48671708|NCT00772109|156650577|FG000|Overall Study|Lost to Follow-up|7|||
48671709|NCT00772109|156650578|FG001|Overall Study|Lost to Follow-up|3|||
48671710|NCT00772109|156650579|FG002|Overall Study|Lost to Follow-up|5|||
48671711|NCT00772109|156650580|FG003|Overall Study|Lost to Follow-up|9|||
48343622|NCT00666835|155453898|FG001|Overall Study|Lack of Efficacy|1|||
48343623|NCT00666835|155453897|FG000|Overall Study|Incl./excl. not fulfilled|7|||
48343624|NCT00666835|155453898|FG001|Overall Study|Incl./excl. not fulfilled|2|||
48343625|NCT00666835|155453897|FG000|Overall Study|Adverse Event|7|||
48343626|NCT00666835|155453898|FG001|Overall Study|Adverse Event|6|||
48343627|NCT00666835|155453897|FG000|Overall Study|Protocol Violation|2|||
48343628|NCT00666835|155453898|FG001|Overall Study|Protocol Violation|0|||
48343629|NCT00666835|155453897|FG000|Overall Study|Death|15|||
48343630|NCT00666835|155453898|FG001|Overall Study|Death|4|||
48343631|NCT00666835|155453897|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
48343632|NCT00666835|155453898|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
48343633|NCT00666835|155453897|FG000|Overall Study|Hemoglobulin concentration|4|||
48343634|NCT00666835|155453898|FG001|Overall Study|Hemoglobulin concentration|3|||
48343635|NCT00666835|155453897|FG000|Overall Study|Planned operation|2|||
48343636|NCT00666835|155453898|FG001|Overall Study|Planned operation|0|||
48343637|NCT00666835|155453897|FG000|Overall Study|Physician Decision|1|||
48343638|NCT00666835|155453898|FG001|Overall Study|Physician Decision|2|||
48343639|NCT02499835|155453899|FG000|Overall Study|Withdrawal by Subject|1|||
48343640|NCT02499835|155453900|FG001|Overall Study|Withdrawal by Subject|0|||
48343641|NCT02499835|155453901|FG002|Overall Study|Withdrawal by Subject|0|||
48343642|NCT02499835|155453902|FG003|Overall Study|Withdrawal by Subject|1|||
48343643|NCT02499835|155453899|FG000|Overall Study|Physician Decision|0|||
48343644|NCT02499835|155453900|FG001|Overall Study|Physician Decision|3|||
48343645|NCT02499835|155453901|FG002|Overall Study|Physician Decision|18|||
48671712|NCT00772109|156650577|FG000|Overall Study|Withdrawal by Subject|8|||
48671713|NCT00772109|156650578|FG001|Overall Study|Withdrawal by Subject|8|||
48671714|NCT00772109|156650579|FG002|Overall Study|Withdrawal by Subject|6|||
48671715|NCT00772109|156650580|FG003|Overall Study|Withdrawal by Subject|16|||
48671716|NCT00752726|156650581|FG000|Overall Study|Lost to Follow-up|2|||
48671717|NCT00752726|156650582|FG001|Overall Study|Lost to Follow-up|1|||
48671718|NCT00752726|156650581|FG000|Overall Study|Adverse Event|3|||
48671719|NCT00752726|156650582|FG001|Overall Study|Adverse Event|0|||
48671720|NCT00752726|156650581|FG000|Overall Study|Withdrawal by Subject|5|||
48671721|NCT00752726|156650582|FG001|Overall Study|Withdrawal by Subject|10|||
48671722|NCT00752726|156650581|FG000|Overall Study|Other Reason|1|||
48671723|NCT00752726|156650582|FG001|Overall Study|Other Reason|2|||
48671724|NCT01403116|156650583|FG000|Overall Study|Adverse Event|7|||
48671725|NCT01403116|156650584|FG001|Overall Study|Adverse Event|4|||
48671726|NCT01403116|156650583|FG000|Overall Study|Lost to Follow-up|7|||
48671727|NCT01403116|156650584|FG001|Overall Study|Lost to Follow-up|5|||
48671728|NCT01403116|156650583|FG000|Overall Study|Withdrawal by Subject|12|||
48671729|NCT01403116|156650584|FG001|Overall Study|Withdrawal by Subject|15|||
48671730|NCT01403116|156650583|FG000|Overall Study|Non-compliance of study drug|3|||
48671731|NCT01403116|156650584|FG001|Overall Study|Non-compliance of study drug|0|||
48671732|NCT01403116|156650583|FG000|Overall Study|Protocol Violation|0|||
48671733|NCT01403116|156650584|FG001|Overall Study|Protocol Violation|1|||
48671734|NCT01403116|156650583|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
48671735|NCT01403116|156650584|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
48671736|NCT01403116|156650583|FG000|Overall Study|Hct >54%|2|||
48671737|NCT01403116|156650584|FG001|Overall Study|Hct >54%|0|||
48671738|NCT01403116|156650583|FG000|Overall Study|unable to keep appointments|0|||
48671739|NCT01403116|156650584|FG001|Overall Study|unable to keep appointments|2|||
48671740|NCT01895309|156650585|FG000|Overall Study|Adverse Event|13|||
48671741|NCT01895309|156650586|FG001|Overall Study|Adverse Event|17|||
48671742|NCT01895309|156650585|FG000|Overall Study|Protocol Violation|1|||
48671743|NCT01895309|156650586|FG001|Overall Study|Protocol Violation|0|||
48671744|NCT01895309|156650585|FG000|Overall Study|Lack of Efficacy|1|||
48671745|NCT01895309|156650586|FG001|Overall Study|Lack of Efficacy|3|||
48671746|NCT01895309|156650585|FG000|Overall Study|Lost to Follow-up|1|||
48671747|NCT01895309|156650586|FG001|Overall Study|Lost to Follow-up|3|||
48671748|NCT01895309|156650585|FG000|Overall Study|Physician Decision|15|||
48671749|NCT01895309|156650586|FG001|Overall Study|Physician Decision|10|||
48671750|NCT01895309|156650585|FG000|Overall Study|Withdrawal by Subject|9|||
48671751|NCT01895309|156650586|FG001|Overall Study|Withdrawal by Subject|18|||
48671752|NCT01457846|156650587|FG000|Overall Study|Death before treatment|1|||
48671753|NCT01457846|156650588|FG001|Overall Study|Death before treatment|2|||
48671754|NCT01457846|156650587|FG000|Overall Study|Did not receive treatment|0|||
48671755|NCT01457846|156650588|FG001|Overall Study|Did not receive treatment|1|||
48343646|NCT02499835|155453902|FG003|Overall Study|Physician Decision|7|||
48343647|NCT02499835|155453899|FG000|Overall Study|Adverse Event|0|||
48343648|NCT02499835|155453900|FG001|Overall Study|Adverse Event|0|||
48343649|NCT02499835|155453901|FG002|Overall Study|Adverse Event|0|||
48343650|NCT02499835|155453902|FG003|Overall Study|Adverse Event|1|||
48343651|NCT02499835|155453899|FG000|Overall Study|Disease progression|2|||
48671756|NCT01457846|156650587|FG000|Overall Study|Death|27|||
48671757|NCT01457846|156650588|FG001|Overall Study|Death|16|||
48671758|NCT01457846|156650587|FG000|Overall Study|Unclassified reason for not completed|11|||
48343652|NCT02499835|155453900|FG001|Overall Study|Disease progression|1|||
48343653|NCT02499835|155453901|FG002|Overall Study|Disease progression|0|||
48343654|NCT02499835|155453902|FG003|Overall Study|Disease progression|7|||
48343655|NCT02581189|155453905|FG000|Overall Study|Failure to return|36|||
48343656|NCT02581189|155453905|FG000|Overall Study|Withdrew consent|5|||
48343657|NCT02581189|155453905|FG000|Overall Study|Death|3|||
48343658|NCT02581189|155453905|FG000|Overall Study|Insufficient virological response|2|||
48343659|NCT02581189|155453905|FG000|Overall Study|Other, not specified|7|||
48343660|NCT02986659|155453906|FG000|First Intervention Period|Adverse Event|3|||
48343661|NCT02986659|155453907|FG001|First Intervention Period|Adverse Event|1|||
48343662|NCT02986659|155453906|FG000|First Intervention Period|Lost to Follow-up|1|||
48343663|NCT02986659|155453907|FG001|First Intervention Period|Lost to Follow-up|0|||
48343664|NCT02986659|155453906|FG000|First Intervention Period|Withdrawal by Subject|0|||
48343665|NCT02986659|155453907|FG001|First Intervention Period|Withdrawal by Subject|1|||
48343666|NCT02986659|155453906|FG000|Second Intervention Period|Adverse Event|0|||
48343667|NCT02986659|155453907|FG001|Second Intervention Period|Adverse Event|6|||
48343668|NCT02973477|155453913|FG000|First Intervention|Lost to Follow-up|0|||
48343669|NCT02973477|155453914|FG001|First Intervention|Lost to Follow-up|2|||
48343670|NCT02973477|155453913|FG000|Washout|Withdrawal by Subject|1|||
48343671|NCT02973477|155453914|FG001|Washout|Withdrawal by Subject|0|||
48343672|NCT02973477|155453913|FG000|Second Intervention|Lost to Follow-up|1|||
48671759|NCT01457846|156650588|FG001|Overall Study|Unclassified reason for not completed|10|||
48671760|NCT01457846|156650587|FG000|Overall Study|Withdrawal by Subject|1|||
48671761|NCT01457846|156650588|FG001|Overall Study|Withdrawal by Subject|1|||
48671762|NCT01457846|156650587|FG000|Overall Study|Lost to Follow-up|1|||
48671763|NCT01457846|156650588|FG001|Overall Study|Lost to Follow-up|0|||
48671764|NCT02726022|156650591|FG000|Overall Study|Adverse Event|14|||
48671765|NCT02726022|156650591|FG000|Overall Study|Treatment Failure|8|||
48671766|NCT02726022|156650591|FG000|Overall Study|Poor Compliance|13|||
48671767|NCT02726022|156650591|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
48671768|NCT00760838|156650592|FG000|Overall Study|Adverse Event|1|||
48671769|NCT00760838|156650593|FG001|Overall Study|Adverse Event|1|||
48671770|NCT00760838|156650592|FG000|Overall Study|Lack of Efficacy|1|||
48671771|NCT00760838|156650593|FG001|Overall Study|Lack of Efficacy|0|||
48671772|NCT00760838|156650592|FG000|Overall Study|Lost to Follow-up|2|||
48671773|NCT00760838|156650593|FG001|Overall Study|Lost to Follow-up|0|||
48671774|NCT00760838|156650592|FG000|Overall Study|Withdrawal by Subject|1|||
48671775|NCT00760838|156650593|FG001|Overall Study|Withdrawal by Subject|1|||
48671776|NCT02039856|156650594|FG000|Overall Study|Death|5|||
48671777|NCT02039856|156650595|FG001|Overall Study|Death|3|||
48671778|NCT02039856|156650594|FG000|Overall Study|Partial survey completion|61|||
48671779|NCT02039856|156650595|FG001|Overall Study|Partial survey completion|26|||
48671780|NCT02039856|156650594|FG000|Overall Study|Lost to Follow-up|388|||
48671781|NCT02039856|156650595|FG001|Overall Study|Lost to Follow-up|206|||
48671782|NCT02039856|156650594|FG000|Overall Study|Withdrawal by Subject|1573|||
48671783|NCT02039856|156650595|FG001|Overall Study|Withdrawal by Subject|618|||
48671784|NCT02607228|156650596|FG000|Overall Study|Progressive Disease|4|||
48671785|NCT02607228|156650597|FG001|Overall Study|Progressive Disease|3|||
48671786|NCT02607228|156650598|FG002|Overall Study|Progressive Disease|1|||
48671787|NCT02607228|156650599|FG003|Overall Study|Progressive Disease|5|||
48671788|NCT02607228|156650600|FG004|Overall Study|Progressive Disease|4|||
48671789|NCT02607228|156650601|FG005|Overall Study|Progressive Disease|3|||
48671790|NCT02607228|156650602|FG006|Overall Study|Progressive Disease|1|||
48671791|NCT02607228|156650596|FG000|Overall Study|Adverse Event|1|||
48671792|NCT02607228|156650597|FG001|Overall Study|Adverse Event|0|||
48671793|NCT02607228|156650598|FG002|Overall Study|Adverse Event|1|||
48671794|NCT02607228|156650599|FG003|Overall Study|Adverse Event|0|||
48671795|NCT02607228|156650600|FG004|Overall Study|Adverse Event|1|||
48671796|NCT02607228|156650601|FG005|Overall Study|Adverse Event|1|||
48671797|NCT02607228|156650602|FG006|Overall Study|Adverse Event|1|||
48671798|NCT02607228|156650596|FG000|Overall Study|Investigator's Discretion|0|||
48671799|NCT02607228|156650597|FG001|Overall Study|Investigator's Discretion|0|||
48671800|NCT02607228|156650598|FG002|Overall Study|Investigator's Discretion|1|||
48671801|NCT02607228|156650599|FG003|Overall Study|Investigator's Discretion|0|||
48343673|NCT02973477|155453914|FG001|Second Intervention|Lost to Follow-up|0|||
48343674|NCT01885936|155453915|FG000|Overall Study|Withdrawal by Subject|1|||
48343675|NCT01885936|155453916|FG001|Overall Study|Withdrawal by Subject|0|||
48343676|NCT02853305|155453917|FG000|Overall Study|Death|287|||
48343677|NCT02853305|155453918|FG001|Overall Study|Death|249|||
48671802|NCT02607228|156650600|FG004|Overall Study|Investigator's Discretion|0|||
48671803|NCT02607228|156650601|FG005|Overall Study|Investigator's Discretion|1|||
48671804|NCT02607228|156650602|FG006|Overall Study|Investigator's Discretion|0|||
48671805|NCT02607228|156650596|FG000|Overall Study|Withdrew Consent|0|||
48671806|NCT02607228|156650597|FG001|Overall Study|Withdrew Consent|1|||
48671807|NCT02607228|156650598|FG002|Overall Study|Withdrew Consent|0|||
48671808|NCT02607228|156650599|FG003|Overall Study|Withdrew Consent|0|||
48671809|NCT02607228|156650600|FG004|Overall Study|Withdrew Consent|0|||
48671810|NCT02607228|156650601|FG005|Overall Study|Withdrew Consent|1|||
48671811|NCT02607228|156650602|FG006|Overall Study|Withdrew Consent|0|||
48671812|NCT02607228|156650596|FG000|Overall Study|Study Terminated by Sponsor|0|||
48671813|NCT02607228|156650597|FG001|Overall Study|Study Terminated by Sponsor|0|||
48671814|NCT02607228|156650598|FG002|Overall Study|Study Terminated by Sponsor|0|||
48671815|NCT02607228|156650599|FG003|Overall Study|Study Terminated by Sponsor|1|||
48671816|NCT02607228|156650600|FG004|Overall Study|Study Terminated by Sponsor|0|||
48671817|NCT02607228|156650601|FG005|Overall Study|Study Terminated by Sponsor|0|||
48671818|NCT02607228|156650602|FG006|Overall Study|Study Terminated by Sponsor|0|||
48671819|NCT03235089|156650603|FG000|Overall Study|Lost to Follow-up|1|||
48671820|NCT03235089|156650604|FG001|Overall Study|Lost to Follow-up|1|||
48671821|NCT03235089|156650603|FG000|Overall Study|Physician Decision|2|||
48671822|NCT03235089|156650604|FG001|Overall Study|Physician Decision|2|||
48671823|NCT03238924|156650605|FG000|Overall Study|Withdrawal by Subject|2|||
48671824|NCT03238924|156650606|FG001|Overall Study|Withdrawal by Subject|2|||
48671825|NCT01455194|156650607|FG000|Overall Study|Screen Failure|20|||
48671826|NCT01455194|156650608|FG001|Overall Study|Screen Failure|0|||
48671827|NCT01455194|156650609|FG002|Overall Study|Screen Failure|0|||
48671828|NCT01455194|156650610|FG003|Overall Study|Screen Failure|0|||
48671829|NCT01455194|156650607|FG000|Overall Study|Randomisation Failure|90|||
48671830|NCT01455194|156650608|FG001|Overall Study|Randomisation Failure|0|||
48671831|NCT01455194|156650609|FG002|Overall Study|Randomisation Failure|0|||
48671832|NCT01455194|156650610|FG003|Overall Study|Randomisation Failure|0|||
48671833|NCT01455194|156650607|FG000|Overall Study|Deterioration in asthma|12|||
48671834|NCT01455194|156650608|FG001|Overall Study|Deterioration in asthma|6|||
48671835|NCT01455194|156650609|FG002|Overall Study|Deterioration in asthma|14|||
48671836|NCT01455194|156650610|FG003|Overall Study|Deterioration in asthma|9|||
48343678|NCT02853305|155453919|FG002|Overall Study|Death|300|||
48671837|NCT01455194|156650607|FG000|Overall Study|Adverse Event|1|||
48671838|NCT01455194|156650608|FG001|Overall Study|Adverse Event|1|||
48671839|NCT01455194|156650609|FG002|Overall Study|Adverse Event|1|||
48671840|NCT01455194|156650610|FG003|Overall Study|Adverse Event|3|||
48671841|NCT01455194|156650607|FG000|Overall Study|Withdrawal by Subject|21|||
48671842|NCT01455194|156650608|FG001|Overall Study|Withdrawal by Subject|16|||
48671843|NCT01455194|156650609|FG002|Overall Study|Withdrawal by Subject|12|||
48671844|NCT01455194|156650610|FG003|Overall Study|Withdrawal by Subject|9|||
48671845|NCT01455194|156650607|FG000|Overall Study|Lost to Follow-up|2|||
48671846|NCT01455194|156650608|FG001|Overall Study|Lost to Follow-up|0|||
48671847|NCT01455194|156650609|FG002|Overall Study|Lost to Follow-up|1|||
48671848|NCT01455194|156650610|FG003|Overall Study|Lost to Follow-up|1|||
48671849|NCT01455194|156650607|FG000|Overall Study|Pregnancy|0|||
48671850|NCT01455194|156650608|FG001|Overall Study|Pregnancy|1|||
48671851|NCT01455194|156650609|FG002|Overall Study|Pregnancy|1|||
48671852|NCT01455194|156650610|FG003|Overall Study|Pregnancy|0|||
48671853|NCT01455194|156650607|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
48671854|NCT01455194|156650608|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
48671855|NCT01455194|156650609|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
48671856|NCT01455194|156650610|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
48671857|NCT01455194|156650607|FG000|Overall Study|Miscellaneous|4|||
48671858|NCT01455194|156650608|FG001|Overall Study|Miscellaneous|5|||
48671859|NCT01455194|156650609|FG002|Overall Study|Miscellaneous|1|||
48671860|NCT01455194|156650610|FG003|Overall Study|Miscellaneous|4|||
48671861|NCT03916484|156650611|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
48671862|NCT03916484|156650612|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
48671863|NCT03916484|156650613|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
48671864|NCT03916484|156650614|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
48671865|NCT03916484|156650611|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
48671866|NCT03916484|156650612|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
48671867|NCT03916484|156650613|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
48671868|NCT03916484|156650614|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
48671869|NCT04407234|156650617|FG000|Overall Study|Adverse Event|3|||
48671870|NCT04407234|156650618|FG001|Overall Study|Adverse Event|3|||
48671871|NCT01879072|156650619|FG000|Overall Study|Withdrawal by Subject|121|||
48671872|NCT01879072|156650619|FG000|Overall Study|Not Transplanted|30|||
48343679|NCT02853305|155453917|FG000|Overall Study|Withdrawal by Subject|2|||
48671873|NCT02277119|156650620|FG000|Overall Study|Lack of Efficacy|1|||
48671874|NCT02277119|156650621|FG001|Overall Study|Lack of Efficacy|1|||
48671875|NCT02277119|156650622|FG002|Overall Study|Lack of Efficacy|1|||
48671876|NCT02277119|156650620|FG000|Overall Study|Protocol Violation|2|||
48671877|NCT02277119|156650621|FG001|Overall Study|Protocol Violation|3|||
48671878|NCT02277119|156650622|FG002|Overall Study|Protocol Violation|7|||
48671879|NCT02461745|156650623|FG000|Overall Study|Lack of Efficacy|9|||
48671880|NCT02461745|156650624|FG001|Overall Study|Lack of Efficacy|1|||
48671881|NCT02461745|156650623|FG000|Overall Study|Lost to Follow-up|2|||
48671882|NCT02461745|156650624|FG001|Overall Study|Lost to Follow-up|2|||
48671883|NCT02461745|156650623|FG000|Overall Study|Withdrawal by Subject|3|||
48671884|NCT02461745|156650624|FG001|Overall Study|Withdrawal by Subject|1|||
48671885|NCT03848949|156650625|FG000|Overall Study|Lost to Follow-up|5|||
48671886|NCT03848949|156650626|FG001|Overall Study|Lost to Follow-up|7|||
48671887|NCT00118430|156650629|FG000|Overall Study|Withdrawal by Subject|6|||
48671888|NCT00118430|156650630|FG001|Overall Study|Withdrawal by Subject|2|||
48671889|NCT00118430|156650631|FG002|Overall Study|Withdrawal by Subject|0|||
48671890|NCT00118430|156650629|FG000|Overall Study|Lost to Follow-up|15|||
48671891|NCT00118430|156650630|FG001|Overall Study|Lost to Follow-up|22|||
48671892|NCT00118430|156650631|FG002|Overall Study|Lost to Follow-up|28|||
48671893|NCT01306656|156651726|FG000|Overall Study|Lost to Follow-up|1|||
48671894|NCT01306656|156651727|FG001|Overall Study|Lost to Follow-up|0|||
48671895|NCT01282294|156651731|FG000|Overall Study|Lost to Follow-up|14|||
48671896|NCT01282294|156651731|FG000|Overall Study|Screening failure|1|||
48671897|NCT01282294|156651731|FG000|Overall Study|Adverse Event|1|||
48343680|NCT02853305|155453918|FG001|Overall Study|Withdrawal by Subject|8|||
48343681|NCT02853305|155453919|FG002|Overall Study|Withdrawal by Subject|3|||
48343682|NCT02853305|155453917|FG000|Overall Study|Transferred to Extension Study|46|||
48343683|NCT02853305|155453918|FG001|Overall Study|Transferred to Extension Study|30|||
48343684|NCT02853305|155453919|FG002|Overall Study|Transferred to Extension Study|25|||
48343685|NCT02853305|155453917|FG000|Overall Study|Did Not Continue on Extension Study|16|||
48343686|NCT02853305|155453918|FG001|Overall Study|Did Not Continue on Extension Study|20|||
48343687|NCT02853305|155453919|FG002|Overall Study|Did Not Continue on Extension Study|24|||
48343688|NCT01093222|155453923|FG000|Overall Study|Ineligible|6|||
48343689|NCT01093222|155453923|FG000|Overall Study|Adverse Event|7|||
48343690|NCT01093222|155453923|FG000|Overall Study|Progression/relapse|24|||
48343691|NCT01093222|155453923|FG000|Overall Study|Death|2|||
48343692|NCT01093222|155453923|FG000|Overall Study|Not protocol specified|1|||
48343693|NCT01281917|155453926|FG000|Overall Study|Withdrawal by Subject|1|||
48671898|NCT01282294|156651731|FG000|Overall Study|Patient non-compliance|2|||
48671899|NCT01282294|156651731|FG000|Overall Study|Physician Decision|1|||
48671900|NCT00701805|156651732|FG000|Overall Study|Withdrawal by Subject|3|||
48671901|NCT00701805|156651733|FG001|Overall Study|Withdrawal by Subject|1|||
48671902|NCT00701805|156651734|FG002|Overall Study|Withdrawal by Subject|4|||
48671903|NCT00701805|156651735|FG003|Overall Study|Withdrawal by Subject|3|||
48671904|NCT00701805|156651732|FG000|Overall Study|Adverse Event|0|||
48671905|NCT00701805|156651733|FG001|Overall Study|Adverse Event|1|||
48671906|NCT00701805|156651734|FG002|Overall Study|Adverse Event|1|||
48671907|NCT00701805|156651735|FG003|Overall Study|Adverse Event|0|||
48671908|NCT00701805|156651732|FG000|Overall Study|Missed 7 consecutive doses|0|||
48671909|NCT00701805|156651733|FG001|Overall Study|Missed 7 consecutive doses|1|||
48671910|NCT00701805|156651734|FG002|Overall Study|Missed 7 consecutive doses|0|||
48671911|NCT00701805|156651735|FG003|Overall Study|Missed 7 consecutive doses|0|||
48671912|NCT00701805|156651732|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
48671913|NCT00701805|156651733|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
48671914|NCT00701805|156651734|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
48671915|NCT00701805|156651735|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
48671916|NCT00701805|156651732|FG000|Overall Study|Physician decision, change of therapy|0|||
48671917|NCT00701805|156651733|FG001|Overall Study|Physician decision, change of therapy|0|||
48671918|NCT00701805|156651734|FG002|Overall Study|Physician decision, change of therapy|0|||
48671919|NCT00701805|156651735|FG003|Overall Study|Physician decision, change of therapy|1|||
48671920|NCT00701805|156651732|FG000|Overall Study|Difficult to travel to dialysis site|0|||
48671921|NCT00701805|156651733|FG001|Overall Study|Difficult to travel to dialysis site|0|||
48671922|NCT00701805|156651734|FG002|Overall Study|Difficult to travel to dialysis site|1|||
48343694|NCT03260894|155453931|FG000|Overall Study|Death|6|||
48671923|NCT00701805|156651735|FG003|Overall Study|Difficult to travel to dialysis site|0|||
48671924|NCT00701805|156651732|FG000|Overall Study|Resumption criteria were not met|0|||
48671925|NCT00701805|156651733|FG001|Overall Study|Resumption criteria were not met|1|||
48671926|NCT00701805|156651734|FG002|Overall Study|Resumption criteria were not met|0|||
48671927|NCT00701805|156651735|FG003|Overall Study|Resumption criteria were not met|0|||
48671928|NCT03769311|156651737|FG000|Overall Study|Withdrawal by Subject|1|||
48671929|NCT00881504|156651738|FG000|Overall Study|Withdrawal by Subject|1|||
48671930|NCT00007020|156651739|FG000|Overall Study|Death|16|||
48671931|NCT00007020|156651739|FG000|Overall Study|Lost to Follow-up|13|||
48671932|NCT00007020|156651739|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
48671933|NCT00007020|156651739|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
48671934|NCT00007020|156651739|FG000|Overall Study|Pt cared for by outside physician|4|||
48671935|NCT00007020|156651739|FG000|Overall Study|No evidence of treatment|6|||
48671936|NCT01571232|156651740|FG000|Overall Study|Lost to Follow-up|0|||
48671937|NCT01571232|156651741|FG001|Overall Study|Lost to Follow-up|1|||
48343695|NCT03260894|155453932|FG001|Overall Study|Death|8|||
48343696|NCT03260894|155453931|FG000|Overall Study|Withdrawal by Subject|4|||
48343697|NCT03260894|155453932|FG001|Overall Study|Withdrawal by Subject|11|||
48343698|NCT03260894|155453931|FG000|Overall Study|On-going at clinical cut off date|36|||
48671938|NCT01571232|156651740|FG000|Overall Study|Withdrawal by Subject|1|||
48671939|NCT01571232|156651741|FG001|Overall Study|Withdrawal by Subject|0|||
48671940|NCT01751139|156651742|FG000|Overall Study|Other|135|||
48671941|NCT01751139|156651742|FG000|Overall Study|Sponsor study termination|1609|||
48343699|NCT03260894|155453932|FG001|Overall Study|On-going at clinical cut off date|31|||
48671942|NCT01751139|156651742|FG000|Overall Study|Lost to Follow-up|240|||
48671943|NCT01751139|156651742|FG000|Overall Study|Withdrawal by Subject|251|||
48671944|NCT01751139|156651742|FG000|Overall Study|Adverse Event|1|||
48671945|NCT01751139|156651742|FG000|Overall Study|Death|31|||
48671946|NCT01266317|156651743|FG000|Overall Study|Withdrawal by Subject|2|||
48671947|NCT01867086|156651744|FG000|Overall Study|Disease Progression|1|||
48671948|NCT01657760|156651747|FG000|Overall Study|Withdrawal by Subject|0|||
48671949|NCT01657760|156651748|FG001|Overall Study|Withdrawal by Subject|0|||
48760754|NCT03045887|156972300|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760755|NCT03045887|156972301|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760756|NCT03045887|156972302|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760757|NCT03045887|156972303|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
48343700|NCT02864147|155453933|FG000|Overall Study|Withdrawal by Subject|3|||
48343701|NCT02864147|155453934|FG001|Overall Study|Withdrawal by Subject|2|||
48343702|NCT02864147|155453935|FG002|Overall Study|Withdrawal by Subject|1|||
48343703|NCT02864147|155453933|FG000|Overall Study|Lost to Follow-up|0|||
48343704|NCT02864147|155453934|FG001|Overall Study|Lost to Follow-up|4|||
48343705|NCT02864147|155453935|FG002|Overall Study|Lost to Follow-up|0|||
48343706|NCT02864147|155453933|FG000|Overall Study|Adverse Event|0|||
48343707|NCT02864147|155453934|FG001|Overall Study|Adverse Event|1|||
48343708|NCT02864147|155453935|FG002|Overall Study|Adverse Event|0|||
48343709|NCT02864147|155453933|FG000|Overall Study|Pregnancy|4|||
48343710|NCT02864147|155453934|FG001|Overall Study|Pregnancy|0|||
48343711|NCT02864147|155453935|FG002|Overall Study|Pregnancy|0|||
48343712|NCT02864147|155453933|FG000|Overall Study|Physician Decision|0|||
48343713|NCT02864147|155453934|FG001|Overall Study|Physician Decision|0|||
48343714|NCT02864147|155453935|FG002|Overall Study|Physician Decision|1|||
48343715|NCT02864147|155453933|FG000|Overall Study|Opted for excisional procedures|0|||
48343716|NCT02864147|155453934|FG001|Overall Study|Opted for excisional procedures|0|||
48343717|NCT02864147|155453935|FG002|Overall Study|Opted for excisional procedures|3|||
48343718|NCT00312845|155453936|FG000|Overall Study|Adverse Event|19|||
48343719|NCT00312845|155453937|FG001|Overall Study|Adverse Event|5|||
48343720|NCT00312845|155453936|FG000|Overall Study|Death|2|||
48343721|NCT00312845|155453937|FG001|Overall Study|Death|2|||
48343722|NCT00312845|155453936|FG000|Overall Study|Withdrawal by Subject|14|||
48343723|NCT00312845|155453937|FG001|Overall Study|Withdrawal by Subject|6|||
48343724|NCT00312845|155453936|FG000|Overall Study|Disease Progression|56|||
48343725|NCT00312845|155453937|FG001|Overall Study|Disease Progression|77|||
48343726|NCT00312845|155453936|FG000|Overall Study|Lost to Follow-up|2|||
48343727|NCT00312845|155453937|FG001|Overall Study|Lost to Follow-up|0|||
48343728|NCT00312845|155453936|FG000|Overall Study|Other|6|||
48343729|NCT00312845|155453937|FG001|Overall Study|Other|5|||
48343730|NCT03015181|155453938|FG000|Overall Study|Enrolled, but product never administered|1|||
48343731|NCT03015181|155453939|FG001|Overall Study|Enrolled, but product never administered|0|||
48343732|NCT03015181|155453940|FG002|Overall Study|Enrolled, but product never administered|0|||
48343733|NCT03015181|155453941|FG003|Overall Study|Enrolled, but product never administered|0|||
48343734|NCT03015181|155453942|FG004|Overall Study|Enrolled, but product never administered|0|||
48343735|NCT03015181|155453943|FG005|Overall Study|Enrolled, but product never administered|0|||
48343736|NCT03015181|155453944|FG006|Overall Study|Enrolled, but product never administered|0|||
48343737|NCT03015181|155453938|FG000|Overall Study|Withdrawal by Subject|0|||
48343738|NCT03015181|155453939|FG001|Overall Study|Withdrawal by Subject|0|||
48343739|NCT03015181|155453940|FG002|Overall Study|Withdrawal by Subject|0|||
48671950|NCT01657760|156651749|FG002|Overall Study|Withdrawal by Subject|0|||
48671951|NCT01657760|156651750|FG003|Overall Study|Withdrawal by Subject|1|||
48671952|NCT01657760|156651747|FG000|Overall Study|Physician Decision|1|||
48671953|NCT01657760|156651748|FG001|Overall Study|Physician Decision|1|||
48671954|NCT01657760|156651749|FG002|Overall Study|Physician Decision|1|||
48671955|NCT01657760|156651750|FG003|Overall Study|Physician Decision|2|||
48671956|NCT02704689|156651753|FG000|Overall Study|Physician Decision|1|||
48671957|NCT02704689|156651753|FG000|Overall Study|Study device not implanted|2|||
48760758|NCT03045887|156972304|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48343740|NCT03015181|155453941|FG003|Overall Study|Withdrawal by Subject|0|||
48343741|NCT03015181|155453942|FG004|Overall Study|Withdrawal by Subject|0|||
48343742|NCT03015181|155453943|FG005|Overall Study|Withdrawal by Subject|1|||
48343743|NCT03015181|155453944|FG006|Overall Study|Withdrawal by Subject|0|||
48343744|NCT03015181|155453938|FG000|Overall Study|Physician Decision|0|||
48343745|NCT03015181|155453939|FG001|Overall Study|Physician Decision|0|||
48343746|NCT03015181|155453940|FG002|Overall Study|Physician Decision|0|||
48343747|NCT03015181|155453941|FG003|Overall Study|Physician Decision|0|||
48343748|NCT03015181|155453942|FG004|Overall Study|Physician Decision|0|||
48343749|NCT03015181|155453943|FG005|Overall Study|Physician Decision|0|||
48671958|NCT03908476|156651759|FG000|Overall Study|Death|3|||
48671959|NCT03908476|156651760|FG001|Overall Study|Death|0|||
48671960|NCT03908476|156651759|FG000|Overall Study|Lost to Follow-up|3|||
48671961|NCT03908476|156651760|FG001|Overall Study|Lost to Follow-up|1|||
48671962|NCT03908476|156651759|FG000|Overall Study|Withdrawal by Subject|7|||
48671963|NCT03908476|156651760|FG001|Overall Study|Withdrawal by Subject|1|||
48671964|NCT03908476|156651759|FG000|Overall Study|Physician Decision|2|||
48671965|NCT03908476|156651760|FG001|Overall Study|Physician Decision|0|||
48671966|NCT03908476|156651759|FG000|Overall Study|System Explanted and not Replaced|4|||
48671967|NCT03908476|156651760|FG001|Overall Study|System Explanted and not Replaced|0|||
48671968|NCT03908476|156651759|FG000|Overall Study|Intrathecal Pump|1|||
48671969|NCT03908476|156651760|FG001|Overall Study|Intrathecal Pump|0|||
48671970|NCT03908476|156651759|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
48671971|NCT03908476|156651760|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
48671972|NCT02936284|156651766|FG000|Overall Study|Withdrawal by Subject|3|||
48671973|NCT02936284|156651767|FG001|Overall Study|Withdrawal by Subject|1|||
48671974|NCT02936284|156651766|FG000|Overall Study|Lost to Follow-up|7|||
48671975|NCT02936284|156651767|FG001|Overall Study|Lost to Follow-up|8|||
48671976|NCT00799591|156651768|FG000|Overall Study|De-escalation of doses|20|||
48671977|NCT00799591|156651768|FG000|Overall Study|Death|14|||
48671978|NCT00799591|156651768|FG000|Overall Study|Technical failure|12|||
48671979|NCT00799591|156651768|FG000|Overall Study|Resistant germ|11|||
48671980|NCT00799591|156651768|FG000|Overall Study|New infection|4|||
48671981|NCT00799591|156651768|FG000|Overall Study|Resistance germ and technical failure|2|||
48671982|NCT00799591|156651768|FG000|Overall Study|Persistance of fever undetermined origin|1|||
48671983|NCT00799591|156651768|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
48671984|NCT00799591|156651768|FG000|Overall Study|Infectious origin not probable|1|||
48671985|NCT03194438|156651771|FG000|Overall Study|Withdrawal by Subject|2|||
48671986|NCT01146288|156651775|FG000|First Intervention(1 Day)|Adverse Event|0|||
48671987|NCT01146288|156651776|FG001|First Intervention(1 Day)|Adverse Event|1|||
48671988|NCT00483041|156651780|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
48671989|NCT00483041|156651781|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
48671990|NCT01110382|156651783|FG000|Overall Study|Withdrawal by Subject|0|||
48671991|NCT01110382|156651784|FG001|Overall Study|Withdrawal by Subject|1|||
48671992|NCT01110382|156651783|FG000|Overall Study|Protocol Violation|0|||
48671993|NCT01110382|156651784|FG001|Overall Study|Protocol Violation|1|||
48671994|NCT03743064|156651793|FG000|Overall Study|Adverse Event|7|||
48671995|NCT03743064|156651794|FG001|Overall Study|Adverse Event|9|||
48671996|NCT03743064|156651793|FG000|Overall Study|Death|25|||
48671997|NCT03743064|156651794|FG001|Overall Study|Death|28|||
48671998|NCT03743064|156651793|FG000|Overall Study|Lost to Follow-up|3|||
48671999|NCT03743064|156651794|FG001|Overall Study|Lost to Follow-up|6|||
48672000|NCT03743064|156651793|FG000|Overall Study|Withdrawal by Subject|28|||
48672001|NCT03743064|156651794|FG001|Overall Study|Withdrawal by Subject|25|||
48672002|NCT03743064|156651793|FG000|Overall Study|Physician Decision|2|||
48672003|NCT03743064|156651794|FG001|Overall Study|Physician Decision|4|||
48672004|NCT03743064|156651793|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
48672005|NCT03743064|156651794|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
48672006|NCT01423916|156651797|FG000|Overall Study|Adverse Event|5|||
48672007|NCT01423916|156651798|FG001|Overall Study|Adverse Event|9|||
48672008|NCT01423916|156651799|FG002|Overall Study|Adverse Event|2|||
48672009|NCT01423916|156651797|FG000|Overall Study|Met Withdrawal Criteria|1|||
48672010|NCT01423916|156651798|FG001|Overall Study|Met Withdrawal Criteria|1|||
48672011|NCT01423916|156651799|FG002|Overall Study|Met Withdrawal Criteria|1|||
48672012|NCT01423916|156651797|FG000|Overall Study|Physician Decision|1|||
48672013|NCT01423916|156651798|FG001|Overall Study|Physician Decision|0|||
48672014|NCT01423916|156651799|FG002|Overall Study|Physician Decision|1|||
48672015|NCT01423916|156651797|FG000|Overall Study|Withdrawal by Subject|3|||
48672016|NCT01423916|156651798|FG001|Overall Study|Withdrawal by Subject|10|||
48672017|NCT01423916|156651799|FG002|Overall Study|Withdrawal by Subject|3|||
48672018|NCT01423916|156651797|FG000|Overall Study|Protocol Deviation|1|||
48672019|NCT01423916|156651798|FG001|Overall Study|Protocol Deviation|0|||
48672020|NCT01423916|156651799|FG002|Overall Study|Protocol Deviation|0|||
48672021|NCT02553538|156651802|FG000|Overall Study|Could Not Reach by Telephone|133|||
48672022|NCT02553538|156651803|FG001|Overall Study|Could Not Reach by Telephone|0|||
48672023|NCT02553538|156651802|FG000|Overall Study|Died or Left Network|54|||
48672024|NCT02553538|156651803|FG001|Overall Study|Died or Left Network|56|||
48672025|NCT03316950|156651806|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
48672026|NCT03316950|156651807|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
48672027|NCT03316950|156651808|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
48672028|NCT03316950|156651809|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
48672029|NCT03316950|156651806|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
48672030|NCT03316950|156651807|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
48672031|NCT03316950|156651808|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
48672032|NCT03316950|156651809|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
48672033|NCT03316950|156651806|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
48672034|NCT03316950|156651807|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
48672035|NCT03316950|156651808|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
48672036|NCT03316950|156651809|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
48672037|NCT01406015|156651810|FG000|Overall Study|Withdrawal by Subject|3|||
48672038|NCT01406015|156651811|FG001|Overall Study|Withdrawal by Subject|3|||
48672039|NCT00576472|156651821|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672040|NCT00576472|156651822|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672041|NCT00576472|156651823|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672042|NCT00576472|156651824|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
48672043|NCT00576472|156651825|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672044|NCT00576472|156651826|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672045|NCT00576472|156651827|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672046|NCT00576472|156651828|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672047|NCT00576472|156651829|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672048|NCT00576472|156651830|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672049|NCT00576472|156651831|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672050|NCT00576472|156651832|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672051|NCT00576472|156651833|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672052|NCT00576472|156651834|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672053|NCT00576472|156651835|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
48672054|NCT00576472|156651821|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
48672055|NCT00576472|156651822|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
48672056|NCT00576472|156651823|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
48672057|NCT00576472|156651824|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
48672058|NCT00576472|156651825|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
48672059|NCT00576472|156651826|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
48672060|NCT00576472|156651827|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
48672061|NCT00576472|156651828|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
48672062|NCT00576472|156651829|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
48672063|NCT00576472|156651830|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
48672064|NCT00576472|156651831|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
48672065|NCT00576472|156651832|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
48672066|NCT00576472|156651833|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
48672067|NCT00576472|156651834|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
48672068|NCT00576472|156651835|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
48672069|NCT00576472|156651821|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672070|NCT00576472|156651822|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672071|NCT00576472|156651823|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672072|NCT00576472|156651824|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
48672073|NCT00576472|156651825|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672074|NCT00576472|156651826|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672075|NCT00576472|156651827|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672076|NCT00576472|156651828|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672077|NCT00576472|156651829|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672078|NCT00576472|156651830|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672079|NCT00576472|156651831|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672080|NCT00576472|156651832|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672081|NCT00576472|156651833|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672082|NCT00576472|156651834|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672083|NCT00576472|156651835|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
48672084|NCT00576472|156651821|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
48672085|NCT00576472|156651822|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
48672086|NCT00576472|156651823|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
48672087|NCT00576472|156651824|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
48672088|NCT00576472|156651825|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
48760759|NCT03045887|156972305|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760760|NCT03045887|156972306|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760761|NCT03045887|156972307|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760762|NCT03045887|156972308|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48343750|NCT03015181|155453944|FG006|Overall Study|Physician Decision|1|||
48343751|NCT03900715|155453945|FG000|Overall Study|Protocol Deviation|1|||
48343752|NCT03900715|155453945|FG000|Overall Study|Lack of Efficacy|1|||
48760763|NCT03045887|156972309|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48760764|NCT01290666|156972310|FG000|Overall Study|Lost to Follow-up|11|||
48760765|NCT01290666|156972310|FG000|Overall Study|Withdrawal by Subject|23|||
48760766|NCT01290666|156972310|FG000|Overall Study|Early Termination of Study|4|||
48760767|NCT00464568|156972311|FG000|Overall Study|Adverse Event|2|||
48760768|NCT03318315|156972317|FG000|Overall Study|Lost to Follow-up|3|||
48760769|NCT03318315|156972318|FG001|Overall Study|Lost to Follow-up|2|||
48343753|NCT03900715|155453945|FG000|Overall Study|Progressive Disease|6|||
48343754|NCT03900715|155453945|FG000|Overall Study|Adverse Event|2|||
48672089|NCT00576472|156651826|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
48672090|NCT00576472|156651827|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
48672091|NCT00576472|156651828|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
48672092|NCT00576472|156651829|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
48672093|NCT00576472|156651830|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
48760770|NCT03318315|156972319|FG002|Overall Study|Lost to Follow-up|1|||
48760771|NCT03318315|156972317|FG000|Overall Study|Protocol Violation|1|||
48343755|NCT03900715|155453945|FG000|Overall Study|Other reasons|11|||
48343756|NCT01123642|155455387|FG000|Overall Study|Lost to Follow-up|23|||
48343757|NCT01123642|155455387|FG000|Overall Study|Withdrawal by Subject|9|||
48343758|NCT01123642|155455387|FG000|Overall Study|ineligible at baseline assessment|36|||
48343759|NCT00088452|155455388|FG000|Overall Study|Did not receive intervention|1|||
48343760|NCT00088452|155455389|FG001|Overall Study|Did not receive intervention|0|||
48343761|NCT00088452|155455390|FG002|Overall Study|Did not receive intervention|1|||
48343762|NCT00143598|155455392|FG000|Overall Study|Lost to Follow-up|23|||
48343763|NCT00143598|155455393|FG001|Overall Study|Lost to Follow-up|21|||
48343764|NCT00143598|155455392|FG000|Overall Study|Withdrawal by Subject|33|||
48343765|NCT00143598|155455393|FG001|Overall Study|Withdrawal by Subject|37|||
48343766|NCT00143598|155455392|FG000|Overall Study|Death|36|||
48343767|NCT00143598|155455393|FG001|Overall Study|Death|36|||
48343768|NCT01589523|155455395|FG000|Overall Study|Withdrawal by Subject|1|||
48343769|NCT01191697|155455404|FG000|Overall Study|Death|1|||
48343770|NCT01191697|155455404|FG000|Overall Study|Physician Decision|2|||
48343771|NCT01191697|155455404|FG000|Overall Study|Pursue chemoradiation|2|||
48343772|NCT01191697|155455404|FG000|Overall Study|Break from chemotherapy|2|||
48343773|NCT01191697|155455404|FG000|Overall Study|Withdrawal by Subject|1|||
48343774|NCT01191697|155455404|FG000|Overall Study|Surveillance|1|||
48343775|NCT01191697|155455404|FG000|Overall Study|Adverse Event|2|||
48343776|NCT01191697|155455404|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
48343777|NCT01191697|155455404|FG000|Overall Study|Not completed but analyzed|25|||
48343778|NCT05060237|155455406|FG000|Overall Study|Withdrawal by Subject|4|||
48343779|NCT05060237|155455406|FG000|Overall Study|Screening failure|8|||
48343780|NCT00265096|155455411|FG000|Overall Study|Adverse Event|14|||
48343781|NCT00265096|155455412|FG001|Overall Study|Adverse Event|18|||
48343782|NCT00265096|155455413|FG002|Overall Study|Adverse Event|18|||
48343783|NCT00265096|155455411|FG000|Overall Study|Lost to Follow-up|2|||
48343784|NCT00265096|155455412|FG001|Overall Study|Lost to Follow-up|5|||
48343785|NCT00265096|155455413|FG002|Overall Study|Lost to Follow-up|3|||
48343786|NCT00265096|155455411|FG000|Overall Study|Death|0|||
48343787|NCT00265096|155455412|FG001|Overall Study|Death|1|||
48343788|NCT00265096|155455413|FG002|Overall Study|Death|2|||
48343789|NCT00265096|155455411|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
48343790|NCT00265096|155455412|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48343791|NCT00265096|155455413|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
48343792|NCT00265096|155455411|FG000|Overall Study|Other|11|||
48343793|NCT00265096|155455412|FG001|Overall Study|Other|19|||
48343794|NCT00265096|155455413|FG002|Overall Study|Other|10|||
48343795|NCT03022045|155455414|FG000|Overall Study|Adverse Event|0|||
48343796|NCT03022045|155455415|FG001|Overall Study|Adverse Event|1|||
48343797|NCT03022045|155455414|FG000|Overall Study|Withdrawal by Subject|1|||
48343798|NCT03022045|155455415|FG001|Overall Study|Withdrawal by Subject|1|||
48343799|NCT03972137|155455416|FG000|Overall Study|Lost to Follow-up|2|||
48343800|NCT03972137|155455416|FG000|Overall Study|Withdrawal by Subject|4|||
48343801|NCT03220776|155455417|FG000|Overall Study|Claustrophobia|0|||
48343802|NCT03220776|155455418|FG001|Overall Study|Claustrophobia|1|||
48343803|NCT03220776|155455419|FG002|Overall Study|Claustrophobia|1|||
48343804|NCT03220776|155455420|FG003|Overall Study|Claustrophobia|0|||
48343805|NCT03220776|155455421|FG004|Overall Study|Claustrophobia|1|||
48343806|NCT03220776|155455422|FG005|Overall Study|Claustrophobia|0|||
48343807|NCT03220776|155455417|FG000|Overall Study|MRI Equipment Failure|1|||
48343808|NCT03220776|155455418|FG001|Overall Study|MRI Equipment Failure|0|||
48343809|NCT03220776|155455419|FG002|Overall Study|MRI Equipment Failure|0|||
48343810|NCT03220776|155455420|FG003|Overall Study|MRI Equipment Failure|0|||
48343811|NCT03220776|155455421|FG004|Overall Study|MRI Equipment Failure|0|||
48343812|NCT03220776|155455422|FG005|Overall Study|MRI Equipment Failure|0|||
48343813|NCT03220776|155455417|FG000|Overall Study|Inclimate Weather|0|||
48343814|NCT03220776|155455418|FG001|Overall Study|Inclimate Weather|0|||
48343815|NCT03220776|155455419|FG002|Overall Study|Inclimate Weather|0|||
48343816|NCT03220776|155455420|FG003|Overall Study|Inclimate Weather|0|||
48672094|NCT00576472|156651831|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
48672095|NCT00576472|156651832|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
48672096|NCT00576472|156651833|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
48672097|NCT00576472|156651834|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
48672098|NCT00576472|156651835|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
48672099|NCT00576472|156651821|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672100|NCT00576472|156651822|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672101|NCT00576472|156651823|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672102|NCT00576472|156651824|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
48672103|NCT00576472|156651825|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
48343817|NCT03220776|155455421|FG004|Overall Study|Inclimate Weather|0|||
48343818|NCT03220776|155455422|FG005|Overall Study|Inclimate Weather|1|||
48343819|NCT03220776|155455417|FG000|Overall Study|Physician Decision|0|||
48672104|NCT00576472|156651826|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672105|NCT00576472|156651827|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
48343820|NCT03220776|155455418|FG001|Overall Study|Physician Decision|0|||
48672106|NCT00576472|156651828|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672107|NCT00576472|156651829|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
48343821|NCT03220776|155455419|FG002|Overall Study|Physician Decision|0|||
48343822|NCT03220776|155455420|FG003|Overall Study|Physician Decision|1|||
48343823|NCT03220776|155455421|FG004|Overall Study|Physician Decision|0|||
48343824|NCT03220776|155455422|FG005|Overall Study|Physician Decision|0|||
48343825|NCT03220776|155455417|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48343826|NCT03220776|155455418|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48343827|NCT03220776|155455419|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48343828|NCT03220776|155455420|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
48429286|NCT01958671|155760338|FG001|Overall Study|Participant moved|0|||
48343829|NCT03220776|155455421|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48343830|NCT03220776|155455422|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
48343831|NCT03220776|155455417|FG000|Overall Study|Protocol Violation|0|||
48343832|NCT03220776|155455418|FG001|Overall Study|Protocol Violation|0|||
48343833|NCT03220776|155455419|FG002|Overall Study|Protocol Violation|0|||
48343834|NCT03220776|155455420|FG003|Overall Study|Protocol Violation|2|||
48343835|NCT03220776|155455421|FG004|Overall Study|Protocol Violation|0|||
48343836|NCT03220776|155455422|FG005|Overall Study|Protocol Violation|1|||
48343837|NCT03220776|155455417|FG000|Overall Study|Withdrawal by Subject|1|||
48343838|NCT03220776|155455418|FG001|Overall Study|Withdrawal by Subject|0|||
48343839|NCT03220776|155455419|FG002|Overall Study|Withdrawal by Subject|0|||
48343840|NCT03220776|155455420|FG003|Overall Study|Withdrawal by Subject|0|||
48343841|NCT03220776|155455421|FG004|Overall Study|Withdrawal by Subject|0|||
48343842|NCT03220776|155455422|FG005|Overall Study|Withdrawal by Subject|0|||
48343843|NCT03226353|155455423|FG000|Overall Study|Withdrawal by Subject|1|||
48343844|NCT03226353|155455423|FG000|Overall Study|Screen Failure|5|||
48343845|NCT00498433|155455424|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
48343846|NCT00498433|155455425|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
48343847|NCT00498433|155455426|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
48343848|NCT00498433|155455424|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
48343849|NCT00498433|155455425|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
48343850|NCT00498433|155455426|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
48343851|NCT00498433|155455424|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
48343852|NCT00498433|155455425|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
48343853|NCT00498433|155455426|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
48343854|NCT00498433|155455424|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
48343855|NCT00498433|155455425|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
48343856|NCT00498433|155455426|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
48343857|NCT00744796|155455428|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
48343858|NCT05372913|155455429|FG000|Overall Study|Withdrawal by Subject|0|||
48343859|NCT05372913|155455430|FG001|Overall Study|Withdrawal by Subject|2|||
48343860|NCT05372913|155455429|FG000|Overall Study|Protocol Violation|2|||
48343861|NCT05372913|155455430|FG001|Overall Study|Protocol Violation|2|||
48343862|NCT05372913|155455429|FG000|Overall Study|Adverse Event|0|||
48343863|NCT05372913|155455430|FG001|Overall Study|Adverse Event|1|||
48343864|NCT03193216|155455431|FG000|Overall Study|Lost to Follow-up|1|||
48343865|NCT03193216|155455432|FG001|Overall Study|Lost to Follow-up|0|||
48343866|NCT03193216|155455431|FG000|Overall Study|Withdrawal by Subject|5|||
48343867|NCT03193216|155455432|FG001|Overall Study|Withdrawal by Subject|0|||
48343868|NCT03193216|155455431|FG000|Overall Study|Physician Decision|4|||
48343869|NCT03193216|155455432|FG001|Overall Study|Physician Decision|0|||
48343870|NCT03275402|155455433|FG000|Overall Study|Death|17|||
48343871|NCT03275402|155455433|FG000|Overall Study|Study terminated by sponsor|21|||
48343872|NCT03275402|155455433|FG000|Overall Study|Withdrawal by Subject|1|||
48343873|NCT05135156|155455434|FG000|Overall Study|Lost to Follow-up|0|||
48343874|NCT05135156|155455435|FG001|Overall Study|Lost to Follow-up|0|||
48343875|NCT05135156|155455436|FG002|Overall Study|Lost to Follow-up|2|||
48343876|NCT01797705|155455437|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
48343877|NCT01797705|155455437|FG000|Overall Study|Withdrawal by Subject|1|||
48672108|NCT00576472|156651830|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672109|NCT00576472|156651831|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672110|NCT00576472|156651832|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672111|NCT00576472|156651833|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
48343878|NCT02512861|155455441|FG000|Overall Study|Protocol Violation|3|||
48343879|NCT02512861|155455442|FG001|Overall Study|Protocol Violation|7|||
48343880|NCT02512861|155455441|FG000|Overall Study|Physician Decision|3|||
48343881|NCT02512861|155455442|FG001|Overall Study|Physician Decision|1|||
48343882|NCT02512861|155455441|FG000|Overall Study|Withdrawal by Subject|0|||
48343883|NCT02512861|155455442|FG001|Overall Study|Withdrawal by Subject|1|||
48672112|NCT00576472|156651834|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672113|NCT00576472|156651835|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
48672114|NCT00576472|156651821|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672115|NCT00576472|156651822|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
48343884|NCT00922441|155455445|FG000|Overall Study|Protocol Violation|0|||
48343885|NCT00922441|155455446|FG001|Overall Study|Protocol Violation|0|||
48343886|NCT00922441|155455447|FG002|Overall Study|Protocol Violation|2|||
48343887|NCT00922441|155455445|FG000|Overall Study|Withdrawal by Subject|0|||
48343888|NCT00922441|155455446|FG001|Overall Study|Withdrawal by Subject|0|||
48343889|NCT00922441|155455447|FG002|Overall Study|Withdrawal by Subject|1|||
48343890|NCT00797511|155455449|FG000|Overall Study|Withdrawal by Subject|1|||
48343891|NCT01388478|155455450|FG000|Overall Study|Adverse Event|4|||
48343892|NCT01388478|155455450|FG000|Overall Study|Withdrawal by Subject|1|||
48343893|NCT02621047|155455451|FG000|Overall Study|Adverse Event|0|||
48672116|NCT00576472|156651823|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672117|NCT00576472|156651824|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
48343894|NCT02621047|155455452|FG001|Overall Study|Adverse Event|0|||
48672118|NCT00576472|156651825|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672119|NCT00576472|156651826|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672120|NCT00576472|156651827|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
48672121|NCT00576472|156651828|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672122|NCT00576472|156651829|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672123|NCT00576472|156651830|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672124|NCT00576472|156651831|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672125|NCT00576472|156651832|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672126|NCT00576472|156651833|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672127|NCT00576472|156651834|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672128|NCT00576472|156651835|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
48672129|NCT00576472|156651821|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
48672130|NCT00576472|156651822|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
48672131|NCT00576472|156651823|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
48672132|NCT00576472|156651824|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
48672133|NCT00576472|156651825|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
48672134|NCT00576472|156651826|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
48672135|NCT00576472|156651827|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
48672136|NCT00576472|156651828|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
48343895|NCT02621047|155455453|FG002|Overall Study|Adverse Event|1|||
48343896|NCT01990664|155455454|FG000|Overall Study|Lost to Follow-up|2|||
48343897|NCT01990664|155455455|FG001|Overall Study|Lost to Follow-up|6|||
48343898|NCT01990664|155455454|FG000|Overall Study|Withdrawal by Subject|2|||
48343899|NCT01990664|155455455|FG001|Overall Study|Withdrawal by Subject|3|||
48343900|NCT01990664|155455454|FG000|Overall Study|Protocol Violation|1|||
48343901|NCT01990664|155455455|FG001|Overall Study|Protocol Violation|0|||
48343902|NCT01990664|155455454|FG000|Overall Study|Lens Discomfort|1|||
48343903|NCT01990664|155455455|FG001|Overall Study|Lens Discomfort|1|||
48343904|NCT01990664|155455454|FG000|Overall Study|Lens Handling Difficulties|1|||
48343905|NCT01990664|155455455|FG001|Overall Study|Lens Handling Difficulties|0|||
48343906|NCT01990664|155455454|FG000|Overall Study|Unsatisfactory Visual Response|0|||
48343907|NCT01990664|155455455|FG001|Overall Study|Unsatisfactory Visual Response|1|||
48343908|NCT02381652|155455462|FG000|Overall Study|Withdrawal by Subject|0|||
48343909|NCT02381652|155455463|FG001|Overall Study|Withdrawal by Subject|0|||
48343910|NCT02381652|155455464|FG002|Overall Study|Withdrawal by Subject|1|||
48343911|NCT05012397|155455465|FG000|Overall Study|Death|10|||
48343912|NCT05012397|155455465|FG000|Overall Study|Physician Decision|9|||
48343913|NCT05012397|155455465|FG000|Overall Study|Withdrawal by Subject|5|||
48343914|NCT05012397|155455465|FG000|Overall Study|Lost to Follow-up|2|||
48343915|NCT00920699|155455466|FG000|Overall Study|Withdrawal by Subject|2|||
48343916|NCT00920699|155455467|FG001|Overall Study|Withdrawal by Subject|0|||
48343917|NCT00920699|155455468|FG002|Overall Study|Withdrawal by Subject|2|||
48343918|NCT00920699|155455466|FG000|Overall Study|no longer met eligibility|0|||
48343919|NCT00920699|155455467|FG001|Overall Study|no longer met eligibility|1|||
48343920|NCT00920699|155455468|FG002|Overall Study|no longer met eligibility|0|||
48343921|NCT00920699|155455466|FG000|Overall Study|Lost to Follow-up|0|||
48343922|NCT00920699|155455467|FG001|Overall Study|Lost to Follow-up|0|||
48343923|NCT00920699|155455468|FG002|Overall Study|Lost to Follow-up|2|||
48343924|NCT00297778|155455475|FG000|Overall Study|Adverse Event|16|||
48343925|NCT00297778|155455476|FG001|Overall Study|Adverse Event|10|||
48343926|NCT00297778|155455475|FG000|Overall Study|Withdrawal by Subject|1|||
48343927|NCT00297778|155455476|FG001|Overall Study|Withdrawal by Subject|5|||
48343928|NCT00297778|155455475|FG000|Overall Study|Lack of Efficacy|2|||
48343929|NCT00297778|155455476|FG001|Overall Study|Lack of Efficacy|1|||
48343930|NCT00297778|155455475|FG000|Overall Study|Non-compliant with trial protocol|0|||
48343931|NCT00297778|155455476|FG001|Overall Study|Non-compliant with trial protocol|3|||
48343932|NCT00297778|155455475|FG000|Overall Study|Other|0|||
48343933|NCT00297778|155455476|FG001|Overall Study|Other|1|||
48343934|NCT03175198|155455481|FG000|Overall Study|Adverse Event|480|||
48343935|NCT03175198|155455481|FG000|Overall Study|No actual visit|120|||
48343936|NCT03175198|155455481|FG000|Overall Study|Registration rule not followed|4|||
48672137|NCT00576472|156651829|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
48672138|NCT00576472|156651830|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
48672139|NCT00576472|156651831|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
48672140|NCT00576472|156651832|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
48343937|NCT03175198|155455481|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
48343938|NCT03175198|155455481|FG000|Overall Study|Other personal reason|509|||
48343939|NCT03175198|155455481|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
48343940|NCT03175198|155455481|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
48343941|NCT03175198|155455481|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
48343942|NCT03175198|155455481|FG000|Overall Study|To conduct invasive treatment of operation|53|||
48343943|NCT03175198|155455481|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
48343944|NCT02996097|155455482|FG000|Overall Study|Lost to Follow-up|11|||
48672141|NCT00576472|156651833|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
48343945|NCT02996097|155455483|FG001|Overall Study|Lost to Follow-up|11|||
48343946|NCT02201771|155455484|FG000|Overall Study|Death|3|||
48672142|NCT00576472|156651834|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
48672143|NCT00576472|156651835|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
48672144|NCT00576472|156651821|FG000|MPH Cross Over Phase|Physician Decision|0|||
48672145|NCT00576472|156651822|FG001|MPH Cross Over Phase|Physician Decision|0|||
48672146|NCT00576472|156651823|FG002|MPH Cross Over Phase|Physician Decision|0|||
48672147|NCT00576472|156651824|FG003|MPH Cross Over Phase|Physician Decision|0|||
48672148|NCT00576472|156651825|FG004|MPH Cross Over Phase|Physician Decision|0|||
48343947|NCT02201771|155455485|FG001|Overall Study|Death|2|||
48672149|NCT00576472|156651826|FG005|MPH Cross Over Phase|Physician Decision|0|||
48672150|NCT00576472|156651827|FG006|MPH Cross Over Phase|Physician Decision|4|||
48672151|NCT00576472|156651828|FG007|MPH Cross Over Phase|Physician Decision|0|||
48672152|NCT00576472|156651829|FG008|MPH Cross Over Phase|Physician Decision|0|||
48672153|NCT00576472|156651830|FG009|MPH Cross Over Phase|Physician Decision|0|||
48672154|NCT00576472|156651831|FG010|MPH Cross Over Phase|Physician Decision|0|||
48672155|NCT00576472|156651832|FG011|MPH Cross Over Phase|Physician Decision|0|||
48672156|NCT00576472|156651833|FG012|MPH Cross Over Phase|Physician Decision|0|||
48672157|NCT00576472|156651834|FG013|MPH Cross Over Phase|Physician Decision|0|||
48672158|NCT00576472|156651835|FG014|MPH Cross Over Phase|Physician Decision|0|||
48672159|NCT00576472|156651821|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672160|NCT00576472|156651822|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672161|NCT00576472|156651823|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672162|NCT00576472|156651824|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672163|NCT00576472|156651825|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672164|NCT00576472|156651826|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672165|NCT00576472|156651827|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
48343948|NCT02201771|155455486|FG002|Overall Study|Death|0|||
48343949|NCT02201771|155455484|FG000|Overall Study|Protocol Violation|10|||
48672166|NCT00576472|156651828|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672167|NCT00576472|156651829|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
48672168|NCT00576472|156651830|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672169|NCT00576472|156651831|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
48672170|NCT00576472|156651832|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
48672171|NCT00576472|156651833|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672172|NCT00576472|156651834|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
48672173|NCT00576472|156651835|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
48343950|NCT02201771|155455485|FG001|Overall Study|Protocol Violation|8|||
48343951|NCT02201771|155455486|FG002|Overall Study|Protocol Violation|10|||
48343952|NCT01820637|155455487|FG000|Overall Study|Death|2|||
48343953|NCT01820637|155455487|FG000|Overall Study|Withdrawal by Subject|1|||
48343954|NCT00583115|155455488|FG000|Overall Study|Death|1|||
48343955|NCT04358068|155455489|FG000|Overall Study|Did not initiate study treatment|2|||
48343956|NCT04358068|155455490|FG001|Overall Study|Did not initiate study treatment|2|||
48343957|NCT00576823|155455495|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
48343958|NCT00576823|155455496|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
48343959|NCT00576823|155455497|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
48343960|NCT00576823|155455495|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
48343961|NCT00576823|155455496|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
48672174|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672175|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672176|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672177|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672178|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672179|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672180|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672181|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672182|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672183|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672184|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672185|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672186|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672187|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
48672188|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
48672189|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
48672190|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
48672191|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
48672192|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
48672193|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
48672194|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
48672195|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
48672196|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
48672197|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
48672198|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
48672199|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
48672200|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
48672201|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
48672202|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
48672203|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
48672204|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
48672205|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
48672206|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
48672207|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
48672208|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
48343962|NCT00576823|155455497|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
48343963|NCT01678898|155455498|FG000|PB-102-F01|Adverse Event|0|||
48343964|NCT01678898|155455499|FG001|PB-102-F01|Adverse Event|1|||
48343965|NCT01678898|155455500|FG002|PB-102-F01|Adverse Event|0|||
48343966|NCT01678898|155455498|FG000|PB-102-F01|Physician Decision|0|||
48343967|NCT01678898|155455499|FG001|PB-102-F01|Physician Decision|1|||
48343968|NCT01678898|155455500|FG002|PB-102-F01|Physician Decision|0|||
48672209|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
48672210|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
48672211|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
48672212|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
48672213|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
48672214|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
48672215|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
48672216|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
48672217|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
48672218|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
48672219|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Side effects|0|||
48672220|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Side effects|0|||
48672221|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Side effects|0|||
48672222|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Side effects|0|||
48672223|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Side effects|0|||
48672224|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Side effects|0|||
48672225|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Side effects|0|||
48672226|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Side effects|0|||
48672227|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Side effects|0|||
48672228|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Side effects|0|||
48672229|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Side effects|0|||
48672230|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Side effects|0|||
48672231|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Side effects|0|||
48672232|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Side effects|0|||
48672233|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Side effects|8|||
48672234|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672235|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672236|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672237|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672238|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672239|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672240|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672241|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672242|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672243|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672244|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672245|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672246|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672247|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
48672248|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
48672249|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
48672250|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
48672251|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
48672252|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
48672253|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
48672254|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
48672255|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
48672256|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
48672257|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
48672258|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
48672259|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
48672260|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
48672261|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
48672262|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
48672263|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
48672264|NCT00576472|156651821|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48343969|NCT00640042|155455501|FG000|Enrollment|Did not receive study drug|83|||
48343970|NCT04043806|155455502|FG000|Overall Study|Commercial drug is available for participants|13|||
48672265|NCT00576472|156651822|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672266|NCT00576472|156651823|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672267|NCT00576472|156651824|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672268|NCT00576472|156651825|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672269|NCT00576472|156651826|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672270|NCT00576472|156651827|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48760772|NCT03318315|156972318|FG001|Overall Study|Protocol Violation|1|||
48343971|NCT04043806|155455502|FG000|Overall Study|Physician Decision|2|||
48343972|NCT04043806|155455502|FG000|Overall Study|Other|12|||
48343973|NCT04043806|155455502|FG000|Overall Study|Adverse Event|2|||
48343974|NCT04043806|155455502|FG000|Overall Study|Lost to Follow-up|6|||
48343975|NCT04043806|155455502|FG000|Overall Study|Other non-compliance|2|||
48343976|NCT04043806|155455502|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
48343977|NCT04043806|155455502|FG000|Overall Study|Never Dosed|1|||
48343978|NCT02604342|155455506|FG000|Overall Study|Death|32|||
48343979|NCT02604342|155455507|FG001|Overall Study|Death|16|||
48343980|NCT02604342|155455506|FG000|Overall Study|Progression of disease|1|||
48343981|NCT02604342|155455507|FG001|Overall Study|Progression of disease|0|||
48343982|NCT02604342|155455506|FG000|Overall Study|Withdrawal by Subject|5|||
48343983|NCT02604342|155455507|FG001|Overall Study|Withdrawal by Subject|6|||
48343984|NCT02604342|155455506|FG000|Overall Study|Other|1|||
48343985|NCT02604342|155455507|FG001|Overall Study|Other|0|||
48343986|NCT02604342|155455506|FG000|Overall Study|Study Termination by Sponsor|1|||
48343987|NCT02604342|155455507|FG001|Overall Study|Study Termination by Sponsor|0|||
48343988|NCT02604342|155455506|FG000|Overall Study|Lost to Follow-up|1|||
48343989|NCT02604342|155455507|FG001|Overall Study|Lost to Follow-up|1|||
48343990|NCT02604342|155455506|FG000|Overall Study|Physician Decision|2|||
48343991|NCT02604342|155455507|FG001|Overall Study|Physician Decision|0|||
48343992|NCT02261285|155455508|FG000|Overall Study|Disease progression|0|||
48343993|NCT02261285|155455509|FG001|Overall Study|Disease progression|0|||
48343994|NCT02261285|155455510|FG002|Overall Study|Disease progression|1|||
48343995|NCT01209286|155455511|FG000|Overall Study|Adverse Event|4|||
48343996|NCT01209286|155455512|FG001|Overall Study|Adverse Event|3|||
48672271|NCT00576472|156651828|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672272|NCT00576472|156651829|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672273|NCT00576472|156651830|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672274|NCT00576472|156651831|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672275|NCT00576472|156651832|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672276|NCT00576472|156651833|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672277|NCT00576472|156651834|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
48672278|NCT00576472|156651835|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
48672279|NCT00599638|156651836|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
48672280|NCT00599638|156651837|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
48672281|NCT00599638|156651838|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
48672282|NCT00599638|156651839|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
48672283|NCT00599638|156651836|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
48672284|NCT00599638|156651837|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
48672285|NCT00599638|156651838|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
48672286|NCT00599638|156651839|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
48672287|NCT00599638|156651836|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
48672288|NCT00599638|156651837|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
48672289|NCT00599638|156651838|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
48672290|NCT00599638|156651839|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
48672291|NCT00599638|156651836|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
48672292|NCT00599638|156651837|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
48672293|NCT00599638|156651838|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
48672294|NCT00599638|156651839|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
48672295|NCT00599638|156651836|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
48672296|NCT00599638|156651837|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
48672297|NCT00599638|156651838|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
48672298|NCT00599638|156651839|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
48672299|NCT00599638|156651836|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
48672300|NCT00599638|156651837|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
48672301|NCT00599638|156651838|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
48672302|NCT00599638|156651839|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
48672303|NCT00599638|156651836|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
48343997|NCT01209286|155455513|FG002|Overall Study|Adverse Event|1|||
48343998|NCT01209286|155455511|FG000|Overall Study|Hematological Relapse After Remission|0|||
48343999|NCT01209286|155455512|FG001|Overall Study|Hematological Relapse After Remission|1|||
48672304|NCT00599638|156651837|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
48672305|NCT00599638|156651838|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
48672306|NCT00599638|156651839|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
48672307|NCT00599638|156651836|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
48672308|NCT00599638|156651837|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
48672309|NCT00599638|156651838|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
48672310|NCT00599638|156651839|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
48672311|NCT00599638|156651836|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
48344000|NCT01209286|155455513|FG002|Overall Study|Hematological Relapse After Remission|1|||
48344001|NCT01209286|155455511|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
48344002|NCT01209286|155455512|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
48344003|NCT01209286|155455513|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
48344004|NCT01209286|155455511|FG000|Overall Study|Physician Decision|0|||
48760773|NCT03318315|156972319|FG002|Overall Study|Protocol Violation|1|||
48672312|NCT00599638|156651837|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
48672313|NCT00599638|156651838|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
48672314|NCT00599638|156651839|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
48672315|NCT05026853|156651840|FG000|Overall Study|Cancelled appointment|1|||
48672316|NCT05026853|156651841|FG001|Overall Study|Cancelled appointment|0|||
48672317|NCT05026853|156651840|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
48672318|NCT05026853|156651841|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
48672319|NCT05026853|156651840|FG000|Overall Study|Did not complete 12-week survey|16|||
48672320|NCT05026853|156651841|FG001|Overall Study|Did not complete 12-week survey|16|||
48672321|NCT02895945|156651842|FG000|Overall Study|Physician Decision|2|||
48672322|NCT02895945|156651843|FG001|Overall Study|Physician Decision|1|||
48344005|NCT01209286|155455512|FG001|Overall Study|Physician Decision|2|||
48672323|NCT03429543|156651844|FG000|Overall Study|Adverse Event|1|||
48672324|NCT03429543|156651845|FG001|Overall Study|Adverse Event|1|||
48672325|NCT03429543|156651846|FG002|Overall Study|Adverse Event|0|||
48672326|NCT03429543|156651847|FG003|Overall Study|Adverse Event|0|||
48672327|NCT03429543|156651848|FG004|Overall Study|Adverse Event|0|||
48672328|NCT03429543|156651849|FG005|Overall Study|Adverse Event|2|||
48672329|NCT03429543|156651850|FG006|Overall Study|Adverse Event|0|||
48672330|NCT03429543|156651844|FG000|Overall Study|Lost to Follow-up|1|||
48672331|NCT03429543|156651845|FG001|Overall Study|Lost to Follow-up|0|||
48672332|NCT03429543|156651846|FG002|Overall Study|Lost to Follow-up|0|||
48672333|NCT03429543|156651847|FG003|Overall Study|Lost to Follow-up|0|||
48672334|NCT03429543|156651848|FG004|Overall Study|Lost to Follow-up|1|||
48672335|NCT03429543|156651849|FG005|Overall Study|Lost to Follow-up|0|||
48672336|NCT03429543|156651850|FG006|Overall Study|Lost to Follow-up|0|||
48672337|NCT03429543|156651844|FG000|Overall Study|Withdrawal by Subject|5|||
48344006|NCT01209286|155455513|FG002|Overall Study|Physician Decision|0|||
48672338|NCT03429543|156651845|FG001|Overall Study|Withdrawal by Subject|0|||
48672339|NCT03429543|156651846|FG002|Overall Study|Withdrawal by Subject|1|||
48672340|NCT03429543|156651847|FG003|Overall Study|Withdrawal by Subject|2|||
48672341|NCT03429543|156651848|FG004|Overall Study|Withdrawal by Subject|6|||
48672342|NCT03429543|156651849|FG005|Overall Study|Withdrawal by Subject|3|||
48672343|NCT03429543|156651850|FG006|Overall Study|Withdrawal by Subject|1|||
48672344|NCT03429543|156651844|FG000|Overall Study|Other reason than listed|0|||
48672345|NCT03429543|156651845|FG001|Overall Study|Other reason than listed|1|||
48672346|NCT03429543|156651846|FG002|Overall Study|Other reason than listed|0|||
48672347|NCT03429543|156651847|FG003|Overall Study|Other reason than listed|0|||
48672348|NCT03429543|156651848|FG004|Overall Study|Other reason than listed|4|||
48672349|NCT03429543|156651849|FG005|Overall Study|Other reason than listed|4|||
48672350|NCT03429543|156651850|FG006|Overall Study|Other reason than listed|0|||
48672351|NCT03429543|156651844|FG000|Overall Study|Not treated|0|||
48672352|NCT03429543|156651845|FG001|Overall Study|Not treated|0|||
48672353|NCT03429543|156651846|FG002|Overall Study|Not treated|0|||
48672354|NCT03429543|156651847|FG003|Overall Study|Not treated|0|||
48672355|NCT03429543|156651848|FG004|Overall Study|Not treated|1|||
48672356|NCT03429543|156651849|FG005|Overall Study|Not treated|0|||
48672357|NCT03429543|156651850|FG006|Overall Study|Not treated|0|||
48672358|NCT02345330|156651852|FG000|Overall Study|Death|1|||
48672359|NCT02345330|156651852|FG000|Overall Study|Progressive Disease|2|||
48672360|NCT03688100|156651853|FG000|Overall Study|Lost to Follow-up|21|||
48672361|NCT03688100|156651854|FG001|Overall Study|Lost to Follow-up|15|||
48672362|NCT03688100|156651855|FG002|Overall Study|Lost to Follow-up|15|||
48672363|NCT03688100|156651856|FG003|Overall Study|Lost to Follow-up|18|||
48672364|NCT03688100|156651853|FG000|Overall Study|Withdrawal by Subject|19|||
48672365|NCT03688100|156651854|FG001|Overall Study|Withdrawal by Subject|16|||
48672366|NCT03688100|156651855|FG002|Overall Study|Withdrawal by Subject|0|||
48672367|NCT03688100|156651856|FG003|Overall Study|Withdrawal by Subject|0|||
48672368|NCT03688100|156651853|FG000|Overall Study|Death|36|||
48672369|NCT03688100|156651854|FG001|Overall Study|Death|27|||
48672370|NCT03688100|156651855|FG002|Overall Study|Death|0|||
48672371|NCT03688100|156651856|FG003|Overall Study|Death|0|||
48672372|NCT00094107|156651859|FG000|Overall Study|Lack of Efficacy|23|||
48672373|NCT00094107|156651859|FG000|Overall Study|Death|5|||
48672374|NCT00094107|156651859|FG000|Overall Study|Adverse Event|3|||
48672375|NCT00094107|156651859|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
48672376|NCT00372697|156653483|FG000|Overall Study|Protocol Violation|1|||
48344007|NCT01209286|155455511|FG000|Overall Study|Other|0|||
48344008|NCT01209286|155455512|FG001|Overall Study|Other|1|||
48672377|NCT00372697|156653484|FG001|Overall Study|Protocol Violation|1|||
48672378|NCT02271945|156653486|FG000|Overall Study|Death|3|||
48672379|NCT02271945|156653487|FG001|Overall Study|Death|3|||
48672380|NCT02271945|156653486|FG000|Overall Study|Withdrawal by Subject|1|||
48672381|NCT02271945|156653487|FG001|Overall Study|Withdrawal by Subject|1|||
48672382|NCT02271945|156653486|FG000|Overall Study|Other|1|||
48344009|NCT01209286|155455513|FG002|Overall Study|Other|0|||
48672383|NCT02271945|156653487|FG001|Overall Study|Other|1|||
48672384|NCT00454181|156653489|FG000|Overall Study|Adverse Event|1|||
48672385|NCT00454181|156653490|FG001|Overall Study|Adverse Event|1|||
48672386|NCT00454181|156653489|FG000|Overall Study|Lost to Follow-up|11|||
48672387|NCT00454181|156653490|FG001|Overall Study|Lost to Follow-up|1|||
48672388|NCT00454181|156653489|FG000|Overall Study|Protocol Violation|1|||
48672389|NCT00454181|156653490|FG001|Overall Study|Protocol Violation|1|||
48672390|NCT00454181|156653489|FG000|Overall Study|Withdrawal by Subject|2|||
48672391|NCT00454181|156653490|FG001|Overall Study|Withdrawal by Subject|0|||
48672392|NCT00109577|156653491|FG000|Overall Study|Withdrawal by Subject|3|||
48672393|NCT00109577|156653492|FG001|Overall Study|Withdrawal by Subject|3|||
48672394|NCT01026220|156653493|FG000|Induction|Death|1|||
48672395|NCT01026220|156653494|FG001|Induction|Death|0|||
48672396|NCT01026220|156653495|FG002|Induction|Death|0|||
48672397|NCT01026220|156653493|FG000|Induction|Lack of Efficacy|2|||
48672398|NCT01026220|156653494|FG001|Induction|Lack of Efficacy|0|||
48672399|NCT01026220|156653495|FG002|Induction|Lack of Efficacy|0|||
48672400|NCT01026220|156653493|FG000|Induction|Physician Decision|12|||
48672401|NCT01026220|156653494|FG001|Induction|Physician Decision|0|||
48672402|NCT01026220|156653495|FG002|Induction|Physician Decision|0|||
48672403|NCT01026220|156653493|FG000|Induction|Withdrawal by Subject|9|||
48672404|NCT01026220|156653494|FG001|Induction|Withdrawal by Subject|0|||
48672405|NCT01026220|156653495|FG002|Induction|Withdrawal by Subject|0|||
48672406|NCT01026220|156653493|FG000|Induction|Ineligible|1|||
48672407|NCT01026220|156653494|FG001|Induction|Ineligible|0|||
48672408|NCT01026220|156653495|FG002|Induction|Ineligible|0|||
48672409|NCT01026220|156653493|FG000|Consolidation Maintenance|Death|0|||
48672410|NCT01026220|156653494|FG001|Consolidation Maintenance|Death|1|||
48672411|NCT01026220|156653495|FG002|Consolidation Maintenance|Death|0|||
48672412|NCT01026220|156653493|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
48672413|NCT01026220|156653494|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
48672414|NCT01026220|156653495|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
48672415|NCT01026220|156653493|FG000|Consolidation Maintenance|Physician Decision|0|||
48672416|NCT01026220|156653494|FG001|Consolidation Maintenance|Physician Decision|2|||
48672417|NCT01026220|156653495|FG002|Consolidation Maintenance|Physician Decision|7|||
48672418|NCT01026220|156653493|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
48672419|NCT01026220|156653494|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
48672420|NCT01026220|156653495|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
48672421|NCT00521222|156653497|FG000|Overall Study|Lost to Follow-up|0|||
48672422|NCT00521222|156653498|FG001|Overall Study|Lost to Follow-up|0|||
48672423|NCT00521222|156653499|FG002|Overall Study|Lost to Follow-up|1|||
48672424|NCT00521222|156653500|FG003|Overall Study|Lost to Follow-up|1|||
48672425|NCT00521222|156653497|FG000|Overall Study|Withdrawal by Subject|0|||
48672426|NCT00521222|156653498|FG001|Overall Study|Withdrawal by Subject|0|||
48672427|NCT00521222|156653499|FG002|Overall Study|Withdrawal by Subject|2|||
48672428|NCT00521222|156653500|FG003|Overall Study|Withdrawal by Subject|0|||
48672429|NCT00521222|156653497|FG000|Overall Study|Physician Decision|0|||
48672430|NCT00521222|156653498|FG001|Overall Study|Physician Decision|1|||
48672431|NCT00521222|156653499|FG002|Overall Study|Physician Decision|0|||
48672432|NCT00521222|156653500|FG003|Overall Study|Physician Decision|1|||
48672433|NCT02879578|156653508|FG000|Overall Study|Adverse Event|1|||
48672434|NCT02879578|156653509|FG001|Overall Study|Adverse Event|2|||
48672435|NCT02879578|156653510|FG002|Overall Study|Adverse Event|14|||
48672436|NCT02879578|156653508|FG000|Overall Study|Protocol Violation|0|||
48672437|NCT02879578|156653509|FG001|Overall Study|Protocol Violation|1|||
48672438|NCT02879578|156653510|FG002|Overall Study|Protocol Violation|1|||
48344010|NCT01260142|155455516|FG000|Treatment Period 1|Study on hold|1|||
48344011|NCT01260142|155455517|FG001|Treatment Period 1|Study on hold|1|||
48344012|NCT01260142|155455518|FG002|Treatment Period 1|Study on hold|0|||
48344013|NCT01260142|155455519|FG003|Treatment Period 1|Study on hold|0|||
48344014|NCT01260142|155455520|FG004|Treatment Period 1|Study on hold|1|||
48344015|NCT01260142|155455521|FG005|Treatment Period 1|Study on hold|2|||
48344016|NCT01260142|155455516|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
48344017|NCT01260142|155455517|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
48672439|NCT02879578|156653508|FG000|Overall Study|Withdrawal by Subject|8|||
48672440|NCT02879578|156653509|FG001|Overall Study|Withdrawal by Subject|6|||
48672441|NCT02879578|156653510|FG002|Overall Study|Withdrawal by Subject|9|||
48672442|NCT02879578|156653508|FG000|Overall Study|Lost to Follow-up|1|||
48672443|NCT02879578|156653509|FG001|Overall Study|Lost to Follow-up|0|||
48672444|NCT02879578|156653510|FG002|Overall Study|Lost to Follow-up|4|||
48672445|NCT02879578|156653508|FG000|Overall Study|Physician Decision|0|||
48344018|NCT01260142|155455518|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
48344019|NCT01260142|155455519|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
48344020|NCT01260142|155455520|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
48672446|NCT02879578|156653509|FG001|Overall Study|Physician Decision|0|||
48672447|NCT02879578|156653510|FG002|Overall Study|Physician Decision|4|||
48672448|NCT01183468|156653511|FG000|Overall Study|Lost to Follow-up|2|||
48672449|NCT01183468|156653512|FG001|Overall Study|Lost to Follow-up|1|||
48672450|NCT01183468|156653513|FG002|Overall Study|Lost to Follow-up|0|||
48672451|NCT01183468|156653514|FG003|Overall Study|Lost to Follow-up|0|||
48344021|NCT01260142|155455521|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
48344022|NCT01260142|155455516|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48344023|NCT01260142|155455517|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48344024|NCT01260142|155455518|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48344025|NCT01260142|155455519|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48344026|NCT01260142|155455520|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48344027|NCT01260142|155455521|FG005|Treatment Period 1|Withdrawal by Subject|1|||
48344028|NCT04479761|155455523|FG000|Overall Study|could not perform the balance tasks|1|||
48344029|NCT04479761|155455524|FG001|Overall Study|could not perform the balance tasks|0|||
48344030|NCT04479761|155455525|FG002|Overall Study|could not perform the balance tasks|0|||
48344031|NCT04479761|155455523|FG000|Overall Study|Adverse Event|1|||
48344032|NCT04479761|155455524|FG001|Overall Study|Adverse Event|0|||
48344033|NCT04479761|155455525|FG002|Overall Study|Adverse Event|0|||
48344034|NCT04479761|155455523|FG000|Overall Study|one control did not meet screening criteria|0|||
48672452|NCT01183468|156653511|FG000|Overall Study|Physician Decision|1|||
48672453|NCT01183468|156653512|FG001|Overall Study|Physician Decision|0|||
48760774|NCT03318315|156972317|FG000|Overall Study|Withdrawal by Subject|0|||
48760775|NCT03318315|156972318|FG001|Overall Study|Withdrawal by Subject|0|||
48760776|NCT03318315|156972319|FG002|Overall Study|Withdrawal by Subject|2|||
48760777|NCT02968563|156972320|FG000|Overall Study|Adverse Event|0|||
48760778|NCT02968563|156972321|FG001|Overall Study|Adverse Event|6|||
48760779|NCT02968563|156972320|FG000|Overall Study|Death|1|||
48672454|NCT01183468|156653513|FG002|Overall Study|Physician Decision|0|||
48672455|NCT01183468|156653514|FG003|Overall Study|Physician Decision|0|||
48672456|NCT01183468|156653511|FG000|Overall Study|Withdrawal by Subject|0|||
48672457|NCT01183468|156653512|FG001|Overall Study|Withdrawal by Subject|1|||
48672458|NCT01183468|156653513|FG002|Overall Study|Withdrawal by Subject|0|||
48672459|NCT01183468|156653514|FG003|Overall Study|Withdrawal by Subject|0|||
48672460|NCT00671437|156653515|FG000|Overall Study|Progressive disease before C1 week 8|8|||
48672461|NCT00671437|156653515|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
48672462|NCT00671437|156653515|FG000|Overall Study|Adverse Event|3|||
48760780|NCT02968563|156972321|FG001|Overall Study|Death|1|||
48672463|NCT00671437|156653515|FG000|Overall Study|Ineligible post-hoc|1|||
48672464|NCT01440881|156653516|FG000|Overall Study|Death|0|||
48760781|NCT02968563|156972320|FG000|Overall Study|Lost to Follow-up|0|||
48760782|NCT02968563|156972321|FG001|Overall Study|Lost to Follow-up|1|||
48760783|NCT02369341|156972322|FG000|Overall Study|Migrated/moved from study area|1|||
48760784|NCT02369341|156972323|FG001|Overall Study|Migrated/moved from study area|0|||
48760785|NCT01996826|156972324|FG000|Overall Study|Lost to Follow-up|6|||
48760786|NCT01996826|156972325|FG001|Overall Study|Lost to Follow-up|2|||
48672465|NCT01440881|156653517|FG001|Overall Study|Death|1|||
48760787|NCT01996826|156972324|FG000|Overall Study|Physician Decision|1|||
48760788|NCT01996826|156972325|FG001|Overall Study|Physician Decision|1|||
48672466|NCT03927404|156653518|FG000|Overall Study|Withdrawal by Subject|1|||
48344035|NCT04479761|155455524|FG001|Overall Study|one control did not meet screening criteria|0|||
48672467|NCT04311463|156653519|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
48672468|NCT04311463|156653520|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
48672469|NCT04311463|156653519|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
48344036|NCT04479761|155455525|FG002|Overall Study|one control did not meet screening criteria|1|||
48344037|NCT04479761|155455523|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
48344038|NCT04479761|155455524|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
48344039|NCT04479761|155455525|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
48344040|NCT00514813|155455528|FG000|Overall Study|Study terminated|14|||
48344041|NCT00514813|155455529|FG001|Overall Study|Study terminated|74|||
48344042|NCT00514813|155455530|FG002|Overall Study|Study terminated|40|||
48344043|NCT00514813|155455531|FG003|Overall Study|Study terminated|2|||
48344044|NCT00514813|155455528|FG000|Overall Study|Adverse Event|0|||
48344045|NCT00514813|155455529|FG001|Overall Study|Adverse Event|2|||
48344046|NCT00514813|155455530|FG002|Overall Study|Adverse Event|2|||
48344047|NCT00514813|155455531|FG003|Overall Study|Adverse Event|0|||
48344048|NCT00514813|155455528|FG000|Overall Study|Protocol Violation|1|||
48344049|NCT00514813|155455529|FG001|Overall Study|Protocol Violation|0|||
48344050|NCT00514813|155455530|FG002|Overall Study|Protocol Violation|0|||
48344051|NCT00514813|155455531|FG003|Overall Study|Protocol Violation|0|||
48344052|NCT00514813|155455528|FG000|Overall Study|Withdrawal by Subject|0|||
48344053|NCT00514813|155455529|FG001|Overall Study|Withdrawal by Subject|1|||
48344054|NCT00514813|155455530|FG002|Overall Study|Withdrawal by Subject|0|||
48344055|NCT00514813|155455531|FG003|Overall Study|Withdrawal by Subject|0|||
48344056|NCT00514813|155455528|FG000|Overall Study|Lack of Efficacy|0|||
48344057|NCT00514813|155455529|FG001|Overall Study|Lack of Efficacy|1|||
48344058|NCT00514813|155455530|FG002|Overall Study|Lack of Efficacy|0|||
48344059|NCT00514813|155455531|FG003|Overall Study|Lack of Efficacy|0|||
48344060|NCT00514813|155455528|FG000|Overall Study|Kidney transplant|0|||
48344061|NCT00514813|155455529|FG001|Overall Study|Kidney transplant|6|||
48344062|NCT00514813|155455530|FG002|Overall Study|Kidney transplant|2|||
48344063|NCT00514813|155455531|FG003|Overall Study|Kidney transplant|0|||
48344064|NCT00514813|155455528|FG000|Overall Study|Death|0|||
48672470|NCT04311463|156653520|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
48672471|NCT04311463|156653519|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
48672472|NCT04311463|156653520|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
48672473|NCT01229449|156653523|FG000|Overall Study|Withdrawal by Subject|0|||
48672474|NCT01229449|156653524|FG001|Overall Study|Withdrawal by Subject|3|||
48672475|NCT01229449|156653525|FG002|Overall Study|Withdrawal by Subject|0|||
48672476|NCT01229449|156653526|FG003|Overall Study|Withdrawal by Subject|1|||
48672477|NCT01229449|156653527|FG004|Overall Study|Withdrawal by Subject|1|||
48672478|NCT01229449|156653523|FG000|Overall Study|Lost to Follow-up|1|||
48672479|NCT01229449|156653524|FG001|Overall Study|Lost to Follow-up|1|||
48344065|NCT00514813|155455529|FG001|Overall Study|Death|2|||
48344066|NCT00514813|155455530|FG002|Overall Study|Death|3|||
48344067|NCT00514813|155455531|FG003|Overall Study|Death|2|||
48344068|NCT02979613|155455532|FG000|Double-Blind Phase|Withdrew Consent|2|||
48672480|NCT01229449|156653525|FG002|Overall Study|Lost to Follow-up|1|||
48672481|NCT01229449|156653526|FG003|Overall Study|Lost to Follow-up|0|||
48672482|NCT01229449|156653527|FG004|Overall Study|Lost to Follow-up|0|||
48672483|NCT01229449|156653523|FG000|Overall Study|Physician Decision|0|||
48672484|NCT01229449|156653524|FG001|Overall Study|Physician Decision|0|||
48672485|NCT01229449|156653525|FG002|Overall Study|Physician Decision|1|||
48672486|NCT01229449|156653526|FG003|Overall Study|Physician Decision|0|||
48672487|NCT01229449|156653527|FG004|Overall Study|Physician Decision|0|||
48672488|NCT00737633|156653528|FG000|Overall Study|Study terminated by sponsor|44|||
48672489|NCT00737633|156653529|FG001|Overall Study|Study terminated by sponsor|55|||
48672490|NCT00737633|156653528|FG000|Overall Study|Lost to Follow-up|0|||
48672491|NCT00737633|156653529|FG001|Overall Study|Lost to Follow-up|1|||
48760789|NCT03164928|156972328|FG000|Overall Study|Lost to Follow-up|1|||
48760790|NCT03164928|156972329|FG001|Overall Study|Lost to Follow-up|0|||
48760791|NCT02092662|156972332|FG000|Overall Study|Lost to Follow-up|13|||
48760792|NCT02092662|156972333|FG001|Overall Study|Lost to Follow-up|0|||
48344069|NCT02979613|155455533|FG001|Double-Blind Phase|Withdrew Consent|4|||
48344070|NCT02979613|155455532|FG000|Double-Blind Phase|Pregnancy|2|||
48344071|NCT02979613|155455533|FG001|Double-Blind Phase|Pregnancy|2|||
48760793|NCT02532647|156972334|FG000|Overall Study|Did not receive trial medication|1|||
48344072|NCT02979613|155455532|FG000|Double-Blind Phase|Adverse Event|2|||
48344073|NCT02979613|155455533|FG001|Double-Blind Phase|Adverse Event|0|||
48344074|NCT02979613|155455532|FG000|Double-Blind Phase|Lost to Follow-up|1|||
48344075|NCT02979613|155455533|FG001|Double-Blind Phase|Lost to Follow-up|1|||
48344076|NCT02979613|155455532|FG000|Double-Blind Phase|Protocol Violation|1|||
48344077|NCT02979613|155455533|FG001|Double-Blind Phase|Protocol Violation|1|||
48344078|NCT02979613|155455532|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
48344079|NCT02979613|155455533|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
48672492|NCT00737633|156653528|FG000|Overall Study|protocol non-compliance|0|||
48672493|NCT00737633|156653529|FG001|Overall Study|protocol non-compliance|1|||
48672494|NCT01147848|156653530|FG000|Run-in Period|Screen Failure|623|||
48672495|NCT01147848|156653531|FG001|Run-in Period|Screen Failure|0|||
48672496|NCT01147848|156653532|FG002|Run-in Period|Screen Failure|0|||
48672497|NCT01147848|156653530|FG000|Run-in Period|Run-in Failure|135|||
48672498|NCT01147848|156653531|FG001|Run-in Period|Run-in Failure|0|||
48672499|NCT01147848|156653532|FG002|Run-in Period|Run-in Failure|0|||
48344080|NCT02979613|155455532|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
48344081|NCT02979613|155455533|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
48344082|NCT02979613|155455532|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
48344083|NCT02979613|155455533|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
48344084|NCT02979613|155455532|FG000|Open-Label Extension (OLE) Phase|Death|0|||
48344085|NCT02979613|155455533|FG001|Open-Label Extension (OLE) Phase|Death|1|||
48344086|NCT02979613|155455532|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
48344087|NCT02979613|155455533|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
48344088|NCT01201915|155455534|FG000|Overall Study|Adverse Event|2|||
48344089|NCT01201915|155455535|FG001|Overall Study|Adverse Event|1|||
48344090|NCT01201915|155455536|FG002|Overall Study|Adverse Event|1|||
48344091|NCT01201915|155455534|FG000|Overall Study|Lost to Follow-up|0|||
48344092|NCT01201915|155455535|FG001|Overall Study|Lost to Follow-up|4|||
48344093|NCT01201915|155455536|FG002|Overall Study|Lost to Follow-up|0|||
48344094|NCT01201915|155455534|FG000|Overall Study|Physician Decision|3|||
48344095|NCT01201915|155455535|FG001|Overall Study|Physician Decision|0|||
48344096|NCT01201915|155455536|FG002|Overall Study|Physician Decision|0|||
48344097|NCT01201915|155455534|FG000|Overall Study|Subject Decision|3|||
48344098|NCT01201915|155455535|FG001|Overall Study|Subject Decision|3|||
48344099|NCT01201915|155455536|FG002|Overall Study|Subject Decision|5|||
48344100|NCT01201915|155455534|FG000|Overall Study|Target Lesion Progression|0|||
48344101|NCT01201915|155455535|FG001|Overall Study|Target Lesion Progression|3|||
48344102|NCT01201915|155455536|FG002|Overall Study|Target Lesion Progression|0|||
48344103|NCT00635570|155457299|FG000|Overall Study|Lost to Follow-up|8|||
48344104|NCT00635570|155457300|FG001|Overall Study|Lost to Follow-up|8|||
48344105|NCT00635570|155457299|FG000|Overall Study|Withdrawal by Subject|1|||
48344106|NCT00635570|155457300|FG001|Overall Study|Withdrawal by Subject|1|||
48344107|NCT00635570|155457299|FG000|Overall Study|Adverse Event|2|||
48344108|NCT00635570|155457300|FG001|Overall Study|Adverse Event|0|||
48344109|NCT00635570|155457299|FG000|Overall Study|Physician Decision|1|||
48344110|NCT00635570|155457300|FG001|Overall Study|Physician Decision|0|||
48344111|NCT00635570|155457299|FG000|Overall Study|Did not complete survey|2|||
48344112|NCT00635570|155457300|FG001|Overall Study|Did not complete survey|1|||
48344113|NCT00635570|155457299|FG000|Overall Study|Early termination(No sexual activity)|1|||
48344114|NCT00635570|155457300|FG001|Overall Study|Early termination(No sexual activity)|1|||
48344115|NCT02176356|155457301|FG000|Overall Study|Screen Failure|14|||
48344116|NCT02176356|155457301|FG000|Overall Study|Lost to Follow-up|4|||
48344117|NCT02176356|155457301|FG000|Overall Study|Personal Reasons|3|||
48344118|NCT02176356|155457301|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48344119|NCT02675998|155457305|FG000|8-Week Treatment Period|Adverse Event|6|||
48344120|NCT02675998|155457306|FG001|8-Week Treatment Period|Adverse Event|5|||
48344121|NCT02675998|155457307|FG002|8-Week Treatment Period|Adverse Event|6|||
48344122|NCT02675998|155457308|FG003|8-Week Treatment Period|Adverse Event|0|||
48344123|NCT02675998|155457305|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
48344124|NCT02675998|155457306|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
48344125|NCT02675998|155457307|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
48344126|NCT02675998|155457308|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
48344127|NCT02675998|155457305|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
48344128|NCT02675998|155457306|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
48672500|NCT01147848|156653530|FG000|Randomized Phase|Adverse Event|0|||
48672501|NCT01147848|156653531|FG001|Randomized Phase|Adverse Event|6|||
48672502|NCT01147848|156653532|FG002|Randomized Phase|Adverse Event|8|||
48672503|NCT01147848|156653530|FG000|Randomized Phase|Lack of Efficacy|0|||
48344129|NCT02675998|155457307|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
48344130|NCT02675998|155457308|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
48344131|NCT02675998|155457305|FG000|8-Week Treatment Period|Physician Decision|1|||
48344132|NCT02675998|155457306|FG001|8-Week Treatment Period|Physician Decision|0|||
48344133|NCT02675998|155457307|FG002|8-Week Treatment Period|Physician Decision|2|||
48344134|NCT02675998|155457308|FG003|8-Week Treatment Period|Physician Decision|0|||
48344135|NCT02675998|155457305|FG000|8-Week Treatment Period|GI side Effects|1|||
48672504|NCT01147848|156653531|FG001|Randomized Phase|Lack of Efficacy|20|||
48672505|NCT01147848|156653532|FG002|Randomized Phase|Lack of Efficacy|11|||
48344136|NCT02675998|155457306|FG001|8-Week Treatment Period|GI side Effects|4|||
48344137|NCT02675998|155457307|FG002|8-Week Treatment Period|GI side Effects|2|||
48344138|NCT02675998|155457308|FG003|8-Week Treatment Period|GI side Effects|0|||
48344139|NCT02675998|155457305|FG000|8-Week Treatment Period|Protocol Violation|1|||
48344140|NCT02675998|155457306|FG001|8-Week Treatment Period|Protocol Violation|1|||
48672506|NCT01147848|156653530|FG000|Randomized Phase|Protocol Violation|0|||
48672507|NCT01147848|156653531|FG001|Randomized Phase|Protocol Violation|7|||
48672508|NCT01147848|156653532|FG002|Randomized Phase|Protocol Violation|10|||
48672509|NCT01147848|156653530|FG000|Randomized Phase|Lost to Follow-up|0|||
48672510|NCT01147848|156653531|FG001|Randomized Phase|Lost to Follow-up|5|||
48672511|NCT01147848|156653532|FG002|Randomized Phase|Lost to Follow-up|7|||
48672512|NCT01147848|156653530|FG000|Randomized Phase|Physician Decision|0|||
48672513|NCT01147848|156653531|FG001|Randomized Phase|Physician Decision|0|||
48672514|NCT01147848|156653532|FG002|Randomized Phase|Physician Decision|1|||
48672515|NCT01147848|156653530|FG000|Randomized Phase|Withdrawal by Subject|0|||
48672516|NCT01147848|156653531|FG001|Randomized Phase|Withdrawal by Subject|7|||
48672517|NCT01147848|156653532|FG002|Randomized Phase|Withdrawal by Subject|9|||
48672518|NCT02986854|156653535|FG000|Overall Study|Withdrawal by Subject|0|||
48672519|NCT02986854|156653536|FG001|Overall Study|Withdrawal by Subject|1|||
48672520|NCT02986854|156653537|FG002|Overall Study|Withdrawal by Subject|1|||
48672521|NCT02986854|156653535|FG000|Overall Study|Lost to Follow-up|3|||
48672522|NCT02986854|156653536|FG001|Overall Study|Lost to Follow-up|11|||
48344141|NCT02675998|155457307|FG002|8-Week Treatment Period|Protocol Violation|1|||
48344142|NCT02675998|155457308|FG003|8-Week Treatment Period|Protocol Violation|0|||
48344143|NCT02675998|155457305|FG000|8-Week Treatment Period|Other|3|||
48344144|NCT02675998|155457306|FG001|8-Week Treatment Period|Other|1|||
48344145|NCT02675998|155457307|FG002|8-Week Treatment Period|Other|2|||
48672523|NCT02986854|156653537|FG002|Overall Study|Lost to Follow-up|2|||
48672524|NCT02014584|156653538|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672525|NCT02014584|156653539|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
48672526|NCT02014584|156653540|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672527|NCT02014584|156653541|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672528|NCT02014584|156653542|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672529|NCT02014584|156653543|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
48672530|NCT02014584|156653538|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
48672531|NCT02014584|156653539|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
48672532|NCT02014584|156653540|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
48672533|NCT02014584|156653541|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
48672534|NCT02014584|156653542|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
48672535|NCT02014584|156653543|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
48672536|NCT02014584|156653538|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672537|NCT02014584|156653539|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672538|NCT02014584|156653540|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
48672539|NCT02014584|156653541|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672540|NCT02014584|156653542|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672541|NCT02014584|156653543|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
48672542|NCT02014584|156653538|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
48672543|NCT02014584|156653539|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
48672544|NCT02014584|156653540|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
48672545|NCT02014584|156653541|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
48672546|NCT02014584|156653542|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
48672547|NCT02014584|156653543|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
48672548|NCT02014584|156653538|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672549|NCT02014584|156653539|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672550|NCT02014584|156653540|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672551|NCT02014584|156653541|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672552|NCT02014584|156653542|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
48672553|NCT02014584|156653543|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
48672554|NCT00666965|156653545|FG000|Overall Study|Adverse Event|0|||
48344146|NCT02675998|155457308|FG003|8-Week Treatment Period|Other|0|||
48344147|NCT02675998|155457305|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
48672555|NCT00666965|156653546|FG001|Overall Study|Adverse Event|2|||
48672556|NCT00666965|156653547|FG002|Overall Study|Adverse Event|1|||
48672557|NCT00666965|156653548|FG003|Overall Study|Adverse Event|9|||
48672558|NCT00666965|156653545|FG000|Overall Study|Lack of Efficacy|1|||
48672559|NCT00666965|156653546|FG001|Overall Study|Lack of Efficacy|1|||
48672560|NCT00666965|156653547|FG002|Overall Study|Lack of Efficacy|0|||
48344148|NCT02675998|155457306|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
48344149|NCT02675998|155457307|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
48672561|NCT00666965|156653548|FG003|Overall Study|Lack of Efficacy|0|||
48672562|NCT00666965|156653545|FG000|Overall Study|Protocol Violation|0|||
48760794|NCT02532647|156972335|FG001|Overall Study|Did not receive trial medication|0|||
48760795|NCT02532647|156972336|FG002|Overall Study|Did not receive trial medication|1|||
48760796|NCT00536107|156972337|FG000|Overall Study|Death|5|||
48760797|NCT00536107|156972338|FG001|Overall Study|Death|1|||
48760798|NCT00536107|156972337|FG000|Overall Study|Incorrect enrolment|1|||
48760799|NCT00536107|156972338|FG001|Overall Study|Incorrect enrolment|0|||
48760800|NCT00536107|156972337|FG000|Overall Study|Withdrawal by Subject|0|||
48760801|NCT00536107|156972338|FG001|Overall Study|Withdrawal by Subject|1|||
48760802|NCT00536107|156972337|FG000|Overall Study|Study Termination|2|||
48760803|NCT00536107|156972338|FG001|Overall Study|Study Termination|4|||
48760804|NCT03897179|156972339|FG000|Overall Study|Withdrawal by Subject|1|||
48760805|NCT01480076|156972340|FG000|Overall Study|Run-in Failure|52|||
48760806|NCT01480076|156972340|FG000|Overall Study|Adverse Event|39|||
48760807|NCT01480076|156972340|FG000|Overall Study|Death|2|||
48344150|NCT02675998|155457308|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
48672563|NCT00666965|156653546|FG001|Overall Study|Protocol Violation|0|||
48672564|NCT00666965|156653547|FG002|Overall Study|Protocol Violation|0|||
48672565|NCT00666965|156653548|FG003|Overall Study|Protocol Violation|2|||
48672566|NCT00666965|156653545|FG000|Overall Study|Discontinuation criteria|2|||
48672567|NCT00666965|156653546|FG001|Overall Study|Discontinuation criteria|1|||
48672568|NCT00666965|156653547|FG002|Overall Study|Discontinuation criteria|1|||
48760808|NCT01480076|156972340|FG000|Overall Study|Disease Progression|5|||
48429287|NCT01958671|155760339|FG002|Overall Study|Participant moved|1|||
48344151|NCT02675998|155457305|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
48344152|NCT02675998|155457306|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
48344153|NCT02675998|155457307|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
48344154|NCT02675998|155457308|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
48344155|NCT02675998|155457305|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
48344156|NCT02675998|155457306|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
48344157|NCT02675998|155457307|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
48344158|NCT02675998|155457308|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
48344159|NCT02675998|155457305|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
48344160|NCT02675998|155457306|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
48344161|NCT02675998|155457307|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
48344162|NCT02675998|155457308|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
48344163|NCT02675998|155457305|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
48344164|NCT02675998|155457306|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
48344165|NCT02675998|155457307|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
48344166|NCT02675998|155457308|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
48344167|NCT01703845|155457309|FG000|Overall Study|Adverse Event|1|||
48344168|NCT01703845|155457310|FG001|Overall Study|Adverse Event|0|||
48344169|NCT01703845|155457309|FG000|Overall Study|Protocol Violation|1|||
48344170|NCT01703845|155457310|FG001|Overall Study|Protocol Violation|0|||
48344171|NCT01703845|155457309|FG000|Overall Study|other than stated above|1|||
48344172|NCT01703845|155457310|FG001|Overall Study|other than stated above|0|||
48344173|NCT00848393|155457311|FG000|Overall Study|Protocol Violation|0|||
48344174|NCT00848393|155457312|FG001|Overall Study|Protocol Violation|0|||
48344175|NCT00848393|155457313|FG002|Overall Study|Protocol Violation|1|||
48344176|NCT00848393|155457311|FG000|Overall Study|surgical complications unrelated to stud|0|||
48344177|NCT00848393|155457312|FG001|Overall Study|surgical complications unrelated to stud|0|||
48344178|NCT00848393|155457313|FG002|Overall Study|surgical complications unrelated to stud|2|||
48344179|NCT01194271|155457318|FG000|Overall Study|Withdrawal by Subject|1|||
48344180|NCT01194271|155457318|FG000|Overall Study|Ineligible, Screen Failure|1|||
48344181|NCT01194271|155457318|FG000|Overall Study|Death|1|||
48344182|NCT00443898|155457323|FG000|Overall Study|Adverse Event|0|||
48344183|NCT00443898|155457324|FG001|Overall Study|Adverse Event|0|||
48344184|NCT00443898|155457325|FG002|Overall Study|Adverse Event|1|||
48344185|NCT00443898|155457326|FG003|Overall Study|Adverse Event|1|||
48344186|NCT00443898|155457323|FG000|Overall Study|Lack of Efficacy|2|||
48344187|NCT00443898|155457324|FG001|Overall Study|Lack of Efficacy|3|||
48344188|NCT00443898|155457325|FG002|Overall Study|Lack of Efficacy|3|||
48344189|NCT00443898|155457326|FG003|Overall Study|Lack of Efficacy|1|||
48344190|NCT00443898|155457323|FG000|Overall Study|Protocol Violation|1|||
48344191|NCT00443898|155457324|FG001|Overall Study|Protocol Violation|1|||
48344192|NCT00443898|155457325|FG002|Overall Study|Protocol Violation|1|||
48344193|NCT00443898|155457326|FG003|Overall Study|Protocol Violation|0|||
48344194|NCT00443898|155457323|FG000|Overall Study|Withdrawal by Subject|11|||
48344195|NCT00443898|155457324|FG001|Overall Study|Withdrawal by Subject|10|||
48344196|NCT00443898|155457325|FG002|Overall Study|Withdrawal by Subject|10|||
48344197|NCT00443898|155457326|FG003|Overall Study|Withdrawal by Subject|6|||
48344198|NCT00443898|155457323|FG000|Overall Study|Lost to Follow-up|10|||
48344199|NCT00443898|155457324|FG001|Overall Study|Lost to Follow-up|10|||
48344200|NCT00443898|155457325|FG002|Overall Study|Lost to Follow-up|14|||
48344201|NCT00443898|155457326|FG003|Overall Study|Lost to Follow-up|10|||
48344202|NCT00443898|155457323|FG000|Overall Study|Death|0|||
48344203|NCT00443898|155457324|FG001|Overall Study|Death|1|||
48344204|NCT00443898|155457325|FG002|Overall Study|Death|0|||
48344205|NCT00443898|155457326|FG003|Overall Study|Death|0|||
48344206|NCT00644332|155457329|FG000|Overall Study|Adverse Event|11|||
48672569|NCT00666965|156653548|FG003|Overall Study|Discontinuation criteria|2|||
48672570|NCT00666965|156653545|FG000|Overall Study|Withdrawal by Subject|0|||
48344207|NCT00644332|155457329|FG000|Overall Study|Withdrawal by Subject|6|||
48344208|NCT00644332|155457329|FG000|Overall Study|Completion Status Unknown|2|||
48344209|NCT00644332|155457329|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
48344210|NCT00644332|155457329|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
48344211|NCT02705625|155457330|FG000|Overall Study|Protocol Violation|1|||
48344212|NCT02705625|155457331|FG001|Overall Study|Protocol Violation|0|||
48344213|NCT02705625|155457332|FG002|Overall Study|Protocol Violation|0|||
48344214|NCT02705625|155457330|FG000|Overall Study|Adverse Event|6|||
48344215|NCT02705625|155457331|FG001|Overall Study|Adverse Event|5|||
48344216|NCT02705625|155457332|FG002|Overall Study|Adverse Event|2|||
48344217|NCT02705625|155457330|FG000|Overall Study|Death|0|||
48344218|NCT02705625|155457331|FG001|Overall Study|Death|0|||
48344219|NCT02705625|155457332|FG002|Overall Study|Death|1|||
48344220|NCT02705625|155457330|FG000|Overall Study|Withdrawal by Subject|1|||
48344221|NCT02705625|155457331|FG001|Overall Study|Withdrawal by Subject|4|||
48344222|NCT02705625|155457332|FG002|Overall Study|Withdrawal by Subject|5|||
48344223|NCT02705625|155457330|FG000|Overall Study|Lost to Follow-up|0|||
48672571|NCT00666965|156653546|FG001|Overall Study|Withdrawal by Subject|0|||
48672572|NCT00666965|156653547|FG002|Overall Study|Withdrawal by Subject|0|||
48672573|NCT00666965|156653548|FG003|Overall Study|Withdrawal by Subject|2|||
48672574|NCT01555125|156653559|FG000|Induction Period|Lost to Follow-up|0|||
48672575|NCT01555125|156653560|FG001|Induction Period|Lost to Follow-up|2|||
48672576|NCT01555125|156653561|FG002|Induction Period|Lost to Follow-up|0|||
48672577|NCT01555125|156653562|FG003|Induction Period|Lost to Follow-up|0|||
48672578|NCT01555125|156653563|FG004|Induction Period|Lost to Follow-up|0|||
48672579|NCT01555125|156653559|FG000|Induction Period|Adverse Event|0|||
48672580|NCT01555125|156653560|FG001|Induction Period|Adverse Event|1|||
48672581|NCT01555125|156653561|FG002|Induction Period|Adverse Event|0|||
48672582|NCT01555125|156653562|FG003|Induction Period|Adverse Event|0|||
48672583|NCT01555125|156653563|FG004|Induction Period|Adverse Event|1|||
48672584|NCT01555125|156653559|FG000|Induction Period|Subject / guardian decision|0|||
48672585|NCT01555125|156653560|FG001|Induction Period|Subject / guardian decision|0|||
48672586|NCT01555125|156653561|FG002|Induction Period|Subject / guardian decision|0|||
48672587|NCT01555125|156653562|FG003|Induction Period|Subject / guardian decision|0|||
48672588|NCT01555125|156653563|FG004|Induction Period|Subject / guardian decision|2|||
48672589|NCT01555125|156653559|FG000|Induction Period|Death|1|||
48672590|NCT01555125|156653560|FG001|Induction Period|Death|0|||
48672591|NCT01555125|156653561|FG002|Induction Period|Death|0|||
48672592|NCT01555125|156653562|FG003|Induction Period|Death|0|||
48672593|NCT01555125|156653563|FG004|Induction Period|Death|0|||
48672594|NCT01555125|156653559|FG000|Maintenance Period|Adverse Event|1|||
48672595|NCT01555125|156653560|FG001|Maintenance Period|Adverse Event|1|||
48672596|NCT01555125|156653561|FG002|Maintenance Period|Adverse Event|0|||
48672597|NCT01555125|156653562|FG003|Maintenance Period|Adverse Event|0|||
48672598|NCT01555125|156653563|FG004|Maintenance Period|Adverse Event|0|||
48672599|NCT01555125|156653559|FG000|Maintenance Period|Subject / guardian decision|1|||
48672600|NCT01555125|156653560|FG001|Maintenance Period|Subject / guardian decision|2|||
48672601|NCT01555125|156653561|FG002|Maintenance Period|Subject / guardian decision|0|||
48672602|NCT01555125|156653562|FG003|Maintenance Period|Subject / guardian decision|0|||
48672603|NCT01555125|156653563|FG004|Maintenance Period|Subject / guardian decision|0|||
48672604|NCT01555125|156653559|FG000|Maintenance Period|Lost to Follow-up|2|||
48672605|NCT01555125|156653560|FG001|Maintenance Period|Lost to Follow-up|0|||
48672606|NCT01555125|156653561|FG002|Maintenance Period|Lost to Follow-up|0|||
48672607|NCT01555125|156653562|FG003|Maintenance Period|Lost to Follow-up|1|||
48672608|NCT01555125|156653563|FG004|Maintenance Period|Lost to Follow-up|0|||
48672609|NCT01555125|156653559|FG000|Maintenance Period|Lack of Efficacy|6|||
48672610|NCT01555125|156653560|FG001|Maintenance Period|Lack of Efficacy|1|||
48672611|NCT01555125|156653561|FG002|Maintenance Period|Lack of Efficacy|3|||
48672612|NCT01555125|156653562|FG003|Maintenance Period|Lack of Efficacy|0|||
48672613|NCT01555125|156653563|FG004|Maintenance Period|Lack of Efficacy|0|||
48672614|NCT01555125|156653559|FG000|Maintenance Period|Physician Decision|0|||
48672615|NCT01555125|156653560|FG001|Maintenance Period|Physician Decision|0|||
48672616|NCT01555125|156653561|FG002|Maintenance Period|Physician Decision|1|||
48672617|NCT01555125|156653562|FG003|Maintenance Period|Physician Decision|0|||
48672618|NCT01555125|156653563|FG004|Maintenance Period|Physician Decision|0|||
48672619|NCT01555125|156653559|FG000|Maintenance Period|Death|0|||
48672620|NCT01555125|156653560|FG001|Maintenance Period|Death|0|||
48672621|NCT01555125|156653561|FG002|Maintenance Period|Death|0|||
48672622|NCT01555125|156653562|FG003|Maintenance Period|Death|1|||
48672623|NCT01555125|156653563|FG004|Maintenance Period|Death|0|||
48672624|NCT01555125|156653559|FG000|Extension|Adverse Event|1|||
48672625|NCT01555125|156653560|FG001|Extension|Adverse Event|2|||
48672626|NCT01555125|156653561|FG002|Extension|Adverse Event|1|||
48672627|NCT01555125|156653562|FG003|Extension|Adverse Event|1|||
48672628|NCT01555125|156653563|FG004|Extension|Adverse Event|0|||
48672629|NCT01555125|156653559|FG000|Extension|Protocol deviation|1|||
48672630|NCT01555125|156653560|FG001|Extension|Protocol deviation|0|||
48672631|NCT01555125|156653561|FG002|Extension|Protocol deviation|0|||
48672632|NCT01555125|156653562|FG003|Extension|Protocol deviation|0|||
48672633|NCT01555125|156653563|FG004|Extension|Protocol deviation|0|||
48672634|NCT01555125|156653559|FG000|Extension|Lack of Efficacy|7|||
48672635|NCT01555125|156653560|FG001|Extension|Lack of Efficacy|6|||
48672636|NCT01555125|156653561|FG002|Extension|Lack of Efficacy|3|||
48672637|NCT01555125|156653562|FG003|Extension|Lack of Efficacy|0|||
48672638|NCT01555125|156653563|FG004|Extension|Lack of Efficacy|0|||
48672639|NCT01555125|156653559|FG000|Extension|Lost to Follow-up|2|||
48672640|NCT01555125|156653560|FG001|Extension|Lost to Follow-up|1|||
48672641|NCT01555125|156653561|FG002|Extension|Lost to Follow-up|2|||
48672642|NCT01555125|156653562|FG003|Extension|Lost to Follow-up|0|||
48672643|NCT01555125|156653563|FG004|Extension|Lost to Follow-up|0|||
48672644|NCT01555125|156653559|FG000|Extension|Study terminated by sponsor|32|||
48344224|NCT02705625|155457331|FG001|Overall Study|Lost to Follow-up|0|||
48344225|NCT02705625|155457332|FG002|Overall Study|Lost to Follow-up|1|||
48344226|NCT02705625|155457330|FG000|Overall Study|Non-compliance|0|||
48344227|NCT02705625|155457331|FG001|Overall Study|Non-compliance|1|||
48344228|NCT02705625|155457332|FG002|Overall Study|Non-compliance|1|||
48344229|NCT02705625|155457330|FG000|Overall Study|Overdosing|0|||
48344230|NCT02705625|155457331|FG001|Overall Study|Overdosing|0|||
48344231|NCT02705625|155457332|FG002|Overall Study|Overdosing|1|||
48344232|NCT00510198|155457333|FG000|Overall Study|Withdrawal by Subject|5|||
48344233|NCT00510198|155457334|FG001|Overall Study|Withdrawal by Subject|4|||
48344234|NCT00329550|155457335|FG000|Overall Study|Adverse Event|3|||
48344235|NCT00329550|155457336|FG001|Overall Study|Adverse Event|4|||
48344236|NCT00329550|155457337|FG002|Overall Study|Adverse Event|2|||
48344237|NCT00329550|155457335|FG000|Overall Study|Withdrawal of Consent|1|||
48344238|NCT00329550|155457336|FG001|Overall Study|Withdrawal of Consent|0|||
48344239|NCT00329550|155457337|FG002|Overall Study|Withdrawal of Consent|1|||
48344240|NCT00329550|155457335|FG000|Overall Study|Due to Relocation|0|||
48344241|NCT00329550|155457336|FG001|Overall Study|Due to Relocation|0|||
48344242|NCT00329550|155457337|FG002|Overall Study|Due to Relocation|1|||
48344243|NCT02158247|155457343|FG000|Overall Study|Invisible vocal cords|5|||
48344244|NCT02973802|155457358|FG000|Overall Study|Lost to Follow-up|1|||
48344245|NCT02973802|155457358|FG000|Overall Study|Withdrawal by Subject|1|||
48344246|NCT03357471|155457359|FG000|Overall Study|Adverse Event|1|||
48344247|NCT03357471|155457360|FG001|Overall Study|Adverse Event|0|||
48344248|NCT03357471|155457359|FG000|Overall Study|Lost to Follow-up|1|||
48344249|NCT03357471|155457360|FG001|Overall Study|Lost to Follow-up|0|||
48344250|NCT03730662|155457363|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
48344251|NCT03730662|155457364|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
48344252|NCT03730662|155457365|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
48344253|NCT03730662|155457366|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
48344254|NCT03730662|155457363|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
48344255|NCT03730662|155457364|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
48344256|NCT03730662|155457365|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
48344257|NCT03730662|155457366|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
48344258|NCT03730662|155457363|FG000|Treatment Period (52 Weeks)|Death|6|||
48344259|NCT03730662|155457364|FG001|Treatment Period (52 Weeks)|Death|2|||
48344260|NCT03730662|155457365|FG002|Treatment Period (52 Weeks)|Death|2|||
48344261|NCT03730662|155457366|FG003|Treatment Period (52 Weeks)|Death|9|||
48344262|NCT03730662|155457363|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
48344263|NCT03730662|155457364|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
48344264|NCT03730662|155457365|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
48344265|NCT03730662|155457366|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
48344266|NCT03730662|155457363|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
48344267|NCT03730662|155457364|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
48344268|NCT03730662|155457365|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
48344269|NCT03730662|155457366|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
48344270|NCT03730662|155457363|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
48344271|NCT03730662|155457364|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
48344272|NCT03730662|155457365|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
48344273|NCT03730662|155457366|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
48344274|NCT03730662|155457363|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
48344275|NCT03730662|155457364|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
48344276|NCT03730662|155457365|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
48344277|NCT03730662|155457366|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
48344278|NCT03730662|155457363|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
48344279|NCT03730662|155457364|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
48344280|NCT03730662|155457365|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
48344281|NCT03730662|155457366|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
48344282|NCT03730662|155457363|FG000|Variable Treatment Period|Adverse Event|1|||
48344283|NCT03730662|155457364|FG001|Variable Treatment Period|Adverse Event|2|||
48344284|NCT03730662|155457365|FG002|Variable Treatment Period|Adverse Event|0|||
48344285|NCT03730662|155457366|FG003|Variable Treatment Period|Adverse Event|7|||
48344286|NCT03730662|155457363|FG000|Variable Treatment Period|Death|9|||
48344287|NCT03730662|155457364|FG001|Variable Treatment Period|Death|0|||
48344288|NCT03730662|155457365|FG002|Variable Treatment Period|Death|6|||
48344289|NCT03730662|155457366|FG003|Variable Treatment Period|Death|26|||
48344290|NCT03730662|155457363|FG000|Variable Treatment Period|Lost to Follow-up|2|||
48344291|NCT03730662|155457364|FG001|Variable Treatment Period|Lost to Follow-up|1|||
48344292|NCT03730662|155457365|FG002|Variable Treatment Period|Lost to Follow-up|4|||
48344293|NCT03730662|155457366|FG003|Variable Treatment Period|Lost to Follow-up|11|||
48344294|NCT03730662|155457363|FG000|Variable Treatment Period|Personal Reason|0|||
48344295|NCT03730662|155457364|FG001|Variable Treatment Period|Personal Reason|2|||
48344296|NCT03730662|155457365|FG002|Variable Treatment Period|Personal Reason|1|||
48344297|NCT03730662|155457366|FG003|Variable Treatment Period|Personal Reason|6|||
48344298|NCT03730662|155457363|FG000|Variable Treatment Period|Physician Decision|0|||
48344299|NCT03730662|155457364|FG001|Variable Treatment Period|Physician Decision|0|||
48344300|NCT03730662|155457365|FG002|Variable Treatment Period|Physician Decision|0|||
48344301|NCT03730662|155457366|FG003|Variable Treatment Period|Physician Decision|3|||
48344302|NCT03730662|155457363|FG000|Variable Treatment Period|Protocol Violation|0|||
48344303|NCT03730662|155457364|FG001|Variable Treatment Period|Protocol Violation|1|||
48344304|NCT03730662|155457365|FG002|Variable Treatment Period|Protocol Violation|1|||
48344305|NCT03730662|155457366|FG003|Variable Treatment Period|Protocol Violation|1|||
48344306|NCT03730662|155457363|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
48344307|NCT03730662|155457364|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
48344308|NCT03730662|155457365|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
48344309|NCT03730662|155457366|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
48344310|NCT03168425|155457371|FG000|Overall Study|Lost to Follow-up|5|||
48344311|NCT03168425|155457372|FG001|Overall Study|Lost to Follow-up|8|||
48344312|NCT03168425|155457371|FG000|Overall Study|unable to confirm post op opioids|2|||
48344313|NCT03168425|155457372|FG001|Overall Study|unable to confirm post op opioids|3|||
48344314|NCT04491006|155457373|FG000|Overall Study|Adverse Event|0|||
48344315|NCT04491006|155457374|FG001|Overall Study|Adverse Event|3|||
48344316|NCT04491006|155457375|FG002|Overall Study|Adverse Event|5|||
48344317|NCT04491006|155457373|FG000|Overall Study|Withdrawal by Subject|1|||
48344318|NCT04491006|155457374|FG001|Overall Study|Withdrawal by Subject|0|||
48344319|NCT04491006|155457375|FG002|Overall Study|Withdrawal by Subject|2|||
48344320|NCT02166047|155457376|FG000|Overall Study|Withdrawal by Participant|0|||
48344321|NCT02166047|155457377|FG001|Overall Study|Withdrawal by Participant|1|||
48344322|NCT02166047|155457378|FG002|Overall Study|Withdrawal by Participant|2|||
48344323|NCT02166047|155457379|FG003|Overall Study|Withdrawal by Participant|0|||
48344324|NCT02166047|155457380|FG004|Overall Study|Withdrawal by Participant|0|||
48344325|NCT02166047|155457381|FG005|Overall Study|Withdrawal by Participant|0|||
48344326|NCT02166047|155457382|FG006|Overall Study|Withdrawal by Participant|1|||
48344327|NCT02166047|155457383|FG007|Overall Study|Withdrawal by Participant|0|||
48344328|NCT02166047|155457384|FG008|Overall Study|Withdrawal by Participant|0|||
48344329|NCT02166047|155457385|FG009|Overall Study|Withdrawal by Participant|0|||
48344330|NCT02166047|155457386|FG010|Overall Study|Withdrawal by Participant|0|||
48344331|NCT02166047|155457387|FG011|Overall Study|Withdrawal by Participant|0|||
48344332|NCT02166047|155457376|FG000|Overall Study|Adverse Event|0|||
48344333|NCT02166047|155457377|FG001|Overall Study|Adverse Event|0|||
48344334|NCT02166047|155457378|FG002|Overall Study|Adverse Event|0|||
48344335|NCT02166047|155457379|FG003|Overall Study|Adverse Event|0|||
48344336|NCT02166047|155457380|FG004|Overall Study|Adverse Event|1|||
48344337|NCT02166047|155457381|FG005|Overall Study|Adverse Event|0|||
48344338|NCT02166047|155457382|FG006|Overall Study|Adverse Event|1|||
48760809|NCT01480076|156972340|FG000|Overall Study|Non-compliance With Study Protocol|15|||
48344339|NCT02166047|155457383|FG007|Overall Study|Adverse Event|0|||
48344340|NCT02166047|155457384|FG008|Overall Study|Adverse Event|0|||
48672645|NCT01555125|156653560|FG001|Extension|Study terminated by sponsor|33|||
48672646|NCT01555125|156653561|FG002|Extension|Study terminated by sponsor|16|||
48760810|NCT01480076|156972340|FG000|Overall Study|Withdrawal by Subject|105|||
48760811|NCT01480076|156972340|FG000|Overall Study|Lost to Follow-up|7|||
48760812|NCT01480076|156972340|FG000|Overall Study|Investigator Decision|13|||
48760813|NCT01480076|156972340|FG000|Overall Study|Other|52|||
48344341|NCT02166047|155457385|FG009|Overall Study|Adverse Event|0|||
48344342|NCT02166047|155457386|FG010|Overall Study|Adverse Event|2|||
48344343|NCT02166047|155457387|FG011|Overall Study|Adverse Event|0|||
48344344|NCT01049984|155457395|FG000|Overall Study|Withdrawal by Subject|1|||
48344345|NCT01049984|155457396|FG001|Overall Study|Withdrawal by Subject|5|||
48672647|NCT01555125|156653562|FG003|Extension|Study terminated by sponsor|20|||
48672648|NCT01555125|156653563|FG004|Extension|Study terminated by sponsor|0|||
48672649|NCT01555125|156653559|FG000|Extension|Subject/guardian decision|1|||
48672650|NCT01555125|156653560|FG001|Extension|Subject/guardian decision|9|||
48672651|NCT01555125|156653561|FG002|Extension|Subject/guardian decision|1|||
48672652|NCT01555125|156653562|FG003|Extension|Subject/guardian decision|0|||
48672653|NCT01555125|156653563|FG004|Extension|Subject/guardian decision|0|||
48672654|NCT01555125|156653559|FG000|Extension|Technical Problems|1|||
48672655|NCT01555125|156653560|FG001|Extension|Technical Problems|0|||
48672656|NCT01555125|156653561|FG002|Extension|Technical Problems|0|||
48672657|NCT01555125|156653562|FG003|Extension|Technical Problems|1|||
48672658|NCT01555125|156653563|FG004|Extension|Technical Problems|0|||
48672659|NCT01555125|156653559|FG000|Follow-Up Period|Lost to Follow-up|1|||
48672660|NCT01555125|156653560|FG001|Follow-Up Period|Lost to Follow-up|0|||
48344346|NCT01049984|155457395|FG000|Overall Study|Protocol Violation|3|||
48344347|NCT01049984|155457396|FG001|Overall Study|Protocol Violation|4|||
48672661|NCT01555125|156653561|FG002|Follow-Up Period|Lost to Follow-up|0|||
48672662|NCT01555125|156653562|FG003|Follow-Up Period|Lost to Follow-up|0|||
48672663|NCT01555125|156653563|FG004|Follow-Up Period|Lost to Follow-up|0|||
48672664|NCT01555125|156653559|FG000|Follow-Up Period|Subject / guardian decision|3|||
48672665|NCT01555125|156653560|FG001|Follow-Up Period|Subject / guardian decision|1|||
48344348|NCT01049984|155457395|FG000|Overall Study|Lost to Follow-up|2|||
48672666|NCT01555125|156653561|FG002|Follow-Up Period|Subject / guardian decision|1|||
48672667|NCT01555125|156653562|FG003|Follow-Up Period|Subject / guardian decision|1|||
48672668|NCT01555125|156653563|FG004|Follow-Up Period|Subject / guardian decision|0|||
48672669|NCT04268745|156653566|FG000|Overall Study|Lost to Follow-up|2|||
48672670|NCT04268745|156653567|FG001|Overall Study|Lost to Follow-up|3|||
48672671|NCT04268745|156653566|FG000|Overall Study|Withdrawal by Subject|4|||
48672672|NCT04268745|156653567|FG001|Overall Study|Withdrawal by Subject|2|||
48672673|NCT04268745|156653566|FG000|Overall Study|Death in the family|1|||
48672674|NCT04268745|156653567|FG001|Overall Study|Death in the family|0|||
48672675|NCT04058886|156653568|FG000|Overall Study|Withdrawal by Subject|4|||
48672676|NCT04058886|156653568|FG000|Overall Study|Inadequate deafness interpreter service|1|||
48672677|NCT01371305|156653569|FG000|Overall Study|Adverse Event|0|||
48672678|NCT01371305|156653570|FG001|Overall Study|Adverse Event|0|||
48672679|NCT01371305|156653571|FG002|Overall Study|Adverse Event|0|||
48672680|NCT01371305|156653572|FG003|Overall Study|Adverse Event|2|||
48672681|NCT01371305|156653573|FG004|Overall Study|Adverse Event|1|||
48672682|NCT01371305|156653574|FG005|Overall Study|Adverse Event|0|||
48672683|NCT01371305|156653569|FG000|Overall Study|Study terminated by sponsor|0|||
48672684|NCT01371305|156653570|FG001|Overall Study|Study terminated by sponsor|0|||
48672685|NCT01371305|156653571|FG002|Overall Study|Study terminated by sponsor|0|||
48672686|NCT01371305|156653572|FG003|Overall Study|Study terminated by sponsor|0|||
48672687|NCT01371305|156653573|FG004|Overall Study|Study terminated by sponsor|3|||
48672688|NCT01371305|156653574|FG005|Overall Study|Study terminated by sponsor|1|||
48672689|NCT01371305|156653569|FG000|Overall Study|Subject request|0|||
48672690|NCT01371305|156653570|FG001|Overall Study|Subject request|0|||
48672691|NCT01371305|156653571|FG002|Overall Study|Subject request|0|||
48672692|NCT01371305|156653572|FG003|Overall Study|Subject request|0|||
48672693|NCT01371305|156653573|FG004|Overall Study|Subject request|0|||
48672694|NCT01371305|156653574|FG005|Overall Study|Subject request|1|||
48760814|NCT00704535|156972341|FG000|Overall Study|Adverse Event|2|||
48760815|NCT00704535|156972341|FG000|Overall Study|Death|2|||
48760816|NCT00704535|156972341|FG000|Overall Study|Lost to Follow-up|8|||
48760817|NCT00704535|156972341|FG000|Overall Study|Protocol Violation|10|||
48760818|NCT00704535|156972341|FG000|Overall Study|Completed status not on Case Report Form|124|||
48760819|NCT00371254|156972344|FG000|Overall Study|Disease progression|13|||
48760820|NCT00371254|156972345|FG001|Overall Study|Disease progression|13|||
48760821|NCT00371254|156972344|FG000|Overall Study|Study drug toxicity|3|||
48760822|NCT00371254|156972345|FG001|Overall Study|Study drug toxicity|5|||
48760823|NCT00371254|156972344|FG000|Overall Study|Subject request|5|||
48760824|NCT00371254|156972345|FG001|Overall Study|Subject request|0|||
48760825|NCT00371254|156972344|FG000|Overall Study|Investigator Decision|2|||
48344349|NCT01049984|155457396|FG001|Overall Study|Lost to Follow-up|1|||
48344350|NCT01049984|155457395|FG000|Overall Study|Adverse Event|13|||
48344351|NCT01049984|155457396|FG001|Overall Study|Adverse Event|7|||
48344352|NCT01049984|155457395|FG000|Overall Study|Treatment failure|0|||
48672695|NCT02999633|156653576|FG000|Overall Study|Adverse Event|2|||
48672696|NCT02999633|156653576|FG000|Overall Study|Progressive disease|12|||
48672697|NCT01092663|156653589|FG000|Overall Study|Withdrawal by Subject|3|||
48672698|NCT01092663|156653590|FG001|Overall Study|Withdrawal by Subject|2|||
48672699|NCT01092663|156653589|FG000|Overall Study|Glucose >300mg/dL|1|||
48672700|NCT01092663|156653590|FG001|Overall Study|Glucose >300mg/dL|0|||
48344353|NCT01049984|155457396|FG001|Overall Study|Treatment failure|2|||
48760826|NCT00371254|156972345|FG001|Overall Study|Investigator Decision|0|||
48344354|NCT02254681|155457397|FG000|Overall Study|Lack of Efficacy|6|||
48344355|NCT03461211|155457403|FG000|Overall Study|Adverse Event|1|||
48344356|NCT03461211|155457404|FG001|Overall Study|Adverse Event|1|||
48344357|NCT03461211|155457403|FG000|Overall Study|Lack of Efficacy|0|||
48344358|NCT03461211|155457404|FG001|Overall Study|Lack of Efficacy|1|||
48344359|NCT03807700|155457405|FG000|Overall Study|Withdrawal by Subject|2|||
48344360|NCT03807700|155457406|FG001|Overall Study|Withdrawal by Subject|1|||
48344361|NCT00053352|155457410|FG000|Overall Study|Lost to Follow-up|0|||
48344362|NCT00053352|155457411|FG001|Overall Study|Lost to Follow-up|1|||
48344363|NCT00053352|155457410|FG000|Overall Study|Physician Decision|11|||
48344364|NCT00053352|155457411|FG001|Overall Study|Physician Decision|1|||
48344365|NCT00053352|155457410|FG000|Overall Study|Withdrawal by Subject|1|||
48344366|NCT00053352|155457411|FG001|Overall Study|Withdrawal by Subject|0|||
48344367|NCT00053352|155457410|FG000|Overall Study|Ineligible|8|||
48344368|NCT00053352|155457411|FG001|Overall Study|Ineligible|8|||
48344369|NCT00053352|155457410|FG000|Overall Study|Disease at new site|1|||
48344370|NCT00053352|155457411|FG001|Overall Study|Disease at new site|0|||
48344371|NCT02316847|155457412|FG000|Overall Study|Adverse Event|0|||
48344372|NCT02316847|155457413|FG001|Overall Study|Adverse Event|3|||
48344373|NCT02316847|155457412|FG000|Overall Study|Lost to Follow-up|0|||
48672701|NCT01092663|156653589|FG000|Overall Study|High fasting triglyceride|2|||
48672702|NCT01092663|156653590|FG001|Overall Study|High fasting triglyceride|0|||
48672703|NCT01092663|156653589|FG000|Overall Study|Adverse Event|1|||
48672704|NCT01092663|156653590|FG001|Overall Study|Adverse Event|1|||
48672705|NCT01092663|156653589|FG000|Overall Study|Protocol Violation|0|||
48672706|NCT01092663|156653590|FG001|Overall Study|Protocol Violation|1|||
48672707|NCT03908970|156653591|FG000|Overall Study|Adverse Event|7|||
48672708|NCT03908970|156653592|FG001|Overall Study|Adverse Event|21|||
48672709|NCT03908970|156653591|FG000|Overall Study|Physician Decision|1|||
48672710|NCT03908970|156653592|FG001|Overall Study|Physician Decision|4|||
48672711|NCT03908970|156653591|FG000|Overall Study|Withdrawal by Subject|9|||
48672712|NCT03908970|156653592|FG001|Overall Study|Withdrawal by Subject|22|||
48672713|NCT03565237|156653593|FG000|Overall Study|Non-compliance of Investigational Product|1|||
48672714|NCT03565237|156653593|FG000|Overall Study|Physician Decision|1|||
48672715|NCT01140061|156653594|FG000|Part I|Adverse Event|1|||
48672716|NCT01140061|156653595|FG001|Part I|Adverse Event|0|||
48672717|NCT01140061|156653596|FG002|Part I|Adverse Event|0|||
48672718|NCT01140061|156653597|FG003|Part I|Adverse Event|0|||
48672719|NCT01140061|156653598|FG004|Part I|Adverse Event|0|||
48672720|NCT01140061|156653599|FG005|Part I|Adverse Event|0|||
48760827|NCT00371254|156972344|FG000|Overall Study|Adverse event unrelated to study drug|0|||
48760828|NCT00371254|156972345|FG001|Overall Study|Adverse event unrelated to study drug|1|||
48760829|NCT00371254|156972344|FG000|Overall Study|Lost to Follow-up|0|||
48760830|NCT00371254|156972345|FG001|Overall Study|Lost to Follow-up|1|||
48760831|NCT00371254|156972344|FG000|Overall Study|Withdrawal by Subject|0|||
48760832|NCT00371254|156972345|FG001|Overall Study|Withdrawal by Subject|1|||
48760833|NCT01324388|156972346|FG000|Part 1 of Study|Adverse Event|2|||
48760834|NCT01324388|156972347|FG001|Part 1 of Study|Adverse Event|0|||
48760835|NCT01324388|156972348|FG002|Part 1 of Study|Adverse Event|0|||
48344374|NCT02316847|155457413|FG001|Overall Study|Lost to Follow-up|2|||
48344375|NCT02316847|155457412|FG000|Overall Study|Physician Decision|0|||
48672721|NCT01140061|156653600|FG006|Part I|Adverse Event|0|||
48672722|NCT01140061|156653601|FG007|Part I|Adverse Event|0|||
48672723|NCT01140061|156653602|FG008|Part I|Adverse Event|0|||
48672724|NCT01140061|156653603|FG009|Part I|Adverse Event|0|||
48672725|NCT01140061|156653594|FG000|Extension|Laboratory Adverse Event|0|||
48672726|NCT01140061|156653595|FG001|Extension|Laboratory Adverse Event|0|||
48672727|NCT01140061|156653596|FG002|Extension|Laboratory Adverse Event|0|||
48672728|NCT01140061|156653597|FG003|Extension|Laboratory Adverse Event|0|||
48672729|NCT01140061|156653598|FG004|Extension|Laboratory Adverse Event|0|||
48672730|NCT01140061|156653599|FG005|Extension|Laboratory Adverse Event|0|||
48672731|NCT01140061|156653600|FG006|Extension|Laboratory Adverse Event|0|||
48672732|NCT01140061|156653601|FG007|Extension|Laboratory Adverse Event|0|||
48672733|NCT01140061|156653602|FG008|Extension|Laboratory Adverse Event|0|||
48672734|NCT01140061|156653603|FG009|Extension|Laboratory Adverse Event|1|||
48672735|NCT04006392|156653607|FG000|Overall Study|Lost to Follow-up|0|||
48672736|NCT04006392|156653608|FG001|Overall Study|Lost to Follow-up|1|||
48672737|NCT01067469|156653610|FG000|Overall Study|Withdrawal by Subject|0|||
48672738|NCT01067469|156653611|FG001|Overall Study|Withdrawal by Subject|1|||
48672739|NCT01067469|156653610|FG000|Overall Study|Disease Progression|0|||
48672740|NCT01067469|156653611|FG001|Overall Study|Disease Progression|1|||
48672741|NCT01959243|156653612|FG000|Overall Study|Investigator Decision|3|||
48672742|NCT01959243|156653613|FG001|Overall Study|Investigator Decision|0|||
48672743|NCT01959243|156653612|FG000|Overall Study|Adverse Event|5|||
48672744|NCT01959243|156653613|FG001|Overall Study|Adverse Event|2|||
48672745|NCT01959243|156653612|FG000|Overall Study|Administrative reasons|2|||
48672746|NCT01959243|156653613|FG001|Overall Study|Administrative reasons|1|||
48672747|NCT01959243|156653612|FG000|Overall Study|Lost to Follow-up|3|||
48672748|NCT01959243|156653613|FG001|Overall Study|Lost to Follow-up|1|||
48672749|NCT00428844|156653614|FG000|Completed Study Drug Treatment|Adverse Event|2|||
48672750|NCT00428844|156653615|FG001|Completed Study Drug Treatment|Adverse Event|4|||
48672751|NCT00428844|156653616|FG002|Completed Study Drug Treatment|Adverse Event|4|||
48672752|NCT00428844|156653614|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
48672753|NCT00428844|156653615|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
48672754|NCT00428844|156653616|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
48672755|NCT00428844|156653614|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
48672756|NCT00428844|156653615|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
48672757|NCT00428844|156653616|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
48672758|NCT00428844|156653614|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
48672759|NCT00428844|156653615|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
48672760|NCT00428844|156653616|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
48672761|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
48672762|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
48672763|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
48672764|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
48672765|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
48672766|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
48672767|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
48672768|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
48672769|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
48672770|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
48672771|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
48672772|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
48672773|NCT00428844|156653614|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
48672774|NCT00428844|156653615|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
48672775|NCT00428844|156653616|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
48672776|NCT04576897|156653617|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
48672777|NCT03824587|156653618|FG000|Run-in Period|Screen Failure|0|||
48672778|NCT03824587|156653619|FG001|Run-in Period|Screen Failure|275|||
48672779|NCT03824587|156653618|FG000|Treatment Period|Adverse Event|4|||
48672780|NCT03824587|156653619|FG001|Treatment Period|Adverse Event|1|||
48760836|NCT01324388|156972349|FG003|Part 1 of Study|Adverse Event|0|||
48760837|NCT01324388|156972346|FG000|Part 1 of Study|Protocol Violation|1|||
48344376|NCT02316847|155457413|FG001|Overall Study|Physician Decision|1|||
48344377|NCT02316847|155457412|FG000|Overall Study|Pregnancy|0|||
48344378|NCT02316847|155457413|FG001|Overall Study|Pregnancy|1|||
48344379|NCT02316847|155457412|FG000|Overall Study|Withdrawal by Subject|2|||
48344380|NCT02316847|155457413|FG001|Overall Study|Withdrawal by Subject|9|||
48672781|NCT03824587|156653618|FG000|Treatment Period|Withdrawal by Subject|0|||
48672782|NCT03824587|156653619|FG001|Treatment Period|Withdrawal by Subject|1|||
48672783|NCT03824587|156653618|FG000|Treatment Period|Kidney Transplant|1|||
48672784|NCT03824587|156653619|FG001|Treatment Period|Kidney Transplant|1|||
48672785|NCT02126839|156653620|FG000|Overall Study|Adverse Event|0|||
48672786|NCT02126839|156653621|FG001|Overall Study|Adverse Event|1|||
48672787|NCT02126839|156653620|FG000|Overall Study|Withdrawal by Subject|1|||
48760838|NCT01324388|156972347|FG001|Part 1 of Study|Protocol Violation|2|||
48429366|NCT01070550|155760355|FG000|Overall Study|Non-responders|493|||
48344381|NCT02316847|155457412|FG000|Overall Study|Noncompliance with study drug|0|||
48344382|NCT02316847|155457413|FG001|Overall Study|Noncompliance with study drug|3|||
48344383|NCT02316847|155457412|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
48344384|NCT02316847|155457413|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
48760839|NCT01324388|156972348|FG002|Part 1 of Study|Protocol Violation|0|||
48344385|NCT01370018|155457414|FG000|Overall Study|Did not meet criteria for analysis|1|||
48429367|NCT01070550|155760356|FG001|Overall Study|Non-responders|4|||
48760840|NCT01324388|156972349|FG003|Part 1 of Study|Protocol Violation|0|||
48760841|NCT01324388|156972346|FG000|Part 1 of Study|Physician Decision|1|||
48760842|NCT01324388|156972347|FG001|Part 1 of Study|Physician Decision|0|||
48760843|NCT01324388|156972348|FG002|Part 1 of Study|Physician Decision|0|||
48760844|NCT01324388|156972349|FG003|Part 1 of Study|Physician Decision|0|||
48760845|NCT01324388|156972346|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
48760846|NCT01324388|156972347|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
48760847|NCT01324388|156972348|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
48760848|NCT01324388|156972349|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
48760849|NCT01324388|156972346|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
48760850|NCT01324388|156972347|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
48760851|NCT01324388|156972348|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
48760852|NCT01324388|156972349|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
48760853|NCT01405963|156972350|FG000|Overall Study|Moved Away|2|||
48760854|NCT01405963|156972351|FG001|Overall Study|Moved Away|0|||
48760855|NCT01405963|156972350|FG000|Overall Study|Adverse Event|0|||
48760856|NCT01405963|156972351|FG001|Overall Study|Adverse Event|1|||
48760857|NCT01405963|156972350|FG000|Overall Study|Lost to Follow-up|0|||
48760858|NCT01405963|156972351|FG001|Overall Study|Lost to Follow-up|1|||
48760859|NCT01187043|156972352|FG000|Overall Study|Adverse Event|0|||
48760860|NCT01187043|156972353|FG001|Overall Study|Adverse Event|0|||
48760861|NCT01187043|156972354|FG002|Overall Study|Adverse Event|0|||
48760862|NCT01187043|156972355|FG003|Overall Study|Adverse Event|0|||
48760863|NCT01187043|156972356|FG004|Overall Study|Adverse Event|1|||
48760864|NCT01187043|156972352|FG000|Overall Study|Unable to make scheduled visits|1|||
48760865|NCT01187043|156972353|FG001|Overall Study|Unable to make scheduled visits|0|||
48760866|NCT01187043|156972354|FG002|Overall Study|Unable to make scheduled visits|4|||
48760867|NCT01187043|156972355|FG003|Overall Study|Unable to make scheduled visits|0|||
48760868|NCT01187043|156972356|FG004|Overall Study|Unable to make scheduled visits|1|||
48760869|NCT02802592|156972360|FG000|Overall Study|Study terminated due to loss of funding|4|||
48760870|NCT00108160|156972361|FG000|Overall Study|Lost to Follow-up|25|||
48760871|NCT00108160|156972362|FG001|Overall Study|Lost to Follow-up|12|||
48760872|NCT00108160|156972361|FG000|Overall Study|Death|1|||
48760873|NCT00108160|156972362|FG001|Overall Study|Death|2|||
48760874|NCT00108160|156972361|FG000|Overall Study|Withdrawal by Subject|4|||
48760875|NCT00108160|156972362|FG001|Overall Study|Withdrawal by Subject|2|||
48760876|NCT00108160|156972361|FG000|Overall Study|Protocol Violation|9|||
48760877|NCT00108160|156972362|FG001|Overall Study|Protocol Violation|5|||
48760878|NCT02081079|156972363|FG000|Overall Study|Lack of Efficacy|3|||
48760879|NCT02081079|156972364|FG001|Overall Study|Lack of Efficacy|2|||
48760880|NCT02081079|156972363|FG000|Overall Study|Lost to Follow-up|1|||
48760881|NCT02081079|156972364|FG001|Overall Study|Lost to Follow-up|0|||
48760882|NCT02225743|156972365|FG000|Overall Study|Withdrawal by Subject|18|||
48760883|NCT00484939|156972372|FG000|Overall Study|Death|9|||
48760884|NCT00484939|156972373|FG001|Overall Study|Death|13|||
48760885|NCT00484939|156972372|FG000|Overall Study|Adverse Event|22|||
48760886|NCT00484939|156972373|FG001|Overall Study|Adverse Event|12|||
48760887|NCT00484939|156972372|FG000|Overall Study|Patient Withdrew Consent|19|||
48760888|NCT00484939|156972373|FG001|Overall Study|Patient Withdrew Consent|10|||
48760889|NCT00484939|156972372|FG000|Overall Study|Protocol Violation|3|||
48760890|NCT00484939|156972373|FG001|Overall Study|Protocol Violation|3|||
48760891|NCT00484939|156972372|FG000|Overall Study|Lost to Follow-up|0|||
48760892|NCT00484939|156972373|FG001|Overall Study|Lost to Follow-up|3|||
48760893|NCT00484939|156972372|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
48760894|NCT00484939|156972373|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
48760895|NCT00484939|156972372|FG000|Overall Study|Disease progression|67|||
48760896|NCT00484939|156972373|FG001|Overall Study|Disease progression|88|||
48760897|NCT00484939|156972372|FG000|Overall Study|Screen Failure|2|||
48760898|NCT00484939|156972373|FG001|Overall Study|Screen Failure|2|||
48760899|NCT00484939|156972372|FG000|Overall Study|Reason Not Specified|11|||
48760900|NCT00484939|156972373|FG001|Overall Study|Reason Not Specified|6|||
48760901|NCT00101907|156972376|FG000|Overall Study|Adverse Event|1|||
48760902|NCT00101907|156972377|FG001|Overall Study|Adverse Event|0|||
48760903|NCT00101907|156972378|FG002|Overall Study|Adverse Event|0|||
48760904|NCT00101907|156972379|FG003|Overall Study|Adverse Event|0|||
48760905|NCT00101907|156972380|FG004|Overall Study|Adverse Event|0|||
48760906|NCT00101907|156972381|FG005|Overall Study|Adverse Event|0|||
48760907|NCT00101907|156972376|FG000|Overall Study|Death|0|||
48760908|NCT00101907|156972377|FG001|Overall Study|Death|1|||
48672788|NCT02126839|156653621|FG001|Overall Study|Withdrawal by Subject|0|||
48672789|NCT02126839|156653620|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48760909|NCT00101907|156972378|FG002|Overall Study|Death|0|||
48672790|NCT02126839|156653621|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48672791|NCT02126839|156653620|FG000|Overall Study|Protocol Violation|2|||
48344386|NCT01525641|155457415|FG000|Overall Study|Case report form not collected|25|||
48344387|NCT01525641|155457415|FG000|Overall Study|No visit since the first visit|16|||
48344388|NCT01525641|155457415|FG000|Overall Study|Adverse Event|73|||
48344389|NCT01525641|155457415|FG000|Overall Study|Lack of Efficacy|24|||
48344390|NCT01525641|155457415|FG000|Overall Study|Improvement|5|||
48344391|NCT01525641|155457415|FG000|Overall Study|Lost to follow-up (relocation)|1|||
48344392|NCT01525641|155457415|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
48344393|NCT01525641|155457415|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
48344394|NCT01525641|155457415|FG000|Overall Study|Other than stated above|7|||
48344395|NCT02236598|155457423|FG000|Overall Study|Adverse Event|0|||
48344396|NCT02236598|155457424|FG001|Overall Study|Adverse Event|1|||
48344397|NCT02236598|155457423|FG000|Overall Study|Withdrawal by Subject|0|||
48344398|NCT02236598|155457424|FG001|Overall Study|Withdrawal by Subject|1|||
48344399|NCT01713998|155457434|FG000|Overall Study|Lost to Follow-up|2|||
48344400|NCT01713998|155457435|FG001|Overall Study|Lost to Follow-up|0|||
48344401|NCT01713998|155457436|FG002|Overall Study|Lost to Follow-up|2|||
48344402|NCT01713998|155457434|FG000|Overall Study|Withdrawal by Subject|1|||
48344403|NCT01713998|155457435|FG001|Overall Study|Withdrawal by Subject|0|||
48344404|NCT01713998|155457436|FG002|Overall Study|Withdrawal by Subject|0|||
48344405|NCT03811834|155457437|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
48344406|NCT01560585|155457443|FG000|Overall Study|Physician Decision|3|||
48344407|NCT01363297|155457446|FG000|Overall Study|Other|0|||
48344408|NCT01363297|155457447|FG001|Overall Study|Other|0|||
48344409|NCT01363297|155457448|FG002|Overall Study|Other|0|||
48344410|NCT01363297|155457449|FG003|Overall Study|Other|0|||
48760910|NCT00101907|156972379|FG003|Overall Study|Death|0|||
48344411|NCT01363297|155457450|FG004|Overall Study|Other|1|||
48344412|NCT01363297|155457446|FG000|Overall Study|Death|3|||
48344413|NCT01363297|155457447|FG001|Overall Study|Death|6|||
48344414|NCT01363297|155457448|FG002|Overall Study|Death|6|||
48344415|NCT01363297|155457449|FG003|Overall Study|Death|10|||
48344416|NCT01363297|155457450|FG004|Overall Study|Death|30|||
48344417|NCT01705145|155457453|FG000|Part B|Adverse Event|1|||
48344418|NCT01203956|155457454|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
48344419|NCT01203956|155457455|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
48344420|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
48344421|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
48344422|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
48672792|NCT02126839|156653621|FG001|Overall Study|Protocol Violation|3|||
48672793|NCT02126839|156653620|FG000|Overall Study|Sponsor request|0|||
48672794|NCT02126839|156653621|FG001|Overall Study|Sponsor request|1|||
48672795|NCT02126839|156653620|FG000|Overall Study|Lost to Follow-up|1|||
48672796|NCT02126839|156653621|FG001|Overall Study|Lost to Follow-up|4|||
48672797|NCT02126839|156653620|FG000|Overall Study|Other|5|||
48672798|NCT02126839|156653621|FG001|Overall Study|Other|5|||
48672799|NCT00812565|156653622|FG000|Overall Study|Did Not Receive Study Medication|1|||
48672800|NCT00812565|156653623|FG001|Overall Study|Did Not Receive Study Medication|1|||
48672801|NCT00812565|156653624|FG002|Overall Study|Did Not Receive Study Medication|0|||
48672802|NCT00812565|156653625|FG003|Overall Study|Did Not Receive Study Medication|0|||
48672803|NCT00812565|156653626|FG004|Overall Study|Did Not Receive Study Medication|0|||
48672804|NCT00812565|156653627|FG005|Overall Study|Did Not Receive Study Medication|0|||
48672805|NCT00812565|156653628|FG006|Overall Study|Did Not Receive Study Medication|0|||
48672806|NCT00812565|156653629|FG007|Overall Study|Did Not Receive Study Medication|0|||
48672807|NCT00812565|156653622|FG000|Overall Study|Adverse Event|0|||
48672808|NCT00812565|156653623|FG001|Overall Study|Adverse Event|0|||
48672809|NCT00812565|156653624|FG002|Overall Study|Adverse Event|0|||
48760911|NCT00101907|156972380|FG004|Overall Study|Death|3|||
48760912|NCT00101907|156972381|FG005|Overall Study|Death|0|||
48344423|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
48760913|NCT00101907|156972376|FG000|Overall Study|Physician Decision|0|||
48344424|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
48344425|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
48344426|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
48344427|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
48344428|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
48344429|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
48344430|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
48672810|NCT00812565|156653625|FG003|Overall Study|Adverse Event|2|||
48672811|NCT00812565|156653626|FG004|Overall Study|Adverse Event|0|||
48672812|NCT00812565|156653627|FG005|Overall Study|Adverse Event|0|||
48760914|NCT00101907|156972377|FG001|Overall Study|Physician Decision|0|||
48344431|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
48344432|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
48429368|NCT01070550|155760357|FG002|Overall Study|Non-responders|21|||
48760915|NCT00101907|156972378|FG002|Overall Study|Physician Decision|0|||
48760916|NCT00101907|156972379|FG003|Overall Study|Physician Decision|1|||
48760917|NCT00101907|156972380|FG004|Overall Study|Physician Decision|1|||
48760918|NCT00101907|156972381|FG005|Overall Study|Physician Decision|0|||
48760919|NCT00101907|156972376|FG000|Overall Study|Withdrawal by Subject|1|||
48760920|NCT00101907|156972377|FG001|Overall Study|Withdrawal by Subject|0|||
48760921|NCT00101907|156972378|FG002|Overall Study|Withdrawal by Subject|1|||
48760922|NCT00101907|156972379|FG003|Overall Study|Withdrawal by Subject|0|||
48760923|NCT00101907|156972380|FG004|Overall Study|Withdrawal by Subject|1|||
48760924|NCT00101907|156972381|FG005|Overall Study|Withdrawal by Subject|0|||
48760925|NCT00994240|156972382|FG000|Overall Study|Lost to Follow-up|3|||
48760926|NCT00994240|156972383|FG001|Overall Study|Lost to Follow-up|2|||
48760927|NCT00994240|156972382|FG000|Overall Study|Withdrawal by Subject|1|||
48760928|NCT00994240|156972383|FG001|Overall Study|Withdrawal by Subject|0|||
48760929|NCT00994240|156972382|FG000|Overall Study|study termination|2|||
48760930|NCT00994240|156972383|FG001|Overall Study|study termination|3|||
48760931|NCT00651755|156972384|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
48760932|NCT00651755|156972385|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
48760933|NCT00651755|156972384|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
48760934|NCT00651755|156972385|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
48760935|NCT03245008|156972388|FG000|Overall Study|Adverse Event|15|||
48760936|NCT03245008|156972389|FG001|Overall Study|Adverse Event|18|||
48760937|NCT03245008|156972390|FG002|Overall Study|Adverse Event|15|||
48760938|NCT03245008|156972391|FG003|Overall Study|Adverse Event|0|||
48760939|NCT03245008|156972392|FG004|Overall Study|Adverse Event|1|||
48760940|NCT03245008|156972388|FG000|Overall Study|Lack of Efficacy|0|||
48760941|NCT03245008|156972389|FG001|Overall Study|Lack of Efficacy|1|||
48760942|NCT03245008|156972390|FG002|Overall Study|Lack of Efficacy|0|||
48760943|NCT03245008|156972391|FG003|Overall Study|Lack of Efficacy|0|||
48760944|NCT03245008|156972392|FG004|Overall Study|Lack of Efficacy|0|||
48760945|NCT03245008|156972388|FG000|Overall Study|Lost to Follow-up|4|||
48760946|NCT03245008|156972389|FG001|Overall Study|Lost to Follow-up|1|||
48760947|NCT03245008|156972390|FG002|Overall Study|Lost to Follow-up|0|||
48760948|NCT03245008|156972391|FG003|Overall Study|Lost to Follow-up|0|||
48672813|NCT00812565|156653628|FG006|Overall Study|Adverse Event|0|||
48672814|NCT00812565|156653629|FG007|Overall Study|Adverse Event|1|||
48672815|NCT00812565|156653622|FG000|Overall Study|Did Not Come to Study Visit|1|||
48672816|NCT00812565|156653623|FG001|Overall Study|Did Not Come to Study Visit|0|||
48344433|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
48344434|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
48344435|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
48344436|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
48344437|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
48344438|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
48344439|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
48344440|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
48344441|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
48344442|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
48344443|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
48344444|NCT02269917|155457456|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
48344445|NCT02269917|155457457|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
48344446|NCT02269917|155457458|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
48344447|NCT02269917|155457456|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
48344448|NCT02269917|155457457|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
48344449|NCT02269917|155457458|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
48344450|NCT02269917|155457456|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
48344451|NCT02269917|155457457|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
48344452|NCT02269917|155457458|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
48344453|NCT02269917|155457456|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
48344454|NCT02269917|155457457|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
48344455|NCT02269917|155457458|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
48344456|NCT02269917|155457456|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
48344457|NCT02269917|155457457|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
48344458|NCT02269917|155457458|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
48344459|NCT02269917|155457456|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
48344460|NCT02269917|155457457|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
48344461|NCT02269917|155457458|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
48344462|NCT02269917|155457456|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
48344463|NCT02269917|155457457|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
48344464|NCT02269917|155457458|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
48344465|NCT02269917|155457456|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
48344466|NCT02269917|155457457|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
48344467|NCT02269917|155457458|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
48344468|NCT02383927|155457459|FG000|Overall Study|Disease Progression|8|||
48344469|NCT02383927|155457460|FG001|Overall Study|Disease Progression|8|||
48344470|NCT02383927|155457461|FG002|Overall Study|Disease Progression|15|||
48344471|NCT02383927|155457462|FG003|Overall Study|Disease Progression|4|||
48344472|NCT02383927|155457459|FG000|Overall Study|Physician Decision|0|||
48344473|NCT02383927|155457460|FG001|Overall Study|Physician Decision|0|||
48344474|NCT02383927|155457461|FG002|Overall Study|Physician Decision|2|||
48344475|NCT02383927|155457462|FG003|Overall Study|Physician Decision|0|||
48344476|NCT02383927|155457459|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
48344477|NCT02383927|155457460|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
48344478|NCT02383927|155457461|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
48344479|NCT02383927|155457462|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
48344480|NCT02383927|155457459|FG000|Overall Study|Adverse Event|4|||
48344481|NCT02383927|155457460|FG001|Overall Study|Adverse Event|1|||
48344482|NCT02383927|155457461|FG002|Overall Study|Adverse Event|3|||
48344483|NCT02383927|155457462|FG003|Overall Study|Adverse Event|5|||
48344484|NCT02383927|155457459|FG000|Overall Study|Miscellaneous|1|||
48344485|NCT02383927|155457460|FG001|Overall Study|Miscellaneous|0|||
48344486|NCT02383927|155457461|FG002|Overall Study|Miscellaneous|0|||
48344487|NCT02383927|155457462|FG003|Overall Study|Miscellaneous|1|||
48344488|NCT02383927|155457459|FG000|Overall Study|Withdrawal by Subject|0|||
48344489|NCT02383927|155457460|FG001|Overall Study|Withdrawal by Subject|1|||
48344490|NCT02383927|155457461|FG002|Overall Study|Withdrawal by Subject|4|||
48344491|NCT02383927|155457462|FG003|Overall Study|Withdrawal by Subject|0|||
48344492|NCT01184859|155459043|FG000|Period 1: Single Dose|Insufficient urine production|0|||
48344493|NCT01184859|155459044|FG001|Period 1: Single Dose|Insufficient urine production|1|||
48344494|NCT01184859|155459045|FG002|Period 1: Single Dose|Insufficient urine production|0|||
48344495|NCT01184859|155459046|FG003|Period 1: Single Dose|Insufficient urine production|0|||
48344496|NCT01184859|155459047|FG004|Period 1: Single Dose|Insufficient urine production|0|||
48672817|NCT00812565|156653624|FG002|Overall Study|Did Not Come to Study Visit|0|||
48672818|NCT00812565|156653625|FG003|Overall Study|Did Not Come to Study Visit|0|||
48672819|NCT00812565|156653626|FG004|Overall Study|Did Not Come to Study Visit|0|||
48672820|NCT00812565|156653627|FG005|Overall Study|Did Not Come to Study Visit|0|||
48672821|NCT00812565|156653628|FG006|Overall Study|Did Not Come to Study Visit|0|||
48672822|NCT00812565|156653629|FG007|Overall Study|Did Not Come to Study Visit|0|||
48672823|NCT00812565|156653622|FG000|Overall Study|Withdrawal of Consent|1|||
48672824|NCT00812565|156653623|FG001|Overall Study|Withdrawal of Consent|0|||
48672825|NCT00812565|156653624|FG002|Overall Study|Withdrawal of Consent|0|||
48672826|NCT00812565|156653625|FG003|Overall Study|Withdrawal of Consent|0|||
48672827|NCT00812565|156653626|FG004|Overall Study|Withdrawal of Consent|1|||
48760949|NCT03245008|156972392|FG004|Overall Study|Lost to Follow-up|1|||
48760950|NCT03245008|156972388|FG000|Overall Study|Physician Decision|1|||
48760951|NCT03245008|156972389|FG001|Overall Study|Physician Decision|3|||
48760952|NCT03245008|156972390|FG002|Overall Study|Physician Decision|4|||
48760953|NCT03245008|156972391|FG003|Overall Study|Physician Decision|0|||
48760954|NCT03245008|156972392|FG004|Overall Study|Physician Decision|0|||
48760955|NCT03245008|156972388|FG000|Overall Study|Protocol Violation|0|||
48760956|NCT03245008|156972389|FG001|Overall Study|Protocol Violation|1|||
48760957|NCT03245008|156972390|FG002|Overall Study|Protocol Violation|0|||
48760958|NCT03245008|156972391|FG003|Overall Study|Protocol Violation|0|||
48760959|NCT03245008|156972392|FG004|Overall Study|Protocol Violation|0|||
48760960|NCT03245008|156972388|FG000|Overall Study|Withdrawal by Subject|20|||
48760961|NCT03245008|156972389|FG001|Overall Study|Withdrawal by Subject|19|||
48760962|NCT03245008|156972390|FG002|Overall Study|Withdrawal by Subject|11|||
48760963|NCT03245008|156972391|FG003|Overall Study|Withdrawal by Subject|0|||
48760964|NCT03245008|156972392|FG004|Overall Study|Withdrawal by Subject|0|||
48760965|NCT03245008|156972388|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
48760966|NCT03245008|156972389|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
48760967|NCT03245008|156972390|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
48760968|NCT03245008|156972391|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
48760969|NCT03245008|156972392|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
48760970|NCT03245008|156972388|FG000|Overall Study|Failure to meet randomization criteria|0|||
48760971|NCT03245008|156972389|FG001|Overall Study|Failure to meet randomization criteria|1|||
48760972|NCT03245008|156972390|FG002|Overall Study|Failure to meet randomization criteria|0|||
48760973|NCT03245008|156972391|FG003|Overall Study|Failure to meet randomization criteria|1|||
48760974|NCT03245008|156972392|FG004|Overall Study|Failure to meet randomization criteria|0|||
48760975|NCT03204981|156973957|FG000|Overall Study|Physician Decision|2|||
48760976|NCT03204981|156973957|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
48760977|NCT00951665|156973958|FG000|Phase 1b|Adverse Event|2|||
48760978|NCT00951665|156973959|FG001|Phase 1b|Adverse Event|1|||
48760979|NCT00951665|156973960|FG002|Phase 1b|Adverse Event|0|||
48760980|NCT00951665|156973961|FG003|Phase 1b|Adverse Event|1|||
48760981|NCT00951665|156973962|FG004|Phase 1b|Adverse Event|0|||
48760982|NCT00951665|156973963|FG005|Phase 1b|Adverse Event|0|||
48760983|NCT00951665|156973958|FG000|Phase 1b|Death|1|||
48760984|NCT00951665|156973959|FG001|Phase 1b|Death|0|||
48760985|NCT00951665|156973960|FG002|Phase 1b|Death|2|||
48344497|NCT01184859|155459043|FG000|Period 1: Single Dose|Protocol Violation|0|||
48344498|NCT01184859|155459044|FG001|Period 1: Single Dose|Protocol Violation|1|||
48344499|NCT01184859|155459045|FG002|Period 1: Single Dose|Protocol Violation|0|||
48344500|NCT01184859|155459046|FG003|Period 1: Single Dose|Protocol Violation|0|||
48344501|NCT01184859|155459047|FG004|Period 1: Single Dose|Protocol Violation|0|||
48344502|NCT01184859|155459043|FG000|Period 1: Single Dose|Adverse Event|0|||
48344503|NCT01184859|155459044|FG001|Period 1: Single Dose|Adverse Event|0|||
48344504|NCT01184859|155459045|FG002|Period 1: Single Dose|Adverse Event|0|||
48344505|NCT01184859|155459046|FG003|Period 1: Single Dose|Adverse Event|0|||
48344506|NCT01184859|155459047|FG004|Period 1: Single Dose|Adverse Event|1|||
48344507|NCT01184859|155459043|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
48344508|NCT01184859|155459044|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
48344509|NCT01184859|155459045|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
48344510|NCT01184859|155459046|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
48344511|NCT01184859|155459047|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
48344512|NCT01184859|155459043|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
48344513|NCT01184859|155459044|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
48344514|NCT01184859|155459045|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
48344515|NCT01184859|155459046|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
48344516|NCT01184859|155459047|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
48344517|NCT00796614|155459051|FG000|Overall Study|Adverse Event|1|||
48344518|NCT00796614|155459052|FG001|Overall Study|Adverse Event|2|||
48344519|NCT00796614|155459053|FG002|Overall Study|Adverse Event|0|||
48344520|NCT00796614|155459054|FG003|Overall Study|Adverse Event|0|||
48344521|NCT00796614|155459051|FG000|Overall Study|Protocol Violation|0|||
48344522|NCT00796614|155459052|FG001|Overall Study|Protocol Violation|0|||
48344523|NCT00796614|155459053|FG002|Overall Study|Protocol Violation|2|||
48344524|NCT00796614|155459054|FG003|Overall Study|Protocol Violation|0|||
48344525|NCT00796614|155459051|FG000|Overall Study|Lost to Follow-up|2|||
48344526|NCT00796614|155459052|FG001|Overall Study|Lost to Follow-up|2|||
48344527|NCT00796614|155459053|FG002|Overall Study|Lost to Follow-up|1|||
48344528|NCT00796614|155459054|FG003|Overall Study|Lost to Follow-up|0|||
48344529|NCT00796614|155459051|FG000|Overall Study|Withdrawal by Subject|1|||
48344530|NCT00796614|155459052|FG001|Overall Study|Withdrawal by Subject|0|||
48344531|NCT00796614|155459053|FG002|Overall Study|Withdrawal by Subject|0|||
48344532|NCT00796614|155459054|FG003|Overall Study|Withdrawal by Subject|1|||
48344533|NCT00796614|155459051|FG000|Overall Study|Other than stated|1|||
48344534|NCT00796614|155459052|FG001|Overall Study|Other than stated|0|||
48344535|NCT00796614|155459053|FG002|Overall Study|Other than stated|0|||
48344536|NCT00796614|155459054|FG003|Overall Study|Other than stated|0|||
48344537|NCT00509821|155459055|FG000|Study Period 1 (Induction)|Death|0|||
48344538|NCT00509821|155459056|FG001|Study Period 1 (Induction)|Death|1|||
48344539|NCT00509821|155459055|FG000|Study Period 1 (Induction)|Adverse Event|0|||
48344540|NCT00509821|155459056|FG001|Study Period 1 (Induction)|Adverse Event|2|||
48344541|NCT00509821|155459055|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
48344542|NCT00509821|155459056|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
48344543|NCT00560313|155459057|FG000|Overall Study|Adverse Events or Death|2|||
48344544|NCT00560313|155459057|FG000|Overall Study|Withdrawal by Subject|2|||
48344545|NCT00560313|155459057|FG000|Overall Study|Lost to Follow-up|1|||
48344546|NCT00560313|155459057|FG000|Overall Study|Protocol Violation|1|||
48344547|NCT03449134|155459058|FG000|52-Week Treatment Period|Death|2|||
48344548|NCT03449134|155459059|FG001|52-Week Treatment Period|Death|1|||
48344549|NCT03449134|155459060|FG002|52-Week Treatment Period|Death|0|||
48672828|NCT00812565|156653627|FG005|Overall Study|Withdrawal of Consent|0|||
48672829|NCT00812565|156653628|FG006|Overall Study|Withdrawal of Consent|0|||
48672830|NCT00812565|156653629|FG007|Overall Study|Withdrawal of Consent|0|||
48672831|NCT00812565|156653622|FG000|Overall Study|Reason Not Specified|0|||
48672832|NCT00812565|156653623|FG001|Overall Study|Reason Not Specified|0|||
48672833|NCT00812565|156653624|FG002|Overall Study|Reason Not Specified|0|||
48344550|NCT03449134|155459058|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
48344551|NCT03449134|155459059|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
48344552|NCT03449134|155459060|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
48672834|NCT00812565|156653625|FG003|Overall Study|Reason Not Specified|0|||
48344553|NCT03449134|155459058|FG000|52-Week Treatment Period|Physician Decision|2|||
48344554|NCT03449134|155459059|FG001|52-Week Treatment Period|Physician Decision|3|||
48344555|NCT03449134|155459060|FG002|52-Week Treatment Period|Physician Decision|3|||
48760986|NCT00951665|156973961|FG003|Phase 1b|Death|0|||
48344556|NCT03449134|155459058|FG000|52-Week Treatment Period|Screen Failure|1|||
48344557|NCT03449134|155459059|FG001|52-Week Treatment Period|Screen Failure|0|||
48344558|NCT03449134|155459060|FG002|52-Week Treatment Period|Screen Failure|1|||
48344559|NCT03449134|155459058|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
48344560|NCT03449134|155459059|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
48672835|NCT00812565|156653626|FG004|Overall Study|Reason Not Specified|0|||
48672836|NCT00812565|156653627|FG005|Overall Study|Reason Not Specified|1|||
48672837|NCT00812565|156653628|FG006|Overall Study|Reason Not Specified|0|||
48344561|NCT03449134|155459060|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
48344562|NCT03449134|155459058|FG000|52-Week Treatment Period|Site Closure|1|||
48344563|NCT03449134|155459059|FG001|52-Week Treatment Period|Site Closure|0|||
48344564|NCT03449134|155459060|FG002|52-Week Treatment Period|Site Closure|0|||
48344565|NCT02514577|155459063|FG000|Overall Study|Lost to Follow-up|6|||
48344566|NCT02514577|155459064|FG001|Overall Study|Lost to Follow-up|6|||
48344567|NCT02514577|155459063|FG000|Overall Study|Protocol Violation|1|||
48344568|NCT02514577|155459064|FG001|Overall Study|Protocol Violation|0|||
48344569|NCT02514577|155459063|FG000|Overall Study|Withdrawal by Subject|6|||
48344570|NCT02514577|155459064|FG001|Overall Study|Withdrawal by Subject|6|||
48344571|NCT02514577|155459063|FG000|Overall Study|Adverse Event|1|||
48344572|NCT02514577|155459064|FG001|Overall Study|Adverse Event|1|||
48344573|NCT01960348|155459065|FG000|Overall Study|Adverse event, not serious|2|||
48344574|NCT01960348|155459066|FG001|Overall Study|Adverse event, not serious|2|||
48344575|NCT01960348|155459065|FG000|Overall Study|Adverse event, serious fatal|6|||
48344576|NCT01960348|155459066|FG001|Overall Study|Adverse event, serious fatal|5|||
48344577|NCT01960348|155459065|FG000|Overall Study|Adverse event, serious non-fatal|0|||
48344578|NCT01960348|155459066|FG001|Overall Study|Adverse event, serious non-fatal|3|||
48344579|NCT01960348|155459065|FG000|Overall Study|Withdrawal by Subject|1|||
48344580|NCT01960348|155459066|FG001|Overall Study|Withdrawal by Subject|11|||
48344581|NCT01960348|155459065|FG000|Overall Study|Physician Decision|0|||
48344582|NCT01960348|155459066|FG001|Overall Study|Physician Decision|1|||
48344583|NCT01960348|155459065|FG000|Overall Study|Protocol Violation|1|||
48344584|NCT01960348|155459066|FG001|Overall Study|Protocol Violation|0|||
48344585|NCT04357964|155459067|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
48672838|NCT00812565|156653629|FG007|Overall Study|Reason Not Specified|0|||
48672839|NCT02328027|156653632|FG000|Overall Study|Withdrawal by Subject|0|||
48344586|NCT04357964|155459068|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
48344587|NCT04357964|155459067|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
48344588|NCT04357964|155459068|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
48344589|NCT04357964|155459067|FG000|Overall Study|Adipose sample was insufficient quality|0|||
48344590|NCT04357964|155459068|FG001|Overall Study|Adipose sample was insufficient quality|1|||
48344591|NCT00766142|155459069|FG000|Overall Study|Protocol Violation|4|||
48344592|NCT00349622|155459072|FG000|Overall Study|Death|168|||
48344593|NCT00349622|155459073|FG001|Overall Study|Death|86|||
48344594|NCT00349622|155459072|FG000|Overall Study|Lost to Follow-up|5|||
48344595|NCT00349622|155459073|FG001|Overall Study|Lost to Follow-up|1|||
48344596|NCT00349622|155459072|FG000|Overall Study|Withdrawal by Subject|5|||
48344597|NCT00349622|155459073|FG001|Overall Study|Withdrawal by Subject|9|||
48344598|NCT02151643|155459074|FG000|Overall Study|Adverse Event|2|||
48344599|NCT02151643|155459075|FG001|Overall Study|Adverse Event|0|||
48344600|NCT02151643|155459076|FG002|Overall Study|Adverse Event|1|||
48344601|NCT02151643|155459077|FG003|Overall Study|Adverse Event|4|||
48344602|NCT02151643|155459078|FG004|Overall Study|Adverse Event|0|||
48344603|NCT02151643|155459074|FG000|Overall Study|Withdrawal by Subject|0|||
48344604|NCT02151643|155459075|FG001|Overall Study|Withdrawal by Subject|1|||
48344605|NCT02151643|155459076|FG002|Overall Study|Withdrawal by Subject|1|||
48344606|NCT02151643|155459077|FG003|Overall Study|Withdrawal by Subject|1|||
48344607|NCT02151643|155459078|FG004|Overall Study|Withdrawal by Subject|1|||
48344608|NCT02151643|155459074|FG000|Overall Study|Hyperphosphataemia|1|||
48344609|NCT02151643|155459075|FG001|Overall Study|Hyperphosphataemia|0|||
48344610|NCT02151643|155459076|FG002|Overall Study|Hyperphosphataemia|0|||
48344611|NCT02151643|155459077|FG003|Overall Study|Hyperphosphataemia|0|||
48344612|NCT02151643|155459078|FG004|Overall Study|Hyperphosphataemia|1|||
48344613|NCT02151643|155459074|FG000|Overall Study|High Ferritin levels|3|||
48344614|NCT02151643|155459075|FG001|Overall Study|High Ferritin levels|3|||
48344615|NCT02151643|155459076|FG002|Overall Study|High Ferritin levels|2|||
48344616|NCT02151643|155459077|FG003|Overall Study|High Ferritin levels|2|||
48344617|NCT02151643|155459078|FG004|Overall Study|High Ferritin levels|1|||
48344618|NCT00460564|155459081|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
48344619|NCT00460564|155459082|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
48344620|NCT00460564|155459083|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48672840|NCT02328027|156653633|FG001|Overall Study|Withdrawal by Subject|1|||
48672841|NCT01736618|156653634|FG000|Overall Study|Death|294|||
48344621|NCT00460564|155459084|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48672842|NCT01736618|156653634|FG000|Overall Study|Lost to Follow-up|193|||
48672843|NCT01736618|156653634|FG000|Overall Study|Withdrawal by Subject|54|||
48672844|NCT01736618|156653634|FG000|Overall Study|Subject unable to be followed at study location|223|||
48672845|NCT01736618|156653634|FG000|Overall Study|Physician Decision|33|||
48760987|NCT00951665|156973962|FG004|Phase 1b|Death|0|||
48344622|NCT00460564|155459085|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48344623|NCT00460564|155459086|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48344624|NCT00460564|155459087|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48429369|NCT01070550|155760358|FG003|Overall Study|Non-responders|20|||
48344625|NCT00460564|155459088|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
48344626|NCT00460564|155459081|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
48344627|NCT00460564|155459082|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48344628|NCT00460564|155459083|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48344629|NCT00460564|155459084|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48344630|NCT00460564|155459085|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48344631|NCT00460564|155459086|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48344632|NCT00460564|155459087|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48344633|NCT00460564|155459088|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
48344634|NCT00460564|155459081|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48672846|NCT01736618|156653634|FG000|Overall Study|Transplant or removal of target organ|19|||
48672847|NCT01736618|156653634|FG000|Overall Study|Change in indication or condition|78|||
48672848|NCT01736618|156653634|FG000|Overall Study|Study device explant|103|||
48672849|NCT01736618|156653634|FG000|Overall Study|Unable to complete implant|2|||
48672850|NCT01748825|156653635|FG000|Dose Escalation|Refused further treatment|2|||
48344635|NCT00460564|155459082|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48344636|NCT00460564|155459083|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48344637|NCT00460564|155459084|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48344638|NCT00460564|155459085|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
48344639|NCT00460564|155459086|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
48344640|NCT00460564|155459087|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
48672851|NCT01748825|156653636|FG001|Dose Escalation|Refused further treatment|2|||
48672852|NCT01748825|156653637|FG002|Dose Escalation|Refused further treatment|0|||
48672853|NCT01748825|156653638|FG003|Dose Escalation|Refused further treatment|0|||
48672854|NCT01748825|156653639|FG004|Dose Escalation|Refused further treatment|1|||
48672855|NCT01748825|156653640|FG005|Dose Escalation|Refused further treatment|2|||
48672856|NCT01748825|156653641|FG006|Dose Escalation|Refused further treatment|0|||
48344641|NCT00460564|155459088|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
48344642|NCT00460564|155459081|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48344643|NCT00460564|155459082|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48344644|NCT00460564|155459083|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48344645|NCT00460564|155459084|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48344646|NCT00460564|155459085|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
48344647|NCT00460564|155459086|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
48672857|NCT01748825|156653642|FG007|Dose Escalation|Refused further treatment|0|||
48672858|NCT01748825|156653643|FG008|Dose Escalation|Refused further treatment|0|||
48672859|NCT01748825|156653644|FG009|Dose Escalation|Refused further treatment|0|||
48344648|NCT00460564|155459087|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48344649|NCT00460564|155459088|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
48344650|NCT00460564|155459081|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48344651|NCT00460564|155459082|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48344652|NCT00460564|155459083|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48344653|NCT00460564|155459084|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48672860|NCT01748825|156653635|FG000|Dose Escalation|Switched to alternative treatment|0|||
48672861|NCT01748825|156653636|FG001|Dose Escalation|Switched to alternative treatment|0|||
48672862|NCT01748825|156653637|FG002|Dose Escalation|Switched to alternative treatment|0|||
48672863|NCT01748825|156653638|FG003|Dose Escalation|Switched to alternative treatment|1|||
48672864|NCT01748825|156653639|FG004|Dose Escalation|Switched to alternative treatment|0|||
48672865|NCT01748825|156653640|FG005|Dose Escalation|Switched to alternative treatment|0|||
48672866|NCT01748825|156653641|FG006|Dose Escalation|Switched to alternative treatment|0|||
48672867|NCT01748825|156653642|FG007|Dose Escalation|Switched to alternative treatment|0|||
48672868|NCT01748825|156653643|FG008|Dose Escalation|Switched to alternative treatment|0|||
48672869|NCT01748825|156653644|FG009|Dose Escalation|Switched to alternative treatment|0|||
48672870|NCT01748825|156653635|FG000|Dose Escalation|Adverse Event|0|||
48672871|NCT01748825|156653636|FG001|Dose Escalation|Adverse Event|0|||
48672872|NCT01748825|156653637|FG002|Dose Escalation|Adverse Event|0|||
48672873|NCT01748825|156653638|FG003|Dose Escalation|Adverse Event|0|||
48672874|NCT01748825|156653639|FG004|Dose Escalation|Adverse Event|0|||
48672875|NCT01748825|156653640|FG005|Dose Escalation|Adverse Event|0|||
48672876|NCT01748825|156653641|FG006|Dose Escalation|Adverse Event|1|||
48672877|NCT01748825|156653642|FG007|Dose Escalation|Adverse Event|0|||
48672878|NCT01748825|156653643|FG008|Dose Escalation|Adverse Event|0|||
48672879|NCT01748825|156653644|FG009|Dose Escalation|Adverse Event|0|||
48672880|NCT01748825|156653635|FG000|Dose Expansion|Refused further treatment|0|||
48672881|NCT01748825|156653636|FG001|Dose Expansion|Refused further treatment|0|||
48672882|NCT01748825|156653637|FG002|Dose Expansion|Refused further treatment|0|||
48672883|NCT01748825|156653638|FG003|Dose Expansion|Refused further treatment|0|||
48672884|NCT01748825|156653639|FG004|Dose Expansion|Refused further treatment|0|||
48672885|NCT01748825|156653640|FG005|Dose Expansion|Refused further treatment|0|||
48672886|NCT01748825|156653641|FG006|Dose Expansion|Refused further treatment|0|||
48672887|NCT01748825|156653642|FG007|Dose Expansion|Refused further treatment|0|||
48672888|NCT01748825|156653643|FG008|Dose Expansion|Refused further treatment|1|||
48344654|NCT00460564|155459085|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
48429370|NCT01070550|155760359|FG004|Overall Study|Non-responders|0|||
48672889|NCT01748825|156653644|FG009|Dose Expansion|Refused further treatment|1|||
48672890|NCT01748825|156653635|FG000|Dose Expansion|Switched to alternative treatment|0|||
48672891|NCT01748825|156653636|FG001|Dose Expansion|Switched to alternative treatment|0|||
48672892|NCT01748825|156653637|FG002|Dose Expansion|Switched to alternative treatment|0|||
48672893|NCT01748825|156653638|FG003|Dose Expansion|Switched to alternative treatment|0|||
48672894|NCT01748825|156653639|FG004|Dose Expansion|Switched to alternative treatment|0|||
48672895|NCT01748825|156653640|FG005|Dose Expansion|Switched to alternative treatment|0|||
48672896|NCT01748825|156653641|FG006|Dose Expansion|Switched to alternative treatment|0|||
48672897|NCT01748825|156653642|FG007|Dose Expansion|Switched to alternative treatment|0|||
48672898|NCT01748825|156653643|FG008|Dose Expansion|Switched to alternative treatment|0|||
48672899|NCT01748825|156653644|FG009|Dose Expansion|Switched to alternative treatment|1|||
48672900|NCT01748825|156653635|FG000|Dose Expansion|Adverse Event|0|||
48672901|NCT01748825|156653636|FG001|Dose Expansion|Adverse Event|0|||
48672902|NCT01748825|156653637|FG002|Dose Expansion|Adverse Event|0|||
48672903|NCT01748825|156653638|FG003|Dose Expansion|Adverse Event|0|||
48672904|NCT01748825|156653639|FG004|Dose Expansion|Adverse Event|0|||
48672905|NCT01748825|156653640|FG005|Dose Expansion|Adverse Event|0|||
48672906|NCT01748825|156653641|FG006|Dose Expansion|Adverse Event|0|||
48672907|NCT01748825|156653642|FG007|Dose Expansion|Adverse Event|0|||
48672908|NCT01748825|156653643|FG008|Dose Expansion|Adverse Event|0|||
48672909|NCT01748825|156653644|FG009|Dose Expansion|Adverse Event|3|||
48672910|NCT01748825|156653635|FG000|Dose Expansion|Physician Decision|0|||
48344655|NCT00460564|155459086|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48344656|NCT00460564|155459087|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48344657|NCT00460564|155459088|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
48344658|NCT01990313|155459089|FG000|Overall Study|Lost to Follow-up|1|||
48344659|NCT03511378|155459092|FG000|Overall Study|Withdrawal by Subject|2|||
48344660|NCT03511378|155459093|FG001|Overall Study|Withdrawal by Subject|2|||
48344661|NCT03511378|155459092|FG000|Overall Study|Patient not coming or schedule visit|1|||
48344662|NCT03511378|155459093|FG001|Overall Study|Patient not coming or schedule visit|0|||
48344663|NCT00730847|155459094|FG000|Overall Study|Adverse Event|1|||
48344664|NCT00730847|155459094|FG000|Overall Study|Protocol Violation|2|||
48344665|NCT00730847|155459094|FG000|Overall Study|Withdrawal by Subject|16|||
48344666|NCT00730847|155459094|FG000|Overall Study|Lost to Follow-up|67|||
48344667|NCT00730847|155459094|FG000|Overall Study|Unknown completion status|21|||
48344668|NCT00730847|155459094|FG000|Overall Study|Other|24|||
48344669|NCT02396953|155459097|FG000|Overall Study|Withdrawal by Subject|0|||
48344670|NCT02396953|155459098|FG001|Overall Study|Withdrawal by Subject|0|||
48344671|NCT02396953|155459099|FG002|Overall Study|Withdrawal by Subject|1|||
48344672|NCT02396953|155459097|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
48344673|NCT02396953|155459098|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
48344674|NCT02396953|155459099|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
48344675|NCT02396953|155459097|FG000|Overall Study|Personal Reasons|1|||
48344676|NCT02396953|155459098|FG001|Overall Study|Personal Reasons|1|||
48344677|NCT02396953|155459099|FG002|Overall Study|Personal Reasons|0|||
48344678|NCT00488319|155459100|FG000|Overall Study|Adverse Event|1|||
48344679|NCT00488319|155459101|FG001|Overall Study|Adverse Event|2|||
48344680|NCT00488319|155459102|FG002|Overall Study|Adverse Event|23|||
48344681|NCT00488319|155459100|FG000|Overall Study|Lack of Efficacy|6|||
48344682|NCT00488319|155459101|FG001|Overall Study|Lack of Efficacy|12|||
48344683|NCT00488319|155459102|FG002|Overall Study|Lack of Efficacy|27|||
48344684|NCT00488319|155459100|FG000|Overall Study|Lost to Follow-up|3|||
48344685|NCT00488319|155459101|FG001|Overall Study|Lost to Follow-up|5|||
48344686|NCT00488319|155459102|FG002|Overall Study|Lost to Follow-up|16|||
48344687|NCT00488319|155459100|FG000|Overall Study|Withdrawal by Subject|5|||
48344688|NCT00488319|155459101|FG001|Overall Study|Withdrawal by Subject|20|||
48344689|NCT00488319|155459102|FG002|Overall Study|Withdrawal by Subject|44|||
48344690|NCT00488319|155459100|FG000|Overall Study|Other reasons for withdrawal|0|||
48344691|NCT00488319|155459101|FG001|Overall Study|Other reasons for withdrawal|4|||
48344692|NCT00488319|155459102|FG002|Overall Study|Other reasons for withdrawal|12|||
48344693|NCT00706914|155459103|FG000|Overall Study|Lack of Efficacy|0|||
48344694|NCT00706914|155459104|FG001|Overall Study|Lack of Efficacy|1|||
48344695|NCT00706914|155459105|FG002|Overall Study|Lack of Efficacy|0|||
48344696|NCT00706914|155459103|FG000|Overall Study|Lost to Follow-up|1|||
48344697|NCT00706914|155459104|FG001|Overall Study|Lost to Follow-up|0|||
48344698|NCT00706914|155459105|FG002|Overall Study|Lost to Follow-up|0|||
48344699|NCT00706914|155459103|FG000|Overall Study|Adverse Event|2|||
48344700|NCT00706914|155459104|FG001|Overall Study|Adverse Event|2|||
48344701|NCT00706914|155459105|FG002|Overall Study|Adverse Event|0|||
48344702|NCT00706914|155459103|FG000|Overall Study|Protocol Violation|3|||
48344703|NCT00706914|155459104|FG001|Overall Study|Protocol Violation|1|||
48344704|NCT00706914|155459105|FG002|Overall Study|Protocol Violation|1|||
48344705|NCT02330562|155459106|FG000|Overall Study|Adverse Event|0|||
48344706|NCT02330562|155459107|FG001|Overall Study|Adverse Event|0|||
48344707|NCT02330562|155459108|FG002|Overall Study|Adverse Event|3|||
48344708|NCT02330562|155459109|FG003|Overall Study|Adverse Event|0|||
48344709|NCT02330562|155459110|FG004|Overall Study|Adverse Event|3|||
48344710|NCT02330562|155459111|FG005|Overall Study|Adverse Event|1|||
48344711|NCT02330562|155459112|FG006|Overall Study|Adverse Event|0|||
48344712|NCT02330562|155459113|FG007|Overall Study|Adverse Event|0|||
48344713|NCT02330562|155459114|FG008|Overall Study|Adverse Event|0|||
48344714|NCT02330562|155459115|FG009|Overall Study|Adverse Event|1|||
48344715|NCT02330562|155459116|FG010|Overall Study|Adverse Event|1|||
48344716|NCT02330562|155459106|FG000|Overall Study|Participant decision|1|||
48344717|NCT02330562|155459107|FG001|Overall Study|Participant decision|0|||
48344718|NCT02330562|155459108|FG002|Overall Study|Participant decision|4|||
48344719|NCT02330562|155459109|FG003|Overall Study|Participant decision|1|||
48344720|NCT02330562|155459110|FG004|Overall Study|Participant decision|5|||
48344721|NCT02330562|155459111|FG005|Overall Study|Participant decision|2|||
48344722|NCT02330562|155459112|FG006|Overall Study|Participant decision|0|||
48344723|NCT02330562|155459113|FG007|Overall Study|Participant decision|0|||
48344724|NCT02330562|155459114|FG008|Overall Study|Participant decision|0|||
48344725|NCT02330562|155459115|FG009|Overall Study|Participant decision|3|||
48344726|NCT02330562|155459116|FG010|Overall Study|Participant decision|0|||
48344727|NCT02330562|155459106|FG000|Overall Study|Disease progression|5|||
48344728|NCT02330562|155459107|FG001|Overall Study|Disease progression|3|||
48344729|NCT02330562|155459108|FG002|Overall Study|Disease progression|20|||
48344730|NCT02330562|155459109|FG003|Overall Study|Disease progression|28|||
48344731|NCT02330562|155459110|FG004|Overall Study|Disease progression|23|||
48344732|NCT02330562|155459111|FG005|Overall Study|Disease progression|7|||
48344733|NCT02330562|155459112|FG006|Overall Study|Disease progression|1|||
48344734|NCT02330562|155459113|FG007|Overall Study|Disease progression|1|||
48344735|NCT02330562|155459114|FG008|Overall Study|Disease progression|1|||
48344736|NCT02330562|155459115|FG009|Overall Study|Disease progression|0|||
48344737|NCT02330562|155459116|FG010|Overall Study|Disease progression|5|||
48344738|NCT02330562|155459106|FG000|Overall Study|Other reasons|0|||
48344739|NCT02330562|155459107|FG001|Overall Study|Other reasons|0|||
48344740|NCT02330562|155459108|FG002|Overall Study|Other reasons|0|||
48344741|NCT02330562|155459109|FG003|Overall Study|Other reasons|1|||
48344742|NCT02330562|155459110|FG004|Overall Study|Other reasons|0|||
48344743|NCT02330562|155459111|FG005|Overall Study|Other reasons|0|||
48344744|NCT02330562|155459112|FG006|Overall Study|Other reasons|0|||
48344745|NCT02330562|155459113|FG007|Overall Study|Other reasons|0|||
48344746|NCT02330562|155459114|FG008|Overall Study|Other reasons|0|||
48344747|NCT02330562|155459115|FG009|Overall Study|Other reasons|0|||
48344748|NCT02330562|155459116|FG010|Overall Study|Other reasons|0|||
48344749|NCT02330562|155459106|FG000|Overall Study|Withdrawal by Subject|0|||
48344750|NCT02330562|155459107|FG001|Overall Study|Withdrawal by Subject|0|||
48344751|NCT02330562|155459108|FG002|Overall Study|Withdrawal by Subject|0|||
48344752|NCT02330562|155459109|FG003|Overall Study|Withdrawal by Subject|0|||
48344753|NCT02330562|155459110|FG004|Overall Study|Withdrawal by Subject|0|||
48344754|NCT02330562|155459111|FG005|Overall Study|Withdrawal by Subject|0|||
48344755|NCT02330562|155459112|FG006|Overall Study|Withdrawal by Subject|0|||
48344756|NCT02330562|155459113|FG007|Overall Study|Withdrawal by Subject|0|||
48344757|NCT02330562|155459114|FG008|Overall Study|Withdrawal by Subject|0|||
48344758|NCT02330562|155459115|FG009|Overall Study|Withdrawal by Subject|1|||
48344759|NCT02330562|155459116|FG010|Overall Study|Withdrawal by Subject|0|||
48344760|NCT03294941|155459117|FG000|Overall Study|Withdrawal by Subject|0|||
48344761|NCT03294941|155459118|FG001|Overall Study|Withdrawal by Subject|2|||
48344762|NCT00520403|155459119|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
48344763|NCT00520403|155459119|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
48344764|NCT00520403|155459119|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
48344765|NCT00520403|155459119|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
48344766|NCT00520403|155459119|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
48344767|NCT00520403|155459119|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
48344768|NCT00520403|155459119|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
48344769|NCT00520403|155459119|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
48383951|NCT02653300|155601514|FG000|Overall Study|Withdrawal by Subject|2|||
48344770|NCT00875615|155459120|FG000|Overall Study|Withdrawal by Subject|1|||
48344771|NCT00405912|155459121|FG000|Overall Study|Withdrawal by Subject|12|||
48344772|NCT00405912|155459122|FG001|Overall Study|Withdrawal by Subject|11|||
48344773|NCT00405912|155459123|FG002|Overall Study|Withdrawal by Subject|12|||
48344774|NCT00405912|155459121|FG000|Overall Study|Lost to Follow-up|4|||
48344775|NCT00405912|155459122|FG001|Overall Study|Lost to Follow-up|8|||
48344776|NCT00405912|155459123|FG002|Overall Study|Lost to Follow-up|4|||
48344777|NCT01797562|155459124|FG000|Overall Study|Protocol Violation|5|||
48344778|NCT00632931|155459125|FG000|Part 1, Period 1|Protocol Violation|1|||
48344779|NCT00632931|155459126|FG001|Part 1, Period 1|Protocol Violation|0|||
48344780|NCT00632931|155459127|FG002|Part 1, Period 1|Protocol Violation|0|||
48344781|NCT00632931|155459125|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
48344782|NCT00632931|155459126|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
48344783|NCT00632931|155459127|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
48344784|NCT00632931|155459125|FG000|Part 2|Adverse Event|0|||
48344785|NCT00632931|155459126|FG001|Part 2|Adverse Event|0|||
48344786|NCT00632931|155459127|FG002|Part 2|Adverse Event|3|||
48344787|NCT00632931|155459125|FG000|Part 2|Death|0|||
48344788|NCT00632931|155459126|FG001|Part 2|Death|0|||
48344789|NCT00632931|155459127|FG002|Part 2|Death|1|||
48344790|NCT00632931|155459125|FG000|Part 2|Lack of Efficacy|0|||
48344791|NCT00632931|155459126|FG001|Part 2|Lack of Efficacy|0|||
48344792|NCT00632931|155459127|FG002|Part 2|Lack of Efficacy|17|||
48344793|NCT00632931|155459125|FG000|Part 2|Withdrawal by Subject|0|||
48344794|NCT00632931|155459126|FG001|Part 2|Withdrawal by Subject|0|||
48344795|NCT00632931|155459127|FG002|Part 2|Withdrawal by Subject|3|||
48344796|NCT01751165|155459128|FG000|Overall Study|Adverse event, serious fatal|1|||
48344797|NCT01751165|155459129|FG001|Overall Study|Adverse event, serious fatal|0|||
48344798|NCT01751165|155459130|FG002|Overall Study|Adverse event, serious fatal|1|||
48344799|NCT01751165|155459128|FG000|Overall Study|Withdrawal by Subject|0|||
48344800|NCT01751165|155459129|FG001|Overall Study|Withdrawal by Subject|0|||
48344801|NCT01751165|155459130|FG002|Overall Study|Withdrawal by Subject|1|||
48344802|NCT01751165|155459128|FG000|Overall Study|Serious adverse event|0|||
48344803|NCT01751165|155459129|FG001|Overall Study|Serious adverse event|2|||
48344804|NCT01751165|155459130|FG002|Overall Study|Serious adverse event|0|||
48344805|NCT01751165|155459128|FG000|Overall Study|Lost to Follow-up|1|||
48344806|NCT01751165|155459129|FG001|Overall Study|Lost to Follow-up|1|||
48344807|NCT01751165|155459130|FG002|Overall Study|Lost to Follow-up|1|||
48344808|NCT00833898|155459131|FG000|Overall Study|Withdrawal by Subject|33|||
48344809|NCT00833898|155459132|FG001|Overall Study|Withdrawal by Subject|27|||
48344810|NCT00833898|155459131|FG000|Overall Study|Lost to Follow-up|7|||
48344811|NCT00833898|155459132|FG001|Overall Study|Lost to Follow-up|7|||
48344812|NCT00833898|155459131|FG000|Overall Study|Patient did not receive transplant|0|||
48344813|NCT00833898|155459132|FG001|Overall Study|Patient did not receive transplant|2|||
48344814|NCT00917462|155459135|FG000|Overall Study|Clinical Deterioration|1|||
48344815|NCT01780545|155459139|FG000|Overall Study|Withdrawal by Subject|3|||
48344816|NCT01780545|155459140|FG001|Overall Study|Withdrawal by Subject|1|||
48344817|NCT01780545|155459139|FG000|Overall Study|Lost to Follow-up|1|||
48344818|NCT01780545|155459140|FG001|Overall Study|Lost to Follow-up|1|||
48344819|NCT03214250|155459147|FG000|Overall Study|Death|5|||
48344820|NCT03214250|155459148|FG001|Overall Study|Death|5|||
48344821|NCT03214250|155459149|FG002|Overall Study|Death|7|||
48344822|NCT03214250|155459150|FG003|Overall Study|Death|4|||
48344823|NCT03214250|155459151|FG004|Overall Study|Death|23|||
48344824|NCT03214250|155459152|FG005|Overall Study|Death|23|||
48344825|NCT03214250|155459153|FG006|Overall Study|Death|24|||
48344826|NCT03214250|155459147|FG000|Overall Study|Lost to Follow-up|0|||
48344827|NCT03214250|155459148|FG001|Overall Study|Lost to Follow-up|0|||
48344828|NCT03214250|155459149|FG002|Overall Study|Lost to Follow-up|0|||
48344829|NCT03214250|155459150|FG003|Overall Study|Lost to Follow-up|1|||
48344830|NCT03214250|155459151|FG004|Overall Study|Lost to Follow-up|1|||
48344831|NCT03214250|155459152|FG005|Overall Study|Lost to Follow-up|2|||
48344832|NCT03214250|155459153|FG006|Overall Study|Lost to Follow-up|0|||
48344833|NCT03214250|155459147|FG000|Overall Study|Other|0|||
48344834|NCT03214250|155459148|FG001|Overall Study|Other|0|||
48344835|NCT03214250|155459149|FG002|Overall Study|Other|0|||
48344836|NCT03214250|155459150|FG003|Overall Study|Other|0|||
48344837|NCT03214250|155459151|FG004|Overall Study|Other|1|||
48344838|NCT03214250|155459152|FG005|Overall Study|Other|1|||
48344839|NCT03214250|155459153|FG006|Overall Study|Other|2|||
48344840|NCT03214250|155459147|FG000|Overall Study|Remains on Study|2|||
48344841|NCT03214250|155459148|FG001|Overall Study|Remains on Study|2|||
48344842|NCT03214250|155459149|FG002|Overall Study|Remains on Study|0|||
48344843|NCT03214250|155459150|FG003|Overall Study|Remains on Study|1|||
48344844|NCT03214250|155459151|FG004|Overall Study|Remains on Study|7|||
48344845|NCT03214250|155459152|FG005|Overall Study|Remains on Study|5|||
48344846|NCT03214250|155459153|FG006|Overall Study|Remains on Study|3|||
48344847|NCT03214250|155459147|FG000|Overall Study|Withdrawal by Subject|0|||
48344848|NCT03214250|155459148|FG001|Overall Study|Withdrawal by Subject|0|||
48344849|NCT03214250|155459149|FG002|Overall Study|Withdrawal by Subject|1|||
48344850|NCT03214250|155459150|FG003|Overall Study|Withdrawal by Subject|2|||
48344851|NCT03214250|155459151|FG004|Overall Study|Withdrawal by Subject|5|||
48344852|NCT03214250|155459152|FG005|Overall Study|Withdrawal by Subject|0|||
48344853|NCT03214250|155459153|FG006|Overall Study|Withdrawal by Subject|2|||
48383952|NCT04029116|155601516|FG000|Overall Study|Adverse Event|0|||
48344854|NCT03036150|155459154|FG000|Overall Study|Withdrawal by Subject|8|||
48344855|NCT03036150|155459155|FG001|Overall Study|Withdrawal by Subject|3|||
48344856|NCT03036150|155459154|FG000|Overall Study|Lost to Follow-up|2|||
48344857|NCT03036150|155459155|FG001|Overall Study|Lost to Follow-up|2|||
48344858|NCT01037413|155459156|FG000|Part A: Skin Testing|Adverse Event|1|||
48344859|NCT01037413|155459157|FG001|Part A: Skin Testing|Adverse Event|0|||
48344860|NCT01037413|155459156|FG000|Part A: Skin Testing|Protocol Violation|1|||
48344861|NCT01037413|155459157|FG001|Part A: Skin Testing|Protocol Violation|0|||
48344862|NCT01037413|155459156|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
48344863|NCT01037413|155459157|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
48344864|NCT01037413|155459156|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
48344865|NCT01037413|155459157|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
48344866|NCT02172950|155459158|FG000|Overall Study|Physician Decision|3|||
48344867|NCT02172950|155459159|FG001|Overall Study|Physician Decision|3|||
48344868|NCT02172950|155459158|FG000|Overall Study|Lack of Efficacy|1|||
48344869|NCT02172950|155459159|FG001|Overall Study|Lack of Efficacy|0|||
48344870|NCT02172950|155459158|FG000|Overall Study|Adverse Event|4|||
48344871|NCT02172950|155459159|FG001|Overall Study|Adverse Event|1|||
48344872|NCT02172950|155459158|FG000|Overall Study|Withdrawal by Subject|10|||
48344873|NCT02172950|155459159|FG001|Overall Study|Withdrawal by Subject|0|||
48344874|NCT02172950|155459158|FG000|Overall Study|Protocol Violation|1|||
48344875|NCT02172950|155459159|FG001|Overall Study|Protocol Violation|0|||
48344876|NCT02172950|155459158|FG000|Overall Study|Lost to Follow-up|1|||
48344877|NCT02172950|155459159|FG001|Overall Study|Lost to Follow-up|0|||
48344878|NCT02172950|155459158|FG000|Overall Study|Death|1|||
48344879|NCT02172950|155459159|FG001|Overall Study|Death|0|||
48344880|NCT02172950|155459158|FG000|Overall Study|Patient traveling|1|||
48344881|NCT02172950|155459159|FG001|Overall Study|Patient traveling|0|||
48344882|NCT02172950|155459158|FG000|Overall Study|Patient went to other country|1|||
48344883|NCT02172950|155459159|FG001|Overall Study|Patient went to other country|0|||
48344884|NCT02172950|155459158|FG000|Overall Study|Patient relocated overseas|1|||
48344885|NCT02172950|155459159|FG001|Overall Study|Patient relocated overseas|1|||
48344886|NCT02172950|155459158|FG000|Overall Study|Patient moving|1|||
48344887|NCT02172950|155459159|FG001|Overall Study|Patient moving|0|||
48344888|NCT00931918|155459160|FG000|Overall Study|Adverse Event|4|||
48344889|NCT00931918|155459161|FG001|Overall Study|Adverse Event|6|||
48344890|NCT00931918|155459160|FG000|Overall Study|Progressive Disease|2|||
48344891|NCT00931918|155459161|FG001|Overall Study|Progressive Disease|1|||
48344892|NCT00931918|155459160|FG000|Overall Study|Symptomatic Deterioration|1|||
48344893|NCT00931918|155459161|FG001|Overall Study|Symptomatic Deterioration|0|||
48344894|NCT00931918|155459160|FG000|Overall Study|Withdrawal by Patient|3|||
48672911|NCT01748825|156653636|FG001|Dose Expansion|Physician Decision|0|||
48672912|NCT01748825|156653637|FG002|Dose Expansion|Physician Decision|0|||
48672913|NCT01748825|156653638|FG003|Dose Expansion|Physician Decision|0|||
48672914|NCT01748825|156653639|FG004|Dose Expansion|Physician Decision|0|||
48672915|NCT01748825|156653640|FG005|Dose Expansion|Physician Decision|0|||
48672916|NCT01748825|156653641|FG006|Dose Expansion|Physician Decision|0|||
48672917|NCT01748825|156653642|FG007|Dose Expansion|Physician Decision|0|||
48672918|NCT01748825|156653643|FG008|Dose Expansion|Physician Decision|1|||
48672919|NCT01748825|156653644|FG009|Dose Expansion|Physician Decision|0|||
48672920|NCT02123576|156653647|FG000|Overall Study|Adverse Event|1|||
48672921|NCT02123576|156653648|FG001|Overall Study|Adverse Event|0|||
48672922|NCT00547521|156653649|FG000|Short Term Study (4 Months)|Adverse Event|1|||
48672923|NCT00547521|156653650|FG001|Short Term Study (4 Months)|Adverse Event|0|||
48672924|NCT00547521|156653649|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
48672925|NCT00547521|156653650|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
48672926|NCT00547521|156653649|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
48672927|NCT00547521|156653650|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
48672928|NCT00547521|156653649|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
48672929|NCT00547521|156653650|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
48672930|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
48672931|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
48672932|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
48672933|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
48344895|NCT00931918|155459161|FG001|Overall Study|Withdrawal by Patient|4|||
48344896|NCT00931918|155459160|FG000|Overall Study|Other Reason not Specified|4|||
48344897|NCT00931918|155459161|FG001|Overall Study|Other Reason not Specified|4|||
48344898|NCT00931918|155459160|FG000|Overall Study|Did not receive study drug|3|||
48344899|NCT00931918|155459161|FG001|Overall Study|Did not receive study drug|2|||
48344900|NCT00496626|155459162|FG000|Overall Study|Lost to Follow-up|0|||
48344901|NCT00496626|155459163|FG001|Overall Study|Lost to Follow-up|1|||
48672934|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
48344902|NCT00496626|155459162|FG000|Overall Study|Protocol Violation|1|||
48344903|NCT00496626|155459163|FG001|Overall Study|Protocol Violation|0|||
48344904|NCT00496626|155459162|FG000|Overall Study|Withdrawal by Subject|5|||
48383953|NCT04029116|155601517|FG001|Overall Study|Adverse Event|2|||
48344905|NCT00496626|155459163|FG001|Overall Study|Withdrawal by Subject|4|||
48344906|NCT00496626|155459162|FG000|Overall Study|Relocated|0|||
48344907|NCT00496626|155459163|FG001|Overall Study|Relocated|1|||
48344908|NCT03772041|155459168|FG000|Overall Study|Adverse Event|8|||
48344909|NCT03772041|155459169|FG001|Overall Study|Adverse Event|3|||
48344910|NCT03772041|155459168|FG000|Overall Study|Withdrawal by Subject|0|||
48344911|NCT03772041|155459169|FG001|Overall Study|Withdrawal by Subject|2|||
48344912|NCT03772041|155459168|FG000|Overall Study|Protocol Violation|4|||
48344913|NCT03772041|155459169|FG001|Overall Study|Protocol Violation|2|||
48344914|NCT03772041|155459168|FG000|Overall Study|Physician Decision|2|||
48344915|NCT03772041|155459169|FG001|Overall Study|Physician Decision|3|||
48344916|NCT02204319|155459170|FG000|Overall Study|Pregnancy|1|||
48344917|NCT02204319|155459170|FG000|Overall Study|Withdrawal by Subject|2|||
48344918|NCT02959177|155459171|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
48344919|NCT02959177|155459172|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
48344920|NCT02959177|155459173|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
48344921|NCT02959177|155459171|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
48344922|NCT02959177|155459172|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
48344923|NCT02959177|155459173|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
48344924|NCT02959177|155459171|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
48344925|NCT02959177|155459172|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
48344926|NCT02959177|155459173|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
48344927|NCT02959177|155459171|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
48672935|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
48672936|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
48672937|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
48344928|NCT02959177|155459172|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48344929|NCT02959177|155459173|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
48344930|NCT02959177|155459171|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
48344931|NCT02959177|155459172|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
48344932|NCT02959177|155459173|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
48344933|NCT02959177|155459171|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
48344934|NCT02959177|155459172|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
48344935|NCT02959177|155459173|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
48344936|NCT02959177|155459171|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
48344937|NCT02959177|155459172|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
48344938|NCT02959177|155459173|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
48344939|NCT00591409|155459174|FG000|Overall Study|Not Treated|0|||
48344940|NCT00591409|155459175|FG001|Overall Study|Not Treated|0|||
48344941|NCT00591409|155459176|FG002|Overall Study|Not Treated|0|||
48344942|NCT00591409|155459177|FG003|Overall Study|Not Treated|0|||
48344943|NCT00591409|155459178|FG004|Overall Study|Not Treated|1|||
48344944|NCT00591409|155459179|FG005|Overall Study|Not Treated|0|||
48344945|NCT00591409|155459180|FG006|Overall Study|Not Treated|0|||
48344946|NCT00591409|155459181|FG007|Overall Study|Not Treated|0|||
48344947|NCT00591409|155459182|FG008|Overall Study|Not Treated|0|||
48344948|NCT00591409|155459183|FG009|Overall Study|Not Treated|1|||
48344949|NCT01898442|155459185|FG000|Overall Study|Hemolysis/technical problems|1|||
48344950|NCT01898442|155459186|FG001|Overall Study|Hemolysis/technical problems|2|||
48344951|NCT01898442|155459187|FG002|Overall Study|Hemolysis/technical problems|2|||
48344952|NCT01898442|155459185|FG000|Overall Study|Patient vomited pills|0|||
48344953|NCT01898442|155459186|FG001|Overall Study|Patient vomited pills|0|||
48344954|NCT01898442|155459187|FG002|Overall Study|Patient vomited pills|1|||
48344955|NCT02143063|155459190|FG000|Overall Study|Lost to Follow-up|16|||
48344956|NCT02143063|155459191|FG001|Overall Study|Lost to Follow-up|28|||
48344957|NCT02143063|155459192|FG002|Overall Study|Lost to Follow-up|29|||
48344958|NCT02143063|155459190|FG000|Overall Study|Withdrawal by Subject|0|||
48344959|NCT02143063|155459191|FG001|Overall Study|Withdrawal by Subject|1|||
48344960|NCT02143063|155459192|FG002|Overall Study|Withdrawal by Subject|0|||
48344961|NCT02143063|155459190|FG000|Overall Study|Death|0|||
48344962|NCT02143063|155459191|FG001|Overall Study|Death|1|||
48344963|NCT02143063|155459192|FG002|Overall Study|Death|1|||
48344964|NCT03188536|155459196|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
48344965|NCT03188536|155459196|FG000|Overall Study|Not participated/met inclusion criteria|1|||
48344966|NCT03638258|155459197|FG000|Overall Study|Adverse Event|1|||
48672938|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Other|0|||
48344967|NCT03638258|155459198|FG001|Overall Study|Adverse Event|0|||
48344968|NCT03638258|155459199|FG002|Overall Study|Adverse Event|2|||
48344969|NCT03638258|155459197|FG000|Overall Study|Lost to Follow-up|2|||
48344970|NCT03638258|155459198|FG001|Overall Study|Lost to Follow-up|4|||
48344971|NCT03638258|155459199|FG002|Overall Study|Lost to Follow-up|5|||
48344972|NCT03638258|155459197|FG000|Overall Study|Pregnancy|0|||
48344973|NCT03638258|155459198|FG001|Overall Study|Pregnancy|0|||
48344974|NCT03638258|155459199|FG002|Overall Study|Pregnancy|1|||
48344975|NCT03638258|155459197|FG000|Overall Study|Protocol Violation|0|||
48344976|NCT03638258|155459198|FG001|Overall Study|Protocol Violation|0|||
48344977|NCT03638258|155459199|FG002|Overall Study|Protocol Violation|1|||
48344978|NCT03638258|155459197|FG000|Overall Study|Withdrawal by Subject|4|||
48344979|NCT03638258|155459198|FG001|Overall Study|Withdrawal by Subject|5|||
48344980|NCT03638258|155459199|FG002|Overall Study|Withdrawal by Subject|12|||
48344981|NCT03638258|155459197|FG000|Overall Study|Lack of Efficacy|0|||
48344982|NCT03638258|155459198|FG001|Overall Study|Lack of Efficacy|0|||
48344983|NCT03638258|155459199|FG002|Overall Study|Lack of Efficacy|2|||
48344984|NCT02168478|155459201|FG000|Overall Study|Withdrawal by Subject|1|||
48344985|NCT02168478|155459201|FG000|Overall Study|Did Not Consent to Participation|2|||
48344986|NCT02168478|155459201|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
48344987|NCT01157377|155459202|FG000|Overall Study|Lost to Follow-up|0|||
48344988|NCT01157377|155459203|FG001|Overall Study|Lost to Follow-up|0|||
48344989|NCT01157377|155459204|FG002|Overall Study|Lost to Follow-up|1|||
48344990|NCT01157377|155459205|FG003|Overall Study|Lost to Follow-up|0|||
48344991|NCT01157377|155459206|FG004|Overall Study|Lost to Follow-up|1|||
48344992|NCT01157377|155459207|FG005|Overall Study|Lost to Follow-up|1|||
48344993|NCT01157377|155459208|FG006|Overall Study|Lost to Follow-up|0|||
48344994|NCT01157377|155459202|FG000|Overall Study|Personal Reasons|2|||
48344995|NCT01157377|155459203|FG001|Overall Study|Personal Reasons|1|||
48344996|NCT01157377|155459204|FG002|Overall Study|Personal Reasons|0|||
48344997|NCT01157377|155459205|FG003|Overall Study|Personal Reasons|1|||
48344998|NCT01157377|155459206|FG004|Overall Study|Personal Reasons|0|||
48344999|NCT01157377|155459207|FG005|Overall Study|Personal Reasons|0|||
48345000|NCT01157377|155459208|FG006|Overall Study|Personal Reasons|0|||
48345001|NCT01157377|155459202|FG000|Overall Study|Protocol Violation|0|||
48345002|NCT01157377|155459203|FG001|Overall Study|Protocol Violation|0|||
48345003|NCT01157377|155459204|FG002|Overall Study|Protocol Violation|0|||
48345004|NCT01157377|155459205|FG003|Overall Study|Protocol Violation|0|||
48345005|NCT01157377|155459206|FG004|Overall Study|Protocol Violation|0|||
48345006|NCT01157377|155459207|FG005|Overall Study|Protocol Violation|1|||
48345007|NCT01157377|155459208|FG006|Overall Study|Protocol Violation|0|||
48345008|NCT01157377|155459202|FG000|Overall Study|Lack of Efficacy|0|||
48345009|NCT01157377|155459203|FG001|Overall Study|Lack of Efficacy|0|||
48345010|NCT01157377|155459204|FG002|Overall Study|Lack of Efficacy|0|||
48345011|NCT01157377|155459205|FG003|Overall Study|Lack of Efficacy|0|||
48345012|NCT01157377|155459206|FG004|Overall Study|Lack of Efficacy|0|||
48345013|NCT01157377|155459207|FG005|Overall Study|Lack of Efficacy|0|||
48345014|NCT01157377|155459208|FG006|Overall Study|Lack of Efficacy|1|||
48345015|NCT01157377|155459202|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48345016|NCT01157377|155459203|FG001|Overall Study|Other Miscellaneous Reasons|2|||
48345017|NCT01157377|155459204|FG002|Overall Study|Other Miscellaneous Reasons|0|||
48345018|NCT01157377|155459205|FG003|Overall Study|Other Miscellaneous Reasons|0|||
48345019|NCT01157377|155459206|FG004|Overall Study|Other Miscellaneous Reasons|1|||
48345020|NCT01157377|155459207|FG005|Overall Study|Other Miscellaneous Reasons|1|||
48345021|NCT01157377|155459208|FG006|Overall Study|Other Miscellaneous Reasons|1|||
48345022|NCT00372255|155459209|FG000|Overall Study|Withdrawn for other reasons|2|||
48345023|NCT00372255|155459210|FG001|Overall Study|Withdrawn for other reasons|1|||
48345024|NCT00118703|155459213|FG000|Overall Study|Protocol Violation|1|||
48345025|NCT00118703|155459214|FG001|Overall Study|Protocol Violation|0|||
48345026|NCT00118703|155459213|FG000|Overall Study|Adverse Event|1|||
48345027|NCT00118703|155459214|FG001|Overall Study|Adverse Event|1|||
48345028|NCT00118703|155459213|FG000|Overall Study|Participant took two different treatment|0|||
48345029|NCT00118703|155459214|FG001|Overall Study|Participant took two different treatment|1|||
48345030|NCT00118703|155459213|FG000|Overall Study|Withdrawal by Subject|2|||
48345031|NCT00118703|155459214|FG001|Overall Study|Withdrawal by Subject|5|||
48345032|NCT00118703|155459213|FG000|Overall Study|Lost to Follow-up|1|||
48345033|NCT00118703|155459214|FG001|Overall Study|Lost to Follow-up|2|||
48345034|NCT05523219|155459215|FG000|Overall Study|Wrong inclusion|1|||
48672939|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Other|2|||
48672940|NCT00547521|156653649|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
48672941|NCT00547521|156653650|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
48672942|NCT03149029|156654977|FG000|Overall Study|Adverse Event|2|||
48672943|NCT03149029|156654978|FG001|Overall Study|Adverse Event|0|||
48345035|NCT05523219|155459215|FG000|Overall Study|Lost to Follow-up|7|||
48345036|NCT01919398|155459218|FG000|Overall Study|Progressive Disease|0|||
48345037|NCT01919398|155459219|FG001|Overall Study|Progressive Disease|0|||
48345038|NCT01919398|155459220|FG002|Overall Study|Progressive Disease|4|||
48345039|NCT03605368|155459222|FG000|Overall Study|Lost to Follow-up|2|||
48345040|NCT03605368|155459223|FG001|Overall Study|Lost to Follow-up|1|||
48345041|NCT03605368|155459224|FG002|Overall Study|Lost to Follow-up|3|||
48345042|NCT03605368|155459225|FG003|Overall Study|Lost to Follow-up|2|||
48345043|NCT03605368|155459222|FG000|Overall Study|Withdrawal by Subject|0|||
48345044|NCT03605368|155459223|FG001|Overall Study|Withdrawal by Subject|0|||
48345045|NCT03605368|155459224|FG002|Overall Study|Withdrawal by Subject|4|||
48345046|NCT03605368|155459225|FG003|Overall Study|Withdrawal by Subject|3|||
48345047|NCT02016690|155459226|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
48345048|NCT02016690|155459226|FG000|Overall Study|Excluded from SAS: Duplication|2|||
48672944|NCT03344172|156654980|FG000|Overall Study|Received <1 dose of treatment|1|||
48345049|NCT02016690|155459226|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
48345050|NCT02016690|155459226|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
48345051|NCT02016690|155459226|FG000|Overall Study|Did not meet inclusion criteria|13|||
48345052|NCT02016690|155459226|FG000|Overall Study|Hospitalized for RSV at study start|3|||
48345053|NCT01726517|155459229|FG000|Overall Study|Withdrawal by Subject|0|||
48345054|NCT01726517|155459230|FG001|Overall Study|Withdrawal by Subject|0|||
48345055|NCT01726517|155459231|FG002|Overall Study|Withdrawal by Subject|1|||
48345056|NCT01726517|155459232|FG003|Overall Study|Withdrawal by Subject|0|||
48345057|NCT01726517|155459233|FG004|Overall Study|Withdrawal by Subject|0|||
48345058|NCT00552513|155461058|FG000|Overall Study|Lost to Follow-up|5|||
48345059|NCT00552513|155461059|FG001|Overall Study|Lost to Follow-up|1|||
48345060|NCT01580995|155461066|FG000|Overall Study|Lost to Follow-up|2|||
48345061|NCT01580995|155461067|FG001|Overall Study|Lost to Follow-up|2|||
48345062|NCT02517528|155461068|FG000|Overall Study|Withdrawal by Subject|1|||
48345063|NCT03440047|155461071|FG000|Overall Study|Withdrawal by Subject|2|||
48760988|NCT00951665|156973963|FG005|Phase 1b|Death|0|||
48760989|NCT00951665|156973958|FG000|Phase 1b|Physician Decision|4|||
48760990|NCT00951665|156973959|FG001|Phase 1b|Physician Decision|0|||
48760991|NCT00951665|156973960|FG002|Phase 1b|Physician Decision|1|||
48760992|NCT00951665|156973961|FG003|Phase 1b|Physician Decision|0|||
48760993|NCT00951665|156973962|FG004|Phase 1b|Physician Decision|0|||
48345064|NCT00043186|155461078|FG000|Overall Study|Physician Decision|0|||
48345065|NCT00043186|155461079|FG001|Overall Study|Physician Decision|0|||
48760994|NCT00951665|156973963|FG005|Phase 1b|Physician Decision|0|||
48760995|NCT00951665|156973958|FG000|Phase 1b|Withdrawal by Subject|0|||
48345066|NCT00043186|155461080|FG002|Overall Study|Physician Decision|3|||
48345067|NCT00043186|155461081|FG003|Overall Study|Physician Decision|0|||
48345068|NCT00043186|155461082|FG004|Overall Study|Physician Decision|1|||
48345069|NCT00043186|155461083|FG005|Overall Study|Physician Decision|0|||
48345070|NCT00043186|155461084|FG006|Overall Study|Physician Decision|0|||
48345071|NCT00043186|155461085|FG007|Overall Study|Physician Decision|1|||
48345072|NCT00043186|155461086|FG008|Overall Study|Physician Decision|1|||
48345073|NCT00043186|155461078|FG000|Overall Study|Adverse Event|2|||
48345074|NCT00043186|155461079|FG001|Overall Study|Adverse Event|2|||
48345075|NCT00043186|155461080|FG002|Overall Study|Adverse Event|2|||
48345076|NCT00043186|155461081|FG003|Overall Study|Adverse Event|3|||
48345077|NCT00043186|155461082|FG004|Overall Study|Adverse Event|2|||
48672945|NCT03344172|156654981|FG001|Overall Study|Received <1 dose of treatment|0|||
48672946|NCT00931801|156654982|FG000|Overall Study|Adverse Event|0|||
48672947|NCT00931801|156654983|FG001|Overall Study|Adverse Event|0|||
48672948|NCT00931801|156654984|FG002|Overall Study|Adverse Event|1|||
48672949|NCT00931801|156654982|FG000|Overall Study|Lost to Follow-up|0|||
48672950|NCT00931801|156654983|FG001|Overall Study|Lost to Follow-up|1|||
48672951|NCT00931801|156654984|FG002|Overall Study|Lost to Follow-up|0|||
48672952|NCT00931801|156654982|FG000|Overall Study|Withdrawal by Subject|1|||
48672953|NCT00931801|156654983|FG001|Overall Study|Withdrawal by Subject|0|||
48672954|NCT00931801|156654984|FG002|Overall Study|Withdrawal by Subject|0|||
48672955|NCT00931801|156654982|FG000|Overall Study|Confirmed Virologic Failure|0|||
48672956|NCT00931801|156654983|FG001|Overall Study|Confirmed Virologic Failure|0|||
48672957|NCT00931801|156654984|FG002|Overall Study|Confirmed Virologic Failure|3|||
48672958|NCT00708734|156654985|FG000|Overall Study|scheduling conflict|2|||
48672959|NCT00708734|156654985|FG000|Overall Study|moved|1|||
48672960|NCT00708734|156654985|FG000|Overall Study|leg injury|1|||
48672961|NCT00708734|156654985|FG000|Overall Study|knee replacement|1|||
48672962|NCT00708734|156654985|FG000|Overall Study|vertigo|1|||
48345078|NCT00043186|155461083|FG005|Overall Study|Adverse Event|1|||
48345079|NCT00043186|155461084|FG006|Overall Study|Adverse Event|2|||
48672963|NCT00708734|156654985|FG000|Overall Study|leg fracture|1|||
48345080|NCT00043186|155461085|FG007|Overall Study|Adverse Event|1|||
48345081|NCT00043186|155461086|FG008|Overall Study|Adverse Event|3|||
48345082|NCT00043186|155461078|FG000|Overall Study|Withdrawal by Subject|11|||
48345083|NCT00043186|155461079|FG001|Overall Study|Withdrawal by Subject|8|||
48345084|NCT00043186|155461080|FG002|Overall Study|Withdrawal by Subject|11|||
48345085|NCT00043186|155461081|FG003|Overall Study|Withdrawal by Subject|13|||
48345086|NCT00043186|155461082|FG004|Overall Study|Withdrawal by Subject|14|||
48345087|NCT00043186|155461083|FG005|Overall Study|Withdrawal by Subject|6|||
48345088|NCT00043186|155461084|FG006|Overall Study|Withdrawal by Subject|12|||
48345089|NCT00043186|155461085|FG007|Overall Study|Withdrawal by Subject|9|||
48345090|NCT00043186|155461086|FG008|Overall Study|Withdrawal by Subject|10|||
48345091|NCT00043186|155461078|FG000|Overall Study|Death|0|||
48345092|NCT00043186|155461079|FG001|Overall Study|Death|0|||
48345093|NCT00043186|155461080|FG002|Overall Study|Death|1|||
48345094|NCT00043186|155461081|FG003|Overall Study|Death|0|||
48345095|NCT00043186|155461082|FG004|Overall Study|Death|0|||
48345096|NCT00043186|155461083|FG005|Overall Study|Death|0|||
48345097|NCT00043186|155461084|FG006|Overall Study|Death|2|||
48345098|NCT00043186|155461085|FG007|Overall Study|Death|0|||
48345099|NCT00043186|155461086|FG008|Overall Study|Death|0|||
48345100|NCT00043186|155461078|FG000|Overall Study|Disease progression|1|||
48345101|NCT00043186|155461079|FG001|Overall Study|Disease progression|0|||
48345102|NCT00043186|155461080|FG002|Overall Study|Disease progression|0|||
48345103|NCT00043186|155461081|FG003|Overall Study|Disease progression|3|||
48345104|NCT00043186|155461082|FG004|Overall Study|Disease progression|0|||
48345105|NCT00043186|155461083|FG005|Overall Study|Disease progression|0|||
48345106|NCT00043186|155461084|FG006|Overall Study|Disease progression|0|||
48345107|NCT00043186|155461085|FG007|Overall Study|Disease progression|4|||
48345108|NCT00043186|155461086|FG008|Overall Study|Disease progression|0|||
48345109|NCT00043186|155461078|FG000|Overall Study|Ineligibility determined|0|||
48345110|NCT00043186|155461079|FG001|Overall Study|Ineligibility determined|0|||
48345111|NCT00043186|155461080|FG002|Overall Study|Ineligibility determined|0|||
48345112|NCT00043186|155461081|FG003|Overall Study|Ineligibility determined|0|||
48345113|NCT00043186|155461082|FG004|Overall Study|Ineligibility determined|0|||
48345114|NCT00043186|155461083|FG005|Overall Study|Ineligibility determined|0|||
48345115|NCT00043186|155461084|FG006|Overall Study|Ineligibility determined|0|||
48345116|NCT00043186|155461085|FG007|Overall Study|Ineligibility determined|0|||
48345117|NCT00043186|155461086|FG008|Overall Study|Ineligibility determined|1|||
48345118|NCT00043186|155461078|FG000|Overall Study|Lost to Follow-up|3|||
48345119|NCT00043186|155461079|FG001|Overall Study|Lost to Follow-up|5|||
48345120|NCT00043186|155461080|FG002|Overall Study|Lost to Follow-up|1|||
48345121|NCT00043186|155461081|FG003|Overall Study|Lost to Follow-up|1|||
48345122|NCT00043186|155461082|FG004|Overall Study|Lost to Follow-up|1|||
48345123|NCT00043186|155461083|FG005|Overall Study|Lost to Follow-up|1|||
48345124|NCT00043186|155461084|FG006|Overall Study|Lost to Follow-up|1|||
48345125|NCT00043186|155461085|FG007|Overall Study|Lost to Follow-up|1|||
48345126|NCT00043186|155461086|FG008|Overall Study|Lost to Follow-up|2|||
48345127|NCT00043186|155461078|FG000|Overall Study|Noncompliance|0|||
48345128|NCT00043186|155461079|FG001|Overall Study|Noncompliance|0|||
48345129|NCT00043186|155461080|FG002|Overall Study|Noncompliance|1|||
48345130|NCT00043186|155461081|FG003|Overall Study|Noncompliance|1|||
48345131|NCT00043186|155461082|FG004|Overall Study|Noncompliance|0|||
48345132|NCT00043186|155461083|FG005|Overall Study|Noncompliance|0|||
48345133|NCT00043186|155461084|FG006|Overall Study|Noncompliance|0|||
48345134|NCT00043186|155461085|FG007|Overall Study|Noncompliance|0|||
48345135|NCT00043186|155461086|FG008|Overall Study|Noncompliance|0|||
48345136|NCT00043186|155461078|FG000|Overall Study|Other|0|||
48345137|NCT00043186|155461079|FG001|Overall Study|Other|0|||
48345138|NCT00043186|155461080|FG002|Overall Study|Other|1|||
48345139|NCT00043186|155461081|FG003|Overall Study|Other|1|||
48345140|NCT00043186|155461082|FG004|Overall Study|Other|0|||
48345141|NCT00043186|155461083|FG005|Overall Study|Other|0|||
48345142|NCT00043186|155461084|FG006|Overall Study|Other|0|||
48345143|NCT00043186|155461085|FG007|Overall Study|Other|0|||
48345144|NCT00043186|155461086|FG008|Overall Study|Other|0|||
48345145|NCT01059526|155461090|FG000|Overall Study|Patient enrolled but not treated|20|||
48345146|NCT01059526|155461091|FG001|Overall Study|Patient enrolled but not treated|17|||
48345147|NCT01059526|155461090|FG000|Overall Study|Adverse Event|2|||
48345148|NCT01059526|155461091|FG001|Overall Study|Adverse Event|2|||
48345149|NCT01059526|155461090|FG000|Overall Study|Protocol Violation|0|||
48345150|NCT01059526|155461091|FG001|Overall Study|Protocol Violation|1|||
48345151|NCT01059526|155461090|FG000|Overall Study|Withdrawal by Subject|3|||
48345152|NCT01059526|155461091|FG001|Overall Study|Withdrawal by Subject|1|||
48345153|NCT01059526|155461090|FG000|Overall Study|Lost to Follow-up|4|||
48345154|NCT01059526|155461091|FG001|Overall Study|Lost to Follow-up|1|||
48345155|NCT01059526|155461090|FG000|Overall Study|Patient found to be dermatographic|1|||
48345156|NCT01059526|155461091|FG001|Overall Study|Patient found to be dermatographic|0|||
48345157|NCT00523549|155461092|FG000|Overall Study|Adverse Event|6|||
48345158|NCT00523549|155461093|FG001|Overall Study|Adverse Event|3|||
48345159|NCT00523549|155461092|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48672964|NCT00895661|156654990|FG000|Overall Study|Death|1|||
48672965|NCT00895661|156654990|FG000|Overall Study|reason unknown|2|||
48672966|NCT02211313|156654991|FG000|Overall Study|Treatment Failure|5|||
48672967|NCT02211313|156654992|FG001|Overall Study|Treatment Failure|2|||
48672968|NCT02211313|156654991|FG000|Overall Study|No Follow up Questionnaires|1|||
48672969|NCT02211313|156654992|FG001|Overall Study|No Follow up Questionnaires|1|||
48672970|NCT01641822|156654995|FG000|Run-in Phase|Noncompliance with study drug|1|||
48672971|NCT01641822|156654996|FG001|Run-in Phase|Noncompliance with study drug|0|||
48345160|NCT00523549|155461093|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48672972|NCT01641822|156654997|FG002|Run-in Phase|Noncompliance with study drug|0|||
48345161|NCT00523549|155461092|FG000|Overall Study|Protocol Deviation|3|||
48345162|NCT00523549|155461093|FG001|Overall Study|Protocol Deviation|1|||
48345163|NCT00523549|155461092|FG000|Overall Study|Patient withdrew consent|7|||
48345164|NCT00523549|155461093|FG001|Overall Study|Patient withdrew consent|6|||
48345165|NCT00523549|155461092|FG000|Overall Study|Lost to Follow-up|3|||
48345166|NCT00523549|155461093|FG001|Overall Study|Lost to Follow-up|5|||
48345167|NCT03463577|155461094|FG000|Overall Study|Lost to Follow-up|238|||
48345168|NCT03463577|155461095|FG001|Overall Study|Lost to Follow-up|435|||
48345169|NCT03463577|155461096|FG002|Overall Study|Lost to Follow-up|0|||
48345170|NCT03463577|155461097|FG003|Overall Study|Lost to Follow-up|0|||
48345171|NCT03463577|155461098|FG004|Overall Study|Lost to Follow-up|0|||
48345172|NCT03463577|155461099|FG005|Overall Study|Lost to Follow-up|0|||
48345173|NCT03463577|155461094|FG000|Overall Study|With unknown pregnancy outcome|0|||
48345174|NCT03463577|155461095|FG001|Overall Study|With unknown pregnancy outcome|5|||
48345175|NCT03463577|155461096|FG002|Overall Study|With unknown pregnancy outcome|0|||
48345176|NCT03463577|155461097|FG003|Overall Study|With unknown pregnancy outcome|0|||
48345177|NCT03463577|155461098|FG004|Overall Study|With unknown pregnancy outcome|0|||
48345178|NCT03463577|155461099|FG005|Overall Study|With unknown pregnancy outcome|0|||
48345179|NCT03463577|155461094|FG000|Overall Study|Maternal death|2|||
48345180|NCT03463577|155461095|FG001|Overall Study|Maternal death|0|||
48345181|NCT03463577|155461096|FG002|Overall Study|Maternal death|0|||
48345182|NCT03463577|155461097|FG003|Overall Study|Maternal death|0|||
48345183|NCT03463577|155461098|FG004|Overall Study|Maternal death|0|||
48345184|NCT03463577|155461099|FG005|Overall Study|Maternal death|0|||
48345185|NCT03463577|155461094|FG000|Overall Study|Neonatal death|0|||
48345186|NCT03463577|155461095|FG001|Overall Study|Neonatal death|0|||
48345187|NCT03463577|155461096|FG002|Overall Study|Neonatal death|0|||
48345188|NCT03463577|155461097|FG003|Overall Study|Neonatal death|15|||
48345189|NCT03463577|155461098|FG004|Overall Study|Neonatal death|17|||
48345190|NCT03463577|155461099|FG005|Overall Study|Neonatal death|0|||
48345191|NCT00843115|155461102|FG000|Overall Study|Death|4|||
48345192|NCT00843115|155461102|FG000|Overall Study|Adverse Event|30|||
48345193|NCT00843115|155461102|FG000|Overall Study|Lost to Follow-up|4|||
48345194|NCT00843115|155461102|FG000|Overall Study|Withdrawal by Subject|17|||
48345195|NCT00843115|155461102|FG000|Overall Study|Family wanted meds stopped|1|||
48345196|NCT00843115|155461102|FG000|Overall Study|Family does not want continuation|1|||
48345197|NCT00843115|155461102|FG000|Overall Study|Patient forgot to take meds|1|||
48345198|NCT00843115|155461102|FG000|Overall Study|Does not meet entrance criteria|1|||
48345199|NCT00843115|155461102|FG000|Overall Study|Physician Decision|1|||
48345200|NCT00843115|155461102|FG000|Overall Study|Family discontinued meds|1|||
48345201|NCT00843115|155461102|FG000|Overall Study|patient took for 2 days then stopped|1|||
48345202|NCT00843115|155461102|FG000|Overall Study|patient never took the medication|1|||
48345203|NCT00843115|155461102|FG000|Overall Study|hospitalized due to deterioration|1|||
48345204|NCT00843115|155461102|FG000|Overall Study|week 12 not done|1|||
48345205|NCT00843115|155461102|FG000|Overall Study|Syndrome De Glissement|1|||
48345206|NCT00292981|155461103|FG000|Overall Study|Adverse Event|1|||
48345207|NCT00292981|155461103|FG000|Overall Study|Lost to Follow-up|13|||
48345208|NCT00292981|155461103|FG000|Overall Study|Withdrawal by Subject|22|||
48345209|NCT00292981|155461103|FG000|Overall Study|Other|3|||
48586759|NCT00483704|156339070|FG001|Randomization|Lack of qualifying migraines|25|||
48586760|NCT00483704|156339071|FG002|Randomization|Lack of qualifying migraines|31|||
48586761|NCT00483704|156339069|FG000|Treatment|Lack of qualifying migraines|101|||
48586762|NCT00483704|156339070|FG001|Treatment|Lack of qualifying migraines|99|||
48586763|NCT00483704|156339071|FG002|Treatment|Lack of qualifying migraines|116|||
48586764|NCT00483704|156339069|FG000|Treatment|Adverse Event|3|||
48586765|NCT00483704|156339070|FG001|Treatment|Adverse Event|5|||
48586766|NCT00483704|156339071|FG002|Treatment|Adverse Event|4|||
48586767|NCT00483704|156339069|FG000|Treatment|Withdrawal by Subject|16|||
48586768|NCT00483704|156339070|FG001|Treatment|Withdrawal by Subject|12|||
48760996|NCT00951665|156973959|FG001|Phase 1b|Withdrawal by Subject|1|||
48760997|NCT00951665|156973960|FG002|Phase 1b|Withdrawal by Subject|0|||
48586769|NCT00483704|156339071|FG002|Treatment|Withdrawal by Subject|21|||
48586770|NCT00483704|156339069|FG000|Treatment|Protocol Violation|6|||
48586771|NCT00483704|156339070|FG001|Treatment|Protocol Violation|3|||
48586772|NCT00483704|156339071|FG002|Treatment|Protocol Violation|5|||
48586773|NCT00483704|156339069|FG000|Treatment|Lost to Follow-up|2|||
48586774|NCT00483704|156339070|FG001|Treatment|Lost to Follow-up|7|||
48345226|NCT01172639|155461108|FG000|Overall Study|Death|1|||
48345227|NCT01172639|155461109|FG001|Overall Study|Death|1|||
48760998|NCT00951665|156973961|FG003|Phase 1b|Withdrawal by Subject|0|||
48345228|NCT01172639|155461110|FG002|Overall Study|Death|0|||
48345229|NCT01172639|155461111|FG003|Overall Study|Death|0|||
48760999|NCT00951665|156973962|FG004|Phase 1b|Withdrawal by Subject|0|||
48345230|NCT01172639|155461112|FG004|Overall Study|Death|0|||
48761000|NCT00951665|156973963|FG005|Phase 1b|Withdrawal by Subject|0|||
48345231|NCT01172639|155461108|FG000|Overall Study|Lost to Follow-up|9|||
48586775|NCT00483704|156339071|FG002|Treatment|Lost to Follow-up|5|||
48586776|NCT00483704|156339069|FG000|Treatment|Lack of Efficacy|1|||
48586777|NCT00483704|156339070|FG001|Treatment|Lack of Efficacy|1|||
48345232|NCT01172639|155461109|FG001|Overall Study|Lost to Follow-up|7|||
48345233|NCT01172639|155461110|FG002|Overall Study|Lost to Follow-up|11|||
48345234|NCT01172639|155461111|FG003|Overall Study|Lost to Follow-up|6|||
48345235|NCT01172639|155461112|FG004|Overall Study|Lost to Follow-up|6|||
48345236|NCT01172639|155461108|FG000|Overall Study|Withdrawal by Subject|3|||
48345237|NCT01172639|155461109|FG001|Overall Study|Withdrawal by Subject|3|||
48345238|NCT01172639|155461110|FG002|Overall Study|Withdrawal by Subject|5|||
48672973|NCT01641822|156654995|FG000|Run-in Phase|Adverse Event|3|||
48672974|NCT01641822|156654996|FG001|Run-in Phase|Adverse Event|0|||
48672975|NCT01641822|156654997|FG002|Run-in Phase|Adverse Event|0|||
48672976|NCT01641822|156654995|FG000|Run-in Phase|Withdrew consent|1|||
48672977|NCT01641822|156654996|FG001|Run-in Phase|Withdrew consent|0|||
48672978|NCT01641822|156654997|FG002|Run-in Phase|Withdrew consent|0|||
48672979|NCT01641822|156654995|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
48672980|NCT01641822|156654996|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
48672981|NCT01641822|156654997|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
48345239|NCT01172639|155461111|FG003|Overall Study|Withdrawal by Subject|5|||
48345240|NCT01172639|155461112|FG004|Overall Study|Withdrawal by Subject|0|||
48345241|NCT00225277|155461115|FG000|Overall Study|Adverse Event|30|||
48345242|NCT00225277|155461116|FG001|Overall Study|Adverse Event|34|||
48345243|NCT00225277|155461115|FG000|Overall Study|Lack of Efficacy|4|||
48345244|NCT00225277|155461116|FG001|Overall Study|Lack of Efficacy|1|||
48345245|NCT00225277|155461115|FG000|Overall Study|Lost to Follow-up|4|||
48345246|NCT00225277|155461116|FG001|Overall Study|Lost to Follow-up|6|||
48345247|NCT00225277|155461115|FG000|Overall Study|Physician Decision|6|||
48345248|NCT00225277|155461116|FG001|Overall Study|Physician Decision|8|||
48345249|NCT00225277|155461115|FG000|Overall Study|Protocol Violation|6|||
48345250|NCT00225277|155461116|FG001|Overall Study|Protocol Violation|3|||
48345251|NCT00225277|155461115|FG000|Overall Study|Withdrawal by Subject|40|||
48345252|NCT00225277|155461116|FG001|Overall Study|Withdrawal by Subject|34|||
48345253|NCT00225277|155461115|FG000|Overall Study|Other|7|||
48345254|NCT00225277|155461116|FG001|Overall Study|Other|9|||
48345255|NCT03371485|155461121|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
48345256|NCT03371485|155461121|FG000|2-year Follow-up|Death|5|||
48345257|NCT01264887|155461130|FG000|Overall Study|Adverse Event|5|||
48345258|NCT01264887|155461130|FG000|Overall Study|Death|7|||
48345259|NCT01264887|155461130|FG000|Overall Study|Lack of Efficacy|5|||
48345260|NCT01264887|155461130|FG000|Overall Study|Physician Decision|4|||
48345261|NCT01264887|155461130|FG000|Overall Study|Withdrawal by Subject|6|||
48345262|NCT01264887|155461130|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
48345263|NCT01264887|155461130|FG000|Overall Study|Other|2|||
48345264|NCT01874665|155461132|FG000|Overall Study|Adverse Event|6|||
48345265|NCT01874665|155461133|FG001|Overall Study|Adverse Event|2|||
48345266|NCT01874665|155461132|FG000|Overall Study|Withdrawal by Subject|4|||
48345267|NCT01874665|155461133|FG001|Overall Study|Withdrawal by Subject|1|||
48345268|NCT01874665|155461132|FG000|Overall Study|Physician Decision|3|||
48345269|NCT01874665|155461133|FG001|Overall Study|Physician Decision|0|||
48345270|NCT01874665|155461132|FG000|Overall Study|Clinical Progressive Disease|4|||
48345271|NCT01874665|155461133|FG001|Overall Study|Clinical Progressive Disease|3|||
48345272|NCT01874665|155461132|FG000|Overall Study|Study Terminated by Sponsor|0|||
48345273|NCT01874665|155461133|FG001|Overall Study|Study Terminated by Sponsor|2|||
48345274|NCT01874665|155461132|FG000|Overall Study|Documented Progressive Disease|11|||
48345275|NCT01874665|155461133|FG001|Overall Study|Documented Progressive Disease|7|||
48345276|NCT01874665|155461132|FG000|Overall Study|Other|2|||
48345277|NCT01874665|155461133|FG001|Overall Study|Other|0|||
48345278|NCT04582669|155461134|FG000|Overall Study|Subject missed appointment(s).|1|||
48672982|NCT01641822|156654995|FG000|Comparative Phase|Noncompliance with study drug|0|||
48345279|NCT04582669|155461135|FG001|Overall Study|Subject missed appointment(s).|0|||
48345280|NCT04582669|155461136|FG002|Overall Study|Subject missed appointment(s).|1|||
48672983|NCT01641822|156654996|FG001|Comparative Phase|Noncompliance with study drug|1|||
48672984|NCT01641822|156654997|FG002|Comparative Phase|Noncompliance with study drug|0|||
48672985|NCT01641822|156654995|FG000|Comparative Phase|Investigator's discretion|0|||
48672986|NCT01641822|156654996|FG001|Comparative Phase|Investigator's discretion|0|||
48672987|NCT01641822|156654997|FG002|Comparative Phase|Investigator's discretion|1|||
48672988|NCT01641822|156654995|FG000|Comparative Phase|Pregnancy|0|||
48672989|NCT01641822|156654996|FG001|Comparative Phase|Pregnancy|0|||
48672990|NCT01641822|156654997|FG002|Comparative Phase|Pregnancy|1|||
48672991|NCT01641822|156654995|FG000|Comparative Phase|Adverse event, serious fatal|0|||
48672992|NCT01641822|156654996|FG001|Comparative Phase|Adverse event, serious fatal|1|||
48672993|NCT01641822|156654997|FG002|Comparative Phase|Adverse event, serious fatal|0|||
48672994|NCT01641822|156654995|FG000|Comparative Phase|Withdrew consent|0|||
48672995|NCT01641822|156654996|FG001|Comparative Phase|Withdrew consent|3|||
48672996|NCT01641822|156654997|FG002|Comparative Phase|Withdrew consent|7|||
48672997|NCT01641822|156654995|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
48672998|NCT01641822|156654996|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
48672999|NCT01641822|156654997|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
48673000|NCT00454584|156654998|FG000|Controlled Period|Adverse Event|5|||
48673001|NCT00454584|156654999|FG001|Controlled Period|Adverse Event|2|||
48673002|NCT00454584|156655000|FG002|Controlled Period|Adverse Event|1|||
48673003|NCT00454584|156655001|FG003|Controlled Period|Adverse Event|0|||
48673004|NCT00454584|156655002|FG004|Controlled Period|Adverse Event|0|||
48673005|NCT00454584|156655003|FG005|Controlled Period|Adverse Event|0|||
48673006|NCT00454584|156654998|FG000|Controlled Period|Lost to Follow-up|1|||
48673007|NCT00454584|156654999|FG001|Controlled Period|Lost to Follow-up|2|||
48673008|NCT00454584|156655000|FG002|Controlled Period|Lost to Follow-up|2|||
48345281|NCT04582669|155461137|FG003|Overall Study|Subject missed appointment(s).|2|||
48345282|NCT04582669|155461134|FG000|Overall Study|Protocol Violation|0|||
48345283|NCT04582669|155461135|FG001|Overall Study|Protocol Violation|1|||
48345284|NCT04582669|155461136|FG002|Overall Study|Protocol Violation|1|||
48345285|NCT04582669|155461137|FG003|Overall Study|Protocol Violation|0|||
48345286|NCT04531813|155461138|FG000|Overall Study|Protocol Violation|1|||
48345287|NCT04531813|155461138|FG000|Overall Study|Withdrawal by Subject|1|||
48673009|NCT00454584|156655001|FG003|Controlled Period|Lost to Follow-up|0|||
48673010|NCT00454584|156655002|FG004|Controlled Period|Lost to Follow-up|0|||
48673011|NCT00454584|156655003|FG005|Controlled Period|Lost to Follow-up|0|||
48673012|NCT00454584|156654998|FG000|Controlled Period|Other|5|||
48345288|NCT00130728|155461139|FG000|Overall Study|Death|258|||
48345289|NCT00130728|155461140|FG001|Overall Study|Death|258|||
48345290|NCT00130728|155461139|FG000|Overall Study|Lost to Follow-up|4|||
48345291|NCT00130728|155461140|FG001|Overall Study|Lost to Follow-up|0|||
48345292|NCT00130728|155461139|FG000|Overall Study|Withdrawal by Subject|0|||
48345293|NCT00130728|155461140|FG001|Overall Study|Withdrawal by Subject|2|||
48345294|NCT01702519|155461142|FG000|Washout Period|Lost to Follow-up|1|||
48345295|NCT01702519|155461143|FG001|Washout Period|Lost to Follow-up|0|||
48345296|NCT01702519|155461142|FG000|Washout Period|Withdrawal by Subject|0|||
48345297|NCT01702519|155461143|FG001|Washout Period|Withdrawal by Subject|2|||
48345298|NCT03738397|155461148|FG000|Overall Study|Adverse Event|3|||
48345299|NCT03738397|155461149|FG001|Overall Study|Adverse Event|7|||
48345300|NCT03738397|155461148|FG000|Overall Study|Withdrawal by Subject|8|||
48345301|NCT03738397|155461149|FG001|Overall Study|Withdrawal by Subject|11|||
48345302|NCT03738397|155461148|FG000|Overall Study|Lost to Follow-up|7|||
48345303|NCT03738397|155461149|FG001|Overall Study|Lost to Follow-up|5|||
48345304|NCT03738397|155461148|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
48345305|NCT03738397|155461149|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
48345306|NCT03738397|155461148|FG000|Overall Study|Other|4|||
48673013|NCT00454584|156654999|FG001|Controlled Period|Other|4|||
48345307|NCT03738397|155461149|FG001|Overall Study|Other|6|||
48345308|NCT00904722|155461150|FG000|Overall Study|Physician Decision|1|||
48345309|NCT04522778|155461152|FG000|Overall Study|Patient did not want to wear the device|1|||
48345310|NCT04522778|155461153|FG001|Overall Study|Patient did not want to wear the device|0|||
48345311|NCT04522778|155461152|FG000|Overall Study|Lost to Follow-up|0|||
48345312|NCT04522778|155461153|FG001|Overall Study|Lost to Follow-up|1|||
48345313|NCT04052997|155461154|FG000|Overall Study|Withdrawal by Subject|17|||
48673014|NCT00454584|156655000|FG002|Controlled Period|Other|2|||
48673015|NCT00454584|156655001|FG003|Controlled Period|Other|0|||
48673016|NCT00454584|156655002|FG004|Controlled Period|Other|0|||
48345314|NCT04052997|155461154|FG000|Overall Study|Physician Decision|50|||
48345315|NCT04052997|155461154|FG000|Overall Study|Death|43|||
48345316|NCT04052997|155461154|FG000|Overall Study|Lost to Follow-up|5|||
48345317|NCT04052997|155461154|FG000|Overall Study|Progression of Disease|1|||
48345318|NCT04750577|155461155|FG000|Overall Study|Adverse Event|2|||
48345319|NCT04750577|155461156|FG001|Overall Study|Adverse Event|10|||
48345320|NCT04750577|155461157|FG002|Overall Study|Adverse Event|8|||
48345321|NCT04750577|155461158|FG003|Overall Study|Adverse Event|1|||
48345322|NCT04750577|155461155|FG000|Overall Study|Change of residence|0|||
48345323|NCT04750577|155461156|FG001|Overall Study|Change of residence|0|||
48345324|NCT04750577|155461157|FG002|Overall Study|Change of residence|1|||
48345325|NCT04750577|155461158|FG003|Overall Study|Change of residence|0|||
48345326|NCT04750577|155461155|FG000|Overall Study|Burden of study procedures|0|||
48345327|NCT04750577|155461156|FG001|Overall Study|Burden of study procedures|2|||
48345328|NCT04750577|155461157|FG002|Overall Study|Burden of study procedures|2|||
48345329|NCT04750577|155461158|FG003|Overall Study|Burden of study procedures|0|||
48345330|NCT04750577|155461155|FG000|Overall Study|Prematurely discontinued|0|||
48761001|NCT00951665|156973958|FG000|Phase 1b|Disease Progression|13|||
48761002|NCT00951665|156973959|FG001|Phase 1b|Disease Progression|2|||
48345331|NCT04750577|155461156|FG001|Overall Study|Prematurely discontinued|0|||
48345332|NCT04750577|155461157|FG002|Overall Study|Prematurely discontinued|0|||
48345333|NCT04750577|155461158|FG003|Overall Study|Prematurely discontinued|2|||
48345334|NCT04750577|155461155|FG000|Overall Study|Protocol deviation|1|||
48345335|NCT04750577|155461156|FG001|Overall Study|Protocol deviation|1|||
48345336|NCT04750577|155461157|FG002|Overall Study|Protocol deviation|1|||
48345337|NCT04750577|155461158|FG003|Overall Study|Protocol deviation|1|||
48345338|NCT04750577|155461155|FG000|Overall Study|Other than listed|3|||
48345339|NCT04750577|155461156|FG001|Overall Study|Other than listed|2|||
48345340|NCT04750577|155461157|FG002|Overall Study|Other than listed|2|||
48345341|NCT04750577|155461158|FG003|Overall Study|Other than listed|1|||
48345342|NCT04750577|155461155|FG000|Overall Study|Not treated|0|||
48345343|NCT04750577|155461156|FG001|Overall Study|Not treated|0|||
48345344|NCT04750577|155461157|FG002|Overall Study|Not treated|0|||
48345345|NCT04750577|155461158|FG003|Overall Study|Not treated|2|||
48345346|NCT00361842|155461159|FG000|Overall Study|Withdrawal by Subject|2|||
48345347|NCT00361842|155461160|FG001|Overall Study|Withdrawal by Subject|3|||
48345348|NCT00361842|155461159|FG000|Overall Study|Death|2|||
48345349|NCT00361842|155461160|FG001|Overall Study|Death|1|||
48345350|NCT00361842|155461159|FG000|Overall Study|Disease progression|19|||
48345351|NCT00361842|155461160|FG001|Overall Study|Disease progression|20|||
48345352|NCT00361842|155461159|FG000|Overall Study|Adverse Event|2|||
48345353|NCT00361842|155461160|FG001|Overall Study|Adverse Event|3|||
48345354|NCT00361842|155461159|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
48345355|NCT00361842|155461160|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
48345356|NCT00361842|155461159|FG000|Overall Study|Other|1|||
48345357|NCT00361842|155461160|FG001|Overall Study|Other|0|||
48345358|NCT00361842|155461159|FG000|Overall Study|Other|0|||
48345359|NCT00361842|155461160|FG001|Overall Study|Other|2|||
48345360|NCT04814992|155461161|FG000|Overall Study|Withdrawal by Subject|6|||
48345361|NCT04814992|155461162|FG001|Overall Study|Withdrawal by Subject|3|||
48345362|NCT04814992|155461161|FG000|Overall Study|Lost to Follow-up|1|||
48345363|NCT04814992|155461162|FG001|Overall Study|Lost to Follow-up|4|||
48345364|NCT01078584|155461163|FG000|Overall Study|Final Status Unknown|1073|||
48345365|NCT01078584|155461163|FG000|Overall Study|Lost to Follow-up|670|||
48345366|NCT01078584|155461163|FG000|Overall Study|Non-serious Adverse Event|577|||
48345367|NCT01078584|155461163|FG000|Overall Study|Withdrawal of Consent|244|||
48345368|NCT01078584|155461163|FG000|Overall Study|Physician Withdrew from Study|90|||
48345369|NCT01078584|155461163|FG000|Overall Study|Non-compliance|67|||
48345370|NCT01078584|155461163|FG000|Overall Study|Blood Pressure Controlled|49|||
48345371|NCT01078584|155461163|FG000|Overall Study|Physician Switched Medication|26|||
48345372|NCT01078584|155461163|FG000|Overall Study|Physician Discontinued Patient|12|||
48345373|NCT01078584|155461163|FG000|Overall Study|Lack of Efficacy|98|||
48345374|NCT01078584|155461163|FG000|Overall Study|Protocol Violation|75|||
48761003|NCT00951665|156973960|FG002|Phase 1b|Disease Progression|14|||
48761004|NCT00951665|156973961|FG003|Phase 1b|Disease Progression|0|||
48345375|NCT01078584|155461163|FG000|Overall Study|Serious Adverse Event|27|||
48345376|NCT01078584|155461163|FG000|Overall Study|Multiple Reasons|2|||
48345377|NCT01121185|155461171|FG000|Overall Study|Not infused|0|||
48345378|NCT01121185|155461172|FG001|Overall Study|Not infused|1|||
48345379|NCT01121185|155461171|FG000|Overall Study|Not transplanted|1|||
48345380|NCT01121185|155461172|FG001|Overall Study|Not transplanted|0|||
48345381|NCT01091519|155461173|FG000|Overall Study|Adverse Event|12|||
48345382|NCT01091519|155461174|FG001|Overall Study|Adverse Event|16|||
48345383|NCT01091519|155461173|FG000|Overall Study|Death|1|||
48345384|NCT01091519|155461174|FG001|Overall Study|Death|0|||
48345385|NCT01091519|155461173|FG000|Overall Study|Lack of Efficacy|16|||
48345386|NCT01091519|155461174|FG001|Overall Study|Lack of Efficacy|19|||
48345387|NCT01091519|155461173|FG000|Overall Study|Lost to Follow-up|14|||
48345388|NCT01091519|155461174|FG001|Overall Study|Lost to Follow-up|24|||
48345389|NCT01091519|155461173|FG000|Overall Study|Withdrawal by Subject|2|||
48345390|NCT01091519|155461174|FG001|Overall Study|Withdrawal by Subject|2|||
48345391|NCT01091519|155461173|FG000|Overall Study|Other|6|||
48345392|NCT01091519|155461174|FG001|Overall Study|Other|8|||
48345393|NCT01091519|155461173|FG000|Overall Study|Randomized not treated|4|||
48345394|NCT01091519|155461174|FG001|Overall Study|Randomized not treated|4|||
48345395|NCT00496834|155461177|FG000|Overall Study|Withdrawal by Subject|4|||
48345396|NCT00496834|155461178|FG001|Overall Study|Withdrawal by Subject|6|||
48345397|NCT00496834|155461177|FG000|Overall Study|Contraindicated medication administered|0|||
48345398|NCT00496834|155461178|FG001|Overall Study|Contraindicated medication administered|1|||
48345399|NCT00496834|155461177|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
48345400|NCT00496834|155461178|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
48345401|NCT00496834|155461177|FG000|Overall Study|Adverse Event|5|||
48345402|NCT00496834|155461178|FG001|Overall Study|Adverse Event|3|||
48345403|NCT00496834|155461177|FG000|Overall Study|IP administration violation|2|||
48345404|NCT00496834|155461178|FG001|Overall Study|IP administration violation|0|||
48345405|NCT00496834|155461177|FG000|Overall Study|Lost to Follow-up|2|||
48345406|NCT00496834|155461178|FG001|Overall Study|Lost to Follow-up|0|||
48345407|NCT00496834|155461177|FG000|Overall Study|Blood Pressure control failure|2|||
48345408|NCT00496834|155461178|FG001|Overall Study|Blood Pressure control failure|1|||
48345409|NCT02647645|155461179|FG000|Overall Study|Lost to Follow-up|2|||
48345410|NCT02647645|155461180|FG001|Overall Study|Lost to Follow-up|1|||
48345411|NCT01494298|155461183|FG000|Overall Study|Protocol Violation|2|||
48345412|NCT01494298|155461184|FG001|Overall Study|Protocol Violation|8|||
48345413|NCT01180790|155461185|FG000|Overall Study|Adverse Event|1|||
48345414|NCT01180790|155461186|FG001|Overall Study|Adverse Event|1|||
48345415|NCT01180790|155461187|FG002|Overall Study|Adverse Event|2|||
48345416|NCT01180790|155461188|FG003|Overall Study|Adverse Event|0|||
48345417|NCT01180790|155461189|FG004|Overall Study|Adverse Event|1|||
48345418|NCT01180790|155461190|FG005|Overall Study|Adverse Event|3|||
48345419|NCT01180790|155461191|FG006|Overall Study|Adverse Event|0|||
48345420|NCT01180790|155461185|FG000|Overall Study|Withdrawal by Subject|3|||
48345421|NCT01180790|155461186|FG001|Overall Study|Withdrawal by Subject|0|||
48345422|NCT01180790|155461187|FG002|Overall Study|Withdrawal by Subject|5|||
48345423|NCT01180790|155461188|FG003|Overall Study|Withdrawal by Subject|0|||
48345424|NCT01180790|155461189|FG004|Overall Study|Withdrawal by Subject|2|||
48345425|NCT01180790|155461190|FG005|Overall Study|Withdrawal by Subject|1|||
48345426|NCT01180790|155461191|FG006|Overall Study|Withdrawal by Subject|0|||
48345427|NCT01180790|155461185|FG000|Overall Study|Lost to Follow-up|3|||
48345428|NCT01180790|155461186|FG001|Overall Study|Lost to Follow-up|1|||
48345429|NCT01180790|155461187|FG002|Overall Study|Lost to Follow-up|0|||
48345430|NCT01180790|155461188|FG003|Overall Study|Lost to Follow-up|2|||
48345431|NCT01180790|155461189|FG004|Overall Study|Lost to Follow-up|1|||
48345432|NCT01180790|155461190|FG005|Overall Study|Lost to Follow-up|0|||
48345433|NCT01180790|155461191|FG006|Overall Study|Lost to Follow-up|1|||
48345434|NCT01180790|155461185|FG000|Overall Study|Physician Decision|1|||
48345435|NCT01180790|155461186|FG001|Overall Study|Physician Decision|0|||
48345436|NCT01180790|155461187|FG002|Overall Study|Physician Decision|0|||
48345437|NCT01180790|155461188|FG003|Overall Study|Physician Decision|1|||
48345438|NCT01180790|155461189|FG004|Overall Study|Physician Decision|0|||
48345439|NCT01180790|155461190|FG005|Overall Study|Physician Decision|0|||
48345440|NCT01180790|155461191|FG006|Overall Study|Physician Decision|0|||
48345441|NCT01180790|155461185|FG000|Overall Study|Lack of Efficacy|1|||
48345442|NCT01180790|155461186|FG001|Overall Study|Lack of Efficacy|2|||
48345443|NCT01180790|155461187|FG002|Overall Study|Lack of Efficacy|5|||
48345444|NCT01180790|155461188|FG003|Overall Study|Lack of Efficacy|6|||
48345445|NCT01180790|155461189|FG004|Overall Study|Lack of Efficacy|1|||
48345446|NCT01180790|155461190|FG005|Overall Study|Lack of Efficacy|3|||
48345447|NCT01180790|155461191|FG006|Overall Study|Lack of Efficacy|0|||
48345448|NCT01180790|155461185|FG000|Overall Study|compliance|0|||
48345449|NCT01180790|155461186|FG001|Overall Study|compliance|1|||
48345450|NCT01180790|155461187|FG002|Overall Study|compliance|0|||
48345451|NCT01180790|155461188|FG003|Overall Study|compliance|0|||
48345452|NCT01180790|155461189|FG004|Overall Study|compliance|0|||
48345453|NCT01180790|155461190|FG005|Overall Study|compliance|0|||
48345454|NCT01180790|155461191|FG006|Overall Study|compliance|0|||
48345455|NCT01180790|155461185|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
48345456|NCT01180790|155461186|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
48345457|NCT01180790|155461187|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
48345458|NCT01180790|155461188|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
48345459|NCT01180790|155461189|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
48345460|NCT01180790|155461190|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
48345461|NCT01180790|155461191|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
48345462|NCT01251887|155461193|FG000|Overall Study|Scheduling conflict|1|||
48345463|NCT01251887|155461194|FG001|Overall Study|Scheduling conflict|2|||
48345464|NCT01251887|155461195|FG002|Overall Study|Scheduling conflict|2|||
48345465|NCT01251887|155461193|FG000|Overall Study|Physician Decision|0|||
48345466|NCT01251887|155461194|FG001|Overall Study|Physician Decision|1|||
48345467|NCT01251887|155461195|FG002|Overall Study|Physician Decision|0|||
48345468|NCT01831726|155461198|FG000|Overall Study|Adverse Event|16|||
48345469|NCT01831726|155461198|FG000|Overall Study|Death|7|||
48345470|NCT01831726|155461198|FG000|Overall Study|Disease Progression|49|||
48345471|NCT01831726|155461198|FG000|Overall Study|Physician Decision|1|||
48345472|NCT01831726|155461198|FG000|Overall Study|Subject/guardian decision|7|||
48345473|NCT01393613|155461199|FG000|Overall Study|Adverse Event|11|||
48345474|NCT01393613|155461200|FG001|Overall Study|Adverse Event|11|||
48345475|NCT01393613|155461201|FG002|Overall Study|Adverse Event|13|||
48345476|NCT01393613|155461202|FG003|Overall Study|Adverse Event|22|||
48345477|NCT01393613|155461199|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
48345478|NCT01393613|155461200|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
48345479|NCT01393613|155461201|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
48345480|NCT01393613|155461202|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
48345481|NCT01393613|155461199|FG000|Overall Study|Physician Decision|2|||
48345482|NCT01393613|155461200|FG001|Overall Study|Physician Decision|0|||
48345483|NCT01393613|155461201|FG002|Overall Study|Physician Decision|0|||
48345484|NCT01393613|155461202|FG003|Overall Study|Physician Decision|1|||
48345485|NCT01393613|155461199|FG000|Overall Study|Withdrawal by Subject|15|||
48345486|NCT01393613|155461200|FG001|Overall Study|Withdrawal by Subject|25|||
48345487|NCT01393613|155461201|FG002|Overall Study|Withdrawal by Subject|23|||
48345488|NCT01393613|155461202|FG003|Overall Study|Withdrawal by Subject|21|||
48345489|NCT01393613|155461199|FG000|Overall Study|Protocol Deviation|2|||
48345490|NCT01393613|155461200|FG001|Overall Study|Protocol Deviation|1|||
48345491|NCT01393613|155461201|FG002|Overall Study|Protocol Deviation|0|||
48345492|NCT01393613|155461202|FG003|Overall Study|Protocol Deviation|0|||
48345493|NCT01393613|155461199|FG000|Overall Study|Lack of Efficacy|9|||
48345494|NCT01393613|155461200|FG001|Overall Study|Lack of Efficacy|20|||
48345495|NCT01393613|155461201|FG002|Overall Study|Lack of Efficacy|16|||
48345496|NCT01393613|155461202|FG003|Overall Study|Lack of Efficacy|21|||
48345497|NCT03821064|155461203|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
48345498|NCT00474383|155461204|FG000|Main Study|Adverse Event|11|||
48345499|NCT00474383|155461205|FG001|Main Study|Adverse Event|0|||
48345500|NCT00474383|155461204|FG000|Main Study|Symptomatic Deterioration|1|||
48345501|NCT00474383|155461205|FG001|Main Study|Symptomatic Deterioration|0|||
48345502|NCT00474383|155461204|FG000|Main Study|Progressive Disease|23|||
48345503|NCT00474383|155461205|FG001|Main Study|Progressive Disease|0|||
48345504|NCT00474383|155461204|FG000|Main Study|Other|1|||
48345505|NCT00474383|155461205|FG001|Main Study|Other|0|||
48345506|NCT00474383|155461204|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
48345507|NCT00474383|155461205|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
48345508|NCT00474383|155461204|FG000|Extension|Progressive Disease|0|||
48345509|NCT00474383|155461205|FG001|Extension|Progressive Disease|5|||
48345510|NCT02598934|155461208|FG000|Overall Study|Adverse Event|11|||
48345511|NCT02598934|155461209|FG001|Overall Study|Adverse Event|13|||
48345512|NCT02598934|155461208|FG000|Overall Study|Failure to Return|3|||
48345513|NCT02598934|155461209|FG001|Overall Study|Failure to Return|3|||
48345514|NCT02598934|155461208|FG000|Overall Study|Withdrawal by Subject|2|||
48345515|NCT02598934|155461209|FG001|Overall Study|Withdrawal by Subject|3|||
48345516|NCT02598934|155461208|FG000|Overall Study|Administrative|2|||
48345517|NCT02598934|155461209|FG001|Overall Study|Administrative|1|||
48673017|NCT00454584|156655003|FG005|Controlled Period|Other|0|||
48345518|NCT02598934|155461208|FG000|Overall Study|Protocol Violation|1|||
48345519|NCT02598934|155461209|FG001|Overall Study|Protocol Violation|2|||
48345520|NCT03918447|155461210|FG000|Overall Study|Death|1|||
48345521|NCT03918447|155461211|FG001|Overall Study|Death|0|||
48345522|NCT03918447|155461210|FG000|Overall Study|Lost to Follow-up|13|||
48345523|NCT03918447|155461211|FG001|Overall Study|Lost to Follow-up|6|||
48345524|NCT03918447|155461210|FG000|Overall Study|Withdrawal by Subject|19|||
48345525|NCT03918447|155461211|FG001|Overall Study|Withdrawal by Subject|17|||
48345526|NCT03918447|155461210|FG000|Overall Study|Study Terminated by Sponsor|195|||
48345527|NCT03918447|155461211|FG001|Overall Study|Study Terminated by Sponsor|197|||
48345528|NCT03918447|155461210|FG000|Overall Study|Reason not Specified|0|||
48673018|NCT00454584|156654998|FG000|After Controlled Period|Adverse Event|0|||
48673019|NCT00454584|156654999|FG001|After Controlled Period|Adverse Event|0|||
48673020|NCT00454584|156655000|FG002|After Controlled Period|Adverse Event|0|||
48345529|NCT03918447|155461211|FG001|Overall Study|Reason not Specified|1|||
48345530|NCT02394925|155461212|FG000|Overall Study|Adverse Event|1|||
48345531|NCT02394925|155461212|FG000|Overall Study|Lens Discomfort|3|||
48345532|NCT02394925|155461212|FG000|Overall Study|Lens handling difficulities|5|||
48345533|NCT02394925|155461212|FG000|Overall Study|Lost to Follow-up|9|||
48345534|NCT02394925|155461212|FG000|Overall Study|Protocol Violation|5|||
48345535|NCT02394925|155461212|FG000|Overall Study|No longer meet eligibility criteria|1|||
48345536|NCT02394925|155461212|FG000|Overall Study|Unsatisfactory Visual Response|5|||
48345537|NCT05896696|155461218|FG000|Overall Study|Screening Failure|7|||
48345538|NCT05896696|155461218|FG000|Overall Study|Withdrawal by Subject|2|||
48345539|NCT03098797|155462832|FG000|Part 2 Open Label Extension|Adverse Event|2|||
48345540|NCT03098797|155462833|FG001|Part 2 Open Label Extension|Adverse Event|0|||
48345541|NCT00740597|155462835|FG000|Overall Study|insurance would not cover treatment|1|||
48673021|NCT00454584|156655001|FG003|After Controlled Period|Adverse Event|9|||
48345542|NCT00332488|155462839|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
48345543|NCT00332488|155462840|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
48345544|NCT00332488|155462841|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
48345545|NCT00332488|155462839|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
48383954|NCT04029116|155601516|FG000|Overall Study|Lost to Follow-up|3|||
48673022|NCT00454584|156655002|FG004|After Controlled Period|Adverse Event|3|||
48673023|NCT00454584|156655003|FG005|After Controlled Period|Adverse Event|9|||
48673024|NCT00454584|156654998|FG000|After Controlled Period|Lack of Efficacy|0|||
48673025|NCT00454584|156654999|FG001|After Controlled Period|Lack of Efficacy|0|||
48673026|NCT00454584|156655000|FG002|After Controlled Period|Lack of Efficacy|0|||
48673027|NCT00454584|156655001|FG003|After Controlled Period|Lack of Efficacy|1|||
48673028|NCT00454584|156655002|FG004|After Controlled Period|Lack of Efficacy|0|||
48673029|NCT00454584|156655003|FG005|After Controlled Period|Lack of Efficacy|0|||
48673030|NCT00454584|156654998|FG000|After Controlled Period|Lost to Follow-up|0|||
48345546|NCT00332488|155462840|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
48345547|NCT00332488|155462841|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
48345548|NCT00332488|155462839|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
48345549|NCT00332488|155462840|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
48345550|NCT00332488|155462841|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
48345551|NCT00332488|155462839|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
48345552|NCT00332488|155462840|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
48345553|NCT00332488|155462841|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
48345554|NCT00332488|155462839|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
48345555|NCT00332488|155462840|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
48345556|NCT00332488|155462841|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
48345557|NCT00332488|155462839|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
48345558|NCT00332488|155462840|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
48345559|NCT00332488|155462841|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
48345560|NCT00332488|155462839|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
48345561|NCT00332488|155462840|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
48345562|NCT00332488|155462841|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
48345563|NCT00332488|155462839|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
48345564|NCT00332488|155462840|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
48345565|NCT00332488|155462841|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
48345566|NCT00332488|155462839|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
48345567|NCT00332488|155462840|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
48345568|NCT00332488|155462841|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
48345569|NCT00332488|155462839|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
48345570|NCT00332488|155462840|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
48345571|NCT00332488|155462841|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
48345572|NCT00332488|155462839|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
48345573|NCT00332488|155462840|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
48345574|NCT00332488|155462841|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
48345575|NCT00332488|155462839|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
48345576|NCT00332488|155462840|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
48345577|NCT00332488|155462841|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
48345578|NCT00275301|155462848|FG000|Overall Study|Adverse Event|5|||
48345579|NCT01845649|155462849|FG000|Overall Study|Adverse Event|7|||
48345580|NCT01845649|155462850|FG001|Overall Study|Adverse Event|10|||
48345581|NCT01845649|155462849|FG000|Overall Study|Lack of Efficacy|1|||
48345582|NCT01845649|155462850|FG001|Overall Study|Lack of Efficacy|1|||
48345583|NCT01845649|155462849|FG000|Overall Study|Lost to Follow-up|2|||
48345584|NCT01845649|155462850|FG001|Overall Study|Lost to Follow-up|2|||
48345585|NCT01845649|155462849|FG000|Overall Study|Withdrew Consent|12|||
48345586|NCT01845649|155462850|FG001|Overall Study|Withdrew Consent|4|||
48345587|NCT01845649|155462849|FG000|Overall Study|Protocol Deviation|7|||
48345588|NCT01845649|155462850|FG001|Overall Study|Protocol Deviation|4|||
48345589|NCT01845649|155462849|FG000|Overall Study|Reason not Specified|2|||
48345590|NCT01845649|155462850|FG001|Overall Study|Reason not Specified|1|||
48345591|NCT00508274|155462851|FG000|Overall Study|Adverse Event|5|||
48345592|NCT00508274|155462851|FG000|Overall Study|Death|7|||
48345593|NCT00508274|155462851|FG000|Overall Study|Disease progression|32|||
48345594|NCT00508274|155462851|FG000|Overall Study|Withdrawal by Subject|1|||
48345595|NCT00508274|155462851|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
48345596|NCT00508274|155462851|FG000|Overall Study|Missing|3|||
48345597|NCT00526097|155462852|FG000|Overall Study|Adverse Event|6|||
48345598|NCT00526097|155462853|FG001|Overall Study|Adverse Event|44|||
48345599|NCT00526097|155462852|FG000|Overall Study|Protocol Violation|4|||
48345600|NCT00526097|155462853|FG001|Overall Study|Protocol Violation|10|||
48345601|NCT00526097|155462852|FG000|Overall Study|Withdrawal by Subject|3|||
48673031|NCT00454584|156654999|FG001|After Controlled Period|Lost to Follow-up|0|||
48345602|NCT00526097|155462853|FG001|Overall Study|Withdrawal by Subject|1|||
48673032|NCT00454584|156655000|FG002|After Controlled Period|Lost to Follow-up|0|||
48673033|NCT00454584|156655001|FG003|After Controlled Period|Lost to Follow-up|2|||
48673034|NCT00454584|156655002|FG004|After Controlled Period|Lost to Follow-up|4|||
48673035|NCT00454584|156655003|FG005|After Controlled Period|Lost to Follow-up|6|||
48673036|NCT00454584|156654998|FG000|After Controlled Period|Other|0|||
48673037|NCT00454584|156654999|FG001|After Controlled Period|Other|0|||
48345603|NCT00526097|155462852|FG000|Overall Study|Other|2|||
48345604|NCT00526097|155462853|FG001|Overall Study|Other|1|||
48345605|NCT04140266|155462854|FG000|Overall Study|Physician Decision|2|||
48345606|NCT04140266|155462855|FG001|Overall Study|Physician Decision|0|||
48345607|NCT04140266|155462854|FG000|Overall Study|Withdrawal by Subject|4|||
48345608|NCT04140266|155462855|FG001|Overall Study|Withdrawal by Subject|2|||
48345609|NCT00463580|155462857|FG000|Overall Study|Lost to Follow-up|1|||
48673038|NCT00454584|156655000|FG002|After Controlled Period|Other|0|||
48673039|NCT00454584|156655001|FG003|After Controlled Period|Other|1|||
48673040|NCT00454584|156655002|FG004|After Controlled Period|Other|0|||
48673041|NCT00454584|156655003|FG005|After Controlled Period|Other|0|||
48673042|NCT00454584|156654998|FG000|After Controlled Period|Other|0|||
48673043|NCT00454584|156654999|FG001|After Controlled Period|Other|0|||
48673044|NCT00454584|156655000|FG002|After Controlled Period|Other|0|||
48673045|NCT00454584|156655001|FG003|After Controlled Period|Other|13|||
48673046|NCT00454584|156655002|FG004|After Controlled Period|Other|5|||
48673047|NCT00454584|156655003|FG005|After Controlled Period|Other|17|||
48673048|NCT04268173|156655007|FG000|Overall Study|Lost to Follow-up|75|||
48673049|NCT04268173|156655008|FG001|Overall Study|Lost to Follow-up|108|||
48673050|NCT01353911|156655009|FG000|Overall Study|Lost to Follow-up|2|||
48673051|NCT01353911|156655010|FG001|Overall Study|Lost to Follow-up|6|||
48673052|NCT01353911|156655011|FG002|Overall Study|Lost to Follow-up|4|||
48673053|NCT01353911|156655012|FG003|Overall Study|Lost to Follow-up|0|||
48673054|NCT01353911|156655013|FG004|Overall Study|Lost to Follow-up|4|||
48673055|NCT01353911|156655014|FG005|Overall Study|Lost to Follow-up|4|||
48345610|NCT00463580|155462858|FG001|Overall Study|Lost to Follow-up|0|||
48345611|NCT00463580|155462857|FG000|Overall Study|Schedule conflict|2|||
48345612|NCT00463580|155462858|FG001|Overall Study|Schedule conflict|0|||
48345613|NCT00463580|155462857|FG000|Overall Study|Medical/psychiatric complications|0|||
48345614|NCT00463580|155462858|FG001|Overall Study|Medical/psychiatric complications|2|||
48345615|NCT00858247|155462859|FG000|Baseline Assessment|Withdrawal by Subject|1|||
48345616|NCT00858247|155462860|FG001|Baseline Assessment|Withdrawal by Subject|1|||
48345617|NCT00858247|155462859|FG000|Baseline Assessment|Poor IV access|1|||
48345618|NCT00858247|155462860|FG001|Baseline Assessment|Poor IV access|0|||
48345619|NCT00858247|155462859|FG000|Baseline Assessment|Protocol Violation|0|||
48345620|NCT00858247|155462860|FG001|Baseline Assessment|Protocol Violation|1|||
48345621|NCT00858247|155462859|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
48345622|NCT00858247|155462860|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
48345623|NCT01746108|155462861|FG000|Overall Study|Migrated /moved from study area|0|||
48345624|NCT01746108|155462862|FG001|Overall Study|Migrated /moved from study area|1|||
48345625|NCT01746108|155462863|FG002|Overall Study|Migrated /moved from study area|0|||
48345626|NCT01746108|155462861|FG000|Overall Study|Adverse event, non-fatal|0|||
48345627|NCT01746108|155462862|FG001|Overall Study|Adverse event, non-fatal|1|||
48345628|NCT01746108|155462863|FG002|Overall Study|Adverse event, non-fatal|0|||
48345629|NCT01746108|155462861|FG000|Overall Study|Withdrawal by Subject|0|||
48345630|NCT01746108|155462862|FG001|Overall Study|Withdrawal by Subject|1|||
48345631|NCT01746108|155462863|FG002|Overall Study|Withdrawal by Subject|0|||
48345632|NCT01746108|155462861|FG000|Overall Study|Lost to Follow-up|0|||
48345633|NCT01746108|155462862|FG001|Overall Study|Lost to Follow-up|1|||
48345634|NCT01746108|155462863|FG002|Overall Study|Lost to Follow-up|0|||
48345635|NCT00553605|155462864|FG000|Overall Study|Did not meet entrance criteria|1|||
48345636|NCT00553605|155462865|FG001|Overall Study|Did not meet entrance criteria|3|||
48345637|NCT00553605|155462864|FG000|Overall Study|Did not receive full dose|1|||
48345638|NCT00553605|155462865|FG001|Overall Study|Did not receive full dose|0|||
48673056|NCT01353911|156655015|FG006|Overall Study|Lost to Follow-up|3|||
48673057|NCT01353911|156655016|FG007|Overall Study|Lost to Follow-up|6|||
48673058|NCT01353911|156655009|FG000|Overall Study|Withdrawal by Subject|2|||
48761005|NCT00951665|156973962|FG004|Phase 1b|Disease Progression|0|||
48345639|NCT00553605|155462864|FG000|Overall Study|Randomized but not treated|2|||
48345640|NCT00553605|155462865|FG001|Overall Study|Randomized but not treated|0|||
48345641|NCT01274559|155462868|FG000|Overall Study|Adverse Event|57|||
48345642|NCT01274559|155462869|FG001|Overall Study|Adverse Event|13|||
48345643|NCT01274559|155462868|FG000|Overall Study|Death|1|||
48345644|NCT01274559|155462869|FG001|Overall Study|Death|1|||
48345645|NCT01274559|155462868|FG000|Overall Study|Lost to Follow-up|3|||
48345646|NCT01274559|155462869|FG001|Overall Study|Lost to Follow-up|3|||
48345647|NCT01274559|155462868|FG000|Overall Study|Non-compliance with Study Drug|2|||
48345648|NCT01274559|155462869|FG001|Overall Study|Non-compliance with Study Drug|4|||
48345649|NCT01274559|155462868|FG000|Overall Study|Physician Decision|2|||
48345650|NCT01274559|155462869|FG001|Overall Study|Physician Decision|1|||
48345651|NCT01274559|155462868|FG000|Overall Study|Protocol Violation|28|||
48345652|NCT01274559|155462869|FG001|Overall Study|Protocol Violation|23|||
48345653|NCT01274559|155462868|FG000|Overall Study|Study Terminated by Sponsor|79|||
48345654|NCT01274559|155462869|FG001|Overall Study|Study Terminated by Sponsor|87|||
48345655|NCT01274559|155462868|FG000|Overall Study|Withdrawal by Subject|25|||
48345656|NCT01274559|155462869|FG001|Overall Study|Withdrawal by Subject|13|||
48345657|NCT02971228|155462871|FG000|Overall Study|Withdrawal by Subject|1|||
48345658|NCT02971228|155462872|FG001|Overall Study|Withdrawal by Subject|1|||
48345659|NCT02971228|155462873|FG002|Overall Study|Withdrawal by Subject|0|||
48345660|NCT02971228|155462874|FG003|Overall Study|Withdrawal by Subject|0|||
48345661|NCT02971228|155462875|FG004|Overall Study|Withdrawal by Subject|0|||
48345662|NCT02971228|155462871|FG000|Overall Study|Logistical challenges|0|||
48345663|NCT02971228|155462872|FG001|Overall Study|Logistical challenges|1|||
48345664|NCT02971228|155462873|FG002|Overall Study|Logistical challenges|0|||
48345665|NCT02971228|155462874|FG003|Overall Study|Logistical challenges|0|||
48345666|NCT02971228|155462875|FG004|Overall Study|Logistical challenges|0|||
48345667|NCT01664923|155462876|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
48345668|NCT01664923|155462877|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
48345669|NCT01664923|155462876|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
48345670|NCT01664923|155462877|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
48345671|NCT01664923|155462876|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
48345672|NCT01664923|155462877|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
48345673|NCT01664923|155462876|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
48345674|NCT01664923|155462877|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
48345675|NCT01664923|155462876|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
48345676|NCT01664923|155462877|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
48345677|NCT01664923|155462876|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
48345678|NCT01664923|155462877|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
48345679|NCT01664923|155462876|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
48673059|NCT01353911|156655010|FG001|Overall Study|Withdrawal by Subject|3|||
48673060|NCT01353911|156655011|FG002|Overall Study|Withdrawal by Subject|4|||
48673061|NCT01353911|156655012|FG003|Overall Study|Withdrawal by Subject|2|||
48673062|NCT01353911|156655013|FG004|Overall Study|Withdrawal by Subject|2|||
48673063|NCT01353911|156655014|FG005|Overall Study|Withdrawal by Subject|3|||
48673064|NCT01353911|156655015|FG006|Overall Study|Withdrawal by Subject|3|||
48673065|NCT01353911|156655016|FG007|Overall Study|Withdrawal by Subject|9|||
48673066|NCT01353911|156655009|FG000|Overall Study|Status Not Recorded|4|||
48673067|NCT01353911|156655010|FG001|Overall Study|Status Not Recorded|0|||
48673068|NCT01353911|156655011|FG002|Overall Study|Status Not Recorded|1|||
48673069|NCT01353911|156655012|FG003|Overall Study|Status Not Recorded|0|||
48673070|NCT01353911|156655013|FG004|Overall Study|Status Not Recorded|0|||
48673071|NCT01353911|156655014|FG005|Overall Study|Status Not Recorded|0|||
48673072|NCT01353911|156655015|FG006|Overall Study|Status Not Recorded|0|||
48673073|NCT01353911|156655016|FG007|Overall Study|Status Not Recorded|0|||
48673074|NCT01729208|156655017|FG000|Baseline|Physician Decision|5|||
48673075|NCT01729208|156655018|FG001|Baseline|Physician Decision|4|||
48673076|NCT01729208|156655017|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
48673077|NCT01729208|156655018|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
48673078|NCT01729208|156655017|FG000|12 Months Follow-up|Lost to Follow-up|3|||
48345680|NCT01664923|155462877|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
48673079|NCT01729208|156655018|FG001|12 Months Follow-up|Lost to Follow-up|3|||
48673080|NCT01729208|156655017|FG000|24 Months Follow-up|Lost to Follow-up|3|||
48673081|NCT01729208|156655018|FG001|24 Months Follow-up|Lost to Follow-up|0|||
48673082|NCT01729208|156655017|FG000|36 Months Follow-up|Physician Decision|1|||
48761006|NCT00951665|156973963|FG005|Phase 1b|Disease Progression|0|||
48761007|NCT00951665|156973958|FG000|Phase 1b|Protocol Violation|2|||
48345681|NCT01664923|155462876|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
48345682|NCT01664923|155462877|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
48345683|NCT01664923|155462876|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
48345684|NCT01664923|155462877|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
48345685|NCT01664923|155462876|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
48383955|NCT04029116|155601517|FG001|Overall Study|Lost to Follow-up|5|||
48673083|NCT01729208|156655018|FG001|36 Months Follow-up|Physician Decision|0|||
48761008|NCT00951665|156973959|FG001|Phase 1b|Protocol Violation|0|||
48345686|NCT01664923|155462877|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
48345687|NCT01664923|155462876|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
48345688|NCT01664923|155462877|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
48345689|NCT01664923|155462876|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
48345690|NCT01664923|155462877|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
48345691|NCT01664923|155462876|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
48345692|NCT01664923|155462877|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
48345693|NCT01664923|155462876|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
48345694|NCT01664923|155462877|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
48345695|NCT04270747|155462878|FG000|Through Week 16|Adverse Event|1|||
48345696|NCT04270747|155462879|FG001|Through Week 16|Adverse Event|2|||
48345697|NCT04270747|155462880|FG002|Through Week 16|Adverse Event|0|||
48345698|NCT04270747|155462878|FG000|Through Week 16|Death|0|||
48345699|NCT04270747|155462879|FG001|Through Week 16|Death|2|||
48345700|NCT04270747|155462880|FG002|Through Week 16|Death|0|||
48345701|NCT04270747|155462878|FG000|Through Week 16|Consent Withdrawn|3|||
48673084|NCT01729208|156655017|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
48673085|NCT01729208|156655018|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
48673086|NCT03995355|156655021|FG000|Overall Study|Adverse Event|1|||
48673087|NCT03995355|156655022|FG001|Overall Study|Adverse Event|0|||
48673088|NCT03995355|156655021|FG000|Overall Study|Withdrawal by Subject|1|||
48673089|NCT03995355|156655022|FG001|Overall Study|Withdrawal by Subject|0|||
48673090|NCT03995355|156655021|FG000|Overall Study|Scheduling Issues|0|||
48673091|NCT03995355|156655022|FG001|Overall Study|Scheduling Issues|1|||
48673092|NCT00494507|156655025|FG000|Double-Blind Phase|Adverse Event|2|||
48673093|NCT00494507|156655026|FG001|Double-Blind Phase|Adverse Event|0|||
48673094|NCT00494507|156655027|FG002|Double-Blind Phase|Adverse Event|1|||
48673095|NCT00494507|156655028|FG003|Double-Blind Phase|Adverse Event|0|||
48673096|NCT00494507|156655025|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
48673097|NCT00494507|156655026|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
48345702|NCT04270747|155462879|FG001|Through Week 16|Consent Withdrawn|3|||
48345703|NCT04270747|155462880|FG002|Through Week 16|Consent Withdrawn|0|||
48345704|NCT04270747|155462878|FG000|Through Week 16|Physician Decision|1|||
48345705|NCT04270747|155462879|FG001|Through Week 16|Physician Decision|1|||
48345706|NCT04270747|155462880|FG002|Through Week 16|Physician Decision|0|||
48345707|NCT04270747|155462878|FG000|Through Week 16|Lost to Follow-up|2|||
48345708|NCT04270747|155462879|FG001|Through Week 16|Lost to Follow-up|0|||
48345709|NCT04270747|155462880|FG002|Through Week 16|Lost to Follow-up|0|||
48345710|NCT04270747|155462878|FG000|Through Week 16|Protocol Violation|1|||
48345711|NCT04270747|155462879|FG001|Through Week 16|Protocol Violation|2|||
48345712|NCT04270747|155462880|FG002|Through Week 16|Protocol Violation|0|||
48345713|NCT04270747|155462878|FG000|Through Week 16|Protocol Specified Criteria|6|||
48345714|NCT04270747|155462879|FG001|Through Week 16|Protocol Specified Criteria|7|||
48345715|NCT04270747|155462880|FG002|Through Week 16|Protocol Specified Criteria|0|||
48345716|NCT04270747|155462878|FG000|Through Week 16|Miscellaneous|1|||
48345717|NCT04270747|155462879|FG001|Through Week 16|Miscellaneous|1|||
48345718|NCT04270747|155462880|FG002|Through Week 16|Miscellaneous|0|||
48345719|NCT04270747|155462878|FG000|Post Week 16|Adverse Event|7|||
48345720|NCT04270747|155462879|FG001|Post Week 16|Adverse Event|5|||
48345721|NCT04270747|155462880|FG002|Post Week 16|Adverse Event|1|||
48345722|NCT04270747|155462878|FG000|Post Week 16|Death|2|||
48345723|NCT04270747|155462879|FG001|Post Week 16|Death|0|||
48345724|NCT04270747|155462880|FG002|Post Week 16|Death|2|||
48345725|NCT04270747|155462878|FG000|Post Week 16|Consent Withdrawn|4|||
48345726|NCT04270747|155462879|FG001|Post Week 16|Consent Withdrawn|3|||
48345727|NCT04270747|155462880|FG002|Post Week 16|Consent Withdrawn|6|||
48345728|NCT04270747|155462878|FG000|Post Week 16|Physician Decision|3|||
48345729|NCT04270747|155462879|FG001|Post Week 16|Physician Decision|1|||
48345730|NCT04270747|155462880|FG002|Post Week 16|Physician Decision|1|||
48673098|NCT00494507|156655027|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48673099|NCT00494507|156655028|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48673100|NCT00494507|156655025|FG000|Double-Blind Phase|Subject Non-compliance|0|||
48673101|NCT00494507|156655026|FG001|Double-Blind Phase|Subject Non-compliance|0|||
48673102|NCT00494507|156655027|FG002|Double-Blind Phase|Subject Non-compliance|1|||
48345731|NCT04270747|155462878|FG000|Post Week 16|Lost to Follow-up|2|||
48345732|NCT04270747|155462879|FG001|Post Week 16|Lost to Follow-up|1|||
48345733|NCT04270747|155462880|FG002|Post Week 16|Lost to Follow-up|0|||
48673103|NCT00494507|156655028|FG003|Double-Blind Phase|Subject Non-compliance|0|||
48345734|NCT04270747|155462878|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
48673104|NCT00494507|156655025|FG000|Double-Blind Phase|Negative DNA test|0|||
48673105|NCT00494507|156655026|FG001|Double-Blind Phase|Negative DNA test|0|||
48345735|NCT04270747|155462879|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
48345736|NCT04270747|155462880|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
48345737|NCT04270747|155462878|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
48345738|NCT04270747|155462879|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
48345739|NCT04270747|155462880|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
48673106|NCT00494507|156655027|FG002|Double-Blind Phase|Negative DNA test|0|||
48673107|NCT00494507|156655028|FG003|Double-Blind Phase|Negative DNA test|1|||
48673108|NCT00494507|156655025|FG000|Open-Label Phase|Adverse Event|0|||
48673109|NCT00494507|156655026|FG001|Open-Label Phase|Adverse Event|1|||
48673110|NCT00494507|156655027|FG002|Open-Label Phase|Adverse Event|5|||
48673111|NCT00494507|156655028|FG003|Open-Label Phase|Adverse Event|3|||
48673112|NCT00494507|156655025|FG000|Open-Label Phase|Worsening Disease|0|||
48673113|NCT00494507|156655026|FG001|Open-Label Phase|Worsening Disease|0|||
48673114|NCT00494507|156655027|FG002|Open-Label Phase|Worsening Disease|0|||
48673115|NCT00494507|156655028|FG003|Open-Label Phase|Worsening Disease|2|||
48673116|NCT00924404|156655029|FG000|Overall Study|Lost to Follow-up|6|||
48673117|NCT00924404|156655030|FG001|Overall Study|Lost to Follow-up|4|||
48673118|NCT00295932|156655035|FG000|Overall Study|Not Treated|0|||
48673119|NCT00295932|156655036|FG001|Overall Study|Not Treated|0|||
48673120|NCT00295932|156655037|FG002|Overall Study|Not Treated|0|||
48673121|NCT00295932|156655038|FG003|Overall Study|Not Treated|0|||
48673122|NCT00295932|156655039|FG004|Overall Study|Not Treated|0|||
48673123|NCT00295932|156655040|FG005|Overall Study|Not Treated|0|||
48673124|NCT00295932|156655041|FG006|Overall Study|Not Treated|0|||
48673125|NCT00295932|156655042|FG007|Overall Study|Not Treated|0|||
48673126|NCT00295932|156655043|FG008|Overall Study|Not Treated|0|||
48673127|NCT00295932|156655044|FG009|Overall Study|Not Treated|0|||
48673128|NCT00295932|156655045|FG010|Overall Study|Not Treated|1|||
48673129|NCT03729245|156655046|FG000|Overall Study|Lost to Follow-up|5|||
48673130|NCT03729245|156655047|FG001|Overall Study|Lost to Follow-up|6|||
48673131|NCT03729245|156655046|FG000|Overall Study|Withdrawal by Subject|16|||
48673132|NCT03729245|156655047|FG001|Overall Study|Withdrawal by Subject|19|||
48673133|NCT03729245|156655046|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
48673134|NCT03729245|156655047|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
48673135|NCT04891107|156655048|FG000|Overall Study|Physician Decision|1|||
48673136|NCT04891107|156655048|FG000|Overall Study|Withdrawal by Subject|1|||
48673137|NCT04891107|156655048|FG000|Overall Study|Screen failure after consent|1|||
48673138|NCT02540993|156655049|FG000|Overall Study|Lost to Follow-up|5|||
48673139|NCT02540993|156655050|FG001|Overall Study|Lost to Follow-up|3|||
48673140|NCT02540993|156655049|FG000|Overall Study|Withdrawal by Subject|4|||
48673141|NCT02540993|156655050|FG001|Overall Study|Withdrawal by Subject|6|||
48673142|NCT02540993|156655049|FG000|Overall Study|GCP violations|33|||
48673143|NCT02540993|156655050|FG001|Overall Study|GCP violations|27|||
48673144|NCT00079677|156655051|FG000|Overall Study|Adverse Event|5|||
48673145|NCT00079677|156655052|FG001|Overall Study|Adverse Event|6|||
48673146|NCT00079677|156655051|FG000|Overall Study|Lack of Efficacy|1|||
48673147|NCT00079677|156655052|FG001|Overall Study|Lack of Efficacy|0|||
48673148|NCT00079677|156655051|FG000|Overall Study|Lost to Follow-up|2|||
48673149|NCT00079677|156655052|FG001|Overall Study|Lost to Follow-up|2|||
48673150|NCT00079677|156655051|FG000|Overall Study|Physician Decision|3|||
48673151|NCT00079677|156655052|FG001|Overall Study|Physician Decision|0|||
48673152|NCT00079677|156655051|FG000|Overall Study|Protocol Violation|2|||
48673153|NCT00079677|156655052|FG001|Overall Study|Protocol Violation|3|||
48673154|NCT00079677|156655051|FG000|Overall Study|Withdrawal by Subject|5|||
48673155|NCT00079677|156655052|FG001|Overall Study|Withdrawal by Subject|3|||
48673156|NCT00079677|156655051|FG000|Overall Study|Miscellaneous|2|||
48673157|NCT00079677|156655052|FG001|Overall Study|Miscellaneous|0|||
48673158|NCT00989781|156655056|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
48673159|NCT00989781|156655057|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
48673160|NCT01270256|156655058|FG000|Overall Study|Withdrawal by Subject|1|||
48673161|NCT01270256|156655059|FG001|Overall Study|Withdrawal by Subject|0|||
48673162|NCT01012323|156655062|FG000|Overall Study|Investigator Judgment|1|||
48673163|NCT00932165|156655063|FG000|Overall Study|Lost to Follow-up|1|||
48673164|NCT02726945|156655064|FG000|Overall Study|Withdrawal by Subject|0|||
48673165|NCT02726945|156655065|FG001|Overall Study|Withdrawal by Subject|0|||
48673166|NCT02726945|156655066|FG002|Overall Study|Withdrawal by Subject|1|||
48673167|NCT02726945|156655064|FG000|Overall Study|Elected to have total knee replacement|0|||
48673168|NCT02726945|156655065|FG001|Overall Study|Elected to have total knee replacement|1|||
48673169|NCT02726945|156655066|FG002|Overall Study|Elected to have total knee replacement|0|||
48673170|NCT00293020|156655070|FG000|Overall Study|Withdrawal by Subject|34|||
48673171|NCT00293020|156655070|FG000|Overall Study|Adverse Event|30|||
48673172|NCT00293020|156655070|FG000|Overall Study|Death|32|||
48673173|NCT00293020|156655070|FG000|Overall Study|Lack of Efficacy|12|||
48761009|NCT00951665|156973960|FG002|Phase 1b|Protocol Violation|0|||
48345740|NCT04270747|155462878|FG000|Post Week 16|Miscellaneous|1|||
48345741|NCT04270747|155462879|FG001|Post Week 16|Miscellaneous|0|||
48345742|NCT04270747|155462880|FG002|Post Week 16|Miscellaneous|1|||
48345743|NCT02482935|155462881|FG000|Period 1|Withdrawal by Subject|1|||
48345744|NCT02482935|155462882|FG001|Period 1|Withdrawal by Subject|0|||
48673174|NCT00293020|156655070|FG000|Overall Study|Lost to Follow-up|4|||
48673175|NCT00293020|156655070|FG000|Overall Study|Protocol Violation|6|||
48673176|NCT00293020|156655070|FG000|Overall Study|Physician Decision|21|||
48673177|NCT00293020|156655070|FG000|Overall Study|Other Reason|22|||
48673178|NCT00293020|156655070|FG000|Overall Study|No dose taken|1|||
48673179|NCT02540265|156655073|FG000|Overall Study|Lost to Follow-up|0|||
48673180|NCT02540265|156655074|FG001|Overall Study|Lost to Follow-up|0|||
48673181|NCT02540265|156655075|FG002|Overall Study|Lost to Follow-up|1|||
48673182|NCT02951429|156655077|FG000|Overall Study|Adverse Event|3|||
48673183|NCT02951429|156655078|FG001|Overall Study|Adverse Event|7|||
48673184|NCT02951429|156655077|FG000|Overall Study|Death|28|||
48673185|NCT02951429|156655078|FG001|Overall Study|Death|36|||
48673186|NCT02951429|156655077|FG000|Overall Study|Lack of Efficacy|0|||
48673187|NCT02951429|156655078|FG001|Overall Study|Lack of Efficacy|1|||
48673188|NCT02951429|156655077|FG000|Overall Study|Lost to Follow-up|0|||
48673189|NCT02951429|156655078|FG001|Overall Study|Lost to Follow-up|1|||
48673190|NCT02951429|156655077|FG000|Overall Study|Lung Transplantation|9|||
48345745|NCT00827775|155462885|FG000|Overall Study|Withdrawal by Subject|0|||
48345746|NCT00827775|155462886|FG001|Overall Study|Withdrawal by Subject|5|||
48345747|NCT03891641|155462887|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
48345748|NCT03891641|155462888|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
48345749|NCT02777242|155462890|FG000|Overall Study|Other|2|||
48345750|NCT02777242|155462890|FG000|Overall Study|Lost to Follow-up|1|||
48345751|NCT02777242|155462890|FG000|Overall Study|Multiple|1|||
48345752|NCT02777242|155462890|FG000|Overall Study|Sponsor's request|1|||
48345753|NCT02777242|155462890|FG000|Overall Study|Withdrawal by Subject|1|||
48673191|NCT02951429|156655078|FG001|Overall Study|Lung Transplantation|6|||
48673192|NCT02951429|156655077|FG000|Overall Study|Other|1|||
48673193|NCT02951429|156655078|FG001|Overall Study|Other|3|||
48673194|NCT02951429|156655077|FG000|Overall Study|Progressive Disease|1|||
48673195|NCT02951429|156655078|FG001|Overall Study|Progressive Disease|1|||
48673196|NCT02951429|156655077|FG000|Overall Study|Withdrawal by Subject|7|||
48673197|NCT02951429|156655078|FG001|Overall Study|Withdrawal by Subject|11|||
48673198|NCT02951429|156655077|FG000|Overall Study|Participant ongoing in the study|23|||
48673199|NCT02951429|156655078|FG001|Overall Study|Participant ongoing in the study|17|||
48673200|NCT03101085|156655079|FG000|Overall Study|Lost to Follow-up|0|||
48345754|NCT00255944|155462893|FG000|Overall Study|Lost to Follow-up|797|||
48345755|NCT00255944|155462894|FG001|Overall Study|Lost to Follow-up|834|||
48345756|NCT01129115|155462895|FG000|Overall Study|Adverse Event|1|||
48345757|NCT01129115|155462896|FG001|Overall Study|Adverse Event|2|||
48345758|NCT01129115|155462897|FG002|Overall Study|Adverse Event|3|||
48345759|NCT01129115|155462898|FG003|Overall Study|Adverse Event|3|||
48345760|NCT01129115|155462895|FG000|Overall Study|Withdrawal by Subject|1|||
48345761|NCT01129115|155462896|FG001|Overall Study|Withdrawal by Subject|3|||
48345762|NCT01129115|155462897|FG002|Overall Study|Withdrawal by Subject|1|||
48345763|NCT01129115|155462898|FG003|Overall Study|Withdrawal by Subject|4|||
48345764|NCT01129115|155462895|FG000|Overall Study|Protocol Violation|0|||
48345765|NCT01129115|155462896|FG001|Overall Study|Protocol Violation|2|||
48345766|NCT01129115|155462897|FG002|Overall Study|Protocol Violation|2|||
48345767|NCT01129115|155462898|FG003|Overall Study|Protocol Violation|2|||
48345768|NCT02212301|155462899|FG000|Period 1|Lost to Follow-up|0|||
48345769|NCT02212301|155462900|FG001|Period 1|Lost to Follow-up|1|||
48345770|NCT03927222|155462901|FG000|Overall Study|Progression|3|||
48345771|NCT03927222|155462901|FG000|Overall Study|CMV testing results inconclusive|1|||
48345772|NCT03927222|155462901|FG000|Overall Study|Unable to generate enough vaccines|1|||
48345773|NCT03927222|155462901|FG000|Overall Study|Early study termination|1|||
48345774|NCT01747837|155462902|FG000|Overall Study|Lost to Follow-up|5|||
48345775|NCT01747837|155462903|FG001|Overall Study|Lost to Follow-up|2|||
48345776|NCT01747837|155462902|FG000|Overall Study|Death|4|||
48345777|NCT01747837|155462903|FG001|Overall Study|Death|4|||
48345778|NCT00817336|155462905|FG000|Overall Study|Withdrawal by Subject|1|||
48345779|NCT00817336|155462906|FG001|Overall Study|Withdrawal by Subject|1|||
48345780|NCT02299427|155462907|FG000|Overall Study|Withdrawal by Subject|1|||
48345781|NCT02299427|155462908|FG001|Overall Study|Withdrawal by Subject|0|||
48345782|NCT02299427|155462907|FG000|Overall Study|Lost to Follow-up|1|||
48345783|NCT02299427|155462908|FG001|Overall Study|Lost to Follow-up|3|||
48673201|NCT03101085|156655080|FG001|Overall Study|Lost to Follow-up|1|||
48673202|NCT00498355|156655086|FG000|Overall Study|Lost to Follow-up|1|||
48345784|NCT02299427|155462907|FG000|Overall Study|not adherent to dog website use|21|||
48345785|NCT02299427|155462908|FG001|Overall Study|not adherent to dog website use|0|||
48345786|NCT00511797|155462916|FG000|Overall Study|Adverse Event|1|||
48345787|NCT00511797|155462917|FG001|Overall Study|Adverse Event|2|||
48673203|NCT02161757|156655089|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
48761010|NCT00951665|156973961|FG003|Phase 1b|Protocol Violation|0|||
48345788|NCT00511797|155462918|FG002|Overall Study|Adverse Event|2|||
48345789|NCT00511797|155462919|FG003|Overall Study|Adverse Event|2|||
48345790|NCT00511797|155462916|FG000|Overall Study|Lost to Follow-up|1|||
48345791|NCT00511797|155462917|FG001|Overall Study|Lost to Follow-up|0|||
48345792|NCT00511797|155462918|FG002|Overall Study|Lost to Follow-up|0|||
48345793|NCT00511797|155462919|FG003|Overall Study|Lost to Follow-up|1|||
48673204|NCT02161757|156655090|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
48673205|NCT02161757|156655091|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
48673206|NCT02161757|156655089|FG000|Treatment Through Study Completion|Adverse Event|1|||
48673207|NCT02161757|156655090|FG001|Treatment Through Study Completion|Adverse Event|1|||
48673208|NCT02161757|156655091|FG002|Treatment Through Study Completion|Adverse Event|0|||
48673209|NCT02161757|156655089|FG000|Treatment Through Study Completion|Protocol Violation|0|||
48673210|NCT02161757|156655090|FG001|Treatment Through Study Completion|Protocol Violation|1|||
48673211|NCT02161757|156655091|FG002|Treatment Through Study Completion|Protocol Violation|2|||
48673212|NCT02161757|156655089|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
48673213|NCT02161757|156655090|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
48673214|NCT02161757|156655091|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
48673215|NCT02161757|156655089|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
48673216|NCT02161757|156655090|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
48345794|NCT00511797|155462916|FG000|Overall Study|Pregnancy|0|||
48345795|NCT00511797|155462917|FG001|Overall Study|Pregnancy|0|||
48345796|NCT00511797|155462918|FG002|Overall Study|Pregnancy|0|||
48345797|NCT00511797|155462919|FG003|Overall Study|Pregnancy|1|||
48673217|NCT02161757|156655091|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
48673218|NCT02161757|156655089|FG000|Treatment Through Study Completion|Other|20|||
48673219|NCT02161757|156655090|FG001|Treatment Through Study Completion|Other|19|||
48673220|NCT02161757|156655091|FG002|Treatment Through Study Completion|Other|12|||
48761011|NCT00951665|156973962|FG004|Phase 1b|Protocol Violation|0|||
48761012|NCT00951665|156973963|FG005|Phase 1b|Protocol Violation|0|||
48761013|NCT00951665|156973958|FG000|Phase 2a|Adverse Event|0|||
48761014|NCT00951665|156973959|FG001|Phase 2a|Adverse Event|0|||
48345798|NCT00511797|155462916|FG000|Overall Study|Protocol Violation|0|||
48345799|NCT00511797|155462917|FG001|Overall Study|Protocol Violation|2|||
48345800|NCT00511797|155462918|FG002|Overall Study|Protocol Violation|2|||
48345801|NCT00511797|155462919|FG003|Overall Study|Protocol Violation|3|||
48345802|NCT00511797|155462916|FG000|Overall Study|Withdrawal by Subject|3|||
48673221|NCT02161757|156655089|FG000|Treatment Through Study Completion|Death|2|||
48673222|NCT02161757|156655090|FG001|Treatment Through Study Completion|Death|1|||
48761015|NCT00951665|156973960|FG002|Phase 2a|Adverse Event|0|||
48761016|NCT00951665|156973961|FG003|Phase 2a|Adverse Event|0|||
48761017|NCT00951665|156973962|FG004|Phase 2a|Adverse Event|2|||
48761018|NCT00951665|156973963|FG005|Phase 2a|Adverse Event|0|||
48761019|NCT00951665|156973958|FG000|Phase 2a|Death|0|||
48761020|NCT00951665|156973959|FG001|Phase 2a|Death|0|||
48761021|NCT00951665|156973960|FG002|Phase 2a|Death|0|||
48761022|NCT00951665|156973961|FG003|Phase 2a|Death|0|||
48761023|NCT00951665|156973962|FG004|Phase 2a|Death|1|||
48761024|NCT00951665|156973963|FG005|Phase 2a|Death|1|||
48761025|NCT00951665|156973958|FG000|Phase 2a|Lost to Follow-up|0|||
48761026|NCT00951665|156973959|FG001|Phase 2a|Lost to Follow-up|0|||
48761027|NCT00951665|156973960|FG002|Phase 2a|Lost to Follow-up|0|||
48761028|NCT00951665|156973961|FG003|Phase 2a|Lost to Follow-up|0|||
48761029|NCT00951665|156973962|FG004|Phase 2a|Lost to Follow-up|1|||
48761030|NCT00951665|156973963|FG005|Phase 2a|Lost to Follow-up|0|||
48761031|NCT00951665|156973958|FG000|Phase 2a|Physician Decision|0|||
48761032|NCT00951665|156973959|FG001|Phase 2a|Physician Decision|0|||
48761033|NCT00951665|156973960|FG002|Phase 2a|Physician Decision|0|||
48761034|NCT00951665|156973961|FG003|Phase 2a|Physician Decision|0|||
48761035|NCT00951665|156973962|FG004|Phase 2a|Physician Decision|0|||
48761036|NCT00951665|156973963|FG005|Phase 2a|Physician Decision|1|||
48761037|NCT00951665|156973958|FG000|Phase 2a|Withdrawal by Subject|0|||
48761038|NCT00951665|156973959|FG001|Phase 2a|Withdrawal by Subject|0|||
48761039|NCT00951665|156973960|FG002|Phase 2a|Withdrawal by Subject|0|||
48761040|NCT00951665|156973961|FG003|Phase 2a|Withdrawal by Subject|0|||
48761041|NCT00951665|156973962|FG004|Phase 2a|Withdrawal by Subject|2|||
48761042|NCT00951665|156973963|FG005|Phase 2a|Withdrawal by Subject|0|||
48761043|NCT00951665|156973958|FG000|Phase 2a|Disease Progression|0|||
48761044|NCT00951665|156973959|FG001|Phase 2a|Disease Progression|0|||
48761045|NCT00951665|156973960|FG002|Phase 2a|Disease Progression|0|||
48761046|NCT00951665|156973961|FG003|Phase 2a|Disease Progression|0|||
48761047|NCT00951665|156973962|FG004|Phase 2a|Disease Progression|6|||
48761048|NCT00951665|156973963|FG005|Phase 2a|Disease Progression|5|||
48761049|NCT02723084|156973964|FG000|Overall Study|Withdrawal by Subject|1|||
48761050|NCT02723084|156973965|FG001|Overall Study|Withdrawal by Subject|1|||
48761051|NCT02723084|156973964|FG000|Overall Study|Lost to Follow-up|3|||
48761052|NCT02723084|156973965|FG001|Overall Study|Lost to Follow-up|0|||
48761053|NCT00312494|156973968|FG000|Overall Study|Randomized; not treated with study drug|9|||
48761054|NCT00312494|156973969|FG001|Overall Study|Randomized; not treated with study drug|10|||
48761055|NCT00312494|156973970|FG002|Overall Study|Randomized; not treated with study drug|5|||
48345803|NCT00511797|155462917|FG001|Overall Study|Withdrawal by Subject|3|||
48345804|NCT00511797|155462918|FG002|Overall Study|Withdrawal by Subject|4|||
48761056|NCT00312494|156973968|FG000|Overall Study|Adverse Event|33|||
48761057|NCT00312494|156973969|FG001|Overall Study|Adverse Event|15|||
48761058|NCT00312494|156973970|FG002|Overall Study|Adverse Event|11|||
48345805|NCT00511797|155462919|FG003|Overall Study|Withdrawal by Subject|2|||
48761059|NCT00312494|156973968|FG000|Overall Study|Lack of Efficacy|4|||
48761060|NCT00312494|156973969|FG001|Overall Study|Lack of Efficacy|6|||
48673223|NCT02161757|156655091|FG002|Treatment Through Study Completion|Death|1|||
48673224|NCT03664765|156655092|FG000|Overall Study|Withdrawal by Subject|4|||
48673225|NCT03664765|156655093|FG001|Overall Study|Withdrawal by Subject|1|||
48673226|NCT03664765|156655092|FG000|Overall Study|Lost to Follow-up|0|||
48673227|NCT03664765|156655093|FG001|Overall Study|Lost to Follow-up|1|||
48673228|NCT01153698|156655094|FG000|Overall Study|Adverse Event|12|||
48673229|NCT01153698|156655094|FG000|Overall Study|Lost to Follow-up|4|||
48673230|NCT01153698|156655094|FG000|Overall Study|Withdrawal by Subject|2|||
48673231|NCT01153698|156655094|FG000|Overall Study|Switch to other anticoagulants|4|||
48673232|NCT01153698|156655094|FG000|Overall Study|Other|2|||
48761061|NCT00312494|156973970|FG002|Overall Study|Lack of Efficacy|8|||
48761062|NCT00312494|156973968|FG000|Overall Study|Laboratory abnormality|1|||
48761063|NCT00312494|156973969|FG001|Overall Study|Laboratory abnormality|0|||
48761064|NCT00312494|156973970|FG002|Overall Study|Laboratory abnormality|0|||
48761065|NCT00312494|156973968|FG000|Overall Study|Lost to Follow-up|8|||
48761066|NCT00312494|156973969|FG001|Overall Study|Lost to Follow-up|8|||
48761067|NCT00312494|156973970|FG002|Overall Study|Lost to Follow-up|8|||
48761068|NCT00312494|156973968|FG000|Overall Study|Withdrawal by Subject|6|||
48761069|NCT00312494|156973969|FG001|Overall Study|Withdrawal by Subject|9|||
48761070|NCT00312494|156973970|FG002|Overall Study|Withdrawal by Subject|10|||
48761071|NCT00312494|156973968|FG000|Overall Study|Other|10|||
48761072|NCT00312494|156973969|FG001|Overall Study|Other|10|||
48761073|NCT00312494|156973970|FG002|Overall Study|Other|1|||
48761074|NCT05024058|156973971|FG000|Treatment|Study terminated by sponsor|5|||
48761075|NCT05024058|156973972|FG001|Treatment|Study terminated by sponsor|6|||
48761076|NCT05024058|156973973|FG002|Treatment|Study terminated by sponsor|4|||
48761077|NCT05024058|156973974|FG003|Treatment|Study terminated by sponsor|2|||
48761078|NCT05024058|156973975|FG004|Treatment|Study terminated by sponsor|3|||
48761079|NCT05024058|156973976|FG005|Treatment|Study terminated by sponsor|3|||
48761080|NCT05024058|156973977|FG006|Treatment|Study terminated by sponsor|1|||
48761081|NCT05024058|156973978|FG007|Treatment|Study terminated by sponsor|3|||
48761082|NCT05024058|156973979|FG008|Treatment|Study terminated by sponsor|6|||
48761083|NCT05024058|156973980|FG009|Treatment|Study terminated by sponsor|6|||
48761084|NCT05024058|156973971|FG000|Follow-up|Withdrawal by Subject|1|||
48761085|NCT05024058|156973972|FG001|Follow-up|Withdrawal by Subject|0|||
48761086|NCT05024058|156973973|FG002|Follow-up|Withdrawal by Subject|1|||
48761087|NCT05024058|156973974|FG003|Follow-up|Withdrawal by Subject|0|||
48761088|NCT05024058|156973975|FG004|Follow-up|Withdrawal by Subject|0|||
48761089|NCT05024058|156973976|FG005|Follow-up|Withdrawal by Subject|0|||
48761090|NCT05024058|156973977|FG006|Follow-up|Withdrawal by Subject|0|||
48761091|NCT05024058|156973978|FG007|Follow-up|Withdrawal by Subject|1|||
48761092|NCT05024058|156973979|FG008|Follow-up|Withdrawal by Subject|0|||
48761093|NCT05024058|156973980|FG009|Follow-up|Withdrawal by Subject|1|||
48761094|NCT00520975|156973981|FG000|Overall Study|Disease progression|31|||
48761095|NCT00520975|156973982|FG001|Overall Study|Disease progression|23|||
48761096|NCT00520975|156973981|FG000|Overall Study|Adverse Event|7|||
48761097|NCT00520975|156973982|FG001|Overall Study|Adverse Event|10|||
48761098|NCT00520975|156973981|FG000|Overall Study|Death|0|||
48761099|NCT00520975|156973982|FG001|Overall Study|Death|2|||
48761100|NCT00520975|156973981|FG000|Overall Study|Withdrawal by Subject|3|||
48761101|NCT00520975|156973982|FG001|Overall Study|Withdrawal by Subject|5|||
48761102|NCT00520975|156973981|FG000|Overall Study|Other therapy|2|||
48761103|NCT00520975|156973982|FG001|Overall Study|Other therapy|4|||
48761104|NCT00520975|156973981|FG000|Overall Study|Other reasons|4|||
48761105|NCT00520975|156973982|FG001|Overall Study|Other reasons|2|||
48761106|NCT00520975|156973981|FG000|Overall Study|Not start protocol therapy|1|||
48761107|NCT00520975|156973982|FG001|Overall Study|Not start protocol therapy|2|||
48761108|NCT01528072|156973985|FG000|Overall Study|Withdrawal by Subject|5|||
48761109|NCT01528072|156973985|FG000|Overall Study|Physician Decision|1|||
48761110|NCT01528072|156973985|FG000|Overall Study|Determined not eligible by AEAC|1|||
48761111|NCT01528072|156973985|FG000|Overall Study|Missed Visit|2|||
48761112|NCT01528072|156973985|FG000|Overall Study|Lost to Follow-up|5|||
48761113|NCT01528072|156973985|FG000|Overall Study|Explanted|2|||
48761114|NCT01528072|156973985|FG000|Overall Study|Site Closure|4|||
48761115|NCT01528072|156973985|FG000|Overall Study|Death|2|||
48761116|NCT01528072|156973985|FG000|Overall Study|Early Termination of Study|52|||
48761117|NCT02436759|156973986|FG000|Overall Study|Adverse Event|3|||
48761118|NCT02436759|156973987|FG001|Overall Study|Adverse Event|0|||
48761119|NCT02436759|156973986|FG000|Overall Study|Protocol Violation|1|||
48761120|NCT02436759|156973987|FG001|Overall Study|Protocol Violation|0|||
48761121|NCT02436759|156973986|FG000|Overall Study|Withdrawal by Subject|0|||
48761122|NCT02436759|156973987|FG001|Overall Study|Withdrawal by Subject|1|||
48761123|NCT05089682|156973992|FG000|Overall Study|Withdrawal by Subject|2|||
48761124|NCT01275833|156973993|FG000|Overall Study|Study terminated|1|||
48761125|NCT01275833|156973994|FG001|Overall Study|Study terminated|1|||
48673233|NCT01153698|156655094|FG000|Overall Study|Not treated with Pradaxa|5|||
48673234|NCT04583956|156655095|FG000|Overall Study|Death|9|||
48761126|NCT02246673|156974003|FG000|Overall Study|Sponsor Decision|1|||
48345806|NCT00511797|155462916|FG000|Overall Study|Never dispensed|1|||
48345807|NCT00511797|155462917|FG001|Overall Study|Never dispensed|0|||
48345808|NCT00511797|155462918|FG002|Overall Study|Never dispensed|1|||
48345809|NCT00511797|155462919|FG003|Overall Study|Never dispensed|3|||
48345810|NCT00511797|155462916|FG000|Overall Study|Study drug not taken|0|||
48345811|NCT00511797|155462917|FG001|Overall Study|Study drug not taken|1|||
48345812|NCT00511797|155462918|FG002|Overall Study|Study drug not taken|0|||
48345813|NCT00511797|155462919|FG003|Overall Study|Study drug not taken|1|||
48345814|NCT00511797|155462916|FG000|Overall Study|Partially missing diary|0|||
48345815|NCT00511797|155462917|FG001|Overall Study|Partially missing diary|0|||
48345816|NCT00511797|155462918|FG002|Overall Study|Partially missing diary|1|||
48345817|NCT00511797|155462919|FG003|Overall Study|Partially missing diary|0|||
48345818|NCT00511797|155462916|FG000|Overall Study|Other (moving etc)|1|||
48345819|NCT00511797|155462917|FG001|Overall Study|Other (moving etc)|0|||
48345820|NCT00511797|155462918|FG002|Overall Study|Other (moving etc)|1|||
48345821|NCT00511797|155462919|FG003|Overall Study|Other (moving etc)|2|||
48345822|NCT02287883|155462924|FG000|Overall Study|Death|8|||
48345823|NCT02287883|155462925|FG001|Overall Study|Death|7|||
48345824|NCT02287883|155462924|FG000|Overall Study|No longer eligible|222|||
48345825|NCT02287883|155462925|FG001|Overall Study|No longer eligible|182|||
48345826|NCT02287883|155462924|FG000|Overall Study|Non-response to survey|229|||
48345827|NCT02287883|155462925|FG001|Overall Study|Non-response to survey|237|||
48345828|NCT00802438|155462934|FG000|Overall Study|Screen Failure|20|||
48345829|NCT00802438|155462934|FG000|Overall Study|Withdrawal by Subject|7|||
48345830|NCT00802438|155462934|FG000|Overall Study|Physician Decision|1|||
48345831|NCT00679549|155462935|FG000|Overall Study|dropout|2|||
48345832|NCT00679549|155462936|FG001|Overall Study|dropout|4|||
48345833|NCT00679549|155462935|FG000|Overall Study|missing outcome echocardiograms|4|||
48345834|NCT00679549|155462936|FG001|Overall Study|missing outcome echocardiograms|5|||
48345835|NCT03280108|155462938|FG000|Overall Study|Lost to Follow-up|2|||
48345836|NCT03280108|155462939|FG001|Overall Study|Lost to Follow-up|0|||
48345837|NCT01978236|155462940|FG000|Overall Study|Discontinued due to study close|2|||
48345838|NCT00125853|155462942|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
48345839|NCT00125853|155462943|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
48345840|NCT04353817|155462944|FG000|Overall Study|Adverse Event|0|||
48345841|NCT04353817|155462945|FG001|Overall Study|Adverse Event|1|||
48345842|NCT02101268|155462946|FG000|Randomized Treatment Phase|Subject Decision|8|||
48345843|NCT02101268|155462947|FG001|Randomized Treatment Phase|Subject Decision|4|||
48345844|NCT02101268|155462948|FG002|Randomized Treatment Phase|Subject Decision|0|||
48345845|NCT02101268|155462949|FG003|Randomized Treatment Phase|Subject Decision|0|||
48345846|NCT02101268|155462946|FG000|Randomized Treatment Phase|Physician Decision|4|||
48345847|NCT02101268|155462947|FG001|Randomized Treatment Phase|Physician Decision|1|||
48673235|NCT04583956|156655096|FG001|Overall Study|Death|11|||
48673236|NCT04583956|156655095|FG000|Overall Study|Lost to Follow-up|7|||
48673237|NCT04583956|156655096|FG001|Overall Study|Lost to Follow-up|9|||
48673238|NCT04583956|156655095|FG000|Overall Study|Protocol Violation|2|||
48673239|NCT04583956|156655096|FG001|Overall Study|Protocol Violation|0|||
48673240|NCT04583956|156655095|FG000|Overall Study|Withdrawal by Subject|0|||
48673241|NCT04583956|156655096|FG001|Overall Study|Withdrawal by Subject|2|||
48673242|NCT04583956|156655095|FG000|Overall Study|Randomized but not dosed|2|||
48673243|NCT04583956|156655096|FG001|Overall Study|Randomized but not dosed|3|||
48673244|NCT04583956|156655095|FG000|Overall Study|Withdrawal of consent before product administration|1|||
48673245|NCT04583956|156655096|FG001|Overall Study|Withdrawal of consent before product administration|0|||
48673246|NCT02332291|156655097|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
48345848|NCT02101268|155462948|FG002|Randomized Treatment Phase|Physician Decision|0|||
48345849|NCT02101268|155462949|FG003|Randomized Treatment Phase|Physician Decision|0|||
48673247|NCT02332291|156655098|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
48345850|NCT02101268|155462946|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
48345851|NCT02101268|155462947|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
48345852|NCT02101268|155462948|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
48345853|NCT02101268|155462949|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
48673248|NCT02332291|156655097|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
48673249|NCT02332291|156655098|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
48673250|NCT02332291|156655097|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
48673251|NCT02332291|156655098|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
48673252|NCT02332291|156655097|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
48345854|NCT02101268|155462946|FG000|Randomized Treatment Phase|Adverse Event|6|||
48345855|NCT02101268|155462947|FG001|Randomized Treatment Phase|Adverse Event|0|||
48345856|NCT02101268|155462948|FG002|Randomized Treatment Phase|Adverse Event|0|||
48345857|NCT02101268|155462949|FG003|Randomized Treatment Phase|Adverse Event|0|||
48345858|NCT02101268|155462946|FG000|Randomized Treatment Phase|Death|5|||
48345859|NCT02101268|155462947|FG001|Randomized Treatment Phase|Death|4|||
48345860|NCT02101268|155462948|FG002|Randomized Treatment Phase|Death|0|||
48761127|NCT02246673|156974004|FG001|Overall Study|Sponsor Decision|0|||
48345861|NCT02101268|155462949|FG003|Randomized Treatment Phase|Death|0|||
48345862|NCT02101268|155462946|FG000|Randomized Treatment Phase|Disease Progression|4|||
48345863|NCT02101268|155462947|FG001|Randomized Treatment Phase|Disease Progression|1|||
48345864|NCT02101268|155462948|FG002|Randomized Treatment Phase|Disease Progression|0|||
48345865|NCT02101268|155462949|FG003|Randomized Treatment Phase|Disease Progression|0|||
48345866|NCT02101268|155462946|FG000|Extended Treatment Phase|Subject Decision|0|||
48345867|NCT02101268|155462947|FG001|Extended Treatment Phase|Subject Decision|0|||
48345868|NCT02101268|155462948|FG002|Extended Treatment Phase|Subject Decision|3|||
48345869|NCT02101268|155462949|FG003|Extended Treatment Phase|Subject Decision|2|||
48345870|NCT02101268|155462946|FG000|Extended Treatment Phase|Physician Decision|0|||
48345871|NCT02101268|155462947|FG001|Extended Treatment Phase|Physician Decision|0|||
48345872|NCT02101268|155462948|FG002|Extended Treatment Phase|Physician Decision|5|||
48345873|NCT02101268|155462949|FG003|Extended Treatment Phase|Physician Decision|2|||
48345874|NCT02101268|155462946|FG000|Extended Treatment Phase|Adverse Event|0|||
48345875|NCT02101268|155462947|FG001|Extended Treatment Phase|Adverse Event|0|||
48345876|NCT02101268|155462948|FG002|Extended Treatment Phase|Adverse Event|14|||
48345877|NCT02101268|155462949|FG003|Extended Treatment Phase|Adverse Event|18|||
48345878|NCT02101268|155462946|FG000|Extended Treatment Phase|Death|0|||
48345879|NCT02101268|155462947|FG001|Extended Treatment Phase|Death|0|||
48345880|NCT02101268|155462948|FG002|Extended Treatment Phase|Death|5|||
48345881|NCT02101268|155462949|FG003|Extended Treatment Phase|Death|1|||
48345882|NCT02101268|155462946|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
48345883|NCT02101268|155462947|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
48345884|NCT02101268|155462948|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
48345885|NCT02101268|155462949|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
48345886|NCT02101268|155462946|FG000|Extended Treatment Phase|Disease Progression|0|||
48345887|NCT02101268|155462947|FG001|Extended Treatment Phase|Disease Progression|0|||
48345888|NCT02101268|155462948|FG002|Extended Treatment Phase|Disease Progression|13|||
48345889|NCT02101268|155462949|FG003|Extended Treatment Phase|Disease Progression|6|||
48345890|NCT02101268|155462946|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
48345891|NCT02101268|155462947|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
48345892|NCT02101268|155462948|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
48345893|NCT02101268|155462949|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
48345894|NCT00740870|155462952|FG000|Overall Study|Not Catheterized|4|||
48345895|NCT00740870|155462952|FG000|Overall Study|Further testing contraindicated implant|17|||
48345896|NCT01193218|155462953|FG000|0-12 Weeks|Adverse Event|6|||
48345897|NCT01193218|155462954|FG001|0-12 Weeks|Adverse Event|0|||
48345898|NCT01193218|155462955|FG002|0-12 Weeks|Adverse Event|1|||
48345899|NCT01193218|155462956|FG003|0-12 Weeks|Adverse Event|0|||
48345900|NCT01193218|155462957|FG004|0-12 Weeks|Adverse Event|0|||
48345901|NCT01193218|155462958|FG005|0-12 Weeks|Adverse Event|2|||
48345902|NCT01193218|155462959|FG006|0-12 Weeks|Adverse Event|2|||
48345903|NCT01193218|155462960|FG007|0-12 Weeks|Adverse Event|0|||
48345904|NCT01193218|155462953|FG000|0-12 Weeks|Protocol Violation|0|||
48345905|NCT01193218|155462954|FG001|0-12 Weeks|Protocol Violation|0|||
48345906|NCT01193218|155462955|FG002|0-12 Weeks|Protocol Violation|0|||
48345907|NCT01193218|155462956|FG003|0-12 Weeks|Protocol Violation|0|||
48345908|NCT01193218|155462957|FG004|0-12 Weeks|Protocol Violation|1|||
48345909|NCT01193218|155462958|FG005|0-12 Weeks|Protocol Violation|1|||
48345910|NCT01193218|155462959|FG006|0-12 Weeks|Protocol Violation|0|||
48345911|NCT01193218|155462960|FG007|0-12 Weeks|Protocol Violation|0|||
48345912|NCT01193218|155462953|FG000|0-12 Weeks|Withdrawal by Subject|3|||
48345913|NCT01193218|155462954|FG001|0-12 Weeks|Withdrawal by Subject|0|||
48345914|NCT01193218|155462955|FG002|0-12 Weeks|Withdrawal by Subject|2|||
48345915|NCT01193218|155462956|FG003|0-12 Weeks|Withdrawal by Subject|0|||
48345916|NCT01193218|155462957|FG004|0-12 Weeks|Withdrawal by Subject|0|||
48345917|NCT01193218|155462958|FG005|0-12 Weeks|Withdrawal by Subject|0|||
48345918|NCT01193218|155462959|FG006|0-12 Weeks|Withdrawal by Subject|1|||
48345919|NCT01193218|155462960|FG007|0-12 Weeks|Withdrawal by Subject|0|||
48345920|NCT01193218|155462953|FG000|12-52 Weeks|Adverse Event|1|||
48345921|NCT01193218|155462954|FG001|12-52 Weeks|Adverse Event|0|||
48345922|NCT01193218|155462955|FG002|12-52 Weeks|Adverse Event|1|||
48345923|NCT01193218|155462956|FG003|12-52 Weeks|Adverse Event|2|||
48345924|NCT01193218|155462957|FG004|12-52 Weeks|Adverse Event|3|||
48673253|NCT02332291|156655098|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
48345925|NCT01193218|155462958|FG005|12-52 Weeks|Adverse Event|3|||
48345926|NCT01193218|155462959|FG006|12-52 Weeks|Adverse Event|1|||
48345927|NCT01193218|155462960|FG007|12-52 Weeks|Adverse Event|2|||
48345928|NCT01193218|155462953|FG000|12-52 Weeks|Lack of Efficacy|0|||
48345929|NCT01193218|155462954|FG001|12-52 Weeks|Lack of Efficacy|0|||
48673254|NCT02332291|156655097|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
48345930|NCT01193218|155462955|FG002|12-52 Weeks|Lack of Efficacy|0|||
48345931|NCT01193218|155462956|FG003|12-52 Weeks|Lack of Efficacy|0|||
48345932|NCT01193218|155462957|FG004|12-52 Weeks|Lack of Efficacy|0|||
48345933|NCT01193218|155462958|FG005|12-52 Weeks|Lack of Efficacy|0|||
48345934|NCT01193218|155462959|FG006|12-52 Weeks|Lack of Efficacy|1|||
48345935|NCT01193218|155462960|FG007|12-52 Weeks|Lack of Efficacy|0|||
48673255|NCT02332291|156655098|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
48345936|NCT01193218|155462953|FG000|12-52 Weeks|Withdrawal by Subject|3|||
48345937|NCT01193218|155462954|FG001|12-52 Weeks|Withdrawal by Subject|0|||
48345938|NCT01193218|155462955|FG002|12-52 Weeks|Withdrawal by Subject|3|||
48345939|NCT01193218|155462956|FG003|12-52 Weeks|Withdrawal by Subject|0|||
48345940|NCT01193218|155462957|FG004|12-52 Weeks|Withdrawal by Subject|0|||
48345941|NCT01193218|155462958|FG005|12-52 Weeks|Withdrawal by Subject|2|||
48345942|NCT01193218|155462959|FG006|12-52 Weeks|Withdrawal by Subject|1|||
48345943|NCT01193218|155462960|FG007|12-52 Weeks|Withdrawal by Subject|2|||
48345944|NCT01193218|155462953|FG000|12-52 Weeks|Other reason than above|1|||
48345945|NCT01193218|155462954|FG001|12-52 Weeks|Other reason than above|0|||
48345946|NCT01193218|155462955|FG002|12-52 Weeks|Other reason than above|0|||
48345947|NCT01193218|155462956|FG003|12-52 Weeks|Other reason than above|1|||
48345948|NCT01193218|155462957|FG004|12-52 Weeks|Other reason than above|1|||
48345949|NCT01193218|155462958|FG005|12-52 Weeks|Other reason than above|0|||
48345950|NCT01193218|155462959|FG006|12-52 Weeks|Other reason than above|0|||
48345951|NCT01193218|155462960|FG007|12-52 Weeks|Other reason than above|0|||
48345952|NCT00239681|155462961|FG000|Overall Study|Adverse Event|100|||
48345953|NCT00239681|155462962|FG001|Overall Study|Adverse Event|99|||
48345954|NCT00239681|155462961|FG000|Overall Study|Withdrawal by Subject|458|||
48345955|NCT00239681|155462962|FG001|Overall Study|Withdrawal by Subject|489|||
48345956|NCT00239681|155462961|FG000|Overall Study|Lost to Follow-up|28|||
48345957|NCT00239681|155462962|FG001|Overall Study|Lost to Follow-up|22|||
48345958|NCT00239681|155462961|FG000|Overall Study|Protocol Violation|4|||
48345959|NCT00239681|155462962|FG001|Overall Study|Protocol Violation|4|||
48345960|NCT00239681|155462961|FG000|Overall Study|Physician Decision|13|||
48345961|NCT00239681|155462962|FG001|Overall Study|Physician Decision|17|||
48345962|NCT00239681|155462961|FG000|Overall Study|No information chacked on CaseReportForm|90|||
48345963|NCT00239681|155462962|FG001|Overall Study|No information chacked on CaseReportForm|84|||
48345964|NCT00363649|155462969|FG000|Overall Study|Withdrawal by Subject|1|||
48345965|NCT00363649|155462970|FG001|Overall Study|Withdrawal by Subject|1|||
48673256|NCT02332291|156655097|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
48673257|NCT02332291|156655098|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
48673258|NCT01983774|156655099|FG000|Overall Study|Lung Transplant|0|||
48673259|NCT01983774|156655100|FG001|Overall Study|Lung Transplant|1|||
48673260|NCT01983774|156655099|FG000|Overall Study|Lost to Follow-up|1|||
48673261|NCT01983774|156655100|FG001|Overall Study|Lost to Follow-up|0|||
48673262|NCT01990859|156655105|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
48673263|NCT01990859|156655105|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
48345966|NCT00363649|155462969|FG000|Overall Study|Adverse Event|6|||
48345967|NCT00363649|155462970|FG001|Overall Study|Adverse Event|0|||
48345968|NCT00002597|155462971|FG000|Overall Study|Protocol Violation|19|||
48345969|NCT00002597|155462972|FG001|Overall Study|Protocol Violation|17|||
48345970|NCT00002597|155462971|FG000|Overall Study|Withdrawal by Subject|7|||
48345971|NCT00002597|155462972|FG001|Overall Study|Withdrawal by Subject|6|||
48345972|NCT02109107|155462976|FG000|Overall Study|Lost to Follow-up|2|||
48345973|NCT00069277|155462977|FG000|Overall Study|Adverse Event|3|||
48345974|NCT00069277|155462977|FG000|Overall Study|Withdrawal by Subject|1|||
48345975|NCT00069277|155462977|FG000|Overall Study|Progressive Disease|15|||
48345976|NCT00069277|155462977|FG000|Overall Study|Physician Decision|2|||
48345977|NCT02956278|155464149|FG000|Overall Study|Withdrawal by Subject|6|||
48345978|NCT02956278|155464150|FG001|Overall Study|Withdrawal by Subject|2|||
48345979|NCT02956278|155464151|FG002|Overall Study|Withdrawal by Subject|0|||
48673264|NCT01439373|156655109|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
48673265|NCT01439373|156655110|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
48673266|NCT01439373|156655109|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
48673267|NCT01439373|156655110|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
48761128|NCT02246673|156974005|FG002|Overall Study|Sponsor Decision|0|||
48761129|NCT02246673|156974006|FG003|Overall Study|Sponsor Decision|0|||
48345980|NCT00961896|155464165|FG000|Overall Study|Abnormal laboratory value|0|||
48345981|NCT00961896|155464166|FG001|Overall Study|Abnormal laboratory value|0|||
48345982|NCT00961896|155464167|FG002|Overall Study|Abnormal laboratory value|1|||
48345983|NCT00695136|155464168|FG000|Overall Study|Withdrawal by Subject|1|||
48761130|NCT02246673|156974007|FG004|Overall Study|Sponsor Decision|0|||
48345984|NCT00695136|155464168|FG000|Overall Study|unrelated adverse event|1|||
48345985|NCT01644188|155464169|FG000|Overall Study|Adverse Event|44|||
48345986|NCT01644188|155464170|FG001|Overall Study|Adverse Event|20|||
48673268|NCT02708355|156655111|FG000|Overall Study|Adverse Event|1|||
48673269|NCT02708355|156655112|FG001|Overall Study|Adverse Event|0|||
48345987|NCT01644188|155464169|FG000|Overall Study|Poor compliance to protocol|26|||
48345988|NCT01644188|155464170|FG001|Overall Study|Poor compliance to protocol|14|||
48345989|NCT01644188|155464169|FG000|Overall Study|Physician Decision|1|||
48345990|NCT01644188|155464170|FG001|Overall Study|Physician Decision|3|||
48673270|NCT02708355|156655113|FG002|Overall Study|Adverse Event|0|||
48345991|NCT01644188|155464169|FG000|Overall Study|Participant moved|7|||
48345992|NCT01644188|155464170|FG001|Overall Study|Participant moved|2|||
48345993|NCT01644188|155464169|FG000|Overall Study|Related to auto-injector administration|2|||
48345994|NCT01644188|155464170|FG001|Overall Study|Related to auto-injector administration|2|||
48345995|NCT01644188|155464169|FG000|Overall Study|Consent withdrawn by participant|14|||
48345996|NCT01644188|155464170|FG001|Overall Study|Consent withdrawn by participant|7|||
48345997|NCT01644188|155464169|FG000|Overall Study|Selection criteria finally not met|2|||
48345998|NCT01644188|155464170|FG001|Overall Study|Selection criteria finally not met|0|||
48345999|NCT01644188|155464169|FG000|Overall Study|Lost to Follow-up|1|||
48346000|NCT01644188|155464170|FG001|Overall Study|Lost to Follow-up|0|||
48346001|NCT01644188|155464169|FG000|Overall Study|Death|4|||
48346002|NCT01644188|155464170|FG001|Overall Study|Death|3|||
48346003|NCT01644188|155464169|FG000|Overall Study|Last visit outside protocol visit window|14|||
48346004|NCT01644188|155464170|FG001|Overall Study|Last visit outside protocol visit window|16|||
48346005|NCT01644188|155464169|FG000|Overall Study|Site closure|1|||
48346006|NCT01644188|155464170|FG001|Overall Study|Site closure|1|||
48346007|NCT01644188|155464169|FG000|Overall Study|Other than specified above|6|||
48346008|NCT01644188|155464170|FG001|Overall Study|Other than specified above|7|||
48673271|NCT02725866|156655114|FG000|Overall Study|Failure to return|6|||
48673272|NCT02725866|156655114|FG000|Overall Study|Withdrew consent|3|||
48673273|NCT02725866|156655114|FG000|Overall Study|Insufficient virological response|1|||
48673274|NCT02725866|156655114|FG000|Overall Study|Other, not specified|4|||
48673275|NCT02593318|156655115|FG000|Overall Study|Withdrawal by Subject|1|||
48673276|NCT02593318|156655116|FG001|Overall Study|Withdrawal by Subject|1|||
48673277|NCT01078168|156655118|FG000|Overall Study|Physician Decision|0|||
48673278|NCT01078168|156655119|FG001|Overall Study|Physician Decision|1|||
48673279|NCT00986362|156655120|FG000|Overall Study|Death|2|||
48673280|NCT00986362|156655121|FG001|Overall Study|Death|0|||
48346009|NCT00721214|155464173|FG000|Overall Study|Chose another center for transplant|1|||
48346010|NCT00721214|155464173|FG000|Overall Study|Death|3|||
48346011|NCT03022578|155464174|FG000|Overall Study|Adverse Event|1|||
48346012|NCT03022578|155464174|FG000|Overall Study|Lack of Efficacy|2|||
48346013|NCT03022578|155464174|FG000|Overall Study|Withdrawal by Subject|1|||
48346014|NCT03924947|155464177|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48346015|NCT03924947|155464178|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48346016|NCT03924947|155464179|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
48346017|NCT03924947|155464180|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48346018|NCT03924947|155464181|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48346019|NCT03924947|155464182|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
48346020|NCT04150341|155464183|FG000|Overall Study|Physician Decision|0|||
48346021|NCT04150341|155464184|FG001|Overall Study|Physician Decision|0|||
48346022|NCT04150341|155464185|FG002|Overall Study|Physician Decision|1|||
48346023|NCT04150341|155464186|FG003|Overall Study|Physician Decision|0|||
48346024|NCT04150341|155464187|FG004|Overall Study|Physician Decision|0|||
48346025|NCT04150341|155464188|FG005|Overall Study|Physician Decision|0|||
48346026|NCT04150341|155464183|FG000|Overall Study|Adverse Event|0|||
48346027|NCT04150341|155464184|FG001|Overall Study|Adverse Event|0|||
48346028|NCT04150341|155464185|FG002|Overall Study|Adverse Event|0|||
48346029|NCT04150341|155464186|FG003|Overall Study|Adverse Event|0|||
48346030|NCT04150341|155464187|FG004|Overall Study|Adverse Event|1|||
48346031|NCT04150341|155464188|FG005|Overall Study|Adverse Event|0|||
48346032|NCT00702650|155464189|FG000|Overall Study|Withdrawal by Subject|9|||
48346033|NCT00702650|155464189|FG000|Overall Study|Non-Compliance of Study Drug|3|||
48346034|NCT00702650|155464189|FG000|Overall Study|Lost to Follow-up|2|||
48346035|NCT00702650|155464189|FG000|Overall Study|Non-Compliance with Site Directives|1|||
48346036|NCT00702650|155464189|FG000|Overall Study|Sponsor Request|1|||
48346037|NCT00702650|155464189|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
48346038|NCT00702650|155464189|FG000|Overall Study|Adverse Event|3|||
48346039|NCT00899379|155464191|FG000|Overall Study|Adverse Event|2|||
48346040|NCT00899379|155464192|FG001|Overall Study|Adverse Event|2|||
48346041|NCT00899379|155464193|FG002|Overall Study|Adverse Event|1|||
48346042|NCT00899379|155464194|FG003|Overall Study|Adverse Event|1|||
48673281|NCT00986362|156655120|FG000|Overall Study|Lost to Follow-up|0|||
48673282|NCT00986362|156655121|FG001|Overall Study|Lost to Follow-up|1|||
48673283|NCT03172130|156657189|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
48673284|NCT03172130|156657190|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
48673285|NCT03667690|156657191|FG000|Overall Study|Adverse Event|0|||
48673286|NCT03667690|156657192|FG001|Overall Study|Adverse Event|3|||
48673287|NCT03667690|156657191|FG000|Overall Study|Death|22|||
48673288|NCT03667690|156657192|FG001|Overall Study|Death|21|||
48673289|NCT03667690|156657191|FG000|Overall Study|Lost to Follow-up|4|||
48673290|NCT03667690|156657192|FG001|Overall Study|Lost to Follow-up|5|||
48673291|NCT03667690|156657191|FG000|Overall Study|Withdrawal by Subject|7|||
48673292|NCT03667690|156657192|FG001|Overall Study|Withdrawal by Subject|8|||
48673293|NCT03667690|156657191|FG000|Overall Study|Subject could not return for additional investigational product|1|||
48673294|NCT03667690|156657192|FG001|Overall Study|Subject could not return for additional investigational product|0|||
48673295|NCT03667690|156657191|FG000|Overall Study|Subject discharged to hospice care|2|||
48673296|NCT03667690|156657192|FG001|Overall Study|Subject discharged to hospice care|0|||
48346043|NCT00899379|155464195|FG004|Overall Study|Adverse Event|2|||
48346044|NCT00899379|155464191|FG000|Overall Study|Lack of Efficacy|0|||
48346045|NCT00899379|155464192|FG001|Overall Study|Lack of Efficacy|4|||
48346046|NCT00899379|155464193|FG002|Overall Study|Lack of Efficacy|3|||
48346047|NCT00899379|155464194|FG003|Overall Study|Lack of Efficacy|0|||
48346048|NCT00899379|155464195|FG004|Overall Study|Lack of Efficacy|1|||
48346049|NCT00899379|155464191|FG000|Overall Study|Lost to Follow-up|9|||
48346050|NCT00899379|155464192|FG001|Overall Study|Lost to Follow-up|3|||
48346051|NCT00899379|155464193|FG002|Overall Study|Lost to Follow-up|0|||
48346052|NCT00899379|155464194|FG003|Overall Study|Lost to Follow-up|6|||
48346053|NCT00899379|155464195|FG004|Overall Study|Lost to Follow-up|2|||
48346054|NCT00899379|155464191|FG000|Overall Study|Protocol Violation|0|||
48346055|NCT00899379|155464192|FG001|Overall Study|Protocol Violation|0|||
48346056|NCT00899379|155464193|FG002|Overall Study|Protocol Violation|1|||
48346057|NCT00899379|155464194|FG003|Overall Study|Protocol Violation|1|||
48346058|NCT00899379|155464195|FG004|Overall Study|Protocol Violation|0|||
48346059|NCT00899379|155464191|FG000|Overall Study|Withdrawal by Subject|2|||
48346060|NCT00899379|155464192|FG001|Overall Study|Withdrawal by Subject|4|||
48346061|NCT00899379|155464193|FG002|Overall Study|Withdrawal by Subject|2|||
48346062|NCT00899379|155464194|FG003|Overall Study|Withdrawal by Subject|3|||
48346063|NCT00899379|155464195|FG004|Overall Study|Withdrawal by Subject|6|||
48346064|NCT00899379|155464191|FG000|Overall Study|Pregnancy|0|||
48346065|NCT00899379|155464192|FG001|Overall Study|Pregnancy|0|||
48346066|NCT00899379|155464193|FG002|Overall Study|Pregnancy|1|||
48346067|NCT00899379|155464194|FG003|Overall Study|Pregnancy|0|||
48346068|NCT00899379|155464195|FG004|Overall Study|Pregnancy|1|||
48346069|NCT00899379|155464191|FG000|Overall Study|Patient Uncooperative|0|||
48346070|NCT00899379|155464192|FG001|Overall Study|Patient Uncooperative|1|||
48346071|NCT00899379|155464193|FG002|Overall Study|Patient Uncooperative|0|||
48346072|NCT00899379|155464194|FG003|Overall Study|Patient Uncooperative|1|||
48346073|NCT00899379|155464195|FG004|Overall Study|Patient Uncooperative|2|||
48346074|NCT00899379|155464191|FG000|Overall Study|Abnormal Baseline ECG|0|||
48346075|NCT00899379|155464192|FG001|Overall Study|Abnormal Baseline ECG|0|||
48346076|NCT00899379|155464193|FG002|Overall Study|Abnormal Baseline ECG|0|||
48346077|NCT00899379|155464194|FG003|Overall Study|Abnormal Baseline ECG|1|||
48346078|NCT00899379|155464195|FG004|Overall Study|Abnormal Baseline ECG|0|||
48346079|NCT00899379|155464191|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48346080|NCT00899379|155464192|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48346081|NCT00899379|155464193|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48346082|NCT00899379|155464194|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48346083|NCT00899379|155464195|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48346084|NCT00899379|155464191|FG000|Overall Study|Not Completed/Entered Extn|5|||
48346085|NCT00899379|155464192|FG001|Overall Study|Not Completed/Entered Extn|1|||
48346086|NCT00899379|155464193|FG002|Overall Study|Not Completed/Entered Extn|6|||
48346087|NCT00899379|155464194|FG003|Overall Study|Not Completed/Entered Extn|4|||
48346088|NCT00899379|155464195|FG004|Overall Study|Not Completed/Entered Extn|3|||
48346089|NCT00899379|155464191|FG000|Overall Study|Study Terminated|3|||
48346090|NCT00899379|155464192|FG001|Overall Study|Study Terminated|0|||
48346091|NCT00899379|155464193|FG002|Overall Study|Study Terminated|3|||
48346092|NCT00899379|155464194|FG003|Overall Study|Study Terminated|3|||
48346093|NCT00899379|155464195|FG004|Overall Study|Study Terminated|1|||
48346094|NCT00899379|155464191|FG000|Overall Study|Lost to Follow-up|3|||
48346095|NCT00899379|155464192|FG001|Overall Study|Lost to Follow-up|1|||
48346096|NCT00899379|155464193|FG002|Overall Study|Lost to Follow-up|0|||
48346097|NCT00899379|155464194|FG003|Overall Study|Lost to Follow-up|2|||
48346098|NCT00899379|155464195|FG004|Overall Study|Lost to Follow-up|5|||
48346099|NCT00899379|155464191|FG000|Overall Study|Withdrawal by Subject|4|||
48346100|NCT00899379|155464192|FG001|Overall Study|Withdrawal by Subject|7|||
48346101|NCT00899379|155464193|FG002|Overall Study|Withdrawal by Subject|4|||
48346102|NCT00899379|155464194|FG003|Overall Study|Withdrawal by Subject|7|||
48346103|NCT00899379|155464195|FG004|Overall Study|Withdrawal by Subject|2|||
48346104|NCT00899379|155464191|FG000|Overall Study|Pregnancy|1|||
48346105|NCT00899379|155464192|FG001|Overall Study|Pregnancy|0|||
48346106|NCT00899379|155464193|FG002|Overall Study|Pregnancy|0|||
48346107|NCT00899379|155464194|FG003|Overall Study|Pregnancy|0|||
48346108|NCT00899379|155464195|FG004|Overall Study|Pregnancy|0|||
48346109|NCT00899379|155464191|FG000|Overall Study|Patient Uncooperative|0|||
48346110|NCT00899379|155464192|FG001|Overall Study|Patient Uncooperative|0|||
48346111|NCT00899379|155464193|FG002|Overall Study|Patient Uncooperative|0|||
48346112|NCT00899379|155464194|FG003|Overall Study|Patient Uncooperative|1|||
48346113|NCT00899379|155464195|FG004|Overall Study|Patient Uncooperative|0|||
48346114|NCT00899379|155464191|FG000|Overall Study|Abnormal Prestudy Labs|0|||
48346115|NCT00899379|155464192|FG001|Overall Study|Abnormal Prestudy Labs|0|||
48346116|NCT00899379|155464193|FG002|Overall Study|Abnormal Prestudy Labs|0|||
48346117|NCT00899379|155464194|FG003|Overall Study|Abnormal Prestudy Labs|0|||
48346118|NCT00899379|155464195|FG004|Overall Study|Abnormal Prestudy Labs|2|||
48346119|NCT00899379|155464191|FG000|Overall Study|Abnormal Baseline ECG|0|||
48346120|NCT00899379|155464192|FG001|Overall Study|Abnormal Baseline ECG|0|||
48346121|NCT00899379|155464193|FG002|Overall Study|Abnormal Baseline ECG|1|||
48346122|NCT00899379|155464194|FG003|Overall Study|Abnormal Baseline ECG|1|||
48346123|NCT00899379|155464195|FG004|Overall Study|Abnormal Baseline ECG|0|||
48346124|NCT00899379|155464191|FG000|Overall Study|No Attack Pretreatment|3|||
48346125|NCT00899379|155464192|FG001|Overall Study|No Attack Pretreatment|5|||
48346126|NCT00899379|155464193|FG002|Overall Study|No Attack Pretreatment|5|||
48346127|NCT00899379|155464194|FG003|Overall Study|No Attack Pretreatment|6|||
48346128|NCT00899379|155464195|FG004|Overall Study|No Attack Pretreatment|4|||
48346129|NCT00899379|155464191|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
48346130|NCT00899379|155464192|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48346131|NCT00899379|155464193|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48346132|NCT00899379|155464194|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48346133|NCT00899379|155464195|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
48346134|NCT00899379|155464191|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
48673297|NCT03667690|156657191|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
48673298|NCT03667690|156657192|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
48673299|NCT03667690|156657191|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
48673300|NCT03667690|156657192|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
48673301|NCT03667690|156657191|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
48673302|NCT03667690|156657192|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
48673303|NCT03667690|156657191|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
48673304|NCT03667690|156657192|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
48761131|NCT02246673|156974003|FG000|Overall Study|Withdrawal by Subject|0|||
48761132|NCT02246673|156974004|FG001|Overall Study|Withdrawal by Subject|0|||
48346135|NCT00899379|155464192|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
48346136|NCT00899379|155464193|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
48346137|NCT00899379|155464194|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
48673305|NCT03667690|156657191|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
48673306|NCT03667690|156657192|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
48673307|NCT03647267|156657196|FG000|Overall Study|Lost to Follow-up|1|||
48673308|NCT03647267|156657197|FG001|Overall Study|Lost to Follow-up|0|||
48673309|NCT01041287|156657198|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
48673310|NCT01041287|156657199|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
48673311|NCT01041287|156657198|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
48673312|NCT01041287|156657199|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
48673313|NCT04544683|156657207|FG000|Overall Study|Lost to Follow-up|2|||
48673314|NCT04544683|156657207|FG000|Overall Study|Underwent cervical spine surgery|6|||
48673315|NCT03459365|156657214|FG000|Overall Study|Withdrawal by Subject|6|||
48761133|NCT02246673|156974005|FG002|Overall Study|Withdrawal by Subject|0|||
48761134|NCT02246673|156974006|FG003|Overall Study|Withdrawal by Subject|0|||
48761135|NCT02246673|156974007|FG004|Overall Study|Withdrawal by Subject|1|||
48761136|NCT02246673|156974003|FG000|Overall Study|Lost to Follow-up|0|||
48761137|NCT02246673|156974004|FG001|Overall Study|Lost to Follow-up|0|||
48761138|NCT02246673|156974005|FG002|Overall Study|Lost to Follow-up|0|||
48761139|NCT02246673|156974006|FG003|Overall Study|Lost to Follow-up|1|||
48761140|NCT02246673|156974007|FG004|Overall Study|Lost to Follow-up|0|||
48761141|NCT02246673|156974003|FG000|Overall Study|Protocol Violation|0|||
48761142|NCT02246673|156974004|FG001|Overall Study|Protocol Violation|0|||
48761143|NCT02246673|156974005|FG002|Overall Study|Protocol Violation|0|||
48761144|NCT02246673|156974006|FG003|Overall Study|Protocol Violation|1|||
48346138|NCT00899379|155464195|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
48346139|NCT01649297|155464197|FG000|Overall Study|Adverse Event|5|||
48346140|NCT01649297|155464198|FG001|Overall Study|Adverse Event|5|||
48346141|NCT01649297|155464199|FG002|Overall Study|Adverse Event|4|||
48346142|NCT01649297|155464200|FG003|Overall Study|Adverse Event|13|||
48346143|NCT01649297|155464201|FG004|Overall Study|Adverse Event|1|||
48346144|NCT01649297|155464197|FG000|Overall Study|Lack of Efficacy|0|||
48346145|NCT01649297|155464198|FG001|Overall Study|Lack of Efficacy|0|||
48346146|NCT01649297|155464199|FG002|Overall Study|Lack of Efficacy|0|||
48346147|NCT01649297|155464200|FG003|Overall Study|Lack of Efficacy|0|||
48346148|NCT01649297|155464201|FG004|Overall Study|Lack of Efficacy|1|||
48346149|NCT01649297|155464197|FG000|Overall Study|Non compliant with Protocol|1|||
48346150|NCT01649297|155464198|FG001|Overall Study|Non compliant with Protocol|0|||
48346151|NCT01649297|155464199|FG002|Overall Study|Non compliant with Protocol|3|||
48346152|NCT01649297|155464200|FG003|Overall Study|Non compliant with Protocol|2|||
48346153|NCT01649297|155464201|FG004|Overall Study|Non compliant with Protocol|1|||
48346154|NCT01649297|155464197|FG000|Overall Study|Lost to Follow-up|1|||
48346155|NCT01649297|155464198|FG001|Overall Study|Lost to Follow-up|1|||
48346156|NCT01649297|155464199|FG002|Overall Study|Lost to Follow-up|4|||
48346157|NCT01649297|155464200|FG003|Overall Study|Lost to Follow-up|3|||
48346158|NCT01649297|155464201|FG004|Overall Study|Lost to Follow-up|0|||
48346159|NCT01649297|155464197|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
48346160|NCT01649297|155464198|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
48346161|NCT01649297|155464199|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
48346162|NCT01649297|155464200|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
48346163|NCT01649297|155464201|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
48673316|NCT03459365|156657214|FG000|Overall Study|Protocol Violation|8|||
48673317|NCT01543776|156657217|FG000|Overall Study|Withdrawal by Subject|2|||
48346164|NCT01649297|155464197|FG000|Overall Study|For other reason|4|||
48346165|NCT01649297|155464198|FG001|Overall Study|For other reason|1|||
48346166|NCT01649297|155464199|FG002|Overall Study|For other reason|2|||
48346167|NCT01649297|155464200|FG003|Overall Study|For other reason|0|||
48346168|NCT01649297|155464201|FG004|Overall Study|For other reason|0|||
48346169|NCT00337285|155464204|FG000|Overall Study|Withdrawal by Subject|42|||
48346170|NCT00337285|155464204|FG000|Overall Study|Lost to Follow-up|41|||
48346171|NCT00337285|155464204|FG000|Overall Study|Adverse Event|28|||
48346172|NCT00337285|155464204|FG000|Overall Study|Protocol Violation|27|||
48346173|NCT00337285|155464204|FG000|Overall Study|Lack of Efficacy|11|||
48346174|NCT00337285|155464204|FG000|Overall Study|Death|1|||
48346175|NCT00337285|155464204|FG000|Overall Study|Physician Decision|1|||
48346176|NCT00337285|155464204|FG000|Overall Study|Lack of protocol compliance|7|||
48346177|NCT04545476|155464209|FG000|Overall Study|Lost to Follow-up|1|||
48346178|NCT04545476|155464210|FG001|Overall Study|Lost to Follow-up|1|||
48346179|NCT04545476|155464211|FG002|Overall Study|Lost to Follow-up|0|||
48346180|NCT04545476|155464212|FG003|Overall Study|Lost to Follow-up|0|||
48346181|NCT01435798|155464215|FG000|Overall Study|Withdrawal by Subject|1|||
48346182|NCT02427958|155464216|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
48346183|NCT02427958|155464216|FG000|Overall Study|Lost to Follow-up|6|||
48346184|NCT02427958|155464216|FG000|Overall Study|Withdrawal by Subject|14|||
48346185|NCT02427958|155464216|FG000|Overall Study|Lack of Efficacy|1|||
48346186|NCT01530087|155464217|FG000|Overall Study|Physician Decision|2|||
48346187|NCT01182181|155464218|FG000|First Intervention|Adverse Event|1|||
48346188|NCT01182181|155464219|FG001|First Intervention|Adverse Event|0|||
48346189|NCT01182181|155464218|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
48346190|NCT01182181|155464219|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
48346191|NCT00866918|155464220|FG000|Overall Study|Death|1|||
48346192|NCT00866918|155464221|FG001|Overall Study|Death|5|||
48346193|NCT00866918|155464220|FG000|Overall Study|Lack of Efficacy|1|||
48346194|NCT00866918|155464221|FG001|Overall Study|Lack of Efficacy|1|||
48346195|NCT00866918|155464220|FG000|Overall Study|Physician Decision|10|||
48673318|NCT01543776|156657218|FG001|Overall Study|Withdrawal by Subject|2|||
48673319|NCT00707954|156657219|FG000|Overall Study|Physician Decision|0|||
48346196|NCT00866918|155464221|FG001|Overall Study|Physician Decision|2|||
48346197|NCT00866918|155464220|FG000|Overall Study|Ineligible|2|||
48346198|NCT00866918|155464221|FG001|Overall Study|Ineligible|4|||
48346199|NCT00866918|155464220|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
48346200|NCT00866918|155464221|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
48346201|NCT00866918|155464220|FG000|Overall Study|Secondary malignancy|1|||
48346202|NCT00866918|155464221|FG001|Overall Study|Secondary malignancy|0|||
48346203|NCT01121913|155464222|FG000|First Intervention Period|Adverse Event|0|||
48346204|NCT01121913|155464223|FG001|First Intervention Period|Adverse Event|0|||
48346205|NCT01121913|155464224|FG002|First Intervention Period|Adverse Event|1|||
48346206|NCT01121913|155464225|FG003|First Intervention Period|Adverse Event|0|||
48346207|NCT01121913|155464222|FG000|First Washout Period|Withdrawal by Subject|1|||
48346208|NCT01121913|155464223|FG001|First Washout Period|Withdrawal by Subject|0|||
48346209|NCT01121913|155464224|FG002|First Washout Period|Withdrawal by Subject|0|||
48346210|NCT01121913|155464225|FG003|First Washout Period|Withdrawal by Subject|0|||
48346211|NCT01121913|155464222|FG000|Second Intervention Period|Adverse Event|0|||
48346212|NCT01121913|155464223|FG001|Second Intervention Period|Adverse Event|0|||
48346213|NCT01121913|155464224|FG002|Second Intervention Period|Adverse Event|1|||
48346214|NCT01121913|155464225|FG003|Second Intervention Period|Adverse Event|0|||
48346215|NCT01121913|155464222|FG000|Second Washout Period|Withdrawal by Subject|0|||
48346216|NCT01121913|155464223|FG001|Second Washout Period|Withdrawal by Subject|0|||
48673320|NCT00707954|156657220|FG001|Overall Study|Physician Decision|0|||
48673321|NCT00707954|156657221|FG002|Overall Study|Physician Decision|0|||
48673322|NCT00707954|156657222|FG003|Overall Study|Physician Decision|0|||
48673323|NCT00707954|156657223|FG004|Overall Study|Physician Decision|1|||
48346217|NCT01121913|155464224|FG002|Second Washout Period|Withdrawal by Subject|1|||
48346218|NCT01121913|155464225|FG003|Second Washout Period|Withdrawal by Subject|0|||
48346219|NCT01121913|155464222|FG000|Third Washout Period|Adverse Event|1|||
48346220|NCT01121913|155464223|FG001|Third Washout Period|Adverse Event|0|||
48346221|NCT01121913|155464224|FG002|Third Washout Period|Adverse Event|0|||
48346222|NCT01121913|155464225|FG003|Third Washout Period|Adverse Event|0|||
48346223|NCT03974100|155464226|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
48346224|NCT03974100|155464227|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
48346225|NCT03974100|155464228|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
48346226|NCT03974100|155464229|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
48346227|NCT03974100|155464230|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
48346228|NCT03974100|155464226|FG000|TP1 - Day 1 to Week 52|Death|1|||
48346229|NCT03974100|155464227|FG001|TP1 - Day 1 to Week 52|Death|0|||
48346230|NCT03974100|155464228|FG002|TP1 - Day 1 to Week 52|Death|0|||
48346231|NCT03974100|155464229|FG003|TP1 - Day 1 to Week 52|Death|0|||
48346232|NCT03974100|155464230|FG004|TP1 - Day 1 to Week 52|Death|0|||
48346233|NCT03974100|155464226|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
48346234|NCT03974100|155464227|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
48346235|NCT03974100|155464228|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
48346236|NCT03974100|155464229|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
48346237|NCT03974100|155464230|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
48346238|NCT03974100|155464226|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
48346239|NCT03974100|155464227|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
48346240|NCT03974100|155464228|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
48346241|NCT03974100|155464229|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
48346242|NCT03974100|155464230|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
48346243|NCT03974100|155464226|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
48346244|NCT03974100|155464227|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
48346245|NCT03974100|155464228|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
48346246|NCT03974100|155464229|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
48346247|NCT03974100|155464230|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
48673324|NCT00528801|156657224|FG000|Overall Study|Withdrawal by Subject|1|||
48673325|NCT00528801|156657225|FG001|Overall Study|Withdrawal by Subject|1|||
48673326|NCT00528801|156657224|FG000|Overall Study|Protocol Violation|11|||
48673327|NCT00528801|156657225|FG001|Overall Study|Protocol Violation|5|||
48673328|NCT00528801|156657224|FG000|Overall Study|Lost to Follow-up|15|||
48673329|NCT00528801|156657225|FG001|Overall Study|Lost to Follow-up|4|||
48673330|NCT00528801|156657224|FG000|Overall Study|Administrative Reasons|0|||
48673331|NCT00528801|156657225|FG001|Overall Study|Administrative Reasons|1|||
48673332|NCT03626545|156657228|FG000|Overall Study|Progressive disease|3|||
48673333|NCT03626545|156657229|FG001|Overall Study|Progressive disease|82|||
48673334|NCT03626545|156657230|FG002|Overall Study|Progressive disease|85|||
48673335|NCT03626545|156657228|FG000|Overall Study|Adverse Event|3|||
48673336|NCT03626545|156657229|FG001|Overall Study|Adverse Event|13|||
48673337|NCT03626545|156657230|FG002|Overall Study|Adverse Event|10|||
48673338|NCT03626545|156657228|FG000|Overall Study|Physician Decision|1|||
48673339|NCT03626545|156657229|FG001|Overall Study|Physician Decision|18|||
48673340|NCT03626545|156657230|FG002|Overall Study|Physician Decision|14|||
48673341|NCT03626545|156657228|FG000|Overall Study|Subject Decision|0|||
48346248|NCT03974100|155464226|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
48346249|NCT03974100|155464227|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
48346250|NCT03974100|155464228|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
48346251|NCT03974100|155464229|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
48673342|NCT03626545|156657229|FG001|Overall Study|Subject Decision|5|||
48761145|NCT02246673|156974007|FG004|Overall Study|Protocol Violation|0|||
48761146|NCT02250443|156974011|FG000|Overall Study|Administrative problems|7|||
48346252|NCT03974100|155464230|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
48346253|NCT03974100|155464226|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
48346254|NCT03974100|155464227|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
48761147|NCT02250443|156974011|FG000|Overall Study|Adverse Event|3|||
48761148|NCT02337907|156974013|FG000|Overall Study|Other than listed|1|||
48673343|NCT03626545|156657230|FG002|Overall Study|Subject Decision|5|||
48673344|NCT03626545|156657228|FG000|Overall Study|Death|1|||
48673345|NCT03626545|156657229|FG001|Overall Study|Death|1|||
48346255|NCT03974100|155464228|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
48673346|NCT03626545|156657230|FG002|Overall Study|Death|1|||
48673347|NCT03626545|156657228|FG000|Overall Study|Protocol Deviation|0|||
48673348|NCT03626545|156657229|FG001|Overall Study|Protocol Deviation|1|||
48673349|NCT03626545|156657230|FG002|Overall Study|Protocol Deviation|1|||
48346256|NCT03974100|155464229|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
48346257|NCT03974100|155464230|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
48346258|NCT01704547|155464231|FG000|Overall Study|Physician Decision|4|||
48346259|NCT01704547|155464231|FG000|Overall Study|Withdrawal by Subject|1|||
48346260|NCT02413593|155464232|FG000|Overall Study|Lost to Follow-up|3|||
48346261|NCT02413593|155464232|FG000|Overall Study|Adverse Event|1|||
48346262|NCT02564718|155464233|FG000|Overall Study|Withdrew from treatment|0|||
48346263|NCT02564718|155464234|FG001|Overall Study|Withdrew from treatment|1|||
48346264|NCT00001941|155464235|FG000|Overall Study|not treated- rapidly progressing disease|0|||
48346265|NCT00001941|155464236|FG001|Overall Study|not treated- rapidly progressing disease|0|||
48346266|NCT00001941|155464237|FG002|Overall Study|not treated- rapidly progressing disease|0|||
48346267|NCT00001941|155464238|FG003|Overall Study|not treated- rapidly progressing disease|0|||
48346268|NCT00001941|155464239|FG004|Overall Study|not treated- rapidly progressing disease|1|||
48346269|NCT03723915|155464240|FG000|Screening|Failed to meet screening requirements.|2|||
48346270|NCT03723915|155464240|FG000|On Treatment|Failed to meet treatment requirements|2|||
48346271|NCT00874497|155464241|FG000|Overall Study|Lost to Follow-up|2|||
48346272|NCT00874497|155464242|FG001|Overall Study|Lost to Follow-up|4|||
48346273|NCT00874497|155464241|FG000|Overall Study|Adverse Event|9|||
48346274|NCT00874497|155464242|FG001|Overall Study|Adverse Event|4|||
48346275|NCT00874497|155464241|FG000|Overall Study|Sponsor Discontinued Trial|7|||
48346276|NCT00874497|155464242|FG001|Overall Study|Sponsor Discontinued Trial|3|||
48346277|NCT00874497|155464241|FG000|Overall Study|Met Withdrawal Criteria|4|||
48346278|NCT00874497|155464242|FG001|Overall Study|Met Withdrawal Criteria|2|||
48346279|NCT00874497|155464241|FG000|Overall Study|Physician Decision|1|||
48346280|NCT00874497|155464242|FG001|Overall Study|Physician Decision|1|||
48346281|NCT00874497|155464241|FG000|Overall Study|Withdrawal by Subject|5|||
48346282|NCT00874497|155464242|FG001|Overall Study|Withdrawal by Subject|4|||
48346283|NCT03269695|155464243|FG000|Overall Study|Adverse Event|2|||
48346284|NCT03269695|155464244|FG001|Overall Study|Adverse Event|1|||
48346285|NCT03269695|155464243|FG000|Overall Study|Lack of Efficacy|0|||
48346286|NCT03269695|155464244|FG001|Overall Study|Lack of Efficacy|1|||
48346287|NCT03269695|155464243|FG000|Overall Study|Withdrawal by Subject|0|||
48346288|NCT03269695|155464244|FG001|Overall Study|Withdrawal by Subject|1|||
48346289|NCT00264498|155464245|FG000|Randomized Treatment|Death|0|||
48346290|NCT00264498|155464246|FG001|Randomized Treatment|Death|3|||
48346291|NCT00264498|155464245|FG000|Randomized Treatment|Withdrawal by Subject|0|||
48346292|NCT00264498|155464246|FG001|Randomized Treatment|Withdrawal by Subject|1|||
48346293|NCT00264498|155464245|FG000|Randomized Treatment|Objective disease Progression|13|||
48346294|NCT00264498|155464246|FG001|Randomized Treatment|Objective disease Progression|14|||
48346295|NCT00264498|155464245|FG000|Randomized Treatment|Physician Decision|1|||
48346296|NCT00264498|155464246|FG001|Randomized Treatment|Physician Decision|0|||
48346297|NCT00264498|155464245|FG000|Randomized Treatment|Incorrectly randomized|1|||
48346298|NCT00264498|155464246|FG001|Randomized Treatment|Incorrectly randomized|0|||
48346299|NCT00264498|155464245|FG000|Randomized Treatment|Study Closure|1|||
48346300|NCT00264498|155464246|FG001|Randomized Treatment|Study Closure|0|||
48346301|NCT00264498|155464245|FG000|Randomized Treatment|Protocol Violation|1|||
48346302|NCT00264498|155464246|FG001|Randomized Treatment|Protocol Violation|0|||
48346303|NCT00264498|155464245|FG000|Crossover Treatment|Death|1|||
48346304|NCT00264498|155464246|FG001|Crossover Treatment|Death|3|||
48346305|NCT00264498|155464245|FG000|Crossover Treatment|Objective disease progression|4|||
48346306|NCT00264498|155464246|FG001|Crossover Treatment|Objective disease progression|5|||
48673350|NCT03626545|156657228|FG000|Overall Study|Guardian Decision|0|||
48673351|NCT03626545|156657229|FG001|Overall Study|Guardian Decision|0|||
48673352|NCT03626545|156657230|FG002|Overall Study|Guardian Decision|1|||
48673353|NCT00679172|156657231|FG000|Overall Study|Non-compliance|1|||
48673354|NCT00679172|156657232|FG001|Overall Study|Non-compliance|1|||
48673355|NCT00679172|156657233|FG002|Overall Study|Non-compliance|0|||
48673356|NCT00679172|156657234|FG003|Overall Study|Non-compliance|1|||
48673357|NCT00679172|156657235|FG004|Overall Study|Non-compliance|0|||
48673358|NCT00679172|156657231|FG000|Overall Study|Other not specified|0|||
48673359|NCT00679172|156657232|FG001|Overall Study|Other not specified|0|||
48673360|NCT00679172|156657233|FG002|Overall Study|Other not specified|1|||
48673361|NCT00679172|156657234|FG003|Overall Study|Other not specified|0|||
48673362|NCT00679172|156657235|FG004|Overall Study|Other not specified|0|||
48673363|NCT00387725|156657250|FG000|Overall Study|Adverse Event|0|||
48673364|NCT00387725|156657251|FG001|Overall Study|Adverse Event|0|||
48673365|NCT00387725|156657252|FG002|Overall Study|Adverse Event|0|||
48761149|NCT02337907|156974014|FG001|Overall Study|Other than listed|0|||
48346307|NCT00264498|155464245|FG000|Crossover Treatment|Study closure|0|||
48673366|NCT00387725|156657253|FG003|Overall Study|Adverse Event|1|||
48673367|NCT00387725|156657250|FG000|Overall Study|Protocol Violation|0|||
48673368|NCT00387725|156657251|FG001|Overall Study|Protocol Violation|1|||
48346308|NCT00264498|155464246|FG001|Crossover Treatment|Study closure|1|||
48673369|NCT00387725|156657252|FG002|Overall Study|Protocol Violation|0|||
48673370|NCT00387725|156657253|FG003|Overall Study|Protocol Violation|0|||
48673371|NCT00387725|156657250|FG000|Overall Study|Withdrawal by Subject|1|||
48761150|NCT02337907|156974015|FG002|Overall Study|Other than listed|0|||
48673372|NCT00387725|156657251|FG001|Overall Study|Withdrawal by Subject|0|||
48346309|NCT00264498|155464245|FG000|Crossover Treatment|Withdrawal by Subject|1|||
48346310|NCT00264498|155464246|FG001|Crossover Treatment|Withdrawal by Subject|0|||
48346311|NCT01560871|155464248|FG000|Overall Study|transportation issues|2|||
48346312|NCT01560871|155464249|FG001|Overall Study|transportation issues|1|||
48346313|NCT01560871|155464248|FG000|Overall Study|relocation|1|||
48346314|NCT01560871|155464249|FG001|Overall Study|relocation|0|||
48346315|NCT01560871|155464248|FG000|Overall Study|readmission to a hospital|2|||
48346316|NCT01560871|155464249|FG001|Overall Study|readmission to a hospital|1|||
48346317|NCT01560871|155464248|FG000|Overall Study|Lost to Follow-up|1|||
48346318|NCT01560871|155464249|FG001|Overall Study|Lost to Follow-up|0|||
48346319|NCT00857233|155464250|FG000|Overall Study|Adverse Event|24|||
48346320|NCT00857233|155464250|FG000|Overall Study|Lack of Efficacy|1|||
48346321|NCT00857233|155464250|FG000|Overall Study|Non-compliance|1|||
48346322|NCT00857233|155464250|FG000|Overall Study|Withdrawal of Consent|9|||
48346323|NCT00857233|155464250|FG000|Overall Study|Lost to Follow-up|4|||
48346324|NCT00857233|155464250|FG000|Overall Study|Nursing Home Placement|14|||
48346325|NCT00857233|155464250|FG000|Overall Study|Other Reasons|2|||
48346326|NCT00634920|155464251|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
48346327|NCT00634920|155464252|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
48346328|NCT00634920|155464253|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
48346329|NCT00634920|155464251|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
48346330|NCT00634920|155464252|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
48346331|NCT00634920|155464253|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
48346332|NCT00634920|155464251|FG000|Period 1 - Pre-Randomization|Rejections|0|||
48346333|NCT00634920|155464252|FG001|Period 1 - Pre-Randomization|Rejections|0|||
48346334|NCT00634920|155464253|FG002|Period 1 - Pre-Randomization|Rejections|55|||
48346335|NCT00634920|155464251|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
48346336|NCT00634920|155464252|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
48346337|NCT00634920|155464253|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
48346338|NCT00634920|155464251|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
48346339|NCT00634920|155464252|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
48346340|NCT00634920|155464253|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
48346341|NCT00634920|155464251|FG000|Period 1 - Pre-Randomization|Other issues|0|||
48346342|NCT00634920|155464252|FG001|Period 1 - Pre-Randomization|Other issues|0|||
48346343|NCT00634920|155464253|FG002|Period 1 - Pre-Randomization|Other issues|6|||
48346344|NCT00634920|155464251|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
48346345|NCT00634920|155464252|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
48346346|NCT00634920|155464253|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
48346347|NCT00634920|155464251|FG000|Period 2 - Post-Randomization|Rejection|11|||
48346348|NCT00634920|155464252|FG001|Period 2 - Post-Randomization|Rejection|5|||
48346349|NCT00634920|155464253|FG002|Period 2 - Post-Randomization|Rejection|0|||
48346350|NCT00634920|155464251|FG000|Period 2 - Post-Randomization|Death|2|||
48346351|NCT00634920|155464252|FG001|Period 2 - Post-Randomization|Death|5|||
48346352|NCT00634920|155464253|FG002|Period 2 - Post-Randomization|Death|0|||
48346353|NCT00634920|155464251|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
48346354|NCT00634920|155464252|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
48346355|NCT00634920|155464253|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
48346356|NCT00634920|155464251|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
48346357|NCT00634920|155464252|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
48346358|NCT00634920|155464253|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
48346359|NCT00004445|155464254|FG000|Overall Study|Physician Decision|2|||
48346360|NCT00004445|155464254|FG000|Overall Study|Withdrawal by Subject|1|||
48346361|NCT02024750|155464255|FG000|Overall Study|Withdrawal by Subject|2|||
48346362|NCT02024750|155464256|FG001|Overall Study|Withdrawal by Subject|1|||
48346363|NCT01182207|155464261|FG000|First Intervention|Positive Hepatitis Results|0|||
48346364|NCT01182207|155464262|FG001|First Intervention|Positive Hepatitis Results|1|||
48346365|NCT01182207|155464261|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
48346366|NCT01182207|155464262|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
48673373|NCT00387725|156657252|FG002|Overall Study|Withdrawal by Subject|1|||
48673374|NCT00387725|156657253|FG003|Overall Study|Withdrawal by Subject|0|||
48346367|NCT01087814|155464263|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
48346368|NCT01087814|155464264|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
48346369|NCT01087814|155464263|FG000|Second Intervention (5 Days)|Physician Decision|1|||
48346370|NCT01087814|155464264|FG001|Second Intervention (5 Days)|Physician Decision|0|||
48346371|NCT01222078|155464267|FG000|Overall Study|Early termination of the study|1|||
48346372|NCT01225159|155464271|FG000|Overall Study|Change operation|1|||
48673375|NCT00387725|156657250|FG000|Overall Study|Parent/legal guardian request|0|||
48673376|NCT00387725|156657251|FG001|Overall Study|Parent/legal guardian request|0|||
48673377|NCT00387725|156657252|FG002|Overall Study|Parent/legal guardian request|1|||
48673378|NCT00387725|156657253|FG003|Overall Study|Parent/legal guardian request|1|||
48673379|NCT01918332|156657254|FG000|Overall Study|Adverse Event|0|||
48346373|NCT01225159|155464272|FG001|Overall Study|Change operation|0|||
48346374|NCT02230306|155464273|FG000|Overall Study|Did not receive study treatment|1|||
48346375|NCT02037256|155464283|FG000|Overall Study|Protocol Violation|0|||
48346376|NCT02037256|155464284|FG001|Overall Study|Protocol Violation|1|||
48346377|NCT02037256|155464283|FG000|Overall Study|Withdrawn prior to Velcade|0|||
48346378|NCT02037256|155464284|FG001|Overall Study|Withdrawn prior to Velcade|2|||
48346379|NCT04599907|155464285|FG000|Overall Study|Withdrawal by Subject|1|||
48346380|NCT04599907|155464286|FG001|Overall Study|Withdrawal by Subject|7|||
48346381|NCT04599907|155464287|FG002|Overall Study|Withdrawal by Subject|6|||
48346382|NCT04599907|155464285|FG000|Overall Study|Lost to Follow-up|0|||
48346383|NCT04599907|155464286|FG001|Overall Study|Lost to Follow-up|1|||
48346384|NCT04599907|155464287|FG002|Overall Study|Lost to Follow-up|0|||
48346385|NCT02633397|155464288|FG000|Overall Study|Adverse Event|8|||
48346386|NCT02633397|155464289|FG001|Overall Study|Adverse Event|8|||
48346387|NCT02633397|155464288|FG000|Overall Study|Study Burden|4|||
48346388|NCT02633397|155464289|FG001|Overall Study|Study Burden|1|||
48346389|NCT02633397|155464288|FG000|Overall Study|Treatment interruption|2|||
48346390|NCT02633397|155464289|FG001|Overall Study|Treatment interruption|5|||
48346391|NCT02633397|155464288|FG000|Overall Study|Death|2|||
48346392|NCT02633397|155464289|FG001|Overall Study|Death|2|||
48346393|NCT02633397|155464288|FG000|Overall Study|Physician Decision|0|||
48346394|NCT02633397|155464289|FG001|Overall Study|Physician Decision|1|||
48346395|NCT03494985|155464290|FG000|Overall Study|Adverse Event|3|||
48346396|NCT03494985|155464291|FG001|Overall Study|Adverse Event|2|||
48346397|NCT03494985|155464292|FG002|Overall Study|Adverse Event|3|||
48346398|NCT03494985|155464293|FG003|Overall Study|Adverse Event|0|||
48346399|NCT03494985|155464290|FG000|Overall Study|Other (Withdrawal of consent)|2|||
48346400|NCT03494985|155464291|FG001|Overall Study|Other (Withdrawal of consent)|3|||
48346401|NCT03494985|155464292|FG002|Overall Study|Other (Withdrawal of consent)|2|||
48346402|NCT03494985|155464293|FG003|Overall Study|Other (Withdrawal of consent)|5|||
48346403|NCT03494985|155464290|FG000|Overall Study|Other (Not specified)|0|||
48346404|NCT03494985|155464291|FG001|Overall Study|Other (Not specified)|1|||
48346405|NCT03494985|155464292|FG002|Overall Study|Other (Not specified)|1|||
48673380|NCT01918332|156657255|FG001|Overall Study|Adverse Event|0|||
48673381|NCT01918332|156657256|FG002|Overall Study|Adverse Event|0|||
48673382|NCT01918332|156657257|FG003|Overall Study|Adverse Event|1|||
48346406|NCT03494985|155464293|FG003|Overall Study|Other (Not specified)|0|||
48346407|NCT02154347|155464294|FG000|Double-blind Period|Adverse Event|1|||
48346408|NCT02154347|155464295|FG001|Double-blind Period|Adverse Event|2|||
48346409|NCT02154347|155464294|FG000|Double-blind Period|Lack of Efficacy|1|||
48346410|NCT02154347|155464295|FG001|Double-blind Period|Lack of Efficacy|0|||
48346411|NCT02154347|155464294|FG000|Double-blind Period|Physician Decision|0|||
48346412|NCT02154347|155464295|FG001|Double-blind Period|Physician Decision|1|||
48346413|NCT02154347|155464294|FG000|Double-blind Period|Withdrawal by Subject|1|||
48346414|NCT02154347|155464295|FG001|Double-blind Period|Withdrawal by Subject|1|||
48346415|NCT02154347|155464294|FG000|Open-label Period|Adverse Event|3|||
48346416|NCT02154347|155464295|FG001|Open-label Period|Adverse Event|4|||
48346417|NCT02154347|155464294|FG000|Open-label Period|Lack of Efficacy|4|||
48346418|NCT02154347|155464295|FG001|Open-label Period|Lack of Efficacy|19|||
48346419|NCT02154347|155464294|FG000|Open-label Period|Protocol Violation|0|||
48346420|NCT02154347|155464295|FG001|Open-label Period|Protocol Violation|1|||
48346421|NCT02154347|155464294|FG000|Open-label Period|Withdrawal by Subject|0|||
48346422|NCT02154347|155464295|FG001|Open-label Period|Withdrawal by Subject|1|||
48346423|NCT04811339|155464297|FG000|Overall Study|lack of transportation not wanting to return|4|||
48346424|NCT04811339|155464298|FG001|Overall Study|lack of transportation not wanting to return|8|||
48346425|NCT04811339|155464299|FG002|Overall Study|lack of transportation not wanting to return|0|||
48346426|NCT04811339|155464297|FG000|Overall Study|Adverse Event|3|||
48346427|NCT04811339|155464298|FG001|Overall Study|Adverse Event|0|||
48346428|NCT04811339|155464299|FG002|Overall Study|Adverse Event|0|||
48346429|NCT04811339|155464297|FG000|Overall Study|Lost to Follow-up|1|||
48346430|NCT04811339|155464298|FG001|Overall Study|Lost to Follow-up|0|||
48346431|NCT04811339|155464299|FG002|Overall Study|Lost to Follow-up|0|||
48346432|NCT04811339|155464297|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
48346433|NCT04811339|155464298|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
48346434|NCT04811339|155464299|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
48346435|NCT04811339|155464297|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
48346436|NCT04811339|155464298|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
48673383|NCT01918332|156657254|FG000|Overall Study|Withdrawal by Subject|2|||
48673384|NCT01918332|156657255|FG001|Overall Study|Withdrawal by Subject|3|||
48673385|NCT01918332|156657256|FG002|Overall Study|Withdrawal by Subject|2|||
48673386|NCT01918332|156657257|FG003|Overall Study|Withdrawal by Subject|3|||
48346437|NCT04811339|155464299|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
48346438|NCT04811339|155464297|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
48673387|NCT01918332|156657254|FG000|Overall Study|Protocol Violation|6|||
48673388|NCT01918332|156657255|FG001|Overall Study|Protocol Violation|2|||
48346439|NCT04811339|155464298|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
48346440|NCT04811339|155464299|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
48346441|NCT04811339|155464297|FG000|Overall Study|Withdrawal by Subject|0|||
48346442|NCT04811339|155464298|FG001|Overall Study|Withdrawal by Subject|3|||
48346443|NCT04811339|155464299|FG002|Overall Study|Withdrawal by Subject|0|||
48346444|NCT04811339|155464297|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
48346445|NCT04811339|155464298|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
48346446|NCT04811339|155464299|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
48346447|NCT04811339|155464297|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
48346448|NCT04811339|155464298|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
48346449|NCT04811339|155464299|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
48346450|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
48346451|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
48346452|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
48346453|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
48346454|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
48346455|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
48346456|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
48346457|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
48346458|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
48346459|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
48346460|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
48346461|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
48346462|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
48346463|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
48346464|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
48346465|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
48346466|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
48346467|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
48346468|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
48346469|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
48346470|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
48673389|NCT01918332|156657256|FG002|Overall Study|Protocol Violation|6|||
48673390|NCT01918332|156657257|FG003|Overall Study|Protocol Violation|3|||
48673391|NCT01918332|156657254|FG000|Overall Study|lipid result by central lab did not meet|0|||
48673392|NCT01918332|156657255|FG001|Overall Study|lipid result by central lab did not meet|0|||
48346471|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
48346472|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
48673393|NCT01918332|156657256|FG002|Overall Study|lipid result by central lab did not meet|1|||
48673394|NCT01918332|156657257|FG003|Overall Study|lipid result by central lab did not meet|0|||
48673395|NCT02408523|156657258|FG000|Overall Study|Adverse Event|4|||
48673396|NCT02408523|156657259|FG001|Overall Study|Adverse Event|10|||
48673397|NCT02408523|156657258|FG000|Overall Study|Lack of Efficacy|0|||
48673398|NCT02408523|156657259|FG001|Overall Study|Lack of Efficacy|1|||
48673399|NCT02408523|156657258|FG000|Overall Study|Protocol Violation|1|||
48673400|NCT02408523|156657259|FG001|Overall Study|Protocol Violation|2|||
48673401|NCT02408523|156657258|FG000|Overall Study|Lost to Follow-up|2|||
48673402|NCT02408523|156657259|FG001|Overall Study|Lost to Follow-up|3|||
48673403|NCT02408523|156657258|FG000|Overall Study|Withdrawal by Subject|3|||
48673404|NCT02408523|156657259|FG001|Overall Study|Withdrawal by Subject|1|||
48673405|NCT02408523|156657258|FG000|Overall Study|Sponsor request|1|||
48673406|NCT02408523|156657259|FG001|Overall Study|Sponsor request|0|||
48673407|NCT02408523|156657258|FG000|Overall Study|Did not satisfy extension conditions|0|||
48673408|NCT02408523|156657259|FG001|Overall Study|Did not satisfy extension conditions|1|||
48673409|NCT01549873|156657260|FG000|Overall Study|Physician Decision|0|||
48673410|NCT01549873|156657261|FG001|Overall Study|Physician Decision|1|||
48673411|NCT02943915|156657262|FG000|Overall Study|Withdrawal by Subject|2|||
48673412|NCT02943915|156657263|FG001|Overall Study|Withdrawal by Subject|1|||
48673413|NCT02943915|156657264|FG002|Overall Study|Withdrawal by Subject|0|||
48673414|NCT02943915|156657265|FG003|Overall Study|Withdrawal by Subject|0|||
48673415|NCT02943915|156657262|FG000|Overall Study|Lost to Follow-up|3|||
48673416|NCT02943915|156657263|FG001|Overall Study|Lost to Follow-up|1|||
48346473|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
48346474|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
48346475|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
48346476|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
48346477|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
48346478|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
48346479|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
48346480|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
48346481|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
48346482|NCT00092521|155466293|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
48346483|NCT00092521|155466294|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
48346484|NCT00092521|155466295|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
48346485|NCT00092521|155466296|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
48346486|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
48346487|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
48346488|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
48346489|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
48346490|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
48346491|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
48346492|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
48346493|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
48346494|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
48346495|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
48346496|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
48346497|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
48346498|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Death|2|||
48346499|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Death|0|||
48346500|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Death|1|||
48346501|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Death|0|||
48346502|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
48346503|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
48346504|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
48346505|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
48346506|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
48346507|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
48346508|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
48346509|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
48673417|NCT02943915|156657264|FG002|Overall Study|Lost to Follow-up|0|||
48346510|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
48346511|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
48346512|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
48346513|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
48346514|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Moved|32|||
48346515|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Moved|2|||
48346516|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Moved|28|||
48346517|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Moved|0|||
48346518|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
48346519|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
48346520|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
48346521|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
48346522|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Travel|2|||
48346523|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Travel|0|||
48346524|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Travel|0|||
48346525|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Travel|0|||
48346526|NCT00092521|155466293|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
48346527|NCT00092521|155466294|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
48346528|NCT00092521|155466295|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
48346529|NCT00092521|155466296|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
48346530|NCT00092521|155466293|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
48346531|NCT00092521|155466294|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
48346532|NCT00092521|155466295|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
48346533|NCT00092521|155466296|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
48346534|NCT00092521|155466293|FG000|Extension Study (Group 4)|Adverse Event|0|||
48346535|NCT00092521|155466294|FG001|Extension Study (Group 4)|Adverse Event|0|||
48346536|NCT00092521|155466295|FG002|Extension Study (Group 4)|Adverse Event|0|||
48346537|NCT00092521|155466296|FG003|Extension Study (Group 4)|Adverse Event|2|||
48673418|NCT02943915|156657265|FG003|Overall Study|Lost to Follow-up|0|||
48673419|NCT02943915|156657262|FG000|Overall Study|excluded|0|||
48346538|NCT00092521|155466293|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
48346539|NCT00092521|155466294|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
48346540|NCT00092521|155466295|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
48346541|NCT00092521|155466296|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
48346542|NCT00092521|155466293|FG000|Extension Study (Group 4)|Pregnancy|0|||
48346543|NCT00092521|155466294|FG001|Extension Study (Group 4)|Pregnancy|0|||
48346544|NCT00092521|155466295|FG002|Extension Study (Group 4)|Pregnancy|0|||
48346545|NCT00092521|155466296|FG003|Extension Study (Group 4)|Pregnancy|4|||
48346546|NCT00092521|155466293|FG000|Extension Study (Group 4)|Protocol Violation|0|||
48346547|NCT00092521|155466294|FG001|Extension Study (Group 4)|Protocol Violation|0|||
48346548|NCT00092521|155466295|FG002|Extension Study (Group 4)|Protocol Violation|0|||
48346549|NCT00092521|155466296|FG003|Extension Study (Group 4)|Protocol Violation|2|||
48673420|NCT02943915|156657263|FG001|Overall Study|excluded|1|||
48673421|NCT02943915|156657264|FG002|Overall Study|excluded|0|||
48673422|NCT02943915|156657265|FG003|Overall Study|excluded|0|||
48673423|NCT02252965|156657268|FG000|Overall Study|Adverse Event|9|||
48673424|NCT02252965|156657269|FG001|Overall Study|Adverse Event|14|||
48673425|NCT02252965|156657268|FG000|Overall Study|Lost to Follow-up|16|||
48673426|NCT02252965|156657269|FG001|Overall Study|Lost to Follow-up|8|||
48673427|NCT02252965|156657268|FG000|Overall Study|Protocol Violation|4|||
48673428|NCT02252965|156657269|FG001|Overall Study|Protocol Violation|5|||
48673429|NCT02252965|156657268|FG000|Overall Study|Lack of Efficacy|0|||
48673430|NCT02252965|156657269|FG001|Overall Study|Lack of Efficacy|2|||
48673431|NCT02252965|156657268|FG000|Overall Study|Withdrawal by Subject|7|||
48673432|NCT02252965|156657269|FG001|Overall Study|Withdrawal by Subject|9|||
48673433|NCT02252965|156657268|FG000|Overall Study|Other|4|||
48673434|NCT02252965|156657269|FG001|Overall Study|Other|5|||
48673435|NCT01068769|156657274|FG000|Overall Study|Ineligible|1|||
48673436|NCT01276223|156657276|FG000|Overall Study|Adverse Event|7|||
48673437|NCT01276223|156657277|FG001|Overall Study|Adverse Event|4|||
48673438|NCT01276223|156657278|FG002|Overall Study|Adverse Event|1|||
48673439|NCT01276223|156657276|FG000|Overall Study|Lost to Follow-up|0|||
48673440|NCT01276223|156657277|FG001|Overall Study|Lost to Follow-up|0|||
48673441|NCT01276223|156657278|FG002|Overall Study|Lost to Follow-up|1|||
48673442|NCT01276223|156657276|FG000|Overall Study|Other|0|||
48673443|NCT01276223|156657277|FG001|Overall Study|Other|0|||
48673444|NCT01276223|156657278|FG002|Overall Study|Other|1|||
48673445|NCT01276223|156657276|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
48673446|NCT01276223|156657277|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
48673447|NCT01276223|156657278|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
48673448|NCT01276223|156657276|FG000|Overall Study|Protocol Violation|1|||
48673449|NCT01276223|156657277|FG001|Overall Study|Protocol Violation|0|||
48673450|NCT01276223|156657278|FG002|Overall Study|Protocol Violation|0|||
48673451|NCT02702414|156657279|FG000|Overall Study|Death|96|||
48673452|NCT02702414|156657280|FG001|Overall Study|Death|42|||
48673453|NCT02702414|156657279|FG000|Overall Study|Lost to Follow-up|0|||
48673454|NCT02702414|156657280|FG001|Overall Study|Lost to Follow-up|1|||
48346550|NCT00092521|155466293|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
48346551|NCT00092521|155466294|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
48346552|NCT00092521|155466295|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
48346553|NCT00092521|155466296|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
48346554|NCT00092521|155466293|FG000|Extension Study (Group 4)|Moved|0|||
48346555|NCT00092521|155466294|FG001|Extension Study (Group 4)|Moved|0|||
48346556|NCT00092521|155466295|FG002|Extension Study (Group 4)|Moved|0|||
48346557|NCT00092521|155466296|FG003|Extension Study (Group 4)|Moved|16|||
48346558|NCT00092521|155466293|FG000|Extension Study (Group 4)|Site Terminated|0|||
48346559|NCT00092521|155466294|FG001|Extension Study (Group 4)|Site Terminated|0|||
48673455|NCT02702414|156657279|FG000|Overall Study|Withdrawal by Subject|0|||
48673456|NCT02702414|156657280|FG001|Overall Study|Withdrawal by Subject|1|||
48673457|NCT02702414|156657279|FG000|Overall Study|Protocol Violation|1|||
48673458|NCT02702414|156657280|FG001|Overall Study|Protocol Violation|0|||
48673459|NCT02702414|156657279|FG000|Overall Study|Sponsor Decision|8|||
48673460|NCT02702414|156657280|FG001|Overall Study|Sponsor Decision|7|||
48673461|NCT00802893|156657284|FG000|Overall Study|study terminated|3|||
48673462|NCT02868229|156657285|FG000|Overall Study|Adverse Event|1|||
48673463|NCT02868229|156657286|FG001|Overall Study|Adverse Event|0|||
48673464|NCT02868229|156657287|FG002|Overall Study|Adverse Event|0|||
48346560|NCT00092521|155466295|FG002|Extension Study (Group 4)|Site Terminated|0|||
48346561|NCT00092521|155466296|FG003|Extension Study (Group 4)|Site Terminated|4|||
48673465|NCT02868229|156657288|FG003|Overall Study|Adverse Event|1|||
48673466|NCT02868229|156657285|FG000|Overall Study|Death|0|||
48673467|NCT02868229|156657286|FG001|Overall Study|Death|0|||
48673468|NCT02868229|156657287|FG002|Overall Study|Death|1|||
48673469|NCT02868229|156657288|FG003|Overall Study|Death|1|||
48673470|NCT02868229|156657285|FG000|Overall Study|Missed dose|0|||
48673471|NCT02868229|156657286|FG001|Overall Study|Missed dose|0|||
48673472|NCT02868229|156657287|FG002|Overall Study|Missed dose|0|||
48673473|NCT02868229|156657288|FG003|Overall Study|Missed dose|3|||
48673474|NCT01113580|156657289|FG000|Overall Study|Protocol Violation|1|||
48673475|NCT01113580|156657290|FG001|Overall Study|Protocol Violation|0|||
48673476|NCT00320424|156657291|FG000|Overall Study|Adverse Event|3|||
48673477|NCT00320424|156657291|FG000|Overall Study|Other|3|||
48673478|NCT02337634|156657296|FG000|Overall Study|Protocol Violation|3|||
48673479|NCT02337634|156657297|FG001|Overall Study|Protocol Violation|1|||
48761151|NCT02337907|156974016|FG003|Overall Study|Other than listed|1|||
48761152|NCT02337907|156974017|FG004|Overall Study|Other than listed|1|||
48761153|NCT02337907|156974018|FG005|Overall Study|Other than listed|0|||
48761154|NCT02337907|156974013|FG000|Overall Study|Withdrawal by Subject|2|||
48761155|NCT02337907|156974014|FG001|Overall Study|Withdrawal by Subject|3|||
48761156|NCT02337907|156974015|FG002|Overall Study|Withdrawal by Subject|0|||
48761157|NCT02337907|156974016|FG003|Overall Study|Withdrawal by Subject|2|||
48761158|NCT02337907|156974017|FG004|Overall Study|Withdrawal by Subject|5|||
48761159|NCT02337907|156974018|FG005|Overall Study|Withdrawal by Subject|0|||
48761160|NCT02337907|156974013|FG000|Overall Study|Lost to Follow-up|0|||
48673480|NCT02337634|156657296|FG000|Overall Study|Lost to Follow-up|1|||
48673481|NCT02337634|156657297|FG001|Overall Study|Lost to Follow-up|0|||
48673482|NCT03422536|156657300|FG000|Randomized|Physician Decision|1|||
48673483|NCT03422536|156657301|FG001|Randomized|Physician Decision|1|||
48673484|NCT03422536|156657300|FG000|Allocation - Received Intervention|Disease progression|19|||
48673485|NCT03422536|156657301|FG001|Allocation - Received Intervention|Disease progression|25|||
48673486|NCT03422536|156657300|FG000|Allocation - Received Intervention|Death|1|||
48673487|NCT03422536|156657301|FG001|Allocation - Received Intervention|Death|3|||
48673488|NCT03422536|156657300|FG000|Allocation - Received Intervention|Adverse Event|1|||
48673489|NCT03422536|156657301|FG001|Allocation - Received Intervention|Adverse Event|0|||
48673490|NCT03422536|156657300|FG000|Allocation - Received Intervention|Physician Decision|1|||
48673491|NCT03422536|156657301|FG001|Allocation - Received Intervention|Physician Decision|1|||
48673492|NCT03422536|156657300|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
48673493|NCT03422536|156657301|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
48673494|NCT03422536|156657300|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
48673495|NCT03422536|156657301|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
48673496|NCT01818284|156657302|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
48673497|NCT01818284|156657303|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
48673498|NCT01818284|156657302|FG000|Overall Study|Death|0|||
48673499|NCT01818284|156657303|FG001|Overall Study|Death|2|||
48673500|NCT00527319|156657305|FG000|Overall Study|Withdrawal by Subject|5|||
48673501|NCT00527319|156657306|FG001|Overall Study|Withdrawal by Subject|0|||
48673502|NCT00527319|156657307|FG002|Overall Study|Withdrawal by Subject|1|||
48673503|NCT00527319|156657305|FG000|Overall Study|Lost to Follow-up|1|||
48673504|NCT00527319|156657306|FG001|Overall Study|Lost to Follow-up|0|||
48673505|NCT00527319|156657307|FG002|Overall Study|Lost to Follow-up|0|||
48673506|NCT00527319|156657305|FG000|Overall Study|Death|0|||
48673507|NCT00527319|156657306|FG001|Overall Study|Death|3|||
48673508|NCT00527319|156657307|FG002|Overall Study|Death|1|||
48673509|NCT00527319|156657305|FG000|Overall Study|Intercurrent Medical Illness|0|||
48673510|NCT00527319|156657306|FG001|Overall Study|Intercurrent Medical Illness|1|||
48673511|NCT00527319|156657307|FG002|Overall Study|Intercurrent Medical Illness|3|||
48673512|NCT00527319|156657305|FG000|Overall Study|Adverse Event|0|||
48673513|NCT00527319|156657306|FG001|Overall Study|Adverse Event|0|||
48673514|NCT00527319|156657307|FG002|Overall Study|Adverse Event|1|||
48673515|NCT02690649|156657308|FG000|Overall Study|Withdrawal by Subject|1|||
48673516|NCT02690649|156657309|FG001|Overall Study|Withdrawal by Subject|1|||
48673517|NCT02690649|156657308|FG000|Overall Study|Protocol Violation|0|||
48673518|NCT02690649|156657309|FG001|Overall Study|Protocol Violation|3|||
48673519|NCT02335424|156657310|FG000|Overall Study|Withdrawal by Subject|19|||
48673520|NCT02335424|156657310|FG000|Overall Study|Adverse Event|25|||
48673521|NCT02335424|156657310|FG000|Overall Study|Death|273|||
48673522|NCT02335424|156657310|FG000|Overall Study|Lost to Follow-up|3|||
48673523|NCT02335424|156657310|FG000|Overall Study|Physician Decision|13|||
48673524|NCT02335424|156657310|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
48673525|NCT02335424|156657310|FG000|Overall Study|Protocol Violation|1|||
48673526|NCT02335424|156657310|FG000|Overall Study|Screen failure|1|||
48673527|NCT02294734|156657311|FG000|Overall Study|Adverse Event|5|||
48673528|NCT02294734|156657312|FG001|Overall Study|Adverse Event|5|||
48673529|NCT02294734|156657311|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
48673530|NCT02294734|156657312|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
48673531|NCT02294734|156657311|FG000|Overall Study|Lost to Follow-up|2|||
48673532|NCT02294734|156657312|FG001|Overall Study|Lost to Follow-up|0|||
48673533|NCT02294734|156657311|FG000|Overall Study|Physician Decision|2|||
48673534|NCT02294734|156657312|FG001|Overall Study|Physician Decision|1|||
48673535|NCT02294734|156657311|FG000|Overall Study|Withdrawal by Subject|4|||
48673536|NCT02294734|156657312|FG001|Overall Study|Withdrawal by Subject|2|||
48673537|NCT01422824|156657313|FG000|Overall Study|Case record form not evaluated|1|||
48673538|NCT01422824|156657313|FG000|Overall Study|Lost to Follow-up|37|||
48673539|NCT00551291|156657315|FG000|Overall Study|Physician Decision|1|||
48673540|NCT01375608|156657317|FG000|Overall Study|Withdrawal by Subject|2|||
48673541|NCT04405245|156657318|FG000|Overall Study|Adverse Event|0|||
48673542|NCT04405245|156657319|FG001|Overall Study|Adverse Event|1|||
48673543|NCT04405245|156657320|FG002|Overall Study|Adverse Event|0|||
48761161|NCT02337907|156974014|FG001|Overall Study|Lost to Follow-up|0|||
48761162|NCT02337907|156974015|FG002|Overall Study|Lost to Follow-up|0|||
48761163|NCT02337907|156974016|FG003|Overall Study|Lost to Follow-up|0|||
48761164|NCT02337907|156974017|FG004|Overall Study|Lost to Follow-up|0|||
48761165|NCT02337907|156974018|FG005|Overall Study|Lost to Follow-up|1|||
48761166|NCT02337907|156974013|FG000|Overall Study|Adverse Event|1|||
48761167|NCT02337907|156974014|FG001|Overall Study|Adverse Event|1|||
48761168|NCT02337907|156974015|FG002|Overall Study|Adverse Event|1|||
48761169|NCT02337907|156974016|FG003|Overall Study|Adverse Event|1|||
48761170|NCT02337907|156974017|FG004|Overall Study|Adverse Event|4|||
48761171|NCT02337907|156974018|FG005|Overall Study|Adverse Event|0|||
48761172|NCT02141997|156974019|FG000|Overall Study|Adverse Event|0|||
48761173|NCT02141997|156974020|FG001|Overall Study|Adverse Event|2|||
48761174|NCT02141997|156974021|FG002|Overall Study|Adverse Event|0|||
48761175|NCT02141997|156974022|FG003|Overall Study|Adverse Event|1|||
48761176|NCT02141997|156974019|FG000|Overall Study|Participant noncompliance|1|||
48761177|NCT02141997|156974020|FG001|Overall Study|Participant noncompliance|0|||
48761178|NCT02141997|156974021|FG002|Overall Study|Participant noncompliance|0|||
48761179|NCT02141997|156974022|FG003|Overall Study|Participant noncompliance|0|||
48761180|NCT02141997|156974019|FG000|Overall Study|Withdrew consent|1|||
48761181|NCT02141997|156974020|FG001|Overall Study|Withdrew consent|0|||
48761182|NCT02141997|156974021|FG002|Overall Study|Withdrew consent|3|||
48761183|NCT02141997|156974022|FG003|Overall Study|Withdrew consent|0|||
48761184|NCT02141997|156974019|FG000|Overall Study|Other|1|||
48761185|NCT02141997|156974020|FG001|Overall Study|Other|4|||
48346562|NCT00092521|155466293|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
48346563|NCT00092521|155466294|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
48346564|NCT00092521|155466295|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
48346565|NCT00092521|155466296|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
48346566|NCT02720185|155466297|FG000|Overall Study|Lost to Follow-up|1|||
48346567|NCT00381888|155466298|FG000|Overall Study|Death|1|||
48346568|NCT00381888|155466298|FG000|Overall Study|Withdrawal by Subject|1|||
48346569|NCT00381888|155466298|FG000|Overall Study|Physician Decision|1|||
48346570|NCT00381888|155466298|FG000|Overall Study|Protocol Violation|9|||
48346571|NCT00381888|155466298|FG000|Overall Study|Had laparoscopic surgery|2|||
48346572|NCT00381888|155466298|FG000|Overall Study|Surgery was cancelled|2|||
48346573|NCT00381888|155466298|FG000|Overall Study|Adverse Event|1|||
48346574|NCT01231464|155466299|FG000|Overall Study|Adverse Event|0|||
48346575|NCT01231464|155466300|FG001|Overall Study|Adverse Event|1|||
48673544|NCT03836677|156657321|FG000|Period 1|Adverse Event|0|||
48673545|NCT03836677|156657322|FG001|Period 1|Adverse Event|1|||
48673546|NCT03836677|156657321|FG000|Period 2|Severe non-compliance to protocol|1|||
48673547|NCT03836677|156657322|FG001|Period 2|Severe non-compliance to protocol|0|||
48673548|NCT01504204|156657329|FG000|Overall Study|Lost to Follow-up|1|||
48673549|NCT01504204|156657330|FG001|Overall Study|Lost to Follow-up|1|||
48673550|NCT03689855|156657334|FG000|Overall Study|Adverse Event|3|||
48673551|NCT03689855|156657334|FG000|Overall Study|Withdrawal by Subject|1|||
48673552|NCT03178669|156657341|FG000|Overall Study|Adverse Event|4|||
48673553|NCT03178669|156657342|FG001|Overall Study|Adverse Event|1|||
48673554|NCT03178669|156657343|FG002|Overall Study|Adverse Event|4|||
48346576|NCT01231464|155466299|FG000|Overall Study|Protocol Violation|1|||
48346577|NCT01231464|155466300|FG001|Overall Study|Protocol Violation|2|||
48346578|NCT01231464|155466299|FG000|Overall Study|Lost to Follow-up|1|||
48346579|NCT01231464|155466300|FG001|Overall Study|Lost to Follow-up|2|||
48346580|NCT01231464|155466299|FG000|Overall Study|Withdrawal by Subject|3|||
48346581|NCT01231464|155466300|FG001|Overall Study|Withdrawal by Subject|2|||
48346582|NCT03475056|155466301|FG000|Overall Study|Lost to Follow-up|0|||
48346583|NCT03475056|155466302|FG001|Overall Study|Lost to Follow-up|1|||
48346584|NCT03475056|155466301|FG000|Overall Study|Moved from Area|0|||
48346585|NCT03475056|155466302|FG001|Overall Study|Moved from Area|2|||
48346586|NCT00195442|155466305|FG000|Overall Study|Less than expected therapeutic effect|38|||
48346587|NCT00195442|155466305|FG000|Overall Study|Lost to Follow-up|27|||
48346588|NCT00195442|155466305|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
48346589|NCT00195442|155466305|FG000|Overall Study|Intermittent product shortage|21|||
48346590|NCT00195442|155466305|FG000|Overall Study|Death|7|||
48673555|NCT03178669|156657344|FG003|Overall Study|Adverse Event|2|||
48673556|NCT03178669|156657345|FG004|Overall Study|Adverse Event|2|||
48673557|NCT03178669|156657341|FG000|Overall Study|Lack of Efficacy|0|||
48346591|NCT00195442|155466305|FG000|Overall Study|No reason specified|4|||
48673558|NCT03178669|156657342|FG001|Overall Study|Lack of Efficacy|0|||
48673559|NCT03178669|156657343|FG002|Overall Study|Lack of Efficacy|2|||
48346592|NCT00195442|155466305|FG000|Overall Study|Poor cooperation|2|||
48346593|NCT00195442|155466305|FG000|Overall Study|Other|14|||
48346594|NCT03305809|155466307|FG000|Overall Study|Adverse Event|2|||
48673560|NCT03178669|156657344|FG003|Overall Study|Lack of Efficacy|0|||
48673561|NCT03178669|156657345|FG004|Overall Study|Lack of Efficacy|1|||
48673562|NCT03178669|156657341|FG000|Overall Study|Physician Decision|0|||
48673563|NCT03178669|156657342|FG001|Overall Study|Physician Decision|0|||
48673564|NCT03178669|156657343|FG002|Overall Study|Physician Decision|0|||
48673565|NCT03178669|156657344|FG003|Overall Study|Physician Decision|0|||
48673566|NCT03178669|156657345|FG004|Overall Study|Physician Decision|1|||
48673567|NCT03178669|156657341|FG000|Overall Study|Withdrawal by Subject|1|||
48673568|NCT03178669|156657342|FG001|Overall Study|Withdrawal by Subject|0|||
48673569|NCT03178669|156657343|FG002|Overall Study|Withdrawal by Subject|1|||
48673570|NCT03178669|156657344|FG003|Overall Study|Withdrawal by Subject|1|||
48673571|NCT03178669|156657345|FG004|Overall Study|Withdrawal by Subject|0|||
48673572|NCT03178669|156657341|FG000|Overall Study|Lost to Follow-up|0|||
48673573|NCT03178669|156657342|FG001|Overall Study|Lost to Follow-up|0|||
48673574|NCT03178669|156657343|FG002|Overall Study|Lost to Follow-up|0|||
48673575|NCT03178669|156657344|FG003|Overall Study|Lost to Follow-up|1|||
48673576|NCT03178669|156657345|FG004|Overall Study|Lost to Follow-up|0|||
48673577|NCT00084487|156657347|FG000|Overall Study|Death|1|||
48673578|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
48673579|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
48673580|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
48673581|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
48673582|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
48673583|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
48673584|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
48673585|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
48673586|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
48673587|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
48673588|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
48673589|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
48673590|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
48346595|NCT03305809|155466308|FG001|Overall Study|Adverse Event|2|||
48346596|NCT03305809|155466309|FG002|Overall Study|Adverse Event|6|||
48346597|NCT03305809|155466310|FG003|Overall Study|Adverse Event|6|||
48346598|NCT03305809|155466307|FG000|Overall Study|Death|0|||
48346599|NCT03305809|155466308|FG001|Overall Study|Death|0|||
48346600|NCT03305809|155466309|FG002|Overall Study|Death|1|||
48346601|NCT03305809|155466310|FG003|Overall Study|Death|1|||
48346602|NCT03305809|155466307|FG000|Overall Study|Lost to Follow-up|1|||
48346603|NCT03305809|155466308|FG001|Overall Study|Lost to Follow-up|2|||
48346604|NCT03305809|155466309|FG002|Overall Study|Lost to Follow-up|0|||
48346605|NCT03305809|155466310|FG003|Overall Study|Lost to Follow-up|0|||
48346606|NCT03305809|155466307|FG000|Overall Study|Sponsor Decision|1|||
48346607|NCT03305809|155466308|FG001|Overall Study|Sponsor Decision|0|||
48346608|NCT03305809|155466309|FG002|Overall Study|Sponsor Decision|1|||
48346609|NCT03305809|155466310|FG003|Overall Study|Sponsor Decision|8|||
48346610|NCT03305809|155466307|FG000|Overall Study|Physician Decision|0|||
48346611|NCT03305809|155466308|FG001|Overall Study|Physician Decision|0|||
48346612|NCT03305809|155466309|FG002|Overall Study|Physician Decision|2|||
48346613|NCT03305809|155466310|FG003|Overall Study|Physician Decision|4|||
48346614|NCT03305809|155466307|FG000|Overall Study|Progressive Disease|0|||
48346615|NCT03305809|155466308|FG001|Overall Study|Progressive Disease|0|||
48346616|NCT03305809|155466309|FG002|Overall Study|Progressive Disease|1|||
48346617|NCT03305809|155466310|FG003|Overall Study|Progressive Disease|0|||
48346618|NCT03305809|155466307|FG000|Overall Study|Protocol Violation|1|||
48346619|NCT03305809|155466308|FG001|Overall Study|Protocol Violation|0|||
48346620|NCT03305809|155466309|FG002|Overall Study|Protocol Violation|2|||
48346621|NCT03305809|155466310|FG003|Overall Study|Protocol Violation|3|||
48346622|NCT03305809|155466307|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
48346623|NCT03305809|155466308|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
48346624|NCT03305809|155466309|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
48346625|NCT03305809|155466310|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
48346626|NCT03305809|155466307|FG000|Overall Study|Withdrawal by Subject|2|||
48346627|NCT03305809|155466308|FG001|Overall Study|Withdrawal by Subject|4|||
48346628|NCT03305809|155466309|FG002|Overall Study|Withdrawal by Subject|5|||
48346629|NCT03305809|155466310|FG003|Overall Study|Withdrawal by Subject|2|||
48346630|NCT03305809|155466307|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
48673591|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
48673592|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
48761186|NCT02141997|156974021|FG002|Overall Study|Other|0|||
48346631|NCT03305809|155466308|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
48761187|NCT02141997|156974022|FG003|Overall Study|Other|0|||
48346632|NCT03305809|155466309|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
48346633|NCT03305809|155466310|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
48346634|NCT01202409|155466318|FG000|Overall Study|Adverse Event|1|||
48346635|NCT01202409|155466318|FG000|Overall Study|Ineligible - KRAS mutants|7|||
48346636|NCT00468858|155466322|FG000|Overall Study|Adverse Event|0|||
48346637|NCT00468858|155466323|FG001|Overall Study|Adverse Event|1|||
48346638|NCT00468858|155466324|FG002|Overall Study|Adverse Event|0|||
48346639|NCT00468858|155466322|FG000|Overall Study|Withdrawal by Subject|7|||
48346640|NCT00468858|155466323|FG001|Overall Study|Withdrawal by Subject|4|||
48346641|NCT00468858|155466324|FG002|Overall Study|Withdrawal by Subject|5|||
48346642|NCT00468858|155466322|FG000|Overall Study|Relocation|1|||
48346643|NCT00468858|155466323|FG001|Overall Study|Relocation|3|||
48346644|NCT00468858|155466324|FG002|Overall Study|Relocation|3|||
48673593|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
48673594|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
48673595|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
48673596|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
48673597|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
48673598|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
48673599|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
48673600|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
48673601|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
48673602|NCT01532869|156657348|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
48673603|NCT01532869|156657349|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
48673604|NCT01532869|156657348|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
48673605|NCT01532869|156657349|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
48673606|NCT01532869|156657348|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
48673607|NCT01532869|156657349|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
48673608|NCT01532869|156657348|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
48673609|NCT01532869|156657349|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
48761188|NCT01592344|156974025|FG000|Overall Study|Adverse Event|1|||
48761189|NCT01592344|156974026|FG001|Overall Study|Adverse Event|1|||
48761190|NCT01592344|156974025|FG000|Overall Study|Lack of Efficacy|1|||
48761191|NCT01592344|156974026|FG001|Overall Study|Lack of Efficacy|0|||
48761192|NCT01592344|156974025|FG000|Overall Study|not available at primary outcome visit|2|||
48761193|NCT01592344|156974026|FG001|Overall Study|not available at primary outcome visit|4|||
48761194|NCT02016482|156974027|FG000|Period A|Adverse Event|3|||
48346645|NCT00468858|155466322|FG000|Overall Study|Lost to Follow-up|1|||
48346646|NCT00468858|155466323|FG001|Overall Study|Lost to Follow-up|2|||
48346647|NCT00468858|155466324|FG002|Overall Study|Lost to Follow-up|5|||
48346648|NCT00468858|155466322|FG000|Overall Study|Other|0|||
48673610|NCT01532869|156657348|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
48673611|NCT01532869|156657349|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
48673612|NCT01009086|156657351|FG000|Overall Study|Lack of Efficacy|16|||
48761195|NCT02016482|156974028|FG001|Period A|Adverse Event|5|||
48761196|NCT02016482|156974027|FG000|Period A|Withdrawal by Subject|3|||
48346649|NCT00468858|155466323|FG001|Overall Study|Other|0|||
48346650|NCT00468858|155466324|FG002|Overall Study|Other|1|||
48346651|NCT03481556|155466325|FG000|Overall Study|Adverse Event|1|||
48761197|NCT02016482|156974028|FG001|Period A|Withdrawal by Subject|4|||
48346652|NCT03481556|155466326|FG001|Overall Study|Adverse Event|0|||
48346653|NCT03481556|155466327|FG002|Overall Study|Adverse Event|0|||
48346654|NCT03481556|155466328|FG003|Overall Study|Adverse Event|0|||
48346655|NCT03481556|155466325|FG000|Overall Study|Death|4|||
48346656|NCT03481556|155466326|FG001|Overall Study|Death|2|||
48346657|NCT03481556|155466327|FG002|Overall Study|Death|3|||
48346658|NCT03481556|155466328|FG003|Overall Study|Death|16|||
48346659|NCT03481556|155466325|FG000|Overall Study|Study Terminated by Sponsor|10|||
48761198|NCT02016482|156974027|FG000|Period A|Lost to Follow-up|3|||
48761199|NCT02016482|156974028|FG001|Period A|Lost to Follow-up|3|||
48761200|NCT02016482|156974027|FG000|Period A|Lack of Efficacy|2|||
48761201|NCT02016482|156974028|FG001|Period A|Lack of Efficacy|1|||
48761202|NCT02016482|156974027|FG000|Period A|Other|3|||
48761203|NCT02016482|156974028|FG001|Period A|Other|0|||
48761204|NCT02016482|156974027|FG000|Period A|Protocol Violation|0|||
48761205|NCT02016482|156974028|FG001|Period A|Protocol Violation|1|||
48761206|NCT02016482|156974027|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
48761207|NCT02016482|156974028|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
48761208|NCT02016482|156974027|FG000|Period B|Withdrawal by Subject|1|||
48761209|NCT02016482|156974028|FG001|Period B|Withdrawal by Subject|1|||
48761210|NCT02016482|156974027|FG000|Period B|Lost to Follow-up|2|||
48761211|NCT02016482|156974028|FG001|Period B|Lost to Follow-up|0|||
48761212|NCT02016482|156974027|FG000|Period B|Lack of Efficacy|6|||
48761213|NCT02016482|156974028|FG001|Period B|Lack of Efficacy|4|||
48761214|NCT02016482|156974027|FG000|Period B|Other|4|||
48761215|NCT02016482|156974028|FG001|Period B|Other|0|||
48761216|NCT02016482|156974027|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
48761217|NCT02016482|156974028|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
48761218|NCT00791518|156974032|FG000|Overall Study|Protocol Violation|93|||
48761219|NCT00751348|156974033|FG000|Overall Study|Withdrawal by Subject|5|||
48761220|NCT00751348|156974034|FG001|Overall Study|Withdrawal by Subject|2|||
48761221|NCT00751348|156974033|FG000|Overall Study|Migration from study area|1|||
48761222|NCT00751348|156974034|FG001|Overall Study|Migration from study area|0|||
48761223|NCT00006478|156974040|FG000|Overall Study|Vaccine could not be produced|1|||
48761224|NCT00006478|156974040|FG000|Overall Study|Physician Decision|6|||
48761225|NCT03054870|156974047|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
48761226|NCT03054870|156974047|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
48761227|NCT01176266|156974050|FG000|Overall Study|Death|6|||
48761228|NCT01176266|156974050|FG000|Overall Study|Withdrawal by Subject|3|||
48761229|NCT00728130|156974051|FG000|Overall Study|Withdrawal by Subject|1|||
48761230|NCT00728130|156974051|FG000|Overall Study|Paperwork not completed in time|1|||
48761231|NCT00728130|156974051|FG000|Overall Study|Physician Decision|1|||
48761232|NCT01154218|156974054|FG000|Third Intervention Period|Adverse Event|0|||
48761233|NCT01154218|156974055|FG001|Third Intervention Period|Adverse Event|1|||
48761234|NCT01154218|156974056|FG002|Third Intervention Period|Adverse Event|0|||
48761235|NCT01154218|156974057|FG003|Third Intervention Period|Adverse Event|0|||
48761236|NCT01154218|156974054|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48761237|NCT01154218|156974055|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48761238|NCT01154218|156974056|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
48761239|NCT01154218|156974057|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
48761240|NCT01154218|156974054|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
48761241|NCT01154218|156974055|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
48761242|NCT01154218|156974056|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
48761243|NCT01154218|156974057|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
48761244|NCT01265849|156974058|FG000|Overall Study|Randomized//Treatment not initiated|1|||
48761245|NCT01265849|156974059|FG001|Overall Study|Randomized//Treatment not initiated|4|||
48761246|NCT01265849|156974060|FG002|Overall Study|Randomized//Treatment not initiated|0|||
48761247|NCT01265849|156974058|FG000|Overall Study|Physician Decision|1|||
48761248|NCT01265849|156974059|FG001|Overall Study|Physician Decision|2|||
48761249|NCT01265849|156974060|FG002|Overall Study|Physician Decision|0|||
48761250|NCT01265849|156974058|FG000|Overall Study|Lost to Follow-up|18|||
48346660|NCT03481556|155466326|FG001|Overall Study|Study Terminated by Sponsor|5|||
48673613|NCT01009086|156657352|FG001|Overall Study|Lack of Efficacy|15|||
48346661|NCT03481556|155466327|FG002|Overall Study|Study Terminated by Sponsor|2|||
48346662|NCT03481556|155466328|FG003|Overall Study|Study Terminated by Sponsor|9|||
48346663|NCT03245619|155466330|FG000|Part A (Up to Day 22)|Physician Decision|4|||
48346664|NCT03245619|155466331|FG001|Part A (Up to Day 22)|Physician Decision|6|||
48346665|NCT03245619|155466332|FG002|Part A (Up to Day 22)|Physician Decision|6|||
48346666|NCT03245619|155466333|FG003|Part A (Up to Day 22)|Physician Decision|0|||
48346667|NCT03245619|155466334|FG004|Part A (Up to Day 22)|Physician Decision|0|||
48346668|NCT03245619|155466335|FG005|Part A (Up to Day 22)|Physician Decision|0|||
48346669|NCT03245619|155466336|FG006|Part A (Up to Day 22)|Physician Decision|0|||
48346670|NCT03245619|155466337|FG007|Part A (Up to Day 22)|Physician Decision|0|||
48346671|NCT03245619|155466338|FG008|Part A (Up to Day 22)|Physician Decision|0|||
48346672|NCT03245619|155466339|FG009|Part A (Up to Day 22)|Physician Decision|0|||
48346673|NCT03245619|155466340|FG010|Part A (Up to Day 22)|Physician Decision|0|||
48346674|NCT03245619|155466341|FG011|Part A (Up to Day 22)|Physician Decision|0|||
48346675|NCT03245619|155466342|FG012|Part A (Up to Day 22)|Physician Decision|0|||
48346676|NCT03245619|155466343|FG013|Part A (Up to Day 22)|Physician Decision|0|||
48346677|NCT03245619|155466344|FG014|Part A (Up to Day 22)|Physician Decision|0|||
48346678|NCT03245619|155466345|FG015|Part A (Up to Day 22)|Physician Decision|0|||
48346679|NCT03245619|155466346|FG016|Part A (Up to Day 22)|Physician Decision|0|||
48346680|NCT00853229|155466349|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
48346681|NCT00853229|155466350|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
48346682|NCT03187353|155466355|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
48346683|NCT03187353|155466356|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
48346684|NCT03187353|155466355|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
48346685|NCT03187353|155466356|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
48346686|NCT03187353|155466355|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
48346687|NCT03187353|155466356|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
48346688|NCT03187353|155466355|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
48346689|NCT03187353|155466356|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
48346690|NCT03187353|155466355|FG000|Washout (2 Weeks)|Adverse Event|2|||
48346691|NCT03187353|155466356|FG001|Washout (2 Weeks)|Adverse Event|0|||
48346692|NCT03187353|155466355|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
48346693|NCT03187353|155466356|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
48346694|NCT02215954|155466357|FG000|Overall Study|Adverse Event|0|||
48346695|NCT02215954|155466358|FG001|Overall Study|Adverse Event|0|||
48346696|NCT02215954|155466359|FG002|Overall Study|Adverse Event|1|||
48346697|NCT02215954|155466357|FG000|Overall Study|Withdrawal by Subject|0|||
48346698|NCT02215954|155466358|FG001|Overall Study|Withdrawal by Subject|0|||
48346699|NCT02215954|155466359|FG002|Overall Study|Withdrawal by Subject|2|||
48346700|NCT02215954|155466357|FG000|Overall Study|Not exposed|1|||
48346701|NCT02215954|155466358|FG001|Overall Study|Not exposed|1|||
48346702|NCT02215954|155466359|FG002|Overall Study|Not exposed|3|||
48346703|NCT01167192|155466360|FG000|Overall Study|Adverse Event|1|||
48346704|NCT01167192|155466360|FG000|Overall Study|Death|1|||
48346705|NCT01167192|155466360|FG000|Overall Study|Withdrawal by Subject|1|||
48346706|NCT01167192|155466360|FG000|Overall Study|Insurance denial|1|||
48346707|NCT03414047|155466361|FG000|Overall Study|Adverse Event|0|||
48346708|NCT03414047|155466362|FG001|Overall Study|Adverse Event|0|||
48346709|NCT03414047|155466363|FG002|Overall Study|Adverse Event|1|||
48346710|NCT03414047|155466364|FG003|Overall Study|Adverse Event|1|||
48346711|NCT03414047|155466361|FG000|Overall Study|Physician Decision|1|||
48346712|NCT03414047|155466362|FG001|Overall Study|Physician Decision|0|||
48346713|NCT03414047|155466363|FG002|Overall Study|Physician Decision|0|||
48346714|NCT03414047|155466364|FG003|Overall Study|Physician Decision|1|||
48346715|NCT03414047|155466361|FG000|Overall Study|Withdrawal by Subject|1|||
48346716|NCT03414047|155466362|FG001|Overall Study|Withdrawal by Subject|0|||
48346717|NCT03414047|155466363|FG002|Overall Study|Withdrawal by Subject|2|||
48346718|NCT03414047|155466364|FG003|Overall Study|Withdrawal by Subject|0|||
48346719|NCT01187407|155466377|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
48346720|NCT01187407|155466378|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48346721|NCT01187407|155466379|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48346722|NCT01187407|155466380|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48346723|NCT01187407|155466381|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48346724|NCT01187407|155466377|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
48346725|NCT01187407|155466378|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48346726|NCT01187407|155466379|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48346727|NCT01187407|155466380|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48673614|NCT01009086|156657353|FG002|Overall Study|Lack of Efficacy|9|||
48346728|NCT01187407|155466381|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48346729|NCT01187407|155466377|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
48346730|NCT01187407|155466378|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48346731|NCT01187407|155466379|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48346732|NCT01187407|155466380|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48383956|NCT04029116|155601516|FG000|Overall Study|Physician Decision|2|||
48346733|NCT01187407|155466381|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48346734|NCT01187407|155466377|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
48346735|NCT01187407|155466378|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48346736|NCT01187407|155466379|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48346737|NCT01187407|155466380|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48346738|NCT01187407|155466381|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48346739|NCT01187407|155466377|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
48346740|NCT01187407|155466378|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48346741|NCT01187407|155466379|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48346742|NCT01187407|155466380|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48346743|NCT01187407|155466381|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48346744|NCT01187407|155466377|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
48346745|NCT01187407|155466378|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48346746|NCT01187407|155466379|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48346747|NCT01187407|155466380|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48346748|NCT01187407|155466381|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48346749|NCT01187407|155466377|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
48346750|NCT01187407|155466378|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48346751|NCT01187407|155466379|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48346752|NCT01187407|155466380|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48346753|NCT01187407|155466381|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48346754|NCT01187407|155466377|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
48346755|NCT01187407|155466378|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
48346756|NCT01187407|155466379|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
48346757|NCT01187407|155466380|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
48346758|NCT01187407|155466381|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
48346759|NCT01187407|155466377|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
48346760|NCT01187407|155466378|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
48346761|NCT01187407|155466379|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
48346762|NCT01187407|155466380|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
48346763|NCT01187407|155466381|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
48346764|NCT01187407|155466377|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
48346765|NCT01187407|155466378|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
48346766|NCT01187407|155466379|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
48346767|NCT01187407|155466380|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
48346768|NCT01187407|155466381|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
48346769|NCT01187407|155466377|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48346770|NCT01187407|155466378|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48346771|NCT01187407|155466379|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48346772|NCT01187407|155466380|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
48346773|NCT01187407|155466381|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
48346774|NCT01187407|155466377|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
48346775|NCT01187407|155466378|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
48346776|NCT01187407|155466379|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48346777|NCT01187407|155466380|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
48346778|NCT01187407|155466381|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
48346779|NCT01187407|155466377|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
48346780|NCT01187407|155466378|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
48346781|NCT01187407|155466379|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
48346782|NCT01187407|155466380|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
48346783|NCT01187407|155466381|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
48346784|NCT01187407|155466377|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48346785|NCT01187407|155466378|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
48346786|NCT01187407|155466379|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
48346787|NCT01187407|155466380|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
48346788|NCT01187407|155466381|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
48346789|NCT04035577|155466382|FG000|Overall Study|Lost to Follow-up|1|||
48346790|NCT04035577|155466382|FG000|Overall Study|Withdrawal by Subject|1|||
48346791|NCT00505414|155466383|FG000|Titration Phase|Adverse Event|0|||
48673615|NCT01009086|156657351|FG000|Overall Study|Lost to Follow-up|4|||
48346792|NCT00505414|155466384|FG001|Titration Phase|Adverse Event|0|||
48346793|NCT00505414|155466385|FG002|Titration Phase|Adverse Event|0|||
48346794|NCT00505414|155466386|FG003|Titration Phase|Adverse Event|8|||
48346795|NCT00505414|155466387|FG004|Titration Phase|Adverse Event|3|||
48673616|NCT01009086|156657352|FG001|Overall Study|Lost to Follow-up|5|||
48673617|NCT01009086|156657353|FG002|Overall Study|Lost to Follow-up|3|||
48346796|NCT00505414|155466383|FG000|Titration Phase|Death|0|||
48346797|NCT00505414|155466384|FG001|Titration Phase|Death|0|||
48346798|NCT00505414|155466385|FG002|Titration Phase|Death|0|||
48346799|NCT00505414|155466386|FG003|Titration Phase|Death|2|||
48346800|NCT00505414|155466387|FG004|Titration Phase|Death|0|||
48346801|NCT00505414|155466383|FG000|Titration Phase|Lack of Efficacy|0|||
48346802|NCT00505414|155466384|FG001|Titration Phase|Lack of Efficacy|0|||
48346803|NCT00505414|155466385|FG002|Titration Phase|Lack of Efficacy|0|||
48346804|NCT00505414|155466386|FG003|Titration Phase|Lack of Efficacy|10|||
48346805|NCT00505414|155466387|FG004|Titration Phase|Lack of Efficacy|1|||
48346806|NCT00505414|155466383|FG000|Titration Phase|Protocol Violation|0|||
48346807|NCT00505414|155466384|FG001|Titration Phase|Protocol Violation|0|||
48346808|NCT00505414|155466385|FG002|Titration Phase|Protocol Violation|0|||
48346809|NCT00505414|155466386|FG003|Titration Phase|Protocol Violation|0|||
48673618|NCT01009086|156657351|FG000|Overall Study|Adverse Event|12|||
48673619|NCT01009086|156657352|FG001|Overall Study|Adverse Event|11|||
48673620|NCT01009086|156657353|FG002|Overall Study|Adverse Event|8|||
48673621|NCT01009086|156657351|FG000|Overall Study|Withdrawal by Subject|9|||
48673622|NCT01009086|156657352|FG001|Overall Study|Withdrawal by Subject|11|||
48673623|NCT01009086|156657353|FG002|Overall Study|Withdrawal by Subject|13|||
48673624|NCT01009086|156657351|FG000|Overall Study|Other|3|||
48673625|NCT01009086|156657352|FG001|Overall Study|Other|5|||
48673626|NCT01009086|156657353|FG002|Overall Study|Other|1|||
48673627|NCT03040986|156657354|FG000|Overall Study|Hospice|1|||
48673628|NCT03040986|156657355|FG001|Overall Study|Hospice|0|||
48673629|NCT03040986|156657354|FG000|Overall Study|Adverse Event|2|||
48673630|NCT03040986|156657355|FG001|Overall Study|Adverse Event|1|||
48673631|NCT03040986|156657354|FG000|Overall Study|Disease progression on study|3|||
48673632|NCT03040986|156657355|FG001|Overall Study|Disease progression on study|1|||
48673633|NCT01793883|156657357|FG000|Overall Study|Withdrawal by Subject|3|||
48673634|NCT01793883|156657358|FG001|Overall Study|Withdrawal by Subject|7|||
48673635|NCT01793883|156657359|FG002|Overall Study|Withdrawal by Subject|3|||
48673636|NCT01793883|156657357|FG000|Overall Study|Subject noncompliance|0|||
48673637|NCT01793883|156657358|FG001|Overall Study|Subject noncompliance|1|||
48673638|NCT01793883|156657359|FG002|Overall Study|Subject noncompliance|1|||
48673639|NCT01793883|156657357|FG000|Overall Study|Lost to Follow-up|5|||
48673640|NCT01793883|156657358|FG001|Overall Study|Lost to Follow-up|1|||
48673641|NCT01793883|156657359|FG002|Overall Study|Lost to Follow-up|3|||
48673642|NCT01793883|156657357|FG000|Overall Study|Randomized in error|1|||
48673643|NCT01793883|156657358|FG001|Overall Study|Randomized in error|0|||
48673644|NCT01793883|156657359|FG002|Overall Study|Randomized in error|0|||
48673645|NCT01793883|156657357|FG000|Overall Study|Unable to complete spriometry|1|||
48673646|NCT01793883|156657358|FG001|Overall Study|Unable to complete spriometry|0|||
48673647|NCT01793883|156657359|FG002|Overall Study|Unable to complete spriometry|0|||
48673648|NCT01793883|156657357|FG000|Overall Study|Unable to complete measurements|1|||
48673649|NCT01793883|156657358|FG001|Overall Study|Unable to complete measurements|0|||
48673650|NCT01793883|156657359|FG002|Overall Study|Unable to complete measurements|0|||
48673651|NCT01793883|156657357|FG000|Overall Study|Met exclusion criteria|1|||
48673652|NCT01793883|156657358|FG001|Overall Study|Met exclusion criteria|0|||
48673653|NCT01793883|156657359|FG002|Overall Study|Met exclusion criteria|0|||
48673654|NCT01793883|156657357|FG000|Overall Study|Dosing error|0|||
48673655|NCT01793883|156657358|FG001|Overall Study|Dosing error|1|||
48673656|NCT01793883|156657359|FG002|Overall Study|Dosing error|0|||
48673657|NCT01793883|156657357|FG000|Overall Study|Respiratory distress during spirometry|0|||
48673658|NCT01793883|156657358|FG001|Overall Study|Respiratory distress during spirometry|0|||
48673659|NCT01793883|156657359|FG002|Overall Study|Respiratory distress during spirometry|1|||
48673660|NCT00761527|156657367|FG000|Overall Study|Adverse Event|3|||
48673661|NCT00761527|156657367|FG000|Overall Study|Poor Compliance|8|||
48673662|NCT00761527|156657367|FG000|Overall Study|Lost to Follow-up|9|||
48673663|NCT00761527|156657367|FG000|Overall Study|Unknown reason|2|||
48673664|NCT01431963|156657368|FG000|Overall Study|Adverse Event|18|||
48673665|NCT01431963|156657368|FG000|Overall Study|Lack of Efficacy|7|||
48673666|NCT01431963|156657368|FG000|Overall Study|Protocol Violation|1|||
48673667|NCT01431963|156657368|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
48673668|NCT01431963|156657368|FG000|Overall Study|Physician Decision|4|||
48673669|NCT01431963|156657368|FG000|Overall Study|Withdrawal by Subject|3|||
48673670|NCT00620113|156657369|FG000|Overall Study|Adverse Event|3|||
48673671|NCT00620113|156657370|FG001|Overall Study|Adverse Event|2|||
48673672|NCT00620113|156657371|FG002|Overall Study|Adverse Event|2|||
48673673|NCT00620113|156657372|FG003|Overall Study|Adverse Event|1|||
48673674|NCT00620113|156657369|FG000|Overall Study|Lack of Efficacy|2|||
48673675|NCT00620113|156657370|FG001|Overall Study|Lack of Efficacy|3|||
48673676|NCT00620113|156657371|FG002|Overall Study|Lack of Efficacy|0|||
48673677|NCT00620113|156657372|FG003|Overall Study|Lack of Efficacy|2|||
48673678|NCT00620113|156657369|FG000|Overall Study|Physician Decision|1|||
48673679|NCT00620113|156657370|FG001|Overall Study|Physician Decision|0|||
48673680|NCT00620113|156657371|FG002|Overall Study|Physician Decision|0|||
48346810|NCT00505414|155466387|FG004|Titration Phase|Protocol Violation|1|||
48673681|NCT00620113|156657372|FG003|Overall Study|Physician Decision|2|||
48673682|NCT00620113|156657369|FG000|Overall Study|Protocol Violation|2|||
48673683|NCT00620113|156657370|FG001|Overall Study|Protocol Violation|1|||
48673684|NCT00620113|156657371|FG002|Overall Study|Protocol Violation|0|||
48673685|NCT00620113|156657372|FG003|Overall Study|Protocol Violation|0|||
48673686|NCT00620113|156657369|FG000|Overall Study|Withdrawal by Subject|5|||
48673687|NCT00620113|156657370|FG001|Overall Study|Withdrawal by Subject|1|||
48673688|NCT00620113|156657371|FG002|Overall Study|Withdrawal by Subject|3|||
48673689|NCT00620113|156657372|FG003|Overall Study|Withdrawal by Subject|5|||
48673690|NCT00619307|156657374|FG000|Overall Study|Adverse Event|0|||
48673691|NCT00619307|156657375|FG001|Overall Study|Adverse Event|1|||
48346811|NCT00505414|155466383|FG000|Titration Phase|Withdrawal by Subject|0|||
48346812|NCT00505414|155466384|FG001|Titration Phase|Withdrawal by Subject|0|||
48346813|NCT00505414|155466385|FG002|Titration Phase|Withdrawal by Subject|0|||
48346814|NCT00505414|155466386|FG003|Titration Phase|Withdrawal by Subject|3|||
48346815|NCT00505414|155466387|FG004|Titration Phase|Withdrawal by Subject|4|||
48346816|NCT00505414|155466383|FG000|Titration Phase|Underlying disease and therapy required|0|||
48346817|NCT00505414|155466384|FG001|Titration Phase|Underlying disease and therapy required|0|||
48673692|NCT00619307|156657374|FG000|Overall Study|Lost to Follow-up|0|||
48673693|NCT00619307|156657375|FG001|Overall Study|Lost to Follow-up|1|||
48673694|NCT00619307|156657374|FG000|Overall Study|Protocol Violation|3|||
48673695|NCT00619307|156657375|FG001|Overall Study|Protocol Violation|0|||
48673696|NCT00619307|156657374|FG000|Overall Study|Withdrew consent|1|||
48673697|NCT00619307|156657375|FG001|Overall Study|Withdrew consent|0|||
48673698|NCT00619307|156657374|FG000|Overall Study|Severe migraine|0|||
48673699|NCT00619307|156657375|FG001|Overall Study|Severe migraine|1|||
48673700|NCT00619307|156657374|FG000|Overall Study|MS attack plus steroids|0|||
48673701|NCT00619307|156657375|FG001|Overall Study|MS attack plus steroids|1|||
48673702|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Adverse Event|33|||
48673703|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
48673704|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
48673705|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
48673706|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Physician Decision|6|||
48673707|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
48673708|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
48673709|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
48673710|NCT00965419|156657376|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
48673711|NCT00965419|156657376|FG000|Follow-up Phase|Adverse Event|9|||
48673712|NCT00965419|156657376|FG000|Follow-up Phase|Protocol Violation|4|||
48673713|NCT00965419|156657376|FG000|Follow-up Phase|Withdrawal by Subject|8|||
48673714|NCT00965419|156657376|FG000|Follow-up Phase|Physician Decision|4|||
48673715|NCT00965419|156657376|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
48673716|NCT00965419|156657376|FG000|Follow-up Phase|Lack of Efficacy|28|||
48673717|NCT00151372|156659501|FG000|Overall Study|Death|12|||
48673718|NCT00151372|156659502|FG001|Overall Study|Death|11|||
48673719|NCT00151372|156659501|FG000|Overall Study|Lost to Follow-up|5|||
48673720|NCT00151372|156659502|FG001|Overall Study|Lost to Follow-up|5|||
48673721|NCT00151372|156659501|FG000|Overall Study|Too sick medically to continue|5|||
48673722|NCT00151372|156659502|FG001|Overall Study|Too sick medically to continue|6|||
48673723|NCT00151372|156659501|FG000|Overall Study|Withdrawal by Subject|7|||
48761251|NCT01265849|156974059|FG001|Overall Study|Lost to Follow-up|15|||
48761252|NCT01265849|156974060|FG002|Overall Study|Lost to Follow-up|5|||
48673724|NCT00151372|156659502|FG001|Overall Study|Withdrawal by Subject|7|||
48673725|NCT00924508|156659503|FG000|Overall Study|Withdrawal by Subject|3|||
48673726|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
48673727|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
48673728|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
48673729|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
48673730|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
48673731|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
48673732|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
48673733|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
48673734|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
48673735|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
48673736|NCT02429791|156659504|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
48673737|NCT02429791|156659505|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
48673738|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
48673739|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
48673740|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
48673741|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
48673742|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
48673743|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
48673744|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
48673745|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
48673746|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
48673747|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
48673748|NCT02429791|156659504|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
48673749|NCT02429791|156659505|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
48673750|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
48673751|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
48761253|NCT01265849|156974058|FG000|Overall Study|Not otherwise specified|1|||
48673752|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
48673753|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
48673754|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
48673755|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
48761254|NCT01265849|156974059|FG001|Overall Study|Not otherwise specified|6|||
48673756|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
48673757|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
48673758|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
48673759|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
48673760|NCT02429791|156659504|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
48673761|NCT02429791|156659505|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
48673762|NCT00859937|156659508|FG000|Overall Study|Protocol Violation|1|||
48673763|NCT00859937|156659509|FG001|Overall Study|Protocol Violation|0|||
48673764|NCT03203291|156659510|FG000|Overall Study|Withdrawal by Subject|1|||
48673765|NCT03180307|156659512|FG000|Overall Study|Lost to Follow-up|2|||
48673766|NCT03180307|156659513|FG001|Overall Study|Lost to Follow-up|0|||
48673767|NCT03180307|156659512|FG000|Overall Study|Death|1|||
48673768|NCT03180307|156659513|FG001|Overall Study|Death|0|||
48673769|NCT03180307|156659512|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
48673770|NCT03180307|156659513|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
48673771|NCT01563172|156659514|FG000|Overall Study|Adverse Event|5|||
48673772|NCT01563172|156659514|FG000|Overall Study|Lost to Follow-up|2|||
48673773|NCT01563172|156659514|FG000|Overall Study|Other (Protocol deviation)|5|||
48673774|NCT01563172|156659514|FG000|Overall Study|Other (Not specified)|1|||
48673775|NCT01620528|156659515|FG000|Treatment Period|Did Not Receive Study Drug|0|||
48673776|NCT01620528|156659516|FG001|Treatment Period|Did Not Receive Study Drug|0|||
48673777|NCT01620528|156659517|FG002|Treatment Period|Did Not Receive Study Drug|1|||
48761255|NCT01265849|156974060|FG002|Overall Study|Not otherwise specified|1|||
48761256|NCT01265849|156974058|FG000|Overall Study|Withdrawal by Subject|25|||
48673778|NCT01620528|156659515|FG000|Treatment Period|Withdrawal by Subject|35|||
48673779|NCT01620528|156659516|FG001|Treatment Period|Withdrawal by Subject|21|||
48673780|NCT01620528|156659517|FG002|Treatment Period|Withdrawal by Subject|16|||
48673781|NCT01620528|156659515|FG000|Treatment Period|Adverse Event|17|||
48673782|NCT01620528|156659516|FG001|Treatment Period|Adverse Event|13|||
48673783|NCT01620528|156659517|FG002|Treatment Period|Adverse Event|21|||
48673784|NCT01620528|156659515|FG000|Treatment Period|Lost to Follow-up|16|||
48673785|NCT01620528|156659516|FG001|Treatment Period|Lost to Follow-up|8|||
48673786|NCT01620528|156659517|FG002|Treatment Period|Lost to Follow-up|14|||
48673787|NCT01620528|156659515|FG000|Treatment Period|Other|9|||
48673788|NCT01620528|156659516|FG001|Treatment Period|Other|5|||
48673789|NCT01620528|156659517|FG002|Treatment Period|Other|7|||
48673790|NCT01620528|156659515|FG000|Treatment Period|Subject Noncompliant|11|||
48673791|NCT01620528|156659516|FG001|Treatment Period|Subject Noncompliant|2|||
48673792|NCT01620528|156659517|FG002|Treatment Period|Subject Noncompliant|2|||
48673793|NCT01620528|156659515|FG000|Treatment Period|Pregnancy|7|||
48673794|NCT01620528|156659516|FG001|Treatment Period|Pregnancy|2|||
48673795|NCT01620528|156659517|FG002|Treatment Period|Pregnancy|2|||
48673796|NCT01620528|156659515|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
48761257|NCT01265849|156974059|FG001|Overall Study|Withdrawal by Subject|34|||
48761258|NCT01265849|156974060|FG002|Overall Study|Withdrawal by Subject|13|||
48761259|NCT03255382|156974061|FG000|Overall Study|Adverse Event|3|||
48673797|NCT01620528|156659516|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
48673798|NCT01620528|156659517|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
48673799|NCT01620528|156659515|FG000|Treatment Period|Exclusionary Medication Received|0|||
48673800|NCT01620528|156659516|FG001|Treatment Period|Exclusionary Medication Received|1|||
48673801|NCT01620528|156659517|FG002|Treatment Period|Exclusionary Medication Received|0|||
48673802|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
48673803|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
48673804|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
48673805|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
48673806|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48673807|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
48673808|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
48673809|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
48673810|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
48673811|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
48673812|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
48673813|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
48673814|NCT01620528|156659515|FG000|Post-Treatment Follow-Up Period|Other|6|||
48673815|NCT01620528|156659516|FG001|Post-Treatment Follow-Up Period|Other|4|||
48673816|NCT01620528|156659517|FG002|Post-Treatment Follow-Up Period|Other|2|||
48673817|NCT02798471|156659518|FG000|Overall Study|Adverse Event|7|||
48673818|NCT02798471|156659519|FG001|Overall Study|Adverse Event|2|||
48673819|NCT02798471|156659518|FG000|Overall Study|Physician Decision|3|||
48673820|NCT02798471|156659519|FG001|Overall Study|Physician Decision|7|||
48673821|NCT02798471|156659518|FG000|Overall Study|Death|2|||
48673822|NCT02798471|156659519|FG001|Overall Study|Death|3|||
48673823|NCT02798471|156659518|FG000|Overall Study|Lost to Follow-up|0|||
48673824|NCT02798471|156659519|FG001|Overall Study|Lost to Follow-up|1|||
48673825|NCT02798471|156659518|FG000|Overall Study|Other|5|||
48673826|NCT02798471|156659519|FG001|Overall Study|Other|3|||
48673827|NCT02798471|156659518|FG000|Overall Study|Subject withdrew consent|0|||
48673828|NCT02798471|156659519|FG001|Overall Study|Subject withdrew consent|6|||
48673829|NCT02798471|156659518|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
48673830|NCT02798471|156659519|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
48673831|NCT02798471|156659518|FG000|Overall Study|Randomized, but not treated|0|||
48673832|NCT02798471|156659519|FG001|Overall Study|Randomized, but not treated|2|||
48673833|NCT05392803|156659530|FG000|Overall Study|Lost to Follow-up|0|||
48673834|NCT05392803|156659531|FG001|Overall Study|Lost to Follow-up|2|||
48673835|NCT04294147|156659532|FG000|Overall Study|Protocol Violation|2|||
48673836|NCT04294147|156659533|FG001|Overall Study|Protocol Violation|0|||
48673837|NCT01772576|156659534|FG000|Overall Study|Death|15|||
48673838|NCT01772576|156659534|FG000|Overall Study|Protocol Violation|1|||
48673839|NCT01772576|156659534|FG000|Overall Study|Lost to Follow-up|3|||
48673840|NCT01772576|156659534|FG000|Overall Study|Study device not used|3|||
48673841|NCT01772576|156659534|FG000|Overall Study|Adverse Event|6|||
48673842|NCT01772576|156659534|FG000|Overall Study|Withdrawal by Subject|6|||
48673843|NCT00923845|156659537|FG000|Induction Therapy|Poor performance status|0|||
48673844|NCT00923845|156659538|FG001|Induction Therapy|Poor performance status|2|||
48673845|NCT00559988|156659539|FG000|Overall Study|Death|147|||
48673846|NCT00559988|156659540|FG001|Overall Study|Death|140|||
48673847|NCT00559988|156659539|FG000|Overall Study|Withdrawal by Subject|152|||
48673848|NCT00559988|156659540|FG001|Overall Study|Withdrawal by Subject|139|||
48673849|NCT00559988|156659539|FG000|Overall Study|Lost to Follow-up|42|||
48673850|NCT00559988|156659540|FG001|Overall Study|Lost to Follow-up|56|||
48673851|NCT00559988|156659539|FG000|Overall Study|ICD device explanted|10|||
48673852|NCT00559988|156659540|FG001|Overall Study|ICD device explanted|17|||
48673853|NCT02891382|156659541|FG000|Overall Study|Lost to Follow-up|3|||
48761260|NCT03255382|156974062|FG001|Overall Study|Adverse Event|0|||
48761261|NCT03255382|156974061|FG000|Overall Study|Lost to Follow-up|2|||
48761262|NCT03255382|156974062|FG001|Overall Study|Lost to Follow-up|0|||
48761263|NCT03255382|156974061|FG000|Overall Study|Withdrawal by Subject|2|||
48761264|NCT03255382|156974062|FG001|Overall Study|Withdrawal by Subject|0|||
48761265|NCT03255382|156974061|FG000|Overall Study|Other|6|||
48761266|NCT03255382|156974062|FG001|Overall Study|Other|0|||
48761267|NCT01522365|156974064|FG000|Overall Study|Withdrawal by Subject|1|||
48761268|NCT01522365|156974065|FG001|Overall Study|Withdrawal by Subject|1|||
48761269|NCT01522365|156974064|FG000|Overall Study|Lost to Follow-up|1|||
48761270|NCT01522365|156974065|FG001|Overall Study|Lost to Follow-up|1|||
48346818|NCT00505414|155466385|FG002|Titration Phase|Underlying disease and therapy required|0|||
48673854|NCT02891382|156659542|FG001|Overall Study|Lost to Follow-up|4|||
48673855|NCT02891382|156659543|FG002|Overall Study|Lost to Follow-up|5|||
48673856|NCT02891382|156659544|FG003|Overall Study|Lost to Follow-up|3|||
48673857|NCT02891382|156659545|FG004|Overall Study|Lost to Follow-up|4|||
48673858|NCT00504894|156659546|FG000|Overall Study|fMRI technical problems|1|||
48761271|NCT00673179|156974066|FG000|Overall Study|Toxicity/Complications|3|||
48346819|NCT00505414|155466386|FG003|Titration Phase|Underlying disease and therapy required|7|||
48346820|NCT00505414|155466387|FG004|Titration Phase|Underlying disease and therapy required|3|||
48346821|NCT00505414|155466383|FG000|Maintenance Phase|Adverse Event|2|||
48346822|NCT00505414|155466384|FG001|Maintenance Phase|Adverse Event|2|||
48346823|NCT00505414|155466385|FG002|Maintenance Phase|Adverse Event|3|||
48346824|NCT00505414|155466386|FG003|Maintenance Phase|Adverse Event|0|||
48346825|NCT00505414|155466387|FG004|Maintenance Phase|Adverse Event|0|||
48346826|NCT00505414|155466383|FG000|Maintenance Phase|Death|2|||
48346827|NCT00505414|155466384|FG001|Maintenance Phase|Death|0|||
48346828|NCT00505414|155466385|FG002|Maintenance Phase|Death|1|||
48346829|NCT00505414|155466386|FG003|Maintenance Phase|Death|0|||
48346830|NCT00505414|155466387|FG004|Maintenance Phase|Death|0|||
48346831|NCT00505414|155466383|FG000|Maintenance Phase|Lack of Efficacy|2|||
48346832|NCT00505414|155466384|FG001|Maintenance Phase|Lack of Efficacy|1|||
48346833|NCT00505414|155466385|FG002|Maintenance Phase|Lack of Efficacy|1|||
48346834|NCT00505414|155466386|FG003|Maintenance Phase|Lack of Efficacy|0|||
48346835|NCT00505414|155466387|FG004|Maintenance Phase|Lack of Efficacy|0|||
48346836|NCT00505414|155466383|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48346837|NCT00505414|155466384|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48346838|NCT00505414|155466385|FG002|Maintenance Phase|Withdrawal by Subject|1|||
48346839|NCT00505414|155466386|FG003|Maintenance Phase|Withdrawal by Subject|0|||
48346840|NCT00505414|155466387|FG004|Maintenance Phase|Withdrawal by Subject|0|||
48346841|NCT00505414|155466383|FG000|Maintenance Phase|underlying disease and therapy required|0|||
48346842|NCT00505414|155466384|FG001|Maintenance Phase|underlying disease and therapy required|2|||
48346843|NCT00505414|155466385|FG002|Maintenance Phase|underlying disease and therapy required|2|||
48346844|NCT00505414|155466386|FG003|Maintenance Phase|underlying disease and therapy required|0|||
48346845|NCT00505414|155466387|FG004|Maintenance Phase|underlying disease and therapy required|0|||
48346846|NCT00436956|155466390|FG000|Overall Study|Not evaluable|1|||
48346847|NCT00436956|155466391|FG001|Overall Study|Not evaluable|0|||
48346848|NCT00607997|155466392|FG000|Overall Study|Lack of Efficacy|6|||
48346849|NCT00607997|155466393|FG001|Overall Study|Lack of Efficacy|20|||
48346850|NCT00607997|155466394|FG002|Overall Study|Lack of Efficacy|14|||
48346851|NCT00607997|155466395|FG003|Overall Study|Lack of Efficacy|10|||
48346852|NCT00607997|155466392|FG000|Overall Study|Death|8|||
48346853|NCT00607997|155466393|FG001|Overall Study|Death|5|||
48346854|NCT00607997|155466394|FG002|Overall Study|Death|2|||
48346855|NCT00607997|155466395|FG003|Overall Study|Death|5|||
48346856|NCT00607997|155466392|FG000|Overall Study|Adverse Event|3|||
48346857|NCT00607997|155466393|FG001|Overall Study|Adverse Event|1|||
48346858|NCT00607997|155466394|FG002|Overall Study|Adverse Event|2|||
48346859|NCT00607997|155466395|FG003|Overall Study|Adverse Event|0|||
48346860|NCT00607997|155466392|FG000|Overall Study|Physician Decision|4|||
48346861|NCT00607997|155466393|FG001|Overall Study|Physician Decision|1|||
48346862|NCT00607997|155466394|FG002|Overall Study|Physician Decision|0|||
48346863|NCT00607997|155466395|FG003|Overall Study|Physician Decision|0|||
48346864|NCT00607997|155466392|FG000|Overall Study|Relapse, recurrent illness|4|||
48346865|NCT00607997|155466393|FG001|Overall Study|Relapse, recurrent illness|0|||
48346866|NCT00607997|155466394|FG002|Overall Study|Relapse, recurrent illness|2|||
48346867|NCT00607997|155466395|FG003|Overall Study|Relapse, recurrent illness|0|||
48346868|NCT00607997|155466392|FG000|Overall Study|Other without explanation|2|||
48346869|NCT00607997|155466393|FG001|Overall Study|Other without explanation|0|||
48346870|NCT00607997|155466394|FG002|Overall Study|Other without explanation|4|||
48346871|NCT00607997|155466395|FG003|Overall Study|Other without explanation|1|||
48346872|NCT00623363|155466396|FG000|Overall Study|Adverse Event|2|||
48346873|NCT00623363|155466397|FG001|Overall Study|Adverse Event|2|||
48346874|NCT04706793|155466398|FG000|Treatment|Disease worsening|10|||
48346875|NCT04706793|155466399|FG001|Treatment|Disease worsening|10|||
48346876|NCT04706793|155466398|FG000|Follow-up|Lack of Efficacy|1|||
48346877|NCT04706793|155466399|FG001|Follow-up|Lack of Efficacy|0|||
48346878|NCT04706793|155466398|FG000|Follow-up|Disease worsening|8|||
48346879|NCT04706793|155466399|FG001|Follow-up|Disease worsening|10|||
48346880|NCT04706793|155466398|FG000|Follow-up|Adverse Event|1|||
48346881|NCT04706793|155466399|FG001|Follow-up|Adverse Event|0|||
48673859|NCT00504894|156659547|FG001|Overall Study|fMRI technical problems|1|||
48673860|NCT00504894|156659548|FG002|Overall Study|fMRI technical problems|0|||
48673861|NCT00504894|156659546|FG000|Overall Study|Withdrawal by Subject|0|||
48673862|NCT00504894|156659547|FG001|Overall Study|Withdrawal by Subject|1|||
48673863|NCT00504894|156659548|FG002|Overall Study|Withdrawal by Subject|0|||
48673864|NCT00504894|156659546|FG000|Overall Study|Infusion technical problems|0|||
48673865|NCT00504894|156659547|FG001|Overall Study|Infusion technical problems|1|||
48346882|NCT00839332|155466400|FG000|Phase 1|Disease Progression|38|||
48346883|NCT00839332|155466401|FG001|Phase 1|Disease Progression|0|||
48346884|NCT00839332|155466402|FG002|Phase 1|Disease Progression|0|||
48346885|NCT00839332|155466400|FG000|Phase 1|Adverse Event|6|||
48346886|NCT00839332|155466401|FG001|Phase 1|Adverse Event|0|||
48346887|NCT00839332|155466402|FG002|Phase 1|Adverse Event|0|||
48346888|NCT00839332|155466400|FG000|Phase 1|Withdrawal by Subject|4|||
48346889|NCT00839332|155466401|FG001|Phase 1|Withdrawal by Subject|0|||
48673866|NCT00504894|156659548|FG002|Overall Study|Infusion technical problems|0|||
48346890|NCT00839332|155466402|FG002|Phase 1|Withdrawal by Subject|0|||
48346891|NCT00839332|155466400|FG000|Phase 1|Physician Decision|2|||
48346892|NCT00839332|155466401|FG001|Phase 1|Physician Decision|0|||
48346893|NCT00839332|155466402|FG002|Phase 1|Physician Decision|0|||
48346894|NCT00839332|155466400|FG000|Phase 2|Protocol Violation|0|||
48346895|NCT00839332|155466401|FG001|Phase 2|Protocol Violation|1|||
48346896|NCT00839332|155466402|FG002|Phase 2|Protocol Violation|0|||
48346897|NCT00839332|155466400|FG000|Phase 2|Disease Progression|0|||
48346898|NCT00839332|155466401|FG001|Phase 2|Disease Progression|46|||
48346899|NCT00839332|155466402|FG002|Phase 2|Disease Progression|21|||
48346900|NCT00839332|155466400|FG000|Phase 2|Adverse Event|0|||
48346901|NCT00839332|155466401|FG001|Phase 2|Adverse Event|8|||
48346902|NCT00839332|155466402|FG002|Phase 2|Adverse Event|6|||
48346903|NCT00839332|155466400|FG000|Phase 2|Death|0|||
48346904|NCT00839332|155466401|FG001|Phase 2|Death|4|||
48346905|NCT00839332|155466402|FG002|Phase 2|Death|2|||
48346906|NCT00839332|155466400|FG000|Phase 2|Withdrawal by Subject|0|||
48346907|NCT00839332|155466401|FG001|Phase 2|Withdrawal by Subject|5|||
48346908|NCT00839332|155466402|FG002|Phase 2|Withdrawal by Subject|8|||
48673867|NCT00504894|156659546|FG000|Overall Study|poor subject data|2|||
48673868|NCT00504894|156659547|FG001|Overall Study|poor subject data|0|||
48673869|NCT00504894|156659548|FG002|Overall Study|poor subject data|0|||
48673870|NCT03244826|156659550|FG000|Overall Study|Withdrawal by Subject|2|||
48673871|NCT03244826|156659551|FG001|Overall Study|Withdrawal by Subject|0|||
48673872|NCT03244826|156659550|FG000|Overall Study|Transplant delayed or withdrawn|12|||
48673873|NCT03244826|156659551|FG001|Overall Study|Transplant delayed or withdrawn|10|||
48673874|NCT02673684|156659554|FG000|Overall Study|Study not completed d/t loss of funding|9|||
48673875|NCT02673684|156659555|FG001|Overall Study|Study not completed d/t loss of funding|8|||
48673876|NCT02678923|156659556|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
48673877|NCT02678923|156659557|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
48673878|NCT02678923|156659556|FG000|Overall Study|Withdrawal by Subject|3|||
48673879|NCT02678923|156659557|FG001|Overall Study|Withdrawal by Subject|2|||
48673880|NCT02678923|156659556|FG000|Overall Study|Lost to Follow-up|1|||
48673881|NCT02678923|156659557|FG001|Overall Study|Lost to Follow-up|0|||
48673882|NCT02678923|156659556|FG000|Overall Study|Did Not Return for Study Visits|1|||
48673883|NCT02678923|156659557|FG001|Overall Study|Did Not Return for Study Visits|0|||
48673884|NCT04356040|156659558|FG000|Overall Study|Death|2|||
48673885|NCT04356040|156659559|FG001|Overall Study|Death|0|||
48673886|NCT04356040|156659558|FG000|Overall Study|Lost to Follow-up|1|||
48346909|NCT00839332|155466400|FG000|Phase 2|Physician Decision|0|||
48346910|NCT00839332|155466401|FG001|Phase 2|Physician Decision|4|||
48346911|NCT00839332|155466402|FG002|Phase 2|Physician Decision|1|||
48346912|NCT00839332|155466400|FG000|Phase 2|Lost to Follow-up|0|||
48346913|NCT00839332|155466401|FG001|Phase 2|Lost to Follow-up|0|||
48673887|NCT04356040|156659559|FG001|Overall Study|Lost to Follow-up|0|||
48673888|NCT04356040|156659558|FG000|Overall Study|Physician Decision|0|||
48673889|NCT04356040|156659559|FG001|Overall Study|Physician Decision|1|||
48673890|NCT04356040|156659558|FG000|Overall Study|Withdrawal by Subject|13|||
48673891|NCT04356040|156659559|FG001|Overall Study|Withdrawal by Subject|1|||
48673892|NCT04356040|156659558|FG000|Overall Study|Enrollment Pause|10|||
48673893|NCT04356040|156659559|FG001|Overall Study|Enrollment Pause|0|||
48673894|NCT04356040|156659558|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
48673895|NCT04356040|156659559|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
48346914|NCT00839332|155466402|FG002|Phase 2|Lost to Follow-up|1|||
48346915|NCT01930214|155466403|FG000|Overall Study|Death|4|||
48346916|NCT01930214|155466404|FG001|Overall Study|Death|4|||
48346917|NCT01930214|155466405|FG002|Overall Study|Death|11|||
48346918|NCT01930214|155466403|FG000|Overall Study|Lost to Follow-up|12|||
48346919|NCT01930214|155466404|FG001|Overall Study|Lost to Follow-up|13|||
48346920|NCT01930214|155466405|FG002|Overall Study|Lost to Follow-up|12|||
48346921|NCT01930214|155466403|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
48346922|NCT01930214|155466404|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
48673896|NCT04356040|156659558|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
48673897|NCT04356040|156659559|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
48673898|NCT04356040|156659558|FG000|Overall Study|PI left institution|3|||
48673899|NCT04356040|156659559|FG001|Overall Study|PI left institution|0|||
48673900|NCT02828020|156659560|FG000|Treatment Period|Adverse Event|3|||
48673901|NCT02828020|156659561|FG001|Treatment Period|Adverse Event|1|||
48673902|NCT02828020|156659562|FG002|Treatment Period|Adverse Event|1|||
48346923|NCT01930214|155466405|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
48346924|NCT01930214|155466403|FG000|Overall Study|Physician Decision|2|||
48346925|NCT01930214|155466404|FG001|Overall Study|Physician Decision|0|||
48346926|NCT01930214|155466405|FG002|Overall Study|Physician Decision|0|||
48346927|NCT02062645|155466406|FG000|Overall Study|Adverse Event|2|||
48346928|NCT02062645|155466406|FG000|Overall Study|Protocol Violation|8|||
48346929|NCT02062645|155466406|FG000|Overall Study|Lost to Follow-up|5|||
48346930|NCT03589300|155466407|FG000|Overall Study|Adverse Event|2|||
48346931|NCT03589300|155466407|FG000|Overall Study|Death|4|||
48346932|NCT03589300|155466407|FG000|Overall Study|Lost to Follow-up|12|||
48346933|NCT03589300|155466407|FG000|Overall Study|Withdrawal by Subject|5|||
48346934|NCT04947436|155466408|FG000|Overall Study|Lost to Follow-up|3|||
48346935|NCT04947436|155466409|FG001|Overall Study|Lost to Follow-up|7|||
48346936|NCT04947436|155466410|FG002|Overall Study|Lost to Follow-up|5|||
48673903|NCT02828020|156659560|FG000|Treatment Period|Withdrawal of Consent|10|||
48346937|NCT04947436|155466408|FG000|Overall Study|Death|1|||
48346938|NCT04947436|155466409|FG001|Overall Study|Death|1|||
48346939|NCT04947436|155466410|FG002|Overall Study|Death|1|||
48346940|NCT00087555|155466414|FG000|Overall Study|Adverse Event|3|||
48346941|NCT00087555|155466415|FG001|Overall Study|Adverse Event|6|||
48346942|NCT00087555|155466416|FG002|Overall Study|Adverse Event|14|||
48346943|NCT00087555|155466414|FG000|Overall Study|Lost to Follow-up|0|||
48346944|NCT00087555|155466415|FG001|Overall Study|Lost to Follow-up|1|||
48346945|NCT00087555|155466416|FG002|Overall Study|Lost to Follow-up|1|||
48346946|NCT00087555|155466414|FG000|Overall Study|Non - Compliance|1|||
48346947|NCT00087555|155466415|FG001|Overall Study|Non - Compliance|0|||
48346948|NCT00087555|155466416|FG002|Overall Study|Non - Compliance|0|||
48346949|NCT00087555|155466414|FG000|Overall Study|Protocol Violation|0|||
48346950|NCT00087555|155466415|FG001|Overall Study|Protocol Violation|0|||
48346951|NCT00087555|155466416|FG002|Overall Study|Protocol Violation|2|||
48346952|NCT00087555|155466414|FG000|Overall Study|Screen Failure|1|||
48346953|NCT00087555|155466415|FG001|Overall Study|Screen Failure|1|||
48346954|NCT00087555|155466416|FG002|Overall Study|Screen Failure|0|||
48346955|NCT00087555|155466414|FG000|Overall Study|Pregnancy|0|||
48346956|NCT00087555|155466415|FG001|Overall Study|Pregnancy|1|||
48346957|NCT00087555|155466416|FG002|Overall Study|Pregnancy|1|||
48346958|NCT00087555|155466414|FG000|Overall Study|Withdrawal by Subject|3|||
48346959|NCT00087555|155466415|FG001|Overall Study|Withdrawal by Subject|2|||
48346960|NCT00087555|155466416|FG002|Overall Study|Withdrawal by Subject|1|||
48346961|NCT00087555|155466414|FG000|Overall Study|Lack of Efficacy|2|||
48346962|NCT00087555|155466415|FG001|Overall Study|Lack of Efficacy|0|||
48346963|NCT00087555|155466416|FG002|Overall Study|Lack of Efficacy|1|||
48346964|NCT00087555|155466414|FG000|Overall Study|Non Compliance|0|||
48346965|NCT00087555|155466415|FG001|Overall Study|Non Compliance|0|||
48346966|NCT00087555|155466416|FG002|Overall Study|Non Compliance|1|||
48346967|NCT00087555|155466414|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
48346968|NCT00087555|155466415|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
48346969|NCT00087555|155466416|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
48346970|NCT00087555|155466414|FG000|Overall Study|Patient wanted to go back on Med|1|||
48346971|NCT00087555|155466415|FG001|Overall Study|Patient wanted to go back on Med|0|||
48346972|NCT00087555|155466416|FG002|Overall Study|Patient wanted to go back on Med|0|||
48346973|NCT03772613|155466417|FG000|Overall Study|Lost to Follow-up|0|||
48346974|NCT03772613|155466418|FG001|Overall Study|Lost to Follow-up|1|||
48346975|NCT03772613|155466419|FG002|Overall Study|Lost to Follow-up|1|||
48346976|NCT01349036|155466421|FG000|Overall Study|Disease progression|13|||
48346977|NCT01349036|155466422|FG001|Overall Study|Disease progression|22|||
48346978|NCT01349036|155466421|FG000|Overall Study|Other|1|||
48346979|NCT01349036|155466422|FG001|Overall Study|Other|0|||
48346980|NCT01349036|155466421|FG000|Overall Study|Withdrawal by Subject|0|||
48346981|NCT01349036|155466422|FG001|Overall Study|Withdrawal by Subject|2|||
48346982|NCT03796208|155466423|FG000|Overall Study|Withdrawal by Subject|3|||
48346983|NCT03796208|155466424|FG001|Overall Study|Withdrawal by Subject|0|||
48346984|NCT03796208|155466423|FG000|Overall Study|Loss of pregnancy|1|||
48346985|NCT03796208|155466424|FG001|Overall Study|Loss of pregnancy|1|||
48346986|NCT03796208|155466423|FG000|Overall Study|Changed prenatal clinics|0|||
48346987|NCT03796208|155466424|FG001|Overall Study|Changed prenatal clinics|5|||
48346988|NCT03796208|155466423|FG000|Overall Study|Lost to Follow-up|20|||
48346989|NCT03796208|155466424|FG001|Overall Study|Lost to Follow-up|16|||
48346990|NCT01891890|155466425|FG000|Overall Study|Lost to Follow-up|0|||
48346991|NCT01891890|155466426|FG001|Overall Study|Lost to Follow-up|0|||
48673904|NCT02828020|156659561|FG001|Treatment Period|Withdrawal of Consent|14|||
48673905|NCT02828020|156659562|FG002|Treatment Period|Withdrawal of Consent|9|||
48673906|NCT02828020|156659560|FG000|Treatment Period|Lost to Follow-up|21|||
48673907|NCT02828020|156659561|FG001|Treatment Period|Lost to Follow-up|24|||
48673908|NCT02828020|156659562|FG002|Treatment Period|Lost to Follow-up|18|||
48673909|NCT02828020|156659560|FG000|Treatment Period|Lack of Qualifying Event|44|||
48673910|NCT02828020|156659561|FG001|Treatment Period|Lack of Qualifying Event|53|||
48673911|NCT02828020|156659562|FG002|Treatment Period|Lack of Qualifying Event|43|||
48346992|NCT01891890|155466427|FG002|Overall Study|Lost to Follow-up|1|||
48346993|NCT01891890|155466425|FG000|Overall Study|Study ended before endpoint reached|7|||
48346994|NCT01891890|155466426|FG001|Overall Study|Study ended before endpoint reached|3|||
48346995|NCT01891890|155466427|FG002|Overall Study|Study ended before endpoint reached|6|||
48346996|NCT00661713|155466428|FG000|Overall Study|Death|1|||
48346997|NCT00661713|155466429|FG001|Overall Study|Death|0|||
48346998|NCT00661713|155466430|FG002|Overall Study|Death|0|||
48346999|NCT00661713|155466431|FG003|Overall Study|Death|0|||
48347000|NCT00661713|155466432|FG004|Overall Study|Death|1|||
48673912|NCT02828020|156659560|FG000|Treatment Period|Pregnancy|0|||
48673913|NCT02828020|156659561|FG001|Treatment Period|Pregnancy|2|||
48673914|NCT02828020|156659562|FG002|Treatment Period|Pregnancy|0|||
48673915|NCT02828020|156659560|FG000|Treatment Period|Protocol Violation|2|||
48673916|NCT02828020|156659561|FG001|Treatment Period|Protocol Violation|4|||
48673917|NCT02828020|156659562|FG002|Treatment Period|Protocol Violation|7|||
48673918|NCT02828020|156659560|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
48673919|NCT02828020|156659561|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
48673920|NCT02828020|156659562|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
48673921|NCT02828020|156659560|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
48673922|NCT02828020|156659561|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
48673923|NCT02828020|156659562|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
48673924|NCT02828020|156659560|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
48673925|NCT02828020|156659561|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
48673926|NCT02828020|156659562|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
48673927|NCT02828020|156659560|FG000|Safety Follow-up Period|Protocol Violation|0|||
48673928|NCT02828020|156659561|FG001|Safety Follow-up Period|Protocol Violation|2|||
48673929|NCT02828020|156659562|FG002|Safety Follow-up Period|Protocol Violation|1|||
48673930|NCT02828020|156659560|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
48673931|NCT02828020|156659561|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
48673932|NCT02828020|156659562|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
48673933|NCT01008904|156659563|FG000|Overall Study|Lost to Follow-up|1|||
48673934|NCT01008904|156659563|FG000|Overall Study|Adverse Event|2|||
48673935|NCT01008904|156659563|FG000|Overall Study|unexpected unrelated surgery|1|||
48673936|NCT00788710|156659564|FG000|Overall Study|Adverse Event|1|||
48673937|NCT00788710|156659565|FG001|Overall Study|Adverse Event|3|||
48673938|NCT00788710|156659566|FG002|Overall Study|Adverse Event|4|||
48673939|NCT00788710|156659564|FG000|Overall Study|Lack of Efficacy|0|||
48673940|NCT00788710|156659565|FG001|Overall Study|Lack of Efficacy|0|||
48673941|NCT00788710|156659566|FG002|Overall Study|Lack of Efficacy|1|||
48673942|NCT00788710|156659564|FG000|Overall Study|Lost to Follow-up|0|||
48673943|NCT00788710|156659565|FG001|Overall Study|Lost to Follow-up|1|||
48673944|NCT00788710|156659566|FG002|Overall Study|Lost to Follow-up|0|||
48673945|NCT00788710|156659564|FG000|Overall Study|Physician Decision|2|||
48673946|NCT00788710|156659565|FG001|Overall Study|Physician Decision|1|||
48347001|NCT00661713|155466433|FG005|Overall Study|Death|0|||
48347002|NCT00661713|155466434|FG006|Overall Study|Death|0|||
48347003|NCT00661713|155466435|FG007|Overall Study|Death|0|||
48347004|NCT00661713|155466428|FG000|Overall Study|Unable to Classify|1|||
48347005|NCT00661713|155466429|FG001|Overall Study|Unable to Classify|0|||
48347006|NCT00661713|155466430|FG002|Overall Study|Unable to Classify|0|||
48347007|NCT00661713|155466431|FG003|Overall Study|Unable to Classify|0|||
48347008|NCT00661713|155466432|FG004|Overall Study|Unable to Classify|0|||
48347009|NCT00661713|155466433|FG005|Overall Study|Unable to Classify|0|||
48347010|NCT00661713|155466434|FG006|Overall Study|Unable to Classify|0|||
48347011|NCT00661713|155466435|FG007|Overall Study|Unable to Classify|0|||
48347012|NCT00661713|155466428|FG000|Overall Study|Protocol Violation|1|||
48347013|NCT00661713|155466429|FG001|Overall Study|Protocol Violation|6|||
48347014|NCT00661713|155466430|FG002|Overall Study|Protocol Violation|3|||
48347015|NCT00661713|155466431|FG003|Overall Study|Protocol Violation|3|||
48347016|NCT00661713|155466432|FG004|Overall Study|Protocol Violation|0|||
48347017|NCT00661713|155466433|FG005|Overall Study|Protocol Violation|2|||
48347018|NCT00661713|155466434|FG006|Overall Study|Protocol Violation|2|||
48347019|NCT00661713|155466435|FG007|Overall Study|Protocol Violation|1|||
48347020|NCT00661713|155466428|FG000|Overall Study|Withdrawal by Subject|11|||
48347021|NCT00661713|155466429|FG001|Overall Study|Withdrawal by Subject|25|||
48347022|NCT00661713|155466430|FG002|Overall Study|Withdrawal by Subject|12|||
48347023|NCT00661713|155466431|FG003|Overall Study|Withdrawal by Subject|21|||
48347024|NCT00661713|155466432|FG004|Overall Study|Withdrawal by Subject|12|||
48347025|NCT00661713|155466433|FG005|Overall Study|Withdrawal by Subject|26|||
48347026|NCT00661713|155466434|FG006|Overall Study|Withdrawal by Subject|45|||
48347027|NCT00661713|155466435|FG007|Overall Study|Withdrawal by Subject|9|||
48347028|NCT00661713|155466428|FG000|Overall Study|Lost to Follow-up|2|||
48347029|NCT00661713|155466429|FG001|Overall Study|Lost to Follow-up|7|||
48347030|NCT00661713|155466430|FG002|Overall Study|Lost to Follow-up|2|||
48347031|NCT00661713|155466431|FG003|Overall Study|Lost to Follow-up|2|||
48347032|NCT00661713|155466432|FG004|Overall Study|Lost to Follow-up|5|||
48347033|NCT00661713|155466433|FG005|Overall Study|Lost to Follow-up|7|||
48347034|NCT00661713|155466434|FG006|Overall Study|Lost to Follow-up|14|||
48347035|NCT00661713|155466435|FG007|Overall Study|Lost to Follow-up|1|||
48347036|NCT00661713|155466428|FG000|Overall Study|Administrative Reason|0|||
48347037|NCT00661713|155466429|FG001|Overall Study|Administrative Reason|1|||
48347038|NCT00661713|155466430|FG002|Overall Study|Administrative Reason|0|||
48347039|NCT00661713|155466431|FG003|Overall Study|Administrative Reason|2|||
48347040|NCT00661713|155466432|FG004|Overall Study|Administrative Reason|2|||
48347041|NCT00661713|155466433|FG005|Overall Study|Administrative Reason|2|||
48347042|NCT00661713|155466434|FG006|Overall Study|Administrative Reason|1|||
48347043|NCT00661713|155466435|FG007|Overall Study|Administrative Reason|0|||
48347044|NCT00661713|155466428|FG000|Overall Study|Adverse Event|0|||
48347045|NCT00661713|155466429|FG001|Overall Study|Adverse Event|0|||
48347046|NCT00661713|155466430|FG002|Overall Study|Adverse Event|0|||
48347047|NCT00661713|155466431|FG003|Overall Study|Adverse Event|0|||
48347048|NCT00661713|155466432|FG004|Overall Study|Adverse Event|0|||
48673947|NCT00788710|156659566|FG002|Overall Study|Physician Decision|0|||
48347049|NCT00661713|155466433|FG005|Overall Study|Adverse Event|0|||
48347050|NCT00661713|155466434|FG006|Overall Study|Adverse Event|1|||
48347051|NCT00661713|155466435|FG007|Overall Study|Adverse Event|0|||
48673948|NCT00788710|156659564|FG000|Overall Study|Protocol Violation|0|||
48673949|NCT00788710|156659565|FG001|Overall Study|Protocol Violation|1|||
48673950|NCT00788710|156659566|FG002|Overall Study|Protocol Violation|1|||
48673951|NCT00788710|156659564|FG000|Overall Study|Withdrawal by Subject|2|||
48673952|NCT00788710|156659565|FG001|Overall Study|Withdrawal by Subject|2|||
48673953|NCT00788710|156659566|FG002|Overall Study|Withdrawal by Subject|0|||
48673954|NCT01183065|156659567|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
48673955|NCT01008449|156659569|FG000|Overall Study|Lost to Follow-up|29|||
48673956|NCT01008449|156659570|FG001|Overall Study|Lost to Follow-up|19|||
48673957|NCT01717326|156659571|FG000|Overall Study|Death|0|||
48673958|NCT01717326|156659572|FG001|Overall Study|Death|0|||
48673959|NCT01717326|156659573|FG002|Overall Study|Death|0|||
48673960|NCT01717326|156659574|FG003|Overall Study|Death|0|||
48673961|NCT01717326|156659575|FG004|Overall Study|Death|0|||
48347052|NCT00661713|155466428|FG000|Overall Study|Inappropriate Enrollment|0|||
48347053|NCT00661713|155466429|FG001|Overall Study|Inappropriate Enrollment|0|||
48673962|NCT01717326|156659576|FG005|Overall Study|Death|0|||
48673963|NCT01717326|156659577|FG006|Overall Study|Death|0|||
48673964|NCT01717326|156659578|FG007|Overall Study|Death|0|||
48347054|NCT00661713|155466430|FG002|Overall Study|Inappropriate Enrollment|0|||
48347055|NCT00661713|155466431|FG003|Overall Study|Inappropriate Enrollment|0|||
48347056|NCT00661713|155466432|FG004|Overall Study|Inappropriate Enrollment|0|||
48347057|NCT00661713|155466433|FG005|Overall Study|Inappropriate Enrollment|0|||
48347058|NCT00661713|155466434|FG006|Overall Study|Inappropriate Enrollment|1|||
48347059|NCT00661713|155466435|FG007|Overall Study|Inappropriate Enrollment|0|||
48673965|NCT01717326|156659579|FG008|Overall Study|Death|0|||
48673966|NCT01717326|156659580|FG009|Overall Study|Death|0|||
48673967|NCT01717326|156659581|FG010|Overall Study|Death|1|||
48673968|NCT01717326|156659582|FG011|Overall Study|Death|0|||
48673969|NCT01717326|156659583|FG012|Overall Study|Death|0|||
48673970|NCT01717326|156659584|FG013|Overall Study|Death|0|||
48673971|NCT01717326|156659585|FG014|Overall Study|Death|0|||
48673972|NCT01717326|156659586|FG015|Overall Study|Death|0|||
48673973|NCT01717326|156659587|FG016|Overall Study|Death|0|||
48673974|NCT01717326|156659588|FG017|Overall Study|Death|0|||
48673975|NCT01717326|156659589|FG018|Overall Study|Death|0|||
48673976|NCT01717326|156659590|FG019|Overall Study|Death|0|||
48673977|NCT01717326|156659571|FG000|Overall Study|Lost to Follow-up|3|||
48673978|NCT01717326|156659572|FG001|Overall Study|Lost to Follow-up|0|||
48673979|NCT01717326|156659573|FG002|Overall Study|Lost to Follow-up|0|||
48673980|NCT01717326|156659574|FG003|Overall Study|Lost to Follow-up|2|||
48673981|NCT01717326|156659575|FG004|Overall Study|Lost to Follow-up|1|||
48673982|NCT01717326|156659576|FG005|Overall Study|Lost to Follow-up|0|||
48673983|NCT01717326|156659577|FG006|Overall Study|Lost to Follow-up|1|||
48673984|NCT01717326|156659578|FG007|Overall Study|Lost to Follow-up|0|||
48673985|NCT01717326|156659579|FG008|Overall Study|Lost to Follow-up|0|||
48673986|NCT01717326|156659580|FG009|Overall Study|Lost to Follow-up|0|||
48673987|NCT01717326|156659581|FG010|Overall Study|Lost to Follow-up|1|||
48673988|NCT01717326|156659582|FG011|Overall Study|Lost to Follow-up|0|||
48673989|NCT01717326|156659583|FG012|Overall Study|Lost to Follow-up|0|||
48673990|NCT01717326|156659584|FG013|Overall Study|Lost to Follow-up|0|||
48673991|NCT01717326|156659585|FG014|Overall Study|Lost to Follow-up|0|||
48673992|NCT01717326|156659586|FG015|Overall Study|Lost to Follow-up|2|||
48673993|NCT01717326|156659587|FG016|Overall Study|Lost to Follow-up|1|||
48673994|NCT01717326|156659588|FG017|Overall Study|Lost to Follow-up|0|||
48673995|NCT01717326|156659589|FG018|Overall Study|Lost to Follow-up|2|||
48673996|NCT01717326|156659590|FG019|Overall Study|Lost to Follow-up|3|||
48673997|NCT01717326|156659571|FG000|Overall Study|Physician Decision|0|||
48673998|NCT01717326|156659572|FG001|Overall Study|Physician Decision|0|||
48673999|NCT01717326|156659573|FG002|Overall Study|Physician Decision|0|||
48674000|NCT01717326|156659574|FG003|Overall Study|Physician Decision|0|||
48674001|NCT01717326|156659575|FG004|Overall Study|Physician Decision|0|||
48674002|NCT01717326|156659576|FG005|Overall Study|Physician Decision|0|||
48674003|NCT01717326|156659577|FG006|Overall Study|Physician Decision|0|||
48674004|NCT01717326|156659578|FG007|Overall Study|Physician Decision|0|||
48674005|NCT01717326|156659579|FG008|Overall Study|Physician Decision|0|||
48674006|NCT01717326|156659580|FG009|Overall Study|Physician Decision|1|||
48674007|NCT01717326|156659581|FG010|Overall Study|Physician Decision|0|||
48674008|NCT01717326|156659582|FG011|Overall Study|Physician Decision|0|||
48674009|NCT01717326|156659583|FG012|Overall Study|Physician Decision|0|||
48674010|NCT01717326|156659584|FG013|Overall Study|Physician Decision|0|||
48674011|NCT01717326|156659585|FG014|Overall Study|Physician Decision|0|||
48674012|NCT01717326|156659586|FG015|Overall Study|Physician Decision|0|||
48674013|NCT01717326|156659587|FG016|Overall Study|Physician Decision|0|||
48674014|NCT01717326|156659588|FG017|Overall Study|Physician Decision|0|||
48674015|NCT01717326|156659589|FG018|Overall Study|Physician Decision|0|||
48674016|NCT01717326|156659590|FG019|Overall Study|Physician Decision|0|||
48674017|NCT01717326|156659571|FG000|Overall Study|Protocol Violation|0|||
48674018|NCT01717326|156659572|FG001|Overall Study|Protocol Violation|0|||
48674019|NCT01717326|156659573|FG002|Overall Study|Protocol Violation|0|||
48674020|NCT01717326|156659574|FG003|Overall Study|Protocol Violation|0|||
48674021|NCT01717326|156659575|FG004|Overall Study|Protocol Violation|1|||
48674022|NCT01717326|156659576|FG005|Overall Study|Protocol Violation|0|||
48674023|NCT01717326|156659577|FG006|Overall Study|Protocol Violation|0|||
48674024|NCT01717326|156659578|FG007|Overall Study|Protocol Violation|0|||
48674025|NCT01717326|156659579|FG008|Overall Study|Protocol Violation|0|||
48674026|NCT01717326|156659580|FG009|Overall Study|Protocol Violation|0|||
48674027|NCT01717326|156659581|FG010|Overall Study|Protocol Violation|0|||
48674028|NCT01717326|156659582|FG011|Overall Study|Protocol Violation|0|||
48674029|NCT01717326|156659583|FG012|Overall Study|Protocol Violation|0|||
48674030|NCT01717326|156659584|FG013|Overall Study|Protocol Violation|0|||
48674031|NCT01717326|156659585|FG014|Overall Study|Protocol Violation|0|||
48674032|NCT01717326|156659586|FG015|Overall Study|Protocol Violation|0|||
48674033|NCT01717326|156659587|FG016|Overall Study|Protocol Violation|0|||
48674034|NCT01717326|156659588|FG017|Overall Study|Protocol Violation|0|||
48674035|NCT01717326|156659589|FG018|Overall Study|Protocol Violation|0|||
48674036|NCT01717326|156659590|FG019|Overall Study|Protocol Violation|0|||
48674037|NCT01717326|156659571|FG000|Overall Study|Withdrawal by Subject|0|||
48674038|NCT01717326|156659572|FG001|Overall Study|Withdrawal by Subject|1|||
48674039|NCT01717326|156659573|FG002|Overall Study|Withdrawal by Subject|0|||
48674040|NCT01717326|156659574|FG003|Overall Study|Withdrawal by Subject|0|||
48674041|NCT01717326|156659575|FG004|Overall Study|Withdrawal by Subject|0|||
48674042|NCT01717326|156659576|FG005|Overall Study|Withdrawal by Subject|0|||
48674043|NCT01717326|156659577|FG006|Overall Study|Withdrawal by Subject|0|||
48674044|NCT01717326|156659578|FG007|Overall Study|Withdrawal by Subject|0|||
48674045|NCT01717326|156659579|FG008|Overall Study|Withdrawal by Subject|0|||
48674046|NCT01717326|156659580|FG009|Overall Study|Withdrawal by Subject|1|||
48674047|NCT01717326|156659581|FG010|Overall Study|Withdrawal by Subject|0|||
48674048|NCT01717326|156659582|FG011|Overall Study|Withdrawal by Subject|0|||
48674049|NCT01717326|156659583|FG012|Overall Study|Withdrawal by Subject|1|||
48674050|NCT01717326|156659584|FG013|Overall Study|Withdrawal by Subject|0|||
48674051|NCT01717326|156659585|FG014|Overall Study|Withdrawal by Subject|0|||
48674052|NCT01717326|156659586|FG015|Overall Study|Withdrawal by Subject|1|||
48674053|NCT01717326|156659587|FG016|Overall Study|Withdrawal by Subject|0|||
48347060|NCT01215032|155466438|FG000|Overall Study|Adverse Event|3|||
48347061|NCT01215032|155466438|FG000|Overall Study|Lack of Efficacy|17|||
48347062|NCT01125566|155466439|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
48347063|NCT01125566|155466440|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
48674054|NCT01717326|156659588|FG017|Overall Study|Withdrawal by Subject|0|||
48674055|NCT01717326|156659589|FG018|Overall Study|Withdrawal by Subject|2|||
48674056|NCT01717326|156659590|FG019|Overall Study|Withdrawal by Subject|3|||
48674057|NCT01123707|156659591|FG000|Overall Study|Lost to Follow-up|3|||
48674058|NCT01123707|156659592|FG001|Overall Study|Lost to Follow-up|1|||
48674059|NCT01123707|156659593|FG002|Overall Study|Lost to Follow-up|3|||
48674060|NCT01123707|156659594|FG003|Overall Study|Lost to Follow-up|2|||
48674061|NCT01123707|156659591|FG000|Overall Study|Adverse Event|5|||
48674062|NCT01123707|156659592|FG001|Overall Study|Adverse Event|7|||
48674063|NCT01123707|156659593|FG002|Overall Study|Adverse Event|5|||
48674064|NCT01123707|156659594|FG003|Overall Study|Adverse Event|3|||
48674065|NCT01123707|156659591|FG000|Overall Study|Sponsor Discontinued Study|30|||
48674066|NCT01123707|156659592|FG001|Overall Study|Sponsor Discontinued Study|24|||
48761272|NCT00673179|156974067|FG001|Overall Study|Toxicity/Complications|0|||
48761273|NCT00281684|156974070|FG000|Overall Study|Lost to Follow-up|0|||
48761274|NCT00281684|156974071|FG001|Overall Study|Lost to Follow-up|0|||
48761275|NCT00281684|156974072|FG002|Overall Study|Lost to Follow-up|1|||
48761276|NCT00281684|156974073|FG003|Overall Study|Lost to Follow-up|0|||
48761277|NCT00281684|156974070|FG000|Overall Study|Withdrawal by Subject|1|||
48761278|NCT00281684|156974071|FG001|Overall Study|Withdrawal by Subject|0|||
48761279|NCT00281684|156974072|FG002|Overall Study|Withdrawal by Subject|0|||
48761280|NCT00281684|156974073|FG003|Overall Study|Withdrawal by Subject|0|||
48761281|NCT01536379|156975597|FG000|Overall Study|Adverse Event|1|||
48761282|NCT01536379|156975598|FG001|Overall Study|Adverse Event|2|||
48761283|NCT01536379|156975597|FG000|Overall Study|Withdrawal by Subject|1|||
48761284|NCT01536379|156975598|FG001|Overall Study|Withdrawal by Subject|1|||
48761285|NCT02081690|156975599|FG000|Overall Study|Death|3|||
48761286|NCT02081690|156975599|FG000|Overall Study|Physician Decision|3|||
48761287|NCT02081690|156975599|FG000|Overall Study|Withdrawal by Subject|1|||
48761288|NCT01852942|156975606|FG000|Overall Study|Physician Decision|1|||
48761289|NCT01852942|156975607|FG001|Overall Study|Physician Decision|0|||
48761290|NCT01852942|156975606|FG000|Overall Study|Death|1|||
48761291|NCT01852942|156975607|FG001|Overall Study|Death|1|||
48761292|NCT01852942|156975606|FG000|Overall Study|Withdrawal by Subject|2|||
48761293|NCT01852942|156975607|FG001|Overall Study|Withdrawal by Subject|3|||
48761294|NCT01852942|156975606|FG000|Overall Study|Lost to Follow-up|1|||
48761295|NCT01852942|156975607|FG001|Overall Study|Lost to Follow-up|2|||
48761296|NCT03025542|156975609|FG000|Overall Study|Adverse Event|0|||
48761297|NCT03025542|156975610|FG001|Overall Study|Adverse Event|2|||
48761298|NCT03025542|156975609|FG000|Overall Study|Lost to Follow-up|1|||
48761299|NCT03025542|156975610|FG001|Overall Study|Lost to Follow-up|0|||
48347064|NCT01125566|155466441|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
48347065|NCT01125566|155466439|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
48347066|NCT01125566|155466440|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
48347067|NCT01125566|155466441|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
48761300|NCT03025542|156975609|FG000|Overall Study|Withdrawal by Subject|1|||
48761301|NCT03025542|156975610|FG001|Overall Study|Withdrawal by Subject|0|||
48761302|NCT00415909|156975611|FG000|Overall Study|Withdrawal by Subject|2|||
48347068|NCT01125566|155466439|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
48347069|NCT01125566|155466440|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
48347070|NCT01125566|155466441|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
48347071|NCT01125566|155466439|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
48347072|NCT01125566|155466440|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
48347073|NCT01125566|155466441|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
48347074|NCT01125566|155466439|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
48383957|NCT04029116|155601517|FG001|Overall Study|Physician Decision|0|||
48674067|NCT01123707|156659593|FG002|Overall Study|Sponsor Discontinued Study|25|||
48761303|NCT00415909|156975611|FG000|Overall Study|Death|1|||
48761304|NCT00702403|156975612|FG000|From Consent to Engraftment|Progressive leukemia|6|||
48761305|NCT00702403|156975612|FG000|From Consent to Engraftment|Critically ill|2|||
48674068|NCT01123707|156659594|FG003|Overall Study|Sponsor Discontinued Study|40|||
48761306|NCT00702403|156975612|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
48761307|NCT00702403|156975612|FG000|From Consent to Engraftment|Myocardial infarction|1|||
48761308|NCT00702403|156975612|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
48347075|NCT01125566|155466440|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
48347076|NCT01125566|155466441|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
48347077|NCT01125566|155466439|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
48347078|NCT01125566|155466440|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
48347079|NCT01125566|155466441|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
48347080|NCT01125566|155466439|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
48347081|NCT01125566|155466440|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
48347082|NCT01125566|155466441|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
48347083|NCT01125566|155466439|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
48347084|NCT01125566|155466440|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
48347085|NCT01125566|155466441|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
48347086|NCT01125566|155466439|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
48347087|NCT01125566|155466440|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
48347088|NCT01125566|155466441|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
48347089|NCT01125566|155466439|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
48347090|NCT01125566|155466440|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
48347091|NCT01125566|155466441|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
48347092|NCT01125566|155466439|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
48347093|NCT01125566|155466440|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
48347094|NCT01125566|155466441|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
48347095|NCT01125566|155466439|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
48347096|NCT01125566|155466440|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
48347097|NCT01125566|155466441|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
48347098|NCT02725008|155466442|FG000|Overall Study|Lost to Follow-up|7|||
48347099|NCT02725008|155466443|FG001|Overall Study|Lost to Follow-up|9|||
48347100|NCT02725008|155466442|FG000|Overall Study|Withdrawal by Subject|2|||
48347101|NCT02725008|155466443|FG001|Overall Study|Withdrawal by Subject|2|||
48347102|NCT02725008|155466442|FG000|Overall Study|Admitted to hospital|0|||
48347103|NCT02725008|155466443|FG001|Overall Study|Admitted to hospital|1|||
48347104|NCT02970305|155466448|FG000|Overall Study|Adverse Event|10|||
48347105|NCT02970305|155466449|FG001|Overall Study|Adverse Event|6|||
48347106|NCT02970305|155466448|FG000|Overall Study|Lack of Efficacy|1|||
48347107|NCT02970305|155466449|FG001|Overall Study|Lack of Efficacy|1|||
48347108|NCT02970305|155466448|FG000|Overall Study|Noncompliance with study drug|2|||
48347109|NCT02970305|155466449|FG001|Overall Study|Noncompliance with study drug|4|||
48347110|NCT02970305|155466448|FG000|Overall Study|Protocol Violation|2|||
48347111|NCT02970305|155466449|FG001|Overall Study|Protocol Violation|2|||
48347112|NCT02970305|155466448|FG000|Overall Study|Withdrawal by Subject|12|||
48347113|NCT02970305|155466449|FG001|Overall Study|Withdrawal by Subject|11|||
48347114|NCT02970305|155466448|FG000|Overall Study|Not further specified|1|||
48347115|NCT02970305|155466449|FG001|Overall Study|Not further specified|2|||
48347116|NCT02970305|155466448|FG000|Overall Study|Lost to Follow-up|1|||
48347117|NCT02970305|155466449|FG001|Overall Study|Lost to Follow-up|2|||
48347118|NCT00983892|155466450|FG000|Overall Study|Withdrawal by Subject|10|||
48347119|NCT00983892|155466451|FG001|Overall Study|Withdrawal by Subject|12|||
48347120|NCT02175745|155466452|FG000|Overall Study|Not Eligible|1|||
48347121|NCT01665599|155466455|FG000|Overall Study|Adverse Event|1|||
48347122|NCT01665599|155466455|FG000|Overall Study|Consent Withdrawn|1|||
48347123|NCT01665599|155466455|FG000|Overall Study|Investigator/Sponsor decision|1|||
48347124|NCT01665599|155466455|FG000|Overall Study|Death|1|||
48347125|NCT01665599|155466455|FG000|Overall Study|Lost to Follow-up|2|||
48347126|NCT01665599|155466455|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
48383958|NCT04029116|155601516|FG000|Overall Study|Pregnancy|1|||
48674069|NCT01123707|156659591|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
48674070|NCT01123707|156659592|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
48674071|NCT01123707|156659593|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
48674072|NCT01123707|156659594|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
48674073|NCT01123707|156659591|FG000|Overall Study|Investigator Withdrew Participant|0|||
48674074|NCT01123707|156659592|FG001|Overall Study|Investigator Withdrew Participant|1|||
48674075|NCT01123707|156659593|FG002|Overall Study|Investigator Withdrew Participant|1|||
48674076|NCT01123707|156659594|FG003|Overall Study|Investigator Withdrew Participant|1|||
48674077|NCT01123707|156659591|FG000|Overall Study|Subject Withdrew Consent|4|||
48674078|NCT01123707|156659592|FG001|Overall Study|Subject Withdrew Consent|5|||
48674079|NCT01123707|156659593|FG002|Overall Study|Subject Withdrew Consent|1|||
48674080|NCT01123707|156659594|FG003|Overall Study|Subject Withdrew Consent|2|||
48674081|NCT01123707|156659591|FG000|Overall Study|Lack of Efficacy|1|||
48674082|NCT01123707|156659592|FG001|Overall Study|Lack of Efficacy|2|||
48674083|NCT01123707|156659593|FG002|Overall Study|Lack of Efficacy|1|||
48674084|NCT01123707|156659594|FG003|Overall Study|Lack of Efficacy|0|||
48674085|NCT01123707|156659591|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
48761309|NCT00702403|156975612|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
48761310|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
48761311|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
48761312|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Non-compliance|2|||
48761313|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
48761314|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
48761315|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Suicide|1|||
48761316|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
48761317|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
48761318|NCT00702403|156975612|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
48761319|NCT00380978|156975614|FG000|Overall Study|Refused allocated intervention|0|||
48761320|NCT00380978|156975615|FG001|Overall Study|Refused allocated intervention|6|||
48761321|NCT00380978|156975614|FG000|Overall Study|Wrong study envelope|0|||
48761322|NCT00380978|156975615|FG001|Overall Study|Wrong study envelope|2|||
48761323|NCT00380978|156975614|FG000|Overall Study|Allocation prior to analgesia request|1|||
48761324|NCT00380978|156975615|FG001|Overall Study|Allocation prior to analgesia request|2|||
48761325|NCT00380978|156975614|FG000|Overall Study|Parous patient|1|||
48761326|NCT00380978|156975615|FG001|Overall Study|Parous patient|0|||
48761327|NCT00225251|156975616|FG000|Overall Study|Withdrawal by Subject|1|||
48761328|NCT00225251|156975617|FG001|Overall Study|Withdrawal by Subject|1|||
48761329|NCT01287897|156975618|FG000|Overall Study|Adverse Event|5|||
48761330|NCT01287897|156975619|FG001|Overall Study|Adverse Event|3|||
48761331|NCT01287897|156975620|FG002|Overall Study|Adverse Event|6|||
48761332|NCT01287897|156975621|FG003|Overall Study|Adverse Event|4|||
48761333|NCT01287897|156975618|FG000|Overall Study|Lack of Efficacy|2|||
48761334|NCT01287897|156975619|FG001|Overall Study|Lack of Efficacy|0|||
48761335|NCT01287897|156975620|FG002|Overall Study|Lack of Efficacy|0|||
48761336|NCT01287897|156975621|FG003|Overall Study|Lack of Efficacy|0|||
48761337|NCT01287897|156975618|FG000|Overall Study|Protocol Violation|1|||
48761338|NCT01287897|156975619|FG001|Overall Study|Protocol Violation|1|||
48761339|NCT01287897|156975620|FG002|Overall Study|Protocol Violation|0|||
48761340|NCT01287897|156975621|FG003|Overall Study|Protocol Violation|1|||
48761341|NCT01287897|156975618|FG000|Overall Study|Lost to Follow-up|0|||
48761342|NCT01287897|156975619|FG001|Overall Study|Lost to Follow-up|0|||
48761343|NCT01287897|156975620|FG002|Overall Study|Lost to Follow-up|2|||
48761344|NCT01287897|156975621|FG003|Overall Study|Lost to Follow-up|0|||
48761345|NCT01287897|156975618|FG000|Overall Study|Withdrawal by Subject|1|||
48761346|NCT01287897|156975619|FG001|Overall Study|Withdrawal by Subject|5|||
48761347|NCT01287897|156975620|FG002|Overall Study|Withdrawal by Subject|3|||
48761348|NCT01287897|156975621|FG003|Overall Study|Withdrawal by Subject|2|||
48761349|NCT01287897|156975618|FG000|Overall Study|Not consented properly|0|||
48761350|NCT01287897|156975619|FG001|Overall Study|Not consented properly|1|||
48761351|NCT01287897|156975620|FG002|Overall Study|Not consented properly|0|||
48761352|NCT01287897|156975621|FG003|Overall Study|Not consented properly|0|||
48761353|NCT01287897|156975618|FG000|Overall Study|Not meeting entrance criteria|1|||
48761354|NCT01287897|156975619|FG001|Overall Study|Not meeting entrance criteria|1|||
48761355|NCT01287897|156975620|FG002|Overall Study|Not meeting entrance criteria|0|||
48761356|NCT01287897|156975621|FG003|Overall Study|Not meeting entrance criteria|0|||
48761357|NCT01287897|156975618|FG000|Overall Study|Other|1|||
48761358|NCT01287897|156975619|FG001|Overall Study|Other|0|||
48761359|NCT01287897|156975620|FG002|Overall Study|Other|1|||
48761360|NCT01287897|156975621|FG003|Overall Study|Other|0|||
48761361|NCT01499667|156975626|FG000|Overall Study|administrative problems|4|||
48761362|NCT01499667|156975627|FG001|Overall Study|administrative problems|5|||
48761363|NCT01499667|156975628|FG002|Overall Study|administrative problems|5|||
48761364|NCT01499667|156975626|FG000|Overall Study|Protocol Violation|1|||
48761365|NCT01499667|156975627|FG001|Overall Study|Protocol Violation|3|||
48761366|NCT01499667|156975628|FG002|Overall Study|Protocol Violation|2|||
48761367|NCT01499667|156975626|FG000|Overall Study|Adverse Event|0|||
48674086|NCT01123707|156659592|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
48674087|NCT01123707|156659593|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
48674088|NCT01123707|156659594|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
48674089|NCT02687581|156659596|FG000|Overall Study|Withdrawal by Subject|1|||
48674090|NCT02687581|156659597|FG001|Overall Study|Withdrawal by Subject|0|||
48674091|NCT02687581|156659598|FG002|Overall Study|Withdrawal by Subject|0|||
48674092|NCT02687581|156659599|FG003|Overall Study|Withdrawal by Subject|1|||
48674093|NCT02687581|156659596|FG000|Overall Study|Lost to Follow-up|2|||
48674094|NCT02687581|156659597|FG001|Overall Study|Lost to Follow-up|2|||
48674095|NCT02687581|156659598|FG002|Overall Study|Lost to Follow-up|0|||
48347127|NCT01665599|155466455|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
48347128|NCT01837797|155466456|FG000|Period 1|Adverse Event|9|||
48347129|NCT01837797|155466457|FG001|Period 1|Adverse Event|0|||
48347130|NCT01837797|155466458|FG002|Period 1|Adverse Event|0|||
48347131|NCT01837797|155466459|FG003|Period 1|Adverse Event|0|||
48347132|NCT01837797|155466460|FG004|Period 1|Adverse Event|0|||
48347133|NCT01837797|155466456|FG000|Period 1|Withdrawal by Subject|6|||
48347134|NCT01837797|155466457|FG001|Period 1|Withdrawal by Subject|0|||
48347135|NCT01837797|155466458|FG002|Period 1|Withdrawal by Subject|0|||
48347136|NCT01837797|155466459|FG003|Period 1|Withdrawal by Subject|0|||
48347137|NCT01837797|155466460|FG004|Period 1|Withdrawal by Subject|0|||
48347138|NCT01837797|155466456|FG000|Period 1|Administrative reasons|76|||
48347139|NCT01837797|155466457|FG001|Period 1|Administrative reasons|0|||
48347140|NCT01837797|155466458|FG002|Period 1|Administrative reasons|0|||
48347141|NCT01837797|155466459|FG003|Period 1|Administrative reasons|0|||
48347142|NCT01837797|155466460|FG004|Period 1|Administrative reasons|0|||
48347143|NCT01837797|155466456|FG000|Period 1|Withdrawal of consent before treatment|1|||
48347144|NCT01837797|155466457|FG001|Period 1|Withdrawal of consent before treatment|0|||
48347145|NCT01837797|155466458|FG002|Period 1|Withdrawal of consent before treatment|0|||
48347146|NCT01837797|155466459|FG003|Period 1|Withdrawal of consent before treatment|0|||
48347147|NCT01837797|155466460|FG004|Period 1|Withdrawal of consent before treatment|0|||
48347148|NCT01837797|155466456|FG000|Period 1|Other|10|||
48347149|NCT01837797|155466457|FG001|Period 1|Other|0|||
48347150|NCT01837797|155466458|FG002|Period 1|Other|0|||
48347151|NCT01837797|155466459|FG003|Period 1|Other|0|||
48347152|NCT01837797|155466460|FG004|Period 1|Other|0|||
48347153|NCT01837797|155466456|FG000|Period 2|Administrative or other reasons|0|||
48347154|NCT01837797|155466457|FG001|Period 2|Administrative or other reasons|5|||
48347155|NCT01837797|155466458|FG002|Period 2|Administrative or other reasons|2|||
48347156|NCT01837797|155466459|FG003|Period 2|Administrative or other reasons|4|||
48347157|NCT01837797|155466460|FG004|Period 2|Administrative or other reasons|0|||
48347158|NCT01837797|155466456|FG000|Period 2|Adverse Event|0|||
48347159|NCT01837797|155466457|FG001|Period 2|Adverse Event|0|||
48674096|NCT02687581|156659599|FG003|Overall Study|Lost to Follow-up|0|||
48674097|NCT02687581|156659596|FG000|Overall Study|the device is too small for the patient.|1|||
48347160|NCT01837797|155466458|FG002|Period 2|Adverse Event|0|||
48347161|NCT01837797|155466459|FG003|Period 2|Adverse Event|1|||
48347162|NCT01837797|155466460|FG004|Period 2|Adverse Event|0|||
48347163|NCT01837797|155466456|FG000|Period 3|Adverse Event|0|||
48347164|NCT01837797|155466457|FG001|Period 3|Adverse Event|0|||
48347165|NCT01837797|155466458|FG002|Period 3|Adverse Event|0|||
48347166|NCT01837797|155466459|FG003|Period 3|Adverse Event|0|||
48347167|NCT01837797|155466460|FG004|Period 3|Adverse Event|1|||
48347168|NCT01837797|155466456|FG000|Period 3|Administrative reasons|0|||
48347169|NCT01837797|155466457|FG001|Period 3|Administrative reasons|0|||
48347170|NCT01837797|155466458|FG002|Period 3|Administrative reasons|0|||
48347171|NCT01837797|155466459|FG003|Period 3|Administrative reasons|0|||
48347172|NCT01837797|155466460|FG004|Period 3|Administrative reasons|20|||
48347173|NCT01837797|155466456|FG000|Period 3|Other|0|||
48347174|NCT01837797|155466457|FG001|Period 3|Other|0|||
48347175|NCT01837797|155466458|FG002|Period 3|Other|0|||
48347176|NCT01837797|155466459|FG003|Period 3|Other|0|||
48347177|NCT01837797|155466460|FG004|Period 3|Other|2|||
48347178|NCT00988117|155466461|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
48347179|NCT00988117|155466461|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
48347180|NCT01220856|155466462|FG000|Overall Study|graft loss|3|||
48347181|NCT01220856|155466463|FG001|Overall Study|graft loss|3|||
48347182|NCT01220856|155466462|FG000|Overall Study|Lost to Follow-up|1|||
48347183|NCT01220856|155466463|FG001|Overall Study|Lost to Follow-up|0|||
48347184|NCT02257918|155466464|FG000|Overall Study|Lost to Follow-up|4|||
48674098|NCT02687581|156659597|FG001|Overall Study|the device is too small for the patient.|0|||
48347185|NCT02257918|155466465|FG001|Overall Study|Lost to Follow-up|1|||
48347186|NCT02257918|155466466|FG002|Overall Study|Lost to Follow-up|0|||
48347187|NCT02257918|155466464|FG000|Overall Study|Withdrawal by Subject|0|||
48674099|NCT02687581|156659598|FG002|Overall Study|the device is too small for the patient.|0|||
48347188|NCT02257918|155466465|FG001|Overall Study|Withdrawal by Subject|0|||
48347189|NCT02257918|155466466|FG002|Overall Study|Withdrawal by Subject|1|||
48347190|NCT02257918|155466464|FG000|Overall Study|Pregnancy|0|||
48347191|NCT02257918|155466465|FG001|Overall Study|Pregnancy|0|||
48347192|NCT02257918|155466466|FG002|Overall Study|Pregnancy|1|||
48347193|NCT00691678|155466469|FG000|Overall Study|Adverse Event|5|||
48347194|NCT00691678|155466469|FG000|Overall Study|life events, pain|11|||
48347195|NCT01878383|155468034|FG000|Overall Study|Lost to Follow-up|0|||
48347196|NCT01878383|155468035|FG001|Overall Study|Lost to Follow-up|1499|||
48347197|NCT03464383|155468036|FG000|Overall Study|Lost to Follow-up|1|||
48347198|NCT03464383|155468037|FG001|Overall Study|Lost to Follow-up|0|||
48347199|NCT03464383|155468038|FG002|Overall Study|Lost to Follow-up|0|||
48347200|NCT03464383|155468036|FG000|Overall Study|Withdrawal by Subject|0|||
48347201|NCT03464383|155468037|FG001|Overall Study|Withdrawal by Subject|1|||
48347202|NCT03464383|155468038|FG002|Overall Study|Withdrawal by Subject|0|||
48347203|NCT00746785|155468039|FG000|Overall Study|Lost to Follow-up|29|||
48347204|NCT00746785|155468040|FG001|Overall Study|Lost to Follow-up|25|||
48347205|NCT00746785|155468041|FG002|Overall Study|Lost to Follow-up|27|||
48347206|NCT00605566|155468042|FG000|Overall Study|Adverse Event|1|||
48347207|NCT00605566|155468042|FG000|Overall Study|Clinical deterioration|1|||
48347208|NCT00605566|155468042|FG000|Overall Study|Poor compliance in run-in period|1|||
48347209|NCT00951171|155468043|FG000|Overall Study|Adverse Event|2|||
48347210|NCT00951171|155468044|FG001|Overall Study|Adverse Event|0|||
48347211|NCT00957996|155468045|FG000|Overall Study|Death|4|||
48347212|NCT00957996|155468046|FG001|Overall Study|Death|10|||
48347213|NCT00957996|155468045|FG000|Overall Study|Lost to Follow-up|4|||
48347214|NCT00957996|155468046|FG001|Overall Study|Lost to Follow-up|7|||
48347215|NCT00957996|155468045|FG000|Overall Study|Withdrawal by Subject|9|||
48347216|NCT00957996|155468046|FG001|Overall Study|Withdrawal by Subject|2|||
48347217|NCT00957996|155468045|FG000|Overall Study|Adverse Event|2|||
48347218|NCT00957996|155468046|FG001|Overall Study|Adverse Event|1|||
48347219|NCT00957996|155468045|FG000|Overall Study|Physician Decision|1|||
48347220|NCT00957996|155468046|FG001|Overall Study|Physician Decision|1|||
48347221|NCT00957996|155468045|FG000|Overall Study|Influenza-related complication|0|||
48347222|NCT00957996|155468046|FG001|Overall Study|Influenza-related complication|1|||
48347223|NCT00957996|155468045|FG000|Overall Study|Missing|1|||
48347224|NCT00957996|155468046|FG001|Overall Study|Missing|0|||
48347225|NCT00957996|155468045|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
48347226|NCT00957996|155468046|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
48347227|NCT00792259|155468047|FG000|Overall Study|Poor Quality Scans|1|||
48347228|NCT00792259|155468048|FG001|Overall Study|Poor Quality Scans|0|||
48347229|NCT00792259|155468049|FG002|Overall Study|Poor Quality Scans|0|||
48347230|NCT00371462|155468050|FG000|Overall Study|Withdrawal by Subject|1|||
48347231|NCT00371462|155468051|FG001|Overall Study|Withdrawal by Subject|0|||
48347232|NCT00371462|155468050|FG000|Overall Study|Other|7|||
48347233|NCT00371462|155468051|FG001|Overall Study|Other|8|||
48347234|NCT00113269|155468055|FG000|Overall Study|Not transplanted, donor issues|4|||
48347235|NCT00113269|155468056|FG001|Overall Study|Not transplanted, donor issues|0|||
48347236|NCT00113269|155468057|FG002|Overall Study|Not transplanted, donor issues|2|||
48347237|NCT00113269|155468058|FG003|Overall Study|Not transplanted, donor issues|2|||
48347238|NCT00113269|155468055|FG000|Overall Study|Not transplanted, recipient issues|2|||
48347239|NCT00113269|155468056|FG001|Overall Study|Not transplanted, recipient issues|1|||
48347240|NCT00113269|155468057|FG002|Overall Study|Not transplanted, recipient issues|7|||
48347241|NCT00113269|155468058|FG003|Overall Study|Not transplanted, recipient issues|4|||
48347242|NCT00113269|155468055|FG000|Overall Study|Early graft loss, technical|0|||
48347243|NCT00113269|155468056|FG001|Overall Study|Early graft loss, technical|0|||
48347244|NCT00113269|155468057|FG002|Overall Study|Early graft loss, technical|2|||
48347245|NCT00113269|155468058|FG003|Overall Study|Early graft loss, technical|0|||
48347246|NCT00113269|155468055|FG000|Overall Study|Death in operating room|0|||
48347247|NCT00113269|155468056|FG001|Overall Study|Death in operating room|0|||
48674100|NCT02687581|156659599|FG003|Overall Study|the device is too small for the patient.|0|||
48347248|NCT00113269|155468057|FG002|Overall Study|Death in operating room|0|||
48347249|NCT00113269|155468058|FG003|Overall Study|Death in operating room|1|||
48347250|NCT00113269|155468055|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
48347251|NCT00113269|155468056|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
48347252|NCT00113269|155468057|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
48347253|NCT00113269|155468058|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
48347254|NCT00113269|155468055|FG000|Overall Study|Adverse Event|2|||
48347255|NCT00113269|155468056|FG001|Overall Study|Adverse Event|7|||
48674101|NCT02305238|156659602|FG000|Overall Study|Death|2|||
48347256|NCT00113269|155468057|FG002|Overall Study|Adverse Event|11|||
48347257|NCT00113269|155468058|FG003|Overall Study|Adverse Event|7|||
48347258|NCT00113269|155468055|FG000|Overall Study|Withdrawal by Subject|4|||
48347259|NCT00113269|155468056|FG001|Overall Study|Withdrawal by Subject|3|||
48347260|NCT00113269|155468057|FG002|Overall Study|Withdrawal by Subject|4|||
48347261|NCT00113269|155468058|FG003|Overall Study|Withdrawal by Subject|2|||
48347262|NCT00113269|155468055|FG000|Overall Study|Graft loss|6|||
48347263|NCT00113269|155468056|FG001|Overall Study|Graft loss|6|||
48347264|NCT00113269|155468057|FG002|Overall Study|Graft loss|4|||
48347265|NCT00113269|155468058|FG003|Overall Study|Graft loss|9|||
48347266|NCT00113269|155468055|FG000|Overall Study|Protocol Violation|1|||
48347267|NCT00113269|155468056|FG001|Overall Study|Protocol Violation|0|||
48347268|NCT00113269|155468057|FG002|Overall Study|Protocol Violation|4|||
48761368|NCT01499667|156975627|FG001|Overall Study|Adverse Event|2|||
48761369|NCT01499667|156975628|FG002|Overall Study|Adverse Event|2|||
48761370|NCT01499667|156975626|FG000|Overall Study|Withdrawal by Subject|2|||
48761371|NCT01499667|156975627|FG001|Overall Study|Withdrawal by Subject|1|||
48761372|NCT01499667|156975628|FG002|Overall Study|Withdrawal by Subject|1|||
48761373|NCT01499667|156975626|FG000|Overall Study|Lack of Efficacy|2|||
48761374|NCT01499667|156975627|FG001|Overall Study|Lack of Efficacy|0|||
48761375|NCT01499667|156975628|FG002|Overall Study|Lack of Efficacy|0|||
48761376|NCT00759863|156975629|FG000|Overall Study|Death, moved, or lost contact|20|||
48761377|NCT00759863|156975630|FG001|Overall Study|Death, moved, or lost contact|18|||
48761378|NCT01729754|156975631|FG000|Part 1|Adverse Event|2|||
48761379|NCT01729754|156975632|FG001|Part 1|Adverse Event|0|||
48761380|NCT01729754|156975633|FG002|Part 1|Adverse Event|0|||
48761381|NCT01729754|156975634|FG003|Part 1|Adverse Event|1|||
48761382|NCT01729754|156975635|FG004|Part 1|Adverse Event|0|||
48761383|NCT01729754|156975636|FG005|Part 1|Adverse Event|0|||
48761384|NCT01729754|156975637|FG006|Part 1|Adverse Event|2|||
48761385|NCT01729754|156975638|FG007|Part 1|Adverse Event|0|||
48761386|NCT01729754|156975639|FG008|Part 1|Adverse Event|0|||
48761387|NCT01729754|156975640|FG009|Part 1|Adverse Event|5|||
48761388|NCT01729754|156975631|FG000|Part 1|Lack of Efficacy|1|||
48761389|NCT01729754|156975632|FG001|Part 1|Lack of Efficacy|0|||
48761390|NCT01729754|156975633|FG002|Part 1|Lack of Efficacy|0|||
48761391|NCT01729754|156975634|FG003|Part 1|Lack of Efficacy|0|||
48761392|NCT01729754|156975635|FG004|Part 1|Lack of Efficacy|0|||
48761393|NCT01729754|156975636|FG005|Part 1|Lack of Efficacy|0|||
48761394|NCT01729754|156975637|FG006|Part 1|Lack of Efficacy|2|||
48761395|NCT01729754|156975638|FG007|Part 1|Lack of Efficacy|0|||
48761396|NCT01729754|156975639|FG008|Part 1|Lack of Efficacy|0|||
48761397|NCT01729754|156975640|FG009|Part 1|Lack of Efficacy|0|||
48761398|NCT01729754|156975631|FG000|Part 1|Lost to Follow-up|1|||
48761399|NCT01729754|156975632|FG001|Part 1|Lost to Follow-up|0|||
48761400|NCT01729754|156975633|FG002|Part 1|Lost to Follow-up|0|||
48761401|NCT01729754|156975634|FG003|Part 1|Lost to Follow-up|2|||
48761402|NCT01729754|156975635|FG004|Part 1|Lost to Follow-up|0|||
48761403|NCT01729754|156975636|FG005|Part 1|Lost to Follow-up|0|||
48761404|NCT01729754|156975637|FG006|Part 1|Lost to Follow-up|3|||
48761405|NCT01729754|156975638|FG007|Part 1|Lost to Follow-up|0|||
48761406|NCT01729754|156975639|FG008|Part 1|Lost to Follow-up|0|||
48761407|NCT01729754|156975640|FG009|Part 1|Lost to Follow-up|3|||
48761408|NCT01729754|156975631|FG000|Part 1|Non-compliance with Study Drug|1|||
48761409|NCT01729754|156975632|FG001|Part 1|Non-compliance with Study Drug|0|||
48761410|NCT01729754|156975633|FG002|Part 1|Non-compliance with Study Drug|0|||
48761411|NCT01729754|156975634|FG003|Part 1|Non-compliance with Study Drug|0|||
48761412|NCT01729754|156975635|FG004|Part 1|Non-compliance with Study Drug|0|||
48761413|NCT01729754|156975636|FG005|Part 1|Non-compliance with Study Drug|0|||
48761414|NCT01729754|156975637|FG006|Part 1|Non-compliance with Study Drug|0|||
48761415|NCT01729754|156975638|FG007|Part 1|Non-compliance with Study Drug|0|||
48761416|NCT01729754|156975639|FG008|Part 1|Non-compliance with Study Drug|0|||
48761417|NCT01729754|156975640|FG009|Part 1|Non-compliance with Study Drug|0|||
48761418|NCT01729754|156975631|FG000|Part 1|Physician Decision|0|||
48761419|NCT01729754|156975632|FG001|Part 1|Physician Decision|0|||
48761420|NCT01729754|156975633|FG002|Part 1|Physician Decision|0|||
48761421|NCT01729754|156975634|FG003|Part 1|Physician Decision|0|||
48761422|NCT01729754|156975635|FG004|Part 1|Physician Decision|0|||
48761423|NCT01729754|156975636|FG005|Part 1|Physician Decision|0|||
48761424|NCT01729754|156975637|FG006|Part 1|Physician Decision|0|||
48761425|NCT01729754|156975638|FG007|Part 1|Physician Decision|0|||
48761426|NCT01729754|156975639|FG008|Part 1|Physician Decision|0|||
48761427|NCT01729754|156975640|FG009|Part 1|Physician Decision|4|||
48761428|NCT01729754|156975631|FG000|Part 1|Pregnancy|0|||
48347269|NCT00113269|155468058|FG003|Overall Study|Protocol Violation|2|||
48347270|NCT00113269|155468055|FG000|Overall Study|Lost to Follow-up|2|||
48347271|NCT00113269|155468056|FG001|Overall Study|Lost to Follow-up|3|||
48347272|NCT00113269|155468057|FG002|Overall Study|Lost to Follow-up|6|||
48347273|NCT00113269|155468058|FG003|Overall Study|Lost to Follow-up|3|||
48347274|NCT00113269|155468055|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
48347275|NCT00113269|155468056|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
48347276|NCT00113269|155468057|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
48347277|NCT00113269|155468058|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
48347278|NCT00113269|155468055|FG000|Overall Study|Discontinued due to rejection|0|||
48347279|NCT00113269|155468056|FG001|Overall Study|Discontinued due to rejection|0|||
48347280|NCT00113269|155468057|FG002|Overall Study|Discontinued due to rejection|1|||
48347281|NCT00113269|155468058|FG003|Overall Study|Discontinued due to rejection|0|||
48347282|NCT00113269|155468055|FG000|Overall Study|Moved|0|||
48347283|NCT00113269|155468056|FG001|Overall Study|Moved|1|||
48347284|NCT00113269|155468057|FG002|Overall Study|Moved|0|||
48347285|NCT00113269|155468058|FG003|Overall Study|Moved|3|||
48347286|NCT00113269|155468055|FG000|Overall Study|Received pancreas transplant|0|||
48347287|NCT00113269|155468056|FG001|Overall Study|Received pancreas transplant|0|||
48347288|NCT00113269|155468057|FG002|Overall Study|Received pancreas transplant|0|||
48347289|NCT00113269|155468058|FG003|Overall Study|Received pancreas transplant|2|||
48347290|NCT00113269|155468055|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
48347291|NCT00113269|155468056|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
48347292|NCT00113269|155468057|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
48347293|NCT00113269|155468058|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
48347294|NCT00113269|155468055|FG000|Overall Study|Did not meet eligibility criteria|1|||
48347295|NCT00113269|155468056|FG001|Overall Study|Did not meet eligibility criteria|0|||
48347296|NCT00113269|155468057|FG002|Overall Study|Did not meet eligibility criteria|0|||
48674102|NCT02305238|156659603|FG001|Overall Study|Death|1|||
48674103|NCT02305238|156659604|FG002|Overall Study|Death|0|||
48674104|NCT02305238|156659602|FG000|Overall Study|Progressive disease|4|||
48674105|NCT02305238|156659603|FG001|Overall Study|Progressive disease|4|||
48674106|NCT02305238|156659604|FG002|Overall Study|Progressive disease|0|||
48674107|NCT02305238|156659602|FG000|Overall Study|Logistical difficulties|1|||
48674108|NCT02305238|156659603|FG001|Overall Study|Logistical difficulties|3|||
48674109|NCT02305238|156659604|FG002|Overall Study|Logistical difficulties|0|||
48674110|NCT02305238|156659602|FG000|Overall Study|Protocol Violation|0|||
48674111|NCT02305238|156659603|FG001|Overall Study|Protocol Violation|3|||
48674112|NCT02305238|156659604|FG002|Overall Study|Protocol Violation|0|||
48674113|NCT02305238|156659602|FG000|Overall Study|Physician Decision|2|||
48674114|NCT02305238|156659603|FG001|Overall Study|Physician Decision|1|||
48674115|NCT02305238|156659604|FG002|Overall Study|Physician Decision|0|||
48674116|NCT02305238|156659602|FG000|Overall Study|Adverse Event|4|||
48674117|NCT02305238|156659603|FG001|Overall Study|Adverse Event|2|||
48674118|NCT02305238|156659604|FG002|Overall Study|Adverse Event|0|||
48674119|NCT02305238|156659602|FG000|Overall Study|Withdrawal by Subject|3|||
48674120|NCT02305238|156659603|FG001|Overall Study|Withdrawal by Subject|4|||
48674121|NCT02305238|156659604|FG002|Overall Study|Withdrawal by Subject|0|||
48674122|NCT02305238|156659602|FG000|Overall Study|Randomized failure|0|||
48674123|NCT02305238|156659603|FG001|Overall Study|Randomized failure|0|||
48674124|NCT02305238|156659604|FG002|Overall Study|Randomized failure|8|||
48674125|NCT02305238|156659602|FG000|Overall Study|Required procedure failed|0|||
48674126|NCT02305238|156659603|FG001|Overall Study|Required procedure failed|1|||
48674127|NCT02305238|156659604|FG002|Overall Study|Required procedure failed|0|||
48674128|NCT01019369|156659605|FG000|Overall Study|Lost to Follow-up|10|||
48674129|NCT01019369|156659606|FG001|Overall Study|Lost to Follow-up|6|||
48674130|NCT01019369|156659605|FG000|Overall Study|Withdrawal by Subject|0|||
48674131|NCT01019369|156659606|FG001|Overall Study|Withdrawal by Subject|1|||
48674132|NCT00488826|156659607|FG000|Overall Study|Withdrawal by Subject|40|||
48674133|NCT00488826|156659608|FG001|Overall Study|Withdrawal by Subject|35|||
48674134|NCT00488826|156659609|FG002|Overall Study|Withdrawal by Subject|19|||
48674135|NCT00488826|156659607|FG000|Overall Study|Protocol Violation|0|||
48674136|NCT00488826|156659608|FG001|Overall Study|Protocol Violation|0|||
48674137|NCT00488826|156659609|FG002|Overall Study|Protocol Violation|2|||
48674138|NCT00488826|156659607|FG000|Overall Study|Adverse Event|9|||
48674139|NCT00488826|156659608|FG001|Overall Study|Adverse Event|15|||
48674140|NCT00488826|156659609|FG002|Overall Study|Adverse Event|4|||
48674141|NCT00488826|156659607|FG000|Overall Study|Lost to Follow-up|5|||
48674142|NCT00488826|156659608|FG001|Overall Study|Lost to Follow-up|1|||
48674143|NCT00488826|156659609|FG002|Overall Study|Lost to Follow-up|0|||
48674144|NCT00488826|156659607|FG000|Overall Study|Protocol Deviations|2|||
48674145|NCT00488826|156659608|FG001|Overall Study|Protocol Deviations|1|||
48674146|NCT00488826|156659609|FG002|Overall Study|Protocol Deviations|1|||
48674147|NCT01990612|156659610|FG000|Overall Study|Lost to Follow-up|2|||
48674148|NCT01990612|156659611|FG001|Overall Study|Lost to Follow-up|1|||
48674149|NCT01990612|156659610|FG000|Overall Study|Withdrawal by Subject|5|||
48674150|NCT01990612|156659611|FG001|Overall Study|Withdrawal by Subject|2|||
48674151|NCT03043651|156659617|FG000|Overall Study|Death|1|||
48674152|NCT03043651|156659617|FG000|Overall Study|Progressive Disease|2|||
48674153|NCT03043651|156659617|FG000|Overall Study|Adverse Event|2|||
48674154|NCT03043651|156659617|FG000|Overall Study|Withdrawal by Subject|4|||
48674155|NCT03043651|156659617|FG000|Overall Study|Study Terminated by Sponsor|39|||
48674156|NCT02428205|156659618|FG000|Overall Study|Lack of Efficacy|1|||
48674157|NCT02428205|156659619|FG001|Overall Study|Lack of Efficacy|0|||
48674158|NCT02428205|156659618|FG000|Overall Study|Lost to Follow-up|1|||
48674159|NCT02428205|156659619|FG001|Overall Study|Lost to Follow-up|1|||
48674160|NCT02428205|156659618|FG000|Overall Study|Worse behavior|0|||
48674161|NCT02428205|156659619|FG001|Overall Study|Worse behavior|1|||
48674162|NCT01630889|156659620|FG000|Overall Study|Death|2|||
48674163|NCT01630889|156659620|FG000|Overall Study|Withdrawal by Subject|1|||
48674164|NCT01630889|156659620|FG000|Overall Study|Other than Specified|2|||
48674165|NCT01630889|156659620|FG000|Overall Study|Lost to Follow-up|4|||
48674166|NCT01630889|156659620|FG000|Overall Study|Other|1|||
48674167|NCT02974842|156659621|FG000|Overall Study|Withdrawal by Subject|4|||
48674168|NCT02974842|156659621|FG000|Overall Study|Screen failures|4|||
48674169|NCT02980133|156659622|FG000|Overall Study|Other than specified|1|||
48674170|NCT02980133|156659623|FG001|Overall Study|Other than specified|1|||
48674171|NCT02980133|156659624|FG002|Overall Study|Other than specified|2|||
48674172|NCT02980133|156659625|FG003|Overall Study|Other than specified|2|||
48674173|NCT02980133|156659622|FG000|Overall Study|Lost to Follow-up|0|||
48674174|NCT02980133|156659623|FG001|Overall Study|Lost to Follow-up|0|||
48674175|NCT02980133|156659624|FG002|Overall Study|Lost to Follow-up|1|||
48674176|NCT02980133|156659625|FG003|Overall Study|Lost to Follow-up|3|||
48674177|NCT02980133|156659622|FG000|Overall Study|Protocol Violation|0|||
48674178|NCT02980133|156659623|FG001|Overall Study|Protocol Violation|1|||
48674179|NCT02980133|156659624|FG002|Overall Study|Protocol Violation|0|||
48674180|NCT02980133|156659625|FG003|Overall Study|Protocol Violation|0|||
48674181|NCT02980133|156659622|FG000|Overall Study|Withdrawal by parent/guardian|6|||
48674182|NCT02980133|156659623|FG001|Overall Study|Withdrawal by parent/guardian|3|||
48674183|NCT02980133|156659624|FG002|Overall Study|Withdrawal by parent/guardian|3|||
48674184|NCT02980133|156659625|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48674185|NCT02980133|156659622|FG000|Overall Study|Withdrawal by Subject|0|||
48674186|NCT02980133|156659623|FG001|Overall Study|Withdrawal by Subject|0|||
48674187|NCT02980133|156659624|FG002|Overall Study|Withdrawal by Subject|1|||
48674188|NCT02980133|156659625|FG003|Overall Study|Withdrawal by Subject|0|||
48674189|NCT03208088|156659628|FG000|Period 2|Withdrawal by Subject|0|||
48674190|NCT03208088|156659629|FG001|Period 2|Withdrawal by Subject|0|||
48674191|NCT03208088|156659630|FG002|Period 2|Withdrawal by Subject|0|||
48674192|NCT03208088|156659631|FG003|Period 2|Withdrawal by Subject|0|||
48674193|NCT03208088|156659632|FG004|Period 2|Withdrawal by Subject|0|||
48674194|NCT03208088|156659633|FG005|Period 2|Withdrawal by Subject|0|||
48674195|NCT03208088|156659634|FG006|Period 2|Withdrawal by Subject|0|||
48674196|NCT03208088|156659635|FG007|Period 2|Withdrawal by Subject|0|||
48674197|NCT03208088|156659636|FG008|Period 2|Withdrawal by Subject|1|||
48674198|NCT03208088|156659637|FG009|Period 2|Withdrawal by Subject|0|||
48674199|NCT03208088|156659628|FG000|Period 3|Unsatisfactory Test Article|0|||
48674200|NCT03208088|156659629|FG001|Period 3|Unsatisfactory Test Article|0|||
48674201|NCT03208088|156659630|FG002|Period 3|Unsatisfactory Test Article|0|||
48674202|NCT03208088|156659631|FG003|Period 3|Unsatisfactory Test Article|1|||
48674203|NCT03208088|156659632|FG004|Period 3|Unsatisfactory Test Article|0|||
48674204|NCT03208088|156659633|FG005|Period 3|Unsatisfactory Test Article|0|||
48674205|NCT03208088|156659634|FG006|Period 3|Unsatisfactory Test Article|0|||
48674206|NCT03208088|156659635|FG007|Period 3|Unsatisfactory Test Article|0|||
48674207|NCT03208088|156659636|FG008|Period 3|Unsatisfactory Test Article|0|||
48674208|NCT03208088|156659637|FG009|Period 3|Unsatisfactory Test Article|0|||
48674209|NCT03208088|156659628|FG000|Period 4|Unsatisfactory Test Article|0|||
48674210|NCT03208088|156659629|FG001|Period 4|Unsatisfactory Test Article|0|||
48674211|NCT03208088|156659630|FG002|Period 4|Unsatisfactory Test Article|0|||
48674212|NCT03208088|156659631|FG003|Period 4|Unsatisfactory Test Article|1|||
48761429|NCT01729754|156975632|FG001|Part 1|Pregnancy|0|||
48674213|NCT03208088|156659632|FG004|Period 4|Unsatisfactory Test Article|0|||
48674214|NCT03208088|156659633|FG005|Period 4|Unsatisfactory Test Article|0|||
48674215|NCT03208088|156659634|FG006|Period 4|Unsatisfactory Test Article|0|||
48674216|NCT03208088|156659635|FG007|Period 4|Unsatisfactory Test Article|0|||
48674217|NCT03208088|156659636|FG008|Period 4|Unsatisfactory Test Article|0|||
48674218|NCT03208088|156659637|FG009|Period 4|Unsatisfactory Test Article|0|||
48674219|NCT01068158|156659638|FG000|Overall Study|Withdrawal by Subject|1|||
48674220|NCT01068158|156659639|FG001|Overall Study|Withdrawal by Subject|2|||
48674221|NCT01068158|156659638|FG000|Overall Study|Lost to Follow-up|7|||
48674222|NCT01068158|156659639|FG001|Overall Study|Lost to Follow-up|0|||
48674223|NCT01068158|156659638|FG000|Overall Study|Protocol Violation|0|||
48674224|NCT01068158|156659639|FG001|Overall Study|Protocol Violation|2|||
48674225|NCT00172042|156659641|FG000|Overall Study|Adverse Event|27|||
48674226|NCT00172042|156659642|FG001|Overall Study|Adverse Event|13|||
48674227|NCT00172042|156659641|FG000|Overall Study|Abnormal laboratory value(s)|5|||
48674228|NCT00172042|156659642|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48674229|NCT00172042|156659641|FG000|Overall Study|Abnormal test procedure(s)|0|||
48674230|NCT00172042|156659642|FG001|Overall Study|Abnormal test procedure(s)|3|||
48674231|NCT00172042|156659641|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
48674232|NCT00172042|156659642|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
48674233|NCT00172042|156659641|FG000|Overall Study|Patient no longer requires study drug|10|||
48674234|NCT00172042|156659642|FG001|Overall Study|Patient no longer requires study drug|8|||
48347297|NCT00113269|155468058|FG003|Overall Study|Did not meet eligibility criteria|1|||
48347298|NCT00113269|155468055|FG000|Overall Study|Unable to return for follow up|2|||
48347299|NCT00113269|155468056|FG001|Overall Study|Unable to return for follow up|1|||
48347300|NCT00113269|155468057|FG002|Overall Study|Unable to return for follow up|0|||
48347301|NCT00113269|155468058|FG003|Overall Study|Unable to return for follow up|0|||
48674235|NCT00172042|156659641|FG000|Overall Study|Protocol Violation|8|||
48674236|NCT00172042|156659642|FG001|Overall Study|Protocol Violation|7|||
48674237|NCT00172042|156659641|FG000|Overall Study|Withdrawal by Subject|37|||
48674238|NCT00172042|156659642|FG001|Overall Study|Withdrawal by Subject|25|||
48674239|NCT00172042|156659641|FG000|Overall Study|Lost to Follow-up|3|||
48674240|NCT00172042|156659642|FG001|Overall Study|Lost to Follow-up|5|||
48674241|NCT00172042|156659641|FG000|Overall Study|Administrative problems|13|||
48674242|NCT00172042|156659642|FG001|Overall Study|Administrative problems|10|||
48674243|NCT00172042|156659641|FG000|Overall Study|Death|42|||
48674244|NCT00172042|156659642|FG001|Overall Study|Death|42|||
48674245|NCT03170193|156659643|FG000|Overall Study|Withdrawal by Subject|0|||
48674246|NCT03170193|156659644|FG001|Overall Study|Withdrawal by Subject|0|||
48674247|NCT03170193|156659645|FG002|Overall Study|Withdrawal by Subject|0|||
48674248|NCT03170193|156659646|FG003|Overall Study|Withdrawal by Subject|1|||
48674249|NCT03170193|156659647|FG004|Overall Study|Withdrawal by Subject|0|||
48674250|NCT03170193|156659648|FG005|Overall Study|Withdrawal by Subject|0|||
48674251|NCT03170193|156659649|FG006|Overall Study|Withdrawal by Subject|0|||
48674252|NCT03170193|156659643|FG000|Overall Study|Lost to Follow-up|1|||
48674253|NCT03170193|156659644|FG001|Overall Study|Lost to Follow-up|1|||
48347302|NCT02210208|155468059|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
48347303|NCT02210208|155468059|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
48347304|NCT02210208|155468059|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
48347305|NCT01171183|155468060|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
48347306|NCT01171183|155468061|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
48347307|NCT01171183|155468060|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
48347308|NCT01171183|155468061|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
48347309|NCT01171183|155468060|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
48347310|NCT01171183|155468061|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
48347311|NCT01171183|155468060|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
48347312|NCT01171183|155468061|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
48347313|NCT01171183|155468060|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
48347314|NCT01171183|155468061|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
48347315|NCT01171183|155468060|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
48347316|NCT01171183|155468061|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
48347317|NCT01101334|155468062|FG000|Overall Study|Adverse Event|9|||
48347318|NCT01101334|155468063|FG001|Overall Study|Adverse Event|4|||
48347319|NCT01101334|155468062|FG000|Overall Study|Death|7|||
48674254|NCT03170193|156659645|FG002|Overall Study|Lost to Follow-up|0|||
48347320|NCT01101334|155468063|FG001|Overall Study|Death|1|||
48347321|NCT01101334|155468062|FG000|Overall Study|Withdrawal by Subject|4|||
48347322|NCT01101334|155468063|FG001|Overall Study|Withdrawal by Subject|3|||
48674255|NCT03170193|156659646|FG003|Overall Study|Lost to Follow-up|0|||
48674256|NCT03170193|156659647|FG004|Overall Study|Lost to Follow-up|0|||
48674257|NCT03170193|156659648|FG005|Overall Study|Lost to Follow-up|0|||
48674258|NCT03170193|156659649|FG006|Overall Study|Lost to Follow-up|0|||
48674259|NCT00238238|156659654|FG000|Overall Study|Withdrawal by Subject|0|||
48674260|NCT00238238|156659655|FG001|Overall Study|Withdrawal by Subject|3|||
48674261|NCT00238238|156659656|FG002|Overall Study|Withdrawal by Subject|0|||
48347323|NCT01101334|155468062|FG000|Overall Study|Withdrawal by Sponsor|1|||
48347324|NCT01101334|155468063|FG001|Overall Study|Withdrawal by Sponsor|1|||
48347325|NCT01101334|155468062|FG000|Overall Study|Progressive Disease|22|||
48347326|NCT01101334|155468063|FG001|Overall Study|Progressive Disease|35|||
48347327|NCT01101334|155468062|FG000|Overall Study|Other|2|||
48347328|NCT01101334|155468063|FG001|Overall Study|Other|1|||
48347329|NCT03864341|155468068|FG000|Overall Study|Withdrawal by Subject|1|||
48674262|NCT03052816|156659658|FG000|Overall Study|Withdrawal by Subject|1|||
48674263|NCT03052816|156659659|FG001|Overall Study|Withdrawal by Subject|0|||
48674264|NCT03052816|156659658|FG000|Overall Study|Desired opioids|2|||
48674265|NCT03052816|156659659|FG001|Overall Study|Desired opioids|0|||
48674266|NCT00895453|156659660|FG000|Overall Study|Lost to Follow-up|25|||
48674267|NCT00895453|156659661|FG001|Overall Study|Lost to Follow-up|25|||
48674268|NCT00895453|156659662|FG002|Overall Study|Lost to Follow-up|23|||
48674269|NCT04699461|156659663|FG000|Overall Study|Withdrawal by Subject|1|||
48674270|NCT04699461|156659664|FG001|Overall Study|Withdrawal by Subject|0|||
48674271|NCT04699461|156659663|FG000|Overall Study|Study termination by sponsor|2|||
48674272|NCT04699461|156659664|FG001|Overall Study|Study termination by sponsor|1|||
48674273|NCT04699461|156659663|FG000|Overall Study|Death|1|||
48674274|NCT04699461|156659664|FG001|Overall Study|Death|0|||
48674275|NCT04699461|156659663|FG000|Overall Study|Radiographic progression|0|||
48674276|NCT04699461|156659664|FG001|Overall Study|Radiographic progression|1|||
48674277|NCT04167137|156659667|FG000|Overall Study|Disease progression|1|||
48674278|NCT04167137|156659668|FG001|Overall Study|Disease progression|1|||
48674279|NCT04167137|156659669|FG002|Overall Study|Disease progression|3|||
48674280|NCT04167137|156659670|FG003|Overall Study|Disease progression|3|||
48674281|NCT04167137|156659671|FG004|Overall Study|Disease progression|2|||
48674282|NCT04167137|156659672|FG005|Overall Study|Disease progression|3|||
48674283|NCT04167137|156659673|FG006|Overall Study|Disease progression|2|||
48674284|NCT04167137|156659674|FG007|Overall Study|Disease progression|2|||
48674285|NCT04167137|156659667|FG000|Overall Study|Withdrawal by Subject|1|||
48674286|NCT04167137|156659668|FG001|Overall Study|Withdrawal by Subject|0|||
48674287|NCT04167137|156659669|FG002|Overall Study|Withdrawal by Subject|0|||
48674288|NCT04167137|156659670|FG003|Overall Study|Withdrawal by Subject|1|||
48674289|NCT04167137|156659671|FG004|Overall Study|Withdrawal by Subject|0|||
48674290|NCT04167137|156659672|FG005|Overall Study|Withdrawal by Subject|2|||
48674291|NCT04167137|156659673|FG006|Overall Study|Withdrawal by Subject|1|||
48674292|NCT04167137|156659674|FG007|Overall Study|Withdrawal by Subject|0|||
48674293|NCT04167137|156659667|FG000|Overall Study|Adverse Event|0|||
48674294|NCT04167137|156659668|FG001|Overall Study|Adverse Event|0|||
48674295|NCT04167137|156659669|FG002|Overall Study|Adverse Event|0|||
48674296|NCT04167137|156659670|FG003|Overall Study|Adverse Event|0|||
48674297|NCT04167137|156659671|FG004|Overall Study|Adverse Event|0|||
48674298|NCT04167137|156659672|FG005|Overall Study|Adverse Event|1|||
48674299|NCT04167137|156659673|FG006|Overall Study|Adverse Event|0|||
48674300|NCT04167137|156659674|FG007|Overall Study|Adverse Event|1|||
48674301|NCT04167137|156659667|FG000|Overall Study|Physician Decision|0|||
48674302|NCT04167137|156659668|FG001|Overall Study|Physician Decision|0|||
48674303|NCT04167137|156659669|FG002|Overall Study|Physician Decision|0|||
48674304|NCT04167137|156659670|FG003|Overall Study|Physician Decision|1|||
48674305|NCT04167137|156659671|FG004|Overall Study|Physician Decision|0|||
48674306|NCT04167137|156659672|FG005|Overall Study|Physician Decision|0|||
48674307|NCT04167137|156659673|FG006|Overall Study|Physician Decision|1|||
48674308|NCT04167137|156659674|FG007|Overall Study|Physician Decision|0|||
48674309|NCT04167137|156659667|FG000|Overall Study|Death|0|||
48674310|NCT04167137|156659668|FG001|Overall Study|Death|1|||
48674311|NCT04167137|156659669|FG002|Overall Study|Death|0|||
48674312|NCT04167137|156659670|FG003|Overall Study|Death|0|||
48674313|NCT04167137|156659671|FG004|Overall Study|Death|0|||
48674314|NCT04167137|156659672|FG005|Overall Study|Death|0|||
48674315|NCT04167137|156659673|FG006|Overall Study|Death|0|||
48761430|NCT01729754|156975633|FG002|Part 1|Pregnancy|0|||
48761431|NCT01729754|156975634|FG003|Part 1|Pregnancy|1|||
48761432|NCT01729754|156975635|FG004|Part 1|Pregnancy|0|||
48761433|NCT01729754|156975636|FG005|Part 1|Pregnancy|0|||
48761434|NCT01729754|156975637|FG006|Part 1|Pregnancy|0|||
48761435|NCT01729754|156975638|FG007|Part 1|Pregnancy|0|||
48674316|NCT04167137|156659674|FG007|Overall Study|Death|0|||
48674317|NCT04167137|156659667|FG000|Overall Study|Study terminated by Sponsor|0|||
48674318|NCT04167137|156659668|FG001|Overall Study|Study terminated by Sponsor|0|||
48674319|NCT04167137|156659669|FG002|Overall Study|Study terminated by Sponsor|0|||
48674320|NCT04167137|156659670|FG003|Overall Study|Study terminated by Sponsor|0|||
48674321|NCT04167137|156659671|FG004|Overall Study|Study terminated by Sponsor|0|||
48674322|NCT04167137|156659672|FG005|Overall Study|Study terminated by Sponsor|0|||
48674323|NCT04167137|156659673|FG006|Overall Study|Study terminated by Sponsor|0|||
48761436|NCT01729754|156975639|FG008|Part 1|Pregnancy|0|||
48761437|NCT01729754|156975640|FG009|Part 1|Pregnancy|1|||
48761438|NCT01729754|156975631|FG000|Part 1|Progressive Disease|0|||
48761439|NCT01729754|156975632|FG001|Part 1|Progressive Disease|0|||
48674324|NCT04167137|156659674|FG007|Overall Study|Study terminated by Sponsor|1|||
48674325|NCT00211887|156659675|FG000|Overall Study|Adverse Event|8|||
48674326|NCT00211887|156659676|FG001|Overall Study|Adverse Event|4|||
48674327|NCT00211887|156659677|FG002|Overall Study|Adverse Event|6|||
48674328|NCT00211887|156659675|FG000|Overall Study|Death|1|||
48674329|NCT00211887|156659676|FG001|Overall Study|Death|1|||
48674330|NCT00211887|156659677|FG002|Overall Study|Death|1|||
48674331|NCT00211887|156659675|FG000|Overall Study|Lost to Follow-up|28|||
48674332|NCT00211887|156659676|FG001|Overall Study|Lost to Follow-up|13|||
48674333|NCT00211887|156659677|FG002|Overall Study|Lost to Follow-up|9|||
48674334|NCT00211887|156659675|FG000|Overall Study|Non-medical reason|31|||
48674335|NCT00211887|156659676|FG001|Overall Study|Non-medical reason|14|||
48674336|NCT00211887|156659677|FG002|Overall Study|Non-medical reason|8|||
48761440|NCT01729754|156975633|FG002|Part 1|Progressive Disease|0|||
48761441|NCT01729754|156975634|FG003|Part 1|Progressive Disease|0|||
48761442|NCT01729754|156975635|FG004|Part 1|Progressive Disease|0|||
48761443|NCT01729754|156975636|FG005|Part 1|Progressive Disease|0|||
48347330|NCT01066936|155468069|FG000|Overall Study|Death|2|||
48347331|NCT01066936|155468069|FG000|Overall Study|Device revised/removed|1|||
48347332|NCT01066936|155468069|FG000|Overall Study|Lost to Follow-up|3|||
48347333|NCT01066936|155468069|FG000|Overall Study|Withdrawal by Subject|4|||
48347334|NCT01904136|155468070|FG000|Overall Study|Physician Decision|0|||
48347335|NCT01904136|155468071|FG001|Overall Study|Physician Decision|0|||
48347336|NCT01904136|155468072|FG002|Overall Study|Physician Decision|0|||
48347337|NCT01904136|155468073|FG003|Overall Study|Physician Decision|0|||
48674337|NCT00211887|156659675|FG000|Overall Study|Other medical reason|15|||
48674338|NCT00211887|156659676|FG001|Overall Study|Other medical reason|11|||
48674339|NCT00211887|156659677|FG002|Overall Study|Other medical reason|7|||
48674340|NCT00211887|156659675|FG000|Overall Study|Side effects|19|||
48674341|NCT00211887|156659676|FG001|Overall Study|Side effects|13|||
48674342|NCT00211887|156659677|FG002|Overall Study|Side effects|5|||
48674343|NCT00687531|156659678|FG000|Overall Study|Did not meet protocol eligibility|104|||
48674344|NCT00687531|156659678|FG000|Overall Study|Adverse Event|5|||
48674345|NCT00687531|156659678|FG000|Overall Study|Lost to Follow-up|26|||
48674346|NCT00856297|156659679|FG000|Overall Study|Unable to classify|2|||
48674347|NCT00856297|156659680|FG001|Overall Study|Unable to classify|0|||
48674348|NCT00856297|156659681|FG002|Overall Study|Unable to classify|0|||
48674349|NCT00856297|156659682|FG003|Overall Study|Unable to classify|0|||
48674350|NCT00856297|156659683|FG004|Overall Study|Unable to classify|0|||
48674351|NCT03890367|156659687|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48674352|NCT03890367|156659688|FG001|Overall Study|Withdrawal by parent/guardian|3|||
48674353|NCT03890367|156659689|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48674354|NCT03890367|156659687|FG000|Overall Study|Protocol deviation|2|||
48674355|NCT03890367|156659688|FG001|Overall Study|Protocol deviation|2|||
48674356|NCT03890367|156659689|FG002|Overall Study|Protocol deviation|1|||
48674357|NCT03890367|156659687|FG000|Overall Study|Lost to Follow-up|1|||
48674358|NCT03890367|156659688|FG001|Overall Study|Lost to Follow-up|1|||
48674359|NCT03890367|156659689|FG002|Overall Study|Lost to Follow-up|0|||
48674360|NCT03857542|156659690|FG000|Overall Study|Adverse Event|1|||
48674361|NCT03857542|156659691|FG001|Overall Study|Adverse Event|3|||
48674362|NCT03857542|156659690|FG000|Overall Study|Withdrawal by Subject|2|||
48674363|NCT03857542|156659691|FG001|Overall Study|Withdrawal by Subject|1|||
48674364|NCT03857542|156659690|FG000|Overall Study|Lost to Follow-up|2|||
48674365|NCT03857542|156659691|FG001|Overall Study|Lost to Follow-up|1|||
48674366|NCT03857542|156659690|FG000|Overall Study|Reason not Specified|1|||
48674367|NCT03857542|156659691|FG001|Overall Study|Reason not Specified|0|||
48674368|NCT02593825|156661466|FG000|Intervention|Lost to Follow-up|10|||
48674369|NCT02593825|156661467|FG001|Intervention|Lost to Follow-up|12|||
48674370|NCT03654885|156661468|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
48674371|NCT03654885|156661469|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
48674372|NCT03654885|156661468|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
48674373|NCT03654885|156661469|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
48674374|NCT03654885|156661468|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
48674375|NCT03654885|156661469|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
48674376|NCT03654885|156661468|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
48674377|NCT03654885|156661469|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
48674378|NCT03654885|156661468|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
48674379|NCT03654885|156661469|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
48674380|NCT03654885|156661468|FG000|Overall Study|Adverse Event in Study Eye|3|||
48674381|NCT03654885|156661469|FG001|Overall Study|Adverse Event in Study Eye|0|||
48674382|NCT03654885|156661468|FG000|Overall Study|Consent Withdrawn|1|||
48674383|NCT03654885|156661469|FG001|Overall Study|Consent Withdrawn|0|||
48674384|NCT03654885|156661468|FG000|Overall Study|Death|3|||
48674385|NCT03654885|156661469|FG001|Overall Study|Death|1|||
48674386|NCT03654885|156661468|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
48674387|NCT03654885|156661469|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
48347338|NCT01904136|155468074|FG004|Overall Study|Physician Decision|0|||
48674388|NCT03654885|156661468|FG000|Overall Study|Lost to Follow-up|3|||
48674389|NCT03654885|156661469|FG001|Overall Study|Lost to Follow-up|3|||
48347339|NCT01904136|155468075|FG005|Overall Study|Physician Decision|1|||
48674390|NCT04736628|156661470|FG000|Overall Study|Not treated|0|||
48674391|NCT04736628|156661471|FG001|Overall Study|Not treated|0|||
48674392|NCT04736628|156661472|FG002|Overall Study|Not treated|0|||
48674393|NCT04736628|156661473|FG003|Overall Study|Not treated|2|||
48674394|NCT04736628|156661470|FG000|Overall Study|Other reason than listed|1|||
48674395|NCT04736628|156661471|FG001|Overall Study|Other reason than listed|2|||
48674396|NCT04736628|156661472|FG002|Overall Study|Other reason than listed|2|||
48347340|NCT01904136|155468076|FG006|Overall Study|Physician Decision|0|||
48347341|NCT01904136|155468077|FG007|Overall Study|Physician Decision|0|||
48674397|NCT04736628|156661473|FG003|Overall Study|Other reason than listed|3|||
48674398|NCT04736628|156661470|FG000|Overall Study|Protocol deviation|0|||
48674399|NCT04736628|156661471|FG001|Overall Study|Protocol deviation|0|||
48674400|NCT04736628|156661472|FG002|Overall Study|Protocol deviation|0|||
48674401|NCT04736628|156661473|FG003|Overall Study|Protocol deviation|1|||
48674402|NCT04736628|156661470|FG000|Overall Study|Burden of study procedures|1|||
48674403|NCT04736628|156661471|FG001|Overall Study|Burden of study procedures|0|||
48674404|NCT04736628|156661472|FG002|Overall Study|Burden of study procedures|0|||
48674405|NCT04736628|156661473|FG003|Overall Study|Burden of study procedures|1|||
48674406|NCT04736628|156661470|FG000|Overall Study|Change of residence|0|||
48674407|NCT04736628|156661471|FG001|Overall Study|Change of residence|1|||
48674408|NCT04736628|156661472|FG002|Overall Study|Change of residence|0|||
48674409|NCT04736628|156661473|FG003|Overall Study|Change of residence|0|||
48674410|NCT04736628|156661470|FG000|Overall Study|Perceived lack of efficacy|1|||
48674411|NCT04736628|156661471|FG001|Overall Study|Perceived lack of efficacy|0|||
48674412|NCT04736628|156661472|FG002|Overall Study|Perceived lack of efficacy|0|||
48674413|NCT04736628|156661473|FG003|Overall Study|Perceived lack of efficacy|1|||
48674414|NCT04736628|156661470|FG000|Overall Study|Adverse Event|3|||
48674415|NCT04736628|156661471|FG001|Overall Study|Adverse Event|2|||
48674416|NCT04736628|156661472|FG002|Overall Study|Adverse Event|4|||
48674417|NCT04736628|156661473|FG003|Overall Study|Adverse Event|3|||
48674418|NCT00820222|156661479|FG000|Overall Study|Lost to Follow-up|10|||
48674419|NCT00820222|156661480|FG001|Overall Study|Lost to Follow-up|9|||
48674420|NCT00820222|156661479|FG000|Overall Study|Withdrawal by Subject|19|||
48674421|NCT00820222|156661480|FG001|Overall Study|Withdrawal by Subject|21|||
48674422|NCT00820222|156661479|FG000|Overall Study|Physician Decision|93|||
48674423|NCT00820222|156661480|FG001|Overall Study|Physician Decision|88|||
48674424|NCT00820222|156661479|FG000|Overall Study|Sponsor Terminated Study|43|||
48674425|NCT00820222|156661480|FG001|Overall Study|Sponsor Terminated Study|65|||
48674426|NCT00820222|156661479|FG000|Overall Study|Unkown|11|||
48674427|NCT00820222|156661480|FG001|Overall Study|Unkown|7|||
48674428|NCT01789606|156661482|FG000|Overall Study|Participant not Purchased the Product|0|||
48674429|NCT01789606|156661483|FG001|Overall Study|Participant not Purchased the Product|20|||
48674430|NCT01789606|156661482|FG000|Overall Study|Withdrawal by Subject|0|||
48674431|NCT01789606|156661483|FG001|Overall Study|Withdrawal by Subject|1|||
48674432|NCT01789606|156661482|FG000|Overall Study|Ineligible|6|||
48674433|NCT01789606|156661483|FG001|Overall Study|Ineligible|2|||
48674434|NCT01789606|156661482|FG000|Overall Study|Administrative Reasons|17|||
48674435|NCT01789606|156661483|FG001|Overall Study|Administrative Reasons|6|||
48674436|NCT01789606|156661482|FG000|Overall Study|No Study Medication Taken|0|||
48674437|NCT01789606|156661483|FG001|Overall Study|No Study Medication Taken|1|||
48674438|NCT01789606|156661482|FG000|Overall Study|Protocol Violation|0|||
48674439|NCT01789606|156661483|FG001|Overall Study|Protocol Violation|55|||
48674440|NCT01789606|156661482|FG000|Overall Study|Adverse Event|0|||
48674441|NCT01789606|156661483|FG001|Overall Study|Adverse Event|3|||
48674442|NCT01789606|156661482|FG000|Overall Study|Lost to Follow-up|0|||
48674443|NCT01789606|156661483|FG001|Overall Study|Lost to Follow-up|14|||
48674444|NCT01789606|156661482|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
48674445|NCT01789606|156661483|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
48674446|NCT00095173|156661484|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
48674447|NCT00095173|156661485|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674448|NCT00095173|156661486|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674449|NCT00095173|156661487|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674450|NCT00095173|156661488|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674451|NCT00095173|156661489|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
48674452|NCT00095173|156661484|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
48674453|NCT00095173|156661485|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674454|NCT00095173|156661486|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674455|NCT00095173|156661487|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674456|NCT00095173|156661488|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674457|NCT00095173|156661489|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
48674458|NCT00095173|156661484|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
48674459|NCT00095173|156661485|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674460|NCT00095173|156661486|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674461|NCT00095173|156661487|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674462|NCT00095173|156661488|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674463|NCT00095173|156661489|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
48674464|NCT00095173|156661484|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
48674465|NCT00095173|156661485|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
48674466|NCT00095173|156661486|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
48674467|NCT00095173|156661487|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
48674468|NCT00095173|156661488|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
48674469|NCT00095173|156661489|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
48674470|NCT00095173|156661484|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
48674471|NCT00095173|156661485|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
48674472|NCT00095173|156661486|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
48674473|NCT00095173|156661487|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
48674474|NCT00095173|156661488|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
48674475|NCT00095173|156661489|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
48674476|NCT00095173|156661484|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48347342|NCT01904136|155468078|FG008|Overall Study|Physician Decision|0|||
48347343|NCT02507687|155468084|FG000|Overall Study|Adverse Event|3|||
48347344|NCT02507687|155468085|FG001|Overall Study|Adverse Event|2|||
48674477|NCT00095173|156661485|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
48674478|NCT00095173|156661486|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48674479|NCT00095173|156661487|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48674480|NCT00095173|156661488|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48674481|NCT00095173|156661489|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
48674482|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Death|0|||
48674483|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Death|0|||
48674484|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Death|0|||
48674485|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Death|0|||
48674486|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Death|0|||
48674487|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Death|1|||
48674488|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
48674489|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
48674490|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
48674491|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
48674492|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
48674493|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
48674494|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
48674495|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
48674496|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
48674497|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
48674498|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
48674499|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
48761444|NCT01729754|156975637|FG006|Part 1|Progressive Disease|0|||
48347345|NCT02507687|155468086|FG002|Overall Study|Adverse Event|2|||
48347346|NCT02507687|155468087|FG003|Overall Study|Adverse Event|2|||
48347347|NCT02507687|155468084|FG000|Overall Study|Withdrawal by Subject|1|||
48347348|NCT02507687|155468085|FG001|Overall Study|Withdrawal by Subject|4|||
48347349|NCT02507687|155468086|FG002|Overall Study|Withdrawal by Subject|6|||
48347350|NCT02507687|155468087|FG003|Overall Study|Withdrawal by Subject|6|||
48347351|NCT02507687|155468084|FG000|Overall Study|Protocol Violation|1|||
48347352|NCT02507687|155468085|FG001|Overall Study|Protocol Violation|0|||
48347353|NCT02507687|155468086|FG002|Overall Study|Protocol Violation|2|||
48347354|NCT02507687|155468087|FG003|Overall Study|Protocol Violation|0|||
48347355|NCT02507687|155468084|FG000|Overall Study|Lost to Follow-up|0|||
48347356|NCT02507687|155468085|FG001|Overall Study|Lost to Follow-up|0|||
48347357|NCT02507687|155468086|FG002|Overall Study|Lost to Follow-up|2|||
48347358|NCT02507687|155468087|FG003|Overall Study|Lost to Follow-up|1|||
48347359|NCT02507687|155468084|FG000|Overall Study|Screen Failure|0|||
48347360|NCT02507687|155468085|FG001|Overall Study|Screen Failure|0|||
48347361|NCT02507687|155468086|FG002|Overall Study|Screen Failure|1|||
48347362|NCT02507687|155468087|FG003|Overall Study|Screen Failure|0|||
48674500|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
48674501|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
48347363|NCT02507687|155468084|FG000|Overall Study|Other, Not Specified|0|||
48347364|NCT02507687|155468085|FG001|Overall Study|Other, Not Specified|0|||
48761445|NCT01729754|156975638|FG007|Part 1|Progressive Disease|0|||
48761446|NCT01729754|156975639|FG008|Part 1|Progressive Disease|0|||
48761447|NCT01729754|156975640|FG009|Part 1|Progressive Disease|1|||
48761448|NCT01729754|156975631|FG000|Part 1|Protocol Violation|2|||
48761449|NCT01729754|156975632|FG001|Part 1|Protocol Violation|0|||
48761450|NCT01729754|156975633|FG002|Part 1|Protocol Violation|0|||
48761451|NCT01729754|156975634|FG003|Part 1|Protocol Violation|1|||
48347365|NCT02507687|155468086|FG002|Overall Study|Other, Not Specified|2|||
48347366|NCT02507687|155468087|FG003|Overall Study|Other, Not Specified|4|||
48674502|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
48674503|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
48674504|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
48761452|NCT01729754|156975635|FG004|Part 1|Protocol Violation|0|||
48761453|NCT01729754|156975636|FG005|Part 1|Protocol Violation|0|||
48761454|NCT01729754|156975637|FG006|Part 1|Protocol Violation|1|||
48674505|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
48674506|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
48347367|NCT00853372|155468088|FG000|Overall Study|Death|30|||
48347368|NCT00853372|155468089|FG001|Overall Study|Death|26|||
48347369|NCT00853372|155468088|FG000|Overall Study|Lost to Follow-up|1|||
48347370|NCT00853372|155468089|FG001|Overall Study|Lost to Follow-up|2|||
48347371|NCT00853372|155468088|FG000|Overall Study|Full Consent Withdrawn|1|||
48674507|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
48674508|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
48347372|NCT00853372|155468089|FG001|Overall Study|Full Consent Withdrawn|1|||
48347373|NCT01821729|155468090|FG000|Overall Study|Withdrawal by Subject|1|||
48761455|NCT01729754|156975638|FG007|Part 1|Protocol Violation|0|||
48761456|NCT01729754|156975639|FG008|Part 1|Protocol Violation|0|||
48761457|NCT01729754|156975640|FG009|Part 1|Protocol Violation|0|||
48761458|NCT01729754|156975631|FG000|Part 1|Withdrawal by Subject|5|||
48761459|NCT01729754|156975632|FG001|Part 1|Withdrawal by Subject|0|||
48761460|NCT01729754|156975633|FG002|Part 1|Withdrawal by Subject|0|||
48761461|NCT01729754|156975634|FG003|Part 1|Withdrawal by Subject|7|||
48761462|NCT01729754|156975635|FG004|Part 1|Withdrawal by Subject|0|||
48761463|NCT01729754|156975636|FG005|Part 1|Withdrawal by Subject|0|||
48761464|NCT01729754|156975637|FG006|Part 1|Withdrawal by Subject|5|||
48761465|NCT01729754|156975638|FG007|Part 1|Withdrawal by Subject|0|||
48761466|NCT01729754|156975639|FG008|Part 1|Withdrawal by Subject|0|||
48761467|NCT01729754|156975640|FG009|Part 1|Withdrawal by Subject|6|||
48761468|NCT01729754|156975631|FG000|Part 1|Other Protocol Specified Criteria|2|||
48674509|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
48674510|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
48674511|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
48674512|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
48674513|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
48674514|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
48674515|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
48674516|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
48674517|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
48674518|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
48674519|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
48674520|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
48674521|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
48674522|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
48674523|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
48674524|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
48674525|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
48674526|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
48674527|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
48674528|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
48674529|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
48674530|NCT00095173|156661484|FG000|Open-Label Extension Phase (Period C)|Other|0|||
48674531|NCT00095173|156661485|FG001|Open-Label Extension Phase (Period C)|Other|0|||
48674532|NCT00095173|156661486|FG002|Open-Label Extension Phase (Period C)|Other|0|||
48674533|NCT00095173|156661487|FG003|Open-Label Extension Phase (Period C)|Other|4|||
48674534|NCT00095173|156661488|FG004|Open-Label Extension Phase (Period C)|Other|6|||
48761469|NCT01729754|156975632|FG001|Part 1|Other Protocol Specified Criteria|0|||
48761470|NCT01729754|156975633|FG002|Part 1|Other Protocol Specified Criteria|0|||
48761471|NCT01729754|156975634|FG003|Part 1|Other Protocol Specified Criteria|0|||
48761472|NCT01729754|156975635|FG004|Part 1|Other Protocol Specified Criteria|0|||
48761473|NCT01729754|156975636|FG005|Part 1|Other Protocol Specified Criteria|0|||
48347374|NCT02916706|155468092|FG000|Overall Study|Adverse Event|0|||
48347375|NCT02916706|155468093|FG001|Overall Study|Adverse Event|1|||
48347376|NCT02916706|155468092|FG000|Overall Study|Lost to Follow-up|0|||
48347377|NCT02916706|155468093|FG001|Overall Study|Lost to Follow-up|1|||
48347378|NCT02916706|155468092|FG000|Overall Study|Physician Decision|1|||
48347379|NCT02916706|155468093|FG001|Overall Study|Physician Decision|0|||
48347380|NCT02916706|155468092|FG000|Overall Study|Protocol Violation|3|||
48347381|NCT02916706|155468093|FG001|Overall Study|Protocol Violation|1|||
48347382|NCT02916706|155468092|FG000|Overall Study|Withdrawal by Subject|6|||
48347383|NCT02916706|155468093|FG001|Overall Study|Withdrawal by Subject|9|||
48347384|NCT02916706|155468092|FG000|Overall Study|Other|5|||
48347385|NCT02916706|155468093|FG001|Overall Study|Other|19|||
48347386|NCT01093599|155468094|FG000|Overall Study|Lost to Follow-up|32|||
48347387|NCT01093599|155468095|FG001|Overall Study|Lost to Follow-up|46|||
48347388|NCT03296566|155468096|FG000|Overall Study|Lost to Follow-up|19|||
48347389|NCT03296566|155468097|FG001|Overall Study|Lost to Follow-up|46|||
48347390|NCT03296566|155468096|FG000|Overall Study|Withdrawal by Subject|0|||
48347391|NCT03296566|155468097|FG001|Overall Study|Withdrawal by Subject|3|||
48347392|NCT00487552|155468100|FG000|Overall Study|Unsuccessful magnet placements|3|||
48347393|NCT00487552|155468100|FG000|Overall Study|Death due to progressive malignancy|2|||
48347394|NCT00487552|155468100|FG000|Overall Study|Stent not placed|1|||
48347395|NCT02412111|155468101|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
48347396|NCT02412111|155468102|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
48347397|NCT02412111|155468103|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
48347398|NCT02412111|155468101|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
48347399|NCT02412111|155468102|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
48347400|NCT02412111|155468103|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
48347401|NCT02412111|155468101|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
48347402|NCT02412111|155468102|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
48347403|NCT02412111|155468103|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
48347404|NCT02412111|155468101|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
48347405|NCT02412111|155468102|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
48347406|NCT02412111|155468103|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
48347407|NCT02412111|155468101|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
48347408|NCT02412111|155468102|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
48347409|NCT02412111|155468103|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
48761474|NCT01729754|156975637|FG006|Part 1|Other Protocol Specified Criteria|1|||
48761475|NCT01729754|156975638|FG007|Part 1|Other Protocol Specified Criteria|0|||
48761476|NCT01729754|156975639|FG008|Part 1|Other Protocol Specified Criteria|0|||
48761477|NCT01729754|156975640|FG009|Part 1|Other Protocol Specified Criteria|4|||
48761478|NCT01729754|156975631|FG000|Part 2|Adverse Event|2|||
48761479|NCT01729754|156975632|FG001|Part 2|Adverse Event|0|||
48761480|NCT01729754|156975633|FG002|Part 2|Adverse Event|0|||
48347410|NCT02412111|155468101|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
48674535|NCT00095173|156661489|FG005|Open-Label Extension Phase (Period C)|Other|8|||
48674536|NCT01105377|156661492|FG000|Overall Study|Withdrawal by Subject|0|||
48674537|NCT01105377|156661493|FG001|Overall Study|Withdrawal by Subject|1|||
48674538|NCT03157037|156661497|FG000|Overall Study|Death|1|||
48674539|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
48674540|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
48674541|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
48674542|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
48761481|NCT01729754|156975634|FG003|Part 2|Adverse Event|0|||
48761482|NCT01729754|156975635|FG004|Part 2|Adverse Event|0|||
48761483|NCT01729754|156975636|FG005|Part 2|Adverse Event|0|||
48761484|NCT01729754|156975637|FG006|Part 2|Adverse Event|0|||
48761485|NCT01729754|156975638|FG007|Part 2|Adverse Event|0|||
48347411|NCT02412111|155468102|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
48347412|NCT02412111|155468103|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
48347413|NCT02412111|155468101|FG000|Active Comparator Period (8 Weeks)|Other|0|||
48347414|NCT02412111|155468102|FG001|Active Comparator Period (8 Weeks)|Other|0|||
48347415|NCT02412111|155468103|FG002|Active Comparator Period (8 Weeks)|Other|2|||
48347416|NCT00630552|155468104|FG000|Overall Study|Adverse Event|0|||
48347417|NCT00630552|155468105|FG001|Overall Study|Adverse Event|1|||
48347418|NCT00630552|155468106|FG002|Overall Study|Adverse Event|5|||
48347419|NCT00630552|155468107|FG003|Overall Study|Adverse Event|4|||
48347420|NCT00630552|155468108|FG004|Overall Study|Adverse Event|2|||
48347421|NCT00630552|155468104|FG000|Overall Study|Disease progression|5|||
48347422|NCT00630552|155468105|FG001|Overall Study|Disease progression|6|||
48347423|NCT00630552|155468106|FG002|Overall Study|Disease progression|27|||
48347424|NCT00630552|155468107|FG003|Overall Study|Disease progression|22|||
48347425|NCT00630552|155468108|FG004|Overall Study|Disease progression|31|||
48347426|NCT00630552|155468104|FG000|Overall Study|Never received IP|0|||
48347427|NCT00630552|155468105|FG001|Overall Study|Never received IP|0|||
48347428|NCT00630552|155468106|FG002|Overall Study|Never received IP|0|||
48347429|NCT00630552|155468107|FG003|Overall Study|Never received IP|2|||
48347430|NCT00630552|155468108|FG004|Overall Study|Never received IP|2|||
48347431|NCT00630552|155468104|FG000|Overall Study|Ineligibility determined|0|||
48347432|NCT00630552|155468105|FG001|Overall Study|Ineligibility determined|0|||
48347433|NCT00630552|155468106|FG002|Overall Study|Ineligibility determined|0|||
48347434|NCT00630552|155468107|FG003|Overall Study|Ineligibility determined|0|||
48347435|NCT00630552|155468108|FG004|Overall Study|Ineligibility determined|1|||
48347436|NCT00630552|155468104|FG000|Overall Study|Protocol Violation|0|||
48347437|NCT00630552|155468105|FG001|Overall Study|Protocol Violation|0|||
48347438|NCT00630552|155468106|FG002|Overall Study|Protocol Violation|0|||
48347439|NCT00630552|155468107|FG003|Overall Study|Protocol Violation|1|||
48347440|NCT00630552|155468108|FG004|Overall Study|Protocol Violation|0|||
48347441|NCT00630552|155468104|FG000|Overall Study|Physician Decision|0|||
48347442|NCT00630552|155468105|FG001|Overall Study|Physician Decision|0|||
48347443|NCT00630552|155468106|FG002|Overall Study|Physician Decision|0|||
48347444|NCT00630552|155468107|FG003|Overall Study|Physician Decision|0|||
48347445|NCT00630552|155468108|FG004|Overall Study|Physician Decision|1|||
48347446|NCT00630552|155468104|FG000|Overall Study|Death|0|||
48347447|NCT00630552|155468105|FG001|Overall Study|Death|0|||
48347448|NCT00630552|155468106|FG002|Overall Study|Death|1|||
48347449|NCT00630552|155468107|FG003|Overall Study|Death|2|||
48347450|NCT00630552|155468108|FG004|Overall Study|Death|2|||
48347451|NCT00630552|155468104|FG000|Overall Study|Withdrawal by Subject|0|||
48347452|NCT00630552|155468105|FG001|Overall Study|Withdrawal by Subject|0|||
48347453|NCT00630552|155468106|FG002|Overall Study|Withdrawal by Subject|0|||
48674543|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
48674544|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
48674545|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
48674546|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
48674547|NCT00383162|156661498|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
48674548|NCT00383162|156661499|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
48674549|NCT00383162|156661498|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
48674550|NCT00383162|156661499|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
48674551|NCT00383162|156661498|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
48674552|NCT00383162|156661499|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
48674553|NCT00383162|156661498|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
48674554|NCT00383162|156661499|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
48674555|NCT00383162|156661498|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
48674556|NCT00383162|156661499|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
48674557|NCT00235716|156661500|FG000|Overall Study|Death|26|||
48674558|NCT00235716|156661501|FG001|Overall Study|Death|39|||
48674559|NCT00235716|156661502|FG002|Overall Study|Death|32|||
48674560|NCT00235716|156661503|FG003|Overall Study|Death|31|||
48674561|NCT00235716|156661500|FG000|Overall Study|Withdrawal by Subject|23|||
48674562|NCT00235716|156661501|FG001|Overall Study|Withdrawal by Subject|19|||
48674563|NCT00235716|156661502|FG002|Overall Study|Withdrawal by Subject|17|||
48674564|NCT00235716|156661503|FG003|Overall Study|Withdrawal by Subject|18|||
48674565|NCT00235716|156661500|FG000|Overall Study|Lost to Follow-up|12|||
48674566|NCT00235716|156661501|FG001|Overall Study|Lost to Follow-up|7|||
48674567|NCT00235716|156661502|FG002|Overall Study|Lost to Follow-up|14|||
48674568|NCT00235716|156661503|FG003|Overall Study|Lost to Follow-up|10|||
48674569|NCT00235716|156661500|FG000|Overall Study|Adverse Event|1|||
48674570|NCT00235716|156661501|FG001|Overall Study|Adverse Event|1|||
48674571|NCT00235716|156661502|FG002|Overall Study|Adverse Event|1|||
48674572|NCT00235716|156661503|FG003|Overall Study|Adverse Event|0|||
48674573|NCT00235716|156661500|FG000|Overall Study|Physician Decision|0|||
48347454|NCT00630552|155468107|FG003|Overall Study|Withdrawal by Subject|1|||
48347455|NCT00630552|155468108|FG004|Overall Study|Withdrawal by Subject|0|||
48347456|NCT00630552|155468104|FG000|Overall Study|Other|0|||
48347457|NCT00630552|155468105|FG001|Overall Study|Other|0|||
48347458|NCT00630552|155468106|FG002|Overall Study|Other|4|||
48347459|NCT00630552|155468107|FG003|Overall Study|Other|2|||
48347460|NCT00630552|155468108|FG004|Overall Study|Other|0|||
48347461|NCT01951378|155468109|FG000|Overall Study|Study Terminated-Not completed|23|||
48347462|NCT01951378|155468110|FG001|Overall Study|Study Terminated-Not completed|17|||
48347463|NCT01402063|155468111|FG000|Overall Study|Withdrawal by Subject|3|||
48347464|NCT01402063|155468112|FG001|Overall Study|Withdrawal by Subject|3|||
48347465|NCT01774019|155468118|FG000|Overall Study|No longer meets protocol criteria|2|||
48347466|NCT01774019|155468119|FG001|Overall Study|No longer meets protocol criteria|0|||
48347467|NCT01774019|155468118|FG000|Overall Study|Withdrawal by Subject|1|||
48347468|NCT01774019|155468119|FG001|Overall Study|Withdrawal by Subject|0|||
48347469|NCT01774019|155468118|FG000|Overall Study|Surgery delayed > 120 days|1|||
48347470|NCT01774019|155468119|FG001|Overall Study|Surgery delayed > 120 days|0|||
48347471|NCT01774019|155468118|FG000|Overall Study|Patient refused surgery|1|||
48347472|NCT01774019|155468119|FG001|Overall Study|Patient refused surgery|1|||
48347473|NCT01774019|155468118|FG000|Overall Study|Unable to implant study device|1|||
48347474|NCT01774019|155468119|FG001|Overall Study|Unable to implant study device|0|||
48347475|NCT01774019|155468118|FG000|Overall Study|Lost to Follow-up|0|||
48347476|NCT01774019|155468119|FG001|Overall Study|Lost to Follow-up|3|||
48347477|NCT01004185|155468120|FG000|Overall Study|Adverse Event|1|||
48347478|NCT01004185|155468121|FG001|Overall Study|Adverse Event|1|||
48347479|NCT01004185|155468120|FG000|Overall Study|Lost to Follow-up|0|||
48674574|NCT00235716|156661501|FG001|Overall Study|Physician Decision|1|||
48674575|NCT00235716|156661502|FG002|Overall Study|Physician Decision|1|||
48674576|NCT00235716|156661503|FG003|Overall Study|Physician Decision|3|||
48347480|NCT01004185|155468121|FG001|Overall Study|Lost to Follow-up|1|||
48347481|NCT01004185|155468120|FG000|Overall Study|Lack of Efficacy|2|||
48347482|NCT01004185|155468121|FG001|Overall Study|Lack of Efficacy|1|||
48347483|NCT01004185|155468120|FG000|Overall Study|Sponsor Terminated Study|4|||
48347484|NCT01004185|155468121|FG001|Overall Study|Sponsor Terminated Study|5|||
48347485|NCT01004185|155468120|FG000|Overall Study|Withdrawal by Subject|2|||
48347486|NCT01004185|155468121|FG001|Overall Study|Withdrawal by Subject|1|||
48347487|NCT00619983|155468125|FG000|Test Drug Alone|Withdrawal by Subject|1|||
48347488|NCT00619983|155468126|FG001|Test Drug Alone|Withdrawal by Subject|0|||
48347489|NCT00619983|155468127|FG002|Test Drug Alone|Withdrawal by Subject|0|||
48347490|NCT00619983|155468128|FG003|Test Drug Alone|Withdrawal by Subject|1|||
48674577|NCT02249182|156661504|FG000|Treatment Phase|Lost to Follow-up|4|||
48674578|NCT02249182|156661505|FG001|Treatment Phase|Lost to Follow-up|0|||
48674579|NCT02249182|156661506|FG002|Treatment Phase|Lost to Follow-up|0|||
48347491|NCT00619983|155468125|FG000|Test Drug Alone|Failure of daily diary device|1|||
48347492|NCT00619983|155468126|FG001|Test Drug Alone|Failure of daily diary device|1|||
48347493|NCT00619983|155468127|FG002|Test Drug Alone|Failure of daily diary device|2|||
48674580|NCT02249182|156661507|FG003|Treatment Phase|Lost to Follow-up|0|||
48347494|NCT00619983|155468128|FG003|Test Drug Alone|Failure of daily diary device|2|||
48347495|NCT01316887|155468129|FG000|Overall Study|Adverse Event|13|||
48347496|NCT01316887|155468130|FG001|Overall Study|Adverse Event|21|||
48347497|NCT01316887|155468131|FG002|Overall Study|Adverse Event|17|||
48347498|NCT01316887|155468129|FG000|Overall Study|Lack of Efficacy|9|||
48347499|NCT01316887|155468130|FG001|Overall Study|Lack of Efficacy|3|||
48347500|NCT01316887|155468131|FG002|Overall Study|Lack of Efficacy|1|||
48347501|NCT01316887|155468129|FG000|Overall Study|Protocol Violation|2|||
48347502|NCT01316887|155468130|FG001|Overall Study|Protocol Violation|6|||
48347503|NCT01316887|155468131|FG002|Overall Study|Protocol Violation|6|||
48347504|NCT01316887|155468129|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
48347505|NCT01316887|155468130|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
48347506|NCT01316887|155468131|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
48347507|NCT01316887|155468129|FG000|Overall Study|Study Closed/Terminated|2|||
48347508|NCT01316887|155468130|FG001|Overall Study|Study Closed/Terminated|4|||
48347509|NCT01316887|155468131|FG002|Overall Study|Study Closed/Terminated|3|||
48347510|NCT01316887|155468129|FG000|Overall Study|Lost to Follow-up|1|||
48347511|NCT01316887|155468130|FG001|Overall Study|Lost to Follow-up|7|||
48347512|NCT01316887|155468131|FG002|Overall Study|Lost to Follow-up|5|||
48347513|NCT01316887|155468129|FG000|Overall Study|Withdrawal by Subject|8|||
48347514|NCT01316887|155468130|FG001|Overall Study|Withdrawal by Subject|16|||
48347515|NCT01316887|155468131|FG002|Overall Study|Withdrawal by Subject|15|||
48347516|NCT00809341|155468132|FG000|Overall Study|Physician Decision|0|||
48347517|NCT00809341|155468133|FG001|Overall Study|Physician Decision|1|||
48347518|NCT02447432|155468136|FG000|Epoch 001|Adverse Event|1|||
48347519|NCT02447432|155468137|FG001|Epoch 001|Adverse Event|1|||
48347520|NCT02447432|155468136|FG000|Epoch 001|Withdrawal by Subject|0|||
48347521|NCT02447432|155468137|FG001|Epoch 001|Withdrawal by Subject|4|||
48347522|NCT02447432|155468136|FG000|Epoch 001|Migrated/moved from study area|3|||
48347523|NCT02447432|155468137|FG001|Epoch 001|Migrated/moved from study area|5|||
48347524|NCT02447432|155468136|FG000|Epoch 001|Lost to Follow-up|1|||
48347525|NCT02447432|155468137|FG001|Epoch 001|Lost to Follow-up|3|||
48347526|NCT01340300|155468140|FG000|Overall Study|Lost to Follow-up|3|||
48347527|NCT01340300|155468141|FG001|Overall Study|Lost to Follow-up|0|||
48347528|NCT01340300|155468142|FG002|Overall Study|Lost to Follow-up|5|||
48347529|NCT01340300|155468143|FG003|Overall Study|Lost to Follow-up|10|||
48347530|NCT01340300|155468140|FG000|Overall Study|Withdrawal by Subject|5|||
48347531|NCT01340300|155468141|FG001|Overall Study|Withdrawal by Subject|6|||
48347532|NCT01340300|155468142|FG002|Overall Study|Withdrawal by Subject|6|||
48347533|NCT01340300|155468143|FG003|Overall Study|Withdrawal by Subject|3|||
48347534|NCT01340300|155468140|FG000|Overall Study|Adverse Event|1|||
48347535|NCT01340300|155468141|FG001|Overall Study|Adverse Event|0|||
48347536|NCT01340300|155468142|FG002|Overall Study|Adverse Event|4|||
48347537|NCT01340300|155468143|FG003|Overall Study|Adverse Event|0|||
48347538|NCT01340300|155468140|FG000|Overall Study|Physician Decision|0|||
48347539|NCT01340300|155468141|FG001|Overall Study|Physician Decision|1|||
48347540|NCT01340300|155468142|FG002|Overall Study|Physician Decision|0|||
48347541|NCT01340300|155468143|FG003|Overall Study|Physician Decision|0|||
48347542|NCT01340300|155468140|FG000|Overall Study|Unrelated sickness|0|||
48347543|NCT01340300|155468141|FG001|Overall Study|Unrelated sickness|2|||
48347544|NCT01340300|155468142|FG002|Overall Study|Unrelated sickness|0|||
48347545|NCT01340300|155468143|FG003|Overall Study|Unrelated sickness|1|||
48347546|NCT03544229|155468144|FG000|Overall Study|Adverse Event|1|||
48347547|NCT03544229|155468145|FG001|Overall Study|Adverse Event|0|||
48347548|NCT03544229|155468146|FG002|Overall Study|Adverse Event|1|||
48347549|NCT03544229|155468147|FG003|Overall Study|Adverse Event|0|||
48674581|NCT02249182|156661508|FG004|Treatment Phase|Lost to Follow-up|0|||
48674582|NCT01299116|156661511|FG000|Overall Study|Lost to Follow-up|65|||
48674583|NCT01299116|156661512|FG001|Overall Study|Lost to Follow-up|9|||
48674584|NCT01299116|156661513|FG002|Overall Study|Lost to Follow-up|11|||
48674585|NCT01620944|156661514|FG000|Overall Study|Early termination of Study|2|||
48347550|NCT03544229|155468144|FG000|Overall Study|Protocol Deviation|0|||
48347551|NCT03544229|155468145|FG001|Overall Study|Protocol Deviation|0|||
48347552|NCT03544229|155468146|FG002|Overall Study|Protocol Deviation|1|||
48347553|NCT03544229|155468147|FG003|Overall Study|Protocol Deviation|0|||
48347554|NCT03544229|155468144|FG000|Overall Study|Lost to Follow-up|3|||
48347555|NCT03544229|155468145|FG001|Overall Study|Lost to Follow-up|0|||
48674586|NCT01620944|156661515|FG001|Overall Study|Early termination of Study|1|||
48347556|NCT03544229|155468146|FG002|Overall Study|Lost to Follow-up|0|||
48347557|NCT03544229|155468147|FG003|Overall Study|Lost to Follow-up|2|||
48347558|NCT03544229|155468144|FG000|Overall Study|Voluntary Withdrawal|2|||
48347559|NCT03544229|155468145|FG001|Overall Study|Voluntary Withdrawal|1|||
48347560|NCT03544229|155468146|FG002|Overall Study|Voluntary Withdrawal|3|||
48674587|NCT01364389|156661521|FG000|Overall Study|Withdrawal by Subject|0|||
48674588|NCT01364389|156661522|FG001|Overall Study|Withdrawal by Subject|1|||
48674589|NCT01364389|156661523|FG002|Overall Study|Withdrawal by Subject|0|||
48674590|NCT01364389|156661521|FG000|Overall Study|Protocol deviation|0|||
48674591|NCT01364389|156661522|FG001|Overall Study|Protocol deviation|0|||
48674592|NCT01364389|156661523|FG002|Overall Study|Protocol deviation|1|||
48674593|NCT01364389|156661521|FG000|Overall Study|Administrative problems|1|||
48674594|NCT01364389|156661522|FG001|Overall Study|Administrative problems|0|||
48674595|NCT01364389|156661523|FG002|Overall Study|Administrative problems|0|||
48674596|NCT01364389|156661521|FG000|Overall Study|Adverse Event|1|||
48674597|NCT01364389|156661522|FG001|Overall Study|Adverse Event|0|||
48674598|NCT01364389|156661523|FG002|Overall Study|Adverse Event|0|||
48347561|NCT03544229|155468147|FG003|Overall Study|Voluntary Withdrawal|0|||
48347562|NCT03544229|155468144|FG000|Overall Study|Lack of Efficacy|0|||
48347563|NCT03544229|155468145|FG001|Overall Study|Lack of Efficacy|1|||
48347564|NCT03544229|155468146|FG002|Overall Study|Lack of Efficacy|0|||
48347565|NCT03544229|155468147|FG003|Overall Study|Lack of Efficacy|0|||
48347566|NCT01836198|155468151|FG000|Part A, Period 2|Protocol Violation|0|||
48347567|NCT01836198|155468152|FG001|Part A, Period 2|Protocol Violation|1|||
48347568|NCT01836198|155468153|FG002|Part A, Period 2|Protocol Violation|0|||
48347569|NCT00585975|155468154|FG000|Overall Study|Withdrawal by Subject|3|||
48347570|NCT00585975|155468155|FG001|Overall Study|Withdrawal by Subject|3|||
48347571|NCT00585975|155468154|FG000|Overall Study|Lost to Follow-up|2|||
48347572|NCT00585975|155468155|FG001|Overall Study|Lost to Follow-up|1|||
48347573|NCT00585975|155468154|FG000|Overall Study|Enrollment met/over-enrolled|10|||
48347574|NCT00585975|155468155|FG001|Overall Study|Enrollment met/over-enrolled|9|||
48347575|NCT00217022|155468164|FG000|Overall Study|Withdrawal by Subject|1|||
48347576|NCT00217022|155468165|FG001|Overall Study|Withdrawal by Subject|1|||
48347577|NCT00409409|155468166|FG000|Overall Study|Adverse Event|7|||
48347578|NCT00409409|155468167|FG001|Overall Study|Adverse Event|2|||
48347579|NCT00409409|155468166|FG000|Overall Study|Withdrawal by Subject|1|||
48347580|NCT00409409|155468167|FG001|Overall Study|Withdrawal by Subject|1|||
48347581|NCT00409409|155468166|FG000|Overall Study|Any other reason not above-mentioned|0|||
48347582|NCT00409409|155468167|FG001|Overall Study|Any other reason not above-mentioned|1|||
48347583|NCT02049515|155468168|FG000|Overall Study|Adverse Event|46|||
48347584|NCT02049515|155468169|FG001|Overall Study|Adverse Event|2|||
48347585|NCT02049515|155468168|FG000|Overall Study|Protocol-specified Disease Progression|23|||
48347586|NCT02049515|155468169|FG001|Overall Study|Protocol-specified Disease Progression|2|||
48347587|NCT02049515|155468168|FG000|Overall Study|Death|6|||
48347588|NCT02049515|155468169|FG001|Overall Study|Death|0|||
48347589|NCT02049515|155468168|FG000|Overall Study|Physician Decision|5|||
48347590|NCT02049515|155468169|FG001|Overall Study|Physician Decision|1|||
48347591|NCT02049515|155468168|FG000|Overall Study|Withdrawal by Subject|3|||
48347592|NCT02049515|155468169|FG001|Overall Study|Withdrawal by Subject|0|||
48347593|NCT02049515|155468168|FG000|Overall Study|Termination of the Study by Sponsor|2|||
48347594|NCT02049515|155468169|FG001|Overall Study|Termination of the Study by Sponsor|0|||
48347595|NCT02049515|155468168|FG000|Overall Study|Protocol Violation|1|||
48347596|NCT02049515|155468169|FG001|Overall Study|Protocol Violation|1|||
48347597|NCT02049515|155468168|FG000|Overall Study|Clinical Deterioration|1|||
48347598|NCT02049515|155468169|FG001|Overall Study|Clinical Deterioration|0|||
48347599|NCT02049515|155468168|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
48347600|NCT02049515|155468169|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
48347601|NCT02049515|155468168|FG000|Overall Study|Treatment Interruption >42 Days|1|||
48347602|NCT02049515|155468169|FG001|Overall Study|Treatment Interruption >42 Days|0|||
48347603|NCT02049515|155468168|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
48347604|NCT02049515|155468169|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
48347605|NCT00591591|155468171|FG000|Overall Study|Withdrawal by Subject|1|||
48347606|NCT00591591|155468172|FG001|Overall Study|Withdrawal by Subject|37|||
48347607|NCT00591591|155468171|FG000|Overall Study|Lack of Efficacy|10|||
48347608|NCT00591591|155468172|FG001|Overall Study|Lack of Efficacy|2|||
48347609|NCT01006889|155468174|FG000|Overall Study|Withdrawal by Subject|3|||
48347610|NCT01880437|155468177|FG000|Overall Study|Death|12|||
48347611|NCT01880437|155468178|FG001|Overall Study|Death|4|||
48347612|NCT01880437|155468179|FG002|Overall Study|Death|17|||
48347613|NCT01880437|155468177|FG000|Overall Study|Study terminated by Sponsor|3|||
48347614|NCT01880437|155468178|FG001|Overall Study|Study terminated by Sponsor|0|||
48674599|NCT03216746|156661524|FG000|Overall Study|Lost to Follow-up|6|||
48347615|NCT01880437|155468179|FG002|Overall Study|Study terminated by Sponsor|2|||
48347616|NCT00510146|155468182|FG000|Double-Blind Treatment|Adverse Event|30|||
48347617|NCT00510146|155468183|FG001|Double-Blind Treatment|Adverse Event|13|||
48347618|NCT00510146|155468182|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
48347619|NCT00510146|155468183|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
48674600|NCT03216746|156661525|FG001|Overall Study|Lost to Follow-up|8|||
48347620|NCT00510146|155468182|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
48347621|NCT00510146|155468183|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
48383959|NCT04029116|155601517|FG001|Overall Study|Pregnancy|2|||
48674601|NCT03216746|156661526|FG002|Overall Study|Lost to Follow-up|5|||
48674602|NCT03216746|156661527|FG003|Overall Study|Lost to Follow-up|6|||
48347622|NCT00510146|155468182|FG000|Double-Blind Treatment|Physician Decision|6|||
48347623|NCT00510146|155468183|FG001|Double-Blind Treatment|Physician Decision|0|||
48347624|NCT00510146|155468182|FG000|Double-Blind Treatment|Protocol Violation|1|||
48347625|NCT00510146|155468183|FG001|Double-Blind Treatment|Protocol Violation|2|||
48347626|NCT00510146|155468182|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
48347627|NCT00510146|155468183|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
48347628|NCT00510146|155468182|FG000|Double-Blind Treatment|Clinical Relapse|0|||
48347629|NCT00510146|155468183|FG001|Double-Blind Treatment|Clinical Relapse|1|||
48347630|NCT00510146|155468182|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
48347631|NCT00510146|155468183|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
48347632|NCT00510146|155468182|FG000|Open-Label Treatment|Adverse Event|22|||
48347633|NCT00510146|155468183|FG001|Open-Label Treatment|Adverse Event|8|||
48347634|NCT00510146|155468182|FG000|Open-Label Treatment|Death|1|||
48347635|NCT00510146|155468183|FG001|Open-Label Treatment|Death|1|||
48347636|NCT00510146|155468182|FG000|Open-Label Treatment|Lack of Efficacy|4|||
48347637|NCT00510146|155468183|FG001|Open-Label Treatment|Lack of Efficacy|0|||
48347638|NCT00510146|155468182|FG000|Open-Label Treatment|Lost to Follow-up|10|||
48347639|NCT00510146|155468183|FG001|Open-Label Treatment|Lost to Follow-up|1|||
48347640|NCT00510146|155468182|FG000|Open-Label Treatment|Physician Decision|3|||
48347641|NCT00510146|155468183|FG001|Open-Label Treatment|Physician Decision|1|||
48347642|NCT00510146|155468182|FG000|Open-Label Treatment|Protocol Violation|4|||
48347643|NCT00510146|155468183|FG001|Open-Label Treatment|Protocol Violation|2|||
48674603|NCT00835341|156661528|FG000|Overall Study|Lost to Follow-up|3|||
48674604|NCT00835341|156661529|FG001|Overall Study|Lost to Follow-up|12|||
48674605|NCT01114438|156661530|FG000|Overall Study|Adverse Event|10|||
48674606|NCT01114438|156661530|FG000|Overall Study|concomitant medication|1|||
48674607|NCT01114438|156661530|FG000|Overall Study|Physician Decision|1|||
48674608|NCT01114438|156661530|FG000|Overall Study|Withdrawal by Subject|2|||
48674609|NCT00991406|156661545|FG000|Overall Study|One participant did not respond to FES.|1|||
48674610|NCT01746173|156661546|FG000|Overall Study|Disease Progression|2|||
48674611|NCT02596945|156661548|FG000|Overall Study|No documentation of study drug dosing|3|||
48347644|NCT00510146|155468182|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
48347645|NCT00510146|155468183|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
48347646|NCT00510146|155468182|FG000|Open-Label Treatment|Clinical Relapse|1|||
48347647|NCT00510146|155468183|FG001|Open-Label Treatment|Clinical Relapse|1|||
48347648|NCT00510146|155468182|FG000|Open-Label Treatment|Sponsor Decision|2|||
48347649|NCT00510146|155468183|FG001|Open-Label Treatment|Sponsor Decision|0|||
48347650|NCT04354168|155468184|FG000|Overall Study|Lost to Follow-up|22|||
48347651|NCT01200485|155468185|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
48347652|NCT01200485|155468186|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
48347653|NCT01200485|155468187|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
48347654|NCT01200485|155468185|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
48347655|NCT01200485|155468186|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
48347656|NCT01200485|155468187|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
48347657|NCT01438840|155468190|FG000|Core Study|Adverse Event|0|||
48674612|NCT02596945|156661548|FG000|Overall Study|Other|32|||
48674613|NCT02596945|156661548|FG000|Overall Study|Change to hemodialysis|15|||
48674614|NCT02596945|156661548|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
48674615|NCT02596945|156661548|FG000|Overall Study|Withdrawal by Subject|1|||
48674616|NCT02596945|156661548|FG000|Overall Study|Missing|1|||
48674617|NCT00411632|156661549|FG000|Overall Study|Death|1|||
48674618|NCT01007838|156661550|FG000|Overall Study|Withdrawal by Subject|1|||
48674619|NCT01007838|156661551|FG001|Overall Study|Withdrawal by Subject|0|||
48674620|NCT01007838|156661552|FG002|Overall Study|Withdrawal by Subject|0|||
48674621|NCT01007838|156661553|FG003|Overall Study|Withdrawal by Subject|0|||
48674622|NCT01007838|156661550|FG000|Overall Study|Physician Decision|1|||
48674623|NCT01007838|156661551|FG001|Overall Study|Physician Decision|0|||
48674624|NCT01007838|156661552|FG002|Overall Study|Physician Decision|0|||
48674625|NCT01007838|156661553|FG003|Overall Study|Physician Decision|0|||
48674626|NCT01007838|156661550|FG000|Overall Study|Started home haemodialysis|1|||
48674627|NCT01007838|156661551|FG001|Overall Study|Started home haemodialysis|0|||
48674628|NCT01007838|156661552|FG002|Overall Study|Started home haemodialysis|0|||
48674629|NCT01007838|156661553|FG003|Overall Study|Started home haemodialysis|0|||
48674630|NCT00455143|156661556|FG000|Overall Study|Physician Decision|1|||
48761486|NCT01729754|156975639|FG008|Part 2|Adverse Event|1|||
48347658|NCT01438840|155468191|FG001|Core Study|Adverse Event|3|||
48347659|NCT01438840|155468192|FG002|Core Study|Adverse Event|0|||
48347660|NCT01438840|155468190|FG000|Core Study|Lack of Efficacy|15|||
48347661|NCT01438840|155468191|FG001|Core Study|Lack of Efficacy|7|||
48347662|NCT01438840|155468192|FG002|Core Study|Lack of Efficacy|0|||
48674631|NCT00455143|156661556|FG000|Overall Study|Withdrawal by Subject|1|||
48674632|NCT00455143|156661556|FG000|Overall Study|Staff was not avail to follow patient|2|||
48674633|NCT00455143|156661556|FG000|Overall Study|No longer met Inclusion Criteria|1|||
48674634|NCT00455143|156661556|FG000|Overall Study|Surgical time, staff not available|1|||
48674635|NCT00408434|156661561|FG000|Overall Study|Adverse Event|0|||
48347663|NCT01438840|155468190|FG000|Core Study|Withdrawal of consent|1|||
48347664|NCT01438840|155468191|FG001|Core Study|Withdrawal of consent|0|||
48347665|NCT01438840|155468192|FG002|Core Study|Withdrawal of consent|0|||
48347666|NCT01438840|155468190|FG000|Extension Phase|Adverse Event|0|||
48347667|NCT01438840|155468191|FG001|Extension Phase|Adverse Event|0|||
48347668|NCT01438840|155468192|FG002|Extension Phase|Adverse Event|3|||
48347669|NCT01438840|155468190|FG000|Extension Phase|Lost to Follow-up|0|||
48347670|NCT01438840|155468191|FG001|Extension Phase|Lost to Follow-up|0|||
48347671|NCT01438840|155468192|FG002|Extension Phase|Lost to Follow-up|1|||
48347672|NCT01438840|155468190|FG000|Extension Phase|Withdrawal by Subject|0|||
48347673|NCT01438840|155468191|FG001|Extension Phase|Withdrawal by Subject|0|||
48347674|NCT01438840|155468192|FG002|Extension Phase|Withdrawal by Subject|3|||
48347675|NCT01438840|155468190|FG000|Extension Phase|Lack of Efficacy|0|||
48347676|NCT01438840|155468191|FG001|Extension Phase|Lack of Efficacy|0|||
48347677|NCT01438840|155468192|FG002|Extension Phase|Lack of Efficacy|2|||
48347678|NCT01438840|155468190|FG000|Extension Phase|Other|0|||
48347679|NCT01438840|155468191|FG001|Extension Phase|Other|0|||
48347680|NCT01438840|155468192|FG002|Extension Phase|Other|1|||
48347681|NCT00025662|155468195|FG000|Overall Study|Withdrawal by Subject|2|||
48347682|NCT00025662|155468195|FG000|Overall Study|Technical failure of manipulation|1|||
48347683|NCT03569475|155468196|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
48347684|NCT03569475|155468197|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
48347685|NCT03569475|155468198|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
48347686|NCT03569475|155468196|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
48347687|NCT03569475|155468197|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
48347688|NCT03569475|155468198|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
48347689|NCT03569475|155468196|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
48347690|NCT03569475|155468197|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
48347691|NCT03569475|155468198|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
48347692|NCT03569475|155468196|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
48347693|NCT03569475|155468197|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
48347694|NCT03569475|155468198|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
48347695|NCT03569475|155468196|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
48347696|NCT03569475|155468197|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
48347697|NCT03569475|155468198|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
48347698|NCT03569475|155468196|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
48347699|NCT03569475|155468197|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
48347700|NCT03569475|155468198|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
48347701|NCT03569475|155468196|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
48347702|NCT03569475|155468197|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
48347703|NCT03569475|155468198|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
48347704|NCT03569475|155468196|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
48347705|NCT03569475|155468197|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
48347706|NCT03569475|155468198|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
48347707|NCT03569475|155468196|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
48347708|NCT03569475|155468197|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
48347709|NCT03569475|155468198|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
48347710|NCT04969224|155468199|FG000|Overall Study|Adverse Event|1|||
48347711|NCT04969224|155468199|FG000|Overall Study|Enrolled but never dosed|1|||
48347712|NCT02506881|155468200|FG000|First Intervention (Day 1)|Protocol Violation|0|||
48674636|NCT00408434|156661562|FG001|Overall Study|Adverse Event|0|||
48674637|NCT00408434|156661563|FG002|Overall Study|Adverse Event|1|||
48674638|NCT00408434|156661564|FG003|Overall Study|Adverse Event|0|||
48347713|NCT02506881|155468201|FG001|First Intervention (Day 1)|Protocol Violation|0|||
48347714|NCT02506881|155468202|FG002|First Intervention (Day 1)|Protocol Violation|1|||
48347715|NCT02506881|155468203|FG003|First Intervention (Day 1)|Protocol Violation|0|||
48347716|NCT02506881|155468200|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
48347717|NCT02506881|155468201|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
48347718|NCT02506881|155468202|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
48347719|NCT02506881|155468203|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
48347720|NCT02506881|155468200|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
48347721|NCT02506881|155468201|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
48347722|NCT02506881|155468202|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
48347723|NCT02506881|155468203|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
48347724|NCT02918292|155468209|FG000|Study Enrollment Prior to Transplant|Death|1|||
48347725|NCT02918292|155468209|FG000|Study Follow up After Transplant|Death|6|||
48347726|NCT00519285|155468210|FG000|Overall Study|Adverse Event|127|||
48347727|NCT00519285|155468211|FG001|Overall Study|Adverse Event|266|||
48347728|NCT00519285|155468210|FG000|Overall Study|Disease progression|334|||
48674639|NCT00408434|156661565|FG004|Overall Study|Adverse Event|0|||
48347729|NCT00519285|155468211|FG001|Overall Study|Disease progression|186|||
48347730|NCT00519285|155468210|FG000|Overall Study|Physician Decision|75|||
48347731|NCT00519285|155468211|FG001|Overall Study|Physician Decision|47|||
48347732|NCT00519285|155468210|FG000|Overall Study|Participant's request|53|||
48347733|NCT00519285|155468211|FG001|Overall Study|Participant's request|84|||
48347734|NCT00519285|155468210|FG000|Overall Study|Consent withdrawn|4|||
48347735|NCT00519285|155468211|FG001|Overall Study|Consent withdrawn|5|||
48347736|NCT00519285|155468210|FG000|Overall Study|Poor compliance to protocol|5|||
48347737|NCT00519285|155468211|FG001|Overall Study|Poor compliance to protocol|7|||
48674640|NCT00408434|156661566|FG005|Overall Study|Adverse Event|0|||
48674641|NCT00408434|156661567|FG006|Overall Study|Adverse Event|0|||
48674642|NCT00408434|156661561|FG000|Overall Study|Progressive disease|6|||
48674643|NCT00408434|156661562|FG001|Overall Study|Progressive disease|3|||
48674644|NCT00408434|156661563|FG002|Overall Study|Progressive disease|4|||
48674645|NCT00408434|156661564|FG003|Overall Study|Progressive disease|3|||
48674646|NCT00408434|156661565|FG004|Overall Study|Progressive disease|3|||
48674647|NCT00408434|156661566|FG005|Overall Study|Progressive disease|1|||
48347738|NCT00519285|155468210|FG000|Overall Study|Reason unspecified|5|||
48347739|NCT00519285|155468211|FG001|Overall Study|Reason unspecified|8|||
48347740|NCT00519285|155468210|FG000|Overall Study|Not treated|8|||
48674648|NCT00408434|156661567|FG006|Overall Study|Progressive disease|4|||
48674649|NCT00408434|156661561|FG000|Overall Study|Other|0|||
48674650|NCT00408434|156661562|FG001|Overall Study|Other|0|||
48674651|NCT00408434|156661563|FG002|Overall Study|Other|1|||
48674652|NCT00408434|156661564|FG003|Overall Study|Other|0|||
48674653|NCT00408434|156661565|FG004|Overall Study|Other|2|||
48674654|NCT00408434|156661566|FG005|Overall Study|Other|1|||
48674655|NCT00408434|156661567|FG006|Overall Study|Other|0|||
48674656|NCT00408434|156661561|FG000|Overall Study|Terminated by Investigator|0|||
48674657|NCT00408434|156661562|FG001|Overall Study|Terminated by Investigator|0|||
48674658|NCT00408434|156661563|FG002|Overall Study|Terminated by Investigator|0|||
48674659|NCT00408434|156661564|FG003|Overall Study|Terminated by Investigator|0|||
48674660|NCT00408434|156661565|FG004|Overall Study|Terminated by Investigator|1|||
48674661|NCT00408434|156661566|FG005|Overall Study|Terminated by Investigator|1|||
48347741|NCT00519285|155468211|FG001|Overall Study|Not treated|7|||
48347742|NCT00519285|155468210|FG000|Overall Study|Treatment ongoing|1|||
48347743|NCT00519285|155468211|FG001|Overall Study|Treatment ongoing|2|||
48347744|NCT00808899|155468212|FG000|Overall Study|Death|1|||
48347745|NCT00808899|155468212|FG000|Overall Study|Physician Decision|3|||
48347746|NCT03774875|155468213|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
48347747|NCT03774875|155468214|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
48347748|NCT03774875|155468213|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
48347749|NCT03774875|155468214|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
48347750|NCT03774875|155468213|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
48347751|NCT03774875|155468214|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
48347752|NCT03774875|155468213|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
48347753|NCT03774875|155468214|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
48347754|NCT03774875|155468213|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
48347755|NCT03774875|155468214|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
48347756|NCT03774875|155468213|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
48347757|NCT03774875|155468214|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
48347758|NCT03774875|155468213|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
48347759|NCT03774875|155468214|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
48347760|NCT03774875|155468213|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
48347761|NCT03774875|155468214|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
48347762|NCT03774875|155468213|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
48347763|NCT03774875|155468214|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
48347764|NCT03774875|155468213|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
48674662|NCT00408434|156661567|FG006|Overall Study|Terminated by Investigator|0|||
48674663|NCT03068767|156661578|FG000|Overall Study|Lost to Follow-up|7|||
48347765|NCT03774875|155468214|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
48347766|NCT03774875|155468213|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
48347767|NCT03774875|155468214|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
48347768|NCT03774875|155468213|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
48347769|NCT03774875|155468214|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
48347770|NCT03774875|155468213|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
48347771|NCT03774875|155468214|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
48347772|NCT03561597|155468217|FG000|Overall Study|Lost to Follow-up|20|||
48347773|NCT00573651|155468222|FG000|Overall Study|Lost to Follow-up|3|||
48347774|NCT00573651|155468222|FG000|Overall Study|Withdrawal by Subject|1|||
48347775|NCT02972242|155470136|FG000|Overall Study|Withdrawal by Subject|1|||
48347776|NCT02972242|155470137|FG001|Overall Study|Withdrawal by Subject|0|||
48674664|NCT03068767|156661579|FG001|Overall Study|Lost to Follow-up|3|||
48674665|NCT03068767|156661578|FG000|Overall Study|Protocol Violation|3|||
48674666|NCT03068767|156661579|FG001|Overall Study|Protocol Violation|0|||
48674667|NCT00186901|156661580|FG000|Overall Study|Pregnancy|6|||
48674668|NCT00186901|156661581|FG001|Overall Study|Pregnancy|3|||
48674669|NCT00186901|156661582|FG002|Overall Study|Pregnancy|0|||
48674670|NCT00186901|156661580|FG000|Overall Study|Lost to Follow-up|6|||
48674671|NCT00186901|156661581|FG001|Overall Study|Lost to Follow-up|3|||
48347777|NCT02826798|155470140|FG000|Overall Study|Withdrawal by Subject|0|||
48347778|NCT02826798|155470141|FG001|Overall Study|Withdrawal by Subject|1|||
48347779|NCT02826798|155470142|FG002|Overall Study|Withdrawal by Subject|0|||
48347780|NCT02826798|155470143|FG003|Overall Study|Withdrawal by Subject|1|||
48347781|NCT02826798|155470144|FG004|Overall Study|Withdrawal by Subject|0|||
48347782|NCT01268098|155470145|FG000|Overall Study|Adverse Event|1|||
48347783|NCT01268098|155470146|FG001|Overall Study|Adverse Event|0|||
48347784|NCT01722045|155470147|FG000|Overall Study|Adverse Event|8|||
48347785|NCT01722045|155470147|FG000|Overall Study|Death|3|||
48347786|NCT01722045|155470147|FG000|Overall Study|Withdrawal by Subject|8|||
48347787|NCT01722045|155470147|FG000|Overall Study|Lost to Follow-up|4|||
48347788|NCT01722045|155470147|FG000|Overall Study|Protocol Deviation|1|||
48347789|NCT01722045|155470147|FG000|Overall Study|Physician Decision|3|||
48347790|NCT01722045|155470147|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
48347791|NCT02561078|155470152|FG000|Overall Study|Adverse Event|5|||
48347792|NCT02561078|155470153|FG001|Overall Study|Adverse Event|2|||
48347793|NCT02561078|155470152|FG000|Overall Study|Death|2|||
48347794|NCT02561078|155470153|FG001|Overall Study|Death|1|||
48347795|NCT02561078|155470152|FG000|Overall Study|Lost to Follow-up|2|||
48347796|NCT02561078|155470153|FG001|Overall Study|Lost to Follow-up|6|||
48347797|NCT02561078|155470152|FG000|Overall Study|Non-Compliance with Study Drug|6|||
48347798|NCT02561078|155470153|FG001|Overall Study|Non-Compliance with Study Drug|3|||
48347799|NCT02561078|155470152|FG000|Overall Study|Physician Decision|2|||
48347800|NCT02561078|155470153|FG001|Overall Study|Physician Decision|3|||
48347801|NCT02561078|155470152|FG000|Overall Study|Withdrawal by Subject|13|||
48347802|NCT02561078|155470153|FG001|Overall Study|Withdrawal by Subject|10|||
48347803|NCT01947517|155470154|FG000|Overall Study|Withdrawal by Subject|1|||
48347804|NCT01947517|155470155|FG001|Overall Study|Withdrawal by Subject|1|||
48674672|NCT00186901|156661582|FG002|Overall Study|Lost to Follow-up|0|||
48674673|NCT00186901|156661580|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
48674674|NCT00186901|156661581|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
48674675|NCT00186901|156661582|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
48674676|NCT00186901|156661580|FG000|Overall Study|ALL relapse or second malignancy|1|||
48674677|NCT00186901|156661581|FG001|Overall Study|ALL relapse or second malignancy|2|||
48674678|NCT00186901|156661582|FG002|Overall Study|ALL relapse or second malignancy|0|||
48674679|NCT00186901|156661580|FG000|Overall Study|Withdrawal by Subject|4|||
48674680|NCT00186901|156661581|FG001|Overall Study|Withdrawal by Subject|5|||
48674681|NCT00186901|156661582|FG002|Overall Study|Withdrawal by Subject|0|||
48674682|NCT00186901|156661580|FG000|Overall Study|Open label|3|||
48674683|NCT00186901|156661581|FG001|Overall Study|Open label|2|||
48674684|NCT00186901|156661582|FG002|Overall Study|Open label|0|||
48674685|NCT00186901|156661580|FG000|Overall Study|Limited adherence to study requirements|20|||
48674686|NCT00186901|156661581|FG001|Overall Study|Limited adherence to study requirements|23|||
48674687|NCT00186901|156661582|FG002|Overall Study|Limited adherence to study requirements|0|||
48674688|NCT00186901|156661580|FG000|Overall Study|Bone Mineral Density > 0|0|||
48347805|NCT02418845|155470159|FG000|Overall Study|Lost to Follow-up|7|||
48347806|NCT02418845|155470160|FG001|Overall Study|Lost to Follow-up|2|||
48347807|NCT02418845|155470159|FG000|Overall Study|Lack of Efficacy|0|||
48347808|NCT02418845|155470160|FG001|Overall Study|Lack of Efficacy|3|||
48347809|NCT02418845|155470159|FG000|Overall Study|Physician Decision|5|||
48347810|NCT02418845|155470160|FG001|Overall Study|Physician Decision|5|||
48674689|NCT00186901|156661581|FG001|Overall Study|Bone Mineral Density > 0|0|||
48674690|NCT00186901|156661582|FG002|Overall Study|Bone Mineral Density > 0|149|||
48674691|NCT00999518|156661583|FG000|Overall Study|Adverse Event|1|||
48674692|NCT00999518|156661584|FG001|Overall Study|Adverse Event|6|||
48674693|NCT00999518|156661585|FG002|Overall Study|Adverse Event|3|||
48674694|NCT00999518|156661586|FG003|Overall Study|Adverse Event|1|||
48674695|NCT00999518|156661587|FG004|Overall Study|Adverse Event|2|||
48674696|NCT00999518|156661583|FG000|Overall Study|Lack of Efficacy|2|||
48674697|NCT00999518|156661584|FG001|Overall Study|Lack of Efficacy|0|||
48674698|NCT00999518|156661585|FG002|Overall Study|Lack of Efficacy|0|||
48674699|NCT00999518|156661586|FG003|Overall Study|Lack of Efficacy|2|||
48674700|NCT00999518|156661587|FG004|Overall Study|Lack of Efficacy|2|||
48674701|NCT00999518|156661583|FG000|Overall Study|Lost to Follow-up|0|||
48347811|NCT02418845|155470159|FG000|Overall Study|Protocol Violation|1|||
48347812|NCT02418845|155470160|FG001|Overall Study|Protocol Violation|0|||
48347813|NCT02418845|155470159|FG000|Overall Study|Withdrawal by Subject|3|||
48347814|NCT02418845|155470160|FG001|Overall Study|Withdrawal by Subject|2|||
48674702|NCT00999518|156661584|FG001|Overall Study|Lost to Follow-up|0|||
48674703|NCT00999518|156661585|FG002|Overall Study|Lost to Follow-up|0|||
48674704|NCT00999518|156661586|FG003|Overall Study|Lost to Follow-up|4|||
48347815|NCT03119688|155470161|FG000|Overall Study|Adverse Event|4|||
48347816|NCT01243411|155470162|FG000|Overall Study|Withdrawal by Subject|18|||
48347817|NCT01243411|155470162|FG000|Overall Study|Lost to Follow-up|10|||
48674705|NCT00999518|156661587|FG004|Overall Study|Lost to Follow-up|1|||
48674706|NCT00999518|156661583|FG000|Overall Study|Did not meet entrance criteria|0|||
48674707|NCT00999518|156661584|FG001|Overall Study|Did not meet entrance criteria|0|||
48761487|NCT01729754|156975640|FG009|Part 2|Adverse Event|2|||
48347818|NCT01243411|155470162|FG000|Overall Study|Adverse Event|5|||
48347819|NCT01243411|155470162|FG000|Overall Study|Other|8|||
48347820|NCT02624869|155470163|FG000|Overall Study|Lost to Follow-up|0|||
48347821|NCT02624869|155470164|FG001|Overall Study|Lost to Follow-up|0|||
48347822|NCT02624869|155470165|FG002|Overall Study|Lost to Follow-up|1|||
48347823|NCT02624869|155470163|FG000|Overall Study|Withdrawal by Subject|1|||
48347824|NCT02624869|155470164|FG001|Overall Study|Withdrawal by Subject|3|||
48674708|NCT00999518|156661585|FG002|Overall Study|Did not meet entrance criteria|0|||
48674709|NCT00999518|156661586|FG003|Overall Study|Did not meet entrance criteria|0|||
48674710|NCT00999518|156661587|FG004|Overall Study|Did not meet entrance criteria|1|||
48674711|NCT00999518|156661583|FG000|Overall Study|Study terminated by sponsor|10|||
48674712|NCT00999518|156661584|FG001|Overall Study|Study terminated by sponsor|6|||
48674713|NCT00999518|156661585|FG002|Overall Study|Study terminated by sponsor|5|||
48761488|NCT01729754|156975631|FG000|Part 2|Lack of Efficacy|0|||
48347825|NCT02624869|155470165|FG002|Overall Study|Withdrawal by Subject|1|||
48347826|NCT00494026|155470166|FG000|Overall Study|Sponsor Decision|4|||
48347827|NCT00477464|155470167|FG000|Overall Study|Lost to Follow-up|1|||
48347828|NCT00477464|155470167|FG000|Overall Study|Death|36|||
48347829|NCT00477464|155470167|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
48347830|NCT00863798|155470168|FG000|Overall Study|Adverse Event|5|||
48761489|NCT01729754|156975632|FG001|Part 2|Lack of Efficacy|0|||
48761490|NCT01729754|156975633|FG002|Part 2|Lack of Efficacy|0|||
48761491|NCT01729754|156975634|FG003|Part 2|Lack of Efficacy|0|||
48761492|NCT01729754|156975635|FG004|Part 2|Lack of Efficacy|0|||
48761493|NCT01729754|156975636|FG005|Part 2|Lack of Efficacy|0|||
48347831|NCT00863798|155470169|FG001|Overall Study|Adverse Event|2|||
48347832|NCT00863798|155470170|FG002|Overall Study|Adverse Event|4|||
48674714|NCT00999518|156661586|FG003|Overall Study|Study terminated by sponsor|5|||
48674715|NCT00999518|156661587|FG004|Overall Study|Study terminated by sponsor|9|||
48674716|NCT00999518|156661583|FG000|Overall Study|Pregnancy|0|||
48674717|NCT00999518|156661584|FG001|Overall Study|Pregnancy|0|||
48761494|NCT01729754|156975637|FG006|Part 2|Lack of Efficacy|0|||
48761495|NCT01729754|156975638|FG007|Part 2|Lack of Efficacy|0|||
48761496|NCT01729754|156975639|FG008|Part 2|Lack of Efficacy|2|||
48761497|NCT01729754|156975640|FG009|Part 2|Lack of Efficacy|2|||
48761498|NCT01729754|156975631|FG000|Part 2|Lost to Follow-up|0|||
48761499|NCT01729754|156975632|FG001|Part 2|Lost to Follow-up|0|||
48761500|NCT01729754|156975633|FG002|Part 2|Lost to Follow-up|0|||
48761501|NCT01729754|156975634|FG003|Part 2|Lost to Follow-up|2|||
48761502|NCT01729754|156975635|FG004|Part 2|Lost to Follow-up|0|||
48761503|NCT01729754|156975636|FG005|Part 2|Lost to Follow-up|0|||
48761504|NCT01729754|156975637|FG006|Part 2|Lost to Follow-up|0|||
48761505|NCT01729754|156975638|FG007|Part 2|Lost to Follow-up|1|||
48761506|NCT01729754|156975639|FG008|Part 2|Lost to Follow-up|0|||
48761507|NCT01729754|156975640|FG009|Part 2|Lost to Follow-up|2|||
48761508|NCT01729754|156975631|FG000|Part 2|Non-Compliance with Study Drug|0|||
48761509|NCT01729754|156975632|FG001|Part 2|Non-Compliance with Study Drug|0|||
48761510|NCT01729754|156975633|FG002|Part 2|Non-Compliance with Study Drug|0|||
48761511|NCT01729754|156975634|FG003|Part 2|Non-Compliance with Study Drug|0|||
48761512|NCT01729754|156975635|FG004|Part 2|Non-Compliance with Study Drug|0|||
48761513|NCT01729754|156975636|FG005|Part 2|Non-Compliance with Study Drug|0|||
48761514|NCT01729754|156975637|FG006|Part 2|Non-Compliance with Study Drug|0|||
48761515|NCT01729754|156975638|FG007|Part 2|Non-Compliance with Study Drug|0|||
48761516|NCT01729754|156975639|FG008|Part 2|Non-Compliance with Study Drug|0|||
48761517|NCT01729754|156975640|FG009|Part 2|Non-Compliance with Study Drug|1|||
48761518|NCT01729754|156975631|FG000|Part 2|Pregnancy|0|||
48761519|NCT01729754|156975632|FG001|Part 2|Pregnancy|0|||
48761520|NCT01729754|156975633|FG002|Part 2|Pregnancy|0|||
48761521|NCT01729754|156975634|FG003|Part 2|Pregnancy|1|||
48761522|NCT01729754|156975635|FG004|Part 2|Pregnancy|0|||
48761523|NCT01729754|156975636|FG005|Part 2|Pregnancy|0|||
48761524|NCT01729754|156975637|FG006|Part 2|Pregnancy|0|||
48761525|NCT01729754|156975638|FG007|Part 2|Pregnancy|0|||
48761526|NCT01729754|156975639|FG008|Part 2|Pregnancy|0|||
48761527|NCT01729754|156975640|FG009|Part 2|Pregnancy|1|||
48761528|NCT01729754|156975631|FG000|Part 2|Withdrawal by Subject|3|||
48761529|NCT01729754|156975632|FG001|Part 2|Withdrawal by Subject|0|||
48761530|NCT01729754|156975633|FG002|Part 2|Withdrawal by Subject|0|||
48761531|NCT01729754|156975634|FG003|Part 2|Withdrawal by Subject|2|||
48761532|NCT01729754|156975635|FG004|Part 2|Withdrawal by Subject|0|||
48761533|NCT01729754|156975636|FG005|Part 2|Withdrawal by Subject|0|||
48761534|NCT01729754|156975637|FG006|Part 2|Withdrawal by Subject|0|||
48761535|NCT01729754|156975638|FG007|Part 2|Withdrawal by Subject|1|||
48761536|NCT01729754|156975639|FG008|Part 2|Withdrawal by Subject|1|||
48761537|NCT01729754|156975640|FG009|Part 2|Withdrawal by Subject|4|||
48761538|NCT01729754|156975631|FG000|Part 2|Other Protocol Specified Criteria|1|||
48761539|NCT01729754|156975632|FG001|Part 2|Other Protocol Specified Criteria|0|||
48347833|NCT00863798|155470168|FG000|Overall Study|Participant failed to return|2|||
48761540|NCT01729754|156975633|FG002|Part 2|Other Protocol Specified Criteria|0|||
48761541|NCT01729754|156975634|FG003|Part 2|Other Protocol Specified Criteria|0|||
48761542|NCT01729754|156975635|FG004|Part 2|Other Protocol Specified Criteria|0|||
48761543|NCT01729754|156975636|FG005|Part 2|Other Protocol Specified Criteria|0|||
48347834|NCT00863798|155470169|FG001|Overall Study|Participant failed to return|1|||
48347835|NCT00863798|155470170|FG002|Overall Study|Participant failed to return|0|||
48347836|NCT00863798|155470168|FG000|Overall Study|Investigator request|1|||
48347837|NCT00863798|155470169|FG001|Overall Study|Investigator request|2|||
48347838|NCT00863798|155470170|FG002|Overall Study|Investigator request|1|||
48347839|NCT00863798|155470168|FG000|Overall Study|Lack of Efficacy|4|||
48347840|NCT00863798|155470169|FG001|Overall Study|Lack of Efficacy|3|||
48347841|NCT00863798|155470170|FG002|Overall Study|Lack of Efficacy|6|||
48347842|NCT00863798|155470168|FG000|Overall Study|Lost to Follow-up|6|||
48347843|NCT00863798|155470169|FG001|Overall Study|Lost to Follow-up|9|||
48347844|NCT00863798|155470170|FG002|Overall Study|Lost to Follow-up|5|||
48347845|NCT00863798|155470168|FG000|Overall Study|Other|2|||
48347846|NCT00863798|155470169|FG001|Overall Study|Other|3|||
48347847|NCT00863798|155470170|FG002|Overall Study|Other|1|||
48347848|NCT00863798|155470168|FG000|Overall Study|Protocol Violation|0|||
48347849|NCT00863798|155470169|FG001|Overall Study|Protocol Violation|1|||
48347850|NCT00863798|155470170|FG002|Overall Study|Protocol Violation|1|||
48347851|NCT00863798|155470168|FG000|Overall Study|Withdrawal by Subject|8|||
48347852|NCT00863798|155470169|FG001|Overall Study|Withdrawal by Subject|7|||
48347853|NCT00863798|155470170|FG002|Overall Study|Withdrawal by Subject|4|||
48347854|NCT00863798|155470168|FG000|Overall Study|Randomized not treated|4|||
48347855|NCT00863798|155470169|FG001|Overall Study|Randomized not treated|2|||
48674718|NCT00999518|156661585|FG002|Overall Study|Pregnancy|1|||
48674719|NCT00999518|156661586|FG003|Overall Study|Pregnancy|0|||
48674720|NCT00999518|156661587|FG004|Overall Study|Pregnancy|0|||
48674721|NCT00999518|156661583|FG000|Overall Study|Protocol Violation|0|||
48674722|NCT00999518|156661584|FG001|Overall Study|Protocol Violation|1|||
48674723|NCT00999518|156661585|FG002|Overall Study|Protocol Violation|0|||
48674724|NCT00999518|156661586|FG003|Overall Study|Protocol Violation|0|||
48674725|NCT00999518|156661587|FG004|Overall Study|Protocol Violation|2|||
48674726|NCT00999518|156661583|FG000|Overall Study|Withdrawal by Subject|5|||
48674727|NCT00999518|156661584|FG001|Overall Study|Withdrawal by Subject|4|||
48674728|NCT00999518|156661585|FG002|Overall Study|Withdrawal by Subject|10|||
48674729|NCT00999518|156661586|FG003|Overall Study|Withdrawal by Subject|6|||
48674730|NCT00999518|156661587|FG004|Overall Study|Withdrawal by Subject|1|||
48674731|NCT00999518|156661583|FG000|Overall Study|Other|5|||
48674732|NCT00999518|156661584|FG001|Overall Study|Other|7|||
48674733|NCT00999518|156661585|FG002|Overall Study|Other|1|||
48674734|NCT00999518|156661586|FG003|Overall Study|Other|4|||
48674735|NCT00999518|156661587|FG004|Overall Study|Other|5|||
48674736|NCT00999518|156661583|FG000|Overall Study|Randomized but not Treated|1|||
48674737|NCT00999518|156661584|FG001|Overall Study|Randomized but not Treated|1|||
48674738|NCT00999518|156661585|FG002|Overall Study|Randomized but not Treated|2|||
48674739|NCT00999518|156661586|FG003|Overall Study|Randomized but not Treated|0|||
48674740|NCT00999518|156661587|FG004|Overall Study|Randomized but not Treated|1|||
48674741|NCT03304873|156661589|FG000|Overall Study|Lost to Follow-up|1|||
48674742|NCT03304873|156661590|FG001|Overall Study|Lost to Follow-up|8|||
48674743|NCT00400569|156661593|FG000|Overall Study|Death|1|||
48674744|NCT02921087|156661594|FG000|Overall Study|Withdrawal by Subject|0|||
48674745|NCT02921087|156661595|FG001|Overall Study|Withdrawal by Subject|1|||
48674746|NCT02697435|156661602|FG000|Overall Study|Withdrawal by Subject|1|||
48674747|NCT02697435|156661603|FG001|Overall Study|Withdrawal by Subject|0|||
48674748|NCT02697435|156661602|FG000|Overall Study|Physician Decision|0|||
48674749|NCT02697435|156661603|FG001|Overall Study|Physician Decision|4|||
48674750|NCT04230213|156661604|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
48674751|NCT04230213|156661605|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
48674752|NCT04230213|156661606|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
48674753|NCT04230213|156661604|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
48674754|NCT04230213|156661605|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
48674755|NCT04230213|156661606|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
48674756|NCT04230213|156661604|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
48674757|NCT04230213|156661605|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
48674758|NCT04230213|156661606|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
48674759|NCT04230213|156661604|FG000|TP2: Week 10 to Week 16|Other|0|||
48674760|NCT04230213|156661605|FG001|TP2: Week 10 to Week 16|Other|2|||
48674761|NCT04230213|156661606|FG002|TP2: Week 10 to Week 16|Other|1|||
48674762|NCT04230213|156661604|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
48674763|NCT04230213|156661605|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
48674764|NCT04230213|156661606|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
48674765|NCT04230213|156661604|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
48347856|NCT00863798|155470170|FG002|Overall Study|Randomized not treated|3|||
48347857|NCT00548847|155470171|FG000|Overall Study|Disease progression|7|||
48347858|NCT00816556|155470172|FG000|Overall Study|Adverse Event|1|||
48347859|NCT00816556|155470173|FG001|Overall Study|Adverse Event|1|||
48347860|NCT00816556|155470174|FG002|Overall Study|Adverse Event|1|||
48347861|NCT00816556|155470172|FG000|Overall Study|Withdrawal by Subject|1|||
48674766|NCT04230213|156661605|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
48674767|NCT04230213|156661606|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
48347862|NCT00816556|155470173|FG001|Overall Study|Withdrawal by Subject|1|||
48347863|NCT00816556|155470174|FG002|Overall Study|Withdrawal by Subject|1|||
48347864|NCT00816556|155470172|FG000|Overall Study|Lost to Follow-up|0|||
48347865|NCT00816556|155470173|FG001|Overall Study|Lost to Follow-up|0|||
48347866|NCT00816556|155470174|FG002|Overall Study|Lost to Follow-up|1|||
48347867|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
48347868|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
48347869|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
48347870|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
48347871|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Death|0|||
48347872|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Death|1|||
48347873|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
48347874|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
48347875|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
48347876|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
48347877|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
48347878|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
48347879|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
48347880|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
48347881|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
48347882|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
48347883|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
48347884|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
48347885|NCT01309243|155470175|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
48347886|NCT01309243|155470176|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
48347887|NCT01309243|155470175|FG000|Extension Phase|Lost to Follow-up|6|||
48347888|NCT01309243|155470176|FG001|Extension Phase|Lost to Follow-up|0|||
48347889|NCT03927690|155470177|FG000|Overall Study|Withdrawal by Subject|3|||
48347890|NCT03927690|155470178|FG001|Overall Study|Withdrawal by Subject|1|||
48347891|NCT03927690|155470179|FG002|Overall Study|Withdrawal by Subject|1|||
48347892|NCT03927690|155470177|FG000|Overall Study|Adverse Event|1|||
48347893|NCT03927690|155470178|FG001|Overall Study|Adverse Event|0|||
48347894|NCT03927690|155470179|FG002|Overall Study|Adverse Event|0|||
48347895|NCT03927690|155470177|FG000|Overall Study|Death|1|||
48674768|NCT04230213|156661604|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
48674769|NCT04230213|156661605|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
48674770|NCT04230213|156661606|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
48674771|NCT04230213|156661604|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
48674772|NCT04230213|156661605|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
48674773|NCT04230213|156661606|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
48674774|NCT04230213|156661604|FG000|TP3: Week 16 to Week 22|Other|0|||
48674775|NCT04230213|156661605|FG001|TP3: Week 16 to Week 22|Other|1|||
48674776|NCT04230213|156661606|FG002|TP3: Week 16 to Week 22|Other|3|||
48674777|NCT04230213|156661604|FG000|TP4: Week 22 to Week 32|Other|0|||
48674778|NCT04230213|156661605|FG001|TP4: Week 22 to Week 32|Other|5|||
48674779|NCT04230213|156661606|FG002|TP4: Week 22 to Week 32|Other|5|||
48674780|NCT04230213|156661604|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
48674781|NCT04230213|156661605|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
48674782|NCT04230213|156661606|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
48674783|NCT04230213|156661604|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
48674784|NCT04230213|156661605|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
48674785|NCT04230213|156661606|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
48674786|NCT04230213|156661604|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
48674787|NCT04230213|156661605|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
48674788|NCT04230213|156661606|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
48674789|NCT04230213|156661604|FG000|Follow up: Week 32 to Week 36|Other|0|||
48674790|NCT04230213|156661605|FG001|Follow up: Week 32 to Week 36|Other|1|||
48674791|NCT04230213|156661606|FG002|Follow up: Week 32 to Week 36|Other|1|||
48674792|NCT02353728|156661607|FG000|Overall Study|Subject non-compliance|1|||
48674793|NCT02301624|156661611|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
48674794|NCT02301624|156661612|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
48674795|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
48674796|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
48347896|NCT03927690|155470178|FG001|Overall Study|Death|0|||
48674797|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Adverse Event|2|||
48674798|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Adverse Event|5|||
48674799|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Physician Decision|3|||
48674800|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Physician Decision|3|||
48674801|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Death|2|||
48347897|NCT03927690|155470179|FG002|Overall Study|Death|0|||
48347898|NCT03927690|155470177|FG000|Overall Study|Lost to Follow-up|2|||
48347899|NCT03927690|155470178|FG001|Overall Study|Lost to Follow-up|2|||
48347900|NCT03927690|155470179|FG002|Overall Study|Lost to Follow-up|1|||
48347901|NCT01850823|155470180|FG000|Overall Study|Early Visit Window|0|||
48347902|NCT01850823|155470181|FG001|Overall Study|Early Visit Window|1|||
48347903|NCT01850823|155470182|FG002|Overall Study|Early Visit Window|4|||
48347904|NCT01850823|155470180|FG000|Overall Study|Enrolled in Error|0|||
48347905|NCT01850823|155470181|FG001|Overall Study|Enrolled in Error|1|||
48347906|NCT01850823|155470182|FG002|Overall Study|Enrolled in Error|2|||
48347907|NCT01850823|155470180|FG000|Overall Study|Lack of Efficacy|1|||
48347908|NCT01850823|155470181|FG001|Overall Study|Lack of Efficacy|0|||
48347909|NCT01850823|155470182|FG002|Overall Study|Lack of Efficacy|0|||
48347910|NCT01850823|155470180|FG000|Overall Study|Lost to Follow-up|0|||
48347911|NCT01850823|155470181|FG001|Overall Study|Lost to Follow-up|0|||
48347912|NCT01850823|155470182|FG002|Overall Study|Lost to Follow-up|1|||
48347913|NCT01850823|155470180|FG000|Overall Study|Restricted Medication|0|||
48347914|NCT01850823|155470181|FG001|Overall Study|Restricted Medication|0|||
48347915|NCT01850823|155470182|FG002|Overall Study|Restricted Medication|2|||
48347916|NCT01850823|155470180|FG000|Overall Study|Significant worstening of SAR|0|||
48347917|NCT01850823|155470181|FG001|Overall Study|Significant worstening of SAR|1|||
48347918|NCT01850823|155470182|FG002|Overall Study|Significant worstening of SAR|0|||
48347919|NCT01850823|155470180|FG000|Overall Study|Withdrawal by Subject|2|||
48347920|NCT01850823|155470181|FG001|Overall Study|Withdrawal by Subject|0|||
48347921|NCT01850823|155470182|FG002|Overall Study|Withdrawal by Subject|1|||
48347922|NCT00805285|155470187|FG000|Overall Study|Lack of Efficacy|1|||
48347923|NCT00551135|155470188|FG000|Overall Study|Adverse Event|1|||
48347924|NCT00551135|155470189|FG001|Overall Study|Adverse Event|0|||
48347925|NCT00551135|155470190|FG002|Overall Study|Adverse Event|1|||
48347926|NCT00551135|155470191|FG003|Overall Study|Adverse Event|1|||
48347927|NCT00551135|155470188|FG000|Overall Study|Lost to Follow-up|0|||
48347928|NCT00551135|155470189|FG001|Overall Study|Lost to Follow-up|0|||
48347929|NCT00551135|155470190|FG002|Overall Study|Lost to Follow-up|0|||
48347930|NCT00551135|155470191|FG003|Overall Study|Lost to Follow-up|1|||
48347931|NCT00551135|155470188|FG000|Overall Study|Other|3|||
48347932|NCT00551135|155470189|FG001|Overall Study|Other|2|||
48347933|NCT00551135|155470190|FG002|Overall Study|Other|1|||
48347934|NCT00551135|155470191|FG003|Overall Study|Other|2|||
48347935|NCT00551135|155470188|FG000|Overall Study|Withdrawal by Subject|1|||
48347936|NCT00551135|155470189|FG001|Overall Study|Withdrawal by Subject|0|||
48347937|NCT00551135|155470190|FG002|Overall Study|Withdrawal by Subject|3|||
48347938|NCT00551135|155470191|FG003|Overall Study|Withdrawal by Subject|1|||
48347939|NCT01379703|155470192|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
48347940|NCT01379703|155470193|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
48347941|NCT01379703|155470194|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
48347942|NCT01379703|155470192|FG000|Study Start Through 9 Months|Adverse Event|0|||
48347943|NCT01379703|155470193|FG001|Study Start Through 9 Months|Adverse Event|14|||
48347944|NCT01379703|155470194|FG002|Study Start Through 9 Months|Adverse Event|10|||
48347945|NCT01379703|155470192|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
48347946|NCT01379703|155470193|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
48347947|NCT01379703|155470194|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
48347948|NCT01379703|155470192|FG000|Study Start Through 9 Months|Treatment Failure|0|||
48347949|NCT01379703|155470193|FG001|Study Start Through 9 Months|Treatment Failure|2|||
48347950|NCT01379703|155470194|FG002|Study Start Through 9 Months|Treatment Failure|2|||
48347951|NCT01379703|155470192|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
48347952|NCT01379703|155470193|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
48761544|NCT01729754|156975637|FG006|Part 2|Other Protocol Specified Criteria|0|||
48761545|NCT01729754|156975638|FG007|Part 2|Other Protocol Specified Criteria|1|||
48761546|NCT01729754|156975639|FG008|Part 2|Other Protocol Specified Criteria|0|||
48761547|NCT01729754|156975640|FG009|Part 2|Other Protocol Specified Criteria|0|||
48761548|NCT01729754|156975631|FG000|Part 3|Adverse Event|0|||
48761549|NCT01729754|156975632|FG001|Part 3|Adverse Event|0|||
48761550|NCT01729754|156975633|FG002|Part 3|Adverse Event|1|||
48761551|NCT01729754|156975634|FG003|Part 3|Adverse Event|0|||
48761552|NCT01729754|156975635|FG004|Part 3|Adverse Event|0|||
48347953|NCT01379703|155470194|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
48347954|NCT01379703|155470192|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
48347955|NCT01379703|155470193|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
48347956|NCT01379703|155470194|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
48347957|NCT01379703|155470192|FG000|Study Start Through 9 Months|Medication not available|0|||
48347958|NCT01379703|155470193|FG001|Study Start Through 9 Months|Medication not available|2|||
48347959|NCT01379703|155470194|FG002|Study Start Through 9 Months|Medication not available|1|||
48347960|NCT01379703|155470192|FG000|Study Start Through 9 Months|Poor general condition|0|||
48761553|NCT01729754|156975636|FG005|Part 3|Adverse Event|5|||
48761554|NCT01729754|156975637|FG006|Part 3|Adverse Event|0|||
48347961|NCT01379703|155470193|FG001|Study Start Through 9 Months|Poor general condition|1|||
48429371|NCT01070550|155760360|FG005|Overall Study|Non-responders|2|||
48761555|NCT01729754|156975638|FG007|Part 3|Adverse Event|0|||
48761556|NCT01729754|156975639|FG008|Part 3|Adverse Event|0|||
48761557|NCT01729754|156975640|FG009|Part 3|Adverse Event|3|||
48761558|NCT01729754|156975631|FG000|Part 3|Death|0|||
48761559|NCT01729754|156975632|FG001|Part 3|Death|0|||
48761560|NCT01729754|156975633|FG002|Part 3|Death|0|||
48761561|NCT01729754|156975634|FG003|Part 3|Death|0|||
48761562|NCT01729754|156975635|FG004|Part 3|Death|0|||
48761563|NCT01729754|156975636|FG005|Part 3|Death|2|||
48761564|NCT01729754|156975637|FG006|Part 3|Death|0|||
48761565|NCT01729754|156975638|FG007|Part 3|Death|0|||
48761566|NCT01729754|156975639|FG008|Part 3|Death|0|||
48761567|NCT01729754|156975640|FG009|Part 3|Death|0|||
48761568|NCT01729754|156975631|FG000|Part 3|Lack of Efficacy|0|||
48761569|NCT01729754|156975632|FG001|Part 3|Lack of Efficacy|0|||
48761570|NCT01729754|156975633|FG002|Part 3|Lack of Efficacy|0|||
48761571|NCT01729754|156975634|FG003|Part 3|Lack of Efficacy|0|||
48761572|NCT01729754|156975635|FG004|Part 3|Lack of Efficacy|2|||
48761573|NCT01729754|156975636|FG005|Part 3|Lack of Efficacy|0|||
48761574|NCT01729754|156975637|FG006|Part 3|Lack of Efficacy|0|||
48761575|NCT01729754|156975638|FG007|Part 3|Lack of Efficacy|0|||
48761576|NCT01729754|156975639|FG008|Part 3|Lack of Efficacy|0|||
48761577|NCT01729754|156975640|FG009|Part 3|Lack of Efficacy|4|||
48761578|NCT01729754|156975631|FG000|Part 3|Lost to Follow-up|0|||
48761579|NCT01729754|156975632|FG001|Part 3|Lost to Follow-up|1|||
48761580|NCT01729754|156975633|FG002|Part 3|Lost to Follow-up|2|||
48761581|NCT01729754|156975634|FG003|Part 3|Lost to Follow-up|0|||
48761582|NCT01729754|156975635|FG004|Part 3|Lost to Follow-up|0|||
48761583|NCT01729754|156975636|FG005|Part 3|Lost to Follow-up|3|||
48761584|NCT01729754|156975637|FG006|Part 3|Lost to Follow-up|0|||
48761585|NCT01729754|156975638|FG007|Part 3|Lost to Follow-up|0|||
48761586|NCT01729754|156975639|FG008|Part 3|Lost to Follow-up|1|||
48761587|NCT01729754|156975640|FG009|Part 3|Lost to Follow-up|0|||
48761588|NCT01729754|156975631|FG000|Part 3|Physician Decision|0|||
48761589|NCT01729754|156975632|FG001|Part 3|Physician Decision|0|||
48761590|NCT01729754|156975633|FG002|Part 3|Physician Decision|1|||
48761591|NCT01729754|156975634|FG003|Part 3|Physician Decision|0|||
48761592|NCT01729754|156975635|FG004|Part 3|Physician Decision|0|||
48761593|NCT01729754|156975636|FG005|Part 3|Physician Decision|0|||
48761594|NCT01729754|156975637|FG006|Part 3|Physician Decision|0|||
48761595|NCT01729754|156975638|FG007|Part 3|Physician Decision|0|||
48347962|NCT01379703|155470194|FG002|Study Start Through 9 Months|Poor general condition|0|||
48347963|NCT01379703|155470192|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
48347964|NCT01379703|155470193|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
48347965|NCT01379703|155470194|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
48347966|NCT01379703|155470192|FG000|Study Start Through 9 Months|Reason unknown|2|||
48347967|NCT01379703|155470193|FG001|Study Start Through 9 Months|Reason unknown|31|||
48347968|NCT01379703|155470194|FG002|Study Start Through 9 Months|Reason unknown|24|||
48347969|NCT01379703|155470192|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
48347970|NCT01379703|155470193|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
48347971|NCT01379703|155470194|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
48347972|NCT01379703|155470192|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
48347973|NCT01379703|155470193|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
48347974|NCT01379703|155470194|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
48347975|NCT01379703|155470192|FG000|9 Months Through 18 Months|Adverse Event|0|||
48347976|NCT01379703|155470193|FG001|9 Months Through 18 Months|Adverse Event|6|||
48347977|NCT01379703|155470194|FG002|9 Months Through 18 Months|Adverse Event|0|||
48347978|NCT01379703|155470192|FG000|9 Months Through 18 Months|Treatment failure|0|||
48347979|NCT01379703|155470193|FG001|9 Months Through 18 Months|Treatment failure|5|||
48347980|NCT01379703|155470194|FG002|9 Months Through 18 Months|Treatment failure|0|||
48347981|NCT01379703|155470192|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
48347982|NCT01379703|155470193|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
48347983|NCT01379703|155470194|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
48347984|NCT01379703|155470192|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
48347985|NCT01379703|155470193|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
48347986|NCT01379703|155470194|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
48761596|NCT01729754|156975639|FG008|Part 3|Physician Decision|0|||
48761597|NCT01729754|156975640|FG009|Part 3|Physician Decision|0|||
48761598|NCT01729754|156975631|FG000|Part 3|Withdrawal by Subject|0|||
48761599|NCT01729754|156975632|FG001|Part 3|Withdrawal by Subject|4|||
48761600|NCT01729754|156975633|FG002|Part 3|Withdrawal by Subject|1|||
48761601|NCT01729754|156975634|FG003|Part 3|Withdrawal by Subject|0|||
48347987|NCT01379703|155470192|FG000|9 Months Through 18 Months|Fatigue|0|||
48347988|NCT01379703|155470193|FG001|9 Months Through 18 Months|Fatigue|1|||
48761602|NCT01729754|156975635|FG004|Part 3|Withdrawal by Subject|2|||
48761603|NCT01729754|156975636|FG005|Part 3|Withdrawal by Subject|1|||
48761604|NCT01729754|156975637|FG006|Part 3|Withdrawal by Subject|0|||
48761605|NCT01729754|156975638|FG007|Part 3|Withdrawal by Subject|2|||
48761606|NCT01729754|156975639|FG008|Part 3|Withdrawal by Subject|0|||
48761607|NCT01729754|156975640|FG009|Part 3|Withdrawal by Subject|0|||
48761608|NCT01729754|156975631|FG000|Part 3|Other Protocol Specified Criteria|0|||
48761609|NCT01729754|156975632|FG001|Part 3|Other Protocol Specified Criteria|0|||
48761610|NCT01729754|156975633|FG002|Part 3|Other Protocol Specified Criteria|0|||
48347989|NCT01379703|155470194|FG002|9 Months Through 18 Months|Fatigue|0|||
48347990|NCT01379703|155470192|FG000|9 Months Through 18 Months|Reason Unknown|0|||
48347991|NCT01379703|155470193|FG001|9 Months Through 18 Months|Reason Unknown|23|||
48347992|NCT01379703|155470194|FG002|9 Months Through 18 Months|Reason Unknown|0|||
48347993|NCT02741713|155470197|FG000|Overall Study|Surgery type changed intra-operatively|2|||
48347994|NCT02741713|155470198|FG001|Overall Study|Surgery type changed intra-operatively|1|||
48347995|NCT00594178|155470199|FG000|Overall Study|Physician Decision|5|||
48674802|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Death|1|||
48674803|NCT02301624|156661611|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
48674804|NCT02301624|156661612|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
48674805|NCT00895310|156661613|FG000|Overall Study|Withdrawal by Subject|1|||
48674806|NCT00659230|156661616|FG000|Overall Study|Lost to Follow-up|2|||
48347996|NCT01588366|155470202|FG000|Overall Study|Adverse Event|0|||
48347997|NCT01588366|155470203|FG001|Overall Study|Adverse Event|1|||
48347998|NCT01588366|155470204|FG002|Overall Study|Adverse Event|0|||
48347999|NCT01588366|155470205|FG003|Overall Study|Adverse Event|1|||
48348000|NCT01588366|155470206|FG004|Overall Study|Adverse Event|0|||
48348001|NCT01588366|155470207|FG005|Overall Study|Adverse Event|2|||
48348002|NCT00677092|155470208|FG000|Overall Study|Adverse Event|1|||
48348003|NCT00677092|155470208|FG000|Overall Study|Lost to Follow-up|1|||
48348004|NCT00677092|155470208|FG000|Overall Study|Withdrawal by Subject|3|||
48348005|NCT00677092|155470208|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
48348006|NCT02716298|155470209|FG000|First Intervention (1 Month)|Lens discomfort|1|||
48348007|NCT02716298|155470210|FG001|First Intervention (1 Month)|Lens discomfort|1|||
48348008|NCT02246218|155470214|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48348009|NCT02246218|155470215|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48348010|NCT02246218|155470214|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
48348011|NCT02246218|155470215|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
48348012|NCT02246218|155470214|FG000|Overall Study|Adverse Event|1|||
48348013|NCT02246218|155470215|FG001|Overall Study|Adverse Event|1|||
48348014|NCT02246218|155470214|FG000|Overall Study|Lost to Follow-up|1|||
48348015|NCT02246218|155470215|FG001|Overall Study|Lost to Follow-up|0|||
48348016|NCT01321723|155470216|FG000|Overall Study|Adverse Event|3|||
48348017|NCT01321723|155470217|FG001|Overall Study|Adverse Event|5|||
48348018|NCT01321723|155470218|FG002|Overall Study|Adverse Event|2|||
48348019|NCT01321723|155470216|FG000|Overall Study|Withdrawal by Subject|2|||
48348020|NCT01321723|155470217|FG001|Overall Study|Withdrawal by Subject|0|||
48348021|NCT01321723|155470218|FG002|Overall Study|Withdrawal by Subject|2|||
48348022|NCT03318783|155470226|FG000|Overall Study|Withdrawal by Subject|0|||
48348023|NCT03318783|155470227|FG001|Overall Study|Withdrawal by Subject|1|||
48348024|NCT03318783|155470226|FG000|Overall Study|Death|0|||
48348025|NCT03318783|155470227|FG001|Overall Study|Death|1|||
48348026|NCT00545571|155470228|FG000|Overall Study|Administrative Reasons|1|||
48348027|NCT00545571|155470228|FG000|Overall Study|Adverse Event|2|||
48348028|NCT00545571|155470228|FG000|Overall Study|Death|5|||
48348029|NCT00545571|155470228|FG000|Overall Study|Lack of Efficacy|1|||
48348030|NCT00545571|155470228|FG000|Overall Study|Protocol Violation|2|||
48348031|NCT00545571|155470228|FG000|Overall Study|Refused Treatment|1|||
48348032|NCT00545571|155470228|FG000|Overall Study|Screen Failure|16|||
48348033|NCT00545571|155470228|FG000|Overall Study|Transfusion|12|||
48348034|NCT00545571|155470228|FG000|Overall Study|Early Termination of Study|24|||
48348035|NCT00545571|155470228|FG000|Overall Study|Kidney Transplantation|3|||
48348036|NCT01721746|155470230|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
48348037|NCT01721746|155470231|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
48348038|NCT01721746|155470230|FG000|Pre-Treatment|Withdrawal by Subject|1|||
48348039|NCT01721746|155470231|FG001|Pre-Treatment|Withdrawal by Subject|16|||
48348040|NCT01721746|155470230|FG000|Pre-Treatment|Poor/Non-compliance|1|||
48348041|NCT01721746|155470231|FG001|Pre-Treatment|Poor/Non-compliance|0|||
48348042|NCT01721746|155470230|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
48348043|NCT01721746|155470231|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
48674807|NCT00659230|156661617|FG001|Overall Study|Lost to Follow-up|5|||
48348044|NCT01721746|155470230|FG000|Treatment|Disease Progression|192|||
48348045|NCT01721746|155470231|FG001|Treatment|Disease Progression|74|||
48348046|NCT01721746|155470230|FG000|Treatment|Study Drug Toxicity|19|||
48348047|NCT01721746|155470231|FG001|Treatment|Study Drug Toxicity|11|||
48348048|NCT01721746|155470230|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
48348049|NCT01721746|155470231|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
48348050|NCT01721746|155470230|FG000|Treatment|Participant request to discontinue Study treatment|26|||
48348051|NCT01721746|155470231|FG001|Treatment|Participant request to discontinue Study treatment|7|||
48348052|NCT01721746|155470230|FG000|Treatment|Participant withdrew consent|4|||
48348053|NCT01721746|155470231|FG001|Treatment|Participant withdrew consent|2|||
48348054|NCT01721746|155470230|FG000|Treatment|Maximum Clinical Benefit|9|||
48348055|NCT01721746|155470231|FG001|Treatment|Maximum Clinical Benefit|3|||
48348056|NCT01721746|155470230|FG000|Treatment|Poor/Non-compliance|2|||
48348057|NCT01721746|155470231|FG001|Treatment|Poor/Non-compliance|0|||
48674808|NCT00659230|156661616|FG000|Overall Study|Lost source documentation|5|||
48674809|NCT00659230|156661617|FG001|Overall Study|Lost source documentation|4|||
48674810|NCT00659230|156661616|FG000|Overall Study|Did not return post-randomization|2|||
48674811|NCT00659230|156661617|FG001|Overall Study|Did not return post-randomization|3|||
48674812|NCT00861471|156661618|FG000|Overall Study|Withdrawal by Subject|1|||
48674813|NCT00861471|156661618|FG000|Overall Study|Adverse Event|2|||
48674814|NCT00861471|156661618|FG000|Overall Study|Lack of Efficacy|3|||
48674815|NCT00861471|156661618|FG000|Overall Study|treatment for lumbar laminectomy|1|||
48674816|NCT00861471|156661618|FG000|Overall Study|Physician Decision|2|||
48674817|NCT00269633|156661621|FG000|Overall Study|Withdrawal by Subject|1|||
48674818|NCT00269633|156661622|FG001|Overall Study|Withdrawal by Subject|0|||
48761611|NCT01729754|156975634|FG003|Part 3|Other Protocol Specified Criteria|0|||
48761612|NCT01729754|156975635|FG004|Part 3|Other Protocol Specified Criteria|0|||
48761613|NCT01729754|156975636|FG005|Part 3|Other Protocol Specified Criteria|2|||
48761614|NCT01729754|156975637|FG006|Part 3|Other Protocol Specified Criteria|0|||
48761615|NCT01729754|156975638|FG007|Part 3|Other Protocol Specified Criteria|1|||
48761616|NCT01729754|156975639|FG008|Part 3|Other Protocol Specified Criteria|0|||
48761617|NCT01729754|156975640|FG009|Part 3|Other Protocol Specified Criteria|0|||
48761618|NCT00605813|156975643|FG000|Overall Study|Protocol Violation|25|||
48761619|NCT03683758|156975647|FG000|Overall Study|Non-study commitment conflict|1|||
48761620|NCT03683758|156975648|FG001|Overall Study|Non-study commitment conflict|3|||
48761621|NCT03683758|156975647|FG000|Overall Study|Illness preventing participation|1|||
48761622|NCT03683758|156975648|FG001|Overall Study|Illness preventing participation|0|||
48761623|NCT03683758|156975647|FG000|Overall Study|Adverse Event|1|||
48761624|NCT03683758|156975648|FG001|Overall Study|Adverse Event|0|||
48761625|NCT00174915|156975651|FG000|Overall Study|Lost to Follow-up|19|||
48761626|NCT00174915|156975652|FG001|Overall Study|Lost to Follow-up|17|||
48761627|NCT00174915|156975653|FG002|Overall Study|Lost to Follow-up|9|||
48761628|NCT00174915|156975654|FG003|Overall Study|Lost to Follow-up|17|||
48761629|NCT00174915|156975655|FG004|Overall Study|Lost to Follow-up|10|||
48761630|NCT00174915|156975651|FG000|Overall Study|Adverse Event|18|||
48761631|NCT00174915|156975652|FG001|Overall Study|Adverse Event|16|||
48761632|NCT00174915|156975653|FG002|Overall Study|Adverse Event|11|||
48761633|NCT00174915|156975654|FG003|Overall Study|Adverse Event|18|||
48761634|NCT00174915|156975655|FG004|Overall Study|Adverse Event|5|||
48761635|NCT00174915|156975651|FG000|Overall Study|Personal Reason(s)|16|||
48761636|NCT00174915|156975652|FG001|Overall Study|Personal Reason(s)|16|||
48761637|NCT00174915|156975653|FG002|Overall Study|Personal Reason(s)|9|||
48761638|NCT00174915|156975654|FG003|Overall Study|Personal Reason(s)|9|||
48761639|NCT00174915|156975655|FG004|Overall Study|Personal Reason(s)|9|||
48761640|NCT00174915|156975651|FG000|Overall Study|Other|15|||
48761641|NCT00174915|156975652|FG001|Overall Study|Other|8|||
48761642|NCT00174915|156975653|FG002|Overall Study|Other|6|||
48761643|NCT00174915|156975654|FG003|Overall Study|Other|5|||
48761644|NCT00174915|156975655|FG004|Overall Study|Other|3|||
48761645|NCT00174915|156975651|FG000|Overall Study|Gout Flare|13|||
48761646|NCT00174915|156975652|FG001|Overall Study|Gout Flare|6|||
48761647|NCT00174915|156975653|FG002|Overall Study|Gout Flare|8|||
48761648|NCT00174915|156975654|FG003|Overall Study|Gout Flare|1|||
48761649|NCT00174915|156975655|FG004|Overall Study|Gout Flare|0|||
48761650|NCT00174915|156975651|FG000|Overall Study|Protocol Violation|6|||
48348058|NCT01721746|155470230|FG000|Treatment|Participant no longer met Study criteria|4|||
48348059|NCT01721746|155470231|FG001|Treatment|Participant no longer met Study criteria|0|||
48348060|NCT01721746|155470230|FG000|Treatment|Other reasons|6|||
48348061|NCT01721746|155470231|FG001|Treatment|Other reasons|2|||
48348062|NCT00537329|155470232|FG000|Overall Study|Death|10|||
48348063|NCT00537329|155470232|FG000|Overall Study|Adverse Event|3|||
48348064|NCT00537329|155470232|FG000|Overall Study|Lack of Efficacy|2|||
48348065|NCT00537329|155470232|FG000|Overall Study|Lost to Follow-up|6|||
48348066|NCT00537329|155470232|FG000|Overall Study|Withdrawal by Subject|4|||
48348067|NCT00537329|155470232|FG000|Overall Study|Other|1|||
48348068|NCT02138253|155470235|FG000|Overall Study|Adverse Event|3|||
48348069|NCT02138253|155470236|FG001|Overall Study|Adverse Event|3|||
48761651|NCT00174915|156975652|FG001|Overall Study|Protocol Violation|3|||
48761652|NCT00174915|156975653|FG002|Overall Study|Protocol Violation|3|||
48761653|NCT00174915|156975654|FG003|Overall Study|Protocol Violation|6|||
48761654|NCT00174915|156975655|FG004|Overall Study|Protocol Violation|3|||
48348070|NCT02138253|155470235|FG000|Overall Study|Lost to Follow-up|2|||
48674819|NCT03887221|156661623|FG000|Overall Study|Protocol Violation|1|||
48674820|NCT03887221|156661624|FG001|Overall Study|Protocol Violation|0|||
48761655|NCT00174915|156975651|FG000|Overall Study|Therapeutic Failure|6|||
48761656|NCT00174915|156975652|FG001|Overall Study|Therapeutic Failure|3|||
48348071|NCT02138253|155470236|FG001|Overall Study|Lost to Follow-up|1|||
48348072|NCT02138253|155470235|FG000|Overall Study|Physician Decision|2|||
48674821|NCT00445770|156661625|FG000|Overall Study|Adverse Event|9|||
48761657|NCT00174915|156975653|FG002|Overall Study|Therapeutic Failure|2|||
48761658|NCT00174915|156975654|FG003|Overall Study|Therapeutic Failure|1|||
48761659|NCT00174915|156975655|FG004|Overall Study|Therapeutic Failure|3|||
48761660|NCT04127786|156975656|FG000|Primary Series|Adverse Event|1|||
48761661|NCT04127786|156975657|FG001|Primary Series|Adverse Event|0|||
48674822|NCT00445770|156661626|FG001|Overall Study|Adverse Event|15|||
48674823|NCT00445770|156661627|FG002|Overall Study|Adverse Event|19|||
48348073|NCT02138253|155470236|FG001|Overall Study|Physician Decision|0|||
48348074|NCT02138253|155470235|FG000|Overall Study|Non compliance|1|||
48348075|NCT02138253|155470236|FG001|Overall Study|Non compliance|0|||
48348076|NCT02138253|155470235|FG000|Overall Study|Withdrawal by Subject|1|||
48348077|NCT02138253|155470236|FG001|Overall Study|Withdrawal by Subject|0|||
48348078|NCT00468130|155470240|FG000|Overall Study|Adverse Event|2|||
48348079|NCT00468130|155470241|FG001|Overall Study|Adverse Event|1|||
48348080|NCT00468130|155470240|FG000|Overall Study|Withdrawal by Subject|0|||
48348081|NCT00468130|155470241|FG001|Overall Study|Withdrawal by Subject|1|||
48348082|NCT01841112|155470242|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
48348083|NCT01841112|155470243|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
48348084|NCT01841112|155470244|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
48348085|NCT01841112|155470245|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
48674824|NCT00445770|156661625|FG000|Overall Study|Lack of Efficacy|38|||
48348086|NCT01841112|155470246|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
48348087|NCT00723125|155470251|FG000|Overall Study|Met Dx|1|||
48348088|NCT00723125|155470252|FG001|Overall Study|Met Dx|0|||
48674825|NCT00445770|156661626|FG001|Overall Study|Lack of Efficacy|13|||
48348089|NCT00723125|155470251|FG000|Overall Study|Withdrawal by Subject|15|||
48348090|NCT00723125|155470252|FG001|Overall Study|Withdrawal by Subject|6|||
48348091|NCT00723125|155470251|FG000|Overall Study|Adverse Event|2|||
48348092|NCT00723125|155470252|FG001|Overall Study|Adverse Event|0|||
48348093|NCT00878553|155470253|FG000|Sleep Study|Withdrawal by Subject|2|||
48348094|NCT00878553|155470254|FG001|Sleep Study|Withdrawal by Subject|0|||
48348095|NCT00878553|155470255|FG002|Sleep Study|Withdrawal by Subject|0|||
48348096|NCT00878553|155470256|FG003|Sleep Study|Withdrawal by Subject|0|||
48348097|NCT00878553|155470257|FG004|Sleep Study|Withdrawal by Subject|0|||
48761662|NCT04127786|156975658|FG002|Primary Series|Adverse Event|0|||
48761663|NCT04127786|156975659|FG003|Primary Series|Adverse Event|1|||
48761664|NCT04127786|156975660|FG004|Primary Series|Adverse Event|0|||
48761665|NCT04127786|156975661|FG005|Primary Series|Adverse Event|1|||
48761666|NCT04127786|156975656|FG000|Primary Series|Protocol Violation|5|||
48348098|NCT00878553|155470253|FG000|Sleep Study|Lost to Follow-up|1|||
48348099|NCT00878553|155470254|FG001|Sleep Study|Lost to Follow-up|0|||
48348100|NCT00878553|155470255|FG002|Sleep Study|Lost to Follow-up|0|||
48348101|NCT00878553|155470256|FG003|Sleep Study|Lost to Follow-up|0|||
48348102|NCT00878553|155470257|FG004|Sleep Study|Lost to Follow-up|0|||
48348103|NCT00878553|155470253|FG000|Sleep Study|car accident|1|||
48348104|NCT00878553|155470254|FG001|Sleep Study|car accident|0|||
48348105|NCT00878553|155470255|FG002|Sleep Study|car accident|0|||
48674826|NCT00445770|156661627|FG002|Overall Study|Lack of Efficacy|6|||
48674827|NCT00445770|156661625|FG000|Overall Study|Lost to Follow-up|0|||
48674828|NCT00445770|156661626|FG001|Overall Study|Lost to Follow-up|2|||
48674829|NCT00445770|156661627|FG002|Overall Study|Lost to Follow-up|0|||
48674830|NCT00445770|156661625|FG000|Overall Study|Other|6|||
48674831|NCT00445770|156661626|FG001|Overall Study|Other|5|||
48674832|NCT00445770|156661627|FG002|Overall Study|Other|6|||
48674833|NCT04412707|156661628|FG000|Cycle 1|Death|0|||
48674834|NCT04412707|156661629|FG001|Cycle 1|Death|3|||
48674835|NCT04412707|156661628|FG000|Cycle 1|Disease progression|1|||
48674836|NCT04412707|156661629|FG001|Cycle 1|Disease progression|2|||
48674837|NCT04412707|156661628|FG000|Cycle 2|Death|0|||
48674838|NCT04412707|156661629|FG001|Cycle 2|Death|1|||
48761667|NCT04127786|156975657|FG001|Primary Series|Protocol Violation|3|||
48761668|NCT04127786|156975658|FG002|Primary Series|Protocol Violation|4|||
48348106|NCT00878553|155470256|FG003|Sleep Study|car accident|0|||
48348107|NCT00878553|155470257|FG004|Sleep Study|car accident|0|||
48348108|NCT00878553|155470253|FG000|Sleep Study|family emergency|1|||
48348109|NCT00878553|155470254|FG001|Sleep Study|family emergency|0|||
48674839|NCT04412707|156661628|FG000|Cycle 2|Disease progression|3|||
48674840|NCT04412707|156661629|FG001|Cycle 2|Disease progression|0|||
48674841|NCT04412707|156661628|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
48674842|NCT04412707|156661629|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
48674843|NCT04412707|156661628|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
48674844|NCT04412707|156661629|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
48674845|NCT04412707|156661628|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
48674846|NCT04412707|156661629|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
48761669|NCT04127786|156975659|FG003|Primary Series|Protocol Violation|3|||
48761670|NCT04127786|156975660|FG004|Primary Series|Protocol Violation|2|||
48761671|NCT04127786|156975661|FG005|Primary Series|Protocol Violation|0|||
48348110|NCT00878553|155470255|FG002|Sleep Study|family emergency|0|||
48348111|NCT00878553|155470256|FG003|Sleep Study|family emergency|0|||
48674847|NCT04412707|156661628|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
48674848|NCT04412707|156661629|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
48674849|NCT02927938|156661630|FG000|Overall Study|Death|0|||
48674850|NCT02927938|156661631|FG001|Overall Study|Death|1|||
48674851|NCT02927938|156661632|FG002|Overall Study|Death|0|||
48674852|NCT02927938|156661633|FG003|Overall Study|Death|4|||
48761672|NCT04127786|156975656|FG000|Primary Series|Withdrawal by Subject|0|||
48348112|NCT00878553|155470257|FG004|Sleep Study|family emergency|0|||
48348113|NCT00878553|155470253|FG000|PK Study|Withdrawal by Subject|0|||
48348114|NCT00878553|155470254|FG001|PK Study|Withdrawal by Subject|0|||
48348115|NCT00878553|155470255|FG002|PK Study|Withdrawal by Subject|0|||
48674853|NCT02927938|156661630|FG000|Overall Study|Early Study Termination|1|||
48348116|NCT00878553|155470256|FG003|PK Study|Withdrawal by Subject|1|||
48348117|NCT00878553|155470257|FG004|PK Study|Withdrawal by Subject|0|||
48348118|NCT02725528|155470262|FG000|Overall Study|Lost to Follow-up|1|||
48348119|NCT02725528|155470263|FG001|Overall Study|Lost to Follow-up|4|||
48348120|NCT02725528|155470262|FG000|Overall Study|Withdrawal by Subject|0|||
48348121|NCT02725528|155470263|FG001|Overall Study|Withdrawal by Subject|1|||
48348122|NCT00778921|155470264|FG000|Overall Study|Adverse Event|9|||
48348123|NCT00778921|155470265|FG001|Overall Study|Adverse Event|10|||
48348124|NCT00778921|155470266|FG002|Overall Study|Adverse Event|14|||
48348125|NCT00778921|155470264|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
48348126|NCT00778921|155470265|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
48348127|NCT00778921|155470266|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
48348128|NCT00778921|155470264|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
48348129|NCT00778921|155470265|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
48348130|NCT00778921|155470266|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
48348131|NCT00778921|155470264|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
48348132|NCT00778921|155470265|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
48348133|NCT00778921|155470266|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
48348134|NCT00778921|155470264|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
48348135|NCT00778921|155470265|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
48348136|NCT00778921|155470266|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
48348137|NCT00778921|155470264|FG000|Overall Study|Patient withdrew request|3|||
48348138|NCT00778921|155470265|FG001|Overall Study|Patient withdrew request|1|||
48348139|NCT00778921|155470266|FG002|Overall Study|Patient withdrew request|6|||
48348140|NCT00778921|155470264|FG000|Overall Study|Lost to Follow-up|0|||
48348141|NCT00778921|155470265|FG001|Overall Study|Lost to Follow-up|2|||
48348142|NCT00778921|155470266|FG002|Overall Study|Lost to Follow-up|1|||
48348143|NCT00778921|155470264|FG000|Overall Study|Administrative Problems|1|||
48348144|NCT00778921|155470265|FG001|Overall Study|Administrative Problems|2|||
48348145|NCT00778921|155470266|FG002|Overall Study|Administrative Problems|0|||
48348146|NCT00778921|155470264|FG000|Overall Study|Protocol Violation|3|||
48348147|NCT00778921|155470265|FG001|Overall Study|Protocol Violation|0|||
48348148|NCT00778921|155470266|FG002|Overall Study|Protocol Violation|2|||
48348149|NCT00778921|155470264|FG000|Overall Study|Not treated|0|||
48348150|NCT00778921|155470265|FG001|Overall Study|Not treated|2|||
48348151|NCT00778921|155470266|FG002|Overall Study|Not treated|2|||
48348152|NCT02132117|155470267|FG000|Overall Study|Adverse Event|6|||
48348153|NCT02132117|155470268|FG001|Overall Study|Adverse Event|1|||
48348154|NCT02132117|155470267|FG000|Overall Study|Lost to Follow-up|2|||
48348155|NCT02132117|155470268|FG001|Overall Study|Lost to Follow-up|2|||
48348156|NCT02132117|155470267|FG000|Overall Study|Personal Reasons|1|||
48348157|NCT02132117|155470268|FG001|Overall Study|Personal Reasons|2|||
48348158|NCT02132117|155470267|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48348159|NCT02132117|155470268|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48348160|NCT02630706|155470270|FG000|Overall Study|Adverse Event|2|||
48348161|NCT02630706|155470271|FG001|Overall Study|Adverse Event|1|||
48348162|NCT02630706|155470272|FG002|Overall Study|Adverse Event|1|||
48348163|NCT02630706|155470270|FG000|Overall Study|Lost to Follow-up|0|||
48348164|NCT02630706|155470271|FG001|Overall Study|Lost to Follow-up|1|||
48348165|NCT02630706|155470272|FG002|Overall Study|Lost to Follow-up|2|||
48348166|NCT02630706|155470270|FG000|Overall Study|Physician Decision|1|||
48348167|NCT02630706|155470271|FG001|Overall Study|Physician Decision|1|||
48348168|NCT02630706|155470272|FG002|Overall Study|Physician Decision|0|||
48348169|NCT02630706|155470270|FG000|Overall Study|Pregnancy|0|||
48348170|NCT02630706|155470271|FG001|Overall Study|Pregnancy|1|||
48348171|NCT02630706|155470272|FG002|Overall Study|Pregnancy|0|||
48348172|NCT02630706|155470270|FG000|Overall Study|Withdrawal by Subject|4|||
48348173|NCT02630706|155470271|FG001|Overall Study|Withdrawal by Subject|5|||
48348174|NCT02630706|155470272|FG002|Overall Study|Withdrawal by Subject|7|||
48348175|NCT00582114|155470274|FG000|Overall Study|Death|4|||
48674854|NCT02927938|156661631|FG001|Overall Study|Early Study Termination|5|||
48674855|NCT02927938|156661632|FG002|Overall Study|Early Study Termination|4|||
48674856|NCT02927938|156661633|FG003|Overall Study|Early Study Termination|3|||
48674857|NCT02834247|156661637|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
48348176|NCT00582114|155470275|FG001|Overall Study|Death|4|||
48348177|NCT00582114|155470274|FG000|Overall Study|Kidney Transplant|3|||
48348178|NCT00582114|155470275|FG001|Overall Study|Kidney Transplant|1|||
48348179|NCT00582114|155470274|FG000|Overall Study|Lost to Follow-up|7|||
48348180|NCT00582114|155470275|FG001|Overall Study|Lost to Follow-up|6|||
48348181|NCT00582114|155470274|FG000|Overall Study|Withdrawal by Subject|8|||
48674858|NCT02834247|156661638|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
48674859|NCT02834247|156661639|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
48674860|NCT02834247|156661640|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
48674861|NCT02834247|156661637|FG000|Dose Escalation Phase|Death|5|||
48674862|NCT02834247|156661638|FG001|Dose Escalation Phase|Death|6|||
48674863|NCT02834247|156661639|FG002|Dose Escalation Phase|Death|5|||
48674864|NCT02834247|156661640|FG003|Dose Escalation Phase|Death|0|||
48674865|NCT02834247|156661637|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
48674866|NCT02834247|156661638|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
48674867|NCT02834247|156661639|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
48674868|NCT02834247|156661640|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
48674869|NCT02834247|156661637|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
48674870|NCT02834247|156661638|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
48674871|NCT02834247|156661639|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48674872|NCT02834247|156661640|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48674873|NCT02834247|156661637|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
48674874|NCT02834247|156661638|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
48674875|NCT02834247|156661639|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
48674876|NCT02834247|156661640|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
48674877|NCT02834247|156661637|FG000|Dose Expansion Phase|Death|0|||
48674878|NCT02834247|156661638|FG001|Dose Expansion Phase|Death|0|||
48674879|NCT02834247|156661639|FG002|Dose Expansion Phase|Death|0|||
48674880|NCT02834247|156661640|FG003|Dose Expansion Phase|Death|8|||
48674881|NCT02834247|156661637|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
48674882|NCT02834247|156661638|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
48674883|NCT02834247|156661639|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
48674884|NCT02834247|156661640|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
48674885|NCT02834247|156661637|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
48674886|NCT02834247|156661638|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
48674887|NCT02834247|156661639|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
48674888|NCT02834247|156661640|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
48674889|NCT01073930|156663364|FG000|Overall Study|Withdrawal by Subject|3|||
48674890|NCT01073930|156663365|FG001|Overall Study|Withdrawal by Subject|2|||
48674891|NCT01073930|156663364|FG000|Overall Study|Lost to Follow-up|0|||
48674892|NCT01073930|156663365|FG001|Overall Study|Lost to Follow-up|1|||
48674893|NCT01073930|156663364|FG000|Overall Study|Adverse Event|0|||
48674894|NCT01073930|156663365|FG001|Overall Study|Adverse Event|1|||
48674895|NCT01073930|156663364|FG000|Overall Study|Noncompliance with study drug|0|||
48674896|NCT01073930|156663365|FG001|Overall Study|Noncompliance with study drug|1|||
48761673|NCT04127786|156975657|FG001|Primary Series|Withdrawal by Subject|0|||
48761674|NCT04127786|156975658|FG002|Primary Series|Withdrawal by Subject|0|||
48761675|NCT04127786|156975659|FG003|Primary Series|Withdrawal by Subject|1|||
48761676|NCT04127786|156975660|FG004|Primary Series|Withdrawal by Subject|0|||
48761677|NCT04127786|156975661|FG005|Primary Series|Withdrawal by Subject|0|||
48761678|NCT04127786|156975656|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
48761679|NCT04127786|156975657|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
48761680|NCT04127786|156975658|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
48761681|NCT04127786|156975659|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
48761682|NCT04127786|156975660|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
48761683|NCT04127786|156975661|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
48761684|NCT04127786|156975656|FG000|Booster Phase|Withdrawal by Subject|2|||
48761685|NCT04127786|156975657|FG001|Booster Phase|Withdrawal by Subject|0|||
48761686|NCT04127786|156975658|FG002|Booster Phase|Withdrawal by Subject|0|||
48761687|NCT04127786|156975659|FG003|Booster Phase|Withdrawal by Subject|0|||
48761688|NCT04127786|156975660|FG004|Booster Phase|Withdrawal by Subject|0|||
48761689|NCT04127786|156975661|FG005|Booster Phase|Withdrawal by Subject|0|||
48761690|NCT02255500|156975662|FG000|Overall Study|Withdrawal by Subject|1|||
48761691|NCT02255500|156975663|FG001|Overall Study|Withdrawal by Subject|0|||
48761692|NCT00460031|156975664|FG000|Overall Study|Adverse Event|5|||
48761693|NCT00460031|156975664|FG000|Overall Study|Withdrawal by Subject|5|||
48761694|NCT00460031|156975664|FG000|Overall Study|Death|1|||
48761695|NCT04254978|156975666|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
48761696|NCT04254978|156975666|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
48761697|NCT04254978|156975666|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
48761698|NCT04254978|156975666|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
48348182|NCT00582114|155470275|FG001|Overall Study|Withdrawal by Subject|16|||
48348183|NCT00582114|155470274|FG000|Overall Study|Adverse Event|1|||
48674897|NCT01073930|156663364|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
48674898|NCT01073930|156663365|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
48761699|NCT04254978|156975666|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
48761700|NCT04254978|156975666|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
48761701|NCT02520011|156975667|FG000|Overall Study|Adverse Event|0|||
48761702|NCT02520011|156975668|FG001|Overall Study|Adverse Event|1|||
48674899|NCT01209078|156663366|FG000|Overall Study|Adverse Event|5|||
48674900|NCT01209078|156663367|FG001|Overall Study|Adverse Event|0|||
48348184|NCT00582114|155470275|FG001|Overall Study|Adverse Event|1|||
48348185|NCT00582114|155470274|FG000|Overall Study|Physician Decision|0|||
48674901|NCT01209078|156663366|FG000|Overall Study|Lost to Follow-up|4|||
48674902|NCT01209078|156663367|FG001|Overall Study|Lost to Follow-up|0|||
48674903|NCT01209078|156663366|FG000|Overall Study|Physician Decision|5|||
48674904|NCT01209078|156663367|FG001|Overall Study|Physician Decision|2|||
48674905|NCT01209078|156663366|FG000|Overall Study|Withdrawal by Subject|2|||
48674906|NCT01209078|156663367|FG001|Overall Study|Withdrawal by Subject|1|||
48674907|NCT01912339|156663368|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
48674908|NCT01912339|156663369|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
48348186|NCT00582114|155470275|FG001|Overall Study|Physician Decision|6|||
48674909|NCT01912339|156663370|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
48674910|NCT01912339|156663368|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
48348187|NCT00582114|155470274|FG000|Overall Study|Stopped by data safety monitoring board|19|||
48348188|NCT00582114|155470275|FG001|Overall Study|Stopped by data safety monitoring board|20|||
48674911|NCT01912339|156663369|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
48348189|NCT01062971|155470276|FG000|Overall Study|Protocol Violation|1|||
48348190|NCT01062971|155470277|FG001|Overall Study|Protocol Violation|3|||
48348191|NCT01062971|155470276|FG000|Overall Study|Lost to Follow-up|3|||
48348192|NCT01062971|155470277|FG001|Overall Study|Lost to Follow-up|4|||
48348193|NCT01161628|155470278|FG000|Overall Study|Death|6|||
48348194|NCT01161628|155470278|FG000|Overall Study|Lack of Efficacy|2|||
48348195|NCT01018732|155470279|FG000|Overall Study|Lost to Follow-up|0|||
48348196|NCT01018732|155470280|FG001|Overall Study|Lost to Follow-up|0|||
48348197|NCT01018732|155470281|FG002|Overall Study|Lost to Follow-up|3|||
48348198|NCT01018732|155470279|FG000|Overall Study|Protocol Violation|1|||
48348199|NCT01018732|155470280|FG001|Overall Study|Protocol Violation|1|||
48348200|NCT01018732|155470281|FG002|Overall Study|Protocol Violation|0|||
48348201|NCT01018732|155470279|FG000|Overall Study|Inappropriate Enrollment|0|||
48348202|NCT01018732|155470280|FG001|Overall Study|Inappropriate Enrollment|1|||
48348203|NCT01018732|155470281|FG002|Overall Study|Inappropriate Enrollment|0|||
48348204|NCT01018732|155470279|FG000|Overall Study|Unable to Classify|0|||
48348205|NCT01018732|155470280|FG001|Overall Study|Unable to Classify|0|||
48348206|NCT01018732|155470281|FG002|Overall Study|Unable to Classify|1|||
48348207|NCT03765164|155470282|FG000|Pre-intervention|Withdrawal by Subject|5|||
48348208|NCT03765164|155470283|FG001|Pre-intervention|Withdrawal by Subject|6|||
48348209|NCT02781311|155470284|FG000|Overall Study|Adverse Event|2|||
48348210|NCT02781311|155470285|FG001|Overall Study|Adverse Event|6|||
48674912|NCT01912339|156663370|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
48674913|NCT01912339|156663368|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
48674914|NCT01912339|156663369|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
48348211|NCT02781311|155470286|FG002|Overall Study|Adverse Event|1|||
48348212|NCT02781311|155470284|FG000|Overall Study|Withdrawal of Consent|11|||
48348213|NCT02781311|155470285|FG001|Overall Study|Withdrawal of Consent|12|||
48348214|NCT02781311|155470286|FG002|Overall Study|Withdrawal of Consent|2|||
48348215|NCT02781311|155470284|FG000|Overall Study|Lost to Follow-up|11|||
48348216|NCT02781311|155470285|FG001|Overall Study|Lost to Follow-up|8|||
48348217|NCT02781311|155470286|FG002|Overall Study|Lost to Follow-up|1|||
48348218|NCT02781311|155470284|FG000|Overall Study|Non-Compliance with Study Drug|2|||
48348219|NCT02781311|155470285|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48348220|NCT02781311|155470286|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48348221|NCT02394665|155470287|FG000|Overall Study|Physician Decision|1|||
48348222|NCT02394665|155470288|FG001|Overall Study|Physician Decision|0|||
48348223|NCT02394665|155470289|FG002|Overall Study|Physician Decision|0|||
48348224|NCT00815919|155470290|FG000|Overall Study|Unrelated Fungal Infection|1|||
48348225|NCT00815919|155470290|FG000|Overall Study|AML Relapse|1|||
48348226|NCT00815919|155470290|FG000|Overall Study|Lack of Efficacy|2|||
48348227|NCT00546078|155470291|FG000|Overall Study|Lost to Follow-up|1|||
48348228|NCT00546078|155470292|FG001|Overall Study|Lost to Follow-up|3|||
48674915|NCT01912339|156663370|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
48674916|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
48674917|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
48674918|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
48674919|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
48674920|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
48674921|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
48674922|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
48674923|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
48674924|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
48674925|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
48674926|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
48674927|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
48674928|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
48348229|NCT00546078|155470291|FG000|Overall Study|Withdrawal by Subject|2|||
48348230|NCT00546078|155470292|FG001|Overall Study|Withdrawal by Subject|3|||
48348231|NCT00546078|155470291|FG000|Overall Study|Other reason|1|||
48348232|NCT00546078|155470292|FG001|Overall Study|Other reason|1|||
48348233|NCT00604188|155470293|FG000|Overall Study|Adverse Event|1|||
48348234|NCT00604188|155470294|FG001|Overall Study|Adverse Event|4|||
48348235|NCT00604188|155470293|FG000|Overall Study|Lost to Follow-up|17|||
48348236|NCT00604188|155470294|FG001|Overall Study|Lost to Follow-up|15|||
48348237|NCT00604188|155470293|FG000|Overall Study|Withdrawal by Subject|5|||
48348238|NCT00604188|155470294|FG001|Overall Study|Withdrawal by Subject|1|||
48674929|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
48674930|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
48348239|NCT00604188|155470293|FG000|Overall Study|Non-compliance with protocol|4|||
48348240|NCT00604188|155470294|FG001|Overall Study|Non-compliance with protocol|4|||
48348241|NCT00604188|155470293|FG000|Overall Study|Did not receive study drug|0|||
48348242|NCT00604188|155470294|FG001|Overall Study|Did not receive study drug|1|||
48348243|NCT01431950|155470296|FG000|Overall Study|Study Site Closed/Terminated|7|||
48348244|NCT01431950|155470297|FG001|Overall Study|Study Site Closed/Terminated|3|||
48348245|NCT01431950|155470296|FG000|Overall Study|Withdrawal by Subject|4|||
48348246|NCT01431950|155470297|FG001|Overall Study|Withdrawal by Subject|3|||
48348247|NCT01431950|155470296|FG000|Overall Study|Protocol Violation|2|||
48348248|NCT01431950|155470297|FG001|Overall Study|Protocol Violation|3|||
48348249|NCT01431950|155470296|FG000|Overall Study|Adverse Event|2|||
48348250|NCT01431950|155470297|FG001|Overall Study|Adverse Event|2|||
48348251|NCT01431950|155470296|FG000|Overall Study|Physician Decision|2|||
48348252|NCT01431950|155470297|FG001|Overall Study|Physician Decision|1|||
48348253|NCT01431950|155470296|FG000|Overall Study|Lack of Efficacy|2|||
48348254|NCT01431950|155470297|FG001|Overall Study|Lack of Efficacy|1|||
48348255|NCT01431950|155470296|FG000|Overall Study|Lost to Follow-up|0|||
48348256|NCT01431950|155470297|FG001|Overall Study|Lost to Follow-up|1|||
48348257|NCT01431950|155470296|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48348258|NCT01431950|155470297|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48348259|NCT02101983|155470298|FG000|Overall Study|Physician Decision|1|||
48348260|NCT02101983|155470299|FG001|Overall Study|Physician Decision|0|||
48348261|NCT02592707|155470304|FG000|Overall Study|Consent Withdrawn|0|||
48348262|NCT02592707|155470305|FG001|Overall Study|Consent Withdrawn|1|||
48348263|NCT02592707|155470306|FG002|Overall Study|Consent Withdrawn|2|||
48348264|NCT02592707|155470307|FG003|Overall Study|Consent Withdrawn|0|||
48348265|NCT02592707|155470304|FG000|Overall Study|Death|1|||
48348266|NCT02592707|155470305|FG001|Overall Study|Death|0|||
48348267|NCT02592707|155470306|FG002|Overall Study|Death|0|||
48348268|NCT02592707|155470307|FG003|Overall Study|Death|0|||
48348269|NCT02592707|155470304|FG000|Overall Study|Progressive Disease|4|||
48674931|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
48674932|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
48674933|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
48674934|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
48674935|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
48674936|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
48761703|NCT02520011|156975669|FG002|Overall Study|Adverse Event|2|||
48348270|NCT02592707|155470305|FG001|Overall Study|Progressive Disease|4|||
48348271|NCT02592707|155470306|FG002|Overall Study|Progressive Disease|3|||
48348272|NCT02592707|155470307|FG003|Overall Study|Progressive Disease|3|||
48348273|NCT02592707|155470304|FG000|Overall Study|Other|0|||
48348274|NCT02592707|155470305|FG001|Overall Study|Other|0|||
48348275|NCT02592707|155470306|FG002|Overall Study|Other|1|||
48348276|NCT02592707|155470307|FG003|Overall Study|Other|2|||
48348277|NCT02592707|155470304|FG000|Overall Study|Never entered LTFU period|1|||
48348278|NCT02592707|155470305|FG001|Overall Study|Never entered LTFU period|0|||
48348279|NCT02592707|155470306|FG002|Overall Study|Never entered LTFU period|0|||
48348280|NCT02592707|155470307|FG003|Overall Study|Never entered LTFU period|2|||
48348281|NCT04124471|155470308|FG000|Overall Study|screen failure|1|||
48761704|NCT02520011|156975667|FG000|Overall Study|Death|0|||
48761705|NCT02520011|156975668|FG001|Overall Study|Death|8|||
48761706|NCT02520011|156975669|FG002|Overall Study|Death|1|||
48761707|NCT02520011|156975667|FG000|Overall Study|Lack of Efficacy|4|||
48761708|NCT02520011|156975668|FG001|Overall Study|Lack of Efficacy|26|||
48761709|NCT02520011|156975669|FG002|Overall Study|Lack of Efficacy|4|||
48761710|NCT02520011|156975667|FG000|Overall Study|Physician Decision|0|||
48761711|NCT02520011|156975668|FG001|Overall Study|Physician Decision|2|||
48761712|NCT02520011|156975669|FG002|Overall Study|Physician Decision|0|||
48761713|NCT02520011|156975667|FG000|Overall Study|Withdrawal by Subject|1|||
48761714|NCT02520011|156975668|FG001|Overall Study|Withdrawal by Subject|3|||
48761715|NCT02520011|156975669|FG002|Overall Study|Withdrawal by Subject|0|||
48761716|NCT02520011|156975667|FG000|Overall Study|Protocol Deviation|0|||
48761717|NCT02520011|156975668|FG001|Overall Study|Protocol Deviation|1|||
48348282|NCT01222533|155471743|FG000|Overall Study|Adverse Event|5|||
48348283|NCT01222533|155471743|FG000|Overall Study|Withdrawal by Subject|5|||
48348284|NCT01222533|155471743|FG000|Overall Study|Other|4|||
48348285|NCT00719212|155471744|FG000|Overall Study|Death|41|||
48348286|NCT00719212|155471744|FG000|Overall Study|Lost to Follow-up|2|||
48348287|NCT00719212|155471744|FG000|Overall Study|Withdrawal by Subject|1|||
48674937|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
48761718|NCT02520011|156975669|FG002|Overall Study|Protocol Deviation|0|||
48761719|NCT02520011|156975667|FG000|Overall Study|Patient went to hospice|0|||
48761720|NCT02520011|156975668|FG001|Overall Study|Patient went to hospice|1|||
48348288|NCT00197106|155471748|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
48348289|NCT00197106|155471749|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
48348290|NCT00197106|155471750|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
48348291|NCT00197106|155471748|FG000|Overall Treatment Period|Lack of Efficacy|0|||
48761721|NCT02520011|156975669|FG002|Overall Study|Patient went to hospice|0|||
48761722|NCT02520011|156975667|FG000|Overall Study|Progressive disease following response|0|||
48761723|NCT02520011|156975668|FG001|Overall Study|Progressive disease following response|4|||
48761724|NCT02520011|156975669|FG002|Overall Study|Progressive disease following response|2|||
48761725|NCT02066467|156975671|FG000|Overall Study|Did not undergo implant procedure|24|||
48761726|NCT02066467|156975671|FG000|Overall Study|Attempted to implant withoput success|43|||
48761727|NCT02066467|156975671|FG000|Overall Study|Consent ineligible|1|||
48761728|NCT02066467|156975671|FG000|Overall Study|Death|54|||
48761729|NCT02066467|156975671|FG000|Overall Study|Lost to Follow-up|51|||
48761730|NCT02066467|156975671|FG000|Overall Study|Adverse Event|20|||
48761731|NCT02066467|156975671|FG000|Overall Study|Withdrawal by Subject|16|||
48761732|NCT02066467|156975671|FG000|Overall Study|Physician Decision|2|||
48761733|NCT02066467|156975671|FG000|Overall Study|Not defined|4|||
48761734|NCT00491387|156975673|FG000|Overall Study|study terminated|20|||
48761735|NCT04267133|156975674|FG000|Overall Study|Withdrawal by Subject|1|||
48761736|NCT04267133|156975674|FG000|Overall Study|Adverse Event|4|||
48761737|NCT02419742|156975677|FG000|Overall Study|Adverse Event|2|||
48761738|NCT02419742|156975678|FG001|Overall Study|Adverse Event|0|||
48761739|NCT02419742|156975677|FG000|Overall Study|Disease Progression|0|||
48761740|NCT02419742|156975678|FG001|Overall Study|Disease Progression|1|||
48761741|NCT02419742|156975677|FG000|Overall Study|Withdrew Consent|2|||
48674938|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
48674939|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
48674940|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
48674941|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
48674942|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
48674943|NCT01912339|156663368|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
48674944|NCT01912339|156663369|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
48674945|NCT01912339|156663370|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
48674946|NCT03221842|156663375|FG000|Period 1 (Open-label)|Adverse Event|4|||
48674947|NCT03221842|156663376|FG001|Period 1 (Open-label)|Adverse Event|0|||
48674948|NCT03221842|156663375|FG000|Period 1 (Open-label)|Physician Decision|2|||
48674949|NCT03221842|156663376|FG001|Period 1 (Open-label)|Physician Decision|0|||
48674950|NCT03221842|156663375|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
48674951|NCT03221842|156663376|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
48674952|NCT03221842|156663375|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
48674953|NCT03221842|156663376|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
48761742|NCT02419742|156975678|FG001|Overall Study|Withdrew Consent|1|||
48761743|NCT02419742|156975677|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
48761744|NCT02419742|156975678|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
48761745|NCT01514760|156975682|FG000|Overall Study|Lost to Follow-up|2|||
48761746|NCT02574247|156975683|FG000|Overall Study|Withdrawal by Subject|1|||
48761747|NCT02574247|156975684|FG001|Overall Study|Withdrawal by Subject|0|||
48761748|NCT02574247|156975685|FG002|Overall Study|Withdrawal by Subject|0|||
48761749|NCT02574247|156975683|FG000|Overall Study|Did not meet inclusion criteria|4|||
48761750|NCT02574247|156975684|FG001|Overall Study|Did not meet inclusion criteria|3|||
48761751|NCT02574247|156975685|FG002|Overall Study|Did not meet inclusion criteria|5|||
48761752|NCT02420691|156975687|FG000|Overall Study|Adverse Event|3|||
48761753|NCT02420691|156975687|FG000|Overall Study|Withdrawal by Subject|3|||
48761754|NCT00003901|156975688|FG000|Overall Study|Adverse Event|1|||
48761755|NCT00003901|156975688|FG000|Overall Study|Withdrawal by Subject|1|||
48761756|NCT00003901|156975688|FG000|Overall Study|Ineligible|6|||
48761757|NCT00003901|156975688|FG000|Overall Study|CT Scan not within protocol requirement|2|||
48761758|NCT00003901|156975688|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
48761759|NCT00003901|156975688|FG000|Overall Study|Medical problems|6|||
48761760|NCT02503332|156975689|FG000|Overall Study|Adverse Event|17|||
48761761|NCT02503332|156975690|FG001|Overall Study|Adverse Event|5|||
48761762|NCT02503332|156975691|FG002|Overall Study|Adverse Event|3|||
48761763|NCT02503332|156975692|FG003|Overall Study|Adverse Event|1|||
48761764|NCT02503332|156975689|FG000|Overall Study|Investigator's Decision|5|||
48761765|NCT02503332|156975690|FG001|Overall Study|Investigator's Decision|1|||
48348292|NCT00197106|155471749|FG001|Overall Treatment Period|Lack of Efficacy|1|||
48348293|NCT00197106|155471750|FG002|Overall Treatment Period|Lack of Efficacy|0|||
48348294|NCT00197106|155471748|FG000|Overall Treatment Period|Lost to Follow-up|0|||
48348295|NCT00197106|155471749|FG001|Overall Treatment Period|Lost to Follow-up|0|||
48761766|NCT02503332|156975691|FG002|Overall Study|Investigator's Decision|0|||
48761767|NCT02503332|156975692|FG003|Overall Study|Investigator's Decision|0|||
48761768|NCT02503332|156975689|FG000|Overall Study|Sponsor's Decision|1|||
48761769|NCT02503332|156975690|FG001|Overall Study|Sponsor's Decision|0|||
48761770|NCT02503332|156975691|FG002|Overall Study|Sponsor's Decision|0|||
48348296|NCT00197106|155471750|FG002|Overall Treatment Period|Lost to Follow-up|2|||
48761771|NCT02503332|156975692|FG003|Overall Study|Sponsor's Decision|1|||
48761772|NCT02503332|156975689|FG000|Overall Study|Subject Request|6|||
48348297|NCT00197106|155471748|FG000|Overall Treatment Period|Protocol Violation|0|||
48348298|NCT00197106|155471749|FG001|Overall Treatment Period|Protocol Violation|0|||
48348299|NCT00197106|155471750|FG002|Overall Treatment Period|Protocol Violation|2|||
48348300|NCT00197106|155471748|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
48348301|NCT00197106|155471749|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
48348302|NCT00197106|155471750|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
48348303|NCT01755546|155471753|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
48348304|NCT01755546|155471753|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
48348305|NCT01755546|155471753|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
48348306|NCT01755546|155471753|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
48348307|NCT01755546|155471753|FG000|Titration Phase|Adverse Event|11|||
48348308|NCT01755546|155471753|FG000|Titration Phase|Lack of Efficacy|18|||
48348309|NCT01755546|155471753|FG000|Titration Phase|Protocol Violation|9|||
48348310|NCT01755546|155471753|FG000|Titration Phase|Lost to Follow-up|2|||
48348311|NCT01755546|155471753|FG000|Titration Phase|Other and Continuing|22|||
48348312|NCT01755546|155471753|FG000|Titration Phase|Withdrawal by Subject|8|||
48348313|NCT01755546|155471753|FG000|Long Term Treatment|Adverse Event|12|||
48348314|NCT01755546|155471753|FG000|Long Term Treatment|Lack of Efficacy|6|||
48348315|NCT01755546|155471753|FG000|Long Term Treatment|Protocol Violation|10|||
48348316|NCT01755546|155471753|FG000|Long Term Treatment|Withdrawal by Subject|35|||
48348317|NCT01755546|155471753|FG000|Long Term Treatment|Lost to Follow-up|17|||
48348318|NCT01755546|155471753|FG000|Long Term Treatment|other and ongoing|41|||
48348319|NCT02166476|155471757|FG000|Overall Study|Withdrawal by Subject|5|||
48348320|NCT02166476|155471758|FG001|Overall Study|Withdrawal by Subject|7|||
48348321|NCT02166476|155471757|FG000|Overall Study|Adverse Event|3|||
48348322|NCT02166476|155471758|FG001|Overall Study|Adverse Event|3|||
48348323|NCT02166476|155471757|FG000|Overall Study|Lost to Follow-up|5|||
48348324|NCT02166476|155471758|FG001|Overall Study|Lost to Follow-up|10|||
48348325|NCT02166476|155471757|FG000|Overall Study|Physician Decision|1|||
48348326|NCT02166476|155471758|FG001|Overall Study|Physician Decision|0|||
48348327|NCT02166476|155471757|FG000|Overall Study|Unable to Come for Visit|0|||
48348328|NCT02166476|155471758|FG001|Overall Study|Unable to Come for Visit|3|||
48348329|NCT04333147|155471759|FG000|Overall Study|Adverse Event|43|||
48348330|NCT04333147|155471760|FG001|Overall Study|Adverse Event|40|||
48348331|NCT04333147|155471759|FG000|Overall Study|Lack of Efficacy|49|||
48348332|NCT04333147|155471760|FG001|Overall Study|Lack of Efficacy|48|||
48348333|NCT04333147|155471759|FG000|Overall Study|Lost to Follow-up|19|||
48348334|NCT04333147|155471760|FG001|Overall Study|Lost to Follow-up|16|||
48348335|NCT04333147|155471759|FG000|Overall Study|Physician Decision|17|||
48348336|NCT04333147|155471760|FG001|Overall Study|Physician Decision|20|||
48348337|NCT04333147|155471759|FG000|Overall Study|Withdrawal by Subject|65|||
48348338|NCT04333147|155471760|FG001|Overall Study|Withdrawal by Subject|68|||
48348339|NCT04333147|155471759|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
48348340|NCT04333147|155471760|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
48348341|NCT04333147|155471759|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
48348342|NCT04333147|155471760|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
48348343|NCT04333147|155471759|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
48348344|NCT04333147|155471760|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
48348345|NCT03062449|155471761|FG000|Overall Study|Withdrawal by Subject|7|||
48674954|NCT03221842|156663375|FG000|Period 1 (Open-label)|Other|2|||
48674955|NCT03221842|156663376|FG001|Period 1 (Open-label)|Other|0|||
48674956|NCT03221842|156663375|FG000|Period 2 (Randomized, Blinded)|Death|0|||
48674957|NCT03221842|156663376|FG001|Period 2 (Randomized, Blinded)|Death|1|||
48674958|NCT03221842|156663375|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
48674959|NCT03221842|156663376|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
48674960|NCT01286077|156663377|FG000|Overall Study|Adverse Event|2|||
48674961|NCT01286077|156663378|FG001|Overall Study|Adverse Event|0|||
48674962|NCT01286077|156663377|FG000|Overall Study|Death|1|||
48674963|NCT01286077|156663378|FG001|Overall Study|Death|0|||
48674964|NCT01286077|156663377|FG000|Overall Study|Protocol Violation|1|||
48674965|NCT01286077|156663378|FG001|Overall Study|Protocol Violation|1|||
48674966|NCT01286077|156663377|FG000|Overall Study|Withdrawal by Subject|0|||
48674967|NCT01286077|156663378|FG001|Overall Study|Withdrawal by Subject|2|||
48348346|NCT03062449|155471762|FG001|Overall Study|Withdrawal by Subject|1|||
48348347|NCT00983905|155471763|FG000|Theophylline Alone|Adverse Event|1|||
48348348|NCT00983905|155471763|FG000|Colchicine Alone|Adverse Event|2|||
48348349|NCT01114139|155471764|FG000|Overall Study|Adverse Event|3|||
48348350|NCT01114139|155471765|FG001|Overall Study|Adverse Event|2|||
48348351|NCT01114139|155471764|FG000|Overall Study|Lost to Follow-up|15|||
48348352|NCT01114139|155471765|FG001|Overall Study|Lost to Follow-up|3|||
48348353|NCT01114139|155471764|FG000|Overall Study|Withdrawal by Subject|17|||
48348354|NCT01114139|155471765|FG001|Overall Study|Withdrawal by Subject|6|||
48674968|NCT01286077|156663377|FG000|Overall Study|Intercurrent illness|1|||
48674969|NCT01286077|156663378|FG001|Overall Study|Intercurrent illness|0|||
48674970|NCT01286077|156663377|FG000|Overall Study|Non-compliance|1|||
48674971|NCT01286077|156663378|FG001|Overall Study|Non-compliance|0|||
48348355|NCT01114139|155471764|FG000|Overall Study|Other-Missed 1 visit|1|||
48348356|NCT01114139|155471765|FG001|Overall Study|Other-Missed 1 visit|0|||
48348357|NCT01114139|155471764|FG000|Overall Study|Other-Protocol Violation|1|||
48348358|NCT01114139|155471765|FG001|Overall Study|Other-Protocol Violation|0|||
48348359|NCT01114139|155471764|FG000|Overall Study|Other-Out of window for study drug dose|1|||
48348360|NCT01114139|155471765|FG001|Overall Study|Other-Out of window for study drug dose|0|||
48348361|NCT01114139|155471764|FG000|Overall Study|Other-Participant falsified records|0|||
48348362|NCT01114139|155471765|FG001|Overall Study|Other-Participant falsified records|1|||
48348363|NCT01114139|155471764|FG000|Overall Study|Other-Participant went on hospice|0|||
48348364|NCT01114139|155471765|FG001|Overall Study|Other-Participant went on hospice|1|||
48348365|NCT01114139|155471764|FG000|Overall Study|Other-Physician changed treatment|1|||
48348366|NCT01114139|155471765|FG001|Overall Study|Other-Physician changed treatment|0|||
48348367|NCT01114139|155471764|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
48348368|NCT01114139|155471765|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
48348369|NCT00280683|155471766|FG000|Overall Study|Withdrawal by Subject|1|||
48348370|NCT00280683|155471767|FG001|Overall Study|Withdrawal by Subject|2|||
48348371|NCT00280683|155471766|FG000|Overall Study|Adverse Event|1|||
48348372|NCT00280683|155471767|FG001|Overall Study|Adverse Event|1|||
48348373|NCT01169636|155471768|FG000|Overall Study|Adverse Event|0|||
48348374|NCT01169636|155471769|FG001|Overall Study|Adverse Event|0|||
48348375|NCT01169636|155471770|FG002|Overall Study|Adverse Event|1|||
48348376|NCT01169636|155471771|FG003|Overall Study|Adverse Event|1|||
48348377|NCT01169636|155471772|FG004|Overall Study|Adverse Event|0|||
48348378|NCT01169636|155471768|FG000|Overall Study|Screen failure|0|||
48348379|NCT01169636|155471769|FG001|Overall Study|Screen failure|0|||
48348380|NCT01169636|155471770|FG002|Overall Study|Screen failure|2|||
48348381|NCT01169636|155471771|FG003|Overall Study|Screen failure|0|||
48348382|NCT01169636|155471772|FG004|Overall Study|Screen failure|0|||
48348383|NCT01169636|155471768|FG000|Overall Study|Withdrawal by Subject|0|||
48348384|NCT01169636|155471769|FG001|Overall Study|Withdrawal by Subject|0|||
48348385|NCT01169636|155471770|FG002|Overall Study|Withdrawal by Subject|0|||
48348386|NCT01169636|155471771|FG003|Overall Study|Withdrawal by Subject|0|||
48348387|NCT01169636|155471772|FG004|Overall Study|Withdrawal by Subject|3|||
48348388|NCT02466243|155471773|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
48348389|NCT02466243|155471774|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
48348390|NCT02466243|155471773|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
48348391|NCT02466243|155471774|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
48348392|NCT02466243|155471773|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
48348393|NCT02466243|155471774|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
48348394|NCT02466243|155471773|FG000|Part B Open-label Treatment Period|Missing|2|||
48348395|NCT02466243|155471774|FG001|Part B Open-label Treatment Period|Missing|2|||
48348396|NCT00784147|155471775|FG000|Overall Study|Lost to Follow-up|2|||
48348397|NCT00784147|155471776|FG001|Overall Study|Lost to Follow-up|4|||
48348398|NCT00784147|155471775|FG000|Overall Study|Withdrawal by Subject|1|||
48348399|NCT00784147|155471776|FG001|Overall Study|Withdrawal by Subject|3|||
48348400|NCT00784147|155471775|FG000|Overall Study|Physician Decision|2|||
48348401|NCT00784147|155471776|FG001|Overall Study|Physician Decision|1|||
48348402|NCT00784147|155471775|FG000|Overall Study|Protocol Violation|1|||
48348403|NCT00784147|155471776|FG001|Overall Study|Protocol Violation|1|||
48348404|NCT00784147|155471775|FG000|Overall Study|Death|2|||
48348405|NCT00784147|155471776|FG001|Overall Study|Death|0|||
48348406|NCT00427778|155471781|FG000|First Intervention (4 Weeks)|no longer interested|1|||
48348407|NCT00427778|155471782|FG001|First Intervention (4 Weeks)|no longer interested|0|||
48348408|NCT00427778|155471781|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
48348409|NCT00427778|155471782|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
48348410|NCT00427778|155471781|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
48348411|NCT00427778|155471782|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
48348412|NCT00427778|155471781|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
48348413|NCT00427778|155471782|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
48674972|NCT01286077|156663377|FG000|Overall Study|The subject starts with alternative MMY|0|||
48348414|NCT01101997|155471783|FG000|Overall Study|Withdrawal by Subject|2|||
48348415|NCT02599688|155471784|FG000|Overall Study|Lack of Efficacy|1|||
48348416|NCT02599688|155471784|FG000|Overall Study|Withdrawal by Subject|1|||
48348417|NCT02599688|155471784|FG000|Overall Study|Termination by Sponsor|2|||
48348418|NCT00611715|155471791|FG000|Overall Study|Disease Progression|24|||
48348419|NCT00611715|155471792|FG001|Overall Study|Disease Progression|4|||
48348420|NCT00611715|155471791|FG000|Overall Study|Withdrawal by Subject|5|||
48348421|NCT00611715|155471792|FG001|Overall Study|Withdrawal by Subject|1|||
48348422|NCT00611715|155471791|FG000|Overall Study|Adverse Event|9|||
48348423|NCT00611715|155471792|FG001|Overall Study|Adverse Event|1|||
48348424|NCT00611715|155471791|FG000|Overall Study|Death|1|||
48348425|NCT00611715|155471792|FG001|Overall Study|Death|0|||
48348426|NCT00611715|155471791|FG000|Overall Study|two patients are still on treatment|2|||
48348427|NCT00611715|155471792|FG001|Overall Study|two patients are still on treatment|0|||
48348428|NCT00727415|155471795|FG000|Phase I|Dose Limiting Toxicity|2|||
48348429|NCT00704171|155471797|FG000|Overall Study|Withdrawal by Subject|1|||
48348430|NCT00704171|155471798|FG001|Overall Study|Withdrawal by Subject|0|||
48348431|NCT00350298|155471800|FG000|Overall Study|Death|7|||
48348432|NCT00350298|155471801|FG001|Overall Study|Death|8|||
48348433|NCT00350298|155471800|FG000|Overall Study|Lost to Follow-up|1|||
48348434|NCT00350298|155471801|FG001|Overall Study|Lost to Follow-up|2|||
48348435|NCT00350298|155471800|FG000|Overall Study|Withdrawal by Subject|1|||
48348436|NCT00350298|155471801|FG001|Overall Study|Withdrawal by Subject|3|||
48348437|NCT02647788|155471804|FG000|Overall Study|Lost to Follow-up|13|||
48348438|NCT02647788|155471805|FG001|Overall Study|Lost to Follow-up|11|||
48348439|NCT02647788|155471804|FG000|Overall Study|Did not want opiate|0|||
48348440|NCT02647788|155471805|FG001|Overall Study|Did not want opiate|1|||
48348441|NCT02647788|155471804|FG000|Overall Study|Withdrawal by Subject|1|||
48348442|NCT02647788|155471805|FG001|Overall Study|Withdrawal by Subject|0|||
48348443|NCT02647788|155471804|FG000|Overall Study|Felt itchy with assigned medication|1|||
48348444|NCT02647788|155471805|FG001|Overall Study|Felt itchy with assigned medication|0|||
48348445|NCT02647788|155471804|FG000|Overall Study|Felt nauseous with assigned medication|1|||
48348446|NCT02647788|155471805|FG001|Overall Study|Felt nauseous with assigned medication|1|||
48348447|NCT02171130|155471806|FG000|Overall Study|Death|1|||
48348448|NCT02171130|155471806|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
48348449|NCT02171130|155471806|FG000|Overall Study|Discontinued; Site Termination|5|||
48348450|NCT02171130|155471806|FG000|Overall Study|Withdrawal by Subject|3|||
48348451|NCT02171130|155471806|FG000|Overall Study|Physician Decision|1|||
48348452|NCT02171130|155471806|FG000|Overall Study|Lost to Follow-up|1|||
48348453|NCT02171130|155471806|FG000|Overall Study|Met Exclusion Criteria|1|||
48348454|NCT00776659|155471814|FG000|Overall Study|Lost to Follow-up|15|||
48348455|NCT00776659|155471814|FG000|Overall Study|Withdrawal by Subject|10|||
48348456|NCT00776659|155471814|FG000|Overall Study|Study Terminated by Sponsor|1|||
48348457|NCT03082612|155471815|FG000|Overall Study|Lost to Follow-up|2|||
48348458|NCT03082612|155471816|FG001|Overall Study|Lost to Follow-up|0|||
48348459|NCT00129649|155471817|FG000|Overall Study|Withdrawal by Subject|76|||
48348460|NCT00129649|155471818|FG001|Overall Study|Withdrawal by Subject|65|||
48348461|NCT00025506|155471823|FG000|Overall Study|Ineligible: clerical error|1|||
48348462|NCT00025506|155471823|FG000|Overall Study|Ineligible: wrong cell type|5|||
48348463|NCT00025506|155471823|FG000|Overall Study|Ineligible: inadequate pathology|2|||
48348464|NCT00025506|155471823|FG000|Overall Study|Never Treated|2|||
48348465|NCT00713206|155471824|FG000|Overall Study|Lost to Follow-up|4|||
48348466|NCT00713206|155471825|FG001|Overall Study|Lost to Follow-up|4|||
48348467|NCT00713206|155471824|FG000|Overall Study|Death|1|||
48761773|NCT02503332|156975690|FG001|Overall Study|Subject Request|5|||
48348468|NCT00713206|155471825|FG001|Overall Study|Death|0|||
48348469|NCT02561806|155471826|FG000|Induction Period|Adverse Event|0|||
48348470|NCT02561806|155471827|FG001|Induction Period|Adverse Event|2|||
48348471|NCT02561806|155471826|FG000|Induction Period|Lack of Efficacy|1|||
48348472|NCT02561806|155471827|FG001|Induction Period|Lack of Efficacy|0|||
48348473|NCT02561806|155471826|FG000|Induction Period|Withdrawal by Subject|0|||
48348474|NCT02561806|155471827|FG001|Induction Period|Withdrawal by Subject|2|||
48348475|NCT02561806|155471826|FG000|Induction Period|Site staff became unblinded|1|||
48348476|NCT02561806|155471827|FG001|Induction Period|Site staff became unblinded|0|||
48348477|NCT02561806|155471826|FG000|Induction Period|Randomized but not treated|0|||
48674973|NCT01286077|156663378|FG001|Overall Study|The subject starts with alternative MMY|3|||
48674974|NCT01286077|156663377|FG000|Overall Study|Patient's decision to stop treatment|3|||
48674975|NCT01286077|156663378|FG001|Overall Study|Patient's decision to stop treatment|0|||
48674976|NCT01286077|156663377|FG000|Overall Study|Progression of disease|0|||
48674977|NCT01286077|156663378|FG001|Overall Study|Progression of disease|1|||
48674978|NCT01286077|156663377|FG000|Overall Study|refill medication not received in time|1|||
48674979|NCT01286077|156663378|FG001|Overall Study|refill medication not received in time|0|||
48674980|NCT00434642|156663379|FG000|Blinded Treatment Phase|Adverse Event|12|||
48674981|NCT00434642|156663380|FG001|Blinded Treatment Phase|Adverse Event|58|||
48674982|NCT00434642|156663379|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
48674983|NCT00434642|156663380|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
48674984|NCT00434642|156663379|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
48674985|NCT00434642|156663380|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
48674986|NCT00434642|156663379|FG000|Blinded Treatment Phase|Physician Decision|19|||
48674987|NCT00434642|156663380|FG001|Blinded Treatment Phase|Physician Decision|27|||
48674988|NCT00434642|156663379|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
48761774|NCT02503332|156975691|FG002|Overall Study|Subject Request|2|||
48761775|NCT02503332|156975692|FG003|Overall Study|Subject Request|1|||
48348478|NCT02561806|155471827|FG001|Induction Period|Randomized but not treated|1|||
48348479|NCT02561806|155471826|FG000|Maintenance Period|Adverse Event|2|||
48348480|NCT02561806|155471827|FG001|Maintenance Period|Adverse Event|1|||
48348481|NCT02561806|155471826|FG000|Maintenance Period|Lack of Efficacy|3|||
48348482|NCT02561806|155471827|FG001|Maintenance Period|Lack of Efficacy|1|||
48348483|NCT02561806|155471826|FG000|Maintenance Period|Lost to Follow-up|2|||
48348484|NCT02561806|155471827|FG001|Maintenance Period|Lost to Follow-up|2|||
48348485|NCT02561806|155471826|FG000|Maintenance Period|Protocol Violation|1|||
48348486|NCT02561806|155471827|FG001|Maintenance Period|Protocol Violation|0|||
48348487|NCT02561806|155471826|FG000|Maintenance Period|Withdrawal by Subject|5|||
48348488|NCT02561806|155471827|FG001|Maintenance Period|Withdrawal by Subject|3|||
48348489|NCT02561806|155471826|FG000|Maintenance Period|Site staff became unblinded|0|||
48348490|NCT02561806|155471827|FG001|Maintenance Period|Site staff became unblinded|1|||
48348491|NCT02561806|155471826|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
48348492|NCT02561806|155471827|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
48348493|NCT02561806|155471826|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
48348494|NCT02561806|155471827|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
48348495|NCT04081389|155471828|FG000|Overall Study|Withdrawal by Subject|0|||
48348496|NCT04081389|155471829|FG001|Overall Study|Withdrawal by Subject|0|||
48348497|NCT04081389|155471830|FG002|Overall Study|Withdrawal by Subject|1|||
48348498|NCT04081389|155471831|FG003|Overall Study|Withdrawal by Subject|0|||
48348499|NCT02460562|155471832|FG000|Overall Study|Lost to Follow-up|15|||
48348500|NCT02460562|155471833|FG001|Overall Study|Lost to Follow-up|16|||
48348501|NCT02725567|155471834|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
48348502|NCT02725567|155471835|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
48348503|NCT02725567|155471834|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
48348504|NCT02725567|155471835|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
48348505|NCT02725567|155471834|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
48348506|NCT02725567|155471835|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
48348507|NCT01585298|155471836|FG000|Overall Study|Study completion was not documented.|1|||
48348508|NCT01585298|155471836|FG000|Overall Study|Protocol deviation|1|||
48348509|NCT01585298|155471836|FG000|Overall Study|Administrative problems|4|||
48348510|NCT01585298|155471836|FG000|Overall Study|Lost to Follow-up|2|||
48348511|NCT01585298|155471836|FG000|Overall Study|Withdrawal by Subject|4|||
48348512|NCT01585298|155471836|FG000|Overall Study|Abnormal test procedure results|1|||
48348513|NCT01585298|155471836|FG000|Overall Study|Adverse Event|24|||
48348514|NCT02108652|155471838|FG000|Overall Study|Death|253|||
48348515|NCT02108652|155471838|FG000|Overall Study|Lost to Follow-up|2|||
48348516|NCT02108652|155471838|FG000|Overall Study|Withdrawal by Subject|16|||
48348517|NCT02108652|155471838|FG000|Overall Study|Study Terminated By Sponsor|31|||
48348518|NCT02108652|155471838|FG000|Overall Study|Non-Compliance|1|||
48348519|NCT02108652|155471838|FG000|Overall Study|Physician Decision|6|||
48348520|NCT02108652|155471838|FG000|Overall Study|Progression Of Disease|1|||
48348521|NCT03845075|155471841|FG000|Part 1 - DB|Withdrawal by Subject|1|||
48348522|NCT03845075|155471842|FG001|Part 1 - DB|Withdrawal by Subject|1|||
48348523|NCT03845075|155471843|FG002|Part 1 - DB|Withdrawal by Subject|0|||
48348524|NCT03845075|155471844|FG003|Part 1 - DB|Withdrawal by Subject|0|||
48348525|NCT03845075|155471841|FG000|Part 1 - DB|Adverse Event|0|||
48348526|NCT03845075|155471842|FG001|Part 1 - DB|Adverse Event|1|||
48348527|NCT03845075|155471843|FG002|Part 1 - DB|Adverse Event|0|||
48348528|NCT03845075|155471844|FG003|Part 1 - DB|Adverse Event|0|||
48348529|NCT03845075|155471841|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
48348530|NCT03845075|155471842|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
48348531|NCT03845075|155471843|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
48761776|NCT02503332|156975689|FG000|Overall Study|Death|0|||
48348532|NCT03845075|155471844|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
48348533|NCT00690378|155471845|FG000|Overall Study|Adverse Event|1|||
48348534|NCT00690378|155471846|FG001|Overall Study|Adverse Event|0|||
48348535|NCT00690378|155471845|FG000|Overall Study|Withdrawal by Subject|2|||
48348536|NCT00690378|155471846|FG001|Overall Study|Withdrawal by Subject|0|||
48348537|NCT00690378|155471845|FG000|Overall Study|Protocol Violation|1|||
48348538|NCT00690378|155471846|FG001|Overall Study|Protocol Violation|0|||
48674989|NCT00434642|156663380|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
48348539|NCT00690378|155471845|FG000|Overall Study|Lost to Follow-up|2|||
48348540|NCT00690378|155471846|FG001|Overall Study|Lost to Follow-up|3|||
48348541|NCT00690378|155471845|FG000|Overall Study|Did not meet inc/exc criteria|13|||
48348542|NCT00690378|155471846|FG001|Overall Study|Did not meet inc/exc criteria|11|||
48348543|NCT00690378|155471845|FG000|Overall Study|Social problem|1|||
48348544|NCT00690378|155471846|FG001|Overall Study|Social problem|0|||
48348545|NCT00935259|155471847|FG000|Period 1|Administrative (scheduling conflict)|1|||
48348546|NCT00935259|155471848|FG001|Period 1|Administrative (scheduling conflict)|1|||
48348547|NCT01242371|155471849|FG000|Overall Study|Withdrawal by Subject|2|||
48348548|NCT01242371|155471850|FG001|Overall Study|Withdrawal by Subject|2|||
48348549|NCT01242371|155471849|FG000|Overall Study|Protocol Violation|0|||
48348550|NCT01242371|155471850|FG001|Overall Study|Protocol Violation|3|||
48348551|NCT00461123|155471851|FG000|Overall Study|Adverse Event|1|||
48348552|NCT00461123|155471852|FG001|Overall Study|Adverse Event|0|||
48348553|NCT00461123|155471851|FG000|Overall Study|Lost to Follow-up|1|||
48348554|NCT00461123|155471852|FG001|Overall Study|Lost to Follow-up|1|||
48348555|NCT00461123|155471851|FG000|Overall Study|Protocol Violation|3|||
48348556|NCT00461123|155471852|FG001|Overall Study|Protocol Violation|2|||
48348557|NCT00461123|155471851|FG000|Overall Study|Withdrawal by Subject|1|||
48348558|NCT00461123|155471852|FG001|Overall Study|Withdrawal by Subject|3|||
48348559|NCT02353871|155471853|FG000|Overall Study|Protocol deviation|0|||
48348560|NCT02353871|155471854|FG001|Overall Study|Protocol deviation|1|||
48348561|NCT02353871|155471853|FG000|Overall Study|Consent withdrawn|1|||
48348562|NCT02353871|155471854|FG001|Overall Study|Consent withdrawn|8|||
48348563|NCT02353871|155471853|FG000|Overall Study|Lost to Follow-up|2|||
48348564|NCT02353871|155471854|FG001|Overall Study|Lost to Follow-up|0|||
48348565|NCT01482429|155471857|FG000|Care Usual|Protocol Violation|0|||
48348566|NCT01482429|155471858|FG001|Care Usual|Protocol Violation|172|||
48348567|NCT01482429|155471857|FG000|Care Usual|Lost to Follow-up|0|||
48348568|NCT01482429|155471858|FG001|Care Usual|Lost to Follow-up|1|||
48348569|NCT01482429|155471857|FG000|Protocol|Protocol Violation|275|||
48348570|NCT01482429|155471858|FG001|Protocol|Protocol Violation|0|||
48348571|NCT02650466|155471859|FG000|Overall Study|Physician Decision|1|||
48348572|NCT02650466|155471859|FG000|Overall Study|Withdrawal by Subject|5|||
48348573|NCT02650466|155471859|FG000|Overall Study|Lost to Follow-up|1|||
48348574|NCT02484547|155471860|FG000|Placebo-Controlled Period|Adverse Event|10|||
48348575|NCT02484547|155471861|FG001|Placebo-Controlled Period|Adverse Event|13|||
48348576|NCT02484547|155471862|FG002|Placebo-Controlled Period|Adverse Event|20|||
48348577|NCT02484547|155471863|FG003|Placebo-Controlled Period|Adverse Event|0|||
48348578|NCT02484547|155471864|FG004|Placebo-Controlled Period|Adverse Event|0|||
48348579|NCT02484547|155471865|FG005|Placebo-Controlled Period|Adverse Event|0|||
48348580|NCT02484547|155471866|FG006|Placebo-Controlled Period|Adverse Event|0|||
48348581|NCT02484547|155471860|FG000|Placebo-Controlled Period|Change of Treatment|0|||
48348582|NCT02484547|155471861|FG001|Placebo-Controlled Period|Change of Treatment|0|||
48348583|NCT02484547|155471862|FG002|Placebo-Controlled Period|Change of Treatment|1|||
48348584|NCT02484547|155471863|FG003|Placebo-Controlled Period|Change of Treatment|0|||
48348585|NCT02484547|155471864|FG004|Placebo-Controlled Period|Change of Treatment|0|||
48348586|NCT02484547|155471865|FG005|Placebo-Controlled Period|Change of Treatment|0|||
48348587|NCT02484547|155471866|FG006|Placebo-Controlled Period|Change of Treatment|0|||
48348588|NCT02484547|155471860|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
48348589|NCT02484547|155471861|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
48348590|NCT02484547|155471862|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
48348591|NCT02484547|155471863|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
48348592|NCT02484547|155471864|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
48674990|NCT00434642|156663379|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
48674991|NCT00434642|156663380|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
48674992|NCT00434642|156663379|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
48674993|NCT00434642|156663380|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
48674994|NCT00434642|156663379|FG000|Open-label Treatment Phase|Adverse Event|0|||
48348593|NCT02484547|155471865|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
48348594|NCT02484547|155471866|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
48348595|NCT02484547|155471860|FG000|Placebo-Controlled Period|Death|5|||
48348596|NCT02484547|155471861|FG001|Placebo-Controlled Period|Death|0|||
48348597|NCT02484547|155471862|FG002|Placebo-Controlled Period|Death|6|||
48348598|NCT02484547|155471863|FG003|Placebo-Controlled Period|Death|0|||
48348599|NCT02484547|155471864|FG004|Placebo-Controlled Period|Death|0|||
48348600|NCT02484547|155471865|FG005|Placebo-Controlled Period|Death|0|||
48348601|NCT02484547|155471866|FG006|Placebo-Controlled Period|Death|0|||
48348602|NCT02484547|155471860|FG000|Placebo-Controlled Period|Disease Progression|2|||
48348603|NCT02484547|155471861|FG001|Placebo-Controlled Period|Disease Progression|0|||
48348604|NCT02484547|155471862|FG002|Placebo-Controlled Period|Disease Progression|1|||
48348605|NCT02484547|155471863|FG003|Placebo-Controlled Period|Disease Progression|0|||
48348606|NCT02484547|155471864|FG004|Placebo-Controlled Period|Disease Progression|0|||
48348607|NCT02484547|155471865|FG005|Placebo-Controlled Period|Disease Progression|0|||
48348608|NCT02484547|155471866|FG006|Placebo-Controlled Period|Disease Progression|0|||
48348609|NCT02484547|155471860|FG000|Placebo-Controlled Period|Investigator Decision|2|||
48348610|NCT02484547|155471861|FG001|Placebo-Controlled Period|Investigator Decision|2|||
48348611|NCT02484547|155471862|FG002|Placebo-Controlled Period|Investigator Decision|5|||
48348612|NCT02484547|155471863|FG003|Placebo-Controlled Period|Investigator Decision|0|||
48348613|NCT02484547|155471864|FG004|Placebo-Controlled Period|Investigator Decision|0|||
48348614|NCT02484547|155471865|FG005|Placebo-Controlled Period|Investigator Decision|0|||
48348615|NCT02484547|155471866|FG006|Placebo-Controlled Period|Investigator Decision|0|||
48348616|NCT02484547|155471860|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
48348617|NCT02484547|155471861|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
48348618|NCT02484547|155471862|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
48348619|NCT02484547|155471863|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
48348620|NCT02484547|155471864|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
48348621|NCT02484547|155471865|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
48348622|NCT02484547|155471866|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
48348623|NCT02484547|155471860|FG000|Placebo-Controlled Period|Relocation|1|||
48348624|NCT02484547|155471861|FG001|Placebo-Controlled Period|Relocation|1|||
48348625|NCT02484547|155471862|FG002|Placebo-Controlled Period|Relocation|1|||
48348626|NCT02484547|155471863|FG003|Placebo-Controlled Period|Relocation|0|||
48348627|NCT02484547|155471864|FG004|Placebo-Controlled Period|Relocation|0|||
48348628|NCT02484547|155471865|FG005|Placebo-Controlled Period|Relocation|0|||
48348629|NCT02484547|155471866|FG006|Placebo-Controlled Period|Relocation|0|||
48348630|NCT02484547|155471860|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
48674995|NCT00434642|156663380|FG001|Open-label Treatment Phase|Adverse Event|5|||
48674996|NCT00434642|156663379|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
48674997|NCT00434642|156663380|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
48348631|NCT02484547|155471861|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
48348632|NCT02484547|155471862|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
48348633|NCT02484547|155471863|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
48348634|NCT02484547|155471864|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
48348635|NCT02484547|155471865|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
48348636|NCT02484547|155471866|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
48348637|NCT02484547|155471860|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
48348638|NCT02484547|155471861|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
48348639|NCT02484547|155471862|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
48348640|NCT02484547|155471863|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48348641|NCT02484547|155471864|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48348642|NCT02484547|155471865|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48348643|NCT02484547|155471866|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48348644|NCT02484547|155471860|FG000|Placebo-Controlled Period|Reason not Specified|216|||
48348645|NCT02484547|155471861|FG001|Placebo-Controlled Period|Reason not Specified|194|||
48348646|NCT02484547|155471862|FG002|Placebo-Controlled Period|Reason not Specified|183|||
48348647|NCT02484547|155471863|FG003|Placebo-Controlled Period|Reason not Specified|0|||
48348648|NCT02484547|155471864|FG004|Placebo-Controlled Period|Reason not Specified|0|||
48348649|NCT02484547|155471865|FG005|Placebo-Controlled Period|Reason not Specified|0|||
48348650|NCT02484547|155471866|FG006|Placebo-Controlled Period|Reason not Specified|0|||
48348651|NCT02484547|155471860|FG000|Long-Term Extension Period|Adverse Event|0|||
48348652|NCT02484547|155471861|FG001|Long-Term Extension Period|Adverse Event|0|||
48348653|NCT02484547|155471862|FG002|Long-Term Extension Period|Adverse Event|0|||
48348654|NCT02484547|155471863|FG003|Long-Term Extension Period|Adverse Event|0|||
48348655|NCT02484547|155471864|FG004|Long-Term Extension Period|Adverse Event|1|||
48348656|NCT02484547|155471865|FG005|Long-Term Extension Period|Adverse Event|3|||
48348657|NCT02484547|155471866|FG006|Long-Term Extension Period|Adverse Event|2|||
48348658|NCT02484547|155471860|FG000|Long-Term Extension Period|Death|0|||
48348659|NCT02484547|155471861|FG001|Long-Term Extension Period|Death|0|||
48348660|NCT02484547|155471862|FG002|Long-Term Extension Period|Death|0|||
48674998|NCT00527982|156663381|FG000|Overall Study|Physician Decision|1|||
48348661|NCT02484547|155471863|FG003|Long-Term Extension Period|Death|0|||
48674999|NCT00527982|156663382|FG001|Overall Study|Physician Decision|0|||
48675000|NCT04541628|156663391|FG000|Overall Study|Study Terminated|1|||
48675001|NCT04541628|156663392|FG001|Overall Study|Study Terminated|1|||
48675002|NCT04541628|156663393|FG002|Overall Study|Study Terminated|1|||
48675003|NCT01192412|156663394|FG000|Overall Study|Lost to Follow-up|2|||
48675004|NCT01192412|156663395|FG001|Overall Study|Lost to Follow-up|1|||
48675005|NCT01192412|156663394|FG000|Overall Study|Withdrawal by Subject|2|||
48348662|NCT02484547|155471864|FG004|Long-Term Extension Period|Death|0|||
48348663|NCT02484547|155471865|FG005|Long-Term Extension Period|Death|3|||
48348664|NCT02484547|155471866|FG006|Long-Term Extension Period|Death|0|||
48348665|NCT02484547|155471860|FG000|Long-Term Extension Period|Disease Progression|0|||
48348666|NCT02484547|155471861|FG001|Long-Term Extension Period|Disease Progression|0|||
48348667|NCT02484547|155471862|FG002|Long-Term Extension Period|Disease Progression|0|||
48348668|NCT02484547|155471863|FG003|Long-Term Extension Period|Disease Progression|0|||
48348669|NCT02484547|155471864|FG004|Long-Term Extension Period|Disease Progression|2|||
48348670|NCT02484547|155471865|FG005|Long-Term Extension Period|Disease Progression|4|||
48348671|NCT02484547|155471866|FG006|Long-Term Extension Period|Disease Progression|0|||
48348672|NCT02484547|155471860|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
48348673|NCT02484547|155471861|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
48348674|NCT02484547|155471862|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
48348675|NCT02484547|155471863|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
48348676|NCT02484547|155471864|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
48348677|NCT02484547|155471865|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
48348678|NCT02484547|155471866|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
48348679|NCT02484547|155471860|FG000|Long-Term Extension Period|Loss of Capacity|0|||
48348680|NCT02484547|155471861|FG001|Long-Term Extension Period|Loss of Capacity|0|||
48348681|NCT02484547|155471862|FG002|Long-Term Extension Period|Loss of Capacity|0|||
48675006|NCT01192412|156663395|FG001|Overall Study|Withdrawal by Subject|1|||
48675007|NCT02421588|156663398|FG000|Overall Study|Non-treatment-related AE|8|||
48675008|NCT02421588|156663399|FG001|Overall Study|Non-treatment-related AE|8|||
48675009|NCT02421588|156663398|FG000|Overall Study|Progressive disease|152|||
48675010|NCT02421588|156663399|FG001|Overall Study|Progressive disease|135|||
48675011|NCT02421588|156663398|FG000|Overall Study|Death|11|||
48675012|NCT02421588|156663399|FG001|Overall Study|Death|3|||
48675013|NCT02421588|156663398|FG000|Overall Study|Physician Decision|8|||
48675014|NCT02421588|156663399|FG001|Overall Study|Physician Decision|17|||
48675015|NCT02421588|156663398|FG000|Overall Study|Other reason not specified|3|||
48348682|NCT02484547|155471863|FG003|Long-Term Extension Period|Loss of Capacity|0|||
48348683|NCT02484547|155471864|FG004|Long-Term Extension Period|Loss of Capacity|1|||
48348684|NCT02484547|155471865|FG005|Long-Term Extension Period|Loss of Capacity|0|||
48348685|NCT02484547|155471866|FG006|Long-Term Extension Period|Loss of Capacity|0|||
48348686|NCT02484547|155471860|FG000|Long-Term Extension Period|Change of Treatment|0|||
48348687|NCT02484547|155471861|FG001|Long-Term Extension Period|Change of Treatment|0|||
48348688|NCT02484547|155471862|FG002|Long-Term Extension Period|Change of Treatment|0|||
48348689|NCT02484547|155471863|FG003|Long-Term Extension Period|Change of Treatment|0|||
48348690|NCT02484547|155471864|FG004|Long-Term Extension Period|Change of Treatment|0|||
48348691|NCT02484547|155471865|FG005|Long-Term Extension Period|Change of Treatment|0|||
48348692|NCT02484547|155471866|FG006|Long-Term Extension Period|Change of Treatment|1|||
48348693|NCT02484547|155471860|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
48348694|NCT02484547|155471861|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
48348695|NCT02484547|155471862|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
48348696|NCT02484547|155471863|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
48348697|NCT02484547|155471864|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
48348698|NCT02484547|155471865|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
48348699|NCT02484547|155471866|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
48348700|NCT02484547|155471860|FG000|Long-Term Extension Period|Investigator Decision|0|||
48348701|NCT02484547|155471861|FG001|Long-Term Extension Period|Investigator Decision|0|||
48348702|NCT02484547|155471862|FG002|Long-Term Extension Period|Investigator Decision|0|||
48348703|NCT02484547|155471863|FG003|Long-Term Extension Period|Investigator Decision|2|||
48348704|NCT02484547|155471864|FG004|Long-Term Extension Period|Investigator Decision|1|||
48348705|NCT02484547|155471865|FG005|Long-Term Extension Period|Investigator Decision|0|||
48348706|NCT02484547|155471866|FG006|Long-Term Extension Period|Investigator Decision|1|||
48348707|NCT02484547|155471860|FG000|Long-Term Extension Period|Relocation|0|||
48348708|NCT02484547|155471861|FG001|Long-Term Extension Period|Relocation|0|||
48348709|NCT02484547|155471862|FG002|Long-Term Extension Period|Relocation|0|||
48348710|NCT02484547|155471863|FG003|Long-Term Extension Period|Relocation|1|||
48348711|NCT02484547|155471864|FG004|Long-Term Extension Period|Relocation|1|||
48348712|NCT02484547|155471865|FG005|Long-Term Extension Period|Relocation|0|||
48348713|NCT02484547|155471866|FG006|Long-Term Extension Period|Relocation|0|||
48348714|NCT02484547|155471860|FG000|Long-Term Extension Period|Study Visit Burden|0|||
48348715|NCT02484547|155471861|FG001|Long-Term Extension Period|Study Visit Burden|0|||
48348716|NCT02484547|155471862|FG002|Long-Term Extension Period|Study Visit Burden|0|||
48348717|NCT02484547|155471863|FG003|Long-Term Extension Period|Study Visit Burden|2|||
48348718|NCT02484547|155471864|FG004|Long-Term Extension Period|Study Visit Burden|0|||
48348719|NCT02484547|155471865|FG005|Long-Term Extension Period|Study Visit Burden|0|||
48348720|NCT02484547|155471866|FG006|Long-Term Extension Period|Study Visit Burden|3|||
48348721|NCT02484547|155471860|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
48675016|NCT02421588|156663399|FG001|Overall Study|Other reason not specified|1|||
48675017|NCT02421588|156663398|FG000|Overall Study|Symptomatic deterioration|13|||
48761777|NCT02503332|156975690|FG001|Overall Study|Death|2|||
48761778|NCT02503332|156975691|FG002|Overall Study|Death|2|||
48348722|NCT02484547|155471861|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
48348723|NCT02484547|155471862|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
48348724|NCT02484547|155471863|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
48348725|NCT02484547|155471864|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
48348726|NCT02484547|155471865|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
48348727|NCT02484547|155471866|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
48348728|NCT02484547|155471860|FG000|Long-Term Extension Period|Reason not Specified|0|||
48348729|NCT02484547|155471861|FG001|Long-Term Extension Period|Reason not Specified|0|||
48348730|NCT02484547|155471862|FG002|Long-Term Extension Period|Reason not Specified|0|||
48348731|NCT02484547|155471863|FG003|Long-Term Extension Period|Reason not Specified|119|||
48348732|NCT02484547|155471864|FG004|Long-Term Extension Period|Reason not Specified|117|||
48348733|NCT02484547|155471865|FG005|Long-Term Extension Period|Reason not Specified|223|||
48348734|NCT02484547|155471866|FG006|Long-Term Extension Period|Reason not Specified|231|||
48348735|NCT04680637|155471867|FG000|Overall Study|Lost to Follow-up|0|||
48348736|NCT04680637|155471868|FG001|Overall Study|Lost to Follow-up|1|||
48348737|NCT04680637|155471869|FG002|Overall Study|Lost to Follow-up|0|||
48348738|NCT04680637|155471870|FG003|Overall Study|Lost to Follow-up|1|||
48675018|NCT02421588|156663399|FG001|Overall Study|Symptomatic deterioration|19|||
48675019|NCT02421588|156663398|FG000|Overall Study|Treatment-related AE|10|||
48675020|NCT02421588|156663399|FG001|Overall Study|Treatment-related AE|14|||
48675021|NCT02421588|156663398|FG000|Overall Study|Withdrawal by Subject|14|||
48675022|NCT02421588|156663399|FG001|Overall Study|Withdrawal by Subject|16|||
48675023|NCT02421588|156663398|FG000|Overall Study|Not treated|2|||
48675024|NCT02421588|156663399|FG001|Overall Study|Not treated|8|||
48675025|NCT00296140|156663400|FG000|Overall Study|Lost to Follow-up|1|||
48675026|NCT00296140|156663401|FG001|Overall Study|Lost to Follow-up|0|||
48675027|NCT00296140|156663400|FG000|Overall Study|Withdrawal by Subject|1|||
48675028|NCT00296140|156663401|FG001|Overall Study|Withdrawal by Subject|0|||
48675029|NCT00296140|156663400|FG000|Overall Study|Discharge to Nursing Home|1|||
48675030|NCT00296140|156663401|FG001|Overall Study|Discharge to Nursing Home|0|||
48675031|NCT04369950|156663402|FG000|Overall Study|Protocol Violation|2|||
48675032|NCT04369950|156663403|FG001|Overall Study|Protocol Violation|2|||
48675033|NCT00773747|156663404|FG000|Overall Study|Lack of Efficacy|112|||
48675034|NCT00773747|156663405|FG001|Overall Study|Lack of Efficacy|144|||
48675035|NCT00773747|156663404|FG000|Overall Study|Physician Decision|26|||
48675036|NCT00773747|156663405|FG001|Overall Study|Physician Decision|18|||
48675037|NCT00773747|156663404|FG000|Overall Study|Lost to Follow-up|0|||
48675038|NCT00773747|156663405|FG001|Overall Study|Lost to Follow-up|1|||
48675039|NCT00773747|156663404|FG000|Overall Study|Protocol Violation|2|||
48675040|NCT00773747|156663405|FG001|Overall Study|Protocol Violation|2|||
48675041|NCT00773747|156663404|FG000|Overall Study|Withdrawal by Subject|89|||
48675042|NCT00773747|156663405|FG001|Overall Study|Withdrawal by Subject|61|||
48675043|NCT00773747|156663404|FG000|Overall Study|Adverse Event|61|||
48675044|NCT00773747|156663405|FG001|Overall Study|Adverse Event|62|||
48675045|NCT00773747|156663404|FG000|Overall Study|Death|5|||
48675046|NCT00773747|156663405|FG001|Overall Study|Death|8|||
48675047|NCT00773747|156663404|FG000|Overall Study|Not Treated|2|||
48675048|NCT00773747|156663405|FG001|Overall Study|Not Treated|0|||
48675049|NCT02540668|156663406|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
48675050|NCT02540668|156663407|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
48675051|NCT03270891|156663408|FG000|Overall Study|Lost to Follow-up|3|||
48675052|NCT03270891|156663409|FG001|Overall Study|Lost to Follow-up|6|||
48675053|NCT03270891|156663410|FG002|Overall Study|Lost to Follow-up|0|||
48675054|NCT03270891|156663408|FG000|Overall Study|Withdrawal by Subject|1|||
48675055|NCT03270891|156663409|FG001|Overall Study|Withdrawal by Subject|0|||
48761779|NCT02503332|156975692|FG003|Overall Study|Death|0|||
48348739|NCT04680637|155471867|FG000|Overall Study|Death|1|||
48348740|NCT04680637|155471868|FG001|Overall Study|Death|0|||
48348741|NCT04680637|155471869|FG002|Overall Study|Death|0|||
48348742|NCT04680637|155471870|FG003|Overall Study|Death|0|||
48348743|NCT04680637|155471867|FG000|Overall Study|Withdrawal by Subject|7|||
48348744|NCT04680637|155471868|FG001|Overall Study|Withdrawal by Subject|10|||
48348745|NCT04680637|155471869|FG002|Overall Study|Withdrawal by Subject|17|||
48348746|NCT04680637|155471870|FG003|Overall Study|Withdrawal by Subject|15|||
48675056|NCT03270891|156663410|FG002|Overall Study|Withdrawal by Subject|0|||
48675057|NCT03270891|156663408|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
48675058|NCT03270891|156663409|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
48675059|NCT03270891|156663410|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
48675060|NCT04302545|156663411|FG000|Overall Study|Lost to Follow-up|3|||
48675061|NCT04302545|156663412|FG001|Overall Study|Lost to Follow-up|4|||
48675062|NCT02516592|156663415|FG000|Overall Study|Patient withdrew consent|5|||
48675063|NCT02516592|156663416|FG001|Overall Study|Patient withdrew consent|2|||
48675064|NCT02516592|156663415|FG000|Overall Study|Protocol deviation|4|||
48761780|NCT02503332|156975689|FG000|Overall Study|Other|5|||
48675065|NCT02516592|156663416|FG001|Overall Study|Protocol deviation|4|||
48675066|NCT02516592|156663415|FG000|Overall Study|Lost to Follow-up|2|||
48675067|NCT02516592|156663416|FG001|Overall Study|Lost to Follow-up|3|||
48675068|NCT02516592|156663415|FG000|Overall Study|Patient/guardian decision|2|||
48675069|NCT02516592|156663416|FG001|Overall Study|Patient/guardian decision|1|||
48675070|NCT02516592|156663415|FG000|Overall Study|Adverse Event|1|||
48675071|NCT02516592|156663416|FG001|Overall Study|Adverse Event|2|||
48675072|NCT02516592|156663415|FG000|Overall Study|Abnormal test procedure result|1|||
48761781|NCT02503332|156975690|FG001|Overall Study|Other|6|||
48761782|NCT02503332|156975691|FG002|Overall Study|Other|1|||
48761783|NCT02503332|156975692|FG003|Overall Study|Other|1|||
48761784|NCT02424383|156975693|FG000|Overall Study|Withdrawal by Subject|32|||
48761785|NCT02424383|156975693|FG000|Overall Study|Death|170|||
48761786|NCT02424383|156975693|FG000|Overall Study|Sponsor's decision|3|||
48348747|NCT04680637|155471867|FG000|Overall Study|Decision by Sponsor|21|||
48348748|NCT04680637|155471868|FG001|Overall Study|Decision by Sponsor|15|||
48348749|NCT04680637|155471869|FG002|Overall Study|Decision by Sponsor|7|||
48348750|NCT04680637|155471870|FG003|Overall Study|Decision by Sponsor|32|||
48348751|NCT00344032|155471871|FG000|Overall Study|Adverse Event|0|||
48348752|NCT00344032|155471872|FG001|Overall Study|Adverse Event|1|||
48348753|NCT00344032|155471871|FG000|Overall Study|Withdrawal by Subject|6|||
48348754|NCT00344032|155471872|FG001|Overall Study|Withdrawal by Subject|2|||
48348755|NCT00344032|155471871|FG000|Overall Study|Lost to Follow-up|4|||
48348756|NCT00344032|155471872|FG001|Overall Study|Lost to Follow-up|6|||
48348757|NCT00344032|155471871|FG000|Overall Study|Physician Decision|4|||
48348758|NCT00344032|155471872|FG001|Overall Study|Physician Decision|1|||
48348759|NCT02202109|155473626|FG000|Overall Study|Lost to Follow-up|88|||
48348760|NCT02202109|155473627|FG001|Overall Study|Lost to Follow-up|87|||
48348761|NCT02202109|155473626|FG000|Overall Study|Withdrawal by Subject|2|||
48348762|NCT02202109|155473627|FG001|Overall Study|Withdrawal by Subject|0|||
48348763|NCT02806505|155473630|FG000|Overall Study|Adverse event/intercurrent illness|1|||
48348764|NCT02806505|155473631|FG001|Overall Study|Adverse event/intercurrent illness|3|||
48348765|NCT02806505|155473630|FG000|Overall Study|Death|4|||
48348766|NCT02806505|155473631|FG001|Overall Study|Death|0|||
48348767|NCT02806505|155473630|FG000|Overall Study|Did not cooperate/refused treatment|3|||
48348768|NCT02806505|155473631|FG001|Overall Study|Did not cooperate/refused treatment|3|||
48348769|NCT02806505|155473630|FG000|Overall Study|Failure to return|0|||
48348770|NCT02806505|155473631|FG001|Overall Study|Failure to return|1|||
48348771|NCT02806505|155473630|FG000|Overall Study|Insufficient therapeutic response|2|||
48348772|NCT02806505|155473631|FG001|Overall Study|Insufficient therapeutic response|4|||
48348773|NCT01181609|155473636|FG000|Overall Study|Adverse Event|1|||
48348774|NCT01181609|155473636|FG000|Overall Study|Withdrawal by Subject|1|||
48348775|NCT01181609|155473636|FG000|Overall Study|Lost to Follow-up|1|||
48348776|NCT01181609|155473636|FG000|Overall Study|Death|50|||
48348777|NCT01333111|155473642|FG000|Overall Study|patient undergoing major surgery|0|||
48348778|NCT01333111|155473643|FG001|Overall Study|patient undergoing major surgery|2|||
48348779|NCT01333111|155473644|FG002|Overall Study|patient undergoing major surgery|0|||
48348780|NCT01333111|155473642|FG000|Overall Study|personal reasons|0|||
48348781|NCT01333111|155473643|FG001|Overall Study|personal reasons|0|||
48348782|NCT01333111|155473644|FG002|Overall Study|personal reasons|1|||
48348783|NCT01333111|155473642|FG000|Overall Study|unclassified|1|||
48348784|NCT01333111|155473643|FG001|Overall Study|unclassified|0|||
48348785|NCT01333111|155473644|FG002|Overall Study|unclassified|0|||
48348786|NCT01333111|155473642|FG000|Overall Study|withdrawal criteria|0|||
48348787|NCT01333111|155473643|FG001|Overall Study|withdrawal criteria|1|||
48348788|NCT01333111|155473644|FG002|Overall Study|withdrawal criteria|0|||
48348789|NCT01333111|155473642|FG000|Overall Study|Non-compliance|1|||
48348790|NCT01333111|155473643|FG001|Overall Study|Non-compliance|0|||
48348791|NCT01333111|155473644|FG002|Overall Study|Non-compliance|0|||
48348792|NCT01333111|155473642|FG000|Overall Study|Ineffective therapy|0|||
48348793|NCT01333111|155473643|FG001|Overall Study|Ineffective therapy|0|||
48348794|NCT01333111|155473644|FG002|Overall Study|Ineffective therapy|1|||
48348795|NCT02161406|155473645|FG000|Overall Study|Death|2|||
48348796|NCT02161406|155473646|FG001|Overall Study|Death|1|||
48348797|NCT02161406|155473645|FG000|Overall Study|Lost to Follow-up|2|||
48348798|NCT02161406|155473646|FG001|Overall Study|Lost to Follow-up|1|||
48348799|NCT02161406|155473645|FG000|Overall Study|Withdrawal by Subject|2|||
48348800|NCT02161406|155473646|FG001|Overall Study|Withdrawal by Subject|4|||
48348801|NCT02161406|155473645|FG000|Overall Study|investigator withdrew subject|3|||
48348802|NCT02161406|155473646|FG001|Overall Study|investigator withdrew subject|1|||
48348803|NCT02161406|155473645|FG000|Overall Study|Lack of Efficacy|1|||
48348804|NCT02161406|155473646|FG001|Overall Study|Lack of Efficacy|1|||
48348805|NCT02161406|155473645|FG000|Overall Study|relocation|0|||
48348806|NCT02161406|155473646|FG001|Overall Study|relocation|1|||
48348807|NCT03458728|155473649|FG000|Overall Study|Adverse Event|1|||
48675073|NCT02516592|156663416|FG001|Overall Study|Abnormal test procedure result|0|||
48675074|NCT02516592|156663415|FG000|Overall Study|Death|1|||
48761787|NCT02424383|156975693|FG000|Overall Study|Investigator's decision|44|||
48761788|NCT02424383|156975693|FG000|Overall Study|Lost to Follow-up|81|||
48675075|NCT02516592|156663416|FG001|Overall Study|Death|1|||
48675076|NCT00098306|156663417|FG000|Double Blind|Randomized, not treated|9|||
48675077|NCT00098306|156663418|FG001|Double Blind|Randomized, not treated|5|||
48675078|NCT00098306|156663419|FG002|Double Blind|Randomized, not treated|2|||
48675079|NCT00098306|156663420|FG003|Double Blind|Randomized, not treated|0|||
48675080|NCT00098306|156663421|FG004|Double Blind|Randomized, not treated|0|||
48675081|NCT00098306|156663422|FG005|Double Blind|Randomized, not treated|0|||
48675082|NCT00098306|156663423|FG006|Double Blind|Randomized, not treated|0|||
48675083|NCT00098306|156663417|FG000|Double Blind|Ongoing at cut-off date|151|||
48675084|NCT00098306|156663418|FG001|Double Blind|Ongoing at cut-off date|166|||
48675085|NCT00098306|156663419|FG002|Double Blind|Ongoing at cut-off date|72|||
48675086|NCT00098306|156663420|FG003|Double Blind|Ongoing at cut-off date|0|||
48675087|NCT00098306|156663421|FG004|Double Blind|Ongoing at cut-off date|0|||
48675088|NCT00098306|156663422|FG005|Double Blind|Ongoing at cut-off date|0|||
48761789|NCT02424383|156975693|FG000|Overall Study|Other|7|||
48761790|NCT02424383|156975693|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
48761791|NCT02625090|156975706|FG000|Overall Study|Participant wants to be pregnant|2|||
48348808|NCT03458728|155473650|FG001|Overall Study|Adverse Event|0|||
48348809|NCT03458728|155473649|FG000|Overall Study|Physician Decision|1|||
48348810|NCT03458728|155473650|FG001|Overall Study|Physician Decision|0|||
48348811|NCT03458728|155473649|FG000|Overall Study|Progressive disease - clinical assessment|1|||
48675089|NCT00098306|156663423|FG006|Double Blind|Ongoing at cut-off date|0|||
48675090|NCT00098306|156663417|FG000|Double Blind|Adverse Event|11|||
48675091|NCT00098306|156663418|FG001|Double Blind|Adverse Event|10|||
48675092|NCT00098306|156663419|FG002|Double Blind|Adverse Event|6|||
48675093|NCT00098306|156663420|FG003|Double Blind|Adverse Event|0|||
48675094|NCT00098306|156663421|FG004|Double Blind|Adverse Event|0|||
48675095|NCT00098306|156663422|FG005|Double Blind|Adverse Event|0|||
48675096|NCT00098306|156663423|FG006|Double Blind|Adverse Event|0|||
48348812|NCT03458728|155473650|FG001|Overall Study|Progressive disease - clinical assessment|0|||
48348813|NCT03458728|155473649|FG000|Overall Study|Progressive disease - radiological progression|21|||
48348814|NCT03458728|155473650|FG001|Overall Study|Progressive disease - radiological progression|6|||
48348815|NCT03458728|155473649|FG000|Overall Study|Withdrawal by Subject|0|||
48348816|NCT03458728|155473650|FG001|Overall Study|Withdrawal by Subject|1|||
48348817|NCT00381797|155473654|FG000|Overall Study|Withdrawal by Subject|1|||
48348818|NCT00381797|155473655|FG001|Overall Study|Withdrawal by Subject|1|||
48348819|NCT00381797|155473656|FG002|Overall Study|Withdrawal by Subject|0|||
48348820|NCT00381797|155473657|FG003|Overall Study|Withdrawal by Subject|0|||
48348821|NCT00381797|155473658|FG004|Overall Study|Withdrawal by Subject|2|||
48348822|NCT00381797|155473654|FG000|Overall Study|Ineligible|0|||
48348823|NCT00381797|155473655|FG001|Overall Study|Ineligible|0|||
48348824|NCT00381797|155473656|FG002|Overall Study|Ineligible|0|||
48348825|NCT00381797|155473657|FG003|Overall Study|Ineligible|1|||
48348826|NCT00381797|155473658|FG004|Overall Study|Ineligible|0|||
48348827|NCT03418493|155473660|FG000|Overall Study|Adverse Event|1|||
48348828|NCT03418493|155473661|FG001|Overall Study|Adverse Event|0|||
48348829|NCT03418493|155473662|FG002|Overall Study|Adverse Event|0|||
48348830|NCT03418493|155473663|FG003|Overall Study|Adverse Event|0|||
48348831|NCT03418493|155473664|FG004|Overall Study|Adverse Event|0|||
48348832|NCT03418493|155473665|FG005|Overall Study|Adverse Event|0|||
48348833|NCT03418493|155473666|FG006|Overall Study|Adverse Event|0|||
48348834|NCT03418493|155473667|FG007|Overall Study|Adverse Event|0|||
48348835|NCT03418493|155473668|FG008|Overall Study|Adverse Event|0|||
48348836|NCT03418493|155473669|FG009|Overall Study|Adverse Event|0|||
48348837|NCT03418493|155473670|FG010|Overall Study|Adverse Event|0|||
48348838|NCT03418493|155473660|FG000|Overall Study|Protocol Violation|0|||
48348839|NCT03418493|155473661|FG001|Overall Study|Protocol Violation|0|||
48348840|NCT03418493|155473662|FG002|Overall Study|Protocol Violation|0|||
48348841|NCT03418493|155473663|FG003|Overall Study|Protocol Violation|0|||
48348842|NCT03418493|155473664|FG004|Overall Study|Protocol Violation|0|||
48675097|NCT00098306|156663417|FG000|Double Blind|Lack of Efficacy|43|||
48761792|NCT02625090|156975706|FG000|Overall Study|For the Promoter|1|||
48348843|NCT03418493|155473665|FG005|Overall Study|Protocol Violation|0|||
48348844|NCT03418493|155473666|FG006|Overall Study|Protocol Violation|0|||
48348845|NCT03418493|155473667|FG007|Overall Study|Protocol Violation|0|||
48348846|NCT03418493|155473668|FG008|Overall Study|Protocol Violation|0|||
48348847|NCT03418493|155473669|FG009|Overall Study|Protocol Violation|1|||
48348848|NCT03418493|155473670|FG010|Overall Study|Protocol Violation|0|||
48348849|NCT04014790|155473671|FG000|Overall Study|Death|4|||
48348850|NCT04014790|155473671|FG000|Overall Study|Adverse Event|1|||
48348851|NCT04014790|155473671|FG000|Overall Study|Withdrawal by Subject|1|||
48348852|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
48675098|NCT00098306|156663418|FG001|Double Blind|Lack of Efficacy|34|||
48675099|NCT00098306|156663419|FG002|Double Blind|Lack of Efficacy|17|||
48675100|NCT00098306|156663420|FG003|Double Blind|Lack of Efficacy|0|||
48675101|NCT00098306|156663421|FG004|Double Blind|Lack of Efficacy|0|||
48675102|NCT00098306|156663422|FG005|Double Blind|Lack of Efficacy|0|||
48761793|NCT02625090|156975706|FG000|Overall Study|Sponsor's Decision|9|||
48348853|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
48348854|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
48348855|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
48348856|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
48348857|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
48348858|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
48348859|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
48348860|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
48348861|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
48348862|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
48348863|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
48348864|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
48348865|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
48348866|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
48348867|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
48348868|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
48348869|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
48348870|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
48348871|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
48348872|NCT02637856|155473672|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
48348873|NCT02637856|155473673|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
48348874|NCT02637856|155473672|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
48348875|NCT02637856|155473673|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
48348876|NCT02637856|155473672|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
48348877|NCT02637856|155473673|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
48348878|NCT01057251|155473674|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
48348879|NCT01057251|155473675|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
48348880|NCT01057251|155473674|FG000|Overall Study|Adverse Event|4|||
48348881|NCT01057251|155473675|FG001|Overall Study|Adverse Event|2|||
48348882|NCT01057251|155473674|FG000|Overall Study|Lack of Efficacy|2|||
48348883|NCT01057251|155473675|FG001|Overall Study|Lack of Efficacy|11|||
48348884|NCT01057251|155473674|FG000|Overall Study|Protocol Violation|6|||
48348885|NCT01057251|155473675|FG001|Overall Study|Protocol Violation|2|||
48348886|NCT01057251|155473674|FG000|Overall Study|Withdrawal by Subject|4|||
48348887|NCT01057251|155473675|FG001|Overall Study|Withdrawal by Subject|5|||
48348888|NCT01057251|155473674|FG000|Overall Study|Lost to Follow-up|7|||
48348889|NCT01057251|155473675|FG001|Overall Study|Lost to Follow-up|6|||
48348890|NCT01057251|155473674|FG000|Overall Study|Other Reason|1|||
48348891|NCT01057251|155473675|FG001|Overall Study|Other Reason|1|||
48348892|NCT04544865|155473676|FG000|Overall Study|Death|0|||
48348893|NCT04544865|155473677|FG001|Overall Study|Death|2|||
48348894|NCT04544865|155473676|FG000|Overall Study|Lost to Follow-up|11|||
48348895|NCT04544865|155473677|FG001|Overall Study|Lost to Follow-up|7|||
48348896|NCT04544865|155473676|FG000|Overall Study|Withdrawal by Subject|0|||
48348897|NCT04544865|155473677|FG001|Overall Study|Withdrawal by Subject|1|||
48348898|NCT04544865|155473676|FG000|Overall Study|Other|0|||
48348899|NCT04544865|155473677|FG001|Overall Study|Other|1|||
48348900|NCT00988533|155473682|FG000|Overall Study|Lost to Follow-up|3|||
48348901|NCT01772823|155473683|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
48348902|NCT01772823|155473684|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
48348903|NCT01772823|155473683|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
48348904|NCT01772823|155473684|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
48348905|NCT01772823|155473683|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
48348906|NCT01772823|155473684|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
48348907|NCT01772823|155473683|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
48348908|NCT01772823|155473684|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
48348909|NCT01772823|155473683|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
48348910|NCT01772823|155473684|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
48348911|NCT01772823|155473683|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
48348912|NCT01772823|155473684|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
48348913|NCT01772823|155473683|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
48348914|NCT01772823|155473684|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
48348915|NCT01772823|155473683|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
48348916|NCT01772823|155473684|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
48429372|NCT01070550|155760355|FG000|Overall Study|Not categorized|33|||
48675103|NCT00098306|156663423|FG006|Double Blind|Lack of Efficacy|0|||
48675104|NCT00098306|156663417|FG000|Double Blind|Death|1|||
48675105|NCT00098306|156663418|FG001|Double Blind|Death|4|||
48675106|NCT00098306|156663419|FG002|Double Blind|Death|1|||
48675107|NCT00098306|156663420|FG003|Double Blind|Death|0|||
48348917|NCT01772823|155473683|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
48348918|NCT01772823|155473684|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
48348919|NCT01772823|155473683|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
48348920|NCT01772823|155473684|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
48348921|NCT01772823|155473683|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
48348922|NCT01772823|155473684|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
48348923|NCT01772823|155473683|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
48348924|NCT01772823|155473684|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
48348925|NCT01772823|155473683|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
48348926|NCT01772823|155473684|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
48348927|NCT01772823|155473683|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
48348928|NCT01772823|155473684|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
48348929|NCT01772823|155473683|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
48348930|NCT01772823|155473684|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
48348931|NCT01772823|155473683|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
48348932|NCT01772823|155473684|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
48348933|NCT02669407|155473689|FG000|Overall Study|Physician Decision|3|||
48348934|NCT01657877|155473690|FG000|Overall Study|Withdrawal by Subject|4|||
48348935|NCT01657877|155473690|FG000|Overall Study|Protocol Violation|6|||
48348936|NCT01657877|155473690|FG000|Overall Study|Adverse Event|2|||
48348937|NCT01657877|155473690|FG000|Overall Study|Other Reason|2|||
48348938|NCT00394589|155473693|FG000|Overall Study|Adverse Event|2|||
48348939|NCT00394589|155473694|FG001|Overall Study|Adverse Event|1|||
48348940|NCT00394589|155473695|FG002|Overall Study|Adverse Event|2|||
48348941|NCT00394589|155473693|FG000|Overall Study|Lack of Efficacy|2|||
48348942|NCT00394589|155473694|FG001|Overall Study|Lack of Efficacy|2|||
48348943|NCT00394589|155473695|FG002|Overall Study|Lack of Efficacy|3|||
48348944|NCT00394589|155473693|FG000|Overall Study|Protocol Violation|4|||
48348945|NCT00394589|155473694|FG001|Overall Study|Protocol Violation|0|||
48348946|NCT00394589|155473695|FG002|Overall Study|Protocol Violation|2|||
48348947|NCT03409731|155473697|FG000|Overall Study|Withdrawal by Subject|17|||
48348948|NCT03409731|155473697|FG000|Overall Study|Death|4|||
48348949|NCT01114672|155473698|FG000|Overall Study|Death|0|||
48348950|NCT01114672|155473699|FG001|Overall Study|Death|1|||
48348951|NCT01114672|155473698|FG000|Overall Study|Withdrawal by Subject|2|||
48348952|NCT01114672|155473699|FG001|Overall Study|Withdrawal by Subject|1|||
48348953|NCT01114672|155473698|FG000|Overall Study|Lost to Follow-up|1|||
48348954|NCT01114672|155473699|FG001|Overall Study|Lost to Follow-up|0|||
48348955|NCT01114672|155473698|FG000|Overall Study|transplanted|1|||
48348956|NCT01114672|155473699|FG001|Overall Study|transplanted|0|||
48348957|NCT00104637|155473706|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
48348958|NCT00104637|155473707|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
48348959|NCT00846768|155473708|FG000|Overall Study|Adverse Event|0|||
48348960|NCT00846768|155473709|FG001|Overall Study|Adverse Event|1|||
48348961|NCT00846768|155473710|FG002|Overall Study|Adverse Event|0|||
48348962|NCT00846768|155473711|FG003|Overall Study|Adverse Event|0|||
48348963|NCT05043883|155473712|FG000|Overall Study|Minimum required measurements could not be taken|4|||
48348964|NCT00644878|155473713|FG000|Overall Study|Adverse Event|2|||
48348965|NCT00644878|155473713|FG000|Overall Study|Abnormal laboratory value|3|||
48348966|NCT00644878|155473713|FG000|Overall Study|Protocol deviation|2|||
48348967|NCT00644878|155473713|FG000|Overall Study|Treatment duration completed as per protocol|11|||
48348968|NCT01278615|155473716|FG000|Overall Study|Withdrawal by Subject|2|||
48348969|NCT00905359|155473717|FG000|Overall Study|Lost to Follow-up|17|||
48348970|NCT00905359|155473718|FG001|Overall Study|Lost to Follow-up|10|||
48348971|NCT00905359|155473717|FG000|Overall Study|Death|2|||
48348972|NCT00905359|155473718|FG001|Overall Study|Death|0|||
48348973|NCT00905359|155473717|FG000|Overall Study|Withdrawal consent|5|||
48348974|NCT00905359|155473718|FG001|Overall Study|Withdrawal consent|6|||
48348975|NCT00338949|155473719|FG000|Subject Screening|Screen failures|11|||
48348976|NCT00338949|155473720|FG001|Subject Screening|Screen failures|11|||
48348977|NCT00338949|155473719|FG000|Randomization|Withdrawal by Subject|1|||
48348978|NCT00338949|155473720|FG001|Randomization|Withdrawal by Subject|0|||
48348979|NCT00338949|155473719|FG000|Randomization|Adverse Event|0|||
48348980|NCT00338949|155473720|FG001|Randomization|Adverse Event|5|||
48348981|NCT03000348|155473722|FG000|Overall Study|Adverse Event|1|||
48348982|NCT03000348|155473723|FG001|Overall Study|Adverse Event|1|||
48348983|NCT03000348|155473724|FG002|Overall Study|Adverse Event|1|||
48348984|NCT03000348|155473725|FG003|Overall Study|Adverse Event|1|||
48348985|NCT03000348|155473726|FG004|Overall Study|Adverse Event|1|||
48348986|NCT03000348|155473727|FG005|Overall Study|Adverse Event|1|||
48348987|NCT03000348|155473722|FG000|Overall Study|Lost to Follow-up|0|||
48348988|NCT03000348|155473723|FG001|Overall Study|Lost to Follow-up|0|||
48348989|NCT03000348|155473724|FG002|Overall Study|Lost to Follow-up|1|||
48348990|NCT03000348|155473725|FG003|Overall Study|Lost to Follow-up|0|||
48348991|NCT03000348|155473726|FG004|Overall Study|Lost to Follow-up|0|||
48348992|NCT03000348|155473727|FG005|Overall Study|Lost to Follow-up|0|||
48348993|NCT03000348|155473722|FG000|Overall Study|Withdrawal by Subject|0|||
48348994|NCT03000348|155473723|FG001|Overall Study|Withdrawal by Subject|1|||
48348995|NCT03000348|155473724|FG002|Overall Study|Withdrawal by Subject|0|||
48348996|NCT03000348|155473725|FG003|Overall Study|Withdrawal by Subject|0|||
48348997|NCT03000348|155473726|FG004|Overall Study|Withdrawal by Subject|0|||
48348998|NCT03000348|155473727|FG005|Overall Study|Withdrawal by Subject|0|||
48348999|NCT03000348|155473722|FG000|Overall Study|Consent|0|||
48349000|NCT03000348|155473723|FG001|Overall Study|Consent|0|||
48349001|NCT03000348|155473724|FG002|Overall Study|Consent|0|||
48349002|NCT03000348|155473725|FG003|Overall Study|Consent|0|||
48349003|NCT03000348|155473726|FG004|Overall Study|Consent|1|||
48349004|NCT03000348|155473727|FG005|Overall Study|Consent|0|||
48349005|NCT03000348|155473722|FG000|Overall Study|Failure to expectorate sputum|1|||
48349006|NCT03000348|155473723|FG001|Overall Study|Failure to expectorate sputum|0|||
48349007|NCT03000348|155473724|FG002|Overall Study|Failure to expectorate sputum|1|||
48349008|NCT03000348|155473725|FG003|Overall Study|Failure to expectorate sputum|0|||
48349009|NCT03000348|155473726|FG004|Overall Study|Failure to expectorate sputum|1|||
48349010|NCT03000348|155473727|FG005|Overall Study|Failure to expectorate sputum|0|||
48349011|NCT03000348|155473722|FG000|Overall Study|No gram negative|1|||
48349012|NCT03000348|155473723|FG001|Overall Study|No gram negative|2|||
48349013|NCT03000348|155473724|FG002|Overall Study|No gram negative|1|||
48349014|NCT03000348|155473725|FG003|Overall Study|No gram negative|1|||
48349015|NCT03000348|155473726|FG004|Overall Study|No gram negative|1|||
48349016|NCT03000348|155473727|FG005|Overall Study|No gram negative|1|||
48349017|NCT03000348|155473722|FG000|Overall Study|Patient had no transport|0|||
48675108|NCT00098306|156663421|FG004|Double Blind|Death|0|||
48675109|NCT00098306|156663422|FG005|Double Blind|Death|0|||
48675110|NCT00098306|156663423|FG006|Double Blind|Death|0|||
48675111|NCT00098306|156663417|FG000|Double Blind|Participant defaulted|19|||
48675112|NCT00098306|156663418|FG001|Double Blind|Participant defaulted|18|||
48675113|NCT00098306|156663419|FG002|Double Blind|Participant defaulted|11|||
48675114|NCT00098306|156663420|FG003|Double Blind|Participant defaulted|0|||
48675115|NCT00098306|156663421|FG004|Double Blind|Participant defaulted|0|||
48675116|NCT00098306|156663422|FG005|Double Blind|Participant defaulted|0|||
48675117|NCT00098306|156663423|FG006|Double Blind|Participant defaulted|0|||
48675118|NCT00098306|156663417|FG000|Double Blind|Un-specified|7|||
48675119|NCT00098306|156663418|FG001|Double Blind|Un-specified|3|||
48675120|NCT00098306|156663419|FG002|Double Blind|Un-specified|11|||
48675121|NCT00098306|156663420|FG003|Double Blind|Un-specified|0|||
48675122|NCT00098306|156663421|FG004|Double Blind|Un-specified|0|||
48675123|NCT00098306|156663422|FG005|Double Blind|Un-specified|0|||
48675124|NCT00098306|156663423|FG006|Double Blind|Un-specified|0|||
48675125|NCT00098306|156663417|FG000|Open Label|Lack of Efficacy|0|||
48675126|NCT00098306|156663418|FG001|Open Label|Lack of Efficacy|0|||
48675127|NCT00098306|156663419|FG002|Open Label|Lack of Efficacy|0|||
48675128|NCT00098306|156663420|FG003|Open Label|Lack of Efficacy|13|||
48675129|NCT00098306|156663421|FG004|Open Label|Lack of Efficacy|0|||
48675130|NCT00098306|156663422|FG005|Open Label|Lack of Efficacy|0|||
48675131|NCT00098306|156663423|FG006|Open Label|Lack of Efficacy|0|||
48675132|NCT00098306|156663417|FG000|Open Label|Adverse Event|0|||
48675133|NCT00098306|156663418|FG001|Open Label|Adverse Event|0|||
48675134|NCT00098306|156663419|FG002|Open Label|Adverse Event|0|||
48761794|NCT02625090|156975706|FG000|Overall Study|Somnolence|1|||
48761795|NCT02625090|156975706|FG000|Overall Study|Study terminated by Sponsor|7|||
48349018|NCT03000348|155473723|FG001|Overall Study|Patient had no transport|0|||
48349019|NCT03000348|155473724|FG002|Overall Study|Patient had no transport|0|||
48349020|NCT03000348|155473725|FG003|Overall Study|Patient had no transport|1|||
48349021|NCT03000348|155473726|FG004|Overall Study|Patient had no transport|0|||
48349022|NCT03000348|155473727|FG005|Overall Study|Patient had no transport|0|||
48349023|NCT03000348|155473722|FG000|Overall Study|Dosing|0|||
48349024|NCT03000348|155473723|FG001|Overall Study|Dosing|0|||
48349025|NCT03000348|155473724|FG002|Overall Study|Dosing|0|||
48349026|NCT03000348|155473725|FG003|Overall Study|Dosing|0|||
48349027|NCT03000348|155473726|FG004|Overall Study|Dosing|1|||
48349028|NCT03000348|155473727|FG005|Overall Study|Dosing|0|||
48349029|NCT03517111|155473728|FG000|Enrolled|Withdrawal by Subject|0|||
48349030|NCT03517111|155473729|FG001|Enrolled|Withdrawal by Subject|1|||
48675135|NCT00098306|156663420|FG003|Open Label|Adverse Event|2|||
48675136|NCT00098306|156663421|FG004|Open Label|Adverse Event|0|||
48349031|NCT03517111|155473730|FG002|Enrolled|Withdrawal by Subject|0|||
48349032|NCT03517111|155473728|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
48349033|NCT03517111|155473729|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
48349034|NCT03517111|155473730|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
48675137|NCT00098306|156663422|FG005|Open Label|Adverse Event|0|||
48675138|NCT00098306|156663423|FG006|Open Label|Adverse Event|0|||
48675139|NCT00098306|156663417|FG000|Open Label|Death|0|||
48675140|NCT00098306|156663418|FG001|Open Label|Death|0|||
48675141|NCT00098306|156663419|FG002|Open Label|Death|0|||
48675142|NCT00098306|156663420|FG003|Open Label|Death|4|||
48761796|NCT02625090|156975706|FG000|Overall Study|Negative Benefit/Risk|1|||
48349035|NCT03517111|155473728|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
48349036|NCT03517111|155473729|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
48349037|NCT03517111|155473730|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
48349038|NCT03517111|155473728|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
48349039|NCT03517111|155473729|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
48349040|NCT03517111|155473730|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
48349041|NCT03517111|155473728|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
48349042|NCT03517111|155473729|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
48349043|NCT03517111|155473730|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
48349044|NCT00912223|155473731|FG000|Overall Study|Withdrawal by Subject|1|||
48349045|NCT00912223|155473731|FG000|Overall Study|Not transplanted|1|||
48349046|NCT00912223|155473731|FG000|Overall Study|Transformed disease|1|||
48349047|NCT02196077|155473732|FG000|Overall Study|Adverse Event|4|||
48349048|NCT02196077|155473732|FG000|Overall Study|Lack of Efficacy|1|||
48675143|NCT00098306|156663421|FG004|Open Label|Death|0|||
48675144|NCT00098306|156663422|FG005|Open Label|Death|0|||
48675145|NCT00098306|156663423|FG006|Open Label|Death|0|||
48675146|NCT00098306|156663417|FG000|Open Label|Participant defaulted|0|||
48675147|NCT00098306|156663418|FG001|Open Label|Participant defaulted|0|||
48675148|NCT00098306|156663419|FG002|Open Label|Participant defaulted|0|||
48349049|NCT02196077|155473732|FG000|Overall Study|Withdrawal by Subject|14|||
48349050|NCT02196077|155473732|FG000|Overall Study|Physician Decision|1|||
48349051|NCT02196077|155473732|FG000|Overall Study|Lost to Follow-up|3|||
48349052|NCT02196077|155473732|FG000|Overall Study|Protocol Violation|24|||
48349053|NCT02344173|155473738|FG000|Procedure|Ablation Procedure Not Performed|7|||
48349054|NCT02344173|155473738|FG000|12-month Visit|Death|8|||
48675149|NCT00098306|156663420|FG003|Open Label|Participant defaulted|24|||
48675150|NCT00098306|156663421|FG004|Open Label|Participant defaulted|0|||
48675151|NCT00098306|156663422|FG005|Open Label|Participant defaulted|0|||
48675152|NCT00098306|156663423|FG006|Open Label|Participant defaulted|0|||
48675153|NCT00098306|156663417|FG000|Open Label|Un-specified|0|||
48675154|NCT00098306|156663418|FG001|Open Label|Un-specified|0|||
48349055|NCT02344173|155473738|FG000|12-month Visit|Withdrawal by Subject|30|||
48349056|NCT02344173|155473738|FG000|12-month Visit|Lost to Follow-up|58|||
48349057|NCT03845023|155473739|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
48349058|NCT03845023|155473740|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
48349059|NCT03845023|155473741|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
48675155|NCT00098306|156663419|FG002|Open Label|Un-specified|0|||
48675156|NCT00098306|156663420|FG003|Open Label|Un-specified|15|||
48675157|NCT00098306|156663421|FG004|Open Label|Un-specified|0|||
48675158|NCT00098306|156663422|FG005|Open Label|Un-specified|0|||
48675159|NCT00098306|156663423|FG006|Open Label|Un-specified|0|||
48675160|NCT00098306|156663417|FG000|Open Label|Ongoing at cut-off date|0|||
48675161|NCT00098306|156663418|FG001|Open Label|Ongoing at cut-off date|0|||
48675162|NCT00098306|156663419|FG002|Open Label|Ongoing at cut-off date|0|||
48675163|NCT00098306|156663420|FG003|Open Label|Ongoing at cut-off date|269|||
48675164|NCT00098306|156663421|FG004|Open Label|Ongoing at cut-off date|62|||
48675165|NCT00098306|156663422|FG005|Open Label|Ongoing at cut-off date|0|||
48675166|NCT00098306|156663423|FG006|Open Label|Ongoing at cut-off date|0|||
48675167|NCT00098306|156663417|FG000|Observational Phase|Death|0|||
48675168|NCT00098306|156663418|FG001|Observational Phase|Death|0|||
48675169|NCT00098306|156663419|FG002|Observational Phase|Death|0|||
48675170|NCT00098306|156663420|FG003|Observational Phase|Death|0|||
48675171|NCT00098306|156663421|FG004|Observational Phase|Death|0|||
48675172|NCT00098306|156663422|FG005|Observational Phase|Death|5|||
48675173|NCT00098306|156663423|FG006|Observational Phase|Death|4|||
48675174|NCT00098306|156663417|FG000|Observational Phase|Participant defaulted|0|||
48675175|NCT00098306|156663418|FG001|Observational Phase|Participant defaulted|0|||
48675176|NCT00098306|156663419|FG002|Observational Phase|Participant defaulted|0|||
48675177|NCT00098306|156663420|FG003|Observational Phase|Participant defaulted|0|||
48349060|NCT03845023|155473742|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
48349061|NCT03845023|155473739|FG000|Follow-Up (14 Days)|Adverse Event|0|||
48675178|NCT00098306|156663421|FG004|Observational Phase|Participant defaulted|0|||
48349062|NCT03845023|155473740|FG001|Follow-Up (14 Days)|Adverse Event|0|||
48349063|NCT03845023|155473741|FG002|Follow-Up (14 Days)|Adverse Event|1|||
48349064|NCT03845023|155473742|FG003|Follow-Up (14 Days)|Adverse Event|1|||
48349065|NCT01185171|155473745|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
48349066|NCT01185171|155473745|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
48429373|NCT01070550|155760356|FG001|Overall Study|Not categorized|2|||
48675179|NCT00098306|156663422|FG005|Observational Phase|Participant defaulted|34|||
48675180|NCT00098306|156663423|FG006|Observational Phase|Participant defaulted|18|||
48675181|NCT00098306|156663417|FG000|Observational Phase|Un-specified|0|||
48675182|NCT00098306|156663418|FG001|Observational Phase|Un-specified|0|||
48675183|NCT00098306|156663419|FG002|Observational Phase|Un-specified|0|||
48675184|NCT00098306|156663420|FG003|Observational Phase|Un-specified|0|||
48675185|NCT00098306|156663421|FG004|Observational Phase|Un-specified|0|||
48675186|NCT00098306|156663422|FG005|Observational Phase|Un-specified|7|||
48675187|NCT00098306|156663423|FG006|Observational Phase|Un-specified|4|||
48761797|NCT02625090|156975706|FG000|Overall Study|Protocol Deviation|2|||
48675188|NCT01374178|156663426|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
48675189|NCT01374178|156663427|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
48675190|NCT01374178|156663426|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
48675191|NCT01374178|156663427|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
48675192|NCT01079936|156663430|FG000|Phase I: MTD|First Remission Status|2|||
48675193|NCT01079936|156663431|FG001|Phase I: MTD|First Remission Status|0|||
48675194|NCT01079936|156663432|FG002|Phase I: MTD|First Remission Status|0|||
48675195|NCT01079936|156663433|FG003|Phase I: MTD|First Remission Status|0|||
48675196|NCT01079936|156663434|FG004|Phase I: MTD|First Remission Status|0|||
48675197|NCT01079936|156663430|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
48675198|NCT01079936|156663431|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
48675199|NCT01079936|156663432|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
48675200|NCT01079936|156663433|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
48675201|NCT01079936|156663434|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
48675202|NCT01079936|156663430|FG000|Phase II|Adverse Event|0|||
48675203|NCT01079936|156663431|FG001|Phase II|Adverse Event|0|||
48675204|NCT01079936|156663432|FG002|Phase II|Adverse Event|1|||
48675205|NCT01079936|156663433|FG003|Phase II|Adverse Event|0|||
48675206|NCT01079936|156663434|FG004|Phase II|Adverse Event|0|||
48675207|NCT01079936|156663430|FG000|Phase II|Insurance Issue|0|||
48675208|NCT01079936|156663431|FG001|Phase II|Insurance Issue|0|||
48675209|NCT01079936|156663432|FG002|Phase II|Insurance Issue|0|||
48675210|NCT01079936|156663433|FG003|Phase II|Insurance Issue|0|||
48675211|NCT01079936|156663434|FG004|Phase II|Insurance Issue|1|||
48761798|NCT02625090|156975706|FG000|Overall Study|Lack of Efficacy|16|||
48761799|NCT02625090|156975706|FG000|Overall Study|Adverse Event|3|||
48675212|NCT00395850|156663441|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
48675213|NCT00395850|156663442|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
48675214|NCT00395850|156663443|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
48675215|NCT00395850|156663444|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
48675216|NCT00395850|156663441|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
48675217|NCT00395850|156663442|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
48675218|NCT00395850|156663443|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
48675219|NCT00395850|156663444|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
48675220|NCT00395850|156663441|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
48675221|NCT00395850|156663442|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
48675222|NCT00395850|156663443|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
48675223|NCT00395850|156663444|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
48675224|NCT00395850|156663441|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
48675225|NCT00395850|156663442|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
48675226|NCT00395850|156663443|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
48675227|NCT00395850|156663444|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
48675228|NCT00395850|156663441|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
48675229|NCT00395850|156663442|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
48675230|NCT00395850|156663443|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
48675231|NCT00395850|156663444|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
48675232|NCT00395850|156663441|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
48675233|NCT00395850|156663442|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
48675234|NCT00395850|156663443|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
48675235|NCT00395850|156663444|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
48675236|NCT00395850|156663441|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
48675237|NCT00395850|156663442|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
48675238|NCT00395850|156663443|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
48761800|NCT00857220|156975707|FG000|Overall Study|Adverse Event|35|||
48761801|NCT00857220|156975707|FG000|Overall Study|Death|1|||
48761802|NCT00857220|156975707|FG000|Overall Study|Lack of Efficacy|11|||
48761803|NCT00857220|156975707|FG000|Overall Study|Lost to Follow-up|30|||
48761804|NCT00857220|156975707|FG000|Overall Study|Physician Decision|4|||
48761805|NCT00857220|156975707|FG000|Overall Study|Protocol Violation|16|||
48761806|NCT00857220|156975707|FG000|Overall Study|Withdrawal by Subject|67|||
48761807|NCT00857220|156975707|FG000|Overall Study|Clinical Hold|6|||
48761808|NCT00857220|156975707|FG000|Overall Study|Site Closed|5|||
48761809|NCT00857220|156975707|FG000|Overall Study|Miscellaneous|8|||
48761810|NCT01505608|156975709|FG000|Phase I|Lack of Efficacy|0|||
48761811|NCT01505608|156975710|FG001|Phase I|Lack of Efficacy|4|||
48761812|NCT01505608|156975709|FG000|Phase I|Adverse Event|0|||
48675239|NCT00395850|156663444|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
48675240|NCT01753401|156663445|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
48761813|NCT01505608|156975710|FG001|Phase I|Adverse Event|1|||
48761814|NCT01505608|156975709|FG000|Phase I|Withdrawal by Subject|0|||
48761815|NCT01505608|156975710|FG001|Phase I|Withdrawal by Subject|1|||
48675241|NCT01753401|156663446|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
48675242|NCT01753401|156663447|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
48675243|NCT01753401|156663448|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
48675244|NCT01753401|156663445|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
48675245|NCT01753401|156663446|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
48675246|NCT01753401|156663447|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
48675247|NCT01753401|156663448|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
48675248|NCT01753401|156663445|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
48675249|NCT01753401|156663446|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
48675250|NCT01753401|156663447|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
48675251|NCT01753401|156663448|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
48675252|NCT01753401|156663445|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
48675253|NCT01753401|156663446|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
48675254|NCT01753401|156663447|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
48675255|NCT01753401|156663448|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
48675256|NCT01753401|156663445|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
48675257|NCT01753401|156663446|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
48675258|NCT01753401|156663447|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
48675259|NCT01753401|156663448|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
48675260|NCT01753401|156663445|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
48675261|NCT01753401|156663446|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
48349067|NCT01185171|155473745|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
48675262|NCT01753401|156663447|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
48349068|NCT01185171|155473745|FG000|Maintenance|Elevated liver transaminases|3|||
48349069|NCT01185171|155473745|FG000|Maintenance|Rush|2|||
48349070|NCT01185171|155473745|FG000|Maintenance|Diarrhea|1|||
48349071|NCT01185171|155473745|FG000|Maintenance|Xerostomia|1|||
48349072|NCT01185171|155473745|FG000|Maintenance|Nausea|1|||
48349073|NCT01185171|155473745|FG000|Maintenance|Comorbid Illness|2|||
48349074|NCT01185171|155473745|FG000|Maintenance|Withdrawal by Subject|1|||
48349075|NCT01185171|155473745|FG000|Maintenance|Disease Recurrence|1|||
48349076|NCT00715117|155473746|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
48349077|NCT00715117|155473747|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
48349078|NCT00365547|155473748|FG000|Overall Study|Insurance did not cover Avastin|1|||
48349079|NCT00365547|155473748|FG000|Overall Study|Screen failure|1|||
48349080|NCT00365547|155473748|FG000|Overall Study|Withdrawal by Subject|1|||
48349081|NCT01503164|155473752|FG000|Overall Study|Withdrawal by Subject|2|||
48349082|NCT01503164|155473753|FG001|Overall Study|Withdrawal by Subject|1|||
48349083|NCT03023423|155473754|FG000|Overall Study|Death|5|||
48349084|NCT03023423|155473755|FG001|Overall Study|Death|12|||
48349085|NCT03023423|155473756|FG002|Overall Study|Death|20|||
48349086|NCT03023423|155473754|FG000|Overall Study|Other|0|||
48349087|NCT03023423|155473755|FG001|Overall Study|Other|2|||
48349088|NCT03023423|155473756|FG002|Overall Study|Other|2|||
48349089|NCT03023423|155473754|FG000|Overall Study|Ongoing|2|||
48349090|NCT03023423|155473755|FG001|Overall Study|Ongoing|32|||
48349091|NCT03023423|155473756|FG002|Overall Study|Ongoing|24|||
48349092|NCT03512197|155473757|FG000|Overall Study|Guardian decision|1|||
48349093|NCT03512197|155473758|FG001|Overall Study|Guardian decision|1|||
48349094|NCT03512197|155473757|FG000|Overall Study|Lack of Efficacy|19|||
48349095|NCT03512197|155473758|FG001|Overall Study|Lack of Efficacy|11|||
48349096|NCT03512197|155473757|FG000|Overall Study|New Therapy for Study Indication|16|||
48349097|NCT03512197|155473758|FG001|Overall Study|New Therapy for Study Indication|16|||
48349098|NCT03512197|155473757|FG000|Overall Study|Physician Decision|60|||
48761816|NCT01505608|156975709|FG000|Phase II|Lack of Efficacy|2|||
48761817|NCT01505608|156975710|FG001|Phase II|Lack of Efficacy|1|||
48761818|NCT01505608|156975709|FG000|Phase II|Protocol Violation|0|||
48761819|NCT01505608|156975710|FG001|Phase II|Protocol Violation|1|||
48761820|NCT03165110|156975714|FG000|Overall Study|Anroid phone software incompatibility|1|||
48761821|NCT02726074|156975715|FG000|Overall Study|Withdrawal by Subject|4|||
48761822|NCT02726074|156975715|FG000|Overall Study|Adverse Event|14|||
48761823|NCT02726074|156975715|FG000|Overall Study|Protocol Violation|3|||
48761824|NCT02726074|156975715|FG000|Overall Study|Lost to Follow-up|2|||
48349099|NCT03512197|155473758|FG001|Overall Study|Physician Decision|60|||
48349100|NCT03512197|155473757|FG000|Overall Study|Protocol Violation|0|||
48349101|NCT03512197|155473758|FG001|Overall Study|Protocol Violation|2|||
48349102|NCT03512197|155473757|FG000|Overall Study|Terminated by Sponsored|46|||
48349103|NCT03512197|155473758|FG001|Overall Study|Terminated by Sponsored|50|||
48349104|NCT03512197|155473757|FG000|Overall Study|Subject Decision|15|||
48349105|NCT03512197|155473758|FG001|Overall Study|Subject Decision|12|||
48675263|NCT01753401|156663448|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
48349106|NCT03512197|155473757|FG000|Overall Study|Withdrawal of informed consent|20|||
48349107|NCT03512197|155473758|FG001|Overall Study|Withdrawal of informed consent|14|||
48349108|NCT03512197|155473757|FG000|Overall Study|Adverse Event|30|||
48349109|NCT03512197|155473758|FG001|Overall Study|Adverse Event|34|||
48349110|NCT03512197|155473757|FG000|Overall Study|Death|14|||
48349111|NCT03512197|155473758|FG001|Overall Study|Death|9|||
48349112|NCT03512197|155473757|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
48349113|NCT03512197|155473758|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
48349114|NCT03512197|155473757|FG000|Overall Study|Missing|3|||
48349115|NCT03512197|155473758|FG001|Overall Study|Missing|13|||
48349116|NCT01227928|155473759|FG000|Overall Study|Lost to Follow-up|4|||
48349117|NCT01227928|155473760|FG001|Overall Study|Lost to Follow-up|2|||
48349118|NCT01227928|155473759|FG000|Overall Study|Withdrawal by Subject|4|||
48349119|NCT01227928|155473760|FG001|Overall Study|Withdrawal by Subject|3|||
48349120|NCT01227928|155473759|FG000|Overall Study|Death|14|||
48349121|NCT01227928|155473760|FG001|Overall Study|Death|12|||
48349122|NCT00356759|155473763|FG000|Overall Study|Death|5|||
48349123|NCT00356759|155473764|FG001|Overall Study|Death|2|||
48349124|NCT00356759|155473763|FG000|Overall Study|Withdrawal by Subject|2|||
48349125|NCT00356759|155473764|FG001|Overall Study|Withdrawal by Subject|2|||
48349126|NCT00356759|155473763|FG000|Overall Study|Adverse Event|1|||
48349127|NCT00356759|155473764|FG001|Overall Study|Adverse Event|3|||
48349128|NCT00356759|155473763|FG000|Overall Study|Lost to Follow-up|1|||
48349129|NCT00356759|155473764|FG001|Overall Study|Lost to Follow-up|1|||
48349130|NCT00356759|155473763|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
48349131|NCT00356759|155473764|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
48349132|NCT00934700|155473768|FG000|Overall Study|missing scan|5|||
48349133|NCT00934700|155473769|FG001|Overall Study|missing scan|9|||
48675264|NCT01753401|156663445|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
48675265|NCT01753401|156663446|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
48675266|NCT01753401|156663447|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
48675267|NCT01753401|156663448|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
48675268|NCT00470418|156663449|FG000|Overall Study|Withdrawal by Subject|1|||
48675269|NCT00470418|156663450|FG001|Overall Study|Withdrawal by Subject|0|||
48675270|NCT00545103|156663451|FG000|Overall Study|Lack of Efficacy|48|||
48349134|NCT00934700|155473768|FG000|Overall Study|Death|8|||
48349135|NCT00934700|155473769|FG001|Overall Study|Death|3|||
48349136|NCT05239598|155473773|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
48349137|NCT05239598|155473774|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
48349138|NCT05239598|155473773|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
48349139|NCT05239598|155473774|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
48349140|NCT02282059|155473775|FG000|Overall Study|Other|15|||
48349141|NCT02282059|155473776|FG001|Overall Study|Other|3|||
48349142|NCT02282059|155473775|FG000|Overall Study|Participant refused further follow-up|8|||
48349143|NCT02282059|155473776|FG001|Overall Study|Participant refused further follow-up|4|||
48349144|NCT02282059|155473775|FG000|Overall Study|Lost to Follow-up|19|||
48349145|NCT02282059|155473776|FG001|Overall Study|Lost to Follow-up|3|||
48349146|NCT02282059|155473775|FG000|Overall Study|Death|40|||
48349147|NCT02282059|155473776|FG001|Overall Study|Death|8|||
48349148|NCT01340014|155473777|FG000|Period 1, First 7 Days|Adverse Event|1|||
48349149|NCT01340014|155473778|FG001|Period 1, First 7 Days|Adverse Event|0|||
48349150|NCT01340014|155473777|FG000|Period 1, First 7 Days|Personal Reasons|1|||
48349151|NCT01340014|155473778|FG001|Period 1, First 7 Days|Personal Reasons|0|||
48349152|NCT01340014|155473777|FG000|Period 2, Second 7 Days|Adverse Event|0|||
48349153|NCT01340014|155473778|FG001|Period 2, Second 7 Days|Adverse Event|1|||
48349154|NCT02194829|155473779|FG000|Overall Study|Adverse Event|2|||
48349155|NCT02194829|155473780|FG001|Overall Study|Adverse Event|2|||
48349156|NCT02194829|155473779|FG000|Overall Study|Death|0|||
48349157|NCT02194829|155473780|FG001|Overall Study|Death|1|||
48349158|NCT02194829|155473779|FG000|Overall Study|Disease progression|0|||
48349159|NCT02194829|155473780|FG001|Overall Study|Disease progression|1|||
48349160|NCT02194829|155473779|FG000|Overall Study|Withdrawal by Subject|0|||
48349161|NCT02194829|155473780|FG001|Overall Study|Withdrawal by Subject|1|||
48349162|NCT02194829|155473779|FG000|Overall Study|Never started protocol therapy|0|||
48349163|NCT02194829|155473780|FG001|Overall Study|Never started protocol therapy|1|||
48675271|NCT00545103|156663452|FG001|Overall Study|Lack of Efficacy|45|||
48675272|NCT00545103|156663453|FG002|Overall Study|Lack of Efficacy|31|||
48675273|NCT00545103|156663454|FG003|Overall Study|Lack of Efficacy|27|||
48675274|NCT00545103|156663451|FG000|Overall Study|Withdrawal by Subject|6|||
48675275|NCT00545103|156663452|FG001|Overall Study|Withdrawal by Subject|10|||
48349164|NCT01816685|155475354|FG000|Overall Study|Lost to Follow-up|7|||
48349165|NCT01816685|155475355|FG001|Overall Study|Lost to Follow-up|9|||
48349166|NCT01816685|155475354|FG000|Overall Study|Surgery Cancelled|3|||
48349167|NCT01816685|155475355|FG001|Overall Study|Surgery Cancelled|2|||
48349168|NCT01157351|155475356|FG000|Overall Study|Adverse Event|5|||
48349169|NCT01157351|155475357|FG001|Overall Study|Adverse Event|4|||
48349170|NCT01157351|155475356|FG000|Overall Study|Death|1|||
48675276|NCT00545103|156663453|FG002|Overall Study|Withdrawal by Subject|18|||
48349171|NCT01157351|155475357|FG001|Overall Study|Death|0|||
48349172|NCT01157351|155475356|FG000|Overall Study|Lost to Follow-up|53|||
48349173|NCT01157351|155475357|FG001|Overall Study|Lost to Follow-up|55|||
48349174|NCT01157351|155475356|FG000|Overall Study|Withdrawal by Subject|37|||
48349175|NCT01157351|155475357|FG001|Overall Study|Withdrawal by Subject|27|||
48349176|NCT01157351|155475356|FG000|Overall Study|Physician Decision|5|||
48349177|NCT01157351|155475357|FG001|Overall Study|Physician Decision|4|||
48349178|NCT01157351|155475356|FG000|Overall Study|Protocol Violation|0|||
48349179|NCT01157351|155475357|FG001|Overall Study|Protocol Violation|1|||
48349180|NCT01157351|155475356|FG000|Overall Study|Other|32|||
48349181|NCT01157351|155475357|FG001|Overall Study|Other|36|||
48349182|NCT01157351|155475356|FG000|Overall Study|Noncompliance with Study Drug|0|||
48349183|NCT01157351|155475357|FG001|Overall Study|Noncompliance with Study Drug|3|||
48349184|NCT01157351|155475356|FG000|Overall Study|Randomized but not Treated|4|||
48349185|NCT01157351|155475357|FG001|Overall Study|Randomized but not Treated|2|||
48349186|NCT01726049|155475361|FG000|Overall Study|Death|1|||
48349187|NCT01726049|155475362|FG001|Overall Study|Death|1|||
48349188|NCT01726049|155475361|FG000|Overall Study|Adverse Event|4|||
48349189|NCT01726049|155475362|FG001|Overall Study|Adverse Event|1|||
48349190|NCT01726049|155475361|FG000|Overall Study|refused second HC|0|||
48349191|NCT01726049|155475362|FG001|Overall Study|refused second HC|2|||
48349192|NCT00664105|155475363|FG000|Overall Study|Death|3|||
48349193|NCT00664105|155475363|FG000|Overall Study|Withdrawal by Subject|5|||
48349194|NCT00664105|155475363|FG000|Overall Study|Adverse Event|9|||
48349195|NCT00664105|155475363|FG000|Overall Study|Disease progression|7|||
48349196|NCT04732871|155475364|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
48349197|NCT04732871|155475365|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
48349198|NCT04732871|155475366|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
48349199|NCT04732871|155475364|FG000|Overall Study|Lost to Follow-up|7|||
48349200|NCT04732871|155475365|FG001|Overall Study|Lost to Follow-up|4|||
48349201|NCT04732871|155475366|FG002|Overall Study|Lost to Follow-up|3|||
48349202|NCT04732871|155475364|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
48349203|NCT04732871|155475365|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
48349204|NCT04732871|155475366|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
48349205|NCT04732871|155475364|FG000|Overall Study|Migrated / moved from the study area|5|||
48349206|NCT04732871|155475365|FG001|Overall Study|Migrated / moved from the study area|0|||
48349207|NCT04732871|155475366|FG002|Overall Study|Migrated / moved from the study area|0|||
48349208|NCT04732871|155475364|FG000|Overall Study|Other|1|||
48349209|NCT04732871|155475365|FG001|Overall Study|Other|0|||
48349210|NCT04732871|155475366|FG002|Overall Study|Other|1|||
48349211|NCT04732871|155475364|FG000|Overall Study|Ongoing|6|||
48349212|NCT04732871|155475365|FG001|Overall Study|Ongoing|0|||
48349213|NCT04732871|155475366|FG002|Overall Study|Ongoing|1|||
48349214|NCT04732871|155475364|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
48349215|NCT04732871|155475365|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
48349216|NCT04732871|155475366|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
48349217|NCT00598871|155475367|FG000|Overall Study|Adverse Event|0|||
48349218|NCT00598871|155475368|FG001|Overall Study|Adverse Event|1|||
48349219|NCT01983462|155475369|FG000|Overall Study|Adverse Event|1|||
48349220|NCT01983462|155475370|FG001|Overall Study|Adverse Event|0|||
48349221|NCT01983462|155475371|FG002|Overall Study|Adverse Event|0|||
48349222|NCT01470599|155475372|FG000|Overall Study|Did not meet entrance criteria|1|||
48349223|NCT01470599|155475373|FG001|Overall Study|Did not meet entrance criteria|0|||
48349224|NCT01470599|155475372|FG000|Overall Study|Lost to Follow-up|2|||
48349225|NCT01470599|155475373|FG001|Overall Study|Lost to Follow-up|1|||
48349226|NCT01470599|155475372|FG000|Overall Study|Withdrawal by Subject|3|||
48349227|NCT01470599|155475373|FG001|Overall Study|Withdrawal by Subject|4|||
48349228|NCT01470599|155475372|FG000|Overall Study|Other|1|||
48349229|NCT01470599|155475373|FG001|Overall Study|Other|0|||
48349230|NCT01470599|155475372|FG000|Overall Study|Protocol Violation|3|||
48761825|NCT02726074|156975715|FG000|Overall Study|Others|3|||
48761826|NCT02140567|156975716|FG000|Overall Study|Problems with recording equipment|6|||
48761827|NCT02036502|156975717|FG000|Part 1:Dose Determination/Escalation|Death|3|||
48761828|NCT02036502|156975718|FG001|Part 1:Dose Determination/Escalation|Death|2|||
48349231|NCT01470599|155475373|FG001|Overall Study|Protocol Violation|1|||
48349232|NCT01470599|155475372|FG000|Overall Study|Adverse event related to study drug|2|||
48349233|NCT01470599|155475373|FG001|Overall Study|Adverse event related to study drug|5|||
48349234|NCT01470599|155475372|FG000|Overall Study|Insufficient clinical response|6|||
48349235|NCT01470599|155475373|FG001|Overall Study|Insufficient clinical response|27|||
48349236|NCT01470599|155475372|FG000|Overall Study|Adverse event not related to study drug|1|||
48349237|NCT01470599|155475373|FG001|Overall Study|Adverse event not related to study drug|5|||
48349238|NCT00847132|155475374|FG000|Overall Study|Death|1|||
48349239|NCT00847132|155475375|FG001|Overall Study|Death|1|||
48349240|NCT02509312|155475381|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
48349241|NCT02509312|155475382|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
48349242|NCT02509312|155475381|FG000|Overall Study|Obstetrician refusal|0|||
48349243|NCT02509312|155475382|FG001|Overall Study|Obstetrician refusal|1|||
48349244|NCT02509312|155475381|FG000|Overall Study|Patient elected for TOLAC|1|||
48349245|NCT02509312|155475382|FG001|Overall Study|Patient elected for TOLAC|0|||
48349246|NCT02509312|155475381|FG000|Overall Study|Cesarean deemed stat|1|||
48349247|NCT02509312|155475382|FG001|Overall Study|Cesarean deemed stat|0|||
48349248|NCT02509312|155475381|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
48349249|NCT02509312|155475382|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
48349250|NCT01547117|155475391|FG000|Overall Study|Physician Decision|0|||
48349251|NCT01547117|155475392|FG001|Overall Study|Physician Decision|1|||
48349252|NCT01547117|155475393|FG002|Overall Study|Physician Decision|1|||
48349253|NCT01547117|155475394|FG003|Overall Study|Physician Decision|3|||
48349254|NCT01547117|155475391|FG000|Overall Study|Withdrawal by Subject|1|||
48349255|NCT01547117|155475392|FG001|Overall Study|Withdrawal by Subject|2|||
48349256|NCT01547117|155475393|FG002|Overall Study|Withdrawal by Subject|1|||
48349257|NCT01547117|155475394|FG003|Overall Study|Withdrawal by Subject|2|||
48349258|NCT00943722|155475398|FG000|Base Study|Adverse Event|0|||
48349259|NCT00943722|155475399|FG001|Base Study|Adverse Event|0|||
48349260|NCT00943722|155475400|FG002|Base Study|Adverse Event|0|||
48349261|NCT00943722|155475401|FG003|Base Study|Adverse Event|1|||
48349262|NCT00943722|155475402|FG004|Base Study|Adverse Event|0|||
48349263|NCT00943722|155475403|FG005|Base Study|Adverse Event|0|||
48349264|NCT00943722|155475404|FG006|Base Study|Adverse Event|0|||
48349265|NCT00943722|155475398|FG000|Base Study|Lost to Follow-up|12|||
48349266|NCT00943722|155475399|FG001|Base Study|Lost to Follow-up|8|||
48349267|NCT00943722|155475400|FG002|Base Study|Lost to Follow-up|10|||
48349268|NCT00943722|155475401|FG003|Base Study|Lost to Follow-up|8|||
48349269|NCT00943722|155475402|FG004|Base Study|Lost to Follow-up|11|||
48349270|NCT00943722|155475403|FG005|Base Study|Lost to Follow-up|0|||
48349271|NCT00943722|155475404|FG006|Base Study|Lost to Follow-up|0|||
48349272|NCT00943722|155475398|FG000|Base Study|Physician Decision|1|||
48349273|NCT00943722|155475399|FG001|Base Study|Physician Decision|0|||
48349274|NCT00943722|155475400|FG002|Base Study|Physician Decision|0|||
48349275|NCT00943722|155475401|FG003|Base Study|Physician Decision|0|||
48349276|NCT00943722|155475402|FG004|Base Study|Physician Decision|1|||
48349277|NCT00943722|155475403|FG005|Base Study|Physician Decision|0|||
48349278|NCT00943722|155475404|FG006|Base Study|Physician Decision|0|||
48349279|NCT00943722|155475398|FG000|Base Study|Pregnancy|0|||
48349280|NCT00943722|155475399|FG001|Base Study|Pregnancy|0|||
48349281|NCT00943722|155475400|FG002|Base Study|Pregnancy|1|||
48349282|NCT00943722|155475401|FG003|Base Study|Pregnancy|0|||
48349283|NCT00943722|155475402|FG004|Base Study|Pregnancy|2|||
48349284|NCT00943722|155475403|FG005|Base Study|Pregnancy|0|||
48349285|NCT00943722|155475404|FG006|Base Study|Pregnancy|0|||
48349286|NCT00943722|155475398|FG000|Base Study|Protocol Violation|0|||
48349287|NCT00943722|155475399|FG001|Base Study|Protocol Violation|1|||
48349288|NCT00943722|155475400|FG002|Base Study|Protocol Violation|0|||
48349289|NCT00943722|155475401|FG003|Base Study|Protocol Violation|0|||
48349290|NCT00943722|155475402|FG004|Base Study|Protocol Violation|2|||
48349291|NCT00943722|155475403|FG005|Base Study|Protocol Violation|0|||
48349292|NCT00943722|155475404|FG006|Base Study|Protocol Violation|0|||
48349293|NCT00943722|155475398|FG000|Base Study|Withdrawal by Subject|12|||
48349294|NCT00943722|155475399|FG001|Base Study|Withdrawal by Subject|13|||
48349295|NCT00943722|155475400|FG002|Base Study|Withdrawal by Subject|2|||
48349296|NCT00943722|155475401|FG003|Base Study|Withdrawal by Subject|13|||
48349297|NCT00943722|155475402|FG004|Base Study|Withdrawal by Subject|8|||
48349298|NCT00943722|155475403|FG005|Base Study|Withdrawal by Subject|0|||
48349299|NCT00943722|155475404|FG006|Base Study|Withdrawal by Subject|0|||
48349300|NCT00943722|155475398|FG000|Base Study|Month 12 visit not completed|0|||
48349301|NCT00943722|155475399|FG001|Base Study|Month 12 visit not completed|0|||
48349302|NCT00943722|155475400|FG002|Base Study|Month 12 visit not completed|0|||
48349303|NCT00943722|155475401|FG003|Base Study|Month 12 visit not completed|0|||
48349304|NCT00943722|155475402|FG004|Base Study|Month 12 visit not completed|2|||
48349305|NCT00943722|155475403|FG005|Base Study|Month 12 visit not completed|0|||
48349306|NCT00943722|155475404|FG006|Base Study|Month 12 visit not completed|0|||
48349307|NCT00943722|155475398|FG000|First Extension Study: EXT 1|Adverse Event|0|||
48349308|NCT00943722|155475399|FG001|First Extension Study: EXT 1|Adverse Event|0|||
48349309|NCT00943722|155475400|FG002|First Extension Study: EXT 1|Adverse Event|0|||
48349310|NCT00943722|155475401|FG003|First Extension Study: EXT 1|Adverse Event|0|||
48349311|NCT00943722|155475402|FG004|First Extension Study: EXT 1|Adverse Event|0|||
48349312|NCT00943722|155475403|FG005|First Extension Study: EXT 1|Adverse Event|1|||
48349313|NCT00943722|155475404|FG006|First Extension Study: EXT 1|Adverse Event|0|||
48675277|NCT00545103|156663454|FG003|Overall Study|Withdrawal by Subject|22|||
48675278|NCT00545103|156663451|FG000|Overall Study|Adverse Event|11|||
48349314|NCT00943722|155475398|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
48349315|NCT00943722|155475399|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
48349316|NCT00943722|155475400|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
48349317|NCT00943722|155475401|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
48349318|NCT00943722|155475402|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
48349319|NCT00943722|155475403|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
48349320|NCT00943722|155475404|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
48349321|NCT00943722|155475398|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48349322|NCT00943722|155475399|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48349323|NCT00943722|155475400|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48349324|NCT00943722|155475401|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48349325|NCT00943722|155475402|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
48349326|NCT00943722|155475403|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
48349327|NCT00943722|155475404|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
48349328|NCT00943722|155475398|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
48349329|NCT00943722|155475399|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
48349330|NCT00943722|155475400|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
48349331|NCT00943722|155475401|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
48349332|NCT00943722|155475402|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
48349333|NCT00943722|155475403|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
48349334|NCT00943722|155475404|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
48349335|NCT00943722|155475398|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
48349336|NCT00943722|155475399|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
48349337|NCT00943722|155475400|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
48349338|NCT00943722|155475401|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
48349339|NCT00943722|155475402|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
48349340|NCT00943722|155475403|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
48349341|NCT00943722|155475404|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
48349342|NCT00943722|155475398|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48349343|NCT00943722|155475399|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48349344|NCT00943722|155475400|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48349345|NCT00943722|155475401|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48349346|NCT00943722|155475402|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
48349347|NCT00943722|155475403|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
48349348|NCT00943722|155475404|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
48349349|NCT00943722|155475398|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
48349350|NCT00943722|155475399|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
48349351|NCT00943722|155475400|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
48349352|NCT00943722|155475401|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
48349353|NCT00943722|155475402|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
48349354|NCT00943722|155475403|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
48349355|NCT00943722|155475404|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
48349356|NCT00943722|155475398|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
48349357|NCT00943722|155475399|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
48349358|NCT00943722|155475400|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
48349359|NCT00943722|155475401|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
48349360|NCT00943722|155475402|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
48349361|NCT00943722|155475403|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
48349362|NCT00943722|155475404|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
48349363|NCT00943722|155475398|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48349364|NCT00943722|155475399|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48349365|NCT00943722|155475400|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48349366|NCT00943722|155475401|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48349367|NCT00943722|155475402|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
48349368|NCT00943722|155475403|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
48349369|NCT00943722|155475404|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
48349370|NCT01036165|155475409|FG000|Overall Study|Adverse Event|6|||
48349371|NCT01036165|155475409|FG000|Overall Study|Lost to Follow-up|2|||
48349372|NCT01036165|155475409|FG000|Overall Study|Withdrawal by Subject|3|||
48349373|NCT01036165|155475409|FG000|Overall Study|Device Related Issues|3|||
48349374|NCT01036165|155475409|FG000|Overall Study|Problems finding proper area to inject|1|||
48349375|NCT01441583|155475411|FG000|Overall Study|Withdrawal by Subject|1|||
48675279|NCT00545103|156663452|FG001|Overall Study|Adverse Event|12|||
48675280|NCT00545103|156663453|FG002|Overall Study|Adverse Event|17|||
48675281|NCT00545103|156663454|FG003|Overall Study|Adverse Event|10|||
48675282|NCT00545103|156663451|FG000|Overall Study|Lost to Follow-up|4|||
48349376|NCT01441583|155475412|FG001|Overall Study|Withdrawal by Subject|1|||
48349377|NCT01441583|155475413|FG002|Overall Study|Withdrawal by Subject|1|||
48675283|NCT00545103|156663452|FG001|Overall Study|Lost to Follow-up|6|||
48675284|NCT00545103|156663453|FG002|Overall Study|Lost to Follow-up|3|||
48675285|NCT00545103|156663454|FG003|Overall Study|Lost to Follow-up|4|||
48675286|NCT00545103|156663451|FG000|Overall Study|Protocol Violation|1|||
48675287|NCT00545103|156663452|FG001|Overall Study|Protocol Violation|2|||
48675288|NCT00545103|156663453|FG002|Overall Study|Protocol Violation|3|||
48675289|NCT00545103|156663454|FG003|Overall Study|Protocol Violation|0|||
48675290|NCT00545103|156663451|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
48349378|NCT01441583|155475411|FG000|Overall Study|Death|1|||
48349379|NCT01441583|155475412|FG001|Overall Study|Death|0|||
48349380|NCT01441583|155475413|FG002|Overall Study|Death|4|||
48349381|NCT01441583|155475411|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
48349382|NCT01441583|155475412|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
48349383|NCT01441583|155475413|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
48349384|NCT00412880|155475417|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
48349385|NCT00412880|155475417|FG000|Overall Study|Consent withdrawn|1|||
48349386|NCT00412880|155475417|FG000|Overall Study|Adverse Event|1|||
48349387|NCT00412880|155475417|FG000|Overall Study|Progressive disease|20|||
48349388|NCT01085812|155475418|FG000|Open-Label Period|Adverse Event|0|||
48349389|NCT01085812|155475419|FG001|Open-Label Period|Adverse Event|80|||
48349390|NCT01085812|155475418|FG000|Open-Label Period|Lack of Efficacy|0|||
48349391|NCT01085812|155475419|FG001|Open-Label Period|Lack of Efficacy|26|||
48349392|NCT01085812|155475418|FG000|Open-Label Period|Protocol Violation|0|||
48349393|NCT01085812|155475419|FG001|Open-Label Period|Protocol Violation|39|||
48349394|NCT01085812|155475418|FG000|Open-Label Period|Withdrawal by Subject|0|||
48349395|NCT01085812|155475419|FG001|Open-Label Period|Withdrawal by Subject|53|||
48349396|NCT01085812|155475418|FG000|Open-Label Period|Lost to Follow-up|0|||
48349397|NCT01085812|155475419|FG001|Open-Label Period|Lost to Follow-up|42|||
48349398|NCT01085812|155475418|FG000|Double-Blind Period|Adverse Event|3|||
48349399|NCT01085812|155475419|FG001|Double-Blind Period|Adverse Event|8|||
48349400|NCT01085812|155475418|FG000|Double-Blind Period|Protocol Violation|2|||
48349401|NCT01085812|155475419|FG001|Double-Blind Period|Protocol Violation|7|||
48349402|NCT01085812|155475418|FG000|Double-Blind Period|Withdrawal by Subject|11|||
48349403|NCT01085812|155475419|FG001|Double-Blind Period|Withdrawal by Subject|24|||
48349404|NCT01085812|155475418|FG000|Double-Blind Period|Lost to Follow-up|5|||
48349405|NCT01085812|155475419|FG001|Double-Blind Period|Lost to Follow-up|17|||
48349406|NCT01085812|155475418|FG000|Double-Blind Period|Other Reasons|0|||
48349407|NCT01085812|155475419|FG001|Double-Blind Period|Other Reasons|2|||
48349408|NCT01085812|155475418|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
48349409|NCT01085812|155475419|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
48349410|NCT01085812|155475418|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
48349411|NCT01085812|155475419|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
48349412|NCT01085812|155475418|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
48349413|NCT01085812|155475419|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
48349414|NCT01085812|155475418|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
48349415|NCT01085812|155475419|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
48349416|NCT01085812|155475418|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
48349417|NCT01085812|155475419|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
48675291|NCT00545103|156663452|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
48675292|NCT00545103|156663453|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
48675293|NCT00545103|156663454|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
48675294|NCT00545103|156663451|FG000|Overall Study|Difficult to open package|0|||
48675295|NCT00545103|156663452|FG001|Overall Study|Difficult to open package|0|||
48675296|NCT00545103|156663453|FG002|Overall Study|Difficult to open package|0|||
48675297|NCT00545103|156663454|FG003|Overall Study|Difficult to open package|1|||
48675298|NCT00545103|156663451|FG000|Overall Study|Investigational product not taken|1|||
48675299|NCT00545103|156663452|FG001|Overall Study|Investigational product not taken|0|||
48675300|NCT00545103|156663453|FG002|Overall Study|Investigational product not taken|0|||
48675301|NCT00545103|156663454|FG003|Overall Study|Investigational product not taken|1|||
48675302|NCT00545103|156663451|FG000|Overall Study|Wish to start a family|0|||
48675303|NCT00545103|156663452|FG001|Overall Study|Wish to start a family|0|||
48675304|NCT00545103|156663453|FG002|Overall Study|Wish to start a family|0|||
48675305|NCT00545103|156663454|FG003|Overall Study|Wish to start a family|1|||
48675306|NCT00545103|156663451|FG000|Overall Study|Diverticulitis crisis|0|||
48675307|NCT00545103|156663452|FG001|Overall Study|Diverticulitis crisis|0|||
48675308|NCT00545103|156663453|FG002|Overall Study|Diverticulitis crisis|0|||
48349418|NCT00107978|155475424|FG000|Overall Study|Adverse Event|1|||
48349419|NCT00107978|155475425|FG001|Overall Study|Adverse Event|5|||
48349420|NCT00107978|155475424|FG000|Overall Study|Death|3|||
48349421|NCT00107978|155475425|FG001|Overall Study|Death|3|||
48349422|NCT00107978|155475424|FG000|Overall Study|Lost to Follow-up|20|||
48675309|NCT00545103|156663454|FG003|Overall Study|Diverticulitis crisis|1|||
48675310|NCT00545103|156663451|FG000|Overall Study|Personal reasons|1|||
48675311|NCT00545103|156663452|FG001|Overall Study|Personal reasons|0|||
48675312|NCT00545103|156663453|FG002|Overall Study|Personal reasons|0|||
48349423|NCT00107978|155475425|FG001|Overall Study|Lost to Follow-up|28|||
48349424|NCT00107978|155475424|FG000|Overall Study|Withdrawal by Subject|4|||
48349425|NCT00107978|155475425|FG001|Overall Study|Withdrawal by Subject|9|||
48349426|NCT00107978|155475424|FG000|Overall Study|Protocol Violation|0|||
48349427|NCT00107978|155475425|FG001|Overall Study|Protocol Violation|1|||
48349428|NCT00107978|155475424|FG000|Overall Study|Other|5|||
48349429|NCT00107978|155475425|FG001|Overall Study|Other|4|||
48349430|NCT03016598|155475428|FG000|Overall Study|Lost to Follow-up|0|||
48349431|NCT03016598|155475429|FG001|Overall Study|Lost to Follow-up|2|||
48349432|NCT04191148|155475430|FG000|Overall Study|Withdrawal by Subject|1|||
48349433|NCT04191148|155475431|FG001|Overall Study|Withdrawal by Subject|0|||
48349434|NCT04191148|155475430|FG000|Overall Study|Adverse Event|1|||
48349435|NCT04191148|155475431|FG001|Overall Study|Adverse Event|0|||
48349436|NCT01710800|155475432|FG000|Overall Study|Withdrawal by Subject|21|||
48349437|NCT01710800|155475432|FG000|Overall Study|Protocol Violation|1|||
48349438|NCT01086384|155475433|FG000|2-week Run-in Period|Adverse Event|1|||
48349439|NCT01086384|155475434|FG001|2-week Run-in Period|Adverse Event|0|||
48349440|NCT01086384|155475435|FG002|2-week Run-in Period|Adverse Event|0|||
48349441|NCT01086384|155475433|FG000|2-week Run-in Period|Protocol Violation|1|||
48349442|NCT01086384|155475434|FG001|2-week Run-in Period|Protocol Violation|0|||
48349443|NCT01086384|155475435|FG002|2-week Run-in Period|Protocol Violation|0|||
48349444|NCT01086384|155475433|FG000|2-week Run-in Period|Lost to Follow-up|1|||
48349445|NCT01086384|155475434|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48349446|NCT01086384|155475435|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48349447|NCT01086384|155475433|FG000|2-week Run-in Period|Physician Decision|6|||
48349448|NCT01086384|155475434|FG001|2-week Run-in Period|Physician Decision|0|||
48349449|NCT01086384|155475435|FG002|2-week Run-in Period|Physician Decision|0|||
48349450|NCT01086384|155475433|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
48349451|NCT01086384|155475434|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48675313|NCT00545103|156663454|FG003|Overall Study|Personal reasons|0|||
48349452|NCT01086384|155475435|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48349453|NCT01086384|155475433|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
48349454|NCT01086384|155475434|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
48349455|NCT01086384|155475435|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
48349456|NCT01086384|155475433|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
48349457|NCT01086384|155475434|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
48349458|NCT01086384|155475435|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
48349459|NCT01086384|155475433|FG000|2-week Run-in Period|Randomized in Error|1|||
48349460|NCT01086384|155475434|FG001|2-week Run-in Period|Randomized in Error|0|||
48349461|NCT01086384|155475435|FG002|2-week Run-in Period|Randomized in Error|0|||
48349462|NCT01086384|155475433|FG000|Treatment Period|Withdrawal by Subject|0|||
48349463|NCT01086384|155475434|FG001|Treatment Period|Withdrawal by Subject|53|||
48349464|NCT01086384|155475435|FG002|Treatment Period|Withdrawal by Subject|55|||
48349465|NCT01086384|155475433|FG000|Treatment Period|Protocol Violation|0|||
48349466|NCT01086384|155475434|FG001|Treatment Period|Protocol Violation|26|||
48349467|NCT01086384|155475435|FG002|Treatment Period|Protocol Violation|17|||
48349468|NCT01086384|155475433|FG000|Treatment Period|Lack of Efficacy|0|||
48349469|NCT01086384|155475434|FG001|Treatment Period|Lack of Efficacy|22|||
48349470|NCT01086384|155475435|FG002|Treatment Period|Lack of Efficacy|13|||
48349471|NCT01086384|155475433|FG000|Treatment Period|Adverse Event|0|||
48349472|NCT01086384|155475434|FG001|Treatment Period|Adverse Event|19|||
48349473|NCT01086384|155475435|FG002|Treatment Period|Adverse Event|15|||
48349474|NCT01086384|155475433|FG000|Treatment Period|Lost to Follow-up|0|||
48349475|NCT01086384|155475434|FG001|Treatment Period|Lost to Follow-up|11|||
48349476|NCT01086384|155475435|FG002|Treatment Period|Lost to Follow-up|9|||
48349477|NCT01086384|155475433|FG000|Treatment Period|Physician Decision|0|||
48349478|NCT01086384|155475434|FG001|Treatment Period|Physician Decision|9|||
48349479|NCT01086384|155475435|FG002|Treatment Period|Physician Decision|6|||
48349480|NCT01086384|155475433|FG000|Treatment Period|Study Closed/Terminated|0|||
48349481|NCT01086384|155475434|FG001|Treatment Period|Study Closed/Terminated|7|||
48349482|NCT01086384|155475435|FG002|Treatment Period|Study Closed/Terminated|8|||
48349483|NCT01086384|155475433|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
48349484|NCT01086384|155475434|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
48349485|NCT01086384|155475435|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
48349486|NCT01086384|155475433|FG000|Treatment Period|Received Treatment in Error|0|||
48349487|NCT01086384|155475434|FG001|Treatment Period|Received Treatment in Error|1|||
48349488|NCT01086384|155475435|FG002|Treatment Period|Received Treatment in Error|0|||
48349489|NCT00458393|155475438|FG000|Overall Study|Withdrawal by Subject|67|||
48349490|NCT00458393|155475439|FG001|Overall Study|Withdrawal by Subject|80|||
48349491|NCT00458393|155475438|FG000|Overall Study|Physician Decision|31|||
48349492|NCT00458393|155475439|FG001|Overall Study|Physician Decision|22|||
48675314|NCT00545103|156663451|FG000|Overall Study|Subject's decision|1|||
48675315|NCT00545103|156663452|FG001|Overall Study|Subject's decision|0|||
48675316|NCT00545103|156663453|FG002|Overall Study|Subject's decision|0|||
48675317|NCT00545103|156663454|FG003|Overall Study|Subject's decision|0|||
48675318|NCT00545103|156663451|FG000|Overall Study|Noncompliance|0|||
48349493|NCT00458393|155475438|FG000|Overall Study|Relocated|77|||
48349494|NCT00458393|155475439|FG001|Overall Study|Relocated|81|||
48349495|NCT00458393|155475438|FG000|Overall Study|Lost to Follow-up|115|||
48349496|NCT00458393|155475439|FG001|Overall Study|Lost to Follow-up|92|||
48349497|NCT00458393|155475438|FG000|Overall Study|Sites marked other on the form.|19|||
48349498|NCT00458393|155475439|FG001|Overall Study|Sites marked other on the form.|20|||
48349499|NCT00937521|155475441|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48349500|NCT00937521|155475442|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48349501|NCT00937521|155475443|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
48349502|NCT00937521|155475444|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48349503|NCT00937521|155475445|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48349504|NCT00937521|155475446|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48349505|NCT00937521|155475447|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
48349506|NCT00937521|155475448|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
48349507|NCT00937521|155475441|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
48349508|NCT00937521|155475442|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
48349509|NCT00937521|155475443|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
48349510|NCT00937521|155475444|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
48349511|NCT00937521|155475445|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
48349512|NCT00937521|155475446|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
48349513|NCT00937521|155475447|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
48349514|NCT00937521|155475448|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
48349515|NCT00937521|155475441|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48349516|NCT00937521|155475442|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48349517|NCT00937521|155475443|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
48349518|NCT00937521|155475444|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
48349519|NCT00937521|155475445|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48349520|NCT00937521|155475446|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48349521|NCT00937521|155475447|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48349522|NCT00937521|155475448|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
48349523|NCT00937521|155475441|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
48349524|NCT00937521|155475442|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
48349525|NCT00937521|155475443|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
48349526|NCT00937521|155475444|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
48349527|NCT00937521|155475445|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
48349528|NCT00937521|155475446|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
48349529|NCT00937521|155475447|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
48349530|NCT00937521|155475448|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
48349531|NCT00937521|155475441|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
48349532|NCT00937521|155475442|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48349533|NCT00937521|155475443|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48349534|NCT00937521|155475444|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48349535|NCT00937521|155475445|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48349536|NCT00937521|155475446|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48349537|NCT00937521|155475447|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
48349538|NCT00937521|155475448|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
48349539|NCT00937521|155475441|FG000|Booster Phase|Adverse Event|0|||
48349540|NCT00937521|155475442|FG001|Booster Phase|Adverse Event|0|||
48349541|NCT00937521|155475443|FG002|Booster Phase|Adverse Event|0|||
48349542|NCT00937521|155475444|FG003|Booster Phase|Adverse Event|0|||
48349543|NCT00937521|155475445|FG004|Booster Phase|Adverse Event|0|||
48349544|NCT00937521|155475446|FG005|Booster Phase|Adverse Event|0|||
48349545|NCT00937521|155475447|FG006|Booster Phase|Adverse Event|1|||
48349546|NCT00937521|155475448|FG007|Booster Phase|Adverse Event|0|||
48349547|NCT00937521|155475441|FG000|Booster Phase|Withdrawal by Subject|1|||
48349548|NCT00937521|155475442|FG001|Booster Phase|Withdrawal by Subject|0|||
48349549|NCT00937521|155475443|FG002|Booster Phase|Withdrawal by Subject|0|||
48349550|NCT00937521|155475444|FG003|Booster Phase|Withdrawal by Subject|1|||
48349551|NCT00937521|155475445|FG004|Booster Phase|Withdrawal by Subject|0|||
48349552|NCT00937521|155475446|FG005|Booster Phase|Withdrawal by Subject|0|||
48349553|NCT00937521|155475447|FG006|Booster Phase|Withdrawal by Subject|0|||
48349554|NCT00937521|155475448|FG007|Booster Phase|Withdrawal by Subject|2|||
48349555|NCT00937521|155475441|FG000|Booster Phase|Lost to Follow-up|2|||
48349556|NCT00937521|155475442|FG001|Booster Phase|Lost to Follow-up|2|||
48349557|NCT00937521|155475443|FG002|Booster Phase|Lost to Follow-up|4|||
48349558|NCT00937521|155475444|FG003|Booster Phase|Lost to Follow-up|2|||
48349559|NCT00937521|155475445|FG004|Booster Phase|Lost to Follow-up|4|||
48349560|NCT00937521|155475446|FG005|Booster Phase|Lost to Follow-up|4|||
48349561|NCT00937521|155475447|FG006|Booster Phase|Lost to Follow-up|3|||
48349562|NCT00937521|155475448|FG007|Booster Phase|Lost to Follow-up|0|||
48349563|NCT00937521|155475441|FG000|Booster Phase|Administrative Reason|0|||
48349564|NCT00937521|155475442|FG001|Booster Phase|Administrative Reason|0|||
48349565|NCT00937521|155475443|FG002|Booster Phase|Administrative Reason|1|||
48349566|NCT00937521|155475444|FG003|Booster Phase|Administrative Reason|0|||
48349567|NCT00937521|155475445|FG004|Booster Phase|Administrative Reason|1|||
48349568|NCT00937521|155475446|FG005|Booster Phase|Administrative Reason|1|||
48349569|NCT00937521|155475447|FG006|Booster Phase|Administrative Reason|0|||
48349570|NCT00937521|155475448|FG007|Booster Phase|Administrative Reason|0|||
48349571|NCT00937521|155475441|FG000|Booster Phase|Protocol Deviation|0|||
48349572|NCT00937521|155475442|FG001|Booster Phase|Protocol Deviation|0|||
48349573|NCT00937521|155475443|FG002|Booster Phase|Protocol Deviation|0|||
48349574|NCT00937521|155475444|FG003|Booster Phase|Protocol Deviation|0|||
48349575|NCT00937521|155475445|FG004|Booster Phase|Protocol Deviation|0|||
48349576|NCT00937521|155475446|FG005|Booster Phase|Protocol Deviation|0|||
48349577|NCT00937521|155475447|FG006|Booster Phase|Protocol Deviation|1|||
48349578|NCT00937521|155475448|FG007|Booster Phase|Protocol Deviation|0|||
48349579|NCT01255761|155475454|FG000|Overall Study|Adverse Event|29|||
48349580|NCT01255761|155475455|FG001|Overall Study|Adverse Event|43|||
48349581|NCT01255761|155475454|FG000|Overall Study|Lack of Efficacy|86|||
48349582|NCT01255761|155475455|FG001|Overall Study|Lack of Efficacy|74|||
48349583|NCT01255761|155475454|FG000|Overall Study|Protocol Violation|9|||
48349584|NCT01255761|155475455|FG001|Overall Study|Protocol Violation|5|||
48349585|NCT01255761|155475454|FG000|Overall Study|Lost to Follow-up|10|||
48349586|NCT01255761|155475455|FG001|Overall Study|Lost to Follow-up|8|||
48349587|NCT01255761|155475454|FG000|Overall Study|Withdrawal by Subject|11|||
48349588|NCT01255761|155475455|FG001|Overall Study|Withdrawal by Subject|27|||
48349589|NCT01255761|155475454|FG000|Overall Study|Other Reasons|37|||
48349590|NCT01255761|155475455|FG001|Overall Study|Other Reasons|18|||
48349591|NCT01313624|155475456|FG000|Double-Blind Phase|Adverse Event|27|||
48349592|NCT01313624|155475457|FG001|Double-Blind Phase|Adverse Event|4|||
48349593|NCT01313624|155475456|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
48349594|NCT01313624|155475457|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
48349595|NCT01313624|155475456|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48349596|NCT01313624|155475457|FG001|Double-Blind Phase|Lost to Follow-up|2|||
48349597|NCT01313624|155475456|FG000|Double-Blind Phase|Physician Decision|1|||
48349598|NCT01313624|155475457|FG001|Double-Blind Phase|Physician Decision|0|||
48349599|NCT01313624|155475456|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48349600|NCT01313624|155475457|FG001|Double-Blind Phase|Lack of Efficacy|0|||
48349601|NCT01313624|155475456|FG000|Open-Label Phase|Adverse Event|1|||
48349602|NCT01313624|155475457|FG001|Open-Label Phase|Adverse Event|10|||
48349603|NCT01313624|155475456|FG000|Open-Label Phase|Withdrawal by Subject|2|||
48349604|NCT01313624|155475457|FG001|Open-Label Phase|Withdrawal by Subject|2|||
48349605|NCT01313624|155475456|FG000|Open-Label Phase|Lost to Follow-up|1|||
48349606|NCT01313624|155475457|FG001|Open-Label Phase|Lost to Follow-up|1|||
48349607|NCT01587118|155475458|FG000|Overall Study|Adverse Event|3|||
48349608|NCT01587118|155475458|FG000|Overall Study|Lost to Follow-up|2|||
48349609|NCT01587118|155475458|FG000|Overall Study|Relocation|1|||
48675319|NCT00545103|156663452|FG001|Overall Study|Noncompliance|1|||
48675320|NCT00545103|156663453|FG002|Overall Study|Noncompliance|0|||
48675321|NCT00545103|156663454|FG003|Overall Study|Noncompliance|0|||
48675322|NCT00545103|156663451|FG000|Overall Study|Investigator decision|0|||
48675323|NCT00545103|156663452|FG001|Overall Study|Investigator decision|0|||
48675324|NCT00545103|156663453|FG002|Overall Study|Investigator decision|1|||
48675325|NCT00545103|156663454|FG003|Overall Study|Investigator decision|0|||
48349610|NCT01587118|155475458|FG000|Overall Study|nonresponse|1|||
48349611|NCT02980705|155475459|FG000|Overall Study|Adverse Event|0|||
48349612|NCT02980705|155475460|FG001|Overall Study|Adverse Event|1|||
48349613|NCT02980705|155475459|FG000|Overall Study|Withdrawal by Subject|6|||
48349614|NCT02980705|155475460|FG001|Overall Study|Withdrawal by Subject|9|||
48349615|NCT02980705|155475459|FG000|Overall Study|withdrew participation|0|||
48349616|NCT02980705|155475460|FG001|Overall Study|withdrew participation|1|||
48349617|NCT02980705|155475459|FG000|Overall Study|Lost to Follow-up|2|||
48349618|NCT02980705|155475460|FG001|Overall Study|Lost to Follow-up|0|||
48349619|NCT03599622|155475461|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
48349620|NCT03599622|155475462|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
48349621|NCT03599622|155475463|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
48349622|NCT03599622|155475464|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
48349623|NCT03599622|155475461|FG000|Pre-Treatment Period|Other reasons|1|||
48349624|NCT03599622|155475462|FG001|Pre-Treatment Period|Other reasons|1|||
48349625|NCT03599622|155475463|FG002|Pre-Treatment Period|Other reasons|1|||
48349626|NCT03599622|155475464|FG003|Pre-Treatment Period|Other reasons|0|||
48349627|NCT03599622|155475461|FG000|Treatment Period|Adverse Event|11|||
48349628|NCT03599622|155475462|FG001|Treatment Period|Adverse Event|20|||
48349629|NCT03599622|155475463|FG002|Treatment Period|Adverse Event|18|||
48349630|NCT03599622|155475464|FG003|Treatment Period|Adverse Event|2|||
48349631|NCT03599622|155475461|FG000|Treatment Period|Lack of Efficacy|18|||
48349632|NCT03599622|155475462|FG001|Treatment Period|Lack of Efficacy|12|||
48675326|NCT00545103|156663451|FG000|Overall Study|Subject moved|0|||
48675327|NCT00545103|156663452|FG001|Overall Study|Subject moved|1|||
48675328|NCT00545103|156663453|FG002|Overall Study|Subject moved|0|||
48675329|NCT00545103|156663454|FG003|Overall Study|Subject moved|0|||
48675330|NCT00545103|156663451|FG000|Overall Study|Use of prohibited medication|0|||
48675331|NCT00545103|156663452|FG001|Overall Study|Use of prohibited medication|0|||
48675332|NCT00545103|156663453|FG002|Overall Study|Use of prohibited medication|1|||
48349633|NCT03599622|155475463|FG002|Treatment Period|Lack of Efficacy|13|||
48349634|NCT03599622|155475464|FG003|Treatment Period|Lack of Efficacy|2|||
48349635|NCT03599622|155475461|FG000|Treatment Period|Withdrawal by Subject|5|||
48349636|NCT03599622|155475462|FG001|Treatment Period|Withdrawal by Subject|11|||
48349637|NCT03599622|155475463|FG002|Treatment Period|Withdrawal by Subject|16|||
48349638|NCT03599622|155475464|FG003|Treatment Period|Withdrawal by Subject|1|||
48349639|NCT03599622|155475461|FG000|Treatment Period|Other reasons|4|||
48349640|NCT03599622|155475462|FG001|Treatment Period|Other reasons|6|||
48349641|NCT03599622|155475463|FG002|Treatment Period|Other reasons|7|||
48349642|NCT03599622|155475464|FG003|Treatment Period|Other reasons|0|||
48349643|NCT03599622|155475461|FG000|Treatment Period|Lost to Follow-up|1|||
48349644|NCT03599622|155475462|FG001|Treatment Period|Lost to Follow-up|0|||
48349645|NCT03599622|155475463|FG002|Treatment Period|Lost to Follow-up|0|||
48349646|NCT03599622|155475464|FG003|Treatment Period|Lost to Follow-up|0|||
48349647|NCT03599622|155475461|FG000|Treatment Period|Study terminated by sponsor|7|||
48349648|NCT03599622|155475462|FG001|Treatment Period|Study terminated by sponsor|20|||
48349649|NCT03599622|155475463|FG002|Treatment Period|Study terminated by sponsor|15|||
48349650|NCT03599622|155475464|FG003|Treatment Period|Study terminated by sponsor|0|||
48349651|NCT03599622|155475461|FG000|Treatment Period|Site terminated by sponsor|0|||
48349652|NCT03599622|155475462|FG001|Treatment Period|Site terminated by sponsor|1|||
48349653|NCT03599622|155475463|FG002|Treatment Period|Site terminated by sponsor|0|||
48349654|NCT03599622|155475464|FG003|Treatment Period|Site terminated by sponsor|0|||
48349655|NCT00665223|155475466|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
48349656|NCT00665223|155475467|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
48349657|NCT00665223|155475468|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
48349658|NCT00665223|155475466|FG000|Randomized Phase (26 Weeks)|Death|0|||
48349659|NCT00665223|155475467|FG001|Randomized Phase (26 Weeks)|Death|0|||
48349660|NCT00665223|155475468|FG002|Randomized Phase (26 Weeks)|Death|1|||
48349661|NCT00665223|155475466|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
48349662|NCT00665223|155475467|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
48349663|NCT00665223|155475468|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
48349664|NCT00665223|155475466|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
48349665|NCT00665223|155475467|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
48349666|NCT00665223|155475468|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
48349667|NCT00665223|155475466|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
48349668|NCT00665223|155475467|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
48349669|NCT00665223|155475468|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
48349670|NCT00665223|155475466|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
48349671|NCT00665223|155475467|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
48349672|NCT00665223|155475468|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
48349673|NCT00665223|155475466|FG000|Open-Label Period (26 Weeks)|Death|0|||
48349674|NCT00665223|155475467|FG001|Open-Label Period (26 Weeks)|Death|1|||
48349675|NCT00665223|155475468|FG002|Open-Label Period (26 Weeks)|Death|0|||
48349676|NCT00665223|155475466|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
48349677|NCT00665223|155475467|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
48349678|NCT00665223|155475468|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
48349679|NCT00665223|155475466|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
48349680|NCT00665223|155475467|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
48349681|NCT00665223|155475468|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
48349682|NCT00665223|155475466|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
48349683|NCT00665223|155475467|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
48349684|NCT00665223|155475468|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
48349685|NCT00665223|155475466|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
48675333|NCT00545103|156663454|FG003|Overall Study|Use of prohibited medication|0|||
48349686|NCT00665223|155475467|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
48349687|NCT00665223|155475468|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
48349688|NCT01013740|155475469|FG000|Overall Study|Lost to Follow-up|3|||
48349689|NCT01013740|155475470|FG001|Overall Study|Lost to Follow-up|5|||
48349690|NCT01013740|155475469|FG000|Overall Study|Physician Decision|2|||
48349691|NCT01013740|155475470|FG001|Overall Study|Physician Decision|0|||
48349692|NCT01013740|155475469|FG000|Overall Study|Withdrawal by Subject|2|||
48349693|NCT01013740|155475470|FG001|Overall Study|Withdrawal by Subject|10|||
48349694|NCT01013740|155475469|FG000|Overall Study|study close / terminated : done in error|2|||
48349695|NCT01013740|155475470|FG001|Overall Study|study close / terminated : done in error|1|||
48349696|NCT01013740|155475469|FG000|Overall Study|Missing|2|||
48349697|NCT01013740|155475470|FG001|Overall Study|Missing|1|||
48349698|NCT01013740|155475469|FG000|Overall Study|Ongoing: Study records not completed|0|||
48349699|NCT01013740|155475470|FG001|Overall Study|Ongoing: Study records not completed|2|||
48349700|NCT02654132|155475471|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
48349701|NCT02654132|155475472|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
48349702|NCT02654132|155475471|FG000|Treatment Period|Disease progression|43|||
48349703|NCT02654132|155475472|FG001|Treatment Period|Disease progression|38|||
48349704|NCT02654132|155475471|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
48349705|NCT02654132|155475472|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
48349706|NCT02654132|155475471|FG000|Treatment Period|Other reasons|4|||
48349707|NCT02654132|155475472|FG001|Treatment Period|Other reasons|2|||
48349708|NCT02654132|155475471|FG000|Treatment Period|Study drug toxicity|2|||
48349709|NCT02654132|155475472|FG001|Treatment Period|Study drug toxicity|2|||
48349710|NCT02654132|155475471|FG000|Treatment Period|Withdrawal by Subject|2|||
48349711|NCT02654132|155475472|FG001|Treatment Period|Withdrawal by Subject|1|||
48349712|NCT02654132|155475471|FG000|Treatment Period|Maximum Clinical Benefit|0|||
48349713|NCT02654132|155475472|FG001|Treatment Period|Maximum Clinical Benefit|2|||
48349714|NCT02654132|155475471|FG000|Treatment Period|Participant request to discontinue|2|||
48349715|NCT02654132|155475472|FG001|Treatment Period|Participant request to discontinue|0|||
48349716|NCT02654132|155475471|FG000|Treatment Period|Administrative reasons by sponsor|0|||
48349717|NCT02654132|155475472|FG001|Treatment Period|Administrative reasons by sponsor|1|||
48349718|NCT02654132|155475471|FG000|Treatment Period|Death|1|||
48349719|NCT02654132|155475472|FG001|Treatment Period|Death|0|||
48349720|NCT01407276|155475473|FG000|Overall Study|Withdrawal by Subject|0|||
48349721|NCT01407276|155475474|FG001|Overall Study|Withdrawal by Subject|0|||
48349722|NCT01407276|155475475|FG002|Overall Study|Withdrawal by Subject|0|||
48349723|NCT01407276|155475476|FG003|Overall Study|Withdrawal by Subject|0|||
48349724|NCT01407276|155475477|FG004|Overall Study|Withdrawal by Subject|0|||
48349725|NCT01407276|155475478|FG005|Overall Study|Withdrawal by Subject|0|||
48349726|NCT01407276|155475479|FG006|Overall Study|Withdrawal by Subject|0|||
48349727|NCT01407276|155475480|FG007|Overall Study|Withdrawal by Subject|1|||
48349728|NCT02760485|155475483|FG000|Phase 1|Death|3|||
48349729|NCT02760485|155475484|FG001|Phase 1|Death|6|||
48349730|NCT02760485|155475485|FG002|Phase 1|Death|0|||
48349731|NCT02760485|155475483|FG000|Phase 1|Withdrawal by Subject|2|||
48349732|NCT02760485|155475484|FG001|Phase 1|Withdrawal by Subject|0|||
48349733|NCT02760485|155475485|FG002|Phase 1|Withdrawal by Subject|0|||
48349734|NCT02760485|155475483|FG000|Phase 1|Progressive Disease|1|||
48349735|NCT02760485|155475484|FG001|Phase 1|Progressive Disease|0|||
48349736|NCT02760485|155475485|FG002|Phase 1|Progressive Disease|0|||
48349737|NCT02760485|155475483|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
48349738|NCT02760485|155475484|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
48349739|NCT02760485|155475485|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
48349740|NCT02760485|155475483|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
48349741|NCT02760485|155475484|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
48349742|NCT02760485|155475485|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
48349743|NCT02760485|155475483|FG000|Phase 2|Death|0|||
48675334|NCT00545103|156663451|FG000|Overall Study|Does not want to take study drug anymore|1|||
48349744|NCT02760485|155475484|FG001|Phase 2|Death|0|||
48349745|NCT02760485|155475485|FG002|Phase 2|Death|12|||
48349746|NCT02760485|155475483|FG000|Phase 2|Withdrawal by Subject|0|||
48349747|NCT02760485|155475484|FG001|Phase 2|Withdrawal by Subject|0|||
48349748|NCT02760485|155475485|FG002|Phase 2|Withdrawal by Subject|3|||
48349749|NCT02760485|155475483|FG000|Phase 2|Progressive Disease|0|||
48349750|NCT02760485|155475484|FG001|Phase 2|Progressive Disease|0|||
48349751|NCT02760485|155475485|FG002|Phase 2|Progressive Disease|1|||
48349752|NCT02760485|155475483|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
48349753|NCT02760485|155475484|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
48349754|NCT02760485|155475485|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
48349755|NCT02658175|155475490|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
48349756|NCT02658175|155475491|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
48675335|NCT00545103|156663452|FG001|Overall Study|Does not want to take study drug anymore|0|||
48675336|NCT00545103|156663453|FG002|Overall Study|Does not want to take study drug anymore|1|||
48675337|NCT00545103|156663454|FG003|Overall Study|Does not want to take study drug anymore|0|||
48675338|NCT00545103|156663451|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
48675339|NCT00545103|156663452|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
48349757|NCT02658175|155475492|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
48349758|NCT02658175|155475490|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
48349759|NCT02658175|155475491|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
48349760|NCT02658175|155475492|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
48349761|NCT02658175|155475490|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
48349762|NCT02658175|155475491|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
48349763|NCT02658175|155475492|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
48349764|NCT02658175|155475490|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
48761829|NCT02036502|156975719|FG002|Part 1:Dose Determination/Escalation|Death|0|||
48761830|NCT02036502|156975720|FG003|Part 1:Dose Determination/Escalation|Death|0|||
48761831|NCT02036502|156975721|FG004|Part 1:Dose Determination/Escalation|Death|0|||
48675340|NCT00545103|156663453|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
48675341|NCT00545103|156663454|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
48675342|NCT00545103|156663451|FG000|Overall Study|Death|0|||
48675343|NCT00545103|156663452|FG001|Overall Study|Death|1|||
48675344|NCT00545103|156663453|FG002|Overall Study|Death|0|||
48675345|NCT00545103|156663454|FG003|Overall Study|Death|0|||
48761832|NCT02036502|156975722|FG005|Part 1:Dose Determination/Escalation|Death|0|||
48761833|NCT02036502|156975723|FG006|Part 1:Dose Determination/Escalation|Death|0|||
48761834|NCT02036502|156975724|FG007|Part 1:Dose Determination/Escalation|Death|0|||
48761835|NCT02036502|156975717|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
48761836|NCT02036502|156975718|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761837|NCT02036502|156975719|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761838|NCT02036502|156975720|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761839|NCT02036502|156975721|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761840|NCT02036502|156975722|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761841|NCT02036502|156975723|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761842|NCT02036502|156975724|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
48761843|NCT02036502|156975717|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761844|NCT02036502|156975718|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
48761845|NCT02036502|156975719|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761846|NCT02036502|156975720|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761847|NCT02036502|156975721|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761848|NCT02036502|156975722|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761849|NCT02036502|156975723|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761850|NCT02036502|156975724|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
48761851|NCT02036502|156975717|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
48761852|NCT02036502|156975718|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
48761853|NCT02036502|156975719|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
48761854|NCT02036502|156975720|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
48761855|NCT02036502|156975721|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
48761856|NCT02036502|156975722|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
48675346|NCT01953913|156663455|FG000|Overall Study|Disease Progression|349|||
48675347|NCT01953913|156663455|FG000|Overall Study|Worsening of underlying cancer|22|||
48675348|NCT01953913|156663455|FG000|Overall Study|Adverse Event|20|||
48761857|NCT02036502|156975723|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
48675349|NCT01953913|156663455|FG000|Overall Study|Protocol Violation|6|||
48675350|NCT01953913|156663455|FG000|Overall Study|Lost to Follow-up|4|||
48761858|NCT02036502|156975724|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
48761859|NCT02036502|156975717|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48761860|NCT02036502|156975718|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48349765|NCT02658175|155475491|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
48349766|NCT02658175|155475492|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
48349767|NCT02658175|155475490|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
48349768|NCT02658175|155475491|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
48429374|NCT01070550|155760357|FG002|Overall Study|Not categorized|6|||
48675351|NCT01953913|156663455|FG000|Overall Study|Withdrawal by Subject|32|||
48675352|NCT01953913|156663455|FG000|Overall Study|Other than listed|108|||
48675353|NCT01953913|156663455|FG000|Overall Study|Not Treated|1|||
48675354|NCT03615066|156663458|FG000|Main Study|Withdrew Consent|0|||
48675355|NCT03615066|156663459|FG001|Main Study|Withdrew Consent|1|||
48675356|NCT03615066|156663460|FG002|Main Study|Withdrew Consent|1|||
48675357|NCT03615066|156663458|FG000|Main Study|Lost to Follow-up|0|||
48675358|NCT03615066|156663459|FG001|Main Study|Lost to Follow-up|0|||
48761861|NCT02036502|156975719|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
48761862|NCT02036502|156975720|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
48761863|NCT02036502|156975721|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
48761864|NCT02036502|156975722|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48761865|NCT02036502|156975723|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48761866|NCT02036502|156975724|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
48761867|NCT02036502|156975717|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761868|NCT02036502|156975718|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761869|NCT02036502|156975719|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
48761870|NCT02036502|156975720|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761871|NCT02036502|156975721|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761872|NCT02036502|156975722|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761873|NCT02036502|156975723|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761874|NCT02036502|156975724|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
48761875|NCT02036502|156975717|FG000|Part 2:Dose Confirmation|Death|0|||
48761876|NCT02036502|156975718|FG001|Part 2:Dose Confirmation|Death|0|||
48761877|NCT02036502|156975719|FG002|Part 2:Dose Confirmation|Death|1|||
48761878|NCT02036502|156975720|FG003|Part 2:Dose Confirmation|Death|0|||
48761879|NCT02036502|156975721|FG004|Part 2:Dose Confirmation|Death|0|||
48761880|NCT02036502|156975722|FG005|Part 2:Dose Confirmation|Death|0|||
48761881|NCT02036502|156975723|FG006|Part 2:Dose Confirmation|Death|0|||
48761882|NCT02036502|156975724|FG007|Part 2:Dose Confirmation|Death|0|||
48761883|NCT02036502|156975717|FG000|Part 2:Dose Confirmation|Not treated|0|||
48761884|NCT02036502|156975718|FG001|Part 2:Dose Confirmation|Not treated|0|||
48761885|NCT02036502|156975719|FG002|Part 2:Dose Confirmation|Not treated|0|||
48761886|NCT02036502|156975720|FG003|Part 2:Dose Confirmation|Not treated|1|||
48761887|NCT02036502|156975721|FG004|Part 2:Dose Confirmation|Not treated|0|||
48761888|NCT02036502|156975722|FG005|Part 2:Dose Confirmation|Not treated|0|||
48761889|NCT02036502|156975723|FG006|Part 2:Dose Confirmation|Not treated|0|||
48761890|NCT02036502|156975724|FG007|Part 2:Dose Confirmation|Not treated|0|||
48761891|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Adverse Event|0|||
48761892|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Adverse Event|0|||
48761893|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Adverse Event|0|||
48761894|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Adverse Event|0|||
48761895|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Adverse Event|0|||
48761896|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Adverse Event|4|||
48761897|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Adverse Event|0|||
48761898|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Adverse Event|2|||
48761899|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Death|0|||
48761900|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Death|0|||
48761901|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Death|0|||
48761902|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Death|0|||
48761903|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Death|0|||
48761904|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Death|24|||
48761905|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Death|0|||
48761906|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Death|3|||
48761907|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761908|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761909|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761910|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761911|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761912|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761913|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
48761914|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
48761915|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Physician Decision|0|||
48761916|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Physician Decision|0|||
48675359|NCT03615066|156663460|FG002|Main Study|Lost to Follow-up|1|||
48675360|NCT03615066|156663458|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
48349769|NCT02658175|155475492|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
48349770|NCT02658175|155475490|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
48349771|NCT02658175|155475491|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
48349772|NCT02658175|155475492|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
48349773|NCT02658175|155475490|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
48349774|NCT02658175|155475491|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
48349775|NCT02658175|155475492|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
48349776|NCT02658175|155475490|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
48349777|NCT02658175|155475491|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
48349778|NCT02658175|155475492|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
48349779|NCT02658175|155475490|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
48349780|NCT02658175|155475491|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
48349781|NCT02658175|155475492|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
48349782|NCT02658175|155475490|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
48349783|NCT02658175|155475491|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
48349784|NCT02658175|155475492|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
48349785|NCT00746356|155475495|FG000|Overall Study|Withdrawal by Subject|2|||
48349786|NCT00746356|155475496|FG001|Overall Study|Withdrawal by Subject|3|||
48349787|NCT00746356|155475495|FG000|Overall Study|Death|7|||
48349788|NCT00746356|155475496|FG001|Overall Study|Death|3|||
48349789|NCT00746356|155475495|FG000|Overall Study|Lost to Follow-up|1|||
48349790|NCT00746356|155475496|FG001|Overall Study|Lost to Follow-up|0|||
48349791|NCT00746356|155475495|FG000|Overall Study|Removal of Device|0|||
48349792|NCT00746356|155475496|FG001|Overall Study|Removal of Device|1|||
48349793|NCT00746356|155475495|FG000|Overall Study|Patient relocated|1|||
48349794|NCT00746356|155475496|FG001|Overall Study|Patient relocated|0|||
48349795|NCT01263925|155475497|FG000|Overall Study|Protocol Violation|1|||
48349796|NCT01263925|155475498|FG001|Overall Study|Protocol Violation|0|||
48349797|NCT01263925|155475497|FG000|Overall Study|Lack of Efficacy|0|||
48349798|NCT01263925|155475498|FG001|Overall Study|Lack of Efficacy|1|||
48349799|NCT01263925|155475497|FG000|Overall Study|Adverse Event|23|||
48349800|NCT01263925|155475498|FG001|Overall Study|Adverse Event|22|||
48349801|NCT01263925|155475497|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
48349802|NCT01263925|155475498|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
48349803|NCT01263925|155475497|FG000|Overall Study|Withdrawal by Subject|6|||
48349804|NCT01263925|155475498|FG001|Overall Study|Withdrawal by Subject|8|||
48349805|NCT01263925|155475497|FG000|Overall Study|Other|4|||
48349806|NCT01263925|155475498|FG001|Overall Study|Other|4|||
48349807|NCT01263925|155475497|FG000|Overall Study|Lost to Follow-up|3|||
48349808|NCT01263925|155475498|FG001|Overall Study|Lost to Follow-up|1|||
48349809|NCT01263925|155475497|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
48349810|NCT01263925|155475498|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
48349811|NCT01263925|155475497|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
48349812|NCT01263925|155475498|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
48349813|NCT01263925|155475497|FG000|Overall Study|AE/ Withdrawal|1|||
48349814|NCT01263925|155475498|FG001|Overall Study|AE/ Withdrawal|4|||
48349815|NCT01263925|155475497|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
48349816|NCT01263925|155475498|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
48349817|NCT01263925|155475497|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
48349818|NCT01263925|155475498|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
48349819|NCT01263925|155475497|FG000|Overall Study|Withdrawal/ Not specified|0|||
48349820|NCT01263925|155475498|FG001|Overall Study|Withdrawal/ Not specified|1|||
48349821|NCT02554383|155475500|FG000|Overall Study|Ineligible|3|||
48349822|NCT02554383|155475501|FG001|Overall Study|Ineligible|2|||
48349823|NCT02554383|155475500|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
48349824|NCT02554383|155475501|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
48349825|NCT02554383|155475500|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
48349826|NCT02554383|155475501|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
48349827|NCT02554383|155475500|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
48349828|NCT02554383|155475501|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
48349829|NCT00826228|155477269|FG000|Overall Study|Withdrawal by Subject|1|||
48349830|NCT02104505|155477270|FG000|First Intervention (14 Days)|Adverse Event|2|||
48349831|NCT02104505|155477271|FG001|First Intervention (14 Days)|Adverse Event|0|||
48349832|NCT02104505|155477270|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
48349833|NCT02104505|155477271|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
48675361|NCT03615066|156663459|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
48349834|NCT02104505|155477270|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
48349835|NCT02104505|155477271|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
48349836|NCT02104505|155477270|FG000|First Intervention (14 Days)|exclusionary condition|0|||
48349837|NCT02104505|155477271|FG001|First Intervention (14 Days)|exclusionary condition|1|||
48349838|NCT02104505|155477270|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
48349839|NCT02104505|155477271|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
48349840|NCT02104505|155477270|FG000|Second Intervention (14 Days)|Adverse Event|2|||
48349841|NCT02104505|155477271|FG001|Second Intervention (14 Days)|Adverse Event|0|||
48349842|NCT03991988|155477272|FG000|Overall Study|Withdrawal by Subject|2|||
48349843|NCT03991988|155477273|FG001|Overall Study|Withdrawal by Subject|2|||
48349844|NCT00684203|155477274|FG000|Overall Study|Adverse Event|6|||
48349845|NCT00684203|155477275|FG001|Overall Study|Adverse Event|4|||
48349846|NCT00684203|155477276|FG002|Overall Study|Adverse Event|8|||
48349847|NCT00684203|155477277|FG003|Overall Study|Adverse Event|0|||
48349848|NCT00684203|155477278|FG004|Overall Study|Adverse Event|0|||
48349849|NCT00684203|155477279|FG005|Overall Study|Adverse Event|0|||
48349850|NCT00684203|155477274|FG000|Overall Study|Protocol-defined clinical event|3|||
48349851|NCT00684203|155477275|FG001|Overall Study|Protocol-defined clinical event|1|||
48349852|NCT00684203|155477276|FG002|Overall Study|Protocol-defined clinical event|0|||
48349853|NCT00684203|155477277|FG003|Overall Study|Protocol-defined clinical event|0|||
48349854|NCT00684203|155477278|FG004|Overall Study|Protocol-defined clinical event|0|||
48349855|NCT00684203|155477279|FG005|Overall Study|Protocol-defined clinical event|0|||
48349856|NCT00684203|155477274|FG000|Overall Study|Withdrawal by Subject|0|||
48349857|NCT00684203|155477275|FG001|Overall Study|Withdrawal by Subject|2|||
48349858|NCT00684203|155477276|FG002|Overall Study|Withdrawal by Subject|1|||
48349859|NCT00684203|155477277|FG003|Overall Study|Withdrawal by Subject|0|||
48349860|NCT00684203|155477278|FG004|Overall Study|Withdrawal by Subject|0|||
48349861|NCT00684203|155477279|FG005|Overall Study|Withdrawal by Subject|0|||
48349862|NCT00684203|155477274|FG000|Overall Study|Did not meet protocol eligibility|0|||
48349863|NCT00684203|155477275|FG001|Overall Study|Did not meet protocol eligibility|1|||
48349864|NCT00684203|155477276|FG002|Overall Study|Did not meet protocol eligibility|0|||
48675362|NCT03615066|156663460|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
48349865|NCT00684203|155477277|FG003|Overall Study|Did not meet protocol eligibility|0|||
48349866|NCT00684203|155477278|FG004|Overall Study|Did not meet protocol eligibility|0|||
48349867|NCT00684203|155477279|FG005|Overall Study|Did not meet protocol eligibility|0|||
48349868|NCT00478647|155477282|FG000|Overall Study|Adverse Event|1|||
48349869|NCT00478647|155477282|FG000|Overall Study|Withdrawal by Subject|1|||
48349870|NCT00320398|155477283|FG000|Overall Study|Adverse Event|1|||
48349871|NCT00320398|155477284|FG001|Overall Study|Adverse Event|4|||
48349872|NCT00320398|155477283|FG000|Overall Study|Other|1|||
48349873|NCT00320398|155477284|FG001|Overall Study|Other|0|||
48349874|NCT04698915|155477286|FG000|Overall Study|Adverse Event|2|||
48349875|NCT04698915|155477287|FG001|Overall Study|Adverse Event|0|||
48349876|NCT04698915|155477286|FG000|Overall Study|Death|23|||
48349877|NCT04698915|155477287|FG001|Overall Study|Death|20|||
48349878|NCT04698915|155477286|FG000|Overall Study|Physician Decision|1|||
48349879|NCT04698915|155477287|FG001|Overall Study|Physician Decision|1|||
48349880|NCT04698915|155477286|FG000|Overall Study|Lost to Follow-up|1|||
48349881|NCT04698915|155477287|FG001|Overall Study|Lost to Follow-up|0|||
48349882|NCT04698915|155477286|FG000|Overall Study|Study Terminated by Sponsor|55|||
48349883|NCT04698915|155477287|FG001|Overall Study|Study Terminated by Sponsor|60|||
48349884|NCT04698915|155477286|FG000|Overall Study|Withdrawal by Subject|2|||
48349885|NCT04698915|155477287|FG001|Overall Study|Withdrawal by Subject|3|||
48349886|NCT00639769|155477288|FG000|Overall Study|Death|2|||
48349887|NCT00639769|155477288|FG000|Overall Study|Adverse Event|7|||
48349888|NCT00639769|155477288|FG000|Overall Study|Lack of Efficacy|1|||
48349889|NCT00639769|155477288|FG000|Overall Study|Disease progression|26|||
48349890|NCT00639769|155477288|FG000|Overall Study|Withdrawal by Subject|4|||
48349891|NCT01917006|155477289|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
48349892|NCT01917006|155477290|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
48349893|NCT01917006|155477291|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
48349894|NCT01917006|155477292|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
48349895|NCT01917006|155477293|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
48349896|NCT01917006|155477294|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
48349897|NCT01917006|155477295|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
48349898|NCT01917006|155477296|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
48349899|NCT01917006|155477289|FG000|Randomized-treatment Period|Personal Reasons|0|||
48349900|NCT01917006|155477290|FG001|Randomized-treatment Period|Personal Reasons|0|||
48349901|NCT01917006|155477291|FG002|Randomized-treatment Period|Personal Reasons|0|||
48349902|NCT01917006|155477292|FG003|Randomized-treatment Period|Personal Reasons|0|||
48349903|NCT01917006|155477293|FG004|Randomized-treatment Period|Personal Reasons|0|||
48349904|NCT01917006|155477294|FG005|Randomized-treatment Period|Personal Reasons|1|||
48349905|NCT01917006|155477295|FG006|Randomized-treatment Period|Personal Reasons|0|||
48349906|NCT01917006|155477296|FG007|Randomized-treatment Period|Personal Reasons|0|||
48349907|NCT01917006|155477289|FG000|Randomized-treatment Period|Protocol Violation|1|||
48349908|NCT01917006|155477290|FG001|Randomized-treatment Period|Protocol Violation|0|||
48349909|NCT01917006|155477291|FG002|Randomized-treatment Period|Protocol Violation|0|||
48675363|NCT03615066|156663458|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
48675364|NCT03615066|156663459|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
48675365|NCT03615066|156663460|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
48349910|NCT01917006|155477292|FG003|Randomized-treatment Period|Protocol Violation|0|||
48349911|NCT01917006|155477293|FG004|Randomized-treatment Period|Protocol Violation|0|||
48349912|NCT01917006|155477294|FG005|Randomized-treatment Period|Protocol Violation|0|||
48349913|NCT01917006|155477295|FG006|Randomized-treatment Period|Protocol Violation|0|||
48349914|NCT01917006|155477296|FG007|Randomized-treatment Period|Protocol Violation|0|||
48349915|NCT01917006|155477289|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48349916|NCT01917006|155477290|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48349917|NCT01917006|155477291|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48349918|NCT01917006|155477292|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48349919|NCT01917006|155477293|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48349920|NCT01917006|155477294|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48349921|NCT01917006|155477295|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
48349922|NCT01917006|155477296|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
48349923|NCT01917006|155477289|FG000|Open-label Period|Adverse Event|0|||
48349924|NCT01917006|155477290|FG001|Open-label Period|Adverse Event|0|||
48349925|NCT01917006|155477291|FG002|Open-label Period|Adverse Event|0|||
48349926|NCT01917006|155477292|FG003|Open-label Period|Adverse Event|0|||
48349927|NCT01917006|155477293|FG004|Open-label Period|Adverse Event|0|||
48349928|NCT01917006|155477294|FG005|Open-label Period|Adverse Event|0|||
48349929|NCT01917006|155477295|FG006|Open-label Period|Adverse Event|0|||
48349930|NCT01917006|155477296|FG007|Open-label Period|Adverse Event|1|||
48349931|NCT01917006|155477289|FG000|Open-label Period|Lost to Follow-up|0|||
48349932|NCT01917006|155477290|FG001|Open-label Period|Lost to Follow-up|0|||
48349933|NCT01917006|155477291|FG002|Open-label Period|Lost to Follow-up|0|||
48349934|NCT01917006|155477292|FG003|Open-label Period|Lost to Follow-up|0|||
48349935|NCT01917006|155477293|FG004|Open-label Period|Lost to Follow-up|0|||
48349936|NCT01917006|155477294|FG005|Open-label Period|Lost to Follow-up|0|||
48349937|NCT01917006|155477295|FG006|Open-label Period|Lost to Follow-up|0|||
48349938|NCT01917006|155477296|FG007|Open-label Period|Lost to Follow-up|1|||
48349939|NCT01649557|155477300|FG000|Overall Study|Lost to Follow-up|5|||
48349940|NCT01649557|155477301|FG001|Overall Study|Lost to Follow-up|0|||
48349941|NCT01649557|155477302|FG002|Overall Study|Lost to Follow-up|3|||
48349942|NCT01649557|155477300|FG000|Overall Study|Adverse Event|7|||
48349943|NCT01649557|155477301|FG001|Overall Study|Adverse Event|5|||
48349944|NCT01649557|155477302|FG002|Overall Study|Adverse Event|1|||
48349945|NCT01649557|155477300|FG000|Overall Study|Met withdrawal criteria|4|||
48349946|NCT01649557|155477301|FG001|Overall Study|Met withdrawal criteria|0|||
48349947|NCT01649557|155477302|FG002|Overall Study|Met withdrawal criteria|0|||
48349948|NCT01649557|155477300|FG000|Overall Study|Physician Decision|8|||
48349949|NCT01649557|155477301|FG001|Overall Study|Physician Decision|2|||
48349950|NCT01649557|155477302|FG002|Overall Study|Physician Decision|1|||
48349951|NCT01649557|155477300|FG000|Overall Study|Withdrawal by Subject|15|||
48349952|NCT01649557|155477301|FG001|Overall Study|Withdrawal by Subject|5|||
48349953|NCT01649557|155477302|FG002|Overall Study|Withdrawal by Subject|4|||
48349954|NCT01649557|155477300|FG000|Overall Study|Protocol deviation|0|||
48349955|NCT01649557|155477301|FG001|Overall Study|Protocol deviation|2|||
48349956|NCT01649557|155477302|FG002|Overall Study|Protocol deviation|0|||
48349957|NCT01649557|155477300|FG000|Overall Study|Lack of Efficacy|5|||
48349958|NCT01649557|155477301|FG001|Overall Study|Lack of Efficacy|0|||
48349959|NCT01649557|155477302|FG002|Overall Study|Lack of Efficacy|0|||
48349960|NCT01161446|155477303|FG000|Overall Study|Lost to Follow-up|18|||
48349961|NCT01161446|155477304|FG001|Overall Study|Lost to Follow-up|14|||
48349962|NCT01161446|155477303|FG000|Overall Study|Withdrawal by Subject|0|||
48349963|NCT01161446|155477304|FG001|Overall Study|Withdrawal by Subject|1|||
48349964|NCT01010204|155477305|FG000|Overall Study|Lost to Follow-up|2|||
48349965|NCT01010204|155477306|FG001|Overall Study|Lost to Follow-up|2|||
48349966|NCT01010204|155477305|FG000|Overall Study|Adverse Event|1|||
48349967|NCT01010204|155477306|FG001|Overall Study|Adverse Event|3|||
48349968|NCT01010204|155477305|FG000|Overall Study|Withdrawal by Subject|2|||
48349969|NCT01010204|155477306|FG001|Overall Study|Withdrawal by Subject|3|||
48349970|NCT01010204|155477305|FG000|Overall Study|psychiatric hospitalization|2|||
48349971|NCT01010204|155477306|FG001|Overall Study|psychiatric hospitalization|1|||
48349972|NCT04629443|155477311|FG000|Overall Study|Adverse Event|2|||
48349973|NCT04629443|155477312|FG001|Overall Study|Adverse Event|1|||
48349974|NCT04629443|155477313|FG002|Overall Study|Adverse Event|2|||
48349975|NCT04629443|155477311|FG000|Overall Study|Progressive Disease|2|||
48349976|NCT04629443|155477312|FG001|Overall Study|Progressive Disease|3|||
48349977|NCT04629443|155477313|FG002|Overall Study|Progressive Disease|3|||
48349978|NCT04629443|155477311|FG000|Overall Study|Physician Decision|1|||
48349979|NCT04629443|155477312|FG001|Overall Study|Physician Decision|3|||
48349980|NCT04629443|155477313|FG002|Overall Study|Physician Decision|0|||
48349981|NCT00913523|155477314|FG000|Overall Study|Withdrawal by Subject|3|||
48349982|NCT00913523|155477315|FG001|Overall Study|Withdrawal by Subject|2|||
48349983|NCT00913523|155477316|FG002|Overall Study|Withdrawal by Subject|2|||
48349984|NCT00913523|155477314|FG000|Overall Study|Lost to Follow-up|1|||
48349985|NCT00913523|155477315|FG001|Overall Study|Lost to Follow-up|1|||
48349986|NCT00913523|155477316|FG002|Overall Study|Lost to Follow-up|1|||
48349987|NCT00913523|155477314|FG000|Overall Study|Adverse Event|1|||
48349988|NCT00913523|155477315|FG001|Overall Study|Adverse Event|0|||
48349989|NCT00913523|155477316|FG002|Overall Study|Adverse Event|0|||
48349990|NCT00913523|155477314|FG000|Overall Study|Protocol Violation|5|||
48349991|NCT00913523|155477315|FG001|Overall Study|Protocol Violation|8|||
48349992|NCT00913523|155477316|FG002|Overall Study|Protocol Violation|8|||
48349993|NCT00913523|155477314|FG000|Overall Study|Pregnancy|1|||
48349994|NCT00913523|155477315|FG001|Overall Study|Pregnancy|3|||
48349995|NCT00913523|155477316|FG002|Overall Study|Pregnancy|0|||
48349996|NCT00913523|155477314|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
48349997|NCT00913523|155477315|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
48349998|NCT00913523|155477316|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
48349999|NCT02895360|155477317|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
48350000|NCT02895360|155477318|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48350001|NCT02895360|155477319|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48350002|NCT02895360|155477320|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48350003|NCT02895360|155477321|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48350004|NCT02895360|155477322|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
48350005|NCT02895360|155477317|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48350006|NCT02895360|155477318|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
48350007|NCT02895360|155477319|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48350008|NCT02895360|155477320|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48350009|NCT02895360|155477321|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48350010|NCT02895360|155477322|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
48350011|NCT02895360|155477317|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48350012|NCT02895360|155477318|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48350013|NCT02895360|155477319|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
48350014|NCT02895360|155477320|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48350015|NCT02895360|155477321|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48350016|NCT02895360|155477322|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
48350017|NCT02895360|155477317|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48350018|NCT02895360|155477318|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48350019|NCT02895360|155477319|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
48350020|NCT02895360|155477320|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48350021|NCT02895360|155477321|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48350022|NCT02895360|155477322|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
48350023|NCT02895360|155477317|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48350024|NCT02895360|155477318|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48350025|NCT02895360|155477319|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48350026|NCT02895360|155477320|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
48350027|NCT02895360|155477321|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48350028|NCT02895360|155477322|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
48350029|NCT02895360|155477317|FG000|Phase 2a|Adverse Event|0|||
48350030|NCT02895360|155477318|FG001|Phase 2a|Adverse Event|0|||
48350031|NCT02895360|155477319|FG002|Phase 2a|Adverse Event|0|||
48350032|NCT02895360|155477320|FG003|Phase 2a|Adverse Event|0|||
48350033|NCT02895360|155477321|FG004|Phase 2a|Adverse Event|0|||
48350034|NCT02895360|155477322|FG005|Phase 2a|Adverse Event|1|||
48350035|NCT02895360|155477317|FG000|Phase 2a|Progressive disease|0|||
48350036|NCT02895360|155477318|FG001|Phase 2a|Progressive disease|0|||
48350037|NCT02895360|155477319|FG002|Phase 2a|Progressive disease|0|||
48350038|NCT02895360|155477320|FG003|Phase 2a|Progressive disease|0|||
48675366|NCT03615066|156663458|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
48350039|NCT02895360|155477321|FG004|Phase 2a|Progressive disease|11|||
48350040|NCT02895360|155477322|FG005|Phase 2a|Progressive disease|11|||
48350041|NCT01844726|155477323|FG000|Overall Study|Withdrawal by Subject|0|||
48350042|NCT01844726|155477324|FG001|Overall Study|Withdrawal by Subject|1|||
48350043|NCT01844726|155477323|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
48350044|NCT01844726|155477324|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
48350045|NCT00469456|155477325|FG000|Overall Study|Adverse Event|4|||
48350046|NCT00469456|155477326|FG001|Overall Study|Adverse Event|3|||
48350047|NCT00469456|155477325|FG000|Overall Study|Protocol Violation|1|||
48350048|NCT00469456|155477326|FG001|Overall Study|Protocol Violation|0|||
48350049|NCT00469456|155477325|FG000|Overall Study|Withdrawal by Subject|4|||
48350050|NCT00469456|155477326|FG001|Overall Study|Withdrawal by Subject|1|||
48675367|NCT03615066|156663459|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
48675368|NCT03615066|156663460|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
48675369|NCT02104947|156663462|FG000|Overall Study|Withdrawal by Subject|10|||
48350051|NCT03634839|155477328|FG000|First Intervention (2 Hours)|Adverse Event|0|||
48350052|NCT03634839|155477329|FG001|First Intervention (2 Hours)|Adverse Event|2|||
48675370|NCT02104947|156663463|FG001|Overall Study|Withdrawal by Subject|3|||
48350053|NCT01776008|155477330|FG000|Overall Study|ineligible|2|||
48350054|NCT02804399|155477333|FG000|Period 2|Adverse Event|0|||
48350055|NCT02804399|155477334|FG001|Period 2|Adverse Event|1|||
48350056|NCT01163474|155477335|FG000|Overall Study|Withdrawal by Subject|1|||
48350057|NCT01163474|155477335|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
48350058|NCT01163474|155477335|FG000|Overall Study|Lost to Follow-up|3|||
48350059|NCT00358644|155477336|FG000|Overall Study|Progressive Disease|21|||
48350060|NCT00358644|155477336|FG000|Overall Study|Adverse Event|7|||
48350061|NCT00358644|155477336|FG000|Overall Study|Death|11|||
48350062|NCT00358644|155477336|FG000|Overall Study|Withdrawal by Subject|4|||
48350063|NCT00358644|155477336|FG000|Overall Study|Physician Decision|6|||
48350064|NCT00358644|155477336|FG000|Overall Study|Patient not eligible for study|1|||
48350065|NCT01427738|155477337|FG000|Overall Study|Death|12|||
48350066|NCT01427738|155477338|FG001|Overall Study|Death|9|||
48350067|NCT01427738|155477337|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48350068|NCT01427738|155477338|FG001|Overall Study|Severe debilitation, unable to continue|1|||
48350069|NCT01427738|155477337|FG000|Overall Study|Subject unable to get to clinic|5|||
48350070|NCT01427738|155477338|FG001|Overall Study|Subject unable to get to clinic|2|||
48350071|NCT01427738|155477337|FG000|Overall Study|Withdrawal by Subject|0|||
48350072|NCT01427738|155477338|FG001|Overall Study|Withdrawal by Subject|2|||
48350073|NCT01427738|155477337|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
48350074|NCT01427738|155477338|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
48350075|NCT01427738|155477337|FG000|Overall Study|Lost to Follow-up|1|||
48350076|NCT01427738|155477338|FG001|Overall Study|Lost to Follow-up|5|||
48675371|NCT02104947|156663462|FG000|Overall Study|Lost to Follow-up|4|||
48675372|NCT02104947|156663463|FG001|Overall Study|Lost to Follow-up|4|||
48675373|NCT02104947|156663462|FG000|Overall Study|Protocol Violation|6|||
48675374|NCT02104947|156663463|FG001|Overall Study|Protocol Violation|8|||
48675375|NCT02104947|156663462|FG000|Overall Study|Adverse Event|57|||
48675376|NCT02104947|156663463|FG001|Overall Study|Adverse Event|38|||
48350077|NCT00115336|155477340|FG000|Overall Study|Hospital discharge before study drug|0|||
48350078|NCT00115336|155477341|FG001|Overall Study|Hospital discharge before study drug|1|||
48350079|NCT03029819|155477342|FG000|Overall Study|Lost to Follow-up|3|||
48350080|NCT03029819|155477343|FG001|Overall Study|Lost to Follow-up|5|||
48350081|NCT03029819|155477342|FG000|Overall Study|Removed due to disruptive behavior|0|||
48350082|NCT03029819|155477343|FG001|Overall Study|Removed due to disruptive behavior|1|||
48350083|NCT01801982|155477344|FG000|Overall Study|Lost to Follow-up|1|||
48350084|NCT02881047|155477346|FG000|Overall Study|Adverse Event|1|||
48350085|NCT02881047|155477346|FG000|Overall Study|Withdrawal by Subject|1|||
48350086|NCT00585078|155477350|FG000|Overall Study|Withdrawal by Subject|4|||
48350087|NCT00585078|155477350|FG000|Overall Study|Poor performance status|1|||
48350088|NCT00585078|155477350|FG000|Overall Study|Disease Progression|24|||
48350089|NCT00585078|155477350|FG000|Overall Study|Adverse Event|10|||
48350090|NCT00585078|155477350|FG000|Overall Study|Death|1|||
48350091|NCT01536171|155477351|FG000|Overall Study|Withdrawal by Subject|1|||
48350092|NCT03783689|155477353|FG000|Overall Study|Adverse Event|2|||
48350093|NCT03783689|155477354|FG001|Overall Study|Adverse Event|0|||
48350094|NCT03783689|155477353|FG000|Overall Study|Lost to Follow-up|2|||
48350095|NCT03783689|155477354|FG001|Overall Study|Lost to Follow-up|1|||
48350096|NCT03783689|155477353|FG000|Overall Study|Physician Decision|2|||
48350097|NCT03783689|155477354|FG001|Overall Study|Physician Decision|1|||
48350098|NCT03783689|155477353|FG000|Overall Study|Withdrawal by Subject|3|||
48350099|NCT03783689|155477354|FG001|Overall Study|Withdrawal by Subject|3|||
48350100|NCT01813305|155477355|FG000|Overall Study|Withdrawal by Subject|12|||
48350101|NCT01813305|155477356|FG001|Overall Study|Withdrawal by Subject|5|||
48350102|NCT01813305|155477355|FG000|Overall Study|Safety Concern|4|||
48675377|NCT02104947|156663462|FG000|Overall Study|Other than stated above|2|||
48675378|NCT02104947|156663463|FG001|Overall Study|Other than stated above|3|||
48675379|NCT01844778|156663464|FG000|Overall Study|Protocol deviation|0|||
48675380|NCT01844778|156663465|FG001|Overall Study|Protocol deviation|1|||
48675381|NCT01844778|156663466|FG002|Overall Study|Protocol deviation|2|||
48675382|NCT01844778|156663464|FG000|Overall Study|Withdrawal by Subject|2|||
48675383|NCT01844778|156663465|FG001|Overall Study|Withdrawal by Subject|0|||
48675384|NCT01844778|156663466|FG002|Overall Study|Withdrawal by Subject|0|||
48675385|NCT01844778|156663464|FG000|Overall Study|Adverse Event|0|||
48675386|NCT01844778|156663465|FG001|Overall Study|Adverse Event|2|||
48675387|NCT01844778|156663466|FG002|Overall Study|Adverse Event|2|||
48675388|NCT00844558|156663470|FG000|Overall Study|Withdrawal by Subject|9|||
48675389|NCT00844558|156663471|FG001|Overall Study|Withdrawal by Subject|2|||
48675390|NCT00844558|156663470|FG000|Overall Study|Death|1|||
48675391|NCT00844558|156663471|FG001|Overall Study|Death|0|||
48675392|NCT00844558|156663470|FG000|Overall Study|Protocol Violation|1|||
48675393|NCT00844558|156663471|FG001|Overall Study|Protocol Violation|1|||
48675394|NCT00844558|156663470|FG000|Overall Study|Lost to Follow-up|0|||
48675395|NCT00844558|156663471|FG001|Overall Study|Lost to Follow-up|1|||
48675396|NCT00844558|156663470|FG000|Overall Study|Physician Decision|1|||
48675397|NCT00844558|156663471|FG001|Overall Study|Physician Decision|0|||
48675398|NCT01300260|156663477|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
48350103|NCT01813305|155477356|FG001|Overall Study|Safety Concern|0|||
48350104|NCT01813305|155477355|FG000|Overall Study|Ulcer became worse|4|||
48350105|NCT01813305|155477356|FG001|Overall Study|Ulcer became worse|0|||
48350106|NCT01813305|155477355|FG000|Overall Study|Physician Decision|4|||
48350107|NCT01813305|155477356|FG001|Overall Study|Physician Decision|0|||
48350108|NCT01813305|155477355|FG000|Overall Study|Lost to Follow-up|3|||
48350109|NCT01813305|155477356|FG001|Overall Study|Lost to Follow-up|1|||
48350110|NCT01813305|155477355|FG000|Overall Study|Protocol Violation|1|||
48350111|NCT01813305|155477356|FG001|Overall Study|Protocol Violation|0|||
48350112|NCT01813305|155477355|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
48350113|NCT01813305|155477356|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
48350114|NCT04594733|155477357|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48350115|NCT04594733|155477358|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
48350116|NCT04594733|155477357|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
48350117|NCT04594733|155477358|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
48350118|NCT04594733|155477357|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
48350119|NCT04594733|155477358|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
48350120|NCT03842436|155477361|FG000|Overall Study|Lost to Follow-up|1|||
48350121|NCT04969276|155477366|FG000|Overall Study|Protocol Deviation|0|||
48350122|NCT04969276|155477367|FG001|Overall Study|Protocol Deviation|1|||
48350123|NCT04969276|155477368|FG002|Overall Study|Protocol Deviation|0|||
48350124|NCT04969276|155477366|FG000|Overall Study|Withdrawal by Subject|1|||
48350125|NCT04969276|155477367|FG001|Overall Study|Withdrawal by Subject|10|||
48350126|NCT04969276|155477368|FG002|Overall Study|Withdrawal by Subject|0|||
48350127|NCT04969276|155477366|FG000|Overall Study|Lost to Follow-up|0|||
48350128|NCT04969276|155477367|FG001|Overall Study|Lost to Follow-up|1|||
48350129|NCT04969276|155477368|FG002|Overall Study|Lost to Follow-up|0|||
48350130|NCT01151423|155477369|FG000|Overall Study|Study terminated by Sponsor|9|||
48350131|NCT01151423|155477370|FG001|Overall Study|Study terminated by Sponsor|10|||
48350132|NCT01151423|155477369|FG000|Overall Study|Protocol Violation|0|||
48350133|NCT01151423|155477370|FG001|Overall Study|Protocol Violation|1|||
48350134|NCT01151423|155477369|FG000|Overall Study|Physician Decision|1|||
48350135|NCT01151423|155477370|FG001|Overall Study|Physician Decision|1|||
48350136|NCT01151423|155477369|FG000|Overall Study|Pregnancy|0|||
48350137|NCT01151423|155477370|FG001|Overall Study|Pregnancy|1|||
48350138|NCT01151423|155477369|FG000|Overall Study|Death|0|||
48350139|NCT01151423|155477370|FG001|Overall Study|Death|1|||
48350140|NCT01151423|155477369|FG000|Overall Study|Adverse Event|3|||
48350141|NCT01151423|155477370|FG001|Overall Study|Adverse Event|0|||
48350142|NCT01151423|155477369|FG000|Overall Study|Withdrawal by Subject|1|||
48350143|NCT01151423|155477370|FG001|Overall Study|Withdrawal by Subject|3|||
48350144|NCT01151423|155477369|FG000|Overall Study|Lost to Follow-up|1|||
48350145|NCT01151423|155477370|FG001|Overall Study|Lost to Follow-up|0|||
48350146|NCT01151423|155477369|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
48350147|NCT01151423|155477370|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
48350148|NCT01151423|155477369|FG000|Overall Study|Participated in other clinical trial|1|||
48350149|NCT01151423|155477370|FG001|Overall Study|Participated in other clinical trial|0|||
48350150|NCT03371823|155477371|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
48350151|NCT03371823|155477372|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
48350152|NCT01103232|155477373|FG000|Overall Study|Withdrawal by Subject|1|||
48350153|NCT01103232|155477374|FG001|Overall Study|Withdrawal by Subject|1|||
48350154|NCT01103232|155477373|FG000|Overall Study|Protocol Violation|0|||
48675399|NCT01300260|156663478|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
48675400|NCT01300260|156663477|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
48675401|NCT01300260|156663478|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
48675402|NCT01300260|156663477|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
48675403|NCT01300260|156663478|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
48675404|NCT01336023|156663482|FG000|Week 0 to Week 26|Adverse Event|8|||
48675405|NCT01336023|156663483|FG001|Week 0 to Week 26|Adverse Event|10|||
48675406|NCT01336023|156663484|FG002|Week 0 to Week 26|Adverse Event|24|||
48761917|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Physician Decision|0|||
48761918|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Physician Decision|0|||
48761919|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Physician Decision|0|||
48761920|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Physician Decision|1|||
48350155|NCT01103232|155477374|FG001|Overall Study|Protocol Violation|1|||
48350156|NCT01466790|155477376|FG000|Overall Study|Adverse Event|1|||
48350157|NCT01466790|155477377|FG001|Overall Study|Adverse Event|0|||
48350158|NCT01466790|155477378|FG002|Overall Study|Adverse Event|0|||
48350159|NCT01466790|155477379|FG003|Overall Study|Adverse Event|0|||
48350160|NCT01466790|155477380|FG004|Overall Study|Adverse Event|2|||
48350161|NCT01466790|155477381|FG005|Overall Study|Adverse Event|0|||
48761921|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Physician Decision|0|||
48350162|NCT01466790|155477382|FG006|Overall Study|Adverse Event|0|||
48350163|NCT01466790|155477383|FG007|Overall Study|Adverse Event|0|||
48350164|NCT01466790|155477376|FG000|Overall Study|Lost to Follow-up|2|||
48350165|NCT01466790|155477377|FG001|Overall Study|Lost to Follow-up|0|||
48350166|NCT01466790|155477378|FG002|Overall Study|Lost to Follow-up|0|||
48350167|NCT01466790|155477379|FG003|Overall Study|Lost to Follow-up|0|||
48350168|NCT01466790|155477380|FG004|Overall Study|Lost to Follow-up|0|||
48350169|NCT01466790|155477381|FG005|Overall Study|Lost to Follow-up|0|||
48350170|NCT01466790|155477382|FG006|Overall Study|Lost to Follow-up|0|||
48350171|NCT01466790|155477383|FG007|Overall Study|Lost to Follow-up|0|||
48350172|NCT01466790|155477376|FG000|Overall Study|Withdrawal by Subject|1|||
48350173|NCT01466790|155477377|FG001|Overall Study|Withdrawal by Subject|1|||
48350174|NCT01466790|155477378|FG002|Overall Study|Withdrawal by Subject|0|||
48350175|NCT01466790|155477379|FG003|Overall Study|Withdrawal by Subject|0|||
48350176|NCT01466790|155477380|FG004|Overall Study|Withdrawal by Subject|1|||
48350177|NCT01466790|155477381|FG005|Overall Study|Withdrawal by Subject|0|||
48350178|NCT01466790|155477382|FG006|Overall Study|Withdrawal by Subject|1|||
48350179|NCT01466790|155477383|FG007|Overall Study|Withdrawal by Subject|1|||
48350180|NCT01263054|155477385|FG000|Overall Study|Death|1|||
48350181|NCT01263054|155477386|FG001|Overall Study|Death|0|||
48350182|NCT01263054|155477385|FG000|Overall Study|Lost to Follow-up|2|||
48350183|NCT01263054|155477386|FG001|Overall Study|Lost to Follow-up|2|||
48350184|NCT01263054|155477385|FG000|Overall Study|Withdrawal by Subject|1|||
48350185|NCT01263054|155477386|FG001|Overall Study|Withdrawal by Subject|3|||
48350186|NCT01263054|155477385|FG000|Overall Study|Qualification Violation|1|||
48350187|NCT01263054|155477386|FG001|Overall Study|Qualification Violation|0|||
48350188|NCT01263054|155477385|FG000|Overall Study|Other|0|||
48350189|NCT01263054|155477386|FG001|Overall Study|Other|1|||
48350190|NCT01310699|155477387|FG000|Overall Study|Patients did not complete tandem.|4|||
48350191|NCT01310699|155477388|FG001|Overall Study|Patients did not complete tandem.|6|||
48350192|NCT00936598|155477389|FG000|Overall Study|Withdrawal by Subject|1|||
48350193|NCT00936598|155477390|FG001|Overall Study|Withdrawal by Subject|0|||
48350194|NCT00936598|155477389|FG000|Overall Study|Ineligible after consent|1|||
48350195|NCT00936598|155477390|FG001|Overall Study|Ineligible after consent|0|||
48350196|NCT02386839|155477391|FG000|Overall Study|Death|1|||
48350197|NCT02386839|155477392|FG001|Overall Study|Death|0|||
48350198|NCT02386839|155477391|FG000|Overall Study|Withdrawal by Subject|9|||
48350199|NCT02386839|155477392|FG001|Overall Study|Withdrawal by Subject|10|||
48350200|NCT02386839|155477391|FG000|Overall Study|Lost to Follow-up|4|||
48350201|NCT02386839|155477392|FG001|Overall Study|Lost to Follow-up|4|||
48350202|NCT02386839|155477391|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
48350203|NCT02386839|155477392|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
48350204|NCT02386839|155477391|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
48350205|NCT02386839|155477392|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
48350206|NCT02386839|155477391|FG000|Overall Study|Other (unspecified)|1|||
48350207|NCT02386839|155477392|FG001|Overall Study|Other (unspecified)|0|||
48350208|NCT00926575|155477393|FG000|Overall Study|Adverse Event|1|||
48350209|NCT00926575|155477394|FG001|Overall Study|Adverse Event|1|||
48350210|NCT00926575|155477393|FG000|Overall Study|Death|4|||
48350211|NCT00926575|155477394|FG001|Overall Study|Death|4|||
48350212|NCT00926575|155477393|FG000|Overall Study|Lost to Follow-up|1|||
48350213|NCT00926575|155477394|FG001|Overall Study|Lost to Follow-up|1|||
48350214|NCT00926575|155477393|FG000|Overall Study|Physician Decision|1|||
48350215|NCT00926575|155477394|FG001|Overall Study|Physician Decision|2|||
48350216|NCT00926575|155477393|FG000|Overall Study|Protocol Violation|1|||
48350217|NCT00926575|155477394|FG001|Overall Study|Protocol Violation|0|||
48350218|NCT00926575|155477393|FG000|Overall Study|Withdrawal by Subject|8|||
48350219|NCT00926575|155477394|FG001|Overall Study|Withdrawal by Subject|9|||
48350220|NCT03128671|155477407|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
48350221|NCT03128671|155477408|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
48350222|NCT03128671|155477407|FG000|Allocation|Death|1|||
48350223|NCT03128671|155477408|FG001|Allocation|Death|0|||
48350224|NCT03128671|155477407|FG000|Allocation|Withdrawal by Subject|4|||
48350225|NCT03128671|155477408|FG001|Allocation|Withdrawal by Subject|0|||
48350226|NCT03128671|155477407|FG000|Intervention|Withdrawal by Subject|11|||
48350227|NCT03128671|155477408|FG001|Intervention|Withdrawal by Subject|10|||
48350228|NCT03128671|155477407|FG000|Intervention|Palliative/hospice care initiated|9|||
48350229|NCT03128671|155477408|FG001|Intervention|Palliative/hospice care initiated|10|||
48350230|NCT03128671|155477407|FG000|Intervention|Death|13|||
48350231|NCT03128671|155477408|FG001|Intervention|Death|11|||
48350232|NCT03128671|155477407|FG000|Intervention|Interrupted by hurricane|1|||
48350233|NCT03128671|155477408|FG001|Intervention|Interrupted by hurricane|0|||
48350234|NCT03128671|155477407|FG000|Intervention|Physician Decision|2|||
48350235|NCT03128671|155477408|FG001|Intervention|Physician Decision|3|||
48350236|NCT00738283|155477413|FG000|Overall Study|Death|1|||
48350237|NCT00738283|155477413|FG000|Overall Study|Transfer to another facility|2|||
48350238|NCT00738283|155477413|FG000|Overall Study|Discharge home prior to end of study|1|||
48350239|NCT00583947|155477414|FG000|Cross-over Period|Adverse Event|2|||
48350240|NCT00583947|155477415|FG001|Cross-over Period|Adverse Event|0|||
48350241|NCT00583947|155477414|FG000|Cross-over Period|Withdrawal by Subject|2|||
48350242|NCT00583947|155477415|FG001|Cross-over Period|Withdrawal by Subject|0|||
48675407|NCT01336023|156663482|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
48761922|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Physician Decision|0|||
48761923|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
48350243|NCT00583947|155477414|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
48350244|NCT00583947|155477415|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
48350245|NCT00583947|155477414|FG000|Cross-over Period|Other|1|||
48350246|NCT00583947|155477415|FG001|Cross-over Period|Other|1|||
48350247|NCT01261247|155477416|FG000|Overall Study|Ineligible|2|||
48350248|NCT01740154|155477417|FG000|Overall Study|Adverse Event|1|||
48350249|NCT00469859|155477418|FG000|Overall Study|Inevaluable|0|||
48350250|NCT00469859|155477419|FG001|Overall Study|Inevaluable|2|||
48350251|NCT02520310|155477420|FG000|At 6 Months Clinical Follow-up|Death|1|||
48350252|NCT02520310|155477420|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
48350253|NCT02520310|155477420|FG000|AT 3 Year Clinical Follow-up|Death|2|||
48350254|NCT02520310|155477420|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
48350255|NCT02520310|155477420|FG000|AT 4 Year Clinical Follow-up|Death|1|||
48350256|NCT02520310|155477420|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
48350257|NCT02575950|155477421|FG000|Overall Study|Withdrawal by Subject|0|||
48350258|NCT02575950|155477422|FG001|Overall Study|Withdrawal by Subject|0|||
48350259|NCT02575950|155477423|FG002|Overall Study|Withdrawal by Subject|0|||
48350260|NCT02575950|155477424|FG003|Overall Study|Withdrawal by Subject|2|||
48350261|NCT02575950|155477421|FG000|Overall Study|Lost to Follow-up|0|||
48350262|NCT02575950|155477422|FG001|Overall Study|Lost to Follow-up|1|||
48350263|NCT02575950|155477423|FG002|Overall Study|Lost to Follow-up|0|||
48350264|NCT02575950|155477424|FG003|Overall Study|Lost to Follow-up|3|||
48350265|NCT01124838|155477429|FG000|Overall Study|Miscellaneous|4|||
48350266|NCT01124838|155477430|FG001|Overall Study|Miscellaneous|2|||
48350267|NCT01124838|155477429|FG000|Overall Study|Adverse Event|7|||
48350268|NCT01124838|155477430|FG001|Overall Study|Adverse Event|11|||
48761924|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
48761925|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
48761926|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
48761927|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
48761928|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
48350269|NCT01124838|155477429|FG000|Overall Study|Lack of Efficacy|2|||
48350270|NCT01124838|155477430|FG001|Overall Study|Lack of Efficacy|0|||
48350271|NCT01124838|155477429|FG000|Overall Study|Withdrawal by Subject|3|||
48350272|NCT01124838|155477430|FG001|Overall Study|Withdrawal by Subject|2|||
48350273|NCT01124838|155477429|FG000|Overall Study|Lost to Follow-up|2|||
48350274|NCT01124838|155477430|FG001|Overall Study|Lost to Follow-up|0|||
48761929|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
48350275|NCT03020069|155480142|FG000|Overall Study|Lost to Follow-up|0|||
48675408|NCT01336023|156663483|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
48675409|NCT01336023|156663484|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
48675410|NCT01336023|156663482|FG000|Week 0 to Week 26|Protocol Violation|1|||
48675411|NCT01336023|156663483|FG001|Week 0 to Week 26|Protocol Violation|2|||
48350276|NCT03020069|155480143|FG001|Overall Study|Lost to Follow-up|1|||
48350277|NCT03546816|155480144|FG000|Overall Study|Adverse Event|5|||
48350278|NCT03546816|155480145|FG001|Overall Study|Adverse Event|3|||
48350279|NCT03546816|155480144|FG000|Overall Study|Lack of Efficacy|2|||
48350280|NCT03546816|155480145|FG001|Overall Study|Lack of Efficacy|4|||
48350281|NCT03546816|155480144|FG000|Overall Study|Pregnancy|1|||
48350282|NCT03546816|155480145|FG001|Overall Study|Pregnancy|0|||
48350283|NCT03546816|155480144|FG000|Overall Study|Physician Decision|2|||
48350284|NCT03546816|155480145|FG001|Overall Study|Physician Decision|0|||
48350285|NCT03546816|155480144|FG000|Overall Study|Withdrawal by Subject|8|||
48350286|NCT03546816|155480145|FG001|Overall Study|Withdrawal by Subject|10|||
48350287|NCT03546816|155480144|FG000|Overall Study|Lost to Follow-up|3|||
48350288|NCT03546816|155480145|FG001|Overall Study|Lost to Follow-up|2|||
48350289|NCT03596242|155480146|FG000|Overall Study|Lost to Follow-up|2|||
48350290|NCT03596242|155480147|FG001|Overall Study|Lost to Follow-up|2|||
48350291|NCT02438371|155480148|FG000|Overall Study|Lost to Follow-up|3|||
48350292|NCT02438371|155480149|FG001|Overall Study|Lost to Follow-up|2|||
48350293|NCT02438371|155480148|FG000|Overall Study|Withdrawal by Subject|1|||
48350294|NCT02438371|155480149|FG001|Overall Study|Withdrawal by Subject|1|||
48350295|NCT03297398|155480152|FG000|Overall Study|Sponsor's decision|6|||
48350296|NCT03297398|155480153|FG001|Overall Study|Sponsor's decision|9|||
48350297|NCT03297398|155480154|FG002|Overall Study|Sponsor's decision|7|||
48350298|NCT03297398|155480152|FG000|Overall Study|Adverse Event|1|||
48350299|NCT03297398|155480153|FG001|Overall Study|Adverse Event|4|||
48350300|NCT03297398|155480154|FG002|Overall Study|Adverse Event|4|||
48350301|NCT03297398|155480152|FG000|Overall Study|Withdrawal by Subject|1|||
48350302|NCT03297398|155480153|FG001|Overall Study|Withdrawal by Subject|2|||
48350303|NCT03297398|155480154|FG002|Overall Study|Withdrawal by Subject|2|||
48350304|NCT03297398|155480152|FG000|Overall Study|Protocol Violation|0|||
48350305|NCT03297398|155480153|FG001|Overall Study|Protocol Violation|2|||
48350306|NCT03297398|155480154|FG002|Overall Study|Protocol Violation|0|||
48350307|NCT03297398|155480152|FG000|Overall Study|Physician Decision|0|||
48350308|NCT03297398|155480153|FG001|Overall Study|Physician Decision|0|||
48350309|NCT03297398|155480154|FG002|Overall Study|Physician Decision|1|||
48350310|NCT03297398|155480152|FG000|Overall Study|Lost to Follow-up|0|||
48350311|NCT03297398|155480153|FG001|Overall Study|Lost to Follow-up|0|||
48350312|NCT03297398|155480154|FG002|Overall Study|Lost to Follow-up|1|||
48350313|NCT00810342|155480157|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
48350314|NCT00810342|155480158|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
48350315|NCT00810342|155480157|FG000|Month 1 Follow-up|Pregnancy|1|||
48350316|NCT00810342|155480158|FG001|Month 1 Follow-up|Pregnancy|0|||
48350317|NCT00810342|155480157|FG000|6-month Follow-up|Lost to Follow-up|18|||
48350318|NCT00810342|155480158|FG001|6-month Follow-up|Lost to Follow-up|6|||
48350319|NCT00810342|155480157|FG000|6-month Follow-up|Pregnancy|6|||
48350320|NCT00810342|155480158|FG001|6-month Follow-up|Pregnancy|2|||
48675412|NCT01336023|156663484|FG002|Week 0 to Week 26|Protocol Violation|0|||
48350321|NCT00810342|155480157|FG000|12-month Followup|Pregnancy|9|||
48350322|NCT00810342|155480158|FG001|12-month Followup|Pregnancy|10|||
48350323|NCT00810342|155480157|FG000|12-month Followup|Lost to Follow-up|3|||
48350324|NCT00810342|155480158|FG001|12-month Followup|Lost to Follow-up|1|||
48350325|NCT04486313|155480159|FG000|Overall Study|Lost to Follow-up|7|||
48350326|NCT04486313|155480160|FG001|Overall Study|Lost to Follow-up|9|||
48350327|NCT04486313|155480159|FG000|Overall Study|Withdrawal by Subject|8|||
48350328|NCT04486313|155480160|FG001|Overall Study|Withdrawal by Subject|6|||
48350329|NCT04486313|155480159|FG000|Overall Study|Physician Decision|1|||
48350330|NCT04486313|155480160|FG001|Overall Study|Physician Decision|1|||
48350331|NCT04486313|155480159|FG000|Overall Study|Death|2|||
48350332|NCT04486313|155480160|FG001|Overall Study|Death|0|||
48350333|NCT04486313|155480159|FG000|Overall Study|Protocol Violation|1|||
48350334|NCT04486313|155480160|FG001|Overall Study|Protocol Violation|1|||
48350335|NCT00916305|155480169|FG000|Overall Study|Lost to Follow-up|21|||
48350336|NCT00916305|155480170|FG001|Overall Study|Lost to Follow-up|27|||
48350337|NCT00916305|155480169|FG000|Overall Study|Withdrawal by Subject|0|||
48350338|NCT00916305|155480170|FG001|Overall Study|Withdrawal by Subject|1|||
48350339|NCT00307164|155480173|FG000|Overall Study|Death|1|||
48350340|NCT00307164|155480174|FG001|Overall Study|Death|0|||
48350341|NCT00307164|155480173|FG000|Overall Study|Severe debilitation, unable to continue|1|||
48350342|NCT00307164|155480174|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48350343|NCT00307164|155480173|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
48350344|NCT00307164|155480174|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
48350345|NCT00307164|155480173|FG000|Overall Study|Withdrawal by Subject|1|||
48350346|NCT00307164|155480174|FG001|Overall Study|Withdrawal by Subject|8|||
48350347|NCT00307164|155480173|FG000|Overall Study|Not compliant with requirements|4|||
48350348|NCT00307164|155480174|FG001|Overall Study|Not compliant with requirements|4|||
48350349|NCT00307164|155480173|FG000|Overall Study|Lost to Follow-up|6|||
48350350|NCT00307164|155480174|FG001|Overall Study|Lost to Follow-up|1|||
48350351|NCT00490945|155480175|FG000|Overall Study|Adverse Event|0|||
48350352|NCT00490945|155480176|FG001|Overall Study|Adverse Event|1|||
48350353|NCT00490945|155480177|FG002|Overall Study|Adverse Event|0|||
48350354|NCT00490945|155480178|FG003|Overall Study|Adverse Event|0|||
48350355|NCT00490945|155480179|FG004|Overall Study|Adverse Event|0|||
48350356|NCT01496365|155480182|FG000|Overall Study|Adverse Event|2|||
48350357|NCT01496365|155480183|FG001|Overall Study|Adverse Event|3|||
48350358|NCT01496365|155480184|FG002|Overall Study|Adverse Event|3|||
48350359|NCT01496365|155480185|FG003|Overall Study|Adverse Event|2|||
48350360|NCT01496365|155480186|FG004|Overall Study|Adverse Event|5|||
48350361|NCT01496365|155480187|FG005|Overall Study|Adverse Event|6|||
48350362|NCT01496365|155480188|FG006|Overall Study|Adverse Event|4|||
48350363|NCT01496365|155480182|FG000|Overall Study|Withdrawal by Subject|6|||
48350364|NCT01496365|155480183|FG001|Overall Study|Withdrawal by Subject|6|||
48350365|NCT01496365|155480184|FG002|Overall Study|Withdrawal by Subject|0|||
48350366|NCT01496365|155480185|FG003|Overall Study|Withdrawal by Subject|1|||
48350367|NCT01496365|155480186|FG004|Overall Study|Withdrawal by Subject|3|||
48350368|NCT01496365|155480187|FG005|Overall Study|Withdrawal by Subject|2|||
48350369|NCT01496365|155480188|FG006|Overall Study|Withdrawal by Subject|1|||
48350370|NCT01496365|155480182|FG000|Overall Study|Protocol Violation|2|||
48350371|NCT01496365|155480183|FG001|Overall Study|Protocol Violation|1|||
48350372|NCT01496365|155480184|FG002|Overall Study|Protocol Violation|1|||
48350373|NCT01496365|155480185|FG003|Overall Study|Protocol Violation|0|||
48350374|NCT01496365|155480186|FG004|Overall Study|Protocol Violation|0|||
48350375|NCT01496365|155480187|FG005|Overall Study|Protocol Violation|1|||
48350376|NCT01496365|155480188|FG006|Overall Study|Protocol Violation|0|||
48350377|NCT01496365|155480182|FG000|Overall Study|Lack of Efficacy|1|||
48350378|NCT01496365|155480183|FG001|Overall Study|Lack of Efficacy|0|||
48350379|NCT01496365|155480184|FG002|Overall Study|Lack of Efficacy|0|||
48350380|NCT01496365|155480185|FG003|Overall Study|Lack of Efficacy|0|||
48350381|NCT01496365|155480186|FG004|Overall Study|Lack of Efficacy|0|||
48350382|NCT01496365|155480187|FG005|Overall Study|Lack of Efficacy|1|||
48350383|NCT01496365|155480188|FG006|Overall Study|Lack of Efficacy|0|||
48350384|NCT01496365|155480182|FG000|Overall Study|Lost to Follow-up|0|||
48350385|NCT01496365|155480183|FG001|Overall Study|Lost to Follow-up|1|||
48350386|NCT01496365|155480184|FG002|Overall Study|Lost to Follow-up|0|||
48350387|NCT01496365|155480185|FG003|Overall Study|Lost to Follow-up|0|||
48350388|NCT01496365|155480186|FG004|Overall Study|Lost to Follow-up|2|||
48350389|NCT01496365|155480187|FG005|Overall Study|Lost to Follow-up|0|||
48350390|NCT01496365|155480188|FG006|Overall Study|Lost to Follow-up|0|||
48350391|NCT01496365|155480182|FG000|Overall Study|Other|4|||
48350392|NCT01496365|155480183|FG001|Overall Study|Other|4|||
48350393|NCT01496365|155480184|FG002|Overall Study|Other|2|||
48350394|NCT01496365|155480185|FG003|Overall Study|Other|1|||
48350395|NCT01496365|155480186|FG004|Overall Study|Other|3|||
48350396|NCT01496365|155480187|FG005|Overall Study|Other|0|||
48350397|NCT01496365|155480188|FG006|Overall Study|Other|1|||
48350398|NCT03712449|155480192|FG000|Overall Study|Withdraw Consent|0|||
48350399|NCT03712449|155480193|FG001|Overall Study|Withdraw Consent|1|||
48350400|NCT02706951|155480194|FG000|Period 1|Adverse Event|1|||
48350401|NCT02706951|155480195|FG001|Period 1|Adverse Event|5|||
48350402|NCT02706951|155480196|FG002|Period 1|Adverse Event|3|||
48350403|NCT02706951|155480197|FG003|Period 1|Adverse Event|0|||
48350404|NCT02706951|155480198|FG004|Period 1|Adverse Event|0|||
48350405|NCT02706951|155480194|FG000|Period 1|Withdrawal by Subject|10|||
48350406|NCT02706951|155480195|FG001|Period 1|Withdrawal by Subject|6|||
48350407|NCT02706951|155480196|FG002|Period 1|Withdrawal by Subject|6|||
48350408|NCT02706951|155480197|FG003|Period 1|Withdrawal by Subject|0|||
48350409|NCT02706951|155480198|FG004|Period 1|Withdrawal by Subject|0|||
48761930|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
48761931|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761932|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761933|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761934|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761935|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761936|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
48761937|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
48761938|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
48761939|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761940|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761941|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761942|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761943|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
48761944|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
48350410|NCT02706951|155480194|FG000|Period 1|Lost to Follow-up|0|||
48350411|NCT02706951|155480195|FG001|Period 1|Lost to Follow-up|4|||
48350412|NCT02706951|155480196|FG002|Period 1|Lost to Follow-up|1|||
48350413|NCT02706951|155480197|FG003|Period 1|Lost to Follow-up|0|||
48350414|NCT02706951|155480198|FG004|Period 1|Lost to Follow-up|0|||
48350415|NCT02706951|155480194|FG000|Period 1|Other|2|||
48350416|NCT02706951|155480195|FG001|Period 1|Other|1|||
48350417|NCT02706951|155480196|FG002|Period 1|Other|0|||
48350418|NCT02706951|155480197|FG003|Period 1|Other|0|||
48350419|NCT02706951|155480198|FG004|Period 1|Other|0|||
48350420|NCT02706951|155480194|FG000|Period 2|Adverse Event|0|||
48350421|NCT02706951|155480195|FG001|Period 2|Adverse Event|0|||
48350422|NCT02706951|155480196|FG002|Period 2|Adverse Event|0|||
48350423|NCT02706951|155480197|FG003|Period 2|Adverse Event|25|||
48350424|NCT02706951|155480198|FG004|Period 2|Adverse Event|34|||
48350425|NCT02706951|155480194|FG000|Period 2|Withdrawal by Subject|0|||
48350426|NCT02706951|155480195|FG001|Period 2|Withdrawal by Subject|0|||
48350427|NCT02706951|155480196|FG002|Period 2|Withdrawal by Subject|0|||
48350428|NCT02706951|155480197|FG003|Period 2|Withdrawal by Subject|38|||
48350429|NCT02706951|155480198|FG004|Period 2|Withdrawal by Subject|44|||
48350430|NCT02706951|155480194|FG000|Period 2|Lost to Follow-up|0|||
48350431|NCT02706951|155480195|FG001|Period 2|Lost to Follow-up|0|||
48350432|NCT02706951|155480196|FG002|Period 2|Lost to Follow-up|0|||
48350433|NCT02706951|155480197|FG003|Period 2|Lost to Follow-up|17|||
48350434|NCT02706951|155480198|FG004|Period 2|Lost to Follow-up|9|||
48350435|NCT02706951|155480194|FG000|Period 2|COVID-19 Related|0|||
48350436|NCT02706951|155480195|FG001|Period 2|COVID-19 Related|0|||
48350437|NCT02706951|155480196|FG002|Period 2|COVID-19 Related|0|||
48350438|NCT02706951|155480197|FG003|Period 2|COVID-19 Related|1|||
48350439|NCT02706951|155480198|FG004|Period 2|COVID-19 Related|2|||
48350440|NCT02706951|155480194|FG000|Period 2|Other|0|||
48350441|NCT02706951|155480195|FG001|Period 2|Other|0|||
48350442|NCT02706951|155480196|FG002|Period 2|Other|0|||
48350443|NCT02706951|155480197|FG003|Period 2|Other|37|||
48350444|NCT02706951|155480198|FG004|Period 2|Other|31|||
48350445|NCT00666198|155480201|FG000|Overall Study|Protocol Violation|10|||
48350446|NCT00666198|155480201|FG000|Overall Study|No Visit After First Day of Treatment|13|||
48350447|NCT00666198|155480201|FG000|Overall Study|Safety Not Assessable|6|||
48350448|NCT00666198|155480201|FG000|Overall Study|No Drug Administration|4|||
48350449|NCT02165397|155480202|FG000|Overall Study|Death|7|||
48350450|NCT02165397|155480203|FG001|Overall Study|Death|10|||
48350451|NCT02165397|155480204|FG002|Overall Study|Death|8|||
48350452|NCT02165397|155480202|FG000|Overall Study|Lost to Follow-up|1|||
48350453|NCT02165397|155480203|FG001|Overall Study|Lost to Follow-up|3|||
48350454|NCT02165397|155480204|FG002|Overall Study|Lost to Follow-up|0|||
48350455|NCT02165397|155480202|FG000|Overall Study|Withdrawal by Subject|6|||
48350456|NCT02165397|155480203|FG001|Overall Study|Withdrawal by Subject|6|||
48350457|NCT02165397|155480204|FG002|Overall Study|Withdrawal by Subject|1|||
48350458|NCT02165397|155480202|FG000|Overall Study|Other, Not Specified|0|||
48350459|NCT02165397|155480203|FG001|Overall Study|Other, Not Specified|0|||
48350460|NCT02165397|155480204|FG002|Overall Study|Other, Not Specified|1|||
48350461|NCT00236184|155480205|FG000|Overall Study|Adverse Event|5|||
48350462|NCT00236184|155480206|FG001|Overall Study|Adverse Event|2|||
48350463|NCT00236184|155480205|FG000|Overall Study|Lack of Efficacy|0|||
48350464|NCT00236184|155480206|FG001|Overall Study|Lack of Efficacy|1|||
48350465|NCT00236184|155480205|FG000|Overall Study|Lost to Follow-up|3|||
48350466|NCT00236184|155480206|FG001|Overall Study|Lost to Follow-up|4|||
48350467|NCT00236184|155480205|FG000|Overall Study|Physician Decision|1|||
48350468|NCT00236184|155480206|FG001|Overall Study|Physician Decision|1|||
48350469|NCT00236184|155480205|FG000|Overall Study|Withdrawal by Subject|3|||
48350470|NCT00236184|155480206|FG001|Overall Study|Withdrawal by Subject|0|||
48350471|NCT00236184|155480205|FG000|Overall Study|Protocol Violation|3|||
48350472|NCT00236184|155480206|FG001|Overall Study|Protocol Violation|0|||
48350473|NCT00236184|155480205|FG000|Overall Study|non-compliance with study drug|2|||
48350474|NCT00236184|155480206|FG001|Overall Study|non-compliance with study drug|1|||
48350475|NCT00236184|155480205|FG000|Overall Study|other|1|||
48350476|NCT00236184|155480206|FG001|Overall Study|other|2|||
48350477|NCT00233389|155480209|FG000|Overall Study|Adverse Event|5|||
48350478|NCT00233389|155480210|FG001|Overall Study|Adverse Event|5|||
48350479|NCT00233389|155480209|FG000|Overall Study|Lack of Efficacy|11|||
48350480|NCT00233389|155480210|FG001|Overall Study|Lack of Efficacy|8|||
48350481|NCT00233389|155480209|FG000|Overall Study|Lost to Follow-up|1|||
48350482|NCT00233389|155480210|FG001|Overall Study|Lost to Follow-up|1|||
48350483|NCT00233389|155480209|FG000|Overall Study|Physician Decision|1|||
48350484|NCT00233389|155480210|FG001|Overall Study|Physician Decision|0|||
48350485|NCT00233389|155480209|FG000|Overall Study|Protocol Violation|0|||
48350486|NCT00233389|155480210|FG001|Overall Study|Protocol Violation|1|||
48350487|NCT00233389|155480209|FG000|Overall Study|Withdrawal by Subject|0|||
48350488|NCT00233389|155480210|FG001|Overall Study|Withdrawal by Subject|1|||
48350489|NCT04962698|155480218|FG000|Motor Imagery|Technical difficulty|1|||
48350490|NCT04962698|155480219|FG001|Motor Imagery|Technical difficulty|0|||
48350491|NCT04962698|155480218|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
48350492|NCT04962698|155480219|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
48350493|NCT04962698|155480218|FG000|Kinesthetic MI|Technical difficulty|1|||
48350494|NCT04962698|155480219|FG001|Kinesthetic MI|Technical difficulty|0|||
48350495|NCT04962698|155480218|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
48350496|NCT04962698|155480219|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
48350497|NCT04962698|155480218|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
48350498|NCT04962698|155480219|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
48350499|NCT04962698|155480218|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
48350500|NCT04962698|155480219|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
48350501|NCT04962698|155480218|FG000|Virtual-hand Interaction|Technical difficulty|1|||
48350502|NCT04962698|155480219|FG001|Virtual-hand Interaction|Technical difficulty|0|||
48350503|NCT04962698|155480218|FG000|Robotic Action Observation|Technical difficulty|1|||
48350504|NCT04962698|155480219|FG001|Robotic Action Observation|Technical difficulty|0|||
48350505|NCT04962698|155480218|FG000|Rest|Technical difficulty|1|||
48350506|NCT04962698|155480219|FG001|Rest|Technical difficulty|0|||
48350507|NCT04962698|155480218|FG000|Rest|Exclusion criteria met after enrollment|0|||
48350508|NCT04962698|155480219|FG001|Rest|Exclusion criteria met after enrollment|2|||
48350509|NCT02560389|155480223|FG000|Overall Study|Lost to Follow-up|1|||
48350510|NCT02560389|155480224|FG001|Overall Study|Lost to Follow-up|2|||
48350511|NCT02560389|155480225|FG002|Overall Study|Lost to Follow-up|2|||
48350512|NCT02560389|155480223|FG000|Overall Study|Tested positive for illicit substance|0|||
48350513|NCT02560389|155480224|FG001|Overall Study|Tested positive for illicit substance|1|||
48350514|NCT02560389|155480225|FG002|Overall Study|Tested positive for illicit substance|0|||
48350515|NCT00550446|155480226|FG000|Up To Week 12|Adverse Event|2|||
48350516|NCT00550446|155480227|FG001|Up To Week 12|Adverse Event|2|||
48350517|NCT00550446|155480228|FG002|Up To Week 12|Adverse Event|0|||
48350518|NCT00550446|155480229|FG003|Up To Week 12|Adverse Event|0|||
48350519|NCT00550446|155480230|FG004|Up To Week 12|Adverse Event|2|||
48350520|NCT00550446|155480231|FG005|Up To Week 12|Adverse Event|2|||
48350521|NCT00550446|155480232|FG006|Up To Week 12|Adverse Event|1|||
48350522|NCT00550446|155480233|FG007|Up To Week 12|Adverse Event|0|||
48350523|NCT00550446|155480234|FG008|Up To Week 12|Adverse Event|0|||
48350524|NCT00550446|155480235|FG009|Up To Week 12|Adverse Event|0|||
48350525|NCT00550446|155480236|FG010|Up To Week 12|Adverse Event|0|||
48350526|NCT00550446|155480226|FG000|Up To Week 12|Lack of Efficacy|3|||
48350527|NCT00550446|155480227|FG001|Up To Week 12|Lack of Efficacy|1|||
48350528|NCT00550446|155480228|FG002|Up To Week 12|Lack of Efficacy|0|||
48350529|NCT00550446|155480229|FG003|Up To Week 12|Lack of Efficacy|1|||
48350530|NCT00550446|155480230|FG004|Up To Week 12|Lack of Efficacy|0|||
48350531|NCT00550446|155480231|FG005|Up To Week 12|Lack of Efficacy|3|||
48350532|NCT00550446|155480232|FG006|Up To Week 12|Lack of Efficacy|3|||
48350533|NCT00550446|155480233|FG007|Up To Week 12|Lack of Efficacy|0|||
48350534|NCT00550446|155480234|FG008|Up To Week 12|Lack of Efficacy|0|||
48350535|NCT00550446|155480235|FG009|Up To Week 12|Lack of Efficacy|0|||
48350536|NCT00550446|155480236|FG010|Up To Week 12|Lack of Efficacy|0|||
48350537|NCT00550446|155480226|FG000|Up To Week 12|Lost to Follow-up|0|||
48350538|NCT00550446|155480227|FG001|Up To Week 12|Lost to Follow-up|1|||
48350539|NCT00550446|155480228|FG002|Up To Week 12|Lost to Follow-up|0|||
48350540|NCT00550446|155480229|FG003|Up To Week 12|Lost to Follow-up|0|||
48350541|NCT00550446|155480230|FG004|Up To Week 12|Lost to Follow-up|1|||
48350542|NCT00550446|155480231|FG005|Up To Week 12|Lost to Follow-up|1|||
48350543|NCT00550446|155480232|FG006|Up To Week 12|Lost to Follow-up|2|||
48350544|NCT00550446|155480233|FG007|Up To Week 12|Lost to Follow-up|0|||
48675413|NCT01336023|156663482|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
48675414|NCT01336023|156663483|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
48675415|NCT01336023|156663484|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
48675416|NCT01336023|156663482|FG000|Week 0 to Week 26|Unclassified|5|||
48675417|NCT01336023|156663483|FG001|Week 0 to Week 26|Unclassified|16|||
48675418|NCT01336023|156663484|FG002|Week 0 to Week 26|Unclassified|9|||
48675419|NCT01336023|156663482|FG000|Week 27 to 52|Adverse Event|1|||
48675420|NCT01336023|156663483|FG001|Week 27 to 52|Adverse Event|5|||
48675421|NCT01336023|156663484|FG002|Week 27 to 52|Adverse Event|2|||
48675422|NCT01336023|156663482|FG000|Week 27 to 52|Protocol Violation|0|||
48675423|NCT01336023|156663483|FG001|Week 27 to 52|Protocol Violation|2|||
48675424|NCT01336023|156663484|FG002|Week 27 to 52|Protocol Violation|1|||
48675425|NCT01336023|156663482|FG000|Week 27 to 52|Withdrawal Criteria|14|||
48675426|NCT01336023|156663483|FG001|Week 27 to 52|Withdrawal Criteria|19|||
48675427|NCT01336023|156663484|FG002|Week 27 to 52|Withdrawal Criteria|16|||
48350545|NCT00550446|155480234|FG008|Up To Week 12|Lost to Follow-up|0|||
48350546|NCT00550446|155480235|FG009|Up To Week 12|Lost to Follow-up|0|||
48350547|NCT00550446|155480236|FG010|Up To Week 12|Lost to Follow-up|0|||
48350548|NCT00550446|155480226|FG000|Up To Week 12|Withdrawal by Subject|2|||
48350549|NCT00550446|155480227|FG001|Up To Week 12|Withdrawal by Subject|0|||
48350550|NCT00550446|155480228|FG002|Up To Week 12|Withdrawal by Subject|3|||
48350551|NCT00550446|155480229|FG003|Up To Week 12|Withdrawal by Subject|2|||
48350552|NCT00550446|155480230|FG004|Up To Week 12|Withdrawal by Subject|0|||
48675428|NCT01336023|156663482|FG000|Week 27 to 52|Unclassified|13|||
48350553|NCT00550446|155480231|FG005|Up To Week 12|Withdrawal by Subject|1|||
48350554|NCT00550446|155480232|FG006|Up To Week 12|Withdrawal by Subject|3|||
48350555|NCT00550446|155480233|FG007|Up To Week 12|Withdrawal by Subject|0|||
48350556|NCT00550446|155480234|FG008|Up To Week 12|Withdrawal by Subject|0|||
48350557|NCT00550446|155480235|FG009|Up To Week 12|Withdrawal by Subject|0|||
48350558|NCT00550446|155480236|FG010|Up To Week 12|Withdrawal by Subject|0|||
48350559|NCT00550446|155480226|FG000|Up To Week 12|Other|3|||
48350560|NCT00550446|155480227|FG001|Up To Week 12|Other|0|||
48350561|NCT00550446|155480228|FG002|Up To Week 12|Other|0|||
48350562|NCT00550446|155480229|FG003|Up To Week 12|Other|0|||
48350563|NCT00550446|155480230|FG004|Up To Week 12|Other|0|||
48350564|NCT00550446|155480231|FG005|Up To Week 12|Other|1|||
48350565|NCT00550446|155480232|FG006|Up To Week 12|Other|4|||
48350566|NCT00550446|155480233|FG007|Up To Week 12|Other|0|||
48350567|NCT00550446|155480234|FG008|Up To Week 12|Other|0|||
48350568|NCT00550446|155480235|FG009|Up To Week 12|Other|0|||
48350569|NCT00550446|155480236|FG010|Up To Week 12|Other|0|||
48350570|NCT00550446|155480226|FG000|Up To Week 12|Randomized not treated|0|||
48350571|NCT00550446|155480227|FG001|Up To Week 12|Randomized not treated|1|||
48350572|NCT00550446|155480228|FG002|Up To Week 12|Randomized not treated|1|||
48350573|NCT00550446|155480229|FG003|Up To Week 12|Randomized not treated|0|||
48350574|NCT00550446|155480230|FG004|Up To Week 12|Randomized not treated|0|||
48350575|NCT00550446|155480231|FG005|Up To Week 12|Randomized not treated|0|||
48350576|NCT00550446|155480232|FG006|Up To Week 12|Randomized not treated|0|||
48350577|NCT00550446|155480233|FG007|Up To Week 12|Randomized not treated|0|||
48350578|NCT00550446|155480234|FG008|Up To Week 12|Randomized not treated|0|||
48350579|NCT00550446|155480235|FG009|Up To Week 12|Randomized not treated|0|||
48350580|NCT00550446|155480236|FG010|Up To Week 12|Randomized not treated|0|||
48350581|NCT00550446|155480226|FG000|Post Week 12|Adverse Event|2|||
48350582|NCT00550446|155480227|FG001|Post Week 12|Adverse Event|1|||
48350583|NCT00550446|155480228|FG002|Post Week 12|Adverse Event|1|||
48350584|NCT00550446|155480229|FG003|Post Week 12|Adverse Event|1|||
48350585|NCT00550446|155480230|FG004|Post Week 12|Adverse Event|1|||
48350586|NCT00550446|155480231|FG005|Post Week 12|Adverse Event|1|||
48350587|NCT00550446|155480232|FG006|Post Week 12|Adverse Event|0|||
48350588|NCT00550446|155480233|FG007|Post Week 12|Adverse Event|0|||
48350589|NCT00550446|155480234|FG008|Post Week 12|Adverse Event|0|||
48350590|NCT00550446|155480235|FG009|Post Week 12|Adverse Event|4|||
48350591|NCT00550446|155480236|FG010|Post Week 12|Adverse Event|0|||
48350592|NCT00550446|155480226|FG000|Post Week 12|Lack of Efficacy|0|||
48350593|NCT00550446|155480227|FG001|Post Week 12|Lack of Efficacy|0|||
48350594|NCT00550446|155480228|FG002|Post Week 12|Lack of Efficacy|1|||
48350595|NCT00550446|155480229|FG003|Post Week 12|Lack of Efficacy|0|||
48350596|NCT00550446|155480230|FG004|Post Week 12|Lack of Efficacy|0|||
48350597|NCT00550446|155480231|FG005|Post Week 12|Lack of Efficacy|0|||
48350598|NCT00550446|155480232|FG006|Post Week 12|Lack of Efficacy|0|||
48350599|NCT00550446|155480233|FG007|Post Week 12|Lack of Efficacy|1|||
48350600|NCT00550446|155480234|FG008|Post Week 12|Lack of Efficacy|1|||
48350601|NCT00550446|155480235|FG009|Post Week 12|Lack of Efficacy|2|||
48350602|NCT00550446|155480236|FG010|Post Week 12|Lack of Efficacy|1|||
48350603|NCT00550446|155480226|FG000|Post Week 12|Lost to Follow-up|0|||
48350604|NCT00550446|155480227|FG001|Post Week 12|Lost to Follow-up|0|||
48350605|NCT00550446|155480228|FG002|Post Week 12|Lost to Follow-up|1|||
48350606|NCT00550446|155480229|FG003|Post Week 12|Lost to Follow-up|1|||
48350607|NCT00550446|155480230|FG004|Post Week 12|Lost to Follow-up|0|||
48350608|NCT00550446|155480231|FG005|Post Week 12|Lost to Follow-up|0|||
48350609|NCT00550446|155480232|FG006|Post Week 12|Lost to Follow-up|1|||
48350610|NCT00550446|155480233|FG007|Post Week 12|Lost to Follow-up|0|||
48350611|NCT00550446|155480234|FG008|Post Week 12|Lost to Follow-up|0|||
48350612|NCT00550446|155480235|FG009|Post Week 12|Lost to Follow-up|0|||
48350613|NCT00550446|155480236|FG010|Post Week 12|Lost to Follow-up|0|||
48350614|NCT00550446|155480226|FG000|Post Week 12|Withdrawal by Subject|0|||
48350615|NCT00550446|155480227|FG001|Post Week 12|Withdrawal by Subject|0|||
48350616|NCT00550446|155480228|FG002|Post Week 12|Withdrawal by Subject|0|||
48350617|NCT00550446|155480229|FG003|Post Week 12|Withdrawal by Subject|0|||
48350618|NCT00550446|155480230|FG004|Post Week 12|Withdrawal by Subject|1|||
48350619|NCT00550446|155480231|FG005|Post Week 12|Withdrawal by Subject|0|||
48350620|NCT00550446|155480232|FG006|Post Week 12|Withdrawal by Subject|0|||
48350621|NCT00550446|155480233|FG007|Post Week 12|Withdrawal by Subject|0|||
48350622|NCT00550446|155480234|FG008|Post Week 12|Withdrawal by Subject|0|||
48350623|NCT00550446|155480235|FG009|Post Week 12|Withdrawal by Subject|0|||
48350624|NCT00550446|155480236|FG010|Post Week 12|Withdrawal by Subject|0|||
48350625|NCT00550446|155480226|FG000|Post Week 12|Other|1|||
48350626|NCT00550446|155480227|FG001|Post Week 12|Other|1|||
48350627|NCT00550446|155480228|FG002|Post Week 12|Other|0|||
48350628|NCT00550446|155480229|FG003|Post Week 12|Other|1|||
48350629|NCT00550446|155480230|FG004|Post Week 12|Other|0|||
48350630|NCT00550446|155480231|FG005|Post Week 12|Other|0|||
48350631|NCT00550446|155480232|FG006|Post Week 12|Other|1|||
48350632|NCT00550446|155480233|FG007|Post Week 12|Other|0|||
48350633|NCT00550446|155480234|FG008|Post Week 12|Other|1|||
48350634|NCT00550446|155480235|FG009|Post Week 12|Other|1|||
48350635|NCT00550446|155480236|FG010|Post Week 12|Other|0|||
48350636|NCT01192776|155480237|FG000|Overall Study|Death|8|||
48350637|NCT01192776|155480238|FG001|Overall Study|Death|15|||
48350638|NCT01192776|155480239|FG002|Overall Study|Death|18|||
48350639|NCT01192776|155480240|FG003|Overall Study|Death|15|||
48350640|NCT01192776|155480237|FG000|Overall Study|Lost to Follow-up|3|||
48350641|NCT01192776|155480238|FG001|Overall Study|Lost to Follow-up|6|||
48350642|NCT01192776|155480239|FG002|Overall Study|Lost to Follow-up|3|||
48350643|NCT01192776|155480240|FG003|Overall Study|Lost to Follow-up|5|||
48350644|NCT02872311|155480245|FG000|Overall Study|Death|2|||
48350645|NCT02872311|155480246|FG001|Overall Study|Death|0|||
48350646|NCT02872311|155480247|FG002|Overall Study|Death|0|||
48350647|NCT02872311|155480248|FG003|Overall Study|Death|0|||
48350648|NCT02872311|155480249|FG004|Overall Study|Death|0|||
48350649|NCT02872311|155480245|FG000|Overall Study|Lost to Follow-up|2|||
48350650|NCT02872311|155480246|FG001|Overall Study|Lost to Follow-up|0|||
48350651|NCT02872311|155480247|FG002|Overall Study|Lost to Follow-up|0|||
48350652|NCT02872311|155480248|FG003|Overall Study|Lost to Follow-up|0|||
48350653|NCT02872311|155480249|FG004|Overall Study|Lost to Follow-up|0|||
48350654|NCT02872311|155480245|FG000|Overall Study|Protocol Violation|0|||
48350655|NCT02872311|155480246|FG001|Overall Study|Protocol Violation|2|||
48350656|NCT02872311|155480247|FG002|Overall Study|Protocol Violation|1|||
48350657|NCT02872311|155480248|FG003|Overall Study|Protocol Violation|0|||
48350658|NCT02872311|155480249|FG004|Overall Study|Protocol Violation|0|||
48350659|NCT00263575|155480256|FG000|Titration Period|Adverse Event|14|||
48350660|NCT00263575|155480256|FG000|Titration Period|Withdrawal by Subject|10|||
48350661|NCT00263575|155480256|FG000|Titration Period|Protocol Violation|9|||
48350662|NCT00263575|155480256|FG000|Titration Period|Sponsor Decision|2|||
48350663|NCT00263575|155480256|FG000|Titration Period|Other|2|||
48350664|NCT00263575|155480256|FG000|Titration Period|Lack of Efficacy|6|||
48350665|NCT00263575|155480256|FG000|Maintence Period|Adverse Event|23|||
48350666|NCT00263575|155480256|FG000|Maintence Period|Withdrawal by Subject|8|||
48350667|NCT00263575|155480256|FG000|Maintence Period|Protocol Violation|4|||
48350668|NCT00263575|155480256|FG000|Maintence Period|Lack of Efficacy|4|||
48350669|NCT00263575|155480256|FG000|Maintence Period|Physician Decision|6|||
48350670|NCT00263575|155480256|FG000|Maintence Period|Lost to Follow-up|1|||
48350671|NCT00263575|155480256|FG000|Maintence Period|Sponsor Decision|24|||
48350672|NCT00263575|155480256|FG000|Maintence Period|Other|7|||
48350673|NCT02447718|155480257|FG000|Overall Study|Lost to Follow-up|8|||
48350674|NCT02447718|155480258|FG001|Overall Study|Lost to Follow-up|0|||
48350675|NCT02447718|155480257|FG000|Overall Study|Withdrawal by Subject|3|||
48350676|NCT02447718|155480258|FG001|Overall Study|Withdrawal by Subject|0|||
48350677|NCT02447718|155480257|FG000|Overall Study|Screen Failure|1|||
48350678|NCT02447718|155480258|FG001|Overall Study|Screen Failure|0|||
48350679|NCT01918371|155480264|FG000|Overall Study|Missing Data|1|||
48350680|NCT01918371|155480265|FG001|Overall Study|Missing Data|1|||
48675429|NCT01336023|156663483|FG001|Week 27 to 52|Unclassified|18|||
48675430|NCT01336023|156663484|FG002|Week 27 to 52|Unclassified|9|||
48675431|NCT00695864|156663495|FG000|Placebo|Withdrawal by Subject|1|||
48675432|NCT00695864|156663495|FG000|Placebo|Physician Decision|4|||
48675433|NCT01894022|156663498|FG000|Overall Study|Death|1|||
48675434|NCT01894022|156663499|FG001|Overall Study|Death|0|||
48675435|NCT01894022|156663498|FG000|Overall Study|Adverse Event, non-fatal|1|||
48675436|NCT01894022|156663499|FG001|Overall Study|Adverse Event, non-fatal|0|||
48675437|NCT01894022|156663498|FG000|Overall Study|Study Closed/terminated|7|||
48675438|NCT01894022|156663499|FG001|Overall Study|Study Closed/terminated|10|||
48675439|NCT02202538|156663500|FG000|Overall Study|Withdrawal by Subject|5|||
48350681|NCT01728623|155480266|FG000|Overall Study|Disease progression|26|||
48350682|NCT01728623|155480266|FG000|Overall Study|Adverse Event|1|||
48350683|NCT01728623|155480266|FG000|Overall Study|Withdrawal by Subject|1|||
48350684|NCT00243022|155480267|FG000|Overall Study|Withdrawal by Subject|1|||
48350685|NCT00243022|155480268|FG001|Overall Study|Withdrawal by Subject|0|||
48350686|NCT00243022|155480267|FG000|Overall Study|Death|1|||
48350687|NCT00243022|155480268|FG001|Overall Study|Death|0|||
48350688|NCT00243022|155480267|FG000|Overall Study|Difficult Travel Distance|0|||
48350689|NCT00243022|155480268|FG001|Overall Study|Difficult Travel Distance|1|||
48350690|NCT03713320|155480269|FG000|Randomized Period|Adverse Event|1|||
48350691|NCT03713320|155480270|FG001|Randomized Period|Adverse Event|5|||
48350692|NCT03713320|155480271|FG002|Randomized Period|Adverse Event|0|||
48350693|NCT03713320|155480269|FG000|Randomized Period|Physician Decision|1|||
48350694|NCT03713320|155480270|FG001|Randomized Period|Physician Decision|1|||
48350695|NCT03713320|155480271|FG002|Randomized Period|Physician Decision|0|||
48350696|NCT03713320|155480269|FG000|Randomized Period|Withdrawal by Subject|4|||
48350697|NCT03713320|155480270|FG001|Randomized Period|Withdrawal by Subject|0|||
48350698|NCT03713320|155480271|FG002|Randomized Period|Withdrawal by Subject|0|||
48350699|NCT03713320|155480269|FG000|Randomized Period|Participant decision|3|||
48350700|NCT03713320|155480270|FG001|Randomized Period|Participant decision|1|||
48350701|NCT03713320|155480271|FG002|Randomized Period|Participant decision|0|||
48350702|NCT03713320|155480269|FG000|Randomized Period|Study terminated by sponsor|6|||
48350703|NCT03713320|155480270|FG001|Randomized Period|Study terminated by sponsor|3|||
48350704|NCT03713320|155480271|FG002|Randomized Period|Study terminated by sponsor|0|||
48350705|NCT03713320|155480269|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
48350706|NCT03713320|155480270|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
48675440|NCT02202538|156663500|FG000|Overall Study|Did not meet all inclusion criteria|2|||
48675441|NCT02202538|156663500|FG000|Overall Study|Investigator Decision|1|||
48675442|NCT02651220|156663501|FG000|Overall Study|Adverse Event|1|||
48675443|NCT02651220|156663502|FG001|Overall Study|Adverse Event|5|||
48675444|NCT02651220|156663503|FG002|Overall Study|Adverse Event|1|||
48675445|NCT02651220|156663501|FG000|Overall Study|Lost to Follow-up|8|||
48675446|NCT02651220|156663502|FG001|Overall Study|Lost to Follow-up|14|||
48675447|NCT02651220|156663503|FG002|Overall Study|Lost to Follow-up|14|||
48675448|NCT02651220|156663501|FG000|Overall Study|Non-Compliance with Study Drug|4|||
48350707|NCT03713320|155480271|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
48675449|NCT02651220|156663502|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48675450|NCT02651220|156663503|FG002|Overall Study|Non-Compliance with Study Drug|1|||
48675451|NCT02651220|156663501|FG000|Overall Study|Pregnancy|1|||
48675452|NCT02651220|156663502|FG001|Overall Study|Pregnancy|0|||
48675453|NCT02651220|156663503|FG002|Overall Study|Pregnancy|1|||
48675454|NCT02651220|156663501|FG000|Overall Study|Protocol Violation|0|||
48675455|NCT02651220|156663502|FG001|Overall Study|Protocol Violation|0|||
48350708|NCT03713320|155480269|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
48350709|NCT03713320|155480270|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
48350710|NCT03713320|155480271|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
48350711|NCT01099579|155480272|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
48350712|NCT01099579|155480273|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
48350713|NCT01099579|155480274|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
48350714|NCT01099579|155480272|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
48350715|NCT01099579|155480273|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
48350716|NCT01099579|155480274|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
48350717|NCT01099579|155480272|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
48350718|NCT01099579|155480273|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
48350719|NCT01099579|155480274|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
48350720|NCT01099579|155480272|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
48350721|NCT01099579|155480273|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
48350722|NCT01099579|155480274|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
48350723|NCT01099579|155480272|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
48350724|NCT01099579|155480273|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
48350725|NCT01099579|155480274|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
48350726|NCT01099579|155480272|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
48350727|NCT01099579|155480273|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
48350728|NCT01099579|155480274|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
48350729|NCT01099579|155480272|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
48350730|NCT01099579|155480273|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
48350731|NCT01099579|155480274|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
48350732|NCT01099579|155480272|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
48350733|NCT01099579|155480273|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
48350734|NCT01099579|155480274|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
48350735|NCT01099579|155480272|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
48350736|NCT01099579|155480273|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
48350737|NCT01099579|155480274|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
48675456|NCT02651220|156663503|FG002|Overall Study|Protocol Violation|1|||
48675457|NCT02651220|156663501|FG000|Overall Study|Withdrawal by Subject|5|||
48350738|NCT01099579|155480272|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
48350739|NCT01099579|155480273|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
48350740|NCT01099579|155480274|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
48350741|NCT02635386|155480277|FG000|Overall Study|Pregnancy|2|||
48350742|NCT02635386|155480278|FG001|Overall Study|Pregnancy|0|||
48350743|NCT02635386|155480279|FG002|Overall Study|Pregnancy|0|||
48350744|NCT02635386|155480280|FG003|Overall Study|Pregnancy|0|||
48350745|NCT02635386|155480281|FG004|Overall Study|Pregnancy|2|||
48350746|NCT02635386|155480277|FG000|Overall Study|Withdrawal by Subject|1|||
48350747|NCT02635386|155480278|FG001|Overall Study|Withdrawal by Subject|1|||
48350748|NCT02635386|155480279|FG002|Overall Study|Withdrawal by Subject|0|||
48675458|NCT02651220|156663502|FG001|Overall Study|Withdrawal by Subject|6|||
48350749|NCT02635386|155480280|FG003|Overall Study|Withdrawal by Subject|1|||
48350750|NCT02635386|155480281|FG004|Overall Study|Withdrawal by Subject|0|||
48350751|NCT02635386|155480277|FG000|Overall Study|Physician Decision|0|||
48350752|NCT02635386|155480278|FG001|Overall Study|Physician Decision|1|||
48350753|NCT02635386|155480279|FG002|Overall Study|Physician Decision|0|||
48350754|NCT02635386|155480280|FG003|Overall Study|Physician Decision|0|||
48350755|NCT02635386|155480281|FG004|Overall Study|Physician Decision|0|||
48350756|NCT02635386|155480277|FG000|Overall Study|Moved Out of State|0|||
48350757|NCT02635386|155480278|FG001|Overall Study|Moved Out of State|1|||
48350758|NCT02635386|155480279|FG002|Overall Study|Moved Out of State|0|||
48350759|NCT02635386|155480280|FG003|Overall Study|Moved Out of State|0|||
48350760|NCT02635386|155480281|FG004|Overall Study|Moved Out of State|0|||
48350761|NCT02635386|155480277|FG000|Overall Study|Noncompliant|0|||
48350762|NCT02635386|155480278|FG001|Overall Study|Noncompliant|2|||
48350763|NCT02635386|155480279|FG002|Overall Study|Noncompliant|1|||
48350764|NCT02635386|155480280|FG003|Overall Study|Noncompliant|1|||
48350765|NCT02635386|155480281|FG004|Overall Study|Noncompliant|1|||
48350766|NCT02635386|155480277|FG000|Overall Study|side effects|0|||
48350767|NCT02635386|155480278|FG001|Overall Study|side effects|0|||
48350768|NCT02635386|155480279|FG002|Overall Study|side effects|1|||
48350769|NCT02635386|155480280|FG003|Overall Study|side effects|4|||
48350770|NCT02635386|155480281|FG004|Overall Study|side effects|6|||
48350771|NCT02635386|155480277|FG000|Overall Study|needed other major surgery|0|||
48675459|NCT02651220|156663503|FG002|Overall Study|Withdrawal by Subject|8|||
48350772|NCT02635386|155480278|FG001|Overall Study|needed other major surgery|1|||
48350773|NCT02635386|155480279|FG002|Overall Study|needed other major surgery|0|||
48350774|NCT02635386|155480280|FG003|Overall Study|needed other major surgery|0|||
48350775|NCT02635386|155480281|FG004|Overall Study|needed other major surgery|0|||
48350776|NCT02635386|155480277|FG000|Overall Study|Other medical problems not drug related|0|||
48350777|NCT02635386|155480278|FG001|Overall Study|Other medical problems not drug related|0|||
48350778|NCT02635386|155480279|FG002|Overall Study|Other medical problems not drug related|0|||
48350779|NCT02635386|155480280|FG003|Overall Study|Other medical problems not drug related|1|||
48350780|NCT02635386|155480281|FG004|Overall Study|Other medical problems not drug related|0|||
48350781|NCT01781832|155480283|FG000|Overall Study|Withdrawal by Subject|1|||
48350782|NCT02719743|155480284|FG000|Overall Study|Consent withdrawal|0|||
48350783|NCT02719743|155480285|FG001|Overall Study|Consent withdrawal|2|||
48350784|NCT02719743|155480286|FG002|Overall Study|Consent withdrawal|0|||
48350785|NCT02719743|155480287|FG003|Overall Study|Consent withdrawal|1|||
48350786|NCT02719743|155480288|FG004|Overall Study|Consent withdrawal|0|||
48350787|NCT02719743|155480284|FG000|Overall Study|Migrated/moved from study area|0|||
48350788|NCT02719743|155480285|FG001|Overall Study|Migrated/moved from study area|0|||
48350789|NCT02719743|155480286|FG002|Overall Study|Migrated/moved from study area|0|||
48350790|NCT02719743|155480287|FG003|Overall Study|Migrated/moved from study area|0|||
48350791|NCT02719743|155480288|FG004|Overall Study|Migrated/moved from study area|2|||
48350792|NCT02719743|155480284|FG000|Overall Study|Lost to Follow-up|1|||
48350793|NCT02719743|155480285|FG001|Overall Study|Lost to Follow-up|1|||
48350794|NCT02719743|155480286|FG002|Overall Study|Lost to Follow-up|0|||
48350795|NCT02719743|155480287|FG003|Overall Study|Lost to Follow-up|0|||
48350796|NCT02719743|155480288|FG004|Overall Study|Lost to Follow-up|0|||
48350797|NCT01209598|155480289|FG000|Overall Study|Withdrawal by Subject|1|||
48350798|NCT01209598|155480290|FG001|Overall Study|Withdrawal by Subject|0|||
48350799|NCT01266161|155480292|FG000|Overall Study|Ineligible|1|||
48350800|NCT01266161|155480293|FG001|Overall Study|Ineligible|0|||
48350801|NCT01266161|155480292|FG000|Overall Study|Lack of Efficacy|0|||
48350802|NCT01266161|155480293|FG001|Overall Study|Lack of Efficacy|1|||
48350803|NCT01266161|155480292|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
48350804|NCT01266161|155480293|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
48350805|NCT00085566|155480294|FG000|Overall Study|Adverse Event|0|||
48350806|NCT00085566|155480295|FG001|Overall Study|Adverse Event|0|||
48350807|NCT00085566|155480296|FG002|Overall Study|Adverse Event|10|||
48350808|NCT00085566|155480294|FG000|Overall Study|Patient Not treated|0|||
48350809|NCT00085566|155480295|FG001|Overall Study|Patient Not treated|0|||
48350810|NCT00085566|155480296|FG002|Overall Study|Patient Not treated|3|||
48350811|NCT00085566|155480294|FG000|Overall Study|Clinical progression|0|||
48350812|NCT00085566|155480295|FG001|Overall Study|Clinical progression|0|||
48350813|NCT00085566|155480296|FG002|Overall Study|Clinical progression|1|||
48350814|NCT02990468|155480297|FG000|Phase 2: MTD|Change in treatment|0|||
48350815|NCT02990468|155480298|FG001|Phase 2: MTD|Change in treatment|0|||
48350816|NCT02990468|155480299|FG002|Phase 2: MTD|Change in treatment|1|||
48350817|NCT04092452|155480300|FG000|Overall Study|Adverse Event|1|||
48350818|NCT04092452|155480301|FG001|Overall Study|Adverse Event|3|||
48350819|NCT04092452|155480302|FG002|Overall Study|Adverse Event|3|||
48350820|NCT04092452|155480303|FG003|Overall Study|Adverse Event|7|||
48350821|NCT04092452|155480300|FG000|Overall Study|Lack of Efficacy|1|||
48350822|NCT04092452|155480301|FG001|Overall Study|Lack of Efficacy|1|||
48350823|NCT04092452|155480302|FG002|Overall Study|Lack of Efficacy|1|||
48350824|NCT04092452|155480303|FG003|Overall Study|Lack of Efficacy|0|||
48350825|NCT04092452|155480300|FG000|Overall Study|Lost to Follow-up|4|||
48350826|NCT04092452|155480301|FG001|Overall Study|Lost to Follow-up|3|||
48350827|NCT04092452|155480302|FG002|Overall Study|Lost to Follow-up|5|||
48350828|NCT04092452|155480303|FG003|Overall Study|Lost to Follow-up|1|||
48350829|NCT04092452|155480300|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48350830|NCT04092452|155480301|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48675460|NCT02651220|156663501|FG000|Overall Study|Miscellaneous|4|||
48675461|NCT02651220|156663502|FG001|Overall Study|Miscellaneous|1|||
48675462|NCT02651220|156663503|FG002|Overall Study|Miscellaneous|2|||
48675463|NCT02651220|156663501|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48675464|NCT02651220|156663502|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48675465|NCT02651220|156663503|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
48675466|NCT02220712|156663513|FG000|Overall Study|Adverse Event|1|||
48675467|NCT02220712|156663513|FG000|Overall Study|Withdrawal by Subject|2|||
48675468|NCT02220712|156663513|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
48675469|NCT01069705|156663514|FG000|Overall Study|Adverse Event|1|||
48675470|NCT01069705|156663514|FG000|Overall Study|Withdrawal by Subject|2|||
48675471|NCT03624127|156663519|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
48675472|NCT03624127|156663520|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
48675473|NCT03624127|156663521|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
48675474|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
48675475|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
48675476|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
48675477|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Death|0|||
48675478|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Death|1|||
48675479|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Death|0|||
48675480|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
48675481|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
48675482|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
48675483|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
48675484|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
48675485|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
48350831|NCT04092452|155480302|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48350832|NCT04092452|155480303|FG003|Overall Study|Non-Compliance With Study Drug|1|||
48350833|NCT04092452|155480300|FG000|Overall Study|Physician Decision|1|||
48350834|NCT04092452|155480301|FG001|Overall Study|Physician Decision|0|||
48350835|NCT04092452|155480302|FG002|Overall Study|Physician Decision|1|||
48350836|NCT04092452|155480303|FG003|Overall Study|Physician Decision|0|||
48350837|NCT04092452|155480300|FG000|Overall Study|Pregnancy|2|||
48350838|NCT04092452|155480301|FG001|Overall Study|Pregnancy|0|||
48350839|NCT04092452|155480302|FG002|Overall Study|Pregnancy|0|||
48350840|NCT04092452|155480303|FG003|Overall Study|Pregnancy|0|||
48350841|NCT04092452|155480300|FG000|Overall Study|Protocol Deviation|1|||
48350842|NCT04092452|155480301|FG001|Overall Study|Protocol Deviation|0|||
48350843|NCT04092452|155480302|FG002|Overall Study|Protocol Deviation|0|||
48350844|NCT04092452|155480303|FG003|Overall Study|Protocol Deviation|0|||
48350845|NCT04092452|155480300|FG000|Overall Study|Withdrawal by Subject|3|||
48350846|NCT04092452|155480301|FG001|Overall Study|Withdrawal by Subject|10|||
48350847|NCT04092452|155480302|FG002|Overall Study|Withdrawal by Subject|3|||
48350848|NCT04092452|155480303|FG003|Overall Study|Withdrawal by Subject|5|||
48675486|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
48350849|NCT04092452|155480300|FG000|Overall Study|Other|0|||
48350850|NCT04092452|155480301|FG001|Overall Study|Other|0|||
48350851|NCT04092452|155480302|FG002|Overall Study|Other|1|||
48350852|NCT04092452|155480303|FG003|Overall Study|Other|2|||
48350853|NCT00745498|155480304|FG000|Overall Study|Lost to Follow-up|1|||
48350854|NCT00745498|155480305|FG001|Overall Study|Lost to Follow-up|1|||
48350855|NCT00745498|155480306|FG002|Overall Study|Lost to Follow-up|3|||
48350856|NCT00745498|155480304|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
48350857|NCT00745498|155480305|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
48350858|NCT00745498|155480306|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
48350859|NCT00745498|155480304|FG000|Overall Study|Non-PDR related VH|0|||
48350860|NCT00745498|155480305|FG001|Overall Study|Non-PDR related VH|1|||
48350861|NCT00745498|155480306|FG002|Overall Study|Non-PDR related VH|1|||
48350862|NCT00745498|155480304|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
48350863|NCT00745498|155480305|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
48350864|NCT00745498|155480306|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
48350865|NCT03174782|155480307|FG000|Overall Study|Protocol Violation|1|||
48350866|NCT03174782|155480308|FG001|Overall Study|Protocol Violation|0|||
48350867|NCT03174782|155480307|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
48350868|NCT03174782|155480308|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
48350869|NCT03636373|155480318|FG000|Overall Study|Study closure due to Covid-19|1|||
48350870|NCT03636373|155480319|FG001|Overall Study|Study closure due to Covid-19|0|||
48350871|NCT04156399|155481692|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
48350872|NCT04156399|155481692|FG000|Overall Study|study suspension due to COVID pandemic|3|||
48350873|NCT01929876|155481696|FG000|Period 2|Non-Compliance|1|||
48350874|NCT03616964|155481697|FG000|Overall Study|Adverse Event|15|||
48350875|NCT03616964|155481698|FG001|Overall Study|Adverse Event|10|||
48350876|NCT03616964|155481699|FG002|Overall Study|Adverse Event|16|||
48350877|NCT03616964|155481697|FG000|Overall Study|Death|3|||
48350878|NCT03616964|155481698|FG001|Overall Study|Death|0|||
48350879|NCT03616964|155481699|FG002|Overall Study|Death|4|||
48350880|NCT03616964|155481697|FG000|Overall Study|Lack of Efficacy|4|||
48350881|NCT03616964|155481698|FG001|Overall Study|Lack of Efficacy|8|||
48350882|NCT03616964|155481699|FG002|Overall Study|Lack of Efficacy|8|||
48350883|NCT03616964|155481697|FG000|Overall Study|Lost to Follow-up|2|||
48350884|NCT03616964|155481698|FG001|Overall Study|Lost to Follow-up|1|||
48350885|NCT03616964|155481699|FG002|Overall Study|Lost to Follow-up|3|||
48350886|NCT03616964|155481697|FG000|Overall Study|Withdrawal by Subject|18|||
48350887|NCT03616964|155481698|FG001|Overall Study|Withdrawal by Subject|14|||
48350888|NCT03616964|155481699|FG002|Overall Study|Withdrawal by Subject|21|||
48350889|NCT03616964|155481697|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
48350890|NCT03616964|155481698|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
48350891|NCT03616964|155481699|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
48350892|NCT03616964|155481697|FG000|Overall Study|Sponsor's Decision|1|||
48350893|NCT03616964|155481698|FG001|Overall Study|Sponsor's Decision|0|||
48350894|NCT03616964|155481699|FG002|Overall Study|Sponsor's Decision|0|||
48350895|NCT03616964|155481697|FG000|Overall Study|Physician Decision|0|||
48350896|NCT03616964|155481698|FG001|Overall Study|Physician Decision|2|||
48350897|NCT03616964|155481699|FG002|Overall Study|Physician Decision|0|||
48350898|NCT03616964|155481697|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
48350899|NCT03616964|155481698|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
48350900|NCT03616964|155481699|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
48350901|NCT03616964|155481697|FG000|Overall Study|Protocol Violation|0|||
48350902|NCT03616964|155481698|FG001|Overall Study|Protocol Violation|1|||
48350903|NCT03616964|155481699|FG002|Overall Study|Protocol Violation|0|||
48350904|NCT03616964|155481697|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
48350905|NCT03616964|155481698|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
48350906|NCT03616964|155481699|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
48350907|NCT03616964|155481697|FG000|Overall Study|Randomized but Never Treated|1|||
48350908|NCT03616964|155481698|FG001|Overall Study|Randomized but Never Treated|1|||
48350909|NCT03616964|155481699|FG002|Overall Study|Randomized but Never Treated|1|||
48350910|NCT00958711|155481700|FG000|Overall Study|Withdrawal by Subject|0|||
48350911|NCT00958711|155481701|FG001|Overall Study|Withdrawal by Subject|4|||
48350912|NCT00958711|155481700|FG000|Overall Study|Physician Decision|5|||
48350913|NCT00958711|155481701|FG001|Overall Study|Physician Decision|7|||
48350914|NCT00958711|155481700|FG000|Overall Study|Lost to Follow-up|4|||
48350915|NCT00958711|155481701|FG001|Overall Study|Lost to Follow-up|1|||
48350916|NCT00958711|155481700|FG000|Overall Study|Other|2|||
48350917|NCT00958711|155481701|FG001|Overall Study|Other|5|||
48350918|NCT00958711|155481700|FG000|Overall Study|Death|1|||
48350919|NCT00958711|155481701|FG001|Overall Study|Death|2|||
48350920|NCT00958711|155481700|FG000|Overall Study|Adverse Event|1|||
48350921|NCT00958711|155481701|FG001|Overall Study|Adverse Event|2|||
48350922|NCT01266018|155481703|FG000|Overall Study|Physician Decision|1|||
48350923|NCT01266018|155481704|FG001|Overall Study|Physician Decision|0|||
48350924|NCT01266018|155481703|FG000|Overall Study|Progressive disease|0|||
48350925|NCT01266018|155481704|FG001|Overall Study|Progressive disease|1|||
48350926|NCT02684123|155481705|FG000|Phase 1|Lack of Efficacy|5|||
48350927|NCT02684123|155481706|FG001|Phase 1|Lack of Efficacy|0|||
48350928|NCT02684123|155481705|FG000|Phase 1|Adverse Event|3|||
48350929|NCT02684123|155481706|FG001|Phase 1|Adverse Event|0|||
48350930|NCT02684123|155481705|FG000|Phase 1|Lost to Follow-up|0|||
48350931|NCT02684123|155481706|FG001|Phase 1|Lost to Follow-up|1|||
48350932|NCT02684123|155481705|FG000|Phase 2|Lack of Efficacy|1|||
48350933|NCT02684123|155481706|FG001|Phase 2|Lack of Efficacy|8|||
48350934|NCT00966979|155481707|FG000|Overall Study|Death|1|||
48675487|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
48675488|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
48675489|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
48675490|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
48675491|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
48675492|NCT03624127|156663519|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
48675493|NCT03624127|156663520|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
48675494|NCT03624127|156663521|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
48350935|NCT00966979|155481707|FG000|Overall Study|Lost to Follow-up|6|||
48350936|NCT00966979|155481707|FG000|Overall Study|Withdrawal by Subject|14|||
48675495|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
48675496|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
48675497|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
48675498|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
48675499|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
48675500|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
48675501|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
48675502|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
48675503|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
48675504|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
48675505|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
48675506|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
48675507|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
48675508|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
48675509|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
48675510|NCT03624127|156663519|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
48675511|NCT03624127|156663520|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
48675512|NCT03624127|156663521|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
48675513|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
48675514|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
48675515|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
48675516|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
48675517|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
48675518|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
48675519|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
48675520|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
48675521|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
48675522|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
48675523|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
48675524|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
48675525|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
48675526|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
48675527|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
48675528|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
48675529|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
48350937|NCT00966979|155481707|FG000|Overall Study|Adverse Event|5|||
48350938|NCT00966979|155481707|FG000|Overall Study|Sponsor terminated early|49|||
48350939|NCT00966979|155481707|FG000|Overall Study|Censored because surgery not done|2|||
48350940|NCT00966979|155481707|FG000|Overall Study|Censored because study device was not implanted|14|||
48350941|NCT00966979|155481707|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
48350942|NCT00511836|155481708|FG000|Double-blind Period|Lost to Follow-up|1|||
48675530|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
48675531|NCT03624127|156663519|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
48675532|NCT03624127|156663520|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
48675533|NCT03624127|156663521|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
48675534|NCT00330681|156663522|FG000|Overall Study|Adverse Event|3|||
48675535|NCT00330681|156663523|FG001|Overall Study|Adverse Event|6|||
48675536|NCT00330681|156663522|FG000|Overall Study|Protocol Violation|0|||
48675537|NCT00330681|156663523|FG001|Overall Study|Protocol Violation|1|||
48350943|NCT00511836|155481709|FG001|Double-blind Period|Lost to Follow-up|0|||
48350944|NCT00030823|155481710|FG000|Overall Study|Withdrawal by Subject|1|||
48350945|NCT00891046|155481718|FG000|Overall Study|Protocol Violation|1|||
48350946|NCT00891046|155481719|FG001|Overall Study|Protocol Violation|1|||
48350947|NCT00891046|155481720|FG002|Overall Study|Protocol Violation|0|||
48675538|NCT00330681|156663522|FG000|Overall Study|Withdrawal by Subject|5|||
48675539|NCT00330681|156663523|FG001|Overall Study|Withdrawal by Subject|5|||
48350948|NCT00891046|155481721|FG003|Overall Study|Protocol Violation|0|||
48350949|NCT00891046|155481722|FG004|Overall Study|Protocol Violation|1|||
48350950|NCT00891046|155481718|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
48675540|NCT00330681|156663522|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
48675541|NCT00330681|156663523|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
48675542|NCT00621140|156663524|FG000|Overall Study|Adverse Event|4|||
48675543|NCT00621140|156663525|FG001|Overall Study|Adverse Event|5|||
48675544|NCT00621140|156663524|FG000|Overall Study|Lost to Follow-up|1|||
48675545|NCT00621140|156663525|FG001|Overall Study|Lost to Follow-up|2|||
48350951|NCT00891046|155481719|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48350952|NCT00891046|155481720|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
48350953|NCT00891046|155481721|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
48350954|NCT00891046|155481722|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
48350955|NCT00891046|155481718|FG000|Overall Study|Administrative problems|0|||
48350956|NCT00891046|155481719|FG001|Overall Study|Administrative problems|0|||
48350957|NCT00891046|155481720|FG002|Overall Study|Administrative problems|0|||
48350958|NCT00891046|155481721|FG003|Overall Study|Administrative problems|0|||
48350959|NCT00891046|155481722|FG004|Overall Study|Administrative problems|1|||
48350960|NCT00891046|155481718|FG000|Overall Study|Participant no longer required drug|0|||
48350961|NCT00891046|155481719|FG001|Overall Study|Participant no longer required drug|2|||
48350962|NCT00891046|155481720|FG002|Overall Study|Participant no longer required drug|0|||
48350963|NCT00891046|155481721|FG003|Overall Study|Participant no longer required drug|0|||
48350964|NCT00891046|155481722|FG004|Overall Study|Participant no longer required drug|1|||
48350965|NCT00891046|155481718|FG000|Overall Study|Adverse Event|4|||
48350966|NCT00891046|155481719|FG001|Overall Study|Adverse Event|3|||
48350967|NCT00891046|155481720|FG002|Overall Study|Adverse Event|2|||
48350968|NCT00891046|155481721|FG003|Overall Study|Adverse Event|0|||
48350969|NCT00891046|155481722|FG004|Overall Study|Adverse Event|14|||
48350970|NCT00891046|155481718|FG000|Overall Study|Withdrawal by Subject|2|||
48350971|NCT00891046|155481719|FG001|Overall Study|Withdrawal by Subject|1|||
48350972|NCT00891046|155481720|FG002|Overall Study|Withdrawal by Subject|2|||
48350973|NCT00891046|155481721|FG003|Overall Study|Withdrawal by Subject|1|||
48350974|NCT00891046|155481722|FG004|Overall Study|Withdrawal by Subject|1|||
48350975|NCT00891046|155481718|FG000|Overall Study|Lost to Follow-up|0|||
48350976|NCT00891046|155481719|FG001|Overall Study|Lost to Follow-up|0|||
48350977|NCT00891046|155481720|FG002|Overall Study|Lost to Follow-up|0|||
48350978|NCT00891046|155481721|FG003|Overall Study|Lost to Follow-up|0|||
48350979|NCT00891046|155481722|FG004|Overall Study|Lost to Follow-up|1|||
48350980|NCT01606319|155481723|FG000|Overall Study|Lost to Follow-up|17|||
48350981|NCT01606319|155481724|FG001|Overall Study|Lost to Follow-up|14|||
48350982|NCT01606319|155481723|FG000|Overall Study|Withdrawal by Subject|9|||
48350983|NCT01606319|155481724|FG001|Overall Study|Withdrawal by Subject|12|||
48350984|NCT01606319|155481723|FG000|Overall Study|Physician Decision|1|||
48350985|NCT01606319|155481724|FG001|Overall Study|Physician Decision|2|||
48350986|NCT01606319|155481723|FG000|Overall Study|Lack of Efficacy|6|||
48675546|NCT00621140|156663524|FG000|Overall Study|Withdrawal by Subject|4|||
48675547|NCT00621140|156663525|FG001|Overall Study|Withdrawal by Subject|6|||
48675548|NCT00621140|156663524|FG000|Overall Study|Other incl. lack of efficacy|6|||
48675549|NCT00621140|156663525|FG001|Overall Study|Other incl. lack of efficacy|5|||
48675550|NCT01138501|156663526|FG000|Overall Study|Protocol Violation|2|||
48675551|NCT01138501|156663526|FG000|Overall Study|Withdrawal by Subject|3|||
48675552|NCT00360568|156663527|FG000|Overall Study|Adverse Event|1|||
48675553|NCT00360568|156663528|FG001|Overall Study|Adverse Event|2|||
48675554|NCT00360568|156663527|FG000|Overall Study|Lack of Efficacy|1|||
48761945|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
48761946|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
48761947|NCT02036502|156975717|FG000|Part 3:Dose Expansion|Not Treated|0|||
48350987|NCT01606319|155481724|FG001|Overall Study|Lack of Efficacy|8|||
48350988|NCT01606319|155481723|FG000|Overall Study|Adverse Event|1|||
48350989|NCT01606319|155481724|FG001|Overall Study|Adverse Event|4|||
48350990|NCT04120376|155481725|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
48350991|NCT04120376|155481726|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
48350992|NCT01519778|155481733|FG000|Overall Study|Withdrawal by Subject|3|||
48350993|NCT01519778|155481733|FG000|Overall Study|Lost to Follow-up|10|||
48350994|NCT01519778|155481733|FG000|Overall Study|Physician Decision|1|||
48350995|NCT03021551|155481735|FG000|Overall Study|Equipment Issues|2|||
48761948|NCT02036502|156975718|FG001|Part 3:Dose Expansion|Not Treated|0|||
48350996|NCT03021551|155481735|FG000|Overall Study|Protocol Violation|1|||
48350997|NCT01841697|155481742|FG000|Overall Study|Death|0|||
48350998|NCT01841697|155481743|FG001|Overall Study|Death|1|||
48350999|NCT01841697|155481742|FG000|Overall Study|Lost to Follow-up|4|||
48351000|NCT01841697|155481743|FG001|Overall Study|Lost to Follow-up|1|||
48351001|NCT01841697|155481742|FG000|Overall Study|Withdrawal by Subject|16|||
48351002|NCT01841697|155481743|FG001|Overall Study|Withdrawal by Subject|16|||
48351003|NCT00302159|155481744|FG000|Overall Study|pt declined before treatment started|1|||
48351004|NCT00302159|155481744|FG000|Overall Study|pt started Avastin|1|||
48351005|NCT00813098|155481745|FG000|Overall Study|Adverse Event|2|||
48351006|NCT00813098|155481746|FG001|Overall Study|Adverse Event|4|||
48675555|NCT00360568|156663528|FG001|Overall Study|Lack of Efficacy|0|||
48675556|NCT00360568|156663527|FG000|Overall Study|Withdrawal by Subject|0|||
48675557|NCT00360568|156663528|FG001|Overall Study|Withdrawal by Subject|3|||
48675558|NCT03657095|156663529|FG000|Overall Study|Withdrawal by Subject|1|||
48351007|NCT00813098|155481747|FG002|Overall Study|Adverse Event|1|||
48675559|NCT03657095|156663530|FG001|Overall Study|Withdrawal by Subject|1|||
48675560|NCT03657095|156663529|FG000|Overall Study|Adverse Event|0|||
48675561|NCT03657095|156663530|FG001|Overall Study|Adverse Event|3|||
48675562|NCT03657095|156663529|FG000|Overall Study|Study Terminated by Sponsor|58|||
48351008|NCT00813098|155481745|FG000|Overall Study|Withdrawal by Subject|0|||
48351009|NCT00813098|155481746|FG001|Overall Study|Withdrawal by Subject|1|||
48351010|NCT00813098|155481747|FG002|Overall Study|Withdrawal by Subject|0|||
48351011|NCT00813098|155481745|FG000|Overall Study|Inability to complete study procedures|1|||
48351012|NCT00813098|155481746|FG001|Overall Study|Inability to complete study procedures|0|||
48351013|NCT00813098|155481747|FG002|Overall Study|Inability to complete study procedures|0|||
48351014|NCT00813098|155481745|FG000|Overall Study|Lost to Follow-up|0|||
48351015|NCT00813098|155481746|FG001|Overall Study|Lost to Follow-up|1|||
48351016|NCT00813098|155481747|FG002|Overall Study|Lost to Follow-up|0|||
48351017|NCT00813098|155481745|FG000|Overall Study|Protocol Violation|0|||
48351018|NCT00813098|155481746|FG001|Overall Study|Protocol Violation|0|||
48351019|NCT00813098|155481747|FG002|Overall Study|Protocol Violation|1|||
48351020|NCT00813098|155481745|FG000|Overall Study|Principal Investigator decision|0|||
48351021|NCT00813098|155481746|FG001|Overall Study|Principal Investigator decision|1|||
48351022|NCT00813098|155481747|FG002|Overall Study|Principal Investigator decision|0|||
48351023|NCT00813098|155481745|FG000|Overall Study|Withdrew Consent|0|||
48351024|NCT00813098|155481746|FG001|Overall Study|Withdrew Consent|1|||
48351025|NCT00813098|155481747|FG002|Overall Study|Withdrew Consent|0|||
48351026|NCT03201900|155481748|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
48351027|NCT03201900|155481748|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
48351028|NCT03201900|155481748|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
48351029|NCT03201900|155481748|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
48351030|NCT03201900|155481748|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
48351031|NCT03201900|155481748|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
48351032|NCT03201900|155481748|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
48351033|NCT03201900|155481748|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
48351034|NCT03201900|155481748|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
48351035|NCT03201900|155481748|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
48351036|NCT03201900|155481748|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
48351037|NCT03201900|155481748|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
48351038|NCT03201900|155481748|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
48351039|NCT03470545|155481749|FG000|Overall Study|Death|0|||
48351040|NCT03470545|155481750|FG001|Overall Study|Death|1|||
48351041|NCT03470545|155481749|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
48351042|NCT03470545|155481750|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
48351043|NCT03470545|155481749|FG000|Overall Study|Adverse Event|2|||
48351044|NCT03470545|155481750|FG001|Overall Study|Adverse Event|0|||
48351045|NCT03470545|155481749|FG000|Overall Study|Withdrawal by Subject|1|||
48351046|NCT03470545|155481750|FG001|Overall Study|Withdrawal by Subject|1|||
48351047|NCT03470545|155481749|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
48351048|NCT03470545|155481750|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
48351049|NCT01233999|155481751|FG000|Overall Study|Withdrawal by Subject|1|||
48351050|NCT01233999|155481751|FG000|Overall Study|Lost to Follow-up|1|||
48351051|NCT02835092|155481756|FG000|Overall Study|Withdrawal by Subject|3|||
48675563|NCT03657095|156663530|FG001|Overall Study|Study Terminated by Sponsor|49|||
48675564|NCT01743040|156663531|FG000|Overall Study|Death|1|||
48675565|NCT01743040|156663531|FG000|Overall Study|Lost to Follow-up|66|||
48675566|NCT01743040|156663531|FG000|Overall Study|Physician Decision|40|||
48351052|NCT02835092|155481757|FG001|Overall Study|Withdrawal by Subject|6|||
48351053|NCT02835092|155481758|FG002|Overall Study|Withdrawal by Subject|3|||
48351054|NCT02835092|155481756|FG000|Overall Study|Lost to Follow-up|0|||
48351055|NCT02835092|155481757|FG001|Overall Study|Lost to Follow-up|2|||
48351056|NCT02835092|155481758|FG002|Overall Study|Lost to Follow-up|0|||
48351057|NCT00621192|155481764|FG000|Overall Study|Withdrawal by Subject|0|||
48351058|NCT00621192|155481765|FG001|Overall Study|Withdrawal by Subject|0|||
48351059|NCT00621192|155481766|FG002|Overall Study|Withdrawal by Subject|2|||
48675567|NCT01743040|156663531|FG000|Overall Study|Protocol Violation|1|||
48675568|NCT01743040|156663531|FG000|Overall Study|Withdrawal by Subject|121|||
48351060|NCT00621192|155481767|FG003|Overall Study|Withdrawal by Subject|0|||
48351061|NCT00621192|155481764|FG000|Overall Study|Physician Decision|1|||
48351062|NCT00621192|155481765|FG001|Overall Study|Physician Decision|3|||
48351063|NCT00621192|155481766|FG002|Overall Study|Physician Decision|0|||
48351064|NCT00621192|155481767|FG003|Overall Study|Physician Decision|0|||
48351065|NCT00621192|155481764|FG000|Overall Study|Protocol Violation|1|||
48351066|NCT00621192|155481765|FG001|Overall Study|Protocol Violation|0|||
48351067|NCT00621192|155481766|FG002|Overall Study|Protocol Violation|0|||
48351068|NCT00621192|155481767|FG003|Overall Study|Protocol Violation|1|||
48351069|NCT00621192|155481764|FG000|Overall Study|Adverse Event|0|||
48351070|NCT00621192|155481765|FG001|Overall Study|Adverse Event|1|||
48351071|NCT00621192|155481766|FG002|Overall Study|Adverse Event|0|||
48351072|NCT00621192|155481767|FG003|Overall Study|Adverse Event|1|||
48351073|NCT00621192|155481764|FG000|Overall Study|Death|2|||
48351074|NCT00621192|155481765|FG001|Overall Study|Death|5|||
48351075|NCT00621192|155481766|FG002|Overall Study|Death|0|||
48351076|NCT00621192|155481767|FG003|Overall Study|Death|0|||
48351077|NCT00621192|155481764|FG000|Overall Study|Final Assessments not Completed|0|||
48351078|NCT00621192|155481765|FG001|Overall Study|Final Assessments not Completed|0|||
48351079|NCT00621192|155481766|FG002|Overall Study|Final Assessments not Completed|3|||
48351080|NCT00621192|155481767|FG003|Overall Study|Final Assessments not Completed|1|||
48351081|NCT04016272|155481775|FG000|Overall Study|Withdrawal by Subject|1|||
48351082|NCT04016272|155481776|FG001|Overall Study|Withdrawal by Subject|2|||
48351083|NCT01078922|155481777|FG000|Overall Study|Adverse Event|1|||
48351084|NCT03432390|155481782|FG000|Apnea Period|Protocol Violation|2|||
48351085|NCT03432390|155481783|FG001|Apnea Period|Protocol Violation|2|||
48351086|NCT00003477|155481784|FG000|Overall Study|Not evalauable|4|||
48351087|NCT01236352|155481785|FG000|Overall Study|Death|0|||
48351088|NCT01236352|155481786|FG001|Overall Study|Death|0|||
48351089|NCT01236352|155481787|FG002|Overall Study|Death|0|||
48351090|NCT01236352|155481788|FG003|Overall Study|Death|0|||
48351091|NCT01236352|155481789|FG004|Overall Study|Death|0|||
48351092|NCT01236352|155481790|FG005|Overall Study|Death|0|||
48351093|NCT01236352|155481791|FG006|Overall Study|Death|0|||
48351094|NCT01236352|155481792|FG007|Overall Study|Death|1|||
48351095|NCT01236352|155481793|FG008|Overall Study|Death|0|||
48351096|NCT01236352|155481794|FG009|Overall Study|Death|0|||
48351097|NCT01236352|155481795|FG010|Overall Study|Death|0|||
48351098|NCT01236352|155481785|FG000|Overall Study|Withdrawal by Subject|0|||
48351099|NCT01236352|155481786|FG001|Overall Study|Withdrawal by Subject|0|||
48351100|NCT01236352|155481787|FG002|Overall Study|Withdrawal by Subject|0|||
48351101|NCT01236352|155481788|FG003|Overall Study|Withdrawal by Subject|0|||
48351102|NCT01236352|155481789|FG004|Overall Study|Withdrawal by Subject|0|||
48351103|NCT01236352|155481790|FG005|Overall Study|Withdrawal by Subject|0|||
48351104|NCT01236352|155481791|FG006|Overall Study|Withdrawal by Subject|0|||
48351105|NCT01236352|155481792|FG007|Overall Study|Withdrawal by Subject|0|||
48351106|NCT01236352|155481793|FG008|Overall Study|Withdrawal by Subject|0|||
48351107|NCT01236352|155481794|FG009|Overall Study|Withdrawal by Subject|2|||
48351108|NCT01236352|155481795|FG010|Overall Study|Withdrawal by Subject|1|||
48351109|NCT01236352|155481785|FG000|Overall Study|Adverse Event|0|||
48351110|NCT01236352|155481786|FG001|Overall Study|Adverse Event|0|||
48351111|NCT01236352|155481787|FG002|Overall Study|Adverse Event|0|||
48761949|NCT02036502|156975719|FG002|Part 3:Dose Expansion|Not Treated|0|||
48761950|NCT02036502|156975720|FG003|Part 3:Dose Expansion|Not Treated|0|||
48351112|NCT01236352|155481788|FG003|Overall Study|Adverse Event|0|||
48351113|NCT01236352|155481789|FG004|Overall Study|Adverse Event|0|||
48351114|NCT01236352|155481790|FG005|Overall Study|Adverse Event|0|||
48351115|NCT01236352|155481791|FG006|Overall Study|Adverse Event|2|||
48351116|NCT01236352|155481792|FG007|Overall Study|Adverse Event|0|||
48351117|NCT01236352|155481793|FG008|Overall Study|Adverse Event|0|||
48351118|NCT01236352|155481794|FG009|Overall Study|Adverse Event|4|||
48351119|NCT01236352|155481795|FG010|Overall Study|Adverse Event|1|||
48761951|NCT02036502|156975721|FG004|Part 3:Dose Expansion|Not Treated|0|||
48351120|NCT01236352|155481785|FG000|Overall Study|Study drug toxicity|0|||
48351121|NCT01236352|155481786|FG001|Overall Study|Study drug toxicity|0|||
48351122|NCT01236352|155481787|FG002|Overall Study|Study drug toxicity|0|||
48351123|NCT01236352|155481788|FG003|Overall Study|Study drug toxicity|0|||
48351124|NCT01236352|155481789|FG004|Overall Study|Study drug toxicity|0|||
48351125|NCT01236352|155481790|FG005|Overall Study|Study drug toxicity|1|||
48351126|NCT01236352|155481791|FG006|Overall Study|Study drug toxicity|1|||
48351127|NCT01236352|155481792|FG007|Overall Study|Study drug toxicity|0|||
48351128|NCT01236352|155481793|FG008|Overall Study|Study drug toxicity|0|||
48351129|NCT01236352|155481794|FG009|Overall Study|Study drug toxicity|2|||
48761952|NCT02036502|156975722|FG005|Part 3:Dose Expansion|Not Treated|2|||
48761953|NCT02036502|156975723|FG006|Part 3:Dose Expansion|Not Treated|0|||
48351130|NCT01236352|155481795|FG010|Overall Study|Study drug toxicity|2|||
48351131|NCT01236352|155481785|FG000|Overall Study|Disease progression|1|||
48351132|NCT01236352|155481786|FG001|Overall Study|Disease progression|2|||
48351133|NCT01236352|155481787|FG002|Overall Study|Disease progression|1|||
48351134|NCT01236352|155481788|FG003|Overall Study|Disease progression|2|||
48761954|NCT02036502|156975724|FG007|Part 3:Dose Expansion|Not Treated|0|||
48351135|NCT01236352|155481789|FG004|Overall Study|Disease progression|2|||
48351136|NCT01236352|155481790|FG005|Overall Study|Disease progression|2|||
48351137|NCT01236352|155481791|FG006|Overall Study|Disease progression|1|||
48351138|NCT01236352|155481792|FG007|Overall Study|Disease progression|3|||
48351139|NCT01236352|155481793|FG008|Overall Study|Disease progression|2|||
48351140|NCT01236352|155481794|FG009|Overall Study|Disease progression|2|||
48351141|NCT01236352|155481795|FG010|Overall Study|Disease progression|2|||
48351142|NCT01236352|155481785|FG000|Overall Study|Poor/Non-compliance|1|||
48351143|NCT01236352|155481786|FG001|Overall Study|Poor/Non-compliance|0|||
48351144|NCT01236352|155481787|FG002|Overall Study|Poor/Non-compliance|0|||
48351145|NCT01236352|155481788|FG003|Overall Study|Poor/Non-compliance|0|||
48351146|NCT01236352|155481789|FG004|Overall Study|Poor/Non-compliance|0|||
48351147|NCT01236352|155481790|FG005|Overall Study|Poor/Non-compliance|0|||
48351148|NCT01236352|155481791|FG006|Overall Study|Poor/Non-compliance|0|||
48351149|NCT01236352|155481792|FG007|Overall Study|Poor/Non-compliance|0|||
48351150|NCT01236352|155481793|FG008|Overall Study|Poor/Non-compliance|0|||
48351151|NCT01236352|155481794|FG009|Overall Study|Poor/Non-compliance|0|||
48351152|NCT01236352|155481795|FG010|Overall Study|Poor/Non-compliance|0|||
48351153|NCT01236352|155481785|FG000|Overall Study|Maximum clinical benefit|1|||
48351154|NCT01236352|155481786|FG001|Overall Study|Maximum clinical benefit|1|||
48351155|NCT01236352|155481787|FG002|Overall Study|Maximum clinical benefit|1|||
48351156|NCT01236352|155481788|FG003|Overall Study|Maximum clinical benefit|0|||
48351157|NCT01236352|155481789|FG004|Overall Study|Maximum clinical benefit|2|||
48351158|NCT01236352|155481790|FG005|Overall Study|Maximum clinical benefit|0|||
48351159|NCT01236352|155481791|FG006|Overall Study|Maximum clinical benefit|3|||
48351160|NCT01236352|155481792|FG007|Overall Study|Maximum clinical benefit|1|||
48351161|NCT01236352|155481793|FG008|Overall Study|Maximum clinical benefit|1|||
48351162|NCT01236352|155481794|FG009|Overall Study|Maximum clinical benefit|4|||
48351163|NCT01236352|155481795|FG010|Overall Study|Maximum clinical benefit|2|||
48351164|NCT01236352|155481785|FG000|Overall Study|Subject request to discontinue treatment|0|||
48351165|NCT01236352|155481786|FG001|Overall Study|Subject request to discontinue treatment|0|||
48351166|NCT01236352|155481787|FG002|Overall Study|Subject request to discontinue treatment|1|||
48351167|NCT01236352|155481788|FG003|Overall Study|Subject request to discontinue treatment|1|||
48351168|NCT01236352|155481789|FG004|Overall Study|Subject request to discontinue treatment|0|||
48351169|NCT01236352|155481790|FG005|Overall Study|Subject request to discontinue treatment|1|||
48351170|NCT01236352|155481791|FG006|Overall Study|Subject request to discontinue treatment|0|||
48351171|NCT01236352|155481792|FG007|Overall Study|Subject request to discontinue treatment|0|||
48351172|NCT01236352|155481793|FG008|Overall Study|Subject request to discontinue treatment|0|||
48351173|NCT01236352|155481794|FG009|Overall Study|Subject request to discontinue treatment|1|||
48351174|NCT01236352|155481795|FG010|Overall Study|Subject request to discontinue treatment|4|||
48351175|NCT01236352|155481785|FG000|Overall Study|Subject to receive drug via EAP|1|||
48351176|NCT01236352|155481786|FG001|Overall Study|Subject to receive drug via EAP|1|||
48351177|NCT01236352|155481787|FG002|Overall Study|Subject to receive drug via EAP|1|||
48351178|NCT01236352|155481788|FG003|Overall Study|Subject to receive drug via EAP|0|||
48351179|NCT01236352|155481789|FG004|Overall Study|Subject to receive drug via EAP|0|||
48351180|NCT01236352|155481790|FG005|Overall Study|Subject to receive drug via EAP|0|||
48351181|NCT01236352|155481791|FG006|Overall Study|Subject to receive drug via EAP|0|||
48351182|NCT01236352|155481792|FG007|Overall Study|Subject to receive drug via EAP|2|||
48351183|NCT01236352|155481793|FG008|Overall Study|Subject to receive drug via EAP|0|||
48351184|NCT01236352|155481794|FG009|Overall Study|Subject to receive drug via EAP|4|||
48351185|NCT01236352|155481795|FG010|Overall Study|Subject to receive drug via EAP|0|||
48351186|NCT01236352|155481785|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
48351187|NCT01236352|155481786|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
48351188|NCT01236352|155481787|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
48351189|NCT01236352|155481788|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
48351190|NCT01236352|155481789|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
48351191|NCT01236352|155481790|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
48675569|NCT01894243|156663532|FG000|Overall Study|Adverse Event|0|||
48675570|NCT01894243|156663533|FG001|Overall Study|Adverse Event|1|||
48351192|NCT01236352|155481791|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
48351193|NCT01236352|155481792|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
48351194|NCT01236352|155481793|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
48351195|NCT01236352|155481794|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
48675571|NCT01894243|156663534|FG002|Overall Study|Adverse Event|2|||
48675572|NCT01894243|156663532|FG000|Overall Study|Death|0|||
48675573|NCT01894243|156663533|FG001|Overall Study|Death|0|||
48351196|NCT01236352|155481795|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
48351197|NCT01236352|155481785|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351198|NCT01236352|155481786|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351199|NCT01236352|155481787|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351200|NCT01236352|155481788|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48675574|NCT01894243|156663534|FG002|Overall Study|Death|3|||
48675575|NCT01894243|156663532|FG000|Overall Study|Lack of Efficacy|3|||
48675576|NCT01894243|156663533|FG001|Overall Study|Lack of Efficacy|3|||
48675577|NCT01894243|156663534|FG002|Overall Study|Lack of Efficacy|1|||
48675578|NCT01894243|156663532|FG000|Overall Study|Condition under investigation worsened|8|||
48675579|NCT01894243|156663533|FG001|Overall Study|Condition under investigation worsened|6|||
48675580|NCT01894243|156663534|FG002|Overall Study|Condition under investigation worsened|2|||
48675581|NCT01894243|156663532|FG000|Overall Study|Subject decision|1|||
48675582|NCT01894243|156663533|FG001|Overall Study|Subject decision|0|||
48675583|NCT01894243|156663534|FG002|Overall Study|Subject decision|0|||
48675584|NCT01894243|156663532|FG000|Overall Study|Other|1|||
48675585|NCT01894243|156663533|FG001|Overall Study|Other|0|||
48675586|NCT01894243|156663534|FG002|Overall Study|Other|0|||
48675587|NCT00828750|156663535|FG000|Overall Study|Lack of Efficacy|3|||
48675588|NCT00828750|156663535|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
48675589|NCT00765063|156665332|FG000|Overall Study|Lack of Efficacy|5|||
48675590|NCT00765063|156665332|FG000|Overall Study|Withdrawal by Subject|1|||
48675591|NCT00765063|156665332|FG000|Overall Study|Other|16|||
48675592|NCT00765063|156665332|FG000|Overall Study|Protocol Violation|6|||
48675593|NCT00765063|156665332|FG000|Overall Study|Adverse Event|4|||
48675594|NCT03416127|156665333|FG000|Overall Study|Withdrawal by Subject|0|||
48675595|NCT03416127|156665334|FG001|Overall Study|Withdrawal by Subject|1|||
48675596|NCT03416127|156665335|FG002|Overall Study|Withdrawal by Subject|1|||
48351201|NCT01236352|155481789|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351202|NCT01236352|155481790|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351203|NCT01236352|155481791|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351204|NCT01236352|155481792|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351205|NCT01236352|155481793|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351206|NCT01236352|155481794|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
48351207|NCT01236352|155481795|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
48351208|NCT01236352|155481785|FG000|Overall Study|Lack of response to drug|0|||
48351209|NCT01236352|155481786|FG001|Overall Study|Lack of response to drug|0|||
48351210|NCT01236352|155481787|FG002|Overall Study|Lack of response to drug|0|||
48351211|NCT01236352|155481788|FG003|Overall Study|Lack of response to drug|0|||
48351212|NCT01236352|155481789|FG004|Overall Study|Lack of response to drug|0|||
48351213|NCT01236352|155481790|FG005|Overall Study|Lack of response to drug|0|||
48351214|NCT01236352|155481791|FG006|Overall Study|Lack of response to drug|0|||
48351215|NCT01236352|155481792|FG007|Overall Study|Lack of response to drug|0|||
48351216|NCT01236352|155481793|FG008|Overall Study|Lack of response to drug|0|||
48351217|NCT01236352|155481794|FG009|Overall Study|Lack of response to drug|1|||
48351218|NCT01236352|155481795|FG010|Overall Study|Lack of response to drug|1|||
48351219|NCT01236352|155481785|FG000|Overall Study|Patient transferred to IST|0|||
48351220|NCT01236352|155481786|FG001|Overall Study|Patient transferred to IST|0|||
48351221|NCT01236352|155481787|FG002|Overall Study|Patient transferred to IST|0|||
48351222|NCT01236352|155481788|FG003|Overall Study|Patient transferred to IST|0|||
48351223|NCT01236352|155481789|FG004|Overall Study|Patient transferred to IST|0|||
48351224|NCT01236352|155481790|FG005|Overall Study|Patient transferred to IST|0|||
48351225|NCT01236352|155481791|FG006|Overall Study|Patient transferred to IST|0|||
48351226|NCT01236352|155481792|FG007|Overall Study|Patient transferred to IST|0|||
48351227|NCT01236352|155481793|FG008|Overall Study|Patient transferred to IST|0|||
48351228|NCT01236352|155481794|FG009|Overall Study|Patient transferred to IST|2|||
48351229|NCT01236352|155481795|FG010|Overall Study|Patient transferred to IST|6|||
48351230|NCT01774305|155481797|FG000|Overall Study|Physician Decision|1|||
48351231|NCT01774305|155481798|FG001|Overall Study|Physician Decision|0|||
48351232|NCT04211389|155481799|FG000|Overall Study|Adverse Event|1|||
48351233|NCT04211389|155481800|FG001|Overall Study|Adverse Event|2|||
48351234|NCT04211389|155481799|FG000|Overall Study|Lost to Follow-up|15|||
48351235|NCT04211389|155481800|FG001|Overall Study|Lost to Follow-up|7|||
48351236|NCT04211389|155481799|FG000|Overall Study|Protocol Violation|0|||
48351237|NCT04211389|155481800|FG001|Overall Study|Protocol Violation|1|||
48351238|NCT04211389|155481799|FG000|Overall Study|Withdrawal by Subject|10|||
48351239|NCT04211389|155481800|FG001|Overall Study|Withdrawal by Subject|11|||
48351240|NCT02689453|155481808|FG000|Overall Study|Progressive disease|0|||
48351241|NCT02689453|155481809|FG001|Overall Study|Progressive disease|1|||
48351242|NCT02689453|155481810|FG002|Overall Study|Progressive disease|1|||
48351243|NCT03327831|155481812|FG000|Overall Study|Lost to Follow-up|2|||
48351244|NCT01658020|155481813|FG000|Overall Study|Adverse Event|3|||
48351245|NCT01658020|155481814|FG001|Overall Study|Adverse Event|3|||
48351246|NCT01658020|155481813|FG000|Overall Study|Lost to Follow-up|1|||
48351247|NCT01658020|155481814|FG001|Overall Study|Lost to Follow-up|0|||
48351248|NCT01658020|155481813|FG000|Overall Study|Withdrawal by Subject|4|||
48351249|NCT01658020|155481814|FG001|Overall Study|Withdrawal by Subject|5|||
48351250|NCT01658020|155481813|FG000|Overall Study|Protocol Violation|0|||
48351251|NCT01658020|155481814|FG001|Overall Study|Protocol Violation|1|||
48351252|NCT00725543|155481818|FG000|Overall Study|Adverse Event|10|||
48351253|NCT00725543|155481818|FG000|Overall Study|Lack of Efficacy|3|||
48351254|NCT00725543|155481818|FG000|Overall Study|Withdrawal by Subject|10|||
48351255|NCT00725543|155481818|FG000|Overall Study|Physician Decision|5|||
48351256|NCT00725543|155481818|FG000|Overall Study|Lost to Follow-up|4|||
48351257|NCT00725543|155481818|FG000|Overall Study|Non-compliance|2|||
48351258|NCT00725543|155481818|FG000|Overall Study|Other|119|||
48351259|NCT00927901|155481819|FG000|Treatment Period 1|Subject withdrew consent|0|||
48351260|NCT00927901|155481820|FG001|Treatment Period 1|Subject withdrew consent|0|||
48351261|NCT00927901|155481821|FG002|Treatment Period 1|Subject withdrew consent|1|||
48351262|NCT00927901|155481822|FG003|Treatment Period 1|Subject withdrew consent|0|||
48351263|NCT00927901|155481819|FG000|Treatment Period 4|Adverse Event|0|||
48351264|NCT00927901|155481820|FG001|Treatment Period 4|Adverse Event|0|||
48351265|NCT00927901|155481821|FG002|Treatment Period 4|Adverse Event|0|||
48351266|NCT00927901|155481822|FG003|Treatment Period 4|Adverse Event|1|||
48351267|NCT00927901|155481819|FG000|Treatment Period 4|Subject withdrew consent|0|||
48351268|NCT00927901|155481820|FG001|Treatment Period 4|Subject withdrew consent|0|||
48351269|NCT00927901|155481821|FG002|Treatment Period 4|Subject withdrew consent|1|||
48351270|NCT00927901|155481822|FG003|Treatment Period 4|Subject withdrew consent|0|||
48351271|NCT01128114|155481823|FG000|Overall Study|Treatment Withdrawn|6|||
48351272|NCT01128114|155481823|FG000|Overall Study|Screening Failed|2|||
48351273|NCT01214421|155481827|FG000|Overall Study|Lost to Follow-up|7|||
48351274|NCT01214421|155481828|FG001|Overall Study|Lost to Follow-up|3|||
48351275|NCT01214421|155481829|FG002|Overall Study|Lost to Follow-up|7|||
48351276|NCT01214421|155481830|FG003|Overall Study|Lost to Follow-up|3|||
48351277|NCT01214421|155481827|FG000|Overall Study|Adverse Event|16|||
48351278|NCT01214421|155481828|FG001|Overall Study|Adverse Event|35|||
48351279|NCT01214421|155481829|FG002|Overall Study|Adverse Event|14|||
48351280|NCT01214421|155481830|FG003|Overall Study|Adverse Event|3|||
48351281|NCT01214421|155481827|FG000|Overall Study|Sponsor Discontinued Site|1|||
48351282|NCT01214421|155481828|FG001|Overall Study|Sponsor Discontinued Site|2|||
48351283|NCT01214421|155481829|FG002|Overall Study|Sponsor Discontinued Site|0|||
48351284|NCT01214421|155481830|FG003|Overall Study|Sponsor Discontinued Site|0|||
48351285|NCT01214421|155481827|FG000|Overall Study|Withdrawal Criteria Met|3|||
48351286|NCT01214421|155481828|FG001|Overall Study|Withdrawal Criteria Met|0|||
48351287|NCT01214421|155481829|FG002|Overall Study|Withdrawal Criteria Met|2|||
48351288|NCT01214421|155481830|FG003|Overall Study|Withdrawal Criteria Met|1|||
48351289|NCT01214421|155481827|FG000|Overall Study|Physician Decision|2|||
48351290|NCT01214421|155481828|FG001|Overall Study|Physician Decision|0|||
48351291|NCT01214421|155481829|FG002|Overall Study|Physician Decision|4|||
48351292|NCT01214421|155481830|FG003|Overall Study|Physician Decision|0|||
48351293|NCT01214421|155481827|FG000|Overall Study|Withdrawal by Subject|21|||
48675597|NCT02522325|156665336|FG000|Overall Study|Adverse Event|0|||
48675598|NCT02522325|156665337|FG001|Overall Study|Adverse Event|1|||
48675599|NCT01629953|156665340|FG000|Overall Study|Death|3|||
48675600|NCT01629953|156665341|FG001|Overall Study|Death|1|||
48675601|NCT01629953|156665340|FG000|Overall Study|Lost to Follow-up|10|||
48675602|NCT01629953|156665341|FG001|Overall Study|Lost to Follow-up|14|||
48675603|NCT02783599|156665342|FG000|Overall Study|Progressive disease|23|||
48675604|NCT02783599|156665342|FG000|Overall Study|Surgical Resection|10|||
48675605|NCT02783599|156665342|FG000|Overall Study|Adverse Event|4|||
48675606|NCT02783599|156665342|FG000|Overall Study|Physician Decision|2|||
48675607|NCT02783599|156665342|FG000|Overall Study|Death|1|||
48675608|NCT00615030|156665343|FG000|Period I|Administrative problem|0|||
48675609|NCT00615030|156665344|FG001|Period I|Administrative problem|0|||
48675610|NCT00615030|156665345|FG002|Period I|Administrative problem|0|||
48675611|NCT00615030|156665346|FG003|Period I|Administrative problem|0|||
48675612|NCT00615030|156665347|FG004|Period I|Administrative problem|1|||
48675613|NCT00615030|156665348|FG005|Period I|Administrative problem|0|||
48675614|NCT00615030|156665349|FG006|Period I|Administrative problem|0|||
48761955|NCT03065244|156975726|FG000|Overall Study|Lost to Follow-up|1|||
48761956|NCT03065244|156975727|FG001|Overall Study|Lost to Follow-up|1|||
48761957|NCT03065244|156975726|FG000|Overall Study|Diagnosed with a different disease|1|||
48761958|NCT03065244|156975727|FG001|Overall Study|Diagnosed with a different disease|1|||
48761959|NCT03065244|156975726|FG000|Overall Study|Protocol Violation|0|||
48761960|NCT03065244|156975727|FG001|Overall Study|Protocol Violation|1|||
48761961|NCT03065244|156975726|FG000|Overall Study|Withdrawal by Subject|1|||
48761962|NCT03065244|156975727|FG001|Overall Study|Withdrawal by Subject|1|||
48761963|NCT02291055|156975731|FG000|Overall Study|Death|2|||
48761964|NCT02291055|156975732|FG001|Overall Study|Death|2|||
48761965|NCT02291055|156975733|FG002|Overall Study|Death|5|||
48761966|NCT02291055|156975734|FG003|Overall Study|Death|8|||
48761967|NCT02291055|156975735|FG004|Overall Study|Death|12|||
48761968|NCT02291055|156975731|FG000|Overall Study|Lost to Follow-up|0|||
48761969|NCT02291055|156975732|FG001|Overall Study|Lost to Follow-up|0|||
48761970|NCT02291055|156975733|FG002|Overall Study|Lost to Follow-up|0|||
48761971|NCT02291055|156975734|FG003|Overall Study|Lost to Follow-up|1|||
48761972|NCT02291055|156975735|FG004|Overall Study|Lost to Follow-up|2|||
48761973|NCT02291055|156975731|FG000|Overall Study|Withdrawal by Subject|3|||
48761974|NCT02291055|156975732|FG001|Overall Study|Withdrawal by Subject|1|||
48761975|NCT02291055|156975733|FG002|Overall Study|Withdrawal by Subject|1|||
48761976|NCT02291055|156975734|FG003|Overall Study|Withdrawal by Subject|5|||
48761977|NCT02291055|156975735|FG004|Overall Study|Withdrawal by Subject|10|||
48761978|NCT02291055|156975731|FG000|Overall Study|Progressive Disease|0|||
48761979|NCT02291055|156975732|FG001|Overall Study|Progressive Disease|0|||
48761980|NCT02291055|156975733|FG002|Overall Study|Progressive Disease|1|||
48761981|NCT02291055|156975734|FG003|Overall Study|Progressive Disease|4|||
48761982|NCT02291055|156975735|FG004|Overall Study|Progressive Disease|2|||
48761983|NCT02291055|156975731|FG000|Overall Study|Study Terminated by Sponsor|0|||
48761984|NCT02291055|156975732|FG001|Overall Study|Study Terminated by Sponsor|0|||
48351294|NCT01214421|155481828|FG001|Overall Study|Withdrawal by Subject|18|||
48351295|NCT01214421|155481829|FG002|Overall Study|Withdrawal by Subject|11|||
48351296|NCT01214421|155481830|FG003|Overall Study|Withdrawal by Subject|2|||
48675615|NCT00615030|156665350|FG007|Period I|Administrative problem|0|||
48675616|NCT00615030|156665351|FG008|Period I|Administrative problem|0|||
48675617|NCT00615030|156665352|FG009|Period I|Administrative problem|0|||
48675618|NCT00615030|156665353|FG010|Period I|Administrative problem|0|||
48761985|NCT02291055|156975733|FG002|Overall Study|Study Terminated by Sponsor|0|||
48761986|NCT02291055|156975734|FG003|Overall Study|Study Terminated by Sponsor|5|||
48761987|NCT02291055|156975735|FG004|Overall Study|Study Terminated by Sponsor|1|||
48761988|NCT02291055|156975731|FG000|Overall Study|Other|0|||
48761989|NCT02291055|156975732|FG001|Overall Study|Other|2|||
48761990|NCT02291055|156975733|FG002|Overall Study|Other|1|||
48761991|NCT02291055|156975734|FG003|Overall Study|Other|4|||
48761992|NCT02291055|156975735|FG004|Overall Study|Other|0|||
48351297|NCT00844597|155481833|FG000|Overall Study|Adverse Event|0|||
48351298|NCT00844597|155481834|FG001|Overall Study|Adverse Event|0|||
48351299|NCT00844597|155481835|FG002|Overall Study|Adverse Event|0|||
48351300|NCT00844597|155481836|FG003|Overall Study|Adverse Event|1|||
48351301|NCT00844597|155481837|FG004|Overall Study|Adverse Event|0|||
48351302|NCT00844597|155481838|FG005|Overall Study|Adverse Event|0|||
48351303|NCT02581059|155481839|FG000|Study Treatment|Disease Progression|1|||
48351304|NCT02581059|155481840|FG001|Study Treatment|Disease Progression|1|||
48351305|NCT02581059|155481839|FG000|Study Treatment|Adverse Event|2|||
48351306|NCT02581059|155481840|FG001|Study Treatment|Adverse Event|1|||
48351307|NCT02581059|155481839|FG000|Study Treatment|Death|1|||
48351308|NCT02581059|155481840|FG001|Study Treatment|Death|1|||
48351309|NCT02581059|155481839|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
48351310|NCT02581059|155481840|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
48351311|NCT02581059|155481839|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
48351312|NCT02581059|155481840|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
48351313|NCT02581059|155481839|FG000|Follow up|Death|1|||
48351314|NCT02581059|155481840|FG001|Follow up|Death|3|||
48351315|NCT02581059|155481839|FG000|Follow up|study terminated|1|||
48351316|NCT02581059|155481840|FG001|Follow up|study terminated|1|||
48351317|NCT02581059|155481839|FG000|Follow up|screen failure|0|||
48351318|NCT02581059|155481840|FG001|Follow up|screen failure|1|||
48351319|NCT02581059|155481839|FG000|Follow up|Patient started new clinical trial|1|||
48351320|NCT02581059|155481840|FG001|Follow up|Patient started new clinical trial|0|||
48351321|NCT01056263|155481843|FG000|Overall Study|Adverse Event|12|||
48351322|NCT01056263|155481843|FG000|Overall Study|Death|1|||
48351323|NCT01056263|155481843|FG000|Overall Study|Withdrawal by Subject|1|||
48351324|NCT01056263|155481843|FG000|Overall Study|Lack of Efficacy|29|||
48351325|NCT01056263|155481843|FG000|Overall Study|Progressive disease|2|||
48351326|NCT01056263|155481843|FG000|Overall Study|Neoplasm progression|1|||
48351327|NCT01056263|155481843|FG000|Overall Study|Objective progression or relapse|1|||
48351328|NCT01056263|155481843|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
48351329|NCT02636608|155481844|FG000|Overall Study|Failure to Return|4|||
48351330|NCT02636608|155481844|FG000|Overall Study|Insufficient Virological Response|1|||
48351331|NCT02636608|155481844|FG000|Overall Study|Death|3|||
48351332|NCT02636608|155481844|FG000|Overall Study|Other|2|||
48351333|NCT02636608|155481844|FG000|Overall Study|Did Not Receive Treatment|1|||
48351334|NCT01256671|155482935|FG000|Overall Study|Adverse Event|29|||
48351335|NCT01256671|155482935|FG000|Overall Study|Lost to Follow-up|16|||
48351336|NCT01256671|155482935|FG000|Overall Study|Withdrawal by Subject|31|||
48351337|NCT01256671|155482935|FG000|Overall Study|Physician Decision|3|||
48351338|NCT01256671|155482935|FG000|Overall Study|Lack of Efficacy|4|||
48351339|NCT01256671|155482935|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
48351340|NCT00908349|155482938|FG000|Overall Study|Adverse Event|10|||
48351341|NCT00908349|155482938|FG000|Overall Study|Withdrawal by Subject|9|||
48351342|NCT00908349|155482938|FG000|Overall Study|Physician Decision|5|||
48351343|NCT00908349|155482938|FG000|Overall Study|Lost to Follow-up|5|||
48351344|NCT00908349|155482938|FG000|Overall Study|Various|6|||
48351345|NCT01468077|155482941|FG000|Overall Study|Adverse Event|2|||
48351346|NCT01468077|155482942|FG001|Overall Study|Adverse Event|2|||
48351347|NCT01468077|155482941|FG000|Overall Study|Lack of Efficacy|1|||
48351348|NCT01468077|155482942|FG001|Overall Study|Lack of Efficacy|1|||
48351349|NCT01468077|155482941|FG000|Overall Study|Physician Decision|1|||
48351350|NCT01468077|155482942|FG001|Overall Study|Physician Decision|0|||
48351351|NCT04009629|155482943|FG000|Overall Study|Withdrawal by Subject|2|||
48351352|NCT04009629|155482944|FG001|Overall Study|Withdrawal by Subject|0|||
48351353|NCT00761956|155482945|FG000|Overall Study|Lost to Follow-up|6|||
48351354|NCT00761956|155482946|FG001|Overall Study|Lost to Follow-up|11|||
48351355|NCT00761956|155482945|FG000|Overall Study|Withdrawal by Subject|3|||
48351356|NCT00761956|155482946|FG001|Overall Study|Withdrawal by Subject|8|||
48351357|NCT00761956|155482945|FG000|Overall Study|Death|0|||
48351358|NCT00761956|155482946|FG001|Overall Study|Death|1|||
48351359|NCT00761956|155482945|FG000|Overall Study|Adverse Event|26|||
48761993|NCT01393405|156975736|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
48761994|NCT01393405|156975737|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
48761995|NCT01393405|156975738|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
48761996|NCT01393405|156975736|FG000|Induction Period (week1-16)|Adverse Event|16|||
48761997|NCT01393405|156975737|FG001|Induction Period (week1-16)|Adverse Event|0|||
48351360|NCT00761956|155482946|FG001|Overall Study|Adverse Event|34|||
48351361|NCT03834623|155482948|FG000|Overall Study|Progression|0|||
48351362|NCT03834623|155482949|FG001|Overall Study|Progression|1|||
48351363|NCT04398368|155482952|FG000|Overall Study|Withdrawal by Subject|2|||
48351364|NCT01375751|155482956|FG000|Overall Study|Other|0|||
48351365|NCT01375751|155482957|FG001|Overall Study|Other|1|||
48351366|NCT01375751|155482958|FG002|Overall Study|Other|0|||
48351367|NCT00559377|155482966|FG000|Overall Study|Withdrawal by Subject|9|||
48351368|NCT03672175|155482969|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
48761998|NCT01393405|156975738|FG002|Induction Period (week1-16)|Adverse Event|0|||
48351369|NCT03672175|155482970|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
48351370|NCT03672175|155482971|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
48351371|NCT03672175|155482969|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
48351372|NCT03672175|155482970|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
48351373|NCT03672175|155482971|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
48351374|NCT03672175|155482969|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
48351375|NCT03672175|155482970|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
48351376|NCT03672175|155482971|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
48351377|NCT03672175|155482969|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
48351378|NCT03672175|155482970|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
48351379|NCT03672175|155482971|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
48351380|NCT03672175|155482969|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
48351381|NCT03672175|155482970|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
48351382|NCT03672175|155482971|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
48351383|NCT03672175|155482969|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
48351384|NCT03672175|155482970|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
48351385|NCT03672175|155482971|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
48351386|NCT03672175|155482969|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
48351387|NCT03672175|155482970|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
48351388|NCT03672175|155482971|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
48351389|NCT03672175|155482969|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
48351390|NCT03672175|155482970|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
48351391|NCT03672175|155482971|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
48351392|NCT03672175|155482969|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
48351393|NCT03672175|155482970|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
48351394|NCT03672175|155482971|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
48351395|NCT03672175|155482969|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
48351396|NCT03672175|155482970|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
48351397|NCT03672175|155482971|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
48351398|NCT03672175|155482969|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
48351399|NCT03672175|155482970|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
48351400|NCT03672175|155482971|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
48351401|NCT03672175|155482969|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
48351402|NCT03672175|155482970|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
48351403|NCT03672175|155482971|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
48351404|NCT02818998|155482974|FG000|Overall Study|Adverse Event|3|||
48351405|NCT02818998|155482975|FG001|Overall Study|Adverse Event|2|||
48351406|NCT02818998|155482976|FG002|Overall Study|Adverse Event|1|||
48351407|NCT02818998|155482974|FG000|Overall Study|Lost to Follow-up|4|||
48351408|NCT02818998|155482975|FG001|Overall Study|Lost to Follow-up|1|||
48351409|NCT02818998|155482976|FG002|Overall Study|Lost to Follow-up|2|||
48351410|NCT02818998|155482974|FG000|Overall Study|Withdrawal by sponsor|0|||
48351411|NCT02818998|155482975|FG001|Overall Study|Withdrawal by sponsor|1|||
48351412|NCT02818998|155482976|FG002|Overall Study|Withdrawal by sponsor|1|||
48351413|NCT02818998|155482974|FG000|Overall Study|Death|3|||
48351414|NCT02818998|155482975|FG001|Overall Study|Death|6|||
48351415|NCT02818998|155482976|FG002|Overall Study|Death|8|||
48351416|NCT02818998|155482974|FG000|Overall Study|Withdrawal by Subject|7|||
48351417|NCT02818998|155482975|FG001|Overall Study|Withdrawal by Subject|6|||
48351418|NCT02818998|155482976|FG002|Overall Study|Withdrawal by Subject|6|||
48351419|NCT02818998|155482974|FG000|Overall Study|Physician Decision|1|||
48351420|NCT02818998|155482975|FG001|Overall Study|Physician Decision|0|||
48351421|NCT02818998|155482976|FG002|Overall Study|Physician Decision|0|||
48351422|NCT02547441|155482977|FG000|Double-Blind Study Period|Adverse Event|4|||
48351423|NCT02547441|155482978|FG001|Double-Blind Study Period|Adverse Event|9|||
48351424|NCT02547441|155482977|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
48351425|NCT02547441|155482978|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
48351426|NCT02547441|155482977|FG000|Double-Blind Study Period|Physician Decision|1|||
48351427|NCT02547441|155482978|FG001|Double-Blind Study Period|Physician Decision|0|||
48351428|NCT02547441|155482977|FG000|Double-Blind Study Period|Protocol Violation|1|||
48351429|NCT02547441|155482978|FG001|Double-Blind Study Period|Protocol Violation|2|||
48351430|NCT02547441|155482977|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
48351431|NCT02547441|155482978|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
48351432|NCT02547441|155482977|FG000|Double-Blind Study Period|Sponsor Decision|1|||
48351433|NCT02547441|155482978|FG001|Double-Blind Study Period|Sponsor Decision|0|||
48351434|NCT02547441|155482977|FG000|Open-Label Study Period|Adverse Event|10|||
48351435|NCT02547441|155482978|FG001|Open-Label Study Period|Adverse Event|11|||
48351436|NCT02547441|155482977|FG000|Open-Label Study Period|Lack of Efficacy|3|||
48351437|NCT02547441|155482978|FG001|Open-Label Study Period|Lack of Efficacy|2|||
48351438|NCT02547441|155482977|FG000|Open-Label Study Period|Lost to Follow-up|7|||
48351439|NCT02547441|155482978|FG001|Open-Label Study Period|Lost to Follow-up|8|||
48351440|NCT02547441|155482977|FG000|Open-Label Study Period|Physician Decision|1|||
48351441|NCT02547441|155482978|FG001|Open-Label Study Period|Physician Decision|0|||
48351442|NCT02547441|155482977|FG000|Open-Label Study Period|Protocol Violation|2|||
48351443|NCT02547441|155482978|FG001|Open-Label Study Period|Protocol Violation|0|||
48351444|NCT02547441|155482977|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
48351445|NCT02547441|155482978|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
48351446|NCT02547441|155482977|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
48351447|NCT02547441|155482978|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
48351448|NCT01322009|155482979|FG000|Overall Study|Death|0|||
48351449|NCT01322009|155482980|FG001|Overall Study|Death|1|||
48351450|NCT01322009|155482979|FG000|Overall Study|Adverse Event|0|||
48351451|NCT01322009|155482980|FG001|Overall Study|Adverse Event|1|||
48351452|NCT01322009|155482979|FG000|Overall Study|ng tube discontinued|0|||
48351453|NCT01322009|155482980|FG001|Overall Study|ng tube discontinued|1|||
48351454|NCT02586415|155482985|FG000|Overall Study|Death|13|||
48351455|NCT02586415|155482986|FG001|Overall Study|Death|23|||
48351456|NCT02586415|155482985|FG000|Overall Study|Lost to Follow-up|1|||
48351457|NCT02586415|155482986|FG001|Overall Study|Lost to Follow-up|2|||
48351458|NCT02250534|155482987|FG000|Overall Study|Lost to Follow-up|18|||
48351459|NCT02250534|155482988|FG001|Overall Study|Lost to Follow-up|28|||
48351460|NCT02250534|155482989|FG002|Overall Study|Lost to Follow-up|33|||
48351461|NCT02250534|155482987|FG000|Overall Study|Personal reasons|7|||
48351462|NCT02250534|155482988|FG001|Overall Study|Personal reasons|8|||
48351463|NCT02250534|155482989|FG002|Overall Study|Personal reasons|14|||
48351464|NCT02250534|155482987|FG000|Overall Study|Adverse Event|6|||
48351465|NCT02250534|155482988|FG001|Overall Study|Adverse Event|3|||
48351466|NCT02250534|155482989|FG002|Overall Study|Adverse Event|8|||
48351467|NCT02250534|155482987|FG000|Overall Study|incarcerated|2|||
48351468|NCT02250534|155482988|FG001|Overall Study|incarcerated|1|||
48351469|NCT02250534|155482989|FG002|Overall Study|incarcerated|2|||
48351470|NCT02250534|155482987|FG000|Overall Study|Withdrawal by Subject|0|||
48351471|NCT02250534|155482988|FG001|Overall Study|Withdrawal by Subject|1|||
48351472|NCT02250534|155482989|FG002|Overall Study|Withdrawal by Subject|2|||
48351473|NCT02250534|155482987|FG000|Overall Study|Death|0|||
48351474|NCT02250534|155482988|FG001|Overall Study|Death|1|||
48351475|NCT02250534|155482989|FG002|Overall Study|Death|1|||
48351476|NCT02250534|155482987|FG000|Overall Study|Physician Decision|1|||
48351477|NCT02250534|155482988|FG001|Overall Study|Physician Decision|3|||
48351478|NCT02250534|155482989|FG002|Overall Study|Physician Decision|1|||
48351479|NCT02250534|155482987|FG000|Overall Study|Protocol Violation|1|||
48761999|NCT01393405|156975736|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
48351480|NCT02250534|155482988|FG001|Overall Study|Protocol Violation|0|||
48351481|NCT02250534|155482989|FG002|Overall Study|Protocol Violation|1|||
48351482|NCT02250534|155482987|FG000|Overall Study|Reason unknown|1|||
48351483|NCT02250534|155482988|FG001|Overall Study|Reason unknown|0|||
48762000|NCT01393405|156975737|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
48351484|NCT02250534|155482989|FG002|Overall Study|Reason unknown|0|||
48351485|NCT00832000|155482990|FG000|Overall Study|Adverse Event|2|||
48351486|NCT00832000|155482991|FG001|Overall Study|Adverse Event|0|||
48351487|NCT00832000|155482990|FG000|Overall Study|Withdrawal by Subject|1|||
48351488|NCT00832000|155482991|FG001|Overall Study|Withdrawal by Subject|0|||
48351489|NCT00832000|155482990|FG000|Overall Study|No calls to IVR in either period|1|||
48351490|NCT00832000|155482991|FG001|Overall Study|No calls to IVR in either period|1|||
48351491|NCT00832000|155482990|FG000|Overall Study|No calls to IVR in period 2|2|||
48351492|NCT00832000|155482991|FG001|Overall Study|No calls to IVR in period 2|0|||
48351493|NCT01253447|155482993|FG000|Overall Study|Adverse Event|2|||
48351494|NCT01017263|155482994|FG000|Overall Study|not eligible|12|||
48351495|NCT00909532|155482995|FG000|Overall Study|Adverse Event|4|||
48351496|NCT00909532|155482996|FG001|Overall Study|Adverse Event|1|||
48351497|NCT00909532|155482995|FG000|Overall Study|Pregnancy|0|||
48351498|NCT00909532|155482996|FG001|Overall Study|Pregnancy|1|||
48351499|NCT00909532|155482995|FG000|Overall Study|Prohibited Medication|2|||
48351500|NCT00909532|155482996|FG001|Overall Study|Prohibited Medication|1|||
48762001|NCT01393405|156975738|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
48762002|NCT01393405|156975736|FG000|Maintenance Period Week|Lack of Efficacy|0|||
48762003|NCT01393405|156975737|FG001|Maintenance Period Week|Lack of Efficacy|22|||
48762004|NCT01393405|156975738|FG002|Maintenance Period Week|Lack of Efficacy|22|||
48762005|NCT01393405|156975736|FG000|Maintenance Period Week|Adverse Event|0|||
48762006|NCT01393405|156975737|FG001|Maintenance Period Week|Adverse Event|5|||
48351501|NCT00909532|155482995|FG000|Overall Study|Withdrawal of Consent|1|||
48351502|NCT00909532|155482996|FG001|Overall Study|Withdrawal of Consent|1|||
48351503|NCT00909532|155482995|FG000|Overall Study|Noncompliance with Study Requirements|0|||
48351504|NCT00909532|155482996|FG001|Overall Study|Noncompliance with Study Requirements|2|||
48351505|NCT00909532|155482995|FG000|Overall Study|Physician Decision|1|||
48351506|NCT00909532|155482996|FG001|Overall Study|Physician Decision|0|||
48351507|NCT00909532|155482995|FG000|Overall Study|Wrong Genotype|1|||
48351508|NCT00909532|155482996|FG001|Overall Study|Wrong Genotype|0|||
48429375|NCT01070550|155760358|FG003|Overall Study|Not categorized|1|||
48351509|NCT00909532|155482995|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
48351510|NCT00909532|155482996|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
48351511|NCT02058836|155482998|FG000|Overall Study|Withdrawal by Subject|1|||
48351512|NCT02058836|155482999|FG001|Overall Study|Withdrawal by Subject|1|||
48351513|NCT02031536|155483002|FG000|Overall Study|ineligible|1|||
48351514|NCT02031536|155483003|FG001|Overall Study|ineligible|0|||
48351515|NCT01850030|155483004|FG000|Overall Study|Adverse Event|64|||
48351516|NCT01850030|155483005|FG001|Overall Study|Adverse Event|82|||
48351517|NCT01850030|155483004|FG000|Overall Study|Lack of Efficacy|3|||
48351518|NCT01850030|155483005|FG001|Overall Study|Lack of Efficacy|1|||
48351519|NCT01850030|155483004|FG000|Overall Study|Lost to Follow-up|5|||
48351520|NCT01850030|155483005|FG001|Overall Study|Lost to Follow-up|5|||
48351521|NCT01850030|155483004|FG000|Overall Study|Withdrawal by Subject|3|||
48351522|NCT01850030|155483005|FG001|Overall Study|Withdrawal by Subject|4|||
48762007|NCT01393405|156975738|FG002|Maintenance Period Week|Adverse Event|2|||
48762008|NCT01393405|156975736|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
48762009|NCT01393405|156975737|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
48351523|NCT01850030|155483004|FG000|Overall Study|Protocol Violation|24|||
48351524|NCT01850030|155483005|FG001|Overall Study|Protocol Violation|28|||
48351525|NCT01850030|155483004|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
48351526|NCT01850030|155483005|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
48351527|NCT01461005|155483014|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
48351528|NCT02165826|155483020|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
48351529|NCT02165826|155483021|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
48351530|NCT02165826|155483022|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
48351531|NCT02165826|155483020|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
48351532|NCT02165826|155483021|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
48351533|NCT02165826|155483022|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
48351534|NCT02165826|155483020|FG000|Main Treatment Period|Lost to Follow-up|4|||
48351535|NCT02165826|155483021|FG001|Main Treatment Period|Lost to Follow-up|2|||
48351536|NCT02165826|155483022|FG002|Main Treatment Period|Lost to Follow-up|1|||
48351537|NCT02165826|155483020|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
48351538|NCT02165826|155483021|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
48351539|NCT02165826|155483022|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
48351540|NCT02165826|155483020|FG000|Main Treatment Period|Lack of Efficacy|2|||
48351541|NCT02165826|155483021|FG001|Main Treatment Period|Lack of Efficacy|0|||
48351542|NCT02165826|155483022|FG002|Main Treatment Period|Lack of Efficacy|0|||
48351543|NCT02165826|155483020|FG000|Main Treatment Period|Reason Not Specified|8|||
48351544|NCT02165826|155483021|FG001|Main Treatment Period|Reason Not Specified|5|||
48351545|NCT02165826|155483022|FG002|Main Treatment Period|Reason Not Specified|16|||
48351546|NCT02165826|155483020|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
48351547|NCT02165826|155483021|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
48351548|NCT02165826|155483022|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
48351549|NCT02165826|155483020|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
48351550|NCT02165826|155483021|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
48351551|NCT02165826|155483022|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
48351552|NCT02165826|155483020|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
48351553|NCT02165826|155483021|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
48351554|NCT02165826|155483022|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
48351555|NCT02165826|155483020|FG000|Down-Titration Period|Reason Not Specified|1|||
48351556|NCT02165826|155483021|FG001|Down-Titration Period|Reason Not Specified|0|||
48351557|NCT02165826|155483022|FG002|Down-Titration Period|Reason Not Specified|2|||
48351558|NCT02392104|155483023|FG000|Overall Study|discontinuation of warfarin|3|||
48351559|NCT02392104|155483023|FG000|Overall Study|bleeding event|1|||
48351560|NCT02392104|155483023|FG000|Overall Study|transferred care to another doctor|2|||
48351561|NCT02392104|155483023|FG000|Overall Study|INR goal range changed|1|||
48351562|NCT02392104|155483023|FG000|Overall Study|admitted to skilled nursing facility|3|||
48351563|NCT02392104|155483023|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
48351564|NCT02670122|155483024|FG000|Overall Study|Lost to Follow-up|4|||
48351565|NCT02762903|155483028|FG000|Overall Study|Lost to Follow-up|0|||
48351566|NCT02762903|155483029|FG001|Overall Study|Lost to Follow-up|1|||
48351567|NCT01262092|155483033|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
48351568|NCT01262092|155483034|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
48351569|NCT01262092|155483033|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
48351570|NCT01262092|155483034|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
48762010|NCT01393405|156975738|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
48762011|NCT01393405|156975736|FG000|Maintenance Period Week|Lost to Follow-up|0|||
48762012|NCT01393405|156975737|FG001|Maintenance Period Week|Lost to Follow-up|1|||
48351571|NCT01262092|155483033|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
48351572|NCT01262092|155483034|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
48351573|NCT01262092|155483033|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
48675619|NCT00615030|156665354|FG011|Period I|Administrative problem|0|||
48675620|NCT00615030|156665343|FG000|Period I|Protocol deviation|1|||
48675621|NCT00615030|156665344|FG001|Period I|Protocol deviation|0|||
48675622|NCT00615030|156665345|FG002|Period I|Protocol deviation|0|||
48675623|NCT00615030|156665346|FG003|Period I|Protocol deviation|0|||
48675624|NCT00615030|156665347|FG004|Period I|Protocol deviation|0|||
48675625|NCT00615030|156665348|FG005|Period I|Protocol deviation|0|||
48675626|NCT00615030|156665349|FG006|Period I|Protocol deviation|0|||
48675627|NCT00615030|156665350|FG007|Period I|Protocol deviation|0|||
48675628|NCT00615030|156665351|FG008|Period I|Protocol deviation|0|||
48675629|NCT00615030|156665352|FG009|Period I|Protocol deviation|0|||
48675630|NCT00615030|156665353|FG010|Period I|Protocol deviation|0|||
48675631|NCT00615030|156665354|FG011|Period I|Protocol deviation|0|||
48675632|NCT00615030|156665343|FG000|Period I|Subject withdrew consent|0|||
48675633|NCT00615030|156665344|FG001|Period I|Subject withdrew consent|0|||
48675634|NCT00615030|156665345|FG002|Period I|Subject withdrew consent|0|||
48675635|NCT00615030|156665346|FG003|Period I|Subject withdrew consent|0|||
48675636|NCT00615030|156665347|FG004|Period I|Subject withdrew consent|0|||
48675637|NCT00615030|156665348|FG005|Period I|Subject withdrew consent|0|||
48675638|NCT00615030|156665349|FG006|Period I|Subject withdrew consent|0|||
48675639|NCT00615030|156665350|FG007|Period I|Subject withdrew consent|0|||
48675640|NCT00615030|156665351|FG008|Period I|Subject withdrew consent|1|||
48675641|NCT00615030|156665352|FG009|Period I|Subject withdrew consent|0|||
48675642|NCT00615030|156665353|FG010|Period I|Subject withdrew consent|1|||
48675643|NCT00615030|156665354|FG011|Period I|Subject withdrew consent|1|||
48675644|NCT00615030|156665343|FG000|Period I|Abnormal laboratory value(s)|0|||
48675645|NCT00615030|156665344|FG001|Period I|Abnormal laboratory value(s)|0|||
48675646|NCT00615030|156665345|FG002|Period I|Abnormal laboratory value(s)|0|||
48675647|NCT00615030|156665346|FG003|Period I|Abnormal laboratory value(s)|0|||
48675648|NCT00615030|156665347|FG004|Period I|Abnormal laboratory value(s)|0|||
48675649|NCT00615030|156665348|FG005|Period I|Abnormal laboratory value(s)|1|||
48675650|NCT00615030|156665349|FG006|Period I|Abnormal laboratory value(s)|0|||
48675651|NCT00615030|156665350|FG007|Period I|Abnormal laboratory value(s)|0|||
48675652|NCT00615030|156665351|FG008|Period I|Abnormal laboratory value(s)|0|||
48675653|NCT00615030|156665352|FG009|Period I|Abnormal laboratory value(s)|0|||
48675654|NCT00615030|156665353|FG010|Period I|Abnormal laboratory value(s)|0|||
48675655|NCT00615030|156665354|FG011|Period I|Abnormal laboratory value(s)|0|||
48675656|NCT00615030|156665343|FG000|Period II|Adverse Event|0|||
48675657|NCT00615030|156665344|FG001|Period II|Adverse Event|0|||
48675658|NCT00615030|156665345|FG002|Period II|Adverse Event|1|||
48675659|NCT00615030|156665346|FG003|Period II|Adverse Event|0|||
48675660|NCT00615030|156665347|FG004|Period II|Adverse Event|0|||
48675661|NCT00615030|156665348|FG005|Period II|Adverse Event|0|||
48675662|NCT00615030|156665349|FG006|Period II|Adverse Event|0|||
48675663|NCT00615030|156665350|FG007|Period II|Adverse Event|0|||
48675664|NCT00615030|156665351|FG008|Period II|Adverse Event|1|||
48675665|NCT00615030|156665352|FG009|Period II|Adverse Event|0|||
48675666|NCT00615030|156665353|FG010|Period II|Adverse Event|0|||
48675667|NCT00615030|156665354|FG011|Period II|Adverse Event|0|||
48351574|NCT01262092|155483034|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
48351575|NCT01806389|155483039|FG000|Overall Study|Withdrawal by Subject|4|||
48351576|NCT02579772|155483040|FG000|Overall Study|Withdrawal by Subject|0|||
48351577|NCT02579772|155483041|FG001|Overall Study|Withdrawal by Subject|1|||
48351578|NCT02579772|155483040|FG000|Overall Study|Usage of additional antioxidants|1|||
48351579|NCT02579772|155483041|FG001|Overall Study|Usage of additional antioxidants|0|||
48351580|NCT02579772|155483040|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
48351581|NCT02579772|155483041|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
48351582|NCT01210651|155483044|FG000|Overall Study|Lost to Follow-up|1|||
48675668|NCT00615030|156665343|FG000|Period II|Subject withdrew consent|0|||
48675669|NCT00615030|156665344|FG001|Period II|Subject withdrew consent|0|||
48351583|NCT01210651|155483045|FG001|Overall Study|Lost to Follow-up|1|||
48351584|NCT01210651|155483044|FG000|Overall Study|schedule conflicts|1|||
48351585|NCT01210651|155483045|FG001|Overall Study|schedule conflicts|5|||
48675670|NCT00615030|156665345|FG002|Period II|Subject withdrew consent|0|||
48675671|NCT00615030|156665346|FG003|Period II|Subject withdrew consent|1|||
48675672|NCT00615030|156665347|FG004|Period II|Subject withdrew consent|0|||
48675673|NCT00615030|156665348|FG005|Period II|Subject withdrew consent|0|||
48675674|NCT00615030|156665349|FG006|Period II|Subject withdrew consent|1|||
48675675|NCT00615030|156665350|FG007|Period II|Subject withdrew consent|0|||
48675676|NCT00615030|156665351|FG008|Period II|Subject withdrew consent|0|||
48675677|NCT00615030|156665352|FG009|Period II|Subject withdrew consent|0|||
48675678|NCT00615030|156665353|FG010|Period II|Subject withdrew consent|0|||
48675679|NCT00615030|156665354|FG011|Period II|Subject withdrew consent|0|||
48675680|NCT00615030|156665343|FG000|Period III|Administrative problems|1|||
48675681|NCT00615030|156665344|FG001|Period III|Administrative problems|0|||
48675682|NCT00615030|156665345|FG002|Period III|Administrative problems|0|||
48675683|NCT00615030|156665346|FG003|Period III|Administrative problems|1|||
48675684|NCT00615030|156665347|FG004|Period III|Administrative problems|0|||
48351586|NCT01210651|155483044|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
48351587|NCT01210651|155483045|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
48351588|NCT01210651|155483044|FG000|Overall Study|Withdrawal by Subject|1|||
48351589|NCT01210651|155483045|FG001|Overall Study|Withdrawal by Subject|1|||
48351590|NCT01210651|155483044|FG000|Overall Study|Injury outside study|2|||
48351591|NCT01210651|155483045|FG001|Overall Study|Injury outside study|0|||
48351592|NCT04043455|155484925|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
48351593|NCT04043455|155484926|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
48351594|NCT04043455|155484927|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
48351595|NCT04043455|155484928|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
48351596|NCT04043455|155484929|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
48675685|NCT00615030|156665348|FG005|Period III|Administrative problems|0|||
48675686|NCT00615030|156665349|FG006|Period III|Administrative problems|0|||
48675687|NCT00615030|156665350|FG007|Period III|Administrative problems|0|||
48675688|NCT00615030|156665351|FG008|Period III|Administrative problems|0|||
48675689|NCT00615030|156665352|FG009|Period III|Administrative problems|0|||
48675690|NCT00615030|156665353|FG010|Period III|Administrative problems|0|||
48675691|NCT00615030|156665354|FG011|Period III|Administrative problems|0|||
48675692|NCT00151476|156665355|FG000|FAP Identified Subjects|Protocol Violation|0|||
48675693|NCT00151476|156665356|FG001|FAP Identified Subjects|Protocol Violation|1|||
48675694|NCT00151476|156665355|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
48675695|NCT00151476|156665356|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
48675696|NCT00151476|156665355|FG000|FAP Analyzed Subjects|Other study participation|0|||
48675697|NCT00151476|156665356|FG001|FAP Analyzed Subjects|Other study participation|1|||
48675698|NCT02708485|156665361|FG000|Overall Study|Withdrawal by Subject|3|||
48675699|NCT02708485|156665362|FG001|Overall Study|Withdrawal by Subject|2|||
48675700|NCT02479139|156665363|FG000|Overall Study|Lost to Follow-up|2|||
48675701|NCT02479139|156665364|FG001|Overall Study|Lost to Follow-up|4|||
48675702|NCT02479139|156665365|FG002|Overall Study|Lost to Follow-up|4|||
48675703|NCT02479139|156665366|FG003|Overall Study|Lost to Follow-up|2|||
48675704|NCT02479139|156665367|FG004|Overall Study|Lost to Follow-up|3|||
48675705|NCT02479139|156665368|FG005|Overall Study|Lost to Follow-up|5|||
48675706|NCT02479139|156665363|FG000|Overall Study|Withdrew Consent|5|||
48675707|NCT02479139|156665364|FG001|Overall Study|Withdrew Consent|6|||
48675708|NCT02479139|156665365|FG002|Overall Study|Withdrew Consent|1|||
48675709|NCT02479139|156665366|FG003|Overall Study|Withdrew Consent|4|||
48675710|NCT02479139|156665367|FG004|Overall Study|Withdrew Consent|1|||
48675711|NCT02479139|156665368|FG005|Overall Study|Withdrew Consent|1|||
48675712|NCT02479139|156665363|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48675713|NCT02479139|156665364|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48675714|NCT02479139|156665365|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
48675715|NCT02479139|156665366|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48675716|NCT02479139|156665367|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48351597|NCT04043455|155484930|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
48351598|NCT04043455|155484925|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
48351599|NCT04043455|155484926|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
48351600|NCT04043455|155484927|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
48351601|NCT04043455|155484928|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
48351602|NCT04043455|155484929|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
48351603|NCT04043455|155484930|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
48351604|NCT04043455|155484925|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
48351605|NCT04043455|155484926|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
48351606|NCT04043455|155484927|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
48351607|NCT04043455|155484928|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
48351608|NCT04043455|155484929|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
48351609|NCT04043455|155484930|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
48351610|NCT04043455|155484925|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
48351611|NCT04043455|155484926|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
48351612|NCT04043455|155484927|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
48675717|NCT02479139|156665368|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
48351613|NCT04043455|155484928|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
48351614|NCT04043455|155484929|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
48351615|NCT04043455|155484930|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
48675718|NCT02479139|156665363|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48675719|NCT02479139|156665364|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48675720|NCT02479139|156665365|FG002|Overall Study|Other Miscellaneous Reasons|1|||
48675721|NCT02479139|156665366|FG003|Overall Study|Other Miscellaneous Reasons|1|||
48675722|NCT02479139|156665367|FG004|Overall Study|Other Miscellaneous Reasons|1|||
48675723|NCT02479139|156665368|FG005|Overall Study|Other Miscellaneous Reasons|0|||
48675724|NCT00764673|156665369|FG000|Overall Study|Death|1|||
48351616|NCT04043455|155484925|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48351617|NCT04043455|155484926|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
48351618|NCT04043455|155484927|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48351619|NCT04043455|155484928|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48351620|NCT04043455|155484929|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48351621|NCT04043455|155484930|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
48351622|NCT04043455|155484925|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
48351623|NCT04043455|155484926|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48351624|NCT04043455|155484927|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48351625|NCT04043455|155484928|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48351626|NCT04043455|155484929|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48351627|NCT04043455|155484930|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
48351628|NCT04043455|155484925|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48351629|NCT04043455|155484926|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
48351630|NCT04043455|155484927|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48351631|NCT04043455|155484928|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48351632|NCT04043455|155484929|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48351633|NCT04043455|155484930|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
48351634|NCT04043455|155484925|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
48351635|NCT04043455|155484926|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
48351636|NCT04043455|155484927|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
48351637|NCT04043455|155484928|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
48351638|NCT04043455|155484929|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
48351639|NCT04043455|155484930|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
48351640|NCT04043455|155484925|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
48351641|NCT04043455|155484926|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
48351642|NCT04043455|155484927|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
48351643|NCT04043455|155484928|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
48351644|NCT04043455|155484929|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
48351645|NCT04043455|155484930|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
48351646|NCT04043455|155484925|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48351647|NCT04043455|155484926|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48351648|NCT04043455|155484927|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48351649|NCT04043455|155484928|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48351650|NCT04043455|155484929|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
48351651|NCT04043455|155484930|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
48351652|NCT04043455|155484925|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
48351653|NCT04043455|155484926|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
48351654|NCT04043455|155484927|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
48351655|NCT04043455|155484928|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
48351656|NCT04043455|155484929|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
48351657|NCT04043455|155484930|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
48351658|NCT00966264|155484931|FG000|Overall Study|Lost to Follow-up|4|||
48351659|NCT00966264|155484932|FG001|Overall Study|Lost to Follow-up|3|||
48351660|NCT02859064|155484933|FG000|Overall Study|Progressive Disease|3|||
48351661|NCT02859064|155484933|FG000|Overall Study|Physician Decision|1|||
48351662|NCT02859064|155484933|FG000|Overall Study|Withdrawal by Subject|1|||
48351663|NCT02859064|155484933|FG000|Overall Study|Death|1|||
48675725|NCT00764673|156665369|FG000|Overall Study|Lost to Follow-up|3|||
48675726|NCT00764673|156665369|FG000|Overall Study|Withdrawal by Subject|6|||
48675727|NCT00764673|156665369|FG000|Overall Study|Revision of Device|2|||
48675728|NCT01727336|156665370|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
48675729|NCT01727336|156665371|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
48675730|NCT01727336|156665372|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
48675731|NCT01727336|156665373|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
48675732|NCT01727336|156665374|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
48675733|NCT01727336|156665375|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
48675734|NCT01727336|156665370|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
48675735|NCT01727336|156665371|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
48675736|NCT01727336|156665372|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
48675737|NCT01727336|156665373|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
48351664|NCT04411186|155484934|FG000|Overall Study|Withdrawn due to protocol violation|0|||
48675738|NCT01727336|156665374|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
48675739|NCT01727336|156665375|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
48675740|NCT01727336|156665370|FG000|Part 2 Blinded|Death|0|||
48351665|NCT04411186|155484935|FG001|Overall Study|Withdrawn due to protocol violation|1|||
48351666|NCT02820597|155484936|FG000|Overall Study|Lost to Follow-up|12|||
48351667|NCT00362375|155484937|FG000|Overall Study|Lost to Follow-up|40|||
48351668|NCT00362375|155484938|FG001|Overall Study|Lost to Follow-up|35|||
48351669|NCT02106195|155484939|FG000|Overall Study|Adverse Event|2|||
48351670|NCT02106195|155484939|FG000|Overall Study|Protocol Violation|1|||
48351671|NCT00753090|155484942|FG000|Overall Study|Withdrawal by Subject|10|||
48351672|NCT00753090|155484943|FG001|Overall Study|Withdrawal by Subject|10|||
48351673|NCT00753090|155484942|FG000|Overall Study|Death|17|||
48351674|NCT00753090|155484943|FG001|Overall Study|Death|6|||
48351675|NCT00753090|155484942|FG000|Overall Study|Study Prosthesis Removed|12|||
48351676|NCT00753090|155484943|FG001|Overall Study|Study Prosthesis Removed|3|||
48351677|NCT00753090|155484942|FG000|Overall Study|Lost to Follow-up|2|||
48351678|NCT00753090|155484943|FG001|Overall Study|Lost to Follow-up|2|||
48351679|NCT00753090|155484942|FG000|Overall Study|Other|127|||
48351680|NCT00753090|155484943|FG001|Overall Study|Other|75|||
48351681|NCT02840474|155484945|FG000|Overall Study|Lost to Follow-up|1|||
48351682|NCT02840474|155484946|FG001|Overall Study|Lost to Follow-up|0|||
48351683|NCT02994784|155484950|FG000|6 Months Follow-up|Lost to Follow-up|3|||
48351684|NCT04292470|155484951|FG000|Overall Study|Withdrawal by Subject|0|||
48351685|NCT04292470|155484952|FG001|Overall Study|Withdrawal by Subject|1|||
48351686|NCT01547598|155484966|FG000|Overall Study|Withdrew consent|1|||
48351687|NCT01547598|155484967|FG001|Overall Study|Withdrew consent|1|||
48351688|NCT01547598|155484966|FG000|Overall Study|Lost to Follow-up|1|||
48351689|NCT01547598|155484967|FG001|Overall Study|Lost to Follow-up|1|||
48351690|NCT01547598|155484966|FG000|Overall Study|Adverse Event|1|||
48351691|NCT01547598|155484967|FG001|Overall Study|Adverse Event|1|||
48351692|NCT01547598|155484966|FG000|Overall Study|Protocol Violation|1|||
48351693|NCT01547598|155484967|FG001|Overall Study|Protocol Violation|1|||
48351694|NCT01547598|155484966|FG000|Overall Study|Other Miscellaneous Reasons|2|||
48351695|NCT01547598|155484967|FG001|Overall Study|Other Miscellaneous Reasons|1|||
48351696|NCT02057575|155484973|FG000|Overall Study|Adverse Event|0|||
48351697|NCT02057575|155484974|FG001|Overall Study|Adverse Event|2|||
48351698|NCT02057575|155484975|FG002|Overall Study|Adverse Event|0|||
48351699|NCT02057575|155484976|FG003|Overall Study|Adverse Event|1|||
48351700|NCT02057575|155484973|FG000|Overall Study|Withdrawal by Subject|1|||
48351701|NCT02057575|155484974|FG001|Overall Study|Withdrawal by Subject|0|||
48351702|NCT02057575|155484975|FG002|Overall Study|Withdrawal by Subject|0|||
48351703|NCT02057575|155484976|FG003|Overall Study|Withdrawal by Subject|0|||
48351704|NCT02057575|155484973|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
48351705|NCT02057575|155484974|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
48351706|NCT02057575|155484975|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
48351707|NCT02057575|155484976|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
48351708|NCT02057575|155484973|FG000|Overall Study|Protocol Violation|0|||
48351709|NCT02057575|155484974|FG001|Overall Study|Protocol Violation|1|||
48351710|NCT02057575|155484975|FG002|Overall Study|Protocol Violation|0|||
48351711|NCT02057575|155484976|FG003|Overall Study|Protocol Violation|0|||
48351712|NCT01777490|155484994|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
48351713|NCT01777490|155484995|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
48351714|NCT01777490|155484996|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
48351715|NCT01777490|155484997|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
48351716|NCT01006616|155484998|FG000|Period 1 (6 Months)|Adverse Event|10|||
48351717|NCT01006616|155484999|FG001|Period 1 (6 Months)|Adverse Event|31|||
48351718|NCT01006616|155485000|FG002|Period 1 (6 Months)|Adverse Event|37|||
48675741|NCT01727336|156665371|FG001|Part 2 Blinded|Death|0|||
48675742|NCT01727336|156665372|FG002|Part 2 Blinded|Death|0|||
48675743|NCT01727336|156665373|FG003|Part 2 Blinded|Death|0|||
48675744|NCT01727336|156665374|FG004|Part 2 Blinded|Death|20|||
48351719|NCT01006616|155485001|FG003|Period 1 (6 Months)|Adverse Event|9|||
48351720|NCT01006616|155484998|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
48351721|NCT01006616|155484999|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
48351722|NCT01006616|155485000|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
48351723|NCT01006616|155485001|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
48351724|NCT01006616|155484998|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
48351725|NCT01006616|155484999|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
48351726|NCT01006616|155485000|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
48351727|NCT01006616|155485001|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
48351728|NCT01006616|155484998|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
48351729|NCT01006616|155484999|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
48351730|NCT01006616|155485000|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
48351731|NCT01006616|155485001|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
48351732|NCT01006616|155484998|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
48675745|NCT01727336|156665375|FG005|Part 2 Blinded|Death|16|||
48675746|NCT01727336|156665370|FG000|Part 2 Blinded|Lack of Efficacy|0|||
48675747|NCT01727336|156665371|FG001|Part 2 Blinded|Lack of Efficacy|0|||
48351733|NCT01006616|155484999|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
48351734|NCT01006616|155485000|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
48351735|NCT01006616|155485001|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
48675748|NCT01727336|156665372|FG002|Part 2 Blinded|Lack of Efficacy|0|||
48675749|NCT01727336|156665373|FG003|Part 2 Blinded|Lack of Efficacy|0|||
48351736|NCT01006616|155484998|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
48675750|NCT01727336|156665374|FG004|Part 2 Blinded|Lack of Efficacy|42|||
48351737|NCT01006616|155484999|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
48351738|NCT01006616|155485000|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
48351739|NCT01006616|155485001|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
48351740|NCT01006616|155484998|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
48351741|NCT01006616|155484999|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
48351742|NCT01006616|155485000|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
48351743|NCT01006616|155485001|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
48351744|NCT01006616|155484998|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
48351745|NCT01006616|155484999|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
48351746|NCT01006616|155485000|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
48351747|NCT01006616|155485001|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
48351748|NCT01006616|155484998|FG000|Period 1 (6 Months)|Not Treated|0|||
48351749|NCT01006616|155484999|FG001|Period 1 (6 Months)|Not Treated|0|||
48351750|NCT01006616|155485000|FG002|Period 1 (6 Months)|Not Treated|1|||
48351751|NCT01006616|155485001|FG003|Period 1 (6 Months)|Not Treated|1|||
48351752|NCT01006616|155484998|FG000|Period 2 (18 Months)|Adverse Event|6|||
48351753|NCT01006616|155484999|FG001|Period 2 (18 Months)|Adverse Event|6|||
48351754|NCT01006616|155485000|FG002|Period 2 (18 Months)|Adverse Event|6|||
48351755|NCT01006616|155485001|FG003|Period 2 (18 Months)|Adverse Event|4|||
48351756|NCT01006616|155484998|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
48351757|NCT01006616|155484999|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
48351758|NCT01006616|155485000|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
48351759|NCT01006616|155485001|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
48351760|NCT01006616|155484998|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
48351761|NCT01006616|155484999|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
48351762|NCT01006616|155485000|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
48351763|NCT01006616|155485001|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
48351764|NCT01006616|155484998|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
48351765|NCT01006616|155484999|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
48351766|NCT01006616|155485000|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
48351767|NCT01006616|155485001|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
48351768|NCT01006616|155484998|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
48351769|NCT01006616|155484999|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
48351770|NCT01006616|155485000|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
48351771|NCT01006616|155485001|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
48351772|NCT01006616|155484998|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
48351773|NCT01006616|155484999|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
48351774|NCT01006616|155485000|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
48351775|NCT01006616|155485001|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
48351776|NCT01006616|155484998|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
48351777|NCT01006616|155484999|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
48351778|NCT01006616|155485000|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
48351779|NCT01006616|155485001|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
48351780|NCT01006616|155484998|FG000|Period 2 (18 Months)|Study Terminated|63|||
48351781|NCT01006616|155484999|FG001|Period 2 (18 Months)|Study Terminated|46|||
48351782|NCT01006616|155485000|FG002|Period 2 (18 Months)|Study Terminated|44|||
48351783|NCT01006616|155485001|FG003|Period 2 (18 Months)|Study Terminated|70|||
48351784|NCT01772563|155485004|FG000|Cycle 1|Dose limiting toxicity|2|||
48351785|NCT01772563|155485004|FG000|Cycle 1|Progressive disease|2|||
48351786|NCT01772563|155485004|FG000|Cycle 2 and Beyond|Progressive disease|17|||
48351787|NCT01772563|155485004|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
48351788|NCT01772563|155485004|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
48351789|NCT04952701|155485005|FG000|Control Lens|Physician Decision|4|||
48351790|NCT04952701|155485005|FG000|Test Lens|Physician Decision|1|||
48351791|NCT02019641|155485008|FG000|10-Week Follow up|Withdrawal by investigator|2|||
48351792|NCT02019641|155485009|FG001|10-Week Follow up|Withdrawal by investigator|0|||
48351793|NCT02019641|155485010|FG002|10-Week Follow up|Withdrawal by investigator|0|||
48351794|NCT02019641|155485008|FG000|10-Week Follow up|Withdrawal by Subject|1|||
48351795|NCT02019641|155485009|FG001|10-Week Follow up|Withdrawal by Subject|1|||
48351796|NCT02019641|155485010|FG002|10-Week Follow up|Withdrawal by Subject|0|||
48351797|NCT02019641|155485008|FG000|20-Week Follow up|Withdrawal by investigator|0|||
48351798|NCT02019641|155485009|FG001|20-Week Follow up|Withdrawal by investigator|0|||
48351799|NCT02019641|155485010|FG002|20-Week Follow up|Withdrawal by investigator|1|||
48351800|NCT03856047|155485011|FG000|Overall Study|Withdrawal by Subject|0|||
48351801|NCT03856047|155485012|FG001|Overall Study|Withdrawal by Subject|1|||
48351802|NCT03856047|155485013|FG002|Overall Study|Withdrawal by Subject|1|||
48351803|NCT03856047|155485014|FG003|Overall Study|Withdrawal by Subject|0|||
48351804|NCT03856047|155485015|FG004|Overall Study|Withdrawal by Subject|3|||
48675751|NCT01727336|156665375|FG005|Part 2 Blinded|Lack of Efficacy|44|||
48675752|NCT01727336|156665370|FG000|Part 2 Blinded|Lost to Follow-up|0|||
48675753|NCT01727336|156665371|FG001|Part 2 Blinded|Lost to Follow-up|0|||
48675754|NCT01727336|156665372|FG002|Part 2 Blinded|Lost to Follow-up|0|||
48351805|NCT03856047|155485016|FG005|Overall Study|Withdrawal by Subject|0|||
48351806|NCT03856047|155485017|FG006|Overall Study|Withdrawal by Subject|2|||
48351807|NCT03856047|155485011|FG000|Overall Study|Lost to Follow-up|4|||
48351808|NCT03856047|155485012|FG001|Overall Study|Lost to Follow-up|2|||
48351809|NCT03856047|155485013|FG002|Overall Study|Lost to Follow-up|3|||
48351810|NCT03856047|155485014|FG003|Overall Study|Lost to Follow-up|1|||
48351811|NCT03856047|155485015|FG004|Overall Study|Lost to Follow-up|4|||
48351812|NCT03856047|155485016|FG005|Overall Study|Lost to Follow-up|4|||
48351813|NCT03856047|155485017|FG006|Overall Study|Lost to Follow-up|4|||
48351814|NCT04016805|155485018|FG000|Overall Study|Sponsor's Discretion|30|||
48351815|NCT04016805|155485019|FG001|Overall Study|Sponsor's Discretion|6|||
48351816|NCT04016805|155485020|FG002|Overall Study|Sponsor's Discretion|5|||
48351817|NCT01101061|155485021|FG000|Overall Study|Adverse Event|0|||
48351818|NCT01101061|155485022|FG001|Overall Study|Adverse Event|0|||
48351819|NCT01101061|155485023|FG002|Overall Study|Adverse Event|1|||
48351820|NCT01101061|155485024|FG003|Overall Study|Adverse Event|0|||
48351821|NCT01101061|155485025|FG004|Overall Study|Adverse Event|0|||
48351822|NCT01101061|155485026|FG005|Overall Study|Adverse Event|0|||
48351823|NCT00770588|155485035|FG000|Overall Study|Adverse Event|9|||
48351824|NCT00770588|155485036|FG001|Overall Study|Adverse Event|2|||
48351825|NCT00770588|155485035|FG000|Overall Study|Death caused by progression of disease|70|||
48351826|NCT00770588|155485036|FG001|Overall Study|Death caused by progression of disease|91|||
48351827|NCT00770588|155485035|FG000|Overall Study|Lost to Follow-up|1|||
48351828|NCT00770588|155485036|FG001|Overall Study|Lost to Follow-up|1|||
48351829|NCT00770588|155485035|FG000|Overall Study|Withdrawal by Subject|1|||
48351830|NCT00770588|155485036|FG001|Overall Study|Withdrawal by Subject|1|||
48351831|NCT01426113|155485037|FG000|Overall Study|Study Discontinued|1|||
48351832|NCT01426113|155485038|FG001|Overall Study|Study Discontinued|1|||
48351833|NCT01426113|155485037|FG000|Overall Study|Adverse Event|0|||
48351834|NCT01426113|155485038|FG001|Overall Study|Adverse Event|1|||
48351835|NCT02485899|155485039|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
48351836|NCT02485899|155485040|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48351837|NCT02485899|155485039|FG000|Overall Study|Withdrawal by Subject|1|||
48351838|NCT02485899|155485040|FG001|Overall Study|Withdrawal by Subject|0|||
48351839|NCT02485899|155485039|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
48351840|NCT02485899|155485040|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
48351841|NCT01834586|155485041|FG000|Overall Study|Adverse Event|1|||
48351842|NCT00732992|155485042|FG000|Overall Study|Adverse Event|1|||
48351843|NCT00732992|155485043|FG001|Overall Study|Adverse Event|1|||
48351844|NCT00732992|155485042|FG000|Overall Study|Objective Progression or Relapse|3|||
48351845|NCT00732992|155485043|FG001|Overall Study|Objective Progression or Relapse|5|||
48351846|NCT00732992|155485042|FG000|Overall Study|Global Deterioration of Health Status|1|||
48351847|NCT00732992|155485043|FG001|Overall Study|Global Deterioration of Health Status|0|||
48351848|NCT00732992|155485042|FG000|Overall Study|Withdrawal by Subject|1|||
48351849|NCT00732992|155485043|FG001|Overall Study|Withdrawal by Subject|0|||
48351850|NCT01667549|155485048|FG000|Overall Study|Withdrawal by Subject|3|||
48351851|NCT01667549|155485049|FG001|Overall Study|Withdrawal by Subject|5|||
48351852|NCT01667549|155485050|FG002|Overall Study|Withdrawal by Subject|7|||
48351853|NCT01667549|155485051|FG003|Overall Study|Withdrawal by Subject|6|||
48351854|NCT01667549|155485052|FG004|Overall Study|Withdrawal by Subject|1|||
48351855|NCT01130168|155485053|FG000|Period 1|Withdrawal by Subject|0|||
48351856|NCT01130168|155485054|FG001|Period 1|Withdrawal by Subject|1|||
48351857|NCT01130168|155485055|FG002|Period 1|Withdrawal by Subject|0|||
48351858|NCT01130168|155485056|FG003|Period 1|Withdrawal by Subject|1|||
48351859|NCT01130168|155485057|FG004|Period 1|Withdrawal by Subject|0|||
48351860|NCT01130168|155485058|FG005|Period 1|Withdrawal by Subject|0|||
48351861|NCT01130168|155485053|FG000|Period 1|Discontinued For Other Reason|0|||
48351862|NCT01130168|155485054|FG001|Period 1|Discontinued For Other Reason|0|||
48351863|NCT01130168|155485055|FG002|Period 1|Discontinued For Other Reason|1|||
48351864|NCT01130168|155485056|FG003|Period 1|Discontinued For Other Reason|1|||
48351865|NCT01130168|155485057|FG004|Period 1|Discontinued For Other Reason|0|||
48351866|NCT01130168|155485058|FG005|Period 1|Discontinued For Other Reason|0|||
48351867|NCT01130168|155485053|FG000|Period 1|Adverse Event|0|||
48351868|NCT01130168|155485054|FG001|Period 1|Adverse Event|0|||
48351869|NCT01130168|155485055|FG002|Period 1|Adverse Event|0|||
48351870|NCT01130168|155485056|FG003|Period 1|Adverse Event|1|||
48351871|NCT01130168|155485057|FG004|Period 1|Adverse Event|0|||
48351872|NCT01130168|155485058|FG005|Period 1|Adverse Event|0|||
48351873|NCT03513068|155485060|FG000|Overall Study|Death|1|||
48351874|NCT03513068|155485061|FG001|Overall Study|Death|0|||
48351875|NCT03513068|155485060|FG000|Overall Study|Withdrawal by Subject|4|||
48351876|NCT03513068|155485061|FG001|Overall Study|Withdrawal by Subject|6|||
48351877|NCT02706847|155485065|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
48351878|NCT02706847|155485066|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
48351879|NCT02706847|155485067|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
48351880|NCT02706847|155485068|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
48351881|NCT02706847|155485065|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
48351882|NCT02706847|155485066|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
48351883|NCT02706847|155485067|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
48351884|NCT02706847|155485068|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
48351885|NCT02706847|155485065|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
48351886|NCT02706847|155485066|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
48351887|NCT02706847|155485067|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
48351888|NCT02706847|155485068|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
48351889|NCT02706847|155485065|FG000|Period 1: Day 1 to Week 12|Other|4|||
48351890|NCT02706847|155485066|FG001|Period 1: Day 1 to Week 12|Other|4|||
48351891|NCT02706847|155485067|FG002|Period 1: Day 1 to Week 12|Other|2|||
48351892|NCT02706847|155485068|FG003|Period 1: Day 1 to Week 12|Other|2|||
48351893|NCT02706847|155485065|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
48351894|NCT02706847|155485066|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
48351895|NCT02706847|155485067|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
48351896|NCT02706847|155485068|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
48351897|NCT02706847|155485065|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
48351898|NCT02706847|155485066|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
48351899|NCT02706847|155485067|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
48351900|NCT02706847|155485068|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
48351901|NCT02706847|155485065|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
48351902|NCT02706847|155485066|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
48351903|NCT02706847|155485067|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
48351904|NCT02706847|155485068|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
48351905|NCT02706847|155485065|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
48351906|NCT02706847|155485066|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
48351907|NCT02706847|155485067|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
48351908|NCT02706847|155485068|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
48351909|NCT02706847|155485065|FG000|Period 1: Week 12 to Week 24|Other|1|||
48351910|NCT02706847|155485066|FG001|Period 1: Week 12 to Week 24|Other|0|||
48351911|NCT02706847|155485067|FG002|Period 1: Week 12 to Week 24|Other|1|||
48351912|NCT02706847|155485068|FG003|Period 1: Week 12 to Week 24|Other|4|||
48351913|NCT02706847|155485065|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
48351914|NCT02706847|155485066|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
48351915|NCT02706847|155485067|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
48351916|NCT02706847|155485068|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
48351917|NCT02706847|155485065|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
48351918|NCT02706847|155485066|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
48351919|NCT02706847|155485067|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
48351920|NCT02706847|155485068|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
48351921|NCT02706847|155485065|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
48351922|NCT02706847|155485066|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
48351923|NCT02706847|155485067|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
48351924|NCT02706847|155485068|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
48351925|NCT02706847|155485065|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
48351926|NCT02706847|155485066|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
48351927|NCT02706847|155485067|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
48351928|NCT02706847|155485068|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
48351929|NCT02706847|155485065|FG000|Period 2: Week 24 to Week 260|Other|8|||
48351930|NCT02706847|155485066|FG001|Period 2: Week 24 to Week 260|Other|5|||
48351931|NCT02706847|155485067|FG002|Period 2: Week 24 to Week 260|Other|15|||
48351932|NCT02706847|155485068|FG003|Period 2: Week 24 to Week 260|Other|15|||
48351933|NCT01174264|155485069|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
48351934|NCT01174264|155485070|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
48351935|NCT01174264|155485071|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
48351936|NCT01174264|155485069|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
48351937|NCT01174264|155485070|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
48351938|NCT01174264|155485071|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
48351939|NCT01174264|155485069|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
48351940|NCT01174264|155485070|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
48351941|NCT01174264|155485071|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
48351942|NCT04206085|155485072|FG000|Overall Study|Lost to Follow-up|0|||
48351943|NCT04206085|155485073|FG001|Overall Study|Lost to Follow-up|1|||
48675755|NCT01727336|156665373|FG003|Part 2 Blinded|Lost to Follow-up|0|||
48351944|NCT04206085|155485074|FG002|Overall Study|Lost to Follow-up|0|||
48351945|NCT04206085|155485072|FG000|Overall Study|Lost to Follow-up|0|||
48351946|NCT04206085|155485073|FG001|Overall Study|Lost to Follow-up|0|||
48351947|NCT04206085|155485074|FG002|Overall Study|Lost to Follow-up|1|||
48351948|NCT01889069|155485083|FG000|Overall Study|Death|18|||
48351949|NCT01889069|155485083|FG000|Overall Study|Progression of Disease|14|||
48675756|NCT01727336|156665374|FG004|Part 2 Blinded|Lost to Follow-up|0|||
48675757|NCT01727336|156665375|FG005|Part 2 Blinded|Lost to Follow-up|1|||
48675758|NCT01727336|156665370|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
48675759|NCT01727336|156665371|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
48675760|NCT01727336|156665372|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
48675761|NCT01727336|156665373|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
48675762|NCT01727336|156665374|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
48675763|NCT01727336|156665375|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
48675764|NCT01727336|156665370|FG000|Part 2 Blinded|use of prohibited medications|0|||
48675765|NCT01727336|156665371|FG001|Part 2 Blinded|use of prohibited medications|0|||
48675766|NCT01727336|156665372|FG002|Part 2 Blinded|use of prohibited medications|0|||
48675767|NCT01727336|156665373|FG003|Part 2 Blinded|use of prohibited medications|0|||
48675768|NCT01727336|156665374|FG004|Part 2 Blinded|use of prohibited medications|1|||
48675769|NCT01727336|156665375|FG005|Part 2 Blinded|use of prohibited medications|3|||
48675770|NCT00565136|156665377|FG000|Overall Study|Lost to Follow-up|1|||
48675771|NCT00565136|156665377|FG000|Overall Study|Withdrawal by Subject|1|||
48675772|NCT00565136|156665377|FG000|Overall Study|Protocol Violation|1|||
48675773|NCT05096312|156665380|FG000|Overall Study|Lost to Follow-up|2|||
48675774|NCT05096312|156665381|FG001|Overall Study|Lost to Follow-up|4|||
48675775|NCT05096312|156665380|FG000|Overall Study|Adverse Event|1|||
48675776|NCT05096312|156665381|FG001|Overall Study|Adverse Event|0|||
48675777|NCT01805037|156665382|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
48675778|NCT01805037|156665383|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
48675779|NCT01805037|156665382|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
48675780|NCT01805037|156665383|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
48675781|NCT01805037|156665382|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
48675782|NCT01805037|156665383|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
48675783|NCT01805037|156665382|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
48675784|NCT01805037|156665383|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
48675785|NCT01805037|156665382|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
48675786|NCT01805037|156665383|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
48675787|NCT01805037|156665382|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
48675788|NCT01805037|156665383|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
48675789|NCT01805037|156665382|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
48675790|NCT01805037|156665383|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
48675791|NCT01805037|156665382|FG000|Follow Up (up to 3 Years)|Death|0|||
48675792|NCT01805037|156665383|FG001|Follow Up (up to 3 Years)|Death|2|||
48675793|NCT01805037|156665382|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
48675794|NCT01805037|156665383|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
48675795|NCT01805037|156665382|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
48675796|NCT01805037|156665383|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
48675797|NCT03517566|156665384|FG000|Overall Study|Adverse Event|5|||
48675798|NCT03517566|156665385|FG001|Overall Study|Adverse Event|2|||
48675799|NCT03517566|156665386|FG002|Overall Study|Adverse Event|2|||
48675800|NCT03517566|156665387|FG003|Overall Study|Adverse Event|8|||
48675801|NCT03517566|156665388|FG004|Overall Study|Adverse Event|7|||
48351950|NCT01889069|155485083|FG000|Overall Study|Lost to Follow-up|6|||
48351951|NCT01889069|155485083|FG000|Overall Study|Other|4|||
48351952|NCT01889069|155485083|FG000|Overall Study|Consent Withdrawal|3|||
48351953|NCT01426347|155485084|FG000|Overall Study|Lost to Follow-up|0|||
48351954|NCT01426347|155485085|FG001|Overall Study|Lost to Follow-up|3|||
48351955|NCT01426347|155485084|FG000|Overall Study|Protocol Violation|2|||
48351956|NCT01426347|155485085|FG001|Overall Study|Protocol Violation|0|||
48351957|NCT01426347|155485084|FG000|Overall Study|Withdrawal by Subject|5|||
48351958|NCT01426347|155485085|FG001|Overall Study|Withdrawal by Subject|0|||
48351959|NCT04147858|155485090|FG000|Overall Study|Adverse Event|6|||
48351960|NCT04147858|155485091|FG001|Overall Study|Adverse Event|6|||
48351961|NCT04147858|155485092|FG002|Overall Study|Adverse Event|6|||
48351962|NCT04147858|155485090|FG000|Overall Study|Lack of Efficacy|3|||
48351963|NCT04147858|155485091|FG001|Overall Study|Lack of Efficacy|3|||
48351964|NCT04147858|155485092|FG002|Overall Study|Lack of Efficacy|1|||
48351965|NCT04147858|155485090|FG000|Overall Study|Lost to Follow-up|1|||
48351966|NCT04147858|155485091|FG001|Overall Study|Lost to Follow-up|6|||
48351967|NCT04147858|155485092|FG002|Overall Study|Lost to Follow-up|2|||
48351968|NCT04147858|155485090|FG000|Overall Study|Withdrawal by Subject|3|||
48351969|NCT04147858|155485091|FG001|Overall Study|Withdrawal by Subject|4|||
48351970|NCT04147858|155485092|FG002|Overall Study|Withdrawal by Subject|10|||
48351971|NCT04147858|155485090|FG000|Overall Study|Subject Noncompliance, Other|4|||
48351972|NCT04147858|155485091|FG001|Overall Study|Subject Noncompliance, Other|3|||
48351973|NCT04147858|155485092|FG002|Overall Study|Subject Noncompliance, Other|1|||
48351974|NCT00975676|155485098|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
48351975|NCT00975676|155485099|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
48351976|NCT02201901|155485100|FG000|Overall Study|Randomized but never treated|0|||
48351977|NCT02201901|155485101|FG001|Overall Study|Randomized but never treated|1|||
48351978|NCT02201901|155485102|FG002|Overall Study|Randomized but never treated|0|||
48351979|NCT02201901|155485100|FG000|Overall Study|Lack of Efficacy|7|||
48351980|NCT02201901|155485101|FG001|Overall Study|Lack of Efficacy|1|||
48351981|NCT02201901|155485102|FG002|Overall Study|Lack of Efficacy|6|||
48351982|NCT02201901|155485100|FG000|Overall Study|Death|3|||
48351983|NCT02201901|155485101|FG001|Overall Study|Death|3|||
48351984|NCT02201901|155485102|FG002|Overall Study|Death|3|||
48351985|NCT02201901|155485100|FG000|Overall Study|Lost to Follow-up|2|||
48351986|NCT02201901|155485101|FG001|Overall Study|Lost to Follow-up|3|||
48351987|NCT02201901|155485102|FG002|Overall Study|Lost to Follow-up|2|||
48351988|NCT02201901|155485100|FG000|Overall Study|Withdrew Consent|2|||
48351989|NCT02201901|155485101|FG001|Overall Study|Withdrew Consent|0|||
48351990|NCT02201901|155485102|FG002|Overall Study|Withdrew Consent|2|||
48351991|NCT02201901|155485100|FG000|Overall Study|Adverse Event|1|||
48351992|NCT02201901|155485101|FG001|Overall Study|Adverse Event|1|||
48351993|NCT02201901|155485102|FG002|Overall Study|Adverse Event|0|||
48351994|NCT02548078|155485103|FG000|Overall Study|Serious adverse event/Adverse event|1|||
48351995|NCT02548078|155485104|FG001|Overall Study|Serious adverse event/Adverse event|0|||
48351996|NCT02548078|155485103|FG000|Overall Study|Moved from study area|3|||
48351997|NCT02548078|155485104|FG001|Overall Study|Moved from study area|3|||
48351998|NCT02548078|155485103|FG000|Overall Study|Lost to Follow-up|1|||
48351999|NCT02548078|155485104|FG001|Overall Study|Lost to Follow-up|3|||
48352000|NCT02242643|155485105|FG000|Overall Study|Protocol Violation|1|||
48352001|NCT02242643|155485106|FG001|Overall Study|Protocol Violation|2|||
48352002|NCT02242643|155485105|FG000|Overall Study|Withdrawal by Subject|15|||
48352003|NCT02242643|155485106|FG001|Overall Study|Withdrawal by Subject|10|||
48352004|NCT02242643|155485105|FG000|Overall Study|Migrated/moved from study area|1|||
48352005|NCT02242643|155485106|FG001|Overall Study|Migrated/moved from study area|3|||
48352006|NCT02242643|155485105|FG000|Overall Study|Lost to Follow-up|54|||
48352007|NCT02242643|155485106|FG001|Overall Study|Lost to Follow-up|61|||
48352008|NCT02242643|155485105|FG000|Overall Study|Child placed in foster care by family|0|||
48352009|NCT02242643|155485106|FG001|Overall Study|Child placed in foster care by family|1|||
48352010|NCT02242643|155485105|FG000|Overall Study|Non-compliance|1|||
48675802|NCT03517566|156665384|FG000|Overall Study|Lack of Efficacy|3|||
48352011|NCT02242643|155485106|FG001|Overall Study|Non-compliance|0|||
48352012|NCT02242643|155485105|FG000|Overall Study|Consent withdrawal by parent|1|||
48352013|NCT02242643|155485106|FG001|Overall Study|Consent withdrawal by parent|0|||
48352014|NCT02242643|155485105|FG000|Overall Study|Protocol requirements not followed|1|||
48352015|NCT02242643|155485106|FG001|Overall Study|Protocol requirements not followed|0|||
48352016|NCT02242643|155485105|FG000|Overall Study|Language barrier|1|||
48352017|NCT02242643|155485106|FG001|Overall Study|Language barrier|0|||
48352018|NCT02242643|155485105|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
48352019|NCT02242643|155485106|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
48352020|NCT03358238|155485107|FG000|Overall Study|Withdrawal by Subject|0|||
48352021|NCT03358238|155485108|FG001|Overall Study|Withdrawal by Subject|1|||
48352022|NCT02080403|155486847|FG000|Overall Study|Adverse Event|5|||
48352023|NCT02080403|155486848|FG001|Overall Study|Adverse Event|1|||
48352024|NCT02080403|155486847|FG000|Overall Study|Death|0|||
48352025|NCT02080403|155486848|FG001|Overall Study|Death|2|||
48352026|NCT02080403|155486847|FG000|Overall Study|Lost to Follow-up|2|||
48352027|NCT02080403|155486848|FG001|Overall Study|Lost to Follow-up|0|||
48352028|NCT02080403|155486847|FG000|Overall Study|Pregnancy|0|||
48352029|NCT02080403|155486848|FG001|Overall Study|Pregnancy|1|||
48352030|NCT02080403|155486847|FG000|Overall Study|Protocol Violation|3|||
48352031|NCT02080403|155486848|FG001|Overall Study|Protocol Violation|7|||
48352032|NCT02080403|155486847|FG000|Overall Study|Withdrawal by Subject|5|||
48352033|NCT02080403|155486848|FG001|Overall Study|Withdrawal by Subject|1|||
48352034|NCT00368641|155486849|FG000|Overall Study|Adverse Event|2|||
48352035|NCT00368641|155486850|FG001|Overall Study|Adverse Event|1|||
48352036|NCT00368641|155486849|FG000|Overall Study|Death|1|||
48352037|NCT00368641|155486850|FG001|Overall Study|Death|0|||
48352038|NCT00368641|155486849|FG000|Overall Study|Withdrawal by Subject|1|||
48352039|NCT00368641|155486850|FG001|Overall Study|Withdrawal by Subject|0|||
48352040|NCT00368641|155486849|FG000|Overall Study|Sponsor decision to terminate study|2|||
48352041|NCT00368641|155486850|FG001|Overall Study|Sponsor decision to terminate study|5|||
48352042|NCT00944229|155486852|FG000|Overall Study|Withdrawal by Subject|11|||
48352043|NCT00944229|155486852|FG000|Overall Study|Physician Decision|14|||
48352044|NCT01270828|155486853|FG000|Pregabalin CR SB|Reason Unspecified|0|||
48352045|NCT01270828|155486854|FG001|Pregabalin CR SB|Reason Unspecified|0|||
48352046|NCT01270828|155486855|FG002|Pregabalin CR SB|Reason Unspecified|8|||
48352047|NCT01270828|155486853|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
48352048|NCT01270828|155486854|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
48352049|NCT01270828|155486855|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
48352050|NCT01270828|155486853|FG000|Pregabalin CR SB|Related adverse event|0|||
48352051|NCT01270828|155486854|FG001|Pregabalin CR SB|Related adverse event|0|||
48352052|NCT01270828|155486855|FG002|Pregabalin CR SB|Related adverse event|46|||
48352053|NCT01270828|155486853|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
48352054|NCT01270828|155486854|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
48352055|NCT01270828|155486855|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
48352056|NCT01270828|155486853|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
48352057|NCT01270828|155486854|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
48352058|NCT01270828|155486855|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
48352059|NCT01270828|155486853|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
48352060|NCT01270828|155486854|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
48352061|NCT01270828|155486855|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
48352062|NCT01270828|155486853|FG000|Pregabalin CR SB|Unrelated AE|0|||
48352063|NCT01270828|155486854|FG001|Pregabalin CR SB|Unrelated AE|0|||
48675803|NCT03517566|156665385|FG001|Overall Study|Lack of Efficacy|2|||
48352064|NCT01270828|155486855|FG002|Pregabalin CR SB|Unrelated AE|8|||
48352065|NCT01270828|155486853|FG000|Pregabalin CR SB|Protocol Violation|0|||
48352066|NCT01270828|155486854|FG001|Pregabalin CR SB|Protocol Violation|0|||
48352067|NCT01270828|155486855|FG002|Pregabalin CR SB|Protocol Violation|8|||
48352068|NCT01270828|155486853|FG000|Double Blind Phase|Death|0|||
48352069|NCT01270828|155486854|FG001|Double Blind Phase|Death|1|||
48352070|NCT01270828|155486855|FG002|Double Blind Phase|Death|0|||
48352071|NCT01270828|155486853|FG000|Double Blind Phase|Protocol Violation|0|||
48352072|NCT01270828|155486854|FG001|Double Blind Phase|Protocol Violation|1|||
48675804|NCT03517566|156665386|FG002|Overall Study|Lack of Efficacy|1|||
48675805|NCT03517566|156665387|FG003|Overall Study|Lack of Efficacy|1|||
48675806|NCT03517566|156665388|FG004|Overall Study|Lack of Efficacy|4|||
48675807|NCT03517566|156665384|FG000|Overall Study|Lost to Follow-up|3|||
48675808|NCT03517566|156665385|FG001|Overall Study|Lost to Follow-up|1|||
48352073|NCT01270828|155486855|FG002|Double Blind Phase|Protocol Violation|0|||
48352074|NCT01270828|155486853|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
48352075|NCT01270828|155486854|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
48352076|NCT01270828|155486855|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
48352077|NCT01270828|155486853|FG000|Double Blind Phase|Reason Unspecified|7|||
48352078|NCT01270828|155486854|FG001|Double Blind Phase|Reason Unspecified|4|||
48352079|NCT01270828|155486855|FG002|Double Blind Phase|Reason Unspecified|0|||
48352080|NCT01270828|155486853|FG000|Double Blind Phase|Withdrawal by Subject|6|||
48352081|NCT01270828|155486854|FG001|Double Blind Phase|Withdrawal by Subject|15|||
48352082|NCT01270828|155486855|FG002|Double Blind Phase|Withdrawal by Subject|0|||
48352083|NCT01270828|155486853|FG000|Double Blind Phase|Lost to Follow-up|1|||
48352084|NCT01270828|155486854|FG001|Double Blind Phase|Lost to Follow-up|2|||
48352085|NCT01270828|155486855|FG002|Double Blind Phase|Lost to Follow-up|0|||
48352086|NCT01270828|155486853|FG000|Double Blind Phase|Lack of Efficacy|2|||
48352087|NCT01270828|155486854|FG001|Double Blind Phase|Lack of Efficacy|11|||
48352088|NCT01270828|155486855|FG002|Double Blind Phase|Lack of Efficacy|0|||
48352089|NCT01270828|155486853|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
48352090|NCT01270828|155486854|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
48352091|NCT01270828|155486855|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
48352092|NCT01270828|155486853|FG000|Double Blind Phase|Adverse event related to study drug|5|||
48352093|NCT01270828|155486854|FG001|Double Blind Phase|Adverse event related to study drug|7|||
48352094|NCT01270828|155486855|FG002|Double Blind Phase|Adverse event related to study drug|0|||
48762013|NCT01393405|156975738|FG002|Maintenance Period Week|Lost to Follow-up|0|||
48762014|NCT00026793|156975739|FG000|Overall Study|Death on study due to underlying disease|4|||
48762015|NCT00026793|156975739|FG000|Overall Study|Physician Decision|2|||
48762016|NCT00026793|156975739|FG000|Overall Study|Off study|2|||
48762017|NCT02226003|156975741|FG000|Overall Study|Lost to Follow-up|2|||
48762018|NCT02226003|156975742|FG001|Overall Study|Lost to Follow-up|1|||
48762019|NCT02226003|156975743|FG002|Overall Study|Lost to Follow-up|3|||
48762020|NCT02226003|156975741|FG000|Overall Study|Withdrawal by Subject|0|||
48762021|NCT02226003|156975742|FG001|Overall Study|Withdrawal by Subject|0|||
48352095|NCT01165177|155486856|FG000|Overall Study|Serious Adverse Event|227|||
48352096|NCT01165177|155486857|FG001|Overall Study|Serious Adverse Event|235|||
48352097|NCT01165177|155486856|FG000|Overall Study|Withdrawal by Subject|368|||
48352098|NCT01165177|155486857|FG001|Overall Study|Withdrawal by Subject|354|||
48352099|NCT01165177|155486856|FG000|Overall Study|Protocol Violation|19|||
48352100|NCT01165177|155486857|FG001|Overall Study|Protocol Violation|21|||
48352101|NCT01165177|155486856|FG000|Overall Study|Non-serious adverse event|30|||
48352102|NCT01165177|155486857|FG001|Overall Study|Non-serious adverse event|18|||
48352103|NCT01165177|155486856|FG000|Overall Study|Other unspecified reasons|47|||
48352104|NCT01165177|155486857|FG001|Overall Study|Other unspecified reasons|35|||
48352105|NCT01165177|155486856|FG000|Overall Study|Suspected HZ episode|0|||
48352106|NCT01165177|155486857|FG001|Overall Study|Suspected HZ episode|2|||
48352107|NCT01165177|155486856|FG000|Overall Study|Lost to Follow-up|183|||
48352108|NCT01165177|155486857|FG001|Overall Study|Lost to Follow-up|194|||
48352109|NCT01165177|155486856|FG000|Overall Study|Migrated/ moved from study area|48|||
48352110|NCT01165177|155486857|FG001|Overall Study|Migrated/ moved from study area|43|||
48352111|NCT00013611|155486858|FG000|Overall Study|Lost to Follow-up|91|||
48352112|NCT00013611|155486859|FG001|Overall Study|Lost to Follow-up|100|||
48352113|NCT03194867|155486860|FG000|Overall Study|Incorrect completion of end of study form|0|||
48352114|NCT03194867|155486861|FG001|Overall Study|Incorrect completion of end of study form|0|||
48352115|NCT03194867|155486862|FG002|Overall Study|Incorrect completion of end of study form|1|||
48352116|NCT03194867|155486863|FG003|Overall Study|Incorrect completion of end of study form|0|||
48352117|NCT00884650|155486864|FG000|Overall Study|Did not return complete pain diaries|7|||
48352118|NCT00884650|155486865|FG001|Overall Study|Did not return complete pain diaries|7|||
48352119|NCT00884650|155486864|FG000|Overall Study|Admitted Post-Op|1|||
48352120|NCT00884650|155486865|FG001|Overall Study|Admitted Post-Op|0|||
48352121|NCT00884650|155486864|FG000|Overall Study|Femoral Stress Fracture|1|||
48352122|NCT00884650|155486865|FG001|Overall Study|Femoral Stress Fracture|0|||
48352123|NCT00884650|155486864|FG000|Overall Study|Pain Pump Complication|0|||
48352124|NCT00884650|155486865|FG001|Overall Study|Pain Pump Complication|1|||
48352125|NCT04334278|155486866|FG000|Overall Study|Lost to Follow-up|0|||
48352126|NCT04334278|155486867|FG001|Overall Study|Lost to Follow-up|3|||
48352127|NCT04334278|155486866|FG000|Overall Study|Withdrawal by Subject|4|||
48352128|NCT04334278|155486867|FG001|Overall Study|Withdrawal by Subject|2|||
48762022|NCT02226003|156975743|FG002|Overall Study|Withdrawal by Subject|3|||
48352129|NCT03065933|155486868|FG000|Overall Study|study terminated|5|||
48352130|NCT02577003|155486869|FG000|Overall Study|Adverse Event|2|||
48352131|NCT02577003|155486870|FG001|Overall Study|Adverse Event|4|||
48352132|NCT02577003|155486869|FG000|Overall Study|Withdrawal by Subject|0|||
48352133|NCT02577003|155486870|FG001|Overall Study|Withdrawal by Subject|1|||
48762023|NCT01400516|156975744|FG000|Primary Trial|Withdrawal by Subject|0|||
48762024|NCT01400516|156975745|FG001|Primary Trial|Withdrawal by Subject|2|||
48762025|NCT00549562|156975746|FG000|Overall Study|Adverse Event|1|||
48352134|NCT04351269|155486871|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
48352135|NCT04351269|155486872|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
48352136|NCT04351269|155486873|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
48352137|NCT04351269|155486871|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
48352138|NCT04351269|155486872|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
48352139|NCT04351269|155486873|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
48352140|NCT04351269|155486871|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
48352141|NCT04351269|155486872|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
48675809|NCT03517566|156665386|FG002|Overall Study|Lost to Follow-up|1|||
48352142|NCT04351269|155486873|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
48675810|NCT03517566|156665387|FG003|Overall Study|Lost to Follow-up|1|||
48675811|NCT03517566|156665388|FG004|Overall Study|Lost to Follow-up|0|||
48675812|NCT03517566|156665384|FG000|Overall Study|Physician Decision|1|||
48675813|NCT03517566|156665385|FG001|Overall Study|Physician Decision|1|||
48675814|NCT03517566|156665386|FG002|Overall Study|Physician Decision|0|||
48675815|NCT03517566|156665387|FG003|Overall Study|Physician Decision|1|||
48675816|NCT03517566|156665388|FG004|Overall Study|Physician Decision|0|||
48675817|NCT03517566|156665384|FG000|Overall Study|Pregnancy|0|||
48675818|NCT03517566|156665385|FG001|Overall Study|Pregnancy|1|||
48675819|NCT03517566|156665386|FG002|Overall Study|Pregnancy|0|||
48675820|NCT03517566|156665387|FG003|Overall Study|Pregnancy|0|||
48675821|NCT03517566|156665388|FG004|Overall Study|Pregnancy|0|||
48675822|NCT03517566|156665384|FG000|Overall Study|Protocol Deviation|0|||
48675823|NCT03517566|156665385|FG001|Overall Study|Protocol Deviation|1|||
48675824|NCT03517566|156665386|FG002|Overall Study|Protocol Deviation|0|||
48675825|NCT03517566|156665387|FG003|Overall Study|Protocol Deviation|1|||
48675826|NCT03517566|156665388|FG004|Overall Study|Protocol Deviation|1|||
48675827|NCT03517566|156665384|FG000|Overall Study|Study terminated by Sponsor|11|||
48675828|NCT03517566|156665385|FG001|Overall Study|Study terminated by Sponsor|5|||
48675829|NCT03517566|156665386|FG002|Overall Study|Study terminated by Sponsor|6|||
48675830|NCT03517566|156665387|FG003|Overall Study|Study terminated by Sponsor|14|||
48675831|NCT03517566|156665388|FG004|Overall Study|Study terminated by Sponsor|12|||
48675832|NCT03517566|156665384|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
48675833|NCT03517566|156665385|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
48675834|NCT03517566|156665386|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
48352143|NCT04351269|155486871|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
48352144|NCT04351269|155486872|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
48352145|NCT04351269|155486873|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
48352146|NCT04351269|155486871|FG000|Overall Study|Lost to Follow-up|1|||
48352147|NCT04351269|155486872|FG001|Overall Study|Lost to Follow-up|3|||
48352148|NCT04351269|155486873|FG002|Overall Study|Lost to Follow-up|0|||
48352149|NCT03210519|155486874|FG000|Overall Study|Adverse Event|2|||
48352150|NCT03210519|155486875|FG001|Overall Study|Adverse Event|0|||
48352151|NCT01657799|155486880|FG000|Overall Study|Adverse Event Related to progression|6|||
48352152|NCT01657799|155486881|FG001|Overall Study|Adverse Event Related to progression|8|||
48352153|NCT01657799|155486882|FG002|Overall Study|Adverse Event Related to progression|12|||
48352154|NCT01657799|155486880|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
48352155|NCT01657799|155486881|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
48352156|NCT01657799|155486882|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
48352157|NCT01657799|155486880|FG000|Overall Study|Withdrawal by Subject|13|||
48352158|NCT01657799|155486881|FG001|Overall Study|Withdrawal by Subject|10|||
48352159|NCT01657799|155486882|FG002|Overall Study|Withdrawal by Subject|10|||
48352160|NCT01657799|155486880|FG000|Overall Study|Lost to Follow-up|1|||
48352161|NCT01657799|155486881|FG001|Overall Study|Lost to Follow-up|0|||
48352162|NCT01657799|155486882|FG002|Overall Study|Lost to Follow-up|1|||
48352163|NCT01657799|155486880|FG000|Overall Study|Disease Progression|2|||
48352164|NCT01657799|155486881|FG001|Overall Study|Disease Progression|4|||
48352165|NCT01657799|155486882|FG002|Overall Study|Disease Progression|4|||
48352166|NCT01657799|155486880|FG000|Overall Study|Progressive Disease Clinical|7|||
48352167|NCT01657799|155486881|FG001|Overall Study|Progressive Disease Clinical|4|||
48352168|NCT01657799|155486882|FG002|Overall Study|Progressive Disease Clinical|7|||
48352169|NCT01657799|155486880|FG000|Overall Study|Radiographic & Clinical Progression|16|||
48352170|NCT01657799|155486881|FG001|Overall Study|Radiographic & Clinical Progression|11|||
48352171|NCT01657799|155486882|FG002|Overall Study|Radiographic & Clinical Progression|15|||
48352172|NCT01657799|155486880|FG000|Overall Study|Other|52|||
48352173|NCT01657799|155486881|FG001|Overall Study|Other|62|||
48352174|NCT01657799|155486882|FG002|Overall Study|Other|49|||
48352175|NCT03445533|155486884|FG000|Overall Study|Progressive Disease|48|||
48352176|NCT03445533|155486885|FG001|Overall Study|Progressive Disease|81|||
48352177|NCT03445533|155486884|FG000|Overall Study|Adverse Event|60|||
48675835|NCT03517566|156665387|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
48675836|NCT03517566|156665388|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
48675837|NCT04566692|156665389|FG000|Overall Study|Adverse Event|2|||
48352178|NCT03445533|155486885|FG001|Overall Study|Adverse Event|64|||
48352179|NCT03445533|155486884|FG000|Overall Study|Death|9|||
48352180|NCT03445533|155486885|FG001|Overall Study|Death|19|||
48352181|NCT03445533|155486884|FG000|Overall Study|Miscellaneous|0|||
48352182|NCT03445533|155486885|FG001|Overall Study|Miscellaneous|16|||
48352183|NCT03445533|155486884|FG000|Overall Study|Withdrawal by Subject|3|||
48352184|NCT03445533|155486885|FG001|Overall Study|Withdrawal by Subject|4|||
48352185|NCT03445533|155486884|FG000|Overall Study|Physician Decision|1|||
48352186|NCT03445533|155486885|FG001|Overall Study|Physician Decision|3|||
48352187|NCT03445533|155486884|FG000|Overall Study|Sponsor Decision|0|||
48352188|NCT03445533|155486885|FG001|Overall Study|Sponsor Decision|1|||
48352189|NCT03445533|155486884|FG000|Overall Study|Lost to Follow-up|0|||
48352190|NCT03445533|155486885|FG001|Overall Study|Lost to Follow-up|1|||
48352191|NCT03445533|155486884|FG000|Overall Study|Never Received any Study Treatment|7|||
48352192|NCT03445533|155486885|FG001|Overall Study|Never Received any Study Treatment|4|||
48352193|NCT02367352|155486886|FG000|Overall Study|Progressive disease|7|||
48352194|NCT02367352|155486887|FG001|Overall Study|Progressive disease|0|||
48352195|NCT02367352|155486888|FG002|Overall Study|Progressive disease|0|||
48352196|NCT02367352|155486886|FG000|Overall Study|Participant Received Alternative Therapy|1|||
48352197|NCT02367352|155486887|FG001|Overall Study|Participant Received Alternative Therapy|0|||
48352198|NCT02367352|155486888|FG002|Overall Study|Participant Received Alternative Therapy|0|||
48352199|NCT02367352|155486886|FG000|Overall Study|Adverse Event|1|||
48352200|NCT02367352|155486887|FG001|Overall Study|Adverse Event|0|||
48352201|NCT02367352|155486888|FG002|Overall Study|Adverse Event|0|||
48352202|NCT00174447|155486889|FG000|Overall Study|Adverse Event|19|||
48352203|NCT00174447|155486889|FG000|Overall Study|Withdrawal by Subject|15|||
48352204|NCT00174447|155486889|FG000|Overall Study|Protocol Violation|1|||
48352205|NCT00174447|155486889|FG000|Overall Study|Lack of Efficacy|1|||
48352206|NCT00174447|155486889|FG000|Overall Study|Administrative reason/Other|2|||
48352207|NCT02153905|155486890|FG000|Overall Study|Death|1|||
48352208|NCT02153905|155486891|FG001|Overall Study|Death|0|||
48352209|NCT00447590|155486906|FG000|Overall Study|Withdrawal by Subject|26|||
48352210|NCT00447590|155486906|FG000|Overall Study|Lost to Follow-up|24|||
48352211|NCT00447590|155486906|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
48352212|NCT02337829|155486908|FG000|Overall Study|Death|0|||
48352213|NCT02337829|155486909|FG001|Overall Study|Death|1|||
48352214|NCT02337829|155486910|FG002|Overall Study|Death|0|||
48352215|NCT02337829|155486911|FG003|Overall Study|Death|0|||
48352216|NCT02337829|155486908|FG000|Overall Study|Study terminated by sponsor|12|||
48352217|NCT02337829|155486909|FG001|Overall Study|Study terminated by sponsor|10|||
48352218|NCT02337829|155486910|FG002|Overall Study|Study terminated by sponsor|5|||
48352219|NCT02337829|155486911|FG003|Overall Study|Study terminated by sponsor|6|||
48352220|NCT02337829|155486908|FG000|Overall Study|discontinued for other reasons|6|||
48352221|NCT02337829|155486909|FG001|Overall Study|discontinued for other reasons|3|||
48352222|NCT02337829|155486910|FG002|Overall Study|discontinued for other reasons|1|||
48352223|NCT02337829|155486911|FG003|Overall Study|discontinued for other reasons|4|||
48352224|NCT00719043|155486927|FG000|Overall Study|Adverse Event|5|||
48352225|NCT00719043|155486928|FG001|Overall Study|Adverse Event|1|||
48352226|NCT00719043|155486929|FG002|Overall Study|Adverse Event|2|||
48352227|NCT00719043|155486930|FG003|Overall Study|Adverse Event|2|||
48352228|NCT00719043|155486931|FG004|Overall Study|Adverse Event|1|||
48352229|NCT00719043|155486932|FG005|Overall Study|Adverse Event|4|||
48352230|NCT00719043|155486933|FG006|Overall Study|Adverse Event|4|||
48352231|NCT00719043|155486927|FG000|Overall Study|Lost to Follow-up|14|||
48352232|NCT00719043|155486928|FG001|Overall Study|Lost to Follow-up|10|||
48352233|NCT00719043|155486929|FG002|Overall Study|Lost to Follow-up|8|||
48352234|NCT00719043|155486930|FG003|Overall Study|Lost to Follow-up|9|||
48352235|NCT00719043|155486931|FG004|Overall Study|Lost to Follow-up|10|||
48352236|NCT00719043|155486932|FG005|Overall Study|Lost to Follow-up|9|||
48352237|NCT00719043|155486933|FG006|Overall Study|Lost to Follow-up|9|||
48352238|NCT00719043|155486927|FG000|Overall Study|Protocol Violation|0|||
48352239|NCT00719043|155486928|FG001|Overall Study|Protocol Violation|0|||
48675838|NCT04566692|156665390|FG001|Overall Study|Adverse Event|0|||
48352240|NCT00719043|155486929|FG002|Overall Study|Protocol Violation|0|||
48352241|NCT00719043|155486930|FG003|Overall Study|Protocol Violation|0|||
48352242|NCT00719043|155486931|FG004|Overall Study|Protocol Violation|0|||
48352243|NCT00719043|155486932|FG005|Overall Study|Protocol Violation|1|||
48352244|NCT00719043|155486933|FG006|Overall Study|Protocol Violation|0|||
48352245|NCT00719043|155486927|FG000|Overall Study|Other|1|||
48352246|NCT00719043|155486928|FG001|Overall Study|Other|0|||
48352247|NCT00719043|155486929|FG002|Overall Study|Other|1|||
48352248|NCT00719043|155486930|FG003|Overall Study|Other|2|||
48352249|NCT00719043|155486931|FG004|Overall Study|Other|0|||
48352250|NCT00719043|155486932|FG005|Overall Study|Other|2|||
48352251|NCT00719043|155486933|FG006|Overall Study|Other|1|||
48352252|NCT00719043|155486927|FG000|Overall Study|Withdrawal by Subject|12|||
48352253|NCT00719043|155486928|FG001|Overall Study|Withdrawal by Subject|14|||
48352254|NCT00719043|155486929|FG002|Overall Study|Withdrawal by Subject|9|||
48352255|NCT00719043|155486930|FG003|Overall Study|Withdrawal by Subject|10|||
48352256|NCT00719043|155486931|FG004|Overall Study|Withdrawal by Subject|16|||
48352257|NCT00719043|155486932|FG005|Overall Study|Withdrawal by Subject|18|||
48352258|NCT00719043|155486933|FG006|Overall Study|Withdrawal by Subject|14|||
48352259|NCT02312206|155486935|FG000|Overall Study|Adverse Event|3|||
48352260|NCT02312206|155486936|FG001|Overall Study|Adverse Event|6|||
48352261|NCT02312206|155486935|FG000|Overall Study|Withdrawal by Subject|6|||
48352262|NCT02312206|155486936|FG001|Overall Study|Withdrawal by Subject|6|||
48352263|NCT02312206|155486935|FG000|Overall Study|Physician Decision|7|||
48352264|NCT02312206|155486936|FG001|Overall Study|Physician Decision|6|||
48352265|NCT02312206|155486935|FG000|Overall Study|Death|31|||
48352266|NCT02312206|155486936|FG001|Overall Study|Death|36|||
48352267|NCT02312206|155486935|FG000|Overall Study|Study Terminated by Sponsor|81|||
48352268|NCT02312206|155486936|FG001|Overall Study|Study Terminated by Sponsor|74|||
48352269|NCT02312206|155486935|FG000|Overall Study|Patient transferred to hospice|0|||
48352270|NCT02312206|155486936|FG001|Overall Study|Patient transferred to hospice|1|||
48352271|NCT02312206|155486935|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
48352272|NCT02312206|155486936|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
48352273|NCT02312206|155486935|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
48352274|NCT02312206|155486936|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
48352275|NCT02312206|155486935|FG000|Overall Study|Disease Progression|1|||
48352276|NCT02312206|155486936|FG001|Overall Study|Disease Progression|0|||
48352277|NCT06516705|155486939|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
48352278|NCT06516705|155486940|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
48352279|NCT06516705|155486939|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
48352280|NCT06516705|155486940|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
48352281|NCT06516705|155486939|FG000|T3 ( 3 Month After Education)|covid-19|1|||
48352282|NCT06516705|155486940|FG001|T3 ( 3 Month After Education)|covid-19|2|||
48352283|NCT06516705|155486939|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
48352284|NCT06516705|155486940|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
48352285|NCT06516705|155486939|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
48352286|NCT06516705|155486940|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
48352287|NCT06516705|155486939|FG000|T4 ( 6 Month After Education)|covid-19|3|||
48352288|NCT06516705|155486940|FG001|T4 ( 6 Month After Education)|covid-19|2|||
48352289|NCT06516705|155486939|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
48352290|NCT06516705|155486940|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
48352291|NCT01336205|155486941|FG000|Overall Study|Other|22|||
48352292|NCT01336205|155486942|FG001|Overall Study|Other|9|||
48352293|NCT01336205|155486941|FG000|Overall Study|Lost to Follow-up|40|||
48352294|NCT01336205|155486942|FG001|Overall Study|Lost to Follow-up|20|||
48352295|NCT01336205|155486941|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
48352296|NCT01336205|155486942|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
48352297|NCT01336205|155486941|FG000|Overall Study|Lack of Efficacy|4|||
48352298|NCT01336205|155486942|FG001|Overall Study|Lack of Efficacy|0|||
48352299|NCT01336205|155486941|FG000|Overall Study|Severe noncompliance with protocol|9|||
48352300|NCT01336205|155486942|FG001|Overall Study|Severe noncompliance with protocol|2|||
48352301|NCT01336205|155486941|FG000|Overall Study|Adverse Event|56|||
48352302|NCT01336205|155486942|FG001|Overall Study|Adverse Event|6|||
48352303|NCT01336205|155486941|FG000|Overall Study|Death|1|||
48352304|NCT01336205|155486942|FG001|Overall Study|Death|1|||
48352305|NCT01336205|155486941|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
48352306|NCT01336205|155486942|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
48352307|NCT01336205|155486941|FG000|Overall Study|Withdrawal by Subject|72|||
48352308|NCT01336205|155486942|FG001|Overall Study|Withdrawal by Subject|38|||
48352309|NCT01336205|155486941|FG000|Overall Study|Did not receive treatment|4|||
48352310|NCT01336205|155486942|FG001|Overall Study|Did not receive treatment|0|||
48352311|NCT00905034|155486945|FG000|Overall Study|Withdrawal by Subject|1|||
48352312|NCT02561247|155486946|FG000|Overall Study|Protocol Violation|1|||
48352313|NCT02561247|155486946|FG000|Overall Study|Withdrawal by Subject|1|||
48352314|NCT02561247|155486946|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
48352315|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
48352316|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
48352317|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
48352318|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
48352319|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
48352320|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
48352321|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
48352322|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
48352323|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
48352324|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
48352325|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
48352326|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
48352327|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
48352328|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
48352329|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
48352330|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
48352331|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
48352332|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
48352333|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Missing|2|||
48352334|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Missing|1|||
48352335|NCT00443209|155486947|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
48352336|NCT00443209|155486948|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
48352337|NCT00443209|155486947|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
48352338|NCT00443209|155486948|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
48352339|NCT00443209|155486947|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
48352340|NCT00443209|155486948|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
48352341|NCT00443209|155486947|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
48352342|NCT00443209|155486948|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
48352343|NCT00443209|155486947|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
48352344|NCT00443209|155486948|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
48352345|NCT00443209|155486947|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
48352346|NCT00443209|155486948|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
48352347|NCT00443209|155486947|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
48352348|NCT00443209|155486948|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
48352349|NCT04295798|155486949|FG000|Overall Study|Lost to Follow-up|1|||
48352350|NCT04245345|155486950|FG000|Overall Study|Death|1|||
48352351|NCT04245345|155486950|FG000|Overall Study|Exited prior to implant|5|||
48352352|NCT04245345|155486950|FG000|Overall Study|Exited prior to 1-month|9|||
48352353|NCT04245345|155486950|FG000|Overall Study|Missed 1-month visit|3|||
48352354|NCT04245345|155486950|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
48352355|NCT04245345|155486950|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
48352356|NCT00224029|155486951|FG000|Overall Study|Lost to Follow-up|1|||
48352357|NCT00224029|155486951|FG000|Overall Study|Withdrawal by Subject|4|||
48352358|NCT00224029|155486951|FG000|Overall Study|Other|1|||
48352359|NCT03635086|155486952|FG000|Overall Study|Withdrawal of consent|0|||
48352360|NCT03635086|155486953|FG001|Overall Study|Withdrawal of consent|0|||
48352361|NCT03635086|155486954|FG002|Overall Study|Withdrawal of consent|1|||
48352362|NCT03635086|155486955|FG003|Overall Study|Withdrawal of consent|0|||
48352363|NCT03635086|155486956|FG004|Overall Study|Withdrawal of consent|0|||
48352364|NCT03635086|155486952|FG000|Overall Study|Adverse Event|0|||
48352365|NCT03635086|155486953|FG001|Overall Study|Adverse Event|1|||
48352366|NCT03635086|155486954|FG002|Overall Study|Adverse Event|0|||
48352367|NCT03635086|155486955|FG003|Overall Study|Adverse Event|0|||
48352368|NCT03635086|155486956|FG004|Overall Study|Adverse Event|0|||
48352369|NCT03635086|155486952|FG000|Overall Study|Lost to Follow-up|1|||
48352370|NCT03635086|155486953|FG001|Overall Study|Lost to Follow-up|0|||
48352371|NCT03635086|155486954|FG002|Overall Study|Lost to Follow-up|0|||
48352372|NCT03635086|155486955|FG003|Overall Study|Lost to Follow-up|0|||
48352373|NCT03635086|155486956|FG004|Overall Study|Lost to Follow-up|0|||
48352374|NCT02872012|155486957|FG000|Overall Study|Withdrawal by Subject|1|||
48352375|NCT02872012|155486958|FG001|Overall Study|Withdrawal by Subject|0|||
48352376|NCT02872012|155486959|FG002|Overall Study|Withdrawal by Subject|0|||
48352377|NCT02872012|155486960|FG003|Overall Study|Withdrawal by Subject|0|||
48352378|NCT02872012|155486961|FG004|Overall Study|Withdrawal by Subject|0|||
48352379|NCT03443414|155486962|FG000|Overall Study|Adverse Event|6|||
48352380|NCT03443414|155486963|FG001|Overall Study|Adverse Event|0|||
48352381|NCT03443414|155486964|FG002|Overall Study|Adverse Event|4|||
48675839|NCT04566692|156665389|FG000|Overall Study|Withdrawal by Subject|1|||
48675840|NCT04566692|156665390|FG001|Overall Study|Withdrawal by Subject|1|||
48352382|NCT03443414|155486965|FG003|Overall Study|Adverse Event|2|||
48352383|NCT03443414|155486966|FG004|Overall Study|Adverse Event|3|||
48352384|NCT03443414|155486962|FG000|Overall Study|Withdrawal by Subject|3|||
48352385|NCT03443414|155486963|FG001|Overall Study|Withdrawal by Subject|2|||
48675841|NCT02690714|156665391|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
48352386|NCT03443414|155486964|FG002|Overall Study|Withdrawal by Subject|2|||
48352387|NCT03443414|155486965|FG003|Overall Study|Withdrawal by Subject|2|||
48675842|NCT02690714|156665391|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
48675843|NCT00377364|156665392|FG000|Overall Study|Lost to Follow-up|1|||
48352388|NCT03443414|155486966|FG004|Overall Study|Withdrawal by Subject|1|||
48352389|NCT03443414|155486962|FG000|Overall Study|Death|0|||
48352390|NCT03443414|155486963|FG001|Overall Study|Death|1|||
48352391|NCT03443414|155486964|FG002|Overall Study|Death|0|||
48352392|NCT03443414|155486965|FG003|Overall Study|Death|1|||
48352393|NCT03443414|155486966|FG004|Overall Study|Death|0|||
48352394|NCT03443414|155486962|FG000|Overall Study|Reason not specified|2|||
48352395|NCT03443414|155486963|FG001|Overall Study|Reason not specified|0|||
48352396|NCT03443414|155486964|FG002|Overall Study|Reason not specified|0|||
48352397|NCT03443414|155486965|FG003|Overall Study|Reason not specified|0|||
48352398|NCT03443414|155486966|FG004|Overall Study|Reason not specified|1|||
48352399|NCT00823836|155486967|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
48352400|NCT00823836|155486968|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
48352401|NCT00823836|155486967|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
48352402|NCT00823836|155486968|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
48352403|NCT00823836|155486967|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
48352404|NCT00823836|155486968|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
48352405|NCT00823836|155486967|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
48352406|NCT00823836|155486968|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
48352407|NCT00823836|155486967|FG000|Long-term Phase|Adverse Event|3|||
48352408|NCT00823836|155486968|FG001|Long-term Phase|Adverse Event|2|||
48352409|NCT00823836|155486967|FG000|Long-term Phase|Physician Decision|1|||
48352410|NCT00823836|155486968|FG001|Long-term Phase|Physician Decision|2|||
48352411|NCT00823836|155486967|FG000|Long-term Phase|Withdrawal by Subject|1|||
48675844|NCT00377364|156665393|FG001|Overall Study|Lost to Follow-up|0|||
48675845|NCT00377364|156665392|FG000|Overall Study|Withdrawal by Subject|1|||
48675846|NCT00377364|156665393|FG001|Overall Study|Withdrawal by Subject|0|||
48675847|NCT00410605|156665398|FG000|Overall Study|Adverse Event|12|||
48675848|NCT00410605|156665398|FG000|Overall Study|Physician Decision|3|||
48675849|NCT00410605|156665398|FG000|Overall Study|Withdrawal by Subject|5|||
48675850|NCT00410605|156665398|FG000|Overall Study|Started Non-Protocol Therapy|3|||
48675851|NCT00410605|156665398|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
48675852|NCT00410605|156665398|FG000|Overall Study|Transferred to another Institution|1|||
48675853|NCT01817959|156665399|FG000|Overall Study|Graft loss|1|||
48675854|NCT01817959|156665400|FG001|Overall Study|Graft loss|1|||
48675855|NCT01817959|156665399|FG000|Overall Study|forbidden medication|1|||
48675856|NCT01817959|156665400|FG001|Overall Study|forbidden medication|1|||
48675857|NCT01817959|156665399|FG000|Overall Study|Adverse Event|1|||
48675858|NCT01817959|156665400|FG001|Overall Study|Adverse Event|0|||
48675859|NCT01817959|156665399|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
48675860|NCT01817959|156665400|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
48675861|NCT03262441|156665401|FG000|Overall Study|Withdrawal by Subject|1|||
48675862|NCT03576716|156665411|FG000|Overall Study|Withdrawal by Subject|0|||
48675863|NCT03576716|156665412|FG001|Overall Study|Withdrawal by Subject|1|||
48675864|NCT02409342|156665414|FG000|Overall Study|Death|211|||
48675865|NCT02409342|156665415|FG001|Overall Study|Death|201|||
48675866|NCT02409342|156665414|FG000|Overall Study|Withdrawal by Subject|24|||
48675867|NCT02409342|156665415|FG001|Overall Study|Withdrawal by Subject|17|||
48675868|NCT02409342|156665414|FG000|Overall Study|Study Terminated By Sponsor|48|||
48352412|NCT00823836|155486968|FG001|Long-term Phase|Withdrawal by Subject|1|||
48352413|NCT01791413|155486969|FG000|Overall Study|Lost to Follow-up|5|||
48352414|NCT01791413|155486970|FG001|Overall Study|Lost to Follow-up|1|||
48675869|NCT02409342|156665415|FG001|Overall Study|Study Terminated By Sponsor|59|||
48762026|NCT00549562|156975746|FG000|Overall Study|Lack of Efficacy|1|||
48762027|NCT02355691|156977989|FG000|Overall Study|Loss of Research Personnel|7|||
48762028|NCT02355691|156977990|FG001|Overall Study|Loss of Research Personnel|9|||
48762029|NCT03989440|156977991|FG000|Overall Study|COVID-19 travel restrictions|0|||
48762030|NCT03989440|156977992|FG001|Overall Study|COVID-19 travel restrictions|0|||
48762031|NCT03989440|156977993|FG002|Overall Study|COVID-19 travel restrictions|1|||
48762032|NCT03989440|156977994|FG003|Overall Study|COVID-19 travel restrictions|0|||
48762033|NCT03989440|156977995|FG004|Overall Study|COVID-19 travel restrictions|0|||
48762034|NCT03989440|156977996|FG005|Overall Study|COVID-19 travel restrictions|0|||
48762035|NCT03989440|156977991|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
48762036|NCT03989440|156977992|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
48762037|NCT03989440|156977993|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
48762038|NCT03989440|156977994|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
48762039|NCT03989440|156977995|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
48762040|NCT03989440|156977996|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
48762041|NCT03265249|156977997|FG000|Overall Study|Withdrawal by Subject|0|||
48762042|NCT03265249|156977998|FG001|Overall Study|Withdrawal by Subject|1|||
48762043|NCT01277523|156977999|FG000|Overall Study|Adverse Event|1|||
48675870|NCT02409342|156665414|FG000|Overall Study|Lost to Follow-up|3|||
48762044|NCT01277523|156978000|FG001|Overall Study|Adverse Event|0|||
48762045|NCT01277523|156978001|FG002|Overall Study|Adverse Event|0|||
48762046|NCT01277523|156977999|FG000|Overall Study|Protocol Violation|2|||
48352415|NCT01602510|155486974|FG000|Open Label Phase|Adverse Event|46|||
48675871|NCT02409342|156665415|FG001|Overall Study|Lost to Follow-up|5|||
48675872|NCT02409342|156665414|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
48762047|NCT01277523|156978000|FG001|Overall Study|Protocol Violation|0|||
48675873|NCT02409342|156665415|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
48675874|NCT02409342|156665414|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
48675875|NCT02409342|156665415|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
48675876|NCT02409342|156665414|FG000|Overall Study|Sponsor Decision|1|||
48675877|NCT02409342|156665415|FG001|Overall Study|Sponsor Decision|0|||
48675878|NCT03688620|156665416|FG000|Overall Study|Other|0|||
48675879|NCT03688620|156665417|FG001|Overall Study|Other|0|||
48675880|NCT03688620|156665418|FG002|Overall Study|Other|1|||
48675881|NCT03688620|156665416|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
48675882|NCT03688620|156665417|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
48352416|NCT01602510|155486975|FG001|Open Label Phase|Adverse Event|0|||
48352417|NCT01602510|155486976|FG002|Open Label Phase|Adverse Event|0|||
48352418|NCT01602510|155486974|FG000|Open Label Phase|Lack of Efficacy|22|||
48352419|NCT01602510|155486975|FG001|Open Label Phase|Lack of Efficacy|0|||
48352420|NCT01602510|155486976|FG002|Open Label Phase|Lack of Efficacy|0|||
48352421|NCT01602510|155486974|FG000|Open Label Phase|Protocol Violation|15|||
48352422|NCT01602510|155486975|FG001|Open Label Phase|Protocol Violation|0|||
48352423|NCT01602510|155486976|FG002|Open Label Phase|Protocol Violation|0|||
48352424|NCT01602510|155486974|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
48352425|NCT01602510|155486975|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
48352426|NCT01602510|155486976|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
48352427|NCT01602510|155486974|FG000|Open Label Phase|Lost to Follow-up|22|||
48352428|NCT01602510|155486975|FG001|Open Label Phase|Lost to Follow-up|0|||
48352429|NCT01602510|155486976|FG002|Open Label Phase|Lost to Follow-up|0|||
48352430|NCT01602510|155486974|FG000|Open Label Phase|Physician Decision|19|||
48352431|NCT01602510|155486975|FG001|Open Label Phase|Physician Decision|0|||
48352432|NCT01602510|155486976|FG002|Open Label Phase|Physician Decision|0|||
48352433|NCT01602510|155486974|FG000|Open Label Phase|Withdrawal by Subject|57|||
48675883|NCT03688620|156665418|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
48675884|NCT03688620|156665416|FG000|Overall Study|Lost to Follow-up|16|||
48675885|NCT03688620|156665417|FG001|Overall Study|Lost to Follow-up|0|||
48675886|NCT03688620|156665418|FG002|Overall Study|Lost to Follow-up|1|||
48675887|NCT03688620|156665416|FG000|Overall Study|Withdrawal by Subject|0|||
48675888|NCT03688620|156665417|FG001|Overall Study|Withdrawal by Subject|0|||
48675889|NCT03688620|156665418|FG002|Overall Study|Withdrawal by Subject|6|||
48675890|NCT00416455|156665426|FG000|Overall Study|PET / CT not done|3|||
48675891|NCT00416455|156665427|FG001|Overall Study|PET / CT not done|5|||
48675892|NCT00416455|156665426|FG000|Overall Study|PET / CT poor quality|2|||
48675893|NCT00416455|156665427|FG001|Overall Study|PET / CT poor quality|1|||
48675894|NCT00416455|156665426|FG000|Overall Study|Inadequate pathology|11|||
48675895|NCT00416455|156665427|FG001|Overall Study|Inadequate pathology|2|||
48675896|NCT01298765|156665428|FG000|Titration Period|Adverse Event|26|||
48675897|NCT01298765|156665428|FG000|Titration Period|Death|1|||
48675898|NCT01298765|156665428|FG000|Titration Period|Lack of Efficacy|21|||
48675899|NCT01298765|156665428|FG000|Titration Period|Lost to Follow-up|9|||
48675900|NCT01298765|156665428|FG000|Titration Period|Physician Decision|1|||
48675901|NCT01298765|156665428|FG000|Titration Period|Withdrawal by Subject|10|||
48675902|NCT01298765|156665428|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
48675903|NCT01298765|156665428|FG000|Long-Term Treatment Period|Adverse Event|19|||
48675904|NCT01298765|156665428|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
48675905|NCT01298765|156665428|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
48675906|NCT01298765|156665428|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
48675907|NCT01298765|156665428|FG000|Long-Term Treatment Period|Physician Decision|1|||
48675908|NCT01298765|156665428|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
48675909|NCT00847197|156665429|FG000|Overall Study|Adverse Event|21|||
48675910|NCT00847197|156665430|FG001|Overall Study|Adverse Event|3|||
48675911|NCT00847197|156665429|FG000|Overall Study|Protocol Violation|0|||
48675912|NCT00847197|156665430|FG001|Overall Study|Protocol Violation|1|||
48675913|NCT00847197|156665429|FG000|Overall Study|Withdrawal by Subject|3|||
48675914|NCT00847197|156665430|FG001|Overall Study|Withdrawal by Subject|1|||
48675915|NCT02283788|156665433|FG000|Overall Study|Adverse Event|1|||
48675916|NCT02283788|156665434|FG001|Overall Study|Adverse Event|3|||
48675917|NCT02283788|156665435|FG002|Overall Study|Adverse Event|5|||
48675918|NCT02283788|156665436|FG003|Overall Study|Adverse Event|1|||
48675919|NCT02283788|156665433|FG000|Overall Study|Withdrawal by Subject|0|||
48762048|NCT01277523|156978001|FG002|Overall Study|Protocol Violation|0|||
48762049|NCT01277523|156977999|FG000|Overall Study|Other Reason not Defined|0|||
48762050|NCT01277523|156978000|FG001|Overall Study|Other Reason not Defined|1|||
48762051|NCT01277523|156978001|FG002|Overall Study|Other Reason not Defined|0|||
48352434|NCT01602510|155486975|FG001|Open Label Phase|Withdrawal by Subject|0|||
48352435|NCT01602510|155486976|FG002|Open Label Phase|Withdrawal by Subject|0|||
48675920|NCT02283788|156665434|FG001|Overall Study|Withdrawal by Subject|1|||
48675921|NCT02283788|156665435|FG002|Overall Study|Withdrawal by Subject|0|||
48762052|NCT04608500|156978002|FG000|Overall Study|Adverse Event|2|||
48352436|NCT01602510|155486974|FG000|Randomized Phase|Adverse Event|0|||
48352437|NCT01602510|155486975|FG001|Randomized Phase|Adverse Event|2|||
48352438|NCT01602510|155486976|FG002|Randomized Phase|Adverse Event|6|||
48352439|NCT01602510|155486974|FG000|Randomized Phase|Lack of Efficacy|0|||
48352440|NCT01602510|155486975|FG001|Randomized Phase|Lack of Efficacy|4|||
48352441|NCT01602510|155486976|FG002|Randomized Phase|Lack of Efficacy|4|||
48352442|NCT01602510|155486974|FG000|Randomized Phase|Protocol Violation|0|||
48352443|NCT01602510|155486975|FG001|Randomized Phase|Protocol Violation|3|||
48352444|NCT01602510|155486976|FG002|Randomized Phase|Protocol Violation|3|||
48352445|NCT01602510|155486974|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
48352446|NCT01602510|155486975|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
48352447|NCT01602510|155486976|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
48352448|NCT01602510|155486974|FG000|Randomized Phase|Lost to Follow-up|0|||
48352449|NCT01602510|155486975|FG001|Randomized Phase|Lost to Follow-up|1|||
48352450|NCT01602510|155486976|FG002|Randomized Phase|Lost to Follow-up|3|||
48352451|NCT01602510|155486974|FG000|Randomized Phase|Physician Decision|0|||
48352452|NCT01602510|155486975|FG001|Randomized Phase|Physician Decision|0|||
48352453|NCT01602510|155486976|FG002|Randomized Phase|Physician Decision|2|||
48352454|NCT01602510|155486974|FG000|Randomized Phase|Withdrawal by Subject|0|||
48352455|NCT01602510|155486975|FG001|Randomized Phase|Withdrawal by Subject|6|||
48352456|NCT01602510|155486976|FG002|Randomized Phase|Withdrawal by Subject|7|||
48352457|NCT01151215|155486979|FG000|Overall Study|Worsening of condition under study|1|||
48352458|NCT01151215|155486980|FG001|Overall Study|Worsening of condition under study|1|||
48352459|NCT01151215|155486981|FG002|Overall Study|Worsening of condition under study|1|||
48352460|NCT01151215|155486979|FG000|Overall Study|Death|16|||
48352461|NCT01151215|155486980|FG001|Overall Study|Death|20|||
48352462|NCT01151215|155486981|FG002|Overall Study|Death|11|||
48352463|NCT01151215|155486979|FG000|Overall Study|Lost to Follow-up|0|||
48352464|NCT01151215|155486980|FG001|Overall Study|Lost to Follow-up|0|||
48352465|NCT01151215|155486981|FG002|Overall Study|Lost to Follow-up|3|||
48352466|NCT01151215|155486979|FG000|Overall Study|Withdrawal by Subject|3|||
48352467|NCT01151215|155486980|FG001|Overall Study|Withdrawal by Subject|1|||
48352468|NCT01151215|155486981|FG002|Overall Study|Withdrawal by Subject|2|||
48352469|NCT01151215|155486979|FG000|Overall Study|Disease progression|0|||
48352470|NCT01151215|155486980|FG001|Overall Study|Disease progression|1|||
48352471|NCT01151215|155486981|FG002|Overall Study|Disease progression|1|||
48352472|NCT01151215|155486979|FG000|Overall Study|Safety as judged by the investigator|0|||
48352473|NCT01151215|155486980|FG001|Overall Study|Safety as judged by the investigator|0|||
48352474|NCT01151215|155486981|FG002|Overall Study|Safety as judged by the investigator|1|||
48352475|NCT00547534|155486982|FG000|Overall Study|Adverse Event|7|||
48352476|NCT00547534|155486982|FG000|Overall Study|Disease Progression|4|||
48352477|NCT01574274|155486989|FG000|Overall Study|Ineligible|0|||
48352478|NCT01574274|155486990|FG001|Overall Study|Ineligible|1|||
48352479|NCT01574274|155486989|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
48352480|NCT01574274|155486990|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
48352481|NCT01574274|155486989|FG000|Overall Study|Ph+ B-ALL|3|||
48352482|NCT01574274|155486990|FG001|Overall Study|Ph+ B-ALL|4|||
48352483|NCT01574274|155486989|FG000|Overall Study|Induction Death|2|||
48352484|NCT01574274|155486990|FG001|Overall Study|Induction Death|0|||
48352485|NCT01574274|155486989|FG000|Overall Study|Induction Failure|4|||
48352486|NCT01574274|155486990|FG001|Overall Study|Induction Failure|1|||
48352487|NCT01574274|155486989|FG000|Overall Study|Adverse Event|16|||
48352488|NCT01574274|155486990|FG001|Overall Study|Adverse Event|13|||
48352489|NCT01574274|155486989|FG000|Overall Study|Remission Death|1|||
48352490|NCT01574274|155486990|FG001|Overall Study|Remission Death|0|||
48352491|NCT01574274|155486989|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
48352492|NCT01574274|155486990|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
48352493|NCT01574274|155486989|FG000|Overall Study|Other, unknown|3|||
48352494|NCT01574274|155486990|FG001|Overall Study|Other, unknown|2|||
48352495|NCT02498236|155486991|FG000|Overall Study|Did not show for testing|1|||
48352496|NCT02498236|155486992|FG001|Overall Study|Did not show for testing|0|||
48352497|NCT02498236|155486993|FG002|Overall Study|Did not show for testing|0|||
48352498|NCT02498236|155486994|FG003|Overall Study|Did not show for testing|0|||
48352499|NCT02498236|155486995|FG004|Overall Study|Did not show for testing|0|||
48352500|NCT02498236|155486996|FG005|Overall Study|Did not show for testing|0|||
48352501|NCT02498236|155486997|FG006|Overall Study|Did not show for testing|0|||
48352502|NCT02498236|155486998|FG007|Overall Study|Did not show for testing|1|||
48352503|NCT02498236|155486991|FG000|Overall Study|Equipment failure|0|||
48352504|NCT02498236|155486992|FG001|Overall Study|Equipment failure|0|||
48352505|NCT02498236|155486993|FG002|Overall Study|Equipment failure|0|||
48352506|NCT02498236|155486994|FG003|Overall Study|Equipment failure|0|||
48352507|NCT02498236|155486995|FG004|Overall Study|Equipment failure|0|||
48352508|NCT02498236|155486996|FG005|Overall Study|Equipment failure|0|||
48352509|NCT02498236|155486997|FG006|Overall Study|Equipment failure|1|||
48352510|NCT02498236|155486998|FG007|Overall Study|Equipment failure|0|||
48352511|NCT02498236|155486991|FG000|Overall Study|Withdrawal by Subject|0|||
48352512|NCT02498236|155486992|FG001|Overall Study|Withdrawal by Subject|0|||
48675922|NCT02283788|156665436|FG003|Overall Study|Withdrawal by Subject|1|||
48675923|NCT04378114|156665437|FG000|Overall Study|Withdrawal by Subject|5|||
48675924|NCT00605345|156665442|FG000|Overall Study|Withdrawal by Subject|1|||
48675925|NCT00605345|156665443|FG001|Overall Study|Withdrawal by Subject|0|||
48352513|NCT02498236|155486993|FG002|Overall Study|Withdrawal by Subject|0|||
48352514|NCT02498236|155486994|FG003|Overall Study|Withdrawal by Subject|0|||
48352515|NCT02498236|155486995|FG004|Overall Study|Withdrawal by Subject|1|||
48352516|NCT02498236|155486996|FG005|Overall Study|Withdrawal by Subject|0|||
48352517|NCT02498236|155486997|FG006|Overall Study|Withdrawal by Subject|0|||
48352518|NCT02498236|155486998|FG007|Overall Study|Withdrawal by Subject|0|||
48352519|NCT01191008|155487004|FG000|Overall Study|Protocol Violation|7|||
48352520|NCT01191008|155487004|FG000|Overall Study|Lost to Follow-up|8|||
48352521|NCT04508309|155487008|FG000|Overall Study|Death|0|||
48352522|NCT04508309|155487009|FG001|Overall Study|Death|0|||
48352523|NCT04508309|155487010|FG002|Overall Study|Death|0|||
48352524|NCT04508309|155487011|FG003|Overall Study|Death|0|||
48352525|NCT04508309|155487012|FG004|Overall Study|Death|1|||
48352526|NCT04508309|155487008|FG000|Overall Study|Lost to Follow-up|0|||
48352527|NCT04508309|155487009|FG001|Overall Study|Lost to Follow-up|0|||
48352528|NCT04508309|155487010|FG002|Overall Study|Lost to Follow-up|1|||
48352529|NCT04508309|155487011|FG003|Overall Study|Lost to Follow-up|1|||
48352530|NCT04508309|155487012|FG004|Overall Study|Lost to Follow-up|0|||
48352531|NCT04508309|155487008|FG000|Overall Study|Withdrawal by Subject|0|||
48352532|NCT04508309|155487009|FG001|Overall Study|Withdrawal by Subject|0|||
48352533|NCT04508309|155487010|FG002|Overall Study|Withdrawal by Subject|0|||
48352534|NCT04508309|155487011|FG003|Overall Study|Withdrawal by Subject|0|||
48352535|NCT04508309|155487012|FG004|Overall Study|Withdrawal by Subject|1|||
48352536|NCT02446236|155487018|FG000|Overall Study|Screen Failure|1|||
48352537|NCT02446236|155487019|FG001|Overall Study|Screen Failure|0|||
48352538|NCT02446236|155487020|FG002|Overall Study|Screen Failure|1|||
48352539|NCT02446236|155487018|FG000|Overall Study|Actively Receiving Therapy|0|||
48352540|NCT02446236|155487019|FG001|Overall Study|Actively Receiving Therapy|0|||
48352541|NCT02446236|155487020|FG002|Overall Study|Actively Receiving Therapy|1|||
48352542|NCT04147195|155487021|FG000|Overall Study|Adverse Event|0|||
48352543|NCT04147195|155487022|FG001|Overall Study|Adverse Event|3|||
48352544|NCT04147195|155487021|FG000|Overall Study|Study Terminated by Sponsor|4|||
48352545|NCT04147195|155487022|FG001|Overall Study|Study Terminated by Sponsor|2|||
48352546|NCT04147195|155487021|FG000|Overall Study|Withdrawal by Subject|0|||
48352547|NCT04147195|155487022|FG001|Overall Study|Withdrawal by Subject|1|||
48352548|NCT02825251|155488738|FG000|Overall Study|Adverse Event|0|||
48352549|NCT02825251|155488739|FG001|Overall Study|Adverse Event|1|||
48352550|NCT02825251|155488738|FG000|Overall Study|Lost to Follow-up|0|||
48352551|NCT02825251|155488739|FG001|Overall Study|Lost to Follow-up|1|||
48352552|NCT02825251|155488738|FG000|Overall Study|Withdrawal by Subject|1|||
48352553|NCT02825251|155488739|FG001|Overall Study|Withdrawal by Subject|4|||
48352554|NCT02825251|155488738|FG000|Overall Study|Unclassified|2|||
48352555|NCT02825251|155488739|FG001|Overall Study|Unclassified|0|||
48352556|NCT01190644|155488740|FG000|Overall Study|Death|2|||
48352557|NCT01190644|155488740|FG000|Overall Study|Disease progression|1|||
48352558|NCT00575042|155488743|FG000|Overall Study|Adverse Event|2|||
48352559|NCT00575042|155488743|FG000|Overall Study|Lost to Follow-up|1|||
48352560|NCT03024996|155488744|FG000|Overall Study|Death|57|||
48352561|NCT03024996|155488745|FG001|Overall Study|Death|55|||
48352562|NCT03024996|155488744|FG000|Overall Study|Disease relapse|1|||
48352563|NCT03024996|155488745|FG001|Overall Study|Disease relapse|0|||
48352564|NCT03024996|155488744|FG000|Overall Study|Lost to Follow-up|5|||
48352565|NCT03024996|155488745|FG001|Overall Study|Lost to Follow-up|10|||
48675926|NCT00605345|156665442|FG000|Overall Study|Adverse Event|0|||
48675927|NCT00605345|156665443|FG001|Overall Study|Adverse Event|1|||
48675928|NCT00605345|156665442|FG000|Overall Study|Protocol Violation|0|||
48675929|NCT00605345|156665443|FG001|Overall Study|Protocol Violation|2|||
48675930|NCT01300572|156665445|FG000|Overall Study|HAMA + post dosimetry|1|||
48675931|NCT00384332|156665446|FG000|Overall Study|Lost to Follow-up|4|||
48675932|NCT00384332|156665447|FG001|Overall Study|Lost to Follow-up|0|||
48352566|NCT03024996|155488744|FG000|Overall Study|Other|3|||
48352567|NCT03024996|155488745|FG001|Overall Study|Other|3|||
48352568|NCT03024996|155488744|FG000|Overall Study|Physician Decision|0|||
48352569|NCT03024996|155488745|FG001|Overall Study|Physician Decision|1|||
48352570|NCT03024996|155488744|FG000|Overall Study|Study terminated by sponsor|303|||
48352571|NCT03024996|155488745|FG001|Overall Study|Study terminated by sponsor|283|||
48352572|NCT03024996|155488744|FG000|Overall Study|Withdrawal by Subject|21|||
48352573|NCT03024996|155488745|FG001|Overall Study|Withdrawal by Subject|36|||
48352574|NCT00475644|155488746|FG000|Overall Study|Protocol Violation|13|||
48352575|NCT03897686|155488747|FG000|Overall Study|Protocol Violation|1|||
48352576|NCT03897686|155488748|FG001|Overall Study|Protocol Violation|1|||
48352577|NCT03897686|155488747|FG000|Overall Study|Withdrawal by Subject|1|||
48352578|NCT03897686|155488748|FG001|Overall Study|Withdrawal by Subject|1|||
48675933|NCT01278797|156665450|FG000|Period 1|Adverse Event|0|||
48675934|NCT01278797|156665451|FG001|Period 1|Adverse Event|1|||
48352579|NCT03113383|155488749|FG000|Overall Study|Death|4|||
48352580|NCT03113383|155488750|FG001|Overall Study|Death|0|||
48352581|NCT02312960|155488753|FG000|Overall Study|Death|24|||
48352582|NCT02312960|155488754|FG001|Overall Study|Death|32|||
48352583|NCT02312960|155488755|FG002|Overall Study|Death|25|||
48352584|NCT02312960|155488756|FG003|Overall Study|Death|11|||
48352585|NCT02312960|155488757|FG004|Overall Study|Death|5|||
48352586|NCT02312960|155488758|FG005|Overall Study|Death|5|||
48352587|NCT02312960|155488759|FG006|Overall Study|Death|8|||
48352588|NCT02312960|155488760|FG007|Overall Study|Death|5|||
48352589|NCT02312960|155488761|FG008|Overall Study|Death|7|||
48352590|NCT02312960|155488762|FG009|Overall Study|Death|3|||
48352591|NCT02312960|155488763|FG010|Overall Study|Death|3|||
48675935|NCT01278797|156665450|FG000|Period 1|Protocol Violation|1|||
48352592|NCT02312960|155488764|FG011|Overall Study|Death|1|||
48352593|NCT02312960|155488765|FG012|Overall Study|Death|25|||
48352594|NCT02312960|155488766|FG013|Overall Study|Death|19|||
48352595|NCT02312960|155488753|FG000|Overall Study|Missing|0|||
48352596|NCT02312960|155488754|FG001|Overall Study|Missing|0|||
48352597|NCT02312960|155488755|FG002|Overall Study|Missing|2|||
48352598|NCT02312960|155488756|FG003|Overall Study|Missing|0|||
48352599|NCT02312960|155488757|FG004|Overall Study|Missing|0|||
48352600|NCT02312960|155488758|FG005|Overall Study|Missing|0|||
48352601|NCT02312960|155488759|FG006|Overall Study|Missing|0|||
48352602|NCT02312960|155488760|FG007|Overall Study|Missing|0|||
48352603|NCT02312960|155488761|FG008|Overall Study|Missing|0|||
48352604|NCT02312960|155488762|FG009|Overall Study|Missing|0|||
48352605|NCT02312960|155488763|FG010|Overall Study|Missing|0|||
48352606|NCT02312960|155488764|FG011|Overall Study|Missing|0|||
48352607|NCT02312960|155488765|FG012|Overall Study|Missing|0|||
48352608|NCT02312960|155488766|FG013|Overall Study|Missing|0|||
48352609|NCT02312960|155488753|FG000|Overall Study|Lost to Follow-up|0|||
48352610|NCT02312960|155488754|FG001|Overall Study|Lost to Follow-up|0|||
48352611|NCT02312960|155488755|FG002|Overall Study|Lost to Follow-up|1|||
48352612|NCT02312960|155488756|FG003|Overall Study|Lost to Follow-up|0|||
48352613|NCT02312960|155488757|FG004|Overall Study|Lost to Follow-up|0|||
48352614|NCT02312960|155488758|FG005|Overall Study|Lost to Follow-up|0|||
48352615|NCT02312960|155488759|FG006|Overall Study|Lost to Follow-up|1|||
48352616|NCT02312960|155488760|FG007|Overall Study|Lost to Follow-up|1|||
48352617|NCT02312960|155488761|FG008|Overall Study|Lost to Follow-up|0|||
48352618|NCT02312960|155488762|FG009|Overall Study|Lost to Follow-up|1|||
48352619|NCT02312960|155488763|FG010|Overall Study|Lost to Follow-up|0|||
48352620|NCT02312960|155488764|FG011|Overall Study|Lost to Follow-up|0|||
48352621|NCT02312960|155488765|FG012|Overall Study|Lost to Follow-up|1|||
48352622|NCT02312960|155488766|FG013|Overall Study|Lost to Follow-up|0|||
48352623|NCT02312960|155488753|FG000|Overall Study|Withdrawal by Subject|1|||
48352624|NCT02312960|155488754|FG001|Overall Study|Withdrawal by Subject|2|||
48352625|NCT02312960|155488755|FG002|Overall Study|Withdrawal by Subject|0|||
48352626|NCT02312960|155488756|FG003|Overall Study|Withdrawal by Subject|0|||
48352627|NCT02312960|155488757|FG004|Overall Study|Withdrawal by Subject|1|||
48352628|NCT02312960|155488758|FG005|Overall Study|Withdrawal by Subject|0|||
48352629|NCT02312960|155488759|FG006|Overall Study|Withdrawal by Subject|1|||
48352630|NCT02312960|155488760|FG007|Overall Study|Withdrawal by Subject|2|||
48352631|NCT02312960|155488761|FG008|Overall Study|Withdrawal by Subject|2|||
48352632|NCT02312960|155488762|FG009|Overall Study|Withdrawal by Subject|3|||
48352633|NCT02312960|155488763|FG010|Overall Study|Withdrawal by Subject|0|||
48352634|NCT02312960|155488764|FG011|Overall Study|Withdrawal by Subject|0|||
48352635|NCT02312960|155488765|FG012|Overall Study|Withdrawal by Subject|2|||
48352636|NCT02312960|155488766|FG013|Overall Study|Withdrawal by Subject|0|||
48352637|NCT02906020|155488767|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
48352638|NCT02906020|155488768|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
48352639|NCT02906020|155488769|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
48352640|NCT02906020|155488770|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
48352641|NCT02906020|155488771|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
48352642|NCT02906020|155488772|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
48352643|NCT02906020|155488773|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
48352644|NCT02906020|155488774|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
48352645|NCT02906020|155488775|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
48352646|NCT02906020|155488776|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
48352647|NCT02906020|155488777|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
48352648|NCT02906020|155488778|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
48352649|NCT02906020|155488779|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
48352650|NCT02906020|155488780|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
48352651|NCT02906020|155488781|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
48352652|NCT02906020|155488782|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
48352653|NCT02906020|155488767|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352654|NCT02906020|155488768|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352655|NCT02906020|155488769|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352656|NCT02906020|155488770|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352657|NCT02906020|155488771|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352658|NCT02906020|155488772|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352659|NCT02906020|155488773|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352660|NCT02906020|155488774|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352661|NCT02906020|155488775|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
48352662|NCT02906020|155488776|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
48352663|NCT02906020|155488777|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352664|NCT02906020|155488778|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352665|NCT02906020|155488779|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352666|NCT02906020|155488780|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352667|NCT02906020|155488781|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352668|NCT02906020|155488782|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
48352669|NCT02906020|155488767|FG000|Part 2: Double-blind Treatment Period|Other|0|||
48352670|NCT02906020|155488768|FG001|Part 2: Double-blind Treatment Period|Other|0|||
48352671|NCT02906020|155488769|FG002|Part 2: Double-blind Treatment Period|Other|0|||
48352672|NCT02906020|155488770|FG003|Part 2: Double-blind Treatment Period|Other|0|||
48352673|NCT02906020|155488771|FG004|Part 2: Double-blind Treatment Period|Other|0|||
48675936|NCT01278797|156665451|FG001|Period 1|Protocol Violation|0|||
48675937|NCT00167310|156665452|FG000|Overall Study|Protocol Violation|5|||
48675938|NCT00167310|156665453|FG001|Overall Study|Protocol Violation|3|||
48675939|NCT00167310|156665452|FG000|Overall Study|Withdrawal by Subject|3|||
48675940|NCT00167310|156665453|FG001|Overall Study|Withdrawal by Subject|7|||
48675941|NCT01868477|156665459|FG000|Overall Study|Adverse Event|2|||
48675942|NCT01868477|156665460|FG001|Overall Study|Adverse Event|4|||
48675943|NCT01868477|156665459|FG000|Overall Study|Disease progression|1|||
48675944|NCT01868477|156665460|FG001|Overall Study|Disease progression|1|||
48352674|NCT02906020|155488772|FG005|Part 2: Double-blind Treatment Period|Other|0|||
48352675|NCT02906020|155488773|FG006|Part 2: Double-blind Treatment Period|Other|0|||
48352676|NCT02906020|155488774|FG007|Part 2: Double-blind Treatment Period|Other|0|||
48352677|NCT02906020|155488775|FG008|Part 2: Double-blind Treatment Period|Other|6|||
48352678|NCT02906020|155488776|FG009|Part 2: Double-blind Treatment Period|Other|10|||
48352679|NCT02906020|155488777|FG010|Part 2: Double-blind Treatment Period|Other|0|||
48352680|NCT02906020|155488778|FG011|Part 2: Double-blind Treatment Period|Other|0|||
48352681|NCT02906020|155488779|FG012|Part 2: Double-blind Treatment Period|Other|0|||
48352682|NCT02906020|155488780|FG013|Part 2: Double-blind Treatment Period|Other|0|||
48352683|NCT02906020|155488781|FG014|Part 2: Double-blind Treatment Period|Other|0|||
48352684|NCT02906020|155488782|FG015|Part 2: Double-blind Treatment Period|Other|0|||
48352685|NCT02906020|155488767|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352686|NCT02906020|155488768|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352687|NCT02906020|155488769|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352688|NCT02906020|155488770|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352689|NCT02906020|155488771|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352690|NCT02906020|155488772|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352691|NCT02906020|155488773|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352692|NCT02906020|155488774|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352693|NCT02906020|155488775|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352694|NCT02906020|155488776|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352695|NCT02906020|155488777|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352696|NCT02906020|155488778|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352697|NCT02906020|155488779|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
48352698|NCT02906020|155488780|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
48352699|NCT02906020|155488781|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352700|NCT02906020|155488782|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
48352701|NCT02906020|155488767|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352702|NCT02906020|155488768|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352703|NCT02906020|155488769|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352704|NCT02906020|155488770|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352705|NCT02906020|155488771|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352706|NCT02906020|155488772|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352707|NCT02906020|155488773|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352708|NCT02906020|155488774|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352709|NCT02906020|155488775|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352710|NCT02906020|155488776|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352711|NCT02906020|155488777|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352712|NCT02906020|155488778|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352713|NCT02906020|155488779|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
48352714|NCT02906020|155488780|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
48352715|NCT02906020|155488781|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
48352716|NCT02906020|155488782|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
48352717|NCT02906020|155488767|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352718|NCT02906020|155488768|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352719|NCT02906020|155488769|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352720|NCT02906020|155488770|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352721|NCT02906020|155488771|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352722|NCT02906020|155488772|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352723|NCT02906020|155488773|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352724|NCT02906020|155488774|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352725|NCT02906020|155488775|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352726|NCT02906020|155488776|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352727|NCT02906020|155488777|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352728|NCT02906020|155488778|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352729|NCT02906020|155488779|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
48352730|NCT02906020|155488780|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
48352731|NCT02906020|155488781|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352732|NCT02906020|155488782|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
48352733|NCT02906020|155488767|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352734|NCT02906020|155488768|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352735|NCT02906020|155488769|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352736|NCT02906020|155488770|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352737|NCT02906020|155488771|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352738|NCT02906020|155488772|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352739|NCT02906020|155488773|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352740|NCT02906020|155488774|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352741|NCT02906020|155488775|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352742|NCT02906020|155488776|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352743|NCT02906020|155488777|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352744|NCT02906020|155488778|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352745|NCT02906020|155488779|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
48352746|NCT02906020|155488780|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
48352747|NCT02906020|155488781|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352748|NCT02906020|155488782|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
48352749|NCT02906020|155488767|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352750|NCT02906020|155488768|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352751|NCT02906020|155488769|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352752|NCT02906020|155488770|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352753|NCT02906020|155488771|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352754|NCT02906020|155488772|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352755|NCT02906020|155488773|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352756|NCT02906020|155488774|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352757|NCT02906020|155488775|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352758|NCT02906020|155488776|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352759|NCT02906020|155488777|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352760|NCT02906020|155488778|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
48352761|NCT02906020|155488779|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
48352762|NCT02906020|155488780|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
48352763|NCT02906020|155488781|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
48352764|NCT02906020|155488782|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
48352765|NCT02906020|155488767|FG000|Part 2: Long-term Follow-up Period|Other|0|||
48352766|NCT02906020|155488768|FG001|Part 2: Long-term Follow-up Period|Other|0|||
48352767|NCT02906020|155488769|FG002|Part 2: Long-term Follow-up Period|Other|0|||
48352768|NCT02906020|155488770|FG003|Part 2: Long-term Follow-up Period|Other|0|||
48352769|NCT02906020|155488771|FG004|Part 2: Long-term Follow-up Period|Other|0|||
48352770|NCT02906020|155488772|FG005|Part 2: Long-term Follow-up Period|Other|0|||
48352771|NCT02906020|155488773|FG006|Part 2: Long-term Follow-up Period|Other|0|||
48352772|NCT02906020|155488774|FG007|Part 2: Long-term Follow-up Period|Other|0|||
48352773|NCT02906020|155488775|FG008|Part 2: Long-term Follow-up Period|Other|0|||
48352774|NCT02906020|155488776|FG009|Part 2: Long-term Follow-up Period|Other|0|||
48352775|NCT02906020|155488777|FG010|Part 2: Long-term Follow-up Period|Other|0|||
48352776|NCT02906020|155488778|FG011|Part 2: Long-term Follow-up Period|Other|0|||
48352777|NCT02906020|155488779|FG012|Part 2: Long-term Follow-up Period|Other|13|||
48352778|NCT02906020|155488780|FG013|Part 2: Long-term Follow-up Period|Other|8|||
48352779|NCT02906020|155488781|FG014|Part 2: Long-term Follow-up Period|Other|3|||
48352780|NCT02906020|155488782|FG015|Part 2: Long-term Follow-up Period|Other|2|||
48352781|NCT02641587|155488785|FG000|Confinement Period|Adverse Event|1|||
48352782|NCT02641587|155488786|FG001|Confinement Period|Adverse Event|0|||
48352783|NCT02641587|155488785|FG000|Confinement Period|Withdrawal by Subject|2|||
48352784|NCT02641587|155488786|FG001|Confinement Period|Withdrawal by Subject|1|||
48352785|NCT02641587|155488785|FG000|Ambulatory Period|Withdrawal by Subject|1|||
48352786|NCT02641587|155488786|FG001|Ambulatory Period|Withdrawal by Subject|0|||
48352787|NCT05082909|155488787|FG000|Overall Study|Protocol Violation|0|||
48352788|NCT05082909|155488788|FG001|Overall Study|Protocol Violation|0|||
48352789|NCT05082909|155488789|FG002|Overall Study|Protocol Violation|1|||
48352790|NCT05082909|155488790|FG003|Overall Study|Protocol Violation|0|||
48352791|NCT05082909|155488791|FG004|Overall Study|Protocol Violation|0|||
48352792|NCT05082909|155488792|FG005|Overall Study|Protocol Violation|0|||
48352793|NCT00781937|155488793|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
48352794|NCT00781937|155488794|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
48352795|NCT00781937|155488793|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
48352796|NCT00781937|155488794|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
48352797|NCT00781937|155488793|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
48352798|NCT00781937|155488794|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
48352799|NCT00781937|155488793|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
48352800|NCT00781937|155488794|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
48352801|NCT00781937|155488793|FG000|Main Trial Period Through Week 56|Unclassified|10|||
48352802|NCT00781937|155488794|FG001|Main Trial Period Through Week 56|Unclassified|15|||
48352803|NCT00781937|155488793|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
48352804|NCT00781937|155488794|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
48352805|NCT00781937|155488793|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
48352806|NCT00781937|155488794|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
48352807|NCT01150045|155488795|FG000|Overall Study|Protocol Violation|0|||
48352808|NCT01150045|155488796|FG001|Overall Study|Protocol Violation|1|||
48352809|NCT01150045|155488797|FG002|Overall Study|Protocol Violation|0|||
48352810|NCT01150045|155488798|FG003|Overall Study|Protocol Violation|1|||
48352811|NCT00634842|155488799|FG000|Overall Study|Adverse Event|2|||
48352812|NCT00634842|155488800|FG001|Overall Study|Adverse Event|3|||
48352813|NCT00634842|155488799|FG000|Overall Study|Protocol Violation|8|||
48352814|NCT00634842|155488800|FG001|Overall Study|Protocol Violation|4|||
48352815|NCT00634842|155488799|FG000|Overall Study|Move to another state|1|||
48352816|NCT00634842|155488800|FG001|Overall Study|Move to another state|0|||
48352817|NCT00634842|155488799|FG000|Overall Study|Inclusion criteria were not met|1|||
48352818|NCT00634842|155488800|FG001|Overall Study|Inclusion criteria were not met|0|||
48352819|NCT00634842|155488799|FG000|Overall Study|Lost to Follow-up|1|||
48352820|NCT00634842|155488800|FG001|Overall Study|Lost to Follow-up|2|||
48352821|NCT00634842|155488799|FG000|Overall Study|Physician Decision|1|||
48352822|NCT00634842|155488800|FG001|Overall Study|Physician Decision|0|||
48352823|NCT00634842|155488799|FG000|Overall Study|Withdrawal by Subject|1|||
48352824|NCT00634842|155488800|FG001|Overall Study|Withdrawal by Subject|3|||
48352825|NCT00634842|155488799|FG000|Overall Study|Lack of time and intolerance to drug|0|||
48352826|NCT00634842|155488800|FG001|Overall Study|Lack of time and intolerance to drug|1|||
48352827|NCT00634842|155488799|FG000|Overall Study|Discontinued due to injection|0|||
48352828|NCT00634842|155488800|FG001|Overall Study|Discontinued due to injection|2|||
48352829|NCT00634842|155488799|FG000|Overall Study|No need of study drug to treat diabetes|0|||
48352830|NCT00634842|155488800|FG001|Overall Study|No need of study drug to treat diabetes|1|||
48352831|NCT00634842|155488799|FG000|Overall Study|No wish to keep taking Avandia|0|||
48352832|NCT00634842|155488800|FG001|Overall Study|No wish to keep taking Avandia|1|||
48352833|NCT00634842|155488799|FG000|Overall Study|Subject off study drug for too long|0|||
48352834|NCT00634842|155488800|FG001|Overall Study|Subject off study drug for too long|1|||
48352835|NCT00543062|155488801|FG000|Overall Study|Withdrawal by Subject|1|||
48352836|NCT00543062|155488802|FG001|Overall Study|Withdrawal by Subject|0|||
48352837|NCT00543062|155488803|FG002|Overall Study|Withdrawal by Subject|2|||
48352838|NCT00543062|155488804|FG003|Overall Study|Withdrawal by Subject|0|||
48352839|NCT00543062|155488801|FG000|Overall Study|Adverse Event|0|||
48352840|NCT00543062|155488802|FG001|Overall Study|Adverse Event|1|||
48352841|NCT00543062|155488803|FG002|Overall Study|Adverse Event|1|||
48352842|NCT00543062|155488804|FG003|Overall Study|Adverse Event|1|||
48352843|NCT00543062|155488801|FG000|Overall Study|Protocol Violation|1|||
48352844|NCT00543062|155488802|FG001|Overall Study|Protocol Violation|0|||
48352845|NCT00543062|155488803|FG002|Overall Study|Protocol Violation|0|||
48352846|NCT00543062|155488804|FG003|Overall Study|Protocol Violation|0|||
48352847|NCT00464945|155488805|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
48352848|NCT00464945|155488806|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
48352849|NCT00464945|155488805|FG000|Infant Series|Protocol Violation|1|||
48352850|NCT00464945|155488806|FG001|Infant Series|Protocol Violation|0|||
48352851|NCT00464945|155488805|FG000|Infant Series|Lost to Follow-up|1|||
48352852|NCT00464945|155488806|FG001|Infant Series|Lost to Follow-up|0|||
48352853|NCT00464945|155488805|FG000|After Infant Series|Withdrawal by Subject|0|||
48352854|NCT00464945|155488806|FG001|After Infant Series|Withdrawal by Subject|2|||
48352855|NCT00464945|155488805|FG000|Toddler Dose|Lost to Follow-up|0|||
48352856|NCT00464945|155488806|FG001|Toddler Dose|Lost to Follow-up|1|||
48352857|NCT05382039|155488809|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
48352858|NCT05382039|155488810|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
48352859|NCT05382039|155488811|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
48352860|NCT05382039|155488809|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
48352861|NCT05382039|155488810|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
48352862|NCT05382039|155488811|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
48352863|NCT05382039|155488809|FG000|Overall Study|waiting for confirmation|0|||
48352864|NCT05382039|155488810|FG001|Overall Study|waiting for confirmation|0|||
48352865|NCT05382039|155488811|FG002|Overall Study|waiting for confirmation|1|||
48352866|NCT01077128|155488817|FG000|Overall Study|Adverse Event|8|||
48352867|NCT01077128|155488817|FG000|Overall Study|Lack of Efficacy|1|||
48352868|NCT01077128|155488817|FG000|Overall Study|Disease exacerbation|1|||
48352869|NCT01077128|155488817|FG000|Overall Study|Adverse event and consent withdrawal|1|||
48352870|NCT01077128|155488817|FG000|Overall Study|Adverse event and disease exacerbation|1|||
48352871|NCT01077128|155488817|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
48352872|NCT01077128|155488817|FG000|Overall Study|Other|54|||
48352873|NCT00943787|155488818|FG000|Overall Study|Physician Decision|4|||
48352874|NCT00943787|155488818|FG000|Overall Study|Withdrawal by Subject|3|||
48352875|NCT00520845|155488819|FG000|Overall Study|Death|3|||
48352876|NCT00520845|155488819|FG000|Overall Study|Adverse Event|4|||
48352877|NCT00520845|155488819|FG000|Overall Study|Disease Progression, relapse|13|||
48352878|NCT00520845|155488819|FG000|Overall Study|Withdrawal by Subject|1|||
48352879|NCT00520845|155488819|FG000|Overall Study|Alternative Therapy|1|||
48352880|NCT01015677|155488820|FG000|Overall Study|Adverse Event|0|||
48352881|NCT01015677|155488821|FG001|Overall Study|Adverse Event|1|||
48352882|NCT01015677|155488822|FG002|Overall Study|Adverse Event|0|||
48352883|NCT01015677|155488820|FG000|Overall Study|Lack of Efficacy|0|||
48352884|NCT01015677|155488821|FG001|Overall Study|Lack of Efficacy|1|||
48352885|NCT01015677|155488822|FG002|Overall Study|Lack of Efficacy|0|||
48352886|NCT01015677|155488820|FG000|Overall Study|Protocol Violation|0|||
48352887|NCT01015677|155488821|FG001|Overall Study|Protocol Violation|1|||
48352888|NCT01015677|155488822|FG002|Overall Study|Protocol Violation|0|||
48352889|NCT01015677|155488820|FG000|Overall Study|Withdrawal by Subject|1|||
48352890|NCT01015677|155488821|FG001|Overall Study|Withdrawal by Subject|1|||
48352891|NCT01015677|155488822|FG002|Overall Study|Withdrawal by Subject|0|||
48352892|NCT02229227|155488823|FG000|Overall Study|Adverse Event|14|||
48352893|NCT02229227|155488824|FG001|Overall Study|Adverse Event|9|||
48675945|NCT01868477|156665459|FG000|Overall Study|Withdrawal by Subject|1|||
48675946|NCT01868477|156665460|FG001|Overall Study|Withdrawal by Subject|0|||
48675947|NCT01730586|156665461|FG000|Overall Study|Progressive Disease|2|||
48675948|NCT01730586|156665461|FG000|Overall Study|Inadequate Trial|8|||
48675949|NCT01730586|156665461|FG000|Overall Study|Adverse Event|2|||
48675950|NCT01730586|156665461|FG000|Overall Study|Hospice|1|||
48675951|NCT00061633|156665462|FG000|Overall Study|Adverse Event|1|||
48675952|NCT00061633|156665463|FG001|Overall Study|Adverse Event|2|||
48675953|NCT00061633|156665462|FG000|Overall Study|Withdrawal by Subject|2|||
48675954|NCT00061633|156665463|FG001|Overall Study|Withdrawal by Subject|2|||
48675955|NCT00061633|156665462|FG000|Overall Study|Lost to Follow-up|1|||
48675956|NCT00061633|156665463|FG001|Overall Study|Lost to Follow-up|4|||
48675957|NCT00061633|156665462|FG000|Overall Study|Other|1|||
48675958|NCT00061633|156665463|FG001|Overall Study|Other|1|||
48675959|NCT00061633|156665462|FG000|Overall Study|Never received study treatment|0|||
48675960|NCT00061633|156665463|FG001|Overall Study|Never received study treatment|2|||
48675961|NCT01408459|156665488|FG000|Overall Study|Withdrawal by Subject|1|||
48675962|NCT01408459|156665489|FG001|Overall Study|Withdrawal by Subject|1|||
48675963|NCT00534976|156665490|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
48675964|NCT00534976|156665491|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
48675965|NCT00534976|156665490|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
48675966|NCT00534976|156665491|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
48675967|NCT00534976|156665490|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
48675968|NCT00534976|156665491|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
48675969|NCT00811174|156665493|FG000|Overall Study|Protocol Violation|2|||
48675970|NCT00811174|156665493|FG000|Overall Study|Sponsors Decision|1|||
48352894|NCT02229227|155488823|FG000|Overall Study|Lack of Efficacy|3|||
48352895|NCT02229227|155488824|FG001|Overall Study|Lack of Efficacy|3|||
48352896|NCT02229227|155488823|FG000|Overall Study|Protocol Violation|6|||
48352897|NCT02229227|155488824|FG001|Overall Study|Protocol Violation|8|||
48352898|NCT02229227|155488823|FG000|Overall Study|Protocol defined stopping criteria|1|||
48352899|NCT02229227|155488824|FG001|Overall Study|Protocol defined stopping criteria|3|||
48352900|NCT02229227|155488823|FG000|Overall Study|Lost to Follow-up|3|||
48352901|NCT02229227|155488824|FG001|Overall Study|Lost to Follow-up|3|||
48352902|NCT02229227|155488823|FG000|Overall Study|Study terminated by sponsor|11|||
48352903|NCT02229227|155488824|FG001|Overall Study|Study terminated by sponsor|11|||
48352904|NCT02229227|155488823|FG000|Overall Study|Withdrawal by Subject|8|||
48352905|NCT02229227|155488824|FG001|Overall Study|Withdrawal by Subject|12|||
48352906|NCT02229227|155488823|FG000|Overall Study|Other|0|||
48352907|NCT02229227|155488824|FG001|Overall Study|Other|1|||
48352908|NCT02229227|155488823|FG000|Overall Study|Physician Decision|5|||
48352909|NCT02229227|155488824|FG001|Overall Study|Physician Decision|12|||
48352910|NCT00872001|155488825|FG000|Overall Study|Adverse Event|34|||
48352911|NCT00872001|155488826|FG001|Overall Study|Adverse Event|23|||
48352912|NCT00872001|155488825|FG000|Overall Study|Protocol Defined Clinical Event|5|||
48675971|NCT02831933|156667150|FG000|Overall Study|Physician Decision|11|||
48675972|NCT01161537|156667152|FG000|Part B|Withdrawal by Subject|2|||
48675973|NCT01673620|156667155|FG000|Overall Study|Adverse Event|1|||
48675974|NCT01673620|156667156|FG001|Overall Study|Adverse Event|0|||
48352913|NCT00872001|155488826|FG001|Overall Study|Protocol Defined Clinical Event|7|||
48352914|NCT00872001|155488825|FG000|Overall Study|Lost to Follow-up|13|||
48352915|NCT00872001|155488826|FG001|Overall Study|Lost to Follow-up|12|||
48352916|NCT00872001|155488825|FG000|Overall Study|Withdrawal by Subject|18|||
48352917|NCT00872001|155488826|FG001|Overall Study|Withdrawal by Subject|30|||
48352918|NCT00872001|155488825|FG000|Overall Study|Protocol Violation|5|||
48352919|NCT00872001|155488826|FG001|Overall Study|Protocol Violation|8|||
48352920|NCT00872001|155488825|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
48675975|NCT01192568|156667157|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
48352921|NCT00872001|155488826|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
48352922|NCT00872001|155488825|FG000|Overall Study|Administrative|23|||
48675976|NCT01192568|156667158|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
48675977|NCT01192568|156667159|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
48675978|NCT01192568|156667160|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
48352923|NCT00872001|155488826|FG001|Overall Study|Administrative|15|||
48352924|NCT01453023|155488829|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
48352925|NCT01453023|155488830|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
48352926|NCT01453023|155488829|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
48352927|NCT01453023|155488830|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
48352928|NCT01453023|155488829|FG000|Treatment Period 2|Protocol Violation|0|||
48352929|NCT01453023|155488830|FG001|Treatment Period 2|Protocol Violation|1|||
48352930|NCT01660256|155488831|FG000|Overall Study|Adverse Event|4|||
48352931|NCT01660256|155488832|FG001|Overall Study|Adverse Event|0|||
48352932|NCT01660256|155488833|FG002|Overall Study|Adverse Event|2|||
48352933|NCT01660256|155488831|FG000|Overall Study|Withdrawal by Subject|1|||
48352934|NCT01660256|155488832|FG001|Overall Study|Withdrawal by Subject|0|||
48352935|NCT01660256|155488833|FG002|Overall Study|Withdrawal by Subject|2|||
48352936|NCT02232399|155488834|FG000|Overall Study|Adverse Event|1|||
48352937|NCT02232399|155488835|FG001|Overall Study|Adverse Event|0|||
48352938|NCT02232399|155488834|FG000|Overall Study|Withdrawal by Subject|0|||
48352939|NCT02232399|155488835|FG001|Overall Study|Withdrawal by Subject|1|||
48352940|NCT04468230|155488838|FG000|Overall Study|Adverse Event|2|||
48352941|NCT05177848|155488839|FG000|Overall Study|Lost to Follow-up|1|||
48352942|NCT05177848|155488840|FG001|Overall Study|Lost to Follow-up|4|||
48352943|NCT05177848|155488839|FG000|Overall Study|Discontinued|2|||
48352944|NCT05177848|155488840|FG001|Overall Study|Discontinued|1|||
48352945|NCT00794924|155488846|FG000|Overall Study|Lost to Follow-up|6|||
48352946|NCT00794924|155488847|FG001|Overall Study|Lost to Follow-up|8|||
48352947|NCT00794924|155488846|FG000|Overall Study|Withdrawal by Subject|48|||
48352948|NCT00794924|155488847|FG001|Overall Study|Withdrawal by Subject|60|||
48352949|NCT00794924|155488846|FG000|Overall Study|Adverse Event|6|||
48352950|NCT00794924|155488847|FG001|Overall Study|Adverse Event|2|||
48352951|NCT00727506|155488848|FG000|Overall Study|Adverse Event|0|||
48352952|NCT00727506|155488849|FG001|Overall Study|Adverse Event|0|||
48352953|NCT00727506|155488850|FG002|Overall Study|Adverse Event|4|||
48352954|NCT00727506|155488851|FG003|Overall Study|Adverse Event|4|||
48352955|NCT00727506|155488852|FG004|Overall Study|Adverse Event|1|||
48352956|NCT00727506|155488853|FG005|Overall Study|Adverse Event|8|||
48352957|NCT00727506|155488848|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48352958|NCT00727506|155488849|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48352959|NCT00727506|155488850|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48352960|NCT00727506|155488851|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48352961|NCT00727506|155488852|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48352962|NCT00727506|155488853|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48352963|NCT00727506|155488848|FG000|Overall Study|Progressive disease|4|||
48352964|NCT00727506|155488849|FG001|Overall Study|Progressive disease|7|||
48352965|NCT00727506|155488850|FG002|Overall Study|Progressive disease|9|||
48352966|NCT00727506|155488851|FG003|Overall Study|Progressive disease|28|||
48352967|NCT00727506|155488852|FG004|Overall Study|Progressive disease|38|||
48352968|NCT00727506|155488853|FG005|Overall Study|Progressive disease|28|||
48352969|NCT00727506|155488848|FG000|Overall Study|Refused to continue medication|0|||
48352970|NCT00727506|155488849|FG001|Overall Study|Refused to continue medication|1|||
48352971|NCT00727506|155488850|FG002|Overall Study|Refused to continue medication|2|||
48352972|NCT00727506|155488851|FG003|Overall Study|Refused to continue medication|3|||
48352973|NCT00727506|155488852|FG004|Overall Study|Refused to continue medication|1|||
48352974|NCT00727506|155488853|FG005|Overall Study|Refused to continue medication|2|||
48352975|NCT00727506|155488848|FG000|Overall Study|Other reason not described above|0|||
48352976|NCT00727506|155488849|FG001|Overall Study|Other reason not described above|0|||
48352977|NCT00727506|155488850|FG002|Overall Study|Other reason not described above|1|||
48352978|NCT00727506|155488851|FG003|Overall Study|Other reason not described above|4|||
48352979|NCT00727506|155488852|FG004|Overall Study|Other reason not described above|1|||
48352980|NCT00727506|155488853|FG005|Overall Study|Other reason not described above|1|||
48352981|NCT03229486|155488854|FG000|Overall Study|Protocol Violation|0|||
48352982|NCT03229486|155488855|FG001|Overall Study|Protocol Violation|1|||
48352983|NCT00383123|155488859|FG000|Overall Study|Adverse Event|1|||
48352984|NCT00383123|155488860|FG001|Overall Study|Adverse Event|0|||
48675979|NCT01192568|156667157|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
48352985|NCT00383123|155488859|FG000|Overall Study|Lost to Follow-up|68|||
48352986|NCT00383123|155488860|FG001|Overall Study|Lost to Follow-up|61|||
48352987|NCT00383123|155488859|FG000|Overall Study|Protocol Violation|5|||
48352988|NCT00383123|155488860|FG001|Overall Study|Protocol Violation|1|||
48352989|NCT00383123|155488859|FG000|Overall Study|Withdrawal by Subject|27|||
48352990|NCT00383123|155488860|FG001|Overall Study|Withdrawal by Subject|18|||
48352991|NCT00383123|155488859|FG000|Overall Study|Other reason|10|||
48352992|NCT00383123|155488860|FG001|Overall Study|Other reason|6|||
48352993|NCT00455741|155488861|FG000|Overall Study|Physician Decision|0|||
48352994|NCT00455741|155488862|FG001|Overall Study|Physician Decision|1|||
48352995|NCT00245960|155488863|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
48352996|NCT00245960|155488864|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
48675980|NCT01192568|156667158|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
48352997|NCT00245960|155488863|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
48352998|NCT00245960|155488864|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
48352999|NCT00245960|155488863|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
48353000|NCT00245960|155488864|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
48353001|NCT00245960|155488863|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
48353002|NCT00245960|155488864|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
48353003|NCT00245960|155488863|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
48353004|NCT00245960|155488864|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
48353005|NCT00245960|155488863|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
48353006|NCT00245960|155488864|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
48353007|NCT00245960|155488863|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
48353008|NCT00245960|155488864|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
48353009|NCT00245960|155488863|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
48353010|NCT00245960|155488864|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
48353011|NCT00245960|155488863|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
48353012|NCT00245960|155488864|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
48353013|NCT00245960|155488863|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
48353014|NCT00245960|155488864|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
48353015|NCT00245960|155488863|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
48353016|NCT00245960|155488864|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
48353017|NCT00245960|155488863|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
48353018|NCT00245960|155488864|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
48353019|NCT00978562|155488870|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
48353020|NCT00570908|155488871|FG000|Overall Study|Adverse Event|5|||
48353021|NCT00570908|155488871|FG000|Overall Study|Withdrawal by Subject|2|||
48353022|NCT00632502|155488872|FG000|Overall Study|Adverse Event|0|||
48353023|NCT00632502|155488873|FG001|Overall Study|Adverse Event|1|||
48353024|NCT00632502|155488872|FG000|Overall Study|Randomized not treated|3|||
48353025|NCT00632502|155488873|FG001|Overall Study|Randomized not treated|0|||
48353026|NCT04097028|155488876|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
48353027|NCT04097028|155488876|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
48353028|NCT04097028|155488876|FG000|Overall Study|Disease Progression prior to Surgery|2|||
48353029|NCT04097028|155488876|FG000|Overall Study|Adverse Event prior to Surgery|1|||
48353030|NCT05452460|155488879|FG000|Overall Study|Lost to Follow-up|3|||
48353031|NCT05452460|155488880|FG001|Overall Study|Lost to Follow-up|3|||
48353032|NCT05452460|155488879|FG000|Overall Study|Did not receive intervention|1|||
48353033|NCT05452460|155488880|FG001|Overall Study|Did not receive intervention|0|||
48353034|NCT05906784|155488881|FG000|Overall Study|Lost to Follow-up|2|||
48353035|NCT05906784|155488882|FG001|Overall Study|Lost to Follow-up|1|||
48353036|NCT05906784|155488883|FG002|Overall Study|Lost to Follow-up|1|||
48353037|NCT05906784|155488884|FG003|Overall Study|Lost to Follow-up|1|||
48353038|NCT00356811|155488886|FG000|Overall Study|Death|35|||
48353039|NCT00356811|155488886|FG000|Overall Study|Lost to Follow-up|2|||
48353040|NCT00356811|155488886|FG000|Overall Study|Withdrawal by Subject|6|||
48353041|NCT00356811|155488886|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
48353042|NCT00356811|155488886|FG000|Overall Study|Study Is Terminating|3|||
48353043|NCT00356811|155488886|FG000|Overall Study|Site Closed during Follow-up|2|||
48353044|NCT01867047|155490722|FG000|Overall Study|Lost to Follow-up|3|||
48353045|NCT01867047|155490723|FG001|Overall Study|Lost to Follow-up|3|||
48353046|NCT01867047|155490722|FG000|Overall Study|Withdrawal by Subject|2|||
48353047|NCT01867047|155490723|FG001|Overall Study|Withdrawal by Subject|0|||
48353048|NCT01867047|155490722|FG000|Overall Study|Physician Decision|2|||
48353049|NCT01867047|155490723|FG001|Overall Study|Physician Decision|0|||
48353050|NCT01867047|155490722|FG000|Overall Study|surgery not indicated in protocol|1|||
48353051|NCT01867047|155490723|FG001|Overall Study|surgery not indicated in protocol|2|||
48353052|NCT01090011|155490724|FG000|Overall Study|Progressive disease|128|||
48353053|NCT01090011|155490724|FG000|Overall Study|Adverse Event|32|||
48353054|NCT01090011|155490724|FG000|Overall Study|Protocol Violation|1|||
48353055|NCT01090011|155490724|FG000|Overall Study|Refusal to start/continue medication|5|||
48353056|NCT01090011|155490724|FG000|Overall Study|Other reason not defined above|5|||
48675981|NCT01192568|156667159|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
48675982|NCT01192568|156667160|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
48675983|NCT01022424|156667161|FG000|Overall Study|Adverse Event|1|||
48353057|NCT01639742|155490727|FG000|Overall Study|Study Ongoing|17|||
48353058|NCT01639742|155490727|FG000|Overall Study|Lost to Follow-up|1|||
48353059|NCT00612352|155490730|FG000|Overall Study|Adverse Event|1|||
48675984|NCT01022424|156667161|FG000|Overall Study|Physician Decision|1|||
48353060|NCT00612352|155490731|FG001|Overall Study|Adverse Event|0|||
48353061|NCT00612352|155490730|FG000|Overall Study|Withdrawal by Subject|3|||
48675985|NCT01022424|156667161|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
48353062|NCT00612352|155490731|FG001|Overall Study|Withdrawal by Subject|5|||
48675986|NCT01971008|156667162|FG000|Overall Study|Protocol Violation|2|||
48353063|NCT00612352|155490730|FG000|Overall Study|moved out of state|1|||
48353064|NCT00612352|155490731|FG001|Overall Study|moved out of state|0|||
48353065|NCT00612352|155490730|FG000|Overall Study|didn't return calls/show up on test date|4|||
48353066|NCT00612352|155490731|FG001|Overall Study|didn't return calls/show up on test date|1|||
48353067|NCT02034162|155490732|FG000|Double-blind|Lost to Follow-up|3|||
48353068|NCT02034162|155490733|FG001|Double-blind|Lost to Follow-up|0|||
48353069|NCT02034162|155490734|FG002|Double-blind|Lost to Follow-up|0|||
48353070|NCT02034162|155490732|FG000|Double-blind|Physician Decision|1|||
48353071|NCT02034162|155490733|FG001|Double-blind|Physician Decision|0|||
48353072|NCT02034162|155490734|FG002|Double-blind|Physician Decision|0|||
48353073|NCT02034162|155490732|FG000|Double-blind|Protocol Violation|0|||
48353074|NCT02034162|155490733|FG001|Double-blind|Protocol Violation|1|||
48353075|NCT02034162|155490734|FG002|Double-blind|Protocol Violation|0|||
48353076|NCT02034162|155490732|FG000|Double-blind|Withdrawal by Subject|5|||
48353077|NCT02034162|155490733|FG001|Double-blind|Withdrawal by Subject|7|||
48353078|NCT02034162|155490734|FG002|Double-blind|Withdrawal by Subject|0|||
48353079|NCT00701909|155490739|FG000|Overall Study|Withdrawal by Subject|0|||
48353080|NCT00701909|155490740|FG001|Overall Study|Withdrawal by Subject|1|||
48353081|NCT03023722|155490741|FG000|Overall Study|No follow-up assessment|4|||
48353082|NCT01377389|155490744|FG000|Overall Study|Withdrawal by Subject|1|||
48353083|NCT01377389|155490744|FG000|Overall Study|Screen failure|2|||
48353084|NCT01667926|155490750|FG000|Overall Study|Withdrawal by Subject|1|||
48353085|NCT01667926|155490751|FG001|Overall Study|Withdrawal by Subject|2|||
48353086|NCT01667926|155490752|FG002|Overall Study|Withdrawal by Subject|2|||
48353087|NCT01667926|155490750|FG000|Overall Study|Physician Decision|0|||
48353088|NCT01667926|155490751|FG001|Overall Study|Physician Decision|0|||
48353089|NCT01667926|155490752|FG002|Overall Study|Physician Decision|1|||
48353090|NCT01667926|155490750|FG000|Overall Study|Time committment|0|||
48353091|NCT01667926|155490751|FG001|Overall Study|Time committment|0|||
48353092|NCT01667926|155490752|FG002|Overall Study|Time committment|2|||
48353093|NCT01667926|155490750|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
48353094|NCT01667926|155490751|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
48353095|NCT01667926|155490752|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
48353096|NCT01667926|155490750|FG000|Overall Study|Lost to Follow-up|1|||
48353097|NCT01667926|155490751|FG001|Overall Study|Lost to Follow-up|2|||
48353098|NCT01667926|155490752|FG002|Overall Study|Lost to Follow-up|1|||
48353099|NCT01667926|155490750|FG000|Overall Study|Side effects|3|||
48353100|NCT01667926|155490751|FG001|Overall Study|Side effects|0|||
48353101|NCT01667926|155490752|FG002|Overall Study|Side effects|0|||
48353102|NCT00730015|155490753|FG000|Overall Study|Adverse Event|11|||
48353103|NCT00730015|155490754|FG001|Overall Study|Adverse Event|10|||
48353104|NCT00730015|155490755|FG002|Overall Study|Adverse Event|8|||
48353105|NCT00730015|155490753|FG000|Overall Study|Protocol Violation|2|||
48353106|NCT00730015|155490754|FG001|Overall Study|Protocol Violation|6|||
48353107|NCT00730015|155490755|FG002|Overall Study|Protocol Violation|4|||
48353108|NCT00730015|155490753|FG000|Overall Study|Withdrawal by Subject|12|||
48353109|NCT00730015|155490754|FG001|Overall Study|Withdrawal by Subject|12|||
48353110|NCT00730015|155490755|FG002|Overall Study|Withdrawal by Subject|8|||
48353111|NCT00730015|155490753|FG000|Overall Study|Lost to Follow-up|4|||
48353112|NCT00730015|155490754|FG001|Overall Study|Lost to Follow-up|10|||
48353113|NCT00730015|155490755|FG002|Overall Study|Lost to Follow-up|3|||
48353114|NCT00730015|155490753|FG000|Overall Study|Lack of Efficacy|1|||
48353115|NCT00730015|155490754|FG001|Overall Study|Lack of Efficacy|2|||
48353116|NCT00730015|155490755|FG002|Overall Study|Lack of Efficacy|8|||
48353117|NCT00730015|155490753|FG000|Overall Study|Other Reason|1|||
48353118|NCT00730015|155490754|FG001|Overall Study|Other Reason|0|||
48353119|NCT00730015|155490755|FG002|Overall Study|Other Reason|1|||
48353120|NCT04075292|155490761|FG000|Overall Study|Withdrawal by Subject|1|||
48353121|NCT04075292|155490762|FG001|Overall Study|Withdrawal by Subject|9|||
48353122|NCT04075292|155490761|FG000|Overall Study|Death|2|||
48353123|NCT04075292|155490762|FG001|Overall Study|Death|5|||
48353124|NCT04075292|155490761|FG000|Overall Study|Remained on study at time of DCO|74|||
48353125|NCT04075292|155490762|FG001|Overall Study|Remained on study at time of DCO|64|||
48353126|NCT01821937|155490763|FG000|Overall Study|Adverse Event|0|||
48353127|NCT01821937|155490764|FG001|Overall Study|Adverse Event|3|||
48353128|NCT01732549|155490765|FG000|Overall Study|Adverse Event|13|||
48353129|NCT01732549|155490766|FG001|Overall Study|Adverse Event|3|||
48353130|NCT01732549|155490765|FG000|Overall Study|Consent withdrawn|13|||
48353131|NCT01732549|155490766|FG001|Overall Study|Consent withdrawn|6|||
48353132|NCT01732549|155490765|FG000|Overall Study|Disease progression|37|||
48353133|NCT01732549|155490766|FG001|Overall Study|Disease progression|50|||
48353134|NCT01732549|155490765|FG000|Overall Study|Other|8|||
48353135|NCT01732549|155490766|FG001|Overall Study|Other|14|||
48353136|NCT05186311|155490767|FG000|Part A: Serum|Withdrawal by Subject|1|||
48353137|NCT03721705|155490768|FG000|Overall Study|Adverse Event|2|||
48353138|NCT03721705|155490769|FG001|Overall Study|Adverse Event|0|||
48675987|NCT01971008|156667163|FG001|Overall Study|Protocol Violation|1|||
48675988|NCT02100969|156667164|FG000|Overall Study|Did not pass screening phase|1|||
48675989|NCT01266590|156667165|FG000|Overall Study|Adverse Event|3|||
48675990|NCT01266590|156667165|FG000|Overall Study|Lost to Follow-up|1|||
48675991|NCT01266590|156667165|FG000|Overall Study|Withdrawal by Subject|1|||
48353139|NCT03721705|155490768|FG000|Overall Study|Withdrawal by Subject|4|||
48353140|NCT03721705|155490769|FG001|Overall Study|Withdrawal by Subject|10|||
48353141|NCT03721705|155490768|FG000|Overall Study|No Suitable Study Partner|1|||
48353142|NCT03721705|155490769|FG001|Overall Study|No Suitable Study Partner|0|||
48353143|NCT03721705|155490768|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
48353144|NCT03721705|155490769|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
48353145|NCT03721705|155490768|FG000|Overall Study|Death|0|||
48353146|NCT03721705|155490769|FG001|Overall Study|Death|1|||
48353147|NCT01646385|155490770|FG000|Overall Study|Death|202|||
48353148|NCT01646385|155490771|FG001|Overall Study|Death|222|||
48353149|NCT01646385|155490770|FG000|Overall Study|Switched to alternate biologic|636|||
48353150|NCT01646385|155490771|FG001|Overall Study|Switched to alternate biologic|649|||
48353151|NCT03721172|155490772|FG000|Placebo-controlled Phase|Adverse Event|7|||
48353152|NCT03721172|155490773|FG001|Placebo-controlled Phase|Adverse Event|7|||
48353153|NCT03721172|155490774|FG002|Placebo-controlled Phase|Adverse Event|0|||
48353154|NCT03721172|155490772|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
48353155|NCT03721172|155490773|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
48353156|NCT03721172|155490774|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
48353157|NCT03721172|155490772|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
48353158|NCT03721172|155490773|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
48353159|NCT03721172|155490774|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
48353160|NCT03721172|155490772|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
48353161|NCT03721172|155490773|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
48353162|NCT03721172|155490774|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
48353163|NCT03721172|155490772|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
48353164|NCT03721172|155490773|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
48353165|NCT03721172|155490774|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
48353166|NCT03721172|155490772|FG000|Placebo-controlled Phase|Other|3|||
48353167|NCT03721172|155490773|FG001|Placebo-controlled Phase|Other|0|||
48353168|NCT03721172|155490774|FG002|Placebo-controlled Phase|Other|0|||
48353169|NCT03721172|155490772|FG000|Apremilast Extension Phase|Adverse Event|0|||
48353170|NCT03721172|155490773|FG001|Apremilast Extension Phase|Adverse Event|0|||
48353171|NCT03721172|155490774|FG002|Apremilast Extension Phase|Adverse Event|10|||
48353172|NCT03721172|155490772|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
48353173|NCT03721172|155490773|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
48353174|NCT03721172|155490774|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
48353175|NCT03721172|155490772|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
48353176|NCT03721172|155490773|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
48353177|NCT03721172|155490774|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
48353178|NCT03721172|155490772|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
48353179|NCT03721172|155490773|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
48353180|NCT03721172|155490774|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
48353181|NCT03721172|155490772|FG000|Apremilast Extension Phase|Protocol Violation|0|||
48353182|NCT03721172|155490773|FG001|Apremilast Extension Phase|Protocol Violation|0|||
48353183|NCT03721172|155490774|FG002|Apremilast Extension Phase|Protocol Violation|1|||
48353184|NCT03721172|155490772|FG000|Apremilast Extension Phase|Physician Decision|0|||
48353185|NCT03721172|155490773|FG001|Apremilast Extension Phase|Physician Decision|0|||
48353186|NCT03721172|155490774|FG002|Apremilast Extension Phase|Physician Decision|1|||
48353187|NCT03721172|155490772|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
48353188|NCT03721172|155490773|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
48353189|NCT03721172|155490774|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
48353190|NCT03721172|155490772|FG000|Apremilast Extension Phase|Other|0|||
48353191|NCT03721172|155490773|FG001|Apremilast Extension Phase|Other|0|||
48353192|NCT03721172|155490774|FG002|Apremilast Extension Phase|Other|3|||
48353193|NCT03721172|155490772|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
48353194|NCT03721172|155490773|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
48675992|NCT01266590|156667165|FG000|Overall Study|Physician Decision|1|||
48675993|NCT01504841|156667166|FG000|Overall Study|Withdrawal by Subject|1|||
48353195|NCT03721172|155490774|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
48353196|NCT01216072|155490778|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
48353197|NCT01216072|155490779|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
48353198|NCT01216072|155490778|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
48353199|NCT01216072|155490779|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
48353200|NCT01216072|155490778|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
48353201|NCT01216072|155490779|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
48353202|NCT01216072|155490778|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
48675994|NCT01504841|156667167|FG001|Overall Study|Withdrawal by Subject|1|||
48675995|NCT01504841|156667168|FG002|Overall Study|Withdrawal by Subject|0|||
48675996|NCT00495625|156667169|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
48675997|NCT00630344|156667172|FG000|Overall Study|Adverse Event|5|||
48675998|NCT00630344|156667172|FG000|Overall Study|Progressive Disease|19|||
48675999|NCT00630344|156667172|FG000|Overall Study|Physician Decision|9|||
48676000|NCT00630344|156667172|FG000|Overall Study|Withdrawal by Subject|1|||
48676001|NCT00630344|156667172|FG000|Overall Study|Intercurrent Illness|1|||
48676002|NCT00630344|156667172|FG000|Overall Study|Other|1|||
48676003|NCT00720343|156667173|FG000|Overall Study|Lost to Follow-up|1|||
48676004|NCT00720343|156667174|FG001|Overall Study|Lost to Follow-up|0|||
48676005|NCT00720343|156667173|FG000|Overall Study|Protocol Violation|0|||
48676006|NCT00720343|156667174|FG001|Overall Study|Protocol Violation|2|||
48676007|NCT01754493|156667175|FG000|Overall Study|Adverse Event|1|||
48676008|NCT01754493|156667175|FG000|Overall Study|Lost to Follow-up|3|||
48676009|NCT01754493|156667175|FG000|Overall Study|Withdrawal by Subject|1|||
48676010|NCT01754493|156667175|FG000|Overall Study|Moved out of town|1|||
48676011|NCT01754493|156667175|FG000|Overall Study|Scheduling conflict|1|||
48676012|NCT02008773|156667176|FG000|Overall Study|Adverse Event|3|||
48676013|NCT02008773|156667177|FG001|Overall Study|Adverse Event|3|||
48676014|NCT02008773|156667178|FG002|Overall Study|Adverse Event|1|||
48676015|NCT02008773|156667179|FG003|Overall Study|Adverse Event|2|||
48676016|NCT02008773|156667176|FG000|Overall Study|Medication Non-compliance|2|||
48676017|NCT02008773|156667177|FG001|Overall Study|Medication Non-compliance|1|||
48676018|NCT02008773|156667178|FG002|Overall Study|Medication Non-compliance|3|||
48676019|NCT02008773|156667179|FG003|Overall Study|Medication Non-compliance|2|||
48676020|NCT02008773|156667176|FG000|Overall Study|Withdrawal by Subject|8|||
48676021|NCT02008773|156667177|FG001|Overall Study|Withdrawal by Subject|4|||
48676022|NCT02008773|156667178|FG002|Overall Study|Withdrawal by Subject|7|||
48676023|NCT02008773|156667179|FG003|Overall Study|Withdrawal by Subject|6|||
48676024|NCT02008773|156667176|FG000|Overall Study|Lost to Follow-up|0|||
48676025|NCT02008773|156667177|FG001|Overall Study|Lost to Follow-up|1|||
48676026|NCT02008773|156667178|FG002|Overall Study|Lost to Follow-up|3|||
48676027|NCT02008773|156667179|FG003|Overall Study|Lost to Follow-up|2|||
48676028|NCT00306527|156667182|FG000|Overall Study|Lost to Follow-up|3|||
48676029|NCT00306527|156667183|FG001|Overall Study|Lost to Follow-up|4|||
48676030|NCT00306527|156667184|FG002|Overall Study|Lost to Follow-up|3|||
48676031|NCT00306527|156667185|FG003|Overall Study|Lost to Follow-up|0|||
48676032|NCT00306527|156667182|FG000|Overall Study|Withdrawal by Subject|2|||
48676033|NCT00306527|156667183|FG001|Overall Study|Withdrawal by Subject|3|||
48676034|NCT00306527|156667184|FG002|Overall Study|Withdrawal by Subject|0|||
48676035|NCT00306527|156667185|FG003|Overall Study|Withdrawal by Subject|3|||
48676036|NCT00306527|156667182|FG000|Overall Study|Adverse Event|0|||
48676037|NCT00306527|156667183|FG001|Overall Study|Adverse Event|0|||
48676038|NCT00306527|156667184|FG002|Overall Study|Adverse Event|1|||
48676039|NCT00306527|156667185|FG003|Overall Study|Adverse Event|1|||
48676040|NCT00306527|156667182|FG000|Overall Study|Death|1|||
48676041|NCT00306527|156667183|FG001|Overall Study|Death|0|||
48676042|NCT00306527|156667184|FG002|Overall Study|Death|1|||
48676043|NCT00306527|156667185|FG003|Overall Study|Death|2|||
48676044|NCT03437577|156667186|FG000|Pre-Randomization|Withdrawal by Subject|0|||
48676045|NCT03437577|156667187|FG001|Pre-Randomization|Withdrawal by Subject|0|||
48676046|NCT03437577|156667188|FG002|Pre-Randomization|Withdrawal by Subject|10|||
48676047|NCT03437577|156667186|FG000|Post-Randomization|Physician Decision|0|||
48676048|NCT03437577|156667187|FG001|Post-Randomization|Physician Decision|2|||
48676049|NCT03437577|156667188|FG002|Post-Randomization|Physician Decision|0|||
48353203|NCT01216072|155490779|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
48353204|NCT01216072|155490778|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
48353205|NCT01216072|155490779|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
48353206|NCT01216072|155490778|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
48353207|NCT01216072|155490779|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
48353208|NCT01216072|155490778|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
48353209|NCT01216072|155490779|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
48353210|NCT01216072|155490778|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
48353211|NCT01216072|155490779|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
48676050|NCT00417963|156667189|FG000|Overall Study|Lost to Follow-up|3|||
48676051|NCT00417963|156667189|FG000|Overall Study|Withdrawal by Subject|18|||
48676052|NCT00417963|156667189|FG000|Overall Study|Death|17|||
48676053|NCT00417963|156667189|FG000|Overall Study|Study device could not be deployed|3|||
48676054|NCT00477152|156667191|FG000|Overall Study|Parent withdrew consent|2|||
48676055|NCT00477152|156667191|FG000|Overall Study|Adverse Event|1|||
48676056|NCT00448747|156667193|FG000|Overall Study|collapsed veins|1|||
48676057|NCT00448747|156667194|FG001|Overall Study|collapsed veins|0|||
48676058|NCT00704288|156667195|FG000|Overall Treatment Period|Adverse Event|11|||
48676059|NCT00704288|156667196|FG001|Overall Treatment Period|Adverse Event|8|||
48676060|NCT00704288|156667197|FG002|Overall Treatment Period|Adverse Event|22|||
48676061|NCT00704288|156667195|FG000|Overall Treatment Period|Death|0|||
48353212|NCT01216072|155490778|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
48353213|NCT01216072|155490779|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
48353214|NCT01216072|155490778|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
48353215|NCT01216072|155490779|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
48353216|NCT00756457|155490780|FG000|Overall Study|Lost to Follow-up|1|||
48676062|NCT00704288|156667196|FG001|Overall Treatment Period|Death|0|||
48353217|NCT00756457|155490781|FG001|Overall Study|Lost to Follow-up|2|||
48353218|NCT02402322|155490783|FG000|Pretreatment|Withdrawal by Subject|3|||
48353219|NCT02402322|155490784|FG001|Pretreatment|Withdrawal by Subject|1|||
48353220|NCT02402322|155490785|FG002|Pretreatment|Withdrawal by Subject|1|||
48353221|NCT02402322|155490783|FG000|Follow-up|Withdrawal by Subject|6|||
48353222|NCT02402322|155490784|FG001|Follow-up|Withdrawal by Subject|3|||
48353223|NCT02402322|155490785|FG002|Follow-up|Withdrawal by Subject|24|||
48353224|NCT00952848|155490786|FG000|Overall Study|Withdrawal by Subject|4|||
48353225|NCT00755417|155490787|FG000|Overall Study|Adverse Event|28|||
48353226|NCT00755417|155490788|FG001|Overall Study|Adverse Event|20|||
48353227|NCT00755417|155490789|FG002|Overall Study|Adverse Event|7|||
48353228|NCT00755417|155490787|FG000|Overall Study|Lack of Efficacy|8|||
48353229|NCT00755417|155490788|FG001|Overall Study|Lack of Efficacy|4|||
48353230|NCT00755417|155490789|FG002|Overall Study|Lack of Efficacy|9|||
48353231|NCT00755417|155490787|FG000|Overall Study|Protocol Violation|2|||
48353232|NCT00755417|155490788|FG001|Overall Study|Protocol Violation|1|||
48353233|NCT00755417|155490789|FG002|Overall Study|Protocol Violation|1|||
48353234|NCT00755417|155490787|FG000|Overall Study|Lost to Follow-up|3|||
48353235|NCT00755417|155490788|FG001|Overall Study|Lost to Follow-up|0|||
48353236|NCT00755417|155490789|FG002|Overall Study|Lost to Follow-up|1|||
48353237|NCT00755417|155490787|FG000|Overall Study|Withdrawal by Subject|12|||
48353238|NCT00755417|155490788|FG001|Overall Study|Withdrawal by Subject|12|||
48353239|NCT00755417|155490789|FG002|Overall Study|Withdrawal by Subject|12|||
48353240|NCT00755417|155490787|FG000|Overall Study|Not specified or missing data|9|||
48353241|NCT00755417|155490788|FG001|Overall Study|Not specified or missing data|18|||
48353242|NCT00755417|155490789|FG002|Overall Study|Not specified or missing data|12|||
48353243|NCT02643628|155490791|FG000|Overall Study|Lost to Follow-up|1|||
48353244|NCT02643628|155490792|FG001|Overall Study|Lost to Follow-up|4|||
48353245|NCT02643628|155490791|FG000|Overall Study|Withdrawal by Subject|0|||
48353246|NCT02643628|155490792|FG001|Overall Study|Withdrawal by Subject|1|||
48353247|NCT02643628|155490791|FG000|Overall Study|Relocated out of state|0|||
48353248|NCT02643628|155490792|FG001|Overall Study|Relocated out of state|1|||
48353249|NCT01628692|155490793|FG000|Overall Study|Lack of Efficacy|4|||
48353250|NCT01628692|155490794|FG001|Overall Study|Lack of Efficacy|4|||
48353251|NCT01628692|155490795|FG002|Overall Study|Lack of Efficacy|5|||
48353252|NCT01628692|155490796|FG003|Overall Study|Lack of Efficacy|1|||
48353253|NCT01628692|155490797|FG004|Overall Study|Lack of Efficacy|4|||
48353254|NCT01628692|155490798|FG005|Overall Study|Lack of Efficacy|7|||
48353255|NCT01628692|155490793|FG000|Overall Study|Adverse Event|2|||
48353256|NCT01628692|155490794|FG001|Overall Study|Adverse Event|0|||
48353257|NCT01628692|155490795|FG002|Overall Study|Adverse Event|2|||
48353258|NCT01628692|155490796|FG003|Overall Study|Adverse Event|0|||
48353259|NCT01628692|155490797|FG004|Overall Study|Adverse Event|0|||
48353260|NCT01628692|155490798|FG005|Overall Study|Adverse Event|0|||
48353261|NCT01628692|155490793|FG000|Overall Study|Withdrawal by Subject|0|||
48353262|NCT01628692|155490794|FG001|Overall Study|Withdrawal by Subject|1|||
48353263|NCT01628692|155490795|FG002|Overall Study|Withdrawal by Subject|1|||
48353264|NCT01628692|155490796|FG003|Overall Study|Withdrawal by Subject|0|||
48353265|NCT01628692|155490797|FG004|Overall Study|Withdrawal by Subject|0|||
48353266|NCT01628692|155490798|FG005|Overall Study|Withdrawal by Subject|0|||
48353267|NCT01628692|155490793|FG000|Overall Study|Death|0|||
48353268|NCT01628692|155490794|FG001|Overall Study|Death|1|||
48353269|NCT01628692|155490795|FG002|Overall Study|Death|0|||
48353270|NCT01628692|155490796|FG003|Overall Study|Death|0|||
48353271|NCT01628692|155490797|FG004|Overall Study|Death|0|||
48353272|NCT01628692|155490798|FG005|Overall Study|Death|0|||
48353273|NCT01628692|155490793|FG000|Overall Study|Poor compliance/noncompliance|1|||
48353274|NCT01628692|155490794|FG001|Overall Study|Poor compliance/noncompliance|0|||
48353275|NCT01628692|155490795|FG002|Overall Study|Poor compliance/noncompliance|0|||
48353276|NCT01628692|155490796|FG003|Overall Study|Poor compliance/noncompliance|0|||
48353277|NCT01628692|155490797|FG004|Overall Study|Poor compliance/noncompliance|0|||
48353278|NCT01628692|155490798|FG005|Overall Study|Poor compliance/noncompliance|0|||
48353279|NCT01628692|155490793|FG000|Overall Study|Administrative reason by sponsor|0|||
48353280|NCT01628692|155490794|FG001|Overall Study|Administrative reason by sponsor|0|||
48353281|NCT01628692|155490795|FG002|Overall Study|Administrative reason by sponsor|0|||
48353282|NCT01628692|155490796|FG003|Overall Study|Administrative reason by sponsor|0|||
48353283|NCT01628692|155490797|FG004|Overall Study|Administrative reason by sponsor|0|||
48353284|NCT01628692|155490798|FG005|Overall Study|Administrative reason by sponsor|1|||
48353285|NCT01628692|155490793|FG000|Overall Study|Completed 12 Week only|0|||
48353286|NCT01628692|155490794|FG001|Overall Study|Completed 12 Week only|0|||
48353287|NCT01628692|155490795|FG002|Overall Study|Completed 12 Week only|0|||
48353288|NCT01628692|155490796|FG003|Overall Study|Completed 12 Week only|0|||
48353289|NCT01628692|155490797|FG004|Overall Study|Completed 12 Week only|0|||
48353290|NCT01628692|155490798|FG005|Overall Study|Completed 12 Week only|1|||
48353291|NCT01390441|155490800|FG000|Treatment Period|Protocol Violation|0|||
48353292|NCT01390441|155490801|FG001|Treatment Period|Protocol Violation|1|||
48353293|NCT01390441|155490802|FG002|Treatment Period|Protocol Violation|0|||
48353294|NCT01390441|155490803|FG003|Treatment Period|Protocol Violation|0|||
48353295|NCT01390441|155490804|FG004|Treatment Period|Protocol Violation|0|||
48353296|NCT01390441|155490800|FG000|Treatment Period|Physician Decision|0|||
48353297|NCT01390441|155490801|FG001|Treatment Period|Physician Decision|0|||
48353298|NCT01390441|155490802|FG002|Treatment Period|Physician Decision|0|||
48353299|NCT01390441|155490803|FG003|Treatment Period|Physician Decision|1|||
48353300|NCT01390441|155490804|FG004|Treatment Period|Physician Decision|0|||
48353301|NCT01390441|155490800|FG000|Treatment Period|Lack of Efficacy|0|||
48353302|NCT01390441|155490801|FG001|Treatment Period|Lack of Efficacy|0|||
48353303|NCT01390441|155490802|FG002|Treatment Period|Lack of Efficacy|0|||
48353304|NCT01390441|155490803|FG003|Treatment Period|Lack of Efficacy|0|||
48353305|NCT01390441|155490804|FG004|Treatment Period|Lack of Efficacy|1|||
48353306|NCT01390441|155490800|FG000|Treatment Period|Unknown due to early stopping of study|0|||
48353307|NCT01390441|155490801|FG001|Treatment Period|Unknown due to early stopping of study|0|||
48353308|NCT01390441|155490802|FG002|Treatment Period|Unknown due to early stopping of study|8|||
48353309|NCT01390441|155490803|FG003|Treatment Period|Unknown due to early stopping of study|11|||
48353310|NCT01390441|155490804|FG004|Treatment Period|Unknown due to early stopping of study|7|||
48353311|NCT01390441|155490800|FG000|Treatment Period|Adverse Event|0|||
48353312|NCT01390441|155490801|FG001|Treatment Period|Adverse Event|0|||
48353313|NCT01390441|155490802|FG002|Treatment Period|Adverse Event|1|||
48353314|NCT01390441|155490803|FG003|Treatment Period|Adverse Event|1|||
48353315|NCT01390441|155490804|FG004|Treatment Period|Adverse Event|2|||
48353316|NCT01390441|155490800|FG000|Treatment Period|Withdrawal by Subject|0|||
48353317|NCT01390441|155490801|FG001|Treatment Period|Withdrawal by Subject|0|||
48353318|NCT01390441|155490802|FG002|Treatment Period|Withdrawal by Subject|1|||
48353319|NCT01390441|155490803|FG003|Treatment Period|Withdrawal by Subject|0|||
48353320|NCT01390441|155490804|FG004|Treatment Period|Withdrawal by Subject|1|||
48353321|NCT01390441|155490800|FG000|Treatment Period|Lost to Follow-up|1|||
48353322|NCT01390441|155490801|FG001|Treatment Period|Lost to Follow-up|0|||
48353323|NCT01390441|155490802|FG002|Treatment Period|Lost to Follow-up|0|||
48353324|NCT01390441|155490803|FG003|Treatment Period|Lost to Follow-up|0|||
48353325|NCT01390441|155490804|FG004|Treatment Period|Lost to Follow-up|0|||
48676063|NCT00704288|156667197|FG002|Overall Treatment Period|Death|1|||
48676064|NCT00704288|156667195|FG000|Overall Treatment Period|Physician Decision|0|||
48353326|NCT01390441|155490800|FG000|Extension Period|Protocol Violation|3|||
48353327|NCT01390441|155490801|FG001|Extension Period|Protocol Violation|1|||
48353328|NCT01390441|155490802|FG002|Extension Period|Protocol Violation|0|||
48353329|NCT01390441|155490803|FG003|Extension Period|Protocol Violation|1|||
48353330|NCT01390441|155490804|FG004|Extension Period|Protocol Violation|0|||
48353331|NCT01807182|155490812|FG000|Overall Study|Death|1|||
48353332|NCT01807182|155490812|FG000|Overall Study|New therapy|1|||
48353333|NCT01807182|155490812|FG000|Overall Study|Moved to hospice care|1|||
48353334|NCT01263509|155490815|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
48353335|NCT01263509|155490816|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
48353336|NCT01263509|155490817|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
48353337|NCT01263509|155490818|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
48353338|NCT01263509|155490815|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48353339|NCT01263509|155490816|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
48353340|NCT01263509|155490817|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
48353341|NCT01263509|155490818|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48353342|NCT01263509|155490815|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48353343|NCT01263509|155490816|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48353344|NCT01263509|155490817|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48353345|NCT01263509|155490818|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48353346|NCT01263509|155490815|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
48353347|NCT01263509|155490816|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
48353348|NCT01263509|155490817|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48353349|NCT01263509|155490818|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
48353350|NCT01263509|155490815|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
48353351|NCT01263509|155490816|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
48353352|NCT01263509|155490817|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
48353353|NCT01263509|155490818|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
48353354|NCT00478205|155490819|FG000|Overall Study|Adverse Event|182|||
48353355|NCT00478205|155490820|FG001|Overall Study|Adverse Event|39|||
48353356|NCT00478205|155490819|FG000|Overall Study|Medication Non-compliance|9|||
48353357|NCT00478205|155490820|FG001|Overall Study|Medication Non-compliance|4|||
48353358|NCT00478205|155490819|FG000|Overall Study|Protocol Violation|15|||
48353359|NCT00478205|155490820|FG001|Overall Study|Protocol Violation|5|||
48353360|NCT00478205|155490819|FG000|Overall Study|Request of Investigator or Sponsor|4|||
48353361|NCT00478205|155490820|FG001|Overall Study|Request of Investigator or Sponsor|5|||
48353362|NCT00478205|155490819|FG000|Overall Study|Withdrawal by Subject|61|||
48353363|NCT00478205|155490820|FG001|Overall Study|Withdrawal by Subject|22|||
48353364|NCT00478205|155490819|FG000|Overall Study|Lack of Efficacy|1|||
48353365|NCT00478205|155490820|FG001|Overall Study|Lack of Efficacy|0|||
48353366|NCT00478205|155490819|FG000|Overall Study|Other|24|||
48353367|NCT00478205|155490820|FG001|Overall Study|Other|12|||
48353368|NCT02287233|155490821|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
48353369|NCT02287233|155490822|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
48353370|NCT02287233|155490823|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
48353371|NCT02287233|155490821|FG000|Overall Study|Adverse Event Related to Progression|0|||
48353372|NCT02287233|155490822|FG001|Overall Study|Adverse Event Related to Progression|2|||
48353373|NCT02287233|155490823|FG002|Overall Study|Adverse Event Related to Progression|8|||
48353374|NCT02287233|155490821|FG000|Overall Study|Physician Decision|1|||
48353375|NCT02287233|155490822|FG001|Overall Study|Physician Decision|2|||
48353376|NCT02287233|155490823|FG002|Overall Study|Physician Decision|4|||
48353377|NCT02287233|155490821|FG000|Overall Study|Progressive Disease with Death|0|||
48353378|NCT02287233|155490822|FG001|Overall Study|Progressive Disease with Death|0|||
48353379|NCT02287233|155490823|FG002|Overall Study|Progressive Disease with Death|10|||
48353380|NCT02287233|155490821|FG000|Overall Study|Progressive Disease Without Death|2|||
48353381|NCT02287233|155490822|FG001|Overall Study|Progressive Disease Without Death|3|||
48353382|NCT02287233|155490823|FG002|Overall Study|Progressive Disease Without Death|20|||
48353383|NCT02287233|155490821|FG000|Overall Study|Withdrawal by Subject|1|||
48353384|NCT02287233|155490822|FG001|Overall Study|Withdrawal by Subject|1|||
48353385|NCT02287233|155490823|FG002|Overall Study|Withdrawal by Subject|7|||
48353386|NCT02287233|155490821|FG000|Overall Study|Other|3|||
48353387|NCT02287233|155490822|FG001|Overall Study|Other|0|||
48353388|NCT02287233|155490823|FG002|Overall Study|Other|15|||
48353389|NCT02287233|155490821|FG000|Overall Study|Did Not Receive Treatment|0|||
48353390|NCT02287233|155490822|FG001|Overall Study|Did Not Receive Treatment|0|||
48353391|NCT02287233|155490823|FG002|Overall Study|Did Not Receive Treatment|2|||
48676065|NCT00704288|156667196|FG001|Overall Treatment Period|Physician Decision|2|||
48676066|NCT00704288|156667197|FG002|Overall Treatment Period|Physician Decision|0|||
48676067|NCT00704288|156667195|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
48676068|NCT00704288|156667196|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
48676069|NCT00704288|156667197|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
48676070|NCT00704288|156667195|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
48676071|NCT00704288|156667196|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
48676072|NCT00704288|156667197|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
48353392|NCT03178045|155490826|FG000|Overall Study|Withdrawal by Subject|5|||
48353393|NCT03178045|155490827|FG001|Overall Study|Withdrawal by Subject|7|||
48353394|NCT03178045|155490826|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
48353395|NCT03178045|155490827|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
48353396|NCT03178045|155490826|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
48353397|NCT03178045|155490827|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
48353398|NCT02344342|155490831|FG000|Overall Study|Industry partner dropped out|11|||
48353399|NCT02344342|155490832|FG001|Overall Study|Industry partner dropped out|9|||
48353400|NCT02344342|155490833|FG002|Overall Study|Industry partner dropped out|14|||
48353401|NCT02344342|155490834|FG003|Overall Study|Industry partner dropped out|10|||
48353402|NCT00798304|155490836|FG000|Overall Study|Adverse Event|0|||
48353403|NCT00798304|155490837|FG001|Overall Study|Adverse Event|1|||
48353404|NCT00798304|155490838|FG002|Overall Study|Adverse Event|1|||
48353405|NCT00798304|155490836|FG000|Overall Study|Discontinuation by Sponsor|14|||
48353406|NCT00798304|155490837|FG001|Overall Study|Discontinuation by Sponsor|21|||
48353407|NCT00798304|155490838|FG002|Overall Study|Discontinuation by Sponsor|9|||
48676073|NCT00704288|156667195|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
48353408|NCT00658606|155490839|FG000|Overall Study|Adverse Event|2|||
48353409|NCT00658606|155490840|FG001|Overall Study|Adverse Event|1|||
48353410|NCT00658606|155490839|FG000|Overall Study|Lack of Efficacy|6|||
48353411|NCT00658606|155490840|FG001|Overall Study|Lack of Efficacy|3|||
48353412|NCT00658606|155490839|FG000|Overall Study|Lost to Follow-up|1|||
48353413|NCT00658606|155490840|FG001|Overall Study|Lost to Follow-up|0|||
48353414|NCT00658606|155490839|FG000|Overall Study|Withdrawal by Subject|7|||
48353415|NCT00658606|155490840|FG001|Overall Study|Withdrawal by Subject|16|||
48353416|NCT00658606|155490839|FG000|Overall Study|Lack of Compliance|0|||
48353417|NCT00658606|155490840|FG001|Overall Study|Lack of Compliance|3|||
48353418|NCT00856245|155490846|FG000|Overall Study|Was not transplanted|5|||
48676074|NCT00704288|156667196|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
48676075|NCT00704288|156667197|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
48676076|NCT00704288|156667195|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
48676077|NCT00704288|156667196|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
48676078|NCT00704288|156667197|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
48676079|NCT00704288|156667195|FG000|Overall Treatment Period|Roll-over to another study|1|||
48676080|NCT00704288|156667196|FG001|Overall Treatment Period|Roll-over to another study|0|||
48676081|NCT00704288|156667197|FG002|Overall Treatment Period|Roll-over to another study|4|||
48676082|NCT00704288|156667195|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
48676083|NCT00704288|156667196|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
48676084|NCT00704288|156667197|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
48676085|NCT00704288|156667195|FG000|Extended Post Treatment Follow Up Period|Death|41|||
48762053|NCT04608500|156978003|FG001|Overall Study|Adverse Event|0|||
48762054|NCT04608500|156978002|FG000|Overall Study|Lost to Follow-up|15|||
48762055|NCT04608500|156978003|FG001|Overall Study|Lost to Follow-up|9|||
48762056|NCT04608500|156978002|FG000|Overall Study|Participant request|11|||
48762057|NCT04608500|156978003|FG001|Overall Study|Participant request|7|||
48762058|NCT04608500|156978002|FG000|Overall Study|Protocol Violation|1|||
48762059|NCT04608500|156978003|FG001|Overall Study|Protocol Violation|0|||
48762060|NCT04608500|156978002|FG000|Overall Study|Other|6|||
48762061|NCT04608500|156978003|FG001|Overall Study|Other|2|||
48762062|NCT02747420|156978004|FG000|Overall Study|Lost to Follow-up|4|||
48762063|NCT02747420|156978005|FG001|Overall Study|Lost to Follow-up|2|||
48762064|NCT02747420|156978004|FG000|Overall Study|Withdrawal by Subject|3|||
48762065|NCT02747420|156978005|FG001|Overall Study|Withdrawal by Subject|2|||
48762066|NCT05129488|156978006|FG000|Overall Study|Protocol Violation|3|||
48762067|NCT02608268|156978007|FG000|Overall Study|Adverse Event|0|||
48762068|NCT02608268|156978008|FG001|Overall Study|Adverse Event|0|||
48762069|NCT02608268|156978009|FG002|Overall Study|Adverse Event|1|||
48762070|NCT02608268|156978010|FG003|Overall Study|Adverse Event|0|||
48762071|NCT02608268|156978011|FG004|Overall Study|Adverse Event|0|||
48353419|NCT03448536|155490847|FG000|Overall Study|Protocol Violation|2|||
48353420|NCT03448536|155490848|FG001|Overall Study|Protocol Violation|0|||
48353421|NCT03448536|155490847|FG000|Overall Study|Pregnancy|1|||
48353422|NCT03448536|155490848|FG001|Overall Study|Pregnancy|0|||
48353423|NCT03448536|155490847|FG000|Overall Study|Withdrawal by Subject|1|||
48353424|NCT03448536|155490848|FG001|Overall Study|Withdrawal by Subject|2|||
48353425|NCT03448536|155490847|FG000|Overall Study|Lost to Follow-up|3|||
48353426|NCT03448536|155490848|FG001|Overall Study|Lost to Follow-up|2|||
48353427|NCT03448536|155490847|FG000|Overall Study|Inadequate pain reporter|1|||
48353428|NCT03448536|155490848|FG001|Overall Study|Inadequate pain reporter|0|||
48353429|NCT03448536|155490847|FG000|Overall Study|Other|3|||
48353430|NCT03448536|155490848|FG001|Overall Study|Other|0|||
48353431|NCT03448536|155490847|FG000|Overall Study|Physician Decision|1|||
48353432|NCT03448536|155490848|FG001|Overall Study|Physician Decision|0|||
48353433|NCT05144009|155490851|FG000|Overall Study|Lost to Follow-up|0|||
48353434|NCT05144009|155490852|FG001|Overall Study|Lost to Follow-up|1|||
48353435|NCT05144009|155490851|FG000|Overall Study|Study Termination by the Sponsor|11|||
48353436|NCT05144009|155490852|FG001|Overall Study|Study Termination by the Sponsor|11|||
48353437|NCT05144009|155490851|FG000|Overall Study|Disease Progression|1|||
48353438|NCT05144009|155490852|FG001|Overall Study|Disease Progression|0|||
48353439|NCT05144009|155490851|FG000|Overall Study|Participant Decision|0|||
48353440|NCT05144009|155490852|FG001|Overall Study|Participant Decision|2|||
48353441|NCT05144009|155490851|FG000|Overall Study|Death|5|||
48353442|NCT05144009|155490852|FG001|Overall Study|Death|10|||
48353443|NCT01447576|155490853|FG000|Overall Study|Lost to Follow-up|52|||
48353444|NCT01447576|155490853|FG000|Overall Study|Adverse Event|127|||
48353445|NCT01447576|155490853|FG000|Overall Study|Participant met withdrawal criteria|40|||
48353446|NCT01447576|155490853|FG000|Overall Study|Withdrawal by Subject|100|||
48353447|NCT01447576|155490853|FG000|Overall Study|Protocol deviation|83|||
48353448|NCT01447576|155490853|FG000|Overall Study|Lack of Efficacy|68|||
48353449|NCT01447576|155490853|FG000|Overall Study|Physician Decision|6|||
48353450|NCT00486252|155490858|FG000|Overall Study|Adverse Event|7|||
48353451|NCT00486252|155490858|FG000|Overall Study|Lack of Efficacy|9|||
48353452|NCT00486252|155490858|FG000|Overall Study|Lost to Follow-up|24|||
48353453|NCT00486252|155490858|FG000|Overall Study|Other|18|||
48353454|NCT04463680|155490859|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
48676086|NCT00704288|156667196|FG001|Extended Post Treatment Follow Up Period|Death|50|||
48676087|NCT00704288|156667197|FG002|Extended Post Treatment Follow Up Period|Death|93|||
48676088|NCT00704288|156667195|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
48762072|NCT02608268|156978012|FG005|Overall Study|Adverse Event|0|||
48762073|NCT02608268|156978013|FG006|Overall Study|Adverse Event|0|||
48762074|NCT02608268|156978014|FG007|Overall Study|Adverse Event|0|||
48762075|NCT02608268|156978015|FG008|Overall Study|Adverse Event|0|||
48762076|NCT02608268|156978016|FG009|Overall Study|Adverse Event|0|||
48353455|NCT04463680|155490859|FG000|Overall Study|Not eligible due to implant duration of use|1|||
48353456|NCT04463680|155490859|FG000|Overall Study|Withdrawal by Subject|3|||
48676089|NCT00704288|156667196|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
48676090|NCT00704288|156667197|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
48676091|NCT00704288|156667195|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
48676092|NCT00704288|156667196|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
48676093|NCT00704288|156667197|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
48676094|NCT00704288|156667195|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
48676095|NCT00704288|156667196|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
48676096|NCT00704288|156667197|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
48676097|NCT04680975|156667200|FG000|Overall Study|Adverse Event|3|||
48676098|NCT04680975|156667200|FG000|Overall Study|Death|1|||
48676099|NCT04680975|156667200|FG000|Overall Study|Progressive Disease|1|||
48676100|NCT04680975|156667200|FG000|Overall Study|Withdrawal by Subject|1|||
48676101|NCT01948063|156667201|FG000|Overall Study|Boston MCI halted research protocol|0|||
48676102|NCT01948063|156667202|FG001|Overall Study|Boston MCI halted research protocol|1|||
48676103|NCT01948063|156667201|FG000|Overall Study|Discovered an enrollment in other study|0|||
48676104|NCT01948063|156667202|FG001|Overall Study|Discovered an enrollment in other study|1|||
48676105|NCT01948063|156667201|FG000|Overall Study|Blood samples were accidentally thawed|1|||
48676106|NCT01948063|156667202|FG001|Overall Study|Blood samples were accidentally thawed|0|||
48676107|NCT02478164|156667206|FG000|Overall Study|Lack of Efficacy|13|||
48676108|NCT02478164|156667206|FG000|Overall Study|Adverse Event|1|||
48676109|NCT02478164|156667206|FG000|Overall Study|Withdrawal by Subject|1|||
48676110|NCT02227199|156667207|FG000|Overall Study|Physician Decision|0|||
48676111|NCT02227199|156667208|FG001|Overall Study|Physician Decision|0|||
48676112|NCT02227199|156667209|FG002|Overall Study|Physician Decision|1|||
48676113|NCT02227199|156667207|FG000|Overall Study|Adverse Event|0|||
48676114|NCT02227199|156667208|FG001|Overall Study|Adverse Event|0|||
48676115|NCT02227199|156667209|FG002|Overall Study|Adverse Event|3|||
48676116|NCT01329939|156667210|FG000|Overall Study|Lost to Follow-up|3|||
48676117|NCT01329939|156667211|FG001|Overall Study|Lost to Follow-up|0|||
48676118|NCT01329939|156667212|FG002|Overall Study|Lost to Follow-up|1|||
48676119|NCT01329939|156667213|FG003|Overall Study|Lost to Follow-up|2|||
48676120|NCT01329939|156667210|FG000|Overall Study|Withdrawal by Subject|0|||
48676121|NCT01329939|156667211|FG001|Overall Study|Withdrawal by Subject|1|||
48676122|NCT01329939|156667212|FG002|Overall Study|Withdrawal by Subject|0|||
48676123|NCT01329939|156667213|FG003|Overall Study|Withdrawal by Subject|0|||
48676124|NCT01329939|156667210|FG000|Overall Study|Adverse Event|0|||
48676125|NCT01329939|156667211|FG001|Overall Study|Adverse Event|0|||
48676126|NCT01329939|156667212|FG002|Overall Study|Adverse Event|0|||
48676127|NCT01329939|156667213|FG003|Overall Study|Adverse Event|3|||
48676128|NCT03364738|156667214|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
48676129|NCT03364738|156667214|FG000|Overall Study|Withdrawal by Subject|1|||
48676130|NCT03364738|156667214|FG000|Overall Study|Adverse Event|1|||
48676131|NCT00989963|156667220|FG000|Overall Study|Adverse Event|1|||
48676132|NCT00989963|156667221|FG001|Overall Study|Adverse Event|1|||
48676133|NCT00989963|156667222|FG002|Overall Study|Adverse Event|1|||
48676134|NCT01677858|156667223|FG000|Overall Study|Adverse Event|0|||
48353457|NCT02671435|155490861|FG000|Overall Study|Death|1|||
48353458|NCT02671435|155490862|FG001|Overall Study|Death|3|||
48353459|NCT02671435|155490863|FG002|Overall Study|Death|0|||
48353460|NCT02671435|155490864|FG003|Overall Study|Death|16|||
48353461|NCT02671435|155490865|FG004|Overall Study|Death|14|||
48353462|NCT02671435|155490866|FG005|Overall Study|Death|29|||
48353463|NCT02671435|155490867|FG006|Overall Study|Death|34|||
48353464|NCT02671435|155490868|FG007|Overall Study|Death|28|||
48353465|NCT02671435|155490869|FG008|Overall Study|Death|19|||
48353466|NCT02671435|155490870|FG009|Overall Study|Death|10|||
48353467|NCT02671435|155490871|FG010|Overall Study|Death|8|||
48353468|NCT02671435|155490872|FG011|Overall Study|Death|29|||
48353469|NCT02671435|155490873|FG012|Overall Study|Death|29|||
48353470|NCT02671435|155490874|FG013|Overall Study|Death|29|||
48353471|NCT02671435|155490875|FG014|Overall Study|Death|27|||
48353472|NCT02671435|155490861|FG000|Overall Study|Lost to Follow-up|0|||
48353473|NCT02671435|155490862|FG001|Overall Study|Lost to Follow-up|0|||
48353474|NCT02671435|155490863|FG002|Overall Study|Lost to Follow-up|1|||
48353475|NCT02671435|155490864|FG003|Overall Study|Lost to Follow-up|0|||
48353476|NCT02671435|155490865|FG004|Overall Study|Lost to Follow-up|1|||
48353477|NCT02671435|155490866|FG005|Overall Study|Lost to Follow-up|1|||
48353478|NCT02671435|155490867|FG006|Overall Study|Lost to Follow-up|2|||
48353479|NCT02671435|155490868|FG007|Overall Study|Lost to Follow-up|2|||
48353480|NCT02671435|155490869|FG008|Overall Study|Lost to Follow-up|0|||
48353481|NCT02671435|155490870|FG009|Overall Study|Lost to Follow-up|2|||
48353482|NCT02671435|155490871|FG010|Overall Study|Lost to Follow-up|0|||
48353483|NCT02671435|155490872|FG011|Overall Study|Lost to Follow-up|3|||
48353484|NCT02671435|155490873|FG012|Overall Study|Lost to Follow-up|3|||
48353485|NCT02671435|155490874|FG013|Overall Study|Lost to Follow-up|2|||
48353486|NCT02671435|155490875|FG014|Overall Study|Lost to Follow-up|0|||
48353487|NCT02671435|155490861|FG000|Overall Study|Withdrawal by Subject|2|||
48353488|NCT02671435|155490862|FG001|Overall Study|Withdrawal by Subject|0|||
48353489|NCT02671435|155490863|FG002|Overall Study|Withdrawal by Subject|2|||
48353490|NCT02671435|155490864|FG003|Overall Study|Withdrawal by Subject|2|||
48353491|NCT02671435|155490865|FG004|Overall Study|Withdrawal by Subject|2|||
48353492|NCT02671435|155490866|FG005|Overall Study|Withdrawal by Subject|7|||
48353493|NCT02671435|155490867|FG006|Overall Study|Withdrawal by Subject|2|||
48353494|NCT02671435|155490868|FG007|Overall Study|Withdrawal by Subject|7|||
48353495|NCT02671435|155490869|FG008|Overall Study|Withdrawal by Subject|1|||
48353496|NCT02671435|155490870|FG009|Overall Study|Withdrawal by Subject|1|||
48353497|NCT02671435|155490871|FG010|Overall Study|Withdrawal by Subject|2|||
48353498|NCT02671435|155490872|FG011|Overall Study|Withdrawal by Subject|4|||
48353499|NCT02671435|155490873|FG012|Overall Study|Withdrawal by Subject|4|||
48353500|NCT02671435|155490874|FG013|Overall Study|Withdrawal by Subject|4|||
48353501|NCT02671435|155490875|FG014|Overall Study|Withdrawal by Subject|2|||
48353502|NCT02671435|155490861|FG000|Overall Study|Un-specified|0|||
48353503|NCT02671435|155490862|FG001|Overall Study|Un-specified|0|||
48353504|NCT02671435|155490863|FG002|Overall Study|Un-specified|0|||
48353505|NCT02671435|155490864|FG003|Overall Study|Un-specified|0|||
48353506|NCT02671435|155490865|FG004|Overall Study|Un-specified|1|||
48353507|NCT02671435|155490866|FG005|Overall Study|Un-specified|3|||
48353508|NCT02671435|155490867|FG006|Overall Study|Un-specified|2|||
48353509|NCT02671435|155490868|FG007|Overall Study|Un-specified|3|||
48353510|NCT02671435|155490869|FG008|Overall Study|Un-specified|0|||
48353511|NCT02671435|155490870|FG009|Overall Study|Un-specified|5|||
48353512|NCT02671435|155490871|FG010|Overall Study|Un-specified|8|||
48353513|NCT02671435|155490872|FG011|Overall Study|Un-specified|4|||
48353514|NCT02671435|155490873|FG012|Overall Study|Un-specified|5|||
48353515|NCT02671435|155490874|FG013|Overall Study|Un-specified|9|||
48353516|NCT02671435|155490875|FG014|Overall Study|Un-specified|8|||
48353517|NCT01999972|155492692|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
48353518|NCT01999972|155492693|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
48762077|NCT02608268|156978017|FG010|Overall Study|Adverse Event|0|||
48762078|NCT02608268|156978018|FG011|Overall Study|Adverse Event|0|||
48353519|NCT01999972|155492694|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
48353520|NCT01999972|155492695|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
48353521|NCT01999972|155492696|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
48353522|NCT01999972|155492697|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
48353523|NCT01999972|155492692|FG000|Dose Escalation Part|Death|0|||
48353524|NCT01999972|155492693|FG001|Dose Escalation Part|Death|1|||
48353525|NCT01999972|155492694|FG002|Dose Escalation Part|Death|0|||
48353526|NCT01999972|155492695|FG003|Dose Escalation Part|Death|0|||
48353527|NCT01999972|155492696|FG004|Dose Escalation Part|Death|0|||
48353528|NCT01999972|155492697|FG005|Dose Escalation Part|Death|0|||
48353529|NCT01999972|155492692|FG000|Dose Escalation Part|Enrolled but not treated|0|||
48353530|NCT01999972|155492693|FG001|Dose Escalation Part|Enrolled but not treated|0|||
48353531|NCT01999972|155492694|FG002|Dose Escalation Part|Enrolled but not treated|1|||
48353532|NCT01999972|155492695|FG003|Dose Escalation Part|Enrolled but not treated|1|||
48762079|NCT02608268|156978019|FG012|Overall Study|Adverse Event|2|||
48353533|NCT01999972|155492696|FG004|Dose Escalation Part|Enrolled but not treated|0|||
48353534|NCT01999972|155492697|FG005|Dose Escalation Part|Enrolled but not treated|0|||
48353535|NCT01999972|155492692|FG000|Dose Escalation Part|Disease progression|3|||
48353536|NCT01999972|155492693|FG001|Dose Escalation Part|Disease progression|2|||
48353537|NCT01999972|155492694|FG002|Dose Escalation Part|Disease progression|3|||
48353538|NCT01999972|155492695|FG003|Dose Escalation Part|Disease progression|6|||
48353539|NCT01999972|155492696|FG004|Dose Escalation Part|Disease progression|0|||
48353540|NCT01999972|155492697|FG005|Dose Escalation Part|Disease progression|0|||
48353541|NCT01999972|155492692|FG000|Dose Escalation Part|Adverse Event|0|||
48353542|NCT01999972|155492693|FG001|Dose Escalation Part|Adverse Event|0|||
48353543|NCT01999972|155492694|FG002|Dose Escalation Part|Adverse Event|0|||
48353544|NCT01999972|155492695|FG003|Dose Escalation Part|Adverse Event|2|||
48353545|NCT01999972|155492696|FG004|Dose Escalation Part|Adverse Event|0|||
48353546|NCT01999972|155492697|FG005|Dose Escalation Part|Adverse Event|0|||
48353547|NCT01999972|155492692|FG000|Dose Escalation Part|Global deterioration of health status|1|||
48353548|NCT01999972|155492693|FG001|Dose Escalation Part|Global deterioration of health status|0|||
48353549|NCT01999972|155492694|FG002|Dose Escalation Part|Global deterioration of health status|0|||
48353550|NCT01999972|155492695|FG003|Dose Escalation Part|Global deterioration of health status|1|||
48353551|NCT01999972|155492696|FG004|Dose Escalation Part|Global deterioration of health status|0|||
48353552|NCT01999972|155492697|FG005|Dose Escalation Part|Global deterioration of health status|0|||
48353553|NCT01999972|155492692|FG000|Dose Expansion Part|Death|0|||
48353554|NCT01999972|155492693|FG001|Dose Expansion Part|Death|0|||
48353555|NCT01999972|155492694|FG002|Dose Expansion Part|Death|0|||
48353556|NCT01999972|155492695|FG003|Dose Expansion Part|Death|0|||
48353557|NCT01999972|155492696|FG004|Dose Expansion Part|Death|2|||
48353558|NCT01999972|155492697|FG005|Dose Expansion Part|Death|1|||
48353559|NCT01999972|155492692|FG000|Dose Expansion Part|Disease progression|0|||
48353560|NCT01999972|155492693|FG001|Dose Expansion Part|Disease progression|0|||
48353561|NCT01999972|155492694|FG002|Dose Expansion Part|Disease progression|0|||
48353562|NCT01999972|155492695|FG003|Dose Expansion Part|Disease progression|0|||
48353563|NCT01999972|155492696|FG004|Dose Expansion Part|Disease progression|9|||
48353564|NCT01999972|155492697|FG005|Dose Expansion Part|Disease progression|3|||
48353565|NCT01999972|155492692|FG000|Dose Expansion Part|Sponsor decision|0|||
48353566|NCT01999972|155492693|FG001|Dose Expansion Part|Sponsor decision|0|||
48353567|NCT01999972|155492694|FG002|Dose Expansion Part|Sponsor decision|0|||
48353568|NCT01999972|155492695|FG003|Dose Expansion Part|Sponsor decision|0|||
48353569|NCT01999972|155492696|FG004|Dose Expansion Part|Sponsor decision|1|||
48353570|NCT01999972|155492697|FG005|Dose Expansion Part|Sponsor decision|0|||
48353571|NCT01999972|155492692|FG000|Dose Expansion Part|Adverse Event|0|||
48353572|NCT01999972|155492693|FG001|Dose Expansion Part|Adverse Event|0|||
48353573|NCT01999972|155492694|FG002|Dose Expansion Part|Adverse Event|0|||
48353574|NCT01999972|155492695|FG003|Dose Expansion Part|Adverse Event|0|||
48353575|NCT01999972|155492696|FG004|Dose Expansion Part|Adverse Event|4|||
48353576|NCT01999972|155492697|FG005|Dose Expansion Part|Adverse Event|2|||
48353577|NCT01999972|155492692|FG000|Dose Expansion Part|Participant's non-compliance|0|||
48353578|NCT01999972|155492693|FG001|Dose Expansion Part|Participant's non-compliance|0|||
48353579|NCT01999972|155492694|FG002|Dose Expansion Part|Participant's non-compliance|0|||
48353580|NCT01999972|155492695|FG003|Dose Expansion Part|Participant's non-compliance|0|||
48353581|NCT01999972|155492696|FG004|Dose Expansion Part|Participant's non-compliance|0|||
48353582|NCT01999972|155492697|FG005|Dose Expansion Part|Participant's non-compliance|1|||
48353583|NCT01999972|155492692|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
48353584|NCT01999972|155492693|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
48353585|NCT01999972|155492694|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
48353586|NCT01999972|155492695|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
48762080|NCT02608268|156978020|FG013|Overall Study|Adverse Event|0|||
48762081|NCT02608268|156978021|FG014|Overall Study|Adverse Event|0|||
48762082|NCT02608268|156978022|FG015|Overall Study|Adverse Event|0|||
48762083|NCT02608268|156978023|FG016|Overall Study|Adverse Event|0|||
48762084|NCT02608268|156978024|FG017|Overall Study|Adverse Event|0|||
48762085|NCT02608268|156978025|FG018|Overall Study|Adverse Event|0|||
48762086|NCT02608268|156978026|FG019|Overall Study|Adverse Event|0|||
48762087|NCT02608268|156978027|FG020|Overall Study|Adverse Event|1|||
48762088|NCT02608268|156978028|FG021|Overall Study|Adverse Event|1|||
48762089|NCT02608268|156978029|FG022|Overall Study|Adverse Event|0|||
48762090|NCT02608268|156978030|FG023|Overall Study|Adverse Event|0|||
48762091|NCT02608268|156978031|FG024|Overall Study|Adverse Event|1|||
48762092|NCT02608268|156978032|FG025|Overall Study|Adverse Event|0|||
48762093|NCT02608268|156978033|FG026|Overall Study|Adverse Event|0|||
48353587|NCT01999972|155492696|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
48353588|NCT01999972|155492697|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
48353589|NCT01999972|155492692|FG000|Dose Expansion Part|Changed to standard of care|0|||
48353590|NCT01999972|155492693|FG001|Dose Expansion Part|Changed to standard of care|0|||
48762094|NCT02608268|156978034|FG027|Overall Study|Adverse Event|0|||
48762095|NCT02608268|156978035|FG028|Overall Study|Adverse Event|1|||
48762096|NCT02608268|156978036|FG029|Overall Study|Adverse Event|0|||
48676135|NCT01677858|156667224|FG001|Overall Study|Adverse Event|0|||
48676136|NCT01677858|156667225|FG002|Overall Study|Adverse Event|2|||
48676137|NCT01677858|156667226|FG003|Overall Study|Adverse Event|3|||
48676138|NCT01677858|156667227|FG004|Overall Study|Adverse Event|13|||
48676139|NCT01677858|156667223|FG000|Overall Study|Death|0|||
48676140|NCT01677858|156667224|FG001|Overall Study|Death|0|||
48676141|NCT01677858|156667225|FG002|Overall Study|Death|0|||
48676142|NCT01677858|156667226|FG003|Overall Study|Death|0|||
48676143|NCT01677858|156667227|FG004|Overall Study|Death|1|||
48676144|NCT01677858|156667223|FG000|Overall Study|Physician Decision|1|||
48676145|NCT01677858|156667224|FG001|Overall Study|Physician Decision|0|||
48676146|NCT01677858|156667225|FG002|Overall Study|Physician Decision|2|||
48676147|NCT01677858|156667226|FG003|Overall Study|Physician Decision|0|||
48676148|NCT01677858|156667227|FG004|Overall Study|Physician Decision|12|||
48676149|NCT01677858|156667223|FG000|Overall Study|Progressive Disease|2|||
48676150|NCT01677858|156667224|FG001|Overall Study|Progressive Disease|1|||
48676151|NCT01677858|156667225|FG002|Overall Study|Progressive Disease|9|||
48676152|NCT01677858|156667226|FG003|Overall Study|Progressive Disease|3|||
48676153|NCT01677858|156667227|FG004|Overall Study|Progressive Disease|43|||
48676154|NCT01677858|156667223|FG000|Overall Study|Withdrawal by Subject|0|||
48676155|NCT01677858|156667224|FG001|Overall Study|Withdrawal by Subject|1|||
48676156|NCT01677858|156667225|FG002|Overall Study|Withdrawal by Subject|1|||
48676157|NCT01677858|156667226|FG003|Overall Study|Withdrawal by Subject|0|||
48676158|NCT01677858|156667227|FG004|Overall Study|Withdrawal by Subject|15|||
48676159|NCT01677858|156667223|FG000|Overall Study|Lost to Follow-up|0|||
48676160|NCT01677858|156667224|FG001|Overall Study|Lost to Follow-up|0|||
48676161|NCT01677858|156667225|FG002|Overall Study|Lost to Follow-up|0|||
48676162|NCT01677858|156667226|FG003|Overall Study|Lost to Follow-up|0|||
48676163|NCT01677858|156667227|FG004|Overall Study|Lost to Follow-up|1|||
48676164|NCT00077649|156667229|FG000|Overall Study|Adverse Event|5|||
48676165|NCT00077649|156667230|FG001|Overall Study|Adverse Event|1|||
48676166|NCT00077649|156667231|FG002|Overall Study|Adverse Event|7|||
48676167|NCT00077649|156667232|FG003|Overall Study|Adverse Event|9|||
48676168|NCT00077649|156667229|FG000|Overall Study|Lack of Efficacy|5|||
48676169|NCT00077649|156667230|FG001|Overall Study|Lack of Efficacy|3|||
48676170|NCT00077649|156667231|FG002|Overall Study|Lack of Efficacy|3|||
48353591|NCT01999972|155492694|FG002|Dose Expansion Part|Changed to standard of care|0|||
48353592|NCT01999972|155492695|FG003|Dose Expansion Part|Changed to standard of care|0|||
48353593|NCT01999972|155492696|FG004|Dose Expansion Part|Changed to standard of care|1|||
48353594|NCT01999972|155492697|FG005|Dose Expansion Part|Changed to standard of care|0|||
48353595|NCT01689363|155492698|FG000|Overall Study|Protocol Violation|0|||
48353596|NCT01689363|155492699|FG001|Overall Study|Protocol Violation|1|||
48353597|NCT01689363|155492700|FG002|Overall Study|Protocol Violation|0|||
48353598|NCT01689363|155492701|FG003|Overall Study|Protocol Violation|0|||
48353599|NCT01689363|155492702|FG004|Overall Study|Protocol Violation|0|||
48353600|NCT01689363|155492703|FG005|Overall Study|Protocol Violation|0|||
48353601|NCT01689363|155492704|FG006|Overall Study|Protocol Violation|0|||
48353602|NCT01689363|155492705|FG007|Overall Study|Protocol Violation|0|||
48353603|NCT00321685|155492708|FG000|Overall Study|Adverse Event|18|||
48353604|NCT00321685|155492708|FG000|Overall Study|Death|2|||
48353605|NCT00321685|155492708|FG000|Overall Study|Withdrawal by Subject|8|||
48353606|NCT00321685|155492708|FG000|Overall Study|Alternative therapy|1|||
48353607|NCT00321685|155492708|FG000|Overall Study|Complicating disese|1|||
48353608|NCT00321685|155492708|FG000|Overall Study|Other|5|||
48353609|NCT00321685|155492708|FG000|Overall Study|Not start protocol therapy|2|||
48353610|NCT00321685|155492708|FG000|Overall Study|Ineligible|2|||
48353611|NCT00263211|155492709|FG000|Overall Study|Death|1|||
48353612|NCT00263211|155492710|FG001|Overall Study|Death|0|||
48353613|NCT00263211|155492709|FG000|Overall Study|Withdrawal by Subject|3|||
48353614|NCT00263211|155492710|FG001|Overall Study|Withdrawal by Subject|0|||
48353615|NCT00263211|155492709|FG000|Overall Study|Protocol Violation|1|||
48353616|NCT00263211|155492710|FG001|Overall Study|Protocol Violation|0|||
48353617|NCT00263211|155492709|FG000|Overall Study|Disease Progression|0|||
48353618|NCT00263211|155492710|FG001|Overall Study|Disease Progression|1|||
48353619|NCT02172911|155492711|FG000|Overall Study|Serious Adverse Event|0|||
48353620|NCT02172911|155492712|FG001|Overall Study|Serious Adverse Event|1|||
48353621|NCT02172911|155492711|FG000|Overall Study|Progression of Disease|0|||
48353622|NCT02172911|155492712|FG001|Overall Study|Progression of Disease|1|||
48353623|NCT02172911|155492711|FG000|Overall Study|Loss of insurance coverage|1|||
48353624|NCT02172911|155492712|FG001|Overall Study|Loss of insurance coverage|0|||
48353625|NCT01053247|155492715|FG000|Overall Study|Withdrawal by Subject|9|||
48353626|NCT01053247|155492716|FG001|Overall Study|Withdrawal by Subject|4|||
48353627|NCT01053247|155492717|FG002|Overall Study|Withdrawal by Subject|15|||
48353628|NCT01053247|155492715|FG000|Overall Study|Lack of Efficacy|1|||
48353629|NCT01053247|155492716|FG001|Overall Study|Lack of Efficacy|0|||
48353630|NCT01053247|155492717|FG002|Overall Study|Lack of Efficacy|1|||
48353631|NCT01053247|155492715|FG000|Overall Study|Protocol Violation|2|||
48353632|NCT01053247|155492716|FG001|Overall Study|Protocol Violation|1|||
48353633|NCT01053247|155492717|FG002|Overall Study|Protocol Violation|2|||
48353634|NCT01053247|155492715|FG000|Overall Study|Lost to Follow-up|8|||
48353635|NCT01053247|155492716|FG001|Overall Study|Lost to Follow-up|5|||
48353636|NCT01053247|155492717|FG002|Overall Study|Lost to Follow-up|7|||
48353637|NCT01053247|155492715|FG000|Overall Study|Adverse Event|0|||
48353638|NCT01053247|155492716|FG001|Overall Study|Adverse Event|9|||
48353639|NCT01053247|155492717|FG002|Overall Study|Adverse Event|3|||
48353640|NCT00590564|155492721|FG000|Overall Study|Withdrawal by Subject|4|||
48353641|NCT00590564|155492721|FG000|Overall Study|Lost to Follow-up|6|||
48353642|NCT00590564|155492721|FG000|Overall Study|Protocol Violation|1|||
48353643|NCT00590564|155492721|FG000|Overall Study|Patient Found to be Ineligible|1|||
48353644|NCT00590564|155492721|FG000|Overall Study|Patient Non-compliance|6|||
48353645|NCT00416598|155492722|FG000|Induction & Intensification|Adverse Event|38|||
48353646|NCT00416598|155492722|FG000|Induction & Intensification|Death|32|||
48353647|NCT00416598|155492722|FG000|Induction & Intensification|Withdrawal by Subject|46|||
48353648|NCT00416598|155492722|FG000|Induction & Intensification|Alternative Treatment|135|||
48353649|NCT00416598|155492722|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
48353650|NCT00416598|155492722|FG000|Induction & Intensification|Relapse/progression|29|||
48762097|NCT02608268|156978007|FG000|Overall Study|Death|1|||
48762098|NCT02608268|156978008|FG001|Overall Study|Death|0|||
48762099|NCT02608268|156978009|FG002|Overall Study|Death|0|||
48353651|NCT00416598|155492722|FG000|Induction & Intensification|Failed induction|87|||
48353652|NCT00416598|155492722|FG000|Decitabine Maintenance|Adverse Event|5|||
48353653|NCT00416598|155492722|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
48353654|NCT00416598|155492722|FG000|Decitabine Maintenance|Progression/relapse|38|||
48353655|NCT00416598|155492722|FG000|Decitabine Maintenance|Alternative treatment|2|||
48353656|NCT00416598|155492722|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
48353657|NCT02053610|155492723|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
48353658|NCT02053610|155492724|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
48353659|NCT02053610|155492723|FG000|Overall Study|Withdrew Consent|2|||
48762100|NCT02608268|156978010|FG003|Overall Study|Death|0|||
48353660|NCT02053610|155492724|FG001|Overall Study|Withdrew Consent|9|||
48353661|NCT02053610|155492723|FG000|Overall Study|Death|5|||
48353662|NCT02053610|155492724|FG001|Overall Study|Death|5|||
48353663|NCT02053610|155492723|FG000|Overall Study|Administrative/Other|1|||
48762101|NCT02608268|156978011|FG004|Overall Study|Death|0|||
48676171|NCT00077649|156667232|FG003|Overall Study|Lack of Efficacy|2|||
48676172|NCT00077649|156667229|FG000|Overall Study|Withdrawal by Subject|0|||
48676173|NCT00077649|156667230|FG001|Overall Study|Withdrawal by Subject|1|||
48676174|NCT00077649|156667231|FG002|Overall Study|Withdrawal by Subject|1|||
48676175|NCT00077649|156667232|FG003|Overall Study|Withdrawal by Subject|2|||
48676176|NCT00077649|156667229|FG000|Overall Study|Lost to Follow-up|2|||
48676177|NCT00077649|156667230|FG001|Overall Study|Lost to Follow-up|2|||
48676178|NCT00077649|156667231|FG002|Overall Study|Lost to Follow-up|3|||
48676179|NCT00077649|156667232|FG003|Overall Study|Lost to Follow-up|2|||
48676180|NCT00077649|156667229|FG000|Overall Study|Abnormality of Laboratory Test|1|||
48676181|NCT00077649|156667230|FG001|Overall Study|Abnormality of Laboratory Test|2|||
48676182|NCT00077649|156667231|FG002|Overall Study|Abnormality of Laboratory Test|1|||
48676183|NCT00077649|156667232|FG003|Overall Study|Abnormality of Laboratory Test|2|||
48676184|NCT00077649|156667229|FG000|Overall Study|Randomized but never dosed|1|||
48676185|NCT00077649|156667230|FG001|Overall Study|Randomized but never dosed|0|||
48676186|NCT00077649|156667231|FG002|Overall Study|Randomized but never dosed|0|||
48676187|NCT00077649|156667232|FG003|Overall Study|Randomized but never dosed|0|||
48676188|NCT00588094|156667235|FG000|Overall Study|Adverse Event|3|||
48676189|NCT00588094|156667235|FG000|Overall Study|Progression of Disease|2|||
48676190|NCT00391625|156667238|FG000|Month 14|Withdrawal by Subject|1|||
48676191|NCT00391625|156667238|FG000|Month 50|Physician Decision|1|||
48762102|NCT02608268|156978012|FG005|Overall Study|Death|0|||
48353664|NCT02053610|155492724|FG001|Overall Study|Administrative/Other|1|||
48353665|NCT02053610|155492723|FG000|Overall Study|Disease Progression|2|||
48353666|NCT02053610|155492724|FG001|Overall Study|Disease Progression|3|||
48353667|NCT02053610|155492723|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
48353668|NCT02053610|155492724|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
48353669|NCT02053610|155492723|FG000|Overall Study|Did not Receive Treatment|4|||
48353670|NCT02053610|155492724|FG001|Overall Study|Did not Receive Treatment|2|||
48353671|NCT02053610|155492723|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48353672|NCT02053610|155492724|FG001|Overall Study|Insufficient Therapeutic Response|1|||
48353673|NCT02053610|155492723|FG000|Overall Study|Violation of Selection Criteria|1|||
48353674|NCT02053610|155492724|FG001|Overall Study|Violation of Selection Criteria|0|||
48353675|NCT01375673|155492725|FG000|Overall Study|Withdrawal by Subject|0|||
48353676|NCT01375673|155492726|FG001|Overall Study|Withdrawal by Subject|1|||
48353677|NCT02536742|155492727|FG000|Overall Study|Did not start protocol therapy|1|||
48353678|NCT02536742|155492727|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
48353679|NCT02980523|155492728|FG000|Overall Study|Lost to Follow-up|1|||
48353680|NCT02980523|155492729|FG001|Overall Study|Lost to Follow-up|4|||
48353681|NCT02980523|155492730|FG002|Overall Study|Lost to Follow-up|1|||
48353682|NCT02980523|155492731|FG003|Overall Study|Lost to Follow-up|2|||
48353683|NCT02980523|155492732|FG004|Overall Study|Lost to Follow-up|1|||
48353684|NCT02980523|155492728|FG000|Overall Study|Excluded from analysis|1|||
48353685|NCT02980523|155492729|FG001|Overall Study|Excluded from analysis|3|||
48353686|NCT02980523|155492730|FG002|Overall Study|Excluded from analysis|1|||
48353687|NCT02980523|155492731|FG003|Overall Study|Excluded from analysis|1|||
48353688|NCT02980523|155492732|FG004|Overall Study|Excluded from analysis|1|||
48353689|NCT02980523|155492728|FG000|Overall Study|Lack of Efficacy|1|||
48353690|NCT02980523|155492729|FG001|Overall Study|Lack of Efficacy|4|||
48353691|NCT02980523|155492730|FG002|Overall Study|Lack of Efficacy|4|||
48353692|NCT02980523|155492731|FG003|Overall Study|Lack of Efficacy|5|||
48353693|NCT02980523|155492732|FG004|Overall Study|Lack of Efficacy|8|||
48353694|NCT02980523|155492728|FG000|Overall Study|Did not receive intervention|0|||
48353695|NCT02980523|155492729|FG001|Overall Study|Did not receive intervention|0|||
48353696|NCT02980523|155492730|FG002|Overall Study|Did not receive intervention|0|||
48353697|NCT02980523|155492731|FG003|Overall Study|Did not receive intervention|1|||
48353698|NCT02980523|155492732|FG004|Overall Study|Did not receive intervention|0|||
48353699|NCT00882115|155492733|FG000|Overall Study|Withdrawal by Subject|3|||
48353700|NCT00882115|155492733|FG000|Overall Study|did not respond to DEP challe|6|||
48353701|NCT03865953|155492734|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
48353702|NCT03865953|155492735|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
48353703|NCT03865953|155492734|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
48353704|NCT03865953|155492735|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
48353705|NCT03865953|155492734|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
48353706|NCT03865953|155492735|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
48353707|NCT04431726|155492749|FG000|Overall Study|Ongoing in the Study|55|||
48353708|NCT00632021|155492750|FG000|Overall Study|Withdrawal/death|4|||
48353709|NCT00632021|155492751|FG001|Overall Study|Withdrawal/death|7|||
48353710|NCT02803593|155492752|FG000|Overall Study|Lost to Follow-up|17|||
48353711|NCT02803593|155492753|FG001|Overall Study|Lost to Follow-up|35|||
48353712|NCT02601209|155492756|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
48353713|NCT02601209|155492757|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
48676192|NCT03997825|156667239|FG000|Overall Study|Death|3|||
48676193|NCT03997825|156667239|FG000|Overall Study|Lost to Follow-up|10|||
48353714|NCT02601209|155492758|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
48676194|NCT03997825|156667239|FG000|Overall Study|Withdrawal by Subject|3|||
48676195|NCT03997825|156667239|FG000|Overall Study|Refused participation|1|||
48676196|NCT00699335|156667242|FG000|Overall Study|Combination of multiple reasons|176|||
48676197|NCT00699335|156667242|FG000|Overall Study|Missing data|52|||
48676198|NCT04390841|156667243|FG000|Overall Study|Withdrawal by Subject|2|||
48676199|NCT02188849|156667247|FG000|Overall Study|Lost to Follow-up|3|||
48676200|NCT02188849|156667248|FG001|Overall Study|Lost to Follow-up|8|||
48676201|NCT00148941|156667249|FG000|Overall Study|Lost to Follow-up|17|||
48676202|NCT00148941|156667250|FG001|Overall Study|Lost to Follow-up|24|||
48676203|NCT00148941|156667251|FG002|Overall Study|Lost to Follow-up|18|||
48676204|NCT00148941|156667252|FG003|Overall Study|Lost to Follow-up|22|||
48676205|NCT00148941|156667249|FG000|Overall Study|Withdrawal by Subject|1|||
48676206|NCT00148941|156667250|FG001|Overall Study|Withdrawal by Subject|0|||
48676207|NCT00148941|156667251|FG002|Overall Study|Withdrawal by Subject|1|||
48676208|NCT00148941|156667252|FG003|Overall Study|Withdrawal by Subject|0|||
48676209|NCT00148941|156667249|FG000|Overall Study|Other|0|||
48676210|NCT00148941|156667250|FG001|Overall Study|Other|0|||
48676211|NCT00148941|156667251|FG002|Overall Study|Other|1|||
48676212|NCT00148941|156667252|FG003|Overall Study|Other|2|||
48762103|NCT02608268|156978013|FG006|Overall Study|Death|0|||
48762104|NCT02608268|156978014|FG007|Overall Study|Death|0|||
48762105|NCT02608268|156978015|FG008|Overall Study|Death|1|||
48762106|NCT02608268|156978016|FG009|Overall Study|Death|1|||
48762107|NCT02608268|156978017|FG010|Overall Study|Death|0|||
48762108|NCT02608268|156978018|FG011|Overall Study|Death|0|||
48762109|NCT02608268|156978019|FG012|Overall Study|Death|0|||
48762110|NCT02608268|156978020|FG013|Overall Study|Death|0|||
48762111|NCT02608268|156978021|FG014|Overall Study|Death|0|||
48762112|NCT02608268|156978022|FG015|Overall Study|Death|1|||
48762113|NCT02608268|156978023|FG016|Overall Study|Death|0|||
48762114|NCT02608268|156978024|FG017|Overall Study|Death|1|||
48762115|NCT02608268|156978025|FG018|Overall Study|Death|0|||
48762116|NCT02608268|156978026|FG019|Overall Study|Death|1|||
48762117|NCT02608268|156978027|FG020|Overall Study|Death|1|||
48762118|NCT02608268|156978028|FG021|Overall Study|Death|0|||
48762119|NCT02608268|156978029|FG022|Overall Study|Death|0|||
48762120|NCT02608268|156978030|FG023|Overall Study|Death|0|||
48762121|NCT02608268|156978031|FG024|Overall Study|Death|1|||
48762122|NCT02608268|156978032|FG025|Overall Study|Death|2|||
48762123|NCT02608268|156978033|FG026|Overall Study|Death|0|||
48762124|NCT02608268|156978034|FG027|Overall Study|Death|1|||
48676213|NCT04356352|156667253|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
48762125|NCT02608268|156978035|FG028|Overall Study|Death|4|||
48762126|NCT02608268|156978036|FG029|Overall Study|Death|0|||
48762127|NCT02608268|156978007|FG000|Overall Study|Physician Decision|0|||
48762128|NCT02608268|156978008|FG001|Overall Study|Physician Decision|0|||
48762129|NCT02608268|156978009|FG002|Overall Study|Physician Decision|0|||
48762130|NCT02608268|156978010|FG003|Overall Study|Physician Decision|0|||
48762131|NCT02608268|156978011|FG004|Overall Study|Physician Decision|0|||
48762132|NCT02608268|156978012|FG005|Overall Study|Physician Decision|0|||
48762133|NCT02608268|156978013|FG006|Overall Study|Physician Decision|0|||
48353715|NCT02601209|155492759|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48353716|NCT02601209|155492760|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48353717|NCT02601209|155492761|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48353718|NCT02601209|155492762|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48353719|NCT02601209|155492763|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48353720|NCT02601209|155492764|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
48353721|NCT02601209|155492756|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48353722|NCT02601209|155492757|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48353723|NCT02601209|155492758|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48353724|NCT02601209|155492759|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48353725|NCT02601209|155492760|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
48353726|NCT02601209|155492761|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
48353727|NCT02601209|155492762|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
48353728|NCT02601209|155492763|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48353729|NCT02601209|155492764|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
48353730|NCT00572533|155492767|FG000|Overall Study|Death|4|||
48353731|NCT00572533|155492768|FG001|Overall Study|Death|1|||
48353732|NCT00572533|155492767|FG000|Overall Study|Received Kidney Transplant|2|||
48353733|NCT00572533|155492768|FG001|Overall Study|Received Kidney Transplant|1|||
48353734|NCT00572533|155492767|FG000|Overall Study|Social Issues|1|||
48353735|NCT00572533|155492768|FG001|Overall Study|Social Issues|0|||
48353736|NCT00572533|155492767|FG000|Overall Study|Transfer out of Facility|0|||
48353737|NCT00572533|155492768|FG001|Overall Study|Transfer out of Facility|1|||
48353738|NCT00825305|155492770|FG000|Overall Study|Adverse Event|1|||
48353739|NCT00825305|155492771|FG001|Overall Study|Adverse Event|1|||
48353740|NCT00825305|155492770|FG000|Overall Study|Withdrawal by Subject|6|||
48353741|NCT00825305|155492771|FG001|Overall Study|Withdrawal by Subject|12|||
48353742|NCT00825305|155492770|FG000|Overall Study|Inappropriate inclusion|1|||
48353743|NCT00825305|155492771|FG001|Overall Study|Inappropriate inclusion|0|||
48353744|NCT00825305|155492770|FG000|Overall Study|Protocol Violation|9|||
48353745|NCT00825305|155492771|FG001|Overall Study|Protocol Violation|9|||
48353746|NCT00825305|155492770|FG000|Overall Study|Can not be classified|0|||
48353747|NCT00825305|155492771|FG001|Overall Study|Can not be classified|1|||
48353748|NCT01485120|155492772|FG000|Overall Study|Withdrawal by Subject|2|||
48353749|NCT00422734|155492773|FG000|Overall Study|Physician Decision|1|||
48353750|NCT00422734|155492774|FG001|Overall Study|Physician Decision|1|||
48353751|NCT00422734|155492773|FG000|Overall Study|Protocol Violation|1|||
48353752|NCT00422734|155492774|FG001|Overall Study|Protocol Violation|6|||
48353753|NCT00422734|155492773|FG000|Overall Study|Withdrawal by Subject|12|||
48353754|NCT00422734|155492774|FG001|Overall Study|Withdrawal by Subject|8|||
48353755|NCT00422734|155492773|FG000|Overall Study|Adverse Event|0|||
48353756|NCT00422734|155492774|FG001|Overall Study|Adverse Event|3|||
48353757|NCT00422734|155492773|FG000|Overall Study|Partner Decision|0|||
48353758|NCT00422734|155492774|FG001|Overall Study|Partner Decision|3|||
48353759|NCT00848484|155492775|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
48353760|NCT00848484|155492776|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
48353761|NCT00848484|155492775|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
48353762|NCT00848484|155492776|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
48353763|NCT00848484|155492775|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
48353764|NCT00848484|155492776|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
48353765|NCT00848484|155492775|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
48353766|NCT00848484|155492776|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
48353767|NCT00848484|155492775|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
48353768|NCT00848484|155492776|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
48353769|NCT00267098|155492781|FG000|Overall Study|Death|0|||
48353770|NCT00267098|155492782|FG001|Overall Study|Death|0|||
48353771|NCT00267098|155492783|FG002|Overall Study|Death|57|||
48353772|NCT00267098|155492784|FG003|Overall Study|Death|66|||
48353773|NCT00267098|155492785|FG004|Overall Study|Death|14|||
48353774|NCT00267098|155492786|FG005|Overall Study|Death|23|||
48353775|NCT00267098|155492787|FG006|Overall Study|Death|28|||
48353776|NCT00267098|155492788|FG007|Overall Study|Death|9|||
48353777|NCT00267098|155492781|FG000|Overall Study|Lost to Follow-up|0|||
48353778|NCT00267098|155492782|FG001|Overall Study|Lost to Follow-up|0|||
48353779|NCT00267098|155492783|FG002|Overall Study|Lost to Follow-up|6|||
48353780|NCT00267098|155492784|FG003|Overall Study|Lost to Follow-up|5|||
48353781|NCT00267098|155492785|FG004|Overall Study|Lost to Follow-up|2|||
48353782|NCT00267098|155492786|FG005|Overall Study|Lost to Follow-up|3|||
48353783|NCT00267098|155492787|FG006|Overall Study|Lost to Follow-up|1|||
48353784|NCT00267098|155492788|FG007|Overall Study|Lost to Follow-up|1|||
48353785|NCT00267098|155492781|FG000|Overall Study|Withdrawal by Subject|8|||
48353786|NCT00267098|155492782|FG001|Overall Study|Withdrawal by Subject|0|||
48353787|NCT00267098|155492783|FG002|Overall Study|Withdrawal by Subject|24|||
48353788|NCT00267098|155492784|FG003|Overall Study|Withdrawal by Subject|21|||
48353789|NCT00267098|155492785|FG004|Overall Study|Withdrawal by Subject|12|||
48353790|NCT00267098|155492786|FG005|Overall Study|Withdrawal by Subject|9|||
48353791|NCT00267098|155492787|FG006|Overall Study|Withdrawal by Subject|12|||
48353792|NCT00267098|155492788|FG007|Overall Study|Withdrawal by Subject|5|||
48353793|NCT00267098|155492781|FG000|Overall Study|Physician Decision|5|||
48353794|NCT00267098|155492782|FG001|Overall Study|Physician Decision|0|||
48353795|NCT00267098|155492783|FG002|Overall Study|Physician Decision|7|||
48353796|NCT00267098|155492784|FG003|Overall Study|Physician Decision|11|||
48353797|NCT00267098|155492785|FG004|Overall Study|Physician Decision|5|||
48353798|NCT00267098|155492786|FG005|Overall Study|Physician Decision|4|||
48353799|NCT00267098|155492787|FG006|Overall Study|Physician Decision|3|||
48353800|NCT00267098|155492788|FG007|Overall Study|Physician Decision|0|||
48353801|NCT00267098|155492781|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
48353802|NCT00267098|155492782|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48353803|NCT00267098|155492783|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48353804|NCT00267098|155492784|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48353805|NCT00267098|155492785|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
48353806|NCT00267098|155492786|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48353807|NCT00267098|155492787|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48353808|NCT00267098|155492788|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48353809|NCT00267098|155492781|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48353810|NCT00267098|155492782|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
48353811|NCT00267098|155492783|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48353812|NCT00267098|155492784|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48353813|NCT00267098|155492785|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48353814|NCT00267098|155492786|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48353815|NCT00267098|155492787|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48353816|NCT00267098|155492788|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
48353817|NCT00267098|155492781|FG000|Overall Study|Site closure|0|||
48353818|NCT00267098|155492782|FG001|Overall Study|Site closure|0|||
48353819|NCT00267098|155492783|FG002|Overall Study|Site closure|0|||
48353820|NCT00267098|155492784|FG003|Overall Study|Site closure|1|||
48353821|NCT00267098|155492785|FG004|Overall Study|Site closure|0|||
48353822|NCT00267098|155492786|FG005|Overall Study|Site closure|1|||
48353823|NCT00267098|155492787|FG006|Overall Study|Site closure|1|||
48353824|NCT00267098|155492788|FG007|Overall Study|Site closure|0|||
48353825|NCT00267098|155492781|FG000|Overall Study|Explanted Medtronic device|0|||
48353826|NCT00267098|155492782|FG001|Overall Study|Explanted Medtronic device|0|||
48353827|NCT00267098|155492783|FG002|Overall Study|Explanted Medtronic device|0|||
48353828|NCT00267098|155492784|FG003|Overall Study|Explanted Medtronic device|1|||
48353829|NCT00267098|155492785|FG004|Overall Study|Explanted Medtronic device|0|||
48353830|NCT00267098|155492786|FG005|Overall Study|Explanted Medtronic device|0|||
48353831|NCT00267098|155492787|FG006|Overall Study|Explanted Medtronic device|0|||
48353832|NCT00267098|155492788|FG007|Overall Study|Explanted Medtronic device|0|||
48353833|NCT00267098|155492781|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48353834|NCT00267098|155492782|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48353835|NCT00267098|155492783|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48353836|NCT00267098|155492784|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48353837|NCT00267098|155492785|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
48353838|NCT00267098|155492786|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48353839|NCT00267098|155492787|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48353840|NCT00267098|155492788|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
48353841|NCT00267098|155492781|FG000|Overall Study|Subject listed for heart transplant|0|||
48676214|NCT04356352|156667254|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
48676215|NCT04356352|156667255|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
48676216|NCT04356352|156667253|FG000|Overall Study|Protocol Violation|0|||
48676217|NCT04356352|156667254|FG001|Overall Study|Protocol Violation|3|||
48676218|NCT04356352|156667255|FG002|Overall Study|Protocol Violation|1|||
48353842|NCT00267098|155492782|FG001|Overall Study|Subject listed for heart transplant|0|||
48353843|NCT00267098|155492783|FG002|Overall Study|Subject listed for heart transplant|0|||
48353844|NCT00267098|155492784|FG003|Overall Study|Subject listed for heart transplant|0|||
48353845|NCT00267098|155492785|FG004|Overall Study|Subject listed for heart transplant|0|||
48676219|NCT00781859|156667256|FG000|Overall Study|Adverse Event|2|||
48676220|NCT00781859|156667257|FG001|Overall Study|Adverse Event|2|||
48353846|NCT00267098|155492786|FG005|Overall Study|Subject listed for heart transplant|0|||
48353847|NCT00267098|155492787|FG006|Overall Study|Subject listed for heart transplant|1|||
48353848|NCT00267098|155492788|FG007|Overall Study|Subject listed for heart transplant|0|||
48353849|NCT00267098|155492781|FG000|Overall Study|Sponsor withdrew subject|0|||
48353850|NCT00267098|155492782|FG001|Overall Study|Sponsor withdrew subject|0|||
48353851|NCT00267098|155492783|FG002|Overall Study|Sponsor withdrew subject|0|||
48353852|NCT00267098|155492784|FG003|Overall Study|Sponsor withdrew subject|1|||
48353853|NCT00267098|155492785|FG004|Overall Study|Sponsor withdrew subject|0|||
48353854|NCT00267098|155492786|FG005|Overall Study|Sponsor withdrew subject|0|||
48353855|NCT00267098|155492787|FG006|Overall Study|Sponsor withdrew subject|0|||
48353856|NCT00267098|155492788|FG007|Overall Study|Sponsor withdrew subject|0|||
48353857|NCT01721954|155492789|FG000|Overall Study|Death|58|||
48353858|NCT01721954|155492790|FG001|Overall Study|Death|64|||
48353859|NCT01721954|155492789|FG000|Overall Study|Withdrawal by Subject|8|||
48353860|NCT01721954|155492790|FG001|Overall Study|Withdrawal by Subject|4|||
48353861|NCT01721954|155492789|FG000|Overall Study|Adverse Event|2|||
48353862|NCT01721954|155492790|FG001|Overall Study|Adverse Event|0|||
48353863|NCT01721954|155492789|FG000|Overall Study|Lost to Follow-up|2|||
48353864|NCT01721954|155492790|FG001|Overall Study|Lost to Follow-up|1|||
48353865|NCT00965497|155492791|FG000|Overall Study|Physician Decision|1|||
48353866|NCT01825577|155492794|FG000|Overall Study|Physician Decision|2|||
48353867|NCT01825577|155492794|FG000|Overall Study|Withdrawal by Subject|1|||
48353868|NCT01825577|155492794|FG000|Overall Study|Withdrawn by family members|2|||
48353869|NCT01825577|155492794|FG000|Overall Study|Lack of Efficacy|3|||
48353870|NCT02838134|155492795|FG000|Overall Study|Lost to Follow-up|1|||
48353871|NCT02838134|155492796|FG001|Overall Study|Lost to Follow-up|2|||
48353872|NCT02838134|155492795|FG000|Overall Study|logistic problems|1|||
48353873|NCT02838134|155492796|FG001|Overall Study|logistic problems|1|||
48353874|NCT01299480|155492797|FG000|Overall Study|No longer willing to participate|19|||
48353875|NCT01299480|155492798|FG001|Overall Study|No longer willing to participate|17|||
48353876|NCT01299480|155492799|FG002|Overall Study|No longer willing to participate|14|||
48353877|NCT01299480|155492800|FG003|Overall Study|No longer willing to participate|13|||
48353878|NCT01299480|155492801|FG004|Overall Study|No longer willing to participate|10|||
48353879|NCT01299480|155492797|FG000|Overall Study|Protocol Violation|7|||
48353880|NCT01299480|155492798|FG001|Overall Study|Protocol Violation|5|||
48353881|NCT01299480|155492799|FG002|Overall Study|Protocol Violation|8|||
48353882|NCT01299480|155492800|FG003|Overall Study|Protocol Violation|1|||
48353883|NCT01299480|155492801|FG004|Overall Study|Protocol Violation|1|||
48353884|NCT01299480|155492797|FG000|Overall Study|Withdrawal by Subject|3|||
48353885|NCT01299480|155492798|FG001|Overall Study|Withdrawal by Subject|4|||
48353886|NCT01299480|155492799|FG002|Overall Study|Withdrawal by Subject|7|||
48353887|NCT01299480|155492800|FG003|Overall Study|Withdrawal by Subject|3|||
48353888|NCT01299480|155492801|FG004|Overall Study|Withdrawal by Subject|4|||
48353889|NCT01299480|155492797|FG000|Overall Study|Adverse Event|6|||
48353890|NCT01299480|155492798|FG001|Overall Study|Adverse Event|4|||
48353891|NCT01299480|155492799|FG002|Overall Study|Adverse Event|5|||
48353892|NCT01299480|155492800|FG003|Overall Study|Adverse Event|4|||
48353893|NCT01299480|155492801|FG004|Overall Study|Adverse Event|0|||
48353894|NCT01299480|155492797|FG000|Overall Study|Withdrawal due to pregnancy|0|||
48353895|NCT01299480|155492798|FG001|Overall Study|Withdrawal due to pregnancy|1|||
48353896|NCT01299480|155492799|FG002|Overall Study|Withdrawal due to pregnancy|1|||
48676221|NCT00781859|156667256|FG000|Overall Study|Withdrawal by Subject|8|||
48676222|NCT00781859|156667257|FG001|Overall Study|Withdrawal by Subject|4|||
48353897|NCT01299480|155492800|FG003|Overall Study|Withdrawal due to pregnancy|0|||
48353898|NCT01299480|155492801|FG004|Overall Study|Withdrawal due to pregnancy|0|||
48353899|NCT01299480|155492797|FG000|Overall Study|Physician Decision|1|||
48353900|NCT01299480|155492798|FG001|Overall Study|Physician Decision|1|||
48353901|NCT01299480|155492799|FG002|Overall Study|Physician Decision|0|||
48353902|NCT01299480|155492800|FG003|Overall Study|Physician Decision|2|||
48353903|NCT01299480|155492801|FG004|Overall Study|Physician Decision|0|||
48353904|NCT01299480|155492797|FG000|Overall Study|Lost to Follow-up|3|||
48353905|NCT01299480|155492798|FG001|Overall Study|Lost to Follow-up|1|||
48353906|NCT01299480|155492799|FG002|Overall Study|Lost to Follow-up|2|||
48353907|NCT01299480|155492800|FG003|Overall Study|Lost to Follow-up|1|||
48353908|NCT01299480|155492801|FG004|Overall Study|Lost to Follow-up|2|||
48353909|NCT01299480|155492797|FG000|Overall Study|Other|3|||
48353910|NCT01299480|155492798|FG001|Overall Study|Other|2|||
48353911|NCT01299480|155492799|FG002|Overall Study|Other|3|||
48353912|NCT01299480|155492800|FG003|Overall Study|Other|0|||
48353913|NCT01299480|155492801|FG004|Overall Study|Other|3|||
48353914|NCT01299480|155492797|FG000|Overall Study|Started, but not vaccinated|0|||
48353915|NCT01299480|155492798|FG001|Overall Study|Started, but not vaccinated|0|||
48353916|NCT01299480|155492799|FG002|Overall Study|Started, but not vaccinated|1|||
48353917|NCT01299480|155492800|FG003|Overall Study|Started, but not vaccinated|1|||
48353918|NCT01299480|155492801|FG004|Overall Study|Started, but not vaccinated|0|||
48353919|NCT04978090|155492804|FG000|Overall Study|unable to adequately fit device|2|||
48353920|NCT01077518|155492806|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
48353921|NCT01077518|155492807|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
48353922|NCT01077518|155492808|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
48353923|NCT01077518|155492806|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
48676223|NCT00781859|156667256|FG000|Overall Study|Lost to Follow-up|6|||
48676224|NCT00781859|156667257|FG001|Overall Study|Lost to Follow-up|3|||
48353924|NCT01077518|155492807|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
48353925|NCT01077518|155492808|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
48353926|NCT01077518|155492806|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
48353927|NCT01077518|155492807|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
48353928|NCT01077518|155492808|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
48353929|NCT01077518|155492806|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
48353930|NCT01077518|155492807|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
48353931|NCT01077518|155492808|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
48353932|NCT01077518|155492806|FG000|Optional Ofa Phase|Physician Decision|0|||
48353933|NCT01077518|155492807|FG001|Optional Ofa Phase|Physician Decision|0|||
48353934|NCT01077518|155492808|FG002|Optional Ofa Phase|Physician Decision|1|||
48353935|NCT01077518|155492806|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
48353936|NCT01077518|155492807|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
48353937|NCT01077518|155492808|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
48353938|NCT01077518|155492806|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
48353939|NCT01077518|155492807|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
48353940|NCT01077518|155492808|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
48353941|NCT05792085|155492810|FG000|Overall Study|Death|0|||
48353942|NCT05792085|155492811|FG001|Overall Study|Death|0|||
48353943|NCT05792085|155492812|FG002|Overall Study|Death|0|||
48353944|NCT05792085|155492813|FG003|Overall Study|Death|0|||
48353945|NCT05792085|155492814|FG004|Overall Study|Death|1|||
48353946|NCT03974178|155492815|FG000|Overall Study|Death|0|||
48353947|NCT03974178|155492816|FG001|Overall Study|Death|1|||
48353948|NCT03604692|155492817|FG000|Overall Study|Investigator's Decision|0|||
48353949|NCT03604692|155492818|FG001|Overall Study|Investigator's Decision|0|||
48353950|NCT03604692|155492819|FG002|Overall Study|Investigator's Decision|0|||
48353951|NCT03604692|155492820|FG003|Overall Study|Investigator's Decision|1|||
48353952|NCT03604692|155492821|FG004|Overall Study|Investigator's Decision|0|||
48353953|NCT03604692|155492822|FG005|Overall Study|Investigator's Decision|7|||
48353954|NCT03604692|155492817|FG000|Overall Study|Withdrawal by Subject|0|||
48353955|NCT03604692|155492818|FG001|Overall Study|Withdrawal by Subject|0|||
48353956|NCT03604692|155492819|FG002|Overall Study|Withdrawal by Subject|0|||
48353957|NCT03604692|155492820|FG003|Overall Study|Withdrawal by Subject|0|||
48353958|NCT03604692|155492821|FG004|Overall Study|Withdrawal by Subject|0|||
48353959|NCT03604692|155492822|FG005|Overall Study|Withdrawal by Subject|2|||
48353960|NCT03604692|155492817|FG000|Overall Study|Progressive Disease|1|||
48353961|NCT03604692|155492818|FG001|Overall Study|Progressive Disease|0|||
48353962|NCT03604692|155492819|FG002|Overall Study|Progressive Disease|1|||
48676225|NCT00781859|156667256|FG000|Overall Study|Death|3|||
48676226|NCT00781859|156667257|FG001|Overall Study|Death|0|||
48676227|NCT00622388|156667258|FG000|Overall Study|Disease Progression|47|||
48676228|NCT00622388|156667258|FG000|Overall Study|Adverse Event|6|||
48676229|NCT00622388|156667258|FG000|Overall Study|Protocol Violation|3|||
48676230|NCT00622388|156667258|FG000|Overall Study|Participant Refusal|1|||
48676231|NCT00622388|156667258|FG000|Overall Study|Death|3|||
48676232|NCT00622388|156667258|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
48676233|NCT00622388|156667258|FG000|Overall Study|Took Prohibited Medication|2|||
48676234|NCT00622388|156667258|FG000|Overall Study|Withdrew Consent|1|||
48676235|NCT00622388|156667258|FG000|Overall Study|Insurance Expired|1|||
48676236|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
48676237|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
48676238|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
48676239|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
48676240|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
48353963|NCT03604692|155492820|FG003|Overall Study|Progressive Disease|0|||
48353964|NCT03604692|155492821|FG004|Overall Study|Progressive Disease|3|||
48676241|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
48676242|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
48676243|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
48353965|NCT03604692|155492822|FG005|Overall Study|Progressive Disease|4|||
48353966|NCT03604692|155492817|FG000|Overall Study|Difficulty Coming into Site.|0|||
48353967|NCT03604692|155492818|FG001|Overall Study|Difficulty Coming into Site.|0|||
48353968|NCT03604692|155492819|FG002|Overall Study|Difficulty Coming into Site.|0|||
48353969|NCT03604692|155492820|FG003|Overall Study|Difficulty Coming into Site.|0|||
48676244|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
48676245|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Physician Decision|1|||
48676246|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Physician Decision|2|||
48676247|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Physician Decision|0|||
48353970|NCT03604692|155492821|FG004|Overall Study|Difficulty Coming into Site.|0|||
48353971|NCT03604692|155492822|FG005|Overall Study|Difficulty Coming into Site.|1|||
48353972|NCT03604692|155492817|FG000|Overall Study|Death|0|||
48353973|NCT03604692|155492818|FG001|Overall Study|Death|0|||
48353974|NCT03604692|155492819|FG002|Overall Study|Death|1|||
48353975|NCT03604692|155492820|FG003|Overall Study|Death|0|||
48353976|NCT03604692|155492821|FG004|Overall Study|Death|0|||
48353977|NCT03604692|155492822|FG005|Overall Study|Death|0|||
48353978|NCT03604692|155492817|FG000|Overall Study|Drug Intolerance|0|||
48353979|NCT03604692|155492818|FG001|Overall Study|Drug Intolerance|0|||
48353980|NCT03604692|155492819|FG002|Overall Study|Drug Intolerance|0|||
48353981|NCT03604692|155492820|FG003|Overall Study|Drug Intolerance|1|||
48353982|NCT03604692|155492821|FG004|Overall Study|Drug Intolerance|0|||
48353983|NCT03604692|155492822|FG005|Overall Study|Drug Intolerance|0|||
48353984|NCT03604692|155492817|FG000|Overall Study|Noncompliance with follow-up visit|0|||
48353985|NCT03604692|155492818|FG001|Overall Study|Noncompliance with follow-up visit|0|||
48353986|NCT03604692|155492819|FG002|Overall Study|Noncompliance with follow-up visit|0|||
48353987|NCT03604692|155492820|FG003|Overall Study|Noncompliance with follow-up visit|1|||
48676248|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Physician Decision|0|||
48676249|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Physician Decision|0|||
48353988|NCT03604692|155492821|FG004|Overall Study|Noncompliance with follow-up visit|0|||
48353989|NCT03604692|155492822|FG005|Overall Study|Noncompliance with follow-up visit|0|||
48353990|NCT03604692|155492817|FG000|Overall Study|Continuing Treatment/In Follow-Up|0|||
48353991|NCT03604692|155492818|FG001|Overall Study|Continuing Treatment/In Follow-Up|0|||
48353992|NCT03604692|155492819|FG002|Overall Study|Continuing Treatment/In Follow-Up|1|||
48353993|NCT03604692|155492820|FG003|Overall Study|Continuing Treatment/In Follow-Up|1|||
48353994|NCT03604692|155492821|FG004|Overall Study|Continuing Treatment/In Follow-Up|0|||
48353995|NCT03604692|155492822|FG005|Overall Study|Continuing Treatment/In Follow-Up|0|||
48353996|NCT03604692|155492817|FG000|Overall Study|Not Treated|0|||
48353997|NCT03604692|155492818|FG001|Overall Study|Not Treated|0|||
48353998|NCT03604692|155492819|FG002|Overall Study|Not Treated|0|||
48353999|NCT03604692|155492820|FG003|Overall Study|Not Treated|0|||
48354000|NCT03604692|155492821|FG004|Overall Study|Not Treated|1|||
48354001|NCT03604692|155492822|FG005|Overall Study|Not Treated|0|||
48354002|NCT01948076|155492823|FG000|Overall Study|Withdrawal by Subject|0|||
48354003|NCT01948076|155492824|FG001|Overall Study|Withdrawal by Subject|1|||
48354004|NCT02209181|155492837|FG000|Overall Study|Adverse Event|1|||
48354005|NCT02209181|155492838|FG001|Overall Study|Adverse Event|0|||
48354006|NCT02209181|155492839|FG002|Overall Study|Adverse Event|1|||
48354007|NCT02209181|155492840|FG003|Overall Study|Adverse Event|0|||
48354008|NCT02209181|155492837|FG000|Overall Study|Withdrawal by Subject|0|||
48354009|NCT02209181|155492838|FG001|Overall Study|Withdrawal by Subject|1|||
48354010|NCT02209181|155492839|FG002|Overall Study|Withdrawal by Subject|0|||
48354011|NCT02209181|155492840|FG003|Overall Study|Withdrawal by Subject|0|||
48354012|NCT04427072|155492841|FG000|Randomized Treatment Phase|Progressive disease|9|||
48354013|NCT04427072|155492842|FG001|Randomized Treatment Phase|Progressive disease|4|||
48354014|NCT04427072|155492841|FG000|Randomized Treatment Phase|Adverse Event|3|||
48676250|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Physician Decision|0|||
48676251|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Physician Decision|0|||
48676252|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Physician Decision|0|||
48354015|NCT04427072|155492842|FG001|Randomized Treatment Phase|Adverse Event|1|||
48354016|NCT04427072|155492841|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
48354017|NCT04427072|155492842|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
48354018|NCT04427072|155492841|FG000|Randomized Treatment Phase|Death|0|||
48354019|NCT04427072|155492842|FG001|Randomized Treatment Phase|Death|1|||
48354020|NCT04427072|155492841|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
48354021|NCT04427072|155492842|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
48354022|NCT04427072|155492841|FG000|Extension Treatment Phase|Progressive disease|0|||
48676253|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Physician Decision|0|||
48354023|NCT04427072|155492842|FG001|Extension Treatment Phase|Progressive disease|5|||
48354024|NCT02559310|155492843|FG000|Overall Study|Death|4|||
48354025|NCT02559310|155492844|FG001|Overall Study|Death|3|||
48354026|NCT02559310|155492843|FG000|Overall Study|Lost to Follow-up|5|||
48354027|NCT02559310|155492844|FG001|Overall Study|Lost to Follow-up|3|||
48354028|NCT02559310|155492843|FG000|Overall Study|Physician Decision|2|||
48354029|NCT02559310|155492844|FG001|Overall Study|Physician Decision|1|||
48354030|NCT02559310|155492843|FG000|Overall Study|Withdrawal by Subject|13|||
48354031|NCT02559310|155492844|FG001|Overall Study|Withdrawal by Subject|9|||
48354032|NCT02559310|155492843|FG000|Overall Study|Sponsor Decision|0|||
48354033|NCT02559310|155492844|FG001|Overall Study|Sponsor Decision|1|||
48354034|NCT02559310|155492843|FG000|Overall Study|Randomized but not treated|3|||
48354035|NCT02559310|155492844|FG001|Overall Study|Randomized but not treated|2|||
48354036|NCT03277352|155492852|FG000|Overall Study|Study Terminated By Sponsor|2|||
48354037|NCT03277352|155492852|FG000|Overall Study|Withdrawal by Subject|4|||
48354038|NCT03277352|155492852|FG000|Overall Study|Death|4|||
48354045|NCT02284009|155492856|FG000|Overall Study|Adverse Event|3|||
48354046|NCT02284009|155492857|FG001|Overall Study|Adverse Event|0|||
48354047|NCT02284009|155492856|FG000|Overall Study|Lost to Follow-up|1|||
48354048|NCT02284009|155492857|FG001|Overall Study|Lost to Follow-up|3|||
48354049|NCT02284009|155492856|FG000|Overall Study|Physician Decision|0|||
48354050|NCT02284009|155492857|FG001|Overall Study|Physician Decision|2|||
48354051|NCT02284009|155492856|FG000|Overall Study|Withdrawal by Subject|2|||
48354052|NCT02284009|155492857|FG001|Overall Study|Withdrawal by Subject|5|||
48354053|NCT02397447|155492858|FG000|Overall Study|Lost to Follow-up|2|||
48354054|NCT02397447|155492859|FG001|Overall Study|Lost to Follow-up|2|||
48354055|NCT03614676|155494652|FG000|Overall Study|Delivery before planned visit|2|||
48354056|NCT03614676|155494653|FG001|Overall Study|Delivery before planned visit|0|||
48354057|NCT03614676|155494652|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
48354058|NCT03614676|155494653|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
48354059|NCT03614676|155494652|FG000|Overall Study|Migrated / moved from the study area|30|||
48354060|NCT03614676|155494653|FG001|Overall Study|Migrated / moved from the study area|22|||
48354061|NCT03614676|155494652|FG000|Overall Study|Lost to Follow-up|17|||
48354062|NCT03614676|155494653|FG001|Overall Study|Lost to Follow-up|42|||
48354063|NCT03614676|155494652|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
48354064|NCT03614676|155494653|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
48354065|NCT03614676|155494652|FG000|Overall Study|Other|16|||
48354066|NCT03614676|155494653|FG001|Overall Study|Other|47|||
48354067|NCT03614676|155494652|FG000|Overall Study|Protocol Violation|0|||
48354068|NCT03614676|155494653|FG001|Overall Study|Protocol Violation|2|||
48354069|NCT03614676|155494652|FG000|Overall Study|Neonatal event of interest|0|||
48354070|NCT03614676|155494653|FG001|Overall Study|Neonatal event of interest|6|||
48354071|NCT03614676|155494652|FG000|Overall Study|Death in infant greater than 28 days old|0|||
48354072|NCT03614676|155494653|FG001|Overall Study|Death in infant greater than 28 days old|12|||
48354073|NCT03614676|155494652|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
48354074|NCT03614676|155494653|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
48354075|NCT01845805|155494657|FG000|Overall Study|Withdrawal by Subject|1|||
48354076|NCT01845805|155494658|FG001|Overall Study|Withdrawal by Subject|2|||
48354077|NCT01845805|155494657|FG000|Overall Study|Disease Progression|13|||
48354078|NCT01845805|155494658|FG001|Overall Study|Disease Progression|14|||
48354079|NCT01845805|155494657|FG000|Overall Study|Drug-related Toxicity|4|||
48354080|NCT01845805|155494658|FG001|Overall Study|Drug-related Toxicity|0|||
48354081|NCT03167151|155494662|FG000|Overall Study|Withdrawal by Subject|1|||
48354082|NCT03167151|155494663|FG001|Overall Study|Withdrawal by Subject|0|||
48354083|NCT03167151|155494664|FG002|Overall Study|Withdrawal by Subject|0|||
48354084|NCT03167151|155494662|FG000|Overall Study|No evidence of tumour at surgery|0|||
48354085|NCT03167151|155494663|FG001|Overall Study|No evidence of tumour at surgery|1|||
48354086|NCT03167151|155494664|FG002|Overall Study|No evidence of tumour at surgery|1|||
48354087|NCT00953147|155494665|FG000|Overall Study|Adverse Event|8|||
48354088|NCT00953147|155494666|FG001|Overall Study|Adverse Event|16|||
48354089|NCT00953147|155494667|FG002|Overall Study|Adverse Event|6|||
48354090|NCT00953147|155494665|FG000|Overall Study|Protocol Violation|2|||
48354091|NCT00953147|155494666|FG001|Overall Study|Protocol Violation|8|||
48354092|NCT00953147|155494667|FG002|Overall Study|Protocol Violation|4|||
48354093|NCT00953147|155494665|FG000|Overall Study|Withdrawal by Subject|13|||
48354094|NCT00953147|155494666|FG001|Overall Study|Withdrawal by Subject|15|||
48354095|NCT00953147|155494667|FG002|Overall Study|Withdrawal by Subject|12|||
48383960|NCT04029116|155601516|FG000|Overall Study|Withdrawal by Subject|4|||
48354096|NCT00953147|155494665|FG000|Overall Study|Lost to Follow-up|8|||
48354097|NCT00953147|155494666|FG001|Overall Study|Lost to Follow-up|9|||
48354098|NCT00953147|155494667|FG002|Overall Study|Lost to Follow-up|4|||
48354099|NCT00953147|155494665|FG000|Overall Study|Physician Decision|2|||
48762134|NCT02608268|156978014|FG007|Overall Study|Physician Decision|0|||
48354100|NCT00953147|155494666|FG001|Overall Study|Physician Decision|7|||
48354101|NCT00953147|155494667|FG002|Overall Study|Physician Decision|3|||
48354102|NCT00953147|155494665|FG000|Overall Study|Other|4|||
48354103|NCT00953147|155494666|FG001|Overall Study|Other|11|||
48354104|NCT00953147|155494667|FG002|Overall Study|Other|13|||
48762135|NCT02608268|156978015|FG008|Overall Study|Physician Decision|0|||
48762136|NCT02608268|156978016|FG009|Overall Study|Physician Decision|0|||
48762137|NCT02608268|156978017|FG010|Overall Study|Physician Decision|1|||
48762138|NCT02608268|156978018|FG011|Overall Study|Physician Decision|0|||
48762139|NCT02608268|156978019|FG012|Overall Study|Physician Decision|0|||
48762140|NCT02608268|156978020|FG013|Overall Study|Physician Decision|1|||
48762141|NCT02608268|156978021|FG014|Overall Study|Physician Decision|0|||
48762142|NCT02608268|156978022|FG015|Overall Study|Physician Decision|0|||
48762143|NCT02608268|156978023|FG016|Overall Study|Physician Decision|0|||
48762144|NCT02608268|156978024|FG017|Overall Study|Physician Decision|0|||
48762145|NCT02608268|156978025|FG018|Overall Study|Physician Decision|0|||
48762146|NCT02608268|156978026|FG019|Overall Study|Physician Decision|0|||
48762147|NCT02608268|156978027|FG020|Overall Study|Physician Decision|0|||
48762148|NCT02608268|156978028|FG021|Overall Study|Physician Decision|0|||
48762149|NCT02608268|156978029|FG022|Overall Study|Physician Decision|1|||
48762150|NCT02608268|156978030|FG023|Overall Study|Physician Decision|1|||
48762151|NCT02608268|156978031|FG024|Overall Study|Physician Decision|1|||
48762152|NCT02608268|156978032|FG025|Overall Study|Physician Decision|0|||
48762153|NCT02608268|156978033|FG026|Overall Study|Physician Decision|0|||
48762154|NCT02608268|156978034|FG027|Overall Study|Physician Decision|2|||
48762155|NCT02608268|156978035|FG028|Overall Study|Physician Decision|1|||
48762156|NCT02608268|156978036|FG029|Overall Study|Physician Decision|1|||
48762157|NCT02608268|156978007|FG000|Overall Study|Progressive disease|12|||
48762158|NCT02608268|156978008|FG001|Overall Study|Progressive disease|8|||
48762159|NCT02608268|156978009|FG002|Overall Study|Progressive disease|13|||
48354105|NCT03602586|155494668|FG000|Overall Study|Withdrawal by Subject|3|||
48762160|NCT02608268|156978010|FG003|Overall Study|Progressive disease|5|||
48762161|NCT02608268|156978011|FG004|Overall Study|Progressive disease|2|||
48762162|NCT02608268|156978012|FG005|Overall Study|Progressive disease|4|||
48762163|NCT02608268|156978013|FG006|Overall Study|Progressive disease|6|||
48762164|NCT02608268|156978014|FG007|Overall Study|Progressive disease|2|||
48762165|NCT02608268|156978015|FG008|Overall Study|Progressive disease|5|||
48762166|NCT02608268|156978016|FG009|Overall Study|Progressive disease|6|||
48354106|NCT00516139|155494670|FG000|Overall Study|Adverse Event|27|||
48354107|NCT00516139|155494670|FG000|Overall Study|Lost to Follow-up|1|||
48354108|NCT00516139|155494670|FG000|Overall Study|Protocol Violation|1|||
48354109|NCT00516139|155494670|FG000|Overall Study|Withdrawal by Subject|8|||
48354110|NCT00516139|155494670|FG000|Overall Study|Lack of Efficacy|1|||
48354111|NCT00334542|155494672|FG000|Overall Study|Adverse Event|3|||
48354112|NCT00334542|155494672|FG000|Overall Study|Withdrawal by Subject|1|||
48354113|NCT00334542|155494672|FG000|Overall Study|New cancer diagnosis|1|||
48354114|NCT02370251|155494676|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
48354115|NCT02370251|155494676|FG000|Overall Study|Death|4|||
48354116|NCT01952847|155494677|FG000|Overall Study|Ineligible|1|||
48354117|NCT01952847|155494678|FG001|Overall Study|Ineligible|0|||
48354118|NCT01952847|155494679|FG002|Overall Study|Ineligible|0|||
48354119|NCT01952847|155494680|FG003|Overall Study|Ineligible|0|||
48354120|NCT01952847|155494677|FG000|Overall Study|Lack of Insurance Coverage|0|||
48354121|NCT01952847|155494678|FG001|Overall Study|Lack of Insurance Coverage|1|||
48354122|NCT01952847|155494679|FG002|Overall Study|Lack of Insurance Coverage|0|||
48354123|NCT01952847|155494680|FG003|Overall Study|Lack of Insurance Coverage|0|||
48354124|NCT01952847|155494677|FG000|Overall Study|Withdrawal by Subject|1|||
48354125|NCT01952847|155494678|FG001|Overall Study|Withdrawal by Subject|1|||
48354126|NCT01952847|155494679|FG002|Overall Study|Withdrawal by Subject|0|||
48354127|NCT01952847|155494680|FG003|Overall Study|Withdrawal by Subject|1|||
48354128|NCT01784523|155494681|FG000|Overall Study|Study closed early|7|||
48354129|NCT01784523|155494682|FG001|Overall Study|Study closed early|4|||
48354130|NCT05144945|155494685|FG000|Overall Study|Withdrawal by Subject|1|||
48354131|NCT05144945|155494686|FG001|Overall Study|Withdrawal by Subject|0|||
48354132|NCT01432626|155494687|FG000|Overall Study|LV function recovered|2|||
48354133|NCT01432626|155494687|FG000|Overall Study|Withdrawal by Subject|2|||
48354134|NCT01432626|155494687|FG000|Overall Study|Only 1 image competed|2|||
48354135|NCT01432626|155494687|FG000|Overall Study|Imaging agent not available|1|||
48354136|NCT01124097|155494688|FG000|Overall Study|Withdrawal by Subject|4|||
48354137|NCT01124097|155494689|FG001|Overall Study|Withdrawal by Subject|3|||
48354138|NCT01124097|155494690|FG002|Overall Study|Withdrawal by Subject|2|||
48354139|NCT01124097|155494691|FG003|Overall Study|Withdrawal by Subject|3|||
48354140|NCT01124097|155494688|FG000|Overall Study|Lack of Efficacy|2|||
48354141|NCT01124097|155494689|FG001|Overall Study|Lack of Efficacy|3|||
48354142|NCT01124097|155494690|FG002|Overall Study|Lack of Efficacy|1|||
48354143|NCT01124097|155494691|FG003|Overall Study|Lack of Efficacy|3|||
48354144|NCT01124097|155494688|FG000|Overall Study|Adverse Event|24|||
48354145|NCT01124097|155494689|FG001|Overall Study|Adverse Event|15|||
48354146|NCT01124097|155494690|FG002|Overall Study|Adverse Event|15|||
48354147|NCT01124097|155494691|FG003|Overall Study|Adverse Event|7|||
48354148|NCT01124097|155494688|FG000|Overall Study|Protocol Violation|2|||
48354149|NCT01124097|155494689|FG001|Overall Study|Protocol Violation|0|||
48354150|NCT01124097|155494690|FG002|Overall Study|Protocol Violation|2|||
48354151|NCT01124097|155494691|FG003|Overall Study|Protocol Violation|1|||
48354152|NCT01124097|155494688|FG000|Overall Study|Physician Decision|2|||
48354153|NCT01124097|155494689|FG001|Overall Study|Physician Decision|1|||
48354154|NCT01124097|155494690|FG002|Overall Study|Physician Decision|0|||
48354155|NCT01124097|155494691|FG003|Overall Study|Physician Decision|0|||
48354156|NCT02960893|155494692|FG000|Randomization Phase (8-week)|Adverse Event|5|||
48354157|NCT02960893|155494693|FG001|Randomization Phase (8-week)|Adverse Event|0|||
48354158|NCT02960893|155494692|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
48354159|NCT02960893|155494693|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
48354160|NCT02960893|155494692|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
48354161|NCT02960893|155494693|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
48354162|NCT02960893|155494692|FG000|Extension Phase (48-week)|Adverse Event|2|||
48354163|NCT02960893|155494693|FG001|Extension Phase (48-week)|Adverse Event|3|||
48354164|NCT02960893|155494692|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
48354165|NCT02960893|155494693|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
48354166|NCT02960893|155494692|FG000|Extension Phase (48-week)|Other Reason|2|||
48354167|NCT02960893|155494693|FG001|Extension Phase (48-week)|Other Reason|1|||
48676254|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
48676255|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
48676256|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
48676257|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
48354168|NCT02960893|155494692|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
48676258|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
48354169|NCT02960893|155494693|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
48354170|NCT02960893|155494692|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
48354171|NCT02960893|155494693|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
48354172|NCT02786004|155494694|FG000|Overall Study|Withdrawal by Subject|0|||
48354173|NCT02786004|155494695|FG001|Overall Study|Withdrawal by Subject|1|||
48354174|NCT01677299|155494696|FG000|Overall Study|Adverse Event|0|||
48354175|NCT01677299|155494697|FG001|Overall Study|Adverse Event|2|||
48354176|NCT01677299|155494698|FG002|Overall Study|Adverse Event|1|||
48676259|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
48354177|NCT01677299|155494699|FG003|Overall Study|Adverse Event|0|||
48354178|NCT01677299|155494696|FG000|Overall Study|Withdrawal by Subject|0|||
48354179|NCT01677299|155494697|FG001|Overall Study|Withdrawal by Subject|1|||
48354180|NCT01677299|155494698|FG002|Overall Study|Withdrawal by Subject|0|||
48354181|NCT01677299|155494699|FG003|Overall Study|Withdrawal by Subject|1|||
48354182|NCT00126659|155494702|FG000|Overall Study|Adverse Event|0|||
48354183|NCT00126659|155494703|FG001|Overall Study|Adverse Event|0|||
48354184|NCT00126659|155494704|FG002|Overall Study|Adverse Event|2|||
48676260|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
48676261|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
48354185|NCT01437423|155494707|FG000|Overall Study|Lost to Follow-up|12|||
48354186|NCT01437423|155494707|FG000|Overall Study|Off label usage|3|||
48354187|NCT02552147|155494712|FG000|First Intervention (7 Days)|Protocol Violation|1|||
48354188|NCT02552147|155494713|FG001|First Intervention (7 Days)|Protocol Violation|0|||
48354189|NCT02552147|155494712|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
48354190|NCT02552147|155494713|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
48354191|NCT00425607|155494718|FG000|Overall Study|Death|1|||
48354192|NCT00425607|155494718|FG000|Overall Study|Withdrawal by Subject|1|||
48354193|NCT02229578|155494719|FG000|Overall Study|Withdrawal by Subject|1|||
48354194|NCT02229578|155494720|FG001|Overall Study|Withdrawal by Subject|3|||
48354195|NCT02229578|155494719|FG000|Overall Study|Protocol Violation|2|||
48354196|NCT02229578|155494720|FG001|Overall Study|Protocol Violation|0|||
48354197|NCT00079339|155494721|FG000|Overall Study|Adverse Event|1|||
48354198|NCT00079339|155494722|FG001|Overall Study|Adverse Event|7|||
48354199|NCT00079339|155494723|FG002|Overall Study|Adverse Event|2|||
48354200|NCT00079339|155494721|FG000|Overall Study|Death|1|||
48383961|NCT04029116|155601517|FG001|Overall Study|Withdrawal by Subject|6|||
48383962|NCT04029116|155601516|FG000|Overall Study|Other|2|||
48383963|NCT04029116|155601517|FG001|Overall Study|Other|1|||
48383964|NCT01177384|155601518|FG000|Overall Study|Adverse Event|6|||
48383965|NCT01177384|155601519|FG001|Overall Study|Adverse Event|4|||
48383966|NCT01177384|155601518|FG000|Overall Study|Lack of Efficacy|0|||
48383967|NCT01177384|155601519|FG001|Overall Study|Lack of Efficacy|1|||
48383968|NCT01177384|155601518|FG000|Overall Study|Lost to Follow-up|3|||
48383969|NCT01177384|155601519|FG001|Overall Study|Lost to Follow-up|4|||
48383970|NCT01177384|155601518|FG000|Overall Study|Physician Decision|0|||
48383971|NCT01177384|155601519|FG001|Overall Study|Physician Decision|3|||
48383972|NCT01177384|155601518|FG000|Overall Study|Protocol Violation|0|||
48383973|NCT01177384|155601519|FG001|Overall Study|Protocol Violation|2|||
48383974|NCT01177384|155601518|FG000|Overall Study|Withdrawal by Subject|5|||
48383975|NCT01177384|155601519|FG001|Overall Study|Withdrawal by Subject|12|||
48383976|NCT01221727|155601520|FG000|Overall Study|Physician Decision|2|||
48383977|NCT01221727|155601521|FG001|Overall Study|Physician Decision|0|||
48383978|NCT01221727|155601520|FG000|Overall Study|Withdrawal by Subject|1|||
48383979|NCT01221727|155601521|FG001|Overall Study|Withdrawal by Subject|1|||
48383980|NCT00590044|155601523|FG000|Overall Study|Withdrawal by Subject|2|||
48383981|NCT00590044|155601524|FG001|Overall Study|Withdrawal by Subject|2|||
48383982|NCT00590044|155601523|FG000|Overall Study|wrong insulin arm assigned|1|||
48383983|NCT00590044|155601524|FG001|Overall Study|wrong insulin arm assigned|0|||
48383984|NCT00590044|155601523|FG000|Overall Study|Protocol Violation|1|||
48383985|NCT00590044|155601524|FG001|Overall Study|Protocol Violation|0|||
48383986|NCT00773136|155601525|FG000|Overall Study|Physician Decision|2|||
48383987|NCT01514136|155601526|FG000|Test Period 1; Test A|Protocol Violation|1|||
48383988|NCT01514136|155601527|FG001|Test Period 1; Test A|Protocol Violation|0|||
48676262|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
48676263|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
48354201|NCT00079339|155494722|FG001|Overall Study|Death|0|||
48354202|NCT00079339|155494723|FG002|Overall Study|Death|0|||
48354203|NCT00079339|155494721|FG000|Overall Study|Non-compliance|0|||
48354204|NCT00079339|155494722|FG001|Overall Study|Non-compliance|0|||
48354205|NCT00079339|155494723|FG002|Overall Study|Non-compliance|1|||
48354206|NCT00079339|155494721|FG000|Overall Study|Withdrawal by Subject|0|||
48354207|NCT00079339|155494722|FG001|Overall Study|Withdrawal by Subject|4|||
48354208|NCT00079339|155494723|FG002|Overall Study|Withdrawal by Subject|1|||
48354209|NCT00079339|155494721|FG000|Overall Study|Disease progression|3|||
48354210|NCT00079339|155494722|FG001|Overall Study|Disease progression|28|||
48354211|NCT00079339|155494723|FG002|Overall Study|Disease progression|2|||
48354212|NCT00940875|155494725|FG000|Treatment Phase|Adverse Event|9|||
48354213|NCT00940875|155494726|FG001|Treatment Phase|Adverse Event|3|||
48354214|NCT00940875|155494725|FG000|Treatment Phase|Death|3|||
48383989|NCT01514136|155601528|FG002|Test Period 1; Test A|Protocol Violation|0|||
48383990|NCT01514136|155601529|FG003|Test Period 1; Test A|Protocol Violation|0|||
48383991|NCT01514136|155601530|FG004|Test Period 1; Test A|Protocol Violation|0|||
48383992|NCT01514136|155601531|FG005|Test Period 1; Test A|Protocol Violation|0|||
48383993|NCT01514136|155601532|FG006|Test Period 1; Test A|Protocol Violation|0|||
48383994|NCT01514136|155601533|FG007|Test Period 1; Test A|Protocol Violation|0|||
48383995|NCT01514136|155601526|FG000|Test Period 1; Test A|Break from study holiday|2|||
48354215|NCT00940875|155494726|FG001|Treatment Phase|Death|5|||
48354216|NCT00940875|155494725|FG000|Treatment Phase|Lack of Efficacy|1|||
48354217|NCT00940875|155494726|FG001|Treatment Phase|Lack of Efficacy|0|||
48354218|NCT00940875|155494725|FG000|Treatment Phase|Withdrawal by Subject|3|||
48354219|NCT00940875|155494726|FG001|Treatment Phase|Withdrawal by Subject|0|||
48354220|NCT00940875|155494725|FG000|Treatment Phase|Disease progression|9|||
48354221|NCT00940875|155494726|FG001|Treatment Phase|Disease progression|11|||
48354222|NCT00940875|155494725|FG000|Treatment Phase|Physician Decision|1|||
48354223|NCT00940875|155494726|FG001|Treatment Phase|Physician Decision|0|||
48354224|NCT00940875|155494725|FG000|Post-Study Treatment|Death|0|||
48354225|NCT00940875|155494726|FG001|Post-Study Treatment|Death|1|||
48354226|NCT00940875|155494725|FG000|Post-Study Treatment|Disease Progression|0|||
48354227|NCT00940875|155494726|FG001|Post-Study Treatment|Disease Progression|2|||
48354228|NCT01288209|155494728|FG000|Overall Study|Withdrawal by Subject|1|||
48354229|NCT01288209|155494729|FG001|Overall Study|Withdrawal by Subject|3|||
48354230|NCT01288209|155494728|FG000|Overall Study|Other|1|||
48354231|NCT01288209|155494729|FG001|Overall Study|Other|0|||
48354232|NCT03334253|155494733|FG000|Overall Study|Withdrawal by Subject|1|||
48354233|NCT03334253|155494734|FG001|Overall Study|Withdrawal by Subject|0|||
48354234|NCT03334253|155494733|FG000|Overall Study|Lost to Follow-up|4|||
48354235|NCT03334253|155494734|FG001|Overall Study|Lost to Follow-up|3|||
48354236|NCT03334253|155494733|FG000|Overall Study|Moved residence|2|||
48354237|NCT03334253|155494734|FG001|Overall Study|Moved residence|2|||
48354238|NCT01516749|155494736|FG000|Active Therapy|Lost to Follow-up|1|||
48354239|NCT01516749|155494736|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
48354240|NCT00351377|155494737|FG000|Overall Study|Adverse Event|5|||
48354241|NCT00351377|155494737|FG000|Overall Study|Death|1|||
48354242|NCT00351377|155494737|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48354243|NCT00731133|155494738|FG000|Overall Study|Withdrawal by Subject|10|||
48354244|NCT03809039|155494739|FG000|Part 1|Withdrawal by Subject|1|||
48354245|NCT03809039|155494740|FG001|Part 1|Withdrawal by Subject|0|||
48354246|NCT03809039|155494741|FG002|Part 1|Withdrawal by Subject|0|||
48354247|NCT03809039|155494742|FG003|Part 1|Withdrawal by Subject|1|||
48354248|NCT03809039|155494743|FG004|Part 1|Withdrawal by Subject|0|||
48354249|NCT03809039|155494744|FG005|Part 1|Withdrawal by Subject|0|||
48354250|NCT03809039|155494745|FG006|Part 1|Withdrawal by Subject|0|||
48354251|NCT03809039|155494746|FG007|Part 1|Withdrawal by Subject|0|||
48354252|NCT03809039|155494747|FG008|Part 1|Withdrawal by Subject|0|||
48354253|NCT03809039|155494739|FG000|Part 3|Withdrawn by study termination|0|||
48354254|NCT03809039|155494740|FG001|Part 3|Withdrawn by study termination|0|||
48354255|NCT03809039|155494741|FG002|Part 3|Withdrawn by study termination|0|||
48354256|NCT03809039|155494742|FG003|Part 3|Withdrawn by study termination|0|||
48354257|NCT03809039|155494743|FG004|Part 3|Withdrawn by study termination|0|||
48676264|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676265|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48354258|NCT03809039|155494744|FG005|Part 3|Withdrawn by study termination|0|||
48354259|NCT03809039|155494745|FG006|Part 3|Withdrawn by study termination|0|||
48354260|NCT03809039|155494746|FG007|Part 3|Withdrawn by study termination|2|||
48354261|NCT03809039|155494747|FG008|Part 3|Withdrawn by study termination|6|||
48354262|NCT01790295|155494748|FG000|Overall Study|Adverse Event|1|||
48354263|NCT01790295|155494748|FG000|Overall Study|Death|4|||
48354264|NCT01790295|155494748|FG000|Overall Study|Lack of Efficacy|2|||
48354265|NCT01790295|155494748|FG000|Overall Study|Study closure|4|||
48354266|NCT01327612|155494749|FG000|Overall Study|Withdrawal by Subject|0|||
48354267|NCT01327612|155494750|FG001|Overall Study|Withdrawal by Subject|0|||
48354268|NCT01327612|155494751|FG002|Overall Study|Withdrawal by Subject|0|||
48354269|NCT01327612|155494752|FG003|Overall Study|Withdrawal by Subject|0|||
48354270|NCT01327612|155494753|FG004|Overall Study|Withdrawal by Subject|0|||
48354271|NCT01327612|155494754|FG005|Overall Study|Withdrawal by Subject|1|||
48354272|NCT01327612|155494755|FG006|Overall Study|Withdrawal by Subject|0|||
48676266|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48354273|NCT01327612|155494749|FG000|Overall Study|Disease Progression|1|||
48676267|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676268|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676269|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676270|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48354274|NCT01327612|155494750|FG001|Overall Study|Disease Progression|1|||
48354275|NCT01327612|155494751|FG002|Overall Study|Disease Progression|1|||
48354276|NCT01327612|155494752|FG003|Overall Study|Disease Progression|0|||
48354277|NCT01327612|155494753|FG004|Overall Study|Disease Progression|1|||
48354278|NCT01327612|155494754|FG005|Overall Study|Disease Progression|2|||
48354279|NCT01327612|155494755|FG006|Overall Study|Disease Progression|2|||
48354280|NCT01327612|155494749|FG000|Overall Study|Administrative Decision|0|||
48354281|NCT01327612|155494750|FG001|Overall Study|Administrative Decision|0|||
48354282|NCT01327612|155494751|FG002|Overall Study|Administrative Decision|0|||
48354283|NCT01327612|155494752|FG003|Overall Study|Administrative Decision|1|||
48354284|NCT01327612|155494753|FG004|Overall Study|Administrative Decision|0|||
48354285|NCT01327612|155494754|FG005|Overall Study|Administrative Decision|0|||
48354286|NCT01327612|155494755|FG006|Overall Study|Administrative Decision|0|||
48354287|NCT01327612|155494749|FG000|Overall Study|Death|0|||
48354288|NCT01327612|155494750|FG001|Overall Study|Death|0|||
48354289|NCT01327612|155494751|FG002|Overall Study|Death|0|||
48354290|NCT01327612|155494752|FG003|Overall Study|Death|0|||
48354291|NCT01327612|155494753|FG004|Overall Study|Death|1|||
48354292|NCT01327612|155494754|FG005|Overall Study|Death|0|||
48354293|NCT01327612|155494755|FG006|Overall Study|Death|0|||
48354294|NCT01843777|155494758|FG000|Overall Study|Withdrawal by Subject|1|||
48354295|NCT01843777|155494759|FG001|Overall Study|Withdrawal by Subject|0|||
48354296|NCT01199068|155494764|FG000|Overall Study|Unacceptable toxicity|0|||
48383996|NCT01514136|155601527|FG001|Test Period 1; Test A|Break from study holiday|0|||
48383997|NCT01514136|155601528|FG002|Test Period 1; Test A|Break from study holiday|0|||
48383998|NCT01514136|155601529|FG003|Test Period 1; Test A|Break from study holiday|0|||
48383999|NCT01514136|155601530|FG004|Test Period 1; Test A|Break from study holiday|0|||
48384000|NCT01514136|155601531|FG005|Test Period 1; Test A|Break from study holiday|0|||
48384001|NCT01514136|155601532|FG006|Test Period 1; Test A|Break from study holiday|0|||
48384002|NCT01514136|155601533|FG007|Test Period 1; Test A|Break from study holiday|0|||
48384003|NCT01514136|155601526|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
48354297|NCT01199068|155494765|FG001|Overall Study|Unacceptable toxicity|0|||
48354298|NCT01199068|155494766|FG002|Overall Study|Unacceptable toxicity|2|||
48354299|NCT01199068|155494764|FG000|Overall Study|Progressive disease|3|||
48676271|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
48676272|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
48354300|NCT01199068|155494765|FG001|Overall Study|Progressive disease|3|||
48354301|NCT01199068|155494766|FG002|Overall Study|Progressive disease|6|||
48384004|NCT01514136|155601527|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
48429376|NCT01070550|155760359|FG004|Overall Study|Not categorized|0|||
48354302|NCT01199068|155494764|FG000|Overall Study|Withdrawal by Subject|0|||
48354303|NCT01199068|155494765|FG001|Overall Study|Withdrawal by Subject|0|||
48354304|NCT01199068|155494766|FG002|Overall Study|Withdrawal by Subject|1|||
48354305|NCT01967069|155494767|FG000|Overall Study|Adverse Event|2|||
48354306|NCT01967069|155494768|FG001|Overall Study|Adverse Event|2|||
48354307|NCT01967069|155494767|FG000|Overall Study|Lost to Follow-up|5|||
48354308|NCT01967069|155494768|FG001|Overall Study|Lost to Follow-up|2|||
48354309|NCT01967069|155494767|FG000|Overall Study|Withdrawal by Subject|1|||
48354310|NCT01967069|155494768|FG001|Overall Study|Withdrawal by Subject|3|||
48354311|NCT01967069|155494767|FG000|Overall Study|Lack of Efficacy|0|||
48354312|NCT01967069|155494768|FG001|Overall Study|Lack of Efficacy|1|||
48354313|NCT01475461|155494770|FG000|Run-in Period|Not meet eligibility criteria|16|||
48354314|NCT01475461|155494771|FG001|Run-in Period|Not meet eligibility criteria|0|||
48354315|NCT01475461|155494772|FG002|Run-in Period|Not meet eligibility criteria|0|||
48354316|NCT01475461|155494773|FG003|Run-in Period|Not meet eligibility criteria|0|||
48354317|NCT01475461|155494774|FG004|Run-in Period|Not meet eligibility criteria|0|||
48354318|NCT01475461|155494775|FG005|Run-in Period|Not meet eligibility criteria|0|||
48354319|NCT01475461|155494776|FG006|Run-in Period|Not meet eligibility criteria|0|||
48354320|NCT01475461|155494770|FG000|Run-in Period|Lost to Follow-up|7|||
48354321|NCT01475461|155494771|FG001|Run-in Period|Lost to Follow-up|0|||
48354322|NCT01475461|155494772|FG002|Run-in Period|Lost to Follow-up|0|||
48354323|NCT01475461|155494773|FG003|Run-in Period|Lost to Follow-up|0|||
48354324|NCT01475461|155494774|FG004|Run-in Period|Lost to Follow-up|0|||
48354325|NCT01475461|155494775|FG005|Run-in Period|Lost to Follow-up|0|||
48354326|NCT01475461|155494776|FG006|Run-in Period|Lost to Follow-up|0|||
48354327|NCT01475461|155494770|FG000|Run-in Period|Withdrawal by Subject|11|||
48354328|NCT01475461|155494771|FG001|Run-in Period|Withdrawal by Subject|0|||
48354329|NCT01475461|155494772|FG002|Run-in Period|Withdrawal by Subject|0|||
48354330|NCT01475461|155494773|FG003|Run-in Period|Withdrawal by Subject|0|||
48354331|NCT01475461|155494774|FG004|Run-in Period|Withdrawal by Subject|0|||
48354332|NCT01475461|155494775|FG005|Run-in Period|Withdrawal by Subject|0|||
48354333|NCT01475461|155494776|FG006|Run-in Period|Withdrawal by Subject|0|||
48354334|NCT01475461|155494770|FG000|Run-in Period|Other|3|||
48354335|NCT01475461|155494771|FG001|Run-in Period|Other|0|||
48354336|NCT01475461|155494772|FG002|Run-in Period|Other|0|||
48676273|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
48676274|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676275|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48354337|NCT01475461|155494773|FG003|Run-in Period|Other|0|||
48354338|NCT01475461|155494774|FG004|Run-in Period|Other|0|||
48354339|NCT01475461|155494775|FG005|Run-in Period|Other|0|||
48354340|NCT01475461|155494776|FG006|Run-in Period|Other|0|||
48354341|NCT01475461|155494770|FG000|Run-in Period|Protocol Violation|4|||
48354342|NCT01475461|155494771|FG001|Run-in Period|Protocol Violation|0|||
48354343|NCT01475461|155494772|FG002|Run-in Period|Protocol Violation|0|||
48354344|NCT01475461|155494773|FG003|Run-in Period|Protocol Violation|0|||
48354345|NCT01475461|155494774|FG004|Run-in Period|Protocol Violation|0|||
48354346|NCT01475461|155494775|FG005|Run-in Period|Protocol Violation|0|||
48354347|NCT01475461|155494776|FG006|Run-in Period|Protocol Violation|0|||
48354348|NCT01475461|155494770|FG000|Treatment Period|Death|0|||
48354349|NCT01475461|155494771|FG001|Treatment Period|Death|0|||
48354350|NCT01475461|155494772|FG002|Treatment Period|Death|0|||
48354351|NCT01475461|155494773|FG003|Treatment Period|Death|1|||
48354352|NCT01475461|155494774|FG004|Treatment Period|Death|0|||
48354353|NCT01475461|155494775|FG005|Treatment Period|Death|0|||
48354354|NCT01475461|155494776|FG006|Treatment Period|Death|0|||
48354355|NCT01475461|155494770|FG000|Treatment Period|Lost to Follow-up|0|||
48354356|NCT01475461|155494771|FG001|Treatment Period|Lost to Follow-up|3|||
48354357|NCT01475461|155494772|FG002|Treatment Period|Lost to Follow-up|2|||
48354358|NCT01475461|155494773|FG003|Treatment Period|Lost to Follow-up|3|||
48354359|NCT01475461|155494774|FG004|Treatment Period|Lost to Follow-up|1|||
48354360|NCT01475461|155494775|FG005|Treatment Period|Lost to Follow-up|2|||
48354361|NCT01475461|155494776|FG006|Treatment Period|Lost to Follow-up|1|||
48354362|NCT01475461|155494770|FG000|Treatment Period|Withdrawal by Subject|0|||
48354363|NCT01475461|155494771|FG001|Treatment Period|Withdrawal by Subject|2|||
48354364|NCT01475461|155494772|FG002|Treatment Period|Withdrawal by Subject|2|||
48354365|NCT01475461|155494773|FG003|Treatment Period|Withdrawal by Subject|0|||
48354366|NCT01475461|155494774|FG004|Treatment Period|Withdrawal by Subject|2|||
48354367|NCT01475461|155494775|FG005|Treatment Period|Withdrawal by Subject|2|||
48354368|NCT01475461|155494776|FG006|Treatment Period|Withdrawal by Subject|0|||
48354369|NCT01475461|155494770|FG000|Treatment Period|Other|0|||
48354370|NCT01475461|155494771|FG001|Treatment Period|Other|1|||
48354371|NCT01475461|155494772|FG002|Treatment Period|Other|0|||
48354372|NCT01475461|155494773|FG003|Treatment Period|Other|0|||
48354373|NCT01475461|155494774|FG004|Treatment Period|Other|0|||
48354374|NCT01475461|155494775|FG005|Treatment Period|Other|0|||
48354375|NCT01475461|155494776|FG006|Treatment Period|Other|0|||
48354376|NCT01475461|155494770|FG000|Treatment Period|Protocol Violation|0|||
48354377|NCT01475461|155494771|FG001|Treatment Period|Protocol Violation|1|||
48384005|NCT01514136|155601528|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
48384006|NCT01514136|155601529|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
48384007|NCT01514136|155601530|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
48384008|NCT01514136|155601531|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
48384009|NCT01514136|155601532|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
48384010|NCT01514136|155601533|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
48384011|NCT01514136|155601526|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
48384012|NCT01514136|155601527|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
48384013|NCT01514136|155601528|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
48384014|NCT01514136|155601529|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
48384015|NCT01514136|155601530|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
48384016|NCT01514136|155601531|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
48384017|NCT01514136|155601532|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
48384018|NCT01514136|155601533|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
48384019|NCT01514136|155601526|FG000|Test Period 2; Test A*|Adverse Event|0|||
48384020|NCT01514136|155601527|FG001|Test Period 2; Test A*|Adverse Event|0|||
48384021|NCT01514136|155601528|FG002|Test Period 2; Test A*|Adverse Event|0|||
48384022|NCT01514136|155601529|FG003|Test Period 2; Test A*|Adverse Event|0|||
48384023|NCT01514136|155601530|FG004|Test Period 2; Test A*|Adverse Event|1|||
48384024|NCT01514136|155601531|FG005|Test Period 2; Test A*|Adverse Event|0|||
48384025|NCT01514136|155601532|FG006|Test Period 2; Test A*|Adverse Event|0|||
48384026|NCT01514136|155601533|FG007|Test Period 2; Test A*|Adverse Event|0|||
48676276|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676277|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676278|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676279|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676280|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
48676281|NCT04405076|156667260|FG000|Part A (Blinded Phase)|Other than Specified|0|||
48676282|NCT04405076|156667261|FG001|Part A (Blinded Phase)|Other than Specified|0|||
48676283|NCT04405076|156667262|FG002|Part A (Blinded Phase)|Other than Specified|3|||
48676284|NCT04405076|156667263|FG003|Part A (Blinded Phase)|Other than Specified|0|||
48676285|NCT04405076|156667264|FG004|Part A (Blinded Phase)|Other than Specified|0|||
48676286|NCT04405076|156667265|FG005|Part A (Blinded Phase)|Other than Specified|0|||
48676287|NCT04405076|156667266|FG006|Part A (Blinded Phase)|Other than Specified|0|||
48354378|NCT01475461|155494772|FG002|Treatment Period|Protocol Violation|0|||
48354379|NCT01475461|155494773|FG003|Treatment Period|Protocol Violation|0|||
48354380|NCT01475461|155494774|FG004|Treatment Period|Protocol Violation|0|||
48354381|NCT01475461|155494775|FG005|Treatment Period|Protocol Violation|0|||
48354382|NCT01475461|155494776|FG006|Treatment Period|Protocol Violation|1|||
48354383|NCT01475461|155494770|FG000|Treatment Period|Lack of Efficacy|0|||
48354384|NCT01475461|155494771|FG001|Treatment Period|Lack of Efficacy|2|||
48354385|NCT01475461|155494772|FG002|Treatment Period|Lack of Efficacy|0|||
48354386|NCT01475461|155494773|FG003|Treatment Period|Lack of Efficacy|2|||
48354387|NCT01475461|155494774|FG004|Treatment Period|Lack of Efficacy|1|||
48354388|NCT01475461|155494775|FG005|Treatment Period|Lack of Efficacy|1|||
48354389|NCT01475461|155494776|FG006|Treatment Period|Lack of Efficacy|0|||
48354390|NCT01475461|155494770|FG000|Treatment Period|Medication Error|0|||
48354391|NCT01475461|155494771|FG001|Treatment Period|Medication Error|0|||
48354392|NCT01475461|155494772|FG002|Treatment Period|Medication Error|0|||
48354393|NCT01475461|155494773|FG003|Treatment Period|Medication Error|1|||
48354394|NCT01475461|155494774|FG004|Treatment Period|Medication Error|0|||
48354395|NCT01475461|155494775|FG005|Treatment Period|Medication Error|0|||
48354396|NCT01475461|155494776|FG006|Treatment Period|Medication Error|0|||
48354397|NCT01475461|155494770|FG000|Treatment Period|Adverse Event|0|||
48354398|NCT01475461|155494771|FG001|Treatment Period|Adverse Event|0|||
48354399|NCT01475461|155494772|FG002|Treatment Period|Adverse Event|0|||
48354400|NCT01475461|155494773|FG003|Treatment Period|Adverse Event|1|||
48354401|NCT01475461|155494774|FG004|Treatment Period|Adverse Event|0|||
48354402|NCT01475461|155494775|FG005|Treatment Period|Adverse Event|0|||
48354403|NCT01475461|155494776|FG006|Treatment Period|Adverse Event|0|||
48354404|NCT00420784|155494777|FG000|Overall Study|Adverse Event|11|||
48354405|NCT00420784|155494778|FG001|Overall Study|Adverse Event|29|||
48354406|NCT00420784|155494779|FG002|Overall Study|Adverse Event|10|||
48354407|NCT00420784|155494780|FG003|Overall Study|Adverse Event|5|||
48354408|NCT00420784|155494777|FG000|Overall Study|Withdrawal by Subject|0|||
48354409|NCT00420784|155494778|FG001|Overall Study|Withdrawal by Subject|1|||
48354410|NCT00420784|155494779|FG002|Overall Study|Withdrawal by Subject|0|||
48354411|NCT00420784|155494780|FG003|Overall Study|Withdrawal by Subject|0|||
48354412|NCT00420784|155494777|FG000|Overall Study|Lost to Follow-up|0|||
48354413|NCT00420784|155494778|FG001|Overall Study|Lost to Follow-up|0|||
48354414|NCT00420784|155494779|FG002|Overall Study|Lost to Follow-up|2|||
48354415|NCT00420784|155494780|FG003|Overall Study|Lost to Follow-up|1|||
48354416|NCT00420784|155494777|FG000|Overall Study|Virologic Stopping Rule|17|||
48354417|NCT00420784|155494778|FG001|Overall Study|Virologic Stopping Rule|26|||
48354418|NCT00420784|155494779|FG002|Overall Study|Virologic Stopping Rule|41|||
48354419|NCT00420784|155494780|FG003|Overall Study|Virologic Stopping Rule|67|||
48354420|NCT00420784|155494777|FG000|Overall Study|Other|1|||
48354421|NCT00420784|155494778|FG001|Overall Study|Other|2|||
48354422|NCT00420784|155494779|FG002|Overall Study|Other|0|||
48354423|NCT00420784|155494780|FG003|Overall Study|Other|5|||
48354424|NCT00992992|155494783|FG000|Overall Study|Lost to Follow-up|3|||
48384027|NCT01514136|155601526|FG000|Test Period 2; Test A*|Holiday|0|||
48384028|NCT01514136|155601527|FG001|Test Period 2; Test A*|Holiday|0|||
48384029|NCT01514136|155601528|FG002|Test Period 2; Test A*|Holiday|0|||
48384030|NCT01514136|155601529|FG003|Test Period 2; Test A*|Holiday|0|||
48384031|NCT01514136|155601530|FG004|Test Period 2; Test A*|Holiday|1|||
48384032|NCT01514136|155601531|FG005|Test Period 2; Test A*|Holiday|0|||
48384033|NCT01514136|155601532|FG006|Test Period 2; Test A*|Holiday|0|||
48384034|NCT01514136|155601533|FG007|Test Period 2; Test A*|Holiday|0|||
48384035|NCT01514136|155601526|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
48384036|NCT01514136|155601527|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
48384037|NCT01514136|155601528|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
48384038|NCT01514136|155601529|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
48384039|NCT01514136|155601530|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
48384040|NCT01514136|155601531|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
48384041|NCT01514136|155601532|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
48384042|NCT01514136|155601533|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
48676288|NCT04405076|156667267|FG007|Part A (Blinded Phase)|Other than Specified|0|||
48676289|NCT04405076|156667268|FG008|Part A (Blinded Phase)|Other than Specified|0|||
48354425|NCT00992992|155494783|FG000|Overall Study|Death|16|||
48354426|NCT00992992|155494783|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
48354427|NCT00992992|155494783|FG000|Overall Study|Sponsor Closed the Study|4|||
48354428|NCT01304498|155494784|FG000|Overall Study|Adverse Event|1|||
48354429|NCT01304498|155494785|FG001|Overall Study|Adverse Event|1|||
48354430|NCT01304498|155494784|FG000|Overall Study|Withdrawal by Subject|2|||
48354431|NCT01304498|155494785|FG001|Overall Study|Withdrawal by Subject|3|||
48354432|NCT01304498|155494784|FG000|Overall Study|Protocol Violation|1|||
48354433|NCT01304498|155494785|FG001|Overall Study|Protocol Violation|0|||
48354434|NCT01304498|155494784|FG000|Overall Study|Lost to Follow-up|2|||
48354435|NCT01304498|155494785|FG001|Overall Study|Lost to Follow-up|1|||
48354436|NCT00839956|155494787|FG000|Overall Study|Adverse Event|2|||
48354437|NCT00839956|155494787|FG000|Overall Study|Lack of Efficacy|6|||
48354438|NCT00839956|155494787|FG000|Overall Study|Physician Decision|1|||
48354439|NCT00839956|155494787|FG000|Overall Study|Withdrawal by Subject|3|||
48354440|NCT00935532|155494788|FG000|Overall Study|Adverse Event|11|||
48354441|NCT00935532|155494789|FG001|Overall Study|Adverse Event|6|||
48354442|NCT00935532|155494788|FG000|Overall Study|Death|1|||
48354443|NCT00935532|155494789|FG001|Overall Study|Death|0|||
48354444|NCT00935532|155494788|FG000|Overall Study|Lost to Follow-up|1|||
48354445|NCT00935532|155494789|FG001|Overall Study|Lost to Follow-up|0|||
48354446|NCT00935532|155494788|FG000|Overall Study|Physician Decision|1|||
48354447|NCT00935532|155494789|FG001|Overall Study|Physician Decision|2|||
48354448|NCT00935532|155494788|FG000|Overall Study|Protocol Violation|2|||
48354449|NCT00935532|155494789|FG001|Overall Study|Protocol Violation|1|||
48354450|NCT00935532|155494788|FG000|Overall Study|Subject Decision|2|||
48354451|NCT00935532|155494789|FG001|Overall Study|Subject Decision|1|||
48354452|NCT00935532|155494788|FG000|Overall Study|Sponsor Decision|0|||
48354453|NCT00935532|155494789|FG001|Overall Study|Sponsor Decision|1|||
48354454|NCT00935532|155494788|FG000|Overall Study|Loss Glucose Control|4|||
48354455|NCT00935532|155494789|FG001|Overall Study|Loss Glucose Control|0|||
48354456|NCT00402051|155494790|FG000|Overall Study|Progressive Disease|13|||
48354457|NCT00402051|155494791|FG001|Overall Study|Progressive Disease|20|||
48354458|NCT00402051|155494790|FG000|Overall Study|Adverse Event|11|||
48354459|NCT00402051|155494791|FG001|Overall Study|Adverse Event|4|||
48354460|NCT00402051|155494790|FG000|Overall Study|Physician Decision|7|||
48676290|NCT04405076|156667260|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676291|NCT04405076|156667261|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676292|NCT04405076|156667262|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676293|NCT04405076|156667263|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
48676294|NCT04405076|156667264|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
48676295|NCT04405076|156667265|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
48676296|NCT04405076|156667266|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676297|NCT04405076|156667267|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48676298|NCT04405076|156667268|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
48354461|NCT00402051|155494791|FG001|Overall Study|Physician Decision|3|||
48354462|NCT00402051|155494790|FG000|Overall Study|Withdrawal by Subject|3|||
48354463|NCT00402051|155494791|FG001|Overall Study|Withdrawal by Subject|3|||
48354464|NCT00402051|155494790|FG000|Overall Study|Death - Related to Study Drug|1|||
48354465|NCT00402051|155494791|FG001|Overall Study|Death - Related to Study Drug|2|||
48354466|NCT00402051|155494790|FG000|Overall Study|Death Due to Study Disease|2|||
48354467|NCT00402051|155494791|FG001|Overall Study|Death Due to Study Disease|1|||
48354468|NCT00402051|155494790|FG000|Overall Study|Death Due to Adverse Event|0|||
48354469|NCT00402051|155494791|FG001|Overall Study|Death Due to Adverse Event|2|||
48354470|NCT00402051|155494790|FG000|Overall Study|Lost to Follow-up|1|||
48354471|NCT00402051|155494791|FG001|Overall Study|Lost to Follow-up|0|||
48354472|NCT04954326|155494798|FG000|Overall Study|Protocol Violation|0|||
48354473|NCT04954326|155494799|FG001|Overall Study|Protocol Violation|1|||
48354474|NCT04954326|155494798|FG000|Overall Study|Death|0|||
48354475|NCT04954326|155494799|FG001|Overall Study|Death|2|||
48354476|NCT04954326|155494798|FG000|Overall Study|Physician Decision|0|||
48354477|NCT04954326|155494799|FG001|Overall Study|Physician Decision|1|||
48354478|NCT00281320|155494800|FG000|Overall Study|Adverse Event|12|||
48354479|NCT00281320|155494801|FG001|Overall Study|Adverse Event|9|||
48354480|NCT00281320|155494800|FG000|Overall Study|Lack of Efficacy|4|||
48354481|NCT00281320|155494801|FG001|Overall Study|Lack of Efficacy|3|||
48354482|NCT00281320|155494800|FG000|Overall Study|Withdrawal by Subject|5|||
48354483|NCT00281320|155494801|FG001|Overall Study|Withdrawal by Subject|6|||
48354484|NCT00281320|155494800|FG000|Overall Study|Lost to Follow-up|1|||
48354485|NCT00281320|155494801|FG001|Overall Study|Lost to Follow-up|2|||
48354486|NCT00281320|155494800|FG000|Overall Study|Other|3|||
48354487|NCT00281320|155494801|FG001|Overall Study|Other|1|||
48354488|NCT00798434|155494802|FG000|Double-Blind|Adverse Event|22|||
48354489|NCT00798434|155494803|FG001|Double-Blind|Adverse Event|46|||
48354490|NCT00798434|155494802|FG000|Double-Blind|Death|0|||
48354491|NCT00798434|155494803|FG001|Double-Blind|Death|1|||
48354492|NCT00798434|155494802|FG000|Double-Blind|Lost to Follow-up|1|||
48354493|NCT00798434|155494803|FG001|Double-Blind|Lost to Follow-up|0|||
48354494|NCT00798434|155494802|FG000|Double-Blind|Lack of Efficacy|8|||
48354495|NCT00798434|155494803|FG001|Double-Blind|Lack of Efficacy|12|||
48354496|NCT00798434|155494802|FG000|Double-Blind|Withdrawal by Subject|17|||
48354497|NCT00798434|155494803|FG001|Double-Blind|Withdrawal by Subject|14|||
48354498|NCT00798434|155494802|FG000|Double-Blind|Protocol Violation|1|||
48354499|NCT00798434|155494803|FG001|Double-Blind|Protocol Violation|4|||
48354500|NCT00798434|155494802|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
48354501|NCT00798434|155494803|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
48354502|NCT00798434|155494802|FG000|Double-Blind|Other|1|||
48354503|NCT00798434|155494803|FG001|Double-Blind|Other|0|||
48354504|NCT00798434|155494802|FG000|Double-Blind|Not Treated|3|||
48354505|NCT00798434|155494803|FG001|Double-Blind|Not Treated|6|||
48354506|NCT00798434|155494802|FG000|Open-Label|Adverse Event|33|||
48354507|NCT00798434|155494803|FG001|Open-Label|Adverse Event|11|||
48354508|NCT00798434|155494802|FG000|Open-Label|Lack of Efficacy|5|||
48354509|NCT00798434|155494803|FG001|Open-Label|Lack of Efficacy|11|||
48354510|NCT00798434|155494802|FG000|Open-Label|Withdrawal by Subject|2|||
48354511|NCT00798434|155494803|FG001|Open-Label|Withdrawal by Subject|7|||
48354512|NCT00798434|155494802|FG000|Open-Label|Protocol Violation|1|||
48354513|NCT00798434|155494803|FG001|Open-Label|Protocol Violation|0|||
48354514|NCT00798434|155494802|FG000|Open-Label|Other|1|||
48354515|NCT00798434|155494803|FG001|Open-Label|Other|2|||
48354516|NCT00798434|155494802|FG000|Open-Label|Not Treated|0|||
48354517|NCT00798434|155494803|FG001|Open-Label|Not Treated|1|||
48354518|NCT06122194|155494806|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
48354519|NCT06122194|155494807|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
48354520|NCT06122194|155494808|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
48354521|NCT06122194|155494809|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
48354522|NCT02336451|155494812|FG000|Overall Study|Adverse Event|1|||
48354523|NCT02336451|155494813|FG001|Overall Study|Adverse Event|2|||
48354524|NCT02336451|155494814|FG002|Overall Study|Adverse Event|0|||
48354525|NCT02336451|155494815|FG003|Overall Study|Adverse Event|6|||
48354526|NCT02336451|155494816|FG004|Overall Study|Adverse Event|4|||
48354527|NCT02336451|155494812|FG000|Overall Study|Death|6|||
48354528|NCT02336451|155494813|FG001|Overall Study|Death|2|||
48354529|NCT02336451|155494814|FG002|Overall Study|Death|3|||
48354530|NCT02336451|155494815|FG003|Overall Study|Death|6|||
48354531|NCT02336451|155494816|FG004|Overall Study|Death|6|||
48354532|NCT02336451|155494812|FG000|Overall Study|Physician Decision|9|||
48354533|NCT02336451|155494813|FG001|Overall Study|Physician Decision|6|||
48354534|NCT02336451|155494814|FG002|Overall Study|Physician Decision|7|||
48354535|NCT02336451|155494815|FG003|Overall Study|Physician Decision|16|||
48354536|NCT02336451|155494816|FG004|Overall Study|Physician Decision|3|||
48354537|NCT02336451|155494812|FG000|Overall Study|Progressive disease|23|||
48354538|NCT02336451|155494813|FG001|Overall Study|Progressive disease|26|||
48354539|NCT02336451|155494814|FG002|Overall Study|Progressive disease|2|||
48354540|NCT02336451|155494815|FG003|Overall Study|Progressive disease|14|||
48354541|NCT02336451|155494816|FG004|Overall Study|Progressive disease|4|||
48354542|NCT02336451|155494812|FG000|Overall Study|Protocol Violation|1|||
48354543|NCT02336451|155494813|FG001|Overall Study|Protocol Violation|0|||
48354544|NCT02336451|155494814|FG002|Overall Study|Protocol Violation|0|||
48354545|NCT02336451|155494815|FG003|Overall Study|Protocol Violation|0|||
48354546|NCT02336451|155494816|FG004|Overall Study|Protocol Violation|0|||
48354547|NCT02336451|155494812|FG000|Overall Study|Patient/guardian decision|2|||
48354548|NCT02336451|155494813|FG001|Overall Study|Patient/guardian decision|4|||
48354549|NCT02336451|155494814|FG002|Overall Study|Patient/guardian decision|0|||
48354550|NCT02336451|155494815|FG003|Overall Study|Patient/guardian decision|2|||
48354551|NCT02336451|155494816|FG004|Overall Study|Patient/guardian decision|1|||
48354552|NCT03786471|155494817|FG000|Overall Study|Death|254|||
48354553|NCT03786471|155494818|FG001|Overall Study|Death|223|||
48354554|NCT03786471|155494819|FG002|Overall Study|Death|37|||
48354555|NCT03786471|155494817|FG000|Overall Study|Lost to Follow-up|63|||
48354556|NCT03786471|155494818|FG001|Overall Study|Lost to Follow-up|50|||
48354557|NCT03786471|155494819|FG002|Overall Study|Lost to Follow-up|15|||
48354558|NCT03786471|155494817|FG000|Overall Study|Withdrawal by Subject|99|||
48354559|NCT03786471|155494818|FG001|Overall Study|Withdrawal by Subject|81|||
48354560|NCT03786471|155494819|FG002|Overall Study|Withdrawal by Subject|11|||
48384043|NCT01514136|155601526|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
48384044|NCT01514136|155601527|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
48384045|NCT01514136|155601528|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
48384046|NCT01514136|155601529|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
48384047|NCT01514136|155601530|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
48384048|NCT01514136|155601531|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
48384049|NCT01514136|155601532|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
48384050|NCT01514136|155601533|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
48384051|NCT01514136|155601526|FG000|Test Period 2; Test C*|holiday|0|||
48384052|NCT01514136|155601527|FG001|Test Period 2; Test C*|holiday|0|||
48384053|NCT01514136|155601528|FG002|Test Period 2; Test C*|holiday|0|||
48384054|NCT01514136|155601529|FG003|Test Period 2; Test C*|holiday|0|||
48384055|NCT01514136|155601530|FG004|Test Period 2; Test C*|holiday|0|||
48384056|NCT01514136|155601531|FG005|Test Period 2; Test C*|holiday|0|||
48384057|NCT01514136|155601532|FG006|Test Period 2; Test C*|holiday|1|||
48384058|NCT01514136|155601533|FG007|Test Period 2; Test C*|holiday|0|||
48384059|NCT01514136|155601526|FG000|Test Period 2; Test C*|Protocol Violation|0|||
48384060|NCT01514136|155601527|FG001|Test Period 2; Test C*|Protocol Violation|0|||
48384061|NCT01514136|155601528|FG002|Test Period 2; Test C*|Protocol Violation|0|||
48384062|NCT01514136|155601529|FG003|Test Period 2; Test C*|Protocol Violation|0|||
48384063|NCT01514136|155601530|FG004|Test Period 2; Test C*|Protocol Violation|0|||
48384064|NCT01514136|155601531|FG005|Test Period 2; Test C*|Protocol Violation|0|||
48384065|NCT01514136|155601532|FG006|Test Period 2; Test C*|Protocol Violation|1|||
48384066|NCT01514136|155601533|FG007|Test Period 2; Test C*|Protocol Violation|0|||
48384067|NCT00757003|155601536|FG000|Overall Study|Death|33|||
48384068|NCT00757003|155601536|FG000|Overall Study|Lost to Follow-up|9|||
48384069|NCT00757003|155601536|FG000|Overall Study|Withdrawal by Subject|4|||
48384070|NCT00757003|155601536|FG000|Overall Study|Surgically explanted|2|||
48384071|NCT00757003|155601536|FG000|Overall Study|Not implanted|1|||
48384072|NCT04936841|155601537|FG000|Overall Study|Death|1|||
48384073|NCT02003014|155601538|FG000|Overall Study|Case report forms uncollected|9|||
48384074|NCT02003014|155601538|FG000|Overall Study|Treatment started after contract period|1|||
48384075|NCT02003014|155601538|FG000|Overall Study|Patient did not visit the study site|5|||
48354561|NCT02035696|155497082|FG000|Overall Study|Lost to Follow-up|0|||
48354562|NCT02035696|155497083|FG001|Overall Study|Lost to Follow-up|3|||
48354563|NCT02035696|155497084|FG002|Overall Study|Lost to Follow-up|1|||
48354564|NCT02035696|155497085|FG003|Overall Study|Lost to Follow-up|2|||
48354565|NCT02035696|155497082|FG000|Overall Study|Withdrawal by Subject|3|||
48354566|NCT02035696|155497083|FG001|Overall Study|Withdrawal by Subject|0|||
48354567|NCT02035696|155497084|FG002|Overall Study|Withdrawal by Subject|2|||
48354568|NCT02035696|155497085|FG003|Overall Study|Withdrawal by Subject|1|||
48354569|NCT04650698|155497086|FG000|Overall Study|Protocol Violation|2|||
48354570|NCT04650698|155497087|FG001|Overall Study|Protocol Violation|1|||
48354571|NCT04650698|155497086|FG000|Overall Study|Withdrawal by Subject|0|||
48354572|NCT04650698|155497087|FG001|Overall Study|Withdrawal by Subject|1|||
48354573|NCT00307047|155497088|FG000|Overall Study|Lost to Follow-up|35|||
48354574|NCT00307047|155497089|FG001|Overall Study|Lost to Follow-up|24|||
48354575|NCT00307047|155497088|FG000|Overall Study|Withdrawal by Subject|6|||
48354576|NCT00307047|155497089|FG001|Overall Study|Withdrawal by Subject|6|||
48354577|NCT00307047|155497088|FG000|Overall Study|Physician Decision|1|||
48354578|NCT00307047|155497089|FG001|Overall Study|Physician Decision|2|||
48354579|NCT00307047|155497088|FG000|Overall Study|Lost to follow-up for other reasons|0|||
48354580|NCT00307047|155497089|FG001|Overall Study|Lost to follow-up for other reasons|1|||
48354581|NCT00307047|155497088|FG000|Overall Study|All death, all MI, all Revascularization|27|||
48354582|NCT00307047|155497089|FG001|Overall Study|All death, all MI, all Revascularization|16|||
48354583|NCT00379769|155497090|FG000|Main Study|Death|57|||
48354584|NCT00379769|155497091|FG001|Main Study|Death|67|||
48354585|NCT00379769|155497092|FG002|Main Study|Death|54|||
48354586|NCT00379769|155497093|FG003|Main Study|Death|72|||
48354587|NCT00379769|155497094|FG004|Main Study|Death|0|||
48354588|NCT00379769|155497095|FG005|Main Study|Death|0|||
48354589|NCT00379769|155497090|FG000|Main Study|Adverse Event|5|||
48354590|NCT00379769|155497091|FG001|Main Study|Adverse Event|8|||
48354591|NCT00379769|155497092|FG002|Main Study|Adverse Event|10|||
48354592|NCT00379769|155497093|FG003|Main Study|Adverse Event|11|||
48354593|NCT00379769|155497094|FG004|Main Study|Adverse Event|0|||
48354594|NCT00379769|155497095|FG005|Main Study|Adverse Event|0|||
48354595|NCT00379769|155497090|FG000|Main Study|Lost to Follow-up|29|||
48354596|NCT00379769|155497091|FG001|Main Study|Lost to Follow-up|29|||
48354597|NCT00379769|155497092|FG002|Main Study|Lost to Follow-up|25|||
48354598|NCT00379769|155497093|FG003|Main Study|Lost to Follow-up|26|||
48354599|NCT00379769|155497094|FG004|Main Study|Lost to Follow-up|0|||
48354600|NCT00379769|155497095|FG005|Main Study|Lost to Follow-up|0|||
48354601|NCT00379769|155497090|FG000|Main Study|Withdrawal by Subject|46|||
48354602|NCT00379769|155497091|FG001|Main Study|Withdrawal by Subject|56|||
48354603|NCT00379769|155497092|FG002|Main Study|Withdrawal by Subject|72|||
48354604|NCT00379769|155497093|FG003|Main Study|Withdrawal by Subject|70|||
48354605|NCT00379769|155497094|FG004|Main Study|Withdrawal by Subject|0|||
48354606|NCT00379769|155497095|FG005|Main Study|Withdrawal by Subject|0|||
48354607|NCT00379769|155497090|FG000|Main Study|Moved to survival status follow-up only|27|||
48354608|NCT00379769|155497091|FG001|Main Study|Moved to survival status follow-up only|25|||
48354609|NCT00379769|155497092|FG002|Main Study|Moved to survival status follow-up only|32|||
48354610|NCT00379769|155497093|FG003|Main Study|Moved to survival status follow-up only|36|||
48354611|NCT00379769|155497094|FG004|Main Study|Moved to survival status follow-up only|0|||
48354612|NCT00379769|155497095|FG005|Main Study|Moved to survival status follow-up only|0|||
48354613|NCT00379769|155497090|FG000|Main Study|Participant moved|3|||
48354614|NCT00379769|155497091|FG001|Main Study|Participant moved|2|||
48354615|NCT00379769|155497092|FG002|Main Study|Participant moved|3|||
48354616|NCT00379769|155497093|FG003|Main Study|Participant moved|3|||
48354617|NCT00379769|155497094|FG004|Main Study|Participant moved|0|||
48354618|NCT00379769|155497095|FG005|Main Study|Participant moved|0|||
48354619|NCT00379769|155497090|FG000|Main Study|Poor compliance|3|||
48354620|NCT00379769|155497091|FG001|Main Study|Poor compliance|2|||
48354621|NCT00379769|155497092|FG002|Main Study|Poor compliance|2|||
48354622|NCT00379769|155497093|FG003|Main Study|Poor compliance|1|||
48354623|NCT00379769|155497094|FG004|Main Study|Poor compliance|0|||
48354624|NCT00379769|155497095|FG005|Main Study|Poor compliance|0|||
48354625|NCT00379769|155497090|FG000|Main Study|Prohibited glucose lowering medication|0|||
48354626|NCT00379769|155497091|FG001|Main Study|Prohibited glucose lowering medication|3|||
48354627|NCT00379769|155497092|FG002|Main Study|Prohibited glucose lowering medication|0|||
48354628|NCT00379769|155497093|FG003|Main Study|Prohibited glucose lowering medication|1|||
48354629|NCT00379769|155497094|FG004|Main Study|Prohibited glucose lowering medication|0|||
48354630|NCT00379769|155497095|FG005|Main Study|Prohibited glucose lowering medication|0|||
48354631|NCT00379769|155497090|FG000|Main Study|Site closed|4|||
48354632|NCT00379769|155497091|FG001|Main Study|Site closed|4|||
48354633|NCT00379769|155497092|FG002|Main Study|Site closed|4|||
48354634|NCT00379769|155497093|FG003|Main Study|Site closed|8|||
48354635|NCT00379769|155497094|FG004|Main Study|Site closed|0|||
48354636|NCT00379769|155497095|FG005|Main Study|Site closed|0|||
48354637|NCT00379769|155497090|FG000|Main Study|Entry criteria violation|0|||
48354638|NCT00379769|155497091|FG001|Main Study|Entry criteria violation|0|||
48354639|NCT00379769|155497092|FG002|Main Study|Entry criteria violation|1|||
48354640|NCT00379769|155497093|FG003|Main Study|Entry criteria violation|1|||
48354641|NCT00379769|155497094|FG004|Main Study|Entry criteria violation|0|||
48354642|NCT00379769|155497095|FG005|Main Study|Entry criteria violation|0|||
48354643|NCT00379769|155497090|FG000|Main Study|Participant did not take study drug|0|||
48354644|NCT00379769|155497091|FG001|Main Study|Participant did not take study drug|0|||
48354645|NCT00379769|155497092|FG002|Main Study|Participant did not take study drug|1|||
48354646|NCT00379769|155497093|FG003|Main Study|Participant did not take study drug|0|||
48354647|NCT00379769|155497094|FG004|Main Study|Participant did not take study drug|0|||
48354648|NCT00379769|155497095|FG005|Main Study|Participant did not take study drug|0|||
48354649|NCT00379769|155497090|FG000|Main Study|Physician Decision|2|||
48354650|NCT00379769|155497091|FG001|Main Study|Physician Decision|2|||
48354651|NCT00379769|155497092|FG002|Main Study|Physician Decision|1|||
48354652|NCT00379769|155497093|FG003|Main Study|Physician Decision|1|||
48354653|NCT00379769|155497094|FG004|Main Study|Physician Decision|0|||
48354654|NCT00379769|155497095|FG005|Main Study|Physician Decision|0|||
48354655|NCT00379769|155497090|FG000|Main Study|Participant completed study at visit 27|1|||
48354656|NCT00379769|155497091|FG001|Main Study|Participant completed study at visit 27|0|||
48354657|NCT00379769|155497092|FG002|Main Study|Participant completed study at visit 27|0|||
48354658|NCT00379769|155497093|FG003|Main Study|Participant completed study at visit 27|0|||
48354659|NCT00379769|155497094|FG004|Main Study|Participant completed study at visit 27|0|||
48354660|NCT00379769|155497095|FG005|Main Study|Participant completed study at visit 27|0|||
48354661|NCT00379769|155497090|FG000|Main Study|Personal reasons|1|||
48354662|NCT00379769|155497091|FG001|Main Study|Personal reasons|0|||
48354663|NCT00379769|155497092|FG002|Main Study|Personal reasons|0|||
48354664|NCT00379769|155497093|FG003|Main Study|Personal reasons|0|||
48354665|NCT00379769|155497094|FG004|Main Study|Personal reasons|0|||
48354666|NCT00379769|155497095|FG005|Main Study|Personal reasons|0|||
48354667|NCT00379769|155497090|FG000|Main Study|Risk of heart failure|0|||
48354668|NCT00379769|155497091|FG001|Main Study|Risk of heart failure|1|||
48354669|NCT00379769|155497092|FG002|Main Study|Risk of heart failure|0|||
48354670|NCT00379769|155497093|FG003|Main Study|Risk of heart failure|0|||
48354671|NCT00379769|155497094|FG004|Main Study|Risk of heart failure|0|||
48354672|NCT00379769|155497095|FG005|Main Study|Risk of heart failure|0|||
48354673|NCT00379769|155497090|FG000|Main Study|Investigator refused to log temperature|0|||
48354674|NCT00379769|155497091|FG001|Main Study|Investigator refused to log temperature|0|||
48354675|NCT00379769|155497092|FG002|Main Study|Investigator refused to log temperature|1|||
48354676|NCT00379769|155497093|FG003|Main Study|Investigator refused to log temperature|0|||
48354677|NCT00379769|155497094|FG004|Main Study|Investigator refused to log temperature|0|||
48354678|NCT00379769|155497095|FG005|Main Study|Investigator refused to log temperature|0|||
48354679|NCT00379769|155497090|FG000|Main Study|Reason unspecified|0|||
48354680|NCT00379769|155497091|FG001|Main Study|Reason unspecified|0|||
48762167|NCT02608268|156978017|FG010|Overall Study|Progressive disease|5|||
48762168|NCT02608268|156978018|FG011|Overall Study|Progressive disease|5|||
48762169|NCT02608268|156978019|FG012|Overall Study|Progressive disease|4|||
48354681|NCT00379769|155497092|FG002|Main Study|Reason unspecified|1|||
48354682|NCT00379769|155497093|FG003|Main Study|Reason unspecified|0|||
48354683|NCT00379769|155497094|FG004|Main Study|Reason unspecified|0|||
48354684|NCT00379769|155497095|FG005|Main Study|Reason unspecified|0|||
48354685|NCT00379769|155497090|FG000|Observational Follow-up|Death|0|||
48354686|NCT00379769|155497091|FG001|Observational Follow-up|Death|0|||
48354687|NCT00379769|155497092|FG002|Observational Follow-up|Death|0|||
48354688|NCT00379769|155497093|FG003|Observational Follow-up|Death|0|||
48354689|NCT00379769|155497094|FG004|Observational Follow-up|Death|78|||
48354690|NCT00379769|155497095|FG005|Observational Follow-up|Death|70|||
48354691|NCT00379769|155497090|FG000|Observational Follow-up|Adverse Event|0|||
48354692|NCT00379769|155497091|FG001|Observational Follow-up|Adverse Event|0|||
48354693|NCT00379769|155497092|FG002|Observational Follow-up|Adverse Event|0|||
48354694|NCT00379769|155497093|FG003|Observational Follow-up|Adverse Event|0|||
48354695|NCT00379769|155497094|FG004|Observational Follow-up|Adverse Event|1|||
48354696|NCT00379769|155497095|FG005|Observational Follow-up|Adverse Event|0|||
48354697|NCT00379769|155497090|FG000|Observational Follow-up|Lost to Follow-up|0|||
48354698|NCT00379769|155497091|FG001|Observational Follow-up|Lost to Follow-up|0|||
48354699|NCT00379769|155497092|FG002|Observational Follow-up|Lost to Follow-up|0|||
48354700|NCT00379769|155497093|FG003|Observational Follow-up|Lost to Follow-up|0|||
48354701|NCT00379769|155497094|FG004|Observational Follow-up|Lost to Follow-up|25|||
48354702|NCT00379769|155497095|FG005|Observational Follow-up|Lost to Follow-up|27|||
48354703|NCT00379769|155497090|FG000|Observational Follow-up|Withdrawal by Subject|0|||
48354704|NCT00379769|155497091|FG001|Observational Follow-up|Withdrawal by Subject|0|||
48354705|NCT00379769|155497092|FG002|Observational Follow-up|Withdrawal by Subject|0|||
48762170|NCT02608268|156978020|FG013|Overall Study|Progressive disease|11|||
48354706|NCT00379769|155497093|FG003|Observational Follow-up|Withdrawal by Subject|0|||
48354707|NCT00379769|155497094|FG004|Observational Follow-up|Withdrawal by Subject|12|||
48354708|NCT00379769|155497095|FG005|Observational Follow-up|Withdrawal by Subject|12|||
48354709|NCT00379769|155497090|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
48762171|NCT02608268|156978021|FG014|Overall Study|Progressive disease|6|||
48354710|NCT00379769|155497091|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
48354711|NCT00379769|155497092|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
48354712|NCT00379769|155497093|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
48354713|NCT00379769|155497094|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
48354714|NCT00379769|155497095|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
48354715|NCT00379769|155497090|FG000|Observational Follow-up|Physician Decision|0|||
48354716|NCT00379769|155497091|FG001|Observational Follow-up|Physician Decision|0|||
48354717|NCT00379769|155497092|FG002|Observational Follow-up|Physician Decision|0|||
48354718|NCT00379769|155497093|FG003|Observational Follow-up|Physician Decision|0|||
48354719|NCT00379769|155497094|FG004|Observational Follow-up|Physician Decision|8|||
48354720|NCT00379769|155497095|FG005|Observational Follow-up|Physician Decision|8|||
48354721|NCT00379769|155497090|FG000|Observational Follow-up|Site Closed Early|0|||
48354722|NCT00379769|155497091|FG001|Observational Follow-up|Site Closed Early|0|||
48354723|NCT00379769|155497092|FG002|Observational Follow-up|Site Closed Early|0|||
48354724|NCT00379769|155497093|FG003|Observational Follow-up|Site Closed Early|0|||
48354725|NCT00379769|155497094|FG004|Observational Follow-up|Site Closed Early|6|||
48354726|NCT00379769|155497095|FG005|Observational Follow-up|Site Closed Early|7|||
48354727|NCT00379769|155497090|FG000|Observational Follow-up|Participant Moved|0|||
48384076|NCT02003014|155601538|FG000|Overall Study|Investigator's transfer|4|||
48384077|NCT01660451|155601539|FG000|Overall Study|Protocol Violation|0|||
48384078|NCT01660451|155601540|FG001|Overall Study|Protocol Violation|1|||
48384079|NCT01660451|155601541|FG002|Overall Study|Protocol Violation|1|||
48384080|NCT01660451|155601539|FG000|Overall Study|AE not associated with clinical disease progression|13|||
48384081|NCT01660451|155601540|FG001|Overall Study|AE not associated with clinical disease progression|10|||
48384082|NCT01660451|155601541|FG002|Overall Study|AE not associated with clinical disease progression|40|||
48676299|NCT04405076|156667260|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676300|NCT04405076|156667261|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676301|NCT04405076|156667262|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676302|NCT04405076|156667263|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676303|NCT04405076|156667264|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
48676304|NCT04405076|156667265|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676305|NCT04405076|156667266|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676306|NCT04405076|156667267|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676307|NCT04405076|156667268|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
48676308|NCT04405076|156667260|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48384083|NCT01660451|155601539|FG000|Overall Study|AE associated with clinical disease progression|1|||
48384084|NCT01660451|155601540|FG001|Overall Study|AE associated with clinical disease progression|3|||
48384085|NCT01660451|155601541|FG002|Overall Study|AE associated with clinical disease progression|11|||
48384086|NCT01660451|155601539|FG000|Overall Study|Sponsor Decision|0|||
48384087|NCT01660451|155601540|FG001|Overall Study|Sponsor Decision|0|||
48384088|NCT01660451|155601541|FG002|Overall Study|Sponsor Decision|1|||
48384089|NCT01660451|155601539|FG000|Overall Study|Protocol Deviation|0|||
48384090|NCT01660451|155601540|FG001|Overall Study|Protocol Deviation|0|||
48384091|NCT01660451|155601541|FG002|Overall Study|Protocol Deviation|1|||
48384092|NCT01660451|155601539|FG000|Overall Study|Physician Decision|1|||
48384093|NCT01660451|155601540|FG001|Overall Study|Physician Decision|2|||
48384094|NCT01660451|155601541|FG002|Overall Study|Physician Decision|5|||
48384095|NCT01660451|155601539|FG000|Overall Study|Withdrawal by Subject|1|||
48384096|NCT01660451|155601540|FG001|Overall Study|Withdrawal by Subject|1|||
48384097|NCT01660451|155601541|FG002|Overall Study|Withdrawal by Subject|20|||
48384098|NCT01660451|155601539|FG000|Overall Study|Trial closure.|0|||
48384099|NCT01660451|155601540|FG001|Overall Study|Trial closure.|0|||
48384100|NCT01660451|155601541|FG002|Overall Study|Trial closure.|1|||
48384101|NCT01660451|155601539|FG000|Overall Study|Switching to other therapy|0|||
48384102|NCT01660451|155601540|FG001|Overall Study|Switching to other therapy|1|||
48384103|NCT01660451|155601541|FG002|Overall Study|Switching to other therapy|1|||
48384104|NCT01660451|155601539|FG000|Overall Study|Progressive disease - clinical progression|4|||
48384105|NCT01660451|155601540|FG001|Overall Study|Progressive disease - clinical progression|10|||
48384106|NCT01660451|155601541|FG002|Overall Study|Progressive disease - clinical progression|9|||
48384107|NCT01660451|155601539|FG000|Overall Study|Progressive disease - radiological progression|12|||
48384108|NCT01660451|155601540|FG001|Overall Study|Progressive disease - radiological progression|23|||
48384109|NCT01660451|155601541|FG002|Overall Study|Progressive disease - radiological progression|50|||
48384110|NCT01660451|155601539|FG000|Overall Study|Death|1|||
48384111|NCT01660451|155601540|FG001|Overall Study|Death|0|||
48384112|NCT01660451|155601541|FG002|Overall Study|Death|1|||
48384113|NCT01660451|155601539|FG000|Overall Study|Other|0|||
48384114|NCT01660451|155601540|FG001|Overall Study|Other|0|||
48384115|NCT01660451|155601541|FG002|Overall Study|Other|1|||
48384116|NCT04695392|155601542|FG000|Overall Study|Withdrawn by parent/guardian|0|||
48762172|NCT02608268|156978022|FG015|Overall Study|Progressive disease|3|||
48384117|NCT04695392|155601543|FG001|Overall Study|Withdrawn by parent/guardian|1|||
48384118|NCT04695392|155601542|FG000|Overall Study|Withdrawn by physician|0|||
48384119|NCT04695392|155601543|FG001|Overall Study|Withdrawn by physician|1|||
48384120|NCT01034540|155601544|FG000|Overall Study|Adverse Event|0|||
48384121|NCT01034540|155601545|FG001|Overall Study|Adverse Event|1|||
48384122|NCT00932425|155601548|FG000|Overall Study|Lost to Follow-up|0|||
48384123|NCT00932425|155601549|FG001|Overall Study|Lost to Follow-up|1|||
48384124|NCT00932425|155601548|FG000|Overall Study|Withdrawal by Subject|0|||
48384125|NCT00932425|155601549|FG001|Overall Study|Withdrawal by Subject|1|||
48384126|NCT01854645|155601550|FG000|Overall Study|Protocol-Specified Criteria|13|||
48384127|NCT01854645|155601551|FG001|Overall Study|Protocol-Specified Criteria|10|||
48384128|NCT01854645|155601552|FG002|Overall Study|Protocol-Specified Criteria|8|||
48384129|NCT01854645|155601553|FG003|Overall Study|Protocol-Specified Criteria|5|||
48384130|NCT01854645|155601554|FG004|Overall Study|Protocol-Specified Criteria|7|||
48384131|NCT01854645|155601550|FG000|Overall Study|Administrative Reasons / Missing|0|||
48384132|NCT01854645|155601551|FG001|Overall Study|Administrative Reasons / Missing|0|||
48384133|NCT01854645|155601552|FG002|Overall Study|Administrative Reasons / Missing|0|||
48384134|NCT01854645|155601553|FG003|Overall Study|Administrative Reasons / Missing|1|||
48384135|NCT01854645|155601554|FG004|Overall Study|Administrative Reasons / Missing|1|||
48384136|NCT01854645|155601550|FG000|Overall Study|Protocol Violation|3|||
48384137|NCT01854645|155601551|FG001|Overall Study|Protocol Violation|0|||
48384138|NCT01854645|155601552|FG002|Overall Study|Protocol Violation|5|||
48384139|NCT01854645|155601553|FG003|Overall Study|Protocol Violation|4|||
48384140|NCT01854645|155601554|FG004|Overall Study|Protocol Violation|1|||
48384141|NCT01854645|155601550|FG000|Overall Study|Lost to Follow-up|10|||
48384142|NCT01854645|155601551|FG001|Overall Study|Lost to Follow-up|7|||
48384143|NCT01854645|155601552|FG002|Overall Study|Lost to Follow-up|8|||
48384144|NCT01854645|155601553|FG003|Overall Study|Lost to Follow-up|5|||
48384145|NCT01854645|155601554|FG004|Overall Study|Lost to Follow-up|0|||
48384146|NCT01854645|155601550|FG000|Overall Study|Physician Decision|1|||
48384147|NCT01854645|155601551|FG001|Overall Study|Physician Decision|5|||
48384148|NCT01854645|155601552|FG002|Overall Study|Physician Decision|3|||
48384149|NCT01854645|155601553|FG003|Overall Study|Physician Decision|3|||
48384150|NCT01854645|155601554|FG004|Overall Study|Physician Decision|7|||
48384151|NCT01854645|155601550|FG000|Overall Study|Withdrawal by Subject|31|||
48384152|NCT01854645|155601551|FG001|Overall Study|Withdrawal by Subject|41|||
48384153|NCT01854645|155601552|FG002|Overall Study|Withdrawal by Subject|30|||
48384154|NCT01854645|155601553|FG003|Overall Study|Withdrawal by Subject|21|||
48384155|NCT01854645|155601554|FG004|Overall Study|Withdrawal by Subject|24|||
48384156|NCT01854645|155601550|FG000|Overall Study|Lack of Efficacy|7|||
48384157|NCT01854645|155601551|FG001|Overall Study|Lack of Efficacy|12|||
48384158|NCT01854645|155601552|FG002|Overall Study|Lack of Efficacy|9|||
48384159|NCT01854645|155601553|FG003|Overall Study|Lack of Efficacy|3|||
48384160|NCT01854645|155601554|FG004|Overall Study|Lack of Efficacy|9|||
48384161|NCT01854645|155601550|FG000|Overall Study|Adverse Event|33|||
48384162|NCT01854645|155601551|FG001|Overall Study|Adverse Event|31|||
48384163|NCT01854645|155601552|FG002|Overall Study|Adverse Event|19|||
48384164|NCT01854645|155601553|FG003|Overall Study|Adverse Event|20|||
48676309|NCT04405076|156667261|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676310|NCT04405076|156667262|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676311|NCT04405076|156667263|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
48384165|NCT01854645|155601554|FG004|Overall Study|Adverse Event|11|||
48384166|NCT00403754|155601555|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
48384167|NCT00403754|155601556|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
48384168|NCT00403754|155601557|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
48384169|NCT00403754|155601558|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
48384170|NCT00403754|155601555|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
48384171|NCT00403754|155601556|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
48384172|NCT00403754|155601557|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
48384173|NCT00403754|155601558|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
48384174|NCT02000427|155601561|FG000|Overall Study|Death|22|||
48384175|NCT04343248|155601563|FG000|Overall Study|Withdrawal by Subject|5|||
48676312|NCT04405076|156667264|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
48384176|NCT04343248|155601564|FG001|Overall Study|Withdrawal by Subject|6|||
48384177|NCT04343248|155601563|FG000|Overall Study|Death|1|||
48384178|NCT04343248|155601564|FG001|Overall Study|Death|2|||
48676313|NCT04405076|156667265|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
48676314|NCT04405076|156667266|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676315|NCT04405076|156667267|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676316|NCT04405076|156667268|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
48676317|NCT04405076|156667260|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48384179|NCT04343248|155601563|FG000|Overall Study|Lost to Follow-up|9|||
48384180|NCT04343248|155601564|FG001|Overall Study|Lost to Follow-up|6|||
48384181|NCT04343248|155601563|FG000|Overall Study|Physician Decision|0|||
48384182|NCT04343248|155601564|FG001|Overall Study|Physician Decision|1|||
48384183|NCT04343248|155601563|FG000|Overall Study|Adverse Event|1|||
48384184|NCT04343248|155601564|FG001|Overall Study|Adverse Event|0|||
48384185|NCT01162239|155601566|FG000|Treatment Phase|Withdrawal by Subject|1|||
48384186|NCT01162239|155601567|FG001|Treatment Phase|Withdrawal by Subject|3|||
48384187|NCT01162239|155601568|FG002|Treatment Phase|Withdrawal by Subject|2|||
48384188|NCT01162239|155601569|FG003|Treatment Phase|Withdrawal by Subject|3|||
48384189|NCT01162239|155601566|FG000|Treatment Phase|Death|0|||
48384190|NCT01162239|155601567|FG001|Treatment Phase|Death|0|||
48384191|NCT01162239|155601568|FG002|Treatment Phase|Death|0|||
48384192|NCT01162239|155601569|FG003|Treatment Phase|Death|1|||
48384193|NCT01162239|155601566|FG000|Treatment Phase|Lost to Follow-up|5|||
48384194|NCT01162239|155601567|FG001|Treatment Phase|Lost to Follow-up|4|||
48384195|NCT01162239|155601568|FG002|Treatment Phase|Lost to Follow-up|2|||
48384196|NCT01162239|155601569|FG003|Treatment Phase|Lost to Follow-up|1|||
48384197|NCT01162239|155601566|FG000|Extended Follow-up|Lost to Follow-up|8|||
48762173|NCT02608268|156978023|FG016|Overall Study|Progressive disease|5|||
48384198|NCT01162239|155601567|FG001|Extended Follow-up|Lost to Follow-up|13|||
48384199|NCT01162239|155601568|FG002|Extended Follow-up|Lost to Follow-up|8|||
48384200|NCT01162239|155601569|FG003|Extended Follow-up|Lost to Follow-up|6|||
48384201|NCT01889238|155601570|FG000|Overall Study|Death|1|||
48384202|NCT01889238|155601570|FG000|Overall Study|Withdrawal by Subject|1|||
48384203|NCT01889238|155601570|FG000|Overall Study|Adverse Event|6|||
48384204|NCT01889238|155601570|FG000|Overall Study|Disease Progression|104|||
48384205|NCT01889238|155601570|FG000|Overall Study|Other|6|||
48384206|NCT01200238|155601571|FG000|Overall Study|Adverse Event|2|||
48384207|NCT01200238|155601572|FG001|Overall Study|Adverse Event|1|||
48384208|NCT01200238|155601571|FG000|Overall Study|Progressive Disease|5|||
48384209|NCT01200238|155601572|FG001|Overall Study|Progressive Disease|8|||
48384210|NCT01200238|155601571|FG000|Overall Study|Withdrawal by Subject|0|||
48384211|NCT01200238|155601572|FG001|Overall Study|Withdrawal by Subject|1|||
48384212|NCT02717754|155601573|FG000|Overall Study|Incorrect Infusion Duration|0|||
48384213|NCT02717754|155601574|FG001|Overall Study|Incorrect Infusion Duration|0|||
48384214|NCT02717754|155601575|FG002|Overall Study|Incorrect Infusion Duration|0|||
48384215|NCT02717754|155601576|FG003|Overall Study|Incorrect Infusion Duration|10|||
48384216|NCT02717754|155601577|FG004|Overall Study|Incorrect Infusion Duration|20|||
48384217|NCT02717754|155601578|FG005|Overall Study|Incorrect Infusion Duration|20|||
48384218|NCT00523718|155602759|FG000|Overall Study|Withdrawal by Subject|1|||
48384219|NCT00523718|155602760|FG001|Overall Study|Withdrawal by Subject|0|||
48384220|NCT00523718|155602759|FG000|Overall Study|Protocol Violation|2|||
48384221|NCT00523718|155602760|FG001|Overall Study|Protocol Violation|0|||
48384222|NCT00594516|155602761|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
48384223|NCT00594516|155602762|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
48384224|NCT00594516|155602763|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
48384225|NCT00594516|155602761|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
48384226|NCT00594516|155602762|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
48384227|NCT00594516|155602763|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
48384228|NCT00594516|155602761|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
48384229|NCT00594516|155602762|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
48384230|NCT00594516|155602763|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
48384231|NCT00594516|155602761|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
48384232|NCT00594516|155602762|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
48384233|NCT00594516|155602763|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
48384234|NCT00594516|155602761|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
48384235|NCT00594516|155602762|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
48384236|NCT00594516|155602763|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
48384237|NCT00594516|155602761|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
48384238|NCT00594516|155602762|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
48384239|NCT00594516|155602763|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
48384240|NCT00594516|155602761|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
48384241|NCT00594516|155602762|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
48384242|NCT00594516|155602763|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
48384243|NCT00594516|155602761|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
48384244|NCT00594516|155602762|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
48384245|NCT00594516|155602763|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
48384246|NCT00594516|155602761|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
48384247|NCT00594516|155602762|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
48384248|NCT00594516|155602763|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
48384249|NCT00088907|155602764|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
48384250|NCT00088907|155602765|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
48384251|NCT00088907|155602764|FG000|Randomized Study (Step 1)|Adverse Event|14|||
48676318|NCT04405076|156667261|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676319|NCT04405076|156667262|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676320|NCT04405076|156667263|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676321|NCT04405076|156667264|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676322|NCT04405076|156667265|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48676323|NCT04405076|156667266|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
48762174|NCT02608268|156978024|FG017|Overall Study|Progressive disease|5|||
48384252|NCT00088907|155602765|FG001|Randomized Study (Step 1)|Adverse Event|19|||
48384253|NCT00088907|155602764|FG000|Randomized Study (Step 1)|Death|11|||
48384254|NCT00088907|155602765|FG001|Randomized Study (Step 1)|Death|12|||
48384255|NCT00088907|155602764|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
48384256|NCT00088907|155602765|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
48384257|NCT00088907|155602764|FG000|Randomized Study (Step 1)|complicating disease|3|||
48384258|NCT00088907|155602765|FG001|Randomized Study (Step 1)|complicating disease|1|||
48384259|NCT00088907|155602764|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
48384260|NCT00088907|155602765|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
48429377|NCT01070550|155760360|FG005|Overall Study|Not categorized|1|||
48384261|NCT00088907|155602764|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
48384262|NCT00088907|155602765|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
48384263|NCT00088907|155602764|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
48384264|NCT00088907|155602765|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
48384265|NCT00088907|155602764|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
48384266|NCT00088907|155602765|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
48384267|NCT00088907|155602764|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
48384268|NCT00088907|155602765|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
48384269|NCT00088907|155602764|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
48384270|NCT00088907|155602765|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
48384271|NCT03426787|155602766|FG000|Overall Study|Withdrawal by Subject|6|||
48384272|NCT03426787|155602766|FG000|Overall Study|Lost to Follow-up|7|||
48384273|NCT03426787|155602766|FG000|Overall Study|Unrelated to intervention death|1|||
48384274|NCT03808688|155602767|FG000|Overall Study|Adverse Event|13|||
48384275|NCT03808688|155602768|FG001|Overall Study|Adverse Event|17|||
48384276|NCT03808688|155602767|FG000|Overall Study|Lack of Efficacy|2|||
48384277|NCT03808688|155602768|FG001|Overall Study|Lack of Efficacy|0|||
48384278|NCT03808688|155602767|FG000|Overall Study|Lost to Follow-up|0|||
48384279|NCT03808688|155602768|FG001|Overall Study|Lost to Follow-up|2|||
48384280|NCT03808688|155602767|FG000|Overall Study|Withdrawal by Subject|1|||
48384281|NCT03808688|155602768|FG001|Overall Study|Withdrawal by Subject|0|||
48384282|NCT03808688|155602767|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
48384283|NCT03808688|155602768|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
48384284|NCT03808688|155602767|FG000|Overall Study|IOP Too High|1|||
48384285|NCT03808688|155602768|FG001|Overall Study|IOP Too High|1|||
48384286|NCT03808688|155602767|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
48384287|NCT03808688|155602768|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
48384288|NCT03808688|155602767|FG000|Overall Study|Visit Out of Window|0|||
48384289|NCT03808688|155602768|FG001|Overall Study|Visit Out of Window|1|||
48384290|NCT03808688|155602767|FG000|Overall Study|Medication Non-Compliance|0|||
48384291|NCT03808688|155602768|FG001|Overall Study|Medication Non-Compliance|1|||
48384292|NCT02012296|155602772|FG000|Overall Study|Lack of Efficacy|0|||
48384293|NCT02012296|155602773|FG001|Overall Study|Lack of Efficacy|0|||
48384294|NCT02012296|155602774|FG002|Overall Study|Lack of Efficacy|15|||
48384295|NCT02012296|155602772|FG000|Overall Study|Adverse Event|0|||
48384296|NCT02012296|155602773|FG001|Overall Study|Adverse Event|0|||
48384297|NCT02012296|155602774|FG002|Overall Study|Adverse Event|2|||
48384298|NCT02012296|155602772|FG000|Overall Study|Early study closure|0|||
48384299|NCT02012296|155602773|FG001|Overall Study|Early study closure|0|||
48384300|NCT02012296|155602774|FG002|Overall Study|Early study closure|5|||
48384301|NCT02012296|155602772|FG000|Overall Study|Protocol Violation|0|||
48384302|NCT02012296|155602773|FG001|Overall Study|Protocol Violation|1|||
48384303|NCT02012296|155602774|FG002|Overall Study|Protocol Violation|0|||
48384304|NCT00929656|155602775|FG000|Overall Study|Lost to Follow-up|0|||
48384305|NCT00929656|155602776|FG001|Overall Study|Lost to Follow-up|1|||
48384306|NCT00607880|155602777|FG000|Overall Study|Unable to place port due to occlusion|1|||
48384307|NCT00607880|155602778|FG001|Overall Study|Unable to place port due to occlusion|0|||
48384308|NCT01170039|155602779|FG000|Overall Study|Withdrawal by Subject|5|||
48384309|NCT01170039|155602780|FG001|Overall Study|Withdrawal by Subject|3|||
48384310|NCT01170039|155602779|FG000|Overall Study|Lack of funding, drug not available|3|||
48384311|NCT01170039|155602780|FG001|Overall Study|Lack of funding, drug not available|3|||
48384312|NCT02464228|155602781|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
48384313|NCT02464228|155602782|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
48384314|NCT02464228|155602783|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
48676324|NCT04405076|156667267|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
48676325|NCT04405076|156667268|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
48676326|NCT04405076|156667260|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676327|NCT04405076|156667261|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676328|NCT04405076|156667262|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676329|NCT04405076|156667263|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676330|NCT04405076|156667264|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676331|NCT04405076|156667265|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676332|NCT04405076|156667266|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
48676333|NCT04405076|156667267|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48762175|NCT02608268|156978025|FG018|Overall Study|Progressive disease|5|||
48384315|NCT02464228|155602784|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
48384316|NCT02464228|155602781|FG000|Overall Study|Physician Decision|2|||
48384317|NCT02464228|155602782|FG001|Overall Study|Physician Decision|0|||
48384318|NCT02464228|155602783|FG002|Overall Study|Physician Decision|1|||
48384319|NCT02464228|155602784|FG003|Overall Study|Physician Decision|0|||
48384320|NCT02464228|155602781|FG000|Overall Study|Miscellaneous|1|||
48384321|NCT02464228|155602782|FG001|Overall Study|Miscellaneous|0|||
48384322|NCT02464228|155602783|FG002|Overall Study|Miscellaneous|1|||
48676334|NCT04405076|156667268|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
48676335|NCT00392990|156667271|FG000|Treatment on Study|Adverse Event|3|||
48676336|NCT00392990|156667272|FG001|Treatment on Study|Adverse Event|1|||
48676337|NCT00392990|156667271|FG000|Follow up for 2 Years|Death|4|||
48676338|NCT00392990|156667272|FG001|Follow up for 2 Years|Death|0|||
48676339|NCT04667104|156667273|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
48676340|NCT04667104|156667274|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
48676341|NCT04667104|156667275|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
48676342|NCT04186871|156667278|FG000|Overall Study|Lack of Efficacy|0|||
48676343|NCT04186871|156667279|FG001|Overall Study|Lack of Efficacy|1|||
48676344|NCT04186871|156667280|FG002|Overall Study|Lack of Efficacy|0|||
48676345|NCT04186871|156667281|FG003|Overall Study|Lack of Efficacy|0|||
48676346|NCT04186871|156667282|FG004|Overall Study|Lack of Efficacy|1|||
48676347|NCT04186871|156667283|FG005|Overall Study|Lack of Efficacy|1|||
48676348|NCT04186871|156667278|FG000|Overall Study|Adverse Event|1|||
48676349|NCT04186871|156667279|FG001|Overall Study|Adverse Event|1|||
48676350|NCT04186871|156667280|FG002|Overall Study|Adverse Event|0|||
48676351|NCT04186871|156667281|FG003|Overall Study|Adverse Event|0|||
48676352|NCT04186871|156667282|FG004|Overall Study|Adverse Event|0|||
48676353|NCT04186871|156667283|FG005|Overall Study|Adverse Event|2|||
48676354|NCT04186871|156667278|FG000|Overall Study|Study terminated by sponsor|1|||
48762176|NCT02608268|156978026|FG019|Overall Study|Progressive disease|2|||
48762177|NCT02608268|156978027|FG020|Overall Study|Progressive disease|10|||
48762178|NCT02608268|156978028|FG021|Overall Study|Progressive disease|4|||
48762179|NCT02608268|156978029|FG022|Overall Study|Progressive disease|5|||
48762180|NCT02608268|156978030|FG023|Overall Study|Progressive disease|5|||
48762181|NCT02608268|156978031|FG024|Overall Study|Progressive disease|3|||
48762182|NCT02608268|156978032|FG025|Overall Study|Progressive disease|11|||
48762183|NCT02608268|156978033|FG026|Overall Study|Progressive disease|16|||
48354728|NCT00379769|155497091|FG001|Observational Follow-up|Participant Moved|0|||
48354729|NCT00379769|155497092|FG002|Observational Follow-up|Participant Moved|0|||
48354730|NCT00379769|155497093|FG003|Observational Follow-up|Participant Moved|0|||
48354731|NCT00379769|155497094|FG004|Observational Follow-up|Participant Moved|0|||
48354732|NCT00379769|155497095|FG005|Observational Follow-up|Participant Moved|1|||
48354733|NCT00379769|155497090|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
48354734|NCT00379769|155497091|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
48354735|NCT00379769|155497092|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
48354736|NCT00379769|155497093|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
48354737|NCT00379769|155497094|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
48354738|NCT00379769|155497095|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
48354739|NCT04949802|155497096|FG000|Overall Study|Lost to Follow-up|3|||
48354740|NCT01932762|155497097|FG000|Overall Study|Withdrawal by Subject|1|||
48354741|NCT01932762|155497098|FG001|Overall Study|Withdrawal by Subject|2|||
48354742|NCT01932762|155497099|FG002|Overall Study|Withdrawal by Subject|0|||
48354743|NCT01932762|155497100|FG003|Overall Study|Withdrawal by Subject|0|||
48354744|NCT01932762|155497097|FG000|Overall Study|Lost to Follow-up|4|||
48354745|NCT01932762|155497098|FG001|Overall Study|Lost to Follow-up|0|||
48354746|NCT01932762|155497099|FG002|Overall Study|Lost to Follow-up|0|||
48354747|NCT01932762|155497100|FG003|Overall Study|Lost to Follow-up|1|||
48354748|NCT01932762|155497097|FG000|Overall Study|Physician Decision|1|||
48354749|NCT01932762|155497098|FG001|Overall Study|Physician Decision|0|||
48354750|NCT01932762|155497099|FG002|Overall Study|Physician Decision|0|||
48354751|NCT01932762|155497100|FG003|Overall Study|Physician Decision|0|||
48354752|NCT00497874|155497101|FG000|Overall Study|Withdrawal by Subject|48|||
48354753|NCT00497874|155497102|FG001|Overall Study|Withdrawal by Subject|17|||
48354754|NCT00497874|155497101|FG000|Overall Study|Illness|8|||
48354755|NCT00497874|155497102|FG001|Overall Study|Illness|4|||
48354756|NCT00497874|155497101|FG000|Overall Study|Death|2|||
48354757|NCT00497874|155497102|FG001|Overall Study|Death|4|||
48354758|NCT00497874|155497101|FG000|Overall Study|Unable to contact|52|||
48354759|NCT00497874|155497102|FG001|Overall Study|Unable to contact|67|||
48354760|NCT00497874|155497101|FG000|Overall Study|Unable to schedule|37|||
48354761|NCT00497874|155497102|FG001|Overall Study|Unable to schedule|24|||
48354762|NCT01986114|155497107|FG000|Overall Study|Adverse Event|59|||
48354763|NCT01986114|155497107|FG000|Overall Study|Lack of Efficacy|23|||
48354764|NCT01986114|155497107|FG000|Overall Study|Withdrawal by Subject|58|||
48354765|NCT01986114|155497107|FG000|Overall Study|Noncompliance|3|||
48354766|NCT01986114|155497107|FG000|Overall Study|Protocol Violation|1|||
48354767|NCT01986114|155497107|FG000|Overall Study|Lost to Follow-up|5|||
48354768|NCT01986114|155497107|FG000|Overall Study|Other reason|7|||
48354769|NCT02366143|155497108|FG000|Overall Study|Death|307|||
48354770|NCT02366143|155497109|FG001|Overall Study|Death|278|||
48676355|NCT04186871|156667279|FG001|Overall Study|Study terminated by sponsor|2|||
48676356|NCT04186871|156667280|FG002|Overall Study|Study terminated by sponsor|0|||
48676357|NCT04186871|156667281|FG003|Overall Study|Study terminated by sponsor|1|||
48762184|NCT02608268|156978034|FG027|Overall Study|Progressive disease|11|||
48762185|NCT02608268|156978035|FG028|Overall Study|Progressive disease|10|||
48676358|NCT04186871|156667282|FG004|Overall Study|Study terminated by sponsor|0|||
48384323|NCT02464228|155602784|FG003|Overall Study|Miscellaneous|0|||
48384324|NCT02464228|155602781|FG000|Overall Study|Adverse Event|9|||
48384325|NCT02464228|155602782|FG001|Overall Study|Adverse Event|0|||
48384326|NCT02464228|155602783|FG002|Overall Study|Adverse Event|3|||
48384327|NCT02464228|155602784|FG003|Overall Study|Adverse Event|0|||
48384328|NCT02464228|155602781|FG000|Overall Study|Withdrawal by Subject|1|||
48384329|NCT02464228|155602782|FG001|Overall Study|Withdrawal by Subject|1|||
48384330|NCT02464228|155602783|FG002|Overall Study|Withdrawal by Subject|1|||
48384331|NCT02464228|155602784|FG003|Overall Study|Withdrawal by Subject|0|||
48384332|NCT02464228|155602781|FG000|Overall Study|Disease Progression|22|||
48384333|NCT02464228|155602782|FG001|Overall Study|Disease Progression|12|||
48384334|NCT02464228|155602783|FG002|Overall Study|Disease Progression|5|||
48384335|NCT02464228|155602784|FG003|Overall Study|Disease Progression|2|||
48384336|NCT00860951|155602785|FG000|Overall Study|Withdrawal by Subject|2|||
48384337|NCT00860951|155602785|FG000|Overall Study|Lost to Follow-up|5|||
48384338|NCT01650285|155602789|FG000|Overall Study|Adverse Event|1|||
48384339|NCT01794520|155602790|FG000|Overall Study|Adverse events- related to progression|0|||
48384340|NCT01794520|155602791|FG001|Overall Study|Adverse events- related to progression|0|||
48384341|NCT01794520|155602792|FG002|Overall Study|Adverse events- related to progression|1|||
48384342|NCT01794520|155602793|FG003|Overall Study|Adverse events- related to progression|2|||
48384343|NCT01794520|155602794|FG004|Overall Study|Adverse events- related to progression|0|||
48384344|NCT01794520|155602795|FG005|Overall Study|Adverse events- related to progression|1|||
48384345|NCT01794520|155602796|FG006|Overall Study|Adverse events- related to progression|0|||
48384346|NCT01794520|155602790|FG000|Overall Study|Adverse event- not related to progression|1|||
48384347|NCT01794520|155602791|FG001|Overall Study|Adverse event- not related to progression|1|||
48384348|NCT01794520|155602792|FG002|Overall Study|Adverse event- not related to progression|0|||
48384349|NCT01794520|155602793|FG003|Overall Study|Adverse event- not related to progression|0|||
48384350|NCT01794520|155602794|FG004|Overall Study|Adverse event- not related to progression|2|||
48384351|NCT01794520|155602795|FG005|Overall Study|Adverse event- not related to progression|0|||
48384352|NCT01794520|155602796|FG006|Overall Study|Adverse event- not related to progression|0|||
48384353|NCT01794520|155602790|FG000|Overall Study|Progressive disease|5|||
48384354|NCT01794520|155602791|FG001|Overall Study|Progressive disease|6|||
48384355|NCT01794520|155602792|FG002|Overall Study|Progressive disease|2|||
48384356|NCT01794520|155602793|FG003|Overall Study|Progressive disease|5|||
48384357|NCT01794520|155602794|FG004|Overall Study|Progressive disease|27|||
48384358|NCT01794520|155602795|FG005|Overall Study|Progressive disease|18|||
48384359|NCT01794520|155602796|FG006|Overall Study|Progressive disease|0|||
48384360|NCT01794520|155602790|FG000|Overall Study|Withdrew consent|0|||
48384361|NCT01794520|155602791|FG001|Overall Study|Withdrew consent|0|||
48384362|NCT01794520|155602792|FG002|Overall Study|Withdrew consent|1|||
48384363|NCT01794520|155602793|FG003|Overall Study|Withdrew consent|1|||
48384364|NCT01794520|155602794|FG004|Overall Study|Withdrew consent|0|||
48384365|NCT01794520|155602795|FG005|Overall Study|Withdrew consent|0|||
48384366|NCT01794520|155602796|FG006|Overall Study|Withdrew consent|0|||
48384367|NCT01794520|155602790|FG000|Overall Study|Lost to Follow-up|0|||
48384368|NCT01794520|155602791|FG001|Overall Study|Lost to Follow-up|0|||
48384369|NCT01794520|155602792|FG002|Overall Study|Lost to Follow-up|0|||
48384370|NCT01794520|155602793|FG003|Overall Study|Lost to Follow-up|0|||
48384371|NCT01794520|155602794|FG004|Overall Study|Lost to Follow-up|1|||
48384372|NCT01794520|155602795|FG005|Overall Study|Lost to Follow-up|0|||
48384373|NCT01794520|155602796|FG006|Overall Study|Lost to Follow-up|0|||
48384374|NCT01794520|155602790|FG000|Overall Study|Toxicity|0|||
48384375|NCT01794520|155602791|FG001|Overall Study|Toxicity|2|||
48384376|NCT01794520|155602792|FG002|Overall Study|Toxicity|0|||
48676359|NCT04186871|156667283|FG005|Overall Study|Study terminated by sponsor|0|||
48676360|NCT04186871|156667278|FG000|Overall Study|Other reasons|0|||
48676361|NCT04186871|156667279|FG001|Overall Study|Other reasons|0|||
48676362|NCT04186871|156667280|FG002|Overall Study|Other reasons|0|||
48676363|NCT04186871|156667281|FG003|Overall Study|Other reasons|0|||
48676364|NCT04186871|156667282|FG004|Overall Study|Other reasons|0|||
48676365|NCT04186871|156667283|FG005|Overall Study|Other reasons|1|||
48384377|NCT01794520|155602793|FG003|Overall Study|Toxicity|0|||
48384378|NCT01794520|155602794|FG004|Overall Study|Toxicity|0|||
48384379|NCT01794520|155602795|FG005|Overall Study|Toxicity|0|||
48384380|NCT01794520|155602796|FG006|Overall Study|Toxicity|0|||
48384381|NCT01794520|155602790|FG000|Overall Study|Study terminated by sponsor|0|||
48384382|NCT01794520|155602791|FG001|Overall Study|Study terminated by sponsor|0|||
48384383|NCT01794520|155602792|FG002|Overall Study|Study terminated by sponsor|1|||
48384384|NCT01794520|155602793|FG003|Overall Study|Study terminated by sponsor|0|||
48384385|NCT01794520|155602794|FG004|Overall Study|Study terminated by sponsor|1|||
48384386|NCT01794520|155602795|FG005|Overall Study|Study terminated by sponsor|0|||
48384387|NCT01794520|155602796|FG006|Overall Study|Study terminated by sponsor|7|||
48384388|NCT01794520|155602790|FG000|Overall Study|Death|0|||
48384389|NCT01794520|155602791|FG001|Overall Study|Death|0|||
48384390|NCT01794520|155602792|FG002|Overall Study|Death|0|||
48676366|NCT04186871|156667278|FG000|Overall Study|Withdrawal by Subject|0|||
48384391|NCT01794520|155602793|FG003|Overall Study|Death|0|||
48384392|NCT01794520|155602794|FG004|Overall Study|Death|1|||
48384393|NCT01794520|155602795|FG005|Overall Study|Death|0|||
48384394|NCT01794520|155602796|FG006|Overall Study|Death|22|||
48384395|NCT01794520|155602790|FG000|Overall Study|Other, not specified|0|||
48384396|NCT01794520|155602791|FG001|Overall Study|Other, not specified|0|||
48384397|NCT01794520|155602792|FG002|Overall Study|Other, not specified|1|||
48384398|NCT01794520|155602793|FG003|Overall Study|Other, not specified|1|||
48384399|NCT01794520|155602794|FG004|Overall Study|Other, not specified|4|||
48384400|NCT01794520|155602795|FG005|Overall Study|Other, not specified|1|||
48384401|NCT01794520|155602796|FG006|Overall Study|Other, not specified|2|||
48384402|NCT01069120|155602798|FG000|Overall Study|Study prematurely terminated|27|||
48384403|NCT01423812|155602800|FG000|Overall Study|Lost to Follow-up|2|||
48384404|NCT01423812|155602801|FG001|Overall Study|Lost to Follow-up|2|||
48384405|NCT01423812|155602800|FG000|Overall Study|Withdrawal by Subject|1|||
48384406|NCT01423812|155602801|FG001|Overall Study|Withdrawal by Subject|2|||
48384407|NCT03842163|155602802|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
48384408|NCT03842163|155602802|FG000|Overall Study|Scintigraphy was not performed|44|||
48384409|NCT02445755|155602803|FG000|Overall Study|Withdrawal by Subject|2|||
48384410|NCT02445755|155602803|FG000|Overall Study|Protocol Violation|6|||
48384411|NCT02445755|155602803|FG000|Overall Study|Screen Failure|5|||
48384412|NCT00068588|155602804|FG000|Overall Study|Adverse Event|0|||
48384413|NCT00068588|155602805|FG001|Overall Study|Adverse Event|0|||
48384414|NCT00068588|155602806|FG002|Overall Study|Adverse Event|2|||
48384415|NCT00068588|155602804|FG000|Overall Study|Withdrawal by Subject|0|||
48384416|NCT00068588|155602805|FG001|Overall Study|Withdrawal by Subject|0|||
48384417|NCT00068588|155602806|FG002|Overall Study|Withdrawal by Subject|1|||
48384418|NCT00068588|155602804|FG000|Overall Study|Poor KPS|0|||
48384419|NCT00068588|155602805|FG001|Overall Study|Poor KPS|0|||
48384420|NCT00068588|155602806|FG002|Overall Study|Poor KPS|1|||
48384421|NCT03829241|155602807|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
48384422|NCT03829241|155602808|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
48384423|NCT03829241|155602807|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
48384424|NCT03829241|155602808|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
48384425|NCT03829241|155602807|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
48384426|NCT03829241|155602808|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
48384427|NCT03829241|155602807|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
48384428|NCT03829241|155602808|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
48384429|NCT03829241|155602807|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
48384430|NCT03829241|155602808|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
48676367|NCT04186871|156667279|FG001|Overall Study|Withdrawal by Subject|0|||
48676368|NCT04186871|156667280|FG002|Overall Study|Withdrawal by Subject|0|||
48676369|NCT04186871|156667281|FG003|Overall Study|Withdrawal by Subject|0|||
48676370|NCT04186871|156667282|FG004|Overall Study|Withdrawal by Subject|0|||
48676371|NCT04186871|156667283|FG005|Overall Study|Withdrawal by Subject|1|||
48676372|NCT04186871|156667278|FG000|Overall Study|Lost to Follow-up|0|||
48384431|NCT03829241|155602807|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
48384432|NCT03829241|155602808|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
48384433|NCT03829241|155602807|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
48384434|NCT03829241|155602808|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
48384435|NCT03829241|155602807|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
48384436|NCT03829241|155602808|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
48384437|NCT03829241|155602807|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
48384438|NCT03829241|155602808|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
48384439|NCT03829241|155602807|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
48384440|NCT03829241|155602808|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
48384441|NCT03829241|155602807|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
48384442|NCT03829241|155602808|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
48384443|NCT03829241|155602807|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
48384444|NCT03829241|155602808|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
48384445|NCT03829241|155602807|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
48676373|NCT04186871|156667279|FG001|Overall Study|Lost to Follow-up|0|||
48676374|NCT04186871|156667280|FG002|Overall Study|Lost to Follow-up|0|||
48762186|NCT02608268|156978036|FG029|Overall Study|Progressive disease|15|||
48384446|NCT03829241|155602808|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
48384447|NCT03829241|155602807|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
48384448|NCT03829241|155602808|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
48384449|NCT00733304|155602811|FG000|Overall Study|Adverse Event|3|||
48384450|NCT00733304|155602812|FG001|Overall Study|Adverse Event|0|||
48384451|NCT00733304|155602813|FG002|Overall Study|Adverse Event|0|||
48384452|NCT00733304|155602811|FG000|Overall Study|Lack of Efficacy|0|||
48384453|NCT00733304|155602812|FG001|Overall Study|Lack of Efficacy|0|||
48384454|NCT00733304|155602813|FG002|Overall Study|Lack of Efficacy|2|||
48676375|NCT04186871|156667281|FG003|Overall Study|Lost to Follow-up|0|||
48384455|NCT00733304|155602811|FG000|Overall Study|Lost to Follow-up|0|||
48384456|NCT00733304|155602812|FG001|Overall Study|Lost to Follow-up|1|||
48384457|NCT00733304|155602813|FG002|Overall Study|Lost to Follow-up|0|||
48384458|NCT00733304|155602811|FG000|Overall Study|Physician Decision|3|||
48384459|NCT00733304|155602812|FG001|Overall Study|Physician Decision|1|||
48384460|NCT00733304|155602813|FG002|Overall Study|Physician Decision|3|||
48384461|NCT00733304|155602811|FG000|Overall Study|Withdrawal by Subject|1|||
48384462|NCT00733304|155602812|FG001|Overall Study|Withdrawal by Subject|1|||
48676376|NCT04186871|156667282|FG004|Overall Study|Lost to Follow-up|0|||
48676377|NCT04186871|156667283|FG005|Overall Study|Lost to Follow-up|1|||
48676378|NCT03188510|156667289|FG000|Overall Study|Inappropriate behavior with site staff|0|||
48676379|NCT03188510|156667290|FG001|Overall Study|Inappropriate behavior with site staff|1|||
48676380|NCT03188510|156667291|FG002|Overall Study|Inappropriate behavior with site staff|0|||
48384463|NCT00733304|155602813|FG002|Overall Study|Withdrawal by Subject|0|||
48384464|NCT03155373|155602814|FG000|Overall Study|No longer required surgery|1|||
48384465|NCT03155373|155602814|FG000|Overall Study|Protocol Violation|1|||
48384466|NCT03155373|155602814|FG000|Overall Study|Death|2|||
48384467|NCT03155373|155602814|FG000|Overall Study|Withdrawal by Subject|3|||
48384468|NCT02616614|155602815|FG000|Overall Study|Withdrawal by Subject|10|||
48384469|NCT02616614|155602816|FG001|Overall Study|Withdrawal by Subject|5|||
48384470|NCT02616614|155602817|FG002|Overall Study|Withdrawal by Subject|6|||
48384471|NCT02616614|155602815|FG000|Overall Study|Physician Decision|2|||
48384472|NCT02616614|155602816|FG001|Overall Study|Physician Decision|1|||
48384473|NCT02616614|155602817|FG002|Overall Study|Physician Decision|0|||
48384474|NCT02616614|155602815|FG000|Overall Study|Adverse Event|1|||
48384475|NCT02616614|155602816|FG001|Overall Study|Adverse Event|4|||
48384476|NCT02616614|155602817|FG002|Overall Study|Adverse Event|1|||
48384477|NCT02616614|155602815|FG000|Overall Study|Protocol Violation|0|||
48384478|NCT02616614|155602816|FG001|Overall Study|Protocol Violation|3|||
48384479|NCT02616614|155602817|FG002|Overall Study|Protocol Violation|1|||
48384480|NCT02616614|155602815|FG000|Overall Study|Prohibited Medication|12|||
48384481|NCT02616614|155602816|FG001|Overall Study|Prohibited Medication|9|||
48384482|NCT02616614|155602817|FG002|Overall Study|Prohibited Medication|5|||
48384483|NCT02616614|155602815|FG000|Overall Study|More than 3 applications missed|6|||
48384484|NCT02616614|155602816|FG001|Overall Study|More than 3 applications missed|8|||
48384485|NCT02616614|155602817|FG002|Overall Study|More than 3 applications missed|1|||
48384486|NCT02616614|155602815|FG000|Overall Study|Lost to Follow-up|31|||
48384487|NCT02616614|155602816|FG001|Overall Study|Lost to Follow-up|28|||
48384488|NCT02616614|155602817|FG002|Overall Study|Lost to Follow-up|13|||
48384489|NCT02616614|155602815|FG000|Overall Study|Pregnancy|2|||
48384490|NCT02616614|155602816|FG001|Overall Study|Pregnancy|0|||
48384491|NCT02616614|155602817|FG002|Overall Study|Pregnancy|1|||
48384492|NCT02616614|155602815|FG000|Overall Study|Other|1|||
48384493|NCT02616614|155602816|FG001|Overall Study|Other|2|||
48384494|NCT02616614|155602817|FG002|Overall Study|Other|1|||
48384495|NCT01233869|155602819|FG000|Initial Treatment Period (24 Months)|Death|1|||
48384496|NCT01233869|155602820|FG001|Initial Treatment Period (24 Months)|Death|0|||
48384497|NCT01233869|155602821|FG002|Initial Treatment Period (24 Months)|Death|0|||
48384498|NCT01233869|155602822|FG003|Initial Treatment Period (24 Months)|Death|0|||
48384499|NCT01233869|155602819|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
48384500|NCT01233869|155602820|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
48384501|NCT01233869|155602821|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
48676381|NCT03052049|156667292|FG000|Overall Study|Withdrawal by Subject|2|||
48676382|NCT03319212|156667293|FG000|Overall Study|Discontinued as moving out of local area|0|||
48676383|NCT03319212|156667294|FG001|Overall Study|Discontinued as moving out of local area|1|||
48384502|NCT01233869|155602822|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
48384503|NCT01233869|155602819|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
48384504|NCT01233869|155602820|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
48676384|NCT03319212|156667293|FG000|Overall Study|Adverse Event|2|||
48676385|NCT03319212|156667294|FG001|Overall Study|Adverse Event|2|||
48762187|NCT02608268|156978007|FG000|Overall Study|Subject/guardian decision|1|||
48762188|NCT02608268|156978008|FG001|Overall Study|Subject/guardian decision|1|||
48762189|NCT02608268|156978009|FG002|Overall Study|Subject/guardian decision|2|||
48762190|NCT02608268|156978010|FG003|Overall Study|Subject/guardian decision|0|||
48762191|NCT02608268|156978011|FG004|Overall Study|Subject/guardian decision|0|||
48384505|NCT01233869|155602821|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
48384506|NCT01233869|155602822|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
48384507|NCT01233869|155602819|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
48384508|NCT01233869|155602820|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
48384509|NCT01233869|155602821|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
48384510|NCT01233869|155602822|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
48384511|NCT01233869|155602819|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
48384512|NCT01233869|155602820|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
48429378|NCT01070550|155760355|FG000|Overall Study|Protocol Violation|15|||
48384513|NCT01233869|155602821|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
48384514|NCT01233869|155602822|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
48384515|NCT01233869|155602819|FG000|Extended Treatment Period (46 Months)|Other|3|||
48384516|NCT01233869|155602820|FG001|Extended Treatment Period (46 Months)|Other|0|||
48384517|NCT01233869|155602821|FG002|Extended Treatment Period (46 Months)|Other|0|||
48384518|NCT01233869|155602822|FG003|Extended Treatment Period (46 Months)|Other|3|||
48384519|NCT01233869|155602819|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
48384520|NCT01233869|155602820|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
48384521|NCT01233869|155602821|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
48384522|NCT01233869|155602822|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
48384523|NCT00117507|155602835|FG000|Overall Study|Adverse Event|4|||
48384524|NCT00117507|155602835|FG000|Overall Study|Abnormal laboratory values|3|||
48384525|NCT00117507|155602835|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48384526|NCT00117507|155602835|FG000|Overall Study|Patient withdrew consent|4|||
48384527|NCT00117507|155602835|FG000|Overall Study|Death|3|||
48384528|NCT02375724|155602836|FG000|Overall Study|Lack of Efficacy|1|||
48384529|NCT02375724|155602837|FG001|Overall Study|Lack of Efficacy|1|||
48384530|NCT02375724|155602836|FG000|Overall Study|Withdrawal by Subject|1|||
48384531|NCT02375724|155602837|FG001|Overall Study|Withdrawal by Subject|1|||
48384532|NCT02375724|155602836|FG000|Overall Study|Lost to Follow-up|1|||
48384533|NCT02375724|155602837|FG001|Overall Study|Lost to Follow-up|0|||
48384534|NCT02375724|155602836|FG000|Overall Study|Protocol Violation|1|||
48384535|NCT02375724|155602837|FG001|Overall Study|Protocol Violation|0|||
48384536|NCT02375724|155602836|FG000|Overall Study|Adverse Event|2|||
48384537|NCT02375724|155602837|FG001|Overall Study|Adverse Event|4|||
48384538|NCT00369785|155602846|FG000|Overall Study|Physician Decision|3|||
48384539|NCT00369785|155602847|FG001|Overall Study|Physician Decision|2|||
48384540|NCT00369785|155602846|FG000|Overall Study|Death|1|||
48384541|NCT00369785|155602847|FG001|Overall Study|Death|2|||
48384542|NCT00369785|155602846|FG000|Overall Study|Withdrawal by Subject|7|||
48384543|NCT00369785|155602847|FG001|Overall Study|Withdrawal by Subject|6|||
48384544|NCT00369785|155602846|FG000|Overall Study|Toxicity|6|||
48384545|NCT00369785|155602847|FG001|Overall Study|Toxicity|4|||
48384546|NCT00369785|155602846|FG000|Overall Study|Never started|0|||
48384547|NCT00369785|155602847|FG001|Overall Study|Never started|2|||
48384548|NCT00369785|155602846|FG000|Overall Study|Progression|4|||
48384549|NCT00369785|155602847|FG001|Overall Study|Progression|4|||
48384550|NCT00369785|155602846|FG000|Overall Study|Multiple reasons|6|||
48384551|NCT00369785|155602847|FG001|Overall Study|Multiple reasons|5|||
48384552|NCT01022502|155602848|FG000|Overall Study|Adverse Event|1|||
48384553|NCT01022502|155602848|FG000|Overall Study|employment related reasons|1|||
48384554|NCT01022502|155602848|FG000|Overall Study|Withdrawal by Subject|1|||
48384555|NCT00685685|155602849|FG000|Washout Period of 7 Days|Adverse Event|2|||
48384556|NCT00685685|155602850|FG001|Washout Period of 7 Days|Adverse Event|0|||
48384557|NCT00685685|155602849|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
48384558|NCT00685685|155602850|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48384559|NCT00132496|155602853|FG000|Overall Study|Withdrawal by Subject|1|||
48384560|NCT00132496|155602854|FG001|Overall Study|Withdrawal by Subject|2|||
48384561|NCT00132496|155602853|FG000|Overall Study|Physician Decision|1|||
48384562|NCT00132496|155602854|FG001|Overall Study|Physician Decision|0|||
48384563|NCT03986866|155602860|FG000|Overall Study|Withdrawal by Subject|0|||
48384564|NCT03986866|155602861|FG001|Overall Study|Withdrawal by Subject|3|||
48384565|NCT03986866|155602860|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
48384566|NCT03986866|155602861|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
48384567|NCT01130051|155602862|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
48384568|NCT01130051|155602863|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
48384569|NCT01130051|155602862|FG000|Washout Period of 14 Days|Protocol Violation|1|||
48384570|NCT01130051|155602863|FG001|Washout Period of 14 Days|Protocol Violation|1|||
48384571|NCT02383589|155602867|FG000|Treatment Period|Adverse Event|1|||
48384572|NCT02383589|155602868|FG001|Treatment Period|Adverse Event|3|||
48384573|NCT02383589|155602867|FG000|Treatment Period|Lost to Follow-up|0|||
48384574|NCT02383589|155602868|FG001|Treatment Period|Lost to Follow-up|1|||
48384575|NCT02383589|155602867|FG000|Treatment Period|Withdrawal by Subject|0|||
48384576|NCT02383589|155602868|FG001|Treatment Period|Withdrawal by Subject|5|||
48384577|NCT02383589|155602867|FG000|Treatment Period|Non-compliance with study drug|0|||
48384578|NCT02383589|155602868|FG001|Treatment Period|Non-compliance with study drug|1|||
48384579|NCT02383589|155602867|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
48384580|NCT02383589|155602868|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
48384581|NCT02383589|155602867|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
48384582|NCT02383589|155602868|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
48384583|NCT02383589|155602867|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
48384584|NCT02383589|155602868|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
48384585|NCT02906787|155602874|FG000|Overall Study|Withdrawal by Subject|12|||
48676386|NCT03319212|156667293|FG000|Overall Study|Withdrawal by Subject|0|||
48384586|NCT02906787|155602875|FG001|Overall Study|Withdrawal by Subject|10|||
48384587|NCT02906787|155602874|FG000|Overall Study|Missed|24|||
48384588|NCT02906787|155602875|FG001|Overall Study|Missed|22|||
48384589|NCT02592018|155602876|FG000|Overall Study|Adverse Event|1|||
48384590|NCT02592018|155602876|FG000|Overall Study|Lost to Follow-up|1|||
48384591|NCT01357577|155602880|FG000|Overall Study|Lost to Follow-up|20|||
48384592|NCT01357577|155602881|FG001|Overall Study|Lost to Follow-up|16|||
48384593|NCT01357577|155602880|FG000|Overall Study|Withdrawal by Subject|16|||
48384594|NCT01357577|155602881|FG001|Overall Study|Withdrawal by Subject|8|||
48384595|NCT01357577|155602880|FG000|Overall Study|look at data in database?|1|||
48384596|NCT01357577|155602881|FG001|Overall Study|look at data in database?|2|||
48384597|NCT00450216|155602883|FG000|Overall Study|Adverse Event|38|||
48384598|NCT00450216|155602884|FG001|Overall Study|Adverse Event|23|||
48384599|NCT00450216|155602883|FG000|Overall Study|Withdrawal by Subject|48|||
48384600|NCT00450216|155602884|FG001|Overall Study|Withdrawal by Subject|26|||
48384601|NCT00450216|155602883|FG000|Overall Study|Lost to Follow-up|16|||
48384602|NCT00450216|155602884|FG001|Overall Study|Lost to Follow-up|9|||
48384603|NCT00450216|155602883|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
48384604|NCT00450216|155602884|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
48384605|NCT00450216|155602883|FG000|Overall Study|misc|21|||
48384606|NCT00450216|155602884|FG001|Overall Study|misc|20|||
48384607|NCT01117454|155604336|FG000|Overall Study|Pregnancy|0|||
48384608|NCT01117454|155604337|FG001|Overall Study|Pregnancy|1|||
48384609|NCT00419120|155604338|FG000|Long Term Follow up Period|study ongoing|10|||
48384610|NCT00388505|155604341|FG000|Overall Study|Adverse Event or Death|43|||
48384611|NCT00388505|155604342|FG001|Overall Study|Adverse Event or Death|17|||
48384612|NCT00388505|155604341|FG000|Overall Study|Withdrawal by Subject|24|||
48384613|NCT00388505|155604342|FG001|Overall Study|Withdrawal by Subject|9|||
48384614|NCT00388505|155604341|FG000|Overall Study|Lost to Follow-up|5|||
48384615|NCT00388505|155604342|FG001|Overall Study|Lost to Follow-up|3|||
48384616|NCT00388505|155604341|FG000|Overall Study|Inappropriate Enrollment|0|||
48676387|NCT03319212|156667294|FG001|Overall Study|Withdrawal by Subject|1|||
48676388|NCT03319212|156667293|FG000|Overall Study|Lost to Follow-up|0|||
48676389|NCT03319212|156667294|FG001|Overall Study|Lost to Follow-up|1|||
48676390|NCT03319212|156667293|FG000|Overall Study|Physician Decision|1|||
48676391|NCT03319212|156667294|FG001|Overall Study|Physician Decision|0|||
48676392|NCT00250276|156667295|FG000|Overall Study|Serious Adverse Event|0|||
48676393|NCT00250276|156667296|FG001|Overall Study|Serious Adverse Event|0|||
48676394|NCT00250276|156667297|FG002|Overall Study|Serious Adverse Event|1|||
48676395|NCT00250276|156667298|FG003|Overall Study|Serious Adverse Event|0|||
48676396|NCT00250276|156667295|FG000|Overall Study|Non-serious Adverse Event|2|||
48676397|NCT00250276|156667296|FG001|Overall Study|Non-serious Adverse Event|0|||
48676398|NCT00250276|156667297|FG002|Overall Study|Non-serious Adverse Event|0|||
48676399|NCT00250276|156667298|FG003|Overall Study|Non-serious Adverse Event|2|||
48676400|NCT00250276|156667295|FG000|Overall Study|Protocol Violation|0|||
48676401|NCT00250276|156667296|FG001|Overall Study|Protocol Violation|1|||
48676402|NCT00250276|156667297|FG002|Overall Study|Protocol Violation|0|||
48676403|NCT00250276|156667298|FG003|Overall Study|Protocol Violation|0|||
48676404|NCT00250276|156667295|FG000|Overall Study|Withdrawal by Subject|1|||
48676405|NCT00250276|156667296|FG001|Overall Study|Withdrawal by Subject|2|||
48676406|NCT00250276|156667297|FG002|Overall Study|Withdrawal by Subject|3|||
48676407|NCT00250276|156667298|FG003|Overall Study|Withdrawal by Subject|2|||
48676408|NCT00250276|156667295|FG000|Overall Study|Migrated/moved from study area|3|||
48676409|NCT00250276|156667296|FG001|Overall Study|Migrated/moved from study area|0|||
48676410|NCT00250276|156667297|FG002|Overall Study|Migrated/moved from study area|2|||
48676411|NCT00250276|156667298|FG003|Overall Study|Migrated/moved from study area|7|||
48676412|NCT00250276|156667295|FG000|Overall Study|Lost to Follow-up|11|||
48676413|NCT00250276|156667296|FG001|Overall Study|Lost to Follow-up|18|||
48676414|NCT00250276|156667297|FG002|Overall Study|Lost to Follow-up|13|||
48676415|NCT00250276|156667298|FG003|Overall Study|Lost to Follow-up|8|||
48676416|NCT01088399|156667299|FG000|Overall Study|Adverse Event|211|||
48676417|NCT01088399|156667300|FG001|Overall Study|Adverse Event|16|||
48676418|NCT01088399|156667301|FG002|Overall Study|Adverse Event|0|||
48676419|NCT01088399|156667299|FG000|Overall Study|Death|204|||
48676420|NCT01088399|156667300|FG001|Overall Study|Death|45|||
48676421|NCT01088399|156667301|FG002|Overall Study|Death|0|||
48676422|NCT01088399|156667299|FG000|Overall Study|Lack of Efficacy|298|||
48676423|NCT01088399|156667300|FG001|Overall Study|Lack of Efficacy|7|||
48676424|NCT01088399|156667301|FG002|Overall Study|Lack of Efficacy|5|||
48676425|NCT01088399|156667299|FG000|Overall Study|Lost to Follow-up|1070|||
48676426|NCT01088399|156667300|FG001|Overall Study|Lost to Follow-up|278|||
48384617|NCT00388505|155604342|FG001|Overall Study|Inappropriate Enrollment|1|||
48384618|NCT00388505|155604341|FG000|Overall Study|Administrative Reason|1|||
48384619|NCT00388505|155604342|FG001|Overall Study|Administrative Reason|0|||
48384620|NCT00388505|155604341|FG000|Overall Study|Protocol Violation|6|||
48384621|NCT00388505|155604342|FG001|Overall Study|Protocol Violation|5|||
48384622|NCT00388505|155604341|FG000|Overall Study|Unable to classify|4|||
48384623|NCT00388505|155604342|FG001|Overall Study|Unable to classify|3|||
48384624|NCT02248259|155604345|FG000|Treatment Period 1|Adverse Event|0|||
48384625|NCT02248259|155604346|FG001|Treatment Period 1|Adverse Event|0|||
48384626|NCT02248259|155604347|FG002|Treatment Period 1|Adverse Event|1|||
48384627|NCT02248259|155604348|FG003|Treatment Period 1|Adverse Event|0|||
48384628|NCT01205438|155604349|FG000|Overall Study|Adverse Event|19|||
48384629|NCT01205438|155604350|FG001|Overall Study|Adverse Event|17|||
48384630|NCT01205438|155604351|FG002|Overall Study|Adverse Event|24|||
48384631|NCT01205438|155604349|FG000|Overall Study|Death|1|||
48384632|NCT01205438|155604350|FG001|Overall Study|Death|1|||
48384633|NCT01205438|155604351|FG002|Overall Study|Death|3|||
48384634|NCT01205438|155604349|FG000|Overall Study|Entry Criteria Not Met|16|||
48384635|NCT01205438|155604350|FG001|Overall Study|Entry Criteria Not Met|15|||
48384636|NCT01205438|155604351|FG002|Overall Study|Entry Criteria Not Met|13|||
48384637|NCT01205438|155604349|FG000|Overall Study|Lack of Efficacy|14|||
48384638|NCT01205438|155604350|FG001|Overall Study|Lack of Efficacy|11|||
48384639|NCT01205438|155604351|FG002|Overall Study|Lack of Efficacy|14|||
48384640|NCT01205438|155604349|FG000|Overall Study|Lost to Follow-up|6|||
48384641|NCT01205438|155604350|FG001|Overall Study|Lost to Follow-up|7|||
48384642|NCT01205438|155604351|FG002|Overall Study|Lost to Follow-up|8|||
48384643|NCT01205438|155604349|FG000|Overall Study|Withdrawal by Subject|19|||
48384644|NCT01205438|155604350|FG001|Overall Study|Withdrawal by Subject|25|||
48384645|NCT01205438|155604351|FG002|Overall Study|Withdrawal by Subject|19|||
48384646|NCT01205438|155604349|FG000|Overall Study|Physician Decision|0|||
48384647|NCT01205438|155604350|FG001|Overall Study|Physician Decision|3|||
48384648|NCT01205438|155604351|FG002|Overall Study|Physician Decision|2|||
48384649|NCT01205438|155604349|FG000|Overall Study|Protocol Violation|2|||
48384650|NCT01205438|155604350|FG001|Overall Study|Protocol Violation|7|||
48384651|NCT01205438|155604351|FG002|Overall Study|Protocol Violation|4|||
48384652|NCT01205438|155604349|FG000|Overall Study|Sponsor Decision|0|||
48384653|NCT01205438|155604350|FG001|Overall Study|Sponsor Decision|1|||
48384654|NCT01205438|155604351|FG002|Overall Study|Sponsor Decision|1|||
48384655|NCT01641237|155604352|FG000|Period II|Withdrawal by Subject|1|||
48384656|NCT01641237|155604353|FG001|Period II|Withdrawal by Subject|0|||
48384657|NCT01641237|155604354|FG002|Period II|Withdrawal by Subject|0|||
48384658|NCT01641237|155604355|FG003|Period II|Withdrawal by Subject|0|||
48676427|NCT01088399|156667301|FG002|Overall Study|Lost to Follow-up|58|||
48676428|NCT01088399|156667299|FG000|Overall Study|Physician Decision|531|||
48676429|NCT01088399|156667300|FG001|Overall Study|Physician Decision|88|||
48676430|NCT01088399|156667301|FG002|Overall Study|Physician Decision|16|||
48676431|NCT01088399|156667299|FG000|Overall Study|Withdrawal by Subject|544|||
48676432|NCT01088399|156667300|FG001|Overall Study|Withdrawal by Subject|195|||
48676433|NCT01088399|156667301|FG002|Overall Study|Withdrawal by Subject|33|||
48676434|NCT01088399|156667299|FG000|Overall Study|Change to or start of somatropin therapy|234|||
48676435|NCT01088399|156667300|FG001|Overall Study|Change to or start of somatropin therapy|17|||
48676436|NCT01088399|156667301|FG002|Overall Study|Change to or start of somatropin therapy|12|||
48676437|NCT01088399|156667299|FG000|Overall Study|Sponsor decision|1573|||
48676438|NCT01088399|156667300|FG001|Overall Study|Sponsor decision|298|||
48676439|NCT01088399|156667301|FG002|Overall Study|Sponsor decision|7|||
48676440|NCT01088399|156667299|FG000|Overall Study|Protocol Violation|10|||
48384659|NCT01641237|155604352|FG000|Period III|Lost to Follow-up|1|||
48384660|NCT01641237|155604353|FG001|Period III|Lost to Follow-up|0|||
48384661|NCT01641237|155604354|FG002|Period III|Lost to Follow-up|0|||
48384662|NCT01641237|155604355|FG003|Period III|Lost to Follow-up|0|||
48384663|NCT00915772|155604356|FG000|Overall Study|Adverse Event|12|||
48384664|NCT00915772|155604357|FG001|Overall Study|Adverse Event|13|||
48384665|NCT00915772|155604358|FG002|Overall Study|Adverse Event|11|||
48384666|NCT00915772|155604356|FG000|Overall Study|Protocol Violation|4|||
48384667|NCT00915772|155604357|FG001|Overall Study|Protocol Violation|1|||
48384668|NCT00915772|155604358|FG002|Overall Study|Protocol Violation|2|||
48384669|NCT00915772|155604356|FG000|Overall Study|Lost to Follow-up|1|||
48384670|NCT00915772|155604357|FG001|Overall Study|Lost to Follow-up|2|||
48384671|NCT00915772|155604358|FG002|Overall Study|Lost to Follow-up|2|||
48676441|NCT01088399|156667300|FG001|Overall Study|Protocol Violation|1|||
48676442|NCT01088399|156667301|FG002|Overall Study|Protocol Violation|0|||
48676443|NCT01088399|156667299|FG000|Overall Study|Enrollment criteria not met|48|||
48762192|NCT02608268|156978012|FG005|Overall Study|Subject/guardian decision|0|||
48762193|NCT02608268|156978013|FG006|Overall Study|Subject/guardian decision|0|||
48762194|NCT02608268|156978014|FG007|Overall Study|Subject/guardian decision|0|||
48384672|NCT00915772|155604356|FG000|Overall Study|Lack of Efficacy|9|||
48384673|NCT00915772|155604357|FG001|Overall Study|Lack of Efficacy|15|||
48384674|NCT00915772|155604358|FG002|Overall Study|Lack of Efficacy|3|||
48384675|NCT00915772|155604356|FG000|Overall Study|Refused to continue trial medication|6|||
48384676|NCT00915772|155604357|FG001|Overall Study|Refused to continue trial medication|8|||
48384677|NCT00915772|155604358|FG002|Overall Study|Refused to continue trial medication|4|||
48384678|NCT00915772|155604356|FG000|Overall Study|Any other reason|4|||
48384679|NCT00915772|155604357|FG001|Overall Study|Any other reason|7|||
48384680|NCT00915772|155604358|FG002|Overall Study|Any other reason|7|||
48384681|NCT00909181|155604361|FG000|Overall Study|Lost to Follow-up|39|||
48384682|NCT00909181|155604362|FG001|Overall Study|Lost to Follow-up|18|||
48762195|NCT02608268|156978015|FG008|Overall Study|Subject/guardian decision|2|||
48384683|NCT00909181|155604363|FG002|Overall Study|Lost to Follow-up|33|||
48384684|NCT00404066|155604366|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
48384685|NCT00404066|155604366|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
48384686|NCT01087957|155604368|FG000|Overall Study|Death|2|||
48384687|NCT01087957|155604369|FG001|Overall Study|Death|2|||
48384688|NCT01087957|155604368|FG000|Overall Study|Lost to Follow-up|3|||
48384689|NCT01087957|155604369|FG001|Overall Study|Lost to Follow-up|4|||
48676444|NCT01088399|156667300|FG001|Overall Study|Enrollment criteria not met|119|||
48676445|NCT01088399|156667301|FG002|Overall Study|Enrollment criteria not met|70|||
48676446|NCT01088399|156667299|FG000|Overall Study|Study summary visit not completed|2398|||
48676447|NCT01088399|156667300|FG001|Overall Study|Study summary visit not completed|283|||
48676448|NCT01088399|156667301|FG002|Overall Study|Study summary visit not completed|80|||
48676449|NCT01052077|156667304|FG000|Phase A|Lost to Follow-up|22|||
48676450|NCT01052077|156667305|FG001|Phase A|Lost to Follow-up|0|||
48676451|NCT01052077|156667306|FG002|Phase A|Lost to Follow-up|0|||
48762196|NCT02608268|156978016|FG009|Overall Study|Subject/guardian decision|2|||
48762197|NCT02608268|156978017|FG010|Overall Study|Subject/guardian decision|0|||
48762198|NCT02608268|156978018|FG011|Overall Study|Subject/guardian decision|1|||
48762199|NCT02608268|156978019|FG012|Overall Study|Subject/guardian decision|0|||
48762200|NCT02608268|156978020|FG013|Overall Study|Subject/guardian decision|1|||
48762201|NCT02608268|156978021|FG014|Overall Study|Subject/guardian decision|0|||
48762202|NCT02608268|156978022|FG015|Overall Study|Subject/guardian decision|1|||
48762203|NCT02608268|156978023|FG016|Overall Study|Subject/guardian decision|0|||
48762204|NCT02608268|156978024|FG017|Overall Study|Subject/guardian decision|0|||
48762205|NCT02608268|156978025|FG018|Overall Study|Subject/guardian decision|1|||
48762206|NCT02608268|156978026|FG019|Overall Study|Subject/guardian decision|0|||
48762207|NCT02608268|156978027|FG020|Overall Study|Subject/guardian decision|0|||
48762208|NCT02608268|156978028|FG021|Overall Study|Subject/guardian decision|0|||
48762209|NCT02608268|156978029|FG022|Overall Study|Subject/guardian decision|1|||
48762210|NCT02608268|156978030|FG023|Overall Study|Subject/guardian decision|0|||
48762211|NCT02608268|156978031|FG024|Overall Study|Subject/guardian decision|0|||
48762212|NCT02608268|156978032|FG025|Overall Study|Subject/guardian decision|1|||
48762213|NCT02608268|156978033|FG026|Overall Study|Subject/guardian decision|1|||
48762214|NCT02608268|156978034|FG027|Overall Study|Subject/guardian decision|1|||
48762215|NCT02608268|156978035|FG028|Overall Study|Subject/guardian decision|1|||
48762216|NCT02608268|156978036|FG029|Overall Study|Subject/guardian decision|0|||
48762217|NCT04865354|156978037|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
48762218|NCT04865354|156978038|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
48762219|NCT04865354|156978037|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
48762220|NCT04865354|156978038|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
48762221|NCT04865354|156978037|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
48762222|NCT04865354|156978038|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
48762223|NCT04782856|156978042|FG000|Overall Study|Withdrawal by Subject|0|||
48762224|NCT04782856|156978043|FG001|Overall Study|Withdrawal by Subject|1|||
48762225|NCT01030523|156978044|FG000|Initial Study (5 Years)|Death|1|||
48762226|NCT01030523|156978045|FG001|Initial Study (5 Years)|Death|0|||
48762227|NCT01030523|156978044|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
48762228|NCT01030523|156978045|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
48762229|NCT01030523|156978044|FG000|Initial Study (5 Years)|Implant failure|1|||
48762230|NCT01030523|156978045|FG001|Initial Study (5 Years)|Implant failure|0|||
48762231|NCT01030523|156978044|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
48762232|NCT01030523|156978045|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
48384690|NCT01087957|155604368|FG000|Overall Study|Protocol Violation|13|||
48384691|NCT01087957|155604369|FG001|Overall Study|Protocol Violation|25|||
48384692|NCT01087957|155604368|FG000|Overall Study|Withdrawal by Subject|18|||
48384693|NCT01087957|155604369|FG001|Overall Study|Withdrawal by Subject|15|||
48676452|NCT01052077|156667307|FG003|Phase A|Lost to Follow-up|0|||
48676453|NCT01052077|156667304|FG000|Phase A|Adverse Event|32|||
48676454|NCT01052077|156667305|FG001|Phase A|Adverse Event|0|||
48676455|NCT01052077|156667306|FG002|Phase A|Adverse Event|0|||
48676456|NCT01052077|156667307|FG003|Phase A|Adverse Event|0|||
48676457|NCT01052077|156667304|FG000|Phase A|Met Withdrawal Criteria|26|||
48384694|NCT01087957|155604368|FG000|Overall Study|Physician Decision|5|||
48384695|NCT01087957|155604369|FG001|Overall Study|Physician Decision|9|||
48384696|NCT00467779|155604372|FG000|Stage 1|Adverse Event|1|||
48384697|NCT00467779|155604373|FG001|Stage 1|Adverse Event|0|||
48384698|NCT00467779|155604374|FG002|Stage 1|Adverse Event|0|||
48676458|NCT01052077|156667305|FG001|Phase A|Met Withdrawal Criteria|0|||
48762233|NCT01030523|156978044|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
48762234|NCT01030523|156978045|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
48762235|NCT01030523|156978044|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
48384699|NCT00467779|155604375|FG003|Stage 1|Adverse Event|0|||
48384700|NCT00467779|155604376|FG004|Stage 1|Adverse Event|0|||
48384701|NCT00467779|155604377|FG005|Stage 1|Adverse Event|1|||
48676459|NCT01052077|156667306|FG002|Phase A|Met Withdrawal Criteria|0|||
48762236|NCT01030523|156978045|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
48676460|NCT01052077|156667307|FG003|Phase A|Met Withdrawal Criteria|0|||
48676461|NCT01052077|156667304|FG000|Phase A|Physician Decision|10|||
48676462|NCT01052077|156667305|FG001|Phase A|Physician Decision|0|||
48676463|NCT01052077|156667306|FG002|Phase A|Physician Decision|0|||
48676464|NCT01052077|156667307|FG003|Phase A|Physician Decision|0|||
48676465|NCT01052077|156667304|FG000|Phase A|Withdrawal by Subject|29|||
48676466|NCT01052077|156667305|FG001|Phase A|Withdrawal by Subject|0|||
48676467|NCT01052077|156667306|FG002|Phase A|Withdrawal by Subject|0|||
48676468|NCT01052077|156667307|FG003|Phase A|Withdrawal by Subject|0|||
48676469|NCT01052077|156667304|FG000|Phase A|Protocol Deviation|27|||
48676470|NCT01052077|156667305|FG001|Phase A|Protocol Deviation|0|||
48676471|NCT01052077|156667306|FG002|Phase A|Protocol Deviation|0|||
48676472|NCT01052077|156667307|FG003|Phase A|Protocol Deviation|0|||
48676473|NCT01052077|156667304|FG000|Phase B|Lost to Follow-up|0|||
48676474|NCT01052077|156667305|FG001|Phase B|Lost to Follow-up|2|||
48676475|NCT01052077|156667306|FG002|Phase B|Lost to Follow-up|3|||
48676476|NCT01052077|156667307|FG003|Phase B|Lost to Follow-up|0|||
48676477|NCT01052077|156667304|FG000|Phase B|Adverse Event|0|||
48676478|NCT01052077|156667305|FG001|Phase B|Adverse Event|9|||
48676479|NCT01052077|156667306|FG002|Phase B|Adverse Event|2|||
48676480|NCT01052077|156667307|FG003|Phase B|Adverse Event|0|||
48676481|NCT01052077|156667304|FG000|Phase B|Met Withdrawal Criteria|0|||
48676482|NCT01052077|156667305|FG001|Phase B|Met Withdrawal Criteria|2|||
48676483|NCT01052077|156667306|FG002|Phase B|Met Withdrawal Criteria|1|||
48676484|NCT01052077|156667307|FG003|Phase B|Met Withdrawal Criteria|0|||
48676485|NCT01052077|156667304|FG000|Phase B|Physician Decision|0|||
48676486|NCT01052077|156667305|FG001|Phase B|Physician Decision|1|||
48676487|NCT01052077|156667306|FG002|Phase B|Physician Decision|1|||
48676488|NCT01052077|156667307|FG003|Phase B|Physician Decision|0|||
48676489|NCT01052077|156667304|FG000|Phase B|Withdrawal by Subject|0|||
48676490|NCT01052077|156667305|FG001|Phase B|Withdrawal by Subject|0|||
48676491|NCT01052077|156667306|FG002|Phase B|Withdrawal by Subject|5|||
48676492|NCT01052077|156667307|FG003|Phase B|Withdrawal by Subject|0|||
48676493|NCT01052077|156667304|FG000|Phase B|Protocol Deviation|0|||
48676494|NCT01052077|156667305|FG001|Phase B|Protocol Deviation|3|||
48676495|NCT01052077|156667306|FG002|Phase B|Protocol Deviation|4|||
48676496|NCT01052077|156667307|FG003|Phase B|Protocol Deviation|0|||
48676497|NCT01052077|156667304|FG000|Phase B|Lack of Efficacy|0|||
48676498|NCT01052077|156667305|FG001|Phase B|Lack of Efficacy|1|||
48676499|NCT01052077|156667306|FG002|Phase B|Lack of Efficacy|0|||
48676500|NCT01052077|156667307|FG003|Phase B|Lack of Efficacy|0|||
48676501|NCT01052077|156667304|FG000|Phase A+|Lost to Follow-up|0|||
48676502|NCT01052077|156667305|FG001|Phase A+|Lost to Follow-up|0|||
48676503|NCT01052077|156667306|FG002|Phase A+|Lost to Follow-up|0|||
48676504|NCT01052077|156667307|FG003|Phase A+|Lost to Follow-up|8|||
48676505|NCT01052077|156667304|FG000|Phase A+|Adverse Event|0|||
48676506|NCT01052077|156667305|FG001|Phase A+|Adverse Event|0|||
48762237|NCT03020823|156978050|FG000|Overall Study|Physician Decision|4|||
48762238|NCT03020823|156978050|FG000|Overall Study|Lack of Efficacy|4|||
48762239|NCT03020823|156978050|FG000|Overall Study|Adverse Event|2|||
48762240|NCT04307446|156978052|FG000|Overall Study|Lost to Follow-up|2|||
48762241|NCT04307446|156978053|FG001|Overall Study|Lost to Follow-up|0|||
48762242|NCT01859494|156978054|FG000|Overall Study|Adverse Event|1|||
48762243|NCT01957462|156978055|FG000|Test Period 1|Withdrawal by Subject|1|||
48762244|NCT01957462|156978056|FG001|Test Period 1|Withdrawal by Subject|0|||
48762245|NCT01957462|156978055|FG000|Test Period 1|Adverse Event|1|||
48762246|NCT01957462|156978056|FG001|Test Period 1|Adverse Event|0|||
48762247|NCT02529137|156978057|FG000|Overall Study|Discontinuation for different reasons|8|||
48762248|NCT02476968|156978058|FG000|Overall Study|Other|0|||
48762249|NCT02476968|156978059|FG001|Overall Study|Other|2|||
48762250|NCT02476968|156978060|FG002|Overall Study|Other|0|||
48762251|NCT02476968|156978058|FG000|Overall Study|Lost to Follow-up|10|||
48762252|NCT02476968|156978059|FG001|Overall Study|Lost to Follow-up|0|||
48762253|NCT02476968|156978060|FG002|Overall Study|Lost to Follow-up|1|||
48676507|NCT01052077|156667306|FG002|Phase A+|Adverse Event|0|||
48676508|NCT01052077|156667307|FG003|Phase A+|Adverse Event|4|||
48676509|NCT01052077|156667304|FG000|Phase A+|Met Withdrawal Criteria|0|||
48676510|NCT01052077|156667305|FG001|Phase A+|Met Withdrawal Criteria|0|||
48676511|NCT01052077|156667306|FG002|Phase A+|Met Withdrawal Criteria|0|||
48676512|NCT01052077|156667307|FG003|Phase A+|Met Withdrawal Criteria|2|||
48676513|NCT01052077|156667304|FG000|Phase A+|Withdrawal by Subject|0|||
48676514|NCT01052077|156667305|FG001|Phase A+|Withdrawal by Subject|0|||
48762254|NCT02476968|156978058|FG000|Overall Study|Death|48|||
48762255|NCT02476968|156978059|FG001|Overall Study|Death|8|||
48676515|NCT01052077|156667306|FG002|Phase A+|Withdrawal by Subject|0|||
48676516|NCT01052077|156667307|FG003|Phase A+|Withdrawal by Subject|7|||
48676517|NCT01811186|156667309|FG000|Overall Study|Adverse Event|54|||
48676518|NCT01811186|156667310|FG001|Overall Study|Adverse Event|38|||
48676519|NCT01811186|156667309|FG000|Overall Study|Protocol Violation|5|||
48676520|NCT01811186|156667310|FG001|Overall Study|Protocol Violation|6|||
48676521|NCT01811186|156667309|FG000|Overall Study|Withdrawal by Subject|5|||
48762256|NCT02476968|156978060|FG002|Overall Study|Death|1|||
48384702|NCT00467779|155604378|FG006|Stage 1|Adverse Event|2|||
48384703|NCT00467779|155604379|FG007|Stage 1|Adverse Event|1|||
48384704|NCT00467779|155604380|FG008|Stage 1|Adverse Event|0|||
48384705|NCT00467779|155604381|FG009|Stage 1|Adverse Event|0|||
48384706|NCT00467779|155604382|FG010|Stage 1|Adverse Event|0|||
48384707|NCT00467779|155604383|FG011|Stage 1|Adverse Event|0|||
48384708|NCT00467779|155604384|FG012|Stage 1|Adverse Event|0|||
48384709|NCT00467779|155604385|FG013|Stage 1|Adverse Event|0|||
48384710|NCT00467779|155604386|FG014|Stage 1|Adverse Event|0|||
48384711|NCT00467779|155604372|FG000|Stage 1|Disease Progression|2|||
48384712|NCT00467779|155604373|FG001|Stage 1|Disease Progression|2|||
48384713|NCT00467779|155604374|FG002|Stage 1|Disease Progression|2|||
48384714|NCT00467779|155604375|FG003|Stage 1|Disease Progression|3|||
48384715|NCT00467779|155604376|FG004|Stage 1|Disease Progression|2|||
48384716|NCT00467779|155604377|FG005|Stage 1|Disease Progression|2|||
48384717|NCT00467779|155604378|FG006|Stage 1|Disease Progression|4|||
48384718|NCT00467779|155604379|FG007|Stage 1|Disease Progression|5|||
48384719|NCT00467779|155604380|FG008|Stage 1|Disease Progression|0|||
48384720|NCT00467779|155604381|FG009|Stage 1|Disease Progression|0|||
48384721|NCT00467779|155604382|FG010|Stage 1|Disease Progression|0|||
48384722|NCT00467779|155604383|FG011|Stage 1|Disease Progression|0|||
48384723|NCT00467779|155604384|FG012|Stage 1|Disease Progression|0|||
48384724|NCT00467779|155604385|FG013|Stage 1|Disease Progression|0|||
48384725|NCT00467779|155604386|FG014|Stage 1|Disease Progression|0|||
48384726|NCT00467779|155604372|FG000|Stage 1|Unspecified Reason|1|||
48384727|NCT00467779|155604373|FG001|Stage 1|Unspecified Reason|0|||
48384728|NCT00467779|155604374|FG002|Stage 1|Unspecified Reason|1|||
48384729|NCT00467779|155604375|FG003|Stage 1|Unspecified Reason|0|||
48384730|NCT00467779|155604376|FG004|Stage 1|Unspecified Reason|1|||
48384731|NCT00467779|155604377|FG005|Stage 1|Unspecified Reason|2|||
48384732|NCT00467779|155604378|FG006|Stage 1|Unspecified Reason|0|||
48384733|NCT00467779|155604379|FG007|Stage 1|Unspecified Reason|0|||
48384734|NCT00467779|155604380|FG008|Stage 1|Unspecified Reason|0|||
48384735|NCT00467779|155604381|FG009|Stage 1|Unspecified Reason|0|||
48676522|NCT01811186|156667310|FG001|Overall Study|Withdrawal by Subject|10|||
48676523|NCT01811186|156667309|FG000|Overall Study|Lack of Efficacy|3|||
48676524|NCT01811186|156667310|FG001|Overall Study|Lack of Efficacy|6|||
48676525|NCT01811186|156667309|FG000|Overall Study|Lost to Follow-up|4|||
48676526|NCT01811186|156667310|FG001|Overall Study|Lost to Follow-up|2|||
48676527|NCT00042991|156667313|FG000|Overall Study|Adverse Event|1|||
48676528|NCT00042991|156667314|FG001|Overall Study|Adverse Event|4|||
48676529|NCT00042991|156667315|FG002|Overall Study|Adverse Event|2|||
48676530|NCT00042991|156667316|FG003|Overall Study|Adverse Event|0|||
48676531|NCT00042991|156667317|FG004|Overall Study|Adverse Event|0|||
48676532|NCT00042991|156667318|FG005|Overall Study|Adverse Event|1|||
48676533|NCT00042991|156667319|FG006|Overall Study|Adverse Event|0|||
48676534|NCT00042991|156667313|FG000|Overall Study|Withdrawal by Subject|0|||
48676535|NCT00042991|156667314|FG001|Overall Study|Withdrawal by Subject|7|||
48676536|NCT00042991|156667315|FG002|Overall Study|Withdrawal by Subject|2|||
48676537|NCT00042991|156667316|FG003|Overall Study|Withdrawal by Subject|0|||
48676538|NCT00042991|156667317|FG004|Overall Study|Withdrawal by Subject|1|||
48676539|NCT00042991|156667318|FG005|Overall Study|Withdrawal by Subject|0|||
48676540|NCT00042991|156667319|FG006|Overall Study|Withdrawal by Subject|0|||
48676541|NCT00042991|156667313|FG000|Overall Study|Disease Progression|5|||
48676542|NCT00042991|156667314|FG001|Overall Study|Disease Progression|29|||
48676543|NCT00042991|156667315|FG002|Overall Study|Disease Progression|2|||
48676544|NCT00042991|156667316|FG003|Overall Study|Disease Progression|2|||
48676545|NCT00042991|156667317|FG004|Overall Study|Disease Progression|1|||
48676546|NCT00042991|156667318|FG005|Overall Study|Disease Progression|4|||
48676547|NCT00042991|156667319|FG006|Overall Study|Disease Progression|2|||
48676548|NCT00042991|156667313|FG000|Overall Study|Alternative Therapy|0|||
48676549|NCT00042991|156667314|FG001|Overall Study|Alternative Therapy|0|||
48676550|NCT00042991|156667315|FG002|Overall Study|Alternative Therapy|0|||
48676551|NCT00042991|156667316|FG003|Overall Study|Alternative Therapy|0|||
48676552|NCT00042991|156667317|FG004|Overall Study|Alternative Therapy|1|||
48676553|NCT00042991|156667318|FG005|Overall Study|Alternative Therapy|0|||
48676554|NCT00042991|156667319|FG006|Overall Study|Alternative Therapy|0|||
48676555|NCT03193736|156667320|FG000|Overall Study|Death|2|||
48676556|NCT03193736|156667320|FG000|Overall Study|Withdrawal by Subject|1|||
48676557|NCT03193736|156667320|FG000|Overall Study|Lost to Follow-up|1|||
48676558|NCT03193736|156667320|FG000|Overall Study|implant not received|1|||
48676559|NCT02508428|156667321|FG000|Overall Study|Death|32|||
48384736|NCT00467779|155604382|FG010|Stage 1|Unspecified Reason|0|||
48384737|NCT00467779|155604383|FG011|Stage 1|Unspecified Reason|0|||
48384738|NCT00467779|155604384|FG012|Stage 1|Unspecified Reason|0|||
48384739|NCT00467779|155604385|FG013|Stage 1|Unspecified Reason|0|||
48384740|NCT00467779|155604386|FG014|Stage 1|Unspecified Reason|0|||
48676560|NCT02508428|156667322|FG001|Overall Study|Death|33|||
48676561|NCT02508428|156667321|FG000|Overall Study|Liner revised|3|||
48676562|NCT02508428|156667322|FG001|Overall Study|Liner revised|19|||
48676563|NCT02508428|156667321|FG000|Overall Study|Incomplete follow-up|17|||
48384741|NCT00467779|155604372|FG000|Stage 1|Physician Decision|0|||
48384742|NCT00467779|155604373|FG001|Stage 1|Physician Decision|1|||
48384743|NCT00467779|155604374|FG002|Stage 1|Physician Decision|0|||
48384744|NCT00467779|155604375|FG003|Stage 1|Physician Decision|0|||
48384745|NCT00467779|155604376|FG004|Stage 1|Physician Decision|0|||
48384746|NCT00467779|155604377|FG005|Stage 1|Physician Decision|0|||
48384747|NCT00467779|155604378|FG006|Stage 1|Physician Decision|0|||
48384748|NCT00467779|155604379|FG007|Stage 1|Physician Decision|0|||
48384749|NCT00467779|155604380|FG008|Stage 1|Physician Decision|0|||
48384750|NCT00467779|155604381|FG009|Stage 1|Physician Decision|0|||
48384751|NCT00467779|155604382|FG010|Stage 1|Physician Decision|0|||
48384752|NCT00467779|155604383|FG011|Stage 1|Physician Decision|0|||
48384753|NCT00467779|155604384|FG012|Stage 1|Physician Decision|0|||
48384754|NCT00467779|155604385|FG013|Stage 1|Physician Decision|0|||
48384755|NCT00467779|155604386|FG014|Stage 1|Physician Decision|0|||
48384756|NCT00467779|155604372|FG000|Stage 1|Withdrawal by Subject|0|||
48384757|NCT00467779|155604373|FG001|Stage 1|Withdrawal by Subject|0|||
48384758|NCT00467779|155604374|FG002|Stage 1|Withdrawal by Subject|0|||
48384759|NCT00467779|155604375|FG003|Stage 1|Withdrawal by Subject|0|||
48384760|NCT00467779|155604376|FG004|Stage 1|Withdrawal by Subject|0|||
48384761|NCT00467779|155604377|FG005|Stage 1|Withdrawal by Subject|0|||
48384762|NCT00467779|155604378|FG006|Stage 1|Withdrawal by Subject|1|||
48384763|NCT00467779|155604379|FG007|Stage 1|Withdrawal by Subject|1|||
48384764|NCT00467779|155604380|FG008|Stage 1|Withdrawal by Subject|0|||
48384765|NCT00467779|155604381|FG009|Stage 1|Withdrawal by Subject|0|||
48384766|NCT00467779|155604382|FG010|Stage 1|Withdrawal by Subject|0|||
48384767|NCT00467779|155604383|FG011|Stage 1|Withdrawal by Subject|0|||
48384768|NCT00467779|155604384|FG012|Stage 1|Withdrawal by Subject|0|||
48384769|NCT00467779|155604385|FG013|Stage 1|Withdrawal by Subject|0|||
48384770|NCT00467779|155604386|FG014|Stage 1|Withdrawal by Subject|0|||
48384771|NCT00467779|155604372|FG000|Stage 1A|Adverse Event|0|||
48384772|NCT00467779|155604373|FG001|Stage 1A|Adverse Event|0|||
48384773|NCT00467779|155604374|FG002|Stage 1A|Adverse Event|0|||
48384774|NCT00467779|155604375|FG003|Stage 1A|Adverse Event|0|||
48384775|NCT00467779|155604376|FG004|Stage 1A|Adverse Event|0|||
48384776|NCT00467779|155604377|FG005|Stage 1A|Adverse Event|0|||
48384777|NCT00467779|155604378|FG006|Stage 1A|Adverse Event|0|||
48384778|NCT00467779|155604379|FG007|Stage 1A|Adverse Event|0|||
48384779|NCT00467779|155604380|FG008|Stage 1A|Adverse Event|0|||
48384780|NCT00467779|155604381|FG009|Stage 1A|Adverse Event|0|||
48384781|NCT00467779|155604382|FG010|Stage 1A|Adverse Event|0|||
48384782|NCT00467779|155604383|FG011|Stage 1A|Adverse Event|0|||
48384783|NCT00467779|155604384|FG012|Stage 1A|Adverse Event|1|||
48384784|NCT00467779|155604385|FG013|Stage 1A|Adverse Event|0|||
48384785|NCT00467779|155604386|FG014|Stage 1A|Adverse Event|0|||
48384786|NCT00467779|155604372|FG000|Stage 1A|Death|0|||
48384787|NCT00467779|155604373|FG001|Stage 1A|Death|0|||
48384788|NCT00467779|155604374|FG002|Stage 1A|Death|0|||
48384789|NCT00467779|155604375|FG003|Stage 1A|Death|0|||
48384790|NCT00467779|155604376|FG004|Stage 1A|Death|0|||
48384791|NCT00467779|155604377|FG005|Stage 1A|Death|0|||
48384792|NCT00467779|155604378|FG006|Stage 1A|Death|0|||
48384793|NCT00467779|155604379|FG007|Stage 1A|Death|0|||
48384794|NCT00467779|155604380|FG008|Stage 1A|Death|0|||
48384795|NCT00467779|155604381|FG009|Stage 1A|Death|0|||
48384796|NCT00467779|155604382|FG010|Stage 1A|Death|0|||
48384797|NCT00467779|155604383|FG011|Stage 1A|Death|1|||
48384798|NCT00467779|155604384|FG012|Stage 1A|Death|1|||
48384799|NCT00467779|155604385|FG013|Stage 1A|Death|0|||
48384800|NCT00467779|155604386|FG014|Stage 1A|Death|0|||
48384801|NCT00467779|155604372|FG000|Stage 1A|Disease Progression|0|||
48384802|NCT00467779|155604373|FG001|Stage 1A|Disease Progression|0|||
48384803|NCT00467779|155604374|FG002|Stage 1A|Disease Progression|0|||
48384804|NCT00467779|155604375|FG003|Stage 1A|Disease Progression|0|||
48384805|NCT00467779|155604376|FG004|Stage 1A|Disease Progression|0|||
48384806|NCT00467779|155604377|FG005|Stage 1A|Disease Progression|0|||
48384807|NCT00467779|155604378|FG006|Stage 1A|Disease Progression|0|||
48384808|NCT00467779|155604379|FG007|Stage 1A|Disease Progression|0|||
48384809|NCT00467779|155604380|FG008|Stage 1A|Disease Progression|0|||
48384810|NCT00467779|155604381|FG009|Stage 1A|Disease Progression|2|||
48384811|NCT00467779|155604382|FG010|Stage 1A|Disease Progression|2|||
48384812|NCT00467779|155604383|FG011|Stage 1A|Disease Progression|5|||
48384813|NCT00467779|155604384|FG012|Stage 1A|Disease Progression|2|||
48384814|NCT00467779|155604385|FG013|Stage 1A|Disease Progression|0|||
48384815|NCT00467779|155604386|FG014|Stage 1A|Disease Progression|0|||
48384816|NCT00467779|155604372|FG000|Stage 1A|Physician Decision|0|||
48384817|NCT00467779|155604373|FG001|Stage 1A|Physician Decision|0|||
48384818|NCT00467779|155604374|FG002|Stage 1A|Physician Decision|0|||
48384819|NCT00467779|155604375|FG003|Stage 1A|Physician Decision|0|||
48384820|NCT00467779|155604376|FG004|Stage 1A|Physician Decision|0|||
48384821|NCT00467779|155604377|FG005|Stage 1A|Physician Decision|0|||
48384822|NCT00467779|155604378|FG006|Stage 1A|Physician Decision|0|||
48384823|NCT00467779|155604379|FG007|Stage 1A|Physician Decision|0|||
48384824|NCT00467779|155604380|FG008|Stage 1A|Physician Decision|0|||
48384825|NCT00467779|155604381|FG009|Stage 1A|Physician Decision|1|||
48384826|NCT00467779|155604382|FG010|Stage 1A|Physician Decision|0|||
48384827|NCT00467779|155604383|FG011|Stage 1A|Physician Decision|0|||
48384828|NCT00467779|155604384|FG012|Stage 1A|Physician Decision|0|||
48384829|NCT00467779|155604385|FG013|Stage 1A|Physician Decision|0|||
48384830|NCT00467779|155604386|FG014|Stage 1A|Physician Decision|0|||
48384831|NCT00467779|155604372|FG000|Stage 1A|Withdrawal by Subject|0|||
48384832|NCT00467779|155604373|FG001|Stage 1A|Withdrawal by Subject|0|||
48384833|NCT00467779|155604374|FG002|Stage 1A|Withdrawal by Subject|0|||
48384834|NCT00467779|155604375|FG003|Stage 1A|Withdrawal by Subject|0|||
48384835|NCT00467779|155604376|FG004|Stage 1A|Withdrawal by Subject|0|||
48384836|NCT00467779|155604377|FG005|Stage 1A|Withdrawal by Subject|0|||
48384837|NCT00467779|155604378|FG006|Stage 1A|Withdrawal by Subject|0|||
48384838|NCT00467779|155604379|FG007|Stage 1A|Withdrawal by Subject|0|||
48384839|NCT00467779|155604380|FG008|Stage 1A|Withdrawal by Subject|0|||
48384840|NCT00467779|155604381|FG009|Stage 1A|Withdrawal by Subject|0|||
48384841|NCT00467779|155604382|FG010|Stage 1A|Withdrawal by Subject|1|||
48384842|NCT00467779|155604383|FG011|Stage 1A|Withdrawal by Subject|1|||
48384843|NCT00467779|155604384|FG012|Stage 1A|Withdrawal by Subject|1|||
48384844|NCT00467779|155604385|FG013|Stage 1A|Withdrawal by Subject|0|||
48384845|NCT00467779|155604386|FG014|Stage 1A|Withdrawal by Subject|0|||
48384846|NCT00467779|155604372|FG000|Stage 1A|Unspecified Reason|0|||
48384847|NCT00467779|155604373|FG001|Stage 1A|Unspecified Reason|0|||
48384848|NCT00467779|155604374|FG002|Stage 1A|Unspecified Reason|0|||
48384849|NCT00467779|155604375|FG003|Stage 1A|Unspecified Reason|0|||
48384850|NCT00467779|155604376|FG004|Stage 1A|Unspecified Reason|0|||
48384851|NCT00467779|155604377|FG005|Stage 1A|Unspecified Reason|0|||
48384852|NCT00467779|155604378|FG006|Stage 1A|Unspecified Reason|0|||
48384853|NCT00467779|155604379|FG007|Stage 1A|Unspecified Reason|0|||
48384854|NCT00467779|155604380|FG008|Stage 1A|Unspecified Reason|0|||
48384855|NCT00467779|155604381|FG009|Stage 1A|Unspecified Reason|0|||
48384856|NCT00467779|155604382|FG010|Stage 1A|Unspecified Reason|0|||
48384857|NCT00467779|155604383|FG011|Stage 1A|Unspecified Reason|1|||
48384858|NCT00467779|155604384|FG012|Stage 1A|Unspecified Reason|1|||
48384859|NCT00467779|155604385|FG013|Stage 1A|Unspecified Reason|0|||
48384860|NCT00467779|155604386|FG014|Stage 1A|Unspecified Reason|0|||
48384861|NCT00467779|155604372|FG000|Stage 2|Adverse Event|0|||
48384862|NCT00467779|155604373|FG001|Stage 2|Adverse Event|0|||
48384863|NCT00467779|155604374|FG002|Stage 2|Adverse Event|0|||
48384864|NCT00467779|155604375|FG003|Stage 2|Adverse Event|0|||
48384865|NCT00467779|155604376|FG004|Stage 2|Adverse Event|0|||
48384866|NCT00467779|155604377|FG005|Stage 2|Adverse Event|0|||
48384867|NCT00467779|155604378|FG006|Stage 2|Adverse Event|0|||
48384868|NCT00467779|155604379|FG007|Stage 2|Adverse Event|0|||
48384869|NCT00467779|155604380|FG008|Stage 2|Adverse Event|1|||
48384870|NCT00467779|155604381|FG009|Stage 2|Adverse Event|0|||
48384871|NCT00467779|155604382|FG010|Stage 2|Adverse Event|0|||
48384872|NCT00467779|155604383|FG011|Stage 2|Adverse Event|0|||
48384873|NCT00467779|155604384|FG012|Stage 2|Adverse Event|0|||
48384874|NCT00467779|155604385|FG013|Stage 2|Adverse Event|0|||
48384875|NCT00467779|155604386|FG014|Stage 2|Adverse Event|0|||
48384876|NCT00467779|155604372|FG000|Stage 2|Death|0|||
48384877|NCT00467779|155604373|FG001|Stage 2|Death|0|||
48384878|NCT00467779|155604374|FG002|Stage 2|Death|0|||
48384879|NCT00467779|155604375|FG003|Stage 2|Death|0|||
48384880|NCT00467779|155604376|FG004|Stage 2|Death|0|||
48384881|NCT00467779|155604377|FG005|Stage 2|Death|0|||
48384882|NCT00467779|155604378|FG006|Stage 2|Death|0|||
48384883|NCT00467779|155604379|FG007|Stage 2|Death|0|||
48384884|NCT00467779|155604380|FG008|Stage 2|Death|1|||
48384885|NCT00467779|155604381|FG009|Stage 2|Death|0|||
48384886|NCT00467779|155604382|FG010|Stage 2|Death|0|||
48384887|NCT00467779|155604383|FG011|Stage 2|Death|0|||
48384888|NCT00467779|155604384|FG012|Stage 2|Death|0|||
48384889|NCT00467779|155604385|FG013|Stage 2|Death|0|||
48384890|NCT00467779|155604386|FG014|Stage 2|Death|0|||
48384891|NCT00467779|155604372|FG000|Stage 2|Disease Progression|0|||
48384892|NCT00467779|155604373|FG001|Stage 2|Disease Progression|0|||
48384893|NCT00467779|155604374|FG002|Stage 2|Disease Progression|0|||
48384894|NCT00467779|155604375|FG003|Stage 2|Disease Progression|0|||
48384895|NCT00467779|155604376|FG004|Stage 2|Disease Progression|0|||
48384896|NCT00467779|155604377|FG005|Stage 2|Disease Progression|0|||
48384897|NCT00467779|155604378|FG006|Stage 2|Disease Progression|0|||
48384898|NCT00467779|155604379|FG007|Stage 2|Disease Progression|0|||
48384899|NCT00467779|155604380|FG008|Stage 2|Disease Progression|16|||
48384900|NCT00467779|155604381|FG009|Stage 2|Disease Progression|0|||
48384901|NCT00467779|155604382|FG010|Stage 2|Disease Progression|0|||
48384902|NCT00467779|155604383|FG011|Stage 2|Disease Progression|0|||
48384903|NCT00467779|155604384|FG012|Stage 2|Disease Progression|0|||
48384904|NCT00467779|155604385|FG013|Stage 2|Disease Progression|0|||
48384905|NCT00467779|155604386|FG014|Stage 2|Disease Progression|0|||
48384906|NCT00467779|155604372|FG000|Stage 2|Unspecified Reason|0|||
48384907|NCT00467779|155604373|FG001|Stage 2|Unspecified Reason|0|||
48384908|NCT00467779|155604374|FG002|Stage 2|Unspecified Reason|0|||
48384909|NCT00467779|155604375|FG003|Stage 2|Unspecified Reason|0|||
48384910|NCT00467779|155604376|FG004|Stage 2|Unspecified Reason|0|||
48384911|NCT00467779|155604377|FG005|Stage 2|Unspecified Reason|0|||
48384912|NCT00467779|155604378|FG006|Stage 2|Unspecified Reason|0|||
48384913|NCT00467779|155604379|FG007|Stage 2|Unspecified Reason|0|||
48384914|NCT00467779|155604380|FG008|Stage 2|Unspecified Reason|3|||
48384915|NCT00467779|155604381|FG009|Stage 2|Unspecified Reason|0|||
48384916|NCT00467779|155604382|FG010|Stage 2|Unspecified Reason|0|||
48384917|NCT00467779|155604383|FG011|Stage 2|Unspecified Reason|0|||
48384918|NCT00467779|155604384|FG012|Stage 2|Unspecified Reason|0|||
48384919|NCT00467779|155604385|FG013|Stage 2|Unspecified Reason|0|||
48384920|NCT00467779|155604386|FG014|Stage 2|Unspecified Reason|0|||
48384921|NCT00467779|155604372|FG000|Stage 2A|Adverse Event|0|||
48384922|NCT00467779|155604373|FG001|Stage 2A|Adverse Event|0|||
48384923|NCT00467779|155604374|FG002|Stage 2A|Adverse Event|0|||
48384924|NCT00467779|155604375|FG003|Stage 2A|Adverse Event|0|||
48384925|NCT00467779|155604376|FG004|Stage 2A|Adverse Event|0|||
48384926|NCT00467779|155604377|FG005|Stage 2A|Adverse Event|0|||
48384927|NCT00467779|155604378|FG006|Stage 2A|Adverse Event|0|||
48384928|NCT00467779|155604379|FG007|Stage 2A|Adverse Event|0|||
48384929|NCT00467779|155604380|FG008|Stage 2A|Adverse Event|0|||
48384930|NCT00467779|155604381|FG009|Stage 2A|Adverse Event|0|||
48384931|NCT00467779|155604382|FG010|Stage 2A|Adverse Event|0|||
48384932|NCT00467779|155604383|FG011|Stage 2A|Adverse Event|0|||
48384933|NCT00467779|155604384|FG012|Stage 2A|Adverse Event|0|||
48384934|NCT00467779|155604385|FG013|Stage 2A|Adverse Event|2|||
48384935|NCT00467779|155604386|FG014|Stage 2A|Adverse Event|0|||
48384936|NCT00467779|155604372|FG000|Stage 2A|Death|0|||
48384937|NCT00467779|155604373|FG001|Stage 2A|Death|0|||
48384938|NCT00467779|155604374|FG002|Stage 2A|Death|0|||
48384939|NCT00467779|155604375|FG003|Stage 2A|Death|0|||
48384940|NCT00467779|155604376|FG004|Stage 2A|Death|0|||
48384941|NCT00467779|155604377|FG005|Stage 2A|Death|0|||
48384942|NCT00467779|155604378|FG006|Stage 2A|Death|0|||
48384943|NCT00467779|155604379|FG007|Stage 2A|Death|0|||
48384944|NCT00467779|155604380|FG008|Stage 2A|Death|0|||
48384945|NCT00467779|155604381|FG009|Stage 2A|Death|0|||
48384946|NCT00467779|155604382|FG010|Stage 2A|Death|0|||
48384947|NCT00467779|155604383|FG011|Stage 2A|Death|0|||
48384948|NCT00467779|155604384|FG012|Stage 2A|Death|0|||
48384949|NCT00467779|155604385|FG013|Stage 2A|Death|1|||
48384950|NCT00467779|155604386|FG014|Stage 2A|Death|0|||
48384951|NCT00467779|155604372|FG000|Stage 2A|Disease Progression|0|||
48384952|NCT00467779|155604373|FG001|Stage 2A|Disease Progression|0|||
48384953|NCT00467779|155604374|FG002|Stage 2A|Disease Progression|0|||
48384954|NCT00467779|155604375|FG003|Stage 2A|Disease Progression|0|||
48384955|NCT00467779|155604376|FG004|Stage 2A|Disease Progression|0|||
48384956|NCT00467779|155604377|FG005|Stage 2A|Disease Progression|0|||
48384957|NCT00467779|155604378|FG006|Stage 2A|Disease Progression|0|||
48384958|NCT00467779|155604379|FG007|Stage 2A|Disease Progression|0|||
48384959|NCT00467779|155604380|FG008|Stage 2A|Disease Progression|0|||
48384960|NCT00467779|155604381|FG009|Stage 2A|Disease Progression|0|||
48384961|NCT00467779|155604382|FG010|Stage 2A|Disease Progression|0|||
48384962|NCT00467779|155604383|FG011|Stage 2A|Disease Progression|0|||
48384963|NCT00467779|155604384|FG012|Stage 2A|Disease Progression|0|||
48384964|NCT00467779|155604385|FG013|Stage 2A|Disease Progression|10|||
48384965|NCT00467779|155604386|FG014|Stage 2A|Disease Progression|0|||
48384966|NCT00467779|155604372|FG000|Stage 2A|Unspecified Reason|0|||
48384967|NCT00467779|155604373|FG001|Stage 2A|Unspecified Reason|0|||
48384968|NCT00467779|155604374|FG002|Stage 2A|Unspecified Reason|0|||
48384969|NCT00467779|155604375|FG003|Stage 2A|Unspecified Reason|0|||
48676564|NCT02508428|156667322|FG001|Overall Study|Incomplete follow-up|15|||
48676565|NCT02476006|156667327|FG000|Overall Study|Death|4|||
48384970|NCT00467779|155604376|FG004|Stage 2A|Unspecified Reason|0|||
48384971|NCT00467779|155604377|FG005|Stage 2A|Unspecified Reason|0|||
48384972|NCT00467779|155604378|FG006|Stage 2A|Unspecified Reason|0|||
48676566|NCT02476006|156667327|FG000|Overall Study|Lack of treatment efficacy|2|||
48384973|NCT00467779|155604379|FG007|Stage 2A|Unspecified Reason|0|||
48384974|NCT00467779|155604380|FG008|Stage 2A|Unspecified Reason|0|||
48384975|NCT00467779|155604381|FG009|Stage 2A|Unspecified Reason|0|||
48384976|NCT00467779|155604382|FG010|Stage 2A|Unspecified Reason|0|||
48384977|NCT00467779|155604383|FG011|Stage 2A|Unspecified Reason|0|||
48384978|NCT00467779|155604384|FG012|Stage 2A|Unspecified Reason|0|||
48384979|NCT00467779|155604385|FG013|Stage 2A|Unspecified Reason|7|||
48384980|NCT00467779|155604386|FG014|Stage 2A|Unspecified Reason|0|||
48384981|NCT00467779|155604372|FG000|Stage 2A|Withdrawal by Subject|0|||
48384982|NCT00467779|155604373|FG001|Stage 2A|Withdrawal by Subject|0|||
48384983|NCT00467779|155604374|FG002|Stage 2A|Withdrawal by Subject|0|||
48384984|NCT00467779|155604375|FG003|Stage 2A|Withdrawal by Subject|0|||
48384985|NCT00467779|155604376|FG004|Stage 2A|Withdrawal by Subject|0|||
48384986|NCT00467779|155604377|FG005|Stage 2A|Withdrawal by Subject|0|||
48384987|NCT00467779|155604378|FG006|Stage 2A|Withdrawal by Subject|0|||
48384988|NCT00467779|155604379|FG007|Stage 2A|Withdrawal by Subject|0|||
48384989|NCT00467779|155604380|FG008|Stage 2A|Withdrawal by Subject|0|||
48384990|NCT00467779|155604381|FG009|Stage 2A|Withdrawal by Subject|0|||
48384991|NCT00467779|155604382|FG010|Stage 2A|Withdrawal by Subject|0|||
48676567|NCT02476006|156667327|FG000|Overall Study|Pregnancy|1|||
48676568|NCT02476006|156667327|FG000|Overall Study|Participant did not wish to continue|39|||
48676569|NCT02476006|156667327|FG000|Overall Study|Adverse Event|41|||
48676570|NCT02476006|156667327|FG000|Overall Study|Poor compliance to study protocol|3|||
48676571|NCT02476006|156667327|FG000|Overall Study|Sponsor decision|6|||
48676572|NCT02476006|156667327|FG000|Overall Study|Lost to Follow-up|5|||
48676573|NCT02476006|156667327|FG000|Overall Study|Physician Decision|5|||
48676574|NCT02476006|156667327|FG000|Overall Study|Study ended treatment not available|4|||
48676575|NCT02476006|156667327|FG000|Overall Study|Switched to commercial drug|4|||
48676576|NCT02476006|156667327|FG000|Overall Study|Excluded from study|1|||
48676577|NCT02476006|156667327|FG000|Overall Study|Protocol Violation|1|||
48676578|NCT02476006|156667327|FG000|Overall Study|Enrolled but not treated|4|||
48676579|NCT03772665|156667328|FG000|Overall Study|Protocol Violation|1|||
48676580|NCT03772665|156667329|FG001|Overall Study|Protocol Violation|0|||
48384992|NCT00467779|155604383|FG011|Stage 2A|Withdrawal by Subject|0|||
48676581|NCT02688985|156669062|FG000|Overall Study|Adverse Event|1|||
48676582|NCT02688985|156669063|FG001|Overall Study|Adverse Event|2|||
48676583|NCT02688985|156669064|FG002|Overall Study|Adverse Event|2|||
48676584|NCT02688985|156669065|FG003|Overall Study|Adverse Event|0|||
48676585|NCT02688985|156669066|FG004|Overall Study|Adverse Event|0|||
48676586|NCT02688985|156669062|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
48676587|NCT02688985|156669063|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
48676588|NCT02688985|156669064|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
48676589|NCT02688985|156669065|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
48676590|NCT02688985|156669066|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
48384993|NCT00467779|155604384|FG012|Stage 2A|Withdrawal by Subject|0|||
48384994|NCT00467779|155604385|FG013|Stage 2A|Withdrawal by Subject|1|||
48384995|NCT00467779|155604386|FG014|Stage 2A|Withdrawal by Subject|0|||
48384996|NCT00467779|155604372|FG000|Stage 3|Adverse Event|0|||
48384997|NCT00467779|155604373|FG001|Stage 3|Adverse Event|0|||
48384998|NCT00467779|155604374|FG002|Stage 3|Adverse Event|0|||
48384999|NCT00467779|155604375|FG003|Stage 3|Adverse Event|0|||
48385000|NCT00467779|155604376|FG004|Stage 3|Adverse Event|0|||
48385001|NCT00467779|155604377|FG005|Stage 3|Adverse Event|0|||
48385002|NCT00467779|155604378|FG006|Stage 3|Adverse Event|0|||
48385003|NCT00467779|155604379|FG007|Stage 3|Adverse Event|0|||
48385004|NCT00467779|155604380|FG008|Stage 3|Adverse Event|0|||
48385005|NCT00467779|155604381|FG009|Stage 3|Adverse Event|0|||
48385006|NCT00467779|155604382|FG010|Stage 3|Adverse Event|0|||
48385007|NCT00467779|155604383|FG011|Stage 3|Adverse Event|0|||
48385008|NCT00467779|155604384|FG012|Stage 3|Adverse Event|0|||
48385009|NCT00467779|155604385|FG013|Stage 3|Adverse Event|0|||
48385010|NCT00467779|155604386|FG014|Stage 3|Adverse Event|2|||
48385011|NCT00467779|155604372|FG000|Stage 3|Death|0|||
48385012|NCT00467779|155604373|FG001|Stage 3|Death|0|||
48385013|NCT00467779|155604374|FG002|Stage 3|Death|0|||
48676591|NCT02688985|156669062|FG000|Overall Study|Death|0|||
48676592|NCT02688985|156669063|FG001|Overall Study|Death|0|||
48385014|NCT00467779|155604375|FG003|Stage 3|Death|0|||
48385015|NCT00467779|155604376|FG004|Stage 3|Death|0|||
48385016|NCT00467779|155604377|FG005|Stage 3|Death|0|||
48385017|NCT00467779|155604378|FG006|Stage 3|Death|0|||
48385018|NCT00467779|155604379|FG007|Stage 3|Death|0|||
48385019|NCT00467779|155604380|FG008|Stage 3|Death|0|||
48385020|NCT00467779|155604381|FG009|Stage 3|Death|0|||
48385021|NCT00467779|155604382|FG010|Stage 3|Death|0|||
48385022|NCT00467779|155604383|FG011|Stage 3|Death|0|||
48385023|NCT00467779|155604384|FG012|Stage 3|Death|0|||
48385024|NCT00467779|155604385|FG013|Stage 3|Death|0|||
48385025|NCT00467779|155604386|FG014|Stage 3|Death|1|||
48385026|NCT00467779|155604372|FG000|Stage 3|Disease Progression|0|||
48385027|NCT00467779|155604373|FG001|Stage 3|Disease Progression|0|||
48385028|NCT00467779|155604374|FG002|Stage 3|Disease Progression|0|||
48385029|NCT00467779|155604375|FG003|Stage 3|Disease Progression|0|||
48385030|NCT00467779|155604376|FG004|Stage 3|Disease Progression|0|||
48385031|NCT00467779|155604377|FG005|Stage 3|Disease Progression|0|||
48385032|NCT00467779|155604378|FG006|Stage 3|Disease Progression|0|||
48385033|NCT00467779|155604379|FG007|Stage 3|Disease Progression|0|||
48385034|NCT00467779|155604380|FG008|Stage 3|Disease Progression|0|||
48385035|NCT00467779|155604381|FG009|Stage 3|Disease Progression|0|||
48385036|NCT00467779|155604382|FG010|Stage 3|Disease Progression|0|||
48385037|NCT00467779|155604383|FG011|Stage 3|Disease Progression|0|||
48385038|NCT00467779|155604384|FG012|Stage 3|Disease Progression|0|||
48385039|NCT00467779|155604385|FG013|Stage 3|Disease Progression|0|||
48385040|NCT00467779|155604386|FG014|Stage 3|Disease Progression|9|||
48385041|NCT00467779|155604372|FG000|Stage 3|Unspecified Reason|0|||
48385042|NCT00467779|155604373|FG001|Stage 3|Unspecified Reason|0|||
48385043|NCT00467779|155604374|FG002|Stage 3|Unspecified Reason|0|||
48385044|NCT00467779|155604375|FG003|Stage 3|Unspecified Reason|0|||
48385045|NCT00467779|155604376|FG004|Stage 3|Unspecified Reason|0|||
48385046|NCT00467779|155604377|FG005|Stage 3|Unspecified Reason|0|||
48385047|NCT00467779|155604378|FG006|Stage 3|Unspecified Reason|0|||
48385048|NCT00467779|155604379|FG007|Stage 3|Unspecified Reason|0|||
48385049|NCT00467779|155604380|FG008|Stage 3|Unspecified Reason|0|||
48385050|NCT00467779|155604381|FG009|Stage 3|Unspecified Reason|0|||
48385051|NCT00467779|155604382|FG010|Stage 3|Unspecified Reason|0|||
48385052|NCT00467779|155604383|FG011|Stage 3|Unspecified Reason|0|||
48385053|NCT00467779|155604384|FG012|Stage 3|Unspecified Reason|0|||
48385054|NCT00467779|155604385|FG013|Stage 3|Unspecified Reason|0|||
48385055|NCT00467779|155604386|FG014|Stage 3|Unspecified Reason|5|||
48385056|NCT05111041|155604387|FG000|Overall Study|Lost to Follow-up|6|||
48385057|NCT05111041|155604388|FG001|Overall Study|Lost to Follow-up|7|||
48385058|NCT05111041|155604387|FG000|Overall Study|Withdrawal by Subject|1|||
48385059|NCT05111041|155604388|FG001|Overall Study|Withdrawal by Subject|0|||
48385060|NCT01519934|155604389|FG000|Overall Study|Lost to Follow-up|3|||
48385061|NCT04784897|155604390|FG000|Overall Study|Death|4|||
48385062|NCT04784897|155604391|FG001|Overall Study|Death|2|||
48385063|NCT04784897|155604392|FG002|Overall Study|Death|1|||
48385064|NCT04784897|155604390|FG000|Overall Study|Withdrawal by Subject|0|||
48385065|NCT04784897|155604391|FG001|Overall Study|Withdrawal by Subject|0|||
48385066|NCT04784897|155604392|FG002|Overall Study|Withdrawal by Subject|1|||
48385067|NCT00698204|155604393|FG000|Overall Study|Withdrawal by Subject|1|||
48385068|NCT00698204|155604394|FG001|Overall Study|Withdrawal by Subject|0|||
48385069|NCT00216203|155604395|FG000|Overall Study|Withdrawal by Subject|2|||
48385070|NCT02224599|155604396|FG000|Overall Study|Physician Decision|1|||
48385071|NCT02224599|155604396|FG000|Overall Study|Progression of Disease|1|||
48385072|NCT00314249|155604397|FG000|Overall Study|Adverse Event|73|||
48385073|NCT00314249|155604398|FG001|Overall Study|Adverse Event|94|||
48676593|NCT02688985|156669064|FG002|Overall Study|Death|0|||
48676594|NCT02688985|156669065|FG003|Overall Study|Death|0|||
48676595|NCT02688985|156669066|FG004|Overall Study|Death|1|||
48676596|NCT02688985|156669062|FG000|Overall Study|Lack of Efficacy|0|||
48385074|NCT00314249|155604397|FG000|Overall Study|Lack of Efficacy|33|||
48385075|NCT00314249|155604398|FG001|Overall Study|Lack of Efficacy|24|||
48385076|NCT00314249|155604397|FG000|Overall Study|Withdrawal by Subject|21|||
48385077|NCT00314249|155604398|FG001|Overall Study|Withdrawal by Subject|28|||
48385078|NCT00314249|155604397|FG000|Overall Study|Lost to Follow-up|15|||
48385079|NCT00314249|155604398|FG001|Overall Study|Lost to Follow-up|9|||
48385080|NCT00314249|155604397|FG000|Overall Study|Physician Decision|1|||
48385081|NCT00314249|155604398|FG001|Overall Study|Physician Decision|1|||
48385082|NCT00314249|155604397|FG000|Overall Study|Withdrawn for other reasons|4|||
48385083|NCT00314249|155604398|FG001|Overall Study|Withdrawn for other reasons|1|||
48385084|NCT00314249|155604397|FG000|Overall Study|Non-Compliant|5|||
48385085|NCT00314249|155604398|FG001|Overall Study|Non-Compliant|6|||
48385086|NCT01187550|155604399|FG000|Overall Study|Protocol Violation|3|||
48385087|NCT01187550|155604400|FG001|Overall Study|Protocol Violation|1|||
48385088|NCT01187550|155604399|FG000|Overall Study|Other|3|||
48385089|NCT01187550|155604400|FG001|Overall Study|Other|0|||
48385090|NCT01187550|155604399|FG000|Overall Study|Randomized but not treated|8|||
48385091|NCT01187550|155604400|FG001|Overall Study|Randomized but not treated|0|||
48385092|NCT03838198|155604412|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
48385093|NCT03838198|155604413|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
48385094|NCT03838198|155604414|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
48385095|NCT03838198|155604415|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
48385096|NCT03838198|155604412|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
48385097|NCT03838198|155604413|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
48385098|NCT03838198|155604414|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
48385099|NCT03838198|155604415|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
48385100|NCT01230554|155604416|FG000|Overall Study|Lost to Follow-up|2|||
48385101|NCT01230554|155604416|FG000|Overall Study|Inability to maintain visit schedule|1|||
48385102|NCT04195581|155604430|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
48385103|NCT04195581|155604430|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
48385104|NCT04195581|155604430|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
48385105|NCT04195581|155604430|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
48385106|NCT04195581|155604430|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
48385107|NCT04195581|155604430|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
48385108|NCT00935272|155604434|FG000|Overall Study|Lost to Follow-up|10|||
48385109|NCT00935272|155604435|FG001|Overall Study|Lost to Follow-up|3|||
48385110|NCT00935272|155604434|FG000|Overall Study|Withdrawal by Subject|8|||
48385111|NCT00935272|155604435|FG001|Overall Study|Withdrawal by Subject|2|||
48385112|NCT00935272|155604434|FG000|Overall Study|Physician Decision|1|||
48385113|NCT00935272|155604435|FG001|Overall Study|Physician Decision|0|||
48385114|NCT00935272|155604434|FG000|Overall Study|Protocol Violation|0|||
48385115|NCT00935272|155604435|FG001|Overall Study|Protocol Violation|1|||
48385116|NCT01910116|155604439|FG000|Overall Study|Adverse Event|0|||
48385117|NCT01910116|155604440|FG001|Overall Study|Adverse Event|3|||
48385118|NCT01910116|155604439|FG000|Overall Study|Lack of Efficacy|3|||
48385119|NCT01910116|155604440|FG001|Overall Study|Lack of Efficacy|4|||
48385120|NCT01910116|155604439|FG000|Overall Study|Lost to Follow-up|1|||
48385121|NCT01910116|155604440|FG001|Overall Study|Lost to Follow-up|0|||
48385122|NCT01910116|155604439|FG000|Overall Study|Protocol Violation|1|||
48385123|NCT01910116|155604440|FG001|Overall Study|Protocol Violation|2|||
48385124|NCT01910116|155604439|FG000|Overall Study|Withdrawal by Subject|8|||
48385125|NCT01910116|155604440|FG001|Overall Study|Withdrawal by Subject|3|||
48385126|NCT01910116|155604439|FG000|Overall Study|uncertain allocation|1|||
48385127|NCT01910116|155604440|FG001|Overall Study|uncertain allocation|3|||
48385128|NCT01910116|155604439|FG000|Overall Study|incomplete data|0|||
48385129|NCT01910116|155604440|FG001|Overall Study|incomplete data|1|||
48385130|NCT00736034|155604441|FG000|Overall Study|Adverse Event|2|||
48385131|NCT01610687|155604445|FG000|Overall Study|Lack of Efficacy|26|||
48385132|NCT01610687|155604445|FG000|Overall Study|Adverse Event|18|||
48676597|NCT02688985|156669063|FG001|Overall Study|Lack of Efficacy|0|||
48676598|NCT02688985|156669064|FG002|Overall Study|Lack of Efficacy|0|||
48676599|NCT02688985|156669065|FG003|Overall Study|Lack of Efficacy|0|||
48385133|NCT01610687|155604445|FG000|Overall Study|Moved out of area|6|||
48385134|NCT01610687|155604445|FG000|Overall Study|Withdrawal by Subject|7|||
48385135|NCT01610687|155604445|FG000|Overall Study|Lost to Follow-up|4|||
48385136|NCT01610687|155604445|FG000|Overall Study|Symptom control without study medication|2|||
48385137|NCT01610687|155604445|FG000|Overall Study|Unable to make journey|1|||
48385138|NCT01610687|155604445|FG000|Overall Study|Death|1|||
48385139|NCT01610687|155604445|FG000|Overall Study|Cannabis affecting job|1|||
48676600|NCT02688985|156669066|FG004|Overall Study|Lack of Efficacy|1|||
48676601|NCT02688985|156669062|FG000|Overall Study|Lost to Follow-up|2|||
48385140|NCT01610687|155604445|FG000|Overall Study|Felt more alter without study medication|1|||
48385141|NCT03716050|155604446|FG000|Overall Study|Lost to Follow-up|0|||
48385142|NCT03716050|155604447|FG001|Overall Study|Lost to Follow-up|0|||
48385143|NCT03716050|155604448|FG002|Overall Study|Lost to Follow-up|1|||
48385144|NCT03716050|155604449|FG003|Overall Study|Lost to Follow-up|0|||
48385145|NCT03716050|155604450|FG004|Overall Study|Lost to Follow-up|0|||
48385146|NCT03716050|155604451|FG005|Overall Study|Lost to Follow-up|0|||
48385147|NCT03716050|155604452|FG006|Overall Study|Lost to Follow-up|0|||
48385148|NCT03716050|155604453|FG007|Overall Study|Lost to Follow-up|0|||
48385149|NCT03716050|155604446|FG000|Overall Study|Physician Decision|0|||
48385150|NCT03716050|155604447|FG001|Overall Study|Physician Decision|0|||
48385151|NCT03716050|155604448|FG002|Overall Study|Physician Decision|0|||
48385152|NCT03716050|155604449|FG003|Overall Study|Physician Decision|1|||
48385153|NCT03716050|155604450|FG004|Overall Study|Physician Decision|0|||
48385154|NCT03716050|155604451|FG005|Overall Study|Physician Decision|0|||
48385155|NCT03716050|155604452|FG006|Overall Study|Physician Decision|0|||
48385156|NCT03716050|155604453|FG007|Overall Study|Physician Decision|0|||
48385157|NCT03716050|155604446|FG000|Overall Study|Protocol Violation|0|||
48385158|NCT03716050|155604447|FG001|Overall Study|Protocol Violation|0|||
48385159|NCT03716050|155604448|FG002|Overall Study|Protocol Violation|0|||
48385160|NCT03716050|155604449|FG003|Overall Study|Protocol Violation|1|||
48385161|NCT03716050|155604450|FG004|Overall Study|Protocol Violation|0|||
48385162|NCT03716050|155604451|FG005|Overall Study|Protocol Violation|0|||
48385163|NCT03716050|155604452|FG006|Overall Study|Protocol Violation|0|||
48385164|NCT03716050|155604453|FG007|Overall Study|Protocol Violation|2|||
48385165|NCT03123250|155604454|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
48385166|NCT00732251|155604455|FG000|Overall Study|Lost to Follow-up|3|||
48385167|NCT00732251|155604455|FG000|Overall Study|Withdrawal by Subject|3|||
48385168|NCT00732251|155604455|FG000|Overall Study|Early Term due to Site Closure|1|||
48385169|NCT00521053|155604456|FG000|Observation Phase|Disease Progression|55|||
48385170|NCT00521053|155604456|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
48385171|NCT00521053|155604456|FG000|Observation Phase|Death|2|||
48385172|NCT00521053|155604456|FG000|Observation Phase|Adverse Event|1|||
48385173|NCT00521053|155604456|FG000|Observation Phase|Other non-study melanoma treatment|1|||
48385174|NCT00521053|155604456|FG000|Observation Phase|Physician Decision|1|||
48385175|NCT02546765|155604461|FG000|Overall Study|Withdrawal by Subject|0|||
48385176|NCT02546765|155604462|FG001|Overall Study|Withdrawal by Subject|1|||
48385177|NCT02546765|155604463|FG002|Overall Study|Withdrawal by Subject|0|||
48385178|NCT02546765|155604464|FG003|Overall Study|Withdrawal by Subject|0|||
48385179|NCT00475722|155604465|FG000|Overall Study|Withdrawal by Subject|12|||
48385180|NCT00475722|155604466|FG001|Overall Study|Withdrawal by Subject|12|||
48385181|NCT00475722|155604465|FG000|Overall Study|Protocol Violation|3|||
48385182|NCT00475722|155604466|FG001|Overall Study|Protocol Violation|0|||
48385183|NCT02568475|155604467|FG000|Overall Study|Lost to Follow-up|40|||
48385184|NCT02568475|155604468|FG001|Overall Study|Lost to Follow-up|39|||
48385185|NCT02568475|155604467|FG000|Overall Study|Withdrawal by Subject|2|||
48385186|NCT02568475|155604468|FG001|Overall Study|Withdrawal by Subject|0|||
48385187|NCT02568475|155604467|FG000|Overall Study|Discharged home|4|||
48385188|NCT02568475|155604468|FG001|Overall Study|Discharged home|4|||
48385189|NCT02568475|155604467|FG000|Overall Study|Short-term: Discharge location unknown|4|||
48385190|NCT02568475|155604468|FG001|Overall Study|Short-term: Discharge location unknown|0|||
48385191|NCT02568475|155604467|FG000|Overall Study|Transferred to another facility|1|||
48385192|NCT02568475|155604468|FG001|Overall Study|Transferred to another facility|0|||
48385193|NCT00493220|155604469|FG000|Third Intervention|Withdrawal by Subject|1|||
48385194|NCT00493220|155604470|FG001|Third Intervention|Withdrawal by Subject|0|||
48385195|NCT00493220|155604471|FG002|Third Intervention|Withdrawal by Subject|0|||
48385196|NCT00493220|155604472|FG003|Third Intervention|Withdrawal by Subject|0|||
48385197|NCT00493220|155604473|FG004|Third Intervention|Withdrawal by Subject|0|||
48385198|NCT00493220|155604474|FG005|Third Intervention|Withdrawal by Subject|0|||
48385199|NCT02064920|155604475|FG000|Overall Study|Adverse Event|0|||
48385200|NCT02064920|155604476|FG001|Overall Study|Adverse Event|4|||
48385201|NCT02064920|155604475|FG000|Overall Study|Physician Decision|0|||
48385202|NCT02064920|155604476|FG001|Overall Study|Physician Decision|1|||
48385203|NCT02064920|155604475|FG000|Overall Study|Technical Problems|0|||
48385204|NCT02064920|155604476|FG001|Overall Study|Technical Problems|1|||
48385205|NCT02064920|155604475|FG000|Overall Study|Withdrawal by Subject|1|||
48385206|NCT02064920|155604476|FG001|Overall Study|Withdrawal by Subject|3|||
48385207|NCT00290186|155604477|FG000|Overall Study|Adverse Event|1|||
48385208|NCT00290186|155604478|FG001|Overall Study|Adverse Event|1|||
48385209|NCT00290186|155604477|FG000|Overall Study|Lost to Follow-up|3|||
48385210|NCT00290186|155604478|FG001|Overall Study|Lost to Follow-up|2|||
48385211|NCT00290186|155604477|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
48385212|NCT00290186|155604478|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
48385213|NCT00290186|155604477|FG000|Overall Study|Withdrawal by Subject|0|||
48385214|NCT00290186|155604478|FG001|Overall Study|Withdrawal by Subject|1|||
48385215|NCT01877915|155604479|FG000|Overall Study|Lost to Follow-up|10|||
48385216|NCT01877915|155604480|FG001|Overall Study|Lost to Follow-up|9|||
48676602|NCT02688985|156669063|FG001|Overall Study|Lost to Follow-up|0|||
48676603|NCT02688985|156669064|FG002|Overall Study|Lost to Follow-up|1|||
48676604|NCT02688985|156669065|FG003|Overall Study|Lost to Follow-up|1|||
48676605|NCT02688985|156669066|FG004|Overall Study|Lost to Follow-up|1|||
48676606|NCT02688985|156669062|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48676607|NCT02688985|156669063|FG001|Overall Study|Non-Compliance With Study Drug|3|||
48676608|NCT02688985|156669064|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48676609|NCT02688985|156669065|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48676610|NCT02688985|156669066|FG004|Overall Study|Non-Compliance With Study Drug|1|||
48676611|NCT02688985|156669062|FG000|Overall Study|Other|3|||
48676612|NCT02688985|156669063|FG001|Overall Study|Other|4|||
48676613|NCT02688985|156669064|FG002|Overall Study|Other|1|||
48676614|NCT02688985|156669065|FG003|Overall Study|Other|0|||
48676615|NCT02688985|156669066|FG004|Overall Study|Other|0|||
48676616|NCT02688985|156669062|FG000|Overall Study|Physician Decision|2|||
48676617|NCT02688985|156669063|FG001|Overall Study|Physician Decision|2|||
48676618|NCT02688985|156669064|FG002|Overall Study|Physician Decision|0|||
48676619|NCT02688985|156669065|FG003|Overall Study|Physician Decision|0|||
48676620|NCT02688985|156669066|FG004|Overall Study|Physician Decision|1|||
48676621|NCT02688985|156669062|FG000|Overall Study|Pregnancy|0|||
48676622|NCT02688985|156669063|FG001|Overall Study|Pregnancy|0|||
48676623|NCT02688985|156669064|FG002|Overall Study|Pregnancy|2|||
48676624|NCT02688985|156669065|FG003|Overall Study|Pregnancy|1|||
48676625|NCT02688985|156669066|FG004|Overall Study|Pregnancy|0|||
48676626|NCT02688985|156669062|FG000|Overall Study|Study Terminated By Sponsor|0|||
48676627|NCT02688985|156669063|FG001|Overall Study|Study Terminated By Sponsor|0|||
48676628|NCT02688985|156669064|FG002|Overall Study|Study Terminated By Sponsor|0|||
48676629|NCT02688985|156669065|FG003|Overall Study|Study Terminated By Sponsor|1|||
48676630|NCT02688985|156669066|FG004|Overall Study|Study Terminated By Sponsor|0|||
48676631|NCT02688985|156669062|FG000|Overall Study|Withdrawal by Subject|2|||
48676632|NCT02688985|156669063|FG001|Overall Study|Withdrawal by Subject|8|||
48676633|NCT02688985|156669064|FG002|Overall Study|Withdrawal by Subject|7|||
48676634|NCT02688985|156669065|FG003|Overall Study|Withdrawal by Subject|1|||
48676635|NCT02688985|156669066|FG004|Overall Study|Withdrawal by Subject|4|||
48676636|NCT01023672|156669067|FG000|Overall Study|Worsening disease|2|||
48676637|NCT01023672|156669067|FG000|Overall Study|Death|1|||
48676638|NCT01055314|156669068|FG000|Overall Study|Adverse Event|7|||
48676639|NCT01055314|156669069|FG001|Overall Study|Adverse Event|4|||
48676640|NCT01055314|156669068|FG000|Overall Study|Death|2|||
48676641|NCT01055314|156669069|FG001|Overall Study|Death|1|||
48676642|NCT01055314|156669068|FG000|Overall Study|Lack of Efficacy|11|||
48676643|NCT01055314|156669069|FG001|Overall Study|Lack of Efficacy|19|||
48676644|NCT01055314|156669068|FG000|Overall Study|Physician Decision|10|||
48676645|NCT01055314|156669069|FG001|Overall Study|Physician Decision|5|||
48676646|NCT01055314|156669068|FG000|Overall Study|Withdrawal by Subject|1|||
48676647|NCT01055314|156669069|FG001|Overall Study|Withdrawal by Subject|0|||
48676648|NCT01055314|156669068|FG000|Overall Study|Ineligible|3|||
48385217|NCT01877915|155604479|FG000|Overall Study|Withdrawal by Subject|42|||
48385218|NCT01877915|155604480|FG001|Overall Study|Withdrawal by Subject|55|||
48676649|NCT01055314|156669069|FG001|Overall Study|Ineligible|5|||
48676650|NCT01055314|156669068|FG000|Overall Study|Refusal of further protocol therapy|10|||
48385219|NCT01877915|155604479|FG000|Overall Study|Other|2|||
48385220|NCT01877915|155604480|FG001|Overall Study|Other|4|||
48676651|NCT01055314|156669069|FG001|Overall Study|Refusal of further protocol therapy|4|||
48676652|NCT01055314|156669068|FG000|Overall Study|No treatment|1|||
48676653|NCT01055314|156669069|FG001|Overall Study|No treatment|0|||
48676654|NCT00568126|156669070|FG000|Overall Study|Adverse Event|3|||
48676655|NCT00568126|156669071|FG001|Overall Study|Adverse Event|0|||
48676656|NCT00568126|156669070|FG000|Overall Study|Withdrawal by Subject|2|||
48676657|NCT00568126|156669071|FG001|Overall Study|Withdrawal by Subject|3|||
48676658|NCT00568126|156669070|FG000|Overall Study|Lost to Follow-up|4|||
48676659|NCT00568126|156669071|FG001|Overall Study|Lost to Follow-up|3|||
48676660|NCT00568126|156669070|FG000|Overall Study|Lack of Efficacy|0|||
48676661|NCT00568126|156669071|FG001|Overall Study|Lack of Efficacy|1|||
48676662|NCT00568126|156669070|FG000|Overall Study|Physician Decision|2|||
48676663|NCT00568126|156669071|FG001|Overall Study|Physician Decision|2|||
48676664|NCT02241343|156669074|FG000|Overall Study|Adverse Event|1|||
48676665|NCT00753454|156669075|FG000|Overall Study|Adverse Event|4|||
48676666|NCT00753454|156669075|FG000|Overall Study|Lack of Efficacy|1|||
48676667|NCT00753454|156669075|FG000|Overall Study|Lost to Follow-up|3|||
48676668|NCT00753454|156669075|FG000|Overall Study|Withdrawal by Subject|5|||
48676669|NCT00753454|156669075|FG000|Overall Study|Investigator Decision|1|||
48676670|NCT03927144|156669076|FG000|Core Phase|Adverse Event|9|||
48676671|NCT03927144|156669077|FG001|Core Phase|Adverse Event|5|||
48676672|NCT03927144|156669076|FG000|Core Phase|Lost to Follow-up|3|||
48676673|NCT03927144|156669077|FG001|Core Phase|Lost to Follow-up|2|||
48676674|NCT03927144|156669076|FG000|Core Phase|New Therapy for Study Indication|0|||
48676675|NCT03927144|156669077|FG001|Core Phase|New Therapy for Study Indication|1|||
48676676|NCT03927144|156669076|FG000|Core Phase|No Longer Clinically Benefiting|4|||
48676677|NCT03927144|156669077|FG001|Core Phase|No Longer Clinically Benefiting|4|||
48385221|NCT04622046|155604483|FG000|Intervention Period|Adverse Event|1|||
48385222|NCT04622046|155604483|FG000|Intervention Period|Withdrawal by Subject|2|||
48385223|NCT04622046|155604483|FG000|Extension Period|Ongoing in the Extension Period|21|||
48385224|NCT01873417|155605878|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
48385225|NCT01873417|155605878|FG000|Overall Study|Adverse Event|24|||
48385226|NCT01873417|155605878|FG000|Overall Study|Lost to Follow-up|2|||
48385227|NCT01873417|155605878|FG000|Overall Study|Withdrawal by Subject|2|||
48385228|NCT01873417|155605878|FG000|Overall Study|Physician Decision|3|||
48385229|NCT01086410|155605879|FG000|Overall Study|Adverse Event|1|||
48385230|NCT01086410|155605880|FG001|Overall Study|Adverse Event|0|||
48385231|NCT01086410|155605881|FG002|Overall Study|Adverse Event|0|||
48385232|NCT01086410|155605882|FG003|Overall Study|Adverse Event|2|||
48385233|NCT01086410|155605879|FG000|Overall Study|Lack of Efficacy|1|||
48385234|NCT01086410|155605880|FG001|Overall Study|Lack of Efficacy|1|||
48385235|NCT01086410|155605881|FG002|Overall Study|Lack of Efficacy|0|||
48385236|NCT01086410|155605882|FG003|Overall Study|Lack of Efficacy|0|||
48385237|NCT01086410|155605879|FG000|Overall Study|Protocol Violation|1|||
48385238|NCT01086410|155605880|FG001|Overall Study|Protocol Violation|1|||
48385239|NCT01086410|155605881|FG002|Overall Study|Protocol Violation|0|||
48385240|NCT01086410|155605882|FG003|Overall Study|Protocol Violation|0|||
48385241|NCT01086410|155605879|FG000|Overall Study|Lost to Follow-up|0|||
48385242|NCT01086410|155605880|FG001|Overall Study|Lost to Follow-up|0|||
48385243|NCT01086410|155605881|FG002|Overall Study|Lost to Follow-up|1|||
48385244|NCT01086410|155605882|FG003|Overall Study|Lost to Follow-up|0|||
48385245|NCT01667081|155605883|FG000|Overall Study|Death|43|||
48385246|NCT01667081|155605884|FG001|Overall Study|Death|3|||
48385247|NCT01667081|155605883|FG000|Overall Study|Lost to Follow-up|99|||
48385248|NCT01667081|155605884|FG001|Overall Study|Lost to Follow-up|48|||
48385249|NCT01667081|155605883|FG000|Overall Study|Physician Decision|16|||
48385250|NCT01667081|155605884|FG001|Overall Study|Physician Decision|2|||
48385251|NCT01667081|155605883|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
48385252|NCT01667081|155605884|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
48385253|NCT01667081|155605883|FG000|Overall Study|Withdrawal by Subject|90|||
48385254|NCT01667081|155605884|FG001|Overall Study|Withdrawal by Subject|35|||
48385255|NCT00295633|155605885|FG000|Overall Study|Lack of Efficacy|19|||
48385256|NCT00295633|155605886|FG001|Overall Study|Lack of Efficacy|7|||
48385257|NCT00295633|155605887|FG002|Overall Study|Lack of Efficacy|16|||
48385258|NCT00295633|155605885|FG000|Overall Study|Withdrawal of consent by subject|16|||
48385259|NCT00295633|155605886|FG001|Overall Study|Withdrawal of consent by subject|16|||
48385260|NCT00295633|155605887|FG002|Overall Study|Withdrawal of consent by subject|26|||
48385261|NCT00295633|155605885|FG000|Overall Study|Adverse Event|9|||
48385262|NCT00295633|155605886|FG001|Overall Study|Adverse Event|17|||
48385263|NCT00295633|155605887|FG002|Overall Study|Adverse Event|9|||
48385264|NCT00295633|155605885|FG000|Overall Study|Lost to Follow-up|6|||
48385265|NCT00295633|155605886|FG001|Overall Study|Lost to Follow-up|11|||
48385266|NCT00295633|155605887|FG002|Overall Study|Lost to Follow-up|7|||
48385267|NCT00295633|155605885|FG000|Overall Study|Physician Decision|9|||
48385268|NCT00295633|155605886|FG001|Overall Study|Physician Decision|10|||
48385269|NCT00295633|155605887|FG002|Overall Study|Physician Decision|8|||
48385270|NCT00295633|155605885|FG000|Overall Study|Poor/Noncompliance|2|||
48385271|NCT00295633|155605886|FG001|Overall Study|Poor/Noncompliance|2|||
48385272|NCT00295633|155605887|FG002|Overall Study|Poor/Noncompliance|6|||
48385273|NCT00295633|155605885|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
48385274|NCT00295633|155605886|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
48385275|NCT00295633|155605887|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
48385276|NCT00295633|155605885|FG000|Overall Study|Death|1|||
48385277|NCT00295633|155605886|FG001|Overall Study|Death|1|||
48385278|NCT00295633|155605887|FG002|Overall Study|Death|0|||
48385279|NCT00295633|155605885|FG000|Overall Study|Administrative reason by sponsor|0|||
48385280|NCT00295633|155605886|FG001|Overall Study|Administrative reason by sponsor|0|||
48385281|NCT00295633|155605887|FG002|Overall Study|Administrative reason by sponsor|1|||
48385282|NCT00709111|155605888|FG000|Overall Study|Withdrawal by Subject|1|||
48385283|NCT00709111|155605888|FG000|Overall Study|Unable to attend clinic visits|1|||
48385284|NCT01524133|155605889|FG000|Treatment Phase|Withdrawal by Subject|13|||
48385285|NCT01524133|155605890|FG001|Treatment Phase|Withdrawal by Subject|28|||
48385286|NCT01524133|155605891|FG002|Treatment Phase|Withdrawal by Subject|31|||
48385287|NCT01524133|155605889|FG000|Treatment Phase|Physician Decision|6|||
48385288|NCT01524133|155605890|FG001|Treatment Phase|Physician Decision|3|||
48385289|NCT01524133|155605891|FG002|Treatment Phase|Physician Decision|3|||
48385290|NCT01524133|155605889|FG000|Treatment Phase|Lost to Follow-up|0|||
48385291|NCT01524133|155605890|FG001|Treatment Phase|Lost to Follow-up|1|||
48385292|NCT01524133|155605891|FG002|Treatment Phase|Lost to Follow-up|2|||
48385293|NCT01524133|155605889|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
48676678|NCT03927144|156669076|FG000|Core Phase|Physician Decision|2|||
48676679|NCT03927144|156669077|FG001|Core Phase|Physician Decision|8|||
48676680|NCT03927144|156669076|FG000|Core Phase|Protocol Violation|2|||
48385294|NCT01524133|155605890|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
48385295|NCT01524133|155605891|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
48385296|NCT01524133|155605889|FG000|Overall Study 52 Weeks|Physician Decision|1|||
48385297|NCT01524133|155605890|FG001|Overall Study 52 Weeks|Physician Decision|0|||
48385298|NCT01524133|155605891|FG002|Overall Study 52 Weeks|Physician Decision|2|||
48385299|NCT01524133|155605889|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
48385300|NCT01524133|155605890|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
48385301|NCT01524133|155605891|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
48385302|NCT03794583|155605892|FG000|Overall Study|Death|8|||
48385303|NCT03794583|155605892|FG000|Overall Study|Study Terminated by Sponsor|24|||
48385304|NCT03794583|155605892|FG000|Overall Study|Withdrawal by Subject|9|||
48385305|NCT01754857|155605893|FG000|Overall Study|Adverse Event|7|||
48385306|NCT01754857|155605893|FG000|Overall Study|Disease progression|3|||
48385307|NCT01754857|155605893|FG000|Overall Study|Physician Decision|2|||
48385308|NCT01754857|155605893|FG000|Overall Study|Withdrawal by Subject|3|||
48385309|NCT01754857|155605893|FG000|Overall Study|other complicating disease|1|||
48385310|NCT01754857|155605893|FG000|Overall Study|ineligible to continue onto maintenance|1|||
48385311|NCT01754857|155605893|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
48385312|NCT01754857|155605893|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
48385313|NCT01509079|155605894|FG000|Overall Study|Lack of Efficacy|0|||
48385314|NCT01509079|155605895|FG001|Overall Study|Lack of Efficacy|2|||
48385315|NCT01509079|155605894|FG000|Overall Study|started an excluded medication|0|||
48385316|NCT01509079|155605895|FG001|Overall Study|started an excluded medication|1|||
48385317|NCT00041080|155605896|FG000|Overall Study|Adverse Event|21|||
48385318|NCT00041080|155605897|FG001|Overall Study|Adverse Event|1|||
48385319|NCT00041080|155605896|FG000|Overall Study|Withdrawal by Subject|6|||
48385320|NCT00041080|155605897|FG001|Overall Study|Withdrawal by Subject|6|||
48385321|NCT00041080|155605896|FG000|Overall Study|Concommitant Illness/Other|1|||
48385322|NCT00041080|155605897|FG001|Overall Study|Concommitant Illness/Other|2|||
48385323|NCT00041080|155605896|FG000|Overall Study|Did not start therapy|1|||
48385324|NCT00041080|155605897|FG001|Overall Study|Did not start therapy|1|||
48385325|NCT00041080|155605896|FG000|Overall Study|Ineligible|1|||
48385326|NCT00041080|155605897|FG001|Overall Study|Ineligible|0|||
48385327|NCT04353596|155605898|FG000|Overall Study|Protocol Violation|4|||
48385328|NCT04353596|155605899|FG001|Overall Study|Protocol Violation|4|||
48385329|NCT04353596|155605898|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
48385330|NCT04353596|155605899|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
48385331|NCT01122576|155605901|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
48385332|NCT01122576|155605902|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
48385333|NCT01122576|155605903|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
48385334|NCT01122576|155605901|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
48385335|NCT01122576|155605902|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
48385336|NCT01122576|155605903|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
48385337|NCT01122576|155605901|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
48385338|NCT01122576|155605902|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
48385339|NCT01122576|155605903|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
48385340|NCT03974334|155605908|FG000|Overall Study|Lost to Follow-up|1|||
48385341|NCT01132612|155605909|FG000|Overall Study|Death|0|||
48385342|NCT01132612|155605910|FG001|Overall Study|Death|0|||
48385343|NCT01132612|155605911|FG002|Overall Study|Death|1|||
48385344|NCT01132612|155605909|FG000|Overall Study|Protocol deviation|0|||
48385345|NCT01132612|155605910|FG001|Overall Study|Protocol deviation|0|||
48385346|NCT01132612|155605911|FG002|Overall Study|Protocol deviation|3|||
48385347|NCT01132612|155605909|FG000|Overall Study|Lost to Follow-up|2|||
48385348|NCT01132612|155605910|FG001|Overall Study|Lost to Follow-up|2|||
48385349|NCT01132612|155605911|FG002|Overall Study|Lost to Follow-up|7|||
48385350|NCT01132612|155605909|FG000|Overall Study|Adverse Event|5|||
48385351|NCT01132612|155605910|FG001|Overall Study|Adverse Event|2|||
48385352|NCT01132612|155605911|FG002|Overall Study|Adverse Event|15|||
48385353|NCT01132612|155605909|FG000|Overall Study|Withdrawal by Subject|5|||
48385354|NCT01132612|155605910|FG001|Overall Study|Withdrawal by Subject|8|||
48385355|NCT01132612|155605911|FG002|Overall Study|Withdrawal by Subject|19|||
48385356|NCT01132612|155605909|FG000|Overall Study|Administrative problems|5|||
48385357|NCT01132612|155605910|FG001|Overall Study|Administrative problems|1|||
48385358|NCT01132612|155605911|FG002|Overall Study|Administrative problems|52|||
48385359|NCT01132612|155605909|FG000|Overall Study|Lack of Efficacy|23|||
48385360|NCT01132612|155605910|FG001|Overall Study|Lack of Efficacy|22|||
48385361|NCT01132612|155605911|FG002|Overall Study|Lack of Efficacy|73|||
48385362|NCT02252536|155605915|FG000|Overall Study|Lost to Follow-up|5|||
48385363|NCT02252536|155605916|FG001|Overall Study|Lost to Follow-up|3|||
48385364|NCT04060563|155605921|FG000|Overall Study|Lost to Follow-up|1|||
48385365|NCT04060563|155605922|FG001|Overall Study|Lost to Follow-up|1|||
48385366|NCT04060563|155605921|FG000|Overall Study|Physician Decision|0|||
48385367|NCT04060563|155605922|FG001|Overall Study|Physician Decision|1|||
48385368|NCT01379573|155605931|FG000|Overall Study|Lost to Follow-up|1|||
48385369|NCT01379573|155605931|FG000|Overall Study|Screen Failure|10|||
48385370|NCT02378220|155605932|FG000|Overall Study|Death|6|||
48385371|NCT02378220|155605933|FG001|Overall Study|Death|1|||
48385372|NCT01490814|155605934|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
48385373|NCT01490814|155605935|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
48385374|NCT01490814|155605934|FG000|Overall Study|Physician Decision|1|||
48385375|NCT01490814|155605935|FG001|Overall Study|Physician Decision|0|||
48385376|NCT01490814|155605934|FG000|Overall Study|Withdrawal by Subject|0|||
48385377|NCT01490814|155605935|FG001|Overall Study|Withdrawal by Subject|5|||
48385378|NCT02170779|155605936|FG000|Overall Study|Withdrawal by Subject|1|||
48385379|NCT02170779|155605937|FG001|Overall Study|Withdrawal by Subject|0|||
48385380|NCT02170779|155605936|FG000|Overall Study|Lost to Follow-up|0|||
48385381|NCT02170779|155605937|FG001|Overall Study|Lost to Follow-up|1|||
48385382|NCT03492554|155605938|FG000|Overall Study|Protocol Violation|0|||
48385383|NCT03492554|155605939|FG001|Overall Study|Protocol Violation|14|||
48385384|NCT01237340|155605940|FG000|Overall Study|Adverse Event|3|||
48385385|NCT01237340|155605940|FG000|Overall Study|Withdrawal by Subject|1|||
48385386|NCT01237340|155605940|FG000|Overall Study|Early termination of the trial|36|||
48385387|NCT02289352|155605941|FG000|Overall Study|Withdrawal by Subject|1|||
48385388|NCT02289352|155605942|FG001|Overall Study|Withdrawal by Subject|1|||
48385389|NCT02289352|155605943|FG002|Overall Study|Withdrawal by Subject|0|||
48385390|NCT01294150|155605946|FG000|Overall Study|Physician Decision|2|||
48385391|NCT01294150|155605947|FG001|Overall Study|Physician Decision|2|||
48385392|NCT00882310|155605952|FG000|Overall Study|Screen Failure|10|||
48385393|NCT00882310|155605952|FG000|Overall Study|Never received treatment|1|||
48385394|NCT00882310|155605952|FG000|Overall Study|Death|6|||
48385395|NCT00882310|155605952|FG000|Overall Study|Progression of disease|4|||
48385396|NCT00882310|155605952|FG000|Overall Study|Adverse Event|1|||
48385397|NCT00601705|155605953|FG000|Overall Study|Withdrawal by Subject|1|||
48385398|NCT04246801|155605954|FG000|Overall Study|Adverse Event|1|||
48385399|NCT04246801|155605955|FG001|Overall Study|Adverse Event|1|||
48385400|NCT04246801|155605954|FG000|Overall Study|Protocol Violation|1|||
48385401|NCT04246801|155605955|FG001|Overall Study|Protocol Violation|1|||
48385402|NCT04246801|155605954|FG000|Overall Study|Lack of Efficacy|0|||
48385403|NCT04246801|155605955|FG001|Overall Study|Lack of Efficacy|2|||
48385404|NCT04246801|155605954|FG000|Overall Study|Lost to Follow-up|1|||
48385405|NCT04246801|155605955|FG001|Overall Study|Lost to Follow-up|1|||
48385406|NCT04246801|155605954|FG000|Overall Study|Withdrawal by Subject|2|||
48385407|NCT04246801|155605955|FG001|Overall Study|Withdrawal by Subject|1|||
48385408|NCT03684642|155605956|FG000|Overall Study|Adverse Event|6|||
48385409|NCT03684642|155605957|FG001|Overall Study|Adverse Event|15|||
48385410|NCT03684642|155605958|FG002|Overall Study|Adverse Event|11|||
48385411|NCT03684642|155605956|FG000|Overall Study|Withdrawal by Subject|35|||
48385412|NCT03684642|155605957|FG001|Overall Study|Withdrawal by Subject|53|||
48385413|NCT03684642|155605958|FG002|Overall Study|Withdrawal by Subject|23|||
48385414|NCT03684642|155605956|FG000|Overall Study|Lack of Efficacy|0|||
48385415|NCT03684642|155605957|FG001|Overall Study|Lack of Efficacy|0|||
48385416|NCT03684642|155605958|FG002|Overall Study|Lack of Efficacy|1|||
48385417|NCT03684642|155605956|FG000|Overall Study|Poor compliance to protocol|0|||
48385418|NCT03684642|155605957|FG001|Overall Study|Poor compliance to protocol|4|||
48385419|NCT03684642|155605958|FG002|Overall Study|Poor compliance to protocol|1|||
48385420|NCT03684642|155605956|FG000|Overall Study|Other than specified|62|||
48385421|NCT03684642|155605957|FG001|Overall Study|Other than specified|60|||
48385422|NCT03684642|155605958|FG002|Overall Study|Other than specified|67|||
48385423|NCT03684642|155605956|FG000|Overall Study|Randomized and not treated|0|||
48385424|NCT03684642|155605957|FG001|Overall Study|Randomized and not treated|0|||
48385425|NCT03684642|155605958|FG002|Overall Study|Randomized and not treated|1|||
48385426|NCT03684642|155605956|FG000|Overall Study|Missing completion status but alive at last contact|0|||
48385427|NCT03684642|155605957|FG001|Overall Study|Missing completion status but alive at last contact|1|||
48385428|NCT03684642|155605958|FG002|Overall Study|Missing completion status but alive at last contact|2|||
48385429|NCT00955279|155605961|FG000|Overall Study|Other|0|||
48385430|NCT00955279|155605962|FG001|Overall Study|Other|0|||
48385431|NCT00955279|155605963|FG002|Overall Study|Other|3|||
48385432|NCT00955279|155605961|FG000|Overall Study|Death|1|||
48385433|NCT00955279|155605962|FG001|Overall Study|Death|1|||
48385434|NCT00955279|155605963|FG002|Overall Study|Death|1|||
48385435|NCT00955279|155605961|FG000|Overall Study|Lost to Follow-up|0|||
48385436|NCT00955279|155605962|FG001|Overall Study|Lost to Follow-up|3|||
48385437|NCT00955279|155605963|FG002|Overall Study|Lost to Follow-up|1|||
48385438|NCT00955279|155605961|FG000|Overall Study|Withdrawal by Subject|2|||
48385439|NCT00955279|155605962|FG001|Overall Study|Withdrawal by Subject|0|||
48385440|NCT00955279|155605963|FG002|Overall Study|Withdrawal by Subject|3|||
48385441|NCT03044886|155605967|FG000|Overall Study|Lost to Follow-up|15|||
48385442|NCT03044886|155605968|FG001|Overall Study|Lost to Follow-up|10|||
48385443|NCT03044886|155605969|FG002|Overall Study|Lost to Follow-up|12|||
48385444|NCT02966223|155605970|FG000|Overall Study|Physician Decision|3|||
48385445|NCT02966223|155605970|FG000|Overall Study|Withdrawal by Subject|11|||
48385446|NCT02966223|155605970|FG000|Overall Study|Lost to Follow-up|1|||
48385447|NCT05093322|155605971|FG000|Overall Study|Death|6|||
48385448|NCT05093322|155605972|FG001|Overall Study|Death|2|||
48385449|NCT05093322|155605971|FG000|Overall Study|Other|4|||
48385450|NCT05093322|155605972|FG001|Overall Study|Other|1|||
48385451|NCT03715153|155605973|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
48385452|NCT03715153|155605974|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
48385453|NCT03715153|155605973|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
48385454|NCT03715153|155605974|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
48385455|NCT03715153|155605973|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
48385456|NCT03715153|155605974|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
48385457|NCT03715153|155605973|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
48385458|NCT03715153|155605974|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
48385459|NCT03715153|155605973|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
48385460|NCT03715153|155605974|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
48385461|NCT03715153|155605973|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
48385462|NCT03715153|155605974|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
48385463|NCT01770912|155605975|FG000|Overall Study|Lost to Follow-up|2|||
48385464|NCT01770912|155605976|FG001|Overall Study|Lost to Follow-up|0|||
48385465|NCT01708291|155605977|FG000|Overall Study|fighting|2|||
48385466|NCT01708291|155605978|FG001|Overall Study|fighting|1|||
48385467|NCT04411628|155605979|FG000|Overall Study|Withdrawal by Subject|1|||
48385468|NCT04411628|155605980|FG001|Overall Study|Withdrawal by Subject|1|||
48385469|NCT04411628|155605981|FG002|Overall Study|Withdrawal by Subject|2|||
48385470|NCT04411628|155605982|FG003|Overall Study|Withdrawal by Subject|0|||
48385471|NCT04411628|155605979|FG000|Overall Study|Lost to Follow-up|0|||
48676681|NCT03927144|156669077|FG001|Core Phase|Protocol Violation|2|||
48676682|NCT03927144|156669076|FG000|Core Phase|Withdrawal by Subject|16|||
48676683|NCT03927144|156669077|FG001|Core Phase|Withdrawal by Subject|40|||
48676684|NCT03927144|156669076|FG000|Extension Phase|Adverse Event|2|||
48676685|NCT03927144|156669077|FG001|Extension Phase|Adverse Event|1|||
48676686|NCT03927144|156669076|FG000|Extension Phase|No longer clinically benefiting|4|||
48676687|NCT03927144|156669077|FG001|Extension Phase|No longer clinically benefiting|5|||
48676688|NCT03927144|156669076|FG000|Extension Phase|Pregnancy|1|||
48385472|NCT04411628|155605980|FG001|Overall Study|Lost to Follow-up|1|||
48385473|NCT04411628|155605981|FG002|Overall Study|Lost to Follow-up|0|||
48385474|NCT04411628|155605982|FG003|Overall Study|Lost to Follow-up|0|||
48385475|NCT01846624|155605983|FG000|Overall Study|Died during induction, no midostaurin|1|||
48385476|NCT04376060|155605984|FG000|Overall Study|Physician Decision|1|||
48676689|NCT03927144|156669077|FG001|Extension Phase|Pregnancy|0|||
48676690|NCT03927144|156669076|FG000|Extension Phase|Protocol Violation|0|||
48676691|NCT03927144|156669077|FG001|Extension Phase|Protocol Violation|1|||
48385477|NCT04275297|155605985|FG000|Overall Study|Lost to Follow-up|1|||
48385478|NCT04275297|155605986|FG001|Overall Study|Lost to Follow-up|1|||
48385479|NCT01293968|155605987|FG000|Overall Study|non-cooperation|3|||
48385480|NCT01293968|155605988|FG001|Overall Study|non-cooperation|3|||
48385481|NCT01210690|155605989|FG000|Overall Study|Adverse Event|7|||
48385482|NCT01210690|155605989|FG000|Overall Study|Lack of Efficacy|12|||
48676692|NCT03927144|156669076|FG000|Extension Phase|Withdrawal by Subject|8|||
48385483|NCT01210690|155605989|FG000|Overall Study|Lost to Follow-up|3|||
48385484|NCT01210690|155605989|FG000|Overall Study|Disease Remission|1|||
48676693|NCT03927144|156669077|FG001|Extension Phase|Withdrawal by Subject|3|||
48385485|NCT01210690|155605989|FG000|Overall Study|Withdrawal by Subject|1|||
48385486|NCT01210690|155605989|FG000|Overall Study|Patient refused to swallow|1|||
48385487|NCT01210690|155605989|FG000|Overall Study|Patient could not take glucose|1|||
48385488|NCT00853749|155605990|FG000|Overall Study|Lost to Follow-up|0|||
48385489|NCT00853749|155605991|FG001|Overall Study|Lost to Follow-up|1|||
48385490|NCT00495820|155605992|FG000|Overall Study|Adverse Event|1|||
48385491|NCT00495820|155605993|FG001|Overall Study|Adverse Event|1|||
48385492|NCT00687440|155605994|FG000|Overall Study|Adverse Event|3|||
48385493|NCT00687440|155605994|FG000|Overall Study|Lost to Follow-up|3|||
48385494|NCT00687440|155605994|FG000|Overall Study|Lack of Efficacy|2|||
48385495|NCT00687440|155605994|FG000|Overall Study|Death|2|||
48385496|NCT00687440|155605994|FG000|Overall Study|Other|1|||
48385497|NCT00687440|155605994|FG000|Overall Study|Missing|1|||
48385498|NCT03337542|155605995|FG000|Overall Study|Withdrew Consent|17|||
48385499|NCT03337542|155605995|FG000|Overall Study|Allergic Adverse Event|1|||
48385500|NCT03337542|155605995|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
48385501|NCT03337542|155605995|FG000|Overall Study|Lost to Follow-up|1|||
48385502|NCT03337542|155605995|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
48385503|NCT03878446|155606002|FG000|Overall Study|Withdrawn by parent or guardian|1|||
48385504|NCT03878446|155606003|FG001|Overall Study|Withdrawn by parent or guardian|0|||
48385505|NCT03878446|155606004|FG002|Overall Study|Withdrawn by parent or guardian|0|||
48385506|NCT03878446|155606005|FG003|Overall Study|Withdrawn by parent or guardian|0|||
48385507|NCT03878446|155606006|FG004|Overall Study|Withdrawn by parent or guardian|0|||
48385508|NCT04881461|155606007|FG000|Overall Study|Adverse Event|2|||
48385509|NCT04881461|155606008|FG001|Overall Study|Adverse Event|4|||
48385510|NCT04881461|155606007|FG000|Overall Study|Withdrawal by Subject|19|||
48385511|NCT04881461|155606008|FG001|Overall Study|Withdrawal by Subject|19|||
48385512|NCT04881461|155606007|FG000|Overall Study|Lost to Follow-up|4|||
48385513|NCT04881461|155606008|FG001|Overall Study|Lost to Follow-up|4|||
48385514|NCT04881461|155606007|FG000|Overall Study|Lack of Efficacy|1|||
48385515|NCT04881461|155606008|FG001|Overall Study|Lack of Efficacy|0|||
48385516|NCT04881461|155606007|FG000|Overall Study|"Reason stated as other in CRF"|1|||
48385517|NCT04881461|155606008|FG001|Overall Study|"Reason stated as other in CRF"|2|||
48385518|NCT02113579|155607614|FG000|Overall Study|Adverse Event|1|||
48385519|NCT02113579|155607615|FG001|Overall Study|Adverse Event|0|||
48762257|NCT02476968|156978058|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48762258|NCT02476968|156978059|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48762259|NCT02476968|156978060|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
48762260|NCT02476968|156978058|FG000|Overall Study|Patient decision|37|||
48385520|NCT02113579|155607614|FG000|Overall Study|Withdrawal by Subject|3|||
48385521|NCT02113579|155607615|FG001|Overall Study|Withdrawal by Subject|2|||
48385522|NCT02113579|155607614|FG000|Overall Study|Lost to Follow-up|6|||
48385523|NCT02113579|155607615|FG001|Overall Study|Lost to Follow-up|2|||
48385524|NCT02982239|155607622|FG000|Overall Study|Lost to Follow-up|3|||
48385525|NCT02982239|155607623|FG001|Overall Study|Lost to Follow-up|2|||
48385526|NCT00880555|155607628|FG000|Overall Study|Physician Decision|0|||
48385527|NCT00880555|155607629|FG001|Overall Study|Physician Decision|8|||
48385528|NCT00880555|155607630|FG002|Overall Study|Physician Decision|0|||
48385529|NCT00880555|155607631|FG003|Overall Study|Physician Decision|2|||
48385530|NCT00880555|155607632|FG004|Overall Study|Physician Decision|1|||
48385531|NCT00880555|155607633|FG005|Overall Study|Physician Decision|0|||
48385532|NCT00880555|155607628|FG000|Overall Study|Withdrawal by Subject|1|||
48385533|NCT00880555|155607629|FG001|Overall Study|Withdrawal by Subject|1|||
48385534|NCT00880555|155607630|FG002|Overall Study|Withdrawal by Subject|0|||
48385535|NCT00880555|155607631|FG003|Overall Study|Withdrawal by Subject|0|||
48676694|NCT02649894|156669084|FG000|Overall Study|Adverse Event|1|||
48676695|NCT02649894|156669085|FG001|Overall Study|Adverse Event|0|||
48676696|NCT02649894|156669084|FG000|Overall Study|Physician Decision|0|||
48676697|NCT02649894|156669085|FG001|Overall Study|Physician Decision|1|||
48676698|NCT02649894|156669084|FG000|Overall Study|Withdrawal by Subject|5|||
48676699|NCT02649894|156669085|FG001|Overall Study|Withdrawal by Subject|2|||
48676700|NCT02649894|156669084|FG000|Overall Study|Lost to Follow-up|2|||
48676701|NCT02649894|156669085|FG001|Overall Study|Lost to Follow-up|1|||
48676702|NCT02649894|156669084|FG000|Overall Study|Death|30|||
48676703|NCT02649894|156669085|FG001|Overall Study|Death|7|||
48676704|NCT02649894|156669084|FG000|Overall Study|Other, not specified|6|||
48676705|NCT02649894|156669085|FG001|Overall Study|Other, not specified|0|||
48676706|NCT00646399|156669088|FG000|Overall Study|Death|63|||
48676707|NCT00646399|156669089|FG001|Overall Study|Death|53|||
48676708|NCT00646399|156669088|FG000|Overall Study|Withdrawal by Subject|9|||
48676709|NCT00646399|156669089|FG001|Overall Study|Withdrawal by Subject|10|||
48676710|NCT00646399|156669088|FG000|Overall Study|Other Reason|11|||
48676711|NCT00646399|156669089|FG001|Overall Study|Other Reason|11|||
48676712|NCT04071158|156669090|FG000|Overall Study|Lost to Follow-up|1|||
48676713|NCT04071158|156669091|FG001|Overall Study|Lost to Follow-up|2|||
48676714|NCT04071158|156669092|FG002|Overall Study|Lost to Follow-up|3|||
48385536|NCT00880555|155607632|FG004|Overall Study|Withdrawal by Subject|0|||
48385537|NCT00880555|155607633|FG005|Overall Study|Withdrawal by Subject|0|||
48385538|NCT00880555|155607628|FG000|Overall Study|Lack of resources (hired rater)|9|||
48385539|NCT00880555|155607629|FG001|Overall Study|Lack of resources (hired rater)|7|||
48385540|NCT00880555|155607630|FG002|Overall Study|Lack of resources (hired rater)|5|||
48385541|NCT00880555|155607631|FG003|Overall Study|Lack of resources (hired rater)|0|||
48385542|NCT00880555|155607632|FG004|Overall Study|Lack of resources (hired rater)|0|||
48676715|NCT04071158|156669093|FG003|Overall Study|Lost to Follow-up|3|||
48676716|NCT04071158|156669094|FG004|Overall Study|Lost to Follow-up|5|||
48676717|NCT04071158|156669090|FG000|Overall Study|Randomized but not treated|2|||
48676718|NCT04071158|156669091|FG001|Overall Study|Randomized but not treated|2|||
48676719|NCT04071158|156669092|FG002|Overall Study|Randomized but not treated|0|||
48676720|NCT04071158|156669093|FG003|Overall Study|Randomized but not treated|0|||
48676721|NCT04071158|156669094|FG004|Overall Study|Randomized but not treated|0|||
48676722|NCT05198843|156669095|FG000|Overall Study|Lack of Efficacy|1|||
48676723|NCT02473367|156669098|FG000|Wait 1|Withdrawal by Subject|1|||
48676724|NCT02473367|156669098|FG000|Period 4|Lost to Follow-up|1|||
48676725|NCT03160885|156669099|FG000|Initial Treatment Period|Not dosed|2|||
48676726|NCT03160885|156669100|FG001|Initial Treatment Period|Not dosed|0|||
48676727|NCT03160885|156669101|FG002|Initial Treatment Period|Not dosed|0|||
48676728|NCT03160885|156669102|FG003|Initial Treatment Period|Not dosed|0|||
48676729|NCT03160885|156669103|FG004|Initial Treatment Period|Not dosed|0|||
48676730|NCT03160885|156669104|FG005|Initial Treatment Period|Not dosed|0|||
48676731|NCT03160885|156669105|FG006|Initial Treatment Period|Not dosed|0|||
48676732|NCT03160885|156669099|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
48676733|NCT03160885|156669100|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
48676734|NCT03160885|156669101|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676735|NCT03160885|156669102|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676736|NCT03160885|156669103|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676737|NCT03160885|156669104|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676738|NCT03160885|156669105|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48676739|NCT03160885|156669099|FG000|Open-label Treatment|Not dosed|0|||
48676740|NCT03160885|156669100|FG001|Open-label Treatment|Not dosed|0|||
48676741|NCT03160885|156669101|FG002|Open-label Treatment|Not dosed|0|||
48676742|NCT03160885|156669102|FG003|Open-label Treatment|Not dosed|0|||
48676743|NCT03160885|156669103|FG004|Open-label Treatment|Not dosed|0|||
48676744|NCT03160885|156669104|FG005|Open-label Treatment|Not dosed|0|||
48676745|NCT03160885|156669105|FG006|Open-label Treatment|Not dosed|2|||
48676746|NCT03160885|156669099|FG000|Open-label Treatment|Discontinued IMP|0|||
48676747|NCT03160885|156669100|FG001|Open-label Treatment|Discontinued IMP|0|||
48676748|NCT03160885|156669101|FG002|Open-label Treatment|Discontinued IMP|0|||
48676749|NCT03160885|156669102|FG003|Open-label Treatment|Discontinued IMP|0|||
48676750|NCT03160885|156669103|FG004|Open-label Treatment|Discontinued IMP|0|||
48676751|NCT03160885|156669104|FG005|Open-label Treatment|Discontinued IMP|0|||
48676752|NCT03160885|156669105|FG006|Open-label Treatment|Discontinued IMP|131|||
48676753|NCT03160885|156669099|FG000|Open-label Treatment|Completed Week 50|0|||
48676754|NCT03160885|156669100|FG001|Open-label Treatment|Completed Week 50|0|||
48676755|NCT03160885|156669101|FG002|Open-label Treatment|Completed Week 50|0|||
48676756|NCT03160885|156669102|FG003|Open-label Treatment|Completed Week 50|0|||
48676757|NCT03160885|156669103|FG004|Open-label Treatment|Completed Week 50|0|||
48676758|NCT03160885|156669104|FG005|Open-label Treatment|Completed Week 50|0|||
48676759|NCT03160885|156669105|FG006|Open-label Treatment|Completed Week 50|4|||
48676760|NCT03160885|156669099|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48676761|NCT03160885|156669100|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48676762|NCT03160885|156669101|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48762261|NCT02476968|156978059|FG001|Overall Study|Patient decision|8|||
48762262|NCT02476968|156978060|FG002|Overall Study|Patient decision|0|||
48762263|NCT00778700|156978065|FG000|Overall Study|Adverse Event|6|||
48762264|NCT00778700|156978066|FG001|Overall Study|Adverse Event|1|||
48762265|NCT00778700|156978067|FG002|Overall Study|Adverse Event|3|||
48762266|NCT00778700|156978068|FG003|Overall Study|Adverse Event|5|||
48762267|NCT00778700|156978065|FG000|Overall Study|Protocol Violation|1|||
48762268|NCT00778700|156978066|FG001|Overall Study|Protocol Violation|1|||
48762269|NCT00778700|156978067|FG002|Overall Study|Protocol Violation|0|||
48762270|NCT00778700|156978068|FG003|Overall Study|Protocol Violation|0|||
48762271|NCT00778700|156978065|FG000|Overall Study|Subject Withdrew Consent|6|||
48762272|NCT00778700|156978066|FG001|Overall Study|Subject Withdrew Consent|4|||
48762273|NCT00778700|156978067|FG002|Overall Study|Subject Withdrew Consent|1|||
48762274|NCT00778700|156978068|FG003|Overall Study|Subject Withdrew Consent|4|||
48385543|NCT00880555|155607633|FG005|Overall Study|Lack of resources (hired rater)|0|||
48385544|NCT00880555|155607628|FG000|Overall Study|Death|0|||
48676763|NCT03160885|156669102|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
48676764|NCT03160885|156669103|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48676765|NCT03160885|156669104|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48762275|NCT00778700|156978065|FG000|Overall Study|Lost to Follow-up|3|||
48762276|NCT00778700|156978066|FG001|Overall Study|Lost to Follow-up|1|||
48676766|NCT03160885|156669105|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
48676767|NCT03160885|156669099|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
48385545|NCT00880555|155607629|FG001|Overall Study|Death|0|||
48385546|NCT00880555|155607630|FG002|Overall Study|Death|0|||
48385547|NCT00880555|155607631|FG003|Overall Study|Death|0|||
48385548|NCT00880555|155607632|FG004|Overall Study|Death|0|||
48385549|NCT00880555|155607633|FG005|Overall Study|Death|1|||
48385550|NCT00880555|155607628|FG000|Overall Study|Lost to Follow-up|0|||
48385551|NCT00880555|155607629|FG001|Overall Study|Lost to Follow-up|1|||
48385552|NCT00880555|155607630|FG002|Overall Study|Lost to Follow-up|0|||
48385553|NCT00880555|155607631|FG003|Overall Study|Lost to Follow-up|0|||
48385554|NCT00880555|155607632|FG004|Overall Study|Lost to Follow-up|0|||
48385555|NCT00880555|155607633|FG005|Overall Study|Lost to Follow-up|0|||
48385556|NCT00385203|155607634|FG000|Overall Study|Adverse Event|5|||
48385557|NCT00385203|155607635|FG001|Overall Study|Adverse Event|4|||
48385558|NCT00385203|155607634|FG000|Overall Study|Death|1|||
48385559|NCT00385203|155607635|FG001|Overall Study|Death|0|||
48385560|NCT00385203|155607634|FG000|Overall Study|Condition under investigation worsened|18|||
48385561|NCT00385203|155607635|FG001|Overall Study|Condition under investigation worsened|3|||
48385562|NCT00385203|155607634|FG000|Overall Study|Incorrect enrollment|2|||
48385563|NCT00385203|155607635|FG001|Overall Study|Incorrect enrollment|0|||
48385564|NCT03034460|155607636|FG000|Overall Study|Adverse Event|0|||
48385565|NCT03034460|155607637|FG001|Overall Study|Adverse Event|1|||
48385566|NCT03034460|155607636|FG000|Overall Study|Withdrawal by Subject|2|||
48385567|NCT03034460|155607637|FG001|Overall Study|Withdrawal by Subject|2|||
48385568|NCT03034460|155607636|FG000|Overall Study|Personal Reasons|1|||
48385569|NCT03034460|155607637|FG001|Overall Study|Personal Reasons|0|||
48385570|NCT00312221|155607639|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
48385571|NCT00312221|155607640|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
48385572|NCT00312221|155607641|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
48385573|NCT00312221|155607642|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
48385574|NCT00312221|155607639|FG000|Open-label Run-in Period|Adverse Event|74|||
48385575|NCT00312221|155607640|FG001|Open-label Run-in Period|Adverse Event|0|||
48385576|NCT00312221|155607641|FG002|Open-label Run-in Period|Adverse Event|0|||
48385577|NCT00312221|155607642|FG003|Open-label Run-in Period|Adverse Event|0|||
48385578|NCT00312221|155607639|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
48385579|NCT00312221|155607640|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
48385580|NCT00312221|155607641|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
48385581|NCT00312221|155607642|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
48385582|NCT00312221|155607639|FG000|Open-label Run-in Period|Administrative|42|||
48385583|NCT00312221|155607640|FG001|Open-label Run-in Period|Administrative|0|||
48385584|NCT00312221|155607641|FG002|Open-label Run-in Period|Administrative|0|||
48385585|NCT00312221|155607642|FG003|Open-label Run-in Period|Administrative|0|||
48385586|NCT00312221|155607639|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
48385587|NCT00312221|155607640|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
48385588|NCT00312221|155607641|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
48385589|NCT00312221|155607642|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
48385590|NCT00312221|155607639|FG000|Open-label Run-in Period|Did not qualify|5|||
48385591|NCT00312221|155607640|FG001|Open-label Run-in Period|Did not qualify|0|||
48385592|NCT00312221|155607641|FG002|Open-label Run-in Period|Did not qualify|0|||
48385593|NCT00312221|155607642|FG003|Open-label Run-in Period|Did not qualify|0|||
48385594|NCT00312221|155607639|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48385595|NCT00312221|155607640|FG001|Double-blind Phase|Withdrawal by Subject|6|||
48385596|NCT00312221|155607641|FG002|Double-blind Phase|Withdrawal by Subject|8|||
48385597|NCT00312221|155607642|FG003|Double-blind Phase|Withdrawal by Subject|7|||
48385598|NCT00312221|155607639|FG000|Double-blind Phase|Adverse Event|0|||
48385599|NCT00312221|155607640|FG001|Double-blind Phase|Adverse Event|10|||
48385600|NCT00312221|155607641|FG002|Double-blind Phase|Adverse Event|19|||
48676768|NCT03160885|156669100|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
48385601|NCT00312221|155607642|FG003|Double-blind Phase|Adverse Event|18|||
48385602|NCT00312221|155607639|FG000|Double-blind Phase|Lost to Follow-up|0|||
48676769|NCT03160885|156669101|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
48676770|NCT03160885|156669102|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
48676771|NCT03160885|156669103|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
48676772|NCT03160885|156669104|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
48676773|NCT03160885|156669105|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
48385603|NCT00312221|155607640|FG001|Double-blind Phase|Lost to Follow-up|0|||
48385604|NCT00312221|155607641|FG002|Double-blind Phase|Lost to Follow-up|2|||
48385605|NCT00312221|155607642|FG003|Double-blind Phase|Lost to Follow-up|2|||
48385606|NCT00312221|155607639|FG000|Double-blind Phase|Administrative|0|||
48385607|NCT00312221|155607640|FG001|Double-blind Phase|Administrative|26|||
48385608|NCT00312221|155607641|FG002|Double-blind Phase|Administrative|37|||
48385609|NCT00312221|155607642|FG003|Double-blind Phase|Administrative|33|||
48385610|NCT00312221|155607639|FG000|Double-blind Phase|Lack of Efficacy|0|||
48385611|NCT00312221|155607640|FG001|Double-blind Phase|Lack of Efficacy|17|||
48385612|NCT00312221|155607641|FG002|Double-blind Phase|Lack of Efficacy|6|||
48385613|NCT00312221|155607642|FG003|Double-blind Phase|Lack of Efficacy|10|||
48385614|NCT02114268|155607643|FG000|Overall Study|Lost to Follow-up|4|||
48385615|NCT02114268|155607644|FG001|Overall Study|Lost to Follow-up|1|||
48385616|NCT02114268|155607645|FG002|Overall Study|Lost to Follow-up|1|||
48385617|NCT02114268|155607646|FG003|Overall Study|Lost to Follow-up|0|||
48385618|NCT02114268|155607647|FG004|Overall Study|Lost to Follow-up|0|||
48385619|NCT02114268|155607648|FG005|Overall Study|Lost to Follow-up|2|||
48385620|NCT02114268|155607643|FG000|Overall Study|Withdrawal by Subject|1|||
48385621|NCT02114268|155607644|FG001|Overall Study|Withdrawal by Subject|0|||
48385622|NCT02114268|155607645|FG002|Overall Study|Withdrawal by Subject|0|||
48676774|NCT03160885|156669099|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48676775|NCT03160885|156669100|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48676776|NCT03160885|156669101|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
48676777|NCT03160885|156669102|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
48676778|NCT03160885|156669103|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
48676779|NCT03160885|156669104|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
48676780|NCT03160885|156669105|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48676781|NCT03160885|156669099|FG000|Maintenance Treatment Period|Completed Week 50|0|||
48676782|NCT03160885|156669100|FG001|Maintenance Treatment Period|Completed Week 50|0|||
48676783|NCT03160885|156669101|FG002|Maintenance Treatment Period|Completed Week 50|1|||
48676784|NCT03160885|156669102|FG003|Maintenance Treatment Period|Completed Week 50|0|||
48676785|NCT03160885|156669103|FG004|Maintenance Treatment Period|Completed Week 50|0|||
48676786|NCT03160885|156669104|FG005|Maintenance Treatment Period|Completed Week 50|0|||
48385623|NCT02114268|155607646|FG003|Overall Study|Withdrawal by Subject|0|||
48385624|NCT02114268|155607647|FG004|Overall Study|Withdrawal by Subject|0|||
48385625|NCT02114268|155607648|FG005|Overall Study|Withdrawal by Subject|1|||
48385626|NCT02114268|155607643|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
48385627|NCT02114268|155607644|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
48385628|NCT02114268|155607645|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
48385629|NCT02114268|155607646|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
48676787|NCT03160885|156669105|FG006|Maintenance Treatment Period|Completed Week 50|0|||
48385630|NCT02114268|155607647|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
48385631|NCT02114268|155607648|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
48385632|NCT00800683|155607650|FG000|Overall Study|Adverse Event|11|||
48676788|NCT03129360|156669106|FG000|Overall Study|Did not meet entry criteria|0|||
48385633|NCT00800683|155607651|FG001|Overall Study|Adverse Event|8|||
48385634|NCT00800683|155607650|FG000|Overall Study|Lost to Follow-up|3|||
48385635|NCT00800683|155607651|FG001|Overall Study|Lost to Follow-up|1|||
48385636|NCT00800683|155607650|FG000|Overall Study|Withdrawal by Subject|1|||
48385637|NCT00800683|155607651|FG001|Overall Study|Withdrawal by Subject|7|||
48385638|NCT00800683|155607650|FG000|Overall Study|Lack of Efficacy|1|||
48385639|NCT00800683|155607651|FG001|Overall Study|Lack of Efficacy|1|||
48385640|NCT00800683|155607650|FG000|Overall Study|Other|1|||
48385641|NCT00800683|155607651|FG001|Overall Study|Other|2|||
48385642|NCT00702325|155607652|FG000|Overall Study|Adverse Event|1|||
48385643|NCT00702325|155607653|FG001|Overall Study|Adverse Event|0|||
48385644|NCT00702325|155607652|FG000|Overall Study|Withdrawal by Subject|7|||
48385645|NCT00702325|155607653|FG001|Overall Study|Withdrawal by Subject|7|||
48385646|NCT00702325|155607652|FG000|Overall Study|Lost to Follow-up|3|||
48385647|NCT00702325|155607653|FG001|Overall Study|Lost to Follow-up|4|||
48385648|NCT00702325|155607652|FG000|Overall Study|Incorrect enrollment|5|||
48385649|NCT00702325|155607653|FG001|Overall Study|Incorrect enrollment|7|||
48385650|NCT00702325|155607652|FG000|Overall Study|Developed study discontinuation criteria|18|||
48385651|NCT00702325|155607653|FG001|Overall Study|Developed study discontinuation criteria|28|||
48385652|NCT00702325|155607652|FG000|Overall Study|Severe noncompliance to protocol|3|||
48385653|NCT00702325|155607653|FG001|Overall Study|Severe noncompliance to protocol|3|||
48385654|NCT00702325|155607652|FG000|Overall Study|Termination due to lab results|1|||
48385655|NCT00702325|155607653|FG001|Overall Study|Termination due to lab results|0|||
48385656|NCT00702325|155607652|FG000|Overall Study|Didn't follow study medication dosage|0|||
48385657|NCT00702325|155607653|FG001|Overall Study|Didn't follow study medication dosage|2|||
48385658|NCT00702325|155607652|FG000|Overall Study|Withdrew consent|0|||
48385659|NCT00702325|155607653|FG001|Overall Study|Withdrew consent|1|||
48385660|NCT00702325|155607652|FG000|Overall Study|Incorrectly Discontinued|0|||
48385661|NCT00702325|155607653|FG001|Overall Study|Incorrectly Discontinued|1|||
48385662|NCT01848353|155607654|FG000|Phase 1|Withdrawal by Subject|3|||
48385663|NCT01848353|155607655|FG001|Phase 1|Withdrawal by Subject|1|||
48385664|NCT01848353|155607656|FG002|Phase 1|Withdrawal by Subject|0|||
48385665|NCT01848353|155607657|FG003|Phase 1|Withdrawal by Subject|0|||
48385666|NCT01848353|155607654|FG000|Phase 2|Withdrawal by Subject|3|||
48385667|NCT01848353|155607655|FG001|Phase 2|Withdrawal by Subject|2|||
48385668|NCT01848353|155607656|FG002|Phase 2|Withdrawal by Subject|0|||
48385669|NCT01848353|155607657|FG003|Phase 2|Withdrawal by Subject|0|||
48385670|NCT01848353|155607654|FG000|Phase 3|Withdrawal by Subject|1|||
48385671|NCT01848353|155607655|FG001|Phase 3|Withdrawal by Subject|1|||
48385672|NCT01848353|155607656|FG002|Phase 3|Withdrawal by Subject|0|||
48385673|NCT01848353|155607657|FG003|Phase 3|Withdrawal by Subject|0|||
48385674|NCT02566577|155607660|FG000|Overall Study|Withdrawal by Subject|1|||
48385675|NCT02566577|155607661|FG001|Overall Study|Withdrawal by Subject|1|||
48385676|NCT02566577|155607660|FG000|Overall Study|Equipment failure|1|||
48385677|NCT02566577|155607661|FG001|Overall Study|Equipment failure|1|||
48385678|NCT02566577|155607660|FG000|Overall Study|Physical limitation|1|||
48385679|NCT02566577|155607661|FG001|Overall Study|Physical limitation|0|||
48385680|NCT02146599|155607676|FG000|Overall Study|Failed to meet inclusion criteria|5|||
48385681|NCT00916149|155607679|FG000|Overall Study|Lost to Follow-up|3|||
48385682|NCT00916149|155607680|FG001|Overall Study|Lost to Follow-up|2|||
48385683|NCT00916149|155607681|FG002|Overall Study|Lost to Follow-up|0|||
48385684|NCT00916149|155607679|FG000|Overall Study|Unable to place scalp EEG leads|1|||
48385685|NCT00916149|155607680|FG001|Overall Study|Unable to place scalp EEG leads|0|||
48385686|NCT00916149|155607681|FG002|Overall Study|Unable to place scalp EEG leads|0|||
48385687|NCT00175877|155607682|FG000|Overall Study|Adverse Event|136|||
48385688|NCT00175877|155607682|FG000|Overall Study|Withdrawal by Subject|141|||
48385689|NCT00175877|155607682|FG000|Overall Study|Lost to Follow-up|9|||
48385690|NCT00175877|155607682|FG000|Overall Study|Lack of Efficacy|26|||
48385691|NCT00175877|155607682|FG000|Overall Study|Protocol Violation|15|||
48385692|NCT00175877|155607682|FG000|Overall Study|Other Reason|20|||
48385693|NCT00175877|155607682|FG000|Overall Study|AE & Other|1|||
48385694|NCT00175877|155607682|FG000|Overall Study|Withdrawal by subject & Other|1|||
48676789|NCT03129360|156669107|FG001|Overall Study|Did not meet entry criteria|2|||
48676790|NCT03129360|156669108|FG002|Overall Study|Did not meet entry criteria|1|||
48385695|NCT00544648|155607685|FG000|Overall Study|Withdrawal by Subject|1|||
48385696|NCT00544648|155607686|FG001|Overall Study|Withdrawal by Subject|0|||
48385697|NCT00544648|155607685|FG000|Overall Study|Adverse Event|1|||
48385698|NCT00544648|155607686|FG001|Overall Study|Adverse Event|1|||
48385699|NCT00544648|155607685|FG000|Overall Study|progression of disease|1|||
48385700|NCT00544648|155607686|FG001|Overall Study|progression of disease|0|||
48385701|NCT04166383|155607687|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
48385702|NCT04166383|155607687|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
48385703|NCT04166383|155607687|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
48385704|NCT02876835|155607701|FG000|Treatment Period (51.1 Month)|Other|1|||
48676791|NCT03129360|156669106|FG000|Overall Study|Excluded due to motion in scanner|1|||
48385705|NCT02876835|155607702|FG001|Treatment Period (51.1 Month)|Other|0|||
48385706|NCT02876835|155607701|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
48385707|NCT02876835|155607702|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
48385708|NCT02876835|155607701|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
48385709|NCT02876835|155607702|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
48385710|NCT02876835|155607701|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
48385711|NCT02876835|155607702|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
48385712|NCT00504153|155607707|FG000|Overall Study|Withdrawal by Subject|1|||
48385713|NCT00504153|155607707|FG000|Overall Study|Adverse Event|4|||
48385714|NCT00504153|155607707|FG000|Overall Study|Death|1|||
48385715|NCT00074581|155607709|FG000|Overall Study|Death|15|||
48385716|NCT00074581|155607710|FG001|Overall Study|Death|16|||
48385717|NCT00074581|155607709|FG000|Overall Study|Withdrawal by Subject|50|||
48385718|NCT00074581|155607710|FG001|Overall Study|Withdrawal by Subject|49|||
48385719|NCT00074581|155607709|FG000|Overall Study|Unable to adhere to visit schedule|13|||
48385720|NCT00074581|155607710|FG001|Overall Study|Unable to adhere to visit schedule|14|||
48385721|NCT00074581|155607709|FG000|Overall Study|Relocated|14|||
48385722|NCT00074581|155607710|FG001|Overall Study|Relocated|9|||
48385723|NCT00074581|155607709|FG000|Overall Study|Were withdrawn by investigator|5|||
48385724|NCT00074581|155607710|FG001|Overall Study|Were withdrawn by investigator|2|||
48385725|NCT00074581|155607709|FG000|Overall Study|Lost to Follow-up|16|||
48676792|NCT03129360|156669107|FG001|Overall Study|Excluded due to motion in scanner|0|||
48676793|NCT03129360|156669108|FG002|Overall Study|Excluded due to motion in scanner|0|||
48676794|NCT02409719|156669116|FG000|Overall Study|Lost to Follow-up|3|||
48676795|NCT02409719|156669117|FG001|Overall Study|Lost to Follow-up|3|||
48676796|NCT00231413|156669118|FG000|Overall Study|Non-serious AE|0|||
48676797|NCT00231413|156669119|FG001|Overall Study|Non-serious AE|0|||
48676798|NCT00231413|156669120|FG002|Overall Study|Non-serious AE|1|||
48676799|NCT00231413|156669121|FG003|Overall Study|Non-serious AE|0|||
48676800|NCT00231413|156669122|FG004|Overall Study|Non-serious AE|0|||
48676801|NCT00231413|156669123|FG005|Overall Study|Non-serious AE|0|||
48676802|NCT00231413|156669124|FG006|Overall Study|Non-serious AE|1|||
48676803|NCT00231413|156669118|FG000|Overall Study|Withdrawal by Subject|3|||
48676804|NCT00231413|156669119|FG001|Overall Study|Withdrawal by Subject|1|||
48676805|NCT00231413|156669120|FG002|Overall Study|Withdrawal by Subject|4|||
48676806|NCT00231413|156669121|FG003|Overall Study|Withdrawal by Subject|2|||
48385726|NCT00074581|155607710|FG001|Overall Study|Lost to Follow-up|11|||
48385727|NCT00074581|155607709|FG000|Overall Study|Ended relationship w. index participant|117|||
48385728|NCT00074581|155607710|FG001|Overall Study|Ended relationship w. index participant|106|||
48385729|NCT00074581|155607709|FG000|Overall Study|Other|14|||
48385730|NCT00074581|155607710|FG001|Overall Study|Other|19|||
48385731|NCT01358760|155607711|FG000|Overall Study|Adverse Event|3|||
48385732|NCT01358760|155607712|FG001|Overall Study|Adverse Event|4|||
48385733|NCT01358760|155607713|FG002|Overall Study|Adverse Event|3|||
48385734|NCT01358760|155607711|FG000|Overall Study|Lost to Follow-up|1|||
48385735|NCT01358760|155607712|FG001|Overall Study|Lost to Follow-up|1|||
48385736|NCT01358760|155607713|FG002|Overall Study|Lost to Follow-up|3|||
48385737|NCT01358760|155607711|FG000|Overall Study|Withdrawal by Subject|5|||
48385738|NCT01358760|155607712|FG001|Overall Study|Withdrawal by Subject|3|||
48385739|NCT01358760|155607713|FG002|Overall Study|Withdrawal by Subject|2|||
48385740|NCT01358760|155607711|FG000|Overall Study|Physician Decision|1|||
48385741|NCT01358760|155607712|FG001|Overall Study|Physician Decision|0|||
48385742|NCT01358760|155607713|FG002|Overall Study|Physician Decision|1|||
48385743|NCT01358760|155607711|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
48385744|NCT01358760|155607712|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
48385745|NCT01358760|155607713|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
48385746|NCT02303704|155607717|FG000|Overall Study|Protocol Violation|5|||
48385747|NCT02303704|155607718|FG001|Overall Study|Protocol Violation|9|||
48385748|NCT01458366|155607719|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
48385749|NCT01458366|155607720|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
48385750|NCT01458366|155607721|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
48385751|NCT01458366|155607722|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
48385752|NCT01458366|155607723|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
48676807|NCT00231413|156669122|FG004|Overall Study|Withdrawal by Subject|2|||
48676808|NCT00231413|156669123|FG005|Overall Study|Withdrawal by Subject|0|||
48676809|NCT00231413|156669124|FG006|Overall Study|Withdrawal by Subject|3|||
48676810|NCT00231413|156669118|FG000|Overall Study|Migrated/moved from study area|0|||
48385753|NCT01458366|155607719|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
48385754|NCT01458366|155607720|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
48385755|NCT01458366|155607721|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
48385756|NCT01458366|155607722|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
48676811|NCT00231413|156669119|FG001|Overall Study|Migrated/moved from study area|0|||
48676812|NCT00231413|156669120|FG002|Overall Study|Migrated/moved from study area|1|||
48676813|NCT00231413|156669121|FG003|Overall Study|Migrated/moved from study area|0|||
48676814|NCT00231413|156669122|FG004|Overall Study|Migrated/moved from study area|0|||
48676815|NCT00231413|156669123|FG005|Overall Study|Migrated/moved from study area|1|||
48762277|NCT00778700|156978067|FG002|Overall Study|Lost to Follow-up|0|||
48762278|NCT00778700|156978068|FG003|Overall Study|Lost to Follow-up|1|||
48762279|NCT00778700|156978065|FG000|Overall Study|Reason not Specified|2|||
48762280|NCT00778700|156978066|FG001|Overall Study|Reason not Specified|0|||
48762281|NCT00778700|156978067|FG002|Overall Study|Reason not Specified|1|||
48385757|NCT01458366|155607723|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
48385758|NCT01843972|155607726|FG000|Overall Study|Withdrawal by Subject|0|||
48385759|NCT01843972|155607727|FG001|Overall Study|Withdrawal by Subject|0|||
48385760|NCT01843972|155607728|FG002|Overall Study|Withdrawal by Subject|0|||
48385761|NCT01843972|155607729|FG003|Overall Study|Withdrawal by Subject|0|||
48385762|NCT01843972|155607730|FG004|Overall Study|Withdrawal by Subject|1|||
48385763|NCT01843972|155607731|FG005|Overall Study|Withdrawal by Subject|0|||
48385764|NCT01843972|155607732|FG006|Overall Study|Withdrawal by Subject|0|||
48385765|NCT01843972|155607733|FG007|Overall Study|Withdrawal by Subject|0|||
48385766|NCT01843972|155607734|FG008|Overall Study|Withdrawal by Subject|0|||
48385767|NCT01843972|155607735|FG009|Overall Study|Withdrawal by Subject|0|||
48385768|NCT00805025|155607736|FG000|Overall Study|Screened but not enrolled/treated|42|||
48385769|NCT00805025|155607736|FG000|Overall Study|Adverse Event|4|||
48385770|NCT00805025|155607736|FG000|Overall Study|Withdrawal by Subject|2|||
48385771|NCT00805025|155607736|FG000|Overall Study|Physician Decision|1|||
48385772|NCT01984164|155607746|FG000|Overall Study|Withdrawal by Subject|4|||
48385773|NCT01984164|155607747|FG001|Overall Study|Withdrawal by Subject|3|||
48385774|NCT01984164|155607746|FG000|Overall Study|Adverse Event|5|||
48385775|NCT01984164|155607747|FG001|Overall Study|Adverse Event|19|||
48385776|NCT01984164|155607746|FG000|Overall Study|Lost to Follow-up|1|||
48385777|NCT01984164|155607747|FG001|Overall Study|Lost to Follow-up|3|||
48385778|NCT03710486|155607748|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
48676816|NCT00231413|156669124|FG006|Overall Study|Migrated/moved from study area|0|||
48676817|NCT00231413|156669118|FG000|Overall Study|Lost to Follow-up|4|||
48676818|NCT00231413|156669119|FG001|Overall Study|Lost to Follow-up|4|||
48676819|NCT00231413|156669120|FG002|Overall Study|Lost to Follow-up|1|||
48676820|NCT00231413|156669121|FG003|Overall Study|Lost to Follow-up|1|||
48676821|NCT00231413|156669122|FG004|Overall Study|Lost to Follow-up|1|||
48676822|NCT00231413|156669123|FG005|Overall Study|Lost to Follow-up|4|||
48676823|NCT00231413|156669124|FG006|Overall Study|Lost to Follow-up|0|||
48676824|NCT00231413|156669118|FG000|Overall Study|Pregnancy|1|||
48676825|NCT00231413|156669119|FG001|Overall Study|Pregnancy|0|||
48676826|NCT00231413|156669120|FG002|Overall Study|Pregnancy|0|||
48676827|NCT00231413|156669121|FG003|Overall Study|Pregnancy|0|||
48762282|NCT00778700|156978068|FG003|Overall Study|Reason not Specified|3|||
48385779|NCT03710486|155607749|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
48385780|NCT03710486|155607748|FG000|Overall Study|Missing|0|||
48385781|NCT03710486|155607749|FG001|Overall Study|Missing|2|||
48385782|NCT02811549|155607750|FG000|Overall Study|Lost to Follow-up|1|||
48385783|NCT02811549|155607750|FG000|Overall Study|Withdrawal by Subject|3|||
48385784|NCT02811549|155607750|FG000|Overall Study|Subject screen failed|4|||
48385785|NCT02811549|155607750|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
48385786|NCT00789880|155607751|FG000|Overall Study|Adverse Event|0|||
48385787|NCT00789880|155607752|FG001|Overall Study|Adverse Event|0|||
48385788|NCT00789880|155607753|FG002|Overall Study|Adverse Event|0|||
48385789|NCT00789880|155607754|FG003|Overall Study|Adverse Event|0|||
48385790|NCT00789880|155607755|FG004|Overall Study|Adverse Event|1|||
48385791|NCT00789880|155607756|FG005|Overall Study|Adverse Event|0|||
48385792|NCT00789880|155607751|FG000|Overall Study|Protocol Violation|0|||
48385793|NCT00789880|155607752|FG001|Overall Study|Protocol Violation|1|||
48385794|NCT00789880|155607753|FG002|Overall Study|Protocol Violation|0|||
48385795|NCT00789880|155607754|FG003|Overall Study|Protocol Violation|1|||
48385796|NCT00789880|155607755|FG004|Overall Study|Protocol Violation|0|||
48385797|NCT00789880|155607756|FG005|Overall Study|Protocol Violation|0|||
48385798|NCT00789880|155607751|FG000|Overall Study|Withdrawal by Subject|1|||
48385799|NCT00789880|155607752|FG001|Overall Study|Withdrawal by Subject|0|||
48385800|NCT00789880|155607753|FG002|Overall Study|Withdrawal by Subject|0|||
48385801|NCT00789880|155607754|FG003|Overall Study|Withdrawal by Subject|0|||
48385802|NCT00789880|155607755|FG004|Overall Study|Withdrawal by Subject|2|||
48385803|NCT00789880|155607756|FG005|Overall Study|Withdrawal by Subject|0|||
48385804|NCT01279850|155607757|FG000|Overall Study|Protocol Violation|50|||
48385805|NCT01279850|155607757|FG000|Overall Study|No Drug Administration Information|7|||
48385806|NCT01279850|155607757|FG000|Overall Study|No Visit After Treatment|34|||
48385807|NCT00418665|155607759|FG000|Treatment Period|Ineligibility determined|1|||
48385808|NCT00418665|155607760|FG001|Treatment Period|Ineligibility determined|1|||
48385809|NCT00418665|155607761|FG002|Treatment Period|Ineligibility determined|0|||
48385810|NCT00418665|155607759|FG000|Treatment Period|Adverse Event|2|||
48385811|NCT00418665|155607760|FG001|Treatment Period|Adverse Event|2|||
48676828|NCT00231413|156669122|FG004|Overall Study|Pregnancy|0|||
48676829|NCT00231413|156669123|FG005|Overall Study|Pregnancy|0|||
48676830|NCT00231413|156669124|FG006|Overall Study|Pregnancy|0|||
48762283|NCT00778700|156978065|FG000|Overall Study|Other|0|||
48762284|NCT00778700|156978066|FG001|Overall Study|Other|0|||
48676831|NCT01331291|156669126|FG000|Overall Study|Lack of Efficacy|2|||
48676832|NCT01331291|156669127|FG001|Overall Study|Lack of Efficacy|8|||
48676833|NCT01331291|156669126|FG000|Overall Study|Death|0|||
48676834|NCT01331291|156669127|FG001|Overall Study|Death|1|||
48676835|NCT00866814|156669128|FG000|Overall Study|Lost to Follow-up|12|||
48676836|NCT00866814|156669128|FG000|Overall Study|Adverse Event|2|||
48676837|NCT00866814|156669128|FG000|Overall Study|Physician Decision|1|||
48676838|NCT00866814|156669128|FG000|Overall Study|Death|1|||
48676839|NCT00866814|156669128|FG000|Overall Study|No longer wished to participate|1|||
48676840|NCT00866814|156669128|FG000|Overall Study|Unable to meet follow-up requirements|2|||
48385812|NCT00418665|155607761|FG002|Treatment Period|Adverse Event|0|||
48385813|NCT00418665|155607759|FG000|Treatment Period|Withdrawal by Subject|0|||
48385814|NCT00418665|155607760|FG001|Treatment Period|Withdrawal by Subject|3|||
48385815|NCT00418665|155607761|FG002|Treatment Period|Withdrawal by Subject|1|||
48385816|NCT00418665|155607759|FG000|Treatment Period|Requirement for alternative therapy|1|||
48385817|NCT00418665|155607760|FG001|Treatment Period|Requirement for alternative therapy|0|||
48385818|NCT00418665|155607761|FG002|Treatment Period|Requirement for alternative therapy|0|||
48385819|NCT00418665|155607759|FG000|Treatment Period|Physician Decision|1|||
48385820|NCT00418665|155607760|FG001|Treatment Period|Physician Decision|0|||
48385821|NCT00418665|155607761|FG002|Treatment Period|Physician Decision|3|||
48385822|NCT00418665|155607759|FG000|Treatment Extension|Adverse Event|1|||
48385823|NCT00418665|155607760|FG001|Treatment Extension|Adverse Event|0|||
48385824|NCT00418665|155607761|FG002|Treatment Extension|Adverse Event|0|||
48385825|NCT00418665|155607759|FG000|Treatment Extension|Withdrawal by Subject|1|||
48385826|NCT00418665|155607760|FG001|Treatment Extension|Withdrawal by Subject|0|||
48385827|NCT00418665|155607761|FG002|Treatment Extension|Withdrawal by Subject|0|||
48385828|NCT00418665|155607759|FG000|Treatment Extension|Requirement for alternative therapy|2|||
48385829|NCT00418665|155607760|FG001|Treatment Extension|Requirement for alternative therapy|2|||
48385830|NCT00418665|155607761|FG002|Treatment Extension|Requirement for alternative therapy|0|||
48676841|NCT00866814|156669128|FG000|Overall Study|Moved to area without study site|1|||
48676842|NCT01620762|156669129|FG000|Overall Study|Protocol Violation|1|||
48385831|NCT00418665|155607759|FG000|Treatment Extension|Physician Decision|2|||
48385832|NCT00418665|155607760|FG001|Treatment Extension|Physician Decision|2|||
48676843|NCT01620762|156669130|FG001|Overall Study|Protocol Violation|1|||
48676844|NCT01620762|156669131|FG002|Overall Study|Protocol Violation|1|||
48676845|NCT01620762|156669129|FG000|Overall Study|Adverse Event|9|||
48676846|NCT01620762|156669130|FG001|Overall Study|Adverse Event|5|||
48676847|NCT01620762|156669131|FG002|Overall Study|Adverse Event|2|||
48676848|NCT01620762|156669129|FG000|Overall Study|Withdrawal by Subject|23|||
48676849|NCT01620762|156669130|FG001|Overall Study|Withdrawal by Subject|26|||
48676850|NCT01620762|156669131|FG002|Overall Study|Withdrawal by Subject|27|||
48676851|NCT01620762|156669129|FG000|Overall Study|Lost to Follow-up|11|||
48676852|NCT01620762|156669130|FG001|Overall Study|Lost to Follow-up|17|||
48676853|NCT01620762|156669131|FG002|Overall Study|Lost to Follow-up|10|||
48676854|NCT01620762|156669129|FG000|Overall Study|Protocol deviation|1|||
48676855|NCT01620762|156669130|FG001|Overall Study|Protocol deviation|1|||
48676856|NCT01620762|156669131|FG002|Overall Study|Protocol deviation|6|||
48676857|NCT01620762|156669129|FG000|Overall Study|Subject deterioration|0|||
48676858|NCT01620762|156669130|FG001|Overall Study|Subject deterioration|1|||
48676859|NCT01620762|156669131|FG002|Overall Study|Subject deterioration|1|||
48676860|NCT01620762|156669129|FG000|Overall Study|Non-specified|3|||
48676861|NCT01620762|156669130|FG001|Overall Study|Non-specified|6|||
48676862|NCT01620762|156669131|FG002|Overall Study|Non-specified|5|||
48676863|NCT01620762|156669129|FG000|Overall Study|Use of prohibted therapies|0|||
48676864|NCT01620762|156669130|FG001|Overall Study|Use of prohibted therapies|1|||
48676865|NCT01620762|156669131|FG002|Overall Study|Use of prohibted therapies|1|||
48676866|NCT00705146|156669136|FG000|Overall Study|Lost to Follow-up|1|||
48676867|NCT00705146|156669137|FG001|Overall Study|Lost to Follow-up|1|||
48385833|NCT00418665|155607761|FG002|Treatment Extension|Physician Decision|1|||
48385834|NCT00418665|155607759|FG000|Treatment Extension|Death|0|||
48385835|NCT00418665|155607760|FG001|Treatment Extension|Death|0|||
48385836|NCT00418665|155607761|FG002|Treatment Extension|Death|1|||
48676868|NCT00465647|156669141|FG000|Overall Study|Administrative|2|||
48762285|NCT00778700|156978067|FG002|Overall Study|Other|1|||
48676869|NCT00465647|156669142|FG001|Overall Study|Administrative|2|||
48676870|NCT00465647|156669143|FG002|Overall Study|Administrative|3|||
48676871|NCT00465647|156669144|FG003|Overall Study|Administrative|2|||
48676872|NCT00465647|156669141|FG000|Overall Study|Adverse Event|2|||
48676873|NCT00465647|156669142|FG001|Overall Study|Adverse Event|0|||
48676874|NCT00465647|156669143|FG002|Overall Study|Adverse Event|3|||
48385837|NCT01133379|155607762|FG000|Overall Study|Withdrawal by Subject|0|||
48385838|NCT01133379|155607763|FG001|Overall Study|Withdrawal by Subject|1|||
48385839|NCT01133379|155607764|FG002|Overall Study|Withdrawal by Subject|1|||
48385840|NCT01133379|155607762|FG000|Overall Study|Lost to Follow-up|1|||
48676875|NCT00465647|156669144|FG003|Overall Study|Adverse Event|2|||
48676876|NCT00465647|156669141|FG000|Overall Study|Withdrawal by Subject|1|||
48676877|NCT00465647|156669142|FG001|Overall Study|Withdrawal by Subject|2|||
48676878|NCT00465647|156669143|FG002|Overall Study|Withdrawal by Subject|2|||
48676879|NCT00465647|156669144|FG003|Overall Study|Withdrawal by Subject|7|||
48676880|NCT00465647|156669141|FG000|Overall Study|"The other reasons included loss of IV"|8|||
48676881|NCT00465647|156669142|FG001|Overall Study|"The other reasons included loss of IV"|4|||
48676882|NCT00465647|156669143|FG002|Overall Study|"The other reasons included loss of IV"|3|||
48676883|NCT00465647|156669144|FG003|Overall Study|"The other reasons included loss of IV"|2|||
48676884|NCT01240135|156669148|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
48676885|NCT01240135|156669149|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
48676886|NCT01240135|156669148|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
48676887|NCT01240135|156669149|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
48676888|NCT02106403|156669150|FG000|Follow-Up Visit 3|Other Reason|0|||
48676889|NCT02106403|156669151|FG001|Follow-Up Visit 3|Other Reason|0|||
48676890|NCT02106403|156669152|FG002|Follow-Up Visit 3|Other Reason|0|||
48676891|NCT02106403|156669153|FG003|Follow-Up Visit 3|Other Reason|0|||
48676892|NCT02106403|156669154|FG004|Follow-Up Visit 3|Other Reason|0|||
48676893|NCT02106403|156669155|FG005|Follow-Up Visit 3|Other Reason|1|||
48676894|NCT01887353|156669156|FG000|Overall Study|Study stopped early|4|||
48676895|NCT01887353|156669157|FG001|Overall Study|Study stopped early|3|||
48676896|NCT04038567|156669158|FG000|Overall Study|Lost to Follow-up|6|||
48676897|NCT04038567|156669159|FG001|Overall Study|Lost to Follow-up|4|||
48676898|NCT04038567|156669160|FG002|Overall Study|Lost to Follow-up|5|||
48676899|NCT04038567|156669161|FG003|Overall Study|Lost to Follow-up|4|||
48676900|NCT04038567|156669162|FG004|Overall Study|Lost to Follow-up|6|||
48676901|NCT04038567|156669163|FG005|Overall Study|Lost to Follow-up|4|||
48676902|NCT04038567|156669164|FG006|Overall Study|Lost to Follow-up|4|||
48676903|NCT04038567|156669165|FG007|Overall Study|Lost to Follow-up|1|||
48676904|NCT04038567|156669158|FG000|Overall Study|Withdrawal by Subject|2|||
48385841|NCT01133379|155607763|FG001|Overall Study|Lost to Follow-up|1|||
48385842|NCT01133379|155607764|FG002|Overall Study|Lost to Follow-up|1|||
48676905|NCT04038567|156669159|FG001|Overall Study|Withdrawal by Subject|1|||
48676906|NCT04038567|156669160|FG002|Overall Study|Withdrawal by Subject|1|||
48762286|NCT00778700|156978068|FG003|Overall Study|Other|0|||
48385843|NCT00591214|155607765|FG000|Overall Study|Physician Decision|7|||
48385844|NCT00591214|155607765|FG000|Overall Study|Withdrawal by Subject|1|||
48385845|NCT02060383|155609299|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
48385846|NCT02060383|155609300|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
48385847|NCT02060383|155609301|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
48385848|NCT02060383|155609302|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
48385849|NCT02060383|155609303|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
48385850|NCT02060383|155609299|FG000|Core Phase|Adverse Event|2|||
48385851|NCT02060383|155609300|FG001|Core Phase|Adverse Event|0|||
48385852|NCT02060383|155609301|FG002|Core Phase|Adverse Event|0|||
48385853|NCT02060383|155609302|FG003|Core Phase|Adverse Event|2|||
48385854|NCT02060383|155609303|FG004|Core Phase|Adverse Event|6|||
48385855|NCT02060383|155609299|FG000|Core Phase|Administrative problems|0|||
48385856|NCT02060383|155609300|FG001|Core Phase|Administrative problems|1|||
48385857|NCT02060383|155609301|FG002|Core Phase|Administrative problems|0|||
48385858|NCT02060383|155609302|FG003|Core Phase|Administrative problems|0|||
48385859|NCT02060383|155609303|FG004|Core Phase|Administrative problems|0|||
48385860|NCT02060383|155609299|FG000|Core Phase|Protocol Violation|0|||
48385861|NCT02060383|155609300|FG001|Core Phase|Protocol Violation|0|||
48385862|NCT02060383|155609301|FG002|Core Phase|Protocol Violation|0|||
48385863|NCT02060383|155609302|FG003|Core Phase|Protocol Violation|1|||
48385864|NCT02060383|155609303|FG004|Core Phase|Protocol Violation|0|||
48385865|NCT02060383|155609299|FG000|Core Phase|Withdrawal by Subject|0|||
48385866|NCT02060383|155609300|FG001|Core Phase|Withdrawal by Subject|0|||
48385867|NCT02060383|155609301|FG002|Core Phase|Withdrawal by Subject|0|||
48385868|NCT02060383|155609302|FG003|Core Phase|Withdrawal by Subject|4|||
48385869|NCT02060383|155609303|FG004|Core Phase|Withdrawal by Subject|2|||
48385870|NCT02060383|155609299|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
48385871|NCT02060383|155609300|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
48385872|NCT02060383|155609301|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
48385873|NCT02060383|155609302|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
48385874|NCT02060383|155609303|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
48385875|NCT02060383|155609299|FG000|Extension Phase|Adverse Event|1|||
48385876|NCT02060383|155609300|FG001|Extension Phase|Adverse Event|1|||
48385877|NCT02060383|155609301|FG002|Extension Phase|Adverse Event|2|||
48385878|NCT02060383|155609302|FG003|Extension Phase|Adverse Event|0|||
48385879|NCT02060383|155609303|FG004|Extension Phase|Adverse Event|1|||
48385880|NCT02060383|155609299|FG000|Extension Phase|Withdrawal by Subject|0|||
48385881|NCT02060383|155609300|FG001|Extension Phase|Withdrawal by Subject|1|||
48385882|NCT02060383|155609301|FG002|Extension Phase|Withdrawal by Subject|0|||
48385883|NCT02060383|155609302|FG003|Extension Phase|Withdrawal by Subject|0|||
48385884|NCT02060383|155609303|FG004|Extension Phase|Withdrawal by Subject|2|||
48385885|NCT02060383|155609299|FG000|Extension Phase|Administrative problems|1|||
48385886|NCT02060383|155609300|FG001|Extension Phase|Administrative problems|0|||
48385887|NCT02060383|155609301|FG002|Extension Phase|Administrative problems|0|||
48385888|NCT02060383|155609302|FG003|Extension Phase|Administrative problems|0|||
48385889|NCT02060383|155609303|FG004|Extension Phase|Administrative problems|0|||
48385890|NCT02060383|155609299|FG000|Extension Phase|Death|0|||
48385891|NCT02060383|155609300|FG001|Extension Phase|Death|0|||
48385892|NCT02060383|155609301|FG002|Extension Phase|Death|1|||
48385893|NCT02060383|155609302|FG003|Extension Phase|Death|0|||
48385894|NCT02060383|155609303|FG004|Extension Phase|Death|1|||
48385895|NCT02060383|155609299|FG000|Extension Phase|Protocol Violation|0|||
48385896|NCT02060383|155609300|FG001|Extension Phase|Protocol Violation|0|||
48385897|NCT02060383|155609301|FG002|Extension Phase|Protocol Violation|0|||
48385898|NCT02060383|155609302|FG003|Extension Phase|Protocol Violation|0|||
48385899|NCT02060383|155609303|FG004|Extension Phase|Protocol Violation|1|||
48385900|NCT00332839|155609304|FG000|Core (Months 0 - 12)|Administrative problems|1|||
48385901|NCT00332839|155609305|FG001|Core (Months 0 - 12)|Administrative problems|1|||
48385902|NCT00332839|155609304|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
48385903|NCT00332839|155609305|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
48385904|NCT00332839|155609304|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
48676907|NCT04038567|156669161|FG003|Overall Study|Withdrawal by Subject|1|||
48385905|NCT00332839|155609305|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
48385906|NCT00332839|155609304|FG000|Core (Months 0 - 12)|Adverse Event|5|||
48676908|NCT04038567|156669162|FG004|Overall Study|Withdrawal by Subject|4|||
48385907|NCT00332839|155609305|FG001|Core (Months 0 - 12)|Adverse Event|15|||
48385908|NCT00332839|155609304|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
48385909|NCT00332839|155609305|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
48385910|NCT00332839|155609304|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
48385911|NCT00332839|155609305|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
48385912|NCT00332839|155609304|FG000|Follow-up (Months 12 - 60)|Death|1|||
48385913|NCT00332839|155609305|FG001|Follow-up (Months 12 - 60)|Death|1|||
48385914|NCT00268437|155609313|FG000|Overall Study|Ineligible|1|||
48385915|NCT00283049|155609316|FG000|Overall Study|Adverse Event|6|||
48385916|NCT00283049|155609317|FG001|Overall Study|Adverse Event|1|||
48385917|NCT00283049|155609318|FG002|Overall Study|Adverse Event|4|||
48385918|NCT00283049|155609316|FG000|Overall Study|Protocol Violation|3|||
48385919|NCT00283049|155609317|FG001|Overall Study|Protocol Violation|0|||
48385920|NCT00283049|155609318|FG002|Overall Study|Protocol Violation|3|||
48385921|NCT00283049|155609316|FG000|Overall Study|Death|1|||
48385922|NCT00283049|155609317|FG001|Overall Study|Death|1|||
48385923|NCT00283049|155609318|FG002|Overall Study|Death|1|||
48385924|NCT00283049|155609316|FG000|Overall Study|Lack of Efficacy|0|||
48385925|NCT00283049|155609317|FG001|Overall Study|Lack of Efficacy|1|||
48385926|NCT00283049|155609318|FG002|Overall Study|Lack of Efficacy|1|||
48385927|NCT00283049|155609316|FG000|Overall Study|Lost to Follow-up|4|||
48385928|NCT00283049|155609317|FG001|Overall Study|Lost to Follow-up|2|||
48385929|NCT00283049|155609318|FG002|Overall Study|Lost to Follow-up|5|||
48385930|NCT00283049|155609316|FG000|Overall Study|Withdrawal by Subject|26|||
48385931|NCT00283049|155609317|FG001|Overall Study|Withdrawal by Subject|24|||
48385932|NCT00283049|155609318|FG002|Overall Study|Withdrawal by Subject|19|||
48385933|NCT00283049|155609316|FG000|Overall Study|Discontinuation of Study|18|||
48385934|NCT00283049|155609317|FG001|Overall Study|Discontinuation of Study|16|||
48385935|NCT00283049|155609318|FG002|Overall Study|Discontinuation of Study|20|||
48385936|NCT00283049|155609316|FG000|Overall Study|No longer requires study treatment|0|||
48385937|NCT00283049|155609317|FG001|Overall Study|No longer requires study treatment|0|||
48385938|NCT00283049|155609318|FG002|Overall Study|No longer requires study treatment|1|||
48385939|NCT01022996|155609319|FG000|Overall Study|Adverse Event|14|||
48385940|NCT01022996|155609319|FG000|Overall Study|Withdrawal by Subject|3|||
48385941|NCT01022996|155609319|FG000|Overall Study|Lost to Follow-up|1|||
48385942|NCT01022996|155609319|FG000|Overall Study|Administrative problems|6|||
48385943|NCT01022996|155609319|FG000|Overall Study|Disease Progression|32|||
48385944|NCT01022996|155609319|FG000|Overall Study|Protocol Violation|1|||
48385945|NCT04490395|155609320|FG000|Overall Study|Lost to Follow-up|0|||
48385946|NCT04490395|155609321|FG001|Overall Study|Lost to Follow-up|1|||
48385947|NCT01798992|155609322|FG000|Overall Study|Administrative withdrawal|0|||
48385948|NCT01798992|155609323|FG001|Overall Study|Administrative withdrawal|1|||
48385949|NCT01798992|155609324|FG002|Overall Study|Administrative withdrawal|0|||
48385950|NCT01798992|155609325|FG003|Overall Study|Administrative withdrawal|1|||
48385951|NCT01798992|155609322|FG000|Overall Study|Lost to Follow-up|0|||
48385952|NCT01798992|155609323|FG001|Overall Study|Lost to Follow-up|1|||
48385953|NCT01798992|155609324|FG002|Overall Study|Lost to Follow-up|1|||
48385954|NCT01798992|155609325|FG003|Overall Study|Lost to Follow-up|0|||
48385955|NCT01798992|155609322|FG000|Overall Study|Insufficient biopsy tissue|0|||
48385956|NCT01798992|155609323|FG001|Overall Study|Insufficient biopsy tissue|0|||
48385957|NCT01798992|155609324|FG002|Overall Study|Insufficient biopsy tissue|1|||
48385958|NCT01798992|155609325|FG003|Overall Study|Insufficient biopsy tissue|0|||
48385959|NCT01131351|155609326|FG000|Overall Study|Adverse Event|0|||
48385960|NCT01131351|155609327|FG001|Overall Study|Adverse Event|2|||
48385961|NCT01131351|155609326|FG000|Overall Study|Protocol Deviation|0|||
48385962|NCT01131351|155609327|FG001|Overall Study|Protocol Deviation|1|||
48385963|NCT01942148|155609328|FG000|Overall Study|Adverse Event|4|||
48385964|NCT01942148|155609328|FG000|Overall Study|Lack of Efficacy|2|||
48385965|NCT01942148|155609328|FG000|Overall Study|Physician Decision|11|||
48385966|NCT01942148|155609328|FG000|Overall Study|Protocol Violation|1|||
48385967|NCT01942148|155609328|FG000|Overall Study|Withdrawal by Subject|8|||
48676909|NCT04038567|156669163|FG005|Overall Study|Withdrawal by Subject|1|||
48676910|NCT04038567|156669164|FG006|Overall Study|Withdrawal by Subject|1|||
48676911|NCT04038567|156669165|FG007|Overall Study|Withdrawal by Subject|1|||
48676912|NCT04038567|156669158|FG000|Overall Study|missed survey window|1|||
48676913|NCT04038567|156669159|FG001|Overall Study|missed survey window|2|||
48676914|NCT04038567|156669160|FG002|Overall Study|missed survey window|0|||
48676915|NCT04038567|156669161|FG003|Overall Study|missed survey window|0|||
48676916|NCT04038567|156669162|FG004|Overall Study|missed survey window|1|||
48676917|NCT04038567|156669163|FG005|Overall Study|missed survey window|1|||
48676918|NCT04038567|156669164|FG006|Overall Study|missed survey window|2|||
48676919|NCT04038567|156669165|FG007|Overall Study|missed survey window|2|||
48385968|NCT01942148|155609328|FG000|Overall Study|Use of the prohibition medicine|1|||
48385969|NCT01809132|155609329|FG000|Overall Study|Withdrawal by Subject|0|||
48385970|NCT01809132|155609330|FG001|Overall Study|Withdrawal by Subject|0|||
48385971|NCT01809132|155609331|FG002|Overall Study|Withdrawal by Subject|1|||
48385972|NCT00884325|155609351|FG000|Overall Study|Lost to Follow-up|1|||
48385973|NCT00884325|155609352|FG001|Overall Study|Lost to Follow-up|2|||
48385974|NCT00884325|155609351|FG000|Overall Study|Lack of Efficacy|0|||
48385975|NCT00884325|155609352|FG001|Overall Study|Lack of Efficacy|1|||
48385976|NCT00884325|155609351|FG000|Overall Study|Withdrawal by Subject|1|||
48385977|NCT00884325|155609352|FG001|Overall Study|Withdrawal by Subject|1|||
48385978|NCT00884325|155609351|FG000|Overall Study|Not provided|1|||
48385979|NCT00884325|155609352|FG001|Overall Study|Not provided|0|||
48385980|NCT02357134|155609353|FG000|Overall Study|Lost to Follow-up|1|||
48385981|NCT02357134|155609354|FG001|Overall Study|Lost to Follow-up|0|||
48385982|NCT02357134|155609355|FG002|Overall Study|Lost to Follow-up|0|||
48385983|NCT02357134|155609356|FG003|Overall Study|Lost to Follow-up|0|||
48385984|NCT01301456|155609361|FG000|Stage 1|Withdrawal by Subject|0|||
48676920|NCT04038567|156669158|FG000|Overall Study|technical issues|0|||
48385985|NCT01301456|155609362|FG001|Stage 1|Withdrawal by Subject|0|||
48676921|NCT04038567|156669159|FG001|Overall Study|technical issues|0|||
48385986|NCT01301456|155609363|FG002|Stage 1|Withdrawal by Subject|1|||
48385987|NCT01301456|155609364|FG003|Stage 1|Withdrawal by Subject|0|||
48385988|NCT01301456|155609365|FG004|Stage 1|Withdrawal by Subject|1|||
48385989|NCT01301456|155609366|FG005|Stage 1|Withdrawal by Subject|0|||
48385990|NCT01301456|155609367|FG006|Stage 1|Withdrawal by Subject|0|||
48385991|NCT01301456|155609368|FG007|Stage 1|Withdrawal by Subject|0|||
48385992|NCT01301456|155609369|FG008|Stage 1|Withdrawal by Subject|0|||
48385993|NCT01301456|155609370|FG009|Stage 1|Withdrawal by Subject|0|||
48676922|NCT04038567|156669160|FG002|Overall Study|technical issues|0|||
48676923|NCT04038567|156669161|FG003|Overall Study|technical issues|0|||
48676924|NCT04038567|156669162|FG004|Overall Study|technical issues|0|||
48676925|NCT04038567|156669163|FG005|Overall Study|technical issues|0|||
48676926|NCT04038567|156669164|FG006|Overall Study|technical issues|1|||
48676927|NCT04038567|156669165|FG007|Overall Study|technical issues|0|||
48676928|NCT04038567|156669158|FG000|Overall Study|Medical issues (i.e., illness)|0|||
48676929|NCT04038567|156669159|FG001|Overall Study|Medical issues (i.e., illness)|1|||
48676930|NCT04038567|156669160|FG002|Overall Study|Medical issues (i.e., illness)|2|||
48676931|NCT04038567|156669161|FG003|Overall Study|Medical issues (i.e., illness)|1|||
48676932|NCT04038567|156669162|FG004|Overall Study|Medical issues (i.e., illness)|1|||
48676933|NCT04038567|156669163|FG005|Overall Study|Medical issues (i.e., illness)|1|||
48676934|NCT04038567|156669164|FG006|Overall Study|Medical issues (i.e., illness)|0|||
48676935|NCT04038567|156669165|FG007|Overall Study|Medical issues (i.e., illness)|0|||
48676936|NCT04038567|156669158|FG000|Overall Study|Death|0|||
48676937|NCT04038567|156669159|FG001|Overall Study|Death|0|||
48676938|NCT04038567|156669160|FG002|Overall Study|Death|0|||
48676939|NCT04038567|156669161|FG003|Overall Study|Death|1|||
48676940|NCT04038567|156669162|FG004|Overall Study|Death|1|||
48385994|NCT01301456|155609371|FG010|Stage 1|Withdrawal by Subject|0|||
48385995|NCT01301456|155609372|FG011|Stage 1|Withdrawal by Subject|0|||
48676941|NCT04038567|156669163|FG005|Overall Study|Death|0|||
48676942|NCT04038567|156669164|FG006|Overall Study|Death|0|||
48676943|NCT04038567|156669165|FG007|Overall Study|Death|1|||
48676944|NCT01628965|156669178|FG000|Overall Study|Adverse Event|30|||
48676945|NCT01628965|156669178|FG000|Overall Study|Lack of Efficacy|7|||
48676946|NCT01628965|156669178|FG000|Overall Study|Withdrawal by Subject|3|||
48385996|NCT01301456|155609361|FG000|Stage 1|Randomized but not treated|0|||
48385997|NCT01301456|155609362|FG001|Stage 1|Randomized but not treated|0|||
48385998|NCT01301456|155609363|FG002|Stage 1|Randomized but not treated|0|||
48385999|NCT01301456|155609364|FG003|Stage 1|Randomized but not treated|0|||
48386000|NCT01301456|155609365|FG004|Stage 1|Randomized but not treated|0|||
48386001|NCT01301456|155609366|FG005|Stage 1|Randomized but not treated|0|||
48386002|NCT01301456|155609367|FG006|Stage 1|Randomized but not treated|1|||
48386003|NCT01301456|155609368|FG007|Stage 1|Randomized but not treated|0|||
48386004|NCT01301456|155609369|FG008|Stage 1|Randomized but not treated|0|||
48386005|NCT01301456|155609370|FG009|Stage 1|Randomized but not treated|0|||
48386006|NCT01301456|155609371|FG010|Stage 1|Randomized but not treated|0|||
48386007|NCT01301456|155609372|FG011|Stage 1|Randomized but not treated|0|||
48386008|NCT01301456|155609361|FG000|Stage 2|Adverse Event|0|||
48386009|NCT01301456|155609362|FG001|Stage 2|Adverse Event|0|||
48386010|NCT01301456|155609363|FG002|Stage 2|Adverse Event|0|||
48386011|NCT01301456|155609364|FG003|Stage 2|Adverse Event|0|||
48386012|NCT01301456|155609365|FG004|Stage 2|Adverse Event|0|||
48386013|NCT01301456|155609366|FG005|Stage 2|Adverse Event|0|||
48386014|NCT01301456|155609367|FG006|Stage 2|Adverse Event|0|||
48386015|NCT01301456|155609368|FG007|Stage 2|Adverse Event|0|||
48386016|NCT01301456|155609369|FG008|Stage 2|Adverse Event|0|||
48386017|NCT01301456|155609370|FG009|Stage 2|Adverse Event|0|||
48386018|NCT01301456|155609371|FG010|Stage 2|Adverse Event|1|||
48386019|NCT01301456|155609372|FG011|Stage 2|Adverse Event|0|||
48386020|NCT03583450|155609373|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
48386021|NCT03583450|155609374|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
48386022|NCT00718549|155609376|FG000|Induction Phase|Disease Progression|1|||
48386023|NCT00718549|155609377|FG001|Induction Phase|Disease Progression|0|||
48386024|NCT00718549|155609378|FG002|Induction Phase|Disease Progression|0|||
48386025|NCT00718549|155609376|FG000|Induction Phase|Eligibility Criteria Violation|2|||
48386026|NCT00718549|155609377|FG001|Induction Phase|Eligibility Criteria Violation|0|||
48386027|NCT00718549|155609378|FG002|Induction Phase|Eligibility Criteria Violation|0|||
48386028|NCT00718549|155609376|FG000|Induction Phase|Early Termination - No Additional Info|59|||
48386029|NCT00718549|155609377|FG001|Induction Phase|Early Termination - No Additional Info|0|||
48386030|NCT00718549|155609378|FG002|Induction Phase|Early Termination - No Additional Info|0|||
48386031|NCT00718549|155609376|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
48386032|NCT00718549|155609377|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
48386033|NCT00718549|155609378|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
48386034|NCT00718549|155609376|FG000|Maintenance/ Observation Phase|Death|0|||
48386035|NCT00718549|155609377|FG001|Maintenance/ Observation Phase|Death|1|||
48386036|NCT00718549|155609378|FG002|Maintenance/ Observation Phase|Death|2|||
48386037|NCT00718549|155609376|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
48386038|NCT00718549|155609377|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
48386039|NCT00718549|155609378|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
48386040|NCT00718549|155609376|FG000|Maintenance/ Observation Phase|Progression|0|||
48386041|NCT00718549|155609377|FG001|Maintenance/ Observation Phase|Progression|5|||
48386042|NCT00718549|155609378|FG002|Maintenance/ Observation Phase|Progression|14|||
48386043|NCT00718549|155609376|FG000|Maintenance/ Observation Phase|Relapse|0|||
48386044|NCT00718549|155609377|FG001|Maintenance/ Observation Phase|Relapse|3|||
48386045|NCT00718549|155609378|FG002|Maintenance/ Observation Phase|Relapse|2|||
48386046|NCT01353508|155609379|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
48386047|NCT01353508|155609380|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
48386048|NCT01353508|155609381|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
48676947|NCT01628965|156669178|FG000|Overall Study|Lost to Follow-up|1|||
48676948|NCT01628965|156669178|FG000|Overall Study|Discontinuation criteria|8|||
48676949|NCT00398320|156669179|FG000|Overall Study|Death|1|||
48676950|NCT00398320|156669179|FG000|Overall Study|Adverse Event|4|||
48676951|NCT00398320|156669179|FG000|Overall Study|Physician Decision|1|||
48676952|NCT05090852|156669180|FG000|Overall Study|Physician Decision|5|||
48676953|NCT02578186|156669186|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
48676954|NCT02578186|156669187|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
48676955|NCT02578186|156669186|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
48676956|NCT02578186|156669187|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
48676957|NCT02873338|156669189|FG000|Overall Study|Adverse Event|0|||
48386049|NCT01353508|155609382|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
48386050|NCT01353508|155609379|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
48386051|NCT01353508|155609380|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
48386052|NCT01353508|155609381|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
48386053|NCT01353508|155609382|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
48386054|NCT02459769|155609389|FG000|Overall Study|Withdrawal by Subject|7|||
48386055|NCT02459769|155609390|FG001|Overall Study|Withdrawal by Subject|4|||
48386056|NCT02459769|155609391|FG002|Overall Study|Withdrawal by Subject|8|||
48386057|NCT02459769|155609392|FG003|Overall Study|Withdrawal by Subject|5|||
48386058|NCT02459769|155609389|FG000|Overall Study|Lost to Follow-up|1|||
48386059|NCT02459769|155609390|FG001|Overall Study|Lost to Follow-up|0|||
48386060|NCT02459769|155609391|FG002|Overall Study|Lost to Follow-up|1|||
48386061|NCT02459769|155609392|FG003|Overall Study|Lost to Follow-up|0|||
48386062|NCT01010633|155609399|FG000|Overall Study|Adverse Event|1|||
48386063|NCT01010633|155609400|FG001|Overall Study|Adverse Event|1|||
48386064|NCT01010633|155609399|FG000|Overall Study|Protocol Violation|1|||
48386065|NCT01010633|155609400|FG001|Overall Study|Protocol Violation|2|||
48386066|NCT01010633|155609399|FG000|Overall Study|Withdrawal by Subject|2|||
48386067|NCT01010633|155609400|FG001|Overall Study|Withdrawal by Subject|1|||
48386068|NCT01010633|155609399|FG000|Overall Study|Investigator decision|0|||
48386069|NCT01010633|155609400|FG001|Overall Study|Investigator decision|1|||
48386070|NCT02790138|155609403|FG000|Overall Study|Adverse Event|5|||
48386071|NCT02790138|155609404|FG001|Overall Study|Adverse Event|2|||
48386072|NCT02790138|155609403|FG000|Overall Study|Significant Protocol Deviation|0|||
48676958|NCT02873338|156669190|FG001|Overall Study|Adverse Event|2|||
48676959|NCT02873338|156669191|FG002|Overall Study|Adverse Event|1|||
48676960|NCT02873338|156669189|FG000|Overall Study|Death|2|||
48676961|NCT02873338|156669190|FG001|Overall Study|Death|1|||
48386073|NCT02790138|155609404|FG001|Overall Study|Significant Protocol Deviation|1|||
48386074|NCT02790138|155609403|FG000|Overall Study|Lost to Follow-up|1|||
48386075|NCT02790138|155609404|FG001|Overall Study|Lost to Follow-up|0|||
48386076|NCT02790138|155609403|FG000|Overall Study|Voluntary Withdrawal|8|||
48386077|NCT02790138|155609404|FG001|Overall Study|Voluntary Withdrawal|9|||
48386078|NCT02790138|155609403|FG000|Overall Study|Lack of Efficacy|6|||
48386079|NCT02790138|155609404|FG001|Overall Study|Lack of Efficacy|7|||
48386080|NCT02790138|155609403|FG000|Overall Study|Reason not Specified|1|||
48676962|NCT02873338|156669191|FG002|Overall Study|Death|1|||
48676963|NCT02873338|156669189|FG000|Overall Study|Withdrawal by Subject|2|||
48676964|NCT02873338|156669190|FG001|Overall Study|Withdrawal by Subject|1|||
48676965|NCT02873338|156669191|FG002|Overall Study|Withdrawal by Subject|3|||
48676966|NCT02873338|156669189|FG000|Overall Study|Lack of Efficacy|0|||
48676967|NCT02873338|156669190|FG001|Overall Study|Lack of Efficacy|2|||
48676968|NCT02873338|156669191|FG002|Overall Study|Lack of Efficacy|0|||
48676969|NCT02873338|156669189|FG000|Overall Study|Other or Missing|14|||
48676970|NCT02873338|156669190|FG001|Overall Study|Other or Missing|15|||
48676971|NCT02873338|156669191|FG002|Overall Study|Other or Missing|13|||
48676972|NCT00428389|156669194|FG000|Core Phase|Adverse Event|6|||
48676973|NCT00428389|156669195|FG001|Core Phase|Adverse Event|4|||
48676974|NCT00428389|156669194|FG000|Core Phase|Lack of Efficacy|2|||
48676975|NCT00428389|156669195|FG001|Core Phase|Lack of Efficacy|0|||
48676976|NCT00428389|156669194|FG000|Core Phase|Abnormal test procedure result(s)|0|||
48676977|NCT00428389|156669195|FG001|Core Phase|Abnormal test procedure result(s)|1|||
48676978|NCT00428389|156669194|FG000|Core Phase|Withdrawal by Subject|3|||
48676979|NCT00428389|156669195|FG001|Core Phase|Withdrawal by Subject|4|||
48676980|NCT00428389|156669194|FG000|Core Phase|Protocol deviation|0|||
48676981|NCT00428389|156669195|FG001|Core Phase|Protocol deviation|2|||
48676982|NCT00428389|156669194|FG000|Extension Phase|Adverse Event|17|||
48676983|NCT00428389|156669195|FG001|Extension Phase|Adverse Event|11|||
48676984|NCT00428389|156669194|FG000|Extension Phase|Lack of Efficacy|4|||
48386081|NCT02790138|155609404|FG001|Overall Study|Reason not Specified|0|||
48386082|NCT03654976|155609405|FG000|Overall Study|Withdrawal by Subject|12|||
48386083|NCT03654976|155609406|FG001|Overall Study|Withdrawal by Subject|11|||
48386084|NCT03654976|155609405|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
48386085|NCT03654976|155609406|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
48386086|NCT03654976|155609405|FG000|Overall Study|Adverse Event|5|||
48676985|NCT00428389|156669195|FG001|Extension Phase|Lack of Efficacy|3|||
48676986|NCT00428389|156669194|FG000|Extension Phase|Withdrawal by Subject|6|||
48676987|NCT00428389|156669195|FG001|Extension Phase|Withdrawal by Subject|6|||
48386087|NCT03654976|155609406|FG001|Overall Study|Adverse Event|0|||
48386088|NCT03654976|155609405|FG000|Overall Study|Lost to Follow-up|2|||
48386089|NCT03654976|155609406|FG001|Overall Study|Lost to Follow-up|0|||
48386090|NCT03654976|155609405|FG000|Overall Study|Lack of Efficacy|0|||
48386091|NCT03654976|155609406|FG001|Overall Study|Lack of Efficacy|1|||
48386092|NCT02632721|155609407|FG000|Overall Study|Adverse Event|0|||
48386093|NCT02632721|155609408|FG001|Overall Study|Adverse Event|0|||
48386094|NCT02632721|155609409|FG002|Overall Study|Adverse Event|2|||
48386095|NCT02632721|155609410|FG003|Overall Study|Adverse Event|5|||
48386096|NCT02632721|155609411|FG004|Overall Study|Adverse Event|3|||
48386097|NCT02632721|155609407|FG000|Overall Study|Dose limiting toxicity|0|||
48386098|NCT02632721|155609408|FG001|Overall Study|Dose limiting toxicity|0|||
48386099|NCT02632721|155609409|FG002|Overall Study|Dose limiting toxicity|0|||
48386100|NCT02632721|155609410|FG003|Overall Study|Dose limiting toxicity|1|||
48386101|NCT02632721|155609411|FG004|Overall Study|Dose limiting toxicity|0|||
48386102|NCT02632721|155609407|FG000|Overall Study|Progressive disease|3|||
48386103|NCT02632721|155609408|FG001|Overall Study|Progressive disease|0|||
48386104|NCT02632721|155609409|FG002|Overall Study|Progressive disease|4|||
48386105|NCT02632721|155609410|FG003|Overall Study|Progressive disease|6|||
48386106|NCT02632721|155609411|FG004|Overall Study|Progressive disease|5|||
48386107|NCT02632721|155609407|FG000|Overall Study|Refused to continue taking trial medication|0|||
48386108|NCT02632721|155609408|FG001|Overall Study|Refused to continue taking trial medication|1|||
48386109|NCT02632721|155609409|FG002|Overall Study|Refused to continue taking trial medication|1|||
48386110|NCT02632721|155609410|FG003|Overall Study|Refused to continue taking trial medication|1|||
48386111|NCT02632721|155609411|FG004|Overall Study|Refused to continue taking trial medication|2|||
48386112|NCT02632721|155609407|FG000|Overall Study|Inadequate clinical condition|0|||
48386113|NCT02632721|155609408|FG001|Overall Study|Inadequate clinical condition|0|||
48386114|NCT02632721|155609409|FG002|Overall Study|Inadequate clinical condition|0|||
48386115|NCT02632721|155609410|FG003|Overall Study|Inadequate clinical condition|0|||
48386116|NCT02632721|155609411|FG004|Overall Study|Inadequate clinical condition|1|||
48386117|NCT02632721|155609407|FG000|Overall Study|No meet eligibility|0|||
48386118|NCT02632721|155609408|FG001|Overall Study|No meet eligibility|0|||
48386119|NCT02632721|155609409|FG002|Overall Study|No meet eligibility|0|||
48386120|NCT02632721|155609410|FG003|Overall Study|No meet eligibility|0|||
48386121|NCT02632721|155609411|FG004|Overall Study|No meet eligibility|1|||
48386122|NCT02632721|155609407|FG000|Overall Study|Allergic reaction|0|||
48386123|NCT02632721|155609408|FG001|Overall Study|Allergic reaction|0|||
48386124|NCT02632721|155609409|FG002|Overall Study|Allergic reaction|0|||
48386125|NCT02632721|155609410|FG003|Overall Study|Allergic reaction|1|||
48386126|NCT02632721|155609411|FG004|Overall Study|Allergic reaction|0|||
48386127|NCT02632721|155609407|FG000|Overall Study|Receiving Decitabine locally|0|||
48386128|NCT02632721|155609408|FG001|Overall Study|Receiving Decitabine locally|0|||
48386129|NCT02632721|155609409|FG002|Overall Study|Receiving Decitabine locally|1|||
48386130|NCT02632721|155609410|FG003|Overall Study|Receiving Decitabine locally|0|||
48386131|NCT02632721|155609411|FG004|Overall Study|Receiving Decitabine locally|0|||
48386132|NCT02632721|155609407|FG000|Overall Study|No benefit from study treatment|1|||
48386133|NCT02632721|155609408|FG001|Overall Study|No benefit from study treatment|1|||
48386134|NCT02632721|155609409|FG002|Overall Study|No benefit from study treatment|0|||
48386135|NCT02632721|155609410|FG003|Overall Study|No benefit from study treatment|0|||
48386136|NCT02632721|155609411|FG004|Overall Study|No benefit from study treatment|1|||
48386137|NCT02632721|155609407|FG000|Overall Study|Patient wish for other treatment|0|||
48386138|NCT02632721|155609408|FG001|Overall Study|Patient wish for other treatment|1|||
48386139|NCT02632721|155609409|FG002|Overall Study|Patient wish for other treatment|0|||
48386140|NCT02632721|155609410|FG003|Overall Study|Patient wish for other treatment|0|||
48386141|NCT02632721|155609411|FG004|Overall Study|Patient wish for other treatment|0|||
48386142|NCT02632721|155609407|FG000|Overall Study|Relapsed Pneumonia|0|||
48386143|NCT02632721|155609408|FG001|Overall Study|Relapsed Pneumonia|0|||
48386144|NCT02632721|155609409|FG002|Overall Study|Relapsed Pneumonia|0|||
48386145|NCT02632721|155609410|FG003|Overall Study|Relapsed Pneumonia|0|||
48386146|NCT02632721|155609411|FG004|Overall Study|Relapsed Pneumonia|1|||
48386147|NCT02632721|155609407|FG000|Overall Study|Therapy refractory AML|0|||
48386148|NCT02632721|155609408|FG001|Overall Study|Therapy refractory AML|0|||
48386149|NCT02632721|155609409|FG002|Overall Study|Therapy refractory AML|0|||
48386150|NCT02632721|155609410|FG003|Overall Study|Therapy refractory AML|0|||
48386151|NCT02632721|155609411|FG004|Overall Study|Therapy refractory AML|1|||
48386152|NCT02632721|155609407|FG000|Overall Study|Increase of white blood cell count|0|||
48386153|NCT02632721|155609408|FG001|Overall Study|Increase of white blood cell count|0|||
48386154|NCT02632721|155609409|FG002|Overall Study|Increase of white blood cell count|0|||
48386155|NCT02632721|155609410|FG003|Overall Study|Increase of white blood cell count|0|||
48386156|NCT02632721|155609411|FG004|Overall Study|Increase of white blood cell count|1|||
48386157|NCT02632721|155609407|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
48386158|NCT02632721|155609408|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
48386159|NCT02632721|155609409|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
48386160|NCT02632721|155609410|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
48386161|NCT02632721|155609411|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
48386162|NCT01572675|155609412|FG000|Overall Study|End of prescribed treatment|140|||
48386163|NCT01572675|155609413|FG001|Overall Study|End of prescribed treatment|118|||
48386164|NCT01572675|155609412|FG000|Overall Study|Recovery|16|||
48386165|NCT01572675|155609413|FG001|Overall Study|Recovery|23|||
48386166|NCT01572675|155609412|FG000|Overall Study|Lack of Efficacy|31|||
48676988|NCT00428389|156669194|FG000|Extension Phase|Lost to Follow-up|0|||
48676989|NCT00428389|156669195|FG001|Extension Phase|Lost to Follow-up|3|||
48676990|NCT00428389|156669194|FG000|Extension Phase|Death|1|||
48676991|NCT00428389|156669195|FG001|Extension Phase|Death|0|||
48676992|NCT00428389|156669194|FG000|Extension Phase|Protocol Violation|3|||
48676993|NCT00428389|156669195|FG001|Extension Phase|Protocol Violation|2|||
48676994|NCT00428389|156669194|FG000|Extension Phase|Administrative problems|1|||
48676995|NCT00428389|156669195|FG001|Extension Phase|Administrative problems|1|||
48676996|NCT01320202|156669197|FG000|Overall Study|Adverse Event|5|||
48676997|NCT01320202|156669198|FG001|Overall Study|Adverse Event|5|||
48676998|NCT01320202|156669197|FG000|Overall Study|Death|5|||
48676999|NCT01320202|156669198|FG001|Overall Study|Death|3|||
48677000|NCT01320202|156669197|FG000|Overall Study|Lost to Follow-up|1|||
48677001|NCT01320202|156669198|FG001|Overall Study|Lost to Follow-up|0|||
48677002|NCT01320202|156669197|FG000|Overall Study|Physician Decision|3|||
48386167|NCT01572675|155609413|FG001|Overall Study|Lack of Efficacy|31|||
48386168|NCT01572675|155609412|FG000|Overall Study|Intolerance|6|||
48386169|NCT01572675|155609413|FG001|Overall Study|Intolerance|5|||
48386170|NCT01572675|155609412|FG000|Overall Study|Improved symptoms|8|||
48386171|NCT01572675|155609413|FG001|Overall Study|Improved symptoms|2|||
48386172|NCT01572675|155609412|FG000|Overall Study|Surgical intervention|3|||
48386173|NCT01572675|155609413|FG001|Overall Study|Surgical intervention|6|||
48386174|NCT01572675|155609412|FG000|Overall Study|Withdrawal by Subject|5|||
48386175|NCT01572675|155609413|FG001|Overall Study|Withdrawal by Subject|1|||
48386176|NCT01572675|155609412|FG000|Overall Study|Physician Decision|2|||
48386177|NCT01572675|155609413|FG001|Overall Study|Physician Decision|2|||
48386178|NCT01572675|155609412|FG000|Overall Study|Death unrelated to coxibs|1|||
48386179|NCT01572675|155609413|FG001|Overall Study|Death unrelated to coxibs|1|||
48386180|NCT01572675|155609412|FG000|Overall Study|Other disease detected|1|||
48677003|NCT01320202|156669198|FG001|Overall Study|Physician Decision|1|||
48677004|NCT01320202|156669197|FG000|Overall Study|Protocol Violation|2|||
48677005|NCT01320202|156669198|FG001|Overall Study|Protocol Violation|1|||
48762287|NCT00076011|156978069|FG000|Overall Study|Death|1|||
48762288|NCT00076011|156978069|FG000|Overall Study|Adverse Event|10|||
48762289|NCT00076011|156978069|FG000|Overall Study|Lack of Efficacy|25|||
48677006|NCT01320202|156669197|FG000|Overall Study|Withdrawal by Subject|10|||
48762290|NCT00076011|156978069|FG000|Overall Study|Withdrawal by Subject|1|||
48762291|NCT00076011|156978069|FG000|Overall Study|Study terminated by sponsor|3|||
48762292|NCT00076011|156978069|FG000|Overall Study|Other|11|||
48762293|NCT00076011|156978069|FG000|Overall Study|Ongoing|1|||
48762294|NCT03406858|156978070|FG000|Overall Study|Failure to receive treatment drug.|1|||
48762295|NCT03406858|156978070|FG000|Overall Study|ineligible|1|||
48762296|NCT00930579|156978073|FG000|Overall Study|Withdrawal by Subject|1|||
48762297|NCT00930579|156978073|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
48762298|NCT02672423|156978076|FG000|Period 1|Adverse Event|0|||
48762299|NCT02672423|156978077|FG001|Period 1|Adverse Event|0|||
48762300|NCT02672423|156978078|FG002|Period 1|Adverse Event|0|||
48762301|NCT02672423|156978079|FG003|Period 1|Adverse Event|0|||
48762302|NCT02672423|156978080|FG004|Period 1|Adverse Event|1|||
48762303|NCT02672423|156978081|FG005|Period 1|Adverse Event|0|||
48762304|NCT02672423|156978082|FG006|Period 1|Adverse Event|0|||
48762305|NCT02672423|156978083|FG007|Period 1|Adverse Event|0|||
48762306|NCT02672423|156978084|FG008|Period 1|Adverse Event|0|||
48762307|NCT02672423|156978085|FG009|Period 1|Adverse Event|0|||
48677007|NCT01320202|156669198|FG001|Overall Study|Withdrawal by Subject|3|||
48762308|NCT02672423|156978076|FG000|Period 2|Withdrawal by Subject|0|||
48762309|NCT02672423|156978077|FG001|Period 2|Withdrawal by Subject|0|||
48762310|NCT02672423|156978078|FG002|Period 2|Withdrawal by Subject|1|||
48386181|NCT01572675|155609413|FG001|Overall Study|Other disease detected|1|||
48386182|NCT01572675|155609412|FG000|Overall Study|Unknown reason|1|||
48386183|NCT01572675|155609413|FG001|Overall Study|Unknown reason|1|||
48386184|NCT01572675|155609412|FG000|Overall Study|Rheumatologist new evaluation|0|||
48386185|NCT01572675|155609413|FG001|Overall Study|Rheumatologist new evaluation|1|||
48386186|NCT01572675|155609412|FG000|Overall Study|Missing data|1|||
48677008|NCT01320202|156669197|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
48762311|NCT02672423|156978079|FG003|Period 2|Withdrawal by Subject|0|||
48677009|NCT01320202|156669198|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
48762312|NCT02672423|156978080|FG004|Period 2|Withdrawal by Subject|0|||
48762313|NCT02672423|156978081|FG005|Period 2|Withdrawal by Subject|0|||
48762314|NCT02672423|156978082|FG006|Period 2|Withdrawal by Subject|0|||
48677010|NCT01320202|156669197|FG000|Overall Study|kidney transplant|1|||
48677011|NCT01320202|156669198|FG001|Overall Study|kidney transplant|2|||
48677012|NCT01320202|156669197|FG000|Overall Study|blood transfusion|1|||
48677013|NCT01320202|156669198|FG001|Overall Study|blood transfusion|7|||
48677014|NCT01320202|156669197|FG000|Overall Study|moved/changed dialysis|5|||
48677015|NCT01320202|156669198|FG001|Overall Study|moved/changed dialysis|2|||
48677016|NCT01320202|156669197|FG000|Overall Study|sponsor request|2|||
48677017|NCT01320202|156669198|FG001|Overall Study|sponsor request|0|||
48677018|NCT01320202|156669197|FG000|Overall Study|ineligible|3|||
48677019|NCT01320202|156669198|FG001|Overall Study|ineligible|0|||
48677020|NCT01320202|156669197|FG000|Overall Study|regained renal function|1|||
48677021|NCT01320202|156669198|FG001|Overall Study|regained renal function|0|||
48677022|NCT02513472|156669199|FG000|Overall Study|Radiological Disease Progression|45|||
48677023|NCT02513472|156669200|FG001|Overall Study|Radiological Disease Progression|57|||
48677024|NCT02513472|156669199|FG000|Overall Study|Clinical Disease Progression|5|||
48677025|NCT02513472|156669200|FG001|Overall Study|Clinical Disease Progression|13|||
48677026|NCT02513472|156669199|FG000|Overall Study|Adverse Event|8|||
48677027|NCT02513472|156669200|FG001|Overall Study|Adverse Event|11|||
48677028|NCT02513472|156669199|FG000|Overall Study|Withdrawal by Subject|0|||
48677029|NCT02513472|156669200|FG001|Overall Study|Withdrawal by Subject|4|||
48677030|NCT02513472|156669199|FG000|Overall Study|Subject Choice|2|||
48677031|NCT02513472|156669200|FG001|Overall Study|Subject Choice|7|||
48354771|NCT02366143|155497110|FG002|Overall Study|Death|280|||
48354772|NCT02366143|155497108|FG000|Overall Study|Lost to Follow-up|2|||
48354773|NCT02366143|155497109|FG001|Overall Study|Lost to Follow-up|4|||
48354774|NCT02366143|155497110|FG002|Overall Study|Lost to Follow-up|2|||
48354775|NCT02366143|155497108|FG000|Overall Study|Physician Decision|1|||
48354776|NCT02366143|155497109|FG001|Overall Study|Physician Decision|2|||
48354777|NCT02366143|155497110|FG002|Overall Study|Physician Decision|1|||
48354778|NCT02366143|155497108|FG000|Overall Study|Protocol Violation|0|||
48354779|NCT02366143|155497109|FG001|Overall Study|Protocol Violation|0|||
48354780|NCT02366143|155497110|FG002|Overall Study|Protocol Violation|2|||
48354781|NCT02366143|155497108|FG000|Overall Study|Withdrawal by Subject|16|||
48354782|NCT02366143|155497109|FG001|Overall Study|Withdrawal by Subject|17|||
48354783|NCT02366143|155497110|FG002|Overall Study|Withdrawal by Subject|22|||
48354784|NCT02366143|155497108|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
48354785|NCT02366143|155497109|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
48354786|NCT02366143|155497110|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
48354787|NCT02366143|155497108|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
48354788|NCT02366143|155497109|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
48354789|NCT02366143|155497110|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
48354790|NCT02366143|155497108|FG000|Overall Study|Randomization Error|1|||
48354791|NCT02366143|155497109|FG001|Overall Study|Randomization Error|0|||
48354792|NCT02366143|155497110|FG002|Overall Study|Randomization Error|0|||
48354793|NCT02366143|155497108|FG000|Overall Study|PI Move and Site Closure|1|||
48354794|NCT02366143|155497109|FG001|Overall Study|PI Move and Site Closure|0|||
48354795|NCT02366143|155497110|FG002|Overall Study|PI Move and Site Closure|1|||
48354796|NCT02366143|155497108|FG000|Overall Study|Study Terminated By Sponsor|0|||
48354797|NCT02366143|155497109|FG001|Overall Study|Study Terminated By Sponsor|0|||
48354798|NCT02366143|155497110|FG002|Overall Study|Study Terminated By Sponsor|2|||
48354799|NCT02366143|155497108|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
48354800|NCT02366143|155497109|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
48354801|NCT02366143|155497110|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
48354802|NCT02366143|155497108|FG000|Overall Study|Patient moved to roll-over study|1|||
48354803|NCT02366143|155497109|FG001|Overall Study|Patient moved to roll-over study|19|||
48354804|NCT02366143|155497110|FG002|Overall Study|Patient moved to roll-over study|28|||
48354805|NCT02366143|155497108|FG000|Overall Study|Patient moved to commercial stock|0|||
48354806|NCT02366143|155497109|FG001|Overall Study|Patient moved to commercial stock|0|||
48354807|NCT02366143|155497110|FG002|Overall Study|Patient moved to commercial stock|1|||
48354808|NCT02366143|155497108|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
48354809|NCT02366143|155497109|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
48354810|NCT02366143|155497110|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
48354811|NCT02366143|155497108|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
48354812|NCT02366143|155497109|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
48354813|NCT02366143|155497110|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
48354814|NCT02366143|155497108|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
48354815|NCT02366143|155497109|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
48354816|NCT02366143|155497110|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
48386187|NCT01572675|155609413|FG001|Overall Study|Missing data|4|||
48386188|NCT01572675|155609412|FG000|Overall Study|Lost to Follow-up|22|||
48386189|NCT01572675|155609413|FG001|Overall Study|Lost to Follow-up|27|||
48386190|NCT00430482|155609414|FG000|Completed Treatment|Insufficient Treatment|7|||
48386191|NCT00430482|155609415|FG001|Completed Treatment|Insufficient Treatment|11|||
48386192|NCT00545402|155609416|FG000|Overall Study|Discontinuation of treatment|17|||
48386193|NCT00545402|155609417|FG001|Overall Study|Discontinuation of treatment|9|||
48386194|NCT00545402|155609416|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
48386195|NCT00545402|155609417|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
48386196|NCT00545402|155609416|FG000|Overall Study|Death|5|||
48386197|NCT00545402|155609417|FG001|Overall Study|Death|7|||
48386198|NCT00545402|155609416|FG000|Overall Study|Graft loss|2|||
48386199|NCT00545402|155609417|FG001|Overall Study|Graft loss|4|||
48386200|NCT00545402|155609416|FG000|Overall Study|Withdrawal by Subject|0|||
48386201|NCT00545402|155609417|FG001|Overall Study|Withdrawal by Subject|1|||
48386202|NCT00545402|155609416|FG000|Overall Study|Protocol Violation|1|||
48386203|NCT00545402|155609417|FG001|Overall Study|Protocol Violation|0|||
48386204|NCT00545402|155609416|FG000|Overall Study|Reason not specified|1|||
48386205|NCT00545402|155609417|FG001|Overall Study|Reason not specified|1|||
48386206|NCT03519867|155609418|FG000|Overall Study|Adverse Event|1|||
48386207|NCT03519867|155609419|FG001|Overall Study|Adverse Event|1|||
48386208|NCT03519867|155609420|FG002|Overall Study|Adverse Event|0|||
48386209|NCT03519867|155609421|FG003|Overall Study|Adverse Event|0|||
48386210|NCT03519867|155609422|FG004|Overall Study|Adverse Event|0|||
48386211|NCT03519867|155609423|FG005|Overall Study|Adverse Event|0|||
48386212|NCT03519867|155609424|FG006|Overall Study|Adverse Event|0|||
48386213|NCT03519867|155609425|FG007|Overall Study|Adverse Event|0|||
48386214|NCT03519867|155609426|FG008|Overall Study|Adverse Event|0|||
48386215|NCT03519867|155609427|FG009|Overall Study|Adverse Event|0|||
48386216|NCT03519867|155609418|FG000|Overall Study|Protocol Violation|0|||
48386217|NCT03519867|155609419|FG001|Overall Study|Protocol Violation|0|||
48386218|NCT03519867|155609420|FG002|Overall Study|Protocol Violation|0|||
48386219|NCT03519867|155609421|FG003|Overall Study|Protocol Violation|0|||
48386220|NCT03519867|155609422|FG004|Overall Study|Protocol Violation|0|||
48386221|NCT03519867|155609423|FG005|Overall Study|Protocol Violation|1|||
48386222|NCT03519867|155609424|FG006|Overall Study|Protocol Violation|0|||
48386223|NCT03519867|155609425|FG007|Overall Study|Protocol Violation|0|||
48386224|NCT03519867|155609426|FG008|Overall Study|Protocol Violation|0|||
48386225|NCT03519867|155609427|FG009|Overall Study|Protocol Violation|0|||
48386226|NCT03519867|155609418|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386227|NCT03519867|155609419|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386228|NCT03519867|155609420|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386229|NCT03519867|155609421|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386230|NCT03519867|155609422|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386231|NCT03519867|155609423|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386232|NCT03519867|155609424|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
48386233|NCT03519867|155609425|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386234|NCT03519867|155609426|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386235|NCT03519867|155609427|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
48386236|NCT03519867|155609418|FG000|Overall Study|Admin. of other reversal agent|1|||
48386237|NCT03519867|155609419|FG001|Overall Study|Admin. of other reversal agent|1|||
48386238|NCT03519867|155609420|FG002|Overall Study|Admin. of other reversal agent|0|||
48386239|NCT03519867|155609421|FG003|Overall Study|Admin. of other reversal agent|0|||
48386240|NCT03519867|155609422|FG004|Overall Study|Admin. of other reversal agent|0|||
48386241|NCT03519867|155609423|FG005|Overall Study|Admin. of other reversal agent|1|||
48386242|NCT03519867|155609424|FG006|Overall Study|Admin. of other reversal agent|0|||
48386243|NCT03519867|155609425|FG007|Overall Study|Admin. of other reversal agent|0|||
48386244|NCT03519867|155609426|FG008|Overall Study|Admin. of other reversal agent|0|||
48386245|NCT03519867|155609427|FG009|Overall Study|Admin. of other reversal agent|0|||
48386246|NCT03519867|155609418|FG000|Overall Study|Reason not provided|1|||
48386247|NCT03519867|155609419|FG001|Overall Study|Reason not provided|1|||
48677032|NCT02513472|156669199|FG000|Overall Study|Treatment Completed as per Protocol|3|||
48386248|NCT03519867|155609420|FG002|Overall Study|Reason not provided|1|||
48386249|NCT03519867|155609421|FG003|Overall Study|Reason not provided|1|||
48677033|NCT02513472|156669200|FG001|Overall Study|Treatment Completed as per Protocol|3|||
48677034|NCT02513472|156669199|FG000|Overall Study|Other|3|||
48677035|NCT02513472|156669200|FG001|Overall Study|Other|6|||
48386250|NCT03519867|155609422|FG004|Overall Study|Reason not provided|0|||
48386251|NCT03519867|155609423|FG005|Overall Study|Reason not provided|1|||
48386252|NCT03519867|155609424|FG006|Overall Study|Reason not provided|0|||
48386253|NCT03519867|155609425|FG007|Overall Study|Reason not provided|1|||
48386254|NCT03519867|155609426|FG008|Overall Study|Reason not provided|1|||
48386255|NCT03519867|155609427|FG009|Overall Study|Reason not provided|0|||
48386256|NCT00382018|155609428|FG000|Overall Study|Progression|0|||
48386257|NCT00382018|155609429|FG001|Overall Study|Progression|136|||
48386258|NCT00382018|155609430|FG002|Overall Study|Progression|51|||
48677036|NCT02292706|156669201|FG000|Overall Study|Lost to Follow-up|20|||
48677037|NCT02292706|156669202|FG001|Overall Study|Lost to Follow-up|44|||
48677038|NCT02292706|156669203|FG002|Overall Study|Lost to Follow-up|24|||
48677039|NCT02292706|156669204|FG003|Overall Study|Lost to Follow-up|61|||
48677040|NCT02292706|156669205|FG004|Overall Study|Lost to Follow-up|21|||
48677041|NCT02292706|156669206|FG005|Overall Study|Lost to Follow-up|52|||
48677042|NCT02292706|156669207|FG006|Overall Study|Lost to Follow-up|25|||
48677043|NCT02292706|156669208|FG007|Overall Study|Lost to Follow-up|0|||
48677044|NCT02292706|156669201|FG000|Overall Study|Withdrew consent|15|||
48677045|NCT02292706|156669202|FG001|Overall Study|Withdrew consent|56|||
48677046|NCT02292706|156669203|FG002|Overall Study|Withdrew consent|43|||
48677047|NCT02292706|156669204|FG003|Overall Study|Withdrew consent|36|||
48677048|NCT02292706|156669205|FG004|Overall Study|Withdrew consent|13|||
48677049|NCT02292706|156669206|FG005|Overall Study|Withdrew consent|51|||
48677050|NCT02292706|156669207|FG006|Overall Study|Withdrew consent|20|||
48677051|NCT02292706|156669208|FG007|Overall Study|Withdrew consent|0|||
48386259|NCT00382018|155609431|FG003|Overall Study|Progression|43|||
48677052|NCT02292706|156669201|FG000|Overall Study|Death|3|||
48677053|NCT02292706|156669202|FG001|Overall Study|Death|11|||
48677054|NCT02292706|156669203|FG002|Overall Study|Death|16|||
48762315|NCT02672423|156978083|FG007|Period 2|Withdrawal by Subject|0|||
48386260|NCT00382018|155609428|FG000|Overall Study|Death|0|||
48386261|NCT00382018|155609429|FG001|Overall Study|Death|9|||
48386262|NCT00382018|155609430|FG002|Overall Study|Death|7|||
48386263|NCT00382018|155609431|FG003|Overall Study|Death|11|||
48386264|NCT00382018|155609428|FG000|Overall Study|Withdrawal by Subject|0|||
48386265|NCT00382018|155609429|FG001|Overall Study|Withdrawal by Subject|4|||
48386266|NCT00382018|155609430|FG002|Overall Study|Withdrawal by Subject|3|||
48386267|NCT00382018|155609431|FG003|Overall Study|Withdrawal by Subject|4|||
48386268|NCT00382018|155609428|FG000|Overall Study|Other, not protocol specified|0|||
48386269|NCT00382018|155609429|FG001|Overall Study|Other, not protocol specified|16|||
48386270|NCT00382018|155609430|FG002|Overall Study|Other, not protocol specified|3|||
48386271|NCT00382018|155609431|FG003|Overall Study|Other, not protocol specified|1|||
48386272|NCT01519765|155609432|FG000|Overall Study|Adverse Event|0|||
48386273|NCT01519765|155609433|FG001|Overall Study|Adverse Event|1|||
48386274|NCT01519765|155609432|FG000|Overall Study|Lack of Efficacy|2|||
48386275|NCT01519765|155609433|FG001|Overall Study|Lack of Efficacy|0|||
48386276|NCT01519765|155609432|FG000|Overall Study|Protocol Violation|1|||
48386277|NCT01519765|155609433|FG001|Overall Study|Protocol Violation|0|||
48386278|NCT01519765|155609432|FG000|Overall Study|Withdrawal by Subject|0|||
48386279|NCT01519765|155609433|FG001|Overall Study|Withdrawal by Subject|1|||
48386280|NCT00698997|155609442|FG000|Overall Study|Lost to Follow-up|3|||
48386281|NCT00698997|155609443|FG001|Overall Study|Lost to Follow-up|0|||
48386282|NCT00698997|155609442|FG000|Overall Study|Withdrawal by Subject|7|||
48386283|NCT00698997|155609443|FG001|Overall Study|Withdrawal by Subject|27|||
48386284|NCT02109562|155609444|FG000|Overall Study|Insufficient clinical response|2|||
48386285|NCT02109562|155609445|FG001|Overall Study|Insufficient clinical response|0|||
48386286|NCT02109562|155609446|FG002|Overall Study|Insufficient clinical response|4|||
48386287|NCT02109562|155609444|FG000|Overall Study|Adverse Event|0|||
48386288|NCT02109562|155609445|FG001|Overall Study|Adverse Event|2|||
48386289|NCT02109562|155609446|FG002|Overall Study|Adverse Event|3|||
48386290|NCT02109562|155609444|FG000|Overall Study|Lost to Follow-up|1|||
48386291|NCT02109562|155609445|FG001|Overall Study|Lost to Follow-up|0|||
48386292|NCT02109562|155609446|FG002|Overall Study|Lost to Follow-up|1|||
48386293|NCT02109562|155609444|FG000|Overall Study|Protocol Violation|0|||
48386294|NCT02109562|155609445|FG001|Overall Study|Protocol Violation|3|||
48386295|NCT02109562|155609446|FG002|Overall Study|Protocol Violation|1|||
48386296|NCT02109562|155609444|FG000|Overall Study|Withdrawal by Subject|20|||
48386297|NCT02109562|155609445|FG001|Overall Study|Withdrawal by Subject|25|||
48386298|NCT02109562|155609446|FG002|Overall Study|Withdrawal by Subject|21|||
48386299|NCT02109562|155609444|FG000|Overall Study|Physician Decision|3|||
48386300|NCT02109562|155609445|FG001|Overall Study|Physician Decision|4|||
48386301|NCT02109562|155609446|FG002|Overall Study|Physician Decision|5|||
48386302|NCT00482703|155609447|FG000|Overall Study|Poor compliance|1|||
48386303|NCT00482703|155609448|FG001|Overall Study|Poor compliance|0|||
48386304|NCT05715528|155609457|FG000|Overall Study|Randomized but never treated|11|||
48386305|NCT05715528|155609458|FG001|Overall Study|Randomized but never treated|13|||
48386306|NCT05715528|155609457|FG000|Overall Study|Withdrew consent|7|||
48386307|NCT05715528|155609458|FG001|Overall Study|Withdrew consent|15|||
48386308|NCT05715528|155609457|FG000|Overall Study|Lost to Follow-up|5|||
48386309|NCT05715528|155609458|FG001|Overall Study|Lost to Follow-up|13|||
48386310|NCT05715528|155609457|FG000|Overall Study|Investigator's discretion|3|||
48386311|NCT05715528|155609458|FG001|Overall Study|Investigator's discretion|1|||
48386312|NCT05715528|155609457|FG000|Overall Study|Protocol Violation|2|||
48386313|NCT05715528|155609458|FG001|Overall Study|Protocol Violation|0|||
48386314|NCT05715528|155609457|FG000|Overall Study|Non-compliance with study drug|0|||
48386315|NCT05715528|155609458|FG001|Overall Study|Non-compliance with study drug|1|||
48386316|NCT02710136|155609459|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
48386317|NCT02710136|155609460|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
48386318|NCT01335009|155609461|FG000|Overall Study|Too ill to travel to study sites|1|||
48386319|NCT01335009|155609462|FG001|Overall Study|Too ill to travel to study sites|0|||
48386320|NCT01335009|155609461|FG000|Overall Study|Death|28|||
48386321|NCT01335009|155609462|FG001|Overall Study|Death|32|||
48386322|NCT01335009|155609461|FG000|Overall Study|Withdrawal by Subject|1|||
48386323|NCT01335009|155609462|FG001|Overall Study|Withdrawal by Subject|1|||
48386324|NCT01335009|155609461|FG000|Overall Study|Lost to Follow-up|1|||
48386325|NCT01335009|155609462|FG001|Overall Study|Lost to Follow-up|0|||
48386326|NCT03329196|155611275|FG000|Overall Study|Adverse Event|10|||
48386327|NCT03329196|155611276|FG001|Overall Study|Adverse Event|5|||
48386328|NCT03329196|155611275|FG000|Overall Study|Physician Decision|2|||
48677055|NCT02292706|156669204|FG003|Overall Study|Death|22|||
48386329|NCT03329196|155611276|FG001|Overall Study|Physician Decision|2|||
48386330|NCT03329196|155611275|FG000|Overall Study|Withdrawal by Subject|11|||
48386331|NCT03329196|155611276|FG001|Overall Study|Withdrawal by Subject|3|||
48386332|NCT03329196|155611275|FG000|Overall Study|Hepatic function abnormalities|0|||
48386333|NCT03329196|155611276|FG001|Overall Study|Hepatic function abnormalities|1|||
48386334|NCT03329196|155611275|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
48386335|NCT03329196|155611276|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
48386336|NCT03329196|155611275|FG000|Overall Study|Difficult to control Hb|2|||
48386337|NCT03329196|155611276|FG001|Overall Study|Difficult to control Hb|3|||
48386338|NCT03329196|155611275|FG000|Overall Study|Dialysis or renal transplant|13|||
48386339|NCT03329196|155611276|FG001|Overall Study|Dialysis or renal transplant|15|||
48386340|NCT04042740|155611280|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
48386341|NCT04042740|155611280|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
48386342|NCT04823611|155611281|FG000|Overall Study|Adverse Event|2|||
48386343|NCT04823611|155611282|FG001|Overall Study|Adverse Event|0|||
48386344|NCT04823611|155611283|FG002|Overall Study|Adverse Event|1|||
48386345|NCT04823611|155611284|FG003|Overall Study|Adverse Event|0|||
48386346|NCT04823611|155611285|FG004|Overall Study|Adverse Event|0|||
48386347|NCT04823611|155611286|FG005|Overall Study|Adverse Event|0|||
48386348|NCT04823611|155611287|FG006|Overall Study|Adverse Event|0|||
48386349|NCT02615470|155611288|FG000|Overall Study|Lost to Follow-up|21|||
48386350|NCT02615470|155611289|FG001|Overall Study|Lost to Follow-up|32|||
48386351|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
48386352|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
48386353|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
48386354|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
48386355|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
48386356|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
48386357|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
48386358|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
48386359|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
48386360|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
48386361|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
48386362|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
48386363|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
48386364|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
48386365|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
48386366|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
48677056|NCT02292706|156669205|FG004|Overall Study|Death|8|||
48677057|NCT02292706|156669206|FG005|Overall Study|Death|17|||
48677058|NCT02292706|156669207|FG006|Overall Study|Death|3|||
48677059|NCT02292706|156669208|FG007|Overall Study|Death|0|||
48677060|NCT02292706|156669201|FG000|Overall Study|Study terminated by sponsor|0|||
48677061|NCT02292706|156669202|FG001|Overall Study|Study terminated by sponsor|9|||
48762316|NCT02672423|156978084|FG008|Period 2|Withdrawal by Subject|0|||
48386367|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
48386368|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
48386369|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
48386370|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
48386371|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
48386372|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
48386373|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
48386374|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
48386375|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
48386376|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
48386377|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
48386378|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
48386379|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
48386380|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
48386381|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
48386382|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
48386383|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
48386384|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
48386385|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
48386386|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
48386387|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
48762317|NCT02672423|156978085|FG009|Period 2|Withdrawal by Subject|0|||
48386388|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
48677062|NCT02292706|156669203|FG002|Overall Study|Study terminated by sponsor|4|||
48762318|NCT02672423|156978076|FG000|Period 3|Withdrawal by Subject|0|||
48762319|NCT02672423|156978077|FG001|Period 3|Withdrawal by Subject|0|||
48677063|NCT02292706|156669204|FG003|Overall Study|Study terminated by sponsor|21|||
48677064|NCT02292706|156669205|FG004|Overall Study|Study terminated by sponsor|11|||
48677065|NCT02292706|156669206|FG005|Overall Study|Study terminated by sponsor|13|||
48762320|NCT02672423|156978078|FG002|Period 3|Withdrawal by Subject|0|||
48762321|NCT02672423|156978079|FG003|Period 3|Withdrawal by Subject|0|||
48677066|NCT02292706|156669207|FG006|Overall Study|Study terminated by sponsor|3|||
48677067|NCT02292706|156669208|FG007|Overall Study|Study terminated by sponsor|0|||
48677068|NCT02292706|156669201|FG000|Overall Study|Investigator's discretion|4|||
48677069|NCT02292706|156669202|FG001|Overall Study|Investigator's discretion|9|||
48677070|NCT02292706|156669203|FG002|Overall Study|Investigator's discretion|7|||
48677071|NCT02292706|156669204|FG003|Overall Study|Investigator's discretion|11|||
48677072|NCT02292706|156669205|FG004|Overall Study|Investigator's discretion|4|||
48677073|NCT02292706|156669206|FG005|Overall Study|Investigator's discretion|10|||
48677074|NCT02292706|156669207|FG006|Overall Study|Investigator's discretion|1|||
48677075|NCT02292706|156669208|FG007|Overall Study|Investigator's discretion|0|||
48677076|NCT02292706|156669201|FG000|Overall Study|Liver transplant|1|||
48762322|NCT02672423|156978080|FG004|Period 3|Withdrawal by Subject|0|||
48762323|NCT02672423|156978081|FG005|Period 3|Withdrawal by Subject|0|||
48762324|NCT02672423|156978082|FG006|Period 3|Withdrawal by Subject|0|||
48762325|NCT02672423|156978083|FG007|Period 3|Withdrawal by Subject|1|||
48762326|NCT02672423|156978084|FG008|Period 3|Withdrawal by Subject|0|||
48762327|NCT02672423|156978085|FG009|Period 3|Withdrawal by Subject|0|||
48762328|NCT02672423|156978076|FG000|Period 3|Physician Decision|0|||
48762329|NCT02672423|156978077|FG001|Period 3|Physician Decision|0|||
48762330|NCT02672423|156978078|FG002|Period 3|Physician Decision|0|||
48762331|NCT02672423|156978079|FG003|Period 3|Physician Decision|0|||
48762332|NCT02672423|156978080|FG004|Period 3|Physician Decision|0|||
48762333|NCT02672423|156978081|FG005|Period 3|Physician Decision|1|||
48762334|NCT02672423|156978082|FG006|Period 3|Physician Decision|0|||
48386389|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
48386390|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
48386391|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
48386392|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
48386393|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
48386394|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
48677077|NCT02292706|156669202|FG001|Overall Study|Liver transplant|1|||
48677078|NCT02292706|156669203|FG002|Overall Study|Liver transplant|11|||
48677079|NCT02292706|156669204|FG003|Overall Study|Liver transplant|16|||
48762335|NCT02672423|156978083|FG007|Period 3|Physician Decision|0|||
48762336|NCT02672423|156978084|FG008|Period 3|Physician Decision|0|||
48762337|NCT02672423|156978085|FG009|Period 3|Physician Decision|0|||
48386395|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
48386396|NCT03627767|155611298|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
48762338|NCT05071183|156978086|FG000|Overall Study|Death|1|||
48677080|NCT02292706|156669205|FG004|Overall Study|Liver transplant|5|||
48677081|NCT02292706|156669206|FG005|Overall Study|Liver transplant|6|||
48677082|NCT02292706|156669207|FG006|Overall Study|Liver transplant|5|||
48677083|NCT02292706|156669208|FG007|Overall Study|Liver transplant|0|||
48677084|NCT02292706|156669201|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
48677085|NCT02292706|156669202|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
48677086|NCT02292706|156669203|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
48677087|NCT02292706|156669204|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
48677088|NCT02292706|156669205|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
48677089|NCT02292706|156669206|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
48677090|NCT02292706|156669207|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
48677091|NCT02292706|156669208|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
48677092|NCT02292706|156669201|FG000|Overall Study|Subject terminated by sponsor|1|||
48677093|NCT02292706|156669202|FG001|Overall Study|Subject terminated by sponsor|0|||
48677094|NCT02292706|156669203|FG002|Overall Study|Subject terminated by sponsor|0|||
48677095|NCT02292706|156669204|FG003|Overall Study|Subject terminated by sponsor|2|||
48677096|NCT02292706|156669205|FG004|Overall Study|Subject terminated by sponsor|1|||
48677097|NCT02292706|156669206|FG005|Overall Study|Subject terminated by sponsor|0|||
48677098|NCT02292706|156669207|FG006|Overall Study|Subject terminated by sponsor|0|||
48677099|NCT02292706|156669208|FG007|Overall Study|Subject terminated by sponsor|0|||
48677100|NCT02292706|156669201|FG000|Overall Study|Missing|0|||
48677101|NCT02292706|156669202|FG001|Overall Study|Missing|0|||
48762339|NCT05071183|156978087|FG001|Overall Study|Death|2|||
48762340|NCT05071183|156978088|FG002|Overall Study|Death|0|||
48762341|NCT05071183|156978086|FG000|Overall Study|Other Reasons|1|||
48762342|NCT05071183|156978087|FG001|Overall Study|Other Reasons|3|||
48762343|NCT05071183|156978088|FG002|Overall Study|Other Reasons|2|||
48677102|NCT02292706|156669203|FG002|Overall Study|Missing|1|||
48677103|NCT02292706|156669204|FG003|Overall Study|Missing|1|||
48677104|NCT02292706|156669205|FG004|Overall Study|Missing|0|||
48677105|NCT02292706|156669206|FG005|Overall Study|Missing|1|||
48677106|NCT02292706|156669207|FG006|Overall Study|Missing|0|||
48677107|NCT02292706|156669208|FG007|Overall Study|Missing|0|||
48677108|NCT02292706|156669201|FG000|Overall Study|Virologic relapse or reinfection|1|||
48677109|NCT02292706|156669202|FG001|Overall Study|Virologic relapse or reinfection|0|||
48677110|NCT02292706|156669203|FG002|Overall Study|Virologic relapse or reinfection|0|||
48677111|NCT02292706|156669204|FG003|Overall Study|Virologic relapse or reinfection|1|||
48677112|NCT02292706|156669205|FG004|Overall Study|Virologic relapse or reinfection|0|||
48677113|NCT02292706|156669206|FG005|Overall Study|Virologic relapse or reinfection|1|||
48677114|NCT02292706|156669207|FG006|Overall Study|Virologic relapse or reinfection|0|||
48677115|NCT02292706|156669208|FG007|Overall Study|Virologic relapse or reinfection|0|||
48677116|NCT04565951|156669214|FG000|Overall Study|Lost to Follow-up|66|||
48677117|NCT04565951|156669215|FG001|Overall Study|Lost to Follow-up|38|||
48677118|NCT04565951|156669214|FG000|Overall Study|Withdrawal by Subject|14|||
48677119|NCT04565951|156669215|FG001|Overall Study|Withdrawal by Subject|7|||
48677120|NCT04565951|156669214|FG000|Overall Study|Death|0|||
48677121|NCT04565951|156669215|FG001|Overall Study|Death|1|||
48677122|NCT03182907|156669216|FG000|Overall Study|Death|3|||
48677123|NCT03182907|156669217|FG001|Overall Study|Death|0|||
48677124|NCT03182907|156669216|FG000|Overall Study|Protocol Violation|4|||
48677125|NCT03182907|156669217|FG001|Overall Study|Protocol Violation|0|||
48677126|NCT03182907|156669216|FG000|Overall Study|Lost to Follow-up|1|||
48677127|NCT03182907|156669217|FG001|Overall Study|Lost to Follow-up|0|||
48677128|NCT03182907|156669216|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48677129|NCT03182907|156669217|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48677130|NCT01123395|156669220|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
48677131|NCT01123395|156669221|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
48677132|NCT01368081|156669222|FG000|Overall Study|Adverse Event|4|||
48762344|NCT01990495|156978093|FG000|Overall Study|Physician Decision|5|||
48762345|NCT01990495|156978094|FG001|Overall Study|Physician Decision|4|||
48677133|NCT01368081|156669223|FG001|Overall Study|Adverse Event|4|||
48677134|NCT01368081|156669224|FG002|Overall Study|Adverse Event|3|||
48677135|NCT01368081|156669225|FG003|Overall Study|Adverse Event|2|||
48677136|NCT01368081|156669226|FG004|Overall Study|Adverse Event|2|||
48677137|NCT01368081|156669227|FG005|Overall Study|Adverse Event|5|||
48677138|NCT01368081|156669228|FG006|Overall Study|Adverse Event|6|||
48677139|NCT01368081|156669229|FG007|Overall Study|Adverse Event|2|||
48677140|NCT01368081|156669230|FG008|Overall Study|Adverse Event|3|||
48677141|NCT01368081|156669231|FG009|Overall Study|Adverse Event|5|||
48677142|NCT01368081|156669232|FG010|Overall Study|Adverse Event|6|||
48677143|NCT01368081|156669233|FG011|Overall Study|Adverse Event|1|||
48677144|NCT01368081|156669234|FG012|Overall Study|Adverse Event|3|||
48677145|NCT01368081|156669222|FG000|Overall Study|Lack of Efficacy|0|||
48677146|NCT01368081|156669223|FG001|Overall Study|Lack of Efficacy|1|||
48677147|NCT01368081|156669224|FG002|Overall Study|Lack of Efficacy|0|||
48677148|NCT01368081|156669225|FG003|Overall Study|Lack of Efficacy|1|||
48677149|NCT01368081|156669226|FG004|Overall Study|Lack of Efficacy|0|||
48677150|NCT01368081|156669227|FG005|Overall Study|Lack of Efficacy|0|||
48677151|NCT01368081|156669228|FG006|Overall Study|Lack of Efficacy|0|||
48677152|NCT01368081|156669229|FG007|Overall Study|Lack of Efficacy|2|||
48677153|NCT01368081|156669230|FG008|Overall Study|Lack of Efficacy|0|||
48677154|NCT01368081|156669231|FG009|Overall Study|Lack of Efficacy|0|||
48386397|NCT03627767|155611299|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
48386398|NCT03627767|155611300|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
48386399|NCT03627767|155611301|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
48386400|NCT03627767|155611302|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
48386401|NCT03627767|155611298|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
48386402|NCT03627767|155611299|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
48386403|NCT03627767|155611300|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
48386404|NCT03627767|155611301|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
48386405|NCT03627767|155611302|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
48386406|NCT03627767|155611298|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48386407|NCT03627767|155611299|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48386408|NCT03627767|155611300|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
48386409|NCT03627767|155611301|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
48386410|NCT03627767|155611302|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
48386411|NCT03627767|155611298|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
48677155|NCT01368081|156669232|FG010|Overall Study|Lack of Efficacy|0|||
48677156|NCT01368081|156669233|FG011|Overall Study|Lack of Efficacy|0|||
48386412|NCT03627767|155611299|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
48386413|NCT03627767|155611300|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
48386414|NCT03627767|155611301|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
48386415|NCT03627767|155611302|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
48386416|NCT03627767|155611298|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48386417|NCT03627767|155611299|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
48386418|NCT03627767|155611300|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
48386419|NCT03627767|155611301|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
48386420|NCT03627767|155611302|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
48386421|NCT03627767|155611298|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
48386422|NCT03627767|155611299|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
48386423|NCT03627767|155611300|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
48386424|NCT03627767|155611301|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
48386425|NCT03627767|155611302|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
48386426|NCT03627767|155611298|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
48386427|NCT03627767|155611299|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
48386428|NCT03627767|155611300|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
48386429|NCT03627767|155611301|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
48386430|NCT03627767|155611302|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
48386431|NCT03627767|155611298|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
48386432|NCT03627767|155611299|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
48386433|NCT03627767|155611300|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
48386434|NCT03627767|155611301|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
48386435|NCT03627767|155611302|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
48386436|NCT03627767|155611298|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
48386437|NCT03627767|155611299|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
48386438|NCT03627767|155611300|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
48386439|NCT03627767|155611301|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
48386440|NCT03627767|155611302|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
48386441|NCT03627767|155611298|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
48386442|NCT03627767|155611299|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
48386443|NCT03627767|155611300|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
48386444|NCT03627767|155611301|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
48386445|NCT03627767|155611302|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
48386446|NCT03627767|155611298|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
48386447|NCT03627767|155611299|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
48386448|NCT03627767|155611300|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
48386449|NCT03627767|155611301|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
48386450|NCT03627767|155611302|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
48386451|NCT01717287|155611303|FG000|Overall Study|Lost to Follow-up|0|||
48677157|NCT01368081|156669234|FG012|Overall Study|Lack of Efficacy|0|||
48677158|NCT01368081|156669222|FG000|Overall Study|Protocol Violation|0|||
48677159|NCT01368081|156669223|FG001|Overall Study|Protocol Violation|0|||
48677160|NCT01368081|156669224|FG002|Overall Study|Protocol Violation|0|||
48386452|NCT01717287|155611304|FG001|Overall Study|Lost to Follow-up|2|||
48386453|NCT01717287|155611303|FG000|Overall Study|Protocol Violation|0|||
48386454|NCT01717287|155611304|FG001|Overall Study|Protocol Violation|1|||
48386455|NCT02767323|155611307|FG000|Overall Study|Withdrawal by Subject|17|||
48386456|NCT02767323|155611308|FG001|Overall Study|Withdrawal by Subject|5|||
48386457|NCT02767323|155611309|FG002|Overall Study|Withdrawal by Subject|13|||
48386458|NCT02767323|155611310|FG003|Overall Study|Withdrawal by Subject|0|||
48386459|NCT02767323|155611307|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
48386460|NCT02767323|155611308|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
48386461|NCT02767323|155611309|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
48386462|NCT02767323|155611310|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
48386463|NCT00930722|155611311|FG000|Overall Study|Lost to Follow-up|16|||
48386464|NCT00930722|155611311|FG000|Overall Study|No longer willing to participate|9|||
48386465|NCT00930722|155611311|FG000|Overall Study|Study terminated by sponsor|2|||
48386466|NCT02194062|155611313|FG000|Overall Study|Lost to Follow-up|2|||
48386467|NCT02194062|155611314|FG001|Overall Study|Lost to Follow-up|2|||
48386468|NCT02194062|155611315|FG002|Overall Study|Lost to Follow-up|5|||
48386469|NCT03823404|155611316|FG000|Overall Study|Lost to Follow-up|1|||
48386470|NCT03823404|155611317|FG001|Overall Study|Lost to Follow-up|2|||
48386471|NCT03823404|155611318|FG002|Overall Study|Lost to Follow-up|3|||
48386472|NCT03823404|155611316|FG000|Overall Study|Protocol Violation|2|||
48386473|NCT03823404|155611317|FG001|Overall Study|Protocol Violation|0|||
48386474|NCT03823404|155611318|FG002|Overall Study|Protocol Violation|2|||
48386475|NCT03823404|155611316|FG000|Overall Study|Adverse Event|35|||
48386476|NCT03823404|155611317|FG001|Overall Study|Adverse Event|38|||
48386477|NCT03823404|155611318|FG002|Overall Study|Adverse Event|8|||
48386478|NCT03823404|155611316|FG000|Overall Study|Withdrawal by Subject|38|||
48386479|NCT03823404|155611317|FG001|Overall Study|Withdrawal by Subject|40|||
48386480|NCT03823404|155611318|FG002|Overall Study|Withdrawal by Subject|35|||
48386481|NCT03823404|155611316|FG000|Overall Study|Death|4|||
48386482|NCT03823404|155611317|FG001|Overall Study|Death|0|||
48386483|NCT03823404|155611318|FG002|Overall Study|Death|0|||
48386484|NCT03823404|155611316|FG000|Overall Study|Other: Various reasons provided|5|||
48386485|NCT03823404|155611317|FG001|Overall Study|Other: Various reasons provided|5|||
48386486|NCT03823404|155611318|FG002|Overall Study|Other: Various reasons provided|6|||
48386487|NCT01211535|155611329|FG000|Overall Study|Adverse Event|0|||
48386488|NCT01211535|155611330|FG001|Overall Study|Adverse Event|1|||
48386489|NCT04498169|155611333|FG000|Study Completion|Adverse Event|1|||
48386490|NCT04498169|155611334|FG001|Study Completion|Adverse Event|1|||
48386491|NCT01195090|155611337|FG000|Overall Study|Adverse Event|1|||
48386492|NCT01195090|155611338|FG001|Overall Study|Adverse Event|2|||
48386493|NCT01195090|155611337|FG000|Overall Study|Lost to Follow-up|2|||
48386494|NCT01195090|155611338|FG001|Overall Study|Lost to Follow-up|2|||
48386495|NCT01195090|155611337|FG000|Overall Study|Protocol Violation|3|||
48762346|NCT00325754|156978095|FG000|Overall Study|Adverse Event|4|||
48762347|NCT00325754|156978096|FG001|Overall Study|Adverse Event|1|||
48762348|NCT01852812|156978097|FG000|Overall Study|Adverse Event|0|||
48762349|NCT01852812|156978098|FG001|Overall Study|Adverse Event|0|||
48762350|NCT01852812|156978099|FG002|Overall Study|Adverse Event|1|||
48762351|NCT01852812|156978097|FG000|Overall Study|Non-compliance With Study Drug|0|||
48762352|NCT01852812|156978098|FG001|Overall Study|Non-compliance With Study Drug|1|||
48762353|NCT01852812|156978099|FG002|Overall Study|Non-compliance With Study Drug|0|||
48762354|NCT01478321|156978100|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
48762355|NCT01478321|156978100|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
48762356|NCT01478321|156978100|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
48762357|NCT01478321|156978100|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
48762358|NCT01478321|156978100|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
48762359|NCT01478321|156978100|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
48762360|NCT01478321|156978100|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
48762361|NCT01478321|156978100|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
48762362|NCT00481195|156978102|FG000|Overall Study|Adverse Event|16|||
48762363|NCT00481195|156978103|FG001|Overall Study|Adverse Event|11|||
48762364|NCT00481195|156978102|FG000|Overall Study|Lack of Efficacy|1|||
48762365|NCT00481195|156978103|FG001|Overall Study|Lack of Efficacy|3|||
48762366|NCT00481195|156978102|FG000|Overall Study|Lost to Follow-up|4|||
48762367|NCT00481195|156978103|FG001|Overall Study|Lost to Follow-up|6|||
48762368|NCT00481195|156978102|FG000|Overall Study|Physician Decision|3|||
48762369|NCT00481195|156978103|FG001|Overall Study|Physician Decision|1|||
48386496|NCT01195090|155611338|FG001|Overall Study|Protocol Violation|4|||
48386497|NCT00791258|155611339|FG000|Overall Study|Adverse Event|87|||
48386498|NCT00791258|155611339|FG000|Overall Study|Lost to Follow-up|18|||
48386499|NCT00791258|155611339|FG000|Overall Study|Protocol Violation|109|||
48386500|NCT00791258|155611339|FG000|Overall Study|Withdrawal by Subject|40|||
48386501|NCT00791258|155611339|FG000|Overall Study|Did not take medication for >3 days|1|||
48762370|NCT00481195|156978102|FG000|Overall Study|Protocol Violation|10|||
48762371|NCT00481195|156978103|FG001|Overall Study|Protocol Violation|7|||
48386502|NCT00791258|155611339|FG000|Overall Study|subject left area|2|||
48386503|NCT00791258|155611339|FG000|Overall Study|non-compliance|3|||
48386504|NCT00791258|155611339|FG000|Overall Study|Subject incarcerated|1|||
48386505|NCT00791258|155611339|FG000|Overall Study|Subject required restricted medication|1|||
48386506|NCT00791258|155611339|FG000|Overall Study|Lack of Efficacy|1|||
48386507|NCT03083847|155611340|FG000|Main|Physician Decision|0|||
48386508|NCT03083847|155611341|FG001|Main|Physician Decision|0|||
48386509|NCT03083847|155611342|FG002|Main|Physician Decision|0|||
48386510|NCT03083847|155611343|FG003|Main|Physician Decision|0|||
48386511|NCT03083847|155611344|FG004|Main|Physician Decision|0|||
48386512|NCT03083847|155611345|FG005|Main|Physician Decision|1|||
48386513|NCT03083847|155611346|FG006|Main|Physician Decision|0|||
48386514|NCT03083847|155611347|FG007|Main|Physician Decision|0|||
48386515|NCT03083847|155611348|FG008|Main|Physician Decision|0|||
48386516|NCT03083847|155611349|FG009|Main|Physician Decision|0|||
48386517|NCT03083847|155611340|FG000|Main|Pregnancy|0|||
48386518|NCT03083847|155611341|FG001|Main|Pregnancy|0|||
48386519|NCT03083847|155611342|FG002|Main|Pregnancy|0|||
48386520|NCT03083847|155611343|FG003|Main|Pregnancy|0|||
48386521|NCT03083847|155611344|FG004|Main|Pregnancy|0|||
48386522|NCT03083847|155611345|FG005|Main|Pregnancy|0|||
48386523|NCT03083847|155611346|FG006|Main|Pregnancy|0|||
48386524|NCT03083847|155611347|FG007|Main|Pregnancy|1|||
48386525|NCT03083847|155611348|FG008|Main|Pregnancy|0|||
48386526|NCT03083847|155611349|FG009|Main|Pregnancy|0|||
48386527|NCT03083847|155611340|FG000|Main|Adverse Event|0|||
48386528|NCT03083847|155611341|FG001|Main|Adverse Event|0|||
48386529|NCT03083847|155611342|FG002|Main|Adverse Event|0|||
48386530|NCT03083847|155611343|FG003|Main|Adverse Event|0|||
48386531|NCT03083847|155611344|FG004|Main|Adverse Event|0|||
48386532|NCT03083847|155611345|FG005|Main|Adverse Event|0|||
48386533|NCT03083847|155611346|FG006|Main|Adverse Event|0|||
48386534|NCT03083847|155611347|FG007|Main|Adverse Event|2|||
48386535|NCT03083847|155611348|FG008|Main|Adverse Event|0|||
48386536|NCT03083847|155611349|FG009|Main|Adverse Event|0|||
48386537|NCT03083847|155611340|FG000|Main|Withdrawal by Subject|0|||
48386538|NCT03083847|155611341|FG001|Main|Withdrawal by Subject|0|||
48386539|NCT03083847|155611342|FG002|Main|Withdrawal by Subject|0|||
48386540|NCT03083847|155611343|FG003|Main|Withdrawal by Subject|0|||
48386541|NCT03083847|155611344|FG004|Main|Withdrawal by Subject|0|||
48386542|NCT03083847|155611345|FG005|Main|Withdrawal by Subject|0|||
48386543|NCT03083847|155611346|FG006|Main|Withdrawal by Subject|1|||
48386544|NCT03083847|155611347|FG007|Main|Withdrawal by Subject|1|||
48386545|NCT03083847|155611348|FG008|Main|Withdrawal by Subject|0|||
48386546|NCT03083847|155611349|FG009|Main|Withdrawal by Subject|0|||
48386547|NCT00058552|155611352|FG000|Overall Study|Died prior to receiving treatment|4|||
48386548|NCT00058552|155611353|FG001|Overall Study|Died prior to receiving treatment|2|||
48386549|NCT00058552|155611352|FG000|Overall Study|Disease progression|52|||
48386550|NCT00058552|155611353|FG001|Overall Study|Disease progression|44|||
48386551|NCT00058552|155611352|FG000|Overall Study|Adverse Event|4|||
48386552|NCT00058552|155611353|FG001|Overall Study|Adverse Event|2|||
48386553|NCT00058552|155611352|FG000|Overall Study|Withdrawal by Subject|3|||
48386554|NCT00058552|155611353|FG001|Overall Study|Withdrawal by Subject|5|||
48386555|NCT00058552|155611352|FG000|Overall Study|Physician Decision|2|||
48386556|NCT00058552|155611353|FG001|Overall Study|Physician Decision|5|||
48386557|NCT00058552|155611352|FG000|Overall Study|Clinical disease progression|0|||
48386558|NCT00058552|155611353|FG001|Overall Study|Clinical disease progression|4|||
48386559|NCT00210184|155611354|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
48386560|NCT02319668|155611355|FG000|Overall Study|Other (Not specified)|0|||
48386561|NCT02319668|155611356|FG001|Overall Study|Other (Not specified)|2|||
48386562|NCT01054144|155611357|FG000|Overall Study|Death|2|||
48386563|NCT01555151|155611361|FG000|Overall Study|Withdrawal by Subject|6|||
48386564|NCT01555151|155611362|FG001|Overall Study|Withdrawal by Subject|2|||
48386565|NCT01555151|155611363|FG002|Overall Study|Withdrawal by Subject|0|||
48386566|NCT01555151|155611364|FG003|Overall Study|Withdrawal by Subject|2|||
48386567|NCT01555151|155611361|FG000|Overall Study|Administrative|3|||
48386568|NCT01555151|155611362|FG001|Overall Study|Administrative|1|||
48386569|NCT01555151|155611363|FG002|Overall Study|Administrative|2|||
48386570|NCT01555151|155611364|FG003|Overall Study|Administrative|0|||
48386571|NCT01555151|155611361|FG000|Overall Study|Protocol Violation|3|||
48386572|NCT01555151|155611362|FG001|Overall Study|Protocol Violation|3|||
48386573|NCT01555151|155611363|FG002|Overall Study|Protocol Violation|3|||
48386574|NCT01555151|155611364|FG003|Overall Study|Protocol Violation|5|||
48386575|NCT01555151|155611361|FG000|Overall Study|Adverse Event|1|||
48386576|NCT01555151|155611362|FG001|Overall Study|Adverse Event|2|||
48386577|NCT01555151|155611363|FG002|Overall Study|Adverse Event|1|||
48386578|NCT01555151|155611364|FG003|Overall Study|Adverse Event|2|||
48386579|NCT01555151|155611361|FG000|Overall Study|Lost to Follow-up|0|||
48386580|NCT01555151|155611362|FG001|Overall Study|Lost to Follow-up|0|||
48386581|NCT01555151|155611363|FG002|Overall Study|Lost to Follow-up|0|||
48386582|NCT01555151|155611364|FG003|Overall Study|Lost to Follow-up|1|||
48386583|NCT03189862|155611365|FG000|Overall Study|Withdrawal by Subject|1|||
48386584|NCT03189862|155611366|FG001|Overall Study|Withdrawal by Subject|0|||
48386585|NCT03189862|155611365|FG000|Overall Study|Lost to Follow-up|54|||
48386586|NCT03189862|155611366|FG001|Overall Study|Lost to Follow-up|62|||
48386587|NCT00381563|155611367|FG000|Overall Study|Withdrawal by Subject|5|||
48386588|NCT00381563|155611368|FG001|Overall Study|Withdrawal by Subject|5|||
48386589|NCT00381563|155611367|FG000|Overall Study|Lost to Follow-up|2|||
48386590|NCT00381563|155611368|FG001|Overall Study|Lost to Follow-up|0|||
48386591|NCT00381563|155611367|FG000|Overall Study|Protocol Violation|0|||
48386592|NCT00381563|155611368|FG001|Overall Study|Protocol Violation|1|||
48386593|NCT00851682|155611369|FG000|Overall Study|screen failure|5|||
48386594|NCT00851682|155611370|FG001|Overall Study|screen failure|0|||
48386595|NCT01886313|155611374|FG000|Overall Study|Adverse Event|1|||
48386596|NCT01886313|155611375|FG001|Overall Study|Adverse Event|1|||
48386597|NCT00006392|155611377|FG000|Overall Study|Ineligible|11|||
48386598|NCT00006392|155611378|FG001|Overall Study|Ineligible|3|||
48386599|NCT00006392|155611379|FG002|Overall Study|Ineligible|5|||
48386600|NCT00006392|155611380|FG003|Overall Study|Ineligible|5|||
48386601|NCT00006392|155611377|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
48386602|NCT00006392|155611378|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
48386603|NCT00006392|155611379|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
48386604|NCT00006392|155611380|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
48386605|NCT04344301|155611387|FG000|Overall Study|Withdrawal by Subject|1|||
48386606|NCT04344301|155611388|FG001|Overall Study|Withdrawal by Subject|0|||
48386607|NCT04344301|155611387|FG000|Overall Study|Death|0|||
48386608|NCT04344301|155611388|FG001|Overall Study|Death|1|||
48386609|NCT02844920|155611389|FG000|Overall Study|Lost to Follow-up|2|||
48386610|NCT04534491|155611391|FG000|Overall Study|Not completed end-of-study interview|24|||
48386611|NCT04534491|155611391|FG000|Overall Study|Non-users|70|||
48386612|NCT04534491|155611391|FG000|Overall Study|Non-verifiable users|58|||
48386613|NCT03000179|155611392|FG000|Overall Study|Lost to Follow-up|2|||
48386614|NCT00865904|155611399|FG000|Overall Study|Randomized but not Treated|2|||
48386615|NCT00865904|155611400|FG001|Overall Study|Randomized but not Treated|0|||
48386616|NCT00865904|155611401|FG002|Overall Study|Randomized but not Treated|0|||
48386617|NCT00865904|155611402|FG003|Overall Study|Randomized but not Treated|1|||
48386618|NCT00865904|155611403|FG004|Overall Study|Randomized but not Treated|1|||
48386619|NCT01543828|155611408|FG000|Treatment 2|Lost to Follow-up|1|||
48386620|NCT01543828|155611409|FG001|Treatment 2|Lost to Follow-up|0|||
48386621|NCT02463071|155611415|FG000|Overall Study|Adverse Event|3|||
48386622|NCT02463071|155611416|FG001|Overall Study|Adverse Event|5|||
48386623|NCT02463071|155611417|FG002|Overall Study|Adverse Event|1|||
48386624|NCT02463071|155611415|FG000|Overall Study|Death|1|||
48386625|NCT02463071|155611416|FG001|Overall Study|Death|0|||
48386626|NCT02463071|155611417|FG002|Overall Study|Death|0|||
48386627|NCT02463071|155611415|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
48386628|NCT02463071|155611416|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48386629|NCT02463071|155611417|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
48386630|NCT02463071|155611415|FG000|Overall Study|Reason not specified|7|||
48386631|NCT02463071|155611416|FG001|Overall Study|Reason not specified|9|||
48386632|NCT02463071|155611417|FG002|Overall Study|Reason not specified|4|||
48386633|NCT02463071|155611415|FG000|Overall Study|Protocol Violation|0|||
48386634|NCT02463071|155611416|FG001|Overall Study|Protocol Violation|2|||
48386635|NCT02463071|155611417|FG002|Overall Study|Protocol Violation|0|||
48386636|NCT02463071|155611415|FG000|Overall Study|Lost to Follow-up|0|||
48386637|NCT02463071|155611416|FG001|Overall Study|Lost to Follow-up|0|||
48386638|NCT02463071|155611417|FG002|Overall Study|Lost to Follow-up|1|||
48386639|NCT00073528|155611418|FG000|Overall Study|Death|488|||
48386640|NCT00073528|155611419|FG001|Overall Study|Death|473|||
48386641|NCT00073528|155611418|FG000|Overall Study|Lost to Follow-up|52|||
48386642|NCT00073528|155611419|FG001|Overall Study|Lost to Follow-up|45|||
48386643|NCT00073528|155611418|FG000|Overall Study|Withdrawal by Subject|50|||
48386644|NCT00073528|155611419|FG001|Overall Study|Withdrawal by Subject|45|||
48386645|NCT00073528|155611418|FG000|Overall Study|Study terminated by Sponsor|10|||
48386646|NCT00073528|155611419|FG001|Overall Study|Study terminated by Sponsor|29|||
48386647|NCT00073528|155611418|FG000|Overall Study|Other|18|||
48386648|NCT00073528|155611419|FG001|Overall Study|Other|19|||
48386649|NCT00073528|155611418|FG000|Overall Study|Other|9|||
48386650|NCT00073528|155611419|FG001|Overall Study|Other|12|||
48386651|NCT00073528|155611418|FG000|Overall Study|Protocol Violation|3|||
48386652|NCT00073528|155611419|FG001|Overall Study|Protocol Violation|5|||
48386653|NCT03086057|155611420|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
48386654|NCT03086057|155611421|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
48386655|NCT03086057|155611422|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
48386656|NCT03086057|155611423|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
48677161|NCT01368081|156669225|FG003|Overall Study|Protocol Violation|0|||
48677162|NCT01368081|156669226|FG004|Overall Study|Protocol Violation|0|||
48386657|NCT03086057|155611420|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
48386658|NCT03086057|155611421|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
48386659|NCT03086057|155611422|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
48386660|NCT03086057|155611423|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
48386661|NCT03086057|155611420|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
48386662|NCT03086057|155611421|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
48386663|NCT03086057|155611422|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
48386664|NCT03086057|155611423|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
48386665|NCT03086057|155611420|FG000|Stage 1: PrEP Uptake|Death|1|||
48386666|NCT03086057|155611421|FG001|Stage 1: PrEP Uptake|Death|0|||
48386667|NCT03086057|155611422|FG002|Stage 1: PrEP Uptake|Death|0|||
48386668|NCT03086057|155611423|FG003|Stage 1: PrEP Uptake|Death|0|||
48386669|NCT03086057|155611420|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
48386670|NCT03086057|155611421|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
48386671|NCT03086057|155611422|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
48386672|NCT03086057|155611423|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
48386673|NCT03086057|155611420|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
48386674|NCT03086057|155611421|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
48386675|NCT03086057|155611422|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
48386676|NCT03086057|155611423|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
48386677|NCT03086057|155611420|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
48386678|NCT03086057|155611421|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
48386679|NCT03086057|155611422|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
48386680|NCT03086057|155611423|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
48386681|NCT02729740|155611424|FG000|Overall Study|Early Termination|130|||
48386682|NCT02729740|155611424|FG000|Overall Study|Other|1|||
48386683|NCT00711425|155611425|FG000|Overall Study|Protocol Violation|1|||
48386684|NCT00711425|155611425|FG000|Overall Study|Death|2|||
48386685|NCT00711425|155611425|FG000|Overall Study|Lost to Follow-up|1|||
48386686|NCT01093625|155611426|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
48386687|NCT01093625|155611427|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
48386688|NCT01093625|155611426|FG000|2-Week Visit|Withdrawal by Subject|1|||
48386689|NCT01093625|155611427|FG001|2-Week Visit|Withdrawal by Subject|0|||
48386690|NCT01093625|155611426|FG000|1-Month Visit|Lost to Follow-up|2|||
48386691|NCT01093625|155611427|FG001|1-Month Visit|Lost to Follow-up|0|||
48386692|NCT01093625|155611426|FG000|3-Month Visit|Lost to Follow-up|2|||
48386693|NCT01093625|155611427|FG001|3-Month Visit|Lost to Follow-up|0|||
48386694|NCT01093625|155611426|FG000|6-Month Visit|Withdrawal by Subject|6|||
48386695|NCT01093625|155611427|FG001|6-Month Visit|Withdrawal by Subject|7|||
48386696|NCT01093625|155611426|FG000|6-Month Visit|Lost to Follow-up|2|||
48386697|NCT01093625|155611427|FG001|6-Month Visit|Lost to Follow-up|2|||
48386698|NCT01093625|155611426|FG000|1-Year Visit|Lost to Follow-up|5|||
48386699|NCT01093625|155611427|FG001|1-Year Visit|Lost to Follow-up|3|||
48386700|NCT00307333|155611428|FG000|Overall Study|Lost to Follow-up|11|||
48386701|NCT00307333|155611429|FG001|Overall Study|Lost to Follow-up|3|||
48386702|NCT00698932|155611430|FG000|Overall Study|Adverse Event|0|||
48386703|NCT00698932|155611431|FG001|Overall Study|Adverse Event|2|||
48386704|NCT00698932|155611430|FG000|Overall Study|Incorrect enrollment|0|||
48386705|NCT00698932|155611431|FG001|Overall Study|Incorrect enrollment|2|||
48386706|NCT00698932|155611430|FG000|Overall Study|Study specific discontinuation criteria|3|||
48386707|NCT00698932|155611431|FG001|Overall Study|Study specific discontinuation criteria|4|||
48386708|NCT00698932|155611430|FG000|Overall Study|Withdrawal by Subject|11|||
48386709|NCT00698932|155611431|FG001|Overall Study|Withdrawal by Subject|23|||
48386710|NCT00698932|155611430|FG000|Overall Study|Lost to Follow-up|6|||
48386711|NCT00698932|155611431|FG001|Overall Study|Lost to Follow-up|1|||
48386712|NCT00698932|155611430|FG000|Overall Study|Severe non-compliance to protocol|1|||
48386713|NCT00698932|155611431|FG001|Overall Study|Severe non-compliance to protocol|2|||
48386714|NCT00698932|155611430|FG000|Overall Study|Safety reasons|0|||
48386715|NCT00698932|155611431|FG001|Overall Study|Safety reasons|2|||
48386716|NCT00698932|155611430|FG000|Overall Study|Death|1|||
48386717|NCT00698932|155611431|FG001|Overall Study|Death|0|||
48386718|NCT01245387|155611432|FG000|Overall Study|Lost to Follow-up|106|||
48386719|NCT01245387|155611432|FG000|Overall Study|Lack of Efficacy|195|||
48386720|NCT01245387|155611432|FG000|Overall Study|Adverse Event|9|||
48386721|NCT01245387|155611432|FG000|Overall Study|Death|3|||
48386722|NCT01245387|155611432|FG000|Overall Study|Other|131|||
48386723|NCT01245387|155611432|FG000|Overall Study|Missing discontinuation status|369|||
48386724|NCT04233164|155611433|FG000|Overall Study|Unable to obtain specimen|0|||
48386725|NCT04233164|155611434|FG001|Overall Study|Unable to obtain specimen|1|||
48386726|NCT01423851|155611435|FG000|Whole Study|Disease progression|2|||
48386727|NCT01423851|155611436|FG001|Whole Study|Disease progression|1|||
48386728|NCT01423851|155611437|FG002|Whole Study|Disease progression|1|||
48386729|NCT01423851|155611438|FG003|Whole Study|Disease progression|4|||
48386730|NCT01423851|155611439|FG004|Whole Study|Disease progression|1|||
48386731|NCT01423851|155611440|FG005|Whole Study|Disease progression|3|||
48386732|NCT01423851|155611441|FG006|Whole Study|Disease progression|1|||
48386733|NCT01423851|155611442|FG007|Whole Study|Disease progression|4|||
48386734|NCT01423851|155611443|FG008|Whole Study|Disease progression|0|||
48386735|NCT01423851|155611444|FG009|Whole Study|Disease progression|2|||
48386736|NCT01423851|155611445|FG010|Whole Study|Disease progression|10|||
48386737|NCT01423851|155611435|FG000|Whole Study|Physician Decision|0|||
48386738|NCT01423851|155611436|FG001|Whole Study|Physician Decision|1|||
48386739|NCT01423851|155611437|FG002|Whole Study|Physician Decision|2|||
48386740|NCT01423851|155611438|FG003|Whole Study|Physician Decision|0|||
48386741|NCT01423851|155611439|FG004|Whole Study|Physician Decision|2|||
48386742|NCT01423851|155611440|FG005|Whole Study|Physician Decision|0|||
48386743|NCT01423851|155611441|FG006|Whole Study|Physician Decision|2|||
48386744|NCT01423851|155611442|FG007|Whole Study|Physician Decision|1|||
48386745|NCT01423851|155611443|FG008|Whole Study|Physician Decision|3|||
48386746|NCT01423851|155611444|FG009|Whole Study|Physician Decision|4|||
48386747|NCT01423851|155611445|FG010|Whole Study|Physician Decision|12|||
48386748|NCT01423851|155611435|FG000|Whole Study|Withdrawal by Subject|1|||
48386749|NCT01423851|155611436|FG001|Whole Study|Withdrawal by Subject|1|||
48386750|NCT01423851|155611437|FG002|Whole Study|Withdrawal by Subject|0|||
48386751|NCT01423851|155611438|FG003|Whole Study|Withdrawal by Subject|0|||
48386752|NCT01423851|155611439|FG004|Whole Study|Withdrawal by Subject|0|||
48386753|NCT01423851|155611440|FG005|Whole Study|Withdrawal by Subject|0|||
48386754|NCT01423851|155611441|FG006|Whole Study|Withdrawal by Subject|0|||
48386755|NCT01423851|155611442|FG007|Whole Study|Withdrawal by Subject|0|||
48386756|NCT01423851|155611443|FG008|Whole Study|Withdrawal by Subject|2|||
48386757|NCT01423851|155611444|FG009|Whole Study|Withdrawal by Subject|0|||
48386758|NCT01423851|155611445|FG010|Whole Study|Withdrawal by Subject|4|||
48386759|NCT01423851|155611435|FG000|Whole Study|Adverse Event|0|||
48386760|NCT01423851|155611436|FG001|Whole Study|Adverse Event|0|||
48386761|NCT01423851|155611437|FG002|Whole Study|Adverse Event|0|||
48386762|NCT01423851|155611438|FG003|Whole Study|Adverse Event|2|||
48386763|NCT01423851|155611439|FG004|Whole Study|Adverse Event|0|||
48386764|NCT01423851|155611440|FG005|Whole Study|Adverse Event|0|||
48386765|NCT01423851|155611441|FG006|Whole Study|Adverse Event|0|||
48386766|NCT01423851|155611442|FG007|Whole Study|Adverse Event|3|||
48386767|NCT01423851|155611443|FG008|Whole Study|Adverse Event|3|||
48386768|NCT01423851|155611444|FG009|Whole Study|Adverse Event|2|||
48386769|NCT01423851|155611445|FG010|Whole Study|Adverse Event|3|||
48386770|NCT02014740|155611446|FG000|Overall Study|Lost to Follow-up|4|||
48386771|NCT02014740|155611447|FG001|Overall Study|Lost to Follow-up|4|||
48386772|NCT02014740|155611446|FG000|Overall Study|Withdrawal by Subject|2|||
48386773|NCT02014740|155611447|FG001|Overall Study|Withdrawal by Subject|1|||
48386774|NCT01704287|155613054|FG000|Initial Treatment Period|Death|139|||
48386775|NCT01704287|155613055|FG001|Initial Treatment Period|Death|129|||
48386776|NCT01704287|155613056|FG002|Initial Treatment Period|Death|71|||
48386777|NCT01704287|155613057|FG003|Initial Treatment Period|Death|0|||
48386778|NCT01704287|155613058|FG004|Initial Treatment Period|Death|0|||
48386779|NCT01704287|155613054|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
48386780|NCT01704287|155613055|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
48386781|NCT01704287|155613056|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
48386782|NCT01704287|155613057|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
48386783|NCT01704287|155613058|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
48386784|NCT01704287|155613054|FG000|Initial Treatment Period|Lost to Follow-up|5|||
48386785|NCT01704287|155613055|FG001|Initial Treatment Period|Lost to Follow-up|3|||
48386786|NCT01704287|155613056|FG002|Initial Treatment Period|Lost to Follow-up|0|||
48386787|NCT01704287|155613057|FG003|Initial Treatment Period|Lost to Follow-up|0|||
48386788|NCT01704287|155613058|FG004|Initial Treatment Period|Lost to Follow-up|0|||
48386789|NCT01704287|155613054|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
48386790|NCT01704287|155613055|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
48386791|NCT01704287|155613056|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
48386792|NCT01704287|155613057|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
48386793|NCT01704287|155613058|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
48386794|NCT01704287|155613054|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
48386795|NCT01704287|155613055|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
48386796|NCT01704287|155613056|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
48386797|NCT01704287|155613057|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
48386798|NCT01704287|155613058|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
48386799|NCT01704287|155613054|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
48386800|NCT01704287|155613055|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
48386801|NCT01704287|155613056|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
48386802|NCT01704287|155613057|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
48386803|NCT01704287|155613058|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
48386804|NCT01704287|155613054|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
48386805|NCT01704287|155613055|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
48386806|NCT01704287|155613056|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
48386807|NCT01704287|155613057|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
48386808|NCT01704287|155613058|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
48386809|NCT03713034|155613059|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
48386810|NCT03713034|155613060|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
48386811|NCT01168973|155613063|FG000|Overall Study|Progressive Disease|341|||
48386812|NCT01168973|155613064|FG001|Overall Study|Progressive Disease|429|||
48386813|NCT01168973|155613063|FG000|Overall Study|Adverse Event|94|||
48386814|NCT01168973|155613064|FG001|Overall Study|Adverse Event|55|||
48386815|NCT01168973|155613063|FG000|Overall Study|Withdrawal by Subject|90|||
48386816|NCT01168973|155613064|FG001|Overall Study|Withdrawal by Subject|53|||
48386817|NCT01168973|155613063|FG000|Overall Study|Death|42|||
48386818|NCT01168973|155613064|FG001|Overall Study|Death|45|||
48386819|NCT01168973|155613063|FG000|Overall Study|Physician Decision|37|||
48386820|NCT01168973|155613064|FG001|Overall Study|Physician Decision|19|||
48386821|NCT01168973|155613063|FG000|Overall Study|Sponsor Decision|2|||
48386822|NCT01168973|155613064|FG001|Overall Study|Sponsor Decision|1|||
48386823|NCT01168973|155613063|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
48386824|NCT01168973|155613064|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
48386825|NCT00938717|155613065|FG000|Overall Study|Adverse Event|10|||
48386826|NCT00938717|155613066|FG001|Overall Study|Adverse Event|41|||
48386827|NCT00938717|155613065|FG000|Overall Study|Protocol Violation|11|||
48386828|NCT00938717|155613066|FG001|Overall Study|Protocol Violation|8|||
48386829|NCT00938717|155613065|FG000|Overall Study|Withdrawal by Subject|26|||
48386830|NCT00938717|155613066|FG001|Overall Study|Withdrawal by Subject|24|||
48386831|NCT00938717|155613065|FG000|Overall Study|Lost to Follow-up|13|||
48386832|NCT00938717|155613066|FG001|Overall Study|Lost to Follow-up|18|||
48386833|NCT00938717|155613065|FG000|Overall Study|Lack of Efficacy|33|||
48386834|NCT00938717|155613066|FG001|Overall Study|Lack of Efficacy|15|||
48386835|NCT00938717|155613065|FG000|Overall Study|Other reason|5|||
48386836|NCT00938717|155613066|FG001|Overall Study|Other reason|2|||
48386837|NCT01007032|155613072|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
48386838|NCT01007032|155613073|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
48386839|NCT01007032|155613074|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
48386840|NCT01007032|155613075|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
48386841|NCT01007032|155613072|FG000|Overall Study|Withdrawal by Subject|0|||
48386842|NCT01007032|155613073|FG001|Overall Study|Withdrawal by Subject|0|||
48386843|NCT01007032|155613074|FG002|Overall Study|Withdrawal by Subject|0|||
48386844|NCT01007032|155613075|FG003|Overall Study|Withdrawal by Subject|1|||
48386845|NCT01101438|155613077|FG000|Overall Study|Withdrawal by Subject|8|||
48386846|NCT01101438|155613078|FG001|Overall Study|Withdrawal by Subject|9|||
48386847|NCT01444742|155613079|FG000|Overall Study|Death|1|||
48386848|NCT00478933|155613080|FG000|Overall Study|Protocol Violation|22|||
48386849|NCT00478933|155613080|FG000|Overall Study|Informed consent not verified|3|||
48386850|NCT00478933|155613080|FG000|Overall Study|Inadequate data available|53|||
48386851|NCT00290290|155613081|FG000|Overall Study|Death|3|||
48386852|NCT00290290|155613082|FG001|Overall Study|Death|4|||
48386853|NCT00290290|155613081|FG000|Overall Study|Withdrawal by Subject|2|||
48386854|NCT00290290|155613082|FG001|Overall Study|Withdrawal by Subject|2|||
48386855|NCT00290290|155613081|FG000|Overall Study|Underwent clean surgical procedure|13|||
48386856|NCT00290290|155613082|FG001|Overall Study|Underwent clean surgical procedure|12|||
48386857|NCT01368536|155613091|FG000|Overall Study|Adverse Event|5|||
48386858|NCT01368536|155613092|FG001|Overall Study|Adverse Event|6|||
48386859|NCT01368536|155613093|FG002|Overall Study|Adverse Event|8|||
48386860|NCT01368536|155613091|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48386861|NCT01368536|155613092|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48386862|NCT01368536|155613093|FG002|Overall Study|Abnormal laboratory value(s)|2|||
48386863|NCT01368536|155613091|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48386864|NCT01368536|155613092|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48386865|NCT01368536|155613093|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48386866|NCT01368536|155613091|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
48386867|NCT01368536|155613092|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48386868|NCT01368536|155613093|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48386869|NCT01368536|155613091|FG000|Overall Study|No longer required study medication|0|||
48386870|NCT01368536|155613092|FG001|Overall Study|No longer required study medication|0|||
48386871|NCT01368536|155613093|FG002|Overall Study|No longer required study medication|1|||
48386872|NCT01368536|155613091|FG000|Overall Study|Withdrawal by Subject|2|||
48386873|NCT01368536|155613092|FG001|Overall Study|Withdrawal by Subject|5|||
48386874|NCT01368536|155613093|FG002|Overall Study|Withdrawal by Subject|4|||
48386875|NCT01368536|155613091|FG000|Overall Study|Lost to Follow-up|3|||
48386876|NCT01368536|155613092|FG001|Overall Study|Lost to Follow-up|3|||
48386877|NCT01368536|155613093|FG002|Overall Study|Lost to Follow-up|5|||
48386878|NCT01368536|155613091|FG000|Overall Study|Administrative problems|34|||
48386879|NCT01368536|155613092|FG001|Overall Study|Administrative problems|39|||
48677163|NCT01368081|156669227|FG005|Overall Study|Protocol Violation|1|||
48386880|NCT01368536|155613093|FG002|Overall Study|Administrative problems|35|||
48386881|NCT01368536|155613091|FG000|Overall Study|Protocol deviation|0|||
48386882|NCT01368536|155613092|FG001|Overall Study|Protocol deviation|3|||
48386883|NCT01368536|155613093|FG002|Overall Study|Protocol deviation|1|||
48386884|NCT00701090|155613094|FG000|Overall Study|Adverse Event|11|||
48677164|NCT01368081|156669228|FG006|Overall Study|Protocol Violation|0|||
48386885|NCT00701090|155613095|FG001|Overall Study|Adverse Event|2|||
48386886|NCT00701090|155613094|FG000|Overall Study|Death|0|||
48386887|NCT00701090|155613095|FG001|Overall Study|Death|1|||
48386888|NCT00701090|155613094|FG000|Overall Study|Lack of Efficacy|5|||
48386889|NCT00701090|155613095|FG001|Overall Study|Lack of Efficacy|4|||
48386890|NCT00701090|155613094|FG000|Overall Study|Lost to Follow-up|9|||
48386891|NCT00701090|155613095|FG001|Overall Study|Lost to Follow-up|9|||
48386892|NCT00701090|155613094|FG000|Overall Study|Physician Decision|3|||
48386893|NCT00701090|155613095|FG001|Overall Study|Physician Decision|4|||
48386894|NCT00701090|155613094|FG000|Overall Study|Protocol Violation|2|||
48386895|NCT00701090|155613095|FG001|Overall Study|Protocol Violation|3|||
48386896|NCT00701090|155613094|FG000|Overall Study|Withdrawal by Subject|11|||
48386897|NCT00701090|155613095|FG001|Overall Study|Withdrawal by Subject|16|||
48386898|NCT00701090|155613094|FG000|Overall Study|Other|7|||
48386899|NCT00701090|155613095|FG001|Overall Study|Other|12|||
48386900|NCT00873366|155613096|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
48386901|NCT00873366|155613096|FG000|Overall Study|Off tamoxifen due to side effects|2|||
48386902|NCT00873366|155613096|FG000|Overall Study|Refused to continue DM-BT testing|3|||
48386903|NCT01576172|155613097|FG000|Overall Study|Ineligible|2|||
48386904|NCT01576172|155613098|FG001|Overall Study|Ineligible|1|||
48386905|NCT01576172|155613097|FG000|Overall Study|Withdrawal by Subject|2|||
48386906|NCT01576172|155613098|FG001|Overall Study|Withdrawal by Subject|0|||
48386907|NCT01576172|155613097|FG000|Overall Study|Insurance issue|1|||
48386908|NCT01576172|155613098|FG001|Overall Study|Insurance issue|0|||
48386909|NCT00646906|155613099|FG000|Crossover Period 1|Withdrawal by Subject|1|||
48386910|NCT00646906|155613100|FG001|Crossover Period 1|Withdrawal by Subject|0|||
48386911|NCT00646906|155613101|FG002|Crossover Period 1|Withdrawal by Subject|0|||
48386912|NCT00646906|155613102|FG003|Crossover Period 1|Withdrawal by Subject|0|||
48386913|NCT00646906|155613103|FG004|Crossover Period 1|Withdrawal by Subject|0|||
48386914|NCT00646906|155613104|FG005|Crossover Period 1|Withdrawal by Subject|1|||
48386915|NCT00646906|155613105|FG006|Crossover Period 1|Withdrawal by Subject|0|||
48386916|NCT00646906|155613099|FG000|Crossover Period 2|Withdrawal by Subject|0|||
48386917|NCT00646906|155613100|FG001|Crossover Period 2|Withdrawal by Subject|1|||
48386918|NCT00646906|155613101|FG002|Crossover Period 2|Withdrawal by Subject|2|||
48386919|NCT00646906|155613102|FG003|Crossover Period 2|Withdrawal by Subject|1|||
48386920|NCT00646906|155613103|FG004|Crossover Period 2|Withdrawal by Subject|0|||
48386921|NCT00646906|155613104|FG005|Crossover Period 2|Withdrawal by Subject|0|||
48386922|NCT00646906|155613105|FG006|Crossover Period 2|Withdrawal by Subject|0|||
48386923|NCT00646906|155613099|FG000|Crossover Period 2|Physician Decision|0|||
48386924|NCT00646906|155613100|FG001|Crossover Period 2|Physician Decision|0|||
48386925|NCT00646906|155613101|FG002|Crossover Period 2|Physician Decision|0|||
48386926|NCT00646906|155613102|FG003|Crossover Period 2|Physician Decision|0|||
48386927|NCT00646906|155613103|FG004|Crossover Period 2|Physician Decision|0|||
48386928|NCT00646906|155613104|FG005|Crossover Period 2|Physician Decision|0|||
48386929|NCT00646906|155613105|FG006|Crossover Period 2|Physician Decision|1|||
48386930|NCT01537198|155613109|FG000|Overall Study|RSV infection|2|||
48386931|NCT01537198|155613109|FG000|Overall Study|Adverse Event|4|||
48386932|NCT01537198|155613109|FG000|Overall Study|No Further Visits to the Clinic|37|||
48386933|NCT01537198|155613109|FG000|Overall Study|Other|111|||
48386934|NCT00770770|155613110|FG000|Overall Study|Lost to Follow-up|1|||
48386935|NCT00770770|155613111|FG001|Overall Study|Lost to Follow-up|0|||
48386936|NCT00770770|155613110|FG000|Overall Study|Withdrawal by Subject|1|||
48386937|NCT00770770|155613111|FG001|Overall Study|Withdrawal by Subject|0|||
48386938|NCT00770770|155613110|FG000|Overall Study|Death|0|||
48386939|NCT00770770|155613111|FG001|Overall Study|Death|1|||
48386940|NCT00770770|155613110|FG000|Overall Study|Study Terminated|8|||
48386941|NCT00770770|155613111|FG001|Overall Study|Study Terminated|0|||
48386942|NCT04206020|155613112|FG000|Overall Study|Adverse Event|1|||
48386943|NCT04206020|155613113|FG001|Overall Study|Adverse Event|4|||
48386944|NCT04206020|155613112|FG000|Overall Study|Protocol Violation|2|||
48386945|NCT04206020|155613113|FG001|Overall Study|Protocol Violation|0|||
48386946|NCT04206020|155613112|FG000|Overall Study|Withdrawal by Subject|2|||
48386947|NCT04206020|155613113|FG001|Overall Study|Withdrawal by Subject|0|||
48386948|NCT04206020|155613112|FG000|Overall Study|Lost to Follow-up|2|||
48677165|NCT01368081|156669229|FG007|Overall Study|Protocol Violation|1|||
48677166|NCT01368081|156669230|FG008|Overall Study|Protocol Violation|0|||
48677167|NCT01368081|156669231|FG009|Overall Study|Protocol Violation|0|||
48677168|NCT01368081|156669232|FG010|Overall Study|Protocol Violation|0|||
48386949|NCT04206020|155613113|FG001|Overall Study|Lost to Follow-up|0|||
48677169|NCT01368081|156669233|FG011|Overall Study|Protocol Violation|0|||
48677170|NCT01368081|156669234|FG012|Overall Study|Protocol Violation|0|||
48677171|NCT01368081|156669222|FG000|Overall Study|Lost to Follow-up|0|||
48677172|NCT01368081|156669223|FG001|Overall Study|Lost to Follow-up|0|||
48677173|NCT01368081|156669224|FG002|Overall Study|Lost to Follow-up|0|||
48386950|NCT04206020|155613112|FG000|Overall Study|Pregnancy|0|||
48386951|NCT04206020|155613113|FG001|Overall Study|Pregnancy|1|||
48386952|NCT04206020|155613112|FG000|Overall Study|Unable to attend visits|1|||
48386953|NCT04206020|155613113|FG001|Overall Study|Unable to attend visits|2|||
48386954|NCT01299376|155613119|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
48386955|NCT01299376|155613120|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
48386956|NCT01299376|155613119|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
48386957|NCT01299376|155613120|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
48386958|NCT01299376|155613119|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
48677174|NCT01368081|156669225|FG003|Overall Study|Lost to Follow-up|0|||
48386959|NCT01299376|155613120|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
48386960|NCT01299376|155613119|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
48386961|NCT01299376|155613120|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
48386962|NCT01299376|155613119|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
48386963|NCT01299376|155613120|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
48386964|NCT01299376|155613119|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
48386965|NCT01299376|155613120|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
48386966|NCT01299376|155613119|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
48386967|NCT01299376|155613120|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
48386968|NCT01299376|155613119|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
48386969|NCT01299376|155613120|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
48386970|NCT01299376|155613119|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
48386971|NCT01299376|155613120|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
48386972|NCT01299376|155613119|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
48386973|NCT01299376|155613120|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
48386974|NCT01299376|155613119|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
48386975|NCT01299376|155613120|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
48386976|NCT00509067|155613123|FG000|Overall Study|Lost to Follow-up|1|||
48386977|NCT00509067|155613124|FG001|Overall Study|Lost to Follow-up|1|||
48386978|NCT00509067|155613123|FG000|Overall Study|Adverse Event|3|||
48386979|NCT00509067|155613124|FG001|Overall Study|Adverse Event|1|||
48386980|NCT00509067|155613123|FG000|Overall Study|Protocol Violation|0|||
48386981|NCT00509067|155613124|FG001|Overall Study|Protocol Violation|3|||
48386982|NCT02361944|155613127|FG000|Overall Study|surgery cancellation|0|||
48386983|NCT02361944|155613128|FG001|Overall Study|surgery cancellation|1|||
48386984|NCT04340557|155613129|FG000|Overall Study|Transferred to ICU and/or death|1|||
48386985|NCT04340557|155613130|FG001|Overall Study|Transferred to ICU and/or death|2|||
48386986|NCT01431274|155613131|FG000|Overall Study|Adverse Event|51|||
48677175|NCT01368081|156669226|FG004|Overall Study|Lost to Follow-up|0|||
48677176|NCT01368081|156669227|FG005|Overall Study|Lost to Follow-up|0|||
48677177|NCT01368081|156669228|FG006|Overall Study|Lost to Follow-up|0|||
48677178|NCT01368081|156669229|FG007|Overall Study|Lost to Follow-up|0|||
48677179|NCT01368081|156669230|FG008|Overall Study|Lost to Follow-up|0|||
48677180|NCT01368081|156669231|FG009|Overall Study|Lost to Follow-up|0|||
48677181|NCT01368081|156669232|FG010|Overall Study|Lost to Follow-up|0|||
48762372|NCT00481195|156978102|FG000|Overall Study|Withdrawal by Subject|3|||
48386987|NCT01431274|155613132|FG001|Overall Study|Adverse Event|37|||
48386988|NCT01431274|155613133|FG002|Overall Study|Adverse Event|43|||
48386989|NCT01431274|155613134|FG003|Overall Study|Adverse Event|30|||
48386990|NCT01431274|155613135|FG004|Overall Study|Adverse Event|37|||
48386991|NCT01431274|155613131|FG000|Overall Study|Consent withdrawn not due to AE|29|||
48386992|NCT01431274|155613132|FG001|Overall Study|Consent withdrawn not due to AE|20|||
48386993|NCT01431274|155613133|FG002|Overall Study|Consent withdrawn not due to AE|17|||
48386994|NCT01431274|155613134|FG003|Overall Study|Consent withdrawn not due to AE|20|||
48386995|NCT01431274|155613135|FG004|Overall Study|Consent withdrawn not due to AE|11|||
48386996|NCT01431274|155613131|FG000|Overall Study|Non compliant with protocol|5|||
48386997|NCT01431274|155613132|FG001|Overall Study|Non compliant with protocol|8|||
48386998|NCT01431274|155613133|FG002|Overall Study|Non compliant with protocol|4|||
48386999|NCT01431274|155613134|FG003|Overall Study|Non compliant with protocol|4|||
48387000|NCT01431274|155613135|FG004|Overall Study|Non compliant with protocol|4|||
48387001|NCT01431274|155613131|FG000|Overall Study|Lost to Follow-up|6|||
48387002|NCT01431274|155613132|FG001|Overall Study|Lost to Follow-up|7|||
48387003|NCT01431274|155613133|FG002|Overall Study|Lost to Follow-up|1|||
48387004|NCT01431274|155613134|FG003|Overall Study|Lost to Follow-up|4|||
48387005|NCT01431274|155613135|FG004|Overall Study|Lost to Follow-up|0|||
48387006|NCT01431274|155613131|FG000|Overall Study|Other reason not stated above|6|||
48387007|NCT01431274|155613132|FG001|Overall Study|Other reason not stated above|5|||
48387008|NCT01431274|155613133|FG002|Overall Study|Other reason not stated above|7|||
48387009|NCT01431274|155613134|FG003|Overall Study|Other reason not stated above|2|||
48387010|NCT01431274|155613135|FG004|Overall Study|Other reason not stated above|4|||
48387011|NCT01092143|155613140|FG000|Overall Study|Adverse Event|10|||
48387012|NCT01092143|155613141|FG001|Overall Study|Adverse Event|5|||
48387013|NCT01092143|155613142|FG002|Overall Study|Adverse Event|1|||
48387014|NCT01092143|155613143|FG003|Overall Study|Adverse Event|4|||
48387015|NCT01092143|155613144|FG004|Overall Study|Adverse Event|3|||
48387016|NCT01092143|155613140|FG000|Overall Study|Lost to Follow-up|1|||
48387017|NCT01092143|155613141|FG001|Overall Study|Lost to Follow-up|0|||
48387018|NCT01092143|155613142|FG002|Overall Study|Lost to Follow-up|1|||
48387019|NCT01092143|155613143|FG003|Overall Study|Lost to Follow-up|0|||
48387020|NCT01092143|155613144|FG004|Overall Study|Lost to Follow-up|0|||
48387021|NCT01092143|155613140|FG000|Overall Study|Consent withdrawn|2|||
48762373|NCT00481195|156978103|FG001|Overall Study|Withdrawal by Subject|9|||
48677182|NCT01368081|156669233|FG011|Overall Study|Lost to Follow-up|0|||
48677183|NCT01368081|156669234|FG012|Overall Study|Lost to Follow-up|1|||
48677184|NCT01368081|156669222|FG000|Overall Study|Withdrawal by Subject|4|||
48677185|NCT01368081|156669223|FG001|Overall Study|Withdrawal by Subject|4|||
48677186|NCT01368081|156669224|FG002|Overall Study|Withdrawal by Subject|1|||
48677187|NCT01368081|156669225|FG003|Overall Study|Withdrawal by Subject|1|||
48677188|NCT01368081|156669226|FG004|Overall Study|Withdrawal by Subject|0|||
48677189|NCT01368081|156669227|FG005|Overall Study|Withdrawal by Subject|3|||
48677190|NCT01368081|156669228|FG006|Overall Study|Withdrawal by Subject|4|||
48677191|NCT01368081|156669229|FG007|Overall Study|Withdrawal by Subject|2|||
48677192|NCT01368081|156669230|FG008|Overall Study|Withdrawal by Subject|5|||
48677193|NCT01368081|156669231|FG009|Overall Study|Withdrawal by Subject|4|||
48677194|NCT01368081|156669232|FG010|Overall Study|Withdrawal by Subject|3|||
48677195|NCT01368081|156669233|FG011|Overall Study|Withdrawal by Subject|2|||
48677196|NCT01368081|156669234|FG012|Overall Study|Withdrawal by Subject|0|||
48677197|NCT01368081|156669222|FG000|Overall Study|Other reason not defined above|2|||
48677198|NCT01368081|156669223|FG001|Overall Study|Other reason not defined above|0|||
48677199|NCT01368081|156669224|FG002|Overall Study|Other reason not defined above|0|||
48677200|NCT01368081|156669225|FG003|Overall Study|Other reason not defined above|1|||
48677201|NCT01368081|156669226|FG004|Overall Study|Other reason not defined above|0|||
48677202|NCT01368081|156669227|FG005|Overall Study|Other reason not defined above|1|||
48677203|NCT01368081|156669228|FG006|Overall Study|Other reason not defined above|2|||
48677204|NCT01368081|156669229|FG007|Overall Study|Other reason not defined above|0|||
48677205|NCT01368081|156669230|FG008|Overall Study|Other reason not defined above|0|||
48677206|NCT01368081|156669231|FG009|Overall Study|Other reason not defined above|1|||
48677207|NCT01368081|156669232|FG010|Overall Study|Other reason not defined above|0|||
48677208|NCT01368081|156669233|FG011|Overall Study|Other reason not defined above|0|||
48677209|NCT01368081|156669234|FG012|Overall Study|Other reason not defined above|3|||
48677210|NCT00422383|156669235|FG000|Overall Study|Adverse Event|5|||
48677211|NCT00422383|156669236|FG001|Overall Study|Adverse Event|3|||
48677212|NCT00422383|156669237|FG002|Overall Study|Adverse Event|1|||
48677213|NCT00422383|156669238|FG003|Overall Study|Adverse Event|1|||
48677214|NCT00422383|156669239|FG004|Overall Study|Adverse Event|0|||
48677215|NCT00422383|156669235|FG000|Overall Study|Lack of Efficacy|4|||
48677216|NCT00422383|156669236|FG001|Overall Study|Lack of Efficacy|4|||
48762374|NCT00481195|156978102|FG000|Overall Study|Miscellaneous|2|||
48762375|NCT00481195|156978103|FG001|Overall Study|Miscellaneous|2|||
48762376|NCT04105998|156978106|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
48387022|NCT01092143|155613141|FG001|Overall Study|Consent withdrawn|1|||
48387023|NCT01092143|155613142|FG002|Overall Study|Consent withdrawn|0|||
48387024|NCT01092143|155613143|FG003|Overall Study|Consent withdrawn|1|||
48387025|NCT01092143|155613144|FG004|Overall Study|Consent withdrawn|3|||
48387026|NCT01092143|155613140|FG000|Overall Study|Not treated|0|||
48387027|NCT01092143|155613141|FG001|Overall Study|Not treated|0|||
48387028|NCT01092143|155613142|FG002|Overall Study|Not treated|1|||
48387029|NCT01092143|155613143|FG003|Overall Study|Not treated|0|||
48387030|NCT01092143|155613144|FG004|Overall Study|Not treated|0|||
48387031|NCT01092143|155613140|FG000|Overall Study|did not reversibility criteria|0|||
48387032|NCT01092143|155613141|FG001|Overall Study|did not reversibility criteria|0|||
48387033|NCT01092143|155613142|FG002|Overall Study|did not reversibility criteria|1|||
48387034|NCT01092143|155613143|FG003|Overall Study|did not reversibility criteria|0|||
48387035|NCT01092143|155613144|FG004|Overall Study|did not reversibility criteria|0|||
48387036|NCT01092143|155613140|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
48387037|NCT01092143|155613141|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
48387038|NCT01092143|155613142|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
48387039|NCT01092143|155613143|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
48387040|NCT01092143|155613144|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
48387041|NCT01092143|155613140|FG000|Overall Study|Ineligible patient|1|||
48387042|NCT01092143|155613141|FG001|Overall Study|Ineligible patient|0|||
48387043|NCT01092143|155613142|FG002|Overall Study|Ineligible patient|0|||
48387044|NCT01092143|155613143|FG003|Overall Study|Ineligible patient|0|||
48387045|NCT01092143|155613144|FG004|Overall Study|Ineligible patient|0|||
48387046|NCT01092143|155613140|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
48387047|NCT01092143|155613141|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
48387048|NCT01092143|155613142|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
48387049|NCT01092143|155613143|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
48387050|NCT01092143|155613144|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
48387051|NCT01092143|155613140|FG000|Overall Study|Patient travel|0|||
48387052|NCT01092143|155613141|FG001|Overall Study|Patient travel|0|||
48677217|NCT00422383|156669237|FG002|Overall Study|Lack of Efficacy|2|||
48677218|NCT00422383|156669238|FG003|Overall Study|Lack of Efficacy|1|||
48677219|NCT00422383|156669239|FG004|Overall Study|Lack of Efficacy|1|||
48387053|NCT01092143|155613142|FG002|Overall Study|Patient travel|0|||
48387054|NCT01092143|155613143|FG003|Overall Study|Patient travel|0|||
48387055|NCT01092143|155613144|FG004|Overall Study|Patient travel|1|||
48387056|NCT01092143|155613140|FG000|Overall Study|Non compliance with study medication|0|||
48387057|NCT01092143|155613141|FG001|Overall Study|Non compliance with study medication|0|||
48677220|NCT00422383|156669235|FG000|Overall Study|Lost to Follow-up|0|||
48677221|NCT00422383|156669236|FG001|Overall Study|Lost to Follow-up|1|||
48677222|NCT00422383|156669237|FG002|Overall Study|Lost to Follow-up|0|||
48677223|NCT00422383|156669238|FG003|Overall Study|Lost to Follow-up|0|||
48677224|NCT00422383|156669239|FG004|Overall Study|Lost to Follow-up|1|||
48677225|NCT00422383|156669235|FG000|Overall Study|Protocol Violation|1|||
48677226|NCT00422383|156669236|FG001|Overall Study|Protocol Violation|1|||
48677227|NCT00422383|156669237|FG002|Overall Study|Protocol Violation|1|||
48677228|NCT00422383|156669238|FG003|Overall Study|Protocol Violation|0|||
48677229|NCT00422383|156669239|FG004|Overall Study|Protocol Violation|0|||
48677230|NCT00422383|156669235|FG000|Overall Study|Withdrawal by Subject|5|||
48677231|NCT00422383|156669236|FG001|Overall Study|Withdrawal by Subject|5|||
48677232|NCT00422383|156669237|FG002|Overall Study|Withdrawal by Subject|0|||
48677233|NCT00422383|156669238|FG003|Overall Study|Withdrawal by Subject|0|||
48677234|NCT00422383|156669239|FG004|Overall Study|Withdrawal by Subject|1|||
48677235|NCT02560012|156669241|FG000|Overall Study|Study Terminated|2|||
48677236|NCT01108523|156669242|FG000|Overall Study|Protocol Violation|4|||
48762377|NCT04105998|156978107|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
48762378|NCT02738333|156978108|FG000|Overall Study|Death|1|||
48762379|NCT02738333|156978109|FG001|Overall Study|Death|0|||
48762380|NCT02738333|156978110|FG002|Overall Study|Death|0|||
48762381|NCT02738333|156978108|FG000|Overall Study|Lost to Follow-up|1|||
48762382|NCT02738333|156978109|FG001|Overall Study|Lost to Follow-up|0|||
48762383|NCT02738333|156978110|FG002|Overall Study|Lost to Follow-up|0|||
48762384|NCT02488681|156978111|FG000|Overall Study|Implant unsuccessful|7|||
48762385|NCT02580357|156978112|FG000|Overall Study|Lost to Follow-up|2|||
48762386|NCT02580357|156978113|FG001|Overall Study|Lost to Follow-up|0|||
48762387|NCT02580357|156978114|FG002|Overall Study|Lost to Follow-up|0|||
48762388|NCT02580357|156978112|FG000|Overall Study|Protocol Violation|1|||
48762389|NCT02580357|156978113|FG001|Overall Study|Protocol Violation|0|||
48762390|NCT02580357|156978114|FG002|Overall Study|Protocol Violation|0|||
48762391|NCT03261947|156978115|FG000|Overall Study|Death|10|||
48762392|NCT03261947|156978116|FG001|Overall Study|Death|13|||
48762393|NCT03261947|156978117|FG002|Overall Study|Death|17|||
48762394|NCT03261947|156978118|FG003|Overall Study|Death|12|||
48762395|NCT03261947|156978119|FG004|Overall Study|Death|8|||
48762396|NCT03261947|156978115|FG000|Overall Study|Lost to Follow-up|0|||
48762397|NCT03261947|156978116|FG001|Overall Study|Lost to Follow-up|0|||
48762398|NCT03261947|156978117|FG002|Overall Study|Lost to Follow-up|2|||
48762399|NCT03261947|156978118|FG003|Overall Study|Lost to Follow-up|1|||
48762400|NCT03261947|156978119|FG004|Overall Study|Lost to Follow-up|0|||
48762401|NCT03261947|156978115|FG000|Overall Study|Withdrawal by Subject|0|||
48762402|NCT03261947|156978116|FG001|Overall Study|Withdrawal by Subject|0|||
48762403|NCT03261947|156978117|FG002|Overall Study|Withdrawal by Subject|3|||
48762404|NCT03261947|156978118|FG003|Overall Study|Withdrawal by Subject|0|||
48762405|NCT03261947|156978119|FG004|Overall Study|Withdrawal by Subject|1|||
48762406|NCT03261947|156978115|FG000|Overall Study|Site Terminated by Sponsor|0|||
48762407|NCT03261947|156978116|FG001|Overall Study|Site Terminated by Sponsor|0|||
48762408|NCT03261947|156978117|FG002|Overall Study|Site Terminated by Sponsor|4|||
48762409|NCT03261947|156978118|FG003|Overall Study|Site Terminated by Sponsor|7|||
48762410|NCT03261947|156978119|FG004|Overall Study|Site Terminated by Sponsor|5|||
48762411|NCT03261947|156978115|FG000|Overall Study|Reason not Specified|2|||
48762412|NCT03261947|156978116|FG001|Overall Study|Reason not Specified|0|||
48762413|NCT03261947|156978117|FG002|Overall Study|Reason not Specified|4|||
48762414|NCT03261947|156978118|FG003|Overall Study|Reason not Specified|1|||
48762415|NCT03261947|156978119|FG004|Overall Study|Reason not Specified|3|||
48762416|NCT04007523|156978125|FG000|Overall Study|Withdrawal by Subject|0|||
48762417|NCT04007523|156978126|FG001|Overall Study|Withdrawal by Subject|1|||
48762418|NCT04007523|156978127|FG002|Overall Study|Withdrawal by Subject|1|||
48762419|NCT04007523|156978128|FG003|Overall Study|Withdrawal by Subject|0|||
48762420|NCT04007523|156978125|FG000|Overall Study|ICU Transfer|0|||
48762421|NCT04007523|156978126|FG001|Overall Study|ICU Transfer|1|||
48762422|NCT04007523|156978127|FG002|Overall Study|ICU Transfer|0|||
48762423|NCT04007523|156978128|FG003|Overall Study|ICU Transfer|0|||
48762424|NCT04007523|156978125|FG000|Overall Study|COVID hospital closure|0|||
48762425|NCT04007523|156978126|FG001|Overall Study|COVID hospital closure|0|||
48762426|NCT04007523|156978127|FG002|Overall Study|COVID hospital closure|1|||
48762427|NCT04007523|156978128|FG003|Overall Study|COVID hospital closure|2|||
48677237|NCT00483938|156669243|FG000|Overall Study|Protocol Violation|0|||
48677238|NCT00483938|156669244|FG001|Overall Study|Protocol Violation|0|||
48677239|NCT00483938|156669245|FG002|Overall Study|Protocol Violation|0|||
48677240|NCT00483938|156669246|FG003|Overall Study|Protocol Violation|0|||
48762428|NCT04007523|156978125|FG000|Overall Study|Surgery cancelled|0|||
48762429|NCT04007523|156978126|FG001|Overall Study|Surgery cancelled|0|||
48762430|NCT04007523|156978127|FG002|Overall Study|Surgery cancelled|1|||
48762431|NCT04007523|156978128|FG003|Overall Study|Surgery cancelled|1|||
48762432|NCT01358357|156978129|FG000|Open Label Phase|Adverse Event|0|||
48762433|NCT01358357|156978130|FG001|Open Label Phase|Adverse Event|0|||
48762434|NCT01358357|156978131|FG002|Open Label Phase|Adverse Event|59|||
48677241|NCT00483938|156669247|FG004|Overall Study|Protocol Violation|0|||
48677242|NCT00483938|156669248|FG005|Overall Study|Protocol Violation|0|||
48677243|NCT00483938|156669249|FG006|Overall Study|Protocol Violation|3|||
48677244|NCT00483938|156669243|FG000|Overall Study|Withdrawal by Subject|1|||
48354817|NCT02366143|155497108|FG000|Overall Study|Requester's instructions|1|||
48354818|NCT02366143|155497109|FG001|Overall Study|Requester's instructions|1|||
48354819|NCT02366143|155497110|FG002|Overall Study|Requester's instructions|1|||
48354820|NCT02366143|155497108|FG000|Overall Study|Uneligible|0|||
48354821|NCT02366143|155497109|FG001|Overall Study|Uneligible|1|||
48354822|NCT02366143|155497110|FG002|Overall Study|Uneligible|0|||
48354823|NCT02366143|155497108|FG000|Overall Study|Post Trial Migration|0|||
48354824|NCT02366143|155497109|FG001|Overall Study|Post Trial Migration|1|||
48354825|NCT02366143|155497110|FG002|Overall Study|Post Trial Migration|0|||
48354826|NCT02366143|155497108|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
48354827|NCT02366143|155497109|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
48354828|NCT02366143|155497110|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
48354829|NCT02366143|155497108|FG000|Overall Study|Patient switched to PTAP|0|||
48354830|NCT02366143|155497109|FG001|Overall Study|Patient switched to PTAP|1|||
48354831|NCT02366143|155497110|FG002|Overall Study|Patient switched to PTAP|0|||
48354832|NCT02366143|155497108|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
48354833|NCT02366143|155497109|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
48354834|NCT02366143|155497110|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
48354835|NCT00127842|155497111|FG000|Overall Study|Adverse Event|15|||
48354836|NCT00127842|155497111|FG000|Overall Study|Withdrawal by Subject|3|||
48354837|NCT00127842|155497111|FG000|Overall Study|Lost to Follow-up|1|||
48354838|NCT00127842|155497111|FG000|Overall Study|Lack of Efficacy|12|||
48354839|NCT00127842|155497111|FG000|Overall Study|Noncompliance|2|||
48354840|NCT00127842|155497111|FG000|Overall Study|Protocol Violation|1|||
48354841|NCT00127842|155497111|FG000|Overall Study|Other|5|||
48354842|NCT03898700|155497112|FG000|Overall Study|Withdrawal by Subject|2|||
48354843|NCT01536587|155497113|FG000|Overall Study|Adverse Event|2|||
48354844|NCT01434680|155497114|FG000|Overall Study|Withdrawal by Subject|1|||
48354845|NCT01434680|155497115|FG001|Overall Study|Withdrawal by Subject|0|||
48354846|NCT01434680|155497116|FG002|Overall Study|Withdrawal by Subject|2|||
48354847|NCT01434680|155497117|FG003|Overall Study|Withdrawal by Subject|0|||
48354848|NCT01434680|155497114|FG000|Overall Study|Lost to Follow-up|1|||
48354849|NCT01434680|155497115|FG001|Overall Study|Lost to Follow-up|1|||
48354850|NCT01434680|155497116|FG002|Overall Study|Lost to Follow-up|0|||
48354851|NCT01434680|155497117|FG003|Overall Study|Lost to Follow-up|0|||
48354852|NCT01434680|155497114|FG000|Overall Study|Protocol Violation|1|||
48354853|NCT01434680|155497115|FG001|Overall Study|Protocol Violation|1|||
48354854|NCT01434680|155497116|FG002|Overall Study|Protocol Violation|0|||
48354855|NCT01434680|155497117|FG003|Overall Study|Protocol Violation|0|||
48354856|NCT01663506|155497118|FG000|Overall Study|Lack of Efficacy|3|||
48354857|NCT01663506|155497118|FG000|Overall Study|Consent Withdrawal by Subject|1|||
48354858|NCT01663506|155497118|FG000|Overall Study|Lost to Follow-up|1|||
48354859|NCT01663506|155497118|FG000|Overall Study|Adverse Event|1|||
48354860|NCT01663506|155497118|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
48354861|NCT02094898|155497119|FG000|Overall Study|Clinical Worsening|2|||
48354862|NCT02094898|155497119|FG000|Overall Study|Adverse Event|2|||
48354863|NCT02094898|155497119|FG000|Overall Study|Lack of Efficacy|1|||
48354864|NCT01513330|155497120|FG000|SenSura Mio First,|Adverse Event|2|||
48354865|NCT01513330|155497121|FG001|SenSura Mio First,|Adverse Event|0|||
48354866|NCT01513330|155497120|FG000|SenSura Mio First,|Lack of Efficacy|0|||
48354867|NCT01513330|155497121|FG001|SenSura Mio First,|Lack of Efficacy|1|||
48354868|NCT01513330|155497120|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
48354869|NCT01513330|155497121|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
48354870|NCT01513330|155497120|FG000|SenSura Mio First,|Other|1|||
48354871|NCT01513330|155497121|FG001|SenSura Mio First,|Other|0|||
48354872|NCT01513330|155497120|FG000|Standard Care First,|Lack of Efficacy|2|||
48354873|NCT01513330|155497121|FG001|Standard Care First,|Lack of Efficacy|2|||
48354874|NCT01513330|155497120|FG000|Standard Care First,|Withdrawal by Subject|1|||
48354875|NCT01513330|155497121|FG001|Standard Care First,|Withdrawal by Subject|2|||
48354876|NCT01513330|155497120|FG000|Standard Care First,|Other|1|||
48354877|NCT01513330|155497121|FG001|Standard Care First,|Other|0|||
48354878|NCT01013961|155497123|FG000|Overall Study|Adverse Event|2|||
48354879|NCT01013961|155497124|FG001|Overall Study|Adverse Event|2|||
48354880|NCT01013961|155497123|FG000|Overall Study|Withdrawal by Subject|1|||
48354881|NCT01013961|155497124|FG001|Overall Study|Withdrawal by Subject|0|||
48354882|NCT01013961|155497123|FG000|Overall Study|Physician Decision|0|||
48354883|NCT01013961|155497124|FG001|Overall Study|Physician Decision|1|||
48354884|NCT00633945|155497125|FG000|Overall Study|Physician Decision|2|||
48354885|NCT02375347|155497126|FG000|Overall Study|Protocol Violation|1|||
48354886|NCT00121667|155497129|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
48354887|NCT00121667|155497130|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
48354888|NCT00121667|155497131|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
48354889|NCT00121667|155497132|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
48387058|NCT01092143|155613142|FG002|Overall Study|Non compliance with study medication|0|||
48762435|NCT01358357|156978129|FG000|Open Label Phase|Lack of Efficacy|0|||
48387059|NCT01092143|155613143|FG003|Overall Study|Non compliance with study medication|0|||
48387060|NCT01092143|155613144|FG004|Overall Study|Non compliance with study medication|1|||
48387061|NCT01092143|155613140|FG000|Overall Study|Randomized by mistake|0|||
48387062|NCT01092143|155613141|FG001|Overall Study|Randomized by mistake|0|||
48387063|NCT01092143|155613142|FG002|Overall Study|Randomized by mistake|0|||
48387064|NCT01092143|155613143|FG003|Overall Study|Randomized by mistake|1|||
48387065|NCT01092143|155613144|FG004|Overall Study|Randomized by mistake|0|||
48387066|NCT01092143|155613140|FG000|Overall Study|Pregnancy|0|||
48387067|NCT01092143|155613141|FG001|Overall Study|Pregnancy|0|||
48387068|NCT01092143|155613142|FG002|Overall Study|Pregnancy|0|||
48387069|NCT01092143|155613143|FG003|Overall Study|Pregnancy|1|||
48387070|NCT01092143|155613144|FG004|Overall Study|Pregnancy|0|||
48387071|NCT02101021|155613145|FG000|Overall Study|Death|4|||
48387072|NCT02101021|155613146|FG001|Overall Study|Death|3|||
48387073|NCT02101021|155613147|FG002|Overall Study|Death|6|||
48387074|NCT02101021|155613148|FG003|Overall Study|Death|0|||
48387075|NCT02101021|155613149|FG004|Overall Study|Death|3|||
48387076|NCT02101021|155613145|FG000|Overall Study|Withdrew Consent from study|1|||
48387077|NCT02101021|155613146|FG001|Overall Study|Withdrew Consent from study|1|||
48387078|NCT02101021|155613147|FG002|Overall Study|Withdrew Consent from study|0|||
48387079|NCT02101021|155613148|FG003|Overall Study|Withdrew Consent from study|2|||
48387080|NCT02101021|155613149|FG004|Overall Study|Withdrew Consent from study|0|||
48387081|NCT02101021|155613145|FG000|Overall Study|Lost to Follow-up|1|||
48387082|NCT02101021|155613146|FG001|Overall Study|Lost to Follow-up|0|||
48387083|NCT02101021|155613147|FG002|Overall Study|Lost to Follow-up|0|||
48387084|NCT02101021|155613148|FG003|Overall Study|Lost to Follow-up|0|||
48387085|NCT02101021|155613149|FG004|Overall Study|Lost to Follow-up|0|||
48387086|NCT02101021|155613145|FG000|Overall Study|Study Terminated by Sponsor|1|||
48387087|NCT02101021|155613146|FG001|Overall Study|Study Terminated by Sponsor|0|||
48387088|NCT02101021|155613147|FG002|Overall Study|Study Terminated by Sponsor|1|||
48387089|NCT02101021|155613148|FG003|Overall Study|Study Terminated by Sponsor|1|||
48387090|NCT02101021|155613149|FG004|Overall Study|Study Terminated by Sponsor|1|||
48387091|NCT01368042|155613150|FG000|Overall Study|Death|14|||
48387092|NCT01368042|155613150|FG000|Overall Study|Protocol Violation|11|||
48387093|NCT01368042|155613150|FG000|Overall Study|Lost to Follow-up|4|||
48387094|NCT01368042|155613150|FG000|Overall Study|Transplanted|1|||
48387095|NCT02663271|155613153|FG000|Overall Study|Withdrawal by Subject|5|||
48387096|NCT02663271|155613153|FG000|Overall Study|Lack of Efficacy|1|||
48387097|NCT01235793|155613157|FG000|Overall Study|Death|6|||
48387098|NCT01721057|155613160|FG000|Treatment Period|Withdrawal by Subject|11|||
48387099|NCT01721057|155613161|FG001|Treatment Period|Withdrawal by Subject|5|||
48387100|NCT01721057|155613162|FG002|Treatment Period|Withdrawal by Subject|8|||
48387101|NCT01721057|155613163|FG003|Treatment Period|Withdrawal by Subject|0|||
48387102|NCT01721057|155613164|FG004|Treatment Period|Withdrawal by Subject|0|||
48387103|NCT01721057|155613165|FG005|Treatment Period|Withdrawal by Subject|0|||
48387104|NCT01721057|155613166|FG006|Treatment Period|Withdrawal by Subject|0|||
48387105|NCT01721057|155613160|FG000|Treatment Period|Adverse Event|7|||
48387106|NCT01721057|155613161|FG001|Treatment Period|Adverse Event|10|||
48387107|NCT01721057|155613162|FG002|Treatment Period|Adverse Event|12|||
48387108|NCT01721057|155613163|FG003|Treatment Period|Adverse Event|0|||
48387109|NCT01721057|155613164|FG004|Treatment Period|Adverse Event|0|||
48387110|NCT01721057|155613165|FG005|Treatment Period|Adverse Event|0|||
48387111|NCT01721057|155613166|FG006|Treatment Period|Adverse Event|0|||
48387112|NCT01721057|155613160|FG000|Treatment Period|Lack of Efficacy|7|||
48387113|NCT01721057|155613161|FG001|Treatment Period|Lack of Efficacy|3|||
48762436|NCT01358357|156978130|FG001|Open Label Phase|Lack of Efficacy|0|||
48762437|NCT01358357|156978131|FG002|Open Label Phase|Lack of Efficacy|107|||
48387114|NCT01721057|155613162|FG002|Treatment Period|Lack of Efficacy|0|||
48387115|NCT01721057|155613163|FG003|Treatment Period|Lack of Efficacy|0|||
48387116|NCT01721057|155613164|FG004|Treatment Period|Lack of Efficacy|0|||
48387117|NCT01721057|155613165|FG005|Treatment Period|Lack of Efficacy|0|||
48387118|NCT01721057|155613166|FG006|Treatment Period|Lack of Efficacy|0|||
48387119|NCT01721057|155613160|FG000|Treatment Period|Lost to Follow-up|1|||
48387120|NCT01721057|155613161|FG001|Treatment Period|Lost to Follow-up|0|||
48387121|NCT01721057|155613162|FG002|Treatment Period|Lost to Follow-up|0|||
48387122|NCT01721057|155613163|FG003|Treatment Period|Lost to Follow-up|0|||
48387123|NCT01721057|155613164|FG004|Treatment Period|Lost to Follow-up|0|||
48387124|NCT01721057|155613165|FG005|Treatment Period|Lost to Follow-up|0|||
48387125|NCT01721057|155613166|FG006|Treatment Period|Lost to Follow-up|0|||
48387126|NCT01721057|155613160|FG000|Treatment Period|Physician Decision|0|||
48387127|NCT01721057|155613161|FG001|Treatment Period|Physician Decision|1|||
48387128|NCT01721057|155613162|FG002|Treatment Period|Physician Decision|3|||
48387129|NCT01721057|155613163|FG003|Treatment Period|Physician Decision|0|||
48387130|NCT01721057|155613164|FG004|Treatment Period|Physician Decision|0|||
48387131|NCT01721057|155613165|FG005|Treatment Period|Physician Decision|0|||
48387132|NCT01721057|155613166|FG006|Treatment Period|Physician Decision|0|||
48762438|NCT01358357|156978129|FG000|Open Label Phase|Lost to Follow-up|0|||
48762439|NCT01358357|156978130|FG001|Open Label Phase|Lost to Follow-up|0|||
48762440|NCT01358357|156978131|FG002|Open Label Phase|Lost to Follow-up|76|||
48762441|NCT01358357|156978129|FG000|Open Label Phase|Protocol Violation|0|||
48354890|NCT00121667|155497129|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
48354891|NCT00121667|155497130|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
48354892|NCT00121667|155497131|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
48354893|NCT00121667|155497132|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
48354894|NCT00121667|155497129|FG000|Short Term (ST) Period|Adverse Event|5|||
48354895|NCT00121667|155497130|FG001|Short Term (ST) Period|Adverse Event|6|||
48354896|NCT00121667|155497131|FG002|Short Term (ST) Period|Adverse Event|5|||
48354897|NCT00121667|155497132|FG003|Short Term (ST) Period|Adverse Event|3|||
48354898|NCT00121667|155497129|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
48354899|NCT00121667|155497130|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
48354900|NCT00121667|155497131|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
48354901|NCT00121667|155497132|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
48354902|NCT00121667|155497129|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
48354903|NCT00121667|155497130|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
48354904|NCT00121667|155497131|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
48354905|NCT00121667|155497132|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
48354906|NCT00121667|155497129|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
48354907|NCT00121667|155497130|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
48354908|NCT00121667|155497131|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
48354909|NCT00121667|155497132|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
48354910|NCT00121667|155497129|FG000|Short Term (ST) Period|Other Reason|3|||
48354911|NCT00121667|155497130|FG001|Short Term (ST) Period|Other Reason|0|||
48354912|NCT00121667|155497131|FG002|Short Term (ST) Period|Other Reason|0|||
48354913|NCT00121667|155497132|FG003|Short Term (ST) Period|Other Reason|0|||
48354914|NCT00121667|155497129|FG000|Short Term (ST) Period|Death|0|||
48354915|NCT00121667|155497130|FG001|Short Term (ST) Period|Death|0|||
48354916|NCT00121667|155497131|FG002|Short Term (ST) Period|Death|0|||
48354917|NCT00121667|155497132|FG003|Short Term (ST) Period|Death|1|||
48354918|NCT00121667|155497129|FG000|Short Term (ST) Period|Pregnancy|0|||
48354919|NCT00121667|155497130|FG001|Short Term (ST) Period|Pregnancy|0|||
48354920|NCT00121667|155497131|FG002|Short Term (ST) Period|Pregnancy|0|||
48354921|NCT00121667|155497132|FG003|Short Term (ST) Period|Pregnancy|1|||
48354922|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
48354923|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
48354924|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
48354925|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
48354926|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
48354927|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
48354928|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
48354929|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
48354930|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
48354931|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
48354932|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
48354933|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
48354934|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
48354935|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
48354936|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
48354937|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
48354938|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
48354939|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
48354940|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
48354941|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
48354942|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
48354943|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
48354944|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
48354945|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
48354946|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
48354947|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
48354948|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
48354949|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
48387133|NCT01721057|155613160|FG000|Treatment Period|Death|2|||
48387134|NCT01721057|155613161|FG001|Treatment Period|Death|0|||
48387135|NCT01721057|155613162|FG002|Treatment Period|Death|0|||
48387136|NCT01721057|155613163|FG003|Treatment Period|Death|0|||
48387137|NCT01721057|155613164|FG004|Treatment Period|Death|0|||
48387138|NCT01721057|155613165|FG005|Treatment Period|Death|0|||
48387139|NCT01721057|155613166|FG006|Treatment Period|Death|0|||
48387140|NCT01721057|155613160|FG000|Rescue Period|Adverse Event|0|||
48387141|NCT01721057|155613161|FG001|Rescue Period|Adverse Event|0|||
48387142|NCT01721057|155613162|FG002|Rescue Period|Adverse Event|0|||
48387143|NCT01721057|155613163|FG003|Rescue Period|Adverse Event|1|||
48387144|NCT01721057|155613164|FG004|Rescue Period|Adverse Event|0|||
48387145|NCT01721057|155613165|FG005|Rescue Period|Adverse Event|0|||
48387146|NCT01721057|155613166|FG006|Rescue Period|Adverse Event|0|||
48387147|NCT01721057|155613160|FG000|Rescue Period|Lack of Efficacy|0|||
48387148|NCT01721057|155613161|FG001|Rescue Period|Lack of Efficacy|0|||
48387149|NCT01721057|155613162|FG002|Rescue Period|Lack of Efficacy|0|||
48387150|NCT01721057|155613163|FG003|Rescue Period|Lack of Efficacy|2|||
48387151|NCT01721057|155613164|FG004|Rescue Period|Lack of Efficacy|0|||
48387152|NCT01721057|155613165|FG005|Rescue Period|Lack of Efficacy|0|||
48387153|NCT01721057|155613166|FG006|Rescue Period|Lack of Efficacy|0|||
48387154|NCT01202279|155613167|FG000|Overall Study|Adverse Event|8|||
48387155|NCT01202279|155613168|FG001|Overall Study|Adverse Event|6|||
48387156|NCT01202279|155613167|FG000|Overall Study|Withdrawal by Subject|13|||
48387157|NCT01202279|155613168|FG001|Overall Study|Withdrawal by Subject|10|||
48387158|NCT01202279|155613167|FG000|Overall Study|Physician Decision|0|||
48387159|NCT01202279|155613168|FG001|Overall Study|Physician Decision|1|||
48387160|NCT01202279|155613167|FG000|Overall Study|Lost to Follow-up|10|||
48387161|NCT01202279|155613168|FG001|Overall Study|Lost to Follow-up|7|||
48387162|NCT01202279|155613167|FG000|Overall Study|Protocol Violation|1|||
48387163|NCT01202279|155613168|FG001|Overall Study|Protocol Violation|1|||
48387164|NCT01202279|155613167|FG000|Overall Study|study compliance|5|||
48387165|NCT01202279|155613168|FG001|Overall Study|study compliance|2|||
48387166|NCT01177683|155613169|FG000|Study Treatment|Disease Progressions during treatment|2|||
48387167|NCT01177683|155613170|FG001|Study Treatment|Disease Progressions during treatment|0|||
48387168|NCT01177683|155613171|FG002|Study Treatment|Disease Progressions during treatment|3|||
48387169|NCT01177683|155613169|FG000|Study Treatment|Adverse Event|0|||
48387170|NCT01177683|155613170|FG001|Study Treatment|Adverse Event|1|||
48387171|NCT01177683|155613171|FG002|Study Treatment|Adverse Event|12|||
48387172|NCT01177683|155613169|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
48387173|NCT01177683|155613170|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
48387174|NCT01177683|155613171|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
48387175|NCT01177683|155613169|FG000|Study Treatment|Alternative therapy|0|||
48387176|NCT01177683|155613170|FG001|Study Treatment|Alternative therapy|0|||
48387177|NCT01177683|155613171|FG002|Study Treatment|Alternative therapy|4|||
48387178|NCT01177683|155613169|FG000|Study Treatment|Physician Decision|1|||
48387179|NCT01177683|155613170|FG001|Study Treatment|Physician Decision|0|||
48387180|NCT01177683|155613171|FG002|Study Treatment|Physician Decision|1|||
48387181|NCT01177683|155613169|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
48387182|NCT01177683|155613170|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
48387183|NCT01177683|155613171|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
48387184|NCT01177683|155613169|FG000|Study Treatment|Symptomatic Deterioration|0|||
48387185|NCT01177683|155613170|FG001|Study Treatment|Symptomatic Deterioration|0|||
48387186|NCT01177683|155613171|FG002|Study Treatment|Symptomatic Deterioration|1|||
48387187|NCT01177683|155613169|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
48387188|NCT01177683|155613170|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
48387189|NCT01177683|155613171|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
48387190|NCT01177683|155613169|FG000|Follow up|Patient lost to follow up|0|||
48387191|NCT01177683|155613170|FG001|Follow up|Patient lost to follow up|0|||
48387192|NCT01177683|155613171|FG002|Follow up|Patient lost to follow up|2|||
48387193|NCT01177683|155613169|FG000|Follow up|Death|2|||
48387194|NCT01177683|155613170|FG001|Follow up|Death|1|||
48387195|NCT01177683|155613171|FG002|Follow up|Death|7|||
48387196|NCT01177683|155613169|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
48387197|NCT01177683|155613170|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
48387198|NCT01177683|155613171|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
48387199|NCT03472924|155613172|FG000|Overall Study|Adverse Event|1|||
48387200|NCT03472924|155613173|FG001|Overall Study|Adverse Event|0|||
48387201|NCT02281357|155613174|FG000|Overall Study|Adverse Event|2|||
48387202|NCT02281357|155613175|FG001|Overall Study|Adverse Event|1|||
48387203|NCT02281357|155613174|FG000|Overall Study|Lost to Follow-up|1|||
48387204|NCT02281357|155613175|FG001|Overall Study|Lost to Follow-up|0|||
48387205|NCT02281357|155613174|FG000|Overall Study|Withdrawal by Subject|4|||
48387206|NCT02281357|155613175|FG001|Overall Study|Withdrawal by Subject|3|||
48387207|NCT05082376|155613178|FG000|Overall Study|Lost to Follow-up|2|||
48387208|NCT00228566|155613179|FG000|Overall Study|Adverse Event|31|||
48387209|NCT00228566|155613179|FG000|Overall Study|Lack of Efficacy|14|||
48387210|NCT00228566|155613179|FG000|Overall Study|Lost to Follow-up|16|||
48387211|NCT00228566|155613179|FG000|Overall Study|Physician Decision|5|||
48387212|NCT00228566|155613179|FG000|Overall Study|Withdrawal by Subject|4|||
48387213|NCT00228566|155613179|FG000|Overall Study|Miscellaneous|1|||
48387214|NCT00916279|155613180|FG000|Overall Study|Death|2|||
48387215|NCT00916279|155613180|FG000|Overall Study|Lost to Follow-up|2|||
48387216|NCT03007979|155613181|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
48387217|NCT00517751|155613182|FG000|Overall Study|Death|3|||
48387218|NCT00517751|155613182|FG000|Overall Study|Withdrawal by Subject|37|||
48387219|NCT00517751|155613182|FG000|Overall Study|Lost to Follow-up|4|||
48387220|NCT00517751|155613182|FG000|Overall Study|patient not over due|6|||
48387221|NCT00517751|155613182|FG000|Overall Study|Patient not due for visit|76|||
48387222|NCT00517751|155613182|FG000|Overall Study|Missing|3|||
48387223|NCT00943579|155613183|FG000|Overall Study|Adverse Event|4|||
48387224|NCT00943579|155613184|FG001|Overall Study|Adverse Event|3|||
48387225|NCT00943579|155613183|FG000|Overall Study|Lack of Efficacy|2|||
48387226|NCT00943579|155613184|FG001|Overall Study|Lack of Efficacy|2|||
48387227|NCT02269787|155613187|FG000|Overall Study|Lost to Follow-up|20|||
48387228|NCT02269787|155613188|FG001|Overall Study|Lost to Follow-up|6|||
48387229|NCT02269787|155613187|FG000|Overall Study|Death|2|||
48387230|NCT02269787|155613188|FG001|Overall Study|Death|3|||
48387231|NCT02269787|155613187|FG000|Overall Study|Incapacitated|0|||
48387232|NCT02269787|155613188|FG001|Overall Study|Incapacitated|1|||
48387233|NCT00798135|155613189|FG000|Overall Study|Disease progression, relapse|11|||
48387234|NCT00798135|155613189|FG000|Overall Study|Disease progression, refractory|1|||
48387235|NCT00798135|155613189|FG000|Overall Study|Physician Decision|1|||
48387236|NCT02228720|155613191|FG000|Open Label - Day 30|Lost to Follow-up|1|||
48387237|NCT00282295|155613192|FG000|Overall Study|Adverse Event|0|||
48387238|NCT00282295|155613193|FG001|Overall Study|Adverse Event|1|||
48387239|NCT00282295|155613194|FG002|Overall Study|Adverse Event|0|||
48387240|NCT00282295|155613192|FG000|Overall Study|Serious Adverse Events|0|||
48387241|NCT00282295|155613193|FG001|Overall Study|Serious Adverse Events|0|||
48387242|NCT00282295|155613194|FG002|Overall Study|Serious Adverse Events|1|||
48387243|NCT00282295|155613192|FG000|Overall Study|Protocol Violation|0|||
48387244|NCT00282295|155613193|FG001|Overall Study|Protocol Violation|2|||
48387245|NCT00282295|155613194|FG002|Overall Study|Protocol Violation|1|||
48387246|NCT00282295|155613192|FG000|Overall Study|Withdrawal by Subject|2|||
48387247|NCT00282295|155613193|FG001|Overall Study|Withdrawal by Subject|6|||
48387248|NCT00282295|155613194|FG002|Overall Study|Withdrawal by Subject|4|||
48387249|NCT00282295|155613192|FG000|Overall Study|Lost to Follow-up|1|||
48387250|NCT00282295|155613193|FG001|Overall Study|Lost to Follow-up|7|||
48387251|NCT00282295|155613194|FG002|Overall Study|Lost to Follow-up|2|||
48387252|NCT00282295|155613192|FG000|Overall Study|Other|0|||
48387253|NCT00282295|155613193|FG001|Overall Study|Other|1|||
48387254|NCT00282295|155613194|FG002|Overall Study|Other|0|||
48387255|NCT01401842|155613195|FG000|Overall Study|Withdrawal by Subject|3|||
48387256|NCT01401842|155613196|FG001|Overall Study|Withdrawal by Subject|2|||
48387257|NCT01401842|155613195|FG000|Overall Study|academic reason|4|||
48387258|NCT01401842|155613196|FG001|Overall Study|academic reason|1|||
48387259|NCT01401842|155613195|FG000|Overall Study|changed companies|20|||
48387260|NCT01401842|155613196|FG001|Overall Study|changed companies|34|||
48387261|NCT01401842|155613195|FG000|Overall Study|discharged from US Army|3|||
48387262|NCT01401842|155613196|FG001|Overall Study|discharged from US Army|4|||
48387263|NCT01401842|155613195|FG000|Overall Study|invalid follow-up strength data|1|||
48387264|NCT01401842|155613196|FG001|Overall Study|invalid follow-up strength data|4|||
48387265|NCT01401842|155613195|FG000|Overall Study|on profile|9|||
48387266|NCT01401842|155613196|FG001|Overall Study|on profile|5|||
48387267|NCT01401842|155613195|FG000|Overall Study|other/unknown|28|||
48387268|NCT01401842|155613196|FG001|Overall Study|other/unknown|17|||
48387269|NCT04869345|155613197|FG000|Overall Study|Lost to Follow-up|8|||
48387270|NCT04869345|155613198|FG001|Overall Study|Lost to Follow-up|3|||
48387271|NCT01979536|155613204|FG000|Overall Study|Physician Decision|2|||
48387272|NCT01979536|155613205|FG001|Overall Study|Physician Decision|3|||
48387273|NCT01979536|155613204|FG000|Overall Study|Withdrawal by Subject|0|||
48387274|NCT01979536|155613205|FG001|Overall Study|Withdrawal by Subject|1|||
48387275|NCT01979536|155613204|FG000|Overall Study|Refusal|0|||
48387276|NCT01979536|155613205|FG001|Overall Study|Refusal|1|||
48387277|NCT01979536|155613204|FG000|Overall Study|Relapse|0|||
48387278|NCT01979536|155613205|FG001|Overall Study|Relapse|1|||
48387279|NCT01979536|155613204|FG000|Overall Study|Study terminated by Sponsor|0|||
48387280|NCT01979536|155613205|FG001|Overall Study|Study terminated by Sponsor|1|||
48387281|NCT01979536|155613204|FG000|Overall Study|Did not start treatment|0|||
48387282|NCT01979536|155613205|FG001|Overall Study|Did not start treatment|1|||
48387283|NCT00528021|155613206|FG000|Overall Study|Lack of Efficacy|17|||
48387284|NCT00528021|155613207|FG001|Overall Study|Lack of Efficacy|13|||
48387285|NCT00528021|155613208|FG002|Overall Study|Lack of Efficacy|7|||
48387286|NCT00528021|155613209|FG003|Overall Study|Lack of Efficacy|9|||
48387287|NCT03441334|155614626|FG000|Overall Study|Withdrawal by Subject|1|||
48387288|NCT03441334|155614627|FG001|Overall Study|Withdrawal by Subject|0|||
48387289|NCT02217436|155614628|FG000|Overall Study|Protocol Violation|1|||
48387290|NCT02217436|155614629|FG001|Overall Study|Protocol Violation|1|||
48387291|NCT02217436|155614628|FG000|Overall Study|Incomplete data|0|||
48387292|NCT02217436|155614629|FG001|Overall Study|Incomplete data|1|||
48387293|NCT04641299|155614630|FG000|Overall Study|Adverse Event|0|||
48354950|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
48354951|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
48354952|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
48354953|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
48354954|NCT00121667|155497129|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
48354955|NCT00121667|155497130|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
48354956|NCT00121667|155497131|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
48354957|NCT00121667|155497132|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
48354958|NCT03510455|155497133|FG000|Overall Study|Physician Decision|1|||
48354959|NCT03054337|155497134|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
48354960|NCT03054337|155497135|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
48354961|NCT03054337|155497136|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
48354962|NCT03054337|155497137|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
48354963|NCT03054337|155497138|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
48354964|NCT03054337|155497139|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
48354965|NCT00609947|155497144|FG000|Overall Study|Death|1|||
48354966|NCT03603639|155497145|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48354967|NCT03603639|155497146|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48354968|NCT03603639|155497147|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48354969|NCT03603639|155497148|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
48354970|NCT03603639|155497149|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48354971|NCT03603639|155497150|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
48354972|NCT03603639|155497145|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
48354973|NCT03603639|155497146|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
48354974|NCT03603639|155497147|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
48354975|NCT03603639|155497148|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
48354976|NCT03603639|155497149|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
48354977|NCT03603639|155497150|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
48354978|NCT01318876|155497151|FG000|Day 8 Survey|email address invalid|96|||
48354979|NCT01318876|155497151|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
48354980|NCT01318876|155497151|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
48354981|NCT03325777|155497154|FG000|Overall Study|Lost to Follow-up|9|||
48354982|NCT03325777|155497155|FG001|Overall Study|Lost to Follow-up|12|||
48354983|NCT04042077|155497156|FG000|Overall Study|Adverse Event|0|||
48354984|NCT04042077|155497157|FG001|Overall Study|Adverse Event|1|||
48354985|NCT04042077|155497156|FG000|Overall Study|Death|2|||
48354986|NCT04042077|155497157|FG001|Overall Study|Death|1|||
48354987|NCT04042077|155497156|FG000|Overall Study|Physician Decision|2|||
48354988|NCT04042077|155497157|FG001|Overall Study|Physician Decision|0|||
48354989|NCT04042077|155497156|FG000|Overall Study|Withdrawal by Subject|3|||
48354990|NCT04042077|155497157|FG001|Overall Study|Withdrawal by Subject|2|||
48354991|NCT04042077|155497156|FG000|Overall Study|Lack of Efficacy|0|||
48354992|NCT04042077|155497157|FG001|Overall Study|Lack of Efficacy|1|||
48354993|NCT03004404|155497159|FG000|Period 2|Adverse Event|0|||
48354994|NCT03004404|155497160|FG001|Period 2|Adverse Event|0|||
48354995|NCT03004404|155497161|FG002|Period 2|Adverse Event|0|||
48354996|NCT03004404|155497162|FG003|Period 2|Adverse Event|0|||
48354997|NCT03004404|155497163|FG004|Period 2|Adverse Event|0|||
48354998|NCT03004404|155497164|FG005|Period 2|Adverse Event|0|||
48354999|NCT03004404|155497165|FG006|Period 2|Adverse Event|0|||
48355000|NCT03004404|155497166|FG007|Period 2|Adverse Event|0|||
48355001|NCT03004404|155497167|FG008|Period 2|Adverse Event|1|||
48355002|NCT03004404|155497168|FG009|Period 2|Adverse Event|0|||
48355003|NCT03004404|155497169|FG010|Period 2|Adverse Event|0|||
48355004|NCT03004404|155497170|FG011|Period 2|Adverse Event|0|||
48355005|NCT03004404|155497171|FG012|Period 2|Adverse Event|0|||
48355006|NCT03004404|155497172|FG013|Period 2|Adverse Event|0|||
48355007|NCT03004404|155497173|FG014|Period 2|Adverse Event|0|||
48355008|NCT03004404|155497174|FG015|Period 2|Adverse Event|1|||
48355009|NCT03482752|155497179|FG000|Overall Study|Withdrawal by Subject|2|||
48355010|NCT03482752|155497179|FG000|Overall Study|Lost to Follow-up|1|||
48355011|NCT03482752|155497179|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
48355012|NCT01080300|155497181|FG000|Overall Study|Adverse Event|49|||
48355013|NCT01080300|155497182|FG001|Overall Study|Adverse Event|35|||
48355014|NCT01080300|155497181|FG000|Overall Study|Lack of Efficacy|12|||
48355015|NCT01080300|155497182|FG001|Overall Study|Lack of Efficacy|15|||
48355016|NCT01080300|155497181|FG000|Overall Study|Protocol Violation|7|||
48355017|NCT01080300|155497182|FG001|Overall Study|Protocol Violation|13|||
48355018|NCT01080300|155497181|FG000|Overall Study|Lost to Follow-up|10|||
48355019|NCT01080300|155497182|FG001|Overall Study|Lost to Follow-up|6|||
48355020|NCT01080300|155497181|FG000|Overall Study|Death|0|||
48355021|NCT01080300|155497182|FG001|Overall Study|Death|1|||
48387294|NCT04641299|155614631|FG001|Overall Study|Adverse Event|0|||
48387295|NCT04641299|155614632|FG002|Overall Study|Adverse Event|2|||
48387296|NCT04641299|155614633|FG003|Overall Study|Adverse Event|0|||
48762442|NCT01358357|156978130|FG001|Open Label Phase|Protocol Violation|0|||
48762443|NCT01358357|156978131|FG002|Open Label Phase|Protocol Violation|45|||
48762444|NCT01358357|156978129|FG000|Open Label Phase|Withdrawal by Subject|0|||
48762445|NCT01358357|156978130|FG001|Open Label Phase|Withdrawal by Subject|0|||
48762446|NCT01358357|156978131|FG002|Open Label Phase|Withdrawal by Subject|112|||
48762447|NCT01358357|156978129|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
48762448|NCT01358357|156978130|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
48762449|NCT01358357|156978131|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
48762450|NCT01358357|156978129|FG000|Open Label Phase|Terminated at study completion|0|||
48677245|NCT00483938|156669244|FG001|Overall Study|Withdrawal by Subject|6|||
48677246|NCT00483938|156669245|FG002|Overall Study|Withdrawal by Subject|0|||
48677247|NCT00483938|156669246|FG003|Overall Study|Withdrawal by Subject|0|||
48677248|NCT00483938|156669247|FG004|Overall Study|Withdrawal by Subject|1|||
48677249|NCT00483938|156669248|FG005|Overall Study|Withdrawal by Subject|3|||
48677250|NCT00483938|156669249|FG006|Overall Study|Withdrawal by Subject|2|||
48677251|NCT00483938|156669243|FG000|Overall Study|Lost to Follow-up|1|||
48677252|NCT00483938|156669244|FG001|Overall Study|Lost to Follow-up|2|||
48677253|NCT00483938|156669245|FG002|Overall Study|Lost to Follow-up|0|||
48677254|NCT00483938|156669246|FG003|Overall Study|Lost to Follow-up|2|||
48677255|NCT00483938|156669247|FG004|Overall Study|Lost to Follow-up|1|||
48677256|NCT00483938|156669248|FG005|Overall Study|Lost to Follow-up|1|||
48677257|NCT00483938|156669249|FG006|Overall Study|Lost to Follow-up|3|||
48677258|NCT00483938|156669243|FG000|Overall Study|Death|0|||
48677259|NCT00483938|156669244|FG001|Overall Study|Death|2|||
48677260|NCT00483938|156669245|FG002|Overall Study|Death|0|||
48677261|NCT00483938|156669246|FG003|Overall Study|Death|0|||
48677262|NCT00483938|156669247|FG004|Overall Study|Death|0|||
48677263|NCT00483938|156669248|FG005|Overall Study|Death|0|||
48677264|NCT00483938|156669249|FG006|Overall Study|Death|0|||
48677265|NCT00483938|156669243|FG000|Overall Study|Other|3|||
48677266|NCT00483938|156669244|FG001|Overall Study|Other|9|||
48677267|NCT00483938|156669245|FG002|Overall Study|Other|0|||
48677268|NCT00483938|156669246|FG003|Overall Study|Other|4|||
48677269|NCT00483938|156669247|FG004|Overall Study|Other|0|||
48677270|NCT00483938|156669248|FG005|Overall Study|Other|4|||
48677271|NCT00483938|156669249|FG006|Overall Study|Other|32|||
48677272|NCT03691571|156669250|FG000|Overall Study|Withdrawal by Subject|9|||
48677273|NCT03691571|156669251|FG001|Overall Study|Withdrawal by Subject|2|||
48677274|NCT02465203|156669253|FG000|Overall Study|Protocol Violation|1|||
48677275|NCT02465203|156669254|FG001|Overall Study|Protocol Violation|1|||
48677276|NCT02465203|156669255|FG002|Overall Study|Protocol Violation|1|||
48677277|NCT02465203|156669253|FG000|Overall Study|Study terminated by sponsor|50|||
48677278|NCT02465203|156669254|FG001|Overall Study|Study terminated by sponsor|34|||
48677279|NCT02465203|156669255|FG002|Overall Study|Study terminated by sponsor|11|||
48677280|NCT02465203|156669253|FG000|Overall Study|New therapy for study indication|4|||
48677281|NCT02465203|156669254|FG001|Overall Study|New therapy for study indication|0|||
48677282|NCT02465203|156669255|FG002|Overall Study|New therapy for study indication|0|||
48677283|NCT02465203|156669253|FG000|Overall Study|Patient/guardian decision|1|||
48677284|NCT02465203|156669254|FG001|Overall Study|Patient/guardian decision|1|||
48677285|NCT02465203|156669255|FG002|Overall Study|Patient/guardian decision|1|||
48677286|NCT03761810|156669256|FG000|Overall Study|Adverse Event|12|||
48677287|NCT03761810|156669257|FG001|Overall Study|Adverse Event|0|||
48677288|NCT03761810|156669256|FG000|Overall Study|Lost to Follow-up|15|||
48677289|NCT03761810|156669257|FG001|Overall Study|Lost to Follow-up|7|||
48677290|NCT03761810|156669256|FG000|Overall Study|Pregnancy|1|||
48677291|NCT03761810|156669257|FG001|Overall Study|Pregnancy|0|||
48677292|NCT03761810|156669256|FG000|Overall Study|Withdrawal by Subject|14|||
48677293|NCT03761810|156669257|FG001|Overall Study|Withdrawal by Subject|5|||
48677294|NCT03761810|156669256|FG000|Overall Study|Physician Decision|1|||
48677295|NCT03761810|156669257|FG001|Overall Study|Physician Decision|0|||
48677296|NCT03761810|156669256|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
48677297|NCT03761810|156669257|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48677298|NCT03761810|156669256|FG000|Overall Study|Other Than Specified|1|||
48677299|NCT03761810|156669257|FG001|Overall Study|Other Than Specified|0|||
48677300|NCT00947115|156669260|FG000|Overall Study|Missed reporting interval|3|||
48677301|NCT00947115|156669261|FG001|Overall Study|Missed reporting interval|4|||
48677302|NCT00947115|156669262|FG002|Overall Study|Missed reporting interval|2|||
48677303|NCT00947115|156669260|FG000|Overall Study|Physician Decision|0|||
48677304|NCT00947115|156669261|FG001|Overall Study|Physician Decision|2|||
48677305|NCT00947115|156669262|FG002|Overall Study|Physician Decision|0|||
48677306|NCT00947115|156669260|FG000|Overall Study|Death|0|||
48677307|NCT00947115|156669261|FG001|Overall Study|Death|1|||
48677308|NCT00947115|156669262|FG002|Overall Study|Death|1|||
48677309|NCT00947115|156669260|FG000|Overall Study|Migrated from study area|2|||
48677310|NCT00947115|156669261|FG001|Overall Study|Migrated from study area|0|||
48677311|NCT00947115|156669262|FG002|Overall Study|Migrated from study area|0|||
48677312|NCT00947115|156669260|FG000|Overall Study|Withdrawal by Subject|1|||
48677313|NCT00947115|156669261|FG001|Overall Study|Withdrawal by Subject|3|||
48387297|NCT04641299|155614630|FG000|Overall Study|Lost to Follow-up|0|||
48677314|NCT00947115|156669262|FG002|Overall Study|Withdrawal by Subject|4|||
48677315|NCT00947115|156669260|FG000|Overall Study|Lost to Follow-up|11|||
48677316|NCT00947115|156669261|FG001|Overall Study|Lost to Follow-up|12|||
48677317|NCT00947115|156669262|FG002|Overall Study|Lost to Follow-up|8|||
48677318|NCT01223183|156669263|FG000|Imaging Day 1|Physician Decision|0|||
48677319|NCT01223183|156669264|FG001|Imaging Day 1|Physician Decision|1|||
48677320|NCT01223183|156669263|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
48677321|NCT01223183|156669264|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
48677322|NCT01223183|156669263|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
48677323|NCT01223183|156669264|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
48677324|NCT00900029|156669265|FG000|Overall Study|Lost to Follow-up|0|||
48677325|NCT00900029|156669266|FG001|Overall Study|Lost to Follow-up|2|||
48677326|NCT00900029|156669267|FG002|Overall Study|Lost to Follow-up|1|||
48677327|NCT00900029|156669268|FG003|Overall Study|Lost to Follow-up|4|||
48677328|NCT00900029|156669269|FG004|Overall Study|Lost to Follow-up|4|||
48677329|NCT00900029|156669265|FG000|Overall Study|Withdrawal by Subject|2|||
48677330|NCT00900029|156669266|FG001|Overall Study|Withdrawal by Subject|2|||
48677331|NCT00900029|156669267|FG002|Overall Study|Withdrawal by Subject|1|||
48677332|NCT00900029|156669268|FG003|Overall Study|Withdrawal by Subject|1|||
48677333|NCT00900029|156669269|FG004|Overall Study|Withdrawal by Subject|1|||
48677334|NCT00900029|156669265|FG000|Overall Study|Adverse Event|0|||
48677335|NCT00900029|156669266|FG001|Overall Study|Adverse Event|0|||
48677336|NCT00900029|156669267|FG002|Overall Study|Adverse Event|1|||
48677337|NCT00900029|156669268|FG003|Overall Study|Adverse Event|1|||
48677338|NCT00900029|156669269|FG004|Overall Study|Adverse Event|1|||
48677339|NCT00900029|156669265|FG000|Overall Study|Death|1|||
48677340|NCT00900029|156669266|FG001|Overall Study|Death|0|||
48677341|NCT00900029|156669267|FG002|Overall Study|Death|0|||
48677342|NCT00900029|156669268|FG003|Overall Study|Death|1|||
48677343|NCT00900029|156669269|FG004|Overall Study|Death|0|||
48677344|NCT03268941|156671317|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677345|NCT03268941|156671318|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677346|NCT03268941|156671319|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677347|NCT03268941|156671320|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
48762451|NCT01358357|156978130|FG001|Open Label Phase|Terminated at study completion|0|||
48762452|NCT01358357|156978131|FG002|Open Label Phase|Terminated at study completion|5|||
48762453|NCT01358357|156978129|FG000|Open Label Phase|Mood episode|0|||
48762454|NCT01358357|156978130|FG001|Open Label Phase|Mood episode|0|||
48762455|NCT01358357|156978131|FG002|Open Label Phase|Mood episode|42|||
48762456|NCT01358357|156978129|FG000|Double-Blind Phase|Adverse Event|8|||
48762457|NCT01358357|156978130|FG001|Double-Blind Phase|Adverse Event|5|||
48762458|NCT01358357|156978131|FG002|Double-Blind Phase|Adverse Event|0|||
48762459|NCT01358357|156978129|FG000|Double-Blind Phase|Lost to Follow-up|5|||
48762460|NCT01358357|156978130|FG001|Double-Blind Phase|Lost to Follow-up|7|||
48762461|NCT01358357|156978131|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48762462|NCT01358357|156978129|FG000|Double-Blind Phase|Protocol Violation|1|||
48762463|NCT01358357|156978130|FG001|Double-Blind Phase|Protocol Violation|11|||
48762464|NCT01358357|156978131|FG002|Double-Blind Phase|Protocol Violation|0|||
48762465|NCT01358357|156978129|FG000|Double-Blind Phase|Protocol Violation|16|||
48762466|NCT01358357|156978130|FG001|Double-Blind Phase|Protocol Violation|12|||
48762467|NCT01358357|156978131|FG002|Double-Blind Phase|Protocol Violation|0|||
48762468|NCT01358357|156978129|FG000|Double-Blind Phase|Terminated at study completion|2|||
48762469|NCT01358357|156978130|FG001|Double-Blind Phase|Terminated at study completion|0|||
48762470|NCT01358357|156978131|FG002|Double-Blind Phase|Terminated at study completion|0|||
48762471|NCT01358357|156978129|FG000|Double-Blind Phase|Recurrence of mood event|48|||
48762472|NCT01358357|156978130|FG001|Double-Blind Phase|Recurrence of mood event|64|||
48762473|NCT01358357|156978131|FG002|Double-Blind Phase|Recurrence of mood event|0|||
48762474|NCT01358357|156978129|FG000|Double-Blind Phase|Administrative|0|||
48762475|NCT01358357|156978130|FG001|Double-Blind Phase|Administrative|1|||
48677348|NCT03268941|156671321|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677349|NCT03268941|156671322|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48677350|NCT03268941|156671323|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
48762476|NCT01358357|156978131|FG002|Double-Blind Phase|Administrative|0|||
48762477|NCT04351087|156978132|FG000|Overall Study|Lost to Follow-up|7|||
48762478|NCT04351087|156978133|FG001|Overall Study|Lost to Follow-up|3|||
48677351|NCT03268941|156671317|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677352|NCT03268941|156671318|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677353|NCT03268941|156671319|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677354|NCT03268941|156671320|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
48677355|NCT03268941|156671321|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
48762479|NCT04351087|156978132|FG000|Overall Study|Withdrawal by Subject|3|||
48762480|NCT04351087|156978133|FG001|Overall Study|Withdrawal by Subject|4|||
48762481|NCT04351087|156978132|FG000|Overall Study|Lack of Efficacy|3|||
48387298|NCT04641299|155614631|FG001|Overall Study|Lost to Follow-up|1|||
48677356|NCT03268941|156671322|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677357|NCT03268941|156671323|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
48677358|NCT03268941|156671317|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
48677359|NCT03268941|156671318|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48355022|NCT01080300|155497181|FG000|Overall Study|Withdrawal by Subject|12|||
48355023|NCT01080300|155497182|FG001|Overall Study|Withdrawal by Subject|28|||
48355024|NCT01080300|155497181|FG000|Overall Study|Reasons not specified|4|||
48355025|NCT01080300|155497182|FG001|Overall Study|Reasons not specified|6|||
48355026|NCT01436305|155497183|FG000|Overall Study|Death|1|||
48355027|NCT01436305|155497184|FG001|Overall Study|Death|0|||
48355028|NCT01436305|155497185|FG002|Overall Study|Death|0|||
48355029|NCT01436305|155497183|FG000|Overall Study|Lost to Follow-up|0|||
48355030|NCT01436305|155497184|FG001|Overall Study|Lost to Follow-up|1|||
48355031|NCT01436305|155497185|FG002|Overall Study|Lost to Follow-up|0|||
48355032|NCT01436305|155497183|FG000|Overall Study|Withdrawal by Subject|1|||
48355033|NCT01436305|155497184|FG001|Overall Study|Withdrawal by Subject|3|||
48355034|NCT01436305|155497185|FG002|Overall Study|Withdrawal by Subject|0|||
48355035|NCT01012947|155497186|FG000|Overall Study|Lost to Follow-up|131|||
48355036|NCT01012947|155497187|FG001|Overall Study|Lost to Follow-up|135|||
48355037|NCT01012947|155497188|FG002|Overall Study|Lost to Follow-up|130|||
48355038|NCT01012947|155497189|FG003|Overall Study|Lost to Follow-up|118|||
48355039|NCT01012947|155497190|FG004|Overall Study|Lost to Follow-up|142|||
48355040|NCT02353468|155497193|FG000|Overall Study|Study terminated|3|||
48355041|NCT02493946|155497194|FG000|DB Period|Withdrawal by Subject|8|||
48355042|NCT02493946|155497195|FG001|DB Period|Withdrawal by Subject|5|||
48355043|NCT02493946|155497196|FG002|DB Period|Withdrawal by Subject|0|||
48355044|NCT02493946|155497194|FG000|Open Label Period|Withdrawal by Subject|0|||
48355045|NCT02493946|155497195|FG001|Open Label Period|Withdrawal by Subject|0|||
48355046|NCT02493946|155497196|FG002|Open Label Period|Withdrawal by Subject|74|||
48355047|NCT02493946|155497194|FG000|Open Label Period|Adverse Event|0|||
48355048|NCT02493946|155497195|FG001|Open Label Period|Adverse Event|0|||
48355049|NCT02493946|155497196|FG002|Open Label Period|Adverse Event|4|||
48355050|NCT02493946|155497194|FG000|Open Label Period|Lost to Follow-up|0|||
48387299|NCT04641299|155614632|FG002|Overall Study|Lost to Follow-up|0|||
48355051|NCT02493946|155497195|FG001|Open Label Period|Lost to Follow-up|0|||
48355052|NCT02493946|155497196|FG002|Open Label Period|Lost to Follow-up|1|||
48355053|NCT02493946|155497194|FG000|Open Label Period|Investigator decision, non-compliance|0|||
48355054|NCT02493946|155497195|FG001|Open Label Period|Investigator decision, non-compliance|0|||
48355055|NCT02493946|155497196|FG002|Open Label Period|Investigator decision, non-compliance|2|||
48355056|NCT02493946|155497194|FG000|Open Label Period|Investigator decision, non-availability|0|||
48355057|NCT02493946|155497195|FG001|Open Label Period|Investigator decision, non-availability|0|||
48355058|NCT02493946|155497196|FG002|Open Label Period|Investigator decision, non-availability|1|||
48355059|NCT02493946|155497194|FG000|Open Label Period|Pregnancy|0|||
48355060|NCT02493946|155497195|FG001|Open Label Period|Pregnancy|0|||
48355061|NCT02493946|155497196|FG002|Open Label Period|Pregnancy|3|||
48355062|NCT02493946|155497194|FG000|Open Label Period|Site error|0|||
48355063|NCT02493946|155497195|FG001|Open Label Period|Site error|0|||
48355064|NCT02493946|155497196|FG002|Open Label Period|Site error|1|||
48355065|NCT00895895|155497200|FG000|Period 1|Adverse Event|7|||
48355066|NCT00895895|155497201|FG001|Period 1|Adverse Event|6|||
48387300|NCT04641299|155614633|FG003|Overall Study|Lost to Follow-up|0|||
48387301|NCT04641299|155614630|FG000|Overall Study|Withdrawal by Subject|1|||
48387302|NCT04641299|155614631|FG001|Overall Study|Withdrawal by Subject|0|||
48387303|NCT04641299|155614632|FG002|Overall Study|Withdrawal by Subject|0|||
48387304|NCT04641299|155614633|FG003|Overall Study|Withdrawal by Subject|0|||
48387305|NCT04641299|155614630|FG000|Overall Study|Reason not given|1|||
48387306|NCT04641299|155614631|FG001|Overall Study|Reason not given|0|||
48387307|NCT04641299|155614632|FG002|Overall Study|Reason not given|0|||
48387308|NCT04641299|155614633|FG003|Overall Study|Reason not given|0|||
48387309|NCT00449670|155614634|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
48387310|NCT00449670|155614635|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
48387311|NCT00449670|155614634|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
48387312|NCT00449670|155614635|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
48387313|NCT00449670|155614634|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
48387314|NCT00449670|155614635|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
48387315|NCT00449670|155614634|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
48387316|NCT00449670|155614635|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
48387317|NCT00449670|155614634|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
48387318|NCT00449670|155614635|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
48387319|NCT00449670|155614634|FG000|Booster Phase (Study no.109873)|Other|0|||
48387320|NCT00449670|155614635|FG001|Booster Phase (Study no.109873)|Other|2|||
48387321|NCT00525044|155614636|FG000|Overall Study|Lost to Follow-up|0|||
48387322|NCT00525044|155614637|FG001|Overall Study|Lost to Follow-up|1|||
48387323|NCT01128361|155614638|FG000|Overall Study|Lost to Follow-up|0|||
48387324|NCT01128361|155614639|FG001|Overall Study|Lost to Follow-up|1|||
48387325|NCT01128361|155614638|FG000|Overall Study|Withdrawal by Subject|5|||
48387326|NCT01128361|155614639|FG001|Overall Study|Withdrawal by Subject|2|||
48387327|NCT02982590|155614641|FG000|Overall Study|Lost to Follow-up|0|||
48677360|NCT03268941|156671319|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677361|NCT03268941|156671320|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677362|NCT03268941|156671321|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677363|NCT03268941|156671322|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677364|NCT03268941|156671323|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
48677365|NCT03268941|156671317|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
48677366|NCT03268941|156671318|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
48677367|NCT03268941|156671319|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
48677368|NCT03268941|156671320|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
48677369|NCT03268941|156671321|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
48677370|NCT03268941|156671322|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
48677371|NCT03268941|156671323|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
48677372|NCT03268941|156671317|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677373|NCT03268941|156671318|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677374|NCT03268941|156671319|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677375|NCT03268941|156671320|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48762482|NCT04351087|156978133|FG001|Overall Study|Lack of Efficacy|2|||
48762483|NCT01774786|156978136|FG000|Overall Study|Death|300|||
48762484|NCT01774786|156978137|FG001|Overall Study|Death|319|||
48762485|NCT01774786|156978136|FG000|Overall Study|Lost to Follow-up|6|||
48762486|NCT01774786|156978137|FG001|Overall Study|Lost to Follow-up|7|||
48762487|NCT01774786|156978136|FG000|Overall Study|Withdrawal by Subject|18|||
48762488|NCT01774786|156978137|FG001|Overall Study|Withdrawal by Subject|14|||
48762489|NCT01774786|156978136|FG000|Overall Study|Physician Decision|2|||
48762490|NCT01774786|156978137|FG001|Overall Study|Physician Decision|0|||
48762491|NCT01774786|156978136|FG000|Overall Study|Non-compliance|0|||
48762492|NCT01774786|156978137|FG001|Overall Study|Non-compliance|1|||
48762493|NCT01774786|156978136|FG000|Overall Study|Reason Not Specified|2|||
48762494|NCT01774786|156978137|FG001|Overall Study|Reason Not Specified|5|||
48762495|NCT02268812|156978138|FG000|Overall Study|Adverse Event|8|||
48762496|NCT02268812|156978139|FG001|Overall Study|Adverse Event|26|||
48677376|NCT03268941|156671321|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677377|NCT03268941|156671322|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
48677378|NCT03268941|156671323|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
48677379|NCT04599465|156671324|FG000|Overall Study|Physician Decision|1|||
48677380|NCT04599465|156671324|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
48677381|NCT00994643|156671326|FG000|Overall Study|Withdrawal by Subject|1|||
48677382|NCT00652951|156671327|FG000|Booster Phase|Adverse event, non-fatal|0|||
48677383|NCT00652951|156671328|FG001|Booster Phase|Adverse event, non-fatal|1|||
48677384|NCT00652951|156671329|FG002|Booster Phase|Adverse event, non-fatal|0|||
48677385|NCT00652951|156671327|FG000|Booster Phase|Other|1|||
48677386|NCT00652951|156671328|FG001|Booster Phase|Other|0|||
48677387|NCT00652951|156671329|FG002|Booster Phase|Other|0|||
48677388|NCT01206582|156671332|FG000|Overall Study|Withdrew prior to study|1|||
48677389|NCT01206582|156671333|FG001|Overall Study|Withdrew prior to study|0|||
48677390|NCT01206582|156671332|FG000|Overall Study|Discontinued intervention before week 8|1|||
48677391|NCT01206582|156671333|FG001|Overall Study|Discontinued intervention before week 8|2|||
48762497|NCT02268812|156978140|FG002|Overall Study|Adverse Event|7|||
48387328|NCT02982590|155614642|FG001|Overall Study|Lost to Follow-up|1|||
48387329|NCT02982590|155614641|FG000|Overall Study|Death|4|||
48387330|NCT02982590|155614642|FG001|Overall Study|Death|0|||
48387331|NCT00785044|155614643|FG000|Overall Study|Dosed at non-participating sites|152|||
48387332|NCT00785044|155614643|FG000|Overall Study|Death|77|||
48387333|NCT00785044|155614643|FG000|Overall Study|Lost to Follow-up|266|||
48387334|NCT00785044|155614643|FG000|Overall Study|Withdrawal by Subject|1|||
48387335|NCT01830855|155614644|FG000|Overall Study|Other|7|||
48387336|NCT01830855|155614645|FG001|Overall Study|Other|1|||
48387337|NCT01830855|155614646|FG002|Overall Study|Other|4|||
48387338|NCT01830855|155614647|FG003|Overall Study|Other|4|||
48387339|NCT01830855|155614644|FG000|Overall Study|Medication error without associated AE|1|||
48677392|NCT01363661|156671334|FG000|Overall Study|Adverse Event|9|||
48677393|NCT01363661|156671335|FG001|Overall Study|Adverse Event|2|||
48677394|NCT01363661|156671334|FG000|Overall Study|Withdrawal by Subject|1|||
48677395|NCT01363661|156671335|FG001|Overall Study|Withdrawal by Subject|1|||
48677396|NCT01363661|156671334|FG000|Overall Study|Protocol Violation|1|||
48677397|NCT01363661|156671335|FG001|Overall Study|Protocol Violation|0|||
48677398|NCT01363661|156671334|FG000|Overall Study|Lost to Follow-up|3|||
48677399|NCT01363661|156671335|FG001|Overall Study|Lost to Follow-up|1|||
48677400|NCT03472586|156671336|FG000|Overall Study|Physician Decision|6|||
48762498|NCT02268812|156978141|FG003|Overall Study|Adverse Event|10|||
48762499|NCT02268812|156978138|FG000|Overall Study|Protocol deviation|0|||
48762500|NCT02268812|156978139|FG001|Overall Study|Protocol deviation|0|||
48387340|NCT01830855|155614645|FG001|Overall Study|Medication error without associated AE|0|||
48387341|NCT01830855|155614646|FG002|Overall Study|Medication error without associated AE|0|||
48429379|NCT01070550|155760356|FG001|Overall Study|Protocol Violation|1|||
48387342|NCT01830855|155614647|FG003|Overall Study|Medication error without associated AE|1|||
48387343|NCT01830855|155614644|FG000|Overall Study|Pregnancy|3|||
48387344|NCT01830855|155614645|FG001|Overall Study|Pregnancy|1|||
48387345|NCT01830855|155614646|FG002|Overall Study|Pregnancy|2|||
48387346|NCT01830855|155614647|FG003|Overall Study|Pregnancy|1|||
48387347|NCT01830855|155614644|FG000|Overall Study|No longer meets eligibility criteria|11|||
48387348|NCT01830855|155614645|FG001|Overall Study|No longer meets eligibility criteria|2|||
48387349|NCT01830855|155614646|FG002|Overall Study|No longer meets eligibility criteria|3|||
48387350|NCT01830855|155614647|FG003|Overall Study|No longer meets eligibility criteria|5|||
48387351|NCT01830855|155614644|FG000|Overall Study|Adverse Event|11|||
48387352|NCT01830855|155614645|FG001|Overall Study|Adverse Event|5|||
48387353|NCT01830855|155614646|FG002|Overall Study|Adverse Event|6|||
48387354|NCT01830855|155614647|FG003|Overall Study|Adverse Event|3|||
48387355|NCT01830855|155614644|FG000|Overall Study|Protocol deviation|10|||
48387356|NCT01830855|155614645|FG001|Overall Study|Protocol deviation|5|||
48387357|NCT01830855|155614646|FG002|Overall Study|Protocol deviation|6|||
48387358|NCT01830855|155614647|FG003|Overall Study|Protocol deviation|6|||
48387359|NCT01830855|155614644|FG000|Overall Study|Withdrawal by Subject|33|||
48387360|NCT01830855|155614645|FG001|Overall Study|Withdrawal by Subject|14|||
48387361|NCT01830855|155614646|FG002|Overall Study|Withdrawal by Subject|10|||
48387362|NCT01830855|155614647|FG003|Overall Study|Withdrawal by Subject|12|||
48387363|NCT01830855|155614644|FG000|Overall Study|No longer willing to participate|32|||
48387364|NCT01830855|155614645|FG001|Overall Study|No longer willing to participate|13|||
48387365|NCT01830855|155614646|FG002|Overall Study|No longer willing to participate|12|||
48387366|NCT01830855|155614647|FG003|Overall Study|No longer willing to participate|17|||
48387367|NCT01830855|155614644|FG000|Overall Study|Lost to Follow-up|47|||
48387368|NCT01830855|155614645|FG001|Overall Study|Lost to Follow-up|20|||
48387369|NCT01830855|155614646|FG002|Overall Study|Lost to Follow-up|23|||
48387370|NCT01830855|155614647|FG003|Overall Study|Lost to Follow-up|33|||
48387371|NCT03523728|155614648|FG000|Stage 1 (24 Months)|Adverse Event|2|||
48387372|NCT03523728|155614649|FG001|Stage 1 (24 Months)|Adverse Event|2|||
48387373|NCT03523728|155614650|FG002|Stage 1 (24 Months)|Adverse Event|4|||
48387374|NCT03523728|155614651|FG003|Stage 1 (24 Months)|Adverse Event|0|||
48387375|NCT03523728|155614652|FG004|Stage 1 (24 Months)|Adverse Event|0|||
48387376|NCT03523728|155614648|FG000|Stage 1 (24 Months)|Progressive disease|0|||
48387377|NCT03523728|155614649|FG001|Stage 1 (24 Months)|Progressive disease|0|||
48387378|NCT03523728|155614650|FG002|Stage 1 (24 Months)|Progressive disease|1|||
48387379|NCT03523728|155614651|FG003|Stage 1 (24 Months)|Progressive disease|0|||
48387380|NCT03523728|155614652|FG004|Stage 1 (24 Months)|Progressive disease|0|||
48387381|NCT03523728|155614648|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
48387382|NCT03523728|155614649|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
48387383|NCT03523728|155614650|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
48387384|NCT03523728|155614651|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
48387385|NCT03523728|155614652|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
48387386|NCT03523728|155614648|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
48387387|NCT03523728|155614649|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
48387388|NCT03523728|155614650|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
48387389|NCT03523728|155614651|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
48387390|NCT03523728|155614652|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
48387391|NCT03523728|155614648|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
48387392|NCT03523728|155614649|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
48387393|NCT03523728|155614650|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
48387394|NCT03523728|155614651|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
48387395|NCT03523728|155614652|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
48387396|NCT03523728|155614648|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
48387397|NCT03523728|155614649|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
48387398|NCT03523728|155614650|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
48387399|NCT03523728|155614651|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
48387400|NCT03523728|155614652|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
48387401|NCT03523728|155614648|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
48387402|NCT03523728|155614649|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
48387403|NCT03523728|155614650|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
48387404|NCT03523728|155614651|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
48387405|NCT03523728|155614652|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
48387406|NCT03523728|155614648|FG000|Stage 2 (24 Months)|Adverse Event|0|||
48387407|NCT03523728|155614649|FG001|Stage 2 (24 Months)|Adverse Event|0|||
48387408|NCT03523728|155614650|FG002|Stage 2 (24 Months)|Adverse Event|0|||
48387409|NCT03523728|155614651|FG003|Stage 2 (24 Months)|Adverse Event|1|||
48387410|NCT03523728|155614652|FG004|Stage 2 (24 Months)|Adverse Event|2|||
48387411|NCT03523728|155614648|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
48387412|NCT03523728|155614649|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
48387413|NCT03523728|155614650|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
48387414|NCT03523728|155614651|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
48387415|NCT03523728|155614652|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
48387416|NCT03523728|155614648|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
48429380|NCT01070550|155760357|FG002|Overall Study|Protocol Violation|1|||
48387417|NCT03523728|155614649|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
48387418|NCT03523728|155614650|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
48387419|NCT03523728|155614651|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
48387420|NCT03523728|155614652|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
48387421|NCT03523728|155614648|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
48387422|NCT03523728|155614649|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
48387423|NCT03523728|155614650|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
48387424|NCT03523728|155614651|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
48387425|NCT03523728|155614652|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
48387426|NCT03523728|155614648|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
48387427|NCT03523728|155614649|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
48387428|NCT03523728|155614650|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
48387429|NCT03523728|155614651|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
48387430|NCT03523728|155614652|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
48762501|NCT02268812|156978140|FG002|Overall Study|Protocol deviation|1|||
48762502|NCT02268812|156978141|FG003|Overall Study|Protocol deviation|0|||
48762503|NCT02268812|156978138|FG000|Overall Study|Withdrawal by Subject|0|||
48762504|NCT02268812|156978139|FG001|Overall Study|Withdrawal by Subject|1|||
48762505|NCT02268812|156978140|FG002|Overall Study|Withdrawal by Subject|0|||
48762506|NCT02268812|156978141|FG003|Overall Study|Withdrawal by Subject|0|||
48762507|NCT02268812|156978138|FG000|Overall Study|Physician Decision|3|||
48387431|NCT00621751|155614655|FG000|Overall Study|Adverse Event|0|||
48387432|NCT00621751|155614656|FG001|Overall Study|Adverse Event|1|||
48387433|NCT00362414|155614657|FG000|Overall Study|Death|2|||
48387434|NCT00362414|155614657|FG000|Overall Study|Adverse Event|1|||
48387435|NCT02667275|155614658|FG000|Overall Study|Protocol Violation|11|||
48387436|NCT02667275|155614659|FG001|Overall Study|Protocol Violation|7|||
48387437|NCT02667275|155614658|FG000|Overall Study|Lost to Follow-up|0|||
48387438|NCT02667275|155614659|FG001|Overall Study|Lost to Follow-up|2|||
48387439|NCT02667275|155614658|FG000|Overall Study|Withdrawal by Subject|0|||
48387440|NCT02667275|155614659|FG001|Overall Study|Withdrawal by Subject|5|||
48387441|NCT02667275|155614658|FG000|Overall Study|Discontinued early without completing|0|||
48387442|NCT02667275|155614659|FG001|Overall Study|Discontinued early without completing|1|||
48387443|NCT03677596|155614661|FG000|Overall Study|Adverse Event|0|||
48387444|NCT03677596|155614662|FG001|Overall Study|Adverse Event|1|||
48387445|NCT03677596|155614661|FG000|Overall Study|Death|10|||
48387446|NCT03677596|155614662|FG001|Overall Study|Death|6|||
48387447|NCT03677596|155614661|FG000|Overall Study|Lost to Follow-up|0|||
48387448|NCT03677596|155614662|FG001|Overall Study|Lost to Follow-up|1|||
48387449|NCT03677596|155614661|FG000|Overall Study|Progressive Disease|8|||
48387450|NCT03677596|155614662|FG001|Overall Study|Progressive Disease|8|||
48387451|NCT03677596|155614661|FG000|Overall Study|Withdrawal by Subject|3|||
48387452|NCT03677596|155614662|FG001|Overall Study|Withdrawal by Subject|0|||
48387453|NCT03677596|155614661|FG000|Overall Study|Disease Relapse|2|||
48387454|NCT03677596|155614662|FG001|Overall Study|Disease Relapse|2|||
48387455|NCT03677596|155614661|FG000|Overall Study|Other|0|||
48387456|NCT03677596|155614662|FG001|Overall Study|Other|1|||
48387457|NCT01735279|155614663|FG000|Overall Study|Lost to Follow-up|11|||
48387458|NCT01735279|155614664|FG001|Overall Study|Lost to Follow-up|8|||
48387459|NCT03945591|155614667|FG000|Overall Study|Participant not transplanted|1|||
48387460|NCT03945591|155614667|FG000|Overall Study|Change in treatment plan|3|||
48387461|NCT03945591|155614667|FG000|Overall Study|Adverse Event|1|||
48387462|NCT00359021|155614668|FG000|Overall Study|Adverse Event|26|||
48387463|NCT00359021|155614669|FG001|Overall Study|Adverse Event|8|||
48387464|NCT00359021|155614668|FG000|Overall Study|Subject Non-Compliant|1|||
48387465|NCT00359021|155614669|FG001|Overall Study|Subject Non-Compliant|2|||
48387466|NCT00359021|155614668|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
48387467|NCT00359021|155614669|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
48387468|NCT00359021|155614668|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
48387469|NCT00359021|155614669|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
48387470|NCT00359021|155614668|FG000|Overall Study|Withdrawal by Subject|2|||
48762508|NCT02268812|156978139|FG001|Overall Study|Physician Decision|1|||
48762509|NCT02268812|156978140|FG002|Overall Study|Physician Decision|0|||
48387471|NCT00359021|155614669|FG001|Overall Study|Withdrawal by Subject|9|||
48387472|NCT00359021|155614668|FG000|Overall Study|Lost to Follow-up|1|||
48387473|NCT00359021|155614669|FG001|Overall Study|Lost to Follow-up|0|||
48387474|NCT00359021|155614668|FG000|Overall Study|Other|4|||
48387475|NCT00359021|155614669|FG001|Overall Study|Other|1|||
48387476|NCT00359021|155614668|FG000|Overall Study|Pregnancy|1|||
48387477|NCT00359021|155614669|FG001|Overall Study|Pregnancy|0|||
48387478|NCT02066311|155614670|FG000|Overall Study|Adverse Event|4|||
48762510|NCT02268812|156978141|FG003|Overall Study|Physician Decision|1|||
48387479|NCT02066311|155614670|FG000|Overall Study|Withdrawal by Subject|1|||
48387480|NCT01372150|155614671|FG000|Overall Study|Lack of Efficacy|3|||
48387481|NCT01372150|155614672|FG001|Overall Study|Lack of Efficacy|0|||
48762511|NCT02268812|156978138|FG000|Overall Study|Other|5|||
48762512|NCT02268812|156978139|FG001|Overall Study|Other|4|||
48762513|NCT02268812|156978140|FG002|Overall Study|Other|1|||
48387482|NCT01372150|155614673|FG002|Overall Study|Lack of Efficacy|1|||
48387483|NCT01372150|155614671|FG000|Overall Study|Lost to Follow-up|4|||
48387484|NCT01372150|155614672|FG001|Overall Study|Lost to Follow-up|5|||
48387485|NCT01372150|155614673|FG002|Overall Study|Lost to Follow-up|6|||
48387486|NCT01372150|155614671|FG000|Overall Study|Protocol Violation|1|||
48387487|NCT01372150|155614672|FG001|Overall Study|Protocol Violation|0|||
48387488|NCT01372150|155614673|FG002|Overall Study|Protocol Violation|3|||
48387489|NCT01372150|155614671|FG000|Overall Study|Withdrawal by Subject|2|||
48387490|NCT01372150|155614672|FG001|Overall Study|Withdrawal by Subject|7|||
48387491|NCT01372150|155614673|FG002|Overall Study|Withdrawal by Subject|2|||
48387492|NCT01372150|155614671|FG000|Overall Study|Other|1|||
48387493|NCT01372150|155614672|FG001|Overall Study|Other|0|||
48387494|NCT01372150|155614673|FG002|Overall Study|Other|2|||
48387495|NCT01372150|155614671|FG000|Overall Study|Adverse Event|2|||
48387496|NCT01372150|155614672|FG001|Overall Study|Adverse Event|1|||
48387497|NCT01372150|155614673|FG002|Overall Study|Adverse Event|2|||
48387498|NCT01372150|155614671|FG000|Overall Study|Randomized but not treated|0|||
48387499|NCT01372150|155614672|FG001|Overall Study|Randomized but not treated|1|||
48387500|NCT01372150|155614673|FG002|Overall Study|Randomized but not treated|0|||
48387501|NCT03198520|155614674|FG000|Overall Study|Physician Decision|2|||
48387502|NCT03198520|155614674|FG000|Overall Study|Protocol Violation|2|||
48677401|NCT03472586|156671336|FG000|Overall Study|Death|6|||
48677402|NCT03472586|156671336|FG000|Overall Study|Adverse Event|1|||
48677403|NCT01835223|156671337|FG000|Overall Study|Adverse Event|1|||
48387503|NCT03198520|155614674|FG000|Overall Study|Withdrawal by Subject|1|||
48387504|NCT03198520|155614674|FG000|Overall Study|Study Ended|1|||
48387505|NCT01161043|155614675|FG000|Overall Study|Withdrawal by Subject|3|||
48387506|NCT00454857|155614683|FG000|Overall Study|Withdrawal by Subject|15|||
48387507|NCT00454857|155614683|FG000|Overall Study|Lost to Follow-up|16|||
48387508|NCT00454857|155614683|FG000|Overall Study|Noncompliance|6|||
48387509|NCT00454857|155614683|FG000|Overall Study|Death|5|||
48387510|NCT00454857|155614683|FG000|Overall Study|Other|11|||
48387511|NCT00454857|155614683|FG000|Overall Study|Reason unknown|1|||
48387512|NCT02247960|155614688|FG000|Patient Consent and Randomization|Physician Decision|2|||
48387513|NCT02247960|155614689|FG001|Patient Consent and Randomization|Physician Decision|2|||
48387514|NCT02247960|155614688|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
48387515|NCT02247960|155614689|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
48387516|NCT02247960|155614688|FG000|Catheter Removed|Lost to Follow-up|7|||
48387517|NCT02247960|155614689|FG001|Catheter Removed|Lost to Follow-up|10|||
48387518|NCT01069172|155614693|FG000|Overall Study|Withdrawal by Subject|1|||
48387519|NCT01069172|155614694|FG001|Overall Study|Withdrawal by Subject|0|||
48387520|NCT01621542|155614697|FG000|Overall Study|Adverse Event|0|||
48387521|NCT01621542|155614698|FG001|Overall Study|Adverse Event|0|||
48387522|NCT01621542|155614699|FG002|Overall Study|Adverse Event|1|||
48387523|NCT01621542|155614700|FG003|Overall Study|Adverse Event|3|||
48387524|NCT01621542|155614701|FG004|Overall Study|Adverse Event|0|||
48387525|NCT01621542|155614702|FG005|Overall Study|Adverse Event|0|||
48387526|NCT01621542|155614697|FG000|Overall Study|Death|0|||
48387527|NCT01621542|155614698|FG001|Overall Study|Death|1|||
48387528|NCT01621542|155614699|FG002|Overall Study|Death|0|||
48387529|NCT01621542|155614700|FG003|Overall Study|Death|0|||
48387530|NCT01621542|155614701|FG004|Overall Study|Death|0|||
48387531|NCT01621542|155614702|FG005|Overall Study|Death|0|||
48387532|NCT01621542|155614697|FG000|Overall Study|Physician Decision|1|||
48387533|NCT01621542|155614698|FG001|Overall Study|Physician Decision|0|||
48387534|NCT01621542|155614699|FG002|Overall Study|Physician Decision|1|||
48387535|NCT01621542|155614700|FG003|Overall Study|Physician Decision|13|||
48387536|NCT01621542|155614701|FG004|Overall Study|Physician Decision|3|||
48387537|NCT01621542|155614702|FG005|Overall Study|Physician Decision|1|||
48387538|NCT01621542|155614697|FG000|Overall Study|Withdrawal by Subject|2|||
48387539|NCT01621542|155614698|FG001|Overall Study|Withdrawal by Subject|0|||
48387540|NCT01621542|155614699|FG002|Overall Study|Withdrawal by Subject|1|||
48387541|NCT01621542|155614700|FG003|Overall Study|Withdrawal by Subject|3|||
48387542|NCT01621542|155614701|FG004|Overall Study|Withdrawal by Subject|3|||
48387543|NCT01621542|155614702|FG005|Overall Study|Withdrawal by Subject|3|||
48387544|NCT01621542|155614697|FG000|Overall Study|progression/treatment failure|2|||
48677404|NCT01835223|156671338|FG001|Overall Study|Adverse Event|0|||
48677405|NCT01835223|156671337|FG000|Overall Study|Withdrawal by Subject|2|||
48387545|NCT01621542|155614698|FG001|Overall Study|progression/treatment failure|4|||
48387546|NCT01621542|155614699|FG002|Overall Study|progression/treatment failure|3|||
48387547|NCT01621542|155614700|FG003|Overall Study|progression/treatment failure|7|||
48387548|NCT01621542|155614701|FG004|Overall Study|progression/treatment failure|3|||
48387549|NCT01621542|155614702|FG005|Overall Study|progression/treatment failure|5|||
48387550|NCT01621542|155614697|FG000|Overall Study|Protocol Violation|0|||
48387551|NCT01621542|155614698|FG001|Overall Study|Protocol Violation|0|||
48387552|NCT01621542|155614699|FG002|Overall Study|Protocol Violation|0|||
48387553|NCT01621542|155614700|FG003|Overall Study|Protocol Violation|1|||
48387554|NCT01621542|155614701|FG004|Overall Study|Protocol Violation|0|||
48677406|NCT01835223|156671338|FG001|Overall Study|Withdrawal by Subject|0|||
48387555|NCT01621542|155614702|FG005|Overall Study|Protocol Violation|0|||
48387556|NCT01621542|155614697|FG000|Overall Study|study stopped by sponsor|0|||
48387557|NCT01621542|155614698|FG001|Overall Study|study stopped by sponsor|0|||
48387558|NCT01621542|155614699|FG002|Overall Study|study stopped by sponsor|0|||
48677407|NCT01835223|156671337|FG000|Overall Study|Disease progression|2|||
48677408|NCT01835223|156671338|FG001|Overall Study|Disease progression|1|||
48677409|NCT01835223|156671337|FG000|Overall Study|Became Inelligible|4|||
48677410|NCT01835223|156671338|FG001|Overall Study|Became Inelligible|0|||
48677411|NCT00303485|156671340|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
48677412|NCT00303485|156671341|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
48677413|NCT00303485|156671340|FG000|Overall Study|Failure to return|0|||
48677414|NCT00303485|156671341|FG001|Overall Study|Failure to return|1|||
48677415|NCT00303485|156671340|FG000|Overall Study|Withdrawal by Subject|1|||
48387559|NCT01621542|155614700|FG003|Overall Study|study stopped by sponsor|1|||
48387560|NCT01621542|155614701|FG004|Overall Study|study stopped by sponsor|0|||
48387561|NCT01621542|155614702|FG005|Overall Study|study stopped by sponsor|0|||
48387562|NCT02973087|155614703|FG000|Overall Study|Withdrawal by Subject|2|||
48387563|NCT02973087|155614704|FG001|Overall Study|Withdrawal by Subject|1|||
48387564|NCT02973087|155614703|FG000|Overall Study|Adverse Event|1|||
48387565|NCT02973087|155614704|FG001|Overall Study|Adverse Event|0|||
48387566|NCT02973087|155614703|FG000|Overall Study|other|1|||
48387567|NCT02973087|155614704|FG001|Overall Study|other|1|||
48387568|NCT01536951|155614705|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48387569|NCT01536951|155614706|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48387570|NCT01536951|155614707|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
48387571|NCT01536951|155614708|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48387572|NCT01536951|155614709|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48387573|NCT01536951|155614710|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48387574|NCT01536951|155614711|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48387575|NCT01536951|155614712|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48387576|NCT01536951|155614713|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
48387577|NCT01536951|155614705|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
48387578|NCT01536951|155614706|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
48387579|NCT01536951|155614707|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
48387580|NCT01536951|155614708|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
48387581|NCT01536951|155614709|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
48387582|NCT01536951|155614710|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
48387583|NCT01536951|155614711|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
48387584|NCT01536951|155614712|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
48387585|NCT01536951|155614713|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
48387586|NCT01817751|155614715|FG000|Overall Study|Physician Decision|1|||
48387587|NCT01721876|155614718|FG000|Overall Study|Not treated|1|||
48387588|NCT01721876|155614719|FG001|Overall Study|Not treated|4|||
48387589|NCT01721876|155614718|FG000|Overall Study|Disease progression / relapse|123|||
48387590|NCT01721876|155614719|FG001|Overall Study|Disease progression / relapse|156|||
48387591|NCT01721876|155614718|FG000|Overall Study|Death|6|||
48387592|NCT01721876|155614719|FG001|Overall Study|Death|13|||
48387593|NCT01721876|155614718|FG000|Overall Study|Adverse Event|41|||
48387594|NCT01721876|155614719|FG001|Overall Study|Adverse Event|165|||
48387595|NCT01721876|155614718|FG000|Overall Study|Protocol Violation|2|||
48387596|NCT01721876|155614719|FG001|Overall Study|Protocol Violation|1|||
48387597|NCT01721876|155614718|FG000|Overall Study|Withdrawal by Subject|15|||
48387598|NCT01721876|155614719|FG001|Overall Study|Withdrawal by Subject|38|||
48387599|NCT01721876|155614718|FG000|Overall Study|Reason not listed|34|||
48387600|NCT01721876|155614719|FG001|Overall Study|Reason not listed|63|||
48387601|NCT01721876|155614718|FG000|Overall Study|Sponsor terminated trial|0|||
48387602|NCT01721876|155614719|FG001|Overall Study|Sponsor terminated trial|4|||
48387603|NCT01473563|155614720|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
48387604|NCT00078325|155614721|FG000|Overall Study|Adverse Event|15|||
48387605|NCT00078325|155614722|FG001|Overall Study|Adverse Event|10|||
48387606|NCT00078325|155614723|FG002|Overall Study|Adverse Event|5|||
48387607|NCT00078325|155614721|FG000|Overall Study|Protocol Violation|2|||
48387608|NCT00078325|155614722|FG001|Overall Study|Protocol Violation|2|||
48387609|NCT00078325|155614723|FG002|Overall Study|Protocol Violation|0|||
48387610|NCT00078325|155614721|FG000|Overall Study|Withdrawal by Subject|1|||
48387611|NCT00078325|155614722|FG001|Overall Study|Withdrawal by Subject|5|||
48677416|NCT00303485|156671341|FG001|Overall Study|Withdrawal by Subject|0|||
48387612|NCT00078325|155614723|FG002|Overall Study|Withdrawal by Subject|3|||
48387613|NCT00078325|155614721|FG000|Overall Study|Lost to Follow-up|0|||
48387614|NCT00078325|155614722|FG001|Overall Study|Lost to Follow-up|1|||
48387615|NCT00078325|155614723|FG002|Overall Study|Lost to Follow-up|1|||
48387616|NCT00078325|155614721|FG000|Overall Study|Physician Decision|2|||
48387617|NCT00078325|155614722|FG001|Overall Study|Physician Decision|0|||
48677417|NCT06359080|156671346|FG000|Overall Study|Withdrawal by Subject|3|||
48677418|NCT01378325|156671348|FG000|Overall Study|Protocol Violation|0|||
48677419|NCT01378325|156671349|FG001|Overall Study|Protocol Violation|1|||
48677420|NCT00193180|156671352|FG000|Overall Study|Lack of Efficacy|1|||
48762514|NCT02268812|156978141|FG003|Overall Study|Other|3|||
48762515|NCT00741039|156978142|FG000|Overall Study|Patient non-compliance|2|||
48762516|NCT00741039|156978143|FG001|Overall Study|Patient non-compliance|0|||
48762517|NCT02171260|156978150|FG000|Overall Study|Death|0|||
48762518|NCT02171260|156978151|FG001|Overall Study|Death|0|||
48762519|NCT02171260|156978152|FG002|Overall Study|Death|0|||
48387618|NCT00078325|155614723|FG002|Overall Study|Physician Decision|1|||
48387619|NCT00078325|155614721|FG000|Overall Study|Miscellaneous|1|||
48387620|NCT00078325|155614722|FG001|Overall Study|Miscellaneous|1|||
48387621|NCT00078325|155614723|FG002|Overall Study|Miscellaneous|1|||
48387622|NCT00786565|155614727|FG000|Enrollment Prior to Surgery|Site Closed|3|||
48387623|NCT00786565|155614727|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
48387624|NCT00786565|155614727|FG000|Post Surgery|Abnormal macular pucker|1|||
48387625|NCT00786565|155614727|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
48387626|NCT00578136|155614728|FG000|Overall Study|Not given intervention|1|||
48387627|NCT00578136|155614729|FG001|Overall Study|Not given intervention|1|||
48387628|NCT02047253|155614732|FG000|Overall Study|Lost to Follow-up|8|||
48387629|NCT03805750|155614733|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
48387630|NCT03805750|155614734|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
48387631|NCT01436084|155614737|FG000|Overall Study|Disease Progression|2|||
48387632|NCT01436084|155614737|FG000|Overall Study|Withdrawal by Subject|1|||
48387633|NCT01436084|155614737|FG000|Overall Study|Early Closure of Study|1|||
48387634|NCT00310804|155614738|FG000|Overall Study|Lost to Follow-up|2|||
48387635|NCT00310804|155614739|FG001|Overall Study|Lost to Follow-up|0|||
48387636|NCT00310804|155614738|FG000|Overall Study|Withdrawal by Subject|3|||
48387637|NCT00310804|155614739|FG001|Overall Study|Withdrawal by Subject|0|||
48387638|NCT00688155|155614740|FG000|Overall Study|Withdrawal by Subject|2|||
48387639|NCT00688155|155614741|FG001|Overall Study|Withdrawal by Subject|2|||
48387640|NCT00688155|155614742|FG002|Overall Study|Withdrawal by Subject|1|||
48387641|NCT00688155|155614743|FG003|Overall Study|Withdrawal by Subject|1|||
48387642|NCT02046096|155614744|FG000|Overall Study|Death|28|||
48387643|NCT02046096|155614745|FG001|Overall Study|Death|45|||
48387644|NCT02046096|155614744|FG000|Overall Study|Lost to Follow-up|9|||
48387645|NCT02046096|155614745|FG001|Overall Study|Lost to Follow-up|20|||
48387646|NCT02046096|155614744|FG000|Overall Study|Withdrawal by Subject|5|||
48387647|NCT02046096|155614745|FG001|Overall Study|Withdrawal by Subject|17|||
48387648|NCT02046096|155614744|FG000|Overall Study|Other endpoint|2|||
48387649|NCT02046096|155614745|FG001|Overall Study|Other endpoint|19|||
48677421|NCT00193180|156671352|FG000|Overall Study|Adverse Event|8|||
48677422|NCT00193180|156671352|FG000|Overall Study|Protocol Violation|1|||
48677423|NCT01235234|156671353|FG000|Overall Study|Adverse Event|2|||
48677424|NCT01235234|156671354|FG001|Overall Study|Adverse Event|2|||
48677425|NCT01235234|156671355|FG002|Overall Study|Adverse Event|1|||
48677426|NCT00344500|156671356|FG000|Overall Study|Adverse Event|6|||
48677427|NCT00344500|156671357|FG001|Overall Study|Adverse Event|2|||
48677428|NCT00344500|156671358|FG002|Overall Study|Adverse Event|0|||
48677429|NCT00344500|156671356|FG000|Overall Study|Lost to Follow-up|5|||
48677430|NCT00344500|156671357|FG001|Overall Study|Lost to Follow-up|13|||
48677431|NCT00344500|156671358|FG002|Overall Study|Lost to Follow-up|1|||
48677432|NCT00344500|156671356|FG000|Overall Study|Withdrawal by Subject|7|||
48677433|NCT00344500|156671357|FG001|Overall Study|Withdrawal by Subject|10|||
48677434|NCT00344500|156671358|FG002|Overall Study|Withdrawal by Subject|0|||
48677435|NCT00344500|156671356|FG000|Overall Study|Protocol Violation|4|||
48677436|NCT00344500|156671357|FG001|Overall Study|Protocol Violation|7|||
48677437|NCT00344500|156671358|FG002|Overall Study|Protocol Violation|1|||
48677438|NCT00344500|156671356|FG000|Overall Study|Not Noted|1|||
48677439|NCT00344500|156671357|FG001|Overall Study|Not Noted|3|||
48677440|NCT00344500|156671358|FG002|Overall Study|Not Noted|0|||
48677441|NCT02207491|156671359|FG000|Overall Study|Adverse Event|20|||
48677442|NCT02207491|156671360|FG001|Overall Study|Adverse Event|4|||
48677443|NCT02207491|156671359|FG000|Overall Study|Withdrawal by Subject|3|||
48677444|NCT02207491|156671360|FG001|Overall Study|Withdrawal by Subject|2|||
48677445|NCT02207491|156671359|FG000|Overall Study|Non-compliant|0|||
48677446|NCT02207491|156671360|FG001|Overall Study|Non-compliant|1|||
48677447|NCT02207491|156671359|FG000|Overall Study|Lost to Follow-up|0|||
48677448|NCT02207491|156671360|FG001|Overall Study|Lost to Follow-up|1|||
48677449|NCT02207491|156671359|FG000|Overall Study|Lack of Efficacy|3|||
48677450|NCT02207491|156671360|FG001|Overall Study|Lack of Efficacy|0|||
48677451|NCT02207491|156671359|FG000|Overall Study|Physician Decision|2|||
48677452|NCT02207491|156671360|FG001|Overall Study|Physician Decision|0|||
48762520|NCT02171260|156978153|FG003|Overall Study|Death|1|||
48387650|NCT02090413|155614746|FG000|Overall Study|Adverse Event|11|||
48677453|NCT02207491|156671359|FG000|Overall Study|Protocol Violation|3|||
48762521|NCT02171260|156978150|FG000|Overall Study|Physician Decision|1|||
48762522|NCT02171260|156978151|FG001|Overall Study|Physician Decision|0|||
48677454|NCT02207491|156671360|FG001|Overall Study|Protocol Violation|5|||
48762523|NCT02171260|156978152|FG002|Overall Study|Physician Decision|1|||
48387651|NCT02090413|155614747|FG001|Overall Study|Adverse Event|15|||
48387652|NCT02090413|155614748|FG002|Overall Study|Adverse Event|20|||
48387653|NCT02090413|155614746|FG000|Overall Study|Flushing event|2|||
48387654|NCT02090413|155614747|FG001|Overall Study|Flushing event|0|||
48387655|NCT02090413|155614748|FG002|Overall Study|Flushing event|1|||
48387656|NCT02090413|155614746|FG000|Overall Study|Withdrawal by Subject|2|||
48387657|NCT02090413|155614747|FG001|Overall Study|Withdrawal by Subject|2|||
48387658|NCT02090413|155614748|FG002|Overall Study|Withdrawal by Subject|2|||
48387659|NCT02090413|155614746|FG000|Overall Study|Investigator Decision|1|||
48387660|NCT02090413|155614747|FG001|Overall Study|Investigator Decision|1|||
48387661|NCT02090413|155614748|FG002|Overall Study|Investigator Decision|0|||
48387662|NCT02090413|155614746|FG000|Overall Study|Other|2|||
48387663|NCT02090413|155614747|FG001|Overall Study|Other|1|||
48387664|NCT02090413|155614748|FG002|Overall Study|Other|0|||
48387665|NCT02090413|155614746|FG000|Overall Study|Lost to Follow-up|1|||
48387666|NCT02090413|155614747|FG001|Overall Study|Lost to Follow-up|1|||
48387667|NCT02090413|155614748|FG002|Overall Study|Lost to Follow-up|0|||
48387668|NCT00121108|155614752|FG000|Overall Study|Lost to Follow-up|10|||
48387669|NCT00121108|155614753|FG001|Overall Study|Lost to Follow-up|22|||
48387670|NCT00121108|155614752|FG000|Overall Study|Withdrawal by Subject|106|||
48387671|NCT00121108|155614753|FG001|Overall Study|Withdrawal by Subject|195|||
48387672|NCT00121108|155614752|FG000|Overall Study|Death|5|||
48387673|NCT00121108|155614753|FG001|Overall Study|Death|8|||
48387674|NCT00102960|155614757|FG000|Overall Study|Death|23|||
48387675|NCT00102960|155614758|FG001|Overall Study|Death|11|||
48387676|NCT00102960|155614759|FG002|Overall Study|Death|11|||
48387677|NCT00102960|155614757|FG000|Overall Study|Lost to Follow-up|6|||
48387678|NCT00102960|155614758|FG001|Overall Study|Lost to Follow-up|12|||
48387679|NCT00102960|155614759|FG002|Overall Study|Lost to Follow-up|16|||
48387680|NCT00102960|155614757|FG000|Overall Study|Withdrawal by Subject|1|||
48387681|NCT00102960|155614758|FG001|Overall Study|Withdrawal by Subject|0|||
48387682|NCT00102960|155614759|FG002|Overall Study|Withdrawal by Subject|1|||
48387683|NCT00766090|155615975|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387684|NCT00766090|155615976|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387685|NCT00766090|155615977|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387686|NCT00766090|155615978|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387687|NCT00766090|155615979|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387688|NCT00766090|155615980|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387689|NCT00766090|155615981|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387690|NCT00766090|155615982|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387691|NCT00766090|155615983|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
48387692|NCT00766090|155615984|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387693|NCT00766090|155615985|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387694|NCT00766090|155615986|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
48387695|NCT00766090|155615975|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
48387696|NCT00766090|155615976|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387697|NCT00766090|155615977|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387698|NCT00766090|155615978|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387699|NCT00766090|155615979|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387700|NCT00766090|155615980|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387701|NCT00766090|155615981|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387702|NCT00766090|155615982|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387703|NCT00766090|155615983|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387704|NCT00766090|155615984|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387705|NCT00766090|155615985|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387706|NCT00766090|155615986|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
48387707|NCT00766090|155615975|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48387708|NCT00766090|155615976|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387709|NCT00766090|155615977|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387710|NCT00766090|155615978|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
48387711|NCT00766090|155615979|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387712|NCT00766090|155615980|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387713|NCT00766090|155615981|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387714|NCT00766090|155615982|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387715|NCT00766090|155615983|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387716|NCT00766090|155615984|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387717|NCT00766090|155615985|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387718|NCT00766090|155615986|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
48387719|NCT00766090|155615975|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387720|NCT00766090|155615976|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387721|NCT00766090|155615977|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
48387722|NCT00766090|155615978|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387723|NCT00766090|155615979|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387724|NCT00766090|155615980|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
48677455|NCT00539305|156671361|FG000|Overall Study|Adverse Event|1|||
48677456|NCT00539305|156671362|FG001|Overall Study|Adverse Event|0|||
48677457|NCT00539305|156671361|FG000|Overall Study|Substance Use|0|||
48762524|NCT02171260|156978153|FG003|Overall Study|Physician Decision|0|||
48762525|NCT02171260|156978150|FG000|Overall Study|Withdrawal by Subject|1|||
48387725|NCT00766090|155615981|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387726|NCT00766090|155615982|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387727|NCT00766090|155615983|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387728|NCT00766090|155615984|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387729|NCT00766090|155615985|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
48387730|NCT00766090|155615986|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
48677458|NCT00539305|156671362|FG001|Overall Study|Substance Use|1|||
48677459|NCT00539305|156671361|FG000|Overall Study|Withdrawal by Subject|0|||
48387731|NCT00766090|155615975|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387732|NCT00766090|155615976|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387733|NCT00766090|155615977|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387734|NCT00766090|155615978|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387735|NCT00766090|155615979|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
48387736|NCT00766090|155615980|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387737|NCT00766090|155615981|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387738|NCT00766090|155615982|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387739|NCT00766090|155615983|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387740|NCT00766090|155615984|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387741|NCT00766090|155615985|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387742|NCT00766090|155615986|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
48387743|NCT00766090|155615975|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387744|NCT00766090|155615976|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387745|NCT00766090|155615977|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
48387746|NCT00766090|155615978|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387747|NCT00766090|155615979|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387748|NCT00766090|155615980|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387749|NCT00766090|155615981|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387750|NCT00766090|155615982|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387751|NCT00766090|155615983|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387752|NCT00766090|155615984|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387753|NCT00766090|155615985|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387754|NCT00766090|155615986|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
48387755|NCT00766090|155615975|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
48387756|NCT00766090|155615976|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
48387757|NCT00766090|155615977|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
48387758|NCT00766090|155615978|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
48387759|NCT00766090|155615979|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
48387760|NCT00766090|155615980|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
48387761|NCT00766090|155615981|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
48387762|NCT00766090|155615982|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
48387763|NCT00766090|155615983|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
48387764|NCT00766090|155615984|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
48387765|NCT00766090|155615985|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
48387766|NCT00766090|155615986|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
48387767|NCT00766090|155615975|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387768|NCT00766090|155615976|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387769|NCT00766090|155615977|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387770|NCT00766090|155615978|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48677460|NCT00539305|156671362|FG001|Overall Study|Withdrawal by Subject|1|||
48677461|NCT00711971|156671363|FG000|Overall Study|Lost to Follow-up|3|||
48677462|NCT00711971|156671364|FG001|Overall Study|Lost to Follow-up|4|||
48677463|NCT00711971|156671365|FG002|Overall Study|Lost to Follow-up|1|||
48677464|NCT00126776|156671368|FG000|Overall Study|follow up complete on all patients|0|||
48677465|NCT00126776|156671369|FG001|Overall Study|follow up complete on all patients|0|||
48677466|NCT00599755|156671370|FG000|Overall Study|Adverse Event|11|||
48677467|NCT00599755|156671370|FG000|Overall Study|Withdrawal by Subject|2|||
48677468|NCT00599755|156671370|FG000|Overall Study|Progression of Disease|3|||
48677469|NCT00599755|156671370|FG000|Overall Study|Other Reason|2|||
48762526|NCT02171260|156978151|FG001|Overall Study|Withdrawal by Subject|0|||
48762527|NCT02171260|156978152|FG002|Overall Study|Withdrawal by Subject|0|||
48387771|NCT00766090|155615979|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387772|NCT00766090|155615980|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
48762528|NCT02171260|156978153|FG003|Overall Study|Withdrawal by Subject|0|||
48387773|NCT00766090|155615981|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387774|NCT00766090|155615982|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387775|NCT00766090|155615983|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387776|NCT00766090|155615984|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387777|NCT00766090|155615985|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387778|NCT00766090|155615986|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
48387779|NCT00766090|155615975|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387780|NCT00766090|155615976|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
48387781|NCT00766090|155615977|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387782|NCT00766090|155615978|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
48387783|NCT00766090|155615979|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387784|NCT00766090|155615980|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387785|NCT00766090|155615981|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387786|NCT00766090|155615982|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387787|NCT00766090|155615983|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387788|NCT00766090|155615984|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387789|NCT00766090|155615985|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
48387790|NCT00766090|155615986|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
48387791|NCT00766090|155615975|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387792|NCT00766090|155615976|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387793|NCT00766090|155615977|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387794|NCT00766090|155615978|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387795|NCT00766090|155615979|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
48387796|NCT00766090|155615980|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387797|NCT00766090|155615981|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387798|NCT00766090|155615982|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387799|NCT00766090|155615983|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387800|NCT00766090|155615984|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387801|NCT00766090|155615985|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387802|NCT00766090|155615986|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
48387803|NCT00113074|155615987|FG000|Overall Study|Lost to Follow-up|10|||
48387804|NCT00113074|155615988|FG001|Overall Study|Lost to Follow-up|10|||
48387805|NCT00113074|155615989|FG002|Overall Study|Lost to Follow-up|14|||
48387806|NCT02409290|155615997|FG000|Overall Study|Protocol Violation|3|||
48387807|NCT02409290|155615998|FG001|Overall Study|Protocol Violation|6|||
48387808|NCT02409290|155615999|FG002|Overall Study|Protocol Violation|9|||
48387809|NCT02409290|155616000|FG003|Overall Study|Protocol Violation|4|||
48387810|NCT02409290|155615997|FG000|Overall Study|No positive culture/no baseline sample|3|||
48387811|NCT02409290|155615998|FG001|Overall Study|No positive culture/no baseline sample|9|||
48387812|NCT02409290|155615999|FG002|Overall Study|No positive culture/no baseline sample|6|||
48387813|NCT02409290|155616000|FG003|Overall Study|No positive culture/no baseline sample|5|||
48387814|NCT02409290|155615997|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
48387815|NCT02409290|155615998|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
48387816|NCT02409290|155615999|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
48387817|NCT02409290|155616000|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
48387818|NCT03625687|155616001|FG000|Overall Study|Death|1|||
48387819|NCT00888381|155616004|FG000|Overall Study|Lost to Follow-up|0|||
48387820|NCT00888381|155616005|FG001|Overall Study|Lost to Follow-up|1|||
48387821|NCT00097773|155616006|FG000|Overall Study|Lost to Follow-up|2|||
48387822|NCT00097773|155616007|FG001|Overall Study|Lost to Follow-up|2|||
48387823|NCT00097773|155616008|FG002|Overall Study|Lost to Follow-up|0|||
48387824|NCT00097773|155616009|FG003|Overall Study|Lost to Follow-up|1|||
48677470|NCT00599755|156671370|FG000|Overall Study|No data available|1|||
48677471|NCT01393639|156671371|FG000|Overall Study|Protocol Violation|0|||
48677472|NCT01393639|156671372|FG001|Overall Study|Protocol Violation|0|||
48677473|NCT01393639|156671373|FG002|Overall Study|Protocol Violation|0|||
48677474|NCT01393639|156671374|FG003|Overall Study|Protocol Violation|1|||
48677475|NCT01393639|156671375|FG004|Overall Study|Protocol Violation|0|||
48387825|NCT00097773|155616006|FG000|Overall Study|Physician Decision|2|||
48677476|NCT01393639|156671376|FG005|Overall Study|Protocol Violation|0|||
48387826|NCT00097773|155616007|FG001|Overall Study|Physician Decision|2|||
48387827|NCT00097773|155616008|FG002|Overall Study|Physician Decision|3|||
48677477|NCT01393639|156671377|FG006|Overall Study|Protocol Violation|0|||
48677478|NCT01393639|156671371|FG000|Overall Study|Other|0|||
48677479|NCT01393639|156671372|FG001|Overall Study|Other|2|||
48677480|NCT01393639|156671373|FG002|Overall Study|Other|0|||
48677481|NCT01393639|156671374|FG003|Overall Study|Other|2|||
48677482|NCT01393639|156671375|FG004|Overall Study|Other|1|||
48677483|NCT01393639|156671376|FG005|Overall Study|Other|0|||
48677484|NCT01393639|156671377|FG006|Overall Study|Other|1|||
48677485|NCT01393639|156671371|FG000|Overall Study|Withdrawal by Subject|1|||
48677486|NCT01393639|156671372|FG001|Overall Study|Withdrawal by Subject|1|||
48677487|NCT01393639|156671373|FG002|Overall Study|Withdrawal by Subject|0|||
48677488|NCT01393639|156671374|FG003|Overall Study|Withdrawal by Subject|0|||
48387828|NCT00097773|155616009|FG003|Overall Study|Physician Decision|1|||
48677489|NCT01393639|156671375|FG004|Overall Study|Withdrawal by Subject|0|||
48677490|NCT01393639|156671376|FG005|Overall Study|Withdrawal by Subject|0|||
48677491|NCT01393639|156671377|FG006|Overall Study|Withdrawal by Subject|1|||
48677492|NCT01393639|156671371|FG000|Overall Study|Medication error without associated AE|0|||
48677493|NCT01393639|156671372|FG001|Overall Study|Medication error without associated AE|0|||
48677494|NCT01393639|156671373|FG002|Overall Study|Medication error without associated AE|0|||
48677495|NCT01393639|156671374|FG003|Overall Study|Medication error without associated AE|0|||
48677496|NCT01393639|156671375|FG004|Overall Study|Medication error without associated AE|0|||
48677497|NCT01393639|156671376|FG005|Overall Study|Medication error without associated AE|0|||
48677498|NCT01393639|156671377|FG006|Overall Study|Medication error without associated AE|1|||
48677499|NCT01393639|156671371|FG000|Overall Study|Lost to Follow-up|0|||
48677500|NCT01393639|156671372|FG001|Overall Study|Lost to Follow-up|1|||
48677501|NCT01393639|156671373|FG002|Overall Study|Lost to Follow-up|0|||
48677502|NCT01393639|156671374|FG003|Overall Study|Lost to Follow-up|0|||
48677503|NCT01393639|156671375|FG004|Overall Study|Lost to Follow-up|0|||
48677504|NCT01393639|156671376|FG005|Overall Study|Lost to Follow-up|0|||
48677505|NCT01393639|156671377|FG006|Overall Study|Lost to Follow-up|1|||
48677506|NCT01393639|156671371|FG000|Overall Study|Lack of Efficacy|0|||
48677507|NCT01393639|156671372|FG001|Overall Study|Lack of Efficacy|0|||
48677508|NCT01393639|156671373|FG002|Overall Study|Lack of Efficacy|0|||
48677509|NCT01393639|156671374|FG003|Overall Study|Lack of Efficacy|0|||
48677510|NCT01393639|156671375|FG004|Overall Study|Lack of Efficacy|0|||
48677511|NCT01393639|156671376|FG005|Overall Study|Lack of Efficacy|0|||
48677512|NCT01393639|156671377|FG006|Overall Study|Lack of Efficacy|1|||
48677513|NCT01393639|156671371|FG000|Overall Study|Adverse Event|2|||
48677514|NCT01393639|156671372|FG001|Overall Study|Adverse Event|3|||
48677515|NCT01393639|156671373|FG002|Overall Study|Adverse Event|1|||
48677516|NCT01393639|156671374|FG003|Overall Study|Adverse Event|2|||
48677517|NCT01393639|156671375|FG004|Overall Study|Adverse Event|0|||
48677518|NCT01393639|156671376|FG005|Overall Study|Adverse Event|2|||
48762529|NCT02171260|156978150|FG000|Overall Study|Evidence of progressive disease|4|||
48762530|NCT02171260|156978151|FG001|Overall Study|Evidence of progressive disease|6|||
48762531|NCT02171260|156978152|FG002|Overall Study|Evidence of progressive disease|4|||
48762532|NCT02171260|156978153|FG003|Overall Study|Evidence of progressive disease|4|||
48762533|NCT03886220|156978154|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
48762534|NCT03886220|156978155|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
48762535|NCT03886220|156978154|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
48762536|NCT03886220|156978155|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48762537|NCT03886220|156978154|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
48762538|NCT03886220|156978155|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
48762539|NCT01523886|156978161|FG000|Overall Study|surgery cancelled|0|||
48762540|NCT01523886|156978162|FG001|Overall Study|surgery cancelled|1|||
48762541|NCT00858442|156980201|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
48762542|NCT00858442|156980202|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
48762543|NCT02734810|156980205|FG000|Overall Study|Adverse Event|1|||
48762544|NCT02734810|156980206|FG001|Overall Study|Adverse Event|0|||
48762545|NCT02734810|156980205|FG000|Overall Study|Lack of Efficacy|1|||
48762546|NCT02734810|156980206|FG001|Overall Study|Lack of Efficacy|0|||
48762547|NCT00127712|156980210|FG000|Overall Study|Adverse Event|3|||
48762548|NCT00127712|156980211|FG001|Overall Study|Adverse Event|0|||
48762549|NCT00127712|156980210|FG000|Overall Study|Lack of GI access to continue|2|||
48762550|NCT00127712|156980211|FG001|Overall Study|Lack of GI access to continue|0|||
48762551|NCT00903617|156980212|FG000|Overall Study|Adverse Event|0|||
48762552|NCT00903617|156980213|FG001|Overall Study|Adverse Event|1|||
48762553|NCT00903617|156980214|FG002|Overall Study|Adverse Event|1|||
48762554|NCT00903617|156980215|FG003|Overall Study|Adverse Event|0|||
48762555|NCT00903617|156980212|FG000|Overall Study|Protocol-defined stopping criteria|0|||
48762556|NCT00903617|156980213|FG001|Overall Study|Protocol-defined stopping criteria|2|||
48762557|NCT00903617|156980214|FG002|Overall Study|Protocol-defined stopping criteria|0|||
48762558|NCT00903617|156980215|FG003|Overall Study|Protocol-defined stopping criteria|0|||
48762559|NCT00903617|156980212|FG000|Overall Study|Lost to Follow-up|2|||
48762560|NCT00903617|156980213|FG001|Overall Study|Lost to Follow-up|0|||
48677519|NCT01393639|156671377|FG006|Overall Study|Adverse Event|3|||
48677520|NCT00793325|156671378|FG000|Overall Study|Protocol Violation|18|||
48677521|NCT00793325|156671378|FG000|Overall Study|Lost to Follow-up|1|||
48677522|NCT00856544|156671379|FG000|Overall Study|Randomized but not treated|3|||
48677523|NCT00856544|156671380|FG001|Overall Study|Randomized but not treated|0|||
48762561|NCT00903617|156980214|FG002|Overall Study|Lost to Follow-up|1|||
48762562|NCT00903617|156980215|FG003|Overall Study|Lost to Follow-up|1|||
48762563|NCT00903617|156980212|FG000|Overall Study|Withdrawal by Subject|1|||
48762564|NCT00903617|156980213|FG001|Overall Study|Withdrawal by Subject|2|||
48762565|NCT00903617|156980214|FG002|Overall Study|Withdrawal by Subject|3|||
48677524|NCT00856544|156671381|FG002|Overall Study|Randomized but not treated|0|||
48677525|NCT00856544|156671382|FG003|Overall Study|Randomized but not treated|0|||
48387829|NCT00097773|155616006|FG000|Overall Study|Withdrawal by Subject|3|||
48387830|NCT00097773|155616007|FG001|Overall Study|Withdrawal by Subject|3|||
48387831|NCT00097773|155616008|FG002|Overall Study|Withdrawal by Subject|3|||
48387832|NCT00097773|155616009|FG003|Overall Study|Withdrawal by Subject|1|||
48387833|NCT00097773|155616006|FG000|Overall Study|Adverse Event|0|||
48387834|NCT00097773|155616007|FG001|Overall Study|Adverse Event|1|||
48387835|NCT00097773|155616008|FG002|Overall Study|Adverse Event|0|||
48387836|NCT00097773|155616009|FG003|Overall Study|Adverse Event|0|||
48387837|NCT00097773|155616006|FG000|Overall Study|Other|1|||
48387838|NCT00097773|155616007|FG001|Overall Study|Other|0|||
48387839|NCT00097773|155616008|FG002|Overall Study|Other|2|||
48387840|NCT00097773|155616009|FG003|Overall Study|Other|0|||
48387841|NCT00003702|155616010|FG000|Overall Study|Ineligible cell types|2|||
48387842|NCT00003702|155616011|FG001|Overall Study|Ineligible cell types|2|||
48387843|NCT00003702|155616010|FG000|Overall Study|Did not meet criteria for persistence|8|||
48387844|NCT00003702|155616011|FG001|Overall Study|Did not meet criteria for persistence|5|||
48387845|NCT00003702|155616010|FG000|Overall Study|WHO score > 6|2|||
48387846|NCT00003702|155616011|FG001|Overall Study|WHO score > 6|1|||
48387847|NCT00003702|155616010|FG000|Overall Study|Inadequate documentation of disease|1|||
48387848|NCT00003702|155616011|FG001|Overall Study|Inadequate documentation of disease|3|||
48387849|NCT00733954|155616012|FG000|Overall Study|Lost to Follow-up|5|||
48387850|NCT00733954|155616013|FG001|Overall Study|Lost to Follow-up|2|||
48387851|NCT00733954|155616012|FG000|Overall Study|Protocol Violation|1|||
48387852|NCT00733954|155616013|FG001|Overall Study|Protocol Violation|0|||
48387853|NCT00733954|155616012|FG000|Overall Study|Withdrawal by Subject|2|||
48387854|NCT00733954|155616013|FG001|Overall Study|Withdrawal by Subject|0|||
48387855|NCT00843518|155616014|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
48387856|NCT00843518|155616015|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
48387857|NCT00843518|155616014|FG000|Period 2 (Double-blind Treatment)|Death|0|||
48387858|NCT00843518|155616015|FG001|Period 2 (Double-blind Treatment)|Death|1|||
48387859|NCT00843518|155616014|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
48387860|NCT00843518|155616015|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
48387861|NCT00843518|155616014|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
48387862|NCT00843518|155616015|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
48387863|NCT00843518|155616014|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
48387864|NCT00843518|155616015|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
48387865|NCT00843518|155616014|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
48387866|NCT00843518|155616015|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
48387867|NCT00843518|155616014|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
48387868|NCT00843518|155616015|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
48387869|NCT01226459|155616020|FG000|Overall Study|Adverse Event|2|||
48387870|NCT01226459|155616021|FG001|Overall Study|Adverse Event|8|||
48387871|NCT01226459|155616020|FG000|Overall Study|Protocol Violation|4|||
48387872|NCT01226459|155616021|FG001|Overall Study|Protocol Violation|3|||
48387873|NCT01226459|155616020|FG000|Overall Study|Withdrawal by Subject|10|||
48387874|NCT01226459|155616021|FG001|Overall Study|Withdrawal by Subject|13|||
48387875|NCT01226459|155616020|FG000|Overall Study|Lost to Follow-up|4|||
48387876|NCT01226459|155616021|FG001|Overall Study|Lost to Follow-up|8|||
48387877|NCT01226459|155616020|FG000|Overall Study|Pregnancy|1|||
48387878|NCT01226459|155616021|FG001|Overall Study|Pregnancy|0|||
48387879|NCT00804570|155616027|FG000|Overall Study|Adverse Event|14|||
48387880|NCT00804570|155616028|FG001|Overall Study|Adverse Event|7|||
48387881|NCT00804570|155616027|FG000|Overall Study|Lack of Efficacy|0|||
48387882|NCT00804570|155616028|FG001|Overall Study|Lack of Efficacy|1|||
48387883|NCT00804570|155616027|FG000|Overall Study|Lost to Follow-up|18|||
48387884|NCT00804570|155616028|FG001|Overall Study|Lost to Follow-up|21|||
48387885|NCT00804570|155616027|FG000|Overall Study|Entry criteria not met|5|||
48387886|NCT00804570|155616028|FG001|Overall Study|Entry criteria not met|5|||
48387887|NCT00804570|155616027|FG000|Overall Study|Protocol Violation|12|||
48387888|NCT00804570|155616028|FG001|Overall Study|Protocol Violation|16|||
48387889|NCT00804570|155616027|FG000|Overall Study|Physician Decision|1|||
48387890|NCT00804570|155616028|FG001|Overall Study|Physician Decision|2|||
48387891|NCT00804570|155616027|FG000|Overall Study|Sponsor decision|1|||
48387892|NCT00804570|155616028|FG001|Overall Study|Sponsor decision|4|||
48387893|NCT00804570|155616027|FG000|Overall Study|Withdrawal by Subject|21|||
48387894|NCT00804570|155616028|FG001|Overall Study|Withdrawal by Subject|38|||
48762566|NCT00903617|156980215|FG003|Overall Study|Withdrawal by Subject|0|||
48387895|NCT03451084|155616036|FG000|Overall Study|Withdrawal by Subject|2|||
48387896|NCT03451084|155616037|FG001|Overall Study|Withdrawal by Subject|1|||
48387897|NCT03451084|155616038|FG002|Overall Study|Withdrawal by Subject|2|||
48387898|NCT03451084|155616039|FG003|Overall Study|Withdrawal by Subject|1|||
48387899|NCT03451084|155616036|FG000|Overall Study|Disease recurrence|0|||
48387900|NCT03451084|155616037|FG001|Overall Study|Disease recurrence|2|||
48387901|NCT03451084|155616038|FG002|Overall Study|Disease recurrence|0|||
48387902|NCT03451084|155616039|FG003|Overall Study|Disease recurrence|0|||
48387903|NCT03451084|155616036|FG000|Overall Study|Lack of Efficacy|0|||
48387904|NCT03451084|155616037|FG001|Overall Study|Lack of Efficacy|3|||
48387905|NCT03451084|155616038|FG002|Overall Study|Lack of Efficacy|0|||
48387906|NCT03451084|155616039|FG003|Overall Study|Lack of Efficacy|1|||
48387907|NCT03451084|155616036|FG000|Overall Study|Death|1|||
48387908|NCT03451084|155616037|FG001|Overall Study|Death|0|||
48387909|NCT03451084|155616038|FG002|Overall Study|Death|2|||
48387910|NCT03451084|155616039|FG003|Overall Study|Death|0|||
48387911|NCT03451084|155616036|FG000|Overall Study|Physician Decision|0|||
48387912|NCT03451084|155616037|FG001|Overall Study|Physician Decision|0|||
48387913|NCT03451084|155616038|FG002|Overall Study|Physician Decision|2|||
48387914|NCT03451084|155616039|FG003|Overall Study|Physician Decision|2|||
48387915|NCT03451084|155616036|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
48387916|NCT03451084|155616037|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
48387917|NCT03451084|155616038|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
48387918|NCT03451084|155616039|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
48387919|NCT01301950|155616046|FG000|Overall Study|Surgery was cancelled by patient|0|||
48387920|NCT01301950|155616047|FG001|Overall Study|Surgery was cancelled by patient|1|||
48387921|NCT02016820|155616048|FG000|Overall Study|Lost to Follow-up|2|||
48387922|NCT02016820|155616049|FG001|Overall Study|Lost to Follow-up|4|||
48387923|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
48387924|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
48387925|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
48387926|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
48387927|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
48387928|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
48387929|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
48387930|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
48387931|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
48387932|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
48387933|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
48387934|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
48387935|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
48387936|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
48387937|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
48387938|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
48387939|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
48677526|NCT00856544|156671379|FG000|Overall Study|Death|0|||
48387940|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
48387941|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
48387942|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
48387943|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
48387944|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
48387945|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
48387946|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
48387947|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Death|2|||
48387948|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Death|1|||
48387949|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Death|0|||
48387950|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Death|0|||
48387951|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
48387952|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
48387953|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
48677527|NCT00856544|156671380|FG001|Overall Study|Death|2|||
48677528|NCT00856544|156671381|FG002|Overall Study|Death|0|||
48387954|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
48387955|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
48387956|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
48387957|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
48387958|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
48387959|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
48387960|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
48387961|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
48387962|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
48387963|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
48387964|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
48677529|NCT00856544|156671382|FG003|Overall Study|Death|0|||
48387965|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
48387966|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
48387967|NCT01940471|155616050|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
48387968|NCT01940471|155616051|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
48387969|NCT01940471|155616052|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
48677530|NCT00856544|156671379|FG000|Overall Study|Adverse Event|20|||
48387970|NCT01940471|155616053|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
48387971|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
48387972|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
48387973|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
48387974|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
48387975|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
48387976|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
48387977|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
48387978|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
48387979|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
48387980|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
48387981|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
48387982|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
48387983|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
48387984|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
48387985|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
48387986|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
48387987|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
48387988|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
48387989|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
48387990|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
48387991|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
48387992|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
48387993|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
48387994|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
48387995|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48387996|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48387997|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
48387998|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
48387999|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
48388000|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
48388001|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
48388002|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
48388003|NCT01940471|155616050|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48388004|NCT01940471|155616051|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48388005|NCT01940471|155616052|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
48388006|NCT01940471|155616053|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
48388007|NCT01378104|155616056|FG000|Overall Study|Adverse Event|8|||
48388008|NCT01378104|155616057|FG001|Overall Study|Adverse Event|8|||
48388009|NCT01378104|155616056|FG000|Overall Study|Lack of Efficacy|7|||
48388010|NCT01378104|155616057|FG001|Overall Study|Lack of Efficacy|5|||
48388011|NCT01378104|155616056|FG000|Overall Study|Withdrawal by Subject|12|||
48388012|NCT01378104|155616057|FG001|Overall Study|Withdrawal by Subject|13|||
48388013|NCT00455013|155616058|FG000|Short Term Period|Adverse Event|2|||
48388014|NCT00455013|155616059|FG001|Short Term Period|Adverse Event|5|||
48388015|NCT00455013|155616060|FG002|Short Term Period|Adverse Event|0|||
48388016|NCT00455013|155616058|FG000|Short Term Period|Withdrawal by Subject|0|||
48388017|NCT00455013|155616059|FG001|Short Term Period|Withdrawal by Subject|0|||
48388018|NCT00455013|155616060|FG002|Short Term Period|Withdrawal by Subject|1|||
48388019|NCT00455013|155616058|FG000|Short Term Period|Lack of Efficacy|4|||
48388020|NCT00455013|155616059|FG001|Short Term Period|Lack of Efficacy|0|||
48388021|NCT00455013|155616060|FG002|Short Term Period|Lack of Efficacy|0|||
48388022|NCT00455013|155616058|FG000|Short Term Period|Other|0|||
48388023|NCT00455013|155616059|FG001|Short Term Period|Other|0|||
48388024|NCT00455013|155616060|FG002|Short Term Period|Other|1|||
48388025|NCT00455013|155616058|FG000|Long Term Extension (LTE)|Adverse Event|0|||
48388026|NCT00455013|155616059|FG001|Long Term Extension (LTE)|Adverse Event|1|||
48388027|NCT00455013|155616060|FG002|Long Term Extension (LTE)|Adverse Event|1|||
48677531|NCT00856544|156671380|FG001|Overall Study|Adverse Event|29|||
48677532|NCT00856544|156671381|FG002|Overall Study|Adverse Event|2|||
48677533|NCT00856544|156671382|FG003|Overall Study|Adverse Event|3|||
48388028|NCT00455013|155616058|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
48677534|NCT00856544|156671379|FG000|Overall Study|Lack of Efficacy|16|||
48388029|NCT00455013|155616059|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
48388030|NCT00455013|155616060|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
48388031|NCT00455013|155616058|FG000|Long Term Extension (LTE)|Death|1|||
48388032|NCT00455013|155616059|FG001|Long Term Extension (LTE)|Death|1|||
48388033|NCT00455013|155616060|FG002|Long Term Extension (LTE)|Death|0|||
48677535|NCT00856544|156671380|FG001|Overall Study|Lack of Efficacy|12|||
48677536|NCT00856544|156671381|FG002|Overall Study|Lack of Efficacy|3|||
48677537|NCT00856544|156671382|FG003|Overall Study|Lack of Efficacy|3|||
48677538|NCT00856544|156671379|FG000|Overall Study|Other|9|||
48677539|NCT00856544|156671380|FG001|Overall Study|Other|16|||
48677540|NCT00856544|156671381|FG002|Overall Study|Other|1|||
48677541|NCT00856544|156671382|FG003|Overall Study|Other|6|||
48677542|NCT00856544|156671379|FG000|Overall Study|Lost to Follow-up|1|||
48762567|NCT01706003|156980218|FG000|Overall Study|Withdrawal by Subject|2|||
48677543|NCT00856544|156671380|FG001|Overall Study|Lost to Follow-up|2|||
48677544|NCT00856544|156671381|FG002|Overall Study|Lost to Follow-up|2|||
48677545|NCT00856544|156671382|FG003|Overall Study|Lost to Follow-up|0|||
48677546|NCT00856544|156671379|FG000|Overall Study|Withdrawal by Subject|8|||
48677547|NCT00856544|156671380|FG001|Overall Study|Withdrawal by Subject|5|||
48677548|NCT00856544|156671381|FG002|Overall Study|Withdrawal by Subject|0|||
48677549|NCT00856544|156671382|FG003|Overall Study|Withdrawal by Subject|1|||
48677550|NCT02462720|156671383|FG000|Part 2|Withdrawal by Subject|1|||
48677551|NCT02462720|156671384|FG001|Part 2|Withdrawal by Subject|0|||
48677552|NCT02462720|156671383|FG000|Part 2|Protocol Violation|0|||
48677553|NCT02462720|156671384|FG001|Part 2|Protocol Violation|1|||
48677554|NCT03282097|156671385|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
48677555|NCT03282097|156671386|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
48677556|NCT03282097|156671385|FG000|Intervention Visit Complete|Patient Death|13|||
48677557|NCT03282097|156671386|FG001|Intervention Visit Complete|Patient Death|15|||
48762568|NCT01706003|156980219|FG001|Overall Study|Withdrawal by Subject|0|||
48762569|NCT01706003|156980218|FG000|Overall Study|Not scheduled|3|||
48762570|NCT01706003|156980219|FG001|Overall Study|Not scheduled|0|||
48762571|NCT01706003|156980218|FG000|Overall Study|Lost to Follow-up|6|||
48762572|NCT01706003|156980219|FG001|Overall Study|Lost to Follow-up|4|||
48762573|NCT00407563|156980220|FG000|Overall Study|Patient continues on treatment|1|||
48762574|NCT02356783|156980221|FG000|Overall Study|Lost to Follow-up|1|||
48762575|NCT02356783|156980222|FG001|Overall Study|Lost to Follow-up|3|||
48762576|NCT01853046|156980223|FG000|Overall Study|Withdrawal by Subject|1|||
48762577|NCT01853046|156980224|FG001|Overall Study|Withdrawal by Subject|1|||
48762578|NCT01853046|156980223|FG000|Overall Study|Adverse Event|4|||
48762579|NCT01853046|156980224|FG001|Overall Study|Adverse Event|2|||
48762580|NCT01853046|156980223|FG000|Overall Study|Disease progression|13|||
48762581|NCT01853046|156980224|FG001|Overall Study|Disease progression|3|||
48762582|NCT00192504|156980227|FG000|Overall Study|Lost to Follow-up|1|||
48762583|NCT00192504|156980228|FG001|Overall Study|Lost to Follow-up|0|||
48762584|NCT00192504|156980229|FG002|Overall Study|Lost to Follow-up|0|||
48762585|NCT00192504|156980230|FG003|Overall Study|Lost to Follow-up|0|||
48762586|NCT00192504|156980227|FG000|Overall Study|Dosing window missed|0|||
48762587|NCT00192504|156980228|FG001|Overall Study|Dosing window missed|0|||
48762588|NCT00192504|156980229|FG002|Overall Study|Dosing window missed|1|||
48762589|NCT00192504|156980230|FG003|Overall Study|Dosing window missed|0|||
48762590|NCT05333900|156980231|FG000|Overall Study|Protocol Violation|0|||
48762591|NCT05333900|156980232|FG001|Overall Study|Protocol Violation|1|||
48762592|NCT05333900|156980231|FG000|Overall Study|Withdrawal by Subject|0|||
48762593|NCT05333900|156980232|FG001|Overall Study|Withdrawal by Subject|1|||
48762594|NCT05333900|156980231|FG000|Overall Study|COVID-19 Pandemic|1|||
48762595|NCT05333900|156980232|FG001|Overall Study|COVID-19 Pandemic|1|||
48762596|NCT02385266|156980233|FG000|Overall Study|Withdrawal by Subject|1|||
48762597|NCT02385266|156980234|FG001|Overall Study|Withdrawal by Subject|3|||
48762598|NCT00265343|156980235|FG000|Overall Study|Adverse Event|10|||
48762599|NCT00265343|156980236|FG001|Overall Study|Adverse Event|7|||
48762600|NCT00265343|156980235|FG000|Overall Study|Withdrawal by Subject|3|||
48762601|NCT00265343|156980236|FG001|Overall Study|Withdrawal by Subject|9|||
48762602|NCT00265343|156980235|FG000|Overall Study|Other|8|||
48762603|NCT00265343|156980236|FG001|Overall Study|Other|3|||
48762604|NCT00573755|156980241|FG000|Overall Study|Still receiving treatment|1|||
48677558|NCT03282097|156671385|FG000|Intervention Visit Complete|Caregiver Death|0|||
48677559|NCT03282097|156671386|FG001|Intervention Visit Complete|Caregiver Death|3|||
48677560|NCT03282097|156671385|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
48677561|NCT03282097|156671386|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
48762605|NCT00573755|156980242|FG001|Overall Study|Still receiving treatment|0|||
48762606|NCT02276872|156980243|FG000|Overall Study|Adverse Event|1|||
48762607|NCT02276872|156980244|FG001|Overall Study|Adverse Event|0|||
48762608|NCT02276872|156980245|FG002|Overall Study|Adverse Event|0|||
48762609|NCT02132767|156980251|FG000|Overall Study|Death|3|||
48762610|NCT02132767|156980252|FG001|Overall Study|Death|2|||
48388034|NCT00455013|155616058|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
48388035|NCT00455013|155616059|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
48388036|NCT00455013|155616060|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
48388037|NCT00455013|155616058|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
48388038|NCT00455013|155616059|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
48388039|NCT00455013|155616060|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
48388040|NCT00455013|155616058|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
48388041|NCT00455013|155616059|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
48388042|NCT00455013|155616060|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
48388043|NCT00455013|155616058|FG000|Long Term Extension (LTE)|non-specified|0|||
48388044|NCT00455013|155616059|FG001|Long Term Extension (LTE)|non-specified|0|||
48388045|NCT00455013|155616060|FG002|Long Term Extension (LTE)|non-specified|1|||
48388046|NCT01506960|155616061|FG000|Overall Study|Did not meet angiographic criteria|47|||
48388047|NCT00555477|155616062|FG000|Overall Study|Adverse Event|0|||
48388048|NCT00555477|155616063|FG001|Overall Study|Adverse Event|9|||
48388049|NCT00555477|155616062|FG000|Overall Study|Withdrawal by Subject|1|||
48388050|NCT00555477|155616063|FG001|Overall Study|Withdrawal by Subject|2|||
48388051|NCT00555477|155616062|FG000|Overall Study|Physician Decision|1|||
48388052|NCT00555477|155616063|FG001|Overall Study|Physician Decision|2|||
48388053|NCT00397033|155616064|FG000|Overall Study|Adverse Event|7|||
48388054|NCT00397033|155616065|FG001|Overall Study|Adverse Event|10|||
48388055|NCT00397033|155616066|FG002|Overall Study|Adverse Event|4|||
48388056|NCT00397033|155616064|FG000|Overall Study|Lack of Efficacy|22|||
48388057|NCT00397033|155616065|FG001|Overall Study|Lack of Efficacy|12|||
48388058|NCT00397033|155616066|FG002|Overall Study|Lack of Efficacy|9|||
48388059|NCT00397033|155616064|FG000|Overall Study|Lost to Follow-up|3|||
48388060|NCT00397033|155616065|FG001|Overall Study|Lost to Follow-up|3|||
48388061|NCT00397033|155616066|FG002|Overall Study|Lost to Follow-up|3|||
48388062|NCT00397033|155616064|FG000|Overall Study|Withdrawal by Subject|12|||
48388063|NCT00397033|155616065|FG001|Overall Study|Withdrawal by Subject|7|||
48388064|NCT00397033|155616066|FG002|Overall Study|Withdrawal by Subject|5|||
48388065|NCT00397033|155616064|FG000|Overall Study|Other|0|||
48388066|NCT00397033|155616065|FG001|Overall Study|Other|5|||
48388067|NCT00397033|155616066|FG002|Overall Study|Other|2|||
48388068|NCT05513625|155616067|FG000|Overall Study|Withdrawal by Subject|1|||
48388069|NCT03574753|155616068|FG000|Overall Study|Adverse Event|3|||
48388070|NCT03574753|155616068|FG000|Overall Study|Progression/relapse|19|||
48388071|NCT03574753|155616068|FG000|Overall Study|Death|1|||
48388072|NCT01987960|155616069|FG000|Period 1|Adverse Event|24|||
48388073|NCT01987960|155616070|FG001|Period 1|Adverse Event|0|||
48388074|NCT01987960|155616071|FG002|Period 1|Adverse Event|0|||
48388075|NCT01987960|155616072|FG003|Period 1|Adverse Event|0|||
48388076|NCT01987960|155616069|FG000|Period 1|Lack of Efficacy|4|||
48388077|NCT01987960|155616070|FG001|Period 1|Lack of Efficacy|0|||
48388078|NCT01987960|155616071|FG002|Period 1|Lack of Efficacy|0|||
48388079|NCT01987960|155616072|FG003|Period 1|Lack of Efficacy|0|||
48388080|NCT01987960|155616069|FG000|Period 1|Non-compliance with IMP|6|||
48388081|NCT01987960|155616070|FG001|Period 1|Non-compliance with IMP|0|||
48388082|NCT01987960|155616071|FG002|Period 1|Non-compliance with IMP|0|||
48388083|NCT01987960|155616072|FG003|Period 1|Non-compliance with IMP|0|||
48388084|NCT01987960|155616069|FG000|Period 1|Protocol Violation|12|||
48388085|NCT01987960|155616070|FG001|Period 1|Protocol Violation|0|||
48388086|NCT01987960|155616071|FG002|Period 1|Protocol Violation|0|||
48388087|NCT01987960|155616072|FG003|Period 1|Protocol Violation|0|||
48388088|NCT01987960|155616069|FG000|Period 1|Withdrawal by Subject|21|||
48388089|NCT01987960|155616070|FG001|Period 1|Withdrawal by Subject|0|||
48388090|NCT01987960|155616071|FG002|Period 1|Withdrawal by Subject|0|||
48388091|NCT01987960|155616072|FG003|Period 1|Withdrawal by Subject|0|||
48677562|NCT03282097|156671385|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
48677563|NCT03282097|156671386|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
48388092|NCT01987960|155616069|FG000|Period 1|Lost to Follow-up|40|||
48388093|NCT01987960|155616070|FG001|Period 1|Lost to Follow-up|0|||
48388094|NCT01987960|155616071|FG002|Period 1|Lost to Follow-up|0|||
48388095|NCT01987960|155616072|FG003|Period 1|Lost to Follow-up|0|||
48388096|NCT01987960|155616069|FG000|Period 1|administrative or other reason|75|||
48388097|NCT01987960|155616070|FG001|Period 1|administrative or other reason|0|||
48388098|NCT01987960|155616071|FG002|Period 1|administrative or other reason|0|||
48388099|NCT01987960|155616072|FG003|Period 1|administrative or other reason|0|||
48388100|NCT01987960|155616069|FG000|Period 1|Withdrawal of consent before treatment|4|||
48388101|NCT01987960|155616070|FG001|Period 1|Withdrawal of consent before treatment|0|||
48388102|NCT01987960|155616071|FG002|Period 1|Withdrawal of consent before treatment|0|||
48388103|NCT01987960|155616072|FG003|Period 1|Withdrawal of consent before treatment|0|||
48388104|NCT01987960|155616069|FG000|Period 2|Adverse Event|0|||
48388105|NCT01987960|155616070|FG001|Period 2|Adverse Event|0|||
48388106|NCT01987960|155616071|FG002|Period 2|Adverse Event|1|||
48388107|NCT01987960|155616072|FG003|Period 2|Adverse Event|0|||
48388108|NCT01987960|155616069|FG000|Period 2|Withdrawal by Subject|0|||
48388109|NCT01987960|155616070|FG001|Period 2|Withdrawal by Subject|0|||
48388110|NCT01987960|155616071|FG002|Period 2|Withdrawal by Subject|1|||
48388111|NCT01987960|155616072|FG003|Period 2|Withdrawal by Subject|0|||
48388112|NCT01987960|155616069|FG000|Period 2|Administrative or other reason|0|||
48388113|NCT01987960|155616070|FG001|Period 2|Administrative or other reason|5|||
48388114|NCT01987960|155616071|FG002|Period 2|Administrative or other reason|7|||
48388115|NCT01987960|155616072|FG003|Period 2|Administrative or other reason|0|||
48388116|NCT01987960|155616069|FG000|Period 3|Adverse Event|0|||
48388117|NCT01987960|155616070|FG001|Period 3|Adverse Event|0|||
48388118|NCT01987960|155616071|FG002|Period 3|Adverse Event|0|||
48388119|NCT01987960|155616072|FG003|Period 3|Adverse Event|7|||
48388120|NCT01987960|155616069|FG000|Period 3|Non-compliance with IMP|0|||
48388121|NCT01987960|155616070|FG001|Period 3|Non-compliance with IMP|0|||
48388122|NCT01987960|155616071|FG002|Period 3|Non-compliance with IMP|0|||
48388123|NCT01987960|155616072|FG003|Period 3|Non-compliance with IMP|1|||
48388124|NCT01987960|155616069|FG000|Period 3|Protocol Violation|0|||
48388125|NCT01987960|155616070|FG001|Period 3|Protocol Violation|0|||
48388126|NCT01987960|155616071|FG002|Period 3|Protocol Violation|0|||
48388127|NCT01987960|155616072|FG003|Period 3|Protocol Violation|6|||
48388128|NCT01987960|155616069|FG000|Period 3|Withdrawal by Subject|0|||
48388129|NCT01987960|155616070|FG001|Period 3|Withdrawal by Subject|0|||
48388130|NCT01987960|155616071|FG002|Period 3|Withdrawal by Subject|0|||
48388131|NCT01987960|155616072|FG003|Period 3|Withdrawal by Subject|9|||
48388132|NCT01987960|155616069|FG000|Period 3|Lost to Follow-up|0|||
48388133|NCT01987960|155616070|FG001|Period 3|Lost to Follow-up|0|||
48388134|NCT01987960|155616071|FG002|Period 3|Lost to Follow-up|0|||
48388135|NCT01987960|155616072|FG003|Period 3|Lost to Follow-up|5|||
48388136|NCT01987960|155616069|FG000|Period 3|Administrative or other reason|0|||
48388137|NCT01987960|155616070|FG001|Period 3|Administrative or other reason|0|||
48388138|NCT01987960|155616071|FG002|Period 3|Administrative or other reason|0|||
48388139|NCT01987960|155616072|FG003|Period 3|Administrative or other reason|43|||
48388140|NCT01131520|155616075|FG000|Overall Study|Computer problem|1|||
48388141|NCT01131520|155616076|FG001|Overall Study|Computer problem|0|||
48388142|NCT01131520|155616075|FG000|Overall Study|Counselor not available|0|||
48388143|NCT01131520|155616076|FG001|Overall Study|Counselor not available|3|||
48388144|NCT01131520|155616075|FG000|Overall Study|Subject changed history after enrollment|0|||
48388145|NCT01131520|155616076|FG001|Overall Study|Subject changed history after enrollment|1|||
48388146|NCT00932360|155616077|FG000|Washout (One Week)|Withdrawal by Subject|0|||
48388147|NCT00932360|155616078|FG001|Washout (One Week)|Withdrawal by Subject|0|||
48388148|NCT00932360|155616079|FG002|Washout (One Week)|Withdrawal by Subject|0|||
48388149|NCT00932360|155616080|FG003|Washout (One Week)|Withdrawal by Subject|0|||
48388150|NCT00932360|155616081|FG004|Washout (One Week)|Withdrawal by Subject|2|||
48388151|NCT00932360|155616082|FG005|Washout (One Week)|Withdrawal by Subject|0|||
48388152|NCT01073267|155616083|FG000|Overall Study|Disease Progression|3|||
48388153|NCT02536313|155616090|FG000|Overall Study|Lack of Efficacy|0|||
48388154|NCT02536313|155616091|FG001|Overall Study|Lack of Efficacy|1|||
48388155|NCT01977820|155616092|FG000|Overall Study|Sponsor terminated the study|1|||
48388156|NCT01977820|155616093|FG001|Overall Study|Sponsor terminated the study|1|||
48388157|NCT02437864|155616096|FG000|Overall Study|Protocol Violation|4|||
48388158|NCT02437864|155616097|FG001|Overall Study|Protocol Violation|0|||
48388159|NCT03302975|155616098|FG000|Overall Study|Lost to Follow-up|4|||
48388160|NCT04425720|155616104|FG000|Overall Study|Withdrawal by Subject|0|||
48388161|NCT04425720|155616105|FG001|Overall Study|Withdrawal by Subject|20|||
48388162|NCT00445224|155616106|FG000|Specific Exercises|Withdrawal by Subject|3|||
48762611|NCT02132767|156980251|FG000|Overall Study|Withdrawal by Subject|10|||
48762612|NCT02132767|156980252|FG001|Overall Study|Withdrawal by Subject|9|||
48762613|NCT02132767|156980251|FG000|Overall Study|Lost to Follow-up|4|||
48762614|NCT02132767|156980252|FG001|Overall Study|Lost to Follow-up|4|||
48388163|NCT00445224|155616107|FG001|Specific Exercises|Withdrawal by Subject|3|||
48388164|NCT00445224|155616106|FG000|Specific Exercises|Withdrawal by Subject|1|||
48388165|NCT00445224|155616107|FG001|Specific Exercises|Withdrawal by Subject|0|||
48388166|NCT01045798|155616109|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
48388167|NCT01045798|155616110|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
48388168|NCT01045798|155616109|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
48388169|NCT01045798|155616110|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
48388170|NCT01045798|155616109|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
48388171|NCT01045798|155616110|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
48388172|NCT01045798|155616109|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
48388173|NCT01045798|155616110|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
48388174|NCT03520959|155616111|FG000|Overall Study|Study terminated by Sponsor|0|||
48388175|NCT03520959|155616112|FG001|Overall Study|Study terminated by Sponsor|1|||
48388176|NCT02321930|155616117|FG000|Overall Study|Lost to Follow-up|1|||
48388177|NCT03021499|155616118|FG000|Overall Study|Adverse Event|1|||
48388178|NCT03021499|155616119|FG001|Overall Study|Adverse Event|0|||
48388179|NCT03021499|155616118|FG000|Overall Study|Death|1|||
48388180|NCT03021499|155616119|FG001|Overall Study|Death|5|||
48388181|NCT03021499|155616118|FG000|Overall Study|Lack of Efficacy|0|||
48388182|NCT03021499|155616119|FG001|Overall Study|Lack of Efficacy|1|||
48677564|NCT03282097|156671385|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
48677565|NCT03282097|156671386|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
48677566|NCT03282097|156671385|FG000|Primary Outcome Data Collection Complete|Missing|2|||
48677567|NCT03282097|156671386|FG001|Primary Outcome Data Collection Complete|Missing|3|||
48677568|NCT03282097|156671385|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
48677569|NCT03282097|156671386|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
48677570|NCT03282097|156671385|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
48762615|NCT01132547|156980259|FG000|Overall Study|Withdrawal by Subject|3|||
48762616|NCT01132547|156980260|FG001|Overall Study|Withdrawal by Subject|1|||
48762617|NCT01132547|156980259|FG000|Overall Study|Death|1|||
48762618|NCT01132547|156980260|FG001|Overall Study|Death|0|||
48762619|NCT03412084|156980264|FG000|Overall Study|Withdrawal by Subject|2|||
48388183|NCT03021499|155616118|FG000|Overall Study|Lost to Follow-up|1|||
48677571|NCT03282097|156671386|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
48677572|NCT03282097|156671385|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
48677573|NCT03282097|156671386|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
48677574|NCT01858740|156671387|FG000|Overall Study|Death|4|||
48677575|NCT00517361|156671390|FG000|Overall Study|Death|6|||
48677576|NCT00517361|156671390|FG000|Overall Study|The study was terminated|5|||
48677577|NCT03916081|156671406|FG000|Overall Study|Adverse Event|1|||
48677578|NCT03916081|156671407|FG001|Overall Study|Adverse Event|0|||
48677579|NCT03916081|156671408|FG002|Overall Study|Adverse Event|0|||
48677580|NCT03916081|156671406|FG000|Overall Study|Physician Decision|0|||
48677581|NCT03916081|156671407|FG001|Overall Study|Physician Decision|0|||
48677582|NCT03916081|156671408|FG002|Overall Study|Physician Decision|1|||
48677583|NCT03916081|156671406|FG000|Overall Study|Lost to Follow-up|0|||
48677584|NCT03916081|156671407|FG001|Overall Study|Lost to Follow-up|1|||
48677585|NCT03916081|156671408|FG002|Overall Study|Lost to Follow-up|0|||
48677586|NCT03916081|156671406|FG000|Overall Study|Withdrawal by Subject|3|||
48677587|NCT03916081|156671407|FG001|Overall Study|Withdrawal by Subject|0|||
48677588|NCT03916081|156671408|FG002|Overall Study|Withdrawal by Subject|1|||
48677589|NCT03916081|156671406|FG000|Overall Study|Worsening of AD|0|||
48677590|NCT03916081|156671407|FG001|Overall Study|Worsening of AD|0|||
48677591|NCT03916081|156671408|FG002|Overall Study|Worsening of AD|1|||
48677592|NCT01371734|156671411|FG000|Overall Study|Other|2|||
48677593|NCT01371734|156671412|FG001|Overall Study|Other|1|||
48677594|NCT01371734|156671413|FG002|Overall Study|Other|2|||
48677595|NCT01371734|156671411|FG000|Overall Study|Withdrawal by Subject|3|||
48677596|NCT01371734|156671412|FG001|Overall Study|Withdrawal by Subject|4|||
48677597|NCT01371734|156671413|FG002|Overall Study|Withdrawal by Subject|9|||
48677598|NCT01371734|156671411|FG000|Overall Study|Lost to Follow-up|5|||
48677599|NCT01371734|156671412|FG001|Overall Study|Lost to Follow-up|3|||
48677600|NCT01371734|156671413|FG002|Overall Study|Lost to Follow-up|1|||
48677601|NCT01371734|156671411|FG000|Overall Study|Protocol Violation|3|||
48677602|NCT01371734|156671412|FG001|Overall Study|Protocol Violation|1|||
48677603|NCT01371734|156671413|FG002|Overall Study|Protocol Violation|2|||
48677604|NCT01371734|156671411|FG000|Overall Study|Adverse Event|8|||
48677605|NCT01371734|156671412|FG001|Overall Study|Adverse Event|8|||
48677606|NCT01371734|156671413|FG002|Overall Study|Adverse Event|3|||
48677607|NCT01371734|156671411|FG000|Overall Study|Lack of Efficacy|2|||
48677608|NCT01371734|156671412|FG001|Overall Study|Lack of Efficacy|2|||
48677609|NCT01371734|156671413|FG002|Overall Study|Lack of Efficacy|0|||
48677610|NCT04079114|156671414|FG000|Overall Study|Study prematuely terminated.|166|||
48677611|NCT01098305|156671415|FG000|Overall Study|Lost to Follow-up|31|||
48762620|NCT03412084|156980265|FG001|Overall Study|Withdrawal by Subject|0|||
48677612|NCT01098305|156671416|FG001|Overall Study|Lost to Follow-up|33|||
48677613|NCT02577016|156671417|FG000|Overall Study|Adverse Event|2|||
48677614|NCT02577016|156671418|FG001|Overall Study|Adverse Event|1|||
48677615|NCT02577016|156671417|FG000|Overall Study|Physician Decision|0|||
48388184|NCT03021499|155616119|FG001|Overall Study|Lost to Follow-up|3|||
48388185|NCT03021499|155616118|FG000|Overall Study|Physician Decision|2|||
48677616|NCT02577016|156671418|FG001|Overall Study|Physician Decision|1|||
48677617|NCT02218008|156671419|FG000|Stage 1 (S1)|Adverse Event|6|||
48677618|NCT02218008|156671420|FG001|Stage 1 (S1)|Adverse Event|5|||
48677619|NCT02218008|156671421|FG002|Stage 1 (S1)|Adverse Event|11|||
48677620|NCT02218008|156671422|FG003|Stage 1 (S1)|Adverse Event|0|||
48677621|NCT02218008|156671423|FG004|Stage 1 (S1)|Adverse Event|0|||
48677622|NCT02218008|156671424|FG005|Stage 1 (S1)|Adverse Event|0|||
48677623|NCT02218008|156671419|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
48677624|NCT02218008|156671420|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
48677625|NCT02218008|156671421|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
48677626|NCT02218008|156671422|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
48677627|NCT02218008|156671423|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
48677628|NCT02218008|156671424|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
48677629|NCT02218008|156671419|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
48762621|NCT03412084|156980264|FG000|Overall Study|Participant moved|1|||
48677630|NCT02218008|156671420|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
48677631|NCT02218008|156671421|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
48762622|NCT03412084|156980265|FG001|Overall Study|Participant moved|0|||
48762623|NCT03412084|156980264|FG000|Overall Study|Lost to Follow-up|1|||
48762624|NCT03412084|156980265|FG001|Overall Study|Lost to Follow-up|1|||
48762625|NCT00634088|156980267|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
48762626|NCT00634088|156980268|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
48762627|NCT00634088|156980269|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
48762628|NCT00634088|156980270|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
48762629|NCT00634088|156980267|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
48762630|NCT00634088|156980268|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
48762631|NCT00634088|156980269|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
48762632|NCT00634088|156980270|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
48762633|NCT00634088|156980267|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
48388186|NCT03021499|155616119|FG001|Overall Study|Physician Decision|3|||
48388187|NCT03021499|155616118|FG000|Overall Study|Pregnancy|1|||
48388188|NCT03021499|155616119|FG001|Overall Study|Pregnancy|0|||
48677632|NCT02218008|156671422|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
48677633|NCT02218008|156671423|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
48677634|NCT02218008|156671424|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
48677635|NCT02218008|156671419|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
48677636|NCT02218008|156671420|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
48677637|NCT02218008|156671421|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
48677638|NCT02218008|156671422|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
48677639|NCT02218008|156671423|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
48677640|NCT02218008|156671424|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
48677641|NCT02218008|156671419|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
48677642|NCT02218008|156671420|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
48677643|NCT02218008|156671421|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
48677644|NCT02218008|156671422|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
48677645|NCT02218008|156671423|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
48677646|NCT02218008|156671424|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
48677647|NCT02218008|156671419|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
48677648|NCT02218008|156671420|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
48677649|NCT02218008|156671421|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
48677650|NCT02218008|156671422|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
48677651|NCT02218008|156671423|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
48677652|NCT02218008|156671424|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
48677653|NCT02218008|156671419|FG000|Stage 1 (S1)|Pregnancy|0|||
48677654|NCT02218008|156671420|FG001|Stage 1 (S1)|Pregnancy|0|||
48677655|NCT02218008|156671421|FG002|Stage 1 (S1)|Pregnancy|1|||
48677656|NCT02218008|156671422|FG003|Stage 1 (S1)|Pregnancy|0|||
48677657|NCT02218008|156671423|FG004|Stage 1 (S1)|Pregnancy|0|||
48677658|NCT02218008|156671424|FG005|Stage 1 (S1)|Pregnancy|0|||
48677659|NCT02218008|156671419|FG000|Stage 1 (S1)|Protocol Violation|0|||
48677660|NCT02218008|156671420|FG001|Stage 1 (S1)|Protocol Violation|0|||
48677661|NCT02218008|156671421|FG002|Stage 1 (S1)|Protocol Violation|1|||
48677662|NCT02218008|156671422|FG003|Stage 1 (S1)|Protocol Violation|0|||
48677663|NCT02218008|156671423|FG004|Stage 1 (S1)|Protocol Violation|0|||
48677664|NCT02218008|156671424|FG005|Stage 1 (S1)|Protocol Violation|0|||
48677665|NCT02218008|156671419|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
48677666|NCT02218008|156671420|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677667|NCT02218008|156671421|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677668|NCT02218008|156671422|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677669|NCT02218008|156671423|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677670|NCT02218008|156671424|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
48677671|NCT02218008|156671419|FG000|Stage 2 (S2)|Adverse Event|0|||
48677672|NCT02218008|156671420|FG001|Stage 2 (S2)|Adverse Event|0|||
48677673|NCT02218008|156671421|FG002|Stage 2 (S2)|Adverse Event|0|||
48677674|NCT02218008|156671422|FG003|Stage 2 (S2)|Adverse Event|2|||
48677675|NCT02218008|156671423|FG004|Stage 2 (S2)|Adverse Event|3|||
48677676|NCT02218008|156671424|FG005|Stage 2 (S2)|Adverse Event|3|||
48677677|NCT02218008|156671419|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
48677678|NCT02218008|156671420|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
48677679|NCT02218008|156671421|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
48677680|NCT02218008|156671422|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
48677681|NCT02218008|156671423|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
48677682|NCT02218008|156671424|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
48677683|NCT02218008|156671419|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
48677684|NCT02218008|156671420|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
48677685|NCT02218008|156671421|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
48677686|NCT02218008|156671422|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
48677687|NCT02218008|156671423|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
48677688|NCT02218008|156671424|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
48677689|NCT02218008|156671419|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48762634|NCT00634088|156980268|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
48762635|NCT00634088|156980269|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
48677690|NCT02218008|156671420|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48677691|NCT02218008|156671421|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48388189|NCT03021499|155616118|FG000|Overall Study|Withdrawal by Subject|7|||
48388190|NCT03021499|155616119|FG001|Overall Study|Withdrawal by Subject|14|||
48762636|NCT00634088|156980270|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
48762637|NCT00634088|156980267|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
48762638|NCT00634088|156980268|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
48762639|NCT00634088|156980269|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
48762640|NCT00634088|156980270|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
48762641|NCT00634088|156980267|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
48762642|NCT00634088|156980268|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
48762643|NCT00634088|156980269|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
48677692|NCT02218008|156671422|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
48677693|NCT02218008|156671423|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48677694|NCT02218008|156671424|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
48677695|NCT02218008|156671419|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
48677696|NCT02218008|156671420|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
48677697|NCT02218008|156671421|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
48677698|NCT02218008|156671422|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
48677699|NCT02218008|156671423|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
48677700|NCT02218008|156671424|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
48677701|NCT02038075|156671425|FG000|Overall Study|Withdrawal by Subject|3|||
48677702|NCT02038075|156671426|FG001|Overall Study|Withdrawal by Subject|0|||
48677703|NCT04039217|156671427|FG000|Overall Study|Lost to Follow-up|1|||
48677704|NCT00106353|156671428|FG000|Part 1|Disease progression|3|||
48677705|NCT00106353|156671429|FG001|Part 1|Disease progression|4|||
48677706|NCT00106353|156671430|FG002|Part 1|Disease progression|1|||
48677707|NCT00106353|156671431|FG003|Part 1|Disease progression|3|||
48677708|NCT00106353|156671432|FG004|Part 1|Disease progression|0|||
48677709|NCT00106353|156671433|FG005|Part 1|Disease progression|0|||
48677710|NCT00106353|156671434|FG006|Part 1|Disease progression|0|||
48677711|NCT00106353|156671428|FG000|Part 1|Withdrawal by Subject|0|||
48677712|NCT00106353|156671429|FG001|Part 1|Withdrawal by Subject|0|||
48677713|NCT00106353|156671430|FG002|Part 1|Withdrawal by Subject|1|||
48677714|NCT00106353|156671431|FG003|Part 1|Withdrawal by Subject|2|||
48677715|NCT00106353|156671432|FG004|Part 1|Withdrawal by Subject|0|||
48677716|NCT00106353|156671433|FG005|Part 1|Withdrawal by Subject|0|||
48677717|NCT00106353|156671434|FG006|Part 1|Withdrawal by Subject|0|||
48677718|NCT00106353|156671428|FG000|Part 1|Symptomatic deterioration|0|||
48677719|NCT00106353|156671429|FG001|Part 1|Symptomatic deterioration|0|||
48677720|NCT00106353|156671430|FG002|Part 1|Symptomatic deterioration|1|||
48677721|NCT00106353|156671431|FG003|Part 1|Symptomatic deterioration|0|||
48677722|NCT00106353|156671432|FG004|Part 1|Symptomatic deterioration|0|||
48677723|NCT00106353|156671433|FG005|Part 1|Symptomatic deterioration|0|||
48677724|NCT00106353|156671434|FG006|Part 1|Symptomatic deterioration|0|||
48677725|NCT00106353|156671428|FG000|Part 1|Entered follow-up phase|1|||
48677726|NCT00106353|156671429|FG001|Part 1|Entered follow-up phase|1|||
48677727|NCT00106353|156671430|FG002|Part 1|Entered follow-up phase|0|||
48677728|NCT00106353|156671431|FG003|Part 1|Entered follow-up phase|1|||
48677729|NCT00106353|156671432|FG004|Part 1|Entered follow-up phase|0|||
48677730|NCT00106353|156671433|FG005|Part 1|Entered follow-up phase|0|||
48677731|NCT00106353|156671434|FG006|Part 1|Entered follow-up phase|0|||
48677732|NCT00106353|156671428|FG000|Part 1|Adverse Event|0|||
48677733|NCT00106353|156671429|FG001|Part 1|Adverse Event|0|||
48677734|NCT00106353|156671430|FG002|Part 1|Adverse Event|0|||
48677735|NCT00106353|156671431|FG003|Part 1|Adverse Event|1|||
48677736|NCT00106353|156671432|FG004|Part 1|Adverse Event|0|||
48677737|NCT00106353|156671433|FG005|Part 1|Adverse Event|0|||
48677738|NCT00106353|156671434|FG006|Part 1|Adverse Event|0|||
48677739|NCT00106353|156671428|FG000|Part 2|Disease progression|0|||
48677740|NCT00106353|156671429|FG001|Part 2|Disease progression|0|||
48677741|NCT00106353|156671430|FG002|Part 2|Disease progression|0|||
48677742|NCT00106353|156671431|FG003|Part 2|Disease progression|0|||
48677743|NCT00106353|156671432|FG004|Part 2|Disease progression|8|||
48677744|NCT00106353|156671433|FG005|Part 2|Disease progression|14|||
48677745|NCT00106353|156671434|FG006|Part 2|Disease progression|13|||
48677746|NCT00106353|156671428|FG000|Part 2|Death|0|||
48762644|NCT00634088|156980270|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
48762645|NCT00634088|156980267|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
48677747|NCT00106353|156671429|FG001|Part 2|Death|0|||
48677748|NCT00106353|156671430|FG002|Part 2|Death|0|||
48677749|NCT00106353|156671431|FG003|Part 2|Death|0|||
48677750|NCT00106353|156671432|FG004|Part 2|Death|3|||
48677751|NCT00106353|156671433|FG005|Part 2|Death|0|||
48677752|NCT00106353|156671434|FG006|Part 2|Death|1|||
48677753|NCT00106353|156671428|FG000|Part 2|Symptomatic deterioration|0|||
48762646|NCT00634088|156980268|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
48677754|NCT00106353|156671429|FG001|Part 2|Symptomatic deterioration|0|||
48677755|NCT00106353|156671430|FG002|Part 2|Symptomatic deterioration|0|||
48677756|NCT00106353|156671431|FG003|Part 2|Symptomatic deterioration|0|||
48677757|NCT00106353|156671432|FG004|Part 2|Symptomatic deterioration|3|||
48677758|NCT00106353|156671433|FG005|Part 2|Symptomatic deterioration|0|||
48388191|NCT03021499|155616118|FG000|Overall Study|Prohibited medication required|1|||
48388192|NCT03021499|155616119|FG001|Overall Study|Prohibited medication required|0|||
48388193|NCT03021499|155616118|FG000|Overall Study|Protocol non-compliance|1|||
48388194|NCT03021499|155616119|FG001|Overall Study|Protocol non-compliance|1|||
48388195|NCT03021499|155616118|FG000|Overall Study|None of the above|0|||
48388196|NCT03021499|155616119|FG001|Overall Study|None of the above|4|||
48388197|NCT03021499|155616118|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
48388198|NCT03021499|155616119|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
48388199|NCT01484977|155616122|FG000|Overall Study|Adverse Event|8|||
48388200|NCT01484977|155616122|FG000|Overall Study|Lack of Efficacy|4|||
48388201|NCT01484977|155616122|FG000|Overall Study|Protocol Violation|6|||
48388202|NCT01484977|155616122|FG000|Overall Study|Lost to Follow-up|1|||
48388203|NCT01484977|155616122|FG000|Overall Study|Withdrawal by Subject|4|||
48388204|NCT01484977|155616122|FG000|Overall Study|Subject Protocol Non-compliant|1|||
48388205|NCT01484977|155616122|FG000|Overall Study|Moving Overseas|1|||
48388206|NCT01484977|155616122|FG000|Overall Study|Low White Blood Cell Count|1|||
48388207|NCT01484977|155616122|FG000|Overall Study|Lack of Compliance|1|||
48388208|NCT00820950|155616127|FG000|Overall Study|Scheduling Conflict|0|||
48388209|NCT00820950|155616128|FG001|Overall Study|Scheduling Conflict|0|||
48388210|NCT00820950|155616129|FG002|Overall Study|Scheduling Conflict|0|||
48388211|NCT00820950|155616130|FG003|Overall Study|Scheduling Conflict|0|||
48388212|NCT00820950|155616131|FG004|Overall Study|Scheduling Conflict|0|||
48388213|NCT00820950|155616132|FG005|Overall Study|Scheduling Conflict|0|||
48388214|NCT00820950|155616133|FG006|Overall Study|Scheduling Conflict|1|||
48388215|NCT00820950|155616134|FG007|Overall Study|Scheduling Conflict|1|||
48388216|NCT00820950|155616135|FG008|Overall Study|Scheduling Conflict|0|||
48388217|NCT00820950|155616136|FG009|Overall Study|Scheduling Conflict|0|||
48388218|NCT00820950|155616127|FG000|Overall Study|Protocol Violation|1|||
48388219|NCT00820950|155616128|FG001|Overall Study|Protocol Violation|1|||
48388220|NCT00820950|155616129|FG002|Overall Study|Protocol Violation|0|||
48388221|NCT00820950|155616130|FG003|Overall Study|Protocol Violation|0|||
48388222|NCT00820950|155616131|FG004|Overall Study|Protocol Violation|0|||
48388223|NCT00820950|155616132|FG005|Overall Study|Protocol Violation|0|||
48388224|NCT00820950|155616133|FG006|Overall Study|Protocol Violation|0|||
48388225|NCT00820950|155616134|FG007|Overall Study|Protocol Violation|0|||
48388226|NCT00820950|155616135|FG008|Overall Study|Protocol Violation|0|||
48388227|NCT00820950|155616136|FG009|Overall Study|Protocol Violation|0|||
48388228|NCT00470054|155616137|FG000|Overall Study|Ineligible|1|||
48388229|NCT01129921|155616138|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
48388230|NCT01129921|155616139|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
48388231|NCT01129921|155616138|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
48388232|NCT01129921|155616139|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
48388233|NCT01129921|155616138|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
48388234|NCT01129921|155616139|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
48388235|NCT01129921|155616138|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
48388236|NCT01129921|155616139|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
48388237|NCT01624259|155616140|FG000|Overall Study|Adverse Event|18|||
48388238|NCT01624259|155616141|FG001|Overall Study|Adverse Event|18|||
48388239|NCT01624259|155616140|FG000|Overall Study|Protocol Violation|1|||
48388240|NCT01624259|155616141|FG001|Overall Study|Protocol Violation|2|||
48388241|NCT01624259|155616140|FG000|Overall Study|Withdrawal by Subject|5|||
48388242|NCT01624259|155616141|FG001|Overall Study|Withdrawal by Subject|7|||
48388243|NCT01624259|155616140|FG000|Overall Study|Physician Decision|1|||
48388244|NCT01624259|155616141|FG001|Overall Study|Physician Decision|1|||
48388245|NCT01624259|155616140|FG000|Overall Study|Lost to Follow-up|2|||
48388246|NCT01624259|155616141|FG001|Overall Study|Lost to Follow-up|3|||
48388247|NCT01624259|155616140|FG000|Overall Study|Abnormal laboratory measure|3|||
48388248|NCT01624259|155616141|FG001|Overall Study|Abnormal laboratory measure|0|||
48388249|NCT00729378|155617430|FG000|Baseline|Did not complete study measurements|72|||
48388250|NCT00729378|155617431|FG001|Baseline|Did not complete study measurements|33|||
48388251|NCT00729378|155617430|FG000|Baseline|Withdrawal by Subject|66|||
48388252|NCT00729378|155617431|FG001|Baseline|Withdrawal by Subject|59|||
48388253|NCT00729378|155617430|FG000|12-months|Lost to Follow-up|100|||
48388254|NCT00729378|155617431|FG001|12-months|Lost to Follow-up|65|||
48388255|NCT00729378|155617430|FG000|24-months|Lost to Follow-up|72|||
48388256|NCT00729378|155617431|FG001|24-months|Lost to Follow-up|51|||
48388257|NCT00729378|155617430|FG000|36-months|Lost to Follow-up|15|||
48388258|NCT00729378|155617431|FG001|36-months|Lost to Follow-up|6|||
48388259|NCT00395863|155617435|FG000|Overall Study|Patients did not complete both exams|2|||
48388260|NCT00395863|155617436|FG001|Overall Study|Patients did not complete both exams|3|||
48388261|NCT00382720|155617441|FG000|Overall Study|Adverse Event|21|||
48388262|NCT00382720|155617442|FG001|Overall Study|Adverse Event|23|||
48388263|NCT00382720|155617443|FG002|Overall Study|Adverse Event|15|||
48388264|NCT00382720|155617441|FG000|Overall Study|Protocol Violation|2|||
48388265|NCT00382720|155617442|FG001|Overall Study|Protocol Violation|5|||
48388266|NCT00382720|155617443|FG002|Overall Study|Protocol Violation|1|||
48388267|NCT00382720|155617441|FG000|Overall Study|Death|0|||
48388268|NCT00382720|155617442|FG001|Overall Study|Death|1|||
48388269|NCT00382720|155617443|FG002|Overall Study|Death|2|||
48388270|NCT00382720|155617441|FG000|Overall Study|Progressive disease|37|||
48388271|NCT00382720|155617442|FG001|Overall Study|Progressive disease|28|||
48388272|NCT00382720|155617443|FG002|Overall Study|Progressive disease|38|||
48388273|NCT00382720|155617441|FG000|Overall Study|Withdrew consent|1|||
48388274|NCT00382720|155617442|FG001|Overall Study|Withdrew consent|1|||
48388275|NCT00382720|155617443|FG002|Overall Study|Withdrew consent|2|||
48388276|NCT00382720|155617441|FG000|Overall Study|Withdrawal by Subject|11|||
48388277|NCT00382720|155617442|FG001|Overall Study|Withdrawal by Subject|20|||
48388278|NCT00382720|155617443|FG002|Overall Study|Withdrawal by Subject|12|||
48388279|NCT00382720|155617441|FG000|Overall Study|Surgery|1|||
48388280|NCT00382720|155617442|FG001|Overall Study|Surgery|1|||
48388281|NCT00382720|155617443|FG002|Overall Study|Surgery|4|||
48388282|NCT00382720|155617441|FG000|Overall Study|Patient did not receive study medication|1|||
48677759|NCT00106353|156671434|FG006|Part 2|Symptomatic deterioration|0|||
48677760|NCT00106353|156671428|FG000|Part 2|Adverse Event|0|||
48677761|NCT00106353|156671429|FG001|Part 2|Adverse Event|0|||
48677762|NCT00106353|156671430|FG002|Part 2|Adverse Event|0|||
48388283|NCT00382720|155617442|FG001|Overall Study|Patient did not receive study medication|1|||
48388284|NCT00382720|155617443|FG002|Overall Study|Patient did not receive study medication|4|||
48388285|NCT00382720|155617441|FG000|Overall Study|Clinically progressive disease|0|||
48388286|NCT00382720|155617442|FG001|Overall Study|Clinically progressive disease|1|||
48388287|NCT00382720|155617443|FG002|Overall Study|Clinically progressive disease|0|||
48388288|NCT00382720|155617441|FG000|Overall Study|Good prognosis|0|||
48388289|NCT00382720|155617442|FG001|Overall Study|Good prognosis|1|||
48388290|NCT00382720|155617443|FG002|Overall Study|Good prognosis|0|||
48388291|NCT00382720|155617441|FG000|Overall Study|Investigator/Clinical decision|5|||
48388292|NCT00382720|155617442|FG001|Overall Study|Investigator/Clinical decision|6|||
48388293|NCT00382720|155617443|FG002|Overall Study|Investigator/Clinical decision|6|||
48388294|NCT00382720|155617441|FG000|Overall Study|Discontinued at end of study|0|||
48388295|NCT00382720|155617442|FG001|Overall Study|Discontinued at end of study|1|||
48388296|NCT00382720|155617443|FG002|Overall Study|Discontinued at end of study|2|||
48388297|NCT00682448|155617444|FG000|Overall Study|Adverse Event|1|||
48388298|NCT00682448|155617445|FG001|Overall Study|Adverse Event|2|||
48388299|NCT00682448|155617444|FG000|Overall Study|Lack of Efficacy|1|||
48388300|NCT00682448|155617445|FG001|Overall Study|Lack of Efficacy|0|||
48388301|NCT00682448|155617444|FG000|Overall Study|Lost to Follow-up|1|||
48388302|NCT00682448|155617445|FG001|Overall Study|Lost to Follow-up|3|||
48388303|NCT00682448|155617444|FG000|Overall Study|Pregnancy|0|||
48388304|NCT00682448|155617445|FG001|Overall Study|Pregnancy|1|||
48677763|NCT00106353|156671431|FG003|Part 2|Adverse Event|0|||
48677764|NCT00106353|156671432|FG004|Part 2|Adverse Event|0|||
48677765|NCT00106353|156671433|FG005|Part 2|Adverse Event|2|||
48677766|NCT00106353|156671434|FG006|Part 2|Adverse Event|1|||
48677767|NCT00106353|156671428|FG000|Part 2|Other|0|||
48677768|NCT00106353|156671429|FG001|Part 2|Other|0|||
48677769|NCT00106353|156671430|FG002|Part 2|Other|0|||
48677770|NCT00106353|156671431|FG003|Part 2|Other|0|||
48677771|NCT00106353|156671432|FG004|Part 2|Other|1|||
48677772|NCT00106353|156671433|FG005|Part 2|Other|1|||
48677773|NCT00106353|156671434|FG006|Part 2|Other|1|||
48677774|NCT00106353|156671428|FG000|Part 2|Withdrawal by Subject|0|||
48677775|NCT00106353|156671429|FG001|Part 2|Withdrawal by Subject|0|||
48677776|NCT00106353|156671430|FG002|Part 2|Withdrawal by Subject|0|||
48677777|NCT00106353|156671431|FG003|Part 2|Withdrawal by Subject|0|||
48677778|NCT00106353|156671432|FG004|Part 2|Withdrawal by Subject|1|||
48677779|NCT00106353|156671433|FG005|Part 2|Withdrawal by Subject|0|||
48677780|NCT00106353|156671434|FG006|Part 2|Withdrawal by Subject|0|||
48677781|NCT00106353|156671428|FG000|Part 2|Physician Decision|0|||
48677782|NCT00106353|156671429|FG001|Part 2|Physician Decision|0|||
48677783|NCT00106353|156671430|FG002|Part 2|Physician Decision|0|||
48677784|NCT00106353|156671431|FG003|Part 2|Physician Decision|0|||
48677785|NCT00106353|156671432|FG004|Part 2|Physician Decision|0|||
48677786|NCT00106353|156671433|FG005|Part 2|Physician Decision|1|||
48677787|NCT00106353|156671434|FG006|Part 2|Physician Decision|0|||
48762647|NCT00634088|156980269|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
48762648|NCT00634088|156980270|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
48762649|NCT02290821|156980271|FG000|Overall Study|Withdrawal by Subject|1|||
48762650|NCT02290821|156980272|FG001|Overall Study|Withdrawal by Subject|1|||
48677788|NCT04000581|156671435|FG000|Overall Study|Withdrawal by Subject|0|||
48677789|NCT04000581|156671436|FG001|Overall Study|Withdrawal by Subject|1|||
48677790|NCT00588354|156671437|FG000|Baseline to 2 Weeks|Adverse Event|1|||
48677791|NCT00588354|156671438|FG001|Baseline to 2 Weeks|Adverse Event|0|||
48677792|NCT00588354|156671437|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
48677793|NCT00588354|156671438|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
48677794|NCT00588354|156671437|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
48677795|NCT00588354|156671438|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
48677796|NCT03790917|156671439|FG000|Overall Study|Death|1|||
48677797|NCT03508609|156671440|FG000|Overall Study|Withdrawal by Subject|1|||
48388305|NCT00682448|155617444|FG000|Overall Study|Withdrawal by Subject|2|||
48388306|NCT00682448|155617445|FG001|Overall Study|Withdrawal by Subject|0|||
48388307|NCT02737852|155617452|FG000|Overall Study|Withdrawal by Subject|2|||
48388308|NCT03511053|155617455|FG000|Overall Study|Withdrawal by Subject|1|||
48388309|NCT01876251|155617456|FG000|Overall Study|Clinical progression|1|||
48388310|NCT01876251|155617457|FG001|Overall Study|Clinical progression|0|||
48388311|NCT01876251|155617458|FG002|Overall Study|Clinical progression|0|||
48388312|NCT01876251|155617456|FG000|Overall Study|Death|2|||
48762651|NCT02290821|156980271|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
48762652|NCT02290821|156980272|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
48762653|NCT02290821|156980271|FG000|Overall Study|Lost to Follow-up|3|||
48762654|NCT02290821|156980272|FG001|Overall Study|Lost to Follow-up|2|||
48762655|NCT04356963|156980273|FG000|First Session|Withdrawal by Subject|1|||
48762656|NCT04356963|156980273|FG000|Second Session|Withdrawal by Subject|3|||
48762657|NCT04356963|156980273|FG000|Second Session|Lost to Follow-up|1|||
48762658|NCT04356963|156980273|FG000|Third Session|Lost to Follow-up|6|||
48762659|NCT04356963|156980273|FG000|Third Session|Withdrawal by Subject|1|||
48762660|NCT01498952|156980281|FG000|Overall Study|Death|2|||
48762661|NCT01498952|156980282|FG001|Overall Study|Death|2|||
48762662|NCT01498952|156980283|FG002|Overall Study|Death|0|||
48762663|NCT01498952|156980284|FG003|Overall Study|Death|0|||
48762664|NCT01498952|156980285|FG004|Overall Study|Death|0|||
48762665|NCT00228917|156980286|FG000|Overall Study|Migrated/moved from study area|0|||
48388313|NCT01876251|155617457|FG001|Overall Study|Death|0|||
48388314|NCT01876251|155617458|FG002|Overall Study|Death|1|||
48388315|NCT01876251|155617456|FG000|Overall Study|Participant started new treatment|1|||
48388316|NCT01876251|155617457|FG001|Overall Study|Participant started new treatment|0|||
48677798|NCT00782483|156671441|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
48677799|NCT04072887|156671442|FG000|Overall Study|Withdrawal by Subject|3|||
48677800|NCT04072887|156671443|FG001|Overall Study|Withdrawal by Subject|8|||
48677801|NCT04072887|156671444|FG002|Overall Study|Withdrawal by Subject|1|||
48677802|NCT04072887|156671445|FG003|Overall Study|Withdrawal by Subject|3|||
48677803|NCT04072887|156671446|FG004|Overall Study|Withdrawal by Subject|3|||
48388317|NCT01876251|155617458|FG002|Overall Study|Participant started new treatment|1|||
48388318|NCT01876251|155617456|FG000|Overall Study|Participant refused further follow-up|0|||
48388319|NCT01876251|155617457|FG001|Overall Study|Participant refused further follow-up|0|||
48388320|NCT01876251|155617458|FG002|Overall Study|Participant refused further follow-up|1|||
48388321|NCT01876251|155617456|FG000|Overall Study|Study terminated|1|||
48388322|NCT01876251|155617457|FG001|Overall Study|Study terminated|0|||
48388323|NCT01876251|155617458|FG002|Overall Study|Study terminated|0|||
48388324|NCT01876251|155617456|FG000|Overall Study|Objective progression or relapse|10|||
48388325|NCT01876251|155617457|FG001|Overall Study|Objective progression or relapse|3|||
48388326|NCT01876251|155617458|FG002|Overall Study|Objective progression or relapse|8|||
48388327|NCT05162027|155617459|FG000|Overall Study|Adverse Event|1|||
48388328|NCT05162027|155617460|FG001|Overall Study|Adverse Event|0|||
48388329|NCT03335163|155617461|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
48388330|NCT03335163|155617461|FG000|Overall Study|Withdrawal by Subject|18|||
48388331|NCT02230254|155617462|FG000|Overall Study|Lost to Follow-up|3|||
48388332|NCT00516048|155617466|FG000|Overall Study|Death|0|||
48388333|NCT00516048|155617467|FG001|Overall Study|Death|0|||
48388334|NCT00516048|155617468|FG002|Overall Study|Death|1|||
48388335|NCT00516048|155617466|FG000|Overall Study|Subject Decision|0|||
48388336|NCT00516048|155617467|FG001|Overall Study|Subject Decision|2|||
48388337|NCT00516048|155617468|FG002|Overall Study|Subject Decision|0|||
48388338|NCT02163187|155617471|FG000|Overall Study|Device removed|1|||
48388339|NCT02163187|155617472|FG001|Overall Study|Device removed|0|||
48388340|NCT02163187|155617471|FG000|Overall Study|Progressive disease|1|||
48388341|NCT02163187|155617472|FG001|Overall Study|Progressive disease|0|||
48677804|NCT04072887|156671447|FG005|Overall Study|Withdrawal by Subject|13|||
48762666|NCT00228917|156980287|FG001|Overall Study|Migrated/moved from study area|0|||
48388342|NCT02865018|155617478|FG000|Overall Study|Withdrawal by Subject|1|||
48388343|NCT00187096|155617481|FG000|Overall Study|unacceptable toxicity|0|||
48388344|NCT00187096|155617482|FG001|Overall Study|unacceptable toxicity|0|||
48388345|NCT00187096|155617483|FG002|Overall Study|unacceptable toxicity|1|||
48388346|NCT02689284|155617485|FG000|Overall Study|Adverse Event|1|||
48677805|NCT04072887|156671442|FG000|Overall Study|Adverse Event|2|||
48677806|NCT04072887|156671443|FG001|Overall Study|Adverse Event|4|||
48677807|NCT04072887|156671444|FG002|Overall Study|Adverse Event|1|||
48677808|NCT04072887|156671445|FG003|Overall Study|Adverse Event|4|||
48762667|NCT00228917|156980288|FG002|Overall Study|Migrated/moved from study area|0|||
48762668|NCT00228917|156980289|FG003|Overall Study|Migrated/moved from study area|0|||
48762669|NCT00228917|156980290|FG004|Overall Study|Migrated/moved from study area|0|||
48762670|NCT00228917|156980291|FG005|Overall Study|Migrated/moved from study area|2|||
48762671|NCT00228917|156980292|FG006|Overall Study|Migrated/moved from study area|0|||
48388347|NCT02689284|155617486|FG001|Overall Study|Adverse Event|8|||
48388348|NCT02689284|155617485|FG000|Overall Study|Death|0|||
48677809|NCT04072887|156671446|FG004|Overall Study|Adverse Event|0|||
48388349|NCT02689284|155617486|FG001|Overall Study|Death|1|||
48388350|NCT02689284|155617485|FG000|Overall Study|Physician Decision|1|||
48388351|NCT02689284|155617486|FG001|Overall Study|Physician Decision|2|||
48388352|NCT02689284|155617485|FG000|Overall Study|Withdrawal by Subject|0|||
48388353|NCT02689284|155617486|FG001|Overall Study|Withdrawal by Subject|1|||
48388354|NCT02689284|155617485|FG000|Overall Study|progression of cancer|1|||
48388355|NCT02689284|155617486|FG001|Overall Study|progression of cancer|72|||
48388356|NCT02689284|155617485|FG000|Overall Study|decreased heart function|0|||
48388357|NCT02689284|155617486|FG001|Overall Study|decreased heart function|1|||
48388358|NCT02689284|155617485|FG000|Overall Study|concern for anemia|0|||
48388359|NCT02689284|155617486|FG001|Overall Study|concern for anemia|1|||
48388360|NCT02689284|155617485|FG000|Overall Study|no measurable cancer for evaluation|0|||
48388361|NCT02689284|155617486|FG001|Overall Study|no measurable cancer for evaluation|1|||
48388362|NCT01011439|155617487|FG000|Overall Study|Death|37|||
48388363|NCT01011439|155617487|FG000|Overall Study|Lost to Follow-up|4|||
48388364|NCT01011439|155617487|FG000|Overall Study|Withdrawal by Subject|1|||
48388365|NCT01011439|155617487|FG000|Overall Study|Sponsor's decision|15|||
48388366|NCT02428855|155617488|FG000|Overall Study|Withdrawal by Subject|2|||
48388367|NCT03179891|155617489|FG000|First Intervention|Withdrawal by Subject|1|||
48762672|NCT00228917|156980293|FG007|Overall Study|Migrated/moved from study area|0|||
48762673|NCT00409617|156980294|FG000|Overall Study|Adverse Event|57|||
48762674|NCT00409617|156980294|FG000|Overall Study|Lack of Efficacy|54|||
48762675|NCT00409617|156980294|FG000|Overall Study|Lost to Follow-up|2|||
48762676|NCT00409617|156980294|FG000|Overall Study|Protocol Violation|24|||
48762677|NCT00409617|156980294|FG000|Overall Study|Withdrawal by Subject|8|||
48762678|NCT00409617|156980294|FG000|Overall Study|Administrative reasons|1|||
48762679|NCT00409617|156980294|FG000|Overall Study|Not described|14|||
48762680|NCT02159521|156980300|FG000|Overall Study|Enrolled but not treated|3|||
48388368|NCT03179891|155617490|FG001|First Intervention|Withdrawal by Subject|1|||
48388369|NCT03179891|155617489|FG000|First Intervention|Unspecified reason|1|||
48388370|NCT03179891|155617490|FG001|First Intervention|Unspecified reason|0|||
48388371|NCT03179891|155617489|FG000|First Intervention|Protocol Violation|0|||
48762681|NCT02159521|156980300|FG000|Overall Study|Withdrawal by Subject|7|||
48388372|NCT03179891|155617490|FG001|First Intervention|Protocol Violation|1|||
48388373|NCT01670539|155617491|FG000|Overall Study|Death|3|||
48388374|NCT01670539|155617492|FG001|Overall Study|Death|5|||
48762682|NCT02159521|156980300|FG000|Overall Study|Lost to Follow-up|6|||
48762683|NCT02159521|156980300|FG000|Overall Study|Death|1|||
48388375|NCT01670539|155617491|FG000|Overall Study|Withdrawal by Subject|3|||
48388376|NCT01670539|155617492|FG001|Overall Study|Withdrawal by Subject|0|||
48388377|NCT05418673|155617493|FG000|Overall Study|Study Terminated by Sponsor|2|||
48388378|NCT05418673|155617494|FG001|Overall Study|Study Terminated by Sponsor|4|||
48388379|NCT05418673|155617493|FG000|Overall Study|Lost to Follow-up|1|||
48388380|NCT05418673|155617494|FG001|Overall Study|Lost to Follow-up|0|||
48388381|NCT02665052|155617495|FG000|Overall Study|Lost to Follow-up|1|||
48388382|NCT02665052|155617496|FG001|Overall Study|Lost to Follow-up|0|||
48388383|NCT02665052|155617497|FG002|Overall Study|Lost to Follow-up|0|||
48388384|NCT02665052|155617498|FG003|Overall Study|Lost to Follow-up|0|||
48388385|NCT02665052|155617495|FG000|Overall Study|Withdrawal by Subject|1|||
48388386|NCT02665052|155617496|FG001|Overall Study|Withdrawal by Subject|1|||
48388387|NCT02665052|155617497|FG002|Overall Study|Withdrawal by Subject|0|||
48388388|NCT02665052|155617498|FG003|Overall Study|Withdrawal by Subject|5|||
48388389|NCT02665052|155617495|FG000|Overall Study|Adverse Event|1|||
48388390|NCT02665052|155617496|FG001|Overall Study|Adverse Event|1|||
48388391|NCT02665052|155617497|FG002|Overall Study|Adverse Event|0|||
48388392|NCT02665052|155617498|FG003|Overall Study|Adverse Event|0|||
48388393|NCT00823823|155617499|FG000|Overall Study|Lost to Follow-up|3|||
48388394|NCT00823823|155617500|FG001|Overall Study|Lost to Follow-up|1|||
48388395|NCT00823823|155617499|FG000|Overall Study|Protocol Violation|5|||
48388396|NCT00823823|155617500|FG001|Overall Study|Protocol Violation|5|||
48388397|NCT02161575|155617501|FG000|Overall Study|Protocol Violation|8|||
48388398|NCT02161575|155617501|FG000|Overall Study|Lack of Efficacy|1|||
48388399|NCT02161575|155617501|FG000|Overall Study|Adverse Event|2|||
48388400|NCT00424749|155617502|FG000|Overall Study|Withdrawal by Subject|1|||
48388401|NCT02576444|155617503|FG000|Overall Study|Death|1|||
48388402|NCT02576444|155617504|FG001|Overall Study|Death|1|||
48388403|NCT02576444|155617505|FG002|Overall Study|Death|0|||
48388404|NCT02576444|155617506|FG003|Overall Study|Death|0|||
48388405|NCT02576444|155617503|FG000|Overall Study|Withdrawal by Subject|0|||
48388406|NCT02576444|155617504|FG001|Overall Study|Withdrawal by Subject|0|||
48388407|NCT02576444|155617505|FG002|Overall Study|Withdrawal by Subject|2|||
48388408|NCT02576444|155617506|FG003|Overall Study|Withdrawal by Subject|0|||
48388409|NCT02576444|155617503|FG000|Overall Study|Adverse Event|0|||
48388410|NCT02576444|155617504|FG001|Overall Study|Adverse Event|0|||
48388411|NCT02576444|155617505|FG002|Overall Study|Adverse Event|1|||
48388412|NCT02576444|155617506|FG003|Overall Study|Adverse Event|0|||
48388413|NCT02576444|155617503|FG000|Overall Study|Physician Decision|0|||
48388414|NCT02576444|155617504|FG001|Overall Study|Physician Decision|0|||
48388415|NCT02576444|155617505|FG002|Overall Study|Physician Decision|1|||
48388416|NCT02576444|155617506|FG003|Overall Study|Physician Decision|0|||
48388417|NCT01732796|155617511|FG000|Overall Study|Adverse Event|16|||
48388418|NCT01732796|155617512|FG001|Overall Study|Adverse Event|16|||
48388419|NCT01732796|155617513|FG002|Overall Study|Adverse Event|4|||
48388420|NCT01732796|155617511|FG000|Overall Study|Lack of Efficacy|21|||
48388421|NCT01732796|155617512|FG001|Overall Study|Lack of Efficacy|18|||
48388422|NCT01732796|155617513|FG002|Overall Study|Lack of Efficacy|5|||
48388423|NCT01732796|155617511|FG000|Overall Study|Lost to Follow-up|2|||
48388424|NCT01732796|155617512|FG001|Overall Study|Lost to Follow-up|0|||
48388425|NCT01732796|155617513|FG002|Overall Study|Lost to Follow-up|0|||
48388426|NCT01732796|155617511|FG000|Overall Study|Withdrawal by Subject|6|||
48388427|NCT01732796|155617512|FG001|Overall Study|Withdrawal by Subject|8|||
48388428|NCT01732796|155617513|FG002|Overall Study|Withdrawal by Subject|2|||
48388429|NCT01732796|155617511|FG000|Overall Study|Other reason not defined above|1|||
48388430|NCT01732796|155617512|FG001|Overall Study|Other reason not defined above|0|||
48388431|NCT01732796|155617513|FG002|Overall Study|Other reason not defined above|2|||
48388432|NCT01231659|155617520|FG000|Overall Study|Adverse Event|9|||
48388433|NCT01231659|155617520|FG000|Overall Study|Disease Progression|48|||
48388434|NCT01231659|155617520|FG000|Overall Study|Death|2|||
48388435|NCT01231659|155617520|FG000|Overall Study|Patient refused to complete study visit|1|||
48677810|NCT04072887|156671447|FG005|Overall Study|Adverse Event|1|||
48677811|NCT04072887|156671442|FG000|Overall Study|Physician Decision|2|||
48677812|NCT04072887|156671443|FG001|Overall Study|Physician Decision|0|||
48677813|NCT04072887|156671444|FG002|Overall Study|Physician Decision|0|||
48677814|NCT04072887|156671445|FG003|Overall Study|Physician Decision|0|||
48388436|NCT01231659|155617520|FG000|Overall Study|Other protocol defined criteria|12|||
48388437|NCT00574288|155617523|FG000|Overall Study|Adverse Event|2|||
48388438|NCT00574288|155617524|FG001|Overall Study|Adverse Event|0|||
48388439|NCT00574288|155617525|FG002|Overall Study|Adverse Event|0|||
48388440|NCT00574288|155617526|FG003|Overall Study|Adverse Event|0|||
48388441|NCT00574288|155617527|FG004|Overall Study|Adverse Event|1|||
48388442|NCT00574288|155617528|FG005|Overall Study|Adverse Event|0|||
48388443|NCT00574288|155617529|FG006|Overall Study|Adverse Event|0|||
48388444|NCT00574288|155617523|FG000|Overall Study|Death|0|||
48388445|NCT00574288|155617524|FG001|Overall Study|Death|0|||
48388446|NCT00574288|155617525|FG002|Overall Study|Death|0|||
48388447|NCT00574288|155617526|FG003|Overall Study|Death|0|||
48677815|NCT04072887|156671446|FG004|Overall Study|Physician Decision|0|||
48677816|NCT04072887|156671447|FG005|Overall Study|Physician Decision|1|||
48388448|NCT00574288|155617527|FG004|Overall Study|Death|0|||
48388449|NCT00574288|155617528|FG005|Overall Study|Death|25|||
48388450|NCT00574288|155617529|FG006|Overall Study|Death|21|||
48388451|NCT00574288|155617523|FG000|Overall Study|Lost to Follow-up|0|||
48388452|NCT00574288|155617524|FG001|Overall Study|Lost to Follow-up|0|||
48388453|NCT00574288|155617525|FG002|Overall Study|Lost to Follow-up|0|||
48388454|NCT00574288|155617526|FG003|Overall Study|Lost to Follow-up|0|||
48388455|NCT00574288|155617527|FG004|Overall Study|Lost to Follow-up|0|||
48388456|NCT00574288|155617528|FG005|Overall Study|Lost to Follow-up|1|||
48388457|NCT00574288|155617529|FG006|Overall Study|Lost to Follow-up|2|||
48388458|NCT00574288|155617523|FG000|Overall Study|Study Terminated By Sponsor|0|||
48388459|NCT00574288|155617524|FG001|Overall Study|Study Terminated By Sponsor|0|||
48388460|NCT00574288|155617525|FG002|Overall Study|Study Terminated By Sponsor|0|||
48388461|NCT00574288|155617526|FG003|Overall Study|Study Terminated By Sponsor|0|||
48388462|NCT00574288|155617527|FG004|Overall Study|Study Terminated By Sponsor|0|||
48388463|NCT00574288|155617528|FG005|Overall Study|Study Terminated By Sponsor|0|||
48388464|NCT00574288|155617529|FG006|Overall Study|Study Terminated By Sponsor|5|||
48677817|NCT04072887|156671442|FG000|Overall Study|Lost to Follow-up|1|||
48677818|NCT04072887|156671443|FG001|Overall Study|Lost to Follow-up|3|||
48388465|NCT00574288|155617523|FG000|Overall Study|Progressive Disease|17|||
48388466|NCT00574288|155617524|FG001|Overall Study|Progressive Disease|2|||
48388467|NCT00574288|155617525|FG002|Overall Study|Progressive Disease|3|||
48388468|NCT00574288|155617526|FG003|Overall Study|Progressive Disease|2|||
48388469|NCT00574288|155617527|FG004|Overall Study|Progressive Disease|1|||
48388470|NCT00574288|155617528|FG005|Overall Study|Progressive Disease|0|||
48388471|NCT00574288|155617529|FG006|Overall Study|Progressive Disease|0|||
48388472|NCT00574288|155617523|FG000|Overall Study|Other|1|||
48388473|NCT00574288|155617524|FG001|Overall Study|Other|1|||
48388474|NCT00574288|155617525|FG002|Overall Study|Other|0|||
48388475|NCT00574288|155617526|FG003|Overall Study|Other|0|||
48388476|NCT00574288|155617527|FG004|Overall Study|Other|0|||
48388477|NCT00574288|155617528|FG005|Overall Study|Other|0|||
48388478|NCT00574288|155617529|FG006|Overall Study|Other|0|||
48388479|NCT00356889|155617530|FG000|Overall Study|Protocol Violation|2|||
48388480|NCT00356889|155617530|FG000|Overall Study|Adverse Event|1|||
48388481|NCT00199836|155617536|FG000|Overall Study|Progressive Disease|5|||
48388482|NCT00199836|155617536|FG000|Overall Study|Death|1|||
48388483|NCT03061175|155617537|FG000|Baseline|Participant was deemed ineligible|1|||
48388484|NCT03061175|155617538|FG001|Baseline|Participant was deemed ineligible|0|||
48388485|NCT03061175|155617537|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
48388486|NCT03061175|155617538|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
48388487|NCT03061175|155617537|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
48388488|NCT03061175|155617538|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
48388489|NCT03061175|155617537|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
48388490|NCT03061175|155617538|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
48388491|NCT03418129|155617544|FG000|Overall Study|Lost to Follow-up|11|||
48388492|NCT03418129|155617545|FG001|Overall Study|Lost to Follow-up|20|||
48388493|NCT03418129|155617546|FG002|Overall Study|Lost to Follow-up|15|||
48388494|NCT03418129|155617544|FG000|Overall Study|Withdrawal by Subject|3|||
48388495|NCT03418129|155617545|FG001|Overall Study|Withdrawal by Subject|6|||
48388496|NCT03418129|155617546|FG002|Overall Study|Withdrawal by Subject|4|||
48388497|NCT00427349|155617556|FG000|Overall Study|Lack of Efficacy|23|||
48388498|NCT00427349|155617556|FG000|Overall Study|Adverse Event|14|||
48388499|NCT00427349|155617556|FG000|Overall Study|Death|1|||
48388500|NCT00427349|155617556|FG000|Overall Study|Withdrawal by Subject|3|||
48388501|NCT00427349|155617556|FG000|Overall Study|Alternative therapy|1|||
48388502|NCT00427349|155617556|FG000|Overall Study|Other|2|||
48388503|NCT00427349|155617556|FG000|Overall Study|Ineligible|1|||
48388504|NCT00427349|155617556|FG000|Overall Study|Never started therapy|1|||
48388505|NCT01357655|155617560|FG000|Overall Study|Administrative Reason by Sponsor|45|||
48388506|NCT01357655|155617561|FG001|Overall Study|Administrative Reason by Sponsor|0|||
48388507|NCT01357655|155617560|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
48388508|NCT01357655|155617561|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
48388509|NCT01357655|155617560|FG000|Overall Study|Disease Progression|1|||
48388510|NCT01357655|155617561|FG001|Overall Study|Disease Progression|0|||
48388511|NCT01357655|155617560|FG000|Overall Study|Lost to Follow-up|2|||
48388512|NCT01357655|155617561|FG001|Overall Study|Lost to Follow-up|0|||
48388513|NCT01357655|155617560|FG000|Overall Study|Maximum Clinical Benefit|2|||
48388514|NCT01357655|155617561|FG001|Overall Study|Maximum Clinical Benefit|0|||
48677819|NCT04072887|156671444|FG002|Overall Study|Lost to Follow-up|0|||
48388515|NCT01357655|155617560|FG000|Overall Study|Reason Unspecified|1|||
48388516|NCT01357655|155617561|FG001|Overall Study|Reason Unspecified|0|||
48388517|NCT01357655|155617560|FG000|Overall Study|Study Drug Toxicity|11|||
48388518|NCT01357655|155617561|FG001|Overall Study|Study Drug Toxicity|0|||
48388519|NCT01357655|155617560|FG000|Overall Study|Subject Withdrew Consent|1|||
48388520|NCT01357655|155617561|FG001|Overall Study|Subject Withdrew Consent|0|||
48388521|NCT05003622|155617562|FG000|Overall Study|Progressive disease|2|||
48388522|NCT05003622|155617562|FG000|Overall Study|Withdrawal by Subject|1|||
48677820|NCT04072887|156671445|FG003|Overall Study|Lost to Follow-up|0|||
48388523|NCT04857996|155617563|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
48388524|NCT04857996|155617564|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
48388525|NCT04857996|155617563|FG000|Overall Study|Lost to Follow-up|1|||
48388526|NCT04857996|155617564|FG001|Overall Study|Lost to Follow-up|3|||
48388527|NCT04857996|155617563|FG000|Overall Study|Site Closure|1|||
48388528|NCT04857996|155617564|FG001|Overall Study|Site Closure|0|||
48388529|NCT04857996|155617563|FG000|Overall Study|Withdrawal by Subject|1|||
48388530|NCT04857996|155617564|FG001|Overall Study|Withdrawal by Subject|0|||
48388531|NCT03996876|155617565|FG000|Overall Study|Incomplete Data|2|||
48388532|NCT03996876|155617566|FG001|Overall Study|Incomplete Data|4|||
48388533|NCT01538628|155617573|FG000|Overall Study|Withdrawal by Subject|1|||
48388534|NCT01538628|155617574|FG001|Overall Study|Withdrawal by Subject|1|||
48388535|NCT01538628|155617573|FG000|Overall Study|Lost to Follow-up|0|||
48388536|NCT01538628|155617574|FG001|Overall Study|Lost to Follow-up|1|||
48388537|NCT00574145|155619410|FG000|Overall Study|Withdrawal by Subject|2|||
48388538|NCT00574145|155619411|FG001|Overall Study|Withdrawal by Subject|1|||
48388539|NCT01524198|155619412|FG000|Overall Study|Protocol Violation|8|||
48388540|NCT01524198|155619413|FG001|Overall Study|Protocol Violation|6|||
48388541|NCT01524198|155619412|FG000|Overall Study|Withdrawal by Subject|15|||
48388542|NCT01524198|155619413|FG001|Overall Study|Withdrawal by Subject|10|||
48388543|NCT02142738|155619414|FG000|Overall Study|Adverse Event|13|||
48388544|NCT02142738|155619415|FG001|Overall Study|Adverse Event|9|||
48388545|NCT02142738|155619414|FG000|Overall Study|Death|92|||
48388546|NCT02142738|155619415|FG001|Overall Study|Death|112|||
48388547|NCT02142738|155619414|FG000|Overall Study|Lost to Follow-up|0|||
48388548|NCT02142738|155619415|FG001|Overall Study|Lost to Follow-up|3|||
48388549|NCT02142738|155619414|FG000|Overall Study|Withdrawal by Subject|6|||
48388550|NCT02142738|155619415|FG001|Overall Study|Withdrawal by Subject|7|||
48388551|NCT02142738|155619414|FG000|Overall Study|Follow up ended by sponsor|43|||
48388552|NCT02142738|155619415|FG001|Overall Study|Follow up ended by sponsor|20|||
48388553|NCT02553265|155619416|FG000|Enrollment|Death|0|||
48388554|NCT02553265|155619417|FG001|Enrollment|Death|0|||
48388555|NCT02553265|155619418|FG002|Enrollment|Death|1|||
48388556|NCT02553265|155619416|FG000|First Intervention (28 Days)|Adverse Event|1|||
48388557|NCT02553265|155619417|FG001|First Intervention (28 Days)|Adverse Event|0|||
48388558|NCT02553265|155619418|FG002|First Intervention (28 Days)|Adverse Event|0|||
48388559|NCT02553265|155619416|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
48388560|NCT02553265|155619417|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
48388561|NCT02553265|155619418|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
48388562|NCT02553265|155619416|FG000|Second Intervention (28 Days)|Adverse Event|1|||
48388563|NCT02553265|155619417|FG001|Second Intervention (28 Days)|Adverse Event|0|||
48677821|NCT04072887|156671446|FG004|Overall Study|Lost to Follow-up|0|||
48677822|NCT04072887|156671447|FG005|Overall Study|Lost to Follow-up|0|||
48677823|NCT04072887|156671442|FG000|Overall Study|Death|0|||
48677824|NCT04072887|156671443|FG001|Overall Study|Death|2|||
48677825|NCT04072887|156671444|FG002|Overall Study|Death|0|||
48677826|NCT04072887|156671445|FG003|Overall Study|Death|2|||
48677827|NCT04072887|156671446|FG004|Overall Study|Death|3|||
48677828|NCT04072887|156671447|FG005|Overall Study|Death|0|||
48677829|NCT00367835|156671453|FG000|Overall Study|Adverse Event|14|||
48677830|NCT00367835|156671454|FG001|Overall Study|Adverse Event|1|||
48677831|NCT00367835|156671453|FG000|Overall Study|Protocol Violation|1|||
48677832|NCT00367835|156671454|FG001|Overall Study|Protocol Violation|7|||
48677833|NCT00367835|156671453|FG000|Overall Study|Withdrawal by Subject|7|||
48677834|NCT00367835|156671454|FG001|Overall Study|Withdrawal by Subject|6|||
48677835|NCT00367835|156671453|FG000|Overall Study|Lost to Follow-up|1|||
48677836|NCT00367835|156671454|FG001|Overall Study|Lost to Follow-up|4|||
48677837|NCT00367835|156671453|FG000|Overall Study|Lack of Efficacy|3|||
48677838|NCT00367835|156671454|FG001|Overall Study|Lack of Efficacy|12|||
48677839|NCT00367835|156671453|FG000|Overall Study|Subject in juvenile detention center|1|||
48677840|NCT00367835|156671454|FG001|Overall Study|Subject in juvenile detention center|0|||
48677841|NCT00367835|156671453|FG000|Overall Study|refused blood collection|1|||
48677842|NCT00367835|156671454|FG001|Overall Study|refused blood collection|0|||
48677843|NCT00367835|156671453|FG000|Overall Study|Did not respond to calls|1|||
48677844|NCT00367835|156671454|FG001|Overall Study|Did not respond to calls|0|||
48677845|NCT00367835|156671453|FG000|Overall Study|History of lead poisoning|0|||
48677846|NCT00367835|156671454|FG001|Overall Study|History of lead poisoning|1|||
48388564|NCT02553265|155619418|FG002|Second Intervention (28 Days)|Adverse Event|0|||
48388565|NCT02553265|155619416|FG000|Third Intervention (28 Days)|Adverse Event|1|||
48677847|NCT04371666|156671455|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
48677848|NCT04371666|156671456|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
48388566|NCT02553265|155619417|FG001|Third Intervention (28 Days)|Adverse Event|0|||
48388567|NCT02553265|155619418|FG002|Third Intervention (28 Days)|Adverse Event|0|||
48388568|NCT02553265|155619416|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
48388569|NCT02553265|155619417|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
48388570|NCT02553265|155619418|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
48388571|NCT01628107|155619419|FG000|Overall Study|Withdrawal by Subject|17|||
48388572|NCT01628107|155619419|FG000|Overall Study|Lost to Follow-up|4|||
48388573|NCT01628107|155619419|FG000|Overall Study|Adverse Event|33|||
48388574|NCT01628107|155619419|FG000|Overall Study|Physician Decision|2|||
48677849|NCT04371666|156671455|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
48677850|NCT04371666|156671456|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
48388575|NCT01628107|155619419|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
48388576|NCT01628107|155619419|FG000|Overall Study|Non-compliant with Study Procedures|10|||
48388577|NCT01628107|155619419|FG000|Overall Study|Not Treated|8|||
48388578|NCT01628107|155619419|FG000|Overall Study|Sponsor Decision|11|||
48388579|NCT01628107|155619419|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
48388580|NCT01628107|155619419|FG000|Overall Study|Relocated|8|||
48388581|NCT01628107|155619419|FG000|Overall Study|Kidney Transplant|9|||
48388582|NCT01628107|155619419|FG000|Overall Study|Use of Standard of Care|9|||
48388583|NCT02023242|155619420|FG000|Overall Study|Lost to Follow-up|3|||
48388584|NCT02023242|155619421|FG001|Overall Study|Lost to Follow-up|1|||
48388585|NCT02023242|155619420|FG000|Overall Study|Death|0|||
48388586|NCT02023242|155619421|FG001|Overall Study|Death|1|||
48388587|NCT05092919|155619422|FG000|Overall Study|Lost to Follow-up|7|||
48388588|NCT05092919|155619422|FG000|Overall Study|Withdrawal by Subject|2|||
48388589|NCT00710879|155619423|FG000|Overall Study|Lost to Follow-up|2|||
48388590|NCT00710879|155619424|FG001|Overall Study|Lost to Follow-up|1|||
48388591|NCT00710879|155619423|FG000|Overall Study|Protocol Violation|0|||
48388592|NCT00710879|155619424|FG001|Overall Study|Protocol Violation|3|||
48388593|NCT03104075|155619427|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
48388594|NCT03104075|155619428|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
48388595|NCT03281668|155619430|FG000|Overall Study|Physician Decision|1|||
48388596|NCT03281668|155619430|FG000|Overall Study|scheduling conflict, family circumstance|2|||
48388597|NCT03281668|155619430|FG000|Overall Study|Withdrawal by Subject|4|||
48388598|NCT03281668|155619430|FG000|Overall Study|Lost to Follow-up|1|||
48388599|NCT01469182|155619431|FG000|Overall Study|Adverse Event|21|||
48388600|NCT01469182|155619432|FG001|Overall Study|Adverse Event|3|||
48388601|NCT01469182|155619431|FG000|Overall Study|Lost to Follow-up|3|||
48388602|NCT01469182|155619432|FG001|Overall Study|Lost to Follow-up|0|||
48388603|NCT01469182|155619431|FG000|Overall Study|Withdrawal by Subject|4|||
48388604|NCT01469182|155619432|FG001|Overall Study|Withdrawal by Subject|1|||
48388605|NCT01469182|155619431|FG000|Overall Study|Protocol Violation|4|||
48388606|NCT01469182|155619432|FG001|Overall Study|Protocol Violation|2|||
48388607|NCT01469182|155619431|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
48388608|NCT01469182|155619432|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
48388609|NCT01516970|155619433|FG000|Overall Study|Lost to Follow-up|7|||
48388610|NCT01516970|155619434|FG001|Overall Study|Lost to Follow-up|8|||
48388611|NCT01516970|155619433|FG000|Overall Study|Adverse Event|1|||
48388612|NCT01516970|155619434|FG001|Overall Study|Adverse Event|5|||
48388613|NCT01516970|155619433|FG000|Overall Study|Withdrawal by Subject|1|||
48388614|NCT01516970|155619434|FG001|Overall Study|Withdrawal by Subject|1|||
48388615|NCT01516970|155619433|FG000|Overall Study|Other|9|||
48388616|NCT01516970|155619434|FG001|Overall Study|Other|7|||
48388617|NCT00636675|155619435|FG000|Overall Study|Lost to Follow-up|121|||
48388618|NCT00636675|155619436|FG001|Overall Study|Lost to Follow-up|31|||
48388619|NCT00636675|155619435|FG000|Overall Study|Withdrawal by Subject|19|||
48388620|NCT00636675|155619436|FG001|Overall Study|Withdrawal by Subject|10|||
48388621|NCT00096785|155619439|FG000|Overall Study|Lost to Follow-up|1|||
48388622|NCT00096785|155619440|FG001|Overall Study|Lost to Follow-up|0|||
48388623|NCT00096785|155619439|FG000|Overall Study|Withdrawal by Subject|0|||
48388624|NCT00096785|155619440|FG001|Overall Study|Withdrawal by Subject|1|||
48388625|NCT00096785|155619439|FG000|Overall Study|Relocated|1|||
48388626|NCT00096785|155619440|FG001|Overall Study|Relocated|0|||
48388627|NCT00257725|155619441|FG000|Overall Study|Adverse Event|3|||
48677851|NCT04371666|156671455|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
48677852|NCT04371666|156671456|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
48677853|NCT04371666|156671455|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
48677854|NCT04371666|156671456|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
48677855|NCT04371666|156671455|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
48677856|NCT04371666|156671456|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
48677857|NCT04371666|156671455|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
48677858|NCT04371666|156671456|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
48677859|NCT02147288|156671470|FG000|Overall Study|post-operative hematoma|1|||
48677860|NCT02147288|156671471|FG001|Overall Study|post-operative hematoma|1|||
48677861|NCT02147288|156671472|FG002|Overall Study|post-operative hematoma|0|||
48388628|NCT02573870|155619442|FG000|Overall Study|Adverse Event|0|||
48388629|NCT02573870|155619443|FG001|Overall Study|Adverse Event|2|||
48388630|NCT02573870|155619442|FG000|Overall Study|Lack of Efficacy|0|||
48388631|NCT02573870|155619443|FG001|Overall Study|Lack of Efficacy|1|||
48388632|NCT02573870|155619442|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
48388633|NCT02573870|155619443|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
48388634|NCT02573870|155619442|FG000|Overall Study|Lost to Follow-up|0|||
48388635|NCT02573870|155619443|FG001|Overall Study|Lost to Follow-up|1|||
48388636|NCT02573870|155619442|FG000|Overall Study|Other: Fail to Meet Visit|0|||
48677862|NCT02147288|156671473|FG003|Overall Study|post-operative hematoma|0|||
48677863|NCT02147288|156671474|FG004|Overall Study|post-operative hematoma|0|||
48677864|NCT02147288|156671475|FG005|Overall Study|post-operative hematoma|0|||
48677865|NCT02147288|156671476|FG006|Overall Study|post-operative hematoma|0|||
48677866|NCT02147288|156671477|FG007|Overall Study|post-operative hematoma|0|||
48677867|NCT02147288|156671478|FG008|Overall Study|post-operative hematoma|0|||
48677868|NCT02147288|156671479|FG009|Overall Study|post-operative hematoma|0|||
48677869|NCT02147288|156671470|FG000|Overall Study|complications from concurrent hernia rep|0|||
48677870|NCT02147288|156671471|FG001|Overall Study|complications from concurrent hernia rep|1|||
48677871|NCT02147288|156671472|FG002|Overall Study|complications from concurrent hernia rep|0|||
48677872|NCT02147288|156671473|FG003|Overall Study|complications from concurrent hernia rep|0|||
48677873|NCT02147288|156671474|FG004|Overall Study|complications from concurrent hernia rep|0|||
48677874|NCT02147288|156671475|FG005|Overall Study|complications from concurrent hernia rep|0|||
48677875|NCT02147288|156671476|FG006|Overall Study|complications from concurrent hernia rep|0|||
48677876|NCT02147288|156671477|FG007|Overall Study|complications from concurrent hernia rep|0|||
48677877|NCT02147288|156671478|FG008|Overall Study|complications from concurrent hernia rep|0|||
48677878|NCT02147288|156671479|FG009|Overall Study|complications from concurrent hernia rep|0|||
48677879|NCT01114828|156671480|FG000|Overall Study|Adverse Event|1|||
48677880|NCT01114828|156671481|FG001|Overall Study|Adverse Event|1|||
48677881|NCT01114828|156671480|FG000|Overall Study|Lack of Efficacy|0|||
48677882|NCT01114828|156671481|FG001|Overall Study|Lack of Efficacy|2|||
48677883|NCT01114828|156671480|FG000|Overall Study|Protocol Violation|2|||
48677884|NCT01114828|156671481|FG001|Overall Study|Protocol Violation|0|||
48677885|NCT01114828|156671480|FG000|Overall Study|Withdrawal by Subject|0|||
48677886|NCT01114828|156671481|FG001|Overall Study|Withdrawal by Subject|1|||
48677887|NCT01740401|156672900|FG000|Overall Study|Progression of disease|6|||
48677888|NCT01740401|156672900|FG000|Overall Study|Adverse Event|2|||
48677889|NCT01740401|156672900|FG000|Overall Study|Did not reach primary endpoint|2|||
48677890|NCT03878758|156672901|FG000|Overall Study|Withdrawal by Subject|1|||
48677891|NCT03878758|156672901|FG000|Overall Study|Protocol defined|2|||
48677892|NCT03878758|156672901|FG000|Overall Study|Improper consent documentation|1|||
48677893|NCT00358436|156672904|FG000|Overall Study|Adverse Event|29|||
48677894|NCT00358436|156672905|FG001|Overall Study|Adverse Event|13|||
48677895|NCT00358436|156672904|FG000|Overall Study|Lack of Efficacy|34|||
48677896|NCT00358436|156672905|FG001|Overall Study|Lack of Efficacy|36|||
48677897|NCT00358436|156672904|FG000|Overall Study|Lost to Follow-up|11|||
48677898|NCT00358436|156672905|FG001|Overall Study|Lost to Follow-up|6|||
48677899|NCT00358436|156672904|FG000|Overall Study|Protocol Violation|8|||
48677900|NCT00358436|156672905|FG001|Overall Study|Protocol Violation|3|||
48677901|NCT00358436|156672904|FG000|Overall Study|Withdrawal by Subject|40|||
48677902|NCT00358436|156672905|FG001|Overall Study|Withdrawal by Subject|17|||
48677903|NCT00358436|156672904|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
48677904|NCT00358436|156672905|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
48677905|NCT00358436|156672904|FG000|Overall Study|COPD exacerbation|22|||
48677906|NCT00358436|156672905|FG001|Overall Study|COPD exacerbation|10|||
48677907|NCT00358436|156672904|FG000|Overall Study|Other|6|||
48677908|NCT00358436|156672905|FG001|Overall Study|Other|1|||
48677909|NCT03614325|156672908|FG000|Overall Study|Withdrawal by Subject|0|||
48677910|NCT03614325|156672909|FG001|Overall Study|Withdrawal by Subject|2|||
48677911|NCT03614325|156672908|FG000|Overall Study|Surgery Cancelled|2|||
48677912|NCT03614325|156672909|FG001|Overall Study|Surgery Cancelled|1|||
48677913|NCT03614325|156672908|FG000|Overall Study|Lost to Follow-up|2|||
48677914|NCT03614325|156672909|FG001|Overall Study|Lost to Follow-up|1|||
48677915|NCT03614325|156672908|FG000|Overall Study|Surgery never scheduled|1|||
48677916|NCT03614325|156672909|FG001|Overall Study|Surgery never scheduled|0|||
48677917|NCT00321464|156672912|FG000|Overall Study|Death|169|||
48677918|NCT00321464|156672913|FG001|Overall Study|Death|174|||
48677919|NCT00321464|156672912|FG000|Overall Study|Disease progression|124|||
48677920|NCT00321464|156672913|FG001|Overall Study|Disease progression|124|||
48677921|NCT00321464|156672912|FG000|Overall Study|Withdrawal by Subject|117|||
48677922|NCT00321464|156672913|FG001|Overall Study|Withdrawal by Subject|118|||
48677923|NCT00321464|156672912|FG000|Overall Study|Participant request|57|||
48677924|NCT00321464|156672913|FG001|Overall Study|Participant request|61|||
48677925|NCT00321464|156672912|FG000|Overall Study|Adverse Event|43|||
48388637|NCT02573870|155619443|FG001|Overall Study|Other: Fail to Meet Visit|2|||
48677926|NCT00321464|156672913|FG001|Overall Study|Adverse Event|28|||
48677927|NCT00321464|156672912|FG000|Overall Study|Physician Decision|15|||
48677928|NCT00321464|156672913|FG001|Overall Study|Physician Decision|14|||
48677929|NCT00321464|156672912|FG000|Overall Study|Noncompliance|4|||
48677930|NCT00321464|156672913|FG001|Overall Study|Noncompliance|10|||
48677931|NCT00321464|156672912|FG000|Overall Study|Lost to Follow-up|7|||
48677932|NCT00321464|156672913|FG001|Overall Study|Lost to Follow-up|8|||
48677933|NCT00321464|156672912|FG000|Overall Study|Protocol deviation|0|||
48677934|NCT00321464|156672913|FG001|Overall Study|Protocol deviation|2|||
48677935|NCT00321464|156672912|FG000|Overall Study|Ineligibility determined|2|||
48677936|NCT00321464|156672913|FG001|Overall Study|Ineligibility determined|1|||
48677937|NCT00321464|156672912|FG000|Overall Study|Other|21|||
48677938|NCT00321464|156672913|FG001|Overall Study|Other|18|||
48677939|NCT01450098|156672919|FG000|Period 3|Protocol Violation|0|||
48677940|NCT01450098|156672920|FG001|Period 3|Protocol Violation|1|||
48677941|NCT01450098|156672919|FG000|Period 3|Withdrawal by Subject|0|||
48677942|NCT01450098|156672920|FG001|Period 3|Withdrawal by Subject|2|||
48677943|NCT02352753|156672926|FG000|6-Month Dosing Period|Decision by sponsor|2|||
48677944|NCT02352753|156672926|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
48677945|NCT02352753|156672926|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
48677946|NCT02352753|156672926|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
48677947|NCT02352753|156672926|FG000|3-Month Dosing Period|Decision by sponsor|14|||
48677948|NCT02352753|156672926|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
48677949|NCT01363908|156672927|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
48677950|NCT01363908|156672928|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
48677951|NCT01363908|156672927|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
48677952|NCT01363908|156672928|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
48677953|NCT01363908|156672927|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
48677954|NCT01363908|156672928|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
48677955|NCT01363908|156672927|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
48762684|NCT02159521|156980300|FG000|Overall Study|Other than specified|1|||
48762685|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|5|||
48762686|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|1|||
48762687|NCT00304356|156980301|FG000|Nitazoxanide|number is 0|1|||
48762688|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|1|||
48762689|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|1|||
48762690|NCT00304356|156980301|FG000|Nitazoxanide|Physician Decision|1|||
48762691|NCT02590939|156980303|FG000|Overall Study|Withdrawal by Subject|3|||
48388638|NCT01858532|155619444|FG000|Overall Study|Adverse Event|58|||
48388639|NCT01858532|155619445|FG001|Overall Study|Adverse Event|50|||
48388640|NCT01858532|155619446|FG002|Overall Study|Adverse Event|23|||
48388641|NCT01858532|155619447|FG003|Overall Study|Adverse Event|28|||
48388642|NCT01858532|155619444|FG000|Overall Study|Withdrew consent|71|||
48388643|NCT01858532|155619445|FG001|Overall Study|Withdrew consent|93|||
48388644|NCT01858532|155619446|FG002|Overall Study|Withdrew consent|46|||
48388645|NCT01858532|155619447|FG003|Overall Study|Withdrew consent|27|||
48388646|NCT01858532|155619444|FG000|Overall Study|Lost to Follow-up|17|||
48388647|NCT01858532|155619445|FG001|Overall Study|Lost to Follow-up|26|||
48388648|NCT01858532|155619446|FG002|Overall Study|Lost to Follow-up|11|||
48388649|NCT01858532|155619447|FG003|Overall Study|Lost to Follow-up|14|||
48388650|NCT01858532|155619444|FG000|Overall Study|Deterioration of medical status|3|||
48388651|NCT01858532|155619445|FG001|Overall Study|Deterioration of medical status|4|||
48388652|NCT01858532|155619446|FG002|Overall Study|Deterioration of medical status|3|||
48388653|NCT01858532|155619447|FG003|Overall Study|Deterioration of medical status|7|||
48388654|NCT01858532|155619444|FG000|Overall Study|Investigator request|3|||
48388655|NCT01858532|155619445|FG001|Overall Study|Investigator request|4|||
48388656|NCT01858532|155619446|FG002|Overall Study|Investigator request|2|||
48388657|NCT01858532|155619447|FG003|Overall Study|Investigator request|6|||
48762692|NCT02590939|156980304|FG001|Overall Study|Withdrawal by Subject|1|||
48388658|NCT01858532|155619444|FG000|Overall Study|Other, not specified|29|||
48388659|NCT01858532|155619445|FG001|Overall Study|Other, not specified|15|||
48388660|NCT01858532|155619446|FG002|Overall Study|Other, not specified|13|||
48388661|NCT01858532|155619447|FG003|Overall Study|Other, not specified|11|||
48388662|NCT00434421|155619448|FG000|Overall Study|Withdrawal by Subject|1|||
48388663|NCT00434421|155619448|FG000|Overall Study|Non-compliance with study treatment|1|||
48388664|NCT01756040|155619452|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
48388665|NCT01756040|155619452|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
48388666|NCT01756040|155619452|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
48388667|NCT01274715|155619453|FG000|Overall Study|Lost to Follow-up|1|||
48388668|NCT01274715|155619453|FG000|Overall Study|After consent, met exclusion criteria.|1|||
48677956|NCT01363908|156672928|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
48677957|NCT01815840|156672930|FG000|Overall Study|Missing|1|||
48677958|NCT01815840|156672931|FG001|Overall Study|Missing|0|||
48677959|NCT01815840|156672930|FG000|Overall Study|Withdrew Consent|31|||
48677960|NCT01815840|156672931|FG001|Overall Study|Withdrew Consent|30|||
48677961|NCT01815840|156672930|FG000|Overall Study|Administrative/Other|1|||
48388669|NCT01274715|155619453|FG000|Overall Study|After consent, met exclusion criteria.|1|||
48388670|NCT01274715|155619453|FG000|Overall Study|After consent, met exclusion criteria.|1|||
48677962|NCT01815840|156672931|FG001|Overall Study|Administrative/Other|3|||
48677963|NCT01815840|156672930|FG000|Overall Study|Adverse Event|10|||
48677964|NCT01815840|156672931|FG001|Overall Study|Adverse Event|16|||
48677965|NCT01815840|156672930|FG000|Overall Study|Death|2|||
48677966|NCT01815840|156672931|FG001|Overall Study|Death|2|||
48677967|NCT01815840|156672930|FG000|Overall Study|Disease progression|3|||
48677968|NCT01815840|156672931|FG001|Overall Study|Disease progression|2|||
48677969|NCT01815840|156672930|FG000|Overall Study|Investigators Decision|2|||
48677970|NCT01815840|156672931|FG001|Overall Study|Investigators Decision|3|||
48677971|NCT01815840|156672930|FG000|Overall Study|Lost to Follow-up|3|||
48677972|NCT01815840|156672931|FG001|Overall Study|Lost to Follow-up|6|||
48677973|NCT01815840|156672930|FG000|Overall Study|Refused Treatment|5|||
48677974|NCT01815840|156672931|FG001|Overall Study|Refused Treatment|1|||
48677975|NCT01815840|156672930|FG000|Overall Study|Sponsor Termination Treatment|1|||
48677976|NCT01815840|156672931|FG001|Overall Study|Sponsor Termination Treatment|0|||
48677977|NCT02504580|156672932|FG000|Overall Study|Other|1|||
48677978|NCT02504580|156672933|FG001|Overall Study|Other|0|||
48677979|NCT02504580|156672934|FG002|Overall Study|Other|0|||
48677980|NCT02504580|156672935|FG003|Overall Study|Other|2|||
48677981|NCT02504580|156672936|FG004|Overall Study|Other|1|||
48677982|NCT02504580|156672937|FG005|Overall Study|Other|1|||
48677983|NCT02504580|156672938|FG006|Overall Study|Other|1|||
48677984|NCT02504580|156672939|FG007|Overall Study|Other|2|||
48677985|NCT02504580|156672940|FG008|Overall Study|Other|0|||
48762693|NCT02590939|156980303|FG000|Overall Study|Failed the nociceptive test|2|||
48762694|NCT02590939|156980304|FG001|Overall Study|Failed the nociceptive test|1|||
48762695|NCT03717480|156980305|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
48762696|NCT05045144|156980306|FG000|Overall Study|Lost to Follow-up|3|||
48762697|NCT05045144|156980307|FG001|Overall Study|Lost to Follow-up|2|||
48762698|NCT05045144|156980308|FG002|Overall Study|Lost to Follow-up|3|||
48762699|NCT05045144|156980309|FG003|Overall Study|Lost to Follow-up|5|||
48762700|NCT05045144|156980310|FG004|Overall Study|Lost to Follow-up|13|||
48762701|NCT05045144|156980306|FG000|Overall Study|Withdrawal by Subject|0|||
48762702|NCT05045144|156980307|FG001|Overall Study|Withdrawal by Subject|1|||
48762703|NCT05045144|156980308|FG002|Overall Study|Withdrawal by Subject|0|||
48762704|NCT05045144|156980309|FG003|Overall Study|Withdrawal by Subject|0|||
48762705|NCT05045144|156980310|FG004|Overall Study|Withdrawal by Subject|0|||
48762706|NCT05045144|156980306|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48762707|NCT05045144|156980307|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48762708|NCT05045144|156980308|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48762709|NCT05045144|156980309|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48762710|NCT05045144|156980310|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48762711|NCT00768144|156980311|FG000|Overall Study|Adverse Event|13|||
48762712|NCT00768144|156980311|FG000|Overall Study|Progressive Disease|21|||
48762713|NCT00768144|156980311|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
48762714|NCT00768144|156980311|FG000|Overall Study|Pt Withdrew Consent|1|||
48762715|NCT03011307|156980312|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
48762716|NCT03011307|156980313|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
48762717|NCT03011307|156980312|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
48762718|NCT03011307|156980313|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
48762719|NCT03011307|156980312|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
48762720|NCT03011307|156980313|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
48762721|NCT02968979|156980314|FG000|Overall Study|Protocol Violation|7|||
48762722|NCT02968979|156980314|FG000|Overall Study|Withdrawal by Subject|1|||
48762723|NCT02466555|156980321|FG000|Overall Study|Lost to Follow-up|2|||
48762724|NCT01527682|156980322|FG000|Overall Study|Protocol Violation|8|||
48762725|NCT03760146|156980323|FG000|Overall Study|Adverse Event|11|||
48762726|NCT03760146|156980324|FG001|Overall Study|Adverse Event|8|||
48762727|NCT03760146|156980325|FG002|Overall Study|Adverse Event|0|||
48762728|NCT03760146|156980326|FG003|Overall Study|Adverse Event|0|||
48762729|NCT03760146|156980327|FG004|Overall Study|Adverse Event|0|||
48388671|NCT02495844|155619456|FG000|Overall Study|Lack of Efficacy|1|||
48762730|NCT03760146|156980328|FG005|Overall Study|Adverse Event|0|||
48762731|NCT03760146|156980323|FG000|Overall Study|Death|1|||
48677986|NCT02504580|156672941|FG009|Overall Study|Other|0|||
48677987|NCT02504580|156672942|FG010|Overall Study|Other|0|||
48677988|NCT02504580|156672943|FG011|Overall Study|Other|2|||
48677989|NCT02504580|156672932|FG000|Overall Study|Subject refusal to continue|0|||
48762732|NCT03760146|156980324|FG001|Overall Study|Death|0|||
48762733|NCT03760146|156980325|FG002|Overall Study|Death|0|||
48677990|NCT02504580|156672933|FG001|Overall Study|Subject refusal to continue|1|||
48677991|NCT02504580|156672934|FG002|Overall Study|Subject refusal to continue|0|||
48677992|NCT02504580|156672935|FG003|Overall Study|Subject refusal to continue|0|||
48677993|NCT02504580|156672936|FG004|Overall Study|Subject refusal to continue|0|||
48677994|NCT02504580|156672937|FG005|Overall Study|Subject refusal to continue|0|||
48388672|NCT02495844|155619457|FG001|Overall Study|Lack of Efficacy|2|||
48388673|NCT02495844|155619456|FG000|Overall Study|AE, non-fatal|0|||
48677995|NCT02504580|156672938|FG006|Overall Study|Subject refusal to continue|0|||
48677996|NCT02504580|156672939|FG007|Overall Study|Subject refusal to continue|0|||
48677997|NCT02504580|156672940|FG008|Overall Study|Subject refusal to continue|0|||
48677998|NCT02504580|156672941|FG009|Overall Study|Subject refusal to continue|0|||
48677999|NCT02504580|156672942|FG010|Overall Study|Subject refusal to continue|0|||
48678000|NCT02504580|156672943|FG011|Overall Study|Subject refusal to continue|0|||
48678001|NCT01564732|156672944|FG000|Overall Study|Early termination by the study sponsor|6|||
48678002|NCT01564732|156672945|FG001|Overall Study|Early termination by the study sponsor|5|||
48678003|NCT01957202|156672946|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678004|NCT01957202|156672947|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
48678005|NCT01957202|156672948|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678006|NCT01957202|156672949|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678007|NCT01957202|156672950|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678008|NCT01957202|156672951|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678009|NCT01957202|156672952|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678010|NCT01957202|156672953|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678011|NCT01957202|156672954|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48388674|NCT02495844|155619457|FG001|Overall Study|AE, non-fatal|1|||
48388675|NCT02495844|155619456|FG000|Overall Study|Hepatitis Positivity|0|||
48388676|NCT02495844|155619457|FG001|Overall Study|Hepatitis Positivity|1|||
48388677|NCT02285920|155619460|FG000|Overall Study|Kidney transplantation|2|||
48388678|NCT02285920|155619461|FG001|Overall Study|Kidney transplantation|2|||
48388679|NCT02285920|155619462|FG002|Overall Study|Kidney transplantation|2|||
48388680|NCT02285920|155619463|FG003|Overall Study|Kidney transplantation|0|||
48388681|NCT02285920|155619460|FG000|Overall Study|Change to peritoneal dialysis|0|||
48388682|NCT02285920|155619461|FG001|Overall Study|Change to peritoneal dialysis|0|||
48388683|NCT02285920|155619462|FG002|Overall Study|Change to peritoneal dialysis|1|||
48388684|NCT02285920|155619463|FG003|Overall Study|Change to peritoneal dialysis|0|||
48388685|NCT02285920|155619460|FG000|Overall Study|Transfer to non-participating unit|0|||
48388686|NCT02285920|155619461|FG001|Overall Study|Transfer to non-participating unit|1|||
48388687|NCT02285920|155619462|FG002|Overall Study|Transfer to non-participating unit|0|||
48388688|NCT02285920|155619463|FG003|Overall Study|Transfer to non-participating unit|0|||
48388689|NCT02285920|155619460|FG000|Overall Study|Dialysis discontinuation|0|||
48388690|NCT02285920|155619461|FG001|Overall Study|Dialysis discontinuation|1|||
48388691|NCT02285920|155619462|FG002|Overall Study|Dialysis discontinuation|0|||
48678012|NCT01957202|156672955|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678013|NCT01957202|156672956|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678014|NCT01957202|156672957|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678015|NCT01957202|156672958|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678016|NCT01957202|156672959|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678017|NCT01957202|156672960|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678018|NCT01957202|156672961|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678019|NCT01957202|156672962|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
48678020|NCT01957202|156672963|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
48678021|NCT01957202|156672946|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678022|NCT01957202|156672947|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678023|NCT01957202|156672948|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678024|NCT01957202|156672949|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
48388692|NCT02285920|155619463|FG003|Overall Study|Dialysis discontinuation|0|||
48388693|NCT02285920|155619460|FG000|Overall Study|Death|2|||
48388694|NCT02285920|155619461|FG001|Overall Study|Death|0|||
48388695|NCT02285920|155619462|FG002|Overall Study|Death|2|||
48388696|NCT02285920|155619463|FG003|Overall Study|Death|1|||
48388697|NCT02716675|155619466|FG000|Overall Study|Death|2|||
48678025|NCT01957202|156672950|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678026|NCT01957202|156672951|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678027|NCT01957202|156672952|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678028|NCT01957202|156672953|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678029|NCT01957202|156672954|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678030|NCT01957202|156672955|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678031|NCT01957202|156672956|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678032|NCT01957202|156672957|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678033|NCT01957202|156672958|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
48762734|NCT03760146|156980326|FG003|Overall Study|Death|0|||
48388698|NCT02716675|155619467|FG001|Overall Study|Death|3|||
48388699|NCT02716675|155619468|FG002|Overall Study|Death|0|||
48388700|NCT02716675|155619466|FG000|Overall Study|Physician Decision|2|||
48388701|NCT02716675|155619467|FG001|Overall Study|Physician Decision|1|||
48388702|NCT02716675|155619468|FG002|Overall Study|Physician Decision|1|||
48388703|NCT02716675|155619466|FG000|Overall Study|Lost to Follow-up|100|||
48388704|NCT02716675|155619467|FG001|Overall Study|Lost to Follow-up|87|||
48388705|NCT02716675|155619468|FG002|Overall Study|Lost to Follow-up|99|||
48678034|NCT01957202|156672959|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678035|NCT01957202|156672960|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678036|NCT01957202|156672961|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678037|NCT01957202|156672962|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
48678038|NCT01957202|156672963|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
48678039|NCT04207060|156672968|FG000|Overall Study|Lost to Follow-up|2|||
48678040|NCT04207060|156672969|FG001|Overall Study|Lost to Follow-up|0|||
48678041|NCT01452919|156672970|FG000|Open-Label Treatment|Adverse Event|5|||
48678042|NCT01452919|156672971|FG001|Open-Label Treatment|Adverse Event|0|||
48678043|NCT01452919|156672972|FG002|Open-Label Treatment|Adverse Event|0|||
48678044|NCT01452919|156672970|FG000|Open-Label Treatment|Lost to Follow-up|4|||
48678045|NCT01452919|156672971|FG001|Open-Label Treatment|Lost to Follow-up|0|||
48678046|NCT01452919|156672972|FG002|Open-Label Treatment|Lost to Follow-up|0|||
48678047|NCT01452919|156672970|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
48678048|NCT01452919|156672971|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
48678049|NCT01452919|156672972|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
48678050|NCT01452919|156672970|FG000|Open-Label Treatment|Protocol Violation|4|||
48678051|NCT01452919|156672971|FG001|Open-Label Treatment|Protocol Violation|0|||
48678052|NCT01452919|156672972|FG002|Open-Label Treatment|Protocol Violation|0|||
48678053|NCT01452919|156672970|FG000|Open-Label Treatment|Sponsor Decision|1|||
48678054|NCT01452919|156672971|FG001|Open-Label Treatment|Sponsor Decision|0|||
48678055|NCT01452919|156672972|FG002|Open-Label Treatment|Sponsor Decision|0|||
48678056|NCT01452919|156672970|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
48762735|NCT03760146|156980327|FG004|Overall Study|Death|0|||
48388706|NCT02716675|155619466|FG000|Overall Study|Withdrawal by Subject|22|||
48388707|NCT02716675|155619467|FG001|Overall Study|Withdrawal by Subject|25|||
48388708|NCT02716675|155619468|FG002|Overall Study|Withdrawal by Subject|20|||
48388709|NCT02716675|155619466|FG000|Overall Study|Protocol Violation|0|||
48388710|NCT02716675|155619467|FG001|Overall Study|Protocol Violation|3|||
48388711|NCT02716675|155619468|FG002|Overall Study|Protocol Violation|1|||
48388712|NCT02716675|155619466|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
48388713|NCT02716675|155619467|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
48388714|NCT02716675|155619468|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
48388715|NCT02716675|155619466|FG000|Overall Study|Other|38|||
48388716|NCT02716675|155619467|FG001|Overall Study|Other|47|||
48388717|NCT02716675|155619468|FG002|Overall Study|Other|48|||
48388718|NCT03593850|155619473|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
48388719|NCT03593850|155619474|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
48388720|NCT01380730|155619477|FG000|Overall Study|Death|0|||
48388721|NCT01380730|155619478|FG001|Overall Study|Death|0|||
48388722|NCT01380730|155619479|FG002|Overall Study|Death|0|||
48388723|NCT01380730|155619480|FG003|Overall Study|Death|0|||
48388724|NCT01380730|155619481|FG004|Overall Study|Death|1|||
48388725|NCT01380730|155619482|FG005|Overall Study|Death|0|||
48388726|NCT01380730|155619483|FG006|Overall Study|Death|0|||
48388727|NCT01380730|155619484|FG007|Overall Study|Death|0|||
48388728|NCT00806195|155619485|FG000|Overall Study|Death|6|||
48388729|NCT00806195|155619486|FG001|Overall Study|Death|0|||
48388730|NCT00806195|155619487|FG002|Overall Study|Death|1|||
48388731|NCT00806195|155619488|FG003|Overall Study|Death|0|||
48388732|NCT00806195|155619485|FG000|Overall Study|Adverse Event|25|||
48388733|NCT00806195|155619486|FG001|Overall Study|Adverse Event|5|||
48388734|NCT00806195|155619487|FG002|Overall Study|Adverse Event|11|||
48388735|NCT00806195|155619488|FG003|Overall Study|Adverse Event|2|||
48388736|NCT00806195|155619485|FG000|Overall Study|Withdrawal by Subject|119|||
48388737|NCT00806195|155619486|FG001|Overall Study|Withdrawal by Subject|31|||
48388738|NCT00806195|155619487|FG002|Overall Study|Withdrawal by Subject|76|||
48388739|NCT00806195|155619488|FG003|Overall Study|Withdrawal by Subject|35|||
48388740|NCT00806195|155619485|FG000|Overall Study|Lost to Follow-up|217|||
48678057|NCT01452919|156672971|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
48678058|NCT01452919|156672972|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
48678059|NCT01452919|156672970|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
48678060|NCT01452919|156672971|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
48678061|NCT01452919|156672972|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
48678062|NCT01452919|156672970|FG000|Randomization Treatment|Adverse Event|0|||
48678063|NCT01452919|156672971|FG001|Randomization Treatment|Adverse Event|0|||
48678064|NCT01452919|156672972|FG002|Randomization Treatment|Adverse Event|2|||
48762736|NCT03760146|156980328|FG005|Overall Study|Death|0|||
48388741|NCT00806195|155619486|FG001|Overall Study|Lost to Follow-up|66|||
48388742|NCT00806195|155619487|FG002|Overall Study|Lost to Follow-up|90|||
48388743|NCT00806195|155619488|FG003|Overall Study|Lost to Follow-up|34|||
48388744|NCT00806195|155619485|FG000|Overall Study|Inappropriate Enrollment|0|||
48388745|NCT00806195|155619486|FG001|Overall Study|Inappropriate Enrollment|1|||
48388746|NCT00806195|155619487|FG002|Overall Study|Inappropriate Enrollment|0|||
48388747|NCT00806195|155619488|FG003|Overall Study|Inappropriate Enrollment|0|||
48388748|NCT00806195|155619485|FG000|Overall Study|Administrative Reason|113|||
48388749|NCT00806195|155619486|FG001|Overall Study|Administrative Reason|35|||
48678065|NCT01452919|156672970|FG000|Randomization Treatment|Sponsor Decision|0|||
48678066|NCT01452919|156672971|FG001|Randomization Treatment|Sponsor Decision|1|||
48678067|NCT01452919|156672972|FG002|Randomization Treatment|Sponsor Decision|0|||
48678068|NCT01452919|156672970|FG000|Randomization Treatment|Withdrawal by Subject|0|||
48678069|NCT01452919|156672971|FG001|Randomization Treatment|Withdrawal by Subject|1|||
48678070|NCT01452919|156672972|FG002|Randomization Treatment|Withdrawal by Subject|0|||
48678071|NCT01452919|156672970|FG000|Randomization Treatment|Subject is moving or has moved|0|||
48678072|NCT01452919|156672971|FG001|Randomization Treatment|Subject is moving or has moved|1|||
48678073|NCT01452919|156672972|FG002|Randomization Treatment|Subject is moving or has moved|0|||
48678074|NCT04752358|156672975|FG000|Overall Study|Death|2|||
48678075|NCT04752358|156672976|FG001|Overall Study|Death|1|||
48678076|NCT02718716|156672977|FG000|Overall Study|Lack of Efficacy|1|||
48678077|NCT02718716|156672978|FG001|Overall Study|Lack of Efficacy|0|||
48678078|NCT02718716|156672979|FG002|Overall Study|Lack of Efficacy|0|||
48678079|NCT02718716|156672980|FG003|Overall Study|Lack of Efficacy|0|||
48678080|NCT02718716|156672981|FG004|Overall Study|Lack of Efficacy|0|||
48678081|NCT01359943|156672982|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
48678082|NCT01359943|156672983|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
48678083|NCT01359943|156672984|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
48678084|NCT01359943|156672982|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
48678085|NCT01359943|156672983|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
48678086|NCT01359943|156672984|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
48678087|NCT01359943|156672982|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
48678088|NCT01359943|156672983|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
48678089|NCT01359943|156672984|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
48678090|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
48678091|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
48678092|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
48678093|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
48678094|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
48678095|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
48678096|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
48678097|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
48678098|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
48678099|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
48678100|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
48678101|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
48678102|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
48678103|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
48678104|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
48678105|NCT01359943|156672982|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
48678106|NCT01359943|156672983|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
48678107|NCT01359943|156672984|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
48678108|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
48678109|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
48678110|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
48678111|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
48678112|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
48678113|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
48678114|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
48678115|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
48678116|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
48678117|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
48678118|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
48678119|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
48678120|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
48678121|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
48678122|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
48678123|NCT01359943|156672982|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
48678124|NCT01359943|156672983|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
48678125|NCT01359943|156672984|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
48678126|NCT03722524|156672987|FG000|Overall Study|Protocol Violation|86|||
48678127|NCT03722524|156672987|FG000|Overall Study|Adverse Event|7|||
48678128|NCT03722524|156672987|FG000|Overall Study|Lost to Follow-up|1|||
48678129|NCT03722524|156672987|FG000|Overall Study|Reason is not stated|1|||
48678130|NCT03722524|156672987|FG000|Overall Study|Physician Decision|1|||
48678131|NCT03722524|156672987|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
48678132|NCT02942485|156672988|FG000|Overall Study|Lost to Follow-up|1|||
48678133|NCT02942485|156672989|FG001|Overall Study|Lost to Follow-up|0|||
48678134|NCT03245398|156672995|FG000|Overall Study|Travelled to another island|1|||
48678135|NCT03245398|156672996|FG001|Overall Study|Travelled to another island|0|||
48678136|NCT00880191|156673002|FG000|Overall Study|Refused further treatment|4|||
48678137|NCT00880191|156673003|FG001|Overall Study|Refused further treatment|1|||
48678138|NCT00880191|156673002|FG000|Overall Study|Adverse Event|8|||
48678139|NCT00880191|156673003|FG001|Overall Study|Adverse Event|6|||
48678140|NCT00880191|156673002|FG000|Overall Study|Hospitalization/efficacy|1|||
48678141|NCT00880191|156673003|FG001|Overall Study|Hospitalization/efficacy|1|||
48678142|NCT00774800|156673007|FG000|Intervention 4|Withdrawal by Subject|1|||
48678143|NCT01240200|156673008|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
48678144|NCT01240200|156673009|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
48678145|NCT01331109|156673010|FG000|Overall Study|Adverse Event|6|||
48678146|NCT01331109|156673010|FG000|Overall Study|Lack of Efficacy|2|||
48678147|NCT01331109|156673010|FG000|Overall Study|Protocol Violation|3|||
48678148|NCT01331109|156673010|FG000|Overall Study|Withdrawal by Subject|7|||
48678149|NCT01331109|156673010|FG000|Overall Study|Lost to Follow-up|1|||
48678150|NCT01331109|156673010|FG000|Overall Study|Study Terminated by Sponsor|38|||
48678151|NCT00988091|156673014|FG000|Double-blind Period|Withdrawal by Subject|15|||
48678152|NCT00988091|156673015|FG001|Double-blind Period|Withdrawal by Subject|13|||
48678153|NCT00988091|156673014|FG000|Double-blind Period|Lost to Follow-up|12|||
48678154|NCT00988091|156673015|FG001|Double-blind Period|Lost to Follow-up|14|||
48678155|NCT00988091|156673014|FG000|Double-blind Period|Other|8|||
48678156|NCT00988091|156673015|FG001|Double-blind Period|Other|8|||
48678157|NCT00988091|156673014|FG000|Double-blind Period|Adverse Event|6|||
48678158|NCT00988091|156673015|FG001|Double-blind Period|Adverse Event|9|||
48678159|NCT00988091|156673014|FG000|Double-blind Period|Use of exclusionary medication|2|||
48678160|NCT00988091|156673015|FG001|Double-blind Period|Use of exclusionary medication|3|||
48678161|NCT00988091|156673014|FG000|Open-label Period|Adverse Event|4|||
48678162|NCT00988091|156673015|FG001|Open-label Period|Adverse Event|7|||
48678163|NCT00988091|156673014|FG000|Open-label Period|Use of exclusionary medication|1|||
48678164|NCT00988091|156673015|FG001|Open-label Period|Use of exclusionary medication|1|||
48678165|NCT00988091|156673014|FG000|Open-label Period|Protocol Violation|1|||
48678166|NCT00988091|156673015|FG001|Open-label Period|Protocol Violation|1|||
48678167|NCT00988091|156673014|FG000|Open-label Period|Withdrawal by Subject|10|||
48678168|NCT00988091|156673015|FG001|Open-label Period|Withdrawal by Subject|16|||
48678169|NCT00988091|156673014|FG000|Open-label Period|Lost to Follow-up|3|||
48678170|NCT00988091|156673015|FG001|Open-label Period|Lost to Follow-up|5|||
48678171|NCT00988091|156673014|FG000|Open-label Period|Other|2|||
48678172|NCT00988091|156673015|FG001|Open-label Period|Other|3|||
48678173|NCT01529034|156673016|FG000|Overall Study|Discontinued prior to study treatment|14|||
48678174|NCT01529034|156673016|FG000|Overall Study|Site closure|62|||
48678175|NCT01529034|156673016|FG000|Overall Study|Study termination|29|||
48678176|NCT01529034|156673016|FG000|Overall Study|Withdrawal by Subject|25|||
48762737|NCT03760146|156980323|FG000|Overall Study|Lost to Follow-up|41|||
48678177|NCT01529034|156673016|FG000|Overall Study|No treated SCs within protocol window|13|||
48678178|NCT01529034|156673016|FG000|Overall Study|Noncompliance|8|||
48678179|NCT01529034|156673016|FG000|Overall Study|Caregiver no longer available|7|||
48678180|NCT01529034|156673016|FG000|Overall Study|Adverse Event|4|||
48678181|NCT01529034|156673016|FG000|Overall Study|Protocol Violation|4|||
48678182|NCT01529034|156673016|FG000|Overall Study|Lack of Efficacy|4|||
48678183|NCT01529034|156673016|FG000|Overall Study|Investigator no longer available|2|||
48678184|NCT01529034|156673016|FG000|Overall Study|Study drug not available|2|||
48678185|NCT00770601|156673024|FG000|Overall Study|Withdrawal by Subject|1|||
48678186|NCT00532298|156673027|FG000|Overall Study|Adverse Event|1|||
48762738|NCT03760146|156980324|FG001|Overall Study|Lost to Follow-up|28|||
48762739|NCT03760146|156980325|FG002|Overall Study|Lost to Follow-up|9|||
48388750|NCT00806195|155619487|FG002|Overall Study|Administrative Reason|66|||
48388751|NCT00806195|155619488|FG003|Overall Study|Administrative Reason|26|||
48388752|NCT00806195|155619485|FG000|Overall Study|Protocol Violation|34|||
48762740|NCT03760146|156980326|FG003|Overall Study|Lost to Follow-up|2|||
48388753|NCT00806195|155619486|FG001|Overall Study|Protocol Violation|24|||
48678187|NCT00532298|156673028|FG001|Overall Study|Adverse Event|0|||
48678188|NCT00532298|156673029|FG002|Overall Study|Adverse Event|0|||
48678189|NCT00532298|156673030|FG003|Overall Study|Adverse Event|0|||
48678190|NCT00532298|156673031|FG004|Overall Study|Adverse Event|1|||
48678191|NCT00532298|156673032|FG005|Overall Study|Adverse Event|1|||
48678192|NCT00532298|156673027|FG000|Overall Study|Lost to Follow-up|1|||
48678193|NCT00532298|156673028|FG001|Overall Study|Lost to Follow-up|1|||
48678194|NCT00532298|156673029|FG002|Overall Study|Lost to Follow-up|1|||
48388754|NCT00806195|155619487|FG002|Overall Study|Protocol Violation|26|||
48678195|NCT00532298|156673030|FG003|Overall Study|Lost to Follow-up|0|||
48678196|NCT00532298|156673031|FG004|Overall Study|Lost to Follow-up|0|||
48678197|NCT00532298|156673032|FG005|Overall Study|Lost to Follow-up|1|||
48678198|NCT00479856|156673033|FG000|Overall Study|Adverse Event|1|||
48678199|NCT00479856|156673033|FG000|Overall Study|Withdrawal by Subject|1|||
48678200|NCT00479856|156673033|FG000|Overall Study|Physician Decision|1|||
48678201|NCT00527904|156673037|FG000|Overall Study|Adverse Event|45|||
48678202|NCT00527904|156673037|FG000|Overall Study|Withdrawal by Subject|21|||
48678203|NCT00527904|156673037|FG000|Overall Study|Lost to Follow-up|8|||
48678204|NCT00527904|156673037|FG000|Overall Study|misc|22|||
48678205|NCT01339897|156673038|FG000|Overall Study|Adverse Event|1|||
48678206|NCT01339897|156673039|FG001|Overall Study|Adverse Event|0|||
48678207|NCT01339897|156673040|FG002|Overall Study|Adverse Event|0|||
48678208|NCT01339897|156673041|FG003|Overall Study|Adverse Event|1|||
48678209|NCT01832532|156673042|FG000|Overall Study|Withdrawal by Subject|5|||
48678210|NCT01832532|156673043|FG001|Overall Study|Withdrawal by Subject|2|||
48678211|NCT02006979|156673048|FG000|Overall Study|Withdrawal by Subject|1|||
48678212|NCT02006979|156673049|FG001|Overall Study|Withdrawal by Subject|1|||
48678213|NCT02006979|156673048|FG000|Overall Study|Protocol Violation|0|||
48678214|NCT02006979|156673049|FG001|Overall Study|Protocol Violation|1|||
48678215|NCT01546688|156673050|FG000|Overall Study|Adverse Event|0|||
48678216|NCT01546688|156673051|FG001|Overall Study|Adverse Event|4|||
48678217|NCT01546688|156673050|FG000|Overall Study|Withdrawal by Subject|2|||
48678218|NCT01546688|156673051|FG001|Overall Study|Withdrawal by Subject|1|||
48678219|NCT01546688|156673050|FG000|Overall Study|Lack of Efficacy|1|||
48678220|NCT01546688|156673051|FG001|Overall Study|Lack of Efficacy|0|||
48678221|NCT01445080|156673055|FG000|Overall Study|Adverse Event|5|||
48678222|NCT01445080|156673056|FG001|Overall Study|Adverse Event|3|||
48678223|NCT01445080|156673057|FG002|Overall Study|Adverse Event|11|||
48678224|NCT01445080|156673058|FG003|Overall Study|Adverse Event|6|||
48678225|NCT01445080|156673059|FG004|Overall Study|Adverse Event|2|||
48678226|NCT01445080|156673060|FG005|Overall Study|Adverse Event|3|||
48678227|NCT01445080|156673061|FG006|Overall Study|Adverse Event|0|||
48678228|NCT01445080|156673062|FG007|Overall Study|Adverse Event|3|||
48678229|NCT01445080|156673063|FG008|Overall Study|Adverse Event|10|||
48678230|NCT01445080|156673055|FG000|Overall Study|Physician Decision|0|||
48678231|NCT01445080|156673056|FG001|Overall Study|Physician Decision|0|||
48678232|NCT01445080|156673057|FG002|Overall Study|Physician Decision|1|||
48678233|NCT01445080|156673058|FG003|Overall Study|Physician Decision|0|||
48678234|NCT01445080|156673059|FG004|Overall Study|Physician Decision|0|||
48678235|NCT01445080|156673060|FG005|Overall Study|Physician Decision|3|||
48678236|NCT01445080|156673061|FG006|Overall Study|Physician Decision|2|||
48678237|NCT01445080|156673062|FG007|Overall Study|Physician Decision|2|||
48678238|NCT01445080|156673063|FG008|Overall Study|Physician Decision|0|||
48678239|NCT01445080|156673055|FG000|Overall Study|Withdrawal by Subject|1|||
48678240|NCT01445080|156673056|FG001|Overall Study|Withdrawal by Subject|0|||
48678241|NCT01445080|156673057|FG002|Overall Study|Withdrawal by Subject|0|||
48678242|NCT01445080|156673058|FG003|Overall Study|Withdrawal by Subject|1|||
48678243|NCT01445080|156673059|FG004|Overall Study|Withdrawal by Subject|0|||
48678244|NCT01445080|156673060|FG005|Overall Study|Withdrawal by Subject|0|||
48678245|NCT01445080|156673061|FG006|Overall Study|Withdrawal by Subject|0|||
48678246|NCT01445080|156673062|FG007|Overall Study|Withdrawal by Subject|0|||
48678247|NCT01445080|156673063|FG008|Overall Study|Withdrawal by Subject|2|||
48678248|NCT01445080|156673055|FG000|Overall Study|Ineligible/Inevaluable|1|||
48678249|NCT01445080|156673056|FG001|Overall Study|Ineligible/Inevaluable|2|||
48678250|NCT01445080|156673057|FG002|Overall Study|Ineligible/Inevaluable|0|||
48678251|NCT01445080|156673058|FG003|Overall Study|Ineligible/Inevaluable|1|||
48678252|NCT01445080|156673059|FG004|Overall Study|Ineligible/Inevaluable|2|||
48678253|NCT01445080|156673060|FG005|Overall Study|Ineligible/Inevaluable|3|||
48678254|NCT01445080|156673061|FG006|Overall Study|Ineligible/Inevaluable|0|||
48678255|NCT01445080|156673062|FG007|Overall Study|Ineligible/Inevaluable|0|||
48678256|NCT01445080|156673063|FG008|Overall Study|Ineligible/Inevaluable|6|||
48678257|NCT02069392|156673064|FG000|Overall Study|Withdrawal by Subject|4|||
48678258|NCT02069392|156673065|FG001|Overall Study|Withdrawal by Subject|2|||
48678259|NCT00869518|156673066|FG000|Overall Study|Lost to Follow-up|1|||
48762741|NCT03760146|156980327|FG004|Overall Study|Lost to Follow-up|14|||
48678260|NCT00869518|156673067|FG001|Overall Study|Lost to Follow-up|1|||
48678261|NCT02487030|156673068|FG000|Overall Study|Lack of Efficacy|2|||
48678262|NCT02487030|156673069|FG001|Overall Study|Lack of Efficacy|4|||
48678263|NCT02487030|156673070|FG002|Overall Study|Lack of Efficacy|1|||
48678264|NCT02487030|156673071|FG003|Overall Study|Lack of Efficacy|0|||
48678265|NCT02487030|156673072|FG004|Overall Study|Lack of Efficacy|1|||
48678266|NCT02487030|156673073|FG005|Overall Study|Lack of Efficacy|0|||
48678267|NCT02487030|156673074|FG006|Overall Study|Lack of Efficacy|0|||
48678268|NCT02487030|156673068|FG000|Overall Study|Lost to Follow-up|0|||
48678269|NCT02487030|156673069|FG001|Overall Study|Lost to Follow-up|0|||
48678270|NCT02487030|156673070|FG002|Overall Study|Lost to Follow-up|1|||
48762742|NCT03760146|156980328|FG005|Overall Study|Lost to Follow-up|8|||
48678271|NCT02487030|156673071|FG003|Overall Study|Lost to Follow-up|1|||
48678272|NCT02487030|156673072|FG004|Overall Study|Lost to Follow-up|0|||
48678273|NCT02487030|156673073|FG005|Overall Study|Lost to Follow-up|1|||
48678274|NCT02487030|156673074|FG006|Overall Study|Lost to Follow-up|0|||
48678275|NCT02487030|156673068|FG000|Overall Study|Adverse Event|0|||
48678276|NCT02487030|156673069|FG001|Overall Study|Adverse Event|0|||
48678277|NCT02487030|156673070|FG002|Overall Study|Adverse Event|0|||
48678278|NCT02487030|156673071|FG003|Overall Study|Adverse Event|1|||
48678279|NCT02487030|156673072|FG004|Overall Study|Adverse Event|0|||
48678280|NCT02487030|156673073|FG005|Overall Study|Adverse Event|0|||
48678281|NCT02487030|156673074|FG006|Overall Study|Adverse Event|0|||
48678282|NCT02487030|156673068|FG000|Overall Study|Death|0|||
48678283|NCT02487030|156673069|FG001|Overall Study|Death|0|||
48678284|NCT02487030|156673070|FG002|Overall Study|Death|0|||
48678285|NCT02487030|156673071|FG003|Overall Study|Death|0|||
48678286|NCT02487030|156673072|FG004|Overall Study|Death|1|||
48678287|NCT02487030|156673073|FG005|Overall Study|Death|0|||
48678288|NCT02487030|156673074|FG006|Overall Study|Death|0|||
48678289|NCT00983385|156673075|FG000|Observation Period|Not eligible to be dosed|20|||
48678290|NCT00983385|156673075|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
48678291|NCT02092025|156673076|FG000|Overall Study|Case Report Forms Uncollected|44|||
48678292|NCT02092025|156673076|FG000|Overall Study|Protocol Deviation|24|||
48678293|NCT04725500|156673077|FG000|Screening|Screen Failure|26|||
48678294|NCT04725500|156673077|FG000|Screening|Withdrawal by Subject|1|||
48678295|NCT04725500|156673077|FG000|2 Week Take Home|Screen Fail|5|||
48678296|NCT03228212|156673080|FG000|Period 1|Adverse Event|1|||
48678297|NCT03228212|156673081|FG001|Period 1|Adverse Event|0|||
48678298|NCT03228212|156673080|FG000|Period 1|no longer meets eligibility criteria|0|||
48678299|NCT03228212|156673081|FG001|Period 1|no longer meets eligibility criteria|1|||
48678300|NCT03228212|156673080|FG000|Period 2|Lost to Follow-up|1|||
48678301|NCT03228212|156673081|FG001|Period 2|Lost to Follow-up|0|||
48678302|NCT00934128|156673082|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
48678303|NCT00934128|156673083|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
48678304|NCT00934128|156673082|FG000|First Intervention (2 Hours)|Adverse Event|4|||
48678305|NCT00934128|156673083|FG001|First Intervention (2 Hours)|Adverse Event|1|||
48678306|NCT00934128|156673082|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
48678307|NCT00934128|156673083|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
48678308|NCT00934128|156673082|FG000|Washout Period (1 Hour)|Patient preference|1|||
48678309|NCT00934128|156673083|FG001|Washout Period (1 Hour)|Patient preference|3|||
48678310|NCT00934128|156673082|FG000|Washout Period (1 Hour)|Pain|1|||
48678311|NCT00934128|156673083|FG001|Washout Period (1 Hour)|Pain|0|||
48678312|NCT00934128|156673082|FG000|Washout Period (1 Hour)|Too tired|1|||
48678313|NCT00934128|156673083|FG001|Washout Period (1 Hour)|Too tired|0|||
48678314|NCT00934128|156673082|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
48678315|NCT00934128|156673083|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
48678316|NCT00934128|156673082|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
48678317|NCT00934128|156673083|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
48678318|NCT01357551|156674879|FG000|Overall Study|Withdrawal by Subject|6|||
48678319|NCT01357551|156674880|FG001|Overall Study|Withdrawal by Subject|4|||
48678320|NCT01357551|156674879|FG000|Overall Study|Death|0|||
48678321|NCT01357551|156674880|FG001|Overall Study|Death|1|||
48678322|NCT01357551|156674879|FG000|Overall Study|Lost to Follow-up|16|||
48678323|NCT01357551|156674880|FG001|Overall Study|Lost to Follow-up|6|||
48678324|NCT00858208|156674881|FG000|Overall Study|Adverse Event|3|||
48678325|NCT00858208|156674881|FG000|Overall Study|Lost to Follow-up|26|||
48678326|NCT00858208|156674881|FG000|Overall Study|Participant refused|40|||
48678327|NCT00858208|156674881|FG000|Overall Study|Other|10|||
48678328|NCT01272635|156674882|FG000|Overall Study|Lost to Follow-up|31|||
48678329|NCT01272635|156674883|FG001|Overall Study|Lost to Follow-up|20|||
48678330|NCT01272635|156674884|FG002|Overall Study|Lost to Follow-up|31|||
48678331|NCT01272635|156674885|FG003|Overall Study|Lost to Follow-up|23|||
48678332|NCT00891228|156674886|FG000|Overall Study|Adverse Event|0|||
48678333|NCT00891228|156674887|FG001|Overall Study|Adverse Event|2|||
48678334|NCT00891228|156674888|FG002|Overall Study|Adverse Event|3|||
48678335|NCT00891228|156674886|FG000|Overall Study|Withdrawal by Subject|2|||
48678336|NCT00891228|156674887|FG001|Overall Study|Withdrawal by Subject|4|||
48678337|NCT00891228|156674888|FG002|Overall Study|Withdrawal by Subject|5|||
48762743|NCT03760146|156980323|FG000|Overall Study|No longer met eligibility criteria|3|||
48762744|NCT03760146|156980324|FG001|Overall Study|No longer met eligibility criteria|9|||
48762745|NCT03760146|156980325|FG002|Overall Study|No longer met eligibility criteria|0|||
48678338|NCT00891228|156674886|FG000|Overall Study|Protocol Violation|3|||
48678339|NCT00891228|156674887|FG001|Overall Study|Protocol Violation|1|||
48678340|NCT00891228|156674888|FG002|Overall Study|Protocol Violation|2|||
48678341|NCT00891228|156674886|FG000|Overall Study|Physician Decision|2|||
48678342|NCT00891228|156674887|FG001|Overall Study|Physician Decision|1|||
48678343|NCT00891228|156674888|FG002|Overall Study|Physician Decision|0|||
48678344|NCT00891228|156674886|FG000|Overall Study|Lost to Follow-up|4|||
48678345|NCT00891228|156674887|FG001|Overall Study|Lost to Follow-up|4|||
48678346|NCT00891228|156674888|FG002|Overall Study|Lost to Follow-up|5|||
48678347|NCT00891228|156674886|FG000|Overall Study|Pregnancy|0|||
48678348|NCT00891228|156674887|FG001|Overall Study|Pregnancy|1|||
48678349|NCT00891228|156674888|FG002|Overall Study|Pregnancy|0|||
48678350|NCT02702180|156674889|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
48678351|NCT02702180|156674890|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48678352|NCT02702180|156674891|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48678353|NCT02702180|156674889|FG000|Double-blind Treatment Period|Adverse Event|0|||
48678354|NCT02702180|156674890|FG001|Double-blind Treatment Period|Adverse Event|0|||
48678355|NCT02702180|156674891|FG002|Double-blind Treatment Period|Adverse Event|1|||
48678356|NCT02702180|156674889|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
48678357|NCT02702180|156674890|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
48678358|NCT02702180|156674891|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
48678359|NCT02702180|156674889|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48678360|NCT02702180|156674890|FG001|Double-blind Treatment Period|Protocol Violation|0|||
48678361|NCT02702180|156674891|FG002|Double-blind Treatment Period|Protocol Violation|2|||
48678362|NCT02702180|156674889|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
48678363|NCT02702180|156674890|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
48678364|NCT02702180|156674891|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
48678365|NCT02702180|156674889|FG000|Open-label Treatment Period|Withdrawn in error|0|||
48678366|NCT02702180|156674890|FG001|Open-label Treatment Period|Withdrawn in error|0|||
48678367|NCT02702180|156674891|FG002|Open-label Treatment Period|Withdrawn in error|1|||
48678368|NCT01832155|156674892|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
48678369|NCT01832155|156674893|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
48678370|NCT01832155|156674892|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
48678371|NCT01832155|156674893|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
48678372|NCT04395690|156674894|FG000|Overall Study|Lost to Follow-up|1|||
48678373|NCT04395690|156674895|FG001|Overall Study|Lost to Follow-up|1|||
48678374|NCT01279616|156674896|FG000|Overall Study|donor could not be located|5|||
48678375|NCT01279616|156674896|FG000|Overall Study|no signs of sickle cell disease|2|||
48678376|NCT01934010|156674897|FG000|Overall Study|Adverse Event|1|||
48678377|NCT01934010|156674898|FG001|Overall Study|Adverse Event|1|||
48678378|NCT01934010|156674899|FG002|Overall Study|Adverse Event|0|||
48678379|NCT01934010|156674897|FG000|Overall Study|Withdrawal by Subject|15|||
48678380|NCT01934010|156674898|FG001|Overall Study|Withdrawal by Subject|6|||
48678381|NCT01934010|156674899|FG002|Overall Study|Withdrawal by Subject|2|||
48678382|NCT01934010|156674897|FG000|Overall Study|Lost to Follow-up|7|||
48678383|NCT01934010|156674898|FG001|Overall Study|Lost to Follow-up|4|||
48678384|NCT01934010|156674899|FG002|Overall Study|Lost to Follow-up|0|||
48678385|NCT03386487|156674900|FG000|Overall Study|Lost to Follow-up|5|||
48678386|NCT03386487|156674901|FG001|Overall Study|Lost to Follow-up|6|||
48678387|NCT03386487|156674900|FG000|Overall Study|Withdrawal by Subject|11|||
48678388|NCT03386487|156674901|FG001|Overall Study|Withdrawal by Subject|7|||
48678389|NCT03386487|156674900|FG000|Overall Study|Physician Decision|11|||
48678390|NCT03386487|156674901|FG001|Overall Study|Physician Decision|8|||
48678391|NCT02141360|156674904|FG000|Overall Study|Withdrawal by Subject|6|||
48678392|NCT02141360|156674905|FG001|Overall Study|Withdrawal by Subject|0|||
48678393|NCT02141360|156674906|FG002|Overall Study|Withdrawal by Subject|0|||
48678394|NCT02141360|156674904|FG000|Overall Study|Study Terminated before Visit|1|||
48678395|NCT02141360|156674905|FG001|Overall Study|Study Terminated before Visit|0|||
48678396|NCT02141360|156674906|FG002|Overall Study|Study Terminated before Visit|0|||
48678397|NCT01702246|156674907|FG000|Overall Study|Lost to Follow-up|2|||
48678398|NCT01702246|156674907|FG000|Overall Study|Withdrawal by Subject|2|||
48678399|NCT01702246|156674907|FG000|Overall Study|Physician Decision|1|||
48678400|NCT04856904|156674915|FG000|Overall Study|Physician Decision|1|||
48678401|NCT04856904|156674916|FG001|Overall Study|Physician Decision|1|||
48678402|NCT04856904|156674915|FG000|Overall Study|Withdrawal by Subject|13|||
48678403|NCT04856904|156674916|FG001|Overall Study|Withdrawal by Subject|13|||
48762746|NCT03760146|156980326|FG003|Overall Study|No longer met eligibility criteria|0|||
48762747|NCT03760146|156980327|FG004|Overall Study|No longer met eligibility criteria|1|||
48762748|NCT03760146|156980328|FG005|Overall Study|No longer met eligibility criteria|0|||
48762749|NCT03760146|156980323|FG000|Overall Study|Protocol Violation|21|||
48762750|NCT03760146|156980324|FG001|Overall Study|Protocol Violation|13|||
48762751|NCT03760146|156980325|FG002|Overall Study|Protocol Violation|1|||
48678404|NCT04856904|156674915|FG000|Overall Study|Adverse Event|1|||
48678405|NCT04856904|156674916|FG001|Overall Study|Adverse Event|1|||
48678406|NCT04856904|156674915|FG000|Overall Study|Non-compliance with study drug|1|||
48678407|NCT04856904|156674916|FG001|Overall Study|Non-compliance with study drug|1|||
48678408|NCT04856904|156674915|FG000|Overall Study|Lost to Follow-up|4|||
48762752|NCT03760146|156980326|FG003|Overall Study|Protocol Violation|0|||
48762753|NCT03760146|156980327|FG004|Overall Study|Protocol Violation|1|||
48762754|NCT03760146|156980328|FG005|Overall Study|Protocol Violation|0|||
48678409|NCT04856904|156674916|FG001|Overall Study|Lost to Follow-up|4|||
48678410|NCT04856904|156674915|FG000|Overall Study|Withdrawal by Subject|1|||
48678411|NCT04856904|156674916|FG001|Overall Study|Withdrawal by Subject|1|||
48678412|NCT04856904|156674915|FG000|Overall Study|Protocol Violation|1|||
48678413|NCT04856904|156674916|FG001|Overall Study|Protocol Violation|1|||
48678414|NCT04896593|156674923|FG000|Overall Study|Withdrawal by Subject|2|||
48678415|NCT04896593|156674923|FG000|Overall Study|Lost to Follow-up|1|||
48678416|NCT04896593|156674923|FG000|Overall Study|Did not complete onboarding|2|||
48678417|NCT02915978|156674924|FG000|Overall Study|Adverse Event|2|||
48678418|NCT02915978|156674925|FG001|Overall Study|Adverse Event|1|||
48678419|NCT02915978|156674926|FG002|Overall Study|Adverse Event|0|||
48678420|NCT02777827|156674927|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678421|NCT02777827|156674928|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678422|NCT02777827|156674929|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
48678423|NCT02777827|156674930|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678424|NCT02777827|156674931|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678425|NCT02777827|156674932|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
48678426|NCT00924443|156674936|FG000|Overall Study|Physician Decision|2|||
48678427|NCT00924443|156674936|FG000|Overall Study|Protocol Violation|1|||
48678428|NCT01846741|156674941|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
48678429|NCT01853878|156674942|FG000|Overall Study|Recurrence|2|||
48678430|NCT01853878|156674943|FG001|Overall Study|Recurrence|0|||
48678431|NCT01853878|156674942|FG000|Overall Study|Adverse Event|2|||
48678432|NCT01853878|156674943|FG001|Overall Study|Adverse Event|0|||
48678433|NCT01853878|156674942|FG000|Overall Study|Withdrawal by Subject|3|||
48678434|NCT01853878|156674943|FG001|Overall Study|Withdrawal by Subject|1|||
48678435|NCT01853878|156674942|FG000|Overall Study|Migrated/moved from the study area|1|||
48678436|NCT01853878|156674943|FG001|Overall Study|Migrated/moved from the study area|0|||
48678437|NCT01853878|156674942|FG000|Overall Study|Other|55|||
48678438|NCT01853878|156674943|FG001|Overall Study|Other|43|||
48678439|NCT01361178|156674944|FG000|Overall Study|Death|13|||
48678440|NCT01361178|156674945|FG001|Overall Study|Death|0|||
48678441|NCT00767819|156674946|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
48678442|NCT00767819|156674947|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
48678443|NCT00767819|156674948|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48678444|NCT00767819|156674946|FG000|Overall Study|Withdrawal by Subject|1|||
48678445|NCT00767819|156674947|FG001|Overall Study|Withdrawal by Subject|1|||
48678446|NCT00767819|156674948|FG002|Overall Study|Withdrawal by Subject|0|||
48678447|NCT00767819|156674946|FG000|Overall Study|Administrative problems|0|||
48678448|NCT00767819|156674947|FG001|Overall Study|Administrative problems|1|||
48678449|NCT00767819|156674948|FG002|Overall Study|Administrative problems|0|||
48678450|NCT00767819|156674946|FG000|Overall Study|Death|2|||
48678451|NCT00767819|156674947|FG001|Overall Study|Death|3|||
48678452|NCT00767819|156674948|FG002|Overall Study|Death|0|||
48678453|NCT00767819|156674946|FG000|Overall Study|Adverse Event|2|||
48678454|NCT00767819|156674947|FG001|Overall Study|Adverse Event|0|||
48678455|NCT00767819|156674948|FG002|Overall Study|Adverse Event|0|||
48678456|NCT00767819|156674946|FG000|Overall Study|Abnormal lab values|1|||
48678457|NCT00767819|156674947|FG001|Overall Study|Abnormal lab values|0|||
48678458|NCT00767819|156674948|FG002|Overall Study|Abnormal lab values|0|||
48678459|NCT00767819|156674946|FG000|Overall Study|Lost to Follow-up|1|||
48678460|NCT00767819|156674947|FG001|Overall Study|Lost to Follow-up|0|||
48678461|NCT00767819|156674948|FG002|Overall Study|Lost to Follow-up|0|||
48678462|NCT01090063|156674952|FG000|Screen|Screen Failed|4|||
48678463|NCT01090063|156674952|FG000|Treatment|Withdrawal by Subject|4|||
48678464|NCT01496846|156674957|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
48678465|NCT01496846|156674958|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
48678466|NCT01496846|156674959|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
48678467|NCT01496846|156674960|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
48678468|NCT01496846|156674961|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
48586778|NCT00483704|156339071|FG002|Treatment|Lack of Efficacy|1|||
48586779|NCT00483704|156339069|FG000|Treatment|Pregnancy|0|||
48586780|NCT00483704|156339070|FG001|Treatment|Pregnancy|1|||
48586781|NCT00483704|156339071|FG002|Treatment|Pregnancy|0|||
48586782|NCT00483704|156339069|FG000|Treatment|Physician Decision|0|||
48586783|NCT00483704|156339070|FG001|Treatment|Physician Decision|1|||
48586784|NCT00483704|156339071|FG002|Treatment|Physician Decision|4|||
48586785|NCT00431067|156339075|FG000|Overall Study|Other Adverse Event|9|||
48678469|NCT01496846|156674962|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
48678470|NCT02863328|156674970|FG000|Overall Study|Lost to Follow-up|4|||
48678471|NCT02863328|156674971|FG001|Overall Study|Lost to Follow-up|10|||
48678472|NCT02863328|156674970|FG000|Overall Study|Withdrawal by Subject|7|||
48678473|NCT02863328|156674971|FG001|Overall Study|Withdrawal by Subject|12|||
48678474|NCT02863328|156674970|FG000|Overall Study|Died|0|||
48678475|NCT02863328|156674971|FG001|Overall Study|Died|1|||
48678476|NCT00699660|156674972|FG000|Overall Study|Lost to Follow-up|4|||
48678477|NCT00699660|156674973|FG001|Overall Study|Lost to Follow-up|2|||
48586786|NCT00431067|156339075|FG000|Overall Study|Progressive disease|30|||
48678478|NCT00699660|156674972|FG000|Overall Study|missing reports and recording failures|10|||
48678479|NCT00699660|156674973|FG001|Overall Study|missing reports and recording failures|6|||
48678480|NCT01196416|156674974|FG000|Overall Study|Withdrawal by Subject|2|||
48678481|NCT00064792|156674976|FG000|Overall Study|Withdrawal by Subject|2|||
48678482|NCT00064792|156674977|FG001|Overall Study|Withdrawal by Subject|0|||
48678483|NCT00064792|156674976|FG000|Overall Study|Adverse Event|3|||
48678484|NCT00064792|156674977|FG001|Overall Study|Adverse Event|0|||
48678485|NCT01870726|156674978|FG000|Overall Study|Withdrawal of informed consent|0|||
48388755|NCT00806195|155619488|FG003|Overall Study|Protocol Violation|9|||
48678486|NCT01870726|156674979|FG001|Overall Study|Withdrawal of informed consent|0|||
48678487|NCT01870726|156674980|FG002|Overall Study|Withdrawal of informed consent|0|||
48678488|NCT01870726|156674981|FG003|Overall Study|Withdrawal of informed consent|1|||
48678489|NCT01870726|156674982|FG004|Overall Study|Withdrawal of informed consent|0|||
48678490|NCT01870726|156674983|FG005|Overall Study|Withdrawal of informed consent|0|||
48678491|NCT01870726|156674984|FG006|Overall Study|Withdrawal of informed consent|0|||
48678492|NCT01870726|156674978|FG000|Overall Study|Withdrawal by Subject|0|||
48678493|NCT01870726|156674979|FG001|Overall Study|Withdrawal by Subject|1|||
48678494|NCT01870726|156674980|FG002|Overall Study|Withdrawal by Subject|0|||
48678495|NCT01870726|156674981|FG003|Overall Study|Withdrawal by Subject|0|||
48678496|NCT01870726|156674982|FG004|Overall Study|Withdrawal by Subject|0|||
48678497|NCT01870726|156674983|FG005|Overall Study|Withdrawal by Subject|0|||
48678498|NCT01870726|156674984|FG006|Overall Study|Withdrawal by Subject|0|||
48678499|NCT01870726|156674978|FG000|Overall Study|Adverse Event|0|||
48678500|NCT01870726|156674979|FG001|Overall Study|Adverse Event|0|||
48678501|NCT01870726|156674980|FG002|Overall Study|Adverse Event|0|||
48678502|NCT01870726|156674981|FG003|Overall Study|Adverse Event|0|||
48678503|NCT01870726|156674982|FG004|Overall Study|Adverse Event|1|||
48678504|NCT01870726|156674983|FG005|Overall Study|Adverse Event|1|||
48678505|NCT01870726|156674984|FG006|Overall Study|Adverse Event|0|||
48678506|NCT01870726|156674978|FG000|Overall Study|Progressive disease|5|||
48678507|NCT01870726|156674979|FG001|Overall Study|Progressive disease|5|||
48678508|NCT01870726|156674980|FG002|Overall Study|Progressive disease|4|||
48678509|NCT01870726|156674981|FG003|Overall Study|Progressive disease|5|||
48678510|NCT01870726|156674982|FG004|Overall Study|Progressive disease|6|||
48678511|NCT01870726|156674983|FG005|Overall Study|Progressive disease|4|||
48678512|NCT01870726|156674984|FG006|Overall Study|Progressive disease|10|||
48678513|NCT01248949|156674988|FG000|Overall Study|Lost to Follow-up|2|||
48678514|NCT01248949|156674989|FG001|Overall Study|Lost to Follow-up|2|||
48678515|NCT01248949|156674990|FG002|Overall Study|Lost to Follow-up|2|||
48678516|NCT01248949|156674991|FG003|Overall Study|Lost to Follow-up|1|||
48678517|NCT01248949|156674992|FG004|Overall Study|Lost to Follow-up|0|||
48678518|NCT01248949|156674988|FG000|Overall Study|Withdrawal by Subject|5|||
48678519|NCT01248949|156674989|FG001|Overall Study|Withdrawal by Subject|3|||
48678520|NCT01248949|156674990|FG002|Overall Study|Withdrawal by Subject|11|||
48678521|NCT01248949|156674991|FG003|Overall Study|Withdrawal by Subject|3|||
48678522|NCT01248949|156674992|FG004|Overall Study|Withdrawal by Subject|1|||
48678523|NCT01248949|156674988|FG000|Overall Study|Death|22|||
48388756|NCT01360554|155619489|FG000|Overall Study|Death|359|||
48388757|NCT01360554|155619490|FG001|Overall Study|Death|371|||
48388758|NCT01360554|155619489|FG000|Overall Study|Lost to Follow-up|4|||
48388759|NCT01360554|155619490|FG001|Overall Study|Lost to Follow-up|4|||
48388760|NCT01360554|155619489|FG000|Overall Study|Withdrawal by Subject|23|||
48388761|NCT01360554|155619490|FG001|Overall Study|Withdrawal by Subject|24|||
48388762|NCT01360554|155619489|FG000|Overall Study|Study terminated by sponsor|49|||
48388763|NCT01360554|155619490|FG001|Overall Study|Study terminated by sponsor|37|||
48388764|NCT01360554|155619489|FG000|Overall Study|Other, not specified|1|||
48388765|NCT01360554|155619490|FG001|Overall Study|Other, not specified|0|||
48388766|NCT01360554|155619489|FG000|Overall Study|Randomized but not treated.|3|||
48678524|NCT01248949|156674989|FG001|Overall Study|Death|7|||
48678525|NCT01248949|156674990|FG002|Overall Study|Death|21|||
48678526|NCT01248949|156674991|FG003|Overall Study|Death|6|||
48678527|NCT01248949|156674992|FG004|Overall Study|Death|2|||
48678528|NCT01248949|156674988|FG000|Overall Study|Alternative Therapy|1|||
48388767|NCT01360554|155619490|FG001|Overall Study|Randomized but not treated.|3|||
48388768|NCT04912245|155619493|FG000|Overall Study|Withdrawal by Subject|21|||
48388769|NCT04912245|155619494|FG001|Overall Study|Withdrawal by Subject|4|||
48388770|NCT04912245|155619493|FG000|Overall Study|Lost to Follow-up|5|||
48388771|NCT04912245|155619494|FG001|Overall Study|Lost to Follow-up|11|||
48388772|NCT01205230|155619499|FG000|Overall Study|Adverse Event|4|||
48678529|NCT01248949|156674989|FG001|Overall Study|Alternative Therapy|0|||
48678530|NCT01248949|156674990|FG002|Overall Study|Alternative Therapy|0|||
48678531|NCT01248949|156674991|FG003|Overall Study|Alternative Therapy|0|||
48678532|NCT01248949|156674992|FG004|Overall Study|Alternative Therapy|0|||
48678533|NCT01248949|156674988|FG000|Overall Study|Alternative Therapy.|1|||
48678534|NCT01248949|156674989|FG001|Overall Study|Alternative Therapy.|0|||
48678535|NCT01248949|156674990|FG002|Overall Study|Alternative Therapy.|0|||
48678536|NCT01248949|156674991|FG003|Overall Study|Alternative Therapy.|0|||
48678537|NCT01248949|156674992|FG004|Overall Study|Alternative Therapy.|0|||
48678538|NCT01248949|156674988|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
48678539|NCT01248949|156674989|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
48678540|NCT01248949|156674990|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
48678541|NCT01248949|156674991|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
48678542|NCT01248949|156674992|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
48678543|NCT01248949|156674988|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
48678544|NCT01248949|156674989|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
48678545|NCT01248949|156674990|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
48678546|NCT01248949|156674991|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
48678547|NCT01248949|156674992|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
48678548|NCT01248949|156674988|FG000|Overall Study|Participant Went To Hospice|0|||
48678549|NCT01248949|156674989|FG001|Overall Study|Participant Went To Hospice|0|||
48678550|NCT01248949|156674990|FG002|Overall Study|Participant Went To Hospice|1|||
48762755|NCT03760146|156980323|FG000|Overall Study|Withdrawal by Subject|19|||
48678551|NCT01248949|156674991|FG003|Overall Study|Participant Went To Hospice|0|||
48678552|NCT01248949|156674992|FG004|Overall Study|Participant Went To Hospice|0|||
48762756|NCT03760146|156980324|FG001|Overall Study|Withdrawal by Subject|20|||
48388773|NCT01205230|155619500|FG001|Overall Study|Adverse Event|0|||
48388774|NCT01205230|155619499|FG000|Overall Study|Physician Decision|1|||
48388775|NCT01205230|155619500|FG001|Overall Study|Physician Decision|0|||
48388776|NCT01911442|155619501|FG000|Overall Study|Adverse Event|2|||
48388777|NCT01911442|155619502|FG001|Overall Study|Adverse Event|2|||
48388778|NCT01911442|155619503|FG002|Overall Study|Adverse Event|4|||
48388779|NCT01911442|155619501|FG000|Overall Study|Lack of Efficacy|1|||
48388780|NCT01911442|155619502|FG001|Overall Study|Lack of Efficacy|1|||
48388781|NCT01911442|155619503|FG002|Overall Study|Lack of Efficacy|1|||
48388782|NCT01911442|155619501|FG000|Overall Study|Lost to Follow-up|2|||
48388783|NCT01911442|155619502|FG001|Overall Study|Lost to Follow-up|0|||
48388784|NCT01911442|155619503|FG002|Overall Study|Lost to Follow-up|1|||
48388785|NCT01911442|155619501|FG000|Overall Study|Withdrawal by Subject|1|||
48388786|NCT01911442|155619502|FG001|Overall Study|Withdrawal by Subject|0|||
48388787|NCT01911442|155619503|FG002|Overall Study|Withdrawal by Subject|6|||
48388788|NCT01911442|155619501|FG000|Overall Study|Mother's Work Schedule|0|||
48388789|NCT01911442|155619502|FG001|Overall Study|Mother's Work Schedule|1|||
48388790|NCT01911442|155619503|FG002|Overall Study|Mother's Work Schedule|0|||
48388791|NCT00122681|155619504|FG000|Overall Study|Adverse Event|20|||
48388792|NCT00122681|155619505|FG001|Overall Study|Adverse Event|16|||
48388793|NCT00122681|155619504|FG000|Overall Study|Lost to Follow-up|1080|||
48388794|NCT00122681|155619505|FG001|Overall Study|Lost to Follow-up|1097|||
48388795|NCT00122681|155619504|FG000|Overall Study|Protocol Violation|7|||
48388796|NCT00122681|155619505|FG001|Overall Study|Protocol Violation|10|||
48388797|NCT00122681|155619504|FG000|Overall Study|Withdrawal by Subject|257|||
48388798|NCT00122681|155619505|FG001|Overall Study|Withdrawal by Subject|251|||
48388799|NCT00122681|155619504|FG000|Overall Study|Personal reasons|150|||
48388800|NCT00122681|155619505|FG001|Overall Study|Personal reasons|147|||
48388801|NCT00922480|155619507|FG000|Main Study|Protocol Violation|3|||
48388802|NCT00922480|155619508|FG001|Main Study|Protocol Violation|6|||
48388803|NCT00922480|155619507|FG000|Main Study|Adverse Event|6|||
48388804|NCT00922480|155619508|FG001|Main Study|Adverse Event|7|||
48388805|NCT00922480|155619507|FG000|Main Study|Lack of Efficacy|3|||
48388806|NCT00922480|155619508|FG001|Main Study|Lack of Efficacy|0|||
48388807|NCT00922480|155619507|FG000|Main Study|Withdrawal by Subject|20|||
48388808|NCT00922480|155619508|FG001|Main Study|Withdrawal by Subject|15|||
48388809|NCT00922480|155619507|FG000|Main Study|Lost to Follow-up|5|||
48678553|NCT01248949|156674988|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
48678554|NCT01248949|156674989|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
48762757|NCT03760146|156980325|FG002|Overall Study|Withdrawal by Subject|1|||
48762758|NCT03760146|156980326|FG003|Overall Study|Withdrawal by Subject|0|||
48388810|NCT00922480|155619508|FG001|Main Study|Lost to Follow-up|0|||
48388811|NCT00922480|155619507|FG000|Main Study|Physician Decision|0|||
48388812|NCT00922480|155619508|FG001|Main Study|Physician Decision|1|||
48388813|NCT00922480|155619507|FG000|Extension Study|Protocol Violation|3|||
48388814|NCT00922480|155619508|FG001|Extension Study|Protocol Violation|0|||
48388815|NCT00922480|155619507|FG000|Extension Study|Adverse Event|1|||
48388816|NCT00922480|155619508|FG001|Extension Study|Adverse Event|1|||
48388817|NCT00922480|155619507|FG000|Extension Study|Withdrawal by Subject|1|||
48388818|NCT00922480|155619508|FG001|Extension Study|Withdrawal by Subject|1|||
48388819|NCT00922480|155619507|FG000|Extension Study|Others|0|||
48388820|NCT00922480|155619508|FG001|Extension Study|Others|1|||
48388821|NCT01994382|155619509|FG000|Overall Study|Informed consent withdrawn|0|||
48388822|NCT01994382|155619510|FG001|Overall Study|Informed consent withdrawn|0|||
48388823|NCT01994382|155619511|FG002|Overall Study|Informed consent withdrawn|0|||
48388824|NCT01994382|155619512|FG003|Overall Study|Informed consent withdrawn|0|||
48388825|NCT01994382|155619513|FG004|Overall Study|Informed consent withdrawn|0|||
48388826|NCT01994382|155619514|FG005|Overall Study|Informed consent withdrawn|0|||
48762759|NCT03760146|156980327|FG004|Overall Study|Withdrawal by Subject|1|||
48762760|NCT03760146|156980328|FG005|Overall Study|Withdrawal by Subject|0|||
48762761|NCT03745144|156980330|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
48762762|NCT03745144|156980331|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
48762763|NCT03745144|156980332|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
48678555|NCT01248949|156674990|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
48678556|NCT01248949|156674991|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
48678557|NCT01248949|156674992|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
48678558|NCT01248949|156674988|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
48678559|NCT01248949|156674989|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
48678560|NCT01248949|156674990|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
48678561|NCT01248949|156674991|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
48678562|NCT01248949|156674992|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
48678563|NCT01248949|156674988|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
48678564|NCT01248949|156674989|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
48678565|NCT01248949|156674990|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
48678566|NCT01248949|156674991|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
48678567|NCT01248949|156674992|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
48678568|NCT01248949|156674988|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
48678569|NCT01248949|156674989|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
48678570|NCT01248949|156674990|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
48678571|NCT01248949|156674991|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
48678572|NCT01248949|156674992|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
48678573|NCT00379912|156674993|FG000|Overall Study|Lack of Efficacy|1|||
48678574|NCT00379912|156674994|FG001|Overall Study|Lack of Efficacy|0|||
48678575|NCT01128946|156674995|FG000|Period I|Protocol Violation|0|||
48678576|NCT01128946|156674996|FG001|Period I|Protocol Violation|1|||
48678577|NCT01128946|156674997|FG002|Period I|Protocol Violation|0|||
48678578|NCT01128946|156674998|FG003|Period I|Protocol Violation|0|||
48678579|NCT01128946|156674995|FG000|Period I|Withdrawal by Subject|0|||
48678580|NCT01128946|156674996|FG001|Period I|Withdrawal by Subject|0|||
48678581|NCT01128946|156674997|FG002|Period I|Withdrawal by Subject|1|||
48678582|NCT01128946|156674998|FG003|Period I|Withdrawal by Subject|1|||
48678583|NCT01128946|156674995|FG000|Period II|Protocol Violation|0|||
48678584|NCT01128946|156674996|FG001|Period II|Protocol Violation|1|||
48678585|NCT01128946|156674997|FG002|Period II|Protocol Violation|0|||
48678586|NCT01128946|156674998|FG003|Period II|Protocol Violation|0|||
48678587|NCT01128946|156674995|FG000|Period II|Withdrawal by Subject|0|||
48678588|NCT01128946|156674996|FG001|Period II|Withdrawal by Subject|0|||
48678589|NCT01128946|156674997|FG002|Period II|Withdrawal by Subject|0|||
48678590|NCT01128946|156674998|FG003|Period II|Withdrawal by Subject|1|||
48678591|NCT01128946|156674995|FG000|Period III|Protocol Violation|1|||
48678592|NCT01128946|156674996|FG001|Period III|Protocol Violation|0|||
48678593|NCT01128946|156674997|FG002|Period III|Protocol Violation|0|||
48678594|NCT01128946|156674998|FG003|Period III|Protocol Violation|0|||
48678595|NCT04698993|156674999|FG000|Overall Study|PCR results not accessible|2|||
48678596|NCT04698993|156675000|FG001|Overall Study|PCR results not accessible|7|||
48678597|NCT04698993|156674999|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
48678598|NCT04698993|156675000|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
48678599|NCT00145574|156675001|FG000|Double Blind|Adverse Event|0|||
48678600|NCT00145574|156675002|FG001|Double Blind|Adverse Event|3|||
48678601|NCT00145574|156675003|FG002|Double Blind|Adverse Event|1|||
48678602|NCT00145574|156675001|FG000|Double Blind|Withdrawal by Subject|1|||
48678603|NCT00145574|156675002|FG001|Double Blind|Withdrawal by Subject|1|||
48678604|NCT00145574|156675003|FG002|Double Blind|Withdrawal by Subject|1|||
48678605|NCT00145574|156675001|FG000|Double Blind|required restricted medicine|0|||
48678606|NCT00145574|156675002|FG001|Double Blind|required restricted medicine|1|||
48678607|NCT00145574|156675003|FG002|Double Blind|required restricted medicine|0|||
48678608|NCT00145574|156675001|FG000|Open Label Long-term Extension|Adverse Event|0|||
48678609|NCT00145574|156675002|FG001|Open Label Long-term Extension|Adverse Event|0|||
48678610|NCT00145574|156675003|FG002|Open Label Long-term Extension|Adverse Event|5|||
48678611|NCT00145574|156675001|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
48678612|NCT00145574|156675002|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
48678613|NCT00145574|156675003|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
48762764|NCT03745144|156980330|FG000|Period 1|Other|0|||
48762765|NCT03745144|156980331|FG001|Period 1|Other|0|||
48678614|NCT00145574|156675001|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
48678615|NCT00145574|156675002|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
48678616|NCT00145574|156675003|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
48678617|NCT00145574|156675001|FG000|Open Label Long-term Extension|required restricted medicine|0|||
48678618|NCT00145574|156675002|FG001|Open Label Long-term Extension|required restricted medicine|0|||
48678619|NCT00145574|156675003|FG002|Open Label Long-term Extension|required restricted medicine|1|||
48678620|NCT00206440|156675004|FG000|Overall Study|Protocol Violation|1|||
48678621|NCT00206440|156675005|FG001|Overall Study|Protocol Violation|2|||
48678622|NCT00206440|156675004|FG000|Overall Study|Adverse Event|4|||
48678623|NCT00206440|156675005|FG001|Overall Study|Adverse Event|2|||
48678624|NCT00595478|156675011|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
48678625|NCT00595478|156675012|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
48678626|NCT00595478|156675011|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
48678627|NCT00595478|156675012|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
48678628|NCT00348309|156675013|FG000|Overall Study|Adverse Event|56|||
48678629|NCT00348309|156675014|FG001|Overall Study|Adverse Event|28|||
48678630|NCT00348309|156675015|FG002|Overall Study|Adverse Event|63|||
48678631|NCT00348309|156675013|FG000|Overall Study|Lost to Follow-up|6|||
48678632|NCT00348309|156675014|FG001|Overall Study|Lost to Follow-up|7|||
48678633|NCT00348309|156675015|FG002|Overall Study|Lost to Follow-up|4|||
48678634|NCT00348309|156675013|FG000|Overall Study|Protocol Violation|7|||
48678635|NCT00348309|156675014|FG001|Overall Study|Protocol Violation|12|||
48678636|NCT00348309|156675015|FG002|Overall Study|Protocol Violation|7|||
48678637|NCT00348309|156675013|FG000|Overall Study|Withdrawal by Subject|33|||
48678638|NCT00348309|156675014|FG001|Overall Study|Withdrawal by Subject|37|||
48678639|NCT00348309|156675015|FG002|Overall Study|Withdrawal by Subject|40|||
48678640|NCT00348309|156675013|FG000|Overall Study|Non-compliance|8|||
48678641|NCT00348309|156675014|FG001|Overall Study|Non-compliance|6|||
48678642|NCT00348309|156675015|FG002|Overall Study|Non-compliance|8|||
48678643|NCT00348309|156675013|FG000|Overall Study|Death of caregiver|1|||
48678644|NCT00348309|156675014|FG001|Overall Study|Death of caregiver|0|||
48678645|NCT00348309|156675015|FG002|Overall Study|Death of caregiver|1|||
48678646|NCT00348309|156675013|FG000|Overall Study|Lack of insight, dementia|1|||
48678647|NCT00348309|156675014|FG001|Overall Study|Lack of insight, dementia|0|||
48678648|NCT00348309|156675015|FG002|Overall Study|Lack of insight, dementia|0|||
48678649|NCT00348309|156675013|FG000|Overall Study|Wrong bottle allocated|1|||
48678650|NCT00348309|156675014|FG001|Overall Study|Wrong bottle allocated|0|||
48678651|NCT00348309|156675015|FG002|Overall Study|Wrong bottle allocated|0|||
48678652|NCT00348309|156675013|FG000|Overall Study|Caregiver sick|1|||
48678653|NCT00348309|156675014|FG001|Overall Study|Caregiver sick|0|||
48678654|NCT00348309|156675015|FG002|Overall Study|Caregiver sick|0|||
48678655|NCT00348309|156675013|FG000|Overall Study|Use of prohibited medication|5|||
48678656|NCT00348309|156675014|FG001|Overall Study|Use of prohibited medication|2|||
48678657|NCT00348309|156675015|FG002|Overall Study|Use of prohibited medication|2|||
48678658|NCT00348309|156675013|FG000|Overall Study|Caregiver withdrawal|3|||
48678659|NCT00348309|156675014|FG001|Overall Study|Caregiver withdrawal|0|||
48678660|NCT00348309|156675015|FG002|Overall Study|Caregiver withdrawal|7|||
48678661|NCT00348309|156675013|FG000|Overall Study|Unable to complete ET visit|1|||
48678662|NCT00348309|156675014|FG001|Overall Study|Unable to complete ET visit|0|||
48678663|NCT00348309|156675015|FG002|Overall Study|Unable to complete ET visit|0|||
48678664|NCT00348309|156675013|FG000|Overall Study|PI closing medical practice|1|||
48678665|NCT00348309|156675014|FG001|Overall Study|PI closing medical practice|0|||
48678666|NCT00348309|156675015|FG002|Overall Study|PI closing medical practice|0|||
48678667|NCT00348309|156675013|FG000|Overall Study|Principal investigator's decision|1|||
48678668|NCT00348309|156675014|FG001|Overall Study|Principal investigator's decision|0|||
48678669|NCT00348309|156675015|FG002|Overall Study|Principal investigator's decision|0|||
48678670|NCT00348309|156675013|FG000|Overall Study|No disponibility of medication|1|||
48678671|NCT00348309|156675014|FG001|Overall Study|No disponibility of medication|0|||
48678672|NCT00348309|156675015|FG002|Overall Study|No disponibility of medication|0|||
48678673|NCT00348309|156675013|FG000|Overall Study|Worsened neurodegenerative disease|1|||
48678674|NCT00348309|156675014|FG001|Overall Study|Worsened neurodegenerative disease|0|||
48678675|NCT00348309|156675015|FG002|Overall Study|Worsened neurodegenerative disease|0|||
48678676|NCT00348309|156675013|FG000|Overall Study|Cognitive and behaviour worsening|2|||
48678677|NCT00348309|156675014|FG001|Overall Study|Cognitive and behaviour worsening|0|||
48678678|NCT00348309|156675015|FG002|Overall Study|Cognitive and behaviour worsening|0|||
48678679|NCT00348309|156675013|FG000|Overall Study|Worsening of alzheimer|1|||
48678680|NCT00348309|156675014|FG001|Overall Study|Worsening of alzheimer|0|||
48678681|NCT00348309|156675015|FG002|Overall Study|Worsening of alzheimer|1|||
48678682|NCT00348309|156675013|FG000|Overall Study|Did not appear in time for Visit 3|1|||
48678683|NCT00348309|156675014|FG001|Overall Study|Did not appear in time for Visit 3|0|||
48678684|NCT00348309|156675015|FG002|Overall Study|Did not appear in time for Visit 3|0|||
48678685|NCT00348309|156675013|FG000|Overall Study|Participant died|2|||
48678686|NCT00348309|156675014|FG001|Overall Study|Participant died|1|||
48678687|NCT00348309|156675015|FG002|Overall Study|Participant died|1|||
48678688|NCT00348309|156675013|FG000|Overall Study|Decision of sponsor|1|||
48678689|NCT00348309|156675014|FG001|Overall Study|Decision of sponsor|0|||
48678690|NCT00348309|156675015|FG002|Overall Study|Decision of sponsor|0|||
48678691|NCT00348309|156675013|FG000|Overall Study|Ineffectiveness of treatment|0|||
48678692|NCT00348309|156675014|FG001|Overall Study|Ineffectiveness of treatment|1|||
48678693|NCT00348309|156675015|FG002|Overall Study|Ineffectiveness of treatment|0|||
48678694|NCT00348309|156675013|FG000|Overall Study|A foul of exclusion criteria|0|||
48678695|NCT00348309|156675014|FG001|Overall Study|A foul of exclusion criteria|1|||
48678696|NCT00348309|156675015|FG002|Overall Study|A foul of exclusion criteria|0|||
48678697|NCT00348309|156675013|FG000|Overall Study|Participant was hospitalized|0|||
48678698|NCT00348309|156675014|FG001|Overall Study|Participant was hospitalized|1|||
48678699|NCT00348309|156675015|FG002|Overall Study|Participant was hospitalized|0|||
48678700|NCT00348309|156675013|FG000|Overall Study|Sponsor refuseal|0|||
48678701|NCT00348309|156675014|FG001|Overall Study|Sponsor refuseal|1|||
48678702|NCT00348309|156675015|FG002|Overall Study|Sponsor refuseal|1|||
48678703|NCT00348309|156675013|FG000|Overall Study|Forgot often medication|0|||
48678704|NCT00348309|156675014|FG001|Overall Study|Forgot often medication|1|||
48678705|NCT00348309|156675015|FG002|Overall Study|Forgot often medication|0|||
48678706|NCT00348309|156675013|FG000|Overall Study|Medical Monitor decision|0|||
48678707|NCT00348309|156675014|FG001|Overall Study|Medical Monitor decision|0|||
48678708|NCT00348309|156675015|FG002|Overall Study|Medical Monitor decision|1|||
48678709|NCT00348309|156675013|FG000|Overall Study|Increased dose of Aricept|0|||
48678710|NCT00348309|156675014|FG001|Overall Study|Increased dose of Aricept|0|||
48678711|NCT00348309|156675015|FG002|Overall Study|Increased dose of Aricept|1|||
48678712|NCT00348309|156675013|FG000|Overall Study|Site closure|0|||
48678713|NCT00348309|156675014|FG001|Overall Study|Site closure|0|||
48678714|NCT00348309|156675015|FG002|Overall Study|Site closure|1|||
48678715|NCT00348309|156675013|FG000|Overall Study|Adverse event not attended|0|||
48678716|NCT00348309|156675014|FG001|Overall Study|Adverse event not attended|0|||
48678717|NCT00348309|156675015|FG002|Overall Study|Adverse event not attended|1|||
48678718|NCT00348309|156675013|FG000|Overall Study|ECG abnormal|0|||
48678719|NCT00348309|156675014|FG001|Overall Study|ECG abnormal|0|||
48678720|NCT00348309|156675015|FG002|Overall Study|ECG abnormal|2|||
48678721|NCT00348309|156675013|FG000|Overall Study|Cardiologist recommendations|0|||
48678722|NCT00348309|156675014|FG001|Overall Study|Cardiologist recommendations|0|||
48678723|NCT00348309|156675015|FG002|Overall Study|Cardiologist recommendations|1|||
48678724|NCT00348309|156675013|FG000|Overall Study|HCV career|0|||
48678725|NCT00348309|156675014|FG001|Overall Study|HCV career|0|||
48678726|NCT00348309|156675015|FG002|Overall Study|HCV career|1|||
48678727|NCT03245775|156675018|FG000|Overall Study|Lost to Follow-up|25|||
48678728|NCT03245775|156675019|FG001|Overall Study|Lost to Follow-up|26|||
48678729|NCT03245775|156675020|FG002|Overall Study|Lost to Follow-up|16|||
48678730|NCT03245775|156675021|FG003|Overall Study|Lost to Follow-up|16|||
48678731|NCT00429169|156675023|FG000|Overall Study|Lost to Follow-up|0|||
48678732|NCT00429169|156675024|FG001|Overall Study|Lost to Follow-up|1|||
48678733|NCT00429169|156675023|FG000|Overall Study|Ineligibility discovered after entry|2|||
48678734|NCT00429169|156675024|FG001|Overall Study|Ineligibility discovered after entry|1|||
48678735|NCT02396589|156675027|FG000|Intervention|Lost to Follow-up|1|||
48678736|NCT02396589|156675028|FG001|Intervention|Lost to Follow-up|0|||
48678737|NCT02396589|156675027|FG000|6 Month Follow-up|change in health status|0|||
48678738|NCT02396589|156675028|FG001|6 Month Follow-up|change in health status|1|||
48678739|NCT02396589|156675027|FG000|9 Month Follow-up|Death|0|||
48678740|NCT02396589|156675028|FG001|9 Month Follow-up|Death|1|||
48678741|NCT02396589|156675027|FG000|12 Month Follow up|Lost to Follow-up|0|||
48678742|NCT02396589|156675028|FG001|12 Month Follow up|Lost to Follow-up|2|||
48678743|NCT03364309|156675042|FG000|Induction Period|Adverse Event|4|||
48678744|NCT03364309|156675043|FG001|Induction Period|Adverse Event|0|||
48678745|NCT03364309|156675044|FG002|Induction Period|Adverse Event|1|||
48678746|NCT03364309|156675045|FG003|Induction Period|Adverse Event|0|||
48678747|NCT03364309|156675046|FG004|Induction Period|Adverse Event|0|||
48678748|NCT03364309|156675047|FG005|Induction Period|Adverse Event|0|||
48678749|NCT03364309|156675048|FG006|Induction Period|Adverse Event|0|||
48678750|NCT03364309|156675049|FG007|Induction Period|Adverse Event|0|||
48678751|NCT03364309|156675050|FG008|Induction Period|Adverse Event|0|||
48678752|NCT03364309|156675051|FG009|Induction Period|Adverse Event|0|||
48678753|NCT03364309|156675052|FG010|Induction Period|Adverse Event|0|||
48678754|NCT03364309|156675053|FG011|Induction Period|Adverse Event|0|||
48678755|NCT03364309|156675054|FG012|Induction Period|Adverse Event|0|||
48678756|NCT03364309|156675055|FG013|Induction Period|Adverse Event|0|||
48678757|NCT03364309|156675056|FG014|Induction Period|Adverse Event|0|||
48678758|NCT03364309|156675057|FG015|Induction Period|Adverse Event|0|||
48678759|NCT03364309|156675058|FG016|Induction Period|Adverse Event|0|||
48678760|NCT03364309|156675059|FG017|Induction Period|Adverse Event|0|||
48678761|NCT03364309|156675060|FG018|Induction Period|Adverse Event|0|||
48678762|NCT03364309|156675042|FG000|Induction Period|Withdrawal by Subject|1|||
48678763|NCT03364309|156675043|FG001|Induction Period|Withdrawal by Subject|3|||
48678764|NCT03364309|156675044|FG002|Induction Period|Withdrawal by Subject|0|||
48678765|NCT03364309|156675045|FG003|Induction Period|Withdrawal by Subject|0|||
48678766|NCT03364309|156675046|FG004|Induction Period|Withdrawal by Subject|0|||
48678767|NCT03364309|156675047|FG005|Induction Period|Withdrawal by Subject|0|||
48678768|NCT03364309|156675048|FG006|Induction Period|Withdrawal by Subject|0|||
48678769|NCT03364309|156675049|FG007|Induction Period|Withdrawal by Subject|0|||
48678770|NCT03364309|156675050|FG008|Induction Period|Withdrawal by Subject|0|||
48678771|NCT03364309|156675051|FG009|Induction Period|Withdrawal by Subject|0|||
48678772|NCT03364309|156675052|FG010|Induction Period|Withdrawal by Subject|0|||
48678773|NCT03364309|156675053|FG011|Induction Period|Withdrawal by Subject|0|||
48678774|NCT03364309|156675054|FG012|Induction Period|Withdrawal by Subject|0|||
48678775|NCT03364309|156675055|FG013|Induction Period|Withdrawal by Subject|0|||
48678776|NCT03364309|156675056|FG014|Induction Period|Withdrawal by Subject|0|||
48678777|NCT03364309|156675057|FG015|Induction Period|Withdrawal by Subject|0|||
48678778|NCT03364309|156675058|FG016|Induction Period|Withdrawal by Subject|0|||
48678779|NCT03364309|156675059|FG017|Induction Period|Withdrawal by Subject|0|||
48678780|NCT03364309|156675060|FG018|Induction Period|Withdrawal by Subject|0|||
48678781|NCT03364309|156675042|FG000|Induction Period|Lost to Follow-up|1|||
48678782|NCT03364309|156675043|FG001|Induction Period|Lost to Follow-up|0|||
48678783|NCT03364309|156675044|FG002|Induction Period|Lost to Follow-up|0|||
48678784|NCT03364309|156675045|FG003|Induction Period|Lost to Follow-up|0|||
48678785|NCT03364309|156675046|FG004|Induction Period|Lost to Follow-up|0|||
48678786|NCT03364309|156675047|FG005|Induction Period|Lost to Follow-up|0|||
48678787|NCT03364309|156675048|FG006|Induction Period|Lost to Follow-up|0|||
48678788|NCT03364309|156675049|FG007|Induction Period|Lost to Follow-up|0|||
48678789|NCT03364309|156675050|FG008|Induction Period|Lost to Follow-up|0|||
48678790|NCT03364309|156675051|FG009|Induction Period|Lost to Follow-up|0|||
48678791|NCT03364309|156675052|FG010|Induction Period|Lost to Follow-up|0|||
48678792|NCT03364309|156675053|FG011|Induction Period|Lost to Follow-up|0|||
48678793|NCT03364309|156675054|FG012|Induction Period|Lost to Follow-up|0|||
48678794|NCT03364309|156675055|FG013|Induction Period|Lost to Follow-up|0|||
48678795|NCT03364309|156675056|FG014|Induction Period|Lost to Follow-up|0|||
48678796|NCT03364309|156675057|FG015|Induction Period|Lost to Follow-up|0|||
48678797|NCT03364309|156675058|FG016|Induction Period|Lost to Follow-up|0|||
48678798|NCT03364309|156675059|FG017|Induction Period|Lost to Follow-up|0|||
48678799|NCT03364309|156675060|FG018|Induction Period|Lost to Follow-up|0|||
48678800|NCT03364309|156675042|FG000|Induction Period|Physician Decision|0|||
48678801|NCT03364309|156675043|FG001|Induction Period|Physician Decision|1|||
48678802|NCT03364309|156675044|FG002|Induction Period|Physician Decision|0|||
48678803|NCT03364309|156675045|FG003|Induction Period|Physician Decision|0|||
48678804|NCT03364309|156675046|FG004|Induction Period|Physician Decision|0|||
48678805|NCT03364309|156675047|FG005|Induction Period|Physician Decision|0|||
48678806|NCT03364309|156675048|FG006|Induction Period|Physician Decision|0|||
48678807|NCT03364309|156675049|FG007|Induction Period|Physician Decision|0|||
48678808|NCT03364309|156675050|FG008|Induction Period|Physician Decision|0|||
48678809|NCT03364309|156675051|FG009|Induction Period|Physician Decision|0|||
48678810|NCT03364309|156675052|FG010|Induction Period|Physician Decision|0|||
48678811|NCT03364309|156675053|FG011|Induction Period|Physician Decision|0|||
48678812|NCT03364309|156675054|FG012|Induction Period|Physician Decision|0|||
48678813|NCT03364309|156675055|FG013|Induction Period|Physician Decision|0|||
48678814|NCT03364309|156675056|FG014|Induction Period|Physician Decision|0|||
48678815|NCT03364309|156675057|FG015|Induction Period|Physician Decision|0|||
48678816|NCT03364309|156675058|FG016|Induction Period|Physician Decision|0|||
48678817|NCT03364309|156675059|FG017|Induction Period|Physician Decision|0|||
48678818|NCT03364309|156675060|FG018|Induction Period|Physician Decision|0|||
48678819|NCT03364309|156675042|FG000|Maintenance Period|Withdrawal by Subject|0|||
48678820|NCT03364309|156675043|FG001|Maintenance Period|Withdrawal by Subject|0|||
48678821|NCT03364309|156675044|FG002|Maintenance Period|Withdrawal by Subject|0|||
48678822|NCT03364309|156675045|FG003|Maintenance Period|Withdrawal by Subject|1|||
48678823|NCT03364309|156675046|FG004|Maintenance Period|Withdrawal by Subject|3|||
48678824|NCT03364309|156675047|FG005|Maintenance Period|Withdrawal by Subject|1|||
48678825|NCT03364309|156675048|FG006|Maintenance Period|Withdrawal by Subject|3|||
48678826|NCT03364309|156675049|FG007|Maintenance Period|Withdrawal by Subject|0|||
48678827|NCT03364309|156675050|FG008|Maintenance Period|Withdrawal by Subject|1|||
48678828|NCT03364309|156675051|FG009|Maintenance Period|Withdrawal by Subject|1|||
48678829|NCT03364309|156675052|FG010|Maintenance Period|Withdrawal by Subject|2|||
48678830|NCT03364309|156675053|FG011|Maintenance Period|Withdrawal by Subject|0|||
48678831|NCT03364309|156675054|FG012|Maintenance Period|Withdrawal by Subject|0|||
48678832|NCT03364309|156675055|FG013|Maintenance Period|Withdrawal by Subject|0|||
48678833|NCT03364309|156675056|FG014|Maintenance Period|Withdrawal by Subject|0|||
48678834|NCT03364309|156675057|FG015|Maintenance Period|Withdrawal by Subject|0|||
48678835|NCT03364309|156675058|FG016|Maintenance Period|Withdrawal by Subject|0|||
48586787|NCT00431067|156339075|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
48586788|NCT03217968|156339076|FG000|Overall Study|Withdrawal by Subject|4|||
48586789|NCT03217968|156339076|FG000|Overall Study|Lost to Follow-up|1|||
48586790|NCT03217968|156339076|FG000|Overall Study|Protocol Violation|6|||
48586791|NCT00314132|156339080|FG000|Overall Study|Lost to Follow-up|3|||
48586792|NCT00314132|156339081|FG001|Overall Study|Lost to Follow-up|13|||
48586793|NCT00314132|156339080|FG000|Overall Study|Withdrawal by Subject|3|||
48586794|NCT00314132|156339081|FG001|Overall Study|Withdrawal by Subject|5|||
48586795|NCT00314132|156339080|FG000|Overall Study|Adverse Event|1|||
48586796|NCT00314132|156339081|FG001|Overall Study|Adverse Event|0|||
48586797|NCT00314132|156339080|FG000|Overall Study|Physician Decision|1|||
48586798|NCT00314132|156339081|FG001|Overall Study|Physician Decision|0|||
48762766|NCT03745144|156980332|FG002|Period 1|Other|1|||
48586799|NCT00966355|156339082|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
48586800|NCT00966355|156339083|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
48586801|NCT00966355|156339084|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
48586802|NCT00966355|156339082|FG000|Overall Study|newly diagnosed advanced HCC|11|||
48586803|NCT00966355|156339083|FG001|Overall Study|newly diagnosed advanced HCC|12|||
48586804|NCT00966355|156339084|FG002|Overall Study|newly diagnosed advanced HCC|10|||
48586805|NCT00966355|156339082|FG000|Overall Study|Lost to Follow-up|5|||
48586806|NCT00966355|156339083|FG001|Overall Study|Lost to Follow-up|4|||
48586807|NCT00966355|156339084|FG002|Overall Study|Lost to Follow-up|3|||
48586808|NCT00958412|156339085|FG000|Overall Study|Study prematurely terminated|18|||
48586809|NCT01643798|156341424|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
48586810|NCT01643798|156341425|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
48586811|NCT00328094|156341426|FG000|Overall Study|Physician Decision|3|||
48586812|NCT00328094|156341427|FG001|Overall Study|Physician Decision|3|||
48586813|NCT02607280|156341428|FG000|Overall Study|Adverse Event|4|||
48586814|NCT02607280|156341429|FG001|Overall Study|Adverse Event|0|||
48586815|NCT02607280|156341428|FG000|Overall Study|Decrease in CrCl <15|0|||
48586816|NCT02607280|156341429|FG001|Overall Study|Decrease in CrCl <15|1|||
48586817|NCT01911780|156341430|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
48586818|NCT01911780|156341431|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
48586819|NCT01911780|156341430|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
48586820|NCT01911780|156341431|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
48355067|NCT00895895|155497202|FG002|Period 1|Adverse Event|4|||
48355068|NCT00895895|155497203|FG003|Period 1|Adverse Event|6|||
48355069|NCT00895895|155497204|FG004|Period 1|Adverse Event|7|||
48355070|NCT00895895|155497200|FG000|Period 1|Death|0|||
48355071|NCT00895895|155497201|FG001|Period 1|Death|0|||
48355072|NCT00895895|155497202|FG002|Period 1|Death|0|||
48355073|NCT00895895|155497203|FG003|Period 1|Death|0|||
48355074|NCT00895895|155497204|FG004|Period 1|Death|1|||
48355075|NCT00895895|155497200|FG000|Period 1|discontinued by sponsor|2|||
48355076|NCT00895895|155497201|FG001|Period 1|discontinued by sponsor|1|||
48355077|NCT00895895|155497202|FG002|Period 1|discontinued by sponsor|2|||
48355078|NCT00895895|155497203|FG003|Period 1|discontinued by sponsor|1|||
48355079|NCT00895895|155497204|FG004|Period 1|discontinued by sponsor|1|||
48355080|NCT00895895|155497200|FG000|Period 1|failed to return|0|||
48355081|NCT00895895|155497201|FG001|Period 1|failed to return|0|||
48355082|NCT00895895|155497202|FG002|Period 1|failed to return|1|||
48355083|NCT00895895|155497203|FG003|Period 1|failed to return|0|||
48355084|NCT00895895|155497204|FG004|Period 1|failed to return|1|||
48355085|NCT00895895|155497200|FG000|Period 1|investigator request|0|||
48355086|NCT00895895|155497201|FG001|Period 1|investigator request|1|||
48355087|NCT00895895|155497202|FG002|Period 1|investigator request|0|||
48355088|NCT00895895|155497203|FG003|Period 1|investigator request|0|||
48355089|NCT00895895|155497204|FG004|Period 1|investigator request|0|||
48355090|NCT00895895|155497200|FG000|Period 1|Lost to Follow-up|2|||
48355091|NCT00895895|155497201|FG001|Period 1|Lost to Follow-up|1|||
48355092|NCT00895895|155497202|FG002|Period 1|Lost to Follow-up|3|||
48355093|NCT00895895|155497203|FG003|Period 1|Lost to Follow-up|2|||
48355094|NCT00895895|155497204|FG004|Period 1|Lost to Follow-up|3|||
48355095|NCT00895895|155497200|FG000|Period 1|Other|1|||
48355096|NCT00895895|155497201|FG001|Period 1|Other|2|||
48355097|NCT00895895|155497202|FG002|Period 1|Other|1|||
48355098|NCT00895895|155497203|FG003|Period 1|Other|1|||
48355099|NCT00895895|155497204|FG004|Period 1|Other|1|||
48355100|NCT00895895|155497200|FG000|Period 1|Protocol Violation|0|||
48355101|NCT00895895|155497201|FG001|Period 1|Protocol Violation|1|||
48355102|NCT00895895|155497202|FG002|Period 1|Protocol Violation|0|||
48355103|NCT00895895|155497203|FG003|Period 1|Protocol Violation|0|||
48355104|NCT00895895|155497204|FG004|Period 1|Protocol Violation|0|||
48355105|NCT00895895|155497200|FG000|Period 1|Withdrawal by Subject|6|||
48355106|NCT00895895|155497201|FG001|Period 1|Withdrawal by Subject|6|||
48355107|NCT00895895|155497202|FG002|Period 1|Withdrawal by Subject|8|||
48355108|NCT00895895|155497203|FG003|Period 1|Withdrawal by Subject|2|||
48355109|NCT00895895|155497204|FG004|Period 1|Withdrawal by Subject|4|||
48355110|NCT00895895|155497200|FG000|Period 1|unsatisfactory response-efficacy|2|||
48355111|NCT00895895|155497201|FG001|Period 1|unsatisfactory response-efficacy|0|||
48355112|NCT00895895|155497202|FG002|Period 1|unsatisfactory response-efficacy|0|||
48355113|NCT00895895|155497203|FG003|Period 1|unsatisfactory response-efficacy|0|||
48355114|NCT00895895|155497204|FG004|Period 1|unsatisfactory response-efficacy|0|||
48355115|NCT00895895|155497200|FG000|Period 1|randomized and not treated|1|||
48355116|NCT00895895|155497201|FG001|Period 1|randomized and not treated|3|||
48355117|NCT00895895|155497202|FG002|Period 1|randomized and not treated|1|||
48355118|NCT00895895|155497203|FG003|Period 1|randomized and not treated|1|||
48355119|NCT00895895|155497204|FG004|Period 1|randomized and not treated|2|||
48355120|NCT00895895|155497200|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
48678836|NCT03364309|156675059|FG017|Maintenance Period|Withdrawal by Subject|0|||
48678837|NCT03364309|156675060|FG018|Maintenance Period|Withdrawal by Subject|0|||
48678838|NCT03364309|156675042|FG000|Maintenance Period|Adverse Event|0|||
48678839|NCT03364309|156675043|FG001|Maintenance Period|Adverse Event|0|||
48678840|NCT03364309|156675044|FG002|Maintenance Period|Adverse Event|0|||
48678841|NCT03364309|156675045|FG003|Maintenance Period|Adverse Event|0|||
48678842|NCT03364309|156675046|FG004|Maintenance Period|Adverse Event|2|||
48678843|NCT03364309|156675047|FG005|Maintenance Period|Adverse Event|0|||
48678844|NCT03364309|156675048|FG006|Maintenance Period|Adverse Event|3|||
48678845|NCT03364309|156675049|FG007|Maintenance Period|Adverse Event|0|||
48678846|NCT03364309|156675050|FG008|Maintenance Period|Adverse Event|1|||
48678847|NCT03364309|156675051|FG009|Maintenance Period|Adverse Event|0|||
48678848|NCT03364309|156675052|FG010|Maintenance Period|Adverse Event|2|||
48678849|NCT03364309|156675053|FG011|Maintenance Period|Adverse Event|0|||
48678850|NCT03364309|156675054|FG012|Maintenance Period|Adverse Event|0|||
48678851|NCT03364309|156675055|FG013|Maintenance Period|Adverse Event|0|||
48678852|NCT03364309|156675056|FG014|Maintenance Period|Adverse Event|0|||
48678853|NCT03364309|156675057|FG015|Maintenance Period|Adverse Event|0|||
48678854|NCT03364309|156675058|FG016|Maintenance Period|Adverse Event|0|||
48678855|NCT03364309|156675059|FG017|Maintenance Period|Adverse Event|0|||
48678856|NCT03364309|156675060|FG018|Maintenance Period|Adverse Event|0|||
48678857|NCT03364309|156675042|FG000|Maintenance Period|Relapsed|0|||
48678858|NCT03364309|156675043|FG001|Maintenance Period|Relapsed|0|||
48678859|NCT03364309|156675044|FG002|Maintenance Period|Relapsed|0|||
48678860|NCT03364309|156675045|FG003|Maintenance Period|Relapsed|43|||
48678861|NCT03364309|156675046|FG004|Maintenance Period|Relapsed|7|||
48678862|NCT03364309|156675047|FG005|Maintenance Period|Relapsed|45|||
48678863|NCT03364309|156675048|FG006|Maintenance Period|Relapsed|10|||
48678864|NCT03364309|156675049|FG007|Maintenance Period|Relapsed|2|||
48678865|NCT03364309|156675050|FG008|Maintenance Period|Relapsed|0|||
48678866|NCT03364309|156675051|FG009|Maintenance Period|Relapsed|0|||
48678867|NCT03364309|156675052|FG010|Maintenance Period|Relapsed|0|||
48678868|NCT03364309|156675053|FG011|Maintenance Period|Relapsed|0|||
48678869|NCT03364309|156675054|FG012|Maintenance Period|Relapsed|0|||
48678870|NCT03364309|156675055|FG013|Maintenance Period|Relapsed|0|||
48678871|NCT03364309|156675056|FG014|Maintenance Period|Relapsed|0|||
48678872|NCT03364309|156675057|FG015|Maintenance Period|Relapsed|0|||
48678873|NCT03364309|156675058|FG016|Maintenance Period|Relapsed|0|||
48678874|NCT03364309|156675059|FG017|Maintenance Period|Relapsed|0|||
48678875|NCT03364309|156675060|FG018|Maintenance Period|Relapsed|0|||
48678876|NCT03364309|156675042|FG000|Maintenance Period|Lack of Efficacy|0|||
48678877|NCT03364309|156675043|FG001|Maintenance Period|Lack of Efficacy|0|||
48678878|NCT03364309|156675044|FG002|Maintenance Period|Lack of Efficacy|0|||
48678879|NCT03364309|156675045|FG003|Maintenance Period|Lack of Efficacy|0|||
48678880|NCT03364309|156675046|FG004|Maintenance Period|Lack of Efficacy|0|||
48678881|NCT03364309|156675047|FG005|Maintenance Period|Lack of Efficacy|0|||
48678882|NCT03364309|156675048|FG006|Maintenance Period|Lack of Efficacy|0|||
48678883|NCT03364309|156675049|FG007|Maintenance Period|Lack of Efficacy|0|||
48678884|NCT03364309|156675050|FG008|Maintenance Period|Lack of Efficacy|1|||
48678885|NCT03364309|156675051|FG009|Maintenance Period|Lack of Efficacy|3|||
48678886|NCT03364309|156675052|FG010|Maintenance Period|Lack of Efficacy|2|||
48678887|NCT03364309|156675053|FG011|Maintenance Period|Lack of Efficacy|0|||
48678888|NCT03364309|156675054|FG012|Maintenance Period|Lack of Efficacy|0|||
48678889|NCT03364309|156675055|FG013|Maintenance Period|Lack of Efficacy|0|||
48678890|NCT03364309|156675056|FG014|Maintenance Period|Lack of Efficacy|0|||
48678891|NCT03364309|156675057|FG015|Maintenance Period|Lack of Efficacy|0|||
48678892|NCT03364309|156675058|FG016|Maintenance Period|Lack of Efficacy|0|||
48678893|NCT03364309|156675059|FG017|Maintenance Period|Lack of Efficacy|0|||
48678894|NCT03364309|156675060|FG018|Maintenance Period|Lack of Efficacy|0|||
48678895|NCT03364309|156675042|FG000|Maintenance Period|Death|0|||
48678896|NCT03364309|156675043|FG001|Maintenance Period|Death|0|||
48678897|NCT03364309|156675044|FG002|Maintenance Period|Death|0|||
48678898|NCT03364309|156675045|FG003|Maintenance Period|Death|0|||
48678899|NCT03364309|156675046|FG004|Maintenance Period|Death|0|||
48678900|NCT03364309|156675047|FG005|Maintenance Period|Death|0|||
48678901|NCT03364309|156675048|FG006|Maintenance Period|Death|0|||
48678902|NCT03364309|156675049|FG007|Maintenance Period|Death|0|||
48429381|NCT01070550|155760358|FG003|Overall Study|Protocol Violation|1|||
48678903|NCT03364309|156675050|FG008|Maintenance Period|Death|1|||
48678904|NCT03364309|156675051|FG009|Maintenance Period|Death|0|||
48678905|NCT03364309|156675052|FG010|Maintenance Period|Death|0|||
48678906|NCT03364309|156675053|FG011|Maintenance Period|Death|0|||
48678907|NCT03364309|156675054|FG012|Maintenance Period|Death|0|||
48678908|NCT03364309|156675055|FG013|Maintenance Period|Death|0|||
48678909|NCT03364309|156675056|FG014|Maintenance Period|Death|0|||
48678910|NCT03364309|156675057|FG015|Maintenance Period|Death|0|||
48678911|NCT03364309|156675058|FG016|Maintenance Period|Death|0|||
48678912|NCT03364309|156675059|FG017|Maintenance Period|Death|0|||
48678913|NCT03364309|156675060|FG018|Maintenance Period|Death|0|||
48678914|NCT03364309|156675042|FG000|Maintenance Period|Lost to Follow-up|0|||
48678915|NCT03364309|156675043|FG001|Maintenance Period|Lost to Follow-up|0|||
48678916|NCT03364309|156675044|FG002|Maintenance Period|Lost to Follow-up|0|||
48678917|NCT03364309|156675045|FG003|Maintenance Period|Lost to Follow-up|0|||
48678918|NCT03364309|156675046|FG004|Maintenance Period|Lost to Follow-up|0|||
48388827|NCT01994382|155619515|FG006|Overall Study|Informed consent withdrawn|1|||
48388828|NCT01994382|155619516|FG007|Overall Study|Informed consent withdrawn|0|||
48388829|NCT01994382|155619517|FG008|Overall Study|Informed consent withdrawn|0|||
48388830|NCT01994382|155619518|FG009|Overall Study|Informed consent withdrawn|0|||
48388831|NCT01994382|155619519|FG010|Overall Study|Informed consent withdrawn|0|||
48388832|NCT01994382|155619520|FG011|Overall Study|Informed consent withdrawn|0|||
48388833|NCT01994382|155619521|FG012|Overall Study|Informed consent withdrawn|0|||
48388834|NCT01994382|155619522|FG013|Overall Study|Informed consent withdrawn|0|||
48388835|NCT01994382|155619523|FG014|Overall Study|Informed consent withdrawn|0|||
48388836|NCT01994382|155619524|FG015|Overall Study|Informed consent withdrawn|0|||
48388837|NCT01994382|155619525|FG016|Overall Study|Informed consent withdrawn|0|||
48388838|NCT01994382|155619509|FG000|Overall Study|Progressive disease|3|||
48388839|NCT01994382|155619510|FG001|Overall Study|Progressive disease|4|||
48388840|NCT01994382|155619511|FG002|Overall Study|Progressive disease|4|||
48388841|NCT01994382|155619512|FG003|Overall Study|Progressive disease|3|||
48388842|NCT01994382|155619513|FG004|Overall Study|Progressive disease|2|||
48388843|NCT01994382|155619514|FG005|Overall Study|Progressive disease|3|||
48388844|NCT01994382|155619515|FG006|Overall Study|Progressive disease|3|||
48678919|NCT03364309|156675047|FG005|Maintenance Period|Lost to Follow-up|0|||
48678920|NCT03364309|156675048|FG006|Maintenance Period|Lost to Follow-up|0|||
48678921|NCT03364309|156675049|FG007|Maintenance Period|Lost to Follow-up|0|||
48678922|NCT03364309|156675050|FG008|Maintenance Period|Lost to Follow-up|1|||
48762767|NCT00896337|156980335|FG000|Overall Study|Death|7|||
48762768|NCT00896337|156980335|FG000|Overall Study|Withdrawal by Subject|7|||
48762769|NCT00896337|156980335|FG000|Overall Study|Lost to Follow-up|11|||
48762770|NCT01359254|156980336|FG000|Overall Study|Death|1|||
48762771|NCT01359254|156980337|FG001|Overall Study|Death|0|||
48762772|NCT04668950|156980341|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
48762773|NCT04668950|156980342|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
48762774|NCT04668950|156980341|FG000|Overall Study|Could not confirm started study medication|15|||
48762775|NCT04668950|156980342|FG001|Overall Study|Could not confirm started study medication|15|||
48762776|NCT04668950|156980341|FG000|Overall Study|Could not confirm baseline status|6|||
48762777|NCT04668950|156980342|FG001|Overall Study|Could not confirm baseline status|2|||
48762778|NCT04668950|156980341|FG000|Overall Study|Drop out and did not start medication|15|||
48762779|NCT04668950|156980342|FG001|Overall Study|Drop out and did not start medication|17|||
48762780|NCT04668950|156980341|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
48762781|NCT04668950|156980342|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
48762782|NCT04668950|156980341|FG000|Overall Study|Other|2|||
48762783|NCT04668950|156980342|FG001|Overall Study|Other|4|||
48762784|NCT00445965|156980345|FG000|Overall Study|Adverse Event|2|||
48762785|NCT00445965|156980345|FG000|Overall Study|Physician Decision|1|||
48762786|NCT00445965|156980345|FG000|Overall Study|Enrolled but not treated|1|||
48762787|NCT00445965|156980345|FG000|Overall Study|Removed due to progressive disease|29|||
48762788|NCT00600938|156980346|FG000|Core Study|Abnormal test procedure result(s)|3|||
48762789|NCT00600938|156980347|FG001|Core Study|Abnormal test procedure result(s)|2|||
48762790|NCT00600938|156980348|FG002|Core Study|Abnormal test procedure result(s)|0|||
48762791|NCT00600938|156980349|FG003|Core Study|Abnormal test procedure result(s)|0|||
48762792|NCT00600938|156980346|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
48762793|NCT00600938|156980347|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
48762794|NCT00600938|156980348|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
48762795|NCT00600938|156980349|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
48762796|NCT00600938|156980346|FG000|Core Study|Patient withdrew consent|7|||
48762797|NCT00600938|156980347|FG001|Core Study|Patient withdrew consent|12|||
48762798|NCT00600938|156980348|FG002|Core Study|Patient withdrew consent|0|||
48762799|NCT00600938|156980349|FG003|Core Study|Patient withdrew consent|0|||
48762800|NCT00600938|156980346|FG000|Core Study|Lost to Follow-up|3|||
48762801|NCT00600938|156980347|FG001|Core Study|Lost to Follow-up|2|||
48762802|NCT00600938|156980348|FG002|Core Study|Lost to Follow-up|0|||
48762803|NCT00600938|156980349|FG003|Core Study|Lost to Follow-up|0|||
48762804|NCT00600938|156980346|FG000|Core Study|Death|1|||
48678923|NCT03364309|156675051|FG009|Maintenance Period|Lost to Follow-up|0|||
48678924|NCT03364309|156675052|FG010|Maintenance Period|Lost to Follow-up|0|||
48678925|NCT03364309|156675053|FG011|Maintenance Period|Lost to Follow-up|0|||
48678926|NCT03364309|156675054|FG012|Maintenance Period|Lost to Follow-up|0|||
48678927|NCT03364309|156675055|FG013|Maintenance Period|Lost to Follow-up|0|||
48678928|NCT03364309|156675056|FG014|Maintenance Period|Lost to Follow-up|0|||
48678929|NCT03364309|156675057|FG015|Maintenance Period|Lost to Follow-up|0|||
48388845|NCT01994382|155619516|FG007|Overall Study|Progressive disease|6|||
48388846|NCT01994382|155619517|FG008|Overall Study|Progressive disease|2|||
48388847|NCT01994382|155619518|FG009|Overall Study|Progressive disease|2|||
48388848|NCT01994382|155619519|FG010|Overall Study|Progressive disease|13|||
48388849|NCT01994382|155619520|FG011|Overall Study|Progressive disease|8|||
48678930|NCT03364309|156675058|FG016|Maintenance Period|Lost to Follow-up|0|||
48678931|NCT03364309|156675059|FG017|Maintenance Period|Lost to Follow-up|0|||
48678932|NCT03364309|156675060|FG018|Maintenance Period|Lost to Follow-up|0|||
48678933|NCT03364309|156675042|FG000|Maintenance Period|Miscellaneous|0|||
48678934|NCT03364309|156675043|FG001|Maintenance Period|Miscellaneous|0|||
48678935|NCT03364309|156675044|FG002|Maintenance Period|Miscellaneous|0|||
48678936|NCT03364309|156675045|FG003|Maintenance Period|Miscellaneous|0|||
48678937|NCT03364309|156675046|FG004|Maintenance Period|Miscellaneous|0|||
48678938|NCT03364309|156675047|FG005|Maintenance Period|Miscellaneous|0|||
48678939|NCT03364309|156675048|FG006|Maintenance Period|Miscellaneous|0|||
48678940|NCT03364309|156675049|FG007|Maintenance Period|Miscellaneous|0|||
48678941|NCT03364309|156675050|FG008|Maintenance Period|Miscellaneous|1|||
48678942|NCT03364309|156675051|FG009|Maintenance Period|Miscellaneous|0|||
48678943|NCT03364309|156675052|FG010|Maintenance Period|Miscellaneous|0|||
48678944|NCT03364309|156675053|FG011|Maintenance Period|Miscellaneous|0|||
48678945|NCT03364309|156675054|FG012|Maintenance Period|Miscellaneous|0|||
48678946|NCT03364309|156675055|FG013|Maintenance Period|Miscellaneous|0|||
48678947|NCT03364309|156675056|FG014|Maintenance Period|Miscellaneous|0|||
48678948|NCT03364309|156675057|FG015|Maintenance Period|Miscellaneous|0|||
48678949|NCT03364309|156675058|FG016|Maintenance Period|Miscellaneous|0|||
48678950|NCT03364309|156675059|FG017|Maintenance Period|Miscellaneous|0|||
48678951|NCT03364309|156675060|FG018|Maintenance Period|Miscellaneous|0|||
48678952|NCT03364309|156675042|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678953|NCT03364309|156675043|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678954|NCT03364309|156675044|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678955|NCT03364309|156675045|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678956|NCT03364309|156675046|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678957|NCT03364309|156675047|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678958|NCT03364309|156675048|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678959|NCT03364309|156675049|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678960|NCT03364309|156675050|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678961|NCT03364309|156675051|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678962|NCT03364309|156675052|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678963|NCT03364309|156675053|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678964|NCT03364309|156675054|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678965|NCT03364309|156675055|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
48678966|NCT03364309|156675056|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
48678967|NCT03364309|156675057|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
48678968|NCT03364309|156675058|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678969|NCT03364309|156675059|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678970|NCT03364309|156675060|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
48678971|NCT03364309|156675042|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678972|NCT03364309|156675043|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678973|NCT03364309|156675044|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678974|NCT03364309|156675045|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678975|NCT03364309|156675046|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678976|NCT03364309|156675047|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678977|NCT03364309|156675048|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678978|NCT03364309|156675049|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678979|NCT03364309|156675050|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678980|NCT03364309|156675051|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678981|NCT03364309|156675052|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678982|NCT03364309|156675053|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678983|NCT03364309|156675054|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678984|NCT03364309|156675055|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678985|NCT03364309|156675056|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
48678986|NCT03364309|156675057|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678987|NCT03364309|156675058|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678988|NCT03364309|156675059|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
48388850|NCT01994382|155619521|FG012|Overall Study|Progressive disease|7|||
48388851|NCT01994382|155619522|FG013|Overall Study|Progressive disease|3|||
48388852|NCT01994382|155619523|FG014|Overall Study|Progressive disease|6|||
48678989|NCT03364309|156675060|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
48678990|NCT03364309|156675042|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
48678991|NCT03364309|156675043|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
48678992|NCT03364309|156675044|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
48678993|NCT03364309|156675045|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
48678994|NCT03364309|156675046|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
48762805|NCT00600938|156980347|FG001|Core Study|Death|1|||
48762806|NCT00600938|156980348|FG002|Core Study|Death|0|||
48678995|NCT03364309|156675047|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
48678996|NCT03364309|156675048|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
48388853|NCT01994382|155619524|FG015|Overall Study|Progressive disease|44|||
48678997|NCT03364309|156675049|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
48678998|NCT03364309|156675050|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
48678999|NCT03364309|156675051|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
48679000|NCT03364309|156675052|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
48679001|NCT03364309|156675053|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
48679002|NCT03364309|156675054|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
48679003|NCT03364309|156675055|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
48679004|NCT03364309|156675056|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
48679005|NCT03364309|156675057|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
48679006|NCT03364309|156675058|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
48679007|NCT03364309|156675059|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
48679008|NCT03364309|156675060|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
48679009|NCT03364309|156675042|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679010|NCT03364309|156675043|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679011|NCT03364309|156675044|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679012|NCT03364309|156675045|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679013|NCT03364309|156675046|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679014|NCT03364309|156675047|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679015|NCT03364309|156675048|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679016|NCT03364309|156675049|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679017|NCT03364309|156675050|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679018|NCT03364309|156675051|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679019|NCT03364309|156675052|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679020|NCT03364309|156675053|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679021|NCT03364309|156675054|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679022|NCT03364309|156675055|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679023|NCT03364309|156675056|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679024|NCT03364309|156675057|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
48679025|NCT03364309|156675058|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
48679026|NCT03364309|156675059|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
48679027|NCT03364309|156675060|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
48679028|NCT03364309|156675042|FG000|Post-Treatment Followup Period|Adverse Event|0|||
48679029|NCT03364309|156675043|FG001|Post-Treatment Followup Period|Adverse Event|0|||
48679030|NCT03364309|156675044|FG002|Post-Treatment Followup Period|Adverse Event|0|||
48679031|NCT03364309|156675045|FG003|Post-Treatment Followup Period|Adverse Event|0|||
48679032|NCT03364309|156675046|FG004|Post-Treatment Followup Period|Adverse Event|0|||
48679033|NCT03364309|156675047|FG005|Post-Treatment Followup Period|Adverse Event|0|||
48679034|NCT03364309|156675048|FG006|Post-Treatment Followup Period|Adverse Event|0|||
48679035|NCT03364309|156675049|FG007|Post-Treatment Followup Period|Adverse Event|0|||
48679036|NCT03364309|156675050|FG008|Post-Treatment Followup Period|Adverse Event|0|||
48679037|NCT03364309|156675051|FG009|Post-Treatment Followup Period|Adverse Event|0|||
48679038|NCT03364309|156675052|FG010|Post-Treatment Followup Period|Adverse Event|0|||
48679039|NCT03364309|156675053|FG011|Post-Treatment Followup Period|Adverse Event|0|||
48679040|NCT03364309|156675054|FG012|Post-Treatment Followup Period|Adverse Event|0|||
48679041|NCT03364309|156675055|FG013|Post-Treatment Followup Period|Adverse Event|0|||
48679042|NCT03364309|156675056|FG014|Post-Treatment Followup Period|Adverse Event|0|||
48679043|NCT03364309|156675057|FG015|Post-Treatment Followup Period|Adverse Event|0|||
48679044|NCT03364309|156675058|FG016|Post-Treatment Followup Period|Adverse Event|2|||
48679045|NCT03364309|156675059|FG017|Post-Treatment Followup Period|Adverse Event|6|||
48679046|NCT03364309|156675060|FG018|Post-Treatment Followup Period|Adverse Event|1|||
48679047|NCT03364309|156675042|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679048|NCT03364309|156675043|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679049|NCT03364309|156675044|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679050|NCT03364309|156675045|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679051|NCT03364309|156675046|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679052|NCT03364309|156675047|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679053|NCT03364309|156675048|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679054|NCT03364309|156675049|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679055|NCT03364309|156675050|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679056|NCT03364309|156675051|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679057|NCT03364309|156675052|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679058|NCT03364309|156675053|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
48762807|NCT00600938|156980349|FG003|Core Study|Death|0|||
48679059|NCT03364309|156675054|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679060|NCT03364309|156675055|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679061|NCT03364309|156675056|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679062|NCT03364309|156675057|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679063|NCT03364309|156675058|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
48762808|NCT00600938|156980346|FG000|Core Study|Protocol Violation|1|||
48679064|NCT03364309|156675059|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
48679065|NCT03364309|156675060|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
48679066|NCT03364309|156675042|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
48679067|NCT03364309|156675043|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
48679068|NCT03364309|156675044|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
48679069|NCT03364309|156675045|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
48679070|NCT03364309|156675046|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
48679071|NCT03364309|156675047|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
48679072|NCT03364309|156675048|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
48679073|NCT03364309|156675049|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
48679074|NCT03364309|156675050|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
48679075|NCT03364309|156675051|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
48679076|NCT03364309|156675052|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
48679077|NCT03364309|156675053|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
48679078|NCT03364309|156675054|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
48679079|NCT03364309|156675055|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
48679080|NCT03364309|156675056|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
48679081|NCT03364309|156675057|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
48679082|NCT03364309|156675058|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
48679083|NCT03364309|156675059|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
48679084|NCT03364309|156675060|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
48679085|NCT03477838|156675061|FG000|Overall Study|Lost to Follow-up|14|||
48679086|NCT01345669|156675062|FG000|Overall Study|Primary tumour recurrence|53|||
48679087|NCT01345669|156675063|FG001|Overall Study|Primary tumour recurrence|32|||
48679088|NCT01345669|156675062|FG000|Overall Study|Second primary tumour|4|||
48679089|NCT01345669|156675063|FG001|Overall Study|Second primary tumour|3|||
48679090|NCT01345669|156675062|FG000|Overall Study|Adverse Event|63|||
48679091|NCT01345669|156675063|FG001|Overall Study|Adverse Event|9|||
48679092|NCT01345669|156675062|FG000|Overall Study|Protocol Violation|3|||
48679093|NCT01345669|156675063|FG001|Overall Study|Protocol Violation|1|||
48679094|NCT01345669|156675062|FG000|Overall Study|Lost to Follow-up|1|||
48679095|NCT01345669|156675063|FG001|Overall Study|Lost to Follow-up|1|||
48679096|NCT01345669|156675062|FG000|Overall Study|Withdrawal by Subject|52|||
48679097|NCT01345669|156675063|FG001|Overall Study|Withdrawal by Subject|13|||
48679098|NCT01345669|156675062|FG000|Overall Study|Other Reasons|111|||
48679099|NCT01345669|156675063|FG001|Overall Study|Other Reasons|60|||
48679100|NCT00615992|156675064|FG000|Overall Study|Protocol Violation|67|||
48679101|NCT03992846|156675067|FG000|Overall Study|Adverse Event|8|||
48679102|NCT03992846|156675068|FG001|Overall Study|Adverse Event|6|||
48679103|NCT03992846|156675069|FG002|Overall Study|Adverse Event|3|||
48679104|NCT03992846|156675067|FG000|Overall Study|Lost to Follow-up|0|||
48679105|NCT03992846|156675068|FG001|Overall Study|Lost to Follow-up|1|||
48679106|NCT03992846|156675069|FG002|Overall Study|Lost to Follow-up|1|||
48679107|NCT03992846|156675067|FG000|Overall Study|Pregnancy|2|||
48679108|NCT03992846|156675068|FG001|Overall Study|Pregnancy|0|||
48679109|NCT03992846|156675069|FG002|Overall Study|Pregnancy|1|||
48679110|NCT03992846|156675067|FG000|Overall Study|Protocol Violation|1|||
48679111|NCT03992846|156675068|FG001|Overall Study|Protocol Violation|2|||
48679112|NCT03992846|156675069|FG002|Overall Study|Protocol Violation|0|||
48679113|NCT03992846|156675067|FG000|Overall Study|Withdrawal by Subject|8|||
48679114|NCT03992846|156675068|FG001|Overall Study|Withdrawal by Subject|10|||
48679115|NCT03992846|156675069|FG002|Overall Study|Withdrawal by Subject|20|||
48679116|NCT03992846|156675067|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
48679117|NCT03992846|156675068|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
48679118|NCT03992846|156675069|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
48679119|NCT02720692|156676559|FG000|Overall Study|Withdrawal by Subject|3|||
48388854|NCT01994382|155619525|FG016|Overall Study|Progressive disease|28|||
48388855|NCT01994382|155619509|FG000|Overall Study|Physician Decision|0|||
48388856|NCT01994382|155619510|FG001|Overall Study|Physician Decision|1|||
48388857|NCT01994382|155619511|FG002|Overall Study|Physician Decision|0|||
48388858|NCT01994382|155619512|FG003|Overall Study|Physician Decision|0|||
48388859|NCT01994382|155619513|FG004|Overall Study|Physician Decision|0|||
48679120|NCT02720692|156676560|FG001|Overall Study|Withdrawal by Subject|0|||
48679121|NCT02720692|156676559|FG000|Overall Study|Physician Decision|1|||
48679122|NCT02720692|156676560|FG001|Overall Study|Physician Decision|0|||
48679123|NCT02720692|156676559|FG000|Overall Study|Lost to Follow-up|8|||
48679124|NCT02720692|156676560|FG001|Overall Study|Lost to Follow-up|3|||
48679125|NCT02720692|156676559|FG000|Overall Study|Subject unable to return for visit|1|||
48679126|NCT02720692|156676560|FG001|Overall Study|Subject unable to return for visit|0|||
48679127|NCT05011513|156676561|FG000|Overall Study|Death|0|||
48679128|NCT05011513|156676562|FG001|Overall Study|Death|1|||
48679129|NCT05011513|156676561|FG000|Overall Study|Lost to Follow-up|4|||
48679130|NCT05011513|156676562|FG001|Overall Study|Lost to Follow-up|0|||
48679131|NCT05011513|156676561|FG000|Overall Study|Withdrawal by Subject|18|||
48679132|NCT05011513|156676562|FG001|Overall Study|Withdrawal by Subject|17|||
48679133|NCT05011513|156676561|FG000|Overall Study|Other|4|||
48679134|NCT05011513|156676562|FG001|Overall Study|Other|2|||
48679135|NCT02503501|156676563|FG000|Overall Study|Physician Decision|1|||
48679136|NCT02503501|156676564|FG001|Overall Study|Physician Decision|0|||
48679137|NCT02503501|156676563|FG000|Overall Study|Protocol Violation|0|||
48679138|NCT02503501|156676564|FG001|Overall Study|Protocol Violation|1|||
48679139|NCT02503501|156676563|FG000|Overall Study|Withdrawal by Subject|0|||
48679140|NCT02503501|156676564|FG001|Overall Study|Withdrawal by Subject|2|||
48679141|NCT02806960|156676565|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
48388860|NCT01994382|155619514|FG005|Overall Study|Physician Decision|0|||
48388861|NCT01994382|155619515|FG006|Overall Study|Physician Decision|0|||
48388862|NCT01994382|155619516|FG007|Overall Study|Physician Decision|0|||
48388863|NCT01994382|155619517|FG008|Overall Study|Physician Decision|0|||
48679142|NCT02806960|156676566|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
48679143|NCT02806960|156676567|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
48679144|NCT02806960|156676568|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
48679145|NCT02315560|156676569|FG000|Overall Study|noncompliance by subjects|3|||
48679146|NCT04327024|156676570|FG000|Overall Study|Death|1|||
48679147|NCT04327024|156676571|FG001|Overall Study|Death|2|||
48679148|NCT04327024|156676572|FG002|Overall Study|Death|1|||
48679149|NCT04327024|156676570|FG000|Overall Study|Non-compliance with study drug|0|||
48679150|NCT04327024|156676571|FG001|Overall Study|Non-compliance with study drug|1|||
48679151|NCT04327024|156676572|FG002|Overall Study|Non-compliance with study drug|0|||
48679152|NCT04327024|156676570|FG000|Overall Study|Withdrawal by Subject|1|||
48679153|NCT04327024|156676571|FG001|Overall Study|Withdrawal by Subject|1|||
48679154|NCT04327024|156676572|FG002|Overall Study|Withdrawal by Subject|2|||
48679155|NCT03056339|156676575|FG000|Overall Study|Failed Requirements|0|||
48679156|NCT03056339|156676576|FG001|Overall Study|Failed Requirements|2|||
48679157|NCT03056339|156676577|FG002|Overall Study|Failed Requirements|7|||
48679158|NCT03056339|156676578|FG003|Overall Study|Failed Requirements|1|||
48679159|NCT01483183|156676582|FG000|Overall Study|Physician Decision|0|||
48679160|NCT01483183|156676583|FG001|Overall Study|Physician Decision|0|||
48679161|NCT01483183|156676584|FG002|Overall Study|Physician Decision|0|||
48679162|NCT01483183|156676585|FG003|Overall Study|Physician Decision|0|||
48679163|NCT01483183|156676586|FG004|Overall Study|Physician Decision|0|||
48679164|NCT01483183|156676587|FG005|Overall Study|Physician Decision|0|||
48679165|NCT01483183|156676588|FG006|Overall Study|Physician Decision|2|||
48679166|NCT01483183|156676589|FG007|Overall Study|Physician Decision|0|||
48679167|NCT01483183|156676590|FG008|Overall Study|Physician Decision|0|||
48679168|NCT01483183|156676591|FG009|Overall Study|Physician Decision|0|||
48679169|NCT01483183|156676582|FG000|Overall Study|Withdrawal by Subject|0|||
48679170|NCT01483183|156676583|FG001|Overall Study|Withdrawal by Subject|0|||
48679171|NCT01483183|156676584|FG002|Overall Study|Withdrawal by Subject|0|||
48679172|NCT01483183|156676585|FG003|Overall Study|Withdrawal by Subject|0|||
48679173|NCT01483183|156676586|FG004|Overall Study|Withdrawal by Subject|0|||
48679174|NCT01483183|156676587|FG005|Overall Study|Withdrawal by Subject|0|||
48679175|NCT01483183|156676588|FG006|Overall Study|Withdrawal by Subject|0|||
48679176|NCT01483183|156676589|FG007|Overall Study|Withdrawal by Subject|0|||
48679177|NCT01483183|156676590|FG008|Overall Study|Withdrawal by Subject|0|||
48679178|NCT01483183|156676591|FG009|Overall Study|Withdrawal by Subject|1|||
48679179|NCT02596230|156676592|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
48679180|NCT02596230|156676593|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
48679181|NCT02596230|156676594|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
48679182|NCT02596230|156676595|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
48679183|NCT02596230|156676596|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
48679184|NCT02596230|156676592|FG000|Objective 2, One Year|Lost to Follow-up|0|||
48679185|NCT02596230|156676593|FG001|Objective 2, One Year|Lost to Follow-up|41|||
48679186|NCT02596230|156676594|FG002|Objective 2, One Year|Lost to Follow-up|41|||
48679187|NCT02596230|156676595|FG003|Objective 2, One Year|Lost to Follow-up|32|||
48679188|NCT02596230|156676596|FG004|Objective 2, One Year|Lost to Follow-up|46|||
48679189|NCT02596230|156676592|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
48679190|NCT02596230|156676593|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
48679191|NCT02596230|156676594|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
48679192|NCT02596230|156676595|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
48679193|NCT02596230|156676596|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
48679194|NCT02596230|156676592|FG000|Objective 2, One Year|Adverse drug reaction|0|||
48679195|NCT02596230|156676593|FG001|Objective 2, One Year|Adverse drug reaction|1|||
48679196|NCT02596230|156676594|FG002|Objective 2, One Year|Adverse drug reaction|0|||
48679197|NCT02596230|156676595|FG003|Objective 2, One Year|Adverse drug reaction|0|||
48679198|NCT02596230|156676596|FG004|Objective 2, One Year|Adverse drug reaction|0|||
48679199|NCT02596230|156676592|FG000|Objective 2, One Year|Death|0|||
48388864|NCT01994382|155619518|FG009|Overall Study|Physician Decision|0|||
48388865|NCT01994382|155619519|FG010|Overall Study|Physician Decision|3|||
48679200|NCT02596230|156676593|FG001|Objective 2, One Year|Death|12|||
48679201|NCT02596230|156676594|FG002|Objective 2, One Year|Death|41|||
48679202|NCT02596230|156676595|FG003|Objective 2, One Year|Death|21|||
48679203|NCT02596230|156676596|FG004|Objective 2, One Year|Death|30|||
48679204|NCT02596230|156676592|FG000|Objective 2, One Year|Other|0|||
48679205|NCT02596230|156676593|FG001|Objective 2, One Year|Other|3|||
48679206|NCT02596230|156676594|FG002|Objective 2, One Year|Other|2|||
48679207|NCT02596230|156676595|FG003|Objective 2, One Year|Other|0|||
48679208|NCT02596230|156676596|FG004|Objective 2, One Year|Other|0|||
48679209|NCT00466921|156676597|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
48679210|NCT00466921|156676597|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
48679211|NCT00466921|156676597|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
48679212|NCT00466921|156676597|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
48679213|NCT00466921|156676597|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
48679214|NCT00466921|156676597|FG000|Follow up for a Minimum of 1 Year|Death|6|||
48679215|NCT02881762|156676598|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
48679216|NCT02881762|156676599|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48679217|NCT00245037|156676600|FG000|Overall Study|Death|17|||
48679218|NCT02524158|156676601|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
48679219|NCT02524158|156676602|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
48679220|NCT02524158|156676601|FG000|12-weeks Assessment|Lost to Follow-up|18|||
48679221|NCT02524158|156676602|FG001|12-weeks Assessment|Lost to Follow-up|12|||
48679222|NCT02524158|156676601|FG000|6-month Assessment|Withdrawal by Subject|1|||
48679223|NCT02524158|156676602|FG001|6-month Assessment|Withdrawal by Subject|1|||
48679224|NCT02524158|156676601|FG000|6-month Assessment|Lost to Follow-up|21|||
48679225|NCT02524158|156676602|FG001|6-month Assessment|Lost to Follow-up|20|||
48679226|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679227|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679228|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
48679229|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
48679230|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
48679231|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679232|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
48679233|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
48679234|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
48679235|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679236|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679237|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679238|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
48679239|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
48679240|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
48679241|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
48679242|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
48679243|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
48679244|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
48679245|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
48679246|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
48679247|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
48679248|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
48679249|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
48679250|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
48679251|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
48679252|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679253|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
48679254|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
48679255|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679256|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679257|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
48679258|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
48679259|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679260|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679261|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679262|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679263|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679264|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
48679265|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679266|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
48679267|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
48679268|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679269|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679270|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679271|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
48679272|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679273|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
48679274|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679275|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679276|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679277|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
48679278|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679279|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679280|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679281|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
48679282|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679283|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679284|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679285|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
48679286|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679287|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679288|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679289|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679290|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
48679291|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679292|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679293|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679294|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
48679295|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679296|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679297|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
48679298|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679299|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679300|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679301|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679302|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679303|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
48679304|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679305|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
48679306|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679307|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679308|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679309|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679310|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679311|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679312|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679313|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679314|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679315|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679316|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
48679317|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
48679318|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679319|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679320|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679321|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679322|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679323|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679324|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679325|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679326|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679327|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679328|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679329|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
48679330|NCT03100058|156676603|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679331|NCT03100058|156676604|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679332|NCT03100058|156676605|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679333|NCT03100058|156676606|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679334|NCT03100058|156676607|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679335|NCT03100058|156676608|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679336|NCT03100058|156676609|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
48679337|NCT03100058|156676610|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679338|NCT03100058|156676611|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679339|NCT03100058|156676612|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679340|NCT03100058|156676613|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679341|NCT03100058|156676614|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679342|NCT03100058|156676615|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
48679343|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679344|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679345|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679346|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679347|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679348|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679349|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679350|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679351|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679352|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
48679353|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
48679354|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
48679355|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
48679356|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679357|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679358|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679359|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679360|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679361|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679362|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679363|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679364|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679365|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679366|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
48679367|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
48679368|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
48679369|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679370|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679371|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679372|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679373|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679374|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679375|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679376|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679377|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679378|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
48679379|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
48679380|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
48679381|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
48679382|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679383|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679384|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679385|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679386|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679387|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679388|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679389|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679390|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679391|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679392|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
48679393|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679394|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
48679395|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679396|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679397|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679398|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679399|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679400|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679401|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679402|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679403|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679404|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679405|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679406|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
48679407|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
48762809|NCT00600938|156980347|FG001|Core Study|Protocol Violation|2|||
48762810|NCT00600938|156980348|FG002|Core Study|Protocol Violation|0|||
48679408|NCT03100058|156676603|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679409|NCT03100058|156676604|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679410|NCT03100058|156676605|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679411|NCT03100058|156676606|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679412|NCT03100058|156676607|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679413|NCT03100058|156676608|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679414|NCT03100058|156676609|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679415|NCT03100058|156676610|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679416|NCT03100058|156676611|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679417|NCT03100058|156676612|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
48679418|NCT03100058|156676613|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679419|NCT03100058|156676614|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679420|NCT03100058|156676615|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
48679421|NCT00555672|156676617|FG000|Overall Study|Death|0|||
48679422|NCT00555672|156676618|FG001|Overall Study|Death|2|||
48679423|NCT00555672|156676617|FG000|Overall Study|Adverse Event|8|||
48679424|NCT00555672|156676618|FG001|Overall Study|Adverse Event|2|||
48679425|NCT00555672|156676617|FG000|Overall Study|Objective progression or relapse|11|||
48679426|NCT00555672|156676618|FG001|Overall Study|Objective progression or relapse|5|||
48679427|NCT00555672|156676617|FG000|Overall Study|Other|3|||
48679428|NCT00555672|156676618|FG001|Overall Study|Other|1|||
48679429|NCT00555672|156676617|FG000|Overall Study|Participant refused|2|||
48679430|NCT00555672|156676618|FG001|Overall Study|Participant refused|0|||
48679431|NCT01919801|156676620|FG000|Overall Study|Withdrawal by Subject|1|||
48679432|NCT01919801|156676621|FG001|Overall Study|Withdrawal by Subject|0|||
48679433|NCT01919801|156676620|FG000|Overall Study|Physician Decision|0|||
48679434|NCT01919801|156676621|FG001|Overall Study|Physician Decision|1|||
48679435|NCT01919801|156676620|FG000|Overall Study|Lost to Follow-up|0|||
48679436|NCT01919801|156676621|FG001|Overall Study|Lost to Follow-up|1|||
48679437|NCT01919801|156676620|FG000|Overall Study|Other|0|||
48679438|NCT01919801|156676621|FG001|Overall Study|Other|1|||
48679439|NCT01625000|156676628|FG000|Overall Study|Physician Decision|15|||
48679440|NCT01625000|156676629|FG001|Overall Study|Physician Decision|7|||
48679441|NCT01625000|156676630|FG002|Overall Study|Physician Decision|7|||
48679442|NCT01625000|156676631|FG003|Overall Study|Physician Decision|2|||
48679443|NCT01625000|156676632|FG004|Overall Study|Physician Decision|15|||
48679444|NCT01625000|156676628|FG000|Overall Study|Protocol Violation|3|||
48679445|NCT01625000|156676629|FG001|Overall Study|Protocol Violation|10|||
48679446|NCT01625000|156676630|FG002|Overall Study|Protocol Violation|4|||
48679447|NCT01625000|156676631|FG003|Overall Study|Protocol Violation|1|||
48679448|NCT01625000|156676632|FG004|Overall Study|Protocol Violation|2|||
48679449|NCT01625000|156676628|FG000|Overall Study|Withdrawal by Subject|19|||
48679450|NCT01625000|156676629|FG001|Overall Study|Withdrawal by Subject|16|||
48679451|NCT01625000|156676630|FG002|Overall Study|Withdrawal by Subject|11|||
48679452|NCT01625000|156676631|FG003|Overall Study|Withdrawal by Subject|9|||
48679453|NCT01625000|156676632|FG004|Overall Study|Withdrawal by Subject|17|||
48679454|NCT01625000|156676628|FG000|Overall Study|Adverse Event (including Death)|15|||
48679455|NCT01625000|156676629|FG001|Overall Study|Adverse Event (including Death)|19|||
48679456|NCT01625000|156676630|FG002|Overall Study|Adverse Event (including Death)|11|||
48679457|NCT01625000|156676631|FG003|Overall Study|Adverse Event (including Death)|7|||
48679458|NCT01625000|156676632|FG004|Overall Study|Adverse Event (including Death)|21|||
48679459|NCT02161380|156676633|FG000|Overall Study|Lost to Follow-up|0|||
48679460|NCT02161380|156676634|FG001|Overall Study|Lost to Follow-up|1|||
48679461|NCT02161380|156676635|FG002|Overall Study|Lost to Follow-up|0|||
48679462|NCT02161380|156676636|FG003|Overall Study|Lost to Follow-up|0|||
48679463|NCT00892775|156676638|FG000|Overall Study|Protocol Violation|1|||
48679464|NCT00892775|156676639|FG001|Overall Study|Protocol Violation|0|||
48679465|NCT00892775|156676638|FG000|Overall Study|Subject difficulties with blood drawing|1|||
48679466|NCT00892775|156676639|FG001|Overall Study|Subject difficulties with blood drawing|0|||
48388866|NCT01994382|155619520|FG011|Overall Study|Physician Decision|1|||
48388867|NCT01994382|155619521|FG012|Overall Study|Physician Decision|1|||
48388868|NCT01994382|155619522|FG013|Overall Study|Physician Decision|0|||
48679467|NCT00892775|156676638|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
48679468|NCT00892775|156676639|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
48679469|NCT00892775|156676638|FG000|Overall Study|Migrated/ moved from study area|1|||
48679470|NCT00892775|156676639|FG001|Overall Study|Migrated/ moved from study area|0|||
48679471|NCT00892775|156676638|FG000|Overall Study|Withdrawal by Subject|0|||
48679472|NCT00892775|156676639|FG001|Overall Study|Withdrawal by Subject|1|||
48679473|NCT00892775|156676638|FG000|Overall Study|Lost to Follow-up|1|||
48679474|NCT00892775|156676639|FG001|Overall Study|Lost to Follow-up|0|||
48679475|NCT00958165|156676640|FG000|Overall Study|Lost to Follow-up|5|||
48679476|NCT00958165|156676640|FG000|Overall Study|Not eligible|9|||
48388869|NCT01994382|155619523|FG014|Overall Study|Physician Decision|1|||
48679477|NCT03405818|156676641|FG000|Overall Study|Withdrawal by Subject|4|||
48679478|NCT03405818|156676641|FG000|Overall Study|Lost to Follow-up|4|||
48679479|NCT00766051|156676642|FG000|Overall Study|Withdrawal by Subject|2|||
48679480|NCT00766051|156676643|FG001|Overall Study|Withdrawal by Subject|0|||
48679481|NCT02713828|156676646|FG000|Overall Study|Death|2|||
48679482|NCT02713828|156676647|FG001|Overall Study|Death|0|||
48679483|NCT02713828|156676646|FG000|Overall Study|Withdrawal by Subject|1|||
48679484|NCT02713828|156676647|FG001|Overall Study|Withdrawal by Subject|0|||
48679485|NCT02713828|156676646|FG000|Overall Study|study terminated but patient allowed to|2|||
48679486|NCT02713828|156676647|FG001|Overall Study|study terminated but patient allowed to|0|||
48679487|NCT01534195|156676648|FG000|Overall Study|Withdrawal by Subject|1|||
48679488|NCT01534195|156676649|FG001|Overall Study|Withdrawal by Subject|1|||
48679489|NCT01635855|156676650|FG000|Overall Study|Withdrawal by Subject|4|||
48679490|NCT03302247|156676651|FG000|Overall Study|the study has closed prematurely|2|||
48679491|NCT03302247|156676651|FG000|Overall Study|Death|1|||
48679492|NCT02669121|156676652|FG000|Overall Study|Adverse Event|4|||
48679493|NCT02669121|156676653|FG001|Overall Study|Adverse Event|5|||
48679494|NCT02669121|156676652|FG000|Overall Study|Lost to Follow-up|15|||
48679495|NCT02669121|156676653|FG001|Overall Study|Lost to Follow-up|27|||
48679496|NCT02669121|156676652|FG000|Overall Study|Withdrawal by Subject|132|||
48679497|NCT02669121|156676653|FG001|Overall Study|Withdrawal by Subject|140|||
48679498|NCT02669121|156676652|FG000|Overall Study|Pregnancy|0|||
48679499|NCT02669121|156676653|FG001|Overall Study|Pregnancy|1|||
48679500|NCT02669121|156676652|FG000|Overall Study|Discharged from US Military Active Service|117|||
48679501|NCT02669121|156676653|FG001|Overall Study|Discharged from US Military Active Service|91|||
48679502|NCT02669121|156676652|FG000|Overall Study|Reason not Specified|22|||
48679503|NCT02669121|156676653|FG001|Overall Study|Reason not Specified|18|||
48679504|NCT00635882|156676654|FG000|Overall Study|Protocol Violation|1|||
48679505|NCT00635882|156676655|FG001|Overall Study|Protocol Violation|0|||
48679506|NCT00635882|156676656|FG002|Overall Study|Protocol Violation|0|||
48679507|NCT00635882|156676657|FG003|Overall Study|Protocol Violation|0|||
48679508|NCT00635882|156676658|FG004|Overall Study|Protocol Violation|0|||
48679509|NCT00635882|156676659|FG005|Overall Study|Protocol Violation|0|||
48679510|NCT00858637|156676660|FG000|Active Comparison Phase|Adverse Event|14|||
48679511|NCT00858637|156676661|FG001|Active Comparison Phase|Adverse Event|0|||
48679512|NCT00858637|156676662|FG002|Active Comparison Phase|Adverse Event|0|||
48679513|NCT00858637|156676663|FG003|Active Comparison Phase|Adverse Event|9|||
48679514|NCT00858637|156676664|FG004|Active Comparison Phase|Adverse Event|0|||
48679515|NCT00858637|156676665|FG005|Active Comparison Phase|Adverse Event|0|||
48679516|NCT00858637|156676660|FG000|Active Comparison Phase|Death|1|||
48679517|NCT00858637|156676661|FG001|Active Comparison Phase|Death|0|||
48679518|NCT00858637|156676662|FG002|Active Comparison Phase|Death|0|||
48679519|NCT00858637|156676663|FG003|Active Comparison Phase|Death|1|||
48679520|NCT00858637|156676664|FG004|Active Comparison Phase|Death|0|||
48679521|NCT00858637|156676665|FG005|Active Comparison Phase|Death|0|||
48679522|NCT00858637|156676660|FG000|Active Comparison Phase|Physician Decision|1|||
48679523|NCT00858637|156676661|FG001|Active Comparison Phase|Physician Decision|0|||
48679524|NCT00858637|156676662|FG002|Active Comparison Phase|Physician Decision|0|||
48679525|NCT00858637|156676663|FG003|Active Comparison Phase|Physician Decision|1|||
48679526|NCT00858637|156676664|FG004|Active Comparison Phase|Physician Decision|0|||
48679527|NCT00858637|156676665|FG005|Active Comparison Phase|Physician Decision|0|||
48679528|NCT00858637|156676660|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
48679529|NCT00858637|156676661|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
48679530|NCT00858637|156676662|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
48679531|NCT00858637|156676663|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
48679532|NCT00858637|156676664|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
48679533|NCT00858637|156676665|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
48679534|NCT00858637|156676660|FG000|Active Comparison Phase|Other Reasons|1|||
48679535|NCT00858637|156676661|FG001|Active Comparison Phase|Other Reasons|0|||
48679536|NCT00858637|156676662|FG002|Active Comparison Phase|Other Reasons|0|||
48679537|NCT00858637|156676663|FG003|Active Comparison Phase|Other Reasons|1|||
48679538|NCT00858637|156676664|FG004|Active Comparison Phase|Other Reasons|0|||
48679539|NCT00858637|156676665|FG005|Active Comparison Phase|Other Reasons|0|||
48679540|NCT00858637|156676660|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
48679541|NCT00858637|156676661|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
48679542|NCT00858637|156676662|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
48679543|NCT00858637|156676663|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
48679544|NCT00858637|156676664|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
48679545|NCT00858637|156676665|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
48679546|NCT00858637|156676660|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679547|NCT00858637|156676661|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679548|NCT00858637|156676662|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679549|NCT00858637|156676663|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679550|NCT00858637|156676664|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
48679551|NCT00858637|156676665|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
48679552|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
48679553|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
48679554|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
48679555|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Death|0|||
48679556|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Death|2|||
48679557|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Death|0|||
48679558|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
48679559|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
48679560|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
48679561|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
48679562|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
48679563|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
48679564|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
48679565|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
48679566|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
48679567|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
48679568|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
48679569|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
48679570|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
48679571|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
48679572|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
48679573|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Recovery|1|||
48679574|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Recovery|0|||
48679575|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Recovery|1|||
48679576|NCT00195663|156676668|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
48679577|NCT00195663|156676669|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
48679578|NCT00195663|156676670|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
48679579|NCT00195663|156676668|FG000|Open-Label Extension Period|Adverse Event|21|||
48679580|NCT00195663|156676669|FG001|Open-Label Extension Period|Adverse Event|32|||
48679581|NCT00195663|156676670|FG002|Open-Label Extension Period|Adverse Event|36|||
48679582|NCT00195663|156676668|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
48679583|NCT00195663|156676669|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
48679584|NCT00195663|156676670|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
48679585|NCT00195663|156676668|FG000|Open-Label Extension Period|Recovery|0|||
48679586|NCT00195663|156676669|FG001|Open-Label Extension Period|Recovery|2|||
48679587|NCT00195663|156676670|FG002|Open-Label Extension Period|Recovery|2|||
48679588|NCT00195663|156676668|FG000|Open-Label Extension Period|Protocol Violation|3|||
48679589|NCT00195663|156676669|FG001|Open-Label Extension Period|Protocol Violation|4|||
48679590|NCT00195663|156676670|FG002|Open-Label Extension Period|Protocol Violation|4|||
48679591|NCT00195663|156676668|FG000|Open-Label Extension Period|Death|2|||
48679592|NCT00195663|156676669|FG001|Open-Label Extension Period|Death|2|||
48679593|NCT00195663|156676670|FG002|Open-Label Extension Period|Death|2|||
48679594|NCT00195663|156676668|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
48679595|NCT00195663|156676669|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
48679596|NCT00195663|156676670|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
48679597|NCT00195663|156676668|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
48679598|NCT00195663|156676669|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
48679599|NCT00195663|156676670|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
48679600|NCT00195663|156676668|FG000|Open-Label Extension Period|Administrative reasons|11|||
48679601|NCT00195663|156676669|FG001|Open-Label Extension Period|Administrative reasons|11|||
48679602|NCT00195663|156676670|FG002|Open-Label Extension Period|Administrative reasons|13|||
48679603|NCT01380834|156676671|FG000|Overall Study|Physician Decision|1|||
48679604|NCT01380834|156676672|FG001|Overall Study|Physician Decision|0|||
48679605|NCT00604695|156676673|FG000|Overall Study|Did not receive first bolus.|0|||
48679606|NCT00604695|156676674|FG001|Overall Study|Did not receive first bolus.|4|||
48679607|NCT03214406|156676675|FG000|Overall Study|did not meet enrollment criteria|9|||
48679608|NCT03214406|156676676|FG001|Overall Study|did not meet enrollment criteria|13|||
48679609|NCT03214406|156676675|FG000|Overall Study|Withdrawal by Subject|1|||
48679610|NCT03214406|156676676|FG001|Overall Study|Withdrawal by Subject|0|||
48679611|NCT03214406|156676675|FG000|Overall Study|Lost to Follow-up|0|||
48679612|NCT03214406|156676676|FG001|Overall Study|Lost to Follow-up|2|||
48679613|NCT04310566|156676682|FG000|Period 1|Study Termination due to COVID-19|15|||
48679614|NCT04310566|156676683|FG001|Period 1|Study Termination due to COVID-19|17|||
48679615|NCT04310566|156676682|FG000|Period 1|Protocol Violation|0|||
48679616|NCT04310566|156676683|FG001|Period 1|Protocol Violation|1|||
48679617|NCT04310566|156676682|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
48762811|NCT00600938|156980349|FG003|Core Study|Protocol Violation|0|||
48679618|NCT04310566|156676683|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
48679619|NCT04310566|156676682|FG000|Period 1|Lost to Follow-up|1|||
48762812|NCT00600938|156980346|FG000|Extension Study|Adverse Event|1|||
48679620|NCT04310566|156676683|FG001|Period 1|Lost to Follow-up|0|||
48679621|NCT04310566|156676682|FG000|Period 1|Withdrawal by Subject|0|||
48679622|NCT04310566|156676683|FG001|Period 1|Withdrawal by Subject|1|||
48679623|NCT04310566|156676682|FG000|Period 2|Study Termination|7|||
48679624|NCT04310566|156676683|FG001|Period 2|Study Termination|5|||
48679625|NCT04677504|156676684|FG000|Overall Study|Death|51|||
48679626|NCT04677504|156676685|FG001|Overall Study|Death|49|||
48679627|NCT04677504|156676684|FG000|Overall Study|Progressive Disease|1|||
48679628|NCT04677504|156676685|FG001|Overall Study|Progressive Disease|0|||
48679629|NCT04677504|156676684|FG000|Overall Study|Symptomatic Deterioration|1|||
48679630|NCT04677504|156676685|FG001|Overall Study|Symptomatic Deterioration|0|||
48679631|NCT04677504|156676684|FG000|Overall Study|Withdrawal by Subject|2|||
48679632|NCT04677504|156676685|FG001|Overall Study|Withdrawal by Subject|5|||
48679633|NCT04677504|156676684|FG000|Overall Study|Study Terminated By Sponsor|28|||
48679634|NCT04677504|156676685|FG001|Overall Study|Study Terminated By Sponsor|24|||
48679635|NCT04677504|156676684|FG000|Overall Study|Adverse Event|0|||
48679636|NCT04677504|156676685|FG001|Overall Study|Adverse Event|1|||
48679637|NCT01771250|156676686|FG000|Period 1|Met exclusion criteria|1|||
48679638|NCT01771250|156676687|FG001|Period 1|Met exclusion criteria|0|||
48679639|NCT01059318|156676690|FG000|Core Study (26 Week)|Adverse Event|3|||
48679640|NCT01059318|156676690|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
48679641|NCT01059318|156676690|FG000|Extension (36 Week)|Adverse Event|3|||
48679642|NCT01371552|156676691|FG000|Part 1, First 3 Days|Inconvenience|0|||
48679643|NCT01371552|156676692|FG001|Part 1, First 3 Days|Inconvenience|0|||
48679644|NCT01371552|156676693|FG002|Part 1, First 3 Days|Inconvenience|1|||
48679645|NCT01371552|156676694|FG003|Part 1, First 3 Days|Inconvenience|0|||
48679646|NCT01371552|156676695|FG004|Part 1, First 3 Days|Inconvenience|0|||
48679647|NCT01371552|156676696|FG005|Part 1, First 3 Days|Inconvenience|0|||
48679648|NCT02519595|156676698|FG000|Overall Study|Protocol Violation|8|||
48679649|NCT02519595|156676699|FG001|Overall Study|Protocol Violation|22|||
48679650|NCT02519595|156676700|FG002|Overall Study|Protocol Violation|16|||
48679651|NCT04522141|156676702|FG000|Overall Study|Withdrawal by Subject|1|||
48679652|NCT04522141|156676703|FG001|Overall Study|Withdrawal by Subject|0|||
48679653|NCT02397057|156676707|FG000|Overall Study|Withdrawal by Subject|6|||
48679654|NCT02397057|156676708|FG001|Overall Study|Withdrawal by Subject|7|||
48679655|NCT02397057|156676707|FG000|Overall Study|Lost to Follow-up|4|||
48679656|NCT02397057|156676708|FG001|Overall Study|Lost to Follow-up|3|||
48679657|NCT02397057|156676707|FG000|Overall Study|Death|1|||
48679658|NCT02397057|156676708|FG001|Overall Study|Death|0|||
48679659|NCT02397057|156676707|FG000|Overall Study|Adverse Event|0|||
48679660|NCT02397057|156676708|FG001|Overall Study|Adverse Event|1|||
48679661|NCT02397057|156676707|FG000|Overall Study|Physician Decision|0|||
48679662|NCT02397057|156676708|FG001|Overall Study|Physician Decision|1|||
48679663|NCT02397057|156676707|FG000|Overall Study|Subject did not receive study drug|0|||
48679664|NCT02397057|156676708|FG001|Overall Study|Subject did not receive study drug|1|||
48679665|NCT03543137|156676709|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
48679666|NCT03543137|156676710|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
48679667|NCT03543137|156676709|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
48679668|NCT03543137|156676710|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
48679669|NCT03543137|156676709|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
48679670|NCT03543137|156676710|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
48679671|NCT00176462|156676712|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
48679672|NCT00176462|156676713|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
48679673|NCT00176462|156676712|FG000|Induction (4 Weeks)|Death|1|||
48679674|NCT00176462|156676713|FG001|Induction (4 Weeks)|Death|2|||
48679675|NCT00176462|156676712|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
48679676|NCT00176462|156676713|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
48679677|NCT00176462|156676712|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
48679678|NCT00176462|156676713|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
48679679|NCT00176462|156676712|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
48679680|NCT00176462|156676713|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
48679681|NCT00176462|156676712|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
48679682|NCT00176462|156676713|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
48679683|NCT00176462|156676712|FG000|Consolidation (12 Weeks)|Not documented|0|||
48679684|NCT00176462|156676713|FG001|Consolidation (12 Weeks)|Not documented|1|||
48679685|NCT00176462|156676712|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
48679686|NCT00176462|156676713|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
48679687|NCT00176462|156676712|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
48679688|NCT00176462|156676713|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
48679689|NCT01099397|156676720|FG000|Overall Study|Lost to Follow-up|4|||
48679690|NCT01099397|156676720|FG000|Overall Study|Protocol Violation|4|||
48762813|NCT00600938|156980347|FG001|Extension Study|Adverse Event|0|||
48679691|NCT01099397|156676720|FG000|Overall Study|Withdrawal by Subject|5|||
48679692|NCT01279681|156676721|FG000|Overall Study|Disease Progression|9|||
48679693|NCT01279681|156676722|FG001|Overall Study|Disease Progression|6|||
48679694|NCT01279681|156676721|FG000|Overall Study|Withdrawal by Subject|3|||
48679695|NCT01279681|156676722|FG001|Overall Study|Withdrawal by Subject|4|||
48679696|NCT01279681|156676721|FG000|Overall Study|Adverse Event|2|||
48679697|NCT01279681|156676722|FG001|Overall Study|Adverse Event|3|||
48679698|NCT01279681|156676721|FG000|Overall Study|Death|0|||
48679699|NCT01279681|156676722|FG001|Overall Study|Death|1|||
48679700|NCT01279681|156676721|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
48679701|NCT01279681|156676722|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
48679702|NCT01279681|156676721|FG000|Overall Study|Physician Decision|1|||
48679703|NCT01279681|156676722|FG001|Overall Study|Physician Decision|0|||
48679704|NCT01279681|156676721|FG000|Overall Study|Other Reason|0|||
48679705|NCT01279681|156676722|FG001|Overall Study|Other Reason|2|||
48679706|NCT01943591|156676723|FG000|Overall Study|Lost to Follow-up|3|||
48679707|NCT01943591|156676724|FG001|Overall Study|Lost to Follow-up|4|||
48679708|NCT01943591|156676723|FG000|Overall Study|Death|2|||
48679709|NCT01943591|156676724|FG001|Overall Study|Death|7|||
48679710|NCT00511238|156676727|FG000|Overall Study|Adverse Event|13|||
48679711|NCT00511238|156676728|FG001|Overall Study|Adverse Event|33|||
48679712|NCT00511238|156676727|FG000|Overall Study|Withdrawal by Subject|2|||
48679713|NCT00511238|156676728|FG001|Overall Study|Withdrawal by Subject|22|||
48679714|NCT00511238|156676727|FG000|Overall Study|Progressive Disease|23|||
48679715|NCT00511238|156676728|FG001|Overall Study|Progressive Disease|157|||
48679716|NCT00511238|156676727|FG000|Overall Study|various reasons|4|||
48679717|NCT00511238|156676728|FG001|Overall Study|various reasons|14|||
48679718|NCT02008227|156678374|FG000|Overall Study|Lost to Follow-up|7|||
48679719|NCT02008227|156678375|FG001|Overall Study|Lost to Follow-up|9|||
48679720|NCT02008227|156678374|FG000|Overall Study|Death|494|||
48679721|NCT02008227|156678375|FG001|Overall Study|Death|485|||
48679722|NCT02008227|156678374|FG000|Overall Study|Withdrawal by Subject|67|||
48679723|NCT02008227|156678375|FG001|Overall Study|Withdrawal by Subject|36|||
48679724|NCT02008227|156678374|FG000|Overall Study|Study Terminated By Sponsor|44|||
48679725|NCT02008227|156678375|FG001|Overall Study|Study Terminated By Sponsor|83|||
48679726|NCT01769196|156678376|FG000|Overall Study|Adverse Event|24|||
48679727|NCT01769196|156678377|FG001|Overall Study|Adverse Event|20|||
48679728|NCT01769196|156678376|FG000|Overall Study|Death|21|||
48679729|NCT01769196|156678377|FG001|Overall Study|Death|26|||
48679730|NCT01769196|156678376|FG000|Overall Study|Investigator Discretion|7|||
48679731|NCT01769196|156678377|FG001|Overall Study|Investigator Discretion|3|||
48679732|NCT01769196|156678376|FG000|Overall Study|Lack of Efficacy|3|||
48679733|NCT01769196|156678377|FG001|Overall Study|Lack of Efficacy|2|||
48679734|NCT01769196|156678376|FG000|Overall Study|Progressive disease|11|||
48679735|NCT01769196|156678377|FG001|Overall Study|Progressive disease|6|||
48679736|NCT01769196|156678376|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
48679737|NCT01769196|156678377|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
48679738|NCT01769196|156678376|FG000|Overall Study|Protocol Violation|0|||
48679739|NCT01769196|156678377|FG001|Overall Study|Protocol Violation|3|||
48679740|NCT01769196|156678376|FG000|Overall Study|Study terminated by sponsor|160|||
48679741|NCT01769196|156678377|FG001|Overall Study|Study terminated by sponsor|161|||
48679742|NCT01769196|156678376|FG000|Overall Study|Participant never dosed with study drug|1|||
48679743|NCT01769196|156678377|FG001|Overall Study|Participant never dosed with study drug|0|||
48679744|NCT01769196|156678376|FG000|Overall Study|Withdrew consent|36|||
48679745|NCT01769196|156678377|FG001|Overall Study|Withdrew consent|40|||
48679746|NCT01618695|156678384|FG000|Core Phase|Adverse Event|4|||
48679747|NCT01618695|156678385|FG001|Core Phase|Adverse Event|5|||
48679748|NCT01618695|156678386|FG002|Core Phase|Adverse Event|15|||
48679749|NCT01618695|156678387|FG003|Core Phase|Adverse Event|20|||
48679750|NCT01618695|156678384|FG000|Core Phase|Lost to Follow-up|0|||
48679751|NCT01618695|156678385|FG001|Core Phase|Lost to Follow-up|0|||
48679752|NCT01618695|156678386|FG002|Core Phase|Lost to Follow-up|1|||
48679753|NCT01618695|156678387|FG003|Core Phase|Lost to Follow-up|0|||
48679754|NCT01618695|156678384|FG000|Core Phase|Withdrawal by Subject|16|||
48679755|NCT01618695|156678385|FG001|Core Phase|Withdrawal by Subject|11|||
48679756|NCT01618695|156678386|FG002|Core Phase|Withdrawal by Subject|9|||
48679757|NCT01618695|156678387|FG003|Core Phase|Withdrawal by Subject|13|||
48679758|NCT01618695|156678384|FG000|Core Phase|Pregnancy|2|||
48679759|NCT01618695|156678385|FG001|Core Phase|Pregnancy|0|||
48679760|NCT01618695|156678386|FG002|Core Phase|Pregnancy|0|||
48679761|NCT01618695|156678387|FG003|Core Phase|Pregnancy|0|||
48679762|NCT01618695|156678384|FG000|Core Phase|Lack of Efficacy|1|||
48679763|NCT01618695|156678385|FG001|Core Phase|Lack of Efficacy|2|||
48679764|NCT01618695|156678386|FG002|Core Phase|Lack of Efficacy|1|||
48679765|NCT01618695|156678387|FG003|Core Phase|Lack of Efficacy|1|||
48679766|NCT01618695|156678384|FG000|Core Phase|Other than specified|1|||
48679767|NCT01618695|156678385|FG001|Core Phase|Other than specified|2|||
48679768|NCT01618695|156678386|FG002|Core Phase|Other than specified|2|||
48679769|NCT01618695|156678387|FG003|Core Phase|Other than specified|2|||
48679770|NCT01618695|156678384|FG000|Core Phase|Not treated|1|||
48679771|NCT01618695|156678385|FG001|Core Phase|Not treated|0|||
48679772|NCT01618695|156678386|FG002|Core Phase|Not treated|2|||
48679773|NCT01618695|156678387|FG003|Core Phase|Not treated|0|||
48679774|NCT01618695|156678384|FG000|Extension Phase|Lack of Efficacy|17|||
48679775|NCT01618695|156678385|FG001|Extension Phase|Lack of Efficacy|33|||
48679776|NCT01618695|156678386|FG002|Extension Phase|Lack of Efficacy|26|||
48679777|NCT01618695|156678387|FG003|Extension Phase|Lack of Efficacy|24|||
48679778|NCT01618695|156678384|FG000|Extension Phase|Pregnancy|2|||
48679779|NCT01618695|156678385|FG001|Extension Phase|Pregnancy|0|||
48679780|NCT01618695|156678386|FG002|Extension Phase|Pregnancy|1|||
48679781|NCT01618695|156678387|FG003|Extension Phase|Pregnancy|1|||
48679782|NCT01618695|156678384|FG000|Extension Phase|Withdrawal by Subject|43|||
48679783|NCT01618695|156678385|FG001|Extension Phase|Withdrawal by Subject|48|||
48679784|NCT01618695|156678386|FG002|Extension Phase|Withdrawal by Subject|42|||
48679785|NCT01618695|156678387|FG003|Extension Phase|Withdrawal by Subject|33|||
48679786|NCT01618695|156678384|FG000|Extension Phase|Adverse Event|18|||
48679787|NCT01618695|156678385|FG001|Extension Phase|Adverse Event|16|||
48679788|NCT01618695|156678386|FG002|Extension Phase|Adverse Event|9|||
48679789|NCT01618695|156678387|FG003|Extension Phase|Adverse Event|20|||
48679790|NCT01618695|156678384|FG000|Extension Phase|Lost to Follow-up|2|||
48679791|NCT01618695|156678385|FG001|Extension Phase|Lost to Follow-up|1|||
48679792|NCT01618695|156678386|FG002|Extension Phase|Lost to Follow-up|1|||
48679793|NCT01618695|156678387|FG003|Extension Phase|Lost to Follow-up|1|||
48679794|NCT01618695|156678384|FG000|Extension Phase|Other than specified|13|||
48679795|NCT01618695|156678385|FG001|Extension Phase|Other than specified|18|||
48679796|NCT01618695|156678386|FG002|Extension Phase|Other than specified|13|||
48679797|NCT01618695|156678387|FG003|Extension Phase|Other than specified|18|||
48679798|NCT03688074|156678392|FG000|Overall Study|Adverse Event|0|||
48679799|NCT03688074|156678393|FG001|Overall Study|Adverse Event|1|||
48679800|NCT03688074|156678392|FG000|Overall Study|Other|1|||
48679801|NCT03688074|156678393|FG001|Overall Study|Other|0|||
48679802|NCT02489942|156678397|FG000|Overall Study|Request by patient|602|||
48679803|NCT02489942|156678397|FG000|Overall Study|Improvement/remission|157|||
48679804|NCT02489942|156678397|FG000|Overall Study|No change/Progressive disease|263|||
48679805|NCT02489942|156678397|FG000|Overall Study|Adverse Event|522|||
48679806|NCT02489942|156678397|FG000|Overall Study|Other personal reasons|1218|||
48679807|NCT02489942|156678397|FG000|Overall Study|Lost to Follow-up|456|||
48679808|NCT02489942|156678397|FG000|Overall Study|Not continuously investigated|7|||
48679809|NCT02489942|156678397|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
48679810|NCT02489942|156678397|FG000|Overall Study|Multiple registration|1|||
48679811|NCT02489942|156678397|FG000|Overall Study|No patient visit after entry|100|||
48679812|NCT02489942|156678397|FG000|Overall Study|No treatment with Jardiance|2|||
48679813|NCT02489942|156678397|FG000|Overall Study|Patient received Jardiance before registration|1|||
48679814|NCT02489942|156678397|FG000|Overall Study|No CRF collected|86|||
48679815|NCT02828436|156678398|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
48679816|NCT02828436|156678399|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
48679817|NCT02828436|156678398|FG000|Period 1|Lost to Follow-up|0|||
48679818|NCT02828436|156678399|FG001|Period 1|Lost to Follow-up|1|||
48679819|NCT02828436|156678398|FG000|Period 2|Withdrawal by Subject|4|||
48679820|NCT02828436|156678399|FG001|Period 2|Withdrawal by Subject|0|||
48679821|NCT02828436|156678398|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
48679822|NCT02828436|156678399|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
48679823|NCT02828436|156678398|FG000|Period 2|Lost to Follow-up|1|||
48679824|NCT02828436|156678399|FG001|Period 2|Lost to Follow-up|0|||
48679825|NCT00536471|156678406|FG000|Overall Study|Lost to Follow-up|48|||
48679826|NCT00536471|156678407|FG001|Overall Study|Lost to Follow-up|23|||
48679827|NCT00536471|156678408|FG002|Overall Study|Lost to Follow-up|48|||
48679828|NCT00536471|156678409|FG003|Overall Study|Lost to Follow-up|22|||
48679829|NCT00536471|156678406|FG000|Overall Study|Adverse Event|32|||
48679830|NCT00536471|156678407|FG001|Overall Study|Adverse Event|16|||
48679831|NCT00536471|156678408|FG002|Overall Study|Adverse Event|28|||
48679832|NCT00536471|156678409|FG003|Overall Study|Adverse Event|13|||
48679833|NCT00536471|156678406|FG000|Overall Study|Withdrawal by Subject|40|||
48679834|NCT00536471|156678407|FG001|Overall Study|Withdrawal by Subject|24|||
48679835|NCT00536471|156678408|FG002|Overall Study|Withdrawal by Subject|43|||
48679836|NCT00536471|156678409|FG003|Overall Study|Withdrawal by Subject|21|||
48679837|NCT00536471|156678406|FG000|Overall Study|Lack of Efficacy|17|||
48679838|NCT00536471|156678407|FG001|Overall Study|Lack of Efficacy|18|||
48679839|NCT00536471|156678408|FG002|Overall Study|Lack of Efficacy|11|||
48679840|NCT00536471|156678409|FG003|Overall Study|Lack of Efficacy|9|||
48762814|NCT00600938|156980348|FG002|Extension Study|Adverse Event|2|||
48762815|NCT00600938|156980349|FG003|Extension Study|Adverse Event|0|||
48679841|NCT00536471|156678406|FG000|Overall Study|Protocol Violation|8|||
48679842|NCT00536471|156678407|FG001|Overall Study|Protocol Violation|1|||
48762816|NCT00600938|156980346|FG000|Extension Study|Abnormal test procedure results|0|||
48762817|NCT00600938|156980347|FG001|Extension Study|Abnormal test procedure results|1|||
48679843|NCT00536471|156678408|FG002|Overall Study|Protocol Violation|2|||
48679844|NCT00536471|156678409|FG003|Overall Study|Protocol Violation|3|||
48679845|NCT00536471|156678406|FG000|Overall Study|Physician Decision|11|||
48679846|NCT00536471|156678407|FG001|Overall Study|Physician Decision|1|||
48679847|NCT00536471|156678408|FG002|Overall Study|Physician Decision|3|||
48679848|NCT00536471|156678409|FG003|Overall Study|Physician Decision|2|||
48679849|NCT00536471|156678406|FG000|Overall Study|Death|0|||
48762818|NCT00600938|156980348|FG002|Extension Study|Abnormal test procedure results|1|||
48388870|NCT01994382|155619524|FG015|Overall Study|Physician Decision|4|||
48388871|NCT01994382|155619525|FG016|Overall Study|Physician Decision|2|||
48388872|NCT01994382|155619509|FG000|Overall Study|Death|0|||
48388873|NCT01994382|155619510|FG001|Overall Study|Death|0|||
48388874|NCT01994382|155619511|FG002|Overall Study|Death|0|||
48388875|NCT01994382|155619512|FG003|Overall Study|Death|0|||
48388876|NCT01994382|155619513|FG004|Overall Study|Death|1|||
48388877|NCT01994382|155619514|FG005|Overall Study|Death|0|||
48388878|NCT01994382|155619515|FG006|Overall Study|Death|0|||
48388879|NCT01994382|155619516|FG007|Overall Study|Death|0|||
48388880|NCT01994382|155619517|FG008|Overall Study|Death|1|||
48388881|NCT01994382|155619518|FG009|Overall Study|Death|1|||
48388882|NCT01994382|155619519|FG010|Overall Study|Death|0|||
48388883|NCT01994382|155619520|FG011|Overall Study|Death|0|||
48388884|NCT01994382|155619521|FG012|Overall Study|Death|0|||
48388885|NCT01994382|155619522|FG013|Overall Study|Death|0|||
48679850|NCT00536471|156678407|FG001|Overall Study|Death|0|||
48679851|NCT00536471|156678408|FG002|Overall Study|Death|1|||
48679852|NCT00536471|156678409|FG003|Overall Study|Death|2|||
48679853|NCT00536471|156678406|FG000|Overall Study|Sponsor Decision|0|||
48679854|NCT00536471|156678407|FG001|Overall Study|Sponsor Decision|1|||
48679855|NCT00536471|156678408|FG002|Overall Study|Sponsor Decision|3|||
48679856|NCT00536471|156678409|FG003|Overall Study|Sponsor Decision|2|||
48679857|NCT05274269|156678410|FG000|Overall Study|Adverse Event|0|||
48679858|NCT05274269|156678411|FG001|Overall Study|Adverse Event|3|||
48679859|NCT05274269|156678410|FG000|Overall Study|Death|0|||
48679860|NCT05274269|156678411|FG001|Overall Study|Death|1|||
48679861|NCT05274269|156678410|FG000|Overall Study|Other|0|||
48679862|NCT05274269|156678411|FG001|Overall Study|Other|2|||
48679863|NCT05274269|156678410|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
48679864|NCT05274269|156678411|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
48679865|NCT02206035|156678412|FG000|Overall Study|Physician Decision|10|||
48679866|NCT02206035|156678413|FG001|Overall Study|Physician Decision|0|||
48679867|NCT02206035|156678414|FG002|Overall Study|Physician Decision|175|||
48679868|NCT05249569|156678415|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
48679869|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Death|0|||
48679870|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Death|0|||
48679871|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Death|0|||
48679872|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Death|0|||
48679873|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Death|1|||
48679874|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Death|0|||
48679875|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Death|0|||
48388886|NCT01994382|155619523|FG014|Overall Study|Death|0|||
48388887|NCT01994382|155619524|FG015|Overall Study|Death|1|||
48388888|NCT01994382|155619525|FG016|Overall Study|Death|0|||
48679876|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Death|0|||
48679877|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
48679878|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
48679879|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
48679880|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
48679881|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
48679882|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
48679883|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
48679884|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
48679885|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
48679886|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679887|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679888|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
48679889|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679890|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
48679891|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679892|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
48679893|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
48679894|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
48679895|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
48679896|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
48679897|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
48679898|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
48679899|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
48679900|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
48679901|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
48388889|NCT01994382|155619509|FG000|Overall Study|Adverse Event|0|||
48388890|NCT01994382|155619510|FG001|Overall Study|Adverse Event|1|||
48388891|NCT01994382|155619511|FG002|Overall Study|Adverse Event|2|||
48388892|NCT01994382|155619512|FG003|Overall Study|Adverse Event|0|||
48388893|NCT01994382|155619513|FG004|Overall Study|Adverse Event|0|||
48679902|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
48679903|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
48679904|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
48679905|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
48679906|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
48679907|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
48679908|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
48679909|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
48679910|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
48679911|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
48679912|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
48679913|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
48679914|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
48679915|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
48679916|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
48679917|NCT00726232|156678417|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
48679918|NCT00726232|156678418|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679919|NCT00726232|156678419|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679920|NCT00726232|156678420|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679921|NCT00726232|156678421|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679922|NCT00726232|156678422|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679923|NCT00726232|156678423|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679924|NCT00726232|156678424|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
48679925|NCT00726232|156678417|FG000|Expansion Phase|Death|0|||
48679926|NCT00726232|156678418|FG001|Expansion Phase|Death|0|||
48679927|NCT00726232|156678419|FG002|Expansion Phase|Death|0|||
48679928|NCT00726232|156678420|FG003|Expansion Phase|Death|0|||
48679929|NCT00726232|156678421|FG004|Expansion Phase|Death|0|||
48679930|NCT00726232|156678422|FG005|Expansion Phase|Death|0|||
48679931|NCT00726232|156678423|FG006|Expansion Phase|Death|0|||
48679932|NCT00726232|156678424|FG007|Expansion Phase|Death|1|||
48679933|NCT00726232|156678417|FG000|Expansion Phase|Adverse Event|0|||
48679934|NCT00726232|156678418|FG001|Expansion Phase|Adverse Event|0|||
48679935|NCT00726232|156678419|FG002|Expansion Phase|Adverse Event|0|||
48679936|NCT00726232|156678420|FG003|Expansion Phase|Adverse Event|0|||
48679937|NCT00726232|156678421|FG004|Expansion Phase|Adverse Event|0|||
48679938|NCT00726232|156678422|FG005|Expansion Phase|Adverse Event|0|||
48679939|NCT00726232|156678423|FG006|Expansion Phase|Adverse Event|6|||
48679940|NCT00726232|156678424|FG007|Expansion Phase|Adverse Event|11|||
48679941|NCT00726232|156678417|FG000|Expansion Phase|Withdrawal by Subject|0|||
48679942|NCT00726232|156678418|FG001|Expansion Phase|Withdrawal by Subject|0|||
48679943|NCT00726232|156678419|FG002|Expansion Phase|Withdrawal by Subject|0|||
48679944|NCT00726232|156678420|FG003|Expansion Phase|Withdrawal by Subject|0|||
48679945|NCT00726232|156678421|FG004|Expansion Phase|Withdrawal by Subject|0|||
48679946|NCT00726232|156678422|FG005|Expansion Phase|Withdrawal by Subject|0|||
48679947|NCT00726232|156678423|FG006|Expansion Phase|Withdrawal by Subject|2|||
48679948|NCT00726232|156678424|FG007|Expansion Phase|Withdrawal by Subject|3|||
48679949|NCT00726232|156678417|FG000|Expansion Phase|Disease progression|0|||
48679950|NCT00726232|156678418|FG001|Expansion Phase|Disease progression|0|||
48679951|NCT00726232|156678419|FG002|Expansion Phase|Disease progression|0|||
48679952|NCT00726232|156678420|FG003|Expansion Phase|Disease progression|0|||
48679953|NCT00726232|156678421|FG004|Expansion Phase|Disease progression|0|||
48679954|NCT00726232|156678422|FG005|Expansion Phase|Disease progression|0|||
48679955|NCT00726232|156678423|FG006|Expansion Phase|Disease progression|4|||
48679956|NCT00726232|156678424|FG007|Expansion Phase|Disease progression|0|||
48679957|NCT00726232|156678417|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
48679958|NCT00726232|156678418|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
48679959|NCT00726232|156678419|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
48679960|NCT00726232|156678420|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
48679961|NCT00726232|156678421|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
48679962|NCT00726232|156678422|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
48388894|NCT01994382|155619514|FG005|Overall Study|Adverse Event|0|||
48679963|NCT00726232|156678423|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
48679964|NCT00726232|156678424|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
48679965|NCT00726232|156678417|FG000|Expansion Phase|Per Investigator: lack of response|0|||
48679966|NCT00726232|156678418|FG001|Expansion Phase|Per Investigator: lack of response|0|||
48679967|NCT00726232|156678419|FG002|Expansion Phase|Per Investigator: lack of response|0|||
48388895|NCT01994382|155619515|FG006|Overall Study|Adverse Event|0|||
48388896|NCT01994382|155619516|FG007|Overall Study|Adverse Event|0|||
48679968|NCT00726232|156678420|FG003|Expansion Phase|Per Investigator: lack of response|0|||
48388897|NCT01994382|155619517|FG008|Overall Study|Adverse Event|0|||
48679969|NCT00726232|156678421|FG004|Expansion Phase|Per Investigator: lack of response|0|||
48679970|NCT00726232|156678422|FG005|Expansion Phase|Per Investigator: lack of response|0|||
48679971|NCT00726232|156678423|FG006|Expansion Phase|Per Investigator: lack of response|1|||
48679972|NCT00726232|156678424|FG007|Expansion Phase|Per Investigator: lack of response|7|||
48679973|NCT00726232|156678417|FG000|Expansion Phase|Unspecified reason|0|||
48679974|NCT00726232|156678418|FG001|Expansion Phase|Unspecified reason|0|||
48679975|NCT00726232|156678419|FG002|Expansion Phase|Unspecified reason|0|||
48679976|NCT00726232|156678420|FG003|Expansion Phase|Unspecified reason|0|||
48679977|NCT00726232|156678421|FG004|Expansion Phase|Unspecified reason|0|||
48679978|NCT00726232|156678422|FG005|Expansion Phase|Unspecified reason|0|||
48679979|NCT00726232|156678423|FG006|Expansion Phase|Unspecified reason|1|||
48679980|NCT00726232|156678424|FG007|Expansion Phase|Unspecified reason|0|||
48679981|NCT00842543|156678425|FG000|Overall Study|Withdrawal by Subject|2|||
48679982|NCT00842543|156678426|FG001|Overall Study|Withdrawal by Subject|0|||
48679983|NCT00842543|156678427|FG002|Overall Study|Withdrawal by Subject|3|||
48679984|NCT00842543|156678428|FG003|Overall Study|Withdrawal by Subject|4|||
48679985|NCT01858766|156678429|FG000|Overall Study|Randomized but Never Treated|0|||
48679986|NCT01858766|156678430|FG001|Overall Study|Randomized but Never Treated|0|||
48679987|NCT01858766|156678431|FG002|Overall Study|Randomized but Never Treated|0|||
48679988|NCT01858766|156678432|FG003|Overall Study|Randomized but Never Treated|0|||
48679989|NCT01858766|156678433|FG004|Overall Study|Randomized but Never Treated|0|||
48679990|NCT01858766|156678434|FG005|Overall Study|Randomized but Never Treated|1|||
48679991|NCT01858766|156678435|FG006|Overall Study|Randomized but Never Treated|0|||
48679992|NCT01858766|156678436|FG007|Overall Study|Randomized but Never Treated|0|||
48679993|NCT01858766|156678437|FG008|Overall Study|Randomized but Never Treated|0|||
48679994|NCT01858766|156678438|FG009|Overall Study|Randomized but Never Treated|0|||
48679995|NCT01858766|156678439|FG010|Overall Study|Randomized but Never Treated|0|||
48679996|NCT01858766|156678440|FG011|Overall Study|Randomized but Never Treated|0|||
48679997|NCT01858766|156678441|FG012|Overall Study|Randomized but Never Treated|0|||
48679998|NCT01858766|156678442|FG013|Overall Study|Randomized but Never Treated|0|||
48679999|NCT01858766|156678443|FG014|Overall Study|Randomized but Never Treated|0|||
48680000|NCT01858766|156678444|FG015|Overall Study|Randomized but Never Treated|0|||
48680001|NCT01858766|156678445|FG016|Overall Study|Randomized but Never Treated|0|||
48680002|NCT01858766|156678446|FG017|Overall Study|Randomized but Never Treated|1|||
48680003|NCT01858766|156678447|FG018|Overall Study|Randomized but Never Treated|0|||
48680004|NCT01858766|156678429|FG000|Overall Study|Death|0|||
48680005|NCT01858766|156678430|FG001|Overall Study|Death|0|||
48680006|NCT01858766|156678431|FG002|Overall Study|Death|1|||
48680007|NCT01858766|156678432|FG003|Overall Study|Death|0|||
48680008|NCT01858766|156678433|FG004|Overall Study|Death|0|||
48680009|NCT01858766|156678434|FG005|Overall Study|Death|0|||
48680010|NCT01858766|156678435|FG006|Overall Study|Death|0|||
48680011|NCT01858766|156678436|FG007|Overall Study|Death|0|||
48680012|NCT01858766|156678437|FG008|Overall Study|Death|0|||
48680013|NCT01858766|156678438|FG009|Overall Study|Death|0|||
48680014|NCT01858766|156678439|FG010|Overall Study|Death|0|||
48680015|NCT01858766|156678440|FG011|Overall Study|Death|0|||
48680016|NCT01858766|156678441|FG012|Overall Study|Death|0|||
48680017|NCT01858766|156678442|FG013|Overall Study|Death|0|||
48680018|NCT01858766|156678443|FG014|Overall Study|Death|0|||
48680019|NCT01858766|156678444|FG015|Overall Study|Death|0|||
48680020|NCT01858766|156678445|FG016|Overall Study|Death|0|||
48680021|NCT01858766|156678446|FG017|Overall Study|Death|0|||
48680022|NCT01858766|156678447|FG018|Overall Study|Death|0|||
48680023|NCT01858766|156678429|FG000|Overall Study|Lack of Efficacy|1|||
48680024|NCT01858766|156678430|FG001|Overall Study|Lack of Efficacy|0|||
48680025|NCT01858766|156678431|FG002|Overall Study|Lack of Efficacy|0|||
48680026|NCT01858766|156678432|FG003|Overall Study|Lack of Efficacy|0|||
48680027|NCT01858766|156678433|FG004|Overall Study|Lack of Efficacy|1|||
48680028|NCT01858766|156678434|FG005|Overall Study|Lack of Efficacy|2|||
48680029|NCT01858766|156678435|FG006|Overall Study|Lack of Efficacy|0|||
48388898|NCT01994382|155619518|FG009|Overall Study|Adverse Event|0|||
48680030|NCT01858766|156678436|FG007|Overall Study|Lack of Efficacy|0|||
48680031|NCT01858766|156678437|FG008|Overall Study|Lack of Efficacy|0|||
48680032|NCT01858766|156678438|FG009|Overall Study|Lack of Efficacy|0|||
48680033|NCT01858766|156678439|FG010|Overall Study|Lack of Efficacy|0|||
48680034|NCT01858766|156678440|FG011|Overall Study|Lack of Efficacy|3|||
48680035|NCT01858766|156678441|FG012|Overall Study|Lack of Efficacy|5|||
48388899|NCT01994382|155619519|FG010|Overall Study|Adverse Event|15|||
48680036|NCT01858766|156678442|FG013|Overall Study|Lack of Efficacy|3|||
48680037|NCT01858766|156678443|FG014|Overall Study|Lack of Efficacy|5|||
48680038|NCT01858766|156678444|FG015|Overall Study|Lack of Efficacy|5|||
48680039|NCT01858766|156678445|FG016|Overall Study|Lack of Efficacy|2|||
48680040|NCT01858766|156678446|FG017|Overall Study|Lack of Efficacy|3|||
48680041|NCT01858766|156678447|FG018|Overall Study|Lack of Efficacy|3|||
48680042|NCT01858766|156678429|FG000|Overall Study|Lost to Follow-up|0|||
48680043|NCT01858766|156678430|FG001|Overall Study|Lost to Follow-up|0|||
48680044|NCT01858766|156678431|FG002|Overall Study|Lost to Follow-up|0|||
48680045|NCT01858766|156678432|FG003|Overall Study|Lost to Follow-up|0|||
48680046|NCT01858766|156678433|FG004|Overall Study|Lost to Follow-up|0|||
48680047|NCT01858766|156678434|FG005|Overall Study|Lost to Follow-up|1|||
48680048|NCT01858766|156678435|FG006|Overall Study|Lost to Follow-up|0|||
48680049|NCT01858766|156678436|FG007|Overall Study|Lost to Follow-up|2|||
48680050|NCT01858766|156678437|FG008|Overall Study|Lost to Follow-up|0|||
48680051|NCT01858766|156678438|FG009|Overall Study|Lost to Follow-up|0|||
48680052|NCT01858766|156678439|FG010|Overall Study|Lost to Follow-up|0|||
48680053|NCT01858766|156678440|FG011|Overall Study|Lost to Follow-up|1|||
48680054|NCT01858766|156678441|FG012|Overall Study|Lost to Follow-up|0|||
48680055|NCT01858766|156678442|FG013|Overall Study|Lost to Follow-up|0|||
48680056|NCT01858766|156678443|FG014|Overall Study|Lost to Follow-up|3|||
48680057|NCT01858766|156678444|FG015|Overall Study|Lost to Follow-up|1|||
48680058|NCT01858766|156678445|FG016|Overall Study|Lost to Follow-up|1|||
48680059|NCT01858766|156678446|FG017|Overall Study|Lost to Follow-up|0|||
48680060|NCT01858766|156678447|FG018|Overall Study|Lost to Follow-up|1|||
48680061|NCT01858766|156678429|FG000|Overall Study|Withdrew Consent|0|||
48680062|NCT01858766|156678430|FG001|Overall Study|Withdrew Consent|0|||
48680063|NCT01858766|156678431|FG002|Overall Study|Withdrew Consent|0|||
48680064|NCT01858766|156678432|FG003|Overall Study|Withdrew Consent|0|||
48680065|NCT01858766|156678433|FG004|Overall Study|Withdrew Consent|0|||
48680066|NCT01858766|156678434|FG005|Overall Study|Withdrew Consent|0|||
48680067|NCT01858766|156678435|FG006|Overall Study|Withdrew Consent|0|||
48680068|NCT01858766|156678436|FG007|Overall Study|Withdrew Consent|0|||
48680069|NCT01858766|156678437|FG008|Overall Study|Withdrew Consent|0|||
48680070|NCT01858766|156678438|FG009|Overall Study|Withdrew Consent|0|||
48680071|NCT01858766|156678439|FG010|Overall Study|Withdrew Consent|0|||
48680072|NCT01858766|156678440|FG011|Overall Study|Withdrew Consent|1|||
48680073|NCT01858766|156678441|FG012|Overall Study|Withdrew Consent|0|||
48680074|NCT01858766|156678442|FG013|Overall Study|Withdrew Consent|0|||
48680075|NCT01858766|156678443|FG014|Overall Study|Withdrew Consent|0|||
48680076|NCT01858766|156678444|FG015|Overall Study|Withdrew Consent|0|||
48680077|NCT01858766|156678445|FG016|Overall Study|Withdrew Consent|0|||
48680078|NCT01858766|156678446|FG017|Overall Study|Withdrew Consent|0|||
48680079|NCT01858766|156678447|FG018|Overall Study|Withdrew Consent|0|||
48680080|NCT03671304|156678448|FG000|Overall Study|study terminated|7|||
48680081|NCT00596830|156678453|FG000|Overall Study|Death|258|||
48680082|NCT00596830|156678454|FG001|Overall Study|Death|247|||
48680083|NCT00596830|156678453|FG000|Overall Study|Lost to Follow-up|7|||
48680084|NCT00596830|156678454|FG001|Overall Study|Lost to Follow-up|11|||
48680085|NCT00596830|156678453|FG000|Overall Study|Withdrawal by Subject|22|||
48680086|NCT00596830|156678454|FG001|Overall Study|Withdrawal by Subject|12|||
48680087|NCT00596830|156678453|FG000|Overall Study|Study terminated by sponsor|51|||
48680088|NCT00596830|156678454|FG001|Overall Study|Study terminated by sponsor|62|||
48680089|NCT00596830|156678453|FG000|Overall Study|Follow-up was discontinued|1|||
48680090|NCT00596830|156678454|FG001|Overall Study|Follow-up was discontinued|0|||
48680091|NCT00596830|156678453|FG000|Overall Study|Randomized but not treated|3|||
48680092|NCT00596830|156678454|FG001|Overall Study|Randomized but not treated|7|||
48680093|NCT00887926|156678455|FG000|Overall Study|Withdrawal by Subject|0|||
48680094|NCT00887926|156678456|FG001|Overall Study|Withdrawal by Subject|1|||
48680095|NCT00887926|156678457|FG002|Overall Study|Withdrawal by Subject|0|||
48680096|NCT00887926|156678458|FG003|Overall Study|Withdrawal by Subject|0|||
48680097|NCT03549104|156678459|FG000|Overall Study|Withdrawal by Subject|5|||
48680098|NCT03549104|156678460|FG001|Overall Study|Withdrawal by Subject|2|||
48680099|NCT03549104|156678459|FG000|Overall Study|Covid shelter in place|1|||
48680100|NCT03549104|156678460|FG001|Overall Study|Covid shelter in place|2|||
48680101|NCT01973998|156678461|FG000|Overall Study|Death|2|||
48680102|NCT01973998|156678462|FG001|Overall Study|Death|2|||
48680103|NCT01178099|156678465|FG000|Overall Study|Physician Decision|0|||
48680104|NCT01178099|156678466|FG001|Overall Study|Physician Decision|1|||
48680105|NCT01518374|156678467|FG000|Overall Study|Withdrawal by Subject|2|||
48680106|NCT01518374|156678467|FG000|Overall Study|Protocol Violation|3|||
48680107|NCT01518374|156678467|FG000|Overall Study|Lost to Follow-up|2|||
48680108|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
48680109|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
48680110|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
48680111|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
48680112|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Death|2|||
48680113|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Death|2|||
48680114|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Death|0|||
48680115|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Death|0|||
48680116|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
48680117|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
48680118|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
48680119|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
48680120|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
48680121|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
48680122|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
48680123|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
48680124|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
48680125|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
48680126|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
48680127|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
48680128|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
48680129|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
48680130|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
48680131|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
48680132|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
48680133|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
48680134|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
48680135|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
48680136|NCT03068754|156678468|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
48680137|NCT03068754|156678469|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
48680138|NCT03068754|156678470|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
48680139|NCT03068754|156678471|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
48680140|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
48680141|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
48680142|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
48680143|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
48680144|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Death|0|||
48680145|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Death|0|||
48680146|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Death|0|||
48680147|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Death|1|||
48680148|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
48680149|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
48680150|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
48680151|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
48680152|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
48680153|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
48680154|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
48680155|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
48680156|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
48680157|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
48680158|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
48680159|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
48680160|NCT03068754|156678468|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
48680161|NCT03068754|156678469|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
48680162|NCT03068754|156678470|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
48680163|NCT03068754|156678471|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
48680164|NCT00048347|156678475|FG000|Overall Study|Screen failure|2|||
48680165|NCT02451124|156678477|FG000|Overall Study|Withdrawal by Subject|1|||
48680166|NCT02119663|156678478|FG000|Overall Study|Disease progression|26|||
48680167|NCT02119663|156678479|FG001|Overall Study|Disease progression|27|||
48680168|NCT02119663|156678478|FG000|Overall Study|Adverse Event|5|||
48680169|NCT02119663|156678479|FG001|Overall Study|Adverse Event|5|||
48762819|NCT00600938|156980349|FG003|Extension Study|Abnormal test procedure results|1|||
48762820|NCT00600938|156980346|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
48762821|NCT00600938|156980347|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
48762822|NCT00600938|156980348|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
48762823|NCT00600938|156980349|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
48762824|NCT00600938|156980346|FG000|Extension Study|Withdrawal by Subject|2|||
48762825|NCT00600938|156980347|FG001|Extension Study|Withdrawal by Subject|2|||
48680170|NCT02119663|156678478|FG000|Overall Study|Death|3|||
48680171|NCT02119663|156678479|FG001|Overall Study|Death|2|||
48680172|NCT02119663|156678478|FG000|Overall Study|Physician Decision|1|||
48680173|NCT02119663|156678479|FG001|Overall Study|Physician Decision|2|||
48680174|NCT02119663|156678478|FG000|Overall Study|Other unspecified|2|||
48680175|NCT02119663|156678479|FG001|Overall Study|Other unspecified|0|||
48680176|NCT02119663|156678478|FG000|Overall Study|Subject decision|0|||
48762826|NCT00600938|156980348|FG002|Extension Study|Withdrawal by Subject|3|||
48762827|NCT00600938|156980349|FG003|Extension Study|Withdrawal by Subject|0|||
48680177|NCT02119663|156678479|FG001|Overall Study|Subject decision|1|||
48680178|NCT02119663|156678478|FG000|Overall Study|Study Terminated by the Sponsor|3|||
48680179|NCT02119663|156678479|FG001|Overall Study|Study Terminated by the Sponsor|4|||
48680180|NCT03197376|156678482|FG000|Primary and Booster Phase|Adverse Event|0|||
48680181|NCT03197376|156678483|FG001|Primary and Booster Phase|Adverse Event|0|||
48680182|NCT03197376|156678484|FG002|Primary and Booster Phase|Adverse Event|0|||
48680183|NCT03197376|156678485|FG003|Primary and Booster Phase|Adverse Event|1|||
48680184|NCT03197376|156678482|FG000|Primary and Booster Phase|Death|1|||
48680185|NCT03197376|156678483|FG001|Primary and Booster Phase|Death|0|||
48680186|NCT03197376|156678484|FG002|Primary and Booster Phase|Death|0|||
48680187|NCT03197376|156678485|FG003|Primary and Booster Phase|Death|2|||
48680188|NCT03197376|156678482|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
48680189|NCT03197376|156678483|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
48680190|NCT03197376|156678484|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
48680191|NCT03197376|156678485|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
48680192|NCT03197376|156678482|FG000|Primary and Booster Phase|Physician Decision|1|||
48680193|NCT03197376|156678483|FG001|Primary and Booster Phase|Physician Decision|0|||
48680194|NCT03197376|156678484|FG002|Primary and Booster Phase|Physician Decision|1|||
48680195|NCT03197376|156678485|FG003|Primary and Booster Phase|Physician Decision|3|||
48680196|NCT03197376|156678482|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
48680197|NCT03197376|156678483|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
48680198|NCT03197376|156678484|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
48680199|NCT03197376|156678485|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
48680200|NCT03197376|156678482|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
48680201|NCT03197376|156678483|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
48680202|NCT03197376|156678484|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
48680203|NCT03197376|156678485|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
48680204|NCT03197376|156678482|FG000|Primary and Booster Phase|Not vaccine related|1|||
48680205|NCT03197376|156678483|FG001|Primary and Booster Phase|Not vaccine related|2|||
48680206|NCT03197376|156678484|FG002|Primary and Booster Phase|Not vaccine related|0|||
48680207|NCT03197376|156678485|FG003|Primary and Booster Phase|Not vaccine related|6|||
48680208|NCT03197376|156678482|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
48680209|NCT03197376|156678483|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
48680210|NCT03197376|156678484|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
48680211|NCT03197376|156678485|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
48680212|NCT03197376|156678482|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
48680213|NCT03197376|156678483|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
48680214|NCT03197376|156678484|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
48680215|NCT03197376|156678485|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
48680216|NCT03197376|156678482|FG000|Immune Persistence Phase|Not vaccine related|1|||
48680217|NCT03197376|156678483|FG001|Immune Persistence Phase|Not vaccine related|0|||
48680218|NCT03197376|156678484|FG002|Immune Persistence Phase|Not vaccine related|1|||
48680219|NCT03197376|156678485|FG003|Immune Persistence Phase|Not vaccine related|1|||
48680220|NCT00825812|156678486|FG000|Overall Study|Never entered follow up|0|||
48680221|NCT00825812|156678487|FG001|Overall Study|Never entered follow up|0|||
48680222|NCT00825812|156678488|FG002|Overall Study|Never entered follow up|0|||
48680223|NCT00825812|156678489|FG003|Overall Study|Never entered follow up|1|||
48680224|NCT00825812|156678486|FG000|Overall Study|Adverse Event|0|||
48680225|NCT00825812|156678487|FG001|Overall Study|Adverse Event|0|||
48680226|NCT00825812|156678488|FG002|Overall Study|Adverse Event|0|||
48680227|NCT00825812|156678489|FG003|Overall Study|Adverse Event|1|||
48680228|NCT00825812|156678486|FG000|Overall Study|Subject withdrew consent|0|||
48680229|NCT00825812|156678487|FG001|Overall Study|Subject withdrew consent|0|||
48680230|NCT00825812|156678488|FG002|Overall Study|Subject withdrew consent|3|||
48680231|NCT00825812|156678489|FG003|Overall Study|Subject withdrew consent|2|||
48680232|NCT00825812|156678486|FG000|Overall Study|Non-compliance with protocol|0|||
48762828|NCT00600938|156980346|FG000|Extension Study|Lost to Follow-up|1|||
48762829|NCT00600938|156980347|FG001|Extension Study|Lost to Follow-up|1|||
48388900|NCT01994382|155619520|FG011|Overall Study|Adverse Event|2|||
48388901|NCT01994382|155619521|FG012|Overall Study|Adverse Event|7|||
48388902|NCT01994382|155619522|FG013|Overall Study|Adverse Event|3|||
48388903|NCT01994382|155619523|FG014|Overall Study|Adverse Event|17|||
48680233|NCT00825812|156678487|FG001|Overall Study|Non-compliance with protocol|0|||
48680234|NCT00825812|156678488|FG002|Overall Study|Non-compliance with protocol|0|||
48680235|NCT00825812|156678489|FG003|Overall Study|Non-compliance with protocol|1|||
48680236|NCT00825812|156678486|FG000|Overall Study|Administrative|0|||
48680237|NCT00825812|156678487|FG001|Overall Study|Administrative|1|||
48680238|NCT00825812|156678488|FG002|Overall Study|Administrative|3|||
48680239|NCT00825812|156678489|FG003|Overall Study|Administrative|5|||
48680240|NCT02058563|156678490|FG000|Overall Study|Lost to Follow-up|26|||
48680241|NCT02058563|156678491|FG001|Overall Study|Lost to Follow-up|22|||
48680242|NCT02058563|156678490|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
48680243|NCT02058563|156678491|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
48680244|NCT02058563|156678490|FG000|Overall Study|Consent Withdrawal|1|||
48680245|NCT02058563|156678491|FG001|Overall Study|Consent Withdrawal|1|||
48680246|NCT02058563|156678490|FG000|Overall Study|Other (patient incarcerated)|0|||
48680247|NCT02058563|156678491|FG001|Overall Study|Other (patient incarcerated)|1|||
48680248|NCT00166439|156678492|FG000|Overall Study|Ineligible|5|||
48680249|NCT02363959|156678495|FG000|Overall Study|Medical instability|1|||
48680250|NCT02363959|156678496|FG001|Overall Study|Medical instability|0|||
48680251|NCT00003199|156678499|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
48680252|NCT00003199|156678499|FG000|Overall Study|Lack of insurance clearance|2|||
48680253|NCT00003199|156678499|FG000|Overall Study|Screen fail|15|||
48680254|NCT00940498|156678500|FG000|Overall Study|Death|2|||
48680255|NCT00940498|156678501|FG001|Overall Study|Death|0|||
48680256|NCT00940498|156678502|FG002|Overall Study|Death|0|||
48680257|NCT00940498|156678503|FG003|Overall Study|Death|1|||
48680258|NCT00940498|156678504|FG004|Overall Study|Death|5|||
48680259|NCT00940498|156678505|FG005|Overall Study|Death|0|||
48680260|NCT00940498|156678506|FG006|Overall Study|Death|1|||
48680261|NCT00940498|156678507|FG007|Overall Study|Death|0|||
48680262|NCT00940498|156678500|FG000|Overall Study|Lost to Follow-up|1|||
48680263|NCT00940498|156678501|FG001|Overall Study|Lost to Follow-up|1|||
48680264|NCT00940498|156678502|FG002|Overall Study|Lost to Follow-up|2|||
48680265|NCT00940498|156678503|FG003|Overall Study|Lost to Follow-up|0|||
48680266|NCT00940498|156678504|FG004|Overall Study|Lost to Follow-up|1|||
48680267|NCT00940498|156678505|FG005|Overall Study|Lost to Follow-up|0|||
48680268|NCT00940498|156678506|FG006|Overall Study|Lost to Follow-up|0|||
48680269|NCT00940498|156678507|FG007|Overall Study|Lost to Follow-up|1|||
48680270|NCT00940498|156678500|FG000|Overall Study|Disease Progression|0|||
48680271|NCT00940498|156678501|FG001|Overall Study|Disease Progression|0|||
48680272|NCT00940498|156678502|FG002|Overall Study|Disease Progression|1|||
48680273|NCT00940498|156678503|FG003|Overall Study|Disease Progression|1|||
48680274|NCT00940498|156678504|FG004|Overall Study|Disease Progression|0|||
48680275|NCT00940498|156678505|FG005|Overall Study|Disease Progression|1|||
48680276|NCT00940498|156678506|FG006|Overall Study|Disease Progression|0|||
48680277|NCT00940498|156678507|FG007|Overall Study|Disease Progression|0|||
48680278|NCT00940498|156678500|FG000|Overall Study|Physician Decision|0|||
48680279|NCT00940498|156678501|FG001|Overall Study|Physician Decision|0|||
48680280|NCT00940498|156678502|FG002|Overall Study|Physician Decision|0|||
48680281|NCT00940498|156678503|FG003|Overall Study|Physician Decision|0|||
48680282|NCT00940498|156678504|FG004|Overall Study|Physician Decision|2|||
48680283|NCT00940498|156678505|FG005|Overall Study|Physician Decision|0|||
48680284|NCT00940498|156678506|FG006|Overall Study|Physician Decision|0|||
48680285|NCT00940498|156678507|FG007|Overall Study|Physician Decision|0|||
48680286|NCT00940498|156678500|FG000|Overall Study|Not treated due to disease related pain|0|||
48680287|NCT00940498|156678501|FG001|Overall Study|Not treated due to disease related pain|0|||
48680288|NCT00940498|156678502|FG002|Overall Study|Not treated due to disease related pain|0|||
48680289|NCT00940498|156678503|FG003|Overall Study|Not treated due to disease related pain|0|||
48680290|NCT00940498|156678504|FG004|Overall Study|Not treated due to disease related pain|1|||
48680291|NCT00940498|156678505|FG005|Overall Study|Not treated due to disease related pain|0|||
48680292|NCT00940498|156678506|FG006|Overall Study|Not treated due to disease related pain|0|||
48680293|NCT00940498|156678507|FG007|Overall Study|Not treated due to disease related pain|0|||
48680294|NCT01657292|156678508|FG000|Overall Study|Adverse Event|6|||
48680295|NCT01657292|156678508|FG000|Overall Study|Withdrawal by Subject|2|||
48680296|NCT01657292|156678508|FG000|Overall Study|Violation of eligibility criteria|1|||
48680297|NCT01657292|156678508|FG000|Overall Study|Change of therapy|1|||
48680298|NCT01792115|156678518|FG000|Overall Study|Lost to Follow-up|0|||
48680299|NCT01792115|156678519|FG001|Overall Study|Lost to Follow-up|1|||
48680300|NCT01792115|156678520|FG002|Overall Study|Lost to Follow-up|0|||
48680301|NCT02587819|156678522|FG000|Overall Study|Adverse Event|1|||
48680302|NCT02587819|156678522|FG000|Overall Study|Lost to Follow-up|1|||
48680303|NCT01286740|156679515|FG000|Overall Study|Enrolled but not treated|1|||
48680304|NCT01286740|156679515|FG000|Overall Study|Protocol Violation|1|||
48680305|NCT01031979|156679516|FG000|Overall Study|Lost to Follow-up|5|||
48680306|NCT01031979|156679517|FG001|Overall Study|Lost to Follow-up|4|||
48680307|NCT03592368|156679518|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
48680308|NCT03592368|156679519|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
48680309|NCT03592368|156679520|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
48680310|NCT03592368|156679521|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
48680311|NCT03592368|156679518|FG000|Overall Study|Adverse Event|0|||
48680312|NCT03592368|156679519|FG001|Overall Study|Adverse Event|0|||
48680313|NCT03592368|156679520|FG002|Overall Study|Adverse Event|0|||
48680314|NCT03592368|156679521|FG003|Overall Study|Adverse Event|1|||
48680315|NCT03592368|156679518|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
48680316|NCT03592368|156679519|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
48680317|NCT03592368|156679520|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
48680318|NCT03592368|156679521|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
48680319|NCT01732770|156679525|FG000|Overall Study|Lost to Follow-up|2|||
48680320|NCT01732770|156679526|FG001|Overall Study|Lost to Follow-up|3|||
48680321|NCT01732770|156679525|FG000|Overall Study|Withdrawal by Subject|5|||
48680322|NCT01732770|156679526|FG001|Overall Study|Withdrawal by Subject|3|||
48680323|NCT01732770|156679525|FG000|Overall Study|Decision by Sponsor|2|||
48680324|NCT01732770|156679526|FG001|Overall Study|Decision by Sponsor|2|||
48680325|NCT01732770|156679525|FG000|Overall Study|Death|1|||
48388904|NCT01994382|155619524|FG015|Overall Study|Adverse Event|6|||
48388905|NCT01994382|155619525|FG016|Overall Study|Adverse Event|3|||
48680326|NCT01732770|156679526|FG001|Overall Study|Death|0|||
48680327|NCT02814175|156679529|FG000|Part 1|Adverse Event|2|||
48680328|NCT02814175|156679530|FG001|Part 1|Adverse Event|3|||
48680329|NCT02814175|156679531|FG002|Part 1|Adverse Event|0|||
48680330|NCT02814175|156679532|FG003|Part 1|Adverse Event|0|||
48680331|NCT02814175|156679533|FG004|Part 1|Adverse Event|0|||
48680332|NCT02814175|156679534|FG005|Part 1|Adverse Event|0|||
48680333|NCT02814175|156679529|FG000|Part 1|Withdrawal Consent|8|||
48680334|NCT02814175|156679530|FG001|Part 1|Withdrawal Consent|1|||
48680335|NCT02814175|156679531|FG002|Part 1|Withdrawal Consent|0|||
48680336|NCT02814175|156679532|FG003|Part 1|Withdrawal Consent|0|||
48680337|NCT02814175|156679533|FG004|Part 1|Withdrawal Consent|0|||
48680338|NCT02814175|156679534|FG005|Part 1|Withdrawal Consent|0|||
48680339|NCT02814175|156679529|FG000|Part 1|Lost to Follow-up|1|||
48680340|NCT02814175|156679530|FG001|Part 1|Lost to Follow-up|0|||
48680341|NCT02814175|156679531|FG002|Part 1|Lost to Follow-up|0|||
48680342|NCT02814175|156679532|FG003|Part 1|Lost to Follow-up|0|||
48680343|NCT02814175|156679533|FG004|Part 1|Lost to Follow-up|0|||
48680344|NCT02814175|156679534|FG005|Part 1|Lost to Follow-up|0|||
48680345|NCT02814175|156679529|FG000|Part 1|Lack of Efficacy|1|||
48680346|NCT02814175|156679530|FG001|Part 1|Lack of Efficacy|2|||
48680347|NCT02814175|156679531|FG002|Part 1|Lack of Efficacy|0|||
48680348|NCT02814175|156679532|FG003|Part 1|Lack of Efficacy|0|||
48680349|NCT02814175|156679533|FG004|Part 1|Lack of Efficacy|0|||
48680350|NCT02814175|156679534|FG005|Part 1|Lack of Efficacy|0|||
48680351|NCT02814175|156679529|FG000|Part 2|Adverse Event|0|||
48680352|NCT02814175|156679530|FG001|Part 2|Adverse Event|0|||
48680353|NCT02814175|156679531|FG002|Part 2|Adverse Event|0|||
48680354|NCT02814175|156679532|FG003|Part 2|Adverse Event|1|||
48680355|NCT02814175|156679533|FG004|Part 2|Adverse Event|1|||
48680356|NCT02814175|156679534|FG005|Part 2|Adverse Event|2|||
48680357|NCT02814175|156679529|FG000|Part 2|Withdrawal Consent|0|||
48680358|NCT02814175|156679530|FG001|Part 2|Withdrawal Consent|0|||
48680359|NCT02814175|156679531|FG002|Part 2|Withdrawal Consent|0|||
48680360|NCT02814175|156679532|FG003|Part 2|Withdrawal Consent|2|||
48680361|NCT02814175|156679533|FG004|Part 2|Withdrawal Consent|1|||
48680362|NCT02814175|156679534|FG005|Part 2|Withdrawal Consent|1|||
48680363|NCT02814175|156679529|FG000|Part 2|Lost to Follow-up|0|||
48680364|NCT02814175|156679530|FG001|Part 2|Lost to Follow-up|0|||
48680365|NCT02814175|156679531|FG002|Part 2|Lost to Follow-up|0|||
48680366|NCT02814175|156679532|FG003|Part 2|Lost to Follow-up|1|||
48680367|NCT02814175|156679533|FG004|Part 2|Lost to Follow-up|0|||
48680368|NCT02814175|156679534|FG005|Part 2|Lost to Follow-up|0|||
48680369|NCT02814175|156679529|FG000|Part 2|Lack of Efficacy|0|||
48680370|NCT02814175|156679530|FG001|Part 2|Lack of Efficacy|0|||
48680371|NCT02814175|156679531|FG002|Part 2|Lack of Efficacy|0|||
48680372|NCT02814175|156679532|FG003|Part 2|Lack of Efficacy|0|||
48680373|NCT02814175|156679533|FG004|Part 2|Lack of Efficacy|0|||
48680374|NCT02814175|156679534|FG005|Part 2|Lack of Efficacy|3|||
48680375|NCT03521141|156679535|FG000|Overall Study|Death|1|||
48680376|NCT03521141|156679536|FG001|Overall Study|Death|0|||
48680377|NCT03521141|156679537|FG002|Overall Study|Death|1|||
48680378|NCT03775512|156679543|FG000|Overall Study|Death|1|||
48680379|NCT03775512|156679544|FG001|Overall Study|Death|1|||
48680380|NCT03775512|156679543|FG000|Overall Study|Withdrawal by Subject|7|||
48680381|NCT03775512|156679544|FG001|Overall Study|Withdrawal by Subject|4|||
48680382|NCT03775512|156679543|FG000|Overall Study|Lost to Follow-up|5|||
48680383|NCT03775512|156679544|FG001|Overall Study|Lost to Follow-up|5|||
48680384|NCT03775512|156679543|FG000|Overall Study|Excluded before Catheter insertion|14|||
48680385|NCT03775512|156679544|FG001|Overall Study|Excluded before Catheter insertion|5|||
48388906|NCT01994382|155619509|FG000|Overall Study|Other than specified|0|||
48680386|NCT03775512|156679543|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
48680387|NCT03775512|156679544|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
48680388|NCT03775512|156679543|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
48680389|NCT03775512|156679544|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
48680390|NCT00741013|156679545|FG000|Overall Study|Adverse Event|1|||
48680391|NCT00741013|156679546|FG001|Overall Study|Adverse Event|0|||
48680392|NCT00741013|156679547|FG002|Overall Study|Adverse Event|0|||
48680393|NCT00741013|156679545|FG000|Overall Study|Withdrawal by Subject|0|||
48680394|NCT00741013|156679546|FG001|Overall Study|Withdrawal by Subject|0|||
48388907|NCT01994382|155619510|FG001|Overall Study|Other than specified|0|||
48388908|NCT01994382|155619511|FG002|Overall Study|Other than specified|0|||
48388909|NCT01994382|155619512|FG003|Overall Study|Other than specified|0|||
48388910|NCT01994382|155619513|FG004|Overall Study|Other than specified|0|||
48388911|NCT01994382|155619514|FG005|Overall Study|Other than specified|0|||
48388912|NCT01994382|155619515|FG006|Overall Study|Other than specified|0|||
48388913|NCT01994382|155619516|FG007|Overall Study|Other than specified|0|||
48388914|NCT01994382|155619517|FG008|Overall Study|Other than specified|0|||
48388915|NCT01994382|155619518|FG009|Overall Study|Other than specified|0|||
48388916|NCT01994382|155619519|FG010|Overall Study|Other than specified|2|||
48388917|NCT01994382|155619520|FG011|Overall Study|Other than specified|0|||
48680395|NCT00741013|156679547|FG002|Overall Study|Withdrawal by Subject|1|||
48680396|NCT00741013|156679545|FG000|Overall Study|Discovered failed screen after enrolled|0|||
48680397|NCT00741013|156679546|FG001|Overall Study|Discovered failed screen after enrolled|2|||
48680398|NCT00741013|156679547|FG002|Overall Study|Discovered failed screen after enrolled|0|||
48680399|NCT00660179|156679548|FG000|Overall Study|Death|44|||
48680400|NCT00660179|156679549|FG001|Overall Study|Death|47|||
48680401|NCT00660179|156679550|FG002|Overall Study|Death|34|||
48680402|NCT00660179|156679548|FG000|Overall Study|Withdrawal of consent|4|||
48680403|NCT00660179|156679549|FG001|Overall Study|Withdrawal of consent|6|||
48680404|NCT00660179|156679550|FG002|Overall Study|Withdrawal of consent|4|||
48680405|NCT00660179|156679548|FG000|Overall Study|Lost to Follow-up|7|||
48680406|NCT00660179|156679549|FG001|Overall Study|Lost to Follow-up|5|||
48680407|NCT00660179|156679550|FG002|Overall Study|Lost to Follow-up|2|||
48680408|NCT00660179|156679548|FG000|Overall Study|Administrative reason|0|||
48680409|NCT00660179|156679549|FG001|Overall Study|Administrative reason|0|||
48680410|NCT00660179|156679550|FG002|Overall Study|Administrative reason|1|||
48680411|NCT00660179|156679548|FG000|Overall Study|Incorrect randomization|1|||
48680412|NCT00660179|156679549|FG001|Overall Study|Incorrect randomization|0|||
48680413|NCT00660179|156679550|FG002|Overall Study|Incorrect randomization|0|||
48680414|NCT00567359|156679555|FG000|Overall Study|Withdrawal by Subject|1|||
48680415|NCT04829916|156679556|FG000|Overall Study|Withdrawal by Subject|1|||
48680416|NCT04829916|156679557|FG001|Overall Study|Withdrawal by Subject|0|||
48680417|NCT01440816|156679561|FG000|Overall Study|Disease Progression|0|||
48680418|NCT01440816|156679562|FG001|Overall Study|Disease Progression|9|||
48680419|NCT01440816|156679561|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
48680420|NCT01440816|156679562|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
48680421|NCT00847886|156679563|FG000|Overall Study|Adverse Event|0|||
48680422|NCT00847886|156679564|FG001|Overall Study|Adverse Event|1|||
48680423|NCT00183625|156679567|FG000|Overall Study|Withdrawal by Subject|18|||
48680424|NCT00183625|156679568|FG001|Overall Study|Withdrawal by Subject|18|||
48680425|NCT00183625|156679569|FG002|Overall Study|Withdrawal by Subject|19|||
48680426|NCT00183625|156679570|FG003|Overall Study|Withdrawal by Subject|14|||
48680427|NCT02652156|156679572|FG000|Overall Study|Physician Decision|1|||
48680428|NCT02652156|156679573|FG001|Overall Study|Physician Decision|0|||
48680429|NCT02652156|156679574|FG002|Overall Study|Physician Decision|0|||
48680430|NCT03250182|156679575|FG000|Overall Study|Withdrawal by Subject|1|||
48680431|NCT03040674|156679576|FG000|Overall Study|Lost to Follow-up|225|||
48680432|NCT03040674|156679576|FG000|Overall Study|Death|23|||
48680433|NCT00193206|156679577|FG000|Preoperative Therapy|Lack of Efficacy|2|||
48680434|NCT00193206|156679577|FG000|Preoperative Therapy|Adverse Event|2|||
48680435|NCT00193206|156679577|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
48680436|NCT00193206|156679577|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
48680437|NCT00193206|156679577|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
48680438|NCT00193206|156679577|FG000|Postoperative Therapy|Physician Decision|3|||
48680439|NCT00193206|156679577|FG000|Postoperative Therapy|Intercurrent Illness|2|||
48680440|NCT00193206|156679577|FG000|Postoperative Therapy|Lack of Efficacy|1|||
48680441|NCT00193206|156679577|FG000|Postoperative Therapy|Protocol Violation|1|||
48680442|NCT01200368|156679578|FG000|Infant Series|Adverse Event|2|||
48680443|NCT01200368|156679579|FG001|Infant Series|Adverse Event|2|||
48680444|NCT01200368|156679580|FG002|Infant Series|Adverse Event|3|||
48680445|NCT01200368|156679578|FG000|Infant Series|Withdrawal by Subject|0|||
48680446|NCT01200368|156679579|FG001|Infant Series|Withdrawal by Subject|2|||
48680447|NCT01200368|156679580|FG002|Infant Series|Withdrawal by Subject|2|||
48680448|NCT01200368|156679578|FG000|Infant Series|Did not meet entrance criteria|0|||
48680449|NCT01200368|156679579|FG001|Infant Series|Did not meet entrance criteria|1|||
48680450|NCT01200368|156679580|FG002|Infant Series|Did not meet entrance criteria|0|||
48388918|NCT01994382|155619521|FG012|Overall Study|Other than specified|2|||
48388919|NCT01994382|155619522|FG013|Overall Study|Other than specified|0|||
48680451|NCT01200368|156679578|FG000|Infant Series|Randomized, not vaccinated|0|||
48680452|NCT01200368|156679579|FG001|Infant Series|Randomized, not vaccinated|1|||
48680453|NCT01200368|156679580|FG002|Infant Series|Randomized, not vaccinated|1|||
48680454|NCT01200368|156679578|FG000|Infant Series|Other|1|||
48680455|NCT01200368|156679579|FG001|Infant Series|Other|0|||
48680456|NCT01200368|156679580|FG002|Infant Series|Other|0|||
48680457|NCT01200368|156679578|FG000|After Infant Series|Adverse Event|6|||
48680458|NCT01200368|156679579|FG001|After Infant Series|Adverse Event|6|||
48680459|NCT01200368|156679580|FG002|After Infant Series|Adverse Event|3|||
48680460|NCT01200368|156679578|FG000|After Infant Series|Withdrawal by Subject|10|||
48680461|NCT01200368|156679579|FG001|After Infant Series|Withdrawal by Subject|8|||
48680462|NCT01200368|156679580|FG002|After Infant Series|Withdrawal by Subject|4|||
48680463|NCT01200368|156679578|FG000|After Infant Series|Lost to Follow-up|1|||
48680464|NCT01200368|156679579|FG001|After Infant Series|Lost to Follow-up|0|||
48680465|NCT01200368|156679580|FG002|After Infant Series|Lost to Follow-up|0|||
48680466|NCT01200368|156679578|FG000|After Infant Series|Other|1|||
48680467|NCT01200368|156679579|FG001|After Infant Series|Other|2|||
48680468|NCT01200368|156679580|FG002|After Infant Series|Other|2|||
48680469|NCT01200368|156679578|FG000|Toddler Dose|Adverse Event|0|||
48680470|NCT01200368|156679579|FG001|Toddler Dose|Adverse Event|3|||
48680471|NCT01200368|156679580|FG002|Toddler Dose|Adverse Event|1|||
48680472|NCT00709618|156679588|FG000|Overall Study|Withdrawal by Subject|4|||
48680473|NCT00709618|156679588|FG000|Overall Study|Lost to Follow-up|1|||
48680474|NCT00709618|156679588|FG000|Overall Study|Study Closed/Terminated|25|||
48680475|NCT02703324|156679589|FG000|Period Two|Withdrawal by Subject|0|||
48680476|NCT02703324|156679590|FG001|Period Two|Withdrawal by Subject|0|||
48680477|NCT02703324|156679591|FG002|Period Two|Withdrawal by Subject|1|||
48680478|NCT02703324|156679592|FG003|Period Two|Withdrawal by Subject|0|||
48680479|NCT02703324|156679593|FG004|Period Two|Withdrawal by Subject|0|||
48680480|NCT02703324|156679594|FG005|Period Two|Withdrawal by Subject|0|||
48680481|NCT03517228|156679599|FG000|Overall Study|Withdrawal by Subject|2|||
48680482|NCT03517228|156679599|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
48680483|NCT03517228|156679599|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
48680484|NCT03517228|156679599|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
48680485|NCT03517228|156679599|FG000|Overall Study|Canceled due to device being updated|1|||
48680486|NCT03517228|156679599|FG000|Overall Study|No V Cares in stock|1|||
48680487|NCT03517228|156679599|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
48680488|NCT00894361|156679600|FG000|Overall Study|deaths and less than 2 years followup|24|||
48680489|NCT00894361|156679601|FG001|Overall Study|deaths and less than 2 years followup|64|||
48680490|NCT01979952|156679602|FG000|Overall Study|Adverse Event|4|||
48680491|NCT01979952|156679603|FG001|Overall Study|Adverse Event|5|||
48680492|NCT01979952|156679602|FG000|Overall Study|Protocol Violation|1|||
48680493|NCT01979952|156679603|FG001|Overall Study|Protocol Violation|0|||
48762830|NCT00600938|156980348|FG002|Extension Study|Lost to Follow-up|2|||
48762831|NCT00600938|156980349|FG003|Extension Study|Lost to Follow-up|0|||
48762832|NCT00600938|156980346|FG000|Extension Study|Death|1|||
48762833|NCT00600938|156980347|FG001|Extension Study|Death|0|||
48388920|NCT01994382|155619523|FG014|Overall Study|Other than specified|0|||
48388921|NCT01994382|155619524|FG015|Overall Study|Other than specified|4|||
48388922|NCT01994382|155619525|FG016|Overall Study|Other than specified|4|||
48388923|NCT01994382|155619509|FG000|Overall Study|Withdrawal by Subject|0|||
48388924|NCT01994382|155619510|FG001|Overall Study|Withdrawal by Subject|0|||
48388925|NCT01994382|155619511|FG002|Overall Study|Withdrawal by Subject|0|||
48388926|NCT01994382|155619512|FG003|Overall Study|Withdrawal by Subject|0|||
48388927|NCT01994382|155619513|FG004|Overall Study|Withdrawal by Subject|0|||
48388928|NCT01994382|155619514|FG005|Overall Study|Withdrawal by Subject|0|||
48388929|NCT01994382|155619515|FG006|Overall Study|Withdrawal by Subject|0|||
48388930|NCT01994382|155619516|FG007|Overall Study|Withdrawal by Subject|0|||
48388931|NCT01994382|155619517|FG008|Overall Study|Withdrawal by Subject|0|||
48388932|NCT01994382|155619518|FG009|Overall Study|Withdrawal by Subject|0|||
48388933|NCT01994382|155619519|FG010|Overall Study|Withdrawal by Subject|6|||
48388934|NCT01994382|155619520|FG011|Overall Study|Withdrawal by Subject|0|||
48388935|NCT01994382|155619521|FG012|Overall Study|Withdrawal by Subject|2|||
48388936|NCT01994382|155619522|FG013|Overall Study|Withdrawal by Subject|0|||
48388937|NCT01994382|155619523|FG014|Overall Study|Withdrawal by Subject|4|||
48388938|NCT01994382|155619524|FG015|Overall Study|Withdrawal by Subject|3|||
48388939|NCT01994382|155619525|FG016|Overall Study|Withdrawal by Subject|0|||
48388940|NCT01994382|155619509|FG000|Overall Study|Lost to Follow-up|0|||
48388941|NCT01994382|155619510|FG001|Overall Study|Lost to Follow-up|0|||
48388942|NCT01994382|155619511|FG002|Overall Study|Lost to Follow-up|0|||
48388943|NCT01994382|155619512|FG003|Overall Study|Lost to Follow-up|0|||
48680494|NCT01979952|156679602|FG000|Overall Study|Withdrawal by Subject|2|||
48680495|NCT01979952|156679603|FG001|Overall Study|Withdrawal by Subject|1|||
48680496|NCT01979952|156679602|FG000|Overall Study|Other than specified above|1|||
48680497|NCT01979952|156679603|FG001|Overall Study|Other than specified above|0|||
48680498|NCT03088917|156679604|FG000|Overall Study|In care/cured elsewhere|15|||
48680499|NCT03088917|156679604|FG000|Overall Study|Refuse re-evaluation|13|||
48680500|NCT03088917|156679604|FG000|Overall Study|Contact not established|13|||
48680501|NCT03088917|156679604|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
48680502|NCT03088917|156679604|FG000|Overall Study|Moved outside study region|50|||
48680503|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
48680504|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48762834|NCT00600938|156980348|FG002|Extension Study|Death|0|||
48388944|NCT01994382|155619513|FG004|Overall Study|Lost to Follow-up|0|||
48388945|NCT01994382|155619514|FG005|Overall Study|Lost to Follow-up|0|||
48388946|NCT01994382|155619515|FG006|Overall Study|Lost to Follow-up|0|||
48388947|NCT01994382|155619516|FG007|Overall Study|Lost to Follow-up|0|||
48388948|NCT01994382|155619517|FG008|Overall Study|Lost to Follow-up|0|||
48388949|NCT01994382|155619518|FG009|Overall Study|Lost to Follow-up|0|||
48388950|NCT01994382|155619519|FG010|Overall Study|Lost to Follow-up|1|||
48388951|NCT01994382|155619520|FG011|Overall Study|Lost to Follow-up|0|||
48388952|NCT01994382|155619521|FG012|Overall Study|Lost to Follow-up|0|||
48388953|NCT01994382|155619522|FG013|Overall Study|Lost to Follow-up|0|||
48388954|NCT01994382|155619523|FG014|Overall Study|Lost to Follow-up|0|||
48388955|NCT01994382|155619524|FG015|Overall Study|Lost to Follow-up|0|||
48388956|NCT01994382|155619525|FG016|Overall Study|Lost to Follow-up|0|||
48388957|NCT01994382|155619509|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388958|NCT01994382|155619510|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388959|NCT01994382|155619511|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388960|NCT01994382|155619512|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388961|NCT01994382|155619513|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388962|NCT01994382|155619514|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388963|NCT01994382|155619515|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388964|NCT01994382|155619516|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388965|NCT01994382|155619517|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388966|NCT01994382|155619518|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388967|NCT01994382|155619519|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
48388968|NCT01994382|155619520|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388969|NCT01994382|155619521|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
48388970|NCT01994382|155619522|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388971|NCT01994382|155619523|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
48388972|NCT01994382|155619524|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
48388973|NCT01994382|155619525|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
48388974|NCT01994382|155619509|FG000|Overall Study|Protocol violation/noncompliance|0|||
48388975|NCT01994382|155619510|FG001|Overall Study|Protocol violation/noncompliance|0|||
48388976|NCT01994382|155619511|FG002|Overall Study|Protocol violation/noncompliance|0|||
48388977|NCT01994382|155619512|FG003|Overall Study|Protocol violation/noncompliance|0|||
48388978|NCT01994382|155619513|FG004|Overall Study|Protocol violation/noncompliance|0|||
48680505|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48680506|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48680507|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48680508|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48680509|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
48680510|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680511|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680512|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680513|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680514|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
48680515|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
48680516|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680517|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680518|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680519|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680520|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48680521|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
48680522|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680523|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680524|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680525|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680526|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
48680527|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
48680528|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
48680529|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
48388979|NCT01994382|155619514|FG005|Overall Study|Protocol violation/noncompliance|0|||
48680530|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
48680531|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
48680532|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
48762835|NCT00600938|156980349|FG003|Extension Study|Death|0|||
48388980|NCT01994382|155619515|FG006|Overall Study|Protocol violation/noncompliance|0|||
48388981|NCT01994382|155619516|FG007|Overall Study|Protocol violation/noncompliance|0|||
48388982|NCT01994382|155619517|FG008|Overall Study|Protocol violation/noncompliance|0|||
48388983|NCT01994382|155619518|FG009|Overall Study|Protocol violation/noncompliance|0|||
48388984|NCT01994382|155619519|FG010|Overall Study|Protocol violation/noncompliance|0|||
48388985|NCT01994382|155619520|FG011|Overall Study|Protocol violation/noncompliance|1|||
48388986|NCT01994382|155619521|FG012|Overall Study|Protocol violation/noncompliance|0|||
48388987|NCT01994382|155619522|FG013|Overall Study|Protocol violation/noncompliance|0|||
48680533|NCT01053988|156679605|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
48680534|NCT01053988|156679606|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680535|NCT01053988|156679607|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680536|NCT01053988|156679608|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680537|NCT01053988|156679609|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680538|NCT01053988|156679610|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48680539|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
48680540|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
48680541|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
48680542|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
48680543|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
48680544|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
48680545|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48680546|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
48680547|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
48680548|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
48388988|NCT01994382|155619523|FG014|Overall Study|Protocol violation/noncompliance|0|||
48680549|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
48680550|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48680551|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
48680552|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
48680553|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
48680554|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
48680555|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
48680556|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
48680557|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48680558|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
48680559|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
48680560|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
48680561|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
48680562|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
48680563|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48680564|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
48680565|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
48680566|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
48680567|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
48680568|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
48680569|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48680570|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
48680571|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48680572|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
48680573|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48680574|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
48680575|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
48762836|NCT02295995|156980351|FG000|Overall Study|Lost to Follow-up|5|||
48388989|NCT01994382|155619524|FG015|Overall Study|Protocol violation/noncompliance|0|||
48388990|NCT01994382|155619525|FG016|Overall Study|Protocol violation/noncompliance|2|||
48388991|NCT01994382|155619509|FG000|Overall Study|Rolled over to Phase 2a|0|||
48388992|NCT01994382|155619510|FG001|Overall Study|Rolled over to Phase 2a|0|||
48388993|NCT01994382|155619511|FG002|Overall Study|Rolled over to Phase 2a|1|||
48388994|NCT01994382|155619512|FG003|Overall Study|Rolled over to Phase 2a|0|||
48388995|NCT01994382|155619513|FG004|Overall Study|Rolled over to Phase 2a|0|||
48388996|NCT01994382|155619514|FG005|Overall Study|Rolled over to Phase 2a|0|||
48388997|NCT01994382|155619515|FG006|Overall Study|Rolled over to Phase 2a|0|||
48388998|NCT01994382|155619516|FG007|Overall Study|Rolled over to Phase 2a|0|||
48388999|NCT01994382|155619517|FG008|Overall Study|Rolled over to Phase 2a|0|||
48389000|NCT01994382|155619518|FG009|Overall Study|Rolled over to Phase 2a|2|||
48389001|NCT01994382|155619519|FG010|Overall Study|Rolled over to Phase 2a|0|||
48389002|NCT01994382|155619520|FG011|Overall Study|Rolled over to Phase 2a|0|||
48389003|NCT01994382|155619521|FG012|Overall Study|Rolled over to Phase 2a|0|||
48389004|NCT01994382|155619522|FG013|Overall Study|Rolled over to Phase 2a|0|||
48389005|NCT01994382|155619523|FG014|Overall Study|Rolled over to Phase 2a|0|||
48389006|NCT01994382|155619524|FG015|Overall Study|Rolled over to Phase 2a|0|||
48389007|NCT01994382|155619525|FG016|Overall Study|Rolled over to Phase 2a|0|||
48389008|NCT04667377|155619526|FG000|Dose Escalation Period|Other not specified below|3|||
48389009|NCT04667377|155619527|FG001|Dose Escalation Period|Other not specified below|3|||
48389010|NCT04667377|155619528|FG002|Dose Escalation Period|Other not specified below|2|||
48389011|NCT04667377|155619529|FG003|Dose Escalation Period|Other not specified below|1|||
48389012|NCT04667377|155619530|FG004|Dose Escalation Period|Other not specified below|3|||
48389013|NCT04667377|155619526|FG000|Dose Escalation Period|Protocol Violation|2|||
48389014|NCT04667377|155619527|FG001|Dose Escalation Period|Protocol Violation|2|||
48389015|NCT04667377|155619528|FG002|Dose Escalation Period|Protocol Violation|0|||
48389016|NCT04667377|155619529|FG003|Dose Escalation Period|Protocol Violation|2|||
48389017|NCT04667377|155619530|FG004|Dose Escalation Period|Protocol Violation|1|||
48389018|NCT04667377|155619526|FG000|Dose Escalation Period|Burden of study procedures|2|||
48389019|NCT04667377|155619527|FG001|Dose Escalation Period|Burden of study procedures|1|||
48389020|NCT04667377|155619528|FG002|Dose Escalation Period|Burden of study procedures|1|||
48389021|NCT04667377|155619529|FG003|Dose Escalation Period|Burden of study procedures|1|||
48389022|NCT04667377|155619530|FG004|Dose Escalation Period|Burden of study procedures|5|||
48389023|NCT04667377|155619526|FG000|Dose Escalation Period|Change of residence|0|||
48389024|NCT04667377|155619527|FG001|Dose Escalation Period|Change of residence|0|||
48389025|NCT04667377|155619528|FG002|Dose Escalation Period|Change of residence|1|||
48389026|NCT04667377|155619529|FG003|Dose Escalation Period|Change of residence|0|||
48389027|NCT04667377|155619530|FG004|Dose Escalation Period|Change of residence|0|||
48389028|NCT04667377|155619526|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
48389029|NCT04667377|155619527|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
48389030|NCT04667377|155619528|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
48389031|NCT04667377|155619529|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
48389032|NCT04667377|155619530|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
48389033|NCT04667377|155619526|FG000|Dose Escalation Period|Adverse Event|9|||
48389034|NCT04667377|155619527|FG001|Dose Escalation Period|Adverse Event|10|||
48389035|NCT04667377|155619528|FG002|Dose Escalation Period|Adverse Event|12|||
48389036|NCT04667377|155619529|FG003|Dose Escalation Period|Adverse Event|17|||
48389037|NCT04667377|155619530|FG004|Dose Escalation Period|Adverse Event|3|||
48389038|NCT04667377|155619526|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
48389039|NCT04667377|155619527|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
48389040|NCT04667377|155619528|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
48389041|NCT04667377|155619529|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
48389042|NCT04667377|155619530|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
48389043|NCT04667377|155619526|FG000|Dose Escalation Period|Not treated|1|||
48389044|NCT04667377|155619527|FG001|Dose Escalation Period|Not treated|0|||
48680576|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
48680577|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
48680578|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
48680579|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
48680580|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
48680581|NCT01053988|156679605|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48680582|NCT01053988|156679606|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
48389045|NCT04667377|155619528|FG002|Dose Escalation Period|Not treated|0|||
48389046|NCT04667377|155619529|FG003|Dose Escalation Period|Not treated|0|||
48389047|NCT04667377|155619530|FG004|Dose Escalation Period|Not treated|0|||
48389048|NCT04667377|155619526|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
48389049|NCT04667377|155619527|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
48389050|NCT04667377|155619528|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
48389051|NCT04667377|155619529|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
48389052|NCT04667377|155619530|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
48389053|NCT04667377|155619526|FG000|Dose Escalation Period|Lost to Follow-up|0|||
48429382|NCT01070550|155760359|FG004|Overall Study|Protocol Violation|0|||
48389054|NCT04667377|155619527|FG001|Dose Escalation Period|Lost to Follow-up|1|||
48389055|NCT04667377|155619528|FG002|Dose Escalation Period|Lost to Follow-up|0|||
48389056|NCT04667377|155619529|FG003|Dose Escalation Period|Lost to Follow-up|0|||
48389057|NCT04667377|155619530|FG004|Dose Escalation Period|Lost to Follow-up|0|||
48389058|NCT04667377|155619526|FG000|Maintenance Period|Perceived lack of efficacy|0|||
48389059|NCT04667377|155619527|FG001|Maintenance Period|Perceived lack of efficacy|2|||
48389060|NCT04667377|155619528|FG002|Maintenance Period|Perceived lack of efficacy|1|||
48389061|NCT04667377|155619529|FG003|Maintenance Period|Perceived lack of efficacy|0|||
48389062|NCT04667377|155619530|FG004|Maintenance Period|Perceived lack of efficacy|1|||
48389063|NCT04667377|155619526|FG000|Maintenance Period|Adverse Event|2|||
48389064|NCT04667377|155619527|FG001|Maintenance Period|Adverse Event|8|||
48389065|NCT04667377|155619528|FG002|Maintenance Period|Adverse Event|5|||
48389066|NCT04667377|155619529|FG003|Maintenance Period|Adverse Event|4|||
48389067|NCT04667377|155619530|FG004|Maintenance Period|Adverse Event|1|||
48389068|NCT04667377|155619526|FG000|Maintenance Period|Adverse event: COVID infection|0|||
48389069|NCT04667377|155619527|FG001|Maintenance Period|Adverse event: COVID infection|1|||
48389070|NCT04667377|155619528|FG002|Maintenance Period|Adverse event: COVID infection|0|||
48389071|NCT04667377|155619529|FG003|Maintenance Period|Adverse event: COVID infection|0|||
48389072|NCT04667377|155619530|FG004|Maintenance Period|Adverse event: COVID infection|0|||
48389073|NCT04667377|155619526|FG000|Maintenance Period|COVID-related|0|||
48389074|NCT04667377|155619527|FG001|Maintenance Period|COVID-related|0|||
48389075|NCT04667377|155619528|FG002|Maintenance Period|COVID-related|1|||
48389076|NCT04667377|155619529|FG003|Maintenance Period|COVID-related|1|||
48389077|NCT04667377|155619530|FG004|Maintenance Period|COVID-related|0|||
48389078|NCT04667377|155619526|FG000|Maintenance Period|Protocol Violation|1|||
48389079|NCT04667377|155619527|FG001|Maintenance Period|Protocol Violation|0|||
48389080|NCT04667377|155619528|FG002|Maintenance Period|Protocol Violation|0|||
48389081|NCT04667377|155619529|FG003|Maintenance Period|Protocol Violation|0|||
48389082|NCT04667377|155619530|FG004|Maintenance Period|Protocol Violation|1|||
48389083|NCT04667377|155619526|FG000|Maintenance Period|Burden of study procedures|1|||
48389084|NCT04667377|155619527|FG001|Maintenance Period|Burden of study procedures|2|||
48389085|NCT04667377|155619528|FG002|Maintenance Period|Burden of study procedures|0|||
48389086|NCT04667377|155619529|FG003|Maintenance Period|Burden of study procedures|1|||
48389087|NCT04667377|155619530|FG004|Maintenance Period|Burden of study procedures|0|||
48389088|NCT04667377|155619526|FG000|Maintenance Period|Change of residence|0|||
48389089|NCT04667377|155619527|FG001|Maintenance Period|Change of residence|1|||
48389090|NCT04667377|155619528|FG002|Maintenance Period|Change of residence|0|||
48389091|NCT04667377|155619529|FG003|Maintenance Period|Change of residence|0|||
48389092|NCT04667377|155619530|FG004|Maintenance Period|Change of residence|1|||
48389093|NCT04667377|155619526|FG000|Maintenance Period|Missing|1|||
48389094|NCT04667377|155619527|FG001|Maintenance Period|Missing|0|||
48389095|NCT04667377|155619528|FG002|Maintenance Period|Missing|0|||
48389096|NCT04667377|155619529|FG003|Maintenance Period|Missing|0|||
48389097|NCT04667377|155619530|FG004|Maintenance Period|Missing|0|||
48389098|NCT04667377|155619526|FG000|Maintenance Period|Other than listed above|2|||
48389099|NCT04667377|155619527|FG001|Maintenance Period|Other than listed above|0|||
48389100|NCT04667377|155619528|FG002|Maintenance Period|Other than listed above|3|||
48389101|NCT04667377|155619529|FG003|Maintenance Period|Other than listed above|2|||
48389102|NCT04667377|155619530|FG004|Maintenance Period|Other than listed above|6|||
48389103|NCT04667377|155619526|FG000|Maintenance Period|Withdrawal by Subject|0|||
48389104|NCT04667377|155619527|FG001|Maintenance Period|Withdrawal by Subject|1|||
48389105|NCT04667377|155619528|FG002|Maintenance Period|Withdrawal by Subject|0|||
48389106|NCT04667377|155619529|FG003|Maintenance Period|Withdrawal by Subject|0|||
48389107|NCT04667377|155619530|FG004|Maintenance Period|Withdrawal by Subject|0|||
48389108|NCT04667377|155619526|FG000|Maintenance Period|Lost to Follow-up|1|||
48389109|NCT04667377|155619527|FG001|Maintenance Period|Lost to Follow-up|0|||
48680583|NCT01053988|156679607|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48680584|NCT01053988|156679608|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
48680585|NCT01053988|156679609|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
48389110|NCT04667377|155619528|FG002|Maintenance Period|Lost to Follow-up|1|||
48389111|NCT04667377|155619529|FG003|Maintenance Period|Lost to Follow-up|0|||
48680586|NCT01053988|156679610|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48680587|NCT01502228|156679611|FG000|Overall Study|Death|1|||
48680588|NCT00719355|156679612|FG000|Overall Study|Death|0|||
48680589|NCT00719355|156679613|FG001|Overall Study|Death|1|||
48389112|NCT04667377|155619530|FG004|Maintenance Period|Lost to Follow-up|1|||
48389113|NCT02819635|155619531|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
48389114|NCT02819635|155619532|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
48680590|NCT00719355|156679612|FG000|Overall Study|Medical|14|||
48389115|NCT02819635|155619533|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
48389116|NCT02819635|155619534|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
48389117|NCT02819635|155619535|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
48389118|NCT02819635|155619536|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
48680591|NCT00719355|156679613|FG001|Overall Study|Medical|5|||
48389119|NCT02819635|155619537|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
48389120|NCT02819635|155619538|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48389121|NCT02819635|155619539|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48389122|NCT02819635|155619540|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48389123|NCT02819635|155619541|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48389124|NCT02819635|155619542|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
48389125|NCT02819635|155619531|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48389126|NCT02819635|155619532|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48389127|NCT02819635|155619533|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48389128|NCT02819635|155619534|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48389129|NCT02819635|155619535|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
48389130|NCT02819635|155619536|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
48389131|NCT02819635|155619537|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
48389132|NCT02819635|155619538|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48389133|NCT02819635|155619539|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48389134|NCT02819635|155619540|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48680592|NCT00719355|156679612|FG000|Overall Study|Compliance|4|||
48680593|NCT00719355|156679613|FG001|Overall Study|Compliance|6|||
48680594|NCT00719355|156679612|FG000|Overall Study|Moved|0|||
48680595|NCT00719355|156679613|FG001|Overall Study|Moved|1|||
48680596|NCT01415401|156679614|FG000|Overall Study|Adverse Event|5|||
48680597|NCT01415401|156679614|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
48680598|NCT01415401|156679614|FG000|Overall Study|Terminated by Sponsor|1|||
48680599|NCT01843062|156679615|FG000|Overall Study|Protocol Violation|1|||
48680600|NCT01843062|156679616|FG001|Overall Study|Protocol Violation|0|||
48680601|NCT01843062|156679615|FG000|Overall Study|New treatment following progression|2|||
48680602|NCT01843062|156679616|FG001|Overall Study|New treatment following progression|0|||
48680603|NCT01843062|156679615|FG000|Overall Study|Pregnancy|1|||
48680604|NCT01843062|156679616|FG001|Overall Study|Pregnancy|0|||
48680605|NCT01843062|156679615|FG000|Overall Study|Adverse Event|2|||
48680606|NCT01843062|156679616|FG001|Overall Study|Adverse Event|0|||
48680607|NCT01843062|156679615|FG000|Overall Study|Incorrect randomisation|1|||
48680608|NCT01843062|156679616|FG001|Overall Study|Incorrect randomisation|0|||
48680609|NCT01843062|156679615|FG000|Overall Study|Withdrawal by Subject|12|||
48680610|NCT01843062|156679616|FG001|Overall Study|Withdrawal by Subject|3|||
48680611|NCT01843062|156679615|FG000|Overall Study|Death|1|||
48680612|NCT01843062|156679616|FG001|Overall Study|Death|2|||
48680613|NCT01843062|156679615|FG000|Overall Study|Lost to Follow-up|2|||
48680614|NCT01843062|156679616|FG001|Overall Study|Lost to Follow-up|4|||
48680615|NCT00994422|156679617|FG000|Overall Study|Lost to Follow-up|7|||
48680616|NCT00994422|156679618|FG001|Overall Study|Lost to Follow-up|1|||
48680617|NCT00132808|156679626|FG000|Stratum I|Adverse Event|2|||
48680618|NCT00132808|156679627|FG001|Stratum I|Adverse Event|1|||
48680619|NCT00132808|156679628|FG002|Stratum I|Adverse Event|0|||
48680620|NCT00132808|156679626|FG000|Stratum I|Lost to Follow-up|3|||
48680621|NCT00132808|156679627|FG001|Stratum I|Lost to Follow-up|4|||
48680622|NCT00132808|156679628|FG002|Stratum I|Lost to Follow-up|1|||
48680623|NCT00132808|156679626|FG000|Stratum I|Withdrawal by Subject|4|||
48680624|NCT00132808|156679627|FG001|Stratum I|Withdrawal by Subject|7|||
48680625|NCT00132808|156679628|FG002|Stratum I|Withdrawal by Subject|3|||
48680626|NCT00132808|156679626|FG000|Stratum I|Abnormal test procedure result (s)|0|||
48680627|NCT00132808|156679627|FG001|Stratum I|Abnormal test procedure result (s)|0|||
48680628|NCT00132808|156679628|FG002|Stratum I|Abnormal test procedure result (s)|1|||
48680629|NCT00132808|156679626|FG000|Stratum II|Adverse Event|1|||
48680630|NCT00132808|156679627|FG001|Stratum II|Adverse Event|2|||
48680631|NCT00132808|156679628|FG002|Stratum II|Adverse Event|1|||
48680632|NCT00132808|156679626|FG000|Stratum II|Death|1|||
48680633|NCT00132808|156679627|FG001|Stratum II|Death|0|||
48680634|NCT00132808|156679628|FG002|Stratum II|Death|0|||
48680635|NCT00132808|156679626|FG000|Stratum II|Lost to Follow-up|2|||
48680636|NCT00132808|156679627|FG001|Stratum II|Lost to Follow-up|2|||
48680637|NCT00132808|156679628|FG002|Stratum II|Lost to Follow-up|1|||
48680638|NCT00132808|156679626|FG000|Stratum II|Protocol Violation|0|||
48680639|NCT00132808|156679627|FG001|Stratum II|Protocol Violation|2|||
48389135|NCT02819635|155619541|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48680640|NCT00132808|156679628|FG002|Stratum II|Protocol Violation|1|||
48680641|NCT00132808|156679626|FG000|Stratum II|Withdrawal by Subject|4|||
48680642|NCT00132808|156679627|FG001|Stratum II|Withdrawal by Subject|9|||
48680643|NCT00132808|156679628|FG002|Stratum II|Withdrawal by Subject|6|||
48680644|NCT03078855|156679629|FG000|Overall Study|Lack of Efficacy|62|||
48680645|NCT03078855|156679630|FG001|Overall Study|Lack of Efficacy|31|||
48680646|NCT03078855|156679629|FG000|Overall Study|Death|1|||
48680647|NCT03078855|156679630|FG001|Overall Study|Death|0|||
48680648|NCT03078855|156679629|FG000|Overall Study|Withdrawal by Subject|12|||
48680649|NCT03078855|156679630|FG001|Overall Study|Withdrawal by Subject|6|||
48680650|NCT03078855|156679629|FG000|Overall Study|Physician Decision|3|||
48680651|NCT03078855|156679630|FG001|Overall Study|Physician Decision|2|||
48680652|NCT03078855|156679629|FG000|Overall Study|Second Malignancy|4|||
48389136|NCT02819635|155619542|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
48389137|NCT02819635|155619531|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389138|NCT02819635|155619532|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389139|NCT02819635|155619533|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389140|NCT02819635|155619534|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389141|NCT02819635|155619535|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389142|NCT02819635|155619536|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
48389143|NCT02819635|155619537|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
48389144|NCT02819635|155619538|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389145|NCT02819635|155619539|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389146|NCT02819635|155619540|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389147|NCT02819635|155619541|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389148|NCT02819635|155619542|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
48389149|NCT02819635|155619531|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389150|NCT02819635|155619532|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389151|NCT02819635|155619533|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389152|NCT02819635|155619534|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389153|NCT02819635|155619535|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389154|NCT02819635|155619536|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389155|NCT02819635|155619537|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
48389156|NCT02819635|155619538|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389157|NCT02819635|155619539|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389158|NCT02819635|155619540|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389159|NCT02819635|155619541|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389160|NCT02819635|155619542|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
48389161|NCT02819635|155619531|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
48389162|NCT02819635|155619532|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
48389163|NCT02819635|155619533|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
48680653|NCT03078855|156679630|FG001|Overall Study|Second Malignancy|0|||
48680654|NCT03078855|156679629|FG000|Overall Study|Ineligible|2|||
48680655|NCT03078855|156679630|FG001|Overall Study|Ineligible|0|||
48680656|NCT03078855|156679629|FG000|Overall Study|Withdrew before day 1 treatment|2|||
48680657|NCT03078855|156679630|FG001|Overall Study|Withdrew before day 1 treatment|1|||
48389164|NCT02819635|155619534|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
48389165|NCT02819635|155619535|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
48389166|NCT02819635|155619536|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
48389167|NCT02819635|155619537|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
48389168|NCT02819635|155619538|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48389169|NCT02819635|155619539|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48389170|NCT02819635|155619540|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48389171|NCT02819635|155619541|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48389172|NCT02819635|155619542|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
48389173|NCT02819635|155619531|FG000|Substudy 2, Part 2|Adverse Event|0|||
48389174|NCT02819635|155619532|FG001|Substudy 2, Part 2|Adverse Event|0|||
48389175|NCT02819635|155619533|FG002|Substudy 2, Part 2|Adverse Event|0|||
48389176|NCT02819635|155619534|FG003|Substudy 2, Part 2|Adverse Event|0|||
48389177|NCT02819635|155619535|FG004|Substudy 2, Part 2|Adverse Event|0|||
48389178|NCT02819635|155619536|FG005|Substudy 2, Part 2|Adverse Event|4|||
48389179|NCT02819635|155619537|FG006|Substudy 2, Part 2|Adverse Event|0|||
48389180|NCT02819635|155619538|FG007|Substudy 2, Part 2|Adverse Event|0|||
48389181|NCT02819635|155619539|FG008|Substudy 2, Part 2|Adverse Event|0|||
48389182|NCT02819635|155619540|FG009|Substudy 2, Part 2|Adverse Event|0|||
48389183|NCT02819635|155619541|FG010|Substudy 2, Part 2|Adverse Event|0|||
48389184|NCT02819635|155619542|FG011|Substudy 2, Part 2|Adverse Event|0|||
48389185|NCT02819635|155619531|FG000|Substudy 2, Part 2|Withdrew consent|0|||
48389186|NCT02819635|155619532|FG001|Substudy 2, Part 2|Withdrew consent|0|||
48389187|NCT02819635|155619533|FG002|Substudy 2, Part 2|Withdrew consent|0|||
48389188|NCT02819635|155619534|FG003|Substudy 2, Part 2|Withdrew consent|0|||
48389189|NCT02819635|155619535|FG004|Substudy 2, Part 2|Withdrew consent|0|||
48389190|NCT02819635|155619536|FG005|Substudy 2, Part 2|Withdrew consent|3|||
48389191|NCT02819635|155619537|FG006|Substudy 2, Part 2|Withdrew consent|1|||
48389192|NCT02819635|155619538|FG007|Substudy 2, Part 2|Withdrew consent|0|||
48389193|NCT02819635|155619539|FG008|Substudy 2, Part 2|Withdrew consent|0|||
48389194|NCT02819635|155619540|FG009|Substudy 2, Part 2|Withdrew consent|0|||
48389195|NCT02819635|155619541|FG010|Substudy 2, Part 2|Withdrew consent|0|||
48680658|NCT00577824|156679631|FG000|Overall Study|Adverse Event|6|||
48389196|NCT02819635|155619542|FG011|Substudy 2, Part 2|Withdrew consent|0|||
48389197|NCT02819635|155619531|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
48680659|NCT00577824|156679632|FG001|Overall Study|Adverse Event|18|||
48680660|NCT00577824|156679633|FG002|Overall Study|Adverse Event|1|||
48680661|NCT00577824|156679631|FG000|Overall Study|Patient decision|0|||
48680662|NCT00577824|156679632|FG001|Overall Study|Patient decision|1|||
48680663|NCT00577824|156679633|FG002|Overall Study|Patient decision|1|||
48680664|NCT00577824|156679631|FG000|Overall Study|Protocol Violation|1|||
48680665|NCT00577824|156679632|FG001|Overall Study|Protocol Violation|1|||
48680666|NCT00577824|156679633|FG002|Overall Study|Protocol Violation|0|||
48680667|NCT00836186|156679634|FG000|Overall Study|Blood could not be drawn|1|||
48680668|NCT04079816|156679635|FG000|Overall Study|Request of Subject|2|||
48680669|NCT04079816|156679635|FG000|Overall Study|Unable to draw samples|1|||
48680670|NCT04137731|156679636|FG000|Overall Study|Surgery Cancellation|1|||
48680671|NCT04137731|156679637|FG001|Overall Study|Surgery Cancellation|2|||
48680672|NCT04137731|156679636|FG000|Overall Study|Withdrawal by Subject|2|||
48680673|NCT04137731|156679637|FG001|Overall Study|Withdrawal by Subject|0|||
48680674|NCT04137731|156679636|FG000|Overall Study|Protocol Violation|0|||
48680675|NCT04137731|156679637|FG001|Overall Study|Protocol Violation|1|||
48680676|NCT00666224|156680859|FG000|Double-Blind|Adverse Event|15|||
48680677|NCT00666224|156680860|FG001|Double-Blind|Adverse Event|5|||
48680678|NCT00666224|156680859|FG000|Double-Blind|Lost to Follow-up|2|||
48680679|NCT00666224|156680860|FG001|Double-Blind|Lost to Follow-up|2|||
48680680|NCT00666224|156680859|FG000|Double-Blind|Withdrawal by Subject|18|||
48680681|NCT00666224|156680860|FG001|Double-Blind|Withdrawal by Subject|14|||
48680682|NCT00666224|156680859|FG000|Double-Blind|Physician Decision|0|||
48680683|NCT00666224|156680860|FG001|Double-Blind|Physician Decision|3|||
48680684|NCT00666224|156680859|FG000|Double-Blind|Sponsor decision|1|||
48680685|NCT00666224|156680860|FG001|Double-Blind|Sponsor decision|0|||
48680686|NCT00666224|156680859|FG000|Double-Blind|Pregnancy|3|||
48680687|NCT00666224|156680860|FG001|Double-Blind|Pregnancy|2|||
48680688|NCT00666224|156680859|FG000|Double-Blind|Noncompliance|1|||
48680689|NCT00666224|156680860|FG001|Double-Blind|Noncompliance|0|||
48680690|NCT00666224|156680859|FG000|Double-Blind|Death|1|||
48680691|NCT00666224|156680860|FG001|Double-Blind|Death|0|||
48680692|NCT00666224|156680859|FG000|Double-Blind|Undefined/Unknown|4|||
48680693|NCT00666224|156680860|FG001|Double-Blind|Undefined/Unknown|1|||
48680694|NCT00666224|156680859|FG000|Open-Label|Adverse Event|8|||
48680695|NCT00666224|156680860|FG001|Open-Label|Adverse Event|43|||
48680696|NCT00666224|156680859|FG000|Open-Label|Lost to Follow-up|4|||
48680697|NCT00666224|156680860|FG001|Open-Label|Lost to Follow-up|5|||
48680698|NCT00666224|156680859|FG000|Open-Label|Withdrawal by Subject|12|||
48680699|NCT00666224|156680860|FG001|Open-Label|Withdrawal by Subject|25|||
48680700|NCT00666224|156680859|FG000|Open-Label|Physician Decision|7|||
48680701|NCT00666224|156680860|FG001|Open-Label|Physician Decision|5|||
48680702|NCT00666224|156680859|FG000|Open-Label|Pregnancy|1|||
48680703|NCT00666224|156680860|FG001|Open-Label|Pregnancy|5|||
48680704|NCT00666224|156680859|FG000|Open-Label|Noncompliance|2|||
48680705|NCT00666224|156680860|FG001|Open-Label|Noncompliance|1|||
48680706|NCT00666224|156680859|FG000|Open-Label|Undefined/Unknown|1|||
48680707|NCT00666224|156680860|FG001|Open-Label|Undefined/Unknown|1|||
48680708|NCT01424501|156680868|FG000|Overall Study|Withdrawal by Subject|1|||
48680709|NCT01424501|156680869|FG001|Overall Study|Withdrawal by Subject|0|||
48680710|NCT01424501|156680870|FG002|Overall Study|Withdrawal by Subject|1|||
48680711|NCT01424501|156680871|FG003|Overall Study|Withdrawal by Subject|0|||
48762837|NCT02295995|156980352|FG001|Overall Study|Lost to Follow-up|1|||
48762838|NCT01324349|156980362|FG000|Overall Study|Death|1|||
48762839|NCT01324349|156980363|FG001|Overall Study|Death|1|||
48680712|NCT01424501|156680872|FG004|Overall Study|Withdrawal by Subject|0|||
48680713|NCT01424501|156680873|FG005|Overall Study|Withdrawal by Subject|0|||
48680714|NCT01424501|156680868|FG000|Overall Study|Lost to Follow-up|0|||
48680715|NCT01424501|156680869|FG001|Overall Study|Lost to Follow-up|1|||
48355121|NCT00895895|155497201|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
48355122|NCT00895895|155497202|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
48355123|NCT00895895|155497203|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
48355124|NCT00895895|155497204|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
48355125|NCT00895895|155497200|FG000|After Period 1, Prior to Period 2|Other|0|||
48355126|NCT00895895|155497201|FG001|After Period 1, Prior to Period 2|Other|0|||
48355127|NCT00895895|155497202|FG002|After Period 1, Prior to Period 2|Other|1|||
48355128|NCT00895895|155497203|FG003|After Period 1, Prior to Period 2|Other|0|||
48680716|NCT01424501|156680870|FG002|Overall Study|Lost to Follow-up|1|||
48680717|NCT01424501|156680871|FG003|Overall Study|Lost to Follow-up|0|||
48680718|NCT01424501|156680872|FG004|Overall Study|Lost to Follow-up|0|||
48680719|NCT01424501|156680873|FG005|Overall Study|Lost to Follow-up|0|||
48680720|NCT00546000|156680874|FG000|Overall Study|Adverse Event|1|||
48680721|NCT00546000|156680874|FG000|Overall Study|Lost to Follow-up|1|||
48680722|NCT00546000|156680874|FG000|Overall Study|Baseline HPA Axis Supression|2|||
48680723|NCT04207749|156680875|FG000|Overall Study|Lost to Follow-up|0|||
48680724|NCT04207749|156680876|FG001|Overall Study|Lost to Follow-up|2|||
48680725|NCT04207749|156680875|FG000|Overall Study|Protocol Violation|0|||
48680726|NCT04207749|156680876|FG001|Overall Study|Protocol Violation|1|||
48680727|NCT04207749|156680875|FG000|Overall Study|Withdrawal by Subject|3|||
48680728|NCT04207749|156680876|FG001|Overall Study|Withdrawal by Subject|0|||
48680729|NCT04207749|156680875|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
48680730|NCT04207749|156680876|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
48680731|NCT02581215|156680877|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
48680732|NCT02581215|156680878|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
48680733|NCT02581215|156680877|FG000|Overall Study|Eligibility Criteria Not Met|0|||
48680734|NCT02581215|156680878|FG001|Overall Study|Eligibility Criteria Not Met|1|||
48680735|NCT00705367|156680885|FG000|Long-term Extension Period|Adverse Event|2|||
48680736|NCT00705367|156680886|FG001|Long-term Extension Period|Adverse Event|0|||
48680737|NCT00705367|156680885|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
48680738|NCT00705367|156680886|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
48680739|NCT00705367|156680885|FG000|Long-term Extension Period|Lack of Efficacy|1|||
48680740|NCT00705367|156680886|FG001|Long-term Extension Period|Lack of Efficacy|0|||
48680741|NCT00705367|156680885|FG000|Long-term Extension Period|No longer met study criteria|1|||
48680742|NCT00705367|156680886|FG001|Long-term Extension Period|No longer met study criteria|0|||
48680743|NCT00705367|156680885|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
48680744|NCT00705367|156680886|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
48680745|NCT03781778|156680895|FG000|Overall Study|Withdrawal by Subject|2|||
48680746|NCT03781778|156680896|FG001|Overall Study|Withdrawal by Subject|2|||
48680747|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Technical problems|0|||
48680748|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Technical problems|0|||
48680749|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Technical problems|0|||
48680750|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Technical problems|1|||
48680751|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
48680752|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
48680753|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
48680754|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
48680755|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
48680756|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
48680757|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
48680758|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
48680759|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
48680760|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
48680761|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
48680762|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
48680763|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Death|0|||
48680764|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Death|3|||
48680765|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Death|1|||
48680766|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Death|0|||
48680767|NCT02152761|156680898|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
48680768|NCT02152761|156680899|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
48680769|NCT02152761|156680900|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
48680770|NCT02152761|156680901|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
48680771|NCT02152761|156680898|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
48680772|NCT02152761|156680899|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
48680773|NCT02152761|156680900|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
48680774|NCT02152761|156680901|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
48680775|NCT02152761|156680898|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
48680776|NCT02152761|156680899|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
48680777|NCT02152761|156680900|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
48680778|NCT02152761|156680901|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
48680779|NCT02152761|156680898|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
48680780|NCT02152761|156680899|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
48680781|NCT02152761|156680900|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
48680782|NCT02152761|156680901|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
48680783|NCT02152761|156680898|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
48680784|NCT02152761|156680899|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
48680785|NCT02152761|156680900|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
48680786|NCT02152761|156680901|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
48680787|NCT04343755|156680902|FG000|Overall Study|Death|11|||
48680788|NCT04343755|156680902|FG000|Overall Study|Screen Failure|1|||
48389198|NCT02819635|155619532|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
48389199|NCT02819635|155619533|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
48389200|NCT02819635|155619534|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
48680789|NCT03755882|156680903|FG000|Period 1|Protocol Violation|1|||
48680790|NCT03755882|156680904|FG001|Period 1|Protocol Violation|0|||
48680791|NCT03755882|156680903|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
48680792|NCT03755882|156680904|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
48680793|NCT01687101|156680905|FG000|Overall Study|Lost to Follow-up|7|||
48680794|NCT03792256|156680914|FG000|Overall Study|Death|0|||
48680795|NCT03792256|156680915|FG001|Overall Study|Death|1|||
48389201|NCT02819635|155619535|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
48389202|NCT02819635|155619536|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
48389203|NCT02819635|155619537|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
48389204|NCT02819635|155619538|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
48389205|NCT02819635|155619539|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
48389206|NCT02819635|155619540|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
48389207|NCT02819635|155619541|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
48389208|NCT02819635|155619542|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
48389209|NCT02819635|155619531|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48680796|NCT03792256|156680914|FG000|Overall Study|Lack of Efficacy|0|||
48680797|NCT03792256|156680915|FG001|Overall Study|Lack of Efficacy|1|||
48680798|NCT03792256|156680914|FG000|Overall Study|Withdrawal by Subject|0|||
48680799|NCT03792256|156680915|FG001|Overall Study|Withdrawal by Subject|1|||
48680800|NCT00991939|156680916|FG000|Overall Study|Lost to Follow-up|0|||
48389210|NCT02819635|155619532|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48680801|NCT00991939|156680917|FG001|Overall Study|Lost to Follow-up|1|||
48680802|NCT00991939|156680916|FG000|Overall Study|Withdrawal by Subject|1|||
48680803|NCT00991939|156680917|FG001|Overall Study|Withdrawal by Subject|0|||
48389211|NCT02819635|155619533|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48680804|NCT00991939|156680916|FG000|Overall Study|Entire study terminated|4|||
48680805|NCT00991939|156680917|FG001|Overall Study|Entire study terminated|1|||
48680806|NCT00714415|156680918|FG000|Overall Study|Lack of Efficacy|1|||
48680807|NCT00714415|156680919|FG001|Overall Study|Lack of Efficacy|0|||
48680808|NCT00714415|156680918|FG000|Overall Study|Death|1|||
48680809|NCT00714415|156680919|FG001|Overall Study|Death|0|||
48680810|NCT04303572|156680922|FG000|Overall Study|Study closed due to poor enrollment|1|||
48680811|NCT02073682|156680923|FG000|Overall Study|Low Creatinine Clearance|1|||
48680812|NCT02073682|156680924|FG001|Overall Study|Low Creatinine Clearance|2|||
48680813|NCT02073682|156680923|FG000|Overall Study|Death|86|||
48680814|NCT02073682|156680924|FG001|Overall Study|Death|100|||
48680815|NCT02073682|156680923|FG000|Overall Study|Cancer Cured|10|||
48680816|NCT02073682|156680924|FG001|Overall Study|Cancer Cured|15|||
48680817|NCT02073682|156680923|FG000|Overall Study|ID: Patient Noncompliance|1|||
48680818|NCT02073682|156680924|FG001|Overall Study|ID: Patient Noncompliance|2|||
48680819|NCT02073682|156680923|FG000|Overall Study|ID: Palliative Treatment Only|10|||
48680820|NCT02073682|156680924|FG001|Overall Study|ID: Palliative Treatment Only|7|||
48680821|NCT02073682|156680923|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
48680822|NCT02073682|156680924|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
48680823|NCT02073682|156680923|FG000|Overall Study|Platelet Count <50,000/mL|1|||
48680824|NCT02073682|156680924|FG001|Overall Study|Platelet Count <50,000/mL|2|||
48680825|NCT02073682|156680923|FG000|Overall Study|Surgery/Medical Procedure|3|||
48680826|NCT02073682|156680924|FG001|Overall Study|Surgery/Medical Procedure|1|||
48680827|NCT02073682|156680923|FG000|Overall Study|Withdrawal by Subject|6|||
48680828|NCT02073682|156680924|FG001|Overall Study|Withdrawal by Subject|8|||
48680829|NCT02073682|156680923|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
48680830|NCT02073682|156680924|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
48680831|NCT02073682|156680923|FG000|Overall Study|Cancer Progression|53|||
48680832|NCT02073682|156680924|FG001|Overall Study|Cancer Progression|33|||
48680833|NCT02073682|156680923|FG000|Overall Study|Protocol Violation|1|||
48680834|NCT02073682|156680924|FG001|Overall Study|Protocol Violation|0|||
48680835|NCT02073682|156680923|FG000|Overall Study|Adverse Event|79|||
48680836|NCT02073682|156680924|FG001|Overall Study|Adverse Event|62|||
48680837|NCT02073682|156680923|FG000|Overall Study|No reason provided|11|||
48680838|NCT02073682|156680924|FG001|Overall Study|No reason provided|9|||
48680839|NCT02073682|156680923|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
48680840|NCT02073682|156680924|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
48680841|NCT02073682|156680923|FG000|Overall Study|Lost to Follow-up|1|||
48680842|NCT02073682|156680924|FG001|Overall Study|Lost to Follow-up|1|||
48680843|NCT02073682|156680923|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
48680844|NCT02073682|156680924|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
48680845|NCT04034004|156680925|FG000|Overall Study|Withdrawal by Subject|1|||
48680846|NCT04034004|156680926|FG001|Overall Study|Withdrawal by Subject|2|||
48680847|NCT04034004|156680927|FG002|Overall Study|Withdrawal by Subject|2|||
48680848|NCT04034004|156680928|FG003|Overall Study|Withdrawal by Subject|3|||
48680849|NCT04034004|156680925|FG000|Overall Study|could not find vein to administer IV|2|||
48680850|NCT04034004|156680926|FG001|Overall Study|could not find vein to administer IV|1|||
48680851|NCT04034004|156680927|FG002|Overall Study|could not find vein to administer IV|0|||
48680852|NCT04034004|156680928|FG003|Overall Study|could not find vein to administer IV|0|||
48680853|NCT04034004|156680925|FG000|Overall Study|nurse accidentally unblinded subject|0|||
48680854|NCT04034004|156680926|FG001|Overall Study|nurse accidentally unblinded subject|0|||
48680855|NCT04034004|156680927|FG002|Overall Study|nurse accidentally unblinded subject|0|||
48680856|NCT04034004|156680928|FG003|Overall Study|nurse accidentally unblinded subject|1|||
48680857|NCT03672292|156680929|FG000|Overall Study|Adverse Event|3|||
48680858|NCT03672292|156680930|FG001|Overall Study|Adverse Event|1|||
48389212|NCT02819635|155619534|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48680859|NCT03672292|156680929|FG000|Overall Study|Physician Decision|0|||
48680860|NCT03672292|156680930|FG001|Overall Study|Physician Decision|1|||
48680861|NCT03672292|156680929|FG000|Overall Study|Withdrawal by Subject|1|||
48680862|NCT03672292|156680930|FG001|Overall Study|Withdrawal by Subject|2|||
48680863|NCT04124705|156680932|FG000|Titration Period|Adverse Event|9|||
48680864|NCT04124705|156680933|FG001|Titration Period|Adverse Event|5|||
48680865|NCT04124705|156680932|FG000|Titration Period|Withdrawal by Subject|6|||
48680866|NCT04124705|156680933|FG001|Titration Period|Withdrawal by Subject|3|||
48680867|NCT04124705|156680932|FG000|Titration Period|Lost to Follow-up|0|||
48680868|NCT04124705|156680933|FG001|Titration Period|Lost to Follow-up|1|||
48680869|NCT04124705|156680932|FG000|Titration Period|Death|1|||
48680870|NCT04124705|156680933|FG001|Titration Period|Death|1|||
48680871|NCT04124705|156680932|FG000|Titration Period|Lack of Efficacy|2|||
48680872|NCT04124705|156680933|FG001|Titration Period|Lack of Efficacy|0|||
48680873|NCT04124705|156680932|FG000|Titration Period|Physician Decision|2|||
48680874|NCT04124705|156680933|FG001|Titration Period|Physician Decision|0|||
48680875|NCT04124705|156680932|FG000|Titration Period|Non-compliance with Study Drug|2|||
48680876|NCT04124705|156680933|FG001|Titration Period|Non-compliance with Study Drug|0|||
48680877|NCT04124705|156680932|FG000|Titration Period|Other|4|||
48680878|NCT04124705|156680933|FG001|Titration Period|Other|9|||
48680879|NCT04124705|156680932|FG000|Stabilization Period|Adverse Event|4|||
48680880|NCT04124705|156680933|FG001|Stabilization Period|Adverse Event|2|||
48680881|NCT04124705|156680932|FG000|Stabilization Period|Withdrawal by Subject|1|||
48762840|NCT01324349|156980362|FG000|Overall Study|Withdrawal by Subject|0|||
48762841|NCT01324349|156980363|FG001|Overall Study|Withdrawal by Subject|1|||
48762842|NCT01367158|156980364|FG000|Overall Study|Withdrew consent|0|||
48762843|NCT01367158|156980365|FG001|Overall Study|Withdrew consent|2|||
48762844|NCT01367158|156980366|FG002|Overall Study|Withdrew consent|1|||
48762845|NCT01367158|156980367|FG003|Overall Study|Withdrew consent|0|||
48762846|NCT01367158|156980368|FG004|Overall Study|Withdrew consent|2|||
48762847|NCT01367158|156980369|FG005|Overall Study|Withdrew consent|0|||
48762848|NCT01367158|156980370|FG006|Overall Study|Withdrew consent|0|||
48762849|NCT01367158|156980371|FG007|Overall Study|Withdrew consent|1|||
48762850|NCT01367158|156980372|FG008|Overall Study|Withdrew consent|0|||
48762851|NCT01367158|156980373|FG009|Overall Study|Withdrew consent|0|||
48762852|NCT01367158|156980374|FG010|Overall Study|Withdrew consent|0|||
48762853|NCT01367158|156980364|FG000|Overall Study|Lost to Follow-up|0|||
48680882|NCT04124705|156680933|FG001|Stabilization Period|Withdrawal by Subject|1|||
48680883|NCT04124705|156680932|FG000|Stabilization Period|Lost to Follow-up|0|||
48680884|NCT04124705|156680933|FG001|Stabilization Period|Lost to Follow-up|1|||
48680885|NCT04124705|156680932|FG000|Stabilization Period|Lack of Efficacy|4|||
48680886|NCT04124705|156680933|FG001|Stabilization Period|Lack of Efficacy|2|||
48680887|NCT04124705|156680932|FG000|Stabilization Period|Protocol Deviation|0|||
48680888|NCT04124705|156680933|FG001|Stabilization Period|Protocol Deviation|2|||
48762854|NCT01367158|156980365|FG001|Overall Study|Lost to Follow-up|0|||
48762855|NCT01367158|156980366|FG002|Overall Study|Lost to Follow-up|0|||
48762856|NCT01367158|156980367|FG003|Overall Study|Lost to Follow-up|1|||
48680889|NCT04124705|156680932|FG000|Stabilization Period|Other|2|||
48680890|NCT04124705|156680933|FG001|Stabilization Period|Other|2|||
48680891|NCT05236257|156680947|FG000|Overall Study|Ongoing with study treatment|29|||
48680892|NCT05236257|156680948|FG001|Overall Study|Ongoing with study treatment|1|||
48680893|NCT05236257|156680947|FG000|Overall Study|Discontinued study treatment|22|||
48680894|NCT05236257|156680948|FG001|Overall Study|Discontinued study treatment|41|||
48680895|NCT01611194|156680949|FG000|Overall Study|Lost to Follow-up|0|||
48680896|NCT01611194|156680950|FG001|Overall Study|Lost to Follow-up|1|||
48680897|NCT01611194|156680949|FG000|Overall Study|Withdrawal by Subject|0|||
48680898|NCT01611194|156680950|FG001|Overall Study|Withdrawal by Subject|1|||
48680899|NCT01611194|156680949|FG000|Overall Study|drug use|0|||
48680900|NCT01611194|156680950|FG001|Overall Study|drug use|1|||
48680901|NCT00874848|156680954|FG000|Overall Study|Adverse Event|13|||
48762857|NCT01367158|156980368|FG004|Overall Study|Lost to Follow-up|0|||
48680902|NCT00874848|156680955|FG001|Overall Study|Adverse Event|2|||
48680903|NCT00874848|156680954|FG000|Overall Study|Progressive neoplastic disease|38|||
48680904|NCT00874848|156680955|FG001|Overall Study|Progressive neoplastic disease|18|||
48680905|NCT00874848|156680954|FG000|Overall Study|Withdrawal by Subject|7|||
48680906|NCT00874848|156680955|FG001|Overall Study|Withdrawal by Subject|4|||
48680907|NCT00874848|156680954|FG000|Overall Study|Noncompliance|1|||
48680908|NCT00874848|156680955|FG001|Overall Study|Noncompliance|1|||
48680909|NCT00874848|156680954|FG000|Overall Study|Failure to comply with protocol|0|||
48680910|NCT00874848|156680955|FG001|Overall Study|Failure to comply with protocol|1|||
48680911|NCT00874848|156680954|FG000|Overall Study|Physician Decision|0|||
48680912|NCT00874848|156680955|FG001|Overall Study|Physician Decision|2|||
48762858|NCT01367158|156980369|FG005|Overall Study|Lost to Follow-up|2|||
48762859|NCT01367158|156980370|FG006|Overall Study|Lost to Follow-up|0|||
48680913|NCT02978833|156680968|FG000|Overall Study|Study terminated|1|||
48680914|NCT02978833|156680969|FG001|Overall Study|Study terminated|1|||
48680915|NCT01712204|156680972|FG000|Overall Study|Adverse Event|3|||
48680916|NCT01712204|156680973|FG001|Overall Study|Adverse Event|1|||
48680917|NCT01712204|156680972|FG000|Overall Study|Withdrawal by Subject|3|||
48680918|NCT01712204|156680973|FG001|Overall Study|Withdrawal by Subject|3|||
48680919|NCT01712204|156680972|FG000|Overall Study|Lost to Follow-up|1|||
48680920|NCT01712204|156680973|FG001|Overall Study|Lost to Follow-up|0|||
48680921|NCT01712204|156680972|FG000|Overall Study|Protocol Violation|1|||
48680922|NCT01712204|156680973|FG001|Overall Study|Protocol Violation|1|||
48680923|NCT02360228|156680974|FG000|Overall Study|Withdrawal by Subject|1|||
48680924|NCT02360228|156680975|FG001|Overall Study|Withdrawal by Subject|0|||
48680925|NCT02360228|156680976|FG002|Overall Study|Withdrawal by Subject|0|||
48680926|NCT02360228|156680974|FG000|Overall Study|Self-discontinued medication|0|||
48680927|NCT02360228|156680975|FG001|Overall Study|Self-discontinued medication|1|||
48680928|NCT02360228|156680976|FG002|Overall Study|Self-discontinued medication|0|||
48389213|NCT02819635|155619535|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48389214|NCT02819635|155619536|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48389215|NCT02819635|155619537|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
48389216|NCT02819635|155619538|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48389217|NCT02819635|155619539|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48389218|NCT02819635|155619540|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48389219|NCT02819635|155619541|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48389220|NCT02819635|155619542|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
48389221|NCT02819635|155619531|FG000|Substudy 2, Part 2|Other, not specified|0|||
48389222|NCT02819635|155619532|FG001|Substudy 2, Part 2|Other, not specified|0|||
48389223|NCT02819635|155619533|FG002|Substudy 2, Part 2|Other, not specified|0|||
48389224|NCT02819635|155619534|FG003|Substudy 2, Part 2|Other, not specified|0|||
48389225|NCT02819635|155619535|FG004|Substudy 2, Part 2|Other, not specified|0|||
48389226|NCT02819635|155619536|FG005|Substudy 2, Part 2|Other, not specified|4|||
48680929|NCT02360228|156680974|FG000|Overall Study|Unstable symptoms during screening|0|||
48680930|NCT02360228|156680975|FG001|Overall Study|Unstable symptoms during screening|0|||
48680931|NCT02360228|156680976|FG002|Overall Study|Unstable symptoms during screening|1|||
48680932|NCT05513053|156680977|FG000|Overall Study|Lost to Follow-up|9|||
48680933|NCT05513053|156680978|FG001|Overall Study|Lost to Follow-up|11|||
48680934|NCT05513053|156680977|FG000|Overall Study|Withdrawal by parent/guardian|2|||
48680935|NCT05513053|156680978|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48680936|NCT05513053|156680977|FG000|Overall Study|Withdrawal by Subject|2|||
48680937|NCT05513053|156680978|FG001|Overall Study|Withdrawal by Subject|9|||
48680938|NCT05513053|156680977|FG000|Overall Study|Protocol Violation|6|||
48680939|NCT05513053|156680978|FG001|Overall Study|Protocol Violation|3|||
48680940|NCT05513053|156680977|FG000|Overall Study|Adverse Event|0|||
48680941|NCT05513053|156680978|FG001|Overall Study|Adverse Event|2|||
48680942|NCT01463306|156680979|FG000|Overall Study|Adverse Event|6|||
48680943|NCT01463306|156680980|FG001|Overall Study|Adverse Event|9|||
48680944|NCT01463306|156680981|FG002|Overall Study|Adverse Event|3|||
48680945|NCT01463306|156680979|FG000|Overall Study|Death|3|||
48680946|NCT01463306|156680980|FG001|Overall Study|Death|3|||
48680947|NCT01463306|156680981|FG002|Overall Study|Death|0|||
48680948|NCT01463306|156680979|FG000|Overall Study|Lack of Efficacy|22|||
48680949|NCT01463306|156680980|FG001|Overall Study|Lack of Efficacy|16|||
48680950|NCT01463306|156680981|FG002|Overall Study|Lack of Efficacy|1|||
48680951|NCT01463306|156680979|FG000|Overall Study|Lost to Follow-up|5|||
48680952|NCT01463306|156680980|FG001|Overall Study|Lost to Follow-up|2|||
48680953|NCT01463306|156680981|FG002|Overall Study|Lost to Follow-up|0|||
48680954|NCT01463306|156680979|FG000|Overall Study|Protocol Violation|4|||
48680955|NCT01463306|156680980|FG001|Overall Study|Protocol Violation|0|||
48680956|NCT01463306|156680981|FG002|Overall Study|Protocol Violation|0|||
48680957|NCT01463306|156680979|FG000|Overall Study|Withdrawal by Subject|19|||
48680958|NCT01463306|156680980|FG001|Overall Study|Withdrawal by Subject|9|||
48680959|NCT01463306|156680981|FG002|Overall Study|Withdrawal by Subject|1|||
48680960|NCT01463306|156680979|FG000|Overall Study|Other|26|||
48680961|NCT01463306|156680980|FG001|Overall Study|Other|13|||
48680962|NCT01463306|156680981|FG002|Overall Study|Other|0|||
48680963|NCT01463306|156680979|FG000|Overall Study|Approval expiry at site|1|||
48680964|NCT01463306|156680980|FG001|Overall Study|Approval expiry at site|0|||
48680965|NCT01463306|156680981|FG002|Overall Study|Approval expiry at site|0|||
48680966|NCT00850538|156680985|FG000|Overall Study|unable/unwilling to complete MRI|13|||
48680967|NCT00850538|156680985|FG000|Overall Study|specimen missed due to scheduling error|14|||
48389227|NCT02819635|155619537|FG006|Substudy 2, Part 2|Other, not specified|8|||
48680968|NCT00850538|156680985|FG000|Overall Study|specimen unusable|7|||
48680969|NCT00850538|156680985|FG000|Overall Study|Withdrawal by Subject|3|||
48680970|NCT00850538|156680985|FG000|Overall Study|radiology error|2|||
48680971|NCT00850538|156680985|FG000|Overall Study|Protocol Violation|2|||
48680972|NCT02464410|156680986|FG000|Overall Study|Death|3|||
48680973|NCT02464410|156680987|FG001|Overall Study|Death|4|||
48680974|NCT02464410|156680986|FG000|Overall Study|Lost to Follow-up|7|||
48680975|NCT02464410|156680987|FG001|Overall Study|Lost to Follow-up|9|||
48680976|NCT02464410|156680986|FG000|Overall Study|Withdrawal by Subject|12|||
48680977|NCT02464410|156680987|FG001|Overall Study|Withdrawal by Subject|3|||
48680978|NCT00950248|156680988|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
48680979|NCT00950248|156680989|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
48680980|NCT00950248|156680990|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
48680981|NCT00950248|156680988|FG000|Year 1: Baseline|worsening of symptoms|2|||
48680982|NCT00950248|156680989|FG001|Year 1: Baseline|worsening of symptoms|0|||
48680983|NCT00950248|156680990|FG002|Year 1: Baseline|worsening of symptoms|0|||
48680984|NCT00950248|156680988|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
48680985|NCT00950248|156680989|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
48680986|NCT00950248|156680990|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
48680987|NCT00950248|156680988|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
48680988|NCT00950248|156680989|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
48680989|NCT00950248|156680990|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
48680990|NCT00950248|156680988|FG000|Year 2&3 Treatment Randomization|Death|0|||
48680991|NCT00950248|156680989|FG001|Year 2&3 Treatment Randomization|Death|0|||
48680992|NCT00950248|156680990|FG002|Year 2&3 Treatment Randomization|Death|1|||
48680993|NCT00950248|156680988|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
48680994|NCT00950248|156680989|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
48680995|NCT00950248|156680990|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
48680996|NCT00320515|156680991|FG000|Overall Study|Death|33|||
48680997|NCT00320515|156680991|FG000|Overall Study|Lost to Follow-up|6|||
48680998|NCT00320515|156680991|FG000|Overall Study|Physician Decision|2|||
48680999|NCT00320515|156680991|FG000|Overall Study|Withdrawal by Subject|8|||
48681000|NCT02485704|156680992|FG000|Overall Study|Lost to Follow-up|4|||
48681001|NCT02485704|156680993|FG001|Overall Study|Lost to Follow-up|5|||
48681002|NCT02485704|156680992|FG000|Overall Study|Withdrawal by Subject|0|||
48681003|NCT02485704|156680993|FG001|Overall Study|Withdrawal by Subject|3|||
48681004|NCT02485704|156680992|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
48681005|NCT02485704|156680993|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
48681006|NCT01900652|156680994|FG000|Overall Study|Progressive Disease|1|||
48681007|NCT01900652|156680995|FG001|Overall Study|Progressive Disease|0|||
48681008|NCT01900652|156680994|FG000|Overall Study|Consent withdrawn by subject|1|||
48681009|NCT01900652|156680995|FG001|Overall Study|Consent withdrawn by subject|1|||
48681010|NCT01900652|156680994|FG000|Overall Study|Death|3|||
48681011|NCT01900652|156680995|FG001|Overall Study|Death|0|||
48681012|NCT01900652|156680994|FG000|Overall Study|Adverse Event|2|||
48681013|NCT01900652|156680995|FG001|Overall Study|Adverse Event|1|||
48681014|NCT01900652|156680994|FG000|Overall Study|Physician Decision|1|||
48681015|NCT01900652|156680995|FG001|Overall Study|Physician Decision|1|||
48681016|NCT03932760|156680996|FG000|Overall Study|Became Ineligible|2|||
48681017|NCT03932760|156680997|FG001|Overall Study|Became Ineligible|5|||
48681018|NCT03932760|156680996|FG000|Overall Study|Withdrawal by Subject|6|||
48681019|NCT03932760|156680997|FG001|Overall Study|Withdrawal by Subject|6|||
48681020|NCT01574651|156680998|FG000|Overall Study|Lost to Follow-up|2|||
48681021|NCT01574651|156680999|FG001|Overall Study|Lost to Follow-up|4|||
48681022|NCT01574651|156680998|FG000|Overall Study|Administrative problems|0|||
48681023|NCT01574651|156680999|FG001|Overall Study|Administrative problems|1|||
48681024|NCT01574651|156680998|FG000|Overall Study|Death|3|||
48681025|NCT01574651|156680999|FG001|Overall Study|Death|3|||
48681026|NCT01574651|156680998|FG000|Overall Study|Patient's inability to use the device|0|||
48681027|NCT01574651|156680999|FG001|Overall Study|Patient's inability to use the device|1|||
48681028|NCT01574651|156680998|FG000|Overall Study|Adverse Event|36|||
48681029|NCT01574651|156680999|FG001|Overall Study|Adverse Event|27|||
48681030|NCT01574651|156680998|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48681031|NCT01574651|156680999|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48681032|NCT01574651|156680998|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48681033|NCT01574651|156680999|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48681034|NCT01574651|156680998|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
48681035|NCT01574651|156680999|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48681036|NCT01574651|156680998|FG000|Overall Study|Protocol Violation|3|||
48681037|NCT01574651|156680999|FG001|Overall Study|Protocol Violation|5|||
48681038|NCT01574651|156680998|FG000|Overall Study|Withdrawal by Subject|9|||
48681039|NCT01574651|156680999|FG001|Overall Study|Withdrawal by Subject|10|||
48681040|NCT03922620|156681000|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
48681041|NCT03922620|156681001|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
48429383|NCT01070550|155760360|FG005|Overall Study|Protocol Violation|0|||
48681042|NCT04177212|156681002|FG000|Overall Study|Withdrawal by Subject|9|||
48681043|NCT04177212|156681003|FG001|Overall Study|Withdrawal by Subject|7|||
48681044|NCT04177212|156681002|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
48762860|NCT01367158|156980371|FG007|Overall Study|Lost to Follow-up|1|||
48762861|NCT01367158|156980372|FG008|Overall Study|Lost to Follow-up|0|||
48389228|NCT02819635|155619538|FG007|Substudy 2, Part 2|Other, not specified|0|||
48389229|NCT02819635|155619539|FG008|Substudy 2, Part 2|Other, not specified|0|||
48389230|NCT02819635|155619540|FG009|Substudy 2, Part 2|Other, not specified|0|||
48389231|NCT02819635|155619541|FG010|Substudy 2, Part 2|Other, not specified|0|||
48681045|NCT04177212|156681003|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
48681046|NCT04177212|156681002|FG000|Overall Study|Physician Decision|1|||
48389232|NCT02819635|155619542|FG011|Substudy 2, Part 2|Other, not specified|0|||
48389233|NCT02819635|155619531|FG000|Substudy 3|Adverse Event|0|||
48389234|NCT02819635|155619532|FG001|Substudy 3|Adverse Event|0|||
48389235|NCT02819635|155619533|FG002|Substudy 3|Adverse Event|0|||
48389236|NCT02819635|155619534|FG003|Substudy 3|Adverse Event|0|||
48389237|NCT02819635|155619535|FG004|Substudy 3|Adverse Event|0|||
48389238|NCT02819635|155619536|FG005|Substudy 3|Adverse Event|0|||
48681047|NCT04177212|156681003|FG001|Overall Study|Physician Decision|0|||
48681048|NCT04177212|156681002|FG000|Overall Study|Lost to Follow-up|0|||
48681049|NCT04177212|156681003|FG001|Overall Study|Lost to Follow-up|3|||
48681050|NCT04177212|156681002|FG000|Overall Study|Adverse Event|0|||
48681051|NCT04177212|156681003|FG001|Overall Study|Adverse Event|1|||
48681052|NCT04177212|156681002|FG000|Overall Study|Other|1|||
48681053|NCT04177212|156681003|FG001|Overall Study|Other|2|||
48681054|NCT01487265|156682545|FG000|Overall Study|Adverse Event|8|||
48681055|NCT01487265|156682545|FG000|Overall Study|Withdrawal by Subject|5|||
48681056|NCT01487265|156682545|FG000|Overall Study|Disease Progression|21|||
48681057|NCT01487265|156682545|FG000|Overall Study|Death|2|||
48681058|NCT01487265|156682545|FG000|Overall Study|Still on Treatment|1|||
48681059|NCT00965575|156682546|FG000|Overall Study|subject unwillingness to swallow study c|1|||
48681060|NCT00965575|156682547|FG001|Overall Study|subject unwillingness to swallow study c|0|||
48681061|NCT02629822|156682548|FG000|Base Study|Lost to Follow-up|2|||
48681062|NCT02629822|156682548|FG000|Base Study|Non-Compliance With Study Drug|1|||
48681063|NCT02629822|156682548|FG000|Extension Study|Adverse Event|1|||
48681064|NCT02629822|156682548|FG000|Extension Study|Lost to Follow-up|1|||
48762862|NCT01367158|156980373|FG009|Overall Study|Lost to Follow-up|0|||
48389239|NCT02819635|155619537|FG006|Substudy 3|Adverse Event|0|||
48389240|NCT02819635|155619538|FG007|Substudy 3|Adverse Event|0|||
48389241|NCT02819635|155619539|FG008|Substudy 3|Adverse Event|32|||
48389242|NCT02819635|155619540|FG009|Substudy 3|Adverse Event|3|||
48389243|NCT02819635|155619541|FG010|Substudy 3|Adverse Event|12|||
48389244|NCT02819635|155619542|FG011|Substudy 3|Adverse Event|18|||
48389245|NCT02819635|155619531|FG000|Substudy 3|Withdrew consent|0|||
48389246|NCT02819635|155619532|FG001|Substudy 3|Withdrew consent|0|||
48389247|NCT02819635|155619533|FG002|Substudy 3|Withdrew consent|0|||
48389248|NCT02819635|155619534|FG003|Substudy 3|Withdrew consent|0|||
48389249|NCT02819635|155619535|FG004|Substudy 3|Withdrew consent|0|||
48389250|NCT02819635|155619536|FG005|Substudy 3|Withdrew consent|0|||
48389251|NCT02819635|155619537|FG006|Substudy 3|Withdrew consent|0|||
48389252|NCT02819635|155619538|FG007|Substudy 3|Withdrew consent|0|||
48389253|NCT02819635|155619539|FG008|Substudy 3|Withdrew consent|11|||
48389254|NCT02819635|155619540|FG009|Substudy 3|Withdrew consent|1|||
48389255|NCT02819635|155619541|FG010|Substudy 3|Withdrew consent|4|||
48389256|NCT02819635|155619542|FG011|Substudy 3|Withdrew consent|9|||
48389257|NCT02819635|155619531|FG000|Substudy 3|Lost to Follow-up|0|||
48389258|NCT02819635|155619532|FG001|Substudy 3|Lost to Follow-up|0|||
48389259|NCT02819635|155619533|FG002|Substudy 3|Lost to Follow-up|0|||
48389260|NCT02819635|155619534|FG003|Substudy 3|Lost to Follow-up|0|||
48389261|NCT02819635|155619535|FG004|Substudy 3|Lost to Follow-up|0|||
48389262|NCT02819635|155619536|FG005|Substudy 3|Lost to Follow-up|0|||
48389263|NCT02819635|155619537|FG006|Substudy 3|Lost to Follow-up|0|||
48389264|NCT02819635|155619538|FG007|Substudy 3|Lost to Follow-up|0|||
48389265|NCT02819635|155619539|FG008|Substudy 3|Lost to Follow-up|1|||
48389266|NCT02819635|155619540|FG009|Substudy 3|Lost to Follow-up|0|||
48389267|NCT02819635|155619541|FG010|Substudy 3|Lost to Follow-up|1|||
48681065|NCT01610336|156682549|FG000|Overall Study|Progressive Disease|4|||
48762863|NCT01367158|156980374|FG010|Overall Study|Lost to Follow-up|1|||
48681066|NCT01610336|156682550|FG001|Overall Study|Progressive Disease|6|||
48389268|NCT02819635|155619542|FG011|Substudy 3|Lost to Follow-up|1|||
48389269|NCT02819635|155619531|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389270|NCT02819635|155619532|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
48681067|NCT01610336|156682551|FG002|Overall Study|Progressive Disease|6|||
48681068|NCT01610336|156682552|FG003|Overall Study|Progressive Disease|5|||
48681069|NCT01610336|156682553|FG004|Overall Study|Progressive Disease|3|||
48681070|NCT01610336|156682554|FG005|Overall Study|Progressive Disease|10|||
48389271|NCT02819635|155619533|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389272|NCT02819635|155619534|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389273|NCT02819635|155619535|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389274|NCT02819635|155619536|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389275|NCT02819635|155619537|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389276|NCT02819635|155619538|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
48762864|NCT01367158|156980364|FG000|Overall Study|Protocol Violation|0|||
48681071|NCT01610336|156682555|FG006|Overall Study|Progressive Disease|1|||
48681072|NCT01610336|156682556|FG007|Overall Study|Progressive Disease|6|||
48681073|NCT01610336|156682557|FG008|Overall Study|Progressive Disease|6|||
48681074|NCT01610336|156682558|FG009|Overall Study|Progressive Disease|40|||
48681075|NCT01610336|156682559|FG010|Overall Study|Progressive Disease|36|||
48681076|NCT01610336|156682549|FG000|Overall Study|Adverse Event|0|||
48681077|NCT01610336|156682550|FG001|Overall Study|Adverse Event|0|||
48681078|NCT01610336|156682551|FG002|Overall Study|Adverse Event|0|||
48681079|NCT01610336|156682552|FG003|Overall Study|Adverse Event|1|||
48681080|NCT01610336|156682553|FG004|Overall Study|Adverse Event|1|||
48681081|NCT01610336|156682554|FG005|Overall Study|Adverse Event|1|||
48681082|NCT01610336|156682555|FG006|Overall Study|Adverse Event|0|||
48681083|NCT01610336|156682556|FG007|Overall Study|Adverse Event|0|||
48681084|NCT01610336|156682557|FG008|Overall Study|Adverse Event|2|||
48681085|NCT01610336|156682558|FG009|Overall Study|Adverse Event|8|||
48681086|NCT01610336|156682559|FG010|Overall Study|Adverse Event|6|||
48389277|NCT02819635|155619539|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389278|NCT02819635|155619540|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389279|NCT02819635|155619541|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
48389280|NCT02819635|155619542|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
48389281|NCT02819635|155619531|FG000|Substudy 3|Other, not specified|0|||
48389282|NCT02819635|155619532|FG001|Substudy 3|Other, not specified|0|||
48389283|NCT02819635|155619533|FG002|Substudy 3|Other, not specified|0|||
48389284|NCT02819635|155619534|FG003|Substudy 3|Other, not specified|0|||
48389285|NCT02819635|155619535|FG004|Substudy 3|Other, not specified|0|||
48389286|NCT02819635|155619536|FG005|Substudy 3|Other, not specified|0|||
48389287|NCT02819635|155619537|FG006|Substudy 3|Other, not specified|0|||
48389288|NCT02819635|155619538|FG007|Substudy 3|Other, not specified|0|||
48681087|NCT01610336|156682549|FG000|Overall Study|Subject/Guardian decision|1|||
48681088|NCT01610336|156682550|FG001|Overall Study|Subject/Guardian decision|1|||
48681089|NCT01610336|156682551|FG002|Overall Study|Subject/Guardian decision|0|||
48681090|NCT01610336|156682552|FG003|Overall Study|Subject/Guardian decision|1|||
48681091|NCT01610336|156682553|FG004|Overall Study|Subject/Guardian decision|0|||
48681092|NCT01610336|156682554|FG005|Overall Study|Subject/Guardian decision|0|||
48681093|NCT01610336|156682555|FG006|Overall Study|Subject/Guardian decision|0|||
48681094|NCT01610336|156682556|FG007|Overall Study|Subject/Guardian decision|1|||
48681095|NCT01610336|156682557|FG008|Overall Study|Subject/Guardian decision|0|||
48681096|NCT01610336|156682558|FG009|Overall Study|Subject/Guardian decision|2|||
48681097|NCT01610336|156682559|FG010|Overall Study|Subject/Guardian decision|2|||
48681098|NCT01610336|156682549|FG000|Overall Study|Death|0|||
48681099|NCT01610336|156682550|FG001|Overall Study|Death|0|||
48681100|NCT01610336|156682551|FG002|Overall Study|Death|0|||
48389289|NCT02819635|155619539|FG008|Substudy 3|Other, not specified|202|||
48389290|NCT02819635|155619540|FG009|Substudy 3|Other, not specified|5|||
48389291|NCT02819635|155619541|FG010|Substudy 3|Other, not specified|89|||
48389292|NCT02819635|155619542|FG011|Substudy 3|Other, not specified|39|||
48389293|NCT03861936|155619545|FG000|Overall Study|Withdrawal by Subject|4|||
48389294|NCT03861936|155619546|FG001|Overall Study|Withdrawal by Subject|1|||
48389295|NCT03861936|155619547|FG002|Overall Study|Withdrawal by Subject|3|||
48389296|NCT03861936|155619545|FG000|Overall Study|Lost to Follow-up|5|||
48389297|NCT03861936|155619546|FG001|Overall Study|Lost to Follow-up|3|||
48389298|NCT03861936|155619547|FG002|Overall Study|Lost to Follow-up|3|||
48389299|NCT03861936|155619545|FG000|Overall Study|Physician Decision|0|||
48681101|NCT01610336|156682552|FG003|Overall Study|Death|0|||
48681102|NCT01610336|156682553|FG004|Overall Study|Death|0|||
48681103|NCT01610336|156682554|FG005|Overall Study|Death|1|||
48681104|NCT01610336|156682555|FG006|Overall Study|Death|3|||
48681105|NCT01610336|156682556|FG007|Overall Study|Death|0|||
48389300|NCT03861936|155619546|FG001|Overall Study|Physician Decision|1|||
48389301|NCT03861936|155619547|FG002|Overall Study|Physician Decision|0|||
48389302|NCT03861936|155619545|FG000|Overall Study|Protocol Deviation|0|||
48681106|NCT01610336|156682557|FG008|Overall Study|Death|0|||
48389303|NCT03861936|155619546|FG001|Overall Study|Protocol Deviation|0|||
48389304|NCT03861936|155619547|FG002|Overall Study|Protocol Deviation|1|||
48681107|NCT01610336|156682558|FG009|Overall Study|Death|1|||
48681108|NCT01610336|156682559|FG010|Overall Study|Death|2|||
48681109|NCT01610336|156682549|FG000|Overall Study|Non-Compliance with study treatment|0|||
48681110|NCT01610336|156682550|FG001|Overall Study|Non-Compliance with study treatment|0|||
48681111|NCT01610336|156682551|FG002|Overall Study|Non-Compliance with study treatment|0|||
48389305|NCT03861936|155619545|FG000|Overall Study|Reason not Specified|5|||
48681112|NCT01610336|156682552|FG003|Overall Study|Non-Compliance with study treatment|0|||
48681113|NCT01610336|156682553|FG004|Overall Study|Non-Compliance with study treatment|0|||
48681114|NCT01610336|156682554|FG005|Overall Study|Non-Compliance with study treatment|0|||
48389306|NCT03861936|155619546|FG001|Overall Study|Reason not Specified|5|||
48389307|NCT03861936|155619547|FG002|Overall Study|Reason not Specified|3|||
48681115|NCT01610336|156682555|FG006|Overall Study|Non-Compliance with study treatment|0|||
48681116|NCT01610336|156682556|FG007|Overall Study|Non-Compliance with study treatment|0|||
48681117|NCT01610336|156682557|FG008|Overall Study|Non-Compliance with study treatment|0|||
48681118|NCT01610336|156682558|FG009|Overall Study|Non-Compliance with study treatment|1|||
48389308|NCT01265615|155619563|FG000|Overall Study|Protocol Violation|2|||
48389309|NCT01265615|155619564|FG001|Overall Study|Protocol Violation|2|||
48389310|NCT01265615|155619565|FG002|Overall Study|Protocol Violation|4|||
48389311|NCT01265615|155619566|FG003|Overall Study|Protocol Violation|3|||
48389312|NCT01186796|155619567|FG000|Overall Study|Adverse Event|3|||
48389313|NCT01186796|155619568|FG001|Overall Study|Adverse Event|0|||
48389314|NCT01186796|155619567|FG000|Overall Study|Withdrawal by Subject|1|||
48389315|NCT01186796|155619568|FG001|Overall Study|Withdrawal by Subject|1|||
48389316|NCT01186796|155619567|FG000|Overall Study|Protocol Violation|0|||
48389317|NCT01186796|155619568|FG001|Overall Study|Protocol Violation|1|||
48389318|NCT02613884|155619569|FG000|Overall Study|Death|1|||
48389319|NCT02613884|155619569|FG000|Overall Study|Lost to Follow-up|1|||
48389320|NCT02700412|155619570|FG000|Overall Study|Adverse Event|6|||
48389321|NCT02700412|155619570|FG000|Overall Study|Death|1|||
48389322|NCT02700412|155619570|FG000|Overall Study|Lack of Efficacy|19|||
48389323|NCT02700412|155619570|FG000|Overall Study|Protocol Violation|5|||
48389324|NCT02700412|155619570|FG000|Overall Study|Withdrawal by Subject|2|||
48389325|NCT02486653|155619571|FG000|Overall Study|Withdrawal by Subject|1|||
48389326|NCT02486653|155619572|FG001|Overall Study|Withdrawal by Subject|3|||
48389327|NCT02486653|155619571|FG000|Overall Study|Protocol Violation|1|||
48389328|NCT02486653|155619572|FG001|Overall Study|Protocol Violation|0|||
48389329|NCT02486653|155619571|FG000|Overall Study|surgery cancelled|4|||
48389330|NCT02486653|155619572|FG001|Overall Study|surgery cancelled|1|||
48389331|NCT04305275|155619573|FG000|Overall Study|Adverse Event|4|||
48389332|NCT04305275|155619574|FG001|Overall Study|Adverse Event|0|||
48389333|NCT04305275|155619573|FG000|Overall Study|Lost to Follow-up|1|||
48681119|NCT01610336|156682559|FG010|Overall Study|Non-Compliance with study treatment|0|||
48681120|NCT01610336|156682549|FG000|Overall Study|Physician Decision|0|||
48681121|NCT01610336|156682550|FG001|Overall Study|Physician Decision|0|||
48681122|NCT01610336|156682551|FG002|Overall Study|Physician Decision|0|||
48681123|NCT01610336|156682552|FG003|Overall Study|Physician Decision|0|||
48681124|NCT01610336|156682553|FG004|Overall Study|Physician Decision|0|||
48681125|NCT01610336|156682554|FG005|Overall Study|Physician Decision|0|||
48681126|NCT01610336|156682555|FG006|Overall Study|Physician Decision|1|||
48681127|NCT01610336|156682556|FG007|Overall Study|Physician Decision|0|||
48681128|NCT01610336|156682557|FG008|Overall Study|Physician Decision|0|||
48681129|NCT01610336|156682558|FG009|Overall Study|Physician Decision|0|||
48681130|NCT01610336|156682559|FG010|Overall Study|Physician Decision|0|||
48681131|NCT01610336|156682549|FG000|Overall Study|Protocol Deviation|0|||
48681132|NCT01610336|156682550|FG001|Overall Study|Protocol Deviation|0|||
48681133|NCT01610336|156682551|FG002|Overall Study|Protocol Deviation|0|||
48681134|NCT01610336|156682552|FG003|Overall Study|Protocol Deviation|0|||
48681135|NCT01610336|156682553|FG004|Overall Study|Protocol Deviation|0|||
48681136|NCT01610336|156682554|FG005|Overall Study|Protocol Deviation|0|||
48681137|NCT01610336|156682555|FG006|Overall Study|Protocol Deviation|0|||
48681138|NCT01610336|156682556|FG007|Overall Study|Protocol Deviation|0|||
48681139|NCT01610336|156682557|FG008|Overall Study|Protocol Deviation|0|||
48681140|NCT01610336|156682558|FG009|Overall Study|Protocol Deviation|1|||
48681141|NCT01610336|156682559|FG010|Overall Study|Protocol Deviation|0|||
48389334|NCT04305275|155619574|FG001|Overall Study|Lost to Follow-up|1|||
48389335|NCT04305275|155619573|FG000|Overall Study|Withdrawal by Participant|8|||
48389336|NCT04305275|155619574|FG001|Overall Study|Withdrawal by Participant|1|||
48389337|NCT01553188|155619578|FG000|Overall Study|Patient choice|1|||
48389338|NCT01553188|155619579|FG001|Overall Study|Patient choice|0|||
48389339|NCT01553188|155619580|FG002|Overall Study|Patient choice|0|||
48389340|NCT01553188|155619581|FG003|Overall Study|Patient choice|0|||
48389341|NCT01553188|155619578|FG000|Overall Study|Intercurrent illness and adverse event|0|||
48389342|NCT01553188|155619579|FG001|Overall Study|Intercurrent illness and adverse event|1|||
48681142|NCT01610336|156682549|FG000|Overall Study|Transfer to another trial|0|||
48681143|NCT01610336|156682550|FG001|Overall Study|Transfer to another trial|0|||
48681144|NCT01610336|156682551|FG002|Overall Study|Transfer to another trial|0|||
48681145|NCT01610336|156682552|FG003|Overall Study|Transfer to another trial|0|||
48681146|NCT01610336|156682553|FG004|Overall Study|Transfer to another trial|0|||
48389343|NCT01553188|155619580|FG002|Overall Study|Intercurrent illness and adverse event|2|||
48389344|NCT01553188|155619581|FG003|Overall Study|Intercurrent illness and adverse event|0|||
48389345|NCT05376215|155619582|FG000|Overall Study|Withdrawal by Subject|2|||
48389346|NCT05376215|155619583|FG001|Overall Study|Withdrawal by Subject|1|||
48389347|NCT05376215|155619582|FG000|Overall Study|Lost to Follow-up|0|||
48389348|NCT05376215|155619583|FG001|Overall Study|Lost to Follow-up|1|||
48681147|NCT01610336|156682554|FG005|Overall Study|Transfer to another trial|0|||
48681148|NCT01610336|156682555|FG006|Overall Study|Transfer to another trial|0|||
48681149|NCT01610336|156682556|FG007|Overall Study|Transfer to another trial|0|||
48681150|NCT01610336|156682557|FG008|Overall Study|Transfer to another trial|0|||
48389349|NCT00942175|155619584|FG000|Overall Study|Adverse Event|2|||
48681151|NCT01610336|156682558|FG009|Overall Study|Transfer to another trial|0|||
48389350|NCT00942175|155619585|FG001|Overall Study|Adverse Event|1|||
48681152|NCT01610336|156682559|FG010|Overall Study|Transfer to another trial|1|||
48681153|NCT04440813|156682560|FG000|Overall Study|Lost to Follow-up|5|||
48681154|NCT04440813|156682561|FG001|Overall Study|Lost to Follow-up|5|||
48389351|NCT00942175|155619586|FG002|Overall Study|Adverse Event|0|||
48389352|NCT00942175|155619587|FG003|Overall Study|Adverse Event|0|||
48389353|NCT00942175|155619584|FG000|Overall Study|Protocol Violation|0|||
48681155|NCT01128244|156682565|FG000|Overall Study|Adverse Event|1|||
48681156|NCT01128244|156682565|FG000|Overall Study|Scheduling conflict|2|||
48681157|NCT03464019|156682566|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
48681158|NCT03464019|156682567|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
48681159|NCT03464019|156682568|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
48681160|NCT03464019|156682566|FG000|NODE-301 Part 1|Ablation|0|||
48681161|NCT03464019|156682567|FG001|NODE-301 Part 1|Ablation|0|||
48681162|NCT03464019|156682568|FG002|NODE-301 Part 1|Ablation|16|||
48681163|NCT03464019|156682566|FG000|NODE-301 Part 1|Test Dose Failure|0|||
48681164|NCT03464019|156682567|FG001|NODE-301 Part 1|Test Dose Failure|0|||
48681165|NCT03464019|156682568|FG002|NODE-301 Part 1|Test Dose Failure|8|||
48681166|NCT03464019|156682566|FG000|NODE-301 Part 1|Adverse Event|0|||
48681167|NCT03464019|156682567|FG001|NODE-301 Part 1|Adverse Event|0|||
48681168|NCT03464019|156682568|FG002|NODE-301 Part 1|Adverse Event|5|||
48681169|NCT03464019|156682566|FG000|NODE-301 Part 1|Physician Decision|0|||
48681170|NCT03464019|156682567|FG001|NODE-301 Part 1|Physician Decision|0|||
48681171|NCT03464019|156682568|FG002|NODE-301 Part 1|Physician Decision|4|||
48681172|NCT03464019|156682566|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
48681173|NCT03464019|156682567|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
48681174|NCT03464019|156682568|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
48681175|NCT03464019|156682566|FG000|NODE-301 Part 1|Protocol Violation|0|||
48681176|NCT03464019|156682567|FG001|NODE-301 Part 1|Protocol Violation|0|||
48681177|NCT03464019|156682568|FG002|NODE-301 Part 1|Protocol Violation|2|||
48681178|NCT03464019|156682566|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
48681179|NCT03464019|156682567|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
48681180|NCT03464019|156682568|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
48681181|NCT03464019|156682566|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
48681182|NCT03464019|156682567|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
48681183|NCT03464019|156682568|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
48681184|NCT03464019|156682566|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
48681185|NCT03464019|156682567|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
48681186|NCT03464019|156682568|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
48681187|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
48681188|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
48681189|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
48681190|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
48681191|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
48681192|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
48681193|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
48389354|NCT00942175|155619585|FG001|Overall Study|Protocol Violation|1|||
48389355|NCT00942175|155619586|FG002|Overall Study|Protocol Violation|2|||
48681194|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
48681195|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
48681196|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
48681197|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
48681198|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
48681199|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
48681200|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
48681201|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
48681202|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
48681203|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
48681204|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
48681205|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
48762865|NCT01367158|156980365|FG001|Overall Study|Protocol Violation|1|||
48762866|NCT01367158|156980366|FG002|Overall Study|Protocol Violation|0|||
48389356|NCT00942175|155619587|FG003|Overall Study|Protocol Violation|0|||
48389357|NCT00942175|155619584|FG000|Overall Study|Pregnancy|0|||
48389358|NCT00942175|155619585|FG001|Overall Study|Pregnancy|0|||
48389359|NCT00942175|155619586|FG002|Overall Study|Pregnancy|0|||
48389360|NCT00942175|155619587|FG003|Overall Study|Pregnancy|1|||
48389361|NCT00942175|155619584|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
48389362|NCT00942175|155619585|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
48389363|NCT00942175|155619586|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
48681206|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
48681207|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
48681208|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
48681209|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
48389364|NCT00942175|155619587|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
48389365|NCT00942175|155619584|FG000|Overall Study|Low Platelet Count|0|||
48389366|NCT00942175|155619585|FG001|Overall Study|Low Platelet Count|2|||
48681210|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
48681211|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
48681212|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
48681213|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
48681214|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
48681215|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
48681216|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
48681217|NCT03464019|156682566|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
48681218|NCT03464019|156682567|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
48681219|NCT03464019|156682568|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
48681220|NCT01726582|156682572|FG000|Overall Study|Physician Decision|99|||
48681221|NCT01726582|156682572|FG000|Overall Study|Death|85|||
48681222|NCT00571038|156682573|FG000|Overall Study|Lost to Follow-up|1|||
48681223|NCT00571038|156682574|FG001|Overall Study|Lost to Follow-up|4|||
48681224|NCT00571038|156682573|FG000|Overall Study|Death|7|||
48681225|NCT00571038|156682574|FG001|Overall Study|Death|5|||
48681226|NCT00571038|156682573|FG000|Overall Study|Withdrawal by Subject|1|||
48681227|NCT00571038|156682574|FG001|Overall Study|Withdrawal by Subject|3|||
48681228|NCT00571038|156682573|FG000|Overall Study|Moved out of state|2|||
48681229|NCT00571038|156682574|FG001|Overall Study|Moved out of state|2|||
48681230|NCT03539601|156682577|FG000|Overall Study|Withdraw by parent/guardian|1|||
48681231|NCT03539601|156682578|FG001|Overall Study|Withdraw by parent/guardian|0|||
48681232|NCT03539601|156682579|FG002|Overall Study|Withdraw by parent/guardian|1|||
48681233|NCT03539601|156682580|FG003|Overall Study|Withdraw by parent/guardian|0|||
48355129|NCT00895895|155497204|FG004|After Period 1, Prior to Period 2|Other|0|||
48355130|NCT00895895|155497200|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
48355131|NCT00895895|155497201|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
48355132|NCT00895895|155497202|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
48355133|NCT00895895|155497203|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
48355134|NCT00895895|155497204|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
48681234|NCT03539601|156682577|FG000|Overall Study|Adverse Event|0|||
48681235|NCT03539601|156682578|FG001|Overall Study|Adverse Event|2|||
48681236|NCT03539601|156682579|FG002|Overall Study|Adverse Event|0|||
48681237|NCT03539601|156682580|FG003|Overall Study|Adverse Event|0|||
48681238|NCT03539601|156682577|FG000|Overall Study|Lost to Follow-up|2|||
48681239|NCT03539601|156682578|FG001|Overall Study|Lost to Follow-up|4|||
48681240|NCT03539601|156682579|FG002|Overall Study|Lost to Follow-up|5|||
48681241|NCT03539601|156682580|FG003|Overall Study|Lost to Follow-up|0|||
48681242|NCT03539601|156682577|FG000|Overall Study|Withdrawal by Subject|2|||
48681243|NCT03539601|156682578|FG001|Overall Study|Withdrawal by Subject|0|||
48681244|NCT03539601|156682579|FG002|Overall Study|Withdrawal by Subject|0|||
48681245|NCT03539601|156682580|FG003|Overall Study|Withdrawal by Subject|1|||
48681246|NCT03539601|156682577|FG000|Overall Study|Randomized but not treated|1|||
48681247|NCT03539601|156682578|FG001|Overall Study|Randomized but not treated|1|||
48681248|NCT03539601|156682579|FG002|Overall Study|Randomized but not treated|0|||
48681249|NCT03539601|156682580|FG003|Overall Study|Randomized but not treated|0|||
48681250|NCT01427933|156682582|FG000|Overall Study|Withdrawal by Subject|5|||
48681251|NCT01427933|156682583|FG001|Overall Study|Withdrawal by Subject|8|||
48681252|NCT01427933|156682582|FG000|Overall Study|Lost to Follow-up|1|||
48681253|NCT01427933|156682583|FG001|Overall Study|Lost to Follow-up|5|||
48681254|NCT01427933|156682582|FG000|Overall Study|Other|1|||
48681255|NCT01427933|156682583|FG001|Overall Study|Other|0|||
48681256|NCT01427933|156682582|FG000|Overall Study|Investigator's Decision|1|||
48681257|NCT01427933|156682583|FG001|Overall Study|Investigator's Decision|0|||
48681258|NCT00475709|156682584|FG000|Overall Study|Did not meet eligibility criteria|8|||
48681259|NCT00475709|156682584|FG000|Overall Study|Death|41|||
48355135|NCT00895895|155497200|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
48355136|NCT00895895|155497201|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
48355137|NCT00895895|155497202|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
48355138|NCT00895895|155497203|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
48355139|NCT00895895|155497204|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
48355140|NCT00895895|155497200|FG000|Period 2|Adverse Event|3|||
48355141|NCT00895895|155497201|FG001|Period 2|Adverse Event|3|||
48355142|NCT00895895|155497202|FG002|Period 2|Adverse Event|5|||
48355143|NCT00895895|155497203|FG003|Period 2|Adverse Event|2|||
48355144|NCT00895895|155497204|FG004|Period 2|Adverse Event|5|||
48355145|NCT00895895|155497200|FG000|Period 2|Death|0|||
48355146|NCT00895895|155497201|FG001|Period 2|Death|0|||
48355147|NCT00895895|155497202|FG002|Period 2|Death|1|||
48355148|NCT00895895|155497203|FG003|Period 2|Death|0|||
48355149|NCT00895895|155497204|FG004|Period 2|Death|0|||
48355150|NCT00895895|155497200|FG000|Period 2|discontinued by sponsor|44|||
48355151|NCT00895895|155497201|FG001|Period 2|discontinued by sponsor|44|||
48355152|NCT00895895|155497202|FG002|Period 2|discontinued by sponsor|38|||
48355153|NCT00895895|155497203|FG003|Period 2|discontinued by sponsor|46|||
48355154|NCT00895895|155497204|FG004|Period 2|discontinued by sponsor|37|||
48355155|NCT00895895|155497200|FG000|Period 2|failed to return|2|||
48681260|NCT00475709|156682584|FG000|Overall Study|Device Explant|6|||
48681261|NCT00475709|156682584|FG000|Overall Study|Lost to Follow-up|21|||
48681262|NCT01835158|156682587|FG000|Overall Study|Withdrawal by Subject|1|||
48681263|NCT01835158|156682588|FG001|Overall Study|Withdrawal by Subject|6|||
48681264|NCT02717494|156682600|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
48681265|NCT02717494|156682601|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
48681266|NCT02717494|156682602|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
48681267|NCT02717494|156682600|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
48681268|NCT02717494|156682601|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
48681269|NCT02717494|156682602|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
48681270|NCT02717494|156682600|FG000|First Intervention (Step 1)|Death|0|||
48681271|NCT02717494|156682601|FG001|First Intervention (Step 1)|Death|0|||
48681272|NCT02717494|156682602|FG002|First Intervention (Step 1)|Death|1|||
48681273|NCT02717494|156682600|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
48681274|NCT02717494|156682601|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
48681275|NCT02717494|156682602|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
48681276|NCT02669212|156682605|FG000|Overall Study|Lost to Follow-up|1|||
48681277|NCT02669212|156682606|FG001|Overall Study|Lost to Follow-up|0|||
48681278|NCT02669212|156682605|FG000|Overall Study|Medical Condition|3|||
48681279|NCT02669212|156682606|FG001|Overall Study|Medical Condition|4|||
48681280|NCT02669212|156682605|FG000|Overall Study|Withdrawal by Subject|0|||
48681281|NCT02669212|156682606|FG001|Overall Study|Withdrawal by Subject|2|||
48681282|NCT02669212|156682605|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
48681283|NCT02669212|156682606|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
48681284|NCT00637416|156682607|FG000|Overall Study|Lost to Follow-up|1|||
48681285|NCT00637416|156682608|FG001|Overall Study|Lost to Follow-up|1|||
48681286|NCT00637416|156682607|FG000|Overall Study|Unable to take study drug|0|||
48681287|NCT00637416|156682608|FG001|Overall Study|Unable to take study drug|1|||
48681288|NCT00566852|156682611|FG000|Overall Study|Protocol Violation|22|||
48681289|NCT00566852|156682612|FG001|Overall Study|Protocol Violation|24|||
48681290|NCT00566852|156682611|FG000|Overall Study|Death|95|||
48681291|NCT00566852|156682612|FG001|Overall Study|Death|78|||
48681292|NCT00566852|156682611|FG000|Overall Study|Withdrawal by Subject|30|||
48681293|NCT00566852|156682612|FG001|Overall Study|Withdrawal by Subject|25|||
48681294|NCT00566852|156682611|FG000|Overall Study|Patient refusal|37|||
48681295|NCT00566852|156682612|FG001|Overall Study|Patient refusal|37|||
48681296|NCT00566852|156682611|FG000|Overall Study|Not tested due to disability|6|||
48681297|NCT00566852|156682612|FG001|Overall Study|Not tested due to disability|12|||
48681298|NCT00566852|156682611|FG000|Overall Study|Missing reason not specified|1|||
48681299|NCT00566852|156682612|FG001|Overall Study|Missing reason not specified|2|||
48681300|NCT00566852|156682611|FG000|Overall Study|Missing reason not reported|16|||
48681301|NCT00566852|156682612|FG001|Overall Study|Missing reason not reported|20|||
48681302|NCT00391027|156682613|FG000|Overall Study|Adverse Event|8|||
48681303|NCT00391027|156682614|FG001|Overall Study|Adverse Event|8|||
48681304|NCT00391027|156682613|FG000|Overall Study|Lack of Efficacy|3|||
48681305|NCT00391027|156682614|FG001|Overall Study|Lack of Efficacy|0|||
48681306|NCT00391027|156682613|FG000|Overall Study|Withdrawal by Subject|10|||
48681307|NCT00391027|156682614|FG001|Overall Study|Withdrawal by Subject|1|||
48681308|NCT00391027|156682613|FG000|Overall Study|Other|4|||
48681309|NCT00391027|156682614|FG001|Overall Study|Other|3|||
48681310|NCT00719680|156682618|FG000|Overall Study|Adverse Event|1|||
48681311|NCT00719680|156682618|FG000|Overall Study|Lost to Follow-up|1|||
48681312|NCT00719680|156682618|FG000|Overall Study|Withdrawal by Subject|3|||
48681313|NCT00310817|156682621|FG000|Overall Study|AE or Death|3|||
48681314|NCT00310817|156682622|FG001|Overall Study|AE or Death|1|||
48681315|NCT00310817|156682623|FG002|Overall Study|AE or Death|0|||
48681316|NCT00310817|156682624|FG003|Overall Study|AE or Death|0|||
48681317|NCT00310817|156682621|FG000|Overall Study|Withdrawal by Subject|1|||
48681318|NCT00310817|156682622|FG001|Overall Study|Withdrawal by Subject|4|||
48681319|NCT00310817|156682623|FG002|Overall Study|Withdrawal by Subject|6|||
48681320|NCT00310817|156682624|FG003|Overall Study|Withdrawal by Subject|7|||
48681321|NCT00310817|156682621|FG000|Overall Study|Lost to Follow-up|2|||
48681322|NCT00310817|156682622|FG001|Overall Study|Lost to Follow-up|1|||
48681323|NCT00310817|156682623|FG002|Overall Study|Lost to Follow-up|0|||
48681324|NCT00310817|156682624|FG003|Overall Study|Lost to Follow-up|0|||
48681325|NCT00310817|156682621|FG000|Overall Study|Inappropriate Enrollment|1|||
48681326|NCT00310817|156682622|FG001|Overall Study|Inappropriate Enrollment|0|||
48681327|NCT00310817|156682623|FG002|Overall Study|Inappropriate Enrollment|1|||
48681328|NCT00310817|156682624|FG003|Overall Study|Inappropriate Enrollment|0|||
48681329|NCT00310817|156682621|FG000|Overall Study|Protocol Violation|1|||
48681330|NCT00310817|156682622|FG001|Overall Study|Protocol Violation|1|||
48681331|NCT00310817|156682623|FG002|Overall Study|Protocol Violation|1|||
48681332|NCT00310817|156682624|FG003|Overall Study|Protocol Violation|1|||
48681333|NCT00310817|156682621|FG000|Overall Study|Unable to classify|3|||
48681334|NCT00310817|156682622|FG001|Overall Study|Unable to classify|1|||
48681335|NCT00310817|156682623|FG002|Overall Study|Unable to classify|0|||
48681336|NCT00310817|156682624|FG003|Overall Study|Unable to classify|0|||
48389367|NCT00942175|155619586|FG002|Overall Study|Low Platelet Count|0|||
48389368|NCT00942175|155619587|FG003|Overall Study|Low Platelet Count|0|||
48389369|NCT01066585|155619588|FG000|Overall Study|Protocol Violation|1|||
48389370|NCT01066585|155619589|FG001|Overall Study|Protocol Violation|0|||
48389371|NCT01066585|155619588|FG000|Overall Study|Withdrawal by Subject|0|||
48389372|NCT01066585|155619589|FG001|Overall Study|Withdrawal by Subject|3|||
48389373|NCT02554903|155619590|FG000|Overall Study|Death|1|||
48389374|NCT02554903|155619591|FG001|Overall Study|Death|1|||
48389375|NCT02554903|155619590|FG000|Overall Study|Physician Decision|2|||
48681337|NCT02362464|156682625|FG000|Overall Study|Switched to alternative therapy|1|||
48681338|NCT02362464|156682625|FG000|Overall Study|Refused further treatment|1|||
48681339|NCT02362464|156682625|FG000|Overall Study|Physician Decision|4|||
48681340|NCT02023996|156682635|FG000|Overall Study|Protocol Violation|6|||
48681341|NCT02343406|156682638|FG000|Overall Study|Progressive disease|72|||
48681342|NCT02343406|156682639|FG001|Overall Study|Progressive disease|70|||
48681343|NCT02343406|156682640|FG002|Overall Study|Progressive disease|43|||
48681344|NCT02343406|156682641|FG003|Overall Study|Progressive disease|15|||
48681345|NCT02343406|156682642|FG004|Overall Study|Progressive disease|5|||
48681346|NCT02343406|156682638|FG000|Overall Study|Adverse Event|6|||
48681347|NCT02343406|156682639|FG001|Overall Study|Adverse Event|8|||
48681348|NCT02343406|156682640|FG002|Overall Study|Adverse Event|6|||
48681349|NCT02343406|156682641|FG003|Overall Study|Adverse Event|3|||
48681350|NCT02343406|156682642|FG004|Overall Study|Adverse Event|0|||
48681351|NCT02343406|156682638|FG000|Overall Study|Withdrawal by Subject|6|||
48681352|NCT02343406|156682639|FG001|Overall Study|Withdrawal by Subject|4|||
48681353|NCT02343406|156682640|FG002|Overall Study|Withdrawal by Subject|8|||
48681354|NCT02343406|156682641|FG003|Overall Study|Withdrawal by Subject|3|||
48681355|NCT02343406|156682642|FG004|Overall Study|Withdrawal by Subject|0|||
48681356|NCT02343406|156682638|FG000|Overall Study|Death|2|||
48681357|NCT02343406|156682639|FG001|Overall Study|Death|1|||
48681358|NCT02343406|156682640|FG002|Overall Study|Death|0|||
48681359|NCT02343406|156682641|FG003|Overall Study|Death|0|||
48681360|NCT02343406|156682642|FG004|Overall Study|Death|0|||
48681361|NCT02343406|156682638|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
48681362|NCT02343406|156682639|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
48681363|NCT02343406|156682640|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
48681364|NCT02343406|156682641|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
48681365|NCT02343406|156682642|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
48681366|NCT02343406|156682638|FG000|Overall Study|Other primary malignancy|0|||
48681367|NCT02343406|156682639|FG001|Overall Study|Other primary malignancy|1|||
48681368|NCT02343406|156682640|FG002|Overall Study|Other primary malignancy|0|||
48681369|NCT02343406|156682641|FG003|Overall Study|Other primary malignancy|0|||
48681370|NCT02343406|156682642|FG004|Overall Study|Other primary malignancy|0|||
48681371|NCT02343406|156682638|FG000|Overall Study|Other, not specified|2|||
48681372|NCT02343406|156682639|FG001|Overall Study|Other, not specified|1|||
48681373|NCT02343406|156682640|FG002|Overall Study|Other, not specified|1|||
48681374|NCT02343406|156682641|FG003|Overall Study|Other, not specified|4|||
48681375|NCT02343406|156682642|FG004|Overall Study|Other, not specified|0|||
48681376|NCT00548145|156682643|FG000|Overall Study|Death|0|||
48681377|NCT00548145|156682644|FG001|Overall Study|Death|1|||
48681378|NCT00548145|156682643|FG000|Overall Study|Withdrawal by Subject|0|||
48681379|NCT00548145|156682644|FG001|Overall Study|Withdrawal by Subject|2|||
48681380|NCT00548145|156682643|FG000|Overall Study|Physician Decision|1|||
48681381|NCT00548145|156682644|FG001|Overall Study|Physician Decision|1|||
48681382|NCT00348673|156682647|FG000|Stage 1|Randomized but not Treated|0|||
48681383|NCT00348673|156682648|FG001|Stage 1|Randomized but not Treated|0|||
48681384|NCT00348673|156682649|FG002|Stage 1|Randomized but not Treated|1|||
48389376|NCT02554903|155619591|FG001|Overall Study|Physician Decision|2|||
48389377|NCT02554903|155619590|FG000|Overall Study|Heart Transplant|1|||
48681385|NCT00348673|156682650|FG003|Stage 1|Randomized but not Treated|0|||
48681386|NCT00348673|156682651|FG004|Stage 1|Randomized but not Treated|0|||
48681387|NCT00348673|156682652|FG005|Stage 1|Randomized but not Treated|0|||
48681388|NCT00348673|156682653|FG006|Stage 1|Randomized but not Treated|0|||
48681389|NCT00348673|156682654|FG007|Stage 1|Randomized but not Treated|0|||
48681390|NCT00348673|156682655|FG008|Stage 1|Randomized but not Treated|0|||
48389378|NCT02554903|155619591|FG001|Overall Study|Heart Transplant|2|||
48681391|NCT04090242|156682656|FG000|Overall Study|Withdrawal by Subject|1|||
48681392|NCT04090242|156682657|FG001|Overall Study|Withdrawal by Subject|0|||
48681393|NCT01180296|156682659|FG000|Overall Study|Protocol Violation|1|||
48681394|NCT01180296|156682660|FG001|Overall Study|Protocol Violation|2|||
48681395|NCT02564978|156682673|FG000|Overall Study|Adverse Event|8|||
48681396|NCT02564978|156682673|FG000|Overall Study|Death|1|||
48681397|NCT02564978|156682673|FG000|Overall Study|Lost to Follow-up|1|||
48681398|NCT02564978|156682673|FG000|Overall Study|Withdrawal by Subject|15|||
48681399|NCT02564978|156682673|FG000|Overall Study|Early Study Closure|2|||
48681400|NCT02564978|156682673|FG000|Overall Study|Other Reason|5|||
48681401|NCT00291486|156682674|FG000|Overall Study|Adverse Event|0|||
48681402|NCT00291486|156682675|FG001|Overall Study|Adverse Event|3|||
48681403|NCT00291486|156682676|FG002|Overall Study|Adverse Event|0|||
48681404|NCT00291486|156682677|FG003|Overall Study|Adverse Event|1|||
48681405|NCT00291486|156682678|FG004|Overall Study|Adverse Event|0|||
48681406|NCT00291486|156682674|FG000|Overall Study|Withdrawal by Subject|0|||
48681407|NCT00291486|156682675|FG001|Overall Study|Withdrawal by Subject|0|||
48681408|NCT00291486|156682676|FG002|Overall Study|Withdrawal by Subject|0|||
48681409|NCT00291486|156682677|FG003|Overall Study|Withdrawal by Subject|0|||
48681410|NCT00291486|156682678|FG004|Overall Study|Withdrawal by Subject|1|||
48681411|NCT00291486|156682674|FG000|Overall Study|Disease progression|1|||
48681412|NCT00291486|156682675|FG001|Overall Study|Disease progression|0|||
48681413|NCT00291486|156682676|FG002|Overall Study|Disease progression|1|||
48681414|NCT00291486|156682677|FG003|Overall Study|Disease progression|0|||
48681415|NCT00291486|156682678|FG004|Overall Study|Disease progression|0|||
48681416|NCT02679287|156682679|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
48681417|NCT02679287|156682680|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
48681418|NCT02679287|156682679|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
48681419|NCT02679287|156682680|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
48681420|NCT02679287|156682679|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
48681421|NCT02679287|156682680|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
48681422|NCT02679287|156682679|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
48681423|NCT02679287|156682680|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
48681424|NCT02679287|156682679|FG000|Period 2|Work/Scheduling Conflict|1|||
48681425|NCT02679287|156682680|FG001|Period 2|Work/Scheduling Conflict|0|||
48681426|NCT02679287|156682679|FG000|Period 2|Disliked Mobile System|2|||
48681427|NCT02679287|156682680|FG001|Period 2|Disliked Mobile System|0|||
48681428|NCT02679287|156682679|FG000|Period 3|Work/Scheduling Conflict|0|||
48681429|NCT02679287|156682680|FG001|Period 3|Work/Scheduling Conflict|1|||
48681430|NCT01045694|156682682|FG000|Overall Study|Withdrawal by Subject|2|||
48681431|NCT00423449|156682683|FG000|Overall Study|Clinical Adverse Event|1|||
48681432|NCT00423449|156682684|FG001|Overall Study|Clinical Adverse Event|0|||
48681433|NCT00423449|156682685|FG002|Overall Study|Clinical Adverse Event|1|||
48681434|NCT00423449|156682686|FG003|Overall Study|Clinical Adverse Event|8|||
48681435|NCT00423449|156682687|FG004|Overall Study|Clinical Adverse Event|2|||
48681436|NCT00423449|156682683|FG000|Overall Study|Death|1|||
48681437|NCT00423449|156682684|FG001|Overall Study|Death|0|||
48681438|NCT00423449|156682685|FG002|Overall Study|Death|2|||
48681439|NCT00423449|156682686|FG003|Overall Study|Death|1|||
48681440|NCT00423449|156682687|FG004|Overall Study|Death|1|||
48681441|NCT00423449|156682683|FG000|Overall Study|Progressive Disease|1|||
48681442|NCT00423449|156682684|FG001|Overall Study|Progressive Disease|3|||
48681443|NCT00423449|156682685|FG002|Overall Study|Progressive Disease|8|||
48681444|NCT00423449|156682686|FG003|Overall Study|Progressive Disease|11|||
48681445|NCT00423449|156682687|FG004|Overall Study|Progressive Disease|4|||
48681446|NCT00423449|156682683|FG000|Overall Study|Laboratory Adverse Event|0|||
48681447|NCT00423449|156682684|FG001|Overall Study|Laboratory Adverse Event|1|||
48681448|NCT00423449|156682685|FG002|Overall Study|Laboratory Adverse Event|2|||
48681449|NCT00423449|156682686|FG003|Overall Study|Laboratory Adverse Event|0|||
48681450|NCT00423449|156682687|FG004|Overall Study|Laboratory Adverse Event|0|||
48681451|NCT00423449|156682683|FG000|Overall Study|Other|0|||
48681452|NCT00423449|156682684|FG001|Overall Study|Other|0|||
48681453|NCT00423449|156682685|FG002|Overall Study|Other|0|||
48681454|NCT00423449|156682686|FG003|Overall Study|Other|1|||
48681455|NCT00423449|156682687|FG004|Overall Study|Other|0|||
48681456|NCT00423449|156682683|FG000|Overall Study|Protocol Violation|0|||
48389379|NCT02700997|155619592|FG000|Overall Study|Did not undergo CT imaging|1|||
48389380|NCT02700997|155619592|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
48389381|NCT01342484|155619593|FG000|Overall Study|Other Reasons|1|||
48389382|NCT01342484|155619594|FG001|Overall Study|Other Reasons|0|||
48389383|NCT01342484|155619595|FG002|Overall Study|Other Reasons|0|||
48389384|NCT01342484|155619593|FG000|Overall Study|Protocol Violation|0|||
48389385|NCT01342484|155619594|FG001|Overall Study|Protocol Violation|0|||
48389386|NCT01342484|155619595|FG002|Overall Study|Protocol Violation|1|||
48389387|NCT01342484|155619593|FG000|Overall Study|Withdrawal by Subject|1|||
48389388|NCT01342484|155619594|FG001|Overall Study|Withdrawal by Subject|0|||
48389389|NCT01342484|155619595|FG002|Overall Study|Withdrawal by Subject|0|||
48681457|NCT00423449|156682684|FG001|Overall Study|Protocol Violation|0|||
48681458|NCT00423449|156682685|FG002|Overall Study|Protocol Violation|2|||
48681459|NCT00423449|156682686|FG003|Overall Study|Protocol Violation|1|||
48681460|NCT00423449|156682687|FG004|Overall Study|Protocol Violation|0|||
48681461|NCT01153724|156682688|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48681462|NCT01153724|156682688|FG000|Treatment Period 2|Adverse Event|1|||
48681463|NCT01153724|156682688|FG000|Treatment Period 2|Other reason not defined above|1|||
48681464|NCT01063153|156682689|FG000|Overall Study|Found Ineligible During Screening|2|||
48681465|NCT01063153|156682690|FG001|Overall Study|Found Ineligible During Screening|0|||
48681466|NCT01063153|156682689|FG000|Overall Study|Lost to Follow-up|0|||
48681467|NCT01063153|156682690|FG001|Overall Study|Lost to Follow-up|7|||
48681468|NCT01063153|156682689|FG000|Overall Study|Withdrawal by Subject|0|||
48681469|NCT01063153|156682690|FG001|Overall Study|Withdrawal by Subject|1|||
48681470|NCT01063153|156682689|FG000|Overall Study|Physician Decision|0|||
48681471|NCT01063153|156682690|FG001|Overall Study|Physician Decision|4|||
48681472|NCT00851786|156682691|FG000|Overall Study|Withdrawal by Subject|0|||
48681473|NCT00851786|156682692|FG001|Overall Study|Withdrawal by Subject|1|||
48681474|NCT00851786|156682691|FG000|Overall Study|Protocol Violation|0|||
48681475|NCT00851786|156682692|FG001|Overall Study|Protocol Violation|1|||
48681476|NCT00851786|156682691|FG000|Overall Study|Lost to Follow-up|1|||
48681477|NCT00851786|156682692|FG001|Overall Study|Lost to Follow-up|0|||
48681478|NCT00851786|156682691|FG000|Overall Study|Incarceration|1|||
48681479|NCT00851786|156682692|FG001|Overall Study|Incarceration|0|||
48681480|NCT00851786|156682691|FG000|Overall Study|Site Closure|1|||
48681481|NCT00851786|156682692|FG001|Overall Study|Site Closure|0|||
48681482|NCT00851786|156682691|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
48681483|NCT00851786|156682692|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
48681484|NCT01301833|156682693|FG000|Overall Study|Adverse Event|7|||
48681485|NCT01301833|156682694|FG001|Overall Study|Adverse Event|5|||
48681486|NCT01301833|156682695|FG002|Overall Study|Adverse Event|5|||
48681487|NCT01301833|156682696|FG003|Overall Study|Adverse Event|5|||
48681488|NCT01301833|156682693|FG000|Overall Study|Lack of Efficacy|1|||
48681489|NCT01301833|156682694|FG001|Overall Study|Lack of Efficacy|1|||
48681490|NCT01301833|156682695|FG002|Overall Study|Lack of Efficacy|0|||
48681491|NCT01301833|156682696|FG003|Overall Study|Lack of Efficacy|0|||
48681492|NCT01301833|156682693|FG000|Overall Study|Physician Decision|3|||
48681493|NCT01301833|156682694|FG001|Overall Study|Physician Decision|1|||
48681494|NCT01301833|156682695|FG002|Overall Study|Physician Decision|1|||
48681495|NCT01301833|156682696|FG003|Overall Study|Physician Decision|0|||
48681496|NCT01301833|156682693|FG000|Overall Study|Withdrawal by Subject|3|||
48681497|NCT01301833|156682694|FG001|Overall Study|Withdrawal by Subject|1|||
48681498|NCT01301833|156682695|FG002|Overall Study|Withdrawal by Subject|1|||
48681499|NCT01301833|156682696|FG003|Overall Study|Withdrawal by Subject|2|||
48681500|NCT01301833|156682693|FG000|Overall Study|Personal matter|1|||
48681501|NCT01301833|156682694|FG001|Overall Study|Personal matter|0|||
48681502|NCT01301833|156682695|FG002|Overall Study|Personal matter|0|||
48681503|NCT01301833|156682696|FG003|Overall Study|Personal matter|0|||
48681504|NCT02663622|156682704|FG000|Overall Study|Death|3|||
48681505|NCT02663622|156682705|FG001|Overall Study|Death|1|||
48681506|NCT02663622|156682706|FG002|Overall Study|Death|1|||
48681507|NCT02663622|156682707|FG003|Overall Study|Death|8|||
48681508|NCT02663622|156682704|FG000|Overall Study|Protocol Violation|0|||
48681509|NCT02663622|156682705|FG001|Overall Study|Protocol Violation|0|||
48681510|NCT02663622|156682706|FG002|Overall Study|Protocol Violation|0|||
48355156|NCT00895895|155497201|FG001|Period 2|failed to return|0|||
48681511|NCT02663622|156682707|FG003|Overall Study|Protocol Violation|1|||
48681512|NCT00930930|156682708|FG000|Overall Study|Death|1|||
48681513|NCT00930930|156682709|FG001|Overall Study|Death|0|||
48681514|NCT00930930|156682708|FG000|Overall Study|Physician Decision|1|||
48681515|NCT00930930|156682709|FG001|Overall Study|Physician Decision|0|||
48681516|NCT00930930|156682708|FG000|Overall Study|Adverse Event|13|||
48681517|NCT00930930|156682709|FG001|Overall Study|Adverse Event|3|||
48681518|NCT00930930|156682708|FG000|Overall Study|Withdrawal by Subject|3|||
48681519|NCT00930930|156682709|FG001|Overall Study|Withdrawal by Subject|1|||
48681520|NCT00930930|156682708|FG000|Overall Study|Disease progression|2|||
48681521|NCT00930930|156682709|FG001|Overall Study|Disease progression|3|||
48681522|NCT00930930|156682708|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
48681523|NCT00930930|156682709|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
48681524|NCT00930930|156682708|FG000|Overall Study|patients not compliant|1|||
48681525|NCT00930930|156682709|FG001|Overall Study|patients not compliant|1|||
48681526|NCT02775916|156682712|FG000|Overall Study|Adverse Event|1|||
48681527|NCT02775916|156682713|FG001|Overall Study|Adverse Event|0|||
48681528|NCT02775916|156682712|FG000|Overall Study|Subject/Guardian Decision|2|||
48681529|NCT02775916|156682713|FG001|Overall Study|Subject/Guardian Decision|0|||
48681530|NCT00163020|156682714|FG000|Overall Study|Lost to Follow-up|0|||
48681531|NCT00163020|156682715|FG001|Overall Study|Lost to Follow-up|2|||
48681532|NCT02291419|156684170|FG000|Overall Study|Early study termination|1|||
48681533|NCT02291419|156684171|FG001|Overall Study|Early study termination|5|||
48681534|NCT02950480|156684172|FG000|Overall Study|Withdrawal by Subject|1|||
48681535|NCT02950480|156684173|FG001|Overall Study|Withdrawal by Subject|0|||
48681536|NCT01496469|156684174|FG000|Overall Study|Adverse Event|1|||
48681537|NCT01496469|156684175|FG001|Overall Study|Adverse Event|0|||
48681538|NCT01496469|156684174|FG000|Overall Study|Protocol Violation|2|||
48681539|NCT01496469|156684175|FG001|Overall Study|Protocol Violation|0|||
48681540|NCT01496469|156684174|FG000|Overall Study|Lost to Follow-up|1|||
48681541|NCT01496469|156684175|FG001|Overall Study|Lost to Follow-up|1|||
48681542|NCT01496469|156684174|FG000|Overall Study|Withdrawal by Subject|4|||
48681543|NCT01496469|156684175|FG001|Overall Study|Withdrawal by Subject|4|||
48681544|NCT01496469|156684174|FG000|Overall Study|BP exceeds protocol limits|1|||
48681545|NCT01496469|156684175|FG001|Overall Study|BP exceeds protocol limits|2|||
48681546|NCT01496469|156684174|FG000|Overall Study|Other|1|||
48681547|NCT01496469|156684175|FG001|Overall Study|Other|1|||
48681548|NCT00511134|156684176|FG000|Overall Study|Withdrawal by Subject|0|||
48681549|NCT00511134|156684177|FG001|Overall Study|Withdrawal by Subject|2|||
48681550|NCT00767806|156684178|FG000|Overall Study|Adverse Event|30|||
48681551|NCT00767806|156684179|FG001|Overall Study|Adverse Event|11|||
48681552|NCT00767806|156684178|FG000|Overall Study|Withdrawal by Subject|8|||
48681553|NCT00767806|156684179|FG001|Overall Study|Withdrawal by Subject|13|||
48681554|NCT00767806|156684178|FG000|Overall Study|Protocol Violation|6|||
48681555|NCT00767806|156684179|FG001|Overall Study|Protocol Violation|5|||
48681556|NCT00767806|156684178|FG000|Overall Study|Lack of Efficacy|1|||
48681557|NCT00767806|156684179|FG001|Overall Study|Lack of Efficacy|9|||
48681558|NCT00767806|156684178|FG000|Overall Study|Physician Decision|4|||
48681559|NCT00767806|156684179|FG001|Overall Study|Physician Decision|3|||
48681560|NCT00767806|156684178|FG000|Overall Study|Lost to Follow-up|1|||
48681561|NCT00767806|156684179|FG001|Overall Study|Lost to Follow-up|4|||
48681562|NCT00767806|156684178|FG000|Overall Study|Entry Criteria Not Met|1|||
48681563|NCT00767806|156684179|FG001|Overall Study|Entry Criteria Not Met|1|||
48681564|NCT00767806|156684178|FG000|Overall Study|Sponsor Decision|0|||
48681565|NCT00767806|156684179|FG001|Overall Study|Sponsor Decision|1|||
48681566|NCT01949090|156684180|FG000|Overall Study|Serious Adverse Event|0|||
48681567|NCT01949090|156684181|FG001|Overall Study|Serious Adverse Event|1|||
48681568|NCT01949090|156684182|FG002|Overall Study|Serious Adverse Event|2|||
48681569|NCT01949090|156684183|FG003|Overall Study|Serious Adverse Event|0|||
48681570|NCT01949090|156684184|FG004|Overall Study|Serious Adverse Event|1|||
48681571|NCT01949090|156684180|FG000|Overall Study|Withdrawal by Subject|2|||
48681572|NCT01949090|156684181|FG001|Overall Study|Withdrawal by Subject|0|||
48681573|NCT01949090|156684182|FG002|Overall Study|Withdrawal by Subject|0|||
48681574|NCT01949090|156684183|FG003|Overall Study|Withdrawal by Subject|0|||
48681575|NCT01949090|156684184|FG004|Overall Study|Withdrawal by Subject|1|||
48681576|NCT01949090|156684180|FG000|Overall Study|Protocol non-compliance|0|||
48681577|NCT01949090|156684181|FG001|Overall Study|Protocol non-compliance|0|||
48681578|NCT01949090|156684182|FG002|Overall Study|Protocol non-compliance|0|||
48681579|NCT01949090|156684183|FG003|Overall Study|Protocol non-compliance|0|||
48681580|NCT01949090|156684184|FG004|Overall Study|Protocol non-compliance|1|||
48681581|NCT01949090|156684180|FG000|Overall Study|Lost to Follow-up|2|||
48681582|NCT01949090|156684181|FG001|Overall Study|Lost to Follow-up|1|||
48681583|NCT01949090|156684182|FG002|Overall Study|Lost to Follow-up|0|||
48681584|NCT01949090|156684183|FG003|Overall Study|Lost to Follow-up|1|||
48681585|NCT01949090|156684184|FG004|Overall Study|Lost to Follow-up|1|||
48681586|NCT00742183|156684185|FG000|Overall Study|Adverse Event|2|||
48681587|NCT00742183|156684186|FG001|Overall Study|Adverse Event|2|||
48681588|NCT00742183|156684185|FG000|Overall Study|Death|1|||
48681589|NCT00742183|156684186|FG001|Overall Study|Death|0|||
48681590|NCT00742183|156684185|FG000|Overall Study|Physician Decision|0|||
48681591|NCT00742183|156684186|FG001|Overall Study|Physician Decision|2|||
48681592|NCT00742183|156684185|FG000|Overall Study|Lost to Follow-up|4|||
48681593|NCT00742183|156684186|FG001|Overall Study|Lost to Follow-up|4|||
48681594|NCT00742183|156684185|FG000|Overall Study|Required skin-graft|1|||
48681595|NCT00742183|156684186|FG001|Overall Study|Required skin-graft|1|||
48681596|NCT00742183|156684185|FG000|Overall Study|Withdrawal by Subject|1|||
48681597|NCT00742183|156684186|FG001|Overall Study|Withdrawal by Subject|0|||
48681598|NCT00742183|156684185|FG000|Overall Study|Lack of Efficacy|0|||
48681599|NCT00742183|156684186|FG001|Overall Study|Lack of Efficacy|3|||
48681600|NCT00787189|156684187|FG000|Overall Study|Lost to Follow-up|2|||
48681601|NCT00787189|156684188|FG001|Overall Study|Lost to Follow-up|2|||
48681602|NCT02292446|156684189|FG000|Overall Study|Adverse Event|12|||
48681603|NCT02292446|156684189|FG000|Overall Study|Death|1|||
48681604|NCT02292446|156684189|FG000|Overall Study|Disease progression|2|||
48681605|NCT02292446|156684189|FG000|Overall Study|Subject/guardian decision|2|||
48681606|NCT02292446|156684189|FG000|Overall Study|Withdrawal by Subject|3|||
48681607|NCT00381693|156684190|FG000|Overall Study|Death|1|||
48762867|NCT01367158|156980367|FG003|Overall Study|Protocol Violation|0|||
48681608|NCT00381693|156684190|FG000|Overall Study|Adverse Event|4|||
48681609|NCT00381693|156684190|FG000|Overall Study|Patient Choice|1|||
48681610|NCT00381693|156684190|FG000|Overall Study|Progression|2|||
48681611|NCT00570310|156684191|FG000|Overall Study|Adverse Event|1|||
48681612|NCT00570310|156684192|FG001|Overall Study|Adverse Event|2|||
48681613|NCT00570310|156684191|FG000|Overall Study|Lack of Efficacy|1|||
48681614|NCT00570310|156684192|FG001|Overall Study|Lack of Efficacy|4|||
48681615|NCT00203424|156684206|FG000|Treatment Period|Withdrawal by Subject|4|||
48681616|NCT00203424|156684206|FG000|Treatment Period|Adverse Event|5|||
48681617|NCT00203424|156684206|FG000|Treatment Period|progressive disease|2|||
48681618|NCT00203424|156684206|FG000|Follow-up Period|Withdrawal by Subject|1|||
48681619|NCT00203424|156684206|FG000|Follow-up Period|progressive disease|4|||
48681620|NCT00203424|156684206|FG000|Follow-up Period|Lost to Follow-up|1|||
48681621|NCT01010971|156684207|FG000|Overall Study|Adverse Event|2|||
48681622|NCT01010971|156684208|FG001|Overall Study|Adverse Event|4|||
48681623|NCT01010971|156684209|FG002|Overall Study|Adverse Event|3|||
48681624|NCT01010971|156684207|FG000|Overall Study|Withdrawal by Subject|0|||
48681625|NCT01010971|156684208|FG001|Overall Study|Withdrawal by Subject|2|||
48681626|NCT01010971|156684209|FG002|Overall Study|Withdrawal by Subject|5|||
48681627|NCT01010971|156684207|FG000|Overall Study|Lost to Follow-up|0|||
48681628|NCT01010971|156684208|FG001|Overall Study|Lost to Follow-up|2|||
48681629|NCT01010971|156684209|FG002|Overall Study|Lost to Follow-up|3|||
48681630|NCT01010971|156684207|FG000|Overall Study|Other|1|||
48681631|NCT01010971|156684208|FG001|Overall Study|Other|0|||
48681632|NCT01010971|156684209|FG002|Overall Study|Other|2|||
48681633|NCT00596752|156684214|FG000|Overall Study|Other Reason|44|||
48681634|NCT00596752|156684215|FG001|Overall Study|Other Reason|49|||
48681635|NCT00596752|156684214|FG000|Overall Study|Adverse Event|34|||
48681636|NCT00596752|156684215|FG001|Overall Study|Adverse Event|34|||
48681637|NCT00596752|156684214|FG000|Overall Study|Lost to Follow-up|22|||
48681638|NCT00596752|156684215|FG001|Overall Study|Lost to Follow-up|38|||
48681639|NCT00596752|156684214|FG000|Overall Study|Withdrawal by Subject|12|||
48681640|NCT00596752|156684215|FG001|Overall Study|Withdrawal by Subject|9|||
48681641|NCT00596752|156684214|FG000|Overall Study|Unsatisfactory Compliance|9|||
48681642|NCT00596752|156684215|FG001|Overall Study|Unsatisfactory Compliance|6|||
48762868|NCT01367158|156980368|FG004|Overall Study|Protocol Violation|0|||
48762869|NCT01367158|156980369|FG005|Overall Study|Protocol Violation|0|||
48762870|NCT01367158|156980370|FG006|Overall Study|Protocol Violation|0|||
48762871|NCT01367158|156980371|FG007|Overall Study|Protocol Violation|0|||
48762872|NCT01367158|156980372|FG008|Overall Study|Protocol Violation|0|||
48762873|NCT01367158|156980373|FG009|Overall Study|Protocol Violation|0|||
48762874|NCT01367158|156980374|FG010|Overall Study|Protocol Violation|0|||
48762875|NCT02113956|156980375|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
48762876|NCT02113956|156980376|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
48762877|NCT02113956|156980375|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
48762878|NCT02113956|156980376|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
48762879|NCT02113956|156980375|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
48762880|NCT02113956|156980376|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
48762881|NCT00851799|156980377|FG000|Overall Study|Death|1|||
48762882|NCT00851799|156980378|FG001|Overall Study|Death|0|||
48762883|NCT00851799|156980379|FG002|Overall Study|Death|1|||
48681643|NCT00596752|156684214|FG000|Overall Study|Lack of Efficacy|4|||
48681644|NCT00596752|156684215|FG001|Overall Study|Lack of Efficacy|7|||
48681645|NCT00596752|156684214|FG000|Overall Study|Protocol Violation|1|||
48681646|NCT00596752|156684215|FG001|Overall Study|Protocol Violation|0|||
48681647|NCT02586727|156684216|FG000|Overall Study|Lost to Follow-up|1|||
48681648|NCT02586727|156684217|FG001|Overall Study|Lost to Follow-up|0|||
48681649|NCT01856582|156684218|FG000|Overall Study|Died prior to Boost infusion|1|||
48681650|NCT01221350|156684221|FG000|Overall Study|Discontinued intervention (GERD)|1|||
48681651|NCT01221350|156684222|FG001|Overall Study|Discontinued intervention (GERD)|0|||
48681652|NCT01221350|156684221|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
48681653|NCT01221350|156684222|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
48681654|NCT01221350|156684221|FG000|Overall Study|Withdrawal by Subject|4|||
48681655|NCT01221350|156684222|FG001|Overall Study|Withdrawal by Subject|2|||
48681656|NCT00731679|156684223|FG000|Overall Study|Adverse Event|7|||
48681657|NCT00731679|156684224|FG001|Overall Study|Adverse Event|8|||
48681658|NCT00731679|156684223|FG000|Overall Study|Withdrawal by Subject|8|||
48681659|NCT00731679|156684224|FG001|Overall Study|Withdrawal by Subject|8|||
48681660|NCT00731679|156684223|FG000|Overall Study|Lost to Follow-up|7|||
48681661|NCT00731679|156684224|FG001|Overall Study|Lost to Follow-up|8|||
48762884|NCT00851799|156980377|FG000|Overall Study|Lost to Follow-up|5|||
48762885|NCT00851799|156980378|FG001|Overall Study|Lost to Follow-up|3|||
48762886|NCT00851799|156980379|FG002|Overall Study|Lost to Follow-up|10|||
48762887|NCT00851799|156980377|FG000|Overall Study|Not able to get to clinic|8|||
48762888|NCT00851799|156980378|FG001|Overall Study|Not able to get to clinic|5|||
48389390|NCT03697720|155621383|FG000|Overall Study|Lost to Follow-up|7|||
48389391|NCT02187172|155621390|FG000|Overall Study|Lost to Follow-up|1|||
48762889|NCT00851799|156980379|FG002|Overall Study|Not able to get to clinic|9|||
48389392|NCT02187172|155621391|FG001|Overall Study|Lost to Follow-up|2|||
48681662|NCT00731679|156684223|FG000|Overall Study|Noncompliance|0|||
48681663|NCT00731679|156684224|FG001|Overall Study|Noncompliance|1|||
48681664|NCT00731679|156684223|FG000|Overall Study|Pregnancy|0|||
48681665|NCT00731679|156684224|FG001|Overall Study|Pregnancy|1|||
48681666|NCT02134925|156684225|FG000|Overall Study|Withdrawal by Subject|1|||
48681667|NCT02134925|156684226|FG001|Overall Study|Withdrawal by Subject|0|||
48762890|NCT00851799|156980377|FG000|Overall Study|Not willing to adhere to requirements|1|||
48762891|NCT00851799|156980378|FG001|Overall Study|Not willing to adhere to requirements|2|||
48762892|NCT00851799|156980379|FG002|Overall Study|Not willing to adhere to requirements|2|||
48762893|NCT00851799|156980377|FG000|Overall Study|Withdrew consent prior study completion|1|||
48681668|NCT02134925|156684225|FG000|Overall Study|Cancel|1|||
48681669|NCT02134925|156684226|FG001|Overall Study|Cancel|6|||
48681670|NCT01514201|156684229|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
48681671|NCT01514201|156684230|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681672|NCT01514201|156684231|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681673|NCT01514201|156684232|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681674|NCT01514201|156684229|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681675|NCT01514201|156684230|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
48681676|NCT01514201|156684231|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
48681677|NCT01514201|156684232|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681678|NCT01514201|156684229|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
48681679|NCT01514201|156684230|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
48681680|NCT01514201|156684231|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
48681681|NCT01514201|156684232|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
48681682|NCT01514201|156684229|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
48681683|NCT01514201|156684230|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
48681684|NCT01514201|156684231|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681685|NCT01514201|156684232|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681686|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
48681687|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
48681688|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
48681689|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
48681690|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
48681691|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
48681692|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
48681693|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
48681694|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
48681695|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
48681696|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
48681697|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
48681698|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681699|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681700|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
48681701|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
48681702|NCT01514201|156684229|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
48681703|NCT01514201|156684230|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
48681704|NCT01514201|156684231|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
48681705|NCT01514201|156684232|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
48681706|NCT01514201|156684229|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681707|NCT01514201|156684230|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681708|NCT01514201|156684231|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
48681709|NCT01514201|156684232|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
48681710|NCT01514201|156684229|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681711|NCT01514201|156684230|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681712|NCT01514201|156684231|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
48681713|NCT01514201|156684232|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
48681714|NCT01514201|156684229|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
48681715|NCT01514201|156684230|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
48681716|NCT01514201|156684231|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
48681717|NCT01514201|156684232|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
48681718|NCT01147055|156684243|FG000|First Intervention Period|Lost to Follow-up|1|||
48681719|NCT01147055|156684244|FG001|First Intervention Period|Lost to Follow-up|0|||
48681720|NCT01636986|156684246|FG000|Overall Study|Withdrawal by Subject|0|||
48681721|NCT01636986|156684247|FG001|Overall Study|Withdrawal by Subject|1|||
48681722|NCT01636986|156684246|FG000|Overall Study|Corneal Staining|0|||
48681723|NCT01636986|156684247|FG001|Overall Study|Corneal Staining|1|||
48681724|NCT00286429|156684251|FG000|Overall Study|Adverse Event|4|||
48681725|NCT00286429|156684252|FG001|Overall Study|Adverse Event|1|||
48681726|NCT00286429|156684253|FG002|Overall Study|Adverse Event|6|||
48681727|NCT00286429|156684251|FG000|Overall Study|Lack of Efficacy|52|||
48681728|NCT00286429|156684252|FG001|Overall Study|Lack of Efficacy|27|||
48681729|NCT00286429|156684253|FG002|Overall Study|Lack of Efficacy|25|||
48681730|NCT00286429|156684251|FG000|Overall Study|Lost to Follow-up|2|||
48681731|NCT00286429|156684252|FG001|Overall Study|Lost to Follow-up|4|||
48681732|NCT00286429|156684253|FG002|Overall Study|Lost to Follow-up|3|||
48681733|NCT00286429|156684251|FG000|Overall Study|Physician Decision|10|||
48681734|NCT00286429|156684252|FG001|Overall Study|Physician Decision|7|||
48681735|NCT00286429|156684253|FG002|Overall Study|Physician Decision|7|||
48762894|NCT00851799|156980378|FG001|Overall Study|Withdrew consent prior study completion|2|||
48762895|NCT00851799|156980379|FG002|Overall Study|Withdrew consent prior study completion|1|||
48681736|NCT00286429|156684251|FG000|Overall Study|Protocol Violation|3|||
48681737|NCT00286429|156684252|FG001|Overall Study|Protocol Violation|5|||
48681738|NCT00286429|156684253|FG002|Overall Study|Protocol Violation|4|||
48681739|NCT00286429|156684251|FG000|Overall Study|Withdrawal by Subject|3|||
48681740|NCT00286429|156684252|FG001|Overall Study|Withdrawal by Subject|2|||
48681741|NCT00286429|156684253|FG002|Overall Study|Withdrawal by Subject|6|||
48681742|NCT00286429|156684251|FG000|Overall Study|Administrative Error|1|||
48681743|NCT00286429|156684252|FG001|Overall Study|Administrative Error|1|||
48681744|NCT00286429|156684253|FG002|Overall Study|Administrative Error|1|||
48681745|NCT00286429|156684251|FG000|Overall Study|Administrative Decision|0|||
48681746|NCT00286429|156684252|FG001|Overall Study|Administrative Decision|1|||
48681747|NCT00286429|156684253|FG002|Overall Study|Administrative Decision|0|||
48681748|NCT01746225|156684254|FG000|Overall Study|Death|1|||
48681749|NCT01746225|156684255|FG001|Overall Study|Death|0|||
48681750|NCT01746225|156684256|FG002|Overall Study|Death|1|||
48681751|NCT01746225|156684254|FG000|Overall Study|Withdrawal by Subject|5|||
48681752|NCT01746225|156684255|FG001|Overall Study|Withdrawal by Subject|15|||
48681753|NCT01746225|156684256|FG002|Overall Study|Withdrawal by Subject|19|||
48681754|NCT01746225|156684254|FG000|Overall Study|Physician Decision|14|||
48681755|NCT01746225|156684255|FG001|Overall Study|Physician Decision|11|||
48762896|NCT00851799|156980377|FG000|Overall Study|Severe Debilitation|0|||
48355157|NCT00895895|155497202|FG002|Period 2|failed to return|0|||
48681756|NCT01746225|156684256|FG002|Overall Study|Physician Decision|3|||
48681757|NCT01746225|156684254|FG000|Overall Study|Adverse Event|15|||
48681758|NCT01746225|156684255|FG001|Overall Study|Adverse Event|12|||
48681759|NCT01746225|156684256|FG002|Overall Study|Adverse Event|17|||
48681760|NCT01746225|156684254|FG000|Overall Study|Continuing Treatment|5|||
48681761|NCT01746225|156684255|FG001|Overall Study|Continuing Treatment|8|||
48681762|NCT01746225|156684256|FG002|Overall Study|Continuing Treatment|3|||
48681763|NCT00434109|156684261|FG000|Overall Study|Physician Decision|9|||
48681764|NCT00434109|156684261|FG000|Overall Study|Adverse Event|5|||
48681765|NCT00434109|156684261|FG000|Overall Study|Protocol Violation|1|||
48681766|NCT00434109|156684261|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
48681767|NCT00319254|156684262|FG000|Overall Study|Withdrawal by Subject|4|||
48681768|NCT00319254|156684262|FG000|Overall Study|Death|46|||
48681769|NCT00319254|156684262|FG000|Overall Study|Lost to Follow-up|2|||
48681770|NCT00319254|156684262|FG000|Overall Study|Enrolled, Not Treated|2|||
48681771|NCT01711645|156684263|FG000|Overall Study|Withdrawal by Subject|8|||
48681772|NCT01711645|156684263|FG000|Overall Study|Lost to Follow-up|6|||
48681773|NCT01711645|156684263|FG000|Overall Study|Physician Decision|5|||
48681774|NCT02452424|156684268|FG000|Overall Study|Death|2|||
48681775|NCT02452424|156684269|FG001|Overall Study|Death|2|||
48681776|NCT02452424|156684270|FG002|Overall Study|Death|2|||
48681777|NCT02452424|156684271|FG003|Overall Study|Death|6|||
48355158|NCT00895895|155497203|FG003|Period 2|failed to return|0|||
48355159|NCT00895895|155497204|FG004|Period 2|failed to return|0|||
48355160|NCT00895895|155497200|FG000|Period 2|investigator request|2|||
48355161|NCT00895895|155497201|FG001|Period 2|investigator request|0|||
48355162|NCT00895895|155497202|FG002|Period 2|investigator request|0|||
48355163|NCT00895895|155497203|FG003|Period 2|investigator request|0|||
48355164|NCT00895895|155497204|FG004|Period 2|investigator request|0|||
48355165|NCT00895895|155497200|FG000|Period 2|Lost to Follow-up|1|||
48355166|NCT00895895|155497201|FG001|Period 2|Lost to Follow-up|2|||
48355167|NCT00895895|155497202|FG002|Period 2|Lost to Follow-up|1|||
48355168|NCT00895895|155497203|FG003|Period 2|Lost to Follow-up|1|||
48355169|NCT00895895|155497204|FG004|Period 2|Lost to Follow-up|0|||
48355170|NCT00895895|155497200|FG000|Period 2|Other|1|||
48355171|NCT00895895|155497201|FG001|Period 2|Other|1|||
48355172|NCT00895895|155497202|FG002|Period 2|Other|3|||
48355173|NCT00895895|155497203|FG003|Period 2|Other|1|||
48355174|NCT00895895|155497204|FG004|Period 2|Other|1|||
48355175|NCT00895895|155497200|FG000|Period 2|Protocol Violation|1|||
48355176|NCT00895895|155497201|FG001|Period 2|Protocol Violation|0|||
48355177|NCT00895895|155497202|FG002|Period 2|Protocol Violation|1|||
48355178|NCT00895895|155497203|FG003|Period 2|Protocol Violation|1|||
48355179|NCT00895895|155497204|FG004|Period 2|Protocol Violation|1|||
48355180|NCT00895895|155497200|FG000|Period 2|Withdrawal by Subject|0|||
48355181|NCT00895895|155497201|FG001|Period 2|Withdrawal by Subject|2|||
48355182|NCT00895895|155497202|FG002|Period 2|Withdrawal by Subject|0|||
48355183|NCT00895895|155497203|FG003|Period 2|Withdrawal by Subject|3|||
48355184|NCT00895895|155497204|FG004|Period 2|Withdrawal by Subject|5|||
48355185|NCT00895895|155497200|FG000|Period 2|unsatisfactory response-efficacy|2|||
48355186|NCT00895895|155497201|FG001|Period 2|unsatisfactory response-efficacy|1|||
48355187|NCT00895895|155497202|FG002|Period 2|unsatisfactory response-efficacy|0|||
48355188|NCT00895895|155497203|FG003|Period 2|unsatisfactory response-efficacy|0|||
48681778|NCT02452424|156684272|FG004|Overall Study|Death|2|||
48681779|NCT02452424|156684273|FG005|Overall Study|Death|0|||
48681780|NCT02452424|156684274|FG006|Overall Study|Death|5|||
48681781|NCT02452424|156684275|FG007|Overall Study|Death|1|||
48355189|NCT00895895|155497204|FG004|Period 2|unsatisfactory response-efficacy|0|||
48389393|NCT02187172|155621390|FG000|Overall Study|Lack of Efficacy|1|||
48389394|NCT02187172|155621391|FG001|Overall Study|Lack of Efficacy|2|||
48389395|NCT02187172|155621390|FG000|Overall Study|Adverse Event|0|||
48389396|NCT02187172|155621391|FG001|Overall Study|Adverse Event|1|||
48389397|NCT02187172|155621390|FG000|Overall Study|Physician Decision|1|||
48389398|NCT02187172|155621391|FG001|Overall Study|Physician Decision|1|||
48389399|NCT02181816|155621392|FG000|Overall Study|Case Report Forms Uncollected|38|||
48389400|NCT02181816|155621392|FG000|Overall Study|Protocol Deviation|21|||
48389401|NCT02535715|155621393|FG000|Overall Study|Withdrawal by Subject|0|||
48389402|NCT02535715|155621394|FG001|Overall Study|Withdrawal by Subject|0|||
48389403|NCT02535715|155621395|FG002|Overall Study|Withdrawal by Subject|1|||
48389404|NCT04353284|155621396|FG000|Overall Study|Adverse Event|1|||
48389405|NCT04353284|155621397|FG001|Overall Study|Adverse Event|1|||
48389406|NCT04353284|155621396|FG000|Overall Study|Lost to Follow-up|1|||
48389407|NCT04353284|155621397|FG001|Overall Study|Lost to Follow-up|0|||
48389408|NCT00549939|155621398|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
48389409|NCT00549939|155621399|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
48389410|NCT00549939|155621400|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
48389411|NCT00549939|155621398|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
48389412|NCT00549939|155621399|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
48389413|NCT00549939|155621400|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
48389414|NCT00549939|155621398|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
48389415|NCT00549939|155621399|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
48389416|NCT00549939|155621400|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
48389417|NCT00549939|155621398|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
48389418|NCT00549939|155621399|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
48389419|NCT00549939|155621400|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
48389420|NCT00549939|155621398|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
48389421|NCT00549939|155621399|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
48389422|NCT00549939|155621400|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
48389423|NCT00549939|155621398|FG000|40-week Open Label Treatment Period|Other|0|||
48389424|NCT00549939|155621399|FG001|40-week Open Label Treatment Period|Other|1|||
48389425|NCT00549939|155621400|FG002|40-week Open Label Treatment Period|Other|4|||
48389426|NCT00003895|155621401|FG000|Overall Study|Adverse Event|4|||
48389427|NCT00003895|155621402|FG001|Overall Study|Adverse Event|0|||
48389428|NCT00003895|155621401|FG000|Overall Study|Lack of Efficacy|1|||
48389429|NCT00003895|155621402|FG001|Overall Study|Lack of Efficacy|1|||
48389430|NCT00003895|155621401|FG000|Overall Study|Patient Vacation|2|||
48389431|NCT00003895|155621402|FG001|Overall Study|Patient Vacation|0|||
48389432|NCT00003895|155621401|FG000|Overall Study|Withdrawal by Subject|0|||
48389433|NCT00003895|155621402|FG001|Overall Study|Withdrawal by Subject|3|||
48389434|NCT02490475|155621403|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
48389435|NCT02490475|155621404|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
48389436|NCT02490475|155621405|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
48389437|NCT02490475|155621406|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
48389438|NCT02490475|155621403|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
48389439|NCT02490475|155621404|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
48389440|NCT02490475|155621405|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
48389441|NCT02490475|155621406|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
48389442|NCT02490475|155621403|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
48389443|NCT02490475|155621404|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
48389444|NCT02490475|155621405|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
48389445|NCT02490475|155621406|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
48389446|NCT02490475|155621403|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
48389447|NCT02490475|155621404|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
48389448|NCT02490475|155621405|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
48389449|NCT02490475|155621406|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
48389450|NCT02490475|155621403|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
48389451|NCT02490475|155621404|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
48389452|NCT02490475|155621405|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
48389453|NCT02490475|155621406|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
48389454|NCT02490475|155621403|FG000|Period 2: Extension Phase|Refused Treatment|0|||
48389455|NCT02490475|155621404|FG001|Period 2: Extension Phase|Refused Treatment|0|||
48389456|NCT02490475|155621405|FG002|Period 2: Extension Phase|Refused Treatment|0|||
48389457|NCT02490475|155621406|FG003|Period 2: Extension Phase|Refused Treatment|1|||
48389458|NCT02490475|155621403|FG000|Period 2: Extension Phase|Adverse Event|0|||
48389459|NCT02490475|155621404|FG001|Period 2: Extension Phase|Adverse Event|0|||
48389460|NCT02490475|155621405|FG002|Period 2: Extension Phase|Adverse Event|1|||
48389461|NCT02490475|155621406|FG003|Period 2: Extension Phase|Adverse Event|0|||
48681782|NCT02452424|156684276|FG008|Overall Study|Death|3|||
48681783|NCT02452424|156684277|FG009|Overall Study|Death|1|||
48681784|NCT02452424|156684278|FG010|Overall Study|Death|0|||
48681785|NCT02452424|156684268|FG000|Overall Study|Lost to Follow-up|0|||
48681786|NCT02452424|156684269|FG001|Overall Study|Lost to Follow-up|1|||
48681787|NCT02452424|156684270|FG002|Overall Study|Lost to Follow-up|1|||
48681788|NCT02452424|156684271|FG003|Overall Study|Lost to Follow-up|0|||
48681789|NCT02452424|156684272|FG004|Overall Study|Lost to Follow-up|0|||
48681790|NCT02452424|156684273|FG005|Overall Study|Lost to Follow-up|0|||
48681791|NCT02452424|156684274|FG006|Overall Study|Lost to Follow-up|0|||
48681792|NCT02452424|156684275|FG007|Overall Study|Lost to Follow-up|0|||
48681793|NCT02452424|156684276|FG008|Overall Study|Lost to Follow-up|0|||
48681794|NCT02452424|156684277|FG009|Overall Study|Lost to Follow-up|0|||
48681795|NCT02452424|156684278|FG010|Overall Study|Lost to Follow-up|0|||
48681796|NCT02452424|156684268|FG000|Overall Study|Withdrawal by Subject|0|||
48681797|NCT02452424|156684269|FG001|Overall Study|Withdrawal by Subject|0|||
48681798|NCT02452424|156684270|FG002|Overall Study|Withdrawal by Subject|3|||
48681799|NCT02452424|156684271|FG003|Overall Study|Withdrawal by Subject|2|||
48681800|NCT02452424|156684272|FG004|Overall Study|Withdrawal by Subject|0|||
48681801|NCT02452424|156684273|FG005|Overall Study|Withdrawal by Subject|0|||
48681802|NCT02452424|156684274|FG006|Overall Study|Withdrawal by Subject|1|||
48681803|NCT02452424|156684275|FG007|Overall Study|Withdrawal by Subject|0|||
48681804|NCT02452424|156684276|FG008|Overall Study|Withdrawal by Subject|1|||
48681805|NCT02452424|156684277|FG009|Overall Study|Withdrawal by Subject|1|||
48681806|NCT02452424|156684278|FG010|Overall Study|Withdrawal by Subject|0|||
48681807|NCT02452424|156684268|FG000|Overall Study|Other|0|||
48681808|NCT02452424|156684269|FG001|Overall Study|Other|0|||
48681809|NCT02452424|156684270|FG002|Overall Study|Other|1|||
48681810|NCT02452424|156684271|FG003|Overall Study|Other|0|||
48681811|NCT02452424|156684272|FG004|Overall Study|Other|0|||
48681812|NCT02452424|156684273|FG005|Overall Study|Other|1|||
48681813|NCT02452424|156684274|FG006|Overall Study|Other|4|||
48681814|NCT02452424|156684275|FG007|Overall Study|Other|3|||
48681815|NCT02452424|156684276|FG008|Overall Study|Other|0|||
48681816|NCT02452424|156684277|FG009|Overall Study|Other|0|||
48681817|NCT02452424|156684278|FG010|Overall Study|Other|1|||
48681818|NCT02452424|156684268|FG000|Overall Study|Progressive disease (per RECIST)|0|||
48681819|NCT02452424|156684269|FG001|Overall Study|Progressive disease (per RECIST)|0|||
48681820|NCT02452424|156684270|FG002|Overall Study|Progressive disease (per RECIST)|0|||
48681821|NCT02452424|156684271|FG003|Overall Study|Progressive disease (per RECIST)|0|||
48681822|NCT02452424|156684272|FG004|Overall Study|Progressive disease (per RECIST)|0|||
48681823|NCT02452424|156684273|FG005|Overall Study|Progressive disease (per RECIST)|0|||
48389462|NCT01349465|155621407|FG000|Overall Study|Adverse Event|1|||
48389463|NCT01349465|155621408|FG001|Overall Study|Adverse Event|0|||
48389464|NCT01349465|155621407|FG000|Overall Study|Death|3|||
48389465|NCT01349465|155621408|FG001|Overall Study|Death|0|||
48389466|NCT01349465|155621407|FG000|Overall Study|Lost to Follow-up|10|||
48389467|NCT01349465|155621408|FG001|Overall Study|Lost to Follow-up|1|||
48389468|NCT01349465|155621407|FG000|Overall Study|Withdrawal by Subject|4|||
48389469|NCT01349465|155621408|FG001|Overall Study|Withdrawal by Subject|2|||
48389470|NCT01349465|155621407|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
48389471|NCT01349465|155621408|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
48389472|NCT00383084|155621409|FG000|Overall Study|Withdrawal by Subject|12|||
48389473|NCT00383084|155621410|FG001|Overall Study|Withdrawal by Subject|10|||
48389474|NCT01877187|155621411|FG000|Overall Study|Death|2|||
48389475|NCT01877187|155621411|FG000|Overall Study|Withdrawal by Subject|4|||
48389476|NCT01877187|155621411|FG000|Overall Study|Lost to Follow-up|3|||
48389477|NCT01877187|155621411|FG000|Overall Study|Declining clinical status|11|||
48389478|NCT01877187|155621411|FG000|Overall Study|Liver transplant|2|||
48389479|NCT01648790|155621416|FG000|Treatment 3|Withdrawal by Subject|0|||
48389480|NCT01648790|155621417|FG001|Treatment 3|Withdrawal by Subject|0|||
48389481|NCT01648790|155621418|FG002|Treatment 3|Withdrawal by Subject|0|||
48389482|NCT01648790|155621419|FG003|Treatment 3|Withdrawal by Subject|1|||
48389483|NCT01648790|155621420|FG004|Treatment 3|Withdrawal by Subject|0|||
48389484|NCT02164929|155621421|FG000|Overall Study|Converted to open procedure|1|||
48389485|NCT02164929|155621422|FG001|Overall Study|Converted to open procedure|0|||
48389486|NCT02164929|155621423|FG002|Overall Study|Converted to open procedure|0|||
48389487|NCT02164929|155621424|FG003|Overall Study|Converted to open procedure|2|||
48389488|NCT02164929|155621421|FG000|Overall Study|Failed regional block|0|||
48389489|NCT02164929|155621422|FG001|Overall Study|Failed regional block|0|||
48389490|NCT02164929|155621423|FG002|Overall Study|Failed regional block|1|||
48389491|NCT02164929|155621424|FG003|Overall Study|Failed regional block|0|||
48389492|NCT02969187|155621425|FG000|Overall Study|Physician Decision|12|||
48389493|NCT02969187|155621426|FG001|Overall Study|Physician Decision|13|||
48389494|NCT01986920|155621427|FG000|A- 101 25%|Withdrawal by Subject|1|||
48681824|NCT02452424|156684274|FG006|Overall Study|Progressive disease (per RECIST)|0|||
48681825|NCT02452424|156684275|FG007|Overall Study|Progressive disease (per RECIST)|0|||
48681826|NCT02452424|156684276|FG008|Overall Study|Progressive disease (per RECIST)|2|||
48681827|NCT02452424|156684277|FG009|Overall Study|Progressive disease (per RECIST)|0|||
48681828|NCT02452424|156684278|FG010|Overall Study|Progressive disease (per RECIST)|0|||
48389495|NCT01986920|155621428|FG001|A- 101 25%|Withdrawal by Subject|0|||
48389496|NCT01986920|155621429|FG002|A- 101 25%|Withdrawal by Subject|0|||
48389497|NCT01986920|155621430|FG003|A- 101 25%|Withdrawal by Subject|0|||
48389498|NCT01986920|155621427|FG000|A-101 32.5%|Withdrawal by Subject|0|||
48389499|NCT01986920|155621428|FG001|A-101 32.5%|Withdrawal by Subject|1|||
48389500|NCT01986920|155621429|FG002|A-101 32.5%|Withdrawal by Subject|0|||
48389501|NCT01986920|155621430|FG003|A-101 32.5%|Withdrawal by Subject|0|||
48389502|NCT01986920|155621427|FG000|A-101 40%|Withdrawal by Subject|0|||
48389503|NCT01986920|155621428|FG001|A-101 40%|Withdrawal by Subject|0|||
48389504|NCT01986920|155621429|FG002|A-101 40%|Withdrawal by Subject|1|||
48389505|NCT01986920|155621430|FG003|A-101 40%|Withdrawal by Subject|0|||
48389506|NCT01986920|155621427|FG000|Placebo|Withdrawal by Subject|0|||
48389507|NCT01986920|155621428|FG001|Placebo|Withdrawal by Subject|0|||
48389508|NCT01986920|155621429|FG002|Placebo|Withdrawal by Subject|0|||
48389509|NCT01986920|155621430|FG003|Placebo|Withdrawal by Subject|1|||
48389510|NCT01471015|155621441|FG000|Overall Study|Death|0|||
48389511|NCT01471015|155621442|FG001|Overall Study|Death|1|||
48389512|NCT01471015|155621443|FG002|Overall Study|Death|1|||
48389513|NCT01376778|155621445|FG000|Overall Study|Lost to Follow-up|3|||
48389514|NCT01376778|155621446|FG001|Overall Study|Lost to Follow-up|2|||
48681829|NCT02452424|156684268|FG000|Overall Study|Adverse Event|0|||
48681830|NCT02452424|156684269|FG001|Overall Study|Adverse Event|0|||
48681831|NCT02452424|156684270|FG002|Overall Study|Adverse Event|0|||
48681832|NCT02452424|156684271|FG003|Overall Study|Adverse Event|0|||
48681833|NCT02452424|156684272|FG004|Overall Study|Adverse Event|0|||
48681834|NCT02452424|156684273|FG005|Overall Study|Adverse Event|0|||
48681835|NCT02452424|156684274|FG006|Overall Study|Adverse Event|0|||
48681836|NCT02452424|156684275|FG007|Overall Study|Adverse Event|0|||
48681837|NCT02452424|156684276|FG008|Overall Study|Adverse Event|0|||
48681838|NCT02452424|156684277|FG009|Overall Study|Adverse Event|0|||
48681839|NCT02452424|156684278|FG010|Overall Study|Adverse Event|1|||
48681840|NCT00103740|156684279|FG000|Period 1 - Core|Adverse Event|1|||
48681841|NCT00103740|156684280|FG001|Period 1 - Core|Adverse Event|0|||
48681842|NCT00103740|156684279|FG000|Period 1 - Core|Protocol Violation|3|||
48681843|NCT00103740|156684280|FG001|Period 1 - Core|Protocol Violation|2|||
48681844|NCT00103740|156684279|FG000|Period 1 - Core|Patient withdrew consent|3|||
48681845|NCT00103740|156684280|FG001|Period 1 - Core|Patient withdrew consent|2|||
48681846|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
48681847|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
48681848|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
48681849|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
48681850|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
48681851|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
48389515|NCT02285777|155621451|FG000|Overall Study|Withdrawal by Subject|1|||
48389516|NCT02285777|155621452|FG001|Overall Study|Withdrawal by Subject|1|||
48681852|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Death|6|||
48681853|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Death|2|||
48681854|NCT00103740|156684279|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
48681855|NCT00103740|156684280|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
48681856|NCT00555217|156684281|FG000|Overall Study|Withdrawal by Subject|35|||
48681857|NCT00555217|156684282|FG001|Overall Study|Withdrawal by Subject|31|||
48681858|NCT00555217|156684281|FG000|Overall Study|Lost to Follow-up|19|||
48681859|NCT00555217|156684282|FG001|Overall Study|Lost to Follow-up|20|||
48681860|NCT00555217|156684281|FG000|Overall Study|close out sites|21|||
48681861|NCT00555217|156684282|FG001|Overall Study|close out sites|17|||
48681862|NCT00992459|156684285|FG000|Overall Study|Withdrawal by Subject|0|||
48681863|NCT00992459|156684286|FG001|Overall Study|Withdrawal by Subject|1|||
48681864|NCT00992459|156684285|FG000|Overall Study|Adverse Event|1|||
48681865|NCT00992459|156684286|FG001|Overall Study|Adverse Event|0|||
48681866|NCT00543387|156684292|FG000|Panel 1 + Panel 2|Adverse Event|0|||
48681867|NCT00543387|156684293|FG001|Panel 1 + Panel 2|Adverse Event|1|||
48762897|NCT00851799|156980378|FG001|Overall Study|Severe Debilitation|1|||
48762898|NCT00851799|156980379|FG002|Overall Study|Severe Debilitation|0|||
48762899|NCT00851799|156980377|FG000|Overall Study|Completed protocol due to pregnancy|0|||
48389517|NCT02285777|155621451|FG000|Overall Study|Lost to Follow-up|4|||
48389518|NCT02285777|155621452|FG001|Overall Study|Lost to Follow-up|2|||
48681868|NCT00543387|156684294|FG002|Panel 1 + Panel 2|Adverse Event|0|||
48681869|NCT00543387|156684295|FG003|Panel 1 + Panel 2|Adverse Event|0|||
48681870|NCT00543387|156684296|FG004|Panel 1 + Panel 2|Adverse Event|0|||
48681871|NCT00543387|156684297|FG005|Panel 1 + Panel 2|Adverse Event|0|||
48681872|NCT00543387|156684298|FG006|Panel 1 + Panel 2|Adverse Event|0|||
48681873|NCT00543387|156684299|FG007|Panel 1 + Panel 2|Adverse Event|1|||
48681874|NCT00543387|156684300|FG008|Panel 1 + Panel 2|Adverse Event|1|||
48681875|NCT00543387|156684301|FG009|Panel 1 + Panel 2|Adverse Event|0|||
48681876|NCT00543387|156684302|FG010|Panel 1 + Panel 2|Adverse Event|0|||
48762900|NCT00851799|156980378|FG001|Overall Study|Completed protocol due to pregnancy|0|||
48389519|NCT04607148|155621453|FG000|Overall Study|Withdrawal by Subject|0|||
48389520|NCT04607148|155621454|FG001|Overall Study|Withdrawal by Subject|4|||
48681877|NCT00543387|156684292|FG000|Panel 1 + Panel 2|Physician Decision|0|||
48681878|NCT00543387|156684293|FG001|Panel 1 + Panel 2|Physician Decision|0|||
48681879|NCT00543387|156684294|FG002|Panel 1 + Panel 2|Physician Decision|1|||
48681880|NCT00543387|156684295|FG003|Panel 1 + Panel 2|Physician Decision|0|||
48681881|NCT00543387|156684296|FG004|Panel 1 + Panel 2|Physician Decision|0|||
48681882|NCT00543387|156684297|FG005|Panel 1 + Panel 2|Physician Decision|0|||
48681883|NCT00543387|156684298|FG006|Panel 1 + Panel 2|Physician Decision|0|||
48681884|NCT00543387|156684299|FG007|Panel 1 + Panel 2|Physician Decision|1|||
48681885|NCT00543387|156684300|FG008|Panel 1 + Panel 2|Physician Decision|0|||
48681886|NCT00543387|156684301|FG009|Panel 1 + Panel 2|Physician Decision|0|||
48681887|NCT00543387|156684302|FG010|Panel 1 + Panel 2|Physician Decision|0|||
48681888|NCT00543387|156684292|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
48681889|NCT00543387|156684293|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
48681890|NCT00543387|156684294|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
48681891|NCT00543387|156684295|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
48681892|NCT00543387|156684296|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
48681893|NCT00543387|156684297|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
48681894|NCT00543387|156684298|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
48681895|NCT00543387|156684299|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
48681896|NCT00543387|156684300|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
48681897|NCT00543387|156684301|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
48681898|NCT00543387|156684302|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
48681899|NCT00543387|156684292|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681900|NCT00543387|156684293|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681901|NCT00543387|156684294|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681902|NCT00543387|156684295|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681903|NCT00543387|156684296|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681904|NCT00543387|156684297|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681905|NCT00543387|156684298|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
48681906|NCT00543387|156684299|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681907|NCT00543387|156684300|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681908|NCT00543387|156684301|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681909|NCT00543387|156684302|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
48681910|NCT00543387|156684292|FG000|Crossover Participants|Progressive Disease|0|||
48681911|NCT00543387|156684293|FG001|Crossover Participants|Progressive Disease|0|||
48681912|NCT00543387|156684294|FG002|Crossover Participants|Progressive Disease|0|||
48681913|NCT00543387|156684295|FG003|Crossover Participants|Progressive Disease|0|||
48681914|NCT00543387|156684296|FG004|Crossover Participants|Progressive Disease|0|||
48681915|NCT00543387|156684297|FG005|Crossover Participants|Progressive Disease|0|||
48681916|NCT00543387|156684298|FG006|Crossover Participants|Progressive Disease|0|||
48681917|NCT00543387|156684299|FG007|Crossover Participants|Progressive Disease|0|||
48681918|NCT00543387|156684300|FG008|Crossover Participants|Progressive Disease|0|||
48681919|NCT00543387|156684301|FG009|Crossover Participants|Progressive Disease|1|||
48681920|NCT00543387|156684302|FG010|Crossover Participants|Progressive Disease|2|||
48681921|NCT00543387|156684292|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
48681922|NCT00543387|156684293|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
48681923|NCT00543387|156684294|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
48681924|NCT00543387|156684295|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
48681925|NCT00543387|156684296|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
48681926|NCT00543387|156684297|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
48681927|NCT00543387|156684298|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
48681928|NCT00543387|156684299|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
48681929|NCT00543387|156684300|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
48681930|NCT00543387|156684301|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
48681931|NCT00543387|156684302|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
48681932|NCT00549445|156684303|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
48681933|NCT00549445|156684304|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
48681934|NCT04178720|156684305|FG000|Overall Study|Withdrawal by Subject|2|||
48681935|NCT04178720|156684306|FG001|Overall Study|Withdrawal by Subject|0|||
48681936|NCT04178720|156684305|FG000|Overall Study|Relocation|0|||
48681937|NCT04178720|156684306|FG001|Overall Study|Relocation|1|||
48681938|NCT03566082|156684307|FG000|Overall Study|Death|7|||
48681939|NCT03566082|156684307|FG000|Overall Study|Failures (revision required)|2|||
48681940|NCT03566082|156684307|FG000|Overall Study|Lost to Follow-up|8|||
48681941|NCT02100475|156686168|FG000|Overall Study|Unclassified|1|||
48681942|NCT02100475|156686169|FG001|Overall Study|Unclassified|2|||
48681943|NCT02100475|156686168|FG000|Overall Study|Withdrawal criteria|1|||
48681944|NCT02100475|156686169|FG001|Overall Study|Withdrawal criteria|0|||
48681945|NCT02475278|156686177|FG000|Overall Study|Lost to Follow-up|1|||
48681946|NCT02475278|156686177|FG000|Overall Study|Reason Not Specified|1|||
48762901|NCT00851799|156980379|FG002|Overall Study|Completed protocol due to pregnancy|1|||
48681947|NCT03831100|156686181|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
48389521|NCT04607148|155621455|FG002|Overall Study|Withdrawal by Subject|2|||
48389522|NCT04607148|155621456|FG003|Overall Study|Withdrawal by Subject|8|||
48389523|NCT04607148|155621453|FG000|Overall Study|Study Terminated by Sponsor|14|||
48389524|NCT04607148|155621454|FG001|Overall Study|Study Terminated by Sponsor|59|||
48389525|NCT04607148|155621455|FG002|Overall Study|Study Terminated by Sponsor|9|||
48389526|NCT04607148|155621456|FG003|Overall Study|Study Terminated by Sponsor|39|||
48389527|NCT04607148|155621453|FG000|Overall Study|Sponsor Decision|0|||
48389528|NCT04607148|155621454|FG001|Overall Study|Sponsor Decision|0|||
48389529|NCT04607148|155621455|FG002|Overall Study|Sponsor Decision|1|||
48389530|NCT04607148|155621456|FG003|Overall Study|Sponsor Decision|0|||
48389531|NCT04607148|155621453|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48389532|NCT04607148|155621454|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48389533|NCT04607148|155621455|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48389534|NCT04607148|155621456|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48389535|NCT04607148|155621453|FG000|Overall Study|Lost to Follow-up|0|||
48389536|NCT04607148|155621454|FG001|Overall Study|Lost to Follow-up|2|||
48389537|NCT04607148|155621455|FG002|Overall Study|Lost to Follow-up|0|||
48389538|NCT04607148|155621456|FG003|Overall Study|Lost to Follow-up|0|||
48389539|NCT04607148|155621453|FG000|Overall Study|Death|0|||
48389540|NCT04607148|155621454|FG001|Overall Study|Death|3|||
48389541|NCT04607148|155621455|FG002|Overall Study|Death|0|||
48389542|NCT04607148|155621456|FG003|Overall Study|Death|1|||
48389543|NCT04607148|155621453|FG000|Overall Study|Adverse Event|0|||
48389544|NCT04607148|155621454|FG001|Overall Study|Adverse Event|1|||
48389545|NCT04607148|155621455|FG002|Overall Study|Adverse Event|0|||
48389546|NCT04607148|155621456|FG003|Overall Study|Adverse Event|0|||
48389547|NCT02285998|155621457|FG000|Overall Study|Adverse Event|9|||
48389548|NCT02285998|155621458|FG001|Overall Study|Adverse Event|8|||
48389549|NCT02285998|155621457|FG000|Overall Study|Physician Decision|1|||
48389550|NCT02285998|155621458|FG001|Overall Study|Physician Decision|2|||
48389551|NCT02285998|155621457|FG000|Overall Study|Lost to Follow-up|176|||
48389552|NCT02285998|155621458|FG001|Overall Study|Lost to Follow-up|172|||
48389553|NCT02285998|155621457|FG000|Overall Study|Withdrawal by Subject|53|||
48389554|NCT02285998|155621458|FG001|Overall Study|Withdrawal by Subject|61|||
48389555|NCT02285998|155621457|FG000|Overall Study|Other Reasons|7|||
48389556|NCT02285998|155621458|FG001|Overall Study|Other Reasons|10|||
48389557|NCT03044249|155621459|FG000|Overall Study|Adverse Event|4|||
48389558|NCT03044249|155621460|FG001|Overall Study|Adverse Event|9|||
48389559|NCT03044249|155621459|FG000|Overall Study|Lost to Follow-up|1|||
48389560|NCT03044249|155621460|FG001|Overall Study|Lost to Follow-up|0|||
48389561|NCT03044249|155621459|FG000|Overall Study|Non-compliance with Study Drug|1|||
48389562|NCT03044249|155621460|FG001|Overall Study|Non-compliance with Study Drug|0|||
48389563|NCT03044249|155621459|FG000|Overall Study|Study Terminated by Sponsor|2|||
48389564|NCT03044249|155621460|FG001|Overall Study|Study Terminated by Sponsor|0|||
48389565|NCT03044249|155621459|FG000|Overall Study|Withdrawal by Subject|2|||
48681948|NCT03831100|156686182|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
48681949|NCT00826618|156686183|FG000|Overall Study|Withdrawal by Subject|1|||
48681950|NCT03495102|156686185|FG000|Overall Study|Adverse Event|5|||
48681951|NCT03495102|156686186|FG001|Overall Study|Adverse Event|7|||
48355190|NCT01289210|155497210|FG000|Overall Study|Adverse Event|1|||
48355191|NCT02595372|155497211|FG000|Overall Study|Adverse Event|6|||
48355192|NCT02595372|155497211|FG000|Overall Study|Physician Decision|2|||
48355193|NCT02595372|155497211|FG000|Overall Study|Disease Progression|1|||
48355194|NCT02688530|155497212|FG000|Overall Study|Withdrawal by Subject|0|||
48355195|NCT02688530|155497213|FG001|Overall Study|Withdrawal by Subject|1|||
48355196|NCT02688530|155497214|FG002|Overall Study|Withdrawal by Subject|0|||
48355197|NCT02688530|155497215|FG003|Overall Study|Withdrawal by Subject|0|||
48355198|NCT02688530|155497212|FG000|Overall Study|Lost to Follow-up|0|||
48355199|NCT02688530|155497213|FG001|Overall Study|Lost to Follow-up|0|||
48355200|NCT02688530|155497214|FG002|Overall Study|Lost to Follow-up|2|||
48355201|NCT02688530|155497215|FG003|Overall Study|Lost to Follow-up|0|||
48355202|NCT00763451|155497221|FG000|Overall Study|Adverse Event|4|||
48355203|NCT00763451|155497222|FG001|Overall Study|Adverse Event|6|||
48355204|NCT00763451|155497223|FG002|Overall Study|Adverse Event|19|||
48355205|NCT00763451|155497224|FG003|Overall Study|Adverse Event|14|||
48355206|NCT00763451|155497221|FG000|Overall Study|Lack of Efficacy|1|||
48355207|NCT00763451|155497222|FG001|Overall Study|Lack of Efficacy|4|||
48355208|NCT00763451|155497223|FG002|Overall Study|Lack of Efficacy|3|||
48389566|NCT03044249|155621460|FG001|Overall Study|Withdrawal by Subject|5|||
48389567|NCT01793142|155621461|FG000|Overall Study|Randomized not treated|7|||
48389568|NCT01820364|155621462|FG000|Part I: LGX818|Death|1|||
48389569|NCT01820364|155621463|FG001|Part I: LGX818|Death|0|||
48355209|NCT00763451|155497224|FG003|Overall Study|Lack of Efficacy|2|||
48355210|NCT00763451|155497221|FG000|Overall Study|Withdrawal by Subject|1|||
48389570|NCT01820364|155621462|FG000|Part I: LGX818|Administrative Problems|3|||
48389571|NCT01820364|155621463|FG001|Part I: LGX818|Administrative Problems|0|||
48355211|NCT00763451|155497222|FG001|Overall Study|Withdrawal by Subject|6|||
48389572|NCT01820364|155621462|FG000|Part I: LGX818|Adverse Event|6|||
48681952|NCT03495102|156686187|FG002|Overall Study|Adverse Event|10|||
48681953|NCT03495102|156686185|FG000|Overall Study|Death|3|||
48681954|NCT03495102|156686186|FG001|Overall Study|Death|4|||
48681955|NCT03495102|156686187|FG002|Overall Study|Death|4|||
48681956|NCT03495102|156686185|FG000|Overall Study|Lost to Follow-up|15|||
48681957|NCT03495102|156686186|FG001|Overall Study|Lost to Follow-up|16|||
48681958|NCT03495102|156686187|FG002|Overall Study|Lost to Follow-up|17|||
48681959|NCT03495102|156686185|FG000|Overall Study|Physician Decision|2|||
48681960|NCT03495102|156686186|FG001|Overall Study|Physician Decision|0|||
48681961|NCT03495102|156686187|FG002|Overall Study|Physician Decision|2|||
48681962|NCT03495102|156686185|FG000|Overall Study|Withdrawal by Subject|25|||
48681963|NCT03495102|156686186|FG001|Overall Study|Withdrawal by Subject|36|||
48681964|NCT03495102|156686187|FG002|Overall Study|Withdrawal by Subject|18|||
48681965|NCT03495102|156686185|FG000|Overall Study|Protocol Violation|1|||
48681966|NCT03495102|156686186|FG001|Overall Study|Protocol Violation|1|||
48681967|NCT03495102|156686187|FG002|Overall Study|Protocol Violation|0|||
48681968|NCT03495102|156686185|FG000|Overall Study|Site Closure|3|||
48681969|NCT03495102|156686186|FG001|Overall Study|Site Closure|1|||
48681970|NCT03495102|156686187|FG002|Overall Study|Site Closure|2|||
48681971|NCT03495102|156686185|FG000|Overall Study|Non-compliance|1|||
48681972|NCT03495102|156686186|FG001|Overall Study|Non-compliance|0|||
48681973|NCT03495102|156686187|FG002|Overall Study|Non-compliance|0|||
48681974|NCT03495102|156686185|FG000|Overall Study|Participant Duplicated at Another Site|0|||
48681975|NCT03495102|156686186|FG001|Overall Study|Participant Duplicated at Another Site|0|||
48681976|NCT03495102|156686187|FG002|Overall Study|Participant Duplicated at Another Site|1|||
48681977|NCT03495102|156686185|FG000|Overall Study|Primary Care Physician Recommendation|0|||
48681978|NCT03495102|156686186|FG001|Overall Study|Primary Care Physician Recommendation|1|||
48681979|NCT03495102|156686187|FG002|Overall Study|Primary Care Physician Recommendation|0|||
48681980|NCT03495102|156686185|FG000|Overall Study|Relocated to Another Country|0|||
48681981|NCT03495102|156686186|FG001|Overall Study|Relocated to Another Country|1|||
48681982|NCT03495102|156686187|FG002|Overall Study|Relocated to Another Country|0|||
48681983|NCT03495102|156686185|FG000|Overall Study|Participant was in Rehabilitation|1|||
48681984|NCT03495102|156686186|FG001|Overall Study|Participant was in Rehabilitation|0|||
48681985|NCT03495102|156686187|FG002|Overall Study|Participant was in Rehabilitation|0|||
48681986|NCT00742417|156686195|FG000|Randomized|Withdrawal by legal representative|0|||
48681987|NCT00742417|156686196|FG001|Randomized|Withdrawal by legal representative|1|||
48681988|NCT00742417|156686195|FG000|Randomized|Withdrawal by Subject|1|||
48681989|NCT00742417|156686196|FG001|Randomized|Withdrawal by Subject|0|||
48681990|NCT00742417|156686195|FG000|Randomized|Physician Decision|1|||
48681991|NCT00742417|156686196|FG001|Randomized|Physician Decision|0|||
48681992|NCT00742417|156686195|FG000|Intensive Period|Withdrawal by Subject|1|||
48681993|NCT00742417|156686196|FG001|Intensive Period|Withdrawal by Subject|1|||
48681994|NCT00742417|156686195|FG000|Intensive Period|Adverse Event|2|||
48681995|NCT00742417|156686196|FG001|Intensive Period|Adverse Event|0|||
48681996|NCT01946152|156686197|FG000|Overall Study|Adverse Event|1|||
48681997|NCT01946152|156686198|FG001|Overall Study|Adverse Event|0|||
48681998|NCT01946152|156686199|FG002|Overall Study|Adverse Event|0|||
48681999|NCT01946152|156686200|FG003|Overall Study|Adverse Event|0|||
48682000|NCT01946152|156686197|FG000|Overall Study|Withdrawal by Subject|0|||
48682001|NCT01946152|156686198|FG001|Overall Study|Withdrawal by Subject|2|||
48682002|NCT01946152|156686199|FG002|Overall Study|Withdrawal by Subject|0|||
48682003|NCT01946152|156686200|FG003|Overall Study|Withdrawal by Subject|0|||
48682004|NCT01946152|156686197|FG000|Overall Study|Progression|0|||
48682005|NCT01946152|156686198|FG001|Overall Study|Progression|1|||
48682006|NCT01946152|156686199|FG002|Overall Study|Progression|4|||
48682007|NCT01946152|156686200|FG003|Overall Study|Progression|7|||
48682008|NCT01946152|156686197|FG000|Overall Study|Physician Decision|0|||
48682009|NCT01946152|156686198|FG001|Overall Study|Physician Decision|0|||
48682010|NCT01946152|156686199|FG002|Overall Study|Physician Decision|1|||
48682011|NCT01946152|156686200|FG003|Overall Study|Physician Decision|0|||
48682012|NCT01946152|156686197|FG000|Overall Study|Second malignancy|0|||
48682013|NCT01946152|156686198|FG001|Overall Study|Second malignancy|0|||
48682014|NCT01946152|156686199|FG002|Overall Study|Second malignancy|1|||
48682015|NCT01946152|156686200|FG003|Overall Study|Second malignancy|0|||
48682016|NCT01946152|156686197|FG000|Overall Study|Adverse Event|0|||
48682017|NCT01946152|156686198|FG001|Overall Study|Adverse Event|0|||
48682018|NCT01946152|156686199|FG002|Overall Study|Adverse Event|0|||
48682019|NCT01946152|156686200|FG003|Overall Study|Adverse Event|1|||
48682020|NCT01865448|156686201|FG000|Overall Study|Adverse Event|1|||
48682021|NCT01865448|156686202|FG001|Overall Study|Adverse Event|1|||
48682022|NCT01865448|156686201|FG000|Overall Study|Pregnancy|0|||
48682023|NCT01865448|156686202|FG001|Overall Study|Pregnancy|1|||
48682024|NCT01865448|156686201|FG000|Overall Study|dropout unrelated to study|1|||
48682025|NCT01865448|156686202|FG001|Overall Study|dropout unrelated to study|1|||
48682026|NCT02454478|156686205|FG000|Overall Study|Incomplete DLT Evaluation|1|||
48682027|NCT05128578|156686213|FG000|Overall Study|Withdrawal by Subject|9|||
48682028|NCT05128578|156686213|FG000|Overall Study|Lost to Follow-up|5|||
48682029|NCT01959841|156686214|FG000|Overall Study|Adverse Event|1|||
48682030|NCT01959841|156686215|FG001|Overall Study|Adverse Event|3|||
48682031|NCT01959841|156686216|FG002|Overall Study|Adverse Event|2|||
48682032|NCT01959841|156686214|FG000|Overall Study|Lack of Efficacy|5|||
48682033|NCT01959841|156686215|FG001|Overall Study|Lack of Efficacy|0|||
48682034|NCT01959841|156686216|FG002|Overall Study|Lack of Efficacy|0|||
48682035|NCT01959841|156686214|FG000|Overall Study|Lost to Follow-up|1|||
48682036|NCT01959841|156686215|FG001|Overall Study|Lost to Follow-up|1|||
48682037|NCT01959841|156686216|FG002|Overall Study|Lost to Follow-up|0|||
48682038|NCT01959841|156686214|FG000|Overall Study|Physician Decision|0|||
48682039|NCT01959841|156686215|FG001|Overall Study|Physician Decision|2|||
48682040|NCT01959841|156686216|FG002|Overall Study|Physician Decision|3|||
48682041|NCT01959841|156686214|FG000|Overall Study|Protocol Violation|16|||
48682042|NCT01959841|156686215|FG001|Overall Study|Protocol Violation|23|||
48682043|NCT01959841|156686216|FG002|Overall Study|Protocol Violation|16|||
48682044|NCT01959841|156686214|FG000|Overall Study|Withdrawal by Subject|7|||
48682045|NCT01959841|156686215|FG001|Overall Study|Withdrawal by Subject|7|||
48682046|NCT01959841|156686216|FG002|Overall Study|Withdrawal by Subject|5|||
48682047|NCT01959841|156686214|FG000|Overall Study|Clinical laboratory value|2|||
48682048|NCT01959841|156686215|FG001|Overall Study|Clinical laboratory value|6|||
48682049|NCT01959841|156686216|FG002|Overall Study|Clinical laboratory value|6|||
48682050|NCT01959841|156686214|FG000|Overall Study|Platelet count below on day1 or 4|11|||
48682051|NCT01959841|156686215|FG001|Overall Study|Platelet count below on day1 or 4|15|||
48682052|NCT01959841|156686216|FG002|Overall Study|Platelet count below on day1 or 4|11|||
48682053|NCT00871338|156686218|FG000|Prior to Booster|Withdrawal by Subject|1|||
48682054|NCT00871338|156686219|FG001|Prior to Booster|Withdrawal by Subject|3|||
48682055|NCT00871338|156686218|FG000|Prior to Booster|Lost to Follow-up|1|||
48682056|NCT00871338|156686219|FG001|Prior to Booster|Lost to Follow-up|0|||
48682057|NCT02391363|156686220|FG000|Overall Study|Lost to Follow-up|5|||
48682058|NCT02391363|156686221|FG001|Overall Study|Lost to Follow-up|5|||
48682059|NCT02391363|156686220|FG000|Overall Study|Withdrawal by Subject|6|||
48682060|NCT02391363|156686221|FG001|Overall Study|Withdrawal by Subject|3|||
48682061|NCT00265317|156686223|FG000|Lead-In|Objective progression or relapse|6|||
48682062|NCT00265317|156686224|FG001|Lead-In|Objective progression or relapse|11|||
48682063|NCT00265317|156686225|FG002|Lead-In|Objective progression or relapse|0|||
48682064|NCT00265317|156686226|FG003|Lead-In|Objective progression or relapse|0|||
48682065|NCT00265317|156686223|FG000|Lead-In|Adverse Event|2|||
48682066|NCT00265317|156686224|FG001|Lead-In|Adverse Event|1|||
48682067|NCT00265317|156686225|FG002|Lead-In|Adverse Event|0|||
48682068|NCT00265317|156686226|FG003|Lead-In|Adverse Event|0|||
48682069|NCT00265317|156686223|FG000|Lead-In|Death|3|||
48682070|NCT00265317|156686224|FG001|Lead-In|Death|5|||
48682071|NCT00265317|156686225|FG002|Lead-In|Death|0|||
48682072|NCT00265317|156686226|FG003|Lead-In|Death|0|||
48682073|NCT00265317|156686223|FG000|Lead-In|Withdrawal/other than adverse event|1|||
48682074|NCT00265317|156686224|FG001|Lead-In|Withdrawal/other than adverse event|0|||
48682075|NCT00265317|156686225|FG002|Lead-In|Withdrawal/other than adverse event|0|||
48682076|NCT00265317|156686226|FG003|Lead-In|Withdrawal/other than adverse event|0|||
48682077|NCT00265317|156686223|FG000|Phase 2|Objective progression or relapse|0|||
48682078|NCT00265317|156686224|FG001|Phase 2|Objective progression or relapse|0|||
48682079|NCT00265317|156686225|FG002|Phase 2|Objective progression or relapse|37|||
48682080|NCT00265317|156686226|FG003|Phase 2|Objective progression or relapse|38|||
48682081|NCT00265317|156686223|FG000|Phase 2|Global deterioration of health status|0|||
48682082|NCT00265317|156686224|FG001|Phase 2|Global deterioration of health status|0|||
48682083|NCT00265317|156686225|FG002|Phase 2|Global deterioration of health status|3|||
48682084|NCT00265317|156686226|FG003|Phase 2|Global deterioration of health status|0|||
48682085|NCT00265317|156686223|FG000|Phase 2|Adverse Event|0|||
48682086|NCT00265317|156686224|FG001|Phase 2|Adverse Event|0|||
48682087|NCT00265317|156686225|FG002|Phase 2|Adverse Event|7|||
48682088|NCT00265317|156686226|FG003|Phase 2|Adverse Event|5|||
48682089|NCT00265317|156686223|FG000|Phase 2|Death|0|||
48682090|NCT00265317|156686224|FG001|Phase 2|Death|0|||
48682091|NCT00265317|156686225|FG002|Phase 2|Death|12|||
48682092|NCT00265317|156686226|FG003|Phase 2|Death|15|||
48682093|NCT00265317|156686223|FG000|Phase 2|Protocol Violation|0|||
48682094|NCT00265317|156686224|FG001|Phase 2|Protocol Violation|0|||
48682095|NCT00265317|156686225|FG002|Phase 2|Protocol Violation|1|||
48682096|NCT00265317|156686226|FG003|Phase 2|Protocol Violation|4|||
48682097|NCT00265317|156686223|FG000|Phase 2|Lost to Follow-up|0|||
48682098|NCT00265317|156686224|FG001|Phase 2|Lost to Follow-up|0|||
48682099|NCT00265317|156686225|FG002|Phase 2|Lost to Follow-up|0|||
48682100|NCT00265317|156686226|FG003|Phase 2|Lost to Follow-up|1|||
48682101|NCT00265317|156686223|FG000|Phase 2|Withdrawal/other than adverse event|0|||
48682102|NCT00265317|156686224|FG001|Phase 2|Withdrawal/other than adverse event|0|||
48682103|NCT00265317|156686225|FG002|Phase 2|Withdrawal/other than adverse event|2|||
48682104|NCT00265317|156686226|FG003|Phase 2|Withdrawal/other than adverse event|1|||
48682105|NCT00265317|156686223|FG000|Phase 2|Study terminated by sponsor|0|||
48682106|NCT00265317|156686224|FG001|Phase 2|Study terminated by sponsor|0|||
48682107|NCT00265317|156686225|FG002|Phase 2|Study terminated by sponsor|1|||
48682108|NCT00265317|156686226|FG003|Phase 2|Study terminated by sponsor|0|||
48682109|NCT00265317|156686223|FG000|Phase 2|Other|0|||
48682110|NCT00265317|156686224|FG001|Phase 2|Other|0|||
48682111|NCT00265317|156686225|FG002|Phase 2|Other|1|||
48682112|NCT00265317|156686226|FG003|Phase 2|Other|1|||
48682113|NCT00801229|156686227|FG000|Signed Consent|Withdrawal by Subject|2|||
48682114|NCT00801229|156686228|FG001|Signed Consent|Withdrawal by Subject|2|||
48682115|NCT00801229|156686227|FG000|Signed Consent|Found Ineligible|1|||
48682116|NCT00801229|156686228|FG001|Signed Consent|Found Ineligible|1|||
48682117|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
48682118|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
48682119|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
48682120|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
48682121|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
48682122|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
48682123|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
48682124|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
48682125|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
48682126|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
48682127|NCT00801229|156686227|FG000|Received Study Drug/Placebo|Adverse Event|1|||
48682128|NCT00801229|156686228|FG001|Received Study Drug/Placebo|Adverse Event|1|||
48682129|NCT01959139|156686236|FG000|Phase II|Disease progression|0|||
48682130|NCT01959139|156686237|FG001|Phase II|Disease progression|0|||
48682131|NCT01959139|156686238|FG002|Phase II|Disease progression|26|||
48682132|NCT01959139|156686239|FG003|Phase II|Disease progression|34|||
48682133|NCT01959139|156686236|FG000|Phase II|Adverse Event|0|||
48682134|NCT01959139|156686237|FG001|Phase II|Adverse Event|0|||
48682135|NCT01959139|156686238|FG002|Phase II|Adverse Event|10|||
48682136|NCT01959139|156686239|FG003|Phase II|Adverse Event|11|||
48682137|NCT01959139|156686236|FG000|Phase II|Patient Refusal|0|||
48682138|NCT01959139|156686237|FG001|Phase II|Patient Refusal|0|||
48682139|NCT01959139|156686238|FG002|Phase II|Patient Refusal|5|||
48682140|NCT01959139|156686239|FG003|Phase II|Patient Refusal|4|||
48682141|NCT01959139|156686236|FG000|Phase II|Death|0|||
48682142|NCT01959139|156686237|FG001|Phase II|Death|0|||
48682143|NCT01959139|156686238|FG002|Phase II|Death|3|||
48682144|NCT01959139|156686239|FG003|Phase II|Death|1|||
48682145|NCT01959139|156686236|FG000|Phase II|Other/Unknown|0|||
48682146|NCT01959139|156686237|FG001|Phase II|Other/Unknown|0|||
48682147|NCT01959139|156686238|FG002|Phase II|Other/Unknown|8|||
48682148|NCT01959139|156686239|FG003|Phase II|Other/Unknown|5|||
48682149|NCT01959139|156686236|FG000|Phase II|On treatment|0|||
48682150|NCT01959139|156686237|FG001|Phase II|On treatment|0|||
48682151|NCT01959139|156686238|FG002|Phase II|On treatment|4|||
48682152|NCT01959139|156686239|FG003|Phase II|On treatment|0|||
48682153|NCT03679624|156686240|FG000|Overall Study|Adverse Event|1|||
48682154|NCT03679624|156686241|FG001|Overall Study|Adverse Event|0|||
48682155|NCT01504412|156686244|FG000|Overall Study|Adverse Event|1|||
48682156|NCT01504412|156686245|FG001|Overall Study|Adverse Event|8|||
48682157|NCT01504412|156686246|FG002|Overall Study|Adverse Event|1|||
48682158|NCT01504412|156686247|FG003|Overall Study|Adverse Event|7|||
48682159|NCT01504412|156686248|FG004|Overall Study|Adverse Event|10|||
48682160|NCT01504412|156686244|FG000|Overall Study|Withdrawal by Subject|2|||
48682161|NCT01504412|156686245|FG001|Overall Study|Withdrawal by Subject|1|||
48355212|NCT00763451|155497223|FG002|Overall Study|Withdrawal by Subject|9|||
48355213|NCT00763451|155497224|FG003|Overall Study|Withdrawal by Subject|7|||
48355214|NCT00763451|155497221|FG000|Overall Study|Protocol Violation|0|||
48355215|NCT00763451|155497222|FG001|Overall Study|Protocol Violation|0|||
48355216|NCT00763451|155497223|FG002|Overall Study|Protocol Violation|1|||
48355217|NCT00763451|155497224|FG003|Overall Study|Protocol Violation|0|||
48355218|NCT00763451|155497221|FG000|Overall Study|Poor Compliance to Protocol|1|||
48355219|NCT00763451|155497222|FG001|Overall Study|Poor Compliance to Protocol|1|||
48355220|NCT00763451|155497223|FG002|Overall Study|Poor Compliance to Protocol|2|||
48355221|NCT00763451|155497224|FG003|Overall Study|Poor Compliance to Protocol|2|||
48355222|NCT00763451|155497221|FG000|Overall Study|Familial and Personal Reasons|5|||
48355223|NCT00763451|155497222|FG001|Overall Study|Familial and Personal Reasons|3|||
48355224|NCT00763451|155497223|FG002|Overall Study|Familial and Personal Reasons|5|||
48355225|NCT00763451|155497224|FG003|Overall Study|Familial and Personal Reasons|4|||
48355226|NCT00763451|155497221|FG000|Overall Study|Randomized but not Treated|1|||
48355227|NCT00763451|155497222|FG001|Overall Study|Randomized but not Treated|1|||
48355228|NCT00763451|155497223|FG002|Overall Study|Randomized but not Treated|0|||
48355229|NCT00763451|155497224|FG003|Overall Study|Randomized but not Treated|0|||
48355230|NCT00763451|155497221|FG000|Overall Study|Study Site Reason|0|||
48355231|NCT00763451|155497222|FG001|Overall Study|Study Site Reason|1|||
48355232|NCT00763451|155497223|FG002|Overall Study|Study Site Reason|1|||
48682162|NCT01504412|156686246|FG002|Overall Study|Withdrawal by Subject|1|||
48682163|NCT01504412|156686247|FG003|Overall Study|Withdrawal by Subject|5|||
48682164|NCT01504412|156686248|FG004|Overall Study|Withdrawal by Subject|1|||
48682165|NCT01504412|156686244|FG000|Overall Study|Other|2|||
48682166|NCT01504412|156686245|FG001|Overall Study|Other|1|||
48682167|NCT01504412|156686246|FG002|Overall Study|Other|1|||
48389573|NCT01820364|155621463|FG001|Part I: LGX818|Adverse Event|0|||
48389574|NCT01820364|155621462|FG000|Part I: LGX818|Disease Progression|4|||
48389575|NCT01820364|155621463|FG001|Part I: LGX818|Disease Progression|0|||
48682168|NCT01504412|156686247|FG003|Overall Study|Other|6|||
48682169|NCT01504412|156686248|FG004|Overall Study|Other|1|||
48682170|NCT01504412|156686244|FG000|Overall Study|Lost to Follow-up|0|||
48682171|NCT01504412|156686245|FG001|Overall Study|Lost to Follow-up|2|||
48682172|NCT01504412|156686246|FG002|Overall Study|Lost to Follow-up|0|||
48682173|NCT01504412|156686247|FG003|Overall Study|Lost to Follow-up|0|||
48389576|NCT01820364|155621462|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
48389577|NCT01820364|155621463|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
48389578|NCT00808236|155621470|FG000|Overall Study|Was not resuscitated|50|||
48682174|NCT01504412|156686248|FG004|Overall Study|Lost to Follow-up|0|||
48682175|NCT01504412|156686244|FG000|Overall Study|Lack of Efficacy|0|||
48682176|NCT01504412|156686245|FG001|Overall Study|Lack of Efficacy|0|||
48682177|NCT01504412|156686246|FG002|Overall Study|Lack of Efficacy|1|||
48682178|NCT01504412|156686247|FG003|Overall Study|Lack of Efficacy|0|||
48682179|NCT01504412|156686248|FG004|Overall Study|Lack of Efficacy|1|||
48682180|NCT01504412|156686244|FG000|Overall Study|Death|0|||
48682181|NCT01504412|156686245|FG001|Overall Study|Death|0|||
48682182|NCT01504412|156686246|FG002|Overall Study|Death|0|||
48682183|NCT01504412|156686247|FG003|Overall Study|Death|1|||
48682184|NCT01504412|156686248|FG004|Overall Study|Death|0|||
48682185|NCT03350815|156686255|FG000|Period 1|Adverse Event|10|||
48682186|NCT03350815|156686256|FG001|Period 1|Adverse Event|0|||
48682187|NCT03350815|156686257|FG002|Period 1|Adverse Event|0|||
48682188|NCT03350815|156686258|FG003|Period 1|Adverse Event|0|||
48682189|NCT03350815|156686255|FG000|Period 1|Technical problems|1|||
48682190|NCT03350815|156686256|FG001|Period 1|Technical problems|0|||
48682191|NCT03350815|156686257|FG002|Period 1|Technical problems|0|||
48682192|NCT03350815|156686258|FG003|Period 1|Technical problems|0|||
48682193|NCT03350815|156686255|FG000|Period 1|Lost to Follow-up|3|||
48682194|NCT03350815|156686256|FG001|Period 1|Lost to Follow-up|0|||
48682195|NCT03350815|156686257|FG002|Period 1|Lost to Follow-up|0|||
48682196|NCT03350815|156686258|FG003|Period 1|Lost to Follow-up|0|||
48682197|NCT03350815|156686255|FG000|Period 1|Physician Decision|1|||
48682198|NCT03350815|156686256|FG001|Period 1|Physician Decision|0|||
48682199|NCT03350815|156686257|FG002|Period 1|Physician Decision|0|||
48682200|NCT03350815|156686258|FG003|Period 1|Physician Decision|0|||
48682201|NCT03350815|156686255|FG000|Period 1|Withdrawal by Subject|8|||
48682202|NCT03350815|156686256|FG001|Period 1|Withdrawal by Subject|0|||
48682203|NCT03350815|156686257|FG002|Period 1|Withdrawal by Subject|0|||
48682204|NCT03350815|156686258|FG003|Period 1|Withdrawal by Subject|0|||
48682205|NCT03350815|156686255|FG000|Period 1|Lack of Efficacy|15|||
48682206|NCT03350815|156686256|FG001|Period 1|Lack of Efficacy|0|||
48682207|NCT03350815|156686257|FG002|Period 1|Lack of Efficacy|0|||
48682208|NCT03350815|156686258|FG003|Period 1|Lack of Efficacy|0|||
48682209|NCT03350815|156686255|FG000|Period 1|Non-compliance with study treatment|2|||
48682210|NCT03350815|156686256|FG001|Period 1|Non-compliance with study treatment|0|||
48682211|NCT03350815|156686257|FG002|Period 1|Non-compliance with study treatment|0|||
48682212|NCT03350815|156686258|FG003|Period 1|Non-compliance with study treatment|0|||
48682213|NCT03350815|156686255|FG000|Period 1|Protocol Violation|3|||
48682214|NCT03350815|156686256|FG001|Period 1|Protocol Violation|0|||
48682215|NCT03350815|156686257|FG002|Period 1|Protocol Violation|0|||
48682216|NCT03350815|156686258|FG003|Period 1|Protocol Violation|0|||
48682217|NCT03350815|156686255|FG000|Period 2|Adverse Event|0|||
48682218|NCT03350815|156686256|FG001|Period 2|Adverse Event|3|||
48682219|NCT03350815|156686257|FG002|Period 2|Adverse Event|5|||
48682220|NCT03350815|156686258|FG003|Period 2|Adverse Event|0|||
48682221|NCT03350815|156686255|FG000|Period 2|Technical problem|0|||
48682222|NCT03350815|156686256|FG001|Period 2|Technical problem|1|||
48682223|NCT03350815|156686257|FG002|Period 2|Technical problem|0|||
48682224|NCT03350815|156686258|FG003|Period 2|Technical problem|0|||
48682225|NCT03350815|156686255|FG000|Period 2|Lost to Follow-up|0|||
48682226|NCT03350815|156686256|FG001|Period 2|Lost to Follow-up|3|||
48682227|NCT03350815|156686257|FG002|Period 2|Lost to Follow-up|3|||
48682228|NCT03350815|156686258|FG003|Period 2|Lost to Follow-up|0|||
48682229|NCT03350815|156686255|FG000|Period 2|Physician Decision|0|||
48682230|NCT03350815|156686256|FG001|Period 2|Physician Decision|0|||
48682231|NCT03350815|156686257|FG002|Period 2|Physician Decision|1|||
48682232|NCT03350815|156686258|FG003|Period 2|Physician Decision|0|||
48682233|NCT03350815|156686255|FG000|Period 2|Withdrawal by Subject|0|||
48682234|NCT03350815|156686256|FG001|Period 2|Withdrawal by Subject|3|||
48682235|NCT03350815|156686257|FG002|Period 2|Withdrawal by Subject|4|||
48682236|NCT03350815|156686258|FG003|Period 2|Withdrawal by Subject|0|||
48682237|NCT03350815|156686255|FG000|Period 2|Lack of Efficacy|0|||
48682238|NCT03350815|156686256|FG001|Period 2|Lack of Efficacy|6|||
48682239|NCT03350815|156686257|FG002|Period 2|Lack of Efficacy|2|||
48682240|NCT03350815|156686258|FG003|Period 2|Lack of Efficacy|0|||
48682241|NCT03350815|156686255|FG000|Period 2|Protocol Violation|0|||
48682242|NCT03350815|156686256|FG001|Period 2|Protocol Violation|0|||
48682243|NCT03350815|156686257|FG002|Period 2|Protocol Violation|1|||
48389579|NCT00808236|155621471|FG001|Overall Study|Was not resuscitated|56|||
48389580|NCT00808236|155621470|FG000|Overall Study|Pre-defined exclusion|13|||
48389581|NCT00808236|155621471|FG001|Overall Study|Pre-defined exclusion|3|||
48389582|NCT00808236|155621470|FG000|Overall Study|Lost to Follow-up|1|||
48389583|NCT00808236|155621471|FG001|Overall Study|Lost to Follow-up|1|||
48389584|NCT00808236|155621470|FG000|Overall Study|Physician Decision|0|||
48389585|NCT00808236|155621471|FG001|Overall Study|Physician Decision|1|||
48389586|NCT00808236|155621470|FG000|Overall Study|Death|18|||
48389587|NCT00808236|155621471|FG001|Overall Study|Death|30|||
48389588|NCT01378858|155621472|FG000|Overall Study|Withdrawal by Subject|4|||
48389589|NCT01378858|155621473|FG001|Overall Study|Withdrawal by Subject|4|||
48389590|NCT02739620|155621478|FG000|Overall Study|Lost to Follow-up|3|||
48389591|NCT02739620|155621479|FG001|Overall Study|Lost to Follow-up|1|||
48389592|NCT02739620|155621478|FG000|Overall Study|Adverse Event|0|||
48389593|NCT02739620|155621479|FG001|Overall Study|Adverse Event|1|||
48389594|NCT04126083|155621480|FG000|Overall Study|Withdrawal by Subject|1|||
48389595|NCT02873936|155621481|FG000|Overall Study|Withdrew Consent|4|||
48389596|NCT02873936|155621482|FG001|Overall Study|Withdrew Consent|11|||
48389597|NCT02873936|155621483|FG002|Overall Study|Withdrew Consent|20|||
48389598|NCT02873936|155621481|FG000|Overall Study|Investigator's Discretion|3|||
48389599|NCT02873936|155621482|FG001|Overall Study|Investigator's Discretion|5|||
48389600|NCT02873936|155621483|FG002|Overall Study|Investigator's Discretion|4|||
48389601|NCT02873936|155621481|FG000|Overall Study|Adverse Event|3|||
48389602|NCT02873936|155621482|FG001|Overall Study|Adverse Event|5|||
48389603|NCT02873936|155621483|FG002|Overall Study|Adverse Event|3|||
48389604|NCT02873936|155621481|FG000|Overall Study|Protocol Violation|0|||
48389605|NCT02873936|155621482|FG001|Overall Study|Protocol Violation|1|||
48389606|NCT02873936|155621483|FG002|Overall Study|Protocol Violation|3|||
48389607|NCT02873936|155621481|FG000|Overall Study|Lost to Follow-up|1|||
48389608|NCT02873936|155621482|FG001|Overall Study|Lost to Follow-up|1|||
48389609|NCT02873936|155621483|FG002|Overall Study|Lost to Follow-up|1|||
48389610|NCT02873936|155621481|FG000|Overall Study|Non-compliance With Study Drug|1|||
48389611|NCT02873936|155621482|FG001|Overall Study|Non-compliance With Study Drug|0|||
48682244|NCT03350815|156686258|FG003|Period 2|Protocol Violation|0|||
48682245|NCT03350815|156686255|FG000|Period 2|New therapy for study indication|0|||
48682246|NCT03350815|156686256|FG001|Period 2|New therapy for study indication|0|||
48389612|NCT02873936|155621483|FG002|Overall Study|Non-compliance With Study Drug|1|||
48389613|NCT02873936|155621481|FG000|Overall Study|Randomized but not Dosed|1|||
48389614|NCT02873936|155621482|FG001|Overall Study|Randomized but not Dosed|0|||
48389615|NCT02873936|155621483|FG002|Overall Study|Randomized but not Dosed|0|||
48389616|NCT01015768|155621484|FG000|Overall Study|Some subject data unuseable|4|||
48682247|NCT03350815|156686257|FG002|Period 2|New therapy for study indication|1|||
48682248|NCT03350815|156686258|FG003|Period 2|New therapy for study indication|0|||
48682249|NCT01964963|156686259|FG000|Overall Study|Case Report Forms Uncollected|888|||
48682250|NCT01964963|156686259|FG000|Overall Study|Protocol Deviation|50|||
48682251|NCT01964963|156686259|FG000|Overall Study|Data Reliability was not Assured|5|||
48682252|NCT00930553|156686260|FG000|Overall Study|Adverse Event|1|||
48682253|NCT00930553|156686260|FG000|Overall Study|Lack of Efficacy|7|||
48682254|NCT00930553|156686260|FG000|Overall Study|Physician Decision|39|||
48682255|NCT00930553|156686260|FG000|Overall Study|Protocol Violation|1|||
48682256|NCT00930553|156686260|FG000|Overall Study|Pregnancy|1|||
48682257|NCT00930553|156686260|FG000|Overall Study|Withdrawal by Subject|88|||
48682258|NCT00930553|156686260|FG000|Overall Study|Lost to Follow-up|25|||
48682259|NCT00930553|156686260|FG000|Overall Study|Death|9|||
48682260|NCT00930553|156686260|FG000|Overall Study|Study terminated by sponsor|24|||
48682261|NCT00930553|156686260|FG000|Overall Study|Other than specified above|28|||
48682262|NCT00785980|156686261|FG000|7 Day Washout Period|Protocol Violation|3|||
48682263|NCT01136408|156686262|FG000|Overall Study|Adverse Event|4|||
48682264|NCT01136408|156686263|FG001|Overall Study|Adverse Event|8|||
48682265|NCT01136408|156686264|FG002|Overall Study|Adverse Event|4|||
48682266|NCT01136408|156686262|FG000|Overall Study|Protocol Violation|1|||
48682267|NCT01136408|156686263|FG001|Overall Study|Protocol Violation|1|||
48682268|NCT01136408|156686264|FG002|Overall Study|Protocol Violation|1|||
48682269|NCT01510158|156686265|FG000|Overall Study|Adverse Event|7|||
48682270|NCT01510158|156686266|FG001|Overall Study|Adverse Event|8|||
48682271|NCT01510158|156686267|FG002|Overall Study|Adverse Event|5|||
48682272|NCT01510158|156686265|FG000|Overall Study|Gout flare|1|||
48682273|NCT01510158|156686266|FG001|Overall Study|Gout flare|0|||
48682274|NCT01510158|156686267|FG002|Overall Study|Gout flare|0|||
48682275|NCT01510158|156686265|FG000|Overall Study|Protocol Violation|17|||
48682276|NCT01510158|156686266|FG001|Overall Study|Protocol Violation|16|||
48682277|NCT01510158|156686267|FG002|Overall Study|Protocol Violation|24|||
48682278|NCT01510158|156686265|FG000|Overall Study|Sponsor terminated study.|2|||
48682279|NCT01510158|156686266|FG001|Overall Study|Sponsor terminated study.|0|||
48389617|NCT01015768|155621485|FG001|Overall Study|Some subject data unuseable|4|||
48389618|NCT00754793|155621486|FG000|Overall Study|voluntary withdrawn from study|0|||
48389619|NCT00754793|155621487|FG001|Overall Study|voluntary withdrawn from study|1|||
48389620|NCT01225731|155621488|FG000|Part 1|Did not meet eligibility criteria|1|||
48682280|NCT01510158|156686267|FG002|Overall Study|Sponsor terminated study.|2|||
48682281|NCT01510158|156686265|FG000|Overall Study|Lost to Follow-up|13|||
48682282|NCT01510158|156686266|FG001|Overall Study|Lost to Follow-up|16|||
48682283|NCT01510158|156686267|FG002|Overall Study|Lost to Follow-up|9|||
48682284|NCT01510158|156686265|FG000|Overall Study|Withdrawal by Subject|10|||
48682285|NCT01510158|156686266|FG001|Overall Study|Withdrawal by Subject|13|||
48682286|NCT01510158|156686267|FG002|Overall Study|Withdrawal by Subject|10|||
48682287|NCT01510158|156686265|FG000|Overall Study|Death|1|||
48682288|NCT01510158|156686266|FG001|Overall Study|Death|0|||
48682289|NCT01510158|156686267|FG002|Overall Study|Death|0|||
48682290|NCT02644343|156686276|FG000|Overall Study|Withdrawal by Subject|1|||
48682291|NCT01442714|156686280|FG000|Overall Study|Death|11|||
48682292|NCT01442714|156686280|FG000|Overall Study|Withdrawal by Subject|1|||
48682293|NCT02588261|156686281|FG000|Overall Study|Study Terminated by Sponsor|157|||
48682294|NCT02588261|156686282|FG001|Overall Study|Study Terminated by Sponsor|142|||
48682295|NCT02588261|156686281|FG000|Overall Study|Protocol Deviation|1|||
48682296|NCT02588261|156686282|FG001|Overall Study|Protocol Deviation|0|||
48682297|NCT02588261|156686281|FG000|Overall Study|Death|1|||
48682298|NCT02588261|156686282|FG001|Overall Study|Death|2|||
48682299|NCT02588261|156686281|FG000|Overall Study|Withdrawal by Subject|12|||
48682300|NCT02588261|156686282|FG001|Overall Study|Withdrawal by Subject|8|||
48682301|NCT02588261|156686281|FG000|Overall Study|Noncompliance with Study Drug|0|||
48682302|NCT02588261|156686282|FG001|Overall Study|Noncompliance with Study Drug|1|||
48682303|NCT02588261|156686281|FG000|Overall Study|Miscellaneous|5|||
48682304|NCT02588261|156686282|FG001|Overall Study|Miscellaneous|4|||
48682305|NCT02588261|156686281|FG000|Overall Study|Progressive Disease|61|||
48682306|NCT02588261|156686282|FG001|Overall Study|Progressive Disease|82|||
48682307|NCT02588261|156686281|FG000|Overall Study|Adverse Event|29|||
48682308|NCT02588261|156686282|FG001|Overall Study|Adverse Event|24|||
48682309|NCT02588261|156686281|FG000|Overall Study|Lost to Follow-up|1|||
48682310|NCT02588261|156686282|FG001|Overall Study|Lost to Follow-up|0|||
48682311|NCT01456169|156686292|FG000|Overall Study|Adverse Event|1|||
48682312|NCT01456169|156686293|FG001|Overall Study|Adverse Event|2|||
48682313|NCT01456169|156686294|FG002|Overall Study|Adverse Event|7|||
48682314|NCT01456169|156686292|FG000|Overall Study|Major Protocol Deviation|3|||
48682315|NCT01456169|156686293|FG001|Overall Study|Major Protocol Deviation|2|||
48682316|NCT01456169|156686294|FG002|Overall Study|Major Protocol Deviation|3|||
48682317|NCT01456169|156686292|FG000|Overall Study|Voluntary Withdrawal|3|||
48682318|NCT01456169|156686293|FG001|Overall Study|Voluntary Withdrawal|0|||
48682319|NCT01456169|156686294|FG002|Overall Study|Voluntary Withdrawal|2|||
48682320|NCT01456169|156686292|FG000|Overall Study|Lack of Efficacy|2|||
48682321|NCT01456169|156686293|FG001|Overall Study|Lack of Efficacy|0|||
48682322|NCT01456169|156686294|FG002|Overall Study|Lack of Efficacy|0|||
48682323|NCT01456169|156686292|FG000|Overall Study|Other|1|||
48682324|NCT01456169|156686293|FG001|Overall Study|Other|1|||
48682325|NCT01456169|156686294|FG002|Overall Study|Other|0|||
48682326|NCT03461146|156686305|FG000|Overall Study|Adverse Event|2|||
48682327|NCT03461146|156686305|FG000|Overall Study|Physician Decision|1|||
48682328|NCT01067144|156686310|FG000|Treatment|Did not receive allocated intervention|4|||
48682329|NCT01067144|156686311|FG001|Treatment|Did not receive allocated intervention|7|||
48682330|NCT01067144|156686310|FG000|Follow-up|Lost to Follow-up|22|||
48682331|NCT01067144|156686311|FG001|Follow-up|Lost to Follow-up|12|||
48682332|NCT01067144|156686310|FG000|Follow-up|Censored owing to second surgery|19|||
48682333|NCT01067144|156686311|FG001|Follow-up|Censored owing to second surgery|28|||
48682334|NCT01067144|156686310|FG000|Follow-up|Withdrawal by Subject|18|||
48682335|NCT01067144|156686311|FG001|Follow-up|Withdrawal by Subject|14|||
48682336|NCT01067144|156686310|FG000|Follow-up|Surgery cancelled|0|||
48682337|NCT01067144|156686311|FG001|Follow-up|Surgery cancelled|1|||
48682338|NCT01067144|156686310|FG000|Follow-up|Death|0|||
48682339|NCT01067144|156686311|FG001|Follow-up|Death|1|||
48682340|NCT03710642|156686312|FG000|Overall Study|Adverse Event|5|||
48389621|NCT01225731|155621489|FG001|Part 1|Did not meet eligibility criteria|0|||
48682341|NCT03710642|156686313|FG001|Overall Study|Adverse Event|1|||
48682342|NCT03710642|156686312|FG000|Overall Study|non-site physician recommendation|1|||
48682343|NCT03710642|156686313|FG001|Overall Study|non-site physician recommendation|0|||
48682344|NCT03710642|156686312|FG000|Overall Study|Participant unwilling or unable to participate|1|||
48682345|NCT03710642|156686313|FG001|Overall Study|Participant unwilling or unable to participate|1|||
48682346|NCT03710642|156686312|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
48682347|NCT03710642|156686313|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
48682348|NCT03710642|156686312|FG000|Overall Study|NA-no code provided|1|||
48762902|NCT01498458|156980380|FG000|Overall Study|Adverse Event|4|||
48682349|NCT03710642|156686313|FG001|Overall Study|NA-no code provided|0|||
48682350|NCT03710642|156686312|FG000|Overall Study|Withdrawal by Subject|1|||
48682351|NCT03710642|156686313|FG001|Overall Study|Withdrawal by Subject|0|||
48682352|NCT03081884|156686315|FG000|Overall Study|deferred prostate cancer treatment|1|||
48682353|NCT03081884|156686315|FG000|Overall Study|metastasis managed with systemic therapy|3|||
48682354|NCT01397461|156686316|FG000|Overall Study|Withdrawal by Subject|2|||
48682355|NCT01397461|156686317|FG001|Overall Study|Withdrawal by Subject|1|||
48682356|NCT01397461|156686318|FG002|Overall Study|Withdrawal by Subject|0|||
48762903|NCT01498458|156980380|FG000|Overall Study|Physician Decision|3|||
48762904|NCT03274986|156980383|FG000|Overall Study|Withdrawal by Subject|0|||
48682357|NCT01397461|156686316|FG000|Overall Study|Lost to Follow-up|0|||
48682358|NCT01397461|156686317|FG001|Overall Study|Lost to Follow-up|2|||
48682359|NCT01397461|156686318|FG002|Overall Study|Lost to Follow-up|1|||
48682360|NCT01397461|156686316|FG000|Overall Study|Lack of Efficacy|0|||
48682361|NCT01397461|156686317|FG001|Overall Study|Lack of Efficacy|3|||
48682362|NCT01397461|156686318|FG002|Overall Study|Lack of Efficacy|0|||
48682363|NCT01397461|156686316|FG000|Overall Study|Not treated|0|||
48682364|NCT01397461|156686317|FG001|Overall Study|Not treated|0|||
48682365|NCT01397461|156686318|FG002|Overall Study|Not treated|1|||
48682366|NCT01369784|156686319|FG000|Overall Study|Protocol Violation|12|||
48682367|NCT01219985|156686320|FG000|Overall Study|Physician Decision|20|||
48682368|NCT02097030|156686322|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
48682369|NCT02097030|156686323|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
48682370|NCT02097030|156686322|FG000|First Intervention (3 Days)|Visual Acuity|0|||
48682371|NCT02097030|156686323|FG001|First Intervention (3 Days)|Visual Acuity|1|||
48682372|NCT02735343|156686325|FG000|Overall Study|screen fail|0|||
48682373|NCT02735343|156686326|FG001|Overall Study|screen fail|2|||
48682374|NCT01327599|156686327|FG000|Overall Study|Adverse Event|1|||
48682375|NCT01327599|156686327|FG000|Overall Study|Could Not Attend Visit|1|||
48682376|NCT01327599|156686327|FG000|Overall Study|Withdrawal of Consent|1|||
48682377|NCT03343626|156688323|FG000|Overall Study|Lost to Follow-up|4|||
48682378|NCT03343626|156688324|FG001|Overall Study|Lost to Follow-up|3|||
48682379|NCT03343626|156688325|FG002|Overall Study|Lost to Follow-up|2|||
48682380|NCT03343626|156688326|FG003|Overall Study|Lost to Follow-up|5|||
48682381|NCT03343626|156688327|FG004|Overall Study|Lost to Follow-up|4|||
48682382|NCT03343626|156688328|FG005|Overall Study|Lost to Follow-up|4|||
48682383|NCT03343626|156688329|FG006|Overall Study|Lost to Follow-up|4|||
48682384|NCT03343626|156688330|FG007|Overall Study|Lost to Follow-up|7|||
48682385|NCT03343626|156688323|FG000|Overall Study|Withdrawal of Consent|2|||
48682386|NCT03343626|156688324|FG001|Overall Study|Withdrawal of Consent|1|||
48682387|NCT03343626|156688325|FG002|Overall Study|Withdrawal of Consent|0|||
48682388|NCT03343626|156688326|FG003|Overall Study|Withdrawal of Consent|3|||
48682389|NCT03343626|156688327|FG004|Overall Study|Withdrawal of Consent|3|||
48682390|NCT03343626|156688328|FG005|Overall Study|Withdrawal of Consent|1|||
48682391|NCT03343626|156688329|FG006|Overall Study|Withdrawal of Consent|1|||
48682392|NCT03343626|156688330|FG007|Overall Study|Withdrawal of Consent|2|||
48682393|NCT03343626|156688323|FG000|Overall Study|Reason not Specified|0|||
48682394|NCT03343626|156688324|FG001|Overall Study|Reason not Specified|1|||
48682395|NCT03343626|156688325|FG002|Overall Study|Reason not Specified|0|||
48762905|NCT03274986|156980384|FG001|Overall Study|Withdrawal by Subject|1|||
48389622|NCT01225731|155621490|FG002|Part 1|Did not meet eligibility criteria|0|||
48389623|NCT01225731|155621491|FG003|Part 1|Did not meet eligibility criteria|0|||
48389624|NCT01225731|155621492|FG004|Part 1|Did not meet eligibility criteria|1|||
48389625|NCT01225731|155621493|FG005|Part 1|Did not meet eligibility criteria|0|||
48389626|NCT01225731|155621494|FG006|Part 1|Did not meet eligibility criteria|0|||
48389627|NCT01225731|155621495|FG007|Part 1|Did not meet eligibility criteria|0|||
48389628|NCT01225731|155621496|FG008|Part 1|Did not meet eligibility criteria|0|||
48389629|NCT01225731|155621497|FG009|Part 1|Did not meet eligibility criteria|0|||
48389630|NCT01225731|155621498|FG010|Part 1|Did not meet eligibility criteria|0|||
48389631|NCT01225731|155621499|FG011|Part 1|Did not meet eligibility criteria|0|||
48389632|NCT01225731|155621500|FG012|Part 1|Did not meet eligibility criteria|0|||
48389633|NCT01225731|155621488|FG000|Part 1|Adverse Event|1|||
48389634|NCT01225731|155621489|FG001|Part 1|Adverse Event|2|||
48389635|NCT01225731|155621490|FG002|Part 1|Adverse Event|1|||
48389636|NCT01225731|155621491|FG003|Part 1|Adverse Event|1|||
48682396|NCT03343626|156688326|FG003|Overall Study|Reason not Specified|0|||
48682397|NCT03343626|156688327|FG004|Overall Study|Reason not Specified|0|||
48682398|NCT03343626|156688328|FG005|Overall Study|Reason not Specified|0|||
48682399|NCT03343626|156688329|FG006|Overall Study|Reason not Specified|0|||
48682400|NCT03343626|156688330|FG007|Overall Study|Reason not Specified|1|||
48682401|NCT03343626|156688323|FG000|Overall Study|Data Entry Error|0|||
48682402|NCT03343626|156688324|FG001|Overall Study|Data Entry Error|0|||
48682403|NCT03343626|156688325|FG002|Overall Study|Data Entry Error|0|||
48682404|NCT03343626|156688326|FG003|Overall Study|Data Entry Error|0|||
48762906|NCT03274986|156980383|FG000|Overall Study|Lost to Follow-up|0|||
48682405|NCT03343626|156688327|FG004|Overall Study|Data Entry Error|0|||
48682406|NCT03343626|156688328|FG005|Overall Study|Data Entry Error|0|||
48682407|NCT03343626|156688329|FG006|Overall Study|Data Entry Error|0|||
48682408|NCT03343626|156688330|FG007|Overall Study|Data Entry Error|1|||
48762907|NCT03274986|156980384|FG001|Overall Study|Lost to Follow-up|1|||
48762908|NCT00718328|156980387|FG000|Overall Study|Lost to Follow-up|1|||
48762909|NCT00718328|156980388|FG001|Overall Study|Lost to Follow-up|0|||
48389637|NCT01225731|155621492|FG004|Part 1|Adverse Event|1|||
48389638|NCT01225731|155621493|FG005|Part 1|Adverse Event|0|||
48389639|NCT01225731|155621494|FG006|Part 1|Adverse Event|0|||
48389640|NCT01225731|155621495|FG007|Part 1|Adverse Event|0|||
48389641|NCT01225731|155621496|FG008|Part 1|Adverse Event|0|||
48389642|NCT01225731|155621497|FG009|Part 1|Adverse Event|0|||
48389643|NCT01225731|155621498|FG010|Part 1|Adverse Event|0|||
48389644|NCT01225731|155621499|FG011|Part 1|Adverse Event|0|||
48389645|NCT01225731|155621500|FG012|Part 1|Adverse Event|0|||
48389646|NCT01225731|155621488|FG000|Part 1|Withdrawal by Subject|0|||
48389647|NCT01225731|155621489|FG001|Part 1|Withdrawal by Subject|3|||
48389648|NCT01225731|155621490|FG002|Part 1|Withdrawal by Subject|0|||
48389649|NCT01225731|155621491|FG003|Part 1|Withdrawal by Subject|0|||
48389650|NCT01225731|155621492|FG004|Part 1|Withdrawal by Subject|4|||
48389651|NCT01225731|155621493|FG005|Part 1|Withdrawal by Subject|0|||
48389652|NCT01225731|155621494|FG006|Part 1|Withdrawal by Subject|0|||
48389653|NCT01225731|155621495|FG007|Part 1|Withdrawal by Subject|0|||
48389654|NCT01225731|155621496|FG008|Part 1|Withdrawal by Subject|0|||
48389655|NCT01225731|155621497|FG009|Part 1|Withdrawal by Subject|0|||
48389656|NCT01225731|155621498|FG010|Part 1|Withdrawal by Subject|0|||
48389657|NCT01225731|155621499|FG011|Part 1|Withdrawal by Subject|0|||
48389658|NCT01225731|155621500|FG012|Part 1|Withdrawal by Subject|0|||
48389659|NCT01225731|155621488|FG000|Part 1|Protocol Violation|0|||
48389660|NCT01225731|155621489|FG001|Part 1|Protocol Violation|0|||
48389661|NCT01225731|155621490|FG002|Part 1|Protocol Violation|0|||
48389662|NCT01225731|155621491|FG003|Part 1|Protocol Violation|1|||
48389663|NCT01225731|155621492|FG004|Part 1|Protocol Violation|0|||
48389664|NCT01225731|155621493|FG005|Part 1|Protocol Violation|0|||
48389665|NCT01225731|155621494|FG006|Part 1|Protocol Violation|0|||
48389666|NCT01225731|155621495|FG007|Part 1|Protocol Violation|0|||
48389667|NCT01225731|155621496|FG008|Part 1|Protocol Violation|0|||
48389668|NCT01225731|155621497|FG009|Part 1|Protocol Violation|0|||
48389669|NCT01225731|155621498|FG010|Part 1|Protocol Violation|0|||
48389670|NCT01225731|155621499|FG011|Part 1|Protocol Violation|0|||
48389671|NCT01225731|155621500|FG012|Part 1|Protocol Violation|0|||
48389672|NCT01225731|155621488|FG000|Part 2|Protocol Violation|0|||
48389673|NCT01225731|155621489|FG001|Part 2|Protocol Violation|0|||
48389674|NCT01225731|155621490|FG002|Part 2|Protocol Violation|0|||
48389675|NCT01225731|155621491|FG003|Part 2|Protocol Violation|0|||
48389676|NCT01225731|155621492|FG004|Part 2|Protocol Violation|0|||
48389677|NCT01225731|155621493|FG005|Part 2|Protocol Violation|1|||
48389678|NCT01225731|155621494|FG006|Part 2|Protocol Violation|0|||
48389679|NCT01225731|155621495|FG007|Part 2|Protocol Violation|0|||
48389680|NCT01225731|155621496|FG008|Part 2|Protocol Violation|1|||
48389681|NCT01225731|155621497|FG009|Part 2|Protocol Violation|0|||
48389682|NCT01225731|155621498|FG010|Part 2|Protocol Violation|0|||
48389683|NCT01225731|155621499|FG011|Part 2|Protocol Violation|0|||
48389684|NCT01225731|155621500|FG012|Part 2|Protocol Violation|0|||
48389685|NCT01225731|155621488|FG000|Part 2|Adverse Event|0|||
48389686|NCT01225731|155621489|FG001|Part 2|Adverse Event|0|||
48389687|NCT01225731|155621490|FG002|Part 2|Adverse Event|0|||
48389688|NCT01225731|155621491|FG003|Part 2|Adverse Event|0|||
48389689|NCT01225731|155621492|FG004|Part 2|Adverse Event|0|||
48389690|NCT01225731|155621493|FG005|Part 2|Adverse Event|0|||
48389691|NCT01225731|155621494|FG006|Part 2|Adverse Event|4|||
48389692|NCT01225731|155621495|FG007|Part 2|Adverse Event|4|||
48389693|NCT01225731|155621496|FG008|Part 2|Adverse Event|2|||
48389694|NCT01225731|155621497|FG009|Part 2|Adverse Event|0|||
48389695|NCT01225731|155621498|FG010|Part 2|Adverse Event|0|||
48389696|NCT01225731|155621499|FG011|Part 2|Adverse Event|0|||
48389697|NCT01225731|155621500|FG012|Part 2|Adverse Event|0|||
48389698|NCT01225731|155621488|FG000|Part 2|Lack of Efficacy|0|||
48389699|NCT01225731|155621489|FG001|Part 2|Lack of Efficacy|0|||
48389700|NCT01225731|155621490|FG002|Part 2|Lack of Efficacy|0|||
48389701|NCT01225731|155621491|FG003|Part 2|Lack of Efficacy|0|||
48389702|NCT01225731|155621492|FG004|Part 2|Lack of Efficacy|0|||
48389703|NCT01225731|155621493|FG005|Part 2|Lack of Efficacy|1|||
48389704|NCT01225731|155621494|FG006|Part 2|Lack of Efficacy|0|||
48389705|NCT01225731|155621495|FG007|Part 2|Lack of Efficacy|12|||
48389706|NCT01225731|155621496|FG008|Part 2|Lack of Efficacy|3|||
48389707|NCT01225731|155621497|FG009|Part 2|Lack of Efficacy|0|||
48389708|NCT01225731|155621498|FG010|Part 2|Lack of Efficacy|0|||
48389709|NCT01225731|155621499|FG011|Part 2|Lack of Efficacy|0|||
48389710|NCT01225731|155621500|FG012|Part 2|Lack of Efficacy|0|||
48389711|NCT01225731|155621488|FG000|Part 2|Pregnancy|0|||
48389712|NCT01225731|155621489|FG001|Part 2|Pregnancy|0|||
48389713|NCT01225731|155621490|FG002|Part 2|Pregnancy|0|||
48389714|NCT01225731|155621491|FG003|Part 2|Pregnancy|0|||
48389715|NCT01225731|155621492|FG004|Part 2|Pregnancy|0|||
48389716|NCT01225731|155621493|FG005|Part 2|Pregnancy|0|||
48389717|NCT01225731|155621494|FG006|Part 2|Pregnancy|1|||
48389718|NCT01225731|155621495|FG007|Part 2|Pregnancy|0|||
48389719|NCT01225731|155621496|FG008|Part 2|Pregnancy|1|||
48389720|NCT01225731|155621497|FG009|Part 2|Pregnancy|0|||
48389721|NCT01225731|155621498|FG010|Part 2|Pregnancy|0|||
48389722|NCT01225731|155621499|FG011|Part 2|Pregnancy|0|||
48389723|NCT01225731|155621500|FG012|Part 2|Pregnancy|0|||
48389724|NCT01225731|155621488|FG000|Part 2|Lost to Follow-up|0|||
48389725|NCT01225731|155621489|FG001|Part 2|Lost to Follow-up|0|||
48389726|NCT01225731|155621490|FG002|Part 2|Lost to Follow-up|0|||
48389727|NCT01225731|155621491|FG003|Part 2|Lost to Follow-up|0|||
48389728|NCT01225731|155621492|FG004|Part 2|Lost to Follow-up|0|||
48389729|NCT01225731|155621493|FG005|Part 2|Lost to Follow-up|0|||
48389730|NCT01225731|155621494|FG006|Part 2|Lost to Follow-up|0|||
48389731|NCT01225731|155621495|FG007|Part 2|Lost to Follow-up|3|||
48389732|NCT01225731|155621496|FG008|Part 2|Lost to Follow-up|1|||
48389733|NCT01225731|155621497|FG009|Part 2|Lost to Follow-up|0|||
48389734|NCT01225731|155621498|FG010|Part 2|Lost to Follow-up|0|||
48389735|NCT01225731|155621499|FG011|Part 2|Lost to Follow-up|0|||
48389736|NCT01225731|155621500|FG012|Part 2|Lost to Follow-up|0|||
48389737|NCT01225731|155621488|FG000|Part 2|Physician Decision|0|||
48389738|NCT01225731|155621489|FG001|Part 2|Physician Decision|0|||
48389739|NCT01225731|155621490|FG002|Part 2|Physician Decision|0|||
48389740|NCT01225731|155621491|FG003|Part 2|Physician Decision|0|||
48389741|NCT01225731|155621492|FG004|Part 2|Physician Decision|0|||
48389742|NCT01225731|155621493|FG005|Part 2|Physician Decision|0|||
48389743|NCT01225731|155621494|FG006|Part 2|Physician Decision|0|||
48389744|NCT01225731|155621495|FG007|Part 2|Physician Decision|2|||
48389745|NCT01225731|155621496|FG008|Part 2|Physician Decision|2|||
48389746|NCT01225731|155621497|FG009|Part 2|Physician Decision|0|||
48389747|NCT01225731|155621498|FG010|Part 2|Physician Decision|0|||
48389748|NCT01225731|155621499|FG011|Part 2|Physician Decision|0|||
48389749|NCT01225731|155621500|FG012|Part 2|Physician Decision|0|||
48389750|NCT01225731|155621488|FG000|Part 2|Withdrawal by Subject|0|||
48389751|NCT01225731|155621489|FG001|Part 2|Withdrawal by Subject|0|||
48389752|NCT01225731|155621490|FG002|Part 2|Withdrawal by Subject|0|||
48389753|NCT01225731|155621491|FG003|Part 2|Withdrawal by Subject|0|||
48389754|NCT01225731|155621492|FG004|Part 2|Withdrawal by Subject|0|||
48389755|NCT01225731|155621493|FG005|Part 2|Withdrawal by Subject|1|||
48389756|NCT01225731|155621494|FG006|Part 2|Withdrawal by Subject|3|||
48389757|NCT01225731|155621495|FG007|Part 2|Withdrawal by Subject|4|||
48389758|NCT01225731|155621496|FG008|Part 2|Withdrawal by Subject|1|||
48389759|NCT01225731|155621497|FG009|Part 2|Withdrawal by Subject|0|||
48389760|NCT01225731|155621498|FG010|Part 2|Withdrawal by Subject|0|||
48389761|NCT01225731|155621499|FG011|Part 2|Withdrawal by Subject|0|||
48389762|NCT01225731|155621500|FG012|Part 2|Withdrawal by Subject|0|||
48389763|NCT01225731|155621488|FG000|Part 3|Adverse Event|0|||
48389764|NCT01225731|155621489|FG001|Part 3|Adverse Event|0|||
48389765|NCT01225731|155621490|FG002|Part 3|Adverse Event|0|||
48389766|NCT01225731|155621491|FG003|Part 3|Adverse Event|0|||
48389767|NCT01225731|155621492|FG004|Part 3|Adverse Event|0|||
48389768|NCT01225731|155621493|FG005|Part 3|Adverse Event|0|||
48389769|NCT01225731|155621494|FG006|Part 3|Adverse Event|0|||
48389770|NCT01225731|155621495|FG007|Part 3|Adverse Event|0|||
48389771|NCT01225731|155621496|FG008|Part 3|Adverse Event|0|||
48682409|NCT00703924|156688331|FG000|Overall Study|Withdrawal by Subject|1|||
48682410|NCT00703924|156688332|FG001|Overall Study|Withdrawal by Subject|1|||
48682411|NCT01525615|156688333|FG000|Overall Study|Adverse Event|11|||
48682412|NCT01525615|156688334|FG001|Overall Study|Adverse Event|7|||
48682413|NCT01525615|156688335|FG002|Overall Study|Adverse Event|5|||
48682414|NCT01525615|156688333|FG000|Overall Study|Lost to Follow-up|1|||
48682415|NCT01525615|156688334|FG001|Overall Study|Lost to Follow-up|0|||
48682416|NCT01525615|156688335|FG002|Overall Study|Lost to Follow-up|0|||
48682417|NCT01525615|156688333|FG000|Overall Study|Withdrawal by Subject|1|||
48682418|NCT01525615|156688334|FG001|Overall Study|Withdrawal by Subject|0|||
48682419|NCT01525615|156688335|FG002|Overall Study|Withdrawal by Subject|0|||
48682420|NCT01525615|156688333|FG000|Overall Study|Other reason not described above|1|||
48682421|NCT01525615|156688334|FG001|Overall Study|Other reason not described above|0|||
48389772|NCT01225731|155621497|FG009|Part 3|Adverse Event|0|||
48389773|NCT01225731|155621498|FG010|Part 3|Adverse Event|1|||
48389774|NCT01225731|155621499|FG011|Part 3|Adverse Event|1|||
48389775|NCT01225731|155621500|FG012|Part 3|Adverse Event|0|||
48389776|NCT01225731|155621488|FG000|Part 3|Lost to Follow-up|0|||
48682422|NCT01525615|156688335|FG002|Overall Study|Other reason not described above|1|||
48682423|NCT00649428|156688338|FG000|Overall Study|Adverse Event|2|||
48682424|NCT00649428|156688339|FG001|Overall Study|Adverse Event|2|||
48682425|NCT00649428|156688338|FG000|Overall Study|Withdrawal by Subject|6|||
48389777|NCT01225731|155621489|FG001|Part 3|Lost to Follow-up|0|||
48389778|NCT01225731|155621490|FG002|Part 3|Lost to Follow-up|0|||
48389779|NCT01225731|155621491|FG003|Part 3|Lost to Follow-up|0|||
48389780|NCT01225731|155621492|FG004|Part 3|Lost to Follow-up|0|||
48389781|NCT01225731|155621493|FG005|Part 3|Lost to Follow-up|0|||
48389782|NCT01225731|155621494|FG006|Part 3|Lost to Follow-up|0|||
48682426|NCT00649428|156688339|FG001|Overall Study|Withdrawal by Subject|6|||
48682427|NCT00649428|156688338|FG000|Overall Study|Lost to Follow-up|1|||
48389783|NCT01225731|155621495|FG007|Part 3|Lost to Follow-up|0|||
48389784|NCT01225731|155621496|FG008|Part 3|Lost to Follow-up|0|||
48389785|NCT01225731|155621497|FG009|Part 3|Lost to Follow-up|0|||
48389786|NCT01225731|155621498|FG010|Part 3|Lost to Follow-up|1|||
48389787|NCT01225731|155621499|FG011|Part 3|Lost to Follow-up|2|||
48682428|NCT00649428|156688339|FG001|Overall Study|Lost to Follow-up|3|||
48682429|NCT00649428|156688338|FG000|Overall Study|Insufficient manufacturing yield|5|||
48682430|NCT00649428|156688339|FG001|Overall Study|Insufficient manufacturing yield|1|||
48682431|NCT00649428|156688338|FG000|Overall Study|Protocol Violation|6|||
48682432|NCT00649428|156688339|FG001|Overall Study|Protocol Violation|2|||
48682433|NCT00649428|156688338|FG000|Overall Study|Physician Decision|0|||
48682434|NCT00649428|156688339|FG001|Overall Study|Physician Decision|1|||
48682435|NCT03712787|156688340|FG000|Overall Study|Adverse Event|2|||
48682436|NCT03712787|156688341|FG001|Overall Study|Adverse Event|3|||
48682437|NCT03712787|156688342|FG002|Overall Study|Adverse Event|0|||
48682438|NCT03712787|156688343|FG003|Overall Study|Adverse Event|4|||
48682439|NCT03712787|156688340|FG000|Overall Study|Withdrawal by Subject|4|||
48682440|NCT03712787|156688341|FG001|Overall Study|Withdrawal by Subject|14|||
48682441|NCT03712787|156688342|FG002|Overall Study|Withdrawal by Subject|12|||
48682442|NCT03712787|156688343|FG003|Overall Study|Withdrawal by Subject|8|||
48682443|NCT03712787|156688340|FG000|Overall Study|Lost to Follow-up|1|||
48682444|NCT03712787|156688341|FG001|Overall Study|Lost to Follow-up|1|||
48682445|NCT03712787|156688342|FG002|Overall Study|Lost to Follow-up|2|||
48682446|NCT03712787|156688343|FG003|Overall Study|Lost to Follow-up|1|||
48682447|NCT03712787|156688340|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
48682448|NCT03712787|156688341|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
48682449|NCT03712787|156688342|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
48682450|NCT03712787|156688343|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
48682451|NCT03712787|156688340|FG000|Overall Study|COVID-19 Infection|0|||
48682452|NCT03712787|156688341|FG001|Overall Study|COVID-19 Infection|1|||
48682453|NCT03712787|156688342|FG002|Overall Study|COVID-19 Infection|0|||
48682454|NCT03712787|156688343|FG003|Overall Study|COVID-19 Infection|0|||
48682455|NCT03712787|156688340|FG000|Overall Study|Other, Not Specified|79|||
48682456|NCT03712787|156688341|FG001|Overall Study|Other, Not Specified|77|||
48682457|NCT03712787|156688342|FG002|Overall Study|Other, Not Specified|74|||
48682458|NCT03712787|156688343|FG003|Overall Study|Other, Not Specified|78|||
48682459|NCT01698814|156688344|FG000|Overall Study|Adverse Event|0|||
48682460|NCT01698814|156688345|FG001|Overall Study|Adverse Event|2|||
48682461|NCT01698814|156688344|FG000|Overall Study|Lost to Follow-up|0|||
48682462|NCT01698814|156688345|FG001|Overall Study|Lost to Follow-up|1|||
48682463|NCT01698814|156688344|FG000|Overall Study|Pregnancy|1|||
48682464|NCT01698814|156688345|FG001|Overall Study|Pregnancy|0|||
48682465|NCT01698814|156688344|FG000|Overall Study|Randomized in error|1|||
48682466|NCT01698814|156688345|FG001|Overall Study|Randomized in error|0|||
48682467|NCT00872599|156688352|FG000|Second Washout Period|Adverse Event|1|||
48682468|NCT00872599|156688353|FG001|Second Washout Period|Adverse Event|1|||
48682469|NCT03354273|156688356|FG000|Overall Study|Adverse Event|5|||
48682470|NCT03354273|156688356|FG000|Overall Study|Screen Failure|21|||
48682471|NCT03354273|156688356|FG000|Overall Study|Withdrawal by Subject|34|||
48682472|NCT03354273|156688356|FG000|Overall Study|Technical Problems|30|||
48682473|NCT03354273|156688356|FG000|Overall Study|Lost to Follow-up|4|||
48682474|NCT03354273|156688356|FG000|Overall Study|Investigator Decision|3|||
48682475|NCT03354273|156688356|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
48682476|NCT03354273|156688356|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
48682477|NCT03354273|156688356|FG000|Overall Study|COVID-19 Restrictions|9|||
48682478|NCT03354273|156688356|FG000|Overall Study|Other|5|||
48682479|NCT02510001|156688359|FG000|Overall Study|Early disease progression|0|||
48682480|NCT02510001|156688360|FG001|Overall Study|Early disease progression|0|||
48682481|NCT02510001|156688361|FG002|Overall Study|Early disease progression|0|||
48682482|NCT02510001|156688362|FG003|Overall Study|Early disease progression|1|||
48682483|NCT02510001|156688363|FG004|Overall Study|Early disease progression|1|||
48682484|NCT02510001|156688364|FG005|Overall Study|Early disease progression|1|||
48682485|NCT02510001|156688365|FG006|Overall Study|Early disease progression|0|||
48682486|NCT02510001|156688366|FG007|Overall Study|Early disease progression|0|||
48762910|NCT01380184|156980389|FG000|Part 1 (19 Days)|Adverse Event|1|||
48762911|NCT01380184|156980389|FG000|Part 2|Adverse Event|5|||
48762912|NCT01380184|156980389|FG000|Part 2|Disease Progression|8|||
48762913|NCT01380184|156980389|FG000|Part 2|Lost to Follow-up|1|||
48762914|NCT01806896|156980391|FG000|Overall Study|Adverse Event|2|||
48762915|NCT01806896|156980392|FG001|Overall Study|Adverse Event|0|||
48762916|NCT01806896|156980391|FG000|Overall Study|Other|1|||
48682487|NCT02510001|156688359|FG000|Overall Study|Adverse Event|0|||
48682488|NCT02510001|156688360|FG001|Overall Study|Adverse Event|0|||
48682489|NCT02510001|156688361|FG002|Overall Study|Adverse Event|0|||
48682490|NCT02510001|156688362|FG003|Overall Study|Adverse Event|1|||
48682491|NCT02510001|156688363|FG004|Overall Study|Adverse Event|2|||
48682492|NCT02510001|156688364|FG005|Overall Study|Adverse Event|1|||
48682493|NCT02510001|156688365|FG006|Overall Study|Adverse Event|2|||
48682494|NCT02510001|156688366|FG007|Overall Study|Adverse Event|5|||
48355233|NCT00763451|155497224|FG003|Overall Study|Study Site Reason|1|||
48355234|NCT03995316|155497227|FG000|Overall Study|Lost to Follow-up|10|||
48355235|NCT03995316|155497228|FG001|Overall Study|Lost to Follow-up|3|||
48355236|NCT01294436|155497229|FG000|Overall Study|Adverse Event|10|||
48682495|NCT02510001|156688359|FG000|Overall Study|Physician Decision|0|||
48682496|NCT02510001|156688360|FG001|Overall Study|Physician Decision|0|||
48682497|NCT02510001|156688361|FG002|Overall Study|Physician Decision|0|||
48682498|NCT02510001|156688362|FG003|Overall Study|Physician Decision|0|||
48682499|NCT02510001|156688363|FG004|Overall Study|Physician Decision|1|||
48682500|NCT02510001|156688364|FG005|Overall Study|Physician Decision|0|||
48682501|NCT02510001|156688365|FG006|Overall Study|Physician Decision|0|||
48682502|NCT02510001|156688366|FG007|Overall Study|Physician Decision|0|||
48682503|NCT02510001|156688359|FG000|Overall Study|Withdrawal by Subject|0|||
48682504|NCT02510001|156688360|FG001|Overall Study|Withdrawal by Subject|0|||
48682505|NCT02510001|156688361|FG002|Overall Study|Withdrawal by Subject|0|||
48682506|NCT02510001|156688362|FG003|Overall Study|Withdrawal by Subject|0|||
48682507|NCT02510001|156688363|FG004|Overall Study|Withdrawal by Subject|0|||
48682508|NCT02510001|156688364|FG005|Overall Study|Withdrawal by Subject|0|||
48682509|NCT02510001|156688365|FG006|Overall Study|Withdrawal by Subject|0|||
48682510|NCT02510001|156688366|FG007|Overall Study|Withdrawal by Subject|2|||
48682511|NCT02255461|156688385|FG000|Overall Study|Adverse Event|0|||
48682512|NCT02255461|156688386|FG001|Overall Study|Adverse Event|1|||
48682513|NCT02255461|156688387|FG002|Overall Study|Adverse Event|0|||
48682514|NCT02255461|156688388|FG003|Overall Study|Adverse Event|0|||
48682515|NCT02255461|156688389|FG004|Overall Study|Adverse Event|1|||
48682516|NCT02255461|156688385|FG000|Overall Study|Withdrawal by Subject|0|||
48682517|NCT02255461|156688386|FG001|Overall Study|Withdrawal by Subject|0|||
48762917|NCT01806896|156980392|FG001|Overall Study|Other|0|||
48355237|NCT01294436|155497230|FG001|Overall Study|Adverse Event|17|||
48355238|NCT01294436|155497229|FG000|Overall Study|Withdrawal by Subject|11|||
48355239|NCT01294436|155497230|FG001|Overall Study|Withdrawal by Subject|28|||
48355240|NCT01294436|155497229|FG000|Overall Study|subject no longer meets study criteria|5|||
48355241|NCT01294436|155497230|FG001|Overall Study|subject no longer meets study criteria|20|||
48355242|NCT01294436|155497229|FG000|Overall Study|poor/non-compliance|2|||
48355243|NCT01294436|155497230|FG001|Overall Study|poor/non-compliance|5|||
48355244|NCT02296892|155497231|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
48355245|NCT02296892|155497232|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
48355246|NCT02296892|155497233|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
48355247|NCT02296892|155497231|FG000|Overall Study|Lost to Follow-up|5|||
48355248|NCT02296892|155497232|FG001|Overall Study|Lost to Follow-up|0|||
48355249|NCT02296892|155497233|FG002|Overall Study|Lost to Follow-up|1|||
48355250|NCT01814072|155497236|FG000|Overall Study|Lost to Follow-up|2|||
48355251|NCT01814072|155497237|FG001|Overall Study|Lost to Follow-up|2|||
48355252|NCT01814072|155497238|FG002|Overall Study|Lost to Follow-up|2|||
48355253|NCT01814072|155497239|FG003|Overall Study|Lost to Follow-up|0|||
48355254|NCT01814072|155497240|FG004|Overall Study|Lost to Follow-up|2|||
48355255|NCT01814072|155497241|FG005|Overall Study|Lost to Follow-up|3|||
48355256|NCT01814072|155497242|FG006|Overall Study|Lost to Follow-up|3|||
48355257|NCT01814072|155497243|FG007|Overall Study|Lost to Follow-up|1|||
48355258|NCT01814072|155497244|FG008|Overall Study|Lost to Follow-up|2|||
48355259|NCT01814072|155497245|FG009|Overall Study|Lost to Follow-up|3|||
48355260|NCT01814072|155497246|FG010|Overall Study|Lost to Follow-up|1|||
48355261|NCT01814072|155497247|FG011|Overall Study|Lost to Follow-up|2|||
48355262|NCT01814072|155497248|FG012|Overall Study|Lost to Follow-up|2|||
48355263|NCT01814072|155497249|FG013|Overall Study|Lost to Follow-up|1|||
48355264|NCT01814072|155497250|FG014|Overall Study|Lost to Follow-up|2|||
48355265|NCT01814072|155497251|FG015|Overall Study|Lost to Follow-up|1|||
48355266|NCT01814072|155497252|FG016|Overall Study|Lost to Follow-up|3|||
48355267|NCT01814072|155497253|FG017|Overall Study|Lost to Follow-up|1|||
48355268|NCT01814072|155497254|FG018|Overall Study|Lost to Follow-up|3|||
48355269|NCT01814072|155497255|FG019|Overall Study|Lost to Follow-up|3|||
48355270|NCT01814072|155497256|FG020|Overall Study|Lost to Follow-up|2|||
48355271|NCT01814072|155497257|FG021|Overall Study|Lost to Follow-up|1|||
48355272|NCT01814072|155497258|FG022|Overall Study|Lost to Follow-up|3|||
48355273|NCT01814072|155497259|FG023|Overall Study|Lost to Follow-up|1|||
48355274|NCT01814072|155497260|FG024|Overall Study|Lost to Follow-up|4|||
48355275|NCT01814072|155497261|FG025|Overall Study|Lost to Follow-up|1|||
48355276|NCT01814072|155497262|FG026|Overall Study|Lost to Follow-up|1|||
48355277|NCT01814072|155497263|FG027|Overall Study|Lost to Follow-up|2|||
48355278|NCT01814072|155497264|FG028|Overall Study|Lost to Follow-up|3|||
48355279|NCT01814072|155497265|FG029|Overall Study|Lost to Follow-up|3|||
48355280|NCT01814072|155497266|FG030|Overall Study|Lost to Follow-up|2|||
48355281|NCT01814072|155497267|FG031|Overall Study|Lost to Follow-up|0|||
48355282|NCT01814072|155497236|FG000|Overall Study|Withdrawal by Subject|2|||
48355283|NCT01814072|155497237|FG001|Overall Study|Withdrawal by Subject|0|||
48355284|NCT01814072|155497238|FG002|Overall Study|Withdrawal by Subject|1|||
48355285|NCT01814072|155497239|FG003|Overall Study|Withdrawal by Subject|0|||
48355286|NCT01814072|155497240|FG004|Overall Study|Withdrawal by Subject|2|||
48355287|NCT01814072|155497241|FG005|Overall Study|Withdrawal by Subject|3|||
48355288|NCT01814072|155497242|FG006|Overall Study|Withdrawal by Subject|1|||
48355289|NCT01814072|155497243|FG007|Overall Study|Withdrawal by Subject|0|||
48682518|NCT02255461|156688387|FG002|Overall Study|Withdrawal by Subject|1|||
48682519|NCT02255461|156688388|FG003|Overall Study|Withdrawal by Subject|0|||
48682520|NCT02255461|156688389|FG004|Overall Study|Withdrawal by Subject|1|||
48682521|NCT02255461|156688385|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
48682522|NCT02255461|156688386|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
48682523|NCT02255461|156688387|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
48389788|NCT01225731|155621500|FG012|Part 3|Lost to Follow-up|1|||
48389789|NCT01225731|155621488|FG000|Part 3|Physician Decision|0|||
48389790|NCT01225731|155621489|FG001|Part 3|Physician Decision|0|||
48389791|NCT01225731|155621490|FG002|Part 3|Physician Decision|0|||
48389792|NCT01225731|155621491|FG003|Part 3|Physician Decision|0|||
48389793|NCT01225731|155621492|FG004|Part 3|Physician Decision|0|||
48389794|NCT01225731|155621493|FG005|Part 3|Physician Decision|0|||
48389795|NCT01225731|155621494|FG006|Part 3|Physician Decision|0|||
48389796|NCT01225731|155621495|FG007|Part 3|Physician Decision|0|||
48389797|NCT01225731|155621496|FG008|Part 3|Physician Decision|0|||
48389798|NCT01225731|155621497|FG009|Part 3|Physician Decision|0|||
48389799|NCT01225731|155621498|FG010|Part 3|Physician Decision|0|||
48682524|NCT02255461|156688388|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
48682525|NCT02255461|156688389|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
48682526|NCT01559675|156688394|FG000|Overall Study|Protocol Violation|1|||
48682527|NCT01559675|156688395|FG001|Overall Study|Protocol Violation|2|||
48682528|NCT01559675|156688394|FG000|Overall Study|2nd operation on same patient excluded|14|||
48682529|NCT01559675|156688395|FG001|Overall Study|2nd operation on same patient excluded|12|||
48682530|NCT00853151|156688396|FG000|Overall Study|Adverse Event|1|||
48682531|NCT00853151|156688397|FG001|Overall Study|Adverse Event|4|||
48682532|NCT00853151|156688398|FG002|Overall Study|Adverse Event|2|||
48682533|NCT00853151|156688399|FG003|Overall Study|Adverse Event|0|||
48682534|NCT00853151|156688396|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
48682535|NCT00853151|156688397|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48682536|NCT00853151|156688398|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48682537|NCT00853151|156688399|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48682538|NCT00853151|156688396|FG000|Overall Study|Lost to Follow-up|2|||
48682539|NCT00853151|156688397|FG001|Overall Study|Lost to Follow-up|0|||
48682540|NCT00853151|156688398|FG002|Overall Study|Lost to Follow-up|3|||
48682541|NCT00853151|156688399|FG003|Overall Study|Lost to Follow-up|0|||
48682542|NCT00853151|156688396|FG000|Overall Study|Death|1|||
48682543|NCT00853151|156688397|FG001|Overall Study|Death|0|||
48762918|NCT04568590|156981956|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
48762919|NCT03220217|156981957|FG000|Overall Study|Withdrawal by Subject|0|||
48762920|NCT03220217|156981958|FG001|Overall Study|Withdrawal by Subject|1|||
48762921|NCT03220217|156981959|FG002|Overall Study|Withdrawal by Subject|0|||
48762922|NCT03220217|156981957|FG000|Overall Study|Subject Missed Procedure|0|||
48762923|NCT03220217|156981958|FG001|Overall Study|Subject Missed Procedure|0|||
48389800|NCT01225731|155621499|FG011|Part 3|Physician Decision|1|||
48389801|NCT01225731|155621500|FG012|Part 3|Physician Decision|2|||
48389802|NCT01225731|155621488|FG000|Part 3|Withdrawal by Subject|0|||
48389803|NCT01225731|155621489|FG001|Part 3|Withdrawal by Subject|0|||
48389804|NCT01225731|155621490|FG002|Part 3|Withdrawal by Subject|0|||
48389805|NCT01225731|155621491|FG003|Part 3|Withdrawal by Subject|0|||
48389806|NCT01225731|155621492|FG004|Part 3|Withdrawal by Subject|0|||
48389807|NCT01225731|155621493|FG005|Part 3|Withdrawal by Subject|0|||
48389808|NCT01225731|155621494|FG006|Part 3|Withdrawal by Subject|0|||
48389809|NCT01225731|155621495|FG007|Part 3|Withdrawal by Subject|0|||
48389810|NCT01225731|155621496|FG008|Part 3|Withdrawal by Subject|0|||
48389811|NCT01225731|155621497|FG009|Part 3|Withdrawal by Subject|0|||
48389812|NCT01225731|155621498|FG010|Part 3|Withdrawal by Subject|4|||
48389813|NCT01225731|155621499|FG011|Part 3|Withdrawal by Subject|6|||
48389814|NCT01225731|155621500|FG012|Part 3|Withdrawal by Subject|4|||
48389815|NCT01147744|155621501|FG000|Overall Study|Protocol Violation|1|||
48389816|NCT01147744|155621502|FG001|Overall Study|Protocol Violation|0|||
48389817|NCT01147744|155621503|FG002|Overall Study|Protocol Violation|1|||
48389818|NCT01147744|155621504|FG003|Overall Study|Protocol Violation|0|||
48389819|NCT01147744|155621505|FG004|Overall Study|Protocol Violation|1|||
48389820|NCT01147744|155621506|FG005|Overall Study|Protocol Violation|3|||
48389821|NCT01147744|155621507|FG006|Overall Study|Protocol Violation|1|||
48762924|NCT03220217|156981959|FG002|Overall Study|Subject Missed Procedure|1|||
48762925|NCT01104636|156981960|FG000|Overall Study|Lack of Efficacy|43|||
48389822|NCT01147744|155621501|FG000|Overall Study|Physician Decision|0|||
48389823|NCT01147744|155621502|FG001|Overall Study|Physician Decision|1|||
48389824|NCT01147744|155621503|FG002|Overall Study|Physician Decision|1|||
48389825|NCT01147744|155621504|FG003|Overall Study|Physician Decision|0|||
48389826|NCT01147744|155621505|FG004|Overall Study|Physician Decision|0|||
48389827|NCT01147744|155621506|FG005|Overall Study|Physician Decision|0|||
48389828|NCT01147744|155621507|FG006|Overall Study|Physician Decision|1|||
48389829|NCT01147744|155621501|FG000|Overall Study|Lack of Efficacy|11|||
48389830|NCT01147744|155621502|FG001|Overall Study|Lack of Efficacy|11|||
48682544|NCT00853151|156688398|FG002|Overall Study|Death|0|||
48682545|NCT00853151|156688399|FG003|Overall Study|Death|1|||
48682546|NCT00853151|156688396|FG000|Overall Study|Protocol Violation|0|||
48682547|NCT00853151|156688397|FG001|Overall Study|Protocol Violation|0|||
48682548|NCT00853151|156688398|FG002|Overall Study|Protocol Violation|0|||
48682549|NCT00853151|156688399|FG003|Overall Study|Protocol Violation|1|||
48682550|NCT00853151|156688396|FG000|Overall Study|Withdrawal by Subject|5|||
48682551|NCT00853151|156688397|FG001|Overall Study|Withdrawal by Subject|4|||
48682552|NCT00853151|156688398|FG002|Overall Study|Withdrawal by Subject|2|||
48682553|NCT00853151|156688399|FG003|Overall Study|Withdrawal by Subject|1|||
48682554|NCT00853151|156688396|FG000|Overall Study|Physician Decision|0|||
48682555|NCT00853151|156688397|FG001|Overall Study|Physician Decision|2|||
48682556|NCT00853151|156688398|FG002|Overall Study|Physician Decision|1|||
48682557|NCT00853151|156688399|FG003|Overall Study|Physician Decision|0|||
48682558|NCT00853151|156688396|FG000|Overall Study|Sponsor Decision|0|||
48682559|NCT00853151|156688397|FG001|Overall Study|Sponsor Decision|3|||
48682560|NCT00853151|156688398|FG002|Overall Study|Sponsor Decision|0|||
48682561|NCT00853151|156688399|FG003|Overall Study|Sponsor Decision|0|||
48682562|NCT00291018|156688400|FG000|Overall Study|Not Consented or Declined PAS|12|||
48682563|NCT00291018|156688401|FG001|Overall Study|Not Consented or Declined PAS|15|||
48682564|NCT00291018|156688402|FG002|Overall Study|Not Consented or Declined PAS|15|||
48682565|NCT00291018|156688400|FG000|Overall Study|Death|3|||
48682566|NCT00291018|156688401|FG001|Overall Study|Death|3|||
48682567|NCT00291018|156688402|FG002|Overall Study|Death|4|||
48682568|NCT00291018|156688400|FG000|Overall Study|Withdrawal by Subject|2|||
48682569|NCT00291018|156688401|FG001|Overall Study|Withdrawal by Subject|8|||
48682570|NCT00291018|156688402|FG002|Overall Study|Withdrawal by Subject|1|||
48682571|NCT00291018|156688400|FG000|Overall Study|Failures|5|||
48682572|NCT00291018|156688401|FG001|Overall Study|Failures|12|||
48682573|NCT00291018|156688402|FG002|Overall Study|Failures|5|||
48682574|NCT00291018|156688400|FG000|Overall Study|Lost to Follow-up|3|||
48682575|NCT00291018|156688401|FG001|Overall Study|Lost to Follow-up|4|||
48682576|NCT00291018|156688402|FG002|Overall Study|Lost to Follow-up|18|||
48682577|NCT00713544|156688403|FG000|Overall Study|Adverse Event|5|||
48682578|NCT00713544|156688404|FG001|Overall Study|Adverse Event|3|||
48682579|NCT00713544|156688405|FG002|Overall Study|Adverse Event|7|||
48682580|NCT00713544|156688406|FG003|Overall Study|Adverse Event|7|||
48682581|NCT00713544|156688407|FG004|Overall Study|Adverse Event|3|||
48682582|NCT00713544|156688408|FG005|Overall Study|Adverse Event|5|||
48682583|NCT00713544|156688403|FG000|Overall Study|Withdrawal by Subject|2|||
48682584|NCT00713544|156688404|FG001|Overall Study|Withdrawal by Subject|0|||
48682585|NCT00713544|156688405|FG002|Overall Study|Withdrawal by Subject|3|||
48762926|NCT01104636|156981960|FG000|Overall Study|Lost to Follow-up|24|||
48762927|NCT01104636|156981960|FG000|Overall Study|Withdrawal by Subject|4|||
48762928|NCT01104636|156981960|FG000|Overall Study|Other|43|||
48762929|NCT01104636|156981960|FG000|Overall Study|Study terminated by sponsor|1|||
48762930|NCT01104636|156981960|FG000|Overall Study|Pregnancy|2|||
48389831|NCT01147744|155621503|FG002|Overall Study|Lack of Efficacy|9|||
48389832|NCT01147744|155621504|FG003|Overall Study|Lack of Efficacy|11|||
48389833|NCT01147744|155621505|FG004|Overall Study|Lack of Efficacy|13|||
48389834|NCT01147744|155621506|FG005|Overall Study|Lack of Efficacy|8|||
48389835|NCT01147744|155621507|FG006|Overall Study|Lack of Efficacy|7|||
48389836|NCT01147744|155621501|FG000|Overall Study|Adverse Event|1|||
48389837|NCT01147744|155621502|FG001|Overall Study|Adverse Event|2|||
48389838|NCT01147744|155621503|FG002|Overall Study|Adverse Event|3|||
48389839|NCT01147744|155621504|FG003|Overall Study|Adverse Event|0|||
48389840|NCT01147744|155621505|FG004|Overall Study|Adverse Event|2|||
48389841|NCT01147744|155621506|FG005|Overall Study|Adverse Event|1|||
48389842|NCT01147744|155621507|FG006|Overall Study|Adverse Event|2|||
48389843|NCT01147744|155621501|FG000|Overall Study|Withdrawal by Subject|8|||
48389844|NCT01147744|155621502|FG001|Overall Study|Withdrawal by Subject|4|||
48389845|NCT01147744|155621503|FG002|Overall Study|Withdrawal by Subject|2|||
48389846|NCT01147744|155621504|FG003|Overall Study|Withdrawal by Subject|2|||
48389847|NCT01147744|155621505|FG004|Overall Study|Withdrawal by Subject|2|||
48389848|NCT01147744|155621506|FG005|Overall Study|Withdrawal by Subject|5|||
48389849|NCT01147744|155621507|FG006|Overall Study|Withdrawal by Subject|2|||
48682586|NCT00713544|156688406|FG003|Overall Study|Withdrawal by Subject|2|||
48682587|NCT00713544|156688407|FG004|Overall Study|Withdrawal by Subject|3|||
48389850|NCT01147744|155621501|FG000|Overall Study|Lost to Follow-up|0|||
48389851|NCT01147744|155621502|FG001|Overall Study|Lost to Follow-up|1|||
48389852|NCT01147744|155621503|FG002|Overall Study|Lost to Follow-up|0|||
48389853|NCT01147744|155621504|FG003|Overall Study|Lost to Follow-up|0|||
48389854|NCT01147744|155621505|FG004|Overall Study|Lost to Follow-up|0|||
48389855|NCT01147744|155621506|FG005|Overall Study|Lost to Follow-up|0|||
48389856|NCT01147744|155621507|FG006|Overall Study|Lost to Follow-up|0|||
48682588|NCT00713544|156688408|FG005|Overall Study|Withdrawal by Subject|1|||
48682589|NCT00713544|156688403|FG000|Overall Study|Protocol Violation|0|||
48682590|NCT00713544|156688404|FG001|Overall Study|Protocol Violation|0|||
48682591|NCT00713544|156688405|FG002|Overall Study|Protocol Violation|0|||
48682592|NCT00713544|156688406|FG003|Overall Study|Protocol Violation|0|||
48682593|NCT00713544|156688407|FG004|Overall Study|Protocol Violation|0|||
48762931|NCT01104636|156981960|FG000|Overall Study|Adverse Event|40|||
48682594|NCT00713544|156688408|FG005|Overall Study|Protocol Violation|1|||
48682595|NCT00713544|156688403|FG000|Overall Study|Physician Decision|0|||
48682596|NCT00713544|156688404|FG001|Overall Study|Physician Decision|0|||
48682597|NCT00713544|156688405|FG002|Overall Study|Physician Decision|0|||
48682598|NCT00713544|156688406|FG003|Overall Study|Physician Decision|0|||
48682599|NCT00713544|156688407|FG004|Overall Study|Physician Decision|0|||
48682600|NCT00713544|156688408|FG005|Overall Study|Physician Decision|2|||
48682601|NCT00713544|156688403|FG000|Overall Study|Lack of Efficacy|0|||
48682602|NCT00713544|156688404|FG001|Overall Study|Lack of Efficacy|1|||
48682603|NCT00713544|156688405|FG002|Overall Study|Lack of Efficacy|0|||
48682604|NCT00713544|156688406|FG003|Overall Study|Lack of Efficacy|1|||
48682605|NCT00713544|156688407|FG004|Overall Study|Lack of Efficacy|1|||
48682606|NCT00713544|156688408|FG005|Overall Study|Lack of Efficacy|0|||
48682607|NCT00713544|156688403|FG000|Overall Study|Lost to Follow-up|0|||
48682608|NCT00713544|156688404|FG001|Overall Study|Lost to Follow-up|0|||
48682609|NCT00713544|156688405|FG002|Overall Study|Lost to Follow-up|1|||
48682610|NCT00713544|156688406|FG003|Overall Study|Lost to Follow-up|0|||
48682611|NCT00713544|156688407|FG004|Overall Study|Lost to Follow-up|0|||
48682612|NCT00713544|156688408|FG005|Overall Study|Lost to Follow-up|0|||
48682613|NCT00713544|156688403|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682614|NCT00713544|156688404|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
48682615|NCT00713544|156688405|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682616|NCT00713544|156688406|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682617|NCT00713544|156688407|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682618|NCT00713544|156688408|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
48682619|NCT00713544|156688403|FG000|Overall Study|Incorrect enrollment|0|||
48682620|NCT00713544|156688404|FG001|Overall Study|Incorrect enrollment|1|||
48682621|NCT00713544|156688405|FG002|Overall Study|Incorrect enrollment|0|||
48682622|NCT00713544|156688406|FG003|Overall Study|Incorrect enrollment|0|||
48682623|NCT00713544|156688407|FG004|Overall Study|Incorrect enrollment|0|||
48682624|NCT00713544|156688408|FG005|Overall Study|Incorrect enrollment|0|||
48682625|NCT00713544|156688403|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
48682626|NCT00713544|156688404|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
48682627|NCT00713544|156688405|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
48682628|NCT00713544|156688406|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
48682629|NCT00713544|156688407|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
48682630|NCT00713544|156688408|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
48682631|NCT00269919|156688409|FG000|Overall Study|Other|26|||
48682632|NCT00269919|156688409|FG000|Overall Study|Started but not treated|1|||
48682633|NCT02219334|156688410|FG000|Overall Study|Withdrawal by Subject|1|||
48682634|NCT02219334|156688411|FG001|Overall Study|Withdrawal by Subject|0|||
48682635|NCT02219334|156688410|FG000|Overall Study|Protocol Violation|7|||
48682636|NCT02219334|156688411|FG001|Overall Study|Protocol Violation|3|||
48682637|NCT01641601|156688412|FG000|Overall Study|Study discontinued.|3|||
48682638|NCT01641601|156688413|FG001|Overall Study|Study discontinued.|5|||
48682639|NCT02517541|156688418|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
48682640|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
48682641|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
48682642|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
48682643|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
48682644|NCT02517541|156688418|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
48682645|NCT00592904|156688419|FG000|Overall Study|Adverse Event|15|||
48682646|NCT00592904|156688420|FG001|Overall Study|Adverse Event|25|||
48682647|NCT00592904|156688421|FG002|Overall Study|Adverse Event|13|||
48682648|NCT00592904|156688422|FG003|Overall Study|Adverse Event|5|||
48682649|NCT00592904|156688419|FG000|Overall Study|Protocol Violation|1|||
48682650|NCT00592904|156688420|FG001|Overall Study|Protocol Violation|1|||
48682651|NCT00592904|156688421|FG002|Overall Study|Protocol Violation|0|||
48682652|NCT00592904|156688422|FG003|Overall Study|Protocol Violation|1|||
48682653|NCT00592904|156688419|FG000|Overall Study|Withdrawal by Subject|4|||
48682654|NCT00592904|156688420|FG001|Overall Study|Withdrawal by Subject|16|||
48682655|NCT00592904|156688421|FG002|Overall Study|Withdrawal by Subject|1|||
48682656|NCT00592904|156688422|FG003|Overall Study|Withdrawal by Subject|2|||
48682657|NCT00592904|156688419|FG000|Overall Study|Lack of Efficacy|2|||
48682658|NCT00592904|156688420|FG001|Overall Study|Lack of Efficacy|7|||
48682659|NCT00592904|156688421|FG002|Overall Study|Lack of Efficacy|2|||
48682660|NCT00592904|156688422|FG003|Overall Study|Lack of Efficacy|3|||
48682661|NCT00592904|156688419|FG000|Overall Study|Physician Decision|0|||
48682662|NCT00592904|156688420|FG001|Overall Study|Physician Decision|3|||
48682663|NCT00592904|156688421|FG002|Overall Study|Physician Decision|1|||
48682664|NCT00592904|156688422|FG003|Overall Study|Physician Decision|0|||
48682665|NCT00592904|156688419|FG000|Overall Study|Other|3|||
48682666|NCT00592904|156688420|FG001|Overall Study|Other|3|||
48682667|NCT00592904|156688421|FG002|Overall Study|Other|0|||
48682668|NCT00592904|156688422|FG003|Overall Study|Other|0|||
48682669|NCT00398567|156688425|FG000|Overall Study|Disease Progression|3|||
48682670|NCT00398567|156688426|FG001|Overall Study|Disease Progression|4|||
48682671|NCT00398567|156688427|FG002|Overall Study|Disease Progression|27|||
48682672|NCT00398567|156688425|FG000|Overall Study|Withdrawal by Subject|1|||
48682673|NCT00398567|156688426|FG001|Overall Study|Withdrawal by Subject|0|||
48682674|NCT00398567|156688427|FG002|Overall Study|Withdrawal by Subject|4|||
48682675|NCT00398567|156688425|FG000|Overall Study|Adverse Event|0|||
48682676|NCT00398567|156688426|FG001|Overall Study|Adverse Event|0|||
48682677|NCT00398567|156688427|FG002|Overall Study|Adverse Event|2|||
48682678|NCT00398567|156688425|FG000|Overall Study|Protocol Violation|0|||
48682679|NCT00398567|156688426|FG001|Overall Study|Protocol Violation|0|||
48682680|NCT00398567|156688427|FG002|Overall Study|Protocol Violation|1|||
48682681|NCT03078556|156688428|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
48682682|NCT03078556|156688429|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
48682683|NCT03078556|156688430|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
48682684|NCT03078556|156688431|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
48682685|NCT03078556|156688428|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
48682686|NCT03078556|156688429|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
48682687|NCT03078556|156688430|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
48682688|NCT03078556|156688431|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
48682689|NCT03078556|156688428|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
48682690|NCT03078556|156688429|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
48682691|NCT03078556|156688430|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
48682692|NCT03078556|156688431|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
48682693|NCT03078556|156688428|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
48682694|NCT03078556|156688429|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
48682695|NCT03078556|156688430|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
48682696|NCT03078556|156688431|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
48682697|NCT03329092|156688438|FG000|Overall Study|Other|2|||
48682698|NCT03329092|156688439|FG001|Overall Study|Other|2|||
48682699|NCT03329092|156688438|FG000|Overall Study|Withdrawal by Subject|16|||
48682700|NCT03329092|156688439|FG001|Overall Study|Withdrawal by Subject|3|||
48682701|NCT03329092|156688438|FG000|Overall Study|Physician Decision|1|||
48682702|NCT03329092|156688439|FG001|Overall Study|Physician Decision|0|||
48682703|NCT03329092|156688438|FG000|Overall Study|Death|17|||
48682704|NCT03329092|156688439|FG001|Overall Study|Death|11|||
48682705|NCT03329092|156688438|FG000|Overall Study|Adverse Event|3|||
48682706|NCT03329092|156688439|FG001|Overall Study|Adverse Event|1|||
48682707|NCT03329092|156688438|FG000|Overall Study|Lost to Follow-up|1|||
48682708|NCT03329092|156688439|FG001|Overall Study|Lost to Follow-up|1|||
48682709|NCT05786508|156688440|FG000|Overall Study|Withdrawal by Subject|2|||
48682710|NCT05786508|156688441|FG001|Overall Study|Withdrawal by Subject|0|||
48682711|NCT04273893|156688442|FG000|Overall Study|Withdrawal by Subject|0|||
48682712|NCT04273893|156688443|FG001|Overall Study|Withdrawal by Subject|2|||
48682713|NCT04273893|156688442|FG000|Overall Study|Treatment of Disease Progression|0|||
48682714|NCT04273893|156688443|FG001|Overall Study|Treatment of Disease Progression|2|||
48682715|NCT04273893|156688442|FG000|Overall Study|Death|1|||
48682716|NCT04273893|156688443|FG001|Overall Study|Death|2|||
48682717|NCT04273893|156688442|FG000|Overall Study|Lost to Follow-up|0|||
48682718|NCT04273893|156688443|FG001|Overall Study|Lost to Follow-up|2|||
48682719|NCT04273893|156688442|FG000|Overall Study|Physician Decision|1|||
48682720|NCT04273893|156688443|FG001|Overall Study|Physician Decision|0|||
48682721|NCT02287467|156688450|FG000|Overall Study|Protocol Violation|12|||
48682722|NCT02287467|156688451|FG001|Overall Study|Protocol Violation|9|||
48682723|NCT01036321|156688452|FG000|Overall Study|Ineligible after randomization|0|||
48682724|NCT01036321|156688453|FG001|Overall Study|Ineligible after randomization|1|||
48682725|NCT01036321|156688452|FG000|Overall Study|Withdrawal by Subject|3|||
48682726|NCT01036321|156688453|FG001|Overall Study|Withdrawal by Subject|2|||
48682727|NCT01036321|156688452|FG000|Overall Study|Adverse Event|2|||
48682728|NCT01036321|156688453|FG001|Overall Study|Adverse Event|1|||
48682729|NCT00394706|156688454|FG000|Overall Study|Withdrawal by Subject|2|||
48389857|NCT01147744|155621501|FG000|Overall Study|Sponsor decision to amend protocol|7|||
48682730|NCT00394706|156688455|FG001|Overall Study|Withdrawal by Subject|0|||
48389858|NCT01147744|155621502|FG001|Overall Study|Sponsor decision to amend protocol|4|||
48389859|NCT01147744|155621503|FG002|Overall Study|Sponsor decision to amend protocol|2|||
48389860|NCT01147744|155621504|FG003|Overall Study|Sponsor decision to amend protocol|5|||
48389861|NCT01147744|155621505|FG004|Overall Study|Sponsor decision to amend protocol|7|||
48389862|NCT01147744|155621506|FG005|Overall Study|Sponsor decision to amend protocol|2|||
48682731|NCT00394706|156688456|FG002|Overall Study|Withdrawal by Subject|1|||
48682732|NCT00394706|156688457|FG003|Overall Study|Withdrawal by Subject|0|||
48682733|NCT00394706|156688458|FG004|Overall Study|Withdrawal by Subject|0|||
48682734|NCT00394706|156688459|FG005|Overall Study|Withdrawal by Subject|2|||
48682735|NCT00394706|156688460|FG006|Overall Study|Withdrawal by Subject|1|||
48682736|NCT00394706|156688461|FG007|Overall Study|Withdrawal by Subject|0|||
48682737|NCT00394706|156688454|FG000|Overall Study|Lost to Follow-up|2|||
48682738|NCT00394706|156688455|FG001|Overall Study|Lost to Follow-up|2|||
48682739|NCT00394706|156688456|FG002|Overall Study|Lost to Follow-up|8|||
48682740|NCT00394706|156688457|FG003|Overall Study|Lost to Follow-up|1|||
48429384|NCT01070550|155760355|FG000|Overall Study|Relapse|44|||
48682741|NCT00394706|156688458|FG004|Overall Study|Lost to Follow-up|2|||
48682742|NCT00394706|156688459|FG005|Overall Study|Lost to Follow-up|5|||
48682743|NCT00394706|156688460|FG006|Overall Study|Lost to Follow-up|2|||
48682744|NCT00394706|156688461|FG007|Overall Study|Lost to Follow-up|0|||
48682745|NCT03387020|156688463|FG000|Overall Study|Adverse Event|0|||
48682746|NCT03387020|156688464|FG001|Overall Study|Adverse Event|2|||
48682747|NCT03387020|156688465|FG002|Overall Study|Adverse Event|0|||
48682748|NCT03387020|156688463|FG000|Overall Study|Withdrawal by Subject|2|||
48682749|NCT03387020|156688464|FG001|Overall Study|Withdrawal by Subject|0|||
48682750|NCT03387020|156688465|FG002|Overall Study|Withdrawal by Subject|0|||
48682751|NCT04112303|156688467|FG000|Overall Study|Death|1|||
48682752|NCT00377858|156688469|FG000|Overall Study|Withdrawal by Subject|12|||
48682753|NCT00377858|156688470|FG001|Overall Study|Withdrawal by Subject|11|||
48682754|NCT00377858|156688469|FG000|Overall Study|Lost to Follow-up|6|||
48682755|NCT00377858|156688470|FG001|Overall Study|Lost to Follow-up|1|||
48682756|NCT00377858|156688469|FG000|Overall Study|Physician Decision|5|||
48682757|NCT00377858|156688470|FG001|Overall Study|Physician Decision|5|||
48682758|NCT00377858|156688469|FG000|Overall Study|Protocol Violation|3|||
48682759|NCT00377858|156688470|FG001|Overall Study|Protocol Violation|4|||
48682760|NCT00377858|156688469|FG000|Overall Study|Adverse Event|2|||
48682761|NCT00377858|156688470|FG001|Overall Study|Adverse Event|1|||
48682762|NCT00377858|156688469|FG000|Overall Study|Entry Criteria Not Met|2|||
48682763|NCT00377858|156688470|FG001|Overall Study|Entry Criteria Not Met|0|||
48682764|NCT00377858|156688469|FG000|Overall Study|Sponsor Decision|1|||
48682765|NCT00377858|156688470|FG001|Overall Study|Sponsor Decision|2|||
48682766|NCT00377858|156688469|FG000|Overall Study|Death|0|||
48682767|NCT00377858|156688470|FG001|Overall Study|Death|3|||
48682768|NCT01685697|156688471|FG000|Overall Study|Protocol Violation|3|||
48682769|NCT01685697|156688472|FG001|Overall Study|Protocol Violation|3|||
48682770|NCT01461707|156688473|FG000|Overall Study|Withdrawal by Subject|1|||
48682771|NCT01461707|156688474|FG001|Overall Study|Withdrawal by Subject|0|||
48682772|NCT00256724|156688485|FG000|Overall Study|Physician Decision|2|||
48682773|NCT00256724|156688486|FG001|Overall Study|Physician Decision|5|||
48682774|NCT00256724|156688485|FG000|Overall Study|Protocol Violation|3|||
48682775|NCT00256724|156688486|FG001|Overall Study|Protocol Violation|3|||
48682776|NCT01076036|156688487|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
48682777|NCT01965704|156688488|FG000|Overall Study|Withdrawal by Subject|2|||
48682778|NCT01965704|156688489|FG001|Overall Study|Withdrawal by Subject|2|||
48682779|NCT01965704|156688490|FG002|Overall Study|Withdrawal by Subject|1|||
48682780|NCT01965704|156688491|FG003|Overall Study|Withdrawal by Subject|1|||
48682781|NCT01965704|156688488|FG000|Overall Study|Delivered at home|1|||
48682782|NCT01965704|156688489|FG001|Overall Study|Delivered at home|1|||
48682783|NCT01965704|156688490|FG002|Overall Study|Delivered at home|0|||
48682784|NCT01965704|156688491|FG003|Overall Study|Delivered at home|0|||
48682785|NCT01965704|156688488|FG000|Overall Study|Experienced complications|0|||
48682786|NCT01965704|156688489|FG001|Overall Study|Experienced complications|0|||
48682787|NCT01965704|156688490|FG002|Overall Study|Experienced complications|2|||
48682788|NCT01965704|156688491|FG003|Overall Study|Experienced complications|2|||
48682789|NCT01965704|156688488|FG000|Overall Study|Adverse Event|0|||
48682790|NCT01965704|156688489|FG001|Overall Study|Adverse Event|0|||
48682791|NCT01965704|156688490|FG002|Overall Study|Adverse Event|1|||
48682792|NCT01965704|156688491|FG003|Overall Study|Adverse Event|1|||
48682793|NCT01965704|156688488|FG000|Overall Study|Did not meet inclusion criteria|0|||
48682794|NCT01965704|156688489|FG001|Overall Study|Did not meet inclusion criteria|0|||
48682795|NCT01965704|156688490|FG002|Overall Study|Did not meet inclusion criteria|1|||
48682796|NCT01965704|156688491|FG003|Overall Study|Did not meet inclusion criteria|1|||
48682797|NCT00687804|156688492|FG000|Core Study|Adverse Event|5|||
48682798|NCT00687804|156688493|FG001|Core Study|Adverse Event|3|||
48682799|NCT00687804|156688494|FG002|Core Study|Adverse Event|3|||
48682800|NCT00687804|156688492|FG000|Core Study|Abnormal laboratory value(s)|1|||
48682801|NCT00687804|156688493|FG001|Core Study|Abnormal laboratory value(s)|0|||
48682802|NCT00687804|156688494|FG002|Core Study|Abnormal laboratory value(s)|0|||
48682803|NCT00687804|156688492|FG000|Core Study|Lack of Efficacy|1|||
48762932|NCT01104636|156981960|FG000|Overall Study|Ongoing|21|||
48682804|NCT00687804|156688493|FG001|Core Study|Lack of Efficacy|1|||
48682805|NCT00687804|156688494|FG002|Core Study|Lack of Efficacy|1|||
48682806|NCT00687804|156688492|FG000|Core Study|Withdrawal by Subject|4|||
48682807|NCT00687804|156688493|FG001|Core Study|Withdrawal by Subject|7|||
48682808|NCT00687804|156688494|FG002|Core Study|Withdrawal by Subject|7|||
48682809|NCT00687804|156688492|FG000|Core Study|Lost to Follow-up|0|||
48682810|NCT00687804|156688493|FG001|Core Study|Lost to Follow-up|1|||
48682811|NCT00687804|156688494|FG002|Core Study|Lost to Follow-up|0|||
48682812|NCT00687804|156688492|FG000|Core Study|Death|2|||
48682813|NCT00687804|156688493|FG001|Core Study|Death|2|||
48682814|NCT00687804|156688494|FG002|Core Study|Death|2|||
48682815|NCT00687804|156688492|FG000|Core Study|Protocol Violation|1|||
48682816|NCT00687804|156688493|FG001|Core Study|Protocol Violation|1|||
48682817|NCT00687804|156688494|FG002|Core Study|Protocol Violation|0|||
48682818|NCT00687804|156688492|FG000|Open-Label Extension Study|Adverse Event|2|||
48762933|NCT02535741|156981965|FG000|Overall Study|Adverse Event|3|||
48682819|NCT00687804|156688493|FG001|Open-Label Extension Study|Adverse Event|2|||
48682820|NCT00687804|156688494|FG002|Open-Label Extension Study|Adverse Event|2|||
48682821|NCT00687804|156688492|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
48389863|NCT01147744|155621507|FG006|Overall Study|Sponsor decision to amend protocol|6|||
48389864|NCT01147744|155621501|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48389865|NCT01147744|155621502|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48682822|NCT00687804|156688493|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
48682823|NCT00687804|156688494|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
48682824|NCT00687804|156688492|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
48682825|NCT00687804|156688493|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
48682826|NCT00687804|156688494|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
48682827|NCT00687804|156688492|FG000|Open-Label Extension Study|Administrative problems|1|||
48682828|NCT00687804|156688493|FG001|Open-Label Extension Study|Administrative problems|1|||
48682829|NCT00687804|156688494|FG002|Open-Label Extension Study|Administrative problems|0|||
48682830|NCT00687804|156688492|FG000|Open-Label Extension Study|Death|2|||
48682831|NCT00687804|156688493|FG001|Open-Label Extension Study|Death|3|||
48682832|NCT00687804|156688494|FG002|Open-Label Extension Study|Death|3|||
48682833|NCT02754726|156688495|FG000|Overall Study|Progressive Disease by RECIST|13|||
48682834|NCT02754726|156688495|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
48682835|NCT02754726|156688495|FG000|Overall Study|Clinical Disease Progression|5|||
48682836|NCT02754726|156688495|FG000|Overall Study|Adverse Event|3|||
48682837|NCT02754726|156688495|FG000|Overall Study|Withdrawal by Subject|1|||
48682838|NCT02754726|156688495|FG000|Overall Study|Tolerability|1|||
48682839|NCT02915263|156688496|FG000|Overall Study|Covid|3|||
48682840|NCT02915263|156688497|FG001|Overall Study|Covid|2|||
48682841|NCT01345188|156688499|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
48682842|NCT01345188|156688499|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
48682843|NCT01807598|156688502|FG000|Overall Study|Withdrawal by Subject|4|||
48682844|NCT01807598|156688502|FG000|Overall Study|Adverse Event|1|||
48682845|NCT01807598|156688502|FG000|Overall Study|Other Physician Decision|1|||
48682846|NCT03852719|156688504|FG000|Overall Study|Still on study after Week 192|37|||
48682847|NCT03852719|156688505|FG001|Overall Study|Still on study after Week 192|35|||
48682848|NCT03852719|156688506|FG002|Overall Study|Still on study after Week 192|35|||
48682849|NCT03852719|156688504|FG000|Overall Study|Withdrawal of consent|5|||
48682850|NCT03852719|156688505|FG001|Overall Study|Withdrawal of consent|8|||
48682851|NCT03852719|156688506|FG002|Overall Study|Withdrawal of consent|7|||
48682852|NCT03852719|156688504|FG000|Overall Study|Physician Decision|0|||
48682853|NCT03852719|156688505|FG001|Overall Study|Physician Decision|1|||
48682854|NCT03852719|156688506|FG002|Overall Study|Physician Decision|1|||
48682855|NCT03852719|156688504|FG000|Overall Study|Pregnancy|2|||
48682856|NCT03852719|156688505|FG001|Overall Study|Pregnancy|1|||
48682857|NCT03852719|156688506|FG002|Overall Study|Pregnancy|0|||
48682858|NCT03852719|156688504|FG000|Overall Study|Death|1|||
48682859|NCT03852719|156688505|FG001|Overall Study|Death|0|||
48682860|NCT03852719|156688506|FG002|Overall Study|Death|0|||
48682861|NCT03852719|156688504|FG000|Overall Study|Reason not Specified|3|||
48682862|NCT03852719|156688505|FG001|Overall Study|Reason not Specified|2|||
48682863|NCT03852719|156688506|FG002|Overall Study|Reason not Specified|2|||
48682864|NCT03852719|156688504|FG000|Overall Study|Adverse Event|1|||
48682865|NCT03852719|156688505|FG001|Overall Study|Adverse Event|0|||
48682866|NCT03852719|156688506|FG002|Overall Study|Adverse Event|4|||
48682867|NCT03852719|156688504|FG000|Overall Study|Progressive disease|1|||
48682868|NCT03852719|156688505|FG001|Overall Study|Progressive disease|2|||
48682869|NCT03852719|156688506|FG002|Overall Study|Progressive disease|1|||
48682870|NCT03852719|156688504|FG000|Overall Study|Lost to Follow-up|1|||
48682871|NCT03852719|156688505|FG001|Overall Study|Lost to Follow-up|0|||
48682872|NCT03852719|156688506|FG002|Overall Study|Lost to Follow-up|0|||
48682873|NCT01587040|156688508|FG000|Overall Study|Protocol Violation|0|||
48682874|NCT01587040|156688509|FG001|Overall Study|Protocol Violation|0|||
48682875|NCT01587040|156688510|FG002|Overall Study|Protocol Violation|1|||
48682876|NCT01587040|156688511|FG003|Overall Study|Protocol Violation|0|||
48682877|NCT01587040|156688508|FG000|Overall Study|Adverse Event|0|||
48682878|NCT01587040|156688509|FG001|Overall Study|Adverse Event|1|||
48682879|NCT01587040|156688510|FG002|Overall Study|Adverse Event|10|||
48682880|NCT01587040|156688511|FG003|Overall Study|Adverse Event|0|||
48682881|NCT01587040|156688508|FG000|Overall Study|Disease progression|12|||
48682882|NCT01587040|156688509|FG001|Overall Study|Disease progression|1|||
48682883|NCT01587040|156688510|FG002|Overall Study|Disease progression|15|||
48682884|NCT01587040|156688511|FG003|Overall Study|Disease progression|3|||
48682885|NCT01587040|156688508|FG000|Overall Study|Other than specified|5|||
48682886|NCT01587040|156688509|FG001|Overall Study|Other than specified|1|||
48682887|NCT01587040|156688510|FG002|Overall Study|Other than specified|11|||
48682888|NCT01587040|156688511|FG003|Overall Study|Other than specified|1|||
48682889|NCT01670721|156688512|FG000|Overall Study|Participant's decision|15|||
48682890|NCT01670721|156688512|FG000|Overall Study|Other than specified above|38|||
48682891|NCT00794950|156688513|FG000|BCG Induction|Withdrawal by Subject|2|||
48682892|NCT00794950|156688513|FG000|BCG Induction|ineligible|3|||
48682893|NCT00794950|156688513|FG000|BCG Induction|noncompliant w. BCG|1|||
48682894|NCT00794950|156688513|FG000|BCG Induction|Adverse Event|1|||
48682895|NCT00794950|156688513|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
48682896|NCT00794950|156688513|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
48682897|NCT00794950|156688513|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
48682898|NCT00794950|156688513|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
48682899|NCT01777776|156688514|FG000|Overall Study|Adverse Event|2|||
48682900|NCT01777776|156688515|FG001|Overall Study|Adverse Event|4|||
48682901|NCT01777776|156688516|FG002|Overall Study|Adverse Event|0|||
48682902|NCT01777776|156688517|FG003|Overall Study|Adverse Event|0|||
48682903|NCT01777776|156688514|FG000|Overall Study|Disease Progression|4|||
48682904|NCT01777776|156688515|FG001|Overall Study|Disease Progression|8|||
48682905|NCT01777776|156688516|FG002|Overall Study|Disease Progression|6|||
48682906|NCT01777776|156688517|FG003|Overall Study|Disease Progression|3|||
48682907|NCT01777776|156688514|FG000|Overall Study|Withdrawal by Subject|0|||
48682908|NCT01777776|156688515|FG001|Overall Study|Withdrawal by Subject|0|||
48682909|NCT01777776|156688516|FG002|Overall Study|Withdrawal by Subject|0|||
48682910|NCT01777776|156688517|FG003|Overall Study|Withdrawal by Subject|1|||
48682911|NCT00650845|156688518|FG000|Overall Study|Withdrawal by Subject|5|||
48682912|NCT00650845|156688519|FG001|Overall Study|Withdrawal by Subject|0|||
48682913|NCT00650845|156688518|FG000|Overall Study|Protocol Violation|0|||
48682914|NCT00650845|156688519|FG001|Overall Study|Protocol Violation|13|||
48682915|NCT00350844|156688520|FG000|Overall Study|Lost to Follow-up|1|||
48682916|NCT00264537|156688521|FG000|Overall Study|Death|0|||
48682917|NCT00264537|156688522|FG001|Overall Study|Death|3|||
48682918|NCT00264537|156688523|FG002|Overall Study|Death|3|||
48682919|NCT00264537|156688524|FG003|Overall Study|Death|2|||
48682920|NCT00264537|156688521|FG000|Overall Study|Lost to Follow-up|3|||
48682921|NCT00264537|156688522|FG001|Overall Study|Lost to Follow-up|4|||
48682922|NCT00264537|156688523|FG002|Overall Study|Lost to Follow-up|7|||
48682923|NCT00264537|156688524|FG003|Overall Study|Lost to Follow-up|6|||
48682924|NCT00264537|156688521|FG000|Overall Study|Adverse Event|21|||
48682925|NCT00264537|156688522|FG001|Overall Study|Adverse Event|32|||
48682926|NCT00264537|156688523|FG002|Overall Study|Adverse Event|24|||
48682927|NCT00264537|156688524|FG003|Overall Study|Adverse Event|34|||
48682928|NCT00264537|156688521|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
48682929|NCT00264537|156688522|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
48682930|NCT00264537|156688523|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
48682931|NCT00264537|156688524|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
48682932|NCT00264537|156688521|FG000|Overall Study|Other|21|||
48682933|NCT00264537|156688522|FG001|Overall Study|Other|11|||
48682934|NCT00264537|156688523|FG002|Overall Study|Other|10|||
48682935|NCT00264537|156688524|FG003|Overall Study|Other|11|||
48682936|NCT00264537|156688521|FG000|Overall Study|Not treated|0|||
48682937|NCT00264537|156688522|FG001|Overall Study|Not treated|2|||
48682938|NCT00264537|156688523|FG002|Overall Study|Not treated|1|||
48682939|NCT00264537|156688524|FG003|Overall Study|Not treated|0|||
48682940|NCT03210961|156690546|FG000|Overall Study|Adverse Event|0|||
48682941|NCT03210961|156690547|FG001|Overall Study|Adverse Event|0|||
48682942|NCT03210961|156690548|FG002|Overall Study|Adverse Event|0|||
48682943|NCT03210961|156690549|FG003|Overall Study|Adverse Event|0|||
48682944|NCT03210961|156690550|FG004|Overall Study|Adverse Event|0|||
48682945|NCT03210961|156690551|FG005|Overall Study|Adverse Event|0|||
48682946|NCT03210961|156690552|FG006|Overall Study|Adverse Event|0|||
48682947|NCT03210961|156690553|FG007|Overall Study|Adverse Event|0|||
48682948|NCT03210961|156690554|FG008|Overall Study|Adverse Event|0|||
48682949|NCT03210961|156690555|FG009|Overall Study|Adverse Event|0|||
48682950|NCT03210961|156690556|FG010|Overall Study|Adverse Event|0|||
48682951|NCT03210961|156690557|FG011|Overall Study|Adverse Event|0|||
48682952|NCT03210961|156690558|FG012|Overall Study|Adverse Event|0|||
48682953|NCT03210961|156690559|FG013|Overall Study|Adverse Event|1|||
48682954|NCT03210961|156690560|FG014|Overall Study|Adverse Event|0|||
48682955|NCT03210961|156690546|FG000|Overall Study|Lost to Follow-up|0|||
48682956|NCT03210961|156690547|FG001|Overall Study|Lost to Follow-up|0|||
48682957|NCT03210961|156690548|FG002|Overall Study|Lost to Follow-up|0|||
48682958|NCT03210961|156690549|FG003|Overall Study|Lost to Follow-up|0|||
48682959|NCT03210961|156690550|FG004|Overall Study|Lost to Follow-up|0|||
48682960|NCT03210961|156690551|FG005|Overall Study|Lost to Follow-up|0|||
48682961|NCT03210961|156690552|FG006|Overall Study|Lost to Follow-up|0|||
48682962|NCT03210961|156690553|FG007|Overall Study|Lost to Follow-up|0|||
48682963|NCT03210961|156690554|FG008|Overall Study|Lost to Follow-up|0|||
48682964|NCT03210961|156690555|FG009|Overall Study|Lost to Follow-up|0|||
48682965|NCT03210961|156690556|FG010|Overall Study|Lost to Follow-up|0|||
48682966|NCT03210961|156690557|FG011|Overall Study|Lost to Follow-up|0|||
48682967|NCT03210961|156690558|FG012|Overall Study|Lost to Follow-up|0|||
48682968|NCT03210961|156690559|FG013|Overall Study|Lost to Follow-up|0|||
48682969|NCT03210961|156690560|FG014|Overall Study|Lost to Follow-up|1|||
48682970|NCT03210961|156690546|FG000|Overall Study|Withdrawal by Subject|0|||
48682971|NCT03210961|156690547|FG001|Overall Study|Withdrawal by Subject|0|||
48682972|NCT03210961|156690548|FG002|Overall Study|Withdrawal by Subject|0|||
48682973|NCT03210961|156690549|FG003|Overall Study|Withdrawal by Subject|0|||
48682974|NCT03210961|156690550|FG004|Overall Study|Withdrawal by Subject|0|||
48682975|NCT03210961|156690551|FG005|Overall Study|Withdrawal by Subject|0|||
48682976|NCT03210961|156690552|FG006|Overall Study|Withdrawal by Subject|0|||
48682977|NCT03210961|156690553|FG007|Overall Study|Withdrawal by Subject|0|||
48682978|NCT03210961|156690554|FG008|Overall Study|Withdrawal by Subject|0|||
48682979|NCT03210961|156690555|FG009|Overall Study|Withdrawal by Subject|0|||
48682980|NCT03210961|156690556|FG010|Overall Study|Withdrawal by Subject|0|||
48682981|NCT03210961|156690557|FG011|Overall Study|Withdrawal by Subject|0|||
48682982|NCT03210961|156690558|FG012|Overall Study|Withdrawal by Subject|0|||
48682983|NCT03210961|156690559|FG013|Overall Study|Withdrawal by Subject|0|||
48682984|NCT03210961|156690560|FG014|Overall Study|Withdrawal by Subject|1|||
48682985|NCT03210961|156690546|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682986|NCT03210961|156690547|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682987|NCT03210961|156690548|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682988|NCT03210961|156690549|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682989|NCT03210961|156690550|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682990|NCT03210961|156690551|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682991|NCT03210961|156690552|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682992|NCT03210961|156690553|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682993|NCT03210961|156690554|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682994|NCT03210961|156690555|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682995|NCT03210961|156690556|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682996|NCT03210961|156690557|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682997|NCT03210961|156690558|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
48682998|NCT03210961|156690559|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
48682999|NCT03210961|156690560|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
48683000|NCT03210961|156690546|FG000|Overall Study|Other|0|||
48683001|NCT03210961|156690547|FG001|Overall Study|Other|0|||
48683002|NCT03210961|156690548|FG002|Overall Study|Other|0|||
48683003|NCT03210961|156690549|FG003|Overall Study|Other|1|||
48683004|NCT03210961|156690550|FG004|Overall Study|Other|0|||
48683005|NCT03210961|156690551|FG005|Overall Study|Other|0|||
48683006|NCT03210961|156690552|FG006|Overall Study|Other|1|||
48683007|NCT03210961|156690553|FG007|Overall Study|Other|0|||
48683008|NCT03210961|156690554|FG008|Overall Study|Other|0|||
48683009|NCT03210961|156690555|FG009|Overall Study|Other|0|||
48683010|NCT03210961|156690556|FG010|Overall Study|Other|1|||
48683011|NCT03210961|156690557|FG011|Overall Study|Other|0|||
48683012|NCT03210961|156690558|FG012|Overall Study|Other|2|||
48683013|NCT03210961|156690559|FG013|Overall Study|Other|2|||
48683014|NCT03210961|156690560|FG014|Overall Study|Other|0|||
48683015|NCT00602420|156690562|FG000|Overall Study|Death|1|||
48683016|NCT00602420|156690563|FG001|Overall Study|Death|4|||
48683017|NCT00602420|156690562|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
48683018|NCT00602420|156690563|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
48683019|NCT00602420|156690562|FG000|Overall Study|Withdrawal by Subject|18|||
48683020|NCT00602420|156690563|FG001|Overall Study|Withdrawal by Subject|17|||
48683021|NCT00602420|156690562|FG000|Overall Study|Adverse Event|1|||
48683022|NCT00602420|156690563|FG001|Overall Study|Adverse Event|0|||
48683023|NCT03077919|156690564|FG000|Overall Study|Lost to Follow-up|4|||
48683024|NCT03077919|156690565|FG001|Overall Study|Lost to Follow-up|1|||
48683025|NCT04566601|156690566|FG000|Overall Study|Other than listed|13|||
48683026|NCT04566601|156690567|FG001|Overall Study|Other than listed|4|||
48683027|NCT04566601|156690568|FG002|Overall Study|Other than listed|2|||
48683028|NCT04566601|156690569|FG003|Overall Study|Other than listed|1|||
48683029|NCT04566601|156690570|FG004|Overall Study|Other than listed|4|||
48683030|NCT04566601|156690566|FG000|Overall Study|Protocol deviation|3|||
48683031|NCT04566601|156690567|FG001|Overall Study|Protocol deviation|0|||
48683032|NCT04566601|156690568|FG002|Overall Study|Protocol deviation|1|||
48683033|NCT04566601|156690569|FG003|Overall Study|Protocol deviation|1|||
48683034|NCT04566601|156690570|FG004|Overall Study|Protocol deviation|1|||
48683035|NCT04566601|156690566|FG000|Overall Study|Technical problems|0|||
48683036|NCT04566601|156690567|FG001|Overall Study|Technical problems|0|||
48683037|NCT04566601|156690568|FG002|Overall Study|Technical problems|1|||
48683038|NCT04566601|156690569|FG003|Overall Study|Technical problems|0|||
48683039|NCT04566601|156690570|FG004|Overall Study|Technical problems|0|||
48683040|NCT04566601|156690566|FG000|Overall Study|No reason available|3|||
48683041|NCT04566601|156690567|FG001|Overall Study|No reason available|2|||
48683042|NCT04566601|156690568|FG002|Overall Study|No reason available|7|||
48683043|NCT04566601|156690569|FG003|Overall Study|No reason available|1|||
48683044|NCT04566601|156690570|FG004|Overall Study|No reason available|5|||
48683045|NCT04566601|156690566|FG000|Overall Study|Burden of study procedures|3|||
48683046|NCT04566601|156690567|FG001|Overall Study|Burden of study procedures|0|||
48683047|NCT04566601|156690568|FG002|Overall Study|Burden of study procedures|0|||
48683048|NCT04566601|156690569|FG003|Overall Study|Burden of study procedures|3|||
48683049|NCT04566601|156690570|FG004|Overall Study|Burden of study procedures|1|||
48683050|NCT04566601|156690566|FG000|Overall Study|Change of residence|2|||
48683051|NCT04566601|156690567|FG001|Overall Study|Change of residence|2|||
48683052|NCT04566601|156690568|FG002|Overall Study|Change of residence|0|||
48683053|NCT04566601|156690569|FG003|Overall Study|Change of residence|1|||
48389866|NCT01147744|155621503|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48389867|NCT01147744|155621504|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48683054|NCT04566601|156690570|FG004|Overall Study|Change of residence|2|||
48683055|NCT04566601|156690566|FG000|Overall Study|Perceived lack of efficacy|2|||
48683056|NCT04566601|156690567|FG001|Overall Study|Perceived lack of efficacy|0|||
48683057|NCT04566601|156690568|FG002|Overall Study|Perceived lack of efficacy|1|||
48389868|NCT01147744|155621505|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48389869|NCT01147744|155621506|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48389870|NCT01147744|155621507|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48389871|NCT01892163|155621511|FG000|Overall Study|Death|1|||
48389872|NCT01892163|155621512|FG001|Overall Study|Death|1|||
48389873|NCT01892163|155621511|FG000|Overall Study|Lost to Follow-up|1|||
48389874|NCT01892163|155621512|FG001|Overall Study|Lost to Follow-up|0|||
48389875|NCT00219284|155621515|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
48389876|NCT00219284|155621516|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
48389877|NCT00219284|155621515|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
48389878|NCT00219284|155621516|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
48389879|NCT00219284|155621515|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
48389880|NCT00219284|155621516|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
48389881|NCT00219284|155621515|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
48389882|NCT00219284|155621516|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
48389883|NCT00219284|155621515|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
48389884|NCT00219284|155621516|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
48389885|NCT00219284|155621515|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
48683058|NCT04566601|156690569|FG003|Overall Study|Perceived lack of efficacy|1|||
48683059|NCT04566601|156690570|FG004|Overall Study|Perceived lack of efficacy|2|||
48683060|NCT04566601|156690566|FG000|Overall Study|Adverse Event|7|||
48683061|NCT04566601|156690567|FG001|Overall Study|Adverse Event|4|||
48683062|NCT04566601|156690568|FG002|Overall Study|Adverse Event|6|||
48683063|NCT04566601|156690569|FG003|Overall Study|Adverse Event|5|||
48683064|NCT04566601|156690570|FG004|Overall Study|Adverse Event|12|||
48683065|NCT00931606|156690573|FG000|Overall Study|Death|1|||
48683066|NCT00931606|156690574|FG001|Overall Study|Death|3|||
48683067|NCT00931606|156690575|FG002|Overall Study|Death|2|||
48683068|NCT00931606|156690576|FG003|Overall Study|Death|0|||
48683069|NCT00931606|156690573|FG000|Overall Study|Lost to Follow-up|0|||
48683070|NCT00931606|156690574|FG001|Overall Study|Lost to Follow-up|1|||
48683071|NCT00931606|156690575|FG002|Overall Study|Lost to Follow-up|0|||
48683072|NCT00931606|156690576|FG003|Overall Study|Lost to Follow-up|0|||
48683073|NCT00931606|156690573|FG000|Overall Study|Physician Decision|0|||
48683074|NCT00931606|156690574|FG001|Overall Study|Physician Decision|0|||
48683075|NCT00931606|156690575|FG002|Overall Study|Physician Decision|3|||
48683076|NCT00931606|156690576|FG003|Overall Study|Physician Decision|0|||
48683077|NCT00931606|156690573|FG000|Overall Study|Sponsor Decision|1|||
48683078|NCT00931606|156690574|FG001|Overall Study|Sponsor Decision|4|||
48762934|NCT02535741|156981965|FG000|Overall Study|Withdrawal by Subject|9|||
48762935|NCT02535741|156981965|FG000|Overall Study|Lost to Follow-up|10|||
48389886|NCT00219284|155621516|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
48683079|NCT00931606|156690575|FG002|Overall Study|Sponsor Decision|0|||
48683080|NCT00931606|156690576|FG003|Overall Study|Sponsor Decision|2|||
48683081|NCT00931606|156690573|FG000|Overall Study|Withdrawal by Subject|3|||
48683082|NCT00931606|156690574|FG001|Overall Study|Withdrawal by Subject|1|||
48683083|NCT00931606|156690575|FG002|Overall Study|Withdrawal by Subject|1|||
48683084|NCT00931606|156690576|FG003|Overall Study|Withdrawal by Subject|1|||
48683085|NCT03828617|156690585|FG000|Overall Study|Lost to Follow-up|22|||
48683086|NCT03828617|156690586|FG001|Overall Study|Lost to Follow-up|12|||
48683087|NCT03828617|156690587|FG002|Overall Study|Lost to Follow-up|23|||
48683088|NCT03828617|156690588|FG003|Overall Study|Lost to Follow-up|7|||
48683089|NCT03828617|156690585|FG000|Overall Study|No longer met eligibility criteria|0|||
48683090|NCT03828617|156690586|FG001|Overall Study|No longer met eligibility criteria|1|||
48683091|NCT03828617|156690587|FG002|Overall Study|No longer met eligibility criteria|1|||
48762936|NCT02535741|156981965|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
48389887|NCT00219284|155621515|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
48389888|NCT00219284|155621516|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
48389889|NCT00219284|155621515|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
48389890|NCT00219284|155621516|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
48389891|NCT00219284|155621515|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
48683092|NCT03828617|156690588|FG003|Overall Study|No longer met eligibility criteria|3|||
48683093|NCT03828617|156690585|FG000|Overall Study|Protocol Violation|0|||
48683094|NCT03828617|156690586|FG001|Overall Study|Protocol Violation|2|||
48683095|NCT03828617|156690587|FG002|Overall Study|Protocol Violation|0|||
48683096|NCT03828617|156690588|FG003|Overall Study|Protocol Violation|0|||
48683097|NCT03828617|156690585|FG000|Overall Study|Withdrawal by Subject|2|||
48683098|NCT03828617|156690586|FG001|Overall Study|Withdrawal by Subject|0|||
48683099|NCT03828617|156690587|FG002|Overall Study|Withdrawal by Subject|2|||
48683100|NCT03828617|156690588|FG003|Overall Study|Withdrawal by Subject|0|||
48683101|NCT01016600|156690591|FG000|Overall Study|Did not start treatment|1|||
48389892|NCT00219284|155621516|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
48389893|NCT03028870|155621517|FG000|Overall Study|Adverse Event|7|||
48389894|NCT03028870|155621518|FG001|Overall Study|Adverse Event|4|||
48389895|NCT03028870|155621519|FG002|Overall Study|Adverse Event|3|||
48389896|NCT03028870|155621520|FG003|Overall Study|Adverse Event|3|||
48683102|NCT01016600|156690592|FG001|Overall Study|Did not start treatment|0|||
48683103|NCT01016600|156690593|FG002|Overall Study|Did not start treatment|0|||
48389897|NCT03028870|155621517|FG000|Overall Study|Withdrawal by Subject|1|||
48389898|NCT03028870|155621518|FG001|Overall Study|Withdrawal by Subject|1|||
48389899|NCT03028870|155621519|FG002|Overall Study|Withdrawal by Subject|1|||
48389900|NCT03028870|155621520|FG003|Overall Study|Withdrawal by Subject|2|||
48389901|NCT03028870|155621517|FG000|Overall Study|Lost to Follow-up|1|||
48389902|NCT03028870|155621518|FG001|Overall Study|Lost to Follow-up|0|||
48389903|NCT03028870|155621519|FG002|Overall Study|Lost to Follow-up|0|||
48389904|NCT03028870|155621520|FG003|Overall Study|Lost to Follow-up|0|||
48389905|NCT03028870|155621517|FG000|Overall Study|Lack of Efficacy|3|||
48389906|NCT03028870|155621518|FG001|Overall Study|Lack of Efficacy|0|||
48389907|NCT03028870|155621519|FG002|Overall Study|Lack of Efficacy|0|||
48389908|NCT03028870|155621520|FG003|Overall Study|Lack of Efficacy|0|||
48389909|NCT03028870|155621517|FG000|Overall Study|Administrative|5|||
48389910|NCT03028870|155621518|FG001|Overall Study|Administrative|5|||
48389911|NCT03028870|155621519|FG002|Overall Study|Administrative|12|||
48389912|NCT03028870|155621520|FG003|Overall Study|Administrative|4|||
48389913|NCT03184077|155621521|FG000|Overall Study|Lost to Follow-up|21|||
48389914|NCT03184077|155621522|FG001|Overall Study|Lost to Follow-up|21|||
48389915|NCT00708123|155621523|FG000|Period 1|Protocol Violation|0|||
48389916|NCT00708123|155621524|FG001|Period 1|Protocol Violation|1|||
48683104|NCT01016600|156690594|FG003|Overall Study|Did not start treatment|0|||
48683105|NCT03229109|156690595|FG000|Overall Study|Withdrawal by Subject|0|||
48683106|NCT03229109|156690596|FG001|Overall Study|Withdrawal by Subject|0|||
48683107|NCT03229109|156690597|FG002|Overall Study|Withdrawal by Subject|0|||
48683108|NCT03229109|156690598|FG003|Overall Study|Withdrawal by Subject|1|||
48683109|NCT01449006|156690603|FG000|Overall Study|Lost to Follow-up|1|||
48683110|NCT01449006|156690604|FG001|Overall Study|Lost to Follow-up|0|||
48683111|NCT01449006|156690603|FG000|Overall Study|Withdrawal by Subject|1|||
48683112|NCT01449006|156690604|FG001|Overall Study|Withdrawal by Subject|0|||
48683113|NCT01449006|156690603|FG000|Overall Study|Protocol Violation|1|||
48683114|NCT01449006|156690604|FG001|Overall Study|Protocol Violation|0|||
48683115|NCT02223715|156690605|FG000|Overall Study|Death|31|||
48683116|NCT02223715|156690605|FG000|Overall Study|Lost to Follow-up|73|||
48683117|NCT02630472|156690610|FG000|Overall Study|Physician Decision|10|||
48683118|NCT02630472|156690611|FG001|Overall Study|Physician Decision|0|||
48683119|NCT02598297|156690612|FG000|Overall Study|Study terminated by Sponsor|21|||
48683120|NCT02598297|156690613|FG001|Overall Study|Study terminated by Sponsor|23|||
48683121|NCT02598297|156690612|FG000|Overall Study|Adverse Event|1|||
48683122|NCT02598297|156690613|FG001|Overall Study|Adverse Event|1|||
48683123|NCT02598297|156690612|FG000|Overall Study|Physician Decision|1|||
48683124|NCT02598297|156690613|FG001|Overall Study|Physician Decision|0|||
48683125|NCT02598297|156690612|FG000|Overall Study|Subject/guardian decision|1|||
48683126|NCT02598297|156690613|FG001|Overall Study|Subject/guardian decision|0|||
48683127|NCT02598297|156690612|FG000|Overall Study|Followed for survival|1|||
48683128|NCT02598297|156690613|FG001|Overall Study|Followed for survival|0|||
48683129|NCT00413036|156690617|FG000|Overall Study|Adverse Event|44|||
48683130|NCT00413036|156690617|FG000|Overall Study|Lack of Efficacy|129|||
48683131|NCT00413036|156690617|FG000|Overall Study|Withdrawal by Subject|7|||
48683132|NCT00413036|156690617|FG000|Overall Study|Death|9|||
48683133|NCT00413036|156690617|FG000|Overall Study|Other|26|||
48683134|NCT00413036|156690617|FG000|Overall Study|Missing|2|||
48389917|NCT00708123|155621525|FG002|Period 1|Protocol Violation|0|||
48389918|NCT00708123|155621526|FG003|Period 1|Protocol Violation|1|||
48389919|NCT00708123|155621527|FG004|Period 1|Protocol Violation|0|||
48389920|NCT00708123|155621523|FG000|Period 1|Adverse Event|0|||
48389921|NCT00708123|155621524|FG001|Period 1|Adverse Event|0|||
48389922|NCT00708123|155621525|FG002|Period 1|Adverse Event|1|||
48683135|NCT02045095|156690620|FG000|Overall Study|Other|0|||
48683136|NCT02045095|156690621|FG001|Overall Study|Other|0|||
48683137|NCT02045095|156690622|FG002|Overall Study|Other|1|||
48683138|NCT02045095|156690623|FG003|Overall Study|Other|0|||
48683139|NCT02045095|156690624|FG004|Overall Study|Other|0|||
48389923|NCT00708123|155621526|FG003|Period 1|Adverse Event|0|||
48389924|NCT00708123|155621527|FG004|Period 1|Adverse Event|0|||
48389925|NCT00708123|155621523|FG000|Period 2|Protocol Violation|0|||
48389926|NCT00708123|155621524|FG001|Period 2|Protocol Violation|0|||
48389927|NCT00708123|155621525|FG002|Period 2|Protocol Violation|0|||
48389928|NCT00708123|155621526|FG003|Period 2|Protocol Violation|1|||
48389929|NCT00708123|155621527|FG004|Period 2|Protocol Violation|0|||
48389930|NCT00708123|155621523|FG000|Period 2|Other Reason|1|||
48389931|NCT00708123|155621524|FG001|Period 2|Other Reason|0|||
48389932|NCT00708123|155621525|FG002|Period 2|Other Reason|0|||
48389933|NCT00708123|155621526|FG003|Period 2|Other Reason|0|||
48389934|NCT00708123|155621527|FG004|Period 2|Other Reason|0|||
48389935|NCT00708123|155621523|FG000|Period 3|Lost to Follow-up|0|||
48389936|NCT00708123|155621524|FG001|Period 3|Lost to Follow-up|0|||
48389937|NCT00708123|155621525|FG002|Period 3|Lost to Follow-up|1|||
48389938|NCT00708123|155621526|FG003|Period 3|Lost to Follow-up|1|||
48389939|NCT00708123|155621527|FG004|Period 3|Lost to Follow-up|0|||
48389940|NCT00708123|155621523|FG000|Period 4|Protocol Violation|0|||
48389941|NCT00708123|155621524|FG001|Period 4|Protocol Violation|1|||
48389942|NCT00708123|155621525|FG002|Period 4|Protocol Violation|0|||
48389943|NCT00708123|155621526|FG003|Period 4|Protocol Violation|0|||
48389944|NCT00708123|155621527|FG004|Period 4|Protocol Violation|0|||
48389945|NCT04013529|155621528|FG000|Overall Study|Withdrawal by Subject|1|||
48389946|NCT04013529|155621529|FG001|Overall Study|Withdrawal by Subject|1|||
48389947|NCT01553136|155621533|FG000|Overall Study|Adverse Event|3|||
48389948|NCT01553136|155621534|FG001|Overall Study|Adverse Event|2|||
48389949|NCT01553136|155621533|FG000|Overall Study|Withdrawal by Subject|2|||
48389950|NCT01553136|155621534|FG001|Overall Study|Withdrawal by Subject|3|||
48389951|NCT01553136|155621533|FG000|Overall Study|Lost to Follow-up|4|||
48389952|NCT01553136|155621534|FG001|Overall Study|Lost to Follow-up|10|||
48389953|NCT01553136|155621533|FG000|Overall Study|Physician Decision|2|||
48389954|NCT01553136|155621534|FG001|Overall Study|Physician Decision|3|||
48389955|NCT01553136|155621533|FG000|Overall Study|Scheduling Difficulties|5|||
48389956|NCT01553136|155621534|FG001|Overall Study|Scheduling Difficulties|4|||
48389957|NCT04202679|155621538|FG000|Overall Study|Adverse Event|2|||
48389958|NCT04202679|155621539|FG001|Overall Study|Adverse Event|0|||
48389959|NCT04202679|155621538|FG000|Overall Study|Poor compliance to protocol|1|||
48389960|NCT04202679|155621539|FG001|Overall Study|Poor compliance to protocol|0|||
48389961|NCT04202679|155621538|FG000|Overall Study|Withdrawal by Subject|23|||
48389962|NCT04202679|155621539|FG001|Overall Study|Withdrawal by Subject|6|||
48389963|NCT02246582|155622948|FG000|Overall Study|Withdrawal by Subject|3|||
48389964|NCT02246582|155622949|FG001|Overall Study|Withdrawal by Subject|4|||
48389965|NCT03496012|155622950|FG000|Overall Study|Withdrawal by Subject|2|||
48389966|NCT03496012|155622951|FG001|Overall Study|Withdrawal by Subject|0|||
48389967|NCT03496012|155622952|FG002|Overall Study|Withdrawal by Subject|2|||
48389968|NCT03496012|155622950|FG000|Overall Study|Adverse Event|0|||
48389969|NCT03496012|155622951|FG001|Overall Study|Adverse Event|0|||
48389970|NCT03496012|155622952|FG002|Overall Study|Adverse Event|1|||
48389971|NCT03496012|155622950|FG000|Overall Study|Reason Not Specified|2|||
48389972|NCT03496012|155622951|FG001|Overall Study|Reason Not Specified|0|||
48389973|NCT03496012|155622952|FG002|Overall Study|Reason Not Specified|1|||
48389974|NCT02592551|155622955|FG000|Overall Study|Not evaluable|1|||
48389975|NCT02592551|155622956|FG001|Overall Study|Not evaluable|3|||
48389976|NCT02592551|155622957|FG002|Overall Study|Not evaluable|0|||
48389977|NCT04419610|155622959|FG000|Overall Study|Withdrawal by Subject|3|||
48389978|NCT04419610|155622960|FG001|Overall Study|Withdrawal by Subject|1|||
48389979|NCT04419610|155622959|FG000|Overall Study|Adverse Event|1|||
48389980|NCT04419610|155622960|FG001|Overall Study|Adverse Event|0|||
48683140|NCT02045095|156690625|FG005|Overall Study|Other|2|||
48389981|NCT04419610|155622959|FG000|Overall Study|discharged early|1|||
48389982|NCT04419610|155622960|FG001|Overall Study|discharged early|1|||
48389983|NCT01490450|155622961|FG000|Period 1|Lack of Efficacy|2|||
48389984|NCT01490450|155622962|FG001|Period 1|Lack of Efficacy|0|||
48389985|NCT01490450|155622963|FG002|Period 1|Lack of Efficacy|3|||
48389986|NCT01490450|155622964|FG003|Period 1|Lack of Efficacy|0|||
48389987|NCT01490450|155622961|FG000|Period 1|Adverse Event|0|||
48389988|NCT01490450|155622962|FG001|Period 1|Adverse Event|0|||
48683141|NCT02045095|156690626|FG006|Overall Study|Other|0|||
48389989|NCT01490450|155622963|FG002|Period 1|Adverse Event|0|||
48389990|NCT01490450|155622964|FG003|Period 1|Adverse Event|5|||
48389991|NCT01490450|155622961|FG000|Period 1|Request to discontinue treatment|1|||
48389992|NCT01490450|155622962|FG001|Period 1|Request to discontinue treatment|0|||
48389993|NCT01490450|155622963|FG002|Period 1|Request to discontinue treatment|0|||
48683142|NCT02045095|156690620|FG000|Overall Study|Progressive Disease|3|||
48683143|NCT02045095|156690621|FG001|Overall Study|Progressive Disease|3|||
48683144|NCT02045095|156690622|FG002|Overall Study|Progressive Disease|2|||
48683145|NCT02045095|156690623|FG003|Overall Study|Progressive Disease|4|||
48683146|NCT02045095|156690624|FG004|Overall Study|Progressive Disease|2|||
48683147|NCT02045095|156690625|FG005|Overall Study|Progressive Disease|4|||
48389994|NCT01490450|155622964|FG003|Period 1|Request to discontinue treatment|0|||
48389995|NCT01490450|155622961|FG000|Period 1|Withdrawal by Subject|0|||
48389996|NCT01490450|155622962|FG001|Period 1|Withdrawal by Subject|0|||
48389997|NCT01490450|155622963|FG002|Period 1|Withdrawal by Subject|0|||
48389998|NCT01490450|155622964|FG003|Period 1|Withdrawal by Subject|3|||
48389999|NCT01490450|155622961|FG000|Period 1|No longer met study criteria|0|||
48390000|NCT01490450|155622962|FG001|Period 1|No longer met study criteria|1|||
48390001|NCT01490450|155622963|FG002|Period 1|No longer met study criteria|1|||
48390002|NCT01490450|155622964|FG003|Period 1|No longer met study criteria|0|||
48390003|NCT01490450|155622961|FG000|Period 2|Lack of Efficacy|0|||
48390004|NCT01490450|155622962|FG001|Period 2|Lack of Efficacy|0|||
48390005|NCT01490450|155622963|FG002|Period 2|Lack of Efficacy|0|||
48683148|NCT02045095|156690626|FG006|Overall Study|Progressive Disease|1|||
48683149|NCT02045095|156690620|FG000|Overall Study|Withdrawal by Subject|0|||
48683150|NCT02045095|156690621|FG001|Overall Study|Withdrawal by Subject|0|||
48683151|NCT02045095|156690622|FG002|Overall Study|Withdrawal by Subject|0|||
48683152|NCT02045095|156690623|FG003|Overall Study|Withdrawal by Subject|0|||
48355290|NCT01814072|155497244|FG008|Overall Study|Withdrawal by Subject|1|||
48355291|NCT01814072|155497245|FG009|Overall Study|Withdrawal by Subject|2|||
48355292|NCT01814072|155497246|FG010|Overall Study|Withdrawal by Subject|0|||
48355293|NCT01814072|155497247|FG011|Overall Study|Withdrawal by Subject|0|||
48355294|NCT01814072|155497248|FG012|Overall Study|Withdrawal by Subject|1|||
48683153|NCT02045095|156690624|FG004|Overall Study|Withdrawal by Subject|3|||
48683154|NCT02045095|156690625|FG005|Overall Study|Withdrawal by Subject|0|||
48683155|NCT02045095|156690626|FG006|Overall Study|Withdrawal by Subject|0|||
48683156|NCT02045095|156690620|FG000|Overall Study|Adverse Event|0|||
48683157|NCT02045095|156690621|FG001|Overall Study|Adverse Event|1|||
48683158|NCT02045095|156690622|FG002|Overall Study|Adverse Event|1|||
48683159|NCT02045095|156690623|FG003|Overall Study|Adverse Event|0|||
48683160|NCT02045095|156690624|FG004|Overall Study|Adverse Event|0|||
48683161|NCT02045095|156690625|FG005|Overall Study|Adverse Event|2|||
48683162|NCT02045095|156690626|FG006|Overall Study|Adverse Event|0|||
48683163|NCT04098809|156690627|FG000|Overall Study|Withdrawal by Subject|1|||
48683164|NCT04098809|156690628|FG001|Overall Study|Withdrawal by Subject|3|||
48683165|NCT04098809|156690627|FG000|Overall Study|Physician Decision|2|||
48683166|NCT04098809|156690628|FG001|Overall Study|Physician Decision|1|||
48683167|NCT00080301|156690631|FG000|Overall Study|Randomized but Never Treated|5|||
48683168|NCT00080301|156690632|FG001|Overall Study|Randomized but Never Treated|10|||
48683169|NCT00080301|156690631|FG000|Overall Study|Still on Treatment as of CSR date|0|||
48683170|NCT00080301|156690632|FG001|Overall Study|Still on Treatment as of CSR date|1|||
48683171|NCT02506192|156690637|FG000|Overall Study|Withdrawal by Subject|1|||
48683172|NCT02506192|156690638|FG001|Overall Study|Withdrawal by Subject|1|||
48683173|NCT00740584|156690639|FG000|Overall Study|Withdrawal by Subject|1|||
48683174|NCT00337207|156690653|FG000|Overall Study|Withdrawal by Subject|3|||
48683175|NCT00837213|156690656|FG000|Overall Study|Lost to Follow-up|3|||
48683176|NCT00837213|156690657|FG001|Overall Study|Lost to Follow-up|2|||
48683177|NCT00837213|156690656|FG000|Overall Study|Withdrawal by Subject|2|||
48683178|NCT00837213|156690657|FG001|Overall Study|Withdrawal by Subject|2|||
48683179|NCT00837213|156690656|FG000|Overall Study|not stated|1|||
48683180|NCT00837213|156690657|FG001|Overall Study|not stated|1|||
48683181|NCT00687739|156690661|FG000|Overall Study|Lost to Follow-up|2|||
48762937|NCT02535741|156981965|FG000|Overall Study|Missing data|6|||
48355295|NCT01814072|155497249|FG013|Overall Study|Withdrawal by Subject|1|||
48355296|NCT01814072|155497250|FG014|Overall Study|Withdrawal by Subject|1|||
48355297|NCT01814072|155497251|FG015|Overall Study|Withdrawal by Subject|1|||
48355298|NCT01814072|155497252|FG016|Overall Study|Withdrawal by Subject|0|||
48355299|NCT01814072|155497253|FG017|Overall Study|Withdrawal by Subject|0|||
48355300|NCT01814072|155497254|FG018|Overall Study|Withdrawal by Subject|0|||
48683182|NCT00687739|156690662|FG001|Overall Study|Lost to Follow-up|2|||
48683183|NCT00687739|156690663|FG002|Overall Study|Lost to Follow-up|1|||
48355301|NCT01814072|155497255|FG019|Overall Study|Withdrawal by Subject|2|||
48355302|NCT01814072|155497256|FG020|Overall Study|Withdrawal by Subject|0|||
48355303|NCT01814072|155497257|FG021|Overall Study|Withdrawal by Subject|0|||
48390006|NCT01490450|155622964|FG003|Period 2|Lack of Efficacy|1|||
48683184|NCT00687739|156690664|FG003|Overall Study|Lost to Follow-up|2|||
48683185|NCT00687739|156690661|FG000|Overall Study|Adverse Event|0|||
48683186|NCT00687739|156690662|FG001|Overall Study|Adverse Event|1|||
48683187|NCT00687739|156690663|FG002|Overall Study|Adverse Event|1|||
48683188|NCT00687739|156690664|FG003|Overall Study|Adverse Event|0|||
48355304|NCT01814072|155497258|FG022|Overall Study|Withdrawal by Subject|1|||
48390007|NCT01490450|155622961|FG000|Period 2|Adverse Event|1|||
48390008|NCT01490450|155622962|FG001|Period 2|Adverse Event|1|||
48390009|NCT01490450|155622963|FG002|Period 2|Adverse Event|0|||
48683189|NCT01012258|156690665|FG000|Overall Study|Death|14|||
48683190|NCT01012258|156690665|FG000|Overall Study|Lost to Follow-up|1|||
48683191|NCT01012258|156690665|FG000|Overall Study|Adverse Event|1|||
48683192|NCT01012258|156690665|FG000|Overall Study|Progressive Disease (PD)|18|||
48683193|NCT01012258|156690665|FG000|Overall Study|Symptomatic Deterioration|1|||
48683194|NCT01012258|156690665|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
48683195|NCT01012258|156690665|FG000|Overall Study|Another Tumor Discovered|1|||
48683196|NCT01012258|156690665|FG000|Overall Study|Ongoing|29|||
48683197|NCT03600740|156690666|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
48683198|NCT00799903|156690667|FG000|Overall Study|Investigator Site Closed|25|||
48683199|NCT00799903|156690668|FG001|Overall Study|Investigator Site Closed|23|||
48683200|NCT00799903|156690667|FG000|Overall Study|Withdrawal by Subject|179|||
48683201|NCT00799903|156690668|FG001|Overall Study|Withdrawal by Subject|175|||
48683202|NCT00799903|156690667|FG000|Overall Study|Lost to Follow-up|69|||
48683203|NCT00799903|156690668|FG001|Overall Study|Lost to Follow-up|80|||
48683204|NCT00239928|156690669|FG000|Overall Study|Lack of Efficacy|1|||
48683205|NCT00239928|156690669|FG000|Overall Study|Adverse Event|4|||
48683206|NCT00239928|156690669|FG000|Overall Study|Not need to continue study|3|||
48683207|NCT00239928|156690669|FG000|Overall Study|Withdrawal by Subject|2|||
48683208|NCT01684202|156690676|FG000|Dose-escalation Period|Adverse Event|0|||
48683209|NCT01684202|156690677|FG001|Dose-escalation Period|Adverse Event|1|||
48683210|NCT01684202|156690678|FG002|Dose-escalation Period|Adverse Event|0|||
48683211|NCT01684202|156690679|FG003|Dose-escalation Period|Adverse Event|0|||
48683212|NCT01684202|156690676|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
48683213|NCT01684202|156690677|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
48683214|NCT01684202|156690678|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
48683215|NCT01684202|156690679|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
48683216|NCT01684202|156690676|FG000|Maintenance Period|Adverse Event|1|||
48683217|NCT01684202|156690677|FG001|Maintenance Period|Adverse Event|1|||
48683218|NCT01684202|156690678|FG002|Maintenance Period|Adverse Event|1|||
48683219|NCT01684202|156690679|FG003|Maintenance Period|Adverse Event|1|||
48683220|NCT01684202|156690676|FG000|Maintenance Period|Physician Decision|0|||
48683221|NCT01684202|156690677|FG001|Maintenance Period|Physician Decision|1|||
48683222|NCT01684202|156690678|FG002|Maintenance Period|Physician Decision|0|||
48683223|NCT01684202|156690679|FG003|Maintenance Period|Physician Decision|0|||
48683224|NCT01684202|156690676|FG000|Maintenance Period|Withdrawal by Subject|0|||
48390010|NCT01490450|155622964|FG003|Period 2|Adverse Event|1|||
48390011|NCT01490450|155622961|FG000|Period 2|Withdrawal by Subject|1|||
48390012|NCT01490450|155622962|FG001|Period 2|Withdrawal by Subject|0|||
48390013|NCT01490450|155622963|FG002|Period 2|Withdrawal by Subject|0|||
48390014|NCT01490450|155622964|FG003|Period 2|Withdrawal by Subject|0|||
48390015|NCT01490450|155622961|FG000|Period 2|Lost to Follow-up|0|||
48390016|NCT01490450|155622962|FG001|Period 2|Lost to Follow-up|0|||
48390017|NCT01490450|155622963|FG002|Period 2|Lost to Follow-up|0|||
48390018|NCT01490450|155622964|FG003|Period 2|Lost to Follow-up|2|||
48390019|NCT00404820|155622965|FG000|Overall Study|Adverse Event|4|||
48683225|NCT01684202|156690677|FG001|Maintenance Period|Withdrawal by Subject|1|||
48683226|NCT01684202|156690678|FG002|Maintenance Period|Withdrawal by Subject|0|||
48683227|NCT01684202|156690679|FG003|Maintenance Period|Withdrawal by Subject|0|||
48683228|NCT01843023|156690680|FG000|Overall Study|Death|1|||
48683229|NCT01843023|156690681|FG001|Overall Study|Death|0|||
48683230|NCT01843023|156690680|FG000|Overall Study|Lost to Follow-up|24|||
48683231|NCT01843023|156690681|FG001|Overall Study|Lost to Follow-up|29|||
48683232|NCT01843023|156690680|FG000|Overall Study|Withdrawal by Subject|8|||
48683233|NCT01843023|156690681|FG001|Overall Study|Withdrawal by Subject|6|||
48683234|NCT00779025|156690682|FG000|Overall Study|Withdrawal by Subject|1|||
48683235|NCT00226811|156690683|FG000|Overall Study|Death|8|||
48683236|NCT00226811|156690683|FG000|Overall Study|Adverse Event|11|||
48683237|NCT00226811|156690683|FG000|Overall Study|Lack of Efficacy|55|||
48683238|NCT00226811|156690683|FG000|Overall Study|Withdrawal by Subject|2|||
48683239|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
48683240|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
48390020|NCT00404820|155622966|FG001|Overall Study|Adverse Event|16|||
48390021|NCT00404820|155622965|FG000|Overall Study|Withdrawal by Subject|5|||
48683241|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
48683242|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
48762938|NCT00798369|156981966|FG000|Overall Study|Subject withdrew consent|0|||
48762939|NCT00798369|156981967|FG001|Overall Study|Subject withdrew consent|0|||
48683243|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
48683244|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
48683245|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Death|7|||
48683246|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Death|5|||
48683247|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Death|6|||
48683248|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
48683249|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
48390022|NCT00404820|155622966|FG001|Overall Study|Withdrawal by Subject|3|||
48390023|NCT00404820|155622965|FG000|Overall Study|Lost to Follow-up|7|||
48683250|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
48683251|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
48683252|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
48683253|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
48683254|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Other|1|||
48683255|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Other|0|||
48683256|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Other|0|||
48683257|NCT00104650|156690687|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
48683258|NCT00104650|156690688|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
48683259|NCT00104650|156690689|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
48683260|NCT00104650|156690687|FG000|Follow-up Period|Physician Decision|1|||
48683261|NCT00104650|156690688|FG001|Follow-up Period|Physician Decision|1|||
48683262|NCT00104650|156690689|FG002|Follow-up Period|Physician Decision|0|||
48683263|NCT00104650|156690687|FG000|Follow-up Period|Adverse Event|1|||
48683264|NCT00104650|156690688|FG001|Follow-up Period|Adverse Event|0|||
48683265|NCT00104650|156690689|FG002|Follow-up Period|Adverse Event|1|||
48683266|NCT00104650|156690687|FG000|Follow-up Period|Withdrawal by Subject|0|||
48683267|NCT00104650|156690688|FG001|Follow-up Period|Withdrawal by Subject|3|||
48683268|NCT00104650|156690689|FG002|Follow-up Period|Withdrawal by Subject|3|||
48683269|NCT00104650|156690687|FG000|Follow-up Period|Death|6|||
48683270|NCT00104650|156690688|FG001|Follow-up Period|Death|6|||
48683271|NCT00104650|156690689|FG002|Follow-up Period|Death|4|||
48683272|NCT00104650|156690687|FG000|Follow-up Period|Disease progression|3|||
48683273|NCT00104650|156690688|FG001|Follow-up Period|Disease progression|1|||
48683274|NCT00104650|156690689|FG002|Follow-up Period|Disease progression|0|||
48683275|NCT00104650|156690687|FG000|Follow-up Period|Lost to Follow-up|0|||
48762940|NCT00798369|156981968|FG002|Overall Study|Subject withdrew consent|1|||
48762941|NCT00798369|156981969|FG003|Overall Study|Subject withdrew consent|1|||
48683276|NCT00104650|156690688|FG001|Follow-up Period|Lost to Follow-up|1|||
48683277|NCT00104650|156690689|FG002|Follow-up Period|Lost to Follow-up|2|||
48683278|NCT00104650|156690687|FG000|Follow-up Period|Other|0|||
48683279|NCT00104650|156690688|FG001|Follow-up Period|Other|1|||
48762942|NCT00798369|156981970|FG004|Overall Study|Subject withdrew consent|0|||
48762943|NCT00798369|156981971|FG005|Overall Study|Subject withdrew consent|2|||
48762944|NCT00798369|156981966|FG000|Overall Study|Lost to Follow-up|1|||
48762945|NCT00798369|156981967|FG001|Overall Study|Lost to Follow-up|1|||
48762946|NCT00798369|156981968|FG002|Overall Study|Lost to Follow-up|1|||
48762947|NCT00798369|156981969|FG003|Overall Study|Lost to Follow-up|0|||
48762948|NCT00798369|156981970|FG004|Overall Study|Lost to Follow-up|1|||
48762949|NCT00798369|156981971|FG005|Overall Study|Lost to Follow-up|0|||
48762950|NCT00798369|156981966|FG000|Overall Study|Adminstrative problems|0|||
48762951|NCT00798369|156981967|FG001|Overall Study|Adminstrative problems|0|||
48762952|NCT00798369|156981968|FG002|Overall Study|Adminstrative problems|0|||
48762953|NCT00798369|156981969|FG003|Overall Study|Adminstrative problems|0|||
48762954|NCT00798369|156981970|FG004|Overall Study|Adminstrative problems|0|||
48762955|NCT00798369|156981971|FG005|Overall Study|Adminstrative problems|1|||
48762956|NCT00218296|156981972|FG000|Overall Study|Lost to Follow-up|9|||
48762957|NCT00218296|156981973|FG001|Overall Study|Lost to Follow-up|7|||
48762958|NCT00218296|156981972|FG000|Overall Study|Withdrawal by Subject|36|||
48762959|NCT00218296|156981973|FG001|Overall Study|Withdrawal by Subject|47|||
48762960|NCT00218296|156981972|FG000|Overall Study|Randomized but did not enter treatment|66|||
48762961|NCT00218296|156981973|FG001|Overall Study|Randomized but did not enter treatment|67|||
48762962|NCT02596854|156981974|FG000|Overall Study|Withdrawn|8|||
48762963|NCT02046148|156981975|FG000|Overall Study|Lost to Follow-up|1|||
48762964|NCT02046148|156981976|FG001|Overall Study|Lost to Follow-up|1|||
48683280|NCT00104650|156690689|FG002|Follow-up Period|Other|0|||
48683281|NCT01633541|156690690|FG000|Overall Study|Death|1|||
48683282|NCT01633541|156690691|FG001|Overall Study|Death|0|||
48683283|NCT03472326|156690692|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
48683284|NCT03472326|156690693|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
48762965|NCT02046148|156981975|FG000|Overall Study|Withdrawal by Subject|0|||
48762966|NCT02046148|156981976|FG001|Overall Study|Withdrawal by Subject|2|||
48762967|NCT02211131|156981983|FG000|Overall Study|Death|26|||
48762968|NCT02211131|156981984|FG001|Overall Study|Death|16|||
48762969|NCT02211131|156981983|FG000|Overall Study|Lost to Follow-up|4|||
48683285|NCT03472326|156690694|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
48683286|NCT03472326|156690695|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
48683287|NCT03472326|156690692|FG000|Part 2: Combination Therapy|Pregnancy|0|||
48683288|NCT03472326|156690693|FG001|Part 2: Combination Therapy|Pregnancy|0|||
48683289|NCT03472326|156690694|FG002|Part 2: Combination Therapy|Pregnancy|0|||
48683290|NCT03472326|156690695|FG003|Part 2: Combination Therapy|Pregnancy|1|||
48683291|NCT02292719|156690696|FG000|Overall Study|Withdrawal by Subject|0|||
48683292|NCT02292719|156690697|FG001|Overall Study|Withdrawal by Subject|0|||
48683293|NCT02292719|156690698|FG002|Overall Study|Withdrawal by Subject|0|||
48683294|NCT02292719|156690699|FG003|Overall Study|Withdrawal by Subject|1|||
48683295|NCT02292719|156690700|FG004|Overall Study|Withdrawal by Subject|1|||
48683296|NCT02292719|156690701|FG005|Overall Study|Withdrawal by Subject|0|||
48683297|NCT02292719|156690696|FG000|Overall Study|Subject enrolled in new study.|0|||
48683298|NCT02292719|156690697|FG001|Overall Study|Subject enrolled in new study.|0|||
48683299|NCT02292719|156690698|FG002|Overall Study|Subject enrolled in new study.|1|||
48683300|NCT02292719|156690699|FG003|Overall Study|Subject enrolled in new study.|0|||
48683301|NCT02292719|156690700|FG004|Overall Study|Subject enrolled in new study.|0|||
48683302|NCT02292719|156690701|FG005|Overall Study|Subject enrolled in new study.|0|||
48683303|NCT01824355|156690704|FG000|Overall Study|Adverse Event|2|||
48683304|NCT01824355|156690704|FG000|Overall Study|unevaluable reference method results per|1|||
48683305|NCT02326597|156690707|FG000|Overall Study|Lost to Follow-up|42|||
48683306|NCT02326597|156690708|FG001|Overall Study|Lost to Follow-up|32|||
48683307|NCT01132313|156690709|FG000|Overall Study|Lack of Efficacy|1|||
48683308|NCT01132313|156690710|FG001|Overall Study|Lack of Efficacy|0|||
48683309|NCT01132313|156690711|FG002|Overall Study|Lack of Efficacy|0|||
48683310|NCT01132313|156690712|FG003|Overall Study|Lack of Efficacy|0|||
48683311|NCT01132313|156690713|FG004|Overall Study|Lack of Efficacy|0|||
48683312|NCT01132313|156690714|FG005|Overall Study|Lack of Efficacy|0|||
48683313|NCT01132313|156690715|FG006|Overall Study|Lack of Efficacy|0|||
48683314|NCT01132313|156690716|FG007|Overall Study|Lack of Efficacy|3|||
48683315|NCT01132313|156690717|FG008|Overall Study|Lack of Efficacy|14|||
48683316|NCT01132313|156690718|FG009|Overall Study|Lack of Efficacy|16|||
48683317|NCT01132313|156690719|FG010|Overall Study|Lack of Efficacy|0|||
48683318|NCT01132313|156690720|FG011|Overall Study|Lack of Efficacy|0|||
48683319|NCT01132313|156690709|FG000|Overall Study|Not treated|2|||
48683320|NCT01132313|156690710|FG001|Overall Study|Not treated|0|||
48683321|NCT01132313|156690711|FG002|Overall Study|Not treated|0|||
48683322|NCT01132313|156690712|FG003|Overall Study|Not treated|0|||
48683323|NCT01132313|156690713|FG004|Overall Study|Not treated|2|||
48683324|NCT01132313|156690714|FG005|Overall Study|Not treated|1|||
48683325|NCT01132313|156690715|FG006|Overall Study|Not treated|3|||
48683326|NCT01132313|156690716|FG007|Overall Study|Not treated|0|||
48683327|NCT01132313|156690717|FG008|Overall Study|Not treated|0|||
48683328|NCT01132313|156690718|FG009|Overall Study|Not treated|0|||
48683329|NCT01132313|156690719|FG010|Overall Study|Not treated|0|||
48683330|NCT01132313|156690720|FG011|Overall Study|Not treated|0|||
48683331|NCT01132313|156690709|FG000|Overall Study|Adverse Event|0|||
48683332|NCT01132313|156690710|FG001|Overall Study|Adverse Event|0|||
48683333|NCT01132313|156690711|FG002|Overall Study|Adverse Event|4|||
48683334|NCT01132313|156690712|FG003|Overall Study|Adverse Event|10|||
48683335|NCT01132313|156690713|FG004|Overall Study|Adverse Event|19|||
48683336|NCT01132313|156690714|FG005|Overall Study|Adverse Event|6|||
48683337|NCT01132313|156690715|FG006|Overall Study|Adverse Event|5|||
48683338|NCT01132313|156690716|FG007|Overall Study|Adverse Event|3|||
48683339|NCT01132313|156690717|FG008|Overall Study|Adverse Event|7|||
48683340|NCT01132313|156690718|FG009|Overall Study|Adverse Event|2|||
48683341|NCT01132313|156690719|FG010|Overall Study|Adverse Event|0|||
48683342|NCT01132313|156690720|FG011|Overall Study|Adverse Event|0|||
48683343|NCT01132313|156690709|FG000|Overall Study|Protocol Violation|0|||
48683344|NCT01132313|156690710|FG001|Overall Study|Protocol Violation|0|||
48683345|NCT01132313|156690711|FG002|Overall Study|Protocol Violation|0|||
48683346|NCT01132313|156690712|FG003|Overall Study|Protocol Violation|1|||
48683347|NCT01132313|156690713|FG004|Overall Study|Protocol Violation|0|||
48683348|NCT01132313|156690714|FG005|Overall Study|Protocol Violation|0|||
48683349|NCT01132313|156690715|FG006|Overall Study|Protocol Violation|0|||
48683350|NCT01132313|156690716|FG007|Overall Study|Protocol Violation|0|||
48683351|NCT01132313|156690717|FG008|Overall Study|Protocol Violation|0|||
48683352|NCT01132313|156690718|FG009|Overall Study|Protocol Violation|0|||
48683353|NCT01132313|156690719|FG010|Overall Study|Protocol Violation|0|||
48683354|NCT01132313|156690720|FG011|Overall Study|Protocol Violation|0|||
48683355|NCT01132313|156690709|FG000|Overall Study|Lost to Follow-up|0|||
48683356|NCT01132313|156690710|FG001|Overall Study|Lost to Follow-up|0|||
48683357|NCT01132313|156690711|FG002|Overall Study|Lost to Follow-up|1|||
48683358|NCT01132313|156690712|FG003|Overall Study|Lost to Follow-up|0|||
48683359|NCT01132313|156690713|FG004|Overall Study|Lost to Follow-up|0|||
48683360|NCT01132313|156690714|FG005|Overall Study|Lost to Follow-up|0|||
48683361|NCT01132313|156690715|FG006|Overall Study|Lost to Follow-up|0|||
48683362|NCT01132313|156690716|FG007|Overall Study|Lost to Follow-up|1|||
48683363|NCT01132313|156690717|FG008|Overall Study|Lost to Follow-up|0|||
48683364|NCT01132313|156690718|FG009|Overall Study|Lost to Follow-up|0|||
48683365|NCT01132313|156690719|FG010|Overall Study|Lost to Follow-up|0|||
48683366|NCT01132313|156690720|FG011|Overall Study|Lost to Follow-up|0|||
48683367|NCT01132313|156690709|FG000|Overall Study|Withdrawal by Subject|0|||
48683368|NCT01132313|156690710|FG001|Overall Study|Withdrawal by Subject|0|||
48683369|NCT01132313|156690711|FG002|Overall Study|Withdrawal by Subject|3|||
48683370|NCT01132313|156690712|FG003|Overall Study|Withdrawal by Subject|3|||
48762970|NCT02211131|156981984|FG001|Overall Study|Lost to Follow-up|3|||
48762971|NCT02211131|156981983|FG000|Overall Study|Decision by Sponsor|1|||
48762972|NCT02211131|156981984|FG001|Overall Study|Decision by Sponsor|1|||
48390024|NCT00404820|155622966|FG001|Overall Study|Lost to Follow-up|3|||
48390025|NCT00404820|155622965|FG000|Overall Study|Administrative problems|2|||
48586821|NCT01911780|156341430|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
48586822|NCT01911780|156341431|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
48586823|NCT01911780|156341430|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
48586824|NCT01911780|156341431|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
48586825|NCT01911780|156341430|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
48586826|NCT01911780|156341431|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
48586827|NCT01911780|156341430|FG000|Extension Period (52 Weeks)|Personal reason|1|||
48586828|NCT01911780|156341431|FG001|Extension Period (52 Weeks)|Personal reason|1|||
48586829|NCT02368210|156341434|FG000|Overall Study|Withdrawal by Subject|1|||
48586830|NCT02368210|156341435|FG001|Overall Study|Withdrawal by Subject|0|||
48586831|NCT02368210|156341434|FG000|Overall Study|Adverse Event|0|||
48586832|NCT02368210|156341435|FG001|Overall Study|Adverse Event|1|||
48586833|NCT00078949|156341436|FG000|Overall Study|No treated|4|||
48586834|NCT00078949|156341437|FG001|Overall Study|No treated|5|||
48586835|NCT00078949|156341438|FG002|Overall Study|No treated|3|||
48586836|NCT00078949|156341439|FG003|Overall Study|No treated|3|||
48586837|NCT00577005|156341440|FG000|Overall Study|Lost to Follow-up|3|||
48586838|NCT00577005|156341441|FG001|Overall Study|Lost to Follow-up|2|||
48586839|NCT00577005|156341440|FG000|Overall Study|Withdrawal by Subject|2|||
48586840|NCT00577005|156341441|FG001|Overall Study|Withdrawal by Subject|1|||
48586841|NCT01133288|156341442|FG000|Eligibility Assessment|met exclusion criteria|5|||
48586842|NCT01133288|156341442|FG000|Intervention Allocation|study terminated|2|||
48586843|NCT02005627|156341449|FG000|Overall Study|Lost to Follow-up|1|||
48586844|NCT02005627|156341450|FG001|Overall Study|Lost to Follow-up|2|||
48586845|NCT02005627|156341449|FG000|Overall Study|Withdrawal by Subject|1|||
48586846|NCT02005627|156341450|FG001|Overall Study|Withdrawal by Subject|2|||
48586847|NCT01080391|156341453|FG000|Overall Study|Randomized but not treated|7|||
48586848|NCT01080391|156341454|FG001|Overall Study|Randomized but not treated|4|||
48586849|NCT01672294|156341459|FG000|Overall Study|Withdrawal by Subject|4|||
48586850|NCT01672294|156341460|FG001|Overall Study|Withdrawal by Subject|4|||
48586851|NCT01672294|156341461|FG002|Overall Study|Withdrawal by Subject|4|||
48586852|NCT01672294|156341462|FG003|Overall Study|Withdrawal by Subject|4|||
48586853|NCT01672294|156341459|FG000|Overall Study|Excluded by study|1|||
48586854|NCT01672294|156341460|FG001|Overall Study|Excluded by study|1|||
48586855|NCT01672294|156341461|FG002|Overall Study|Excluded by study|0|||
48586856|NCT01672294|156341462|FG003|Overall Study|Excluded by study|0|||
48586857|NCT01672294|156341459|FG000|Overall Study|Lost to Follow-up|1|||
48586858|NCT01672294|156341460|FG001|Overall Study|Lost to Follow-up|16|||
48586859|NCT01672294|156341461|FG002|Overall Study|Lost to Follow-up|7|||
48586860|NCT01672294|156341462|FG003|Overall Study|Lost to Follow-up|9|||
48586861|NCT01285492|156341463|FG000|Overall Study|Adverse Event|11|||
48586862|NCT01285492|156341464|FG001|Overall Study|Adverse Event|0|||
48586863|NCT01285492|156341463|FG000|Overall Study|Protocol Violation|3|||
48586864|NCT01285492|156341464|FG001|Overall Study|Protocol Violation|0|||
48586865|NCT01285492|156341463|FG000|Overall Study|Withdrawal by Subject|2|||
48586866|NCT01285492|156341464|FG001|Overall Study|Withdrawal by Subject|1|||
48586867|NCT01285492|156341463|FG000|Overall Study|Death|1|||
48586868|NCT01285492|156341464|FG001|Overall Study|Death|0|||
48586869|NCT03379792|156341465|FG000|Overall Study|Physician Decision|0|||
48586870|NCT03379792|156341466|FG001|Overall Study|Physician Decision|0|||
48586871|NCT03379792|156341467|FG002|Overall Study|Physician Decision|0|||
48586872|NCT03379792|156341468|FG003|Overall Study|Physician Decision|1|||
48586873|NCT03379792|156341469|FG004|Overall Study|Physician Decision|0|||
48586874|NCT03379792|156341470|FG005|Overall Study|Physician Decision|0|||
48586875|NCT03379792|156341465|FG000|Overall Study|Withdrawal by Subject|0|||
48586876|NCT03379792|156341466|FG001|Overall Study|Withdrawal by Subject|0|||
48586877|NCT03379792|156341467|FG002|Overall Study|Withdrawal by Subject|0|||
48586878|NCT03379792|156341468|FG003|Overall Study|Withdrawal by Subject|0|||
48586879|NCT03379792|156341469|FG004|Overall Study|Withdrawal by Subject|1|||
48586880|NCT03379792|156341470|FG005|Overall Study|Withdrawal by Subject|1|||
48586881|NCT01121536|156341471|FG000|Overall Study|Adverse Event|63|||
48586882|NCT01121536|156341471|FG000|Overall Study|Lack of Efficacy|35|||
48586883|NCT01121536|156341471|FG000|Overall Study|Withdrawal by Subject|65|||
48586884|NCT01121536|156341471|FG000|Overall Study|Protocol Violation|20|||
48586885|NCT01121536|156341471|FG000|Overall Study|Noncompliance with study medication|12|||
48586886|NCT01121536|156341471|FG000|Overall Study|Noncompliance with study procedures|9|||
48586887|NCT01121536|156341471|FG000|Overall Study|Lost to Follow-up|39|||
48586888|NCT01121536|156341471|FG000|Overall Study|Other|118|||
48586889|NCT00096993|156341475|FG000|Overall Study|Death|1|||
48586890|NCT00096993|156341476|FG001|Overall Study|Death|0|||
48683371|NCT01132313|156690713|FG004|Overall Study|Withdrawal by Subject|6|||
48683372|NCT01132313|156690714|FG005|Overall Study|Withdrawal by Subject|0|||
48683373|NCT01132313|156690715|FG006|Overall Study|Withdrawal by Subject|1|||
48683374|NCT01132313|156690716|FG007|Overall Study|Withdrawal by Subject|0|||
48683375|NCT01132313|156690717|FG008|Overall Study|Withdrawal by Subject|0|||
48683376|NCT01132313|156690718|FG009|Overall Study|Withdrawal by Subject|2|||
48683377|NCT01132313|156690719|FG010|Overall Study|Withdrawal by Subject|0|||
48683378|NCT01132313|156690720|FG011|Overall Study|Withdrawal by Subject|0|||
48683379|NCT01132313|156690709|FG000|Overall Study|Lack of antiviral response|0|||
48683380|NCT01132313|156690710|FG001|Overall Study|Lack of antiviral response|0|||
48683381|NCT01132313|156690711|FG002|Overall Study|Lack of antiviral response|12|||
48683382|NCT01132313|156690712|FG003|Overall Study|Lack of antiviral response|18|||
48683383|NCT01132313|156690713|FG004|Overall Study|Lack of antiviral response|18|||
48683384|NCT01132313|156690714|FG005|Overall Study|Lack of antiviral response|18|||
48683385|NCT01132313|156690715|FG006|Overall Study|Lack of antiviral response|21|||
48683386|NCT01132313|156690716|FG007|Overall Study|Lack of antiviral response|0|||
48683387|NCT01132313|156690717|FG008|Overall Study|Lack of antiviral response|0|||
48683388|NCT01132313|156690718|FG009|Overall Study|Lack of antiviral response|0|||
48683389|NCT01132313|156690719|FG010|Overall Study|Lack of antiviral response|1|||
48683390|NCT01132313|156690720|FG011|Overall Study|Lack of antiviral response|0|||
48683391|NCT01132313|156690709|FG000|Overall Study|Other reason not defined above|0|||
48683392|NCT01132313|156690710|FG001|Overall Study|Other reason not defined above|0|||
48683393|NCT01132313|156690711|FG002|Overall Study|Other reason not defined above|0|||
48683394|NCT01132313|156690712|FG003|Overall Study|Other reason not defined above|0|||
48683395|NCT01132313|156690713|FG004|Overall Study|Other reason not defined above|0|||
48683396|NCT01132313|156690714|FG005|Overall Study|Other reason not defined above|0|||
48683397|NCT01132313|156690715|FG006|Overall Study|Other reason not defined above|0|||
48683398|NCT01132313|156690716|FG007|Overall Study|Other reason not defined above|1|||
48683399|NCT01132313|156690717|FG008|Overall Study|Other reason not defined above|0|||
48683400|NCT01132313|156690718|FG009|Overall Study|Other reason not defined above|0|||
48683401|NCT01132313|156690719|FG010|Overall Study|Other reason not defined above|0|||
48683402|NCT01132313|156690720|FG011|Overall Study|Other reason not defined above|0|||
48683403|NCT01156714|156690721|FG000|Overall Study|Withdrawal by Subject|9|||
48683404|NCT01156714|156690722|FG001|Overall Study|Withdrawal by Subject|4|||
48683405|NCT01156714|156690723|FG002|Overall Study|Withdrawal by Subject|3|||
48683406|NCT04970654|156690726|FG000|Overall Study|Withdrawal by parents/guardian|1|||
48683407|NCT04970654|156690727|FG001|Overall Study|Withdrawal by parents/guardian|2|||
48683408|NCT04970654|156690726|FG000|Overall Study|Unclassified|2|||
48683409|NCT04970654|156690727|FG001|Overall Study|Unclassified|1|||
48683410|NCT04970654|156690726|FG000|Overall Study|Lost to Follow-up|1|||
48683411|NCT04970654|156690727|FG001|Overall Study|Lost to Follow-up|0|||
48683412|NCT03915470|156690728|FG000|Overall Study|Death|3|||
48683413|NCT03915470|156690729|FG001|Overall Study|Death|1|||
48683414|NCT03915470|156690728|FG000|Overall Study|Adverse Event|1|||
48683415|NCT03915470|156690729|FG001|Overall Study|Adverse Event|0|||
48683416|NCT03915470|156690728|FG000|Overall Study|Physician Decision|1|||
48683417|NCT03915470|156690729|FG001|Overall Study|Physician Decision|0|||
48683418|NCT03915470|156690728|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
48683419|NCT03915470|156690729|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
48683420|NCT03160898|156690730|FG000|Overall Study|Adverse Event|4|||
48683421|NCT03160898|156690731|FG001|Overall Study|Adverse Event|8|||
48683422|NCT03160898|156690732|FG002|Overall Study|Adverse Event|7|||
48683423|NCT03160898|156690733|FG003|Overall Study|Adverse Event|10|||
48683424|NCT03160898|156690730|FG000|Overall Study|Death|1|||
48683425|NCT03160898|156690731|FG001|Overall Study|Death|0|||
48683426|NCT03160898|156690732|FG002|Overall Study|Death|0|||
48683427|NCT03160898|156690733|FG003|Overall Study|Death|1|||
48355305|NCT01814072|155497259|FG023|Overall Study|Withdrawal by Subject|0|||
48683428|NCT03160898|156690730|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
48683429|NCT03160898|156690731|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
48683430|NCT03160898|156690732|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
48683431|NCT03160898|156690733|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
48683432|NCT03160898|156690730|FG000|Overall Study|Lost to Follow-up|1|||
48683433|NCT03160898|156690731|FG001|Overall Study|Lost to Follow-up|1|||
48683434|NCT03160898|156690732|FG002|Overall Study|Lost to Follow-up|1|||
48683435|NCT03160898|156690733|FG003|Overall Study|Lost to Follow-up|2|||
48683436|NCT03160898|156690730|FG000|Overall Study|Physician Decision|1|||
48683437|NCT03160898|156690731|FG001|Overall Study|Physician Decision|0|||
48683438|NCT03160898|156690732|FG002|Overall Study|Physician Decision|0|||
48683439|NCT03160898|156690733|FG003|Overall Study|Physician Decision|1|||
48683440|NCT03160898|156690730|FG000|Overall Study|Progressive Disease|4|||
48683441|NCT03160898|156690731|FG001|Overall Study|Progressive Disease|1|||
48683442|NCT03160898|156690732|FG002|Overall Study|Progressive Disease|2|||
48683443|NCT03160898|156690733|FG003|Overall Study|Progressive Disease|1|||
48683444|NCT03160898|156690730|FG000|Overall Study|Protocol Violation|1|||
48683445|NCT03160898|156690731|FG001|Overall Study|Protocol Violation|0|||
48683446|NCT03160898|156690732|FG002|Overall Study|Protocol Violation|2|||
48683447|NCT03160898|156690733|FG003|Overall Study|Protocol Violation|0|||
48683448|NCT03160898|156690730|FG000|Overall Study|Sponsor Discretion|2|||
48683449|NCT03160898|156690731|FG001|Overall Study|Sponsor Discretion|0|||
48683450|NCT03160898|156690732|FG002|Overall Study|Sponsor Discretion|0|||
48683451|NCT03160898|156690733|FG003|Overall Study|Sponsor Discretion|0|||
48683452|NCT03160898|156690730|FG000|Overall Study|Withdrawal by Subject|1|||
48683453|NCT03160898|156690731|FG001|Overall Study|Withdrawal by Subject|3|||
48683454|NCT03160898|156690732|FG002|Overall Study|Withdrawal by Subject|2|||
48683455|NCT03160898|156690733|FG003|Overall Study|Withdrawal by Subject|1|||
48683456|NCT03160898|156690730|FG000|Overall Study|Other|2|||
48683457|NCT03160898|156690731|FG001|Overall Study|Other|0|||
48683458|NCT03160898|156690732|FG002|Overall Study|Other|2|||
48683459|NCT03160898|156690733|FG003|Overall Study|Other|2|||
48683460|NCT01505374|156690734|FG000|Overall Study|Lost to Follow-up|1|||
48683461|NCT01505374|156690735|FG001|Overall Study|Lost to Follow-up|0|||
48683462|NCT01150097|156690736|FG000|Months 24 to 36 Post-transplantation|Death|2|||
48683463|NCT01150097|156690737|FG001|Months 24 to 36 Post-transplantation|Death|0|||
48683464|NCT01150097|156690738|FG002|Months 24 to 36 Post-transplantation|Death|0|||
48683465|NCT01150097|156690736|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
48683466|NCT01150097|156690737|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
48683467|NCT01150097|156690738|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
48683468|NCT01150097|156690736|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
48683469|NCT01150097|156690737|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
48683470|NCT01150097|156690738|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
48683471|NCT01150097|156690736|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
48683472|NCT01150097|156690737|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
48390026|NCT00404820|155622966|FG001|Overall Study|Administrative problems|0|||
48390027|NCT00404820|155622965|FG000|Overall Study|Death|1|||
48390028|NCT00404820|155622966|FG001|Overall Study|Death|0|||
48390029|NCT00404820|155622965|FG000|Overall Study|Other|0|||
48390030|NCT00404820|155622966|FG001|Overall Study|Other|2|||
48390031|NCT03349775|155622973|FG000|Overall Study|Side Effects|1|||
48390032|NCT03349775|155622974|FG001|Overall Study|Side Effects|2|||
48390033|NCT03349775|155622973|FG000|Overall Study|Withdrawal by Subject|1|||
48390034|NCT03349775|155622974|FG001|Overall Study|Withdrawal by Subject|1|||
48390035|NCT03349775|155622973|FG000|Overall Study|No primary outcome measurements|0|||
48683473|NCT01150097|156690738|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
48683474|NCT01150097|156690736|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
48683475|NCT01150097|156690737|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
48683476|NCT01150097|156690738|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
48683477|NCT01150097|156690736|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
48683478|NCT01150097|156690737|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
48683479|NCT01150097|156690738|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
48683480|NCT01150097|156690736|FG000|Months 24 to 48 Post-transplantation|Death|2|||
48683481|NCT01150097|156690737|FG001|Months 24 to 48 Post-transplantation|Death|0|||
48683482|NCT01150097|156690738|FG002|Months 24 to 48 Post-transplantation|Death|0|||
48683483|NCT04158583|156690739|FG000|Overall Study|Withdrawal by Subject|1|||
48683484|NCT04158583|156690740|FG001|Overall Study|Withdrawal by Subject|1|||
48683485|NCT04158583|156690741|FG002|Overall Study|Withdrawal by Subject|0|||
48683486|NCT04158583|156690742|FG003|Overall Study|Withdrawal by Subject|0|||
48683487|NCT04158583|156690743|FG004|Overall Study|Withdrawal by Subject|1|||
48683488|NCT04158583|156690744|FG005|Overall Study|Withdrawal by Subject|0|||
48683489|NCT04158583|156690745|FG006|Overall Study|Withdrawal by Subject|0|||
48683490|NCT04158583|156690746|FG007|Overall Study|Withdrawal by Subject|0|||
48683491|NCT04158583|156690747|FG008|Overall Study|Withdrawal by Subject|2|||
48683492|NCT04158583|156690748|FG009|Overall Study|Withdrawal by Subject|0|||
48683493|NCT04158583|156690739|FG000|Overall Study|Study Terminated by Sponsor|0|||
48683494|NCT04158583|156690740|FG001|Overall Study|Study Terminated by Sponsor|0|||
48683495|NCT04158583|156690741|FG002|Overall Study|Study Terminated by Sponsor|0|||
48683496|NCT04158583|156690742|FG003|Overall Study|Study Terminated by Sponsor|1|||
48683497|NCT04158583|156690743|FG004|Overall Study|Study Terminated by Sponsor|0|||
48683498|NCT04158583|156690744|FG005|Overall Study|Study Terminated by Sponsor|0|||
48683499|NCT04158583|156690745|FG006|Overall Study|Study Terminated by Sponsor|0|||
48683500|NCT04158583|156690746|FG007|Overall Study|Study Terminated by Sponsor|0|||
48683501|NCT04158583|156690747|FG008|Overall Study|Study Terminated by Sponsor|0|||
48683502|NCT04158583|156690748|FG009|Overall Study|Study Terminated by Sponsor|0|||
48683503|NCT04158583|156690739|FG000|Overall Study|Progressive Disease|1|||
48683504|NCT04158583|156690740|FG001|Overall Study|Progressive Disease|0|||
48683505|NCT04158583|156690741|FG002|Overall Study|Progressive Disease|3|||
48683506|NCT04158583|156690742|FG003|Overall Study|Progressive Disease|5|||
48683507|NCT04158583|156690743|FG004|Overall Study|Progressive Disease|0|||
48683508|NCT04158583|156690744|FG005|Overall Study|Progressive Disease|1|||
48683509|NCT04158583|156690745|FG006|Overall Study|Progressive Disease|6|||
48683510|NCT04158583|156690746|FG007|Overall Study|Progressive Disease|2|||
48683511|NCT04158583|156690747|FG008|Overall Study|Progressive Disease|1|||
48683512|NCT04158583|156690748|FG009|Overall Study|Progressive Disease|2|||
48683513|NCT04158583|156690739|FG000|Overall Study|Lost to Follow-up|0|||
48683514|NCT04158583|156690740|FG001|Overall Study|Lost to Follow-up|0|||
48683515|NCT04158583|156690741|FG002|Overall Study|Lost to Follow-up|1|||
48683516|NCT04158583|156690742|FG003|Overall Study|Lost to Follow-up|1|||
48683517|NCT04158583|156690743|FG004|Overall Study|Lost to Follow-up|1|||
48683518|NCT04158583|156690744|FG005|Overall Study|Lost to Follow-up|0|||
48683519|NCT04158583|156690745|FG006|Overall Study|Lost to Follow-up|0|||
48683520|NCT04158583|156690746|FG007|Overall Study|Lost to Follow-up|0|||
48683521|NCT04158583|156690747|FG008|Overall Study|Lost to Follow-up|0|||
48683522|NCT04158583|156690748|FG009|Overall Study|Lost to Follow-up|0|||
48683523|NCT04158583|156690739|FG000|Overall Study|Due To Patient Status|0|||
48683524|NCT04158583|156690740|FG001|Overall Study|Due To Patient Status|0|||
48683525|NCT04158583|156690741|FG002|Overall Study|Due To Patient Status|0|||
48683526|NCT04158583|156690742|FG003|Overall Study|Due To Patient Status|0|||
48683527|NCT04158583|156690743|FG004|Overall Study|Due To Patient Status|0|||
48683528|NCT04158583|156690744|FG005|Overall Study|Due To Patient Status|0|||
48683529|NCT04158583|156690745|FG006|Overall Study|Due To Patient Status|0|||
48683530|NCT04158583|156690746|FG007|Overall Study|Due To Patient Status|0|||
48683531|NCT04158583|156690747|FG008|Overall Study|Due To Patient Status|1|||
48683532|NCT04158583|156690748|FG009|Overall Study|Due To Patient Status|0|||
48683533|NCT04158583|156690739|FG000|Overall Study|Death|3|||
48683534|NCT04158583|156690740|FG001|Overall Study|Death|4|||
48683535|NCT04158583|156690741|FG002|Overall Study|Death|2|||
48683536|NCT04158583|156690742|FG003|Overall Study|Death|2|||
48683537|NCT04158583|156690743|FG004|Overall Study|Death|4|||
48683538|NCT04158583|156690744|FG005|Overall Study|Death|3|||
48683539|NCT04158583|156690745|FG006|Overall Study|Death|5|||
48683540|NCT04158583|156690746|FG007|Overall Study|Death|2|||
48683541|NCT04158583|156690747|FG008|Overall Study|Death|0|||
48683542|NCT04158583|156690748|FG009|Overall Study|Death|1|||
48683543|NCT04158583|156690739|FG000|Overall Study|Clinical Progression Disease|0|||
48683544|NCT04158583|156690740|FG001|Overall Study|Clinical Progression Disease|0|||
48683545|NCT04158583|156690741|FG002|Overall Study|Clinical Progression Disease|0|||
48683546|NCT04158583|156690742|FG003|Overall Study|Clinical Progression Disease|1|||
48683547|NCT04158583|156690743|FG004|Overall Study|Clinical Progression Disease|0|||
48683548|NCT04158583|156690744|FG005|Overall Study|Clinical Progression Disease|0|||
48762973|NCT02211131|156981983|FG000|Overall Study|Withdrawal by Subject|3|||
48762974|NCT02211131|156981984|FG001|Overall Study|Withdrawal by Subject|8|||
48762975|NCT02939560|156981985|FG000|Overall Study|Withdrawal by Subject|2|||
48762976|NCT02939560|156981985|FG000|Overall Study|Protocol Violation|1|||
48683549|NCT04158583|156690745|FG006|Overall Study|Clinical Progression Disease|0|||
48683550|NCT04158583|156690746|FG007|Overall Study|Clinical Progression Disease|0|||
48683551|NCT04158583|156690747|FG008|Overall Study|Clinical Progression Disease|0|||
48683552|NCT04158583|156690748|FG009|Overall Study|Clinical Progression Disease|0|||
48762977|NCT02612428|156981998|FG000|VTL-308|Death|14|||
48762978|NCT02612428|156981999|FG001|VTL-308|Death|16|||
48762979|NCT02612428|156981998|FG000|VTL-308|Withdrawal by Subject|0|||
48762980|NCT02612428|156981999|FG001|VTL-308|Withdrawal by Subject|1|||
48762981|NCT02612428|156981998|FG000|VTL-308E|Death|9|||
48762982|NCT02612428|156981999|FG001|VTL-308E|Death|7|||
48762983|NCT02612428|156981998|FG000|VTL-308E|Lost to Follow-up|2|||
48762984|NCT02612428|156981999|FG001|VTL-308E|Lost to Follow-up|0|||
48762985|NCT01293240|156982005|FG000|Overall Study|Noncompliance|2|||
48762986|NCT01251380|156982009|FG000|Overall Study|Other (Not otherwise specified)|12|||
48762987|NCT01251380|156982009|FG000|Overall Study|Withdrawal by Subject|6|||
48762988|NCT01251380|156982009|FG000|Overall Study|Lack of Efficacy|1|||
48355306|NCT01814072|155497260|FG024|Overall Study|Withdrawal by Subject|2|||
48762989|NCT01251380|156982009|FG000|Overall Study|Adverse Event|1|||
48355307|NCT01814072|155497261|FG025|Overall Study|Withdrawal by Subject|1|||
48355308|NCT01814072|155497262|FG026|Overall Study|Withdrawal by Subject|1|||
48355309|NCT01814072|155497263|FG027|Overall Study|Withdrawal by Subject|2|||
48355310|NCT01814072|155497264|FG028|Overall Study|Withdrawal by Subject|1|||
48355311|NCT01814072|155497265|FG029|Overall Study|Withdrawal by Subject|0|||
48355312|NCT01814072|155497266|FG030|Overall Study|Withdrawal by Subject|0|||
48355313|NCT01814072|155497267|FG031|Overall Study|Withdrawal by Subject|0|||
48355314|NCT00760747|155497268|FG000|Study Period II|Adverse Event|3|||
48355315|NCT00760747|155497269|FG001|Study Period II|Adverse Event|4|||
48355316|NCT00760747|155497268|FG000|Study Period II|Lack of Efficacy|0|||
48355317|NCT00760747|155497269|FG001|Study Period II|Lack of Efficacy|6|||
48355318|NCT00760747|155497268|FG000|Study Period II|Parent/Caregiver Decision|3|||
48683553|NCT04158583|156690739|FG000|Overall Study|Clinical Progression|0|||
48683554|NCT04158583|156690740|FG001|Overall Study|Clinical Progression|0|||
48390036|NCT03349775|155622974|FG001|Overall Study|No primary outcome measurements|1|||
48390037|NCT03680911|155622975|FG000|At Home Treatment|Study Termination|3|||
48390038|NCT03680911|155622976|FG001|At Home Treatment|Study Termination|0|||
48390039|NCT03680911|155622975|FG000|At Home Treatment|Lost to Follow-up|0|||
48390040|NCT03680911|155622976|FG001|At Home Treatment|Lost to Follow-up|1|||
48390041|NCT03680911|155622975|FG000|At Home Treatment|Withdrawal by Subject|0|||
48390042|NCT03680911|155622976|FG001|At Home Treatment|Withdrawal by Subject|2|||
48390043|NCT03680911|155622975|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
48390044|NCT03680911|155622976|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
48390045|NCT01075412|155622979|FG000|Overall Study|Withdrawal by Subject|0|||
48390046|NCT01075412|155622980|FG001|Overall Study|Withdrawal by Subject|1|||
48390047|NCT03962738|155622981|FG000|Overall Study|Protocol Deviation|3|||
48390048|NCT03962738|155622982|FG001|Overall Study|Protocol Deviation|0|||
48390049|NCT03962738|155622983|FG002|Overall Study|Protocol Deviation|1|||
48390050|NCT03962738|155622984|FG003|Overall Study|Protocol Deviation|1|||
48390051|NCT03962738|155622981|FG000|Overall Study|Withdrawal by Subject|4|||
48390052|NCT03962738|155622982|FG001|Overall Study|Withdrawal by Subject|0|||
48390053|NCT03962738|155622983|FG002|Overall Study|Withdrawal by Subject|0|||
48390054|NCT03962738|155622984|FG003|Overall Study|Withdrawal by Subject|0|||
48683555|NCT04158583|156690741|FG002|Overall Study|Clinical Progression|0|||
48683556|NCT04158583|156690742|FG003|Overall Study|Clinical Progression|0|||
48683557|NCT04158583|156690743|FG004|Overall Study|Clinical Progression|1|||
48683558|NCT04158583|156690744|FG005|Overall Study|Clinical Progression|0|||
48683559|NCT04158583|156690745|FG006|Overall Study|Clinical Progression|2|||
48683560|NCT04158583|156690746|FG007|Overall Study|Clinical Progression|0|||
48390055|NCT03962738|155622981|FG000|Overall Study|Lost to Follow-up|0|||
48390056|NCT03962738|155622982|FG001|Overall Study|Lost to Follow-up|0|||
48390057|NCT03962738|155622983|FG002|Overall Study|Lost to Follow-up|1|||
48390058|NCT03962738|155622984|FG003|Overall Study|Lost to Follow-up|0|||
48390059|NCT02614859|155622985|FG000|Overall Study|Physician Decision|0|||
48390060|NCT02614859|155622986|FG001|Overall Study|Physician Decision|1|||
48390061|NCT00131469|155622987|FG000|Overall Study|Withdrawal by Subject|3|||
48390062|NCT00131469|155622988|FG001|Overall Study|Withdrawal by Subject|4|||
48390063|NCT00131469|155622987|FG000|Overall Study|Protocol Violation|3|||
48390064|NCT00131469|155622988|FG001|Overall Study|Protocol Violation|1|||
48390065|NCT00131469|155622987|FG000|Overall Study|Death|0|||
48390066|NCT00131469|155622988|FG001|Overall Study|Death|1|||
48390067|NCT00131469|155622987|FG000|Overall Study|Lost to Follow-up|0|||
48390068|NCT00131469|155622988|FG001|Overall Study|Lost to Follow-up|1|||
48390069|NCT00131469|155622987|FG000|Overall Study|scan not analyzable|3|||
48390070|NCT00131469|155622988|FG001|Overall Study|scan not analyzable|6|||
48390071|NCT02871778|155622989|FG000|Part A: Treatment Period 1|Adverse Event|1|||
48390072|NCT02871778|155622990|FG001|Part A: Treatment Period 1|Adverse Event|1|||
48390073|NCT02871778|155622991|FG002|Part A: Treatment Period 1|Adverse Event|1|||
48390074|NCT02871778|155622992|FG003|Part A: Treatment Period 1|Adverse Event|0|||
48390075|NCT02871778|155622993|FG004|Part A: Treatment Period 1|Adverse Event|0|||
48390076|NCT02871778|155622994|FG005|Part A: Treatment Period 1|Adverse Event|0|||
48390077|NCT02871778|155622995|FG006|Part A: Treatment Period 1|Adverse Event|0|||
48390078|NCT02871778|155622996|FG007|Part A: Treatment Period 1|Adverse Event|0|||
48390079|NCT02871778|155622989|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
48390080|NCT02871778|155622990|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
48390081|NCT02871778|155622991|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48390082|NCT02871778|155622992|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
48390083|NCT02871778|155622993|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48390084|NCT02871778|155622994|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48390085|NCT02871778|155622995|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48390086|NCT02871778|155622996|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
48390087|NCT02871778|155622989|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48390088|NCT02871778|155622990|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48390089|NCT02871778|155622991|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
48390090|NCT02871778|155622992|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48390091|NCT02871778|155622993|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48390092|NCT02871778|155622994|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48683561|NCT04158583|156690747|FG008|Overall Study|Clinical Progression|0|||
48390093|NCT02871778|155622995|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48390094|NCT02871778|155622996|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
48762990|NCT01251380|156982009|FG000|Overall Study|Lost to Follow-up|2|||
48390095|NCT02871778|155622989|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48390096|NCT02871778|155622990|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48390097|NCT02871778|155622991|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
48390098|NCT02871778|155622992|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48390099|NCT02871778|155622993|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48390100|NCT02871778|155622994|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48390101|NCT02871778|155622995|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48683562|NCT04158583|156690748|FG009|Overall Study|Clinical Progression|0|||
48683563|NCT04158583|156690739|FG000|Overall Study|Clinical Deterioration|0|||
48683564|NCT04158583|156690740|FG001|Overall Study|Clinical Deterioration|0|||
48683565|NCT04158583|156690741|FG002|Overall Study|Clinical Deterioration|0|||
48683566|NCT04158583|156690742|FG003|Overall Study|Clinical Deterioration|1|||
48683567|NCT04158583|156690743|FG004|Overall Study|Clinical Deterioration|0|||
48683568|NCT04158583|156690744|FG005|Overall Study|Clinical Deterioration|0|||
48683569|NCT04158583|156690745|FG006|Overall Study|Clinical Deterioration|0|||
48683570|NCT04158583|156690746|FG007|Overall Study|Clinical Deterioration|0|||
48683571|NCT04158583|156690747|FG008|Overall Study|Clinical Deterioration|0|||
48683572|NCT04158583|156690748|FG009|Overall Study|Clinical Deterioration|1|||
48683573|NCT04618744|156690749|FG000|Overall Study|Adverse Event|0|||
48683574|NCT04618744|156690750|FG001|Overall Study|Adverse Event|1|||
48683575|NCT04618744|156690749|FG000|Overall Study|Withdrawal by Subject|0|||
48683576|NCT04618744|156690750|FG001|Overall Study|Withdrawal by Subject|1|||
48683577|NCT02709330|156690751|FG000|Overall Study|Death|5|||
48683578|NCT02709330|156690752|FG001|Overall Study|Death|0|||
48683579|NCT02709330|156690751|FG000|Overall Study|Lost to Follow-up|2|||
48390102|NCT02871778|155622996|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
48390103|NCT02871778|155622989|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
48390104|NCT02871778|155622990|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
48390105|NCT02871778|155622991|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
48390106|NCT02871778|155622992|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
48390107|NCT02871778|155622993|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
48683580|NCT02709330|156690752|FG001|Overall Study|Lost to Follow-up|0|||
48683581|NCT02709330|156690751|FG000|Overall Study|Physician Decision|2|||
48683582|NCT02709330|156690752|FG001|Overall Study|Physician Decision|0|||
48683583|NCT02709330|156690751|FG000|Overall Study|Withdrawal by Subject|4|||
48683584|NCT02709330|156690752|FG001|Overall Study|Withdrawal by Subject|0|||
48683585|NCT01807299|156690753|FG000|Overall Study|Protocol Violation|3|||
48683586|NCT01807299|156690754|FG001|Overall Study|Protocol Violation|1|||
48683587|NCT01807299|156690755|FG002|Overall Study|Protocol Violation|0|||
48683588|NCT01807299|156690756|FG003|Overall Study|Protocol Violation|2|||
48683589|NCT01370265|156692600|FG000|First Intervention|Adverse Event|1|||
48683590|NCT01370265|156692601|FG001|First Intervention|Adverse Event|1|||
48683591|NCT03738618|156692606|FG000|Overall Study|Protocol deviation|23|||
48683592|NCT03738618|156692607|FG001|Overall Study|Protocol deviation|0|||
48683593|NCT03738618|156692606|FG000|Overall Study|Adverse Event|4|||
48683594|NCT03738618|156692607|FG001|Overall Study|Adverse Event|0|||
48683595|NCT03738618|156692606|FG000|Overall Study|Lost to Follow-up|2|||
48683596|NCT03738618|156692607|FG001|Overall Study|Lost to Follow-up|0|||
48683597|NCT03738618|156692606|FG000|Overall Study|Randomization failure|1|||
48683598|NCT03738618|156692607|FG001|Overall Study|Randomization failure|0|||
48683599|NCT03738618|156692606|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
48683600|NCT03738618|156692607|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
48683601|NCT03738618|156692606|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
48683602|NCT03738618|156692607|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
48683603|NCT01216683|156692608|FG000|Induction|Never started treatment|0|||
48683604|NCT01216683|156692609|FG001|Induction|Never started treatment|6|||
48683605|NCT01216683|156692610|FG002|Induction|Never started treatment|3|||
48683606|NCT01216683|156692608|FG000|Induction|Lack of Efficacy|4|||
48683607|NCT01216683|156692609|FG001|Induction|Lack of Efficacy|3|||
48683608|NCT01216683|156692610|FG002|Induction|Lack of Efficacy|7|||
48390108|NCT02871778|155622994|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
48390109|NCT02871778|155622995|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
48683609|NCT01216683|156692608|FG000|Induction|Adverse Event|0|||
48683610|NCT01216683|156692609|FG001|Induction|Adverse Event|5|||
48683611|NCT01216683|156692610|FG002|Induction|Adverse Event|5|||
48683612|NCT01216683|156692608|FG000|Induction|Death|0|||
48683613|NCT01216683|156692609|FG001|Induction|Death|0|||
48683614|NCT01216683|156692610|FG002|Induction|Death|2|||
48683615|NCT01216683|156692608|FG000|Induction|Withdrawal by Subject|0|||
48683616|NCT01216683|156692609|FG001|Induction|Withdrawal by Subject|4|||
48683617|NCT01216683|156692610|FG002|Induction|Withdrawal by Subject|2|||
48683618|NCT01216683|156692608|FG000|Induction|Other disease|0|||
48683619|NCT01216683|156692609|FG001|Induction|Other disease|1|||
48683620|NCT01216683|156692610|FG002|Induction|Other disease|2|||
48683621|NCT01216683|156692608|FG000|Continuation|Lack of Efficacy|3|||
48683622|NCT01216683|156692609|FG001|Continuation|Lack of Efficacy|2|||
48390110|NCT02871778|155622996|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
48683623|NCT01216683|156692610|FG002|Continuation|Lack of Efficacy|7|||
48683624|NCT01216683|156692608|FG000|Continuation|Adverse Event|5|||
48683625|NCT01216683|156692609|FG001|Continuation|Adverse Event|3|||
48683626|NCT01216683|156692610|FG002|Continuation|Adverse Event|16|||
48683627|NCT01216683|156692608|FG000|Continuation|Death|1|||
48683628|NCT01216683|156692609|FG001|Continuation|Death|0|||
48683629|NCT01216683|156692610|FG002|Continuation|Death|2|||
48683630|NCT01216683|156692608|FG000|Continuation|Withdrawal by Subject|4|||
48683631|NCT01216683|156692609|FG001|Continuation|Withdrawal by Subject|5|||
48683632|NCT01216683|156692610|FG002|Continuation|Withdrawal by Subject|9|||
48683633|NCT01216683|156692608|FG000|Continuation|Other diseases|0|||
48683634|NCT01216683|156692609|FG001|Continuation|Other diseases|2|||
48683635|NCT01216683|156692610|FG002|Continuation|Other diseases|1|||
48683636|NCT01216683|156692608|FG000|Continuation|Physician Decision|1|||
48683637|NCT01216683|156692609|FG001|Continuation|Physician Decision|0|||
48683638|NCT01216683|156692610|FG002|Continuation|Physician Decision|1|||
48683639|NCT01216683|156692608|FG000|Continuation|Non-compliance|1|||
48683640|NCT01216683|156692609|FG001|Continuation|Non-compliance|0|||
48683641|NCT01216683|156692610|FG002|Continuation|Non-compliance|1|||
48683642|NCT01216683|156692608|FG000|Continuation|Insurance change|0|||
48683643|NCT01216683|156692609|FG001|Continuation|Insurance change|1|||
48683644|NCT01216683|156692610|FG002|Continuation|Insurance change|0|||
48683645|NCT01216683|156692608|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
48683646|NCT01216683|156692609|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
48683647|NCT01216683|156692610|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
48683648|NCT01216683|156692608|FG000|Continuation|Not reported|0|||
48683649|NCT01216683|156692609|FG001|Continuation|Not reported|0|||
48683650|NCT01216683|156692610|FG002|Continuation|Not reported|1|||
48683651|NCT01216683|156692608|FG000|Continuation|Never started treatment|0|||
48683652|NCT01216683|156692609|FG001|Continuation|Never started treatment|1|||
48683653|NCT01216683|156692610|FG002|Continuation|Never started treatment|5|||
48683654|NCT00780416|156692611|FG000|Overall Study|Physician Decision|3|||
48683655|NCT00780416|156692612|FG001|Overall Study|Physician Decision|3|||
48683656|NCT00780416|156692611|FG000|Overall Study|Protocol Violation|1|||
48683657|NCT00780416|156692612|FG001|Overall Study|Protocol Violation|0|||
48683658|NCT00780416|156692611|FG000|Overall Study|Withdrawal by Subject|8|||
48683659|NCT00780416|156692612|FG001|Overall Study|Withdrawal by Subject|6|||
48683660|NCT02679755|156692615|FG000|Overall Study|Death|0|||
48683661|NCT02679755|156692616|FG001|Overall Study|Death|3|||
48683662|NCT02679755|156692615|FG000|Overall Study|Global deterioration of health status|1|||
48683663|NCT02679755|156692616|FG001|Overall Study|Global deterioration of health status|8|||
48683664|NCT02679755|156692615|FG000|Overall Study|Lost to Follow-up|1|||
48683665|NCT02679755|156692616|FG001|Overall Study|Lost to Follow-up|0|||
48683666|NCT02679755|156692615|FG000|Overall Study|Objective progression or relapse|24|||
48683667|NCT02679755|156692616|FG001|Overall Study|Objective progression or relapse|83|||
48683668|NCT02679755|156692615|FG000|Overall Study|Not defined|0|||
48683669|NCT02679755|156692616|FG001|Overall Study|Not defined|2|||
48683670|NCT02679755|156692615|FG000|Overall Study|Withdrawal by participant|6|||
48683671|NCT02679755|156692616|FG001|Overall Study|Withdrawal by participant|3|||
48683672|NCT02679755|156692615|FG000|Overall Study|Adverse Event|1|||
48683673|NCT02679755|156692616|FG001|Overall Study|Adverse Event|4|||
48683674|NCT02679755|156692615|FG000|Overall Study|Adverse events not related to study drug|1|||
48683675|NCT02679755|156692616|FG001|Overall Study|Adverse events not related to study drug|2|||
48683676|NCT01061359|156692617|FG000|Overall Study|Death|32|||
48683677|NCT01061359|156692617|FG000|Overall Study|Lost to Follow-up|1072|||
48683678|NCT01061359|156692617|FG000|Overall Study|Relapse|187|||
48390111|NCT02871778|155622989|FG000|Part A: Treatment Period 2|Adverse Event|2|||
48683679|NCT01061359|156692617|FG000|Overall Study|Secondary neoplasm|11|||
48683680|NCT00732875|156692618|FG000|Overall Study|Adverse Event|16|||
48390112|NCT02871778|155622990|FG001|Part A: Treatment Period 2|Adverse Event|2|||
48683681|NCT00732875|156692618|FG000|Overall Study|Withdrawal by Subject|6|||
48683682|NCT00732875|156692618|FG000|Overall Study|Lack of Efficacy|13|||
48683683|NCT03826186|156692619|FG000|Overall Study|Protocol Violation|2|||
48683684|NCT03826186|156692620|FG001|Overall Study|Protocol Violation|0|||
48683685|NCT03826186|156692619|FG000|Overall Study|Withdrawal by Subject|1|||
48683686|NCT03826186|156692620|FG001|Overall Study|Withdrawal by Subject|0|||
48683687|NCT00655629|156692621|FG000|Overall Study|Adverse Event|4|||
48683688|NCT00655629|156692622|FG001|Overall Study|Adverse Event|1|||
48683689|NCT00655629|156692621|FG000|Overall Study|Lack of Efficacy|2|||
48683690|NCT00655629|156692622|FG001|Overall Study|Lack of Efficacy|12|||
48683691|NCT00655629|156692621|FG000|Overall Study|Lost to Follow-up|4|||
48683692|NCT00655629|156692622|FG001|Overall Study|Lost to Follow-up|3|||
48683693|NCT00655629|156692621|FG000|Overall Study|Protocol Violation|5|||
48683694|NCT00655629|156692622|FG001|Overall Study|Protocol Violation|3|||
48683695|NCT00655629|156692621|FG000|Overall Study|consent withdrawn|6|||
48683696|NCT00655629|156692622|FG001|Overall Study|consent withdrawn|4|||
48683697|NCT05258149|156692624|FG000|Period 1|Protocol Deviation|1|||
48390113|NCT02871778|155622991|FG002|Part A: Treatment Period 2|Adverse Event|0|||
48683698|NCT05258149|156692625|FG001|Period 1|Protocol Deviation|0|||
48683699|NCT05258149|156692624|FG000|Period 1|Adverse Event|0|||
48683700|NCT05258149|156692625|FG001|Period 1|Adverse Event|1|||
48683701|NCT05258149|156692624|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
48683702|NCT05258149|156692625|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
48683703|NCT05258149|156692624|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
48683704|NCT05258149|156692625|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
48683705|NCT05258149|156692624|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
48683706|NCT05258149|156692625|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
48762991|NCT02319031|156982016|FG000|Treatment Period|Death|1|||
48762992|NCT02319031|156982017|FG001|Treatment Period|Death|0|||
48762993|NCT02009046|156982018|FG000|Overall Study|Lost to Follow-up|256|||
48762994|NCT02009046|156982019|FG001|Overall Study|Lost to Follow-up|206|||
48762995|NCT01085097|156982022|FG000|Overall Study|Adverse Event|0|||
48390114|NCT02871778|155622992|FG003|Part A: Treatment Period 2|Adverse Event|0|||
48390115|NCT02871778|155622993|FG004|Part A: Treatment Period 2|Adverse Event|0|||
48390116|NCT02871778|155622994|FG005|Part A: Treatment Period 2|Adverse Event|0|||
48390117|NCT02871778|155622995|FG006|Part A: Treatment Period 2|Adverse Event|0|||
48390118|NCT02871778|155622996|FG007|Part A: Treatment Period 2|Adverse Event|0|||
48390119|NCT02871778|155622989|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
48390120|NCT02871778|155622990|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
48390121|NCT02871778|155622991|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
48390122|NCT02871778|155622992|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
48390123|NCT02871778|155622993|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
48390124|NCT02871778|155622994|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
48390125|NCT02871778|155622995|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
48390126|NCT02871778|155622996|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
48390127|NCT02871778|155622989|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
48390128|NCT02871778|155622990|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48390129|NCT02871778|155622991|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
48390130|NCT02871778|155622992|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48390131|NCT02871778|155622993|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48762996|NCT01085097|156982023|FG001|Overall Study|Adverse Event|0|||
48762997|NCT01085097|156982024|FG002|Overall Study|Adverse Event|2|||
48762998|NCT01085097|156982022|FG000|Overall Study|Treatment failure|2|||
48762999|NCT01085097|156982023|FG001|Overall Study|Treatment failure|0|||
48763000|NCT01085097|156982024|FG002|Overall Study|Treatment failure|0|||
48763001|NCT03316885|156982025|FG000|Overall Study|Adverse Event|1|||
48763002|NCT03316885|156982025|FG000|Overall Study|Death|10|||
48763003|NCT03316885|156982025|FG000|Overall Study|Lost to Follow-up|4|||
48763004|NCT03316885|156982025|FG000|Overall Study|Withdrawal by Subject|9|||
48763005|NCT03316885|156982025|FG000|Overall Study|COVID related|8|||
48763006|NCT03338062|156982026|FG000|Overall Study|Alternative Therapy|1|||
48763007|NCT03338062|156982027|FG001|Overall Study|Alternative Therapy|0|||
48763008|NCT00537381|156982032|FG000|Overall Study|Adverse Event|13|||
48763009|NCT00537381|156982033|FG001|Overall Study|Adverse Event|9|||
48763010|NCT00537381|156982032|FG000|Overall Study|Death|3|||
48763011|NCT00537381|156982033|FG001|Overall Study|Death|3|||
48763012|NCT00537381|156982032|FG000|Overall Study|Withdrawal by Subject|5|||
48763013|NCT00537381|156982033|FG001|Overall Study|Withdrawal by Subject|14|||
48763014|NCT00537381|156982032|FG000|Overall Study|Physician Decision|7|||
48763015|NCT00537381|156982033|FG001|Overall Study|Physician Decision|6|||
48763016|NCT00537381|156982032|FG000|Overall Study|Disease Progression|9|||
48763017|NCT00537381|156982033|FG001|Overall Study|Disease Progression|18|||
48763018|NCT00537381|156982032|FG000|Overall Study|Sponsor decision|14|||
48763019|NCT00537381|156982033|FG001|Overall Study|Sponsor decision|9|||
48763020|NCT00537381|156982032|FG000|Overall Study|Other|5|||
48763021|NCT00537381|156982033|FG001|Overall Study|Other|3|||
48763022|NCT01708174|156982034|FG000|Treatment Period|Withdrawal by Subject|1|||
48763023|NCT01708174|156982035|FG001|Treatment Period|Withdrawal by Subject|0|||
48763024|NCT01708174|156982036|FG002|Treatment Period|Withdrawal by Subject|0|||
48763025|NCT01708174|156982034|FG000|Treatment Period|Progressive disease|0|||
48763026|NCT01708174|156982035|FG001|Treatment Period|Progressive disease|1|||
48763027|NCT01708174|156982036|FG002|Treatment Period|Progressive disease|0|||
48390132|NCT02871778|155622994|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48683707|NCT00832416|156692626|FG000|Overall Study|Lack of Efficacy|17|||
48683708|NCT00832416|156692627|FG001|Overall Study|Lack of Efficacy|15|||
48683709|NCT00832416|156692628|FG002|Overall Study|Lack of Efficacy|13|||
48763028|NCT01708174|156982034|FG000|Treatment Period|Death|0|||
48763029|NCT01708174|156982035|FG001|Treatment Period|Death|0|||
48763030|NCT01708174|156982036|FG002|Treatment Period|Death|1|||
48763031|NCT01708174|156982034|FG000|Treatment Period|Adverse Event|0|||
48763032|NCT01708174|156982035|FG001|Treatment Period|Adverse Event|1|||
48763033|NCT01708174|156982036|FG002|Treatment Period|Adverse Event|0|||
48763034|NCT01062555|156982043|FG000|Phase 1|Death|10|||
48763035|NCT01062555|156982044|FG001|Phase 1|Death|17|||
48390133|NCT02871778|155622995|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48390134|NCT02871778|155622996|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
48390135|NCT02871778|155622989|FG000|Part B: Treatment Period 3|Adverse Event|0|||
48390136|NCT02871778|155622990|FG001|Part B: Treatment Period 3|Adverse Event|0|||
48390137|NCT02871778|155622991|FG002|Part B: Treatment Period 3|Adverse Event|0|||
48390138|NCT02871778|155622992|FG003|Part B: Treatment Period 3|Adverse Event|0|||
48390139|NCT02871778|155622993|FG004|Part B: Treatment Period 3|Adverse Event|1|||
48390140|NCT02871778|155622994|FG005|Part B: Treatment Period 3|Adverse Event|1|||
48390141|NCT02871778|155622995|FG006|Part B: Treatment Period 3|Adverse Event|1|||
48390142|NCT02871778|155622996|FG007|Part B: Treatment Period 3|Adverse Event|0|||
48390143|NCT00474708|155623001|FG000|Overall Study|Lack of Efficacy|11|||
48390144|NCT00474708|155623002|FG001|Overall Study|Lack of Efficacy|5|||
48390145|NCT00474708|155623001|FG000|Overall Study|Suicide ideation/behavior|0|||
48390146|NCT00474708|155623002|FG001|Overall Study|Suicide ideation/behavior|1|||
48390147|NCT00474708|155623001|FG000|Overall Study|Withdrawal by Subject|7|||
48390148|NCT00474708|155623002|FG001|Overall Study|Withdrawal by Subject|0|||
48390149|NCT00474708|155623001|FG000|Overall Study|Lack of compliance|12|||
48390150|NCT00474708|155623002|FG001|Overall Study|Lack of compliance|4|||
48390151|NCT00474708|155623001|FG000|Overall Study|Lost to Follow-up|18|||
48390152|NCT00474708|155623002|FG001|Overall Study|Lost to Follow-up|9|||
48390153|NCT00474708|155623001|FG000|Overall Study|Physician Decision|9|||
48390154|NCT00474708|155623002|FG001|Overall Study|Physician Decision|6|||
48390155|NCT03700320|155623003|FG000|Overall Study|Adverse Event|5|||
48390156|NCT03700320|155623004|FG001|Overall Study|Adverse Event|31|||
48390157|NCT03700320|155623003|FG000|Overall Study|Lack of Efficacy|2|||
48390158|NCT03700320|155623004|FG001|Overall Study|Lack of Efficacy|5|||
48390159|NCT03700320|155623003|FG000|Overall Study|Withdrawal by Subject|29|||
48390160|NCT03700320|155623004|FG001|Overall Study|Withdrawal by Subject|75|||
48390161|NCT03700320|155623003|FG000|Overall Study|Lost to Follow-up|16|||
48390162|NCT03700320|155623004|FG001|Overall Study|Lost to Follow-up|23|||
48390163|NCT03700320|155623003|FG000|Overall Study|Pregnancy|2|||
48390164|NCT03700320|155623004|FG001|Overall Study|Pregnancy|4|||
48390165|NCT03700320|155623003|FG000|Overall Study|Protocol Deviation|7|||
48390166|NCT03700320|155623004|FG001|Overall Study|Protocol Deviation|31|||
48390167|NCT03700320|155623003|FG000|Overall Study|Non-compliance with Study Drug|1|||
48390168|NCT03700320|155623004|FG001|Overall Study|Non-compliance with Study Drug|3|||
48390169|NCT03700320|155623003|FG000|Overall Study|Reason not Specified|0|||
48390170|NCT03700320|155623004|FG001|Overall Study|Reason not Specified|1|||
48390171|NCT00243386|155623005|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
48390172|NCT00243386|155623006|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
48390173|NCT00243386|155623007|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
48390174|NCT00243386|155623005|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
48390175|NCT00243386|155623006|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
48390176|NCT00243386|155623007|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
48390177|NCT00243386|155623005|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
48390178|NCT00243386|155623006|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
48390179|NCT00243386|155623007|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
48390180|NCT00243386|155623005|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
48390181|NCT00243386|155623006|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
48390182|NCT00243386|155623007|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
48390183|NCT00243386|155623005|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
48390184|NCT00243386|155623006|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
48390185|NCT00243386|155623007|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
48390186|NCT00243386|155623005|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
48390187|NCT00243386|155623006|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
48390188|NCT00243386|155623007|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
48390189|NCT00243386|155623005|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
48390190|NCT00243386|155623006|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
48390191|NCT00243386|155623007|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
48390192|NCT00243386|155623005|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
48390193|NCT00243386|155623006|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
48390194|NCT00243386|155623007|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
48390195|NCT04037748|155623008|FG000|Treatment Period 1|Withdrawal by Subject|3|||
48390196|NCT04037748|155623009|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48390197|NCT04037748|155623008|FG000|Treatment Period 1|Adverse Event|1|||
48390198|NCT04037748|155623009|FG001|Treatment Period 1|Adverse Event|1|||
48390199|NCT04037748|155623008|FG000|Treatment Period 1|Protocol Violation|4|||
48390200|NCT04037748|155623009|FG001|Treatment Period 1|Protocol Violation|5|||
48390201|NCT04037748|155623008|FG000|Treatment Period 2|Adverse Event|0|||
48390202|NCT04037748|155623009|FG001|Treatment Period 2|Adverse Event|1|||
48390203|NCT04037748|155623008|FG000|Treatment Period 2|Protocol Violation|2|||
48683710|NCT00832416|156692629|FG003|Overall Study|Lack of Efficacy|52|||
48683711|NCT00832416|156692626|FG000|Overall Study|Withdrawal by Subject|5|||
48683712|NCT00832416|156692627|FG001|Overall Study|Withdrawal by Subject|7|||
48683713|NCT00832416|156692628|FG002|Overall Study|Withdrawal by Subject|2|||
48683714|NCT00832416|156692629|FG003|Overall Study|Withdrawal by Subject|10|||
48683715|NCT00832416|156692626|FG000|Overall Study|Physician Decision|2|||
48683716|NCT00832416|156692627|FG001|Overall Study|Physician Decision|12|||
48683717|NCT00832416|156692628|FG002|Overall Study|Physician Decision|5|||
48683718|NCT00832416|156692629|FG003|Overall Study|Physician Decision|10|||
48683719|NCT00832416|156692626|FG000|Overall Study|Administrative|0|||
48683720|NCT00832416|156692627|FG001|Overall Study|Administrative|0|||
48683721|NCT00832416|156692628|FG002|Overall Study|Administrative|0|||
48683722|NCT00832416|156692629|FG003|Overall Study|Administrative|1|||
48683723|NCT00832416|156692626|FG000|Overall Study|Adverse Event|21|||
48683724|NCT00832416|156692627|FG001|Overall Study|Adverse Event|19|||
48683725|NCT00832416|156692628|FG002|Overall Study|Adverse Event|41|||
48683726|NCT00832416|156692629|FG003|Overall Study|Adverse Event|10|||
48683727|NCT00832416|156692626|FG000|Overall Study|Death|1|||
48683728|NCT00832416|156692627|FG001|Overall Study|Death|0|||
48683729|NCT00832416|156692628|FG002|Overall Study|Death|0|||
48683730|NCT00832416|156692629|FG003|Overall Study|Death|0|||
48683731|NCT01388907|156692630|FG000|Overall Study|Adverse Event|2|||
48683732|NCT01388907|156692631|FG001|Overall Study|Adverse Event|0|||
48683733|NCT02034877|156692633|FG000|Overall Study|Lost to Follow-up|0|||
48683734|NCT02034877|156692634|FG001|Overall Study|Lost to Follow-up|3|||
48683735|NCT02034877|156692633|FG000|Overall Study|No Longer Willing to Participate|0|||
48683736|NCT02034877|156692634|FG001|Overall Study|No Longer Willing to Participate|3|||
48683737|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
48683738|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
48683739|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
48683740|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
48683741|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
48683742|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
48683743|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
48683744|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
48683745|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
48683746|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
48683747|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
48683748|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
48683749|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
48683750|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
48683751|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
48683752|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
48683753|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
48683754|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
48683755|NCT01910402|156692635|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
48683756|NCT01910402|156692636|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
48683757|NCT01910402|156692637|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
48683758|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
48683759|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
48683760|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
48683761|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
48683762|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
48683763|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
48683764|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
48683765|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
48683766|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
48683767|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
48683768|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
48683769|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
48683770|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
48683771|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
48683772|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
48683773|NCT01910402|156692635|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
48683774|NCT01910402|156692636|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
48683775|NCT01910402|156692637|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
48683776|NCT02128724|156692640|FG000|Overall Study|Death|1|||
48683777|NCT02128724|156692641|FG001|Overall Study|Death|0|||
48683778|NCT02128724|156692642|FG002|Overall Study|Death|0|||
48683779|NCT02128724|156692643|FG003|Overall Study|Death|0|||
48683780|NCT02128724|156692640|FG000|Overall Study|Adverse Event|0|||
48683781|NCT02128724|156692641|FG001|Overall Study|Adverse Event|1|||
48683782|NCT02128724|156692642|FG002|Overall Study|Adverse Event|0|||
48683783|NCT02128724|156692643|FG003|Overall Study|Adverse Event|0|||
48683784|NCT02128724|156692640|FG000|Overall Study|Physician Decision|0|||
48683785|NCT02128724|156692641|FG001|Overall Study|Physician Decision|0|||
48683786|NCT02128724|156692642|FG002|Overall Study|Physician Decision|0|||
48683787|NCT02128724|156692643|FG003|Overall Study|Physician Decision|2|||
48683788|NCT02128724|156692640|FG000|Overall Study|Withdrawal by Subject|0|||
48683789|NCT02128724|156692641|FG001|Overall Study|Withdrawal by Subject|0|||
48683790|NCT02128724|156692642|FG002|Overall Study|Withdrawal by Subject|0|||
48683791|NCT02128724|156692643|FG003|Overall Study|Withdrawal by Subject|1|||
48683792|NCT00622505|156692646|FG000|Overall Study|Adverse Event|9|||
48683793|NCT00622505|156692647|FG001|Overall Study|Adverse Event|7|||
48683794|NCT00622505|156692646|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
48683795|NCT00622505|156692647|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
48683796|NCT00622505|156692646|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
48683797|NCT00622505|156692647|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
48683798|NCT00622505|156692646|FG000|Overall Study|Withdrawal by Subject|12|||
48683799|NCT00622505|156692647|FG001|Overall Study|Withdrawal by Subject|5|||
48683800|NCT00622505|156692646|FG000|Overall Study|Administrative Problems|2|||
48683801|NCT00622505|156692647|FG001|Overall Study|Administrative Problems|4|||
48683802|NCT00622505|156692646|FG000|Overall Study|Death|2|||
48683803|NCT00622505|156692647|FG001|Overall Study|Death|2|||
48683804|NCT01359904|156692650|FG000|Overall Study|Withdrawal by Subject|1|||
48683805|NCT01359904|156692651|FG001|Overall Study|Withdrawal by Subject|0|||
48683806|NCT02003534|156692652|FG000|Overall Study|Lost to Follow-up|47|||
48683807|NCT01818596|156692653|FG000|Overall Study|Enrolled but Not Treated|4|||
48683808|NCT01818596|156692654|FG001|Overall Study|Enrolled but Not Treated|0|||
48683809|NCT01818596|156692653|FG000|Overall Study|Adverse Event|7|||
48683810|NCT01818596|156692654|FG001|Overall Study|Adverse Event|0|||
48683811|NCT01818596|156692653|FG000|Overall Study|Death|3|||
48683812|NCT01818596|156692654|FG001|Overall Study|Death|0|||
48683813|NCT01818596|156692653|FG000|Overall Study|Investigator's Discretion|4|||
48683814|NCT01818596|156692654|FG001|Overall Study|Investigator's Discretion|0|||
48683815|NCT01818596|156692653|FG000|Overall Study|Protocol Violation|1|||
48683816|NCT01818596|156692654|FG001|Overall Study|Protocol Violation|0|||
48683817|NCT01818596|156692653|FG000|Overall Study|Withdrew Consent|5|||
48683818|NCT01818596|156692654|FG001|Overall Study|Withdrew Consent|0|||
48683819|NCT01818596|156692653|FG000|Overall Study|Lost to Follow-up|7|||
48683820|NCT01818596|156692654|FG001|Overall Study|Lost to Follow-up|0|||
48683821|NCT03801174|156692655|FG000|Overall Study|Withdrawal by Subject|14|||
48683822|NCT03801174|156692656|FG001|Overall Study|Withdrawal by Subject|15|||
48683823|NCT03801174|156692655|FG000|Overall Study|Death|1|||
48683824|NCT03801174|156692656|FG001|Overall Study|Death|0|||
48683825|NCT03801174|156692655|FG000|Overall Study|Pregnancy|2|||
48683826|NCT03801174|156692656|FG001|Overall Study|Pregnancy|2|||
48683827|NCT03801174|156692655|FG000|Overall Study|Lost to Follow-up|19|||
48683828|NCT03801174|156692656|FG001|Overall Study|Lost to Follow-up|10|||
48683829|NCT03801174|156692655|FG000|Overall Study|Other|4|||
48683830|NCT03801174|156692656|FG001|Overall Study|Other|3|||
48683831|NCT03801174|156692655|FG000|Overall Study|Lack of Efficacy|4|||
48683832|NCT03801174|156692656|FG001|Overall Study|Lack of Efficacy|0|||
48683833|NCT03801174|156692655|FG000|Overall Study|Unwilling to complete activities|5|||
48763036|NCT01062555|156982045|FG002|Phase 1|Death|0|||
48763037|NCT01062555|156982046|FG003|Phase 1|Death|0|||
48763038|NCT01062555|156982043|FG000|Phase 1|Graft Failure|12|||
48763039|NCT01062555|156982044|FG001|Phase 1|Graft Failure|8|||
48763040|NCT01062555|156982045|FG002|Phase 1|Graft Failure|0|||
48763041|NCT01062555|156982046|FG003|Phase 1|Graft Failure|0|||
48763042|NCT01062555|156982043|FG000|Phase 1|Withdrawal by Subject|1|||
48763043|NCT01062555|156982044|FG001|Phase 1|Withdrawal by Subject|1|||
48763044|NCT01062555|156982045|FG002|Phase 1|Withdrawal by Subject|0|||
48763045|NCT01062555|156982046|FG003|Phase 1|Withdrawal by Subject|0|||
48683834|NCT03801174|156692656|FG001|Overall Study|Unwilling to complete activities|6|||
48683835|NCT03801174|156692655|FG000|Overall Study|Moved out of area|3|||
48683836|NCT03801174|156692656|FG001|Overall Study|Moved out of area|0|||
48683837|NCT00855816|156692659|FG000|Overall Study|Withdrawal by Subject|22|||
48683838|NCT00855816|156692660|FG001|Overall Study|Withdrawal by Subject|15|||
48683839|NCT00855816|156692659|FG000|Overall Study|Lost to Follow-up|3|||
48683840|NCT00855816|156692660|FG001|Overall Study|Lost to Follow-up|5|||
48683841|NCT00855816|156692659|FG000|Overall Study|Death|1|||
48683842|NCT00855816|156692660|FG001|Overall Study|Death|0|||
48683843|NCT00855816|156692659|FG000|Overall Study|Became ineligible|0|||
48683844|NCT00855816|156692660|FG001|Overall Study|Became ineligible|1|||
48763046|NCT01062555|156982043|FG000|Phase 2|Death|0|||
48390204|NCT04037748|155623009|FG001|Treatment Period 2|Protocol Violation|0|||
48683845|NCT02221674|156692662|FG000|Overall Study|Lost to Follow-up|1|||
48683846|NCT02221674|156692663|FG001|Overall Study|Lost to Follow-up|0|||
48683847|NCT02221674|156692664|FG002|Overall Study|Lost to Follow-up|0|||
48763047|NCT01062555|156982044|FG001|Phase 2|Death|0|||
48763048|NCT01062555|156982045|FG002|Phase 2|Death|8|||
48683848|NCT01702558|156692671|FG000|Overall Study|Withdrawal by Subject|0|||
48683849|NCT01702558|156692672|FG001|Overall Study|Withdrawal by Subject|0|||
48683850|NCT01702558|156692673|FG002|Overall Study|Withdrawal by Subject|0|||
48683851|NCT01702558|156692674|FG003|Overall Study|Withdrawal by Subject|12|||
48683852|NCT01702558|156692675|FG004|Overall Study|Withdrawal by Subject|4|||
48683853|NCT01702558|156692671|FG000|Overall Study|Lost to Follow-up|0|||
48683854|NCT01702558|156692672|FG001|Overall Study|Lost to Follow-up|0|||
48683855|NCT01702558|156692673|FG002|Overall Study|Lost to Follow-up|0|||
48390205|NCT02663453|155623010|FG000|Overall Study|Death|4|||
48683856|NCT01702558|156692674|FG003|Overall Study|Lost to Follow-up|3|||
48683857|NCT01702558|156692675|FG004|Overall Study|Lost to Follow-up|0|||
48683858|NCT01702558|156692671|FG000|Overall Study|Death|4|||
48683859|NCT01702558|156692672|FG001|Overall Study|Death|3|||
48683860|NCT01702558|156692673|FG002|Overall Study|Death|3|||
48683861|NCT01702558|156692674|FG003|Overall Study|Death|16|||
48683862|NCT01702558|156692675|FG004|Overall Study|Death|20|||
48683863|NCT01702558|156692671|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
48683864|NCT01702558|156692672|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
48683865|NCT01702558|156692673|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
48683866|NCT01702558|156692674|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
48683867|NCT01702558|156692675|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
48683868|NCT01702558|156692671|FG000|Overall Study|Study Terminated by Sponsor|0|||
48683869|NCT01702558|156692672|FG001|Overall Study|Study Terminated by Sponsor|1|||
48683870|NCT01702558|156692673|FG002|Overall Study|Study Terminated by Sponsor|0|||
48683871|NCT01702558|156692674|FG003|Overall Study|Study Terminated by Sponsor|0|||
48683872|NCT01702558|156692675|FG004|Overall Study|Study Terminated by Sponsor|1|||
48683873|NCT01702558|156692671|FG000|Overall Study|Other|0|||
48683874|NCT01702558|156692672|FG001|Overall Study|Other|0|||
48683875|NCT01702558|156692673|FG002|Overall Study|Other|0|||
48683876|NCT01702558|156692674|FG003|Overall Study|Other|16|||
48683877|NCT01702558|156692675|FG004|Overall Study|Other|17|||
48683878|NCT02396212|156692678|FG000|Overall Study|Adverse Event|1|||
48683879|NCT02396212|156692678|FG000|Overall Study|Lack of Efficacy|2|||
48683880|NCT03030417|156692681|FG000|Dose Expansion|Disease progression before treatment|0|||
48683881|NCT03030417|156692682|FG001|Dose Expansion|Disease progression before treatment|0|||
48683882|NCT03030417|156692683|FG002|Dose Expansion|Disease progression before treatment|0|||
48683883|NCT03030417|156692684|FG003|Dose Expansion|Disease progression before treatment|0|||
48683884|NCT03030417|156692685|FG004|Dose Expansion|Disease progression before treatment|0|||
48683885|NCT03030417|156692686|FG005|Dose Expansion|Disease progression before treatment|0|||
48683886|NCT03030417|156692687|FG006|Dose Expansion|Disease progression before treatment|0|||
48683887|NCT03030417|156692688|FG007|Dose Expansion|Disease progression before treatment|0|||
48683888|NCT03030417|156692689|FG008|Dose Expansion|Disease progression before treatment|0|||
48683889|NCT03030417|156692690|FG009|Dose Expansion|Disease progression before treatment|0|||
48683890|NCT03030417|156692691|FG010|Dose Expansion|Disease progression before treatment|0|||
48683891|NCT03030417|156692692|FG011|Dose Expansion|Disease progression before treatment|0|||
48683892|NCT03030417|156692693|FG012|Dose Expansion|Disease progression before treatment|1|||
48683893|NCT04915729|156692694|FG000|Overall Study|Lost to Follow-up|20|||
48683894|NCT04915729|156692695|FG001|Overall Study|Lost to Follow-up|10|||
48683895|NCT04915729|156692694|FG000|Overall Study|Withdrawal by Subject|12|||
48683896|NCT04915729|156692695|FG001|Overall Study|Withdrawal by Subject|5|||
48683897|NCT04915729|156692694|FG000|Overall Study|Death|34|||
48683898|NCT04915729|156692695|FG001|Overall Study|Death|44|||
48390206|NCT02663453|155623011|FG001|Overall Study|Death|4|||
48390207|NCT02663453|155623010|FG000|Overall Study|Withdrawal by Subject|1|||
48390208|NCT02663453|155623011|FG001|Overall Study|Withdrawal by Subject|0|||
48390209|NCT01087775|155623012|FG000|Overall Study|failed inclusion criteria|2|||
48390210|NCT01617070|155623020|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
48390211|NCT02230384|155623022|FG000|Phase 1|Lost to Follow-up|1|||
48683899|NCT04915729|156692694|FG000|Overall Study|not treated|3|||
48683900|NCT04915729|156692695|FG001|Overall Study|not treated|6|||
48683901|NCT04915729|156692694|FG000|Overall Study|Investigator removed subject|1|||
48683902|NCT04915729|156692695|FG001|Overall Study|Investigator removed subject|2|||
48683903|NCT04915729|156692694|FG000|Overall Study|questionnaire result not evaluated|1|||
48683904|NCT04915729|156692695|FG001|Overall Study|questionnaire result not evaluated|0|||
48390212|NCT02230384|155623023|FG001|Phase 1|Lost to Follow-up|0|||
48683905|NCT04915729|156692694|FG000|Overall Study|refuse of hospital visit|1|||
48683906|NCT04915729|156692695|FG001|Overall Study|refuse of hospital visit|3|||
48683907|NCT04915729|156692694|FG000|Overall Study|Subject withdrew|1|||
48683908|NCT04915729|156692695|FG001|Overall Study|Subject withdrew|0|||
48390213|NCT02230384|155623022|FG000|Phase 1|Physician Decision|0|||
48390214|NCT02230384|155623023|FG001|Phase 1|Physician Decision|1|||
48390215|NCT02230384|155623022|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
48390216|NCT02230384|155623023|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
48683909|NCT00191308|156692696|FG000|Overall Study|Adverse Event|1|||
48683910|NCT01433172|156692697|FG000|Overall Study|Withdrawal by Subject|0|||
48683911|NCT01433172|156692698|FG001|Overall Study|Withdrawal by Subject|1|||
48390217|NCT02230384|155623022|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
48390218|NCT02230384|155623023|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
48390219|NCT02230384|155623022|FG000|Phase 2 - Switch|Adverse Event|2|||
48390220|NCT02230384|155623023|FG001|Phase 2 - Switch|Adverse Event|0|||
48390221|NCT02664272|155623028|FG000|Overall Study|Fluoroscopic images not made available|2|||
48390222|NCT03073980|155623035|FG000|Overall Study|Lost to Follow-up|10|||
48390223|NCT03073980|155623036|FG001|Overall Study|Lost to Follow-up|2|||
48390224|NCT03073980|155623037|FG002|Overall Study|Lost to Follow-up|9|||
48390225|NCT03073980|155623035|FG000|Overall Study|No post-procedure data|0|||
48390226|NCT03073980|155623036|FG001|Overall Study|No post-procedure data|0|||
48390227|NCT03073980|155623037|FG002|Overall Study|No post-procedure data|2|||
48390228|NCT00545064|155623040|FG000|Overall Study|Lost to Follow-up|3|||
48390229|NCT00545064|155623040|FG000|Overall Study|Withdrawal by Subject|2|||
48390230|NCT00545064|155623040|FG000|Overall Study|did not complete course of treatment|1|||
48763049|NCT01062555|156982046|FG003|Phase 2|Death|3|||
48763050|NCT01062555|156982043|FG000|Phase 2|Graft failure|0|||
48763051|NCT01062555|156982044|FG001|Phase 2|Graft failure|0|||
48390231|NCT00545064|155623040|FG000|Overall Study|cancel all appointments, no rebooking|1|||
48390232|NCT00545064|155623040|FG000|Overall Study|inclement weather|1|||
48390233|NCT00501007|155623041|FG000|Overall Study|Inclusion criteria not met.|29|||
48390234|NCT00501007|155623042|FG001|Overall Study|Inclusion criteria not met.|25|||
48390235|NCT00450723|155623051|FG000|Overall Study|Physician Decision|5|||
48390236|NCT03610724|155623052|FG000|Overall Study|Death|17|||
48390237|NCT03610724|155623052|FG000|Overall Study|Lost to Follow-up|1|||
48390238|NCT03610724|155623052|FG000|Overall Study|Physician Decision|1|||
48390239|NCT03610724|155623052|FG000|Overall Study|Died prior to infusion|1|||
48390240|NCT01840579|155623060|FG000|Overall Study|Status not recorded|0|||
48390241|NCT01840579|155623061|FG001|Overall Study|Status not recorded|0|||
48390242|NCT01840579|155623062|FG002|Overall Study|Status not recorded|2|||
48390243|NCT01840579|155623063|FG003|Overall Study|Status not recorded|3|||
48390244|NCT01840579|155623064|FG004|Overall Study|Status not recorded|4|||
48390245|NCT01840579|155623065|FG005|Overall Study|Status not recorded|3|||
48390246|NCT01840579|155623066|FG006|Overall Study|Status not recorded|0|||
48390247|NCT01840579|155623067|FG007|Overall Study|Status not recorded|3|||
48390248|NCT01840579|155623068|FG008|Overall Study|Status not recorded|3|||
48390249|NCT01840579|155623069|FG009|Overall Study|Status not recorded|3|||
48390250|NCT01840579|155623060|FG000|Overall Study|Progressive disease|3|||
48390251|NCT01840579|155623061|FG001|Overall Study|Progressive disease|5|||
48390252|NCT01840579|155623062|FG002|Overall Study|Progressive disease|0|||
48390253|NCT01840579|155623063|FG003|Overall Study|Progressive disease|0|||
48390254|NCT01840579|155623064|FG004|Overall Study|Progressive disease|0|||
48390255|NCT01840579|155623065|FG005|Overall Study|Progressive disease|0|||
48390256|NCT01840579|155623066|FG006|Overall Study|Progressive disease|0|||
48390257|NCT01840579|155623067|FG007|Overall Study|Progressive disease|0|||
48390258|NCT01840579|155623068|FG008|Overall Study|Progressive disease|0|||
48390259|NCT01840579|155623069|FG009|Overall Study|Progressive disease|0|||
48390260|NCT01840579|155623060|FG000|Overall Study|Ongoing in study|0|||
48390261|NCT01840579|155623061|FG001|Overall Study|Ongoing in study|1|||
48390262|NCT01840579|155623062|FG002|Overall Study|Ongoing in study|0|||
48390263|NCT01840579|155623063|FG003|Overall Study|Ongoing in study|0|||
48390264|NCT01840579|155623064|FG004|Overall Study|Ongoing in study|0|||
48390265|NCT01840579|155623065|FG005|Overall Study|Ongoing in study|0|||
48390266|NCT01840579|155623066|FG006|Overall Study|Ongoing in study|0|||
48390267|NCT01840579|155623067|FG007|Overall Study|Ongoing in study|0|||
48390268|NCT01840579|155623068|FG008|Overall Study|Ongoing in study|0|||
48763052|NCT01062555|156982045|FG002|Phase 2|Graft failure|7|||
48763053|NCT01062555|156982046|FG003|Phase 2|Graft failure|4|||
48763054|NCT01062555|156982043|FG000|Phase 2|Withdrawal by Subject|0|||
48390269|NCT01840579|155623069|FG009|Overall Study|Ongoing in study|0|||
48390270|NCT01840579|155623060|FG000|Overall Study|Death|0|||
48390271|NCT01840579|155623061|FG001|Overall Study|Death|0|||
48390272|NCT01840579|155623062|FG002|Overall Study|Death|0|||
48390273|NCT01840579|155623063|FG003|Overall Study|Death|0|||
48390274|NCT01840579|155623064|FG004|Overall Study|Death|0|||
48390275|NCT01840579|155623065|FG005|Overall Study|Death|1|||
48390276|NCT01840579|155623066|FG006|Overall Study|Death|0|||
48390277|NCT01840579|155623067|FG007|Overall Study|Death|0|||
48390278|NCT01840579|155623068|FG008|Overall Study|Death|0|||
48390279|NCT01840579|155623069|FG009|Overall Study|Death|0|||
48390280|NCT01840579|155623060|FG000|Overall Study|Adverse Event|0|||
48390281|NCT01840579|155623061|FG001|Overall Study|Adverse Event|1|||
48390282|NCT01840579|155623062|FG002|Overall Study|Adverse Event|0|||
48390283|NCT01840579|155623063|FG003|Overall Study|Adverse Event|0|||
48390284|NCT01840579|155623064|FG004|Overall Study|Adverse Event|0|||
48763055|NCT01062555|156982044|FG001|Phase 2|Withdrawal by Subject|0|||
48390285|NCT01840579|155623065|FG005|Overall Study|Adverse Event|0|||
48390286|NCT01840579|155623066|FG006|Overall Study|Adverse Event|0|||
48390287|NCT01840579|155623067|FG007|Overall Study|Adverse Event|0|||
48390288|NCT01840579|155623068|FG008|Overall Study|Adverse Event|0|||
48390289|NCT01840579|155623069|FG009|Overall Study|Adverse Event|0|||
48390290|NCT01840579|155623060|FG000|Overall Study|Follow-up ended by Sponsor|0|||
48683912|NCT01433172|156692699|FG002|Overall Study|Withdrawal by Subject|0|||
48683913|NCT01433172|156692697|FG000|Overall Study|Disease Progression|0|||
48683914|NCT01433172|156692698|FG001|Overall Study|Disease Progression|0|||
48683915|NCT01433172|156692699|FG002|Overall Study|Disease Progression|1|||
48683916|NCT01433172|156692697|FG000|Overall Study|Death|0|||
48683917|NCT01433172|156692698|FG001|Overall Study|Death|2|||
48683918|NCT01433172|156692699|FG002|Overall Study|Death|0|||
48683919|NCT03305770|156692700|FG000|Overall Study|Physician Decision - prior to dispense|0|||
48683920|NCT03305770|156692701|FG001|Overall Study|Physician Decision - prior to dispense|1|||
48683921|NCT03305770|156692700|FG000|Overall Study|Subject moved|1|||
48683922|NCT03305770|156692701|FG001|Overall Study|Subject moved|0|||
48683923|NCT02741635|156692702|FG000|Overall Study|Withdrawal by Subject|1|||
48683924|NCT02680665|156692703|FG000|Overall Study|No visit after the first prescription|5|||
48683925|NCT03384940|156692708|FG000|Overall Study|Progressive disease|36|||
48683926|NCT03384940|156692709|FG001|Overall Study|Progressive disease|11|||
48683927|NCT03384940|156692710|FG002|Overall Study|Progressive disease|13|||
48683928|NCT03384940|156692708|FG000|Overall Study|Clinical progression|4|||
48683929|NCT03384940|156692709|FG001|Overall Study|Clinical progression|0|||
48683930|NCT03384940|156692710|FG002|Overall Study|Clinical progression|3|||
48683931|NCT03384940|156692708|FG000|Overall Study|Adverse Event|7|||
48683932|NCT03384940|156692709|FG001|Overall Study|Adverse Event|1|||
48683933|NCT03384940|156692710|FG002|Overall Study|Adverse Event|1|||
48683934|NCT03384940|156692708|FG000|Overall Study|Withdrawal by Subject|3|||
48390291|NCT01840579|155623061|FG001|Overall Study|Follow-up ended by Sponsor|0|||
48390292|NCT01840579|155623062|FG002|Overall Study|Follow-up ended by Sponsor|0|||
48390293|NCT01840579|155623063|FG003|Overall Study|Follow-up ended by Sponsor|0|||
48390294|NCT01840579|155623064|FG004|Overall Study|Follow-up ended by Sponsor|0|||
48390295|NCT01840579|155623065|FG005|Overall Study|Follow-up ended by Sponsor|0|||
48390296|NCT01840579|155623066|FG006|Overall Study|Follow-up ended by Sponsor|2|||
48390297|NCT01840579|155623067|FG007|Overall Study|Follow-up ended by Sponsor|0|||
48390298|NCT01840579|155623068|FG008|Overall Study|Follow-up ended by Sponsor|0|||
48683935|NCT03384940|156692709|FG001|Overall Study|Withdrawal by Subject|1|||
48683936|NCT03384940|156692710|FG002|Overall Study|Withdrawal by Subject|0|||
48683937|NCT03384940|156692708|FG000|Overall Study|Physician Decision|1|||
48683938|NCT03384940|156692709|FG001|Overall Study|Physician Decision|1|||
48683939|NCT03384940|156692710|FG002|Overall Study|Physician Decision|0|||
48683940|NCT03384940|156692708|FG000|Overall Study|Death|2|||
48683941|NCT03384940|156692709|FG001|Overall Study|Death|1|||
48683942|NCT03384940|156692710|FG002|Overall Study|Death|0|||
48683943|NCT03384940|156692708|FG000|Overall Study|Other|0|||
48683944|NCT03384940|156692709|FG001|Overall Study|Other|0|||
48683945|NCT03384940|156692710|FG002|Overall Study|Other|1|||
48683946|NCT03089580|156692711|FG000|Overall Study|Lost to Follow-up|2|||
48683947|NCT04303559|156692715|FG000|Overall Study|Study closed due to poor enrollment.|1|||
48683948|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
48683949|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
48683950|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
48683951|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
48683952|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
48683953|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
48683954|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
48683955|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
48683956|NCT01987102|156692716|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
48683957|NCT01987102|156692717|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
48683958|NCT01987102|156692716|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
48683959|NCT01987102|156692717|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
48683960|NCT01288989|156692718|FG000|Overall Study|Death|0|||
48683961|NCT01288989|156692719|FG001|Overall Study|Death|0|||
48390299|NCT01840579|155623069|FG009|Overall Study|Follow-up ended by Sponsor|0|||
48390300|NCT02625233|155623070|FG000|Overall Study|Adverse Event|2|||
48390301|NCT02625233|155623071|FG001|Overall Study|Adverse Event|0|||
48390302|NCT01924182|155623074|FG000|Overall Study|Withdrawal by Subject|1|||
48390303|NCT01924182|155623075|FG001|Overall Study|Withdrawal by Subject|0|||
48683962|NCT01288989|156692720|FG002|Overall Study|Death|0|||
48683963|NCT01288989|156692721|FG003|Overall Study|Death|1|||
48683964|NCT01288989|156692722|FG004|Overall Study|Death|0|||
48683965|NCT01288989|156692718|FG000|Overall Study|Dose limiting toxicity|1|||
48683966|NCT01288989|156692719|FG001|Overall Study|Dose limiting toxicity|0|||
48683967|NCT01288989|156692720|FG002|Overall Study|Dose limiting toxicity|0|||
48683968|NCT01288989|156692721|FG003|Overall Study|Dose limiting toxicity|0|||
48683969|NCT01288989|156692722|FG004|Overall Study|Dose limiting toxicity|0|||
48683970|NCT01288989|156692718|FG000|Overall Study|Adverse Event|0|||
48390304|NCT01585272|155623078|FG000|Overall Study|Adverse Event|22|||
48390305|NCT01585272|155623078|FG000|Overall Study|Protocol Violation|7|||
48683971|NCT01288989|156692719|FG001|Overall Study|Adverse Event|0|||
48683972|NCT01288989|156692720|FG002|Overall Study|Adverse Event|0|||
48683973|NCT01288989|156692721|FG003|Overall Study|Adverse Event|0|||
48683974|NCT01288989|156692722|FG004|Overall Study|Adverse Event|2|||
48683975|NCT01288989|156692718|FG000|Overall Study|Physician Decision|0|||
48683976|NCT01288989|156692719|FG001|Overall Study|Physician Decision|0|||
48683977|NCT01288989|156692720|FG002|Overall Study|Physician Decision|0|||
48683978|NCT01288989|156692721|FG003|Overall Study|Physician Decision|0|||
48683979|NCT01288989|156692722|FG004|Overall Study|Physician Decision|1|||
48683980|NCT01288989|156692718|FG000|Overall Study|Withdrawal by Subject|0|||
48683981|NCT01288989|156692719|FG001|Overall Study|Withdrawal by Subject|0|||
48683982|NCT01288989|156692720|FG002|Overall Study|Withdrawal by Subject|0|||
48683983|NCT01288989|156692721|FG003|Overall Study|Withdrawal by Subject|0|||
48683984|NCT01288989|156692722|FG004|Overall Study|Withdrawal by Subject|3|||
48683985|NCT03370718|156692723|FG000|Overall Study|Withdrawal by Subject|1|||
48683986|NCT03116685|156692727|FG000|Overall Study|Physician Decision|0|||
48683987|NCT03116685|156692728|FG001|Overall Study|Physician Decision|1|||
48683988|NCT06385483|156692729|FG000|Overall Study|Withdrawal by Subject|2|||
48683989|NCT06385483|156692729|FG000|Overall Study|Never start protocol therapy|2|||
48683990|NCT06385483|156692729|FG000|Overall Study|Disease progression|15|||
48683991|NCT02429830|156692732|FG000|Overall Study|Lost to Follow-up|1|||
48683992|NCT02429830|156692732|FG000|Overall Study|Device Explant|2|||
48683993|NCT03301350|156692733|FG000|Overall Study|Withdrawal by Subject|4|||
48683994|NCT03301350|156692733|FG000|Overall Study|Adverse Event|1|||
48683995|NCT03301350|156692733|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
48683996|NCT03301350|156692733|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
48683997|NCT03301350|156692733|FG000|Overall Study|no detail provided|1|||
48683998|NCT02926638|156692735|FG000|Overall Study|Progression|2|||
48683999|NCT02926638|156692736|FG001|Overall Study|Progression|5|||
48684000|NCT02926638|156692735|FG000|Overall Study|Ineligible|1|||
48684001|NCT02926638|156692736|FG001|Overall Study|Ineligible|0|||
48684002|NCT02926638|156692735|FG000|Overall Study|Not protocol specified|1|||
48684003|NCT02926638|156692736|FG001|Overall Study|Not protocol specified|0|||
48684004|NCT01420926|156692739|FG000|Overall Study|Adverse Event|6|||
48684005|NCT01420926|156692740|FG001|Overall Study|Adverse Event|4|||
48684006|NCT01420926|156692739|FG000|Overall Study|Death|18|||
48684007|NCT01420926|156692740|FG001|Overall Study|Death|17|||
48684008|NCT01420926|156692739|FG000|Overall Study|Withdrawal by Subject|11|||
48684009|NCT01420926|156692740|FG001|Overall Study|Withdrawal by Subject|17|||
48684010|NCT01420926|156692739|FG000|Overall Study|Non-protocol treatment|17|||
48684011|NCT01420926|156692740|FG001|Overall Study|Non-protocol treatment|20|||
48684012|NCT01420926|156692739|FG000|Overall Study|Physician Decision|8|||
48684013|NCT01420926|156692740|FG001|Overall Study|Physician Decision|5|||
48684014|NCT05066165|156694815|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
48684015|NCT05066165|156694816|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
48684016|NCT05066165|156694815|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
48684017|NCT05066165|156694816|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
48684018|NCT03109184|156694817|FG000|Overall Study|Lost to Follow-up|6|||
48684019|NCT03109184|156694818|FG001|Overall Study|Lost to Follow-up|6|||
48684020|NCT03109184|156694817|FG000|Overall Study|Withdrawal by Subject|1|||
48684021|NCT03109184|156694818|FG001|Overall Study|Withdrawal by Subject|1|||
48684022|NCT00615017|156694819|FG000|Overall Study|Adverse Event|0|||
48684023|NCT00615017|156694820|FG001|Overall Study|Adverse Event|1|||
48684024|NCT00615017|156694821|FG002|Overall Study|Adverse Event|2|||
48684025|NCT00615017|156694822|FG003|Overall Study|Adverse Event|0|||
48684026|NCT00615017|156694823|FG004|Overall Study|Adverse Event|0|||
48684027|NCT00615017|156694824|FG005|Overall Study|Adverse Event|1|||
48684028|NCT00615017|156694819|FG000|Overall Study|Death|0|||
48684029|NCT00615017|156694820|FG001|Overall Study|Death|0|||
48684030|NCT00615017|156694821|FG002|Overall Study|Death|2|||
48684031|NCT00615017|156694822|FG003|Overall Study|Death|0|||
48684032|NCT00615017|156694823|FG004|Overall Study|Death|1|||
48684033|NCT00615017|156694824|FG005|Overall Study|Death|1|||
48684034|NCT00615017|156694819|FG000|Overall Study|Sepsis resolved|0|||
48684035|NCT00615017|156694820|FG001|Overall Study|Sepsis resolved|0|||
48684036|NCT00615017|156694821|FG002|Overall Study|Sepsis resolved|1|||
48684037|NCT00615017|156694822|FG003|Overall Study|Sepsis resolved|0|||
48684038|NCT00615017|156694823|FG004|Overall Study|Sepsis resolved|0|||
48684039|NCT00615017|156694824|FG005|Overall Study|Sepsis resolved|0|||
48684040|NCT00615017|156694819|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
48763056|NCT01062555|156982045|FG002|Phase 2|Withdrawal by Subject|0|||
48763057|NCT01062555|156982046|FG003|Phase 2|Withdrawal by Subject|7|||
48684041|NCT00615017|156694820|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
48684042|NCT00615017|156694821|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
48684043|NCT00615017|156694822|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
48684044|NCT00615017|156694823|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
48684045|NCT00615017|156694824|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
48684046|NCT00615017|156694819|FG000|Overall Study|Physician discontinued drug|0|||
48684047|NCT00615017|156694820|FG001|Overall Study|Physician discontinued drug|0|||
48763058|NCT01062555|156982043|FG000|Phase 2|Protocol Violation|0|||
48684048|NCT00615017|156694821|FG002|Overall Study|Physician discontinued drug|0|||
48684049|NCT00615017|156694822|FG003|Overall Study|Physician discontinued drug|0|||
48684050|NCT00615017|156694823|FG004|Overall Study|Physician discontinued drug|0|||
48684051|NCT00615017|156694824|FG005|Overall Study|Physician discontinued drug|1|||
48684052|NCT02333799|156694831|FG000|Treatment Period|Withdrawal by Subject|1|||
48684053|NCT02333799|156694831|FG000|Treatment Period|Death|6|||
48684054|NCT02333799|156694831|FG000|6 Month Follow Up Period|Physician Decision|1|||
48684055|NCT02333799|156694831|FG000|6 Month Follow Up Period|Death|1|||
48684056|NCT02333799|156694831|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
48684057|NCT02333799|156694831|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
48684058|NCT03499314|156694832|FG000|Overall Study|Time Commitment|1|||
48684059|NCT03499314|156694833|FG001|Overall Study|Time Commitment|2|||
48684060|NCT03499314|156694832|FG000|Overall Study|Medical issue unrelated to research study|1|||
48684061|NCT03499314|156694833|FG001|Overall Study|Medical issue unrelated to research study|1|||
48684062|NCT01271725|156694834|FG000|Part A|Progressive disease according to RECIST|8|||
48684063|NCT01271725|156694835|FG001|Part A|Progressive disease according to RECIST|0|||
48684064|NCT01271725|156694834|FG000|Part A|Clinical signs/symptoms of progression|2|||
48684065|NCT01271725|156694835|FG001|Part A|Clinical signs/symptoms of progression|0|||
48684066|NCT01271725|156694834|FG000|Part A|Other Adverse Event|8|||
48684067|NCT01271725|156694835|FG001|Part A|Other Adverse Event|0|||
48684068|NCT01271725|156694834|FG000|Part A|Lost to Follow-up|1|||
48684069|NCT01271725|156694835|FG001|Part A|Lost to Follow-up|0|||
48684070|NCT01271725|156694834|FG000|Part A|Withdrawal by Subject|12|||
48684071|NCT01271725|156694835|FG001|Part A|Withdrawal by Subject|0|||
48684072|NCT01271725|156694834|FG000|Part A|Other than specified|3|||
48684073|NCT01271725|156694835|FG001|Part A|Other than specified|0|||
48684074|NCT01271725|156694834|FG000|Part A|Protocol Violation|1|||
48684075|NCT01271725|156694835|FG001|Part A|Protocol Violation|0|||
48684076|NCT01271725|156694834|FG000|Part B|Other than specified|0|||
48684077|NCT01271725|156694835|FG001|Part B|Other than specified|2|||
48684078|NCT01271725|156694834|FG000|Part B|Clinical signs/symptoms of progression|0|||
48684079|NCT01271725|156694835|FG001|Part B|Clinical signs/symptoms of progression|2|||
48684080|NCT01271725|156694834|FG000|Part B|Other Adverse Event|0|||
48684081|NCT01271725|156694835|FG001|Part B|Other Adverse Event|1|||
48684082|NCT01271725|156694834|FG000|Part B|Protocol Violation|0|||
48684083|NCT01271725|156694835|FG001|Part B|Protocol Violation|1|||
48684084|NCT01271725|156694834|FG000|Part B|Withdrawal by Subject|0|||
48684085|NCT01271725|156694835|FG001|Part B|Withdrawal by Subject|6|||
48684086|NCT01702025|156694836|FG000|Overall Study|Equipment failure|1|||
48684087|NCT01702025|156694837|FG001|Overall Study|Equipment failure|0|||
48684088|NCT01702025|156694838|FG002|Overall Study|Equipment failure|0|||
48684089|NCT01702025|156694839|FG003|Overall Study|Equipment failure|0|||
48684090|NCT01702025|156694836|FG000|Overall Study|Adverse Event|1|||
48684091|NCT01702025|156694837|FG001|Overall Study|Adverse Event|1|||
48684092|NCT01702025|156694838|FG002|Overall Study|Adverse Event|1|||
48684093|NCT01702025|156694839|FG003|Overall Study|Adverse Event|0|||
48684094|NCT04014062|156694840|FG000|Period I: Dosing|Medical Grounds|4|||
48684095|NCT04014062|156694841|FG001|Period I: Dosing|Medical Grounds|5|||
48684096|NCT04014062|156694840|FG000|Period I: Dosing|Withdrawal by Subject|3|||
48684097|NCT04014062|156694841|FG001|Period I: Dosing|Withdrawal by Subject|1|||
48684098|NCT02871635|156694844|FG000|Overall Study|Primary lack of efficacy|4|||
48684099|NCT02871635|156694845|FG001|Overall Study|Primary lack of efficacy|4|||
48684100|NCT02871635|156694844|FG000|Overall Study|Protocol Violation|3|||
48684101|NCT02871635|156694845|FG001|Overall Study|Protocol Violation|1|||
48684102|NCT02871635|156694844|FG000|Overall Study|Lost to Follow-up|1|||
48684103|NCT02871635|156694845|FG001|Overall Study|Lost to Follow-up|2|||
48684104|NCT02871635|156694844|FG000|Overall Study|Pregnancy|0|||
48684105|NCT02871635|156694845|FG001|Overall Study|Pregnancy|2|||
48684106|NCT02871635|156694844|FG000|Overall Study|Physician Decision|1|||
48684107|NCT02871635|156694845|FG001|Overall Study|Physician Decision|1|||
48684108|NCT02871635|156694844|FG000|Overall Study|Withdrawal by Subject|3|||
48684109|NCT02871635|156694845|FG001|Overall Study|Withdrawal by Subject|4|||
48684110|NCT02871635|156694844|FG000|Overall Study|Adverse Event|4|||
48684111|NCT02871635|156694845|FG001|Overall Study|Adverse Event|4|||
48684112|NCT02871635|156694844|FG000|Overall Study|Secondary lack of efficacy|2|||
48684113|NCT02871635|156694845|FG001|Overall Study|Secondary lack of efficacy|1|||
48684114|NCT00082407|156694849|FG000|Overall Study|Adverse Event|20|||
48684115|NCT00082407|156694850|FG001|Overall Study|Adverse Event|0|||
48684116|NCT00082407|156694849|FG000|Overall Study|Protocol Violation|14|||
48684117|NCT00082407|156694850|FG001|Overall Study|Protocol Violation|12|||
48684118|NCT00082407|156694849|FG000|Overall Study|Patient Decision|13|||
48684119|NCT00082407|156694850|FG001|Overall Study|Patient Decision|6|||
48684120|NCT00082407|156694849|FG000|Overall Study|Physician Decision|5|||
48684121|NCT00082407|156694850|FG001|Overall Study|Physician Decision|3|||
48684122|NCT00082407|156694849|FG000|Overall Study|Loss of Glucose Control|2|||
48684123|NCT00082407|156694850|FG001|Overall Study|Loss of Glucose Control|2|||
48684124|NCT00082407|156694849|FG000|Overall Study|Death|2|||
48684125|NCT00082407|156694850|FG001|Overall Study|Death|1|||
48684126|NCT00082407|156694849|FG000|Overall Study|Lost to Follow-up|0|||
48684127|NCT00082407|156694850|FG001|Overall Study|Lost to Follow-up|3|||
48684128|NCT04809285|156694854|FG000|Phase 1|Lost to Follow-up|6|||
48684129|NCT04809285|156694854|FG000|Phase 1|Protocol Violation|2|||
48684130|NCT04809285|156694854|FG000|Phase 1|Physician Decision|3|||
48684131|NCT04809285|156694854|FG000|Phase 1|Withdrawal by Subject|29|||
48684132|NCT04809285|156694854|FG000|Phase 2|Protocol Violation|3|||
48684133|NCT04809285|156694854|FG000|Phase 2|Withdrawal by Subject|4|||
48684134|NCT01745367|156694855|FG000|Overall Study|Death|1|||
48684135|NCT01745367|156694856|FG001|Overall Study|Death|0|||
48684136|NCT01745367|156694855|FG000|Overall Study|Withdrawal by Subject|1|||
48684137|NCT01745367|156694856|FG001|Overall Study|Withdrawal by Subject|2|||
48684138|NCT01745367|156694855|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
48684139|NCT01745367|156694856|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
48684140|NCT01745367|156694855|FG000|Overall Study|Other Reasons Unspecified|0|||
48684141|NCT01745367|156694856|FG001|Overall Study|Other Reasons Unspecified|2|||
48684142|NCT00699608|156694857|FG000|First Intervention|Withdrawal by Subject|0|||
48684143|NCT00699608|156694858|FG001|First Intervention|Withdrawal by Subject|0|||
48684144|NCT00699608|156694859|FG002|First Intervention|Withdrawal by Subject|1|||
48684145|NCT00699608|156694860|FG003|First Intervention|Withdrawal by Subject|0|||
48684146|NCT00699608|156694861|FG004|First Intervention|Withdrawal by Subject|0|||
48684147|NCT00699608|156694862|FG005|First Intervention|Withdrawal by Subject|0|||
48684148|NCT00699608|156694857|FG000|First Intervention|Protocol Violation|0|||
48684149|NCT00699608|156694858|FG001|First Intervention|Protocol Violation|0|||
48684150|NCT00699608|156694859|FG002|First Intervention|Protocol Violation|0|||
48684151|NCT00699608|156694860|FG003|First Intervention|Protocol Violation|0|||
48684152|NCT00699608|156694861|FG004|First Intervention|Protocol Violation|1|||
48684153|NCT00699608|156694862|FG005|First Intervention|Protocol Violation|0|||
48684154|NCT00699608|156694857|FG000|Second Intervention|Adverse Event|0|||
48684155|NCT00699608|156694858|FG001|Second Intervention|Adverse Event|0|||
48684156|NCT00699608|156694859|FG002|Second Intervention|Adverse Event|1|||
48684157|NCT00699608|156694860|FG003|Second Intervention|Adverse Event|0|||
48684158|NCT00699608|156694861|FG004|Second Intervention|Adverse Event|0|||
48684159|NCT00699608|156694862|FG005|Second Intervention|Adverse Event|0|||
48684160|NCT00699608|156694857|FG000|Second Intervention|Withdrawal by Subject|0|||
48684161|NCT00699608|156694858|FG001|Second Intervention|Withdrawal by Subject|0|||
48684162|NCT00699608|156694859|FG002|Second Intervention|Withdrawal by Subject|0|||
48684163|NCT00699608|156694860|FG003|Second Intervention|Withdrawal by Subject|1|||
48684164|NCT00699608|156694861|FG004|Second Intervention|Withdrawal by Subject|0|||
48684165|NCT00699608|156694862|FG005|Second Intervention|Withdrawal by Subject|0|||
48684166|NCT02837029|156694863|FG000|Screening|Failed to meet screening requirements.|7|||
48684167|NCT02837029|156694864|FG001|Screening|Failed to meet screening requirements.|3|||
48684168|NCT02837029|156694865|FG002|Screening|Failed to meet screening requirements.|0|||
48684169|NCT02837029|156694863|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
48684170|NCT02837029|156694864|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
48390306|NCT01585272|155623078|FG000|Overall Study|Withdrawal by Subject|10|||
48390307|NCT00609986|155623083|FG000|Overall Study|Did not receive transplant or treatment|8|||
48390308|NCT00609986|155623084|FG001|Overall Study|Did not receive transplant or treatment|3|||
48390309|NCT02374099|155623085|FG000|Overall Study|Adverse Event|1|||
48390310|NCT02374099|155623086|FG001|Overall Study|Adverse Event|0|||
48390311|NCT02374099|155623085|FG000|Overall Study|Progressive Disease|35|||
48390312|NCT02374099|155623086|FG001|Overall Study|Progressive Disease|40|||
48684171|NCT02837029|156694865|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
48684172|NCT02837029|156694863|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
48684173|NCT02837029|156694864|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
48684174|NCT02837029|156694865|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
48684175|NCT02837029|156694863|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
48684176|NCT02837029|156694864|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
48684177|NCT02837029|156694865|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
48684178|NCT02837029|156694863|FG000|Cycle 2 and Beyond|Adverse Event|1|||
48684179|NCT02837029|156694864|FG001|Cycle 2 and Beyond|Adverse Event|0|||
48390313|NCT02374099|155623085|FG000|Overall Study|Withdrawal by Subject|5|||
48684180|NCT02837029|156694865|FG002|Cycle 2 and Beyond|Adverse Event|0|||
48684181|NCT02837029|156694863|FG000|2 Year Follow-up|Death|6|||
48684182|NCT02837029|156694864|FG001|2 Year Follow-up|Death|7|||
48684183|NCT02837029|156694865|FG002|2 Year Follow-up|Death|0|||
48684184|NCT03920254|156694872|FG000|Overall Study|Adverse Event|1|||
48684185|NCT03920254|156694873|FG001|Overall Study|Adverse Event|0|||
48684186|NCT03920254|156694874|FG002|Overall Study|Adverse Event|0|||
48684187|NCT03920254|156694872|FG000|Overall Study|Physician Decision|0|||
48390314|NCT02374099|155623086|FG001|Overall Study|Withdrawal by Subject|1|||
48684188|NCT03920254|156694873|FG001|Overall Study|Physician Decision|1|||
48684189|NCT03920254|156694874|FG002|Overall Study|Physician Decision|2|||
48684190|NCT03920254|156694872|FG000|Overall Study|Study Terminated By Sponsor|12|||
48684191|NCT03920254|156694873|FG001|Overall Study|Study Terminated By Sponsor|17|||
48390315|NCT02374099|155623085|FG000|Overall Study|Miscellaneous|2|||
48390316|NCT02374099|155623086|FG001|Overall Study|Miscellaneous|3|||
48684192|NCT03920254|156694874|FG002|Overall Study|Study Terminated By Sponsor|12|||
48684193|NCT03920254|156694872|FG000|Overall Study|Withdrawal by Subject|0|||
48684194|NCT03920254|156694873|FG001|Overall Study|Withdrawal by Subject|0|||
48684195|NCT03920254|156694874|FG002|Overall Study|Withdrawal by Subject|1|||
48684196|NCT01797263|156694875|FG000|Overall Study|Withdrawal by Subject|21|||
48684197|NCT01797263|156694876|FG001|Overall Study|Withdrawal by Subject|25|||
48684198|NCT01797263|156694875|FG000|Overall Study|Death|1|||
48390317|NCT02374099|155623085|FG000|Overall Study|Randomized, but not treated|2|||
48390318|NCT02374099|155623086|FG001|Overall Study|Randomized, but not treated|1|||
48390319|NCT02374099|155623085|FG000|Overall Study|Study Terminated by Sponsor|3|||
48390320|NCT02374099|155623086|FG001|Overall Study|Study Terminated by Sponsor|4|||
48390321|NCT00254501|155623087|FG000|Overall Study|Lost to Follow-up|1|||
48390322|NCT00254501|155623088|FG001|Overall Study|Lost to Follow-up|1|||
48684199|NCT01797263|156694876|FG001|Overall Study|Death|0|||
48684200|NCT01797263|156694875|FG000|Overall Study|Lost to Follow-up|15|||
48684201|NCT01797263|156694876|FG001|Overall Study|Lost to Follow-up|15|||
48684202|NCT02342223|156694880|FG000|Overall Study|Lost to Follow-up|1|||
48684203|NCT03329846|156694884|FG000|Overall Study|Disease progression|4|||
48684204|NCT03329846|156694885|FG001|Overall Study|Disease progression|6|||
48684205|NCT03329846|156694884|FG000|Overall Study|Study drug toxicity|1|||
48684206|NCT03329846|156694885|FG001|Overall Study|Study drug toxicity|0|||
48684207|NCT03329846|156694884|FG000|Overall Study|Participant request to discontinue treatment|0|||
48684208|NCT03329846|156694885|FG001|Overall Study|Participant request to discontinue treatment|1|||
48684209|NCT03329846|156694884|FG000|Overall Study|Participant withdrew consent|1|||
48684210|NCT03329846|156694885|FG001|Overall Study|Participant withdrew consent|0|||
48684211|NCT03329846|156694884|FG000|Overall Study|Other reasons|2|||
48684212|NCT03329846|156694885|FG001|Overall Study|Other reasons|2|||
48684213|NCT02741596|156694886|FG000|Overall Study|Adverse Event|1|||
48684214|NCT02741596|156694887|FG001|Overall Study|Adverse Event|5|||
48684215|NCT02741596|156694886|FG000|Overall Study|Lost to Follow-up|1|||
48684216|NCT02741596|156694887|FG001|Overall Study|Lost to Follow-up|1|||
48684217|NCT02741596|156694886|FG000|Overall Study|Physician Decision|2|||
48684218|NCT02741596|156694887|FG001|Overall Study|Physician Decision|1|||
48684219|NCT02741596|156694886|FG000|Overall Study|Pregnancy|3|||
48684220|NCT02741596|156694887|FG001|Overall Study|Pregnancy|1|||
48684221|NCT02741596|156694886|FG000|Overall Study|Other (Unspecified)|0|||
48684222|NCT02741596|156694887|FG001|Overall Study|Other (Unspecified)|3|||
48684223|NCT02741596|156694886|FG000|Overall Study|Subject withdrawn-Other|17|||
48684224|NCT02741596|156694887|FG001|Overall Study|Subject withdrawn-Other|4|||
48684225|NCT02741596|156694886|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
48684226|NCT02741596|156694887|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
48684227|NCT00479336|156694888|FG000|Overall Study|Adverse Event|1|||
48684228|NCT00479336|156694889|FG001|Overall Study|Adverse Event|1|||
48684229|NCT00479336|156694890|FG002|Overall Study|Adverse Event|1|||
48684230|NCT00479336|156694891|FG003|Overall Study|Adverse Event|3|||
48684231|NCT00479336|156694888|FG000|Overall Study|Lack of Efficacy|1|||
48684232|NCT00479336|156694889|FG001|Overall Study|Lack of Efficacy|0|||
48684233|NCT00479336|156694890|FG002|Overall Study|Lack of Efficacy|0|||
48684234|NCT00479336|156694891|FG003|Overall Study|Lack of Efficacy|0|||
48684235|NCT00479336|156694888|FG000|Overall Study|Protocol Violation|0|||
48684236|NCT00479336|156694889|FG001|Overall Study|Protocol Violation|1|||
48684237|NCT00479336|156694890|FG002|Overall Study|Protocol Violation|0|||
48684238|NCT00479336|156694891|FG003|Overall Study|Protocol Violation|0|||
48684239|NCT00479336|156694888|FG000|Overall Study|Withdrawal by Subject|1|||
48684240|NCT00479336|156694889|FG001|Overall Study|Withdrawal by Subject|2|||
48684241|NCT00479336|156694890|FG002|Overall Study|Withdrawal by Subject|0|||
48684242|NCT00479336|156694891|FG003|Overall Study|Withdrawal by Subject|0|||
48684243|NCT00479336|156694888|FG000|Overall Study|Physician Decision|0|||
48684244|NCT00479336|156694889|FG001|Overall Study|Physician Decision|1|||
48684245|NCT00479336|156694890|FG002|Overall Study|Physician Decision|0|||
48684246|NCT00479336|156694891|FG003|Overall Study|Physician Decision|2|||
48684247|NCT00479336|156694888|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
48390323|NCT00262522|155623089|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
48390324|NCT00262522|155623090|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
48684248|NCT00479336|156694889|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
48684249|NCT00479336|156694890|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
48684250|NCT00479336|156694891|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
48684251|NCT03066193|156694892|FG000|Overall Study|Withdrawal by Subject|1|||
48684252|NCT02021643|156694893|FG000|Overall Study|Enrolled but Never Treated|1|||
48684253|NCT02021643|156694894|FG001|Overall Study|Enrolled but Never Treated|0|||
48684254|NCT02021643|156694895|FG002|Overall Study|Enrolled but Never Treated|0|||
48390325|NCT00262522|155623091|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
48390326|NCT00262522|155623092|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
48390327|NCT00262522|155623089|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
48684255|NCT02021643|156694896|FG003|Overall Study|Enrolled but Never Treated|0|||
48390328|NCT00262522|155623090|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
48390329|NCT00262522|155623091|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
48390330|NCT00262522|155623092|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
48390331|NCT00262522|155623089|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
48390332|NCT00262522|155623090|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
48390333|NCT00262522|155623091|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
48390334|NCT00262522|155623092|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
48390335|NCT00262522|155623089|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
48390336|NCT00262522|155623090|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
48390337|NCT00262522|155623091|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
48390338|NCT00262522|155623092|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
48390339|NCT00262522|155623089|FG000|Study Start Through 8 Weeks|Death|1|||
48390340|NCT00262522|155623090|FG001|Study Start Through 8 Weeks|Death|0|||
48390341|NCT00262522|155623091|FG002|Study Start Through 8 Weeks|Death|0|||
48390342|NCT00262522|155623092|FG003|Study Start Through 8 Weeks|Death|0|||
48390343|NCT00262522|155623089|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
48390344|NCT00262522|155623090|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
48390345|NCT00262522|155623091|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
48390346|NCT00262522|155623092|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
48390347|NCT00262522|155623089|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
48390348|NCT00262522|155623090|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
48390349|NCT00262522|155623091|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
48390350|NCT00262522|155623092|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
48390351|NCT00262522|155623089|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
48390352|NCT00262522|155623090|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
48390353|NCT00262522|155623091|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
48390354|NCT00262522|155623092|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
48390355|NCT00262522|155623089|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
48390356|NCT00262522|155623090|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
48390357|NCT00262522|155623091|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
48390358|NCT00262522|155623092|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
48390359|NCT00262522|155623089|FG000|Study Start Through 48 Weeks|Death|2|||
48390360|NCT00262522|155623090|FG001|Study Start Through 48 Weeks|Death|0|||
48390361|NCT00262522|155623091|FG002|Study Start Through 48 Weeks|Death|1|||
48390362|NCT00262522|155623092|FG003|Study Start Through 48 Weeks|Death|0|||
48390363|NCT00262522|155623089|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
48390364|NCT00262522|155623090|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
48390365|NCT00262522|155623091|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
48390366|NCT00262522|155623092|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
48390367|NCT00262522|155623089|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
48390368|NCT00262522|155623090|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
48390369|NCT00262522|155623091|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
48390370|NCT00262522|155623092|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
48390371|NCT00262522|155623089|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
48390372|NCT00262522|155623090|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
48390373|NCT00262522|155623091|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
48390374|NCT00262522|155623092|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
48390375|NCT00262522|155623089|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
48390376|NCT00262522|155623090|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
48390377|NCT00262522|155623091|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
48390378|NCT00262522|155623092|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
48390379|NCT00262522|155623089|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
48390380|NCT00262522|155623090|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
48390381|NCT00262522|155623091|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
48390382|NCT00262522|155623092|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
48390383|NCT00262522|155623089|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
48390384|NCT00262522|155623090|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
48390385|NCT00262522|155623091|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
48390386|NCT00262522|155623092|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
48390387|NCT00262522|155623089|FG000|Study Start Through 96 Weeks|Death|2|||
48390388|NCT00262522|155623090|FG001|Study Start Through 96 Weeks|Death|0|||
48390389|NCT00262522|155623091|FG002|Study Start Through 96 Weeks|Death|2|||
48390390|NCT00262522|155623092|FG003|Study Start Through 96 Weeks|Death|0|||
48390391|NCT00262522|155623089|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
48390392|NCT00262522|155623090|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
48390393|NCT00262522|155623091|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
48390394|NCT00262522|155623092|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
48390395|NCT00262522|155623089|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
48390396|NCT00262522|155623090|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
48390397|NCT00262522|155623091|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
48390398|NCT00262522|155623092|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
48390399|NCT03069352|155623094|FG000|Overall Study|Ongoing|12|||
48390400|NCT03069352|155623095|FG001|Overall Study|Ongoing|40|||
48390401|NCT03349099|155623096|FG000|Overall Study|Physician Decision|3|||
48390402|NCT03349099|155623097|FG001|Overall Study|Physician Decision|4|||
48390403|NCT03349099|155623096|FG000|Overall Study|Stone migrated from the kidney|1|||
48390404|NCT03349099|155623097|FG001|Overall Study|Stone migrated from the kidney|0|||
48390405|NCT01380379|155623105|FG000|Overall Study|Pregnancy|1|||
48390406|NCT04050670|155624972|FG000|Period 3|Physician Decision|0|||
48390407|NCT04050670|155624973|FG001|Period 3|Physician Decision|1|||
48390408|NCT04050670|155624974|FG002|Period 3|Physician Decision|0|||
48390409|NCT00761306|155624975|FG000|Overall Study|Adverse Event|5|||
48390410|NCT00761306|155624975|FG000|Overall Study|Lack of Efficacy|4|||
48390411|NCT00761306|155624975|FG000|Overall Study|Protocol Violation|2|||
48390412|NCT00761306|155624975|FG000|Overall Study|Withdrawal of Consent|3|||
48390413|NCT00761306|155624975|FG000|Overall Study|Lost to Follow-up|1|||
48390414|NCT00761306|155624975|FG000|Overall Study|Administrative or Other Reasons|5|||
48390415|NCT00847145|155624978|FG000|Overall Study|AE or Death|0|||
48390416|NCT00847145|155624979|FG001|Overall Study|AE or Death|1|||
48390417|NCT00847145|155624980|FG002|Overall Study|AE or Death|1|||
48390418|NCT00847145|155624981|FG003|Overall Study|AE or Death|0|||
48390419|NCT00847145|155624982|FG004|Overall Study|AE or Death|0|||
48390420|NCT00847145|155624983|FG005|Overall Study|AE or Death|0|||
48390421|NCT00847145|155624984|FG006|Overall Study|AE or Death|0|||
48390422|NCT00847145|155624985|FG007|Overall Study|AE or Death|0|||
48390423|NCT00847145|155624978|FG000|Overall Study|Withdrawal by Subject|3|||
48390424|NCT00847145|155624979|FG001|Overall Study|Withdrawal by Subject|4|||
48684256|NCT02021643|156694893|FG000|Overall Study|Adverse Event|0|||
48684257|NCT02021643|156694894|FG001|Overall Study|Adverse Event|1|||
48684258|NCT02021643|156694895|FG002|Overall Study|Adverse Event|0|||
48684259|NCT02021643|156694896|FG003|Overall Study|Adverse Event|0|||
48684260|NCT02021643|156694893|FG000|Overall Study|Death|0|||
48684261|NCT02021643|156694894|FG001|Overall Study|Death|1|||
48684262|NCT02021643|156694895|FG002|Overall Study|Death|0|||
48684263|NCT02021643|156694896|FG003|Overall Study|Death|0|||
48684264|NCT02021643|156694893|FG000|Overall Study|Investigator's Discretion|1|||
48684265|NCT02021643|156694894|FG001|Overall Study|Investigator's Discretion|0|||
48684266|NCT02021643|156694895|FG002|Overall Study|Investigator's Discretion|0|||
48684267|NCT02021643|156694896|FG003|Overall Study|Investigator's Discretion|0|||
48684268|NCT02021643|156694893|FG000|Overall Study|Lack of Efficacy|7|||
48684269|NCT02021643|156694894|FG001|Overall Study|Lack of Efficacy|6|||
48684270|NCT02021643|156694895|FG002|Overall Study|Lack of Efficacy|0|||
48684271|NCT02021643|156694896|FG003|Overall Study|Lack of Efficacy|12|||
48684272|NCT02021643|156694893|FG000|Overall Study|Lost to Follow-up|0|||
48684273|NCT02021643|156694894|FG001|Overall Study|Lost to Follow-up|1|||
48684274|NCT02021643|156694895|FG002|Overall Study|Lost to Follow-up|0|||
48684275|NCT02021643|156694896|FG003|Overall Study|Lost to Follow-up|0|||
48684276|NCT02021643|156694893|FG000|Overall Study|Withdrew Consent|0|||
48684277|NCT02021643|156694894|FG001|Overall Study|Withdrew Consent|1|||
48684278|NCT02021643|156694895|FG002|Overall Study|Withdrew Consent|0|||
48684279|NCT02021643|156694896|FG003|Overall Study|Withdrew Consent|0|||
48684280|NCT04854551|156694899|FG000|Overall Study|Withdrawal by Subject|1|||
48684281|NCT04854551|156694900|FG001|Overall Study|Withdrawal by Subject|1|||
48684282|NCT00100789|156694902|FG000|Overall Study|Adverse Event|10|||
48684283|NCT00100789|156694902|FG000|Overall Study|Withdrawal by Subject|1|||
48684284|NCT00100789|156694902|FG000|Overall Study|Progression/relapse|42|||
48684285|NCT00100789|156694902|FG000|Overall Study|Death|2|||
48684286|NCT00100789|156694902|FG000|Overall Study|Not protocol specified|5|||
48684287|NCT00100789|156694902|FG000|Overall Study|Ineligible|3|||
48684288|NCT00100789|156694902|FG000|Overall Study|Never received treatment|1|||
48684289|NCT03472950|156694903|FG000|Overall Study|Lost to Follow-up|0|||
48684290|NCT03472950|156694904|FG001|Overall Study|Lost to Follow-up|1|||
48684291|NCT03472950|156694903|FG000|Overall Study|Adverse Event|0|||
48390425|NCT00847145|155624980|FG002|Overall Study|Withdrawal by Subject|6|||
48390426|NCT00847145|155624981|FG003|Overall Study|Withdrawal by Subject|1|||
48684292|NCT03472950|156694904|FG001|Overall Study|Adverse Event|3|||
48684293|NCT01450761|156694907|FG000|Randomization|Subject no longer meets study criteria|1|||
48390427|NCT00847145|155624982|FG004|Overall Study|Withdrawal by Subject|0|||
48390428|NCT00847145|155624983|FG005|Overall Study|Withdrawal by Subject|0|||
48684294|NCT01450761|156694908|FG001|Randomization|Subject no longer meets study criteria|2|||
48684295|NCT01450761|156694907|FG000|Randomization|Withdrawal by Subject|2|||
48684296|NCT01450761|156694908|FG001|Randomization|Withdrawal by Subject|0|||
48684297|NCT01450761|156694907|FG000|Randomization|Disease progression|0|||
48684298|NCT01450761|156694908|FG001|Randomization|Disease progression|2|||
48390429|NCT00847145|155624984|FG006|Overall Study|Withdrawal by Subject|1|||
48390430|NCT00847145|155624985|FG007|Overall Study|Withdrawal by Subject|1|||
48390431|NCT00847145|155624978|FG000|Overall Study|Lost to Follow-up|3|||
48390432|NCT00847145|155624979|FG001|Overall Study|Lost to Follow-up|1|||
48390433|NCT00847145|155624980|FG002|Overall Study|Lost to Follow-up|1|||
48390434|NCT00847145|155624981|FG003|Overall Study|Lost to Follow-up|0|||
48390435|NCT00847145|155624982|FG004|Overall Study|Lost to Follow-up|4|||
48390436|NCT00847145|155624983|FG005|Overall Study|Lost to Follow-up|4|||
48390437|NCT00847145|155624984|FG006|Overall Study|Lost to Follow-up|8|||
48390438|NCT00847145|155624985|FG007|Overall Study|Lost to Follow-up|2|||
48390439|NCT00847145|155624978|FG000|Overall Study|Inappropriate enrollment|0|||
48390440|NCT00847145|155624979|FG001|Overall Study|Inappropriate enrollment|0|||
48390441|NCT00847145|155624980|FG002|Overall Study|Inappropriate enrollment|0|||
48390442|NCT00847145|155624981|FG003|Overall Study|Inappropriate enrollment|0|||
48390443|NCT00847145|155624982|FG004|Overall Study|Inappropriate enrollment|1|||
48390444|NCT00847145|155624983|FG005|Overall Study|Inappropriate enrollment|0|||
48390445|NCT00847145|155624984|FG006|Overall Study|Inappropriate enrollment|0|||
48390446|NCT00847145|155624985|FG007|Overall Study|Inappropriate enrollment|0|||
48390447|NCT00847145|155624978|FG000|Overall Study|Protocol Violation|0|||
48390448|NCT00847145|155624979|FG001|Overall Study|Protocol Violation|0|||
48390449|NCT00847145|155624980|FG002|Overall Study|Protocol Violation|3|||
48390450|NCT00847145|155624981|FG003|Overall Study|Protocol Violation|0|||
48390451|NCT00847145|155624982|FG004|Overall Study|Protocol Violation|1|||
48390452|NCT00847145|155624983|FG005|Overall Study|Protocol Violation|0|||
48390453|NCT00847145|155624984|FG006|Overall Study|Protocol Violation|0|||
48390454|NCT00847145|155624985|FG007|Overall Study|Protocol Violation|1|||
48390455|NCT00885703|155624990|FG000|Overall Study|Death|9|||
48390456|NCT00885703|155624991|FG001|Overall Study|Death|7|||
48390457|NCT00885703|155624992|FG002|Overall Study|Death|8|||
48390458|NCT00885703|155624993|FG003|Overall Study|Death|7|||
48390459|NCT00885703|155624994|FG004|Overall Study|Death|7|||
48390460|NCT00885703|155624995|FG005|Overall Study|Death|8|||
48390461|NCT00885703|155624996|FG006|Overall Study|Death|4|||
48390462|NCT00885703|155624990|FG000|Overall Study|Lost to Follow-up|0|||
48390463|NCT00885703|155624991|FG001|Overall Study|Lost to Follow-up|0|||
48390464|NCT00885703|155624992|FG002|Overall Study|Lost to Follow-up|1|||
48390465|NCT00885703|155624993|FG003|Overall Study|Lost to Follow-up|0|||
48390466|NCT00885703|155624994|FG004|Overall Study|Lost to Follow-up|0|||
48390467|NCT00885703|155624995|FG005|Overall Study|Lost to Follow-up|1|||
48390468|NCT00885703|155624996|FG006|Overall Study|Lost to Follow-up|0|||
48390469|NCT00885703|155624990|FG000|Overall Study|Withdrawal by Subject|0|||
48390470|NCT00885703|155624991|FG001|Overall Study|Withdrawal by Subject|0|||
48390471|NCT00885703|155624992|FG002|Overall Study|Withdrawal by Subject|0|||
48390472|NCT00885703|155624993|FG003|Overall Study|Withdrawal by Subject|1|||
48390473|NCT00885703|155624994|FG004|Overall Study|Withdrawal by Subject|3|||
48390474|NCT00885703|155624995|FG005|Overall Study|Withdrawal by Subject|1|||
48390475|NCT00885703|155624996|FG006|Overall Study|Withdrawal by Subject|1|||
48390476|NCT00885703|155624990|FG000|Overall Study|Ineligible (no CM)|1|||
48390477|NCT00885703|155624991|FG001|Overall Study|Ineligible (no CM)|3|||
48684299|NCT01450761|156694907|FG000|Randomization|Adverse Event unrelated to study drug|1|||
48684300|NCT01450761|156694908|FG001|Randomization|Adverse Event unrelated to study drug|0|||
48684301|NCT01450761|156694907|FG000|Randomization|Other|0|||
48684302|NCT01450761|156694908|FG001|Randomization|Other|1|||
48684303|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Disease progression|33|||
48684304|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Disease progression|32|||
48684305|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
48684306|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
48684307|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
48684308|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
48763059|NCT01062555|156982044|FG001|Phase 2|Protocol Violation|0|||
48763060|NCT01062555|156982045|FG002|Phase 2|Protocol Violation|0|||
48763061|NCT01062555|156982046|FG003|Phase 2|Protocol Violation|3|||
48763062|NCT01062555|156982043|FG000|Phase 2|Physician Decision|0|||
48763063|NCT01062555|156982044|FG001|Phase 2|Physician Decision|0|||
48763064|NCT01062555|156982045|FG002|Phase 2|Physician Decision|0|||
48763065|NCT01062555|156982046|FG003|Phase 2|Physician Decision|17|||
48763066|NCT00329407|156982049|FG000|Overall Study|Withdrawal by Subject|1|||
48763067|NCT02347189|156982050|FG000|Overall Study|No implant attempted of study device|9|||
48763068|NCT02347189|156982050|FG000|Overall Study|No primary outcome data available|2|||
48763069|NCT00698581|156982053|FG000|Overall Study|Lack of Efficacy|23|||
48763070|NCT00698581|156982054|FG001|Overall Study|Lack of Efficacy|11|||
48763071|NCT00698581|156982053|FG000|Overall Study|Withdrawal by Subject|6|||
48763072|NCT00698581|156982054|FG001|Overall Study|Withdrawal by Subject|0|||
48390478|NCT00885703|155624992|FG002|Overall Study|Ineligible (no CM)|2|||
48390479|NCT00885703|155624993|FG003|Overall Study|Ineligible (no CM)|1|||
48684309|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
48390480|NCT00885703|155624994|FG004|Overall Study|Ineligible (no CM)|2|||
48390481|NCT00885703|155624995|FG005|Overall Study|Ineligible (no CM)|3|||
48390482|NCT00885703|155624996|FG006|Overall Study|Ineligible (no CM)|1|||
48390483|NCT03688880|155624997|FG000|Overall Study|Withdrawal by Subject|0|||
48390484|NCT03688880|155624998|FG001|Overall Study|Withdrawal by Subject|2|||
48763073|NCT00698581|156982053|FG000|Overall Study|Other reason|9|||
48684310|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
48684311|NCT01450761|156694907|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
48684312|NCT01450761|156694908|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
48684313|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Death|3|||
48684314|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Death|3|||
48684315|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Other|2|||
48684316|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Other|2|||
48684317|NCT01450761|156694907|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
48684318|NCT01450761|156694908|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
48684319|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
48684320|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
48684321|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
48684322|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
48684323|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
48684324|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
48684325|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
48684326|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
48684327|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
48684328|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
48684329|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Death|5|||
48684330|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Death|6|||
48684331|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
48684332|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
48684333|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
48684334|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
48684335|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
48684336|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
48684337|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
48684338|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
48684339|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
48684340|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
48684341|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
48684342|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
48684343|NCT01450761|156694907|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
48684344|NCT01450761|156694908|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
48684345|NCT01858363|156694911|FG000|Overall Study|Death|35|||
48684346|NCT01858363|156694912|FG001|Overall Study|Death|9|||
48684347|NCT01858363|156694911|FG000|Overall Study|Withdrawal by Subject|28|||
48684348|NCT01858363|156694912|FG001|Overall Study|Withdrawal by Subject|14|||
48684349|NCT01858363|156694911|FG000|Overall Study|Lost to Follow-up|13|||
48390485|NCT03688880|155624997|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
48390486|NCT03688880|155624998|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
48390487|NCT03688880|155624997|FG000|Overall Study|Lost to Follow-up|4|||
48390488|NCT03688880|155624998|FG001|Overall Study|Lost to Follow-up|7|||
48390489|NCT03688880|155624997|FG000|Overall Study|Adverse Event|0|||
48390490|NCT03688880|155624998|FG001|Overall Study|Adverse Event|2|||
48684350|NCT01858363|156694912|FG001|Overall Study|Lost to Follow-up|3|||
48684351|NCT04390243|156694913|FG000|Overall Study|Death|1|||
48684352|NCT04390243|156694913|FG000|Overall Study|Disease Progression|4|||
48684353|NCT04390243|156694913|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
48684354|NCT02478463|156694918|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
48684355|NCT02478463|156694918|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
48684356|NCT02478463|156694918|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
48390491|NCT03688880|155624997|FG000|Overall Study|Device deficiencies|0|||
48684357|NCT03259087|156694927|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
48684358|NCT03259087|156694928|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
48684359|NCT03259087|156694929|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
48684360|NCT03259087|156694930|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
48684361|NCT03259087|156694931|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
48684362|NCT03259087|156694927|FG000|Period 2 of Part 2|Adverse Event|0|||
48684363|NCT03259087|156694928|FG001|Period 2 of Part 2|Adverse Event|0|||
48684364|NCT03259087|156694929|FG002|Period 2 of Part 2|Adverse Event|0|||
48684365|NCT03259087|156694930|FG003|Period 2 of Part 2|Adverse Event|0|||
48684366|NCT03259087|156694931|FG004|Period 2 of Part 2|Adverse Event|1|||
48684367|NCT02518971|156694932|FG000|Overall Study|Lost to Follow-up|0|||
48684368|NCT02518971|156694933|FG001|Overall Study|Lost to Follow-up|1|||
48684369|NCT02518971|156694932|FG000|Overall Study|Physician Decision|6|||
48684370|NCT02518971|156694933|FG001|Overall Study|Physician Decision|6|||
48684371|NCT02518971|156694932|FG000|Overall Study|Protocol Violation|6|||
48684372|NCT02518971|156694933|FG001|Overall Study|Protocol Violation|4|||
48684373|NCT02518971|156694932|FG000|Overall Study|Withdrawal by Subject|4|||
48684374|NCT02518971|156694933|FG001|Overall Study|Withdrawal by Subject|5|||
48684375|NCT02518971|156694932|FG000|Overall Study|Side effects|1|||
48684376|NCT02518971|156694933|FG001|Overall Study|Side effects|0|||
48684377|NCT02518971|156694932|FG000|Overall Study|medication lost in mail|0|||
48684378|NCT02518971|156694933|FG001|Overall Study|medication lost in mail|1|||
48684379|NCT02518971|156694932|FG000|Overall Study|eligibility criteria no longer met|6|||
48684380|NCT02518971|156694933|FG001|Overall Study|eligibility criteria no longer met|3|||
48684381|NCT03551626|156694934|FG000|Overall Study|Adverse Event|88|||
48684382|NCT03551626|156694934|FG000|Overall Study|Disease relapse|18|||
48684383|NCT03551626|156694934|FG000|Overall Study|Withdrawal of informed consent|6|||
48684384|NCT03551626|156694934|FG000|Overall Study|Patient decision|5|||
48684385|NCT03551626|156694934|FG000|Overall Study|Physician Decision|4|||
48684386|NCT03551626|156694934|FG000|Overall Study|Lost to Follow-up|3|||
48684387|NCT03551626|156694934|FG000|Overall Study|Pregnancy|1|||
48684388|NCT03551626|156694934|FG000|Overall Study|Protocol deviation|1|||
48684389|NCT03551626|156694934|FG000|Overall Study|Technical problems|1|||
48684390|NCT02336230|156694935|FG000|Overall Study|Adverse Event|1|||
48684391|NCT02336230|156694935|FG000|Overall Study|Withdrawal of consent|1|||
48684392|NCT02336230|156694935|FG000|Overall Study|Death|9|||
48684393|NCT02336230|156694935|FG000|Overall Study|Dose not received due to shipping delay|1|||
48684394|NCT02336230|156694935|FG000|Overall Study|Discontinuation of MSC infusion|1|||
48684395|NCT01362348|156694936|FG000|Overall Study|Protocol-defined stopping criteria|9|||
48684396|NCT01362348|156694936|FG000|Overall Study|Study closed/terminated|5|||
48684397|NCT00684996|156694937|FG000|Overall Study|Adverse Event|1|||
48684398|NCT00684996|156694937|FG000|Overall Study|Refusal unrelated to adverse event|1|||
48684399|NCT00684996|156694937|FG000|Overall Study|Progression/relapse|2|||
48684400|NCT00684996|156694937|FG000|Overall Study|Other reasons not protocol specified|1|||
48684401|NCT00556998|156694938|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
48763074|NCT00698581|156982054|FG001|Overall Study|Other reason|1|||
48763075|NCT00698581|156982053|FG000|Overall Study|SAE, non-fatal|1|||
48763076|NCT00698581|156982054|FG001|Overall Study|SAE, non-fatal|0|||
48390492|NCT03688880|155624998|FG001|Overall Study|Device deficiencies|2|||
48390493|NCT03688880|155624997|FG000|Overall Study|Other|10|||
48390494|NCT03688880|155624998|FG001|Overall Study|Other|16|||
48390495|NCT03723707|155624999|FG000|Overall Study|Death|32|||
48390496|NCT03723707|155625000|FG001|Overall Study|Death|32|||
48390497|NCT03723707|155624999|FG000|Overall Study|Admitted to long term care|12|||
48684402|NCT00556998|156694938|FG000|Voriconazole Intravenous (IV)|Other|4|||
48684403|NCT00556998|156694938|FG000|Voriconazole Oral|Adverse Event|1|||
48684404|NCT00556998|156694938|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
48763077|NCT00698581|156982053|FG000|Overall Study|AE, non-serious non-fatal|4|||
48390498|NCT03723707|155625000|FG001|Overall Study|Admitted to long term care|12|||
48390499|NCT03723707|155624999|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
48390500|NCT03723707|155625000|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
48390501|NCT03723707|155624999|FG000|Overall Study|Lost to Follow-up|40|||
48684405|NCT00286494|156694943|FG000|Overall Study|Hyperglycemic rescue|12|||
48684406|NCT00286494|156694944|FG001|Overall Study|Hyperglycemic rescue|19|||
48390502|NCT03723707|155625000|FG001|Overall Study|Lost to Follow-up|22|||
48390503|NCT03723707|155624999|FG000|Overall Study|Discontinued after study closure|24|||
48390504|NCT03723707|155625000|FG001|Overall Study|Discontinued after study closure|12|||
48390505|NCT05121480|155625001|FG000|Overall Study|Lack of Efficacy|2|||
48390506|NCT05121480|155625002|FG001|Overall Study|Lack of Efficacy|2|||
48390507|NCT05121480|155625003|FG002|Overall Study|Lack of Efficacy|1|||
48390508|NCT05121480|155625004|FG003|Overall Study|Lack of Efficacy|4|||
48390509|NCT05121480|155625005|FG004|Overall Study|Lack of Efficacy|0|||
48390510|NCT05121480|155625006|FG005|Overall Study|Lack of Efficacy|1|||
48390511|NCT05121480|155625007|FG006|Overall Study|Lack of Efficacy|0|||
48390512|NCT05121480|155625008|FG007|Overall Study|Lack of Efficacy|2|||
48390513|NCT05121480|155625001|FG000|Overall Study|Treatment Failure|0|||
48390514|NCT05121480|155625002|FG001|Overall Study|Treatment Failure|2|||
48390515|NCT05121480|155625003|FG002|Overall Study|Treatment Failure|0|||
48390516|NCT05121480|155625004|FG003|Overall Study|Treatment Failure|1|||
48390517|NCT05121480|155625005|FG004|Overall Study|Treatment Failure|0|||
48390518|NCT05121480|155625006|FG005|Overall Study|Treatment Failure|0|||
48390519|NCT05121480|155625007|FG006|Overall Study|Treatment Failure|0|||
48390520|NCT05121480|155625008|FG007|Overall Study|Treatment Failure|0|||
48390521|NCT05121480|155625001|FG000|Overall Study|Adverse Event|0|||
48390522|NCT05121480|155625002|FG001|Overall Study|Adverse Event|1|||
48390523|NCT05121480|155625003|FG002|Overall Study|Adverse Event|0|||
48390524|NCT05121480|155625004|FG003|Overall Study|Adverse Event|5|||
48390525|NCT05121480|155625005|FG004|Overall Study|Adverse Event|3|||
48390526|NCT05121480|155625006|FG005|Overall Study|Adverse Event|2|||
48390527|NCT05121480|155625007|FG006|Overall Study|Adverse Event|0|||
48390528|NCT05121480|155625008|FG007|Overall Study|Adverse Event|4|||
48390529|NCT05121480|155625001|FG000|Overall Study|Withdrawal by Subject|4|||
48390530|NCT05121480|155625002|FG001|Overall Study|Withdrawal by Subject|9|||
48390531|NCT05121480|155625003|FG002|Overall Study|Withdrawal by Subject|1|||
48390532|NCT05121480|155625004|FG003|Overall Study|Withdrawal by Subject|8|||
48390533|NCT05121480|155625005|FG004|Overall Study|Withdrawal by Subject|0|||
48684407|NCT00286494|156694945|FG002|Overall Study|Hyperglycemic rescue|18|||
48684408|NCT00286494|156694943|FG000|Overall Study|Withdrawal by Subject|2|||
48684409|NCT00286494|156694944|FG001|Overall Study|Withdrawal by Subject|10|||
48684410|NCT00286494|156694945|FG002|Overall Study|Withdrawal by Subject|9|||
48684411|NCT00286494|156694943|FG000|Overall Study|Adverse Event|3|||
48684412|NCT00286494|156694944|FG001|Overall Study|Adverse Event|8|||
48684413|NCT00286494|156694945|FG002|Overall Study|Adverse Event|6|||
48684414|NCT00286494|156694943|FG000|Overall Study|Physician Decision|5|||
48684415|NCT00286494|156694944|FG001|Overall Study|Physician Decision|5|||
48684416|NCT00286494|156694945|FG002|Overall Study|Physician Decision|1|||
48684417|NCT00286494|156694943|FG000|Overall Study|Lost to Follow-up|3|||
48684418|NCT00286494|156694944|FG001|Overall Study|Lost to Follow-up|1|||
48684419|NCT00286494|156694945|FG002|Overall Study|Lost to Follow-up|3|||
48684420|NCT00286494|156694943|FG000|Overall Study|Protocol Violation|1|||
48684421|NCT00286494|156694944|FG001|Overall Study|Protocol Violation|1|||
48684422|NCT00286494|156694945|FG002|Overall Study|Protocol Violation|2|||
48684423|NCT02175017|156694946|FG000|Overall Study|Did not receive the investigational product|1|||
48684424|NCT02175017|156694947|FG001|Overall Study|Did not receive the investigational product|2|||
48684425|NCT02175017|156694946|FG000|Overall Study|Withdrawal by Subject|6|||
48684426|NCT02175017|156694947|FG001|Overall Study|Withdrawal by Subject|3|||
48684427|NCT02175017|156694946|FG000|Overall Study|Met an exclusion criteria|0|||
48684428|NCT02175017|156694947|FG001|Overall Study|Met an exclusion criteria|1|||
48684429|NCT02175017|156694946|FG000|Overall Study|Adverse Event|3|||
48684430|NCT02175017|156694947|FG001|Overall Study|Adverse Event|10|||
48390534|NCT05121480|155625006|FG005|Overall Study|Withdrawal by Subject|9|||
48390535|NCT05121480|155625007|FG006|Overall Study|Withdrawal by Subject|0|||
48390536|NCT05121480|155625008|FG007|Overall Study|Withdrawal by Subject|4|||
48390537|NCT05121480|155625001|FG000|Overall Study|Non-compliance with the protocol|0|||
48390538|NCT05121480|155625002|FG001|Overall Study|Non-compliance with the protocol|0|||
48390539|NCT05121480|155625003|FG002|Overall Study|Non-compliance with the protocol|0|||
48390540|NCT05121480|155625004|FG003|Overall Study|Non-compliance with the protocol|0|||
48390541|NCT05121480|155625005|FG004|Overall Study|Non-compliance with the protocol|1|||
48684431|NCT02175017|156694946|FG000|Overall Study|Disease progression|20|||
48684432|NCT02175017|156694947|FG001|Overall Study|Disease progression|27|||
48684433|NCT02175017|156694946|FG000|Overall Study|Other than above reasons|3|||
48684434|NCT02175017|156694947|FG001|Overall Study|Other than above reasons|0|||
48390542|NCT05121480|155625006|FG005|Overall Study|Non-compliance with the protocol|6|||
48390543|NCT05121480|155625007|FG006|Overall Study|Non-compliance with the protocol|0|||
48390544|NCT05121480|155625008|FG007|Overall Study|Non-compliance with the protocol|1|||
48390545|NCT05121480|155625001|FG000|Overall Study|Lost to Follow-up|0|||
48390546|NCT05121480|155625002|FG001|Overall Study|Lost to Follow-up|4|||
48390547|NCT05121480|155625003|FG002|Overall Study|Lost to Follow-up|1|||
48390548|NCT05121480|155625004|FG003|Overall Study|Lost to Follow-up|3|||
48390549|NCT05121480|155625005|FG004|Overall Study|Lost to Follow-up|1|||
48390550|NCT05121480|155625006|FG005|Overall Study|Lost to Follow-up|1|||
48390551|NCT05121480|155625007|FG006|Overall Study|Lost to Follow-up|1|||
48390552|NCT05121480|155625008|FG007|Overall Study|Lost to Follow-up|4|||
48390553|NCT05121480|155625001|FG000|Overall Study|Physician Decision|0|||
48390554|NCT05121480|155625002|FG001|Overall Study|Physician Decision|0|||
48390555|NCT05121480|155625003|FG002|Overall Study|Physician Decision|0|||
48684435|NCT01970306|156694952|FG000|Overall Study|Not eligible|3|||
48684436|NCT01970306|156694952|FG000|Overall Study|Not able to be treated|9|||
48684437|NCT02330055|156694958|FG000|Overall Study|technical issues|2|||
48684438|NCT02330055|156694959|FG001|Overall Study|technical issues|0|||
48684439|NCT02330055|156694958|FG000|Overall Study|participant forgot to wear device|5|||
48684440|NCT02330055|156694959|FG001|Overall Study|participant forgot to wear device|5|||
48684441|NCT02330055|156694958|FG000|Overall Study|data for less than 60 minutes|3|||
48684442|NCT02330055|156694959|FG001|Overall Study|data for less than 60 minutes|3|||
48684443|NCT02330055|156694958|FG000|Overall Study|participant did not sleep|0|||
48684444|NCT02330055|156694959|FG001|Overall Study|participant did not sleep|1|||
48684445|NCT02488005|156694960|FG000|Overall Study|Lost to Follow-up|2|||
48684446|NCT00650767|156694961|FG000|Overall Study|Adverse Event|0|||
48684447|NCT00650767|156694962|FG001|Overall Study|Adverse Event|3|||
48684448|NCT00650767|156694963|FG002|Overall Study|Adverse Event|10|||
48684449|NCT00650767|156694964|FG003|Overall Study|Adverse Event|8|||
48684450|NCT00650767|156694961|FG000|Overall Study|Death|1|||
48684451|NCT00650767|156694962|FG001|Overall Study|Death|0|||
48684452|NCT00650767|156694963|FG002|Overall Study|Death|0|||
48390556|NCT05121480|155625004|FG003|Overall Study|Physician Decision|0|||
48390557|NCT05121480|155625005|FG004|Overall Study|Physician Decision|0|||
48684453|NCT00650767|156694964|FG003|Overall Study|Death|0|||
48684454|NCT00650767|156694961|FG000|Overall Study|Withdrawal by Subject|2|||
48684455|NCT00650767|156694962|FG001|Overall Study|Withdrawal by Subject|4|||
48684456|NCT00650767|156694963|FG002|Overall Study|Withdrawal by Subject|3|||
48684457|NCT00650767|156694964|FG003|Overall Study|Withdrawal by Subject|3|||
48684458|NCT00650767|156694961|FG000|Overall Study|Lost to Follow-up|1|||
48684459|NCT00650767|156694962|FG001|Overall Study|Lost to Follow-up|1|||
48684460|NCT00650767|156694963|FG002|Overall Study|Lost to Follow-up|1|||
48684461|NCT00650767|156694964|FG003|Overall Study|Lost to Follow-up|0|||
48684462|NCT00650767|156694961|FG000|Overall Study|Other|1|||
48684463|NCT00650767|156694962|FG001|Overall Study|Other|1|||
48684464|NCT00650767|156694963|FG002|Overall Study|Other|0|||
48684465|NCT00650767|156694964|FG003|Overall Study|Other|0|||
48684466|NCT00801216|156694968|FG000|Overall Study|Screening Failure|2|||
48684467|NCT01597635|156697746|FG000|Part A|Adverse Event|3|||
48684468|NCT01597635|156697747|FG001|Part A|Adverse Event|0|||
48684469|NCT01597635|156697748|FG002|Part A|Adverse Event|0|||
48390558|NCT05121480|155625006|FG005|Overall Study|Physician Decision|1|||
48390559|NCT05121480|155625007|FG006|Overall Study|Physician Decision|0|||
48390560|NCT05121480|155625008|FG007|Overall Study|Physician Decision|1|||
48390561|NCT05121480|155625001|FG000|Overall Study|Other Reason|0|||
48684470|NCT01597635|156697746|FG000|Part B|Adverse Event|0|||
48684471|NCT01597635|156697747|FG001|Part B|Adverse Event|0|||
48684472|NCT01597635|156697748|FG002|Part B|Adverse Event|1|||
48684473|NCT01597635|156697746|FG000|Part B|Protocol Violation|0|||
48684474|NCT01597635|156697747|FG001|Part B|Protocol Violation|1|||
48684475|NCT01597635|156697748|FG002|Part B|Protocol Violation|0|||
48684476|NCT01597635|156697746|FG000|Part B|Protocol-defined stopping criteria|0|||
48684477|NCT01597635|156697747|FG001|Part B|Protocol-defined stopping criteria|4|||
48390562|NCT05121480|155625002|FG001|Overall Study|Other Reason|0|||
48390563|NCT05121480|155625003|FG002|Overall Study|Other Reason|0|||
48390564|NCT05121480|155625004|FG003|Overall Study|Other Reason|0|||
48390565|NCT05121480|155625005|FG004|Overall Study|Other Reason|0|||
48390566|NCT05121480|155625006|FG005|Overall Study|Other Reason|1|||
48390567|NCT05121480|155625007|FG006|Overall Study|Other Reason|1|||
48684478|NCT01597635|156697748|FG002|Part B|Protocol-defined stopping criteria|3|||
48684479|NCT01597635|156697746|FG000|Part B|Withdrawal by Subject|0|||
48684480|NCT01597635|156697747|FG001|Part B|Withdrawal by Subject|1|||
48684481|NCT01597635|156697748|FG002|Part B|Withdrawal by Subject|0|||
48684482|NCT02300259|156697749|FG000|Period 1|Adverse Event|0|||
48684483|NCT02300259|156697750|FG001|Period 1|Adverse Event|0|||
48684484|NCT02300259|156697751|FG002|Period 1|Adverse Event|1|||
48684485|NCT02300259|156697749|FG000|Period 1|Withdrawal by Subject|0|||
48684486|NCT02300259|156697750|FG001|Period 1|Withdrawal by Subject|0|||
48684487|NCT02300259|156697751|FG002|Period 1|Withdrawal by Subject|1|||
48684488|NCT02300259|156697749|FG000|Period 2|Adverse Event|1|||
48684489|NCT02300259|156697750|FG001|Period 2|Adverse Event|0|||
48684490|NCT02300259|156697751|FG002|Period 2|Adverse Event|0|||
48684491|NCT02300259|156697749|FG000|Period 2|Withdrawal by Subject|0|||
48684492|NCT02300259|156697750|FG001|Period 2|Withdrawal by Subject|0|||
48684493|NCT02300259|156697751|FG002|Period 2|Withdrawal by Subject|1|||
48684494|NCT01980095|156697755|FG000|Overall Study|Lost to Follow-up|6|||
48684495|NCT01980095|156697756|FG001|Overall Study|Lost to Follow-up|7|||
48684496|NCT01980095|156697755|FG000|Overall Study|Withdrawal by Subject|2|||
48684497|NCT01980095|156697756|FG001|Overall Study|Withdrawal by Subject|3|||
48684498|NCT01980095|156697755|FG000|Overall Study|Poor compliance|5|||
48684499|NCT01980095|156697756|FG001|Overall Study|Poor compliance|0|||
48684500|NCT01980095|156697755|FG000|Overall Study|Safety issue|0|||
48684501|NCT01980095|156697756|FG001|Overall Study|Safety issue|1|||
48684502|NCT01980095|156697755|FG000|Overall Study|Study drug discontinued|1|||
48684503|NCT01980095|156697756|FG001|Overall Study|Study drug discontinued|0|||
48684504|NCT01980095|156697755|FG000|Overall Study|Randomized by mistake|1|||
48684505|NCT01980095|156697756|FG001|Overall Study|Randomized by mistake|0|||
48684506|NCT00412893|156697757|FG000|Overall Study|Adverse Event|31|||
48684507|NCT00412893|156697758|FG001|Overall Study|Adverse Event|53|||
48684508|NCT00412893|156697757|FG000|Overall Study|Death|17|||
48684509|NCT00412893|156697758|FG001|Overall Study|Death|21|||
48684510|NCT00412893|156697757|FG000|Overall Study|Insufficient Therapeutic Response|39|||
48684511|NCT00412893|156697758|FG001|Overall Study|Insufficient Therapeutic Response|23|||
48684512|NCT00412893|156697757|FG000|Overall Study|Lost to Follow-up|2|||
48390568|NCT05121480|155625008|FG007|Overall Study|Other Reason|1|||
48390569|NCT01429584|155625010|FG000|Overall Study|Withdrawal by Subject|1|||
48390570|NCT01429584|155625011|FG001|Overall Study|Withdrawal by Subject|0|||
48390571|NCT01429584|155625010|FG000|Overall Study|Protocol Violation|0|||
48390572|NCT01429584|155625011|FG001|Overall Study|Protocol Violation|1|||
48390573|NCT02953639|155625015|FG000|Overall Study|Adverse Event|2|||
48684513|NCT00412893|156697758|FG001|Overall Study|Lost to Follow-up|1|||
48684514|NCT00412893|156697757|FG000|Overall Study|Violation of Selection at Entry|17|||
48684515|NCT00412893|156697758|FG001|Overall Study|Violation of Selection at Entry|10|||
48684516|NCT00412893|156697757|FG000|Overall Study|Other Protocol Violation|10|||
48684517|NCT00412893|156697758|FG001|Overall Study|Other Protocol Violation|6|||
48684518|NCT00412893|156697757|FG000|Overall Study|Did Not Cooperate|12|||
48684519|NCT00412893|156697758|FG001|Overall Study|Did Not Cooperate|9|||
48684520|NCT00412893|156697757|FG000|Overall Study|Administrative Reason|12|||
48684521|NCT00412893|156697758|FG001|Overall Study|Administrative Reason|15|||
48684522|NCT00412893|156697757|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
48684523|NCT00412893|156697758|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
48684524|NCT02737475|156697759|FG000|Overall Study|Other reasons|0|||
48684525|NCT02737475|156697760|FG001|Overall Study|Other reasons|0|||
48684526|NCT02737475|156697761|FG002|Overall Study|Other reasons|0|||
48684527|NCT02737475|156697762|FG003|Overall Study|Other reasons|0|||
48684528|NCT02737475|156697763|FG004|Overall Study|Other reasons|1|||
48684529|NCT02737475|156697764|FG005|Overall Study|Other reasons|1|||
48684530|NCT02737475|156697765|FG006|Overall Study|Other reasons|0|||
48684531|NCT02737475|156697766|FG007|Overall Study|Other reasons|0|||
48684532|NCT02737475|156697767|FG008|Overall Study|Other reasons|1|||
48684533|NCT02737475|156697768|FG009|Overall Study|Other reasons|0|||
48684534|NCT02737475|156697769|FG010|Overall Study|Other reasons|1|||
48684535|NCT02737475|156697770|FG011|Overall Study|Other reasons|0|||
48684536|NCT02737475|156697771|FG012|Overall Study|Other reasons|0|||
48684537|NCT02737475|156697772|FG013|Overall Study|Other reasons|0|||
48684538|NCT02737475|156697773|FG014|Overall Study|Other reasons|0|||
48684539|NCT02737475|156697774|FG015|Overall Study|Other reasons|0|||
48684540|NCT02737475|156697775|FG016|Overall Study|Other reasons|0|||
48684541|NCT02737475|156697776|FG017|Overall Study|Other reasons|0|||
48684542|NCT02737475|156697777|FG018|Overall Study|Other reasons|0|||
48684543|NCT02737475|156697778|FG019|Overall Study|Other reasons|0|||
48684544|NCT02737475|156697779|FG020|Overall Study|Other reasons|0|||
48684545|NCT02737475|156697780|FG021|Overall Study|Other reasons|1|||
48684546|NCT02737475|156697781|FG022|Overall Study|Other reasons|0|||
48684547|NCT02737475|156697782|FG023|Overall Study|Other reasons|1|||
48684548|NCT02737475|156697783|FG024|Overall Study|Other reasons|1|||
48684549|NCT02737475|156697784|FG025|Overall Study|Other reasons|1|||
48390574|NCT02953639|155625016|FG001|Overall Study|Adverse Event|0|||
48390575|NCT02953639|155625017|FG002|Overall Study|Adverse Event|1|||
48684550|NCT02737475|156697785|FG026|Overall Study|Other reasons|0|||
48684551|NCT02737475|156697759|FG000|Overall Study|Death|1|||
48684552|NCT02737475|156697760|FG001|Overall Study|Death|0|||
48684553|NCT02737475|156697761|FG002|Overall Study|Death|0|||
48390576|NCT02953639|155625015|FG000|Overall Study|Lost to Follow-up|8|||
48390577|NCT02953639|155625016|FG001|Overall Study|Lost to Follow-up|4|||
48390578|NCT02953639|155625017|FG002|Overall Study|Lost to Follow-up|3|||
48390579|NCT02953639|155625015|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48390580|NCT02953639|155625016|FG001|Overall Study|Non-Compliance With Study Drug|2|||
48390581|NCT02953639|155625017|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48390582|NCT02953639|155625015|FG000|Overall Study|Multiple Reasons|1|||
48684554|NCT02737475|156697762|FG003|Overall Study|Death|1|||
48684555|NCT02737475|156697763|FG004|Overall Study|Death|0|||
48684556|NCT02737475|156697764|FG005|Overall Study|Death|0|||
48684557|NCT02737475|156697765|FG006|Overall Study|Death|0|||
48684558|NCT02737475|156697766|FG007|Overall Study|Death|2|||
48684559|NCT02737475|156697767|FG008|Overall Study|Death|0|||
48684560|NCT02737475|156697768|FG009|Overall Study|Death|0|||
48684561|NCT02737475|156697769|FG010|Overall Study|Death|0|||
48684562|NCT02737475|156697770|FG011|Overall Study|Death|4|||
48684563|NCT02737475|156697771|FG012|Overall Study|Death|2|||
48684564|NCT02737475|156697772|FG013|Overall Study|Death|2|||
48684565|NCT02737475|156697773|FG014|Overall Study|Death|0|||
48684566|NCT02737475|156697774|FG015|Overall Study|Death|2|||
48684567|NCT02737475|156697775|FG016|Overall Study|Death|2|||
48684568|NCT02737475|156697776|FG017|Overall Study|Death|2|||
48684569|NCT02737475|156697777|FG018|Overall Study|Death|1|||
48763078|NCT00698581|156982054|FG001|Overall Study|AE, non-serious non-fatal|0|||
48763079|NCT00698581|156982053|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48763080|NCT00698581|156982054|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48763081|NCT00698581|156982053|FG000|Overall Study|AE of unknown type|1|||
48763082|NCT00698581|156982054|FG001|Overall Study|AE of unknown type|0|||
48390583|NCT02953639|155625016|FG001|Overall Study|Multiple Reasons|0|||
48390584|NCT02953639|155625017|FG002|Overall Study|Multiple Reasons|1|||
48390585|NCT02953639|155625015|FG000|Overall Study|Physician Decision|1|||
48390586|NCT02953639|155625016|FG001|Overall Study|Physician Decision|0|||
48390587|NCT02953639|155625017|FG002|Overall Study|Physician Decision|0|||
48390588|NCT02953639|155625015|FG000|Overall Study|Withdrawal by Subject|7|||
48390589|NCT02953639|155625016|FG001|Overall Study|Withdrawal by Subject|8|||
48390590|NCT02953639|155625017|FG002|Overall Study|Withdrawal by Subject|10|||
48390591|NCT02953639|155625015|FG000|Overall Study|Completed or Discontinued information is missing|1|||
48390592|NCT02953639|155625016|FG001|Overall Study|Completed or Discontinued information is missing|0|||
48390593|NCT02953639|155625017|FG002|Overall Study|Completed or Discontinued information is missing|0|||
48390594|NCT00747643|155625019|FG000|Overall Study|Withdrawal by Subject|36|||
48390595|NCT00747643|155625020|FG001|Overall Study|Withdrawal by Subject|27|||
48390596|NCT00750698|155625021|FG000|Overall Study|Withdrawal by Subject|1|||
48390597|NCT00750698|155625022|FG001|Overall Study|Withdrawal by Subject|0|||
48390598|NCT00750698|155625021|FG000|Overall Study|Progressive disease|5|||
48390599|NCT00750698|155625022|FG001|Overall Study|Progressive disease|2|||
48390600|NCT01462435|155625023|FG000|Overall Study|Lack of Efficacy|1|||
48390601|NCT01462435|155625024|FG001|Overall Study|Lack of Efficacy|0|||
48390602|NCT01462435|155625025|FG002|Overall Study|Lack of Efficacy|0|||
48390603|NCT01462435|155625026|FG003|Overall Study|Lack of Efficacy|3|||
48390604|NCT01462435|155625023|FG000|Overall Study|Physician Decision|0|||
48390605|NCT01462435|155625024|FG001|Overall Study|Physician Decision|0|||
48390606|NCT01462435|155625025|FG002|Overall Study|Physician Decision|1|||
48390607|NCT01462435|155625026|FG003|Overall Study|Physician Decision|0|||
48390608|NCT01462435|155625023|FG000|Overall Study|Withdrawal by Subject|0|||
48390609|NCT01462435|155625024|FG001|Overall Study|Withdrawal by Subject|0|||
48390610|NCT01462435|155625025|FG002|Overall Study|Withdrawal by Subject|0|||
48390611|NCT01462435|155625026|FG003|Overall Study|Withdrawal by Subject|1|||
48390612|NCT01462435|155625023|FG000|Overall Study|Lost to Follow-up|0|||
48390613|NCT01462435|155625024|FG001|Overall Study|Lost to Follow-up|0|||
48390614|NCT01462435|155625025|FG002|Overall Study|Lost to Follow-up|0|||
48390615|NCT01462435|155625026|FG003|Overall Study|Lost to Follow-up|1|||
48390616|NCT00054704|155625027|FG000|Overall Study|Lack of Efficacy|2|||
48684570|NCT02737475|156697778|FG019|Overall Study|Death|0|||
48684571|NCT02737475|156697779|FG020|Overall Study|Death|0|||
48684572|NCT02737475|156697780|FG021|Overall Study|Death|0|||
48684573|NCT02737475|156697781|FG022|Overall Study|Death|0|||
48390617|NCT00054704|155625028|FG001|Overall Study|Lack of Efficacy|3|||
48390618|NCT00054704|155625027|FG000|Overall Study|Adverse Event|3|||
48390619|NCT00054704|155625028|FG001|Overall Study|Adverse Event|1|||
48390620|NCT00054704|155625027|FG000|Overall Study|Lost to Follow-up|0|||
48390621|NCT00054704|155625028|FG001|Overall Study|Lost to Follow-up|1|||
48390622|NCT01417195|155625033|FG000|Overall Study|Stimulation failure|1|||
48390623|NCT01417195|155625034|FG001|Overall Study|Stimulation failure|0|||
48684574|NCT02737475|156697782|FG023|Overall Study|Death|0|||
48390624|NCT01417195|155625033|FG000|Overall Study|No embryos for transfer|0|||
48390625|NCT01417195|155625034|FG001|Overall Study|No embryos for transfer|1|||
48684575|NCT02737475|156697783|FG024|Overall Study|Death|0|||
48390626|NCT01417195|155625033|FG000|Overall Study|No transfer due to risk of OHSS|1|||
48684576|NCT02737475|156697784|FG025|Overall Study|Death|0|||
48684577|NCT02737475|156697785|FG026|Overall Study|Death|0|||
48684578|NCT02737475|156697759|FG000|Overall Study|Participant withdrew consent|0|||
48390627|NCT01417195|155625034|FG001|Overall Study|No transfer due to risk of OHSS|0|||
48390628|NCT01417195|155625033|FG000|Overall Study|No transfer due to elevated progesterone|1|||
48390629|NCT01417195|155625034|FG001|Overall Study|No transfer due to elevated progesterone|0|||
48390630|NCT02234479|155625035|FG000|Overall Study|Withdrawal by Subject|1|||
48390631|NCT02234479|155625036|FG001|Overall Study|Withdrawal by Subject|3|||
48390632|NCT01848288|155625037|FG000|Overall Study|Death|1|||
48390633|NCT01848288|155625037|FG000|Overall Study|Protocol Violation|1|||
48684579|NCT02737475|156697760|FG001|Overall Study|Participant withdrew consent|0|||
48684580|NCT02737475|156697761|FG002|Overall Study|Participant withdrew consent|0|||
48684581|NCT02737475|156697762|FG003|Overall Study|Participant withdrew consent|0|||
48684582|NCT02737475|156697763|FG004|Overall Study|Participant withdrew consent|0|||
48684583|NCT02737475|156697764|FG005|Overall Study|Participant withdrew consent|2|||
48390634|NCT01848288|155625037|FG000|Overall Study|Withdrawal by Subject|1|||
48390635|NCT00677820|155625038|FG000|Overall Study|Lost to Follow-up|1|||
48390636|NCT00677820|155625039|FG001|Overall Study|Lost to Follow-up|0|||
48390637|NCT02713542|155625040|FG000|Overall Study|Use of prohibited medication|14|||
48390638|NCT02713542|155625041|FG001|Overall Study|Use of prohibited medication|5|||
48684584|NCT02737475|156697765|FG006|Overall Study|Participant withdrew consent|0|||
48684585|NCT02737475|156697766|FG007|Overall Study|Participant withdrew consent|0|||
48684586|NCT02737475|156697767|FG008|Overall Study|Participant withdrew consent|0|||
48390639|NCT02713542|155625040|FG000|Overall Study|Withdrawal by Subject|4|||
48390640|NCT02713542|155625041|FG001|Overall Study|Withdrawal by Subject|1|||
48390641|NCT03807349|155625042|FG000|Overall Study|Early Study Termination|9|||
48390642|NCT00129766|155625043|FG000|Overall Study|Death|3|||
48390643|NCT00129766|155625044|FG001|Overall Study|Death|8|||
48390644|NCT00129766|155625043|FG000|Overall Study|Withdrawal of consent|31|||
48390645|NCT00129766|155625044|FG001|Overall Study|Withdrawal of consent|30|||
48390646|NCT00129766|155625043|FG000|Overall Study|Lost to Follow-up|26|||
48390647|NCT00129766|155625044|FG001|Overall Study|Lost to Follow-up|21|||
48390648|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
48390649|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
48390650|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
48390651|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
48390652|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
48390653|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
48390654|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
48390655|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
48390656|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
48390657|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
48390658|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
48390659|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
48390660|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
48390661|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
48390662|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
48390663|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
48390664|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
48390665|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
48390666|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
48390667|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
48390668|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
48390669|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
48390670|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
48390671|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
48390672|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
48390673|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
48390674|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
48390675|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
48390676|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
48390677|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
48390678|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48390679|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48390680|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48390681|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48390682|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48684587|NCT02737475|156697768|FG009|Overall Study|Participant withdrew consent|0|||
48684588|NCT02737475|156697769|FG010|Overall Study|Participant withdrew consent|0|||
48684589|NCT02737475|156697770|FG011|Overall Study|Participant withdrew consent|0|||
48684590|NCT02737475|156697771|FG012|Overall Study|Participant withdrew consent|0|||
48390683|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48390684|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
48390685|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
48390686|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
48390687|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
48390688|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
48390689|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
48390690|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
48390691|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
48390692|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
48390693|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
48390694|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
48390695|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
48390696|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
48390697|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48390698|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48390699|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48390700|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48390701|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
48390702|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48390703|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
48390704|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48684591|NCT02737475|156697772|FG013|Overall Study|Participant withdrew consent|0|||
48684592|NCT02737475|156697773|FG014|Overall Study|Participant withdrew consent|1|||
48684593|NCT02737475|156697774|FG015|Overall Study|Participant withdrew consent|0|||
48684594|NCT02737475|156697775|FG016|Overall Study|Participant withdrew consent|0|||
48684595|NCT02737475|156697776|FG017|Overall Study|Participant withdrew consent|2|||
48390705|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48429385|NCT01070550|155760356|FG001|Overall Study|Relapse|5|||
48684596|NCT02737475|156697777|FG018|Overall Study|Participant withdrew consent|1|||
48684597|NCT02737475|156697778|FG019|Overall Study|Participant withdrew consent|0|||
48684598|NCT02737475|156697779|FG020|Overall Study|Participant withdrew consent|2|||
48684599|NCT02737475|156697780|FG021|Overall Study|Participant withdrew consent|0|||
48684600|NCT02737475|156697781|FG022|Overall Study|Participant withdrew consent|0|||
48684601|NCT02737475|156697782|FG023|Overall Study|Participant withdrew consent|0|||
48684602|NCT02737475|156697783|FG024|Overall Study|Participant withdrew consent|0|||
48684603|NCT02737475|156697784|FG025|Overall Study|Participant withdrew consent|0|||
48684604|NCT02737475|156697785|FG026|Overall Study|Participant withdrew consent|0|||
48684605|NCT02737475|156697759|FG000|Overall Study|Lost to Follow-up|0|||
48684606|NCT02737475|156697760|FG001|Overall Study|Lost to Follow-up|0|||
48684607|NCT02737475|156697761|FG002|Overall Study|Lost to Follow-up|0|||
48684608|NCT02737475|156697762|FG003|Overall Study|Lost to Follow-up|0|||
48684609|NCT02737475|156697763|FG004|Overall Study|Lost to Follow-up|0|||
48684610|NCT02737475|156697764|FG005|Overall Study|Lost to Follow-up|0|||
48684611|NCT02737475|156697765|FG006|Overall Study|Lost to Follow-up|0|||
48684612|NCT02737475|156697766|FG007|Overall Study|Lost to Follow-up|0|||
48684613|NCT02737475|156697767|FG008|Overall Study|Lost to Follow-up|0|||
48684614|NCT02737475|156697768|FG009|Overall Study|Lost to Follow-up|0|||
48684615|NCT02737475|156697769|FG010|Overall Study|Lost to Follow-up|0|||
48684616|NCT02737475|156697770|FG011|Overall Study|Lost to Follow-up|0|||
48684617|NCT02737475|156697771|FG012|Overall Study|Lost to Follow-up|0|||
48684618|NCT02737475|156697772|FG013|Overall Study|Lost to Follow-up|0|||
48763083|NCT03642717|156982055|FG000|Overall Study|Lost to Follow-up|2|||
48763084|NCT03642717|156982055|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
48763085|NCT03642717|156982055|FG000|Overall Study|Taken study drug prior to contract date|3|||
48763086|NCT00642668|156982056|FG000|Overall Study|Lost to Follow-up|1|||
48763087|NCT00642668|156982056|FG000|Overall Study|Adverse Event|2|||
48763088|NCT00642668|156982056|FG000|Overall Study|Death|2|||
48763089|NCT00642668|156982056|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48763090|NCT00642668|156982056|FG000|Overall Study|Failure to Return|1|||
48763091|NCT00642668|156982056|FG000|Overall Study|Dialysis Initiation|5|||
48763092|NCT00642668|156982056|FG000|Overall Study|Blood Transfusion|2|||
48763093|NCT01559012|156982057|FG000|Overall Study|Withdrawal by Subject|0|||
48763094|NCT01559012|156982058|FG001|Overall Study|Withdrawal by Subject|1|||
48684619|NCT02737475|156697773|FG014|Overall Study|Lost to Follow-up|0|||
48684620|NCT02737475|156697774|FG015|Overall Study|Lost to Follow-up|1|||
48684621|NCT02737475|156697775|FG016|Overall Study|Lost to Follow-up|0|||
48684622|NCT02737475|156697776|FG017|Overall Study|Lost to Follow-up|0|||
48684623|NCT02737475|156697777|FG018|Overall Study|Lost to Follow-up|0|||
48684624|NCT02737475|156697778|FG019|Overall Study|Lost to Follow-up|0|||
48684625|NCT02737475|156697779|FG020|Overall Study|Lost to Follow-up|0|||
48684626|NCT02737475|156697780|FG021|Overall Study|Lost to Follow-up|0|||
48684627|NCT02737475|156697781|FG022|Overall Study|Lost to Follow-up|0|||
48684628|NCT02737475|156697782|FG023|Overall Study|Lost to Follow-up|0|||
48684629|NCT02737475|156697783|FG024|Overall Study|Lost to Follow-up|0|||
48684630|NCT02737475|156697784|FG025|Overall Study|Lost to Follow-up|0|||
48684631|NCT02737475|156697785|FG026|Overall Study|Lost to Follow-up|0|||
48684632|NCT02737475|156697759|FG000|Overall Study|Disease Progression|0|||
48684633|NCT02737475|156697760|FG001|Overall Study|Disease Progression|0|||
48684634|NCT02737475|156697761|FG002|Overall Study|Disease Progression|0|||
48684635|NCT02737475|156697762|FG003|Overall Study|Disease Progression|0|||
48684636|NCT02737475|156697763|FG004|Overall Study|Disease Progression|0|||
48684637|NCT02737475|156697764|FG005|Overall Study|Disease Progression|0|||
48684638|NCT02737475|156697765|FG006|Overall Study|Disease Progression|0|||
48684639|NCT02737475|156697766|FG007|Overall Study|Disease Progression|0|||
48684640|NCT02737475|156697767|FG008|Overall Study|Disease Progression|0|||
48684641|NCT02737475|156697768|FG009|Overall Study|Disease Progression|0|||
48684642|NCT02737475|156697769|FG010|Overall Study|Disease Progression|0|||
48684643|NCT02737475|156697770|FG011|Overall Study|Disease Progression|0|||
48684644|NCT02737475|156697771|FG012|Overall Study|Disease Progression|0|||
48684645|NCT02737475|156697772|FG013|Overall Study|Disease Progression|0|||
48684646|NCT02737475|156697773|FG014|Overall Study|Disease Progression|0|||
48684647|NCT02737475|156697774|FG015|Overall Study|Disease Progression|0|||
48684648|NCT02737475|156697775|FG016|Overall Study|Disease Progression|0|||
48684649|NCT02737475|156697776|FG017|Overall Study|Disease Progression|0|||
48684650|NCT02737475|156697777|FG018|Overall Study|Disease Progression|0|||
48684651|NCT02737475|156697778|FG019|Overall Study|Disease Progression|0|||
48684652|NCT02737475|156697779|FG020|Overall Study|Disease Progression|0|||
48684653|NCT02737475|156697780|FG021|Overall Study|Disease Progression|0|||
48684654|NCT02737475|156697781|FG022|Overall Study|Disease Progression|0|||
48684655|NCT02737475|156697782|FG023|Overall Study|Disease Progression|0|||
48684656|NCT02737475|156697783|FG024|Overall Study|Disease Progression|0|||
48684657|NCT02737475|156697784|FG025|Overall Study|Disease Progression|0|||
48684658|NCT02737475|156697785|FG026|Overall Study|Disease Progression|1|||
48684659|NCT02471014|156697790|FG000|Overall Study|Lost to Follow-up|2|||
48684660|NCT02471014|156697791|FG001|Overall Study|Lost to Follow-up|2|||
48684661|NCT00786799|156697792|FG000|Overall Study|Lost to Follow-up|1|||
48684662|NCT00786799|156697793|FG001|Overall Study|Lost to Follow-up|1|||
48684663|NCT00937937|156697794|FG000|Overall Study|Adverse Event|6|||
48684664|NCT00937937|156697794|FG000|Overall Study|Withdrawal by Subject|2|||
48684665|NCT00937937|156697794|FG000|Overall Study|Progression/relapse|61|||
48684666|NCT00937937|156697794|FG000|Overall Study|Death|1|||
48684667|NCT00937937|156697794|FG000|Overall Study|Other|2|||
48684668|NCT03956550|156697797|FG000|Overall Study|Sponsor decision|65|||
48684669|NCT03956550|156697798|FG001|Overall Study|Sponsor decision|66|||
48684670|NCT03956550|156697799|FG002|Overall Study|Sponsor decision|64|||
48684671|NCT03956550|156697797|FG000|Overall Study|Adverse Event|0|||
48684672|NCT03956550|156697798|FG001|Overall Study|Adverse Event|1|||
48684673|NCT03956550|156697799|FG002|Overall Study|Adverse Event|0|||
48684674|NCT03956550|156697797|FG000|Overall Study|Withdrawal by Subject|5|||
48684675|NCT03956550|156697798|FG001|Overall Study|Withdrawal by Subject|5|||
48684676|NCT03956550|156697799|FG002|Overall Study|Withdrawal by Subject|6|||
48684677|NCT00950846|156697803|FG000|Overall Study|Death|6|||
48684678|NCT00950846|156697803|FG000|Overall Study|Lost to Follow-up|3|||
48684679|NCT00950846|156697803|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
48684680|NCT02274792|156697806|FG000|Overall Study|Withdrawal by Subject|13|||
48684681|NCT02274792|156697806|FG000|Overall Study|Lost to Follow-up|8|||
48684682|NCT02274792|156697806|FG000|Overall Study|Protocol Specified Criteria|2|||
48684683|NCT02274792|156697806|FG000|Overall Study|Sponsor Decision|2|||
48684684|NCT02114606|156697809|FG000|Overall Study|Unable to swallow Cytosponge|6|||
48684685|NCT00981461|156697810|FG000|Overall Study|Lost to Follow-up|5|||
48684686|NCT00981461|156697811|FG001|Overall Study|Lost to Follow-up|2|||
48684687|NCT05192200|156697814|FG000|Treatment Period|Other|1|||
48684688|NCT05192200|156697814|FG000|Treatment Period|Lack of Efficacy|1|||
48684689|NCT05192200|156697814|FG000|Treatment Period|Withdrawal by Subject|1|||
48684690|NCT05192200|156697814|FG000|Follow-up|Withdrawal by Subject|1|||
48684691|NCT00601900|156697815|FG000|Overall Study|Withdrawal by Subject|0|||
48684692|NCT00601900|156697816|FG001|Overall Study|Withdrawal by Subject|3|||
48684693|NCT01176058|156697819|FG000|Overall Study|Adverse Event|1|||
48684694|NCT01176058|156697820|FG001|Overall Study|Adverse Event|0|||
48684695|NCT01176058|156697819|FG000|Overall Study|Insufficient clinical response|2|||
48684696|NCT01176058|156697820|FG001|Overall Study|Insufficient clinical response|2|||
48684697|NCT01176058|156697819|FG000|Overall Study|Insufficient mycological response|0|||
48684698|NCT01176058|156697820|FG001|Overall Study|Insufficient mycological response|1|||
48684699|NCT01176058|156697819|FG000|Overall Study|Withdrawal by Subject|1|||
48684700|NCT01176058|156697820|FG001|Overall Study|Withdrawal by Subject|0|||
48684701|NCT00181766|156697821|FG000|Overall Study|Lost to Follow-up|6|||
48684702|NCT00181766|156697821|FG000|Overall Study|Adverse Event|4|||
48684703|NCT00181766|156697821|FG000|Overall Study|non-compliance|2|||
48684704|NCT02079038|156697831|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
48684705|NCT02079038|156697832|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
48684706|NCT02079038|156697831|FG000|Modified Intent to Treat Population|Death|1|||
48684707|NCT02079038|156697832|FG001|Modified Intent to Treat Population|Death|0|||
48684708|NCT02079038|156697831|FG000|Completed 6 Months|Lost to Follow-up|2|||
48684709|NCT02079038|156697832|FG001|Completed 6 Months|Lost to Follow-up|1|||
48684710|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
48390706|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48390707|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
48390708|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48390709|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
48390710|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48390711|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48390712|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48390713|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
48390714|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48390715|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
48390716|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48684711|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
48684712|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
48684713|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
48684714|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
48684715|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
48684716|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
48763095|NCT01586819|156982059|FG000|Overall Study|Withdrawal by Subject|1|||
48763096|NCT01586819|156982060|FG001|Overall Study|Withdrawal by Subject|0|||
48763097|NCT00302458|156982061|FG000|Overall Study|Lost to Follow-up|1|||
48763098|NCT00302458|156982061|FG000|Overall Study|Ineligible after screening|1|||
48684717|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
48684718|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
48684719|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
48684720|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
48684721|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
48684722|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
48684723|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
48684724|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
48684725|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
48684726|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
48684727|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
48684728|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
48684729|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
48763099|NCT00302458|156982061|FG000|Overall Study|Withdrawal by Subject|1|||
48763100|NCT04248933|156982068|FG000|Overall Study|Lost to Follow-up|9|||
48763101|NCT04248933|156982068|FG000|Overall Study|Withdrawal by Subject|2|||
48763102|NCT01464346|156982081|FG000|Overall Study|Withdrawal by Subject|0|||
48763103|NCT01464346|156982082|FG001|Overall Study|Withdrawal by Subject|0|||
48763104|NCT01464346|156982083|FG002|Overall Study|Withdrawal by Subject|1|||
48763105|NCT00733746|156982084|FG000|Overall Study|Ineligible|5|||
48763106|NCT00747435|156982085|FG000|Overall Study|Lost to Follow-up|2|||
48763107|NCT00747435|156982085|FG000|Overall Study|Withdrawal by Subject|3|||
48763108|NCT00747435|156982085|FG000|Overall Study|Still undergoing follow up|1|||
48763109|NCT01712256|156982087|FG000|Overall Study|Lost to Follow-up|1|||
48763110|NCT02013167|156982088|FG000|Overall Study|Withdrawal by Subject|15|||
48763111|NCT02013167|156982089|FG001|Overall Study|Withdrawal by Subject|14|||
48763112|NCT02013167|156982088|FG000|Overall Study|Sponsor Decision|1|||
48763113|NCT02013167|156982089|FG001|Overall Study|Sponsor Decision|3|||
48390717|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48390718|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48390719|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
48763114|NCT02013167|156982088|FG000|Overall Study|Lost to Follow-up|0|||
48684730|NCT03573323|156697833|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
48684731|NCT03573323|156697834|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
48684732|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
48684733|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
48763115|NCT02013167|156982089|FG001|Overall Study|Lost to Follow-up|1|||
48763116|NCT02013167|156982088|FG000|Overall Study|Death|85|||
48763117|NCT02013167|156982089|FG001|Overall Study|Death|160|||
48684734|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
48684735|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
48684736|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
48684737|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
48763118|NCT03200899|156982090|FG000|Overall Study|Lost to Follow-up|10|||
48763119|NCT03200899|156982091|FG001|Overall Study|Lost to Follow-up|23|||
48390720|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48684738|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
48684739|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
48684740|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
48684741|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
48684742|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
48684743|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
48684744|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
48684745|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
48684746|NCT03573323|156697833|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
48684747|NCT03573323|156697834|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
48684748|NCT00972478|156697835|FG000|Overall Study|Adverse Event|3|||
48684749|NCT00972478|156697836|FG001|Overall Study|Adverse Event|16|||
48763120|NCT03465878|156982093|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
48763121|NCT03465878|156982094|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
48763122|NCT03465878|156982095|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
48763123|NCT03465878|156982096|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
48390721|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
48390722|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48390723|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48390724|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48390725|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
48390726|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48390727|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48390728|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48390729|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
48390730|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48390731|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
48390732|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48390733|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48390734|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48390735|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
48390736|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48390737|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
48390738|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48390739|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48390740|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48390741|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48429386|NCT01070550|155760357|FG002|Overall Study|Relapse|14|||
48684750|NCT00972478|156697835|FG000|Overall Study|Withdrawal by Subject|1|||
48684751|NCT00972478|156697836|FG001|Overall Study|Withdrawal by Subject|8|||
48763124|NCT03465878|156982093|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
48763125|NCT03465878|156982094|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
48763126|NCT03465878|156982095|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
48763127|NCT03465878|156982096|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
48763128|NCT03465878|156982093|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
48763129|NCT03465878|156982094|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
48684752|NCT00972478|156697835|FG000|Overall Study|Progression/Relapse|0|||
48763130|NCT03465878|156982095|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
48763131|NCT03465878|156982096|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
48763132|NCT01342510|156982097|FG000|Overall Study|Protocol Violation|12|||
48763133|NCT01342510|156982098|FG001|Overall Study|Protocol Violation|6|||
48763134|NCT01342510|156982099|FG002|Overall Study|Protocol Violation|13|||
48763135|NCT01342510|156982100|FG003|Overall Study|Protocol Violation|11|||
48763136|NCT00256698|156982103|FG000|Overall Study|Withdrawal by Subject|7|||
48763137|NCT00256698|156982104|FG001|Overall Study|Withdrawal by Subject|7|||
48763138|NCT00256698|156982103|FG000|Overall Study|Adverse Event|13|||
48763139|NCT00256698|156982104|FG001|Overall Study|Adverse Event|6|||
48763140|NCT00256698|156982103|FG000|Overall Study|Protocol Violation|6|||
48390742|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
48390743|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
48390744|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48763141|NCT00256698|156982104|FG001|Overall Study|Protocol Violation|5|||
48763142|NCT00256698|156982103|FG000|Overall Study|Lost to Follow-up|1|||
48763143|NCT00256698|156982104|FG001|Overall Study|Lost to Follow-up|3|||
48763144|NCT00256698|156982103|FG000|Overall Study|disease progression|97|||
48763145|NCT00256698|156982104|FG001|Overall Study|disease progression|105|||
48763146|NCT00256698|156982103|FG000|Overall Study|still ongoing at data cut-off|41|||
48763147|NCT00256698|156982104|FG001|Overall Study|still ongoing at data cut-off|46|||
48763148|NCT00256698|156982103|FG000|Overall Study|withdrawn due to osteoporosis|1|||
48763149|NCT00256698|156982104|FG001|Overall Study|withdrawn due to osteoporosis|0|||
48763150|NCT00256698|156982103|FG000|Overall Study|Prematurely Discontinued|1|||
48763151|NCT00256698|156982104|FG001|Overall Study|Prematurely Discontinued|0|||
48763152|NCT00316199|156982106|FG000|Overall Study|Adverse Event|2|||
48763153|NCT00316199|156982106|FG000|Overall Study|Death|8|||
48763154|NCT00316199|156982106|FG000|Overall Study|Lost to Follow-up|2|||
48763155|NCT00560950|156982107|FG000|Overall Study|Lost to Follow-up|1|||
48763156|NCT00560950|156982108|FG001|Overall Study|Lost to Follow-up|0|||
48763157|NCT01921179|156983799|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
48763158|NCT01921179|156983800|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
48763159|NCT01921179|156983799|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
48763160|NCT01921179|156983800|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
48763161|NCT02558790|156983803|FG000|Overall Study|Lost to Follow-up|2|||
48763162|NCT02558790|156983803|FG000|Overall Study|Physician Decision|1|||
48763163|NCT02558790|156983803|FG000|Overall Study|Withdrawal by Subject|1|||
48763164|NCT02558790|156983803|FG000|Overall Study|Screen Fail|3|||
48763165|NCT04475588|156983804|FG000|Overall Study|Adverse Event|2|||
48763166|NCT04475588|156983805|FG001|Overall Study|Adverse Event|0|||
48763167|NCT03662542|156983806|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
48763168|NCT03662542|156983807|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763169|NCT03662542|156983808|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763170|NCT03662542|156983809|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763171|NCT03662542|156983810|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763172|NCT03662542|156983811|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763173|NCT03662542|156983812|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763174|NCT03662542|156983813|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763175|NCT03662542|156983814|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
48763176|NCT03662542|156983806|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763177|NCT03662542|156983807|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
48763178|NCT03662542|156983808|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763179|NCT03662542|156983809|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763180|NCT03662542|156983810|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763181|NCT03662542|156983811|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763182|NCT03662542|156983812|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763183|NCT03662542|156983813|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763184|NCT03662542|156983814|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
48763185|NCT03662542|156983806|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
48763186|NCT03662542|156983807|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
48763187|NCT03662542|156983808|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
48763188|NCT03662542|156983809|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
48763189|NCT03662542|156983810|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
48763190|NCT03662542|156983811|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
48763191|NCT03662542|156983812|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
48763192|NCT03662542|156983813|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
48763193|NCT03662542|156983814|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
48763194|NCT03662542|156983806|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
48763195|NCT03662542|156983807|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763196|NCT03662542|156983808|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763197|NCT03662542|156983809|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763198|NCT03662542|156983810|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763199|NCT03662542|156983811|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763200|NCT03662542|156983812|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48390745|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48429387|NCT01070550|155760358|FG003|Overall Study|Relapse|4|||
48763201|NCT03662542|156983813|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763202|NCT03662542|156983814|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
48763203|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48763204|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48763205|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48684753|NCT00972478|156697836|FG001|Overall Study|Progression/Relapse|2|||
48684754|NCT00972478|156697835|FG000|Overall Study|Death|0|||
48684755|NCT00972478|156697836|FG001|Overall Study|Death|2|||
48684756|NCT00972478|156697835|FG000|Overall Study|Not protocol specified|1|||
48684757|NCT00972478|156697836|FG001|Overall Study|Not protocol specified|1|||
48684758|NCT00972478|156697835|FG000|Overall Study|Ineligible|1|||
48684759|NCT00972478|156697836|FG001|Overall Study|Ineligible|7|||
48684760|NCT00972478|156697835|FG000|Overall Study|Not start protocol treatment|1|||
48684761|NCT00972478|156697836|FG001|Overall Study|Not start protocol treatment|2|||
48684762|NCT01196026|156697839|FG000|Overall Study|Withdrawal by Subject|1|||
48684763|NCT01196026|156697840|FG001|Overall Study|Withdrawal by Subject|4|||
48684764|NCT01196026|156697841|FG002|Overall Study|Withdrawal by Subject|0|||
48684765|NCT01196026|156697842|FG003|Overall Study|Withdrawal by Subject|0|||
48684766|NCT01196026|156697843|FG004|Overall Study|Withdrawal by Subject|0|||
48684767|NCT01196026|156697844|FG005|Overall Study|Withdrawal by Subject|0|||
48684768|NCT01196026|156697839|FG000|Overall Study|Lost to Follow-up|0|||
48684769|NCT01196026|156697840|FG001|Overall Study|Lost to Follow-up|3|||
48684770|NCT01196026|156697841|FG002|Overall Study|Lost to Follow-up|0|||
48684771|NCT01196026|156697842|FG003|Overall Study|Lost to Follow-up|0|||
48684772|NCT01196026|156697843|FG004|Overall Study|Lost to Follow-up|1|||
48684773|NCT01196026|156697844|FG005|Overall Study|Lost to Follow-up|0|||
48684774|NCT01196026|156697839|FG000|Overall Study|Other|0|||
48684775|NCT01196026|156697840|FG001|Overall Study|Other|1|||
48684776|NCT01196026|156697841|FG002|Overall Study|Other|0|||
48684777|NCT01196026|156697842|FG003|Overall Study|Other|0|||
48684778|NCT01196026|156697843|FG004|Overall Study|Other|0|||
48684779|NCT01196026|156697844|FG005|Overall Study|Other|0|||
48684780|NCT02855268|156697845|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
48684781|NCT02855268|156697846|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
48684782|NCT02855268|156697845|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
48684783|NCT02855268|156697846|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
48684784|NCT02855268|156697845|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
48684785|NCT02855268|156697846|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
48684786|NCT02855268|156697845|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
48684787|NCT02855268|156697846|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
48684788|NCT02855268|156697845|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
48684789|NCT02855268|156697846|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
48684790|NCT02855268|156697845|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
48684791|NCT02855268|156697846|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
48684792|NCT01687296|156697847|FG000|Overall Study|Lack of Efficacy|1|||
48684793|NCT01687296|156697848|FG001|Overall Study|Lack of Efficacy|1|||
48684794|NCT01687296|156697847|FG000|Overall Study|Protocol Violation|0|||
48684795|NCT01687296|156697848|FG001|Overall Study|Protocol Violation|1|||
48684796|NCT01687296|156697847|FG000|Overall Study|Withdrawal by Subject|6|||
48684797|NCT01687296|156697848|FG001|Overall Study|Withdrawal by Subject|3|||
48684798|NCT03500640|156697854|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
48684799|NCT03500640|156697855|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
48684800|NCT03500640|156697856|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
48684801|NCT03500640|156697854|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
48684802|NCT03500640|156697855|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
48684803|NCT03500640|156697856|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
48684804|NCT03500640|156697854|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
48684805|NCT03500640|156697855|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
48684806|NCT03500640|156697856|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
48684807|NCT03500640|156697854|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
48684808|NCT03500640|156697855|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
48684809|NCT03500640|156697856|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
48390746|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48684810|NCT03500640|156697854|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
48763206|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48763207|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48684811|NCT03500640|156697855|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
48684812|NCT03500640|156697856|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
48763208|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
48684813|NCT03500640|156697854|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
48684814|NCT03500640|156697855|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
48684815|NCT03500640|156697856|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
48684816|NCT03500640|156697854|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
48684817|NCT03500640|156697855|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
48684818|NCT03500640|156697856|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
48684819|NCT03500640|156697854|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
48763209|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48684820|NCT03500640|156697855|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
48684821|NCT03500640|156697856|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
48684822|NCT03500640|156697854|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
48684823|NCT03500640|156697855|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
48684824|NCT03500640|156697856|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
48684825|NCT03500640|156697854|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
48684826|NCT03500640|156697855|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
48684827|NCT03500640|156697856|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
48684828|NCT03571204|156697857|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
48684829|NCT03571204|156697858|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
48684830|NCT03571204|156697859|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
48684831|NCT03571204|156697857|FG000|Overall Study|Physician Decision|0|||
48684832|NCT03571204|156697858|FG001|Overall Study|Physician Decision|1|||
48684833|NCT03571204|156697859|FG002|Overall Study|Physician Decision|0|||
48684834|NCT02562716|156697860|FG000|Overall Study|Adverse Event|7|||
48684835|NCT02562716|156697861|FG001|Overall Study|Adverse Event|14|||
48684836|NCT02562716|156697860|FG000|Overall Study|Withdrawal unrelated to AE|7|||
48684837|NCT02562716|156697861|FG001|Overall Study|Withdrawal unrelated to AE|1|||
48684838|NCT02562716|156697860|FG000|Overall Study|Progression|8|||
48684839|NCT02562716|156697861|FG001|Overall Study|Progression|10|||
48684840|NCT02562716|156697860|FG000|Overall Study|Death|2|||
48684841|NCT02562716|156697861|FG001|Overall Study|Death|1|||
48684842|NCT02562716|156697860|FG000|Overall Study|Not protocol specified|4|||
48684843|NCT02562716|156697861|FG001|Overall Study|Not protocol specified|2|||
48684844|NCT02491983|156697862|FG000|Overall Study|Physician Decision|1|||
48684845|NCT02491983|156697863|FG001|Overall Study|Physician Decision|0|||
48684846|NCT02491983|156697862|FG000|Overall Study|Not meet selection criteria|1|||
48684847|NCT02491983|156697863|FG001|Overall Study|Not meet selection criteria|0|||
48684848|NCT02491983|156697862|FG000|Overall Study|Withdrawal by Subject|0|||
48684849|NCT02491983|156697863|FG001|Overall Study|Withdrawal by Subject|1|||
48684850|NCT00369577|156697864|FG000|Overall Study|Withdrawal by Subject|0|||
48684851|NCT00369577|156697865|FG001|Overall Study|Withdrawal by Subject|0|||
48684852|NCT00369577|156697866|FG002|Overall Study|Withdrawal by Subject|1|||
48684853|NCT03386721|156697867|FG000|Overall Study|Death|12|||
48684854|NCT03386721|156697868|FG001|Overall Study|Death|21|||
48684855|NCT03386721|156697869|FG002|Overall Study|Death|2|||
48684856|NCT03386721|156697870|FG003|Overall Study|Death|5|||
48684857|NCT03386721|156697871|FG004|Overall Study|Death|1|||
48684858|NCT03386721|156697872|FG005|Overall Study|Death|12|||
48684859|NCT03386721|156697873|FG006|Overall Study|Death|1|||
48684860|NCT03386721|156697874|FG007|Overall Study|Death|1|||
48684861|NCT03386721|156697875|FG008|Overall Study|Death|12|||
48684862|NCT03386721|156697876|FG009|Overall Study|Death|20|||
48684863|NCT03386721|156697877|FG010|Overall Study|Death|21|||
48684864|NCT03386721|156697878|FG011|Overall Study|Death|21|||
48684865|NCT03386721|156697879|FG012|Overall Study|Death|14|||
48684866|NCT03386721|156697880|FG013|Overall Study|Death|2|||
48684867|NCT03386721|156697881|FG014|Overall Study|Death|1|||
48684868|NCT03386721|156697867|FG000|Overall Study|Lost to Follow-up|1|||
48684869|NCT03386721|156697868|FG001|Overall Study|Lost to Follow-up|3|||
48684870|NCT03386721|156697869|FG002|Overall Study|Lost to Follow-up|0|||
48684871|NCT03386721|156697870|FG003|Overall Study|Lost to Follow-up|0|||
48763210|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48390747|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48390748|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
48390749|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
48390750|NCT00111800|155625045|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48390751|NCT00111800|155625046|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48390752|NCT00111800|155625047|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48390753|NCT00111800|155625048|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48429388|NCT01070550|155760359|FG004|Overall Study|Relapse|0|||
48684872|NCT03386721|156697871|FG004|Overall Study|Lost to Follow-up|0|||
48684873|NCT03386721|156697872|FG005|Overall Study|Lost to Follow-up|2|||
48684874|NCT03386721|156697873|FG006|Overall Study|Lost to Follow-up|1|||
48684875|NCT03386721|156697874|FG007|Overall Study|Lost to Follow-up|0|||
48684876|NCT03386721|156697875|FG008|Overall Study|Lost to Follow-up|1|||
48684877|NCT03386721|156697876|FG009|Overall Study|Lost to Follow-up|2|||
48684878|NCT03386721|156697877|FG010|Overall Study|Lost to Follow-up|1|||
48684879|NCT03386721|156697878|FG011|Overall Study|Lost to Follow-up|0|||
48684880|NCT03386721|156697879|FG012|Overall Study|Lost to Follow-up|0|||
48684881|NCT03386721|156697880|FG013|Overall Study|Lost to Follow-up|0|||
48684882|NCT03386721|156697881|FG014|Overall Study|Lost to Follow-up|0|||
48684883|NCT03386721|156697867|FG000|Overall Study|Reason not specified|3|||
48684884|NCT03386721|156697868|FG001|Overall Study|Reason not specified|0|||
48684885|NCT03386721|156697869|FG002|Overall Study|Reason not specified|0|||
48684886|NCT03386721|156697870|FG003|Overall Study|Reason not specified|0|||
48684887|NCT03386721|156697871|FG004|Overall Study|Reason not specified|0|||
48684888|NCT03386721|156697872|FG005|Overall Study|Reason not specified|3|||
48684889|NCT03386721|156697873|FG006|Overall Study|Reason not specified|1|||
48684890|NCT03386721|156697874|FG007|Overall Study|Reason not specified|0|||
48684891|NCT03386721|156697875|FG008|Overall Study|Reason not specified|0|||
48684892|NCT03386721|156697876|FG009|Overall Study|Reason not specified|1|||
48684893|NCT03386721|156697877|FG010|Overall Study|Reason not specified|2|||
48684894|NCT03386721|156697878|FG011|Overall Study|Reason not specified|6|||
48684895|NCT03386721|156697879|FG012|Overall Study|Reason not specified|1|||
48684896|NCT03386721|156697880|FG013|Overall Study|Reason not specified|0|||
48684897|NCT03386721|156697881|FG014|Overall Study|Reason not specified|0|||
48684898|NCT03386721|156697867|FG000|Overall Study|Progressive Disease|0|||
48684899|NCT03386721|156697868|FG001|Overall Study|Progressive Disease|0|||
48684900|NCT03386721|156697869|FG002|Overall Study|Progressive Disease|1|||
48684901|NCT03386721|156697870|FG003|Overall Study|Progressive Disease|0|||
48684902|NCT03386721|156697871|FG004|Overall Study|Progressive Disease|0|||
48684903|NCT03386721|156697872|FG005|Overall Study|Progressive Disease|1|||
48684904|NCT03386721|156697873|FG006|Overall Study|Progressive Disease|0|||
48684905|NCT03386721|156697874|FG007|Overall Study|Progressive Disease|0|||
48684906|NCT03386721|156697875|FG008|Overall Study|Progressive Disease|2|||
48684907|NCT03386721|156697876|FG009|Overall Study|Progressive Disease|1|||
48684908|NCT03386721|156697877|FG010|Overall Study|Progressive Disease|1|||
48684909|NCT03386721|156697878|FG011|Overall Study|Progressive Disease|0|||
48684910|NCT03386721|156697879|FG012|Overall Study|Progressive Disease|1|||
48684911|NCT03386721|156697880|FG013|Overall Study|Progressive Disease|0|||
48684912|NCT03386721|156697881|FG014|Overall Study|Progressive Disease|0|||
48684913|NCT03386721|156697867|FG000|Overall Study|Site Terminated by Sponsor|5|||
48684914|NCT03386721|156697868|FG001|Overall Study|Site Terminated by Sponsor|5|||
48684915|NCT03386721|156697869|FG002|Overall Study|Site Terminated by Sponsor|0|||
48684916|NCT03386721|156697870|FG003|Overall Study|Site Terminated by Sponsor|0|||
48684917|NCT03386721|156697871|FG004|Overall Study|Site Terminated by Sponsor|1|||
48684918|NCT03386721|156697872|FG005|Overall Study|Site Terminated by Sponsor|3|||
48684919|NCT03386721|156697873|FG006|Overall Study|Site Terminated by Sponsor|0|||
48684920|NCT03386721|156697874|FG007|Overall Study|Site Terminated by Sponsor|1|||
48684921|NCT03386721|156697875|FG008|Overall Study|Site Terminated by Sponsor|4|||
48684922|NCT03386721|156697876|FG009|Overall Study|Site Terminated by Sponsor|5|||
48684923|NCT03386721|156697877|FG010|Overall Study|Site Terminated by Sponsor|3|||
48684924|NCT03386721|156697878|FG011|Overall Study|Site Terminated by Sponsor|11|||
48684925|NCT03386721|156697879|FG012|Overall Study|Site Terminated by Sponsor|6|||
48684926|NCT03386721|156697880|FG013|Overall Study|Site Terminated by Sponsor|0|||
48684927|NCT03386721|156697881|FG014|Overall Study|Site Terminated by Sponsor|0|||
48684928|NCT03386721|156697867|FG000|Overall Study|Symptomatic Deterioration|0|||
48684929|NCT03386721|156697868|FG001|Overall Study|Symptomatic Deterioration|0|||
48684930|NCT03386721|156697869|FG002|Overall Study|Symptomatic Deterioration|0|||
48684931|NCT03386721|156697870|FG003|Overall Study|Symptomatic Deterioration|0|||
48684932|NCT03386721|156697871|FG004|Overall Study|Symptomatic Deterioration|0|||
48684933|NCT03386721|156697872|FG005|Overall Study|Symptomatic Deterioration|0|||
48684934|NCT03386721|156697873|FG006|Overall Study|Symptomatic Deterioration|0|||
48684935|NCT03386721|156697874|FG007|Overall Study|Symptomatic Deterioration|0|||
48684936|NCT03386721|156697875|FG008|Overall Study|Symptomatic Deterioration|1|||
48684937|NCT03386721|156697876|FG009|Overall Study|Symptomatic Deterioration|0|||
48684938|NCT03386721|156697877|FG010|Overall Study|Symptomatic Deterioration|0|||
48684939|NCT03386721|156697878|FG011|Overall Study|Symptomatic Deterioration|1|||
48684940|NCT03386721|156697879|FG012|Overall Study|Symptomatic Deterioration|0|||
48684941|NCT03386721|156697880|FG013|Overall Study|Symptomatic Deterioration|0|||
48684942|NCT03386721|156697881|FG014|Overall Study|Symptomatic Deterioration|0|||
48684943|NCT03386721|156697867|FG000|Overall Study|Withdrawal by Subject|1|||
48684944|NCT03386721|156697868|FG001|Overall Study|Withdrawal by Subject|2|||
48684945|NCT03386721|156697869|FG002|Overall Study|Withdrawal by Subject|0|||
48390754|NCT00111800|155625049|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
48390755|NCT00111800|155625050|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
48684946|NCT03386721|156697870|FG003|Overall Study|Withdrawal by Subject|0|||
48684947|NCT03386721|156697871|FG004|Overall Study|Withdrawal by Subject|0|||
48684948|NCT03386721|156697872|FG005|Overall Study|Withdrawal by Subject|0|||
48684949|NCT03386721|156697873|FG006|Overall Study|Withdrawal by Subject|0|||
48684950|NCT03386721|156697874|FG007|Overall Study|Withdrawal by Subject|0|||
48684951|NCT03386721|156697875|FG008|Overall Study|Withdrawal by Subject|2|||
48684952|NCT03386721|156697876|FG009|Overall Study|Withdrawal by Subject|1|||
48684953|NCT03386721|156697877|FG010|Overall Study|Withdrawal by Subject|3|||
48684954|NCT03386721|156697878|FG011|Overall Study|Withdrawal by Subject|2|||
48684955|NCT03386721|156697879|FG012|Overall Study|Withdrawal by Subject|3|||
48684956|NCT03386721|156697880|FG013|Overall Study|Withdrawal by Subject|0|||
48684957|NCT03386721|156697881|FG014|Overall Study|Withdrawal by Subject|0|||
48684958|NCT03948334|156697883|FG000|Overall Study|Adverse Event|1|||
48684959|NCT03948334|156697884|FG001|Overall Study|Adverse Event|4|||
48684960|NCT03948334|156697883|FG000|Overall Study|Lack of Efficacy|2|||
48684961|NCT03948334|156697884|FG001|Overall Study|Lack of Efficacy|0|||
48684962|NCT03948334|156697883|FG000|Overall Study|Lost to Follow-up|1|||
48684963|NCT03948334|156697884|FG001|Overall Study|Lost to Follow-up|0|||
48684964|NCT03948334|156697883|FG000|Overall Study|Physician Decision|1|||
48684965|NCT03948334|156697884|FG001|Overall Study|Physician Decision|0|||
48684966|NCT03948334|156697883|FG000|Overall Study|Pregnancy|0|||
48684967|NCT03948334|156697884|FG001|Overall Study|Pregnancy|1|||
48684968|NCT03948334|156697883|FG000|Overall Study|Protocol Deviation|1|||
48684969|NCT03948334|156697884|FG001|Overall Study|Protocol Deviation|0|||
48684970|NCT03948334|156697883|FG000|Overall Study|Study terminated by Sponsor|50|||
48684971|NCT03948334|156697884|FG001|Overall Study|Study terminated by Sponsor|51|||
48684972|NCT03948334|156697883|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
48684973|NCT03948334|156697884|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
48684974|NCT01391663|156697885|FG000|Overall Study|Withdrawal by Subject|0|||
48684975|NCT01391663|156697886|FG001|Overall Study|Withdrawal by Subject|0|||
48684976|NCT01391663|156697887|FG002|Overall Study|Withdrawal by Subject|1|||
48684977|NCT01391663|156697888|FG003|Overall Study|Withdrawal by Subject|0|||
48684978|NCT02294058|156697889|FG000|Overall Study|Adverse Event|16|||
48684979|NCT02294058|156697890|FG001|Overall Study|Adverse Event|7|||
48684980|NCT02294058|156697891|FG002|Overall Study|Adverse Event|13|||
48684981|NCT02294058|156697889|FG000|Overall Study|Lack of Efficacy|3|||
48684982|NCT02294058|156697890|FG001|Overall Study|Lack of Efficacy|3|||
48684983|NCT02294058|156697891|FG002|Overall Study|Lack of Efficacy|0|||
48684984|NCT02294058|156697889|FG000|Overall Study|Lost to Follow-up|1|||
48684985|NCT02294058|156697890|FG001|Overall Study|Lost to Follow-up|0|||
48684986|NCT02294058|156697891|FG002|Overall Study|Lost to Follow-up|2|||
48684987|NCT02294058|156697889|FG000|Overall Study|Withdrawal by Subject|10|||
48684988|NCT02294058|156697890|FG001|Overall Study|Withdrawal by Subject|14|||
48684989|NCT02294058|156697891|FG002|Overall Study|Withdrawal by Subject|13|||
48684990|NCT02294058|156697889|FG000|Overall Study|Physician Decision|2|||
48684991|NCT02294058|156697890|FG001|Overall Study|Physician Decision|1|||
48684992|NCT02294058|156697891|FG002|Overall Study|Physician Decision|0|||
48684993|NCT02294058|156697889|FG000|Overall Study|Miscellaneous|4|||
48684994|NCT02294058|156697890|FG001|Overall Study|Miscellaneous|1|||
48684995|NCT02294058|156697891|FG002|Overall Study|Miscellaneous|1|||
48684996|NCT02728089|156697892|FG000|Overall Study|Physician Decision|2|||
48684997|NCT02728089|156697892|FG000|Overall Study|Withdrawal by Subject|1|||
48684998|NCT00782717|156697894|FG000|Overall Study|Adverse Event|2|||
48684999|NCT00782717|156697895|FG001|Overall Study|Adverse Event|5|||
48685000|NCT00782717|156697894|FG000|Overall Study|Patient decision unrelated to AE|6|||
48685001|NCT00782717|156697895|FG001|Overall Study|Patient decision unrelated to AE|3|||
48685002|NCT00782717|156697894|FG000|Overall Study|Noncompliance|2|||
48685003|NCT00782717|156697895|FG001|Overall Study|Noncompliance|1|||
48685004|NCT00782717|156697894|FG000|Overall Study|Treatment failure|3|||
48685005|NCT00782717|156697895|FG001|Overall Study|Treatment failure|14|||
48685006|NCT00782717|156697894|FG000|Overall Study|Enrollment close prior to surgery|1|||
48685007|NCT00782717|156697895|FG001|Overall Study|Enrollment close prior to surgery|0|||
48685008|NCT00782717|156697894|FG000|Overall Study|Did not meet entrance criteria|1|||
48685009|NCT00782717|156697895|FG001|Overall Study|Did not meet entrance criteria|3|||
48685010|NCT00782717|156697894|FG000|Overall Study|Exited in error|0|||
48685011|NCT00782717|156697895|FG001|Overall Study|Exited in error|2|||
48685012|NCT00607087|156697896|FG000|Overall Study|Withdrawal by Subject|9|||
48685013|NCT00607087|156697897|FG001|Overall Study|Withdrawal by Subject|4|||
48685014|NCT00607087|156697898|FG002|Overall Study|Withdrawal by Subject|4|||
48685015|NCT00607087|156697896|FG000|Overall Study|Adverse Event|3|||
48685016|NCT00607087|156697897|FG001|Overall Study|Adverse Event|2|||
48685017|NCT00607087|156697898|FG002|Overall Study|Adverse Event|3|||
48685018|NCT00607087|156697896|FG000|Overall Study|Other reason|1|||
48685019|NCT00607087|156697897|FG001|Overall Study|Other reason|5|||
48685020|NCT00607087|156697898|FG002|Overall Study|Other reason|2|||
48685021|NCT00607087|156697896|FG000|Overall Study|Poor compliance to protocol|1|||
48685022|NCT00607087|156697897|FG001|Overall Study|Poor compliance to protocol|0|||
48685023|NCT00607087|156697898|FG002|Overall Study|Poor compliance to protocol|1|||
48685024|NCT00607087|156697896|FG000|Overall Study|Lost to Follow-up|1|||
48685025|NCT00607087|156697897|FG001|Overall Study|Lost to Follow-up|0|||
48685026|NCT00607087|156697898|FG002|Overall Study|Lost to Follow-up|0|||
48685027|NCT00607087|156697896|FG000|Period 1|Withdrawal by Subject|7|||
48685028|NCT00607087|156697897|FG001|Period 1|Withdrawal by Subject|2|||
48685029|NCT00607087|156697898|FG002|Period 1|Withdrawal by Subject|3|||
48685030|NCT00607087|156697896|FG000|Period 1|Adverse Event|3|||
48685031|NCT00607087|156697897|FG001|Period 1|Adverse Event|0|||
48685032|NCT00607087|156697898|FG002|Period 1|Adverse Event|0|||
48685033|NCT00607087|156697896|FG000|Period 1|Poor compliance to protocol|1|||
48685034|NCT00607087|156697897|FG001|Period 1|Poor compliance to protocol|0|||
48685035|NCT00607087|156697898|FG002|Period 1|Poor compliance to protocol|0|||
48685036|NCT00607087|156697896|FG000|Period 1|Lost to Follow-up|1|||
48685037|NCT00607087|156697897|FG001|Period 1|Lost to Follow-up|0|||
48685038|NCT00607087|156697898|FG002|Period 1|Lost to Follow-up|0|||
48685039|NCT00607087|156697896|FG000|Period 1|Other reason|0|||
48685040|NCT00607087|156697897|FG001|Period 1|Other reason|4|||
48685041|NCT00607087|156697898|FG002|Period 1|Other reason|2|||
48685042|NCT00607087|156697896|FG000|Period 2|Withdrawal by Subject|0|||
48685043|NCT00607087|156697897|FG001|Period 2|Withdrawal by Subject|1|||
48685044|NCT00607087|156697898|FG002|Period 2|Withdrawal by Subject|1|||
48685045|NCT00607087|156697896|FG000|Period 2|Other reason|1|||
48685046|NCT00607087|156697897|FG001|Period 2|Other reason|1|||
48685047|NCT00607087|156697898|FG002|Period 2|Other reason|0|||
48685048|NCT00607087|156697896|FG000|Period 2|Adverse Event|0|||
48685049|NCT00607087|156697897|FG001|Period 2|Adverse Event|1|||
48685050|NCT00607087|156697898|FG002|Period 2|Adverse Event|3|||
48685051|NCT00607087|156697896|FG000|Period 2|Poor compliance to protocol|0|||
48685052|NCT00607087|156697897|FG001|Period 2|Poor compliance to protocol|0|||
48685053|NCT00607087|156697898|FG002|Period 2|Poor compliance to protocol|1|||
48685054|NCT00607087|156697896|FG000|Period 3|Withdrawal by Subject|2|||
48685055|NCT00607087|156697897|FG001|Period 3|Withdrawal by Subject|1|||
48685056|NCT00607087|156697898|FG002|Period 3|Withdrawal by Subject|0|||
48685057|NCT00607087|156697896|FG000|Period 3|Adverse Event|0|||
48685058|NCT00607087|156697897|FG001|Period 3|Adverse Event|1|||
48685059|NCT00607087|156697898|FG002|Period 3|Adverse Event|0|||
48685060|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
48685061|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
48685062|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
48685063|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
48685064|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
48685065|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
48685066|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
48685067|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
48685068|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
48685069|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
48685070|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
48685071|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
48685072|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
48685073|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
48685074|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
48685075|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
48685076|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
48685077|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
48685078|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
48685079|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
48685080|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
48685081|NCT00550407|156697899|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
48685082|NCT00550407|156697900|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
48685083|NCT00550407|156697901|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
48685084|NCT00550407|156697899|FG000|26-Week Randomized Phase|Adverse Event|0|||
48685085|NCT00550407|156697900|FG001|26-Week Randomized Phase|Adverse Event|5|||
48685086|NCT00550407|156697901|FG002|26-Week Randomized Phase|Adverse Event|2|||
48685087|NCT00550407|156697899|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
48685088|NCT00550407|156697900|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
48685089|NCT00550407|156697901|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
48685090|NCT00550407|156697899|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
48685091|NCT00550407|156697900|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
48685092|NCT00550407|156697901|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
48685093|NCT00550407|156697899|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
48685094|NCT00550407|156697900|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
48685095|NCT00550407|156697901|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
48685096|NCT02487095|156697904|FG000|Dose Expansion|Unable to scan/restage participant|0|||
48685097|NCT02487095|156697905|FG001|Dose Expansion|Unable to scan/restage participant|0|||
48685098|NCT02487095|156697906|FG002|Dose Expansion|Unable to scan/restage participant|0|||
48685099|NCT02487095|156697907|FG003|Dose Expansion|Unable to scan/restage participant|0|||
48685100|NCT02487095|156697908|FG004|Dose Expansion|Unable to scan/restage participant|1|||
48685101|NCT03201419|156697925|FG000|Overall Study|Adverse Event|3|||
48685102|NCT03201419|156697926|FG001|Overall Study|Adverse Event|1|||
48685103|NCT03201419|156697927|FG002|Overall Study|Adverse Event|0|||
48685104|NCT03201419|156697928|FG003|Overall Study|Adverse Event|0|||
48685105|NCT03201419|156697929|FG004|Overall Study|Adverse Event|1|||
48685106|NCT03201419|156697930|FG005|Overall Study|Adverse Event|1|||
48685107|NCT03201419|156697931|FG006|Overall Study|Adverse Event|5|||
48685108|NCT03201419|156697932|FG007|Overall Study|Adverse Event|0|||
48685109|NCT03201419|156697933|FG008|Overall Study|Adverse Event|0|||
48685110|NCT03201419|156697925|FG000|Overall Study|Lost to Follow-up|1|||
48685111|NCT03201419|156697926|FG001|Overall Study|Lost to Follow-up|0|||
48685112|NCT03201419|156697927|FG002|Overall Study|Lost to Follow-up|0|||
48685113|NCT03201419|156697928|FG003|Overall Study|Lost to Follow-up|0|||
48685114|NCT03201419|156697929|FG004|Overall Study|Lost to Follow-up|0|||
48685115|NCT03201419|156697930|FG005|Overall Study|Lost to Follow-up|0|||
48390756|NCT00111800|155625045|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
48390757|NCT00111800|155625046|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
48390758|NCT00111800|155625047|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
48390759|NCT00111800|155625048|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
48685116|NCT03201419|156697931|FG006|Overall Study|Lost to Follow-up|0|||
48685117|NCT03201419|156697932|FG007|Overall Study|Lost to Follow-up|0|||
48685118|NCT03201419|156697933|FG008|Overall Study|Lost to Follow-up|0|||
48685119|NCT03201419|156697925|FG000|Overall Study|Protocol Deviation|0|||
48685120|NCT03201419|156697926|FG001|Overall Study|Protocol Deviation|0|||
48685121|NCT03201419|156697927|FG002|Overall Study|Protocol Deviation|0|||
48685122|NCT03201419|156697928|FG003|Overall Study|Protocol Deviation|0|||
48685123|NCT03201419|156697929|FG004|Overall Study|Protocol Deviation|0|||
48685124|NCT03201419|156697930|FG005|Overall Study|Protocol Deviation|0|||
48685125|NCT03201419|156697931|FG006|Overall Study|Protocol Deviation|1|||
48685126|NCT03201419|156697932|FG007|Overall Study|Protocol Deviation|0|||
48685127|NCT03201419|156697933|FG008|Overall Study|Protocol Deviation|0|||
48685128|NCT03201419|156697925|FG000|Overall Study|Withdrawal by Subject|4|||
48685129|NCT03201419|156697926|FG001|Overall Study|Withdrawal by Subject|2|||
48685130|NCT03201419|156697927|FG002|Overall Study|Withdrawal by Subject|1|||
48685131|NCT03201419|156697928|FG003|Overall Study|Withdrawal by Subject|0|||
48685132|NCT03201419|156697929|FG004|Overall Study|Withdrawal by Subject|0|||
48685133|NCT03201419|156697930|FG005|Overall Study|Withdrawal by Subject|0|||
48685134|NCT03201419|156697931|FG006|Overall Study|Withdrawal by Subject|0|||
48685135|NCT03201419|156697932|FG007|Overall Study|Withdrawal by Subject|1|||
48685136|NCT03201419|156697933|FG008|Overall Study|Withdrawal by Subject|2|||
48685137|NCT03201419|156697925|FG000|Overall Study|Other|0|||
48685138|NCT03201419|156697926|FG001|Overall Study|Other|0|||
48685139|NCT03201419|156697927|FG002|Overall Study|Other|1|||
48685140|NCT03201419|156697928|FG003|Overall Study|Other|0|||
48685141|NCT03201419|156697929|FG004|Overall Study|Other|0|||
48685142|NCT03201419|156697930|FG005|Overall Study|Other|0|||
48685143|NCT03201419|156697931|FG006|Overall Study|Other|0|||
48685144|NCT03201419|156697932|FG007|Overall Study|Other|0|||
48685145|NCT03201419|156697933|FG008|Overall Study|Other|0|||
48685146|NCT04842500|156699138|FG000|Overall Study|Withdrawal by Subject|4|||
48685147|NCT04842500|156699139|FG001|Overall Study|Withdrawal by Subject|1|||
48685148|NCT04842500|156699140|FG002|Overall Study|Withdrawal by Subject|2|||
48685149|NCT04842500|156699141|FG003|Overall Study|Withdrawal by Subject|3|||
48685150|NCT04842500|156699138|FG000|Overall Study|Protocol Violation|1|||
48685151|NCT04842500|156699139|FG001|Overall Study|Protocol Violation|0|||
48685152|NCT04842500|156699140|FG002|Overall Study|Protocol Violation|0|||
48685153|NCT04842500|156699141|FG003|Overall Study|Protocol Violation|1|||
48685154|NCT03038126|156699142|FG000|Overall Study|Death|1|||
48685155|NCT03038126|156699143|FG001|Overall Study|Death|1|||
48685156|NCT03038126|156699142|FG000|Overall Study|Withdrawal by Subject|5|||
48685157|NCT03038126|156699143|FG001|Overall Study|Withdrawal by Subject|0|||
48685158|NCT03038126|156699142|FG000|Overall Study|Lost to Follow-up|0|||
48685159|NCT03038126|156699143|FG001|Overall Study|Lost to Follow-up|1|||
48685160|NCT03038126|156699142|FG000|Overall Study|Long Term Hospitalization|2|||
48685161|NCT03038126|156699143|FG001|Overall Study|Long Term Hospitalization|0|||
48685162|NCT03038126|156699142|FG000|Overall Study|Too Ill to Participate|1|||
48685163|NCT03038126|156699143|FG001|Overall Study|Too Ill to Participate|2|||
48685164|NCT02610777|156699144|FG000|Overall Study|Lost to Follow-up|1|||
48685165|NCT02610777|156699145|FG001|Overall Study|Lost to Follow-up|0|||
48685166|NCT02610777|156699144|FG000|Overall Study|Site Terminated by Sponsor|9|||
48685167|NCT02610777|156699145|FG001|Overall Study|Site Terminated by Sponsor|8|||
48685168|NCT02610777|156699144|FG000|Overall Study|Withdrawal by Subject|2|||
48685169|NCT02610777|156699145|FG001|Overall Study|Withdrawal by Subject|2|||
48390760|NCT00111800|155625049|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
48390761|NCT00111800|155625050|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
48685170|NCT02610777|156699144|FG000|Overall Study|Reason not Specified|0|||
48685171|NCT02610777|156699145|FG001|Overall Study|Reason not Specified|1|||
48685172|NCT02610777|156699144|FG000|Overall Study|Death|50|||
48685173|NCT02610777|156699145|FG001|Overall Study|Death|47|||
48685174|NCT01362608|156699151|FG000|Overall Study|Protocol Violation|0|||
48685175|NCT01362608|156699152|FG001|Overall Study|Protocol Violation|1|||
48685176|NCT01362608|156699151|FG000|Overall Study|Lost to Follow-up|3|||
48685177|NCT01362608|156699152|FG001|Overall Study|Lost to Follow-up|1|||
48685178|NCT01362608|156699151|FG000|Overall Study|Withdrawal by Subject|1|||
48685179|NCT01362608|156699152|FG001|Overall Study|Withdrawal by Subject|2|||
48685180|NCT01362608|156699151|FG000|Overall Study|Lack of Efficacy|0|||
48685181|NCT01362608|156699152|FG001|Overall Study|Lack of Efficacy|2|||
48685182|NCT01362608|156699151|FG000|Overall Study|Adverse Event|0|||
48685183|NCT01362608|156699152|FG001|Overall Study|Adverse Event|2|||
48685184|NCT01395901|156699154|FG000|Overall Study|Lost to Follow-up|4|||
48685185|NCT01395901|156699155|FG001|Overall Study|Lost to Follow-up|0|||
48685186|NCT01395901|156699154|FG000|Overall Study|Randomized but not received study drug|5|||
48685187|NCT01395901|156699155|FG001|Overall Study|Randomized but not received study drug|4|||
48685188|NCT01395901|156699154|FG000|Overall Study|Adverse Event|0|||
48685189|NCT01395901|156699155|FG001|Overall Study|Adverse Event|1|||
48685190|NCT01395901|156699154|FG000|Overall Study|Withdrawal of consent|1|||
48685191|NCT01395901|156699155|FG001|Overall Study|Withdrawal of consent|0|||
48685192|NCT01380769|156699156|FG000|Overall Study|Withdrawal by Subject|7|||
48685193|NCT01380769|156699157|FG001|Overall Study|Withdrawal by Subject|11|||
48685194|NCT01380769|156699156|FG000|Overall Study|Physician Decision|1|||
48685195|NCT01380769|156699157|FG001|Overall Study|Physician Decision|1|||
48685196|NCT01380769|156699156|FG000|Overall Study|Adverse Event|1|||
48685197|NCT01380769|156699157|FG001|Overall Study|Adverse Event|1|||
48685198|NCT01380769|156699156|FG000|Overall Study|Protocol Violation|0|||
48390762|NCT00111800|155625045|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
48685199|NCT01380769|156699157|FG001|Overall Study|Protocol Violation|1|||
48685200|NCT04337372|156699158|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
48685201|NCT04337372|156699159|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
48685202|NCT04337372|156699160|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
48685203|NCT04337372|156699161|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
48685204|NCT04337372|156699158|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
48685205|NCT04337372|156699159|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
48685206|NCT04337372|156699160|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
48685207|NCT04337372|156699161|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
48685208|NCT04337372|156699158|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
48685209|NCT04337372|156699159|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
48685210|NCT04337372|156699160|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
48685211|NCT04337372|156699161|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
48685212|NCT04337372|156699158|FG000|Day 2: EEG Measures|Protocol Violation|6|||
48685213|NCT04337372|156699159|FG001|Day 2: EEG Measures|Protocol Violation|6|||
48685214|NCT04337372|156699160|FG002|Day 2: EEG Measures|Protocol Violation|5|||
48685215|NCT04337372|156699161|FG003|Day 2: EEG Measures|Protocol Violation|17|||
48685244|NCT02201108|156699164|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
48685245|NCT02201108|156699165|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
48685246|NCT02201108|156699166|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
48685247|NCT02201108|156699164|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
48685248|NCT02201108|156699165|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
48685249|NCT02201108|156699166|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
48685250|NCT02201108|156699164|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
48685251|NCT02201108|156699165|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
48685252|NCT02201108|156699166|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
48685253|NCT02201108|156699164|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
48685254|NCT02201108|156699165|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
48390763|NCT00111800|155625046|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
48685255|NCT02201108|156699166|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
48685256|NCT02201108|156699164|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
48685257|NCT02201108|156699165|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
48685258|NCT02201108|156699166|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
48685259|NCT02201108|156699164|FG000|Open Label Period (up to Week 192)|Other reason|4|||
48685260|NCT02201108|156699165|FG001|Open Label Period (up to Week 192)|Other reason|7|||
48685261|NCT02201108|156699166|FG002|Open Label Period (up to Week 192)|Other reason|0|||
48685262|NCT02201108|156699164|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
48685263|NCT02201108|156699165|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
48685264|NCT02201108|156699166|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
48685265|NCT02201108|156699164|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
48685266|NCT02201108|156699165|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
48685267|NCT02201108|156699166|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
48685268|NCT02201108|156699164|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
48685269|NCT02201108|156699165|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
48685270|NCT02201108|156699166|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
48685271|NCT04205812|156699167|FG000|Randomized Treatment Period|Ongoing|28|||
48685272|NCT04205812|156699168|FG001|Randomized Treatment Period|Ongoing|138|||
48390764|NCT00111800|155625047|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
48390765|NCT00111800|155625048|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
48390766|NCT00111800|155625049|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
48390767|NCT00111800|155625050|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
48390768|NCT00111800|155625045|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
48390769|NCT00111800|155625046|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
48390770|NCT00111800|155625047|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
48390771|NCT00111800|155625048|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
48390772|NCT00111800|155625049|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
48390773|NCT00111800|155625050|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
48390774|NCT00111800|155625045|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
48390775|NCT00111800|155625046|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
48390776|NCT00111800|155625047|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
48390777|NCT00111800|155625048|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
48390778|NCT00111800|155625049|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
48390779|NCT00111800|155625050|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
48390780|NCT00111800|155625045|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48390781|NCT00111800|155625046|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48390782|NCT00111800|155625047|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
48390783|NCT00111800|155625048|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48390784|NCT00111800|155625049|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48390785|NCT00111800|155625050|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
48390786|NCT00111800|155625045|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48390787|NCT00111800|155625046|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
48390788|NCT00111800|155625047|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48390789|NCT00111800|155625048|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48390790|NCT00111800|155625049|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48390791|NCT00111800|155625050|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
48390792|NCT00111800|155625045|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48390793|NCT00111800|155625046|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48390794|NCT00111800|155625047|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
48390795|NCT00111800|155625048|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48685273|NCT04205812|156699167|FG000|Randomized Treatment Period|Death|94|||
48685274|NCT04205812|156699168|FG001|Randomized Treatment Period|Death|226|||
48685275|NCT04205812|156699167|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
48685276|NCT04205812|156699168|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
48685277|NCT04205812|156699167|FG000|Randomized Treatment Period|Physician Decision|1|||
48390796|NCT00111800|155625049|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48390797|NCT00111800|155625050|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
48390798|NCT00111800|155625045|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48390799|NCT00111800|155625046|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48390800|NCT00111800|155625047|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
48390801|NCT00111800|155625048|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48763211|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
48763212|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763213|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48390802|NCT00111800|155625049|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48390803|NCT00111800|155625050|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
48390804|NCT00253643|155625051|FG000|Overall Study|Withdrawal by Subject|0|||
48390805|NCT00253643|155625052|FG001|Overall Study|Withdrawal by Subject|0|||
48390806|NCT00253643|155625053|FG002|Overall Study|Withdrawal by Subject|1|||
48390807|NCT00253643|155625054|FG003|Overall Study|Withdrawal by Subject|1|||
48390808|NCT00253643|155625051|FG000|Overall Study|Non-Compliance|0|||
48390809|NCT00253643|155625052|FG001|Overall Study|Non-Compliance|0|||
48390810|NCT00253643|155625053|FG002|Overall Study|Non-Compliance|0|||
48390811|NCT00253643|155625054|FG003|Overall Study|Non-Compliance|2|||
48390812|NCT02256540|155625059|FG000|Overall Study|Withdrawal by Subject|0|||
48390813|NCT02256540|155625060|FG001|Overall Study|Withdrawal by Subject|1|||
48390814|NCT02256540|155625061|FG002|Overall Study|Withdrawal by Subject|1|||
48390815|NCT02256540|155625059|FG000|Overall Study|Back pain preventing exercise|0|||
48390816|NCT02256540|155625060|FG001|Overall Study|Back pain preventing exercise|0|||
48685278|NCT04205812|156699168|FG001|Randomized Treatment Period|Physician Decision|4|||
48685279|NCT04205812|156699167|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
48685280|NCT04205812|156699168|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
48685281|NCT04205812|156699167|FG000|Randomized Treatment Period|Progressive Disease|0|||
48685282|NCT04205812|156699168|FG001|Randomized Treatment Period|Progressive Disease|1|||
48685283|NCT04205812|156699167|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
48685284|NCT04205812|156699168|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
48685285|NCT04205812|156699167|FG000|Monotherapy Treatment Period|Ongoing|17|||
48685286|NCT04205812|156699168|FG001|Monotherapy Treatment Period|Ongoing|0|||
48685287|NCT04205812|156699167|FG000|Monotherapy Treatment Period|Death|39|||
48685288|NCT04205812|156699168|FG001|Monotherapy Treatment Period|Death|0|||
48685289|NCT04205812|156699167|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
48685290|NCT04205812|156699168|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
48685291|NCT04205812|156699167|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
48685292|NCT04205812|156699168|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
48685293|NCT00413218|156699172|FG000|Overall Study|Randomized but didn't receive study drug|2|||
48685294|NCT00413218|156699173|FG001|Overall Study|Randomized but didn't receive study drug|8|||
48685295|NCT00413218|156699172|FG000|Overall Study|Death|57|||
48685296|NCT00413218|156699173|FG001|Overall Study|Death|56|||
48685297|NCT00413218|156699172|FG000|Overall Study|Lost to Follow-up|14|||
48685298|NCT00413218|156699173|FG001|Overall Study|Lost to Follow-up|17|||
48685299|NCT00413218|156699172|FG000|Overall Study|Admin|20|||
48685300|NCT00413218|156699173|FG001|Overall Study|Admin|14|||
48685301|NCT00413218|156699172|FG000|Overall Study|Missing|1|||
48685302|NCT00413218|156699173|FG001|Overall Study|Missing|0|||
48685303|NCT00413218|156699172|FG000|Overall Study|Withdrawal by Subject|9|||
48685304|NCT00413218|156699173|FG001|Overall Study|Withdrawal by Subject|1|||
48763214|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763215|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
48763216|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
48390817|NCT02256540|155625061|FG002|Overall Study|Back pain preventing exercise|1|||
48390818|NCT00365456|155625062|FG000|Trial Period I (12 Months)|Adverse Event|84|||
48685305|NCT01824875|156699174|FG000|Overall Study|Disease progression|22|||
48685306|NCT01824875|156699175|FG001|Overall Study|Disease progression|15|||
48685307|NCT01824875|156699174|FG000|Overall Study|Withdrawal by Subject|5|||
48685308|NCT01824875|156699175|FG001|Overall Study|Withdrawal by Subject|4|||
48685309|NCT01824875|156699174|FG000|Overall Study|Adverse Event|4|||
48763217|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763218|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48685310|NCT01824875|156699175|FG001|Overall Study|Adverse Event|10|||
48685311|NCT01824875|156699174|FG000|Overall Study|Alternative therapy|3|||
48685312|NCT01824875|156699175|FG001|Overall Study|Alternative therapy|0|||
48685313|NCT01824875|156699174|FG000|Overall Study|Complicating disease|1|||
48685314|NCT01824875|156699175|FG001|Overall Study|Complicating disease|0|||
48685315|NCT01824875|156699174|FG000|Overall Study|Physician Decision|0|||
48685316|NCT01824875|156699175|FG001|Overall Study|Physician Decision|1|||
48685317|NCT01824875|156699174|FG000|Overall Study|Non-compliance|1|||
48685318|NCT01824875|156699175|FG001|Overall Study|Non-compliance|1|||
48685319|NCT01824875|156699174|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
48685320|NCT01824875|156699175|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
48390819|NCT00365456|155625063|FG001|Trial Period I (12 Months)|Adverse Event|0|||
48390820|NCT00365456|155625062|FG000|Trial Period I (12 Months)|Non-compliance|3|||
48390821|NCT00365456|155625063|FG001|Trial Period I (12 Months)|Non-compliance|0|||
48390822|NCT00365456|155625062|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
48390823|NCT00365456|155625063|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
48390824|NCT00365456|155625062|FG000|Trial Period I (12 Months)|Other|11|||
48390825|NCT00365456|155625063|FG001|Trial Period I (12 Months)|Other|0|||
48390826|NCT00365456|155625062|FG000|Trial Period II (12 Months)|Adverse Event|0|||
48390827|NCT00365456|155625063|FG001|Trial Period II (12 Months)|Adverse Event|6|||
48390828|NCT00365456|155625062|FG000|Trial Period II (12 Months)|Non-compliance|0|||
48390829|NCT00365456|155625063|FG001|Trial Period II (12 Months)|Non-compliance|2|||
48390830|NCT00365456|155625062|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
48390831|NCT00365456|155625063|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
48390832|NCT00365456|155625062|FG000|Trial Period II (12 Months)|Other|0|||
48390833|NCT00365456|155625063|FG001|Trial Period II (12 Months)|Other|1|||
48390834|NCT00365456|155625062|FG000|Trial Period III (12 Months)|Adverse Event|13|||
48390835|NCT00365456|155625063|FG001|Trial Period III (12 Months)|Adverse Event|3|||
48390836|NCT00365456|155625062|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
48390837|NCT00365456|155625063|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
48390838|NCT00365456|155625062|FG000|Trial Period III (12 Months)|Other|1|||
48390839|NCT00365456|155625063|FG001|Trial Period III (12 Months)|Other|1|||
48390840|NCT03668600|155625064|FG000|Overall Study|Study Terminated by the Sponsor|157|||
48390841|NCT03668600|155625064|FG000|Overall Study|Protocol Violation|1|||
48390842|NCT03668600|155625064|FG000|Overall Study|Pregnancy|1|||
48390843|NCT03668600|155625064|FG000|Overall Study|Lost to Follow-up|7|||
48390844|NCT03668600|155625064|FG000|Overall Study|Withdrawal by Subject|56|||
48390845|NCT03668600|155625064|FG000|Overall Study|Lack of Efficacy|7|||
48390846|NCT03668600|155625064|FG000|Overall Study|Adverse Event|1|||
48390847|NCT01438489|155625067|FG000|Overall Study|Lost to Follow-up|4|||
48390848|NCT01438489|155625068|FG001|Overall Study|Lost to Follow-up|2|||
48390849|NCT01438489|155625069|FG002|Overall Study|Lost to Follow-up|2|||
48390850|NCT01438489|155625067|FG000|Overall Study|Withdrawal by Subject|11|||
48390851|NCT01438489|155625068|FG001|Overall Study|Withdrawal by Subject|3|||
48390852|NCT01438489|155625069|FG002|Overall Study|Withdrawal by Subject|8|||
48390853|NCT01438489|155625067|FG000|Overall Study|Death|0|||
48685321|NCT01824875|156699174|FG000|Overall Study|Administrative issues|0|||
48685322|NCT01824875|156699175|FG001|Overall Study|Administrative issues|2|||
48685323|NCT01824875|156699174|FG000|Overall Study|Ineligible or never started treatment|9|||
48685324|NCT01824875|156699175|FG001|Overall Study|Ineligible or never started treatment|5|||
48685325|NCT01824875|156699174|FG000|Overall Study|Other|0|||
48763219|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763220|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
48763221|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48763222|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48390854|NCT01438489|155625068|FG001|Overall Study|Death|0|||
48390855|NCT01438489|155625069|FG002|Overall Study|Death|1|||
48390856|NCT01438489|155625067|FG000|Overall Study|Sponsor decision|4|||
48390857|NCT01438489|155625068|FG001|Overall Study|Sponsor decision|1|||
48390858|NCT01438489|155625069|FG002|Overall Study|Sponsor decision|4|||
48390859|NCT01438489|155625067|FG000|Overall Study|Subject choice/Subject moved|2|||
48390860|NCT01438489|155625068|FG001|Overall Study|Subject choice/Subject moved|1|||
48390861|NCT01438489|155625069|FG002|Overall Study|Subject choice/Subject moved|1|||
48390862|NCT01438489|155625067|FG000|Overall Study|Investigator decision|0|||
48390863|NCT01438489|155625068|FG001|Overall Study|Investigator decision|1|||
48390864|NCT01438489|155625069|FG002|Overall Study|Investigator decision|0|||
48390865|NCT01438489|155625067|FG000|Overall Study|AE/SAEs|2|||
48390866|NCT01438489|155625068|FG001|Overall Study|AE/SAEs|1|||
48685326|NCT01824875|156699175|FG001|Overall Study|Other|2|||
48685327|NCT04810650|156699176|FG000|Overall Study|Disenrolled in error|0|||
48685328|NCT04810650|156699177|FG001|Overall Study|Disenrolled in error|0|||
48685329|NCT04810650|156699178|FG002|Overall Study|Disenrolled in error|0|||
48763223|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48685330|NCT04810650|156699179|FG003|Overall Study|Disenrolled in error|0|||
48685331|NCT04810650|156699180|FG004|Overall Study|Disenrolled in error|0|||
48685332|NCT04810650|156699181|FG005|Overall Study|Disenrolled in error|0|||
48685333|NCT04810650|156699182|FG006|Overall Study|Disenrolled in error|0|||
48685334|NCT04810650|156699183|FG007|Overall Study|Disenrolled in error|0|||
48685335|NCT04810650|156699184|FG008|Overall Study|Disenrolled in error|1|||
48685336|NCT04810650|156699185|FG009|Overall Study|Disenrolled in error|0|||
48685337|NCT04810650|156699186|FG010|Overall Study|Disenrolled in error|0|||
48685338|NCT04810650|156699187|FG011|Overall Study|Disenrolled in error|0|||
48685339|NCT04810650|156699188|FG012|Overall Study|Disenrolled in error|0|||
48685340|NCT04810650|156699189|FG013|Overall Study|Disenrolled in error|0|||
48685341|NCT04810650|156699176|FG000|Overall Study|Death|0|||
48685342|NCT04810650|156699177|FG001|Overall Study|Death|0|||
48685343|NCT04810650|156699178|FG002|Overall Study|Death|0|||
48685344|NCT04810650|156699179|FG003|Overall Study|Death|0|||
48685345|NCT04810650|156699180|FG004|Overall Study|Death|0|||
48685346|NCT04810650|156699181|FG005|Overall Study|Death|0|||
48685347|NCT04810650|156699182|FG006|Overall Study|Death|2|||
48685348|NCT04810650|156699183|FG007|Overall Study|Death|2|||
48685349|NCT04810650|156699184|FG008|Overall Study|Death|0|||
48685350|NCT04810650|156699185|FG009|Overall Study|Death|1|||
48685351|NCT04810650|156699186|FG010|Overall Study|Death|0|||
48685352|NCT04810650|156699187|FG011|Overall Study|Death|0|||
48685353|NCT04810650|156699188|FG012|Overall Study|Death|2|||
48685354|NCT04810650|156699189|FG013|Overall Study|Death|1|||
48685355|NCT04810650|156699176|FG000|Overall Study|Moved/transferred care|0|||
48685356|NCT04810650|156699177|FG001|Overall Study|Moved/transferred care|0|||
48685357|NCT04810650|156699178|FG002|Overall Study|Moved/transferred care|0|||
48685358|NCT04810650|156699179|FG003|Overall Study|Moved/transferred care|0|||
48685359|NCT04810650|156699180|FG004|Overall Study|Moved/transferred care|0|||
48685360|NCT04810650|156699181|FG005|Overall Study|Moved/transferred care|0|||
48685361|NCT04810650|156699182|FG006|Overall Study|Moved/transferred care|0|||
48685362|NCT04810650|156699183|FG007|Overall Study|Moved/transferred care|1|||
48685363|NCT04810650|156699184|FG008|Overall Study|Moved/transferred care|12|||
48685364|NCT04810650|156699185|FG009|Overall Study|Moved/transferred care|10|||
48685365|NCT04810650|156699186|FG010|Overall Study|Moved/transferred care|0|||
48685366|NCT04810650|156699187|FG011|Overall Study|Moved/transferred care|0|||
48685367|NCT04810650|156699188|FG012|Overall Study|Moved/transferred care|0|||
48685368|NCT04810650|156699189|FG013|Overall Study|Moved/transferred care|0|||
48685369|NCT04810650|156699176|FG000|Overall Study|Lost to Follow-up|15|||
48685370|NCT04810650|156699177|FG001|Overall Study|Lost to Follow-up|12|||
48685371|NCT04810650|156699178|FG002|Overall Study|Lost to Follow-up|7|||
48390867|NCT01438489|155625069|FG002|Overall Study|AE/SAEs|1|||
48390868|NCT01438489|155625067|FG000|Overall Study|Received prohibited medication|1|||
48685372|NCT04810650|156699179|FG003|Overall Study|Lost to Follow-up|9|||
48390869|NCT01438489|155625068|FG001|Overall Study|Received prohibited medication|0|||
48390870|NCT01438489|155625069|FG002|Overall Study|Received prohibited medication|0|||
48390871|NCT01438489|155625067|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
48390872|NCT01438489|155625068|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
48390873|NCT01438489|155625069|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
48390874|NCT01438489|155625067|FG000|Overall Study|Inadequate venous access|0|||
48390875|NCT01438489|155625068|FG001|Overall Study|Inadequate venous access|2|||
48390876|NCT01438489|155625069|FG002|Overall Study|Inadequate venous access|0|||
48390877|NCT01835015|155625070|FG000|Overall Study|Adverse Event|0|||
48390878|NCT01835015|155625071|FG001|Overall Study|Adverse Event|0|||
48390879|NCT01835015|155625072|FG002|Overall Study|Adverse Event|1|||
48390880|NCT01835015|155625073|FG003|Overall Study|Adverse Event|0|||
48390881|NCT01835015|155625074|FG004|Overall Study|Adverse Event|0|||
48390882|NCT00441974|155625075|FG000|Overall Study|Adverse Event|6|||
48390883|NCT00441974|155625075|FG000|Overall Study|Consent Withdrawn|35|||
48390884|NCT00441974|155625075|FG000|Overall Study|Lost to Follow-up|80|||
48390885|NCT00441974|155625075|FG000|Overall Study|Protocol Violation|7|||
48390886|NCT01816061|155625076|FG000|Overall Study|Lost to Follow-up|13|||
48685373|NCT04810650|156699180|FG004|Overall Study|Lost to Follow-up|10|||
48685374|NCT04810650|156699181|FG005|Overall Study|Lost to Follow-up|6|||
48685375|NCT04810650|156699182|FG006|Overall Study|Lost to Follow-up|0|||
48685376|NCT04810650|156699183|FG007|Overall Study|Lost to Follow-up|0|||
48685377|NCT04810650|156699184|FG008|Overall Study|Lost to Follow-up|0|||
48685378|NCT04810650|156699185|FG009|Overall Study|Lost to Follow-up|0|||
48685379|NCT04810650|156699186|FG010|Overall Study|Lost to Follow-up|1|||
48685380|NCT04810650|156699187|FG011|Overall Study|Lost to Follow-up|0|||
48685381|NCT04810650|156699188|FG012|Overall Study|Lost to Follow-up|3|||
48685382|NCT04810650|156699189|FG013|Overall Study|Lost to Follow-up|9|||
48685383|NCT04810650|156699176|FG000|Overall Study|Participant declined|0|||
48685384|NCT04810650|156699177|FG001|Overall Study|Participant declined|0|||
48685385|NCT04810650|156699178|FG002|Overall Study|Participant declined|0|||
48685386|NCT04810650|156699179|FG003|Overall Study|Participant declined|0|||
48685387|NCT04810650|156699180|FG004|Overall Study|Participant declined|0|||
48685388|NCT04810650|156699181|FG005|Overall Study|Participant declined|0|||
48685389|NCT04810650|156699182|FG006|Overall Study|Participant declined|0|||
48685390|NCT04810650|156699183|FG007|Overall Study|Participant declined|0|||
48685391|NCT04810650|156699184|FG008|Overall Study|Participant declined|0|||
48685392|NCT04810650|156699185|FG009|Overall Study|Participant declined|0|||
48685393|NCT04810650|156699186|FG010|Overall Study|Participant declined|2|||
48685394|NCT04810650|156699187|FG011|Overall Study|Participant declined|0|||
48685395|NCT04810650|156699188|FG012|Overall Study|Participant declined|0|||
48685396|NCT04810650|156699189|FG013|Overall Study|Participant declined|0|||
48685397|NCT01358825|156699190|FG000|Overall Study|Blood sample not drawn|0|||
48685398|NCT01358825|156699191|FG001|Overall Study|Blood sample not drawn|1|||
48685399|NCT02524171|156699194|FG000|6-month Follow-up|Lost to Follow-up|53|||
48685400|NCT02524171|156699195|FG001|6-month Follow-up|Lost to Follow-up|45|||
48685401|NCT02524171|156699194|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
48685402|NCT02524171|156699195|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
48685419|NCT00773513|156699200|FG000|Overall Study|Renal Transplant|254|||
48685420|NCT00773513|156699201|FG001|Overall Study|Renal Transplant|263|||
48685421|NCT00773513|156699200|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
48685422|NCT00773513|156699201|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
48685423|NCT00773513|156699200|FG000|Overall Study|Withdrew Consent|68|||
48685424|NCT00773513|156699201|FG001|Overall Study|Withdrew Consent|69|||
48685425|NCT00773513|156699200|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
48685426|NCT00773513|156699201|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
48685427|NCT00773513|156699200|FG000|Overall Study|Failure to Return|22|||
48685428|NCT00773513|156699201|FG001|Overall Study|Failure to Return|8|||
48685429|NCT00773513|156699200|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48685430|NCT00773513|156699201|FG001|Overall Study|Insufficient Therapeutic Response|18|||
48390887|NCT01816061|155625077|FG001|Overall Study|Lost to Follow-up|24|||
48390888|NCT03370120|155625078|FG000|Overall Study|Adverse event, non-fatal|24|||
48390889|NCT03370120|155625078|FG000|Overall Study|Withdrawal by Subject|6|||
48390890|NCT03370120|155625078|FG000|Overall Study|Lost to Follow-up|1|||
48390891|NCT03370120|155625078|FG000|Overall Study|Lack of Efficacy|37|||
48390892|NCT03370120|155625078|FG000|Overall Study|Per sponsor's instructions|1|||
48390893|NCT03370120|155625078|FG000|Overall Study|Study was terminated by parent company UCB|2|||
48390894|NCT03370120|155625078|FG000|Overall Study|The study was ended by the promoter|3|||
48390895|NCT03370120|155625078|FG000|Overall Study|Discontinuation of drug development|3|||
48390896|NCT03370120|155625078|FG000|Overall Study|End of project|2|||
48390897|NCT03370120|155625078|FG000|Overall Study|Premature study closure|2|||
48390898|NCT03370120|155625078|FG000|Overall Study|Premature program termination|1|||
48390899|NCT03370120|155625078|FG000|Overall Study|Premature study termination|7|||
48390900|NCT03370120|155625078|FG000|Overall Study|Trial terminated by sponsor|2|||
48685431|NCT00773513|156699200|FG000|Overall Study|Reason Not Specified|159|||
48685432|NCT00773513|156699201|FG001|Overall Study|Reason Not Specified|126|||
48685433|NCT00773513|156699200|FG000|Overall Study|Death|531|||
48685434|NCT00773513|156699201|FG001|Overall Study|Death|545|||
48390901|NCT03370120|155625078|FG000|Overall Study|Trial discontinued by sponsor|2|||
48390902|NCT03370120|155625078|FG000|Overall Study|Study ended|15|||
48390903|NCT03370120|155625078|FG000|Overall Study|Clinical trial has been cancelled|1|||
48390904|NCT03370120|155625078|FG000|Overall Study|End of study per sponsor decision|2|||
48685435|NCT00700713|156699202|FG000|Overall Study|Protocol Violation|1|||
48685436|NCT00700713|156699203|FG001|Overall Study|Protocol Violation|0|||
48685437|NCT00700713|156699204|FG002|Overall Study|Protocol Violation|1|||
48685438|NCT00700713|156699202|FG000|Overall Study|Withdrawal by Subject|0|||
48685439|NCT00700713|156699203|FG001|Overall Study|Withdrawal by Subject|0|||
48685440|NCT00700713|156699204|FG002|Overall Study|Withdrawal by Subject|1|||
48685441|NCT01922271|156699205|FG000|WASHOUT Period|Withdrawal by Subject|1|||
48685442|NCT01922271|156699206|FG001|WASHOUT Period|Withdrawal by Subject|0|||
48390905|NCT03370120|155625078|FG000|Overall Study|Promoter's decision|2|||
48390906|NCT03370120|155625078|FG000|Overall Study|The trial has been suspended|3|||
48390907|NCT03370120|155625078|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
48390908|NCT03370120|155625078|FG000|Overall Study|Early termination by order of sponsor|2|||
48390909|NCT03370120|155625078|FG000|Overall Study|Discontinuation of the study|5|||
48390910|NCT03370120|155625078|FG000|Overall Study|End of clinical trial discontinuation|1|||
48390911|NCT03370120|155625078|FG000|Overall Study|Because the clinical trial ended halfway|4|||
48390912|NCT03370120|155625078|FG000|Overall Study|Development discontinued|5|||
48390913|NCT03370120|155625078|FG000|Overall Study|Padsenovil program closed|3|||
48685467|NCT02446717|156699213|FG000|Overall Study|Adverse Event|0|||
48685468|NCT02446717|156699214|FG001|Overall Study|Adverse Event|0|||
48685469|NCT02446717|156699215|FG002|Overall Study|Adverse Event|1|||
48390914|NCT03370120|155625078|FG000|Overall Study|End of project|2|||
48390915|NCT03370120|155625078|FG000|Overall Study|Termination of project|1|||
48390916|NCT03370120|155625078|FG000|Overall Study|The study was interrupted by sponsor|4|||
48390917|NCT03370120|155625078|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
48390918|NCT03370120|155625078|FG000|Overall Study|End of sponsor decision|1|||
48390919|NCT03370120|155625078|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
48390920|NCT03370120|155625078|FG000|Overall Study|Early termination of studies|5|||
48390921|NCT03370120|155625078|FG000|Overall Study|This study is ended early|1|||
48685470|NCT02446717|156699216|FG003|Overall Study|Adverse Event|0|||
48685471|NCT02446717|156699217|FG004|Overall Study|Adverse Event|0|||
48685472|NCT02446717|156699213|FG000|Overall Study|Lost to Follow-up|0|||
48685473|NCT02446717|156699214|FG001|Overall Study|Lost to Follow-up|1|||
48685474|NCT02446717|156699215|FG002|Overall Study|Lost to Follow-up|1|||
48685475|NCT02446717|156699216|FG003|Overall Study|Lost to Follow-up|0|||
48685476|NCT02446717|156699217|FG004|Overall Study|Lost to Follow-up|1|||
48685477|NCT02446717|156699213|FG000|Overall Study|Withdrew consent|0|||
48685478|NCT02446717|156699214|FG001|Overall Study|Withdrew consent|0|||
48685479|NCT02446717|156699215|FG002|Overall Study|Withdrew consent|0|||
48685480|NCT02446717|156699216|FG003|Overall Study|Withdrew consent|1|||
48685481|NCT02446717|156699217|FG004|Overall Study|Withdrew consent|0|||
48685482|NCT00279916|156699223|FG000|Overall Study|Withdrawal by Subject|4|||
48685483|NCT00279916|156699224|FG001|Overall Study|Withdrawal by Subject|3|||
48685484|NCT00279916|156699223|FG000|Overall Study|Lost to Follow-up|3|||
48685485|NCT00279916|156699224|FG001|Overall Study|Lost to Follow-up|2|||
48685486|NCT01774799|156699227|FG000|Overall Study|Lost to Follow-up|1|||
48685487|NCT01774799|156699228|FG001|Overall Study|Lost to Follow-up|1|||
48685488|NCT01774799|156699229|FG002|Overall Study|Lost to Follow-up|0|||
48685489|NCT01774799|156699230|FG003|Overall Study|Lost to Follow-up|0|||
48390922|NCT03370120|155625078|FG000|Overall Study|End of padsevonil program|2|||
48390923|NCT03370120|155625078|FG000|Overall Study|Decision of sponsor|6|||
48390924|NCT03370120|155625078|FG000|Overall Study|Asked by the sponsor|3|||
48390925|NCT03370120|155625078|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
48685490|NCT04089761|156699231|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
48685491|NCT04089761|156699231|FG000|"Run In Phase"|Lost to Follow-up|1|||
48685492|NCT04089761|156699231|FG000|"Treatment Phase"|No evaluable data|5|||
48685493|NCT04089761|156699231|FG000|"Treatment Phase"|Lost to Follow-up|1|||
48685494|NCT00556894|156699236|FG000|Overall Study|Adverse Event|2|||
48685495|NCT00556894|156699237|FG001|Overall Study|Adverse Event|3|||
48685496|NCT00556894|156699238|FG002|Overall Study|Adverse Event|3|||
48685497|NCT00556894|156699236|FG000|Overall Study|Death|1|||
48685498|NCT00556894|156699237|FG001|Overall Study|Death|0|||
48685499|NCT00556894|156699238|FG002|Overall Study|Death|0|||
48685500|NCT00556894|156699236|FG000|Overall Study|regulatory decision in Bulgaria|10|||
48685501|NCT00556894|156699237|FG001|Overall Study|regulatory decision in Bulgaria|14|||
48390926|NCT03370120|155625078|FG000|Overall Study|PI decision poor compliance from participant|1|||
48390927|NCT03370120|155625078|FG000|Overall Study|Promoter ended the study|3|||
48390928|NCT03370120|155625078|FG000|Overall Study|Premature study close by sponsor's decision|4|||
48390929|NCT03370120|155625078|FG000|Overall Study|Study terminated by sponsor|33|||
48390930|NCT03370120|155625078|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
48390931|NCT03370120|155625078|FG000|Overall Study|Sponsor decision to terminate study|63|||
48390932|NCT03370120|155625078|FG000|Overall Study|Program closure|3|||
48390933|NCT03370120|155625078|FG000|Overall Study|Study ended prematurely|1|||
48390934|NCT03370120|155625078|FG000|Overall Study|Study stopped by sponsor|2|||
48390935|NCT03370120|155625078|FG000|Overall Study|Program termination|55|||
48390936|NCT03370120|155625078|FG000|Overall Study|Sponsor decision|62|||
48390937|NCT03370120|155625078|FG000|Overall Study|Sponsor study closure|10|||
48390938|NCT00829179|155625079|FG000|Overall Study|Withdrawal by Subject|1|||
48390939|NCT00596947|155625080|FG000|Overall Study|study halted due to low enrollment|5|||
48685502|NCT00556894|156699238|FG002|Overall Study|regulatory decision in Bulgaria|13|||
48763224|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
48763225|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
48763226|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
48763227|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48763228|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48763229|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
48763230|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763231|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763232|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763233|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763234|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
48685503|NCT00556894|156699236|FG000|Overall Study|Change in therapy|2|||
48685504|NCT00556894|156699237|FG001|Overall Study|Change in therapy|1|||
48685505|NCT00556894|156699238|FG002|Overall Study|Change in therapy|2|||
48685506|NCT00556894|156699236|FG000|Overall Study|Withdrawal by Subject|1|||
48685507|NCT00556894|156699237|FG001|Overall Study|Withdrawal by Subject|1|||
48685508|NCT00556894|156699238|FG002|Overall Study|Withdrawal by Subject|1|||
48685509|NCT04417361|156699239|FG000|Overall Study|Withdrawal by Subject|1|||
48685510|NCT04417361|156699240|FG001|Overall Study|Withdrawal by Subject|0|||
48685511|NCT04417361|156699239|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
48685512|NCT04417361|156699240|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
48685513|NCT01236521|156699246|FG000|Overall Study|Withdrawal by Subject|12|||
48685514|NCT01236521|156699247|FG001|Overall Study|Withdrawal by Subject|17|||
48685515|NCT01236521|156699246|FG000|Overall Study|Death|2|||
48685516|NCT01236521|156699247|FG001|Overall Study|Death|1|||
48685517|NCT01236521|156699246|FG000|Overall Study|Lost to Follow-up|9|||
48685518|NCT01236521|156699247|FG001|Overall Study|Lost to Follow-up|7|||
48685519|NCT04531241|156699248|FG000|Period 1|Withdrawal by Subject|2|||
48685520|NCT04531241|156699249|FG001|Period 1|Withdrawal by Subject|0|||
48685521|NCT04531241|156699248|FG000|Period 1|Dispesed incorrect lens power|1|||
48685522|NCT04531241|156699249|FG001|Period 1|Dispesed incorrect lens power|0|||
48685523|NCT04531241|156699248|FG000|Period 1|Protocol Violation|1|||
48685524|NCT04531241|156699249|FG001|Period 1|Protocol Violation|0|||
48685525|NCT04531241|156699248|FG000|Period 1|No longer eligible|0|||
48685526|NCT04531241|156699249|FG001|Period 1|No longer eligible|1|||
48685527|NCT04531241|156699248|FG000|Period 1|Lens Discomfort|0|||
48685528|NCT04531241|156699249|FG001|Period 1|Lens Discomfort|1|||
48685529|NCT04531241|156699248|FG000|Period 2|Covid-19 Related|1|||
48685530|NCT04531241|156699249|FG001|Period 2|Covid-19 Related|1|||
48685531|NCT04332107|156699257|FG000|Day 3|Lost to Follow-up|23|||
48685532|NCT04332107|156699258|FG001|Day 3|Lost to Follow-up|14|||
48685533|NCT04332107|156699257|FG000|Day 3|Missing outcome data|3|||
48390940|NCT00596947|155625081|FG001|Overall Study|study halted due to low enrollment|3|||
48390941|NCT00596947|155625080|FG000|Overall Study|Lost to Follow-up|1|||
48390942|NCT00596947|155625081|FG001|Overall Study|Lost to Follow-up|0|||
48390943|NCT04416555|155625083|FG000|Overall Study|Withdrawal by Subject|0|||
48390944|NCT04416555|155625084|FG001|Overall Study|Withdrawal by Subject|3|||
48685534|NCT04332107|156699258|FG001|Day 3|Missing outcome data|6|||
48685535|NCT04332107|156699257|FG000|Day 14|Lost to Follow-up|13|||
48685536|NCT04332107|156699258|FG001|Day 14|Lost to Follow-up|4|||
48685537|NCT04332107|156699257|FG000|Day 14|Missing outcome data|4|||
48685538|NCT04332107|156699258|FG001|Day 14|Missing outcome data|4|||
48685539|NCT04332107|156699257|FG000|Day 21|Lost to Follow-up|10|||
48685540|NCT04332107|156699258|FG001|Day 21|Lost to Follow-up|2|||
48685541|NCT03734679|156699261|FG000|Overall Study|Missed Visit|1|||
48763235|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
48763236|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763237|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48763238|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
48685542|NCT00479713|156699264|FG000|Overall Study|Adverse Event|8|||
48685543|NCT00479713|156699265|FG001|Overall Study|Adverse Event|6|||
48685544|NCT00479713|156699264|FG000|Overall Study|Death|1|||
48685545|NCT00479713|156699265|FG001|Overall Study|Death|0|||
48685546|NCT00479713|156699264|FG000|Overall Study|Lost to Follow-up|0|||
48390945|NCT00800436|155625087|FG000|Overall Study|Withdrawal by Subject|0|||
48390946|NCT00800436|155625088|FG001|Overall Study|Withdrawal by Subject|0|||
48390947|NCT00800436|155625089|FG002|Overall Study|Withdrawal by Subject|1|||
48390948|NCT00800436|155625090|FG003|Overall Study|Withdrawal by Subject|1|||
48390949|NCT00800436|155625091|FG004|Overall Study|Withdrawal by Subject|0|||
48390950|NCT00800436|155625092|FG005|Overall Study|Withdrawal by Subject|0|||
48390951|NCT00800436|155625093|FG006|Overall Study|Withdrawal by Subject|0|||
48390952|NCT01967628|155625094|FG000|Overall Study|Withdrawal by Subject|2|||
48390953|NCT01967628|155625095|FG001|Overall Study|Withdrawal by Subject|0|||
48390954|NCT01967628|155625094|FG000|Overall Study|Unable to complete bronchoscopy|4|||
48390955|NCT01967628|155625095|FG001|Overall Study|Unable to complete bronchoscopy|6|||
48390956|NCT01967628|155625094|FG000|Overall Study|Lost to Follow-up|1|||
48390957|NCT01967628|155625095|FG001|Overall Study|Lost to Follow-up|0|||
48390958|NCT01967628|155625094|FG000|Overall Study|Low protein concentration in sample|20|||
48390959|NCT01967628|155625095|FG001|Overall Study|Low protein concentration in sample|25|||
48390960|NCT01328951|155625096|FG000|Overall Study|Disease Progression|17|||
48390961|NCT01328951|155625097|FG001|Overall Study|Disease Progression|14|||
48390962|NCT01328951|155625096|FG000|Overall Study|Adverse Event|2|||
48390963|NCT01328951|155625097|FG001|Overall Study|Adverse Event|0|||
48390964|NCT01328951|155625096|FG000|Overall Study|Death|243|||
48390965|NCT01328951|155625097|FG001|Overall Study|Death|258|||
48390966|NCT01328951|155625096|FG000|Overall Study|Lost to Follow-up|6|||
48390967|NCT01328951|155625097|FG001|Overall Study|Lost to Follow-up|7|||
48390968|NCT01328951|155625096|FG000|Overall Study|Withdrawal by Subject|6|||
48390969|NCT01328951|155625097|FG001|Overall Study|Withdrawal by Subject|6|||
48390970|NCT01328951|155625096|FG000|Overall Study|Study Closed by the Sponsor|36|||
48390971|NCT01328951|155625097|FG001|Overall Study|Study Closed by the Sponsor|31|||
48390972|NCT01328951|155625096|FG000|Overall Study|Other|11|||
48390973|NCT01328951|155625097|FG001|Overall Study|Other|6|||
48390974|NCT01517893|155625102|FG000|Overall Study|Withdrawal by Subject|3|||
48390975|NCT01517893|155625103|FG001|Overall Study|Withdrawal by Subject|0|||
48390976|NCT03200366|155625104|FG000|Patient Navigation Intervention Given|Death|0|||
48390977|NCT03200366|155625105|FG001|Patient Navigation Intervention Given|Death|2|||
48390978|NCT03200366|155625106|FG002|Patient Navigation Intervention Given|Death|0|||
48390979|NCT03200366|155625104|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
48390980|NCT03200366|155625105|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
48390981|NCT03200366|155625106|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
48390982|NCT03200366|155625104|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
48390983|NCT03200366|155625105|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
48390984|NCT03200366|155625106|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
48390985|NCT03200366|155625104|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
48390986|NCT03200366|155625105|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
48390987|NCT03200366|155625106|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
48390988|NCT03200366|155625104|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
48390989|NCT03200366|155625105|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
48390990|NCT03200366|155625106|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
48390991|NCT03200366|155625104|FG000|6 Month Post-Baseline Interview|Death|1|||
48390992|NCT03200366|155625105|FG001|6 Month Post-Baseline Interview|Death|1|||
48390993|NCT03200366|155625106|FG002|6 Month Post-Baseline Interview|Death|1|||
48390994|NCT03200366|155625104|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
48390995|NCT03200366|155625105|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
48390996|NCT03200366|155625106|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
48390997|NCT03200366|155625104|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
48390998|NCT03200366|155625105|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
48390999|NCT03200366|155625106|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
48391000|NCT03200366|155625104|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
48685547|NCT00479713|156699265|FG001|Overall Study|Lost to Follow-up|1|||
48685548|NCT00479713|156699264|FG000|Overall Study|Protocol Violation|0|||
48391001|NCT03200366|155625105|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
48391002|NCT03200366|155625106|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
48391003|NCT03200366|155625104|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
48391004|NCT03200366|155625105|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
48391005|NCT03200366|155625106|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
48685549|NCT00479713|156699265|FG001|Overall Study|Protocol Violation|1|||
48685550|NCT00479713|156699264|FG000|Overall Study|Withdrawal by Subject|4|||
48391006|NCT03200366|155625104|FG000|9 Month Post-Baseline Interview|Death|1|||
48391007|NCT03200366|155625105|FG001|9 Month Post-Baseline Interview|Death|1|||
48391008|NCT03200366|155625106|FG002|9 Month Post-Baseline Interview|Death|1|||
48391009|NCT03200366|155625104|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
48391010|NCT03200366|155625105|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
48391011|NCT03200366|155625106|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
48391012|NCT03200366|155625104|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
48391013|NCT03200366|155625105|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
48391014|NCT03200366|155625106|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
48391015|NCT03200366|155625104|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
48391016|NCT03200366|155625105|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
48391017|NCT03200366|155625106|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
48391018|NCT00715026|155625115|FG000|Overall Study|Withdrawal by Subject|5|||
48391019|NCT00715026|155625115|FG000|Overall Study|Lost to Follow-up|3|||
48391020|NCT00715026|155625115|FG000|Overall Study|Protocol Violation|1|||
48391021|NCT00715026|155625115|FG000|Overall Study|Surgery done on non-study consented hip|1|||
48391022|NCT00552175|155625116|FG000|Overall Study|Lack of Efficacy|2|||
48391023|NCT00552175|155625117|FG001|Overall Study|Lack of Efficacy|0|||
48391024|NCT00552175|155625118|FG002|Overall Study|Lack of Efficacy|1|||
48391025|NCT00552175|155625116|FG000|Overall Study|Adverse Event|9|||
48391026|NCT00552175|155625117|FG001|Overall Study|Adverse Event|9|||
48391027|NCT00552175|155625118|FG002|Overall Study|Adverse Event|10|||
48391028|NCT00552175|155625116|FG000|Overall Study|Withdrawal by Subject|2|||
48391029|NCT00552175|155625117|FG001|Overall Study|Withdrawal by Subject|2|||
48391030|NCT00552175|155625118|FG002|Overall Study|Withdrawal by Subject|1|||
48391031|NCT00552175|155625116|FG000|Overall Study|Lost to Follow-up|0|||
48391032|NCT00552175|155625117|FG001|Overall Study|Lost to Follow-up|0|||
48391033|NCT00552175|155625118|FG002|Overall Study|Lost to Follow-up|1|||
48391034|NCT00552175|155625116|FG000|Overall Study|Entry Criteria Not Met|1|||
48391035|NCT00552175|155625117|FG001|Overall Study|Entry Criteria Not Met|1|||
48391036|NCT00552175|155625118|FG002|Overall Study|Entry Criteria Not Met|0|||
48391037|NCT00552175|155625116|FG000|Overall Study|Reason Not Specified|3|||
48391038|NCT00552175|155625117|FG001|Overall Study|Reason Not Specified|1|||
48391039|NCT00552175|155625118|FG002|Overall Study|Reason Not Specified|1|||
48391040|NCT00631020|155625121|FG000|Overall Study|Lost to Follow-up|7|||
48391041|NCT00631020|155625121|FG000|Overall Study|Incarcerated|1|||
48391042|NCT03221751|155625122|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
48391043|NCT03221751|155625123|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
48391044|NCT04677959|155625125|FG000|Overall Study|Adverse Event|1|||
48391045|NCT04677959|155625126|FG001|Overall Study|Adverse Event|9|||
48391046|NCT04677959|155625125|FG000|Overall Study|Withdrawal by Subject|2|||
48391047|NCT04677959|155625126|FG001|Overall Study|Withdrawal by Subject|15|||
48391048|NCT04677959|155625125|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48391049|NCT04677959|155625126|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48391050|NCT04677959|155625125|FG000|Overall Study|Non-compliance with study drug|0|||
48391051|NCT04677959|155625126|FG001|Overall Study|Non-compliance with study drug|2|||
48685551|NCT00479713|156699265|FG001|Overall Study|Withdrawal by Subject|1|||
48685552|NCT04661150|156699266|FG000|Overall Study|Ongoing in study|19|||
48685553|NCT04661150|156699267|FG001|Overall Study|Ongoing in study|20|||
48685554|NCT04661150|156699266|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
48685555|NCT04661150|156699267|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
48685556|NCT04661150|156699266|FG000|Overall Study|Death|2|||
48685557|NCT04661150|156699267|FG001|Overall Study|Death|0|||
48685558|NCT00191334|156699268|FG000|Overall Study|Adverse Event|4|||
48685559|NCT00191334|156699268|FG000|Overall Study|Disease Progression or Relapse|8|||
48685560|NCT00191334|156699268|FG000|Overall Study|Physician Decision|1|||
48685561|NCT00191334|156699268|FG000|Overall Study|Withdrawal by Subject|4|||
48685562|NCT02257528|156699271|FG000|Overall Study|Never received study treatment|1|||
48685563|NCT01871519|156699281|FG000|Overall Study|Death|26|||
48685564|NCT01871519|156699281|FG000|Overall Study|Lost to Follow-up|15|||
48685565|NCT01871519|156699281|FG000|Overall Study|Withdrawal by Subject|49|||
48391052|NCT04677959|155625125|FG000|Overall Study|Protocol deviation|0|||
48391053|NCT04677959|155625126|FG001|Overall Study|Protocol deviation|11|||
48391054|NCT04677959|155625125|FG000|Overall Study|Lost to Follow-up|9|||
48391055|NCT04677959|155625126|FG001|Overall Study|Lost to Follow-up|13|||
48391056|NCT04677959|155625125|FG000|Overall Study|Other than specified|0|||
48391057|NCT04677959|155625126|FG001|Overall Study|Other than specified|8|||
48391058|NCT01390272|155625133|FG000|Overall Study|Death|3|||
48391059|NCT01390272|155625134|FG001|Overall Study|Death|2|||
48391060|NCT01390272|155625133|FG000|Overall Study|Withdrawal by Subject|9|||
48391061|NCT01390272|155625134|FG001|Overall Study|Withdrawal by Subject|5|||
48685566|NCT02611817|156700445|FG000|Open-label Induction Phase|Reason not Specified|9|||
48685567|NCT02611817|156700446|FG001|Open-label Induction Phase|Reason not Specified|0|||
48685568|NCT02611817|156700447|FG002|Open-label Induction Phase|Reason not Specified|0|||
48685569|NCT02611817|156700445|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
48685570|NCT02611817|156700446|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
48685571|NCT02611817|156700447|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
48685572|NCT02611817|156700445|FG000|Open-label Induction Phase|Pregnancy|1|||
48685573|NCT02611817|156700446|FG001|Open-label Induction Phase|Pregnancy|0|||
48685574|NCT02611817|156700447|FG002|Open-label Induction Phase|Pregnancy|0|||
48685575|NCT02611817|156700445|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
48391062|NCT01390272|155625133|FG000|Overall Study|Patient moved, no longer eligible|5|||
48391063|NCT01390272|155625134|FG001|Overall Study|Patient moved, no longer eligible|8|||
48391064|NCT04206605|155625136|FG000|Overall Study|Adverse Event|0|||
48685576|NCT02611817|156700446|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
48685577|NCT02611817|156700447|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
48685578|NCT02611817|156700445|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
48685579|NCT02611817|156700446|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
48685580|NCT02611817|156700447|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
48685581|NCT02611817|156700445|FG000|Open-label Induction Phase|Protocol Violation|5|||
48685582|NCT02611817|156700446|FG001|Open-label Induction Phase|Protocol Violation|0|||
48685583|NCT02611817|156700447|FG002|Open-label Induction Phase|Protocol Violation|0|||
48685584|NCT02611817|156700445|FG000|Open-label Induction Phase|Adverse Event|16|||
48685585|NCT02611817|156700446|FG001|Open-label Induction Phase|Adverse Event|0|||
48685586|NCT02611817|156700447|FG002|Open-label Induction Phase|Adverse Event|0|||
48685587|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
48685588|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
48685589|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
48685590|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
48685591|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
48685592|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
48685593|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
48685594|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
48685595|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
48685596|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
48685597|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
48685598|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
48685599|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
48685600|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
48685601|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
48685602|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
48685603|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
48685604|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
48685605|NCT02611817|156700445|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
48685606|NCT02611817|156700446|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
48685607|NCT02611817|156700447|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
48685608|NCT00584012|156700448|FG000|Overall Study|Withdrawal by Subject|1|||
48685609|NCT04050618|156700449|FG000|First Intervention|Withdrawal by Subject|2|||
48685610|NCT04050618|156700450|FG001|First Intervention|Withdrawal by Subject|0|||
48685611|NCT04050618|156700449|FG000|Second Intervention|Withdrawal by Subject|1|||
48685612|NCT04050618|156700450|FG001|Second Intervention|Withdrawal by Subject|0|||
48685613|NCT02229539|156700455|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
48685614|NCT02229539|156700456|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
48685615|NCT02229539|156700457|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
48685616|NCT02229539|156700455|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
48685617|NCT02229539|156700456|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
48685618|NCT02229539|156700457|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
48685619|NCT02229539|156700455|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
48685620|NCT02229539|156700456|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
48685621|NCT02229539|156700457|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
48685622|NCT02229539|156700455|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
48685623|NCT02229539|156700456|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
48685624|NCT02229539|156700457|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
48685625|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
48685626|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
48685627|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
48685628|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
48685629|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
48685630|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
48391065|NCT04206605|155625137|FG001|Overall Study|Adverse Event|1|||
48391066|NCT04206605|155625136|FG000|Overall Study|Withdrawal by Subject|1|||
48391067|NCT04206605|155625137|FG001|Overall Study|Withdrawal by Subject|0|||
48391068|NCT03631784|155625140|FG000|Overall Study|Death|48|||
48391069|NCT03631784|155625141|FG001|Overall Study|Death|28|||
48391070|NCT03631784|155625140|FG000|Overall Study|Lost to Follow-up|1|||
48391071|NCT03631784|155625141|FG001|Overall Study|Lost to Follow-up|0|||
48391072|NCT03631784|155625140|FG000|Overall Study|Withdrawal by Subject|0|||
48391073|NCT03631784|155625141|FG001|Overall Study|Withdrawal by Subject|3|||
48391074|NCT03631784|155625140|FG000|Overall Study|Participants Ongoing|63|||
48391075|NCT03631784|155625141|FG001|Overall Study|Participants Ongoing|71|||
48391076|NCT00618410|155625148|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
48391077|NCT00618410|155625149|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
48391078|NCT04251910|155625150|FG000|Overall Study|Covid 19 lockdown|0|||
48391079|NCT04251910|155625151|FG001|Overall Study|Covid 19 lockdown|5|||
48391080|NCT04251910|155625152|FG002|Overall Study|Covid 19 lockdown|0|||
48391081|NCT04251910|155625153|FG003|Overall Study|Covid 19 lockdown|4|||
48391082|NCT04251910|155625154|FG004|Overall Study|Covid 19 lockdown|0|||
48391083|NCT04251910|155625155|FG005|Overall Study|Covid 19 lockdown|0|||
48391084|NCT04251910|155625150|FG000|Overall Study|Assisted living facility was closed|0|||
48391085|NCT04251910|155625151|FG001|Overall Study|Assisted living facility was closed|0|||
48391086|NCT04251910|155625152|FG002|Overall Study|Assisted living facility was closed|0|||
48391087|NCT04251910|155625153|FG003|Overall Study|Assisted living facility was closed|0|||
48391088|NCT04251910|155625154|FG004|Overall Study|Assisted living facility was closed|1|||
48391089|NCT04251910|155625155|FG005|Overall Study|Assisted living facility was closed|0|||
48391090|NCT05289570|155625161|FG000|Overall Study|Physician Decision|1|||
48391091|NCT04544475|155625162|FG000|Overall Study|Withdrawal by Subject|1|||
48391092|NCT04544475|155625163|FG001|Overall Study|Withdrawal by Subject|3|||
48391093|NCT03227471|155626698|FG000|Overall Study|Withdrawal by Subject|0|||
48391094|NCT03227471|155626699|FG001|Overall Study|Withdrawal by Subject|0|||
48391095|NCT03227471|155626700|FG002|Overall Study|Withdrawal by Subject|0|||
48391096|NCT03227471|155626701|FG003|Overall Study|Withdrawal by Subject|0|||
48391097|NCT03227471|155626702|FG004|Overall Study|Withdrawal by Subject|1|||
48391098|NCT03227471|155626703|FG005|Overall Study|Withdrawal by Subject|0|||
48391099|NCT03227471|155626704|FG006|Overall Study|Withdrawal by Subject|0|||
48391100|NCT03227471|155626705|FG007|Overall Study|Withdrawal by Subject|0|||
48391101|NCT03227471|155626706|FG008|Overall Study|Withdrawal by Subject|0|||
48391102|NCT03227471|155626707|FG009|Overall Study|Withdrawal by Subject|0|||
48391103|NCT03227471|155626708|FG010|Overall Study|Withdrawal by Subject|0|||
48391104|NCT03227471|155626709|FG011|Overall Study|Withdrawal by Subject|0|||
48391105|NCT03227471|155626710|FG012|Overall Study|Withdrawal by Subject|1|||
48391106|NCT03227471|155626711|FG013|Overall Study|Withdrawal by Subject|0|||
48391107|NCT03227471|155626712|FG014|Overall Study|Withdrawal by Subject|0|||
48391108|NCT03227471|155626698|FG000|Overall Study|Randomized, Never Dosed|0|||
48391109|NCT03227471|155626699|FG001|Overall Study|Randomized, Never Dosed|0|||
48391110|NCT03227471|155626700|FG002|Overall Study|Randomized, Never Dosed|0|||
48391111|NCT03227471|155626701|FG003|Overall Study|Randomized, Never Dosed|0|||
48391112|NCT03227471|155626702|FG004|Overall Study|Randomized, Never Dosed|0|||
48391113|NCT03227471|155626703|FG005|Overall Study|Randomized, Never Dosed|0|||
48391114|NCT03227471|155626704|FG006|Overall Study|Randomized, Never Dosed|0|||
48391115|NCT03227471|155626705|FG007|Overall Study|Randomized, Never Dosed|0|||
48391116|NCT03227471|155626706|FG008|Overall Study|Randomized, Never Dosed|0|||
48391117|NCT03227471|155626707|FG009|Overall Study|Randomized, Never Dosed|0|||
48391118|NCT03227471|155626708|FG010|Overall Study|Randomized, Never Dosed|0|||
48391119|NCT03227471|155626709|FG011|Overall Study|Randomized, Never Dosed|0|||
48391120|NCT03227471|155626710|FG012|Overall Study|Randomized, Never Dosed|0|||
48391121|NCT03227471|155626711|FG013|Overall Study|Randomized, Never Dosed|0|||
48391122|NCT03227471|155626712|FG014|Overall Study|Randomized, Never Dosed|1|||
48391123|NCT00257166|155626713|FG000|Overall Study|Adverse Event|18|||
48391124|NCT00257166|155626714|FG001|Overall Study|Adverse Event|13|||
48685631|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
48685632|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
48685633|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
48685634|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
48685635|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
48391125|NCT00257166|155626713|FG000|Overall Study|Laboratory abnormality|1|||
48391126|NCT00257166|155626714|FG001|Overall Study|Laboratory abnormality|0|||
48391127|NCT00257166|155626713|FG000|Overall Study|Lost to Follow-up|8|||
48391128|NCT00257166|155626714|FG001|Overall Study|Lost to Follow-up|1|||
48391129|NCT00257166|155626713|FG000|Overall Study|Withdrawal by Subject|9|||
48391130|NCT00257166|155626714|FG001|Overall Study|Withdrawal by Subject|2|||
48391131|NCT00257166|155626713|FG000|Overall Study|Other|16|||
48391132|NCT00257166|155626714|FG001|Overall Study|Other|21|||
48391133|NCT00257166|155626713|FG000|Overall Study|Randomized, but not treated|1|||
48391134|NCT00257166|155626714|FG001|Overall Study|Randomized, but not treated|0|||
48391135|NCT01543152|155626721|FG000|Overall Study|Withdrawal by Subject|0|||
48391136|NCT01543152|155626722|FG001|Overall Study|Withdrawal by Subject|2|||
48685636|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
48685637|NCT02229539|156700455|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
48685638|NCT02229539|156700456|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
48685639|NCT02229539|156700457|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
48685640|NCT00770809|156700458|FG000|Overall Study|Adverse Event|9|||
48685641|NCT00770809|156700459|FG001|Overall Study|Adverse Event|1|||
48685642|NCT00770809|156700460|FG002|Overall Study|Adverse Event|12|||
48685643|NCT00770809|156700458|FG000|Overall Study|Death|1|||
48685644|NCT00770809|156700459|FG001|Overall Study|Death|0|||
48685645|NCT00770809|156700460|FG002|Overall Study|Death|0|||
48685646|NCT00770809|156700458|FG000|Overall Study|Withdrawal by Subject|3|||
48685647|NCT00770809|156700459|FG001|Overall Study|Withdrawal by Subject|3|||
48685648|NCT00770809|156700460|FG002|Overall Study|Withdrawal by Subject|7|||
48685649|NCT00770809|156700458|FG000|Overall Study|Progression|2|||
48685650|NCT00770809|156700459|FG001|Overall Study|Progression|2|||
48685651|NCT00770809|156700460|FG002|Overall Study|Progression|0|||
48685652|NCT00770809|156700458|FG000|Overall Study|Complicating illness|0|||
48685653|NCT00770809|156700459|FG001|Overall Study|Complicating illness|0|||
48685654|NCT00770809|156700460|FG002|Overall Study|Complicating illness|1|||
48685655|NCT00770809|156700458|FG000|Overall Study|Other Medical Reasons|2|||
48685656|NCT00770809|156700459|FG001|Overall Study|Other Medical Reasons|4|||
48685657|NCT00770809|156700460|FG002|Overall Study|Other Medical Reasons|3|||
48685658|NCT02763644|156700473|FG000|Overall Study|Patient/guardian decision|1|||
48685659|NCT02763644|156700474|FG001|Overall Study|Patient/guardian decision|0|||
48685660|NCT02763644|156700473|FG000|Overall Study|Death|1|||
48685661|NCT02763644|156700474|FG001|Overall Study|Death|1|||
48685662|NCT02763644|156700473|FG000|Overall Study|Adverse Event|1|||
48685663|NCT02763644|156700474|FG001|Overall Study|Adverse Event|1|||
48685664|NCT00483405|156700479|FG000|Overall Study|Adverse Event|8|||
48685665|NCT00483405|156700479|FG000|Overall Study|Lack of Efficacy|14|||
48685666|NCT00483405|156700479|FG000|Overall Study|Death|3|||
48685667|NCT00483405|156700479|FG000|Overall Study|Withdrawal by Subject|2|||
48685668|NCT00483405|156700479|FG000|Overall Study|Other complicating disease|1|||
48685669|NCT05215314|156700490|FG000|Overall Study|Lost to Follow-up|2|||
48685670|NCT05215314|156700491|FG001|Overall Study|Lost to Follow-up|2|||
48685671|NCT05215314|156700490|FG000|Overall Study|Withdrawal by Subject|2|||
48685672|NCT05215314|156700491|FG001|Overall Study|Withdrawal by Subject|0|||
48685673|NCT05215314|156700490|FG000|Overall Study|Physician Decision|1|||
48685674|NCT05215314|156700491|FG001|Overall Study|Physician Decision|0|||
48685683|NCT00108862|156700494|FG000|Overall Study|Death|31|||
48685684|NCT00108862|156700495|FG001|Overall Study|Death|37|||
48685685|NCT00108862|156700494|FG000|Overall Study|Withdrawal by Subject|10|||
48685686|NCT00108862|156700495|FG001|Overall Study|Withdrawal by Subject|6|||
48685687|NCT00108862|156700494|FG000|Overall Study|Lost to Follow-up|27|||
48685688|NCT00108862|156700495|FG001|Overall Study|Lost to Follow-up|19|||
48685689|NCT01134614|156700496|FG000|Overall Study|Still on treatment as of March 2013|21|||
48685690|NCT01134614|156700497|FG001|Overall Study|Still on treatment as of March 2013|13|||
48685691|NCT01134614|156700496|FG000|Overall Study|Progressive disease|60|||
48685692|NCT01134614|156700497|FG001|Overall Study|Progressive disease|54|||
48685693|NCT01134614|156700496|FG000|Overall Study|Adverse Event|26|||
48685694|NCT01134614|156700497|FG001|Overall Study|Adverse Event|39|||
48685695|NCT01134614|156700496|FG000|Overall Study|Death|5|||
48391137|NCT01543152|155626723|FG002|Overall Study|Withdrawal by Subject|0|||
48391138|NCT01543152|155626724|FG003|Overall Study|Withdrawal by Subject|0|||
48391139|NCT01543152|155626725|FG004|Overall Study|Withdrawal by Subject|0|||
48391140|NCT01999465|155626726|FG000|Overall Study|Lost to Follow-up|0|||
48391141|NCT01999465|155626727|FG001|Overall Study|Lost to Follow-up|2|||
48391142|NCT01999465|155626726|FG000|Overall Study|Protocol Violation|0|||
48685696|NCT01134614|156700497|FG001|Overall Study|Death|8|||
48685697|NCT01134614|156700496|FG000|Overall Study|Withdrawal by Subject|3|||
48685698|NCT01134614|156700497|FG001|Overall Study|Withdrawal by Subject|2|||
48685699|NCT01134614|156700496|FG000|Overall Study|Alternative therapy|2|||
48685700|NCT01134614|156700497|FG001|Overall Study|Alternative therapy|0|||
48391143|NCT01999465|155626727|FG001|Overall Study|Protocol Violation|1|||
48391144|NCT02687542|155626728|FG000|Overall Study|Medication error without associated AEs|0|||
48391145|NCT02687542|155626729|FG001|Overall Study|Medication error without associated AEs|0|||
48685701|NCT01134614|156700496|FG000|Overall Study|Complicating disease|2|||
48685702|NCT01134614|156700497|FG001|Overall Study|Complicating disease|1|||
48685703|NCT01134614|156700496|FG000|Overall Study|Physician's decision|0|||
48391146|NCT02687542|155626730|FG002|Overall Study|Medication error without associated AEs|0|||
48391147|NCT02687542|155626731|FG003|Overall Study|Medication error without associated AEs|0|||
48391148|NCT02687542|155626732|FG004|Overall Study|Medication error without associated AEs|1|||
48391149|NCT02687542|155626728|FG000|Overall Study|Lost to Follow-up|0|||
48391150|NCT02687542|155626729|FG001|Overall Study|Lost to Follow-up|0|||
48391151|NCT02687542|155626730|FG002|Overall Study|Lost to Follow-up|0|||
48391152|NCT02687542|155626731|FG003|Overall Study|Lost to Follow-up|0|||
48391153|NCT02687542|155626732|FG004|Overall Study|Lost to Follow-up|1|||
48391154|NCT02687542|155626728|FG000|Overall Study|Protocol Violation|0|||
48391155|NCT02687542|155626729|FG001|Overall Study|Protocol Violation|1|||
48391156|NCT02687542|155626730|FG002|Overall Study|Protocol Violation|0|||
48391157|NCT02687542|155626731|FG003|Overall Study|Protocol Violation|0|||
48391158|NCT02687542|155626732|FG004|Overall Study|Protocol Violation|0|||
48391159|NCT02687542|155626728|FG000|Overall Study|Other|5|||
48391160|NCT02687542|155626729|FG001|Overall Study|Other|9|||
48391161|NCT02687542|155626730|FG002|Overall Study|Other|10|||
48391162|NCT02687542|155626731|FG003|Overall Study|Other|6|||
48391163|NCT02687542|155626732|FG004|Overall Study|Other|5|||
48685704|NCT01134614|156700497|FG001|Overall Study|Physician's decision|1|||
48685705|NCT01134614|156700496|FG000|Overall Study|Never started treatment|4|||
48685706|NCT01134614|156700497|FG001|Overall Study|Never started treatment|1|||
48685707|NCT01134614|156700496|FG000|Overall Study|Pt received tx not allowed on study|0|||
48685708|NCT01134614|156700497|FG001|Overall Study|Pt received tx not allowed on study|1|||
48685709|NCT01134614|156700496|FG000|Overall Study|Symptomatic deterioration|0|||
48685710|NCT01134614|156700497|FG001|Overall Study|Symptomatic deterioration|1|||
48685711|NCT01134614|156700496|FG000|Overall Study|Patient in hospice care|0|||
48685712|NCT01134614|156700497|FG001|Overall Study|Patient in hospice care|1|||
48685723|NCT04276233|156700502|FG000|Overall Study|Adverse Event|1|||
48685724|NCT04276233|156700502|FG000|Overall Study|Lost to Follow-up|3|||
48685725|NCT04276233|156700502|FG000|Overall Study|Physician Decision|4|||
48685726|NCT04276233|156700502|FG000|Overall Study|Withdrawal by Subject|2|||
48685727|NCT04456517|156700503|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
48685728|NCT04456517|156700504|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
48685729|NCT03106779|156700505|FG000|Overall Study|Lack of Efficacy|33|||
48685730|NCT03106779|156700506|FG001|Overall Study|Lack of Efficacy|24|||
48685731|NCT03106779|156700505|FG000|Overall Study|Adverse Event|8|||
48685732|NCT03106779|156700506|FG001|Overall Study|Adverse Event|16|||
48685733|NCT03106779|156700505|FG000|Overall Study|Physician Decision|10|||
48685734|NCT03106779|156700506|FG001|Overall Study|Physician Decision|6|||
48685735|NCT03106779|156700505|FG000|Overall Study|Patient/guardian decision|4|||
48685736|NCT03106779|156700506|FG001|Overall Study|Patient/guardian decision|3|||
48685737|NCT03106779|156700505|FG000|Overall Study|Progressive disease|1|||
48685738|NCT03106779|156700506|FG001|Overall Study|Progressive disease|3|||
48685739|NCT03106779|156700505|FG000|Overall Study|Lost to Follow-up|1|||
48685740|NCT03106779|156700506|FG001|Overall Study|Lost to Follow-up|2|||
48685741|NCT03106779|156700505|FG000|Overall Study|Death|1|||
48685742|NCT03106779|156700506|FG001|Overall Study|Death|0|||
48685743|NCT03106779|156700505|FG000|Overall Study|Protocol Violation|1|||
48685744|NCT03106779|156700506|FG001|Overall Study|Protocol Violation|0|||
48685745|NCT03106779|156700505|FG000|Overall Study|Not treated|1|||
48685746|NCT03106779|156700506|FG001|Overall Study|Not treated|0|||
48685747|NCT01575548|156700507|FG000|Overall Study|Adverse Event|15|||
48685748|NCT01575548|156700508|FG001|Overall Study|Adverse Event|2|||
48685749|NCT01575548|156700507|FG000|Overall Study|Disease progression|12|||
48685750|NCT01575548|156700508|FG001|Overall Study|Disease progression|25|||
48685751|NCT01575548|156700507|FG000|Overall Study|Death|1|||
48685752|NCT01575548|156700508|FG001|Overall Study|Death|0|||
48685753|NCT01575548|156700507|FG000|Overall Study|Other complicating disease|1|||
48685754|NCT01575548|156700508|FG001|Overall Study|Other complicating disease|0|||
48685755|NCT01575548|156700507|FG000|Overall Study|Withdrawal by Subject|7|||
48685756|NCT01575548|156700508|FG001|Overall Study|Withdrawal by Subject|3|||
48685757|NCT01575548|156700507|FG000|Overall Study|Noncompliance|1|||
48685758|NCT01575548|156700508|FG001|Overall Study|Noncompliance|0|||
48685759|NCT01575548|156700507|FG000|Overall Study|Anticipated surgery|0|||
48391164|NCT02687542|155626728|FG000|Overall Study|Adverse Event|3|||
48391165|NCT02687542|155626729|FG001|Overall Study|Adverse Event|1|||
48391166|NCT02687542|155626730|FG002|Overall Study|Adverse Event|3|||
48685760|NCT01575548|156700508|FG001|Overall Study|Anticipated surgery|1|||
48391167|NCT02687542|155626731|FG003|Overall Study|Adverse Event|2|||
48685761|NCT01575548|156700507|FG000|Overall Study|Never started protocol therapy|3|||
48391168|NCT02687542|155626732|FG004|Overall Study|Adverse Event|9|||
48391169|NCT02687542|155626728|FG000|Overall Study|Withdrawal by Subject|0|||
48391170|NCT02687542|155626729|FG001|Overall Study|Withdrawal by Subject|1|||
48391171|NCT02687542|155626730|FG002|Overall Study|Withdrawal by Subject|1|||
48391172|NCT02687542|155626731|FG003|Overall Study|Withdrawal by Subject|2|||
48391173|NCT02687542|155626732|FG004|Overall Study|Withdrawal by Subject|4|||
48391174|NCT00514514|155626733|FG000|Pre-phase|Death|10|||
48391175|NCT00514514|155626734|FG001|Pre-phase|Death|0|||
48391176|NCT00514514|155626735|FG002|Pre-phase|Death|0|||
48391177|NCT00514514|155626733|FG000|Pre-phase|administrative problems|2|||
48391178|NCT00514514|155626734|FG001|Pre-phase|administrative problems|0|||
48391179|NCT00514514|155626735|FG002|Pre-phase|administrative problems|0|||
48391180|NCT00514514|155626733|FG000|Pre-phase|Protocol Violation|6|||
48391181|NCT00514514|155626734|FG001|Pre-phase|Protocol Violation|0|||
48391182|NCT00514514|155626735|FG002|Pre-phase|Protocol Violation|0|||
48391183|NCT00514514|155626733|FG000|Pre-phase|condition no longer requires study drug|7|||
48391184|NCT00514514|155626734|FG001|Pre-phase|condition no longer requires study drug|0|||
48391185|NCT00514514|155626735|FG002|Pre-phase|condition no longer requires study drug|0|||
48685762|NCT01575548|156700508|FG001|Overall Study|Never started protocol therapy|2|||
48685763|NCT01708954|156700509|FG000|Step 1|Disease progression|26|||
48391186|NCT00514514|155626733|FG000|Pre-phase|abnormal test procedure results|15|||
48391187|NCT00514514|155626734|FG001|Pre-phase|abnormal test procedure results|0|||
48391188|NCT00514514|155626735|FG002|Pre-phase|abnormal test procedure results|0|||
48391189|NCT00514514|155626733|FG000|Pre-phase|Lost to Follow-up|2|||
48391190|NCT00514514|155626734|FG001|Pre-phase|Lost to Follow-up|0|||
48391191|NCT00514514|155626735|FG002|Pre-phase|Lost to Follow-up|0|||
48391192|NCT00514514|155626733|FG000|Pre-phase|abnormal lab values|23|||
48391193|NCT00514514|155626734|FG001|Pre-phase|abnormal lab values|0|||
48391194|NCT00514514|155626735|FG002|Pre-phase|abnormal lab values|0|||
48391195|NCT00514514|155626733|FG000|Pre-phase|Lack of Efficacy|35|||
48391196|NCT00514514|155626734|FG001|Pre-phase|Lack of Efficacy|0|||
48391197|NCT00514514|155626735|FG002|Pre-phase|Lack of Efficacy|0|||
48391198|NCT00514514|155626733|FG000|Pre-phase|Adverse Event|137|||
48391199|NCT00514514|155626734|FG001|Pre-phase|Adverse Event|0|||
48391200|NCT00514514|155626735|FG002|Pre-phase|Adverse Event|0|||
48391201|NCT00514514|155626733|FG000|Pre-phase|Withdrawal by Subject|66|||
48391202|NCT00514514|155626734|FG001|Pre-phase|Withdrawal by Subject|0|||
48391203|NCT00514514|155626735|FG002|Pre-phase|Withdrawal by Subject|0|||
48391204|NCT00514514|155626733|FG000|Randomized - 9 Month|Death|3|||
48391205|NCT00514514|155626734|FG001|Randomized - 9 Month|Death|2|||
48391206|NCT00514514|155626735|FG002|Randomized - 9 Month|Death|2|||
48391207|NCT00514514|155626733|FG000|Randomized - 9 Month|Administrative problems|1|||
48391208|NCT00514514|155626734|FG001|Randomized - 9 Month|Administrative problems|1|||
48391209|NCT00514514|155626735|FG002|Randomized - 9 Month|Administrative problems|2|||
48685764|NCT01708954|156700510|FG001|Step 1|Disease progression|17|||
48685765|NCT01708954|156700511|FG002|Step 1|Disease progression|14|||
48685766|NCT01708954|156700509|FG000|Step 1|Adverse Event|3|||
48685767|NCT01708954|156700510|FG001|Step 1|Adverse Event|11|||
48685768|NCT01708954|156700511|FG002|Step 1|Adverse Event|13|||
48685769|NCT01708954|156700509|FG000|Step 1|Death|3|||
48685770|NCT01708954|156700510|FG001|Step 1|Death|2|||
48685771|NCT01708954|156700511|FG002|Step 1|Death|3|||
48685772|NCT01708954|156700509|FG000|Step 1|Withdrawal by Subject|2|||
48685773|NCT01708954|156700510|FG001|Step 1|Withdrawal by Subject|5|||
48685774|NCT01708954|156700511|FG002|Step 1|Withdrawal by Subject|3|||
48685775|NCT01708954|156700509|FG000|Step 1|Other complicating disease|0|||
48685776|NCT01708954|156700510|FG001|Step 1|Other complicating disease|2|||
48685777|NCT01708954|156700511|FG002|Step 1|Other complicating disease|0|||
48685778|NCT01708954|156700509|FG000|Step 1|Crossed over to Step 2|2|||
48685779|NCT01708954|156700510|FG001|Step 1|Crossed over to Step 2|0|||
48685780|NCT01708954|156700511|FG002|Step 1|Crossed over to Step 2|0|||
48685781|NCT01708954|156700509|FG000|Step 1|Symptomatic deterioration|1|||
48685782|NCT01708954|156700510|FG001|Step 1|Symptomatic deterioration|0|||
48685783|NCT01708954|156700511|FG002|Step 1|Symptomatic deterioration|1|||
48685784|NCT01708954|156700509|FG000|Step 1|Off-treatment reason not submitted|1|||
48391210|NCT00514514|155626733|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
48391211|NCT00514514|155626734|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
48391212|NCT00514514|155626735|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
48391213|NCT00514514|155626733|FG000|Randomized - 9 Month|Protocol Violation|1|||
48391214|NCT00514514|155626734|FG001|Randomized - 9 Month|Protocol Violation|1|||
48685785|NCT01708954|156700510|FG001|Step 1|Off-treatment reason not submitted|1|||
48685786|NCT01708954|156700511|FG002|Step 1|Off-treatment reason not submitted|1|||
48685787|NCT01708954|156700509|FG000|Step 1|Ineligible or never received treatment|4|||
48391215|NCT00514514|155626735|FG002|Randomized - 9 Month|Protocol Violation|0|||
48391216|NCT00514514|155626733|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
48391217|NCT00514514|155626734|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
48391218|NCT00514514|155626735|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
48391219|NCT00514514|155626733|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
48391220|NCT00514514|155626734|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
48391221|NCT00514514|155626735|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
48391222|NCT00514514|155626733|FG000|Randomized - 9 Month|Adverse Event|25|||
48391223|NCT00514514|155626734|FG001|Randomized - 9 Month|Adverse Event|44|||
48391224|NCT00514514|155626735|FG002|Randomized - 9 Month|Adverse Event|27|||
48391225|NCT00514514|155626733|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
48391226|NCT00514514|155626734|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
48391227|NCT00514514|155626735|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
48391228|NCT00514514|155626733|FG000|Extension - 4 Years|Lost to Follow-up|12|||
48391229|NCT00514514|155626734|FG001|Extension - 4 Years|Lost to Follow-up|10|||
48391230|NCT00514514|155626735|FG002|Extension - 4 Years|Lost to Follow-up|9|||
48391231|NCT00514514|155626733|FG000|Extension - 4 Years|Administrative problems|3|||
48391232|NCT00514514|155626734|FG001|Extension - 4 Years|Administrative problems|1|||
48391233|NCT00514514|155626735|FG002|Extension - 4 Years|Administrative problems|1|||
48391234|NCT00514514|155626733|FG000|Extension - 4 Years|Death|8|||
48391235|NCT00514514|155626734|FG001|Extension - 4 Years|Death|3|||
48391236|NCT00514514|155626735|FG002|Extension - 4 Years|Death|6|||
48391237|NCT00514514|155626733|FG000|Extension - 4 Years|Adverse Event|9|||
48391238|NCT00514514|155626734|FG001|Extension - 4 Years|Adverse Event|6|||
48391239|NCT00514514|155626735|FG002|Extension - 4 Years|Adverse Event|3|||
48391240|NCT01785160|155626736|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
48391241|NCT01785160|155626736|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
48391242|NCT01365039|155626738|FG000|Overall Study|Study related symptoms and complaints|1|||
48391243|NCT01365039|155626739|FG001|Overall Study|Study related symptoms and complaints|0|||
48391244|NCT00914927|155626740|FG000|Overall Study|Adverse Event|0|||
48391245|NCT00914927|155626741|FG001|Overall Study|Adverse Event|0|||
48391246|NCT00914927|155626742|FG002|Overall Study|Adverse Event|0|||
48391247|NCT00914927|155626743|FG003|Overall Study|Adverse Event|0|||
48391248|NCT00914927|155626744|FG004|Overall Study|Adverse Event|1|||
48391249|NCT00914927|155626745|FG005|Overall Study|Adverse Event|0|||
48391250|NCT00914927|155626746|FG006|Overall Study|Adverse Event|0|||
48391251|NCT00914927|155626740|FG000|Overall Study|Withdrawal by Subject|0|||
48391252|NCT00914927|155626741|FG001|Overall Study|Withdrawal by Subject|1|||
48391253|NCT00914927|155626742|FG002|Overall Study|Withdrawal by Subject|0|||
48391254|NCT00914927|155626743|FG003|Overall Study|Withdrawal by Subject|1|||
48391255|NCT00914927|155626744|FG004|Overall Study|Withdrawal by Subject|0|||
48391256|NCT00914927|155626745|FG005|Overall Study|Withdrawal by Subject|0|||
48391257|NCT00914927|155626746|FG006|Overall Study|Withdrawal by Subject|0|||
48391258|NCT00914927|155626740|FG000|Overall Study|Lost to Follow-up|0|||
48391259|NCT00914927|155626741|FG001|Overall Study|Lost to Follow-up|0|||
48391260|NCT00914927|155626742|FG002|Overall Study|Lost to Follow-up|0|||
48391261|NCT00914927|155626743|FG003|Overall Study|Lost to Follow-up|1|||
48391262|NCT00914927|155626744|FG004|Overall Study|Lost to Follow-up|0|||
48391263|NCT00914927|155626745|FG005|Overall Study|Lost to Follow-up|0|||
48391264|NCT00914927|155626746|FG006|Overall Study|Lost to Follow-up|0|||
48391265|NCT00914927|155626740|FG000|Overall Study|Administrative/Other|2|||
48391266|NCT00914927|155626741|FG001|Overall Study|Administrative/Other|1|||
48391267|NCT00914927|155626742|FG002|Overall Study|Administrative/Other|0|||
48391268|NCT00914927|155626743|FG003|Overall Study|Administrative/Other|0|||
48391269|NCT00914927|155626744|FG004|Overall Study|Administrative/Other|1|||
48391270|NCT00914927|155626745|FG005|Overall Study|Administrative/Other|0|||
48391271|NCT00914927|155626746|FG006|Overall Study|Administrative/Other|0|||
48391272|NCT01236573|155626747|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48391273|NCT01236573|155626748|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48391274|NCT01236573|155626749|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48391275|NCT01236573|155626750|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48391276|NCT01236573|155626751|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48391277|NCT01236573|155626752|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48391278|NCT01236573|155626753|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
48391279|NCT01236573|155626754|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48391280|NCT01236573|155626755|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
48685788|NCT01708954|156700510|FG001|Step 1|Ineligible or never received treatment|2|||
48685789|NCT01708954|156700511|FG002|Step 1|Ineligible or never received treatment|8|||
48685790|NCT01708954|156700509|FG000|Step 2|Disease progression|9|||
48685791|NCT01708954|156700510|FG001|Step 2|Disease progression|4|||
48685792|NCT01708954|156700511|FG002|Step 2|Disease progression|0|||
48685793|NCT01708954|156700509|FG000|Step 2|Adverse Event|3|||
48685794|NCT01708954|156700510|FG001|Step 2|Adverse Event|2|||
48685795|NCT01708954|156700511|FG002|Step 2|Adverse Event|0|||
48685796|NCT01708954|156700509|FG000|Step 2|Withdrawal by Subject|1|||
48685797|NCT01708954|156700510|FG001|Step 2|Withdrawal by Subject|1|||
48685798|NCT01708954|156700511|FG002|Step 2|Withdrawal by Subject|0|||
48685799|NCT01013649|156700513|FG000|First Step|Withdrawal by Subject|36|||
48391281|NCT01236573|155626756|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
48391282|NCT01236573|155626757|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
48391283|NCT01236573|155626747|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391284|NCT01236573|155626748|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391285|NCT01236573|155626749|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391286|NCT01236573|155626750|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391287|NCT01236573|155626751|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391288|NCT01236573|155626752|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391289|NCT01236573|155626753|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391290|NCT01236573|155626754|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391291|NCT01236573|155626755|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
48391292|NCT01236573|155626756|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48685800|NCT01013649|156700514|FG001|First Step|Withdrawal by Subject|19|||
48685801|NCT01013649|156700515|FG002|First Step|Withdrawal by Subject|0|||
48685802|NCT01013649|156700516|FG003|First Step|Withdrawal by Subject|0|||
48685803|NCT01013649|156700513|FG000|First Step|Progression|58|||
48685804|NCT01013649|156700514|FG001|First Step|Progression|23|||
48685805|NCT01013649|156700515|FG002|First Step|Progression|0|||
48685806|NCT01013649|156700516|FG003|First Step|Progression|0|||
48685807|NCT01013649|156700513|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
48685808|NCT01013649|156700514|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
48685809|NCT01013649|156700515|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
48685810|NCT01013649|156700516|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
48685811|NCT01013649|156700513|FG000|First Step|Death|3|||
48685812|NCT01013649|156700514|FG001|First Step|Death|4|||
48685813|NCT01013649|156700515|FG002|First Step|Death|0|||
48685814|NCT01013649|156700516|FG003|First Step|Death|0|||
48763239|NCT03662542|156983806|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48763240|NCT03662542|156983807|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48391293|NCT01236573|155626757|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
48391294|NCT01236573|155626747|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391295|NCT01236573|155626748|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391296|NCT01236573|155626749|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391297|NCT01236573|155626750|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391298|NCT01236573|155626751|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391299|NCT01236573|155626752|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391300|NCT01236573|155626753|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391301|NCT01236573|155626754|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391302|NCT01236573|155626755|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48685815|NCT01013649|156700513|FG000|First Step|Adverse Event|9|||
48685816|NCT01013649|156700514|FG001|First Step|Adverse Event|5|||
48685817|NCT01013649|156700515|FG002|First Step|Adverse Event|0|||
48685818|NCT01013649|156700516|FG003|First Step|Adverse Event|0|||
48685819|NCT01013649|156700513|FG000|First Step|Other|4|||
48685820|NCT01013649|156700514|FG001|First Step|Other|6|||
48685821|NCT01013649|156700515|FG002|First Step|Other|0|||
48685822|NCT01013649|156700516|FG003|First Step|Other|0|||
48685823|NCT00985465|156700524|FG000|Overall Study|Withdrawal by Subject|1|||
48685824|NCT00985465|156700525|FG001|Overall Study|Withdrawal by Subject|2|||
48685825|NCT00985465|156700524|FG000|Overall Study|Considered to be part of the other group|0|||
48685826|NCT00985465|156700525|FG001|Overall Study|Considered to be part of the other group|1|||
48685827|NCT01177007|156700526|FG000|Overall Study|Lost to Follow-up|2|||
48685828|NCT01177007|156700526|FG000|Overall Study|Death|4|||
48685829|NCT01177007|156700526|FG000|Overall Study|Entered hospice care|5|||
48685830|NCT01177007|156700526|FG000|Overall Study|Required additional Y90 treatment|6|||
48391303|NCT01236573|155626756|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
48391304|NCT01236573|155626757|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
48391305|NCT01961349|155626759|FG000|Overall Study|Withdrawal by Subject|1|||
48391306|NCT01961349|155626760|FG001|Overall Study|Withdrawal by Subject|4|||
48391307|NCT01961349|155626761|FG002|Overall Study|Withdrawal by Subject|0|||
48391308|NCT01961349|155626759|FG000|Overall Study|Adverse Event|0|||
48685831|NCT01177007|156700526|FG000|Overall Study|Change in treatment modality|21|||
48763241|NCT03662542|156983808|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48391309|NCT01961349|155626760|FG001|Overall Study|Adverse Event|0|||
48391310|NCT01961349|155626761|FG002|Overall Study|Adverse Event|1|||
48391311|NCT01961349|155626759|FG000|Overall Study|registration error, personal reason etc|2|||
48391312|NCT01961349|155626760|FG001|Overall Study|registration error, personal reason etc|2|||
48685832|NCT01292187|156700527|FG000|Overall Study|Adverse Event|10|||
48685833|NCT01292187|156700528|FG001|Overall Study|Adverse Event|5|||
48685834|NCT01292187|156700527|FG000|Overall Study|Withdrawal by Subject|6|||
48685835|NCT01292187|156700528|FG001|Overall Study|Withdrawal by Subject|5|||
48685836|NCT01292187|156700527|FG000|Overall Study|All other reasons|1|||
48685837|NCT01292187|156700528|FG001|Overall Study|All other reasons|3|||
48391313|NCT01961349|155626761|FG002|Overall Study|registration error, personal reason etc|1|||
48391314|NCT00496730|155626772|FG000|Overall Study|Lost to Follow-up|4|||
48391315|NCT00496730|155626773|FG001|Overall Study|Lost to Follow-up|3|||
48391316|NCT00496730|155626772|FG000|Overall Study|Withdrawal by Subject|2|||
48391317|NCT00496730|155626773|FG001|Overall Study|Withdrawal by Subject|2|||
48391318|NCT01197521|155626774|FG000|Overall Study|Not reported|24|||
48391319|NCT01197521|155626775|FG001|Overall Study|Not reported|25|||
48391320|NCT01197521|155626776|FG002|Overall Study|Not reported|21|||
48391321|NCT01197521|155626774|FG000|Overall Study|Enrolment in long term extension|42|||
48391322|NCT01197521|155626775|FG001|Overall Study|Enrolment in long term extension|36|||
48391323|NCT01197521|155626776|FG002|Overall Study|Enrolment in long term extension|87|||
48391324|NCT01197521|155626774|FG000|Overall Study|Severe non-compliance to protocol|1|||
48391325|NCT01197521|155626775|FG001|Overall Study|Severe non-compliance to protocol|3|||
48391326|NCT01197521|155626776|FG002|Overall Study|Severe non-compliance to protocol|3|||
48391327|NCT01197521|155626774|FG000|Overall Study|Lack of therapeutic response|2|||
48685838|NCT04950465|156700529|FG000|Overall Study|Lost to Follow-up|1|||
48685839|NCT04950465|156700530|FG001|Overall Study|Lost to Follow-up|0|||
48685840|NCT04950465|156700531|FG002|Overall Study|Lost to Follow-up|0|||
48685841|NCT01620086|156700538|FG000|Overall Study|Withdrawal by Subject|3|||
48685842|NCT01620086|156700539|FG001|Overall Study|Withdrawal by Subject|3|||
48685843|NCT01620086|156700540|FG002|Overall Study|Withdrawal by Subject|0|||
48685844|NCT01620086|156700538|FG000|Overall Study|failed study criteria|1|||
48685845|NCT01620086|156700539|FG001|Overall Study|failed study criteria|4|||
48685846|NCT01620086|156700540|FG002|Overall Study|failed study criteria|0|||
48685847|NCT01620086|156700538|FG000|Overall Study|Physician Decision|1|||
48685848|NCT01620086|156700539|FG001|Overall Study|Physician Decision|0|||
48685849|NCT01620086|156700540|FG002|Overall Study|Physician Decision|0|||
48685850|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Progressive disease|50|||
48685851|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Progressive disease|110|||
48685852|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Progressive disease|0|||
48685853|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Progressive disease|0|||
48685854|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
48685855|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
48685856|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48685857|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48685858|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Adverse Event|7|||
48685859|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Adverse Event|7|||
48685860|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Adverse Event|0|||
48685861|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Adverse Event|0|||
48685862|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Other|1|||
48685863|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Other|3|||
48685864|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Other|0|||
48685865|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Other|0|||
48685866|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Physician Decision|6|||
48685867|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Physician Decision|3|||
48685868|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Physician Decision|0|||
48685869|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Physician Decision|0|||
48685870|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Death|1|||
48685871|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Death|1|||
48685872|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Death|0|||
48685873|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Death|0|||
48685874|NCT01695135|156700541|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
48685875|NCT01695135|156700542|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
48685876|NCT01695135|156700543|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
48685877|NCT01695135|156700544|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
48685878|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
48685879|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
48685880|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
48685881|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
48685882|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
48685883|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
48391328|NCT01197521|155626775|FG001|Overall Study|Lack of therapeutic response|3|||
48685884|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
48685885|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
48685886|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
48685887|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
48685888|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
48685889|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
48763242|NCT03662542|156983809|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48391329|NCT01197521|155626776|FG002|Overall Study|Lack of therapeutic response|4|||
48429389|NCT01070550|155760360|FG005|Overall Study|Relapse|0|||
48685890|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Other|0|||
48685891|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Other|0|||
48685892|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Other|4|||
48685893|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Other|7|||
48685894|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
48685895|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
48685896|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
48685897|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
48685898|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Death|0|||
48685899|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Death|0|||
48685900|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Death|2|||
48685901|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Death|7|||
48685902|NCT01695135|156700541|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
48685903|NCT01695135|156700542|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
48685904|NCT01695135|156700543|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
48685905|NCT01695135|156700544|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
48685906|NCT00880698|156700545|FG000|Overall Study|Death|0|||
48685907|NCT00880698|156700546|FG001|Overall Study|Death|0|||
48685908|NCT00880698|156700547|FG002|Overall Study|Death|1|||
48685909|NCT00880698|156700548|FG003|Overall Study|Death|2|||
48685910|NCT00880698|156700545|FG000|Overall Study|Lost to Follow-up|1|||
48685911|NCT00880698|156700546|FG001|Overall Study|Lost to Follow-up|3|||
48685912|NCT00880698|156700547|FG002|Overall Study|Lost to Follow-up|0|||
48685913|NCT00880698|156700548|FG003|Overall Study|Lost to Follow-up|1|||
48685914|NCT04307355|156700553|FG000|Overall Study|Non-Compliance|3|||
48685915|NCT04307355|156700554|FG001|Overall Study|Non-Compliance|3|||
48685916|NCT04307355|156700555|FG002|Overall Study|Non-Compliance|0|||
48685917|NCT00920855|156700556|FG000|Overall Study|Adverse Event|1|||
48685918|NCT00920855|156700557|FG001|Overall Study|Adverse Event|1|||
48685919|NCT00920855|156700558|FG002|Overall Study|Adverse Event|4|||
48685920|NCT00920855|156700556|FG000|Overall Study|Withdrawal by Subject|2|||
48685921|NCT00920855|156700557|FG001|Overall Study|Withdrawal by Subject|1|||
48685922|NCT00920855|156700558|FG002|Overall Study|Withdrawal by Subject|6|||
48685923|NCT00920855|156700556|FG000|Overall Study|Disease progression|2|||
48685924|NCT00920855|156700557|FG001|Overall Study|Disease progression|1|||
48685925|NCT00920855|156700558|FG002|Overall Study|Disease progression|10|||
48685926|NCT00920855|156700556|FG000|Overall Study|Noncompliance to study medication|0|||
48685927|NCT00920855|156700557|FG001|Overall Study|Noncompliance to study medication|0|||
48685928|NCT00920855|156700558|FG002|Overall Study|Noncompliance to study medication|1|||
48685929|NCT00920855|156700556|FG000|Overall Study|Response plateau; started maintenance|0|||
48685930|NCT00920855|156700557|FG001|Overall Study|Response plateau; started maintenance|0|||
48685931|NCT00920855|156700558|FG002|Overall Study|Response plateau; started maintenance|1|||
48685932|NCT01100320|156700559|FG000|Period 1|Withdrawal by Subject|2|||
48685933|NCT01100320|156700560|FG001|Period 1|Withdrawal by Subject|4|||
48685934|NCT01100320|156700559|FG000|Period 1|Positive Drug Screen|1|||
48685935|NCT01100320|156700560|FG001|Period 1|Positive Drug Screen|1|||
48685936|NCT01100320|156700559|FG000|Period 1|Adverse Event|2|||
48685937|NCT01100320|156700560|FG001|Period 1|Adverse Event|2|||
48685938|NCT01100320|156700559|FG000|Period 2|Withdrawal by Subject|1|||
48685939|NCT01100320|156700560|FG001|Period 2|Withdrawal by Subject|1|||
48685940|NCT00104676|156700561|FG000|Overall Study|Death|3|||
48685941|NCT00104676|156700562|FG001|Overall Study|Death|2|||
48685942|NCT00104676|156700561|FG000|Overall Study|Withdrawal by Subject|0|||
48685943|NCT00104676|156700562|FG001|Overall Study|Withdrawal by Subject|2|||
48685944|NCT00104676|156700561|FG000|Overall Study|treatment interruption|4|||
48685945|NCT00104676|156700562|FG001|Overall Study|treatment interruption|10|||
48685946|NCT00569127|156700563|FG000|Overall Study|Adverse Event|57|||
48685947|NCT00569127|156700564|FG001|Overall Study|Adverse Event|47|||
48685948|NCT00569127|156700563|FG000|Overall Study|Withdrawal by Subject|13|||
48685949|NCT00569127|156700564|FG001|Overall Study|Withdrawal by Subject|27|||
48685950|NCT00569127|156700563|FG000|Overall Study|Progression|99|||
48685951|NCT00569127|156700564|FG001|Overall Study|Progression|100|||
48685952|NCT00569127|156700563|FG000|Overall Study|Death|4|||
48685953|NCT00569127|156700564|FG001|Overall Study|Death|3|||
48685954|NCT00569127|156700563|FG000|Overall Study|Other|20|||
48685955|NCT00569127|156700564|FG001|Overall Study|Other|19|||
48685956|NCT00569127|156700563|FG000|Overall Study|Lost to Follow-up|0|||
48685957|NCT00569127|156700564|FG001|Overall Study|Lost to Follow-up|3|||
48685958|NCT00569127|156700563|FG000|Overall Study|Not Eligible|14|||
48685959|NCT00569127|156700564|FG001|Overall Study|Not Eligible|11|||
48685960|NCT00569127|156700563|FG000|Overall Study|Still on Treatment|7|||
48685961|NCT00569127|156700564|FG001|Overall Study|Still on Treatment|3|||
48685962|NCT02936635|156701884|FG000|Overall Study|Adverse Event|43|||
48685963|NCT02936635|156701885|FG001|Overall Study|Adverse Event|25|||
48685964|NCT02936635|156701884|FG000|Overall Study|Progressive Disease|10|||
48685965|NCT02936635|156701885|FG001|Overall Study|Progressive Disease|18|||
48685966|NCT02936635|156701884|FG000|Overall Study|Sponsor Discretion|10|||
48685967|NCT02936635|156701885|FG001|Overall Study|Sponsor Discretion|16|||
48685968|NCT02936635|156701884|FG000|Overall Study|Death|9|||
48685969|NCT02936635|156701885|FG001|Overall Study|Death|15|||
48685970|NCT02936635|156701884|FG000|Overall Study|Withdrawal by Subject|8|||
48685971|NCT02936635|156701885|FG001|Overall Study|Withdrawal by Subject|15|||
48685972|NCT02936635|156701884|FG000|Overall Study|Physician Decision|2|||
48685973|NCT02936635|156701885|FG001|Overall Study|Physician Decision|9|||
48685974|NCT02936635|156701884|FG000|Overall Study|Lost to Follow-up|1|||
48685975|NCT02936635|156701885|FG001|Overall Study|Lost to Follow-up|2|||
48685976|NCT02936635|156701884|FG000|Overall Study|Protocol Violation|1|||
48685977|NCT02936635|156701885|FG001|Overall Study|Protocol Violation|0|||
48685978|NCT02936635|156701884|FG000|Overall Study|Lack of effect/Entry into other study|31|||
48685979|NCT02936635|156701885|FG001|Overall Study|Lack of effect/Entry into other study|65|||
48685980|NCT01633788|156701886|FG000|Overall Study|Adverse Event|1|||
48685981|NCT01633788|156701887|FG001|Overall Study|Adverse Event|3|||
48685982|NCT01633788|156701888|FG002|Overall Study|Adverse Event|3|||
48685983|NCT01633788|156701889|FG003|Overall Study|Adverse Event|3|||
48685984|NCT01633788|156701886|FG000|Overall Study|Lost to Follow-up|2|||
48685985|NCT01633788|156701887|FG001|Overall Study|Lost to Follow-up|2|||
48685986|NCT01633788|156701888|FG002|Overall Study|Lost to Follow-up|2|||
48685987|NCT01633788|156701889|FG003|Overall Study|Lost to Follow-up|0|||
48685988|NCT01633788|156701886|FG000|Overall Study|Personal Reasons|3|||
48685989|NCT01633788|156701887|FG001|Overall Study|Personal Reasons|1|||
48685990|NCT01633788|156701888|FG002|Overall Study|Personal Reasons|1|||
48685991|NCT01633788|156701889|FG003|Overall Study|Personal Reasons|3|||
48685992|NCT01633788|156701886|FG000|Overall Study|Protocol Violation|1|||
48685993|NCT01633788|156701887|FG001|Overall Study|Protocol Violation|0|||
48685994|NCT01633788|156701888|FG002|Overall Study|Protocol Violation|1|||
48685995|NCT01633788|156701889|FG003|Overall Study|Protocol Violation|0|||
48685996|NCT01633788|156701886|FG000|Overall Study|Other Reasons|0|||
48685997|NCT01633788|156701887|FG001|Overall Study|Other Reasons|2|||
48685998|NCT01633788|156701888|FG002|Overall Study|Other Reasons|3|||
48685999|NCT01633788|156701889|FG003|Overall Study|Other Reasons|7|||
48686000|NCT01929226|156701890|FG000|Overall Study|Lost to Follow-up|4|||
48686001|NCT01929226|156701891|FG001|Overall Study|Lost to Follow-up|0|||
48686002|NCT01929226|156701890|FG000|Overall Study|Withdrawal by Subject|1|||
48686003|NCT01929226|156701891|FG001|Overall Study|Withdrawal by Subject|1|||
48686004|NCT00806988|156701892|FG000|Overall Study|Death|15|||
48686005|NCT00806988|156701893|FG001|Overall Study|Death|16|||
48686006|NCT00806988|156701892|FG000|Overall Study|Withdrawal by Subject|8|||
48686007|NCT00806988|156701893|FG001|Overall Study|Withdrawal by Subject|8|||
48686008|NCT00806988|156701892|FG000|Overall Study|Lost to Follow-up|4|||
48686009|NCT00806988|156701893|FG001|Overall Study|Lost to Follow-up|19|||
48686010|NCT01142388|156701901|FG000|Overall Study|Lack of Efficacy|21|||
48686011|NCT01142388|156701902|FG001|Overall Study|Lack of Efficacy|31|||
48686012|NCT01142388|156701901|FG000|Overall Study|Adverse Event|9|||
48686013|NCT01142388|156701902|FG001|Overall Study|Adverse Event|5|||
48686014|NCT01142388|156701901|FG000|Overall Study|Death|3|||
48686015|NCT01142388|156701902|FG001|Overall Study|Death|2|||
48686016|NCT01142388|156701901|FG000|Overall Study|Withdrawal by Subject|5|||
48686017|NCT01142388|156701902|FG001|Overall Study|Withdrawal by Subject|3|||
48686018|NCT01142388|156701901|FG000|Overall Study|Alternative therapy|1|||
48686019|NCT01142388|156701902|FG001|Overall Study|Alternative therapy|0|||
48686020|NCT01142388|156701901|FG000|Overall Study|Other complications|0|||
48763243|NCT03662542|156983810|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48763244|NCT03662542|156983811|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
48763245|NCT03662542|156983812|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48763246|NCT03662542|156983813|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48763247|NCT03662542|156983814|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
48391330|NCT01197521|155626774|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
48686021|NCT01142388|156701902|FG001|Overall Study|Other complications|2|||
48686022|NCT01142388|156701901|FG000|Overall Study|Other|1|||
48686023|NCT01142388|156701902|FG001|Overall Study|Other|1|||
48686024|NCT01142388|156701901|FG000|Overall Study|Never started therapy|7|||
48686025|NCT01142388|156701902|FG001|Overall Study|Never started therapy|3|||
48763248|NCT03662542|156983806|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
48391331|NCT01197521|155626775|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
48391332|NCT01197521|155626776|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
48391333|NCT01197521|155626774|FG000|Overall Study|Lost to Follow-up|3|||
48391334|NCT01197521|155626775|FG001|Overall Study|Lost to Follow-up|2|||
48391335|NCT01197521|155626776|FG002|Overall Study|Lost to Follow-up|2|||
48391336|NCT01197521|155626774|FG000|Overall Study|Adverse Event|25|||
48391337|NCT01197521|155626775|FG001|Overall Study|Adverse Event|28|||
48391338|NCT01197521|155626776|FG002|Overall Study|Adverse Event|24|||
48391339|NCT01560780|155626777|FG000|Overall Study|Death|2|||
48391340|NCT01560780|155626778|FG001|Overall Study|Death|1|||
48391341|NCT01560780|155626777|FG000|Overall Study|Patient Preference|11|||
48391342|NCT01560780|155626778|FG001|Overall Study|Patient Preference|11|||
48391343|NCT03975920|155626785|FG000|Overall Study|Lost to Follow-up|1|||
48391344|NCT03975920|155626786|FG001|Overall Study|Lost to Follow-up|2|||
48391345|NCT03975920|155626785|FG000|Overall Study|Protocol Violation|1|||
48391346|NCT03975920|155626786|FG001|Overall Study|Protocol Violation|1|||
48391347|NCT03975920|155626785|FG000|Overall Study|Did not complete survey|2|||
48391348|NCT03975920|155626786|FG001|Overall Study|Did not complete survey|1|||
48391349|NCT03199040|155626787|FG000|Overall Study|Lack of Efficacy|2|||
48391350|NCT03199040|155626788|FG001|Overall Study|Lack of Efficacy|0|||
48391351|NCT03199040|155626787|FG000|Overall Study|Withdrawal by Subject|2|||
48391352|NCT03199040|155626788|FG001|Overall Study|Withdrawal by Subject|0|||
48391353|NCT03199040|155626787|FG000|Overall Study|Adverse Event|0|||
48391354|NCT03199040|155626788|FG001|Overall Study|Adverse Event|1|||
48391355|NCT03199040|155626787|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
48391356|NCT03199040|155626788|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
48391357|NCT01786603|155626789|FG000|Overall Study|Death|5|||
48391358|NCT01786603|155626790|FG001|Overall Study|Death|1|||
48391359|NCT01786603|155626789|FG000|Overall Study|Adverse Event|6|||
48391360|NCT01786603|155626790|FG001|Overall Study|Adverse Event|2|||
48391361|NCT01786603|155626789|FG000|Overall Study|Physician decision to withdraw|6|||
48391362|NCT01786603|155626790|FG001|Overall Study|Physician decision to withdraw|7|||
48391363|NCT01786603|155626789|FG000|Overall Study|Lost to Follow-up|1|||
48391364|NCT01786603|155626790|FG001|Overall Study|Lost to Follow-up|2|||
48686086|NCT00799266|156701915|FG000|Overall Study|Adverse Event|0|||
48686087|NCT00799266|156701916|FG001|Overall Study|Adverse Event|1|||
48686088|NCT00799266|156701915|FG000|Overall Study|Subject withdrew consent|3|||
48686089|NCT00799266|156701916|FG001|Overall Study|Subject withdrew consent|0|||
48686090|NCT01276639|156701917|FG000|Week 0 to 16|Death|1|||
48686091|NCT01276639|156701918|FG001|Week 0 to 16|Death|0|||
48686092|NCT01276639|156701919|FG002|Week 0 to 16|Death|0|||
48686093|NCT01276639|156701920|FG003|Week 0 to 16|Death|0|||
48686094|NCT01276639|156701921|FG004|Week 0 to 16|Death|0|||
48686095|NCT01276639|156701917|FG000|Week 0 to 16|Adverse Event|11|||
48686096|NCT01276639|156701918|FG001|Week 0 to 16|Adverse Event|8|||
48686097|NCT01276639|156701919|FG002|Week 0 to 16|Adverse Event|11|||
48686098|NCT01276639|156701920|FG003|Week 0 to 16|Adverse Event|0|||
48686099|NCT01276639|156701921|FG004|Week 0 to 16|Adverse Event|0|||
48686100|NCT01276639|156701917|FG000|Week 0 to 16|Lack of Efficacy|20|||
48686101|NCT01276639|156701918|FG001|Week 0 to 16|Lack of Efficacy|15|||
48686102|NCT01276639|156701919|FG002|Week 0 to 16|Lack of Efficacy|25|||
48686103|NCT01276639|156701920|FG003|Week 0 to 16|Lack of Efficacy|0|||
48686104|NCT01276639|156701921|FG004|Week 0 to 16|Lack of Efficacy|0|||
48686105|NCT01276639|156701917|FG000|Week 0 to 16|Lost to Follow-up|3|||
48686106|NCT01276639|156701918|FG001|Week 0 to 16|Lost to Follow-up|5|||
48686107|NCT01276639|156701919|FG002|Week 0 to 16|Lost to Follow-up|3|||
48686108|NCT01276639|156701920|FG003|Week 0 to 16|Lost to Follow-up|0|||
48686109|NCT01276639|156701921|FG004|Week 0 to 16|Lost to Follow-up|0|||
48686110|NCT01276639|156701917|FG000|Week 0 to 16|Withdrawal by Subject|8|||
48686111|NCT01276639|156701918|FG001|Week 0 to 16|Withdrawal by Subject|5|||
48686112|NCT01276639|156701919|FG002|Week 0 to 16|Withdrawal by Subject|4|||
48686113|NCT01276639|156701920|FG003|Week 0 to 16|Withdrawal by Subject|0|||
48686114|NCT01276639|156701921|FG004|Week 0 to 16|Withdrawal by Subject|0|||
48686115|NCT01276639|156701917|FG000|Week 0 to 16|Other|7|||
48686116|NCT01276639|156701918|FG001|Week 0 to 16|Other|7|||
48686117|NCT01276639|156701919|FG002|Week 0 to 16|Other|2|||
48686118|NCT01276639|156701920|FG003|Week 0 to 16|Other|0|||
48686119|NCT01276639|156701921|FG004|Week 0 to 16|Other|0|||
48686120|NCT01276639|156701917|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
48686121|NCT01276639|156701918|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
48686122|NCT01276639|156701919|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
48686123|NCT01276639|156701920|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
48763249|NCT03662542|156983807|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
48391365|NCT00827606|155626792|FG000|Overall Study|Protocol Violation|4|||
48391366|NCT00827606|155626793|FG001|Overall Study|Protocol Violation|3|||
48391367|NCT00827606|155626792|FG000|Overall Study|Lost to Follow-up|3|||
48391368|NCT00827606|155626793|FG001|Overall Study|Lost to Follow-up|1|||
48391369|NCT00827606|155626792|FG000|Overall Study|Withdrawal by Subject|7|||
48391370|NCT00827606|155626793|FG001|Overall Study|Withdrawal by Subject|6|||
48391371|NCT00827606|155626792|FG000|Overall Study|Pregnancy|0|||
48391372|NCT00827606|155626793|FG001|Overall Study|Pregnancy|1|||
48391373|NCT00827606|155626792|FG000|Overall Study|Other|5|||
48391374|NCT00827606|155626793|FG001|Overall Study|Other|13|||
48391375|NCT00827606|155626792|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
48391376|NCT00827606|155626793|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
48391377|NCT00827606|155626792|FG000|Overall Study|Adverse Event|4|||
48391378|NCT00827606|155626793|FG001|Overall Study|Adverse Event|2|||
48391379|NCT02184195|155626796|FG000|Overall Study|Patient decision|5|||
48391380|NCT02184195|155626797|FG001|Overall Study|Patient decision|2|||
48391381|NCT02184195|155626796|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48391382|NCT02184195|155626797|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48686124|NCT01276639|156701921|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
48686125|NCT01276639|156701917|FG000|Week 16 to 52|Death|1|||
48686126|NCT01276639|156701918|FG001|Week 16 to 52|Death|0|||
48763250|NCT03662542|156983808|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
48391383|NCT02184195|155626796|FG000|Overall Study|Death|67|||
48391384|NCT02184195|155626797|FG001|Overall Study|Death|44|||
48391385|NCT02184195|155626796|FG000|Overall Study|Lost to Follow-up|1|||
48391386|NCT02184195|155626797|FG001|Overall Study|Lost to Follow-up|5|||
48391387|NCT02184195|155626796|FG000|Overall Study|Other|0|||
48391388|NCT02184195|155626797|FG001|Overall Study|Other|3|||
48391389|NCT00290342|155626798|FG000|Overall Study|Other|0|||
48391390|NCT00290342|155626799|FG001|Overall Study|Other|1|||
48391391|NCT00290342|155626798|FG000|Overall Study|Withdrawal by Subject|6|||
48391392|NCT00290342|155626799|FG001|Overall Study|Withdrawal by Subject|4|||
48686127|NCT01276639|156701919|FG002|Week 16 to 52|Death|0|||
48686128|NCT01276639|156701920|FG003|Week 16 to 52|Death|0|||
48686129|NCT01276639|156701921|FG004|Week 16 to 52|Death|0|||
48686130|NCT01276639|156701917|FG000|Week 16 to 52|Adverse Event|10|||
48686131|NCT01276639|156701918|FG001|Week 16 to 52|Adverse Event|13|||
48686132|NCT01276639|156701919|FG002|Week 16 to 52|Adverse Event|0|||
48686133|NCT01276639|156701920|FG003|Week 16 to 52|Adverse Event|1|||
48686134|NCT01276639|156701921|FG004|Week 16 to 52|Adverse Event|3|||
48686135|NCT01276639|156701917|FG000|Week 16 to 52|Lack of Efficacy|99|||
48686136|NCT01276639|156701918|FG001|Week 16 to 52|Lack of Efficacy|71|||
48686137|NCT01276639|156701919|FG002|Week 16 to 52|Lack of Efficacy|0|||
48686138|NCT01276639|156701920|FG003|Week 16 to 52|Lack of Efficacy|14|||
48686139|NCT01276639|156701921|FG004|Week 16 to 52|Lack of Efficacy|13|||
48686140|NCT01276639|156701917|FG000|Week 16 to 52|Lost to Follow-up|3|||
48686141|NCT01276639|156701918|FG001|Week 16 to 52|Lost to Follow-up|1|||
48686142|NCT01276639|156701919|FG002|Week 16 to 52|Lost to Follow-up|0|||
48686143|NCT01276639|156701920|FG003|Week 16 to 52|Lost to Follow-up|0|||
48686144|NCT01276639|156701921|FG004|Week 16 to 52|Lost to Follow-up|1|||
48686145|NCT01276639|156701917|FG000|Week 16 to 52|Withdrawal by Subject|4|||
48686146|NCT01276639|156701918|FG001|Week 16 to 52|Withdrawal by Subject|4|||
48686147|NCT01276639|156701919|FG002|Week 16 to 52|Withdrawal by Subject|0|||
48686148|NCT01276639|156701920|FG003|Week 16 to 52|Withdrawal by Subject|0|||
48686149|NCT01276639|156701921|FG004|Week 16 to 52|Withdrawal by Subject|1|||
48686150|NCT01276639|156701917|FG000|Week 16 to 52|Other|10|||
48686151|NCT01276639|156701918|FG001|Week 16 to 52|Other|12|||
48686152|NCT01276639|156701919|FG002|Week 16 to 52|Other|0|||
48686153|NCT01276639|156701920|FG003|Week 16 to 52|Other|1|||
48686154|NCT01276639|156701921|FG004|Week 16 to 52|Other|3|||
48686155|NCT00086047|156701922|FG000|Overall Study|Lost to Follow-up|7|||
48686156|NCT00086047|156701923|FG001|Overall Study|Lost to Follow-up|6|||
48686157|NCT00086047|156701922|FG000|Overall Study|Physician Decision|0|||
48686158|NCT00086047|156701923|FG001|Overall Study|Physician Decision|1|||
48686159|NCT01473732|156701926|FG000|Overall Study|Adverse Event|1|||
48686160|NCT01473732|156701927|FG001|Overall Study|Adverse Event|0|||
48686161|NCT01473732|156701926|FG000|Overall Study|Death|1|||
48686162|NCT01473732|156701927|FG001|Overall Study|Death|0|||
48686163|NCT02544503|156701928|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
48686164|NCT02544503|156701929|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
48686165|NCT02544503|156701928|FG000|Overall Study|Lost to Follow-up|9|||
48686166|NCT02544503|156701929|FG001|Overall Study|Lost to Follow-up|0|||
48686167|NCT02544503|156701928|FG000|Overall Study|Withdrawal by Subject|1|||
48686168|NCT02544503|156701929|FG001|Overall Study|Withdrawal by Subject|0|||
48686169|NCT02380287|156701933|FG000|Overall Study|Adverse Event|0|||
48686170|NCT02380287|156701934|FG001|Overall Study|Adverse Event|0|||
48686171|NCT02380287|156701935|FG002|Overall Study|Adverse Event|1|||
48686172|NCT02380287|156701936|FG003|Overall Study|Adverse Event|0|||
48686173|NCT02380287|156701937|FG004|Overall Study|Adverse Event|0|||
48686174|NCT02380287|156701938|FG005|Overall Study|Adverse Event|0|||
48686175|NCT02380287|156701939|FG006|Overall Study|Adverse Event|0|||
48686176|NCT02380287|156701940|FG007|Overall Study|Adverse Event|0|||
48686177|NCT03400852|156701941|FG000|Blinded Treatment Period|Physician Decision|0|||
48686178|NCT03400852|156701942|FG001|Blinded Treatment Period|Physician Decision|1|||
48686179|NCT03400852|156701943|FG002|Blinded Treatment Period|Physician Decision|0|||
48686180|NCT03400852|156701941|FG000|Blinded Treatment Period|Adverse Event|1|||
48686181|NCT03400852|156701942|FG001|Blinded Treatment Period|Adverse Event|1|||
48686182|NCT03400852|156701943|FG002|Blinded Treatment Period|Adverse Event|0|||
48686183|NCT03400852|156701941|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
48686184|NCT03400852|156701942|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
48686185|NCT03400852|156701943|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
48686186|NCT03400852|156701941|FG000|Open Label Period|Physician Decision|0|||
48686187|NCT03400852|156701942|FG001|Open Label Period|Physician Decision|0|||
48686188|NCT03400852|156701943|FG002|Open Label Period|Physician Decision|1|||
48686189|NCT03400852|156701941|FG000|Open Label Period|Study terminated by sponsor|0|||
48686190|NCT03400852|156701942|FG001|Open Label Period|Study terminated by sponsor|0|||
48686191|NCT03400852|156701943|FG002|Open Label Period|Study terminated by sponsor|21|||
48686192|NCT00587158|156701944|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
48686193|NCT00587158|156701945|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
48686194|NCT00587158|156701944|FG000|Overall Study|Physician Decision|0|||
48686195|NCT00587158|156701945|FG001|Overall Study|Physician Decision|1|||
48686196|NCT00587158|156701944|FG000|Overall Study|Lost to Follow-up|1|||
48686197|NCT00587158|156701945|FG001|Overall Study|Lost to Follow-up|2|||
48686198|NCT00587158|156701944|FG000|Overall Study|Death|0|||
48686199|NCT00587158|156701945|FG001|Overall Study|Death|1|||
48686200|NCT00587158|156701944|FG000|Overall Study|Subject did not want to take study med|0|||
48686201|NCT00587158|156701945|FG001|Overall Study|Subject did not want to take study med|1|||
48686202|NCT03010319|156701948|FG000|Overall Study|Adverse Event|15|||
48686203|NCT03010319|156701949|FG001|Overall Study|Adverse Event|9|||
48686204|NCT03010319|156701948|FG000|Overall Study|Withdrawal by Subject|1|||
48686205|NCT03010319|156701949|FG001|Overall Study|Withdrawal by Subject|6|||
48686206|NCT03010319|156701948|FG000|Overall Study|Physician Decision|2|||
48686207|NCT03010319|156701949|FG001|Overall Study|Physician Decision|4|||
48686208|NCT03010319|156701948|FG000|Overall Study|Sponsor requested withdrawal|2|||
48686209|NCT03010319|156701949|FG001|Overall Study|Sponsor requested withdrawal|2|||
48686210|NCT03010319|156701948|FG000|Overall Study|Death|1|||
48686211|NCT03010319|156701949|FG001|Overall Study|Death|0|||
48686212|NCT03010319|156701948|FG000|Overall Study|Lost to Follow-up|0|||
48686213|NCT03010319|156701949|FG001|Overall Study|Lost to Follow-up|1|||
48686214|NCT03010319|156701948|FG000|Overall Study|Other Reason|5|||
48686215|NCT03010319|156701949|FG001|Overall Study|Other Reason|7|||
48686216|NCT02532465|156701950|FG000|Overall Study|Protocol Violation|1|||
48686217|NCT02532465|156701951|FG001|Overall Study|Protocol Violation|0|||
48686218|NCT02532465|156701950|FG000|Overall Study|Lack of Efficacy|0|||
48686219|NCT02532465|156701951|FG001|Overall Study|Lack of Efficacy|1|||
48686220|NCT00718510|156701958|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
48686221|NCT00718510|156701959|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48686222|NCT00718510|156701958|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
48686223|NCT00718510|156701959|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48686224|NCT01217463|156701967|FG000|Overall Study|Adverse Event|8|||
48686225|NCT01217463|156701968|FG001|Overall Study|Adverse Event|5|||
48686226|NCT01217463|156701967|FG000|Overall Study|Physician Decision|0|||
48686227|NCT01217463|156701968|FG001|Overall Study|Physician Decision|1|||
48686228|NCT01217463|156701967|FG000|Overall Study|Withdrawal by Subject|3|||
48686229|NCT01217463|156701968|FG001|Overall Study|Withdrawal by Subject|0|||
48686230|NCT01217463|156701967|FG000|Overall Study|Surgery on the Target Limb|0|||
48686231|NCT01217463|156701968|FG001|Overall Study|Surgery on the Target Limb|1|||
48686232|NCT01217463|156701967|FG000|Overall Study|Patient Non-compliant|1|||
48686233|NCT01217463|156701968|FG001|Overall Study|Patient Non-compliant|0|||
48686234|NCT01217463|156701967|FG000|Overall Study|Other|1|||
48686235|NCT01217463|156701968|FG001|Overall Study|Other|1|||
48686236|NCT01521507|156701969|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
48686237|NCT01521507|156701970|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
48686238|NCT01521507|156701969|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
48686239|NCT01521507|156701970|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
48686240|NCT01521507|156701969|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
48686241|NCT01521507|156701970|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
48686242|NCT01521507|156701969|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
48686243|NCT01521507|156701970|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
48686244|NCT01521507|156701969|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
48686245|NCT01521507|156701970|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
48686246|NCT01521507|156701969|FG000|Stage 2: Observational Design|Physician Decision|1|||
48686247|NCT01521507|156701970|FG001|Stage 2: Observational Design|Physician Decision|0|||
48686256|NCT00580723|156701974|FG000|Overall Study|Did not want to participate in extension|3|||
48686257|NCT00580723|156701974|FG000|Overall Study|Lost to Follow-up|5|||
48686258|NCT02642042|156701977|FG000|Overall Study|Adverse Event|22|||
48686259|NCT02642042|156701977|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
48686260|NCT02642042|156701977|FG000|Overall Study|Progression/Relapse|28|||
48686261|NCT02642042|156701977|FG000|Overall Study|Death|1|||
48686262|NCT02642042|156701977|FG000|Overall Study|Not Protocol Specified|2|||
48686263|NCT05962814|156701978|FG000|Overall Study|failed eligibility|1|||
48686264|NCT00362648|156701979|FG000|Overall Study|Adverse Event|12|||
48686265|NCT00362648|156701980|FG001|Overall Study|Adverse Event|21|||
48686266|NCT00362648|156701981|FG002|Overall Study|Adverse Event|1|||
48686267|NCT00362648|156701982|FG003|Overall Study|Adverse Event|0|||
48686268|NCT00362648|156701979|FG000|Overall Study|Lost to Follow-up|62|||
48686269|NCT00362648|156701980|FG001|Overall Study|Lost to Follow-up|69|||
48686270|NCT00362648|156701981|FG002|Overall Study|Lost to Follow-up|4|||
48686271|NCT00362648|156701982|FG003|Overall Study|Lost to Follow-up|3|||
48686272|NCT00362648|156701979|FG000|Overall Study|Protocol Violation|4|||
48686273|NCT00362648|156701980|FG001|Overall Study|Protocol Violation|2|||
48686274|NCT00362648|156701981|FG002|Overall Study|Protocol Violation|2|||
48686275|NCT00362648|156701982|FG003|Overall Study|Protocol Violation|2|||
48686276|NCT00362648|156701979|FG000|Overall Study|Withdrawal by Subject|48|||
48686277|NCT00362648|156701980|FG001|Overall Study|Withdrawal by Subject|42|||
48686278|NCT00362648|156701981|FG002|Overall Study|Withdrawal by Subject|2|||
48686279|NCT00362648|156701982|FG003|Overall Study|Withdrawal by Subject|6|||
48686280|NCT00165672|156701984|FG000|Overall Study|Adverse Event|0|||
48686281|NCT00165672|156701985|FG001|Overall Study|Adverse Event|1|||
48686282|NCT05318937|156701986|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48686283|NCT05318937|156701987|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48686284|NCT05318937|156701986|FG000|Overall Study|Lost to Follow-up|0|||
48686285|NCT05318937|156701987|FG001|Overall Study|Lost to Follow-up|1|||
48686286|NCT05318937|156701986|FG000|Overall Study|Withdrawal by Subject|0|||
48686287|NCT05318937|156701987|FG001|Overall Study|Withdrawal by Subject|2|||
48686288|NCT05318937|156701986|FG000|Overall Study|Protocol Violation|0|||
48686289|NCT05318937|156701987|FG001|Overall Study|Protocol Violation|1|||
48686290|NCT02532621|156701988|FG000|Overall Study|Death|3|||
48686291|NCT02532621|156701988|FG000|Overall Study|Lost to Follow-up|3|||
48686292|NCT02532621|156701988|FG000|Overall Study|Withdrawal by Subject|6|||
48686293|NCT02532621|156701988|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
48686294|NCT02532621|156701988|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
48391393|NCT00290342|155626798|FG000|Overall Study|Lost to Follow-up|1|||
48391394|NCT00290342|155626799|FG001|Overall Study|Lost to Follow-up|0|||
48391395|NCT01056510|155626804|FG000|Overall Study|Dropout Before Start of Treatment|1|||
48391396|NCT01056510|155626805|FG001|Overall Study|Dropout Before Start of Treatment|1|||
48391397|NCT01056510|155626804|FG000|Overall Study|Withdrawal by Subject|4|||
48391398|NCT01056510|155626805|FG001|Overall Study|Withdrawal by Subject|2|||
48391399|NCT01056510|155626804|FG000|Overall Study|Death|29|||
48391400|NCT01056510|155626805|FG001|Overall Study|Death|34|||
48391401|NCT01056510|155626804|FG000|Overall Study|Noncompliance|1|||
48391402|NCT01056510|155626805|FG001|Overall Study|Noncompliance|3|||
48391403|NCT01056510|155626804|FG000|Overall Study|Physician Decision|4|||
48391404|NCT01056510|155626805|FG001|Overall Study|Physician Decision|5|||
48391405|NCT01056510|155626804|FG000|Overall Study|Lost to Follow-up|5|||
48391406|NCT01056510|155626805|FG001|Overall Study|Lost to Follow-up|6|||
48391407|NCT01056510|155626804|FG000|Overall Study|Other|10|||
48391408|NCT01056510|155626805|FG001|Overall Study|Other|12|||
48391409|NCT01056510|155626804|FG000|Overall Study|Missing|0|||
48391410|NCT01056510|155626805|FG001|Overall Study|Missing|1|||
48391411|NCT00589420|155626808|FG000|Overall Study|screen failure|1|||
48391412|NCT00841568|155626809|FG000|Overall Study|Adverse Event|1|||
48391413|NCT00841568|155626809|FG000|Overall Study|Death|1|||
48391414|NCT00841568|155626809|FG000|Overall Study|Withdrawal by Subject|2|||
48391415|NCT00841568|155626809|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
48391416|NCT00545298|155626812|FG000|Overall Study|Issues with Standard of Care|2|||
48391417|NCT00545298|155626813|FG001|Overall Study|Issues with Standard of Care|0|||
48391418|NCT00545298|155626814|FG002|Overall Study|Issues with Standard of Care|1|||
48391419|NCT04995055|155626815|FG000|Period 1|COVID-19 Related|1|||
48391420|NCT04995055|155626816|FG001|Period 1|COVID-19 Related|0|||
48391421|NCT04995055|155626815|FG000|Period 1|Withdrawal by Subject|0|||
48391422|NCT04995055|155626816|FG001|Period 1|Withdrawal by Subject|1|||
48391423|NCT04995055|155626815|FG000|Period 1|Subject discontinued due to timing|4|||
48391424|NCT04995055|155626816|FG001|Period 1|Subject discontinued due to timing|4|||
48391425|NCT01265797|155626823|FG000|Run-in Month|Withdrawal by Subject|0|||
48391426|NCT01265797|155626824|FG001|Run-in Month|Withdrawal by Subject|4|||
48391427|NCT01265797|155626823|FG000|Run-in Month|1st seizure during run-in month|0|||
48391428|NCT01265797|155626824|FG001|Run-in Month|1st seizure during run-in month|1|||
48391429|NCT01265797|155626823|FG000|Blinded Month|Lack of Efficacy|5|||
48391430|NCT01265797|155626824|FG001|Blinded Month|Lack of Efficacy|0|||
48391431|NCT01265797|155626823|FG000|Blinded Month|Lost to Follow-up|1|||
48391432|NCT01265797|155626824|FG001|Blinded Month|Lost to Follow-up|0|||
48391433|NCT01265797|155626823|FG000|Blinded Month|Protocol Violation|2|||
48391434|NCT01265797|155626824|FG001|Blinded Month|Protocol Violation|1|||
48391435|NCT01265797|155626823|FG000|Blinded Month|Adverse Event|2|||
48391436|NCT01265797|155626824|FG001|Blinded Month|Adverse Event|0|||
48391437|NCT01265797|155626823|FG000|Blinded Month|Diary data incomplete|0|||
48391438|NCT01265797|155626824|FG001|Blinded Month|Diary data incomplete|1|||
48686351|NCT01251861|156701998|FG000|Overall Study|Disease progression|6|||
48686352|NCT01251861|156701999|FG001|Overall Study|Disease progression|6|||
48686353|NCT01251861|156701998|FG000|Overall Study|Adverse Event|2|||
48686354|NCT01251861|156701999|FG001|Overall Study|Adverse Event|17|||
48686355|NCT01251861|156701998|FG000|Overall Study|Withdrawal by Subject|2|||
48391439|NCT01265797|155626823|FG000|Open Label Month|Lost to Follow-up|0|||
48391440|NCT01265797|155626824|FG001|Open Label Month|Lost to Follow-up|1|||
48391441|NCT01422915|155626825|FG000|Overall Study|Adverse Event|1|||
48391442|NCT04247061|155626829|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
48391443|NCT04247061|155626829|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
48391444|NCT04247061|155626829|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
48391445|NCT04688775|155626830|FG000|Placebo-controlled Period|Randomized, not treated|1|||
48686356|NCT01251861|156701999|FG001|Overall Study|Withdrawal by Subject|2|||
48686357|NCT01251861|156701998|FG000|Overall Study|Alternative therapy|1|||
48686358|NCT01251861|156701999|FG001|Overall Study|Alternative therapy|0|||
48686359|NCT01251861|156701998|FG000|Overall Study|Other complicating disease|0|||
48686360|NCT01251861|156701999|FG001|Overall Study|Other complicating disease|1|||
48686361|NCT01251861|156701998|FG000|Overall Study|Physician Decision|1|||
48686362|NCT01251861|156701999|FG001|Overall Study|Physician Decision|0|||
48686363|NCT01251861|156701998|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
48686364|NCT01251861|156701999|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
48686365|NCT01251861|156701998|FG000|Overall Study|Other|1|||
48686366|NCT01251861|156701999|FG001|Overall Study|Other|0|||
48686367|NCT01251861|156701998|FG000|Overall Study|Never started therapy|4|||
48686368|NCT01251861|156701999|FG001|Overall Study|Never started therapy|1|||
48686369|NCT01251861|156701998|FG000|Overall Study|Potential interaction of drugs|0|||
48686370|NCT01251861|156701999|FG001|Overall Study|Potential interaction of drugs|1|||
48686371|NCT03976323|156702002|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
48686372|NCT03976323|156702003|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
48686373|NCT03976323|156702004|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
48686374|NCT03976323|156702002|FG000|Induction Phase|Death|80|||
48686375|NCT03976323|156702003|FG001|Induction Phase|Death|0|||
48391446|NCT04688775|155626831|FG001|Placebo-controlled Period|Randomized, not treated|1|||
48391447|NCT04688775|155626832|FG002|Placebo-controlled Period|Randomized, not treated|0|||
48391448|NCT04688775|155626833|FG003|Placebo-controlled Period|Randomized, not treated|0|||
48686376|NCT03976323|156702004|FG002|Induction Phase|Death|0|||
48686377|NCT03976323|156702002|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
48686378|NCT03976323|156702003|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
48686379|NCT03976323|156702004|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
48686380|NCT03976323|156702002|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48686381|NCT03976323|156702003|FG001|Maintenance Phase|Withdrawal by Subject|9|||
48686382|NCT03976323|156702004|FG002|Maintenance Phase|Withdrawal by Subject|3|||
48686383|NCT03976323|156702002|FG000|Maintenance Phase|Physician Decision|0|||
48686384|NCT03976323|156702003|FG001|Maintenance Phase|Physician Decision|0|||
48686385|NCT03976323|156702004|FG002|Maintenance Phase|Physician Decision|1|||
48686386|NCT03976323|156702002|FG000|Maintenance Phase|Death|0|||
48686387|NCT03976323|156702003|FG001|Maintenance Phase|Death|228|||
48686388|NCT03976323|156702004|FG002|Maintenance Phase|Death|234|||
48686389|NCT01928927|156702005|FG000|Overall Study|Lost to Follow-up|1|||
48686390|NCT01928927|156702006|FG001|Overall Study|Lost to Follow-up|0|||
48686391|NCT01928927|156702005|FG000|Overall Study|Withdrawal by Subject|1|||
48686392|NCT01928927|156702006|FG001|Overall Study|Withdrawal by Subject|1|||
48686393|NCT03058692|156703590|FG000|Overall Study|Lost to Follow-up|2|||
48686394|NCT03058692|156703591|FG001|Overall Study|Lost to Follow-up|1|||
48686395|NCT03058692|156703590|FG000|Overall Study|Withdrawal by Subject|1|||
48686396|NCT03058692|156703591|FG001|Overall Study|Withdrawal by Subject|1|||
48686397|NCT04775953|156703592|FG000|Overall Study|Lost to Follow-up|6|||
48686398|NCT04775953|156703593|FG001|Overall Study|Lost to Follow-up|11|||
48686399|NCT04775953|156703592|FG000|Overall Study|Death|5|||
48686400|NCT04775953|156703593|FG001|Overall Study|Death|4|||
48686401|NCT04775953|156703592|FG000|Overall Study|Withdrawal by Subject|3|||
48686402|NCT04775953|156703593|FG001|Overall Study|Withdrawal by Subject|3|||
48686403|NCT04775953|156703592|FG000|Overall Study|Protocol Violation|2|||
48686404|NCT04775953|156703593|FG001|Overall Study|Protocol Violation|0|||
48686405|NCT04775953|156703592|FG000|Overall Study|Participant non-compliance|0|||
48686406|NCT04775953|156703593|FG001|Overall Study|Participant non-compliance|1|||
48686407|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
48686408|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
48686409|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
48686410|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
48686411|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
48686412|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
48686413|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
48686414|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
48686415|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
48686416|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
48686417|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
48686418|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
48686419|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
48686420|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
48686421|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
48686422|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
48686423|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
48686424|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
48686425|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
48686426|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
48686427|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
48686428|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
48686429|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
48686430|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
48686431|NCT03777059|156703594|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
48686432|NCT03777059|156703595|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
48686433|NCT03777059|156703596|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
48686434|NCT03777059|156703597|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
48686435|NCT03777059|156703594|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
48686436|NCT03777059|156703595|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
48686437|NCT03777059|156703596|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
48686438|NCT03777059|156703597|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
48686439|NCT03777059|156703594|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
48686440|NCT03777059|156703595|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
48686441|NCT03777059|156703596|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
48686442|NCT03777059|156703597|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
48686443|NCT03777059|156703594|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
48686444|NCT03777059|156703595|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
48686445|NCT03777059|156703596|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
48686446|NCT03777059|156703597|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
48686447|NCT03777059|156703594|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
48686448|NCT03777059|156703595|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
48686449|NCT03777059|156703596|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
48686450|NCT03777059|156703597|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
48686451|NCT04426318|156703603|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
48686452|NCT04426318|156703604|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
48686453|NCT03294590|156703610|FG000|Overall Study|Lost to Follow-up|105|||
48686454|NCT03294590|156703611|FG001|Overall Study|Lost to Follow-up|107|||
48391449|NCT04688775|155626830|FG000|Placebo-controlled Period|Adverse Event|2|||
48391450|NCT04688775|155626831|FG001|Placebo-controlled Period|Adverse Event|0|||
48391451|NCT04688775|155626832|FG002|Placebo-controlled Period|Adverse Event|0|||
48391452|NCT04688775|155626833|FG003|Placebo-controlled Period|Adverse Event|0|||
48391453|NCT04688775|155626830|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
48391454|NCT04688775|155626831|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
48391455|NCT04688775|155626832|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
48391456|NCT04688775|155626833|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
48391457|NCT04688775|155626830|FG000|Placebo-controlled Period|Protocol Violation|0|||
48391458|NCT04688775|155626831|FG001|Placebo-controlled Period|Protocol Violation|1|||
48391459|NCT04688775|155626832|FG002|Placebo-controlled Period|Protocol Violation|0|||
48391460|NCT04688775|155626833|FG003|Placebo-controlled Period|Protocol Violation|0|||
48391461|NCT04688775|155626830|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
48391462|NCT04688775|155626831|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
48391463|NCT04688775|155626832|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
48391464|NCT04688775|155626833|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
48391465|NCT04688775|155626830|FG000|Placebo-controlled Period|Other reasons|0|||
48391466|NCT04688775|155626831|FG001|Placebo-controlled Period|Other reasons|1|||
48686455|NCT03187132|156703612|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
48686456|NCT03187132|156703613|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
48686457|NCT03187132|156703612|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
48686458|NCT03187132|156703613|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
48686459|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
48686460|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
48686461|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
48686462|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
48686463|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
48686464|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
48686465|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
48686466|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
48686467|NCT03187132|156703612|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
48686468|NCT03187132|156703613|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
48686469|NCT03187132|156703612|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
48686470|NCT03187132|156703613|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
48686471|NCT03187132|156703612|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
48686472|NCT03187132|156703613|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
48686473|NCT03187132|156703612|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
48686474|NCT03187132|156703613|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
48686475|NCT03187132|156703612|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
48686476|NCT03187132|156703613|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
48686477|NCT03191630|156703614|FG000|Overall Study|Lost to Follow-up|7|||
48686478|NCT03191630|156703615|FG001|Overall Study|Lost to Follow-up|7|||
48686479|NCT02525588|156703616|FG000|Overall Study|Death|3|||
48686480|NCT02525588|156703617|FG001|Overall Study|Death|1|||
48686481|NCT02525588|156703616|FG000|Overall Study|Lost to Follow-up|2|||
48686482|NCT02525588|156703617|FG001|Overall Study|Lost to Follow-up|0|||
48686483|NCT02525588|156703616|FG000|Overall Study|Withdrawal by Subject|1|||
48686484|NCT02525588|156703617|FG001|Overall Study|Withdrawal by Subject|1|||
48686485|NCT02525588|156703616|FG000|Overall Study|Adverse Event|0|||
48686486|NCT02525588|156703617|FG001|Overall Study|Adverse Event|1|||
48686487|NCT03018691|156703618|FG000|Overall Study|Adverse Event|1|||
48686488|NCT03018691|156703619|FG001|Overall Study|Adverse Event|1|||
48686489|NCT03018691|156703620|FG002|Overall Study|Adverse Event|4|||
48686490|NCT03018691|156703618|FG000|Overall Study|Lack of Efficacy|0|||
48686491|NCT03018691|156703619|FG001|Overall Study|Lack of Efficacy|0|||
48391467|NCT04688775|155626832|FG002|Placebo-controlled Period|Other reasons|0|||
48391468|NCT04688775|155626833|FG003|Placebo-controlled Period|Other reasons|0|||
48391469|NCT04688775|155626830|FG000|Delayed Start Period|Adverse Event|0|||
48391470|NCT04688775|155626831|FG001|Delayed Start Period|Adverse Event|0|||
48391471|NCT04688775|155626832|FG002|Delayed Start Period|Adverse Event|1|||
48391472|NCT04688775|155626833|FG003|Delayed Start Period|Adverse Event|0|||
48391473|NCT04688775|155626830|FG000|Delayed Start Period|Lack of Efficacy|0|||
48686492|NCT03018691|156703620|FG002|Overall Study|Lack of Efficacy|1|||
48686493|NCT03018691|156703618|FG000|Overall Study|Withdrawal by Subject|0|||
48686494|NCT03018691|156703619|FG001|Overall Study|Withdrawal by Subject|0|||
48686495|NCT03018691|156703620|FG002|Overall Study|Withdrawal by Subject|1|||
48686496|NCT03018691|156703618|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48686497|NCT03018691|156703619|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48686498|NCT03018691|156703620|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48391474|NCT04688775|155626831|FG001|Delayed Start Period|Lack of Efficacy|0|||
48391475|NCT04688775|155626832|FG002|Delayed Start Period|Lack of Efficacy|0|||
48391476|NCT04688775|155626833|FG003|Delayed Start Period|Lack of Efficacy|3|||
48391477|NCT04688775|155626830|FG000|Delayed Start Period|Withdrawal by Subject|0|||
48391478|NCT04688775|155626831|FG001|Delayed Start Period|Withdrawal by Subject|0|||
48391479|NCT04688775|155626832|FG002|Delayed Start Period|Withdrawal by Subject|2|||
48391480|NCT04688775|155626833|FG003|Delayed Start Period|Withdrawal by Subject|4|||
48391481|NCT04688775|155626830|FG000|Delayed Start Period|Lost to Follow-up|0|||
48391482|NCT04688775|155626831|FG001|Delayed Start Period|Lost to Follow-up|0|||
48391483|NCT04688775|155626832|FG002|Delayed Start Period|Lost to Follow-up|2|||
48391484|NCT04688775|155626833|FG003|Delayed Start Period|Lost to Follow-up|1|||
48391485|NCT04688775|155626830|FG000|Delayed Start Period|other reasons|0|||
48391486|NCT04688775|155626831|FG001|Delayed Start Period|other reasons|0|||
48391487|NCT04688775|155626832|FG002|Delayed Start Period|other reasons|1|||
48391488|NCT04688775|155626833|FG003|Delayed Start Period|other reasons|0|||
48391489|NCT02354222|155626834|FG000|Overall Study|Adverse Event|0|||
48391490|NCT02354222|155626835|FG001|Overall Study|Adverse Event|3|||
48391491|NCT02354222|155626834|FG000|Overall Study|Physician Decision|1|||
48391492|NCT02354222|155626835|FG001|Overall Study|Physician Decision|1|||
48391493|NCT02354222|155626834|FG000|Overall Study|Pregnancy|1|||
48391494|NCT02354222|155626835|FG001|Overall Study|Pregnancy|0|||
48686499|NCT02611479|156703624|FG000|Baseline Enrollment|Exited study|13|||
48686500|NCT02611479|156703624|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
48686501|NCT02611479|156703624|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
48686502|NCT02611479|156703624|FG000|Data Cleaning|No baseline function or pain metrics|2|||
48686539|NCT01708941|156703630|FG000|Overall Study|Adverse Event|4|||
48391495|NCT02354222|155626834|FG000|Overall Study|Withdrawal by Subject|2|||
48391496|NCT02354222|155626835|FG001|Overall Study|Withdrawal by Subject|3|||
48391497|NCT02354222|155626834|FG000|Overall Study|Conflict with the stopping criteria|0|||
48391498|NCT02354222|155626835|FG001|Overall Study|Conflict with the stopping criteria|4|||
48391499|NCT02943564|155626836|FG000|Overall Study|Miscellaneous Reasons|0|||
48391500|NCT02943564|155626837|FG001|Overall Study|Miscellaneous Reasons|0|||
48391501|NCT02943564|155626838|FG002|Overall Study|Miscellaneous Reasons|3|||
48686540|NCT01708941|156703631|FG001|Overall Study|Adverse Event|6|||
48686541|NCT01708941|156703632|FG002|Overall Study|Adverse Event|1|||
48686542|NCT01708941|156703633|FG003|Overall Study|Adverse Event|0|||
48686543|NCT01708941|156703630|FG000|Overall Study|Death|1|||
48686544|NCT01708941|156703631|FG001|Overall Study|Death|1|||
48686545|NCT01708941|156703632|FG002|Overall Study|Death|2|||
48686546|NCT01708941|156703633|FG003|Overall Study|Death|14|||
48686547|NCT01708941|156703630|FG000|Overall Study|Withdrawal by Subject|1|||
48686548|NCT01708941|156703631|FG001|Overall Study|Withdrawal by Subject|0|||
48391502|NCT02943564|155626836|FG000|Overall Study|Site terminated by sponsor|0|||
48391503|NCT02943564|155626837|FG001|Overall Study|Site terminated by sponsor|1|||
48391504|NCT02943564|155626838|FG002|Overall Study|Site terminated by sponsor|0|||
48391505|NCT02943564|155626836|FG000|Overall Study|Non-compliance with study drug|0|||
48391506|NCT02943564|155626837|FG001|Overall Study|Non-compliance with study drug|1|||
48391507|NCT02943564|155626838|FG002|Overall Study|Non-compliance with study drug|0|||
48391508|NCT02943564|155626836|FG000|Overall Study|Pregnancy|0|||
48391509|NCT02943564|155626837|FG001|Overall Study|Pregnancy|1|||
48391510|NCT02943564|155626838|FG002|Overall Study|Pregnancy|1|||
48391511|NCT02943564|155626836|FG000|Overall Study|Protocol Violation|2|||
48391512|NCT02943564|155626837|FG001|Overall Study|Protocol Violation|2|||
48391513|NCT02943564|155626838|FG002|Overall Study|Protocol Violation|2|||
48391514|NCT02943564|155626836|FG000|Overall Study|Lost to Follow-up|1|||
48391515|NCT02943564|155626837|FG001|Overall Study|Lost to Follow-up|0|||
48686549|NCT01708941|156703632|FG002|Overall Study|Withdrawal by Subject|3|||
48686550|NCT01708941|156703633|FG003|Overall Study|Withdrawal by Subject|4|||
48686551|NCT01708941|156703630|FG000|Overall Study|Disease progression|9|||
48686552|NCT01708941|156703631|FG001|Overall Study|Disease progression|10|||
48686553|NCT01708941|156703632|FG002|Overall Study|Disease progression|8|||
48391516|NCT02943564|155626838|FG002|Overall Study|Lost to Follow-up|0|||
48686554|NCT01708941|156703633|FG003|Overall Study|Disease progression|0|||
48686555|NCT01708941|156703630|FG000|Overall Study|Alternative therapy|0|||
48686556|NCT01708941|156703631|FG001|Overall Study|Alternative therapy|0|||
48686557|NCT01708941|156703632|FG002|Overall Study|Alternative therapy|2|||
48686558|NCT01708941|156703633|FG003|Overall Study|Alternative therapy|0|||
48686559|NCT01708941|156703630|FG000|Overall Study|Ineligible and never started treatment|1|||
48686560|NCT01708941|156703631|FG001|Overall Study|Ineligible and never started treatment|0|||
48686561|NCT01708941|156703632|FG002|Overall Study|Ineligible and never started treatment|1|||
48686562|NCT01708941|156703633|FG003|Overall Study|Ineligible and never started treatment|0|||
48686563|NCT01708941|156703630|FG000|Overall Study|Never started treatment|2|||
48686564|NCT01708941|156703631|FG001|Overall Study|Never started treatment|1|||
48686565|NCT01708941|156703632|FG002|Overall Study|Never started treatment|0|||
48686566|NCT01708941|156703633|FG003|Overall Study|Never started treatment|0|||
48763251|NCT03662542|156983809|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
48763252|NCT03662542|156983810|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
48763253|NCT03662542|156983811|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
48763254|NCT03662542|156983812|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
48763255|NCT03662542|156983813|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
48763256|NCT03662542|156983814|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
48391517|NCT02943564|155626836|FG000|Overall Study|Withdrawal by Subject|6|||
48391518|NCT02943564|155626837|FG001|Overall Study|Withdrawal by Subject|5|||
48391519|NCT02943564|155626838|FG002|Overall Study|Withdrawal by Subject|2|||
48391520|NCT02943564|155626836|FG000|Overall Study|Adverse Event|1|||
48391521|NCT02943564|155626837|FG001|Overall Study|Adverse Event|2|||
48391522|NCT02943564|155626838|FG002|Overall Study|Adverse Event|1|||
48391523|NCT02943564|155626836|FG000|Overall Study|Lack of Efficacy|0|||
48391524|NCT02943564|155626837|FG001|Overall Study|Lack of Efficacy|1|||
48391525|NCT02943564|155626838|FG002|Overall Study|Lack of Efficacy|0|||
48391526|NCT00577642|155626839|FG000|Overall Study|Clinical Disease Progression|1|||
48391527|NCT00807742|155626846|FG000|Overall Study|Death|9|||
48391528|NCT00807742|155626847|FG001|Overall Study|Death|2|||
48391529|NCT00807742|155626846|FG000|Overall Study|Withdrawal by Subject|2|||
48391530|NCT00807742|155626847|FG001|Overall Study|Withdrawal by Subject|1|||
48391531|NCT00807742|155626846|FG000|Overall Study|Lost to Follow-up|35|||
48391532|NCT00807742|155626847|FG001|Overall Study|Lost to Follow-up|51|||
48391533|NCT00788372|155626851|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
48763257|NCT03662542|156983806|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48763258|NCT03662542|156983807|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48763259|NCT03662542|156983808|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48391534|NCT00788372|155626851|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
48391535|NCT00788372|155626851|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
48391536|NCT00788372|155626851|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
48391537|NCT00788372|155626851|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
48391538|NCT00788372|155626851|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
48686567|NCT01708941|156703630|FG000|Overall Study|Ineligible|0|||
48391539|NCT00788372|155626851|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
48391540|NCT04066491|155626858|FG000|Overall Study|Randomized, not treated|0|||
48686568|NCT01708941|156703631|FG001|Overall Study|Ineligible|0|||
48686569|NCT01708941|156703632|FG002|Overall Study|Ineligible|2|||
48686570|NCT01708941|156703633|FG003|Overall Study|Ineligible|0|||
48686571|NCT02698826|156703634|FG000|Overall Study|Death|13|||
48391541|NCT04066491|155626859|FG001|Overall Study|Randomized, not treated|0|||
48391542|NCT04066491|155626860|FG002|Overall Study|Randomized, not treated|2|||
48391543|NCT02043548|155626861|FG000|Overall Study|Lack of Efficacy|1|||
48686572|NCT02698826|156703634|FG000|Overall Study|Adverse Event|1|||
48686573|NCT00867165|156703635|FG000|Overall Study|Adverse Event|3|||
48686574|NCT00867165|156703636|FG001|Overall Study|Adverse Event|0|||
48686575|NCT00867165|156703635|FG000|Overall Study|Withdrawal by Subject|1|||
48686576|NCT00867165|156703636|FG001|Overall Study|Withdrawal by Subject|0|||
48686577|NCT03275740|156703637|FG000|Overall Study|Adverse Event|0|||
48686578|NCT03275740|156703638|FG001|Overall Study|Adverse Event|0|||
48686579|NCT03275740|156703639|FG002|Overall Study|Adverse Event|0|||
48686580|NCT03275740|156703640|FG003|Overall Study|Adverse Event|0|||
48686581|NCT03275740|156703641|FG004|Overall Study|Adverse Event|1|||
48686582|NCT03275740|156703642|FG005|Overall Study|Adverse Event|0|||
48686583|NCT03275740|156703643|FG006|Overall Study|Adverse Event|0|||
48686584|NCT03275740|156703644|FG007|Overall Study|Adverse Event|0|||
48686585|NCT03275740|156703645|FG008|Overall Study|Adverse Event|0|||
48686586|NCT03275740|156703646|FG009|Overall Study|Adverse Event|0|||
48686587|NCT03275740|156703647|FG010|Overall Study|Adverse Event|0|||
48686588|NCT03275740|156703648|FG011|Overall Study|Adverse Event|0|||
48686589|NCT03275740|156703637|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686590|NCT03275740|156703638|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686591|NCT03275740|156703639|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686592|NCT03275740|156703640|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686593|NCT03275740|156703641|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686594|NCT03275740|156703642|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
48686595|NCT03275740|156703643|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686596|NCT03275740|156703644|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686597|NCT03275740|156703645|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686598|NCT03275740|156703646|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686599|NCT03275740|156703647|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686600|NCT03275740|156703648|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
48686601|NCT03275740|156703637|FG000|Overall Study|Withdrawal by Subject|0|||
48686602|NCT03275740|156703638|FG001|Overall Study|Withdrawal by Subject|0|||
48686603|NCT03275740|156703639|FG002|Overall Study|Withdrawal by Subject|0|||
48686604|NCT03275740|156703640|FG003|Overall Study|Withdrawal by Subject|0|||
48686605|NCT03275740|156703641|FG004|Overall Study|Withdrawal by Subject|0|||
48686606|NCT03275740|156703642|FG005|Overall Study|Withdrawal by Subject|0|||
48686607|NCT03275740|156703643|FG006|Overall Study|Withdrawal by Subject|0|||
48686608|NCT03275740|156703644|FG007|Overall Study|Withdrawal by Subject|0|||
48686609|NCT03275740|156703645|FG008|Overall Study|Withdrawal by Subject|1|||
48686610|NCT03275740|156703646|FG009|Overall Study|Withdrawal by Subject|1|||
48686611|NCT03275740|156703647|FG010|Overall Study|Withdrawal by Subject|0|||
48686612|NCT03275740|156703648|FG011|Overall Study|Withdrawal by Subject|0|||
48686613|NCT01479868|156703651|FG000|Overall Study|Adverse Event|1|||
48686614|NCT01479868|156703651|FG000|Overall Study|Lost to Follow-up|4|||
48686615|NCT01479868|156703651|FG000|Overall Study|Protocol Violation|1|||
48686616|NCT01479868|156703651|FG000|Overall Study|Withdrawal by Subject|1|||
48686617|NCT01479868|156703651|FG000|Overall Study|Sponsor's Decision|1|||
48686618|NCT01479868|156703651|FG000|Overall Study|Initiation of new HCV Therapy|1|||
48686619|NCT01618669|156703652|FG000|Overall Study|Lost to Follow-up|1|||
48763260|NCT03662542|156983809|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48763261|NCT03662542|156983810|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48391544|NCT02043548|155626862|FG001|Overall Study|Lack of Efficacy|0|||
48391545|NCT02043548|155626861|FG000|Overall Study|Adverse Event|0|||
48391546|NCT02043548|155626862|FG001|Overall Study|Adverse Event|1|||
48391547|NCT02322125|155628370|FG000|Overall Study|Withdrawal by Subject|2|||
48391548|NCT00388973|155628373|FG000|Overall Study|Adverse Event|16|||
48391549|NCT00388973|155628374|FG001|Overall Study|Adverse Event|6|||
48391550|NCT00388973|155628373|FG000|Overall Study|Lack of Efficacy|1|||
48391551|NCT00388973|155628374|FG001|Overall Study|Lack of Efficacy|12|||
48391552|NCT00388973|155628373|FG000|Overall Study|Protocol Violation|3|||
48686620|NCT01618669|156703653|FG001|Overall Study|Lost to Follow-up|1|||
48686621|NCT01618669|156703652|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
48686622|NCT01618669|156703653|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
48686623|NCT01618669|156703652|FG000|Overall Study|Adverse Event|16|||
48686624|NCT01618669|156703653|FG001|Overall Study|Adverse Event|7|||
48391553|NCT00388973|155628374|FG001|Overall Study|Protocol Violation|0|||
48391554|NCT00388973|155628373|FG000|Overall Study|Withdrawal by Subject|14|||
48391555|NCT00388973|155628374|FG001|Overall Study|Withdrawal by Subject|17|||
48686625|NCT01618669|156703652|FG000|Overall Study|Protocol Violation|5|||
48763262|NCT03662542|156983811|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48391556|NCT00388973|155628373|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
48391557|NCT00388973|155628374|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
48686626|NCT01618669|156703653|FG001|Overall Study|Protocol Violation|3|||
48686627|NCT01618669|156703652|FG000|Overall Study|Withdrawal by Subject|9|||
48686628|NCT01618669|156703653|FG001|Overall Study|Withdrawal by Subject|9|||
48686629|NCT01618669|156703652|FG000|Overall Study|Miscellaneous Reason|0|||
48686630|NCT01618669|156703653|FG001|Overall Study|Miscellaneous Reason|1|||
48686631|NCT04317040|156703654|FG000|Overall Study|Lost to Follow-up|2|||
48686632|NCT04317040|156703655|FG001|Overall Study|Lost to Follow-up|0|||
48686633|NCT04317040|156703654|FG000|Overall Study|Death|16|||
48686634|NCT04317040|156703655|FG001|Overall Study|Death|18|||
48686635|NCT04317040|156703654|FG000|Overall Study|Withdrawal by Subject|0|||
48686636|NCT04317040|156703655|FG001|Overall Study|Withdrawal by Subject|1|||
48686637|NCT04317040|156703654|FG000|Overall Study|Incomplete assessments|0|||
48686638|NCT04317040|156703655|FG001|Overall Study|Incomplete assessments|1|||
48686639|NCT01632020|156703656|FG000|Overall Study|Withdrawal by Subject|1|||
48686640|NCT01632020|156703657|FG001|Overall Study|Withdrawal by Subject|0|||
48686641|NCT01632020|156703656|FG000|Overall Study|Adverse Event|1|||
48686642|NCT01632020|156703657|FG001|Overall Study|Adverse Event|0|||
48686643|NCT01076959|156703668|FG000|Overall Study|Adverse Event|767|||
48686644|NCT01076959|156703668|FG000|Overall Study|Lack of Efficacy|849|||
48686645|NCT01076959|156703668|FG000|Overall Study|Non-compliance|274|||
48686646|NCT01076959|156703668|FG000|Overall Study|Lost to Follow-up|241|||
48686647|NCT01076959|156703668|FG000|Overall Study|Other|119|||
48686648|NCT02868554|156703672|FG000|Overall Study|Lost to Follow-up|3|||
48686649|NCT02868554|156703673|FG001|Overall Study|Lost to Follow-up|0|||
48686650|NCT02868554|156703674|FG002|Overall Study|Lost to Follow-up|1|||
48686651|NCT00216671|156703675|FG000|Overall Study|Adverse Event|4|||
48686652|NCT00216671|156703676|FG001|Overall Study|Adverse Event|9|||
48686653|NCT00216671|156703675|FG000|Overall Study|Pregnancy|0|||
48686654|NCT00216671|156703676|FG001|Overall Study|Pregnancy|1|||
48686655|NCT00216671|156703675|FG000|Overall Study|Withdrawal by Subject|4|||
48686656|NCT00216671|156703676|FG001|Overall Study|Withdrawal by Subject|2|||
48686657|NCT00216671|156703675|FG000|Overall Study|Refused Injections|3|||
48686658|NCT00216671|156703676|FG001|Overall Study|Refused Injections|13|||
48686659|NCT00216671|156703675|FG000|Overall Study|No Need to Continue Medication|1|||
48686660|NCT00216671|156703676|FG001|Overall Study|No Need to Continue Medication|1|||
48686661|NCT00216671|156703675|FG000|Overall Study|Insufficient Response|9|||
48686662|NCT00216671|156703676|FG001|Overall Study|Insufficient Response|4|||
48686663|NCT00216671|156703675|FG000|Overall Study|Lost to Follow-up|3|||
48686664|NCT00216671|156703676|FG001|Overall Study|Lost to Follow-up|5|||
48686665|NCT00216671|156703675|FG000|Overall Study|Non compliant|2|||
48686666|NCT00216671|156703676|FG001|Overall Study|Non compliant|2|||
48686667|NCT00216671|156703675|FG000|Overall Study|Ineligible|0|||
48686668|NCT00216671|156703676|FG001|Overall Study|Ineligible|2|||
48686669|NCT00216671|156703675|FG000|Overall Study|Physician Decision|1|||
48686670|NCT00216671|156703676|FG001|Overall Study|Physician Decision|1|||
48686671|NCT00216671|156703675|FG000|Overall Study|Protocol Violation|3|||
48686672|NCT00216671|156703676|FG001|Overall Study|Protocol Violation|5|||
48686673|NCT00216671|156703675|FG000|Overall Study|Relapse|1|||
48686674|NCT00216671|156703676|FG001|Overall Study|Relapse|0|||
48686675|NCT00216671|156703675|FG000|Overall Study|Investigator Illness|0|||
48686676|NCT00216671|156703676|FG001|Overall Study|Investigator Illness|1|||
48686677|NCT00216671|156703675|FG000|Overall Study|Patient Moved|0|||
48391558|NCT00388973|155628373|FG000|Overall Study|Did not complete 61 days of treatment|5|||
48391559|NCT00388973|155628374|FG001|Overall Study|Did not complete 61 days of treatment|4|||
48391560|NCT00388973|155628373|FG000|Overall Study|Left region|0|||
48391561|NCT00388973|155628374|FG001|Overall Study|Left region|1|||
48391562|NCT00388973|155628373|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
48391563|NCT00388973|155628374|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
48391564|NCT03703882|155628379|FG000|Overall Study|Adverse Event|1|||
48686678|NCT00216671|156703676|FG001|Overall Study|Patient Moved|1|||
48686679|NCT00216671|156703675|FG000|Overall Study|Ineligible, no efficacy data|2|||
48686680|NCT00216671|156703676|FG001|Overall Study|Ineligible, no efficacy data|2|||
48686681|NCT00216671|156703675|FG000|Overall Study|Insufficient Response Adverse Event|2|||
48686682|NCT00216671|156703676|FG001|Overall Study|Insufficient Response Adverse Event|1|||
48391565|NCT03703882|155628380|FG001|Overall Study|Adverse Event|0|||
48391566|NCT03703882|155628379|FG000|Overall Study|Lost to Follow-up|0|||
48686683|NCT04119843|156703679|FG000|Overall Study|Adverse Event|3|||
48686684|NCT04119843|156703679|FG000|Overall Study|Death|1|||
48686685|NCT02910466|156703689|FG000|Overall Study|Adverse Event|1|||
48686686|NCT02910466|156703689|FG000|Overall Study|Withdrawal by Subject|3|||
48686687|NCT02910466|156703689|FG000|Overall Study|Lost to Follow-up|5|||
48686688|NCT02910466|156703689|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
48686689|NCT02910466|156703689|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
48686690|NCT02516241|156703690|FG000|Overall Study|Death|255|||
48686691|NCT02516241|156703691|FG001|Overall Study|Death|262|||
48686692|NCT02516241|156703692|FG002|Overall Study|Death|270|||
48686693|NCT02516241|156703690|FG000|Overall Study|Lost to Follow-up|1|||
48686694|NCT02516241|156703691|FG001|Overall Study|Lost to Follow-up|1|||
48686695|NCT02516241|156703692|FG002|Overall Study|Lost to Follow-up|3|||
48391567|NCT03703882|155628380|FG001|Overall Study|Lost to Follow-up|2|||
48391568|NCT03703882|155628379|FG000|Overall Study|Non-compliance with study drug|0|||
48391569|NCT03703882|155628380|FG001|Overall Study|Non-compliance with study drug|1|||
48391570|NCT03703882|155628379|FG000|Overall Study|Physician Decision|0|||
48391571|NCT03703882|155628380|FG001|Overall Study|Physician Decision|1|||
48391572|NCT03703882|155628379|FG000|Overall Study|Progressive disease|1|||
48391573|NCT03703882|155628380|FG001|Overall Study|Progressive disease|0|||
48391574|NCT03703882|155628379|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48391575|NCT03703882|155628380|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48391576|NCT03703882|155628379|FG000|Overall Study|Starting another treatment|0|||
48391577|NCT03703882|155628380|FG001|Overall Study|Starting another treatment|1|||
48391578|NCT03703882|155628379|FG000|Overall Study|noncompliance with study procedures|0|||
48391579|NCT03703882|155628380|FG001|Overall Study|noncompliance with study procedures|1|||
48391580|NCT02369848|155628381|FG000|Overall Study|Death|1|||
48391581|NCT02369848|155628381|FG000|Overall Study|Withdrawal by Subject|2|||
48686696|NCT02516241|156703690|FG000|Overall Study|Withdrawal by Subject|2|||
48391582|NCT02369848|155628381|FG000|Overall Study|Lost to Follow-up|1|||
48391583|NCT00402649|155628382|FG000|Overall Study|Lost to Follow-up|1|||
48391584|NCT00402649|155628382|FG000|Overall Study|Withdrawal by Subject|1|||
48391585|NCT04053868|155628383|FG000|Overall Study|Withdrawal by Subject|1|||
48391586|NCT04053868|155628384|FG001|Overall Study|Withdrawal by Subject|0|||
48391587|NCT01838616|155628385|FG000|Titration Period|Adverse Event|18|||
48391588|NCT01838616|155628386|FG001|Titration Period|Adverse Event|48|||
48391589|NCT01838616|155628385|FG000|Titration Period|Lack of Efficacy|5|||
48391590|NCT01838616|155628386|FG001|Titration Period|Lack of Efficacy|12|||
48391591|NCT01838616|155628385|FG000|Titration Period|Withdrawal by Subject|5|||
48391592|NCT01838616|155628386|FG001|Titration Period|Withdrawal by Subject|5|||
48391593|NCT01838616|155628385|FG000|Titration Period|Technical problems|1|||
48391594|NCT01838616|155628386|FG001|Titration Period|Technical problems|0|||
48391595|NCT01838616|155628385|FG000|Titration Period|Other|1|||
48391596|NCT01838616|155628386|FG001|Titration Period|Other|0|||
48391597|NCT01838616|155628385|FG000|Titration Period|Protocol Violation|0|||
48391598|NCT01838616|155628386|FG001|Titration Period|Protocol Violation|1|||
48391599|NCT01838616|155628385|FG000|Continuation Period|Lack of Efficacy|3|||
48391600|NCT01838616|155628386|FG001|Continuation Period|Lack of Efficacy|5|||
48391601|NCT01838616|155628385|FG000|Continuation Period|Adverse Event|8|||
48391602|NCT01838616|155628386|FG001|Continuation Period|Adverse Event|4|||
48391603|NCT01838616|155628385|FG000|Continuation Period|Protocol Violation|2|||
48391604|NCT01838616|155628386|FG001|Continuation Period|Protocol Violation|0|||
48391605|NCT01838616|155628385|FG000|Continuation Period|Lost to Follow-up|1|||
48391606|NCT01838616|155628386|FG001|Continuation Period|Lost to Follow-up|0|||
48391607|NCT01838616|155628385|FG000|Continuation Period|Withdrawal by Subject|0|||
48391608|NCT01838616|155628386|FG001|Continuation Period|Withdrawal by Subject|4|||
48391609|NCT01838616|155628385|FG000|Continuation Period|Technical problems|0|||
48391610|NCT01838616|155628386|FG001|Continuation Period|Technical problems|1|||
48391611|NCT01838616|155628385|FG000|Pick-up Arm|Lack of Efficacy|4|||
48686697|NCT02516241|156703691|FG001|Overall Study|Withdrawal by Subject|7|||
48686698|NCT02516241|156703692|FG002|Overall Study|Withdrawal by Subject|12|||
48686699|NCT02516241|156703690|FG000|Overall Study|participants ongoing at data cut-off|84|||
48686700|NCT02516241|156703691|FG001|Overall Study|participants ongoing at data cut-off|76|||
48686701|NCT02516241|156703692|FG002|Overall Study|participants ongoing at data cut-off|59|||
48686702|NCT06473662|156703693|FG000|Overall Study|Withdrawal by Subject|1|||
48686703|NCT06473662|156703694|FG001|Overall Study|Withdrawal by Subject|6|||
48686704|NCT06473662|156703695|FG002|Overall Study|Withdrawal by Subject|5|||
48686705|NCT06473662|156703693|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
48686706|NCT06473662|156703694|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
48686707|NCT06473662|156703695|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
48686708|NCT06473662|156703693|FG000|Overall Study|Starting HbA1c below 7%|0|||
48686709|NCT06473662|156703694|FG001|Overall Study|Starting HbA1c below 7%|1|||
48686710|NCT06473662|156703695|FG002|Overall Study|Starting HbA1c below 7%|1|||
48686711|NCT06473662|156703693|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
48391612|NCT01838616|155628386|FG001|Pick-up Arm|Lack of Efficacy|0|||
48391613|NCT01838616|155628385|FG000|Pick-up Arm|Adverse Event|9|||
48391614|NCT01838616|155628386|FG001|Pick-up Arm|Adverse Event|0|||
48391615|NCT01838616|155628385|FG000|Pick-up Arm|Withdrawal by Subject|1|||
48391616|NCT01838616|155628386|FG001|Pick-up Arm|Withdrawal by Subject|0|||
48391617|NCT01838616|155628385|FG000|Pick-up Arm|Technical problems|1|||
48391618|NCT01838616|155628386|FG001|Pick-up Arm|Technical problems|0|||
48391619|NCT03785925|155628389|FG000|Overall Study|Withdrawal by Subject|15|||
48391620|NCT03785925|155628389|FG000|Overall Study|Lost to Follow-up|1|||
48391621|NCT00840086|155628393|FG000|Overall Study|Adverse Event|1|||
48391622|NCT00840086|155628393|FG000|Overall Study|Protocol Violation|2|||
48391623|NCT00840086|155628393|FG000|Overall Study|Lost to Follow-up|1|||
48391624|NCT03332498|155628394|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
48391625|NCT03332498|155628395|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
48391626|NCT03332498|155628396|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
48686712|NCT06473662|156703694|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
48686713|NCT06473662|156703695|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
48686714|NCT06473662|156703693|FG000|Overall Study|Did not take medication|2|||
48686715|NCT06473662|156703694|FG001|Overall Study|Did not take medication|3|||
48686716|NCT06473662|156703695|FG002|Overall Study|Did not take medication|2|||
48686717|NCT00843882|156703696|FG000|Step 1|Lack of Efficacy|14|||
48686718|NCT00843882|156703697|FG001|Step 1|Lack of Efficacy|10|||
48686719|NCT00843882|156703698|FG002|Step 1|Lack of Efficacy|21|||
48686720|NCT00843882|156703696|FG000|Step 1|Adverse Event|8|||
48686721|NCT00843882|156703697|FG001|Step 1|Adverse Event|17|||
48686722|NCT00843882|156703698|FG002|Step 1|Adverse Event|20|||
48686723|NCT00843882|156703696|FG000|Step 1|Death|1|||
48686724|NCT00843882|156703697|FG001|Step 1|Death|2|||
48686725|NCT00843882|156703698|FG002|Step 1|Death|4|||
48686726|NCT00843882|156703696|FG000|Step 1|Withdrawal by Subject|6|||
48686727|NCT00843882|156703697|FG001|Step 1|Withdrawal by Subject|12|||
48686728|NCT00843882|156703698|FG002|Step 1|Withdrawal by Subject|9|||
48686729|NCT00843882|156703696|FG000|Step 1|Physician Decision|0|||
48686730|NCT00843882|156703697|FG001|Step 1|Physician Decision|5|||
48686731|NCT00843882|156703698|FG002|Step 1|Physician Decision|1|||
48686732|NCT00843882|156703696|FG000|Step 1|Patient and physician's decision|0|||
48686733|NCT00843882|156703697|FG001|Step 1|Patient and physician's decision|0|||
48686734|NCT00843882|156703698|FG002|Step 1|Patient and physician's decision|1|||
48686735|NCT00843882|156703696|FG000|Step 1|Other complicating disease|1|||
48686736|NCT00843882|156703697|FG001|Step 1|Other complicating disease|3|||
48686737|NCT00843882|156703698|FG002|Step 1|Other complicating disease|4|||
48686738|NCT00843882|156703696|FG000|Step 1|Alternative therapy|0|||
48686739|NCT00843882|156703697|FG001|Step 1|Alternative therapy|1|||
48686740|NCT00843882|156703698|FG002|Step 1|Alternative therapy|1|||
48686741|NCT00843882|156703696|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
48686742|NCT00843882|156703697|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
48686743|NCT00843882|156703698|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
48763263|NCT03662542|156983812|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
48763264|NCT03662542|156983813|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
48763265|NCT03662542|156983814|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
48763266|NCT03662542|156983806|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763267|NCT03662542|156983807|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763268|NCT03662542|156983808|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763269|NCT03662542|156983809|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763270|NCT03662542|156983810|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763271|NCT03662542|156983811|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763272|NCT03662542|156983812|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
48763273|NCT03662542|156983813|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
48763274|NCT03662542|156983814|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
48763275|NCT03662542|156983806|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763276|NCT03662542|156983807|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763277|NCT03662542|156983808|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763278|NCT03662542|156983809|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763279|NCT03662542|156983810|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763280|NCT03662542|156983811|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
48763281|NCT03662542|156983812|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
48763282|NCT03662542|156983813|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
48763283|NCT03662542|156983814|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
48763284|NCT00588822|156983817|FG000|Overall Study|progression of disease|8|||
48763285|NCT04014075|156983818|FG000|Overall Study|Progressive Disease|48|||
48763286|NCT04014075|156983818|FG000|Overall Study|Adverse Event|11|||
48763287|NCT04014075|156983818|FG000|Overall Study|Clinical Progression|4|||
48763288|NCT04014075|156983818|FG000|Overall Study|Death|2|||
48763289|NCT04014075|156983818|FG000|Overall Study|Withdrawal by Subject|2|||
48763290|NCT04014075|156983818|FG000|Overall Study|Miscellaneous|1|||
48686744|NCT00843882|156703696|FG000|Step 1|Off treatment reason unknown|0|||
48686745|NCT00843882|156703697|FG001|Step 1|Off treatment reason unknown|1|||
48686746|NCT00843882|156703698|FG002|Step 1|Off treatment reason unknown|4|||
48686747|NCT00843882|156703696|FG000|Step 1|Never started treatment|2|||
48686748|NCT00843882|156703697|FG001|Step 1|Never started treatment|0|||
48763291|NCT04014075|156983818|FG000|Overall Study|Physician Decision|1|||
48763292|NCT02945410|156983819|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48686749|NCT00843882|156703698|FG002|Step 1|Never started treatment|0|||
48686750|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
48763293|NCT02945410|156983820|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
48686751|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
48686752|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
48686753|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
48686754|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
48686755|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
48686756|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
48686757|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
48686758|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
48686759|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
48686760|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
48686761|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
48686762|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
48686763|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
48686764|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
48686765|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
48686766|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
48686767|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
48686768|NCT00843882|156703696|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
48686769|NCT00843882|156703697|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
48686770|NCT00843882|156703698|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
48686793|NCT00644228|156703701|FG000|Randomization & Eligibility|Ineligible|31|||
48686794|NCT00644228|156703702|FG001|Randomization & Eligibility|Ineligible|21|||
48686795|NCT00644228|156703701|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
48686796|NCT00644228|156703702|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
48686797|NCT00644228|156703701|FG000|Randomization & Eligibility|Invalid Consent|0|||
48686798|NCT00644228|156703702|FG001|Randomization & Eligibility|Invalid Consent|1|||
48686799|NCT00644228|156703701|FG000|Induction Therapy|Adverse Event|22|||
48686800|NCT00644228|156703702|FG001|Induction Therapy|Adverse Event|55|||
48686801|NCT00644228|156703701|FG000|Induction Therapy|Withdrawal by Subject|10|||
48686802|NCT00644228|156703702|FG001|Induction Therapy|Withdrawal by Subject|3|||
48686803|NCT00644228|156703701|FG000|Induction Therapy|Progression/Relapse|24|||
48686804|NCT00644228|156703702|FG001|Induction Therapy|Progression/Relapse|12|||
48686805|NCT00644228|156703701|FG000|Induction Therapy|Death|3|||
48686806|NCT00644228|156703702|FG001|Induction Therapy|Death|7|||
48686807|NCT00644228|156703701|FG000|Induction Therapy|Not Protocol-Specified|24|||
48686808|NCT00644228|156703702|FG001|Induction Therapy|Not Protocol-Specified|28|||
48391627|NCT02554019|155628397|FG000|Overall Study|Withdrawal by Subject|1|||
48391628|NCT02554019|155628398|FG001|Overall Study|Withdrawal by Subject|0|||
48391629|NCT02554019|155628399|FG002|Overall Study|Withdrawal by Subject|2|||
48391630|NCT02554019|155628397|FG000|Overall Study|Adverse Event|1|||
48391631|NCT02554019|155628398|FG001|Overall Study|Adverse Event|0|||
48391632|NCT02554019|155628399|FG002|Overall Study|Adverse Event|0|||
48686809|NCT00644228|156703701|FG000|Maintenance|Adverse Event|27|||
48686810|NCT00644228|156703702|FG001|Maintenance|Adverse Event|31|||
48686811|NCT00644228|156703701|FG000|Maintenance|Withdrawal by Subject|6|||
48686812|NCT00644228|156703702|FG001|Maintenance|Withdrawal by Subject|4|||
48686813|NCT00644228|156703701|FG000|Maintenance|Progression/Relapse|67|||
48686814|NCT00644228|156703702|FG001|Maintenance|Progression/Relapse|42|||
48391633|NCT00833053|155628400|FG000|Overall Study|Adverse Event|4|||
48391634|NCT00833053|155628401|FG001|Overall Study|Adverse Event|0|||
48686815|NCT00644228|156703701|FG000|Maintenance|Death|3|||
48686816|NCT00644228|156703702|FG001|Maintenance|Death|3|||
48686817|NCT00644228|156703701|FG000|Maintenance|Not Protocol-Specified|14|||
48391635|NCT00833053|155628400|FG000|Overall Study|Treatment Failure|3|||
48391636|NCT00833053|155628401|FG001|Overall Study|Treatment Failure|1|||
48391637|NCT00833053|155628400|FG000|Overall Study|Withdrawal by Subject|0|||
48391638|NCT00833053|155628401|FG001|Overall Study|Withdrawal by Subject|1|||
48391639|NCT00833053|155628400|FG000|Overall Study|Protocol Violation|2|||
48391640|NCT00833053|155628401|FG001|Overall Study|Protocol Violation|1|||
48391641|NCT00957528|155628403|FG000|Overall Study|Protocol Violation|0|||
48391642|NCT00957528|155628404|FG001|Overall Study|Protocol Violation|1|||
48391643|NCT00957528|155628405|FG002|Overall Study|Protocol Violation|0|||
48391644|NCT00957528|155628403|FG000|Overall Study|Withdrawal by Subject|0|||
48391645|NCT00957528|155628404|FG001|Overall Study|Withdrawal by Subject|0|||
48391646|NCT00957528|155628405|FG002|Overall Study|Withdrawal by Subject|1|||
48391647|NCT03357731|155628406|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
48391648|NCT03357731|155628407|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
48391649|NCT03357731|155628408|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
48391650|NCT03357731|155628409|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
48391651|NCT03357731|155628410|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
48391652|NCT03357731|155628411|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
48391653|NCT03357731|155628406|FG000|Overall Study|Acute bradycardia and hypotension|0|||
48391654|NCT03357731|155628407|FG001|Overall Study|Acute bradycardia and hypotension|0|||
48391655|NCT03357731|155628408|FG002|Overall Study|Acute bradycardia and hypotension|0|||
48391656|NCT03357731|155628409|FG003|Overall Study|Acute bradycardia and hypotension|1|||
48391657|NCT03357731|155628410|FG004|Overall Study|Acute bradycardia and hypotension|0|||
48391658|NCT03357731|155628411|FG005|Overall Study|Acute bradycardia and hypotension|0|||
48391659|NCT03357731|155628406|FG000|Overall Study|Adverse Event|0|||
48391660|NCT03357731|155628407|FG001|Overall Study|Adverse Event|0|||
48391661|NCT03357731|155628408|FG002|Overall Study|Adverse Event|0|||
48391662|NCT03357731|155628409|FG003|Overall Study|Adverse Event|0|||
48391663|NCT03357731|155628410|FG004|Overall Study|Adverse Event|0|||
48391664|NCT03357731|155628411|FG005|Overall Study|Adverse Event|1|||
48686818|NCT00644228|156703702|FG001|Maintenance|Not Protocol-Specified|15|||
48686819|NCT00644228|156703701|FG000|Maintenance|On Treatment|26|||
48686820|NCT00644228|156703702|FG001|Maintenance|On Treatment|40|||
48686821|NCT04378270|156703705|FG000|Overall Study|Lack of Efficacy|1|||
48686822|NCT04378270|156703705|FG000|Overall Study|Withdrawal by Subject|1|||
48686823|NCT04378270|156703705|FG000|Overall Study|Screen Failure|1|||
48686824|NCT04378270|156703705|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
48686825|NCT00717249|156703716|FG000|Overall Study|Lens Discomfort|4|||
48686826|NCT00717249|156703717|FG001|Overall Study|Lens Discomfort|1|||
48686827|NCT00717249|156703716|FG000|Overall Study|Unsatisfactory visual Response|0|||
48686828|NCT00717249|156703717|FG001|Overall Study|Unsatisfactory visual Response|2|||
48686829|NCT00717249|156703716|FG000|Overall Study|Adverse Event|4|||
48686830|NCT00717249|156703717|FG001|Overall Study|Adverse Event|2|||
48686831|NCT00717249|156703716|FG000|Overall Study|Lost to Follow-up|2|||
48686832|NCT00717249|156703717|FG001|Overall Study|Lost to Follow-up|0|||
48686833|NCT00717249|156703716|FG000|Overall Study|Withdrawal by Subject|1|||
48686834|NCT00717249|156703717|FG001|Overall Study|Withdrawal by Subject|2|||
48686835|NCT00717249|156703716|FG000|Overall Study|Pregnancy|6|||
48686836|NCT00717249|156703717|FG001|Overall Study|Pregnancy|3|||
48686837|NCT00717249|156703716|FG000|Overall Study|Protocol Violation|0|||
48686838|NCT00717249|156703717|FG001|Overall Study|Protocol Violation|2|||
48391665|NCT03357731|155628406|FG000|Overall Study|Hypotension|0|||
48391666|NCT03357731|155628407|FG001|Overall Study|Hypotension|0|||
48391667|NCT03357731|155628408|FG002|Overall Study|Hypotension|1|||
48391668|NCT03357731|155628409|FG003|Overall Study|Hypotension|1|||
48391669|NCT03357731|155628410|FG004|Overall Study|Hypotension|0|||
48391670|NCT03357731|155628411|FG005|Overall Study|Hypotension|0|||
48391671|NCT03357731|155628406|FG000|Overall Study|Lost to Follow-up|0|||
48391672|NCT03357731|155628407|FG001|Overall Study|Lost to Follow-up|0|||
48391673|NCT03357731|155628408|FG002|Overall Study|Lost to Follow-up|0|||
48391674|NCT03357731|155628409|FG003|Overall Study|Lost to Follow-up|1|||
48686839|NCT00717249|156703716|FG000|Overall Study|Subject became Ineligible|1|||
48391675|NCT03357731|155628410|FG004|Overall Study|Lost to Follow-up|0|||
48391676|NCT03357731|155628411|FG005|Overall Study|Lost to Follow-up|0|||
48391677|NCT01239342|155628413|FG000|Overall Study|Adverse Event|1|||
48391678|NCT01239342|155628414|FG001|Overall Study|Adverse Event|0|||
48391679|NCT01239342|155628413|FG000|Overall Study|Withdrawal by Subject|1|||
48391680|NCT01239342|155628414|FG001|Overall Study|Withdrawal by Subject|5|||
48391681|NCT01239342|155628413|FG000|Overall Study|Reason Unknown|1|||
48686840|NCT00717249|156703717|FG001|Overall Study|Subject became Ineligible|1|||
48686841|NCT00717249|156703716|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
48686842|NCT00717249|156703717|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
48686843|NCT00717249|156703716|FG000|Overall Study|Gastric Surgery|0|||
48686844|NCT00717249|156703717|FG001|Overall Study|Gastric Surgery|1|||
48391682|NCT01239342|155628414|FG001|Overall Study|Reason Unknown|1|||
48391683|NCT02318667|155628417|FG000|Overall Study|Adverse Event|1|||
48391684|NCT02318667|155628417|FG000|Overall Study|Lack of Efficacy|6|||
48391685|NCT02318667|155628417|FG000|Overall Study|Protocol Violation|2|||
48391686|NCT02257372|155628418|FG000|Overall Study|Adverse Event|3|||
48391687|NCT02257372|155628419|FG001|Overall Study|Adverse Event|7|||
48391688|NCT02257372|155628418|FG000|Overall Study|Lack of Efficacy|2|||
48391689|NCT02257372|155628419|FG001|Overall Study|Lack of Efficacy|1|||
48391690|NCT02257372|155628418|FG000|Overall Study|Protocol Violation|1|||
48391691|NCT02257372|155628419|FG001|Overall Study|Protocol Violation|1|||
48391692|NCT02257372|155628418|FG000|Overall Study|Lost to Follow-up|0|||
48391693|NCT02257372|155628419|FG001|Overall Study|Lost to Follow-up|1|||
48391694|NCT02257372|155628418|FG000|Overall Study|Withdrew consent|1|||
48391695|NCT02257372|155628419|FG001|Overall Study|Withdrew consent|0|||
48391696|NCT02634151|155628420|FG000|Overall Study|Withdrawal by Subject|1|||
48391697|NCT02634151|155628421|FG001|Overall Study|Withdrawal by Subject|0|||
48391698|NCT02634151|155628420|FG000|Overall Study|Non-Compliance|0|||
48391699|NCT02634151|155628421|FG001|Overall Study|Non-Compliance|1|||
48391700|NCT02634151|155628420|FG000|Overall Study|Other|0|||
48391701|NCT02634151|155628421|FG001|Overall Study|Other|1|||
48391702|NCT00003535|155628422|FG000|Overall Study|Not evaluable|5|||
48391703|NCT02289742|155628423|FG000|First Wear Period|Adverse event prior to treatment|0|||
48391704|NCT02289742|155628424|FG001|First Wear Period|Adverse event prior to treatment|1|||
48391705|NCT02289742|155628425|FG002|First Wear Period|Adverse event prior to treatment|0|||
48391706|NCT02289742|155628426|FG003|First Wear Period|Adverse event prior to treatment|0|||
48391707|NCT02289742|155628423|FG000|First Wear Period|Adverse Event|0|||
48391708|NCT02289742|155628424|FG001|First Wear Period|Adverse Event|0|||
48391709|NCT02289742|155628425|FG002|First Wear Period|Adverse Event|1|||
48391710|NCT02289742|155628426|FG003|First Wear Period|Adverse Event|0|||
48391711|NCT02289742|155628423|FG000|First Wear Period|Other prior to treatment|0|||
48391712|NCT02289742|155628424|FG001|First Wear Period|Other prior to treatment|0|||
48391713|NCT02289742|155628425|FG002|First Wear Period|Other prior to treatment|0|||
48391714|NCT02289742|155628426|FG003|First Wear Period|Other prior to treatment|1|||
48391715|NCT02289742|155628423|FG000|Third Wear Period|Adverse Event|0|||
48391716|NCT02289742|155628424|FG001|Third Wear Period|Adverse Event|1|||
48391717|NCT02289742|155628425|FG002|Third Wear Period|Adverse Event|0|||
48391718|NCT02289742|155628426|FG003|Third Wear Period|Adverse Event|0|||
48391719|NCT02289742|155628423|FG000|Third Wear Period|Reason not given|0|||
48391720|NCT02289742|155628424|FG001|Third Wear Period|Reason not given|0|||
48686845|NCT00717249|156703716|FG000|Overall Study|Diagnosed with Diabetes|1|||
48686846|NCT00717249|156703717|FG001|Overall Study|Diagnosed with Diabetes|0|||
48686847|NCT00717249|156703716|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
48686848|NCT00717249|156703717|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
48686849|NCT00717249|156703716|FG000|Overall Study|Subject relocated|1|||
48763294|NCT02945410|156983821|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48763295|NCT02945410|156983822|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48763296|NCT02945410|156983823|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48763297|NCT02945410|156983824|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
48763298|NCT02945410|156983819|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
48763299|NCT02945410|156983820|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
48763300|NCT02945410|156983821|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
48763301|NCT02945410|156983822|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
48763302|NCT02945410|156983823|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
48763303|NCT02945410|156983824|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
48763304|NCT02945410|156983819|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
48763305|NCT02945410|156983820|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
48763306|NCT02945410|156983821|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
48763307|NCT02945410|156983822|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
48763308|NCT02945410|156983823|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
48763309|NCT02945410|156983824|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
48763310|NCT00923559|156983827|FG000|Overall Study|Lost to Follow-up|2|||
48763311|NCT00923559|156983828|FG001|Overall Study|Lost to Follow-up|3|||
48391721|NCT02289742|155628425|FG002|Third Wear Period|Reason not given|0|||
48391722|NCT02289742|155628426|FG003|Third Wear Period|Reason not given|1|||
48391723|NCT00825162|155628433|FG000|Overall Study|Withdrawal by Subject|11|||
48391724|NCT00825162|155628434|FG001|Overall Study|Withdrawal by Subject|13|||
48686850|NCT00717249|156703717|FG001|Overall Study|Subject relocated|0|||
48686851|NCT00717249|156703716|FG000|Overall Study|Headaches|1|||
48686852|NCT00717249|156703717|FG001|Overall Study|Headaches|0|||
48686853|NCT03228537|156703718|FG000|Neoadjuvant|Adverse Event|2|||
48686854|NCT03228537|156703718|FG000|Neoadjuvant|Progression/Relapse|4|||
48763312|NCT00811577|156983829|FG000|Overall Study|Lost to Follow-up|7|||
48763313|NCT00811577|156983830|FG001|Overall Study|Lost to Follow-up|1|||
48763314|NCT00811577|156983829|FG000|Overall Study|Withdrawal by Subject|3|||
48391725|NCT00825162|155628435|FG002|Overall Study|Withdrawal by Subject|3|||
48391726|NCT00825162|155628433|FG000|Overall Study|Lost to Follow-up|9|||
48391727|NCT00825162|155628434|FG001|Overall Study|Lost to Follow-up|6|||
48391728|NCT00825162|155628435|FG002|Overall Study|Lost to Follow-up|3|||
48391729|NCT00825162|155628433|FG000|Overall Study|Physician Decision|2|||
48763315|NCT00811577|156983830|FG001|Overall Study|Withdrawal by Subject|0|||
48763316|NCT02385084|156983831|FG000|Period 2|Protocol Violation|0|||
48763317|NCT02385084|156983832|FG001|Period 2|Protocol Violation|0|||
48763318|NCT02385084|156983833|FG002|Period 2|Protocol Violation|1|||
48763319|NCT02385084|156983834|FG003|Period 2|Protocol Violation|0|||
48763320|NCT02385084|156983835|FG004|Period 2|Protocol Violation|0|||
48763321|NCT02385084|156983836|FG005|Period 2|Protocol Violation|0|||
48391730|NCT00825162|155628434|FG001|Overall Study|Physician Decision|0|||
48391731|NCT00825162|155628435|FG002|Overall Study|Physician Decision|0|||
48391732|NCT00825162|155628433|FG000|Overall Study|Move away from the study area|1|||
48391733|NCT00825162|155628434|FG001|Overall Study|Move away from the study area|0|||
48391734|NCT00825162|155628435|FG002|Overall Study|Move away from the study area|0|||
48391735|NCT00825162|155628433|FG000|Overall Study|Unable to attend the study visit|5|||
48391736|NCT00825162|155628434|FG001|Overall Study|Unable to attend the study visit|2|||
48391737|NCT00825162|155628435|FG002|Overall Study|Unable to attend the study visit|0|||
48391738|NCT00964743|155628436|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
48391739|NCT00939783|155628441|FG000|Overall Study|Death|6|||
48391740|NCT00939783|155628441|FG000|Overall Study|Adverse Event|39|||
48391741|NCT00939783|155628441|FG000|Overall Study|Study Terminated by Sponsor|498|||
48391742|NCT00939783|155628441|FG000|Overall Study|Withdrawal by Subject|78|||
48391743|NCT00939783|155628441|FG000|Overall Study|Other|16|||
48391744|NCT00939783|155628441|FG000|Overall Study|Lost to Follow-up|8|||
48391745|NCT00939783|155628441|FG000|Overall Study|Protocol Violation|3|||
48391746|NCT00939783|155628441|FG000|Overall Study|Enrolled but not treated|1|||
48391747|NCT02255409|155628442|FG000|Overall Study|Administrative Reason|3|||
48391748|NCT02255409|155628443|FG001|Overall Study|Administrative Reason|7|||
48391749|NCT02255409|155628442|FG000|Overall Study|Withdrawal by Subject|1|||
48391750|NCT02255409|155628443|FG001|Overall Study|Withdrawal by Subject|5|||
48391751|NCT02255409|155628442|FG000|Overall Study|Lost to Follow-up|10|||
48391752|NCT02255409|155628443|FG001|Overall Study|Lost to Follow-up|19|||
48391753|NCT04770389|155628444|FG000|Overall Study|Adverse Event|1|||
48391754|NCT04770389|155628445|FG001|Overall Study|Adverse Event|2|||
48391755|NCT04770389|155628446|FG002|Overall Study|Adverse Event|0|||
48391756|NCT04770389|155628447|FG003|Overall Study|Adverse Event|1|||
48391757|NCT04770389|155628444|FG000|Overall Study|Withdrawal by Subject|0|||
48391758|NCT04770389|155628445|FG001|Overall Study|Withdrawal by Subject|2|||
48391759|NCT04770389|155628446|FG002|Overall Study|Withdrawal by Subject|1|||
48391760|NCT04770389|155628447|FG003|Overall Study|Withdrawal by Subject|0|||
48391761|NCT04770389|155628444|FG000|Overall Study|Failed attempt to draw blood|1|||
48391762|NCT04770389|155628445|FG001|Overall Study|Failed attempt to draw blood|0|||
48391763|NCT04770389|155628446|FG002|Overall Study|Failed attempt to draw blood|0|||
48391764|NCT04770389|155628447|FG003|Overall Study|Failed attempt to draw blood|0|||
48391765|NCT04770389|155628444|FG000|Overall Study|Left the country|0|||
48391766|NCT04770389|155628445|FG001|Overall Study|Left the country|0|||
48391767|NCT04770389|155628446|FG002|Overall Study|Left the country|1|||
48391768|NCT04770389|155628447|FG003|Overall Study|Left the country|2|||
48391769|NCT04770389|155628444|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
48391770|NCT04770389|155628445|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
48391771|NCT04770389|155628446|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
48391772|NCT04770389|155628447|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
48391773|NCT04770389|155628444|FG000|Overall Study|Lost to Follow-up|0|||
48391774|NCT04770389|155628445|FG001|Overall Study|Lost to Follow-up|0|||
48391775|NCT04770389|155628446|FG002|Overall Study|Lost to Follow-up|0|||
48391776|NCT04770389|155628447|FG003|Overall Study|Lost to Follow-up|1|||
48391777|NCT04770389|155628444|FG000|Overall Study|Moved away from study site|0|||
48391778|NCT04770389|155628445|FG001|Overall Study|Moved away from study site|1|||
48391779|NCT04770389|155628446|FG002|Overall Study|Moved away from study site|0|||
48686855|NCT03228537|156703718|FG000|Neoadjuvant|Death|1|||
48686856|NCT03228537|156703718|FG000|Surgery|Death|1|||
48686857|NCT03228537|156703718|FG000|Surgery|Other - Not Protocol Specified|2|||
48686858|NCT03228537|156703718|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
48686859|NCT03228537|156703718|FG000|Maintenance|Progression/Relapse|10|||
48686860|NCT02038153|156705231|FG000|Overall Study|Withdrawal by Subject|1|||
48686861|NCT01101035|156705232|FG000|Overall Study|Adverse Event|191|||
48686862|NCT01101035|156705233|FG001|Overall Study|Adverse Event|172|||
48686863|NCT01101035|156705232|FG000|Overall Study|Major Protocol Deviation|52|||
48686864|NCT01101035|156705233|FG001|Overall Study|Major Protocol Deviation|46|||
48686865|NCT01101035|156705232|FG000|Overall Study|Lost to Follow-up|226|||
48686866|NCT01101035|156705233|FG001|Overall Study|Lost to Follow-up|223|||
48686867|NCT01101035|156705232|FG000|Overall Study|Voluntary Withdrawal|595|||
48686868|NCT01101035|156705233|FG001|Overall Study|Voluntary Withdrawal|587|||
48686869|NCT01101035|156705232|FG000|Overall Study|Reason not Specified|333|||
48763330|NCT01150123|156983843|FG000|Overall Study|Withdrawal by Subject|1|||
48763331|NCT01150123|156983844|FG001|Overall Study|Withdrawal by Subject|1|||
48763332|NCT01150123|156983845|FG002|Overall Study|Withdrawal by Subject|2|||
48763333|NCT01150123|156983846|FG003|Overall Study|Withdrawal by Subject|1|||
48763334|NCT01150123|156983847|FG004|Overall Study|Withdrawal by Subject|1|||
48763335|NCT01150123|156983848|FG005|Overall Study|Withdrawal by Subject|1|||
48763336|NCT01150123|156983849|FG006|Overall Study|Withdrawal by Subject|0|||
48763337|NCT01150123|156983850|FG007|Overall Study|Withdrawal by Subject|3|||
48763338|NCT01150123|156983851|FG008|Overall Study|Withdrawal by Subject|2|||
48391780|NCT04770389|155628447|FG003|Overall Study|Moved away from study site|0|||
48391781|NCT03127384|155628448|FG000|Overall Study|Lost to Follow-up|4|||
48391782|NCT03127384|155628448|FG000|Overall Study|Subject request|2|||
48391783|NCT04143009|155628449|FG000|Pilot Trial|Lost to Follow-up|0|||
48391784|NCT04143009|155628450|FG001|Pilot Trial|Lost to Follow-up|1|||
48391785|NCT04143009|155628451|FG002|Pilot Trial|Lost to Follow-up|1|||
48391786|NCT01033825|155628458|FG000|Overall Study|Withdrawal by Subject|2|||
48391787|NCT01033825|155628459|FG001|Overall Study|Withdrawal by Subject|3|||
48686870|NCT01101035|156705233|FG001|Overall Study|Reason not Specified|363|||
48686871|NCT00410761|156705234|FG000|Overall Study|Adverse Event|29|||
48686872|NCT00410761|156705235|FG001|Overall Study|Adverse Event|3|||
48686873|NCT00410761|156705234|FG000|Overall Study|objective disease progression|71|||
48686874|NCT00410761|156705235|FG001|Overall Study|objective disease progression|55|||
48686875|NCT00410761|156705234|FG000|Overall Study|Withdrawal by Subject|8|||
48686876|NCT00410761|156705235|FG001|Overall Study|Withdrawal by Subject|4|||
48686877|NCT00410761|156705234|FG000|Overall Study|Other|12|||
48686878|NCT00410761|156705235|FG001|Overall Study|Other|9|||
48686879|NCT00410761|156705234|FG000|Overall Study|Never received randomised treatment|0|||
48686880|NCT00410761|156705235|FG001|Overall Study|Never received randomised treatment|1|||
48686881|NCT00411671|156705240|FG000|Overall Study|Adverse Event|15|||
48686882|NCT00411671|156705240|FG000|Overall Study|Death|2|||
48686883|NCT00411671|156705240|FG000|Overall Study|Lost to Follow-up|3|||
48686884|NCT01080807|156705245|FG000|Overall Study|Adverse Event|9|||
48686885|NCT01080807|156705246|FG001|Overall Study|Adverse Event|1|||
48686886|NCT01080807|156705245|FG000|Overall Study|Lack of Efficacy|0|||
48686887|NCT01080807|156705246|FG001|Overall Study|Lack of Efficacy|1|||
48686888|NCT01080807|156705245|FG000|Overall Study|Withdrawal by Subject|7|||
48686889|NCT01080807|156705246|FG001|Overall Study|Withdrawal by Subject|2|||
48686890|NCT01080807|156705245|FG000|Overall Study|Protocol Violation|7|||
48686891|NCT01080807|156705246|FG001|Overall Study|Protocol Violation|6|||
48686892|NCT01080807|156705245|FG000|Overall Study|Lost to Follow-up|6|||
48686893|NCT01080807|156705246|FG001|Overall Study|Lost to Follow-up|4|||
48686894|NCT01080807|156705245|FG000|Overall Study|Noncompliance with drug administration|1|||
48686895|NCT01080807|156705246|FG001|Overall Study|Noncompliance with drug administration|1|||
48686896|NCT01080807|156705245|FG000|Overall Study|Noncompliance to study procedures|1|||
48686897|NCT01080807|156705246|FG001|Overall Study|Noncompliance to study procedures|1|||
48686898|NCT01080807|156705245|FG000|Overall Study|Began working day shift|0|||
48686899|NCT01080807|156705246|FG001|Overall Study|Began working day shift|2|||
48686900|NCT01080807|156705245|FG000|Overall Study|Laid off or terminated from job|1|||
48686901|NCT01080807|156705246|FG001|Overall Study|Laid off or terminated from job|2|||
48686902|NCT01080807|156705245|FG000|Overall Study|Stopped working consistent night shifts|0|||
48686903|NCT01080807|156705246|FG001|Overall Study|Stopped working consistent night shifts|1|||
48686904|NCT01080807|156705245|FG000|Overall Study|Work schedule changing|1|||
48686905|NCT01080807|156705246|FG001|Overall Study|Work schedule changing|1|||
48686906|NCT01080807|156705245|FG000|Overall Study|Work schedule and travel|0|||
48686907|NCT01080807|156705246|FG001|Overall Study|Work schedule and travel|1|||
48686908|NCT01080807|156705245|FG000|Overall Study|Switched to first shift|1|||
48686909|NCT01080807|156705246|FG001|Overall Study|Switched to first shift|0|||
48686910|NCT01080807|156705245|FG000|Overall Study|Moved away without notifying center|1|||
48686911|NCT01080807|156705246|FG001|Overall Study|Moved away without notifying center|0|||
48686912|NCT02836652|156705247|FG000|Overall Study|Death|3|||
48686913|NCT02836652|156705248|FG001|Overall Study|Death|3|||
48763339|NCT01150123|156983852|FG009|Overall Study|Withdrawal by Subject|0|||
48763340|NCT01150123|156983853|FG010|Overall Study|Withdrawal by Subject|1|||
48763341|NCT01150123|156983854|FG011|Overall Study|Withdrawal by Subject|0|||
48686914|NCT02836652|156705247|FG000|Overall Study|Transplant/Explant|3|||
48391788|NCT01033825|155628460|FG002|Overall Study|Withdrawal by Subject|2|||
48391789|NCT01033825|155628461|FG003|Overall Study|Withdrawal by Subject|1|||
48391790|NCT01033825|155628462|FG004|Overall Study|Withdrawal by Subject|1|||
48686915|NCT02836652|156705248|FG001|Overall Study|Transplant/Explant|4|||
48686916|NCT02836652|156705247|FG000|Overall Study|Withdrawn|9|||
48391791|NCT01033825|155628463|FG005|Overall Study|Withdrawal by Subject|0|||
48391792|NCT01033825|155628464|FG006|Overall Study|Withdrawal by Subject|0|||
48391793|NCT01033825|155628458|FG000|Overall Study|Adverse Event|0|||
48391794|NCT01033825|155628459|FG001|Overall Study|Adverse Event|0|||
48391795|NCT01033825|155628460|FG002|Overall Study|Adverse Event|0|||
48391796|NCT01033825|155628461|FG003|Overall Study|Adverse Event|1|||
48391797|NCT01033825|155628462|FG004|Overall Study|Adverse Event|0|||
48391798|NCT01033825|155628463|FG005|Overall Study|Adverse Event|0|||
48391799|NCT01033825|155628464|FG006|Overall Study|Adverse Event|0|||
48391800|NCT01033825|155628458|FG000|Overall Study|Protocol Violation|1|||
48391801|NCT01033825|155628459|FG001|Overall Study|Protocol Violation|0|||
48391802|NCT01033825|155628460|FG002|Overall Study|Protocol Violation|0|||
48391803|NCT01033825|155628461|FG003|Overall Study|Protocol Violation|0|||
48391804|NCT01033825|155628462|FG004|Overall Study|Protocol Violation|0|||
48391805|NCT01033825|155628463|FG005|Overall Study|Protocol Violation|0|||
48391806|NCT01033825|155628464|FG006|Overall Study|Protocol Violation|0|||
48391807|NCT01033825|155628458|FG000|Overall Study|Other|0|||
48391808|NCT01033825|155628459|FG001|Overall Study|Other|0|||
48391809|NCT01033825|155628460|FG002|Overall Study|Other|0|||
48391810|NCT01033825|155628461|FG003|Overall Study|Other|0|||
48391811|NCT01033825|155628462|FG004|Overall Study|Other|1|||
48391812|NCT01033825|155628463|FG005|Overall Study|Other|0|||
48391813|NCT01033825|155628464|FG006|Overall Study|Other|0|||
48391814|NCT00923130|155628467|FG000|Overall Study|Stopped treatment due to progression|17|||
48391815|NCT00923130|155628467|FG000|Overall Study|Death|1|||
48391816|NCT00923130|155628467|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
48391817|NCT00923130|155628467|FG000|Overall Study|Switched to alternative treatment|2|||
48391818|NCT00923130|155628467|FG000|Overall Study|Refused further treatment|2|||
48391819|NCT03159091|155628468|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
48391820|NCT03159091|155628469|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
48391821|NCT03159091|155628468|FG000|Overall Study|Patient has taken no dose of study drug|0|||
48391822|NCT03159091|155628469|FG001|Overall Study|Patient has taken no dose of study drug|1|||
48391823|NCT03693625|155628470|FG000|Overall Study|Adverse Event|2|||
48391824|NCT03693625|155628471|FG001|Overall Study|Adverse Event|0|||
48391825|NCT03693625|155628470|FG000|Overall Study|Study Terminated By Sponsor|20|||
48391826|NCT03693625|155628471|FG001|Overall Study|Study Terminated By Sponsor|7|||
48391827|NCT03693625|155628470|FG000|Overall Study|Withdrawal by Subject|1|||
48391828|NCT03693625|155628471|FG001|Overall Study|Withdrawal by Subject|1|||
48391829|NCT00761514|155628474|FG000|Overall Study|Adverse Event|1|||
48391830|NCT00761514|155628474|FG000|Overall Study|Withdrawal by Subject|2|||
48391831|NCT00761514|155628474|FG000|Overall Study|Lost to Follow-up|1|||
48391832|NCT00761514|155628474|FG000|Overall Study|Health insurance didn't cover study drug|1|||
48391833|NCT00761514|155628474|FG000|Overall Study|Problem complying with study visit|1|||
48391834|NCT00761514|155628474|FG000|Overall Study|Unable to pay for medications|1|||
48391835|NCT01003210|155628475|FG000|Overall Study|Lost to Follow-up|1|||
48391836|NCT01003210|155628476|FG001|Overall Study|Lost to Follow-up|3|||
48391837|NCT03077685|155628479|FG000|Overall Study|Lost to Follow-up|0|||
48391838|NCT03077685|155628480|FG001|Overall Study|Lost to Follow-up|0|||
48391839|NCT03077685|155628481|FG002|Overall Study|Lost to Follow-up|0|||
48391840|NCT03077685|155628482|FG003|Overall Study|Lost to Follow-up|0|||
48391841|NCT03077685|155628483|FG004|Overall Study|Lost to Follow-up|1|||
48391842|NCT03077685|155628479|FG000|Overall Study|Death|0|||
48391843|NCT03077685|155628480|FG001|Overall Study|Death|0|||
48391844|NCT03077685|155628481|FG002|Overall Study|Death|1|||
48391845|NCT03077685|155628482|FG003|Overall Study|Death|1|||
48391846|NCT03077685|155628483|FG004|Overall Study|Death|3|||
48391847|NCT03077685|155628479|FG000|Overall Study|Withdrawal by Subject|0|||
48391848|NCT03077685|155628480|FG001|Overall Study|Withdrawal by Subject|0|||
48391849|NCT03077685|155628481|FG002|Overall Study|Withdrawal by Subject|0|||
48391850|NCT03077685|155628482|FG003|Overall Study|Withdrawal by Subject|2|||
48391851|NCT03077685|155628483|FG004|Overall Study|Withdrawal by Subject|1|||
48391852|NCT03077685|155628479|FG000|Overall Study|Physician Decision|0|||
48391853|NCT03077685|155628480|FG001|Overall Study|Physician Decision|0|||
48391854|NCT03077685|155628481|FG002|Overall Study|Physician Decision|1|||
48391855|NCT03077685|155628482|FG003|Overall Study|Physician Decision|0|||
48391856|NCT03077685|155628483|FG004|Overall Study|Physician Decision|3|||
48391857|NCT03077685|155628479|FG000|Overall Study|Disease Progression|1|||
48391858|NCT03077685|155628480|FG001|Overall Study|Disease Progression|0|||
48391859|NCT03077685|155628481|FG002|Overall Study|Disease Progression|0|||
48391860|NCT03077685|155628482|FG003|Overall Study|Disease Progression|2|||
48391861|NCT03077685|155628483|FG004|Overall Study|Disease Progression|1|||
48391862|NCT03077685|155628479|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
48391863|NCT03077685|155628480|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
48391864|NCT03077685|155628481|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
48391865|NCT03077685|155628482|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
48391866|NCT03077685|155628483|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
48391867|NCT03077685|155628479|FG000|Overall Study|Subject entered hospice care|0|||
48391868|NCT03077685|155628480|FG001|Overall Study|Subject entered hospice care|0|||
48686917|NCT02836652|156705248|FG001|Overall Study|Withdrawn|9|||
48686918|NCT02836652|156705247|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
48686919|NCT02836652|156705248|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
48686920|NCT01220167|156705250|FG000|Period 3|Urine positive for substance abuse|0|||
48686921|NCT01220167|156705251|FG001|Period 3|Urine positive for substance abuse|1|||
48686922|NCT01220167|156705252|FG002|Period 3|Urine positive for substance abuse|0|||
48686923|NCT02366312|156705253|FG000|Overall Study|Lost to Follow-up|0|||
48686924|NCT02366312|156705254|FG001|Overall Study|Lost to Follow-up|1|||
48686925|NCT03594773|156705255|FG000|Overall Study|Withdrawal by Subject|3|||
48686926|NCT03594773|156705256|FG001|Overall Study|Withdrawal by Subject|2|||
48686927|NCT03594773|156705255|FG000|Overall Study|Lost to Follow-up|3|||
48686928|NCT03594773|156705256|FG001|Overall Study|Lost to Follow-up|4|||
48686929|NCT01290757|156705257|FG000|Overall Study|Adverse Event|1|||
48686930|NCT01290757|156705258|FG001|Overall Study|Adverse Event|0|||
48686931|NCT01290757|156705257|FG000|Overall Study|Protocol Violation|1|||
48686932|NCT01290757|156705258|FG001|Overall Study|Protocol Violation|1|||
48686933|NCT01290757|156705257|FG000|Overall Study|Other|0|||
48686934|NCT01290757|156705258|FG001|Overall Study|Other|1|||
48391869|NCT03077685|155628481|FG002|Overall Study|Subject entered hospice care|0|||
48391870|NCT03077685|155628482|FG003|Overall Study|Subject entered hospice care|0|||
48391871|NCT03077685|155628483|FG004|Overall Study|Subject entered hospice care|1|||
48391872|NCT02116777|155628487|FG000|Overall Study|Adverse Event|0|||
48391873|NCT02116777|155628488|FG001|Overall Study|Adverse Event|0|||
48391874|NCT02116777|155628489|FG002|Overall Study|Adverse Event|0|||
48686935|NCT02634333|156705260|FG000|Overall Study|Completed out of Window|3|||
48686936|NCT02634333|156705261|FG001|Overall Study|Completed out of Window|2|||
48686937|NCT02634333|156705260|FG000|Overall Study|Missed Visit|5|||
48686938|NCT02634333|156705261|FG001|Overall Study|Missed Visit|2|||
48686939|NCT02634333|156705260|FG000|Overall Study|Lost to Follow-up|12|||
48686940|NCT02634333|156705261|FG001|Overall Study|Lost to Follow-up|7|||
48686941|NCT02634333|156705260|FG000|Overall Study|Withdrawal by Subject|9|||
48686942|NCT02634333|156705261|FG001|Overall Study|Withdrawal by Subject|13|||
48686943|NCT02634333|156705260|FG000|Overall Study|Death|11|||
48686944|NCT02634333|156705261|FG001|Overall Study|Death|8|||
48686945|NCT01426958|156705262|FG000|Overall Study|Adverse Event|2|||
48686946|NCT02631551|156705263|FG000|Overall Study|Adverse Event|1|||
48686947|NCT02631551|156705264|FG001|Overall Study|Adverse Event|2|||
48686948|NCT02631551|156705265|FG002|Overall Study|Adverse Event|4|||
48686949|NCT02631551|156705266|FG003|Overall Study|Adverse Event|0|||
48686950|NCT02631551|156705263|FG000|Overall Study|Lack of Efficacy|0|||
48391875|NCT02116777|155628490|FG003|Overall Study|Adverse Event|0|||
48391876|NCT02116777|155628491|FG004|Overall Study|Adverse Event|2|||
48391877|NCT02116777|155628492|FG005|Overall Study|Adverse Event|2|||
48391878|NCT02116777|155628493|FG006|Overall Study|Adverse Event|0|||
48391879|NCT02116777|155628487|FG000|Overall Study|Death|0|||
48391880|NCT02116777|155628488|FG001|Overall Study|Death|0|||
48391881|NCT02116777|155628489|FG002|Overall Study|Death|0|||
48391882|NCT02116777|155628490|FG003|Overall Study|Death|1|||
48686951|NCT02631551|156705264|FG001|Overall Study|Lack of Efficacy|0|||
48686952|NCT02631551|156705265|FG002|Overall Study|Lack of Efficacy|1|||
48686953|NCT02631551|156705266|FG003|Overall Study|Lack of Efficacy|0|||
48686954|NCT02631551|156705263|FG000|Overall Study|Lost to Follow-up|1|||
48686955|NCT02631551|156705264|FG001|Overall Study|Lost to Follow-up|2|||
48686956|NCT02631551|156705265|FG002|Overall Study|Lost to Follow-up|0|||
48686957|NCT02631551|156705266|FG003|Overall Study|Lost to Follow-up|3|||
48686958|NCT02631551|156705263|FG000|Overall Study|Withdrawal by Subject|2|||
48686959|NCT02631551|156705264|FG001|Overall Study|Withdrawal by Subject|2|||
48686960|NCT02631551|156705265|FG002|Overall Study|Withdrawal by Subject|0|||
48686961|NCT02631551|156705266|FG003|Overall Study|Withdrawal by Subject|5|||
48391883|NCT02116777|155628491|FG004|Overall Study|Death|0|||
48391884|NCT02116777|155628492|FG005|Overall Study|Death|0|||
48391885|NCT02116777|155628493|FG006|Overall Study|Death|0|||
48391886|NCT02116777|155628487|FG000|Overall Study|Lack of Efficacy|3|||
48391887|NCT02116777|155628488|FG001|Overall Study|Lack of Efficacy|3|||
48686962|NCT02631551|156705263|FG000|Overall Study|Protocol deviation|3|||
48686963|NCT02631551|156705264|FG001|Overall Study|Protocol deviation|6|||
48686964|NCT02631551|156705265|FG002|Overall Study|Protocol deviation|3|||
48686965|NCT02631551|156705266|FG003|Overall Study|Protocol deviation|0|||
48391888|NCT02116777|155628489|FG002|Overall Study|Lack of Efficacy|3|||
48391889|NCT02116777|155628490|FG003|Overall Study|Lack of Efficacy|8|||
48686966|NCT02631551|156705263|FG000|Overall Study|Non-compliance with study procedures|0|||
48686967|NCT02631551|156705264|FG001|Overall Study|Non-compliance with study procedures|0|||
48686968|NCT02631551|156705265|FG002|Overall Study|Non-compliance with study procedures|1|||
48686969|NCT02631551|156705266|FG003|Overall Study|Non-compliance with study procedures|1|||
48686970|NCT02631551|156705263|FG000|Overall Study|Non-compliance with study drug|1|||
48686971|NCT02631551|156705264|FG001|Overall Study|Non-compliance with study drug|0|||
48391890|NCT02116777|155628491|FG004|Overall Study|Lack of Efficacy|4|||
48686972|NCT02631551|156705265|FG002|Overall Study|Non-compliance with study drug|0|||
48391891|NCT02116777|155628492|FG005|Overall Study|Lack of Efficacy|1|||
48391892|NCT02116777|155628493|FG006|Overall Study|Lack of Efficacy|9|||
48391893|NCT02116777|155628487|FG000|Overall Study|Physician Decision|0|||
48391894|NCT02116777|155628488|FG001|Overall Study|Physician Decision|0|||
48391895|NCT02116777|155628489|FG002|Overall Study|Physician Decision|0|||
48391896|NCT02116777|155628490|FG003|Overall Study|Physician Decision|2|||
48391897|NCT02116777|155628491|FG004|Overall Study|Physician Decision|0|||
48391898|NCT02116777|155628492|FG005|Overall Study|Physician Decision|0|||
48391899|NCT02116777|155628493|FG006|Overall Study|Physician Decision|0|||
48391900|NCT02116777|155628487|FG000|Overall Study|Protocol Violation|0|||
48391901|NCT02116777|155628488|FG001|Overall Study|Protocol Violation|0|||
48391902|NCT02116777|155628489|FG002|Overall Study|Protocol Violation|0|||
48391903|NCT02116777|155628490|FG003|Overall Study|Protocol Violation|1|||
48391904|NCT02116777|155628491|FG004|Overall Study|Protocol Violation|0|||
48391905|NCT02116777|155628492|FG005|Overall Study|Protocol Violation|0|||
48391906|NCT02116777|155628493|FG006|Overall Study|Protocol Violation|0|||
48391907|NCT02116777|155628487|FG000|Overall Study|Withdrawal by Subject|0|||
48391908|NCT02116777|155628488|FG001|Overall Study|Withdrawal by Subject|0|||
48391909|NCT02116777|155628489|FG002|Overall Study|Withdrawal by Subject|0|||
48391910|NCT02116777|155628490|FG003|Overall Study|Withdrawal by Subject|1|||
48391911|NCT02116777|155628491|FG004|Overall Study|Withdrawal by Subject|0|||
48686973|NCT02631551|156705266|FG003|Overall Study|Non-compliance with study drug|0|||
48686974|NCT02631551|156705263|FG000|Overall Study|Other, specific reasons not collected|5|||
48686975|NCT02631551|156705264|FG001|Overall Study|Other, specific reasons not collected|7|||
48686976|NCT02631551|156705265|FG002|Overall Study|Other, specific reasons not collected|2|||
48686977|NCT02631551|156705266|FG003|Overall Study|Other, specific reasons not collected|2|||
48686978|NCT01367834|156705267|FG000|Overall Study|Withdrawal by Subject|2|||
48686979|NCT01367834|156705268|FG001|Overall Study|Withdrawal by Subject|2|||
48686980|NCT01367834|156705267|FG000|Overall Study|Study was ended.|0|||
48686981|NCT01367834|156705268|FG001|Overall Study|Study was ended.|1|||
48686982|NCT01011673|156705273|FG000|Randomized|Secondary headache|2|||
48686983|NCT01011673|156705274|FG001|Randomized|Secondary headache|1|||
48686984|NCT01011673|156705273|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
48686985|NCT01011673|156705274|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
48686986|NCT00539994|156705280|FG000|Overall Study|Lost to Follow-up|2|||
48686987|NCT00539994|156705281|FG001|Overall Study|Lost to Follow-up|1|||
48686988|NCT00539994|156705282|FG002|Overall Study|Lost to Follow-up|0|||
48391912|NCT02116777|155628492|FG005|Overall Study|Withdrawal by Subject|0|||
48391913|NCT02116777|155628493|FG006|Overall Study|Withdrawal by Subject|0|||
48391914|NCT05038020|155628494|FG000|Overall Study|Early Termination|3|||
48391915|NCT05038020|155628495|FG001|Overall Study|Early Termination|0|||
48391916|NCT03581786|155630346|FG000|Overall Study|Death|17|||
48391917|NCT03581786|155630347|FG001|Overall Study|Death|12|||
48391918|NCT03581786|155630346|FG000|Overall Study|Withdrawal by Subject|2|||
48391919|NCT03581786|155630347|FG001|Overall Study|Withdrawal by Subject|4|||
48391920|NCT03581786|155630346|FG000|Overall Study|Lost to Follow-up|1|||
48391921|NCT03581786|155630347|FG001|Overall Study|Lost to Follow-up|0|||
48391922|NCT03581786|155630346|FG000|Overall Study|reason other than specified above|0|||
48391923|NCT03581786|155630347|FG001|Overall Study|reason other than specified above|1|||
48391924|NCT03581786|155630346|FG000|Overall Study|Ongoing in the study|123|||
48391925|NCT03581786|155630347|FG001|Overall Study|Ongoing in the study|129|||
48391926|NCT01251653|155630348|FG000|Overall Study|Progressive Disease|1|||
48391927|NCT01251653|155630349|FG001|Overall Study|Progressive Disease|7|||
48391928|NCT01251653|155630350|FG002|Overall Study|Progressive Disease|16|||
48391929|NCT01251653|155630351|FG003|Overall Study|Progressive Disease|4|||
48391930|NCT01251653|155630352|FG004|Overall Study|Progressive Disease|0|||
48686989|NCT00539994|156705280|FG000|Overall Study|Withdrawal by Subject|1|||
48686990|NCT00539994|156705281|FG001|Overall Study|Withdrawal by Subject|0|||
48686991|NCT00539994|156705282|FG002|Overall Study|Withdrawal by Subject|1|||
48391931|NCT01251653|155630353|FG005|Overall Study|Progressive Disease|17|||
48391932|NCT01251653|155630354|FG006|Overall Study|Progressive Disease|14|||
48391933|NCT01251653|155630355|FG007|Overall Study|Progressive Disease|7|||
48391934|NCT01251653|155630356|FG008|Overall Study|Progressive Disease|5|||
48391935|NCT01251653|155630348|FG000|Overall Study|Dose-limiting toxicity|0|||
48391936|NCT01251653|155630349|FG001|Overall Study|Dose-limiting toxicity|1|||
48686992|NCT00539994|156705280|FG000|Overall Study|Physician Decision|0|||
48686993|NCT00539994|156705281|FG001|Overall Study|Physician Decision|0|||
48686994|NCT00539994|156705282|FG002|Overall Study|Physician Decision|1|||
48686995|NCT01917747|156705284|FG000|Overall Study|Withdrawal by Subject|1|||
48686996|NCT01917747|156705285|FG001|Overall Study|Withdrawal by Subject|2|||
48686997|NCT01917747|156705284|FG000|Overall Study|Lost to Follow-up|18|||
48686998|NCT01917747|156705285|FG001|Overall Study|Lost to Follow-up|9|||
48686999|NCT03359174|156705292|FG000|Overall Study|Adverse Event|1|||
48687000|NCT02905266|156705295|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
48391937|NCT01251653|155630350|FG002|Overall Study|Dose-limiting toxicity|1|||
48391938|NCT01251653|155630351|FG003|Overall Study|Dose-limiting toxicity|1|||
48391939|NCT01251653|155630352|FG004|Overall Study|Dose-limiting toxicity|0|||
48391940|NCT01251653|155630353|FG005|Overall Study|Dose-limiting toxicity|0|||
48687001|NCT02905266|156705296|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
48687002|NCT02905266|156705295|FG000|Treatment Phase Part 1|Disease Progression|6|||
48687003|NCT02905266|156705296|FG001|Treatment Phase Part 1|Disease Progression|7|||
48687004|NCT02905266|156705295|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
48687005|NCT02905266|156705296|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
48687006|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
48687007|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
48687008|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
48687009|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
48687010|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
48687011|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
48687012|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Death|0|||
48687013|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Death|1|||
48687014|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
48687015|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
48687016|NCT02905266|156705295|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
48687017|NCT02905266|156705296|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
48687018|NCT02905266|156705295|FG000|Maintenance Phase Part 2|Disease Progression|9|||
48687019|NCT02905266|156705296|FG001|Maintenance Phase Part 2|Disease Progression|2|||
48687020|NCT02905266|156705295|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
48687021|NCT02905266|156705296|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
48687022|NCT02905266|156705295|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
48687023|NCT02905266|156705296|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
48687024|NCT00402168|156705297|FG000|Randomized|Lost to Follow-up|1|||
48687025|NCT00402168|156705298|FG001|Randomized|Lost to Follow-up|0|||
48687026|NCT00402168|156705297|FG000|Randomized|Withdrawal by Subject|0|||
48687027|NCT00402168|156705298|FG001|Randomized|Withdrawal by Subject|1|||
48687028|NCT00402168|156705297|FG000|Treatment (up to 12 Months)|Death|0|||
48687029|NCT00402168|156705298|FG001|Treatment (up to 12 Months)|Death|1|||
48687030|NCT00402168|156705297|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
48687031|NCT00402168|156705298|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
48687032|NCT00402168|156705297|FG000|Treatment (up to 12 Months)|non-specified|0|||
48687033|NCT00402168|156705298|FG001|Treatment (up to 12 Months)|non-specified|1|||
48687034|NCT00402168|156705297|FG000|Long Term (LT)|Adverse Event|1|||
48687035|NCT00402168|156705298|FG001|Long Term (LT)|Adverse Event|5|||
48687036|NCT00402168|156705297|FG000|Long Term (LT)|Withdrawal by Subject|4|||
48687037|NCT00402168|156705298|FG001|Long Term (LT)|Withdrawal by Subject|7|||
48687038|NCT00402168|156705297|FG000|Long Term (LT)|Pregnancy|0|||
48687039|NCT00402168|156705298|FG001|Long Term (LT)|Pregnancy|1|||
48687040|NCT00402168|156705297|FG000|Long Term (LT)|Lost to Follow-up|1|||
48687041|NCT00402168|156705298|FG001|Long Term (LT)|Lost to Follow-up|0|||
48687042|NCT00402168|156705297|FG000|Long Term (LT)|Death|4|||
48687043|NCT00402168|156705298|FG001|Long Term (LT)|Death|0|||
48687044|NCT00402168|156705297|FG000|Long Term (LT)|Lack of Efficacy|0|||
48687045|NCT00402168|156705298|FG001|Long Term (LT)|Lack of Efficacy|2|||
48687046|NCT00402168|156705297|FG000|Long Term (LT)|non-specified|1|||
48687047|NCT00402168|156705298|FG001|Long Term (LT)|non-specified|2|||
48687048|NCT00402168|156705297|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
48687049|NCT00402168|156705298|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
48687050|NCT00402168|156705297|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
48687051|NCT00402168|156705298|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
48687052|NCT02362724|156705299|FG000|Overall Study|Withdrawal by Subject|3|||
48687053|NCT02362724|156705300|FG001|Overall Study|Withdrawal by Subject|1|||
48687054|NCT02362724|156705299|FG000|Overall Study|Adverse Event|3|||
48687055|NCT02362724|156705300|FG001|Overall Study|Adverse Event|0|||
48391941|NCT01251653|155630354|FG006|Overall Study|Dose-limiting toxicity|2|||
48391942|NCT01251653|155630355|FG007|Overall Study|Dose-limiting toxicity|0|||
48391943|NCT01251653|155630356|FG008|Overall Study|Dose-limiting toxicity|0|||
48391944|NCT01251653|155630348|FG000|Overall Study|Adverse Event|1|||
48391945|NCT01251653|155630349|FG001|Overall Study|Adverse Event|0|||
48391946|NCT01251653|155630350|FG002|Overall Study|Adverse Event|2|||
48391947|NCT01251653|155630351|FG003|Overall Study|Adverse Event|1|||
48763342|NCT01150123|156983855|FG012|Overall Study|Withdrawal by Subject|1|||
48763343|NCT01150123|156983856|FG013|Overall Study|Withdrawal by Subject|0|||
48391948|NCT01251653|155630352|FG004|Overall Study|Adverse Event|1|||
48391949|NCT01251653|155630353|FG005|Overall Study|Adverse Event|0|||
48687056|NCT01332994|156705304|FG000|Overall Study|Adverse Event|34|||
48687057|NCT01332994|156705304|FG000|Overall Study|Death|1|||
48687058|NCT01332994|156705304|FG000|Overall Study|Lack of Efficacy|1|||
48687059|NCT01332994|156705304|FG000|Overall Study|Lost to Follow-up|4|||
48391950|NCT01251653|155630354|FG006|Overall Study|Adverse Event|2|||
48391951|NCT01251653|155630355|FG007|Overall Study|Adverse Event|2|||
48687060|NCT01332994|156705304|FG000|Overall Study|Protocol Violation|6|||
48687061|NCT01332994|156705304|FG000|Overall Study|Withdrawal by Subject|15|||
48687062|NCT01332994|156705304|FG000|Overall Study|Administrative Problem|2|||
48687063|NCT01332994|156705304|FG000|Overall Study|Other|8|||
48687064|NCT02800863|156705305|FG000|Overall Study|Adverse Event|14|||
48687065|NCT02800863|156705305|FG000|Overall Study|Another Device Implanted|1|||
48687066|NCT02800863|156705305|FG000|Overall Study|Device Explanted|1|||
48687067|NCT02800863|156705305|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
48687068|NCT02800863|156705305|FG000|Overall Study|Health Issues|1|||
48687069|NCT02800863|156705305|FG000|Overall Study|Insurance Denial|8|||
48687070|NCT02800863|156705305|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
48687071|NCT02800863|156705305|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
48687072|NCT02800863|156705305|FG000|Overall Study|Screen Failure|1|||
48687073|NCT02800863|156705305|FG000|Overall Study|Sponsor Request|6|||
48687074|NCT02800863|156705305|FG000|Overall Study|Death|3|||
48687075|NCT02800863|156705305|FG000|Overall Study|Subject Implant at Another Facility|1|||
48687076|NCT02800863|156705305|FG000|Overall Study|Lost to Follow-up|26|||
48687077|NCT02800863|156705305|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
48687078|NCT02800863|156705305|FG000|Overall Study|Subject and/or Family Request|64|||
48687079|NCT02800863|156705305|FG000|Overall Study|Trial Failure|81|||
48687080|NCT02800863|156705305|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
48687081|NCT02966873|156705306|FG000|Overall Study|Lost to Follow-up|16|||
48687082|NCT02966873|156705307|FG001|Overall Study|Lost to Follow-up|15|||
48687083|NCT04816214|156705312|FG000|Overall Study|Progressive Disease|4|||
48687084|NCT04816214|156705313|FG001|Overall Study|Progressive Disease|0|||
48687085|NCT04816214|156705314|FG002|Overall Study|Progressive Disease|0|||
48687086|NCT04816214|156705312|FG000|Overall Study|Death|1|||
48687087|NCT04816214|156705313|FG001|Overall Study|Death|0|||
48687088|NCT04816214|156705314|FG002|Overall Study|Death|0|||
48687089|NCT04816214|156705312|FG000|Overall Study|Study Terminated by Sponsor|1|||
48687090|NCT04816214|156705313|FG001|Overall Study|Study Terminated by Sponsor|0|||
48687091|NCT04816214|156705314|FG002|Overall Study|Study Terminated by Sponsor|0|||
48687092|NCT00584415|156705320|FG000|Overall Study|Adverse Event|7|||
48687093|NCT04170543|156705321|FG000|Overall Study|Death|1|||
48687094|NCT04170543|156705322|FG001|Overall Study|Death|1|||
48687095|NCT04170543|156705323|FG002|Overall Study|Death|1|||
48687096|NCT04170543|156705324|FG003|Overall Study|Death|1|||
48687097|NCT04170543|156705325|FG004|Overall Study|Death|1|||
48763344|NCT01150123|156983857|FG014|Overall Study|Withdrawal by Subject|0|||
48763345|NCT01150123|156983858|FG015|Overall Study|Withdrawal by Subject|1|||
48763346|NCT01150123|156983859|FG016|Overall Study|Withdrawal by Subject|0|||
48391952|NCT01251653|155630356|FG008|Overall Study|Adverse Event|1|||
48391953|NCT01251653|155630348|FG000|Overall Study|Withdrawal by Subject|1|||
48391954|NCT01251653|155630349|FG001|Overall Study|Withdrawal by Subject|0|||
48391955|NCT01251653|155630350|FG002|Overall Study|Withdrawal by Subject|1|||
48391956|NCT01251653|155630351|FG003|Overall Study|Withdrawal by Subject|0|||
48391957|NCT01251653|155630352|FG004|Overall Study|Withdrawal by Subject|1|||
48391958|NCT01251653|155630353|FG005|Overall Study|Withdrawal by Subject|1|||
48391959|NCT01251653|155630354|FG006|Overall Study|Withdrawal by Subject|0|||
48391960|NCT01251653|155630355|FG007|Overall Study|Withdrawal by Subject|1|||
48391961|NCT01251653|155630356|FG008|Overall Study|Withdrawal by Subject|0|||
48391962|NCT01251653|155630348|FG000|Overall Study|Other reason not mentioned above|0|||
48391963|NCT01251653|155630349|FG001|Overall Study|Other reason not mentioned above|0|||
48391964|NCT01251653|155630350|FG002|Overall Study|Other reason not mentioned above|0|||
48391965|NCT01251653|155630351|FG003|Overall Study|Other reason not mentioned above|0|||
48391966|NCT01251653|155630352|FG004|Overall Study|Other reason not mentioned above|0|||
48391967|NCT01251653|155630353|FG005|Overall Study|Other reason not mentioned above|0|||
48391968|NCT01251653|155630354|FG006|Overall Study|Other reason not mentioned above|0|||
48391969|NCT01251653|155630355|FG007|Overall Study|Other reason not mentioned above|2|||
48391970|NCT01251653|155630356|FG008|Overall Study|Other reason not mentioned above|0|||
48391971|NCT01439282|155630357|FG000|Overall Study|Adverse Event|5|||
48391972|NCT01439282|155630358|FG001|Overall Study|Adverse Event|0|||
48391973|NCT01439282|155630357|FG000|Overall Study|Withdrawal by Subject|2|||
48391974|NCT01439282|155630358|FG001|Overall Study|Withdrawal by Subject|0|||
48391975|NCT01439282|155630357|FG000|Overall Study|Other|1|||
48391976|NCT01439282|155630358|FG001|Overall Study|Other|1|||
48391977|NCT01502709|155630359|FG000|Overall Study|Lost to Follow-up|4|||
48391978|NCT01502709|155630360|FG001|Overall Study|Lost to Follow-up|0|||
48391979|NCT04179734|155630362|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
48687098|NCT04170543|156705321|FG000|Overall Study|Lost to Follow-up|3|||
48687099|NCT04170543|156705322|FG001|Overall Study|Lost to Follow-up|3|||
48687100|NCT04170543|156705323|FG002|Overall Study|Lost to Follow-up|0|||
48687101|NCT04170543|156705324|FG003|Overall Study|Lost to Follow-up|3|||
48687102|NCT04170543|156705325|FG004|Overall Study|Lost to Follow-up|1|||
48687103|NCT04170543|156705321|FG000|Overall Study|Withdrawal by Subject|13|||
48687104|NCT04170543|156705322|FG001|Overall Study|Withdrawal by Subject|6|||
48391980|NCT04179734|155630363|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
48687105|NCT04170543|156705323|FG002|Overall Study|Withdrawal by Subject|5|||
48391981|NCT04179734|155630362|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
48687106|NCT04170543|156705324|FG003|Overall Study|Withdrawal by Subject|4|||
48687107|NCT04170543|156705325|FG004|Overall Study|Withdrawal by Subject|9|||
48687108|NCT04170543|156705321|FG000|Overall Study|Not able to transition to phase 2b|8|||
48687109|NCT04170543|156705322|FG001|Overall Study|Not able to transition to phase 2b|0|||
48687110|NCT04170543|156705323|FG002|Overall Study|Not able to transition to phase 2b|10|||
48687111|NCT04170543|156705324|FG003|Overall Study|Not able to transition to phase 2b|0|||
48687112|NCT04170543|156705325|FG004|Overall Study|Not able to transition to phase 2b|6|||
48687113|NCT04170543|156705321|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
48687114|NCT04170543|156705322|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
48687115|NCT04170543|156705323|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
48687116|NCT04170543|156705324|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
48687117|NCT04170543|156705325|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
48687118|NCT04170543|156705321|FG000|Overall Study|Not Treated|0|||
48687119|NCT04170543|156705322|FG001|Overall Study|Not Treated|0|||
48687120|NCT04170543|156705323|FG002|Overall Study|Not Treated|0|||
48687121|NCT04170543|156705324|FG003|Overall Study|Not Treated|0|||
48687122|NCT04170543|156705325|FG004|Overall Study|Not Treated|2|||
48687123|NCT04170543|156705321|FG000|Overall Study|(CRF)|16|||
48687124|NCT04170543|156705322|FG001|Overall Study|(CRF)|15|||
48687125|NCT04170543|156705323|FG002|Overall Study|(CRF)|12|||
48687126|NCT04170543|156705324|FG003|Overall Study|(CRF)|17|||
48687127|NCT04170543|156705325|FG004|Overall Study|(CRF)|17|||
48687128|NCT04170543|156705321|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
48687129|NCT04170543|156705322|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
48687130|NCT04170543|156705323|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
48687131|NCT04170543|156705324|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
48687132|NCT04170543|156705325|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
48687133|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
48687134|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
48687135|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
48687136|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
48687137|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
48687138|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
48687139|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
48687140|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
48687141|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
48687142|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
48687143|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
48687144|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
48687145|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
48687146|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
48687147|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
48687148|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
48687149|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
48687150|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
48687151|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
48687152|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
48687153|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
48687154|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
48687155|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
48687156|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
48687157|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
48687158|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
48687159|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
48687160|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
48687161|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
48687162|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
48687163|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
48687164|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
48687165|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
48687166|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
48687167|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
48687168|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
48391982|NCT04179734|155630363|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
48687169|NCT02586623|156705326|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
48687170|NCT02586623|156705327|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
48687171|NCT02586623|156705328|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
48687172|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
48763347|NCT01150123|156983860|FG017|Overall Study|Withdrawal by Subject|1|||
48687173|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
48687174|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
48687175|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
48687176|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
48687177|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
48687178|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
48687179|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
48687180|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
48687181|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
48687182|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
48687183|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
48687184|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
48687185|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
48687186|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
48687187|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
48687188|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
48687189|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
48687190|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
48687191|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
48687192|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
48687193|NCT02586623|156705326|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
48687194|NCT02586623|156705327|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
48687195|NCT02586623|156705328|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
48687196|NCT02370420|156705329|FG000|Overall Study|Physician Decision|3|||
48687197|NCT02370420|156705330|FG001|Overall Study|Physician Decision|3|||
48687198|NCT02370420|156705329|FG000|Overall Study|Lost to Follow-up|11|||
48687199|NCT02370420|156705330|FG001|Overall Study|Lost to Follow-up|9|||
48687200|NCT04628780|156705331|FG000|Overall Study|Death|0|||
48687201|NCT04628780|156705332|FG001|Overall Study|Death|1|||
48687202|NCT04628780|156705333|FG002|Overall Study|Death|0|||
48687203|NCT04628780|156705334|FG003|Overall Study|Death|0|||
48687204|NCT04628780|156705335|FG004|Overall Study|Death|1|||
48687205|NCT04628780|156705336|FG005|Overall Study|Death|0|||
48687206|NCT04628780|156705331|FG000|Overall Study|Physician Decision|2|||
48687207|NCT04628780|156705332|FG001|Overall Study|Physician Decision|0|||
48687208|NCT04628780|156705333|FG002|Overall Study|Physician Decision|0|||
48687209|NCT04628780|156705334|FG003|Overall Study|Physician Decision|0|||
48687210|NCT04628780|156705335|FG004|Overall Study|Physician Decision|2|||
48687211|NCT04628780|156705336|FG005|Overall Study|Physician Decision|0|||
48687212|NCT04628780|156705331|FG000|Overall Study|Progressive disease|2|||
48687213|NCT04628780|156705332|FG001|Overall Study|Progressive disease|2|||
48687214|NCT04628780|156705333|FG002|Overall Study|Progressive disease|2|||
48687215|NCT04628780|156705334|FG003|Overall Study|Progressive disease|3|||
48687216|NCT04628780|156705335|FG004|Overall Study|Progressive disease|9|||
48687217|NCT04628780|156705336|FG005|Overall Study|Progressive disease|4|||
48687218|NCT04628780|156705331|FG000|Overall Study|Withdrawal by Subject|0|||
48687219|NCT04628780|156705332|FG001|Overall Study|Withdrawal by Subject|1|||
48687220|NCT04628780|156705333|FG002|Overall Study|Withdrawal by Subject|2|||
48687221|NCT04628780|156705334|FG003|Overall Study|Withdrawal by Subject|0|||
48687222|NCT04628780|156705335|FG004|Overall Study|Withdrawal by Subject|3|||
48687223|NCT04628780|156705336|FG005|Overall Study|Withdrawal by Subject|1|||
48687224|NCT04628780|156705331|FG000|Overall Study|Global deterioration of health status|0|||
48687225|NCT04628780|156705332|FG001|Overall Study|Global deterioration of health status|0|||
48687226|NCT04628780|156705333|FG002|Overall Study|Global deterioration of health status|0|||
48687227|NCT04628780|156705334|FG003|Overall Study|Global deterioration of health status|0|||
48687228|NCT04628780|156705335|FG004|Overall Study|Global deterioration of health status|1|||
48687229|NCT04628780|156705336|FG005|Overall Study|Global deterioration of health status|1|||
48687230|NCT00795704|156705338|FG000|Overall Study|Withdrawal by Subject|3|||
48687231|NCT00795704|156705339|FG001|Overall Study|Withdrawal by Subject|2|||
48687232|NCT00795704|156705338|FG000|Overall Study|Adverse Event|1|||
48687233|NCT00795704|156705339|FG001|Overall Study|Adverse Event|1|||
48687234|NCT03980730|156705340|FG000|Overall Study|Study Terminated by Sponsor|0|||
48687235|NCT03980730|156705341|FG001|Overall Study|Study Terminated by Sponsor|3|||
48687236|NCT03980730|156705340|FG000|Overall Study|Adverse Event|2|||
48687237|NCT03980730|156705341|FG001|Overall Study|Adverse Event|0|||
48687238|NCT03980730|156705340|FG000|Overall Study|Sponsor Request|0|||
48687239|NCT03980730|156705341|FG001|Overall Study|Sponsor Request|1|||
48687240|NCT00428948|156705342|FG000|Overall Study|Lost to Follow-up|15|||
48687241|NCT00428948|156705343|FG001|Overall Study|Lost to Follow-up|8|||
48687242|NCT00428948|156705342|FG000|Overall Study|Adverse Event|148|||
48763348|NCT01150123|156983843|FG000|Overall Study|Lost to Follow-up|2|||
48763349|NCT01150123|156983844|FG001|Overall Study|Lost to Follow-up|1|||
48763350|NCT01150123|156983845|FG002|Overall Study|Lost to Follow-up|2|||
48763351|NCT01150123|156983846|FG003|Overall Study|Lost to Follow-up|2|||
48687243|NCT00428948|156705343|FG001|Overall Study|Adverse Event|24|||
48763352|NCT01150123|156983847|FG004|Overall Study|Lost to Follow-up|2|||
48763353|NCT01150123|156983848|FG005|Overall Study|Lost to Follow-up|5|||
48687244|NCT00428948|156705342|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
48687245|NCT00428948|156705343|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
48687246|NCT00428948|156705342|FG000|Overall Study|Investigator Withdrew Subject|3|||
48687247|NCT00428948|156705343|FG001|Overall Study|Investigator Withdrew Subject|4|||
48687248|NCT00428948|156705342|FG000|Overall Study|Subject Withdrew Consent|50|||
48687249|NCT00428948|156705343|FG001|Overall Study|Subject Withdrew Consent|30|||
48687250|NCT00428948|156705342|FG000|Overall Study|Protocol Deviation|1|||
48687251|NCT00428948|156705343|FG001|Overall Study|Protocol Deviation|1|||
48687252|NCT04076618|156705344|FG000|Overall Study|Lost to Follow-up|2|||
48687253|NCT04076618|156705345|FG001|Overall Study|Lost to Follow-up|1|||
48687254|NCT04076618|156705346|FG002|Overall Study|Lost to Follow-up|3|||
48687255|NCT04076618|156705344|FG000|Overall Study|Withdrawal by Subject|3|||
48687256|NCT04076618|156705345|FG001|Overall Study|Withdrawal by Subject|1|||
48687257|NCT04076618|156705346|FG002|Overall Study|Withdrawal by Subject|2|||
48687258|NCT04076618|156705344|FG000|Overall Study|Relocated out of state|0|||
48687259|NCT04076618|156705345|FG001|Overall Study|Relocated out of state|2|||
48687260|NCT04076618|156705346|FG002|Overall Study|Relocated out of state|0|||
48687261|NCT04076618|156705344|FG000|Overall Study|COVID concerns|0|||
48687262|NCT04076618|156705345|FG001|Overall Study|COVID concerns|1|||
48687263|NCT04076618|156705346|FG002|Overall Study|COVID concerns|0|||
48687264|NCT04076618|156705344|FG000|Overall Study|Adverse Event|0|||
48687265|NCT04076618|156705345|FG001|Overall Study|Adverse Event|0|||
48687266|NCT04076618|156705346|FG002|Overall Study|Adverse Event|2|||
48687267|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
48687268|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
48687269|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
48687270|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
48687271|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
48687272|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
48687273|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Death|1|||
48687274|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Death|4|||
48687275|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
48687276|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
48687277|NCT00658814|156705350|FG000|Remission Induction Chemotherapy|Not eligible|1|||
48687278|NCT00658814|156705351|FG001|Remission Induction Chemotherapy|Not eligible|2|||
48687279|NCT00658814|156705350|FG000|Consolidation Therapy|Not protocol specified|0|||
48687280|NCT00658814|156705351|FG001|Consolidation Therapy|Not protocol specified|1|||
48687281|NCT00658814|156705350|FG000|Consolidation Therapy|Not eligible|2|||
48687282|NCT00658814|156705351|FG001|Consolidation Therapy|Not eligible|2|||
48687283|NCT00658814|156705350|FG000|Maintenance Therapy|Adverse Event|1|||
48687284|NCT00658814|156705351|FG001|Maintenance Therapy|Adverse Event|1|||
48687285|NCT00658814|156705350|FG000|Maintenance Therapy|Not protocol specified|1|||
48687286|NCT00658814|156705351|FG001|Maintenance Therapy|Not protocol specified|0|||
48687287|NCT00658814|156705350|FG000|Maintenance Therapy|Not eligible|1|||
48687288|NCT00658814|156705351|FG001|Maintenance Therapy|Not eligible|0|||
48687289|NCT03863509|156705352|FG000|Overall Study|COVID-19 shutdown period|0|||
48687290|NCT03863509|156705353|FG001|Overall Study|COVID-19 shutdown period|4|||
48687291|NCT03863509|156705354|FG002|Overall Study|COVID-19 shutdown period|0|||
48687292|NCT03863509|156705352|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
48687293|NCT03863509|156705353|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
48687294|NCT03863509|156705354|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
48687295|NCT03863509|156705352|FG000|Overall Study|Lost to Follow-up|8|||
48687296|NCT03863509|156705353|FG001|Overall Study|Lost to Follow-up|0|||
48687297|NCT03863509|156705354|FG002|Overall Study|Lost to Follow-up|2|||
48687298|NCT03863509|156705352|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
48687299|NCT03863509|156705353|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
48687300|NCT03863509|156705354|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
48687301|NCT03863509|156705352|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
48687302|NCT03863509|156705353|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
48687303|NCT03863509|156705354|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
48763354|NCT01150123|156983849|FG006|Overall Study|Lost to Follow-up|0|||
48763355|NCT01150123|156983850|FG007|Overall Study|Lost to Follow-up|0|||
48763356|NCT01150123|156983851|FG008|Overall Study|Lost to Follow-up|3|||
48687312|NCT05736458|156705358|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
48687313|NCT05736458|156705359|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
48687314|NCT05736458|156705360|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
48687315|NCT05736458|156705358|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
48687316|NCT05736458|156705359|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
48687317|NCT05736458|156705360|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
48687318|NCT05736458|156705358|FG000|TMS/fMRI #1|Physician Decision|0|||
48687319|NCT05736458|156705359|FG001|TMS/fMRI #1|Physician Decision|0|||
48687320|NCT05736458|156705360|FG002|TMS/fMRI #1|Physician Decision|2|||
48687321|NCT05736458|156705358|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
48687322|NCT05736458|156705359|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
48687323|NCT05736458|156705360|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
48687324|NCT05274958|156705361|FG000|Overall Study|Only completed 1 set of PROMs|22|||
48687325|NCT05274958|156705362|FG001|Overall Study|Only completed 1 set of PROMs|35|||
48687326|NCT00855959|156706820|FG000|Overall Study|Adverse Event|2|||
48687327|NCT00855959|156706820|FG000|Overall Study|Lost to Follow-up|2|||
48687328|NCT00855959|156706820|FG000|Overall Study|Withdrawal by Subject|3|||
48687329|NCT00855959|156706820|FG000|Overall Study|Pregnancy|1|||
48687330|NCT00855959|156706820|FG000|Overall Study|Incorrect enrolment|1|||
48687331|NCT04794270|156706822|FG000|Period 1|Non Compliance|1|||
48687332|NCT04794270|156706823|FG001|Period 1|Non Compliance|0|||
48687333|NCT04794270|156706822|FG000|Period 1|Adverse Event|1|||
48687334|NCT04794270|156706823|FG001|Period 1|Adverse Event|0|||
48687335|NCT04794270|156706822|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
48687336|NCT04794270|156706823|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
48687337|NCT02178995|156706836|FG000|Double Blind|Adverse Event|0|||
48687338|NCT02178995|156706837|FG001|Double Blind|Adverse Event|0|||
48687339|NCT02178995|156706838|FG002|Double Blind|Adverse Event|0|||
48687340|NCT02178995|156706839|FG003|Double Blind|Adverse Event|0|||
48687341|NCT02178995|156706840|FG004|Double Blind|Adverse Event|0|||
48687342|NCT02178995|156706841|FG005|Double Blind|Adverse Event|1|||
48687343|NCT02178995|156706842|FG006|Double Blind|Adverse Event|0|||
48687344|NCT02178995|156706843|FG007|Double Blind|Adverse Event|1|||
48687345|NCT02178995|156706844|FG008|Double Blind|Adverse Event|1|||
48687346|NCT02178995|156706836|FG000|Double Blind|Lost to Follow-up|0|||
48687347|NCT02178995|156706837|FG001|Double Blind|Lost to Follow-up|1|||
48687348|NCT02178995|156706838|FG002|Double Blind|Lost to Follow-up|0|||
48687349|NCT02178995|156706839|FG003|Double Blind|Lost to Follow-up|0|||
48687350|NCT02178995|156706840|FG004|Double Blind|Lost to Follow-up|0|||
48687351|NCT02178995|156706841|FG005|Double Blind|Lost to Follow-up|0|||
48687352|NCT02178995|156706842|FG006|Double Blind|Lost to Follow-up|0|||
48687353|NCT02178995|156706843|FG007|Double Blind|Lost to Follow-up|1|||
48687354|NCT02178995|156706844|FG008|Double Blind|Lost to Follow-up|0|||
48687355|NCT02178995|156706836|FG000|Open Label|Adverse Event|2|||
48687356|NCT02178995|156706837|FG001|Open Label|Adverse Event|0|||
48687357|NCT02178995|156706838|FG002|Open Label|Adverse Event|0|||
48687358|NCT02178995|156706839|FG003|Open Label|Adverse Event|0|||
48687359|NCT02178995|156706840|FG004|Open Label|Adverse Event|0|||
48687360|NCT02178995|156706841|FG005|Open Label|Adverse Event|0|||
48687361|NCT02178995|156706842|FG006|Open Label|Adverse Event|0|||
48687362|NCT02178995|156706843|FG007|Open Label|Adverse Event|0|||
48687363|NCT02178995|156706844|FG008|Open Label|Adverse Event|0|||
48687364|NCT01008943|156706846|FG000|Overall Study|Withdrawal by Subject|1|||
48687365|NCT00824473|156706847|FG000|Overall Study|Adverse Event|4|||
48687366|NCT00824473|156706848|FG001|Overall Study|Adverse Event|5|||
48687367|NCT00824473|156706847|FG000|Overall Study|Lack of Efficacy|2|||
48687368|NCT00824473|156706848|FG001|Overall Study|Lack of Efficacy|2|||
48687369|NCT00824473|156706847|FG000|Overall Study|Protocol Violation|2|||
48687370|NCT00824473|156706848|FG001|Overall Study|Protocol Violation|0|||
48687371|NCT00824473|156706847|FG000|Overall Study|Non-Compliance|4|||
48687372|NCT00824473|156706848|FG001|Overall Study|Non-Compliance|2|||
48687373|NCT00824473|156706847|FG000|Overall Study|Withdrawal by Subject|2|||
48687374|NCT00824473|156706848|FG001|Overall Study|Withdrawal by Subject|3|||
48687375|NCT00824473|156706847|FG000|Overall Study|Other|1|||
48687376|NCT00824473|156706848|FG001|Overall Study|Other|1|||
48687377|NCT00466440|156706849|FG000|Overall Study|Adverse Event|0|||
48687378|NCT00466440|156706850|FG001|Overall Study|Adverse Event|3|||
48687379|NCT00466440|156706851|FG002|Overall Study|Adverse Event|1|||
48687380|NCT00466440|156706849|FG000|Overall Study|Death|1|||
48687381|NCT00466440|156706850|FG001|Overall Study|Death|1|||
48687382|NCT00466440|156706851|FG002|Overall Study|Death|0|||
48687383|NCT00466440|156706849|FG000|Overall Study|Progressive disease|13|||
48687384|NCT00466440|156706850|FG001|Overall Study|Progressive disease|5|||
48687385|NCT00466440|156706851|FG002|Overall Study|Progressive disease|4|||
48687386|NCT00466440|156706849|FG000|Overall Study|Lost to Follow-up|0|||
48687387|NCT00466440|156706850|FG001|Overall Study|Lost to Follow-up|1|||
48687388|NCT00466440|156706851|FG002|Overall Study|Lost to Follow-up|0|||
48687389|NCT00466440|156706849|FG000|Overall Study|Physician Decision|0|||
48687390|NCT00466440|156706850|FG001|Overall Study|Physician Decision|1|||
48687391|NCT00466440|156706851|FG002|Overall Study|Physician Decision|2|||
48687392|NCT00466440|156706849|FG000|Overall Study|Protocol entry criteria not met|0|||
48687393|NCT00466440|156706850|FG001|Overall Study|Protocol entry criteria not met|0|||
48687394|NCT00466440|156706851|FG002|Overall Study|Protocol entry criteria not met|4|||
48687395|NCT00466440|156706849|FG000|Overall Study|Withdrawal by Subject|0|||
48687396|NCT00466440|156706850|FG001|Overall Study|Withdrawal by Subject|1|||
48687397|NCT00466440|156706851|FG002|Overall Study|Withdrawal by Subject|0|||
48687398|NCT00466440|156706849|FG000|Overall Study|Sponsor decision|0|||
48687399|NCT00466440|156706850|FG001|Overall Study|Sponsor decision|0|||
48687400|NCT00466440|156706851|FG002|Overall Study|Sponsor decision|1|||
48687401|NCT02420093|156706854|FG000|Overall Study|Withdrawal by Subject|1|||
48687402|NCT02420093|156706855|FG001|Overall Study|Withdrawal by Subject|1|||
48687403|NCT01550757|156706858|FG000|Overall Study|Lost to Follow-up|21|||
48687404|NCT01550757|156706859|FG001|Overall Study|Lost to Follow-up|14|||
48687405|NCT01550757|156706860|FG002|Overall Study|Lost to Follow-up|42|||
48687406|NCT01550757|156706861|FG003|Overall Study|Lost to Follow-up|53|||
48687407|NCT01550757|156706858|FG000|Overall Study|Withdrawal by Subject|2|||
48687408|NCT01550757|156706859|FG001|Overall Study|Withdrawal by Subject|0|||
48687409|NCT01550757|156706860|FG002|Overall Study|Withdrawal by Subject|3|||
48763357|NCT01150123|156983852|FG009|Overall Study|Lost to Follow-up|1|||
48763358|NCT01150123|156983853|FG010|Overall Study|Lost to Follow-up|1|||
48763359|NCT01150123|156983854|FG011|Overall Study|Lost to Follow-up|1|||
48763360|NCT01150123|156983855|FG012|Overall Study|Lost to Follow-up|2|||
48763361|NCT01150123|156983856|FG013|Overall Study|Lost to Follow-up|0|||
48763362|NCT01150123|156983857|FG014|Overall Study|Lost to Follow-up|0|||
48763363|NCT01150123|156983858|FG015|Overall Study|Lost to Follow-up|0|||
48763364|NCT01150123|156983859|FG016|Overall Study|Lost to Follow-up|0|||
48763365|NCT01150123|156983860|FG017|Overall Study|Lost to Follow-up|0|||
48763366|NCT04809220|156983868|FG000|Overall Study|Adverse Event|4|||
48763367|NCT04809220|156983869|FG001|Overall Study|Adverse Event|0|||
48763368|NCT04809220|156983868|FG000|Overall Study|Death|1|||
48763369|NCT04809220|156983869|FG001|Overall Study|Death|0|||
48763370|NCT04809220|156983868|FG000|Overall Study|Lost to Follow-up|3|||
48763371|NCT04809220|156983869|FG001|Overall Study|Lost to Follow-up|0|||
48763372|NCT04809220|156983868|FG000|Overall Study|Physician Decision|0|||
48763373|NCT04809220|156983869|FG001|Overall Study|Physician Decision|1|||
48391983|NCT02053168|155630364|FG000|Overall Study|Withdrawal by Subject|1|||
48687410|NCT01550757|156706861|FG003|Overall Study|Withdrawal by Subject|1|||
48687411|NCT00496080|156706864|FG000|Overall Study|Lost to Follow-up|9|||
48687412|NCT00496080|156706864|FG000|Overall Study|Surgical re-intervention|7|||
48687413|NCT00496080|156706864|FG000|Overall Study|Withdrawal by Subject|5|||
48687414|NCT00496080|156706864|FG000|Overall Study|Physician Decision|6|||
48687415|NCT00764361|156706874|FG000|Overall Study|Withdrawal by Subject|2|||
48687416|NCT00764361|156706875|FG001|Overall Study|Withdrawal by Subject|3|||
48687417|NCT00764361|156706874|FG000|Overall Study|Adverse Event|0|||
48687418|NCT00764361|156706875|FG001|Overall Study|Adverse Event|1|||
48687419|NCT01141712|156706879|FG000|Overall Study|Disease progression|3|||
48687420|NCT01168349|156706881|FG000|Overall Study|Death|157|||
48687421|NCT01168349|156706881|FG000|Overall Study|Lost to Follow-up|34|||
48687422|NCT01168349|156706881|FG000|Overall Study|Withdrawal by Subject|9|||
48687423|NCT01168349|156706881|FG000|Overall Study|Kidney transplantation|3|||
48687424|NCT01168349|156706881|FG000|Overall Study|Other|22|||
48687425|NCT01168349|156706881|FG000|Overall Study|Protocol Violation|76|||
48687426|NCT00890825|156706882|FG000|Overall Study|Withdrawal by Subject|1|||
48687427|NCT00890825|156706883|FG001|Overall Study|Withdrawal by Subject|0|||
48687428|NCT00890825|156706882|FG000|Overall Study|Alive at data cut off (DCO)|13|||
48687429|NCT00890825|156706883|FG001|Overall Study|Alive at data cut off (DCO)|14|||
48687430|NCT02678351|156706887|FG000|Overall Study|Withdrawal by Subject|1|||
48687431|NCT01919229|156706888|FG000|Overall Study|Subject/guardian decision|0|||
48687432|NCT01919229|156706889|FG001|Overall Study|Subject/guardian decision|0|||
48687433|NCT01919229|156706890|FG002|Overall Study|Subject/guardian decision|1|||
48687434|NCT04524858|156706891|FG000|Overall Study|Adverse Event|1|||
48687435|NCT02366195|156706894|FG000|Overall Study|Protocol-specified criteria|3|||
48687436|NCT02366195|156706894|FG000|Overall Study|Withdrawal by Subject|9|||
48687437|NCT02366195|156706894|FG000|Overall Study|Lost to Follow-up|1|||
48763374|NCT04809220|156983868|FG000|Overall Study|Withdrawal by Subject|9|||
48763375|NCT04809220|156983869|FG001|Overall Study|Withdrawal by Subject|5|||
48687438|NCT02366195|156706894|FG000|Overall Study|Death|41|||
48687439|NCT01338818|156706895|FG000|Overall Study|Adverse Event|8|||
48687440|NCT01338818|156706895|FG000|Overall Study|Lack of Efficacy|5|||
48687441|NCT01338818|156706895|FG000|Overall Study|no longer require study drug|1|||
48687442|NCT01338818|156706895|FG000|Overall Study|Withdrawal by Subject|11|||
48687443|NCT01338818|156706895|FG000|Overall Study|Lost to Follow-up|4|||
48391984|NCT02053168|155630364|FG000|Overall Study|Physician Decision|1|||
48687444|NCT01338818|156706895|FG000|Overall Study|Administrative problems|3|||
48687445|NCT01338818|156706895|FG000|Overall Study|Protocol Deviation|4|||
48687446|NCT01078441|156706899|FG000|Overall Study|Withdrawal by Subject|1|||
48687447|NCT02714569|156706900|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
48687448|NCT02714569|156706901|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
48687449|NCT02714569|156706902|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
48687450|NCT02714569|156706903|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
48687451|NCT02714569|156706904|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
48687452|NCT02714569|156706905|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
48687453|NCT02714569|156706906|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
48687454|NCT02714569|156706907|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
48687455|NCT02714569|156706908|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
48687456|NCT02714569|156706909|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
48687457|NCT02714569|156706910|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
48687458|NCT02714569|156706900|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687459|NCT02714569|156706901|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687460|NCT02714569|156706902|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687461|NCT02714569|156706903|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
48687462|NCT02714569|156706904|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687463|NCT02714569|156706905|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687464|NCT02714569|156706906|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687465|NCT02714569|156706907|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687466|NCT02714569|156706908|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687467|NCT02714569|156706909|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687468|NCT02714569|156706910|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
48687469|NCT02714569|156706900|FG000|Part A Third Intervention|Adverse Event|0|||
48687470|NCT02714569|156706901|FG001|Part A Third Intervention|Adverse Event|0|||
48687471|NCT02714569|156706902|FG002|Part A Third Intervention|Adverse Event|1|||
48687472|NCT02714569|156706903|FG003|Part A Third Intervention|Adverse Event|0|||
48687473|NCT02714569|156706904|FG004|Part A Third Intervention|Adverse Event|0|||
48687474|NCT02714569|156706905|FG005|Part A Third Intervention|Adverse Event|0|||
48687475|NCT02714569|156706906|FG006|Part A Third Intervention|Adverse Event|0|||
48687476|NCT02714569|156706907|FG007|Part A Third Intervention|Adverse Event|0|||
48687477|NCT02714569|156706908|FG008|Part A Third Intervention|Adverse Event|0|||
48687478|NCT02714569|156706909|FG009|Part A Third Intervention|Adverse Event|0|||
48687479|NCT02714569|156706910|FG010|Part A Third Intervention|Adverse Event|0|||
48687480|NCT02714569|156706900|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
48687481|NCT02714569|156706901|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687482|NCT02714569|156706902|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687483|NCT02714569|156706903|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48391985|NCT02053168|155630364|FG000|Overall Study|Lost to Follow-up|1|||
48391986|NCT02463409|155630365|FG000|Overall Study|Withdrawal by Subject|1|||
48391987|NCT02463409|155630365|FG000|Overall Study|Screen failure|1|||
48391988|NCT00880399|155630366|FG000|Overall Study|Adverse Event|4|||
48391989|NCT00880399|155630367|FG001|Overall Study|Adverse Event|6|||
48391990|NCT00880399|155630368|FG002|Overall Study|Adverse Event|5|||
48391991|NCT00880399|155630366|FG000|Overall Study|Lack of Efficacy|1|||
48391992|NCT00880399|155630367|FG001|Overall Study|Lack of Efficacy|4|||
48391993|NCT00880399|155630368|FG002|Overall Study|Lack of Efficacy|2|||
48391994|NCT00880399|155630366|FG000|Overall Study|Protocol Violation|4|||
48391995|NCT00880399|155630367|FG001|Overall Study|Protocol Violation|4|||
48391996|NCT00880399|155630368|FG002|Overall Study|Protocol Violation|6|||
48391997|NCT00880399|155630366|FG000|Overall Study|Study closed/terminated|3|||
48391998|NCT00880399|155630367|FG001|Overall Study|Study closed/terminated|7|||
48391999|NCT00880399|155630368|FG002|Overall Study|Study closed/terminated|4|||
48392000|NCT00880399|155630366|FG000|Overall Study|Lost to Follow-up|8|||
48392001|NCT00880399|155630367|FG001|Overall Study|Lost to Follow-up|5|||
48392002|NCT00880399|155630368|FG002|Overall Study|Lost to Follow-up|3|||
48392003|NCT00880399|155630366|FG000|Overall Study|Physician Decision|5|||
48392004|NCT00880399|155630367|FG001|Overall Study|Physician Decision|0|||
48392005|NCT00880399|155630368|FG002|Overall Study|Physician Decision|3|||
48392006|NCT00880399|155630366|FG000|Overall Study|Withdrawal by Subject|6|||
48392007|NCT00880399|155630367|FG001|Overall Study|Withdrawal by Subject|3|||
48687484|NCT02714569|156706904|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687485|NCT02714569|156706905|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
48687486|NCT02714569|156706906|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687487|NCT02714569|156706907|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687488|NCT02714569|156706908|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687489|NCT02714569|156706909|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48687490|NCT02714569|156706910|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
48392008|NCT00880399|155630368|FG002|Overall Study|Withdrawal by Subject|3|||
48392009|NCT01549275|155630371|FG000|Overall Study|Lost to Follow-up|1|||
48392010|NCT01549275|155630372|FG001|Overall Study|Lost to Follow-up|0|||
48392011|NCT01040351|155630373|FG000|Overall Study|poor ovarian response|1|||
48392012|NCT01040351|155630374|FG001|Overall Study|poor ovarian response|2|||
48392013|NCT02316340|155630375|FG000|First Progression|Clinical progression|2|||
48392014|NCT02316340|155630376|FG001|First Progression|Clinical progression|1|||
48392015|NCT02316340|155630375|FG000|First Progression|Withdrawal by Subject|1|||
48392016|NCT02316340|155630376|FG001|First Progression|Withdrawal by Subject|0|||
48392017|NCT02159729|155630377|FG000|Overall Study|Adverse Event|0|||
48392018|NCT02159729|155630378|FG001|Overall Study|Adverse Event|1|||
48392019|NCT02159729|155630377|FG000|Overall Study|Subject's Request|13|||
48392020|NCT02159729|155630378|FG001|Overall Study|Subject's Request|10|||
48392021|NCT02159729|155630377|FG000|Overall Study|Lost to Follow-up|24|||
48392022|NCT02159729|155630378|FG001|Overall Study|Lost to Follow-up|9|||
48392023|NCT02159729|155630377|FG000|Overall Study|Non compliance|2|||
48392024|NCT02159729|155630378|FG001|Overall Study|Non compliance|0|||
48392025|NCT02159729|155630377|FG000|Overall Study|Other Unspecified|3|||
48392026|NCT02159729|155630378|FG001|Overall Study|Other Unspecified|1|||
48392027|NCT01476475|155630379|FG000|Overall Study|Adverse Event|6|||
48392028|NCT01476475|155630380|FG001|Overall Study|Adverse Event|0|||
48392029|NCT01476475|155630379|FG000|Overall Study|Poor compliance to protocol|1|||
48392030|NCT01476475|155630380|FG001|Overall Study|Poor compliance to protocol|1|||
48392031|NCT01476475|155630379|FG000|Overall Study|Other reasons|4|||
48392032|NCT01476475|155630380|FG001|Overall Study|Other reasons|2|||
48392033|NCT00326209|155630382|FG000|Overall Study|Adverse Event|28|||
48392034|NCT00326209|155630382|FG000|Overall Study|Withdrawal by Subject|22|||
48392035|NCT00326209|155630382|FG000|Overall Study|Lack of Efficacy|31|||
48392036|NCT00326209|155630382|FG000|Overall Study|Lost to Follow-up|18|||
48392037|NCT00326209|155630382|FG000|Overall Study|Participant non-compliant|6|||
48392038|NCT00326209|155630382|FG000|Overall Study|Sponsor closed study|173|||
48392039|NCT00326209|155630382|FG000|Overall Study|Prohibited medication use|1|||
48392040|NCT00326209|155630382|FG000|Overall Study|Violation of entry criteria|1|||
48392041|NCT00326209|155630382|FG000|Overall Study|Withdrawn in error|1|||
48392042|NCT00326209|155630382|FG000|Overall Study|Pregnancy|1|||
48392043|NCT02037295|155630383|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
48392044|NCT02037295|155630384|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
48392045|NCT02037295|155630385|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
48392046|NCT02037295|155630386|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
48392047|NCT01131676|155630387|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
48392048|NCT01131676|155630388|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
48392049|NCT01131676|155630389|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
48392050|NCT01131676|155630387|FG000|Discontinuation From Treatment|Not treated|4|||
48392051|NCT01131676|155630388|FG001|Discontinuation From Treatment|Not treated|2|||
48392052|NCT01131676|155630389|FG002|Discontinuation From Treatment|Not treated|2|||
48392053|NCT01131676|155630387|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
48392054|NCT01131676|155630388|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
48392055|NCT01131676|155630389|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
48392056|NCT01131676|155630387|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
48392057|NCT01131676|155630388|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
48392058|NCT01131676|155630389|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
48392059|NCT01131676|155630387|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
48392060|NCT01131676|155630388|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
48392061|NCT01131676|155630389|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
48392062|NCT01131676|155630387|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
48392063|NCT01131676|155630388|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
48392064|NCT01131676|155630389|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
48392065|NCT01131676|155630387|FG000|Discontinuation From Treatment|Other than those specified|162|||
48392066|NCT01131676|155630388|FG001|Discontinuation From Treatment|Other than those specified|142|||
48392067|NCT01131676|155630389|FG002|Discontinuation From Treatment|Other than those specified|125|||
48687491|NCT02714569|156706900|FG000|Part B (Overall)|Lost to Follow-up|0|||
48687492|NCT02714569|156706901|FG001|Part B (Overall)|Lost to Follow-up|0|||
48392068|NCT01131676|155630387|FG000|Discontinuation From Treatment|Adverse Event|303|||
48392069|NCT01131676|155630388|FG001|Discontinuation From Treatment|Adverse Event|267|||
48392070|NCT01131676|155630389|FG002|Discontinuation From Treatment|Adverse Event|273|||
48392071|NCT01131676|155630387|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
48687493|NCT02714569|156706902|FG002|Part B (Overall)|Lost to Follow-up|0|||
48392072|NCT01131676|155630388|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
48392073|NCT01131676|155630389|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
48392074|NCT01131676|155630387|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
48426293|NCT00053846|155749527|FG000|Overall Study|Quit due to side effects|1|||
48687494|NCT02714569|156706903|FG003|Part B (Overall)|Lost to Follow-up|0|||
48687495|NCT02714569|156706904|FG004|Part B (Overall)|Lost to Follow-up|0|||
48687496|NCT02714569|156706905|FG005|Part B (Overall)|Lost to Follow-up|0|||
48687497|NCT02714569|156706906|FG006|Part B (Overall)|Lost to Follow-up|1|||
48687498|NCT02714569|156706907|FG007|Part B (Overall)|Lost to Follow-up|0|||
48687499|NCT02714569|156706908|FG008|Part B (Overall)|Lost to Follow-up|0|||
48687500|NCT02714569|156706909|FG009|Part B (Overall)|Lost to Follow-up|0|||
48687501|NCT02714569|156706910|FG010|Part B (Overall)|Lost to Follow-up|0|||
48687502|NCT02714569|156706900|FG000|Part B (Overall)|Withdrawal by Subject|0|||
48687503|NCT02714569|156706901|FG001|Part B (Overall)|Withdrawal by Subject|0|||
48687504|NCT02714569|156706902|FG002|Part B (Overall)|Withdrawal by Subject|0|||
48687505|NCT02714569|156706903|FG003|Part B (Overall)|Withdrawal by Subject|0|||
48687506|NCT02714569|156706904|FG004|Part B (Overall)|Withdrawal by Subject|0|||
48687507|NCT02714569|156706905|FG005|Part B (Overall)|Withdrawal by Subject|0|||
48687508|NCT02714569|156706906|FG006|Part B (Overall)|Withdrawal by Subject|0|||
48687509|NCT02714569|156706907|FG007|Part B (Overall)|Withdrawal by Subject|1|||
48687510|NCT02714569|156706908|FG008|Part B (Overall)|Withdrawal by Subject|0|||
48687511|NCT02714569|156706909|FG009|Part B (Overall)|Withdrawal by Subject|1|||
48687512|NCT02714569|156706910|FG010|Part B (Overall)|Withdrawal by Subject|0|||
48687513|NCT02714569|156706900|FG000|Part B (Overall)|Adverse Event|0|||
48687514|NCT02714569|156706901|FG001|Part B (Overall)|Adverse Event|0|||
48687515|NCT02714569|156706902|FG002|Part B (Overall)|Adverse Event|0|||
48687516|NCT02714569|156706903|FG003|Part B (Overall)|Adverse Event|0|||
48687517|NCT02714569|156706904|FG004|Part B (Overall)|Adverse Event|0|||
48687518|NCT02714569|156706905|FG005|Part B (Overall)|Adverse Event|0|||
48687519|NCT02714569|156706906|FG006|Part B (Overall)|Adverse Event|0|||
48687520|NCT02714569|156706907|FG007|Part B (Overall)|Adverse Event|0|||
48763376|NCT04809220|156983868|FG000|Overall Study|Due to long-term overseas business trips|1|||
48763377|NCT04809220|156983869|FG001|Overall Study|Due to long-term overseas business trips|0|||
48392075|NCT01131676|155630388|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
48392076|NCT01131676|155630389|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
48392077|NCT01131676|155630387|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
48392078|NCT01131676|155630388|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
48392079|NCT01131676|155630389|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
48392080|NCT01131676|155630387|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
48392081|NCT01131676|155630388|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
48392082|NCT01131676|155630389|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
48392083|NCT01131676|155630387|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
48392084|NCT01131676|155630388|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
48392085|NCT01131676|155630389|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
48392086|NCT01131676|155630387|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
48392087|NCT01131676|155630388|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
48392088|NCT01131676|155630389|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
48392089|NCT01278745|155630390|FG000|Overall Study|Death|2|||
48392090|NCT01278745|155630391|FG001|Overall Study|Death|5|||
48392091|NCT01278745|155630392|FG002|Overall Study|Death|7|||
48392092|NCT01278745|155630393|FG003|Overall Study|Death|0|||
48392093|NCT01278745|155630390|FG000|Overall Study|Physician Decision|1|||
48392094|NCT01278745|155630391|FG001|Overall Study|Physician Decision|0|||
48392095|NCT01278745|155630392|FG002|Overall Study|Physician Decision|0|||
48392096|NCT01278745|155630393|FG003|Overall Study|Physician Decision|9|||
48392097|NCT01278745|155630390|FG000|Overall Study|Withdrawal by Subject|1|||
48392098|NCT01278745|155630391|FG001|Overall Study|Withdrawal by Subject|1|||
48392099|NCT01278745|155630392|FG002|Overall Study|Withdrawal by Subject|5|||
48392100|NCT01278745|155630393|FG003|Overall Study|Withdrawal by Subject|1|||
48392101|NCT01278745|155630390|FG000|Overall Study|Sponsor Decision|1|||
48392102|NCT01278745|155630391|FG001|Overall Study|Sponsor Decision|0|||
48392103|NCT01278745|155630392|FG002|Overall Study|Sponsor Decision|62|||
48392104|NCT01278745|155630393|FG003|Overall Study|Sponsor Decision|6|||
48392105|NCT01278745|155630390|FG000|Overall Study|Ineligible|0|||
48392106|NCT01278745|155630391|FG001|Overall Study|Ineligible|0|||
48392107|NCT01278745|155630392|FG002|Overall Study|Ineligible|42|||
48392108|NCT01278745|155630393|FG003|Overall Study|Ineligible|61|||
48392109|NCT01278745|155630390|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
48392110|NCT01278745|155630391|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
48392111|NCT01278745|155630392|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
48763378|NCT02515045|156983870|FG000|Overall Study|Adverse Event|0|||
48392112|NCT01278745|155630393|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
48687521|NCT02714569|156706908|FG008|Part B (Overall)|Adverse Event|0|||
48687522|NCT02714569|156706909|FG009|Part B (Overall)|Adverse Event|1|||
48687523|NCT02714569|156706910|FG010|Part B (Overall)|Adverse Event|0|||
48687524|NCT00462306|156706911|FG000|Overall Study|insufficient data|0|||
48392113|NCT00960661|155630394|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
48392114|NCT00960661|155630395|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
48392115|NCT00960661|155630396|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
48392116|NCT00960661|155630394|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
48392117|NCT00960661|155630395|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
48392118|NCT00960661|155630396|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
48392119|NCT00960661|155630394|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
48392120|NCT00960661|155630395|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
48392121|NCT00960661|155630396|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
48687525|NCT00462306|156706912|FG001|Overall Study|insufficient data|13|||
48687526|NCT03155724|156706913|FG000|Overall Study|Death|3|||
48687527|NCT03155724|156706913|FG000|Overall Study|Physician Decision|1|||
48687528|NCT03155724|156706913|FG000|Overall Study|Study closure|7|||
48687529|NCT03515824|156706914|FG000|Overall Study|Death|3|||
48687530|NCT03515824|156706915|FG001|Overall Study|Death|2|||
48687531|NCT03515824|156706916|FG002|Overall Study|Death|6|||
48687532|NCT03515824|156706917|FG003|Overall Study|Death|0|||
48687533|NCT03515824|156706914|FG000|Overall Study|Lost to Follow-up|0|||
48687534|NCT03515824|156706915|FG001|Overall Study|Lost to Follow-up|1|||
48687535|NCT03515824|156706916|FG002|Overall Study|Lost to Follow-up|1|||
48687536|NCT03515824|156706917|FG003|Overall Study|Lost to Follow-up|0|||
48687537|NCT03515824|156706914|FG000|Overall Study|Study terminated by sponsor|0|||
48687538|NCT03515824|156706915|FG001|Overall Study|Study terminated by sponsor|1|||
48687539|NCT03515824|156706916|FG002|Overall Study|Study terminated by sponsor|6|||
48687540|NCT03515824|156706917|FG003|Overall Study|Study terminated by sponsor|0|||
48687541|NCT03515824|156706914|FG000|Overall Study|Status not recorded|0|||
48687542|NCT03515824|156706915|FG001|Overall Study|Status not recorded|0|||
48687543|NCT03515824|156706916|FG002|Overall Study|Status not recorded|2|||
48392122|NCT00960661|155630394|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
48392123|NCT00960661|155630395|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
48392124|NCT00960661|155630396|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
48392125|NCT00960661|155630394|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
48392126|NCT00960661|155630395|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
48392127|NCT00960661|155630396|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
48392128|NCT00960661|155630394|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
48392129|NCT00960661|155630395|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
48392130|NCT00960661|155630396|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
48392131|NCT00960661|155630394|FG000|Interventional Phase|Adverse Event|0|||
48392132|NCT00960661|155630395|FG001|Interventional Phase|Adverse Event|17|||
48392133|NCT00960661|155630396|FG002|Interventional Phase|Adverse Event|8|||
48392134|NCT00960661|155630394|FG000|Interventional Phase|Death|0|||
48392135|NCT00960661|155630395|FG001|Interventional Phase|Death|1|||
48392136|NCT00960661|155630396|FG002|Interventional Phase|Death|0|||
48392137|NCT00960661|155630394|FG000|Interventional Phase|Lost to Follow-up|0|||
48392138|NCT00960661|155630395|FG001|Interventional Phase|Lost to Follow-up|0|||
48392139|NCT00960661|155630396|FG002|Interventional Phase|Lost to Follow-up|2|||
48392140|NCT00960661|155630394|FG000|Interventional Phase|entry criteria not met|0|||
48392141|NCT00960661|155630395|FG001|Interventional Phase|entry criteria not met|3|||
48392142|NCT00960661|155630396|FG002|Interventional Phase|entry criteria not met|0|||
48392143|NCT00960661|155630394|FG000|Interventional Phase|Protocol Violation|0|||
48392144|NCT00960661|155630395|FG001|Interventional Phase|Protocol Violation|7|||
48687544|NCT03515824|156706917|FG003|Overall Study|Status not recorded|0|||
48687545|NCT00550953|156706925|FG000|Overall Study|Adverse Event|4|||
48687546|NCT00550953|156706926|FG001|Overall Study|Adverse Event|3|||
48687547|NCT00550953|156706925|FG000|Overall Study|Not able to visit the site|2|||
48687548|NCT00550953|156706926|FG001|Overall Study|Not able to visit the site|3|||
48687549|NCT02741245|156706927|FG000|Overall Study|Adverse Event|0|||
48687550|NCT02741245|156706928|FG001|Overall Study|Adverse Event|0|||
48392145|NCT00960661|155630396|FG002|Interventional Phase|Protocol Violation|2|||
48392146|NCT00960661|155630394|FG000|Interventional Phase|Withdrawal by Subject|0|||
48392147|NCT00960661|155630395|FG001|Interventional Phase|Withdrawal by Subject|18|||
48392148|NCT00960661|155630396|FG002|Interventional Phase|Withdrawal by Subject|29|||
48687551|NCT02741245|156706929|FG002|Overall Study|Adverse Event|0|||
48687552|NCT02741245|156706930|FG003|Overall Study|Adverse Event|2|||
48687553|NCT02741245|156706931|FG004|Overall Study|Adverse Event|2|||
48687554|NCT02741245|156706927|FG000|Overall Study|Protocol Violation|0|||
48687555|NCT02741245|156706928|FG001|Overall Study|Protocol Violation|1|||
48687556|NCT02741245|156706929|FG002|Overall Study|Protocol Violation|0|||
48687557|NCT02741245|156706930|FG003|Overall Study|Protocol Violation|1|||
48687558|NCT02741245|156706931|FG004|Overall Study|Protocol Violation|0|||
48687559|NCT02741245|156706927|FG000|Overall Study|Withdrawal by Subject|0|||
48687560|NCT02741245|156706928|FG001|Overall Study|Withdrawal by Subject|0|||
48687561|NCT02741245|156706929|FG002|Overall Study|Withdrawal by Subject|0|||
48687562|NCT02741245|156706930|FG003|Overall Study|Withdrawal by Subject|1|||
48687563|NCT02741245|156706931|FG004|Overall Study|Withdrawal by Subject|0|||
48687564|NCT02025179|156706932|FG000|Overall Study|Lost to Follow-up|0|||
48687565|NCT02025179|156706933|FG001|Overall Study|Lost to Follow-up|0|||
48687566|NCT02025179|156706934|FG002|Overall Study|Lost to Follow-up|1|||
48687567|NCT04393493|156706940|FG000|First 4 Days of Intervention|Early improvement|5|||
48687568|NCT04393493|156706941|FG001|First 4 Days of Intervention|Early improvement|7|||
48687569|NCT01125800|156706942|FG000|Phase I|Protocol Violation|0|||
48687570|NCT01125800|156706943|FG001|Phase I|Protocol Violation|3|||
48687571|NCT01125800|156706944|FG002|Phase I|Protocol Violation|1|||
48687572|NCT01125800|156706945|FG003|Phase I|Protocol Violation|1|||
48687573|NCT01125800|156706946|FG004|Phase I|Protocol Violation|0|||
48687574|NCT01125800|156706942|FG000|Phase I|Adverse Event|2|||
48687575|NCT01125800|156706943|FG001|Phase I|Adverse Event|2|||
48687576|NCT01125800|156706944|FG002|Phase I|Adverse Event|1|||
48687577|NCT01125800|156706945|FG003|Phase I|Adverse Event|7|||
48687578|NCT01125800|156706946|FG004|Phase I|Adverse Event|0|||
48687579|NCT01125800|156706942|FG000|Phase I|Administrative problems|1|||
48687580|NCT01125800|156706943|FG001|Phase I|Administrative problems|0|||
48687581|NCT01125800|156706944|FG002|Phase I|Administrative problems|0|||
48687582|NCT01125800|156706945|FG003|Phase I|Administrative problems|0|||
48687583|NCT01125800|156706946|FG004|Phase I|Administrative problems|0|||
48687584|NCT01125800|156706942|FG000|Phase I|Withdrawal by Subject|0|||
48687585|NCT01125800|156706943|FG001|Phase I|Withdrawal by Subject|0|||
48687586|NCT01125800|156706944|FG002|Phase I|Withdrawal by Subject|1|||
48687587|NCT01125800|156706945|FG003|Phase I|Withdrawal by Subject|0|||
48687588|NCT01125800|156706946|FG004|Phase I|Withdrawal by Subject|0|||
48687589|NCT01125800|156706942|FG000|Phase I|Disease progression|5|||
48687590|NCT01125800|156706943|FG001|Phase I|Disease progression|4|||
48687591|NCT01125800|156706944|FG002|Phase I|Disease progression|1|||
48687592|NCT01125800|156706945|FG003|Phase I|Disease progression|3|||
48687593|NCT01125800|156706946|FG004|Phase I|Disease progression|0|||
48687594|NCT01125800|156706942|FG000|Phase II|Protocol Violation|0|||
48687595|NCT01125800|156706943|FG001|Phase II|Protocol Violation|0|||
48687596|NCT01125800|156706944|FG002|Phase II|Protocol Violation|0|||
48687597|NCT01125800|156706945|FG003|Phase II|Protocol Violation|0|||
48687598|NCT01125800|156706946|FG004|Phase II|Protocol Violation|1|||
48687599|NCT01125800|156706942|FG000|Phase II|Adverse Event|0|||
48687600|NCT01125800|156706943|FG001|Phase II|Adverse Event|0|||
48687601|NCT01125800|156706944|FG002|Phase II|Adverse Event|0|||
48687602|NCT01125800|156706945|FG003|Phase II|Adverse Event|0|||
48687603|NCT01125800|156706946|FG004|Phase II|Adverse Event|2|||
48687604|NCT01125800|156706942|FG000|Phase II|Disease progression|0|||
48687605|NCT01125800|156706943|FG001|Phase II|Disease progression|0|||
48687606|NCT01125800|156706944|FG002|Phase II|Disease progression|0|||
48687607|NCT01125800|156706945|FG003|Phase II|Disease progression|1|||
48687608|NCT01125800|156706946|FG004|Phase II|Disease progression|8|||
48687609|NCT02919761|156706951|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
48687610|NCT02919761|156706952|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
48687611|NCT02919761|156706953|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
48687612|NCT02919761|156706951|FG000|Part 1: Open Label|Adverse Event|1|||
48687613|NCT02919761|156706952|FG001|Part 1: Open Label|Adverse Event|0|||
48687614|NCT02919761|156706953|FG002|Part 1: Open Label|Adverse Event|0|||
48687615|NCT02919761|156706951|FG000|Part 1: Open Label|Lost to Follow-up|1|||
48687616|NCT02919761|156706952|FG001|Part 1: Open Label|Lost to Follow-up|0|||
48687617|NCT02919761|156706953|FG002|Part 1: Open Label|Lost to Follow-up|0|||
48687618|NCT02919761|156706951|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
48687619|NCT02919761|156706952|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
48687620|NCT02919761|156706953|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
48687621|NCT02919761|156706951|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
48687622|NCT02919761|156706952|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
48687623|NCT02919761|156706953|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
48687624|NCT02919761|156706951|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
48687625|NCT02919761|156706952|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
48687626|NCT02919761|156706953|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
48687627|NCT02919761|156706951|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
48687628|NCT02919761|156706952|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
48687629|NCT02919761|156706953|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
48687630|NCT02919761|156706951|FG000|Part 1: Open Label|Termination by Sponsor|1|||
48687631|NCT02919761|156706952|FG001|Part 1: Open Label|Termination by Sponsor|0|||
48687632|NCT02919761|156706953|FG002|Part 1: Open Label|Termination by Sponsor|0|||
48687633|NCT02919761|156706951|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
48392149|NCT00960661|155630394|FG000|Interventional Phase|Physician Decision|0|||
48687634|NCT02919761|156706952|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
48687635|NCT02919761|156706953|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
48687636|NCT02919761|156706951|FG000|Part 2: Double-blind|Adverse Event|0|||
48687637|NCT02919761|156706952|FG001|Part 2: Double-blind|Adverse Event|1|||
48687638|NCT02919761|156706953|FG002|Part 2: Double-blind|Adverse Event|0|||
48687639|NCT02919761|156706951|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
48687640|NCT02919761|156706952|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
48687641|NCT02919761|156706953|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
48687642|NCT02919761|156706951|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
48687643|NCT02919761|156706952|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
48763379|NCT02515045|156983871|FG001|Overall Study|Adverse Event|3|||
48763380|NCT02515045|156983872|FG002|Overall Study|Adverse Event|3|||
48763381|NCT02515045|156983870|FG000|Overall Study|Lost to Follow-up|0|||
48763382|NCT02515045|156983871|FG001|Overall Study|Lost to Follow-up|1|||
48763383|NCT02515045|156983872|FG002|Overall Study|Lost to Follow-up|1|||
48763384|NCT00323492|156983873|FG000|Study Phase 1|Adverse Event|2|||
48763385|NCT00323492|156983874|FG001|Study Phase 1|Adverse Event|0|||
48763386|NCT00323492|156983875|FG002|Study Phase 1|Adverse Event|0|||
48763387|NCT00323492|156983873|FG000|Study Phase 2|Adverse Event|1|||
48763388|NCT00323492|156983874|FG001|Study Phase 2|Adverse Event|0|||
48763389|NCT00323492|156983875|FG002|Study Phase 2|Adverse Event|0|||
48763390|NCT00323492|156983873|FG000|Study Phase 2|Physician Decision|1|||
48763391|NCT00323492|156983874|FG001|Study Phase 2|Physician Decision|0|||
48763392|NCT00323492|156983875|FG002|Study Phase 2|Physician Decision|0|||
48763393|NCT00323492|156983873|FG000|Study Phase 2|Lost to Follow-up|1|||
48763394|NCT00323492|156983874|FG001|Study Phase 2|Lost to Follow-up|0|||
48763395|NCT00323492|156983875|FG002|Study Phase 2|Lost to Follow-up|0|||
48763396|NCT00323492|156983873|FG000|Study Phase 2|Withdrawal by Subject|0|||
48763397|NCT00323492|156983874|FG001|Study Phase 2|Withdrawal by Subject|1|||
48763398|NCT00323492|156983875|FG002|Study Phase 2|Withdrawal by Subject|0|||
48763399|NCT00323492|156983873|FG000|Study Phase 2|Noncompliance with study schedule|0|||
48763400|NCT00323492|156983874|FG001|Study Phase 2|Noncompliance with study schedule|0|||
48763401|NCT00323492|156983875|FG002|Study Phase 2|Noncompliance with study schedule|1|||
48763402|NCT00323492|156983873|FG000|Study Phase 2|Protocol Violation|1|||
48763403|NCT00323492|156983874|FG001|Study Phase 2|Protocol Violation|0|||
48763404|NCT00323492|156983875|FG002|Study Phase 2|Protocol Violation|0|||
48763405|NCT03082599|156983877|FG000|Overall Study|Lost to Follow-up|1|||
48763406|NCT03082599|156983878|FG001|Overall Study|Lost to Follow-up|0|||
48763407|NCT01319877|156983879|FG000|Overall Study|Lost to Follow-up|100|||
48763408|NCT01319877|156983880|FG001|Overall Study|Lost to Follow-up|37|||
48763409|NCT01319877|156983879|FG000|Overall Study|Physician Decision|2|||
48763410|NCT01319877|156983880|FG001|Overall Study|Physician Decision|0|||
48763411|NCT01319877|156983879|FG000|Overall Study|Disease Progression|2|||
48763412|NCT01319877|156983880|FG001|Overall Study|Disease Progression|2|||
48763413|NCT01319877|156983879|FG000|Overall Study|Withdrawal by Subject|0|||
48687644|NCT02919761|156706953|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
48687645|NCT02919761|156706951|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
48687646|NCT02919761|156706952|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
48687647|NCT02919761|156706953|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
48687648|NCT02919761|156706951|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
48687649|NCT02919761|156706952|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
48687650|NCT02919761|156706953|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
48687651|NCT02919761|156706951|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
48687652|NCT02919761|156706952|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
48687653|NCT02919761|156706953|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
48687654|NCT02919761|156706951|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
48687655|NCT02919761|156706952|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
48687656|NCT02919761|156706953|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
48687657|NCT00452790|156706955|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
48687658|NCT00452790|156706956|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
48687659|NCT00452790|156706955|FG000|Infant Series|Parent/legal guardian request|8|||
48687660|NCT00452790|156706956|FG001|Infant Series|Parent/legal guardian request|6|||
48687661|NCT00452790|156706955|FG000|Infant Series|Failed to return|4|||
48687662|NCT00452790|156706956|FG001|Infant Series|Failed to return|1|||
48687663|NCT00452790|156706955|FG000|Infant Series|Protocol Violation|1|||
48687664|NCT00452790|156706956|FG001|Infant Series|Protocol Violation|3|||
48687665|NCT00452790|156706955|FG000|Infant Series|Lost to Follow-up|2|||
48687666|NCT00452790|156706956|FG001|Infant Series|Lost to Follow-up|2|||
48687667|NCT00452790|156706955|FG000|Infant Series|Adverse Event|1|||
48687668|NCT00452790|156706956|FG001|Infant Series|Adverse Event|2|||
48687669|NCT00452790|156706955|FG000|Infant Series|Other reasons|1|||
48687670|NCT00452790|156706956|FG001|Infant Series|Other reasons|2|||
48763414|NCT01319877|156983880|FG001|Overall Study|Withdrawal by Subject|1|||
48687671|NCT00452790|156706955|FG000|Infant Series|Investigator request|0|||
48687672|NCT00452790|156706956|FG001|Infant Series|Investigator request|1|||
48763415|NCT01319877|156983879|FG000|Overall Study|Reason Not Specified|4|||
48763416|NCT01319877|156983880|FG001|Overall Study|Reason Not Specified|5|||
48763417|NCT00978068|156983883|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
48763418|NCT00978068|156983884|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
48763419|NCT00978068|156983883|FG000|Overall Study|Death|1|||
48763420|NCT00978068|156983884|FG001|Overall Study|Death|2|||
48763421|NCT00978068|156983883|FG000|Overall Study|Lost to Follow-up|1|||
48687673|NCT00452790|156706955|FG000|Infant Series|Death|0|||
48687674|NCT00452790|156706956|FG001|Infant Series|Death|1|||
48687675|NCT00452790|156706955|FG000|After Infant Series|Investigator request|10|||
48687676|NCT00452790|156706956|FG001|After Infant Series|Investigator request|10|||
48687677|NCT00452790|156706955|FG000|After Infant Series|Adverse Event|4|||
48687678|NCT00452790|156706956|FG001|After Infant Series|Adverse Event|1|||
48687679|NCT00452790|156706955|FG000|After Infant Series|Parent/legal guardian request|1|||
48687680|NCT00452790|156706956|FG001|After Infant Series|Parent/legal guardian request|3|||
48687681|NCT00452790|156706955|FG000|After Infant Series|Lost to Follow-up|4|||
48687682|NCT00452790|156706956|FG001|After Infant Series|Lost to Follow-up|0|||
48687683|NCT00452790|156706955|FG000|After Infant Series|Failed to return|1|||
48687684|NCT00452790|156706956|FG001|After Infant Series|Failed to return|0|||
48687685|NCT00452790|156706955|FG000|After Infant Series|Other reasons|1|||
48687686|NCT00452790|156706956|FG001|After Infant Series|Other reasons|0|||
48687687|NCT00452790|156706955|FG000|Toddler Dose|Failed to return|0|||
48687688|NCT00452790|156706956|FG001|Toddler Dose|Failed to return|1|||
48687689|NCT00452790|156706955|FG000|Toddler Dose|Parent/legal guardian request|0|||
48687690|NCT00452790|156706956|FG001|Toddler Dose|Parent/legal guardian request|1|||
48687691|NCT01478971|156708224|FG000|Standard of Care Period|Adverse Event|1|||
48687692|NCT01478971|156708224|FG000|Standard of Care Period|Withdrawal by Subject|3|||
48687693|NCT01478971|156708224|FG000|Standard of Care Period|Death|8|||
48687694|NCT01478971|156708224|FG000|Standard of Care Period|Lost to Follow-up|9|||
48687695|NCT01478971|156708224|FG000|Standard of Care Period|Other|4|||
48687696|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Adverse Event|1|||
48687697|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
48687698|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Death|4|||
48687699|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
48687700|NCT01478971|156708224|FG000|Peginesatide Treatment Period|Other|4|||
48687701|NCT01535807|156708230|FG000|Overall Study|Withdrawal by Subject|1|||
48687702|NCT01535807|156708231|FG001|Overall Study|Withdrawal by Subject|1|||
48687703|NCT01535807|156708230|FG000|Overall Study|Data collection error|1|||
48687704|NCT01535807|156708231|FG001|Overall Study|Data collection error|1|||
48392150|NCT00960661|155630395|FG001|Interventional Phase|Physician Decision|3|||
48392151|NCT00960661|155630396|FG002|Interventional Phase|Physician Decision|5|||
48392152|NCT00960661|155630394|FG000|Interventional Phase|sponsor decision|0|||
48392153|NCT00960661|155630395|FG001|Interventional Phase|sponsor decision|1|||
48392154|NCT00960661|155630396|FG002|Interventional Phase|sponsor decision|0|||
48392155|NCT00960661|155630394|FG000|Interventional Phase|Lack of Efficacy|0|||
48392156|NCT00960661|155630395|FG001|Interventional Phase|Lack of Efficacy|2|||
48392157|NCT00960661|155630396|FG002|Interventional Phase|Lack of Efficacy|0|||
48392158|NCT03134599|155630402|FG000|Week 1|Lost to Follow-up|0|||
48392159|NCT03134599|155630403|FG001|Week 1|Lost to Follow-up|0|||
48392160|NCT03134599|155630404|FG002|Week 1|Lost to Follow-up|0|||
48392161|NCT03134599|155630405|FG003|Week 1|Lost to Follow-up|0|||
48392162|NCT03134599|155630406|FG004|Week 1|Lost to Follow-up|1|||
48392163|NCT03134599|155630407|FG005|Week 1|Lost to Follow-up|0|||
48392164|NCT03134599|155630402|FG000|Week 2|Lost to Follow-up|1|||
48392165|NCT03134599|155630403|FG001|Week 2|Lost to Follow-up|0|||
48392166|NCT03134599|155630404|FG002|Week 2|Lost to Follow-up|0|||
48392167|NCT03134599|155630405|FG003|Week 2|Lost to Follow-up|1|||
48392168|NCT03134599|155630406|FG004|Week 2|Lost to Follow-up|1|||
48392169|NCT03134599|155630407|FG005|Week 2|Lost to Follow-up|0|||
48392170|NCT03134599|155630402|FG000|Week 3|Lost to Follow-up|0|||
48392171|NCT03134599|155630403|FG001|Week 3|Lost to Follow-up|0|||
48392172|NCT03134599|155630404|FG002|Week 3|Lost to Follow-up|0|||
48392173|NCT03134599|155630405|FG003|Week 3|Lost to Follow-up|1|||
48392174|NCT03134599|155630406|FG004|Week 3|Lost to Follow-up|0|||
48392175|NCT03134599|155630407|FG005|Week 3|Lost to Follow-up|1|||
48392176|NCT01923285|155630410|FG000|Overall Study|Withdrawal by Subject|7|||
48392177|NCT01923285|155630411|FG001|Overall Study|Withdrawal by Subject|6|||
48392178|NCT03024970|155630414|FG000|First Intervention|Adverse Event|1|||
48392179|NCT03024970|155630415|FG001|First Intervention|Adverse Event|0|||
48392180|NCT03024970|155630414|FG000|Second Intervention|Lost to Follow-up|1|||
48392181|NCT03024970|155630415|FG001|Second Intervention|Lost to Follow-up|0|||
48392182|NCT03462576|155630416|FG000|Overall Study|Protocol Violation|5|||
48392183|NCT03462576|155630417|FG001|Overall Study|Protocol Violation|11|||
48687705|NCT02451917|156708232|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
48687706|NCT02451917|156708233|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
48687707|NCT02451917|156708232|FG000|First Intervention (24 Weeks)|Death|0|||
48687708|NCT02451917|156708233|FG001|First Intervention (24 Weeks)|Death|1|||
48392184|NCT03462576|155630418|FG002|Overall Study|Protocol Violation|7|||
48392185|NCT03462576|155630416|FG000|Overall Study|Device Malfunction|0|||
48392186|NCT03462576|155630417|FG001|Overall Study|Device Malfunction|0|||
48392187|NCT03462576|155630418|FG002|Overall Study|Device Malfunction|1|||
48392188|NCT03363321|155630419|FG000|Overall Study|Withdrawal by Subject|0|||
48392189|NCT03363321|155630420|FG001|Overall Study|Withdrawal by Subject|1|||
48392190|NCT03363321|155630421|FG002|Overall Study|Withdrawal by Subject|0|||
48392191|NCT03363321|155630422|FG003|Overall Study|Withdrawal by Subject|1|||
48763422|NCT00978068|156983884|FG001|Overall Study|Lost to Follow-up|2|||
48687709|NCT02451917|156708232|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
48687710|NCT02451917|156708233|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
48687711|NCT01724866|156708234|FG000|Overall Study|Adverse Event|0|||
48687712|NCT01724866|156708235|FG001|Overall Study|Adverse Event|0|||
48687713|NCT01724866|156708236|FG002|Overall Study|Adverse Event|1|||
48687714|NCT01724866|156708237|FG003|Overall Study|Adverse Event|1|||
48687715|NCT01724866|156708234|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
48687716|NCT01724866|156708235|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
48687717|NCT01724866|156708236|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
48687718|NCT01724866|156708237|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
48687719|NCT01724866|156708234|FG000|Overall Study|Investigator's Discretion|0|||
48687720|NCT01724866|156708235|FG001|Overall Study|Investigator's Discretion|1|||
48687721|NCT01724866|156708236|FG002|Overall Study|Investigator's Discretion|1|||
48687722|NCT01724866|156708237|FG003|Overall Study|Investigator's Discretion|0|||
48687723|NCT01724866|156708234|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
48687724|NCT01724866|156708235|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
48687725|NCT01724866|156708236|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
48687726|NCT01724866|156708237|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
48687727|NCT01724866|156708234|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
48687728|NCT01724866|156708235|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
48687729|NCT01724866|156708236|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
48687730|NCT01724866|156708237|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
48687731|NCT02420379|156708238|FG000|Overall Study|Withdrawal by Subject|0|||
48687732|NCT02420379|156708239|FG001|Overall Study|Withdrawal by Subject|3|||
48687733|NCT02420379|156708238|FG000|Overall Study|Unable to complete due to schooling|0|||
48687734|NCT02420379|156708239|FG001|Overall Study|Unable to complete due to schooling|1|||
48687735|NCT02420379|156708238|FG000|Overall Study|Transitioned to commercial drug|1|||
48687736|NCT02420379|156708239|FG001|Overall Study|Transitioned to commercial drug|0|||
48687737|NCT01402817|156708240|FG000|Overall Study|Withdrawal by Subject|3|||
48687738|NCT01402817|156708240|FG000|Overall Study|Study Suspended by FDA|8|||
48687739|NCT00502671|156708241|FG000|Overall Study|Disease Progression|13|||
48687740|NCT00502671|156708241|FG000|Overall Study|Personal Reasons|22|||
48687741|NCT00502671|156708241|FG000|Overall Study|Lost to Follow-up|7|||
48687742|NCT00502671|156708241|FG000|Overall Study|Protocol Violation|16|||
48687743|NCT00502671|156708241|FG000|Overall Study|Adverse Event|19|||
48687744|NCT00681629|156708250|FG000|Overall Study|Study termination|4|||
48687745|NCT00681629|156708251|FG001|Overall Study|Study termination|2|||
48687746|NCT00681629|156708250|FG000|Overall Study|Adverse Event|1|||
48687747|NCT00681629|156708251|FG001|Overall Study|Adverse Event|0|||
48687748|NCT02098746|156708261|FG000|Overall Study|Changes of Investigator|2|||
48687749|NCT02098746|156708261|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48687750|NCT02098746|156708261|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
48687751|NCT02098746|156708261|FG000|Overall Study|Data Not Available After Treatment|1|||
48687752|NCT01217944|156708266|FG000|Overall Study|Protocol Violation|1|||
48687753|NCT01217944|156708267|FG001|Overall Study|Protocol Violation|1|||
48687754|NCT01217944|156708268|FG002|Overall Study|Protocol Violation|0|||
48687755|NCT01217944|156708266|FG000|Overall Study|Lost to Follow-up|3|||
48687756|NCT01217944|156708267|FG001|Overall Study|Lost to Follow-up|1|||
48687757|NCT01217944|156708268|FG002|Overall Study|Lost to Follow-up|0|||
48687758|NCT01217944|156708266|FG000|Overall Study|Withdrawal by Subject|1|||
48687759|NCT01217944|156708267|FG001|Overall Study|Withdrawal by Subject|2|||
48687760|NCT01217944|156708268|FG002|Overall Study|Withdrawal by Subject|0|||
48687761|NCT01217944|156708266|FG000|Overall Study|Lack of Efficacy|1|||
48687762|NCT01217944|156708267|FG001|Overall Study|Lack of Efficacy|0|||
48687763|NCT01217944|156708268|FG002|Overall Study|Lack of Efficacy|0|||
48429863|NCT01808118|155761871|FG001|Period 1|Enrolled in error|0|||
48687764|NCT03579940|156708269|FG000|Period 2|Withdrawal by Subject|0|||
48687765|NCT03579940|156708270|FG001|Period 2|Withdrawal by Subject|0|||
48687766|NCT03579940|156708271|FG002|Period 2|Withdrawal by Subject|1|||
48687767|NCT03579940|156708272|FG003|Period 2|Withdrawal by Subject|0|||
48687768|NCT03579940|156708273|FG004|Period 2|Withdrawal by Subject|0|||
48687769|NCT03579940|156708274|FG005|Period 2|Withdrawal by Subject|0|||
48687770|NCT03579940|156708275|FG006|Period 2|Withdrawal by Subject|0|||
48687771|NCT03579940|156708276|FG007|Period 2|Withdrawal by Subject|0|||
48687772|NCT03579940|156708277|FG008|Period 2|Withdrawal by Subject|0|||
48763423|NCT00978068|156983883|FG000|Overall Study|Physician Decision|0|||
48763424|NCT00978068|156983884|FG001|Overall Study|Physician Decision|1|||
48763425|NCT00978068|156983883|FG000|Overall Study|Unable to Comply with Study|0|||
48687773|NCT03579940|156708278|FG009|Period 2|Withdrawal by Subject|0|||
48763426|NCT00978068|156983884|FG001|Overall Study|Unable to Comply with Study|2|||
48763427|NCT01165138|156983885|FG000|Overall Study|Adverse Event|0|||
48687774|NCT03579940|156708279|FG010|Period 2|Withdrawal by Subject|0|||
48687775|NCT01751984|156708280|FG000|Overall Study|Adverse Event|5|||
48687776|NCT01751984|156708281|FG001|Overall Study|Adverse Event|3|||
48687777|NCT01751984|156708280|FG000|Overall Study|Withdrawal by Subject|0|||
48687778|NCT01751984|156708281|FG001|Overall Study|Withdrawal by Subject|1|||
48687779|NCT01751984|156708280|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
48687780|NCT01751984|156708281|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
48687781|NCT02469623|156708287|FG000|Overall Study|Not consented for long-term follow-up|4|||
48687782|NCT02469623|156708287|FG000|Overall Study|Lost to Follow-up|4|||
48687783|NCT02469623|156708287|FG000|Overall Study|Withdrawal by Subject|2|||
48687784|NCT02469623|156708287|FG000|Overall Study|Death|3|||
48687785|NCT01799226|156708288|FG000|Overall Study|Withdrawal by Subject|1|||
48687786|NCT01799226|156708289|FG001|Overall Study|Withdrawal by Subject|0|||
48687787|NCT01799226|156708288|FG000|Overall Study|Disqualified at Day 14|1|||
48687788|NCT01799226|156708289|FG001|Overall Study|Disqualified at Day 14|0|||
48687789|NCT03361293|156708292|FG000|Overall Study|Lost to Follow-up|0|||
48687790|NCT03361293|156708293|FG001|Overall Study|Lost to Follow-up|2|||
48687791|NCT03361293|156708292|FG000|Overall Study|Withdrawal by Subject|1|||
48687792|NCT03361293|156708293|FG001|Overall Study|Withdrawal by Subject|3|||
48687793|NCT00936702|156708297|FG000|Overall Study|Disease progression|34|||
48687794|NCT00936702|156708297|FG000|Overall Study|Adverse Event|8|||
48687795|NCT00936702|156708297|FG000|Overall Study|Withdrawal by Subject|2|||
48687796|NCT00936702|156708297|FG000|Overall Study|Alternative Treatment|1|||
48687797|NCT00936702|156708297|FG000|Overall Study|Other|1|||
48687798|NCT01544920|156708299|FG000|Overall Study|Adverse Event|0|||
48687799|NCT01544920|156708300|FG001|Overall Study|Adverse Event|3|||
48687800|NCT01544920|156708299|FG000|Overall Study|Death|0|||
48687801|NCT01544920|156708300|FG001|Overall Study|Death|1|||
48687802|NCT01544920|156708299|FG000|Overall Study|Lost to Follow-up|11|||
48687803|NCT01544920|156708300|FG001|Overall Study|Lost to Follow-up|12|||
48355319|NCT00760747|155497269|FG001|Study Period II|Parent/Caregiver Decision|0|||
48355320|NCT00760747|155497268|FG000|Study Period II|Protocol Violation|6|||
48355321|NCT00760747|155497269|FG001|Study Period II|Protocol Violation|3|||
48355322|NCT00760747|155497268|FG000|Study Period II|Withdrawal by Subject|1|||
48355323|NCT00760747|155497269|FG001|Study Period II|Withdrawal by Subject|0|||
48355324|NCT00760747|155497268|FG000|Study Period II|No drug administered|0|||
48355325|NCT00760747|155497269|FG001|Study Period II|No drug administered|1|||
48355326|NCT00760747|155497268|FG000|Study Period III|Adverse Event|1|||
48355327|NCT00760747|155497269|FG001|Study Period III|Adverse Event|0|||
48355328|NCT00760747|155497268|FG000|Study Period III|Lack of Efficacy|1|||
48355329|NCT00760747|155497269|FG001|Study Period III|Lack of Efficacy|0|||
48355330|NCT00760747|155497268|FG000|Study Period III|Parent/Caregiver Decision|0|||
48355331|NCT00760747|155497269|FG001|Study Period III|Parent/Caregiver Decision|1|||
48355332|NCT00760747|155497268|FG000|Study Period III|Protocol Violation|1|||
48355333|NCT00760747|155497269|FG001|Study Period III|Protocol Violation|1|||
48355334|NCT00760747|155497268|FG000|Study Period III|Physician Decision|0|||
48355335|NCT00760747|155497269|FG001|Study Period III|Physician Decision|1|||
48355336|NCT03566979|155497270|FG000|Overall Study|Withdrawal by Subject|2|||
48355337|NCT03566979|155497271|FG001|Overall Study|Withdrawal by Subject|0|||
48355338|NCT03566979|155497272|FG002|Overall Study|Withdrawal by Subject|1|||
48355339|NCT03566979|155497273|FG003|Overall Study|Withdrawal by Subject|1|||
48355340|NCT03566979|155497270|FG000|Overall Study|Lost to Follow-up|2|||
48355341|NCT03566979|155497271|FG001|Overall Study|Lost to Follow-up|7|||
48355342|NCT03566979|155497272|FG002|Overall Study|Lost to Follow-up|9|||
48355343|NCT03566979|155497273|FG003|Overall Study|Lost to Follow-up|5|||
48355344|NCT03566979|155497270|FG000|Overall Study|Adverse Event|1|||
48355345|NCT03566979|155497271|FG001|Overall Study|Adverse Event|0|||
48355346|NCT03566979|155497272|FG002|Overall Study|Adverse Event|0|||
48355347|NCT03566979|155497273|FG003|Overall Study|Adverse Event|0|||
48355348|NCT04887506|155497276|FG000|Overall Study|Death|1|||
48355349|NCT04887506|155497277|FG001|Overall Study|Death|1|||
48355350|NCT04887506|155497276|FG000|Overall Study|Withdrawal by Subject|0|||
48355351|NCT04887506|155497277|FG001|Overall Study|Withdrawal by Subject|3|||
48355352|NCT04887506|155497276|FG000|Overall Study|Adverse Event|4|||
48355353|NCT04887506|155497277|FG001|Overall Study|Adverse Event|3|||
48355354|NCT04887506|155497276|FG000|Overall Study|Other - Not Reported|1|||
48355355|NCT04887506|155497277|FG001|Overall Study|Other - Not Reported|1|||
48355356|NCT04547023|155497278|FG000|Overall Study|Did Not Receive Intervention|3|||
48355357|NCT04547023|155497279|FG001|Overall Study|Did Not Receive Intervention|2|||
48355358|NCT04547023|155497278|FG000|Overall Study|Lost to Follow-up|1|||
48355359|NCT04547023|155497279|FG001|Overall Study|Lost to Follow-up|1|||
48355360|NCT00250432|155497280|FG000|Overall Study|Adverse Event|25|||
48355361|NCT00250432|155497281|FG001|Overall Study|Adverse Event|29|||
48355362|NCT00250432|155497280|FG000|Overall Study|Lack of Efficacy|2|||
48355363|NCT00250432|155497281|FG001|Overall Study|Lack of Efficacy|1|||
48355364|NCT00250432|155497280|FG000|Overall Study|Lost to Follow-up|6|||
48355365|NCT00250432|155497281|FG001|Overall Study|Lost to Follow-up|5|||
48687804|NCT01544920|156708299|FG000|Overall Study|Protocol Violation|0|||
48392192|NCT03363321|155630423|FG004|Overall Study|Withdrawal by Subject|0|||
48392193|NCT00781911|155630441|FG000|Overall Study|Adverse Event|4|||
48392194|NCT00781911|155630442|FG001|Overall Study|Adverse Event|4|||
48392195|NCT00781911|155630441|FG000|Overall Study|Withdrawal by Subject|1|||
48392196|NCT00781911|155630442|FG001|Overall Study|Withdrawal by Subject|2|||
48392197|NCT00781911|155630441|FG000|Overall Study|Physician Decision|0|||
48392198|NCT00781911|155630442|FG001|Overall Study|Physician Decision|2|||
48392199|NCT00781911|155630441|FG000|Overall Study|Sponsor Decision|1|||
48392200|NCT00781911|155630442|FG001|Overall Study|Sponsor Decision|0|||
48392201|NCT03317795|155630445|FG000|Overall Study|IUD Expulsion|1|||
48392202|NCT03317795|155630446|FG001|Overall Study|IUD Expulsion|0|||
48392203|NCT03317795|155630445|FG000|Overall Study|Lost to Follow-up|1|||
48392204|NCT03317795|155630446|FG001|Overall Study|Lost to Follow-up|3|||
48392205|NCT03317795|155630445|FG000|Overall Study|Treatment change|0|||
48392206|NCT03317795|155630446|FG001|Overall Study|Treatment change|3|||
48392207|NCT03317795|155630445|FG000|Overall Study|Intolerance of medication|0|||
48392208|NCT03317795|155630446|FG001|Overall Study|Intolerance of medication|1|||
48392209|NCT00432042|155630451|FG000|Overall Study|Protocol Violation|2|||
48392210|NCT00432042|155630452|FG001|Overall Study|Protocol Violation|0|||
48392211|NCT00432042|155630453|FG002|Overall Study|Protocol Violation|0|||
48392212|NCT00432042|155630451|FG000|Overall Study|Withdrawal by Subject|0|||
48687805|NCT01544920|156708300|FG001|Overall Study|Protocol Violation|2|||
48687806|NCT01544920|156708299|FG000|Overall Study|Physician Decision|4|||
48687807|NCT01544920|156708300|FG001|Overall Study|Physician Decision|1|||
48687808|NCT01544920|156708299|FG000|Overall Study|Withdrawal by Subject|4|||
48687809|NCT01544920|156708300|FG001|Overall Study|Withdrawal by Subject|4|||
48687810|NCT03244917|156708302|FG000|Overall Study|Lost to Follow-up|2|||
48687811|NCT03244917|156708303|FG001|Overall Study|Lost to Follow-up|2|||
48687812|NCT01135134|156708310|FG000|Overall Study|Adverse Event|1|||
48687813|NCT01135134|156708311|FG001|Overall Study|Adverse Event|1|||
48687814|NCT01135134|156708310|FG000|Overall Study|Did not meet protocol eligibility|1|||
48687815|NCT01135134|156708311|FG001|Overall Study|Did not meet protocol eligibility|0|||
48687816|NCT00988598|156708315|FG000|Overall Study|Withdrawal by Subject|2|||
48687817|NCT00988598|156708316|FG001|Overall Study|Withdrawal by Subject|0|||
48687818|NCT01569841|156708327|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
48687819|NCT01569841|156708328|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
48687820|NCT00300755|156708329|FG000|Overall Study|Adverse Event|1|||
48687821|NCT00300755|156708330|FG001|Overall Study|Adverse Event|2|||
48687822|NCT00300755|156708331|FG002|Overall Study|Adverse Event|1|||
48687823|NCT00300755|156708329|FG000|Overall Study|Withdrawal by Subject|0|||
48687824|NCT00300755|156708330|FG001|Overall Study|Withdrawal by Subject|2|||
48687825|NCT00300755|156708331|FG002|Overall Study|Withdrawal by Subject|0|||
48687826|NCT00300755|156708329|FG000|Overall Study|Protocol Violation|0|||
48687827|NCT00300755|156708330|FG001|Overall Study|Protocol Violation|0|||
48687828|NCT00300755|156708331|FG002|Overall Study|Protocol Violation|1|||
48687829|NCT03634085|156708332|FG000|Overall Study|Adverse Event|1|||
48687830|NCT03634085|156708333|FG001|Overall Study|Adverse Event|0|||
48687831|NCT03634085|156708332|FG000|Overall Study|Withdrawal by Subject|0|||
48392213|NCT00432042|155630452|FG001|Overall Study|Withdrawal by Subject|0|||
48392214|NCT00432042|155630453|FG002|Overall Study|Withdrawal by Subject|2|||
48392215|NCT00432042|155630451|FG000|Overall Study|Lost to Follow-up|5|||
48392216|NCT00432042|155630452|FG001|Overall Study|Lost to Follow-up|1|||
48392217|NCT00432042|155630453|FG002|Overall Study|Lost to Follow-up|0|||
48392218|NCT00993265|155630468|FG000|Overall Study|Adverse Event|1|||
48392219|NCT00993265|155630469|FG001|Overall Study|Adverse Event|0|||
48392220|NCT00993265|155630468|FG000|Overall Study|Changed dose of concomitant drug|2|||
48392221|NCT00993265|155630469|FG001|Overall Study|Changed dose of concomitant drug|0|||
48392222|NCT00993265|155630468|FG000|Overall Study|Non-compliant with study medication|1|||
48392223|NCT00993265|155630469|FG001|Overall Study|Non-compliant with study medication|0|||
48392224|NCT00960843|155630470|FG000|Overall Study|Lost to Follow-up|2|||
48392225|NCT00960843|155630471|FG001|Overall Study|Lost to Follow-up|0|||
48392226|NCT00960843|155630470|FG000|Overall Study|Protocol Violation|0|||
48392227|NCT00960843|155630471|FG001|Overall Study|Protocol Violation|4|||
48687832|NCT03634085|156708333|FG001|Overall Study|Withdrawal by Subject|2|||
48687833|NCT01946139|156708339|FG000|Overall Study|Withdrawal by Subject|8|||
48687834|NCT01946139|156708339|FG000|Overall Study|ineligible|8|||
48687835|NCT01946139|156708339|FG000|Overall Study|Specimens not available|4|||
48687836|NCT00296816|156708340|FG000|Overall Study|Disease Progression|37|||
48687837|NCT00296816|156708340|FG000|Overall Study|Adverse Event|18|||
48392228|NCT00960843|155630470|FG000|Overall Study|Repeated needle dislodgment|0|||
48392229|NCT00960843|155630471|FG001|Overall Study|Repeated needle dislodgment|1|||
48392230|NCT00652366|155630472|FG000|Overall Study|Adverse Event|8|||
48392231|NCT00652366|155630473|FG001|Overall Study|Adverse Event|4|||
48392232|NCT00652366|155630474|FG002|Overall Study|Adverse Event|7|||
48392233|NCT00652366|155630475|FG003|Overall Study|Adverse Event|17|||
48392234|NCT00652366|155630476|FG004|Overall Study|Adverse Event|13|||
48687838|NCT00296816|156708340|FG000|Overall Study|Investigator/Participant request|5|||
48392235|NCT00652366|155630472|FG000|Overall Study|Death|5|||
48392236|NCT00652366|155630473|FG001|Overall Study|Death|4|||
48392237|NCT00652366|155630474|FG002|Overall Study|Death|1|||
48392238|NCT00652366|155630475|FG003|Overall Study|Death|8|||
48392239|NCT00652366|155630476|FG004|Overall Study|Death|5|||
48392240|NCT00652366|155630472|FG000|Overall Study|Lack of Efficacy|84|||
48392241|NCT00652366|155630473|FG001|Overall Study|Lack of Efficacy|58|||
48392242|NCT00652366|155630474|FG002|Overall Study|Lack of Efficacy|53|||
48392243|NCT00652366|155630475|FG003|Overall Study|Lack of Efficacy|133|||
48392244|NCT00652366|155630476|FG004|Overall Study|Lack of Efficacy|13|||
48392245|NCT00652366|155630472|FG000|Overall Study|Violation of Selection Criteria|0|||
48392246|NCT00652366|155630473|FG001|Overall Study|Violation of Selection Criteria|0|||
48392247|NCT00652366|155630474|FG002|Overall Study|Violation of Selection Criteria|1|||
48392248|NCT00652366|155630475|FG003|Overall Study|Violation of Selection Criteria|0|||
48392249|NCT00652366|155630476|FG004|Overall Study|Violation of Selection Criteria|0|||
48392250|NCT00652366|155630472|FG000|Overall Study|Protocol Violation|1|||
48392251|NCT00652366|155630473|FG001|Overall Study|Protocol Violation|0|||
48392252|NCT00652366|155630474|FG002|Overall Study|Protocol Violation|0|||
48392253|NCT00652366|155630475|FG003|Overall Study|Protocol Violation|0|||
48392254|NCT00652366|155630476|FG004|Overall Study|Protocol Violation|0|||
48392255|NCT00652366|155630472|FG000|Overall Study|Refused treatment|3|||
48392256|NCT00652366|155630473|FG001|Overall Study|Refused treatment|7|||
48392257|NCT00652366|155630474|FG002|Overall Study|Refused treatment|6|||
48392258|NCT00652366|155630475|FG003|Overall Study|Refused treatment|17|||
48392259|NCT00652366|155630476|FG004|Overall Study|Refused treatment|5|||
48392260|NCT00652366|155630472|FG000|Overall Study|Other|5|||
48392261|NCT00652366|155630473|FG001|Overall Study|Other|2|||
48392262|NCT00652366|155630474|FG002|Overall Study|Other|3|||
48392263|NCT00652366|155630475|FG003|Overall Study|Other|4|||
48392264|NCT00652366|155630476|FG004|Overall Study|Other|0|||
48392265|NCT02577146|155630480|FG000|Overall Study|Lost to Follow-up|8|||
48392266|NCT02577146|155630480|FG000|Overall Study|Physician Decision|3|||
48392267|NCT02577146|155630480|FG000|Overall Study|Screen Failure|17|||
48392268|NCT01970501|155630481|FG000|Overall Study|Discontinuation of study by sponsor|16|||
48392269|NCT01970501|155630482|FG001|Overall Study|Discontinuation of study by sponsor|14|||
48392270|NCT01970501|155630481|FG000|Overall Study|Withdrawal by Subject|6|||
48392271|NCT01970501|155630482|FG001|Overall Study|Withdrawal by Subject|7|||
48392272|NCT01970501|155630481|FG000|Overall Study|Adverse Event|2|||
48392273|NCT01970501|155630482|FG001|Overall Study|Adverse Event|4|||
48687839|NCT00296816|156708340|FG000|Overall Study|Non-compliance|1|||
48687840|NCT00296816|156708340|FG000|Overall Study|Missing for end of treatment|4|||
48687841|NCT00296816|156708340|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
48687842|NCT00296816|156708340|FG000|Overall Study|Poor performance status|1|||
48687843|NCT00296816|156708340|FG000|Overall Study|Relocation to Florida|1|||
48687844|NCT00296816|156708340|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
48687845|NCT00296816|156708340|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
48687846|NCT00296816|156708340|FG000|Overall Study|Neuropathy/patient preference|1|||
48687847|NCT00296816|156708340|FG000|Overall Study|Proteinuria|1|||
48687848|NCT00296816|156708340|FG000|Overall Study|ineligibility due to radiation treatment|1|||
48687849|NCT01664910|156708341|FG000|Overall Study|Adverse Event|0|||
48687850|NCT01664910|156708342|FG001|Overall Study|Adverse Event|0|||
48687851|NCT01664910|156708343|FG002|Overall Study|Adverse Event|1|||
48687852|NCT01879683|156708344|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
48687853|NCT01054456|156708348|FG000|Overall Study|Other|1|||
48687854|NCT04701333|156708349|FG000|Overall Study|Lost to Follow-up|3|||
48687855|NCT04701333|156708350|FG001|Overall Study|Lost to Follow-up|7|||
48687856|NCT04701333|156708349|FG000|Overall Study|Withdrawal by Subject|0|||
48687857|NCT04701333|156708350|FG001|Overall Study|Withdrawal by Subject|1|||
48687858|NCT01363700|156708351|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
48687859|NCT01363700|156708352|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
48687860|NCT01363700|156708353|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
48763428|NCT01165138|156983886|FG001|Overall Study|Adverse Event|1|||
48392274|NCT01970501|155630481|FG000|Overall Study|Death|1|||
48392275|NCT01970501|155630482|FG001|Overall Study|Death|3|||
48392276|NCT01970501|155630481|FG000|Overall Study|Physician Decision|2|||
48763429|NCT01165138|156983887|FG002|Overall Study|Adverse Event|0|||
48392277|NCT01970501|155630482|FG001|Overall Study|Physician Decision|0|||
48392278|NCT00794157|155630483|FG000|Overall Study|Adverse Event|4|||
48392279|NCT00794157|155630484|FG001|Overall Study|Adverse Event|1|||
48392280|NCT00794157|155630485|FG002|Overall Study|Adverse Event|8|||
48687861|NCT01363700|156708354|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
48392281|NCT00794157|155630483|FG000|Overall Study|Subject withdrew consent|2|||
48392282|NCT00794157|155630484|FG001|Overall Study|Subject withdrew consent|0|||
48392283|NCT00794157|155630485|FG002|Overall Study|Subject withdrew consent|3|||
48392284|NCT00794157|155630483|FG000|Overall Study|Lost to Follow-up|2|||
48687862|NCT01363700|156708355|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
48392285|NCT00794157|155630484|FG001|Overall Study|Lost to Follow-up|0|||
48392286|NCT00794157|155630485|FG002|Overall Study|Lost to Follow-up|1|||
48687863|NCT00148759|156708356|FG000|Overall Study|Withdrawal by Subject|1|||
48687864|NCT00148759|156708357|FG001|Overall Study|Withdrawal by Subject|1|||
48687865|NCT00148759|156708356|FG000|Overall Study|Lost to Follow-up|1|||
48687866|NCT00148759|156708357|FG001|Overall Study|Lost to Follow-up|0|||
48687867|NCT01454596|156708358|FG000|Overall Study|Death|0|||
48687868|NCT01454596|156708359|FG001|Overall Study|Death|0|||
48687869|NCT01454596|156708360|FG002|Overall Study|Death|0|||
48687870|NCT01454596|156708361|FG003|Overall Study|Death|0|||
48687871|NCT01454596|156708362|FG004|Overall Study|Death|0|||
48763430|NCT01165138|156983888|FG003|Overall Study|Adverse Event|2|||
48763431|NCT01165138|156983885|FG000|Overall Study|Lack of Efficacy|0|||
48763432|NCT01165138|156983886|FG001|Overall Study|Lack of Efficacy|32|||
48763433|NCT01165138|156983887|FG002|Overall Study|Lack of Efficacy|6|||
48763434|NCT01165138|156983888|FG003|Overall Study|Lack of Efficacy|7|||
48763435|NCT01165138|156983885|FG000|Overall Study|Protocol Violation|0|||
48763436|NCT01165138|156983886|FG001|Overall Study|Protocol Violation|7|||
48763437|NCT01165138|156983887|FG002|Overall Study|Protocol Violation|0|||
48763438|NCT01165138|156983888|FG003|Overall Study|Protocol Violation|2|||
48763439|NCT01165138|156983885|FG000|Overall Study|Lost to Follow-up|0|||
48763440|NCT01165138|156983886|FG001|Overall Study|Lost to Follow-up|0|||
48392287|NCT00794157|155630483|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48392288|NCT00794157|155630484|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48392289|NCT00794157|155630485|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48392290|NCT00794157|155630483|FG000|Overall Study|Administrative problems|1|||
48392291|NCT00794157|155630484|FG001|Overall Study|Administrative problems|7|||
48392292|NCT00794157|155630485|FG002|Overall Study|Administrative problems|4|||
48392293|NCT00794157|155630483|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48392294|NCT00794157|155630484|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48392295|NCT00794157|155630485|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48392296|NCT00794157|155630483|FG000|Overall Study|Protocol deviation|0|||
48392297|NCT00794157|155630484|FG001|Overall Study|Protocol deviation|1|||
48392298|NCT00794157|155630485|FG002|Overall Study|Protocol deviation|1|||
48392299|NCT00814892|155630486|FG000|Overall Study|Disease Progression|1|||
48392300|NCT00814892|155630486|FG000|Overall Study|Study Termination|1|||
48687872|NCT01454596|156708363|FG005|Overall Study|Death|0|||
48687873|NCT01454596|156708364|FG006|Overall Study|Death|0|||
48687874|NCT01454596|156708365|FG007|Overall Study|Death|0|||
48687875|NCT01454596|156708366|FG008|Overall Study|Death|0|||
48687876|NCT01454596|156708367|FG009|Overall Study|Death|1|||
48687877|NCT01454596|156708368|FG010|Overall Study|Death|1|||
48687878|NCT01454596|156708369|FG011|Overall Study|Death|0|||
48687879|NCT00614380|156708371|FG000|Overall Study|Adverse Event|14|||
48687880|NCT00614380|156708372|FG001|Overall Study|Adverse Event|4|||
48687881|NCT00614380|156708373|FG002|Overall Study|Adverse Event|0|||
48687882|NCT00614380|156708374|FG003|Overall Study|Adverse Event|0|||
48687883|NCT00614380|156708371|FG000|Overall Study|Lost to Follow-up|6|||
48687884|NCT00614380|156708372|FG001|Overall Study|Lost to Follow-up|1|||
48687885|NCT00614380|156708373|FG002|Overall Study|Lost to Follow-up|0|||
48687886|NCT00614380|156708374|FG003|Overall Study|Lost to Follow-up|0|||
48687887|NCT00614380|156708371|FG000|Overall Study|Non compliant with the protocol|12|||
48687888|NCT00614380|156708372|FG001|Overall Study|Non compliant with the protocol|2|||
48687889|NCT00614380|156708373|FG002|Overall Study|Non compliant with the protocol|1|||
48687890|NCT00614380|156708374|FG003|Overall Study|Non compliant with the protocol|2|||
48687891|NCT00614380|156708371|FG000|Overall Study|Consent withdrawn|3|||
48687892|NCT00614380|156708372|FG001|Overall Study|Consent withdrawn|1|||
48687893|NCT00614380|156708373|FG002|Overall Study|Consent withdrawn|0|||
48687894|NCT00614380|156708374|FG003|Overall Study|Consent withdrawn|0|||
48763441|NCT01165138|156983887|FG002|Overall Study|Lost to Follow-up|1|||
48763442|NCT01165138|156983888|FG003|Overall Study|Lost to Follow-up|2|||
48763443|NCT01165138|156983885|FG000|Overall Study|Physician Decision|0|||
48763444|NCT01165138|156983886|FG001|Overall Study|Physician Decision|6|||
48392301|NCT00550680|155630491|FG000|Overall Study|Administrative Reasons|1|||
48392302|NCT00550680|155630491|FG000|Overall Study|Adverse Event|5|||
48392303|NCT00550680|155630491|FG000|Overall Study|Death|3|||
48392304|NCT00550680|155630491|FG000|Overall Study|Early Improvement|1|||
48392305|NCT00550680|155630491|FG000|Overall Study|Lost to Follow-up|3|||
48392306|NCT00550680|155630491|FG000|Overall Study|Lack of Efficacy|1|||
48687895|NCT00857285|156708375|FG000|Overall Study|Adverse Event|4|||
48687896|NCT00857285|156708376|FG001|Overall Study|Adverse Event|2|||
48687897|NCT00857285|156708375|FG000|Overall Study|Lack of Efficacy|0|||
48687898|NCT00857285|156708376|FG001|Overall Study|Lack of Efficacy|2|||
48392307|NCT00550680|155630491|FG000|Overall Study|Other|10|||
48687899|NCT00857285|156708375|FG000|Overall Study|Protocol Violation|3|||
48687900|NCT00857285|156708376|FG001|Overall Study|Protocol Violation|1|||
48687901|NCT00857285|156708375|FG000|Overall Study|Withdrawal by Subject|4|||
48687902|NCT00857285|156708376|FG001|Overall Study|Withdrawal by Subject|0|||
48763445|NCT01165138|156983887|FG002|Overall Study|Physician Decision|7|||
48763446|NCT01165138|156983888|FG003|Overall Study|Physician Decision|6|||
48687903|NCT00857285|156708375|FG000|Overall Study|Randomization criteria not met|1|||
48687904|NCT00857285|156708376|FG001|Overall Study|Randomization criteria not met|1|||
48687905|NCT02675907|156708381|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
48687906|NCT02675907|156708382|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
48687907|NCT02675907|156708381|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
48687908|NCT02675907|156708382|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
48687909|NCT02675907|156708381|FG000|Study Overall|Lack of Efficacy|1|||
48687910|NCT02675907|156708382|FG001|Study Overall|Lack of Efficacy|0|||
48392308|NCT00550680|155630491|FG000|Overall Study|Protocol Violation|7|||
48392309|NCT00550680|155630491|FG000|Overall Study|Refused Treatment|19|||
48392310|NCT00550680|155630491|FG000|Overall Study|Screen Failure|6|||
48392311|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
48392312|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
48392313|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
48392314|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
48392315|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
48392316|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
48392317|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
48392318|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
48687911|NCT02675907|156708381|FG000|Study Overall|Withdrawal by Subject|2|||
48687912|NCT02675907|156708382|FG001|Study Overall|Withdrawal by Subject|2|||
48687913|NCT02675907|156708381|FG000|Study Overall|Lost to Follow-up|0|||
48687914|NCT02675907|156708382|FG001|Study Overall|Lost to Follow-up|2|||
48687915|NCT01594931|156709932|FG000|Overall Study|Adverse Event|3|||
48687916|NCT01594931|156709933|FG001|Overall Study|Adverse Event|1|||
48687917|NCT01594931|156709934|FG002|Overall Study|Adverse Event|1|||
48687918|NCT01594931|156709932|FG000|Overall Study|Withdrawal by Subject|2|||
48687919|NCT01594931|156709933|FG001|Overall Study|Withdrawal by Subject|1|||
48687920|NCT01594931|156709934|FG002|Overall Study|Withdrawal by Subject|1|||
48687921|NCT01594931|156709932|FG000|Overall Study|Lack of Efficacy|7|||
48687922|NCT01594931|156709933|FG001|Overall Study|Lack of Efficacy|2|||
48687923|NCT01594931|156709934|FG002|Overall Study|Lack of Efficacy|2|||
48687924|NCT01594931|156709932|FG000|Overall Study|Lost to Follow-up|4|||
48687925|NCT01594931|156709933|FG001|Overall Study|Lost to Follow-up|3|||
48687926|NCT01594931|156709934|FG002|Overall Study|Lost to Follow-up|3|||
48687927|NCT01594931|156709932|FG000|Overall Study|Protocol Violation|2|||
48687928|NCT01594931|156709933|FG001|Overall Study|Protocol Violation|1|||
48687929|NCT01594931|156709934|FG002|Overall Study|Protocol Violation|0|||
48687930|NCT01594931|156709932|FG000|Overall Study|No defiined|11|||
48687931|NCT01594931|156709933|FG001|Overall Study|No defiined|4|||
48687932|NCT01594931|156709934|FG002|Overall Study|No defiined|7|||
48687933|NCT04549545|156709935|FG000|Initial Period|Withdrawal by Subject|4|||
48687934|NCT04549545|156709936|FG001|Initial Period|Withdrawal by Subject|0|||
48687935|NCT04549545|156709935|FG000|Initial Period|Additional ENT Procedure|3|||
48687936|NCT04549545|156709936|FG001|Initial Period|Additional ENT Procedure|0|||
48687937|NCT04549545|156709935|FG000|Initial Period|Lost to Follow-up|3|||
48687938|NCT04549545|156709936|FG001|Initial Period|Lost to Follow-up|1|||
48687939|NCT04549545|156709935|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
48687940|NCT04549545|156709936|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
48687941|NCT04549545|156709935|FG000|Crossover Period|Additional ENT Procedure|0|||
48687942|NCT04549545|156709936|FG001|Crossover Period|Additional ENT Procedure|6|||
48687943|NCT04549545|156709935|FG000|Crossover Period|Lost to Follow-up|0|||
48687944|NCT04549545|156709936|FG001|Crossover Period|Lost to Follow-up|1|||
48429864|NCT01808118|155761872|FG002|Period 1|Enrolled in error|0|||
48687945|NCT04549545|156709935|FG000|Crossover Period|Withdrawal by Subject|0|||
48687946|NCT04549545|156709936|FG001|Crossover Period|Withdrawal by Subject|4|||
48687947|NCT01467505|156709944|FG000|Overall Study|Adverse Event|1|||
48687948|NCT01467505|156709945|FG001|Overall Study|Adverse Event|0|||
48687949|NCT01467505|156709944|FG000|Overall Study|Withdrawal by Subject|4|||
48687950|NCT01467505|156709945|FG001|Overall Study|Withdrawal by Subject|0|||
48687951|NCT01467505|156709944|FG000|Overall Study|Study Terminated by Sponsor|28|||
48687952|NCT01467505|156709945|FG001|Overall Study|Study Terminated by Sponsor|3|||
48687953|NCT02614729|156709946|FG000|Overall Study|Withdrawal by Subject|1|||
48687954|NCT02614729|156709947|FG001|Overall Study|Withdrawal by Subject|0|||
48687955|NCT00227721|156709948|FG000|Overall Study|On study, but never treated.|1|||
48687956|NCT02539797|156709949|FG000|Overall Study|Lost to Follow-up|0|||
48687957|NCT02539797|156709950|FG001|Overall Study|Lost to Follow-up|1|||
48687958|NCT02539797|156709951|FG002|Overall Study|Lost to Follow-up|0|||
48687959|NCT00961181|156709952|FG000|Overall Study|Death|2|||
48687960|NCT00961181|156709952|FG000|Overall Study|Withdrawal by Subject|2|||
48687961|NCT00961181|156709952|FG000|Overall Study|Lost to Follow-up|1|||
48687962|NCT02252146|156709956|FG000|Overall Study|Lack of Efficacy|4|||
48687963|NCT02252146|156709956|FG000|Overall Study|Entered hospice care|1|||
48687964|NCT02252146|156709956|FG000|Overall Study|Inability to travel to study site|1|||
48687965|NCT00763386|156709961|FG000|Overall Study|Adverse Event|43|||
48687966|NCT00763386|156709962|FG001|Overall Study|Adverse Event|33|||
48687967|NCT00763386|156709961|FG000|Overall Study|Death|1|||
48687968|NCT00763386|156709962|FG001|Overall Study|Death|2|||
48687969|NCT00763386|156709961|FG000|Overall Study|Lost to Follow-up|3|||
48687970|NCT00763386|156709962|FG001|Overall Study|Lost to Follow-up|3|||
48687971|NCT00763386|156709961|FG000|Overall Study|Withdrawal by Subject|0|||
48687972|NCT00763386|156709962|FG001|Overall Study|Withdrawal by Subject|1|||
48687973|NCT00763386|156709961|FG000|Overall Study|CRF missing|0|||
48687974|NCT00763386|156709962|FG001|Overall Study|CRF missing|1|||
48687975|NCT00763386|156709961|FG000|Overall Study|Study Prosthesis Removed|1|||
48687976|NCT00763386|156709962|FG001|Overall Study|Study Prosthesis Removed|0|||
48687977|NCT01132807|156709963|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
48687978|NCT01132807|156709964|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
48687979|NCT01132807|156709965|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
48687980|NCT01132807|156709963|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
48687981|NCT01132807|156709964|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
48687982|NCT01132807|156709965|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
48687983|NCT03010527|156709966|FG000|Overall Study|Death|0|||
48687984|NCT03010527|156709967|FG001|Overall Study|Death|0|||
48687985|NCT03010527|156709968|FG002|Overall Study|Death|1|||
48687986|NCT03010527|156709966|FG000|Overall Study|Adverse Event|0|||
48687987|NCT03010527|156709967|FG001|Overall Study|Adverse Event|4|||
48687988|NCT03010527|156709968|FG002|Overall Study|Adverse Event|2|||
48687989|NCT03010527|156709966|FG000|Overall Study|Protocol Violation|0|||
48687990|NCT03010527|156709967|FG001|Overall Study|Protocol Violation|1|||
48687991|NCT03010527|156709968|FG002|Overall Study|Protocol Violation|0|||
48687992|NCT03010527|156709966|FG000|Overall Study|Lost to Follow-up|0|||
48687993|NCT03010527|156709967|FG001|Overall Study|Lost to Follow-up|2|||
48687994|NCT03010527|156709968|FG002|Overall Study|Lost to Follow-up|1|||
48687995|NCT03010527|156709966|FG000|Overall Study|Withdrawal by Subject|0|||
48687996|NCT03010527|156709967|FG001|Overall Study|Withdrawal by Subject|3|||
48687997|NCT03010527|156709968|FG002|Overall Study|Withdrawal by Subject|4|||
48763447|NCT01165138|156983885|FG000|Overall Study|Withdrawal by Subject|0|||
48687998|NCT03010527|156709966|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
48687999|NCT03010527|156709967|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
48688000|NCT03010527|156709968|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
48688001|NCT03010527|156709966|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
48688002|NCT03010527|156709967|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
48688003|NCT03010527|156709968|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
48688004|NCT03010527|156709966|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
48688005|NCT03010527|156709967|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
48688006|NCT03010527|156709968|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
48688007|NCT01458639|156709969|FG000|Overall Study|Physician Decision|4|||
48688008|NCT01458639|156709969|FG000|Overall Study|Equipment issue|1|||
48688009|NCT01458639|156709969|FG000|Overall Study|Inability to obtain subject blood sample|1|||
48688010|NCT04439136|156709973|FG000|Overall Study|Ineligible|1|||
48688011|NCT04439136|156709973|FG000|Overall Study|Never Started Treatment|2|||
48688012|NCT04439136|156709973|FG000|Overall Study|Adverse Event|4|||
48688013|NCT04439136|156709973|FG000|Overall Study|Death|3|||
48688014|NCT04439136|156709973|FG000|Overall Study|Disease Progression|27|||
48688015|NCT04439136|156709973|FG000|Overall Study|Alternative Therapy|1|||
48688016|NCT04439136|156709973|FG000|Overall Study|Increased Tumor Burden|1|||
48688017|NCT04439136|156709973|FG000|Overall Study|Symptomatic Detrioration|1|||
48688018|NCT02222558|156709974|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
48688019|NCT02222558|156709975|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
48688020|NCT02222558|156709976|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
48688021|NCT02222558|156709977|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
48763448|NCT01165138|156983886|FG001|Overall Study|Withdrawal by Subject|6|||
48763449|NCT01165138|156983887|FG002|Overall Study|Withdrawal by Subject|6|||
48688022|NCT02222558|156709978|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
48688023|NCT02222558|156709979|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
48688024|NCT02222558|156709974|FG000|Period 3|Withdrawal by Subject|0|||
48763450|NCT01165138|156983888|FG003|Overall Study|Withdrawal by Subject|3|||
48763451|NCT03526458|156983889|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
48688025|NCT02222558|156709975|FG001|Period 3|Withdrawal by Subject|0|||
48688026|NCT02222558|156709976|FG002|Period 3|Withdrawal by Subject|0|||
48688027|NCT02222558|156709977|FG003|Period 3|Withdrawal by Subject|0|||
48763452|NCT03526458|156983890|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
48763453|NCT03526458|156983889|FG000|Overall Study|Stone passed, surgery cancelled|2|||
48763454|NCT03526458|156983890|FG001|Overall Study|Stone passed, surgery cancelled|1|||
48763455|NCT03526458|156983889|FG000|Overall Study|Withdrawal by Subject|1|||
48688028|NCT02222558|156709978|FG004|Period 3|Withdrawal by Subject|0|||
48688029|NCT02222558|156709979|FG005|Period 3|Withdrawal by Subject|1|||
48688030|NCT04073186|156709980|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
48688031|NCT04073186|156709980|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
48688032|NCT04073186|156709980|FG000|First Wearing Cycle|Protocol Violation|1|||
48688033|NCT04073186|156709980|FG000|First Wearing Cycle|Lens Discomfort|2|||
48688034|NCT04073186|156709980|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
48688035|NCT04073186|156709980|FG000|Second Wearing Cycle|Adverse Event|1|||
48688036|NCT00981149|156709981|FG000|Overall Study|Lost to Follow-up|1|||
48688037|NCT00981149|156709982|FG001|Overall Study|Lost to Follow-up|2|||
48688038|NCT00981149|156709981|FG000|Overall Study|Withdrawal by Subject|1|||
48688039|NCT00981149|156709982|FG001|Overall Study|Withdrawal by Subject|1|||
48688040|NCT00354679|156709985|FG000|Overall Study|Patient Not Treated|1|||
48688041|NCT02640547|156709986|FG000|Overall Study|Failure to Return|1|||
48688042|NCT02640547|156709986|FG000|Overall Study|Withdrawal by Subject|1|||
48688043|NCT02640547|156709986|FG000|Overall Study|Death|6|||
48688044|NCT02640547|156709986|FG000|Overall Study|Miscellaneous|3|||
48688045|NCT01453140|156709988|FG000|Overall Study|Adverse Event|3|||
48688046|NCT00887549|156709989|FG000|Induction Therapy|Adverse Event|8|||
48688047|NCT00887549|156709989|FG000|Induction Therapy|Physician Decision|1|||
48688048|NCT00887549|156709989|FG000|Induction Therapy|Progressive Disease|13|||
48688049|NCT00887549|156709989|FG000|Induction Therapy|Death due to Study Disease|4|||
48688050|NCT00887549|156709989|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
48688051|NCT00887549|156709989|FG000|Maintenance Therapy|Adverse Event|16|||
48688052|NCT00887549|156709989|FG000|Maintenance Therapy|Physician Decision|1|||
48688053|NCT00887549|156709989|FG000|Maintenance Therapy|Progressive Disease|25|||
48688054|NCT00887549|156709989|FG000|Maintenance Therapy|Death due to adverse event|1|||
48688055|NCT01485094|156709991|FG000|Overall Study|Adverse Event|1|||
48688056|NCT01485094|156709992|FG001|Overall Study|Adverse Event|1|||
48688057|NCT01485094|156709993|FG002|Overall Study|Adverse Event|1|||
48688058|NCT01485094|156709991|FG000|Overall Study|Lost to Follow-up|1|||
48688059|NCT01485094|156709992|FG001|Overall Study|Lost to Follow-up|0|||
48688060|NCT01485094|156709993|FG002|Overall Study|Lost to Follow-up|0|||
48688061|NCT01485094|156709991|FG000|Overall Study|Withdrawal by Subject|1|||
48688062|NCT01485094|156709992|FG001|Overall Study|Withdrawal by Subject|1|||
48688063|NCT01485094|156709993|FG002|Overall Study|Withdrawal by Subject|0|||
48688064|NCT00688259|156709994|FG000|Overall Study|Lost to Follow-up|2|||
48688065|NCT00688259|156709995|FG001|Overall Study|Lost to Follow-up|4|||
48688066|NCT00688259|156709994|FG000|Overall Study|Physician Decision|1|||
48688067|NCT00688259|156709995|FG001|Overall Study|Physician Decision|0|||
48688068|NCT00688259|156709994|FG000|Overall Study|Withdrawal by Subject|2|||
48688069|NCT00688259|156709995|FG001|Overall Study|Withdrawal by Subject|0|||
48688070|NCT00688259|156709994|FG000|Overall Study|Declined Interview|2|||
48688071|NCT00688259|156709995|FG001|Overall Study|Declined Interview|3|||
48688072|NCT00688259|156709994|FG000|Overall Study|Hospitalized at Follow-up|0|||
48688073|NCT00688259|156709995|FG001|Overall Study|Hospitalized at Follow-up|1|||
48688074|NCT01272232|156709999|FG000|Weeks 0-56|Adverse Event|39|||
48688075|NCT01272232|156710000|FG001|Weeks 0-56|Adverse Event|18|||
48688076|NCT01272232|156710001|FG002|Weeks 0-56|Adverse Event|7|||
48688077|NCT01272232|156709999|FG000|Weeks 0-56|Lack of Efficacy|0|||
48688078|NCT01272232|156710000|FG001|Weeks 0-56|Lack of Efficacy|0|||
48688079|NCT01272232|156710001|FG002|Weeks 0-56|Lack of Efficacy|3|||
48688080|NCT01272232|156709999|FG000|Weeks 0-56|Protocol Violation|12|||
48688081|NCT01272232|156710000|FG001|Weeks 0-56|Protocol Violation|8|||
48688082|NCT01272232|156710001|FG002|Weeks 0-56|Protocol Violation|13|||
48688083|NCT01272232|156709999|FG000|Weeks 0-56|Withdrawal criteria|32|||
48688084|NCT01272232|156710000|FG001|Weeks 0-56|Withdrawal criteria|14|||
48688085|NCT01272232|156710001|FG002|Weeks 0-56|Withdrawal criteria|37|||
48688086|NCT01272232|156709999|FG000|Weeks 0-56|Unclassified|16|||
48392319|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to death|4|||
48392320|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to death|3|||
48392321|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
48392322|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
48426294|NCT00053846|155749528|FG001|Overall Study|Quit due to side effects|3|||
48688087|NCT01272232|156710000|FG001|Weeks 0-56|Unclassified|7|||
48688088|NCT01272232|156710001|FG002|Weeks 0-56|Unclassified|12|||
48688089|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
48688090|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
48688091|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
48688092|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
48688093|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
48688094|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
48688095|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
48688096|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
48688097|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
48688098|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
48688099|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
48688100|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
48688101|NCT01272232|156709999|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
48688102|NCT01272232|156710000|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
48688103|NCT01272232|156710001|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
48688104|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
48688105|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
48688106|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
48688107|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688108|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688109|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688110|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688111|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688112|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688113|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688114|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688115|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688116|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
48688117|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688118|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
48688119|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688120|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
48688121|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688122|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688123|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
48688124|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
48688125|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
48688126|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
48688127|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688128|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
48688129|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688130|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688131|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
48688132|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
48688133|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
48688134|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
48688135|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
48688136|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
48688137|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
48688138|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
48688139|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
48688140|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
48688141|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
48688142|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
48688143|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
48688144|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
48688145|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
48688146|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
48688147|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
48688148|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
48688149|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
48688150|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688151|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688152|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
48688153|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688154|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688155|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688156|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688157|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48392323|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
48392324|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
48688158|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688159|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
48688160|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688161|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48392325|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
48392326|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
48688162|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688163|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
48688164|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688165|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688166|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688167|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688168|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688169|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688170|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48763456|NCT03526458|156983890|FG001|Overall Study|Withdrawal by Subject|0|||
48763457|NCT03526458|156983889|FG000|Overall Study|Physician Decision|2|||
48763458|NCT03526458|156983890|FG001|Overall Study|Physician Decision|1|||
48763459|NCT03526458|156983889|FG000|Overall Study|Lack of equipment|1|||
48763460|NCT03526458|156983890|FG001|Overall Study|Lack of equipment|1|||
48763461|NCT04964128|156983891|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
48763462|NCT04964128|156983891|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
48763463|NCT01471379|156983892|FG000|Overall Study|Adverse Event|1|||
48763464|NCT01471379|156983893|FG001|Overall Study|Adverse Event|0|||
48763465|NCT01471379|156983894|FG002|Overall Study|Adverse Event|0|||
48763466|NCT01471379|156983892|FG000|Overall Study|Study terminated|0|||
48763467|NCT01471379|156983893|FG001|Overall Study|Study terminated|1|||
48763468|NCT01471379|156983894|FG002|Overall Study|Study terminated|0|||
48763469|NCT02275481|156983895|FG000|Overall Study|Death|2|||
48763470|NCT02275481|156983896|FG001|Overall Study|Death|1|||
48763471|NCT02275481|156983895|FG000|Overall Study|Lost to Follow-up|2|||
48763472|NCT02275481|156983896|FG001|Overall Study|Lost to Follow-up|0|||
48763473|NCT02275481|156983895|FG000|Overall Study|Withdrawal by Subject|3|||
48763474|NCT02275481|156983896|FG001|Overall Study|Withdrawal by Subject|0|||
48763475|NCT02275481|156983895|FG000|Overall Study|all other reasons combined|2|||
48688171|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688172|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688173|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688174|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688175|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688176|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688177|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
48688178|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
48688179|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688180|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688181|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688182|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
48763476|NCT02275481|156983896|FG001|Overall Study|all other reasons combined|1|||
48763477|NCT02275481|156983895|FG000|Overall Study|Physician Decision|0|||
48688183|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688184|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688185|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688186|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688187|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688188|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688189|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
48688190|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688191|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688192|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688193|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
48688194|NCT01147666|156710002|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688195|NCT01147666|156710003|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688196|NCT01147666|156710004|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688197|NCT01147666|156710005|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688198|NCT01147666|156710006|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688199|NCT01147666|156710007|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688200|NCT01147666|156710008|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688201|NCT01147666|156710009|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688202|NCT01147666|156710010|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688203|NCT01147666|156710011|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688204|NCT01147666|156710012|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688205|NCT01147666|156710013|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
48688206|NCT01147666|156710014|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
48688207|NCT01147666|156710015|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
48688208|NCT01147666|156710016|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
48688209|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
48688210|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
48688211|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
48688212|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
48688213|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
48688214|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
48688215|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
48688216|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
48688217|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
48688218|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
48688219|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
48688220|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
48688221|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
48688222|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
48688223|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
48688224|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688225|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688226|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688227|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688228|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
48688229|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
48688230|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
48688231|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
48688232|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688233|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
48688234|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688235|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688236|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
48688237|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
48688238|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
48688239|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688240|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688241|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688242|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
48688243|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688244|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688245|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688246|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48763478|NCT02275481|156983896|FG001|Overall Study|Physician Decision|1|||
48688247|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688248|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688249|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688250|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48763479|NCT04404855|156983898|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
48763480|NCT04404855|156983899|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
48763481|NCT00352846|156983901|FG000|Overall Study|Disease progression|0|||
48392327|NCT02258451|155630492|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
48392328|NCT02258451|155630493|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
48392329|NCT02258451|155630492|FG000|Overall Study|Other reason|1|||
48392330|NCT02258451|155630493|FG001|Overall Study|Other reason|1|||
48392331|NCT02258451|155630492|FG000|Overall Study|Never treated|2|||
48392332|NCT02258451|155630493|FG001|Overall Study|Never treated|3|||
48392333|NCT01449461|155630494|FG000|Overall Study|Adverse Event|0|||
48392334|NCT01449461|155630495|FG001|Overall Study|Adverse Event|3|||
48392335|NCT01449461|155630496|FG002|Overall Study|Adverse Event|2|||
48392336|NCT01449461|155630497|FG003|Overall Study|Adverse Event|3|||
48392337|NCT01449461|155630498|FG004|Overall Study|Adverse Event|4|||
48392338|NCT01449461|155630499|FG005|Overall Study|Adverse Event|4|||
48392339|NCT01449461|155630494|FG000|Overall Study|Death|0|||
48392340|NCT01449461|155630495|FG001|Overall Study|Death|2|||
48392341|NCT01449461|155630496|FG002|Overall Study|Death|0|||
48392342|NCT01449461|155630497|FG003|Overall Study|Death|0|||
48392343|NCT01449461|155630498|FG004|Overall Study|Death|7|||
48392344|NCT01449461|155630499|FG005|Overall Study|Death|1|||
48392345|NCT01449461|155630494|FG000|Overall Study|Physician Decision|0|||
48392346|NCT01449461|155630495|FG001|Overall Study|Physician Decision|1|||
48392347|NCT01449461|155630496|FG002|Overall Study|Physician Decision|0|||
48392348|NCT01449461|155630497|FG003|Overall Study|Physician Decision|4|||
48392349|NCT01449461|155630498|FG004|Overall Study|Physician Decision|1|||
48392350|NCT01449461|155630499|FG005|Overall Study|Physician Decision|0|||
48392351|NCT01449461|155630494|FG000|Overall Study|Documented Progressive Disease|4|||
48392352|NCT01449461|155630495|FG001|Overall Study|Documented Progressive Disease|7|||
48392353|NCT01449461|155630496|FG002|Overall Study|Documented Progressive Disease|14|||
48392354|NCT01449461|155630497|FG003|Overall Study|Documented Progressive Disease|15|||
48392355|NCT01449461|155630498|FG004|Overall Study|Documented Progressive Disease|24|||
48392356|NCT01449461|155630499|FG005|Overall Study|Documented Progressive Disease|5|||
48392357|NCT01449461|155630494|FG000|Overall Study|Clinical Progressive Disease|2|||
48392358|NCT01449461|155630495|FG001|Overall Study|Clinical Progressive Disease|2|||
48392359|NCT01449461|155630496|FG002|Overall Study|Clinical Progressive Disease|0|||
48392360|NCT01449461|155630497|FG003|Overall Study|Clinical Progressive Disease|3|||
48392361|NCT01449461|155630498|FG004|Overall Study|Clinical Progressive Disease|4|||
48392362|NCT01449461|155630499|FG005|Overall Study|Clinical Progressive Disease|2|||
48392363|NCT01449461|155630494|FG000|Overall Study|Protocol Violation|0|||
48688251|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688252|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688253|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
48688254|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688255|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688256|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688257|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688258|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688259|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688260|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688261|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688262|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688263|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688264|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688265|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48763482|NCT00352846|156983902|FG001|Overall Study|Disease progression|2|||
48392364|NCT01449461|155630495|FG001|Overall Study|Protocol Violation|0|||
48392365|NCT01449461|155630496|FG002|Overall Study|Protocol Violation|0|||
48392366|NCT01449461|155630497|FG003|Overall Study|Protocol Violation|1|||
48392367|NCT01449461|155630498|FG004|Overall Study|Protocol Violation|0|||
48392368|NCT01449461|155630499|FG005|Overall Study|Protocol Violation|0|||
48392369|NCT01449461|155630494|FG000|Overall Study|Site Terminated by Sponsor|0|||
48392370|NCT01449461|155630495|FG001|Overall Study|Site Terminated by Sponsor|1|||
48392371|NCT01449461|155630496|FG002|Overall Study|Site Terminated by Sponsor|2|||
48392372|NCT01449461|155630497|FG003|Overall Study|Site Terminated by Sponsor|3|||
48392373|NCT01449461|155630498|FG004|Overall Study|Site Terminated by Sponsor|4|||
48392374|NCT01449461|155630499|FG005|Overall Study|Site Terminated by Sponsor|1|||
48392375|NCT01449461|155630494|FG000|Overall Study|Withdrawal by Subject|0|||
48688266|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48763483|NCT00352846|156983901|FG000|Overall Study|Withdrawal by Subject|3|||
48763484|NCT00352846|156983902|FG001|Overall Study|Withdrawal by Subject|8|||
48688267|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
48688268|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
48688269|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688270|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688271|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688272|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
48688273|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688274|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688275|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48763485|NCT00352846|156983901|FG000|Overall Study|Ineligible|3|||
48763486|NCT00352846|156983902|FG001|Overall Study|Ineligible|2|||
48763487|NCT00352846|156983901|FG000|Overall Study|Non-compliance|2|||
48763488|NCT00352846|156983902|FG001|Overall Study|Non-compliance|0|||
48763489|NCT00352846|156983901|FG000|Overall Study|Death|0|||
48763490|NCT00352846|156983902|FG001|Overall Study|Death|1|||
48763491|NCT03571581|156983903|FG000|Overall Study|Death|2|||
48763492|NCT03571581|156983903|FG000|Overall Study|Withdrawal by Subject|2|||
48763493|NCT00729183|156983904|FG000|Overall Study|Adverse Event|11|||
48763494|NCT00729183|156983905|FG001|Overall Study|Adverse Event|5|||
48763495|NCT00729183|156983904|FG000|Overall Study|Lack of Efficacy|0|||
48763496|NCT00729183|156983905|FG001|Overall Study|Lack of Efficacy|1|||
48763497|NCT00729183|156983904|FG000|Overall Study|Lost to Follow-up|3|||
48763498|NCT00729183|156983905|FG001|Overall Study|Lost to Follow-up|1|||
48763499|NCT00729183|156983904|FG000|Overall Study|Physician Decision|1|||
48763500|NCT00729183|156983905|FG001|Overall Study|Physician Decision|1|||
48763501|NCT00729183|156983904|FG000|Overall Study|Protocol Violation|1|||
48763502|NCT00729183|156983905|FG001|Overall Study|Protocol Violation|0|||
48763503|NCT00729183|156983904|FG000|Overall Study|Withdrawal by Subject|9|||
48763504|NCT00729183|156983905|FG001|Overall Study|Withdrawal by Subject|7|||
48763505|NCT01120756|156983906|FG000|Overall Study|Withdrawal by Subject|1|||
48763506|NCT01120756|156983907|FG001|Overall Study|Withdrawal by Subject|1|||
48763507|NCT00449644|156983908|FG000|Overall Study|Adverse Event|0|||
48763508|NCT00449644|156983909|FG001|Overall Study|Adverse Event|0|||
48763509|NCT00449644|156983910|FG002|Overall Study|Adverse Event|3|||
48763510|NCT00449644|156983911|FG003|Overall Study|Adverse Event|5|||
48763511|NCT00449644|156983908|FG000|Overall Study|Death|1|||
48763512|NCT00449644|156983909|FG001|Overall Study|Death|0|||
48763513|NCT00449644|156983910|FG002|Overall Study|Death|6|||
48763514|NCT00449644|156983911|FG003|Overall Study|Death|1|||
48763515|NCT00449644|156983908|FG000|Overall Study|Lost to Follow-up|1|||
48763516|NCT00449644|156983909|FG001|Overall Study|Lost to Follow-up|1|||
48763517|NCT00449644|156983910|FG002|Overall Study|Lost to Follow-up|5|||
48763518|NCT00449644|156983911|FG003|Overall Study|Lost to Follow-up|3|||
48763519|NCT00449644|156983908|FG000|Overall Study|Pregnancy|0|||
48392376|NCT01449461|155630495|FG001|Overall Study|Withdrawal by Subject|1|||
48392377|NCT01449461|155630496|FG002|Overall Study|Withdrawal by Subject|0|||
48392378|NCT01449461|155630497|FG003|Overall Study|Withdrawal by Subject|0|||
48392379|NCT01449461|155630498|FG004|Overall Study|Withdrawal by Subject|2|||
48392380|NCT01449461|155630499|FG005|Overall Study|Withdrawal by Subject|1|||
48392381|NCT01449461|155630494|FG000|Overall Study|Reason not Specified|0|||
48392382|NCT01449461|155630495|FG001|Overall Study|Reason not Specified|1|||
48392383|NCT01449461|155630496|FG002|Overall Study|Reason not Specified|0|||
48392384|NCT01449461|155630497|FG003|Overall Study|Reason not Specified|3|||
48392385|NCT01449461|155630498|FG004|Overall Study|Reason not Specified|2|||
48392386|NCT01449461|155630499|FG005|Overall Study|Reason not Specified|1|||
48763520|NCT00449644|156983909|FG001|Overall Study|Pregnancy|0|||
48763521|NCT00449644|156983910|FG002|Overall Study|Pregnancy|3|||
48763522|NCT00449644|156983911|FG003|Overall Study|Pregnancy|2|||
48763523|NCT00449644|156983908|FG000|Overall Study|Protocol Violation|4|||
48392387|NCT04518462|155630502|FG000|Overall Study|Withdrawal by Subject|0|||
48688276|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688277|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688278|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48392388|NCT04518462|155630503|FG001|Overall Study|Withdrawal by Subject|0|||
48688279|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
48688280|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48763524|NCT00449644|156983909|FG001|Overall Study|Protocol Violation|4|||
48763525|NCT00449644|156983910|FG002|Overall Study|Protocol Violation|3|||
48763526|NCT00449644|156983911|FG003|Overall Study|Protocol Violation|7|||
48763527|NCT00449644|156983908|FG000|Overall Study|Withdrawal by Subject|3|||
48763528|NCT00449644|156983909|FG001|Overall Study|Withdrawal by Subject|4|||
48763529|NCT00449644|156983910|FG002|Overall Study|Withdrawal by Subject|6|||
48763530|NCT00449644|156983911|FG003|Overall Study|Withdrawal by Subject|7|||
48688281|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688282|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688283|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
48688284|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688285|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688286|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688287|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688288|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688289|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688290|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688291|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48392389|NCT04518462|155630504|FG002|Overall Study|Withdrawal by Subject|1|||
48392390|NCT04518462|155630502|FG000|Overall Study|Physician Decision|1|||
48392391|NCT04518462|155630503|FG001|Overall Study|Physician Decision|1|||
48392392|NCT04518462|155630504|FG002|Overall Study|Physician Decision|0|||
48392393|NCT01392677|155630507|FG000|Overall Study|Adverse Event|3|||
48392394|NCT01392677|155630508|FG001|Overall Study|Adverse Event|1|||
48392395|NCT01392677|155630507|FG000|Overall Study|Withdrawal by Subject|0|||
48392396|NCT01392677|155630508|FG001|Overall Study|Withdrawal by Subject|2|||
48392397|NCT01392677|155630507|FG000|Overall Study|Incorrect enrollment|2|||
48392398|NCT01392677|155630508|FG001|Overall Study|Incorrect enrollment|3|||
48392399|NCT01392677|155630507|FG000|Overall Study|Other reason|3|||
48392400|NCT01392677|155630508|FG001|Overall Study|Other reason|2|||
48392401|NCT01430455|155630509|FG000|Overall Study|Withdrawal by Subject|1|||
48392402|NCT01430455|155630509|FG000|Overall Study|Switched to follow-up phase|1|||
48392403|NCT03921424|155630514|FG000|Overall Study|Lost to Follow-up|0|||
48392404|NCT03921424|155630515|FG001|Overall Study|Lost to Follow-up|1|||
48392405|NCT03921424|155630514|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48392406|NCT03921424|155630515|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
48392407|NCT02581202|155630521|FG000|Overall Study|Lack of Efficacy|2|||
48392408|NCT02581202|155630521|FG000|Overall Study|Withdrawal by Subject|4|||
48392409|NCT02581202|155630521|FG000|Overall Study|Lost to Follow-up|5|||
48392410|NCT02581202|155630521|FG000|Overall Study|Pregnancy|3|||
48392411|NCT04050982|155630522|FG000|Overall Study|Did not meet eligibility criteria|0|||
48392412|NCT04050982|155630523|FG001|Overall Study|Did not meet eligibility criteria|1|||
48688292|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688293|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688294|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688295|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688296|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
48688297|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688298|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
48688299|NCT01147666|156710002|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688300|NCT01147666|156710003|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688301|NCT01147666|156710004|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688302|NCT01147666|156710005|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688303|NCT01147666|156710006|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688304|NCT01147666|156710007|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688305|NCT01147666|156710008|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688306|NCT01147666|156710009|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688307|NCT01147666|156710010|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688308|NCT01147666|156710011|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688309|NCT01147666|156710012|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688310|NCT01147666|156710013|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688311|NCT01147666|156710014|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
48688312|NCT01147666|156710015|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
48688313|NCT01147666|156710016|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
48688314|NCT00796666|156710017|FG000|Overall Study|Death|2|||
48688315|NCT00796666|156710018|FG001|Overall Study|Death|4|||
48688316|NCT00796666|156710017|FG000|Overall Study|Withdrawal by Subject|2|||
48688317|NCT00796666|156710018|FG001|Overall Study|Withdrawal by Subject|0|||
48688318|NCT00796666|156710017|FG000|Overall Study|Adverse Event|7|||
48688319|NCT00796666|156710018|FG001|Overall Study|Adverse Event|5|||
48688320|NCT00796666|156710017|FG000|Overall Study|Protocol Violation|1|||
48688321|NCT00796666|156710018|FG001|Overall Study|Protocol Violation|0|||
48688322|NCT00796666|156710017|FG000|Overall Study|Other|1|||
48688323|NCT00796666|156710018|FG001|Overall Study|Other|0|||
48688324|NCT00796666|156710017|FG000|Overall Study|Terminated by sponsor|53|||
48688325|NCT00796666|156710018|FG001|Overall Study|Terminated by sponsor|55|||
48688326|NCT00796666|156710017|FG000|Overall Study|Randomized and not treated|1|||
48688327|NCT00796666|156710018|FG001|Overall Study|Randomized and not treated|0|||
48688328|NCT00117637|156710019|FG000|First Intervention (Period 1)|Adverse Event|11|||
48688329|NCT00117637|156710020|FG001|First Intervention (Period 1)|Adverse Event|16|||
48688330|NCT00117637|156710019|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
48688331|NCT00117637|156710020|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
48688332|NCT00117637|156710019|FG000|First Intervention (Period 1)|Protocol Violation|1|||
48763531|NCT00449644|156983908|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
48763532|NCT00449644|156983909|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
48763533|NCT00449644|156983910|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
48763534|NCT00449644|156983911|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
48763535|NCT00449644|156983908|FG000|Overall Study|Other|1|||
48763536|NCT00449644|156983909|FG001|Overall Study|Other|4|||
48763537|NCT00449644|156983910|FG002|Overall Study|Other|1|||
48763538|NCT00449644|156983911|FG003|Overall Study|Other|0|||
48763539|NCT00449644|156983908|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
48763540|NCT00449644|156983909|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
48763541|NCT00449644|156983910|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
48763542|NCT00449644|156983911|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
48763543|NCT03608774|156983912|FG000|Overall Study|Lost to Follow-up|5|||
48763544|NCT03608774|156983913|FG001|Overall Study|Lost to Follow-up|5|||
48763545|NCT03608774|156983912|FG000|Overall Study|Withdrawal by Subject|1|||
48763546|NCT03608774|156983913|FG001|Overall Study|Withdrawal by Subject|0|||
48763547|NCT03608774|156983912|FG000|Overall Study|Protocol Violation|1|||
48763548|NCT03608774|156983913|FG001|Overall Study|Protocol Violation|0|||
48763549|NCT03608774|156983912|FG000|Overall Study|Not eligible at enrollment|0|||
48763550|NCT03608774|156983913|FG001|Overall Study|Not eligible at enrollment|1|||
48763551|NCT03608774|156983912|FG000|Overall Study|Health related event|0|||
48763552|NCT03608774|156983913|FG001|Overall Study|Health related event|1|||
48763553|NCT01177540|156983914|FG000|Overall Study|Adverse Event|1|||
48763554|NCT01177540|156983915|FG001|Overall Study|Adverse Event|0|||
48763555|NCT02028988|156983928|FG000|Overall Study|Withdrawal by Subject|2|||
48763556|NCT02680639|156983933|FG000|Screening Period|Screen Failure|7|||
48763557|NCT02680639|156983934|FG001|Screening Period|Screen Failure|0|||
48763558|NCT02680639|156983935|FG002|Screening Period|Screen Failure|0|||
48763559|NCT00451035|156983936|FG000|Overall Study|Disease progression|11|||
48763560|NCT00451035|156983936|FG000|Overall Study|Death|3|||
48763561|NCT00451035|156983936|FG000|Overall Study|New anti-neoplastic therapy|3|||
48763562|NCT01623596|156983937|FG000|Overall Study|Abnormal laboratory values|2|||
48763563|NCT01623596|156983938|FG001|Overall Study|Abnormal laboratory values|0|||
48763564|NCT01623596|156983937|FG000|Overall Study|Administrative problems|9|||
48763565|NCT01623596|156983938|FG001|Overall Study|Administrative problems|13|||
48763566|NCT01623596|156983937|FG000|Overall Study|Adverse Event|20|||
48763567|NCT01623596|156983938|FG001|Overall Study|Adverse Event|29|||
48763568|NCT01623596|156983937|FG000|Overall Study|Death|0|||
48763569|NCT01623596|156983938|FG001|Overall Study|Death|2|||
48763570|NCT01623596|156983937|FG000|Overall Study|Lost to Follow-up|12|||
48763571|NCT01623596|156983938|FG001|Overall Study|Lost to Follow-up|16|||
48763572|NCT01623596|156983937|FG000|Overall Study|Withdrawal by Subject|13|||
48355366|NCT00250432|155497280|FG000|Overall Study|Patient Moved|0|||
48688333|NCT00117637|156710020|FG001|First Intervention (Period 1)|Protocol Violation|0|||
48763573|NCT01623596|156983938|FG001|Overall Study|Withdrawal by Subject|31|||
48763574|NCT01623596|156983937|FG000|Overall Study|Patient no longer requires study drug|1|||
48763575|NCT01623596|156983938|FG001|Overall Study|Patient no longer requires study drug|0|||
48688334|NCT00117637|156710019|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
48763576|NCT01623596|156983937|FG000|Overall Study|Protocol Violation|0|||
48392413|NCT04050982|155630524|FG002|Overall Study|Did not meet eligibility criteria|0|||
48392414|NCT04050982|155630522|FG000|Overall Study|Withdrawal by Subject|1|||
48392415|NCT04050982|155630523|FG001|Overall Study|Withdrawal by Subject|0|||
48392416|NCT04050982|155630524|FG002|Overall Study|Withdrawal by Subject|0|||
48392417|NCT04050982|155630522|FG000|Overall Study|Unable to enroll on platform|1|||
48392418|NCT04050982|155630523|FG001|Overall Study|Unable to enroll on platform|0|||
48688335|NCT00117637|156710020|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
48688336|NCT00117637|156710019|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
48688337|NCT00117637|156710020|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
48688338|NCT00117637|156710019|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
48688339|NCT00117637|156710020|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
48688340|NCT00117637|156710019|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
48688341|NCT00117637|156710020|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
48688342|NCT00117637|156710019|FG000|First Intervention (Period 1)|reason not reported|0|||
48688343|NCT00117637|156710020|FG001|First Intervention (Period 1)|reason not reported|1|||
48688344|NCT00117637|156710019|FG000|Second Intervention (Period 2)|Adverse Event|0|||
48688345|NCT00117637|156710020|FG001|Second Intervention (Period 2)|Adverse Event|9|||
48688346|NCT00117637|156710019|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
48688347|NCT00117637|156710020|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
48688348|NCT00117637|156710019|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
48688349|NCT00117637|156710020|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
48688350|NCT00117637|156710019|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
48688351|NCT00117637|156710020|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
48688352|NCT00117637|156710019|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
48688353|NCT00117637|156710020|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
48688354|NCT00117637|156710019|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
48688355|NCT00117637|156710020|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
48688356|NCT00117637|156710019|FG000|Second Intervention (Period 2)|reason not reported|1|||
48688357|NCT00117637|156710020|FG001|Second Intervention (Period 2)|reason not reported|0|||
48688358|NCT02576639|156710021|FG000|Overall Study|Withdrawal by Subject|1|||
48688359|NCT02576639|156710022|FG001|Overall Study|Withdrawal by Subject|2|||
48688360|NCT02576639|156710023|FG002|Overall Study|Withdrawal by Subject|1|||
48688361|NCT02576639|156710024|FG003|Overall Study|Withdrawal by Subject|0|||
48688362|NCT02576639|156710025|FG004|Overall Study|Withdrawal by Subject|1|||
48688363|NCT02576639|156710021|FG000|Overall Study|Adverse Event|1|||
48688364|NCT02576639|156710022|FG001|Overall Study|Adverse Event|0|||
48688365|NCT02576639|156710023|FG002|Overall Study|Adverse Event|1|||
48688366|NCT02576639|156710024|FG003|Overall Study|Adverse Event|1|||
48688367|NCT02576639|156710025|FG004|Overall Study|Adverse Event|2|||
48688368|NCT02576639|156710021|FG000|Overall Study|Physician Decision|0|||
48688369|NCT02576639|156710022|FG001|Overall Study|Physician Decision|0|||
48688370|NCT02576639|156710023|FG002|Overall Study|Physician Decision|0|||
48688371|NCT02576639|156710024|FG003|Overall Study|Physician Decision|0|||
48688372|NCT02576639|156710025|FG004|Overall Study|Physician Decision|1|||
48688373|NCT01020786|156710026|FG000|Induction Period|Entry Criteria Not Met|2|||
48688374|NCT01020786|156710026|FG000|Induction Period|Adverse Event|10|||
48688375|NCT01020786|156710026|FG000|Induction Period|Progressive Disease|31|||
48688376|NCT01020786|156710026|FG000|Induction Period|Investigator Decision|3|||
48688377|NCT01020786|156710026|FG000|Induction Period|Withdrawal by Subject|3|||
48688378|NCT01020786|156710026|FG000|Maintenance Period|Adverse Event|8|||
48688379|NCT01020786|156710026|FG000|Maintenance Period|Progressive Disease|43|||
48688380|NCT01020786|156710026|FG000|Maintenance Period|Withdrawal by Subject|8|||
48688381|NCT01020786|156710026|FG000|Maintenance Period|Sponsor Decision|1|||
48688382|NCT03367858|156710027|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
48688383|NCT03367858|156710028|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
48392419|NCT04050982|155630524|FG002|Overall Study|Unable to enroll on platform|0|||
48392420|NCT01246583|155630525|FG000|Overall Study|Lost to Follow-up|0|||
48392421|NCT01246583|155630526|FG001|Overall Study|Lost to Follow-up|0|||
48392422|NCT01246583|155630527|FG002|Overall Study|Lost to Follow-up|0|||
48392423|NCT01246583|155630528|FG003|Overall Study|Lost to Follow-up|1|||
48392424|NCT01246583|155630525|FG000|Overall Study|Protocol Violation|0|||
48392425|NCT01246583|155630526|FG001|Overall Study|Protocol Violation|0|||
48392426|NCT01246583|155630527|FG002|Overall Study|Protocol Violation|1|||
48392427|NCT01246583|155630528|FG003|Overall Study|Protocol Violation|0|||
48688384|NCT03367858|156710027|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
48688385|NCT03367858|156710028|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
48688386|NCT03367858|156710027|FG000|3 Month Follow Up|Lost to Follow-up|8|||
48392428|NCT01246583|155630525|FG000|Overall Study|Withdrawal by Subject|1|||
48392429|NCT01246583|155630526|FG001|Overall Study|Withdrawal by Subject|0|||
48688387|NCT03367858|156710028|FG001|3 Month Follow Up|Lost to Follow-up|3|||
48763577|NCT01623596|156983938|FG001|Overall Study|Protocol Violation|6|||
48392430|NCT01246583|155630527|FG002|Overall Study|Withdrawal by Subject|0|||
48688388|NCT03367858|156710027|FG000|3 Month Follow Up|Moved out of study area|2|||
48688389|NCT03367858|156710028|FG001|3 Month Follow Up|Moved out of study area|6|||
48688390|NCT03367858|156710027|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
48688391|NCT03367858|156710028|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
48688392|NCT03367858|156710027|FG000|3 Month Follow Up|MRI contraindication|2|||
48688393|NCT03367858|156710028|FG001|3 Month Follow Up|MRI contraindication|1|||
48688394|NCT03367858|156710027|FG000|3 Month Follow Up|Incarcerated|0|||
48688395|NCT03367858|156710028|FG001|3 Month Follow Up|Incarcerated|1|||
48688396|NCT03367858|156710027|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
48688397|NCT03367858|156710028|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
48688398|NCT03367858|156710027|FG000|6 Month Follow Up|Lost to Follow-up|5|||
48688399|NCT03367858|156710028|FG001|6 Month Follow Up|Lost to Follow-up|2|||
48688400|NCT03367858|156710027|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
48688401|NCT03367858|156710028|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
48688402|NCT03367858|156710027|FG000|12 Month Follow Up|Lost to Follow-up|3|||
48688403|NCT03367858|156710028|FG001|12 Month Follow Up|Lost to Follow-up|3|||
48688404|NCT03367858|156710027|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
48688405|NCT03367858|156710028|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
48688406|NCT00088530|156710029|FG000|Overall Study|Progressive/Relapsed Disease|28|||
48688407|NCT00088530|156710030|FG001|Overall Study|Progressive/Relapsed Disease|39|||
48763578|NCT01623596|156983937|FG000|Overall Study|Lack of Efficacy|5|||
48763579|NCT01623596|156983938|FG001|Overall Study|Lack of Efficacy|3|||
48763580|NCT01070316|156983942|FG000|Extension Phase|Lack of Efficacy|3|||
48392431|NCT01246583|155630528|FG003|Overall Study|Withdrawal by Subject|0|||
48392432|NCT00075400|155631834|FG000|Overall Study|Ineligible: wrong primary|1|||
48392433|NCT00075400|155631834|FG000|Overall Study|Never treated|2|||
48392434|NCT00346073|155631835|FG000|Overall Study|Serious Adverse Event|2|||
48392435|NCT00346073|155631836|FG001|Overall Study|Serious Adverse Event|0|||
48763581|NCT01070316|156983942|FG000|Extension Phase|Withdrawal by Subject|1|||
48763582|NCT04151290|156983950|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
48763583|NCT01524627|156983951|FG000|Overall Study|Physician Decision|0|||
48763584|NCT01524627|156983952|FG001|Overall Study|Physician Decision|1|||
48392436|NCT00346073|155631835|FG000|Overall Study|Lost to Follow-up|39|||
48392437|NCT00346073|155631836|FG001|Overall Study|Lost to Follow-up|24|||
48392438|NCT02966509|155631839|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
48392439|NCT02966509|155631840|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
48392440|NCT02966509|155631839|FG000|Baseline Satisfaction Survey|Death|0|||
48392441|NCT02966509|155631840|FG001|Baseline Satisfaction Survey|Death|1|||
48392442|NCT02966509|155631839|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
48392443|NCT02966509|155631840|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
48392444|NCT02966509|155631839|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
48392445|NCT02966509|155631840|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
48392446|NCT02966509|155631839|FG000|6 Month Satisfaction Decision Survey|Death|22|||
48392447|NCT02966509|155631840|FG001|6 Month Satisfaction Decision Survey|Death|25|||
48392448|NCT02966509|155631839|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
48392449|NCT02966509|155631840|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
48392450|NCT02966509|155631839|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
48392451|NCT02966509|155631840|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
48392452|NCT02966509|155631839|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
48392453|NCT02966509|155631840|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
48392454|NCT02966509|155631839|FG000|6 Month Satisfaction Survey|Death|36|||
48392455|NCT02966509|155631840|FG001|6 Month Satisfaction Survey|Death|33|||
48392456|NCT02966509|155631839|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
48392457|NCT02966509|155631840|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
48392458|NCT02966509|155631839|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
48392459|NCT02966509|155631840|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
48392460|NCT02966509|155631839|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
48392461|NCT02966509|155631840|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
48392462|NCT02966509|155631839|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
48392463|NCT02966509|155631840|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
48426295|NCT00053846|155749527|FG000|Overall Study|Pills too large|0|||
48688408|NCT00088530|156710029|FG000|Overall Study|Adverse Event|15|||
48688409|NCT00088530|156710030|FG001|Overall Study|Adverse Event|9|||
48688410|NCT00088530|156710029|FG000|Overall Study|Withdrawal by Subject|2|||
48688411|NCT00088530|156710030|FG001|Overall Study|Withdrawal by Subject|5|||
48688412|NCT00088530|156710029|FG000|Overall Study|Lost to Follow-up|2|||
48688413|NCT00088530|156710030|FG001|Overall Study|Lost to Follow-up|0|||
48688414|NCT00088530|156710029|FG000|Overall Study|Physician Decision|2|||
48688415|NCT00088530|156710030|FG001|Overall Study|Physician Decision|0|||
48688416|NCT00088530|156710029|FG000|Overall Study|Sponsor decision|0|||
48688417|NCT00088530|156710030|FG001|Overall Study|Sponsor decision|1|||
48688418|NCT00088530|156710029|FG000|Overall Study|Patient never treated|1|||
48688419|NCT00088530|156710030|FG001|Overall Study|Patient never treated|0|||
48688420|NCT01508169|156710031|FG000|Overall Study|Adverse Event|1|||
48688421|NCT01508169|156710032|FG001|Overall Study|Adverse Event|0|||
48688422|NCT01508169|156710031|FG000|Overall Study|Withdrawal by Subject|1|||
48688423|NCT01508169|156710032|FG001|Overall Study|Withdrawal by Subject|0|||
48688424|NCT01508169|156710031|FG000|Overall Study|Lost to Follow-up|1|||
48688425|NCT01508169|156710032|FG001|Overall Study|Lost to Follow-up|2|||
48688426|NCT02336607|156710037|FG000|Overall Study|Physician Decision|1|||
48688427|NCT02336607|156710038|FG001|Overall Study|Physician Decision|4|||
48688428|NCT02336607|156710039|FG002|Overall Study|Physician Decision|3|||
48688429|NCT02336607|156710040|FG003|Overall Study|Physician Decision|15|||
48688430|NCT02336607|156710037|FG000|Overall Study|Lack of Efficacy|1|||
48688431|NCT02336607|156710038|FG001|Overall Study|Lack of Efficacy|0|||
48688432|NCT02336607|156710039|FG002|Overall Study|Lack of Efficacy|0|||
48688433|NCT02336607|156710040|FG003|Overall Study|Lack of Efficacy|2|||
48688434|NCT02336607|156710037|FG000|Overall Study|Lost to Follow-up|2|||
48688435|NCT02336607|156710038|FG001|Overall Study|Lost to Follow-up|1|||
48688436|NCT02336607|156710039|FG002|Overall Study|Lost to Follow-up|0|||
48688437|NCT02336607|156710040|FG003|Overall Study|Lost to Follow-up|21|||
48688438|NCT02336607|156710037|FG000|Overall Study|Protocol Violation|0|||
48688439|NCT02336607|156710038|FG001|Overall Study|Protocol Violation|1|||
48688440|NCT02336607|156710039|FG002|Overall Study|Protocol Violation|1|||
48688441|NCT02336607|156710040|FG003|Overall Study|Protocol Violation|3|||
48688442|NCT02336607|156710037|FG000|Overall Study|Adverse Event|0|||
48763585|NCT01524627|156983951|FG000|Overall Study|Lost to Follow-up|1|||
48763586|NCT01524627|156983952|FG001|Overall Study|Lost to Follow-up|1|||
48763587|NCT01449526|156983953|FG000|Overall Study|Lost to Follow-up|1|||
48392464|NCT02966509|155631839|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
48392465|NCT02966509|155631840|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
48392466|NCT04854434|155631842|FG000|Overall Study|Death|1|||
48392467|NCT04854434|155631843|FG001|Overall Study|Death|3|||
48392468|NCT04854434|155631844|FG002|Overall Study|Death|4|||
48392469|NCT04854434|155631842|FG000|Overall Study|Study Terminated by Sponsor|2|||
48392470|NCT04854434|155631843|FG001|Overall Study|Study Terminated by Sponsor|0|||
48392471|NCT04854434|155631844|FG002|Overall Study|Study Terminated by Sponsor|0|||
48392472|NCT04854434|155631842|FG000|Overall Study|Other|1|||
48392473|NCT04854434|155631843|FG001|Overall Study|Other|1|||
48688443|NCT02336607|156710038|FG001|Overall Study|Adverse Event|2|||
48688444|NCT02336607|156710039|FG002|Overall Study|Adverse Event|2|||
48688445|NCT02336607|156710040|FG003|Overall Study|Adverse Event|26|||
48688446|NCT02336607|156710037|FG000|Overall Study|Withdrawal by Subject|0|||
48688447|NCT02336607|156710038|FG001|Overall Study|Withdrawal by Subject|2|||
48688448|NCT02336607|156710039|FG002|Overall Study|Withdrawal by Subject|0|||
48688449|NCT02336607|156710040|FG003|Overall Study|Withdrawal by Subject|20|||
48688450|NCT00430716|156710048|FG000|Double Blind Phase|Death|1|||
48688451|NCT00430716|156710049|FG001|Double Blind Phase|Death|0|||
48688452|NCT00430716|156710050|FG002|Double Blind Phase|Death|0|||
48688453|NCT00430716|156710048|FG000|Double Blind Phase|No longer willing to participate|2|||
48688454|NCT00430716|156710049|FG001|Double Blind Phase|No longer willing to participate|1|||
48688455|NCT00430716|156710050|FG002|Double Blind Phase|No longer willing to participate|1|||
48688456|NCT00430716|156710048|FG000|Double Blind Phase|Other|0|||
48688457|NCT00430716|156710049|FG001|Double Blind Phase|Other|2|||
48688458|NCT00430716|156710050|FG002|Double Blind Phase|Other|0|||
48688459|NCT00430716|156710048|FG000|Double Blind Phase|Study terminated by sponsor|1|||
48688460|NCT00430716|156710049|FG001|Double Blind Phase|Study terminated by sponsor|1|||
48688461|NCT00430716|156710050|FG002|Double Blind Phase|Study terminated by sponsor|2|||
48688462|NCT00430716|156710048|FG000|Double Blind Phase|Adverse Event|1|||
48688463|NCT00430716|156710049|FG001|Double Blind Phase|Adverse Event|1|||
48763588|NCT01449526|156983954|FG001|Overall Study|Lost to Follow-up|2|||
48763589|NCT01449526|156983953|FG000|Overall Study|Withdrawal by Subject|1|||
48392474|NCT04854434|155631844|FG002|Overall Study|Other|0|||
48392475|NCT01199042|155631845|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
48392476|NCT01199042|155631845|FG000|At Home (3 Months)|Lost to Follow-up|1|||
48688464|NCT00430716|156710050|FG002|Double Blind Phase|Adverse Event|3|||
48688465|NCT00430716|156710048|FG000|Double Blind Phase|Not treated|1|||
48688466|NCT00430716|156710049|FG001|Double Blind Phase|Not treated|0|||
48688467|NCT00430716|156710050|FG002|Double Blind Phase|Not treated|0|||
48688468|NCT00430716|156710048|FG000|Open Label Phase|Lost to Follow-up|1|||
48688469|NCT00430716|156710049|FG001|Open Label Phase|Lost to Follow-up|0|||
48688470|NCT00430716|156710050|FG002|Open Label Phase|Lost to Follow-up|1|||
48688471|NCT00430716|156710048|FG000|Open Label Phase|No longer willing to participate|0|||
48688472|NCT00430716|156710049|FG001|Open Label Phase|No longer willing to participate|1|||
48688473|NCT00430716|156710050|FG002|Open Label Phase|No longer willing to participate|1|||
48688474|NCT00430716|156710048|FG000|Open Label Phase|Other|3|||
48688475|NCT00430716|156710049|FG001|Open Label Phase|Other|1|||
48688476|NCT00430716|156710050|FG002|Open Label Phase|Other|1|||
48688477|NCT00430716|156710048|FG000|Open Label Phase|Protocol Violation|1|||
48688478|NCT00430716|156710049|FG001|Open Label Phase|Protocol Violation|0|||
48688479|NCT00430716|156710050|FG002|Open Label Phase|Protocol Violation|0|||
48688480|NCT00430716|156710048|FG000|Open Label Phase|Study terminated by sponsor|4|||
48688481|NCT00430716|156710049|FG001|Open Label Phase|Study terminated by sponsor|5|||
48688482|NCT00430716|156710050|FG002|Open Label Phase|Study terminated by sponsor|4|||
48688483|NCT01384734|156710056|FG000|Overall Study|Adverse Event|0|||
48688484|NCT01384734|156710057|FG001|Overall Study|Adverse Event|3|||
48688485|NCT01384734|156710058|FG002|Overall Study|Adverse Event|0|||
48688486|NCT01384734|156710059|FG003|Overall Study|Adverse Event|2|||
48392477|NCT00139776|155631856|FG000|Period I|Did not enter Period II|575|||
48392478|NCT00139776|155631857|FG001|Period I|Did not enter Period II|0|||
48392479|NCT00139776|155631858|FG002|Period I|Did not enter Period II|0|||
48392480|NCT00139776|155631859|FG003|Period I|Did not enter Period II|0|||
48392481|NCT00139776|155631856|FG000|Period II|Not Randomized into Period III|0|||
48392482|NCT00139776|155631857|FG001|Period II|Not Randomized into Period III|322|||
48392483|NCT00139776|155631858|FG002|Period II|Not Randomized into Period III|0|||
48392484|NCT00139776|155631859|FG003|Period II|Not Randomized into Period III|0|||
48392485|NCT00139776|155631856|FG000|Period III|Adverse Event|0|||
48392486|NCT00139776|155631857|FG001|Period III|Adverse Event|0|||
48392487|NCT00139776|155631858|FG002|Period III|Adverse Event|22|||
48392488|NCT00139776|155631859|FG003|Period III|Adverse Event|23|||
48392489|NCT00139776|155631856|FG000|Period III|Other|0|||
48392490|NCT00139776|155631857|FG001|Period III|Other|0|||
48392491|NCT00139776|155631858|FG002|Period III|Other|23|||
48392492|NCT00139776|155631859|FG003|Period III|Other|34|||
48392493|NCT00139776|155631856|FG000|Period III|Lack of Efficacy|0|||
48392494|NCT00139776|155631857|FG001|Period III|Lack of Efficacy|0|||
48392495|NCT00139776|155631858|FG002|Period III|Lack of Efficacy|10|||
48392496|NCT00139776|155631859|FG003|Period III|Lack of Efficacy|24|||
48392497|NCT00139776|155631856|FG000|Period III|Lost to Follow-up|0|||
48392498|NCT00139776|155631857|FG001|Period III|Lost to Follow-up|0|||
48392499|NCT00139776|155631858|FG002|Period III|Lost to Follow-up|5|||
48392500|NCT00139776|155631859|FG003|Period III|Lost to Follow-up|4|||
48392501|NCT00139776|155631856|FG000|Period III|Withdrawal by Subject|0|||
48392502|NCT00139776|155631857|FG001|Period III|Withdrawal by Subject|0|||
48392503|NCT00139776|155631858|FG002|Period III|Withdrawal by Subject|16|||
48392504|NCT00139776|155631859|FG003|Period III|Withdrawal by Subject|21|||
48392505|NCT02349048|155631865|FG000|Overall Study|Withdrawal by Subject|4|||
48392506|NCT02349048|155631866|FG001|Overall Study|Withdrawal by Subject|0|||
48392507|NCT02349048|155631865|FG000|Overall Study|Lost to Follow-up|1|||
48392508|NCT02349048|155631866|FG001|Overall Study|Lost to Follow-up|0|||
48392509|NCT01230307|155631867|FG000|Overall Study|LVAD Placement|0|||
48392510|NCT01230307|155631868|FG001|Overall Study|LVAD Placement|2|||
48392511|NCT02113436|155631870|FG000|Period 1: 8 Weeks|Adverse Event|1|||
48392512|NCT02113436|155631871|FG001|Period 1: 8 Weeks|Adverse Event|0|||
48392513|NCT02113436|155631872|FG002|Period 1: 8 Weeks|Adverse Event|0|||
48392514|NCT02113436|155631873|FG003|Period 1: 8 Weeks|Adverse Event|0|||
48392515|NCT02113436|155631870|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
48392516|NCT02113436|155631871|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
48392517|NCT02113436|155631872|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
48392518|NCT02113436|155631873|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
48392519|NCT02113436|155631870|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
48392520|NCT02113436|155631871|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
48688487|NCT01384734|156710060|FG004|Overall Study|Adverse Event|7|||
48688488|NCT01384734|156710056|FG000|Overall Study|Death|1|||
48688489|NCT01384734|156710057|FG001|Overall Study|Death|0|||
48688490|NCT01384734|156710058|FG002|Overall Study|Death|1|||
48688491|NCT01384734|156710059|FG003|Overall Study|Death|0|||
48688492|NCT01384734|156710060|FG004|Overall Study|Death|0|||
48392521|NCT02113436|155631872|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
48392522|NCT02113436|155631873|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
48392523|NCT02113436|155631870|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
48392524|NCT02113436|155631871|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
48392525|NCT02113436|155631872|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
48392526|NCT02113436|155631873|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
48392527|NCT02113436|155631870|FG000|Period 2: 16 Weeks|Adverse Event|0|||
48392528|NCT02113436|155631871|FG001|Period 2: 16 Weeks|Adverse Event|0|||
48688493|NCT01384734|156710056|FG000|Overall Study|Continuation criteria not met|0|||
48688494|NCT01384734|156710057|FG001|Overall Study|Continuation criteria not met|0|||
48392529|NCT02113436|155631872|FG002|Period 2: 16 Weeks|Adverse Event|4|||
48392530|NCT02113436|155631873|FG003|Period 2: 16 Weeks|Adverse Event|5|||
48392531|NCT02113436|155631870|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
48426296|NCT00053846|155749528|FG001|Overall Study|Pills too large|1|||
48688495|NCT01384734|156710058|FG002|Overall Study|Continuation criteria not met|1|||
48688496|NCT01384734|156710059|FG003|Overall Study|Continuation criteria not met|1|||
48688497|NCT01384734|156710060|FG004|Overall Study|Continuation criteria not met|0|||
48688498|NCT01384734|156710056|FG000|Overall Study|Lack of Efficacy|3|||
48688499|NCT01384734|156710057|FG001|Overall Study|Lack of Efficacy|7|||
48688500|NCT01384734|156710058|FG002|Overall Study|Lack of Efficacy|4|||
48688501|NCT01384734|156710059|FG003|Overall Study|Lack of Efficacy|4|||
48688502|NCT01384734|156710060|FG004|Overall Study|Lack of Efficacy|2|||
48688503|NCT01384734|156710056|FG000|Overall Study|Lost to Follow-up|5|||
48688504|NCT01384734|156710057|FG001|Overall Study|Lost to Follow-up|3|||
48688505|NCT01384734|156710058|FG002|Overall Study|Lost to Follow-up|3|||
48688506|NCT01384734|156710059|FG003|Overall Study|Lost to Follow-up|8|||
48688507|NCT01384734|156710060|FG004|Overall Study|Lost to Follow-up|5|||
48688508|NCT01384734|156710056|FG000|Overall Study|Non-compliance with study drug|1|||
48392532|NCT02113436|155631871|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
48392533|NCT02113436|155631872|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
48392534|NCT02113436|155631873|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
48688509|NCT01384734|156710057|FG001|Overall Study|Non-compliance with study drug|2|||
48688510|NCT01384734|156710058|FG002|Overall Study|Non-compliance with study drug|6|||
48688511|NCT01384734|156710059|FG003|Overall Study|Non-compliance with study drug|0|||
48688512|NCT01384734|156710060|FG004|Overall Study|Non-compliance with study drug|2|||
48688513|NCT01384734|156710056|FG000|Overall Study|Pregnancy|0|||
48688514|NCT01384734|156710057|FG001|Overall Study|Pregnancy|1|||
48688515|NCT01384734|156710058|FG002|Overall Study|Pregnancy|0|||
48688516|NCT01384734|156710059|FG003|Overall Study|Pregnancy|0|||
48688517|NCT01384734|156710060|FG004|Overall Study|Pregnancy|1|||
48688518|NCT01384734|156710056|FG000|Overall Study|Sponsor terminated|0|||
48688519|NCT01384734|156710057|FG001|Overall Study|Sponsor terminated|0|||
48688520|NCT01384734|156710058|FG002|Overall Study|Sponsor terminated|0|||
48688521|NCT01384734|156710059|FG003|Overall Study|Sponsor terminated|0|||
48688522|NCT01384734|156710060|FG004|Overall Study|Sponsor terminated|1|||
48688523|NCT01384734|156710056|FG000|Overall Study|Withdrawal by Subject|5|||
48688524|NCT01384734|156710057|FG001|Overall Study|Withdrawal by Subject|5|||
48688525|NCT01384734|156710058|FG002|Overall Study|Withdrawal by Subject|6|||
48688526|NCT01384734|156710059|FG003|Overall Study|Withdrawal by Subject|7|||
48688527|NCT01384734|156710060|FG004|Overall Study|Withdrawal by Subject|9|||
48688528|NCT01384734|156710056|FG000|Overall Study|Investigator relocating|0|||
48688529|NCT01384734|156710057|FG001|Overall Study|Investigator relocating|2|||
48688530|NCT01384734|156710058|FG002|Overall Study|Investigator relocating|0|||
48688531|NCT01384734|156710059|FG003|Overall Study|Investigator relocating|3|||
48688532|NCT01384734|156710060|FG004|Overall Study|Investigator relocating|1|||
48688533|NCT01384734|156710056|FG000|Overall Study|Unable to come back for visit|1|||
48688534|NCT01384734|156710057|FG001|Overall Study|Unable to come back for visit|0|||
48688535|NCT01384734|156710058|FG002|Overall Study|Unable to come back for visit|1|||
48688536|NCT01384734|156710059|FG003|Overall Study|Unable to come back for visit|1|||
48688537|NCT01384734|156710060|FG004|Overall Study|Unable to come back for visit|0|||
48688538|NCT01384734|156710056|FG000|Overall Study|Prison|0|||
48688539|NCT01384734|156710057|FG001|Overall Study|Prison|0|||
48688540|NCT01384734|156710058|FG002|Overall Study|Prison|1|||
48688541|NCT01384734|156710059|FG003|Overall Study|Prison|0|||
48688542|NCT01384734|156710060|FG004|Overall Study|Prison|0|||
48688543|NCT01384734|156710056|FG000|Overall Study|As per Exclusion criteria|0|||
48688544|NCT01384734|156710057|FG001|Overall Study|As per Exclusion criteria|1|||
48688545|NCT01384734|156710058|FG002|Overall Study|As per Exclusion criteria|0|||
48688546|NCT01384734|156710059|FG003|Overall Study|As per Exclusion criteria|0|||
48688547|NCT01384734|156710060|FG004|Overall Study|As per Exclusion criteria|0|||
48688548|NCT01384734|156710056|FG000|Overall Study|Missed End of treatment visit|0|||
48688549|NCT01384734|156710057|FG001|Overall Study|Missed End of treatment visit|0|||
48392535|NCT02113436|155631870|FG000|Period 2: 16 Weeks|Physician Decision|0|||
48392536|NCT02113436|155631871|FG001|Period 2: 16 Weeks|Physician Decision|0|||
48392537|NCT02113436|155631872|FG002|Period 2: 16 Weeks|Physician Decision|2|||
48392538|NCT02113436|155631873|FG003|Period 2: 16 Weeks|Physician Decision|0|||
48688550|NCT01384734|156710058|FG002|Overall Study|Missed End of treatment visit|0|||
48688551|NCT01384734|156710059|FG003|Overall Study|Missed End of treatment visit|1|||
48688552|NCT01384734|156710060|FG004|Overall Study|Missed End of treatment visit|0|||
48688553|NCT01384734|156710056|FG000|Overall Study|Adhesion problem|0|||
48688554|NCT01384734|156710057|FG001|Overall Study|Adhesion problem|0|||
48688555|NCT01384734|156710058|FG002|Overall Study|Adhesion problem|0|||
48688556|NCT01384734|156710059|FG003|Overall Study|Adhesion problem|1|||
48688557|NCT01384734|156710060|FG004|Overall Study|Adhesion problem|0|||
48688558|NCT01384734|156710056|FG000|Overall Study|Early termination|0|||
48688559|NCT01384734|156710057|FG001|Overall Study|Early termination|0|||
48688560|NCT01384734|156710058|FG002|Overall Study|Early termination|0|||
48688561|NCT01384734|156710059|FG003|Overall Study|Early termination|0|||
48688562|NCT01384734|156710060|FG004|Overall Study|Early termination|1|||
48688563|NCT01384734|156710056|FG000|Overall Study|Physician Decision|1|||
48688564|NCT01384734|156710057|FG001|Overall Study|Physician Decision|0|||
48688565|NCT01384734|156710058|FG002|Overall Study|Physician Decision|0|||
48688566|NCT01384734|156710059|FG003|Overall Study|Physician Decision|0|||
48688567|NCT01384734|156710060|FG004|Overall Study|Physician Decision|0|||
48688568|NCT00795535|156710061|FG000|Overall Study|incomplete data and technical problems|20|||
48688569|NCT01787461|156710071|FG000|Overall Study|Adverse Event|4|||
48688570|NCT01787461|156710072|FG001|Overall Study|Adverse Event|3|||
48688571|NCT01787461|156710071|FG000|Overall Study|Lost to Follow-up|3|||
48688572|NCT01787461|156710072|FG001|Overall Study|Lost to Follow-up|2|||
48688573|NCT01787461|156710071|FG000|Overall Study|No longer met eligibility criteria|1|||
48688574|NCT01787461|156710072|FG001|Overall Study|No longer met eligibility criteria|0|||
48688575|NCT01787461|156710071|FG000|Overall Study|Withdrawal by Subject|3|||
48688576|NCT01787461|156710072|FG001|Overall Study|Withdrawal by Subject|4|||
48688577|NCT01787461|156710071|FG000|Overall Study|Protocol Violation|3|||
48688578|NCT01787461|156710072|FG001|Overall Study|Protocol Violation|0|||
48688579|NCT00360412|156710078|FG000|Overall Study|Adverse Event|37|||
48688580|NCT00360412|156710079|FG001|Overall Study|Adverse Event|65|||
48688581|NCT00360412|156710078|FG000|Overall Study|Protocol Violation|2|||
48688582|NCT00360412|156710079|FG001|Overall Study|Protocol Violation|5|||
48688583|NCT00360412|156710078|FG000|Overall Study|Patient withdrew consent|27|||
48688584|NCT00360412|156710079|FG001|Overall Study|Patient withdrew consent|52|||
48688585|NCT00360412|156710078|FG000|Overall Study|Lack of therapeutic efficacy|46|||
48688586|NCT00360412|156710079|FG001|Overall Study|Lack of therapeutic efficacy|61|||
48688587|NCT00360412|156710078|FG000|Overall Study|Physician Decision|2|||
48688588|NCT00360412|156710079|FG001|Overall Study|Physician Decision|4|||
48688589|NCT00360412|156710078|FG000|Overall Study|Other|5|||
48688590|NCT00360412|156710079|FG001|Overall Study|Other|6|||
48688591|NCT00360412|156710078|FG000|Overall Study|Study termination by Sponsor|214|||
48688592|NCT00360412|156710079|FG001|Overall Study|Study termination by Sponsor|469|||
48688593|NCT00999544|156711591|FG000|Overall Study|Withdrawal by Subject|1|||
48688594|NCT02813889|156711606|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
48688595|NCT02813889|156711607|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
48688596|NCT04737278|156711609|FG000|Overall Study|Lost to Follow-up|1|||
48688597|NCT04737278|156711610|FG001|Overall Study|Lost to Follow-up|1|||
48688598|NCT04737278|156711609|FG000|Overall Study|Withdrawal by Subject|1|||
48688599|NCT04737278|156711610|FG001|Overall Study|Withdrawal by Subject|0|||
48688600|NCT04737278|156711609|FG000|Overall Study|Protocol Violation|1|||
48688601|NCT04737278|156711610|FG001|Overall Study|Protocol Violation|1|||
48688602|NCT04737278|156711609|FG000|Overall Study|failure to complete questionnaire|1|||
48688603|NCT04737278|156711610|FG001|Overall Study|failure to complete questionnaire|1|||
48688604|NCT03951077|156711611|FG000|Overall Study|Adverse Event|1|||
48688605|NCT03951077|156711612|FG001|Overall Study|Adverse Event|0|||
48688606|NCT03951077|156711613|FG002|Overall Study|Adverse Event|0|||
48688607|NCT03951077|156711614|FG003|Overall Study|Adverse Event|0|||
48688608|NCT03951077|156711615|FG004|Overall Study|Adverse Event|0|||
48688609|NCT03951077|156711616|FG005|Overall Study|Adverse Event|0|||
48688610|NCT03951077|156711611|FG000|Overall Study|Withdrawal by Subject|3|||
48688611|NCT03951077|156711612|FG001|Overall Study|Withdrawal by Subject|3|||
48688612|NCT03951077|156711613|FG002|Overall Study|Withdrawal by Subject|0|||
48688613|NCT03951077|156711614|FG003|Overall Study|Withdrawal by Subject|3|||
48688614|NCT03951077|156711615|FG004|Overall Study|Withdrawal by Subject|3|||
48688615|NCT03951077|156711616|FG005|Overall Study|Withdrawal by Subject|2|||
48688616|NCT03951077|156711611|FG000|Overall Study|Lost to Follow-up|1|||
48688617|NCT03951077|156711612|FG001|Overall Study|Lost to Follow-up|1|||
48688618|NCT03951077|156711613|FG002|Overall Study|Lost to Follow-up|2|||
48688619|NCT03951077|156711614|FG003|Overall Study|Lost to Follow-up|3|||
48688620|NCT03951077|156711615|FG004|Overall Study|Lost to Follow-up|2|||
48688621|NCT03951077|156711616|FG005|Overall Study|Lost to Follow-up|3|||
48688622|NCT03951077|156711611|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
48688623|NCT03951077|156711612|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
48688624|NCT03951077|156711613|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
48688625|NCT03951077|156711614|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
48688626|NCT03951077|156711615|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
48688627|NCT03951077|156711616|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
48688628|NCT03951077|156711611|FG000|Overall Study|Other, Not Specified|12|||
48763590|NCT01449526|156983954|FG001|Overall Study|Withdrawal by Subject|1|||
48763591|NCT01449526|156983953|FG000|Overall Study|Symptoms/complaints|0|||
48688629|NCT03951077|156711612|FG001|Overall Study|Other, Not Specified|10|||
48688630|NCT03951077|156711613|FG002|Overall Study|Other, Not Specified|10|||
48688631|NCT03951077|156711614|FG003|Overall Study|Other, Not Specified|5|||
48688632|NCT03951077|156711615|FG004|Overall Study|Other, Not Specified|9|||
48688633|NCT03951077|156711616|FG005|Overall Study|Other, Not Specified|6|||
48688634|NCT03951077|156711611|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
48688635|NCT03951077|156711612|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
48688636|NCT03951077|156711613|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
48688637|NCT03951077|156711614|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
48688638|NCT03951077|156711615|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
48688639|NCT03951077|156711616|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
48688640|NCT00743249|156711617|FG000|Overall Study|Adverse Event|0|||
48688641|NCT00743249|156711618|FG001|Overall Study|Adverse Event|4|||
48688642|NCT00743249|156711617|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
48688643|NCT00743249|156711618|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
48688644|NCT00743249|156711617|FG000|Overall Study|Unsuccessful insertion of stent|2|||
48688645|NCT00743249|156711618|FG001|Overall Study|Unsuccessful insertion of stent|1|||
48688646|NCT00965081|156711619|FG000|Overall Study|Adverse Event|14|||
48688647|NCT00965081|156711620|FG001|Overall Study|Adverse Event|9|||
48688648|NCT00965081|156711619|FG000|Overall Study|Lack of Efficacy|2|||
48688649|NCT00965081|156711620|FG001|Overall Study|Lack of Efficacy|5|||
48688650|NCT00965081|156711619|FG000|Overall Study|Lost to Follow-up|4|||
48688651|NCT00965081|156711620|FG001|Overall Study|Lost to Follow-up|5|||
48688652|NCT00965081|156711619|FG000|Overall Study|Physician Decision|2|||
48688653|NCT00965081|156711620|FG001|Overall Study|Physician Decision|0|||
48688654|NCT00965081|156711619|FG000|Overall Study|Protocol Violation|2|||
48688655|NCT00965081|156711620|FG001|Overall Study|Protocol Violation|5|||
48688656|NCT00965081|156711619|FG000|Overall Study|Sponsor Decision|1|||
48688657|NCT00965081|156711620|FG001|Overall Study|Sponsor Decision|0|||
48688658|NCT00965081|156711619|FG000|Overall Study|Withdrawal by Subject|4|||
48688659|NCT00965081|156711620|FG001|Overall Study|Withdrawal by Subject|7|||
48688660|NCT00965081|156711619|FG000|Overall Study|Switched to Rescue Arm|5|||
48688661|NCT00965081|156711620|FG001|Overall Study|Switched to Rescue Arm|12|||
48688662|NCT00474955|156711622|FG000|Overall Study|Adverse Event|2|||
48688663|NCT00474955|156711622|FG000|Overall Study|Drug unavailability|1|||
48688664|NCT00474955|156711622|FG000|Overall Study|Personal reasons|5|||
48688665|NCT00255190|156711623|FG000|Overall Study|Adverse Event|17|||
48688666|NCT00255190|156711624|FG001|Overall Study|Adverse Event|36|||
48688667|NCT00255190|156711623|FG000|Overall Study|Protocol Violation|2|||
48688668|NCT00255190|156711624|FG001|Overall Study|Protocol Violation|2|||
48688669|NCT00255190|156711623|FG000|Overall Study|Lost to Follow-up|10|||
48688670|NCT00255190|156711624|FG001|Overall Study|Lost to Follow-up|27|||
48688671|NCT00255190|156711623|FG000|Overall Study|Withdrew Consent|17|||
48688672|NCT00255190|156711624|FG001|Overall Study|Withdrew Consent|48|||
48688673|NCT00255190|156711623|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
48688674|NCT00255190|156711624|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
48688675|NCT00255190|156711623|FG000|Overall Study|Erosive esophagitis not healed|0|||
48688676|NCT00255190|156711624|FG001|Overall Study|Erosive esophagitis not healed|20|||
48688677|NCT00255190|156711623|FG000|Overall Study|Various|4|||
48688678|NCT00255190|156711624|FG001|Overall Study|Various|23|||
48688679|NCT00628030|156711625|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
48688680|NCT00628030|156711626|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
48688681|NCT00628030|156711625|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
48688682|NCT00628030|156711626|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
48688683|NCT00628030|156711625|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
48688684|NCT00628030|156711626|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
48688685|NCT01172535|156711627|FG000|Overall Study|Death|3|||
48688686|NCT01172535|156711627|FG000|Overall Study|Withdrawal by Subject|2|||
48688687|NCT01172535|156711627|FG000|Overall Study|Lost to Follow-up|1|||
48688688|NCT01172535|156711627|FG000|Overall Study|Ineligible at study entry|1|||
48688689|NCT01172535|156711627|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
48688690|NCT01156480|156711628|FG000|Overall Study|change in diagnosis|0|||
48688691|NCT01156480|156711629|FG001|Overall Study|change in diagnosis|1|||
48688692|NCT01582061|156711630|FG000|Overall Study|Lack of Efficacy|3|||
48688693|NCT01582061|156711631|FG001|Overall Study|Lack of Efficacy|23|||
48688694|NCT01582061|156711630|FG000|Overall Study|Adverse Event|12|||
48688695|NCT01582061|156711631|FG001|Overall Study|Adverse Event|8|||
48688696|NCT01582061|156711630|FG000|Overall Study|Withdrawal by Subject|10|||
48688697|NCT01582061|156711631|FG001|Overall Study|Withdrawal by Subject|4|||
48688698|NCT01582061|156711630|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48688699|NCT01582061|156711631|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48688700|NCT01582061|156711630|FG000|Overall Study|Death|0|||
48688701|NCT01582061|156711631|FG001|Overall Study|Death|1|||
48688702|NCT01582061|156711630|FG000|Overall Study|condition no longer requires study drug|1|||
48688703|NCT01582061|156711631|FG001|Overall Study|condition no longer requires study drug|0|||
48688704|NCT01582061|156711630|FG000|Overall Study|Lost to Follow-up|1|||
48688705|NCT01582061|156711631|FG001|Overall Study|Lost to Follow-up|0|||
48688706|NCT02859246|156711632|FG000|Overall Study|Screen fails|3|||
48688707|NCT02859246|156711632|FG000|Overall Study|Adverse Event|1|||
48688708|NCT02859246|156711632|FG000|Overall Study|Withdrawal by Subject|1|||
48688709|NCT01746368|156711635|FG000|Overall Study|Lost to Follow-up|2|||
48763592|NCT01449526|156983954|FG001|Overall Study|Symptoms/complaints|1|||
48763593|NCT01449526|156983953|FG000|Overall Study|Lack of Motivation|0|||
48688710|NCT01746368|156711636|FG001|Overall Study|Lost to Follow-up|0|||
48688711|NCT01746368|156711635|FG000|Overall Study|Withdrawal by Subject|0|||
48763594|NCT01449526|156983954|FG001|Overall Study|Lack of Motivation|1|||
48688712|NCT01746368|156711636|FG001|Overall Study|Withdrawal by Subject|1|||
48688713|NCT00499681|156711640|FG000|Overall Study|toxicity|0|||
48688714|NCT00499681|156711641|FG001|Overall Study|toxicity|1|||
48688715|NCT00499681|156711640|FG000|Overall Study|disease progression|0|||
48688716|NCT00499681|156711641|FG001|Overall Study|disease progression|1|||
48688717|NCT00659061|156711642|FG000|Overall Study|Migration due to political unrest|21|||
48688718|NCT00659061|156711643|FG001|Overall Study|Migration due to political unrest|15|||
48688719|NCT03480152|156711644|FG000|Phase I|Signed consent. Died before treatment.|1|||
48688720|NCT03480152|156711645|FG001|Phase I|Signed consent. Died before treatment.|0|||
48688721|NCT03480152|156711646|FG002|Phase I|Signed consent. Died before treatment.|0|||
48688722|NCT03535974|156711647|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
48688723|NCT03535974|156711648|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
48688724|NCT03535974|156711649|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
48688725|NCT03535974|156711647|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
48688726|NCT03535974|156711648|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
48688727|NCT03535974|156711649|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
48688728|NCT02913482|156711650|FG000|Overall Study|Death|0|||
48688729|NCT02913482|156711651|FG001|Overall Study|Death|2|||
48688730|NCT02913482|156711652|FG002|Overall Study|Death|2|||
48688731|NCT02913482|156711650|FG000|Overall Study|Progressive Disease|1|||
48688732|NCT02913482|156711651|FG001|Overall Study|Progressive Disease|1|||
48688733|NCT02913482|156711652|FG002|Overall Study|Progressive Disease|1|||
48688734|NCT02913482|156711650|FG000|Overall Study|Reason not specified|0|||
48688735|NCT02913482|156711651|FG001|Overall Study|Reason not specified|0|||
48688736|NCT02913482|156711652|FG002|Overall Study|Reason not specified|1|||
48688737|NCT02913482|156711650|FG000|Overall Study|Withdrawal by Subject|0|||
48688738|NCT02913482|156711651|FG001|Overall Study|Withdrawal by Subject|1|||
48688739|NCT02913482|156711652|FG002|Overall Study|Withdrawal by Subject|1|||
48688740|NCT00988884|156711653|FG000|Overall Study|Adverse Event|0|||
48688741|NCT00988884|156711654|FG001|Overall Study|Adverse Event|1|||
48688742|NCT00988884|156711653|FG000|Overall Study|Lost to Follow-up|20|||
48688743|NCT00988884|156711654|FG001|Overall Study|Lost to Follow-up|16|||
48688744|NCT00988884|156711653|FG000|Overall Study|Protocol Violation|0|||
48688745|NCT00988884|156711654|FG001|Overall Study|Protocol Violation|1|||
48688746|NCT00988884|156711653|FG000|Overall Study|Withdrawal by Subject|15|||
48688747|NCT00988884|156711654|FG001|Overall Study|Withdrawal by Subject|18|||
48688748|NCT01623115|156711655|FG000|Overall Study|Randomized but not treated|0|||
48688749|NCT01623115|156711656|FG001|Overall Study|Randomized but not treated|1|||
48688750|NCT01623115|156711655|FG000|Overall Study|Physician Decision|1|||
48688751|NCT01623115|156711656|FG001|Overall Study|Physician Decision|0|||
48688752|NCT01623115|156711655|FG000|Overall Study|Participants moved|1|||
48688753|NCT01623115|156711656|FG001|Overall Study|Participants moved|5|||
48688754|NCT01623115|156711655|FG000|Overall Study|Adverse Event|10|||
48688755|NCT01623115|156711656|FG001|Overall Study|Adverse Event|13|||
48688756|NCT01623115|156711655|FG000|Overall Study|Poor compliance to protocol|4|||
48688757|NCT01623115|156711656|FG001|Overall Study|Poor compliance to protocol|10|||
48688758|NCT01623115|156711655|FG000|Overall Study|Consent withdrawn by participant|2|||
48688759|NCT01623115|156711656|FG001|Overall Study|Consent withdrawn by participant|6|||
48688760|NCT01623115|156711655|FG000|Overall Study|Related to study drug administration|0|||
48688761|NCT01623115|156711656|FG001|Overall Study|Related to study drug administration|2|||
48688762|NCT01623115|156711655|FG000|Overall Study|Last visit outside protocol visit window|14|||
48688763|NCT01623115|156711656|FG001|Overall Study|Last visit outside protocol visit window|26|||
48688764|NCT01623115|156711655|FG000|Overall Study|Site closure|1|||
48688765|NCT01623115|156711656|FG001|Overall Study|Site closure|7|||
48688766|NCT01623115|156711655|FG000|Overall Study|Death|0|||
48688767|NCT01623115|156711656|FG001|Overall Study|Death|4|||
48688768|NCT01623115|156711655|FG000|Overall Study|Other than specified above|0|||
48688769|NCT01623115|156711656|FG001|Overall Study|Other than specified above|3|||
48688770|NCT00687401|156711663|FG000|Overall Study|Protocol Violation|7|||
48688771|NCT00687401|156711663|FG000|Overall Study|Adverse Event|6|||
48688772|NCT00687401|156711663|FG000|Overall Study|Lack of Efficacy|6|||
48688773|NCT00687401|156711663|FG000|Overall Study|Withdrawal by Subject|4|||
48688774|NCT00687401|156711663|FG000|Overall Study|Did not return for visit|3|||
48688775|NCT00687401|156711663|FG000|Overall Study|For reasons different from those above|4|||
48688776|NCT00626275|156711664|FG000|Part A - Treatment Period 1|Adverse Event|1|||
48688777|NCT00626275|156711665|FG001|Part A - Treatment Period 1|Adverse Event|0|||
48688778|NCT00626275|156711666|FG002|Part A - Treatment Period 1|Adverse Event|0|||
48688779|NCT00626275|156711667|FG003|Part A - Treatment Period 1|Adverse Event|0|||
48688780|NCT00626275|156711668|FG004|Part A - Treatment Period 1|Adverse Event|0|||
48426297|NCT00064662|155749535|FG000|Overall Study|Death|1|||
48688781|NCT00626275|156711669|FG005|Part A - Treatment Period 1|Adverse Event|0|||
48688782|NCT00626275|156711670|FG006|Part A - Treatment Period 1|Adverse Event|0|||
48688783|NCT00626275|156711671|FG007|Part A - Treatment Period 1|Adverse Event|0|||
48688784|NCT00626275|156711664|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688785|NCT00626275|156711665|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688786|NCT00626275|156711666|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
48688787|NCT00626275|156711667|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688788|NCT00626275|156711668|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688789|NCT00626275|156711669|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688790|NCT00626275|156711670|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688791|NCT00626275|156711671|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
48688792|NCT00626275|156711664|FG000|Part B|Lost to Follow-up|0|||
48688793|NCT00626275|156711665|FG001|Part B|Lost to Follow-up|0|||
48688794|NCT00626275|156711666|FG002|Part B|Lost to Follow-up|0|||
48688795|NCT00626275|156711667|FG003|Part B|Lost to Follow-up|0|||
48688796|NCT00626275|156711668|FG004|Part B|Lost to Follow-up|0|||
48688797|NCT00626275|156711669|FG005|Part B|Lost to Follow-up|0|||
48688798|NCT00626275|156711670|FG006|Part B|Lost to Follow-up|1|||
48688799|NCT00626275|156711671|FG007|Part B|Lost to Follow-up|0|||
48688800|NCT00626275|156711664|FG000|Part B|Withdrawal by Subject|0|||
48688801|NCT00626275|156711665|FG001|Part B|Withdrawal by Subject|0|||
48688802|NCT00626275|156711666|FG002|Part B|Withdrawal by Subject|0|||
48688803|NCT00626275|156711667|FG003|Part B|Withdrawal by Subject|0|||
48688804|NCT00626275|156711668|FG004|Part B|Withdrawal by Subject|0|||
48688805|NCT00626275|156711669|FG005|Part B|Withdrawal by Subject|0|||
48688806|NCT00626275|156711670|FG006|Part B|Withdrawal by Subject|0|||
48688807|NCT00626275|156711671|FG007|Part B|Withdrawal by Subject|1|||
48688808|NCT00468299|156711674|FG000|Overall Study|Withdrawal by Subject|0|||
48688809|NCT00468299|156711675|FG001|Overall Study|Withdrawal by Subject|1|||
48688810|NCT03649217|156711676|FG000|Overall Study|subject had severe ataxia not initially found|1|||
48688811|NCT03649217|156711676|FG000|Overall Study|subject had cognitive issues not initially found|1|||
48688812|NCT01092728|156711677|FG000|Overall Study|Withdrawal by Subject|2|||
48688813|NCT01092728|156711678|FG001|Overall Study|Withdrawal by Subject|0|||
48688814|NCT01092728|156711677|FG000|Overall Study|Adverse Event|0|||
48688815|NCT01092728|156711678|FG001|Overall Study|Adverse Event|1|||
48688816|NCT01092728|156711677|FG000|Overall Study|Disease Progression|1|||
48688817|NCT01092728|156711678|FG001|Overall Study|Disease Progression|13|||
48688818|NCT01092728|156711677|FG000|Overall Study|Prohibited Concomitant Medications|1|||
48688819|NCT01092728|156711678|FG001|Overall Study|Prohibited Concomitant Medications|0|||
48392539|NCT02113436|155631870|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
48688820|NCT01788566|156711679|FG000|Overall Study|Death|4|||
48688821|NCT01788566|156711679|FG000|Overall Study|Adverse Event|1|||
48688822|NCT01788566|156711679|FG000|Overall Study|Clinical Progressive Disease|3|||
48688823|NCT00721396|156711684|FG000|Overall Study|Adverse Event|4|||
48688824|NCT00721396|156711685|FG001|Overall Study|Adverse Event|7|||
48688825|NCT00721396|156711686|FG002|Overall Study|Adverse Event|2|||
48688826|NCT00721396|156711687|FG003|Overall Study|Adverse Event|0|||
48688827|NCT00721396|156711684|FG000|Overall Study|Withdrawal by Subject|12|||
48688828|NCT00721396|156711685|FG001|Overall Study|Withdrawal by Subject|15|||
48688829|NCT00721396|156711686|FG002|Overall Study|Withdrawal by Subject|3|||
48688830|NCT00721396|156711687|FG003|Overall Study|Withdrawal by Subject|7|||
48688831|NCT00721396|156711684|FG000|Overall Study|Lost to Follow-up|7|||
48688832|NCT00721396|156711685|FG001|Overall Study|Lost to Follow-up|9|||
48688833|NCT00721396|156711686|FG002|Overall Study|Lost to Follow-up|3|||
48688834|NCT00721396|156711687|FG003|Overall Study|Lost to Follow-up|3|||
48688835|NCT00721396|156711684|FG000|Overall Study|Protocol Violation|4|||
48688836|NCT00721396|156711685|FG001|Overall Study|Protocol Violation|3|||
48688837|NCT00721396|156711686|FG002|Overall Study|Protocol Violation|1|||
48392540|NCT02113436|155631871|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
48392541|NCT02113436|155631872|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
48392542|NCT02113436|155631873|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
48392543|NCT00971178|155631880|FG000|Overall Study|Lost to Follow-up|2|||
48392544|NCT00971178|155631881|FG001|Overall Study|Lost to Follow-up|2|||
48392545|NCT00971178|155631882|FG002|Overall Study|Lost to Follow-up|2|||
48392546|NCT03719690|155631883|FG000|Overall Study|Withdrawal by Subject|5|||
48392547|NCT03719690|155631884|FG001|Overall Study|Withdrawal by Subject|10|||
48392548|NCT03719690|155631883|FG000|Overall Study|Death|40|||
48392549|NCT03719690|155631884|FG001|Overall Study|Death|149|||
48392550|NCT03719690|155631883|FG000|Overall Study|Miscellaneous|12|||
48392551|NCT03719690|155631884|FG001|Overall Study|Miscellaneous|56|||
48392552|NCT03719690|155631883|FG000|Overall Study|Lost to Follow-up|2|||
48392553|NCT03719690|155631884|FG001|Overall Study|Lost to Follow-up|18|||
48688838|NCT00721396|156711687|FG003|Overall Study|Protocol Violation|0|||
48688839|NCT00721396|156711684|FG000|Overall Study|Inappropriate enrollment|0|||
48688840|NCT00721396|156711685|FG001|Overall Study|Inappropriate enrollment|2|||
48688841|NCT00721396|156711686|FG002|Overall Study|Inappropriate enrollment|0|||
48688842|NCT00721396|156711687|FG003|Overall Study|Inappropriate enrollment|0|||
48688843|NCT00721396|156711684|FG000|Overall Study|Administrative reason|3|||
48688844|NCT00721396|156711685|FG001|Overall Study|Administrative reason|0|||
48688845|NCT00721396|156711686|FG002|Overall Study|Administrative reason|1|||
48688846|NCT00721396|156711687|FG003|Overall Study|Administrative reason|0|||
48392554|NCT03719690|155631883|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
48688847|NCT00757237|156711688|FG000|Overall Study|Lost to Follow-up|0|||
48688848|NCT00757237|156711689|FG001|Overall Study|Lost to Follow-up|1|||
48688849|NCT00757237|156711688|FG000|Overall Study|Protocol Violation|0|||
48688850|NCT00757237|156711689|FG001|Overall Study|Protocol Violation|2|||
48688851|NCT00757237|156711688|FG000|Overall Study|Physician Decision|2|||
48688852|NCT00757237|156711689|FG001|Overall Study|Physician Decision|3|||
48688853|NCT00757237|156711688|FG000|Overall Study|Withdrawal by Subject|8|||
48392555|NCT03719690|155631884|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
48392556|NCT00393887|155631885|FG000|Overall Study|Physician Decision|5|||
48392557|NCT00393887|155631886|FG001|Overall Study|Physician Decision|0|||
48392558|NCT00393887|155631885|FG000|Overall Study|Lost to Follow-up|11|||
48688854|NCT00757237|156711689|FG001|Overall Study|Withdrawal by Subject|12|||
48688855|NCT00757237|156711688|FG000|Overall Study|Safety or Tolerability|3|||
48688856|NCT00757237|156711689|FG001|Overall Study|Safety or Tolerability|5|||
48688857|NCT00757237|156711688|FG000|Overall Study|Other|0|||
48688858|NCT00757237|156711689|FG001|Overall Study|Other|2|||
48688859|NCT01721161|156711690|FG000|Overall Study|Adverse Event|2|||
48688860|NCT01721161|156711691|FG001|Overall Study|Adverse Event|3|||
48688861|NCT01721161|156711690|FG000|Overall Study|Lost to Follow-up|1|||
48688862|NCT01721161|156711691|FG001|Overall Study|Lost to Follow-up|2|||
48688863|NCT01721161|156711690|FG000|Overall Study|Withdrawal by Subject|1|||
48688864|NCT01721161|156711691|FG001|Overall Study|Withdrawal by Subject|1|||
48688865|NCT01721161|156711690|FG000|Overall Study|Other|0|||
48688866|NCT01721161|156711691|FG001|Overall Study|Other|1|||
48688867|NCT02753946|156711695|FG000|Overall Study|Adverse Event|7|||
48688868|NCT02753946|156711696|FG001|Overall Study|Adverse Event|6|||
48688869|NCT02753946|156711695|FG000|Overall Study|Withdrawal by Subject|6|||
48688870|NCT02753946|156711696|FG001|Overall Study|Withdrawal by Subject|1|||
48688871|NCT02753946|156711695|FG000|Overall Study|Lack of Efficacy|1|||
48688872|NCT02753946|156711696|FG001|Overall Study|Lack of Efficacy|0|||
48688873|NCT02753946|156711695|FG000|Overall Study|Physician Decision|0|||
48688874|NCT02753946|156711696|FG001|Overall Study|Physician Decision|2|||
48688875|NCT03546621|156711699|FG000|Overall Study|Withdrawal by Subject|0|||
48688876|NCT03546621|156711700|FG001|Overall Study|Withdrawal by Subject|1|||
48688877|NCT03546621|156711701|FG002|Overall Study|Withdrawal by Subject|2|||
48688878|NCT03546621|156711702|FG003|Overall Study|Withdrawal by Subject|1|||
48688879|NCT03546621|156711699|FG000|Overall Study|Lost to Follow-up|0|||
48688880|NCT03546621|156711700|FG001|Overall Study|Lost to Follow-up|1|||
48688881|NCT03546621|156711701|FG002|Overall Study|Lost to Follow-up|0|||
48688882|NCT03546621|156711702|FG003|Overall Study|Lost to Follow-up|0|||
48688883|NCT03546621|156711699|FG000|Overall Study|Adverse Event|0|||
48688884|NCT03546621|156711700|FG001|Overall Study|Adverse Event|1|||
48688885|NCT03546621|156711701|FG002|Overall Study|Adverse Event|0|||
48688886|NCT03546621|156711702|FG003|Overall Study|Adverse Event|1|||
48688887|NCT03546621|156711699|FG000|Overall Study|Progressive disease|0|||
48688888|NCT03546621|156711700|FG001|Overall Study|Progressive disease|0|||
48688889|NCT03546621|156711701|FG002|Overall Study|Progressive disease|0|||
48688890|NCT03546621|156711702|FG003|Overall Study|Progressive disease|1|||
48688891|NCT02721875|156711707|FG000|Overall Study|Progressive disease/relapse|1|||
48688892|NCT02721875|156711708|FG001|Overall Study|Progressive disease/relapse|0|||
48688893|NCT01290523|156711709|FG000|Overall Study|Death|3|||
48688894|NCT03914417|156711710|FG000|Overall Study|Withdrawal by Subject|2|||
48688895|NCT03259555|156711713|FG000|Overall Study|Adverse Event|6|||
48688896|NCT03259555|156711714|FG001|Overall Study|Adverse Event|4|||
48688897|NCT03259555|156711713|FG000|Overall Study|Lack of Efficacy|6|||
48688898|NCT03259555|156711714|FG001|Overall Study|Lack of Efficacy|4|||
48688899|NCT03259555|156711713|FG000|Overall Study|Lost to Follow-up|0|||
48688900|NCT03259555|156711714|FG001|Overall Study|Lost to Follow-up|2|||
48688901|NCT03259555|156711713|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48688902|NCT03259555|156711714|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48688903|NCT03259555|156711713|FG000|Overall Study|Progressive Disease|0|||
48688904|NCT03259555|156711714|FG001|Overall Study|Progressive Disease|2|||
48392559|NCT00393887|155631886|FG001|Overall Study|Lost to Follow-up|9|||
48392560|NCT01111851|155631887|FG000|Overall Study|All planned PET scans were not obtained.|2|||
48392561|NCT01111851|155631888|FG001|Overall Study|All planned PET scans were not obtained.|0|||
48688905|NCT03259555|156711713|FG000|Overall Study|Withdrawal by Subject|19|||
48688906|NCT03259555|156711714|FG001|Overall Study|Withdrawal by Subject|16|||
48392562|NCT01372384|155631889|FG000|Overall Study|Progression of disease|3|||
48688907|NCT03259555|156711713|FG000|Overall Study|Physician Decision|1|||
48688908|NCT03259555|156711714|FG001|Overall Study|Physician Decision|2|||
48688909|NCT03259555|156711713|FG000|Overall Study|Other|1|||
48688910|NCT03259555|156711714|FG001|Overall Study|Other|0|||
48688911|NCT00154297|156711715|FG000|Overall Study|Death|5|||
48688912|NCT00154297|156711716|FG001|Overall Study|Death|2|||
48688913|NCT00154297|156711715|FG000|Overall Study|Withdrawal by Subject|0|||
48688914|NCT00154297|156711716|FG001|Overall Study|Withdrawal by Subject|5|||
48688915|NCT00154297|156711715|FG000|Overall Study|Lost to Follow-up|3|||
48688916|NCT00154297|156711716|FG001|Overall Study|Lost to Follow-up|0|||
48688917|NCT03087513|156711717|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
48688918|NCT03077542|156711721|FG000|Overall Study|Death|4|||
48688919|NCT03077542|156711722|FG001|Overall Study|Death|0|||
48688920|NCT03077542|156711721|FG000|Overall Study|Physician Decision|6|||
48688921|NCT03077542|156711722|FG001|Overall Study|Physician Decision|1|||
48688922|NCT03077542|156711721|FG000|Overall Study|Withdrawal by Subject|0|||
48688923|NCT03077542|156711722|FG001|Overall Study|Withdrawal by Subject|1|||
48688924|NCT01486966|156711724|FG000|Overall Study|Adverse Event|0|||
48688925|NCT01486966|156711725|FG001|Overall Study|Adverse Event|1|||
48688926|NCT01486966|156711724|FG000|Overall Study|Withdrawal by Subject|0|||
48688927|NCT01486966|156711725|FG001|Overall Study|Withdrawal by Subject|1|||
48688928|NCT02532517|156711726|FG000|Overall Study|Did not complete 24-Month visit|4|||
48688929|NCT02532517|156711726|FG000|Overall Study|Failed Angiographic eligibility|1|||
48688930|NCT02532517|156711726|FG000|Overall Study|Lost to Follow-up|4|||
48688931|NCT02532517|156711726|FG000|Overall Study|Withdrawal by Subject|4|||
48688932|NCT02532517|156711726|FG000|Overall Study|Death|4|||
48688933|NCT05051579|156711728|FG000|Overall Study|Withdrawal by Subject|3|||
48688934|NCT05051579|156711729|FG001|Overall Study|Withdrawal by Subject|5|||
48688935|NCT05051579|156711730|FG002|Overall Study|Withdrawal by Subject|2|||
48688936|NCT05051579|156711731|FG003|Overall Study|Withdrawal by Subject|1|||
48688937|NCT05051579|156711732|FG004|Overall Study|Withdrawal by Subject|4|||
48688938|NCT05051579|156711733|FG005|Overall Study|Withdrawal by Subject|0|||
48688939|NCT05051579|156711734|FG006|Overall Study|Withdrawal by Subject|4|||
48688940|NCT05051579|156711728|FG000|Overall Study|Lost to Follow-up|1|||
48688941|NCT05051579|156711729|FG001|Overall Study|Lost to Follow-up|0|||
48688942|NCT05051579|156711730|FG002|Overall Study|Lost to Follow-up|0|||
48688943|NCT05051579|156711731|FG003|Overall Study|Lost to Follow-up|0|||
48688944|NCT05051579|156711732|FG004|Overall Study|Lost to Follow-up|1|||
48688945|NCT05051579|156711733|FG005|Overall Study|Lost to Follow-up|0|||
48688946|NCT05051579|156711734|FG006|Overall Study|Lost to Follow-up|1|||
48688947|NCT05051579|156711728|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688948|NCT05051579|156711729|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688949|NCT05051579|156711730|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688950|NCT05051579|156711731|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688951|NCT05051579|156711732|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688952|NCT05051579|156711733|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
48688953|NCT05051579|156711734|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
48688954|NCT05051579|156711728|FG000|Overall Study|Adverse Event|2|||
48688955|NCT05051579|156711729|FG001|Overall Study|Adverse Event|1|||
48688956|NCT05051579|156711730|FG002|Overall Study|Adverse Event|0|||
48688957|NCT05051579|156711731|FG003|Overall Study|Adverse Event|4|||
48688958|NCT05051579|156711732|FG004|Overall Study|Adverse Event|1|||
48688959|NCT05051579|156711733|FG005|Overall Study|Adverse Event|2|||
48688960|NCT05051579|156711734|FG006|Overall Study|Adverse Event|0|||
48688961|NCT05051579|156711728|FG000|Overall Study|Inadvertent Enrollment|0|||
48688962|NCT05051579|156711729|FG001|Overall Study|Inadvertent Enrollment|0|||
48688963|NCT05051579|156711730|FG002|Overall Study|Inadvertent Enrollment|0|||
48688964|NCT05051579|156711731|FG003|Overall Study|Inadvertent Enrollment|0|||
48688965|NCT05051579|156711732|FG004|Overall Study|Inadvertent Enrollment|0|||
48688966|NCT05051579|156711733|FG005|Overall Study|Inadvertent Enrollment|0|||
48688967|NCT05051579|156711734|FG006|Overall Study|Inadvertent Enrollment|1|||
48688968|NCT05051579|156711728|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688969|NCT05051579|156711729|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
48688970|NCT05051579|156711730|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688971|NCT05051579|156711731|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688972|NCT05051579|156711732|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688973|NCT05051579|156711733|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688974|NCT05051579|156711734|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
48688975|NCT05051579|156711728|FG000|Overall Study|Sponsor Decision|0|||
48688976|NCT05051579|156711729|FG001|Overall Study|Sponsor Decision|0|||
48688977|NCT05051579|156711730|FG002|Overall Study|Sponsor Decision|0|||
48688978|NCT05051579|156711731|FG003|Overall Study|Sponsor Decision|0|||
48688979|NCT05051579|156711732|FG004|Overall Study|Sponsor Decision|1|||
48688980|NCT05051579|156711733|FG005|Overall Study|Sponsor Decision|0|||
48688981|NCT05051579|156711734|FG006|Overall Study|Sponsor Decision|0|||
48688982|NCT05051579|156711728|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688983|NCT05051579|156711729|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48692814|NCT01188772|156724610|FG000|Overall Study|Withdrawal by Subject|0|||
48692815|NCT01188772|156724611|FG001|Overall Study|Withdrawal by Subject|0|||
48692816|NCT01188772|156724612|FG002|Overall Study|Withdrawal by Subject|2|||
48692817|NCT01188772|156724613|FG003|Overall Study|Withdrawal by Subject|0|||
48692818|NCT03040141|156724614|FG000|Overall Study|Death|1|||
48692819|NCT03040141|156724615|FG001|Overall Study|Death|2|||
48688984|NCT05051579|156711730|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688985|NCT05051579|156711731|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688986|NCT05051579|156711732|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
48688987|NCT05051579|156711733|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688988|NCT05051579|156711734|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
48688989|NCT00880620|156711735|FG000|Overall Study|Adverse Event|4|||
48688990|NCT00880620|156711736|FG001|Overall Study|Adverse Event|5|||
48688991|NCT00880620|156711737|FG002|Overall Study|Adverse Event|15|||
48688992|NCT00880620|156711738|FG003|Overall Study|Adverse Event|15|||
48688993|NCT00880620|156711735|FG000|Overall Study|Death|0|||
48688994|NCT00880620|156711736|FG001|Overall Study|Death|0|||
48688995|NCT00880620|156711737|FG002|Overall Study|Death|1|||
48688996|NCT00880620|156711738|FG003|Overall Study|Death|0|||
48688997|NCT00880620|156711735|FG000|Overall Study|Lack of Efficacy|12|||
48688998|NCT00880620|156711736|FG001|Overall Study|Lack of Efficacy|4|||
48688999|NCT00880620|156711737|FG002|Overall Study|Lack of Efficacy|0|||
48689000|NCT00880620|156711738|FG003|Overall Study|Lack of Efficacy|1|||
48689001|NCT00880620|156711735|FG000|Overall Study|Lost to Follow-up|0|||
48689002|NCT00880620|156711736|FG001|Overall Study|Lost to Follow-up|1|||
48689003|NCT00880620|156711737|FG002|Overall Study|Lost to Follow-up|1|||
48689004|NCT00880620|156711738|FG003|Overall Study|Lost to Follow-up|0|||
48689005|NCT00880620|156711735|FG000|Overall Study|Protocol Violation|0|||
48689006|NCT00880620|156711736|FG001|Overall Study|Protocol Violation|1|||
48689007|NCT00880620|156711737|FG002|Overall Study|Protocol Violation|0|||
48689008|NCT00880620|156711738|FG003|Overall Study|Protocol Violation|2|||
48689009|NCT00880620|156711735|FG000|Overall Study|Withdrawal by Subject|4|||
48689010|NCT00880620|156711736|FG001|Overall Study|Withdrawal by Subject|3|||
48689011|NCT00880620|156711737|FG002|Overall Study|Withdrawal by Subject|1|||
48689012|NCT00880620|156711738|FG003|Overall Study|Withdrawal by Subject|3|||
48689013|NCT00880620|156711735|FG000|Overall Study|Noncompliance|0|||
48689014|NCT00880620|156711736|FG001|Overall Study|Noncompliance|0|||
48689015|NCT00880620|156711737|FG002|Overall Study|Noncompliance|1|||
48689016|NCT00880620|156711738|FG003|Overall Study|Noncompliance|1|||
48689017|NCT00880620|156711735|FG000|Overall Study|Other|1|||
48689018|NCT00880620|156711736|FG001|Overall Study|Other|1|||
48689019|NCT00880620|156711737|FG002|Overall Study|Other|2|||
48689020|NCT00880620|156711738|FG003|Overall Study|Other|2|||
48689021|NCT00871871|156711745|FG000|Part I|Adverse Event|0|||
48689022|NCT00871871|156711746|FG001|Part I|Adverse Event|2|||
48689023|NCT00871871|156711747|FG002|Part I|Adverse Event|0|||
48689024|NCT00871871|156711748|FG003|Part I|Adverse Event|0|||
48689025|NCT00871871|156711745|FG000|Part I|Withdrawal by Subject|3|||
48689026|NCT00871871|156711746|FG001|Part I|Withdrawal by Subject|0|||
48689027|NCT00871871|156711747|FG002|Part I|Withdrawal by Subject|0|||
48689028|NCT00871871|156711748|FG003|Part I|Withdrawal by Subject|0|||
48689029|NCT00871871|156711745|FG000|Part I|Laboratory abnormality|0|||
48689030|NCT00871871|156711746|FG001|Part I|Laboratory abnormality|1|||
48689031|NCT00871871|156711747|FG002|Part I|Laboratory abnormality|0|||
48689032|NCT00871871|156711748|FG003|Part I|Laboratory abnormality|0|||
48689033|NCT00871871|156711745|FG000|Part II|Lack of Efficacy|0|||
48689034|NCT00871871|156711746|FG001|Part II|Lack of Efficacy|0|||
48689035|NCT00871871|156711747|FG002|Part II|Lack of Efficacy|1|||
48689036|NCT00871871|156711748|FG003|Part II|Lack of Efficacy|0|||
48689037|NCT00871871|156711745|FG000|Part II|Withdrawal by Subject|0|||
48689038|NCT00871871|156711746|FG001|Part II|Withdrawal by Subject|0|||
48689039|NCT00871871|156711747|FG002|Part II|Withdrawal by Subject|2|||
48689040|NCT00871871|156711748|FG003|Part II|Withdrawal by Subject|1|||
48689041|NCT00871871|156711745|FG000|Part II|Adverse Event|0|||
48689042|NCT00871871|156711746|FG001|Part II|Adverse Event|0|||
48689043|NCT00871871|156711747|FG002|Part II|Adverse Event|1|||
48689044|NCT00871871|156711748|FG003|Part II|Adverse Event|2|||
48689045|NCT00871871|156711745|FG000|Part II|Protocol Violation|0|||
48689046|NCT00871871|156711746|FG001|Part II|Protocol Violation|0|||
48689047|NCT00871871|156711747|FG002|Part II|Protocol Violation|0|||
48689048|NCT00871871|156711748|FG003|Part II|Protocol Violation|1|||
48689049|NCT02354235|156711749|FG000|Overall Study|Adverse Event|2|||
48689050|NCT02354235|156711750|FG001|Overall Study|Adverse Event|2|||
48689051|NCT02354235|156711749|FG000|Overall Study|Physician Decision|0|||
48689052|NCT02354235|156711750|FG001|Overall Study|Physician Decision|1|||
48689053|NCT02354235|156711749|FG000|Overall Study|Withdrawal by Subject|1|||
48689054|NCT02354235|156711750|FG001|Overall Study|Withdrawal by Subject|3|||
48689055|NCT02354235|156711749|FG000|Overall Study|Conflict with the stopping criteria|0|||
48689056|NCT02354235|156711750|FG001|Overall Study|Conflict with the stopping criteria|1|||
48689057|NCT00410956|156711755|FG000|Overall Study|Adverse Event|1|||
48689058|NCT00410956|156711755|FG000|Overall Study|Death|2|||
48689059|NCT00410956|156711755|FG000|Overall Study|Lack of Efficacy|10|||
48763595|NCT01449526|156983953|FG000|Overall Study|Cannot maintain visits|0|||
48689060|NCT00410956|156711755|FG000|Overall Study|Physician Decision|6|||
48689061|NCT01650194|156711756|FG000|Overall Study|Progressive Disease (PD)|35|||
48689062|NCT01650194|156711756|FG000|Overall Study|Withdrawal by Subject|2|||
48689063|NCT01650194|156711756|FG000|Overall Study|Miscellaneous|10|||
48689064|NCT02407223|156713430|FG000|Overall Study|Adverse Event|1|||
48689065|NCT02407223|156713431|FG001|Overall Study|Adverse Event|0|||
48689066|NCT02407223|156713432|FG002|Overall Study|Adverse Event|1|||
48689067|NCT02407223|156713430|FG000|Overall Study|Lack of Efficacy|6|||
48689068|NCT02407223|156713431|FG001|Overall Study|Lack of Efficacy|6|||
48689069|NCT02407223|156713432|FG002|Overall Study|Lack of Efficacy|4|||
48689070|NCT02407223|156713430|FG000|Overall Study|Lost to Follow-up|1|||
48689071|NCT02407223|156713431|FG001|Overall Study|Lost to Follow-up|0|||
48689072|NCT02407223|156713432|FG002|Overall Study|Lost to Follow-up|2|||
48689073|NCT02407223|156713430|FG000|Overall Study|Withdrawal by Subject|2|||
48689074|NCT02407223|156713431|FG001|Overall Study|Withdrawal by Subject|4|||
48689075|NCT02407223|156713432|FG002|Overall Study|Withdrawal by Subject|4|||
48689076|NCT02407223|156713430|FG000|Overall Study|Study Terminated by Sponsor|77|||
48689077|NCT02407223|156713431|FG001|Overall Study|Study Terminated by Sponsor|80|||
48689078|NCT02407223|156713432|FG002|Overall Study|Study Terminated by Sponsor|86|||
48689079|NCT02407223|156713430|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
48689080|NCT02407223|156713431|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
48689081|NCT02407223|156713432|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
48689082|NCT02407223|156713430|FG000|Overall Study|Other|29|||
48689083|NCT02407223|156713431|FG001|Overall Study|Other|27|||
48689084|NCT02407223|156713432|FG002|Overall Study|Other|25|||
48689085|NCT03553758|156713433|FG000|Overall Study|Lost to Follow-up|1|||
48689086|NCT04864639|156713434|FG000|Overall Study|Death|1|||
48689087|NCT04864639|156713434|FG000|Overall Study|Lost to Follow-up|1|||
48689088|NCT02719171|156713435|FG000|Overall Study|Adverse Event|1|||
48689089|NCT02719171|156713436|FG001|Overall Study|Adverse Event|2|||
48689090|NCT02719171|156713437|FG002|Overall Study|Adverse Event|0|||
48689091|NCT02719171|156713438|FG003|Overall Study|Adverse Event|0|||
48689092|NCT02719171|156713439|FG004|Overall Study|Adverse Event|2|||
48689093|NCT02719171|156713435|FG000|Overall Study|Lost to Follow-up|0|||
48689094|NCT02719171|156713436|FG001|Overall Study|Lost to Follow-up|0|||
48689095|NCT02719171|156713437|FG002|Overall Study|Lost to Follow-up|1|||
48689096|NCT02719171|156713438|FG003|Overall Study|Lost to Follow-up|0|||
48689097|NCT02719171|156713439|FG004|Overall Study|Lost to Follow-up|0|||
48689098|NCT02719171|156713435|FG000|Overall Study|Subject Withdrawal|0|||
48689099|NCT02719171|156713436|FG001|Overall Study|Subject Withdrawal|2|||
48689100|NCT02719171|156713437|FG002|Overall Study|Subject Withdrawal|2|||
48689101|NCT02719171|156713438|FG003|Overall Study|Subject Withdrawal|1|||
48689102|NCT02719171|156713439|FG004|Overall Study|Subject Withdrawal|0|||
48689103|NCT02719171|156713435|FG000|Overall Study|Other|0|||
48689104|NCT02719171|156713436|FG001|Overall Study|Other|0|||
48689105|NCT02719171|156713437|FG002|Overall Study|Other|0|||
48689106|NCT02719171|156713438|FG003|Overall Study|Other|1|||
48689107|NCT02719171|156713439|FG004|Overall Study|Other|0|||
48689108|NCT02807623|156713440|FG000|Overall Study|Lost to Follow-up|23|||
48689109|NCT02807623|156713441|FG001|Overall Study|Lost to Follow-up|18|||
48689110|NCT02807623|156713442|FG002|Overall Study|Lost to Follow-up|22|||
48689111|NCT02807623|156713440|FG000|Overall Study|Drug intolerance|0|||
48689112|NCT02807623|156713441|FG001|Overall Study|Drug intolerance|1|||
48689113|NCT02807623|156713442|FG002|Overall Study|Drug intolerance|0|||
48689114|NCT02807623|156713440|FG000|Overall Study|incomplete blood draw|0|||
48689115|NCT02807623|156713441|FG001|Overall Study|incomplete blood draw|2|||
48763596|NCT01449526|156983954|FG001|Overall Study|Cannot maintain visits|1|||
48763597|NCT02865915|156983955|FG000|Overall Study|Pregnancy|1|||
48763598|NCT02865915|156983956|FG001|Overall Study|Pregnancy|0|||
48763599|NCT02865915|156983955|FG000|Overall Study|Withdrawal by Subject|1|||
48763600|NCT02865915|156983956|FG001|Overall Study|Withdrawal by Subject|1|||
48763601|NCT02865915|156983955|FG000|Overall Study|Adverse Event|0|||
48689116|NCT02807623|156713442|FG002|Overall Study|incomplete blood draw|1|||
48689117|NCT01389882|156713450|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
48689118|NCT01389882|156713451|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
48689119|NCT01389882|156713450|FG000|Overall Study|Withdrawal by Subject|0|||
48689120|NCT01389882|156713451|FG001|Overall Study|Withdrawal by Subject|1|||
48689121|NCT03449758|156713452|FG000|Overall Study|Major protocol deviation|1|||
48689122|NCT03449758|156713452|FG000|Overall Study|Treatment inefficacy|5|||
48689123|NCT03449758|156713452|FG000|Overall Study|Adverse Event|9|||
48689124|NCT03449758|156713452|FG000|Overall Study|Consent withdrawal|1|||
48689125|NCT03449758|156713452|FG000|Overall Study|Other unspecified reason|3|||
48689126|NCT02796677|156713453|FG000|Overall Study|Adverse Event|11|||
48763602|NCT02865915|156983956|FG001|Overall Study|Adverse Event|4|||
48763603|NCT02865915|156983955|FG000|Overall Study|Lost to Follow-up|0|||
48763604|NCT02865915|156983956|FG001|Overall Study|Lost to Follow-up|1|||
48689127|NCT02796677|156713454|FG001|Overall Study|Adverse Event|22|||
48689128|NCT02796677|156713455|FG002|Overall Study|Adverse Event|14|||
48689129|NCT02796677|156713456|FG003|Overall Study|Adverse Event|14|||
48689130|NCT02796677|156713453|FG000|Overall Study|Protocol Violation|7|||
48689131|NCT02796677|156713454|FG001|Overall Study|Protocol Violation|5|||
48689132|NCT02796677|156713455|FG002|Overall Study|Protocol Violation|4|||
48689133|NCT02796677|156713456|FG003|Overall Study|Protocol Violation|8|||
48689134|NCT02796677|156713453|FG000|Overall Study|Lost to Follow-up|1|||
48689135|NCT02796677|156713454|FG001|Overall Study|Lost to Follow-up|5|||
48689136|NCT02796677|156713455|FG002|Overall Study|Lost to Follow-up|2|||
48689137|NCT02796677|156713456|FG003|Overall Study|Lost to Follow-up|2|||
48689138|NCT02796677|156713453|FG000|Overall Study|Lack of Efficacy|7|||
48689139|NCT02796677|156713454|FG001|Overall Study|Lack of Efficacy|9|||
48689140|NCT02796677|156713455|FG002|Overall Study|Lack of Efficacy|14|||
48689141|NCT02796677|156713456|FG003|Overall Study|Lack of Efficacy|20|||
48689142|NCT02796677|156713453|FG000|Overall Study|Withdrawal by Subject|4|||
48689143|NCT02796677|156713454|FG001|Overall Study|Withdrawal by Subject|14|||
48689144|NCT02796677|156713455|FG002|Overall Study|Withdrawal by Subject|6|||
48689145|NCT02796677|156713456|FG003|Overall Study|Withdrawal by Subject|7|||
48689146|NCT02796677|156713453|FG000|Overall Study|Progressive disease|6|||
48689147|NCT02796677|156713454|FG001|Overall Study|Progressive disease|15|||
48689148|NCT02796677|156713455|FG002|Overall Study|Progressive disease|13|||
48689149|NCT02796677|156713456|FG003|Overall Study|Progressive disease|18|||
48689150|NCT02796677|156713453|FG000|Overall Study|Reason not mentioned|2|||
48689151|NCT02796677|156713454|FG001|Overall Study|Reason not mentioned|3|||
48689152|NCT02796677|156713455|FG002|Overall Study|Reason not mentioned|0|||
48689153|NCT02796677|156713456|FG003|Overall Study|Reason not mentioned|5|||
48689154|NCT04024891|156713462|FG000|Overall Study|Pregnancy|0|||
48689155|NCT04024891|156713463|FG001|Overall Study|Pregnancy|1|||
48689156|NCT00496015|156713464|FG000|Overall Study|Other|1|||
48689157|NCT00496015|156713465|FG001|Overall Study|Other|0|||
48689158|NCT00496015|156713466|FG002|Overall Study|Other|0|||
48689159|NCT00496015|156713467|FG003|Overall Study|Other|1|||
48689160|NCT00496015|156713468|FG004|Overall Study|Other|0|||
48689161|NCT02587520|156713469|FG000|Overall Study|Protocol Violation|2|||
48689162|NCT02587520|156713470|FG001|Overall Study|Protocol Violation|0|||
48689163|NCT02587520|156713471|FG002|Overall Study|Protocol Violation|0|||
48689164|NCT02587520|156713472|FG003|Overall Study|Protocol Violation|2|||
48689165|NCT02587520|156713473|FG004|Overall Study|Protocol Violation|0|||
48689166|NCT02587520|156713474|FG005|Overall Study|Protocol Violation|1|||
48689167|NCT02587520|156713475|FG006|Overall Study|Protocol Violation|1|||
48689168|NCT02587520|156713476|FG007|Overall Study|Protocol Violation|1|||
48689169|NCT02587520|156713477|FG008|Overall Study|Protocol Violation|3|||
48689170|NCT02587520|156713478|FG009|Overall Study|Protocol Violation|3|||
48689171|NCT02587520|156713479|FG010|Overall Study|Protocol Violation|1|||
48689172|NCT02587520|156713480|FG011|Overall Study|Protocol Violation|2|||
48689173|NCT02587520|156713481|FG012|Overall Study|Protocol Violation|0|||
48689174|NCT02587520|156713482|FG013|Overall Study|Protocol Violation|0|||
48689175|NCT02587520|156713483|FG014|Overall Study|Protocol Violation|0|||
48689176|NCT02587520|156713484|FG015|Overall Study|Protocol Violation|0|||
48689177|NCT02587520|156713485|FG016|Overall Study|Protocol Violation|0|||
48689178|NCT02587520|156713486|FG017|Overall Study|Protocol Violation|0|||
48689179|NCT02587520|156713469|FG000|Overall Study|Adverse Event|0|||
48689180|NCT02587520|156713470|FG001|Overall Study|Adverse Event|0|||
48689181|NCT02587520|156713471|FG002|Overall Study|Adverse Event|0|||
48689182|NCT02587520|156713472|FG003|Overall Study|Adverse Event|0|||
48689183|NCT02587520|156713473|FG004|Overall Study|Adverse Event|0|||
48689184|NCT02587520|156713474|FG005|Overall Study|Adverse Event|0|||
48689185|NCT02587520|156713475|FG006|Overall Study|Adverse Event|0|||
48689186|NCT02587520|156713476|FG007|Overall Study|Adverse Event|0|||
48689187|NCT02587520|156713477|FG008|Overall Study|Adverse Event|0|||
48689188|NCT02587520|156713478|FG009|Overall Study|Adverse Event|0|||
48689189|NCT02587520|156713479|FG010|Overall Study|Adverse Event|0|||
48763605|NCT02865915|156983955|FG000|Overall Study|Protocol Violation|0|||
48763606|NCT02865915|156983956|FG001|Overall Study|Protocol Violation|1|||
48763607|NCT02865915|156983955|FG000|Overall Study|Study terminated by sponsor|23|||
48763608|NCT02865915|156983956|FG001|Overall Study|Study terminated by sponsor|18|||
48763609|NCT02865915|156983955|FG000|Overall Study|Dosing group discontinued|0|||
48763610|NCT02865915|156983956|FG001|Overall Study|Dosing group discontinued|5|||
48689190|NCT02587520|156713480|FG011|Overall Study|Adverse Event|1|||
48689191|NCT02587520|156713481|FG012|Overall Study|Adverse Event|0|||
48689192|NCT02587520|156713482|FG013|Overall Study|Adverse Event|0|||
48689193|NCT02587520|156713483|FG014|Overall Study|Adverse Event|0|||
48689194|NCT02587520|156713484|FG015|Overall Study|Adverse Event|0|||
48689195|NCT02587520|156713485|FG016|Overall Study|Adverse Event|0|||
48689196|NCT02587520|156713486|FG017|Overall Study|Adverse Event|0|||
48689197|NCT02587520|156713469|FG000|Overall Study|Withdrawal by Subject|0|||
48689198|NCT02587520|156713470|FG001|Overall Study|Withdrawal by Subject|0|||
48689199|NCT02587520|156713471|FG002|Overall Study|Withdrawal by Subject|1|||
48689200|NCT02587520|156713472|FG003|Overall Study|Withdrawal by Subject|1|||
48689201|NCT02587520|156713473|FG004|Overall Study|Withdrawal by Subject|0|||
48763611|NCT00615056|156983960|FG000|Overall Study|Death|31|||
48763612|NCT00615056|156983961|FG001|Overall Study|Death|31|||
48689202|NCT02587520|156713474|FG005|Overall Study|Withdrawal by Subject|1|||
48763613|NCT00615056|156983962|FG002|Overall Study|Death|21|||
48689203|NCT02587520|156713475|FG006|Overall Study|Withdrawal by Subject|1|||
48689204|NCT02587520|156713476|FG007|Overall Study|Withdrawal by Subject|0|||
48689205|NCT02587520|156713477|FG008|Overall Study|Withdrawal by Subject|0|||
48689206|NCT02587520|156713478|FG009|Overall Study|Withdrawal by Subject|0|||
48689207|NCT02587520|156713479|FG010|Overall Study|Withdrawal by Subject|0|||
48689208|NCT02587520|156713480|FG011|Overall Study|Withdrawal by Subject|0|||
48689209|NCT02587520|156713481|FG012|Overall Study|Withdrawal by Subject|0|||
48689210|NCT02587520|156713482|FG013|Overall Study|Withdrawal by Subject|1|||
48689211|NCT02587520|156713483|FG014|Overall Study|Withdrawal by Subject|0|||
48689212|NCT02587520|156713484|FG015|Overall Study|Withdrawal by Subject|0|||
48689213|NCT02587520|156713485|FG016|Overall Study|Withdrawal by Subject|0|||
48689214|NCT02587520|156713486|FG017|Overall Study|Withdrawal by Subject|0|||
48689215|NCT02587520|156713469|FG000|Overall Study|Lost to Follow-up|0|||
48689216|NCT02587520|156713470|FG001|Overall Study|Lost to Follow-up|2|||
48689217|NCT02587520|156713471|FG002|Overall Study|Lost to Follow-up|0|||
48689218|NCT02587520|156713472|FG003|Overall Study|Lost to Follow-up|2|||
48689219|NCT02587520|156713473|FG004|Overall Study|Lost to Follow-up|0|||
48689220|NCT02587520|156713474|FG005|Overall Study|Lost to Follow-up|1|||
48689221|NCT02587520|156713475|FG006|Overall Study|Lost to Follow-up|1|||
48689222|NCT02587520|156713476|FG007|Overall Study|Lost to Follow-up|1|||
48689223|NCT02587520|156713477|FG008|Overall Study|Lost to Follow-up|0|||
48689224|NCT02587520|156713478|FG009|Overall Study|Lost to Follow-up|2|||
48689225|NCT02587520|156713479|FG010|Overall Study|Lost to Follow-up|2|||
48689226|NCT02587520|156713480|FG011|Overall Study|Lost to Follow-up|1|||
48689227|NCT02587520|156713481|FG012|Overall Study|Lost to Follow-up|0|||
48689228|NCT02587520|156713482|FG013|Overall Study|Lost to Follow-up|0|||
48689229|NCT02587520|156713483|FG014|Overall Study|Lost to Follow-up|0|||
48689230|NCT02587520|156713484|FG015|Overall Study|Lost to Follow-up|0|||
48689231|NCT02587520|156713485|FG016|Overall Study|Lost to Follow-up|0|||
48689232|NCT02587520|156713486|FG017|Overall Study|Lost to Follow-up|0|||
48689233|NCT00527735|156713487|FG000|Overall Study|Disease progression|47|||
48689234|NCT00527735|156713488|FG001|Overall Study|Disease progression|61|||
48689235|NCT00527735|156713489|FG002|Overall Study|Disease progression|53|||
48689236|NCT00527735|156713487|FG000|Overall Study|Death|23|||
48689237|NCT00527735|156713488|FG001|Overall Study|Death|13|||
48689238|NCT00527735|156713489|FG002|Overall Study|Death|15|||
48689239|NCT00527735|156713487|FG000|Overall Study|Completed treatment in treatment phase|14|||
48689240|NCT00527735|156713488|FG001|Overall Study|Completed treatment in treatment phase|13|||
48689241|NCT00527735|156713489|FG002|Overall Study|Completed treatment in treatment phase|18|||
48689242|NCT00527735|156713487|FG000|Overall Study|Adverse Event|10|||
48689243|NCT00527735|156713488|FG001|Overall Study|Adverse Event|6|||
48689244|NCT00527735|156713489|FG002|Overall Study|Adverse Event|7|||
48689245|NCT00527735|156713487|FG000|Overall Study|Not identified|5|||
48689246|NCT00527735|156713488|FG001|Overall Study|Not identified|5|||
48689247|NCT00527735|156713489|FG002|Overall Study|Not identified|5|||
48689248|NCT00527735|156713487|FG000|Overall Study|Withdrawal by Subject|5|||
48689249|NCT00527735|156713488|FG001|Overall Study|Withdrawal by Subject|4|||
48689250|NCT00527735|156713489|FG002|Overall Study|Withdrawal by Subject|3|||
48689251|NCT00527735|156713487|FG000|Overall Study|No longer met study criteria|2|||
48689252|NCT00527735|156713488|FG001|Overall Study|No longer met study criteria|2|||
48689253|NCT00527735|156713489|FG002|Overall Study|No longer met study criteria|1|||
48689254|NCT00527735|156713487|FG000|Overall Study|Lost to Follow-up|0|||
48689255|NCT00527735|156713488|FG001|Overall Study|Lost to Follow-up|0|||
48689256|NCT00527735|156713489|FG002|Overall Study|Lost to Follow-up|3|||
48689257|NCT00527735|156713487|FG000|Overall Study|Poor compliance or noncompliance|0|||
48689258|NCT00527735|156713488|FG001|Overall Study|Poor compliance or noncompliance|1|||
48689259|NCT00527735|156713489|FG002|Overall Study|Poor compliance or noncompliance|1|||
48689260|NCT00527735|156713487|FG000|Overall Study|Completed treatment during maintenance|2|||
48689261|NCT00527735|156713488|FG001|Overall Study|Completed treatment during maintenance|2|||
48689262|NCT00527735|156713489|FG002|Overall Study|Completed treatment during maintenance|1|||
48689263|NCT02210000|156713490|FG000|Overall Study|Study Terminated|11|||
48689264|NCT02210000|156713491|FG001|Overall Study|Study Terminated|12|||
48689265|NCT02210000|156713490|FG000|Overall Study|Withdrawal by Subject|7|||
48689266|NCT02210000|156713491|FG001|Overall Study|Withdrawal by Subject|1|||
48689267|NCT02210000|156713490|FG000|Overall Study|Adverse Event|1|||
48689268|NCT02210000|156713491|FG001|Overall Study|Adverse Event|5|||
48689269|NCT02210000|156713490|FG000|Overall Study|Lost to Follow-up|0|||
48689270|NCT02210000|156713491|FG001|Overall Study|Lost to Follow-up|2|||
48689271|NCT02210000|156713490|FG000|Overall Study|Physician Decision|0|||
48689272|NCT02210000|156713491|FG001|Overall Study|Physician Decision|1|||
48689273|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
48689274|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48689275|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48689276|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48689277|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
48689278|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
48689279|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48689280|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48689281|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48355367|NCT00250432|155497281|FG001|Overall Study|Patient Moved|1|||
48355368|NCT00250432|155497280|FG000|Overall Study|Protocol Violation|0|||
48355369|NCT00250432|155497281|FG001|Overall Study|Protocol Violation|3|||
48689282|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
48689283|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
48689284|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48689285|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48689286|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48689287|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
48689288|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
48689289|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48689290|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48689291|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48689292|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
48689293|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
48689294|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48689295|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48689296|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48689297|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
48689298|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
48689299|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48689300|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48689301|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48689302|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
48689303|NCT01173601|156713494|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
48689304|NCT01173601|156713495|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48689305|NCT01173601|156713496|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48689306|NCT01173601|156713497|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48689307|NCT01173601|156713498|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
48689308|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
48689309|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
48689310|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
48689311|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
48689312|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
48689313|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
48355370|NCT00250432|155497280|FG000|Overall Study|Withdrawal by Subject|6|||
48355371|NCT00250432|155497281|FG001|Overall Study|Withdrawal by Subject|2|||
48355372|NCT00250432|155497280|FG000|Overall Study|Pt died out of posttherapy report period|6|||
48355373|NCT00250432|155497281|FG001|Overall Study|Pt died out of posttherapy report period|5|||
48689314|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
48689315|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
48689316|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
48689317|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
48689318|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
48689319|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
48689320|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
48689321|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
48689322|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
48689323|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48689324|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
48689325|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
48689326|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
48689327|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
48689328|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
48689329|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
48689330|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48689331|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
48689332|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
48689333|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
48689334|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
48689335|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
48689336|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
48692820|NCT03040141|156724616|FG002|Overall Study|Death|3|||
48392563|NCT01843842|155631897|FG000|Overall Study|Do not meet inclusion criteria|1|||
48392564|NCT01843842|155631898|FG001|Overall Study|Do not meet inclusion criteria|1|||
48392565|NCT01671111|155631899|FG000|Overall Study|Adverse Event|2|||
48392566|NCT01671111|155631899|FG000|Overall Study|Lack of Efficacy|1|||
48392567|NCT01671111|155631899|FG000|Overall Study|Withdrawal by Subject|2|||
48392568|NCT01671111|155631899|FG000|Overall Study|Physician Decision|1|||
48392569|NCT01671111|155631899|FG000|Overall Study|Other|24|||
48392570|NCT02953340|155631900|FG000|Overall Study|Death|0|||
48392571|NCT02953340|155631901|FG001|Overall Study|Death|1|||
48392572|NCT02953340|155631900|FG000|Overall Study|Investigator Decision|3|||
48392573|NCT02953340|155631901|FG001|Overall Study|Investigator Decision|3|||
48392574|NCT02953340|155631900|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
48689337|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
48689338|NCT01173601|156713494|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48689339|NCT01173601|156713495|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48689340|NCT01173601|156713496|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
48689341|NCT01173601|156713497|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
48689342|NCT01173601|156713498|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
48689343|NCT01410890|156713499|FG000|Overall Study|Withdrawal by Subject|0|||
48689344|NCT01410890|156713500|FG001|Overall Study|Withdrawal by Subject|1|||
48689345|NCT00217425|156713502|FG000|Overall Study|Never started treatment|2|||
48689346|NCT00217425|156713502|FG000|Overall Study|Patient ineligible|5|||
48689347|NCT00217425|156713502|FG000|Overall Study|Lack of Efficacy|13|||
48689348|NCT00217425|156713502|FG000|Overall Study|Adverse Event|8|||
48689349|NCT00217425|156713502|FG000|Overall Study|Withdrawal by Subject|4|||
48689350|NCT00217425|156713502|FG000|Overall Study|Other complicating disease|1|||
48689351|NCT00217425|156713502|FG000|Overall Study|Other|4|||
48689352|NCT01121146|156713503|FG000|Overall Study|Death|17|||
48689353|NCT01121146|156713504|FG001|Overall Study|Death|15|||
48689354|NCT01121146|156713503|FG000|Overall Study|Adverse Event|2|||
48689355|NCT01121146|156713504|FG001|Overall Study|Adverse Event|11|||
48689356|NCT01121146|156713503|FG000|Overall Study|Lost to Follow-up|7|||
48689357|NCT01121146|156713504|FG001|Overall Study|Lost to Follow-up|16|||
48689358|NCT00791388|156713505|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
48689359|NCT00791388|156713506|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
48689360|NCT00791388|156713507|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
48689361|NCT00791388|156713508|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
48689362|NCT00791388|156713509|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
48689363|NCT00791388|156713505|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
48689364|NCT00791388|156713506|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
48689365|NCT00791388|156713507|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
48689366|NCT00791388|156713508|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
48689367|NCT00791388|156713509|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
48689368|NCT00791388|156713505|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
48392575|NCT02953340|155631901|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
48392576|NCT02953340|155631900|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
48392577|NCT02953340|155631901|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
48392578|NCT02953340|155631900|FG000|Overall Study|Withdrawal by Subject|9|||
48392579|NCT02953340|155631901|FG001|Overall Study|Withdrawal by Subject|9|||
48392580|NCT02953340|155631900|FG000|Overall Study|Sponsor decision|0|||
48392581|NCT02953340|155631901|FG001|Overall Study|Sponsor decision|2|||
48392582|NCT02953340|155631900|FG000|Overall Study|Lost to Follow-up|3|||
48392583|NCT02953340|155631901|FG001|Overall Study|Lost to Follow-up|2|||
48392584|NCT02953340|155631900|FG000|Overall Study|Reason not specified|2|||
48392585|NCT02953340|155631901|FG001|Overall Study|Reason not specified|2|||
48392586|NCT00433914|155631902|FG000|Overall Study|Withdrawal by Subject|0|||
48689369|NCT00791388|156713506|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
48689370|NCT00791388|156713507|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
48689371|NCT00791388|156713508|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
48689372|NCT00791388|156713509|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
48689373|NCT03431441|156713510|FG000|Overall Study|Withdrawal by Subject|2|||
48689374|NCT03431441|156713510|FG000|Overall Study|Adverse Event|2|||
48689375|NCT03431441|156713510|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
48689376|NCT00330759|156713511|FG000|Overall Study|Death|316|||
48689377|NCT00330759|156713512|FG001|Overall Study|Death|310|||
48689378|NCT00330759|156713511|FG000|Overall Study|Disease progression|104|||
48689379|NCT00330759|156713512|FG001|Overall Study|Disease progression|126|||
48392587|NCT00433914|155631903|FG001|Overall Study|Withdrawal by Subject|2|||
48392588|NCT00433914|155631902|FG000|Overall Study|Lost to Follow-up|0|||
48392589|NCT00433914|155631903|FG001|Overall Study|Lost to Follow-up|1|||
48392590|NCT00928889|155631905|FG000|Overall Study|Lost to Follow-up|3|||
48392591|NCT00928889|155631906|FG001|Overall Study|Lost to Follow-up|1|||
48392592|NCT00928889|155631905|FG000|Overall Study|Protocol Violation|0|||
48392593|NCT00928889|155631906|FG001|Overall Study|Protocol Violation|1|||
48392594|NCT00928889|155631905|FG000|Overall Study|Adverse Event|1|||
48392595|NCT00928889|155631906|FG001|Overall Study|Adverse Event|0|||
48392596|NCT00928889|155631905|FG000|Overall Study|Other|1|||
48392597|NCT00928889|155631906|FG001|Overall Study|Other|0|||
48392598|NCT00632099|155631907|FG000|Overall Study|Lost to Follow-up|3|||
48392599|NCT00632099|155631908|FG001|Overall Study|Lost to Follow-up|3|||
48392600|NCT00530270|155631909|FG000|Overall Study|Protocol Violation|1|||
48392601|NCT00530270|155631910|FG001|Overall Study|Protocol Violation|0|||
48392602|NCT02343159|155631914|FG000|Overall Study|Early Study Termination|16|||
48392603|NCT02343159|155631915|FG001|Overall Study|Early Study Termination|19|||
48392604|NCT02343159|155631916|FG002|Overall Study|Early Study Termination|23|||
48392605|NCT02343159|155631914|FG000|Overall Study|Physician Decision|2|||
48392606|NCT02343159|155631915|FG001|Overall Study|Physician Decision|0|||
48392607|NCT02343159|155631916|FG002|Overall Study|Physician Decision|1|||
48392608|NCT02343159|155631914|FG000|Overall Study|Withdrawal by Subject|3|||
48392609|NCT02343159|155631915|FG001|Overall Study|Withdrawal by Subject|0|||
48392610|NCT02343159|155631916|FG002|Overall Study|Withdrawal by Subject|2|||
48392611|NCT02343159|155631914|FG000|Overall Study|Lost to Follow-up|0|||
48392612|NCT02343159|155631915|FG001|Overall Study|Lost to Follow-up|2|||
48392613|NCT02343159|155631916|FG002|Overall Study|Lost to Follow-up|2|||
48392614|NCT02343159|155631914|FG000|Overall Study|Adverse Event|4|||
48392615|NCT02343159|155631915|FG001|Overall Study|Adverse Event|4|||
48392616|NCT02343159|155631916|FG002|Overall Study|Adverse Event|2|||
48392617|NCT02343159|155631914|FG000|Overall Study|Sponsor Decision|0|||
48392618|NCT02343159|155631915|FG001|Overall Study|Sponsor Decision|1|||
48392619|NCT02343159|155631916|FG002|Overall Study|Sponsor Decision|0|||
48392620|NCT02343159|155631914|FG000|Overall Study|Enrollment Error|1|||
48392621|NCT02343159|155631915|FG001|Overall Study|Enrollment Error|0|||
48392622|NCT02343159|155631916|FG002|Overall Study|Enrollment Error|0|||
48392623|NCT02004262|155631917|FG000|Overall Study|Death|67|||
48392624|NCT02004262|155631918|FG001|Overall Study|Death|64|||
48392625|NCT02004262|155631919|FG002|Overall Study|Death|66|||
48392626|NCT02004262|155631920|FG003|Overall Study|Death|28|||
48392627|NCT02004262|155631921|FG004|Overall Study|Death|29|||
48392628|NCT02004262|155631922|FG005|Overall Study|Death|22|||
48392629|NCT02004262|155631917|FG000|Overall Study|Withdrawal by Subject|1|||
48392630|NCT02004262|155631918|FG001|Overall Study|Withdrawal by Subject|0|||
48392631|NCT02004262|155631919|FG002|Overall Study|Withdrawal by Subject|4|||
48392632|NCT02004262|155631920|FG003|Overall Study|Withdrawal by Subject|0|||
48392633|NCT02004262|155631921|FG004|Overall Study|Withdrawal by Subject|1|||
48392634|NCT02004262|155631922|FG005|Overall Study|Withdrawal by Subject|3|||
48392635|NCT02004262|155631917|FG000|Overall Study|Lost to Follow-up|1|||
48392636|NCT02004262|155631918|FG001|Overall Study|Lost to Follow-up|1|||
48392637|NCT02004262|155631919|FG002|Overall Study|Lost to Follow-up|0|||
48392638|NCT02004262|155631920|FG003|Overall Study|Lost to Follow-up|0|||
48392639|NCT02004262|155631921|FG004|Overall Study|Lost to Follow-up|0|||
48392640|NCT02004262|155631922|FG005|Overall Study|Lost to Follow-up|0|||
48392641|NCT02004262|155631917|FG000|Overall Study|Study Terminated by Sponsor|4|||
48392642|NCT02004262|155631918|FG001|Overall Study|Study Terminated by Sponsor|3|||
48392643|NCT02004262|155631919|FG002|Overall Study|Study Terminated by Sponsor|2|||
48392644|NCT02004262|155631920|FG003|Overall Study|Study Terminated by Sponsor|1|||
48392645|NCT02004262|155631921|FG004|Overall Study|Study Terminated by Sponsor|1|||
48392646|NCT02004262|155631922|FG005|Overall Study|Study Terminated by Sponsor|5|||
48392647|NCT02311153|155631924|FG000|Overall Study|Lost to Follow-up|5|||
48392648|NCT02311153|155631925|FG001|Overall Study|Lost to Follow-up|7|||
48392649|NCT03374189|155631926|FG000|Overall Study|Lost to Follow-up|1|||
48392650|NCT03374189|155631927|FG001|Overall Study|Lost to Follow-up|0|||
48689380|NCT00330759|156713511|FG000|Overall Study|Withdrawal by Subject|143|||
48392651|NCT04712110|155631928|FG000|Overall Study|Lost to Follow-up|0|||
48392652|NCT04712110|155631929|FG001|Overall Study|Lost to Follow-up|1|||
48392653|NCT04712110|155631928|FG000|Overall Study|Withdrawal by Subject|0|||
48392654|NCT04712110|155631929|FG001|Overall Study|Withdrawal by Subject|4|||
48392655|NCT04712110|155631928|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
48689381|NCT00330759|156713512|FG001|Overall Study|Withdrawal by Subject|124|||
48689382|NCT00330759|156713511|FG000|Overall Study|Adverse Event|48|||
48689383|NCT00330759|156713512|FG001|Overall Study|Adverse Event|36|||
48689384|NCT00330759|156713511|FG000|Overall Study|Participant request|31|||
48689385|NCT00330759|156713512|FG001|Overall Study|Participant request|22|||
48689386|NCT00330759|156713511|FG000|Overall Study|Lost to Follow-up|16|||
48689387|NCT00330759|156713512|FG001|Overall Study|Lost to Follow-up|22|||
48689388|NCT00330759|156713511|FG000|Overall Study|Noncompliance|15|||
48689389|NCT00330759|156713512|FG001|Overall Study|Noncompliance|17|||
48689390|NCT00330759|156713511|FG000|Overall Study|Physician Decision|1|||
48392656|NCT04712110|155631929|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
48392657|NCT03201458|155631932|FG000|Overall Study|No longer eligible|2|||
48392658|NCT03201458|155631933|FG001|Overall Study|No longer eligible|5|||
48392659|NCT03201458|155631932|FG000|Overall Study|Health event before starting|1|||
48392660|NCT03201458|155631933|FG001|Overall Study|Health event before starting|0|||
48689391|NCT00330759|156713512|FG001|Overall Study|Physician Decision|2|||
48689392|NCT00330759|156713511|FG000|Overall Study|Protocol deviation|0|||
48689393|NCT00330759|156713512|FG001|Overall Study|Protocol deviation|2|||
48689394|NCT00330759|156713511|FG000|Overall Study|Ineligibility determined|2|||
48689395|NCT00330759|156713512|FG001|Overall Study|Ineligibility determined|1|||
48689396|NCT00330759|156713511|FG000|Overall Study|Other|36|||
48689397|NCT00330759|156713512|FG001|Overall Study|Other|44|||
48689398|NCT00997035|156713518|FG000|3-week Followup Visit|Lost to Follow-up|9|||
48689399|NCT00997035|156713519|FG001|3-week Followup Visit|Lost to Follow-up|6|||
48689400|NCT00997035|156713518|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
48689401|NCT00997035|156713519|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
48689402|NCT02995980|156713526|FG000|Overall Study|Lost to Follow-up|14|||
48689403|NCT02792231|156713534|FG000|Overall Study|Patient/guardian decision|32|||
48689404|NCT02792231|156713535|FG001|Overall Study|Patient/guardian decision|42|||
48689405|NCT02792231|156713534|FG000|Overall Study|Adverse Event|15|||
48689406|NCT02792231|156713535|FG001|Overall Study|Adverse Event|11|||
48689407|NCT02792231|156713534|FG000|Overall Study|Physician Decision|14|||
48689408|NCT02792231|156713535|FG001|Overall Study|Physician Decision|12|||
48689409|NCT02792231|156713534|FG000|Overall Study|Lack of Efficacy|7|||
48689410|NCT02792231|156713535|FG001|Overall Study|Lack of Efficacy|9|||
48689411|NCT02792231|156713534|FG000|Overall Study|Lost to Follow-up|9|||
48689412|NCT02792231|156713535|FG001|Overall Study|Lost to Follow-up|5|||
48689413|NCT02792231|156713534|FG000|Overall Study|Pregnancy|1|||
48689414|NCT02792231|156713535|FG001|Overall Study|Pregnancy|3|||
48689415|NCT02792231|156713534|FG000|Overall Study|Non-compliance with study treatment|2|||
48689416|NCT02792231|156713535|FG001|Overall Study|Non-compliance with study treatment|1|||
48689417|NCT02792231|156713534|FG000|Overall Study|Protocol deviation|2|||
48689418|NCT02792231|156713535|FG001|Overall Study|Protocol deviation|0|||
48689419|NCT02792231|156713534|FG000|Overall Study|Technical problems|0|||
48689420|NCT02792231|156713535|FG001|Overall Study|Technical problems|1|||
48689421|NCT03309878|156713536|FG000|Overall Study|Adverse Event|1|||
48689422|NCT03309878|156713537|FG001|Overall Study|Adverse Event|0|||
48689423|NCT03309878|156713538|FG002|Overall Study|Adverse Event|0|||
48689424|NCT03309878|156713539|FG003|Overall Study|Adverse Event|0|||
48689425|NCT03309878|156713536|FG000|Overall Study|Did not maintain eligibility|2|||
48689426|NCT03309878|156713537|FG001|Overall Study|Did not maintain eligibility|1|||
48689427|NCT03309878|156713538|FG002|Overall Study|Did not maintain eligibility|0|||
48689428|NCT03309878|156713539|FG003|Overall Study|Did not maintain eligibility|0|||
48689429|NCT03309878|156713536|FG000|Overall Study|Withdrawal by Subject|0|||
48689430|NCT03309878|156713537|FG001|Overall Study|Withdrawal by Subject|1|||
48689431|NCT03309878|156713538|FG002|Overall Study|Withdrawal by Subject|0|||
48689432|NCT03309878|156713539|FG003|Overall Study|Withdrawal by Subject|0|||
48689433|NCT01096316|156713540|FG000|Overall Study|Lost to Follow-up|15|||
48689434|NCT01096316|156713541|FG001|Overall Study|Lost to Follow-up|9|||
48763614|NCT00615056|156983963|FG003|Overall Study|Death|23|||
48763615|NCT00615056|156983960|FG000|Overall Study|Lost to Follow-up|1|||
48763616|NCT00615056|156983961|FG001|Overall Study|Lost to Follow-up|2|||
48392661|NCT03201458|155631932|FG000|Overall Study|Physician Decision|1|||
48392662|NCT03201458|155631933|FG001|Overall Study|Physician Decision|0|||
48392663|NCT03962101|155631938|FG000|Overall Study|Adverse Event|1|||
48392664|NCT03962101|155631938|FG000|Overall Study|Physician Decision|2|||
48392665|NCT03962101|155631938|FG000|Overall Study|Not related to medical events|1|||
48392666|NCT00930761|155631939|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
48392667|NCT00930761|155631940|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
48392668|NCT00930761|155631939|FG000|Overall Study|less than 3 music therapy sessions|0|||
48392669|NCT00930761|155631940|FG001|Overall Study|less than 3 music therapy sessions|3|||
48392670|NCT00271596|155631948|FG000|Overall Study|Protocol Violation|1|||
48392671|NCT00271596|155631949|FG001|Overall Study|Protocol Violation|0|||
48392672|NCT00271596|155631948|FG000|Overall Study|Withdrawal by Subject|0|||
48689435|NCT00248495|156713543|FG000|Overall Study|Withdrawal by Subject|1|||
48689436|NCT00619515|156713545|FG000|Overall Study|Study Termination by IRB|73|||
48689437|NCT00836589|156713550|FG000|Overall Study|Lost to Follow-up|246|||
48689438|NCT00836589|156713550|FG000|Overall Study|Death|429|||
48689439|NCT00836589|156713550|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
48689440|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
48392673|NCT00271596|155631949|FG001|Overall Study|Withdrawal by Subject|1|||
48689441|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
48689442|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Death|1|||
48689443|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Death|2|||
48689444|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
48689445|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
48689446|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
48426298|NCT00064662|155749536|FG001|Overall Study|Death|1|||
48689447|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
48689448|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
48763617|NCT00615056|156983962|FG002|Overall Study|Lost to Follow-up|4|||
48763618|NCT00615056|156983963|FG003|Overall Study|Lost to Follow-up|5|||
48689449|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
48689450|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
48689451|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
48689452|NCT01794000|156713551|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
48689453|NCT01794000|156713552|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
48689454|NCT01794000|156713551|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
48689455|NCT01794000|156713552|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
48689456|NCT04033367|156713555|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
48689457|NCT04033367|156713556|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
48689458|NCT04033367|156713555|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
48689459|NCT04033367|156713556|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
48689460|NCT04033367|156713555|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
48689461|NCT04033367|156713556|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
48689462|NCT04033367|156713555|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
48689463|NCT04033367|156713556|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
48689464|NCT04537793|156713557|FG000|Part B (24 Weeks)|Adverse Event|0|||
48689465|NCT04537793|156713558|FG001|Part B (24 Weeks)|Adverse Event|1|||
48689466|NCT01255423|156713559|FG000|Overall Study|Abnormal Laboratory value|3|||
48689467|NCT01255423|156713560|FG001|Overall Study|Abnormal Laboratory value|2|||
48689468|NCT01255423|156713559|FG000|Overall Study|Use of prohibited medications|0|||
48689469|NCT01255423|156713560|FG001|Overall Study|Use of prohibited medications|1|||
48689470|NCT05470387|156713561|FG000|Overall Study|Protocol Violation|0|||
48689471|NCT05470387|156713562|FG001|Overall Study|Protocol Violation|3|||
48689472|NCT00231777|156713563|FG000|Overall Study|Lost to Follow-up|3|||
48689473|NCT00231777|156713564|FG001|Overall Study|Lost to Follow-up|0|||
48689474|NCT00231777|156713563|FG000|Overall Study|Other|3|||
48689475|NCT00231777|156713564|FG001|Overall Study|Other|2|||
48689476|NCT05280717|156713566|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
48689477|NCT05280717|156713567|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
48689478|NCT05280717|156713568|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
48689479|NCT05280717|156713569|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
48689480|NCT05280717|156713570|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
48689481|NCT05280717|156713571|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
48689482|NCT05280717|156713572|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
48689483|NCT05280717|156713566|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
48689484|NCT05280717|156713567|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689485|NCT05280717|156713568|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689486|NCT05280717|156713569|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689487|NCT05280717|156713570|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689488|NCT05280717|156713571|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689489|NCT05280717|156713572|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
48689490|NCT05280717|156713566|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689491|NCT05280717|156713567|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
48689492|NCT05280717|156713568|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689493|NCT05280717|156713569|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689494|NCT05280717|156713570|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689495|NCT05280717|156713571|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689496|NCT05280717|156713572|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
48689497|NCT05280717|156713566|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689498|NCT05280717|156713567|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689499|NCT05280717|156713568|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
48689500|NCT05280717|156713569|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689501|NCT05280717|156713570|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689502|NCT05280717|156713571|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689503|NCT05280717|156713572|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
48689504|NCT05280717|156713566|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689505|NCT05280717|156713567|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689506|NCT05280717|156713568|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689507|NCT05280717|156713569|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689508|NCT05280717|156713570|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689509|NCT05280717|156713571|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
48689510|NCT05280717|156713572|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
48689511|NCT05280717|156713566|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689512|NCT05280717|156713567|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48763619|NCT00615056|156983960|FG000|Overall Study|Other|13|||
48392674|NCT00794677|155631954|FG000|First Intervention|Withdrawal by Subject|2|||
48392675|NCT00794677|155631955|FG001|First Intervention|Withdrawal by Subject|0|||
48392676|NCT01744665|155631960|FG000|Monitoring Phase|Adverse Event|4|||
48392677|NCT01744665|155631960|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
48392678|NCT01744665|155631960|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
48392679|NCT01744665|155631960|FG000|Monitoring Phase|Withdrawal by Subject|5|||
48392680|NCT01744665|155631960|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
48689513|NCT05280717|156713568|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689514|NCT05280717|156713569|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689515|NCT05280717|156713570|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689516|NCT05280717|156713571|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
48689517|NCT05280717|156713572|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
48689518|NCT00657046|156713573|FG000|Overall Study|Adverse Event|1|||
48392681|NCT01744665|155631960|FG000|Consolidation Phase|Adverse Event|2|||
48689519|NCT00657046|156713574|FG001|Overall Study|Adverse Event|1|||
48689520|NCT00657046|156713575|FG002|Overall Study|Adverse Event|0|||
48689521|NCT00657046|156713573|FG000|Overall Study|Protocol Violation|2|||
48689522|NCT00657046|156713574|FG001|Overall Study|Protocol Violation|2|||
48689523|NCT00657046|156713575|FG002|Overall Study|Protocol Violation|0|||
48689524|NCT00657046|156713573|FG000|Overall Study|Withdrawal by Subject|1|||
48689525|NCT00657046|156713574|FG001|Overall Study|Withdrawal by Subject|0|||
48689526|NCT00657046|156713575|FG002|Overall Study|Withdrawal by Subject|0|||
48689527|NCT00657046|156713573|FG000|Overall Study|Death|0|||
48689528|NCT00657046|156713574|FG001|Overall Study|Death|0|||
48689529|NCT00657046|156713575|FG002|Overall Study|Death|1|||
48689530|NCT00657046|156713573|FG000|Overall Study|Surgery|0|||
48689531|NCT00657046|156713574|FG001|Overall Study|Surgery|0|||
48689532|NCT00657046|156713575|FG002|Overall Study|Surgery|1|||
48689533|NCT02525471|156713585|FG000|Overall Study|Screen Failure|6|||
48689534|NCT02525471|156713585|FG000|Overall Study|Withdrawal by Subject|4|||
48689535|NCT02525471|156713585|FG000|Overall Study|Death|1|||
48689536|NCT00844376|156713590|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
48689537|NCT00844376|156713591|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
48689538|NCT01392547|156715481|FG000|Overall Study|Adverse Event|2|||
48689539|NCT01392547|156715481|FG000|Overall Study|Non-compliance|2|||
48689540|NCT01392547|156715481|FG000|Overall Study|Withdrawal criteria|3|||
48689541|NCT01392547|156715481|FG000|Overall Study|Unclassified|1|||
48689542|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
48689543|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
48689544|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
48689545|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
48689546|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
48689547|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
48689548|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
48689549|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
48689550|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
48689551|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
48689552|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
48689553|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
48689554|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
48689555|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
48689556|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
48689557|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
48689558|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
48689559|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
48689560|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
48689561|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
48689562|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
48689563|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
48689564|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
48689565|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
48689566|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
48689567|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
48689568|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
48689569|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
48689570|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
48689571|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
48689572|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
48392682|NCT01744665|155631960|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
48689573|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
48689574|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
48689575|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
48689576|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
48689577|NCT02831764|156715482|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
48689578|NCT02831764|156715483|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
48689579|NCT02831764|156715484|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
48763620|NCT00615056|156983961|FG001|Overall Study|Other|15|||
48763621|NCT00615056|156983962|FG002|Overall Study|Other|10|||
48763622|NCT00615056|156983963|FG003|Overall Study|Other|7|||
48763623|NCT00615056|156983960|FG000|Overall Study|Objective progression or relapse|0|||
48763624|NCT00615056|156983961|FG001|Overall Study|Objective progression or relapse|2|||
48763625|NCT00615056|156983962|FG002|Overall Study|Objective progression or relapse|0|||
48763626|NCT00615056|156983963|FG003|Overall Study|Objective progression or relapse|0|||
48763627|NCT00615056|156983960|FG000|Overall Study|Withdrawal by Subject|0|||
48763628|NCT00615056|156983961|FG001|Overall Study|Withdrawal by Subject|1|||
48763629|NCT00615056|156983962|FG002|Overall Study|Withdrawal by Subject|1|||
48763630|NCT00615056|156983963|FG003|Overall Study|Withdrawal by Subject|0|||
48763631|NCT00615056|156983960|FG000|Overall Study|Discontinued by Sponsor|1|||
48763632|NCT00615056|156983961|FG001|Overall Study|Discontinued by Sponsor|0|||
48763633|NCT00615056|156983962|FG002|Overall Study|Discontinued by Sponsor|0|||
48763634|NCT00615056|156983963|FG003|Overall Study|Discontinued by Sponsor|0|||
48763635|NCT00615056|156983960|FG000|Overall Study|Randomized but not treated|3|||
48763636|NCT00615056|156983961|FG001|Overall Study|Randomized but not treated|0|||
48763637|NCT00615056|156983962|FG002|Overall Study|Randomized but not treated|0|||
48763638|NCT00615056|156983963|FG003|Overall Study|Randomized but not treated|0|||
48763639|NCT02276612|156983966|FG000|Overall Study|Death|1|||
48763640|NCT02276612|156983967|FG001|Overall Study|Death|0|||
48763641|NCT02276612|156983966|FG000|Overall Study|Pregnancy|1|||
48763642|NCT02276612|156983967|FG001|Overall Study|Pregnancy|0|||
48763643|NCT02276612|156983966|FG000|Overall Study|Withdrew Consent|1|||
48763644|NCT02276612|156983967|FG001|Overall Study|Withdrew Consent|0|||
48689580|NCT02831764|156715485|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
48689581|NCT02831764|156715486|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
48689582|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48689583|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48689584|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
48689585|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
48689586|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48689587|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48689588|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48689589|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
48763645|NCT02276612|156983966|FG000|Overall Study|Lost to Follow-up|1|||
48763646|NCT02276612|156983967|FG001|Overall Study|Lost to Follow-up|0|||
48763647|NCT04327986|156983968|FG000|Overall Study|Physician Decision|2|||
48763648|NCT04327986|156983969|FG001|Overall Study|Physician Decision|0|||
48763649|NCT04327986|156983970|FG002|Overall Study|Physician Decision|0|||
48763650|NCT04327986|156983968|FG000|Overall Study|Death|1|||
48689590|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48689591|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48689592|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48689593|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48689594|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
48689595|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
48689596|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48689597|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
48689598|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
48689599|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
48689600|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
48689601|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
48689602|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48689603|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48689604|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
48689605|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
48689606|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48689607|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48689608|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48689609|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
48689610|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
48689611|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48689612|NCT02831764|156715482|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48689613|NCT02831764|156715483|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48689614|NCT02831764|156715484|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
48689615|NCT02831764|156715485|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
48689616|NCT02831764|156715486|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48689617|NCT02831764|156715482|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48689618|NCT02831764|156715483|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48689619|NCT02831764|156715484|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48689620|NCT02831764|156715485|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48689621|NCT02831764|156715486|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
48689622|NCT02831764|156715482|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48689623|NCT02831764|156715483|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48689624|NCT02831764|156715484|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48689625|NCT02831764|156715485|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48689626|NCT02831764|156715486|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
48689627|NCT02831764|156715482|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48689628|NCT02831764|156715483|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48689629|NCT02831764|156715484|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48689630|NCT02831764|156715485|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48689631|NCT02831764|156715486|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
48689632|NCT02831764|156715482|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48689633|NCT02831764|156715483|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48689634|NCT02831764|156715484|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48689635|NCT02831764|156715485|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48689636|NCT02831764|156715486|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
48689637|NCT01045967|156715487|FG000|Second Intervention|Protocol Violation|0|||
48689638|NCT01045967|156715488|FG001|Second Intervention|Protocol Violation|1|||
48689639|NCT06308822|156715491|FG000|Overall Study|Mutation Status Not Confirmed|17|||
48689640|NCT06308822|156715491|FG000|Overall Study|Adverse Event|1|||
48689641|NCT06308822|156715491|FG000|Overall Study|Death|5|||
48689642|NCT06308822|156715491|FG000|Overall Study|Disease progression|8|||
48689643|NCT06308822|156715491|FG000|Overall Study|Withdrawal by Subject|1|||
48689644|NCT06308822|156715491|FG000|Overall Study|Physician Decision|3|||
48689645|NCT03007966|156715492|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
48763651|NCT04327986|156983969|FG001|Overall Study|Death|0|||
48763652|NCT04327986|156983970|FG002|Overall Study|Death|0|||
48763653|NCT00834912|156983971|FG000|Treatment Period 1|Adverse Event|0|||
48763654|NCT00834912|156983972|FG001|Treatment Period 1|Adverse Event|1|||
48763655|NCT00834912|156983973|FG002|Treatment Period 1|Adverse Event|0|||
48763656|NCT00834912|156983974|FG003|Treatment Period 1|Adverse Event|1|||
48763657|NCT00834912|156983975|FG004|Treatment Period 1|Adverse Event|0|||
48763658|NCT00834912|156983976|FG005|Treatment Period 1|Adverse Event|0|||
48763659|NCT00834912|156983971|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48763660|NCT00834912|156983972|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48689646|NCT03007966|156715493|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
48689647|NCT01421017|156715494|FG000|Overall Study|Withdrawal by Subject|2|||
48689648|NCT01421017|156715495|FG001|Overall Study|Withdrawal by Subject|0|||
48689649|NCT01421017|156715496|FG002|Overall Study|Withdrawal by Subject|0|||
48689650|NCT01421017|156715494|FG000|Overall Study|POD|0|||
48763661|NCT00834912|156983973|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48763662|NCT00834912|156983974|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48763663|NCT00834912|156983975|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48763664|NCT00834912|156983976|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48763665|NCT04536727|156983977|FG000|Overall Study|Lost to Follow-up|1|||
48763666|NCT04536727|156983978|FG001|Overall Study|Lost to Follow-up|1|||
48763667|NCT04536727|156983977|FG000|Overall Study|Death|0|||
48763668|NCT04536727|156983978|FG001|Overall Study|Death|1|||
48763669|NCT00344773|156983979|FG000|Overall Study|Adverse Event|2|||
48763670|NCT00344773|156983979|FG000|Overall Study|Objective Disease Progression|16|||
48763671|NCT00344773|156983979|FG000|Overall Study|Withdrawal by Subject|1|||
48763672|NCT00344773|156983979|FG000|Overall Study|Not Eligible for the study|2|||
48763673|NCT00244712|156983980|FG000|Overall Study|Adverse Event|20|||
48763674|NCT00244712|156983981|FG001|Overall Study|Adverse Event|21|||
48763675|NCT00244712|156983980|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
48689651|NCT01421017|156715495|FG001|Overall Study|POD|6|||
48689652|NCT01421017|156715496|FG002|Overall Study|POD|3|||
48689653|NCT00859547|156715499|FG000|Overall Study|Lost to Follow-up|1|||
48689654|NCT00859547|156715499|FG000|Overall Study|Parent withdrew consent|1|||
48689655|NCT03310723|156715502|FG000|Overall Study|Withdrawal by Subject|0|||
48689656|NCT03310723|156715503|FG001|Overall Study|Withdrawal by Subject|1|||
48689657|NCT03310723|156715502|FG000|Overall Study|Protocol Violation|0|||
48689658|NCT03310723|156715503|FG001|Overall Study|Protocol Violation|2|||
48689659|NCT05579977|156715504|FG000|Treatment Phase|Other|0|||
48689660|NCT05579977|156715505|FG001|Treatment Phase|Other|0|||
48689661|NCT05579977|156715506|FG002|Treatment Phase|Other|0|||
48689662|NCT05579977|156715507|FG003|Treatment Phase|Other|2|||
48689663|NCT05579977|156715508|FG004|Treatment Phase|Other|1|||
48689664|NCT05579977|156715509|FG005|Treatment Phase|Other|2|||
48689665|NCT05579977|156715510|FG006|Treatment Phase|Other|1|||
48689666|NCT05579977|156715511|FG007|Treatment Phase|Other|2|||
48689667|NCT05579977|156715512|FG008|Treatment Phase|Other|2|||
48689668|NCT05579977|156715513|FG009|Treatment Phase|Other|1|||
48689669|NCT05579977|156715514|FG010|Treatment Phase|Other|0|||
48689670|NCT05579977|156715515|FG011|Treatment Phase|Other|0|||
48689671|NCT05579977|156715516|FG012|Treatment Phase|Other|3|||
48689672|NCT05579977|156715504|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
48689673|NCT05579977|156715505|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
48689674|NCT05579977|156715506|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
48689675|NCT05579977|156715507|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
48689676|NCT05579977|156715508|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
48689677|NCT05579977|156715509|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
48689678|NCT05579977|156715510|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
48763676|NCT00244712|156983981|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
48763677|NCT00244712|156983980|FG000|Overall Study|Lack of Compliance|10|||
48763678|NCT00244712|156983981|FG001|Overall Study|Lack of Compliance|11|||
48763679|NCT00244712|156983980|FG000|Overall Study|Lost to Follow-up|45|||
48763680|NCT00244712|156983981|FG001|Overall Study|Lost to Follow-up|52|||
48763681|NCT00244712|156983980|FG000|Overall Study|Withdrawal by Subject|13|||
48763682|NCT00244712|156983981|FG001|Overall Study|Withdrawal by Subject|23|||
48763683|NCT00244712|156983980|FG000|Overall Study|Protocol Violation, disease progression|13|||
48763684|NCT00244712|156983981|FG001|Overall Study|Protocol Violation, disease progression|11|||
48763685|NCT00500370|156983984|FG000|Overall Study|Adverse Event|9|||
48689679|NCT05579977|156715511|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
48689680|NCT05579977|156715512|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
48689681|NCT05579977|156715513|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
48689682|NCT05579977|156715514|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
48689683|NCT05579977|156715515|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
48689684|NCT05579977|156715516|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
48763686|NCT00500370|156983985|FG001|Overall Study|Adverse Event|3|||
48763687|NCT00500370|156983984|FG000|Overall Study|Lost to Follow-up|10|||
48689685|NCT05579977|156715504|FG000|Treatment Phase|Withdrawal by Subject|2|||
48689686|NCT05579977|156715505|FG001|Treatment Phase|Withdrawal by Subject|0|||
48763688|NCT00500370|156983985|FG001|Overall Study|Lost to Follow-up|10|||
48763689|NCT00500370|156983984|FG000|Overall Study|Protocol Violation|2|||
48763690|NCT00500370|156983985|FG001|Overall Study|Protocol Violation|4|||
48763691|NCT00500370|156983984|FG000|Overall Study|Sponsor Decision|2|||
48689687|NCT05579977|156715506|FG002|Treatment Phase|Withdrawal by Subject|0|||
48689688|NCT05579977|156715507|FG003|Treatment Phase|Withdrawal by Subject|1|||
48689689|NCT05579977|156715508|FG004|Treatment Phase|Withdrawal by Subject|2|||
48763692|NCT00500370|156983985|FG001|Overall Study|Sponsor Decision|0|||
48689690|NCT05579977|156715509|FG005|Treatment Phase|Withdrawal by Subject|0|||
48689691|NCT05579977|156715510|FG006|Treatment Phase|Withdrawal by Subject|1|||
48689692|NCT05579977|156715511|FG007|Treatment Phase|Withdrawal by Subject|8|||
48689693|NCT05579977|156715512|FG008|Treatment Phase|Withdrawal by Subject|3|||
48689694|NCT05579977|156715513|FG009|Treatment Phase|Withdrawal by Subject|3|||
48689695|NCT05579977|156715514|FG010|Treatment Phase|Withdrawal by Subject|5|||
48689696|NCT05579977|156715515|FG011|Treatment Phase|Withdrawal by Subject|1|||
48689697|NCT05579977|156715516|FG012|Treatment Phase|Withdrawal by Subject|3|||
48689698|NCT05579977|156715504|FG000|Treatment Phase|Study terminated by sponsor|70|||
48689699|NCT05579977|156715505|FG001|Treatment Phase|Study terminated by sponsor|70|||
48689700|NCT05579977|156715506|FG002|Treatment Phase|Study terminated by sponsor|61|||
48689701|NCT05579977|156715507|FG003|Treatment Phase|Study terminated by sponsor|59|||
48689702|NCT05579977|156715508|FG004|Treatment Phase|Study terminated by sponsor|63|||
48689703|NCT05579977|156715509|FG005|Treatment Phase|Study terminated by sponsor|53|||
48689704|NCT05579977|156715510|FG006|Treatment Phase|Study terminated by sponsor|66|||
48689705|NCT05579977|156715511|FG007|Treatment Phase|Study terminated by sponsor|48|||
48689706|NCT05579977|156715512|FG008|Treatment Phase|Study terminated by sponsor|47|||
48689707|NCT05579977|156715513|FG009|Treatment Phase|Study terminated by sponsor|37|||
48689708|NCT05579977|156715514|FG010|Treatment Phase|Study terminated by sponsor|44|||
48689709|NCT05579977|156715515|FG011|Treatment Phase|Study terminated by sponsor|36|||
48689710|NCT05579977|156715516|FG012|Treatment Phase|Study terminated by sponsor|32|||
48689711|NCT05579977|156715504|FG000|Treatment Phase|Pregnancy|0|||
48689712|NCT05579977|156715505|FG001|Treatment Phase|Pregnancy|0|||
48689713|NCT05579977|156715506|FG002|Treatment Phase|Pregnancy|0|||
48689714|NCT05579977|156715507|FG003|Treatment Phase|Pregnancy|0|||
48689715|NCT05579977|156715508|FG004|Treatment Phase|Pregnancy|0|||
48689716|NCT05579977|156715509|FG005|Treatment Phase|Pregnancy|0|||
48689717|NCT05579977|156715510|FG006|Treatment Phase|Pregnancy|0|||
48689718|NCT05579977|156715511|FG007|Treatment Phase|Pregnancy|0|||
48689719|NCT05579977|156715512|FG008|Treatment Phase|Pregnancy|0|||
48689720|NCT05579977|156715513|FG009|Treatment Phase|Pregnancy|1|||
48689721|NCT05579977|156715514|FG010|Treatment Phase|Pregnancy|0|||
48689722|NCT05579977|156715515|FG011|Treatment Phase|Pregnancy|0|||
48689723|NCT05579977|156715516|FG012|Treatment Phase|Pregnancy|0|||
48689724|NCT05579977|156715504|FG000|Treatment Phase|Physician Decision|0|||
48689725|NCT05579977|156715505|FG001|Treatment Phase|Physician Decision|0|||
48689726|NCT05579977|156715506|FG002|Treatment Phase|Physician Decision|0|||
48689727|NCT05579977|156715507|FG003|Treatment Phase|Physician Decision|0|||
48689728|NCT05579977|156715508|FG004|Treatment Phase|Physician Decision|0|||
48689729|NCT05579977|156715509|FG005|Treatment Phase|Physician Decision|0|||
48689730|NCT05579977|156715510|FG006|Treatment Phase|Physician Decision|0|||
48689731|NCT05579977|156715511|FG007|Treatment Phase|Physician Decision|0|||
48689732|NCT05579977|156715512|FG008|Treatment Phase|Physician Decision|0|||
48689733|NCT05579977|156715513|FG009|Treatment Phase|Physician Decision|0|||
48689734|NCT05579977|156715514|FG010|Treatment Phase|Physician Decision|0|||
48689735|NCT05579977|156715515|FG011|Treatment Phase|Physician Decision|1|||
48689736|NCT05579977|156715516|FG012|Treatment Phase|Physician Decision|0|||
48689737|NCT05579977|156715504|FG000|Treatment Phase|Lost to Follow-up|0|||
48689738|NCT05579977|156715505|FG001|Treatment Phase|Lost to Follow-up|0|||
48689739|NCT05579977|156715506|FG002|Treatment Phase|Lost to Follow-up|0|||
48689740|NCT05579977|156715507|FG003|Treatment Phase|Lost to Follow-up|1|||
48689741|NCT05579977|156715508|FG004|Treatment Phase|Lost to Follow-up|1|||
48689742|NCT05579977|156715509|FG005|Treatment Phase|Lost to Follow-up|1|||
48689743|NCT05579977|156715510|FG006|Treatment Phase|Lost to Follow-up|0|||
48689744|NCT05579977|156715511|FG007|Treatment Phase|Lost to Follow-up|1|||
48689745|NCT05579977|156715512|FG008|Treatment Phase|Lost to Follow-up|2|||
48689746|NCT05579977|156715513|FG009|Treatment Phase|Lost to Follow-up|2|||
48689747|NCT05579977|156715514|FG010|Treatment Phase|Lost to Follow-up|1|||
48689748|NCT05579977|156715515|FG011|Treatment Phase|Lost to Follow-up|4|||
48689749|NCT05579977|156715516|FG012|Treatment Phase|Lost to Follow-up|3|||
48689750|NCT05579977|156715504|FG000|Treatment Phase|Death|1|||
48763693|NCT00500370|156983984|FG000|Overall Study|Subject Decision|10|||
48689751|NCT05579977|156715505|FG001|Treatment Phase|Death|0|||
48689752|NCT05579977|156715506|FG002|Treatment Phase|Death|0|||
48689753|NCT05579977|156715507|FG003|Treatment Phase|Death|0|||
48689754|NCT05579977|156715508|FG004|Treatment Phase|Death|0|||
48689755|NCT05579977|156715509|FG005|Treatment Phase|Death|0|||
48689756|NCT05579977|156715510|FG006|Treatment Phase|Death|0|||
48689757|NCT05579977|156715511|FG007|Treatment Phase|Death|0|||
48689758|NCT05579977|156715512|FG008|Treatment Phase|Death|0|||
48689759|NCT05579977|156715513|FG009|Treatment Phase|Death|0|||
48689760|NCT05579977|156715514|FG010|Treatment Phase|Death|0|||
48689761|NCT05579977|156715515|FG011|Treatment Phase|Death|0|||
48689762|NCT05579977|156715516|FG012|Treatment Phase|Death|0|||
48689763|NCT05579977|156715504|FG000|Treatment Phase|Adverse Event|0|||
48689764|NCT05579977|156715505|FG001|Treatment Phase|Adverse Event|3|||
48689765|NCT05579977|156715506|FG002|Treatment Phase|Adverse Event|11|||
48689766|NCT05579977|156715507|FG003|Treatment Phase|Adverse Event|10|||
48763694|NCT00500370|156983985|FG001|Overall Study|Subject Decision|17|||
48763695|NCT00714259|156983987|FG000|Overall Study|Death|2|||
48763696|NCT02016625|156985706|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
48763697|NCT02016625|156985707|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
48763698|NCT02016625|156985706|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
48763699|NCT02016625|156985707|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
48763700|NCT02016625|156985706|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
48392683|NCT01744665|155631960|FG000|Consolidation Phase|Withdrawal by Subject|4|||
48392684|NCT01744665|155631960|FG000|Consolidation Phase|Administrative problems|9|||
48392685|NCT01744665|155631960|FG000|Re-initiation Phase|Administrative problems|10|||
48392686|NCT01744665|155631960|FG000|Re-initiation Phase|Adverse Event|1|||
48392687|NCT01744665|155631960|FG000|Re-initiation Phase|No longer required treatment|1|||
48392688|NCT01744665|155631960|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
48392689|NCT03765138|155631963|FG000|Overall Study|Lost to Follow-up|1|||
48392690|NCT00889265|155631964|FG000|Overall Study|Adverse Event|1|||
48392691|NCT00889265|155631964|FG000|Overall Study|Lost to Follow-up|5|||
48392692|NCT00889265|155631964|FG000|Overall Study|Protocol Violation|1|||
48392693|NCT00845650|155631965|FG000|Overall Study|Withdrawal by Subject|0|||
48392694|NCT00845650|155631966|FG001|Overall Study|Withdrawal by Subject|0|||
48392695|NCT00845650|155631967|FG002|Overall Study|Withdrawal by Subject|0|||
48392696|NCT00845650|155631968|FG003|Overall Study|Withdrawal by Subject|0|||
48392697|NCT00845650|155631969|FG004|Overall Study|Withdrawal by Subject|2|||
48392698|NCT00845650|155631970|FG005|Overall Study|Withdrawal by Subject|0|||
48392699|NCT00845650|155631965|FG000|Overall Study|Lost to Follow-up|0|||
48392700|NCT00845650|155631966|FG001|Overall Study|Lost to Follow-up|0|||
48392701|NCT00845650|155631967|FG002|Overall Study|Lost to Follow-up|3|||
48392702|NCT00845650|155631968|FG003|Overall Study|Lost to Follow-up|1|||
48392703|NCT00845650|155631969|FG004|Overall Study|Lost to Follow-up|0|||
48392704|NCT00845650|155631970|FG005|Overall Study|Lost to Follow-up|1|||
48392705|NCT00845650|155631965|FG000|Overall Study|Sponsor hold on dosing|0|||
48392706|NCT00845650|155631966|FG001|Overall Study|Sponsor hold on dosing|0|||
48392707|NCT00845650|155631967|FG002|Overall Study|Sponsor hold on dosing|0|||
48392708|NCT00845650|155631968|FG003|Overall Study|Sponsor hold on dosing|0|||
48392709|NCT00845650|155631969|FG004|Overall Study|Sponsor hold on dosing|1|||
48392710|NCT00845650|155631970|FG005|Overall Study|Sponsor hold on dosing|1|||
48392711|NCT00845650|155631965|FG000|Overall Study|Unable to access IV line|1|||
48392712|NCT00845650|155631966|FG001|Overall Study|Unable to access IV line|0|||
48392713|NCT00845650|155631967|FG002|Overall Study|Unable to access IV line|0|||
48392714|NCT00845650|155631968|FG003|Overall Study|Unable to access IV line|0|||
48392715|NCT00845650|155631969|FG004|Overall Study|Unable to access IV line|0|||
48392716|NCT00845650|155631970|FG005|Overall Study|Unable to access IV line|0|||
48392717|NCT03803059|155631971|FG000|Overall Study|Protocol Violation|2|||
48392718|NCT03803059|155631971|FG000|Overall Study|Lost to Follow-up|1|||
48392719|NCT00081159|155631973|FG000|Overall Study|Withdrawal by Subject|0|||
48392720|NCT00081159|155631974|FG001|Overall Study|Withdrawal by Subject|3|||
48392721|NCT00081159|155631973|FG000|Overall Study|Myelosuppression prior to treatment|0|||
48392722|NCT00081159|155631974|FG001|Overall Study|Myelosuppression prior to treatment|1|||
48392723|NCT00081159|155631973|FG000|Overall Study|Lost to Follow-up|2|||
48392724|NCT00081159|155631974|FG001|Overall Study|Lost to Follow-up|1|||
48392725|NCT03075527|155631975|FG000|Overall Study|Ongoing treatment|2|||
48392726|NCT04342871|155634077|FG000|Overall Study|Death|4|||
48392727|NCT04342871|155634077|FG000|Overall Study|Clinical deterioration/illness progression|2|||
48392728|NCT04342871|155634077|FG000|Overall Study|Did not complete baseline assessments|5|||
48392729|NCT04342871|155634077|FG000|Overall Study|Lost to Follow-up|13|||
48392730|NCT02807480|155634078|FG000|Overall Study|Withdrawal by Subject|14|||
48392731|NCT02807480|155634079|FG001|Overall Study|Withdrawal by Subject|10|||
48392732|NCT01611974|155634080|FG000|Overall Study|Death|10|||
48392733|NCT01611974|155634081|FG001|Overall Study|Death|12|||
48392734|NCT01611974|155634082|FG002|Overall Study|Death|10|||
48392735|NCT01611974|155634080|FG000|Overall Study|Lost to Follow-up|0|||
48392736|NCT01611974|155634081|FG001|Overall Study|Lost to Follow-up|1|||
48392737|NCT01611974|155634082|FG002|Overall Study|Lost to Follow-up|0|||
48392738|NCT01611974|155634080|FG000|Overall Study|Physician Decision|5|||
48392739|NCT01611974|155634081|FG001|Overall Study|Physician Decision|1|||
48392740|NCT01611974|155634082|FG002|Overall Study|Physician Decision|2|||
48763701|NCT02016625|156985707|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
48763702|NCT02155738|156985708|FG000|Overall Study|Missing critical information|1|||
48392741|NCT01611974|155634080|FG000|Overall Study|Withdrawal by Subject|0|||
48392742|NCT01611974|155634081|FG001|Overall Study|Withdrawal by Subject|1|||
48392743|NCT01611974|155634082|FG002|Overall Study|Withdrawal by Subject|4|||
48392744|NCT04640272|155634085|FG000|Overall Study|Subject moved out of area|1|||
48392745|NCT00573430|155634090|FG000|Overall Study|Incorrect enrollment of randomization|0|||
48392746|NCT00573430|155634091|FG001|Overall Study|Incorrect enrollment of randomization|4|||
48392747|NCT00573430|155634092|FG002|Overall Study|Incorrect enrollment of randomization|3|||
48392748|NCT00573430|155634090|FG000|Overall Study|Adverse Event|0|||
48392749|NCT00573430|155634091|FG001|Overall Study|Adverse Event|0|||
48689767|NCT05579977|156715508|FG004|Treatment Phase|Adverse Event|5|||
48689768|NCT05579977|156715509|FG005|Treatment Phase|Adverse Event|17|||
48689769|NCT05579977|156715510|FG006|Treatment Phase|Adverse Event|5|||
48689770|NCT05579977|156715511|FG007|Treatment Phase|Adverse Event|5|||
48689771|NCT05579977|156715512|FG008|Treatment Phase|Adverse Event|12|||
48689772|NCT05579977|156715513|FG009|Treatment Phase|Adverse Event|20|||
48689773|NCT05579977|156715514|FG010|Treatment Phase|Adverse Event|15|||
48689774|NCT05579977|156715515|FG011|Treatment Phase|Adverse Event|24|||
48689775|NCT05579977|156715516|FG012|Treatment Phase|Adverse Event|23|||
48689776|NCT05579977|156715504|FG000|Treatment Phase|Randomized not treated|0|||
48689777|NCT05579977|156715505|FG001|Treatment Phase|Randomized not treated|0|||
48689778|NCT05579977|156715506|FG002|Treatment Phase|Randomized not treated|0|||
48689779|NCT05579977|156715507|FG003|Treatment Phase|Randomized not treated|0|||
48689780|NCT05579977|156715508|FG004|Treatment Phase|Randomized not treated|1|||
48689781|NCT05579977|156715509|FG005|Treatment Phase|Randomized not treated|0|||
48689782|NCT05579977|156715510|FG006|Treatment Phase|Randomized not treated|0|||
48689783|NCT05579977|156715511|FG007|Treatment Phase|Randomized not treated|0|||
48689784|NCT05579977|156715512|FG008|Treatment Phase|Randomized not treated|0|||
48689785|NCT05579977|156715513|FG009|Treatment Phase|Randomized not treated|0|||
48689786|NCT05579977|156715514|FG010|Treatment Phase|Randomized not treated|0|||
48689787|NCT05579977|156715515|FG011|Treatment Phase|Randomized not treated|0|||
48689788|NCT05579977|156715516|FG012|Treatment Phase|Randomized not treated|0|||
48689789|NCT05579977|156715504|FG000|Follow up|Death|1|||
48689790|NCT05579977|156715505|FG001|Follow up|Death|0|||
48689791|NCT05579977|156715506|FG002|Follow up|Death|0|||
48689792|NCT05579977|156715507|FG003|Follow up|Death|0|||
48689793|NCT05579977|156715508|FG004|Follow up|Death|0|||
48689794|NCT05579977|156715509|FG005|Follow up|Death|0|||
48689795|NCT05579977|156715510|FG006|Follow up|Death|0|||
48689796|NCT05579977|156715511|FG007|Follow up|Death|0|||
48689797|NCT05579977|156715512|FG008|Follow up|Death|0|||
48689798|NCT05579977|156715513|FG009|Follow up|Death|0|||
48689799|NCT05579977|156715514|FG010|Follow up|Death|0|||
48689800|NCT05579977|156715515|FG011|Follow up|Death|0|||
48392750|NCT00573430|155634092|FG002|Overall Study|Adverse Event|2|||
48392751|NCT00573430|155634090|FG000|Overall Study|Withdrawal by Subject|1|||
48392752|NCT00573430|155634091|FG001|Overall Study|Withdrawal by Subject|0|||
48392753|NCT00573430|155634092|FG002|Overall Study|Withdrawal by Subject|1|||
48392754|NCT00573430|155634090|FG000|Overall Study|Protocol Violation|0|||
48392755|NCT00573430|155634091|FG001|Overall Study|Protocol Violation|1|||
48392756|NCT00573430|155634092|FG002|Overall Study|Protocol Violation|1|||
48392757|NCT00573430|155634090|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48392758|NCT00573430|155634091|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48392759|NCT00573430|155634092|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
48392760|NCT01263483|155634094|FG000|Overall Study|Adverse Event|4|||
48392761|NCT01263483|155634095|FG001|Overall Study|Adverse Event|0|||
48392762|NCT01263483|155634096|FG002|Overall Study|Adverse Event|3|||
48392763|NCT01263483|155634094|FG000|Overall Study|Withdrawal by Subject|1|||
48392764|NCT01263483|155634095|FG001|Overall Study|Withdrawal by Subject|0|||
48392765|NCT01263483|155634096|FG002|Overall Study|Withdrawal by Subject|0|||
48392766|NCT01263483|155634094|FG000|Overall Study|Lack of Efficacy|2|||
48392767|NCT01263483|155634095|FG001|Overall Study|Lack of Efficacy|0|||
48392768|NCT01263483|155634096|FG002|Overall Study|Lack of Efficacy|0|||
48392769|NCT01263483|155634094|FG000|Overall Study|Protocol Violation|0|||
48392770|NCT01263483|155634095|FG001|Overall Study|Protocol Violation|1|||
48392771|NCT01263483|155634096|FG002|Overall Study|Protocol Violation|1|||
48392772|NCT01263483|155634094|FG000|Overall Study|Participant Unavailability|0|||
48392773|NCT01263483|155634095|FG001|Overall Study|Participant Unavailability|1|||
48689801|NCT05579977|156715516|FG012|Follow up|Death|0|||
48689802|NCT05579977|156715504|FG000|Follow up|Lost to Follow-up|0|||
48689803|NCT05579977|156715505|FG001|Follow up|Lost to Follow-up|0|||
48763703|NCT02155738|156985709|FG001|Overall Study|Missing critical information|0|||
48392774|NCT01263483|155634096|FG002|Overall Study|Participant Unavailability|1|||
48392775|NCT02770547|155634097|FG000|Overall Study|Patient non-compliant|1|||
48392776|NCT02770547|155634098|FG001|Overall Study|Patient non-compliant|0|||
48392777|NCT02770547|155634097|FG000|Overall Study|Adverse Event|0|||
48392778|NCT02770547|155634098|FG001|Overall Study|Adverse Event|1|||
48392779|NCT03703102|155634099|FG000|Overall Study|Adverse Event|4|||
48392780|NCT03703102|155634100|FG001|Overall Study|Adverse Event|3|||
48689804|NCT05579977|156715506|FG002|Follow up|Lost to Follow-up|0|||
48689805|NCT05579977|156715507|FG003|Follow up|Lost to Follow-up|1|||
48689806|NCT05579977|156715508|FG004|Follow up|Lost to Follow-up|1|||
48689807|NCT05579977|156715509|FG005|Follow up|Lost to Follow-up|2|||
48689808|NCT05579977|156715510|FG006|Follow up|Lost to Follow-up|1|||
48689809|NCT05579977|156715511|FG007|Follow up|Lost to Follow-up|1|||
48689810|NCT05579977|156715512|FG008|Follow up|Lost to Follow-up|3|||
48689811|NCT05579977|156715513|FG009|Follow up|Lost to Follow-up|2|||
48689812|NCT05579977|156715514|FG010|Follow up|Lost to Follow-up|2|||
48689813|NCT05579977|156715515|FG011|Follow up|Lost to Follow-up|4|||
48689814|NCT05579977|156715516|FG012|Follow up|Lost to Follow-up|4|||
48689815|NCT05579977|156715504|FG000|Follow up|Withdrawal by Subject|2|||
48689816|NCT05579977|156715505|FG001|Follow up|Withdrawal by Subject|0|||
48689817|NCT05579977|156715506|FG002|Follow up|Withdrawal by Subject|0|||
48689818|NCT05579977|156715507|FG003|Follow up|Withdrawal by Subject|0|||
48689819|NCT05579977|156715508|FG004|Follow up|Withdrawal by Subject|1|||
48689820|NCT05579977|156715509|FG005|Follow up|Withdrawal by Subject|0|||
48689821|NCT05579977|156715510|FG006|Follow up|Withdrawal by Subject|1|||
48689822|NCT05579977|156715511|FG007|Follow up|Withdrawal by Subject|4|||
48689823|NCT05579977|156715512|FG008|Follow up|Withdrawal by Subject|2|||
48689824|NCT05579977|156715513|FG009|Follow up|Withdrawal by Subject|3|||
48689825|NCT05579977|156715514|FG010|Follow up|Withdrawal by Subject|3|||
48689826|NCT05579977|156715515|FG011|Follow up|Withdrawal by Subject|1|||
48689827|NCT05579977|156715516|FG012|Follow up|Withdrawal by Subject|3|||
48689828|NCT00671034|156715519|FG000|Overall Study|Adverse Event|5|||
48689829|NCT00671034|156715520|FG001|Overall Study|Adverse Event|7|||
48689830|NCT00671034|156715521|FG002|Overall Study|Adverse Event|1|||
48689831|NCT00671034|156715519|FG000|Overall Study|Death|3|||
48689832|NCT00671034|156715520|FG001|Overall Study|Death|2|||
48689833|NCT00671034|156715521|FG002|Overall Study|Death|1|||
48689834|NCT00671034|156715519|FG000|Overall Study|Physician Decision|12|||
48689835|NCT00671034|156715520|FG001|Overall Study|Physician Decision|4|||
48689836|NCT00671034|156715521|FG002|Overall Study|Physician Decision|5|||
48689837|NCT00671034|156715519|FG000|Overall Study|VHR ALL feature|8|||
48689838|NCT00671034|156715520|FG001|Overall Study|VHR ALL feature|3|||
48689839|NCT00671034|156715521|FG002|Overall Study|VHR ALL feature|5|||
48392781|NCT03703102|155634101|FG002|Overall Study|Adverse Event|7|||
48392782|NCT03703102|155634102|FG003|Overall Study|Adverse Event|3|||
48392783|NCT03703102|155634103|FG004|Overall Study|Adverse Event|13|||
48392784|NCT03703102|155634099|FG000|Overall Study|Lack of Efficacy|4|||
48392785|NCT03703102|155634100|FG001|Overall Study|Lack of Efficacy|0|||
48392786|NCT03703102|155634101|FG002|Overall Study|Lack of Efficacy|1|||
48392787|NCT03703102|155634102|FG003|Overall Study|Lack of Efficacy|4|||
48392788|NCT03703102|155634103|FG004|Overall Study|Lack of Efficacy|1|||
48392789|NCT03703102|155634099|FG000|Overall Study|Lost to Follow-up|0|||
48392790|NCT03703102|155634100|FG001|Overall Study|Lost to Follow-up|0|||
48392791|NCT03703102|155634101|FG002|Overall Study|Lost to Follow-up|1|||
48392792|NCT03703102|155634102|FG003|Overall Study|Lost to Follow-up|2|||
48392793|NCT03703102|155634103|FG004|Overall Study|Lost to Follow-up|2|||
48392794|NCT03703102|155634099|FG000|Overall Study|Physician Decision|2|||
48392795|NCT03703102|155634100|FG001|Overall Study|Physician Decision|2|||
48392796|NCT03703102|155634101|FG002|Overall Study|Physician Decision|2|||
48392797|NCT03703102|155634102|FG003|Overall Study|Physician Decision|2|||
48392798|NCT03703102|155634103|FG004|Overall Study|Physician Decision|4|||
48392799|NCT03703102|155634099|FG000|Overall Study|Withdrawal by Subject|7|||
48392800|NCT03703102|155634100|FG001|Overall Study|Withdrawal by Subject|5|||
48392801|NCT03703102|155634101|FG002|Overall Study|Withdrawal by Subject|5|||
48392802|NCT03703102|155634102|FG003|Overall Study|Withdrawal by Subject|5|||
48392803|NCT03703102|155634103|FG004|Overall Study|Withdrawal by Subject|9|||
48392804|NCT03703102|155634099|FG000|Overall Study|Ineligibility|0|||
48392805|NCT03703102|155634100|FG001|Overall Study|Ineligibility|0|||
48392806|NCT03703102|155634101|FG002|Overall Study|Ineligibility|1|||
48392807|NCT03703102|155634102|FG003|Overall Study|Ineligibility|0|||
48392808|NCT03703102|155634103|FG004|Overall Study|Ineligibility|0|||
48392809|NCT03703102|155634099|FG000|Overall Study|Protocol Deviation|4|||
48392810|NCT03703102|155634100|FG001|Overall Study|Protocol Deviation|4|||
48392811|NCT03703102|155634101|FG002|Overall Study|Protocol Deviation|3|||
48392812|NCT03703102|155634102|FG003|Overall Study|Protocol Deviation|0|||
48392813|NCT03703102|155634103|FG004|Overall Study|Protocol Deviation|0|||
48392814|NCT03703102|155634099|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48392815|NCT03703102|155634100|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48689840|NCT00671034|156715519|FG000|Overall Study|Refusal|5|||
48689841|NCT00671034|156715520|FG001|Overall Study|Refusal|3|||
48689842|NCT00671034|156715521|FG002|Overall Study|Refusal|5|||
48689843|NCT00671034|156715519|FG000|Overall Study|includes Alternative therapy, etc.|6|||
48689844|NCT00671034|156715520|FG001|Overall Study|includes Alternative therapy, etc.|1|||
48689845|NCT00671034|156715521|FG002|Overall Study|includes Alternative therapy, etc.|7|||
48689846|NCT02043938|156715522|FG000|Overall Study|Withdrawal by Subject|7|||
48392816|NCT03703102|155634101|FG002|Overall Study|Non-Compliance with Study Drug|2|||
48392817|NCT03703102|155634102|FG003|Overall Study|Non-Compliance with Study Drug|1|||
48689847|NCT02043938|156715522|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
48689848|NCT02043938|156715522|FG000|Overall Study|No show by subject|1|||
48392818|NCT03703102|155634103|FG004|Overall Study|Non-Compliance with Study Drug|4|||
48392819|NCT01356407|155634104|FG000|Overall Study|Lost to Follow-up|2|||
48689849|NCT02043938|156715522|FG000|Overall Study|Investigator decision|1|||
48689850|NCT00443040|156715523|FG000|Overall Study|Withdrawal by Subject|1|||
48689851|NCT00443040|156715524|FG001|Overall Study|Withdrawal by Subject|0|||
48689852|NCT00443040|156715525|FG002|Overall Study|Withdrawal by Subject|0|||
48689853|NCT00443040|156715523|FG000|Overall Study|Converted to an open laparotomy|3|||
48689854|NCT00443040|156715524|FG001|Overall Study|Converted to an open laparotomy|0|||
48689855|NCT00443040|156715525|FG002|Overall Study|Converted to an open laparotomy|1|||
48392820|NCT01356407|155634105|FG001|Overall Study|Lost to Follow-up|0|||
48392821|NCT01356407|155634104|FG000|Overall Study|Patient Withdrew Consent|2|||
48392822|NCT01356407|155634105|FG001|Overall Study|Patient Withdrew Consent|1|||
48392823|NCT01356407|155634104|FG000|Overall Study|Could not afford IMP administration|0|||
48392824|NCT01356407|155634105|FG001|Overall Study|Could not afford IMP administration|1|||
48392825|NCT01356407|155634104|FG000|Overall Study|Not complete Endoscopy|2|||
48392826|NCT01356407|155634105|FG001|Overall Study|Not complete Endoscopy|2|||
48392827|NCT00405067|155634110|FG000|Overall Study|Adverse Event|4|||
48392828|NCT00405067|155634111|FG001|Overall Study|Adverse Event|9|||
48689856|NCT03922581|156715526|FG000|Overall Study|Lost to Follow-up|20|||
48689857|NCT03922581|156715527|FG001|Overall Study|Lost to Follow-up|9|||
48689858|NCT03922581|156715526|FG000|Overall Study|Physician Decision|1|||
48689859|NCT03922581|156715527|FG001|Overall Study|Physician Decision|1|||
48689860|NCT03922581|156715526|FG000|Overall Study|Withdrawal by Subject|1|||
48689861|NCT03922581|156715527|FG001|Overall Study|Withdrawal by Subject|0|||
48689862|NCT03369418|156715528|FG000|Overall Study|Withdrawal by Subject|3|||
48689863|NCT03369418|156715529|FG001|Overall Study|Withdrawal by Subject|3|||
48689864|NCT02756338|156715534|FG000|Overall Study|Withdrawn by Investigator|1|||
48689865|NCT02756338|156715534|FG000|Overall Study|Device Replaced with Pacemaker|4|||
48689866|NCT01176032|156715540|FG000|Overall Study|Adverse Event|1|||
48689867|NCT01176032|156715541|FG001|Overall Study|Adverse Event|0|||
48689868|NCT01176032|156715540|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48689869|NCT01176032|156715541|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48689870|NCT01176032|156715540|FG000|Overall Study|Protocol Violation|1|||
48689871|NCT01176032|156715541|FG001|Overall Study|Protocol Violation|0|||
48689872|NCT01176032|156715540|FG000|Overall Study|Informed consent withdrawn|3|||
48689873|NCT01176032|156715541|FG001|Overall Study|Informed consent withdrawn|0|||
48689874|NCT01176032|156715540|FG000|Overall Study|Other|1|||
48689875|NCT01176032|156715541|FG001|Overall Study|Other|0|||
48689876|NCT00667888|156715542|FG000|Overall Study|Death|1|||
48689877|NCT00667888|156715543|FG001|Overall Study|Death|1|||
48689878|NCT00667888|156715542|FG000|Overall Study|Withdrawal by Subject|6|||
48689879|NCT00667888|156715543|FG001|Overall Study|Withdrawal by Subject|3|||
48689880|NCT00667888|156715542|FG000|Overall Study|Proceed with other treatment|3|||
48689881|NCT00667888|156715543|FG001|Overall Study|Proceed with other treatment|3|||
48689882|NCT00667888|156715542|FG000|Overall Study|Ineligible after SIM|0|||
48689883|NCT00667888|156715543|FG001|Overall Study|Ineligible after SIM|2|||
48689884|NCT01945021|156715544|FG000|Overall Study|Adverse Event|1|||
48689885|NCT01945021|156715544|FG000|Overall Study|Withdrawal of consent|12|||
48689886|NCT01945021|156715544|FG000|Overall Study|Lost to Follow-up|5|||
48689887|NCT01945021|156715544|FG000|Overall Study|Death|65|||
48392829|NCT00405067|155634112|FG002|Overall Study|Adverse Event|4|||
48392830|NCT00405067|155634110|FG000|Overall Study|Lost to Follow-up|0|||
48392831|NCT00405067|155634111|FG001|Overall Study|Lost to Follow-up|0|||
48392832|NCT00405067|155634112|FG002|Overall Study|Lost to Follow-up|1|||
48392833|NCT03548935|155634114|FG000|Overall Study|Withdrawal by Subject|26|||
48392834|NCT03548935|155634115|FG001|Overall Study|Withdrawal by Subject|17|||
48392835|NCT03548935|155634114|FG000|Overall Study|Lost to Follow-up|39|||
48392836|NCT03548935|155634115|FG001|Overall Study|Lost to Follow-up|28|||
48392837|NCT03548935|155634114|FG000|Overall Study|Death|1|||
48392838|NCT03548935|155634115|FG001|Overall Study|Death|1|||
48392839|NCT03972969|155634116|FG000|3-month Follow-up|Death|1|||
48392840|NCT03972969|155634117|FG001|3-month Follow-up|Death|1|||
48689888|NCT00079040|156715545|FG000|Overall Study|Withdrew before treatment|1|||
48689889|NCT00079040|156715545|FG000|Overall Study|Ineligible|1|||
48689890|NCT01308736|156715546|FG000|Overall Study|Did not attend a single session|6|||
48689891|NCT01308736|156715547|FG001|Overall Study|Did not attend a single session|5|||
48689892|NCT00467740|156715554|FG000|Overall Study|Adverse Event|0|||
48689893|NCT00467740|156715555|FG001|Overall Study|Adverse Event|0|||
48689894|NCT00467740|156715556|FG002|Overall Study|Adverse Event|1|||
48689895|NCT00467740|156715557|FG003|Overall Study|Adverse Event|0|||
48689896|NCT00467740|156715558|FG004|Overall Study|Adverse Event|0|||
48689897|NCT00467740|156715554|FG000|Overall Study|Protocol Violation|0|||
48689898|NCT00467740|156715555|FG001|Overall Study|Protocol Violation|0|||
48689899|NCT00467740|156715556|FG002|Overall Study|Protocol Violation|1|||
48689900|NCT00467740|156715557|FG003|Overall Study|Protocol Violation|0|||
48392841|NCT03972969|155634118|FG002|3-month Follow-up|Death|0|||
48392842|NCT03972969|155634116|FG000|6-month Follow-up|Death|1|||
48392843|NCT03972969|155634117|FG001|6-month Follow-up|Death|1|||
48392844|NCT03972969|155634118|FG002|6-month Follow-up|Death|1|||
48689901|NCT00467740|156715558|FG004|Overall Study|Protocol Violation|0|||
48689902|NCT00467740|156715554|FG000|Overall Study|Lost to Follow-up|0|||
48689903|NCT00467740|156715555|FG001|Overall Study|Lost to Follow-up|1|||
48689904|NCT00467740|156715556|FG002|Overall Study|Lost to Follow-up|0|||
48689905|NCT00467740|156715557|FG003|Overall Study|Lost to Follow-up|0|||
48392845|NCT03972969|155634116|FG000|6-month Follow-up|Lost to Follow-up|2|||
48392846|NCT03972969|155634117|FG001|6-month Follow-up|Lost to Follow-up|2|||
48689906|NCT00467740|156715558|FG004|Overall Study|Lost to Follow-up|0|||
48689907|NCT00467740|156715554|FG000|Overall Study|Withdrawal by Subject|1|||
48689908|NCT00467740|156715555|FG001|Overall Study|Withdrawal by Subject|1|||
48689909|NCT00467740|156715556|FG002|Overall Study|Withdrawal by Subject|0|||
48689910|NCT00467740|156715557|FG003|Overall Study|Withdrawal by Subject|1|||
48689911|NCT00467740|156715558|FG004|Overall Study|Withdrawal by Subject|0|||
48689912|NCT00467740|156715554|FG000|Overall Study|Lack of Efficacy|0|||
48689913|NCT00467740|156715555|FG001|Overall Study|Lack of Efficacy|1|||
48392847|NCT03972969|155634118|FG002|6-month Follow-up|Lost to Follow-up|2|||
48392848|NCT01074190|155634125|FG000|Overall Study|Emergency Cesarean Delivery|1|||
48392849|NCT01074190|155634126|FG001|Overall Study|Emergency Cesarean Delivery|2|||
48392850|NCT01074190|155634127|FG002|Overall Study|Emergency Cesarean Delivery|1|||
48392851|NCT01074190|155634125|FG000|Overall Study|Protocol Violation|2|||
48392852|NCT01074190|155634126|FG001|Overall Study|Protocol Violation|1|||
48392853|NCT01074190|155634127|FG002|Overall Study|Protocol Violation|0|||
48392854|NCT01074190|155634125|FG000|Overall Study|Delivered in under 90 minutes|0|||
48392855|NCT01074190|155634126|FG001|Overall Study|Delivered in under 90 minutes|2|||
48392856|NCT01074190|155634127|FG002|Overall Study|Delivered in under 90 minutes|1|||
48392857|NCT01074190|155634125|FG000|Overall Study|Subject withdrew consent|1|||
48392858|NCT01074190|155634126|FG001|Overall Study|Subject withdrew consent|1|||
48392859|NCT01074190|155634127|FG002|Overall Study|Subject withdrew consent|1|||
48392860|NCT04707157|155634128|FG000|Overall Study|Adverse Event|12|||
48392861|NCT04707157|155634129|FG001|Overall Study|Adverse Event|3|||
48392862|NCT04707157|155634128|FG000|Overall Study|Lost to Follow-up|2|||
48392863|NCT04707157|155634129|FG001|Overall Study|Lost to Follow-up|0|||
48392864|NCT04707157|155634128|FG000|Overall Study|Sponsor's decision|1|||
48392865|NCT04707157|155634129|FG001|Overall Study|Sponsor's decision|0|||
48392866|NCT04707157|155634128|FG000|Overall Study|Physician Decision|8|||
48392867|NCT04707157|155634129|FG001|Overall Study|Physician Decision|5|||
48392868|NCT04707157|155634128|FG000|Overall Study|Protocol Deviation|1|||
48392869|NCT04707157|155634129|FG001|Overall Study|Protocol Deviation|0|||
48392870|NCT04707157|155634128|FG000|Overall Study|Withdrawal by Subject|1|||
48392871|NCT04707157|155634129|FG001|Overall Study|Withdrawal by Subject|1|||
48392872|NCT01500278|155634131|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
48392873|NCT01500278|155634132|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
48392874|NCT01500278|155634131|FG000|Week 0 - Week 12|Protocol Violation|10|||
48392875|NCT01500278|155634132|FG001|Week 0 - Week 12|Protocol Violation|16|||
48392876|NCT01500278|155634131|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
48392877|NCT01500278|155634132|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
48689914|NCT00467740|156715556|FG002|Overall Study|Lack of Efficacy|0|||
48689915|NCT00467740|156715557|FG003|Overall Study|Lack of Efficacy|0|||
48689916|NCT00467740|156715558|FG004|Overall Study|Lack of Efficacy|0|||
48689917|NCT02903160|156715559|FG000|Overall Study|Adverse Event|2|||
48689918|NCT02903160|156715559|FG000|Overall Study|Death|1|||
48689919|NCT02903160|156715559|FG000|Overall Study|Lost to Follow-up|2|||
48689920|NCT02903160|156715559|FG000|Overall Study|Withdrawal by Subject|1|||
48689921|NCT02903160|156715559|FG000|Overall Study|Medical Insurance Barriers|1|||
48689922|NCT00101686|156715560|FG000|Overall Study|Progressive Disease|37|||
48689923|NCT00101686|156715561|FG001|Overall Study|Progressive Disease|28|||
48689924|NCT00101686|156715562|FG002|Overall Study|Progressive Disease|37|||
48689925|NCT00101686|156715563|FG003|Overall Study|Progressive Disease|38|||
48689926|NCT00101686|156715564|FG004|Overall Study|Progressive Disease|28|||
48392878|NCT01500278|155634131|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
48392879|NCT01500278|155634132|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
48392880|NCT01500278|155634131|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
48392881|NCT01500278|155634132|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
48392882|NCT01500278|155634131|FG000|Week 0 - Week 12|Patient decision|1|||
48392883|NCT01500278|155634132|FG001|Week 0 - Week 12|Patient decision|0|||
48689927|NCT00101686|156715565|FG005|Overall Study|Progressive Disease|25|||
48689928|NCT00101686|156715566|FG006|Overall Study|Progressive Disease|5|||
48689929|NCT00101686|156715567|FG007|Overall Study|Progressive Disease|7|||
48689930|NCT00101686|156715568|FG008|Overall Study|Progressive Disease|10|||
48689931|NCT00101686|156715569|FG009|Overall Study|Progressive Disease|8|||
48689932|NCT00101686|156715560|FG000|Overall Study|initiation other anti-cancer treatment|4|||
48689933|NCT00101686|156715561|FG001|Overall Study|initiation other anti-cancer treatment|3|||
48689934|NCT00101686|156715562|FG002|Overall Study|initiation other anti-cancer treatment|4|||
48689935|NCT00101686|156715563|FG003|Overall Study|initiation other anti-cancer treatment|3|||
48392884|NCT01500278|155634131|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
48689936|NCT00101686|156715564|FG004|Overall Study|initiation other anti-cancer treatment|1|||
48689937|NCT00101686|156715565|FG005|Overall Study|initiation other anti-cancer treatment|1|||
48689938|NCT00101686|156715566|FG006|Overall Study|initiation other anti-cancer treatment|2|||
48689939|NCT00101686|156715567|FG007|Overall Study|initiation other anti-cancer treatment|2|||
48392885|NCT01500278|155634132|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
48392886|NCT01500278|155634131|FG000|Week 0 - Week 12|Investigator decision|1|||
48392887|NCT01500278|155634132|FG001|Week 0 - Week 12|Investigator decision|0|||
48392888|NCT01500278|155634131|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
48689940|NCT00101686|156715568|FG008|Overall Study|initiation other anti-cancer treatment|3|||
48392889|NCT01500278|155634132|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
48392890|NCT01500278|155634131|FG000|Week 0 - Week 12|Sponsor decision|1|||
48392891|NCT01500278|155634132|FG001|Week 0 - Week 12|Sponsor decision|0|||
48392892|NCT01500278|155634131|FG000|Week 0 - Week 12|Personal reason|0|||
48392893|NCT01500278|155634132|FG001|Week 0 - Week 12|Personal reason|1|||
48392894|NCT01500278|155634131|FG000|Week 0 - Week 12|Other serious disease|0|||
48392895|NCT01500278|155634132|FG001|Week 0 - Week 12|Other serious disease|1|||
48392896|NCT01500278|155634131|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
48392897|NCT01500278|155634132|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
48392898|NCT01500278|155634131|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
48392899|NCT01500278|155634132|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
48392900|NCT01500278|155634131|FG000|Week 13 - Week 104|Protocol Violation|6|||
48392901|NCT01500278|155634132|FG001|Week 13 - Week 104|Protocol Violation|6|||
48392902|NCT01500278|155634131|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
48392903|NCT01500278|155634132|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
48392904|NCT01500278|155634131|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
48392905|NCT01500278|155634132|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
48392906|NCT01500278|155634131|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
48392907|NCT01500278|155634132|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
48392908|NCT01500278|155634131|FG000|Week 13 - Week 104|Non/bad compliance|7|||
48392909|NCT01500278|155634132|FG001|Week 13 - Week 104|Non/bad compliance|5|||
48392910|NCT01500278|155634131|FG000|Week 13 - Week 104|Recurrent infections|1|||
48392911|NCT01500278|155634132|FG001|Week 13 - Week 104|Recurrent infections|0|||
48392912|NCT01500278|155634131|FG000|Week 13 - Week 104|False positive test|1|||
48392913|NCT01500278|155634132|FG001|Week 13 - Week 104|False positive test|2|||
48392914|NCT01500278|155634131|FG000|Week 13 - Week 104|Sponsor request|4|||
48689941|NCT00101686|156715569|FG009|Overall Study|initiation other anti-cancer treatment|3|||
48689942|NCT00101686|156715560|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
48689943|NCT00101686|156715561|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
48689944|NCT00101686|156715562|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
48689945|NCT00101686|156715563|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
48689946|NCT00101686|156715564|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
48689947|NCT00101686|156715565|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
48689948|NCT00101686|156715566|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
48689949|NCT00101686|156715567|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
48689950|NCT00101686|156715568|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
48689951|NCT00101686|156715569|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
48689952|NCT00101686|156715560|FG000|Overall Study|unacceptable toxicity|3|||
48689953|NCT00101686|156715561|FG001|Overall Study|unacceptable toxicity|9|||
48689954|NCT00101686|156715562|FG002|Overall Study|unacceptable toxicity|10|||
48689955|NCT00101686|156715563|FG003|Overall Study|unacceptable toxicity|6|||
48689956|NCT00101686|156715564|FG004|Overall Study|unacceptable toxicity|16|||
48689957|NCT00101686|156715565|FG005|Overall Study|unacceptable toxicity|10|||
48689958|NCT00101686|156715566|FG006|Overall Study|unacceptable toxicity|4|||
48689959|NCT00101686|156715567|FG007|Overall Study|unacceptable toxicity|2|||
48689960|NCT00101686|156715568|FG008|Overall Study|unacceptable toxicity|1|||
48689961|NCT00101686|156715569|FG009|Overall Study|unacceptable toxicity|4|||
48689962|NCT00101686|156715560|FG000|Overall Study|Randomized but did not receive treament|1|||
48689963|NCT00101686|156715561|FG001|Overall Study|Randomized but did not receive treament|6|||
48689964|NCT00101686|156715562|FG002|Overall Study|Randomized but did not receive treament|2|||
48689965|NCT00101686|156715563|FG003|Overall Study|Randomized but did not receive treament|2|||
48689966|NCT00101686|156715564|FG004|Overall Study|Randomized but did not receive treament|2|||
48689967|NCT00101686|156715565|FG005|Overall Study|Randomized but did not receive treament|2|||
48689968|NCT00101686|156715566|FG006|Overall Study|Randomized but did not receive treament|0|||
48689969|NCT00101686|156715567|FG007|Overall Study|Randomized but did not receive treament|1|||
48689970|NCT00101686|156715568|FG008|Overall Study|Randomized but did not receive treament|0|||
48689971|NCT00101686|156715569|FG009|Overall Study|Randomized but did not receive treament|1|||
48689972|NCT00101686|156715560|FG000|Overall Study|intercurrent non-cancer related illness|0|||
48689973|NCT00101686|156715561|FG001|Overall Study|intercurrent non-cancer related illness|0|||
48689974|NCT00101686|156715562|FG002|Overall Study|intercurrent non-cancer related illness|2|||
48689975|NCT00101686|156715563|FG003|Overall Study|intercurrent non-cancer related illness|0|||
48689976|NCT00101686|156715564|FG004|Overall Study|intercurrent non-cancer related illness|1|||
48689977|NCT00101686|156715565|FG005|Overall Study|intercurrent non-cancer related illness|3|||
48689978|NCT00101686|156715566|FG006|Overall Study|intercurrent non-cancer related illness|1|||
48689979|NCT00101686|156715567|FG007|Overall Study|intercurrent non-cancer related illness|0|||
48392915|NCT01500278|155634132|FG001|Week 13 - Week 104|Sponsor request|0|||
48392916|NCT01500278|155634131|FG000|Week 13 - Week 104|Withdrawn in error|1|||
48392917|NCT01500278|155634132|FG001|Week 13 - Week 104|Withdrawn in error|0|||
48392918|NCT01500278|155634131|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
48392919|NCT01500278|155634132|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
48392920|NCT01500278|155634131|FG000|Week 13 - Week 104|Protocol deviation|1|||
48689980|NCT00101686|156715568|FG008|Overall Study|intercurrent non-cancer related illness|1|||
48689981|NCT00101686|156715569|FG009|Overall Study|intercurrent non-cancer related illness|1|||
48689982|NCT00101686|156715560|FG000|Overall Study|Physician Decision|10|||
48689983|NCT00101686|156715561|FG001|Overall Study|Physician Decision|13|||
48689984|NCT00101686|156715562|FG002|Overall Study|Physician Decision|6|||
48689985|NCT00101686|156715563|FG003|Overall Study|Physician Decision|7|||
48689986|NCT00101686|156715564|FG004|Overall Study|Physician Decision|8|||
48689987|NCT00101686|156715565|FG005|Overall Study|Physician Decision|9|||
48689988|NCT00101686|156715566|FG006|Overall Study|Physician Decision|5|||
48689989|NCT00101686|156715567|FG007|Overall Study|Physician Decision|5|||
48689990|NCT00101686|156715568|FG008|Overall Study|Physician Decision|1|||
48689991|NCT00101686|156715569|FG009|Overall Study|Physician Decision|1|||
48689992|NCT00101686|156715560|FG000|Overall Study|Other|1|||
48689993|NCT00101686|156715561|FG001|Overall Study|Other|4|||
48689994|NCT00101686|156715562|FG002|Overall Study|Other|1|||
48689995|NCT00101686|156715563|FG003|Overall Study|Other|6|||
48689996|NCT00101686|156715564|FG004|Overall Study|Other|2|||
48689997|NCT00101686|156715565|FG005|Overall Study|Other|12|||
48689998|NCT00101686|156715566|FG006|Overall Study|Other|1|||
48689999|NCT00101686|156715567|FG007|Overall Study|Other|5|||
48690000|NCT00101686|156715568|FG008|Overall Study|Other|3|||
48690001|NCT00101686|156715569|FG009|Overall Study|Other|3|||
48690002|NCT00101686|156715560|FG000|Overall Study|Withdrawal by Subject|9|||
48690003|NCT00101686|156715561|FG001|Overall Study|Withdrawal by Subject|8|||
48690004|NCT00101686|156715562|FG002|Overall Study|Withdrawal by Subject|6|||
48690005|NCT00101686|156715563|FG003|Overall Study|Withdrawal by Subject|8|||
48690006|NCT00101686|156715564|FG004|Overall Study|Withdrawal by Subject|8|||
48690007|NCT00101686|156715565|FG005|Overall Study|Withdrawal by Subject|7|||
48690008|NCT00101686|156715566|FG006|Overall Study|Withdrawal by Subject|7|||
48690009|NCT00101686|156715567|FG007|Overall Study|Withdrawal by Subject|7|||
48690010|NCT00101686|156715568|FG008|Overall Study|Withdrawal by Subject|8|||
48355374|NCT00250432|155497280|FG000|Overall Study|Pt was considered untreatable|0|||
48355375|NCT00250432|155497281|FG001|Overall Study|Pt was considered untreatable|1|||
48355376|NCT01228175|155497282|FG000|Overall Study|Lost to Follow-up|64|||
48355377|NCT01228175|155497283|FG001|Overall Study|Lost to Follow-up|50|||
48355378|NCT01228175|155497282|FG000|Overall Study|Withdrawal by Subject|1|||
48355379|NCT01228175|155497283|FG001|Overall Study|Withdrawal by Subject|2|||
48355380|NCT01228175|155497282|FG000|Overall Study|Physician Decision|1|||
48355381|NCT01228175|155497283|FG001|Overall Study|Physician Decision|1|||
48586891|NCT00096993|156341475|FG000|Overall Study|Disease progression|56|||
48586892|NCT00096993|156341476|FG001|Overall Study|Disease progression|53|||
48586893|NCT00096993|156341475|FG000|Overall Study|Adverse Event|2|||
48586894|NCT00096993|156341476|FG001|Overall Study|Adverse Event|8|||
48586895|NCT00096993|156341475|FG000|Overall Study|Subject's decision|3|||
48586896|NCT00096993|156341476|FG001|Overall Study|Subject's decision|1|||
48355388|NCT00760513|155498488|FG000|Overall Study|Withdrawal by Subject|5|||
48355389|NCT00760513|155498489|FG001|Overall Study|Withdrawal by Subject|7|||
48355390|NCT04596995|155498492|FG000|Overall Study|Lack of Efficacy|8|||
48586897|NCT00096993|156341475|FG000|Overall Study|Physician Decision|2|||
48586898|NCT00096993|156341476|FG001|Overall Study|Physician Decision|1|||
48586899|NCT00096993|156341475|FG000|Overall Study|Non-compliance|0|||
48586900|NCT00096993|156341476|FG001|Overall Study|Non-compliance|1|||
48586901|NCT00096993|156341475|FG000|Overall Study|Other unspecified|1|||
48586902|NCT00096993|156341476|FG001|Overall Study|Other unspecified|1|||
48586903|NCT01935128|156341477|FG000|Overall Study|Death|1|||
48586904|NCT01935128|156341477|FG000|Overall Study|Adverse Event|6|||
48586905|NCT00772005|156341479|FG000|Overall Study|Adverse Event|9|||
48586906|NCT00772005|156341480|FG001|Overall Study|Adverse Event|14|||
48586907|NCT00772005|156341481|FG002|Overall Study|Adverse Event|10|||
48586908|NCT00772005|156341482|FG003|Overall Study|Adverse Event|13|||
48586909|NCT00772005|156341479|FG000|Overall Study|Lack of Efficacy|0|||
48586910|NCT00772005|156341480|FG001|Overall Study|Lack of Efficacy|1|||
48586911|NCT00772005|156341481|FG002|Overall Study|Lack of Efficacy|0|||
48586912|NCT00772005|156341482|FG003|Overall Study|Lack of Efficacy|0|||
48586913|NCT00772005|156341479|FG000|Overall Study|Withdrawal by Subject|3|||
48586914|NCT00772005|156341480|FG001|Overall Study|Withdrawal by Subject|7|||
48586915|NCT00772005|156341481|FG002|Overall Study|Withdrawal by Subject|10|||
48586916|NCT00772005|156341482|FG003|Overall Study|Withdrawal by Subject|2|||
48586917|NCT00772005|156341479|FG000|Overall Study|Protocol Violation|2|||
48586918|NCT00772005|156341480|FG001|Overall Study|Protocol Violation|4|||
48586919|NCT00772005|156341481|FG002|Overall Study|Protocol Violation|1|||
48586920|NCT00772005|156341482|FG003|Overall Study|Protocol Violation|6|||
48586921|NCT00772005|156341479|FG000|Overall Study|Lost to Follow-up|7|||
48586922|NCT00772005|156341480|FG001|Overall Study|Lost to Follow-up|3|||
48586923|NCT00772005|156341481|FG002|Overall Study|Lost to Follow-up|6|||
48586924|NCT00772005|156341482|FG003|Overall Study|Lost to Follow-up|3|||
48586925|NCT00772005|156341479|FG000|Overall Study|Non-compliance with study procedures|1|||
48586926|NCT00772005|156341480|FG001|Overall Study|Non-compliance with study procedures|1|||
48690011|NCT00101686|156715569|FG009|Overall Study|Withdrawal by Subject|9|||
48690012|NCT00702702|156715570|FG000|Overall Study|Study prematurely terminated|56|||
48690013|NCT01814527|156715573|FG000|Overall Study|RTP greater than 30 days|6|||
48690014|NCT01814527|156715574|FG001|Overall Study|RTP greater than 30 days|1|||
48690015|NCT00549640|156715575|FG000|Overall Study|Withdrawal by Subject|6|||
48392921|NCT01500278|155634132|FG001|Week 13 - Week 104|Protocol deviation|0|||
48392922|NCT01500278|155634131|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
48392923|NCT01500278|155634132|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
48392924|NCT01500278|155634131|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
48392925|NCT01500278|155634132|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
48392926|NCT01500278|155634131|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
48392927|NCT01500278|155634132|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
48690016|NCT00549640|156715576|FG001|Overall Study|Withdrawal by Subject|12|||
48690017|NCT00549640|156715575|FG000|Overall Study|Adverse Event|5|||
48690018|NCT00549640|156715576|FG001|Overall Study|Adverse Event|0|||
48690019|NCT00549640|156715575|FG000|Overall Study|Lost to Follow-up|7|||
48690020|NCT00549640|156715576|FG001|Overall Study|Lost to Follow-up|4|||
48690021|NCT02920892|156715579|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
48690022|NCT02920892|156715580|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
48690023|NCT02920892|156715581|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
48690024|NCT02920892|156715579|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
48690025|NCT02920892|156715580|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
48690026|NCT02920892|156715581|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
48690027|NCT02920892|156715579|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
48690028|NCT02920892|156715580|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
48690029|NCT02920892|156715581|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
48690030|NCT02920892|156715579|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
48690031|NCT02920892|156715580|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
48690032|NCT02920892|156715581|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
48690033|NCT02920892|156715579|FG000|Placebo-Controlled Period|Physician Decision|0|||
48690034|NCT02920892|156715580|FG001|Placebo-Controlled Period|Physician Decision|0|||
48690035|NCT02920892|156715581|FG002|Placebo-Controlled Period|Physician Decision|1|||
48690036|NCT02920892|156715579|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
48690037|NCT02920892|156715580|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
48690038|NCT02920892|156715581|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
48690039|NCT02920892|156715579|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48690040|NCT02920892|156715580|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
48690041|NCT02920892|156715581|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
48690042|NCT02920892|156715579|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
48690043|NCT02920892|156715580|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
48690044|NCT02920892|156715581|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
48690045|NCT03827655|156715586|FG000|Overall Study|Death|0|||
48690046|NCT03827655|156715587|FG001|Overall Study|Death|0|||
48690047|NCT03827655|156715588|FG002|Overall Study|Death|0|||
48690048|NCT03827655|156715589|FG003|Overall Study|Death|0|||
48690049|NCT03827655|156715590|FG004|Overall Study|Death|1|||
48690050|NCT03827655|156715586|FG000|Overall Study|Protocol Deviation|1|||
48690051|NCT03827655|156715587|FG001|Overall Study|Protocol Deviation|0|||
48690052|NCT03827655|156715588|FG002|Overall Study|Protocol Deviation|1|||
48690053|NCT03827655|156715589|FG003|Overall Study|Protocol Deviation|1|||
48690054|NCT03827655|156715590|FG004|Overall Study|Protocol Deviation|0|||
48690055|NCT03827655|156715586|FG000|Overall Study|Withdrawal by Subject|3|||
48690056|NCT03827655|156715587|FG001|Overall Study|Withdrawal by Subject|2|||
48690057|NCT03827655|156715588|FG002|Overall Study|Withdrawal by Subject|2|||
48690058|NCT03827655|156715589|FG003|Overall Study|Withdrawal by Subject|0|||
48690059|NCT03827655|156715590|FG004|Overall Study|Withdrawal by Subject|1|||
48690060|NCT03827655|156715586|FG000|Overall Study|Reason not Specified|3|||
48690061|NCT03827655|156715587|FG001|Overall Study|Reason not Specified|1|||
48690062|NCT03827655|156715588|FG002|Overall Study|Reason not Specified|1|||
48690063|NCT03827655|156715589|FG003|Overall Study|Reason not Specified|1|||
48690064|NCT03827655|156715590|FG004|Overall Study|Reason not Specified|1|||
48690065|NCT04486235|156715591|FG000|Overall Study|Pregnancy|1|||
48690066|NCT04486235|156715592|FG001|Overall Study|Pregnancy|0|||
48690067|NCT04486235|156715591|FG000|Overall Study|Lost to Follow-up|1|||
48690068|NCT04486235|156715592|FG001|Overall Study|Lost to Follow-up|0|||
48690069|NCT00644358|156715603|FG000|Overall Study|Adverse Event|124|||
48392928|NCT01500278|155634131|FG000|Week 13 - Week 104|Relocation|0|||
48690070|NCT00644358|156715603|FG000|Overall Study|Lost to Follow-up|105|||
48690071|NCT00644358|156715603|FG000|Overall Study|Consent Withdrawal|64|||
48690072|NCT00644358|156715603|FG000|Overall Study|Lack of Effectiveness|39|||
48690073|NCT00644358|156715603|FG000|Overall Study|Protocol Violation|5|||
48690074|NCT00644358|156715603|FG000|Overall Study|Noncompliance|14|||
48392929|NCT01500278|155634132|FG001|Week 13 - Week 104|Relocation|1|||
48392930|NCT01500278|155634131|FG000|Week 13 - Week 104|Sponsor decision|0|||
48392931|NCT01500278|155634132|FG001|Week 13 - Week 104|Sponsor decision|2|||
48392932|NCT01500278|155634131|FG000|Week 13 - Week 104|Medical monitor decision|0|||
48392933|NCT01500278|155634132|FG001|Week 13 - Week 104|Medical monitor decision|2|||
48690075|NCT00644358|156715603|FG000|Overall Study|Other Unspecified|11|||
48690076|NCT00651924|156715605|FG000|Overall Study|Withdrawal by PI|0|||
48690077|NCT00651924|156715606|FG001|Overall Study|Withdrawal by PI|2|||
48690078|NCT00651924|156715605|FG000|Overall Study|Withdrawal by Subject|0|||
48690079|NCT00651924|156715606|FG001|Overall Study|Withdrawal by Subject|5|||
48690080|NCT00960063|156715607|FG000|Overall Study|Adverse Event|1|||
48690081|NCT00960063|156715608|FG001|Overall Study|Adverse Event|0|||
48690082|NCT00960063|156715609|FG002|Overall Study|Adverse Event|0|||
48690083|NCT00960063|156715607|FG000|Overall Study|Progression of Disease|0|||
48690084|NCT00960063|156715608|FG001|Overall Study|Progression of Disease|0|||
48690085|NCT00960063|156715609|FG002|Overall Study|Progression of Disease|3|||
48690086|NCT00317473|156715612|FG000|Overall Study|Withdrawal by Subject|2|||
48690087|NCT00317473|156715613|FG001|Overall Study|Withdrawal by Subject|1|||
48690088|NCT00317473|156715614|FG002|Overall Study|Withdrawal by Subject|2|||
48690089|NCT00317473|156715615|FG003|Overall Study|Withdrawal by Subject|1|||
48690090|NCT00317473|156715616|FG004|Overall Study|Withdrawal by Subject|3|||
48690091|NCT00317473|156715617|FG005|Overall Study|Withdrawal by Subject|1|||
48690092|NCT00317473|156715612|FG000|Overall Study|Relocation|1|||
48690093|NCT00317473|156715613|FG001|Overall Study|Relocation|0|||
48690094|NCT00317473|156715614|FG002|Overall Study|Relocation|1|||
48690095|NCT00317473|156715615|FG003|Overall Study|Relocation|1|||
48690096|NCT00317473|156715616|FG004|Overall Study|Relocation|5|||
48690097|NCT00317473|156715617|FG005|Overall Study|Relocation|2|||
48690098|NCT00317473|156715612|FG000|Overall Study|Death|1|||
48690099|NCT00317473|156715613|FG001|Overall Study|Death|0|||
48690100|NCT00317473|156715614|FG002|Overall Study|Death|0|||
48690101|NCT00317473|156715615|FG003|Overall Study|Death|0|||
48690102|NCT00317473|156715616|FG004|Overall Study|Death|0|||
48690103|NCT00317473|156715617|FG005|Overall Study|Death|0|||
48690104|NCT00317473|156715612|FG000|Overall Study|Other|0|||
48690105|NCT00317473|156715613|FG001|Overall Study|Other|2|||
48690106|NCT00317473|156715614|FG002|Overall Study|Other|0|||
48690107|NCT00317473|156715615|FG003|Overall Study|Other|0|||
48690108|NCT00317473|156715616|FG004|Overall Study|Other|0|||
48690109|NCT00317473|156715617|FG005|Overall Study|Other|0|||
48690110|NCT01611792|156715618|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
48763704|NCT02155738|156985710|FG002|Overall Study|Missing critical information|0|||
48763705|NCT02155738|156985711|FG003|Overall Study|Missing critical information|1|||
48690111|NCT01611792|156715619|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
48690112|NCT01611792|156715618|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
48690113|NCT01611792|156715619|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
48690114|NCT01759420|156715620|FG000|Overall Study|Screen failure|5|||
48690115|NCT01759420|156715620|FG000|Overall Study|Inaccurate EKG machine readings|1|||
48763706|NCT00112502|156985712|FG000|Overall Study|Withdrawal by Subject|0|||
48763707|NCT00112502|156985713|FG001|Overall Study|Withdrawal by Subject|1|||
48763708|NCT00112502|156985714|FG002|Overall Study|Withdrawal by Subject|1|||
48763709|NCT00112502|156985715|FG003|Overall Study|Withdrawal by Subject|4|||
48763710|NCT00112502|156985716|FG004|Overall Study|Withdrawal by Subject|2|||
48763711|NCT00112502|156985717|FG005|Overall Study|Withdrawal by Subject|5|||
48763712|NCT00112502|156985718|FG006|Overall Study|Withdrawal by Subject|3|||
48763713|NCT00112502|156985719|FG007|Overall Study|Withdrawal by Subject|7|||
48763714|NCT00914810|156985722|FG000|Overall Study|Withdrawal by Subject|1|||
48763715|NCT00914810|156985723|FG001|Overall Study|Withdrawal by Subject|0|||
48763716|NCT00914810|156985722|FG000|Overall Study|Relocated out of state|1|||
48392934|NCT01500278|155634131|FG000|Week 13 - Week 104|Personal reason|0|||
48690116|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
48690117|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
48690118|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
48690119|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
48690120|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
48690121|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
48690122|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
48690123|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
48690124|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
48690125|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
48690126|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
48690127|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
48690128|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
48392935|NCT01500278|155634132|FG001|Week 13 - Week 104|Personal reason|1|||
48392936|NCT01500278|155634131|FG000|Week 13 - Week 104|Not completed|0|||
48690129|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
48690130|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
48690131|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
48690132|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
48690133|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
48690134|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
48690135|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
48690136|NCT01329978|156715621|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
48690137|NCT01329978|156715622|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
48690138|NCT01329978|156715623|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
48690139|NCT01329978|156715624|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
48690140|NCT01329978|156715625|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
48690141|NCT01329978|156715621|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
48690142|NCT01329978|156715622|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
48690143|NCT01329978|156715623|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
48690144|NCT01329978|156715624|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
48690145|NCT01329978|156715625|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
48690146|NCT01329978|156715621|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
48690147|NCT01329978|156715622|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
48690148|NCT01329978|156715623|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
48690149|NCT01329978|156715624|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
48690150|NCT01329978|156715625|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
48690151|NCT00960375|156715626|FG000|Overall Study|Lost to Follow-up|20|||
48690152|NCT00960375|156715627|FG001|Overall Study|Lost to Follow-up|22|||
48690153|NCT00689390|156715628|FG000|Overall Study|Adverse Event|19|||
48690154|NCT00689390|156715629|FG001|Overall Study|Adverse Event|0|||
48690155|NCT00689390|156715628|FG000|Overall Study|Lost to Follow-up|179|||
48690156|NCT00689390|156715629|FG001|Overall Study|Lost to Follow-up|7|||
48690157|NCT00689390|156715628|FG000|Overall Study|Withdrawal by Subject|117|||
48690158|NCT00689390|156715629|FG001|Overall Study|Withdrawal by Subject|3|||
48690159|NCT00689390|156715628|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
48690160|NCT00689390|156715629|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
48690161|NCT00689390|156715628|FG000|Overall Study|Non-Compliance With Protocol|21|||
48690162|NCT00689390|156715629|FG001|Overall Study|Non-Compliance With Protocol|0|||
48690163|NCT00689390|156715628|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
48690164|NCT00689390|156715629|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
48690165|NCT00689390|156715628|FG000|Overall Study|Administrative|37|||
48690166|NCT00689390|156715629|FG001|Overall Study|Administrative|0|||
48690167|NCT03557970|156715630|FG000|Overall Study|Study closure|1|||
48690168|NCT03557970|156715631|FG001|Overall Study|Study closure|0|||
48690169|NCT03557970|156715630|FG000|Overall Study|Physician Decision|0|||
48690170|NCT03557970|156715631|FG001|Overall Study|Physician Decision|1|||
48690171|NCT03557970|156715630|FG000|Overall Study|Death|0|||
48690172|NCT03557970|156715631|FG001|Overall Study|Death|1|||
48690173|NCT03071263|156715632|FG000|Overall Study|Adverse Event|1|||
48690174|NCT03071263|156715633|FG001|Overall Study|Adverse Event|3|||
48690175|NCT03071263|156715632|FG000|Overall Study|Withdrawal by Subject|1|||
48690176|NCT03071263|156715633|FG001|Overall Study|Withdrawal by Subject|3|||
48690177|NCT03071263|156715632|FG000|Overall Study|Physician Decision|1|||
48690178|NCT03071263|156715633|FG001|Overall Study|Physician Decision|0|||
48690179|NCT03071263|156715632|FG000|Overall Study|Participant moved to another city|0|||
48690180|NCT03071263|156715633|FG001|Overall Study|Participant moved to another city|1|||
48690181|NCT04258423|156715638|FG000|Overall Study|Study Closure|2|||
48690182|NCT04258423|156715639|FG001|Overall Study|Study Closure|2|||
48690183|NCT01601535|156715640|FG000|Phase 1|Adverse Event|1|||
48690184|NCT01601535|156715641|FG001|Phase 1|Adverse Event|0|||
48690185|NCT01601535|156715642|FG002|Phase 1|Adverse Event|2|||
48690186|NCT01601535|156715643|FG003|Phase 1|Adverse Event|1|||
48690187|NCT01601535|156715644|FG004|Phase 1|Adverse Event|0|||
48690188|NCT01601535|156715645|FG005|Phase 1|Adverse Event|0|||
48690189|NCT01601535|156715640|FG000|Phase 1|Withdrawal by Subject|2|||
48690190|NCT01601535|156715641|FG001|Phase 1|Withdrawal by Subject|1|||
48690191|NCT01601535|156715642|FG002|Phase 1|Withdrawal by Subject|1|||
48690192|NCT01601535|156715643|FG003|Phase 1|Withdrawal by Subject|2|||
48690193|NCT01601535|156715644|FG004|Phase 1|Withdrawal by Subject|0|||
48690194|NCT01601535|156715645|FG005|Phase 1|Withdrawal by Subject|0|||
48690195|NCT01601535|156715640|FG000|Phase 1|Progressive Disease|2|||
48690196|NCT01601535|156715641|FG001|Phase 1|Progressive Disease|3|||
48690197|NCT01601535|156715642|FG002|Phase 1|Progressive Disease|2|||
48690198|NCT01601535|156715643|FG003|Phase 1|Progressive Disease|1|||
48690199|NCT01601535|156715644|FG004|Phase 1|Progressive Disease|0|||
48690200|NCT01601535|156715645|FG005|Phase 1|Progressive Disease|0|||
48690201|NCT01601535|156715640|FG000|Phase 1|Started Another Treatment|1|||
48690202|NCT01601535|156715641|FG001|Phase 1|Started Another Treatment|2|||
48690203|NCT01601535|156715642|FG002|Phase 1|Started Another Treatment|0|||
48690204|NCT01601535|156715643|FG003|Phase 1|Started Another Treatment|0|||
48690205|NCT01601535|156715644|FG004|Phase 1|Started Another Treatment|0|||
48690206|NCT01601535|156715645|FG005|Phase 1|Started Another Treatment|0|||
48690207|NCT01601535|156715640|FG000|Phase 2|Adverse Event|0|||
48690208|NCT01601535|156715641|FG001|Phase 2|Adverse Event|0|||
48690209|NCT01601535|156715642|FG002|Phase 2|Adverse Event|0|||
48690210|NCT01601535|156715643|FG003|Phase 2|Adverse Event|0|||
48690211|NCT01601535|156715644|FG004|Phase 2|Adverse Event|5|||
48690212|NCT01601535|156715645|FG005|Phase 2|Adverse Event|1|||
48690213|NCT01601535|156715640|FG000|Phase 2|Withdrawal by Subject|0|||
48690214|NCT01601535|156715641|FG001|Phase 2|Withdrawal by Subject|0|||
48690215|NCT01601535|156715642|FG002|Phase 2|Withdrawal by Subject|0|||
48690216|NCT01601535|156715643|FG003|Phase 2|Withdrawal by Subject|0|||
48690217|NCT01601535|156715644|FG004|Phase 2|Withdrawal by Subject|8|||
48690218|NCT01601535|156715645|FG005|Phase 2|Withdrawal by Subject|2|||
48690219|NCT01601535|156715640|FG000|Phase 2|Progressive Disease|0|||
48690220|NCT01601535|156715641|FG001|Phase 2|Progressive Disease|0|||
48690221|NCT01601535|156715642|FG002|Phase 2|Progressive Disease|0|||
48690222|NCT01601535|156715643|FG003|Phase 2|Progressive Disease|0|||
48690223|NCT01601535|156715644|FG004|Phase 2|Progressive Disease|5|||
48690224|NCT01601535|156715645|FG005|Phase 2|Progressive Disease|7|||
48690225|NCT01601535|156715640|FG000|Phase 2|Started Another Treatment|0|||
48690226|NCT01601535|156715641|FG001|Phase 2|Started Another Treatment|0|||
48690227|NCT01601535|156715642|FG002|Phase 2|Started Another Treatment|0|||
48690228|NCT01601535|156715643|FG003|Phase 2|Started Another Treatment|0|||
48690229|NCT01601535|156715644|FG004|Phase 2|Started Another Treatment|1|||
48690230|NCT01601535|156715645|FG005|Phase 2|Started Another Treatment|2|||
48690231|NCT03084796|156715646|FG000|Overall Study|Adverse Event|4|||
48690232|NCT03084796|156715647|FG001|Overall Study|Adverse Event|5|||
48690233|NCT03084796|156715648|FG002|Overall Study|Adverse Event|6|||
48690234|NCT03084796|156715649|FG003|Overall Study|Adverse Event|2|||
48690235|NCT03084796|156715650|FG004|Overall Study|Adverse Event|3|||
48690236|NCT03084796|156715651|FG005|Overall Study|Adverse Event|5|||
48690237|NCT03084796|156715646|FG000|Overall Study|Withdrawal by Subject|3|||
48690238|NCT03084796|156715647|FG001|Overall Study|Withdrawal by Subject|5|||
48690239|NCT03084796|156715648|FG002|Overall Study|Withdrawal by Subject|2|||
48690240|NCT03084796|156715649|FG003|Overall Study|Withdrawal by Subject|1|||
48690241|NCT03084796|156715650|FG004|Overall Study|Withdrawal by Subject|3|||
48690242|NCT03084796|156715651|FG005|Overall Study|Withdrawal by Subject|0|||
48690243|NCT03084796|156715646|FG000|Overall Study|Protocol Violation|0|||
48690244|NCT03084796|156715647|FG001|Overall Study|Protocol Violation|0|||
48690245|NCT03084796|156715648|FG002|Overall Study|Protocol Violation|1|||
48690246|NCT03084796|156715649|FG003|Overall Study|Protocol Violation|0|||
48690247|NCT03084796|156715650|FG004|Overall Study|Protocol Violation|1|||
48690248|NCT03084796|156715651|FG005|Overall Study|Protocol Violation|1|||
48690249|NCT03084796|156715646|FG000|Overall Study|Lack of Efficacy|0|||
48690250|NCT03084796|156715647|FG001|Overall Study|Lack of Efficacy|0|||
48690251|NCT03084796|156715648|FG002|Overall Study|Lack of Efficacy|1|||
48690252|NCT03084796|156715649|FG003|Overall Study|Lack of Efficacy|0|||
48763717|NCT00914810|156985723|FG001|Overall Study|Relocated out of state|0|||
48690253|NCT03084796|156715650|FG004|Overall Study|Lack of Efficacy|1|||
48690254|NCT03084796|156715651|FG005|Overall Study|Lack of Efficacy|0|||
48690255|NCT03084796|156715646|FG000|Overall Study|Lost to Follow-up|0|||
48690256|NCT03084796|156715647|FG001|Overall Study|Lost to Follow-up|0|||
48690257|NCT03084796|156715648|FG002|Overall Study|Lost to Follow-up|1|||
48690258|NCT03084796|156715649|FG003|Overall Study|Lost to Follow-up|1|||
48690259|NCT03084796|156715650|FG004|Overall Study|Lost to Follow-up|3|||
48690260|NCT03084796|156715651|FG005|Overall Study|Lost to Follow-up|1|||
48763718|NCT00914810|156985722|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
48355391|NCT04596995|155498492|FG000|Overall Study|Lost to Follow-up|3|||
48690261|NCT03084796|156715646|FG000|Overall Study|Randomization error|0|||
48690262|NCT03084796|156715647|FG001|Overall Study|Randomization error|0|||
48690263|NCT03084796|156715648|FG002|Overall Study|Randomization error|1|||
48690264|NCT03084796|156715649|FG003|Overall Study|Randomization error|0|||
48690265|NCT03084796|156715650|FG004|Overall Study|Randomization error|0|||
48690266|NCT03084796|156715651|FG005|Overall Study|Randomization error|0|||
48690267|NCT00141102|156715657|FG000|Overall Study|Adverse Event|233|||
48690268|NCT00141102|156715658|FG001|Overall Study|Adverse Event|305|||
48690269|NCT00141102|156715657|FG000|Overall Study|Laboratory Abnormality|9|||
48690270|NCT00141102|156715658|FG001|Overall Study|Laboratory Abnormality|33|||
48690271|NCT00141102|156715657|FG000|Overall Study|Lack of Efficacy|21|||
48690272|NCT00141102|156715658|FG001|Overall Study|Lack of Efficacy|26|||
48690273|NCT00141102|156715657|FG000|Overall Study|Lost to Follow-up|29|||
48690274|NCT00141102|156715658|FG001|Overall Study|Lost to Follow-up|32|||
48690275|NCT00141102|156715657|FG000|Overall Study|Other|87|||
48690276|NCT00141102|156715658|FG001|Overall Study|Other|76|||
48690277|NCT00141102|156715657|FG000|Overall Study|Withdrawal by Subject|112|||
48690278|NCT00141102|156715658|FG001|Overall Study|Withdrawal by Subject|142|||
48690279|NCT00141102|156715657|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
48690280|NCT00141102|156715658|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
48690281|NCT00141102|156715657|FG000|Overall Study|Death|2|||
48690282|NCT00141102|156715658|FG001|Overall Study|Death|2|||
48690283|NCT04388111|156717557|FG000|Overall Study|Lost to Follow-up|5|||
48690284|NCT04388111|156717558|FG001|Overall Study|Lost to Follow-up|3|||
48690285|NCT04388111|156717557|FG000|Overall Study|Adverse Event|1|||
48690286|NCT04388111|156717558|FG001|Overall Study|Adverse Event|1|||
48690287|NCT04388111|156717557|FG000|Overall Study|Protocol Violation|2|||
48690288|NCT04388111|156717558|FG001|Overall Study|Protocol Violation|4|||
48690289|NCT04388111|156717557|FG000|Overall Study|Withdrawal by Subject|1|||
48690290|NCT04388111|156717558|FG001|Overall Study|Withdrawal by Subject|0|||
48690291|NCT01790594|156717566|FG000|Overall Study|Death|1|||
48690292|NCT01790594|156717567|FG001|Overall Study|Death|0|||
48690293|NCT01790594|156717568|FG002|Overall Study|Death|0|||
48690294|NCT01790594|156717566|FG000|Overall Study|Physician Decision|2|||
48690295|NCT01790594|156717567|FG001|Overall Study|Physician Decision|1|||
48690296|NCT01790594|156717568|FG002|Overall Study|Physician Decision|0|||
48690297|NCT01790594|156717566|FG000|Overall Study|Withdrawal by Subject|2|||
48690298|NCT01790594|156717567|FG001|Overall Study|Withdrawal by Subject|0|||
48690299|NCT01790594|156717568|FG002|Overall Study|Withdrawal by Subject|0|||
48690300|NCT01790594|156717566|FG000|Overall Study|Transplant was not done|0|||
48690301|NCT01790594|156717567|FG001|Overall Study|Transplant was not done|0|||
48690302|NCT01790594|156717568|FG002|Overall Study|Transplant was not done|3|||
48690303|NCT01790594|156717566|FG000|Overall Study|Terminated prior to week 76|0|||
48690304|NCT01790594|156717567|FG001|Overall Study|Terminated prior to week 76|2|||
48690305|NCT01790594|156717568|FG002|Overall Study|Terminated prior to week 76|0|||
48690306|NCT03683173|156717577|FG000|Completed Follow-up|Unavailable|235|||
48690307|NCT03683173|156717578|FG001|Completed Follow-up|Unavailable|217|||
48690308|NCT03683173|156717577|FG000|Completed Follow-up|Refused|69|||
48690309|NCT03683173|156717578|FG001|Completed Follow-up|Refused|59|||
48690310|NCT03683173|156717577|FG000|Completed Follow-up|Disconnected phone|65|||
48690311|NCT03683173|156717578|FG001|Completed Follow-up|Disconnected phone|95|||
48690312|NCT03683173|156717577|FG000|Completed Follow-up|Health issue/deceased|10|||
48690313|NCT03683173|156717578|FG001|Completed Follow-up|Health issue/deceased|4|||
48690314|NCT03683173|156717577|FG000|Completed Follow-up|Moved away|8|||
48690315|NCT03683173|156717578|FG001|Completed Follow-up|Moved away|1|||
48690316|NCT03016312|156717579|FG000|Overall Study|discontinued before the treatment started|0|||
48690317|NCT03016312|156717580|FG001|Overall Study|discontinued before the treatment started|1|||
48690318|NCT03016312|156717579|FG000|Overall Study|Withdrawal by Subject|37|||
48690319|NCT03016312|156717580|FG001|Overall Study|Withdrawal by Subject|44|||
48690320|NCT03016312|156717579|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
48690321|NCT03016312|156717580|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
48690322|NCT03016312|156717579|FG000|Overall Study|Physician Decision|1|||
48690323|NCT03016312|156717580|FG001|Overall Study|Physician Decision|3|||
48690324|NCT03016312|156717579|FG000|Overall Study|Lost to Follow-up|12|||
48690325|NCT03016312|156717580|FG001|Overall Study|Lost to Follow-up|12|||
48690326|NCT03016312|156717579|FG000|Overall Study|Death|210|||
48690327|NCT03016312|156717580|FG001|Overall Study|Death|184|||
48690328|NCT03016312|156717579|FG000|Overall Study|loss to contact|1|||
48690329|NCT03016312|156717580|FG001|Overall Study|loss to contact|0|||
48690330|NCT03016312|156717579|FG000|Overall Study|started a new cancer therapy|1|||
48690331|NCT03016312|156717580|FG001|Overall Study|started a new cancer therapy|0|||
48690332|NCT01050634|156717581|FG000|Overall Study|Enrolled, but Not Treated|56|||
48690333|NCT01050634|156717581|FG000|Overall Study|Death|2|||
48690334|NCT01050634|156717581|FG000|Overall Study|Adverse Event|42|||
48690335|NCT01050634|156717581|FG000|Overall Study|Lost to Follow-up|2|||
48690336|NCT01050634|156717581|FG000|Overall Study|Other|21|||
48690337|NCT01050634|156717581|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
48690338|NCT01855412|156717584|FG000|Overall Study|Death|77|||
48690339|NCT01855412|156717585|FG001|Overall Study|Death|123|||
48690340|NCT01855412|156717586|FG002|Overall Study|Death|30|||
48690341|NCT01855412|156717584|FG000|Overall Study|Lost to Follow-up|28|||
48690342|NCT01855412|156717585|FG001|Overall Study|Lost to Follow-up|46|||
48690343|NCT01855412|156717586|FG002|Overall Study|Lost to Follow-up|15|||
48690344|NCT01855412|156717584|FG000|Overall Study|Withdrawal by Subject|77|||
48690345|NCT01855412|156717585|FG001|Overall Study|Withdrawal by Subject|123|||
48690346|NCT01855412|156717586|FG002|Overall Study|Withdrawal by Subject|24|||
48690347|NCT01855412|156717584|FG000|Overall Study|Physician Decision|25|||
48392937|NCT01500278|155634132|FG001|Week 13 - Week 104|Not completed|1|||
48690348|NCT01855412|156717585|FG001|Overall Study|Physician Decision|31|||
48690349|NCT01855412|156717586|FG002|Overall Study|Physician Decision|3|||
48690350|NCT01855412|156717584|FG000|Overall Study|Site Closure|4|||
48690351|NCT01855412|156717585|FG001|Overall Study|Site Closure|18|||
48690352|NCT01855412|156717586|FG002|Overall Study|Site Closure|1|||
48690353|NCT01855412|156717584|FG000|Overall Study|Reason not Specified|1|||
48690354|NCT01855412|156717585|FG001|Overall Study|Reason not Specified|2|||
48690355|NCT01855412|156717586|FG002|Overall Study|Reason not Specified|3|||
48690356|NCT00423657|156717592|FG000|Overall Study|Withdrew consent|10|||
48690357|NCT00423657|156717593|FG001|Overall Study|Withdrew consent|8|||
48690358|NCT00423657|156717592|FG000|Overall Study|Non-compliance|0|||
48690359|NCT00423657|156717593|FG001|Overall Study|Non-compliance|1|||
48690360|NCT00423657|156717592|FG000|Overall Study|Other|15|||
48690361|NCT00423657|156717593|FG001|Overall Study|Other|16|||
48690362|NCT00423657|156717592|FG000|Overall Study|Request of sponsor/investigator|1|||
48690363|NCT00423657|156717593|FG001|Overall Study|Request of sponsor/investigator|0|||
48690364|NCT03206216|156717594|FG000|Overall Study|Withdrawal by Subject|0|||
48690365|NCT03206216|156717595|FG001|Overall Study|Withdrawal by Subject|1|||
48690366|NCT00286442|156717598|FG000|Overall Study|Hyperglycemic Rescue|19|||
48690367|NCT00286442|156717599|FG001|Overall Study|Hyperglycemic Rescue|17|||
48690368|NCT00286442|156717600|FG002|Overall Study|Hyperglycemic Rescue|25|||
48392938|NCT01500278|155634131|FG000|Week 13 - Week 104|Death|2|||
48392939|NCT01500278|155634132|FG001|Week 13 - Week 104|Death|4|||
48392940|NCT01500278|155634131|FG000|Week 13 - Week 104|Adverse Event|54|||
48392941|NCT01500278|155634132|FG001|Week 13 - Week 104|Adverse Event|54|||
48392942|NCT04315181|155634133|FG000|Overall Study|Non-responsive to drug conditions.|1|||
48392943|NCT03901079|155634134|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
48392944|NCT02830776|155634138|FG000|Overall Study|Lost to Follow-up|1|||
48392945|NCT00906087|155634139|FG000|Initial Washout|Withdrawal by Subject|1|||
48392946|NCT00906087|155634139|FG000|Initial Washout|Physician Decision|1|||
48392947|NCT01765920|155634142|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
48392948|NCT01765920|155634143|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
48392949|NCT01765920|155634142|FG000|Overall Study|Patient code disclosure|0|||
48392950|NCT01765920|155634143|FG001|Overall Study|Patient code disclosure|1|||
48690369|NCT00286442|156717598|FG000|Overall Study|Adverse Event|7|||
48690370|NCT00286442|156717599|FG001|Overall Study|Adverse Event|6|||
48690371|NCT00286442|156717600|FG002|Overall Study|Adverse Event|1|||
48690372|NCT00286442|156717598|FG000|Overall Study|Protocol Violation|2|||
48690373|NCT00286442|156717599|FG001|Overall Study|Protocol Violation|4|||
48690374|NCT00286442|156717600|FG002|Overall Study|Protocol Violation|2|||
48690375|NCT00286442|156717598|FG000|Overall Study|Lost to Follow-up|5|||
48690376|NCT00286442|156717599|FG001|Overall Study|Lost to Follow-up|2|||
48690377|NCT00286442|156717600|FG002|Overall Study|Lost to Follow-up|1|||
48690378|NCT00286442|156717598|FG000|Overall Study|Physician Decision|1|||
48690379|NCT00286442|156717599|FG001|Overall Study|Physician Decision|1|||
48690380|NCT00286442|156717600|FG002|Overall Study|Physician Decision|1|||
48690381|NCT00286442|156717598|FG000|Overall Study|Administrative Error|1|||
48392951|NCT01081249|155634144|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
48690382|NCT00286442|156717599|FG001|Overall Study|Administrative Error|1|||
48690383|NCT00286442|156717600|FG002|Overall Study|Administrative Error|0|||
48690384|NCT00286442|156717598|FG000|Overall Study|Withdrawal by Subject|2|||
48690385|NCT00286442|156717599|FG001|Overall Study|Withdrawal by Subject|14|||
48690386|NCT00286442|156717600|FG002|Overall Study|Withdrawal by Subject|2|||
48690387|NCT01546857|156717601|FG000|Overall Study|Withdrawal by Subject|2|||
48690388|NCT01546857|156717602|FG001|Overall Study|Withdrawal by Subject|3|||
48690389|NCT01859923|156717603|FG000|Overall Study|Adverse Event|0|||
48690390|NCT01859923|156717604|FG001|Overall Study|Adverse Event|0|||
48690391|NCT01859923|156717605|FG002|Overall Study|Adverse Event|1|||
48690392|NCT01859923|156717606|FG003|Overall Study|Adverse Event|1|||
48690393|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
48690394|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
48690395|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Disease progression|75|||
48690396|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Disease progression|59|||
48690397|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Adverse Event|16|||
48690398|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Adverse Event|16|||
48690399|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Death|2|||
48690400|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Death|3|||
48690401|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
48690402|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
48690403|NCT00883779|156717610|FG000|Primary Study Treatment Phase|Other|3|||
48690404|NCT00883779|156717611|FG001|Primary Study Treatment Phase|Other|0|||
48392952|NCT01081249|155634145|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
48392953|NCT00777101|155634149|FG000|Overall Study|Death|48|||
48392954|NCT00777101|155634150|FG001|Overall Study|Death|43|||
48392955|NCT00777101|155634149|FG000|Overall Study|Withdrawal by Subject|11|||
48426299|NCT00064662|155749535|FG000|Overall Study|Lost to Follow-up|57|||
48690405|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Adverse Event|2|||
48690406|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Adverse Event|3|||
48690407|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Death|1|||
48690408|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Death|3|||
48690409|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
48690410|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
48690411|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
48690412|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
48690413|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Disease progression|103|||
48690414|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Disease progression|122|||
48690415|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Other|3|||
48690416|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Other|0|||
48690417|NCT00883779|156717610|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
48690418|NCT00883779|156717611|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
48690419|NCT00883779|156717610|FG000|Off-study Phase|Death|185|||
48690420|NCT00883779|156717611|FG001|Off-study Phase|Death|174|||
48690421|NCT00883779|156717610|FG000|Off-study Phase|Refused treatment|1|||
48690422|NCT00883779|156717611|FG001|Off-study Phase|Refused treatment|1|||
48690423|NCT00883779|156717610|FG000|Off-study Phase|Failure to return|5|||
48690424|NCT00883779|156717611|FG001|Off-study Phase|Failure to return|6|||
48690425|NCT00883779|156717610|FG000|Off-study Phase|Other|18|||
48690426|NCT00883779|156717611|FG001|Off-study Phase|Other|21|||
48690427|NCT00475670|156717614|FG000|Overall Study|Death|0|||
48690428|NCT00475670|156717615|FG001|Overall Study|Death|1|||
48690429|NCT00475670|156717614|FG000|Overall Study|Lack of Efficacy|3|||
48690430|NCT00475670|156717615|FG001|Overall Study|Lack of Efficacy|34|||
48690431|NCT00475670|156717614|FG000|Overall Study|Refused treatment|0|||
48690432|NCT00475670|156717615|FG001|Overall Study|Refused treatment|2|||
48690433|NCT00475670|156717614|FG000|Overall Study|Failure to Return|0|||
48690434|NCT00475670|156717615|FG001|Overall Study|Failure to Return|1|||
48690435|NCT00475670|156717614|FG000|Overall Study|Other|0|||
48690436|NCT00475670|156717615|FG001|Overall Study|Other|3|||
48690437|NCT04590014|156717616|FG000|Overall Study|Withdrawal by Subject|1|||
48690438|NCT04590014|156717617|FG001|Overall Study|Withdrawal by Subject|0|||
48690439|NCT00399516|156717620|FG000|Overall Study|Lost to Follow-up|2|||
48690440|NCT01216202|156717621|FG000|Overall Study|Withdrawal by Subject|8|||
48690441|NCT01216202|156717622|FG001|Overall Study|Withdrawal by Subject|0|||
48690442|NCT01216202|156717621|FG000|Overall Study|Death|0|||
48690443|NCT01216202|156717622|FG001|Overall Study|Death|2|||
48690444|NCT01216202|156717621|FG000|Overall Study|Lost to Follow-up|14|||
48690445|NCT01216202|156717622|FG001|Overall Study|Lost to Follow-up|0|||
48690446|NCT01650558|156717623|FG000|Overall Study|Migration out of study area|61|||
48690447|NCT01650558|156717624|FG001|Overall Study|Migration out of study area|71|||
48690448|NCT01650558|156717625|FG002|Overall Study|Migration out of study area|56|||
48690449|NCT01650558|156717623|FG000|Overall Study|Lost to Follow-up|10|||
48690450|NCT01650558|156717624|FG001|Overall Study|Lost to Follow-up|13|||
48690451|NCT01650558|156717625|FG002|Overall Study|Lost to Follow-up|6|||
48392956|NCT00777101|155634150|FG001|Overall Study|Withdrawal by Subject|6|||
48392957|NCT00777101|155634149|FG000|Overall Study|Lost to Follow-up|2|||
48392958|NCT00777101|155634150|FG001|Overall Study|Lost to Follow-up|1|||
48392959|NCT00777101|155634149|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
48690452|NCT01650558|156717623|FG000|Overall Study|Death|10|||
48690453|NCT01650558|156717624|FG001|Overall Study|Death|6|||
48690454|NCT01650558|156717625|FG002|Overall Study|Death|8|||
48690455|NCT01650558|156717623|FG000|Overall Study|Withdrawal by Subject|1|||
48690456|NCT01650558|156717624|FG001|Overall Study|Withdrawal by Subject|1|||
48690457|NCT01650558|156717625|FG002|Overall Study|Withdrawal by Subject|3|||
48690458|NCT01650558|156717623|FG000|Overall Study|Non-compliant participant|1|||
48690459|NCT01650558|156717624|FG001|Overall Study|Non-compliant participant|0|||
48690460|NCT01650558|156717625|FG002|Overall Study|Non-compliant participant|2|||
48690461|NCT01650558|156717623|FG000|Overall Study|Physician Decision|0|||
48690462|NCT01650558|156717624|FG001|Overall Study|Physician Decision|1|||
48690463|NCT01650558|156717625|FG002|Overall Study|Physician Decision|0|||
48690464|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
48690465|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
48690466|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
48690467|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
48690468|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
48690469|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
48392960|NCT00777101|155634150|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48392961|NCT00777101|155634149|FG000|Overall Study|Failed to Return|0|||
48690470|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
48690471|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
48690472|NCT02960217|156717626|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
48690473|NCT02960217|156717627|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
48690474|NCT02960217|156717626|FG000|Open-Label Extension Phase|Adverse Event|1|||
48690475|NCT02960217|156717627|FG001|Open-Label Extension Phase|Adverse Event|0|||
48690476|NCT02960217|156717626|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
48690477|NCT02960217|156717627|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
48690478|NCT02960217|156717626|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
48690479|NCT02960217|156717627|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
48690480|NCT02960217|156717626|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
48690481|NCT02960217|156717627|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
48690482|NCT02519439|156717630|FG000|Overall Study|Study Termination|19|||
48690483|NCT02519439|156717630|FG000|Overall Study|Withdrawal by Subject|1|||
48690484|NCT02519439|156717630|FG000|Overall Study|Adverse Event|1|||
48690485|NCT01091675|156717631|FG000|Overall Study|Adverse Event|7|||
48690486|NCT01091675|156717631|FG000|Overall Study|Lack of Efficacy|27|||
48690487|NCT00528957|156717636|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
48690488|NCT00528957|156717637|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
48690489|NCT00528957|156717636|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
48690490|NCT00528957|156717637|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
48690491|NCT00528957|156717636|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
48690492|NCT00528957|156717637|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
48690493|NCT00528957|156717636|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
48690494|NCT00528957|156717637|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
48690495|NCT00528957|156717636|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
48690496|NCT00528957|156717637|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
48690497|NCT00528957|156717636|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
48690498|NCT00528957|156717637|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
48690499|NCT00528957|156717636|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
48690500|NCT00528957|156717637|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
48690501|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
48690502|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
48690503|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
48690504|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
48690505|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
48690506|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
48690507|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
48690508|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
48690509|NCT00528957|156717636|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
48690510|NCT00528957|156717637|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
48690511|NCT00528957|156717636|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
48690512|NCT00528957|156717637|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
48690513|NCT00528957|156717636|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
48690514|NCT00528957|156717637|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
48690515|NCT00528957|156717636|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
48690516|NCT00528957|156717637|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
48690517|NCT00528957|156717636|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
48355392|NCT04596995|155498492|FG000|Overall Study|Withdrawal by Subject|12|||
48355393|NCT04596995|155498492|FG000|Overall Study|Sponsor decision|3|||
48355394|NCT04596995|155498492|FG000|Overall Study|Enrolled in managed access program|3|||
48355395|NCT01458522|155498494|FG000|Overall Study|Withdrawal by Subject|2|||
48355396|NCT01458522|155498495|FG001|Overall Study|Withdrawal by Subject|2|||
48355397|NCT01458522|155498494|FG000|Overall Study|Physician Decision|1|||
48355398|NCT01458522|155498495|FG001|Overall Study|Physician Decision|9|||
48355399|NCT02763215|155498504|FG000|Overall Study|Participants withdrew from study|3|||
48355400|NCT02763215|155498504|FG000|Overall Study|Missed visit|1|||
48355401|NCT02763215|155498504|FG000|Overall Study|Visit outside visit-window|1|||
48355402|NCT02763215|155498504|FG000|Overall Study|Death|1|||
48355403|NCT02763215|155498504|FG000|Overall Study|Lost to Follow-up|1|||
48355404|NCT00589303|155498505|FG000|Overall Study|Withdrawal by Subject|2|||
48355405|NCT00589303|155498506|FG001|Overall Study|Withdrawal by Subject|1|||
48355406|NCT01411241|155498507|FG000|Overall Study|Protocol Violation|0|||
48355407|NCT01411241|155498508|FG001|Overall Study|Protocol Violation|5|||
48355408|NCT01411241|155498507|FG000|Overall Study|Withdrawal by Subject|9|||
48355409|NCT01411241|155498508|FG001|Overall Study|Withdrawal by Subject|10|||
48355410|NCT01411241|155498507|FG000|Overall Study|Serious Adverse Event|0|||
48355411|NCT01411241|155498508|FG001|Overall Study|Serious Adverse Event|3|||
48355412|NCT01411241|155498507|FG000|Overall Study|Lost to Follow-up|2|||
48355413|NCT01411241|155498508|FG001|Overall Study|Lost to Follow-up|4|||
48355414|NCT01483144|155498509|FG000|Overall Study|Adverse Event|9|||
48690518|NCT00528957|156717637|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
48690519|NCT01539759|156717638|FG000|Overall Study|Lost to Follow-up|6|||
48690520|NCT01539759|156717639|FG001|Overall Study|Lost to Follow-up|8|||
48690521|NCT02872116|156717640|FG000|Pre-Treatment|Disease Progression|0|||
48690522|NCT02872116|156717641|FG001|Pre-Treatment|Disease Progression|1|||
48690523|NCT02872116|156717642|FG002|Pre-Treatment|Disease Progression|0|||
48690524|NCT02872116|156717640|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
48690525|NCT02872116|156717641|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
48690526|NCT02872116|156717642|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
48690527|NCT02872116|156717640|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
48690528|NCT02872116|156717641|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
48690529|NCT02872116|156717642|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
48690530|NCT02872116|156717640|FG000|Pre-Treatment|Participant withdrew consent|2|||
48690531|NCT02872116|156717641|FG001|Pre-Treatment|Participant withdrew consent|20|||
48690532|NCT02872116|156717642|FG002|Pre-Treatment|Participant withdrew consent|3|||
48690533|NCT02872116|156717640|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
48690534|NCT02872116|156717641|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
48690535|NCT02872116|156717642|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
48690536|NCT02872116|156717640|FG000|Pre-Treatment|Other reasons|1|||
48690537|NCT02872116|156717641|FG001|Pre-Treatment|Other reasons|2|||
48690538|NCT02872116|156717642|FG002|Pre-Treatment|Other reasons|2|||
48690539|NCT02872116|156717640|FG000|Treatment|Death|122|||
48690540|NCT02872116|156717641|FG001|Treatment|Death|94|||
48690541|NCT02872116|156717642|FG002|Treatment|Death|68|||
48690542|NCT02872116|156717640|FG000|Treatment|Lost to Follow-up|5|||
48690543|NCT02872116|156717641|FG001|Treatment|Lost to Follow-up|7|||
48690544|NCT02872116|156717642|FG002|Treatment|Lost to Follow-up|3|||
48690545|NCT02872116|156717640|FG000|Treatment|Participant withdrew consent|20|||
48690546|NCT02872116|156717641|FG001|Treatment|Participant withdrew consent|40|||
48690547|NCT02872116|156717642|FG002|Treatment|Participant withdrew consent|8|||
48690548|NCT02872116|156717640|FG000|Treatment|Other reasons|12|||
48690549|NCT02872116|156717641|FG001|Treatment|Other reasons|12|||
48690550|NCT02872116|156717642|FG002|Treatment|Other reasons|5|||
48690551|NCT04349072|156717643|FG000|Randomization Period|Found ineligible post enrollment|0|||
48690552|NCT04349072|156717644|FG001|Randomization Period|Found ineligible post enrollment|1|||
48690553|NCT04349072|156717643|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
48690554|NCT04349072|156717644|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
48690555|NCT04349072|156717643|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
48690556|NCT04349072|156717644|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
48690557|NCT04349072|156717643|FG000|Treatment Period|Physician Decision|0|||
48690558|NCT04349072|156717644|FG001|Treatment Period|Physician Decision|1|||
48690559|NCT04349072|156717643|FG000|Treatment Period|Protocol Violation|0|||
48690560|NCT04349072|156717644|FG001|Treatment Period|Protocol Violation|1|||
48690561|NCT04349072|156717643|FG000|Treatment Period|Withdrawal by Subject|1|||
48690562|NCT04349072|156717644|FG001|Treatment Period|Withdrawal by Subject|1|||
48690563|NCT03901144|156717647|FG000|Overall Study|Lost to Follow-up|1|||
48690564|NCT03901144|156717648|FG001|Overall Study|Lost to Follow-up|1|||
48690565|NCT03901144|156717649|FG002|Overall Study|Lost to Follow-up|1|||
48690566|NCT03901144|156717650|FG003|Overall Study|Lost to Follow-up|1|||
48690567|NCT00990106|156717651|FG000|Overall Study|"too busy to continue"|1|||
48690568|NCT00990106|156717652|FG001|Overall Study|"too busy to continue"|2|||
48690569|NCT00990106|156717651|FG000|Overall Study|Lost to Follow-up|1|||
48690570|NCT00990106|156717652|FG001|Overall Study|Lost to Follow-up|3|||
48690571|NCT00990106|156717651|FG000|Overall Study|Withdrawal by Subject|2|||
48690572|NCT00990106|156717652|FG001|Overall Study|Withdrawal by Subject|1|||
48690573|NCT00990106|156717651|FG000|Overall Study|opted for open label prazosin|1|||
48690574|NCT00990106|156717652|FG001|Overall Study|opted for open label prazosin|1|||
48690575|NCT00990106|156717651|FG000|Overall Study|relocation/deployment|4|||
48690576|NCT00990106|156717652|FG001|Overall Study|relocation/deployment|1|||
48690577|NCT00990106|156717651|FG000|Overall Study|started exclusionary medication|0|||
48690578|NCT00990106|156717652|FG001|Overall Study|started exclusionary medication|1|||
48690579|NCT00990106|156717651|FG000|Overall Study|planned major surgery|0|||
48690580|NCT00990106|156717652|FG001|Overall Study|planned major surgery|1|||
48690581|NCT00990106|156717651|FG000|Overall Study|scheduling conflicts|0|||
48690582|NCT00990106|156717652|FG001|Overall Study|scheduling conflicts|2|||
48690583|NCT02138890|156717653|FG000|Overall Study|Adverse Event|1|||
48690584|NCT02138890|156717654|FG001|Overall Study|Adverse Event|0|||
48690585|NCT03318549|156717657|FG000|Overall Study|Withdrawal by Subject|5|||
48763719|NCT00914810|156985723|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
48690586|NCT03318549|156717658|FG001|Overall Study|Withdrawal by Subject|19|||
48690587|NCT03318549|156717659|FG002|Overall Study|Withdrawal by Subject|2|||
48690588|NCT03318549|156717660|FG003|Overall Study|Withdrawal by Subject|0|||
48690589|NCT03318549|156717661|FG004|Overall Study|Withdrawal by Subject|0|||
48690590|NCT03318549|156717662|FG005|Overall Study|Withdrawal by Subject|0|||
48690591|NCT03318549|156717663|FG006|Overall Study|Withdrawal by Subject|0|||
48690592|NCT03318549|156717657|FG000|Overall Study|Physician Decision|0|||
48690593|NCT03318549|156717658|FG001|Overall Study|Physician Decision|4|||
48690594|NCT03318549|156717659|FG002|Overall Study|Physician Decision|1|||
48690595|NCT03318549|156717660|FG003|Overall Study|Physician Decision|0|||
48690596|NCT03318549|156717661|FG004|Overall Study|Physician Decision|0|||
48690597|NCT03318549|156717662|FG005|Overall Study|Physician Decision|0|||
48690598|NCT03318549|156717663|FG006|Overall Study|Physician Decision|0|||
48690599|NCT03318549|156717657|FG000|Overall Study|Lost to Follow-up|0|||
48690600|NCT03318549|156717658|FG001|Overall Study|Lost to Follow-up|3|||
48690601|NCT03318549|156717659|FG002|Overall Study|Lost to Follow-up|3|||
48690602|NCT03318549|156717660|FG003|Overall Study|Lost to Follow-up|0|||
48690603|NCT03318549|156717661|FG004|Overall Study|Lost to Follow-up|0|||
48690604|NCT03318549|156717662|FG005|Overall Study|Lost to Follow-up|0|||
48690605|NCT03318549|156717663|FG006|Overall Study|Lost to Follow-up|0|||
48690606|NCT02657889|156717664|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
48690607|NCT02657889|156717665|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
48690608|NCT02657889|156717666|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
48690609|NCT02657889|156717667|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
48690610|NCT02657889|156717664|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
48690611|NCT02657889|156717665|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
48690612|NCT02657889|156717666|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
48690613|NCT02657889|156717667|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
48690614|NCT02657889|156717664|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
48690615|NCT02657889|156717665|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
48690616|NCT02657889|156717666|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
48690617|NCT02657889|156717667|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
48690618|NCT02657889|156717664|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
48690619|NCT02657889|156717665|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
48690620|NCT02657889|156717666|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
48690621|NCT02657889|156717667|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
48690622|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
48690623|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
48690624|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
48690625|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
48690626|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
48690627|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
48690628|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
48690629|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
48690630|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
48690631|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
48690632|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
48690633|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
48763720|NCT01816893|156985724|FG000|Washout Period|Withdrawal by Subject|2|||
48763721|NCT01816893|156985725|FG001|Washout Period|Withdrawal by Subject|0|||
48763722|NCT00004888|156985726|FG000|Overall Study|Adverse Event|5|||
48763723|NCT00004888|156985727|FG001|Overall Study|Adverse Event|10|||
48763724|NCT00004888|156985726|FG000|Overall Study|Withdrawal by Subject|0|||
48763725|NCT00004888|156985727|FG001|Overall Study|Withdrawal by Subject|3|||
48763726|NCT00004888|156985726|FG000|Overall Study|Physician Decision|1|||
48763727|NCT00004888|156985727|FG001|Overall Study|Physician Decision|1|||
48763728|NCT00004888|156985726|FG000|Overall Study|Progressive Disease|4|||
48763729|NCT00004888|156985727|FG001|Overall Study|Progressive Disease|9|||
48763730|NCT00004888|156985726|FG000|Overall Study|Death without progressive disease|0|||
48763731|NCT00004888|156985727|FG001|Overall Study|Death without progressive disease|1|||
48690634|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
48690635|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
48690636|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
48690637|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
48690638|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
48763732|NCT00004888|156985726|FG000|Overall Study|Toxic death|1|||
48763733|NCT00004888|156985727|FG001|Overall Study|Toxic death|0|||
48763734|NCT02082210|156985735|FG000|Overall Study|Death|0|||
48763735|NCT02082210|156985736|FG001|Overall Study|Death|0|||
48763736|NCT02082210|156985737|FG002|Overall Study|Death|1|||
48763737|NCT02082210|156985738|FG003|Overall Study|Death|1|||
48763738|NCT02082210|156985739|FG004|Overall Study|Death|1|||
48763739|NCT02082210|156985740|FG005|Overall Study|Death|0|||
48763740|NCT02082210|156985735|FG000|Overall Study|Withdrawal by Subject|0|||
48763741|NCT02082210|156985736|FG001|Overall Study|Withdrawal by Subject|0|||
48763742|NCT02082210|156985737|FG002|Overall Study|Withdrawal by Subject|0|||
48763743|NCT02082210|156985738|FG003|Overall Study|Withdrawal by Subject|1|||
48690639|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
48690640|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
48690641|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
48690642|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
48690643|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
48690644|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
48392962|NCT00777101|155634150|FG001|Overall Study|Failed to Return|1|||
48690645|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
48690646|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
48690647|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
48690648|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
48690649|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
48690650|NCT02657889|156717664|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
48690651|NCT02657889|156717665|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
48690652|NCT02657889|156717666|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
48690653|NCT02657889|156717667|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
48690654|NCT00685165|156717668|FG000|Washout Period of 14 Days|Adverse Event|1|||
48690655|NCT00685165|156717669|FG001|Washout Period of 14 Days|Adverse Event|0|||
48690656|NCT01894607|156717679|FG000|Overall Study|Ineligible|1|||
48690657|NCT00849940|156717680|FG000|Overall Study|Physician Decision|4|||
48690658|NCT05135871|156717681|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
48690659|NCT05135871|156717682|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
48690660|NCT05135871|156717683|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
48690661|NCT05135871|156717684|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
48690662|NCT00556075|156717685|FG000|Overall Study|Lost to Follow-up|3|||
48690663|NCT00556075|156717686|FG001|Overall Study|Lost to Follow-up|0|||
48690664|NCT00556075|156717687|FG002|Overall Study|Lost to Follow-up|3|||
48690665|NCT00556075|156717685|FG000|Overall Study|Withdrawal by Subject|3|||
48690666|NCT00556075|156717686|FG001|Overall Study|Withdrawal by Subject|3|||
48690667|NCT00556075|156717687|FG002|Overall Study|Withdrawal by Subject|0|||
48690668|NCT00556075|156717685|FG000|Overall Study|Protocol Violation|1|||
48690669|NCT00556075|156717686|FG001|Overall Study|Protocol Violation|1|||
48690670|NCT00556075|156717687|FG002|Overall Study|Protocol Violation|3|||
48690671|NCT00556075|156717685|FG000|Overall Study|Not eligible|1|||
48690672|NCT00556075|156717686|FG001|Overall Study|Not eligible|1|||
48690673|NCT00556075|156717687|FG002|Overall Study|Not eligible|2|||
48690674|NCT00556075|156717685|FG000|Overall Study|Adverse Event|1|||
48690675|NCT00556075|156717686|FG001|Overall Study|Adverse Event|2|||
48690676|NCT00556075|156717687|FG002|Overall Study|Adverse Event|0|||
48690677|NCT00556075|156717685|FG000|Overall Study|Personal issues|4|||
48690678|NCT00556075|156717686|FG001|Overall Study|Personal issues|1|||
48690679|NCT00556075|156717687|FG002|Overall Study|Personal issues|0|||
48690680|NCT00556075|156717685|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
48690681|NCT00556075|156717686|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
48690682|NCT00556075|156717687|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
48690683|NCT02922725|156717688|FG000|Overall Study|Withdrawal by Subject|1|||
48690684|NCT02922725|156717689|FG001|Overall Study|Withdrawal by Subject|0|||
48690685|NCT02922725|156717690|FG002|Overall Study|Withdrawal by Subject|0|||
48690686|NCT03649074|156717693|FG000|Overall Study|Lost to Follow-up|2|||
48690687|NCT03649074|156717694|FG001|Overall Study|Lost to Follow-up|1|||
48690688|NCT03649074|156717693|FG000|Overall Study|Adverse Event|1|||
48690689|NCT03649074|156717694|FG001|Overall Study|Adverse Event|0|||
48690690|NCT03649074|156717693|FG000|Overall Study|Physician Decision|1|||
48690691|NCT03649074|156717694|FG001|Overall Study|Physician Decision|0|||
48690692|NCT03649074|156717693|FG000|Overall Study|Withdrawal by Subject|0|||
48690693|NCT03649074|156717694|FG001|Overall Study|Withdrawal by Subject|2|||
48690694|NCT03649074|156717693|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
48690695|NCT03649074|156717694|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
48690696|NCT03649074|156717693|FG000|Overall Study|Other|1|||
48690697|NCT03649074|156717694|FG001|Overall Study|Other|0|||
48690698|NCT01300728|156717695|FG000|Overall Study|Withdrawal by Subject|1|||
48690699|NCT01300728|156717696|FG001|Overall Study|Withdrawal by Subject|1|||
48690700|NCT01300728|156717695|FG000|Overall Study|Physician Decision|1|||
48690701|NCT01300728|156717696|FG001|Overall Study|Physician Decision|0|||
48690702|NCT01253291|156717697|FG000|Overall Study|Withdrawal by Subject|1|||
48690703|NCT01253291|156717698|FG001|Overall Study|Withdrawal by Subject|1|||
48690704|NCT01253291|156717699|FG002|Overall Study|Withdrawal by Subject|0|||
48690705|NCT01253291|156717700|FG003|Overall Study|Withdrawal by Subject|0|||
48690706|NCT01253291|156717701|FG004|Overall Study|Withdrawal by Subject|0|||
48392963|NCT02411539|155634151|FG000|Overall Study|Lost to Follow-up|2|||
48763744|NCT02082210|156985739|FG004|Overall Study|Withdrawal by Subject|2|||
48690707|NCT01253291|156717697|FG000|Overall Study|Adverse Event|0|||
48690708|NCT01253291|156717698|FG001|Overall Study|Adverse Event|1|||
48690709|NCT01253291|156717699|FG002|Overall Study|Adverse Event|0|||
48690710|NCT01253291|156717700|FG003|Overall Study|Adverse Event|0|||
48690711|NCT01253291|156717701|FG004|Overall Study|Adverse Event|0|||
48690712|NCT01253291|156717697|FG000|Overall Study|Lack of Efficacy|1|||
48690713|NCT01253291|156717698|FG001|Overall Study|Lack of Efficacy|0|||
48690714|NCT01253291|156717699|FG002|Overall Study|Lack of Efficacy|0|||
48690715|NCT01253291|156717700|FG003|Overall Study|Lack of Efficacy|0|||
48690716|NCT01253291|156717701|FG004|Overall Study|Lack of Efficacy|0|||
48690717|NCT01253291|156717697|FG000|Overall Study|Physician Decision|2|||
48690718|NCT01253291|156717698|FG001|Overall Study|Physician Decision|0|||
48690719|NCT01253291|156717699|FG002|Overall Study|Physician Decision|0|||
48690720|NCT01253291|156717700|FG003|Overall Study|Physician Decision|0|||
48690721|NCT01253291|156717701|FG004|Overall Study|Physician Decision|2|||
48690722|NCT03883581|156717702|FG000|Overall Study|Withdrawal by Subject|4|||
48690723|NCT01808196|156717706|FG000|Overall Study|Lost to Follow-up|1|||
48690724|NCT04612725|156717707|FG000|Overall Study|Adverse Event|1|||
48690725|NCT04612725|156717708|FG001|Overall Study|Adverse Event|3|||
48690726|NCT04612725|156717709|FG002|Overall Study|Adverse Event|1|||
48690727|NCT04612725|156717710|FG003|Overall Study|Adverse Event|0|||
48690728|NCT04612725|156717711|FG004|Overall Study|Adverse Event|1|||
48690729|NCT04612725|156717707|FG000|Overall Study|Lost to Follow-up|0|||
48690730|NCT04612725|156717708|FG001|Overall Study|Lost to Follow-up|1|||
48690731|NCT04612725|156717709|FG002|Overall Study|Lost to Follow-up|0|||
48690732|NCT04612725|156717710|FG003|Overall Study|Lost to Follow-up|0|||
48690733|NCT04612725|156717711|FG004|Overall Study|Lost to Follow-up|0|||
48690734|NCT04612725|156717707|FG000|Overall Study|Physician Decision|2|||
48690735|NCT04612725|156717708|FG001|Overall Study|Physician Decision|0|||
48690736|NCT04612725|156717709|FG002|Overall Study|Physician Decision|0|||
48690737|NCT04612725|156717710|FG003|Overall Study|Physician Decision|0|||
48690738|NCT04612725|156717711|FG004|Overall Study|Physician Decision|0|||
48690739|NCT04612725|156717707|FG000|Overall Study|Study terminated by sponsor|3|||
48690740|NCT04612725|156717708|FG001|Overall Study|Study terminated by sponsor|1|||
48690741|NCT04612725|156717709|FG002|Overall Study|Study terminated by sponsor|2|||
48690742|NCT04612725|156717710|FG003|Overall Study|Study terminated by sponsor|4|||
48690743|NCT04612725|156717711|FG004|Overall Study|Study terminated by sponsor|5|||
48690744|NCT04612725|156717707|FG000|Overall Study|Withdrawal by Subject|8|||
48690745|NCT04612725|156717708|FG001|Overall Study|Withdrawal by Subject|3|||
48690746|NCT04612725|156717709|FG002|Overall Study|Withdrawal by Subject|5|||
48690747|NCT04612725|156717710|FG003|Overall Study|Withdrawal by Subject|1|||
48690748|NCT04612725|156717711|FG004|Overall Study|Withdrawal by Subject|9|||
48690749|NCT04612725|156717707|FG000|Overall Study|Other|0|||
48690750|NCT04612725|156717708|FG001|Overall Study|Other|0|||
48690751|NCT04612725|156717709|FG002|Overall Study|Other|0|||
48690752|NCT04612725|156717710|FG003|Overall Study|Other|0|||
48690753|NCT04612725|156717711|FG004|Overall Study|Other|1|||
48690754|NCT00506350|156717712|FG000|Overall Study|Serious Adverse Event|1|||
48690755|NCT00506350|156717713|FG001|Overall Study|Serious Adverse Event|0|||
48690756|NCT00506350|156717714|FG002|Overall Study|Serious Adverse Event|0|||
48690757|NCT00506350|156717715|FG003|Overall Study|Serious Adverse Event|0|||
48690758|NCT00506350|156717716|FG004|Overall Study|Serious Adverse Event|0|||
48690759|NCT00506350|156717717|FG005|Overall Study|Serious Adverse Event|0|||
48690760|NCT00506350|156717718|FG006|Overall Study|Serious Adverse Event|0|||
48690761|NCT00506350|156717719|FG007|Overall Study|Serious Adverse Event|0|||
48690762|NCT00506350|156717720|FG008|Overall Study|Serious Adverse Event|0|||
48690763|NCT00506350|156717712|FG000|Overall Study|Adverse Event|0|||
48690764|NCT00506350|156717713|FG001|Overall Study|Adverse Event|0|||
48690765|NCT00506350|156717714|FG002|Overall Study|Adverse Event|0|||
48690766|NCT00506350|156717715|FG003|Overall Study|Adverse Event|0|||
48690767|NCT00506350|156717716|FG004|Overall Study|Adverse Event|0|||
48690768|NCT00506350|156717717|FG005|Overall Study|Adverse Event|0|||
48690769|NCT00506350|156717718|FG006|Overall Study|Adverse Event|0|||
48690770|NCT00506350|156717719|FG007|Overall Study|Adverse Event|1|||
48690771|NCT00506350|156717720|FG008|Overall Study|Adverse Event|1|||
48690772|NCT00506350|156717712|FG000|Overall Study|Protocol Violation|0|||
48690773|NCT00506350|156717713|FG001|Overall Study|Protocol Violation|0|||
48690774|NCT00506350|156717714|FG002|Overall Study|Protocol Violation|1|||
48690775|NCT00506350|156717715|FG003|Overall Study|Protocol Violation|0|||
48690776|NCT00506350|156717716|FG004|Overall Study|Protocol Violation|0|||
48690777|NCT00506350|156717717|FG005|Overall Study|Protocol Violation|0|||
48690778|NCT00506350|156717718|FG006|Overall Study|Protocol Violation|1|||
48690779|NCT00506350|156717719|FG007|Overall Study|Protocol Violation|0|||
48690780|NCT00506350|156717720|FG008|Overall Study|Protocol Violation|0|||
48690781|NCT00506350|156717712|FG000|Overall Study|Withdrawal by Subject|0|||
48690782|NCT00506350|156717713|FG001|Overall Study|Withdrawal by Subject|1|||
48690783|NCT00506350|156717714|FG002|Overall Study|Withdrawal by Subject|1|||
48690784|NCT00506350|156717715|FG003|Overall Study|Withdrawal by Subject|1|||
48392964|NCT02411539|155634152|FG001|Overall Study|Lost to Follow-up|0|||
48392965|NCT02411539|155634151|FG000|Overall Study|Confounding medical condition|0|||
48392966|NCT02411539|155634152|FG001|Overall Study|Confounding medical condition|1|||
48392967|NCT03917823|155634156|FG000|Overall Study|Lost to Follow-up|1|||
48392968|NCT03917823|155634157|FG001|Overall Study|Lost to Follow-up|1|||
48392969|NCT03917823|155634156|FG000|Overall Study|Withdrawal by Subject|0|||
48392970|NCT03917823|155634157|FG001|Overall Study|Withdrawal by Subject|1|||
48392971|NCT00135668|155634158|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
48392972|NCT00135668|155634159|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
48392973|NCT00135668|155634160|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
48392974|NCT00135668|155634161|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
48392975|NCT00473343|155634162|FG000|Overall Study|Adverse Event|9|||
48392976|NCT00473343|155634162|FG000|Overall Study|Lost to Follow-up|8|||
48392977|NCT00473343|155634162|FG000|Overall Study|Treatment failure|27|||
48392978|NCT00473343|155634162|FG000|Overall Study|Withdrew consent|3|||
48392979|NCT00473343|155634162|FG000|Overall Study|Other un-specified reason|3|||
48392980|NCT00258674|155634163|FG000|Overall Study|Death|32|||
48690785|NCT00506350|156717716|FG004|Overall Study|Withdrawal by Subject|4|||
48690786|NCT00506350|156717717|FG005|Overall Study|Withdrawal by Subject|1|||
48690787|NCT00506350|156717718|FG006|Overall Study|Withdrawal by Subject|1|||
48690788|NCT00506350|156717719|FG007|Overall Study|Withdrawal by Subject|2|||
48690789|NCT00506350|156717720|FG008|Overall Study|Withdrawal by Subject|0|||
48690790|NCT00506350|156717712|FG000|Overall Study|Lost to Follow-up|1|||
48690791|NCT00506350|156717713|FG001|Overall Study|Lost to Follow-up|1|||
48690792|NCT00506350|156717714|FG002|Overall Study|Lost to Follow-up|1|||
48690793|NCT00506350|156717715|FG003|Overall Study|Lost to Follow-up|1|||
48690794|NCT00506350|156717716|FG004|Overall Study|Lost to Follow-up|2|||
48690795|NCT00506350|156717717|FG005|Overall Study|Lost to Follow-up|1|||
48690796|NCT00506350|156717718|FG006|Overall Study|Lost to Follow-up|0|||
48690797|NCT00506350|156717719|FG007|Overall Study|Lost to Follow-up|0|||
48690798|NCT00506350|156717720|FG008|Overall Study|Lost to Follow-up|2|||
48690799|NCT00506350|156717712|FG000|Overall Study|Medical Reason|0|||
48690800|NCT00506350|156717713|FG001|Overall Study|Medical Reason|0|||
48690801|NCT00506350|156717714|FG002|Overall Study|Medical Reason|0|||
48690802|NCT00506350|156717715|FG003|Overall Study|Medical Reason|0|||
48690803|NCT00506350|156717716|FG004|Overall Study|Medical Reason|1|||
48690804|NCT00506350|156717717|FG005|Overall Study|Medical Reason|0|||
48690805|NCT00506350|156717718|FG006|Overall Study|Medical Reason|0|||
48690806|NCT00506350|156717719|FG007|Overall Study|Medical Reason|0|||
48690807|NCT00506350|156717720|FG008|Overall Study|Medical Reason|0|||
48690808|NCT00506350|156717712|FG000|Overall Study|Other|1|||
48690809|NCT00506350|156717713|FG001|Overall Study|Other|1|||
48690810|NCT00506350|156717714|FG002|Overall Study|Other|3|||
48690811|NCT00506350|156717715|FG003|Overall Study|Other|0|||
48690812|NCT00506350|156717716|FG004|Overall Study|Other|3|||
48690813|NCT00506350|156717717|FG005|Overall Study|Other|0|||
48690814|NCT00506350|156717718|FG006|Overall Study|Other|0|||
48690815|NCT00506350|156717719|FG007|Overall Study|Other|2|||
48690816|NCT00506350|156717720|FG008|Overall Study|Other|2|||
48690817|NCT00301808|156717721|FG000|Overall Study|Adverse Event|5|||
48690818|NCT00301808|156717721|FG000|Overall Study|Death|3|||
48690819|NCT00301808|156717721|FG000|Overall Study|Lack of Efficacy|4|||
48690820|NCT00668148|156717722|FG000|Overall Study|Adverse Event|5|||
48690821|NCT00668148|156717722|FG000|Overall Study|Subject Non-compliance|1|||
48690822|NCT00668148|156717722|FG000|Overall Study|Progressive Disease Before Treatment|2|||
48690823|NCT00668148|156717722|FG000|Overall Study|Withdrawal of Consent|2|||
48690824|NCT04801420|156717723|FG000|Overall Study|Other|1|||
48690825|NCT04801420|156717724|FG001|Overall Study|Other|2|||
48690826|NCT04801420|156717725|FG002|Overall Study|Other|1|||
48690827|NCT04801420|156717723|FG000|Overall Study|Lost to Follow-up|7|||
48690828|NCT04801420|156717724|FG001|Overall Study|Lost to Follow-up|9|||
48690829|NCT04801420|156717725|FG002|Overall Study|Lost to Follow-up|10|||
48690830|NCT04801420|156717723|FG000|Overall Study|Moved from study area|0|||
48690831|NCT04801420|156717724|FG001|Overall Study|Moved from study area|1|||
48690832|NCT04801420|156717725|FG002|Overall Study|Moved from study area|1|||
48690833|NCT04801420|156717723|FG000|Overall Study|Withdrawal by Subject|5|||
48690834|NCT04801420|156717724|FG001|Overall Study|Withdrawal by Subject|1|||
48690835|NCT04801420|156717725|FG002|Overall Study|Withdrawal by Subject|4|||
48690836|NCT04801420|156717723|FG000|Overall Study|Individual stopping criteria reached|0|||
48690837|NCT04801420|156717724|FG001|Overall Study|Individual stopping criteria reached|1|||
48690838|NCT04801420|156717725|FG002|Overall Study|Individual stopping criteria reached|0|||
48690839|NCT04801420|156717723|FG000|Overall Study|Ongoing in the study|195|||
48392981|NCT00258674|155634164|FG001|Overall Study|Death|53|||
48690840|NCT04801420|156717724|FG001|Overall Study|Ongoing in the study|195|||
48690841|NCT04801420|156717725|FG002|Overall Study|Ongoing in the study|192|||
48690842|NCT03790111|156720092|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
48690843|NCT03798717|156720096|FG000|Overall Study|Failed Screening|0|||
48690844|NCT03798717|156720097|FG001|Overall Study|Failed Screening|0|||
48763745|NCT02082210|156985740|FG005|Overall Study|Withdrawal by Subject|2|||
48763746|NCT02082210|156985735|FG000|Overall Study|Clinical Progression|0|||
48763747|NCT02082210|156985736|FG001|Overall Study|Clinical Progression|0|||
48763748|NCT02082210|156985737|FG002|Overall Study|Clinical Progression|0|||
48763749|NCT02082210|156985738|FG003|Overall Study|Clinical Progression|1|||
48763750|NCT02082210|156985739|FG004|Overall Study|Clinical Progression|0|||
48763751|NCT02082210|156985740|FG005|Overall Study|Clinical Progression|0|||
48763752|NCT02082210|156985735|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
48763753|NCT02082210|156985736|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
48763754|NCT02082210|156985737|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
48763755|NCT02082210|156985738|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
48763756|NCT02082210|156985739|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
48763757|NCT02082210|156985740|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
48763758|NCT02082210|156985735|FG000|Overall Study|Physician Decision|0|||
48763759|NCT02082210|156985736|FG001|Overall Study|Physician Decision|0|||
48355415|NCT01483144|155498510|FG001|Overall Study|Adverse Event|4|||
48355416|NCT01483144|155498511|FG002|Overall Study|Adverse Event|6|||
48355417|NCT01483144|155498509|FG000|Overall Study|Withdrawal by Subject|0|||
48355418|NCT01483144|155498510|FG001|Overall Study|Withdrawal by Subject|2|||
48355419|NCT01483144|155498511|FG002|Overall Study|Withdrawal by Subject|5|||
48355420|NCT01483144|155498509|FG000|Overall Study|Physician Decision|1|||
48355421|NCT01483144|155498510|FG001|Overall Study|Physician Decision|0|||
48355422|NCT01483144|155498511|FG002|Overall Study|Physician Decision|0|||
48355423|NCT01483144|155498509|FG000|Overall Study|Lost to Follow-up|2|||
48355424|NCT01483144|155498510|FG001|Overall Study|Lost to Follow-up|4|||
48355425|NCT01483144|155498511|FG002|Overall Study|Lost to Follow-up|1|||
48355426|NCT01483144|155498509|FG000|Overall Study|Protocol Violation|3|||
48355427|NCT01483144|155498510|FG001|Overall Study|Protocol Violation|3|||
48355428|NCT01483144|155498511|FG002|Overall Study|Protocol Violation|3|||
48355429|NCT00983749|155498512|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
48355430|NCT00983749|155498513|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
48355431|NCT04829747|155498522|FG000|Overall Study|Protocol Violation|1|||
48355432|NCT04593823|155498530|FG000|Overall Study|Withdrawal by Subject|1|||
48355433|NCT04593823|155498531|FG001|Overall Study|Withdrawal by Subject|1|||
48355434|NCT04593823|155498530|FG000|Overall Study|Lost to Follow-up|0|||
48355435|NCT04593823|155498531|FG001|Overall Study|Lost to Follow-up|1|||
48355436|NCT01296555|155498532|FG000|Overall Study|Adverse Event|0|||
48355437|NCT01296555|155498533|FG001|Overall Study|Adverse Event|0|||
48355438|NCT01296555|155498534|FG002|Overall Study|Adverse Event|1|||
48355439|NCT01296555|155498535|FG003|Overall Study|Adverse Event|1|||
48355440|NCT01296555|155498536|FG004|Overall Study|Adverse Event|2|||
48355441|NCT01296555|155498537|FG005|Overall Study|Adverse Event|4|||
48355442|NCT01296555|155498538|FG006|Overall Study|Adverse Event|1|||
48355443|NCT01296555|155498539|FG007|Overall Study|Adverse Event|4|||
48355444|NCT01296555|155498540|FG008|Overall Study|Adverse Event|3|||
48355445|NCT01296555|155498541|FG009|Overall Study|Adverse Event|1|||
48355446|NCT01296555|155498542|FG010|Overall Study|Adverse Event|0|||
48355447|NCT01296555|155498543|FG011|Overall Study|Adverse Event|4|||
48355448|NCT01296555|155498544|FG012|Overall Study|Adverse Event|1|||
48355449|NCT01296555|155498545|FG013|Overall Study|Adverse Event|4|||
48355450|NCT01296555|155498546|FG014|Overall Study|Adverse Event|0|||
48355451|NCT01296555|155498547|FG015|Overall Study|Adverse Event|0|||
48355452|NCT01296555|155498548|FG016|Overall Study|Adverse Event|0|||
48355453|NCT01296555|155498549|FG017|Overall Study|Adverse Event|0|||
48355454|NCT01296555|155498550|FG018|Overall Study|Adverse Event|0|||
48355455|NCT01296555|155498551|FG019|Overall Study|Adverse Event|1|||
48355456|NCT01296555|155498552|FG020|Overall Study|Adverse Event|0|||
48355457|NCT01296555|155498553|FG021|Overall Study|Adverse Event|0|||
48355458|NCT01296555|155498554|FG022|Overall Study|Adverse Event|0|||
48355459|NCT01296555|155498555|FG023|Overall Study|Adverse Event|0|||
48355460|NCT01296555|155498556|FG024|Overall Study|Adverse Event|0|||
48355461|NCT01296555|155498557|FG025|Overall Study|Adverse Event|0|||
48355462|NCT01296555|155498558|FG026|Overall Study|Adverse Event|0|||
48355463|NCT01296555|155498559|FG027|Overall Study|Adverse Event|0|||
48355464|NCT01296555|155498560|FG028|Overall Study|Adverse Event|0|||
48355465|NCT01296555|155498532|FG000|Overall Study|Reason Not Specified|0|||
48355466|NCT01296555|155498533|FG001|Overall Study|Reason Not Specified|0|||
48355467|NCT01296555|155498534|FG002|Overall Study|Reason Not Specified|0|||
48355468|NCT01296555|155498535|FG003|Overall Study|Reason Not Specified|0|||
48355469|NCT01296555|155498536|FG004|Overall Study|Reason Not Specified|0|||
48355470|NCT01296555|155498537|FG005|Overall Study|Reason Not Specified|0|||
48355471|NCT01296555|155498538|FG006|Overall Study|Reason Not Specified|0|||
48355472|NCT01296555|155498539|FG007|Overall Study|Reason Not Specified|0|||
48355473|NCT01296555|155498540|FG008|Overall Study|Reason Not Specified|0|||
48355474|NCT01296555|155498541|FG009|Overall Study|Reason Not Specified|0|||
48392982|NCT00258674|155634165|FG002|Overall Study|Death|34|||
48392983|NCT02290873|155634166|FG000|Overall Study|Withdrawal by Subject|0|||
48392984|NCT02290873|155634167|FG001|Overall Study|Withdrawal by Subject|1|||
48392985|NCT02290873|155634168|FG002|Overall Study|Withdrawal by Subject|1|||
48392986|NCT02290873|155634166|FG000|Overall Study|Nellcor device error|1|||
48392987|NCT02290873|155634167|FG001|Overall Study|Nellcor device error|0|||
48392988|NCT02290873|155634168|FG002|Overall Study|Nellcor device error|0|||
48392989|NCT02290873|155634166|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
48392990|NCT02290873|155634167|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
48392991|NCT02290873|155634168|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
48392992|NCT02290873|155634166|FG000|Overall Study|Protocol Violation|0|||
48392993|NCT02290873|155634167|FG001|Overall Study|Protocol Violation|0|||
48392994|NCT02290873|155634168|FG002|Overall Study|Protocol Violation|1|||
48392995|NCT01136655|155634169|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
48392996|NCT01136655|155634169|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
48392997|NCT01136655|155634169|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
48392998|NCT01136655|155634169|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
48392999|NCT02937818|155634170|FG000|Overall Study|Participants decision|2|||
48393000|NCT02937818|155634171|FG001|Overall Study|Participants decision|1|||
48393001|NCT02937818|155634172|FG002|Overall Study|Participants decision|1|||
48393002|NCT02937818|155634173|FG003|Overall Study|Participants decision|1|||
48393003|NCT02937818|155634170|FG000|Overall Study|Adverse Event|2|||
48393004|NCT02937818|155634171|FG001|Overall Study|Adverse Event|4|||
48393005|NCT02937818|155634172|FG002|Overall Study|Adverse Event|1|||
48393006|NCT02937818|155634173|FG003|Overall Study|Adverse Event|1|||
48690845|NCT03798717|156720098|FG002|Overall Study|Failed Screening|0|||
48690846|NCT03798717|156720099|FG003|Overall Study|Failed Screening|0|||
48393007|NCT02937818|155634170|FG000|Overall Study|Disease progression|17|||
48393008|NCT02937818|155634171|FG001|Overall Study|Disease progression|15|||
48393009|NCT02937818|155634172|FG002|Overall Study|Disease progression|7|||
48393010|NCT02937818|155634173|FG003|Overall Study|Disease progression|19|||
48690847|NCT03798717|156720100|FG004|Overall Study|Failed Screening|0|||
48690848|NCT03798717|156720101|FG005|Overall Study|Failed Screening|1|||
48690849|NCT03798717|156720096|FG000|Overall Study|Physician Decision|1|||
48690850|NCT03798717|156720097|FG001|Overall Study|Physician Decision|0|||
48690851|NCT03798717|156720098|FG002|Overall Study|Physician Decision|1|||
48690852|NCT03798717|156720099|FG003|Overall Study|Physician Decision|0|||
48690853|NCT03798717|156720100|FG004|Overall Study|Physician Decision|0|||
48690854|NCT03798717|156720101|FG005|Overall Study|Physician Decision|0|||
48690855|NCT03798717|156720096|FG000|Overall Study|Withdrawal by Subject|0|||
48690856|NCT03798717|156720097|FG001|Overall Study|Withdrawal by Subject|0|||
48690857|NCT03798717|156720098|FG002|Overall Study|Withdrawal by Subject|0|||
48690858|NCT03798717|156720099|FG003|Overall Study|Withdrawal by Subject|1|||
48690859|NCT03798717|156720100|FG004|Overall Study|Withdrawal by Subject|0|||
48690860|NCT03798717|156720101|FG005|Overall Study|Withdrawal by Subject|0|||
48690861|NCT03798717|156720096|FG000|Overall Study|Lost to Follow-up|1|||
48690862|NCT03798717|156720097|FG001|Overall Study|Lost to Follow-up|0|||
48690863|NCT03798717|156720098|FG002|Overall Study|Lost to Follow-up|0|||
48690864|NCT03798717|156720099|FG003|Overall Study|Lost to Follow-up|1|||
48690865|NCT03798717|156720100|FG004|Overall Study|Lost to Follow-up|0|||
48690866|NCT03798717|156720101|FG005|Overall Study|Lost to Follow-up|0|||
48690867|NCT03798717|156720096|FG000|Overall Study|Adverse Event|0|||
48690868|NCT03798717|156720097|FG001|Overall Study|Adverse Event|1|||
48690869|NCT03798717|156720098|FG002|Overall Study|Adverse Event|0|||
48690870|NCT03798717|156720099|FG003|Overall Study|Adverse Event|0|||
48763760|NCT02082210|156985737|FG002|Overall Study|Physician Decision|1|||
48763761|NCT02082210|156985738|FG003|Overall Study|Physician Decision|1|||
48763762|NCT02082210|156985739|FG004|Overall Study|Physician Decision|0|||
48763763|NCT02082210|156985740|FG005|Overall Study|Physician Decision|0|||
48690871|NCT03798717|156720100|FG004|Overall Study|Adverse Event|0|||
48690872|NCT03798717|156720101|FG005|Overall Study|Adverse Event|0|||
48690873|NCT03798717|156720096|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48690874|NCT03798717|156720097|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48690875|NCT03798717|156720098|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48763764|NCT02579265|156985743|FG000|Overall Study|Weaned off earlier than 28 days|44|||
48763765|NCT02579265|156985744|FG001|Overall Study|Weaned off earlier than 28 days|43|||
48393011|NCT02937818|155634170|FG000|Overall Study|Condition under investigation worsened|0|||
48393012|NCT02937818|155634171|FG001|Overall Study|Condition under investigation worsened|0|||
48393013|NCT02937818|155634172|FG002|Overall Study|Condition under investigation worsened|1|||
48393014|NCT02937818|155634173|FG003|Overall Study|Condition under investigation worsened|0|||
48393015|NCT02287623|155634176|FG000|Overall Study|Protocol Violation|0|||
48393016|NCT02287623|155634177|FG001|Overall Study|Protocol Violation|1|||
48393017|NCT00917150|155634180|FG000|Overall Study|Adverse Event|12|||
48690876|NCT03798717|156720099|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48763766|NCT02579265|156985743|FG000|Overall Study|Adverse Event|2|||
48763767|NCT02579265|156985744|FG001|Overall Study|Adverse Event|0|||
48690877|NCT03798717|156720100|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
48690878|NCT03798717|156720101|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
48690879|NCT03057496|156720103|FG000|Overall Study|Withdrawal by Subject|8|||
48690880|NCT03057496|156720103|FG000|Overall Study|Lost to Follow-up|5|||
48690881|NCT03057496|156720103|FG000|Overall Study|Did not use device during home trial|3|||
48690882|NCT03057496|156720103|FG000|Overall Study|Device failure|2|||
48690883|NCT01307319|156720104|FG000|Overall Study|Adverse Event|2|||
48690884|NCT01307319|156720105|FG001|Overall Study|Adverse Event|2|||
48690885|NCT01307319|156720106|FG002|Overall Study|Adverse Event|1|||
48690886|NCT01307319|156720104|FG000|Overall Study|Lost to Follow-up|1|||
48393018|NCT00917150|155634181|FG001|Overall Study|Adverse Event|7|||
48393019|NCT00917150|155634182|FG002|Overall Study|Adverse Event|12|||
48393020|NCT00917150|155634183|FG003|Overall Study|Adverse Event|11|||
48393021|NCT00917150|155634180|FG000|Overall Study|Death|1|||
48393022|NCT00917150|155634181|FG001|Overall Study|Death|4|||
48393023|NCT00917150|155634182|FG002|Overall Study|Death|3|||
48393024|NCT00917150|155634183|FG003|Overall Study|Death|2|||
48393025|NCT00917150|155634180|FG000|Overall Study|Lost to Follow-up|1|||
48393026|NCT00917150|155634181|FG001|Overall Study|Lost to Follow-up|0|||
48393027|NCT00917150|155634182|FG002|Overall Study|Lost to Follow-up|4|||
48393028|NCT00917150|155634183|FG003|Overall Study|Lost to Follow-up|2|||
48393029|NCT00917150|155634180|FG000|Overall Study|Physician Decision|0|||
48393030|NCT00917150|155634181|FG001|Overall Study|Physician Decision|2|||
48393031|NCT00917150|155634182|FG002|Overall Study|Physician Decision|0|||
48393032|NCT00917150|155634183|FG003|Overall Study|Physician Decision|1|||
48393033|NCT00917150|155634180|FG000|Overall Study|Protocol Violation|5|||
48393034|NCT00917150|155634181|FG001|Overall Study|Protocol Violation|5|||
48393035|NCT00917150|155634182|FG002|Overall Study|Protocol Violation|3|||
48393036|NCT00917150|155634183|FG003|Overall Study|Protocol Violation|5|||
48393037|NCT00917150|155634180|FG000|Overall Study|Withdrawal by Subject|15|||
48393038|NCT00917150|155634181|FG001|Overall Study|Withdrawal by Subject|16|||
48393039|NCT00917150|155634182|FG002|Overall Study|Withdrawal by Subject|18|||
48690887|NCT01307319|156720105|FG001|Overall Study|Lost to Follow-up|0|||
48690888|NCT01307319|156720106|FG002|Overall Study|Lost to Follow-up|1|||
48690889|NCT01307319|156720104|FG000|Overall Study|Protocol Violation|1|||
48690890|NCT01307319|156720105|FG001|Overall Study|Protocol Violation|1|||
48690891|NCT01307319|156720106|FG002|Overall Study|Protocol Violation|0|||
48690892|NCT01307319|156720104|FG000|Overall Study|Withdrawal by Subject|0|||
48690893|NCT01307319|156720105|FG001|Overall Study|Withdrawal by Subject|1|||
48690894|NCT01307319|156720106|FG002|Overall Study|Withdrawal by Subject|2|||
48690895|NCT01307319|156720104|FG000|Overall Study|Other|0|||
48690896|NCT01307319|156720105|FG001|Overall Study|Other|4|||
48690897|NCT01307319|156720106|FG002|Overall Study|Other|3|||
48690898|NCT04924062|156720108|FG000|Overall Study|Death|49|||
48690899|NCT04924062|156720109|FG001|Overall Study|Death|63|||
48690900|NCT04924062|156720108|FG000|Overall Study|Participant On-going|26|||
48690901|NCT04924062|156720109|FG001|Overall Study|Participant On-going|20|||
48690902|NCT02730728|156720110|FG000|Overall Study|Withdrawal by Subject|0|||
48690903|NCT02730728|156720111|FG001|Overall Study|Withdrawal by Subject|1|||
48690904|NCT02730728|156720112|FG002|Overall Study|Withdrawal by Subject|0|||
48690905|NCT02730728|156720110|FG000|Overall Study|Lack of Efficacy|0|||
48690906|NCT02730728|156720111|FG001|Overall Study|Lack of Efficacy|1|||
48690907|NCT02730728|156720112|FG002|Overall Study|Lack of Efficacy|1|||
48690908|NCT03623243|156720113|FG000|Overall Study|Adverse Event|15|||
48690909|NCT03623243|156720113|FG000|Overall Study|Guardian Decision|1|||
48690910|NCT03623243|156720113|FG000|Overall Study|New Therapy for Study Indication|1|||
48690911|NCT03623243|156720113|FG000|Overall Study|Protocol Deviation|3|||
48690912|NCT03623243|156720113|FG000|Overall Study|Physician Decision|4|||
48690913|NCT03623243|156720113|FG000|Overall Study|Patient Decision|15|||
48690914|NCT01329263|156720116|FG000|Overall Study|Lost to Follow-up|4|||
48690915|NCT01329263|156720117|FG001|Overall Study|Lost to Follow-up|21|||
48690916|NCT01329263|156720116|FG000|Overall Study|Withdrawal by Subject|1|||
48690917|NCT01329263|156720117|FG001|Overall Study|Withdrawal by Subject|2|||
48763768|NCT02579265|156985743|FG000|Overall Study|Any other reason not specified|0|||
48763769|NCT02579265|156985744|FG001|Overall Study|Any other reason not specified|2|||
48393040|NCT00917150|155634183|FG003|Overall Study|Withdrawal by Subject|11|||
48393041|NCT00917150|155634180|FG000|Overall Study|Other than specified|3|||
48690918|NCT01631435|156720119|FG000|Overall Study|Adverse Event|2|||
48690919|NCT01631435|156720119|FG000|Overall Study|Withdrawal by Subject|2|||
48690920|NCT01631435|156720119|FG000|Overall Study|incomplete study procedure|5|||
48690921|NCT04023526|156720124|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
48393042|NCT00917150|155634181|FG001|Overall Study|Other than specified|3|||
48393043|NCT00917150|155634182|FG002|Overall Study|Other than specified|2|||
48393044|NCT00917150|155634183|FG003|Overall Study|Other than specified|2|||
48393045|NCT02039375|155634184|FG000|Overall Study|Lost to Follow-up|2|||
48393046|NCT03891264|155634185|FG000|Overall Study|Adverse Event|1|||
48393047|NCT03891264|155634185|FG000|Overall Study|Withdrawal by Subject|2|||
48393048|NCT03891264|155634185|FG000|Overall Study|Physician Decision|2|||
48690922|NCT04023526|156720125|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
48393049|NCT00574275|155634188|FG000|Overall Study|Randomized but not treated|2|||
48393050|NCT00574275|155634189|FG001|Overall Study|Randomized but not treated|3|||
48393051|NCT00574275|155634188|FG000|Overall Study|Adverse Event|32|||
48393052|NCT00574275|155634189|FG001|Overall Study|Adverse Event|76|||
48393053|NCT00574275|155634188|FG000|Overall Study|Disease progression|160|||
48393054|NCT00574275|155634189|FG001|Overall Study|Disease progression|146|||
48393055|NCT00574275|155634188|FG000|Overall Study|Lost to Follow-up|2|||
48393056|NCT00574275|155634189|FG001|Overall Study|Lost to Follow-up|1|||
48393057|NCT00574275|155634188|FG000|Overall Study|Study stopped based on DMC decision|62|||
48393058|NCT00574275|155634189|FG001|Overall Study|Study stopped based on DMC decision|23|||
48393059|NCT00574275|155634188|FG000|Overall Study|Withdrawal by Subject|15|||
48393060|NCT00574275|155634189|FG001|Overall Study|Withdrawal by Subject|17|||
48393061|NCT00574275|155634188|FG000|Overall Study|Error calculating tumor measurement|1|||
48393062|NCT00574275|155634189|FG001|Overall Study|Error calculating tumor measurement|0|||
48393063|NCT00574275|155634188|FG000|Overall Study|Physician Decision|1|||
48393064|NCT00574275|155634189|FG001|Overall Study|Physician Decision|1|||
48393065|NCT00574275|155634188|FG000|Overall Study|Protocol Violation|0|||
48393066|NCT00574275|155634189|FG001|Overall Study|Protocol Violation|1|||
48393067|NCT00574275|155634188|FG000|Overall Study|Patient and Investigator decision|0|||
48393068|NCT00574275|155634189|FG001|Overall Study|Patient and Investigator decision|1|||
48393069|NCT00574275|155634188|FG000|Overall Study|Insurance change|0|||
48393070|NCT00574275|155634189|FG001|Overall Study|Insurance change|1|||
48393071|NCT00574275|155634188|FG000|Overall Study|Operation for curative intent|0|||
48393072|NCT00574275|155634189|FG001|Overall Study|Operation for curative intent|1|||
48393073|NCT02703311|155634194|FG000|Overall Study|Death|5|||
48393074|NCT02703311|155634194|FG000|Overall Study|Withdrawal by Subject|3|||
48393075|NCT00950664|155634200|FG000|First Intervention|Lost to Follow-up|1|||
48393076|NCT00950664|155634201|FG001|First Intervention|Lost to Follow-up|3|||
48393077|NCT00950664|155634200|FG000|First Intervention|Withdrawal by Subject|2|||
48393078|NCT00950664|155634201|FG001|First Intervention|Withdrawal by Subject|2|||
48393079|NCT00677014|155634202|FG000|Overall Study|Lost to Follow-up|20|||
48393080|NCT00677014|155634203|FG001|Overall Study|Lost to Follow-up|12|||
48393081|NCT00677014|155634204|FG002|Overall Study|Lost to Follow-up|24|||
48393082|NCT00677014|155634202|FG000|Overall Study|Death|6|||
48393083|NCT00677014|155634203|FG001|Overall Study|Death|15|||
48393084|NCT00677014|155634204|FG002|Overall Study|Death|7|||
48393085|NCT00677014|155634202|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
48393086|NCT00677014|155634203|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
48393087|NCT00677014|155634204|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
48393088|NCT01714687|155634207|FG000|Overall Study|Withdrawal by Subject|1|||
48393089|NCT01714687|155634208|FG001|Overall Study|Withdrawal by Subject|0|||
48393090|NCT01714687|155634207|FG000|Overall Study|Lost to Follow-up|2|||
48393091|NCT01714687|155634208|FG001|Overall Study|Lost to Follow-up|4|||
48393092|NCT03116698|155634209|FG000|Overall Study|Adverse Event|1|||
48393093|NCT03116698|155634210|FG001|Overall Study|Adverse Event|1|||
48393094|NCT03116698|155634211|FG002|Overall Study|Adverse Event|1|||
48393095|NCT03116698|155634212|FG003|Overall Study|Adverse Event|0|||
48393096|NCT03116698|155634209|FG000|Overall Study|Withdrawal by Subject|1|||
48393097|NCT03116698|155634210|FG001|Overall Study|Withdrawal by Subject|4|||
48393098|NCT03116698|155634211|FG002|Overall Study|Withdrawal by Subject|5|||
48393099|NCT03116698|155634212|FG003|Overall Study|Withdrawal by Subject|2|||
48393100|NCT03116698|155634209|FG000|Overall Study|Lost to Follow-up|2|||
48393101|NCT03116698|155634210|FG001|Overall Study|Lost to Follow-up|0|||
48393102|NCT03116698|155634211|FG002|Overall Study|Lost to Follow-up|0|||
48393103|NCT03116698|155634212|FG003|Overall Study|Lost to Follow-up|0|||
48393104|NCT03116698|155634209|FG000|Overall Study|Physician Decision|1|||
48393105|NCT03116698|155634210|FG001|Overall Study|Physician Decision|1|||
48393106|NCT03116698|155634211|FG002|Overall Study|Physician Decision|0|||
48393107|NCT03116698|155634212|FG003|Overall Study|Physician Decision|0|||
48393108|NCT03116698|155634209|FG000|Overall Study|Protocol Violation|1|||
48393109|NCT03116698|155634210|FG001|Overall Study|Protocol Violation|0|||
48393110|NCT03116698|155634211|FG002|Overall Study|Protocol Violation|0|||
48393111|NCT03116698|155634212|FG003|Overall Study|Protocol Violation|0|||
48393112|NCT03116698|155634209|FG000|Overall Study|Death|0|||
48690923|NCT04023526|156720124|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
48690924|NCT04023526|156720125|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
48690925|NCT00768989|156720126|FG000|Prior to Week 24|Withdrawal by Subject|1|||
48690926|NCT00768989|156720127|FG001|Prior to Week 24|Withdrawal by Subject|0|||
48690927|NCT00768989|156720126|FG000|Prior to Week 24|Adverse Event|3|||
48393113|NCT03116698|155634210|FG001|Overall Study|Death|0|||
48393114|NCT03116698|155634211|FG002|Overall Study|Death|2|||
48690928|NCT00768989|156720127|FG001|Prior to Week 24|Adverse Event|0|||
48690929|NCT00768989|156720126|FG000|Prior to Week 24|Lost to Follow-up|0|||
48393115|NCT03116698|155634212|FG003|Overall Study|Death|0|||
48393116|NCT00317109|155634213|FG000|Overall Study|Withdrawal by Subject|2|||
48393117|NCT00317109|155634214|FG001|Overall Study|Withdrawal by Subject|0|||
48393118|NCT00317109|155634213|FG000|Overall Study|Migated/moved from study area|1|||
48690930|NCT00768989|156720127|FG001|Prior to Week 24|Lost to Follow-up|1|||
48690931|NCT00768989|156720126|FG000|Prior to Week 24|Protocol Violation|0|||
48690932|NCT00768989|156720127|FG001|Prior to Week 24|Protocol Violation|2|||
48690933|NCT00768989|156720126|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
48690934|NCT00768989|156720127|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
48690935|NCT00768989|156720126|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
48690936|NCT00768989|156720127|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
48690937|NCT00768989|156720126|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
48690938|NCT00768989|156720127|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
48690939|NCT00768989|156720126|FG000|On or After Week 36|Lack of Efficacy|1|||
48690940|NCT00768989|156720127|FG001|On or After Week 36|Lack of Efficacy|0|||
48690941|NCT00768989|156720126|FG000|On or After Week 36|Adverse Event|0|||
48690942|NCT00768989|156720127|FG001|On or After Week 36|Adverse Event|1|||
48690943|NCT00768989|156720126|FG000|On or After Week 36|Lost to Follow-up|1|||
48690944|NCT00768989|156720127|FG001|On or After Week 36|Lost to Follow-up|0|||
48690945|NCT00768989|156720126|FG000|On or After Week 36|Poor Compliance|1|||
48690946|NCT00768989|156720127|FG001|On or After Week 36|Poor Compliance|0|||
48690947|NCT00768989|156720126|FG000|On or After Week 36|Protocol Violation|1|||
48690948|NCT00768989|156720127|FG001|On or After Week 36|Protocol Violation|0|||
48690949|NCT00768989|156720126|FG000|On or After Week 36|Did not attend termination visit|2|||
48690950|NCT00768989|156720127|FG001|On or After Week 36|Did not attend termination visit|0|||
48393119|NCT00317109|155634214|FG001|Overall Study|Migated/moved from study area|0|||
48393120|NCT01508702|155634215|FG000|Overall Study|Adverse Event|7|||
48393121|NCT01508702|155634216|FG001|Overall Study|Adverse Event|3|||
48393122|NCT01508702|155634215|FG000|Overall Study|Gout flare|2|||
48393123|NCT01508702|155634216|FG001|Overall Study|Gout flare|0|||
48393124|NCT01508702|155634215|FG000|Overall Study|Protocol Violation|2|||
48393125|NCT01508702|155634216|FG001|Overall Study|Protocol Violation|1|||
48393126|NCT01508702|155634215|FG000|Overall Study|Lost to Follow-up|1|||
48393127|NCT01508702|155634216|FG001|Overall Study|Lost to Follow-up|2|||
48393128|NCT01508702|155634215|FG000|Overall Study|Withdrawal by Subject|11|||
48393129|NCT01508702|155634216|FG001|Overall Study|Withdrawal by Subject|7|||
48393130|NCT00844753|155634217|FG000|Overall Study|Lack of Efficacy|1|||
48393131|NCT00844753|155634218|FG001|Overall Study|Lack of Efficacy|0|||
48393132|NCT00844753|155634219|FG002|Overall Study|Lack of Efficacy|2|||
48393133|NCT00844753|155634220|FG003|Overall Study|Lack of Efficacy|2|||
48393134|NCT00844753|155634217|FG000|Overall Study|Adverse Event|3|||
48393135|NCT00844753|155634218|FG001|Overall Study|Adverse Event|2|||
48393136|NCT00844753|155634219|FG002|Overall Study|Adverse Event|5|||
48393137|NCT00844753|155634220|FG003|Overall Study|Adverse Event|5|||
48690951|NCT00768989|156720126|FG000|On or After Week 36|Sponsor Termination|45|||
48690952|NCT00768989|156720127|FG001|On or After Week 36|Sponsor Termination|26|||
48690953|NCT00866177|156720129|FG000|Overall Study|Withdrawal by Subject|1|||
48690954|NCT00866177|156720129|FG000|Overall Study|Not Treated|151|||
48690955|NCT03585660|156720130|FG000|Overall Study|operator error|1|||
48690956|NCT03585660|156720130|FG000|Overall Study|technical error|2|||
48690957|NCT03585660|156720130|FG000|Overall Study|hip prosthesis|2|||
48690958|NCT03585660|156720130|FG000|Overall Study|did not undergo biopsy|8|||
48690959|NCT03585660|156720130|FG000|Overall Study|scanner problem|2|||
48690960|NCT04143061|156720131|FG000|Overall Study|Protocol Deviation|0|||
48690961|NCT04143061|156720132|FG001|Overall Study|Protocol Deviation|0|||
48690962|NCT04143061|156720133|FG002|Overall Study|Protocol Deviation|0|||
48690963|NCT04143061|156720134|FG003|Overall Study|Protocol Deviation|0|||
48690964|NCT04143061|156720135|FG004|Overall Study|Protocol Deviation|0|||
48690965|NCT04143061|156720136|FG005|Overall Study|Protocol Deviation|0|||
48690966|NCT04143061|156720137|FG006|Overall Study|Protocol Deviation|5|||
48393138|NCT00844753|155634217|FG000|Overall Study|Lost to Follow-up|1|||
48393139|NCT00844753|155634218|FG001|Overall Study|Lost to Follow-up|1|||
48393140|NCT00844753|155634219|FG002|Overall Study|Lost to Follow-up|0|||
48393141|NCT00844753|155634220|FG003|Overall Study|Lost to Follow-up|1|||
48393142|NCT00844753|155634217|FG000|Overall Study|could not swallow medication|2|||
48393143|NCT00844753|155634218|FG001|Overall Study|could not swallow medication|0|||
48393144|NCT00844753|155634219|FG002|Overall Study|could not swallow medication|0|||
48393145|NCT00844753|155634220|FG003|Overall Study|could not swallow medication|0|||
48393146|NCT00844753|155634217|FG000|Overall Study|Withdrawal by Subject|1|||
48393147|NCT00844753|155634218|FG001|Overall Study|Withdrawal by Subject|0|||
48393148|NCT00844753|155634219|FG002|Overall Study|Withdrawal by Subject|0|||
48393149|NCT00844753|155634220|FG003|Overall Study|Withdrawal by Subject|3|||
48690967|NCT04143061|156720138|FG007|Overall Study|Protocol Deviation|5|||
48690968|NCT04143061|156720131|FG000|Overall Study|Withdrawal by Subject|2|||
48690969|NCT04143061|156720132|FG001|Overall Study|Withdrawal by Subject|0|||
48690970|NCT04143061|156720133|FG002|Overall Study|Withdrawal by Subject|0|||
48690971|NCT04143061|156720134|FG003|Overall Study|Withdrawal by Subject|0|||
48690972|NCT04143061|156720135|FG004|Overall Study|Withdrawal by Subject|0|||
48393150|NCT03084536|155634224|FG000|Overall Study|Determined to be ineligible|0|||
48393151|NCT03084536|155634225|FG001|Overall Study|Determined to be ineligible|0|||
48763770|NCT02579265|156985743|FG000|Overall Study|Withdrawal by Subject|2|||
48763771|NCT02579265|156985744|FG001|Overall Study|Withdrawal by Subject|0|||
48763772|NCT02579265|156985743|FG000|Overall Study|Physician Decision|1|||
48690973|NCT04143061|156720136|FG005|Overall Study|Withdrawal by Subject|1|||
48690974|NCT04143061|156720137|FG006|Overall Study|Withdrawal by Subject|0|||
48690975|NCT04143061|156720138|FG007|Overall Study|Withdrawal by Subject|0|||
48690976|NCT04143061|156720131|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48690977|NCT04143061|156720132|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48690978|NCT04143061|156720133|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48690979|NCT04143061|156720134|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48690980|NCT04143061|156720135|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
48690981|NCT04143061|156720136|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
48690982|NCT04143061|156720137|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
48690983|NCT04143061|156720138|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
48690984|NCT05288283|156720139|FG000|Overall Study|Study Terminated Early|1|||
48690985|NCT05288283|156720140|FG001|Overall Study|Study Terminated Early|1|||
48690986|NCT04685798|156720141|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
48690987|NCT03812380|156720142|FG000|Overall Study|Protocol Violation|3|||
48690988|NCT03812380|156720143|FG001|Overall Study|Protocol Violation|3|||
48690989|NCT03812380|156720142|FG000|Overall Study|Withdrawal by Subject|5|||
48690990|NCT03812380|156720143|FG001|Overall Study|Withdrawal by Subject|4|||
48690991|NCT03812380|156720142|FG000|Overall Study|Early termination of study|14|||
48690992|NCT03812380|156720143|FG001|Overall Study|Early termination of study|14|||
48690993|NCT03303625|156720144|FG000|Overall Study|Withdrawal by Subject|2|||
48690994|NCT03303625|156720145|FG001|Overall Study|Withdrawal by Subject|0|||
48690995|NCT03303625|156720146|FG002|Overall Study|Withdrawal by Subject|0|||
48690996|NCT03303625|156720147|FG003|Overall Study|Withdrawal by Subject|0|||
48690997|NCT01962441|156720148|FG000|Randomized Period|Randomized but Never Treated|4|||
48690998|NCT01962441|156720149|FG001|Randomized Period|Randomized but Never Treated|2|||
48690999|NCT01962441|156720150|FG002|Randomized Period|Randomized but Never Treated|3|||
48691000|NCT01962441|156720148|FG000|Randomized Period|Lost to Follow-up|2|||
48691001|NCT01962441|156720149|FG001|Randomized Period|Lost to Follow-up|4|||
48691002|NCT01962441|156720150|FG002|Randomized Period|Lost to Follow-up|4|||
48691003|NCT01962441|156720148|FG000|Randomized Period|Withdrew Consent|3|||
48691004|NCT01962441|156720149|FG001|Randomized Period|Withdrew Consent|3|||
48691005|NCT01962441|156720150|FG002|Randomized Period|Withdrew Consent|2|||
48691006|NCT01962441|156720148|FG000|Randomized Period|Adverse Event|1|||
48691007|NCT01962441|156720149|FG001|Randomized Period|Adverse Event|1|||
48691008|NCT01962441|156720150|FG002|Randomized Period|Adverse Event|0|||
48691009|NCT01962441|156720148|FG000|Randomized Period|Death|0|||
48691010|NCT01962441|156720149|FG001|Randomized Period|Death|0|||
48691011|NCT01962441|156720150|FG002|Randomized Period|Death|2|||
48691012|NCT01962441|156720148|FG000|Randomized Period|Protocol Violation|0|||
48691013|NCT01962441|156720149|FG001|Randomized Period|Protocol Violation|1|||
48691014|NCT01962441|156720150|FG002|Randomized Period|Protocol Violation|0|||
48691015|NCT01962441|156720148|FG000|Retreatment Substudy|Lack of Efficacy|1|||
48691016|NCT01962441|156720149|FG001|Retreatment Substudy|Lack of Efficacy|0|||
48691017|NCT01962441|156720150|FG002|Retreatment Substudy|Lack of Efficacy|0|||
48691018|NCT01962441|156720148|FG000|Retreatment Substudy|Lost to Follow-up|1|||
48691019|NCT01962441|156720149|FG001|Retreatment Substudy|Lost to Follow-up|0|||
48691020|NCT01962441|156720150|FG002|Retreatment Substudy|Lost to Follow-up|0|||
48691021|NCT04862065|156720151|FG000|Screening|Protocol Violation|54|||
48691022|NCT04862065|156720152|FG001|Screening|Protocol Violation|0|||
48691023|NCT04862065|156720153|FG002|Screening|Protocol Violation|0|||
48691024|NCT04862065|156720151|FG000|Screening|Insufficient Sample|1|||
48691025|NCT04862065|156720152|FG001|Screening|Insufficient Sample|0|||
48691026|NCT04862065|156720153|FG002|Screening|Insufficient Sample|0|||
48691027|NCT04862065|156720151|FG000|Follow-Up|Lost to Follow-up|3|||
48691028|NCT04862065|156720152|FG001|Follow-Up|Lost to Follow-up|0|||
48691029|NCT04862065|156720153|FG002|Follow-Up|Lost to Follow-up|0|||
48691030|NCT02055898|156720154|FG000|First Intervention (5 Days)|Physician Decision|2|||
48691031|NCT02055898|156720155|FG001|First Intervention (5 Days)|Physician Decision|0|||
48691032|NCT02055898|156720154|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
48691033|NCT02055898|156720155|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
48691034|NCT01488045|156720157|FG000|Overall Study|Withdrawal by Subject|6|||
48691035|NCT01488045|156720158|FG001|Overall Study|Withdrawal by Subject|11|||
48691036|NCT01488045|156720157|FG000|Overall Study|Failure to present for colonoscopy|3|||
48691037|NCT01488045|156720158|FG001|Overall Study|Failure to present for colonoscopy|6|||
48691038|NCT01488045|156720157|FG000|Overall Study|Failure to report exclusion criteria|0|||
48763773|NCT02579265|156985744|FG001|Overall Study|Physician Decision|0|||
48763774|NCT02579265|156985743|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
48393152|NCT03084536|155634226|FG002|Overall Study|Determined to be ineligible|16|||
48691039|NCT01488045|156720158|FG001|Overall Study|Failure to report exclusion criteria|1|||
48691040|NCT02159066|156720159|FG000|Part I|Adverse Event|7|||
48426300|NCT00064662|155749536|FG001|Overall Study|Lost to Follow-up|44|||
48691041|NCT02159066|156720160|FG001|Part I|Adverse Event|5|||
48691042|NCT02159066|156720161|FG002|Part I|Adverse Event|0|||
48691043|NCT02159066|156720162|FG003|Part I|Adverse Event|0|||
48691044|NCT02159066|156720163|FG004|Part I|Adverse Event|0|||
48691045|NCT02159066|156720164|FG005|Part I|Adverse Event|0|||
48691046|NCT02159066|156720159|FG000|Part I|Death|11|||
48691047|NCT02159066|156720160|FG001|Part I|Death|9|||
48691048|NCT02159066|156720161|FG002|Part I|Death|0|||
48691049|NCT02159066|156720162|FG003|Part I|Death|0|||
48691050|NCT02159066|156720163|FG004|Part I|Death|0|||
48691051|NCT02159066|156720164|FG005|Part I|Death|0|||
48691052|NCT02159066|156720159|FG000|Part I|Progressive Disease|37|||
48691053|NCT02159066|156720160|FG001|Part I|Progressive Disease|46|||
48691054|NCT02159066|156720161|FG002|Part I|Progressive Disease|0|||
48691055|NCT02159066|156720162|FG003|Part I|Progressive Disease|0|||
48691056|NCT02159066|156720163|FG004|Part I|Progressive Disease|0|||
48691057|NCT02159066|156720164|FG005|Part I|Progressive Disease|0|||
48691058|NCT02159066|156720159|FG000|Part I|New Therapy for Study Indication|5|||
48691059|NCT02159066|156720160|FG001|Part I|New Therapy for Study Indication|4|||
48691060|NCT02159066|156720161|FG002|Part I|New Therapy for Study Indication|0|||
48691061|NCT02159066|156720162|FG003|Part I|New Therapy for Study Indication|0|||
48691062|NCT02159066|156720163|FG004|Part I|New Therapy for Study Indication|0|||
48691063|NCT02159066|156720164|FG005|Part I|New Therapy for Study Indication|0|||
48691064|NCT02159066|156720159|FG000|Part I|Termination of participants from the study|3|||
48691065|NCT02159066|156720160|FG001|Part I|Termination of participants from the study|3|||
48691066|NCT02159066|156720161|FG002|Part I|Termination of participants from the study|0|||
48691067|NCT02159066|156720162|FG003|Part I|Termination of participants from the study|0|||
48691068|NCT02159066|156720163|FG004|Part I|Termination of participants from the study|0|||
48691069|NCT02159066|156720164|FG005|Part I|Termination of participants from the study|0|||
48691070|NCT02159066|156720159|FG000|Part I|Physician Decision|2|||
48691071|NCT02159066|156720160|FG001|Part I|Physician Decision|9|||
48691072|NCT02159066|156720161|FG002|Part I|Physician Decision|0|||
48691073|NCT02159066|156720162|FG003|Part I|Physician Decision|0|||
48691074|NCT02159066|156720163|FG004|Part I|Physician Decision|0|||
48691075|NCT02159066|156720164|FG005|Part I|Physician Decision|0|||
48691076|NCT02159066|156720159|FG000|Part I|Participant/Guardian Decision|9|||
48691077|NCT02159066|156720160|FG001|Part I|Participant/Guardian Decision|3|||
48691078|NCT02159066|156720161|FG002|Part I|Participant/Guardian Decision|0|||
48691079|NCT02159066|156720162|FG003|Part I|Participant/Guardian Decision|0|||
48691080|NCT02159066|156720163|FG004|Part I|Participant/Guardian Decision|0|||
48691081|NCT02159066|156720164|FG005|Part I|Participant/Guardian Decision|0|||
48691082|NCT02159066|156720159|FG000|Part I|Missing Data|1|||
48691083|NCT02159066|156720160|FG001|Part I|Missing Data|0|||
48691084|NCT02159066|156720161|FG002|Part I|Missing Data|0|||
48691085|NCT02159066|156720162|FG003|Part I|Missing Data|0|||
48691086|NCT02159066|156720163|FG004|Part I|Missing Data|0|||
48691087|NCT02159066|156720164|FG005|Part I|Missing Data|0|||
48691088|NCT02159066|156720159|FG000|Part II|Adverse Event|0|||
48691089|NCT02159066|156720160|FG001|Part II|Adverse Event|0|||
48691090|NCT02159066|156720161|FG002|Part II|Adverse Event|1|||
48691091|NCT02159066|156720162|FG003|Part II|Adverse Event|0|||
48691092|NCT02159066|156720163|FG004|Part II|Adverse Event|1|||
48691093|NCT02159066|156720164|FG005|Part II|Adverse Event|1|||
48691094|NCT02159066|156720159|FG000|Part II|Death|0|||
48691095|NCT02159066|156720160|FG001|Part II|Death|0|||
48691096|NCT02159066|156720161|FG002|Part II|Death|1|||
48691097|NCT02159066|156720162|FG003|Part II|Death|0|||
48691098|NCT02159066|156720163|FG004|Part II|Death|2|||
48691099|NCT02159066|156720164|FG005|Part II|Death|1|||
48691100|NCT02159066|156720159|FG000|Part II|Progressive Disease|0|||
48763775|NCT02579265|156985744|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
48393153|NCT03084536|155634224|FG000|Overall Study|Withdrawal by Subject|0|||
48393154|NCT03084536|155634225|FG001|Overall Study|Withdrawal by Subject|0|||
48393155|NCT03084536|155634226|FG002|Overall Study|Withdrawal by Subject|4|||
48393156|NCT03084536|155634224|FG000|Overall Study|Physician Decision|0|||
48691101|NCT02159066|156720160|FG001|Part II|Progressive Disease|0|||
48691102|NCT02159066|156720161|FG002|Part II|Progressive Disease|35|||
48691103|NCT02159066|156720162|FG003|Part II|Progressive Disease|1|||
48691104|NCT02159066|156720163|FG004|Part II|Progressive Disease|7|||
48691105|NCT02159066|156720164|FG005|Part II|Progressive Disease|4|||
48691106|NCT02159066|156720159|FG000|Part II|New Therapy for Study Indication|0|||
48691107|NCT02159066|156720160|FG001|Part II|New Therapy for Study Indication|0|||
48691108|NCT02159066|156720161|FG002|Part II|New Therapy for Study Indication|0|||
48691109|NCT02159066|156720162|FG003|Part II|New Therapy for Study Indication|0|||
48691110|NCT02159066|156720163|FG004|Part II|New Therapy for Study Indication|1|||
48691111|NCT02159066|156720164|FG005|Part II|New Therapy for Study Indication|0|||
48691112|NCT02159066|156720159|FG000|Part II|Physician Decision|0|||
48691113|NCT02159066|156720160|FG001|Part II|Physician Decision|0|||
48763776|NCT02174848|156985745|FG000|Overall Study|Adverse Event|2|||
48691114|NCT02159066|156720161|FG002|Part II|Physician Decision|1|||
48691115|NCT02159066|156720162|FG003|Part II|Physician Decision|0|||
48691116|NCT02159066|156720163|FG004|Part II|Physician Decision|0|||
48691117|NCT02159066|156720164|FG005|Part II|Physician Decision|0|||
48691118|NCT02159066|156720159|FG000|Part II|Participant/Guardian Decision|0|||
48691119|NCT02159066|156720160|FG001|Part II|Participant/Guardian Decision|0|||
48691120|NCT02159066|156720161|FG002|Part II|Participant/Guardian Decision|0|||
48691121|NCT02159066|156720162|FG003|Part II|Participant/Guardian Decision|0|||
48691122|NCT02159066|156720163|FG004|Part II|Participant/Guardian Decision|2|||
48691123|NCT02159066|156720164|FG005|Part II|Participant/Guardian Decision|0|||
48691124|NCT02314052|156720165|FG000|Cycle One|Adverse Event|0|||
48691125|NCT02314052|156720166|FG001|Cycle One|Adverse Event|0|||
48691126|NCT02314052|156720167|FG002|Cycle One|Adverse Event|0|||
48691127|NCT02314052|156720168|FG003|Cycle One|Adverse Event|1|||
48691128|NCT02314052|156720169|FG004|Cycle One|Adverse Event|0|||
48691129|NCT02314052|156720170|FG005|Cycle One|Adverse Event|0|||
48691130|NCT02748863|156720171|FG000|Treatment Period 1|Adverse Event|0|||
48691131|NCT02748863|156720172|FG001|Treatment Period 1|Adverse Event|1|||
48691132|NCT02748863|156720173|FG002|Treatment Period 1|Adverse Event|0|||
48691133|NCT02748863|156720174|FG003|Treatment Period 1|Adverse Event|0|||
48691134|NCT02748863|156720175|FG004|Treatment Period 1|Adverse Event|0|||
48691135|NCT02748863|156720171|FG000|Treatment Period 1|Lack of Efficacy|0|||
48691136|NCT02748863|156720172|FG001|Treatment Period 1|Lack of Efficacy|0|||
48691137|NCT02748863|156720173|FG002|Treatment Period 1|Lack of Efficacy|1|||
48691138|NCT02748863|156720174|FG003|Treatment Period 1|Lack of Efficacy|0|||
48691139|NCT02748863|156720175|FG004|Treatment Period 1|Lack of Efficacy|0|||
48691140|NCT02748863|156720171|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48691141|NCT02748863|156720172|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48691142|NCT02748863|156720173|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48691143|NCT02748863|156720174|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48691144|NCT02748863|156720175|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48691145|NCT02748863|156720171|FG000|Treatment Period 2|Lost to Follow-up|2|||
48691146|NCT02748863|156720172|FG001|Treatment Period 2|Lost to Follow-up|0|||
48691147|NCT02748863|156720173|FG002|Treatment Period 2|Lost to Follow-up|0|||
48691148|NCT02748863|156720174|FG003|Treatment Period 2|Lost to Follow-up|0|||
48691149|NCT02748863|156720175|FG004|Treatment Period 2|Lost to Follow-up|0|||
48691150|NCT02748863|156720171|FG000|Treatment Period 2|Adverse Event|3|||
48691151|NCT02748863|156720172|FG001|Treatment Period 2|Adverse Event|2|||
48691152|NCT02748863|156720173|FG002|Treatment Period 2|Adverse Event|0|||
48691153|NCT02748863|156720174|FG003|Treatment Period 2|Adverse Event|2|||
48691154|NCT02748863|156720175|FG004|Treatment Period 2|Adverse Event|0|||
48691155|NCT02748863|156720171|FG000|Treatment Period 2|Lack of Efficacy|0|||
48691156|NCT02748863|156720172|FG001|Treatment Period 2|Lack of Efficacy|1|||
48691157|NCT02748863|156720173|FG002|Treatment Period 2|Lack of Efficacy|0|||
48691158|NCT02748863|156720174|FG003|Treatment Period 2|Lack of Efficacy|0|||
48691159|NCT02748863|156720175|FG004|Treatment Period 2|Lack of Efficacy|0|||
48691160|NCT02748863|156720171|FG000|Treatment Period 2|Pregnancy|0|||
48691161|NCT02748863|156720172|FG001|Treatment Period 2|Pregnancy|0|||
48691162|NCT02748863|156720173|FG002|Treatment Period 2|Pregnancy|0|||
48691163|NCT02748863|156720174|FG003|Treatment Period 2|Pregnancy|0|||
48691164|NCT02748863|156720175|FG004|Treatment Period 2|Pregnancy|1|||
48691165|NCT02653326|156720177|FG000|Overall Study|Lost to Follow-up|10|||
48691166|NCT02653326|156720178|FG001|Overall Study|Lost to Follow-up|7|||
48691167|NCT02422498|156720179|FG000|Overall Study|Inevaluable|4|||
48691168|NCT02914639|156720180|FG000|Overall Study|Withdrawal by Subject|0|||
48691169|NCT02914639|156720181|FG001|Overall Study|Withdrawal by Subject|2|||
48691170|NCT01960140|156720182|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
48691171|NCT01046565|156720186|FG000|Overall Study|Adverse Event|2|||
48691172|NCT01046565|156720186|FG000|Overall Study|Withdrawal by Subject|7|||
48691173|NCT00660192|156720187|FG000|Overall Study|Lost to Follow-up|2|||
48691174|NCT00660192|156720188|FG001|Overall Study|Lost to Follow-up|3|||
48691175|NCT02734693|156720189|FG000|Overall Study|Adverse Event|1|||
48691176|NCT02734693|156720190|FG001|Overall Study|Adverse Event|3|||
48691177|NCT02734693|156720191|FG002|Overall Study|Adverse Event|3|||
48691178|NCT02734693|156720189|FG000|Overall Study|Lack of Efficacy|1|||
48691179|NCT02734693|156720190|FG001|Overall Study|Lack of Efficacy|0|||
48691180|NCT02734693|156720191|FG002|Overall Study|Lack of Efficacy|0|||
48691181|NCT02734693|156720189|FG000|Overall Study|Lost to Follow-up|2|||
48691182|NCT02734693|156720190|FG001|Overall Study|Lost to Follow-up|0|||
48691183|NCT02734693|156720191|FG002|Overall Study|Lost to Follow-up|0|||
48691184|NCT02734693|156720189|FG000|Overall Study|Protocol Violation|1|||
48691185|NCT02734693|156720190|FG001|Overall Study|Protocol Violation|0|||
48691186|NCT02734693|156720191|FG002|Overall Study|Protocol Violation|0|||
48691187|NCT02734693|156720189|FG000|Overall Study|Withdrawal by Subject|1|||
48691188|NCT02734693|156720190|FG001|Overall Study|Withdrawal by Subject|0|||
48691189|NCT02734693|156720191|FG002|Overall Study|Withdrawal by Subject|0|||
48691190|NCT01069484|156720199|FG000|Overall Study|Death-in-near-family|1|||
48691191|NCT01069484|156720200|FG001|Overall Study|Death-in-near-family|0|||
48691192|NCT01069484|156720199|FG000|Overall Study|No specific reason|8|||
48691193|NCT01069484|156720200|FG001|Overall Study|No specific reason|2|||
48691194|NCT01069484|156720199|FG000|Overall Study|Illness mother or child|3|||
48763777|NCT02174848|156985746|FG001|Overall Study|Adverse Event|1|||
48763778|NCT02174848|156985745|FG000|Overall Study|Withdrawal by Subject|3|||
48763779|NCT02174848|156985746|FG001|Overall Study|Withdrawal by Subject|3|||
48763780|NCT02174848|156985745|FG000|Overall Study|Lost to Follow-up|0|||
48763781|NCT02174848|156985746|FG001|Overall Study|Lost to Follow-up|1|||
48763782|NCT02174848|156985745|FG000|Overall Study|Worsening of disease|1|||
48763783|NCT02174848|156985746|FG001|Overall Study|Worsening of disease|1|||
48763784|NCT02174848|156985745|FG000|Overall Study|Unable to comply with study requirements|1|||
48763785|NCT02174848|156985746|FG001|Overall Study|Unable to comply with study requirements|0|||
48763786|NCT03257631|156985752|FG000|Overall Study|Death|1|||
48393157|NCT03084536|155634225|FG001|Overall Study|Physician Decision|0|||
48691195|NCT01069484|156720200|FG001|Overall Study|Illness mother or child|1|||
48691196|NCT01506271|156720201|FG000|Overall Study|Progressive disease|0|||
48691197|NCT01506271|156720202|FG001|Overall Study|Progressive disease|1|||
48691198|NCT01506271|156720203|FG002|Overall Study|Progressive disease|0|||
48691199|NCT01506271|156720201|FG000|Overall Study|Protocol Violation|3|||
48691200|NCT01506271|156720202|FG001|Overall Study|Protocol Violation|1|||
48691201|NCT01506271|156720203|FG002|Overall Study|Protocol Violation|0|||
48691202|NCT01506271|156720201|FG000|Overall Study|Death|0|||
48691203|NCT01506271|156720202|FG001|Overall Study|Death|1|||
48691204|NCT01506271|156720203|FG002|Overall Study|Death|0|||
48691205|NCT01506271|156720201|FG000|Overall Study|Adverse Event|0|||
48691206|NCT01506271|156720202|FG001|Overall Study|Adverse Event|2|||
48691207|NCT01506271|156720203|FG002|Overall Study|Adverse Event|0|||
48691208|NCT01506271|156720201|FG000|Overall Study|Insufficient supply of study drug|1|||
48691209|NCT01506271|156720202|FG001|Overall Study|Insufficient supply of study drug|0|||
48691210|NCT01506271|156720203|FG002|Overall Study|Insufficient supply of study drug|0|||
48691211|NCT01506271|156720201|FG000|Overall Study|Withdrawal by Subject|0|||
48691212|NCT01506271|156720202|FG001|Overall Study|Withdrawal by Subject|1|||
48691213|NCT01506271|156720203|FG002|Overall Study|Withdrawal by Subject|1|||
48691214|NCT01506271|156720201|FG000|Overall Study|Lost to Follow-up|0|||
48691215|NCT01506271|156720202|FG001|Overall Study|Lost to Follow-up|1|||
48763787|NCT03257631|156985753|FG001|Overall Study|Death|0|||
48763788|NCT03257631|156985754|FG002|Overall Study|Death|1|||
48763789|NCT03257631|156985755|FG003|Overall Study|Death|1|||
48763790|NCT03257631|156985752|FG000|Overall Study|Progressive Disease|10|||
48393158|NCT03084536|155634226|FG002|Overall Study|Physician Decision|3|||
48763791|NCT03257631|156985753|FG001|Overall Study|Progressive Disease|9|||
48393159|NCT03084536|155634224|FG000|Overall Study|Death|0|||
48691216|NCT01506271|156720203|FG002|Overall Study|Lost to Follow-up|2|||
48691217|NCT01129622|156720209|FG000|Overall Study|Withdrawal by Subject|2|||
48691218|NCT01425801|156720210|FG000|Period 1|Withdrawal by Subject|0|||
48763792|NCT03257631|156985754|FG002|Overall Study|Progressive Disease|17|||
48763793|NCT03257631|156985755|FG003|Overall Study|Progressive Disease|8|||
48763794|NCT03257631|156985752|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48763795|NCT03257631|156985753|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48763796|NCT03257631|156985754|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48763797|NCT03257631|156985755|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
48763798|NCT03257631|156985752|FG000|Overall Study|Adverse Event|0|||
48763799|NCT03257631|156985753|FG001|Overall Study|Adverse Event|0|||
48763800|NCT03257631|156985754|FG002|Overall Study|Adverse Event|2|||
48393160|NCT03084536|155634225|FG001|Overall Study|Death|0|||
48393161|NCT03084536|155634226|FG002|Overall Study|Death|1|||
48691219|NCT01425801|156720211|FG001|Period 1|Withdrawal by Subject|0|||
48691220|NCT01425801|156720212|FG002|Period 1|Withdrawal by Subject|0|||
48691221|NCT01425801|156720213|FG003|Period 1|Withdrawal by Subject|0|||
48763801|NCT03257631|156985755|FG003|Overall Study|Adverse Event|0|||
48763802|NCT01063764|156985756|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
48763803|NCT01063764|156985756|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
48763804|NCT01063764|156985756|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
48691222|NCT01425801|156720214|FG004|Period 1|Withdrawal by Subject|1|||
48691223|NCT01425801|156720215|FG005|Period 1|Withdrawal by Subject|0|||
48691224|NCT01425801|156720210|FG000|Period 2|Withdrawal by Subject|0|||
48691225|NCT01425801|156720211|FG001|Period 2|Withdrawal by Subject|0|||
48691226|NCT01425801|156720212|FG002|Period 2|Withdrawal by Subject|0|||
48691227|NCT01425801|156720213|FG003|Period 2|Withdrawal by Subject|0|||
48691228|NCT01425801|156720214|FG004|Period 2|Withdrawal by Subject|1|||
48691229|NCT01425801|156720215|FG005|Period 2|Withdrawal by Subject|0|||
48691230|NCT01425801|156720210|FG000|Period 3|Stability criteria not fullfilled|0|||
48691231|NCT01425801|156720211|FG001|Period 3|Stability criteria not fullfilled|0|||
48691232|NCT01425801|156720212|FG002|Period 3|Stability criteria not fullfilled|1|||
48691233|NCT01425801|156720213|FG003|Period 3|Stability criteria not fullfilled|0|||
48691234|NCT01425801|156720214|FG004|Period 3|Stability criteria not fullfilled|0|||
48691235|NCT01425801|156720215|FG005|Period 3|Stability criteria not fullfilled|0|||
48691236|NCT01425801|156720210|FG000|Period 4|Not able to maintain visit schedule|0|||
48691237|NCT01425801|156720211|FG001|Period 4|Not able to maintain visit schedule|0|||
48691238|NCT01425801|156720212|FG002|Period 4|Not able to maintain visit schedule|1|||
48763805|NCT01063764|156985756|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
48393162|NCT03084536|155634224|FG000|Overall Study|Lost to Follow-up|0|||
48691239|NCT01425801|156720213|FG003|Period 4|Not able to maintain visit schedule|0|||
48763806|NCT01063764|156985756|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
48691240|NCT01425801|156720214|FG004|Period 4|Not able to maintain visit schedule|0|||
48393163|NCT03084536|155634225|FG001|Overall Study|Lost to Follow-up|0|||
48393164|NCT03084536|155634226|FG002|Overall Study|Lost to Follow-up|1|||
48393165|NCT03084536|155634224|FG000|Overall Study|Protocol Violation|0|||
48393166|NCT03084536|155634225|FG001|Overall Study|Protocol Violation|0|||
48691241|NCT01425801|156720215|FG005|Period 4|Not able to maintain visit schedule|0|||
48691242|NCT02898454|156720216|FG000|Overall Study|Adverse Event|4|||
48691243|NCT02898454|156720217|FG001|Overall Study|Adverse Event|1|||
48691244|NCT02898454|156720218|FG002|Overall Study|Adverse Event|2|||
48691245|NCT02898454|156720216|FG000|Overall Study|Protocol Violation|1|||
48691246|NCT02898454|156720217|FG001|Overall Study|Protocol Violation|0|||
48691247|NCT02898454|156720218|FG002|Overall Study|Protocol Violation|1|||
48691248|NCT02898454|156720216|FG000|Overall Study|Lack of Efficacy|4|||
48691249|NCT02898454|156720217|FG001|Overall Study|Lack of Efficacy|1|||
48691250|NCT02898454|156720218|FG002|Overall Study|Lack of Efficacy|0|||
48691251|NCT02898454|156720216|FG000|Overall Study|Withdrawal by Subject|6|||
48691252|NCT02898454|156720217|FG001|Overall Study|Withdrawal by Subject|3|||
48691253|NCT02898454|156720218|FG002|Overall Study|Withdrawal by Subject|3|||
48691254|NCT02898454|156720216|FG000|Overall Study|Lost to Follow-up|1|||
48691255|NCT02898454|156720217|FG001|Overall Study|Lost to Follow-up|0|||
48691256|NCT02898454|156720218|FG002|Overall Study|Lost to Follow-up|0|||
48691257|NCT02898454|156720216|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
48691258|NCT02898454|156720217|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
48691259|NCT02898454|156720218|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
48691260|NCT00525512|156720220|FG000|Double-Blind Phase|Adverse Event|48|||
48691261|NCT00525512|156720221|FG001|Double-Blind Phase|Adverse Event|28|||
48691262|NCT00525512|156720222|FG002|Double-Blind Phase|Adverse Event|0|||
48691263|NCT00525512|156720223|FG003|Double-Blind Phase|Adverse Event|0|||
48691264|NCT00525512|156720220|FG000|Double-Blind Phase|Protocol Violation|3|||
48691265|NCT00525512|156720221|FG001|Double-Blind Phase|Protocol Violation|1|||
48691266|NCT00525512|156720222|FG002|Double-Blind Phase|Protocol Violation|0|||
48691267|NCT00525512|156720223|FG003|Double-Blind Phase|Protocol Violation|0|||
48691268|NCT00525512|156720220|FG000|Double-Blind Phase|Lost to Follow-up|3|||
48691269|NCT00525512|156720221|FG001|Double-Blind Phase|Lost to Follow-up|7|||
48691270|NCT00525512|156720222|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48691271|NCT00525512|156720223|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48691272|NCT00525512|156720220|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
48691273|NCT00525512|156720221|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
48691274|NCT00525512|156720222|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48691275|NCT00525512|156720223|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48691276|NCT00525512|156720220|FG000|Double-Blind Phase|Lack of Efficacy|13|||
48691277|NCT00525512|156720221|FG001|Double-Blind Phase|Lack of Efficacy|5|||
48691278|NCT00525512|156720222|FG002|Double-Blind Phase|Lack of Efficacy|0|||
48691279|NCT00525512|156720223|FG003|Double-Blind Phase|Lack of Efficacy|0|||
48691280|NCT00525512|156720220|FG000|Double-Blind Phase|Other reason (not specified)|12|||
48691281|NCT00525512|156720221|FG001|Double-Blind Phase|Other reason (not specified)|13|||
48691282|NCT00525512|156720222|FG002|Double-Blind Phase|Other reason (not specified)|0|||
48691283|NCT00525512|156720223|FG003|Double-Blind Phase|Other reason (not specified)|0|||
48691284|NCT00525512|156720220|FG000|Open-Label Phase|Adverse Event|0|||
48691285|NCT00525512|156720221|FG001|Open-Label Phase|Adverse Event|0|||
48691286|NCT00525512|156720222|FG002|Open-Label Phase|Adverse Event|1|||
48691287|NCT00525512|156720223|FG003|Open-Label Phase|Adverse Event|0|||
48691288|NCT00525512|156720220|FG000|Open-Label Phase|Lost to Follow-up|0|||
48691289|NCT00525512|156720221|FG001|Open-Label Phase|Lost to Follow-up|0|||
48691290|NCT00525512|156720222|FG002|Open-Label Phase|Lost to Follow-up|1|||
48691291|NCT00525512|156720223|FG003|Open-Label Phase|Lost to Follow-up|0|||
48691292|NCT00525512|156720220|FG000|Open-Label Phase|Other reason (not specified)|0|||
48691293|NCT00525512|156720221|FG001|Open-Label Phase|Other reason (not specified)|0|||
48691294|NCT00525512|156720222|FG002|Open-Label Phase|Other reason (not specified)|4|||
48691295|NCT00525512|156720223|FG003|Open-Label Phase|Other reason (not specified)|5|||
48763807|NCT01063764|156985756|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
48691296|NCT01903460|156720224|FG000|Overall Study|Adverse Event|0|||
48691297|NCT01903460|156720225|FG001|Overall Study|Adverse Event|0|||
48691298|NCT01903460|156720226|FG002|Overall Study|Adverse Event|0|||
48763808|NCT01063764|156985756|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
48763809|NCT03240133|156985764|FG000|Overall Study|Withdrawal by Subject|0|||
48763810|NCT03240133|156985765|FG001|Overall Study|Withdrawal by Subject|1|||
48763811|NCT03240133|156985766|FG002|Overall Study|Withdrawal by Subject|0|||
48763812|NCT03240133|156985764|FG000|Overall Study|Adverse Event|1|||
48393167|NCT03084536|155634226|FG002|Overall Study|Protocol Violation|1|||
48393168|NCT03084536|155634224|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
48393169|NCT03084536|155634225|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
48691299|NCT01903460|156720227|FG003|Overall Study|Adverse Event|1|||
48691300|NCT00321789|156720230|FG000|Overall Study|Lost to Follow-up|4|||
48691301|NCT00321789|156720231|FG001|Overall Study|Lost to Follow-up|7|||
48691302|NCT00321789|156720230|FG000|Overall Study|Withdrawal by Subject|6|||
48691303|NCT00321789|156720231|FG001|Overall Study|Withdrawal by Subject|6|||
48691304|NCT00321789|156720230|FG000|Overall Study|Protocol Violation|5|||
48691305|NCT00321789|156720231|FG001|Overall Study|Protocol Violation|3|||
48691306|NCT00647296|156720232|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691307|NCT00647296|156720233|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691308|NCT00647296|156720234|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691309|NCT00647296|156720235|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
48691310|NCT00647296|156720232|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
48691311|NCT00647296|156720233|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
48691312|NCT00647296|156720234|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
48691313|NCT00647296|156720235|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
48691314|NCT00647296|156720232|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
48691315|NCT00647296|156720233|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
48691316|NCT00647296|156720234|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
48691317|NCT00647296|156720235|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
48691318|NCT00647296|156720232|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
48691319|NCT00647296|156720233|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
48691320|NCT00647296|156720234|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
48691321|NCT00647296|156720235|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
48691322|NCT00647296|156720232|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
48691323|NCT00647296|156720233|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
48691324|NCT00647296|156720234|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
48691325|NCT00647296|156720235|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
48691326|NCT00647296|156720232|FG000|Part 2: 4-week Placebo Washout|Death|3|||
48691327|NCT00647296|156720233|FG001|Part 2: 4-week Placebo Washout|Death|0|||
48691328|NCT00647296|156720234|FG002|Part 2: 4-week Placebo Washout|Death|0|||
48691329|NCT00647296|156720235|FG003|Part 2: 4-week Placebo Washout|Death|0|||
48691330|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691331|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
48691332|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
48691333|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
48691334|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
48691335|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
48691336|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
48691337|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
48691338|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
48691339|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
48691340|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
48691341|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
48691342|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
48691343|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
48691344|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
48691345|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
48691346|NCT00647296|156720232|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
48691347|NCT00647296|156720233|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
48691348|NCT00647296|156720234|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
48691349|NCT00647296|156720235|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
48691350|NCT02485691|156720236|FG000|Overall Study|Adverse Event|25|||
48691351|NCT02485691|156720237|FG001|Overall Study|Adverse Event|11|||
48691352|NCT02485691|156720236|FG000|Overall Study|Poor compliance to protocol|0|||
48763813|NCT03240133|156985765|FG001|Overall Study|Adverse Event|1|||
48691353|NCT02485691|156720237|FG001|Overall Study|Poor compliance to protocol|1|||
48691354|NCT02485691|156720236|FG000|Overall Study|Disease progression|57|||
48691355|NCT02485691|156720237|FG001|Overall Study|Disease progression|92|||
48691356|NCT02485691|156720236|FG000|Overall Study|Investigator's decision|23|||
48763814|NCT03240133|156985766|FG002|Overall Study|Adverse Event|0|||
48763815|NCT03240133|156985764|FG000|Overall Study|Rash|1|||
48763816|NCT03240133|156985765|FG001|Overall Study|Rash|0|||
48763817|NCT03240133|156985766|FG002|Overall Study|Rash|0|||
48763818|NCT03240133|156985764|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
48393170|NCT03084536|155634226|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
48393171|NCT02124564|155634227|FG000|Treatment Period|Adverse Event|2|||
48393172|NCT02124564|155634227|FG000|Treatment Period|Lack of Efficacy|3|||
48691357|NCT02485691|156720237|FG001|Overall Study|Investigator's decision|5|||
48691358|NCT02485691|156720236|FG000|Overall Study|Participant's request|13|||
48691359|NCT02485691|156720237|FG001|Overall Study|Participant's request|6|||
48691360|NCT02485691|156720236|FG000|Overall Study|Other reason|8|||
48691361|NCT02485691|156720237|FG001|Overall Study|Other reason|9|||
48691362|NCT02485691|156720236|FG000|Overall Study|Randomized and not treated|3|||
48691363|NCT02485691|156720237|FG001|Overall Study|Randomized and not treated|2|||
48393173|NCT02124564|155634227|FG000|Treatment Period|Withdrawal by Subject|2|||
48393174|NCT03099187|155634228|FG000|Double-blind Treatment|Adverse Event|19|||
48393175|NCT03099187|155634229|FG001|Double-blind Treatment|Adverse Event|1|||
48393176|NCT03099187|155634230|FG002|Double-blind Treatment|Adverse Event|0|||
48393177|NCT03099187|155634231|FG003|Double-blind Treatment|Adverse Event|0|||
48393178|NCT03099187|155634228|FG000|Double-blind Treatment|Death|1|||
48393179|NCT03099187|155634229|FG001|Double-blind Treatment|Death|3|||
48393180|NCT03099187|155634230|FG002|Double-blind Treatment|Death|0|||
48393181|NCT03099187|155634231|FG003|Double-blind Treatment|Death|0|||
48393182|NCT03099187|155634228|FG000|Double-blind Treatment|Lack of Efficacy|1|||
48393183|NCT03099187|155634229|FG001|Double-blind Treatment|Lack of Efficacy|0|||
48393184|NCT03099187|155634230|FG002|Double-blind Treatment|Lack of Efficacy|0|||
48393185|NCT03099187|155634231|FG003|Double-blind Treatment|Lack of Efficacy|0|||
48393186|NCT03099187|155634228|FG000|Double-blind Treatment|Physician Decision|2|||
48393187|NCT03099187|155634229|FG001|Double-blind Treatment|Physician Decision|1|||
48393188|NCT03099187|155634230|FG002|Double-blind Treatment|Physician Decision|0|||
48393189|NCT03099187|155634231|FG003|Double-blind Treatment|Physician Decision|0|||
48393190|NCT03099187|155634228|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
48393191|NCT03099187|155634229|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
48393192|NCT03099187|155634230|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
48393193|NCT03099187|155634231|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
48393194|NCT03099187|155634228|FG000|Double-blind Treatment|Lung transplantation|0|||
48393195|NCT03099187|155634229|FG001|Double-blind Treatment|Lung transplantation|1|||
48393196|NCT03099187|155634230|FG002|Double-blind Treatment|Lung transplantation|0|||
48393197|NCT03099187|155634231|FG003|Double-blind Treatment|Lung transplantation|0|||
48393198|NCT03099187|155634228|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
48393199|NCT03099187|155634229|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
48393200|NCT03099187|155634230|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
48691364|NCT02260934|156720239|FG000|Overall Study|Lost to Follow-up|2|||
48691365|NCT02260934|156720240|FG001|Overall Study|Lost to Follow-up|1|||
48691366|NCT02260934|156720239|FG000|Overall Study|Withdrawal by Subject|0|||
48691367|NCT02260934|156720240|FG001|Overall Study|Withdrawal by Subject|2|||
48691368|NCT02260934|156720239|FG000|Overall Study|Participant Relocated|1|||
48691369|NCT02260934|156720240|FG001|Overall Study|Participant Relocated|0|||
48691370|NCT02260934|156720239|FG000|Overall Study|Site error|0|||
48691371|NCT02260934|156720240|FG001|Overall Study|Site error|1|||
48691372|NCT04292535|156720241|FG000|Overall Study|Withdrawal by Subject|0|||
48691373|NCT04292535|156720242|FG001|Overall Study|Withdrawal by Subject|0|||
48691374|NCT04292535|156720243|FG002|Overall Study|Withdrawal by Subject|0|||
48691375|NCT04292535|156720244|FG003|Overall Study|Withdrawal by Subject|0|||
48691376|NCT04292535|156720245|FG004|Overall Study|Withdrawal by Subject|0|||
48691377|NCT04292535|156720246|FG005|Overall Study|Withdrawal by Subject|0|||
48691378|NCT04292535|156720247|FG006|Overall Study|Withdrawal by Subject|0|||
48691379|NCT04292535|156720248|FG007|Overall Study|Withdrawal by Subject|1|||
48691380|NCT04292535|156720249|FG008|Overall Study|Withdrawal by Subject|0|||
48691381|NCT04292535|156720250|FG009|Overall Study|Withdrawal by Subject|0|||
48691382|NCT04292535|156720251|FG010|Overall Study|Withdrawal by Subject|0|||
48763819|NCT03240133|156985765|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
48393201|NCT03099187|155634231|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
48393202|NCT03099187|155634228|FG000|Double-blind Treatment|Disease progression|0|||
48393203|NCT03099187|155634229|FG001|Double-blind Treatment|Disease progression|1|||
48393204|NCT03099187|155634230|FG002|Double-blind Treatment|Disease progression|0|||
48393205|NCT03099187|155634231|FG003|Double-blind Treatment|Disease progression|0|||
48393206|NCT03099187|155634228|FG000|Double-blind Treatment|Randomization error|0|||
48691383|NCT04292535|156720252|FG011|Overall Study|Withdrawal by Subject|0|||
48691384|NCT04292535|156720253|FG012|Overall Study|Withdrawal by Subject|0|||
48691385|NCT04292535|156720254|FG013|Overall Study|Withdrawal by Subject|0|||
48691386|NCT04292535|156720241|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691387|NCT04292535|156720242|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691388|NCT04292535|156720243|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691389|NCT04292535|156720244|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691390|NCT04292535|156720245|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691391|NCT04292535|156720246|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691392|NCT04292535|156720247|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691393|NCT04292535|156720248|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
48691394|NCT04292535|156720249|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691395|NCT04292535|156720250|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691396|NCT04292535|156720251|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691397|NCT04292535|156720252|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
48691398|NCT04292535|156720253|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
48691399|NCT04292535|156720254|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
48691400|NCT04292535|156720241|FG000|Overall Study|Report of Dizziness|0|||
48691401|NCT04292535|156720242|FG001|Overall Study|Report of Dizziness|0|||
48691402|NCT04292535|156720243|FG002|Overall Study|Report of Dizziness|0|||
48691403|NCT04292535|156720244|FG003|Overall Study|Report of Dizziness|0|||
48691404|NCT04292535|156720245|FG004|Overall Study|Report of Dizziness|0|||
48691405|NCT04292535|156720246|FG005|Overall Study|Report of Dizziness|0|||
48691406|NCT04292535|156720247|FG006|Overall Study|Report of Dizziness|0|||
48691407|NCT04292535|156720248|FG007|Overall Study|Report of Dizziness|0|||
48691408|NCT04292535|156720249|FG008|Overall Study|Report of Dizziness|0|||
48691409|NCT04292535|156720250|FG009|Overall Study|Report of Dizziness|0|||
48691410|NCT04292535|156720251|FG010|Overall Study|Report of Dizziness|0|||
48691411|NCT04292535|156720252|FG011|Overall Study|Report of Dizziness|0|||
48691412|NCT04292535|156720253|FG012|Overall Study|Report of Dizziness|0|||
48691413|NCT04292535|156720254|FG013|Overall Study|Report of Dizziness|1|||
48691414|NCT04292535|156720241|FG000|Overall Study|Equipment Failure|0|||
48691415|NCT04292535|156720242|FG001|Overall Study|Equipment Failure|0|||
48691416|NCT04292535|156720243|FG002|Overall Study|Equipment Failure|0|||
48691417|NCT04292535|156720244|FG003|Overall Study|Equipment Failure|0|||
48691418|NCT04292535|156720245|FG004|Overall Study|Equipment Failure|0|||
48691419|NCT04292535|156720246|FG005|Overall Study|Equipment Failure|0|||
48691420|NCT04292535|156720247|FG006|Overall Study|Equipment Failure|0|||
48691421|NCT04292535|156720248|FG007|Overall Study|Equipment Failure|0|||
48691422|NCT04292535|156720249|FG008|Overall Study|Equipment Failure|0|||
48691423|NCT04292535|156720250|FG009|Overall Study|Equipment Failure|0|||
48691424|NCT04292535|156720251|FG010|Overall Study|Equipment Failure|0|||
48691425|NCT04292535|156720252|FG011|Overall Study|Equipment Failure|1|||
48691426|NCT04292535|156720253|FG012|Overall Study|Equipment Failure|0|||
48691427|NCT04292535|156720254|FG013|Overall Study|Equipment Failure|0|||
48691428|NCT04528641|156720257|FG000|Overall Study|Withdrawal by Subject|0|||
48691429|NCT04528641|156720258|FG001|Overall Study|Withdrawal by Subject|0|||
48691430|NCT04528641|156720259|FG002|Overall Study|Withdrawal by Subject|0|||
48691431|NCT04528641|156720260|FG003|Overall Study|Withdrawal by Subject|1|||
48691432|NCT04528641|156720261|FG004|Overall Study|Withdrawal by Subject|0|||
48691433|NCT04528641|156720262|FG005|Overall Study|Withdrawal by Subject|1|||
48691434|NCT04972786|156720265|FG000|First Intervention (1 Day)|Adverse Event|1|||
48355475|NCT01296555|155498542|FG010|Overall Study|Reason Not Specified|0|||
48355476|NCT01296555|155498543|FG011|Overall Study|Reason Not Specified|0|||
48355477|NCT01296555|155498544|FG012|Overall Study|Reason Not Specified|0|||
48355478|NCT01296555|155498545|FG013|Overall Study|Reason Not Specified|1|||
48355479|NCT01296555|155498546|FG014|Overall Study|Reason Not Specified|2|||
48355480|NCT01296555|155498547|FG015|Overall Study|Reason Not Specified|3|||
48355481|NCT01296555|155498548|FG016|Overall Study|Reason Not Specified|7|||
48355482|NCT01296555|155498549|FG017|Overall Study|Reason Not Specified|4|||
48355483|NCT01296555|155498550|FG018|Overall Study|Reason Not Specified|3|||
48355484|NCT01296555|155498551|FG019|Overall Study|Reason Not Specified|7|||
48355485|NCT01296555|155498552|FG020|Overall Study|Reason Not Specified|11|||
48355486|NCT01296555|155498553|FG021|Overall Study|Reason Not Specified|5|||
48355487|NCT01296555|155498554|FG022|Overall Study|Reason Not Specified|5|||
48355488|NCT01296555|155498555|FG023|Overall Study|Reason Not Specified|7|||
48355489|NCT01296555|155498556|FG024|Overall Study|Reason Not Specified|2|||
48355490|NCT01296555|155498557|FG025|Overall Study|Reason Not Specified|2|||
48355491|NCT01296555|155498558|FG026|Overall Study|Reason Not Specified|19|||
48355492|NCT01296555|155498559|FG027|Overall Study|Reason Not Specified|11|||
48355493|NCT01296555|155498560|FG028|Overall Study|Reason Not Specified|9|||
48355494|NCT01296555|155498532|FG000|Overall Study|Physician Decision|0|||
48355495|NCT01296555|155498533|FG001|Overall Study|Physician Decision|0|||
48355496|NCT01296555|155498534|FG002|Overall Study|Physician Decision|0|||
48355497|NCT01296555|155498535|FG003|Overall Study|Physician Decision|0|||
48355498|NCT01296555|155498536|FG004|Overall Study|Physician Decision|1|||
48355499|NCT01296555|155498537|FG005|Overall Study|Physician Decision|0|||
48355500|NCT01296555|155498538|FG006|Overall Study|Physician Decision|0|||
48355501|NCT01296555|155498539|FG007|Overall Study|Physician Decision|0|||
48355502|NCT01296555|155498540|FG008|Overall Study|Physician Decision|0|||
48355503|NCT01296555|155498541|FG009|Overall Study|Physician Decision|0|||
48691435|NCT04972786|156720266|FG001|First Intervention (1 Day)|Adverse Event|0|||
48355504|NCT01296555|155498542|FG010|Overall Study|Physician Decision|0|||
48355505|NCT01296555|155498543|FG011|Overall Study|Physician Decision|0|||
48355506|NCT01296555|155498544|FG012|Overall Study|Physician Decision|0|||
48355507|NCT01296555|155498545|FG013|Overall Study|Physician Decision|1|||
48355508|NCT01296555|155498546|FG014|Overall Study|Physician Decision|0|||
48355509|NCT01296555|155498547|FG015|Overall Study|Physician Decision|0|||
48355510|NCT01296555|155498548|FG016|Overall Study|Physician Decision|0|||
48355511|NCT01296555|155498549|FG017|Overall Study|Physician Decision|0|||
48355512|NCT01296555|155498550|FG018|Overall Study|Physician Decision|0|||
48355513|NCT01296555|155498551|FG019|Overall Study|Physician Decision|1|||
48355514|NCT01296555|155498552|FG020|Overall Study|Physician Decision|0|||
48393207|NCT03099187|155634229|FG001|Double-blind Treatment|Randomization error|2|||
48393208|NCT03099187|155634230|FG002|Double-blind Treatment|Randomization error|0|||
48393209|NCT03099187|155634231|FG003|Double-blind Treatment|Randomization error|0|||
48393210|NCT03099187|155634228|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
48393211|NCT03099187|155634229|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
48691436|NCT02016781|156720269|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
48691437|NCT02016781|156720270|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
48691438|NCT02016781|156720269|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
48691439|NCT02016781|156720270|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
48691440|NCT02016781|156720269|FG000|Final Database Lock|Withdrawal by Subject|2|||
48691441|NCT02016781|156720270|FG001|Final Database Lock|Withdrawal by Subject|1|||
48691442|NCT02016781|156720269|FG000|Final Database Lock|Lost to Follow-up|11|||
48691443|NCT02016781|156720270|FG001|Final Database Lock|Lost to Follow-up|4|||
48691444|NCT02016781|156720269|FG000|Final Database Lock|Missing data|0|||
48691445|NCT02016781|156720270|FG001|Final Database Lock|Missing data|3|||
48691446|NCT00447226|156722418|FG000|12-Week Open-label Phase|Adverse Event|0|||
48691447|NCT00447226|156722419|FG001|12-Week Open-label Phase|Adverse Event|3|||
48691448|NCT00447226|156722418|FG000|12-Week Open-label Phase|Protocol Violation|0|||
48691449|NCT00447226|156722419|FG001|12-Week Open-label Phase|Protocol Violation|1|||
48691450|NCT00447226|156722418|FG000|12-Week Open-label Phase|Disease Progression|0|||
48691451|NCT00447226|156722419|FG001|12-Week Open-label Phase|Disease Progression|20|||
48691452|NCT00447226|156722418|FG000|12-Week Open-label Phase|Physician Decision|0|||
48691453|NCT00447226|156722419|FG001|12-Week Open-label Phase|Physician Decision|1|||
48691454|NCT00447226|156722418|FG000|Double-blind Phase|Disease Progression|4|||
48691455|NCT00447226|156722419|FG001|Double-blind Phase|Disease Progression|3|||
48691456|NCT01232868|156722422|FG000|Overall Study|Lost to Follow-up|2|||
48691457|NCT01232868|156722423|FG001|Overall Study|Lost to Follow-up|4|||
48691458|NCT01853748|156722429|FG000|Allocation|Withdrawal by Subject|1|||
48691459|NCT01853748|156722430|FG001|Allocation|Withdrawal by Subject|13|||
48691460|NCT01853748|156722429|FG000|Allocation|not sufficient to receive intervention|0|||
48691461|NCT01853748|156722430|FG001|Allocation|not sufficient to receive intervention|1|||
48691462|NCT01853748|156722429|FG000|Follow-Up|Withdrawal by Subject|7|||
48691463|NCT01853748|156722430|FG001|Follow-Up|Withdrawal by Subject|6|||
48691464|NCT01853748|156722429|FG000|Follow-Up|Adverse Event|67|||
48691465|NCT01853748|156722430|FG001|Follow-Up|Adverse Event|7|||
48393212|NCT03099187|155634230|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
48393213|NCT03099187|155634231|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
48393214|NCT03099187|155634228|FG000|12-month Safety Follow-up|Adverse Event|0|||
48393215|NCT03099187|155634229|FG001|12-month Safety Follow-up|Adverse Event|0|||
48393216|NCT03099187|155634230|FG002|12-month Safety Follow-up|Adverse Event|5|||
48393217|NCT03099187|155634231|FG003|12-month Safety Follow-up|Adverse Event|12|||
48393218|NCT03099187|155634228|FG000|12-month Safety Follow-up|Death|0|||
48393219|NCT03099187|155634229|FG001|12-month Safety Follow-up|Death|0|||
48393220|NCT03099187|155634230|FG002|12-month Safety Follow-up|Death|7|||
48393221|NCT03099187|155634231|FG003|12-month Safety Follow-up|Death|9|||
48430014|NCT01728584|155761913|FG002|Overall Study|Screen failure|0|||
48691466|NCT01853748|156722429|FG000|Follow-Up|not available for data collection|16|||
48691467|NCT01853748|156722430|FG001|Follow-Up|not available for data collection|4|||
48691468|NCT00985673|156722431|FG000|Overall Study|Lost to Follow-up|6|||
48691469|NCT00985673|156722432|FG001|Overall Study|Lost to Follow-up|7|||
48691470|NCT00985673|156722433|FG002|Overall Study|Lost to Follow-up|6|||
48691471|NCT00985673|156722434|FG003|Overall Study|Lost to Follow-up|10|||
48691472|NCT00985673|156722435|FG004|Overall Study|Lost to Follow-up|5|||
48691473|NCT00985673|156722436|FG005|Overall Study|Lost to Follow-up|3|||
48691474|NCT00985673|156722431|FG000|Overall Study|Withdrawal by Subject|0|||
48691475|NCT00985673|156722432|FG001|Overall Study|Withdrawal by Subject|4|||
48691476|NCT00985673|156722433|FG002|Overall Study|Withdrawal by Subject|5|||
48355515|NCT01296555|155498553|FG021|Overall Study|Physician Decision|0|||
48355516|NCT01296555|155498554|FG022|Overall Study|Physician Decision|0|||
48355517|NCT01296555|155498555|FG023|Overall Study|Physician Decision|0|||
48355518|NCT01296555|155498556|FG024|Overall Study|Physician Decision|0|||
48355519|NCT01296555|155498557|FG025|Overall Study|Physician Decision|0|||
48355520|NCT01296555|155498558|FG026|Overall Study|Physician Decision|0|||
48355521|NCT01296555|155498559|FG027|Overall Study|Physician Decision|0|||
48355522|NCT01296555|155498560|FG028|Overall Study|Physician Decision|0|||
48763820|NCT03240133|156985766|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
48763821|NCT03240133|156985764|FG000|Overall Study|Intercurrent illness.|0|||
48763822|NCT03240133|156985765|FG001|Overall Study|Intercurrent illness.|1|||
48393222|NCT03099187|155634228|FG000|12-month Safety Follow-up|Lung transplantation|0|||
48393223|NCT03099187|155634229|FG001|12-month Safety Follow-up|Lung transplantation|0|||
48393224|NCT03099187|155634230|FG002|12-month Safety Follow-up|Lung transplantation|2|||
48393225|NCT03099187|155634231|FG003|12-month Safety Follow-up|Lung transplantation|1|||
48393226|NCT03099187|155634228|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
48393227|NCT03099187|155634229|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
48393228|NCT03099187|155634230|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
48393229|NCT03099187|155634231|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
48393230|NCT03099187|155634228|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
48393231|NCT03099187|155634229|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
48691477|NCT00985673|156722434|FG003|Overall Study|Withdrawal by Subject|2|||
48691478|NCT00985673|156722435|FG004|Overall Study|Withdrawal by Subject|2|||
48763823|NCT03240133|156985766|FG002|Overall Study|Intercurrent illness.|0|||
48763824|NCT03240133|156985764|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
48763825|NCT03240133|156985765|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
48763826|NCT03240133|156985766|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
48763827|NCT01023581|156985767|FG000|Overall Study|Adverse Event|4|||
48763828|NCT01023581|156985768|FG001|Overall Study|Adverse Event|4|||
48763829|NCT01023581|156985769|FG002|Overall Study|Adverse Event|7|||
48763830|NCT01023581|156985770|FG003|Overall Study|Adverse Event|3|||
48763831|NCT01023581|156985771|FG004|Overall Study|Adverse Event|2|||
48763832|NCT01023581|156985772|FG005|Overall Study|Adverse Event|5|||
48763833|NCT01023581|156985773|FG006|Overall Study|Adverse Event|11|||
48763834|NCT01023581|156985767|FG000|Overall Study|Major protocol deviation|2|||
48763835|NCT01023581|156985768|FG001|Overall Study|Major protocol deviation|0|||
48763836|NCT01023581|156985769|FG002|Overall Study|Major protocol deviation|3|||
48691479|NCT00985673|156722436|FG005|Overall Study|Withdrawal by Subject|3|||
48763837|NCT01023581|156985770|FG003|Overall Study|Major protocol deviation|0|||
48763838|NCT01023581|156985771|FG004|Overall Study|Major protocol deviation|0|||
48763839|NCT01023581|156985772|FG005|Overall Study|Major protocol deviation|0|||
48763840|NCT01023581|156985773|FG006|Overall Study|Major protocol deviation|0|||
48763841|NCT01023581|156985767|FG000|Overall Study|Lost to Follow-up|4|||
48763842|NCT01023581|156985768|FG001|Overall Study|Lost to Follow-up|8|||
48691480|NCT00985673|156722431|FG000|Overall Study|Other|1|||
48691481|NCT00985673|156722432|FG001|Overall Study|Other|0|||
48691482|NCT00985673|156722433|FG002|Overall Study|Other|1|||
48691483|NCT00985673|156722434|FG003|Overall Study|Other|0|||
48691484|NCT00985673|156722435|FG004|Overall Study|Other|1|||
48691485|NCT00985673|156722436|FG005|Overall Study|Other|0|||
48691486|NCT00531284|156722437|FG000|Overall Study|Progressive Disease|1|||
48691487|NCT00531284|156722438|FG001|Overall Study|Progressive Disease|3|||
48691488|NCT00531284|156722439|FG002|Overall Study|Progressive Disease|5|||
48691489|NCT00531284|156722440|FG003|Overall Study|Progressive Disease|42|||
48691490|NCT00531284|156722441|FG004|Overall Study|Progressive Disease|4|||
48691491|NCT00531284|156722442|FG005|Overall Study|Progressive Disease|4|||
48691492|NCT00531284|156722443|FG006|Overall Study|Progressive Disease|3|||
48691493|NCT00531284|156722444|FG007|Overall Study|Progressive Disease|8|||
48691494|NCT00531284|156722445|FG008|Overall Study|Progressive Disease|6|||
48691495|NCT00531284|156722446|FG009|Overall Study|Progressive Disease|3|||
48691496|NCT00531284|156722447|FG010|Overall Study|Progressive Disease|3|||
48691497|NCT00531284|156722448|FG011|Overall Study|Progressive Disease|14|||
48691498|NCT00531284|156722449|FG012|Overall Study|Progressive Disease|2|||
48691499|NCT00531284|156722450|FG013|Overall Study|Progressive Disease|1|||
48691500|NCT00531284|156722451|FG014|Overall Study|Progressive Disease|2|||
48691501|NCT00531284|156722452|FG015|Overall Study|Progressive Disease|11|||
48691502|NCT00531284|156722453|FG016|Overall Study|Progressive Disease|5|||
48691503|NCT00531284|156722437|FG000|Overall Study|Adverse Event|0|||
48691504|NCT00531284|156722438|FG001|Overall Study|Adverse Event|1|||
48691505|NCT00531284|156722439|FG002|Overall Study|Adverse Event|1|||
48691506|NCT00531284|156722440|FG003|Overall Study|Adverse Event|7|||
48691507|NCT00531284|156722441|FG004|Overall Study|Adverse Event|0|||
48763843|NCT01023581|156985769|FG002|Overall Study|Lost to Follow-up|7|||
48763844|NCT01023581|156985770|FG003|Overall Study|Lost to Follow-up|2|||
48691508|NCT00531284|156722442|FG005|Overall Study|Adverse Event|2|||
48691509|NCT00531284|156722443|FG006|Overall Study|Adverse Event|3|||
48691510|NCT00531284|156722444|FG007|Overall Study|Adverse Event|2|||
48691511|NCT00531284|156722445|FG008|Overall Study|Adverse Event|3|||
48691512|NCT00531284|156722446|FG009|Overall Study|Adverse Event|0|||
48691513|NCT00531284|156722447|FG010|Overall Study|Adverse Event|0|||
48691514|NCT00531284|156722448|FG011|Overall Study|Adverse Event|5|||
48763845|NCT01023581|156985771|FG004|Overall Study|Lost to Follow-up|5|||
48691515|NCT00531284|156722449|FG012|Overall Study|Adverse Event|0|||
48691516|NCT00531284|156722450|FG013|Overall Study|Adverse Event|1|||
48691517|NCT00531284|156722451|FG014|Overall Study|Adverse Event|1|||
48691518|NCT00531284|156722452|FG015|Overall Study|Adverse Event|0|||
48691519|NCT00531284|156722453|FG016|Overall Study|Adverse Event|2|||
48691520|NCT00531284|156722437|FG000|Overall Study|Withdrawal by Subject|1|||
48691521|NCT00531284|156722438|FG001|Overall Study|Withdrawal by Subject|0|||
48691522|NCT00531284|156722439|FG002|Overall Study|Withdrawal by Subject|0|||
48691523|NCT00531284|156722440|FG003|Overall Study|Withdrawal by Subject|4|||
48691524|NCT00531284|156722441|FG004|Overall Study|Withdrawal by Subject|0|||
48691525|NCT00531284|156722442|FG005|Overall Study|Withdrawal by Subject|0|||
48691526|NCT00531284|156722443|FG006|Overall Study|Withdrawal by Subject|0|||
48691527|NCT00531284|156722444|FG007|Overall Study|Withdrawal by Subject|0|||
48691528|NCT00531284|156722445|FG008|Overall Study|Withdrawal by Subject|0|||
48691529|NCT00531284|156722446|FG009|Overall Study|Withdrawal by Subject|0|||
48691530|NCT00531284|156722447|FG010|Overall Study|Withdrawal by Subject|0|||
48691531|NCT00531284|156722448|FG011|Overall Study|Withdrawal by Subject|3|||
48691532|NCT00531284|156722449|FG012|Overall Study|Withdrawal by Subject|0|||
48691533|NCT00531284|156722450|FG013|Overall Study|Withdrawal by Subject|1|||
48691534|NCT00531284|156722451|FG014|Overall Study|Withdrawal by Subject|0|||
48691535|NCT00531284|156722452|FG015|Overall Study|Withdrawal by Subject|1|||
48691536|NCT00531284|156722453|FG016|Overall Study|Withdrawal by Subject|1|||
48691537|NCT00531284|156722437|FG000|Overall Study|Other|1|||
48691538|NCT00531284|156722438|FG001|Overall Study|Other|0|||
48691539|NCT00531284|156722439|FG002|Overall Study|Other|0|||
48691540|NCT00531284|156722440|FG003|Overall Study|Other|10|||
48691541|NCT00531284|156722441|FG004|Overall Study|Other|2|||
48691542|NCT00531284|156722442|FG005|Overall Study|Other|1|||
48691543|NCT00531284|156722443|FG006|Overall Study|Other|0|||
48691544|NCT00531284|156722444|FG007|Overall Study|Other|0|||
48691545|NCT00531284|156722445|FG008|Overall Study|Other|2|||
48691546|NCT00531284|156722446|FG009|Overall Study|Other|1|||
48691547|NCT00531284|156722447|FG010|Overall Study|Other|0|||
48691548|NCT00531284|156722448|FG011|Overall Study|Other|2|||
48691549|NCT00531284|156722449|FG012|Overall Study|Other|0|||
48691550|NCT00531284|156722450|FG013|Overall Study|Other|0|||
48691551|NCT00531284|156722451|FG014|Overall Study|Other|1|||
48691552|NCT00531284|156722452|FG015|Overall Study|Other|0|||
48691553|NCT00531284|156722453|FG016|Overall Study|Other|0|||
48691554|NCT02219464|156722454|FG000|Overall Study|Withdrawal by Subject|1|||
48691555|NCT02219464|156722455|FG001|Overall Study|Withdrawal by Subject|0|||
48691556|NCT02219464|156722454|FG000|Overall Study|case cancelled|1|||
48691557|NCT02219464|156722455|FG001|Overall Study|case cancelled|0|||
48691558|NCT02219464|156722454|FG000|Overall Study|catheter malfunction|1|||
48691559|NCT02219464|156722455|FG001|Overall Study|catheter malfunction|0|||
48691560|NCT01519323|156722456|FG000|Overall Study|Death|3|||
48691561|NCT01519323|156722457|FG001|Overall Study|Death|2|||
48691562|NCT01519323|156722456|FG000|Overall Study|Study terminated by sponsor|0|||
48691563|NCT01519323|156722457|FG001|Overall Study|Study terminated by sponsor|1|||
48691564|NCT01419769|156722458|FG000|Overall Study|Did not receive the AXIOS stent|3|||
48691565|NCT01419769|156722458|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
48691566|NCT02544321|156722461|FG000|Overall Study|Withdrawal by Subject|1|||
48691567|NCT02544321|156722462|FG001|Overall Study|Withdrawal by Subject|2|||
48691568|NCT02544321|156722461|FG000|Overall Study|Adverse Event|1|||
48691569|NCT02544321|156722462|FG001|Overall Study|Adverse Event|1|||
48691570|NCT02544321|156722461|FG000|Overall Study|Protocol Violation|0|||
48691571|NCT02544321|156722462|FG001|Overall Study|Protocol Violation|1|||
48691572|NCT05568615|156722463|FG000|Overall Study|Death|1|||
48691573|NCT05568615|156722463|FG000|Overall Study|Physician Decision|1|||
48691574|NCT04617782|156722468|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
48691575|NCT04617782|156722468|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
48691576|NCT04617782|156722468|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
48691577|NCT04617782|156722468|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
48691578|NCT04617782|156722468|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
48691579|NCT04617782|156722468|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
48691580|NCT01453049|156722474|FG000|Overall Study|Protocol Violation|2|||
48691581|NCT01453049|156722475|FG001|Overall Study|Protocol Violation|5|||
48691582|NCT01453049|156722474|FG000|Overall Study|Lost to Follow-up|2|||
48691583|NCT01453049|156722475|FG001|Overall Study|Lost to Follow-up|1|||
48691584|NCT01453049|156722474|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
48691585|NCT01453049|156722475|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
48691586|NCT01453049|156722474|FG000|Overall Study|Withdrawal by Subject|1|||
48691587|NCT01453049|156722475|FG001|Overall Study|Withdrawal by Subject|0|||
48691588|NCT01453049|156722474|FG000|Overall Study|Randomized in Error|1|||
48763846|NCT01023581|156985772|FG005|Overall Study|Lost to Follow-up|2|||
48691589|NCT01453049|156722475|FG001|Overall Study|Randomized in Error|0|||
48691590|NCT01342913|156722476|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
48691591|NCT01342913|156722477|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48763847|NCT01023581|156985773|FG006|Overall Study|Lost to Follow-up|2|||
48691592|NCT01342913|156722478|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
48691593|NCT01342913|156722476|FG000|2-week Run-in Period|Physician Decision|6|||
48691594|NCT01342913|156722477|FG001|2-week Run-in Period|Physician Decision|0|||
48691595|NCT01342913|156722478|FG002|2-week Run-in Period|Physician Decision|0|||
48691596|NCT01342913|156722476|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
48691597|NCT01342913|156722477|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48691598|NCT01342913|156722478|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48691599|NCT01342913|156722476|FG000|2-week Run-in Period|Adverse Event|2|||
48691600|NCT01342913|156722477|FG001|2-week Run-in Period|Adverse Event|0|||
48691601|NCT01342913|156722478|FG002|2-week Run-in Period|Adverse Event|0|||
48691602|NCT01342913|156722476|FG000|2-week Run-in Period|Protocol Violation|5|||
48691603|NCT01342913|156722477|FG001|2-week Run-in Period|Protocol Violation|0|||
48691604|NCT01342913|156722478|FG002|2-week Run-in Period|Protocol Violation|0|||
48691605|NCT01342913|156722476|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
48691606|NCT01342913|156722477|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
48691607|NCT01342913|156722478|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
48691608|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48691609|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Adverse Event|3|||
48691610|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Adverse Event|6|||
48691611|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
48691612|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
48691613|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
48691614|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48691615|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
48691616|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
48691617|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48691618|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48691619|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
48691620|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Physician Decision|0|||
48691621|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Physician Decision|2|||
48691622|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Physician Decision|0|||
48691623|NCT01342913|156722476|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48691624|NCT01342913|156722477|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48691625|NCT01342913|156722478|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48691626|NCT00683878|156722479|FG000|Overall Study|Lack of Efficacy|3|||
48691627|NCT00683878|156722480|FG001|Overall Study|Lack of Efficacy|0|||
48691628|NCT00683878|156722481|FG002|Overall Study|Lack of Efficacy|1|||
48691629|NCT00683878|156722479|FG000|Overall Study|Adverse Event|4|||
48691630|NCT00683878|156722480|FG001|Overall Study|Adverse Event|3|||
48691631|NCT00683878|156722481|FG002|Overall Study|Adverse Event|3|||
48691632|NCT00683878|156722479|FG000|Overall Study|Withdrawal by Subject|9|||
48691633|NCT00683878|156722480|FG001|Overall Study|Withdrawal by Subject|8|||
48763848|NCT01023581|156985767|FG000|Overall Study|Withdrawal by Subject|13|||
48763849|NCT01023581|156985768|FG001|Overall Study|Withdrawal by Subject|8|||
48763850|NCT01023581|156985769|FG002|Overall Study|Withdrawal by Subject|16|||
48763851|NCT01023581|156985770|FG003|Overall Study|Withdrawal by Subject|10|||
48763852|NCT01023581|156985771|FG004|Overall Study|Withdrawal by Subject|6|||
48763853|NCT01023581|156985772|FG005|Overall Study|Withdrawal by Subject|8|||
48393232|NCT03099187|155634230|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
48393233|NCT03099187|155634231|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
48393234|NCT03099187|155634228|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
48393235|NCT03099187|155634229|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
48393236|NCT03099187|155634230|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
48393237|NCT03099187|155634231|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
48393238|NCT03099187|155634228|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
48393239|NCT03099187|155634229|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
48393240|NCT03099187|155634230|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
48393241|NCT03099187|155634231|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
48393242|NCT01439555|155634234|FG000|Overall Study|Protocol Violation|1|||
48393243|NCT04194528|155634237|FG000|Overall Study|Adverse Event|1|||
48393244|NCT00271817|155634238|FG000|Part 1|Adverse Event|68|||
48393245|NCT00271817|155634239|FG001|Part 1|Adverse Event|25|||
48393246|NCT00271817|155634240|FG002|Part 1|Adverse Event|156|||
48691634|NCT00683878|156722481|FG002|Overall Study|Withdrawal by Subject|6|||
48763854|NCT01023581|156985773|FG006|Overall Study|Withdrawal by Subject|5|||
48393247|NCT00271817|155634238|FG000|Part 1|Lost to Follow-up|6|||
48393248|NCT00271817|155634239|FG001|Part 1|Lost to Follow-up|8|||
48691635|NCT00683878|156722479|FG000|Overall Study|Death|0|||
48691636|NCT00683878|156722480|FG001|Overall Study|Death|1|||
48393249|NCT00271817|155634240|FG002|Part 1|Lost to Follow-up|24|||
48691637|NCT00683878|156722481|FG002|Overall Study|Death|0|||
48691638|NCT00683878|156722479|FG000|Overall Study|Lost to Follow-up|4|||
48763855|NCT01023581|156985767|FG000|Overall Study|Pregnancy|0|||
48763856|NCT01023581|156985768|FG001|Overall Study|Pregnancy|0|||
48763857|NCT01023581|156985769|FG002|Overall Study|Pregnancy|0|||
48763858|NCT01023581|156985770|FG003|Overall Study|Pregnancy|2|||
48763859|NCT01023581|156985771|FG004|Overall Study|Pregnancy|0|||
48763860|NCT01023581|156985772|FG005|Overall Study|Pregnancy|1|||
48763861|NCT01023581|156985773|FG006|Overall Study|Pregnancy|0|||
48763862|NCT01023581|156985767|FG000|Overall Study|Lack of Efficacy|9|||
48763863|NCT01023581|156985768|FG001|Overall Study|Lack of Efficacy|3|||
48763864|NCT01023581|156985769|FG002|Overall Study|Lack of Efficacy|6|||
48763865|NCT01023581|156985770|FG003|Overall Study|Lack of Efficacy|2|||
48763866|NCT01023581|156985771|FG004|Overall Study|Lack of Efficacy|1|||
48763867|NCT01023581|156985772|FG005|Overall Study|Lack of Efficacy|2|||
48763868|NCT01023581|156985773|FG006|Overall Study|Lack of Efficacy|1|||
48763869|NCT01023581|156985767|FG000|Overall Study|Physician Decision|2|||
48763870|NCT01023581|156985768|FG001|Overall Study|Physician Decision|0|||
48763871|NCT01023581|156985769|FG002|Overall Study|Physician Decision|2|||
48763872|NCT01023581|156985770|FG003|Overall Study|Physician Decision|1|||
48763873|NCT01023581|156985771|FG004|Overall Study|Physician Decision|1|||
48763874|NCT01023581|156985772|FG005|Overall Study|Physician Decision|1|||
48763875|NCT01023581|156985773|FG006|Overall Study|Physician Decision|1|||
48763876|NCT01023581|156985767|FG000|Overall Study|Other|1|||
48763877|NCT01023581|156985768|FG001|Overall Study|Other|0|||
48763878|NCT01023581|156985769|FG002|Overall Study|Other|1|||
48763879|NCT01023581|156985770|FG003|Overall Study|Other|0|||
48763880|NCT01023581|156985771|FG004|Overall Study|Other|1|||
48763881|NCT01023581|156985772|FG005|Overall Study|Other|0|||
48763882|NCT01023581|156985773|FG006|Overall Study|Other|0|||
48763883|NCT00922766|156985774|FG000|Overall Study|Death|3|||
48763884|NCT00922766|156985774|FG000|Overall Study|Withdrawal by Subject|2|||
48763885|NCT00922766|156985774|FG000|Overall Study|Other|1|||
48763886|NCT00922766|156985774|FG000|Overall Study|Adverse Event|1|||
48763887|NCT02603432|156985775|FG000|Overall Study|Adverse Event|1|||
48763888|NCT02603432|156985776|FG001|Overall Study|Adverse Event|0|||
48763889|NCT02603432|156985775|FG000|Overall Study|Death|221|||
48763890|NCT02603432|156985776|FG001|Overall Study|Death|242|||
48763891|NCT02603432|156985775|FG000|Overall Study|Lost to Follow-up|3|||
48763892|NCT02603432|156985776|FG001|Overall Study|Lost to Follow-up|9|||
48763893|NCT02603432|156985775|FG000|Overall Study|Progressive Disease|7|||
48763894|NCT02603432|156985776|FG001|Overall Study|Progressive Disease|5|||
48763895|NCT02603432|156985775|FG000|Overall Study|Withdrawal by Subject|12|||
48763896|NCT02603432|156985776|FG001|Overall Study|Withdrawal by Subject|18|||
48763897|NCT02603432|156985775|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
48763898|NCT02603432|156985776|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48763899|NCT02603432|156985775|FG000|Overall Study|Study terminated by sponsor|74|||
48763900|NCT02603432|156985776|FG001|Overall Study|Study terminated by sponsor|75|||
48393250|NCT00271817|155634238|FG000|Part 1|Protocol Violation|5|||
48393251|NCT00271817|155634239|FG001|Part 1|Protocol Violation|4|||
48393252|NCT00271817|155634240|FG002|Part 1|Protocol Violation|7|||
48393253|NCT00271817|155634238|FG000|Part 1|Patient Moved|3|||
48393254|NCT00271817|155634239|FG001|Part 1|Patient Moved|1|||
48393255|NCT00271817|155634240|FG002|Part 1|Patient Moved|5|||
48393256|NCT00271817|155634238|FG000|Part 1|Withdrawal by Subject|23|||
48393257|NCT00271817|155634239|FG001|Part 1|Withdrawal by Subject|17|||
48393258|NCT00271817|155634240|FG002|Part 1|Withdrawal by Subject|45|||
48393259|NCT00271817|155634238|FG000|Part 1|LDL < 50 mg/dL|1|||
48393260|NCT00271817|155634239|FG001|Part 1|LDL < 50 mg/dL|4|||
48393261|NCT00271817|155634240|FG002|Part 1|LDL < 50 mg/dL|48|||
48393262|NCT00271817|155634238|FG000|Part 2|Adverse Event|0|||
48393263|NCT00271817|155634239|FG001|Part 2|Adverse Event|17|||
48393264|NCT00271817|155634240|FG002|Part 2|Adverse Event|33|||
48393265|NCT00271817|155634238|FG000|Part 2|Lack of Efficacy|0|||
48393266|NCT00271817|155634239|FG001|Part 2|Lack of Efficacy|1|||
48393267|NCT00271817|155634240|FG002|Part 2|Lack of Efficacy|6|||
48393268|NCT00271817|155634238|FG000|Part 2|Lost to Follow-up|0|||
48393269|NCT00271817|155634239|FG001|Part 2|Lost to Follow-up|6|||
48393270|NCT00271817|155634240|FG002|Part 2|Lost to Follow-up|18|||
48393271|NCT00271817|155634238|FG000|Part 2|Protocol Violation|0|||
48393272|NCT00271817|155634239|FG001|Part 2|Protocol Violation|3|||
48393273|NCT00271817|155634240|FG002|Part 2|Protocol Violation|5|||
48393274|NCT00271817|155634238|FG000|Part 2|Patient Moved|0|||
48393275|NCT00271817|155634239|FG001|Part 2|Patient Moved|0|||
48393276|NCT00271817|155634240|FG002|Part 2|Patient Moved|5|||
48393277|NCT00271817|155634238|FG000|Part 2|Withdrawal by Subject|0|||
48763901|NCT02603432|156985775|FG000|Overall Study|Other|13|||
48763902|NCT02603432|156985776|FG001|Overall Study|Other|0|||
48763903|NCT00297037|156985780|FG000|Overall Study|Withdrawal by Subject|2|||
48763904|NCT00297037|156985781|FG001|Overall Study|Withdrawal by Subject|0|||
48763905|NCT03340025|156985782|FG000|Overall Study|Lost to Follow-up|2|||
48763906|NCT03340025|156985783|FG001|Overall Study|Lost to Follow-up|2|||
48763907|NCT01413360|156985786|FG000|Overall Study|Lost to Follow-up|2|||
48763908|NCT01413360|156985786|FG000|Overall Study|Adverse Event|1|||
48393278|NCT00271817|155634239|FG001|Part 2|Withdrawal by Subject|2|||
48393279|NCT00271817|155634240|FG002|Part 2|Withdrawal by Subject|13|||
48393280|NCT00271817|155634238|FG000|Part 2|LDL < 50 mg/dL|0|||
48393281|NCT00271817|155634239|FG001|Part 2|LDL < 50 mg/dL|3|||
48393282|NCT00271817|155634240|FG002|Part 2|LDL < 50 mg/dL|4|||
48393283|NCT05054114|155634245|FG000|Overall Study|Protocol Violation|13|||
48393284|NCT05054114|155634246|FG001|Overall Study|Protocol Violation|1|||
48393285|NCT05054114|155634245|FG000|Overall Study|Pregnancy|0|||
48393286|NCT05054114|155634246|FG001|Overall Study|Pregnancy|1|||
48393287|NCT00333359|155634247|FG000|Overall Study|Adverse Event|29|||
48393288|NCT00333359|155634248|FG001|Overall Study|Adverse Event|35|||
48393289|NCT00333359|155634247|FG000|Overall Study|Withdrawal by Subject|19|||
48393290|NCT00333359|155634248|FG001|Overall Study|Withdrawal by Subject|37|||
48393291|NCT00333359|155634247|FG000|Overall Study|Physician Decision|2|||
48393292|NCT00333359|155634248|FG001|Overall Study|Physician Decision|2|||
48393293|NCT00333359|155634247|FG000|Overall Study|Protocol Non-compliance|2|||
48393294|NCT00333359|155634248|FG001|Overall Study|Protocol Non-compliance|8|||
48393295|NCT00333359|155634247|FG000|Overall Study|Lost to Follow-up|15|||
48393296|NCT00333359|155634248|FG001|Overall Study|Lost to Follow-up|25|||
48393297|NCT00333359|155634247|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
48393298|NCT00333359|155634248|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
48393299|NCT00333359|155634247|FG000|Overall Study|Treatment Failure|3|||
48393300|NCT00333359|155634248|FG001|Overall Study|Treatment Failure|8|||
48393301|NCT00333359|155634247|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
48393302|NCT00333359|155634248|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
48393303|NCT02833974|155635880|FG000|Overall Study|Lost to Follow-up|1|||
48393304|NCT02833974|155635881|FG001|Overall Study|Lost to Follow-up|0|||
48393305|NCT02833974|155635880|FG000|Overall Study|Adverse Event|0|||
48393306|NCT02833974|155635881|FG001|Overall Study|Adverse Event|3|||
48393307|NCT02232802|155635882|FG000|Period 1|Sponsor request|1|||
48393308|NCT02232802|155635883|FG001|Period 1|Sponsor request|0|||
48393309|NCT02232802|155635882|FG000|Period 1|Adverse Event|1|||
48393310|NCT02232802|155635883|FG001|Period 1|Adverse Event|1|||
48393311|NCT01183143|155635884|FG000|Overall Study|Protocol Violation|115|||
48393312|NCT01183143|155635884|FG000|Overall Study|Withdrawal by Subject|19|||
48393313|NCT01183143|155635884|FG000|Overall Study|Subject Questionnaires not returned|5|||
48393314|NCT01183143|155635884|FG000|Overall Study|Subjects enrolled, but not treated|11|||
48393315|NCT00307151|155635885|FG000|Overall Study|Death|4|||
48393316|NCT00307151|155635886|FG001|Overall Study|Death|3|||
48393317|NCT00307151|155635887|FG002|Overall Study|Death|10|||
48393318|NCT00307151|155635888|FG003|Overall Study|Death|3|||
48393319|NCT00307151|155635885|FG000|Overall Study|Severe debilitation, unable to continue|1|||
48393320|NCT00307151|155635886|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48393321|NCT00307151|155635887|FG002|Overall Study|Severe debilitation, unable to continue|0|||
48393322|NCT00307151|155635888|FG003|Overall Study|Severe debilitation, unable to continue|0|||
48393323|NCT00307151|155635885|FG000|Overall Study|Subject unable to get to clinic|1|||
48393324|NCT00307151|155635886|FG001|Overall Study|Subject unable to get to clinic|0|||
48393325|NCT00307151|155635887|FG002|Overall Study|Subject unable to get to clinic|6|||
48393326|NCT00307151|155635888|FG003|Overall Study|Subject unable to get to clinic|2|||
48393327|NCT00307151|155635885|FG000|Overall Study|Withdrew consent|0|||
48393328|NCT00307151|155635886|FG001|Overall Study|Withdrew consent|1|||
48393329|NCT00307151|155635887|FG002|Overall Study|Withdrew consent|1|||
48393330|NCT00307151|155635888|FG003|Overall Study|Withdrew consent|3|||
48393331|NCT00307151|155635885|FG000|Overall Study|Not willing to adhere to study reqs|2|||
48393332|NCT00307151|155635886|FG001|Overall Study|Not willing to adhere to study reqs|0|||
48691639|NCT00683878|156722480|FG001|Overall Study|Lost to Follow-up|2|||
48691640|NCT00683878|156722481|FG002|Overall Study|Lost to Follow-up|4|||
48691641|NCT00683878|156722479|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
48691642|NCT00683878|156722480|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
48691643|NCT00683878|156722481|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
48691644|NCT02869633|156722482|FG000|Overall Study|Death|2|||
48393333|NCT00307151|155635887|FG002|Overall Study|Not willing to adhere to study reqs|2|||
48393334|NCT00307151|155635888|FG003|Overall Study|Not willing to adhere to study reqs|2|||
48393335|NCT00307151|155635885|FG000|Overall Study|Clinic unable to contact subject|3|||
48393336|NCT00307151|155635886|FG001|Overall Study|Clinic unable to contact subject|3|||
48393337|NCT00307151|155635887|FG002|Overall Study|Clinic unable to contact subject|1|||
48393338|NCT00307151|155635888|FG003|Overall Study|Clinic unable to contact subject|1|||
48393339|NCT01617460|155635889|FG000|Overall Study|Adverse Event|10|||
48393340|NCT01617460|155635889|FG000|Overall Study|Physician Decision|16|||
48393341|NCT01617460|155635889|FG000|Overall Study|Protocol Violation|5|||
48393342|NCT01617460|155635889|FG000|Overall Study|Withdrawal by Subject|9|||
48393343|NCT00457015|155635890|FG000|Overall Study|Left study site against medical advice|0|||
48393344|NCT00457015|155635891|FG001|Overall Study|Left study site against medical advice|1|||
48691645|NCT02869633|156722483|FG001|Overall Study|Death|1|||
48691646|NCT02869633|156722482|FG000|Overall Study|Patient refused follow-up|1|||
48393345|NCT02982954|155635892|FG000|Overall Study|Death|55|||
48691647|NCT02869633|156722483|FG001|Overall Study|Patient refused follow-up|0|||
48763909|NCT01928862|156985787|FG000|Overall Study|Lost to Follow-up|1|||
48763910|NCT01928862|156985788|FG001|Overall Study|Lost to Follow-up|0|||
48763911|NCT01928862|156985789|FG002|Overall Study|Lost to Follow-up|0|||
48763912|NCT01928862|156985790|FG003|Overall Study|Lost to Follow-up|0|||
48763913|NCT01928862|156985791|FG004|Overall Study|Lost to Follow-up|1|||
48763914|NCT01549964|156985795|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
48763915|NCT01549964|156985796|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
48763916|NCT01549964|156985797|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
48763917|NCT01549964|156985798|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
48763918|NCT01549964|156985795|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
48763919|NCT01549964|156985796|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
48763920|NCT01549964|156985797|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
48763921|NCT01549964|156985798|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
48763922|NCT01549964|156985795|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
48763923|NCT01549964|156985796|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
48763924|NCT01549964|156985797|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
48763925|NCT01549964|156985798|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
48763926|NCT01549964|156985795|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
48763927|NCT01549964|156985796|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
48763928|NCT01549964|156985797|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
48763929|NCT01549964|156985798|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
48763930|NCT01549964|156985795|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
48763931|NCT01549964|156985796|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
48763932|NCT01549964|156985797|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
48763933|NCT01549964|156985798|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
48763934|NCT01549964|156985795|FG000|24-Week Treatment Period|Other|1|||
48763935|NCT01549964|156985796|FG001|24-Week Treatment Period|Other|0|||
48763936|NCT01549964|156985797|FG002|24-Week Treatment Period|Other|1|||
48763937|NCT01549964|156985798|FG003|24-Week Treatment Period|Other|0|||
48763938|NCT01549964|156985795|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
48763939|NCT01549964|156985796|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
48763940|NCT01549964|156985797|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
48763941|NCT01549964|156985798|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
48763942|NCT01549964|156985795|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
48763943|NCT01549964|156985796|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
48763944|NCT01549964|156985797|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
48763945|NCT01549964|156985798|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
48763946|NCT01549964|156985795|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
48393346|NCT02982954|155635893|FG001|Overall Study|Death|29|||
48393347|NCT02982954|155635894|FG002|Overall Study|Death|15|||
48393348|NCT02982954|155635895|FG003|Overall Study|Death|20|||
48393349|NCT02982954|155635892|FG000|Overall Study|Lost to Follow-up|2|||
48393350|NCT02982954|155635893|FG001|Overall Study|Lost to Follow-up|1|||
48393351|NCT02982954|155635894|FG002|Overall Study|Lost to Follow-up|0|||
48393352|NCT02982954|155635895|FG003|Overall Study|Lost to Follow-up|0|||
48393353|NCT02982954|155635892|FG000|Overall Study|Participant withdrew consent|7|||
48393354|NCT02982954|155635893|FG001|Overall Study|Participant withdrew consent|5|||
48393355|NCT02982954|155635894|FG002|Overall Study|Participant withdrew consent|1|||
48393356|NCT02982954|155635895|FG003|Overall Study|Participant withdrew consent|1|||
48691648|NCT02869633|156722482|FG000|Overall Study|Provider discretion|1|||
48691649|NCT02869633|156722483|FG001|Overall Study|Provider discretion|0|||
48691650|NCT02869633|156722482|FG000|Overall Study|Investigator decision|1|||
48691651|NCT02869633|156722483|FG001|Overall Study|Investigator decision|0|||
48691652|NCT02869633|156722482|FG000|Overall Study|Lost to Follow-up|0|||
48691653|NCT02869633|156722483|FG001|Overall Study|Lost to Follow-up|1|||
48691654|NCT02869633|156722482|FG000|Overall Study|Not eligible|6|||
48691655|NCT02869633|156722483|FG001|Overall Study|Not eligible|1|||
48691656|NCT02869633|156722482|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
48691657|NCT02869633|156722483|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
48691658|NCT02869633|156722482|FG000|Overall Study|Withdrawal by Subject|0|||
48691659|NCT02869633|156722483|FG001|Overall Study|Withdrawal by Subject|1|||
48691660|NCT01381016|156722484|FG000|Overall Study|Lost to Follow-up|1|||
48691661|NCT01381016|156722485|FG001|Overall Study|Lost to Follow-up|1|||
48691662|NCT01381016|156722484|FG000|Overall Study|Screen Failure|2|||
48691663|NCT01381016|156722485|FG001|Overall Study|Screen Failure|2|||
48691664|NCT01381016|156722484|FG000|Overall Study|Withdrawal by Subject|0|||
48691665|NCT01381016|156722485|FG001|Overall Study|Withdrawal by Subject|1|||
48691666|NCT01381016|156722484|FG000|Overall Study|Physician Decision|0|||
48691667|NCT01381016|156722485|FG001|Overall Study|Physician Decision|2|||
48763947|NCT01549964|156985796|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
48763948|NCT01549964|156985797|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
48691668|NCT01693029|156722490|FG000|Overall Study|Withdrawal by Subject|15|||
48691669|NCT01693029|156722491|FG001|Overall Study|Withdrawal by Subject|22|||
48691670|NCT01693029|156722490|FG000|Overall Study|Kidney transplantation|7|||
48691671|NCT01693029|156722491|FG001|Overall Study|Kidney transplantation|7|||
48393357|NCT02982954|155635892|FG000|Overall Study|Other reasons|42|||
48393358|NCT02982954|155635893|FG001|Overall Study|Other reasons|17|||
48393359|NCT02982954|155635894|FG002|Overall Study|Other reasons|12|||
48393360|NCT02982954|155635895|FG003|Overall Study|Other reasons|3|||
48691672|NCT01693029|156722490|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
48691673|NCT01693029|156722491|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
48691674|NCT01693029|156722490|FG000|Overall Study|Protocol Violation|6|||
48691675|NCT01693029|156722491|FG001|Overall Study|Protocol Violation|7|||
48691676|NCT01693029|156722490|FG000|Overall Study|Change in dialysis modality|2|||
48691677|NCT01693029|156722491|FG001|Overall Study|Change in dialysis modality|1|||
48691678|NCT01693029|156722490|FG000|Overall Study|Physician Decision|0|||
48691679|NCT01693029|156722491|FG001|Overall Study|Physician Decision|2|||
48691680|NCT01693029|156722490|FG000|Overall Study|Lost to Follow-up|0|||
48691681|NCT01693029|156722491|FG001|Overall Study|Lost to Follow-up|1|||
48691682|NCT01693029|156722490|FG000|Overall Study|Adverse Event|1|||
48691683|NCT01693029|156722491|FG001|Overall Study|Adverse Event|6|||
48691684|NCT01693029|156722490|FG000|Overall Study|Death|5|||
48691685|NCT01693029|156722491|FG001|Overall Study|Death|8|||
48691686|NCT01693029|156722490|FG000|Overall Study|Non-compliance|2|||
48691687|NCT01693029|156722491|FG001|Overall Study|Non-compliance|1|||
48691688|NCT03190330|156722493|FG000|Overall Study|Adverse Event|2|||
48691689|NCT03190330|156722493|FG000|Overall Study|Death|10|||
48691690|NCT03190330|156722493|FG000|Overall Study|Lost to Follow-up|1|||
48691691|NCT03190330|156722493|FG000|Overall Study|Withdrawal by Subject|6|||
48691692|NCT03190330|156722493|FG000|Overall Study|Progressive Disease|1|||
48691693|NCT00922623|156722494|FG000|Overall Study|Other|4|||
48691694|NCT00922623|156722494|FG000|Overall Study|Lost to Follow-up|1|||
48691695|NCT00404651|156722495|FG000|Overall Study|Serious Adverse Event|0|||
48691696|NCT00404651|156722496|FG001|Overall Study|Serious Adverse Event|0|||
48691697|NCT00404651|156722497|FG002|Overall Study|Serious Adverse Event|2|||
48691698|NCT00404651|156722498|FG003|Overall Study|Serious Adverse Event|0|||
48691699|NCT00404651|156722495|FG000|Overall Study|Protocol Violation|10|||
48691700|NCT00404651|156722496|FG001|Overall Study|Protocol Violation|5|||
48691701|NCT00404651|156722497|FG002|Overall Study|Protocol Violation|14|||
48691702|NCT00404651|156722498|FG003|Overall Study|Protocol Violation|5|||
48691703|NCT00404651|156722495|FG000|Overall Study|Lost to Follow-up|15|||
48691704|NCT00404651|156722496|FG001|Overall Study|Lost to Follow-up|11|||
48691705|NCT00404651|156722497|FG002|Overall Study|Lost to Follow-up|13|||
48691706|NCT00404651|156722498|FG003|Overall Study|Lost to Follow-up|10|||
48691707|NCT00404651|156722495|FG000|Overall Study|Withdrawal by Subject|14|||
48691708|NCT00404651|156722496|FG001|Overall Study|Withdrawal by Subject|12|||
48393361|NCT02982954|155635892|FG000|Overall Study|Premature site closure|0|||
48393362|NCT02982954|155635893|FG001|Overall Study|Premature site closure|0|||
48393363|NCT02982954|155635894|FG002|Overall Study|Premature site closure|0|||
48393364|NCT02982954|155635895|FG003|Overall Study|Premature site closure|1|||
48393365|NCT02263079|155635896|FG000|Overall Study|Physician Decision|1|||
48393366|NCT02263079|155635897|FG001|Overall Study|Physician Decision|0|||
48393367|NCT02263079|155635898|FG002|Overall Study|Physician Decision|0|||
48393368|NCT02263079|155635896|FG000|Overall Study|Withdrawal by Subject|2|||
48393369|NCT02263079|155635897|FG001|Overall Study|Withdrawal by Subject|8|||
48393370|NCT02263079|155635898|FG002|Overall Study|Withdrawal by Subject|0|||
48393371|NCT01227187|155635904|FG000|Overall Study|Physician Decision|0|||
48393372|NCT01227187|155635905|FG001|Overall Study|Physician Decision|0|||
48393373|NCT01227187|155635906|FG002|Overall Study|Physician Decision|0|||
48393374|NCT01227187|155635907|FG003|Overall Study|Physician Decision|1|||
48393375|NCT00066703|155635910|FG000|Overall Study|Adverse Event|80|||
48393376|NCT00066703|155635911|FG001|Overall Study|Adverse Event|111|||
48691709|NCT00404651|156722497|FG002|Overall Study|Withdrawal by Subject|16|||
48691710|NCT00404651|156722498|FG003|Overall Study|Withdrawal by Subject|6|||
48691711|NCT01428258|156722499|FG000|Intervention 1|Withdrawal by Subject|2|||
48691712|NCT01428258|156722500|FG001|Intervention 1|Withdrawal by Subject|0|||
48691713|NCT00833040|156722501|FG000|Overall Study|Adverse Event|0|||
48691714|NCT00833040|156722502|FG001|Overall Study|Adverse Event|0|||
48393377|NCT00066703|155635910|FG000|Overall Study|Death|3|||
48393378|NCT00066703|155635911|FG001|Overall Study|Death|0|||
48691715|NCT00833040|156722503|FG002|Overall Study|Adverse Event|0|||
48393379|NCT00066703|155635910|FG000|Overall Study|Lack of Efficacy|114|||
48393380|NCT00066703|155635911|FG001|Overall Study|Lack of Efficacy|69|||
48393381|NCT00066703|155635910|FG000|Overall Study|Lost to Follow-up|31|||
48393382|NCT00066703|155635911|FG001|Overall Study|Lost to Follow-up|28|||
48691716|NCT00833040|156722504|FG003|Overall Study|Adverse Event|0|||
48691717|NCT00833040|156722505|FG004|Overall Study|Adverse Event|0|||
48691718|NCT00833040|156722506|FG005|Overall Study|Adverse Event|1|||
48691719|NCT03347123|156722507|FG000|Overall Study|Death|1|||
48691720|NCT03347123|156722508|FG001|Overall Study|Death|2|||
48691721|NCT03347123|156722509|FG002|Overall Study|Death|0|||
48691722|NCT03347123|156722510|FG003|Overall Study|Death|0|||
48691723|NCT03347123|156722511|FG004|Overall Study|Death|0|||
48355523|NCT01296555|155498532|FG000|Overall Study|Progressive Disease|6|||
48691724|NCT03347123|156722512|FG005|Overall Study|Death|0|||
48691725|NCT03347123|156722513|FG006|Overall Study|Death|0|||
48691726|NCT03347123|156722507|FG000|Overall Study|Withdrawal by Subject|1|||
48691727|NCT03347123|156722508|FG001|Overall Study|Withdrawal by Subject|0|||
48691728|NCT03347123|156722509|FG002|Overall Study|Withdrawal by Subject|0|||
48691729|NCT03347123|156722510|FG003|Overall Study|Withdrawal by Subject|0|||
48691730|NCT03347123|156722511|FG004|Overall Study|Withdrawal by Subject|0|||
48691731|NCT03347123|156722512|FG005|Overall Study|Withdrawal by Subject|0|||
48691732|NCT03347123|156722513|FG006|Overall Study|Withdrawal by Subject|0|||
48691733|NCT03347123|156722507|FG000|Overall Study|Reason not Specified|3|||
48691734|NCT03347123|156722508|FG001|Overall Study|Reason not Specified|4|||
48691735|NCT03347123|156722509|FG002|Overall Study|Reason not Specified|0|||
48691736|NCT03347123|156722510|FG003|Overall Study|Reason not Specified|0|||
48691737|NCT03347123|156722511|FG004|Overall Study|Reason not Specified|0|||
48691738|NCT03347123|156722512|FG005|Overall Study|Reason not Specified|0|||
48691739|NCT03347123|156722513|FG006|Overall Study|Reason not Specified|0|||
48691740|NCT00416624|156722521|FG000|Overall Study|Withdrawal by Subject|1|||
48691741|NCT00416624|156722522|FG001|Overall Study|Withdrawal by Subject|6|||
48691742|NCT00416624|156722523|FG002|Overall Study|Withdrawal by Subject|4|||
48691743|NCT00416624|156722524|FG003|Overall Study|Withdrawal by Subject|9|||
48691744|NCT00416624|156722521|FG000|Overall Study|Death|4|||
48691745|NCT00416624|156722522|FG001|Overall Study|Death|7|||
48691746|NCT00416624|156722523|FG002|Overall Study|Death|7|||
48691747|NCT00416624|156722524|FG003|Overall Study|Death|1|||
48691748|NCT00416624|156722521|FG000|Overall Study|Adverse Event|8|||
48691749|NCT00416624|156722522|FG001|Overall Study|Adverse Event|3|||
48691750|NCT00416624|156722523|FG002|Overall Study|Adverse Event|2|||
48691751|NCT00416624|156722524|FG003|Overall Study|Adverse Event|2|||
48691752|NCT00416624|156722521|FG000|Overall Study|Other|8|||
48691753|NCT00416624|156722522|FG001|Overall Study|Other|11|||
48691754|NCT00416624|156722523|FG002|Overall Study|Other|5|||
48691755|NCT00416624|156722524|FG003|Overall Study|Other|5|||
48691756|NCT00416624|156722521|FG000|Overall Study|Cancel|1|||
48691757|NCT00416624|156722522|FG001|Overall Study|Cancel|0|||
48691758|NCT00416624|156722523|FG002|Overall Study|Cancel|0|||
48691759|NCT00416624|156722524|FG003|Overall Study|Cancel|0|||
48691760|NCT02123134|156722528|FG000|Overall Study|Withdrawal of consent|3|||
48691761|NCT02123134|156722529|FG001|Overall Study|Withdrawal of consent|2|||
48691762|NCT02123134|156722528|FG000|Overall Study|Administrative decision|0|||
48691763|NCT02123134|156722529|FG001|Overall Study|Administrative decision|1|||
48691764|NCT00657540|156722536|FG000|Overall Study|Lost to Follow-up|1|||
48691765|NCT00657540|156722537|FG001|Overall Study|Lost to Follow-up|4|||
48691766|NCT03149055|156722542|FG000|Overall Study|Not treated|4|||
48691767|NCT02349633|156722544|FG000|Overall Study|Death|0|||
48691768|NCT02349633|156722545|FG001|Overall Study|Death|1|||
48691769|NCT02349633|156722546|FG002|Overall Study|Death|0|||
48691770|NCT02349633|156722547|FG003|Overall Study|Death|0|||
48691771|NCT02349633|156722548|FG004|Overall Study|Death|0|||
48691772|NCT02349633|156722549|FG005|Overall Study|Death|1|||
48691773|NCT02349633|156722550|FG006|Overall Study|Death|1|||
48691774|NCT02349633|156722551|FG007|Overall Study|Death|1|||
48691775|NCT02349633|156722552|FG008|Overall Study|Death|0|||
48691776|NCT02349633|156722553|FG009|Overall Study|Death|1|||
48691777|NCT02349633|156722554|FG010|Overall Study|Death|0|||
48691778|NCT02349633|156722555|FG011|Overall Study|Death|0|||
48691779|NCT02349633|156722556|FG012|Overall Study|Death|0|||
48691780|NCT02349633|156722557|FG013|Overall Study|Death|0|||
48691781|NCT02349633|156722544|FG000|Overall Study|Withdrawal by Subject|0|||
48691782|NCT02349633|156722545|FG001|Overall Study|Withdrawal by Subject|0|||
48691783|NCT02349633|156722546|FG002|Overall Study|Withdrawal by Subject|0|||
48691784|NCT02349633|156722547|FG003|Overall Study|Withdrawal by Subject|1|||
48691785|NCT02349633|156722548|FG004|Overall Study|Withdrawal by Subject|0|||
48691786|NCT02349633|156722549|FG005|Overall Study|Withdrawal by Subject|0|||
48691787|NCT02349633|156722550|FG006|Overall Study|Withdrawal by Subject|0|||
48355524|NCT01296555|155498533|FG001|Overall Study|Progressive Disease|3|||
48691788|NCT02349633|156722551|FG007|Overall Study|Withdrawal by Subject|2|||
48691789|NCT02349633|156722552|FG008|Overall Study|Withdrawal by Subject|2|||
48691790|NCT02349633|156722553|FG009|Overall Study|Withdrawal by Subject|1|||
48691791|NCT02349633|156722554|FG010|Overall Study|Withdrawal by Subject|0|||
48691792|NCT02349633|156722555|FG011|Overall Study|Withdrawal by Subject|0|||
48691793|NCT02349633|156722556|FG012|Overall Study|Withdrawal by Subject|0|||
48691794|NCT02349633|156722557|FG013|Overall Study|Withdrawal by Subject|0|||
48691795|NCT02349633|156722544|FG000|Overall Study|Withdrawal of informed consent|0|||
48691796|NCT02349633|156722545|FG001|Overall Study|Withdrawal of informed consent|0|||
48691797|NCT02349633|156722546|FG002|Overall Study|Withdrawal of informed consent|0|||
48691798|NCT02349633|156722547|FG003|Overall Study|Withdrawal of informed consent|1|||
48691799|NCT02349633|156722548|FG004|Overall Study|Withdrawal of informed consent|1|||
48763949|NCT01549964|156985798|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
48763950|NCT01549964|156985795|FG000|80-Week Extension Period|Pregnancy|0|||
48763951|NCT01549964|156985796|FG001|80-Week Extension Period|Pregnancy|0|||
48763952|NCT01549964|156985797|FG002|80-Week Extension Period|Pregnancy|1|||
48763953|NCT01549964|156985798|FG003|80-Week Extension Period|Pregnancy|0|||
48763954|NCT01549964|156985795|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
48763955|NCT01549964|156985796|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
48763956|NCT01549964|156985797|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
48763957|NCT01549964|156985798|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
48763958|NCT01549964|156985795|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
48763959|NCT01549964|156985796|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
48763960|NCT01549964|156985797|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
48763961|NCT01549964|156985798|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
48763962|NCT01549964|156985795|FG000|80-Week Extension Period|Lost to Follow-up|1|||
48763963|NCT01549964|156985796|FG001|80-Week Extension Period|Lost to Follow-up|0|||
48691800|NCT02349633|156722549|FG005|Overall Study|Withdrawal of informed consent|0|||
48691801|NCT02349633|156722550|FG006|Overall Study|Withdrawal of informed consent|0|||
48691802|NCT02349633|156722551|FG007|Overall Study|Withdrawal of informed consent|3|||
48691803|NCT02349633|156722552|FG008|Overall Study|Withdrawal of informed consent|0|||
48691804|NCT02349633|156722553|FG009|Overall Study|Withdrawal of informed consent|0|||
48691805|NCT02349633|156722554|FG010|Overall Study|Withdrawal of informed consent|0|||
48691806|NCT02349633|156722555|FG011|Overall Study|Withdrawal of informed consent|0|||
48691807|NCT02349633|156722556|FG012|Overall Study|Withdrawal of informed consent|0|||
48691808|NCT02349633|156722557|FG013|Overall Study|Withdrawal of informed consent|0|||
48691809|NCT02349633|156722544|FG000|Overall Study|Transition to compassionate use|0|||
48691810|NCT02349633|156722545|FG001|Overall Study|Transition to compassionate use|0|||
48691811|NCT02349633|156722546|FG002|Overall Study|Transition to compassionate use|0|||
48691812|NCT02349633|156722547|FG003|Overall Study|Transition to compassionate use|0|||
48691813|NCT02349633|156722548|FG004|Overall Study|Transition to compassionate use|1|||
48691814|NCT02349633|156722549|FG005|Overall Study|Transition to compassionate use|0|||
48691815|NCT02349633|156722550|FG006|Overall Study|Transition to compassionate use|0|||
48763964|NCT01549964|156985797|FG002|80-Week Extension Period|Lost to Follow-up|2|||
48691816|NCT02349633|156722551|FG007|Overall Study|Transition to compassionate use|3|||
48691817|NCT02349633|156722552|FG008|Overall Study|Transition to compassionate use|0|||
48691818|NCT02349633|156722553|FG009|Overall Study|Transition to compassionate use|1|||
48691819|NCT02349633|156722554|FG010|Overall Study|Transition to compassionate use|0|||
48691820|NCT02349633|156722555|FG011|Overall Study|Transition to compassionate use|0|||
48691821|NCT02349633|156722556|FG012|Overall Study|Transition to compassionate use|0|||
48691822|NCT02349633|156722557|FG013|Overall Study|Transition to compassionate use|0|||
48691823|NCT02349633|156722544|FG000|Overall Study|Early termination of survival follow-up|0|||
48691824|NCT02349633|156722545|FG001|Overall Study|Early termination of survival follow-up|0|||
48691825|NCT02349633|156722546|FG002|Overall Study|Early termination of survival follow-up|0|||
48691826|NCT02349633|156722547|FG003|Overall Study|Early termination of survival follow-up|0|||
48691827|NCT02349633|156722548|FG004|Overall Study|Early termination of survival follow-up|0|||
48691828|NCT02349633|156722549|FG005|Overall Study|Early termination of survival follow-up|0|||
48691829|NCT02349633|156722550|FG006|Overall Study|Early termination of survival follow-up|0|||
48691830|NCT02349633|156722551|FG007|Overall Study|Early termination of survival follow-up|4|||
48691831|NCT02349633|156722552|FG008|Overall Study|Early termination of survival follow-up|0|||
48691832|NCT02349633|156722553|FG009|Overall Study|Early termination of survival follow-up|0|||
48691833|NCT02349633|156722554|FG010|Overall Study|Early termination of survival follow-up|0|||
48691834|NCT02349633|156722555|FG011|Overall Study|Early termination of survival follow-up|0|||
48691835|NCT02349633|156722556|FG012|Overall Study|Early termination of survival follow-up|0|||
48691836|NCT02349633|156722557|FG013|Overall Study|Early termination of survival follow-up|0|||
48763965|NCT01549964|156985798|FG003|80-Week Extension Period|Lost to Follow-up|1|||
48763966|NCT01549964|156985795|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
48763967|NCT01549964|156985796|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
48763968|NCT01549964|156985797|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
48763969|NCT01549964|156985798|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
48763970|NCT01232296|156985799|FG000|Overall Study|Adverse Event|24|||
48763971|NCT01232296|156985800|FG001|Overall Study|Adverse Event|12|||
48763972|NCT01232296|156985799|FG000|Overall Study|Physician Decision|1|||
48763973|NCT01232296|156985800|FG001|Overall Study|Physician Decision|1|||
48763974|NCT01232296|156985799|FG000|Overall Study|Progressive disease|43|||
48691837|NCT02349633|156722544|FG000|Overall Study|Termination by sponsor|0|||
48691838|NCT02349633|156722545|FG001|Overall Study|Termination by sponsor|0|||
48691839|NCT02349633|156722546|FG002|Overall Study|Termination by sponsor|0|||
48763975|NCT01232296|156985800|FG001|Overall Study|Progressive disease|61|||
48763976|NCT01232296|156985799|FG000|Overall Study|Study terminated by sponsor|0|||
48763977|NCT01232296|156985800|FG001|Overall Study|Study terminated by sponsor|1|||
48355525|NCT01296555|155498534|FG002|Overall Study|Progressive Disease|3|||
48691840|NCT02349633|156722547|FG003|Overall Study|Termination by sponsor|0|||
48691841|NCT02349633|156722548|FG004|Overall Study|Termination by sponsor|0|||
48691842|NCT02349633|156722549|FG005|Overall Study|Termination by sponsor|0|||
48691843|NCT02349633|156722550|FG006|Overall Study|Termination by sponsor|0|||
48691844|NCT02349633|156722551|FG007|Overall Study|Termination by sponsor|1|||
48691845|NCT02349633|156722552|FG008|Overall Study|Termination by sponsor|0|||
48691846|NCT02349633|156722553|FG009|Overall Study|Termination by sponsor|2|||
48691847|NCT02349633|156722554|FG010|Overall Study|Termination by sponsor|0|||
48691848|NCT02349633|156722555|FG011|Overall Study|Termination by sponsor|0|||
48393383|NCT00066703|155635910|FG000|Overall Study|Withdrawal by Subject|38|||
48393384|NCT00066703|155635911|FG001|Overall Study|Withdrawal by Subject|63|||
48393385|NCT00066703|155635910|FG000|Overall Study|Treatment ongoing|346|||
48393386|NCT00066703|155635911|FG001|Overall Study|Treatment ongoing|311|||
48393387|NCT02347098|155635912|FG000|Overall Study|Death|1|||
48393388|NCT02347098|155635913|FG001|Overall Study|Death|0|||
48393389|NCT02347098|155635912|FG000|Overall Study|Withdrawal by Subject|1|||
48393390|NCT02347098|155635913|FG001|Overall Study|Withdrawal by Subject|0|||
48393391|NCT02347098|155635912|FG000|Overall Study|Lost to Follow-up|2|||
48393392|NCT02347098|155635913|FG001|Overall Study|Lost to Follow-up|2|||
48393393|NCT02347098|155635912|FG000|Overall Study|Refuse Follow-up Visit|1|||
48393394|NCT02347098|155635913|FG001|Overall Study|Refuse Follow-up Visit|5|||
48393395|NCT02347098|155635912|FG000|Overall Study|no visit due to illness|2|||
48393396|NCT02347098|155635913|FG001|Overall Study|no visit due to illness|1|||
48393397|NCT00294060|155635914|FG000|Overall Study|Death|225|||
48691849|NCT02349633|156722556|FG012|Overall Study|Termination by sponsor|0|||
48691850|NCT02349633|156722557|FG013|Overall Study|Termination by sponsor|0|||
48355526|NCT01296555|155498535|FG003|Overall Study|Progressive Disease|7|||
48355527|NCT01296555|155498536|FG004|Overall Study|Progressive Disease|6|||
48355528|NCT01296555|155498537|FG005|Overall Study|Progressive Disease|16|||
48355529|NCT01296555|155498538|FG006|Overall Study|Progressive Disease|16|||
48355530|NCT01296555|155498539|FG007|Overall Study|Progressive Disease|8|||
48355531|NCT01296555|155498540|FG008|Overall Study|Progressive Disease|7|||
48355532|NCT01296555|155498541|FG009|Overall Study|Progressive Disease|18|||
48355533|NCT01296555|155498542|FG010|Overall Study|Progressive Disease|7|||
48355534|NCT01296555|155498543|FG011|Overall Study|Progressive Disease|14|||
48355535|NCT01296555|155498544|FG012|Overall Study|Progressive Disease|5|||
48355536|NCT01296555|155498545|FG013|Overall Study|Progressive Disease|12|||
48355537|NCT01296555|155498546|FG014|Overall Study|Progressive Disease|1|||
48355538|NCT01296555|155498547|FG015|Overall Study|Progressive Disease|1|||
48355539|NCT01296555|155498548|FG016|Overall Study|Progressive Disease|0|||
48355540|NCT01296555|155498549|FG017|Overall Study|Progressive Disease|0|||
48355541|NCT01296555|155498550|FG018|Overall Study|Progressive Disease|0|||
48355542|NCT01296555|155498551|FG019|Overall Study|Progressive Disease|1|||
48355543|NCT01296555|155498552|FG020|Overall Study|Progressive Disease|0|||
48355544|NCT01296555|155498553|FG021|Overall Study|Progressive Disease|0|||
48355545|NCT01296555|155498554|FG022|Overall Study|Progressive Disease|0|||
48355546|NCT01296555|155498555|FG023|Overall Study|Progressive Disease|0|||
48355547|NCT01296555|155498556|FG024|Overall Study|Progressive Disease|1|||
48355548|NCT01296555|155498557|FG025|Overall Study|Progressive Disease|0|||
48355549|NCT01296555|155498558|FG026|Overall Study|Progressive Disease|5|||
48355550|NCT01296555|155498559|FG027|Overall Study|Progressive Disease|1|||
48355551|NCT01296555|155498560|FG028|Overall Study|Progressive Disease|0|||
48355552|NCT01296555|155498532|FG000|Overall Study|Protocol Violation|0|||
48355553|NCT01296555|155498533|FG001|Overall Study|Protocol Violation|0|||
48355554|NCT01296555|155498534|FG002|Overall Study|Protocol Violation|0|||
48355555|NCT01296555|155498535|FG003|Overall Study|Protocol Violation|0|||
48355556|NCT01296555|155498536|FG004|Overall Study|Protocol Violation|0|||
48355557|NCT01296555|155498537|FG005|Overall Study|Protocol Violation|0|||
48355558|NCT01296555|155498538|FG006|Overall Study|Protocol Violation|0|||
48355559|NCT01296555|155498539|FG007|Overall Study|Protocol Violation|0|||
48355560|NCT01296555|155498540|FG008|Overall Study|Protocol Violation|0|||
48355561|NCT01296555|155498541|FG009|Overall Study|Protocol Violation|0|||
48355562|NCT01296555|155498542|FG010|Overall Study|Protocol Violation|0|||
48355563|NCT01296555|155498543|FG011|Overall Study|Protocol Violation|0|||
48355564|NCT01296555|155498544|FG012|Overall Study|Protocol Violation|0|||
48355565|NCT01296555|155498545|FG013|Overall Study|Protocol Violation|1|||
48355566|NCT01296555|155498546|FG014|Overall Study|Protocol Violation|0|||
48355567|NCT01296555|155498547|FG015|Overall Study|Protocol Violation|0|||
48355568|NCT01296555|155498548|FG016|Overall Study|Protocol Violation|0|||
48355569|NCT01296555|155498549|FG017|Overall Study|Protocol Violation|0|||
48355570|NCT01296555|155498550|FG018|Overall Study|Protocol Violation|0|||
48355571|NCT01296555|155498551|FG019|Overall Study|Protocol Violation|0|||
48355572|NCT01296555|155498552|FG020|Overall Study|Protocol Violation|0|||
48355573|NCT01296555|155498553|FG021|Overall Study|Protocol Violation|0|||
48355574|NCT01296555|155498554|FG022|Overall Study|Protocol Violation|0|||
48355575|NCT01296555|155498555|FG023|Overall Study|Protocol Violation|0|||
48355576|NCT01296555|155498556|FG024|Overall Study|Protocol Violation|0|||
48355577|NCT01296555|155498557|FG025|Overall Study|Protocol Violation|0|||
48691851|NCT02349633|156722544|FG000|Overall Study|Other|0|||
48691852|NCT02349633|156722545|FG001|Overall Study|Other|0|||
48691853|NCT02349633|156722546|FG002|Overall Study|Other|0|||
48691854|NCT02349633|156722547|FG003|Overall Study|Other|0|||
48691855|NCT02349633|156722548|FG004|Overall Study|Other|0|||
48691856|NCT02349633|156722549|FG005|Overall Study|Other|0|||
48691857|NCT02349633|156722550|FG006|Overall Study|Other|0|||
48691858|NCT02349633|156722551|FG007|Overall Study|Other|2|||
48691859|NCT02349633|156722552|FG008|Overall Study|Other|0|||
48691860|NCT02349633|156722553|FG009|Overall Study|Other|0|||
48691861|NCT02349633|156722554|FG010|Overall Study|Other|0|||
48691862|NCT02349633|156722555|FG011|Overall Study|Other|0|||
48691863|NCT02349633|156722556|FG012|Overall Study|Other|0|||
48691864|NCT02349633|156722557|FG013|Overall Study|Other|0|||
48691865|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
48691866|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
48691867|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
48691868|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
48691869|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
48691870|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
48691871|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
48691872|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
48691873|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
48691874|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
48691875|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
48691876|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
48691877|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
48691878|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
48691879|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
48691880|NCT02788045|156722560|FG000|Main Study (Up to Week 72)|Other|3|||
48691881|NCT02788045|156722561|FG001|Main Study (Up to Week 72)|Other|0|||
48691882|NCT02788045|156722562|FG002|Main Study (Up to Week 72)|Other|0|||
48691883|NCT02788045|156722560|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
48691884|NCT02788045|156722561|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
48691885|NCT02788045|156722562|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
48691886|NCT02788045|156722560|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
48691887|NCT02788045|156722561|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
48691888|NCT02788045|156722562|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
48691889|NCT02788045|156722560|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
48691890|NCT02788045|156722561|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
48691891|NCT02788045|156722562|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
48691892|NCT05789745|156722563|FG000|Overall Study|Withdrawal by Subject|0|||
48691893|NCT05789745|156722564|FG001|Overall Study|Withdrawal by Subject|0|||
48691894|NCT05789745|156722565|FG002|Overall Study|Withdrawal by Subject|0|||
48691895|NCT05789745|156722566|FG003|Overall Study|Withdrawal by Subject|0|||
48691896|NCT05789745|156722567|FG004|Overall Study|Withdrawal by Subject|1|||
48691897|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
48691898|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
48691899|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691900|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691901|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691902|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691903|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691904|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691905|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691906|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691907|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691908|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691909|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691910|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
48691911|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
48691912|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
48691913|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691914|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691915|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691916|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691917|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691918|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691919|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691920|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691921|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691922|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691923|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691924|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
48691925|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
48691926|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
48691927|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48763978|NCT01232296|156985799|FG000|Overall Study|Technical problems|3|||
48763979|NCT01232296|156985800|FG001|Overall Study|Technical problems|0|||
48763980|NCT01232296|156985799|FG000|Overall Study|Subject/guardian decision|10|||
48763981|NCT01232296|156985800|FG001|Overall Study|Subject/guardian decision|2|||
48763982|NCT01232296|156985799|FG000|Overall Study|Death|1|||
48763983|NCT01232296|156985800|FG001|Overall Study|Death|6|||
48763984|NCT02932904|156985803|FG000|Overall Study|Reason not Specified|1|||
48763985|NCT02932904|156985804|FG001|Overall Study|Reason not Specified|0|||
48763986|NCT02932904|156985805|FG002|Overall Study|Reason not Specified|2|||
48763987|NCT02932904|156985806|FG003|Overall Study|Reason not Specified|2|||
48763988|NCT02932904|156985803|FG000|Overall Study|Noncompliance with Study Drug|2|||
48763989|NCT02932904|156985804|FG001|Overall Study|Noncompliance with Study Drug|3|||
48763990|NCT02932904|156985805|FG002|Overall Study|Noncompliance with Study Drug|3|||
48763991|NCT02932904|156985806|FG003|Overall Study|Noncompliance with Study Drug|4|||
48763992|NCT02932904|156985803|FG000|Overall Study|Pregnancy|0|||
48763993|NCT02932904|156985804|FG001|Overall Study|Pregnancy|1|||
48763994|NCT02932904|156985805|FG002|Overall Study|Pregnancy|1|||
48763995|NCT02932904|156985806|FG003|Overall Study|Pregnancy|0|||
48763996|NCT02932904|156985803|FG000|Overall Study|Study Termination|0|||
48763997|NCT02932904|156985804|FG001|Overall Study|Study Termination|1|||
48763998|NCT02932904|156985805|FG002|Overall Study|Study Termination|0|||
48763999|NCT02932904|156985806|FG003|Overall Study|Study Termination|0|||
48764000|NCT02932904|156985803|FG000|Overall Study|Voluntary Withdrawal|2|||
48691928|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691929|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691930|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691931|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691932|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691933|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691934|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691935|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691936|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691937|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691938|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
48691939|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
48691940|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
48691941|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691942|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691943|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691944|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691945|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691946|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691947|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691948|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691949|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691950|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691951|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691952|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
48691953|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
48691954|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
48691955|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691956|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691957|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691958|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691959|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691960|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691961|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691962|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48764001|NCT02932904|156985804|FG001|Overall Study|Voluntary Withdrawal|1|||
48764002|NCT02932904|156985805|FG002|Overall Study|Voluntary Withdrawal|4|||
48764003|NCT02932904|156985806|FG003|Overall Study|Voluntary Withdrawal|2|||
48764004|NCT02932904|156985803|FG000|Overall Study|Lost to Follow-up|5|||
48764005|NCT02932904|156985804|FG001|Overall Study|Lost to Follow-up|3|||
48764006|NCT02932904|156985805|FG002|Overall Study|Lost to Follow-up|6|||
48691963|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691964|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691965|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691966|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
48691967|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
48691968|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
48691969|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691970|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691971|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691972|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691973|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691974|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691975|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691976|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691977|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691978|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691979|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691980|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
48691981|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
48691982|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
48691983|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691984|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691985|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691986|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691987|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691988|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691989|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691990|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691991|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691992|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691993|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691994|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
48691995|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
48691996|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
48691997|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48691998|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48691999|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692000|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692001|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692002|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692003|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692004|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692005|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692006|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692007|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692008|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
48692009|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
48692010|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
48692011|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692012|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692013|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692014|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692015|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692016|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692017|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692018|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692019|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692020|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692021|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692022|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
48692023|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
48692024|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
48692025|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692026|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692027|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692028|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48764007|NCT02932904|156985806|FG003|Overall Study|Lost to Follow-up|0|||
48764008|NCT02932904|156985803|FG000|Overall Study|Significant Protocol Deviation|2|||
48764009|NCT02932904|156985804|FG001|Overall Study|Significant Protocol Deviation|3|||
48764010|NCT02932904|156985805|FG002|Overall Study|Significant Protocol Deviation|6|||
48764011|NCT02932904|156985806|FG003|Overall Study|Significant Protocol Deviation|1|||
48764012|NCT02932904|156985803|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
48764013|NCT02932904|156985804|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
48764014|NCT02932904|156985805|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
48764015|NCT02932904|156985806|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
48764016|NCT02932904|156985803|FG000|Overall Study|Randomized But Not Treated|1|||
48764017|NCT02932904|156985804|FG001|Overall Study|Randomized But Not Treated|1|||
48764018|NCT02932904|156985805|FG002|Overall Study|Randomized But Not Treated|0|||
48764019|NCT02932904|156985806|FG003|Overall Study|Randomized But Not Treated|2|||
48764020|NCT00909779|156985807|FG000|Overall Study|Adverse Event|53|||
48692029|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692030|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692031|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692032|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692033|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692034|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692035|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692036|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
48692037|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
48764021|NCT00909779|156985808|FG001|Overall Study|Adverse Event|55|||
48764022|NCT00909779|156985807|FG000|Overall Study|Lack of Efficacy|7|||
48764023|NCT00909779|156985808|FG001|Overall Study|Lack of Efficacy|4|||
48393398|NCT00294060|155635914|FG000|Overall Study|Other|59|||
48393399|NCT00294060|155635914|FG000|Overall Study|Lost to Follow-up|55|||
48692038|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
48692039|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692040|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692041|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692042|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692043|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692044|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692045|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692046|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692047|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692048|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692049|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692050|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
48692051|NCT03982199|156722568|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
48692052|NCT03982199|156722569|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
48692053|NCT03982199|156722570|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692054|NCT03982199|156722571|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692055|NCT03982199|156722572|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692056|NCT03982199|156722573|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692057|NCT03982199|156722574|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692058|NCT03982199|156722575|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692059|NCT03982199|156722576|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692060|NCT03982199|156722577|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692061|NCT03982199|156722578|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692062|NCT03982199|156722579|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48764024|NCT00909779|156985807|FG000|Overall Study|Lost to Follow-up|19|||
48764025|NCT00909779|156985808|FG001|Overall Study|Lost to Follow-up|15|||
48764026|NCT00909779|156985807|FG000|Overall Study|Physician Decision|8|||
48393400|NCT00294060|155635914|FG000|Overall Study|Withdrawal by Subject|11|||
48393401|NCT00294060|155635914|FG000|Overall Study|Physician Decision|797|||
48393402|NCT00294060|155635914|FG000|Overall Study|Medical condition|3|||
48393403|NCT00294060|155635914|FG000|Overall Study|Device explanted/not replaced|23|||
48393404|NCT04329702|155635921|FG000|Overall Study|illness|3|||
48393405|NCT04329702|155635922|FG001|Overall Study|illness|4|||
48764027|NCT00909779|156985808|FG001|Overall Study|Physician Decision|2|||
48764028|NCT00909779|156985807|FG000|Overall Study|Protocol Violation|2|||
48764029|NCT00909779|156985808|FG001|Overall Study|Protocol Violation|5|||
48764030|NCT00909779|156985807|FG000|Overall Study|Withdrawal by Subject|116|||
48393406|NCT04329702|155635923|FG002|Overall Study|illness|0|||
48393407|NCT04329702|155635921|FG000|Overall Study|Lost to Follow-up|0|||
48764031|NCT00909779|156985808|FG001|Overall Study|Withdrawal by Subject|80|||
48764032|NCT00909779|156985807|FG000|Overall Study|Site Ceasing Operation|2|||
48764033|NCT00909779|156985808|FG001|Overall Study|Site Ceasing Operation|2|||
48764034|NCT00909779|156985807|FG000|Overall Study|Medical Monitor Decision|1|||
48764035|NCT00909779|156985808|FG001|Overall Study|Medical Monitor Decision|0|||
48764036|NCT00909779|156985807|FG000|Overall Study|Noncompliance|1|||
48764037|NCT00909779|156985808|FG001|Overall Study|Noncompliance|1|||
48764038|NCT00909779|156985807|FG000|Overall Study|Randomized in error|1|||
48764039|NCT00909779|156985808|FG001|Overall Study|Randomized in error|1|||
48764040|NCT03792672|156985811|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
48764041|NCT03792672|156985812|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
48764042|NCT03792672|156985813|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
48764043|NCT03792672|156985814|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
48764044|NCT03792672|156985815|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
48764045|NCT03792672|156985816|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
48764046|NCT03792672|156985811|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
48764047|NCT03792672|156985812|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
48764048|NCT03792672|156985813|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
48764049|NCT03792672|156985814|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
48764050|NCT03792672|156985815|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
48393408|NCT04329702|155635922|FG001|Overall Study|Lost to Follow-up|0|||
48393409|NCT04329702|155635923|FG002|Overall Study|Lost to Follow-up|2|||
48393410|NCT04329702|155635921|FG000|Overall Study|Death|0|||
48393411|NCT04329702|155635922|FG001|Overall Study|Death|2|||
48393412|NCT04329702|155635923|FG002|Overall Study|Death|0|||
48393413|NCT03923426|155635924|FG000|Overall Study|Other|19|||
48393414|NCT03923426|155635924|FG000|Overall Study|Lost to Follow-up|16|||
48393415|NCT03923426|155635924|FG000|Overall Study|Death|107|||
48692063|NCT03982199|156722580|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692064|NCT03982199|156722581|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
48692065|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692066|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692067|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692068|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
48692069|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48393416|NCT03923426|155635924|FG000|Overall Study|Incomplete response to question|13|||
48393417|NCT02234284|155635925|FG000|Overall Study|Death|4|||
48692070|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692071|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692072|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692073|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692074|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692075|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692076|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692077|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692078|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
48692079|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692080|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692081|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
48692082|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692083|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692084|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692085|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692086|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48764051|NCT03792672|156985816|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
48393418|NCT02234284|155635926|FG001|Overall Study|Death|2|||
48393419|NCT02234284|155635925|FG000|Overall Study|Withdrawal by Subject|1|||
48393420|NCT02234284|155635926|FG001|Overall Study|Withdrawal by Subject|0|||
48393421|NCT02234284|155635925|FG000|Overall Study|Lost to Follow-up|20|||
48393422|NCT02234284|155635926|FG001|Overall Study|Lost to Follow-up|7|||
48393423|NCT01918007|155635929|FG000|Overall Study|Baseline oximetry not acceptable|11|||
48692087|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48393424|NCT01918007|155635930|FG001|Overall Study|Baseline oximetry not acceptable|7|||
48764052|NCT03792672|156985811|FG000|Treatment Period 4 (2 Days)|Other|1|||
48764053|NCT03792672|156985812|FG001|Treatment Period 4 (2 Days)|Other|0|||
48764054|NCT03792672|156985813|FG002|Treatment Period 4 (2 Days)|Other|0|||
48764055|NCT03792672|156985814|FG003|Treatment Period 4 (2 Days)|Other|0|||
48393425|NCT01918007|155635929|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
48393426|NCT01918007|155635930|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
48393427|NCT01918007|155635929|FG000|Overall Study|Lost to Follow-up|4|||
48393428|NCT01918007|155635930|FG001|Overall Study|Lost to Follow-up|7|||
48692088|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692089|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692090|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692091|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692092|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
48692093|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48393429|NCT04360551|155635936|FG000|Overall Study|Withdrawal by Subject|1|||
48393430|NCT04360551|155635937|FG001|Overall Study|Withdrawal by Subject|0|||
48393431|NCT00876187|155635940|FG000|Overall Study|Adverse Event|14|||
48393432|NCT00876187|155635941|FG001|Overall Study|Adverse Event|12|||
48764056|NCT03792672|156985815|FG004|Treatment Period 4 (2 Days)|Other|0|||
48764057|NCT03792672|156985816|FG005|Treatment Period 4 (2 Days)|Other|0|||
48764058|NCT01256593|156985822|FG000|Overall Study|Protocol Violation|26|||
48764059|NCT01256593|156985822|FG000|Overall Study|No Drug Administration Information|2|||
48393433|NCT00876187|155635942|FG002|Overall Study|Adverse Event|19|||
48393434|NCT00876187|155635943|FG003|Overall Study|Adverse Event|29|||
48393435|NCT00876187|155635944|FG004|Overall Study|Adverse Event|10|||
48393436|NCT00876187|155635940|FG000|Overall Study|Lack of Efficacy|59|||
48393437|NCT00876187|155635941|FG001|Overall Study|Lack of Efficacy|34|||
48393438|NCT00876187|155635942|FG002|Overall Study|Lack of Efficacy|45|||
48393439|NCT00876187|155635943|FG003|Overall Study|Lack of Efficacy|34|||
48393440|NCT00876187|155635944|FG004|Overall Study|Lack of Efficacy|59|||
48393441|NCT00876187|155635940|FG000|Overall Study|Lost to Follow-up|9|||
48692094|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692095|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
48692096|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692097|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692098|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692099|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692100|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692101|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692102|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692103|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692104|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692105|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692106|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
48692107|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692108|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692109|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
48692110|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
48692111|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692112|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692113|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692114|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692115|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48764060|NCT01256593|156985822|FG000|Overall Study|No Visit After Treatment|186|||
48764061|NCT02689258|156985823|FG000|Overall Study|Subject Non-Compliance|0|||
48764062|NCT02689258|156985824|FG001|Overall Study|Subject Non-Compliance|1|||
48764063|NCT02689258|156985825|FG002|Overall Study|Subject Non-Compliance|0|||
48393442|NCT00876187|155635941|FG001|Overall Study|Lost to Follow-up|10|||
48393443|NCT00876187|155635942|FG002|Overall Study|Lost to Follow-up|8|||
48393444|NCT00876187|155635943|FG003|Overall Study|Lost to Follow-up|8|||
48393445|NCT00876187|155635944|FG004|Overall Study|Lost to Follow-up|11|||
48393446|NCT00876187|155635940|FG000|Overall Study|Protocol Violation|6|||
48393447|NCT00876187|155635941|FG001|Overall Study|Protocol Violation|7|||
48393448|NCT00876187|155635942|FG002|Overall Study|Protocol Violation|7|||
48393449|NCT00876187|155635943|FG003|Overall Study|Protocol Violation|6|||
48692116|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692117|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48764064|NCT02689258|156985826|FG003|Overall Study|Subject Non-Compliance|0|||
48764065|NCT02689258|156985827|FG004|Overall Study|Subject Non-Compliance|0|||
48393450|NCT00876187|155635944|FG004|Overall Study|Protocol Violation|3|||
48393451|NCT00876187|155635940|FG000|Overall Study|Withdrawal by Subject|16|||
48393452|NCT00876187|155635941|FG001|Overall Study|Withdrawal by Subject|26|||
48393453|NCT00876187|155635942|FG002|Overall Study|Withdrawal by Subject|32|||
48692118|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692119|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692120|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
48692121|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692122|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692123|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692124|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
48692125|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692126|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692127|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692128|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692129|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692130|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692131|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692132|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692133|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692134|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
48692135|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692136|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692137|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
48692138|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
48692139|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692140|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692141|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692142|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692143|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692144|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692145|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692146|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692147|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692148|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
48692149|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692150|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692151|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692152|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692153|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692154|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692155|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692156|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692157|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
48692158|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692159|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692160|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692161|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692162|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
48692163|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692164|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692165|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692166|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692167|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692168|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692169|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692170|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692171|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
48692172|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692173|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692174|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692175|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692176|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
48692177|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692178|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692179|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692180|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48764066|NCT02689258|156985828|FG005|Overall Study|Subject Non-Compliance|0|||
48764067|NCT02689258|156985829|FG006|Overall Study|Subject Non-Compliance|0|||
48764068|NCT02689258|156985830|FG007|Overall Study|Subject Non-Compliance|0|||
48764069|NCT02689258|156985831|FG008|Overall Study|Subject Non-Compliance|0|||
48764070|NCT02689258|156985832|FG009|Overall Study|Subject Non-Compliance|0|||
48764071|NCT02689258|156985833|FG010|Overall Study|Subject Non-Compliance|0|||
48764072|NCT02689258|156985834|FG011|Overall Study|Subject Non-Compliance|0|||
48764073|NCT02689258|156985823|FG000|Overall Study|Subject Refusal to Continue|0|||
48764074|NCT02689258|156985824|FG001|Overall Study|Subject Refusal to Continue|1|||
48764075|NCT02689258|156985825|FG002|Overall Study|Subject Refusal to Continue|0|||
48764076|NCT02689258|156985826|FG003|Overall Study|Subject Refusal to Continue|0|||
48764077|NCT02689258|156985827|FG004|Overall Study|Subject Refusal to Continue|0|||
48764078|NCT02689258|156985828|FG005|Overall Study|Subject Refusal to Continue|0|||
48764079|NCT02689258|156985829|FG006|Overall Study|Subject Refusal to Continue|0|||
48764080|NCT02689258|156985830|FG007|Overall Study|Subject Refusal to Continue|0|||
48764081|NCT02689258|156985831|FG008|Overall Study|Subject Refusal to Continue|1|||
48764082|NCT02689258|156985832|FG009|Overall Study|Subject Refusal to Continue|0|||
48764083|NCT02689258|156985833|FG010|Overall Study|Subject Refusal to Continue|0|||
48764084|NCT02689258|156985834|FG011|Overall Study|Subject Refusal to Continue|1|||
48764085|NCT02689258|156985823|FG000|Overall Study|Other|0|||
48764086|NCT02689258|156985824|FG001|Overall Study|Other|2|||
48764087|NCT02689258|156985825|FG002|Overall Study|Other|0|||
48764088|NCT02689258|156985826|FG003|Overall Study|Other|0|||
48764089|NCT02689258|156985827|FG004|Overall Study|Other|1|||
48764090|NCT02689258|156985828|FG005|Overall Study|Other|0|||
48764091|NCT02689258|156985829|FG006|Overall Study|Other|0|||
48764092|NCT02689258|156985830|FG007|Overall Study|Other|0|||
48764093|NCT02689258|156985831|FG008|Overall Study|Other|1|||
48764094|NCT02689258|156985832|FG009|Overall Study|Other|0|||
48764095|NCT02689258|156985833|FG010|Overall Study|Other|0|||
48764096|NCT02689258|156985834|FG011|Overall Study|Other|0|||
48764097|NCT00405548|156985843|FG000|Overall Study|Cognitive Memory problems on study day|1|||
48764098|NCT00405548|156985844|FG001|Overall Study|Cognitive Memory problems on study day|0|||
48764099|NCT00405548|156985843|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
48764100|NCT00405548|156985844|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
48764101|NCT00405548|156985843|FG000|Overall Study|Unable to self-administer shots|1|||
48764102|NCT00405548|156985844|FG001|Overall Study|Unable to self-administer shots|0|||
48764103|NCT00405548|156985843|FG000|Overall Study|Venous access failed during study day|1|||
48764104|NCT00405548|156985844|FG001|Overall Study|Venous access failed during study day|0|||
48764105|NCT00405548|156985843|FG000|Overall Study|Withdrawal by Subject|1|||
48764106|NCT00405548|156985844|FG001|Overall Study|Withdrawal by Subject|0|||
48764107|NCT01894152|156985845|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
48764108|NCT02486042|156985848|FG000|Overall Study|Physician Decision|1|||
48764109|NCT02486042|156985849|FG001|Overall Study|Physician Decision|7|||
48764110|NCT02486042|156985848|FG000|Overall Study|Hospital transfer|2|||
48764111|NCT02486042|156985849|FG001|Overall Study|Hospital transfer|2|||
48764112|NCT02486042|156985848|FG000|Overall Study|Withdrawal by Subject|0|||
48764113|NCT02486042|156985849|FG001|Overall Study|Withdrawal by Subject|2|||
48764114|NCT02120794|156985850|FG000|Overall Study|Withdrawal by Subject|43|||
48764115|NCT02120794|156985850|FG000|Overall Study|Adverse Event|10|||
48764116|NCT02120794|156985850|FG000|Overall Study|Physician Decision|4|||
48764117|NCT02120794|156985850|FG000|Overall Study|Due to insurance coverage|1|||
48764118|NCT00735878|156985851|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
48764119|NCT00735878|156985852|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
48764120|NCT00735878|156985853|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
48764121|NCT03320564|156985854|FG000|Overall Study|Protocol Violation|1|||
48764122|NCT01148511|156985855|FG000|Exposed to Study Drug|Protocol Violation|2|||
48764123|NCT01148511|156985856|FG001|Exposed to Study Drug|Protocol Violation|0|||
48764124|NCT01148511|156985857|FG002|Exposed to Study Drug|Protocol Violation|0|||
48764125|NCT01148511|156985855|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
48764126|NCT01148511|156985856|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
48764127|NCT01148511|156985857|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
48393454|NCT00876187|155635943|FG003|Overall Study|Withdrawal by Subject|38|||
48393455|NCT00876187|155635944|FG004|Overall Study|Withdrawal by Subject|37|||
48393456|NCT00876187|155635940|FG000|Overall Study|Entered extension study|101|||
48764128|NCT01148511|156985855|FG000|Randomized|Adverse Event|0|||
48764129|NCT01148511|156985856|FG001|Randomized|Adverse Event|1|||
48764130|NCT01148511|156985857|FG002|Randomized|Adverse Event|0|||
48764131|NCT01148511|156985855|FG000|Randomized|Protocol Violation|0|||
48764132|NCT01148511|156985856|FG001|Randomized|Protocol Violation|2|||
48393457|NCT00876187|155635941|FG001|Overall Study|Entered extension study|120|||
48764133|NCT01148511|156985857|FG002|Randomized|Protocol Violation|1|||
48764134|NCT01148511|156985855|FG000|Randomized|Lost to Follow-up|0|||
48393458|NCT00876187|155635942|FG002|Overall Study|Entered extension study|156|||
48764135|NCT01148511|156985856|FG001|Randomized|Lost to Follow-up|1|||
48764136|NCT01148511|156985857|FG002|Randomized|Lost to Follow-up|1|||
48764137|NCT01148511|156985855|FG000|Randomized|Consent withdrawal|0|||
48393459|NCT00876187|155635943|FG003|Overall Study|Entered extension study|151|||
48393460|NCT00876187|155635944|FG004|Overall Study|Entered extension study|144|||
48393461|NCT00876187|155635940|FG000|Overall Study|Randomized but not treated|3|||
48393462|NCT00876187|155635941|FG001|Overall Study|Randomized but not treated|1|||
48393463|NCT00876187|155635942|FG002|Overall Study|Randomized but not treated|3|||
48393464|NCT00876187|155635943|FG003|Overall Study|Randomized but not treated|2|||
48393465|NCT00876187|155635944|FG004|Overall Study|Randomized but not treated|3|||
48393466|NCT00876187|155635940|FG000|Overall Study|Other|2|||
48393467|NCT00876187|155635941|FG001|Overall Study|Other|5|||
48393468|NCT00876187|155635942|FG002|Overall Study|Other|9|||
48393469|NCT00876187|155635943|FG003|Overall Study|Other|7|||
48393470|NCT00876187|155635944|FG004|Overall Study|Other|4|||
48393471|NCT00535132|155635949|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
48393472|NCT00535132|155635950|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
48393473|NCT00535132|155635949|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
48393474|NCT00535132|155635950|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
48393475|NCT01399788|155635951|FG000|First Intervention Period|Adverse Event|1|||
48393476|NCT01399788|155635952|FG001|First Intervention Period|Adverse Event|0|||
48393477|NCT01970995|155635953|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
48393478|NCT01970995|155635954|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
48692181|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692182|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692183|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692184|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692185|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
48692186|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692187|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692188|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692189|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692190|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
48692191|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692192|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692193|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692194|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692195|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692196|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692197|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692198|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692199|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
48692200|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692201|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692202|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692203|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692204|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
48692205|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692206|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692207|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692208|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692209|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692210|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692211|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692212|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692213|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
48692214|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692215|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692216|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692217|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692218|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
48692219|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692220|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692221|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692222|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692223|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48764138|NCT01148511|156985856|FG001|Randomized|Consent withdrawal|5|||
48393479|NCT01970995|155635955|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
48393480|NCT01970995|155635953|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
48393481|NCT01970995|155635954|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
48764139|NCT01148511|156985857|FG002|Randomized|Consent withdrawal|3|||
48764140|NCT01148511|156985855|FG000|Randomized|Other|0|||
48764141|NCT01148511|156985856|FG001|Randomized|Other|1|||
48764142|NCT01148511|156985857|FG002|Randomized|Other|1|||
48764143|NCT01200797|156985860|FG000|Overall Study|symptomatic deterioration|2|||
48764144|NCT01200797|156985860|FG000|Overall Study|Adverse Event|4|||
48764145|NCT01200797|156985860|FG000|Overall Study|Disease Progression|13|||
48764146|NCT03979638|156985866|FG000|Period 1|Physician Decision|1|||
48764147|NCT03979638|156985867|FG001|Period 1|Physician Decision|1|||
48764148|NCT03979638|156985866|FG000|Period 1|Withdrawal by Subject|4|||
48692224|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
48692225|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692226|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
48692227|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
48692228|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692229|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692230|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692231|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48764149|NCT03979638|156985867|FG001|Period 1|Withdrawal by Subject|3|||
48764150|NCT03979638|156985866|FG000|Period 1|Study terminated by Sponsor|1|||
48764151|NCT03979638|156985867|FG001|Period 1|Study terminated by Sponsor|3|||
48764152|NCT03979638|156985866|FG000|Period 1|Protocol Violation|1|||
48764153|NCT03979638|156985867|FG001|Period 1|Protocol Violation|0|||
48764154|NCT03979638|156985866|FG000|Period 2|Study terminated by Sponsor|1|||
48764155|NCT03979638|156985867|FG001|Period 2|Study terminated by Sponsor|1|||
48764156|NCT01531387|156985868|FG000|Overall Study|Early termination of study|11|||
48764157|NCT01531387|156985869|FG001|Overall Study|Early termination of study|11|||
48764158|NCT02910167|156985872|FG000|Overall Study|Adverse Event|1|||
48764159|NCT02910167|156985872|FG000|Overall Study|Lost to Follow-up|18|||
48764160|NCT02642432|156985873|FG000|Overall Study|Adverse Event|2|||
48764161|NCT02642432|156985873|FG000|Overall Study|Withdrew Consent|1|||
48764162|NCT02642432|156985873|FG000|Overall Study|Lost to Follow-up|2|||
48764163|NCT02642432|156985873|FG000|Overall Study|Other|3|||
48764164|NCT03999892|156985874|FG000|Overall Study|Lost to Follow-up|1|||
48764165|NCT00856908|156985875|FG000|Overall Study|Lost to Follow-up|1|||
48764166|NCT00856908|156985876|FG001|Overall Study|Lost to Follow-up|0|||
48764167|NCT01063595|156985877|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
48764168|NCT01063595|156985878|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
48764169|NCT01063595|156985877|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
48764170|NCT01063595|156985878|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
48764171|NCT01063595|156985877|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
48764172|NCT01063595|156985878|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
48764173|NCT01063595|156985877|FG000|First Intervention|Adverse Event|1|||
48764174|NCT01063595|156985878|FG001|First Intervention|Adverse Event|4|||
48764175|NCT01063595|156985877|FG000|First Intervention|Withdrawal by Subject|1|||
48764176|NCT01063595|156985878|FG001|First Intervention|Withdrawal by Subject|0|||
48764177|NCT01063595|156985877|FG000|First Intervention|Reason not Specified|0|||
48764178|NCT01063595|156985878|FG001|First Intervention|Reason not Specified|1|||
48764179|NCT00748215|156985879|FG000|Overall Study|Withdrawal by Subject|7|||
48764180|NCT00748215|156985880|FG001|Overall Study|Withdrawal by Subject|7|||
48764181|NCT00748215|156985879|FG000|Overall Study|Treatment change|2|||
48764182|NCT00748215|156985880|FG001|Overall Study|Treatment change|1|||
48764183|NCT00748215|156985879|FG000|Overall Study|Change in patient condition|0|||
48764184|NCT00748215|156985880|FG001|Overall Study|Change in patient condition|3|||
48764185|NCT00748215|156985879|FG000|Overall Study|Non-compliant|0|||
48393482|NCT01970995|155635955|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
48393483|NCT04225923|155635956|FG000|Overall Study|Protocol Violation|1|||
48764186|NCT00748215|156985880|FG001|Overall Study|Non-compliant|2|||
48764187|NCT00748215|156985879|FG000|Overall Study|Adverse Event|0|||
48393484|NCT04225923|155635957|FG001|Overall Study|Protocol Violation|0|||
48393485|NCT04225923|155635958|FG002|Overall Study|Protocol Violation|1|||
48393486|NCT04225923|155635956|FG000|Overall Study|Withdrawal by Subject|4|||
48393487|NCT04225923|155635957|FG001|Overall Study|Withdrawal by Subject|1|||
48393488|NCT04225923|155635958|FG002|Overall Study|Withdrawal by Subject|3|||
48393489|NCT04225923|155635956|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
48393490|NCT04225923|155635957|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
48393491|NCT04225923|155635958|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
48393492|NCT01157364|155635959|FG000|Overall Study|Other Reasons|1|||
48393493|NCT01157364|155635960|FG001|Overall Study|Other Reasons|1|||
48764188|NCT00748215|156985880|FG001|Overall Study|Adverse Event|5|||
48764189|NCT00962104|156985881|FG000|Overall Study|Adverse Event|10|||
48764190|NCT00962104|156985882|FG001|Overall Study|Adverse Event|3|||
48764191|NCT00962104|156985881|FG000|Overall Study|Entry Criteria Not Met|1|||
48393494|NCT01157364|155635961|FG002|Overall Study|Other Reasons|2|||
48764192|NCT00962104|156985882|FG001|Overall Study|Entry Criteria Not Met|2|||
48764193|NCT00962104|156985881|FG000|Overall Study|Lack of Efficacy|0|||
48764194|NCT00962104|156985882|FG001|Overall Study|Lack of Efficacy|1|||
48764195|NCT00962104|156985881|FG000|Overall Study|Lost to Follow-up|10|||
48764196|NCT00962104|156985882|FG001|Overall Study|Lost to Follow-up|4|||
48764197|NCT00962104|156985881|FG000|Overall Study|Physician Decision|1|||
48764198|NCT00962104|156985882|FG001|Overall Study|Physician Decision|0|||
48764199|NCT00962104|156985881|FG000|Overall Study|Protocol Violation|6|||
48764200|NCT00962104|156985882|FG001|Overall Study|Protocol Violation|8|||
48764201|NCT00962104|156985881|FG000|Overall Study|Sponsor Decision|0|||
48764202|NCT00962104|156985882|FG001|Overall Study|Sponsor Decision|1|||
48764203|NCT00962104|156985881|FG000|Overall Study|Withdrawal by Subject|10|||
48764204|NCT00962104|156985882|FG001|Overall Study|Withdrawal by Subject|6|||
48764205|NCT00962104|156985881|FG000|Overall Study|Other|2|||
48764206|NCT00962104|156985882|FG001|Overall Study|Other|0|||
48764207|NCT04056195|156985883|FG000|Overall Study|Adverse Event|1|||
48764208|NCT04056195|156985884|FG001|Overall Study|Adverse Event|0|||
48764209|NCT04056195|156985885|FG002|Overall Study|Adverse Event|0|||
48764210|NCT04056195|156985883|FG000|Overall Study|Withdrawal by Subject|0|||
48764211|NCT04056195|156985884|FG001|Overall Study|Withdrawal by Subject|1|||
48764212|NCT04056195|156985885|FG002|Overall Study|Withdrawal by Subject|1|||
48764213|NCT04056195|156985883|FG000|Overall Study|Physician Decision|1|||
48764214|NCT04056195|156985884|FG001|Overall Study|Physician Decision|1|||
48764215|NCT04056195|156985885|FG002|Overall Study|Physician Decision|1|||
48764216|NCT00603746|156985888|FG000|Overall Study|Adverse Event|2|||
48764217|NCT00603746|156985889|FG001|Overall Study|Adverse Event|3|||
48764218|NCT00603746|156985890|FG002|Overall Study|Adverse Event|0|||
48764219|NCT00603746|156985891|FG003|Overall Study|Adverse Event|1|||
48764220|NCT00603746|156985892|FG004|Overall Study|Adverse Event|0|||
48764221|NCT00603746|156985893|FG005|Overall Study|Adverse Event|4|||
48764222|NCT00603746|156985888|FG000|Overall Study|Lack of Efficacy|34|||
48764223|NCT00603746|156985889|FG001|Overall Study|Lack of Efficacy|11|||
48764224|NCT00603746|156985890|FG002|Overall Study|Lack of Efficacy|6|||
48764225|NCT00603746|156985891|FG003|Overall Study|Lack of Efficacy|11|||
48764226|NCT00603746|156985892|FG004|Overall Study|Lack of Efficacy|12|||
48393495|NCT01157364|155635962|FG003|Overall Study|Other Reasons|1|||
48393496|NCT01157364|155635963|FG004|Overall Study|Other Reasons|0|||
48393497|NCT01157364|155635964|FG005|Overall Study|Other Reasons|0|||
48393498|NCT01157364|155635959|FG000|Overall Study|Personal Reasons|0|||
48393499|NCT01157364|155635960|FG001|Overall Study|Personal Reasons|2|||
48393500|NCT01157364|155635961|FG002|Overall Study|Personal Reasons|0|||
48393501|NCT01157364|155635962|FG003|Overall Study|Personal Reasons|0|||
48393502|NCT01157364|155635963|FG004|Overall Study|Personal Reasons|1|||
48393503|NCT01157364|155635964|FG005|Overall Study|Personal Reasons|1|||
48393504|NCT01157364|155635959|FG000|Overall Study|Lost to Follow-up|1|||
48393505|NCT01157364|155635960|FG001|Overall Study|Lost to Follow-up|0|||
48393506|NCT01157364|155635961|FG002|Overall Study|Lost to Follow-up|1|||
48393507|NCT01157364|155635962|FG003|Overall Study|Lost to Follow-up|0|||
48393508|NCT01157364|155635963|FG004|Overall Study|Lost to Follow-up|0|||
48393509|NCT01157364|155635964|FG005|Overall Study|Lost to Follow-up|0|||
48692232|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
48692233|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692234|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692235|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692236|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692237|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692238|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692239|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692240|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692241|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
48764227|NCT00603746|156985893|FG005|Overall Study|Lack of Efficacy|8|||
48764228|NCT00603746|156985888|FG000|Overall Study|Protocol Violation|0|||
48764229|NCT00603746|156985889|FG001|Overall Study|Protocol Violation|3|||
48764230|NCT00603746|156985890|FG002|Overall Study|Protocol Violation|1|||
48764231|NCT00603746|156985891|FG003|Overall Study|Protocol Violation|0|||
48764232|NCT00603746|156985892|FG004|Overall Study|Protocol Violation|1|||
48764233|NCT00603746|156985893|FG005|Overall Study|Protocol Violation|0|||
48764234|NCT00603746|156985888|FG000|Overall Study|Lost to Follow-up|0|||
48764235|NCT00603746|156985889|FG001|Overall Study|Lost to Follow-up|1|||
48764236|NCT00603746|156985890|FG002|Overall Study|Lost to Follow-up|1|||
48764237|NCT00603746|156985891|FG003|Overall Study|Lost to Follow-up|0|||
48764238|NCT00603746|156985892|FG004|Overall Study|Lost to Follow-up|0|||
48764239|NCT00603746|156985893|FG005|Overall Study|Lost to Follow-up|0|||
48764240|NCT00603746|156985888|FG000|Overall Study|Physician Decision|1|||
48393510|NCT01157364|155635959|FG000|Overall Study|Lack of Efficacy|0|||
48393511|NCT01157364|155635960|FG001|Overall Study|Lack of Efficacy|0|||
48393512|NCT01157364|155635961|FG002|Overall Study|Lack of Efficacy|0|||
48393513|NCT01157364|155635962|FG003|Overall Study|Lack of Efficacy|1|||
48393514|NCT01157364|155635963|FG004|Overall Study|Lack of Efficacy|0|||
48393515|NCT01157364|155635964|FG005|Overall Study|Lack of Efficacy|0|||
48692242|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692243|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692244|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692245|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692246|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
48692247|NCT03982199|156722568|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692248|NCT03982199|156722569|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692249|NCT03982199|156722570|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692250|NCT03982199|156722571|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692251|NCT03982199|156722572|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692252|NCT03982199|156722573|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
48692253|NCT03982199|156722574|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692254|NCT03982199|156722575|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
48692255|NCT03982199|156722576|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
48692256|NCT03982199|156722577|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692257|NCT03982199|156722578|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692258|NCT03982199|156722579|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48393516|NCT01157364|155635959|FG000|Overall Study|Adverse Event|0|||
48393517|NCT01157364|155635960|FG001|Overall Study|Adverse Event|1|||
48393518|NCT01157364|155635961|FG002|Overall Study|Adverse Event|1|||
48393519|NCT01157364|155635962|FG003|Overall Study|Adverse Event|0|||
48393520|NCT01157364|155635963|FG004|Overall Study|Adverse Event|1|||
48692259|NCT03982199|156722580|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692260|NCT03982199|156722581|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
48692261|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692262|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692263|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692264|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692265|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692266|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692267|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692268|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692269|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
48692270|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
48692271|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
48692272|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
48692273|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
48692274|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
48692275|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48764241|NCT00603746|156985889|FG001|Overall Study|Physician Decision|0|||
48764242|NCT00603746|156985890|FG002|Overall Study|Physician Decision|0|||
48764243|NCT00603746|156985891|FG003|Overall Study|Physician Decision|0|||
48764244|NCT00603746|156985892|FG004|Overall Study|Physician Decision|1|||
48764245|NCT00603746|156985893|FG005|Overall Study|Physician Decision|0|||
48393521|NCT01157364|155635964|FG005|Overall Study|Adverse Event|0|||
48393522|NCT01576549|155635965|FG000|Overall Study|Sponsor Decision|2|||
48393523|NCT00053417|155635966|FG000|Overall Study|Adverse Event|1|||
48393524|NCT00053417|155635967|FG001|Overall Study|Adverse Event|0|||
48393525|NCT00053417|155635968|FG002|Overall Study|Adverse Event|1|||
48393526|NCT00053417|155635969|FG003|Overall Study|Adverse Event|5|||
48393527|NCT00053417|155635966|FG000|Overall Study|Non-Compliance|0|||
48393528|NCT00053417|155635967|FG001|Overall Study|Non-Compliance|0|||
48393529|NCT00053417|155635968|FG002|Overall Study|Non-Compliance|0|||
48393530|NCT00053417|155635969|FG003|Overall Study|Non-Compliance|1|||
48393531|NCT00053417|155635966|FG000|Overall Study|Withdrawal by Subject|0|||
48393532|NCT00053417|155635967|FG001|Overall Study|Withdrawal by Subject|1|||
48393533|NCT00053417|155635968|FG002|Overall Study|Withdrawal by Subject|0|||
48393534|NCT00053417|155635969|FG003|Overall Study|Withdrawal by Subject|0|||
48393535|NCT00053417|155635966|FG000|Overall Study|Lost to Follow-up|1|||
48393536|NCT00053417|155635967|FG001|Overall Study|Lost to Follow-up|1|||
48393537|NCT00053417|155635968|FG002|Overall Study|Lost to Follow-up|0|||
48764246|NCT00603746|156985888|FG000|Overall Study|Withdrawal by Subject|1|||
48393538|NCT00053417|155635969|FG003|Overall Study|Lost to Follow-up|0|||
48393539|NCT04951037|155635970|FG000|Overall Study|Lost to Follow-up|16|||
48393540|NCT04951037|155635970|FG000|Overall Study|Withdrawal by Subject|5|||
48430015|NCT01728584|155761914|FG003|Overall Study|Screen failure|0|||
48764247|NCT00603746|156985889|FG001|Overall Study|Withdrawal by Subject|0|||
48764248|NCT00603746|156985890|FG002|Overall Study|Withdrawal by Subject|0|||
48764249|NCT00603746|156985891|FG003|Overall Study|Withdrawal by Subject|1|||
48764250|NCT00603746|156985892|FG004|Overall Study|Withdrawal by Subject|3|||
48764251|NCT00603746|156985893|FG005|Overall Study|Withdrawal by Subject|1|||
48764252|NCT01113879|156985896|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
48764253|NCT01113879|156985897|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
48764254|NCT03350503|156985904|FG000|Overall Study|Adverse Event|5|||
48764255|NCT03350503|156985904|FG000|Overall Study|Withdrawal by Subject|5|||
48764256|NCT03350503|156985904|FG000|Overall Study|Continuation impossible due to move|4|||
48764257|NCT03350503|156985904|FG000|Overall Study|Physician Decision|3|||
48764258|NCT03873987|156988122|FG000|Overall Study|Adverse Event|1|||
48764259|NCT03873987|156988123|FG001|Overall Study|Adverse Event|0|||
48764260|NCT03873987|156988122|FG000|Overall Study|staff was unable to start a new IV line|1|||
48764261|NCT03873987|156988123|FG001|Overall Study|staff was unable to start a new IV line|0|||
48764262|NCT03873987|156988122|FG000|Overall Study|Lost to Follow-up|0|||
48764263|NCT03873987|156988123|FG001|Overall Study|Lost to Follow-up|1|||
48764264|NCT01904604|156988124|FG000|Overall Study|Withdrew before receiving dosing|0|||
48764265|NCT01904604|156988125|FG001|Overall Study|Withdrew before receiving dosing|1|||
48764266|NCT01904604|156988126|FG002|Overall Study|Withdrew before receiving dosing|0|||
48764267|NCT01904604|156988124|FG000|Overall Study|Non-compliance|1|||
48764268|NCT01904604|156988125|FG001|Overall Study|Non-compliance|0|||
48764269|NCT01904604|156988126|FG002|Overall Study|Non-compliance|0|||
48764270|NCT01904604|156988124|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
48764271|NCT01904604|156988125|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
48764272|NCT01904604|156988126|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
48764273|NCT01904604|156988124|FG000|Overall Study|Patch site reactions|1|||
48764274|NCT01904604|156988125|FG001|Overall Study|Patch site reactions|1|||
48764275|NCT01904604|156988126|FG002|Overall Study|Patch site reactions|0|||
48764276|NCT01904604|156988124|FG000|Overall Study|Increased syncope|0|||
48764277|NCT01904604|156988125|FG001|Overall Study|Increased syncope|1|||
48764278|NCT01904604|156988126|FG002|Overall Study|Increased syncope|0|||
48764279|NCT01904604|156988124|FG000|Overall Study|Unrelated illness|0|||
48764280|NCT01904604|156988125|FG001|Overall Study|Unrelated illness|1|||
48764281|NCT01904604|156988126|FG002|Overall Study|Unrelated illness|0|||
48764282|NCT01904604|156988124|FG000|Overall Study|Passed Week 52 OFC|1|||
48393541|NCT04951037|155635970|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
48764283|NCT01904604|156988125|FG001|Overall Study|Passed Week 52 OFC|0|||
48764284|NCT01904604|156988126|FG002|Overall Study|Passed Week 52 OFC|0|||
48764285|NCT01904604|156988124|FG000|Overall Study|Withdrawal by Subject|1|||
48764286|NCT01904604|156988125|FG001|Overall Study|Withdrawal by Subject|2|||
48764287|NCT01904604|156988126|FG002|Overall Study|Withdrawal by Subject|0|||
48764288|NCT01904604|156988124|FG000|Overall Study|Participant Relocated|1|||
48764289|NCT01904604|156988125|FG001|Overall Study|Participant Relocated|1|||
48764290|NCT01904604|156988126|FG002|Overall Study|Participant Relocated|1|||
48764291|NCT01904604|156988124|FG000|Overall Study|Lost to Follow-up|0|||
48764292|NCT01904604|156988125|FG001|Overall Study|Lost to Follow-up|0|||
48764293|NCT01904604|156988126|FG002|Overall Study|Lost to Follow-up|1|||
48764294|NCT00666757|156988130|FG000|Overall Study|Lost to Follow-up|39|||
48764295|NCT00666757|156988131|FG001|Overall Study|Lost to Follow-up|35|||
48764296|NCT00666757|156988130|FG000|Overall Study|Protocol Violation|23|||
48764297|NCT00666757|156988131|FG001|Overall Study|Protocol Violation|24|||
48764298|NCT00666757|156988130|FG000|Overall Study|Adverse Event|22|||
48764299|NCT00666757|156988131|FG001|Overall Study|Adverse Event|12|||
48764300|NCT00666757|156988130|FG000|Overall Study|Withdrawal by Subject|13|||
48764301|NCT00666757|156988131|FG001|Overall Study|Withdrawal by Subject|17|||
48764302|NCT00666757|156988130|FG000|Overall Study|Lack of Efficacy|3|||
48764303|NCT00666757|156988131|FG001|Overall Study|Lack of Efficacy|6|||
48764304|NCT00666757|156988130|FG000|Overall Study|Physician Decision|0|||
48764305|NCT00666757|156988131|FG001|Overall Study|Physician Decision|2|||
48764306|NCT00666757|156988130|FG000|Overall Study|Sponsor decision|0|||
48764307|NCT00666757|156988131|FG001|Overall Study|Sponsor decision|1|||
48764308|NCT04145895|156988132|FG000|Overall Study|Physician Decision|2|||
48764309|NCT04145895|156988133|FG001|Overall Study|Physician Decision|0|||
48764310|NCT04145895|156988132|FG000|Overall Study|Withdrawal by Subject|0|||
48764311|NCT04145895|156988133|FG001|Overall Study|Withdrawal by Subject|2|||
48764312|NCT03616912|156988134|FG000|Overall Study|Adverse Event|17|||
48764313|NCT03616912|156988135|FG001|Overall Study|Adverse Event|21|||
48764314|NCT03616912|156988136|FG002|Overall Study|Adverse Event|9|||
48764315|NCT03616912|156988137|FG003|Overall Study|Adverse Event|0|||
48764316|NCT03616912|156988138|FG004|Overall Study|Adverse Event|0|||
48764317|NCT03616912|156988139|FG005|Overall Study|Adverse Event|0|||
48764318|NCT03616912|156988134|FG000|Overall Study|Death|1|||
48764319|NCT03616912|156988135|FG001|Overall Study|Death|1|||
48764320|NCT03616912|156988136|FG002|Overall Study|Death|0|||
48764321|NCT03616912|156988137|FG003|Overall Study|Death|0|||
48764322|NCT03616912|156988138|FG004|Overall Study|Death|0|||
48764323|NCT03616912|156988139|FG005|Overall Study|Death|0|||
48764324|NCT03616912|156988134|FG000|Overall Study|Lack of Efficacy|13|||
48764325|NCT03616912|156988135|FG001|Overall Study|Lack of Efficacy|6|||
48764326|NCT03616912|156988136|FG002|Overall Study|Lack of Efficacy|8|||
48393542|NCT01006265|155635972|FG000|Overall Study|Lost to Follow-up|1|||
48393543|NCT01006265|155635973|FG001|Overall Study|Lost to Follow-up|0|||
48393544|NCT01006265|155635974|FG002|Overall Study|Lost to Follow-up|1|||
48393545|NCT01006265|155635975|FG003|Overall Study|Lost to Follow-up|0|||
48393546|NCT01006265|155635972|FG000|Overall Study|Withdrawal by Subject|4|||
48393547|NCT01006265|155635973|FG001|Overall Study|Withdrawal by Subject|7|||
48393548|NCT01006265|155635974|FG002|Overall Study|Withdrawal by Subject|5|||
48393549|NCT01006265|155635975|FG003|Overall Study|Withdrawal by Subject|5|||
48393550|NCT01006265|155635972|FG000|Overall Study|Administrative reason|1|||
48393551|NCT01006265|155635973|FG001|Overall Study|Administrative reason|2|||
48393552|NCT01006265|155635974|FG002|Overall Study|Administrative reason|3|||
48393553|NCT01006265|155635975|FG003|Overall Study|Administrative reason|0|||
48393554|NCT04191382|155635976|FG000|Overall Study|Withdrawal by Subject|1|||
48393555|NCT04191382|155635977|FG001|Overall Study|Withdrawal by Subject|0|||
48393556|NCT04191382|155635978|FG002|Overall Study|Withdrawal by Subject|0|||
48393557|NCT00708500|155635982|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
48393558|NCT00708500|155635983|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
48393559|NCT00708500|155635984|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
48393560|NCT00708500|155635982|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
48393561|NCT00708500|155635983|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
48393562|NCT00708500|155635984|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
48393563|NCT00708500|155635982|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
48393564|NCT00708500|155635983|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
48393565|NCT00708500|155635984|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
48393566|NCT00708500|155635982|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
48393567|NCT00708500|155635983|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
48764327|NCT03616912|156988137|FG003|Overall Study|Lack of Efficacy|4|||
48764328|NCT03616912|156988138|FG004|Overall Study|Lack of Efficacy|5|||
48764329|NCT03616912|156988139|FG005|Overall Study|Lack of Efficacy|1|||
48764330|NCT03616912|156988134|FG000|Overall Study|Lost to Follow-up|1|||
48764331|NCT03616912|156988135|FG001|Overall Study|Lost to Follow-up|2|||
48764332|NCT03616912|156988136|FG002|Overall Study|Lost to Follow-up|3|||
48764333|NCT03616912|156988137|FG003|Overall Study|Lost to Follow-up|0|||
48764334|NCT03616912|156988138|FG004|Overall Study|Lost to Follow-up|0|||
48764335|NCT03616912|156988139|FG005|Overall Study|Lost to Follow-up|0|||
48764336|NCT03616912|156988134|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
48764337|NCT03616912|156988135|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
48764338|NCT03616912|156988136|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
48764339|NCT03616912|156988137|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
48764340|NCT03616912|156988138|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
48764341|NCT03616912|156988139|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
48764342|NCT03616912|156988134|FG000|Overall Study|Withdrawal by Subject|12|||
48764343|NCT03616912|156988135|FG001|Overall Study|Withdrawal by Subject|12|||
48764344|NCT03616912|156988136|FG002|Overall Study|Withdrawal by Subject|15|||
48764345|NCT03616912|156988137|FG003|Overall Study|Withdrawal by Subject|2|||
48764346|NCT03616912|156988138|FG004|Overall Study|Withdrawal by Subject|0|||
48764347|NCT03616912|156988139|FG005|Overall Study|Withdrawal by Subject|2|||
48764348|NCT03616912|156988134|FG000|Overall Study|Study Terminated by Sponsor|0|||
48764349|NCT03616912|156988135|FG001|Overall Study|Study Terminated by Sponsor|0|||
48764350|NCT03616912|156988136|FG002|Overall Study|Study Terminated by Sponsor|0|||
48393568|NCT00708500|155635984|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
48393569|NCT00708500|155635982|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
48393570|NCT00708500|155635983|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
48764351|NCT03616912|156988137|FG003|Overall Study|Study Terminated by Sponsor|10|||
48764352|NCT03616912|156988138|FG004|Overall Study|Study Terminated by Sponsor|9|||
48764353|NCT03616912|156988139|FG005|Overall Study|Study Terminated by Sponsor|11|||
48764354|NCT03616912|156988134|FG000|Overall Study|Protocol Deviation|1|||
48764355|NCT03616912|156988135|FG001|Overall Study|Protocol Deviation|1|||
48764356|NCT03616912|156988136|FG002|Overall Study|Protocol Deviation|0|||
48764357|NCT03616912|156988137|FG003|Overall Study|Protocol Deviation|0|||
48764358|NCT03616912|156988138|FG004|Overall Study|Protocol Deviation|0|||
48764359|NCT03616912|156988139|FG005|Overall Study|Protocol Deviation|0|||
48764360|NCT03616912|156988134|FG000|Overall Study|Pregnancy|1|||
48764361|NCT03616912|156988135|FG001|Overall Study|Pregnancy|0|||
48764362|NCT03616912|156988136|FG002|Overall Study|Pregnancy|4|||
48764363|NCT03616912|156988137|FG003|Overall Study|Pregnancy|0|||
48764364|NCT03616912|156988138|FG004|Overall Study|Pregnancy|0|||
48764365|NCT03616912|156988139|FG005|Overall Study|Pregnancy|0|||
48764366|NCT03616912|156988134|FG000|Overall Study|Protocol Violation|1|||
48764367|NCT03616912|156988135|FG001|Overall Study|Protocol Violation|0|||
48764368|NCT03616912|156988136|FG002|Overall Study|Protocol Violation|2|||
48764369|NCT03616912|156988137|FG003|Overall Study|Protocol Violation|0|||
48764370|NCT03616912|156988138|FG004|Overall Study|Protocol Violation|0|||
48764371|NCT03616912|156988139|FG005|Overall Study|Protocol Violation|0|||
48764372|NCT03616912|156988134|FG000|Overall Study|Physician Decision|2|||
48764373|NCT03616912|156988135|FG001|Overall Study|Physician Decision|0|||
48764374|NCT03616912|156988136|FG002|Overall Study|Physician Decision|0|||
48764375|NCT03616912|156988137|FG003|Overall Study|Physician Decision|0|||
48764376|NCT03616912|156988138|FG004|Overall Study|Physician Decision|1|||
48764377|NCT03616912|156988139|FG005|Overall Study|Physician Decision|0|||
48764378|NCT03616912|156988134|FG000|Overall Study|Randomized But Never Treated|0|||
48764379|NCT03616912|156988135|FG001|Overall Study|Randomized But Never Treated|2|||
48764380|NCT03616912|156988136|FG002|Overall Study|Randomized But Never Treated|0|||
48764381|NCT03616912|156988137|FG003|Overall Study|Randomized But Never Treated|0|||
48764382|NCT03616912|156988138|FG004|Overall Study|Randomized But Never Treated|0|||
48764383|NCT03616912|156988139|FG005|Overall Study|Randomized But Never Treated|0|||
48764384|NCT02780804|156988140|FG000|Overall Study|Death|1|||
48764385|NCT02780804|156988141|FG001|Overall Study|Death|0|||
48764386|NCT02780804|156988142|FG002|Overall Study|Death|0|||
48764387|NCT02780804|156988140|FG000|Overall Study|Lack of Efficacy|5|||
48764388|NCT02780804|156988141|FG001|Overall Study|Lack of Efficacy|8|||
48764389|NCT02780804|156988142|FG002|Overall Study|Lack of Efficacy|4|||
48764390|NCT02780804|156988140|FG000|Overall Study|Physician Decision|0|||
48764391|NCT02780804|156988141|FG001|Overall Study|Physician Decision|0|||
48764392|NCT02780804|156988142|FG002|Overall Study|Physician Decision|2|||
48764393|NCT02780804|156988140|FG000|Overall Study|Withdrawal by Subject|0|||
48764394|NCT02780804|156988141|FG001|Overall Study|Withdrawal by Subject|1|||
48764395|NCT02780804|156988142|FG002|Overall Study|Withdrawal by Subject|0|||
48764396|NCT01124604|156988143|FG000|Overall Study|Adverse Event|10|||
48764397|NCT01124604|156988144|FG001|Overall Study|Adverse Event|1|||
48764398|NCT01124604|156988143|FG000|Overall Study|Lack of Efficacy|1|||
48764399|NCT01124604|156988144|FG001|Overall Study|Lack of Efficacy|0|||
48764400|NCT01124604|156988143|FG000|Overall Study|Withdrawal by Subject|4|||
48764401|NCT01124604|156988144|FG001|Overall Study|Withdrawal by Subject|0|||
48764402|NCT01124604|156988143|FG000|Overall Study|Disease Progression|0|||
48764403|NCT01124604|156988144|FG001|Overall Study|Disease Progression|1|||
48764404|NCT02584504|156988145|FG000|Double-blind Treatment|Participant withdrew consent|0|||
48764405|NCT02584504|156988146|FG001|Double-blind Treatment|Participant withdrew consent|0|||
48764406|NCT02584504|156988147|FG002|Double-blind Treatment|Participant withdrew consent|1|||
48764407|NCT02584504|156988145|FG000|Double-blind Treatment|Adverse Event|0|||
48764408|NCT02584504|156988146|FG001|Double-blind Treatment|Adverse Event|1|||
48764409|NCT02584504|156988147|FG002|Double-blind Treatment|Adverse Event|0|||
48764410|NCT02584504|156988145|FG000|Double-blind Treatment|Family Matter|0|||
48764411|NCT02584504|156988146|FG001|Double-blind Treatment|Family Matter|1|||
48764412|NCT02584504|156988147|FG002|Double-blind Treatment|Family Matter|0|||
48764413|NCT02584504|156988145|FG000|Open-label Treatment|Participant withdrew consent|0|||
48764414|NCT02584504|156988146|FG001|Open-label Treatment|Participant withdrew consent|0|||
48764415|NCT02584504|156988147|FG002|Open-label Treatment|Participant withdrew consent|4|||
48764416|NCT02584504|156988145|FG000|Open-label Treatment|Adverse Event|2|||
48764417|NCT02584504|156988146|FG001|Open-label Treatment|Adverse Event|2|||
48764418|NCT02584504|156988147|FG002|Open-label Treatment|Adverse Event|3|||
48764419|NCT02584504|156988145|FG000|Open-label Treatment|Physician Decision|0|||
48764420|NCT02584504|156988146|FG001|Open-label Treatment|Physician Decision|1|||
48764421|NCT02584504|156988147|FG002|Open-label Treatment|Physician Decision|0|||
48764422|NCT02584504|156988145|FG000|Open-label Treatment|Entered but not treated|0|||
48355578|NCT01296555|155498558|FG026|Overall Study|Protocol Violation|0|||
48764423|NCT02584504|156988146|FG001|Open-label Treatment|Entered but not treated|1|||
48764424|NCT02584504|156988147|FG002|Open-label Treatment|Entered but not treated|1|||
48764425|NCT00539838|156988151|FG000|Overall Study|Fail to return|2|||
48764426|NCT00539838|156988152|FG001|Overall Study|Fail to return|0|||
48764427|NCT00539838|156988153|FG002|Overall Study|Fail to return|0|||
48764428|NCT00539838|156988151|FG000|Overall Study|Withdrawal by Subject|0|||
48764429|NCT00539838|156988152|FG001|Overall Study|Withdrawal by Subject|4|||
48764430|NCT00539838|156988153|FG002|Overall Study|Withdrawal by Subject|0|||
48764431|NCT00539838|156988151|FG000|Overall Study|Death|0|||
48764432|NCT00539838|156988152|FG001|Overall Study|Death|2|||
48764433|NCT00539838|156988153|FG002|Overall Study|Death|0|||
48764434|NCT00539838|156988151|FG000|Overall Study|Did not cooperate|1|||
48764435|NCT00539838|156988152|FG001|Overall Study|Did not cooperate|0|||
48764436|NCT00539838|156988153|FG002|Overall Study|Did not cooperate|1|||
48764437|NCT00539838|156988151|FG000|Overall Study|Administrative|4|||
48764438|NCT00539838|156988152|FG001|Overall Study|Administrative|0|||
48764439|NCT00539838|156988153|FG002|Overall Study|Administrative|8|||
48764440|NCT03090100|156988156|FG000|Overall Study|Adverse Event|9|||
48764441|NCT03090100|156988157|FG001|Overall Study|Adverse Event|11|||
48764442|NCT03090100|156988156|FG000|Overall Study|Pregnancy|1|||
48764443|NCT03090100|156988157|FG001|Overall Study|Pregnancy|1|||
48764444|NCT03090100|156988156|FG000|Overall Study|Lack of Efficacy|2|||
48764445|NCT03090100|156988157|FG001|Overall Study|Lack of Efficacy|7|||
48764446|NCT03090100|156988156|FG000|Overall Study|Lost to Follow-up|2|||
48764447|NCT03090100|156988157|FG001|Overall Study|Lost to Follow-up|2|||
48764448|NCT03090100|156988156|FG000|Overall Study|Withdrawal by Subject|7|||
48764449|NCT03090100|156988157|FG001|Overall Study|Withdrawal by Subject|19|||
48764450|NCT03090100|156988156|FG000|Overall Study|Protocol Violation|2|||
48764451|NCT03090100|156988157|FG001|Overall Study|Protocol Violation|6|||
48764452|NCT03090100|156988156|FG000|Overall Study|Non-compliance|2|||
48764453|NCT03090100|156988157|FG001|Overall Study|Non-compliance|0|||
48764454|NCT03090100|156988156|FG000|Overall Study|Other|2|||
48764455|NCT03090100|156988157|FG001|Overall Study|Other|2|||
48764456|NCT02506816|156988158|FG000|Overall Study|Adverse Event|3|||
48764457|NCT01316276|156988159|FG000|Overall Study|Death|1|||
48764458|NCT01316276|156988159|FG000|Overall Study|Adverse Event|19|||
48764459|NCT01316276|156988159|FG000|Overall Study|Withdrawal of consent|24|||
48764460|NCT01316276|156988159|FG000|Overall Study|Lost to Follow-up|1|||
48764461|NCT01316276|156988159|FG000|Overall Study|Other|22|||
48764462|NCT01652664|156988160|FG000|Overall Study|Treatment Failure|5|||
48764463|NCT01652664|156988161|FG001|Overall Study|Treatment Failure|1|||
48764464|NCT01652664|156988160|FG000|Overall Study|Inadequate IOP control|1|||
48764465|NCT01652664|156988161|FG001|Overall Study|Inadequate IOP control|0|||
48764466|NCT00581776|156988162|FG000|Overall Study|Disease progression or no response|3|||
48764467|NCT02120950|156988167|FG000|Overall Study|Adverse Event|5|||
48764468|NCT02120950|156988168|FG001|Overall Study|Adverse Event|4|||
48764469|NCT02120950|156988169|FG002|Overall Study|Adverse Event|3|||
48764470|NCT02120950|156988167|FG000|Overall Study|Death|3|||
48764471|NCT02120950|156988168|FG001|Overall Study|Death|0|||
48764472|NCT02120950|156988169|FG002|Overall Study|Death|1|||
48764473|NCT02120950|156988167|FG000|Overall Study|Withdrawal by Subject|6|||
48764474|NCT02120950|156988168|FG001|Overall Study|Withdrawal by Subject|3|||
48764475|NCT02120950|156988169|FG002|Overall Study|Withdrawal by Subject|2|||
48764476|NCT02120950|156988167|FG000|Overall Study|Protocol Violation|1|||
48764477|NCT02120950|156988168|FG001|Overall Study|Protocol Violation|1|||
48764478|NCT02120950|156988169|FG002|Overall Study|Protocol Violation|7|||
48764479|NCT02120950|156988167|FG000|Overall Study|Other reasons|5|||
48764480|NCT02120950|156988168|FG001|Overall Study|Other reasons|4|||
48764481|NCT02120950|156988169|FG002|Overall Study|Other reasons|1|||
48764482|NCT02120950|156988167|FG000|Overall Study|Lost to Follow-up|0|||
48764483|NCT02120950|156988168|FG001|Overall Study|Lost to Follow-up|2|||
48764484|NCT02120950|156988169|FG002|Overall Study|Lost to Follow-up|1|||
48764485|NCT03329690|156988170|FG000|Overall Study|Progressive disease per RECIST|85|||
48764486|NCT03329690|156988171|FG001|Overall Study|Progressive disease per RECIST|44|||
48764487|NCT03329690|156988172|FG002|Overall Study|Progressive disease per RECIST|6|||
48764488|NCT03329690|156988173|FG003|Overall Study|Progressive disease per RECIST|16|||
48764489|NCT03329690|156988174|FG004|Overall Study|Progressive disease per RECIST|20|||
48764490|NCT03329690|156988170|FG000|Overall Study|Clinical progression|7|||
48764491|NCT03329690|156988171|FG001|Overall Study|Clinical progression|4|||
48764492|NCT03329690|156988172|FG002|Overall Study|Clinical progression|1|||
48764493|NCT03329690|156988173|FG003|Overall Study|Clinical progression|1|||
48764494|NCT03329690|156988174|FG004|Overall Study|Clinical progression|1|||
48764495|NCT03329690|156988170|FG000|Overall Study|Adverse Event|22|||
48764496|NCT03329690|156988171|FG001|Overall Study|Adverse Event|4|||
48764497|NCT03329690|156988172|FG002|Overall Study|Adverse Event|0|||
48764498|NCT03329690|156988173|FG003|Overall Study|Adverse Event|1|||
48764499|NCT03329690|156988174|FG004|Overall Study|Adverse Event|2|||
48764500|NCT03329690|156988170|FG000|Overall Study|Death|2|||
48764501|NCT03329690|156988171|FG001|Overall Study|Death|0|||
48764502|NCT03329690|156988172|FG002|Overall Study|Death|0|||
48764503|NCT03329690|156988173|FG003|Overall Study|Death|1|||
48764504|NCT03329690|156988174|FG004|Overall Study|Death|0|||
48764505|NCT03329690|156988170|FG000|Overall Study|Withdrawal by Subject|2|||
48764506|NCT03329690|156988171|FG001|Overall Study|Withdrawal by Subject|3|||
48764507|NCT03329690|156988172|FG002|Overall Study|Withdrawal by Subject|0|||
48764508|NCT03329690|156988173|FG003|Overall Study|Withdrawal by Subject|1|||
48764509|NCT03329690|156988174|FG004|Overall Study|Withdrawal by Subject|0|||
48764510|NCT03329690|156988170|FG000|Overall Study|Physician Decision|1|||
48764511|NCT03329690|156988171|FG001|Overall Study|Physician Decision|0|||
48764512|NCT03329690|156988172|FG002|Overall Study|Physician Decision|0|||
48764513|NCT03329690|156988173|FG003|Overall Study|Physician Decision|0|||
48764514|NCT03329690|156988174|FG004|Overall Study|Physician Decision|1|||
48764515|NCT03329690|156988170|FG000|Overall Study|Miscellaneous|6|||
48764516|NCT03329690|156988171|FG001|Overall Study|Miscellaneous|0|||
48764517|NCT03329690|156988172|FG002|Overall Study|Miscellaneous|0|||
48764518|NCT03329690|156988173|FG003|Overall Study|Miscellaneous|0|||
48764519|NCT03329690|156988174|FG004|Overall Study|Miscellaneous|0|||
48764520|NCT03329690|156988170|FG000|Overall Study|Did not receive treatment|1|||
48764521|NCT03329690|156988171|FG001|Overall Study|Did not receive treatment|0|||
48764522|NCT03329690|156988172|FG002|Overall Study|Did not receive treatment|0|||
48764523|NCT03329690|156988173|FG003|Overall Study|Did not receive treatment|1|||
48764524|NCT03329690|156988174|FG004|Overall Study|Did not receive treatment|0|||
48764525|NCT02018458|156988175|FG000|Overall Study|Death|4|||
48764526|NCT01752855|156988176|FG000|Overall Study|Adverse Event|1|||
48393571|NCT00708500|155635984|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
48393572|NCT00708500|155635982|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
48393573|NCT00708500|155635983|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
48393574|NCT00708500|155635984|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
48393575|NCT00708500|155635982|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
48393576|NCT00708500|155635983|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
48393577|NCT00708500|155635984|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
48393578|NCT00708500|155635982|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
48764527|NCT01752855|156988177|FG001|Overall Study|Adverse Event|0|||
48764528|NCT01752855|156988176|FG000|Overall Study|Withdrew Consent|0|||
48764529|NCT01752855|156988177|FG001|Overall Study|Withdrew Consent|2|||
48764530|NCT01752855|156988176|FG000|Overall Study|Lack of Efficacy|0|||
48764531|NCT01752855|156988177|FG001|Overall Study|Lack of Efficacy|2|||
48764532|NCT04649164|156988181|FG000|Overall Study|Withdrawal by Subject|1|||
48764533|NCT04649164|156988182|FG001|Overall Study|Withdrawal by Subject|1|||
48764534|NCT04649164|156988183|FG002|Overall Study|Withdrawal by Subject|2|||
48764535|NCT04649164|156988181|FG000|Overall Study|Participant's care recipient expired|0|||
48764536|NCT04649164|156988182|FG001|Overall Study|Participant's care recipient expired|0|||
48764537|NCT04649164|156988183|FG002|Overall Study|Participant's care recipient expired|2|||
48764538|NCT02053753|156988184|FG000|Overall Study|Withdrawal by Subject|2|||
48764539|NCT02053753|156988185|FG001|Overall Study|Withdrawal by Subject|4|||
48764540|NCT02053753|156988184|FG000|Overall Study|Decision by Sponsor|1|||
48764541|NCT02053753|156988185|FG001|Overall Study|Decision by Sponsor|1|||
48764542|NCT02053753|156988184|FG000|Overall Study|Lost to Follow-up|4|||
48764543|NCT02053753|156988185|FG001|Overall Study|Lost to Follow-up|3|||
48764544|NCT02439320|156988186|FG000|Overall Study|Adverse Event|0|||
48764545|NCT02439320|156988187|FG001|Overall Study|Adverse Event|2|||
48764546|NCT02439320|156988188|FG002|Overall Study|Adverse Event|0|||
48764547|NCT02439320|156988186|FG000|Overall Study|Lost to Follow-up|37|||
48764548|NCT02439320|156988187|FG001|Overall Study|Lost to Follow-up|34|||
48764549|NCT02439320|156988188|FG002|Overall Study|Lost to Follow-up|42|||
48764550|NCT02439320|156988186|FG000|Overall Study|Death|0|||
48764551|NCT02439320|156988187|FG001|Overall Study|Death|1|||
48764552|NCT02439320|156988188|FG002|Overall Study|Death|0|||
48764553|NCT02439320|156988186|FG000|Overall Study|Noncompliance with Protocol|10|||
48764554|NCT02439320|156988187|FG001|Overall Study|Noncompliance with Protocol|11|||
48764555|NCT02439320|156988188|FG002|Overall Study|Noncompliance with Protocol|7|||
48764556|NCT02439320|156988186|FG000|Overall Study|Pregnancy|0|||
48764557|NCT02439320|156988187|FG001|Overall Study|Pregnancy|1|||
48764558|NCT02439320|156988188|FG002|Overall Study|Pregnancy|1|||
48764559|NCT02439320|156988186|FG000|Overall Study|Withdrawal by Subject|12|||
48764560|NCT02439320|156988187|FG001|Overall Study|Withdrawal by Subject|16|||
48764561|NCT02439320|156988188|FG002|Overall Study|Withdrawal by Subject|14|||
48764562|NCT02439320|156988186|FG000|Overall Study|Physician Decision|2|||
48764563|NCT02439320|156988187|FG001|Overall Study|Physician Decision|1|||
48393579|NCT00708500|155635983|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
48393580|NCT00708500|155635984|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
48764564|NCT02439320|156988188|FG002|Overall Study|Physician Decision|0|||
48764565|NCT02439320|156988186|FG000|Overall Study|Sponsor Request|0|||
48764566|NCT02439320|156988187|FG001|Overall Study|Sponsor Request|2|||
48764567|NCT02439320|156988188|FG002|Overall Study|Sponsor Request|1|||
48764568|NCT02439320|156988186|FG000|Overall Study|Randomization Failure|35|||
48764569|NCT02439320|156988187|FG001|Overall Study|Randomization Failure|46|||
48764570|NCT02439320|156988188|FG002|Overall Study|Randomization Failure|34|||
48393581|NCT00708500|155635982|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
48764571|NCT00116558|156988189|FG000|Overall Study|Death|11|||
48764572|NCT00116558|156988190|FG001|Overall Study|Death|5|||
48764573|NCT00116558|156988191|FG002|Overall Study|Death|3|||
48764574|NCT00116558|156988189|FG000|Overall Study|Withdrawal by Subject|17|||
48764575|NCT00116558|156988190|FG001|Overall Study|Withdrawal by Subject|3|||
48764576|NCT00116558|156988191|FG002|Overall Study|Withdrawal by Subject|12|||
48764577|NCT00116558|156988189|FG000|Overall Study|disease progression|3|||
48764578|NCT00116558|156988190|FG001|Overall Study|disease progression|7|||
48764579|NCT00116558|156988191|FG002|Overall Study|disease progression|18|||
48764580|NCT02972632|156988192|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
48764581|NCT02972632|156988192|FG000|Overall Study|Lost to Follow-up|4|||
48764582|NCT02972632|156988192|FG000|Overall Study|Voluntary Withdrawal|10|||
48764583|NCT03450707|156988193|FG000|Overall Study|Outside enrollment window|4|||
48764584|NCT03450707|156988194|FG001|Overall Study|Outside enrollment window|1|||
48764585|NCT03450707|156988193|FG000|Overall Study|Death|1|||
48764586|NCT03450707|156988194|FG001|Overall Study|Death|0|||
48764587|NCT03450707|156988193|FG000|Overall Study|Indication for thiamine|1|||
48764588|NCT03450707|156988194|FG001|Overall Study|Indication for thiamine|1|||
48764589|NCT03450707|156988193|FG000|Overall Study|Evidence of traumatic brain injury|1|||
48764590|NCT03450707|156988194|FG001|Overall Study|Evidence of traumatic brain injury|0|||
48764591|NCT03450707|156988193|FG000|Overall Study|Following commands|0|||
48764592|NCT03450707|156988194|FG001|Overall Study|Following commands|3|||
48764593|NCT03450707|156988193|FG000|Overall Study|Lactate < 3.5|0|||
48764594|NCT03450707|156988194|FG001|Overall Study|Lactate < 3.5|2|||
48764595|NCT03450707|156988193|FG000|Overall Study|Rearrest with ECMO|0|||
48764596|NCT03450707|156988194|FG001|Overall Study|Rearrest with ECMO|1|||
48764597|NCT03450707|156988193|FG000|Overall Study|Indication for thiamine + head CT results|0|||
48764598|NCT03450707|156988194|FG001|Overall Study|Indication for thiamine + head CT results|1|||
48764599|NCT03450707|156988193|FG000|Overall Study|Family/patient goals of care|0|||
48764600|NCT03450707|156988194|FG001|Overall Study|Family/patient goals of care|1|||
48764601|NCT03343483|156988195|FG000|Overall Study|Death|0|||
48764602|NCT03343483|156988196|FG001|Overall Study|Death|3|||
48764603|NCT03343483|156988195|FG000|Overall Study|Lost to Follow-up|9|||
48764604|NCT03343483|156988196|FG001|Overall Study|Lost to Follow-up|13|||
48764605|NCT03343483|156988195|FG000|Overall Study|Withdrawal by Subject|8|||
48764606|NCT03343483|156988196|FG001|Overall Study|Withdrawal by Subject|17|||
48764607|NCT01452412|156988202|FG000|Overall Study|Withdrawal by Subject|15|||
48764608|NCT01452412|156988203|FG001|Overall Study|Withdrawal by Subject|11|||
48764609|NCT01452412|156988202|FG000|Overall Study|Adverse Event|4|||
48764610|NCT01452412|156988203|FG001|Overall Study|Adverse Event|3|||
48764611|NCT01452412|156988202|FG000|Overall Study|Lost to Follow-up|5|||
48764612|NCT01452412|156988203|FG001|Overall Study|Lost to Follow-up|3|||
48764613|NCT01452412|156988202|FG000|Overall Study|Death|1|||
48764614|NCT01452412|156988203|FG001|Overall Study|Death|0|||
48764615|NCT01452412|156988202|FG000|Overall Study|Initiated dialysis|1|||
48764616|NCT01452412|156988203|FG001|Overall Study|Initiated dialysis|0|||
48764617|NCT01452412|156988202|FG000|Overall Study|Other|2|||
48764618|NCT01452412|156988203|FG001|Overall Study|Other|0|||
48764619|NCT00453999|156988204|FG000|Overall Study|Adverse Event|1|||
48764620|NCT00453999|156988205|FG001|Overall Study|Adverse Event|2|||
48764621|NCT00453999|156988206|FG002|Overall Study|Adverse Event|1|||
48764622|NCT00453999|156988204|FG000|Overall Study|Lost to Follow-up|0|||
48764623|NCT00453999|156988205|FG001|Overall Study|Lost to Follow-up|1|||
48764624|NCT00453999|156988206|FG002|Overall Study|Lost to Follow-up|1|||
48764625|NCT00453999|156988204|FG000|Overall Study|Withdrawal by Subject|2|||
48764626|NCT00453999|156988205|FG001|Overall Study|Withdrawal by Subject|1|||
48764627|NCT00453999|156988206|FG002|Overall Study|Withdrawal by Subject|1|||
48764628|NCT00453999|156988204|FG000|Overall Study|Subject Request|2|||
48764629|NCT00453999|156988205|FG001|Overall Study|Subject Request|1|||
48764630|NCT00453999|156988206|FG002|Overall Study|Subject Request|0|||
48764631|NCT00579826|156988208|FG000|Overall Study|Withdrawal by Subject|5|||
48764632|NCT00579826|156988209|FG001|Overall Study|Withdrawal by Subject|3|||
48692276|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692277|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692278|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692279|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692280|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692281|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692282|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692283|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692284|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
48692285|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48764633|NCT02659020|156988212|FG000|Overall Study|Adverse Event|0|||
48764634|NCT02659020|156988213|FG001|Overall Study|Adverse Event|0|||
48764635|NCT02659020|156988214|FG002|Overall Study|Adverse Event|0|||
48764636|NCT02659020|156988215|FG003|Overall Study|Adverse Event|2|||
48764637|NCT02659020|156988216|FG004|Overall Study|Adverse Event|0|||
48764638|NCT02659020|156988217|FG005|Overall Study|Adverse Event|0|||
48764639|NCT02659020|156988218|FG006|Overall Study|Adverse Event|2|||
48764640|NCT02659020|156988212|FG000|Overall Study|Lost to Follow-up|1|||
48764641|NCT02659020|156988213|FG001|Overall Study|Lost to Follow-up|2|||
48764642|NCT02659020|156988214|FG002|Overall Study|Lost to Follow-up|1|||
48764643|NCT02659020|156988215|FG003|Overall Study|Lost to Follow-up|6|||
48764644|NCT02659020|156988216|FG004|Overall Study|Lost to Follow-up|1|||
48764645|NCT02659020|156988217|FG005|Overall Study|Lost to Follow-up|5|||
48764646|NCT02659020|156988218|FG006|Overall Study|Lost to Follow-up|0|||
48764647|NCT02659020|156988212|FG000|Overall Study|Physician Decision|0|||
48764648|NCT02659020|156988213|FG001|Overall Study|Physician Decision|0|||
48764649|NCT02659020|156988214|FG002|Overall Study|Physician Decision|0|||
48764650|NCT02659020|156988215|FG003|Overall Study|Physician Decision|1|||
48764651|NCT02659020|156988216|FG004|Overall Study|Physician Decision|1|||
48764652|NCT02659020|156988217|FG005|Overall Study|Physician Decision|0|||
48764653|NCT02659020|156988218|FG006|Overall Study|Physician Decision|1|||
48764654|NCT02659020|156988212|FG000|Overall Study|Withdrawal by Subject|2|||
48764655|NCT02659020|156988213|FG001|Overall Study|Withdrawal by Subject|1|||
48764656|NCT02659020|156988214|FG002|Overall Study|Withdrawal by Subject|0|||
48764657|NCT02659020|156988215|FG003|Overall Study|Withdrawal by Subject|3|||
48764658|NCT02659020|156988216|FG004|Overall Study|Withdrawal by Subject|3|||
48764659|NCT02659020|156988217|FG005|Overall Study|Withdrawal by Subject|6|||
48764660|NCT02659020|156988218|FG006|Overall Study|Withdrawal by Subject|3|||
48764661|NCT02659020|156988212|FG000|Overall Study|Progressive Disease|0|||
48764662|NCT02659020|156988213|FG001|Overall Study|Progressive Disease|0|||
48764663|NCT02659020|156988214|FG002|Overall Study|Progressive Disease|0|||
48764664|NCT02659020|156988215|FG003|Overall Study|Progressive Disease|4|||
48764665|NCT02659020|156988216|FG004|Overall Study|Progressive Disease|1|||
48764666|NCT02659020|156988217|FG005|Overall Study|Progressive Disease|0|||
48764667|NCT02659020|156988218|FG006|Overall Study|Progressive Disease|2|||
48764668|NCT02404350|156988219|FG000|Overall Study|Adverse Event|2|||
48764669|NCT02404350|156988220|FG001|Overall Study|Adverse Event|2|||
48764670|NCT02404350|156988221|FG002|Overall Study|Adverse Event|3|||
48764671|NCT02404350|156988222|FG003|Overall Study|Adverse Event|9|||
48764672|NCT02404350|156988219|FG000|Overall Study|Lack of Efficacy|3|||
48393582|NCT00708500|155635983|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
48426301|NCT00064662|155749535|FG000|Overall Study|Withdrawal by Subject|14|||
48764673|NCT02404350|156988220|FG001|Overall Study|Lack of Efficacy|1|||
48764674|NCT02404350|156988221|FG002|Overall Study|Lack of Efficacy|0|||
48764675|NCT02404350|156988222|FG003|Overall Study|Lack of Efficacy|3|||
48764676|NCT02404350|156988219|FG000|Overall Study|Lost to Follow-up|2|||
48764677|NCT02404350|156988220|FG001|Overall Study|Lost to Follow-up|0|||
48764678|NCT02404350|156988221|FG002|Overall Study|Lost to Follow-up|0|||
48764679|NCT02404350|156988222|FG003|Overall Study|Lost to Follow-up|1|||
48764680|NCT02404350|156988219|FG000|Overall Study|Physician Decision|1|||
48764681|NCT02404350|156988220|FG001|Overall Study|Physician Decision|0|||
48764682|NCT02404350|156988221|FG002|Overall Study|Physician Decision|0|||
48764683|NCT02404350|156988222|FG003|Overall Study|Physician Decision|2|||
48764684|NCT02404350|156988219|FG000|Overall Study|Pregnancy|0|||
48764685|NCT02404350|156988220|FG001|Overall Study|Pregnancy|0|||
48764686|NCT02404350|156988221|FG002|Overall Study|Pregnancy|0|||
48764687|NCT02404350|156988222|FG003|Overall Study|Pregnancy|1|||
48764688|NCT02404350|156988219|FG000|Overall Study|Withdrawal by Subject|7|||
48764689|NCT02404350|156988220|FG001|Overall Study|Withdrawal by Subject|3|||
48764690|NCT02404350|156988221|FG002|Overall Study|Withdrawal by Subject|3|||
48764691|NCT02404350|156988222|FG003|Overall Study|Withdrawal by Subject|19|||
48764692|NCT02404350|156988219|FG000|Overall Study|Due to Non-compliance with treatment|0|||
48764693|NCT02404350|156988220|FG001|Overall Study|Due to Non-compliance with treatment|0|||
48764694|NCT02404350|156988221|FG002|Overall Study|Due to Non-compliance with treatment|0|||
48764695|NCT02404350|156988222|FG003|Overall Study|Due to Non-compliance with treatment|1|||
48764696|NCT02404350|156988219|FG000|Overall Study|Due to Technical problems|0|||
48764697|NCT02404350|156988220|FG001|Overall Study|Due to Technical problems|0|||
48764698|NCT02404350|156988221|FG002|Overall Study|Due to Technical problems|0|||
48764699|NCT02404350|156988222|FG003|Overall Study|Due to Technical problems|1|||
48764700|NCT01417481|156988225|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
48764701|NCT01417481|156988226|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
48764702|NCT01364428|156988227|FG000|Overall Study|Adverse Event|1|||
48764703|NCT01364428|156988228|FG001|Overall Study|Adverse Event|2|||
48764704|NCT01364428|156988227|FG000|Overall Study|Protocol Violation|2|||
48764705|NCT01364428|156988228|FG001|Overall Study|Protocol Violation|0|||
48764706|NCT01364428|156988227|FG000|Overall Study|Withdrawal Criteria|14|||
48764707|NCT01364428|156988228|FG001|Overall Study|Withdrawal Criteria|10|||
48764708|NCT01364428|156988227|FG000|Overall Study|Other|3|||
48764709|NCT01364428|156988228|FG001|Overall Study|Other|3|||
48764710|NCT00600756|156988229|FG000|Analysis After 6 Months|Adverse Event|43|||
48764711|NCT00600756|156988230|FG001|Analysis After 6 Months|Adverse Event|33|||
48764712|NCT00600756|156988229|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
48764713|NCT00600756|156988230|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
48764714|NCT00600756|156988229|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
48764715|NCT00600756|156988230|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
48764716|NCT00600756|156988229|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
48764717|NCT00600756|156988230|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
48764718|NCT00600756|156988229|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
48764719|NCT00600756|156988230|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
48764720|NCT00600756|156988229|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
48764721|NCT00600756|156988230|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
48764722|NCT00600756|156988229|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
48764723|NCT00600756|156988230|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
48764724|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
48764725|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
48764726|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
48764727|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
48764728|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
48764729|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
48764730|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
48764731|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
48764732|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
48764733|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
48764734|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
48764735|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
48764736|NCT00600756|156988229|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
48764737|NCT00600756|156988230|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
48764738|NCT02063737|156988232|FG000|Overall Study|Lost to Follow-up|11|||
48764739|NCT02063737|156988233|FG001|Overall Study|Lost to Follow-up|4|||
48764740|NCT01526889|156988234|FG000|Treatment Period|Adverse Event|2|||
48692286|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48764741|NCT01526889|156988235|FG001|Treatment Period|Adverse Event|0|||
48764742|NCT01526889|156988234|FG000|Treatment Extension Period|Administrative problems|1|||
48692287|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692288|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
48692289|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692290|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692291|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692292|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692293|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692294|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692295|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692296|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692297|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692298|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692299|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692300|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692301|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
48692302|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
48692303|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692304|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692305|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692306|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692307|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692308|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692309|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692310|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692311|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692312|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692313|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
48692314|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
48692315|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
48692316|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
48692317|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692318|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692319|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692320|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692321|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692322|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692323|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692324|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692325|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692326|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692327|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692328|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48692329|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
48764743|NCT01526889|156988235|FG001|Treatment Extension Period|Administrative problems|0|||
48764744|NCT00694369|156988236|FG000|Overall Study|Adverse Event|0|||
48764745|NCT00694369|156988237|FG001|Overall Study|Adverse Event|1|||
48764746|NCT00694369|156988238|FG002|Overall Study|Adverse Event|0|||
48764747|NCT00694369|156988239|FG003|Overall Study|Adverse Event|1|||
48764748|NCT00694369|156988240|FG004|Overall Study|Adverse Event|3|||
48764749|NCT00694369|156988236|FG000|Overall Study|Lost to Follow-up|0|||
48764750|NCT00694369|156988237|FG001|Overall Study|Lost to Follow-up|0|||
48764751|NCT00694369|156988238|FG002|Overall Study|Lost to Follow-up|1|||
48764752|NCT00694369|156988239|FG003|Overall Study|Lost to Follow-up|1|||
48764753|NCT00694369|156988240|FG004|Overall Study|Lost to Follow-up|0|||
48764754|NCT00694369|156988236|FG000|Overall Study|Physician Decision|0|||
48764755|NCT00694369|156988237|FG001|Overall Study|Physician Decision|0|||
48764756|NCT00694369|156988238|FG002|Overall Study|Physician Decision|0|||
48764757|NCT00694369|156988239|FG003|Overall Study|Physician Decision|0|||
48764758|NCT00694369|156988240|FG004|Overall Study|Physician Decision|1|||
48764759|NCT00694369|156988236|FG000|Overall Study|Protocol Violation|0|||
48764760|NCT00694369|156988237|FG001|Overall Study|Protocol Violation|1|||
48764761|NCT00694369|156988238|FG002|Overall Study|Protocol Violation|0|||
48764762|NCT00694369|156988239|FG003|Overall Study|Protocol Violation|0|||
48764763|NCT00694369|156988240|FG004|Overall Study|Protocol Violation|0|||
48764764|NCT00694369|156988236|FG000|Overall Study|Withdrawal by Subject|1|||
48764765|NCT00694369|156988237|FG001|Overall Study|Withdrawal by Subject|1|||
48764766|NCT00694369|156988238|FG002|Overall Study|Withdrawal by Subject|1|||
48764767|NCT00694369|156988239|FG003|Overall Study|Withdrawal by Subject|1|||
48764768|NCT00694369|156988240|FG004|Overall Study|Withdrawal by Subject|2|||
48764769|NCT02871739|156988245|FG000|Overall Study|Lost to Follow-up|3|||
48764770|NCT02871739|156988246|FG001|Overall Study|Lost to Follow-up|2|||
48764771|NCT02871739|156988247|FG002|Overall Study|Lost to Follow-up|0|||
48764772|NCT02871739|156988248|FG003|Overall Study|Lost to Follow-up|2|||
48764773|NCT03131440|156988249|FG000|Overall Study|Withdrawal by Subject|1|||
48764774|NCT03131440|156988250|FG001|Overall Study|Withdrawal by Subject|3|||
48764775|NCT03131440|156988251|FG002|Overall Study|Withdrawal by Subject|0|||
48764776|NCT03131440|156988252|FG003|Overall Study|Withdrawal by Subject|0|||
48764777|NCT03131440|156988253|FG004|Overall Study|Withdrawal by Subject|1|||
48764778|NCT03131440|156988254|FG005|Overall Study|Withdrawal by Subject|0|||
48764779|NCT03131440|156988255|FG006|Overall Study|Withdrawal by Subject|0|||
48764780|NCT03131440|156988256|FG007|Overall Study|Withdrawal by Subject|1|||
48764781|NCT03131440|156988257|FG008|Overall Study|Withdrawal by Subject|1|||
48764782|NCT03131440|156988258|FG009|Overall Study|Withdrawal by Subject|1|||
48764783|NCT03131440|156988259|FG010|Overall Study|Withdrawal by Subject|0|||
48764784|NCT03131440|156988260|FG011|Overall Study|Withdrawal by Subject|1|||
48764785|NCT03131440|156988261|FG012|Overall Study|Withdrawal by Subject|1|||
48764786|NCT03131440|156988262|FG013|Overall Study|Withdrawal by Subject|0|||
48764787|NCT03131440|156988263|FG014|Overall Study|Withdrawal by Subject|1|||
48764788|NCT03131440|156988264|FG015|Overall Study|Withdrawal by Subject|0|||
48764789|NCT03131440|156988265|FG016|Overall Study|Withdrawal by Subject|0|||
48764790|NCT03131440|156988266|FG017|Overall Study|Withdrawal by Subject|0|||
48764791|NCT03131440|156988267|FG018|Overall Study|Withdrawal by Subject|1|||
48764792|NCT03131440|156988268|FG019|Overall Study|Withdrawal by Subject|0|||
48764793|NCT03131440|156988269|FG020|Overall Study|Withdrawal by Subject|1|||
48764794|NCT03131440|156988270|FG021|Overall Study|Withdrawal by Subject|1|||
48764795|NCT03131440|156988271|FG022|Overall Study|Withdrawal by Subject|1|||
48764796|NCT03131440|156988272|FG023|Overall Study|Withdrawal by Subject|0|||
48764797|NCT03131440|156988273|FG024|Overall Study|Withdrawal by Subject|0|||
48764798|NCT03131440|156988274|FG025|Overall Study|Withdrawal by Subject|0|||
48764799|NCT03131440|156988275|FG026|Overall Study|Withdrawal by Subject|0|||
48764800|NCT03131440|156988276|FG027|Overall Study|Withdrawal by Subject|0|||
48764801|NCT03131440|156988277|FG028|Overall Study|Withdrawal by Subject|0|||
48764802|NCT03131440|156988278|FG029|Overall Study|Withdrawal by Subject|0|||
48764803|NCT03131440|156988279|FG030|Overall Study|Withdrawal by Subject|1|||
48426302|NCT00064662|155749536|FG001|Overall Study|Withdrawal by Subject|14|||
48764804|NCT03131440|156988280|FG031|Overall Study|Withdrawal by Subject|0|||
48764805|NCT03131440|156988249|FG000|Overall Study|Lost to Follow-up|0|||
48764806|NCT03131440|156988250|FG001|Overall Study|Lost to Follow-up|0|||
48764807|NCT03131440|156988251|FG002|Overall Study|Lost to Follow-up|0|||
48764808|NCT03131440|156988252|FG003|Overall Study|Lost to Follow-up|0|||
48764809|NCT03131440|156988253|FG004|Overall Study|Lost to Follow-up|0|||
48764810|NCT03131440|156988254|FG005|Overall Study|Lost to Follow-up|1|||
48764811|NCT03131440|156988255|FG006|Overall Study|Lost to Follow-up|0|||
48764812|NCT03131440|156988256|FG007|Overall Study|Lost to Follow-up|0|||
48764813|NCT03131440|156988257|FG008|Overall Study|Lost to Follow-up|0|||
48764814|NCT03131440|156988258|FG009|Overall Study|Lost to Follow-up|0|||
48764815|NCT03131440|156988259|FG010|Overall Study|Lost to Follow-up|0|||
48764816|NCT03131440|156988260|FG011|Overall Study|Lost to Follow-up|0|||
48764817|NCT03131440|156988261|FG012|Overall Study|Lost to Follow-up|0|||
48764818|NCT03131440|156988262|FG013|Overall Study|Lost to Follow-up|0|||
48764819|NCT03131440|156988263|FG014|Overall Study|Lost to Follow-up|0|||
48764820|NCT03131440|156988264|FG015|Overall Study|Lost to Follow-up|0|||
48764821|NCT03131440|156988265|FG016|Overall Study|Lost to Follow-up|0|||
48764822|NCT03131440|156988266|FG017|Overall Study|Lost to Follow-up|0|||
48764823|NCT03131440|156988267|FG018|Overall Study|Lost to Follow-up|0|||
48764824|NCT03131440|156988268|FG019|Overall Study|Lost to Follow-up|2|||
48764825|NCT03131440|156988269|FG020|Overall Study|Lost to Follow-up|1|||
48764826|NCT03131440|156988270|FG021|Overall Study|Lost to Follow-up|0|||
48764827|NCT03131440|156988271|FG022|Overall Study|Lost to Follow-up|1|||
48764828|NCT03131440|156988272|FG023|Overall Study|Lost to Follow-up|0|||
48764829|NCT03131440|156988273|FG024|Overall Study|Lost to Follow-up|1|||
48764830|NCT03131440|156988274|FG025|Overall Study|Lost to Follow-up|0|||
48764831|NCT03131440|156988275|FG026|Overall Study|Lost to Follow-up|0|||
48764832|NCT03131440|156988276|FG027|Overall Study|Lost to Follow-up|2|||
48764833|NCT03131440|156988277|FG028|Overall Study|Lost to Follow-up|0|||
48764834|NCT03131440|156988278|FG029|Overall Study|Lost to Follow-up|2|||
48764835|NCT03131440|156988279|FG030|Overall Study|Lost to Follow-up|0|||
48764836|NCT03131440|156988280|FG031|Overall Study|Lost to Follow-up|0|||
48764837|NCT03131440|156988249|FG000|Overall Study|Death|0|||
48764838|NCT03131440|156988250|FG001|Overall Study|Death|0|||
48764839|NCT03131440|156988251|FG002|Overall Study|Death|0|||
48764840|NCT03131440|156988252|FG003|Overall Study|Death|0|||
48764841|NCT03131440|156988253|FG004|Overall Study|Death|0|||
48764842|NCT03131440|156988254|FG005|Overall Study|Death|0|||
48764843|NCT03131440|156988255|FG006|Overall Study|Death|0|||
48764844|NCT03131440|156988256|FG007|Overall Study|Death|0|||
48764845|NCT03131440|156988257|FG008|Overall Study|Death|0|||
48764846|NCT03131440|156988258|FG009|Overall Study|Death|0|||
48764847|NCT03131440|156988259|FG010|Overall Study|Death|0|||
48764848|NCT03131440|156988260|FG011|Overall Study|Death|0|||
48764849|NCT03131440|156988261|FG012|Overall Study|Death|0|||
48764850|NCT03131440|156988262|FG013|Overall Study|Death|0|||
48764851|NCT03131440|156988263|FG014|Overall Study|Death|0|||
48764852|NCT03131440|156988264|FG015|Overall Study|Death|0|||
48764853|NCT03131440|156988265|FG016|Overall Study|Death|0|||
48764854|NCT03131440|156988266|FG017|Overall Study|Death|0|||
48764855|NCT03131440|156988267|FG018|Overall Study|Death|0|||
48764856|NCT03131440|156988268|FG019|Overall Study|Death|0|||
48764857|NCT03131440|156988269|FG020|Overall Study|Death|0|||
48764858|NCT03131440|156988270|FG021|Overall Study|Death|0|||
48764859|NCT03131440|156988271|FG022|Overall Study|Death|0|||
48764860|NCT03131440|156988272|FG023|Overall Study|Death|0|||
48764861|NCT03131440|156988273|FG024|Overall Study|Death|0|||
48764862|NCT03131440|156988274|FG025|Overall Study|Death|1|||
48764863|NCT03131440|156988275|FG026|Overall Study|Death|0|||
48764864|NCT03131440|156988276|FG027|Overall Study|Death|0|||
48764865|NCT03131440|156988277|FG028|Overall Study|Death|0|||
48764866|NCT03131440|156988278|FG029|Overall Study|Death|0|||
48764867|NCT03131440|156988279|FG030|Overall Study|Death|0|||
48764868|NCT03131440|156988280|FG031|Overall Study|Death|0|||
48764869|NCT00746941|156988281|FG000|Overall Study|Death|2|||
48764870|NCT00746941|156988282|FG001|Overall Study|Death|0|||
48764871|NCT00746941|156988283|FG002|Overall Study|Death|0|||
48764872|NCT00746941|156988284|FG003|Overall Study|Death|6|||
48764873|NCT00746941|156988281|FG000|Overall Study|Physician Decision|0|||
48764874|NCT00746941|156988282|FG001|Overall Study|Physician Decision|0|||
48764875|NCT00746941|156988283|FG002|Overall Study|Physician Decision|2|||
48764876|NCT00746941|156988284|FG003|Overall Study|Physician Decision|0|||
48764877|NCT00746941|156988281|FG000|Overall Study|Withdrawal by Subject|3|||
48764878|NCT00746941|156988282|FG001|Overall Study|Withdrawal by Subject|0|||
48764879|NCT00746941|156988283|FG002|Overall Study|Withdrawal by Subject|0|||
48764880|NCT00746941|156988284|FG003|Overall Study|Withdrawal by Subject|2|||
48764881|NCT00746941|156988281|FG000|Overall Study|Other, reason not provided|2|||
48764882|NCT00746941|156988282|FG001|Overall Study|Other, reason not provided|4|||
48764883|NCT00746941|156988283|FG002|Overall Study|Other, reason not provided|0|||
48764884|NCT00746941|156988284|FG003|Overall Study|Other, reason not provided|4|||
48764885|NCT00746941|156988281|FG000|Overall Study|Adverse Event|0|||
48764886|NCT00746941|156988282|FG001|Overall Study|Adverse Event|0|||
48764887|NCT00746941|156988283|FG002|Overall Study|Adverse Event|0|||
48764888|NCT00746941|156988284|FG003|Overall Study|Adverse Event|1|||
48764889|NCT00973479|156988287|FG000|Overall Study|Lost to Follow-up|0|||
48764890|NCT00973479|156988288|FG001|Overall Study|Lost to Follow-up|3|||
48764891|NCT00973479|156988287|FG000|Overall Study|Death|2|||
48764892|NCT00973479|156988288|FG001|Overall Study|Death|2|||
48764893|NCT00973479|156988287|FG000|Overall Study|Withdrawal by Subject|15|||
48764894|NCT00973479|156988288|FG001|Overall Study|Withdrawal by Subject|16|||
48764895|NCT00973479|156988287|FG000|Overall Study|Lack of Efficacy|5|||
48764896|NCT00973479|156988288|FG001|Overall Study|Lack of Efficacy|7|||
48764897|NCT00973479|156988287|FG000|Overall Study|Adverse Event|12|||
48764898|NCT00973479|156988288|FG001|Overall Study|Adverse Event|32|||
48764899|NCT00973479|156988287|FG000|Overall Study|Protocol Violation|2|||
48764900|NCT00973479|156988288|FG001|Overall Study|Protocol Violation|2|||
48764901|NCT00973479|156988287|FG000|Overall Study|Other|1|||
48764902|NCT00973479|156988288|FG001|Overall Study|Other|7|||
48764903|NCT00129129|156988289|FG000|Primary Phase|Adverse Event|2|||
48764904|NCT00129129|156988290|FG001|Primary Phase|Adverse Event|1|||
48764905|NCT00129129|156988291|FG002|Primary Phase|Adverse Event|0|||
48393583|NCT00708500|155635984|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
48393584|NCT00708500|155635982|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
48393585|NCT00708500|155635983|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
48393586|NCT00708500|155635984|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
48393587|NCT00708500|155635982|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
48393588|NCT00708500|155635983|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
48393589|NCT00708500|155635984|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
48393590|NCT00708500|155635982|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
48393591|NCT00708500|155635983|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
48393592|NCT00708500|155635984|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
48393593|NCT00708500|155635982|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
48393594|NCT00708500|155635983|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
48393595|NCT00708500|155635984|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
48393596|NCT00708500|155635982|FG000|FOLLOWUP|Adverse Event|0|||
48393597|NCT00708500|155635983|FG001|FOLLOWUP|Adverse Event|1|||
48393598|NCT00708500|155635984|FG002|FOLLOWUP|Adverse Event|0|||
48393599|NCT00708500|155635982|FG000|FOLLOWUP|Lost to Follow-up|1|||
48393600|NCT00708500|155635983|FG001|FOLLOWUP|Lost to Follow-up|6|||
48393601|NCT00708500|155635984|FG002|FOLLOWUP|Lost to Follow-up|4|||
48393602|NCT00708500|155635982|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
48393603|NCT00708500|155635983|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
48393604|NCT00708500|155635984|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
48393605|NCT00708500|155635982|FG000|FOLLOWUP|Subject withdrew consent|31|||
48393606|NCT00708500|155635983|FG001|FOLLOWUP|Subject withdrew consent|4|||
48393607|NCT00708500|155635984|FG002|FOLLOWUP|Subject withdrew consent|5|||
48393608|NCT00708500|155635982|FG000|FOLLOWUP|Non-compliance with protocol|5|||
48393609|NCT00708500|155635983|FG001|FOLLOWUP|Non-compliance with protocol|0|||
48393610|NCT00708500|155635984|FG002|FOLLOWUP|Non-compliance with protocol|1|||
48393611|NCT00912028|155635998|FG000|Overall Study|Lost to Follow-up|2|||
48393612|NCT00912028|155635999|FG001|Overall Study|Lost to Follow-up|3|||
48393613|NCT00912028|155636000|FG002|Overall Study|Lost to Follow-up|0|||
48393614|NCT00912028|155636001|FG003|Overall Study|Lost to Follow-up|1|||
48393615|NCT00912028|155636002|FG004|Overall Study|Lost to Follow-up|3|||
48393616|NCT00912028|155635998|FG000|Overall Study|Withdrawal by Subject|3|||
48393617|NCT00912028|155635999|FG001|Overall Study|Withdrawal by Subject|0|||
48393618|NCT00912028|155636000|FG002|Overall Study|Withdrawal by Subject|0|||
48393619|NCT00912028|155636001|FG003|Overall Study|Withdrawal by Subject|0|||
48393620|NCT00912028|155636002|FG004|Overall Study|Withdrawal by Subject|0|||
48393621|NCT00440947|155636005|FG000|36-Week Induction Phase|Adverse Event|16|||
48393622|NCT00440947|155636006|FG001|36-Week Induction Phase|Adverse Event|0|||
48393623|NCT00440947|155636007|FG002|36-Week Induction Phase|Adverse Event|0|||
48393624|NCT00440947|155636008|FG003|36-Week Induction Phase|Adverse Event|0|||
48393625|NCT00440947|155636009|FG004|36-Week Induction Phase|Adverse Event|0|||
48393626|NCT00440947|155636005|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
48393627|NCT00440947|155636006|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
48393628|NCT00440947|155636007|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
48764906|NCT00129129|156988292|FG003|Primary Phase|Adverse Event|0|||
48764907|NCT00129129|156988293|FG004|Primary Phase|Adverse Event|0|||
48764908|NCT00129129|156988289|FG000|Primary Phase|Withdrawal by Subject|12|||
48764909|NCT00129129|156988290|FG001|Primary Phase|Withdrawal by Subject|10|||
48764910|NCT00129129|156988291|FG002|Primary Phase|Withdrawal by Subject|0|||
48764911|NCT00129129|156988292|FG003|Primary Phase|Withdrawal by Subject|0|||
48393629|NCT00440947|155636008|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
48393630|NCT00440947|155636009|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
48764912|NCT00129129|156988293|FG004|Primary Phase|Withdrawal by Subject|0|||
48764913|NCT00129129|156988289|FG000|Primary Phase|Migration from study area|1|||
48764914|NCT00129129|156988290|FG001|Primary Phase|Migration from study area|3|||
48764915|NCT00129129|156988291|FG002|Primary Phase|Migration from study area|0|||
48764916|NCT00129129|156988292|FG003|Primary Phase|Migration from study area|0|||
48764917|NCT00129129|156988293|FG004|Primary Phase|Migration from study area|0|||
48764918|NCT00129129|156988289|FG000|Primary Phase|Lost to Follow-up|8|||
48764919|NCT00129129|156988290|FG001|Primary Phase|Lost to Follow-up|6|||
48764920|NCT00129129|156988291|FG002|Primary Phase|Lost to Follow-up|0|||
48764921|NCT00129129|156988292|FG003|Primary Phase|Lost to Follow-up|0|||
48764922|NCT00129129|156988293|FG004|Primary Phase|Lost to Follow-up|0|||
48764923|NCT00129129|156988289|FG000|Primary Phase|Other|2|||
48764924|NCT00129129|156988290|FG001|Primary Phase|Other|5|||
48764925|NCT00129129|156988291|FG002|Primary Phase|Other|0|||
48764926|NCT00129129|156988292|FG003|Primary Phase|Other|0|||
48393631|NCT00440947|155636005|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
48393632|NCT00440947|155636006|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
48430093|NCT03116399|155761949|FG001|Overall Study|Lost to Follow-up|11|||
48764927|NCT00129129|156988293|FG004|Primary Phase|Other|0|||
48764928|NCT00129129|156988289|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
48393633|NCT00440947|155636007|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
48393634|NCT00440947|155636008|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
48393635|NCT00440947|155636009|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
48393636|NCT00440947|155636005|FG000|36-Week Induction Phase|Non-compliance|10|||
48393637|NCT00440947|155636006|FG001|36-Week Induction Phase|Non-compliance|0|||
48393638|NCT00440947|155636007|FG002|36-Week Induction Phase|Non-compliance|0|||
48393639|NCT00440947|155636008|FG003|36-Week Induction Phase|Non-compliance|0|||
48393640|NCT00440947|155636009|FG004|36-Week Induction Phase|Non-compliance|0|||
48393641|NCT00440947|155636005|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
48764929|NCT00129129|156988290|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
48764930|NCT00129129|156988291|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
48764931|NCT00129129|156988292|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
48764932|NCT00129129|156988293|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
48764933|NCT00129129|156988289|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
48764934|NCT00129129|156988290|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
48764935|NCT00129129|156988291|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
48764936|NCT00129129|156988292|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
48764937|NCT00129129|156988293|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
48764938|NCT00129129|156988289|FG000|Fourth Dose Phase|Migration from study area|0|||
48764939|NCT00129129|156988290|FG001|Fourth Dose Phase|Migration from study area|0|||
48764940|NCT00129129|156988291|FG002|Fourth Dose Phase|Migration from study area|0|||
48764941|NCT00129129|156988292|FG003|Fourth Dose Phase|Migration from study area|0|||
48764942|NCT00129129|156988293|FG004|Fourth Dose Phase|Migration from study area|2|||
48764943|NCT00129129|156988289|FG000|Fourth Dose Phase|Other|0|||
48393642|NCT00440947|155636006|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
48393643|NCT00440947|155636007|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
48393644|NCT00440947|155636008|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
48393645|NCT00440947|155636009|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
48393646|NCT00440947|155636005|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
48393647|NCT00440947|155636006|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
48393648|NCT00440947|155636007|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
48393649|NCT00440947|155636008|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
48393650|NCT00440947|155636009|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
48393651|NCT00440947|155636005|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
48393652|NCT00440947|155636006|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
48393653|NCT00440947|155636007|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
48393654|NCT00440947|155636008|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
48393655|NCT00440947|155636009|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
48393656|NCT00440947|155636005|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
48393657|NCT00440947|155636006|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
48393658|NCT00440947|155636007|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
48393659|NCT00440947|155636008|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
48393660|NCT00440947|155636009|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
48393661|NCT00440947|155636005|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
48393662|NCT00440947|155636006|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
48393663|NCT00440947|155636007|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
48393664|NCT00440947|155636008|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
48393665|NCT00440947|155636009|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
48393666|NCT00440947|155636005|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
48393667|NCT00440947|155636006|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
48393668|NCT00440947|155636007|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
48764944|NCT00129129|156988290|FG001|Fourth Dose Phase|Other|0|||
48764945|NCT00129129|156988291|FG002|Fourth Dose Phase|Other|0|||
48764946|NCT00129129|156988292|FG003|Fourth Dose Phase|Other|1|||
48764947|NCT00129129|156988293|FG004|Fourth Dose Phase|Other|1|||
48764948|NCT00129129|156988289|FG000|Fourth Dose Phase|Protocol Violation|0|||
48764949|NCT00129129|156988290|FG001|Fourth Dose Phase|Protocol Violation|0|||
48764950|NCT00129129|156988291|FG002|Fourth Dose Phase|Protocol Violation|0|||
48764951|NCT00129129|156988292|FG003|Fourth Dose Phase|Protocol Violation|1|||
48764952|NCT00129129|156988293|FG004|Fourth Dose Phase|Protocol Violation|0|||
48764953|NCT02098109|156988298|FG000|Overall Study|Protocol Violation|3|||
48764954|NCT02098109|156988299|FG001|Overall Study|Protocol Violation|0|||
48764955|NCT01709695|156988300|FG000|Overall Study|Withdrawal by Subject|1|||
48764956|NCT01709695|156988301|FG001|Overall Study|Withdrawal by Subject|1|||
48764957|NCT00500292|156988305|FG000|Overall Study|Adverse Event|3|||
48764958|NCT00500292|156988306|FG001|Overall Study|Adverse Event|6|||
48764959|NCT00500292|156988307|FG002|Overall Study|Adverse Event|4|||
48764960|NCT00500292|156988305|FG000|Overall Study|Condition under investigation worsened|21|||
48764961|NCT00500292|156988306|FG001|Overall Study|Condition under investigation worsened|23|||
48764962|NCT00500292|156988307|FG002|Overall Study|Condition under investigation worsened|19|||
48764963|NCT00500292|156988305|FG000|Overall Study|Withdrawal by Subject|0|||
48764964|NCT00500292|156988306|FG001|Overall Study|Withdrawal by Subject|1|||
48764965|NCT00500292|156988307|FG002|Overall Study|Withdrawal by Subject|0|||
48764966|NCT00500292|156988305|FG000|Overall Study|Other|1|||
48764967|NCT00500292|156988306|FG001|Overall Study|Other|1|||
48764968|NCT00500292|156988307|FG002|Overall Study|Other|4|||
48764969|NCT02741700|156988308|FG000|Overall Study|Lost to Follow-up|17|||
48764970|NCT02741700|156988309|FG001|Overall Study|Lost to Follow-up|8|||
48764971|NCT02741700|156988308|FG000|Overall Study|Withdrawal by Subject|2|||
48764972|NCT02741700|156988309|FG001|Overall Study|Withdrawal by Subject|5|||
48764973|NCT02741700|156988308|FG000|Overall Study|Physician Decision|3|||
48764974|NCT02741700|156988309|FG001|Overall Study|Physician Decision|0|||
48764975|NCT02741700|156988308|FG000|Overall Study|Moved out of State|0|||
48764976|NCT02741700|156988309|FG001|Overall Study|Moved out of State|1|||
48764977|NCT02741700|156988308|FG000|Overall Study|Death|4|||
48764978|NCT02741700|156988309|FG001|Overall Study|Death|5|||
48764979|NCT02641379|156988312|FG000|Overall Study|Exclusion criterion during screening|1|||
48764980|NCT02641379|156988313|FG001|Overall Study|Exclusion criterion during screening|0|||
48764981|NCT02641379|156988314|FG002|Overall Study|Exclusion criterion during screening|0|||
48393669|NCT00440947|155636008|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
48393670|NCT00440947|155636009|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
48393671|NCT00440947|155636005|FG000|36-Week Induction Phase|Incarceration|3|||
48393672|NCT00440947|155636006|FG001|36-Week Induction Phase|Incarceration|0|||
48393673|NCT00440947|155636007|FG002|36-Week Induction Phase|Incarceration|0|||
48393674|NCT00440947|155636008|FG003|36-Week Induction Phase|Incarceration|0|||
48393675|NCT00440947|155636009|FG004|36-Week Induction Phase|Incarceration|0|||
48393676|NCT00440947|155636005|FG000|36-Week Induction Phase|Pregnancy|1|||
48393677|NCT00440947|155636006|FG001|36-Week Induction Phase|Pregnancy|0|||
48393678|NCT00440947|155636007|FG002|36-Week Induction Phase|Pregnancy|0|||
48393679|NCT00440947|155636008|FG003|36-Week Induction Phase|Pregnancy|0|||
48393680|NCT00440947|155636009|FG004|36-Week Induction Phase|Pregnancy|0|||
48393681|NCT00440947|155636005|FG000|48-Week Randomization Phase|Adverse Event|0|||
48393682|NCT00440947|155636006|FG001|48-Week Randomization Phase|Adverse Event|2|||
48393683|NCT00440947|155636007|FG002|48-Week Randomization Phase|Adverse Event|5|||
48393684|NCT00440947|155636008|FG003|48-Week Randomization Phase|Adverse Event|0|||
48393685|NCT00440947|155636009|FG004|48-Week Randomization Phase|Adverse Event|0|||
48393686|NCT00440947|155636005|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
48393687|NCT00440947|155636006|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
48393688|NCT00440947|155636007|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
48393689|NCT00440947|155636008|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
48393690|NCT00440947|155636009|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
48393691|NCT00440947|155636005|FG000|48-Week Randomization Phase|Non-compliance|0|||
48393692|NCT00440947|155636006|FG001|48-Week Randomization Phase|Non-compliance|3|||
48393693|NCT00440947|155636007|FG002|48-Week Randomization Phase|Non-compliance|4|||
48393694|NCT00440947|155636008|FG003|48-Week Randomization Phase|Non-compliance|0|||
48393695|NCT00440947|155636009|FG004|48-Week Randomization Phase|Non-compliance|0|||
48393696|NCT00440947|155636005|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
48393697|NCT00440947|155636006|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
48393698|NCT00440947|155636007|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
48393699|NCT00440947|155636008|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
48393700|NCT00440947|155636009|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
48393701|NCT00440947|155636005|FG000|48-Week Randomization Phase|Protocol Violation|0|||
48393702|NCT00440947|155636006|FG001|48-Week Randomization Phase|Protocol Violation|0|||
48393703|NCT00440947|155636007|FG002|48-Week Randomization Phase|Protocol Violation|1|||
48393704|NCT00440947|155636008|FG003|48-Week Randomization Phase|Protocol Violation|0|||
48393705|NCT00440947|155636009|FG004|48-Week Randomization Phase|Protocol Violation|0|||
48393706|NCT00440947|155636005|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
48393707|NCT00440947|155636006|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
48393708|NCT00440947|155636007|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
48393709|NCT00440947|155636008|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
48393710|NCT00440947|155636009|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
48393711|NCT00440947|155636005|FG000|48-Week Randomization Phase|Pregnancy|0|||
48393712|NCT00440947|155636006|FG001|48-Week Randomization Phase|Pregnancy|0|||
48764982|NCT02641379|156988315|FG003|Overall Study|Exclusion criterion during screening|1|||
48764983|NCT02641379|156988316|FG004|Overall Study|Exclusion criterion during screening|2|||
48764984|NCT02641379|156988317|FG005|Overall Study|Exclusion criterion during screening|0|||
48764985|NCT02641379|156988318|FG006|Overall Study|Exclusion criterion during screening|0|||
48764986|NCT02641379|156988319|FG007|Overall Study|Exclusion criterion during screening|0|||
48764987|NCT02641379|156988320|FG008|Overall Study|Exclusion criterion during screening|0|||
48764988|NCT02641379|156988321|FG009|Overall Study|Exclusion criterion during screening|0|||
48393713|NCT00440947|155636007|FG002|48-Week Randomization Phase|Pregnancy|1|||
48393714|NCT00440947|155636008|FG003|48-Week Randomization Phase|Pregnancy|0|||
48393715|NCT00440947|155636009|FG004|48-Week Randomization Phase|Pregnancy|0|||
48393716|NCT00440947|155636005|FG000|48-Week Randomization Phase|Incarceration|0|||
48764989|NCT02641379|156988322|FG010|Overall Study|Exclusion criterion during screening|0|||
48764990|NCT02641379|156988312|FG000|Overall Study|Withdrawal of informed consent|0|||
48764991|NCT02641379|156988313|FG001|Overall Study|Withdrawal of informed consent|1|||
48764992|NCT02641379|156988314|FG002|Overall Study|Withdrawal of informed consent|0|||
48764993|NCT02641379|156988315|FG003|Overall Study|Withdrawal of informed consent|0|||
48764994|NCT02641379|156988316|FG004|Overall Study|Withdrawal of informed consent|0|||
48764995|NCT02641379|156988317|FG005|Overall Study|Withdrawal of informed consent|0|||
48764996|NCT02641379|156988318|FG006|Overall Study|Withdrawal of informed consent|0|||
48764997|NCT02641379|156988319|FG007|Overall Study|Withdrawal of informed consent|1|||
48764998|NCT02641379|156988320|FG008|Overall Study|Withdrawal of informed consent|0|||
48764999|NCT02641379|156988321|FG009|Overall Study|Withdrawal of informed consent|0|||
48765000|NCT02641379|156988322|FG010|Overall Study|Withdrawal of informed consent|0|||
48765001|NCT02641379|156988312|FG000|Overall Study|Adverse Event|7|||
48765002|NCT02641379|156988313|FG001|Overall Study|Adverse Event|8|||
48765003|NCT02641379|156988314|FG002|Overall Study|Adverse Event|2|||
48765004|NCT02641379|156988315|FG003|Overall Study|Adverse Event|2|||
48765005|NCT02641379|156988316|FG004|Overall Study|Adverse Event|5|||
48765006|NCT02641379|156988317|FG005|Overall Study|Adverse Event|1|||
48765007|NCT02641379|156988318|FG006|Overall Study|Adverse Event|5|||
48393717|NCT00440947|155636006|FG001|48-Week Randomization Phase|Incarceration|3|||
48393718|NCT00440947|155636007|FG002|48-Week Randomization Phase|Incarceration|0|||
48393719|NCT00440947|155636008|FG003|48-Week Randomization Phase|Incarceration|0|||
48393720|NCT00440947|155636009|FG004|48-Week Randomization Phase|Incarceration|0|||
48393721|NCT00440947|155636005|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
48393722|NCT00440947|155636006|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
48393723|NCT00440947|155636007|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
48393724|NCT00440947|155636008|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
48393725|NCT00440947|155636009|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
48393726|NCT00440947|155636005|FG000|48-Week Randomization Phase|Physician Decision|0|||
48393727|NCT00440947|155636006|FG001|48-Week Randomization Phase|Physician Decision|2|||
48393728|NCT00440947|155636007|FG002|48-Week Randomization Phase|Physician Decision|0|||
48393729|NCT00440947|155636008|FG003|48-Week Randomization Phase|Physician Decision|0|||
48393730|NCT00440947|155636009|FG004|48-Week Randomization Phase|Physician Decision|0|||
48393731|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
48393732|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
48393733|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
48393734|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
48393735|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
48393736|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
48393737|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
48393738|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
48393739|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
48393740|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
48393741|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
48393742|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
48393743|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
48393744|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
48393745|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
48393746|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
48393747|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
48393748|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
48393749|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
48393750|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
48393751|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
48765008|NCT02641379|156988319|FG007|Overall Study|Adverse Event|0|||
48765009|NCT02641379|156988320|FG008|Overall Study|Adverse Event|1|||
48765010|NCT02641379|156988321|FG009|Overall Study|Adverse Event|1|||
48393752|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
48393753|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
48765011|NCT02641379|156988322|FG010|Overall Study|Adverse Event|5|||
48765012|NCT02641379|156988312|FG000|Overall Study|Lack of Efficacy|0|||
48765013|NCT02641379|156988313|FG001|Overall Study|Lack of Efficacy|0|||
48765014|NCT02641379|156988314|FG002|Overall Study|Lack of Efficacy|2|||
48765015|NCT02641379|156988315|FG003|Overall Study|Lack of Efficacy|0|||
48393754|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
48393755|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
48393756|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
48393757|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
48393758|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
48393759|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
48393760|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
48393761|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
48393762|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
48393763|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
48393764|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
48393765|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
48393766|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
48393767|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
48393768|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
48393769|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
48393770|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
48393771|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
48765016|NCT02641379|156988316|FG004|Overall Study|Lack of Efficacy|0|||
48765017|NCT02641379|156988317|FG005|Overall Study|Lack of Efficacy|2|||
48765018|NCT02641379|156988318|FG006|Overall Study|Lack of Efficacy|0|||
48765019|NCT02641379|156988319|FG007|Overall Study|Lack of Efficacy|5|||
48765020|NCT02641379|156988320|FG008|Overall Study|Lack of Efficacy|0|||
48765021|NCT02641379|156988321|FG009|Overall Study|Lack of Efficacy|0|||
48765022|NCT02641379|156988322|FG010|Overall Study|Lack of Efficacy|0|||
48765023|NCT02641379|156988312|FG000|Overall Study|Participant unable to attend study visit|4|||
48765024|NCT02641379|156988313|FG001|Overall Study|Participant unable to attend study visit|10|||
48765025|NCT02641379|156988314|FG002|Overall Study|Participant unable to attend study visit|1|||
48765026|NCT02641379|156988315|FG003|Overall Study|Participant unable to attend study visit|2|||
48765027|NCT02641379|156988316|FG004|Overall Study|Participant unable to attend study visit|5|||
48765028|NCT02641379|156988317|FG005|Overall Study|Participant unable to attend study visit|1|||
48765029|NCT02641379|156988318|FG006|Overall Study|Participant unable to attend study visit|1|||
48765030|NCT02641379|156988319|FG007|Overall Study|Participant unable to attend study visit|1|||
48765031|NCT02641379|156988320|FG008|Overall Study|Participant unable to attend study visit|0|||
48393772|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
48393773|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
48393774|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
48393775|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
48393776|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
48692330|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
48692331|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692332|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692333|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692334|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692335|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692336|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692337|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692338|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692339|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692340|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692341|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692342|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
48692343|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
48692344|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
48692345|NCT03982199|156722568|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692346|NCT03982199|156722569|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692347|NCT03982199|156722570|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692348|NCT03982199|156722571|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692349|NCT03982199|156722572|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692350|NCT03982199|156722573|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692351|NCT03982199|156722574|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692352|NCT03982199|156722575|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692353|NCT03982199|156722576|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692354|NCT03982199|156722577|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692355|NCT03982199|156722578|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692356|NCT03982199|156722579|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692357|NCT03982199|156722580|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
48765032|NCT02641379|156988321|FG009|Overall Study|Participant unable to attend study visit|2|||
48765033|NCT02641379|156988322|FG010|Overall Study|Participant unable to attend study visit|0|||
48765034|NCT02641379|156988312|FG000|Overall Study|Participant's compliance|0|||
48765035|NCT02641379|156988313|FG001|Overall Study|Participant's compliance|1|||
48765036|NCT02641379|156988314|FG002|Overall Study|Participant's compliance|0|||
48765037|NCT02641379|156988315|FG003|Overall Study|Participant's compliance|1|||
48765038|NCT02641379|156988316|FG004|Overall Study|Participant's compliance|0|||
48765039|NCT02641379|156988317|FG005|Overall Study|Participant's compliance|2|||
48765040|NCT02641379|156988318|FG006|Overall Study|Participant's compliance|0|||
48765041|NCT02641379|156988319|FG007|Overall Study|Participant's compliance|0|||
48765042|NCT02641379|156988320|FG008|Overall Study|Participant's compliance|1|||
48765043|NCT02641379|156988321|FG009|Overall Study|Participant's compliance|1|||
48765044|NCT02641379|156988322|FG010|Overall Study|Participant's compliance|1|||
48765045|NCT02641379|156988312|FG000|Overall Study|Participant cannot be reached|4|||
48765046|NCT02641379|156988313|FG001|Overall Study|Participant cannot be reached|4|||
48765047|NCT02641379|156988314|FG002|Overall Study|Participant cannot be reached|0|||
48765048|NCT02641379|156988315|FG003|Overall Study|Participant cannot be reached|8|||
48765049|NCT02641379|156988316|FG004|Overall Study|Participant cannot be reached|2|||
48765050|NCT02641379|156988317|FG005|Overall Study|Participant cannot be reached|1|||
48765051|NCT02641379|156988318|FG006|Overall Study|Participant cannot be reached|0|||
48765052|NCT02641379|156988319|FG007|Overall Study|Participant cannot be reached|1|||
48765053|NCT02641379|156988320|FG008|Overall Study|Participant cannot be reached|0|||
48765054|NCT02641379|156988321|FG009|Overall Study|Participant cannot be reached|2|||
48765055|NCT02641379|156988322|FG010|Overall Study|Participant cannot be reached|1|||
48765056|NCT02641379|156988312|FG000|Overall Study|PCR positive at Week 24|15|||
48765057|NCT02641379|156988313|FG001|Overall Study|PCR positive at Week 24|21|||
48765058|NCT02641379|156988314|FG002|Overall Study|PCR positive at Week 24|62|||
48765059|NCT02641379|156988315|FG003|Overall Study|PCR positive at Week 24|0|||
48765060|NCT02641379|156988316|FG004|Overall Study|PCR positive at Week 24|0|||
48765061|NCT02641379|156988317|FG005|Overall Study|PCR positive at Week 24|6|||
48765062|NCT02641379|156988318|FG006|Overall Study|PCR positive at Week 24|3|||
48765063|NCT02641379|156988319|FG007|Overall Study|PCR positive at Week 24|8|||
48765064|NCT02641379|156988320|FG008|Overall Study|PCR positive at Week 24|0|||
48765065|NCT02641379|156988321|FG009|Overall Study|PCR positive at Week 24|1|||
48765066|NCT02641379|156988322|FG010|Overall Study|PCR positive at Week 24|0|||
48765067|NCT02641379|156988312|FG000|Overall Study|PCR positive at follow up 2|1|||
48765068|NCT02641379|156988313|FG001|Overall Study|PCR positive at follow up 2|0|||
48765069|NCT02641379|156988314|FG002|Overall Study|PCR positive at follow up 2|0|||
48765070|NCT02641379|156988315|FG003|Overall Study|PCR positive at follow up 2|0|||
48765071|NCT02641379|156988316|FG004|Overall Study|PCR positive at follow up 2|0|||
48765072|NCT02641379|156988317|FG005|Overall Study|PCR positive at follow up 2|0|||
48765073|NCT02641379|156988318|FG006|Overall Study|PCR positive at follow up 2|0|||
48765074|NCT02641379|156988319|FG007|Overall Study|PCR positive at follow up 2|0|||
48765075|NCT02641379|156988320|FG008|Overall Study|PCR positive at follow up 2|0|||
48765076|NCT02641379|156988321|FG009|Overall Study|PCR positive at follow up 2|0|||
48765077|NCT02641379|156988322|FG010|Overall Study|PCR positive at follow up 2|0|||
48765078|NCT02641379|156988312|FG000|Overall Study|Participant showed relapse|1|||
48765079|NCT02641379|156988313|FG001|Overall Study|Participant showed relapse|0|||
48765080|NCT02641379|156988314|FG002|Overall Study|Participant showed relapse|0|||
48765081|NCT02641379|156988315|FG003|Overall Study|Participant showed relapse|0|||
48765082|NCT02641379|156988316|FG004|Overall Study|Participant showed relapse|0|||
48765083|NCT02641379|156988317|FG005|Overall Study|Participant showed relapse|0|||
48765084|NCT02641379|156988318|FG006|Overall Study|Participant showed relapse|1|||
48765085|NCT02641379|156988319|FG007|Overall Study|Participant showed relapse|0|||
48765086|NCT02641379|156988320|FG008|Overall Study|Participant showed relapse|0|||
48765087|NCT02641379|156988321|FG009|Overall Study|Participant showed relapse|0|||
48765088|NCT02641379|156988322|FG010|Overall Study|Participant showed relapse|0|||
48765089|NCT02641379|156988312|FG000|Overall Study|Participant stopped study/treatment|1|||
48765090|NCT02641379|156988313|FG001|Overall Study|Participant stopped study/treatment|3|||
48765091|NCT02641379|156988314|FG002|Overall Study|Participant stopped study/treatment|1|||
48393777|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
48393778|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
48393779|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
48765092|NCT02641379|156988315|FG003|Overall Study|Participant stopped study/treatment|0|||
48765093|NCT02641379|156988316|FG004|Overall Study|Participant stopped study/treatment|0|||
48765094|NCT02641379|156988317|FG005|Overall Study|Participant stopped study/treatment|1|||
48765095|NCT02641379|156988318|FG006|Overall Study|Participant stopped study/treatment|2|||
48765096|NCT02641379|156988319|FG007|Overall Study|Participant stopped study/treatment|0|||
48765097|NCT02641379|156988320|FG008|Overall Study|Participant stopped study/treatment|1|||
48765098|NCT02641379|156988321|FG009|Overall Study|Participant stopped study/treatment|0|||
48765099|NCT02641379|156988322|FG010|Overall Study|Participant stopped study/treatment|0|||
48765100|NCT02641379|156988312|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
48765101|NCT02641379|156988313|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
48765102|NCT02641379|156988314|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
48765103|NCT02641379|156988315|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
48765104|NCT02641379|156988316|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
48765105|NCT02641379|156988317|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
48765106|NCT02641379|156988318|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
48765107|NCT02641379|156988319|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
48765108|NCT02641379|156988320|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
48765109|NCT02641379|156988321|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
48765110|NCT02641379|156988322|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
48765111|NCT02641379|156988312|FG000|Overall Study|Financial problems|0|||
48765112|NCT02641379|156988313|FG001|Overall Study|Financial problems|1|||
48765113|NCT02641379|156988314|FG002|Overall Study|Financial problems|0|||
48765114|NCT02641379|156988315|FG003|Overall Study|Financial problems|0|||
48765115|NCT02641379|156988316|FG004|Overall Study|Financial problems|0|||
48765116|NCT02641379|156988317|FG005|Overall Study|Financial problems|0|||
48765117|NCT02641379|156988318|FG006|Overall Study|Financial problems|0|||
48765118|NCT02641379|156988319|FG007|Overall Study|Financial problems|0|||
48765119|NCT02641379|156988320|FG008|Overall Study|Financial problems|0|||
48765120|NCT02641379|156988321|FG009|Overall Study|Financial problems|0|||
48765121|NCT02641379|156988322|FG010|Overall Study|Financial problems|0|||
48765122|NCT02641379|156988312|FG000|Overall Study|PCR positive at Week 68|0|||
48765123|NCT02641379|156988313|FG001|Overall Study|PCR positive at Week 68|1|||
48765124|NCT02641379|156988314|FG002|Overall Study|PCR positive at Week 68|0|||
48765125|NCT02641379|156988315|FG003|Overall Study|PCR positive at Week 68|0|||
48765126|NCT02641379|156988316|FG004|Overall Study|PCR positive at Week 68|0|||
48765127|NCT02641379|156988317|FG005|Overall Study|PCR positive at Week 68|0|||
48765128|NCT02641379|156988318|FG006|Overall Study|PCR positive at Week 68|0|||
48765129|NCT02641379|156988319|FG007|Overall Study|PCR positive at Week 68|0|||
48765130|NCT02641379|156988320|FG008|Overall Study|PCR positive at Week 68|0|||
48765131|NCT02641379|156988321|FG009|Overall Study|PCR positive at Week 68|0|||
48765132|NCT02641379|156988322|FG010|Overall Study|PCR positive at Week 68|0|||
48765133|NCT02641379|156988312|FG000|Overall Study|PCR positive at Week 48|0|||
48765134|NCT02641379|156988313|FG001|Overall Study|PCR positive at Week 48|1|||
48765135|NCT02641379|156988314|FG002|Overall Study|PCR positive at Week 48|0|||
48765136|NCT02641379|156988315|FG003|Overall Study|PCR positive at Week 48|0|||
48765137|NCT02641379|156988316|FG004|Overall Study|PCR positive at Week 48|0|||
48765138|NCT02641379|156988317|FG005|Overall Study|PCR positive at Week 48|0|||
48765139|NCT02641379|156988318|FG006|Overall Study|PCR positive at Week 48|0|||
48765140|NCT02641379|156988319|FG007|Overall Study|PCR positive at Week 48|0|||
48765141|NCT02641379|156988320|FG008|Overall Study|PCR positive at Week 48|0|||
48765142|NCT02641379|156988321|FG009|Overall Study|PCR positive at Week 48|0|||
48765143|NCT02641379|156988322|FG010|Overall Study|PCR positive at Week 48|0|||
48765144|NCT02641379|156988312|FG000|Overall Study|PCR not performed at Week 12|0|||
48765145|NCT02641379|156988313|FG001|Overall Study|PCR not performed at Week 12|0|||
48765146|NCT02641379|156988314|FG002|Overall Study|PCR not performed at Week 12|1|||
48765147|NCT02641379|156988315|FG003|Overall Study|PCR not performed at Week 12|0|||
48765148|NCT02641379|156988316|FG004|Overall Study|PCR not performed at Week 12|0|||
48765149|NCT02641379|156988317|FG005|Overall Study|PCR not performed at Week 12|0|||
48765150|NCT02641379|156988318|FG006|Overall Study|PCR not performed at Week 12|0|||
48765151|NCT02641379|156988319|FG007|Overall Study|PCR not performed at Week 12|0|||
48765152|NCT02641379|156988320|FG008|Overall Study|PCR not performed at Week 12|0|||
48765153|NCT02641379|156988321|FG009|Overall Study|PCR not performed at Week 12|0|||
48765154|NCT02641379|156988322|FG010|Overall Study|PCR not performed at Week 12|0|||
48765155|NCT02641379|156988312|FG000|Overall Study|No PCR at baseline|0|||
48765156|NCT02641379|156988313|FG001|Overall Study|No PCR at baseline|0|||
48765157|NCT02641379|156988314|FG002|Overall Study|No PCR at baseline|1|||
48765158|NCT02641379|156988315|FG003|Overall Study|No PCR at baseline|0|||
48765159|NCT02641379|156988316|FG004|Overall Study|No PCR at baseline|0|||
48765160|NCT02641379|156988317|FG005|Overall Study|No PCR at baseline|0|||
48765161|NCT02641379|156988318|FG006|Overall Study|No PCR at baseline|0|||
48765162|NCT02641379|156988319|FG007|Overall Study|No PCR at baseline|0|||
48765163|NCT02641379|156988320|FG008|Overall Study|No PCR at baseline|0|||
48765164|NCT02641379|156988321|FG009|Overall Study|No PCR at baseline|0|||
48765165|NCT02641379|156988322|FG010|Overall Study|No PCR at baseline|0|||
48765166|NCT02641379|156988312|FG000|Overall Study|PCR positive at Week 28|0|||
48765167|NCT02641379|156988313|FG001|Overall Study|PCR positive at Week 28|0|||
48765168|NCT02641379|156988314|FG002|Overall Study|PCR positive at Week 28|1|||
48765169|NCT02641379|156988315|FG003|Overall Study|PCR positive at Week 28|0|||
48765170|NCT02641379|156988316|FG004|Overall Study|PCR positive at Week 28|0|||
48765171|NCT02641379|156988317|FG005|Overall Study|PCR positive at Week 28|0|||
48765172|NCT02641379|156988318|FG006|Overall Study|PCR positive at Week 28|0|||
48765173|NCT02641379|156988319|FG007|Overall Study|PCR positive at Week 28|0|||
48765174|NCT02641379|156988320|FG008|Overall Study|PCR positive at Week 28|0|||
48765175|NCT02641379|156988321|FG009|Overall Study|PCR positive at Week 28|0|||
48765176|NCT02641379|156988322|FG010|Overall Study|PCR positive at Week 28|0|||
48765177|NCT02641379|156988312|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
48765178|NCT02641379|156988313|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
48765179|NCT02641379|156988314|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
48765180|NCT02641379|156988315|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
48765181|NCT02641379|156988316|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
48765182|NCT02641379|156988317|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
48765183|NCT02641379|156988318|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
48765184|NCT02641379|156988319|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
48765185|NCT02641379|156988320|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
48765186|NCT02641379|156988321|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
48765187|NCT02641379|156988322|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
48765188|NCT02641379|156988312|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
48765189|NCT02641379|156988313|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
48765190|NCT02641379|156988314|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
48765191|NCT02641379|156988315|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
48765192|NCT02641379|156988316|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
48765193|NCT02641379|156988317|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
48765194|NCT02641379|156988318|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
48765195|NCT02641379|156988319|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
48765196|NCT02641379|156988320|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
48765197|NCT02641379|156988321|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
48765198|NCT02641379|156988322|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
48765199|NCT02641379|156988312|FG000|Overall Study|Baseline viral load unavailable|0|||
48765200|NCT02641379|156988313|FG001|Overall Study|Baseline viral load unavailable|0|||
48765201|NCT02641379|156988314|FG002|Overall Study|Baseline viral load unavailable|0|||
48765202|NCT02641379|156988315|FG003|Overall Study|Baseline viral load unavailable|1|||
48765203|NCT02641379|156988316|FG004|Overall Study|Baseline viral load unavailable|0|||
48765204|NCT02641379|156988317|FG005|Overall Study|Baseline viral load unavailable|0|||
48765205|NCT02641379|156988318|FG006|Overall Study|Baseline viral load unavailable|0|||
48765206|NCT02641379|156988319|FG007|Overall Study|Baseline viral load unavailable|0|||
48765207|NCT02641379|156988320|FG008|Overall Study|Baseline viral load unavailable|0|||
48765208|NCT02641379|156988321|FG009|Overall Study|Baseline viral load unavailable|0|||
48765209|NCT02641379|156988322|FG010|Overall Study|Baseline viral load unavailable|0|||
48765210|NCT02641379|156988312|FG000|Overall Study|Blood could not be drawn|0|||
48765211|NCT02641379|156988313|FG001|Overall Study|Blood could not be drawn|0|||
48765212|NCT02641379|156988314|FG002|Overall Study|Blood could not be drawn|0|||
48765213|NCT02641379|156988315|FG003|Overall Study|Blood could not be drawn|0|||
48765214|NCT02641379|156988316|FG004|Overall Study|Blood could not be drawn|1|||
48765215|NCT02641379|156988317|FG005|Overall Study|Blood could not be drawn|0|||
48765216|NCT02641379|156988318|FG006|Overall Study|Blood could not be drawn|0|||
48765217|NCT02641379|156988319|FG007|Overall Study|Blood could not be drawn|0|||
48765218|NCT02641379|156988320|FG008|Overall Study|Blood could not be drawn|0|||
48765219|NCT02641379|156988321|FG009|Overall Study|Blood could not be drawn|0|||
48765220|NCT02641379|156988322|FG010|Overall Study|Blood could not be drawn|0|||
48765221|NCT02641379|156988312|FG000|Overall Study|Protocol Violation|0|||
48765222|NCT02641379|156988313|FG001|Overall Study|Protocol Violation|0|||
48765223|NCT02641379|156988314|FG002|Overall Study|Protocol Violation|0|||
48765224|NCT02641379|156988315|FG003|Overall Study|Protocol Violation|0|||
48765225|NCT02641379|156988316|FG004|Overall Study|Protocol Violation|2|||
48765226|NCT02641379|156988317|FG005|Overall Study|Protocol Violation|0|||
48765227|NCT02641379|156988318|FG006|Overall Study|Protocol Violation|0|||
48765228|NCT02641379|156988319|FG007|Overall Study|Protocol Violation|0|||
48765229|NCT02641379|156988320|FG008|Overall Study|Protocol Violation|1|||
48765230|NCT02641379|156988321|FG009|Overall Study|Protocol Violation|0|||
48765231|NCT02641379|156988322|FG010|Overall Study|Protocol Violation|0|||
48765232|NCT02641379|156988312|FG000|Overall Study|Participation in sili rescue study|0|||
48765233|NCT02641379|156988313|FG001|Overall Study|Participation in sili rescue study|0|||
48765234|NCT02641379|156988314|FG002|Overall Study|Participation in sili rescue study|0|||
48765235|NCT02641379|156988315|FG003|Overall Study|Participation in sili rescue study|0|||
48765236|NCT02641379|156988316|FG004|Overall Study|Participation in sili rescue study|0|||
48765237|NCT02641379|156988317|FG005|Overall Study|Participation in sili rescue study|1|||
48765238|NCT02641379|156988318|FG006|Overall Study|Participation in sili rescue study|0|||
48765239|NCT02641379|156988319|FG007|Overall Study|Participation in sili rescue study|0|||
48765240|NCT02641379|156988320|FG008|Overall Study|Participation in sili rescue study|0|||
48765241|NCT02641379|156988321|FG009|Overall Study|Participation in sili rescue study|0|||
48765242|NCT02641379|156988322|FG010|Overall Study|Participation in sili rescue study|0|||
48430169|NCT00601523|155761977|FG000|Overall Study|Protocol Violation|5|||
48765243|NCT02641379|156988312|FG000|Overall Study|Lost to Follow-up|0|||
48765244|NCT02641379|156988313|FG001|Overall Study|Lost to Follow-up|0|||
48765245|NCT02641379|156988314|FG002|Overall Study|Lost to Follow-up|0|||
48765246|NCT02641379|156988315|FG003|Overall Study|Lost to Follow-up|0|||
48765247|NCT02641379|156988316|FG004|Overall Study|Lost to Follow-up|0|||
48765248|NCT02641379|156988317|FG005|Overall Study|Lost to Follow-up|0|||
48765249|NCT02641379|156988318|FG006|Overall Study|Lost to Follow-up|0|||
48765250|NCT02641379|156988319|FG007|Overall Study|Lost to Follow-up|0|||
48765251|NCT02641379|156988320|FG008|Overall Study|Lost to Follow-up|1|||
48765252|NCT02641379|156988321|FG009|Overall Study|Lost to Follow-up|0|||
48765253|NCT02641379|156988322|FG010|Overall Study|Lost to Follow-up|0|||
48765254|NCT02641379|156988312|FG000|Overall Study|Source data not found|0|||
48765255|NCT02641379|156988313|FG001|Overall Study|Source data not found|0|||
48765256|NCT02641379|156988314|FG002|Overall Study|Source data not found|0|||
48765257|NCT02641379|156988315|FG003|Overall Study|Source data not found|0|||
48765258|NCT02641379|156988316|FG004|Overall Study|Source data not found|0|||
48765259|NCT02641379|156988317|FG005|Overall Study|Source data not found|1|||
48765260|NCT02641379|156988318|FG006|Overall Study|Source data not found|0|||
48765261|NCT02641379|156988319|FG007|Overall Study|Source data not found|0|||
48765262|NCT02641379|156988320|FG008|Overall Study|Source data not found|0|||
48765263|NCT02641379|156988321|FG009|Overall Study|Source data not found|0|||
48765264|NCT02641379|156988322|FG010|Overall Study|Source data not found|0|||
48765265|NCT02641379|156988312|FG000|Overall Study|Participant showed weight reduction|0|||
48765266|NCT02641379|156988313|FG001|Overall Study|Participant showed weight reduction|0|||
48765267|NCT02641379|156988314|FG002|Overall Study|Participant showed weight reduction|0|||
48765268|NCT02641379|156988315|FG003|Overall Study|Participant showed weight reduction|0|||
48765269|NCT02641379|156988316|FG004|Overall Study|Participant showed weight reduction|0|||
48765270|NCT02641379|156988317|FG005|Overall Study|Participant showed weight reduction|0|||
48765271|NCT02641379|156988318|FG006|Overall Study|Participant showed weight reduction|0|||
48765272|NCT02641379|156988319|FG007|Overall Study|Participant showed weight reduction|1|||
48765273|NCT02641379|156988320|FG008|Overall Study|Participant showed weight reduction|0|||
48765274|NCT02641379|156988321|FG009|Overall Study|Participant showed weight reduction|0|||
48765275|NCT02641379|156988322|FG010|Overall Study|Participant showed weight reduction|0|||
48765276|NCT02641379|156988312|FG000|Overall Study|Non-response Week 12|0|||
48765277|NCT02641379|156988313|FG001|Overall Study|Non-response Week 12|0|||
48765278|NCT02641379|156988314|FG002|Overall Study|Non-response Week 12|0|||
48765279|NCT02641379|156988315|FG003|Overall Study|Non-response Week 12|0|||
48765280|NCT02641379|156988316|FG004|Overall Study|Non-response Week 12|0|||
48765281|NCT02641379|156988317|FG005|Overall Study|Non-response Week 12|0|||
48765282|NCT02641379|156988318|FG006|Overall Study|Non-response Week 12|0|||
48765283|NCT02641379|156988319|FG007|Overall Study|Non-response Week 12|1|||
48765284|NCT02641379|156988320|FG008|Overall Study|Non-response Week 12|0|||
48765285|NCT02641379|156988321|FG009|Overall Study|Non-response Week 12|0|||
48765286|NCT02641379|156988322|FG010|Overall Study|Non-response Week 12|0|||
48765287|NCT02641379|156988312|FG000|Overall Study|No 2 Log drop at Week 12|0|||
48765288|NCT02641379|156988313|FG001|Overall Study|No 2 Log drop at Week 12|0|||
48765289|NCT02641379|156988314|FG002|Overall Study|No 2 Log drop at Week 12|0|||
48765290|NCT02641379|156988315|FG003|Overall Study|No 2 Log drop at Week 12|0|||
48765291|NCT02641379|156988316|FG004|Overall Study|No 2 Log drop at Week 12|0|||
48765292|NCT02641379|156988317|FG005|Overall Study|No 2 Log drop at Week 12|0|||
48765293|NCT02641379|156988318|FG006|Overall Study|No 2 Log drop at Week 12|0|||
48765294|NCT02641379|156988319|FG007|Overall Study|No 2 Log drop at Week 12|0|||
48765295|NCT02641379|156988320|FG008|Overall Study|No 2 Log drop at Week 12|0|||
48765296|NCT02641379|156988321|FG009|Overall Study|No 2 Log drop at Week 12|0|||
48765297|NCT02641379|156988322|FG010|Overall Study|No 2 Log drop at Week 12|1|||
48765298|NCT02641379|156988312|FG000|Overall Study|Negative PCR result|0|||
48765299|NCT02641379|156988313|FG001|Overall Study|Negative PCR result|0|||
48765300|NCT02641379|156988314|FG002|Overall Study|Negative PCR result|0|||
48765301|NCT02641379|156988315|FG003|Overall Study|Negative PCR result|0|||
48765302|NCT02641379|156988316|FG004|Overall Study|Negative PCR result|0|||
48765303|NCT02641379|156988317|FG005|Overall Study|Negative PCR result|0|||
48765304|NCT02641379|156988318|FG006|Overall Study|Negative PCR result|0|||
48765305|NCT02641379|156988319|FG007|Overall Study|Negative PCR result|0|||
48765306|NCT02641379|156988320|FG008|Overall Study|Negative PCR result|0|||
48765307|NCT02641379|156988321|FG009|Overall Study|Negative PCR result|1|||
48765308|NCT02641379|156988322|FG010|Overall Study|Negative PCR result|0|||
48765309|NCT02641379|156988312|FG000|Overall Study|Participant's PCR high|0|||
48765310|NCT02641379|156988313|FG001|Overall Study|Participant's PCR high|0|||
48765311|NCT02641379|156988314|FG002|Overall Study|Participant's PCR high|0|||
48765312|NCT02641379|156988315|FG003|Overall Study|Participant's PCR high|0|||
48765313|NCT02641379|156988316|FG004|Overall Study|Participant's PCR high|0|||
48765314|NCT02641379|156988317|FG005|Overall Study|Participant's PCR high|0|||
48765315|NCT02641379|156988318|FG006|Overall Study|Participant's PCR high|0|||
48765316|NCT02641379|156988319|FG007|Overall Study|Participant's PCR high|1|||
48765317|NCT02641379|156988320|FG008|Overall Study|Participant's PCR high|0|||
48765318|NCT02641379|156988321|FG009|Overall Study|Participant's PCR high|0|||
48765319|NCT02641379|156988322|FG010|Overall Study|Participant's PCR high|0|||
48765320|NCT02641379|156988312|FG000|Overall Study|Participant treated after Week 24|0|||
48765321|NCT02641379|156988313|FG001|Overall Study|Participant treated after Week 24|0|||
48765322|NCT02641379|156988314|FG002|Overall Study|Participant treated after Week 24|0|||
48765323|NCT02641379|156988315|FG003|Overall Study|Participant treated after Week 24|0|||
48765324|NCT02641379|156988316|FG004|Overall Study|Participant treated after Week 24|0|||
48393780|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
48393781|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
48393782|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
48393783|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
48393784|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
48393785|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
48393786|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Other|0|||
48393787|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Other|0|||
48393788|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Other|0|||
48393789|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Other|1|||
48393790|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Other|0|||
48393791|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
48393792|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
48393793|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
48393794|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
48393795|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
48393796|NCT00440947|155636005|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
48393797|NCT00440947|155636006|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
48393798|NCT00440947|155636007|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
48393799|NCT00440947|155636008|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
48393800|NCT00440947|155636009|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
48393801|NCT00974675|155636010|FG000|Overall Study|Adverse Event|2|||
48393802|NCT00974675|155636011|FG001|Overall Study|Adverse Event|1|||
48393803|NCT00974675|155636012|FG002|Overall Study|Adverse Event|1|||
48765325|NCT02641379|156988317|FG005|Overall Study|Participant treated after Week 24|0|||
48765326|NCT02641379|156988318|FG006|Overall Study|Participant treated after Week 24|0|||
48765327|NCT02641379|156988319|FG007|Overall Study|Participant treated after Week 24|0|||
48765328|NCT02641379|156988320|FG008|Overall Study|Participant treated after Week 24|1|||
48765329|NCT02641379|156988321|FG009|Overall Study|Participant treated after Week 24|0|||
48765330|NCT02641379|156988322|FG010|Overall Study|Participant treated after Week 24|0|||
48765331|NCT02641379|156988312|FG000|Overall Study|Missing PCR result at Week 8|0|||
48765332|NCT02641379|156988313|FG001|Overall Study|Missing PCR result at Week 8|0|||
48765333|NCT02641379|156988314|FG002|Overall Study|Missing PCR result at Week 8|0|||
48765334|NCT02641379|156988315|FG003|Overall Study|Missing PCR result at Week 8|0|||
48765335|NCT02641379|156988316|FG004|Overall Study|Missing PCR result at Week 8|0|||
48765336|NCT02641379|156988317|FG005|Overall Study|Missing PCR result at Week 8|0|||
48765337|NCT02641379|156988318|FG006|Overall Study|Missing PCR result at Week 8|0|||
48765338|NCT02641379|156988319|FG007|Overall Study|Missing PCR result at Week 8|0|||
48765339|NCT02641379|156988320|FG008|Overall Study|Missing PCR result at Week 8|0|||
48765340|NCT02641379|156988321|FG009|Overall Study|Missing PCR result at Week 8|1|||
48765341|NCT02641379|156988322|FG010|Overall Study|Missing PCR result at Week 8|0|||
48765342|NCT02641379|156988312|FG000|Overall Study|PCR positive|0|||
48765343|NCT02641379|156988313|FG001|Overall Study|PCR positive|0|||
48765344|NCT02641379|156988314|FG002|Overall Study|PCR positive|0|||
48765345|NCT02641379|156988315|FG003|Overall Study|PCR positive|0|||
48765346|NCT02641379|156988316|FG004|Overall Study|PCR positive|0|||
48765347|NCT02641379|156988317|FG005|Overall Study|PCR positive|0|||
48765348|NCT02641379|156988318|FG006|Overall Study|PCR positive|1|||
48765349|NCT02641379|156988319|FG007|Overall Study|PCR positive|0|||
48765350|NCT02641379|156988320|FG008|Overall Study|PCR positive|0|||
48765351|NCT02641379|156988321|FG009|Overall Study|PCR positive|0|||
48765352|NCT02641379|156988322|FG010|Overall Study|PCR positive|0|||
48765353|NCT00271947|156988323|FG000|Overall Study|Lost to Follow-up|1|||
48765354|NCT02818777|156988332|FG000|Overall Study|Adverse Event|3|||
48765355|NCT04220411|156988333|FG000|Overall Study|Adverse Event|0|||
48765356|NCT04220411|156988334|FG001|Overall Study|Adverse Event|0|||
48765357|NCT04220411|156988335|FG002|Overall Study|Adverse Event|0|||
48765358|NCT04220411|156988336|FG003|Overall Study|Adverse Event|1|||
48765359|NCT01398956|156988337|FG000|Overall Study|Withdrawal by Subject|4|||
48765360|NCT01398956|156988337|FG000|Overall Study|AE, non-serious non-fatal|4|||
48765361|NCT01398956|156988337|FG000|Overall Study|Withdrawal Criteria No.3|1|||
48765362|NCT01398956|156988337|FG000|Overall Study|Subject moved a long distance|1|||
48765363|NCT01132495|156988340|FG000|Overall Study|Various reasons|40|||
48765364|NCT01132495|156988341|FG001|Overall Study|Various reasons|38|||
48393804|NCT00974675|155636013|FG003|Overall Study|Adverse Event|1|||
48393805|NCT00974675|155636010|FG000|Overall Study|Physician Decision|0|||
48765365|NCT01132495|156988342|FG002|Overall Study|Various reasons|20|||
48765366|NCT01132495|156988343|FG003|Overall Study|Various reasons|12|||
48765367|NCT00663052|156988344|FG000|Overall Study|Adverse Event|6|||
48765368|NCT00663052|156988345|FG001|Overall Study|Adverse Event|3|||
48765369|NCT00663052|156988344|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
48765370|NCT00663052|156988345|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48765371|NCT00663052|156988344|FG000|Overall Study|Protocol Violation|1|||
48393806|NCT00974675|155636011|FG001|Overall Study|Physician Decision|0|||
48393807|NCT00974675|155636012|FG002|Overall Study|Physician Decision|1|||
48393808|NCT00974675|155636013|FG003|Overall Study|Physician Decision|0|||
48765372|NCT00663052|156988345|FG001|Overall Study|Protocol Violation|0|||
48393809|NCT00974675|155636010|FG000|Overall Study|Participant on holiday; unable to attend|0|||
48765373|NCT00663052|156988344|FG000|Overall Study|Withdrawal by Subject|2|||
48765374|NCT00663052|156988345|FG001|Overall Study|Withdrawal by Subject|5|||
48765375|NCT00663052|156988344|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
48765376|NCT00663052|156988345|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
48765377|NCT00663052|156988344|FG000|Overall Study|Other|0|||
48765378|NCT00663052|156988345|FG001|Overall Study|Other|1|||
48765379|NCT01786629|156990224|FG000|Overall Study|Lack of Efficacy|0|||
48765380|NCT01786629|156990225|FG001|Overall Study|Lack of Efficacy|4|||
48765381|NCT01786629|156990224|FG000|Overall Study|Adverse Event|0|||
48765382|NCT01786629|156990225|FG001|Overall Study|Adverse Event|1|||
48765383|NCT00397982|156990228|FG000|Overall Study|Withdrawal by Subject|1|||
48765384|NCT00397982|156990228|FG000|Overall Study|Adverse Event|1|||
48765385|NCT00397982|156990228|FG000|Overall Study|noncompliance|1|||
48765386|NCT00397982|156990228|FG000|Overall Study|Unrelated health issues|1|||
48765387|NCT04244786|156990229|FG000|Overall Study|Adverse Event|0|||
48765388|NCT04244786|156990230|FG001|Overall Study|Adverse Event|0|||
48765389|NCT04244786|156990231|FG002|Overall Study|Adverse Event|2|||
48765390|NCT04244786|156990229|FG000|Overall Study|Withdrawal by Subject|0|||
48765391|NCT04244786|156990230|FG001|Overall Study|Withdrawal by Subject|0|||
48765392|NCT04244786|156990231|FG002|Overall Study|Withdrawal by Subject|5|||
48765393|NCT00720941|156990232|FG000|Overall Study|Death|334|||
48765394|NCT00720941|156990233|FG001|Overall Study|Death|335|||
48765395|NCT00720941|156990232|FG000|Overall Study|Protocol Violation|0|||
48765396|NCT00720941|156990233|FG001|Overall Study|Protocol Violation|2|||
48765397|NCT00720941|156990232|FG000|Overall Study|Lost to Follow-up|17|||
48765398|NCT00720941|156990233|FG001|Overall Study|Lost to Follow-up|15|||
48765399|NCT00720941|156990232|FG000|Overall Study|Physician Decision|1|||
48765400|NCT00720941|156990233|FG001|Overall Study|Physician Decision|5|||
48765401|NCT00720941|156990232|FG000|Overall Study|Withdrawal by Subject|27|||
48393810|NCT00974675|155636011|FG001|Overall Study|Participant on holiday; unable to attend|0|||
48393811|NCT00974675|155636012|FG002|Overall Study|Participant on holiday; unable to attend|0|||
48393812|NCT00974675|155636013|FG003|Overall Study|Participant on holiday; unable to attend|1|||
48393813|NCT02121262|155636014|FG000|Overall Study|Adverse Event|6|||
48393814|NCT02121262|155636015|FG001|Overall Study|Adverse Event|3|||
48393815|NCT02121262|155636014|FG000|Overall Study|Lack of Efficacy|3|||
48765402|NCT00720941|156990233|FG001|Overall Study|Withdrawal by Subject|35|||
48765403|NCT00720941|156990232|FG000|Overall Study|Ongoing|34|||
48765404|NCT00720941|156990233|FG001|Overall Study|Ongoing|23|||
48765405|NCT00066066|156990237|FG000|Overall Study|Lost to Follow-up|6|||
48765406|NCT00066066|156990238|FG001|Overall Study|Lost to Follow-up|4|||
48765407|NCT00066066|156990239|FG002|Overall Study|Lost to Follow-up|7|||
48765408|NCT00066066|156990240|FG003|Overall Study|Lost to Follow-up|4|||
48765409|NCT00066066|156990241|FG004|Overall Study|Lost to Follow-up|3|||
48765410|NCT00066066|156990242|FG005|Overall Study|Lost to Follow-up|5|||
48765411|NCT01572038|156990247|FG000|Overall Study|Death|648|||
48765412|NCT01572038|156990247|FG000|Overall Study|Withdrawal by Subject|204|||
48765413|NCT01572038|156990247|FG000|Overall Study|Lost to Follow-up|81|||
48765414|NCT01572038|156990247|FG000|Overall Study|Physician Decision|20|||
48765415|NCT01572038|156990247|FG000|Overall Study|Patient Decision|14|||
48765416|NCT01572038|156990247|FG000|Overall Study|Progressive Disease|8|||
48765417|NCT01572038|156990247|FG000|Overall Study|Site Closed Before Completing Form|6|||
48765418|NCT01572038|156990247|FG000|Overall Study|Enrolled into Another Trial|3|||
48765419|NCT01572038|156990247|FG000|Overall Study|Participated in Another Trial|3|||
48765420|NCT01572038|156990247|FG000|Overall Study|Termination by Sponsor|2|||
48765421|NCT01572038|156990247|FG000|Overall Study|Patient Deterioration|1|||
48765422|NCT01572038|156990247|FG000|Overall Study|Sponsor Decision|1|||
48765423|NCT00489853|156990248|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
48765424|NCT00489853|156990249|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
48765425|NCT00489853|156990250|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
48765426|NCT00489853|156990248|FG000|Wash-out Period 1|Adverse Event|0|||
48765427|NCT00489853|156990249|FG001|Wash-out Period 1|Adverse Event|1|||
48765428|NCT00489853|156990250|FG002|Wash-out Period 1|Adverse Event|1|||
48765429|NCT00489853|156990248|FG000|Wash-out Period 1|Protocol Violation|0|||
48765430|NCT00489853|156990249|FG001|Wash-out Period 1|Protocol Violation|1|||
48765431|NCT00489853|156990250|FG002|Wash-out Period 1|Protocol Violation|1|||
48765432|NCT00489853|156990248|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
48765433|NCT00489853|156990249|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
48765434|NCT00489853|156990250|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
48765435|NCT00489853|156990248|FG000|Wash-out Period 2|Adverse Event|1|||
48765436|NCT00489853|156990249|FG001|Wash-out Period 2|Adverse Event|1|||
48765437|NCT00489853|156990250|FG002|Wash-out Period 2|Adverse Event|0|||
48765438|NCT00489853|156990248|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
48765439|NCT00489853|156990249|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
48765440|NCT00489853|156990250|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
48765441|NCT00489853|156990248|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
48765442|NCT00489853|156990249|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
48765443|NCT00489853|156990250|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
48765444|NCT02603809|156990251|FG000|Overall Study|Withdrawal by Subject|4|||
48765445|NCT02603809|156990252|FG001|Overall Study|Withdrawal by Subject|1|||
48765446|NCT02603809|156990253|FG002|Overall Study|Withdrawal by Subject|2|||
48765447|NCT02603809|156990254|FG003|Overall Study|Withdrawal by Subject|3|||
48765448|NCT02603809|156990255|FG004|Overall Study|Withdrawal by Subject|3|||
48765449|NCT02603809|156990256|FG005|Overall Study|Withdrawal by Subject|4|||
48765450|NCT02603809|156990251|FG000|Overall Study|Lost to Follow-up|2|||
48765451|NCT02603809|156990252|FG001|Overall Study|Lost to Follow-up|3|||
48765452|NCT02603809|156990253|FG002|Overall Study|Lost to Follow-up|1|||
48765453|NCT02603809|156990254|FG003|Overall Study|Lost to Follow-up|4|||
48765454|NCT02603809|156990255|FG004|Overall Study|Lost to Follow-up|2|||
48765455|NCT02603809|156990256|FG005|Overall Study|Lost to Follow-up|2|||
48765456|NCT02603809|156990251|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
48765457|NCT02603809|156990252|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
48765458|NCT02603809|156990253|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
48765459|NCT02603809|156990254|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
48765460|NCT02603809|156990255|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
48765461|NCT02603809|156990256|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
48765462|NCT02603809|156990251|FG000|Overall Study|Physician Decision|0|||
48765463|NCT02603809|156990252|FG001|Overall Study|Physician Decision|0|||
48765464|NCT02603809|156990253|FG002|Overall Study|Physician Decision|0|||
48765465|NCT02603809|156990254|FG003|Overall Study|Physician Decision|1|||
48765466|NCT02603809|156990255|FG004|Overall Study|Physician Decision|2|||
48765467|NCT02603809|156990256|FG005|Overall Study|Physician Decision|1|||
48765468|NCT02603809|156990251|FG000|Overall Study|Adverse Event|3|||
48765469|NCT02603809|156990252|FG001|Overall Study|Adverse Event|0|||
48765470|NCT02603809|156990253|FG002|Overall Study|Adverse Event|2|||
48765471|NCT02603809|156990254|FG003|Overall Study|Adverse Event|2|||
48765472|NCT02603809|156990255|FG004|Overall Study|Adverse Event|1|||
48765473|NCT02603809|156990256|FG005|Overall Study|Adverse Event|1|||
48765474|NCT02603809|156990251|FG000|Overall Study|Lack of Efficacy|0|||
48765475|NCT02603809|156990252|FG001|Overall Study|Lack of Efficacy|1|||
48765476|NCT02603809|156990253|FG002|Overall Study|Lack of Efficacy|0|||
48765477|NCT02603809|156990254|FG003|Overall Study|Lack of Efficacy|0|||
48765478|NCT02603809|156990255|FG004|Overall Study|Lack of Efficacy|0|||
48765479|NCT02603809|156990256|FG005|Overall Study|Lack of Efficacy|1|||
48765480|NCT00542919|156990258|FG000|Overall Study|Adverse Event|1|||
48765481|NCT00542919|156990259|FG001|Overall Study|Adverse Event|5|||
48765482|NCT00542919|156990260|FG002|Overall Study|Adverse Event|1|||
48765483|NCT00542919|156990258|FG000|Overall Study|Withdrawal by Subject|1|||
48765484|NCT00542919|156990259|FG001|Overall Study|Withdrawal by Subject|0|||
48765485|NCT00542919|156990260|FG002|Overall Study|Withdrawal by Subject|3|||
48765486|NCT00542919|156990258|FG000|Overall Study|Physician Decision|2|||
48765487|NCT00542919|156990259|FG001|Overall Study|Physician Decision|2|||
48765488|NCT00542919|156990260|FG002|Overall Study|Physician Decision|1|||
48765489|NCT00542919|156990258|FG000|Overall Study|Sponsor Decision|1|||
48765490|NCT00542919|156990259|FG001|Overall Study|Sponsor Decision|0|||
48765491|NCT00542919|156990260|FG002|Overall Study|Sponsor Decision|0|||
48765492|NCT00542919|156990258|FG000|Overall Study|Lost to Follow-up|2|||
48765493|NCT00542919|156990259|FG001|Overall Study|Lost to Follow-up|0|||
48765494|NCT00542919|156990260|FG002|Overall Study|Lost to Follow-up|1|||
48765495|NCT00706641|156990261|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
48765496|NCT00706641|156990261|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
48765497|NCT00706641|156990261|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
48765498|NCT01851720|156990262|FG000|Overall Study|Lost to Follow-up|0|||
48355579|NCT01296555|155498559|FG027|Overall Study|Protocol Violation|0|||
48355580|NCT01296555|155498560|FG028|Overall Study|Protocol Violation|0|||
48355581|NCT01296555|155498532|FG000|Overall Study|Study Terminated By Sponsor|0|||
48355582|NCT01296555|155498533|FG001|Overall Study|Study Terminated By Sponsor|0|||
48355583|NCT01296555|155498534|FG002|Overall Study|Study Terminated By Sponsor|0|||
48355584|NCT01296555|155498535|FG003|Overall Study|Study Terminated By Sponsor|0|||
48355585|NCT01296555|155498536|FG004|Overall Study|Study Terminated By Sponsor|0|||
48355586|NCT01296555|155498537|FG005|Overall Study|Study Terminated By Sponsor|0|||
48355587|NCT01296555|155498538|FG006|Overall Study|Study Terminated By Sponsor|0|||
48393816|NCT02121262|155636015|FG001|Overall Study|Lack of Efficacy|0|||
48765499|NCT01851720|156990263|FG001|Overall Study|Lost to Follow-up|1|||
48765500|NCT02515942|156990264|FG000|Overall Study|Adverse Event|5|||
48765501|NCT02515942|156990265|FG001|Overall Study|Adverse Event|0|||
48765502|NCT02515942|156990266|FG002|Overall Study|Adverse Event|0|||
48765503|NCT02515942|156990264|FG000|Overall Study|Death|0|||
48765504|NCT02515942|156990265|FG001|Overall Study|Death|0|||
48765505|NCT02515942|156990266|FG002|Overall Study|Death|1|||
48765506|NCT02515942|156990264|FG000|Overall Study|Lack of Efficacy|0|||
48765507|NCT02515942|156990265|FG001|Overall Study|Lack of Efficacy|0|||
48765508|NCT02515942|156990266|FG002|Overall Study|Lack of Efficacy|1|||
48765509|NCT02515942|156990264|FG000|Overall Study|Lost to Follow-up|2|||
48765510|NCT02515942|156990265|FG001|Overall Study|Lost to Follow-up|0|||
48765511|NCT02515942|156990266|FG002|Overall Study|Lost to Follow-up|0|||
48765512|NCT02515942|156990264|FG000|Overall Study|Withdrawal by Subject|0|||
48765513|NCT02515942|156990265|FG001|Overall Study|Withdrawal by Subject|3|||
48765514|NCT02515942|156990266|FG002|Overall Study|Withdrawal by Subject|2|||
48765515|NCT00394212|156990269|FG000|Overall Study|Lost to Follow-up|3|||
48765516|NCT00394212|156990270|FG001|Overall Study|Lost to Follow-up|0|||
48393817|NCT02121262|155636014|FG000|Overall Study|Personal Reasons|19|||
48393818|NCT02121262|155636015|FG001|Overall Study|Personal Reasons|5|||
48393819|NCT02121262|155636014|FG000|Overall Study|Protocol Violation|1|||
48393820|NCT02121262|155636015|FG001|Overall Study|Protocol Violation|1|||
48393821|NCT02121262|155636014|FG000|Overall Study|Participant Dropped-out|0|||
48393822|NCT02121262|155636015|FG001|Overall Study|Participant Dropped-out|1|||
48393823|NCT02121262|155636014|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
48393824|NCT02121262|155636015|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
48393825|NCT02121262|155636014|FG000|Overall Study|Consent Withdrawn|1|||
48393826|NCT02121262|155636015|FG001|Overall Study|Consent Withdrawn|0|||
48393827|NCT04744207|155636017|FG000|Treatment|Withdrawal by Subject|2|||
48393828|NCT04744207|155636018|FG001|Treatment|Withdrawal by Subject|0|||
48393829|NCT04744207|155636017|FG000|Treatment|Adverse Event|1|||
48393830|NCT04744207|155636018|FG001|Treatment|Adverse Event|2|||
48393831|NCT00117598|155636023|FG000|Prior to Treatment Cross Over|Death|40|||
48393832|NCT00117598|155636024|FG001|Prior to Treatment Cross Over|Death|41|||
48393833|NCT00117598|155636025|FG002|Prior to Treatment Cross Over|Death|37|||
48393834|NCT00117598|155636026|FG003|Prior to Treatment Cross Over|Death|0|||
48393835|NCT00117598|155636027|FG004|Prior to Treatment Cross Over|Death|0|||
48393836|NCT00117598|155636023|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
48393837|NCT00117598|155636024|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
48765517|NCT00394212|156990269|FG000|Overall Study|Withdrawal by Subject|4|||
48765518|NCT00394212|156990270|FG001|Overall Study|Withdrawal by Subject|1|||
48765519|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
48765520|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
48765521|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
48393838|NCT00117598|155636025|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
48393839|NCT00117598|155636026|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
48393840|NCT00117598|155636027|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
48393841|NCT00117598|155636023|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
48393842|NCT00117598|155636024|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
48430170|NCT00601523|155761978|FG001|Overall Study|Protocol Violation|1|||
48765522|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
48765523|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
48765524|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
48765525|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
48765526|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
48765527|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
48765528|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
48765529|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
48765530|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
48765531|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
48765532|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
48765533|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
48765534|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
48765535|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
48765536|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
48765537|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
48765538|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
48765539|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
48393843|NCT00117598|155636025|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
48393844|NCT00117598|155636026|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
48393845|NCT00117598|155636027|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
48393846|NCT00117598|155636023|FG000|Prior to Treatment Cross Over|Other|15|||
48393847|NCT00117598|155636024|FG001|Prior to Treatment Cross Over|Other|9|||
48393848|NCT00117598|155636025|FG002|Prior to Treatment Cross Over|Other|9|||
48393849|NCT00117598|155636026|FG003|Prior to Treatment Cross Over|Other|0|||
48393850|NCT00117598|155636027|FG004|Prior to Treatment Cross Over|Other|0|||
48393851|NCT00117598|155636023|FG000|After Treament Cross Over|Death|0|||
48765540|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
48765541|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
48765542|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
48765543|NCT00277212|156990271|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
48765544|NCT00277212|156990272|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
48765545|NCT00277212|156990273|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
48765546|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
48765547|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
48765548|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
48765549|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
48765550|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
48765551|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
48765552|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
48765553|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
48765554|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
48765555|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
48765556|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
48765557|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
48765558|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
48765559|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
48765560|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
48765561|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
48765562|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
48765563|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
48765564|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
48765565|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
48765566|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
48765567|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
48765568|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
48765569|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
48765570|NCT00277212|156990271|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
48765571|NCT00277212|156990272|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
48765572|NCT00277212|156990273|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
48765573|NCT00902564|156990274|FG000|Overall Study|Withdrawal by Subject|2|||
48765574|NCT01727141|156990277|FG000|Overall Study|Physician Decision|0|||
48765575|NCT01727141|156990278|FG001|Overall Study|Physician Decision|1|||
48765576|NCT01727141|156990279|FG002|Overall Study|Physician Decision|0|||
48765577|NCT01727141|156990280|FG003|Overall Study|Physician Decision|2|||
48765578|NCT01727141|156990277|FG000|Overall Study|Lost to Follow-up|0|||
48765579|NCT01727141|156990278|FG001|Overall Study|Lost to Follow-up|2|||
48765580|NCT01727141|156990279|FG002|Overall Study|Lost to Follow-up|0|||
48393852|NCT00117598|155636024|FG001|After Treament Cross Over|Death|0|||
48393853|NCT00117598|155636025|FG002|After Treament Cross Over|Death|0|||
48393854|NCT00117598|155636026|FG003|After Treament Cross Over|Death|1|||
48393855|NCT00117598|155636027|FG004|After Treament Cross Over|Death|2|||
48393856|NCT00117598|155636023|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
48393857|NCT00117598|155636024|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
48393858|NCT00117598|155636025|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
48393859|NCT00117598|155636026|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
48393860|NCT00117598|155636027|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
48393861|NCT00117598|155636023|FG000|After Treament Cross Over|Other|0|||
48393862|NCT00117598|155636024|FG001|After Treament Cross Over|Other|0|||
48393863|NCT00117598|155636025|FG002|After Treament Cross Over|Other|0|||
48393864|NCT00117598|155636026|FG003|After Treament Cross Over|Other|1|||
48393865|NCT00117598|155636027|FG004|After Treament Cross Over|Other|2|||
48393866|NCT03223428|155636028|FG000|Overall Study|No longer taking Xermelo|27|||
48393867|NCT03223428|155636028|FG000|Overall Study|Declined Consent|1|||
48393868|NCT03223428|155636028|FG000|Overall Study|Non-responders|56|||
48393869|NCT03223428|155636028|FG000|Overall Study|Withdrawal by Subject|14|||
48393870|NCT01834274|155636029|FG000|Overall Study|Study Termination|41|||
48393871|NCT01834274|155636030|FG001|Overall Study|Study Termination|38|||
48393872|NCT01834274|155636029|FG000|Overall Study|Withdrawal by Subject|1|||
48393873|NCT01834274|155636030|FG001|Overall Study|Withdrawal by Subject|1|||
48393874|NCT01834274|155636029|FG000|Overall Study|Lost to Follow-up|3|||
48393875|NCT01834274|155636030|FG001|Overall Study|Lost to Follow-up|1|||
48393876|NCT01834274|155636029|FG000|Overall Study|Other|2|||
48393877|NCT01834274|155636030|FG001|Overall Study|Other|1|||
48393878|NCT01827670|155636031|FG000|Overall Study|Withdrawal of Consent|3|||
48393879|NCT01827670|155636032|FG001|Overall Study|Withdrawal of Consent|2|||
48393880|NCT01827670|155636031|FG000|Overall Study|Lost to Follow-up|0|||
48393881|NCT01827670|155636032|FG001|Overall Study|Lost to Follow-up|1|||
48393882|NCT02025907|155636033|FG000|Overall Study|Lack of Efficacy|1|||
48393883|NCT02025907|155636034|FG001|Overall Study|Lack of Efficacy|0|||
48393884|NCT02025907|155636033|FG000|Overall Study|Withdrawal by Subject|15|||
48393885|NCT02025907|155636034|FG001|Overall Study|Withdrawal by Subject|8|||
48393886|NCT02025907|155636033|FG000|Overall Study|Protocol Violation|2|||
48393887|NCT02025907|155636034|FG001|Overall Study|Protocol Violation|0|||
48393888|NCT02025907|155636033|FG000|Overall Study|Physician Decision|2|||
48765581|NCT01727141|156990280|FG003|Overall Study|Lost to Follow-up|0|||
48765582|NCT01727141|156990277|FG000|Overall Study|Death|0|||
48765583|NCT01727141|156990278|FG001|Overall Study|Death|1|||
48765584|NCT01727141|156990279|FG002|Overall Study|Death|1|||
48765585|NCT01727141|156990280|FG003|Overall Study|Death|1|||
48765586|NCT01727141|156990277|FG000|Overall Study|Protocol deviation|1|||
48765587|NCT01727141|156990278|FG001|Overall Study|Protocol deviation|1|||
48765588|NCT01727141|156990279|FG002|Overall Study|Protocol deviation|0|||
48765589|NCT01727141|156990280|FG003|Overall Study|Protocol deviation|1|||
48765590|NCT01727141|156990277|FG000|Overall Study|Withdrawal by Subject|4|||
48765591|NCT01727141|156990278|FG001|Overall Study|Withdrawal by Subject|4|||
48765592|NCT01727141|156990279|FG002|Overall Study|Withdrawal by Subject|2|||
48765593|NCT01727141|156990280|FG003|Overall Study|Withdrawal by Subject|11|||
48765594|NCT05620576|156990282|FG000|Overall Study|Adverse Event|1|||
48765595|NCT05620576|156990283|FG001|Overall Study|Adverse Event|1|||
48765596|NCT05620576|156990282|FG000|Overall Study|Lost to Follow-up|3|||
48765597|NCT05620576|156990283|FG001|Overall Study|Lost to Follow-up|1|||
48765598|NCT05620576|156990282|FG000|Overall Study|Physician Decision|0|||
48765599|NCT05620576|156990283|FG001|Overall Study|Physician Decision|1|||
48393889|NCT02025907|155636034|FG001|Overall Study|Physician Decision|0|||
48393890|NCT02025907|155636033|FG000|Overall Study|Lost to Follow-up|2|||
48393891|NCT02025907|155636034|FG001|Overall Study|Lost to Follow-up|2|||
48393892|NCT02025907|155636033|FG000|Overall Study|Adverse Event|3|||
48393893|NCT02025907|155636034|FG001|Overall Study|Adverse Event|1|||
48393894|NCT02025907|155636033|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
48393895|NCT02025907|155636034|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
48393896|NCT00961220|155636038|FG000|Overall Study|Adverse Event|3|||
48393897|NCT00961220|155636038|FG000|Overall Study|Lack of Efficacy|1|||
48393898|NCT00961220|155636038|FG000|Overall Study|No IV access for O6BG|1|||
48393899|NCT00961220|155636038|FG000|Overall Study|O6BG no longer supplied|1|||
48393900|NCT00961220|155636038|FG000|Overall Study|Complete Response prior to 12 courses|1|||
48393901|NCT04288154|155636043|FG000|Overall Study|Withdrawal by Subject|9|||
48393902|NCT04288154|155636044|FG001|Overall Study|Withdrawal by Subject|9|||
48393903|NCT01227044|155636046|FG000|Overall Study|Lost to Follow-up|5|||
48393904|NCT01227044|155636047|FG001|Overall Study|Lost to Follow-up|7|||
48393905|NCT01227044|155636046|FG000|Overall Study|Discontinued Intervention|1|||
48765600|NCT05620576|156990282|FG000|Overall Study|Protocol Deviation|1|||
48765601|NCT05620576|156990283|FG001|Overall Study|Protocol Deviation|1|||
48765602|NCT05620576|156990282|FG000|Overall Study|Withdrawal by Subject|2|||
48765603|NCT05620576|156990283|FG001|Overall Study|Withdrawal by Subject|3|||
48765604|NCT03239470|156990284|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
48765605|NCT03239470|156990285|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
48765606|NCT02622828|156990286|FG000|Overall Study|participant withdrew|3|||
48765607|NCT00116831|156990290|FG000|Overall Study|Adverse Event|14|||
48765608|NCT00116831|156990291|FG001|Overall Study|Adverse Event|16|||
48765609|NCT00116831|156990290|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
48393906|NCT01227044|155636047|FG001|Overall Study|Discontinued Intervention|2|||
48393907|NCT00884273|155636048|FG000|Overall Study|Adverse Event|0|||
48393908|NCT00884273|155636049|FG001|Overall Study|Adverse Event|2|||
48393909|NCT00884273|155636048|FG000|Overall Study|Protocol Violation|1|||
48393910|NCT00884273|155636049|FG001|Overall Study|Protocol Violation|3|||
48765610|NCT00116831|156990291|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
48765611|NCT00116831|156990290|FG000|Overall Study|Lost to Follow-up|8|||
48765612|NCT00116831|156990291|FG001|Overall Study|Lost to Follow-up|6|||
48765613|NCT00116831|156990290|FG000|Overall Study|Protocol Violation|3|||
48393911|NCT00884273|155636048|FG000|Overall Study|Practical reasons|1|||
48393912|NCT00884273|155636049|FG001|Overall Study|Practical reasons|0|||
48393913|NCT00623428|155636050|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
48393914|NCT00623428|155636051|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
48765614|NCT00116831|156990291|FG001|Overall Study|Protocol Violation|6|||
48765615|NCT00116831|156990290|FG000|Overall Study|Hypoglycaemic events|1|||
48765616|NCT00116831|156990291|FG001|Overall Study|Hypoglycaemic events|0|||
48765617|NCT00116831|156990290|FG000|Overall Study|Low haemoglobin on screening|1|||
48765618|NCT00116831|156990291|FG001|Overall Study|Low haemoglobin on screening|0|||
48765619|NCT00116831|156990290|FG000|Overall Study|Withdrawn investigational product|1|||
48765620|NCT00116831|156990291|FG001|Overall Study|Withdrawn investigational product|0|||
48765621|NCT00116831|156990290|FG000|Overall Study|Withdrawal by Subject|32|||
48765622|NCT00116831|156990291|FG001|Overall Study|Withdrawal by Subject|32|||
48765623|NCT00116831|156990290|FG000|Overall Study|Insufficient therapeutic effect|0|||
48765624|NCT00116831|156990291|FG001|Overall Study|Insufficient therapeutic effect|1|||
48765625|NCT00116831|156990290|FG000|Overall Study|Missing data for participant|1|||
48765626|NCT00116831|156990291|FG001|Overall Study|Missing data for participant|0|||
48765627|NCT01649375|156990292|FG000|Up to Week 16|Adverse Event|2|||
48765628|NCT01649375|156990293|FG001|Up to Week 16|Adverse Event|5|||
48765629|NCT01649375|156990294|FG002|Up to Week 16|Adverse Event|4|||
48765630|NCT01649375|156990295|FG003|Up to Week 16|Adverse Event|0|||
48765631|NCT01649375|156990296|FG004|Up to Week 16|Adverse Event|0|||
48765632|NCT01649375|156990292|FG000|Up to Week 16|Lack of Efficacy|0|||
48765633|NCT01649375|156990293|FG001|Up to Week 16|Lack of Efficacy|0|||
48765634|NCT01649375|156990294|FG002|Up to Week 16|Lack of Efficacy|1|||
48765635|NCT01649375|156990295|FG003|Up to Week 16|Lack of Efficacy|0|||
48765636|NCT01649375|156990296|FG004|Up to Week 16|Lack of Efficacy|0|||
48765637|NCT01649375|156990292|FG000|Up to Week 16|Physician Decision|0|||
48765638|NCT01649375|156990293|FG001|Up to Week 16|Physician Decision|0|||
48765639|NCT01649375|156990294|FG002|Up to Week 16|Physician Decision|1|||
48765640|NCT01649375|156990295|FG003|Up to Week 16|Physician Decision|0|||
48765641|NCT01649375|156990296|FG004|Up to Week 16|Physician Decision|0|||
48765642|NCT01649375|156990292|FG000|Up to Week 16|Withdrawal by Subject|2|||
48765643|NCT01649375|156990293|FG001|Up to Week 16|Withdrawal by Subject|1|||
48765644|NCT01649375|156990294|FG002|Up to Week 16|Withdrawal by Subject|2|||
48765645|NCT01649375|156990295|FG003|Up to Week 16|Withdrawal by Subject|0|||
48765646|NCT01649375|156990296|FG004|Up to Week 16|Withdrawal by Subject|0|||
48765647|NCT01649375|156990292|FG000|Up to Week 16|Death|1|||
48765648|NCT01649375|156990293|FG001|Up to Week 16|Death|0|||
48765649|NCT01649375|156990294|FG002|Up to Week 16|Death|0|||
48765650|NCT01649375|156990295|FG003|Up to Week 16|Death|0|||
48765651|NCT01649375|156990296|FG004|Up to Week 16|Death|0|||
48765652|NCT01649375|156990292|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
48765653|NCT01649375|156990293|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
48765654|NCT01649375|156990294|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
48765655|NCT01649375|156990295|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
48765656|NCT01649375|156990296|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
48765657|NCT01649375|156990292|FG000|Week 16 up to Week 260|Non-compliance|0|||
48765658|NCT01649375|156990293|FG001|Week 16 up to Week 260|Non-compliance|1|||
48765659|NCT01649375|156990294|FG002|Week 16 up to Week 260|Non-compliance|0|||
48765660|NCT01649375|156990295|FG003|Week 16 up to Week 260|Non-compliance|1|||
48765661|NCT01649375|156990296|FG004|Week 16 up to Week 260|Non-compliance|0|||
48765662|NCT01649375|156990292|FG000|Week 16 up to Week 260|Physician Decision|0|||
48393915|NCT00623428|155636050|FG000|Treatment Period|Death|0|||
48765663|NCT01649375|156990293|FG001|Week 16 up to Week 260|Physician Decision|2|||
48765664|NCT01649375|156990294|FG002|Week 16 up to Week 260|Physician Decision|0|||
48765665|NCT01649375|156990295|FG003|Week 16 up to Week 260|Physician Decision|0|||
48765666|NCT01649375|156990296|FG004|Week 16 up to Week 260|Physician Decision|0|||
48765667|NCT01649375|156990292|FG000|Week 16 up to Week 260|Technical issues|0|||
48765668|NCT01649375|156990293|FG001|Week 16 up to Week 260|Technical issues|1|||
48765669|NCT01649375|156990294|FG002|Week 16 up to Week 260|Technical issues|0|||
48765670|NCT01649375|156990295|FG003|Week 16 up to Week 260|Technical issues|1|||
48393916|NCT00623428|155636051|FG001|Treatment Period|Death|1|||
48393917|NCT00623428|155636050|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
48393918|NCT00623428|155636051|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
48393919|NCT00623428|155636050|FG000|Treatment Period|Insufficient therapeutic response|0|||
48393920|NCT00623428|155636051|FG001|Treatment Period|Insufficient therapeutic response|2|||
48393921|NCT00623428|155636050|FG000|Treatment Period|Other|0|||
48393922|NCT00623428|155636051|FG001|Treatment Period|Other|1|||
48393923|NCT00623428|155636050|FG000|Treatment Period|Withdrawal by Subject|0|||
48393924|NCT00623428|155636051|FG001|Treatment Period|Withdrawal by Subject|1|||
48393925|NCT00623428|155636050|FG000|Follow-up Period|Relapse post-treatment|11|||
48393926|NCT00623428|155636051|FG001|Follow-up Period|Relapse post-treatment|3|||
48393927|NCT00623428|155636050|FG000|Follow-up Period|Failure to return|10|||
48393928|NCT00623428|155636051|FG001|Follow-up Period|Failure to return|2|||
48393929|NCT00623428|155636050|FG000|Follow-up Period|Patient withdrew consent|5|||
48393930|NCT00623428|155636051|FG001|Follow-up Period|Patient withdrew consent|4|||
48393931|NCT00623428|155636050|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
48393932|NCT00623428|155636051|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
48393933|NCT00623428|155636050|FG000|Follow-up Period|Did not cooperate|0|||
48393934|NCT00623428|155636051|FG001|Follow-up Period|Did not cooperate|3|||
48393935|NCT00623428|155636050|FG000|Follow-up Period|Reason not specified|1|||
48393936|NCT00623428|155636051|FG001|Follow-up Period|Reason not specified|1|||
48393937|NCT00623428|155636050|FG000|Follow-up Period|Death|0|||
48393938|NCT00623428|155636051|FG001|Follow-up Period|Death|1|||
48393939|NCT03215771|155636052|FG000|Overall Study|Withdrawal by Subject|2|||
48393940|NCT03215771|155636052|FG000|Overall Study|Physician Decision|1|||
48393941|NCT00736255|155638038|FG000|Overall Study|Adverse Event|1|||
48393942|NCT00736255|155638039|FG001|Overall Study|Adverse Event|0|||
48393943|NCT00736255|155638038|FG000|Overall Study|Physician Decision|1|||
48393944|NCT00736255|155638039|FG001|Overall Study|Physician Decision|0|||
48393945|NCT00736255|155638038|FG000|Overall Study|Non-compliance|1|||
48393946|NCT00736255|155638039|FG001|Overall Study|Non-compliance|1|||
48393947|NCT00075023|155638050|FG000|Pilot Study|Physician Decision|1|||
48393948|NCT00075023|155638051|FG001|Pilot Study|Physician Decision|2|||
48393949|NCT00075023|155638050|FG000|Pilot Study|Withdrawal by Subject|1|||
48765671|NCT01649375|156990296|FG004|Week 16 up to Week 260|Technical issues|0|||
48765672|NCT01649375|156990292|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
48765673|NCT01649375|156990293|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
48765674|NCT01649375|156990294|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
48765675|NCT01649375|156990295|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
48765676|NCT01649375|156990296|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
48765677|NCT01649375|156990292|FG000|Week 16 up to Week 260|Death|1|||
48765678|NCT01649375|156990293|FG001|Week 16 up to Week 260|Death|1|||
48765679|NCT01649375|156990294|FG002|Week 16 up to Week 260|Death|0|||
48765680|NCT01649375|156990295|FG003|Week 16 up to Week 260|Death|0|||
48765681|NCT01649375|156990296|FG004|Week 16 up to Week 260|Death|0|||
48765682|NCT01649375|156990292|FG000|Week 16 up to Week 260|Adverse Event|5|||
48765683|NCT01649375|156990293|FG001|Week 16 up to Week 260|Adverse Event|2|||
48765684|NCT01649375|156990294|FG002|Week 16 up to Week 260|Adverse Event|0|||
48765685|NCT01649375|156990295|FG003|Week 16 up to Week 260|Adverse Event|3|||
48765686|NCT01649375|156990296|FG004|Week 16 up to Week 260|Adverse Event|2|||
48765687|NCT01856790|156990299|FG000|Closed Loop Control|Withdrawal by Subject|2|||
48765688|NCT01856790|156990299|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
48765689|NCT04765358|156990300|FG000|Overall Study|Withdrawal by Subject|1|||
48765690|NCT01802775|156990303|FG000|Overall Study|Death|0|||
48765691|NCT01802775|156990304|FG001|Overall Study|Death|3|||
48765692|NCT01802775|156990303|FG000|Overall Study|Reason not provided|0|||
48765693|NCT01802775|156990304|FG001|Overall Study|Reason not provided|1|||
48765694|NCT01802775|156990303|FG000|Overall Study|Physician Decision|1|||
48765695|NCT01802775|156990304|FG001|Overall Study|Physician Decision|0|||
48765696|NCT01802775|156990303|FG000|Overall Study|Adverse Event|1|||
48765697|NCT01802775|156990304|FG001|Overall Study|Adverse Event|1|||
48765698|NCT01802775|156990303|FG000|Overall Study|Withdrawal by Subject|3|||
48765699|NCT01802775|156990304|FG001|Overall Study|Withdrawal by Subject|5|||
48765700|NCT01802775|156990303|FG000|Overall Study|Lost to Follow-up|1|||
48765701|NCT01802775|156990304|FG001|Overall Study|Lost to Follow-up|2|||
48765702|NCT01096784|156990305|FG000|Overall Study|Withdrawal by Subject|2|||
48393950|NCT00075023|155638051|FG001|Pilot Study|Withdrawal by Subject|0|||
48393951|NCT00916357|155638054|FG000|Period 1|Withdrawal by Subject|1|||
48393952|NCT00916357|155638055|FG001|Period 1|Withdrawal by Subject|0|||
48393953|NCT00916357|155638056|FG002|Period 1|Withdrawal by Subject|0|||
48393954|NCT00916357|155638057|FG003|Period 1|Withdrawal by Subject|0|||
48393955|NCT00916357|155638058|FG004|Period 1|Withdrawal by Subject|0|||
48393956|NCT00916357|155638059|FG005|Period 1|Withdrawal by Subject|0|||
48393957|NCT00916357|155638054|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
48765703|NCT01096784|156990306|FG001|Overall Study|Withdrawal by Subject|1|||
48765704|NCT01096784|156990305|FG000|Overall Study|Adverse Event|11|||
48393958|NCT00916357|155638055|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
48393959|NCT00916357|155638056|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
48393960|NCT00916357|155638057|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
48393961|NCT00916357|155638058|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
48393962|NCT00916357|155638059|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
48393963|NCT00772954|155638060|FG000|Overall Study|Adverse Event|0|||
48393964|NCT00772954|155638061|FG001|Overall Study|Adverse Event|0|||
48393965|NCT00772954|155638062|FG002|Overall Study|Adverse Event|1|||
48393966|NCT01773109|155638063|FG000|Overall Study|Symptomatic Progression|2|||
48393967|NCT01773109|155638063|FG000|Overall Study|Death|1|||
48393968|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
48393969|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
48393970|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
48393971|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
48393972|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
48393973|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
48393974|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
48393975|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
48393976|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
48393977|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
48393978|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
48393979|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
48393980|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
48765705|NCT01096784|156990306|FG001|Overall Study|Adverse Event|9|||
48765706|NCT01096784|156990305|FG000|Overall Study|Protocol Deviation|2|||
48765707|NCT01096784|156990306|FG001|Overall Study|Protocol Deviation|2|||
48765708|NCT01096784|156990305|FG000|Overall Study|Administrative Decision|0|||
48765709|NCT01096784|156990306|FG001|Overall Study|Administrative Decision|1|||
48765710|NCT01096784|156990305|FG000|Overall Study|Other Unspecified|0|||
48765711|NCT01096784|156990306|FG001|Overall Study|Other Unspecified|1|||
48765712|NCT02418468|156990315|FG000|Overall Study|Adverse Event|1|||
48765713|NCT02418468|156990316|FG001|Overall Study|Adverse Event|0|||
48765714|NCT02418468|156990315|FG000|Overall Study|Withdrawal of informed consent|1|||
48765715|NCT02418468|156990316|FG001|Overall Study|Withdrawal of informed consent|1|||
48765716|NCT01488097|156990326|FG000|Overall Study|Lost to Follow-up|1|||
48765717|NCT01577758|156990330|FG000|Dose Escalation Phase|Adverse Event|0|||
48765718|NCT01577758|156990331|FG001|Dose Escalation Phase|Adverse Event|0|||
48765719|NCT01577758|156990332|FG002|Dose Escalation Phase|Adverse Event|0|||
48765720|NCT01577758|156990333|FG003|Dose Escalation Phase|Adverse Event|0|||
48765721|NCT01577758|156990334|FG004|Dose Escalation Phase|Adverse Event|0|||
48765722|NCT01577758|156990335|FG005|Dose Escalation Phase|Adverse Event|2|||
48765723|NCT01577758|156990336|FG006|Dose Escalation Phase|Adverse Event|1|||
48765724|NCT01577758|156990337|FG007|Dose Escalation Phase|Adverse Event|0|||
48765725|NCT01577758|156990330|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765726|NCT01577758|156990331|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765727|NCT01577758|156990332|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
48765728|NCT01577758|156990333|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765729|NCT01577758|156990334|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
48765730|NCT01577758|156990335|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
48765731|NCT01577758|156990336|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765732|NCT01577758|156990337|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
48765733|NCT01577758|156990330|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48765734|NCT01577758|156990331|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48765735|NCT01577758|156990332|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48765736|NCT01577758|156990333|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48765737|NCT01577758|156990334|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
48765738|NCT01577758|156990335|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
48765739|NCT01577758|156990336|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
48765740|NCT01577758|156990337|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
48765741|NCT01577758|156990330|FG000|Dose Escalation Phase|Progression Disease|2|||
48765742|NCT01577758|156990331|FG001|Dose Escalation Phase|Progression Disease|2|||
48765743|NCT01577758|156990332|FG002|Dose Escalation Phase|Progression Disease|1|||
48765744|NCT01577758|156990333|FG003|Dose Escalation Phase|Progression Disease|2|||
48765745|NCT01577758|156990334|FG004|Dose Escalation Phase|Progression Disease|5|||
48393981|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
48765746|NCT01577758|156990335|FG005|Dose Escalation Phase|Progression Disease|0|||
48765747|NCT01577758|156990336|FG006|Dose Escalation Phase|Progression Disease|0|||
48765748|NCT01577758|156990337|FG007|Dose Escalation Phase|Progression Disease|0|||
48393982|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
48393983|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
48393984|NCT00094770|155638066|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
48765749|NCT01577758|156990330|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765750|NCT01577758|156990331|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765751|NCT01577758|156990332|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765752|NCT01577758|156990333|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765753|NCT01577758|156990334|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765754|NCT01577758|156990335|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765755|NCT01577758|156990336|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
48765756|NCT01577758|156990337|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
48765757|NCT01577758|156990330|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765758|NCT01577758|156990331|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765759|NCT01577758|156990332|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765760|NCT01577758|156990333|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765761|NCT01577758|156990334|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765762|NCT01577758|156990335|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765763|NCT01577758|156990336|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
48765764|NCT01577758|156990337|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
48765765|NCT01577758|156990330|FG000|mCRC Expansion Phase|Progression Disease|0|||
48765766|NCT01577758|156990331|FG001|mCRC Expansion Phase|Progression Disease|0|||
48765767|NCT01577758|156990332|FG002|mCRC Expansion Phase|Progression Disease|0|||
48765768|NCT01577758|156990333|FG003|mCRC Expansion Phase|Progression Disease|0|||
48765769|NCT01577758|156990334|FG004|mCRC Expansion Phase|Progression Disease|0|||
48765770|NCT01577758|156990335|FG005|mCRC Expansion Phase|Progression Disease|0|||
48765771|NCT01577758|156990336|FG006|mCRC Expansion Phase|Progression Disease|0|||
48765772|NCT01577758|156990337|FG007|mCRC Expansion Phase|Progression Disease|19|||
48765773|NCT04327999|156990342|FG000|Overall Study|Protocol Violation|1|||
48765774|NCT00486265|156990347|FG000|Overall Study|Adverse Event|1|||
48765775|NCT00486265|156990347|FG000|Overall Study|Lack of Efficacy|8|||
48765776|NCT01907828|156990352|FG000|Overall Study|Exclusion criteria not met|0|||
48765777|NCT01907828|156990353|FG001|Overall Study|Exclusion criteria not met|1|||
48765778|NCT01907828|156990352|FG000|Overall Study|Withdrawal by Subject|3|||
48765779|NCT01907828|156990353|FG001|Overall Study|Withdrawal by Subject|4|||
48765780|NCT01907828|156990352|FG000|Overall Study|Lost to Follow-up|3|||
48765781|NCT01907828|156990353|FG001|Overall Study|Lost to Follow-up|0|||
48765782|NCT01907828|156990352|FG000|Overall Study|Participant refused 24-month follow-up|1|||
48765783|NCT01907828|156990353|FG001|Overall Study|Participant refused 24-month follow-up|0|||
48765784|NCT01907828|156990352|FG000|Overall Study|Participant met exclusion criteria|0|||
48765785|NCT01907828|156990353|FG001|Overall Study|Participant met exclusion criteria|1|||
48765786|NCT00805766|156990354|FG000|Screening Period|Adverse Event|1|||
48765787|NCT00805766|156990354|FG000|Screening Period|Lack of Efficacy|2|||
48765788|NCT00805766|156990354|FG000|Screening Period|Pregnancy|1|||
48765789|NCT00805766|156990354|FG000|Screening Period|Responder|2|||
48765790|NCT00805766|156990354|FG000|Increased Dose Period|Adverse Event|4|||
48765791|NCT00805766|156990354|FG000|Increased Dose Period|Lack of Efficacy|7|||
48765792|NCT00805766|156990354|FG000|Increased Dose Period|Pregnancy|1|||
48765793|NCT00805766|156990354|FG000|Increased Dose Period|Withdrawal by Subject|1|||
48765794|NCT00696137|156990355|FG000|Overall Study|Withdrawal by Subject|2|||
48765795|NCT02073279|156990356|FG000|Double-blind Period|Adverse Event|1|||
48765796|NCT02073279|156990357|FG001|Double-blind Period|Adverse Event|1|||
48765797|NCT02073279|156990356|FG000|Double-blind Period|Switched to another treatment|1|||
48765798|NCT02073279|156990357|FG001|Double-blind Period|Switched to another treatment|2|||
48765799|NCT02073279|156990356|FG000|Double-blind Period|Protocol Violation|0|||
48765800|NCT02073279|156990357|FG001|Double-blind Period|Protocol Violation|1|||
48765801|NCT02073279|156990356|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
48765802|NCT02073279|156990357|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
48765803|NCT02073279|156990356|FG000|Double-blind Period|Withdrawal by Subject|2|||
48765804|NCT02073279|156990357|FG001|Double-blind Period|Withdrawal by Subject|2|||
48765805|NCT02073279|156990356|FG000|Open-label Extension Period|Adverse Event|1|||
48765806|NCT02073279|156990357|FG001|Open-label Extension Period|Adverse Event|0|||
48765807|NCT02073279|156990356|FG000|Open-label Extension Period|Lack of Efficacy|1|||
48355588|NCT01296555|155498539|FG007|Overall Study|Study Terminated By Sponsor|0|||
48355589|NCT01296555|155498540|FG008|Overall Study|Study Terminated By Sponsor|0|||
48355590|NCT01296555|155498541|FG009|Overall Study|Study Terminated By Sponsor|0|||
48355591|NCT01296555|155498542|FG010|Overall Study|Study Terminated By Sponsor|0|||
48355592|NCT01296555|155498543|FG011|Overall Study|Study Terminated By Sponsor|0|||
48355593|NCT01296555|155498544|FG012|Overall Study|Study Terminated By Sponsor|0|||
48765808|NCT02073279|156990357|FG001|Open-label Extension Period|Lack of Efficacy|0|||
48765809|NCT02073279|156990356|FG000|Open-label Extension Period|Lost to Follow-up|0|||
48765810|NCT02073279|156990357|FG001|Open-label Extension Period|Lost to Follow-up|4|||
48393985|NCT00094770|155638067|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
48765811|NCT02073279|156990356|FG000|Open-label Extension Period|Switched to another treatment|1|||
48355594|NCT01296555|155498545|FG013|Overall Study|Study Terminated By Sponsor|0|||
48355595|NCT01296555|155498546|FG014|Overall Study|Study Terminated By Sponsor|0|||
48355596|NCT01296555|155498547|FG015|Overall Study|Study Terminated By Sponsor|0|||
48765812|NCT02073279|156990357|FG001|Open-label Extension Period|Switched to another treatment|4|||
48765813|NCT02073279|156990356|FG000|Open-label Extension Period|Protocol Violation|0|||
48355597|NCT01296555|155498548|FG016|Overall Study|Study Terminated By Sponsor|0|||
48355598|NCT01296555|155498549|FG017|Overall Study|Study Terminated By Sponsor|0|||
48355599|NCT01296555|155498550|FG018|Overall Study|Study Terminated By Sponsor|0|||
48355600|NCT01296555|155498551|FG019|Overall Study|Study Terminated By Sponsor|0|||
48355601|NCT01296555|155498552|FG020|Overall Study|Study Terminated By Sponsor|0|||
48355602|NCT01296555|155498553|FG021|Overall Study|Study Terminated By Sponsor|0|||
48355603|NCT01296555|155498554|FG022|Overall Study|Study Terminated By Sponsor|0|||
48355604|NCT01296555|155498555|FG023|Overall Study|Study Terminated By Sponsor|0|||
48355605|NCT01296555|155498556|FG024|Overall Study|Study Terminated By Sponsor|0|||
48355606|NCT01296555|155498557|FG025|Overall Study|Study Terminated By Sponsor|1|||
48355607|NCT01296555|155498558|FG026|Overall Study|Study Terminated By Sponsor|0|||
48355608|NCT01296555|155498559|FG027|Overall Study|Study Terminated By Sponsor|0|||
48355609|NCT01296555|155498560|FG028|Overall Study|Study Terminated By Sponsor|0|||
48355610|NCT01296555|155498532|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355611|NCT01296555|155498533|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355612|NCT01296555|155498534|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355613|NCT01296555|155498535|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355614|NCT01296555|155498536|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355615|NCT01296555|155498537|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355616|NCT01296555|155498538|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355617|NCT01296555|155498539|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355618|NCT01296555|155498540|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355619|NCT01296555|155498541|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355620|NCT01296555|155498542|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355621|NCT01296555|155498543|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355622|NCT01296555|155498544|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355623|NCT01296555|155498545|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355624|NCT01296555|155498546|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355625|NCT01296555|155498547|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355626|NCT01296555|155498548|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355627|NCT01296555|155498549|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355628|NCT01296555|155498550|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355629|NCT01296555|155498551|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
48355630|NCT01296555|155498552|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355631|NCT01296555|155498553|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355632|NCT01296555|155498554|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355633|NCT01296555|155498555|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355634|NCT01296555|155498556|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355635|NCT01296555|155498557|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355636|NCT01296555|155498558|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355637|NCT01296555|155498559|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355638|NCT01296555|155498560|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
48355639|NCT01296555|155498532|FG000|Overall Study|Death|0|||
48355640|NCT01296555|155498533|FG001|Overall Study|Death|0|||
48765814|NCT02073279|156990357|FG001|Open-label Extension Period|Protocol Violation|1|||
48765815|NCT02073279|156990356|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
48765816|NCT02073279|156990357|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
48765817|NCT02073279|156990356|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
48765818|NCT02073279|156990357|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
48765819|NCT01116232|156990359|FG000|Overall Study|Progressive diease|4|||
48765820|NCT02519712|156990361|FG000|Overall Study|Disease Relapse|1|||
48765821|NCT02519712|156990361|FG000|Overall Study|Disease Progression|1|||
48765822|NCT02519712|156990361|FG000|Overall Study|Accruals are donors|2|||
48765823|NCT01124643|156990362|FG000|Overall Study|Death|1|||
48765824|NCT00291668|156990363|FG000|Overall Study|Lack of Efficacy|1|||
48765825|NCT00291668|156990364|FG001|Overall Study|Lack of Efficacy|0|||
48765826|NCT00291668|156990365|FG002|Overall Study|Lack of Efficacy|0|||
48765827|NCT00291668|156990363|FG000|Overall Study|SAE, non-fatal|1|||
48765828|NCT00291668|156990364|FG001|Overall Study|SAE, non-fatal|1|||
48765829|NCT00291668|156990365|FG002|Overall Study|SAE, non-fatal|1|||
48765830|NCT00291668|156990363|FG000|Overall Study|AE, non-serious non-fatal|1|||
48765831|NCT00291668|156990364|FG001|Overall Study|AE, non-serious non-fatal|0|||
48765832|NCT00291668|156990365|FG002|Overall Study|AE, non-serious non-fatal|0|||
48765833|NCT00291668|156990363|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
48765834|NCT00291668|156990364|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48765835|NCT00291668|156990365|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
48765836|NCT04059146|156990366|FG000|Overall Study|Withdrawal by Subject|0|||
48765837|NCT04059146|156990367|FG001|Overall Study|Withdrawal by Subject|1|||
48765838|NCT03323658|156990372|FG000|Overall Study|Adverse Event|0|||
48765839|NCT03323658|156990373|FG001|Overall Study|Adverse Event|1|||
48765840|NCT03323658|156990374|FG002|Overall Study|Adverse Event|0|||
48355641|NCT01296555|155498534|FG002|Overall Study|Death|0|||
48765841|NCT03913091|156990379|FG000|Overall Study|Lost to Follow-up|18|||
48765842|NCT03913091|156990380|FG001|Overall Study|Lost to Follow-up|11|||
48765843|NCT03913091|156990379|FG000|Overall Study|Required additional meds/surgery|1|||
48765844|NCT03913091|156990380|FG001|Overall Study|Required additional meds/surgery|2|||
48765845|NCT03913091|156990379|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
48765846|NCT03913091|156990380|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
48765847|NCT00082433|156990381|FG000|Overall Study|Adverse Event|12|||
48765848|NCT00082433|156990382|FG001|Overall Study|Adverse Event|17|||
48765849|NCT00082433|156990381|FG000|Overall Study|Death|8|||
48765850|NCT00082433|156990382|FG001|Overall Study|Death|18|||
48355642|NCT01296555|155498535|FG003|Overall Study|Death|2|||
48355643|NCT01296555|155498536|FG004|Overall Study|Death|1|||
48765851|NCT00082433|156990381|FG000|Overall Study|Disease Progression/Relapse|270|||
48765852|NCT00082433|156990382|FG001|Overall Study|Disease Progression/Relapse|388|||
48765853|NCT00082433|156990381|FG000|Overall Study|Physician Decision|50|||
48765854|NCT00082433|156990382|FG001|Overall Study|Physician Decision|61|||
48765855|NCT00082433|156990381|FG000|Overall Study|Lost to Follow-up|1|||
48765856|NCT00082433|156990382|FG001|Overall Study|Lost to Follow-up|2|||
48765857|NCT00082433|156990381|FG000|Overall Study|Study Drug Toxicity|179|||
48765858|NCT00082433|156990382|FG001|Overall Study|Study Drug Toxicity|66|||
48765859|NCT00082433|156990381|FG000|Overall Study|Withdrawal by Subject|55|||
48765860|NCT00082433|156990382|FG001|Overall Study|Withdrawal by Subject|30|||
48765861|NCT00082433|156990381|FG000|Overall Study|Still On Treatment|2|||
48765862|NCT00082433|156990382|FG001|Overall Study|Still On Treatment|1|||
48765863|NCT00082433|156990381|FG000|Overall Study|Not Treated|12|||
48765864|NCT00082433|156990382|FG001|Overall Study|Not Treated|11|||
48765865|NCT00082433|156990381|FG000|Overall Study|Ineligible|2|||
48765866|NCT00082433|156990382|FG001|Overall Study|Ineligible|1|||
48765867|NCT00082433|156990381|FG000|Overall Study|Noncompliance|2|||
48765868|NCT00082433|156990382|FG001|Overall Study|Noncompliance|1|||
48765869|NCT00082433|156990381|FG000|Overall Study|New primary cancer|1|||
48765870|NCT00082433|156990382|FG001|Overall Study|New primary cancer|0|||
48765871|NCT00082433|156990381|FG000|Overall Study|Impending surgery|0|||
48765872|NCT00082433|156990382|FG001|Overall Study|Impending surgery|1|||
48765873|NCT00558103|156990384|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
48765874|NCT00558103|156990385|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
48765875|NCT00558103|156990386|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
48765876|NCT00558103|156990387|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
48765877|NCT00558103|156990388|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
48765878|NCT00558103|156990389|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
48765879|NCT00558103|156990384|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
48765880|NCT00558103|156990385|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
48765881|NCT00558103|156990386|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
48765882|NCT00558103|156990387|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
48765883|NCT00558103|156990388|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
48765884|NCT00558103|156990389|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
48765885|NCT00558103|156990384|FG000|Randomized Treatment Phase|Disease Progression|1|||
48765886|NCT00558103|156990385|FG001|Randomized Treatment Phase|Disease Progression|0|||
48765887|NCT00558103|156990386|FG002|Randomized Treatment Phase|Disease Progression|1|||
48765888|NCT00558103|156990387|FG003|Randomized Treatment Phase|Disease Progression|0|||
48765889|NCT00558103|156990388|FG004|Randomized Treatment Phase|Disease Progression|0|||
48765890|NCT00558103|156990389|FG005|Randomized Treatment Phase|Disease Progression|0|||
48765891|NCT00558103|156990384|FG000|Randomized Treatment Phase|Adverse Event|0|||
48765892|NCT00558103|156990385|FG001|Randomized Treatment Phase|Adverse Event|0|||
48765893|NCT00558103|156990386|FG002|Randomized Treatment Phase|Adverse Event|0|||
48765894|NCT00558103|156990387|FG003|Randomized Treatment Phase|Adverse Event|1|||
48765895|NCT00558103|156990388|FG004|Randomized Treatment Phase|Adverse Event|1|||
48765896|NCT00558103|156990389|FG005|Randomized Treatment Phase|Adverse Event|0|||
48765897|NCT00558103|156990384|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
48765898|NCT00558103|156990385|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
48765899|NCT00558103|156990386|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
48765900|NCT00558103|156990387|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
48765901|NCT00558103|156990388|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
48355644|NCT01296555|155498537|FG005|Overall Study|Death|0|||
48355645|NCT01296555|155498538|FG006|Overall Study|Death|2|||
48355646|NCT01296555|155498539|FG007|Overall Study|Death|0|||
48355647|NCT01296555|155498540|FG008|Overall Study|Death|0|||
48355648|NCT01296555|155498541|FG009|Overall Study|Death|1|||
48355649|NCT01296555|155498542|FG010|Overall Study|Death|0|||
48355650|NCT01296555|155498543|FG011|Overall Study|Death|1|||
48355651|NCT01296555|155498544|FG012|Overall Study|Death|0|||
48765902|NCT00558103|156990389|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
48765903|NCT00558103|156990384|FG000|Monotherapy Extension Phase|Disease Progression|0|||
48765904|NCT00558103|156990385|FG001|Monotherapy Extension Phase|Disease Progression|0|||
48765905|NCT00558103|156990386|FG002|Monotherapy Extension Phase|Disease Progression|0|||
48765906|NCT00558103|156990387|FG003|Monotherapy Extension Phase|Disease Progression|0|||
48765907|NCT00558103|156990388|FG004|Monotherapy Extension Phase|Disease Progression|0|||
48765908|NCT00558103|156990389|FG005|Monotherapy Extension Phase|Disease Progression|8|||
48765909|NCT03388138|156992426|FG000|Overall Study|Protocol Violation|1|||
48765910|NCT03388138|156992427|FG001|Overall Study|Protocol Violation|0|||
48765911|NCT03336216|156992428|FG000|Randomization|Not reported|2|||
48765912|NCT03336216|156992429|FG001|Randomization|Not reported|0|||
48765913|NCT03336216|156992430|FG002|Randomization|Not reported|1|||
48765914|NCT03336216|156992431|FG003|Randomization|Not reported|0|||
48765915|NCT03336216|156992428|FG000|Randomization|Other reasons|1|||
48765916|NCT03336216|156992429|FG001|Randomization|Other reasons|1|||
48765917|NCT03336216|156992430|FG002|Randomization|Other reasons|1|||
48765918|NCT03336216|156992431|FG003|Randomization|Other reasons|0|||
48765919|NCT03336216|156992428|FG000|Randomization|Participant no longer meets study criteria|0|||
48765920|NCT03336216|156992429|FG001|Randomization|Participant no longer meets study criteria|2|||
48765921|NCT03336216|156992430|FG002|Randomization|Participant no longer meets study criteria|4|||
48765922|NCT03336216|156992431|FG003|Randomization|Participant no longer meets study criteria|1|||
48765923|NCT03336216|156992428|FG000|Randomization|Lost to Follow-up|1|||
48765924|NCT03336216|156992429|FG001|Randomization|Lost to Follow-up|0|||
48765925|NCT03336216|156992430|FG002|Randomization|Lost to Follow-up|0|||
48765926|NCT03336216|156992431|FG003|Randomization|Lost to Follow-up|0|||
48765927|NCT03336216|156992428|FG000|Randomization|Participant withdrew consent|9|||
48765928|NCT03336216|156992429|FG001|Randomization|Participant withdrew consent|1|||
48765929|NCT03336216|156992430|FG002|Randomization|Participant withdrew consent|0|||
48765930|NCT03336216|156992431|FG003|Randomization|Participant withdrew consent|0|||
48765931|NCT03336216|156992428|FG000|Randomization|Adverse Event|1|||
48765932|NCT03336216|156992429|FG001|Randomization|Adverse Event|1|||
48765933|NCT03336216|156992430|FG002|Randomization|Adverse Event|0|||
48765934|NCT03336216|156992431|FG003|Randomization|Adverse Event|0|||
48765935|NCT03336216|156992428|FG000|Treatment|Adverse Event|2|||
48765936|NCT03336216|156992429|FG001|Treatment|Adverse Event|3|||
48765937|NCT03336216|156992430|FG002|Treatment|Adverse Event|4|||
48765938|NCT03336216|156992431|FG003|Treatment|Adverse Event|4|||
48765939|NCT03336216|156992428|FG000|Treatment|Participant request to discontinue treatment|2|||
48765940|NCT03336216|156992429|FG001|Treatment|Participant request to discontinue treatment|1|||
48765941|NCT03336216|156992430|FG002|Treatment|Participant request to discontinue treatment|2|||
48765942|NCT03336216|156992431|FG003|Treatment|Participant request to discontinue treatment|2|||
48765943|NCT03336216|156992428|FG000|Treatment|Participant withdrew consent|7|||
48765944|NCT03336216|156992429|FG001|Treatment|Participant withdrew consent|2|||
48765945|NCT03336216|156992430|FG002|Treatment|Participant withdrew consent|3|||
48765946|NCT03336216|156992431|FG003|Treatment|Participant withdrew consent|2|||
48765947|NCT03336216|156992428|FG000|Treatment|Death|2|||
48765948|NCT03336216|156992429|FG001|Treatment|Death|3|||
48765949|NCT03336216|156992430|FG002|Treatment|Death|3|||
48765950|NCT03336216|156992431|FG003|Treatment|Death|4|||
48765951|NCT03336216|156992428|FG000|Treatment|Participant no longer meets study criteria|0|||
48765952|NCT03336216|156992429|FG001|Treatment|Participant no longer meets study criteria|1|||
48765953|NCT03336216|156992430|FG002|Treatment|Participant no longer meets study criteria|0|||
48765954|NCT03336216|156992431|FG003|Treatment|Participant no longer meets study criteria|0|||
48765955|NCT03336216|156992428|FG000|Treatment|Other reasons|2|||
48765956|NCT03336216|156992429|FG001|Treatment|Other reasons|0|||
48765957|NCT03336216|156992430|FG002|Treatment|Other reasons|0|||
48765958|NCT03336216|156992431|FG003|Treatment|Other reasons|3|||
48765959|NCT03336216|156992428|FG000|Treatment|Disease progression|23|||
48765960|NCT03336216|156992429|FG001|Treatment|Disease progression|34|||
48765961|NCT03336216|156992430|FG002|Treatment|Disease progression|33|||
48765962|NCT03336216|156992431|FG003|Treatment|Disease progression|26|||
48765963|NCT03336216|156992428|FG000|Treatment|Study drug toxicity|0|||
48765964|NCT03336216|156992429|FG001|Treatment|Study drug toxicity|3|||
48765965|NCT03336216|156992430|FG002|Treatment|Study drug toxicity|2|||
48765966|NCT03336216|156992431|FG003|Treatment|Study drug toxicity|0|||
48355652|NCT01296555|155498545|FG013|Overall Study|Death|2|||
48765967|NCT03336216|156992428|FG000|Treatment|Adverse Event unrelated to study drug|1|||
48765968|NCT03336216|156992429|FG001|Treatment|Adverse Event unrelated to study drug|1|||
48765969|NCT03336216|156992430|FG002|Treatment|Adverse Event unrelated to study drug|1|||
48765970|NCT03336216|156992431|FG003|Treatment|Adverse Event unrelated to study drug|0|||
48765971|NCT03336216|156992428|FG000|Treatment|Disease Recurrence|1|||
48765972|NCT03336216|156992429|FG001|Treatment|Disease Recurrence|0|||
48765973|NCT03336216|156992430|FG002|Treatment|Disease Recurrence|0|||
48765974|NCT03336216|156992431|FG003|Treatment|Disease Recurrence|0|||
48765975|NCT03238911|156992432|FG000|Overall Study|Withdrawal by Subject|1|||
48765976|NCT03238911|156992433|FG001|Overall Study|Withdrawal by Subject|2|||
48765977|NCT03238911|156992432|FG000|Overall Study|Lost to Follow-up|2|||
48765978|NCT03238911|156992433|FG001|Overall Study|Lost to Follow-up|1|||
48765979|NCT01641367|156992439|FG000|Cohorts|Death|18|||
48765980|NCT01641367|156992440|FG001|Cohorts|Death|1|||
48765981|NCT01641367|156992441|FG002|Cohorts|Death|2|||
48765982|NCT01641367|156992442|FG003|Cohorts|Death|0|||
48765983|NCT01641367|156992443|FG004|Cohorts|Death|1|||
48765984|NCT01641367|156992444|FG005|Cohorts|Death|1|||
48765985|NCT01641367|156992445|FG006|Cohorts|Death|0|||
48765986|NCT01641367|156992446|FG007|Cohorts|Death|0|||
48765987|NCT01641367|156992439|FG000|Cohorts|Lost to Follow-up|16|||
48765988|NCT01641367|156992440|FG001|Cohorts|Lost to Follow-up|0|||
48765989|NCT01641367|156992441|FG002|Cohorts|Lost to Follow-up|2|||
48765990|NCT01641367|156992442|FG003|Cohorts|Lost to Follow-up|0|||
48765991|NCT01641367|156992443|FG004|Cohorts|Lost to Follow-up|2|||
48765992|NCT01641367|156992444|FG005|Cohorts|Lost to Follow-up|0|||
48765993|NCT01641367|156992445|FG006|Cohorts|Lost to Follow-up|0|||
48765994|NCT01641367|156992446|FG007|Cohorts|Lost to Follow-up|0|||
48765995|NCT01641367|156992439|FG000|Randomized Adherence Intervention|Death|0|||
48765996|NCT01641367|156992440|FG001|Randomized Adherence Intervention|Death|0|||
48765997|NCT01641367|156992441|FG002|Randomized Adherence Intervention|Death|0|||
48765998|NCT01641367|156992442|FG003|Randomized Adherence Intervention|Death|0|||
48765999|NCT01641367|156992443|FG004|Randomized Adherence Intervention|Death|0|||
48766000|NCT01641367|156992444|FG005|Randomized Adherence Intervention|Death|0|||
48766001|NCT01641367|156992445|FG006|Randomized Adherence Intervention|Death|11|||
48766002|NCT01641367|156992446|FG007|Randomized Adherence Intervention|Death|12|||
48766003|NCT01641367|156992439|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766004|NCT01641367|156992440|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766005|NCT01641367|156992441|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766006|NCT01641367|156992442|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766007|NCT01641367|156992443|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766008|NCT01641367|156992444|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
48766009|NCT01641367|156992445|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
48766010|NCT01641367|156992446|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
48766011|NCT02586493|156992453|FG000|Overall Study|Adverse Event|4|||
48766012|NCT02586493|156992453|FG000|Overall Study|Protocol Violation|6|||
48766013|NCT02586493|156992453|FG000|Overall Study|Lost to Follow-up|1|||
48766014|NCT02586493|156992453|FG000|Overall Study|Withdrawal by Subject|1|||
48766015|NCT01675882|156992455|FG000|Overall Study|Adverse Event|0|||
48766016|NCT01675882|156992456|FG001|Overall Study|Adverse Event|2|||
48766017|NCT01675882|156992457|FG002|Overall Study|Adverse Event|1|||
48766018|NCT01675882|156992458|FG003|Overall Study|Adverse Event|0|||
48766019|NCT01675882|156992455|FG000|Overall Study|Participant unwilling to continue|2|||
48766020|NCT01675882|156992456|FG001|Overall Study|Participant unwilling to continue|4|||
48766021|NCT01675882|156992457|FG002|Overall Study|Participant unwilling to continue|2|||
48355653|NCT01296555|155498546|FG014|Overall Study|Death|27|||
48355654|NCT01296555|155498547|FG015|Overall Study|Death|15|||
48355655|NCT01296555|155498548|FG016|Overall Study|Death|11|||
48355656|NCT01296555|155498549|FG017|Overall Study|Death|11|||
48355657|NCT01296555|155498550|FG018|Overall Study|Death|17|||
48355658|NCT01296555|155498551|FG019|Overall Study|Death|12|||
48355659|NCT01296555|155498552|FG020|Overall Study|Death|13|||
48355660|NCT01296555|155498553|FG021|Overall Study|Death|12|||
48355661|NCT01296555|155498554|FG022|Overall Study|Death|12|||
48355662|NCT01296555|155498555|FG023|Overall Study|Death|13|||
48355663|NCT01296555|155498556|FG024|Overall Study|Death|7|||
48355664|NCT01296555|155498557|FG025|Overall Study|Death|7|||
48355665|NCT01296555|155498558|FG026|Overall Study|Death|35|||
48355666|NCT01296555|155498559|FG027|Overall Study|Death|92|||
48355667|NCT01296555|155498560|FG028|Overall Study|Death|44|||
48355668|NCT01296555|155498532|FG000|Overall Study|Lost to Follow-up|0|||
48355669|NCT01296555|155498533|FG001|Overall Study|Lost to Follow-up|0|||
48355670|NCT01296555|155498534|FG002|Overall Study|Lost to Follow-up|0|||
48355671|NCT01296555|155498535|FG003|Overall Study|Lost to Follow-up|0|||
48355672|NCT01296555|155498536|FG004|Overall Study|Lost to Follow-up|0|||
48355673|NCT01296555|155498537|FG005|Overall Study|Lost to Follow-up|0|||
48355674|NCT01296555|155498538|FG006|Overall Study|Lost to Follow-up|0|||
48355675|NCT01296555|155498539|FG007|Overall Study|Lost to Follow-up|0|||
48355676|NCT01296555|155498540|FG008|Overall Study|Lost to Follow-up|0|||
48355677|NCT01296555|155498541|FG009|Overall Study|Lost to Follow-up|0|||
48355678|NCT01296555|155498542|FG010|Overall Study|Lost to Follow-up|0|||
48355679|NCT01296555|155498543|FG011|Overall Study|Lost to Follow-up|0|||
48355680|NCT01296555|155498544|FG012|Overall Study|Lost to Follow-up|0|||
48355681|NCT01296555|155498545|FG013|Overall Study|Lost to Follow-up|0|||
48355682|NCT01296555|155498546|FG014|Overall Study|Lost to Follow-up|2|||
48355683|NCT01296555|155498547|FG015|Overall Study|Lost to Follow-up|1|||
48355684|NCT01296555|155498548|FG016|Overall Study|Lost to Follow-up|0|||
48355685|NCT01296555|155498549|FG017|Overall Study|Lost to Follow-up|2|||
48355686|NCT01296555|155498550|FG018|Overall Study|Lost to Follow-up|0|||
48355687|NCT01296555|155498551|FG019|Overall Study|Lost to Follow-up|2|||
48355688|NCT01296555|155498552|FG020|Overall Study|Lost to Follow-up|3|||
48393986|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
48766022|NCT01675882|156992458|FG003|Overall Study|Participant unwilling to continue|1|||
48766023|NCT01675882|156992455|FG000|Overall Study|Lost to Follow-up|0|||
48766024|NCT01675882|156992456|FG001|Overall Study|Lost to Follow-up|1|||
48766025|NCT01675882|156992457|FG002|Overall Study|Lost to Follow-up|0|||
48766026|NCT01675882|156992458|FG003|Overall Study|Lost to Follow-up|0|||
48393987|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
48393988|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
48393989|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
48393990|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
48393991|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
48393992|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
48393993|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
48393994|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
48393995|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
48393996|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
48393997|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
48393998|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
48393999|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
48394000|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
48394001|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
48394002|NCT00094770|155638066|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
48394003|NCT00094770|155638067|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
48394004|NCT00530894|155638068|FG000|Overall Study|Death|84|||
48394005|NCT00530894|155638069|FG001|Overall Study|Death|89|||
48394006|NCT00530894|155638070|FG002|Overall Study|Death|55|||
48394007|NCT00530894|155638071|FG003|Overall Study|Death|89|||
48394008|NCT00530894|155638068|FG000|Overall Study|Lost to Follow-up|1|||
48394009|NCT00530894|155638069|FG001|Overall Study|Lost to Follow-up|3|||
48394010|NCT00530894|155638070|FG002|Overall Study|Lost to Follow-up|0|||
48394011|NCT00530894|155638071|FG003|Overall Study|Lost to Follow-up|0|||
48394012|NCT00530894|155638068|FG000|Overall Study|Withdrawal by Subject|1|||
48394013|NCT00530894|155638069|FG001|Overall Study|Withdrawal by Subject|23|||
48394014|NCT00530894|155638070|FG002|Overall Study|Withdrawal by Subject|0|||
48394015|NCT00530894|155638071|FG003|Overall Study|Withdrawal by Subject|5|||
48394016|NCT00530894|155638068|FG000|Overall Study|Alive and censored prior to 1 year|2|||
48394017|NCT00530894|155638069|FG001|Overall Study|Alive and censored prior to 1 year|0|||
48394018|NCT00530894|155638070|FG002|Overall Study|Alive and censored prior to 1 year|0|||
48394019|NCT00530894|155638071|FG003|Overall Study|Alive and censored prior to 1 year|0|||
48394020|NCT01081912|155638072|FG000|Conversion/Titration|Adverse Event|47|||
48394021|NCT01081912|155638073|FG001|Conversion/Titration|Adverse Event|0|||
48394022|NCT01081912|155638074|FG002|Conversion/Titration|Adverse Event|0|||
48394023|NCT01081912|155638072|FG000|Conversion/Titration|Lack of Efficacy|17|||
48394024|NCT01081912|155638073|FG001|Conversion/Titration|Lack of Efficacy|0|||
48394025|NCT01081912|155638074|FG002|Conversion/Titration|Lack of Efficacy|0|||
48394026|NCT01081912|155638072|FG000|Conversion/Titration|Lost to Follow-up|5|||
48394027|NCT01081912|155638073|FG001|Conversion/Titration|Lost to Follow-up|0|||
48394028|NCT01081912|155638074|FG002|Conversion/Titration|Lost to Follow-up|0|||
48394029|NCT01081912|155638072|FG000|Conversion/Titration|Physician Decision|2|||
48394030|NCT01081912|155638073|FG001|Conversion/Titration|Physician Decision|0|||
48766027|NCT01675882|156992455|FG000|Overall Study|Non-compliance|0|||
48766028|NCT01675882|156992456|FG001|Overall Study|Non-compliance|0|||
48766029|NCT01675882|156992457|FG002|Overall Study|Non-compliance|0|||
48766030|NCT01675882|156992458|FG003|Overall Study|Non-compliance|1|||
48766031|NCT02759120|156992459|FG000|Overall Study|Death|34|||
48766032|NCT02759120|156992460|FG001|Overall Study|Death|36|||
48766033|NCT02759120|156992459|FG000|Overall Study|Lost to Follow-up|4|||
48766034|NCT02759120|156992460|FG001|Overall Study|Lost to Follow-up|7|||
48766035|NCT02759120|156992459|FG000|Overall Study|Physician Decision|3|||
48766036|NCT02759120|156992460|FG001|Overall Study|Physician Decision|0|||
48766037|NCT02759120|156992459|FG000|Overall Study|Withdrawal by Subject|28|||
48766038|NCT02759120|156992460|FG001|Overall Study|Withdrawal by Subject|15|||
48394031|NCT01081912|155638074|FG002|Conversion/Titration|Physician Decision|0|||
48394032|NCT01081912|155638072|FG000|Conversion/Titration|Protocol Violation|67|||
48766039|NCT02759120|156992459|FG000|Overall Study|Moved out of area|3|||
48766040|NCT02759120|156992460|FG001|Overall Study|Moved out of area|4|||
48766041|NCT02759120|156992459|FG000|Overall Study|Lung transplant|3|||
48766042|NCT02759120|156992460|FG001|Overall Study|Lung transplant|5|||
48766043|NCT02759120|156992459|FG000|Overall Study|Other reason not completed|10|||
48394033|NCT01081912|155638073|FG001|Conversion/Titration|Protocol Violation|0|||
48394034|NCT01081912|155638074|FG002|Conversion/Titration|Protocol Violation|0|||
48394035|NCT01081912|155638072|FG000|Conversion/Titration|Withdrawal by Subject|23|||
48394036|NCT01081912|155638073|FG001|Conversion/Titration|Withdrawal by Subject|0|||
48394037|NCT01081912|155638074|FG002|Conversion/Titration|Withdrawal by Subject|0|||
48766044|NCT02759120|156992460|FG001|Overall Study|Other reason not completed|12|||
48766045|NCT00048542|156992462|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
48766046|NCT00048542|156992463|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
48766047|NCT00048542|156992464|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
48766048|NCT00048542|156992465|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48766049|NCT00048542|156992466|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
48766050|NCT00048542|156992467|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
48394038|NCT01081912|155638072|FG000|Conversion/Titration|Non-Compliance|47|||
48394039|NCT01081912|155638073|FG001|Conversion/Titration|Non-Compliance|0|||
48394040|NCT01081912|155638074|FG002|Conversion/Titration|Non-Compliance|0|||
48394041|NCT01081912|155638072|FG000|Maintenance Treatment|Adverse Event|0|||
48766051|NCT00048542|156992468|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
48766052|NCT00048542|156992469|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
48766053|NCT00048542|156992462|FG000|Double-Blind Phase|Protocol Violation|0|||
48766054|NCT00048542|156992463|FG001|Double-Blind Phase|Protocol Violation|0|||
48766055|NCT00048542|156992464|FG002|Double-Blind Phase|Protocol Violation|1|||
48766056|NCT00048542|156992465|FG003|Double-Blind Phase|Protocol Violation|0|||
48766057|NCT00048542|156992466|FG004|Double-Blind Phase|Protocol Violation|0|||
48766058|NCT00048542|156992467|FG005|Double-Blind Phase|Protocol Violation|0|||
48766059|NCT00048542|156992468|FG006|Double-Blind Phase|Protocol Violation|0|||
48766060|NCT00048542|156992469|FG007|Double-Blind Phase|Protocol Violation|0|||
48766061|NCT00048542|156992462|FG000|Double-Blind Phase|Sponsor request or decision|2|||
48766062|NCT00048542|156992463|FG001|Double-Blind Phase|Sponsor request or decision|0|||
48766063|NCT00048542|156992464|FG002|Double-Blind Phase|Sponsor request or decision|0|||
48766064|NCT00048542|156992465|FG003|Double-Blind Phase|Sponsor request or decision|0|||
48766065|NCT00048542|156992466|FG004|Double-Blind Phase|Sponsor request or decision|0|||
48766066|NCT00048542|156992467|FG005|Double-Blind Phase|Sponsor request or decision|0|||
48766067|NCT00048542|156992468|FG006|Double-Blind Phase|Sponsor request or decision|0|||
48766068|NCT00048542|156992469|FG007|Double-Blind Phase|Sponsor request or decision|0|||
48766069|NCT00048542|156992462|FG000|Double-Blind Phase|Randomized in error|1|||
48766070|NCT00048542|156992463|FG001|Double-Blind Phase|Randomized in error|0|||
48766071|NCT00048542|156992464|FG002|Double-Blind Phase|Randomized in error|0|||
48766072|NCT00048542|156992465|FG003|Double-Blind Phase|Randomized in error|0|||
48766073|NCT00048542|156992466|FG004|Double-Blind Phase|Randomized in error|0|||
48766074|NCT00048542|156992467|FG005|Double-Blind Phase|Randomized in error|0|||
48766075|NCT00048542|156992468|FG006|Double-Blind Phase|Randomized in error|0|||
48766076|NCT00048542|156992469|FG007|Double-Blind Phase|Randomized in error|0|||
48766077|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766078|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766079|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48394042|NCT01081912|155638073|FG001|Maintenance Treatment|Adverse Event|2|||
48766080|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766081|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
48766082|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
48766083|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766084|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
48766085|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766086|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766087|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766088|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766089|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766090|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
48766091|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766092|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
48766093|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766094|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766095|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766096|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766097|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
48766098|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
48766099|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48394043|NCT01081912|155638074|FG002|Maintenance Treatment|Adverse Event|12|||
48394044|NCT01081912|155638072|FG000|Maintenance Treatment|Lack of Efficacy|0|||
48394045|NCT01081912|155638073|FG001|Maintenance Treatment|Lack of Efficacy|14|||
48766100|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
48766101|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
48766102|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
48766103|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
48766104|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
48766105|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
48766106|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
48394046|NCT01081912|155638074|FG002|Maintenance Treatment|Lack of Efficacy|64|||
48766107|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
48766108|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
48766109|NCT00048542|156992462|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766110|NCT00048542|156992463|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766111|NCT00048542|156992464|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766112|NCT00048542|156992465|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766113|NCT00048542|156992466|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
48766114|NCT00048542|156992467|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
48766115|NCT00048542|156992468|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766116|NCT00048542|156992469|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
48766117|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766118|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766119|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766120|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766121|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766122|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
48766123|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
48766124|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
48766125|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766126|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766127|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766128|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766129|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766130|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
48766131|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
48766132|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
48766133|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766134|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766135|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766136|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766137|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766138|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
48766139|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
48766140|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
48766141|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766142|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766143|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766144|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766145|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766146|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
48766147|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
48766148|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
48766149|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766150|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766151|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766152|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766153|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766154|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
48766155|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
48766156|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
48766157|NCT00048542|156992462|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48355689|NCT01296555|155498553|FG021|Overall Study|Lost to Follow-up|2|||
48355690|NCT01296555|155498554|FG022|Overall Study|Lost to Follow-up|0|||
48355691|NCT01296555|155498555|FG023|Overall Study|Lost to Follow-up|0|||
48355692|NCT01296555|155498556|FG024|Overall Study|Lost to Follow-up|0|||
48355693|NCT01296555|155498557|FG025|Overall Study|Lost to Follow-up|0|||
48355694|NCT01296555|155498558|FG026|Overall Study|Lost to Follow-up|3|||
48355695|NCT01296555|155498559|FG027|Overall Study|Lost to Follow-up|13|||
48355696|NCT01296555|155498560|FG028|Overall Study|Lost to Follow-up|5|||
48355697|NCT01296555|155498532|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48355698|NCT01296555|155498533|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48355699|NCT01296555|155498534|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48355700|NCT01296555|155498535|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48355701|NCT01296555|155498536|FG004|Overall Study|Non-Compliance With Study Drug|0|||
48355702|NCT01296555|155498537|FG005|Overall Study|Non-Compliance With Study Drug|0|||
48355703|NCT01296555|155498538|FG006|Overall Study|Non-Compliance With Study Drug|0|||
48355704|NCT01296555|155498539|FG007|Overall Study|Non-Compliance With Study Drug|1|||
48766158|NCT00048542|156992463|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766159|NCT00048542|156992464|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766160|NCT00048542|156992465|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766161|NCT00048542|156992466|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766162|NCT00048542|156992467|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
48766163|NCT00048542|156992468|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
48766164|NCT00048542|156992469|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
48766165|NCT01350128|156992470|FG000|Overall Study|Withdrawal by Subject|3|||
48766166|NCT01350128|156992470|FG000|Overall Study|Protocol discontinuation criteria|8|||
48766167|NCT01350128|156992470|FG000|Overall Study|Physician Decision|1|||
48766168|NCT01350128|156992470|FG000|Overall Study|Lost to Follow-up|2|||
48766169|NCT01817725|156992471|FG000|Overall Study|Withdrawal by Subject|1|||
48766170|NCT00314574|156992473|FG000|Overall Study|Death|3|||
48766171|NCT00314574|156992474|FG001|Overall Study|Death|0|||
48766172|NCT00314574|156992473|FG000|Overall Study|Adverse Event|11|||
48766173|NCT00314574|156992474|FG001|Overall Study|Adverse Event|16|||
48766174|NCT00314574|156992473|FG000|Overall Study|Lost to Follow-up|19|||
48766175|NCT00314574|156992474|FG001|Overall Study|Lost to Follow-up|25|||
48766176|NCT00314574|156992473|FG000|Overall Study|Withdrawal by Subject|33|||
48766177|NCT00314574|156992474|FG001|Overall Study|Withdrawal by Subject|22|||
48766178|NCT00314574|156992473|FG000|Overall Study|Physician Decision|22|||
48766179|NCT00314574|156992474|FG001|Overall Study|Physician Decision|15|||
48766180|NCT00314574|156992473|FG000|Overall Study|Pregnancy|6|||
48766181|NCT00314574|156992474|FG001|Overall Study|Pregnancy|4|||
48766182|NCT00314574|156992473|FG000|Overall Study|Data unknown at database lock|0|||
48766183|NCT00314574|156992474|FG001|Overall Study|Data unknown at database lock|1|||
48766184|NCT00006489|156992475|FG000|Overall Study|Adverse Event|3|||
48766185|NCT00006489|156992476|FG001|Overall Study|Adverse Event|2|||
48766186|NCT00006489|156992477|FG002|Overall Study|Adverse Event|4|||
48766187|NCT00006489|156992478|FG003|Overall Study|Adverse Event|3|||
48766188|NCT00006489|156992475|FG000|Overall Study|Withdrawal by Subject|10|||
48766189|NCT00006489|156992476|FG001|Overall Study|Withdrawal by Subject|9|||
48766190|NCT00006489|156992477|FG002|Overall Study|Withdrawal by Subject|9|||
48766191|NCT00006489|156992478|FG003|Overall Study|Withdrawal by Subject|6|||
48766192|NCT00006489|156992475|FG000|Overall Study|Scheduling Conflict|0|||
48766193|NCT00006489|156992476|FG001|Overall Study|Scheduling Conflict|3|||
48766194|NCT00006489|156992477|FG002|Overall Study|Scheduling Conflict|2|||
48766195|NCT00006489|156992478|FG003|Overall Study|Scheduling Conflict|1|||
48766196|NCT00006489|156992475|FG000|Overall Study|Death|0|||
48766197|NCT00006489|156992476|FG001|Overall Study|Death|0|||
48766198|NCT00006489|156992477|FG002|Overall Study|Death|0|||
48766199|NCT00006489|156992478|FG003|Overall Study|Death|1|||
48766200|NCT02086110|156992479|FG000|Overall Study|Withdrawal by Subject|1|||
48766201|NCT02086110|156992480|FG001|Overall Study|Withdrawal by Subject|1|||
48766202|NCT02286193|156992481|FG000|Overall Study|Referred: CRS unable to make contact|62|||
48766203|NCT02286193|156992481|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
48766204|NCT02286193|156992481|FG000|Overall Study|Referred: Declined service|38|||
48766205|NCT01289847|156992482|FG000|Overall Study|Patient could not comply with visits|1|||
48766206|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
48766207|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
48766208|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
48766209|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
48766210|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
48766211|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
48766212|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
48766213|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48766214|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48766215|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
48766216|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
48766217|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
48766218|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
48766219|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
48766220|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
48766221|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
48766222|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
48766223|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
48766224|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
48766225|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
48355705|NCT01296555|155498540|FG008|Overall Study|Non-Compliance With Study Drug|0|||
48766226|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
48766227|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
48766228|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
48766229|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
48766230|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
48766231|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
48766232|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
48766233|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
48766234|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
48766235|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
48766236|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
48766237|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
48766238|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
48766239|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
48394047|NCT01081912|155638072|FG000|Maintenance Treatment|Lost to Follow-up|0|||
48394048|NCT01081912|155638073|FG001|Maintenance Treatment|Lost to Follow-up|1|||
48394049|NCT01081912|155638074|FG002|Maintenance Treatment|Lost to Follow-up|0|||
48394050|NCT01081912|155638072|FG000|Maintenance Treatment|Physician Decision|0|||
48394051|NCT01081912|155638073|FG001|Maintenance Treatment|Physician Decision|0|||
48394052|NCT01081912|155638074|FG002|Maintenance Treatment|Physician Decision|1|||
48766240|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
48766241|NCT03373383|156992486|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
48766242|NCT03373383|156992487|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
48766243|NCT03373383|156992488|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
48766244|NCT03373383|156992489|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
48766245|NCT03373383|156992490|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
48766246|NCT03373383|156992486|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
48766247|NCT03373383|156992487|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
48766248|NCT03373383|156992488|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
48766249|NCT03373383|156992489|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
48766250|NCT03373383|156992490|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
48766251|NCT01498640|156992495|FG000|Overall Study|Lost to Follow-up|1|||
48766252|NCT01498640|156992495|FG000|Overall Study|Death|1|||
48766253|NCT01498640|156992495|FG000|Overall Study|Other|3|||
48766254|NCT00850395|156992500|FG000|Overall Study|Death|1|||
48766255|NCT00850395|156992500|FG000|Overall Study|Adverse Event|1|||
48766256|NCT00850395|156992500|FG000|Overall Study|Insufficient clinical response|3|||
48766257|NCT00850395|156992500|FG000|Overall Study|Other|5|||
48766258|NCT00477672|156992503|FG000|Overall Study|Adverse Event|3|||
48766259|NCT00477672|156992504|FG001|Overall Study|Adverse Event|5|||
48766260|NCT00477672|156992505|FG002|Overall Study|Adverse Event|6|||
48766261|NCT00477672|156992503|FG000|Overall Study|Death|0|||
48766262|NCT00477672|156992504|FG001|Overall Study|Death|1|||
48766263|NCT00477672|156992505|FG002|Overall Study|Death|0|||
48766264|NCT00477672|156992503|FG000|Overall Study|Disease progression|0|||
48766265|NCT00477672|156992504|FG001|Overall Study|Disease progression|1|||
48766266|NCT00477672|156992505|FG002|Overall Study|Disease progression|0|||
48766267|NCT00477672|156992503|FG000|Overall Study|Physician Decision|1|||
48766268|NCT00477672|156992504|FG001|Overall Study|Physician Decision|0|||
48766269|NCT00477672|156992505|FG002|Overall Study|Physician Decision|0|||
48766270|NCT00477672|156992503|FG000|Overall Study|Protocol noncompliance|0|||
48766271|NCT00477672|156992504|FG001|Overall Study|Protocol noncompliance|2|||
48766272|NCT00477672|156992505|FG002|Overall Study|Protocol noncompliance|0|||
48766273|NCT00477672|156992503|FG000|Overall Study|Consent withdrawn|2|||
48766274|NCT00477672|156992504|FG001|Overall Study|Consent withdrawn|5|||
48766275|NCT00477672|156992505|FG002|Overall Study|Consent withdrawn|10|||
48766276|NCT00477672|156992503|FG000|Overall Study|Discretion of Sponsor|1|||
48766277|NCT00477672|156992504|FG001|Overall Study|Discretion of Sponsor|2|||
48766278|NCT00477672|156992505|FG002|Overall Study|Discretion of Sponsor|0|||
48766279|NCT02739269|156992506|FG000|Overall Study|Protocol Violation|5|||
48766280|NCT02739269|156992507|FG001|Overall Study|Protocol Violation|0|||
48766281|NCT02739269|156992506|FG000|Overall Study|Cycle cancellation|2|||
48766282|NCT02739269|156992507|FG001|Overall Study|Cycle cancellation|2|||
48766283|NCT02739269|156992506|FG000|Overall Study|Withdrawal by Subject|0|||
48766284|NCT02739269|156992507|FG001|Overall Study|Withdrawal by Subject|2|||
48766285|NCT02244580|156992508|FG000|Overall Study|No cancer tissues available|241|||
48766286|NCT01736696|156992509|FG000|Overall Study|Withdrawal by Subject|0|||
48766287|NCT01736696|156992510|FG001|Overall Study|Withdrawal by Subject|0|||
48766288|NCT01736696|156992511|FG002|Overall Study|Withdrawal by Subject|1|||
48766289|NCT01736696|156992512|FG003|Overall Study|Withdrawal by Subject|0|||
48766290|NCT01736696|156992513|FG004|Overall Study|Withdrawal by Subject|0|||
48766291|NCT01736696|156992514|FG005|Overall Study|Withdrawal by Subject|0|||
48394053|NCT01081912|155638072|FG000|Maintenance Treatment|Protocol Violation|0|||
48766292|NCT01736696|156992515|FG006|Overall Study|Withdrawal by Subject|0|||
48766293|NCT02114879|156992516|FG000|Overall Study|Withdrawal by Subject|9|||
48394054|NCT01081912|155638073|FG001|Maintenance Treatment|Protocol Violation|1|||
48766294|NCT02114879|156992517|FG001|Overall Study|Withdrawal by Subject|5|||
48766295|NCT02114879|156992516|FG000|Overall Study|Death|6|||
48766296|NCT02114879|156992517|FG001|Overall Study|Death|11|||
48766297|NCT02114879|156992516|FG000|Overall Study|Lost to Follow-up|4|||
48766298|NCT02114879|156992517|FG001|Overall Study|Lost to Follow-up|6|||
48766299|NCT02114879|156992516|FG000|Overall Study|Physician Decision|0|||
48766300|NCT02114879|156992517|FG001|Overall Study|Physician Decision|2|||
48766301|NCT01068509|156992521|FG000|Overall Study|Death|0|||
48766302|NCT01068509|156992522|FG001|Overall Study|Death|0|||
48766303|NCT01068509|156992523|FG002|Overall Study|Death|1|||
48766304|NCT01068509|156992521|FG000|Overall Study|Disease Progression|5|||
48766305|NCT01068509|156992522|FG001|Overall Study|Disease Progression|20|||
48766306|NCT01068509|156992523|FG002|Overall Study|Disease Progression|18|||
48766307|NCT01068509|156992521|FG000|Overall Study|Lost to Follow-up|1|||
48766308|NCT01068509|156992522|FG001|Overall Study|Lost to Follow-up|0|||
48766309|NCT01068509|156992523|FG002|Overall Study|Lost to Follow-up|0|||
48766310|NCT01068509|156992521|FG000|Overall Study|Withdrew Consent|0|||
48766311|NCT01068509|156992522|FG001|Overall Study|Withdrew Consent|1|||
48766312|NCT01068509|156992523|FG002|Overall Study|Withdrew Consent|2|||
48766313|NCT01068509|156992521|FG000|Overall Study|Reason Not Specified|0|||
48766314|NCT01068509|156992522|FG001|Overall Study|Reason Not Specified|1|||
48766315|NCT01068509|156992523|FG002|Overall Study|Reason Not Specified|0|||
48766316|NCT02357940|156992524|FG000|Overall Study|Adverse Event|0|||
48766317|NCT02357940|156992525|FG001|Overall Study|Adverse Event|1|||
48766318|NCT02357940|156992524|FG000|Overall Study|Investigator's judgement|0|||
48766319|NCT02357940|156992525|FG001|Overall Study|Investigator's judgement|1|||
48766320|NCT00788827|156992526|FG000|Overall Study|Lack of Efficacy|2|||
48766321|NCT01644175|156992529|FG000|Overall Study|Randomized But Not Treated|0|||
48766322|NCT01644175|156992530|FG001|Overall Study|Randomized But Not Treated|2|||
48766323|NCT01644175|156992529|FG000|Overall Study|Adverse Event|8|||
48766324|NCT01644175|156992530|FG001|Overall Study|Adverse Event|13|||
48766325|NCT01644175|156992529|FG000|Overall Study|Death|1|||
48766326|NCT01644175|156992530|FG001|Overall Study|Death|2|||
48766327|NCT01644175|156992529|FG000|Overall Study|Poor compliance to protocol|9|||
48766328|NCT01644175|156992530|FG001|Overall Study|Poor compliance to protocol|10|||
48766329|NCT01644175|156992529|FG000|Overall Study|Physician Decision|1|||
48766330|NCT01644175|156992530|FG001|Overall Study|Physician Decision|2|||
48766331|NCT01644175|156992529|FG000|Overall Study|Participant Moved|1|||
48394055|NCT01081912|155638074|FG002|Maintenance Treatment|Protocol Violation|2|||
48394056|NCT01081912|155638072|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
48394057|NCT01081912|155638073|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
48394058|NCT01081912|155638074|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
48394059|NCT01081912|155638072|FG000|Maintenance Treatment|Non-Compliance|0|||
48394060|NCT01081912|155638073|FG001|Maintenance Treatment|Non-Compliance|4|||
48394061|NCT01081912|155638074|FG002|Maintenance Treatment|Non-Compliance|7|||
48394062|NCT01081912|155638072|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
48394063|NCT01081912|155638073|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
48394064|NCT01081912|155638074|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
48394065|NCT00751400|155638077|FG000|Overall Study|Lost to Follow-up|10|||
48394066|NCT02055820|155638082|FG000|Phase I: Dose-Finding|Death|1|||
48394067|NCT02055820|155638083|FG001|Phase I: Dose-Finding|Death|0|||
48394068|NCT02055820|155638084|FG002|Phase I: Dose-Finding|Death|1|||
48394069|NCT02055820|155638085|FG003|Phase I: Dose-Finding|Death|2|||
48394070|NCT02055820|155638086|FG004|Phase I: Dose-Finding|Death|0|||
48394071|NCT02055820|155638087|FG005|Phase I: Dose-Finding|Death|1|||
48766332|NCT01644175|156992530|FG001|Overall Study|Participant Moved|2|||
48766333|NCT01644175|156992529|FG000|Overall Study|Consent withdrawn by participant|3|||
48766334|NCT01644175|156992530|FG001|Overall Study|Consent withdrawn by participant|4|||
48766335|NCT01644175|156992529|FG000|Overall Study|Related to Autoinjector Administration|2|||
48766336|NCT01644175|156992530|FG001|Overall Study|Related to Autoinjector Administration|1|||
48766337|NCT01644175|156992529|FG000|Overall Study|Last visit outside protocol visit window|4|||
48766338|NCT01644175|156992530|FG001|Overall Study|Last visit outside protocol visit window|11|||
48766339|NCT01644175|156992529|FG000|Overall Study|Selection criteria finally not met|0|||
48766340|NCT01644175|156992530|FG001|Overall Study|Selection criteria finally not met|1|||
48766341|NCT01644175|156992529|FG000|Overall Study|Site closure|2|||
48766342|NCT01644175|156992530|FG001|Overall Study|Site closure|2|||
48766343|NCT01644175|156992529|FG000|Overall Study|Lost to Follow-up|1|||
48766344|NCT01644175|156992530|FG001|Overall Study|Lost to Follow-up|0|||
48766345|NCT01644175|156992529|FG000|Overall Study|Other than specified above|0|||
48766346|NCT01644175|156992530|FG001|Overall Study|Other than specified above|3|||
48394072|NCT02055820|155638088|FG006|Phase I: Dose-Finding|Death|1|||
48394073|NCT02055820|155638089|FG007|Phase I: Dose-Finding|Death|0|||
48394074|NCT02055820|155638090|FG008|Phase I: Dose-Finding|Death|0|||
48394075|NCT02055820|155638091|FG009|Phase I: Dose-Finding|Death|0|||
48766347|NCT01838642|156992533|FG000|Overall Study|Died on study|1|||
48394076|NCT02055820|155638082|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48766348|NCT00578942|156992536|FG000|Overall Study|Lost to Follow-up|1|||
48766349|NCT00313612|156992537|FG000|Overall Study|Patient never received treatment|0|||
48766350|NCT00313612|156992538|FG001|Overall Study|Patient never received treatment|1|||
48766351|NCT00842348|156992540|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
48766352|NCT00842348|156992541|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
48766353|NCT00842348|156992540|FG000|Study 729|Disease progression/death|19|||
48766354|NCT00842348|156992541|FG001|Study 729|Disease progression/death|30|||
48766355|NCT00842348|156992540|FG000|Study 729|Adverse Event|1|||
48766356|NCT00842348|156992541|FG001|Study 729|Adverse Event|1|||
48766357|NCT00842348|156992540|FG000|Study 729|Protocol Violation|1|||
48766358|NCT00842348|156992541|FG001|Study 729|Protocol Violation|1|||
48766359|NCT00842348|156992540|FG000|Study 729|Withdrawal by Subject|2|||
48766360|NCT00842348|156992541|FG001|Study 729|Withdrawal by Subject|4|||
48766361|NCT00842348|156992540|FG000|Study 729|Due to Sponsor stopping the study|1|||
48355706|NCT01296555|155498541|FG009|Overall Study|Non-Compliance With Study Drug|0|||
48355707|NCT01296555|155498542|FG010|Overall Study|Non-Compliance With Study Drug|0|||
48355708|NCT01296555|155498543|FG011|Overall Study|Non-Compliance With Study Drug|0|||
48355709|NCT01296555|155498544|FG012|Overall Study|Non-Compliance With Study Drug|0|||
48355710|NCT01296555|155498545|FG013|Overall Study|Non-Compliance With Study Drug|0|||
48355711|NCT01296555|155498546|FG014|Overall Study|Non-Compliance With Study Drug|0|||
48355712|NCT01296555|155498547|FG015|Overall Study|Non-Compliance With Study Drug|0|||
48355713|NCT01296555|155498548|FG016|Overall Study|Non-Compliance With Study Drug|0|||
48355714|NCT01296555|155498549|FG017|Overall Study|Non-Compliance With Study Drug|0|||
48355715|NCT01296555|155498550|FG018|Overall Study|Non-Compliance With Study Drug|0|||
48355716|NCT01296555|155498551|FG019|Overall Study|Non-Compliance With Study Drug|0|||
48355717|NCT01296555|155498552|FG020|Overall Study|Non-Compliance With Study Drug|0|||
48355718|NCT01296555|155498553|FG021|Overall Study|Non-Compliance With Study Drug|0|||
48355719|NCT01296555|155498554|FG022|Overall Study|Non-Compliance With Study Drug|0|||
48355720|NCT01296555|155498555|FG023|Overall Study|Non-Compliance With Study Drug|0|||
48355721|NCT01296555|155498556|FG024|Overall Study|Non-Compliance With Study Drug|0|||
48355722|NCT01296555|155498557|FG025|Overall Study|Non-Compliance With Study Drug|0|||
48355723|NCT01296555|155498558|FG026|Overall Study|Non-Compliance With Study Drug|0|||
48355724|NCT01296555|155498559|FG027|Overall Study|Non-Compliance With Study Drug|0|||
48355725|NCT01296555|155498560|FG028|Overall Study|Non-Compliance With Study Drug|0|||
48355726|NCT01296555|155498532|FG000|Overall Study|Withdrawal by Subject|0|||
48355727|NCT01296555|155498533|FG001|Overall Study|Withdrawal by Subject|0|||
48355728|NCT01296555|155498534|FG002|Overall Study|Withdrawal by Subject|0|||
48355729|NCT01296555|155498535|FG003|Overall Study|Withdrawal by Subject|0|||
48355730|NCT01296555|155498536|FG004|Overall Study|Withdrawal by Subject|1|||
48355731|NCT01296555|155498537|FG005|Overall Study|Withdrawal by Subject|0|||
48355732|NCT01296555|155498538|FG006|Overall Study|Withdrawal by Subject|1|||
48355733|NCT01296555|155498539|FG007|Overall Study|Withdrawal by Subject|0|||
48355734|NCT01296555|155498540|FG008|Overall Study|Withdrawal by Subject|0|||
48355735|NCT01296555|155498541|FG009|Overall Study|Withdrawal by Subject|0|||
48355736|NCT01296555|155498542|FG010|Overall Study|Withdrawal by Subject|1|||
48355737|NCT01296555|155498543|FG011|Overall Study|Withdrawal by Subject|1|||
48355738|NCT01296555|155498544|FG012|Overall Study|Withdrawal by Subject|0|||
48355739|NCT01296555|155498545|FG013|Overall Study|Withdrawal by Subject|0|||
48355740|NCT01296555|155498546|FG014|Overall Study|Withdrawal by Subject|3|||
48355741|NCT01296555|155498547|FG015|Overall Study|Withdrawal by Subject|0|||
48355742|NCT01296555|155498548|FG016|Overall Study|Withdrawal by Subject|2|||
48355743|NCT01296555|155498549|FG017|Overall Study|Withdrawal by Subject|1|||
48355744|NCT01296555|155498550|FG018|Overall Study|Withdrawal by Subject|0|||
48355745|NCT01296555|155498551|FG019|Overall Study|Withdrawal by Subject|1|||
48355746|NCT01296555|155498552|FG020|Overall Study|Withdrawal by Subject|1|||
48355747|NCT01296555|155498553|FG021|Overall Study|Withdrawal by Subject|1|||
48355748|NCT01296555|155498554|FG022|Overall Study|Withdrawal by Subject|3|||
48355749|NCT01296555|155498555|FG023|Overall Study|Withdrawal by Subject|0|||
48355750|NCT01296555|155498556|FG024|Overall Study|Withdrawal by Subject|0|||
48355751|NCT01296555|155498557|FG025|Overall Study|Withdrawal by Subject|0|||
48355752|NCT01296555|155498558|FG026|Overall Study|Withdrawal by Subject|8|||
48355753|NCT01296555|155498559|FG027|Overall Study|Withdrawal by Subject|4|||
48355754|NCT01296555|155498560|FG028|Overall Study|Withdrawal by Subject|2|||
48355755|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
48355756|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
48355757|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
48355758|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
48355759|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
48355760|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
48355761|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
48355762|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
48355763|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
48355764|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
48355765|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
48355766|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
48766362|NCT00842348|156992541|FG001|Study 729|Due to Sponsor stopping the study|1|||
48766363|NCT00842348|156992540|FG000|Study 729|Due to non-availability of IP|0|||
48766364|NCT00842348|156992541|FG001|Study 729|Due to non-availability of IP|1|||
48766365|NCT00842348|156992540|FG000|Study 729|Sponsor's decision|1|||
48766366|NCT00842348|156992541|FG001|Study 729|Sponsor's decision|0|||
48766367|NCT00842348|156992540|FG000|Study 729|Surgical resection|1|||
48766368|NCT00842348|156992541|FG001|Study 729|Surgical resection|0|||
48766369|NCT04656132|156992550|FG000|Overall Study|Lost to Follow-up|4|||
48766370|NCT04656132|156992550|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
48766371|NCT02321462|156992554|FG000|Overall Study|Withdrawal by Subject|5|||
48766372|NCT02321462|156992555|FG001|Overall Study|Withdrawal by Subject|2|||
48766373|NCT02321462|156992554|FG000|Overall Study|Subject withdrawn before any treatment|1|||
48766374|NCT02321462|156992555|FG001|Overall Study|Subject withdrawn before any treatment|1|||
48766375|NCT02196324|156992556|FG000|Overall Study|Withdrawal by Subject|8|||
48766376|NCT02196324|156992557|FG001|Overall Study|Withdrawal by Subject|4|||
48766377|NCT02196324|156992556|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
48766378|NCT02196324|156992557|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
48766379|NCT02196324|156992556|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
48766380|NCT02196324|156992557|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
48766381|NCT02196324|156992556|FG000|Overall Study|Other|1|||
48766382|NCT02196324|156992557|FG001|Overall Study|Other|0|||
48766383|NCT00692770|156992566|FG000|Overall Study|Protocol Violation|2|||
48766384|NCT00692770|156992567|FG001|Overall Study|Protocol Violation|7|||
48766385|NCT00692770|156992566|FG000|Overall Study|Withdrawal by Subject|97|||
48766386|NCT00692770|156992567|FG001|Overall Study|Withdrawal by Subject|36|||
48766387|NCT00692770|156992566|FG000|Overall Study|Adverse Event|136|||
48766388|NCT00692770|156992567|FG001|Overall Study|Adverse Event|41|||
48766389|NCT00692770|156992566|FG000|Overall Study|Death|10|||
48766390|NCT00692770|156992567|FG001|Overall Study|Death|5|||
48766391|NCT00692770|156992566|FG000|Overall Study|Lost to Follow-up|7|||
48766392|NCT00692770|156992567|FG001|Overall Study|Lost to Follow-up|3|||
48766393|NCT00692770|156992566|FG000|Overall Study|Non-compliant with study medication|11|||
48766394|NCT00692770|156992567|FG001|Overall Study|Non-compliant with study medication|5|||
48766395|NCT00692770|156992566|FG000|Overall Study|Progression by clinical judgment|2|||
48766396|NCT00692770|156992567|FG001|Overall Study|Progression by clinical judgment|3|||
48766397|NCT00692770|156992566|FG000|Overall Study|Physician decision not protocol driven|10|||
48766398|NCT00692770|156992567|FG001|Overall Study|Physician decision not protocol driven|14|||
48766399|NCT00692770|156992566|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
48766400|NCT00692770|156992567|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
48766401|NCT00692770|156992566|FG000|Overall Study|Protocol driven decision point|3|||
48766402|NCT00692770|156992567|FG001|Overall Study|Protocol driven decision point|7|||
48766403|NCT00692770|156992566|FG000|Overall Study|Completed all planned assessments|79|||
48766404|NCT00692770|156992567|FG001|Overall Study|Completed all planned assessments|101|||
48766405|NCT00692770|156992566|FG000|Overall Study|Radiological and clinical progression|8|||
48766406|NCT00692770|156992567|FG001|Overall Study|Radiological and clinical progression|8|||
48766407|NCT00692770|156992566|FG000|Overall Study|Clinical endpoint reached|16|||
48766408|NCT00692770|156992567|FG001|Overall Study|Clinical endpoint reached|43|||
48766409|NCT00692770|156992566|FG000|Overall Study|Study terminated by sponsor|2|||
48766410|NCT00692770|156992567|FG001|Overall Study|Study terminated by sponsor|2|||
48766411|NCT00692770|156992566|FG000|Overall Study|Randomized but not treated|3|||
48766412|NCT00692770|156992567|FG001|Overall Study|Randomized but not treated|4|||
48766413|NCT04248816|156992568|FG000|Overall Study|Ineligible post-randomization|7|||
48766414|NCT04248816|156992569|FG001|Overall Study|Ineligible post-randomization|21|||
48766415|NCT04248816|156992570|FG002|Overall Study|Ineligible post-randomization|25|||
48766416|NCT00660348|156992579|FG000|Overall Study|Withdrawal by Subject|1|||
48766417|NCT00660348|156992580|FG001|Overall Study|Withdrawal by Subject|0|||
48766418|NCT02849548|156992581|FG000|Overall Study|Lost to Follow-up|1|||
48766419|NCT02849548|156992582|FG001|Overall Study|Lost to Follow-up|2|||
48766420|NCT02849548|156992581|FG000|Overall Study|Protocol Violation|1|||
48766421|NCT02849548|156992582|FG001|Overall Study|Protocol Violation|0|||
48766422|NCT01239368|156994671|FG000|Overall Study|Principal investigator discretion|1|||
48766423|NCT01239368|156994672|FG001|Overall Study|Principal investigator discretion|0|||
48766424|NCT01239368|156994673|FG002|Overall Study|Principal investigator discretion|0|||
48766425|NCT01239368|156994674|FG003|Overall Study|Principal investigator discretion|0|||
48766426|NCT01239368|156994675|FG004|Overall Study|Principal investigator discretion|1|||
48394077|NCT02055820|155638083|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48766427|NCT01239368|156994676|FG005|Overall Study|Principal investigator discretion|2|||
48766428|NCT01239368|156994677|FG006|Overall Study|Principal investigator discretion|0|||
48766429|NCT01239368|156994678|FG007|Overall Study|Principal investigator discretion|0|||
48766430|NCT01239368|156994679|FG008|Overall Study|Principal investigator discretion|0|||
48766431|NCT01239368|156994680|FG009|Overall Study|Principal investigator discretion|1|||
48766432|NCT01239368|156994671|FG000|Overall Study|Disease progression on study|1|||
48766433|NCT01239368|156994672|FG001|Overall Study|Disease progression on study|1|||
48766434|NCT01239368|156994673|FG002|Overall Study|Disease progression on study|1|||
48766435|NCT01239368|156994674|FG003|Overall Study|Disease progression on study|1|||
48766436|NCT01239368|156994675|FG004|Overall Study|Disease progression on study|4|||
48766437|NCT01239368|156994676|FG005|Overall Study|Disease progression on study|2|||
48766438|NCT01239368|156994677|FG006|Overall Study|Disease progression on study|5|||
48766439|NCT01239368|156994678|FG007|Overall Study|Disease progression on study|0|||
48766440|NCT01239368|156994679|FG008|Overall Study|Disease progression on study|0|||
48766441|NCT01239368|156994680|FG009|Overall Study|Disease progression on study|2|||
48766442|NCT01239368|156994671|FG000|Overall Study|Refused further treatment|0|||
48766443|NCT01239368|156994672|FG001|Overall Study|Refused further treatment|0|||
48766444|NCT01239368|156994673|FG002|Overall Study|Refused further treatment|0|||
48766445|NCT01239368|156994674|FG003|Overall Study|Refused further treatment|0|||
48766446|NCT01239368|156994675|FG004|Overall Study|Refused further treatment|0|||
48766447|NCT01239368|156994676|FG005|Overall Study|Refused further treatment|0|||
48766448|NCT01239368|156994677|FG006|Overall Study|Refused further treatment|0|||
48766449|NCT01239368|156994678|FG007|Overall Study|Refused further treatment|0|||
48766450|NCT01239368|156994679|FG008|Overall Study|Refused further treatment|0|||
48766451|NCT01239368|156994680|FG009|Overall Study|Refused further treatment|1|||
48766452|NCT01239368|156994671|FG000|Overall Study|Death|0|||
48766453|NCT01239368|156994672|FG001|Overall Study|Death|0|||
48766454|NCT01239368|156994673|FG002|Overall Study|Death|0|||
48766455|NCT01239368|156994674|FG003|Overall Study|Death|0|||
48766456|NCT01239368|156994675|FG004|Overall Study|Death|0|||
48766457|NCT01239368|156994676|FG005|Overall Study|Death|0|||
48766458|NCT01239368|156994677|FG006|Overall Study|Death|1|||
48766459|NCT01239368|156994678|FG007|Overall Study|Death|0|||
48766460|NCT01239368|156994679|FG008|Overall Study|Death|0|||
48766461|NCT01239368|156994680|FG009|Overall Study|Death|0|||
48766462|NCT00670800|156994682|FG000|Overall Study|2 controls were insulin resistant|0|||
48766463|NCT00670800|156994683|FG001|Overall Study|2 controls were insulin resistant|2|||
48766464|NCT02268409|156994686|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
48766465|NCT02268409|156994686|FG000|Overall Study|Death|1|||
48766466|NCT02268409|156994686|FG000|Overall Study|Lost to Follow-up|1|||
48766467|NCT02268409|156994686|FG000|Overall Study|Protocol Violation|3|||
48766468|NCT02268409|156994686|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
48766469|NCT02268409|156994686|FG000|Overall Study|Withdrawal by Subject|5|||
48766470|NCT03026257|156994687|FG000|Overall Study|Adverse Event|3|||
48766471|NCT03026257|156994688|FG001|Overall Study|Adverse Event|0|||
48766472|NCT03026257|156994689|FG002|Overall Study|Adverse Event|0|||
48766473|NCT03026257|156994690|FG003|Overall Study|Adverse Event|0|||
48766474|NCT03026257|156994691|FG004|Overall Study|Adverse Event|0|||
48766475|NCT03026257|156994692|FG005|Overall Study|Adverse Event|0|||
48766476|NCT03026257|156994687|FG000|Overall Study|Lost to Follow-up|1|||
48766477|NCT03026257|156994688|FG001|Overall Study|Lost to Follow-up|0|||
48766478|NCT03026257|156994689|FG002|Overall Study|Lost to Follow-up|0|||
48766479|NCT03026257|156994690|FG003|Overall Study|Lost to Follow-up|0|||
48766480|NCT03026257|156994691|FG004|Overall Study|Lost to Follow-up|0|||
48766481|NCT03026257|156994692|FG005|Overall Study|Lost to Follow-up|0|||
48766482|NCT03026257|156994687|FG000|Overall Study|Protocol Violation|1|||
48766483|NCT03026257|156994688|FG001|Overall Study|Protocol Violation|0|||
48766484|NCT03026257|156994689|FG002|Overall Study|Protocol Violation|0|||
48766485|NCT03026257|156994690|FG003|Overall Study|Protocol Violation|1|||
48766486|NCT03026257|156994691|FG004|Overall Study|Protocol Violation|1|||
48766487|NCT03026257|156994692|FG005|Overall Study|Protocol Violation|0|||
48766488|NCT03026257|156994687|FG000|Overall Study|Withdrawal by Subject|1|||
48766489|NCT03026257|156994688|FG001|Overall Study|Withdrawal by Subject|1|||
48766490|NCT03026257|156994689|FG002|Overall Study|Withdrawal by Subject|0|||
48766491|NCT03026257|156994690|FG003|Overall Study|Withdrawal by Subject|0|||
48766492|NCT03026257|156994691|FG004|Overall Study|Withdrawal by Subject|0|||
48766493|NCT03026257|156994692|FG005|Overall Study|Withdrawal by Subject|0|||
48766494|NCT02181556|156994693|FG000|Overall Study|Withdrawal by Subject|1|||
48766495|NCT01190254|156994694|FG000|Overall Study|Adverse Event|3|||
48766496|NCT01190254|156994695|FG001|Overall Study|Adverse Event|6|||
48766497|NCT01190254|156994696|FG002|Overall Study|Adverse Event|8|||
48766498|NCT01190254|156994694|FG000|Overall Study|Lack of Efficacy|7|||
48766499|NCT01190254|156994695|FG001|Overall Study|Lack of Efficacy|4|||
48766500|NCT01190254|156994696|FG002|Overall Study|Lack of Efficacy|5|||
48766501|NCT01190254|156994694|FG000|Overall Study|Lost to Follow-up|4|||
48766502|NCT01190254|156994695|FG001|Overall Study|Lost to Follow-up|2|||
48766503|NCT01190254|156994696|FG002|Overall Study|Lost to Follow-up|0|||
48430171|NCT00601523|155761977|FG000|Overall Study|Lost to Follow-up|0|||
48766504|NCT01190254|156994694|FG000|Overall Study|Withdrawal by Subject|4|||
48766505|NCT01190254|156994695|FG001|Overall Study|Withdrawal by Subject|5|||
48766506|NCT01190254|156994696|FG002|Overall Study|Withdrawal by Subject|7|||
48766507|NCT01190254|156994694|FG000|Overall Study|Protocol Violation|2|||
48766508|NCT01190254|156994695|FG001|Overall Study|Protocol Violation|0|||
48766509|NCT01190254|156994696|FG002|Overall Study|Protocol Violation|2|||
48766510|NCT01190254|156994694|FG000|Overall Study|Did not meet protocol eligibility|1|||
48766511|NCT01190254|156994695|FG001|Overall Study|Did not meet protocol eligibility|0|||
48766512|NCT01190254|156994696|FG002|Overall Study|Did not meet protocol eligibility|0|||
48766513|NCT04013191|156994699|FG000|Overall Study|Adverse Event|1|||
48766514|NCT04013191|156994700|FG001|Overall Study|Adverse Event|0|||
48766515|NCT01217060|156994707|FG000|Overall Study|Withdrawal by Subject|1|||
48766516|NCT00136084|156994708|FG000|Overall Study|Death|12|||
48766517|NCT00136084|156994709|FG001|Overall Study|Death|5|||
48766518|NCT00136084|156994708|FG000|Overall Study|Unacceptable toxicity|8|||
48766519|NCT00136084|156994709|FG001|Overall Study|Unacceptable toxicity|11|||
48766520|NCT00136084|156994708|FG000|Overall Study|Relapse|20|||
48766521|NCT00136084|156994709|FG001|Overall Study|Relapse|23|||
48766522|NCT00136084|156994708|FG000|Overall Study|Lost to Follow-up|2|||
48766523|NCT00136084|156994709|FG001|Overall Study|Lost to Follow-up|0|||
48766524|NCT00136084|156994708|FG000|Overall Study|No Response|1|||
48766525|NCT00136084|156994709|FG001|Overall Study|No Response|2|||
48766526|NCT00136084|156994708|FG000|Overall Study|Withdrawal by Subject|5|||
48766527|NCT00136084|156994709|FG001|Overall Study|Withdrawal by Subject|1|||
48766528|NCT00588445|156994710|FG000|Overall Study|Protocol Violation|1|||
48766529|NCT00588445|156994710|FG000|Overall Study|Withdrawal by Subject|3|||
48766530|NCT00588445|156994710|FG000|Overall Study|Disease Progression|1|||
48766531|NCT00588445|156994710|FG000|Overall Study|Not Treated|10|||
48766532|NCT03569371|156994714|FG000|Overall Study|Lack of Efficacy|1|||
48766533|NCT03569371|156994714|FG000|Overall Study|Lost to Follow-up|1|||
48766534|NCT03569371|156994714|FG000|Overall Study|Adverse Event|1|||
48766535|NCT01982253|156994719|FG000|Overall Study|Withdrawal by Subject|1|||
48766536|NCT01982253|156994720|FG001|Overall Study|Withdrawal by Subject|0|||
48766537|NCT01982253|156994721|FG002|Overall Study|Withdrawal by Subject|0|||
48766538|NCT01982253|156994719|FG000|Overall Study|Study terminated by sponsor|1|||
48766539|NCT01982253|156994720|FG001|Overall Study|Study terminated by sponsor|4|||
48766540|NCT01982253|156994721|FG002|Overall Study|Study terminated by sponsor|4|||
48766541|NCT01231581|156994722|FG000|Overall Study|Lost to Follow-up|2|||
48766542|NCT01231581|156994723|FG001|Overall Study|Lost to Follow-up|2|||
48766543|NCT01231581|156994722|FG000|Overall Study|Withdrawal by Subject|6|||
48766544|NCT01231581|156994723|FG001|Overall Study|Withdrawal by Subject|9|||
48766545|NCT01231581|156994722|FG000|Overall Study|Study Closed/Terminated|6|||
48766546|NCT01231581|156994723|FG001|Overall Study|Study Closed/Terminated|5|||
48766547|NCT01231581|156994722|FG000|Overall Study|Death|65|||
48766548|NCT01231581|156994723|FG001|Overall Study|Death|64|||
48766549|NCT01231581|156994722|FG000|Overall Study|Ongoing|1|||
48766550|NCT01231581|156994723|FG001|Overall Study|Ongoing|0|||
48766551|NCT01176292|156994724|FG000|Overall Study|Lost to Follow-up|2|||
48766552|NCT01176292|156994725|FG001|Overall Study|Lost to Follow-up|4|||
48766553|NCT01176292|156994724|FG000|Overall Study|Adverse Event|1|||
48766554|NCT01176292|156994725|FG001|Overall Study|Adverse Event|1|||
48766555|NCT01176292|156994724|FG000|Overall Study|Physician Decision|0|||
48766556|NCT01176292|156994725|FG001|Overall Study|Physician Decision|2|||
48766557|NCT01176292|156994724|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
48766558|NCT01176292|156994725|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
48766559|NCT00913744|156994728|FG000|Overall Study|Adverse Event|2|||
48766560|NCT00913744|156994729|FG001|Overall Study|Adverse Event|0|||
48766561|NCT00913744|156994728|FG000|Overall Study|Withdrawal by Subject|2|||
48766562|NCT00913744|156994729|FG001|Overall Study|Withdrawal by Subject|1|||
48766563|NCT00913744|156994728|FG000|Overall Study|Death|1|||
48766564|NCT00913744|156994729|FG001|Overall Study|Death|0|||
48766565|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
48766566|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
48766567|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
48766568|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
48766569|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
48766570|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
48766571|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
48766572|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
48766573|NCT00380393|156994732|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
48766574|NCT00380393|156994733|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
48766575|NCT00380393|156994732|FG000|Month 14|Withdrawal by Subject|9|||
48766576|NCT00380393|156994733|FG001|Month 14|Withdrawal by Subject|7|||
48766577|NCT00380393|156994732|FG000|Month 14|Death|1|||
48766578|NCT00380393|156994733|FG001|Month 14|Death|0|||
48766579|NCT00380393|156994732|FG000|Month 14|Lost to Follow-up|0|||
48766580|NCT00380393|156994733|FG001|Month 14|Lost to Follow-up|1|||
48766581|NCT00380393|156994732|FG000|Month 14|Migrated/moved from study area|39|||
48766582|NCT00380393|156994733|FG001|Month 14|Migrated/moved from study area|42|||
48766583|NCT00380393|156994732|FG000|Month 14|Protocol Violation|2|||
48766584|NCT00380393|156994733|FG001|Month 14|Protocol Violation|0|||
48766585|NCT00380393|156994732|FG000|Month 14|Others|6|||
48766586|NCT00380393|156994733|FG001|Month 14|Others|6|||
48766587|NCT02510794|156994734|FG000|Overall Study|Adverse Event|0|||
48394078|NCT02055820|155638084|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48394079|NCT02055820|155638085|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48394080|NCT02055820|155638086|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48394081|NCT02055820|155638087|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
48394082|NCT02055820|155638088|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48394083|NCT02055820|155638089|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48394084|NCT02055820|155638090|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48394085|NCT02055820|155638091|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
48394086|NCT02055820|155638082|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
48394087|NCT02055820|155638083|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
48394088|NCT02055820|155638084|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
48394089|NCT02055820|155638085|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
48394090|NCT02055820|155638086|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
48394091|NCT02055820|155638087|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
48394092|NCT02055820|155638088|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
48394093|NCT02055820|155638089|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
48394094|NCT02055820|155638090|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
48394095|NCT02055820|155638091|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
48394096|NCT02055820|155638082|FG000|Phase II: Expansion|Death|0|||
48394097|NCT02055820|155638083|FG001|Phase II: Expansion|Death|0|||
48394098|NCT02055820|155638084|FG002|Phase II: Expansion|Death|0|||
48394099|NCT02055820|155638085|FG003|Phase II: Expansion|Death|0|||
48766588|NCT02510794|156994735|FG001|Overall Study|Adverse Event|1|||
48766589|NCT02510794|156994736|FG002|Overall Study|Adverse Event|0|||
48766590|NCT02510794|156994737|FG003|Overall Study|Adverse Event|0|||
48394100|NCT02055820|155638086|FG004|Phase II: Expansion|Death|33|||
48766591|NCT02510794|156994734|FG000|Overall Study|Death|1|||
48766592|NCT02510794|156994735|FG001|Overall Study|Death|2|||
48766593|NCT02510794|156994736|FG002|Overall Study|Death|1|||
48766594|NCT02510794|156994737|FG003|Overall Study|Death|1|||
48766595|NCT02510794|156994734|FG000|Overall Study|Lack of Efficacy|3|||
48766596|NCT02510794|156994735|FG001|Overall Study|Lack of Efficacy|1|||
48766597|NCT02510794|156994736|FG002|Overall Study|Lack of Efficacy|1|||
48766598|NCT02510794|156994737|FG003|Overall Study|Lack of Efficacy|0|||
48766599|NCT02510794|156994734|FG000|Overall Study|Participant moved out of the area|0|||
48394101|NCT02055820|155638087|FG005|Phase II: Expansion|Death|0|||
48394102|NCT02055820|155638088|FG006|Phase II: Expansion|Death|0|||
48394103|NCT02055820|155638089|FG007|Phase II: Expansion|Death|0|||
48394104|NCT02055820|155638090|FG008|Phase II: Expansion|Death|0|||
48394105|NCT02055820|155638091|FG009|Phase II: Expansion|Death|0|||
48394106|NCT02055820|155638082|FG000|Phase II: Expansion|Lost to Follow-up|0|||
48394107|NCT02055820|155638083|FG001|Phase II: Expansion|Lost to Follow-up|0|||
48766600|NCT02510794|156994735|FG001|Overall Study|Participant moved out of the area|0|||
48394108|NCT02055820|155638084|FG002|Phase II: Expansion|Lost to Follow-up|0|||
48394109|NCT02055820|155638085|FG003|Phase II: Expansion|Lost to Follow-up|0|||
48766601|NCT02510794|156994736|FG002|Overall Study|Participant moved out of the area|0|||
48766602|NCT02510794|156994737|FG003|Overall Study|Participant moved out of the area|1|||
48766603|NCT02510794|156994734|FG000|Overall Study|Physician Decision|3|||
48766604|NCT02510794|156994735|FG001|Overall Study|Physician Decision|0|||
48766605|NCT02510794|156994736|FG002|Overall Study|Physician Decision|0|||
48766606|NCT02510794|156994737|FG003|Overall Study|Physician Decision|0|||
48766607|NCT02510794|156994734|FG000|Overall Study|Protocol Violation|0|||
48766608|NCT02510794|156994735|FG001|Overall Study|Protocol Violation|0|||
48766609|NCT02510794|156994736|FG002|Overall Study|Protocol Violation|1|||
48766610|NCT02510794|156994737|FG003|Overall Study|Protocol Violation|0|||
48766611|NCT02510794|156994734|FG000|Overall Study|Withdrawal by Subject|1|||
48766612|NCT02510794|156994735|FG001|Overall Study|Withdrawal by Subject|2|||
48766613|NCT02510794|156994736|FG002|Overall Study|Withdrawal by Subject|4|||
48766614|NCT02510794|156994737|FG003|Overall Study|Withdrawal by Subject|3|||
48766615|NCT04200248|156994738|FG000|Overall Study|Personal reasons|0|||
48766616|NCT04200248|156994739|FG001|Overall Study|Personal reasons|0|||
48766617|NCT04200248|156994740|FG002|Overall Study|Personal reasons|1|||
48766618|NCT04200248|156994738|FG000|Overall Study|Discontinued prior to treatment|3|||
48766619|NCT04200248|156994739|FG001|Overall Study|Discontinued prior to treatment|3|||
48766620|NCT04200248|156994740|FG002|Overall Study|Discontinued prior to treatment|2|||
48766621|NCT03848845|156994741|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
48766622|NCT03848845|156994742|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
48766623|NCT03848845|156994743|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
48766624|NCT03848845|156994744|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
48766625|NCT03848845|156994741|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
48766626|NCT03848845|156994742|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
48766627|NCT03848845|156994743|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
48766628|NCT03848845|156994744|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
48766629|NCT03848845|156994741|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
48766630|NCT03848845|156994742|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
48766631|NCT03848845|156994743|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
48766632|NCT03848845|156994744|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
48766633|NCT03848845|156994741|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
48766634|NCT03848845|156994742|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
48766635|NCT03848845|156994743|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
48766636|NCT03848845|156994744|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
48766637|NCT01859507|156994745|FG000|Overall Study|left the country|4|||
48766638|NCT04091646|156994746|FG000|Overall Study|Adverse Event|2|||
48766639|NCT04091646|156994747|FG001|Overall Study|Adverse Event|1|||
48394110|NCT02055820|155638086|FG004|Phase II: Expansion|Lost to Follow-up|4|||
48394111|NCT02055820|155638087|FG005|Phase II: Expansion|Lost to Follow-up|0|||
48766640|NCT04091646|156994746|FG000|Overall Study|Lost to Follow-up|6|||
48766641|NCT04091646|156994747|FG001|Overall Study|Lost to Follow-up|2|||
48766642|NCT04091646|156994746|FG000|Overall Study|Protocol Violation|0|||
48766643|NCT04091646|156994747|FG001|Overall Study|Protocol Violation|1|||
48766644|NCT04091646|156994746|FG000|Overall Study|Withdrawal by Subject|4|||
48766645|NCT04091646|156994747|FG001|Overall Study|Withdrawal by Subject|1|||
48766646|NCT04091646|156994746|FG000|Overall Study|Participant Incarcerated|1|||
48766647|NCT04091646|156994747|FG001|Overall Study|Participant Incarcerated|0|||
48766648|NCT02658890|156994748|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766649|NCT02658890|156994749|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766650|NCT02658890|156994750|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766651|NCT02658890|156994751|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766652|NCT02658890|156994752|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766653|NCT02658890|156994753|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766654|NCT02658890|156994754|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766655|NCT02658890|156994755|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766656|NCT02658890|156994756|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766657|NCT02658890|156994757|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766658|NCT02658890|156994758|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766659|NCT02658890|156994759|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766660|NCT02658890|156994760|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766661|NCT02658890|156994761|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766662|NCT02658890|156994762|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766663|NCT02658890|156994763|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766664|NCT02658890|156994764|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766665|NCT02658890|156994765|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766666|NCT02658890|156994766|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766667|NCT02658890|156994767|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766668|NCT02658890|156994768|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766669|NCT02658890|156994769|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766670|NCT02658890|156994770|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766671|NCT02658890|156994771|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766672|NCT02658890|156994772|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766673|NCT02658890|156994773|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766674|NCT02658890|156994774|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766675|NCT02658890|156994748|FG000|Treatment Phase|Adverse Event|0|||
48766676|NCT02658890|156994749|FG001|Treatment Phase|Adverse Event|1|||
48766677|NCT02658890|156994750|FG002|Treatment Phase|Adverse Event|2|||
48766678|NCT02658890|156994751|FG003|Treatment Phase|Adverse Event|2|||
48766679|NCT02658890|156994752|FG004|Treatment Phase|Adverse Event|1|||
48766680|NCT02658890|156994753|FG005|Treatment Phase|Adverse Event|0|||
48766681|NCT02658890|156994754|FG006|Treatment Phase|Adverse Event|0|||
48766682|NCT02658890|156994755|FG007|Treatment Phase|Adverse Event|2|||
48766683|NCT02658890|156994756|FG008|Treatment Phase|Adverse Event|1|||
48766684|NCT02658890|156994757|FG009|Treatment Phase|Adverse Event|2|||
48766685|NCT02658890|156994758|FG010|Treatment Phase|Adverse Event|3|||
48766686|NCT02658890|156994759|FG011|Treatment Phase|Adverse Event|0|||
48766687|NCT02658890|156994760|FG012|Treatment Phase|Adverse Event|1|||
48766688|NCT02658890|156994761|FG013|Treatment Phase|Adverse Event|4|||
48766689|NCT02658890|156994762|FG014|Treatment Phase|Adverse Event|0|||
48766690|NCT02658890|156994763|FG015|Treatment Phase|Adverse Event|0|||
48766691|NCT02658890|156994764|FG016|Treatment Phase|Adverse Event|0|||
48766692|NCT02658890|156994765|FG017|Treatment Phase|Adverse Event|0|||
48766693|NCT02658890|156994766|FG018|Treatment Phase|Adverse Event|5|||
48766694|NCT02658890|156994767|FG019|Treatment Phase|Adverse Event|1|||
48766695|NCT02658890|156994768|FG020|Treatment Phase|Adverse Event|3|||
48766696|NCT02658890|156994769|FG021|Treatment Phase|Adverse Event|0|||
48766697|NCT02658890|156994770|FG022|Treatment Phase|Adverse Event|5|||
48766698|NCT02658890|156994771|FG023|Treatment Phase|Adverse Event|0|||
48766699|NCT02658890|156994772|FG024|Treatment Phase|Adverse Event|0|||
48766700|NCT02658890|156994773|FG025|Treatment Phase|Adverse Event|2|||
48766701|NCT02658890|156994774|FG026|Treatment Phase|Adverse Event|1|||
48766702|NCT02658890|156994748|FG000|Treatment Phase|Death|0|||
48766703|NCT02658890|156994749|FG001|Treatment Phase|Death|0|||
48766704|NCT02658890|156994750|FG002|Treatment Phase|Death|0|||
48766705|NCT02658890|156994751|FG003|Treatment Phase|Death|0|||
48766706|NCT02658890|156994752|FG004|Treatment Phase|Death|0|||
48766707|NCT02658890|156994753|FG005|Treatment Phase|Death|0|||
48766708|NCT02658890|156994754|FG006|Treatment Phase|Death|0|||
48766709|NCT02658890|156994755|FG007|Treatment Phase|Death|0|||
48766710|NCT02658890|156994756|FG008|Treatment Phase|Death|0|||
48766711|NCT02658890|156994757|FG009|Treatment Phase|Death|0|||
48766712|NCT02658890|156994758|FG010|Treatment Phase|Death|0|||
48766713|NCT02658890|156994759|FG011|Treatment Phase|Death|0|||
48766714|NCT02658890|156994760|FG012|Treatment Phase|Death|0|||
48766715|NCT02658890|156994761|FG013|Treatment Phase|Death|0|||
48766716|NCT02658890|156994762|FG014|Treatment Phase|Death|0|||
48766717|NCT02658890|156994763|FG015|Treatment Phase|Death|0|||
48766718|NCT02658890|156994764|FG016|Treatment Phase|Death|0|||
48766719|NCT02658890|156994765|FG017|Treatment Phase|Death|0|||
48766720|NCT02658890|156994766|FG018|Treatment Phase|Death|1|||
48766721|NCT02658890|156994767|FG019|Treatment Phase|Death|0|||
48766722|NCT02658890|156994768|FG020|Treatment Phase|Death|0|||
48766723|NCT02658890|156994769|FG021|Treatment Phase|Death|0|||
48355767|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
48766724|NCT02658890|156994770|FG022|Treatment Phase|Death|0|||
48766725|NCT02658890|156994771|FG023|Treatment Phase|Death|0|||
48766726|NCT02658890|156994772|FG024|Treatment Phase|Death|0|||
48766727|NCT02658890|156994773|FG025|Treatment Phase|Death|0|||
48766728|NCT02658890|156994774|FG026|Treatment Phase|Death|0|||
48766729|NCT02658890|156994748|FG000|Treatment Phase|Lost to Follow-up|0|||
48766730|NCT02658890|156994749|FG001|Treatment Phase|Lost to Follow-up|0|||
48766731|NCT02658890|156994750|FG002|Treatment Phase|Lost to Follow-up|0|||
48394112|NCT02055820|155638088|FG006|Phase II: Expansion|Lost to Follow-up|0|||
48394113|NCT02055820|155638089|FG007|Phase II: Expansion|Lost to Follow-up|0|||
48394114|NCT02055820|155638090|FG008|Phase II: Expansion|Lost to Follow-up|0|||
48394115|NCT02055820|155638091|FG009|Phase II: Expansion|Lost to Follow-up|0|||
48394116|NCT02055820|155638082|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
48394117|NCT02055820|155638083|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
48394118|NCT02055820|155638084|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
48394119|NCT02055820|155638085|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
48394120|NCT02055820|155638086|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
48394121|NCT02055820|155638087|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
48394122|NCT02055820|155638088|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
48394123|NCT02055820|155638089|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
48394124|NCT02055820|155638090|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
48394125|NCT02055820|155638091|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
48394126|NCT01032915|155638092|FG000|Overall Study|Adverse Event|2|||
48394127|NCT01032915|155638093|FG001|Overall Study|Adverse Event|2|||
48394128|NCT01032915|155638094|FG002|Overall Study|Adverse Event|1|||
48394129|NCT01032915|155638095|FG003|Overall Study|Adverse Event|1|||
48394130|NCT01032915|155638092|FG000|Overall Study|Abnormal test procedure result|0|||
48394131|NCT01032915|155638093|FG001|Overall Study|Abnormal test procedure result|0|||
48394132|NCT01032915|155638094|FG002|Overall Study|Abnormal test procedure result|1|||
48394133|NCT01032915|155638095|FG003|Overall Study|Abnormal test procedure result|0|||
48394134|NCT01032915|155638092|FG000|Overall Study|Withdrawal by Subject|0|||
48394135|NCT01032915|155638093|FG001|Overall Study|Withdrawal by Subject|3|||
48394136|NCT01032915|155638094|FG002|Overall Study|Withdrawal by Subject|1|||
48394137|NCT01032915|155638095|FG003|Overall Study|Withdrawal by Subject|1|||
48394138|NCT01032915|155638092|FG000|Overall Study|Administrative reasons|5|||
48394139|NCT01032915|155638093|FG001|Overall Study|Administrative reasons|6|||
48394140|NCT01032915|155638094|FG002|Overall Study|Administrative reasons|4|||
48394141|NCT01032915|155638095|FG003|Overall Study|Administrative reasons|4|||
48394142|NCT01032915|155638092|FG000|Overall Study|Protocol Violation|1|||
48394143|NCT01032915|155638093|FG001|Overall Study|Protocol Violation|0|||
48394144|NCT01032915|155638094|FG002|Overall Study|Protocol Violation|0|||
48394145|NCT01032915|155638095|FG003|Overall Study|Protocol Violation|1|||
48394146|NCT03259074|155638101|FG000|Overall Study|Adverse Event|9|||
48394147|NCT03259074|155638102|FG001|Overall Study|Adverse Event|12|||
48394148|NCT03259074|155638103|FG002|Overall Study|Adverse Event|8|||
48394149|NCT03259074|155638101|FG000|Overall Study|Death|1|||
48394150|NCT03259074|155638102|FG001|Overall Study|Death|1|||
48394151|NCT03259074|155638103|FG002|Overall Study|Death|3|||
48394152|NCT03259074|155638101|FG000|Overall Study|Lost to Follow-up|2|||
48394153|NCT03259074|155638102|FG001|Overall Study|Lost to Follow-up|4|||
48394154|NCT03259074|155638103|FG002|Overall Study|Lost to Follow-up|3|||
48394155|NCT03259074|155638101|FG000|Overall Study|New Therapy For Study Indication|1|||
48394156|NCT03259074|155638102|FG001|Overall Study|New Therapy For Study Indication|2|||
48394157|NCT03259074|155638103|FG002|Overall Study|New Therapy For Study Indication|2|||
48394158|NCT03259074|155638101|FG000|Overall Study|Physician Decision|4|||
48394159|NCT03259074|155638102|FG001|Overall Study|Physician Decision|12|||
48394160|NCT03259074|155638103|FG002|Overall Study|Physician Decision|10|||
48394161|NCT03259074|155638101|FG000|Overall Study|Pregnancy|1|||
48394162|NCT03259074|155638102|FG001|Overall Study|Pregnancy|1|||
48394163|NCT03259074|155638103|FG002|Overall Study|Pregnancy|0|||
48394164|NCT03259074|155638101|FG000|Overall Study|Progressive Disease|1|||
48394165|NCT03259074|155638102|FG001|Overall Study|Progressive Disease|0|||
48394166|NCT03259074|155638103|FG002|Overall Study|Progressive Disease|0|||
48394167|NCT03259074|155638101|FG000|Overall Study|Protocol Deviation|1|||
48394168|NCT03259074|155638102|FG001|Overall Study|Protocol Deviation|1|||
48394169|NCT03259074|155638103|FG002|Overall Study|Protocol Deviation|3|||
48394170|NCT03259074|155638101|FG000|Overall Study|Subject/Guardian Decision|13|||
48394171|NCT03259074|155638102|FG001|Overall Study|Subject/Guardian Decision|16|||
48394172|NCT03259074|155638103|FG002|Overall Study|Subject/Guardian Decision|14|||
48394173|NCT04081363|155638104|FG000|Overall Study|Withdrawal by Subject|1|||
48394174|NCT04081363|155638105|FG001|Overall Study|Withdrawal by Subject|0|||
48394175|NCT00133991|155638106|FG000|Overall Study|Death|4|||
48394176|NCT00143312|155638107|FG000|Overall Study|Death|11|||
48394177|NCT00143312|155638107|FG000|Overall Study|Adverse Event|2|||
48394178|NCT00143312|155638107|FG000|Overall Study|Lost to Follow-up|1|||
48394179|NCT00143312|155638107|FG000|Overall Study|Other|1|||
48394180|NCT00143312|155638107|FG000|Overall Study|Withdrawal by Subject|1|||
48394181|NCT03029143|155638108|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
48394182|NCT03029143|155638109|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
48394183|NCT03029143|155638110|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
48394184|NCT03029143|155638108|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
48394185|NCT03029143|155638109|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
48394186|NCT03029143|155638110|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
48394187|NCT03029143|155638108|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
48394188|NCT03029143|155638109|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
48394189|NCT03029143|155638110|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
48394190|NCT03029143|155638108|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
48394191|NCT03029143|155638109|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
48394192|NCT03029143|155638110|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
48394193|NCT03029143|155638108|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
48394194|NCT03029143|155638109|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
48394195|NCT03029143|155638110|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
48394196|NCT03029143|155638108|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
48394197|NCT03029143|155638109|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
48394198|NCT03029143|155638110|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
48394199|NCT03029143|155638108|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
48394200|NCT03029143|155638109|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
48394201|NCT03029143|155638110|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
48394202|NCT03029143|155638108|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48394203|NCT03029143|155638109|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48394204|NCT03029143|155638110|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
48394205|NCT03029143|155638108|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
48394206|NCT03029143|155638109|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
48394207|NCT03029143|155638110|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
48394208|NCT03029143|155638108|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48394209|NCT03029143|155638109|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
48394210|NCT03029143|155638110|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
48394211|NCT03029143|155638108|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
48766732|NCT02658890|156994751|FG003|Treatment Phase|Lost to Follow-up|0|||
48766733|NCT02658890|156994752|FG004|Treatment Phase|Lost to Follow-up|0|||
48766734|NCT02658890|156994753|FG005|Treatment Phase|Lost to Follow-up|0|||
48766735|NCT02658890|156994754|FG006|Treatment Phase|Lost to Follow-up|1|||
48766736|NCT02658890|156994755|FG007|Treatment Phase|Lost to Follow-up|0|||
48766737|NCT02658890|156994756|FG008|Treatment Phase|Lost to Follow-up|0|||
48766738|NCT02658890|156994757|FG009|Treatment Phase|Lost to Follow-up|0|||
48766739|NCT02658890|156994758|FG010|Treatment Phase|Lost to Follow-up|0|||
48766740|NCT02658890|156994759|FG011|Treatment Phase|Lost to Follow-up|0|||
48766741|NCT02658890|156994760|FG012|Treatment Phase|Lost to Follow-up|0|||
48766742|NCT02658890|156994761|FG013|Treatment Phase|Lost to Follow-up|0|||
48766743|NCT02658890|156994762|FG014|Treatment Phase|Lost to Follow-up|0|||
48766744|NCT02658890|156994763|FG015|Treatment Phase|Lost to Follow-up|0|||
48766745|NCT02658890|156994764|FG016|Treatment Phase|Lost to Follow-up|0|||
48766746|NCT02658890|156994765|FG017|Treatment Phase|Lost to Follow-up|0|||
48766747|NCT02658890|156994766|FG018|Treatment Phase|Lost to Follow-up|0|||
48766748|NCT02658890|156994767|FG019|Treatment Phase|Lost to Follow-up|0|||
48766749|NCT02658890|156994768|FG020|Treatment Phase|Lost to Follow-up|0|||
48766750|NCT02658890|156994769|FG021|Treatment Phase|Lost to Follow-up|0|||
48766751|NCT02658890|156994770|FG022|Treatment Phase|Lost to Follow-up|0|||
48766752|NCT02658890|156994771|FG023|Treatment Phase|Lost to Follow-up|0|||
48766753|NCT02658890|156994772|FG024|Treatment Phase|Lost to Follow-up|0|||
48766754|NCT02658890|156994773|FG025|Treatment Phase|Lost to Follow-up|0|||
48766755|NCT02658890|156994774|FG026|Treatment Phase|Lost to Follow-up|0|||
48766756|NCT02658890|156994748|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
48766757|NCT02658890|156994749|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
48766758|NCT02658890|156994750|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
48766759|NCT02658890|156994751|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
48766760|NCT02658890|156994752|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
48766761|NCT02658890|156994753|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
48394212|NCT03029143|155638109|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
48394213|NCT03029143|155638110|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
48394214|NCT00607386|155638111|FG000|Overall Study|Physician Decision|1|||
48394215|NCT02716987|155638112|FG000|Overall Study|Ligand synthesis failure|0|||
48766762|NCT02658890|156994754|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
48766763|NCT02658890|156994755|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
48766764|NCT02658890|156994756|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
48766765|NCT02658890|156994757|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
48766766|NCT02658890|156994758|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
48766767|NCT02658890|156994759|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
48766768|NCT02658890|156994760|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
48766769|NCT02658890|156994761|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
48766770|NCT02658890|156994762|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
48766771|NCT02658890|156994763|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
48766772|NCT02658890|156994764|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
48766773|NCT02658890|156994765|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
48766774|NCT02658890|156994766|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
48766775|NCT02658890|156994767|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
48394216|NCT02716987|155638113|FG001|Overall Study|Ligand synthesis failure|0|||
48394217|NCT02716987|155638114|FG002|Overall Study|Ligand synthesis failure|1|||
48394218|NCT02716987|155638115|FG003|Overall Study|Ligand synthesis failure|0|||
48394219|NCT02716987|155638116|FG004|Overall Study|Ligand synthesis failure|0|||
48394220|NCT02716987|155638117|FG005|Overall Study|Ligand synthesis failure|0|||
48394221|NCT02716987|155638112|FG000|Overall Study|Withdrawal by Subject|0|||
48394222|NCT02716987|155638113|FG001|Overall Study|Withdrawal by Subject|0|||
48394223|NCT02716987|155638114|FG002|Overall Study|Withdrawal by Subject|0|||
48394224|NCT02716987|155638115|FG003|Overall Study|Withdrawal by Subject|0|||
48394225|NCT02716987|155638116|FG004|Overall Study|Withdrawal by Subject|1|||
48394226|NCT02716987|155638117|FG005|Overall Study|Withdrawal by Subject|1|||
48394227|NCT00282334|155638123|FG000|Overall Study|Withdrawal by Subject|8|||
48394228|NCT00282334|155638124|FG001|Overall Study|Withdrawal by Subject|5|||
48394229|NCT03016325|155638125|FG000|Treatment Period|Participant withdrew consent|0|||
48394230|NCT03016325|155638126|FG001|Treatment Period|Participant withdrew consent|1|||
48394231|NCT03016325|155638127|FG002|Treatment Period|Participant withdrew consent|0|||
48394232|NCT03016325|155638128|FG003|Treatment Period|Participant withdrew consent|0|||
48394233|NCT03016325|155638129|FG004|Treatment Period|Participant withdrew consent|0|||
48766776|NCT02658890|156994768|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
48766777|NCT02658890|156994769|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
48766778|NCT02658890|156994770|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
48766779|NCT02658890|156994771|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
48766780|NCT02658890|156994772|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
48766781|NCT02658890|156994773|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
48766782|NCT02658890|156994774|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
48766783|NCT02658890|156994748|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
48766784|NCT02658890|156994749|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
48766785|NCT02658890|156994750|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
48766786|NCT02658890|156994751|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
48766787|NCT02658890|156994752|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
48766788|NCT02658890|156994753|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
48766789|NCT02658890|156994754|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
48766790|NCT02658890|156994755|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
48766791|NCT02658890|156994756|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
48766792|NCT02658890|156994757|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
48766793|NCT02658890|156994758|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
48766794|NCT02658890|156994759|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
48766795|NCT02658890|156994760|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
48766796|NCT02658890|156994761|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
48766797|NCT02658890|156994762|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
48766798|NCT02658890|156994763|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
48766799|NCT02658890|156994764|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
48766800|NCT02658890|156994765|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
48766801|NCT02658890|156994766|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
48766802|NCT02658890|156994767|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
48766803|NCT02658890|156994768|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
48766804|NCT02658890|156994769|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
48766805|NCT02658890|156994770|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
48766806|NCT02658890|156994771|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
48766807|NCT02658890|156994772|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
48394234|NCT03016325|155638130|FG005|Treatment Period|Participant withdrew consent|0|||
48394235|NCT03016325|155638131|FG006|Treatment Period|Participant withdrew consent|0|||
48394236|NCT03016325|155638132|FG007|Treatment Period|Participant withdrew consent|0|||
48394237|NCT03016325|155638125|FG000|Treatment Period|Death|0|||
48394238|NCT03016325|155638126|FG001|Treatment Period|Death|0|||
48394239|NCT03016325|155638127|FG002|Treatment Period|Death|0|||
48394240|NCT03016325|155638128|FG003|Treatment Period|Death|0|||
48394241|NCT03016325|155638129|FG004|Treatment Period|Death|2|||
48394242|NCT03016325|155638130|FG005|Treatment Period|Death|0|||
48394243|NCT03016325|155638131|FG006|Treatment Period|Death|0|||
48394244|NCT03016325|155638132|FG007|Treatment Period|Death|0|||
48394245|NCT03016325|155638125|FG000|Treatment Period|Participant refuses assessments|0|||
48394246|NCT03016325|155638126|FG001|Treatment Period|Participant refuses assessments|0|||
48394247|NCT03016325|155638127|FG002|Treatment Period|Participant refuses assessments|1|||
48394248|NCT03016325|155638128|FG003|Treatment Period|Participant refuses assessments|0|||
48394249|NCT03016325|155638129|FG004|Treatment Period|Participant refuses assessments|0|||
48394250|NCT03016325|155638130|FG005|Treatment Period|Participant refuses assessments|0|||
48394251|NCT03016325|155638131|FG006|Treatment Period|Participant refuses assessments|0|||
48766808|NCT02658890|156994773|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
48766809|NCT02658890|156994774|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
48766810|NCT02658890|156994748|FG000|Treatment Phase|Other Reasons|0|||
48766811|NCT02658890|156994749|FG001|Treatment Phase|Other Reasons|0|||
48766812|NCT02658890|156994750|FG002|Treatment Phase|Other Reasons|0|||
48766813|NCT02658890|156994751|FG003|Treatment Phase|Other Reasons|0|||
48766814|NCT02658890|156994752|FG004|Treatment Phase|Other Reasons|0|||
48766815|NCT02658890|156994753|FG005|Treatment Phase|Other Reasons|0|||
48766816|NCT02658890|156994754|FG006|Treatment Phase|Other Reasons|1|||
48766817|NCT02658890|156994755|FG007|Treatment Phase|Other Reasons|0|||
48766818|NCT02658890|156994756|FG008|Treatment Phase|Other Reasons|1|||
48766819|NCT02658890|156994757|FG009|Treatment Phase|Other Reasons|0|||
48766820|NCT02658890|156994758|FG010|Treatment Phase|Other Reasons|0|||
48766821|NCT02658890|156994759|FG011|Treatment Phase|Other Reasons|0|||
48766822|NCT02658890|156994760|FG012|Treatment Phase|Other Reasons|0|||
48766823|NCT02658890|156994761|FG013|Treatment Phase|Other Reasons|2|||
48766824|NCT02658890|156994762|FG014|Treatment Phase|Other Reasons|0|||
48394252|NCT03016325|155638132|FG007|Treatment Period|Participant refuses assessments|0|||
48394253|NCT03016325|155638125|FG000|32-Day Follow-Up Period|Death|2|||
48394254|NCT03016325|155638126|FG001|32-Day Follow-Up Period|Death|0|||
48766825|NCT02658890|156994763|FG015|Treatment Phase|Other Reasons|0|||
48766826|NCT02658890|156994764|FG016|Treatment Phase|Other Reasons|0|||
48766827|NCT02658890|156994765|FG017|Treatment Phase|Other Reasons|0|||
48766828|NCT02658890|156994766|FG018|Treatment Phase|Other Reasons|1|||
48766829|NCT02658890|156994767|FG019|Treatment Phase|Other Reasons|0|||
48766830|NCT02658890|156994768|FG020|Treatment Phase|Other Reasons|0|||
48766831|NCT02658890|156994769|FG021|Treatment Phase|Other Reasons|0|||
48766832|NCT02658890|156994770|FG022|Treatment Phase|Other Reasons|0|||
48766833|NCT02658890|156994771|FG023|Treatment Phase|Other Reasons|0|||
48766834|NCT02658890|156994772|FG024|Treatment Phase|Other Reasons|1|||
48766835|NCT02658890|156994773|FG025|Treatment Phase|Other Reasons|0|||
48766836|NCT02658890|156994774|FG026|Treatment Phase|Other Reasons|1|||
48766837|NCT02658890|156994748|FG000|Treatment Phase|Progressive Disease|6|||
48394255|NCT03016325|155638127|FG002|32-Day Follow-Up Period|Death|5|||
48394256|NCT03016325|155638128|FG003|32-Day Follow-Up Period|Death|6|||
48394257|NCT03016325|155638129|FG004|32-Day Follow-Up Period|Death|3|||
48394258|NCT03016325|155638130|FG005|32-Day Follow-Up Period|Death|0|||
48394259|NCT03016325|155638131|FG006|32-Day Follow-Up Period|Death|0|||
48394260|NCT03016325|155638132|FG007|32-Day Follow-Up Period|Death|0|||
48394261|NCT03016325|155638125|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
48394262|NCT03016325|155638126|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
48394263|NCT03016325|155638127|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
48394264|NCT03016325|155638128|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
48394265|NCT03016325|155638129|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
48394266|NCT03016325|155638130|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
48394267|NCT03016325|155638131|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
48394268|NCT03016325|155638132|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
48394269|NCT03016325|155638125|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
48394270|NCT03016325|155638126|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
48394271|NCT03016325|155638127|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
48394272|NCT03016325|155638128|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
48394273|NCT03016325|155638129|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
48394274|NCT03016325|155638130|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
48394275|NCT03016325|155638131|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
48394276|NCT03016325|155638132|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
48394277|NCT03016325|155638125|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
48394278|NCT03016325|155638126|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
48394279|NCT03016325|155638127|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
48394280|NCT03016325|155638128|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
48394281|NCT03016325|155638129|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
48394282|NCT03016325|155638130|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
48394283|NCT03016325|155638131|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
48394284|NCT03016325|155638132|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
48394285|NCT03016325|155638125|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
48394286|NCT03016325|155638126|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
48394287|NCT03016325|155638127|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
48394288|NCT03016325|155638128|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
48394289|NCT03016325|155638129|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
48394290|NCT03016325|155638130|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
48394291|NCT03016325|155638131|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
48394292|NCT03016325|155638132|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
48394293|NCT03016325|155638125|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48394294|NCT03016325|155638126|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48394295|NCT03016325|155638127|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
48394296|NCT03016325|155638128|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48394297|NCT03016325|155638129|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48766838|NCT02658890|156994749|FG001|Treatment Phase|Progressive Disease|7|||
48766839|NCT02658890|156994750|FG002|Treatment Phase|Progressive Disease|6|||
48766840|NCT02658890|156994751|FG003|Treatment Phase|Progressive Disease|12|||
48766841|NCT02658890|156994752|FG004|Treatment Phase|Progressive Disease|6|||
48766842|NCT02658890|156994753|FG005|Treatment Phase|Progressive Disease|18|||
48766843|NCT02658890|156994754|FG006|Treatment Phase|Progressive Disease|12|||
48766844|NCT02658890|156994755|FG007|Treatment Phase|Progressive Disease|19|||
48766845|NCT02658890|156994756|FG008|Treatment Phase|Progressive Disease|26|||
48766846|NCT02658890|156994757|FG009|Treatment Phase|Progressive Disease|8|||
48766847|NCT02658890|156994758|FG010|Treatment Phase|Progressive Disease|7|||
48766848|NCT02658890|156994759|FG011|Treatment Phase|Progressive Disease|9|||
48766849|NCT02658890|156994760|FG012|Treatment Phase|Progressive Disease|8|||
48766850|NCT02658890|156994761|FG013|Treatment Phase|Progressive Disease|29|||
48766851|NCT02658890|156994762|FG014|Treatment Phase|Progressive Disease|6|||
48394298|NCT03016325|155638130|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48394299|NCT03016325|155638131|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48394300|NCT03016325|155638132|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
48394301|NCT03016325|155638125|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48394302|NCT03016325|155638126|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
48430172|NCT00601523|155761978|FG001|Overall Study|Lost to Follow-up|1|||
48766852|NCT02658890|156994763|FG015|Treatment Phase|Progressive Disease|2|||
48766853|NCT02658890|156994764|FG016|Treatment Phase|Progressive Disease|32|||
48766854|NCT02658890|156994765|FG017|Treatment Phase|Progressive Disease|14|||
48766855|NCT02658890|156994766|FG018|Treatment Phase|Progressive Disease|40|||
48766856|NCT02658890|156994767|FG019|Treatment Phase|Progressive Disease|32|||
48766857|NCT02658890|156994768|FG020|Treatment Phase|Progressive Disease|19|||
48766858|NCT02658890|156994769|FG021|Treatment Phase|Progressive Disease|30|||
48766859|NCT02658890|156994770|FG022|Treatment Phase|Progressive Disease|15|||
48766860|NCT02658890|156994771|FG023|Treatment Phase|Progressive Disease|0|||
48766861|NCT02658890|156994772|FG024|Treatment Phase|Progressive Disease|0|||
48766862|NCT02658890|156994773|FG025|Treatment Phase|Progressive Disease|14|||
48766863|NCT02658890|156994774|FG026|Treatment Phase|Progressive Disease|11|||
48766864|NCT02658890|156994748|FG000|Treatment Phase|Study Drug Toxicity|0|||
48766865|NCT02658890|156994749|FG001|Treatment Phase|Study Drug Toxicity|0|||
48766866|NCT02658890|156994750|FG002|Treatment Phase|Study Drug Toxicity|2|||
48766867|NCT02658890|156994751|FG003|Treatment Phase|Study Drug Toxicity|0|||
48766868|NCT02658890|156994752|FG004|Treatment Phase|Study Drug Toxicity|0|||
48766869|NCT02658890|156994753|FG005|Treatment Phase|Study Drug Toxicity|0|||
48766870|NCT02658890|156994754|FG006|Treatment Phase|Study Drug Toxicity|0|||
48766871|NCT02658890|156994755|FG007|Treatment Phase|Study Drug Toxicity|0|||
48766872|NCT02658890|156994756|FG008|Treatment Phase|Study Drug Toxicity|3|||
48766873|NCT02658890|156994757|FG009|Treatment Phase|Study Drug Toxicity|0|||
48394303|NCT03016325|155638127|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48394304|NCT03016325|155638128|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48394305|NCT03016325|155638129|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48394306|NCT03016325|155638130|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48394307|NCT03016325|155638131|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48394308|NCT03016325|155638132|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
48394309|NCT03016325|155638125|FG000|182-Day Follow-Up Period|Death|3|||
48394310|NCT03016325|155638126|FG001|182-Day Follow-Up Period|Death|3|||
48394311|NCT03016325|155638127|FG002|182-Day Follow-Up Period|Death|11|||
48394312|NCT03016325|155638128|FG003|182-Day Follow-Up Period|Death|12|||
48394313|NCT03016325|155638129|FG004|182-Day Follow-Up Period|Death|9|||
48394314|NCT03016325|155638130|FG005|182-Day Follow-Up Period|Death|0|||
48394315|NCT03016325|155638131|FG006|182-Day Follow-Up Period|Death|0|||
48394316|NCT03016325|155638132|FG007|182-Day Follow-Up Period|Death|1|||
48394317|NCT03016325|155638125|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
48394318|NCT03016325|155638126|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48766874|NCT02658890|156994758|FG010|Treatment Phase|Study Drug Toxicity|1|||
48766875|NCT02658890|156994759|FG011|Treatment Phase|Study Drug Toxicity|1|||
48394319|NCT03016325|155638127|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48394320|NCT03016325|155638128|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48394321|NCT03016325|155638129|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48394322|NCT03016325|155638130|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48394323|NCT03016325|155638131|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48394324|NCT03016325|155638132|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
48394325|NCT03016325|155638125|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
48394326|NCT03016325|155638126|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
48394327|NCT03016325|155638127|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
48394328|NCT03016325|155638128|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
48394329|NCT03016325|155638129|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
48394330|NCT03016325|155638130|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
48394331|NCT03016325|155638131|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
48394332|NCT03016325|155638132|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
48394333|NCT03016325|155638125|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48394334|NCT03016325|155638126|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48394335|NCT03016325|155638127|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48394336|NCT03016325|155638128|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48394337|NCT03016325|155638129|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
48394338|NCT03016325|155638130|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48766876|NCT02658890|156994760|FG012|Treatment Phase|Study Drug Toxicity|2|||
48766877|NCT02658890|156994761|FG013|Treatment Phase|Study Drug Toxicity|9|||
48766878|NCT02658890|156994762|FG014|Treatment Phase|Study Drug Toxicity|0|||
48766879|NCT02658890|156994763|FG015|Treatment Phase|Study Drug Toxicity|1|||
48766880|NCT02658890|156994764|FG016|Treatment Phase|Study Drug Toxicity|1|||
48766881|NCT02658890|156994765|FG017|Treatment Phase|Study Drug Toxicity|0|||
48394339|NCT03016325|155638131|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48430252|NCT01909453|155762004|FG003|Overall Study|Lost to Follow-up|3|||
48766882|NCT02658890|156994766|FG018|Treatment Phase|Study Drug Toxicity|8|||
48766883|NCT02658890|156994767|FG019|Treatment Phase|Study Drug Toxicity|3|||
48766884|NCT02658890|156994768|FG020|Treatment Phase|Study Drug Toxicity|2|||
48766885|NCT02658890|156994769|FG021|Treatment Phase|Study Drug Toxicity|0|||
48766886|NCT02658890|156994770|FG022|Treatment Phase|Study Drug Toxicity|8|||
48766887|NCT02658890|156994771|FG023|Treatment Phase|Study Drug Toxicity|0|||
48766888|NCT02658890|156994772|FG024|Treatment Phase|Study Drug Toxicity|0|||
48766889|NCT02658890|156994773|FG025|Treatment Phase|Study Drug Toxicity|2|||
48766890|NCT02658890|156994774|FG026|Treatment Phase|Study Drug Toxicity|0|||
48766891|NCT02658890|156994748|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766892|NCT02658890|156994749|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766893|NCT02658890|156994750|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766894|NCT02658890|156994751|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766895|NCT02658890|156994752|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766896|NCT02658890|156994753|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766897|NCT02658890|156994754|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766898|NCT02658890|156994755|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766899|NCT02658890|156994756|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766900|NCT02658890|156994757|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766901|NCT02658890|156994758|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766902|NCT02658890|156994759|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766903|NCT02658890|156994760|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766904|NCT02658890|156994761|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766905|NCT02658890|156994762|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766906|NCT02658890|156994763|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766907|NCT02658890|156994764|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766908|NCT02658890|156994765|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766909|NCT02658890|156994766|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766910|NCT02658890|156994767|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766911|NCT02658890|156994768|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766912|NCT02658890|156994769|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766913|NCT02658890|156994770|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
48766914|NCT02658890|156994771|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766915|NCT02658890|156994772|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766916|NCT02658890|156994773|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766917|NCT02658890|156994774|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
48766918|NCT02658890|156994748|FG000|Treatment Phase|Withdrawal by Subject|0|||
48766919|NCT02658890|156994749|FG001|Treatment Phase|Withdrawal by Subject|1|||
48766920|NCT02658890|156994750|FG002|Treatment Phase|Withdrawal by Subject|0|||
48766921|NCT02658890|156994751|FG003|Treatment Phase|Withdrawal by Subject|0|||
48766922|NCT02658890|156994752|FG004|Treatment Phase|Withdrawal by Subject|0|||
48766923|NCT02658890|156994753|FG005|Treatment Phase|Withdrawal by Subject|0|||
48766924|NCT02658890|156994754|FG006|Treatment Phase|Withdrawal by Subject|1|||
48766925|NCT02658890|156994755|FG007|Treatment Phase|Withdrawal by Subject|0|||
48766926|NCT02658890|156994756|FG008|Treatment Phase|Withdrawal by Subject|0|||
48766927|NCT02658890|156994757|FG009|Treatment Phase|Withdrawal by Subject|1|||
48766928|NCT02658890|156994758|FG010|Treatment Phase|Withdrawal by Subject|0|||
48766929|NCT02658890|156994759|FG011|Treatment Phase|Withdrawal by Subject|0|||
48766930|NCT02658890|156994760|FG012|Treatment Phase|Withdrawal by Subject|1|||
48766931|NCT02658890|156994761|FG013|Treatment Phase|Withdrawal by Subject|3|||
48766932|NCT02658890|156994762|FG014|Treatment Phase|Withdrawal by Subject|0|||
48766933|NCT02658890|156994763|FG015|Treatment Phase|Withdrawal by Subject|0|||
48766934|NCT02658890|156994764|FG016|Treatment Phase|Withdrawal by Subject|1|||
48766935|NCT02658890|156994765|FG017|Treatment Phase|Withdrawal by Subject|0|||
48766936|NCT02658890|156994766|FG018|Treatment Phase|Withdrawal by Subject|4|||
48766937|NCT02658890|156994767|FG019|Treatment Phase|Withdrawal by Subject|3|||
48766938|NCT02658890|156994768|FG020|Treatment Phase|Withdrawal by Subject|0|||
48766939|NCT02658890|156994769|FG021|Treatment Phase|Withdrawal by Subject|4|||
48766940|NCT02658890|156994770|FG022|Treatment Phase|Withdrawal by Subject|1|||
48766941|NCT02658890|156994771|FG023|Treatment Phase|Withdrawal by Subject|1|||
48766942|NCT02658890|156994772|FG024|Treatment Phase|Withdrawal by Subject|0|||
48766943|NCT02658890|156994773|FG025|Treatment Phase|Withdrawal by Subject|0|||
48766944|NCT02658890|156994774|FG026|Treatment Phase|Withdrawal by Subject|0|||
48766945|NCT02342704|156994776|FG000|Overall Study|Physician Decision|0|||
48766946|NCT02342704|156994777|FG001|Overall Study|Physician Decision|3|||
48766947|NCT02342704|156994776|FG000|Overall Study|Sponsor Termination|49|||
48766948|NCT02342704|156994777|FG001|Overall Study|Sponsor Termination|43|||
48766949|NCT02342704|156994776|FG000|Overall Study|Other|0|||
48766950|NCT02342704|156994777|FG001|Overall Study|Other|1|||
48766951|NCT02342704|156994776|FG000|Overall Study|Withdrawal by Subject|1|||
48766952|NCT02342704|156994777|FG001|Overall Study|Withdrawal by Subject|0|||
48766953|NCT02342704|156994776|FG000|Overall Study|Lost to Follow-up|2|||
48766954|NCT02342704|156994777|FG001|Overall Study|Lost to Follow-up|1|||
48766955|NCT02342704|156994776|FG000|Overall Study|Adverse Event|1|||
48766956|NCT02342704|156994777|FG001|Overall Study|Adverse Event|3|||
48766957|NCT02347527|156994778|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
48766958|NCT02347527|156994779|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
48766959|NCT02347527|156994780|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
48766960|NCT02347527|156994781|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
48766961|NCT02347527|156994778|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
48766962|NCT02347527|156994779|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
48766963|NCT02347527|156994780|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
48766964|NCT02347527|156994781|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
48766965|NCT02347527|156994778|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
48766966|NCT02347527|156994779|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
48766967|NCT02347527|156994780|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
48766968|NCT02347527|156994781|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
48766969|NCT02347527|156994778|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
48766970|NCT02347527|156994779|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
48766971|NCT02347527|156994780|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
48766972|NCT02347527|156994781|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
48766973|NCT02347527|156994778|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
48766974|NCT02347527|156994779|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
48766975|NCT02347527|156994780|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
48766976|NCT02347527|156994781|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
48766977|NCT00302003|156994785|FG000|Overall Study|Lack of Efficacy|62|||
48766978|NCT00302003|156994785|FG000|Overall Study|Lost to Follow-up|1|||
48766979|NCT00302003|156994785|FG000|Overall Study|Physician Decision|2|||
48766980|NCT00302003|156994785|FG000|Overall Study|Withdrawal by Subject|5|||
48766981|NCT00302003|156994785|FG000|Overall Study|Ineligible|9|||
48766982|NCT00302003|156994785|FG000|Overall Study|Protocol Violation|1|||
48766983|NCT00283439|156994786|FG000|Overall Study|Adverse Event|0|||
48766984|NCT00283439|156994787|FG001|Overall Study|Adverse Event|0|||
48766985|NCT00283439|156994788|FG002|Overall Study|Adverse Event|0|||
48766986|NCT00283439|156994789|FG003|Overall Study|Adverse Event|1|||
48766987|NCT00283439|156994786|FG000|Overall Study|Death|0|||
48766988|NCT00283439|156994787|FG001|Overall Study|Death|0|||
48766989|NCT00283439|156994788|FG002|Overall Study|Death|1|||
48766990|NCT00283439|156994789|FG003|Overall Study|Death|0|||
48766991|NCT00283439|156994786|FG000|Overall Study|Disease progression|0|||
48766992|NCT00283439|156994787|FG001|Overall Study|Disease progression|1|||
48766993|NCT00283439|156994788|FG002|Overall Study|Disease progression|0|||
48766994|NCT00283439|156994789|FG003|Overall Study|Disease progression|0|||
48766995|NCT00283439|156994786|FG000|Overall Study|Requirement for alternative therapy|1|||
48766996|NCT00283439|156994787|FG001|Overall Study|Requirement for alternative therapy|2|||
48766997|NCT00283439|156994788|FG002|Overall Study|Requirement for alternative therapy|5|||
48766998|NCT00283439|156994789|FG003|Overall Study|Requirement for alternative therapy|2|||
48766999|NCT00283439|156994786|FG000|Overall Study|Stem cell transplant|6|||
48767000|NCT00283439|156994787|FG001|Overall Study|Stem cell transplant|6|||
48767001|NCT00283439|156994788|FG002|Overall Study|Stem cell transplant|4|||
48767002|NCT00283439|156994789|FG003|Overall Study|Stem cell transplant|3|||
48767003|NCT00283439|156994786|FG000|Overall Study|Treatment discontinued|0|||
48767004|NCT00283439|156994787|FG001|Overall Study|Treatment discontinued|2|||
48767005|NCT00283439|156994788|FG002|Overall Study|Treatment discontinued|1|||
48767006|NCT00283439|156994789|FG003|Overall Study|Treatment discontinued|3|||
48767007|NCT00283439|156994786|FG000|Overall Study|Other|1|||
48767008|NCT00283439|156994787|FG001|Overall Study|Other|0|||
48767009|NCT00283439|156994788|FG002|Overall Study|Other|0|||
48767010|NCT00283439|156994789|FG003|Overall Study|Other|0|||
48767011|NCT02042924|156994790|FG000|Overall Study|Early Death|1|||
48767012|NCT00348556|156994791|FG000|Overall Study|Adverse Event|1|||
48767013|NCT02731729|156994792|FG000|Overall Study|Death|2|||
48767014|NCT02731729|156994793|FG001|Overall Study|Death|2|||
48767015|NCT02731729|156994792|FG000|Overall Study|Study terminated by Sponsor|6|||
48767016|NCT02731729|156994793|FG001|Overall Study|Study terminated by Sponsor|6|||
48767017|NCT02731729|156994792|FG000|Overall Study|Withdrawal by Subject|1|||
48394340|NCT03016325|155638132|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
48767018|NCT02731729|156994793|FG001|Overall Study|Withdrawal by Subject|0|||
48767019|NCT00159588|156994794|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
48767020|NCT00159588|156994795|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
48767021|NCT00159588|156994796|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
48767022|NCT04206293|156994801|FG000|Overall Study|Consent withdrawal|1|||
48767023|NCT00430092|156994805|FG000|Overall Study|Adverse Event|0|||
48767024|NCT00430092|156994806|FG001|Overall Study|Adverse Event|0|||
48394341|NCT03016325|155638125|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
48767025|NCT00430092|156994807|FG002|Overall Study|Adverse Event|1|||
48767026|NCT00430092|156994805|FG000|Overall Study|Lack of Efficacy|5|||
48767027|NCT00430092|156994806|FG001|Overall Study|Lack of Efficacy|2|||
48767028|NCT00430092|156994807|FG002|Overall Study|Lack of Efficacy|54|||
48767029|NCT00430092|156994805|FG000|Overall Study|Lost to Follow-up|1|||
48767030|NCT00430092|156994806|FG001|Overall Study|Lost to Follow-up|0|||
48767031|NCT00430092|156994807|FG002|Overall Study|Lost to Follow-up|0|||
48767032|NCT00430092|156994805|FG000|Overall Study|Protocol Violation|0|||
48767033|NCT00430092|156994806|FG001|Overall Study|Protocol Violation|1|||
48767034|NCT00430092|156994807|FG002|Overall Study|Protocol Violation|1|||
48767035|NCT00430092|156994805|FG000|Overall Study|Withdrawal by Subject|0|||
48767036|NCT00430092|156994806|FG001|Overall Study|Withdrawal by Subject|1|||
48767037|NCT00430092|156994807|FG002|Overall Study|Withdrawal by Subject|1|||
48767038|NCT03325166|156994808|FG000|Overall Study|Adverse Event|1|||
48767039|NCT00952341|156994812|FG000|Cycle 1|Adverse Event|4|||
48767040|NCT00952341|156994813|FG001|Cycle 1|Adverse Event|1|||
48767041|NCT00952341|156994812|FG000|Cycle 1|Withdrawal by Subject|3|||
48767042|NCT00952341|156994813|FG001|Cycle 1|Withdrawal by Subject|8|||
48767043|NCT00952341|156994812|FG000|Cycle 1|Protocol Violation|2|||
48767044|NCT00952341|156994813|FG001|Cycle 1|Protocol Violation|1|||
48767045|NCT00952341|156994812|FG000|Cycle 1|Lost to Follow-up|11|||
48767046|NCT00952341|156994813|FG001|Cycle 1|Lost to Follow-up|2|||
48767047|NCT00952341|156994812|FG000|Cycle 1|Physician Decision|0|||
48767048|NCT00952341|156994813|FG001|Cycle 1|Physician Decision|1|||
48767049|NCT00952341|156994812|FG000|Cycle 2|Withdrawal by Subject|1|||
48767050|NCT00952341|156994813|FG001|Cycle 2|Withdrawal by Subject|1|||
48767051|NCT00952341|156994812|FG000|Cycle 2|Protocol Violation|1|||
48767052|NCT00952341|156994813|FG001|Cycle 2|Protocol Violation|0|||
48767053|NCT00952341|156994812|FG000|Cycle 2|Lost to Follow-up|6|||
48767054|NCT00952341|156994813|FG001|Cycle 2|Lost to Follow-up|9|||
48767055|NCT00952341|156994812|FG000|Cycle 2|Physician Decision|1|||
48767056|NCT00952341|156994813|FG001|Cycle 2|Physician Decision|1|||
48767057|NCT00952341|156994812|FG000|Cycle 2|Progressive Disease|0|||
48767058|NCT00952341|156994813|FG001|Cycle 2|Progressive Disease|1|||
48767059|NCT01467076|156994814|FG000|Overall Study|Lost to Follow-up|1|||
48767060|NCT01467076|156994815|FG001|Overall Study|Lost to Follow-up|0|||
48767061|NCT01467076|156994816|FG002|Overall Study|Lost to Follow-up|0|||
48767062|NCT00994448|156994820|FG000|Overall Study|Adverse Event|1|||
48767063|NCT00994448|156994821|FG001|Overall Study|Adverse Event|0|||
48767064|NCT00994448|156994820|FG000|Overall Study|Lost to Follow-up|5|||
48767065|NCT00994448|156994821|FG001|Overall Study|Lost to Follow-up|1|||
48767066|NCT00994448|156994820|FG000|Overall Study|Withdrawal by Subject|1|||
48767067|NCT00994448|156994821|FG001|Overall Study|Withdrawal by Subject|1|||
48767068|NCT00994448|156994820|FG000|Overall Study|Physician Decision|1|||
48767069|NCT00994448|156994821|FG001|Overall Study|Physician Decision|0|||
48767070|NCT00578175|156994828|FG000|Overall Study|Adverse Event|0|||
48767071|NCT00578175|156994829|FG001|Overall Study|Adverse Event|1|||
48767072|NCT00578175|156994830|FG002|Overall Study|Adverse Event|1|||
48767073|NCT00578175|156994828|FG000|Overall Study|Other reasons|70|||
48767074|NCT00578175|156994829|FG001|Overall Study|Other reasons|42|||
48767075|NCT00578175|156994830|FG002|Overall Study|Other reasons|23|||
48767076|NCT01203072|156994831|FG000|Overall Study|Adverse Event|5|||
48767077|NCT01203072|156994832|FG001|Overall Study|Adverse Event|3|||
48767078|NCT01203072|156994833|FG002|Overall Study|Adverse Event|2|||
48767079|NCT01203072|156994834|FG003|Overall Study|Adverse Event|4|||
48767080|NCT01203072|156994835|FG004|Overall Study|Adverse Event|2|||
48767081|NCT01203072|156994831|FG000|Overall Study|Lack of Efficacy|1|||
48767082|NCT01203072|156994832|FG001|Overall Study|Lack of Efficacy|0|||
48767083|NCT01203072|156994833|FG002|Overall Study|Lack of Efficacy|0|||
48767084|NCT01203072|156994834|FG003|Overall Study|Lack of Efficacy|0|||
48767085|NCT01203072|156994835|FG004|Overall Study|Lack of Efficacy|0|||
48767086|NCT01203072|156994831|FG000|Overall Study|Lost to Follow-up|0|||
48394342|NCT03016325|155638126|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
48394343|NCT03016325|155638127|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
48767087|NCT01203072|156994832|FG001|Overall Study|Lost to Follow-up|1|||
48767088|NCT01203072|156994833|FG002|Overall Study|Lost to Follow-up|0|||
48767089|NCT01203072|156994834|FG003|Overall Study|Lost to Follow-up|0|||
48767090|NCT01203072|156994835|FG004|Overall Study|Lost to Follow-up|0|||
48767091|NCT01203072|156994831|FG000|Overall Study|Protocol Violation|2|||
48767092|NCT01203072|156994832|FG001|Overall Study|Protocol Violation|0|||
48394344|NCT03016325|155638128|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
48394345|NCT03016325|155638129|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
48767093|NCT01203072|156994833|FG002|Overall Study|Protocol Violation|0|||
48767094|NCT01203072|156994834|FG003|Overall Study|Protocol Violation|0|||
48767095|NCT01203072|156994835|FG004|Overall Study|Protocol Violation|1|||
48767096|NCT01203072|156994831|FG000|Overall Study|Withdrawal by Subject|2|||
48767097|NCT01203072|156994832|FG001|Overall Study|Withdrawal by Subject|2|||
48767098|NCT01203072|156994833|FG002|Overall Study|Withdrawal by Subject|1|||
48767099|NCT01203072|156994834|FG003|Overall Study|Withdrawal by Subject|2|||
48767100|NCT01203072|156994835|FG004|Overall Study|Withdrawal by Subject|3|||
48394346|NCT03016325|155638130|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
48767101|NCT00235872|156994836|FG000|Overall Study|Adverse Event|34|||
48767102|NCT00235872|156994836|FG000|Overall Study|Death|1|||
48767103|NCT00235872|156994836|FG000|Overall Study|Lost to Follow-up|1|||
48767104|NCT00235872|156994836|FG000|Overall Study|Withdrawal by Subject|50|||
48767105|NCT00235872|156994836|FG000|Overall Study|Administrative reason|61|||
48767106|NCT02027844|156994837|FG000|Overall Study|Withdrawal by Subject|3|||
48767107|NCT02027844|156994838|FG001|Overall Study|Withdrawal by Subject|2|||
48767108|NCT02027844|156994839|FG002|Overall Study|Withdrawal by Subject|1|||
48767109|NCT02027844|156994837|FG000|Overall Study|Lost to Follow-up|0|||
48767110|NCT02027844|156994838|FG001|Overall Study|Lost to Follow-up|2|||
48767111|NCT02027844|156994839|FG002|Overall Study|Lost to Follow-up|1|||
48767112|NCT02027844|156994837|FG000|Overall Study|Protocol Violation|0|||
48767113|NCT02027844|156994838|FG001|Overall Study|Protocol Violation|2|||
48767114|NCT02027844|156994839|FG002|Overall Study|Protocol Violation|0|||
48767115|NCT02027844|156994837|FG000|Overall Study|Incomlete data|2|||
48767116|NCT02027844|156994838|FG001|Overall Study|Incomlete data|0|||
48767117|NCT02027844|156994839|FG002|Overall Study|Incomlete data|0|||
48767118|NCT04889625|156994847|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
48767119|NCT04889625|156994848|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
48767120|NCT04889625|156994847|FG000|Period 1|Subject out of window|0|||
48767121|NCT04889625|156994848|FG001|Period 1|Subject out of window|1|||
48767122|NCT04889625|156994847|FG000|Period 1|Wrong add power dispensed|0|||
48767123|NCT04889625|156994848|FG001|Period 1|Wrong add power dispensed|1|||
48767124|NCT04889625|156994847|FG000|Period 1|Discontinued due to fitting guide error|1|||
48394347|NCT03016325|155638131|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
48394348|NCT03016325|155638132|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
48394349|NCT03016325|155638125|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48394350|NCT03016325|155638126|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48394351|NCT03016325|155638127|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48394352|NCT03016325|155638128|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
48394353|NCT03016325|155638129|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48394354|NCT03016325|155638130|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48394355|NCT03016325|155638131|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48394356|NCT03016325|155638132|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
48394357|NCT03016325|155638125|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48394358|NCT03016325|155638126|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
48394359|NCT03016325|155638127|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48394360|NCT03016325|155638128|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48394361|NCT03016325|155638129|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48394362|NCT03016325|155638130|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48394363|NCT03016325|155638131|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48394364|NCT03016325|155638132|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
48394365|NCT03016325|155638125|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48394366|NCT03016325|155638126|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48394367|NCT03016325|155638127|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48394368|NCT03016325|155638128|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48394369|NCT03016325|155638129|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
48394370|NCT03016325|155638130|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
48394371|NCT03016325|155638131|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
48767125|NCT04889625|156994848|FG001|Period 1|Discontinued due to fitting guide error|1|||
48767126|NCT04889625|156994847|FG000|Period 2|Test article no longer available|1|||
48767127|NCT04889625|156994848|FG001|Period 2|Test article no longer available|0|||
48767128|NCT04889625|156994847|FG000|Period 2|Incorrect lens dispensed|1|||
48767129|NCT04889625|156994848|FG001|Period 2|Incorrect lens dispensed|0|||
48767130|NCT04889625|156994847|FG000|Period 2|Wrong add power dispensed|0|||
48430253|NCT01909453|155762005|FG004|Overall Study|Lost to Follow-up|3|||
48767131|NCT04889625|156994848|FG001|Period 2|Wrong add power dispensed|1|||
48767132|NCT03690388|156994852|FG000|Overall Study|Adverse Event|8|||
48767133|NCT03690388|156994853|FG001|Overall Study|Adverse Event|1|||
48767134|NCT03690388|156994852|FG000|Overall Study|Radiographic Progression|14|||
48767135|NCT03690388|156994853|FG001|Overall Study|Radiographic Progression|29|||
48767136|NCT03690388|156994852|FG000|Overall Study|Clinical deterioration|10|||
48767137|NCT03690388|156994853|FG001|Overall Study|Clinical deterioration|6|||
48767138|NCT03690388|156994852|FG000|Overall Study|Withdrawal by Subject|2|||
48767139|NCT03690388|156994853|FG001|Overall Study|Withdrawal by Subject|0|||
48767140|NCT03690388|156994852|FG000|Overall Study|Lack of Efficacy|1|||
48767141|NCT03690388|156994853|FG001|Overall Study|Lack of Efficacy|0|||
48767142|NCT03690388|156994852|FG000|Overall Study|Lost to Follow-up|1|||
48767143|NCT03690388|156994853|FG001|Overall Study|Lost to Follow-up|0|||
48767144|NCT02308735|156994857|FG000|Overall Study|Physician Decision|2|||
48767145|NCT02308735|156994858|FG001|Overall Study|Physician Decision|0|||
48394372|NCT03016325|155638132|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
48394373|NCT03681119|155638133|FG000|Overall Study|No specific reason|4|||
48394374|NCT03681119|155638134|FG001|Overall Study|No specific reason|0|||
48394375|NCT03681119|155638133|FG000|Overall Study|Sickness|2|||
48394376|NCT03681119|155638134|FG001|Overall Study|Sickness|0|||
48394377|NCT00606320|155638135|FG000|Overall Study|Adverse Event|3|||
48394378|NCT00606320|155638135|FG000|Overall Study|Lack of Efficacy|5|||
48394379|NCT00606320|155638135|FG000|Overall Study|Physician Decision|7|||
48767146|NCT02308735|156994859|FG002|Overall Study|Physician Decision|0|||
48767147|NCT02308735|156994860|FG003|Overall Study|Physician Decision|2|||
48767148|NCT04372602|156994869|FG000|Overall Study|Withdrawal by Subject|1|||
48767149|NCT04372602|156994870|FG001|Overall Study|Withdrawal by Subject|1|||
48767150|NCT04372602|156994869|FG000|Overall Study|Adverse Event|0|||
48767151|NCT04372602|156994870|FG001|Overall Study|Adverse Event|1|||
48767152|NCT04372602|156994869|FG000|Overall Study|Transitioned to comfort care|0|||
48767153|NCT04372602|156994870|FG001|Overall Study|Transitioned to comfort care|1|||
48767154|NCT04334460|156994871|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
48767155|NCT04334460|156994872|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
48767156|NCT04334460|156994871|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
48767157|NCT04334460|156994872|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
48767158|NCT02357147|156994873|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
48767159|NCT02357147|156994874|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
48767160|NCT02357147|156994873|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
48767161|NCT02357147|156994874|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
48767162|NCT02357147|156994873|FG000|Combination Treatment Phase|Investigator Discretion|1|||
48767163|NCT02357147|156994874|FG001|Combination Treatment Phase|Investigator Discretion|1|||
48767164|NCT02357147|156994873|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
48767165|NCT02357147|156994874|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
48767166|NCT02357147|156994873|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
48767167|NCT02357147|156994874|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
48767168|NCT02357147|156994873|FG000|Combination Treatment Phase|Adverse Event|12|||
48767169|NCT02357147|156994874|FG001|Combination Treatment Phase|Adverse Event|4|||
48767170|NCT02357147|156994873|FG000|Combination Treatment Phase|Death|1|||
48767171|NCT02357147|156994874|FG001|Combination Treatment Phase|Death|1|||
48767172|NCT02357147|156994873|FG000|Combination Treatment Phase|Sponsor Decision|0|||
48767173|NCT02357147|156994874|FG001|Combination Treatment Phase|Sponsor Decision|12|||
48767174|NCT02357147|156994873|FG000|Combination Treatment Phase|Other|1|||
48767175|NCT02357147|156994874|FG001|Combination Treatment Phase|Other|0|||
48767176|NCT02357147|156994873|FG000|Combination Treatment Phase|Not treated|0|||
48767177|NCT02357147|156994874|FG001|Combination Treatment Phase|Not treated|2|||
48394380|NCT00606320|155638135|FG000|Overall Study|Protocol Violation|8|||
48394381|NCT00606320|155638135|FG000|Overall Study|Withdrawal by Subject|10|||
48767178|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
48767179|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
48767180|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
48767181|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
48394382|NCT00606320|155638135|FG000|Overall Study|Progression to depressive phase|4|||
48394383|NCT01152021|155638136|FG000|Overall Study|Adverse Event|4|||
48394384|NCT01152021|155638137|FG001|Overall Study|Adverse Event|4|||
48394385|NCT01152021|155638136|FG000|Overall Study|Study drug had expired|1|||
48394386|NCT01152021|155638137|FG001|Overall Study|Study drug had expired|0|||
48394387|NCT01152021|155638136|FG000|Overall Study|Physician Decision|1|||
48394388|NCT01152021|155638137|FG001|Overall Study|Physician Decision|1|||
48430330|NCT00696657|155763702|FG002|Overall Study|Protocol Violation|0|||
48767182|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
48767183|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
48767184|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Adverse Event|0|||
48767185|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Adverse Event|3|||
48767186|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
48767187|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
48767188|NCT02357147|156994873|FG000|Maintenance Treatment Phase|Not Treated|1|||
48767189|NCT02357147|156994874|FG001|Maintenance Treatment Phase|Not Treated|0|||
48767190|NCT03299842|156996849|FG000|Overall Study|Caregiver withdrew consent|2|||
48767191|NCT03299842|156996849|FG000|Overall Study|Child would not keep the watch on|3|||
48767192|NCT01940120|156996850|FG000|Overall Study|Death|40|||
48767193|NCT01940120|156996850|FG000|Overall Study|Withdrawal by Subject|8|||
48767194|NCT00997503|156996854|FG000|Overall Study|Death|53|||
48767195|NCT00997503|156996854|FG000|Overall Study|Withdrawal by Subject|76|||
48767196|NCT00997503|156996854|FG000|Overall Study|Lost to Follow-up|33|||
48767197|NCT00997503|156996854|FG000|Overall Study|Adverse Event|3|||
48767198|NCT00997503|156996854|FG000|Overall Study|Physician Decision|10|||
48767199|NCT00997503|156996854|FG000|Overall Study|Missed 12-month follow-up|85|||
48767200|NCT00997503|156996854|FG000|Overall Study|Other reason|13|||
48767201|NCT00805935|156996855|FG000|Overall Study|Stimulation Failure|1|||
48767202|NCT00805935|156996856|FG001|Overall Study|Stimulation Failure|5|||
48767203|NCT00805935|156996857|FG002|Overall Study|Stimulation Failure|2|||
48767204|NCT00805935|156996858|FG003|Overall Study|Stimulation Failure|2|||
48767205|NCT00805935|156996855|FG000|Overall Study|Cycle cancelled|0|||
48767206|NCT00805935|156996856|FG001|Overall Study|Cycle cancelled|0|||
48767207|NCT00805935|156996857|FG002|Overall Study|Cycle cancelled|2|||
48767208|NCT00805935|156996858|FG003|Overall Study|Cycle cancelled|0|||
48767209|NCT00805935|156996855|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
48767210|NCT00805935|156996856|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
48767211|NCT00805935|156996857|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
48767212|NCT00805935|156996858|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
48767213|NCT00805935|156996855|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
48767214|NCT00805935|156996856|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
48767215|NCT00805935|156996857|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
48767216|NCT00805935|156996858|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
48767217|NCT00805935|156996855|FG000|Overall Study|Lost to Follow-up|1|||
48767218|NCT00805935|156996856|FG001|Overall Study|Lost to Follow-up|0|||
48767219|NCT00805935|156996857|FG002|Overall Study|Lost to Follow-up|0|||
48767220|NCT00805935|156996858|FG003|Overall Study|Lost to Follow-up|0|||
48767221|NCT00805935|156996855|FG000|Overall Study|No positive serum pregnancy|8|||
48767222|NCT00805935|156996856|FG001|Overall Study|No positive serum pregnancy|7|||
48767223|NCT00805935|156996857|FG002|Overall Study|No positive serum pregnancy|6|||
48355768|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
48355769|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
48355770|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
48355771|NCT04210843|155498561|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
48355772|NCT04210843|155498562|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
48355773|NCT04210843|155498561|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
48355774|NCT04210843|155498562|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
48355775|NCT04210843|155498561|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
48355776|NCT04210843|155498562|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
48355777|NCT04210843|155498561|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
48355778|NCT04210843|155498562|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
48355779|NCT04210843|155498561|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
48355780|NCT04210843|155498562|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
48355781|NCT04210843|155498561|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
48355782|NCT04210843|155498562|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
48355783|NCT04210843|155498561|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
48355784|NCT04210843|155498562|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
48355785|NCT04210843|155498561|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
48355786|NCT04210843|155498562|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
48767224|NCT00805935|156996858|FG003|Overall Study|No positive serum pregnancy|5|||
48767225|NCT00805935|156996855|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48767226|NCT00805935|156996856|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48767227|NCT00805935|156996857|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48767228|NCT00805935|156996858|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
48767229|NCT00805935|156996855|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
48767230|NCT00805935|156996856|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
48767231|NCT00805935|156996857|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
48767232|NCT00805935|156996858|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
48767233|NCT00805935|156996855|FG000|Overall Study|Biochemical pregnancy|0|||
48767234|NCT00805935|156996856|FG001|Overall Study|Biochemical pregnancy|1|||
48767235|NCT00805935|156996857|FG002|Overall Study|Biochemical pregnancy|0|||
48767236|NCT00805935|156996858|FG003|Overall Study|Biochemical pregnancy|0|||
48767237|NCT00805935|156996855|FG000|Overall Study|Chemical pregnancy|0|||
48767238|NCT00805935|156996856|FG001|Overall Study|Chemical pregnancy|5|||
48767239|NCT00805935|156996857|FG002|Overall Study|Chemical pregnancy|3|||
48767240|NCT00805935|156996858|FG003|Overall Study|Chemical pregnancy|2|||
48767241|NCT00805935|156996855|FG000|Overall Study|Ectopic pregnancy|0|||
48767242|NCT00805935|156996856|FG001|Overall Study|Ectopic pregnancy|0|||
48767243|NCT00805935|156996857|FG002|Overall Study|Ectopic pregnancy|1|||
48767244|NCT00805935|156996858|FG003|Overall Study|Ectopic pregnancy|0|||
48767245|NCT00805935|156996855|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
48767246|NCT00805935|156996856|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
48767247|NCT00805935|156996857|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
48767248|NCT00805935|156996858|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
48767249|NCT01344369|156996859|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
48767250|NCT01344369|156996860|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
48767251|NCT01344369|156996859|FG000|Washout of 28 Days|Physician Decision|0|||
48767252|NCT01344369|156996860|FG001|Washout of 28 Days|Physician Decision|1|||
48767253|NCT01344369|156996859|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
48767254|NCT01344369|156996860|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
48767255|NCT01762943|156996868|FG000|Overall Study|Physician Decision|1|||
48394389|NCT01152021|155638136|FG000|Overall Study|No access to study drug in Pharmacy|0|||
48394390|NCT01152021|155638137|FG001|Overall Study|No access to study drug in Pharmacy|1|||
48394391|NCT01087905|155638138|FG000|Overall Study|Lost to Follow-up|24|||
48394392|NCT01087905|155638139|FG001|Overall Study|Lost to Follow-up|28|||
48394393|NCT01087905|155638140|FG002|Overall Study|Lost to Follow-up|18|||
48394394|NCT01087905|155638141|FG003|Overall Study|Lost to Follow-up|31|||
48394395|NCT01087905|155638142|FG004|Overall Study|Lost to Follow-up|27|||
48394396|NCT01087905|155638143|FG005|Overall Study|Lost to Follow-up|25|||
48394397|NCT01087905|155638144|FG006|Overall Study|Lost to Follow-up|20|||
48394398|NCT01087905|155638145|FG007|Overall Study|Lost to Follow-up|24|||
48394399|NCT01087905|155638138|FG000|Overall Study|Withdrawal by Subject|5|||
48394400|NCT01087905|155638139|FG001|Overall Study|Withdrawal by Subject|4|||
48394401|NCT01087905|155638140|FG002|Overall Study|Withdrawal by Subject|4|||
48394402|NCT01087905|155638141|FG003|Overall Study|Withdrawal by Subject|5|||
48394403|NCT01087905|155638142|FG004|Overall Study|Withdrawal by Subject|4|||
48394404|NCT01087905|155638143|FG005|Overall Study|Withdrawal by Subject|3|||
48394405|NCT01087905|155638144|FG006|Overall Study|Withdrawal by Subject|3|||
48394406|NCT01087905|155638145|FG007|Overall Study|Withdrawal by Subject|5|||
48394407|NCT00879645|155638146|FG000|Overall Study|Adverse Event|1|||
48394408|NCT00879645|155638147|FG001|Overall Study|Adverse Event|0|||
48394409|NCT00879645|155638148|FG002|Overall Study|Adverse Event|0|||
48394410|NCT00879645|155638149|FG003|Overall Study|Adverse Event|0|||
48394411|NCT01549002|155638150|FG000|Overall Study|Excessive pain|0|||
48767256|NCT01762943|156996869|FG001|Overall Study|Physician Decision|1|||
48767257|NCT01762943|156996868|FG000|Overall Study|Protocol Violation|1|||
48767258|NCT01762943|156996869|FG001|Overall Study|Protocol Violation|0|||
48767259|NCT01762943|156996868|FG000|Overall Study|Withdrawal by Subject|2|||
48767260|NCT01762943|156996869|FG001|Overall Study|Withdrawal by Subject|1|||
48767261|NCT02487394|156996870|FG000|Phase 1|Withdrawal by Subject|0|||
48767262|NCT02487394|156996871|FG001|Phase 1|Withdrawal by Subject|1|||
48767263|NCT03670810|156996875|FG000|Main Study|Adverse Event|37|||
48767264|NCT03670810|156996876|FG001|Main Study|Adverse Event|38|||
48394412|NCT01549002|155638151|FG001|Overall Study|Excessive pain|2|||
48767265|NCT03670810|156996877|FG002|Main Study|Adverse Event|3|||
48767266|NCT03670810|156996878|FG003|Main Study|Adverse Event|4|||
48394413|NCT01549002|155638150|FG000|Overall Study|Moderate sedation required|0|||
48394414|NCT01549002|155638151|FG001|Overall Study|Moderate sedation required|2|||
48394415|NCT01347554|155638152|FG000|Overall Study|Lack of Efficacy|7|||
48394416|NCT01347554|155638153|FG001|Overall Study|Lack of Efficacy|11|||
48767267|NCT03670810|156996879|FG004|Main Study|Adverse Event|4|||
48767268|NCT03670810|156996880|FG005|Main Study|Adverse Event|5|||
48767269|NCT03670810|156996881|FG006|Main Study|Adverse Event|0|||
48767270|NCT03670810|156996882|FG007|Main Study|Adverse Event|0|||
48767271|NCT03670810|156996883|FG008|Main Study|Adverse Event|0|||
48394417|NCT03631732|155638154|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
48767272|NCT03670810|156996875|FG000|Main Study|Lack of Efficacy|8|||
48767273|NCT03670810|156996876|FG001|Main Study|Lack of Efficacy|9|||
48767274|NCT03670810|156996877|FG002|Main Study|Lack of Efficacy|3|||
48767275|NCT03670810|156996878|FG003|Main Study|Lack of Efficacy|4|||
48767276|NCT03670810|156996879|FG004|Main Study|Lack of Efficacy|0|||
48767277|NCT03670810|156996880|FG005|Main Study|Lack of Efficacy|0|||
48767278|NCT03670810|156996881|FG006|Main Study|Lack of Efficacy|0|||
48767279|NCT03670810|156996882|FG007|Main Study|Lack of Efficacy|0|||
48767280|NCT03670810|156996883|FG008|Main Study|Lack of Efficacy|0|||
48767281|NCT03670810|156996875|FG000|Main Study|Lost to Follow-up|9|||
48767282|NCT03670810|156996876|FG001|Main Study|Lost to Follow-up|7|||
48394418|NCT03631732|155638155|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
48767283|NCT03670810|156996877|FG002|Main Study|Lost to Follow-up|4|||
48767284|NCT03670810|156996878|FG003|Main Study|Lost to Follow-up|6|||
48767285|NCT03670810|156996879|FG004|Main Study|Lost to Follow-up|1|||
48767286|NCT03670810|156996880|FG005|Main Study|Lost to Follow-up|0|||
48767287|NCT03670810|156996881|FG006|Main Study|Lost to Follow-up|0|||
48767288|NCT03670810|156996882|FG007|Main Study|Lost to Follow-up|0|||
48767289|NCT03670810|156996883|FG008|Main Study|Lost to Follow-up|0|||
48767290|NCT03670810|156996875|FG000|Main Study|Non-compliance with Study Drug|0|||
48767291|NCT03670810|156996876|FG001|Main Study|Non-compliance with Study Drug|2|||
48767292|NCT03670810|156996877|FG002|Main Study|Non-compliance with Study Drug|3|||
48767293|NCT03670810|156996878|FG003|Main Study|Non-compliance with Study Drug|0|||
48767294|NCT03670810|156996879|FG004|Main Study|Non-compliance with Study Drug|0|||
48767295|NCT03670810|156996880|FG005|Main Study|Non-compliance with Study Drug|0|||
48767296|NCT03670810|156996881|FG006|Main Study|Non-compliance with Study Drug|0|||
48767297|NCT03670810|156996882|FG007|Main Study|Non-compliance with Study Drug|1|||
48767298|NCT03670810|156996883|FG008|Main Study|Non-compliance with Study Drug|0|||
48767299|NCT03670810|156996875|FG000|Main Study|Physician Decision|3|||
48767300|NCT03670810|156996876|FG001|Main Study|Physician Decision|0|||
48767301|NCT03670810|156996877|FG002|Main Study|Physician Decision|1|||
48767302|NCT03670810|156996878|FG003|Main Study|Physician Decision|0|||
48767303|NCT03670810|156996879|FG004|Main Study|Physician Decision|0|||
48767304|NCT03670810|156996880|FG005|Main Study|Physician Decision|0|||
48767305|NCT03670810|156996881|FG006|Main Study|Physician Decision|1|||
48767306|NCT03670810|156996882|FG007|Main Study|Physician Decision|1|||
48394419|NCT03631732|155638154|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
48394420|NCT03631732|155638155|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
48394421|NCT03631732|155638154|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
48394422|NCT03631732|155638155|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
48767307|NCT03670810|156996883|FG008|Main Study|Physician Decision|0|||
48767308|NCT03670810|156996875|FG000|Main Study|Pregnancy|1|||
48767309|NCT03670810|156996876|FG001|Main Study|Pregnancy|2|||
48767310|NCT03670810|156996877|FG002|Main Study|Pregnancy|0|||
48767311|NCT03670810|156996878|FG003|Main Study|Pregnancy|0|||
48767312|NCT03670810|156996879|FG004|Main Study|Pregnancy|0|||
48767313|NCT03670810|156996880|FG005|Main Study|Pregnancy|0|||
48767314|NCT03670810|156996881|FG006|Main Study|Pregnancy|0|||
48767315|NCT03670810|156996882|FG007|Main Study|Pregnancy|0|||
48767316|NCT03670810|156996883|FG008|Main Study|Pregnancy|0|||
48767317|NCT03670810|156996875|FG000|Main Study|Protocol Deviation|2|||
48767318|NCT03670810|156996876|FG001|Main Study|Protocol Deviation|12|||
48767319|NCT03670810|156996877|FG002|Main Study|Protocol Deviation|8|||
48767320|NCT03670810|156996878|FG003|Main Study|Protocol Deviation|4|||
48767321|NCT03670810|156996879|FG004|Main Study|Protocol Deviation|0|||
48767322|NCT03670810|156996880|FG005|Main Study|Protocol Deviation|0|||
48767323|NCT03670810|156996881|FG006|Main Study|Protocol Deviation|0|||
48767324|NCT03670810|156996882|FG007|Main Study|Protocol Deviation|0|||
48767325|NCT03670810|156996883|FG008|Main Study|Protocol Deviation|0|||
48767326|NCT03670810|156996875|FG000|Main Study|Withdrawal by Subject|21|||
48767327|NCT03670810|156996876|FG001|Main Study|Withdrawal by Subject|21|||
48767328|NCT03670810|156996877|FG002|Main Study|Withdrawal by Subject|8|||
48767329|NCT03670810|156996878|FG003|Main Study|Withdrawal by Subject|9|||
48767330|NCT03670810|156996879|FG004|Main Study|Withdrawal by Subject|5|||
48767331|NCT03670810|156996880|FG005|Main Study|Withdrawal by Subject|2|||
48767332|NCT03670810|156996881|FG006|Main Study|Withdrawal by Subject|1|||
48767333|NCT03670810|156996882|FG007|Main Study|Withdrawal by Subject|1|||
48767334|NCT03670810|156996883|FG008|Main Study|Withdrawal by Subject|0|||
48767335|NCT03670810|156996875|FG000|Main Study|Participant did not want to take the three other treatments|1|||
48767336|NCT03670810|156996876|FG001|Main Study|Participant did not want to take the three other treatments|0|||
48767337|NCT03670810|156996877|FG002|Main Study|Participant did not want to take the three other treatments|0|||
48767338|NCT03670810|156996878|FG003|Main Study|Participant did not want to take the three other treatments|0|||
48767339|NCT03670810|156996879|FG004|Main Study|Participant did not want to take the three other treatments|0|||
48767340|NCT03670810|156996880|FG005|Main Study|Participant did not want to take the three other treatments|0|||
48767341|NCT03670810|156996881|FG006|Main Study|Participant did not want to take the three other treatments|0|||
48767342|NCT03670810|156996882|FG007|Main Study|Participant did not want to take the three other treatments|0|||
48767343|NCT03670810|156996883|FG008|Main Study|Participant did not want to take the three other treatments|0|||
48767344|NCT03670810|156996875|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767345|NCT03670810|156996876|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
48767346|NCT03670810|156996877|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767347|NCT03670810|156996878|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767348|NCT03670810|156996879|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767349|NCT03670810|156996880|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767350|NCT03670810|156996881|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767351|NCT03670810|156996882|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767352|NCT03670810|156996883|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
48767353|NCT03670810|156996875|FG000|Main Study|Travel and Coronavirus issues|0|||
48767354|NCT03670810|156996876|FG001|Main Study|Travel and Coronavirus issues|0|||
48767355|NCT03670810|156996877|FG002|Main Study|Travel and Coronavirus issues|0|||
48767356|NCT03670810|156996878|FG003|Main Study|Travel and Coronavirus issues|1|||
48767357|NCT03670810|156996879|FG004|Main Study|Travel and Coronavirus issues|0|||
48767358|NCT03670810|156996880|FG005|Main Study|Travel and Coronavirus issues|0|||
48767359|NCT03670810|156996881|FG006|Main Study|Travel and Coronavirus issues|0|||
48767360|NCT03670810|156996882|FG007|Main Study|Travel and Coronavirus issues|0|||
48767361|NCT03670810|156996883|FG008|Main Study|Travel and Coronavirus issues|0|||
48767362|NCT03670810|156996875|FG000|Open Label Extension|Protocol Deviation|0|||
48767363|NCT03670810|156996876|FG001|Open Label Extension|Protocol Deviation|0|||
48767364|NCT03670810|156996877|FG002|Open Label Extension|Protocol Deviation|0|||
48767365|NCT03670810|156996878|FG003|Open Label Extension|Protocol Deviation|0|||
48767366|NCT03670810|156996879|FG004|Open Label Extension|Protocol Deviation|0|||
48767367|NCT03670810|156996880|FG005|Open Label Extension|Protocol Deviation|0|||
48767368|NCT03670810|156996881|FG006|Open Label Extension|Protocol Deviation|0|||
48767369|NCT03670810|156996882|FG007|Open Label Extension|Protocol Deviation|0|||
48767370|NCT03670810|156996883|FG008|Open Label Extension|Protocol Deviation|5|||
48767371|NCT03670810|156996875|FG000|Open Label Extension|Death|0|||
48767372|NCT03670810|156996876|FG001|Open Label Extension|Death|0|||
48767373|NCT03670810|156996877|FG002|Open Label Extension|Death|0|||
48767374|NCT03670810|156996878|FG003|Open Label Extension|Death|0|||
48767375|NCT03670810|156996879|FG004|Open Label Extension|Death|0|||
48767376|NCT03670810|156996880|FG005|Open Label Extension|Death|0|||
48767377|NCT03670810|156996881|FG006|Open Label Extension|Death|0|||
48394423|NCT03631732|155638154|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
48394424|NCT03631732|155638155|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
48394425|NCT03631732|155638154|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
48394426|NCT03631732|155638155|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
48394427|NCT03631732|155638154|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
48394428|NCT03631732|155638155|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
48394429|NCT03631732|155638154|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
48394430|NCT03631732|155638155|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
48394431|NCT03631732|155638154|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
48394432|NCT03631732|155638155|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
48394433|NCT03631732|155638154|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
48394434|NCT03631732|155638155|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
48394435|NCT03631732|155638154|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
48394436|NCT03631732|155638155|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
48394437|NCT01439204|155638156|FG000|Overall Study|Withdrawal by Subject|0|||
48394438|NCT01439204|155638157|FG001|Overall Study|Withdrawal by Subject|1|||
48394439|NCT01439204|155638156|FG000|Overall Study|Lost to Follow-up|0|||
48394440|NCT01439204|155638157|FG001|Overall Study|Lost to Follow-up|2|||
48394441|NCT01439204|155638156|FG000|Overall Study|No longer meets study criteria|1|||
48394442|NCT01439204|155638157|FG001|Overall Study|No longer meets study criteria|0|||
48394443|NCT01439204|155638156|FG000|Overall Study|poor/non-compliance|3|||
48394444|NCT01439204|155638157|FG001|Overall Study|poor/non-compliance|0|||
48394445|NCT01251367|155638158|FG000|Overall Study|Protocol Violation|1|||
48394446|NCT01251367|155638158|FG000|Overall Study|Lack of Efficacy|2|||
48394447|NCT01251367|155638158|FG000|Overall Study|Adverse Event|19|||
48394448|NCT01251367|155638158|FG000|Overall Study|Withdrawal by Subject|36|||
48394449|NCT01251367|155638158|FG000|Overall Study|Lost to Follow-up|5|||
48767378|NCT03670810|156996882|FG007|Open Label Extension|Death|0|||
48767379|NCT03670810|156996883|FG008|Open Label Extension|Death|1|||
48767380|NCT03670810|156996875|FG000|Open Label Extension|COVID-19|0|||
48767381|NCT03670810|156996876|FG001|Open Label Extension|COVID-19|0|||
48767382|NCT03670810|156996877|FG002|Open Label Extension|COVID-19|0|||
48767383|NCT03670810|156996878|FG003|Open Label Extension|COVID-19|0|||
48767384|NCT03670810|156996879|FG004|Open Label Extension|COVID-19|0|||
48767385|NCT03670810|156996880|FG005|Open Label Extension|COVID-19|0|||
48767386|NCT03670810|156996881|FG006|Open Label Extension|COVID-19|0|||
48767387|NCT03670810|156996882|FG007|Open Label Extension|COVID-19|0|||
48767388|NCT03670810|156996883|FG008|Open Label Extension|COVID-19|1|||
48355787|NCT04210843|155498561|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
48355788|NCT04210843|155498562|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
48355789|NCT04210843|155498561|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
48355790|NCT04210843|155498562|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
48355791|NCT04210843|155498561|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
48355792|NCT04210843|155498562|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
48355793|NCT04210843|155498561|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
48355794|NCT04210843|155498562|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
48355795|NCT04210843|155498561|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
48355796|NCT04210843|155498562|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
48355797|NCT04210843|155498561|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
48355798|NCT04210843|155498562|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
48355799|NCT04210843|155498561|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
48355800|NCT04210843|155498562|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
48355801|NCT04210843|155498561|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
48355802|NCT04210843|155498562|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
48355803|NCT00967005|155498569|FG000|Overall Study|Lost to Follow-up|7|||
48355804|NCT00967005|155498570|FG001|Overall Study|Lost to Follow-up|10|||
48355805|NCT02127125|155498571|FG000|Overall Study|Lost to Follow-up|0|||
48355806|NCT02127125|155498572|FG001|Overall Study|Lost to Follow-up|0|||
48355807|NCT02127125|155498573|FG002|Overall Study|Lost to Follow-up|0|||
48355808|NCT02127125|155498574|FG003|Overall Study|Lost to Follow-up|0|||
48355809|NCT02127125|155498575|FG004|Overall Study|Lost to Follow-up|2|||
48355810|NCT02127125|155498576|FG005|Overall Study|Lost to Follow-up|1|||
48355811|NCT02127125|155498577|FG006|Overall Study|Lost to Follow-up|0|||
48355812|NCT02127125|155498578|FG007|Overall Study|Lost to Follow-up|0|||
48355813|NCT02127125|155498579|FG008|Overall Study|Lost to Follow-up|0|||
48355814|NCT02127125|155498571|FG000|Overall Study|Withdrawal by Subject|0|||
48355815|NCT02127125|155498572|FG001|Overall Study|Withdrawal by Subject|0|||
48355816|NCT02127125|155498573|FG002|Overall Study|Withdrawal by Subject|0|||
48355817|NCT02127125|155498574|FG003|Overall Study|Withdrawal by Subject|1|||
48355818|NCT02127125|155498575|FG004|Overall Study|Withdrawal by Subject|0|||
48355819|NCT02127125|155498576|FG005|Overall Study|Withdrawal by Subject|0|||
48355820|NCT02127125|155498577|FG006|Overall Study|Withdrawal by Subject|0|||
48355821|NCT02127125|155498578|FG007|Overall Study|Withdrawal by Subject|0|||
48355822|NCT02127125|155498579|FG008|Overall Study|Withdrawal by Subject|0|||
48355823|NCT02127125|155498571|FG000|Overall Study|Physician Decision|0|||
48355824|NCT02127125|155498572|FG001|Overall Study|Physician Decision|0|||
48355825|NCT02127125|155498573|FG002|Overall Study|Physician Decision|1|||
48355826|NCT02127125|155498574|FG003|Overall Study|Physician Decision|0|||
48355827|NCT02127125|155498575|FG004|Overall Study|Physician Decision|1|||
48355828|NCT02127125|155498576|FG005|Overall Study|Physician Decision|2|||
48355829|NCT02127125|155498577|FG006|Overall Study|Physician Decision|0|||
48355830|NCT02127125|155498578|FG007|Overall Study|Physician Decision|0|||
48355831|NCT02127125|155498579|FG008|Overall Study|Physician Decision|0|||
48355832|NCT03017742|155498580|FG000|Overall Study|Protocol Violation|36|||
48355833|NCT03017742|155498580|FG000|Overall Study|Withdrawal by Subject|37|||
48355834|NCT00762476|155498587|FG000|Overall Study|Adverse Event|7|||
48355835|NCT00762476|155498588|FG001|Overall Study|Adverse Event|1|||
48355836|NCT00762476|155498587|FG000|Overall Study|Lost to Follow-up|2|||
48355837|NCT00762476|155498588|FG001|Overall Study|Lost to Follow-up|0|||
48355838|NCT00762476|155498587|FG000|Overall Study|Protocol Violation|5|||
48355839|NCT00762476|155498588|FG001|Overall Study|Protocol Violation|6|||
48355840|NCT00762476|155498587|FG000|Overall Study|Physician Decision|2|||
48355841|NCT00762476|155498588|FG001|Overall Study|Physician Decision|14|||
48355842|NCT00762476|155498587|FG000|Overall Study|Withdrawal by Subject|6|||
48355843|NCT00762476|155498588|FG001|Overall Study|Withdrawal by Subject|12|||
48355844|NCT00762476|155498587|FG000|Overall Study|antibiotic use|0|||
48355845|NCT00762476|155498588|FG001|Overall Study|antibiotic use|1|||
48355846|NCT00762476|155498587|FG000|Overall Study|non-compliance with study visits|0|||
48355847|NCT00762476|155498588|FG001|Overall Study|non-compliance with study visits|2|||
48355848|NCT00762476|155498587|FG000|Overall Study|Seasonal allergies|1|||
48355849|NCT00762476|155498588|FG001|Overall Study|Seasonal allergies|0|||
48355850|NCT02637323|155498589|FG000|Overall Study|Lost to Follow-up|2|||
48355851|NCT02637323|155498590|FG001|Overall Study|Lost to Follow-up|0|||
48394450|NCT01251367|155638158|FG000|Overall Study|Subject Required Alternative Treatment|7|||
48394451|NCT01251367|155638158|FG000|Overall Study|No Study Drug Available|1|||
48767389|NCT03670810|156996875|FG000|Open Label Extension|Lack of Efficacy|0|||
48394452|NCT01251367|155638158|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
48394453|NCT01251367|155638158|FG000|Overall Study|End of Study Visit Performed in Error|1|||
48394454|NCT00004259|155638159|FG000|Overall Study|Protocol Violation|1|||
48394455|NCT00004259|155638160|FG001|Overall Study|Protocol Violation|2|||
48394456|NCT00004259|155638161|FG002|Overall Study|Protocol Violation|0|||
48394457|NCT00004259|155638162|FG003|Overall Study|Protocol Violation|0|||
48394458|NCT00004259|155638159|FG000|Overall Study|Withdrawal by Subject|0|||
48394459|NCT00004259|155638160|FG001|Overall Study|Withdrawal by Subject|2|||
48394460|NCT00004259|155638161|FG002|Overall Study|Withdrawal by Subject|0|||
48394461|NCT00004259|155638162|FG003|Overall Study|Withdrawal by Subject|0|||
48394462|NCT00996944|155638163|FG000|Double-blind Treatment Period|Adverse Event|2|||
48394463|NCT00996944|155638164|FG001|Double-blind Treatment Period|Adverse Event|1|||
48394464|NCT00996944|155638163|FG000|Double-blind Treatment Period|Protocol Violation|1|||
48394465|NCT00996944|155638164|FG001|Double-blind Treatment Period|Protocol Violation|0|||
48394466|NCT00996944|155638163|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
48394467|NCT00996944|155638164|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
48394468|NCT00996944|155638163|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
48394469|NCT00996944|155638164|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48394470|NCT00996944|155638163|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
48394471|NCT00996944|155638164|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
48394472|NCT03594227|155638166|FG000|Overall Study|Adverse Event|2|||
48394473|NCT03594227|155638167|FG001|Overall Study|Adverse Event|1|||
48394474|NCT03594227|155638168|FG002|Overall Study|Adverse Event|0|||
48394475|NCT03594227|155638169|FG003|Overall Study|Adverse Event|2|||
48394476|NCT03594227|155638166|FG000|Overall Study|Lost to Follow-up|1|||
48394477|NCT03594227|155638167|FG001|Overall Study|Lost to Follow-up|1|||
48394478|NCT03594227|155638168|FG002|Overall Study|Lost to Follow-up|1|||
48394479|NCT03594227|155638169|FG003|Overall Study|Lost to Follow-up|0|||
48394480|NCT03594227|155638166|FG000|Overall Study|Withdrawal by Subject|1|||
48394481|NCT03594227|155638167|FG001|Overall Study|Withdrawal by Subject|1|||
48394482|NCT03594227|155638168|FG002|Overall Study|Withdrawal by Subject|1|||
48394483|NCT03594227|155638169|FG003|Overall Study|Withdrawal by Subject|1|||
48394484|NCT03594227|155638166|FG000|Overall Study|Pregnancy|0|||
48394485|NCT03594227|155638167|FG001|Overall Study|Pregnancy|1|||
48394486|NCT03594227|155638168|FG002|Overall Study|Pregnancy|0|||
48394487|NCT03594227|155638169|FG003|Overall Study|Pregnancy|0|||
48394488|NCT03594227|155638166|FG000|Overall Study|Sponsor Decision|0|||
48394489|NCT03594227|155638167|FG001|Overall Study|Sponsor Decision|0|||
48394490|NCT03594227|155638168|FG002|Overall Study|Sponsor Decision|0|||
48394491|NCT03594227|155638169|FG003|Overall Study|Sponsor Decision|1|||
48394492|NCT03594227|155638166|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
48394493|NCT03594227|155638167|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
48767390|NCT03670810|156996876|FG001|Open Label Extension|Lack of Efficacy|0|||
48767391|NCT03670810|156996877|FG002|Open Label Extension|Lack of Efficacy|0|||
48767392|NCT03670810|156996878|FG003|Open Label Extension|Lack of Efficacy|0|||
48767393|NCT03670810|156996879|FG004|Open Label Extension|Lack of Efficacy|0|||
48767394|NCT03670810|156996880|FG005|Open Label Extension|Lack of Efficacy|0|||
48767395|NCT03670810|156996881|FG006|Open Label Extension|Lack of Efficacy|0|||
48767396|NCT03670810|156996882|FG007|Open Label Extension|Lack of Efficacy|0|||
48767397|NCT03670810|156996883|FG008|Open Label Extension|Lack of Efficacy|39|||
48767398|NCT03670810|156996875|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
48767399|NCT03670810|156996876|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
48767400|NCT03670810|156996877|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
48767401|NCT03670810|156996878|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
48767402|NCT03670810|156996879|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
48767403|NCT03670810|156996880|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
48767404|NCT03670810|156996881|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
48767405|NCT03670810|156996882|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
48767406|NCT03670810|156996883|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
48394494|NCT03594227|155638168|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
48394495|NCT03594227|155638169|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
48394496|NCT01888640|155638170|FG000|Overall Study|Lost to Follow-up|1|||
48394497|NCT01888640|155638171|FG001|Overall Study|Lost to Follow-up|2|||
48394498|NCT01888640|155638172|FG002|Overall Study|Lost to Follow-up|0|||
48394499|NCT01888640|155638170|FG000|Overall Study|Withdrawal by Subject|15|||
48394500|NCT01888640|155638171|FG001|Overall Study|Withdrawal by Subject|11|||
48394501|NCT01888640|155638172|FG002|Overall Study|Withdrawal by Subject|4|||
48394502|NCT01888640|155638170|FG000|Overall Study|Minimum dose not met|10|||
48394503|NCT01888640|155638171|FG001|Overall Study|Minimum dose not met|16|||
48394504|NCT01888640|155638172|FG002|Overall Study|Minimum dose not met|0|||
48394505|NCT01888640|155638170|FG000|Overall Study|Given wrong unit (placebo)|1|||
48394506|NCT01888640|155638171|FG001|Overall Study|Given wrong unit (placebo)|0|||
48394507|NCT01888640|155638172|FG002|Overall Study|Given wrong unit (placebo)|0|||
48394508|NCT01888640|155638170|FG000|Overall Study|Excluded for prior TENS|0|||
48394509|NCT01888640|155638171|FG001|Overall Study|Excluded for prior TENS|1|||
48394510|NCT01888640|155638172|FG002|Overall Study|Excluded for prior TENS|0|||
48767407|NCT03670810|156996875|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767408|NCT03670810|156996876|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48394511|NCT01888640|155638170|FG000|Overall Study|Researcher Termination of Participant|0|||
48767409|NCT03670810|156996877|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767410|NCT03670810|156996878|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767411|NCT03670810|156996879|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767412|NCT03670810|156996880|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767413|NCT03670810|156996881|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767414|NCT03670810|156996882|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
48767415|NCT03670810|156996883|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
48767416|NCT03670810|156996875|FG000|Open Label Extension|Withdrawal by Subject|0|||
48767417|NCT03670810|156996876|FG001|Open Label Extension|Withdrawal by Subject|0|||
48767418|NCT03670810|156996877|FG002|Open Label Extension|Withdrawal by Subject|0|||
48767419|NCT03670810|156996878|FG003|Open Label Extension|Withdrawal by Subject|0|||
48767420|NCT03670810|156996879|FG004|Open Label Extension|Withdrawal by Subject|0|||
48767421|NCT03670810|156996880|FG005|Open Label Extension|Withdrawal by Subject|0|||
48767422|NCT03670810|156996881|FG006|Open Label Extension|Withdrawal by Subject|0|||
48767423|NCT03670810|156996882|FG007|Open Label Extension|Withdrawal by Subject|0|||
48767424|NCT03670810|156996883|FG008|Open Label Extension|Withdrawal by Subject|46|||
48767425|NCT03670810|156996875|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767426|NCT03670810|156996876|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767427|NCT03670810|156996877|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767428|NCT03670810|156996878|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48394512|NCT01888640|155638171|FG001|Overall Study|Researcher Termination of Participant|1|||
48394513|NCT01888640|155638172|FG002|Overall Study|Researcher Termination of Participant|1|||
48394514|NCT00645593|155638178|FG000|Overall Study|Later found to be ineligible|1|||
48767429|NCT03670810|156996879|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767430|NCT03670810|156996880|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767431|NCT03670810|156996881|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48767432|NCT03670810|156996882|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
48394515|NCT00645593|155638179|FG001|Overall Study|Later found to be ineligible|0|||
48394516|NCT02054897|155638183|FG000|Overall Study|Withdrawal by Subject|2|||
48394517|NCT02054897|155638184|FG001|Overall Study|Withdrawal by Subject|0|||
48394518|NCT02054897|155638185|FG002|Overall Study|Withdrawal by Subject|2|||
48394519|NCT02054897|155638183|FG000|Overall Study|Missing follow-up information|3|||
48394520|NCT02054897|155638184|FG001|Overall Study|Missing follow-up information|5|||
48394521|NCT02054897|155638185|FG002|Overall Study|Missing follow-up information|3|||
48394522|NCT02054897|155638183|FG000|Overall Study|Lost to Follow-up|4|||
48394523|NCT02054897|155638184|FG001|Overall Study|Lost to Follow-up|2|||
48394524|NCT02054897|155638185|FG002|Overall Study|Lost to Follow-up|7|||
48394525|NCT02054897|155638183|FG000|Overall Study|Randomized but not exposed|1|||
48394526|NCT02054897|155638184|FG001|Overall Study|Randomized but not exposed|0|||
48394527|NCT02054897|155638185|FG002|Overall Study|Randomized but not exposed|0|||
48394528|NCT00343889|155638187|FG000|Overall Study|Lost to Follow-up|2|||
48394529|NCT00343889|155638188|FG001|Overall Study|Lost to Follow-up|0|||
48394530|NCT00343889|155638187|FG000|Overall Study|Withdrawal by Subject|0|||
48394531|NCT00343889|155638188|FG001|Overall Study|Withdrawal by Subject|1|||
48394532|NCT00343889|155638187|FG000|Overall Study|Protocol Violation|1|||
48394533|NCT00343889|155638188|FG001|Overall Study|Protocol Violation|0|||
48394534|NCT00542269|155638189|FG000|Overall Study|Adverse Event|10|||
48394535|NCT00542269|155638190|FG001|Overall Study|Adverse Event|4|||
48394536|NCT00542269|155638191|FG002|Overall Study|Adverse Event|5|||
48394537|NCT00542269|155638189|FG000|Overall Study|Protocol Violation|1|||
48394538|NCT00542269|155638190|FG001|Overall Study|Protocol Violation|1|||
48394539|NCT00542269|155638191|FG002|Overall Study|Protocol Violation|0|||
48394540|NCT00542269|155638189|FG000|Overall Study|Withdrawal by Subject|1|||
48394541|NCT00542269|155638190|FG001|Overall Study|Withdrawal by Subject|0|||
48394542|NCT00542269|155638191|FG002|Overall Study|Withdrawal by Subject|0|||
48394543|NCT00542269|155638189|FG000|Overall Study|Administrative problems|1|||
48394544|NCT00542269|155638190|FG001|Overall Study|Administrative problems|1|||
48394545|NCT00542269|155638191|FG002|Overall Study|Administrative problems|1|||
48394546|NCT00492752|155638192|FG000|Double Blind Treatment|Death|13|||
48394547|NCT00492752|155638193|FG001|Double Blind Treatment|Death|0|||
48394548|NCT00492752|155638194|FG002|Double Blind Treatment|Death|2|||
48394549|NCT00492752|155638195|FG003|Double Blind Treatment|Death|0|||
48394550|NCT00492752|155638192|FG000|Double Blind Treatment|Adverse Event|1|||
48394551|NCT00492752|155638193|FG001|Double Blind Treatment|Adverse Event|0|||
48394552|NCT00492752|155638194|FG002|Double Blind Treatment|Adverse Event|0|||
48394553|NCT00492752|155638195|FG003|Double Blind Treatment|Adverse Event|0|||
48394554|NCT00492752|155638192|FG000|Double Blind Treatment|Protocol Violation|0|||
48394555|NCT00492752|155638193|FG001|Double Blind Treatment|Protocol Violation|0|||
48394556|NCT00492752|155638194|FG002|Double Blind Treatment|Protocol Violation|1|||
48394557|NCT00492752|155638195|FG003|Double Blind Treatment|Protocol Violation|0|||
48394558|NCT00492752|155638192|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
48394559|NCT00492752|155638193|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
48394560|NCT00492752|155638194|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
48394561|NCT00492752|155638195|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
48767433|NCT03670810|156996883|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
48767434|NCT03670810|156996875|FG000|Open Label Extension|Physician Decision|0|||
48767435|NCT03670810|156996876|FG001|Open Label Extension|Physician Decision|0|||
48767436|NCT03670810|156996877|FG002|Open Label Extension|Physician Decision|0|||
48767437|NCT03670810|156996878|FG003|Open Label Extension|Physician Decision|0|||
48767438|NCT03670810|156996879|FG004|Open Label Extension|Physician Decision|0|||
48767439|NCT03670810|156996880|FG005|Open Label Extension|Physician Decision|0|||
48767440|NCT03670810|156996881|FG006|Open Label Extension|Physician Decision|0|||
48767441|NCT03670810|156996882|FG007|Open Label Extension|Physician Decision|0|||
48767442|NCT03670810|156996883|FG008|Open Label Extension|Physician Decision|2|||
48767443|NCT03670810|156996875|FG000|Open Label Extension|Non-compliance with study drug|0|||
48767444|NCT03670810|156996876|FG001|Open Label Extension|Non-compliance with study drug|0|||
48767445|NCT03670810|156996877|FG002|Open Label Extension|Non-compliance with study drug|0|||
48767446|NCT03670810|156996878|FG003|Open Label Extension|Non-compliance with study drug|0|||
48394562|NCT00492752|155638192|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
48394563|NCT00492752|155638193|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
48394564|NCT00492752|155638194|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
48394565|NCT00492752|155638195|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
48394566|NCT00492752|155638192|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
48394567|NCT00492752|155638193|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
48394568|NCT00492752|155638194|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
48394569|NCT00492752|155638195|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
48394570|NCT00492752|155638192|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
48394571|NCT00492752|155638193|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
48394572|NCT00492752|155638194|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
48394573|NCT00492752|155638195|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
48394574|NCT00492752|155638192|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
48394575|NCT00492752|155638193|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
48394576|NCT00492752|155638194|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
48394577|NCT00492752|155638195|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
48394578|NCT00492752|155638192|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
48394579|NCT00492752|155638193|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
48394580|NCT00492752|155638194|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
48394581|NCT00492752|155638195|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
48394582|NCT00492752|155638192|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
48394583|NCT00492752|155638193|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
48394584|NCT00492752|155638194|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
48394585|NCT00492752|155638195|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
48394586|NCT00492752|155638192|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
48394587|NCT00492752|155638193|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
48394588|NCT00492752|155638194|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
48394589|NCT00492752|155638195|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
48394590|NCT01692275|155638203|FG000|Overall Study|Lost to Follow-up|57|||
48394591|NCT01692275|155638204|FG001|Overall Study|Lost to Follow-up|48|||
48394592|NCT01692275|155638203|FG000|Overall Study|Withdrawal by Subject|9|||
48394593|NCT01692275|155638204|FG001|Overall Study|Withdrawal by Subject|11|||
48394594|NCT00531752|155638207|FG000|First Double-blind Intervention Period|Adverse Event|2|||
48394595|NCT00531752|155638208|FG001|First Double-blind Intervention Period|Adverse Event|0|||
48394596|NCT00531752|155638209|FG002|First Double-blind Intervention Period|Adverse Event|1|||
48394597|NCT00531752|155638210|FG003|First Double-blind Intervention Period|Adverse Event|1|||
48394598|NCT00531752|155638207|FG000|First Double-blind Intervention Period|Other|1|||
48394599|NCT00531752|155638208|FG001|First Double-blind Intervention Period|Other|4|||
48394600|NCT00531752|155638209|FG002|First Double-blind Intervention Period|Other|4|||
48394601|NCT00531752|155638210|FG003|First Double-blind Intervention Period|Other|0|||
48394602|NCT00531752|155638207|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
48394603|NCT00531752|155638208|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
48394604|NCT00531752|155638209|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
48394605|NCT00531752|155638210|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
48394606|NCT00531752|155638207|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
48394607|NCT00531752|155638208|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
48394608|NCT00531752|155638209|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
48394609|NCT00531752|155638210|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
48394610|NCT00531752|155638207|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
48394611|NCT00531752|155638208|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
48394612|NCT00531752|155638209|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
48394613|NCT00531752|155638210|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
48394614|NCT00531752|155638207|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
48394615|NCT00531752|155638208|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
48394616|NCT00531752|155638209|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
48394617|NCT00531752|155638210|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
48394618|NCT00531752|155638207|FG000|Second Double-blind Intervention Period|Other|1|||
48394619|NCT00531752|155638208|FG001|Second Double-blind Intervention Period|Other|1|||
48394620|NCT00531752|155638209|FG002|Second Double-blind Intervention Period|Other|0|||
48394621|NCT00531752|155638210|FG003|Second Double-blind Intervention Period|Other|0|||
48767447|NCT03670810|156996879|FG004|Open Label Extension|Non-compliance with study drug|0|||
48767448|NCT03670810|156996880|FG005|Open Label Extension|Non-compliance with study drug|0|||
48767449|NCT03670810|156996881|FG006|Open Label Extension|Non-compliance with study drug|0|||
48767450|NCT03670810|156996882|FG007|Open Label Extension|Non-compliance with study drug|0|||
48767451|NCT03670810|156996883|FG008|Open Label Extension|Non-compliance with study drug|5|||
48767452|NCT03670810|156996875|FG000|Open Label Extension|Pregnancy|0|||
48767453|NCT03670810|156996876|FG001|Open Label Extension|Pregnancy|0|||
48767454|NCT03670810|156996877|FG002|Open Label Extension|Pregnancy|0|||
48767455|NCT03670810|156996878|FG003|Open Label Extension|Pregnancy|0|||
48767456|NCT03670810|156996879|FG004|Open Label Extension|Pregnancy|0|||
48767457|NCT03670810|156996880|FG005|Open Label Extension|Pregnancy|0|||
48767458|NCT03670810|156996881|FG006|Open Label Extension|Pregnancy|0|||
48394622|NCT00531752|155638207|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
48394623|NCT00531752|155638208|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
48394624|NCT00531752|155638209|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
48394625|NCT00531752|155638210|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
48394626|NCT00531752|155638207|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
48394627|NCT00531752|155638208|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
48394628|NCT00531752|155638209|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
48394629|NCT00531752|155638210|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
48394630|NCT04486950|155638211|FG000|Overall Study|Lost to Follow-up|0|||
48394631|NCT04486950|155638212|FG001|Overall Study|Lost to Follow-up|0|||
48394632|NCT04486950|155638213|FG002|Overall Study|Lost to Follow-up|0|||
48394633|NCT04486950|155638214|FG003|Overall Study|Lost to Follow-up|0|||
48394634|NCT04486950|155638215|FG004|Overall Study|Lost to Follow-up|0|||
48394635|NCT04486950|155638216|FG005|Overall Study|Lost to Follow-up|1|||
48394636|NCT04486950|155638217|FG006|Overall Study|Lost to Follow-up|0|||
48394637|NCT00490451|155638218|FG000|Overall Study|Adverse Event|3|||
48394638|NCT00490451|155638219|FG001|Overall Study|Adverse Event|3|||
48394639|NCT00490451|155638218|FG000|Overall Study|Death|3|||
48394640|NCT00490451|155638219|FG001|Overall Study|Death|1|||
48394641|NCT00490451|155638218|FG000|Overall Study|Withdrawal by Subject|2|||
48394642|NCT00490451|155638219|FG001|Overall Study|Withdrawal by Subject|0|||
48394643|NCT00490451|155638218|FG000|Overall Study|Investigator Decision|1|||
48394644|NCT00490451|155638219|FG001|Overall Study|Investigator Decision|0|||
48394645|NCT00490451|155638218|FG000|Overall Study|Protocol Violation|1|||
48394646|NCT00490451|155638219|FG001|Overall Study|Protocol Violation|0|||
48394647|NCT00490451|155638218|FG000|Overall Study|Progressive Disease|53|||
48394648|NCT00490451|155638219|FG001|Overall Study|Progressive Disease|34|||
48394649|NCT01624662|155638220|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
48394650|NCT01624662|155638221|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
48394651|NCT01624662|155638222|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
48394652|NCT01624662|155638223|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
48394653|NCT01624662|155638220|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
48394654|NCT01624662|155638221|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
48394655|NCT01624662|155638222|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
48394656|NCT01624662|155638223|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
48394657|NCT01624662|155638220|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48394658|NCT01624662|155638221|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
48394659|NCT01624662|155638222|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48394660|NCT01624662|155638223|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48394661|NCT01624662|155638220|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
48394662|NCT01624662|155638221|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
48394663|NCT01624662|155638222|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
48394664|NCT01624662|155638223|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
48394665|NCT01624662|155638220|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
48767459|NCT03670810|156996882|FG007|Open Label Extension|Pregnancy|0|||
48767460|NCT03670810|156996883|FG008|Open Label Extension|Pregnancy|3|||
48767461|NCT03670810|156996875|FG000|Open Label Extension|Adverse Event|0|||
48767462|NCT03670810|156996876|FG001|Open Label Extension|Adverse Event|0|||
48767463|NCT03670810|156996877|FG002|Open Label Extension|Adverse Event|0|||
48767464|NCT03670810|156996878|FG003|Open Label Extension|Adverse Event|0|||
48767465|NCT03670810|156996879|FG004|Open Label Extension|Adverse Event|0|||
48767466|NCT03670810|156996880|FG005|Open Label Extension|Adverse Event|0|||
48767467|NCT03670810|156996881|FG006|Open Label Extension|Adverse Event|0|||
48767468|NCT03670810|156996882|FG007|Open Label Extension|Adverse Event|0|||
48767469|NCT03670810|156996883|FG008|Open Label Extension|Adverse Event|24|||
48767470|NCT03670810|156996875|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
48767471|NCT03670810|156996876|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
48767472|NCT03670810|156996877|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
48767473|NCT03670810|156996878|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
48767474|NCT03670810|156996879|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
48767475|NCT03670810|156996880|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
48767476|NCT03670810|156996881|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
48767477|NCT03670810|156996882|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
48767478|NCT03670810|156996883|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
48767479|NCT03670810|156996875|FG000|Open Label Extension|Lost to Follow-up|0|||
48767480|NCT03670810|156996876|FG001|Open Label Extension|Lost to Follow-up|0|||
48767481|NCT03670810|156996877|FG002|Open Label Extension|Lost to Follow-up|0|||
48394666|NCT01624662|155638221|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
48394667|NCT01624662|155638222|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
48767482|NCT03670810|156996878|FG003|Open Label Extension|Lost to Follow-up|0|||
48394668|NCT01624662|155638223|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
48394669|NCT01624662|155638220|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48394670|NCT01624662|155638221|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
48394671|NCT01624662|155638222|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48394672|NCT01624662|155638223|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48394673|NCT01624662|155638220|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
48394674|NCT01624662|155638221|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
48394675|NCT01624662|155638222|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
48394676|NCT01624662|155638223|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
48394677|NCT00361270|155638224|FG000|Overall Study|Death|0|||
48394678|NCT00361270|155638225|FG001|Overall Study|Death|0|||
48394679|NCT00361270|155638226|FG002|Overall Study|Death|0|||
48394680|NCT00361270|155638227|FG003|Overall Study|Death|2|||
48767483|NCT03670810|156996879|FG004|Open Label Extension|Lost to Follow-up|0|||
48767484|NCT03670810|156996880|FG005|Open Label Extension|Lost to Follow-up|0|||
48767485|NCT03670810|156996881|FG006|Open Label Extension|Lost to Follow-up|0|||
48767486|NCT03670810|156996882|FG007|Open Label Extension|Lost to Follow-up|0|||
48394681|NCT00361270|155638224|FG000|Overall Study|Lost to Follow-up|4|||
48394682|NCT00361270|155638225|FG001|Overall Study|Lost to Follow-up|1|||
48394683|NCT00361270|155638226|FG002|Overall Study|Lost to Follow-up|0|||
48394684|NCT00361270|155638227|FG003|Overall Study|Lost to Follow-up|0|||
48394685|NCT00361270|155638224|FG000|Overall Study|Physician Decision|0|||
48394686|NCT00361270|155638225|FG001|Overall Study|Physician Decision|0|||
48394687|NCT00361270|155638226|FG002|Overall Study|Physician Decision|1|||
48394688|NCT00361270|155638227|FG003|Overall Study|Physician Decision|0|||
48394689|NCT00361270|155638224|FG000|Overall Study|Protocol Violation|9|||
48394690|NCT00361270|155638225|FG001|Overall Study|Protocol Violation|4|||
48767487|NCT03670810|156996883|FG008|Open Label Extension|Lost to Follow-up|23|||
48767488|NCT02775344|156996887|FG000|Overall Study|No ovarian cyst identified|3|||
48767489|NCT02775344|156996888|FG001|Overall Study|No ovarian cyst identified|2|||
48767490|NCT04098458|156996912|FG000|Overall Study|Death|1|||
48767491|NCT04098458|156996912|FG000|Overall Study|did not meet study inclusion criteria|3|||
48767492|NCT04033159|156996913|FG000|Washout Period|Physician Decision|0|||
48767493|NCT04033159|156996914|FG001|Washout Period|Physician Decision|1|||
48767494|NCT04033159|156996915|FG002|Washout Period|Physician Decision|0|||
48767495|NCT04033159|156996913|FG000|Washout Period|Study terminated by Sponsor|0|||
48767496|NCT04033159|156996914|FG001|Washout Period|Study terminated by Sponsor|7|||
48767497|NCT04033159|156996915|FG002|Washout Period|Study terminated by Sponsor|0|||
48767498|NCT04033159|156996913|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
48767499|NCT04033159|156996914|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
48767500|NCT04033159|156996915|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
48767501|NCT00449956|156996918|FG000|Overall Study|Adverse Event|7|||
48767502|NCT00449956|156996919|FG001|Overall Study|Adverse Event|1|||
48767503|NCT00449956|156996920|FG002|Overall Study|Adverse Event|6|||
48767504|NCT00449956|156996918|FG000|Overall Study|Lack of Efficacy|0|||
48767505|NCT00449956|156996919|FG001|Overall Study|Lack of Efficacy|0|||
48767506|NCT00449956|156996920|FG002|Overall Study|Lack of Efficacy|1|||
48767507|NCT00449956|156996918|FG000|Overall Study|Protocol Violation|1|||
48767508|NCT00449956|156996919|FG001|Overall Study|Protocol Violation|1|||
48767509|NCT00449956|156996920|FG002|Overall Study|Protocol Violation|1|||
48767510|NCT00449956|156996918|FG000|Overall Study|Withdrawal by Subject|0|||
48767511|NCT00449956|156996919|FG001|Overall Study|Withdrawal by Subject|1|||
48767512|NCT00449956|156996920|FG002|Overall Study|Withdrawal by Subject|0|||
48767513|NCT00449956|156996918|FG000|Overall Study|Physician Decision|2|||
48767514|NCT00449956|156996919|FG001|Overall Study|Physician Decision|1|||
48767515|NCT00449956|156996920|FG002|Overall Study|Physician Decision|1|||
48767516|NCT04074317|156996933|FG000|Third Period|Withdrawal by Subject|0|||
48767517|NCT04074317|156996934|FG001|Third Period|Withdrawal by Subject|0|||
48767518|NCT04074317|156996935|FG002|Third Period|Withdrawal by Subject|0|||
48767519|NCT04074317|156996936|FG003|Third Period|Withdrawal by Subject|1|||
48767520|NCT04074317|156996937|FG004|Third Period|Withdrawal by Subject|0|||
48767521|NCT04074317|156996938|FG005|Third Period|Withdrawal by Subject|0|||
48767522|NCT00423891|156996939|FG000|Enrolled|Withdrawal by Subject|0|||
48767523|NCT00423891|156996940|FG001|Enrolled|Withdrawal by Subject|0|||
48767524|NCT00423891|156996941|FG002|Enrolled|Withdrawal by Subject|1|||
48767525|NCT00423891|156996939|FG000|Enrolled|Lost to Follow-up|0|||
48767526|NCT00423891|156996940|FG001|Enrolled|Lost to Follow-up|0|||
48767527|NCT00423891|156996941|FG002|Enrolled|Lost to Follow-up|1|||
48767528|NCT00423891|156996939|FG000|Enrolled|No longer met criteria|11|||
48767529|NCT00423891|156996940|FG001|Enrolled|No longer met criteria|2|||
48394691|NCT00361270|155638226|FG002|Overall Study|Protocol Violation|5|||
48394692|NCT00361270|155638227|FG003|Overall Study|Protocol Violation|4|||
48394693|NCT00361270|155638224|FG000|Overall Study|Withdrawal by Subject|6|||
48394694|NCT00361270|155638225|FG001|Overall Study|Withdrawal by Subject|6|||
48767530|NCT00423891|156996941|FG002|Enrolled|No longer met criteria|1|||
48767531|NCT00423891|156996939|FG000|Treatment|Withdrawal by Subject|1|||
48767532|NCT00423891|156996940|FG001|Treatment|Withdrawal by Subject|0|||
48767533|NCT00423891|156996941|FG002|Treatment|Withdrawal by Subject|0|||
48767534|NCT00423891|156996939|FG000|Treatment|Lost to Follow-up|1|||
48767535|NCT00423891|156996940|FG001|Treatment|Lost to Follow-up|0|||
48767536|NCT00423891|156996941|FG002|Treatment|Lost to Follow-up|0|||
48767537|NCT00423891|156996939|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
48767538|NCT00423891|156996940|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
48767539|NCT00423891|156996941|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
48767540|NCT00423891|156996939|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
48767541|NCT00423891|156996940|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
48767542|NCT00423891|156996941|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
48767543|NCT02023151|156996945|FG000|Overall Study|Lost to Follow-up|4|||
48767544|NCT05179421|156996946|FG000|First Infusion Day|Adverse Event|1|||
48767545|NCT05179421|156996947|FG001|First Infusion Day|Adverse Event|0|||
48767546|NCT03013543|156996953|FG000|Overall Study|Withdrawal by Subject|0|||
48767547|NCT03013543|156996954|FG001|Overall Study|Withdrawal by Subject|2|||
48767548|NCT03013543|156996955|FG002|Overall Study|Withdrawal by Subject|0|||
48767549|NCT03013543|156996956|FG003|Overall Study|Withdrawal by Subject|5|||
48767550|NCT03013543|156996957|FG004|Overall Study|Withdrawal by Subject|6|||
48767551|NCT03013543|156996958|FG005|Overall Study|Withdrawal by Subject|2|||
48767552|NCT03013543|156996959|FG006|Overall Study|Withdrawal by Subject|3|||
48767553|NCT03013543|156996960|FG007|Overall Study|Withdrawal by Subject|1|||
48767554|NCT03013543|156996961|FG008|Overall Study|Withdrawal by Subject|0|||
48767555|NCT03013543|156996962|FG009|Overall Study|Withdrawal by Subject|4|||
48767556|NCT03013543|156996953|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
48767557|NCT03013543|156996954|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
48767558|NCT03013543|156996955|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
48767559|NCT03013543|156996956|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
48767560|NCT03013543|156996957|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
48767561|NCT03013543|156996958|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
48767562|NCT03013543|156996959|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
48767563|NCT03013543|156996960|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
48767564|NCT03013543|156996961|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
48767565|NCT03013543|156996962|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
48767566|NCT03013543|156996953|FG000|Overall Study|Other|0|||
48767567|NCT03013543|156996954|FG001|Overall Study|Other|0|||
48767568|NCT03013543|156996955|FG002|Overall Study|Other|2|||
48767569|NCT03013543|156996956|FG003|Overall Study|Other|0|||
48767570|NCT03013543|156996957|FG004|Overall Study|Other|2|||
48767571|NCT03013543|156996958|FG005|Overall Study|Other|0|||
48767572|NCT03013543|156996959|FG006|Overall Study|Other|0|||
48767573|NCT03013543|156996960|FG007|Overall Study|Other|0|||
48767574|NCT03013543|156996961|FG008|Overall Study|Other|1|||
48767575|NCT03013543|156996962|FG009|Overall Study|Other|0|||
48767576|NCT03013543|156996953|FG000|Overall Study|Adverse Event|0|||
48767577|NCT03013543|156996954|FG001|Overall Study|Adverse Event|0|||
48767578|NCT03013543|156996955|FG002|Overall Study|Adverse Event|0|||
48767579|NCT03013543|156996956|FG003|Overall Study|Adverse Event|3|||
48767580|NCT03013543|156996957|FG004|Overall Study|Adverse Event|2|||
48767581|NCT03013543|156996958|FG005|Overall Study|Adverse Event|1|||
48767582|NCT03013543|156996959|FG006|Overall Study|Adverse Event|3|||
48767583|NCT03013543|156996960|FG007|Overall Study|Adverse Event|8|||
48767584|NCT03013543|156996961|FG008|Overall Study|Adverse Event|0|||
48767585|NCT03013543|156996962|FG009|Overall Study|Adverse Event|2|||
48767586|NCT03013543|156996953|FG000|Overall Study|Death|0|||
48767587|NCT03013543|156996954|FG001|Overall Study|Death|0|||
48767588|NCT03013543|156996955|FG002|Overall Study|Death|0|||
48767589|NCT03013543|156996956|FG003|Overall Study|Death|1|||
48767590|NCT03013543|156996957|FG004|Overall Study|Death|0|||
48767591|NCT03013543|156996958|FG005|Overall Study|Death|0|||
48767592|NCT03013543|156996959|FG006|Overall Study|Death|0|||
48767593|NCT03013543|156996960|FG007|Overall Study|Death|0|||
48767594|NCT03013543|156996961|FG008|Overall Study|Death|0|||
48767595|NCT03013543|156996962|FG009|Overall Study|Death|0|||
48767596|NCT03013543|156996953|FG000|Overall Study|Lack of Efficacy|0|||
48767597|NCT03013543|156996954|FG001|Overall Study|Lack of Efficacy|0|||
48355852|NCT02637323|155498589|FG000|Overall Study|Protocol Violation|0|||
48355853|NCT02637323|155498590|FG001|Overall Study|Protocol Violation|1|||
48355854|NCT00368875|155498593|FG000|Overall Study|Adverse Event|0|||
48355855|NCT00368875|155498594|FG001|Overall Study|Adverse Event|12|||
48355856|NCT00368875|155498593|FG000|Overall Study|Progressive disease|3|||
48355857|NCT00368875|155498594|FG001|Overall Study|Progressive disease|27|||
48355858|NCT00368875|155498593|FG000|Overall Study|Withdrawal by Subject|2|||
48355859|NCT00368875|155498594|FG001|Overall Study|Withdrawal by Subject|6|||
48355860|NCT00368875|155498593|FG000|Overall Study|Other Reason|0|||
48355861|NCT00368875|155498594|FG001|Overall Study|Other Reason|2|||
48355862|NCT00368875|155498593|FG000|Overall Study|Alternative Therapy|1|||
48355863|NCT00368875|155498594|FG001|Overall Study|Alternative Therapy|1|||
48355864|NCT01465763|155498595|FG000|Overall Study|Withdrawal by Subject|4|||
48767598|NCT03013543|156996955|FG002|Overall Study|Lack of Efficacy|0|||
48767599|NCT03013543|156996956|FG003|Overall Study|Lack of Efficacy|1|||
48767600|NCT03013543|156996957|FG004|Overall Study|Lack of Efficacy|0|||
48767601|NCT03013543|156996958|FG005|Overall Study|Lack of Efficacy|0|||
48767602|NCT03013543|156996959|FG006|Overall Study|Lack of Efficacy|0|||
48767603|NCT03013543|156996960|FG007|Overall Study|Lack of Efficacy|0|||
48767604|NCT03013543|156996961|FG008|Overall Study|Lack of Efficacy|0|||
48767605|NCT03013543|156996962|FG009|Overall Study|Lack of Efficacy|0|||
48767606|NCT03013543|156996953|FG000|Overall Study|Lost to Follow-up|0|||
48767607|NCT03013543|156996954|FG001|Overall Study|Lost to Follow-up|0|||
48767608|NCT03013543|156996955|FG002|Overall Study|Lost to Follow-up|0|||
48767609|NCT03013543|156996956|FG003|Overall Study|Lost to Follow-up|1|||
48767610|NCT03013543|156996957|FG004|Overall Study|Lost to Follow-up|0|||
48767611|NCT03013543|156996958|FG005|Overall Study|Lost to Follow-up|0|||
48767612|NCT03013543|156996959|FG006|Overall Study|Lost to Follow-up|1|||
48767613|NCT03013543|156996960|FG007|Overall Study|Lost to Follow-up|0|||
48767614|NCT03013543|156996961|FG008|Overall Study|Lost to Follow-up|0|||
48767615|NCT03013543|156996962|FG009|Overall Study|Lost to Follow-up|2|||
48767616|NCT03013543|156996953|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48767617|NCT03013543|156996954|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48767618|NCT03013543|156996955|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48767619|NCT03013543|156996956|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48767620|NCT03013543|156996957|FG004|Overall Study|Non-Compliance With Study Drug|0|||
48767621|NCT03013543|156996958|FG005|Overall Study|Non-Compliance With Study Drug|0|||
48767622|NCT03013543|156996959|FG006|Overall Study|Non-Compliance With Study Drug|0|||
48767623|NCT03013543|156996960|FG007|Overall Study|Non-Compliance With Study Drug|0|||
48767624|NCT03013543|156996961|FG008|Overall Study|Non-Compliance With Study Drug|1|||
48767625|NCT03013543|156996962|FG009|Overall Study|Non-Compliance With Study Drug|0|||
48767626|NCT03013543|156996953|FG000|Overall Study|Physician Decision|0|||
48767627|NCT03013543|156996954|FG001|Overall Study|Physician Decision|0|||
48767628|NCT03013543|156996955|FG002|Overall Study|Physician Decision|0|||
48767629|NCT03013543|156996956|FG003|Overall Study|Physician Decision|0|||
48767630|NCT03013543|156996957|FG004|Overall Study|Physician Decision|1|||
48767631|NCT03013543|156996958|FG005|Overall Study|Physician Decision|0|||
48767632|NCT03013543|156996959|FG006|Overall Study|Physician Decision|0|||
48767633|NCT03013543|156996960|FG007|Overall Study|Physician Decision|0|||
48767634|NCT03013543|156996961|FG008|Overall Study|Physician Decision|0|||
48767635|NCT03013543|156996962|FG009|Overall Study|Physician Decision|0|||
48767636|NCT03013543|156996953|FG000|Overall Study|Protocol Violation|0|||
48767637|NCT03013543|156996954|FG001|Overall Study|Protocol Violation|0|||
48767638|NCT03013543|156996955|FG002|Overall Study|Protocol Violation|0|||
48767639|NCT03013543|156996956|FG003|Overall Study|Protocol Violation|0|||
48767640|NCT03013543|156996957|FG004|Overall Study|Protocol Violation|0|||
48767641|NCT03013543|156996958|FG005|Overall Study|Protocol Violation|0|||
48767642|NCT03013543|156996959|FG006|Overall Study|Protocol Violation|0|||
48767643|NCT03013543|156996960|FG007|Overall Study|Protocol Violation|0|||
48767644|NCT03013543|156996961|FG008|Overall Study|Protocol Violation|0|||
48767645|NCT03013543|156996962|FG009|Overall Study|Protocol Violation|1|||
48767646|NCT00323414|156996963|FG000|Overall Study|Withdrawal by Subject|0|||
48767647|NCT00323414|156996964|FG001|Overall Study|Withdrawal by Subject|1|||
48767648|NCT03161483|156996965|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
48767649|NCT03161483|156996966|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
48767650|NCT03161483|156996967|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
48767651|NCT03161483|156996968|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
48767652|NCT03161483|156996965|FG000|Treatment Period|Death|1|||
48767653|NCT03161483|156996966|FG001|Treatment Period|Death|0|||
48767654|NCT03161483|156996967|FG002|Treatment Period|Death|0|||
48767655|NCT03161483|156996968|FG003|Treatment Period|Death|0|||
48767656|NCT03161483|156996965|FG000|Treatment Period|Adverse Event|5|||
48767657|NCT03161483|156996966|FG001|Treatment Period|Adverse Event|2|||
48767658|NCT03161483|156996967|FG002|Treatment Period|Adverse Event|1|||
48767659|NCT03161483|156996968|FG003|Treatment Period|Adverse Event|11|||
48767660|NCT03161483|156996965|FG000|Treatment Period|Pregnancy|1|||
48767661|NCT03161483|156996966|FG001|Treatment Period|Pregnancy|0|||
48767662|NCT03161483|156996967|FG002|Treatment Period|Pregnancy|0|||
48767663|NCT03161483|156996968|FG003|Treatment Period|Pregnancy|0|||
48767664|NCT03161483|156996965|FG000|Treatment Period|Lack of Efficacy|0|||
48767665|NCT03161483|156996966|FG001|Treatment Period|Lack of Efficacy|0|||
48767666|NCT03161483|156996967|FG002|Treatment Period|Lack of Efficacy|0|||
48767667|NCT03161483|156996968|FG003|Treatment Period|Lack of Efficacy|1|||
48586927|NCT00772005|156341481|FG002|Overall Study|Non-compliance with study procedures|0|||
48586928|NCT00772005|156341482|FG003|Overall Study|Non-compliance with study procedures|1|||
48586929|NCT00772005|156341479|FG000|Overall Study|Non-compliance with drug administration|3|||
48767668|NCT03161483|156996965|FG000|Treatment Period|Withdrawal by Subject|2|||
48767669|NCT03161483|156996966|FG001|Treatment Period|Withdrawal by Subject|5|||
48767670|NCT03161483|156996967|FG002|Treatment Period|Withdrawal by Subject|2|||
48767671|NCT03161483|156996968|FG003|Treatment Period|Withdrawal by Subject|6|||
48767672|NCT03161483|156996965|FG000|Treatment Period|Lost to Follow-up|0|||
48767673|NCT03161483|156996966|FG001|Treatment Period|Lost to Follow-up|0|||
48394695|NCT00361270|155638226|FG002|Overall Study|Withdrawal by Subject|3|||
48394696|NCT00361270|155638227|FG003|Overall Study|Withdrawal by Subject|7|||
48394697|NCT00361270|155638224|FG000|Overall Study|Afraid of Hypnosis|1|||
48394698|NCT00361270|155638225|FG001|Overall Study|Afraid of Hypnosis|2|||
48394699|NCT00361270|155638226|FG002|Overall Study|Afraid of Hypnosis|0|||
48394700|NCT00361270|155638227|FG003|Overall Study|Afraid of Hypnosis|0|||
48394701|NCT00361270|155638224|FG000|Overall Study|Problems with Transportation|4|||
48394702|NCT00361270|155638225|FG001|Overall Study|Problems with Transportation|0|||
48394703|NCT00361270|155638226|FG002|Overall Study|Problems with Transportation|0|||
48394704|NCT00361270|155638227|FG003|Overall Study|Problems with Transportation|0|||
48394705|NCT00361270|155638224|FG000|Overall Study|Adverse Event|0|||
48394706|NCT00361270|155638225|FG001|Overall Study|Adverse Event|1|||
48394707|NCT00361270|155638226|FG002|Overall Study|Adverse Event|1|||
48394708|NCT00361270|155638227|FG003|Overall Study|Adverse Event|0|||
48394709|NCT01967537|155638229|FG000|Overall Study|Withdrawal by Subject|52|||
48394710|NCT01967537|155638229|FG000|Overall Study|Refuse treatment|2|||
48767674|NCT03161483|156996967|FG002|Treatment Period|Lost to Follow-up|0|||
48767675|NCT03161483|156996968|FG003|Treatment Period|Lost to Follow-up|1|||
48767676|NCT03161483|156996965|FG000|Treatment Period|Protocol Violation|0|||
48394711|NCT01967537|155638229|FG000|Overall Study|Lost to Follow-up|6|||
48394712|NCT00562354|155638233|FG000|Overall Study|Physician Decision|0|||
48394713|NCT00562354|155638234|FG001|Overall Study|Physician Decision|1|||
48767677|NCT03161483|156996966|FG001|Treatment Period|Protocol Violation|0|||
48767678|NCT03161483|156996967|FG002|Treatment Period|Protocol Violation|0|||
48767679|NCT03161483|156996968|FG003|Treatment Period|Protocol Violation|1|||
48394714|NCT00562354|155638233|FG000|Overall Study|Lost to Follow-up|0|||
48394715|NCT00562354|155638234|FG001|Overall Study|Lost to Follow-up|1|||
48394716|NCT00250835|155638235|FG000|Overall Study|Withdrawal by Subject|1|||
48767680|NCT03161483|156996965|FG000|Treatment Period|Other reasons|1|||
48767681|NCT03161483|156996966|FG001|Treatment Period|Other reasons|1|||
48767682|NCT03161483|156996967|FG002|Treatment Period|Other reasons|0|||
48767683|NCT03161483|156996968|FG003|Treatment Period|Other reasons|0|||
48767684|NCT01073865|156996971|FG000|Overall Study|Reasons other than below|19|||
48767685|NCT01073865|156996972|FG001|Overall Study|Reasons other than below|31|||
48767686|NCT01073865|156996971|FG000|Overall Study|Lost to Follow-up|1|||
48767687|NCT01073865|156996972|FG001|Overall Study|Lost to Follow-up|1|||
48767688|NCT01073865|156996971|FG000|Overall Study|Death|3|||
48767689|NCT01073865|156996972|FG001|Overall Study|Death|2|||
48767690|NCT01073865|156996971|FG000|Overall Study|Withdrawal by Subject|5|||
48767691|NCT01073865|156996972|FG001|Overall Study|Withdrawal by Subject|5|||
48767692|NCT00743652|156996973|FG000|Overall Study|Parent/Legal Guardian Request|3|||
48767693|NCT00743652|156996974|FG001|Overall Study|Parent/Legal Guardian Request|2|||
48767694|NCT00743652|156996975|FG002|Overall Study|Parent/Legal Guardian Request|2|||
48767695|NCT00743652|156996976|FG003|Overall Study|Parent/Legal Guardian Request|2|||
48767696|NCT00743652|156996977|FG004|Overall Study|Parent/Legal Guardian Request|0|||
48767697|NCT00743652|156996973|FG000|Overall Study|Adverse Event|3|||
48767698|NCT00743652|156996974|FG001|Overall Study|Adverse Event|0|||
48767699|NCT00743652|156996975|FG002|Overall Study|Adverse Event|0|||
48767700|NCT00743652|156996976|FG003|Overall Study|Adverse Event|0|||
48767701|NCT00743652|156996977|FG004|Overall Study|Adverse Event|0|||
48767702|NCT00743652|156996973|FG000|Overall Study|Death|2|||
48767703|NCT00743652|156996974|FG001|Overall Study|Death|0|||
48767704|NCT00743652|156996975|FG002|Overall Study|Death|0|||
48767705|NCT00743652|156996976|FG003|Overall Study|Death|0|||
48767706|NCT00743652|156996977|FG004|Overall Study|Death|0|||
48767707|NCT00743652|156996973|FG000|Overall Study|Investigator Request|0|||
48767708|NCT00743652|156996974|FG001|Overall Study|Investigator Request|0|||
48767709|NCT00743652|156996975|FG002|Overall Study|Investigator Request|0|||
48767710|NCT00743652|156996976|FG003|Overall Study|Investigator Request|2|||
48767711|NCT00743652|156996977|FG004|Overall Study|Investigator Request|0|||
48767712|NCT00743652|156996973|FG000|Overall Study|Other|1|||
48767713|NCT00743652|156996974|FG001|Overall Study|Other|1|||
48767714|NCT00743652|156996975|FG002|Overall Study|Other|0|||
48767715|NCT00743652|156996976|FG003|Overall Study|Other|0|||
48767716|NCT00743652|156996977|FG004|Overall Study|Other|0|||
48767717|NCT00743652|156996973|FG000|Overall Study|Lost to Follow-up|1|||
48767718|NCT00743652|156996974|FG001|Overall Study|Lost to Follow-up|0|||
48767719|NCT00743652|156996975|FG002|Overall Study|Lost to Follow-up|0|||
48767720|NCT00743652|156996976|FG003|Overall Study|Lost to Follow-up|0|||
48767721|NCT00743652|156996977|FG004|Overall Study|Lost to Follow-up|0|||
48767722|NCT02547129|156996978|FG000|Overall Study|Difficulty with ongoing infection|1|||
48767723|NCT02547129|156996979|FG001|Overall Study|Difficulty with ongoing infection|0|||
48767724|NCT02129803|156996983|FG000|Overall Study|Protocol Violation|4|||
48767725|NCT02129803|156996984|FG001|Overall Study|Protocol Violation|0|||
48767726|NCT02129803|156996983|FG000|Overall Study|Physician Decision|0|||
48767727|NCT02129803|156996984|FG001|Overall Study|Physician Decision|1|||
48767728|NCT02129803|156996983|FG000|Overall Study|Difficulty sleeping|1|||
48767729|NCT02129803|156996984|FG001|Overall Study|Difficulty sleeping|0|||
48767730|NCT02129803|156996983|FG000|Overall Study|Morning headache|0|||
48767731|NCT02129803|156996984|FG001|Overall Study|Morning headache|1|||
48767732|NCT02129803|156996983|FG000|Overall Study|Withdrawal by Subject|1|||
48767733|NCT02129803|156996984|FG001|Overall Study|Withdrawal by Subject|1|||
48767734|NCT01537783|156996994|FG000|Overall Study|Lost to Follow-up|11|||
48767735|NCT01537783|156996995|FG001|Overall Study|Lost to Follow-up|2|||
48767736|NCT03025828|156996996|FG000|Overall Study|Lost to Follow-up|1|||
48767737|NCT01554618|156996997|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
48394717|NCT02678390|155638236|FG000|AE (1 Day)|Withdrawal by Subject|0|||
48394718|NCT02678390|155638237|FG001|AE (1 Day)|Withdrawal by Subject|1|||
48394719|NCT01627899|155638238|FG000|Overall Study|Study terminated early by sponsor.|5|||
48394720|NCT00766038|155639772|FG000|Overall Study|Lost to Follow-up|15|||
48394721|NCT00766038|155639773|FG001|Overall Study|Lost to Follow-up|14|||
48394722|NCT04649255|155639774|FG000|Overall Study|Death|9|||
48394723|NCT04649255|155639774|FG000|Overall Study|Withdrawal by Subject|1|||
48394724|NCT04096274|155639780|FG000|Phase I|Lost to Follow-up|5|||
48394725|NCT04096274|155639781|FG001|Phase I|Lost to Follow-up|5|||
48394726|NCT04096274|155639780|FG000|Phase II|Lost to Follow-up|11|||
48394727|NCT04096274|155639781|FG001|Phase II|Lost to Follow-up|11|||
48394728|NCT02603120|155639787|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
48394729|NCT02603120|155639788|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
48394730|NCT02603120|155639787|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
48394731|NCT02603120|155639788|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
48767738|NCT01554618|156996998|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
48767739|NCT01554618|156996997|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
48767740|NCT01554618|156996998|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
48767741|NCT01554618|156996997|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
48767742|NCT01554618|156996998|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
48767743|NCT01554618|156996997|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
48394732|NCT02603120|155639787|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
48394733|NCT02603120|155639788|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
48394734|NCT02603120|155639787|FG000|Double-Blind Treatment Phase|Death|2|||
48394735|NCT02603120|155639788|FG001|Double-Blind Treatment Phase|Death|0|||
48394736|NCT02603120|155639787|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
48394737|NCT02603120|155639788|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
48394738|NCT02603120|155639787|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
48394739|NCT02603120|155639788|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
48394740|NCT02603120|155639787|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
48394741|NCT02603120|155639788|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
48394742|NCT02603120|155639787|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
48394743|NCT02603120|155639788|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
48394744|NCT02603120|155639787|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
48394745|NCT02603120|155639788|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
48394746|NCT02603120|155639787|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
48394747|NCT02603120|155639788|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
48394748|NCT02603120|155639787|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
48394749|NCT02603120|155639788|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
48394750|NCT02603120|155639787|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
48394751|NCT02603120|155639788|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
48394752|NCT02603120|155639787|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
48394753|NCT02603120|155639788|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
48394754|NCT02603120|155639787|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
48394755|NCT02603120|155639788|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
48394756|NCT01849874|155639789|FG000|Overall Study|Death|89|||
48394757|NCT01849874|155639790|FG001|Overall Study|Death|42|||
48767744|NCT01554618|156996998|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
48767745|NCT01554618|156996997|FG000|Open-Label Extension Period|Physician Decision|0|||
48767746|NCT01554618|156996998|FG001|Open-Label Extension Period|Physician Decision|1|||
48767747|NCT01554618|156996997|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
48767748|NCT01554618|156996998|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
48767749|NCT02442778|156997004|FG000|Overall Study|Adverse Event|2|||
48767750|NCT02442778|156997005|FG001|Overall Study|Adverse Event|6|||
48767751|NCT02442778|156997006|FG002|Overall Study|Adverse Event|6|||
48767752|NCT02442778|156997004|FG000|Overall Study|Death|0|||
48767753|NCT02442778|156997005|FG001|Overall Study|Death|2|||
48767754|NCT02442778|156997006|FG002|Overall Study|Death|0|||
48767755|NCT02442778|156997004|FG000|Overall Study|Lack of Efficacy|1|||
48767756|NCT02442778|156997005|FG001|Overall Study|Lack of Efficacy|0|||
48767757|NCT02442778|156997006|FG002|Overall Study|Lack of Efficacy|0|||
48767758|NCT02442778|156997004|FG000|Overall Study|Lost to Follow-up|1|||
48767759|NCT02442778|156997005|FG001|Overall Study|Lost to Follow-up|1|||
48767760|NCT02442778|156997006|FG002|Overall Study|Lost to Follow-up|1|||
48394758|NCT01849874|155639789|FG000|Overall Study|Withdrawal by Subject|17|||
48394759|NCT01849874|155639790|FG001|Overall Study|Withdrawal by Subject|16|||
48394760|NCT01849874|155639789|FG000|Overall Study|Lost to Follow-up|3|||
48394761|NCT01849874|155639790|FG001|Overall Study|Lost to Follow-up|2|||
48394762|NCT01849874|155639789|FG000|Overall Study|Study Termination By Sponsor|93|||
48394763|NCT01849874|155639790|FG001|Overall Study|Study Termination By Sponsor|48|||
48394764|NCT01849874|155639789|FG000|Overall Study|Completed as per protocol amendment 6|3|||
48394765|NCT01849874|155639790|FG001|Overall Study|Completed as per protocol amendment 6|0|||
48394766|NCT01849874|155639789|FG000|Overall Study|Physician Decision|7|||
48394767|NCT01849874|155639790|FG001|Overall Study|Physician Decision|1|||
48394768|NCT01849874|155639789|FG000|Overall Study|Other|16|||
48767761|NCT02442778|156997004|FG000|Overall Study|Non-compliance with study drug|2|||
48767762|NCT02442778|156997005|FG001|Overall Study|Non-compliance with study drug|0|||
48767763|NCT02442778|156997006|FG002|Overall Study|Non-compliance with study drug|1|||
48767764|NCT02442778|156997004|FG000|Overall Study|Physician Decision|1|||
48394769|NCT01849874|155639790|FG001|Overall Study|Other|4|||
48394770|NCT04718974|155639800|FG000|Overall Study|Death|0|||
48394771|NCT04718974|155639801|FG001|Overall Study|Death|2|||
48394772|NCT04718974|155639800|FG000|Overall Study|Lost to Follow-up|10|||
48394773|NCT04718974|155639801|FG001|Overall Study|Lost to Follow-up|20|||
48394774|NCT04718974|155639800|FG000|Overall Study|Transferred out|2|||
48394775|NCT04718974|155639801|FG001|Overall Study|Transferred out|4|||
48394776|NCT00183274|155639802|FG000|Phase 1: Open-Label|Adverse Event|31|||
48394777|NCT00183274|155639803|FG001|Phase 1: Open-Label|Adverse Event|0|||
48394778|NCT00183274|155639804|FG002|Phase 1: Open-Label|Adverse Event|0|||
48394779|NCT00183274|155639805|FG003|Phase 1: Open-Label|Adverse Event|0|||
48394780|NCT00183274|155639806|FG004|Phase 1: Open-Label|Adverse Event|0|||
48394781|NCT00183274|155639807|FG005|Phase 1: Open-Label|Adverse Event|0|||
48394782|NCT00183274|155639802|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
48394783|NCT00183274|155639803|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
48394784|NCT00183274|155639804|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
48394785|NCT00183274|155639805|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
48394786|NCT00183274|155639806|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
48394787|NCT00183274|155639807|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
48394788|NCT00183274|155639802|FG000|Phase 1: Open-Label|Protocol Violation|11|||
48394789|NCT00183274|155639803|FG001|Phase 1: Open-Label|Protocol Violation|0|||
48394790|NCT00183274|155639804|FG002|Phase 1: Open-Label|Protocol Violation|0|||
48394791|NCT00183274|155639805|FG003|Phase 1: Open-Label|Protocol Violation|0|||
48394792|NCT00183274|155639806|FG004|Phase 1: Open-Label|Protocol Violation|0|||
48394793|NCT00183274|155639807|FG005|Phase 1: Open-Label|Protocol Violation|0|||
48394794|NCT00183274|155639802|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
48394795|NCT00183274|155639803|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
48394796|NCT00183274|155639804|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
48394797|NCT00183274|155639805|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
48394798|NCT00183274|155639806|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
48394799|NCT00183274|155639807|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
48394800|NCT00183274|155639802|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
48767765|NCT02442778|156997005|FG001|Overall Study|Physician Decision|1|||
48767766|NCT02442778|156997006|FG002|Overall Study|Physician Decision|1|||
48767767|NCT02442778|156997004|FG000|Overall Study|Protocol Deviation|3|||
48767768|NCT02442778|156997005|FG001|Overall Study|Protocol Deviation|0|||
48767769|NCT02442778|156997006|FG002|Overall Study|Protocol Deviation|1|||
48767770|NCT02442778|156997004|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
48767771|NCT02442778|156997005|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
48767772|NCT02442778|156997006|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
48767773|NCT02442778|156997004|FG000|Overall Study|Withdrawal by Subject|4|||
48767774|NCT02442778|156997005|FG001|Overall Study|Withdrawal by Subject|4|||
48767775|NCT02442778|156997006|FG002|Overall Study|Withdrawal by Subject|3|||
48767776|NCT02442778|156997004|FG000|Overall Study|Reason not specified|1|||
48767777|NCT02442778|156997005|FG001|Overall Study|Reason not specified|4|||
48767778|NCT02442778|156997006|FG002|Overall Study|Reason not specified|0|||
48767779|NCT01455012|156997007|FG000|Overall Study|Adverse Event|0|||
48767780|NCT01455012|156997008|FG001|Overall Study|Adverse Event|2|||
48767781|NCT01455012|156997007|FG000|Overall Study|Lack of Efficacy|6|||
48767782|NCT01455012|156997008|FG001|Overall Study|Lack of Efficacy|1|||
48767783|NCT01455012|156997007|FG000|Overall Study|Withdrawal by Subject|3|||
48767784|NCT01455012|156997008|FG001|Overall Study|Withdrawal by Subject|1|||
48767785|NCT01455012|156997007|FG000|Overall Study|Unknown reason|2|||
48767786|NCT01455012|156997008|FG001|Overall Study|Unknown reason|0|||
48767787|NCT04552587|156997009|FG000|Overall Study|Lost to Follow-up|4|||
48767788|NCT01822132|156997010|FG000|Overall Study|Lost to Follow-up|4|||
48767789|NCT01822132|156997011|FG001|Overall Study|Lost to Follow-up|2|||
48767790|NCT01215227|156997013|FG000|Overall Study|Adverse Event|11|||
48767791|NCT01215227|156997014|FG001|Overall Study|Adverse Event|11|||
48767792|NCT01215227|156997015|FG002|Overall Study|Adverse Event|4|||
48767793|NCT01215227|156997016|FG003|Overall Study|Adverse Event|8|||
48767794|NCT01215227|156997017|FG004|Overall Study|Adverse Event|7|||
48767795|NCT01215227|156997018|FG005|Overall Study|Adverse Event|6|||
48767796|NCT01215227|156997013|FG000|Overall Study|Treatment Failure|8|||
48767797|NCT01215227|156997014|FG001|Overall Study|Treatment Failure|4|||
48767798|NCT01215227|156997015|FG002|Overall Study|Treatment Failure|1|||
48767799|NCT01215227|156997016|FG003|Overall Study|Treatment Failure|5|||
48767800|NCT01215227|156997017|FG004|Overall Study|Treatment Failure|1|||
48767801|NCT01215227|156997018|FG005|Overall Study|Treatment Failure|1|||
48394801|NCT00183274|155639803|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
48394802|NCT00183274|155639804|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
48394803|NCT00183274|155639805|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
48394804|NCT00183274|155639806|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
48767802|NCT01215227|156997013|FG000|Overall Study|Lost to Follow-up|1|||
48767803|NCT01215227|156997014|FG001|Overall Study|Lost to Follow-up|4|||
48767804|NCT01215227|156997015|FG002|Overall Study|Lost to Follow-up|1|||
48767805|NCT01215227|156997016|FG003|Overall Study|Lost to Follow-up|1|||
48767806|NCT01215227|156997017|FG004|Overall Study|Lost to Follow-up|1|||
48394805|NCT00183274|155639807|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
48394806|NCT00183274|155639802|FG000|Phase 1: Open-Label|Other|9|||
48394807|NCT00183274|155639803|FG001|Phase 1: Open-Label|Other|0|||
48394808|NCT00183274|155639804|FG002|Phase 1: Open-Label|Other|0|||
48767807|NCT01215227|156997018|FG005|Overall Study|Lost to Follow-up|2|||
48767808|NCT01215227|156997013|FG000|Overall Study|Subject Withdrew Consent|16|||
48767809|NCT01215227|156997014|FG001|Overall Study|Subject Withdrew Consent|20|||
48767810|NCT01215227|156997015|FG002|Overall Study|Subject Withdrew Consent|7|||
48767811|NCT01215227|156997016|FG003|Overall Study|Subject Withdrew Consent|10|||
48767812|NCT01215227|156997017|FG004|Overall Study|Subject Withdrew Consent|11|||
48767813|NCT01215227|156997018|FG005|Overall Study|Subject Withdrew Consent|8|||
48767814|NCT01215227|156997013|FG000|Overall Study|Non-Compliance With Protocol|2|||
48767815|NCT01215227|156997014|FG001|Overall Study|Non-Compliance With Protocol|6|||
48767816|NCT01215227|156997015|FG002|Overall Study|Non-Compliance With Protocol|1|||
48767817|NCT01215227|156997016|FG003|Overall Study|Non-Compliance With Protocol|0|||
48767818|NCT01215227|156997017|FG004|Overall Study|Non-Compliance With Protocol|0|||
48767819|NCT01215227|156997018|FG005|Overall Study|Non-Compliance With Protocol|0|||
48767820|NCT01215227|156997013|FG000|Overall Study|Administrative|83|||
48767821|NCT01215227|156997014|FG001|Overall Study|Administrative|73|||
48767822|NCT01215227|156997015|FG002|Overall Study|Administrative|42|||
48767823|NCT01215227|156997016|FG003|Overall Study|Administrative|24|||
48767824|NCT01215227|156997017|FG004|Overall Study|Administrative|28|||
48767825|NCT01215227|156997018|FG005|Overall Study|Administrative|40|||
48767826|NCT01215227|156997013|FG000|Overall Study|Missing Status|0|||
48767827|NCT01215227|156997014|FG001|Overall Study|Missing Status|1|||
48767828|NCT01215227|156997015|FG002|Overall Study|Missing Status|0|||
48767829|NCT01215227|156997016|FG003|Overall Study|Missing Status|0|||
48767830|NCT01215227|156997017|FG004|Overall Study|Missing Status|0|||
48767831|NCT01215227|156997018|FG005|Overall Study|Missing Status|0|||
48767832|NCT01215227|156997013|FG000|Overall Study|Randomized but not treated|0|||
48767833|NCT01215227|156997014|FG001|Overall Study|Randomized but not treated|0|||
48767834|NCT01215227|156997015|FG002|Overall Study|Randomized but not treated|1|||
48767835|NCT01215227|156997016|FG003|Overall Study|Randomized but not treated|1|||
48767836|NCT01215227|156997017|FG004|Overall Study|Randomized but not treated|0|||
48767837|NCT01215227|156997018|FG005|Overall Study|Randomized but not treated|1|||
48767838|NCT02678676|156997020|FG000|Overall Study|Death|619|||
48767839|NCT02678676|156997021|FG001|Overall Study|Death|649|||
48767840|NCT02678676|156997020|FG000|Overall Study|Withdrawal by Subject|13|||
48767841|NCT02678676|156997021|FG001|Overall Study|Withdrawal by Subject|5|||
48767842|NCT02678676|156997020|FG000|Overall Study|Lost to Follow-up|171|||
48767843|NCT02678676|156997021|FG001|Overall Study|Lost to Follow-up|151|||
48767844|NCT02678676|156997020|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
48767845|NCT02678676|156997021|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
48767846|NCT00989833|156997022|FG000|Overall Study|Lost to Follow-up|0|||
48767847|NCT00989833|156997023|FG001|Overall Study|Lost to Follow-up|1|||
48767848|NCT00989833|156997024|FG002|Overall Study|Lost to Follow-up|0|||
48767849|NCT00989833|156997022|FG000|Overall Study|Protocol Violation|1|||
48767850|NCT00989833|156997023|FG001|Overall Study|Protocol Violation|2|||
48767851|NCT00989833|156997024|FG002|Overall Study|Protocol Violation|1|||
48767852|NCT00989833|156997022|FG000|Overall Study|Withdrawal by Subject|0|||
48767853|NCT00989833|156997023|FG001|Overall Study|Withdrawal by Subject|0|||
48767854|NCT00989833|156997024|FG002|Overall Study|Withdrawal by Subject|1|||
48767855|NCT00989833|156997022|FG000|Overall Study|Incorrectly randomized|1|||
48767856|NCT00989833|156997023|FG001|Overall Study|Incorrectly randomized|0|||
48767857|NCT00989833|156997024|FG002|Overall Study|Incorrectly randomized|0|||
48767858|NCT00308711|156997026|FG000|Overall Study|Withdrawal by Subject|1|||
48767859|NCT00308711|156997027|FG001|Overall Study|Withdrawal by Subject|0|||
48767860|NCT00308711|156997028|FG002|Overall Study|Withdrawal by Subject|1|||
48767861|NCT00308711|156997026|FG000|Overall Study|Protocol Violation|0|||
48767862|NCT00308711|156997027|FG001|Overall Study|Protocol Violation|1|||
48767863|NCT00308711|156997028|FG002|Overall Study|Protocol Violation|1|||
48767864|NCT00308711|156997026|FG000|Overall Study|Lost to Follow-up|0|||
48767865|NCT00308711|156997027|FG001|Overall Study|Lost to Follow-up|1|||
48767866|NCT00308711|156997028|FG002|Overall Study|Lost to Follow-up|0|||
48767867|NCT00308711|156997026|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
48767868|NCT00308711|156997027|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
48767869|NCT00308711|156997028|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
48767870|NCT00308711|156997026|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
48767871|NCT00308711|156997027|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
48767872|NCT00308711|156997028|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
48767873|NCT03149237|156997029|FG000|Overall Study|Withdrawal by Subject|4|||
48767874|NCT03149237|156997030|FG001|Overall Study|Withdrawal by Subject|5|||
48767875|NCT02167256|156997031|FG000|Overall Study|Adverse Event|13|||
48767876|NCT02167256|156997032|FG001|Overall Study|Adverse Event|6|||
48394809|NCT00183274|155639805|FG003|Phase 1: Open-Label|Other|0|||
48767877|NCT02167256|156997031|FG000|Overall Study|Withdrawal by Subject|4|||
48767878|NCT02167256|156997032|FG001|Overall Study|Withdrawal by Subject|4|||
48767879|NCT02167256|156997031|FG000|Overall Study|non-compliance|3|||
48767880|NCT02167256|156997032|FG001|Overall Study|non-compliance|0|||
48767881|NCT02167256|156997031|FG000|Overall Study|Study partner unable to participate|1|||
48767882|NCT02167256|156997032|FG001|Overall Study|Study partner unable to participate|0|||
48767883|NCT01466192|156997033|FG000|Overall Study|Physician Decision|1|||
48767884|NCT01466192|156997033|FG000|Overall Study|Withdrawal by Subject|3|||
48767885|NCT00414388|156997034|FG000|Overall Study|Adverse Event|1|||
48767886|NCT03467425|156997035|FG000|Overall Study|Adverse Event|9|||
48767887|NCT03467425|156997036|FG001|Overall Study|Adverse Event|9|||
48767888|NCT03467425|156997035|FG000|Overall Study|Lack of Efficacy|3|||
48767889|NCT03467425|156997036|FG001|Overall Study|Lack of Efficacy|1|||
48767890|NCT03467425|156997035|FG000|Overall Study|Protocol Violation|0|||
48767891|NCT03467425|156997036|FG001|Overall Study|Protocol Violation|1|||
48767892|NCT03467425|156997035|FG000|Overall Study|Lost to Follow-up|18|||
48767893|NCT03467425|156997036|FG001|Overall Study|Lost to Follow-up|25|||
48767894|NCT03467425|156997035|FG000|Overall Study|Physician Decision|2|||
48767895|NCT03467425|156997036|FG001|Overall Study|Physician Decision|1|||
48767896|NCT03467425|156997035|FG000|Overall Study|Withdrawal by Subject|15|||
48767897|NCT03467425|156997036|FG001|Overall Study|Withdrawal by Subject|17|||
48767898|NCT00813358|156997037|FG000|Overall Study|Death|32|||
48767899|NCT00813358|156997037|FG000|Overall Study|Lost to Follow-up|12|||
48767900|NCT00813358|156997037|FG000|Overall Study|other endpoints|5|||
48767901|NCT00813358|156997037|FG000|Overall Study|Withdrawal by Subject|20|||
48767902|NCT01660412|156997050|FG000|Overall Study|Protocol Violation|0|||
48767903|NCT01660412|156997051|FG001|Overall Study|Protocol Violation|3|||
48767904|NCT00403273|156998878|FG000|Overall Study|Lost to Follow-up|3|||
48767905|NCT00403273|156998879|FG001|Overall Study|Lost to Follow-up|2|||
48767906|NCT00403273|156998878|FG000|Overall Study|Physician Decision|0|||
48767907|NCT00403273|156998879|FG001|Overall Study|Physician Decision|1|||
48767908|NCT00403273|156998878|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
48767909|NCT00403273|156998879|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
48767910|NCT04709575|156998880|FG000|Overall Study|Withdrawal by Subject|6|||
48767911|NCT04709575|156998881|FG001|Overall Study|Withdrawal by Subject|2|||
48767912|NCT04709575|156998880|FG000|Overall Study|Lost to Follow-up|2|||
48767913|NCT04709575|156998881|FG001|Overall Study|Lost to Follow-up|2|||
48767914|NCT04709575|156998880|FG000|Overall Study|Adverse Event|1|||
48767915|NCT04709575|156998881|FG001|Overall Study|Adverse Event|0|||
48767916|NCT04709575|156998880|FG000|Overall Study|Protocol Violation|1|||
48767917|NCT04709575|156998881|FG001|Overall Study|Protocol Violation|1|||
48767918|NCT01852292|156998886|FG000|Overall Study|Untreated - did not receive study drug|3|||
48767919|NCT01852292|156998887|FG001|Overall Study|Untreated - did not receive study drug|1|||
48767920|NCT01852292|156998886|FG000|Overall Study|Death|9|||
48767921|NCT01852292|156998887|FG001|Overall Study|Death|8|||
48767922|NCT01852292|156998886|FG000|Overall Study|Patient/guardian decision|8|||
48767923|NCT01852292|156998887|FG001|Overall Study|Patient/guardian decision|4|||
48767924|NCT01852292|156998886|FG000|Overall Study|Adverse Event|8|||
48767925|NCT01852292|156998887|FG001|Overall Study|Adverse Event|11|||
48767926|NCT01852292|156998886|FG000|Overall Study|Physician Decision|6|||
48767927|NCT01852292|156998887|FG001|Overall Study|Physician Decision|2|||
48767928|NCT01852292|156998886|FG000|Overall Study|Protocol Violation|2|||
48767929|NCT01852292|156998887|FG001|Overall Study|Protocol Violation|0|||
48767930|NCT01852292|156998886|FG000|Overall Study|Non-compliance with study treatment|1|||
48767931|NCT01852292|156998887|FG001|Overall Study|Non-compliance with study treatment|0|||
48767932|NCT01852292|156998886|FG000|Overall Study|Study terminated by Sponsor|0|||
48767933|NCT01852292|156998887|FG001|Overall Study|Study terminated by Sponsor|1|||
48767934|NCT01852292|156998886|FG000|Overall Study|Progressive disease|42|||
48767935|NCT01852292|156998887|FG001|Overall Study|Progressive disease|52|||
48767936|NCT01914666|156998888|FG000|Treatment Period|Lack of Efficacy|0|||
48767937|NCT01914666|156998889|FG001|Treatment Period|Lack of Efficacy|0|||
48767938|NCT01914666|156998890|FG002|Treatment Period|Lack of Efficacy|2|||
48767939|NCT01914666|156998888|FG000|Treatment Period|Adverse Event|10|||
48767940|NCT01914666|156998889|FG001|Treatment Period|Adverse Event|4|||
48767941|NCT01914666|156998890|FG002|Treatment Period|Adverse Event|2|||
48767942|NCT01914666|156998888|FG000|Treatment Period|Withdrawal by Subject|3|||
48394810|NCT00183274|155639806|FG004|Phase 1: Open-Label|Other|0|||
48767943|NCT01914666|156998889|FG001|Treatment Period|Withdrawal by Subject|2|||
48394811|NCT00183274|155639807|FG005|Phase 1: Open-Label|Other|0|||
48394812|NCT00183274|155639802|FG000|Phase 2: Double-Blind|Relapsed|0|||
48767944|NCT01914666|156998890|FG002|Treatment Period|Withdrawal by Subject|2|||
48767945|NCT01914666|156998888|FG000|Treatment Period|Physician Decision|0|||
48394813|NCT00183274|155639803|FG001|Phase 2: Double-Blind|Relapsed|8|||
48767946|NCT01914666|156998889|FG001|Treatment Period|Physician Decision|0|||
48767947|NCT01914666|156998890|FG002|Treatment Period|Physician Decision|2|||
48767948|NCT02586012|156998891|FG000|Overall Study|Withdrawal by Subject|1|||
48394814|NCT00183274|155639804|FG002|Phase 2: Double-Blind|Relapsed|29|||
48767949|NCT02586012|156998892|FG001|Overall Study|Withdrawal by Subject|1|||
48767950|NCT02586012|156998893|FG002|Overall Study|Withdrawal by Subject|0|||
48767951|NCT02586012|156998894|FG003|Overall Study|Withdrawal by Subject|1|||
48767952|NCT02586012|156998895|FG004|Overall Study|Withdrawal by Subject|0|||
48767953|NCT02586012|156998896|FG005|Overall Study|Withdrawal by Subject|2|||
48767954|NCT02586012|156998891|FG000|Overall Study|Protocol Violation|0|||
48767955|NCT02586012|156998892|FG001|Overall Study|Protocol Violation|0|||
48767956|NCT02586012|156998893|FG002|Overall Study|Protocol Violation|0|||
48767957|NCT02586012|156998894|FG003|Overall Study|Protocol Violation|0|||
48767958|NCT02586012|156998895|FG004|Overall Study|Protocol Violation|0|||
48767959|NCT02586012|156998896|FG005|Overall Study|Protocol Violation|1|||
48767960|NCT02586012|156998891|FG000|Overall Study|study terminated|0|||
48767961|NCT02586012|156998892|FG001|Overall Study|study terminated|2|||
48767962|NCT02586012|156998893|FG002|Overall Study|study terminated|1|||
48767963|NCT02586012|156998894|FG003|Overall Study|study terminated|1|||
48767964|NCT02586012|156998895|FG004|Overall Study|study terminated|1|||
48767965|NCT02586012|156998896|FG005|Overall Study|study terminated|0|||
48767966|NCT02388737|156998897|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
48767967|NCT02388737|156998898|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
48767968|NCT02388737|156998899|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
48767969|NCT02388737|156998897|FG000|Overall Study|Major Protocol Deviation|18|||
48767970|NCT02388737|156998898|FG001|Overall Study|Major Protocol Deviation|25|||
48767971|NCT02388737|156998899|FG002|Overall Study|Major Protocol Deviation|22|||
48767972|NCT02388737|156998897|FG000|Overall Study|Lost to Follow-up|5|||
48767973|NCT02388737|156998898|FG001|Overall Study|Lost to Follow-up|1|||
48767974|NCT02388737|156998899|FG002|Overall Study|Lost to Follow-up|4|||
48767975|NCT02388737|156998897|FG000|Overall Study|Voluntary Withdrawal|10|||
48767976|NCT02388737|156998898|FG001|Overall Study|Voluntary Withdrawal|18|||
48767977|NCT02388737|156998899|FG002|Overall Study|Voluntary Withdrawal|17|||
48767978|NCT02388737|156998897|FG000|Overall Study|Lack of Efficacy|3|||
48767979|NCT02388737|156998898|FG001|Overall Study|Lack of Efficacy|0|||
48767980|NCT02388737|156998899|FG002|Overall Study|Lack of Efficacy|3|||
48767981|NCT02388737|156998897|FG000|Overall Study|Reason Not Specified|5|||
48767982|NCT02388737|156998898|FG001|Overall Study|Reason Not Specified|5|||
48767983|NCT02388737|156998899|FG002|Overall Study|Reason Not Specified|4|||
48767984|NCT03711162|156998901|FG000|Overall Study|Adverse Event|5|||
48767985|NCT03711162|156998902|FG001|Overall Study|Adverse Event|2|||
48767986|NCT03711162|156998903|FG002|Overall Study|Adverse Event|4|||
48767987|NCT03711162|156998901|FG000|Overall Study|Death|11|||
48767988|NCT03711162|156998902|FG001|Overall Study|Death|7|||
48767989|NCT03711162|156998903|FG002|Overall Study|Death|8|||
48767990|NCT03711162|156998901|FG000|Overall Study|Lost to Follow-up|1|||
48767991|NCT03711162|156998902|FG001|Overall Study|Lost to Follow-up|0|||
48767992|NCT03711162|156998903|FG002|Overall Study|Lost to Follow-up|1|||
48767993|NCT03711162|156998901|FG000|Overall Study|Study Terminated by Sponsor|139|||
48767994|NCT03711162|156998902|FG001|Overall Study|Study Terminated by Sponsor|152|||
48767995|NCT03711162|156998903|FG002|Overall Study|Study Terminated by Sponsor|146|||
48767996|NCT03711162|156998901|FG000|Overall Study|Withdrawal by Subject|17|||
48767997|NCT03711162|156998902|FG001|Overall Study|Withdrawal by Subject|10|||
48767998|NCT03711162|156998903|FG002|Overall Study|Withdrawal by Subject|10|||
48767999|NCT03711162|156998901|FG000|Overall Study|Miscellaneous|1|||
48768000|NCT03711162|156998902|FG001|Overall Study|Miscellaneous|2|||
48768001|NCT03711162|156998903|FG002|Overall Study|Miscellaneous|2|||
48768002|NCT03711162|156998901|FG000|Overall Study|Not Treated|1|||
48768003|NCT03711162|156998902|FG001|Overall Study|Not Treated|0|||
48768004|NCT03711162|156998903|FG002|Overall Study|Not Treated|1|||
48768005|NCT03711162|156998901|FG000|Overall Study|Physician Decision|0|||
48768006|NCT03711162|156998902|FG001|Overall Study|Physician Decision|2|||
48768007|NCT03711162|156998903|FG002|Overall Study|Physician Decision|0|||
48768008|NCT03711162|156998901|FG000|Overall Study|Lack of Efficacy|0|||
48768009|NCT03711162|156998902|FG001|Overall Study|Lack of Efficacy|0|||
48768010|NCT03711162|156998903|FG002|Overall Study|Lack of Efficacy|2|||
48768011|NCT03711162|156998901|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
48768012|NCT03711162|156998902|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
48768013|NCT03711162|156998903|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
48768014|NCT03102918|156998907|FG000|Overall Study|Protocol Violation|1|||
48768015|NCT03102918|156998908|FG001|Overall Study|Protocol Violation|0|||
48768016|NCT00953329|156998911|FG000|Overall Study|Lack of Efficacy|1|||
48768017|NCT00097721|156998918|FG000|Overall Study|Adverse Event|8|||
48768018|NCT00097721|156998919|FG001|Overall Study|Adverse Event|1|||
48768019|NCT00097721|156998918|FG000|Overall Study|Withdrawal by Subject|6|||
48768020|NCT00097721|156998919|FG001|Overall Study|Withdrawal by Subject|1|||
48768021|NCT00097721|156998918|FG000|Overall Study|Progressive Disease|55|||
48768022|NCT00097721|156998919|FG001|Overall Study|Progressive Disease|27|||
48768023|NCT00097721|156998918|FG000|Overall Study|Physician Decision|1|||
48768024|NCT00097721|156998919|FG001|Overall Study|Physician Decision|3|||
48768025|NCT00097721|156998918|FG000|Overall Study|Reason not given|1|||
48768026|NCT00097721|156998919|FG001|Overall Study|Reason not given|1|||
48768027|NCT03168464|156998920|FG000|Overall Study|Death|9|||
48768028|NCT03168464|156998920|FG000|Overall Study|Progression of disease|6|||
48768029|NCT01869192|156998923|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
48768030|NCT01869192|156998924|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
48768031|NCT01869192|156998923|FG000|Postoperative Chemotherapy|Physician Decision|0|||
48768032|NCT01869192|156998924|FG001|Postoperative Chemotherapy|Physician Decision|2|||
48768033|NCT01533246|156998925|FG000|Overall Study|Adverse Event|1|||
48768034|NCT01533246|156998925|FG000|Overall Study|Withdrawal by Subject|1|||
48768035|NCT01446965|156998926|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
48768036|NCT01446965|156998927|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
48768037|NCT01446965|156998926|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
48768038|NCT01446965|156998927|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
48768039|NCT01143090|156998928|FG000|Overall Study|Lack of Efficacy|2|||
48768040|NCT01143090|156998928|FG000|Overall Study|Adverse Event|17|||
48768041|NCT01143090|156998928|FG000|Overall Study|Lost to Follow-up|9|||
48768042|NCT01143090|156998928|FG000|Overall Study|Protocol Violation|2|||
48768043|NCT01143090|156998928|FG000|Overall Study|Withdrawal by Subject|18|||
48768044|NCT01143090|156998928|FG000|Overall Study|Non-compliance with study drug|1|||
48768045|NCT01143090|156998928|FG000|Overall Study|Failure to meet eligibility criteria|1|||
48768046|NCT01143090|156998928|FG000|Overall Study|Administrative|1|||
48768047|NCT00337103|156998929|FG000|Overall Study|Progressive Disease|414|||
48768048|NCT00337103|156998930|FG001|Overall Study|Progressive Disease|410|||
48768049|NCT00337103|156998929|FG000|Overall Study|Adverse Event|45|||
48768050|NCT00337103|156998930|FG001|Overall Study|Adverse Event|59|||
48768051|NCT00337103|156998929|FG000|Overall Study|Subject Choice|34|||
48768052|NCT00337103|156998930|FG001|Overall Study|Subject Choice|27|||
48768053|NCT00337103|156998929|FG000|Overall Study|Clinical Progression|27|||
48768054|NCT00337103|156998930|FG001|Overall Study|Clinical Progression|24|||
48768055|NCT00337103|156998929|FG000|Overall Study|Physician Decision|15|||
48768056|NCT00337103|156998930|FG001|Overall Study|Physician Decision|14|||
48768057|NCT00337103|156998929|FG000|Overall Study|Withdrawal by Subject|8|||
48768058|NCT00337103|156998930|FG001|Overall Study|Withdrawal by Subject|5|||
48768059|NCT00337103|156998929|FG000|Overall Study|Other|5|||
48768060|NCT00337103|156998930|FG001|Overall Study|Other|6|||
48768061|NCT00337103|156998929|FG000|Overall Study|Entry Criteria Not Met|4|||
48768062|NCT00337103|156998930|FG001|Overall Study|Entry Criteria Not Met|1|||
48768063|NCT00337103|156998929|FG000|Overall Study|Lost to Follow-up|1|||
48768064|NCT00337103|156998930|FG001|Overall Study|Lost to Follow-up|2|||
48768065|NCT00337103|156998929|FG000|Overall Study|Death|1|||
48768066|NCT00337103|156998930|FG001|Overall Study|Death|0|||
48768067|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
48768068|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
48768069|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
48768070|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
48768071|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
48768072|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
48768073|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
48768074|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
48768075|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
48768076|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
48768077|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
48768078|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
48768079|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
48768080|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
48768081|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
48768082|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
48768083|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
48768084|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
48768085|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Death|0|||
48768086|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Death|0|||
48768087|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Death|1|||
48768088|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Death|0|||
48768089|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Death|0|||
48768090|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Death|0|||
48768091|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Death|0|||
48768092|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Death|0|||
48768093|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Death|0|||
48768094|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
48768095|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
48768096|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
48768097|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768098|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768099|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768100|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768101|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768102|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
48768103|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
48768104|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
48768105|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
48768106|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768107|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768108|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768109|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768110|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768111|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
48768112|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
48768113|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
48768114|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
48768115|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
48768116|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
48768117|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
48768118|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
48768119|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
48768120|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
48768121|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
48768122|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
48768123|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
48768124|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
48768125|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
48768126|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
48768127|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
48768128|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
48768129|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
48768130|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
48768131|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
48768132|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
48768133|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768134|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768135|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768136|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768137|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768138|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
48768139|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768140|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
48768141|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768142|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768143|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768144|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768145|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768146|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768147|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
48768148|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
48768149|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
48768150|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
48768151|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
48768152|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
48768153|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
48394815|NCT00183274|155639805|FG003|Phase 2: Double-Blind|Relapsed|0|||
48394816|NCT00183274|155639806|FG004|Phase 2: Double-Blind|Relapsed|0|||
48394817|NCT00183274|155639807|FG005|Phase 2: Double-Blind|Relapsed|0|||
48394818|NCT00183274|155639802|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
48394819|NCT00183274|155639803|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
48394820|NCT00183274|155639804|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
48394821|NCT00183274|155639805|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
48394822|NCT00183274|155639806|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
48394823|NCT00183274|155639807|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
48430331|NCT00696657|155763703|FG003|Overall Study|Protocol Violation|0|||
48768154|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
48768155|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
48768156|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
48768157|NCT00404352|156998931|FG000|Double Blind (up to 24 Month)|Other|0|||
48768158|NCT00404352|156998932|FG001|Double Blind (up to 24 Month)|Other|1|||
48768159|NCT00404352|156998933|FG002|Double Blind (up to 24 Month)|Other|0|||
48768160|NCT00404352|156998934|FG003|Double Blind (up to 24 Month)|Other|0|||
48768161|NCT00404352|156998935|FG004|Double Blind (up to 24 Month)|Other|0|||
48768162|NCT00404352|156998936|FG005|Double Blind (up to 24 Month)|Other|0|||
48768163|NCT00404352|156998937|FG006|Double Blind (up to 24 Month)|Other|0|||
48768164|NCT00404352|156998938|FG007|Double Blind (up to 24 Month)|Other|0|||
48768165|NCT00404352|156998939|FG008|Double Blind (up to 24 Month)|Other|0|||
48768166|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
48768167|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
48768168|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
48768169|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
48394824|NCT00183274|155639802|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
48394825|NCT00183274|155639803|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
48394826|NCT00183274|155639804|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
48394827|NCT00183274|155639805|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
48394828|NCT00183274|155639806|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
48768170|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
48768171|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
48768172|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
48768173|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
48768174|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
48768175|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
48768176|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
48768177|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
48768178|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
48768179|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
48768180|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
48768181|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
48768182|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
48768183|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
48768184|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768185|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768186|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768187|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768188|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
48768189|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768190|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768191|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768192|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
48768193|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768194|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768195|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768196|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768197|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768198|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
48768199|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768200|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768201|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
48768202|NCT00404352|156998931|FG000|Open Label (up to 24 Month)|Disease progression|0|||
48768203|NCT00404352|156998932|FG001|Open Label (up to 24 Month)|Disease progression|0|||
48768204|NCT00404352|156998933|FG002|Open Label (up to 24 Month)|Disease progression|0|||
48768205|NCT00404352|156998934|FG003|Open Label (up to 24 Month)|Disease progression|1|||
48768206|NCT00404352|156998935|FG004|Open Label (up to 24 Month)|Disease progression|0|||
48768207|NCT00404352|156998936|FG005|Open Label (up to 24 Month)|Disease progression|0|||
48768208|NCT00404352|156998937|FG006|Open Label (up to 24 Month)|Disease progression|0|||
48768209|NCT00404352|156998938|FG007|Open Label (up to 24 Month)|Disease progression|0|||
48768210|NCT00404352|156998939|FG008|Open Label (up to 24 Month)|Disease progression|0|||
48768211|NCT00404352|156998931|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768212|NCT00404352|156998932|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768213|NCT00404352|156998933|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768214|NCT00404352|156998934|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768215|NCT00404352|156998935|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768216|NCT00404352|156998936|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768217|NCT00404352|156998937|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
48394829|NCT00183274|155639807|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
48768218|NCT00404352|156998938|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
48768219|NCT00404352|156998939|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
48768220|NCT00404352|156998931|FG000|Open Label Extension (up to 36 Months)|Other|0|||
48768221|NCT00404352|156998932|FG001|Open Label Extension (up to 36 Months)|Other|0|||
48768222|NCT00404352|156998933|FG002|Open Label Extension (up to 36 Months)|Other|0|||
48768223|NCT00404352|156998934|FG003|Open Label Extension (up to 36 Months)|Other|0|||
48768224|NCT00404352|156998935|FG004|Open Label Extension (up to 36 Months)|Other|0|||
48768225|NCT00404352|156998936|FG005|Open Label Extension (up to 36 Months)|Other|0|||
48768226|NCT00404352|156998937|FG006|Open Label Extension (up to 36 Months)|Other|0|||
48768227|NCT00404352|156998938|FG007|Open Label Extension (up to 36 Months)|Other|0|||
48768228|NCT00404352|156998939|FG008|Open Label Extension (up to 36 Months)|Other|2|||
48768229|NCT01520363|156998940|FG000|Overall Study|Withdrawal by Subject|2|||
48768230|NCT01520363|156998941|FG001|Overall Study|Withdrawal by Subject|0|||
48768231|NCT00606892|156998942|FG000|First Intervention|Protocol Violation|1|||
48768232|NCT00606892|156998943|FG001|First Intervention|Protocol Violation|4|||
48768233|NCT00829296|156998951|FG000|Overall Study|Adverse Event|5|||
48768234|NCT00829296|156998952|FG001|Overall Study|Adverse Event|4|||
48768235|NCT00582933|156998955|FG000|Overall Study|Physician Decision|3|||
48768236|NCT01494610|156998959|FG000|Period 1|Withdrawal by Subject|1|||
48768237|NCT01494610|156998960|FG001|Period 1|Withdrawal by Subject|1|||
48768238|NCT01494610|156998959|FG000|Period 3|Adverse Event|1|||
48768239|NCT01494610|156998960|FG001|Period 3|Adverse Event|0|||
48768240|NCT01494610|156998959|FG000|Period 3|Withdrawal by Subject|1|||
48768241|NCT01494610|156998960|FG001|Period 3|Withdrawal by Subject|0|||
48768242|NCT01494610|156998959|FG000|Period 4|Protocol Violation|1|||
48768243|NCT01494610|156998960|FG001|Period 4|Protocol Violation|0|||
48768244|NCT00594464|156998961|FG000|Overall Study|Withdrawal by Subject|1|||
48768245|NCT00594464|156998961|FG000|Overall Study|Delay in operation|2|||
48768246|NCT02385799|156998965|FG000|Overall Study|Lost to Follow-up|1|||
48768247|NCT02385799|156998966|FG001|Overall Study|Lost to Follow-up|2|||
48768248|NCT02385799|156998965|FG000|Overall Study|Adverse Event|4|||
48768249|NCT02385799|156998966|FG001|Overall Study|Adverse Event|2|||
48768250|NCT02385799|156998965|FG000|Overall Study|Withdrawal by Subject|0|||
48768251|NCT02385799|156998966|FG001|Overall Study|Withdrawal by Subject|4|||
48768252|NCT00547703|156998967|FG000|Overall Study|Lost to Follow-up|1|||
48768253|NCT00547703|156998968|FG001|Overall Study|Lost to Follow-up|0|||
48768254|NCT02350309|156998969|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768255|NCT02350309|156998970|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768256|NCT02350309|156998971|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
48768257|NCT02350309|156998972|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768258|NCT02350309|156998973|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768259|NCT02350309|156998974|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
48768260|NCT02350309|156998969|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768261|NCT02350309|156998970|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768262|NCT02350309|156998971|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768263|NCT02350309|156998972|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768264|NCT02350309|156998973|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
48768265|NCT02350309|156998974|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
48768266|NCT00207142|156998975|FG000|Induction Phase|Adverse Event|9|||
48768267|NCT00207142|156998976|FG001|Induction Phase|Adverse Event|0|||
48768268|NCT00207142|156998977|FG002|Induction Phase|Adverse Event|0|||
48768269|NCT00207142|156998978|FG003|Induction Phase|Adverse Event|0|||
48768270|NCT00207142|156998975|FG000|Induction Phase|Death|1|||
48768271|NCT00207142|156998976|FG001|Induction Phase|Death|0|||
48768272|NCT00207142|156998977|FG002|Induction Phase|Death|0|||
48768273|NCT00207142|156998978|FG003|Induction Phase|Death|0|||
48768274|NCT00207142|156998975|FG000|Induction Phase|Lack of Efficacy|1|||
48768275|NCT00207142|156998976|FG001|Induction Phase|Lack of Efficacy|0|||
48768276|NCT00207142|156998977|FG002|Induction Phase|Lack of Efficacy|0|||
48768277|NCT00207142|156998978|FG003|Induction Phase|Lack of Efficacy|0|||
48768278|NCT00207142|156998975|FG000|Induction Phase|Lost to Follow-up|5|||
48768279|NCT00207142|156998976|FG001|Induction Phase|Lost to Follow-up|0|||
48768280|NCT00207142|156998977|FG002|Induction Phase|Lost to Follow-up|0|||
48768281|NCT00207142|156998978|FG003|Induction Phase|Lost to Follow-up|0|||
48768282|NCT00207142|156998975|FG000|Induction Phase|Physician Decision|2|||
48768283|NCT00207142|156998976|FG001|Induction Phase|Physician Decision|0|||
48768284|NCT00207142|156998977|FG002|Induction Phase|Physician Decision|0|||
48768285|NCT00207142|156998978|FG003|Induction Phase|Physician Decision|0|||
48768286|NCT00207142|156998975|FG000|Induction Phase|Poor/noncompliance|2|||
48768287|NCT00207142|156998976|FG001|Induction Phase|Poor/noncompliance|0|||
48768288|NCT00207142|156998977|FG002|Induction Phase|Poor/noncompliance|0|||
48768289|NCT00207142|156998978|FG003|Induction Phase|Poor/noncompliance|0|||
48768290|NCT00207142|156998975|FG000|Induction Phase|Pregnancy|1|||
48768291|NCT00207142|156998976|FG001|Induction Phase|Pregnancy|0|||
48768292|NCT00207142|156998977|FG002|Induction Phase|Pregnancy|0|||
48768293|NCT00207142|156998978|FG003|Induction Phase|Pregnancy|0|||
48768294|NCT00207142|156998975|FG000|Induction Phase|Subject no longer meets study criteria|3|||
48768295|NCT00207142|156998976|FG001|Induction Phase|Subject no longer meets study criteria|0|||
48768296|NCT00207142|156998977|FG002|Induction Phase|Subject no longer meets study criteria|0|||
48768297|NCT00207142|156998978|FG003|Induction Phase|Subject no longer meets study criteria|0|||
48768298|NCT00207142|156998975|FG000|Induction Phase|Withdrawal by Subject|4|||
48768299|NCT00207142|156998976|FG001|Induction Phase|Withdrawal by Subject|0|||
48768300|NCT00207142|156998977|FG002|Induction Phase|Withdrawal by Subject|0|||
48768301|NCT00207142|156998978|FG003|Induction Phase|Withdrawal by Subject|0|||
48768302|NCT00207142|156998975|FG000|Induction Phase|Incarceration|1|||
48768303|NCT00207142|156998976|FG001|Induction Phase|Incarceration|0|||
48768304|NCT00207142|156998977|FG002|Induction Phase|Incarceration|0|||
48768305|NCT00207142|156998978|FG003|Induction Phase|Incarceration|0|||
48768306|NCT00207142|156998975|FG000|Induction Phase|Missing lab data|1|||
48768307|NCT00207142|156998976|FG001|Induction Phase|Missing lab data|0|||
48768308|NCT00207142|156998977|FG002|Induction Phase|Missing lab data|0|||
48768309|NCT00207142|156998978|FG003|Induction Phase|Missing lab data|0|||
48768310|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
48768311|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
48768312|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
48768313|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
48768314|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
48768315|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
48394830|NCT00183274|155639802|FG000|Phase 3: Double-Blind|Relapsed|0|||
48394831|NCT00183274|155639803|FG001|Phase 3: Double-Blind|Relapsed|0|||
48768316|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
48768317|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
48768318|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
48768319|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
48768320|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
48768321|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
48768322|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
48768323|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
48768324|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
48768325|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
48768326|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
48768327|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
48768328|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
48768329|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
48768330|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
48768331|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
48768332|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
48768333|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
48768334|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
48768335|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
48768336|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
48768337|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
48768338|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Death|0|||
48768339|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Death|0|||
48768340|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Death|0|||
48768341|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Death|1|||
48768342|NCT00207142|156998975|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
48768343|NCT00207142|156998976|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
48768344|NCT00207142|156998977|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
48768345|NCT00207142|156998978|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
48768346|NCT02214121|156998979|FG000|Part A|Patient decision|2|||
48768347|NCT02214121|156998980|FG001|Part A|Patient decision|0|||
48768348|NCT02214121|156998981|FG002|Part A|Patient decision|0|||
48768349|NCT02214121|156998979|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
48768350|NCT02214121|156998980|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
48768351|NCT02214121|156998981|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
48768352|NCT02214121|156998979|FG000|Part A|Other|1|||
48768353|NCT02214121|156998980|FG001|Part A|Other|0|||
48768354|NCT02214121|156998981|FG002|Part A|Other|0|||
48768355|NCT02214121|156998979|FG000|Part B|Patient decision|0|||
48768356|NCT02214121|156998980|FG001|Part B|Patient decision|1|||
48768357|NCT02214121|156998981|FG002|Part B|Patient decision|0|||
48768358|NCT02214121|156998979|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
48768359|NCT02214121|156998980|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
48768360|NCT02214121|156998981|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
48768361|NCT02214121|156998979|FG000|Part B|Lost to Follow-up|0|||
48768362|NCT02214121|156998980|FG001|Part B|Lost to Follow-up|0|||
48768363|NCT02214121|156998981|FG002|Part B|Lost to Follow-up|1|||
48768364|NCT01256710|156998982|FG000|Overall Study|Death|449|||
48768365|NCT01256710|156998982|FG000|Overall Study|System Explant|67|||
48768366|NCT01256710|156998982|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
48768367|NCT01256710|156998982|FG000|Overall Study|Lost to Follow-up|67|||
48768368|NCT01256710|156998982|FG000|Overall Study|Withdrawal by Subject|29|||
48768369|NCT01256710|156998982|FG000|Overall Study|Physician Decision|9|||
48768370|NCT01256710|156998982|FG000|Overall Study|Subject Noncompliance|2|||
48768371|NCT01256710|156998982|FG000|Overall Study|Study Terminated by Sponsor|273|||
48768372|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768373|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768374|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
48768375|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768376|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768377|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
48768378|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
48768379|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
48768380|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
48768381|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
48768382|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
48768383|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
48768384|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
48768385|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
48768386|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
48768387|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768388|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768389|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768390|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768391|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768392|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
48768393|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48768394|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48768395|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
48768396|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48768397|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48768398|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
48394832|NCT00183274|155639804|FG002|Phase 3: Double-Blind|Relapsed|0|||
48394833|NCT00183274|155639805|FG003|Phase 3: Double-Blind|Relapsed|1|||
48394834|NCT00183274|155639806|FG004|Phase 3: Double-Blind|Relapsed|11|||
48394835|NCT00183274|155639807|FG005|Phase 3: Double-Blind|Relapsed|2|||
48768399|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
48768400|NCT01573624|156998983|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
48768401|NCT01573624|156998984|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
48768402|NCT01573624|156998985|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
48768403|NCT01573624|156998986|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
48768404|NCT01573624|156998987|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
48768405|NCT01573624|156998988|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
48768406|NCT01573624|156998989|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
48768407|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768408|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768409|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768410|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768411|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768412|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
48768413|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
48768414|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
48768415|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
48394836|NCT01029366|155639808|FG000|Overall Study|Withdrawal by Subject|1|||
48394837|NCT01029366|155639809|FG001|Overall Study|Withdrawal by Subject|0|||
48394838|NCT01029366|155639808|FG000|Overall Study|Death|1|||
48394839|NCT01029366|155639809|FG001|Overall Study|Death|1|||
48394840|NCT01029366|155639808|FG000|Overall Study|disease progression|2|||
48768416|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
48768417|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
48768418|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
48768419|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
48768420|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
48394841|NCT01029366|155639809|FG001|Overall Study|disease progression|0|||
48768421|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
48394842|NCT01029366|155639808|FG000|Overall Study|manufacturing failure|0|||
48394843|NCT01029366|155639809|FG001|Overall Study|manufacturing failure|1|||
48394844|NCT01394627|155639810|FG000|First Intervention (1 Day)|poor intravenous access|0|||
48394845|NCT01394627|155639811|FG001|First Intervention (1 Day)|poor intravenous access|1|||
48394846|NCT01394627|155639810|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
48394847|NCT01394627|155639811|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
48768422|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48768423|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
48768424|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
48768425|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48768426|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48768427|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
48768428|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768429|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768430|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768431|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768432|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768433|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
48768434|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
48768435|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768436|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768437|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768438|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
48768439|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768440|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
48768441|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
48768442|NCT01573624|156998983|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768443|NCT01573624|156998984|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768444|NCT01573624|156998985|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768445|NCT01573624|156998986|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768446|NCT01573624|156998987|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768447|NCT01573624|156998988|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768448|NCT01573624|156998989|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768449|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
48768450|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
48768451|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
48768452|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
48768453|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
48768454|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
48768455|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
48768456|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768457|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
48768458|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768459|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768460|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768461|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
48768462|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
48768463|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
48768464|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768465|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768466|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768467|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768468|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768469|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
48768470|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48768471|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
48768472|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
48768473|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48394848|NCT02813694|155639812|FG000|Overall Study|Physician Decision|0|||
48394849|NCT02813694|155639813|FG001|Overall Study|Physician Decision|1|||
48394850|NCT02813694|155639812|FG000|Overall Study|Withdrawal by Subject|10|||
48768474|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48768475|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
48768476|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48768477|NCT01573624|156998983|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
48768478|NCT01573624|156998984|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768479|NCT01573624|156998985|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768480|NCT01573624|156998986|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768481|NCT01573624|156998987|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768482|NCT01573624|156998988|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768483|NCT01573624|156998989|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
48768484|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
48768485|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768486|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768487|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768488|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768489|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
48768490|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
48768491|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
48768492|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48394851|NCT02813694|155639813|FG001|Overall Study|Withdrawal by Subject|9|||
48394852|NCT02813694|155639812|FG000|Overall Study|Lost to Follow-up|1|||
48768493|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48768494|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48768495|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48768496|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
48768497|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
48768498|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48394853|NCT02813694|155639813|FG001|Overall Study|Lost to Follow-up|1|||
48394854|NCT02813694|155639812|FG000|Overall Study|Death|3|||
48394855|NCT02813694|155639813|FG001|Overall Study|Death|3|||
48394856|NCT02813694|155639812|FG000|Overall Study|Randomized- did not receive study drug|2|||
48768499|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
48768500|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768501|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768502|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768503|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768504|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
48768505|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768506|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
48394857|NCT02813694|155639813|FG001|Overall Study|Randomized- did not receive study drug|0|||
48394858|NCT02813694|155639812|FG000|Overall Study|Patient hospitalized|1|||
48768507|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768508|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768509|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768510|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768511|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
48768512|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768513|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768514|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768515|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768516|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
48768517|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48768518|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
48768519|NCT01573624|156998983|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768520|NCT01573624|156998984|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768521|NCT01573624|156998985|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768522|NCT01573624|156998986|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
48768523|NCT01573624|156998987|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768524|NCT01573624|156998988|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
48797681|NCT00828984|157097046|FG000|Overall Study|Withdrawal by Subject|4|||
48797682|NCT00828984|157097047|FG001|Overall Study|Withdrawal by Subject|4|||
48394859|NCT02813694|155639813|FG001|Overall Study|Patient hospitalized|0|||
48430332|NCT00696657|155763704|FG004|Overall Study|Protocol Violation|0|||
48768525|NCT01573624|156998989|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
48768526|NCT01573624|156998983|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
48768527|NCT01573624|156998984|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48768528|NCT01573624|156998985|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48768529|NCT01573624|156998986|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
48768530|NCT01573624|156998987|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
48768531|NCT01573624|156998988|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
48768532|NCT01573624|156998989|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
48768533|NCT01573624|156998983|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768534|NCT01573624|156998984|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
48768535|NCT01573624|156998985|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768536|NCT01573624|156998986|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768537|NCT01573624|156998987|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768538|NCT01573624|156998988|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
48768539|NCT01573624|156998989|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
48768540|NCT01573624|156998983|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
48768541|NCT01573624|156998984|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768542|NCT01573624|156998985|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768543|NCT01573624|156998986|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768544|NCT01573624|156998987|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768545|NCT01573624|156998988|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768546|NCT01573624|156998989|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
48768547|NCT01573624|156998983|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768548|NCT01573624|156998984|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768549|NCT01573624|156998985|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768550|NCT01573624|156998986|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768551|NCT01573624|156998987|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
48768552|NCT01573624|156998988|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
48768553|NCT01573624|156998989|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
48768554|NCT01573624|156998983|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
48768555|NCT01573624|156998984|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768556|NCT01573624|156998985|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768557|NCT01573624|156998986|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768558|NCT01573624|156998987|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768559|NCT01573624|156998988|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768560|NCT01573624|156998989|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
48768561|NCT03216850|156998992|FG000|Overall Study|Pre-analytical error|6|||
48768562|NCT03554291|156998993|FG000|Overall Study|Death|2|||
48768563|NCT03554291|156998994|FG001|Overall Study|Death|1|||
48768564|NCT03554291|156998993|FG000|Overall Study|Lost to Follow-up|1|||
48768565|NCT03554291|156998994|FG001|Overall Study|Lost to Follow-up|0|||
48768566|NCT03554291|156998993|FG000|Overall Study|Withdrawal by Subject|1|||
48768567|NCT03554291|156998994|FG001|Overall Study|Withdrawal by Subject|0|||
48768568|NCT03554291|156998993|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
48768569|NCT03554291|156998994|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
48768570|NCT01418937|156999003|FG000|Overall Study|Lost to Follow-up|5|||
48768571|NCT01418937|156999003|FG000|Overall Study|Protocol Violation|1|||
48768572|NCT01418937|156999003|FG000|Overall Study|Pregnancy|1|||
48768573|NCT01418937|156999003|FG000|Overall Study|Withdrawal by Subject|1|||
48768574|NCT01462357|156999021|FG000|Overall Study|Death|0|||
48768575|NCT01462357|156999022|FG001|Overall Study|Death|0|||
48768576|NCT01462357|156999023|FG002|Overall Study|Death|1|||
48768577|NCT01462357|156999021|FG000|Overall Study|Withdrawal by Subject|3|||
48768578|NCT01462357|156999022|FG001|Overall Study|Withdrawal by Subject|11|||
48768579|NCT01462357|156999023|FG002|Overall Study|Withdrawal by Subject|3|||
48768580|NCT01462357|156999021|FG000|Overall Study|Migrated/moved from study area|2|||
48768581|NCT01462357|156999022|FG001|Overall Study|Migrated/moved from study area|3|||
48768582|NCT01462357|156999023|FG002|Overall Study|Migrated/moved from study area|1|||
48768583|NCT01462357|156999021|FG000|Overall Study|Lost to Follow-up|3|||
48768584|NCT01462357|156999022|FG001|Overall Study|Lost to Follow-up|5|||
48768585|NCT01462357|156999023|FG002|Overall Study|Lost to Follow-up|7|||
48394860|NCT00769184|155639814|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
48768586|NCT01334866|156999029|FG000|Overall Study|Withdrawal by Subject|10|||
48768587|NCT01334866|156999029|FG000|Overall Study|Lost to Follow-up|3|||
48768588|NCT01334866|156999029|FG000|Overall Study|Physician Decision|3|||
48768589|NCT01334866|156999029|FG000|Overall Study|medically necessary prior to procedure|2|||
48768590|NCT01334866|156999029|FG000|Overall Study|medically necessary post-procedure|1|||
48768591|NCT00677807|156999031|FG000|Overall Study|Adverse Event|4|||
48768592|NCT00677807|156999032|FG001|Overall Study|Adverse Event|1|||
48768593|NCT00677807|156999033|FG002|Overall Study|Adverse Event|6|||
48768594|NCT00677807|156999031|FG000|Overall Study|Lack of Efficacy|0|||
48768595|NCT00677807|156999032|FG001|Overall Study|Lack of Efficacy|0|||
48768596|NCT00677807|156999033|FG002|Overall Study|Lack of Efficacy|2|||
48768597|NCT00677807|156999031|FG000|Overall Study|Participant no longer needs study drug|0|||
48768598|NCT00677807|156999032|FG001|Overall Study|Participant no longer needs study drug|0|||
48768599|NCT00677807|156999033|FG002|Overall Study|Participant no longer needs study drug|1|||
48768600|NCT00677807|156999031|FG000|Overall Study|Withdrawal by Subject|10|||
48768601|NCT00677807|156999032|FG001|Overall Study|Withdrawal by Subject|3|||
48768602|NCT00677807|156999033|FG002|Overall Study|Withdrawal by Subject|6|||
48768603|NCT00677807|156999031|FG000|Overall Study|Lost to Follow-up|2|||
48768604|NCT00677807|156999032|FG001|Overall Study|Lost to Follow-up|2|||
48768605|NCT00677807|156999033|FG002|Overall Study|Lost to Follow-up|2|||
48768606|NCT00677807|156999031|FG000|Overall Study|Administrative problems|1|||
48768607|NCT00677807|156999032|FG001|Overall Study|Administrative problems|1|||
48768608|NCT00677807|156999033|FG002|Overall Study|Administrative problems|2|||
48768609|NCT00677807|156999031|FG000|Overall Study|Death|0|||
48768610|NCT00677807|156999032|FG001|Overall Study|Death|1|||
48768611|NCT00677807|156999033|FG002|Overall Study|Death|1|||
48768612|NCT00677807|156999031|FG000|Overall Study|Protocol Deviation|1|||
48768613|NCT00677807|156999032|FG001|Overall Study|Protocol Deviation|3|||
48768614|NCT00677807|156999033|FG002|Overall Study|Protocol Deviation|0|||
48768615|NCT02540954|156999036|FG000|Overall Study|Physician Decision|3|||
48768616|NCT02540954|156999037|FG001|Overall Study|Physician Decision|1|||
48768617|NCT02540954|156999036|FG000|Overall Study|Withdrawal by Subject|6|||
48768618|NCT02540954|156999037|FG001|Overall Study|Withdrawal by Subject|5|||
48768619|NCT02540954|156999036|FG000|Overall Study|Lost to Follow-up|1|||
48768620|NCT02540954|156999037|FG001|Overall Study|Lost to Follow-up|1|||
48768621|NCT02540954|156999036|FG000|Overall Study|Adverse Event|4|||
48768622|NCT02540954|156999037|FG001|Overall Study|Adverse Event|2|||
48768623|NCT02540954|156999036|FG000|Overall Study|Death|0|||
48768624|NCT02540954|156999037|FG001|Overall Study|Death|3|||
48768625|NCT02540954|156999036|FG000|Overall Study|Treatment failure|1|||
48768626|NCT02540954|156999037|FG001|Overall Study|Treatment failure|0|||
48768627|NCT02540954|156999036|FG000|Overall Study|Other reason|4|||
48768628|NCT02540954|156999037|FG001|Overall Study|Other reason|2|||
48768629|NCT01527292|156999038|FG000|Overall Study|Physician Decision|0|||
48768630|NCT01527292|156999039|FG001|Overall Study|Physician Decision|3|||
48768631|NCT00983580|156999040|FG000|Overall Study|Cancel Prior to treatment|1|||
48768632|NCT00983580|156999041|FG001|Overall Study|Cancel Prior to treatment|3|||
48768633|NCT00983580|156999040|FG000|Overall Study|Protocol Violation|1|||
48768634|NCT00983580|156999041|FG001|Overall Study|Protocol Violation|1|||
48768635|NCT00983580|156999040|FG000|Overall Study|Ineligible|3|||
48768636|NCT00983580|156999041|FG001|Overall Study|Ineligible|0|||
48768637|NCT01482767|156999042|FG000|Overall Study|Death|1|||
48768638|NCT01482767|156999043|FG001|Overall Study|Death|1|||
48768639|NCT01482767|156999042|FG000|Overall Study|Withdrawal by Subject|7|||
48768640|NCT01482767|156999043|FG001|Overall Study|Withdrawal by Subject|5|||
48768641|NCT01482767|156999042|FG000|Overall Study|Lost to Follow-up|12|||
48768642|NCT01482767|156999043|FG001|Overall Study|Lost to Follow-up|6|||
48768643|NCT01482767|156999042|FG000|Overall Study|Adverse Event|0|||
48768644|NCT01482767|156999043|FG001|Overall Study|Adverse Event|3|||
48768645|NCT01482767|156999042|FG000|Overall Study|Site closure|22|||
48768646|NCT01482767|156999043|FG001|Overall Study|Site closure|14|||
48768647|NCT01482767|156999042|FG000|Overall Study|Non-adherence to study requirements|4|||
48768648|NCT01482767|156999043|FG001|Overall Study|Non-adherence to study requirements|7|||
48768649|NCT01482767|156999042|FG000|Overall Study|Alternate HCV treatment|7|||
48768650|NCT01482767|156999043|FG001|Overall Study|Alternate HCV treatment|8|||
48768651|NCT01482767|156999042|FG000|Overall Study|Ineligible|0|||
48768652|NCT01482767|156999043|FG001|Overall Study|Ineligible|5|||
48768653|NCT01482767|156999042|FG000|Overall Study|Nurse error|1|||
48768654|NCT01482767|156999043|FG001|Overall Study|Nurse error|0|||
48768655|NCT00314366|156999046|FG000|Overall Study|not treated due to patient medical condi|1|||
48768656|NCT00314366|156999047|FG001|Overall Study|not treated due to patient medical condi|0|||
48768657|NCT00806546|156999048|FG000|Overall Study|Enrolled, not treated|35|||
48768658|NCT00806546|156999048|FG000|Overall Study|Lost to Follow-up|32|||
48768659|NCT00806546|156999048|FG000|Overall Study|Adverse Event|74|||
48768660|NCT00806546|156999048|FG000|Overall Study|Withdrawal by Subject|75|||
48768661|NCT00806546|156999048|FG000|Overall Study|Protocol Violation|49|||
48768662|NCT00806546|156999048|FG000|Overall Study|Various|42|||
48768663|NCT00006916|156999049|FG000|Overall Study|Device not inserted|4|||
48768664|NCT00006916|156999049|FG000|Overall Study|Complication of device insertion|1|||
48768665|NCT03829046|156999054|FG000|Overall Study|Withdrawal by Subject|1|||
48768666|NCT03829046|156999055|FG001|Overall Study|Withdrawal by Subject|0|||
48768667|NCT02296112|156999057|FG000|Overall Study|Disease progression|7|||
48768668|NCT02296112|156999057|FG000|Overall Study|Toxicity|1|||
48768669|NCT02296112|156999057|FG000|Overall Study|Began an alternate therapy|1|||
48768670|NCT04568122|156999060|FG000|Overall Study|Lost to Follow-up|48|||
48768671|NCT04568122|156999061|FG001|Overall Study|Lost to Follow-up|44|||
48768672|NCT04568122|156999062|FG002|Overall Study|Lost to Follow-up|4|||
48768673|NCT04568122|156999063|FG003|Overall Study|Lost to Follow-up|0|||
48768674|NCT04568122|156999064|FG004|Overall Study|Lost to Follow-up|0|||
48768675|NCT00245765|156999066|FG000|Overall Study|Adverse Event|1|||
48768676|NCT00245765|156999067|FG001|Overall Study|Adverse Event|1|||
48768677|NCT00245765|156999068|FG002|Overall Study|Adverse Event|0|||
48768678|NCT00245765|156999066|FG000|Overall Study|Lack of Efficacy|14|||
48768679|NCT00245765|156999067|FG001|Overall Study|Lack of Efficacy|7|||
48768680|NCT00245765|156999068|FG002|Overall Study|Lack of Efficacy|0|||
48768681|NCT00245765|156999066|FG000|Overall Study|Lost to Follow-up|1|||
48768682|NCT00245765|156999067|FG001|Overall Study|Lost to Follow-up|2|||
48768683|NCT00245765|156999068|FG002|Overall Study|Lost to Follow-up|0|||
48768684|NCT00245765|156999066|FG000|Overall Study|Withdrawal by Subject|1|||
48768685|NCT00245765|156999067|FG001|Overall Study|Withdrawal by Subject|0|||
48768686|NCT00245765|156999068|FG002|Overall Study|Withdrawal by Subject|3|||
48768687|NCT00245765|156999066|FG000|Overall Study|Other reason|2|||
48768688|NCT00245765|156999067|FG001|Overall Study|Other reason|0|||
48768689|NCT00245765|156999068|FG002|Overall Study|Other reason|1|||
48768690|NCT00245765|156999066|FG000|Overall Study|Other|13|||
48768691|NCT00245765|156999067|FG001|Overall Study|Other|4|||
48768692|NCT00245765|156999068|FG002|Overall Study|Other|4|||
48768693|NCT03080961|156999069|FG000|Overall Study|Withdrawal by Subject|3|||
48768694|NCT03945981|156999070|FG000|Overall Study|Lost to Follow-up|12|||
48768695|NCT03945981|156999070|FG000|Overall Study|Physician Decision|4|||
48768696|NCT03945981|156999070|FG000|Overall Study|Withdrawal by Subject|6|||
48768697|NCT03945981|156999070|FG000|Overall Study|Protocol Violation|1|||
48768698|NCT00590954|156999072|FG000|Overall Study|Inevaluable|2|||
48768699|NCT03551210|156999073|FG000|Overall Study|Adverse Event|5|||
48768700|NCT03551210|156999074|FG001|Overall Study|Adverse Event|6|||
48768701|NCT03551210|156999073|FG000|Overall Study|Withdrawal by Subject|1|||
48768702|NCT03551210|156999074|FG001|Overall Study|Withdrawal by Subject|7|||
48768703|NCT03551210|156999073|FG000|Overall Study|Needed in other antibiotic treatment|2|||
48355865|NCT01465763|155498596|FG001|Overall Study|Withdrawal by Subject|0|||
48355866|NCT01465763|155498597|FG002|Overall Study|Withdrawal by Subject|1|||
48355867|NCT01465763|155498595|FG000|Overall Study|Insufficient Clinical Response|11|||
48355868|NCT01465763|155498596|FG001|Overall Study|Insufficient Clinical Response|0|||
48355869|NCT01465763|155498597|FG002|Overall Study|Insufficient Clinical Response|1|||
48355870|NCT01465763|155498595|FG000|Overall Study|Adverse Event|9|||
48355871|NCT01465763|155498596|FG001|Overall Study|Adverse Event|0|||
48355872|NCT01465763|155498597|FG002|Overall Study|Adverse Event|1|||
48355873|NCT01465763|155498595|FG000|Overall Study|Other|2|||
48355874|NCT01465763|155498596|FG001|Overall Study|Other|0|||
48355875|NCT01465763|155498597|FG002|Overall Study|Other|0|||
48355876|NCT01465763|155498595|FG000|Overall Study|Protocol Violation|4|||
48355877|NCT01465763|155498596|FG001|Overall Study|Protocol Violation|1|||
48355878|NCT01465763|155498597|FG002|Overall Study|Protocol Violation|1|||
48768704|NCT03551210|156999074|FG001|Overall Study|Needed in other antibiotic treatment|5|||
48768705|NCT03551210|156999073|FG000|Overall Study|Lost to Follow-up|1|||
48768706|NCT03551210|156999074|FG001|Overall Study|Lost to Follow-up|1|||
48394861|NCT00769184|155639815|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
48394862|NCT00769184|155639814|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
48394863|NCT00769184|155639815|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
48394864|NCT00769184|155639814|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
48394865|NCT00769184|155639815|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
48394866|NCT03775421|155639816|FG000|Overall Study|Lost to Follow-up|2|||
48394867|NCT03775421|155639816|FG000|Overall Study|Withdrawal by Subject|10|||
48394868|NCT03775421|155639816|FG000|Overall Study|Physician Decision|3|||
48394869|NCT03775421|155639816|FG000|Overall Study|Death|1|||
48394870|NCT03775421|155639816|FG000|Overall Study|Study Terminated by Sponsor|94|||
48768707|NCT03551210|156999073|FG000|Overall Study|Absence of visit 4 and 5|1|||
48768708|NCT03551210|156999074|FG001|Overall Study|Absence of visit 4 and 5|0|||
48768709|NCT03551210|156999073|FG000|Overall Study|No drug for dispensing|0|||
48768710|NCT03551210|156999074|FG001|Overall Study|No drug for dispensing|1|||
48768711|NCT02382016|157000435|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
48768712|NCT02382016|157000436|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
48768713|NCT02382016|157000435|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
48768714|NCT02382016|157000436|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
48768715|NCT02382016|157000435|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
48768716|NCT02382016|157000436|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
48768717|NCT02382016|157000435|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
48768718|NCT02382016|157000436|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
48768719|NCT02382016|157000435|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
48768720|NCT02382016|157000436|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
48768721|NCT02382016|157000435|FG000|Open-label (OL) Treatment Period|Death|4|||
48768722|NCT02382016|157000436|FG001|Open-label (OL) Treatment Period|Death|0|||
48768723|NCT02382016|157000435|FG000|OL Extension Period|Physician Decision|3|||
48768724|NCT02382016|157000436|FG001|OL Extension Period|Physician Decision|0|||
48768725|NCT02382016|157000435|FG000|OL Extension Period|Death|2|||
48768726|NCT02382016|157000436|FG001|OL Extension Period|Death|0|||
48768727|NCT02382016|157000435|FG000|OL Extension Period|Withdrawal by Subject|1|||
48768728|NCT02382016|157000436|FG001|OL Extension Period|Withdrawal by Subject|0|||
48768729|NCT03034954|157000439|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
48768730|NCT03034954|157000440|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
48768731|NCT03925324|157000443|FG000|Overall Study|Death|1|||
48768732|NCT03925324|157000444|FG001|Overall Study|Death|1|||
48768733|NCT00794196|157000445|FG000|Overall Study|Lost to Follow-up|5|||
48768734|NCT00794196|157000446|FG001|Overall Study|Lost to Follow-up|23|||
48768735|NCT01077960|157000447|FG000|Overall Study|Adverse Event|6|||
48768736|NCT01077960|157000447|FG000|Overall Study|Protocol Violation|3|||
48768737|NCT01077960|157000447|FG000|Overall Study|Lost to Follow-up|5|||
48768738|NCT01077960|157000447|FG000|Overall Study|Subject decision|1|||
48768739|NCT01077960|157000447|FG000|Overall Study|Reason unspecified|1|||
48768740|NCT04753164|157000448|FG000|Overall Study|Adverse Event|0|||
48768741|NCT04753164|157000449|FG001|Overall Study|Adverse Event|2|||
48768742|NCT04753164|157000448|FG000|Overall Study|Withdrawal by Subject|9|||
48768743|NCT04753164|157000449|FG001|Overall Study|Withdrawal by Subject|7|||
48768744|NCT04753164|157000448|FG000|Overall Study|Lost to Follow-up|6|||
48768745|NCT04753164|157000449|FG001|Overall Study|Lost to Follow-up|6|||
48768746|NCT04753164|157000448|FG000|Overall Study|Other|12|||
48768747|NCT04753164|157000449|FG001|Overall Study|Other|5|||
48768748|NCT00907374|157000459|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
48768749|NCT00907374|157000460|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
48768750|NCT00439556|157000461|FG000|Overall Study|Patient was taken off study for non-comp|0|||
48768751|NCT00439556|157000462|FG001|Overall Study|Patient was taken off study for non-comp|1|||
48768752|NCT00439556|157000463|FG002|Overall Study|Patient was taken off study for non-comp|0|||
48768753|NCT03818516|157000464|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
48768754|NCT02703636|157000465|FG000|Overall Study|Adverse Event|14|||
48768755|NCT02703636|157000465|FG000|Overall Study|Study stopped by sponsor|1|||
48768756|NCT02703636|157000465|FG000|Overall Study|Withdrawal by Subject|1|||
48768757|NCT01465464|157000472|FG000|Overall Study|Adverse Event|96|||
48394871|NCT00517829|155639817|FG000|Overall Study|Adverse Event|22|||
48768758|NCT01465464|157000473|FG001|Overall Study|Adverse Event|49|||
48768759|NCT01465464|157000472|FG000|Overall Study|Lack of Efficacy|139|||
48768760|NCT01465464|157000473|FG001|Overall Study|Lack of Efficacy|190|||
48768761|NCT01465464|157000472|FG000|Overall Study|Physician Decision|13|||
48768762|NCT01465464|157000473|FG001|Overall Study|Physician Decision|5|||
48394872|NCT00517829|155639818|FG001|Overall Study|Adverse Event|34|||
48768763|NCT01465464|157000472|FG000|Overall Study|Protocol Violation|1|||
48768764|NCT01465464|157000473|FG001|Overall Study|Protocol Violation|1|||
48768765|NCT01465464|157000472|FG000|Overall Study|Withdrawal by Subject|46|||
48394873|NCT00517829|155639817|FG000|Overall Study|Disease Progression|39|||
48768766|NCT01465464|157000473|FG001|Overall Study|Withdrawal by Subject|30|||
48768767|NCT01465464|157000472|FG000|Overall Study|Other|9|||
48768768|NCT01465464|157000473|FG001|Overall Study|Other|3|||
48768769|NCT01465464|157000472|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
48768770|NCT01465464|157000473|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
48768771|NCT02907359|157000476|FG000|Overall Study|Death|234|||
48768772|NCT02907359|157000477|FG001|Overall Study|Death|117|||
48768773|NCT02907359|157000476|FG000|Overall Study|Withdrawal by Subject|6|||
48768774|NCT02907359|157000477|FG001|Overall Study|Withdrawal by Subject|11|||
48768775|NCT02907359|157000476|FG000|Overall Study|Lost to Follow-up|1|||
48768776|NCT02907359|157000477|FG001|Overall Study|Lost to Follow-up|0|||
48768777|NCT05091528|157000478|FG000|Overall Study|Study Termination by Sponsor|0|||
48768778|NCT05091528|157000479|FG001|Overall Study|Study Termination by Sponsor|1|||
48768779|NCT05091528|157000480|FG002|Overall Study|Study Termination by Sponsor|0|||
48768780|NCT05091528|157000481|FG003|Overall Study|Study Termination by Sponsor|1|||
48768781|NCT03742141|157000482|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
48768782|NCT00058825|157000483|FG000|Overall Study|Relapse|9|||
48768783|NCT00058825|157000483|FG000|Overall Study|Progressive Disease|5|||
48768784|NCT00058825|157000483|FG000|Overall Study|Graft Failure|5|||
48768785|NCT00058825|157000483|FG000|Overall Study|Death|3|||
48768786|NCT04371380|157000484|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
48768787|NCT04371380|157000485|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
48768788|NCT04371380|157000486|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
48768789|NCT02376166|157000488|FG000|Overall Study|Adverse Event|1|||
48768790|NCT02376166|157000488|FG000|Overall Study|Discontinued metformin early|2|||
48768791|NCT01640366|157000489|FG000|Overall Study|Withdrawal by Subject|1|||
48768792|NCT01640366|157000489|FG000|Overall Study|Protocol Violation|16|||
48768793|NCT01640366|157000489|FG000|Overall Study|Lost to Follow-up|5|||
48768794|NCT01354496|157000494|FG000|Period 1|Adverse Event|0|||
48768795|NCT01354496|157000495|FG001|Period 1|Adverse Event|0|||
48768796|NCT01354496|157000496|FG002|Period 1|Adverse Event|1|||
48768797|NCT01354496|157000497|FG003|Period 1|Adverse Event|0|||
48768798|NCT01354496|157000498|FG004|Period 1|Adverse Event|0|||
48768799|NCT01354496|157000499|FG005|Period 1|Adverse Event|0|||
48768800|NCT01354496|157000494|FG000|Period 1|Physician Decision|0|||
48768801|NCT01354496|157000495|FG001|Period 1|Physician Decision|0|||
48768802|NCT01354496|157000496|FG002|Period 1|Physician Decision|1|||
48768803|NCT01354496|157000497|FG003|Period 1|Physician Decision|0|||
48768804|NCT01354496|157000498|FG004|Period 1|Physician Decision|0|||
48768805|NCT01354496|157000499|FG005|Period 1|Physician Decision|0|||
48768806|NCT01354496|157000494|FG000|Period 2|Adverse Event|0|||
48768807|NCT01354496|157000495|FG001|Period 2|Adverse Event|0|||
48768808|NCT01354496|157000496|FG002|Period 2|Adverse Event|0|||
48768809|NCT01354496|157000497|FG003|Period 2|Adverse Event|1|||
48768810|NCT01354496|157000498|FG004|Period 2|Adverse Event|0|||
48768811|NCT01354496|157000499|FG005|Period 2|Adverse Event|0|||
48768812|NCT01354496|157000494|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
48768813|NCT01354496|157000495|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
48768814|NCT01354496|157000496|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
48768815|NCT01354496|157000497|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
48768816|NCT01354496|157000498|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
48768817|NCT01354496|157000499|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
48768818|NCT00838565|157000500|FG000|Overall Study|Withdrawal by Subject|0|||
48768819|NCT00838565|157000501|FG001|Overall Study|Withdrawal by Subject|0|||
48768820|NCT00838565|157000502|FG002|Overall Study|Withdrawal by Subject|1|||
48768821|NCT00838565|157000503|FG003|Overall Study|Withdrawal by Subject|0|||
48768822|NCT00838565|157000504|FG004|Overall Study|Withdrawal by Subject|0|||
48768823|NCT00838565|157000505|FG005|Overall Study|Withdrawal by Subject|2|||
48768824|NCT00838565|157000500|FG000|Overall Study|Other|0|||
48768825|NCT00838565|157000501|FG001|Overall Study|Other|2|||
48768826|NCT00838565|157000502|FG002|Overall Study|Other|0|||
48768827|NCT00838565|157000503|FG003|Overall Study|Other|0|||
48768828|NCT00838565|157000504|FG004|Overall Study|Other|0|||
48768829|NCT00838565|157000505|FG005|Overall Study|Other|0|||
48768830|NCT00838565|157000500|FG000|Overall Study|Randomized but not Treated|0|||
48768831|NCT00838565|157000501|FG001|Overall Study|Randomized but not Treated|1|||
48768832|NCT00838565|157000502|FG002|Overall Study|Randomized but not Treated|0|||
48768833|NCT00838565|157000503|FG003|Overall Study|Randomized but not Treated|0|||
48768834|NCT00838565|157000504|FG004|Overall Study|Randomized but not Treated|0|||
48768835|NCT00838565|157000505|FG005|Overall Study|Randomized but not Treated|0|||
48768836|NCT00480779|157000507|FG000|Overall Study|Other|2|||
48768837|NCT00480779|157000508|FG001|Overall Study|Other|0|||
48768838|NCT00480779|157000507|FG000|Overall Study|Job and Health-related|0|||
48768839|NCT00480779|157000508|FG001|Overall Study|Job and Health-related|3|||
48768840|NCT04907032|157000511|FG000|Overall Study|Withdrawal by Subject|7|||
48768841|NCT04907032|157000512|FG001|Overall Study|Withdrawal by Subject|1|||
48768842|NCT00613509|157000515|FG000|Cycle 1|Adverse Event|2|||
48768843|NCT00613509|157000516|FG001|Cycle 1|Adverse Event|1|||
48768844|NCT00613509|157000515|FG000|Cycle 1|Disease Progression|2|||
48768845|NCT00613509|157000516|FG001|Cycle 1|Disease Progression|6|||
48768846|NCT00613509|157000515|FG000|Cycle 1|Unacceptable Toxicity|1|||
48768847|NCT00613509|157000516|FG001|Cycle 1|Unacceptable Toxicity|0|||
48768848|NCT00613509|157000515|FG000|Cycle 1|Other administrative reason|0|||
48768849|NCT00613509|157000516|FG001|Cycle 1|Other administrative reason|1|||
48768850|NCT02563028|157000519|FG000|Overall Study|Lack of equipment|1|||
48768851|NCT02563028|157000519|FG000|Overall Study|Unable to elicit VEP post induction|1|||
48768852|NCT02281552|157000520|FG000|Overall Study|Medication error|1|||
48768853|NCT02281552|157000521|FG001|Overall Study|Medication error|0|||
48768854|NCT02281552|157000520|FG000|Overall Study|Insufficient clinical response|0|||
48768855|NCT02281552|157000521|FG001|Overall Study|Insufficient clinical response|1|||
48768856|NCT02281552|157000520|FG000|Overall Study|Adverse Event|3|||
48768857|NCT02281552|157000521|FG001|Overall Study|Adverse Event|9|||
48768858|NCT01009099|157000522|FG000|Overall Study|Lost to Follow-up|1|||
48768859|NCT01009099|157000523|FG001|Overall Study|Lost to Follow-up|0|||
48768860|NCT01009099|157000522|FG000|Overall Study|Physician Decision|3|||
48768861|NCT01009099|157000523|FG001|Overall Study|Physician Decision|2|||
48768862|NCT01009099|157000522|FG000|Overall Study|Withdrawal by Subject|1|||
48768863|NCT01009099|157000523|FG001|Overall Study|Withdrawal by Subject|1|||
48768864|NCT01009099|157000522|FG000|Overall Study|Death|0|||
48768865|NCT01009099|157000523|FG001|Overall Study|Death|1|||
48768866|NCT03925727|157000527|FG000|Overall Study|Adverse Event|4|||
48768867|NCT03925727|157000528|FG001|Overall Study|Adverse Event|0|||
48768868|NCT03925727|157000529|FG002|Overall Study|Adverse Event|3|||
48768869|NCT03925727|157000527|FG000|Overall Study|Protocol Violation|1|||
48768870|NCT03925727|157000528|FG001|Overall Study|Protocol Violation|2|||
48768871|NCT03925727|157000529|FG002|Overall Study|Protocol Violation|2|||
48768872|NCT03925727|157000527|FG000|Overall Study|Withdrawal by Subject|3|||
48768873|NCT03925727|157000528|FG001|Overall Study|Withdrawal by Subject|2|||
48768874|NCT03925727|157000529|FG002|Overall Study|Withdrawal by Subject|4|||
48768875|NCT03925727|157000527|FG000|Overall Study|Administrative Reasons|3|||
48768876|NCT03925727|157000528|FG001|Overall Study|Administrative Reasons|1|||
48768877|NCT03925727|157000529|FG002|Overall Study|Administrative Reasons|2|||
48768878|NCT03925727|157000527|FG000|Overall Study|Randomized in error or Disqualified|8|||
48768879|NCT03925727|157000528|FG001|Overall Study|Randomized in error or Disqualified|1|||
48768880|NCT03925727|157000529|FG002|Overall Study|Randomized in error or Disqualified|7|||
48768881|NCT01393743|157000530|FG000|Core Study|Adverse Event|5|||
48768882|NCT01393743|157000531|FG001|Core Study|Adverse Event|9|||
48768883|NCT01393743|157000532|FG002|Core Study|Adverse Event|0|||
48768884|NCT01393743|157000530|FG000|Core Study|Lost to Follow-up|1|||
48768885|NCT01393743|157000531|FG001|Core Study|Lost to Follow-up|1|||
48768886|NCT01393743|157000532|FG002|Core Study|Lost to Follow-up|0|||
48768887|NCT01393743|157000530|FG000|Core Study|Participant's Choice|2|||
48768888|NCT01393743|157000531|FG001|Core Study|Participant's Choice|3|||
48768889|NCT01393743|157000532|FG002|Core Study|Participant's Choice|0|||
48768890|NCT01393743|157000530|FG000|Core Study|Inadequate therapeutic effect|2|||
48768891|NCT01393743|157000531|FG001|Core Study|Inadequate therapeutic effect|0|||
48768892|NCT01393743|157000532|FG002|Core Study|Inadequate therapeutic effect|0|||
48768893|NCT01393743|157000530|FG000|Extension Phase|Adverse Event|0|||
48768894|NCT01393743|157000531|FG001|Extension Phase|Adverse Event|0|||
48768895|NCT01393743|157000532|FG002|Extension Phase|Adverse Event|12|||
48768896|NCT01393743|157000530|FG000|Extension Phase|Lost to Follow-up|0|||
48768897|NCT01393743|157000531|FG001|Extension Phase|Lost to Follow-up|0|||
48768898|NCT01393743|157000532|FG002|Extension Phase|Lost to Follow-up|2|||
48768899|NCT01393743|157000530|FG000|Extension Phase|Participant choice|0|||
48768900|NCT01393743|157000531|FG001|Extension Phase|Participant choice|0|||
48768901|NCT01393743|157000532|FG002|Extension Phase|Participant choice|16|||
48768902|NCT01393743|157000530|FG000|Extension Phase|Inadequate therapeutic effect|0|||
48768903|NCT01393743|157000531|FG001|Extension Phase|Inadequate therapeutic effect|0|||
48768904|NCT01393743|157000532|FG002|Extension Phase|Inadequate therapeutic effect|7|||
48768905|NCT01393743|157000530|FG000|Extension Phase|Withdrawal by Subject|0|||
48768906|NCT01393743|157000531|FG001|Extension Phase|Withdrawal by Subject|0|||
48768907|NCT01393743|157000532|FG002|Extension Phase|Withdrawal by Subject|8|||
48768908|NCT01393743|157000530|FG000|Extension Phase|Pregnancy|0|||
48768909|NCT01393743|157000531|FG001|Extension Phase|Pregnancy|0|||
48768910|NCT01393743|157000532|FG002|Extension Phase|Pregnancy|1|||
48768911|NCT01393743|157000530|FG000|Extension Phase|Other|0|||
48768912|NCT01393743|157000531|FG001|Extension Phase|Other|0|||
48768913|NCT01393743|157000532|FG002|Extension Phase|Other|14|||
48768914|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
48768915|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
48768916|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
48768917|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
48768918|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
48768919|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
48768920|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
48768921|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
48768922|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
48768923|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
48768924|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
48768925|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
48768926|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
48768927|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
48768928|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
48768929|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
48768930|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
48768931|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
48768932|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
48768933|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
48768934|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Other|3|||
48768935|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Other|0|||
48768936|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Other|2|||
48768937|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Other|2|||
48768938|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Other|7|||
48768939|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768940|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768941|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768942|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
48768943|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768944|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768945|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768946|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768947|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768948|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
48768949|NCT00213148|157000533|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
48768950|NCT00213148|157000534|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
48768951|NCT00213148|157000535|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
48768952|NCT00213148|157000536|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
48768953|NCT00213148|157000537|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
48768954|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
48768955|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
48768956|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
48768957|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
48768958|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
48768959|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
48768960|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
48768961|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
48768962|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
48768963|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
48768964|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Other|2|||
48768965|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Other|1|||
48768966|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Other|2|||
48768967|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Other|8|||
48768968|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Other|7|||
48768969|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768970|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
48768971|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768972|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768973|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
48768974|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
48768975|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768976|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768977|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768978|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
48768979|NCT00213148|157000533|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
48768980|NCT00213148|157000534|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
48768981|NCT00213148|157000535|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
48394874|NCT00517829|155639818|FG001|Overall Study|Disease Progression|32|||
48394875|NCT00517829|155639817|FG000|Overall Study|Patient Request|6|||
48394876|NCT00517829|155639818|FG001|Overall Study|Patient Request|5|||
48394877|NCT00517829|155639817|FG000|Overall Study|Investigator Request|5|||
48394878|NCT00517829|155639818|FG001|Overall Study|Investigator Request|3|||
48768982|NCT00213148|157000536|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
48768983|NCT00213148|157000537|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
48768984|NCT00213148|157000533|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
48768985|NCT00213148|157000534|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
48768986|NCT00213148|157000535|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
48768987|NCT00213148|157000536|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
48394879|NCT00517829|155639817|FG000|Overall Study|Other|3|||
48768988|NCT00213148|157000537|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
48768989|NCT00213148|157000533|FG000|Cycle 3 (1 Month)|Other|0|||
48394880|NCT00517829|155639818|FG001|Overall Study|Other|1|||
48768990|NCT00213148|157000534|FG001|Cycle 3 (1 Month)|Other|0|||
48768991|NCT00213148|157000535|FG002|Cycle 3 (1 Month)|Other|1|||
48768992|NCT00213148|157000536|FG003|Cycle 3 (1 Month)|Other|1|||
48768993|NCT00213148|157000537|FG004|Cycle 3 (1 Month)|Other|0|||
48768994|NCT00717769|157000538|FG000|Overall Study|Adverse Event|9|||
48768995|NCT00717769|157000539|FG001|Overall Study|Adverse Event|6|||
48768996|NCT00717769|157000540|FG002|Overall Study|Adverse Event|1|||
48768997|NCT00717769|157000538|FG000|Overall Study|Lack of compliance|0|||
48768998|NCT00717769|157000539|FG001|Overall Study|Lack of compliance|2|||
48768999|NCT00717769|157000540|FG002|Overall Study|Lack of compliance|0|||
48769000|NCT00717769|157000538|FG000|Overall Study|Lost to Follow-up|3|||
48769001|NCT00717769|157000539|FG001|Overall Study|Lost to Follow-up|4|||
48769002|NCT00717769|157000540|FG002|Overall Study|Lost to Follow-up|0|||
48769003|NCT00717769|157000538|FG000|Overall Study|Lack of Efficacy|1|||
48769004|NCT00717769|157000539|FG001|Overall Study|Lack of Efficacy|2|||
48769005|NCT00717769|157000540|FG002|Overall Study|Lack of Efficacy|0|||
48769006|NCT00717769|157000538|FG000|Overall Study|Protocol Violation|0|||
48769007|NCT00717769|157000539|FG001|Overall Study|Protocol Violation|2|||
48769008|NCT00717769|157000540|FG002|Overall Study|Protocol Violation|0|||
48769009|NCT00717769|157000538|FG000|Overall Study|Sponsor decision|1|||
48769010|NCT00717769|157000539|FG001|Overall Study|Sponsor decision|0|||
48769011|NCT00717769|157000540|FG002|Overall Study|Sponsor decision|10|||
48769012|NCT00717769|157000538|FG000|Overall Study|Withdrew consent|2|||
48769013|NCT00717769|157000539|FG001|Overall Study|Withdrew consent|2|||
48769014|NCT00717769|157000540|FG002|Overall Study|Withdrew consent|0|||
48769015|NCT01071512|157000552|FG000|Overall Study|Adverse Event|1|||
48769016|NCT01071512|157000552|FG000|Overall Study|Development of antibodies to drug|2|||
48769017|NCT01071512|157000552|FG000|Overall Study|positive anti-JC virus antibody test|2|||
48769018|NCT01541930|157000555|FG000|Overall Study|Withdrawal by Subject|1|||
48769019|NCT00262067|157000556|FG000|Overall Study|Death|190|||
48769020|NCT00262067|157000557|FG001|Overall Study|Death|89|||
48769021|NCT00262067|157000558|FG002|Overall Study|Death|186|||
48769022|NCT00262067|157000559|FG003|Overall Study|Death|99|||
48769023|NCT00262067|157000556|FG000|Overall Study|Lost to Follow-up|5|||
48769024|NCT00262067|157000557|FG001|Overall Study|Lost to Follow-up|4|||
48769025|NCT00262067|157000558|FG002|Overall Study|Lost to Follow-up|7|||
48769026|NCT00262067|157000559|FG003|Overall Study|Lost to Follow-up|5|||
48769027|NCT00262067|157000556|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
48769028|NCT00262067|157000557|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
48769029|NCT00262067|157000558|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
48769030|NCT00262067|157000559|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
48769031|NCT00262067|157000556|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
48769032|NCT00262067|157000557|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
48769033|NCT00262067|157000558|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
48769034|NCT00262067|157000559|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
48769035|NCT00586469|157000563|FG000|Overall Study|Adverse Event|0|||
48769036|NCT00586469|157000564|FG001|Overall Study|Adverse Event|1|||
48769037|NCT01755416|157000567|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
48769038|NCT01755416|157000568|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
48769039|NCT02449239|157001915|FG000|Induction Phase|Lack of Efficacy|64|||
48769040|NCT02449239|157001915|FG000|Induction Phase|Adverse Event|1|||
48769041|NCT02449239|157001915|FG000|Induction Phase|Lost to Follow-up|1|||
48769042|NCT02449239|157001915|FG000|Induction Phase|Protocol Violation|1|||
48769043|NCT02449239|157001915|FG000|Induction Phase|Physician Decision|1|||
48769044|NCT02449239|157001915|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
48769045|NCT02449239|157001915|FG000|Induction Phase|Withdrawal by Subject|1|||
48769046|NCT02449239|157001915|FG000|Maintenance Month 3|Lack of Efficacy|14|||
48769047|NCT02449239|157001915|FG000|Maintenance Month 6|Lack of Efficacy|10|||
48769048|NCT02449239|157001915|FG000|Maintenance Month 6|Adverse Event|2|||
48769049|NCT02449239|157001915|FG000|Maintenance Month 6|Physician Decision|1|||
48769050|NCT02449239|157001915|FG000|Maintenance Month 9|Lack of Efficacy|2|||
48355879|NCT01465763|155498595|FG000|Overall Study|Death|1|||
48769051|NCT02449239|157001915|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
48769052|NCT02449239|157001915|FG000|Maintenance Month 12|Lack of Efficacy|5|||
48769053|NCT02449239|157001915|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
48769054|NCT02449239|157001915|FG000|Maintenance Month 12|Subject moved from area|1|||
48769055|NCT02449239|157001915|FG000|Maintenance Month 15|Lack of Efficacy|1|||
48769056|NCT02449239|157001915|FG000|Maintenance Month 21|Lack of Efficacy|1|||
48769057|NCT02449239|157001915|FG000|Maintenance Month 21|Sponsor decision|1|||
48769058|NCT01275066|157001916|FG000|Overall Study|Withdrawal by Subject|0|||
48769059|NCT01275066|157001917|FG001|Overall Study|Withdrawal by Subject|0|||
48355880|NCT01465763|155498596|FG001|Overall Study|Death|0|||
48769060|NCT01275066|157001918|FG002|Overall Study|Withdrawal by Subject|1|||
48769061|NCT01275066|157001916|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
48769062|NCT01275066|157001917|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
48769063|NCT01275066|157001918|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
48769064|NCT03509675|157001921|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
48769065|NCT03509675|157001922|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
48769066|NCT03509675|157001921|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
48769067|NCT03509675|157001922|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
48769068|NCT03509675|157001921|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
48769069|NCT03509675|157001922|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
48769070|NCT03509675|157001921|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
48769071|NCT03509675|157001922|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
48769072|NCT00326612|157001927|FG000|Overall Study|They did not have a seizure requiring tx|129|||
48769073|NCT00326612|157001928|FG001|Overall Study|They did not have a seizure requiring tx|137|||
48769074|NCT01236755|157001929|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
48769075|NCT01236755|157001929|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
48769076|NCT01236755|157001929|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
48769077|NCT01236755|157001929|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
48769078|NCT00110812|157001930|FG000|Main Study|Death|0|||
48769079|NCT00110812|157001931|FG001|Main Study|Death|0|||
48769080|NCT00110812|157001932|FG002|Main Study|Death|2|||
48769081|NCT00110812|157001930|FG000|Main Study|Withdrawal by Subject|0|||
48769082|NCT00110812|157001931|FG001|Main Study|Withdrawal by Subject|0|||
48769083|NCT00110812|157001932|FG002|Main Study|Withdrawal by Subject|1|||
48769084|NCT00110812|157001930|FG000|Main Study|Lost to Follow-up|8|||
48769085|NCT00110812|157001931|FG001|Main Study|Lost to Follow-up|11|||
48769086|NCT00110812|157001932|FG002|Main Study|Lost to Follow-up|10|||
48769087|NCT00110812|157001930|FG000|Extended Follow-up|Death|1|||
48769088|NCT00110812|157001931|FG001|Extended Follow-up|Death|0|||
48769089|NCT00110812|157001932|FG002|Extended Follow-up|Death|3|||
48769090|NCT00110812|157001930|FG000|Extended Follow-up|Withdrawal by Subject|0|||
48769091|NCT00110812|157001931|FG001|Extended Follow-up|Withdrawal by Subject|1|||
48769092|NCT00110812|157001932|FG002|Extended Follow-up|Withdrawal by Subject|0|||
48769093|NCT00110812|157001930|FG000|Extended Follow-up|Lost to Follow-up|1|||
48769094|NCT00110812|157001931|FG001|Extended Follow-up|Lost to Follow-up|3|||
48769095|NCT00110812|157001932|FG002|Extended Follow-up|Lost to Follow-up|1|||
48769096|NCT01933048|157001933|FG000|Overall Study|Lost to Follow-up|15|||
48769097|NCT01933048|157001934|FG001|Overall Study|Lost to Follow-up|18|||
48769098|NCT01933048|157001933|FG000|Overall Study|personal reasons|1|||
48769099|NCT01933048|157001934|FG001|Overall Study|personal reasons|1|||
48769100|NCT01933048|157001933|FG000|Overall Study|Protocol Violation|7|||
48769101|NCT01933048|157001934|FG001|Overall Study|Protocol Violation|8|||
48769102|NCT01933048|157001933|FG000|Overall Study|Physician Decision|1|||
48769103|NCT01933048|157001934|FG001|Overall Study|Physician Decision|0|||
48769104|NCT01933048|157001933|FG000|Overall Study|unknown reasons|1|||
48769105|NCT01933048|157001934|FG001|Overall Study|unknown reasons|1|||
48769106|NCT01454726|157001937|FG000|Overall Study|Withdrawal by Subject|0|||
48769107|NCT01454726|157001938|FG001|Overall Study|Withdrawal by Subject|1|||
48769108|NCT02821962|157001945|FG000|Overall Study|Lost to Follow-up|2|||
48769109|NCT02821962|157001946|FG001|Overall Study|Lost to Follow-up|0|||
48769110|NCT01344447|157001947|FG000|Overall Study|Adverse Event|1|||
48769111|NCT01344447|157001947|FG000|Overall Study|Protocol Violation|1|||
48769112|NCT01344447|157001947|FG000|Overall Study|Withdrawal by Subject|1|||
48769113|NCT01344447|157001947|FG000|Overall Study|The contrast was not seen|1|||
48769114|NCT01344447|157001947|FG000|Overall Study|Physician Decision|1|||
48769115|NCT01344447|157001947|FG000|Overall Study|MRA unsuccessful|1|||
48769116|NCT01344447|157001947|FG000|Overall Study|Bolus tracking failed|1|||
48769117|NCT01344447|157001947|FG000|Overall Study|Error of power injector|1|||
48769118|NCT00355238|157001951|FG000|Overall Study|Adverse event unrelated to study drug|2|||
48769119|NCT00355238|157001952|FG001|Overall Study|Adverse event unrelated to study drug|2|||
48769120|NCT00355238|157001953|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48769121|NCT00355238|157001954|FG003|Overall Study|Adverse event unrelated to study drug|1|||
48769122|NCT00355238|157001951|FG000|Overall Study|Death|1|||
48769123|NCT00355238|157001952|FG001|Overall Study|Death|0|||
48769124|NCT00355238|157001953|FG002|Overall Study|Death|0|||
48769125|NCT00355238|157001954|FG003|Overall Study|Death|0|||
48769126|NCT00355238|157001951|FG000|Overall Study|Disease progression|37|||
48769127|NCT00355238|157001952|FG001|Overall Study|Disease progression|36|||
48769128|NCT00355238|157001953|FG002|Overall Study|Disease progression|16|||
48355881|NCT01465763|155498597|FG002|Overall Study|Death|0|||
48769129|NCT00355238|157001954|FG003|Overall Study|Disease progression|11|||
48769130|NCT00355238|157001951|FG000|Overall Study|Study drug toxicity|11|||
48769131|NCT00355238|157001952|FG001|Overall Study|Study drug toxicity|7|||
48769132|NCT00355238|157001953|FG002|Overall Study|Study drug toxicity|5|||
48769133|NCT00355238|157001954|FG003|Overall Study|Study drug toxicity|2|||
48430333|NCT00696657|155763705|FG005|Overall Study|Protocol Violation|1|||
48769134|NCT00355238|157001951|FG000|Overall Study|Participant withdrew consent|3|||
48769135|NCT00355238|157001952|FG001|Overall Study|Participant withdrew consent|1|||
48769136|NCT00355238|157001953|FG002|Overall Study|Participant withdrew consent|0|||
48769137|NCT00355238|157001954|FG003|Overall Study|Participant withdrew consent|0|||
48769138|NCT00355238|157001951|FG000|Overall Study|Participant request to discontinue study treatment|1|||
48769139|NCT00355238|157001952|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48769140|NCT00355238|157001953|FG002|Overall Study|Participant request to discontinue study treatment|1|||
48769141|NCT00355238|157001954|FG003|Overall Study|Participant request to discontinue study treatment|0|||
48394881|NCT00385255|155639819|FG000|Overall Study|Serious Adverse Event|1|||
48394882|NCT00385255|155639820|FG001|Overall Study|Serious Adverse Event|2|||
48394883|NCT00385255|155639819|FG000|Overall Study|Protocol Violation|0|||
48394884|NCT00385255|155639820|FG001|Overall Study|Protocol Violation|4|||
48394885|NCT00385255|155639819|FG000|Overall Study|Withdrawal by Subject|0|||
48394886|NCT00385255|155639820|FG001|Overall Study|Withdrawal by Subject|8|||
48394887|NCT00385255|155639819|FG000|Overall Study|Migrated/moved from study area|0|||
48394888|NCT00385255|155639820|FG001|Overall Study|Migrated/moved from study area|1|||
48394889|NCT00385255|155639819|FG000|Overall Study|Lost to Follow-up|20|||
48394890|NCT00385255|155639820|FG001|Overall Study|Lost to Follow-up|58|||
48394891|NCT02443883|155639821|FG000|Overall Study|Adverse Event|0|||
48394892|NCT02443883|155639822|FG001|Overall Study|Adverse Event|1|||
48394893|NCT02443883|155639823|FG002|Overall Study|Adverse Event|0|||
48394894|NCT02443883|155639824|FG003|Overall Study|Adverse Event|0|||
48394895|NCT02443883|155639821|FG000|Overall Study|Lost to Follow-up|3|||
48769142|NCT00749775|157001960|FG000|Overall Study|Protocol Violation|24|||
48769143|NCT00749775|157001960|FG000|Overall Study|Lost to Follow-up|36|||
48769144|NCT00749775|157001960|FG000|Overall Study|No visit after first day of treatment|44|||
48769145|NCT00749775|157001960|FG000|Overall Study|No drug administration|3|||
48769146|NCT01714310|157001967|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
48769147|NCT01714310|157001968|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
48769148|NCT01714310|157001969|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
48769149|NCT01714310|157001967|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
48769150|NCT01714310|157001968|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
48769151|NCT01714310|157001969|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
48769152|NCT01714310|157001967|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
48769153|NCT01714310|157001968|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
48769154|NCT01714310|157001969|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
48769155|NCT01714310|157001967|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
48769156|NCT01714310|157001968|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
48769157|NCT01714310|157001969|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
48769158|NCT00908960|157001972|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
48769159|NCT00908960|157001973|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
48769160|NCT00908960|157001974|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
48769161|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
48769162|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
48769163|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Graft loss|1|||
48769164|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Graft loss|2|||
48769165|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Death|5|||
48769166|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Death|3|||
48769167|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
48769168|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
48769169|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
48769170|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
48769171|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
48769172|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
48769173|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
48769174|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
48769175|NCT00378014|157001975|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
48769176|NCT00378014|157001976|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
48769177|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
48769178|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
48769179|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Death|1|||
48769180|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Death|2|||
48769181|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
48769182|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
48769183|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
48769184|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
48394896|NCT02443883|155639822|FG001|Overall Study|Lost to Follow-up|2|||
48394897|NCT02443883|155639823|FG002|Overall Study|Lost to Follow-up|1|||
48394898|NCT02443883|155639824|FG003|Overall Study|Lost to Follow-up|0|||
48769185|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
48769186|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
48769187|NCT00378014|157001975|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
48769188|NCT00378014|157001976|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
48769189|NCT02777125|157001982|FG000|Overall Study|Consent form violation|14|||
48769190|NCT02777125|157001983|FG001|Overall Study|Consent form violation|12|||
48769191|NCT02777125|157001982|FG000|Overall Study|Assent form violation|21|||
48769192|NCT02777125|157001983|FG001|Overall Study|Assent form violation|23|||
48769193|NCT02777125|157001982|FG000|Overall Study|Protocol Violation|8|||
48769194|NCT02777125|157001983|FG001|Overall Study|Protocol Violation|12|||
48769195|NCT01828034|157001984|FG000|Overall Study|Withdrawal by Subject|0|||
48769196|NCT01828034|157001985|FG001|Overall Study|Withdrawal by Subject|0|||
48769197|NCT01828034|157001986|FG002|Overall Study|Withdrawal by Subject|0|||
48769198|NCT01828034|157001987|FG003|Overall Study|Withdrawal by Subject|1|||
48769199|NCT00499603|157001989|FG000|Overall Study|Adverse Event|0|||
48769200|NCT00499603|157001990|FG001|Overall Study|Adverse Event|1|||
48769201|NCT01639040|157001993|FG000|Overall Study|Adverse Event|1|||
48769202|NCT01639040|157001994|FG001|Overall Study|Adverse Event|0|||
48769203|NCT04238728|157001999|FG000|Overall Study|Withdrawal by Subject|1|||
48769204|NCT04238728|157001999|FG000|Overall Study|Lost to Follow-up|2|||
48769205|NCT04382911|157002000|FG000|Overall Study|unable to be imaged prior to surgery|2|||
48769206|NCT00974571|157002005|FG000|Overall Study|Adverse Event|31|||
48769207|NCT00974571|157002006|FG001|Overall Study|Adverse Event|4|||
48769208|NCT00974571|157002007|FG002|Overall Study|Adverse Event|27|||
48769209|NCT00974571|157002005|FG000|Overall Study|Lack of Efficacy|3|||
48769210|NCT00974571|157002006|FG001|Overall Study|Lack of Efficacy|2|||
48769211|NCT00974571|157002007|FG002|Overall Study|Lack of Efficacy|9|||
48769212|NCT00974571|157002005|FG000|Overall Study|Lost to Follow-up|2|||
48769213|NCT00974571|157002006|FG001|Overall Study|Lost to Follow-up|1|||
48769214|NCT00974571|157002007|FG002|Overall Study|Lost to Follow-up|2|||
48769215|NCT00974571|157002005|FG000|Overall Study|Protocol Violation|13|||
48769216|NCT00974571|157002006|FG001|Overall Study|Protocol Violation|4|||
48769217|NCT00974571|157002007|FG002|Overall Study|Protocol Violation|18|||
48769218|NCT00974571|157002005|FG000|Overall Study|Withdrawal by Subject|14|||
48769219|NCT00974571|157002006|FG001|Overall Study|Withdrawal by Subject|5|||
48769220|NCT00974571|157002007|FG002|Overall Study|Withdrawal by Subject|16|||
48769221|NCT00974571|157002005|FG000|Overall Study|Patient Moved|1|||
48769222|NCT00974571|157002006|FG001|Overall Study|Patient Moved|0|||
48769223|NCT00974571|157002007|FG002|Overall Study|Patient Moved|1|||
48769224|NCT00974571|157002005|FG000|Overall Study|Other|4|||
48769225|NCT00974571|157002006|FG001|Overall Study|Other|0|||
48769226|NCT00974571|157002007|FG002|Overall Study|Other|10|||
48769227|NCT01183975|157002010|FG000|Overall Study|Lost to Follow-up|73|||
48769228|NCT00376168|157002011|FG000|Overall Study|Adverse Event|1|||
48769229|NCT00376168|157002012|FG001|Overall Study|Adverse Event|1|||
48769230|NCT00376168|157002011|FG000|Overall Study|Pregnancy|1|||
48769231|NCT00376168|157002012|FG001|Overall Study|Pregnancy|0|||
48769232|NCT02722928|157002013|FG000|Overall Study|Standard CT was not as required per prot|5|||
48769233|NCT02722928|157002014|FG001|Overall Study|Standard CT was not as required per prot|13|||
48769234|NCT02722928|157002013|FG000|Overall Study|Required Intraoperative MRI|5|||
48769235|NCT02722928|157002014|FG001|Overall Study|Required Intraoperative MRI|7|||
48769236|NCT00515827|157002015|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
48769237|NCT00515827|157002016|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
48769238|NCT00515827|157002015|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
48769239|NCT00515827|157002016|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
48769240|NCT02253810|157002020|FG000|Overall Study|Withdrawal by Subject|2|||
48769241|NCT02253810|157002021|FG001|Overall Study|Withdrawal by Subject|1|||
48769242|NCT02253810|157002020|FG000|Overall Study|Unknown concomitant procedure|3|||
48769243|NCT02253810|157002021|FG001|Overall Study|Unknown concomitant procedure|2|||
48769244|NCT01339390|157002022|FG000|Overall Study|Death|32|||
48769245|NCT01339390|157002023|FG001|Overall Study|Death|29|||
48769246|NCT01339390|157002022|FG000|Overall Study|Lost to Follow-up|125|||
48769247|NCT01339390|157002023|FG001|Overall Study|Lost to Follow-up|127|||
48769248|NCT03254134|157002024|FG000|Overall Study|Not eligible patients|599|||
48769249|NCT03254134|157002025|FG001|Overall Study|Not eligible patients|3630|||
48769250|NCT01224639|157002039|FG000|Overall Study|Withdrawal by Subject|0|||
48769251|NCT01224639|157002040|FG001|Overall Study|Withdrawal by Subject|0|||
48769252|NCT01224639|157002041|FG002|Overall Study|Withdrawal by Subject|0|||
48769253|NCT01224639|157002042|FG003|Overall Study|Withdrawal by Subject|0|||
48769254|NCT01224639|157002043|FG004|Overall Study|Withdrawal by Subject|2|||
48769255|NCT01224639|157002044|FG005|Overall Study|Withdrawal by Subject|0|||
48769256|NCT01224639|157002045|FG006|Overall Study|Withdrawal by Subject|1|||
48769257|NCT01224639|157002046|FG007|Overall Study|Withdrawal by Subject|1|||
48769258|NCT01224639|157002039|FG000|Overall Study|Adverse Event|0|||
48769259|NCT01224639|157002040|FG001|Overall Study|Adverse Event|0|||
48769260|NCT01224639|157002041|FG002|Overall Study|Adverse Event|0|||
48769261|NCT01224639|157002042|FG003|Overall Study|Adverse Event|0|||
48769262|NCT01224639|157002043|FG004|Overall Study|Adverse Event|0|||
48769263|NCT01224639|157002044|FG005|Overall Study|Adverse Event|0|||
48394899|NCT02443883|155639821|FG000|Overall Study|Physician Decision|1|||
48394900|NCT02443883|155639822|FG001|Overall Study|Physician Decision|1|||
48394901|NCT02443883|155639823|FG002|Overall Study|Physician Decision|0|||
48394902|NCT02443883|155639824|FG003|Overall Study|Physician Decision|3|||
48394903|NCT02443883|155639821|FG000|Overall Study|Withdrawal by Subject|1|||
48394904|NCT02443883|155639822|FG001|Overall Study|Withdrawal by Subject|0|||
48394905|NCT02443883|155639823|FG002|Overall Study|Withdrawal by Subject|0|||
48394906|NCT02443883|155639824|FG003|Overall Study|Withdrawal by Subject|2|||
48394907|NCT02443883|155639821|FG000|Overall Study|Randomized, but never treated|1|||
48769264|NCT01224639|157002045|FG006|Overall Study|Adverse Event|0|||
48769265|NCT01224639|157002046|FG007|Overall Study|Adverse Event|1|||
48769266|NCT02702401|157002049|FG000|Overall Study|Death|242|||
48769267|NCT02702401|157002050|FG001|Overall Study|Death|125|||
48769268|NCT02702401|157002049|FG000|Overall Study|Withdrawal by Subject|15|||
48769269|NCT02702401|157002050|FG001|Overall Study|Withdrawal by Subject|5|||
48769270|NCT02702401|157002049|FG000|Overall Study|Sponsor Decision|19|||
48769271|NCT02702401|157002050|FG001|Overall Study|Sponsor Decision|3|||
48769272|NCT02702401|157002049|FG000|Overall Study|Physician Decision|1|||
48769273|NCT02702401|157002050|FG001|Overall Study|Physician Decision|2|||
48769274|NCT02702401|157002049|FG000|Overall Study|Lost to Follow-up|1|||
48769275|NCT02702401|157002050|FG001|Overall Study|Lost to Follow-up|0|||
48769276|NCT04019041|157002063|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
48769277|NCT04019041|157002064|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
48769278|NCT04019041|157002065|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
48769279|NCT04019041|157002066|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48769280|NCT04019041|157002067|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48769281|NCT04019041|157002068|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48769282|NCT04019041|157002063|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769283|NCT04019041|157002064|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769284|NCT04019041|157002065|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
48769285|NCT04019041|157002066|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769286|NCT04019041|157002067|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769287|NCT04019041|157002068|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
48769288|NCT04019041|157002063|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
48769289|NCT04019041|157002064|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
48769290|NCT04019041|157002065|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
48769291|NCT04019041|157002066|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48769292|NCT04019041|157002067|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48769293|NCT04019041|157002068|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48769294|NCT04019041|157002063|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769295|NCT04019041|157002064|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769296|NCT04019041|157002065|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
48769297|NCT04019041|157002066|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769298|NCT04019041|157002067|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769299|NCT04019041|157002068|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
48769300|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48769301|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48769302|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48769303|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
48769304|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
48769305|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
48769306|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769307|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769308|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769309|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
48769310|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769311|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
48769312|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48769313|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48769314|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48769315|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48769316|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
48769317|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
48394908|NCT02443883|155639822|FG001|Overall Study|Randomized, but never treated|0|||
48394909|NCT02443883|155639823|FG002|Overall Study|Randomized, but never treated|0|||
48769318|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48769319|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48769320|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48430334|NCT00696657|155763706|FG006|Overall Study|Protocol Violation|0|||
48769321|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
48769322|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
48769323|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
48769324|NCT04019041|157002063|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48769325|NCT04019041|157002064|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48769326|NCT04019041|157002065|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48769327|NCT04019041|157002066|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48769328|NCT04019041|157002067|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
48769329|NCT04019041|157002068|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
48769330|NCT04365699|157002069|FG000|Overall Study|Death|2|||
48769331|NCT04365699|157002070|FG001|Overall Study|Death|5|||
48769332|NCT04365699|157002071|FG002|Overall Study|Death|15|||
48769333|NCT04292730|157002073|FG000|Overall Study|Lost to Follow-up|8|||
48769334|NCT04292730|157002074|FG001|Overall Study|Lost to Follow-up|12|||
48769335|NCT04292730|157002075|FG002|Overall Study|Lost to Follow-up|12|||
48769336|NCT04292730|157002076|FG003|Overall Study|Lost to Follow-up|48|||
48769337|NCT04292730|157002073|FG000|Overall Study|Death|2|||
48769338|NCT04292730|157002074|FG001|Overall Study|Death|2|||
48769339|NCT04292730|157002075|FG002|Overall Study|Death|4|||
48769340|NCT04292730|157002076|FG003|Overall Study|Death|12|||
48769341|NCT04292730|157002073|FG000|Overall Study|Withdrew Consent|2|||
48769342|NCT04292730|157002074|FG001|Overall Study|Withdrew Consent|2|||
48769343|NCT04292730|157002075|FG002|Overall Study|Withdrew Consent|5|||
48769344|NCT04292730|157002076|FG003|Overall Study|Withdrew Consent|6|||
48769345|NCT04292730|157002073|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48769346|NCT04292730|157002074|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48769347|NCT04292730|157002075|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48769348|NCT04292730|157002076|FG003|Overall Study|Non-Compliance with Study Drug|0|||
48769349|NCT04292730|157002073|FG000|Overall Study|Protocol Violation|0|||
48769350|NCT04292730|157002074|FG001|Overall Study|Protocol Violation|0|||
48769351|NCT04292730|157002075|FG002|Overall Study|Protocol Violation|1|||
48769352|NCT04292730|157002076|FG003|Overall Study|Protocol Violation|0|||
48769353|NCT04292730|157002073|FG000|Overall Study|Randomized but not Treated|8|||
48769354|NCT04292730|157002074|FG001|Overall Study|Randomized but not Treated|4|||
48769355|NCT04292730|157002075|FG002|Overall Study|Randomized but not Treated|0|||
48769356|NCT04292730|157002076|FG003|Overall Study|Randomized but not Treated|14|||
48769357|NCT01247090|157002078|FG000|Overall Study|Physician Decision|1|||
48769358|NCT01247090|157002079|FG001|Overall Study|Physician Decision|0|||
48769359|NCT01247090|157002080|FG002|Overall Study|Physician Decision|0|||
48769360|NCT01247090|157002078|FG000|Overall Study|Withdrawal by Subject|0|||
48769361|NCT01247090|157002079|FG001|Overall Study|Withdrawal by Subject|1|||
48769362|NCT01247090|157002080|FG002|Overall Study|Withdrawal by Subject|0|||
48769363|NCT01574703|157002083|FG000|Overall Study|Adverse Event|0|||
48769364|NCT01574703|157002084|FG001|Overall Study|Adverse Event|2|||
48769365|NCT01574703|157002085|FG002|Overall Study|Adverse Event|1|||
48769366|NCT01574703|157002086|FG003|Overall Study|Adverse Event|1|||
48769367|NCT01574703|157002083|FG000|Overall Study|Protocol Violation|0|||
48769368|NCT01574703|157002084|FG001|Overall Study|Protocol Violation|0|||
48769369|NCT01574703|157002085|FG002|Overall Study|Protocol Violation|0|||
48769370|NCT01574703|157002086|FG003|Overall Study|Protocol Violation|1|||
48769371|NCT01574703|157002083|FG000|Overall Study|Unspecified Reason|27|||
48769372|NCT01574703|157002084|FG001|Overall Study|Unspecified Reason|15|||
48769373|NCT01574703|157002085|FG002|Overall Study|Unspecified Reason|20|||
48769374|NCT01574703|157002086|FG003|Overall Study|Unspecified Reason|16|||
48769375|NCT01574703|157002083|FG000|Overall Study|Withdrawal by Subject|53|||
48769376|NCT01574703|157002084|FG001|Overall Study|Withdrawal by Subject|52|||
48769377|NCT01574703|157002085|FG002|Overall Study|Withdrawal by Subject|36|||
48769378|NCT01574703|157002086|FG003|Overall Study|Withdrawal by Subject|61|||
48769379|NCT01574703|157002083|FG000|Overall Study|Met Withdrawal Criteria|0|||
48769380|NCT01574703|157002084|FG001|Overall Study|Met Withdrawal Criteria|1|||
48355882|NCT03552523|155498599|FG000|Overall Study|Withdrawal by Subject|1|||
48355883|NCT03552523|155498600|FG001|Overall Study|Withdrawal by Subject|1|||
48355884|NCT01896726|155498601|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
48355885|NCT01896726|155498601|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
48355886|NCT01754753|155498602|FG000|Overall Study|Study close|43|||
48355887|NCT01754753|155498603|FG001|Overall Study|Study close|44|||
48355888|NCT01754753|155498602|FG000|Overall Study|Lost to Follow-up|9|||
48355889|NCT01754753|155498603|FG001|Overall Study|Lost to Follow-up|5|||
48355890|NCT01111240|155498604|FG000|Overall Study|Adverse Event|190|||
48769381|NCT01574703|157002085|FG002|Overall Study|Met Withdrawal Criteria|1|||
48769382|NCT01574703|157002086|FG003|Overall Study|Met Withdrawal Criteria|0|||
48769383|NCT01574703|157002083|FG000|Overall Study|Lost to Follow-up|43|||
48769384|NCT01574703|157002084|FG001|Overall Study|Lost to Follow-up|41|||
48769385|NCT01574703|157002085|FG002|Overall Study|Lost to Follow-up|46|||
48769386|NCT01574703|157002086|FG003|Overall Study|Lost to Follow-up|35|||
48769387|NCT01574703|157002083|FG000|Overall Study|Death|2|||
48769388|NCT01574703|157002084|FG001|Overall Study|Death|1|||
48769389|NCT01574703|157002085|FG002|Overall Study|Death|1|||
48769390|NCT01574703|157002086|FG003|Overall Study|Death|0|||
48769391|NCT01524770|157002087|FG000|First Intervention|Withdrawal by Subject|1|||
48769392|NCT01524770|157002088|FG001|First Intervention|Withdrawal by Subject|0|||
48769393|NCT01524770|157002087|FG000|First Intervention|Adverse Event|1|||
48769394|NCT01524770|157002088|FG001|First Intervention|Adverse Event|1|||
48769395|NCT01524770|157002087|FG000|First Intervention|Protocol Violation|1|||
48769396|NCT01524770|157002088|FG001|First Intervention|Protocol Violation|0|||
48769397|NCT00508742|157002089|FG000|Period 1: Infant Series|Adverse Event|5|||
48769398|NCT00508742|157002090|FG001|Period 1: Infant Series|Adverse Event|4|||
48769399|NCT00508742|157002089|FG000|Period 1: Infant Series|Protocol Violation|1|||
48769400|NCT00508742|157002090|FG001|Period 1: Infant Series|Protocol Violation|0|||
48769401|NCT00508742|157002089|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
48769402|NCT00508742|157002090|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
48394910|NCT02443883|155639824|FG003|Overall Study|Randomized, but never treated|0|||
48769403|NCT00508742|157002089|FG000|Period 1: Infant Series|Physician Decision|1|||
48769404|NCT00508742|157002090|FG001|Period 1: Infant Series|Physician Decision|0|||
48769405|NCT00508742|157002089|FG000|Period 1: Infant Series|Other|4|||
48769406|NCT00508742|157002090|FG001|Period 1: Infant Series|Other|1|||
48769407|NCT00508742|157002089|FG000|Period 2: After Infant Series|Adverse Event|2|||
48769408|NCT00508742|157002090|FG001|Period 2: After Infant Series|Adverse Event|6|||
48769409|NCT00508742|157002089|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
48769410|NCT00508742|157002090|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
48769411|NCT00508742|157002089|FG000|Period 2: After Infant Series|Protocol Violation|1|||
48769412|NCT00508742|157002090|FG001|Period 2: After Infant Series|Protocol Violation|0|||
48769413|NCT00508742|157002089|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
48769414|NCT00508742|157002090|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
48769415|NCT00508742|157002089|FG000|Period 2: After Infant Series|Failed to Return|1|||
48769416|NCT00508742|157002090|FG001|Period 2: After Infant Series|Failed to Return|0|||
48769417|NCT00508742|157002089|FG000|Period 2: After Infant Series|Other|2|||
48769418|NCT00508742|157002090|FG001|Period 2: After Infant Series|Other|1|||
48769419|NCT00508742|157002089|FG000|Period 3: Toddler Dose|Adverse Event|1|||
48769420|NCT00508742|157002090|FG001|Period 3: Toddler Dose|Adverse Event|0|||
48769421|NCT00508742|157002089|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
48769422|NCT00508742|157002090|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
48769423|NCT00508742|157002089|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
48769424|NCT00508742|157002090|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
48769425|NCT00508742|157002089|FG000|Period 3: Toddler Dose|Other|5|||
48769426|NCT00508742|157002090|FG001|Period 3: Toddler Dose|Other|4|||
48769427|NCT01574352|157002094|FG000|Overall Study|Withdrawal by Subject|6|||
48769428|NCT01574352|157002095|FG001|Overall Study|Withdrawal by Subject|13|||
48769429|NCT01574352|157002094|FG000|Overall Study|Injury in non-camp related sport|1|||
48769430|NCT01574352|157002095|FG001|Overall Study|Injury in non-camp related sport|0|||
48769431|NCT00528528|157002101|FG000|Overall Study|Lost to Follow-up|0|||
48769432|NCT00528528|157002102|FG001|Overall Study|Lost to Follow-up|0|||
48769433|NCT00528528|157002103|FG002|Overall Study|Lost to Follow-up|1|||
48769434|NCT00528528|157002104|FG003|Overall Study|Lost to Follow-up|1|||
48769435|NCT00528528|157002101|FG000|Overall Study|Ineligible to continue the trial|0|||
48769436|NCT00528528|157002102|FG001|Overall Study|Ineligible to continue the trial|0|||
48769437|NCT00528528|157002103|FG002|Overall Study|Ineligible to continue the trial|0|||
48769438|NCT00528528|157002104|FG003|Overall Study|Ineligible to continue the trial|1|||
48769439|NCT00528528|157002101|FG000|Overall Study|Other|0|||
48769440|NCT00528528|157002102|FG001|Overall Study|Other|1|||
48769441|NCT00528528|157002103|FG002|Overall Study|Other|0|||
48769442|NCT00528528|157002104|FG003|Overall Study|Other|0|||
48769443|NCT00528528|157002101|FG000|Overall Study|Withdrawal by Subject|3|||
48769444|NCT00528528|157002102|FG001|Overall Study|Withdrawal by Subject|2|||
48769445|NCT00528528|157002103|FG002|Overall Study|Withdrawal by Subject|1|||
48769446|NCT00528528|157002104|FG003|Overall Study|Withdrawal by Subject|1|||
48769447|NCT00528528|157002101|FG000|Overall Study|Ongoing participant|0|||
48769448|NCT00528528|157002102|FG001|Overall Study|Ongoing participant|0|||
48769449|NCT00528528|157002103|FG002|Overall Study|Ongoing participant|1|||
48769450|NCT00528528|157002104|FG003|Overall Study|Ongoing participant|0|||
48769451|NCT01545817|157003894|FG000|Pazopanib|Disease progression|51|||
48769452|NCT01545817|157003895|FG001|Pazopanib|Disease progression|0|||
48769453|NCT01545817|157003894|FG000|Pazopanib|Adverse Event|19|||
48769454|NCT01545817|157003895|FG001|Pazopanib|Adverse Event|0|||
48769455|NCT01545817|157003894|FG000|Pazopanib|Other reason|4|||
48769456|NCT01545817|157003895|FG001|Pazopanib|Other reason|0|||
48769457|NCT01545817|157003894|FG000|Everolimus|Other reason|0|||
48769458|NCT01545817|157003895|FG001|Everolimus|Other reason|7|||
48769459|NCT01545817|157003894|FG000|Everolimus|Disease progression|0|||
48769460|NCT01545817|157003895|FG001|Everolimus|Disease progression|25|||
48769461|NCT01545817|157003894|FG000|Everolimus|Adverse Event|0|||
48769462|NCT01545817|157003895|FG001|Everolimus|Adverse Event|6|||
48769463|NCT03252522|157003899|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
48769464|NCT03252522|157003900|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
48769465|NCT03252522|157003901|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
48769466|NCT03252522|157003899|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
48769467|NCT03252522|157003900|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
48769468|NCT03252522|157003901|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
48769469|NCT03252522|157003899|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
48769470|NCT03252522|157003900|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
48769471|NCT03252522|157003901|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
48769472|NCT03252522|157003899|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
48769473|NCT03252522|157003900|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
48769474|NCT03252522|157003901|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
48769475|NCT03252522|157003899|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
48769476|NCT03252522|157003900|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
48769477|NCT03252522|157003901|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
48769478|NCT03252522|157003899|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
48769479|NCT03252522|157003900|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
48769480|NCT03252522|157003901|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
48769481|NCT03252522|157003899|FG000|Phase 2: Open Label|Adverse Event|0|||
48769482|NCT03252522|157003900|FG001|Phase 2: Open Label|Adverse Event|0|||
48769483|NCT03252522|157003901|FG002|Phase 2: Open Label|Adverse Event|2|||
48769484|NCT03252522|157003899|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
48769485|NCT03252522|157003900|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
48769486|NCT03252522|157003901|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
48769487|NCT02239536|157003903|FG000|Overall Study|Non-neoplastic polyp|23|||
48769488|NCT02239536|157003904|FG001|Overall Study|Non-neoplastic polyp|17|||
48769489|NCT00838201|157003905|FG000|Overall Study|Investigator decision, or other reasons|2|||
48769490|NCT00838201|157003906|FG001|Overall Study|Investigator decision, or other reasons|3|||
48769491|NCT00838201|157003905|FG000|Overall Study|Noncompliance|0|||
48769492|NCT00838201|157003906|FG001|Overall Study|Noncompliance|1|||
48769493|NCT00838201|157003905|FG000|Overall Study|Administrative decision|1|||
48769494|NCT00838201|157003906|FG001|Overall Study|Administrative decision|2|||
48769495|NCT00838201|157003905|FG000|Overall Study|Disease progression|3|||
48769496|NCT00838201|157003906|FG001|Overall Study|Disease progression|3|||
48769497|NCT00838201|157003905|FG000|Overall Study|Consent withdrawn|16|||
48769498|NCT00838201|157003906|FG001|Overall Study|Consent withdrawn|19|||
48769499|NCT00838201|157003905|FG000|Overall Study|Lost to Follow-up|4|||
48769500|NCT00838201|157003906|FG001|Overall Study|Lost to Follow-up|3|||
48769501|NCT00838201|157003905|FG000|Overall Study|Adverse Event|5|||
48769502|NCT00838201|157003906|FG001|Overall Study|Adverse Event|9|||
48769503|NCT00838201|157003905|FG000|Overall Study|Death|11|||
48769504|NCT00838201|157003906|FG001|Overall Study|Death|13|||
48769505|NCT01140477|157003907|FG000|Overall Study|Lost to Follow-up|4|||
48769506|NCT01140477|157003908|FG001|Overall Study|Lost to Follow-up|0|||
48769507|NCT01140477|157003907|FG000|Overall Study|Withdrawal by Subject|1|||
48769508|NCT01140477|157003908|FG001|Overall Study|Withdrawal by Subject|4|||
48394911|NCT02228590|155639839|FG000|Overall Study|Withdrawal by Subject|1|||
48394912|NCT01445951|155639840|FG000|Overall Study|Adverse Event|16|||
48769509|NCT01140477|157003907|FG000|Overall Study|Surgical complication preventing implant|2|||
48769510|NCT01140477|157003908|FG001|Overall Study|Surgical complication preventing implant|0|||
48769511|NCT01140477|157003907|FG000|Overall Study|Death|1|||
48769512|NCT01140477|157003908|FG001|Overall Study|Death|1|||
48769513|NCT01140477|157003907|FG000|Overall Study|Subject explanted|0|||
48769514|NCT01140477|157003908|FG001|Overall Study|Subject explanted|1|||
48769515|NCT05439603|157003923|FG000|Overall Study|met withdrawal criteria|2|||
48769516|NCT01945489|157003924|FG000|Cycle 1|Adverse Event|2|||
48769517|NCT01945489|157003925|FG001|Cycle 1|Adverse Event|0|||
48769518|NCT01945489|157003924|FG000|Cycle 1|Lost to Follow-up|4|||
48769519|NCT01945489|157003925|FG001|Cycle 1|Lost to Follow-up|0|||
48769520|NCT01945489|157003924|FG000|Cycle 1|Personal Reasons|4|||
48769521|NCT01945489|157003925|FG001|Cycle 1|Personal Reasons|2|||
48769522|NCT01945489|157003924|FG000|Cycle 1|Protocol Violation|0|||
48769523|NCT01945489|157003925|FG001|Cycle 1|Protocol Violation|1|||
48769524|NCT01945489|157003924|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
48769525|NCT01945489|157003925|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
48769526|NCT01945489|157003924|FG000|Cycle 2|Adverse Event|1|||
48769527|NCT01945489|157003925|FG001|Cycle 2|Adverse Event|0|||
48769528|NCT01945489|157003924|FG000|Cycle 2|Lost to Follow-up|0|||
48769529|NCT01945489|157003925|FG001|Cycle 2|Lost to Follow-up|1|||
48769530|NCT00358527|157003929|FG000|Overall Study|Adverse Event|4|||
48769531|NCT00358527|157003930|FG001|Overall Study|Adverse Event|0|||
48769532|NCT00358527|157003929|FG000|Overall Study|Withdrawal by Subject|1|||
48769533|NCT00358527|157003930|FG001|Overall Study|Withdrawal by Subject|1|||
48769534|NCT00358527|157003929|FG000|Overall Study|Non-compliance with protocol|6|||
48394913|NCT01445951|155639841|FG001|Overall Study|Adverse Event|9|||
48769535|NCT00358527|157003930|FG001|Overall Study|Non-compliance with protocol|1|||
48769536|NCT00358527|157003929|FG000|Overall Study|Administrative|2|||
48769537|NCT00358527|157003930|FG001|Overall Study|Administrative|1|||
48769538|NCT04144166|157003931|FG000|Overall Study|Discharged before study start|1|||
48769539|NCT04144166|157003931|FG000|Overall Study|Pregnancy|1|||
48769540|NCT04144166|157003931|FG000|Overall Study|Nail polish could not be removed from finger|1|||
48769541|NCT00749463|157003932|FG000|Overall Study|Adverse Event|0|||
48769542|NCT00749463|157003933|FG001|Overall Study|Adverse Event|4|||
48769543|NCT00749463|157003934|FG002|Overall Study|Adverse Event|1|||
48769544|NCT00749463|157003932|FG000|Overall Study|Withdrawal by Subject|1|||
48769545|NCT00749463|157003933|FG001|Overall Study|Withdrawal by Subject|0|||
48769546|NCT00749463|157003934|FG002|Overall Study|Withdrawal by Subject|0|||
48769547|NCT00697346|157003943|FG000|Overall Study|Adverse Event|4|||
48769548|NCT00697346|157003944|FG001|Overall Study|Adverse Event|5|||
48769549|NCT00697346|157003945|FG002|Overall Study|Adverse Event|0|||
48769550|NCT00697346|157003943|FG000|Overall Study|Progressive Disease|19|||
48769551|NCT00697346|157003944|FG001|Overall Study|Progressive Disease|18|||
48769552|NCT00697346|157003945|FG002|Overall Study|Progressive Disease|0|||
48769553|NCT00697346|157003943|FG000|Overall Study|Symptomatic Deterioration|0|||
48769554|NCT00697346|157003944|FG001|Overall Study|Symptomatic Deterioration|1|||
48769555|NCT00697346|157003945|FG002|Overall Study|Symptomatic Deterioration|0|||
48769556|NCT00697346|157003943|FG000|Overall Study|Withdrawal by Subject|2|||
48769557|NCT00697346|157003944|FG001|Overall Study|Withdrawal by Subject|2|||
48769558|NCT00697346|157003945|FG002|Overall Study|Withdrawal by Subject|0|||
48769559|NCT00697346|157003943|FG000|Overall Study|Reason not Specified|3|||
48769560|NCT00697346|157003944|FG001|Overall Study|Reason not Specified|0|||
48769561|NCT00697346|157003945|FG002|Overall Study|Reason not Specified|1|||
48769562|NCT03643562|157003946|FG000|Overall Study|Adverse Event|1|||
48769563|NCT03643562|157003947|FG001|Overall Study|Adverse Event|0|||
48769564|NCT03643562|157003946|FG000|Overall Study|Lack of Efficacy|0|||
48769565|NCT03643562|157003947|FG001|Overall Study|Lack of Efficacy|1|||
48769566|NCT03643562|157003946|FG000|Overall Study|Physician Decision|0|||
48769567|NCT03643562|157003947|FG001|Overall Study|Physician Decision|1|||
48769568|NCT03643562|157003946|FG000|Overall Study|Study Terminated by Sponsor|2|||
48769569|NCT03643562|157003947|FG001|Overall Study|Study Terminated by Sponsor|10|||
48769570|NCT03643562|157003946|FG000|Overall Study|Withdrawal by Subject|2|||
48769571|NCT03643562|157003947|FG001|Overall Study|Withdrawal by Subject|2|||
48769572|NCT03643562|157003946|FG000|Overall Study|Other than specified|3|||
48769573|NCT03643562|157003947|FG001|Overall Study|Other than specified|2|||
48769574|NCT00419562|157003949|FG000|Overall Study|Lost to Follow-up|12|||
48769575|NCT00419562|157003950|FG001|Overall Study|Lost to Follow-up|13|||
48769576|NCT00419562|157003949|FG000|Overall Study|Withdrawal by Subject|20|||
48769577|NCT00419562|157003950|FG001|Overall Study|Withdrawal by Subject|18|||
48769578|NCT00419562|157003949|FG000|Overall Study|Participant Institutionalized|1|||
48769579|NCT00419562|157003950|FG001|Overall Study|Participant Institutionalized|0|||
48769580|NCT01723163|157003951|FG000|Treatment Phase|Withdrawal by Subject|14|||
48769581|NCT01723163|157003952|FG001|Treatment Phase|Withdrawal by Subject|6|||
48769582|NCT01723163|157003951|FG000|Treatment Phase|Withdrawal by PI|5|||
48769583|NCT01723163|157003952|FG001|Treatment Phase|Withdrawal by PI|1|||
48769584|NCT01723163|157003951|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
48769585|NCT01723163|157003952|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
48769586|NCT01723163|157003951|FG000|3-Month Follow-up|Unable to Contact|12|||
48769587|NCT01723163|157003952|FG001|3-Month Follow-up|Unable to Contact|19|||
48769588|NCT01723163|157003951|FG000|6-Month Follow-up|Death|1|||
48355891|NCT01111240|155498604|FG000|Overall Study|Lack of Efficacy|545|||
48355892|NCT01111240|155498604|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
48355893|NCT01111240|155498604|FG000|Overall Study|Other|312|||
48355894|NCT00617929|155498605|FG000|Overall Study|Physician Decision|1|||
48355895|NCT01443923|155498606|FG000|Overall Study|Adverse Event|1|||
48355896|NCT01443923|155498607|FG001|Overall Study|Adverse Event|0|||
48355897|NCT04160988|155498608|FG000|Overall Study|poor image quality|28|||
48355898|NCT00243074|155498614|FG000|Overall Study|Ineligible|6|||
48355899|NCT00243074|155498614|FG000|Overall Study|Adverse Event|6|||
48355900|NCT00243074|155498614|FG000|Overall Study|Withdrawal by Subject|2|||
48355901|NCT00243074|155498614|FG000|Overall Study|Lack of Efficacy|36|||
48355902|NCT00243074|155498614|FG000|Overall Study|Death|2|||
48355903|NCT00243074|155498614|FG000|Overall Study|not protocol specified|1|||
48355904|NCT00243074|155498614|FG000|Overall Study|Did not receive any treatment|1|||
48355905|NCT00203268|155498615|FG000|Early Treatment|only treated one headache|2|||
48355906|NCT00203268|155498615|FG000|Early Treatment|Lost to Follow-up|1|||
48355907|NCT00203268|155498615|FG000|Early Treatment|Withdrawal by Subject|1|||
48355908|NCT03784820|155498616|FG000|Overall Study|Lost to Follow-up|5|||
48355909|NCT03784820|155498617|FG001|Overall Study|Lost to Follow-up|5|||
48355910|NCT03784820|155498618|FG002|Overall Study|Lost to Follow-up|3|||
48355911|NCT03784820|155498619|FG003|Overall Study|Lost to Follow-up|3|||
48355912|NCT00600613|155498620|FG000|Overall Study|Protocol Deviation|1|||
48355913|NCT00664534|155498621|FG000|Overall Study|Adverse Event|2|||
48355914|NCT00664534|155498622|FG001|Overall Study|Adverse Event|3|||
48355915|NCT00664534|155498621|FG000|Overall Study|Lost to Follow-up|6|||
48769589|NCT01723163|157003952|FG001|6-Month Follow-up|Death|0|||
48769590|NCT01723163|157003951|FG000|6-Month Follow-up|Unable to Contact|17|||
48769591|NCT01723163|157003952|FG001|6-Month Follow-up|Unable to Contact|15|||
48769592|NCT01723163|157003951|FG000|12-Month Follow-up|Death|1|||
48769593|NCT01723163|157003952|FG001|12-Month Follow-up|Death|0|||
48769594|NCT01723163|157003951|FG000|12-Month Follow-up|Unable to Contact|23|||
48769595|NCT01723163|157003952|FG001|12-Month Follow-up|Unable to Contact|28|||
48769596|NCT00640510|157003958|FG000|Overall Study|Lack of Efficacy|0|||
48769597|NCT00640510|157003959|FG001|Overall Study|Lack of Efficacy|1|||
48769598|NCT00640510|157003958|FG000|Overall Study|Protocol Violation|1|||
48769599|NCT00640510|157003959|FG001|Overall Study|Protocol Violation|0|||
48769600|NCT00640510|157003958|FG000|Overall Study|Physician Decision|0|||
48769601|NCT00640510|157003959|FG001|Overall Study|Physician Decision|1|||
48769602|NCT02474199|157003960|FG000|Overall Study|Lost to Follow-up|1|||
48769603|NCT02474199|157003961|FG001|Overall Study|Lost to Follow-up|0|||
48769604|NCT02474199|157003962|FG002|Overall Study|Lost to Follow-up|0|||
48769605|NCT02474199|157003963|FG003|Overall Study|Lost to Follow-up|0|||
48769606|NCT02474199|157003960|FG000|Overall Study|Withdrawal by Subject|1|||
48355916|NCT00664534|155498622|FG001|Overall Study|Lost to Follow-up|10|||
48355917|NCT00664534|155498621|FG000|Overall Study|Protocol Violation|10|||
48355918|NCT00664534|155498622|FG001|Overall Study|Protocol Violation|8|||
48355919|NCT00664534|155498621|FG000|Overall Study|Withdrawal by Subject|7|||
48355920|NCT00664534|155498622|FG001|Overall Study|Withdrawal by Subject|6|||
48355921|NCT00664534|155498621|FG000|Overall Study|Physician Decision|8|||
48355922|NCT00664534|155498622|FG001|Overall Study|Physician Decision|0|||
48355923|NCT00664534|155498621|FG000|Overall Study|Sponsor decision|8|||
48355924|NCT00664534|155498622|FG001|Overall Study|Sponsor decision|6|||
48355925|NCT03041792|155498624|FG000|Overall Study|Adverse Event|4|||
48355926|NCT03041792|155498625|FG001|Overall Study|Adverse Event|0|||
48355927|NCT03041792|155498624|FG000|Overall Study|Death in the family|0|||
48355928|NCT03041792|155498625|FG001|Overall Study|Death in the family|2|||
48355929|NCT03041792|155498624|FG000|Overall Study|Randomized but not treated|0|||
48355930|NCT03041792|155498625|FG001|Overall Study|Randomized but not treated|1|||
48355931|NCT02227992|155498626|FG000|Overall Study|Lost to Follow-up|1|||
48355932|NCT02227992|155498627|FG001|Overall Study|Lost to Follow-up|1|||
48355933|NCT01371708|155498628|FG000|Overall Study|Insufficient clinical response|3|||
48355934|NCT01371708|155498629|FG001|Overall Study|Insufficient clinical response|2|||
48355935|NCT01371708|155498630|FG002|Overall Study|Insufficient clinical response|0|||
48355936|NCT01371708|155498628|FG000|Overall Study|Lost to Follow-up|5|||
48355937|NCT01371708|155498629|FG001|Overall Study|Lost to Follow-up|9|||
48355938|NCT01371708|155498630|FG002|Overall Study|Lost to Follow-up|7|||
48355939|NCT01371708|155498628|FG000|Overall Study|Protocol Violation|2|||
48355940|NCT01371708|155498629|FG001|Overall Study|Protocol Violation|1|||
48355941|NCT01371708|155498630|FG002|Overall Study|Protocol Violation|2|||
48355942|NCT01371708|155498628|FG000|Overall Study|No longer willing to participate|7|||
48355943|NCT01371708|155498629|FG001|Overall Study|No longer willing to participate|7|||
48355944|NCT01371708|155498630|FG002|Overall Study|No longer willing to participate|13|||
48355945|NCT01371708|155498628|FG000|Overall Study|Medication error/not related to AE|0|||
48355946|NCT01371708|155498629|FG001|Overall Study|Medication error/not related to AE|1|||
48355947|NCT01371708|155498630|FG002|Overall Study|Medication error/not related to AE|0|||
48355948|NCT01371708|155498628|FG000|Overall Study|Other|3|||
48355949|NCT01371708|155498629|FG001|Overall Study|Other|2|||
48355950|NCT01371708|155498630|FG002|Overall Study|Other|4|||
48355951|NCT01371708|155498628|FG000|Overall Study|Adverse Event|5|||
48355952|NCT01371708|155498629|FG001|Overall Study|Adverse Event|8|||
48355953|NCT01371708|155498630|FG002|Overall Study|Adverse Event|12|||
48355954|NCT01371708|155498628|FG000|Overall Study|Started but did not receive treatment|1|||
48355955|NCT01371708|155498629|FG001|Overall Study|Started but did not receive treatment|0|||
48355956|NCT01371708|155498630|FG002|Overall Study|Started but did not receive treatment|1|||
48355957|NCT02514551|155498631|FG000|Overall Study|Lost to Follow-up|0|||
48355958|NCT02514551|155498632|FG001|Overall Study|Lost to Follow-up|1|||
48355959|NCT02514551|155498631|FG000|Overall Study|Participant Never Treated|0|||
48355960|NCT02514551|155498632|FG001|Overall Study|Participant Never Treated|2|||
48355961|NCT03197766|155498633|FG000|Overall Study|Withdrawal by Subject|2|||
48355962|NCT03197766|155498634|FG001|Overall Study|Withdrawal by Subject|0|||
48355963|NCT01607476|155498635|FG000|Overall Study|Withdrawal by Subject|1|||
48355964|NCT01607476|155498636|FG001|Overall Study|Withdrawal by Subject|0|||
48355965|NCT01607476|155498637|FG002|Overall Study|Withdrawal by Subject|1|||
48355966|NCT01607476|155498635|FG000|Overall Study|Lost to Follow-up|0|||
48355967|NCT01607476|155498636|FG001|Overall Study|Lost to Follow-up|0|||
48355968|NCT01607476|155498637|FG002|Overall Study|Lost to Follow-up|2|||
48355969|NCT00475228|155498642|FG000|Overall Study|Lost to Follow-up|17|||
48355970|NCT00475228|155498643|FG001|Overall Study|Lost to Follow-up|17|||
48355971|NCT02980042|155500963|FG000|Overall Study|Lost to Follow-up|5|||
48394914|NCT01445951|155639842|FG002|Overall Study|Adverse Event|0|||
48394915|NCT01445951|155639840|FG000|Overall Study|Protocol Violation|2|||
48394916|NCT01445951|155639841|FG001|Overall Study|Protocol Violation|2|||
48394917|NCT01445951|155639842|FG002|Overall Study|Protocol Violation|2|||
48394918|NCT01445951|155639840|FG000|Overall Study|Withdrawal by Subject|21|||
48394919|NCT01445951|155639841|FG001|Overall Study|Withdrawal by Subject|16|||
48394920|NCT01445951|155639842|FG002|Overall Study|Withdrawal by Subject|8|||
48394921|NCT01445951|155639840|FG000|Overall Study|Physician Decision|3|||
48394922|NCT01445951|155639841|FG001|Overall Study|Physician Decision|1|||
48394923|NCT01445951|155639842|FG002|Overall Study|Physician Decision|0|||
48394924|NCT01445951|155639840|FG000|Overall Study|Lost to Follow-up|1|||
48394925|NCT01445951|155639841|FG001|Overall Study|Lost to Follow-up|2|||
48394926|NCT01445951|155639842|FG002|Overall Study|Lost to Follow-up|4|||
48394927|NCT01445951|155639840|FG000|Overall Study|Pregnancy|0|||
48394928|NCT01445951|155639841|FG001|Overall Study|Pregnancy|1|||
48394929|NCT01445951|155639842|FG002|Overall Study|Pregnancy|4|||
48394930|NCT01445951|155639840|FG000|Overall Study|Death|0|||
48394931|NCT01445951|155639841|FG001|Overall Study|Death|0|||
48769607|NCT02474199|157003961|FG001|Overall Study|Withdrawal by Subject|2|||
48769608|NCT02474199|157003962|FG002|Overall Study|Withdrawal by Subject|0|||
48769609|NCT02474199|157003963|FG003|Overall Study|Withdrawal by Subject|1|||
48769610|NCT02474199|157003960|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
48769611|NCT02474199|157003961|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
48769612|NCT02474199|157003962|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
48769613|NCT02474199|157003963|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
48769614|NCT02474199|157003960|FG000|Overall Study|Did not meet eligibility criteria|0|||
48769615|NCT02474199|157003961|FG001|Overall Study|Did not meet eligibility criteria|0|||
48769616|NCT02474199|157003962|FG002|Overall Study|Did not meet eligibility criteria|2|||
48769617|NCT02474199|157003963|FG003|Overall Study|Did not meet eligibility criteria|2|||
48769618|NCT02404311|157003964|FG000|Part A: Month 0-18|Death|2|||
48769619|NCT02404311|157003965|FG001|Part A: Month 0-18|Death|0|||
48394932|NCT01445951|155639842|FG002|Overall Study|Death|1|||
48394933|NCT01445951|155639840|FG000|Overall Study|Non-compliance with study drug|1|||
48394934|NCT01445951|155639841|FG001|Overall Study|Non-compliance with study drug|2|||
48394935|NCT01445951|155639842|FG002|Overall Study|Non-compliance with study drug|0|||
48394936|NCT01445951|155639840|FG000|Overall Study|Non-compliance with protocol|0|||
48394937|NCT01445951|155639841|FG001|Overall Study|Non-compliance with protocol|1|||
48394938|NCT01445951|155639842|FG002|Overall Study|Non-compliance with protocol|0|||
48394939|NCT01445951|155639840|FG000|Overall Study|Sponsor decision - subject travel|0|||
48394940|NCT01445951|155639841|FG001|Overall Study|Sponsor decision - subject travel|1|||
48394941|NCT01445951|155639842|FG002|Overall Study|Sponsor decision - subject travel|0|||
48394942|NCT01445951|155639840|FG000|Overall Study|Cough|0|||
48394943|NCT01445951|155639841|FG001|Overall Study|Cough|1|||
48394944|NCT01445951|155639842|FG002|Overall Study|Cough|0|||
48394945|NCT00401375|155639843|FG000|Overall Study|Protocol Violation|2|||
48394946|NCT00401375|155639844|FG001|Overall Study|Protocol Violation|2|||
48394947|NCT00401375|155639845|FG002|Overall Study|Protocol Violation|1|||
48394948|NCT00401375|155639843|FG000|Overall Study|Adverse Event|6|||
48394949|NCT00401375|155639844|FG001|Overall Study|Adverse Event|11|||
48394950|NCT00401375|155639845|FG002|Overall Study|Adverse Event|10|||
48769620|NCT02404311|157003966|FG002|Part A: Month 0-18|Death|0|||
48394951|NCT00401375|155639843|FG000|Overall Study|Withdrawal by Subject|9|||
48394952|NCT00401375|155639844|FG001|Overall Study|Withdrawal by Subject|7|||
48769621|NCT02404311|157003967|FG003|Part A: Month 0-18|Death|0|||
48769622|NCT02404311|157003968|FG004|Part A: Month 0-18|Death|0|||
48769623|NCT02404311|157003964|FG000|Part A: Month 0-18|Physician Decision|1|||
48769624|NCT02404311|157003965|FG001|Part A: Month 0-18|Physician Decision|0|||
48769625|NCT02404311|157003966|FG002|Part A: Month 0-18|Physician Decision|0|||
48769626|NCT02404311|157003967|FG003|Part A: Month 0-18|Physician Decision|0|||
48769627|NCT02404311|157003968|FG004|Part A: Month 0-18|Physician Decision|0|||
48769628|NCT02404311|157003964|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
48769629|NCT02404311|157003965|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
48769630|NCT02404311|157003966|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
48769631|NCT02404311|157003967|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
48769632|NCT02404311|157003968|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
48769633|NCT02404311|157003964|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
48769634|NCT02404311|157003965|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
48769635|NCT02404311|157003966|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
48769636|NCT02404311|157003967|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
48769637|NCT02404311|157003968|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
48769638|NCT02404311|157003964|FG000|Part A: Month 0-18|HIV Infection|6|||
48769639|NCT02404311|157003965|FG001|Part A: Month 0-18|HIV Infection|2|||
48394953|NCT00401375|155639845|FG002|Overall Study|Withdrawal by Subject|7|||
48394954|NCT00401375|155639843|FG000|Overall Study|Lost to Follow-up|0|||
48394955|NCT00401375|155639844|FG001|Overall Study|Lost to Follow-up|1|||
48769640|NCT02404311|157003966|FG002|Part A: Month 0-18|HIV Infection|0|||
48769641|NCT02404311|157003967|FG003|Part A: Month 0-18|HIV Infection|0|||
48769642|NCT02404311|157003968|FG004|Part A: Month 0-18|HIV Infection|0|||
48769643|NCT02404311|157003964|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
48769644|NCT02404311|157003965|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
48769645|NCT02404311|157003966|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
48769646|NCT02404311|157003967|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
48769647|NCT02404311|157003968|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
48769648|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
48769649|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
48769650|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
48769651|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
48769652|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
48769653|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
48769654|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
48769655|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
48769656|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
48769657|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
48769658|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
48769659|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
48769660|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
48769661|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
48769662|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
48769663|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
48769664|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
48769665|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
48769666|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
48769667|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
48769668|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
48769669|NCT00934544|157003969|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
48769670|NCT00934544|157003970|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
48769671|NCT00934544|157003971|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
48769672|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
48769673|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
48769674|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
48769675|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
48769676|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
48769677|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
48769678|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
48769679|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
48769680|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
48769681|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
48769682|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
48769683|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
48769684|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
48769685|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
48769686|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
48769687|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
48769688|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
48769689|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
48769690|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
48769691|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
48769692|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
48769693|NCT00934544|157003969|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
48769694|NCT00934544|157003970|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
48769695|NCT00934544|157003971|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
48769696|NCT01539226|157003972|FG000|Overall Study|Withdrawal by Subject|24|||
48769697|NCT01539226|157003973|FG001|Overall Study|Withdrawal by Subject|54|||
48769698|NCT01539226|157003972|FG000|Overall Study|Lost to Follow-up|20|||
48769699|NCT01539226|157003973|FG001|Overall Study|Lost to Follow-up|54|||
48769700|NCT01539226|157003972|FG000|Overall Study|Death|1|||
48769701|NCT01539226|157003973|FG001|Overall Study|Death|2|||
48769702|NCT01539226|157003972|FG000|Overall Study|Adverse Event|2|||
48769703|NCT01539226|157003973|FG001|Overall Study|Adverse Event|0|||
48769704|NCT01539226|157003972|FG000|Overall Study|Pregnancy|13|||
48769705|NCT01539226|157003973|FG001|Overall Study|Pregnancy|29|||
48769706|NCT01539226|157003972|FG000|Overall Study|inappropriate enrollment|0|||
48769707|NCT01539226|157003973|FG001|Overall Study|inappropriate enrollment|1|||
48769708|NCT01539226|157003972|FG000|Overall Study|Multiple Reasons|3|||
48769709|NCT01539226|157003973|FG001|Overall Study|Multiple Reasons|1|||
48769710|NCT01539226|157003972|FG000|Overall Study|not HIV seroconversion-related|93|||
48769711|NCT01539226|157003973|FG001|Overall Study|not HIV seroconversion-related|176|||
48769712|NCT01539226|157003972|FG000|Overall Study|HIV seroconversion-related|55|||
48769713|NCT01539226|157003973|FG001|Overall Study|HIV seroconversion-related|80|||
48769714|NCT01539226|157003972|FG000|Overall Study|Non-compliance|6|||
48769715|NCT01539226|157003973|FG001|Overall Study|Non-compliance|8|||
48769716|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
48769717|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
48769718|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
48769719|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
48769720|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
48769721|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
48769722|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
48769723|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
48769724|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
48769725|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
48769726|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
48769727|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
48769728|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
48769729|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
48769730|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
48769731|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
48769732|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
48769733|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
48769734|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
48769735|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
48769736|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
48769737|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
48769738|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
48769739|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
48769740|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
48769741|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
48769742|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
48769743|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
48769744|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
48769745|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
48769746|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
48769747|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
48769748|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
48769749|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
48769750|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
48769751|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
48769752|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
48769753|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
48769754|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
48769755|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
48769756|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
48769757|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
48769758|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
48769759|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
48769760|NCT01218516|157003974|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
48797683|NCT00828984|157097048|FG002|Overall Study|Withdrawal by Subject|4|||
48797684|NCT00828984|157097046|FG000|Overall Study|Ineligable|1|||
48797685|NCT00828984|157097047|FG001|Overall Study|Ineligable|2|||
48797686|NCT00828984|157097048|FG002|Overall Study|Ineligable|0|||
48797687|NCT00828984|157097046|FG000|Overall Study|Medical Contraindication|0|||
48797688|NCT00828984|157097047|FG001|Overall Study|Medical Contraindication|1|||
48797689|NCT00828984|157097048|FG002|Overall Study|Medical Contraindication|0|||
48797690|NCT00828984|157097046|FG000|Overall Study|Noncompliant|1|||
48797691|NCT00828984|157097047|FG001|Overall Study|Noncompliant|2|||
48797692|NCT00828984|157097048|FG002|Overall Study|Noncompliant|3|||
48769761|NCT01218516|157003975|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
48769762|NCT01218516|157003976|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
48769763|NCT01218516|157003977|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
48769764|NCT02643251|157003978|FG000|Overall Study|Adverse Event|3|||
48769765|NCT02643251|157003979|FG001|Overall Study|Adverse Event|1|||
48769766|NCT02643251|157003978|FG000|Overall Study|Withdrawal by Subject|2|||
48769767|NCT02643251|157003979|FG001|Overall Study|Withdrawal by Subject|0|||
48769768|NCT02643251|157003978|FG000|Overall Study|Lost to Follow-up|4|||
48769769|NCT02643251|157003979|FG001|Overall Study|Lost to Follow-up|1|||
48769770|NCT02643251|157003978|FG000|Overall Study|Protocol Violation|1|||
48769771|NCT02643251|157003979|FG001|Overall Study|Protocol Violation|0|||
48769772|NCT02643251|157003978|FG000|Overall Study|PI Decision to terminate patient|1|||
48769773|NCT02643251|157003979|FG001|Overall Study|PI Decision to terminate patient|0|||
48769774|NCT01632891|157003980|FG000|Overall Study|Lost to Follow-up|0|||
48769775|NCT01632891|157003981|FG001|Overall Study|Lost to Follow-up|1|||
48769776|NCT01632891|157003980|FG000|Overall Study|Withdrawal by Subject|1|||
48769777|NCT01632891|157003981|FG001|Overall Study|Withdrawal by Subject|0|||
48769778|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
48769779|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
48355972|NCT02980042|155500964|FG001|Overall Study|Lost to Follow-up|0|||
48355973|NCT02980042|155500963|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
48769780|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
48769781|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
48769782|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
48769783|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
48769784|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
48769785|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
48769786|NCT04033003|157003985|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
48769787|NCT04033003|157003986|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
48769788|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
48769789|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
48769790|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
48769791|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
48769792|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
48769793|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
48769794|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
48769795|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
48769796|NCT04033003|157003985|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
48769797|NCT04033003|157003986|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
48769798|NCT04033003|157003985|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
48769799|NCT04033003|157003986|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
48769800|NCT04033003|157003985|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
48769801|NCT04033003|157003986|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
48769802|NCT04033003|157003985|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
48769803|NCT04033003|157003986|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
48769804|NCT00240071|157003987|FG000|Overall Study|Withdrawal by Subject|3|||
48769805|NCT02256891|157003988|FG000|Overall Study|Death|0|||
48769806|NCT02256891|157003989|FG001|Overall Study|Death|2|||
48769807|NCT02256891|157003988|FG000|Overall Study|Lost to Follow-up|0|||
48769808|NCT02256891|157003989|FG001|Overall Study|Lost to Follow-up|3|||
48769809|NCT02256891|157003988|FG000|Overall Study|Physician Decision|7|||
48769810|NCT02256891|157003989|FG001|Overall Study|Physician Decision|3|||
48769811|NCT02256891|157003988|FG000|Overall Study|Screen Fail|5|||
48769812|NCT02256891|157003989|FG001|Overall Study|Screen Fail|4|||
48769813|NCT02256891|157003988|FG000|Overall Study|Equipment Malfunction|0|||
48769814|NCT02256891|157003989|FG001|Overall Study|Equipment Malfunction|1|||
48769815|NCT01660711|157003993|FG000|Overall Study|Adverse Event|7|||
48769816|NCT01660711|157003993|FG000|Overall Study|Withdrawal by Subject|1|||
48769817|NCT04171414|157003994|FG000|Overall Study|Death|1|||
48769818|NCT04171414|157003994|FG000|Overall Study|Withdrawal by Subject|1|||
48769819|NCT00463060|157003995|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
48769820|NCT00463060|157003995|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
48769821|NCT03907683|157004002|FG000|Overall Study|Pregnancy|1|||
48769822|NCT03907683|157004002|FG000|Overall Study|Withdrawal by Subject|1|||
48769823|NCT02272413|157004005|FG000|Randomized Through Treatment Start|Not treated|3|||
48769824|NCT02272413|157004006|FG001|Randomized Through Treatment Start|Not treated|5|||
48769825|NCT02272413|157004005|FG000|Pre-switch Period|Adverse Event|38|||
48355974|NCT02980042|155500964|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
48769826|NCT02272413|157004006|FG001|Pre-switch Period|Adverse Event|37|||
48769827|NCT02272413|157004005|FG000|Pre-switch Period|Death|26|||
48769828|NCT02272413|157004006|FG001|Pre-switch Period|Death|26|||
48769829|NCT02272413|157004005|FG000|Pre-switch Period|Withdrawal by Subject|27|||
48769830|NCT02272413|157004006|FG001|Pre-switch Period|Withdrawal by Subject|15|||
48769831|NCT02272413|157004005|FG000|Pre-switch Period|Physician Decision|6|||
48769832|NCT02272413|157004006|FG001|Pre-switch Period|Physician Decision|18|||
48769833|NCT02272413|157004005|FG000|Pre-switch Period|Progressive disease|185|||
48769834|NCT02272413|157004006|FG001|Pre-switch Period|Progressive disease|173|||
48769835|NCT02272413|157004005|FG000|Pre-switch Period|Lost to Follow-up|0|||
48769836|NCT02272413|157004006|FG001|Pre-switch Period|Lost to Follow-up|2|||
48769837|NCT02272413|157004005|FG000|Pre-switch Period|Protocol Violation|1|||
48769838|NCT02272413|157004006|FG001|Pre-switch Period|Protocol Violation|0|||
48769839|NCT02272413|157004005|FG000|Pre-switch Period|Other than listed|10|||
48769840|NCT02272413|157004006|FG001|Pre-switch Period|Other than listed|11|||
48769841|NCT02272413|157004005|FG000|Post-switch Period|Adverse Event|4|||
48769842|NCT02272413|157004006|FG001|Post-switch Period|Adverse Event|4|||
48769843|NCT02272413|157004005|FG000|Post-switch Period|Death|3|||
48769844|NCT02272413|157004006|FG001|Post-switch Period|Death|2|||
48769845|NCT02272413|157004005|FG000|Post-switch Period|Withdrawal by Subject|1|||
48769846|NCT02272413|157004006|FG001|Post-switch Period|Withdrawal by Subject|2|||
48769847|NCT02272413|157004005|FG000|Post-switch Period|Physician Decision|1|||
48769848|NCT02272413|157004006|FG001|Post-switch Period|Physician Decision|1|||
48769849|NCT02272413|157004005|FG000|Post-switch Period|Progressive disease|21|||
48769850|NCT02272413|157004006|FG001|Post-switch Period|Progressive disease|21|||
48769851|NCT02272413|157004005|FG000|Post-switch Period|Study terminated by sponsor|8|||
48769852|NCT02272413|157004006|FG001|Post-switch Period|Study terminated by sponsor|11|||
48769853|NCT02272413|157004005|FG000|Post-switch Period|Other than listed|4|||
48769854|NCT02272413|157004006|FG001|Post-switch Period|Other than listed|5|||
48769855|NCT02852265|157004007|FG000|3-month Follow-up|Lost to Follow-up|1|||
48769856|NCT02852265|157004008|FG001|3-month Follow-up|Lost to Follow-up|1|||
48769857|NCT02287896|157004011|FG000|Second Injection Visit|Withdrawal by Subject|0|||
48769858|NCT02287896|157004012|FG001|Second Injection Visit|Withdrawal by Subject|1|||
48769859|NCT03029624|157004013|FG000|Overall Study|Adverse Event|1|||
48769860|NCT03029624|157004013|FG000|Overall Study|Withdrawal by Subject|1|||
48769861|NCT03029624|157004013|FG000|Overall Study|Lack of Efficacy|1|||
48769862|NCT03029624|157004013|FG000|Overall Study|MRI need|2|||
48769863|NCT00854581|157004014|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
48769864|NCT00854581|157004014|FG000|Induction (Up to Day 21)|Death|1|||
48769865|NCT00854581|157004014|FG000|Induction (Up to Day 21)|Physician Decision|1|||
48769866|NCT00854581|157004014|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
48769867|NCT04847674|157004015|FG000|Overall Study|Withdrawal by Subject|0|||
48769868|NCT04847674|157004016|FG001|Overall Study|Withdrawal by Subject|1|||
48769869|NCT04847674|157004017|FG002|Overall Study|Withdrawal by Subject|0|||
48769870|NCT04847674|157004015|FG000|Overall Study|Lost to Follow-up|0|||
48769871|NCT04847674|157004016|FG001|Overall Study|Lost to Follow-up|0|||
48769872|NCT04847674|157004017|FG002|Overall Study|Lost to Follow-up|2|||
48769873|NCT04847674|157004015|FG000|Overall Study|Other than specified|21|||
48769874|NCT04847674|157004016|FG001|Overall Study|Other than specified|20|||
48769875|NCT04847674|157004017|FG002|Overall Study|Other than specified|20|||
48769876|NCT01557400|157004018|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
48769877|NCT01557400|157004018|FG000|Overall Study|Adverse Event|3|||
48769878|NCT01557400|157004018|FG000|Overall Study|Lost to Follow-up|5|||
48769879|NCT01557400|157004018|FG000|Overall Study|Withdrawal by Subject|9|||
48769880|NCT01434290|157004021|FG000|Overall Study|Protocol Violation|6|||
48769881|NCT01434290|157004022|FG001|Overall Study|Protocol Violation|3|||
48769882|NCT01434290|157004021|FG000|Overall Study|No protocol treatment|2|||
48769883|NCT01434290|157004022|FG001|Overall Study|No protocol treatment|4|||
48769884|NCT00235989|157004023|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769885|NCT00235989|157004024|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769886|NCT00235989|157004025|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769887|NCT00235989|157004026|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769888|NCT00235989|157004027|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
48769889|NCT00235989|157004028|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
48769890|NCT00235989|157004023|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
48769891|NCT00235989|157004024|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
48769892|NCT00235989|157004025|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
48769893|NCT00235989|157004026|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
48769894|NCT00235989|157004027|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
48769895|NCT00235989|157004028|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
48769896|NCT00235989|157004023|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
48769897|NCT00235989|157004024|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
48769898|NCT00235989|157004025|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
48769899|NCT00235989|157004026|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
48769900|NCT00235989|157004027|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
48769901|NCT00235989|157004028|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
48769902|NCT00235989|157004023|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
48769903|NCT00235989|157004024|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
48769904|NCT00235989|157004025|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
48769905|NCT00235989|157004026|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
48769906|NCT00235989|157004027|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
48769907|NCT00235989|157004028|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
48769908|NCT00235989|157004023|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
48769909|NCT00235989|157004024|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
48769910|NCT00235989|157004025|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
48769911|NCT00235989|157004026|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
48769912|NCT00235989|157004027|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
48769913|NCT00235989|157004028|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
48769914|NCT03181542|157004029|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
48769915|NCT03181542|157004030|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
48769916|NCT00969553|157004035|FG000|Overall Study|Progressive disease (PD)|2|||
48769917|NCT00969553|157004036|FG001|Overall Study|Progressive disease (PD)|2|||
48769918|NCT00969553|157004037|FG002|Overall Study|Progressive disease (PD)|6|||
48769919|NCT00969553|157004038|FG003|Overall Study|Progressive disease (PD)|9|||
48769920|NCT00969553|157004039|FG004|Overall Study|Progressive disease (PD)|2|||
48769921|NCT00969553|157004040|FG005|Overall Study|Progressive disease (PD)|4|||
48769922|NCT00969553|157004041|FG006|Overall Study|Progressive disease (PD)|2|||
48769923|NCT00969553|157004042|FG007|Overall Study|Progressive disease (PD)|12|||
48769924|NCT00969553|157004043|FG008|Overall Study|Progressive disease (PD)|3|||
48769925|NCT00969553|157004035|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769926|NCT00969553|157004036|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769927|NCT00969553|157004037|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769928|NCT00969553|157004038|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769929|NCT00969553|157004039|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
48769930|NCT00969553|157004040|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769931|NCT00969553|157004041|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769932|NCT00969553|157004042|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769933|NCT00969553|157004043|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
48769934|NCT00969553|157004035|FG000|Overall Study|Other Adverse Event|0|||
48769935|NCT00969553|157004036|FG001|Overall Study|Other Adverse Event|0|||
48769936|NCT00969553|157004037|FG002|Overall Study|Other Adverse Event|0|||
48769937|NCT00969553|157004038|FG003|Overall Study|Other Adverse Event|1|||
48769938|NCT00969553|157004039|FG004|Overall Study|Other Adverse Event|0|||
48769939|NCT00969553|157004040|FG005|Overall Study|Other Adverse Event|0|||
48769940|NCT00969553|157004041|FG006|Overall Study|Other Adverse Event|1|||
48769941|NCT00969553|157004042|FG007|Overall Study|Other Adverse Event|0|||
48769942|NCT00969553|157004043|FG008|Overall Study|Other Adverse Event|0|||
48769943|NCT00969553|157004035|FG000|Overall Study|Refused cont. medication|1|||
48769944|NCT00969553|157004036|FG001|Overall Study|Refused cont. medication|1|||
48769945|NCT00969553|157004037|FG002|Overall Study|Refused cont. medication|0|||
48769946|NCT00969553|157004038|FG003|Overall Study|Refused cont. medication|2|||
48769947|NCT00969553|157004039|FG004|Overall Study|Refused cont. medication|0|||
48769948|NCT00969553|157004040|FG005|Overall Study|Refused cont. medication|0|||
48769949|NCT00969553|157004041|FG006|Overall Study|Refused cont. medication|0|||
48355975|NCT04367480|155500967|FG000|Overall Study|Adverse Event|1|||
48797693|NCT00828984|157097046|FG000|Overall Study|ConMed|1|||
48797694|NCT00828984|157097047|FG001|Overall Study|ConMed|1|||
48769950|NCT00969553|157004042|FG007|Overall Study|Refused cont. medication|1|||
48769951|NCT00969553|157004043|FG008|Overall Study|Refused cont. medication|0|||
48769952|NCT00969553|157004035|FG000|Overall Study|Not specified above|0|||
48769953|NCT00969553|157004036|FG001|Overall Study|Not specified above|0|||
48769954|NCT00969553|157004037|FG002|Overall Study|Not specified above|0|||
48769955|NCT00969553|157004038|FG003|Overall Study|Not specified above|4|||
48769956|NCT00969553|157004039|FG004|Overall Study|Not specified above|0|||
48769957|NCT00969553|157004040|FG005|Overall Study|Not specified above|0|||
48769958|NCT00969553|157004041|FG006|Overall Study|Not specified above|1|||
48769959|NCT00969553|157004042|FG007|Overall Study|Not specified above|1|||
48769960|NCT00969553|157004043|FG008|Overall Study|Not specified above|0|||
48769961|NCT03400033|157004044|FG000|Overall Study|Withdrawal by Subject|1|||
48769962|NCT03400033|157004045|FG001|Overall Study|Withdrawal by Subject|2|||
48769963|NCT02457325|157004048|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
48769964|NCT02457325|157004049|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
48769965|NCT01399593|157004051|FG000|Overall Study|Physician Decision|1|||
48769966|NCT01399593|157004052|FG001|Overall Study|Physician Decision|0|||
48769967|NCT01399593|157004051|FG000|Overall Study|Adverse Event|1|||
48769968|NCT01399593|157004052|FG001|Overall Study|Adverse Event|0|||
48769969|NCT01399593|157004051|FG000|Overall Study|Death|1|||
48769970|NCT01399593|157004052|FG001|Overall Study|Death|1|||
48769971|NCT01399593|157004051|FG000|Overall Study|Transplantectomy|0|||
48769972|NCT01399593|157004052|FG001|Overall Study|Transplantectomy|1|||
48769973|NCT00096044|157004055|FG000|Overall Study|Withdrawal by Subject|9|||
48769974|NCT00096044|157004055|FG000|Overall Study|Adverse Event|21|||
48769975|NCT00096044|157004055|FG000|Overall Study|Disease Progression|4|||
48769976|NCT03595878|157004056|FG000|Overall Study|Death|2|||
48769977|NCT03595878|157004057|FG001|Overall Study|Death|1|||
48769978|NCT03595878|157004058|FG002|Overall Study|Death|0|||
48769979|NCT03595878|157004056|FG000|Overall Study|Disease progression|2|||
48769980|NCT03595878|157004057|FG001|Overall Study|Disease progression|1|||
48769981|NCT03595878|157004058|FG002|Overall Study|Disease progression|2|||
48769982|NCT01552772|157004059|FG000|Overall Study|Lost to Follow-up|2|||
48769983|NCT01552772|157004059|FG000|Overall Study|Adverse Event|1|||
48769984|NCT01552772|157004059|FG000|Overall Study|Protocol Deviation|1|||
48769985|NCT01420081|157004060|FG000|Overall Study|Death|1|||
48769986|NCT01420081|157004061|FG001|Overall Study|Death|0|||
48769987|NCT01420081|157004062|FG002|Overall Study|Death|8|||
48769988|NCT01420081|157004063|FG003|Overall Study|Death|0|||
48769989|NCT01420081|157004064|FG004|Overall Study|Death|7|||
48769990|NCT01420081|157004065|FG005|Overall Study|Death|12|||
48769991|NCT01420081|157004066|FG006|Overall Study|Death|0|||
48769992|NCT01420081|157004067|FG007|Overall Study|Death|1|||
48769993|NCT01420081|157004068|FG008|Overall Study|Death|1|||
48769994|NCT01420081|157004060|FG000|Overall Study|Lost to Follow-up|0|||
48769995|NCT01420081|157004061|FG001|Overall Study|Lost to Follow-up|0|||
48769996|NCT01420081|157004062|FG002|Overall Study|Lost to Follow-up|0|||
48769997|NCT01420081|157004063|FG003|Overall Study|Lost to Follow-up|0|||
48769998|NCT01420081|157004064|FG004|Overall Study|Lost to Follow-up|1|||
48769999|NCT01420081|157004065|FG005|Overall Study|Lost to Follow-up|1|||
48770000|NCT01420081|157004066|FG006|Overall Study|Lost to Follow-up|0|||
48770001|NCT01420081|157004067|FG007|Overall Study|Lost to Follow-up|0|||
48770002|NCT01420081|157004068|FG008|Overall Study|Lost to Follow-up|0|||
48770003|NCT01420081|157004060|FG000|Overall Study|Study Terminated by Sponsor|2|||
48770004|NCT01420081|157004061|FG001|Overall Study|Study Terminated by Sponsor|1|||
48770005|NCT01420081|157004062|FG002|Overall Study|Study Terminated by Sponsor|1|||
48770006|NCT01420081|157004063|FG003|Overall Study|Study Terminated by Sponsor|3|||
48770007|NCT01420081|157004064|FG004|Overall Study|Study Terminated by Sponsor|11|||
48770008|NCT01420081|157004065|FG005|Overall Study|Study Terminated by Sponsor|7|||
48770009|NCT01420081|157004066|FG006|Overall Study|Study Terminated by Sponsor|3|||
48770010|NCT01420081|157004067|FG007|Overall Study|Study Terminated by Sponsor|2|||
48770011|NCT01420081|157004068|FG008|Overall Study|Study Terminated by Sponsor|2|||
48770012|NCT01420081|157004060|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
48770013|NCT01420081|157004061|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
48770014|NCT01420081|157004062|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
48770015|NCT01420081|157004063|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
48770016|NCT01420081|157004064|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
48770017|NCT01420081|157004065|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
48770018|NCT01420081|157004066|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
48770019|NCT01420081|157004067|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
48770020|NCT01420081|157004068|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
48770021|NCT01420081|157004060|FG000|Overall Study|Other Reasons|0|||
48770022|NCT01420081|157004061|FG001|Overall Study|Other Reasons|0|||
48770023|NCT01420081|157004062|FG002|Overall Study|Other Reasons|1|||
48770024|NCT01420081|157004063|FG003|Overall Study|Other Reasons|0|||
48770025|NCT01420081|157004064|FG004|Overall Study|Other Reasons|0|||
48770026|NCT01420081|157004065|FG005|Overall Study|Other Reasons|0|||
48770027|NCT01420081|157004066|FG006|Overall Study|Other Reasons|0|||
48770028|NCT01420081|157004067|FG007|Overall Study|Other Reasons|0|||
48770029|NCT01420081|157004068|FG008|Overall Study|Other Reasons|0|||
48770030|NCT00360334|157004069|FG000|Overall Study|Adverse Event|7|||
48770031|NCT00360334|157004070|FG001|Overall Study|Adverse Event|4|||
48770032|NCT00360334|157004069|FG000|Overall Study|Protocol Violation|1|||
48770033|NCT00360334|157004070|FG001|Overall Study|Protocol Violation|1|||
48770034|NCT00360334|157004069|FG000|Overall Study|Physician Decision|2|||
48770035|NCT00360334|157004070|FG001|Overall Study|Physician Decision|3|||
48770036|NCT00360334|157004069|FG000|Overall Study|Lack of Efficacy|0|||
48770037|NCT00360334|157004070|FG001|Overall Study|Lack of Efficacy|1|||
48770038|NCT00360334|157004069|FG000|Overall Study|Entry criterion not met|1|||
48770039|NCT00360334|157004070|FG001|Overall Study|Entry criterion not met|2|||
48770040|NCT00360334|157004069|FG000|Overall Study|Subject decision|8|||
48770041|NCT00360334|157004070|FG001|Overall Study|Subject decision|2|||
48770042|NCT01451424|157004072|FG000|Overall Study|Withdrawal by Subject|1|||
48770043|NCT01451424|157004073|FG001|Overall Study|Withdrawal by Subject|1|||
48770044|NCT01451424|157004074|FG002|Overall Study|Withdrawal by Subject|0|||
48770045|NCT01451424|157004075|FG003|Overall Study|Withdrawal by Subject|2|||
48770046|NCT01451424|157004072|FG000|Overall Study|Lost to Follow-up|0|||
48770047|NCT01451424|157004073|FG001|Overall Study|Lost to Follow-up|1|||
48770048|NCT01451424|157004074|FG002|Overall Study|Lost to Follow-up|0|||
48770049|NCT01451424|157004075|FG003|Overall Study|Lost to Follow-up|1|||
48770050|NCT01451424|157004072|FG000|Overall Study|Physician Decision|0|||
48770051|NCT01451424|157004073|FG001|Overall Study|Physician Decision|0|||
48770052|NCT01451424|157004074|FG002|Overall Study|Physician Decision|1|||
48770053|NCT01451424|157004075|FG003|Overall Study|Physician Decision|1|||
48770054|NCT01451424|157004072|FG000|Overall Study|Adverse Event|0|||
48770055|NCT01451424|157004073|FG001|Overall Study|Adverse Event|0|||
48770056|NCT01451424|157004074|FG002|Overall Study|Adverse Event|0|||
48770057|NCT01451424|157004075|FG003|Overall Study|Adverse Event|1|||
48770058|NCT04476030|157005717|FG000|Overall Study|Withdrawal by Subject|20|||
48770059|NCT04476030|157005718|FG001|Overall Study|Withdrawal by Subject|16|||
48770060|NCT04476030|157005717|FG000|Overall Study|Adverse Event|10|||
48770061|NCT04476030|157005718|FG001|Overall Study|Adverse Event|11|||
48770062|NCT04476030|157005717|FG000|Overall Study|Lost to Follow-up|7|||
48770063|NCT04476030|157005718|FG001|Overall Study|Lost to Follow-up|4|||
48770064|NCT04476030|157005717|FG000|Overall Study|Physician Decision|1|||
48770065|NCT04476030|157005718|FG001|Overall Study|Physician Decision|1|||
48770066|NCT04476030|157005717|FG000|Overall Study|Protocol Deviation|2|||
48770067|NCT04476030|157005718|FG001|Overall Study|Protocol Deviation|0|||
48770068|NCT04476030|157005717|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
48770069|NCT04476030|157005718|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
48770070|NCT04476030|157005717|FG000|Overall Study|Randomized but not Dosed|2|||
48770071|NCT04476030|157005718|FG001|Overall Study|Randomized but not Dosed|8|||
48770072|NCT02884089|157005719|FG000|Period 1|Dosing error|2|||
48770073|NCT02884089|157005720|FG001|Period 1|Dosing error|2|||
48770074|NCT02884089|157005721|FG002|Period 1|Dosing error|0|||
48770075|NCT02884089|157005722|FG003|Period 1|Dosing error|0|||
48770076|NCT02884089|157005719|FG000|Washout Period 1|Lost to Follow-up|0|||
48770077|NCT02884089|157005720|FG001|Washout Period 1|Lost to Follow-up|1|||
48770078|NCT02884089|157005721|FG002|Washout Period 1|Lost to Follow-up|0|||
48770079|NCT02884089|157005722|FG003|Washout Period 1|Lost to Follow-up|1|||
48770080|NCT02884089|157005719|FG000|Washout Period 1|Withdrawal by Subject|0|||
48770081|NCT02884089|157005720|FG001|Washout Period 1|Withdrawal by Subject|1|||
48770082|NCT02884089|157005721|FG002|Washout Period 1|Withdrawal by Subject|0|||
48770083|NCT02884089|157005722|FG003|Washout Period 1|Withdrawal by Subject|0|||
48770084|NCT02884089|157005719|FG000|Period 2|Adverse Event|1|||
48770085|NCT02884089|157005720|FG001|Period 2|Adverse Event|0|||
48770086|NCT02884089|157005721|FG002|Period 2|Adverse Event|0|||
48770087|NCT02884089|157005722|FG003|Period 2|Adverse Event|0|||
48770088|NCT02884089|157005719|FG000|Period 3|Withdrawal by Subject|0|||
48770089|NCT02884089|157005720|FG001|Period 3|Withdrawal by Subject|0|||
48770090|NCT02884089|157005721|FG002|Period 3|Withdrawal by Subject|1|||
48770091|NCT02884089|157005722|FG003|Period 3|Withdrawal by Subject|0|||
48770092|NCT02884089|157005719|FG000|Washout Period 3|Withdrawal by Subject|0|||
48770093|NCT02884089|157005720|FG001|Washout Period 3|Withdrawal by Subject|0|||
48770094|NCT02884089|157005721|FG002|Washout Period 3|Withdrawal by Subject|1|||
48770095|NCT02884089|157005722|FG003|Washout Period 3|Withdrawal by Subject|0|||
48770096|NCT02884089|157005719|FG000|Washout Period 3|Lost to Follow-up|0|||
48770097|NCT02884089|157005720|FG001|Washout Period 3|Lost to Follow-up|0|||
48770098|NCT02884089|157005721|FG002|Washout Period 3|Lost to Follow-up|0|||
48770099|NCT02884089|157005722|FG003|Washout Period 3|Lost to Follow-up|1|||
48770100|NCT02884089|157005719|FG000|Period 4|Withdrawal by Subject|0|||
48770101|NCT02884089|157005720|FG001|Period 4|Withdrawal by Subject|1|||
48770102|NCT02884089|157005721|FG002|Period 4|Withdrawal by Subject|0|||
48770103|NCT02884089|157005722|FG003|Period 4|Withdrawal by Subject|0|||
48770104|NCT02884089|157005719|FG000|Period 4|Lost to Follow-up|1|||
48770105|NCT02884089|157005720|FG001|Period 4|Lost to Follow-up|0|||
48770106|NCT02884089|157005721|FG002|Period 4|Lost to Follow-up|0|||
48770107|NCT02884089|157005722|FG003|Period 4|Lost to Follow-up|0|||
48770108|NCT02884089|157005719|FG000|Follow-up Visit|Withdrawal by Subject|1|||
48770109|NCT02884089|157005720|FG001|Follow-up Visit|Withdrawal by Subject|0|||
48770110|NCT02884089|157005721|FG002|Follow-up Visit|Withdrawal by Subject|0|||
48770111|NCT02884089|157005722|FG003|Follow-up Visit|Withdrawal by Subject|1|||
48770112|NCT02624284|157005723|FG000|Overall Study|Withdrawal by Subject|3|||
48770113|NCT02624284|157005724|FG001|Overall Study|Withdrawal by Subject|6|||
48770114|NCT02624284|157005725|FG002|Overall Study|Withdrawal by Subject|3|||
48770115|NCT02624284|157005723|FG000|Overall Study|Protocol Violation|9|||
48770116|NCT02624284|157005724|FG001|Overall Study|Protocol Violation|10|||
48770117|NCT02624284|157005725|FG002|Overall Study|Protocol Violation|7|||
48394956|NCT00401375|155639845|FG002|Overall Study|Lost to Follow-up|1|||
48394957|NCT00401375|155639843|FG000|Overall Study|Other than specified|2|||
48394958|NCT00401375|155639844|FG001|Overall Study|Other than specified|1|||
48394959|NCT00401375|155639845|FG002|Overall Study|Other than specified|3|||
48394960|NCT00401375|155639843|FG000|Overall Study|Randomized but not treated|3|||
48394961|NCT00401375|155639844|FG001|Overall Study|Randomized but not treated|3|||
48394962|NCT00401375|155639845|FG002|Overall Study|Randomized but not treated|3|||
48394963|NCT02821715|155639846|FG000|Overall Study|Protocol Violation|1|||
48394964|NCT02821715|155639847|FG001|Overall Study|Protocol Violation|0|||
48394965|NCT02821715|155639848|FG002|Overall Study|Protocol Violation|0|||
48394966|NCT02821715|155639849|FG003|Overall Study|Protocol Violation|0|||
48394967|NCT02821715|155639850|FG004|Overall Study|Protocol Violation|0|||
48394968|NCT02821715|155639851|FG005|Overall Study|Protocol Violation|0|||
48394969|NCT00137111|155639852|FG000|Total Therapy|Death|35|||
48394970|NCT00137111|155639853|FG001|Total Therapy|Death|0|||
48394971|NCT00137111|155639854|FG002|Total Therapy|Death|0|||
48394972|NCT00137111|155639855|FG003|Total Therapy|Death|0|||
48394973|NCT00137111|155639852|FG000|Total Therapy|Non Compliance|5|||
48394974|NCT00137111|155639853|FG001|Total Therapy|Non Compliance|0|||
48394975|NCT00137111|155639854|FG002|Total Therapy|Non Compliance|0|||
48770118|NCT02624284|157005723|FG000|Overall Study|Revealed exclusionary condition|2|||
48394976|NCT00137111|155639855|FG003|Total Therapy|Non Compliance|0|||
48394977|NCT01187953|155639860|FG000|Overall Study|Death|11|||
48770119|NCT02624284|157005724|FG001|Overall Study|Revealed exclusionary condition|2|||
48770120|NCT02624284|157005725|FG002|Overall Study|Revealed exclusionary condition|0|||
48770121|NCT02624284|157005723|FG000|Overall Study|Adverse Event|0|||
48770122|NCT02624284|157005724|FG001|Overall Study|Adverse Event|0|||
48770123|NCT02624284|157005725|FG002|Overall Study|Adverse Event|1|||
48770124|NCT00418691|157005727|FG000|Overall Study|Lost to Follow-up|1|||
48770125|NCT00418691|157005728|FG001|Overall Study|Lost to Follow-up|2|||
48770126|NCT00418691|157005729|FG002|Overall Study|Lost to Follow-up|3|||
48770127|NCT00418691|157005727|FG000|Overall Study|Started new medication voiding entry|0|||
48770128|NCT00418691|157005728|FG001|Overall Study|Started new medication voiding entry|0|||
48770129|NCT00418691|157005729|FG002|Overall Study|Started new medication voiding entry|1|||
48770130|NCT00418691|157005727|FG000|Overall Study|Progressive Disease|1|||
48770131|NCT00418691|157005728|FG001|Overall Study|Progressive Disease|0|||
48770132|NCT00418691|157005729|FG002|Overall Study|Progressive Disease|1|||
48770133|NCT00519649|157005734|FG000|Overall Study|Withdrawal by Subject|1|||
48770134|NCT01067352|157005739|FG000|Overall Study|Withdrawal by Subject|1|||
48770135|NCT01067352|157005740|FG001|Overall Study|Withdrawal by Subject|2|||
48770136|NCT01067352|157005741|FG002|Overall Study|Withdrawal by Subject|1|||
48770137|NCT01067352|157005739|FG000|Overall Study|Physician Decision|0|||
48770138|NCT01067352|157005740|FG001|Overall Study|Physician Decision|1|||
48770139|NCT01067352|157005741|FG002|Overall Study|Physician Decision|0|||
48770140|NCT00723606|157005743|FG000|Overall Study|Adverse Event|2|||
48770141|NCT00723606|157005744|FG001|Overall Study|Adverse Event|5|||
48770142|NCT00723606|157005743|FG000|Overall Study|Other|2|||
48770143|NCT00723606|157005744|FG001|Overall Study|Other|0|||
48770144|NCT00723606|157005743|FG000|Overall Study|Withdrawal by Subject|0|||
48770145|NCT00723606|157005744|FG001|Overall Study|Withdrawal by Subject|2|||
48770146|NCT00735371|157005751|FG000|Overall Study|Adverse Event|3|||
48770147|NCT00735371|157005752|FG001|Overall Study|Adverse Event|3|||
48770148|NCT00735371|157005753|FG002|Overall Study|Adverse Event|4|||
48770149|NCT00735371|157005754|FG003|Overall Study|Adverse Event|1|||
48770150|NCT00735371|157005751|FG000|Overall Study|Protocol Violation|2|||
48770151|NCT00735371|157005752|FG001|Overall Study|Protocol Violation|2|||
48770152|NCT00735371|157005753|FG002|Overall Study|Protocol Violation|0|||
48770153|NCT00735371|157005754|FG003|Overall Study|Protocol Violation|3|||
48770154|NCT00735371|157005751|FG000|Overall Study|Withdrawal by Subject|0|||
48770155|NCT00735371|157005752|FG001|Overall Study|Withdrawal by Subject|2|||
48394978|NCT01187953|155639861|FG001|Overall Study|Death|13|||
48394979|NCT01187953|155639860|FG000|Overall Study|Adverse Event|1|||
48394980|NCT01187953|155639861|FG001|Overall Study|Adverse Event|2|||
48394981|NCT01187953|155639860|FG000|Overall Study|Lost to Follow-up|0|||
48394982|NCT01187953|155639861|FG001|Overall Study|Lost to Follow-up|3|||
48394983|NCT01187953|155639860|FG000|Overall Study|Withdrawal by Subject|3|||
48770156|NCT00735371|157005753|FG002|Overall Study|Withdrawal by Subject|2|||
48770157|NCT00735371|157005754|FG003|Overall Study|Withdrawal by Subject|0|||
48770158|NCT00735371|157005751|FG000|Overall Study|Lost to Follow-up|1|||
48770159|NCT00735371|157005752|FG001|Overall Study|Lost to Follow-up|1|||
48770160|NCT00735371|157005753|FG002|Overall Study|Lost to Follow-up|3|||
48770161|NCT00735371|157005754|FG003|Overall Study|Lost to Follow-up|1|||
48770162|NCT00735371|157005751|FG000|Overall Study|Lack of Efficacy|4|||
48770163|NCT00735371|157005752|FG001|Overall Study|Lack of Efficacy|2|||
48770164|NCT00735371|157005753|FG002|Overall Study|Lack of Efficacy|0|||
48770165|NCT00735371|157005754|FG003|Overall Study|Lack of Efficacy|4|||
48770166|NCT00735371|157005751|FG000|Overall Study|Sponsor Decision|3|||
48770167|NCT00735371|157005752|FG001|Overall Study|Sponsor Decision|1|||
48770168|NCT00735371|157005753|FG002|Overall Study|Sponsor Decision|0|||
48770169|NCT00735371|157005754|FG003|Overall Study|Sponsor Decision|1|||
48770170|NCT00735371|157005751|FG000|Overall Study|Protocol Violation|0|||
48770171|NCT00735371|157005752|FG001|Overall Study|Protocol Violation|1|||
48770172|NCT00735371|157005753|FG002|Overall Study|Protocol Violation|2|||
48770173|NCT00735371|157005754|FG003|Overall Study|Protocol Violation|0|||
48770174|NCT00735371|157005751|FG000|Overall Study|Prior Vyvanse Exposure|1|||
48770175|NCT00735371|157005752|FG001|Overall Study|Prior Vyvanse Exposure|1|||
48770176|NCT00735371|157005753|FG002|Overall Study|Prior Vyvanse Exposure|0|||
48770177|NCT00735371|157005754|FG003|Overall Study|Prior Vyvanse Exposure|0|||
48770178|NCT00735371|157005751|FG000|Overall Study|Exclusion criteria|1|||
48770179|NCT00735371|157005752|FG001|Overall Study|Exclusion criteria|0|||
48770180|NCT00735371|157005753|FG002|Overall Study|Exclusion criteria|0|||
48770181|NCT00735371|157005754|FG003|Overall Study|Exclusion criteria|0|||
48770182|NCT00436748|157005757|FG000|Overall Study|Ineligibility Determined|1|||
48770183|NCT00436748|157005758|FG001|Overall Study|Ineligibility Determined|1|||
48770184|NCT00436748|157005757|FG000|Overall Study|Adverse Event|0|||
48770185|NCT00436748|157005758|FG001|Overall Study|Adverse Event|2|||
48770186|NCT00436748|157005757|FG000|Overall Study|Consent Withdrawn|1|||
48770187|NCT00436748|157005758|FG001|Overall Study|Consent Withdrawn|4|||
48770188|NCT00436748|157005757|FG000|Overall Study|Administrative Decision|1|||
48770189|NCT00436748|157005758|FG001|Overall Study|Administrative Decision|0|||
48770190|NCT00436748|157005757|FG000|Overall Study|Lost to Follow-up|0|||
48770191|NCT00436748|157005758|FG001|Overall Study|Lost to Follow-up|1|||
48770192|NCT00436748|157005757|FG000|Overall Study|Protocol-specified Criteria|5|||
48770193|NCT00436748|157005758|FG001|Overall Study|Protocol-specified Criteria|4|||
48770194|NCT00436748|157005757|FG000|Overall Study|Other|3|||
48770195|NCT00436748|157005758|FG001|Overall Study|Other|0|||
48770196|NCT01610791|157005759|FG000|Overall Study|Lost to Follow-up|7|||
48770197|NCT01610791|157005759|FG000|Overall Study|Adverse Event|6|||
48770198|NCT01610791|157005759|FG000|Overall Study|Physician Decision|1|||
48770199|NCT01610791|157005759|FG000|Overall Study|Adverse event and Investigator decision|1|||
48770200|NCT01610791|157005759|FG000|Overall Study|Death|1|||
48770201|NCT01610791|157005759|FG000|Overall Study|Not determined|5|||
48770202|NCT00482391|157005760|FG000|Overall Study|Withdrawal by Subject|1|||
48770203|NCT00482391|157005760|FG000|Overall Study|Adverse Event|1|||
48770204|NCT00482391|157005760|FG000|Overall Study|Death|1|||
48770205|NCT02711800|157005761|FG000|Overall Study|Lost to Follow-up|1|||
48770206|NCT02711800|157005761|FG000|Overall Study|Withdrawal by Subject|1|||
48770207|NCT01428193|157005762|FG000|Overall Study|Physician Decision|1|||
48770208|NCT01428193|157005762|FG000|Overall Study|Elevated screening liver enzymes|1|||
48770209|NCT02871375|157005763|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
48770210|NCT02871375|157005764|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
48770211|NCT00004412|157005767|FG000|Randomized Period|Moved to Crossover Period|3|||
48770212|NCT00004412|157005768|FG001|Randomized Period|Moved to Crossover Period|0|||
48770213|NCT00004412|157005769|FG002|Randomized Period|Moved to Crossover Period|0|||
48355976|NCT04367480|155500968|FG001|Overall Study|Adverse Event|1|||
48355977|NCT04367480|155500967|FG000|Overall Study|Death|1|||
48355978|NCT04367480|155500968|FG001|Overall Study|Death|0|||
48355979|NCT04367480|155500967|FG000|Overall Study|Lost to Follow-up|1|||
48355980|NCT04367480|155500968|FG001|Overall Study|Lost to Follow-up|1|||
48355981|NCT04367480|155500967|FG000|Overall Study|Withdrawal by Subject|0|||
48355982|NCT04367480|155500968|FG001|Overall Study|Withdrawal by Subject|3|||
48355983|NCT04367480|155500967|FG000|Overall Study|App glitch during the study|1|||
48355984|NCT04367480|155500968|FG001|Overall Study|App glitch during the study|0|||
48355985|NCT04367480|155500967|FG000|Overall Study|Device Distribution Error|0|||
48355986|NCT04367480|155500968|FG001|Overall Study|Device Distribution Error|2|||
48355987|NCT04367480|155500967|FG000|Overall Study|Ineligible after Randomization|0|||
48770214|NCT00727714|157005774|FG000|Overall Study|Lost to Follow-up|2|||
48770215|NCT02346136|157005776|FG000|Overall Study|Withdrawal by Subject|7|||
48770216|NCT02346136|157005777|FG001|Overall Study|Withdrawal by Subject|5|||
48770217|NCT02346136|157005776|FG000|Overall Study|Death|1|||
48770218|NCT02346136|157005777|FG001|Overall Study|Death|0|||
48355988|NCT04367480|155500968|FG001|Overall Study|Ineligible after Randomization|1|||
48770219|NCT02346136|157005776|FG000|Overall Study|Study termination|14|||
48770220|NCT02346136|157005777|FG001|Overall Study|Study termination|18|||
48770221|NCT02075320|157005780|FG000|Overall Study|Withdrawal by Subject|2|||
48770222|NCT00855309|157005784|FG000|Overall Study|patient never recieved drug|1|||
48770223|NCT00855309|157005785|FG001|Overall Study|patient never recieved drug|0|||
48770224|NCT01987427|157005790|FG000|Overall Study|Adverse Event|4|||
48770225|NCT01987427|157005791|FG001|Overall Study|Adverse Event|2|||
48770226|NCT01987427|157005792|FG002|Overall Study|Adverse Event|8|||
48770227|NCT01987427|157005790|FG000|Overall Study|Lost to Follow-up|6|||
48770228|NCT01987427|157005791|FG001|Overall Study|Lost to Follow-up|6|||
48770229|NCT01987427|157005792|FG002|Overall Study|Lost to Follow-up|9|||
48770230|NCT01987427|157005790|FG000|Overall Study|Withdrawal by Subject|2|||
48770231|NCT01987427|157005791|FG001|Overall Study|Withdrawal by Subject|1|||
48770232|NCT01987427|157005792|FG002|Overall Study|Withdrawal by Subject|3|||
48770233|NCT01987427|157005790|FG000|Overall Study|Lack of Efficacy|1|||
48770234|NCT01987427|157005791|FG001|Overall Study|Lack of Efficacy|0|||
48770235|NCT01987427|157005792|FG002|Overall Study|Lack of Efficacy|0|||
48770236|NCT01987427|157005790|FG000|Overall Study|Other|1|||
48770237|NCT01987427|157005791|FG001|Overall Study|Other|1|||
48770238|NCT01987427|157005792|FG002|Overall Study|Other|0|||
48770239|NCT01857063|157005794|FG000|Period 1 (7 Days)|Adverse Event|0|||
48770240|NCT01857063|157005795|FG001|Period 1 (7 Days)|Adverse Event|1|||
48770241|NCT01857063|157005794|FG000|Period 1 (7 Days)|Physician Decision|1|||
48770242|NCT01857063|157005795|FG001|Period 1 (7 Days)|Physician Decision|0|||
48770243|NCT01857063|157005794|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
48394984|NCT01187953|155639861|FG001|Overall Study|Withdrawal by Subject|3|||
48394985|NCT03861559|155639865|FG000|Overall Study|Adverse Event|0|||
48394986|NCT03861559|155639866|FG001|Overall Study|Adverse Event|2|||
48394987|NCT03861559|155639865|FG000|Overall Study|Treatment failure|0|||
48394988|NCT03861559|155639866|FG001|Overall Study|Treatment failure|2|||
48770244|NCT01857063|157005795|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
48770245|NCT01857063|157005794|FG000|Period 2 (7 Days)|Adverse Event|2|||
48770246|NCT01857063|157005795|FG001|Period 2 (7 Days)|Adverse Event|1|||
48770247|NCT01857063|157005794|FG000|Period 2 (7 Days)|Physician Decision|1|||
48770248|NCT01857063|157005795|FG001|Period 2 (7 Days)|Physician Decision|1|||
48770249|NCT01857063|157005794|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
48770250|NCT01857063|157005795|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
48770251|NCT01192152|157005796|FG000|Period 1|left prematurely (while on treatment B)|0|||
48770252|NCT01192152|157005797|FG001|Period 1|left prematurely (while on treatment B)|1|||
48770253|NCT01192152|157005796|FG000|Period 3|family emergency|1|||
48770254|NCT01192152|157005797|FG001|Period 3|family emergency|0|||
48770255|NCT02375672|157005798|FG000|Overall Study|remain on follow up|20|||
48770256|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770257|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
48770258|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
48770259|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
48770260|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770261|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770262|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770263|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770264|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770265|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770266|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770267|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770268|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770269|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770270|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770271|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770272|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770273|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770274|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770275|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770276|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770277|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770278|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48394989|NCT03861559|155639865|FG000|Overall Study|Noncompliance|1|||
48770279|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
48770280|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770281|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
48770282|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770283|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770284|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770285|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770286|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770287|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770288|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770289|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770290|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770291|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770292|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770293|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770294|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770295|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770296|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770297|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770298|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770299|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770300|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770301|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770302|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770303|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
48770304|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770305|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
48770306|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770307|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770308|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770309|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770310|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770311|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770312|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770313|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770314|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770315|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770316|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770317|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770318|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770319|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770320|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770321|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770322|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770323|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770324|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770325|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770326|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770327|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
48770328|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
48770329|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
48770330|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
48770331|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
48770332|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770333|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770334|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770335|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770336|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770337|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770338|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770339|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770340|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770341|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770342|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770343|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48394990|NCT03861559|155639866|FG001|Overall Study|Noncompliance|1|||
48394991|NCT03861559|155639865|FG000|Overall Study|Did not meet eligibility requirements|1|||
48394992|NCT03861559|155639866|FG001|Overall Study|Did not meet eligibility requirements|0|||
48394993|NCT03440814|155639868|FG000|Overall Study|Adverse Event|2|||
48394994|NCT03440814|155639869|FG001|Overall Study|Adverse Event|1|||
48394995|NCT03440814|155639868|FG000|Overall Study|Lost to Follow-up|2|||
48770344|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770345|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770346|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48394996|NCT03440814|155639869|FG001|Overall Study|Lost to Follow-up|0|||
48394997|NCT03440814|155639868|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
48394998|NCT03440814|155639869|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
48394999|NCT00879697|155639870|FG000|Overall Study|Physician Decision|2|||
48395000|NCT00879697|155639871|FG001|Overall Study|Physician Decision|2|||
48395001|NCT02500121|155639872|FG000|Overall Study|Lost to Follow-up|0|||
48395002|NCT02500121|155639873|FG001|Overall Study|Lost to Follow-up|1|||
48395003|NCT02500121|155639872|FG000|Overall Study|Withdrawal by Subject|1|||
48395004|NCT02500121|155639873|FG001|Overall Study|Withdrawal by Subject|1|||
48395005|NCT02500121|155639872|FG000|Overall Study|Death|26|||
48395006|NCT02500121|155639873|FG001|Overall Study|Death|24|||
48395007|NCT02457637|155639874|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
48395008|NCT01437397|155639875|FG000|Overall Study|Lost to Follow-up|9|||
48395009|NCT01437397|155639876|FG001|Overall Study|Lost to Follow-up|4|||
48395010|NCT01437397|155639877|FG002|Overall Study|Lost to Follow-up|2|||
48395011|NCT01437397|155639878|FG003|Overall Study|Lost to Follow-up|4|||
48395012|NCT01437397|155639879|FG004|Overall Study|Lost to Follow-up|5|||
48395013|NCT01437397|155639875|FG000|Overall Study|Withdrawal by Subject|11|||
48395014|NCT01437397|155639876|FG001|Overall Study|Withdrawal by Subject|12|||
48395015|NCT01437397|155639877|FG002|Overall Study|Withdrawal by Subject|24|||
48395016|NCT01437397|155639878|FG003|Overall Study|Withdrawal by Subject|11|||
48395017|NCT01437397|155639879|FG004|Overall Study|Withdrawal by Subject|22|||
48395018|NCT01437397|155639875|FG000|Overall Study|Protocol Violation|10|||
48770347|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770348|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770349|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770350|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770351|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
48770352|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
48770353|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
48770354|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
48770355|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
48770356|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770357|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770358|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770359|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770360|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770361|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770362|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770363|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770364|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770365|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770366|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770367|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770368|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770369|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770370|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770371|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770372|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770373|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770374|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770375|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
48770376|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770377|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
48770378|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770379|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
48770380|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770381|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770382|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770383|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770384|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770385|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770386|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770387|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48395019|NCT01437397|155639876|FG001|Overall Study|Protocol Violation|12|||
48395020|NCT01437397|155639877|FG002|Overall Study|Protocol Violation|13|||
48770388|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48395021|NCT01437397|155639878|FG003|Overall Study|Protocol Violation|21|||
48395022|NCT01437397|155639879|FG004|Overall Study|Protocol Violation|19|||
48770389|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770390|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770391|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770392|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770393|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770394|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770395|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770396|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770397|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770398|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770399|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
48770400|NCT02346240|157005803|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770401|NCT02346240|157005804|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770402|NCT02346240|157005805|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
48770403|NCT02346240|157005806|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770404|NCT02346240|157005807|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770405|NCT02346240|157005808|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770406|NCT02346240|157005809|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770407|NCT02346240|157005810|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770408|NCT02346240|157005811|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770409|NCT02346240|157005812|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770410|NCT02346240|157005813|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770411|NCT02346240|157005814|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770412|NCT02346240|157005815|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770413|NCT02346240|157005816|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770414|NCT02346240|157005817|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770415|NCT02346240|157005818|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770416|NCT02346240|157005819|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770417|NCT02346240|157005820|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770418|NCT02346240|157005821|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770419|NCT02346240|157005822|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770420|NCT02346240|157005823|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770421|NCT02346240|157005824|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770422|NCT02346240|157005825|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770423|NCT02346240|157005826|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
48770424|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770425|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770426|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770427|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770428|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770429|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770430|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770431|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
48770432|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
48770433|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770434|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770435|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770436|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770437|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
48770438|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
48770439|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
48770440|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
48770441|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770442|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770443|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770444|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770445|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770446|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770447|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
48770448|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770449|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770450|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48395023|NCT01437397|155639875|FG000|Overall Study|Lack of Efficacy|5|||
48770451|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770452|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770453|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770454|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770455|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770456|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770457|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770458|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770459|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770460|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770461|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
48770462|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770463|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
48770464|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770465|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770466|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770467|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770468|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770469|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770470|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770471|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
48770472|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770473|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770474|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770475|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770476|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770477|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770478|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770479|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770480|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770481|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770482|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770483|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770484|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770485|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770486|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
48770487|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770488|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770489|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770490|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770491|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770492|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770493|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770494|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770495|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
48770496|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770497|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770498|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770499|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770500|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48395024|NCT01437397|155639876|FG001|Overall Study|Lack of Efficacy|4|||
48395025|NCT01437397|155639877|FG002|Overall Study|Lack of Efficacy|8|||
48395026|NCT01437397|155639878|FG003|Overall Study|Lack of Efficacy|10|||
48395027|NCT01437397|155639879|FG004|Overall Study|Lack of Efficacy|20|||
48395028|NCT01437397|155639875|FG000|Overall Study|Adverse Event|21|||
48395029|NCT01437397|155639876|FG001|Overall Study|Adverse Event|22|||
48395030|NCT01437397|155639877|FG002|Overall Study|Adverse Event|16|||
48395031|NCT01437397|155639878|FG003|Overall Study|Adverse Event|14|||
48770501|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770502|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48797695|NCT00828984|157097048|FG002|Overall Study|ConMed|1|||
48797696|NCT01733732|157097049|FG000|Overall Study|Adverse Event|1|||
48797697|NCT01733732|157097050|FG001|Overall Study|Adverse Event|0|||
48797698|NCT01733732|157097049|FG000|Overall Study|Did not attend all study visits|1|||
48395032|NCT01437397|155639879|FG004|Overall Study|Adverse Event|21|||
48395033|NCT01437397|155639875|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
48395034|NCT01437397|155639876|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
48395035|NCT01437397|155639877|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
48770503|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770504|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770505|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770506|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770507|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
48770508|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770509|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
48770510|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
48770511|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
48770512|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
48770513|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770514|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770515|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770516|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770517|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770518|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770519|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
48770520|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770521|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770522|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770523|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770524|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770525|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770526|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770527|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770528|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770529|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770530|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770531|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770532|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770533|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
48770534|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
48770535|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
48770536|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
48770537|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770538|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770539|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770540|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770541|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770542|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770543|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
48770544|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770545|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770546|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770547|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770548|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770549|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770550|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
48770551|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770552|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770553|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770554|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770555|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48395036|NCT01437397|155639878|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
48395037|NCT01437397|155639879|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
48395038|NCT01273883|155639880|FG000|First Intervention|Adverse Event|2|||
48395039|NCT01273883|155639881|FG001|First Intervention|Adverse Event|1|||
48395040|NCT01273883|155639880|FG000|Second Intervention|Lost to Follow-up|1|||
48395041|NCT01273883|155639881|FG001|Second Intervention|Lost to Follow-up|1|||
48395042|NCT01273883|155639880|FG000|Second Intervention|Lack of Efficacy|1|||
48395043|NCT01273883|155639881|FG001|Second Intervention|Lack of Efficacy|0|||
48395044|NCT00371865|155639882|FG000|Overall Study|Lack of Efficacy|0|||
48395045|NCT00371865|155639883|FG001|Overall Study|Lack of Efficacy|2|||
48770556|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770557|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770558|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770559|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770560|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770561|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770562|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770563|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770564|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770565|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770566|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770567|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
48770568|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770569|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770570|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770571|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770572|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770573|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770574|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770575|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770576|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
48770577|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770578|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770579|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
48770580|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770581|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
48770582|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
48770583|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770584|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770585|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770586|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770587|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770588|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770589|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770590|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770591|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
48770592|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770593|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770594|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770595|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770596|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770597|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770598|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770599|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770600|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770601|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
48770602|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770603|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770604|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770605|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770606|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770607|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770608|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770609|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770610|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770611|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770612|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770613|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770614|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770615|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
48770616|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770617|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770618|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770619|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770620|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770621|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770622|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770623|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770624|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770625|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770626|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
48770627|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770628|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770629|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770630|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770631|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770632|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770633|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770634|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770635|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770636|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770637|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770638|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770639|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
48770640|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770641|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770642|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770643|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770644|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770645|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770646|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770647|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770648|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770649|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770650|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770651|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770652|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770653|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770654|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
48770655|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770656|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770657|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770658|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770659|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770660|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770661|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770662|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770663|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
48770664|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770665|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48395046|NCT00371865|155639882|FG000|Overall Study|Protocol Violation|3|||
48395047|NCT00371865|155639883|FG001|Overall Study|Protocol Violation|2|||
48395048|NCT00371865|155639882|FG000|Overall Study|Withdrawal by Subject|12|||
48395049|NCT00371865|155639883|FG001|Overall Study|Withdrawal by Subject|10|||
48770666|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770667|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770668|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770669|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770670|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770671|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770672|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770673|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770674|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770675|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770676|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770677|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770678|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
48770679|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770680|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770681|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770682|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770683|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770684|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770685|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770686|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770687|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
48770688|NCT02346240|157005803|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770689|NCT02346240|157005804|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770690|NCT02346240|157005805|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770691|NCT02346240|157005806|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770692|NCT02346240|157005807|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770693|NCT02346240|157005808|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770694|NCT02346240|157005809|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770695|NCT02346240|157005810|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48395050|NCT04042103|155639886|FG000|Overall Study|Lost to Follow-up|1|||
48770696|NCT02346240|157005811|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770697|NCT02346240|157005812|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770698|NCT02346240|157005813|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770699|NCT02346240|157005814|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770700|NCT02346240|157005815|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48797699|NCT01733732|157097050|FG001|Overall Study|Did not attend all study visits|0|||
48395051|NCT04042103|155639886|FG000|Overall Study|Withdrawal by Subject|1|||
48395052|NCT00894556|155639891|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
48395053|NCT00894556|155639892|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
48355989|NCT04367480|155500967|FG000|Overall Study|Other Medical Reasons|0|||
48355990|NCT04367480|155500968|FG001|Overall Study|Other Medical Reasons|2|||
48355991|NCT01131104|155500969|FG000|Overall Study|Withdrawal by Subject|3|||
48355992|NCT01131104|155500969|FG000|Overall Study|Physician Decision|4|||
48355993|NCT01131104|155500969|FG000|Overall Study|Information Not Available|5|||
48355994|NCT01131104|155500969|FG000|Overall Study|No Information on Index Date of Onset|1|||
48355995|NCT02525692|155500975|FG000|Overall Study|Withdrawal by Subject|1|||
48355996|NCT02525692|155500976|FG001|Overall Study|Withdrawal by Subject|1|||
48355997|NCT02525692|155500977|FG002|Overall Study|Withdrawal by Subject|0|||
48355998|NCT02525692|155500978|FG003|Overall Study|Withdrawal by Subject|5|||
48355999|NCT02525692|155500979|FG004|Overall Study|Withdrawal by Subject|0|||
48356000|NCT02525692|155500980|FG005|Overall Study|Withdrawal by Subject|1|||
48356001|NCT02525692|155500975|FG000|Overall Study|Death|16|||
48356002|NCT02525692|155500976|FG001|Overall Study|Death|18|||
48356003|NCT02525692|155500977|FG002|Overall Study|Death|7|||
48356004|NCT02525692|155500978|FG003|Overall Study|Death|20|||
48356005|NCT02525692|155500979|FG004|Overall Study|Death|3|||
48356006|NCT02525692|155500980|FG005|Overall Study|Death|6|||
48356007|NCT02525692|155500975|FG000|Overall Study|Lost to Follow-up|0|||
48356008|NCT02525692|155500976|FG001|Overall Study|Lost to Follow-up|0|||
48356009|NCT02525692|155500977|FG002|Overall Study|Lost to Follow-up|1|||
48356010|NCT02525692|155500978|FG003|Overall Study|Lost to Follow-up|5|||
48356011|NCT02525692|155500979|FG004|Overall Study|Lost to Follow-up|0|||
48356012|NCT02525692|155500980|FG005|Overall Study|Lost to Follow-up|0|||
48356013|NCT02271984|155500981|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356014|NCT02271984|155500982|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48770701|NCT02346240|157005816|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770702|NCT02346240|157005817|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
48395054|NCT00894556|155639893|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
48395055|NCT00894556|155639894|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
48770703|NCT02346240|157005818|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770704|NCT02346240|157005819|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770705|NCT02346240|157005820|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770706|NCT02346240|157005821|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770707|NCT02346240|157005822|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770708|NCT02346240|157005823|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770709|NCT02346240|157005824|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770710|NCT02346240|157005825|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770711|NCT02346240|157005826|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
48770712|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770713|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770714|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770715|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770716|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770717|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770718|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770719|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770720|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770721|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770722|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770723|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770724|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770725|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770726|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770727|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770728|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
48770729|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
48770730|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
48770731|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
48770732|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
48770733|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
48770734|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
48770735|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
48770736|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770737|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770738|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770739|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770740|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770741|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770742|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770743|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770744|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770745|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770746|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770747|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770748|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770749|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770750|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770751|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770752|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770753|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770754|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
48770755|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
48770756|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770757|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
48770758|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770759|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
48770760|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770761|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48395056|NCT00894556|155639891|FG000|Treatment Phase|Lost to Follow-up|2|||
48770762|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770763|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770764|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770765|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770766|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770767|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770768|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770769|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770770|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770771|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770772|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770773|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770774|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770775|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770776|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770777|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770778|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
48770779|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770780|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770781|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
48770782|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770783|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
48770784|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770785|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770786|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770787|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770788|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770789|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48356015|NCT02271984|155500983|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356016|NCT02271984|155500984|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356017|NCT02271984|155500985|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356018|NCT02271984|155500986|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
48356019|NCT02271984|155500987|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356020|NCT02271984|155500988|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
48356021|NCT02271984|155500989|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356022|NCT02271984|155500990|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356023|NCT02271984|155500991|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356024|NCT02271984|155500992|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
48356025|NCT00863512|155500994|FG000|Overall Study|Adverse Event|2|||
48356026|NCT00863512|155500995|FG001|Overall Study|Adverse Event|0|||
48356027|NCT00863512|155500994|FG000|Overall Study|Withdrawal by Subject|11|||
48356028|NCT00863512|155500995|FG001|Overall Study|Withdrawal by Subject|0|||
48356029|NCT00863512|155500994|FG000|Overall Study|Physician Decision|1|||
48356030|NCT00863512|155500995|FG001|Overall Study|Physician Decision|0|||
48356031|NCT01107899|155501000|FG000|Overall Study|Physician Decision|5|||
48356032|NCT01107899|155501001|FG001|Overall Study|Physician Decision|0|||
48356033|NCT01107899|155501002|FG002|Overall Study|Physician Decision|3|||
48356034|NCT01107899|155501000|FG000|Overall Study|Withdrawal by Subject|0|||
48356035|NCT01107899|155501001|FG001|Overall Study|Withdrawal by Subject|0|||
48356036|NCT01107899|155501002|FG002|Overall Study|Withdrawal by Subject|1|||
48356037|NCT01454739|155501004|FG000|Overall Study|Protocol Violation|2|||
48395057|NCT00894556|155639892|FG001|Treatment Phase|Lost to Follow-up|3|||
48395058|NCT00894556|155639893|FG002|Treatment Phase|Lost to Follow-up|1|||
48395059|NCT00894556|155639894|FG003|Treatment Phase|Lost to Follow-up|0|||
48395060|NCT00894556|155639891|FG000|Treatment Phase|Lack of Qualifying Event|2|||
48395061|NCT00894556|155639892|FG001|Treatment Phase|Lack of Qualifying Event|1|||
48395062|NCT00894556|155639893|FG002|Treatment Phase|Lack of Qualifying Event|0|||
48395063|NCT00894556|155639894|FG003|Treatment Phase|Lack of Qualifying Event|0|||
48395064|NCT02289950|155639895|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
48395065|NCT02289950|155639896|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
48395066|NCT02289950|155639895|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
48770790|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770791|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770792|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770793|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770794|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770795|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770796|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770797|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770798|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770799|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770800|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770801|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770802|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770803|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770804|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770805|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
48770806|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770807|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
48770808|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770809|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770810|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770811|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770812|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770813|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770814|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770815|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770816|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770817|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770818|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770819|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770820|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770821|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770822|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770823|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770824|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770825|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
48770826|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
48770827|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
48770828|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
48770829|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
48770830|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
48770831|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
48770832|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48395067|NCT02289950|155639896|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
48770833|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770834|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770835|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770836|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770837|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770838|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770839|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770840|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770841|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770842|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48395068|NCT02289950|155639895|FG000|Overall Study|Lost to Follow-up|1|||
48395069|NCT02289950|155639896|FG001|Overall Study|Lost to Follow-up|0|||
48395070|NCT02289950|155639895|FG000|Overall Study|Physician Decision|9|||
48395071|NCT02289950|155639896|FG001|Overall Study|Physician Decision|3|||
48395072|NCT02289950|155639895|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
48395073|NCT02289950|155639896|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
48395074|NCT02289950|155639895|FG000|Overall Study|Withdrawal by Subject|1|||
48395075|NCT02289950|155639896|FG001|Overall Study|Withdrawal by Subject|3|||
48395076|NCT02289950|155639895|FG000|Overall Study|Test article held for greater than 28 days|0|||
48395077|NCT02289950|155639896|FG001|Overall Study|Test article held for greater than 28 days|1|||
48395078|NCT02289950|155639895|FG000|Overall Study|Adverse Event|11|||
48395079|NCT02289950|155639896|FG001|Overall Study|Adverse Event|3|||
48395080|NCT02289950|155639895|FG000|Overall Study|Death|1|||
48395081|NCT02289950|155639896|FG001|Overall Study|Death|1|||
48395082|NCT02289950|155639895|FG000|Overall Study|Other|5|||
48395083|NCT02289950|155639896|FG001|Overall Study|Other|2|||
48395084|NCT02289950|155639895|FG000|Overall Study|Not Treated|2|||
48395085|NCT02289950|155639896|FG001|Overall Study|Not Treated|1|||
48395086|NCT03829657|155639901|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
48770843|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770844|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770845|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770846|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770847|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770848|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770849|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770850|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
48770851|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
48770852|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
48770853|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
48770854|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
48770855|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
48770856|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770857|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770858|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770859|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770860|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770861|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770862|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770863|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770864|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770865|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770866|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770867|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770868|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770869|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770870|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770871|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770872|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770873|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770874|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
48770875|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770876|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
48770877|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
48770878|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
48770879|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
48770880|NCT02346240|157005803|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770881|NCT02346240|157005804|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770882|NCT02346240|157005805|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770883|NCT02346240|157005806|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770884|NCT02346240|157005807|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770885|NCT02346240|157005808|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770886|NCT02346240|157005809|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48395087|NCT03829657|155639902|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
48770887|NCT02346240|157005810|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770888|NCT02346240|157005811|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770889|NCT02346240|157005812|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770890|NCT02346240|157005813|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770891|NCT02346240|157005814|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770892|NCT02346240|157005815|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770893|NCT02346240|157005816|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770894|NCT02346240|157005817|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770895|NCT02346240|157005818|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770896|NCT02346240|157005819|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770897|NCT02346240|157005820|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770898|NCT02346240|157005821|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
48770899|NCT02346240|157005822|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770900|NCT02346240|157005823|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770901|NCT02346240|157005824|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770902|NCT02346240|157005825|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770903|NCT02346240|157005826|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
48770904|NCT01849588|157005827|FG000|Overall Study|Lack of Efficacy|3|||
48770905|NCT04399161|157005828|FG000|Overall Study|Withdrawal by Subject|1|||
48770906|NCT04399161|157005829|FG001|Overall Study|Withdrawal by Subject|0|||
48770907|NCT04399161|157005830|FG002|Overall Study|Withdrawal by Subject|2|||
48770908|NCT04399161|157005828|FG000|Overall Study|Protocol Violation|1|||
48770909|NCT04399161|157005829|FG001|Overall Study|Protocol Violation|2|||
48770910|NCT04399161|157005830|FG002|Overall Study|Protocol Violation|0|||
48770911|NCT03571516|157005833|FG000|Overall Study|Severe diarrhea|1|||
48395088|NCT03829657|155639903|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
48395089|NCT03829657|155639904|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
48395090|NCT03829657|155639905|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
48395091|NCT03829657|155639901|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
48395092|NCT03829657|155639902|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
48395093|NCT03829657|155639903|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
48395094|NCT03829657|155639904|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
48395095|NCT03829657|155639905|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
48395096|NCT03829657|155639901|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
48395097|NCT03829657|155639902|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
48395098|NCT03829657|155639903|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
48395099|NCT03829657|155639904|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
48395100|NCT03829657|155639905|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
48395101|NCT03829657|155639901|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
48395102|NCT03829657|155639902|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
48395103|NCT03829657|155639903|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
48395104|NCT03829657|155639904|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
48395105|NCT03829657|155639905|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
48395106|NCT03829657|155639901|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
48395107|NCT03829657|155639902|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
48395108|NCT03829657|155639903|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
48395109|NCT03829657|155639904|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
48395110|NCT03829657|155639905|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
48770912|NCT03571516|157005834|FG001|Overall Study|Severe diarrhea|0|||
48395111|NCT03829657|155639901|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
48395112|NCT03829657|155639902|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
48395113|NCT03829657|155639903|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
48395114|NCT03829657|155639904|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
48395115|NCT03829657|155639905|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
48395116|NCT03829657|155639901|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
48395117|NCT03829657|155639902|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
48395118|NCT03829657|155639903|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
48395119|NCT03829657|155639904|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
48770913|NCT03571516|157005833|FG000|Overall Study|Withdrawal by Subject|0|||
48770914|NCT03571516|157005834|FG001|Overall Study|Withdrawal by Subject|1|||
48770915|NCT01541826|157005835|FG000|Overall Study|Lost to Follow-up|2|||
48770916|NCT01541826|157005836|FG001|Overall Study|Lost to Follow-up|3|||
48770917|NCT01541826|157005837|FG002|Overall Study|Lost to Follow-up|0|||
48770918|NCT01541826|157005835|FG000|Overall Study|Withdrawal by Subject|2|||
48770919|NCT01541826|157005836|FG001|Overall Study|Withdrawal by Subject|0|||
48770920|NCT01541826|157005837|FG002|Overall Study|Withdrawal by Subject|0|||
48770921|NCT02673775|157005838|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
48770922|NCT02673775|157005839|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
48770923|NCT02673775|157005838|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
48770924|NCT02673775|157005839|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
48770925|NCT02673775|157005838|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
48770926|NCT02673775|157005839|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
48770927|NCT02673775|157005838|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
48770928|NCT02673775|157005839|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
48770929|NCT03299192|157005845|FG000|Overall Study|Fell before classes started|1|||
48770930|NCT03299192|157005846|FG001|Overall Study|Fell before classes started|0|||
48770931|NCT03299192|157005847|FG002|Overall Study|Fell before classes started|0|||
48770932|NCT03299192|157005845|FG000|Overall Study|Other|0|||
48770933|NCT03299192|157005846|FG001|Overall Study|Other|2|||
48770934|NCT03299192|157005847|FG002|Overall Study|Other|1|||
48770935|NCT01365273|157005848|FG000|Overall Study|Lost to Follow-up|1|||
48770936|NCT01365273|157005849|FG001|Overall Study|Lost to Follow-up|0|||
48770937|NCT01365273|157005848|FG000|Overall Study|Protocol Violation|0|||
48770938|NCT01365273|157005849|FG001|Overall Study|Protocol Violation|1|||
48770939|NCT01365273|157005848|FG000|Overall Study|Physician Decision|1|||
48770940|NCT01365273|157005849|FG001|Overall Study|Physician Decision|0|||
48770941|NCT00378703|157005852|FG000|Overall Study|Disease progression|59|||
48770942|NCT00378703|157005853|FG001|Overall Study|Disease progression|43|||
48770943|NCT00378703|157005854|FG002|Overall Study|Disease progression|48|||
48770944|NCT00378703|157005855|FG003|Overall Study|Disease progression|49|||
48770945|NCT00378703|157005852|FG000|Overall Study|Adverse Event|11|||
48770946|NCT00378703|157005853|FG001|Overall Study|Adverse Event|17|||
48770947|NCT00378703|157005854|FG002|Overall Study|Adverse Event|20|||
48770948|NCT00378703|157005855|FG003|Overall Study|Adverse Event|18|||
48770949|NCT00378703|157005852|FG000|Overall Study|Death|2|||
48770950|NCT00378703|157005853|FG001|Overall Study|Death|2|||
48770951|NCT00378703|157005854|FG002|Overall Study|Death|4|||
48770952|NCT00378703|157005855|FG003|Overall Study|Death|3|||
48770953|NCT00378703|157005852|FG000|Overall Study|Withdrawal by Subject|4|||
48770954|NCT00378703|157005853|FG001|Overall Study|Withdrawal by Subject|8|||
48770955|NCT00378703|157005854|FG002|Overall Study|Withdrawal by Subject|5|||
48770956|NCT00378703|157005855|FG003|Overall Study|Withdrawal by Subject|7|||
48770957|NCT00378703|157005852|FG000|Overall Study|Physician Decision|1|||
48770958|NCT00378703|157005853|FG001|Overall Study|Physician Decision|4|||
48770959|NCT00378703|157005854|FG002|Overall Study|Physician Decision|1|||
48770960|NCT00378703|157005855|FG003|Overall Study|Physician Decision|0|||
48770961|NCT00378703|157005852|FG000|Overall Study|Alternative therapy|4|||
48770962|NCT00378703|157005853|FG001|Overall Study|Alternative therapy|2|||
48770963|NCT00378703|157005854|FG002|Overall Study|Alternative therapy|0|||
48770964|NCT00378703|157005855|FG003|Overall Study|Alternative therapy|0|||
48770965|NCT00378703|157005852|FG000|Overall Study|Other complicated disease|0|||
48770966|NCT00378703|157005853|FG001|Overall Study|Other complicated disease|2|||
48770967|NCT00378703|157005854|FG002|Overall Study|Other complicated disease|2|||
48770968|NCT00378703|157005855|FG003|Overall Study|Other complicated disease|0|||
48770969|NCT00378703|157005852|FG000|Overall Study|Symptomatic deterioration|0|||
48770970|NCT00378703|157005853|FG001|Overall Study|Symptomatic deterioration|1|||
48770971|NCT00378703|157005854|FG002|Overall Study|Symptomatic deterioration|0|||
48770972|NCT00378703|157005855|FG003|Overall Study|Symptomatic deterioration|2|||
48770973|NCT00378703|157005852|FG000|Overall Study|Surgery|1|||
48770974|NCT00378703|157005853|FG001|Overall Study|Surgery|0|||
48770975|NCT00378703|157005854|FG002|Overall Study|Surgery|0|||
48770976|NCT00378703|157005855|FG003|Overall Study|Surgery|1|||
48770977|NCT00378703|157005852|FG000|Overall Study|Joint decision of physician and patient|1|||
48770978|NCT00378703|157005853|FG001|Overall Study|Joint decision of physician and patient|0|||
48770979|NCT00378703|157005854|FG002|Overall Study|Joint decision of physician and patient|0|||
48770980|NCT00378703|157005855|FG003|Overall Study|Joint decision of physician and patient|0|||
48770981|NCT00378703|157005852|FG000|Overall Study|Adverse events and progressive disease|0|||
48395120|NCT03829657|155639905|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
48395121|NCT03829657|155639901|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
48770982|NCT00378703|157005853|FG001|Overall Study|Adverse events and progressive disease|0|||
48770983|NCT00378703|157005854|FG002|Overall Study|Adverse events and progressive disease|0|||
48770984|NCT00378703|157005855|FG003|Overall Study|Adverse events and progressive disease|1|||
48770985|NCT00378703|157005852|FG000|Overall Study|Relocation|0|||
48770986|NCT00378703|157005853|FG001|Overall Study|Relocation|0|||
48770987|NCT00378703|157005854|FG002|Overall Study|Relocation|1|||
48770988|NCT00378703|157005855|FG003|Overall Study|Relocation|0|||
48770989|NCT00378703|157005852|FG000|Overall Study|Ineligible|4|||
48770990|NCT00378703|157005853|FG001|Overall Study|Ineligible|7|||
48770991|NCT00378703|157005854|FG002|Overall Study|Ineligible|7|||
48770992|NCT00378703|157005855|FG003|Overall Study|Ineligible|7|||
48770993|NCT00378703|157005852|FG000|Overall Study|Never started treatment|1|||
48770994|NCT00378703|157005853|FG001|Overall Study|Never started treatment|4|||
48770995|NCT00378703|157005854|FG002|Overall Study|Never started treatment|0|||
48770996|NCT00378703|157005855|FG003|Overall Study|Never started treatment|0|||
48770997|NCT00378703|157005852|FG000|Overall Study|Other|1|||
48770998|NCT00378703|157005853|FG001|Overall Study|Other|1|||
48770999|NCT00378703|157005854|FG002|Overall Study|Other|2|||
48771000|NCT00378703|157005855|FG003|Overall Study|Other|3|||
48771001|NCT05402995|157005856|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
48771002|NCT05402995|157005857|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
48771003|NCT05402995|157005858|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
48771004|NCT05402995|157005859|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
48771005|NCT00205712|157005860|FG000|Overall Study|Lost to Follow-up|0|||
48771006|NCT00205712|157005861|FG001|Overall Study|Lost to Follow-up|1|||
48771007|NCT03385239|157005866|FG000|Overall Study|Voluntary Withdrawal|2|||
48771008|NCT03385239|157005867|FG001|Overall Study|Voluntary Withdrawal|3|||
48771009|NCT03385239|157005868|FG002|Overall Study|Voluntary Withdrawal|2|||
48771010|NCT03385239|157005869|FG003|Overall Study|Voluntary Withdrawal|3|||
48771011|NCT03385239|157005870|FG004|Overall Study|Voluntary Withdrawal|0|||
48771012|NCT03385239|157005866|FG000|Overall Study|Adverse Event|0|||
48771013|NCT03385239|157005867|FG001|Overall Study|Adverse Event|0|||
48771014|NCT03385239|157005868|FG002|Overall Study|Adverse Event|1|||
48771015|NCT03385239|157005869|FG003|Overall Study|Adverse Event|0|||
48771016|NCT03385239|157005870|FG004|Overall Study|Adverse Event|0|||
48771017|NCT03385239|157005866|FG000|Overall Study|Other|0|||
48771018|NCT03385239|157005867|FG001|Overall Study|Other|0|||
48771019|NCT03385239|157005868|FG002|Overall Study|Other|0|||
48771020|NCT03385239|157005869|FG003|Overall Study|Other|1|||
48771021|NCT03385239|157005870|FG004|Overall Study|Other|0|||
48771022|NCT02501096|157005871|FG000|Overall Study|Lost to Follow-up|0|||
48771023|NCT02501096|157005872|FG001|Overall Study|Lost to Follow-up|0|||
48771024|NCT02501096|157005873|FG002|Overall Study|Lost to Follow-up|0|||
48771025|NCT02501096|157005874|FG003|Overall Study|Lost to Follow-up|0|||
48771026|NCT02501096|157005875|FG004|Overall Study|Lost to Follow-up|1|||
48771027|NCT02501096|157005876|FG005|Overall Study|Lost to Follow-up|1|||
48771028|NCT02501096|157005877|FG006|Overall Study|Lost to Follow-up|3|||
48771029|NCT02501096|157005878|FG007|Overall Study|Lost to Follow-up|0|||
48771030|NCT02501096|157005879|FG008|Overall Study|Lost to Follow-up|0|||
48771031|NCT02501096|157005871|FG000|Overall Study|Withdrawal by Subject|1|||
48771032|NCT02501096|157005872|FG001|Overall Study|Withdrawal by Subject|0|||
48771033|NCT02501096|157005873|FG002|Overall Study|Withdrawal by Subject|7|||
48771034|NCT02501096|157005874|FG003|Overall Study|Withdrawal by Subject|13|||
48771035|NCT02501096|157005875|FG004|Overall Study|Withdrawal by Subject|2|||
48771036|NCT02501096|157005876|FG005|Overall Study|Withdrawal by Subject|2|||
48771037|NCT02501096|157005877|FG006|Overall Study|Withdrawal by Subject|2|||
48771038|NCT02501096|157005878|FG007|Overall Study|Withdrawal by Subject|3|||
48771039|NCT02501096|157005879|FG008|Overall Study|Withdrawal by Subject|0|||
48771040|NCT02501096|157005871|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
48771041|NCT02501096|157005872|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
48771042|NCT02501096|157005873|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
48771043|NCT02501096|157005874|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
48771044|NCT02501096|157005875|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
48771045|NCT02501096|157005876|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
48771046|NCT02501096|157005877|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
48771047|NCT02501096|157005878|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
48771048|NCT02501096|157005879|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
48771049|NCT02501096|157005871|FG000|Overall Study|Death|1|||
48771050|NCT02501096|157005872|FG001|Overall Study|Death|1|||
48395122|NCT03829657|155639902|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
48395123|NCT03829657|155639903|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
48771051|NCT02501096|157005873|FG002|Overall Study|Death|88|||
48771052|NCT02501096|157005874|FG003|Overall Study|Death|74|||
48771053|NCT02501096|157005875|FG004|Overall Study|Death|15|||
48771054|NCT02501096|157005876|FG005|Overall Study|Death|16|||
48771055|NCT02501096|157005877|FG006|Overall Study|Death|15|||
48771056|NCT02501096|157005878|FG007|Overall Study|Death|16|||
48771057|NCT02501096|157005879|FG008|Overall Study|Death|1|||
48771058|NCT00655564|157005881|FG000|Overall Study|Adverse Event|1|||
48771059|NCT00655564|157005881|FG000|Overall Study|Lost to Follow-up|1|||
48771060|NCT00655564|157005881|FG000|Overall Study|Desired Alternate Therapy|1|||
48771061|NCT02755831|157005887|FG000|Overall Study|Lost to Follow-up|3|||
48771062|NCT02755831|157005888|FG001|Overall Study|Lost to Follow-up|3|||
48771063|NCT01516879|157005889|FG000|Overall Study|Withdrawal by Subject|9|||
48771064|NCT01516879|157005890|FG001|Overall Study|Withdrawal by Subject|11|||
48771065|NCT01516879|157005889|FG000|Overall Study|Death|0|||
48771066|NCT01516879|157005890|FG001|Overall Study|Death|2|||
48771067|NCT01516879|157005889|FG000|Overall Study|Lost to Follow-up|2|||
48771068|NCT01516879|157005890|FG001|Overall Study|Lost to Follow-up|11|||
48771069|NCT01516879|157005889|FG000|Overall Study|Other|5|||
48771070|NCT01516879|157005890|FG001|Overall Study|Other|10|||
48771071|NCT03591575|157005893|FG000|Overall Study|Adverse Event|2|||
48771072|NCT03591575|157005894|FG001|Overall Study|Adverse Event|0|||
48771073|NCT03591575|157005893|FG000|Overall Study|Withdrawal by Subject|4|||
48771074|NCT03591575|157005894|FG001|Overall Study|Withdrawal by Subject|1|||
48771075|NCT00025883|157005895|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
48771076|NCT00025883|157005895|FG000|Overall Study|no baseline data|1|||
48771077|NCT00025883|157005895|FG000|Overall Study|Death|1|||
48771078|NCT00025883|157005895|FG000|Overall Study|Adverse Event|1|||
48771079|NCT00025883|157005895|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
48771080|NCT02448875|157005896|FG000|Overall Study|Adverse Event|2|||
48771081|NCT02448875|157005897|FG001|Overall Study|Adverse Event|1|||
48771082|NCT02448875|157005898|FG002|Overall Study|Adverse Event|0|||
48771083|NCT02448875|157005896|FG000|Overall Study|Lost to Follow-up|1|||
48771084|NCT02448875|157005897|FG001|Overall Study|Lost to Follow-up|0|||
48771085|NCT02448875|157005898|FG002|Overall Study|Lost to Follow-up|0|||
48771086|NCT02448875|157005896|FG000|Overall Study|Investigator Decision|3|||
48771087|NCT02448875|157005897|FG001|Overall Study|Investigator Decision|0|||
48771088|NCT02448875|157005898|FG002|Overall Study|Investigator Decision|1|||
48771089|NCT02448875|157005896|FG000|Overall Study|Withdrawal by Subject|1|||
48771090|NCT02448875|157005897|FG001|Overall Study|Withdrawal by Subject|0|||
48771091|NCT02448875|157005898|FG002|Overall Study|Withdrawal by Subject|0|||
48771092|NCT02434770|157005899|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
48771093|NCT02434770|157005900|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
48771094|NCT02434770|157005901|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
48771095|NCT02434770|157005899|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
48771096|NCT02434770|157005900|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
48771097|NCT02434770|157005901|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
48771098|NCT02434770|157005899|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
48771099|NCT02434770|157005900|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
48771100|NCT02434770|157005901|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
48771101|NCT02434770|157005899|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
48771102|NCT02434770|157005900|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
48771103|NCT02434770|157005901|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
48771104|NCT02434770|157005899|FG000|Week 1 to Week 18|Death|1|||
48771105|NCT02434770|157005900|FG001|Week 1 to Week 18|Death|0|||
48771106|NCT02434770|157005901|FG002|Week 1 to Week 18|Death|0|||
48771107|NCT02434770|157005899|FG000|Week 18 to Week|Lost to Follow-up|2|||
48771108|NCT02434770|157005900|FG001|Week 18 to Week|Lost to Follow-up|2|||
48395124|NCT03829657|155639904|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
48395125|NCT03829657|155639905|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
48395126|NCT03829657|155639901|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
48395127|NCT03829657|155639902|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
48395128|NCT03829657|155639903|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
48395129|NCT03829657|155639904|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
48395130|NCT03829657|155639905|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
48395131|NCT03829657|155639901|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
48395132|NCT03829657|155639902|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
48395133|NCT03829657|155639903|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
48395134|NCT03829657|155639904|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
48395135|NCT03829657|155639905|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
48771109|NCT02434770|157005901|FG002|Week 18 to Week|Lost to Follow-up|1|||
48771110|NCT02434770|157005899|FG000|Week 18 to Week|Withdrawal by Subject|0|||
48771111|NCT02434770|157005900|FG001|Week 18 to Week|Withdrawal by Subject|0|||
48771112|NCT02434770|157005901|FG002|Week 18 to Week|Withdrawal by Subject|2|||
48771113|NCT02434770|157005899|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
48771114|NCT02434770|157005900|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
48771115|NCT02434770|157005901|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
48771116|NCT01227512|157005903|FG000|Overall Study|Physician Decision|6|||
48771117|NCT01227512|157005904|FG001|Overall Study|Physician Decision|6|||
48771118|NCT01227512|157005903|FG000|Overall Study|Adverse Event|4|||
48771119|NCT01227512|157005904|FG001|Overall Study|Adverse Event|3|||
48771120|NCT01227512|157005903|FG000|Overall Study|Withdrawal by Subject|3|||
48771121|NCT01227512|157005904|FG001|Overall Study|Withdrawal by Subject|0|||
48771122|NCT01227512|157005903|FG000|Overall Study|Participant met withdrawal criteria|0|||
48771123|NCT01227512|157005904|FG001|Overall Study|Participant met withdrawal criteria|1|||
48771124|NCT02774681|157005905|FG000|Treatment on Study|Progressive Disease|7|||
48771125|NCT02774681|157005905|FG000|Follow-Up for 3 Years|Death|11|||
48771126|NCT02774681|157005905|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
48771127|NCT04497987|157005906|FG000|Overall Study|Adverse Event|1|||
48771128|NCT04497987|157005907|FG001|Overall Study|Adverse Event|0|||
48771129|NCT04497987|157005906|FG000|Overall Study|Death|21|||
48771130|NCT04497987|157005907|FG001|Overall Study|Death|13|||
48771131|NCT04497987|157005906|FG000|Overall Study|Lost to Follow-up|19|||
48771132|NCT04497987|157005907|FG001|Overall Study|Lost to Follow-up|17|||
48771133|NCT04497987|157005906|FG000|Overall Study|Other - as reported by the investigator|22|||
48771134|NCT04497987|157005907|FG001|Overall Study|Other - as reported by the investigator|16|||
48771135|NCT04497987|157005906|FG000|Overall Study|Physician Decision|1|||
48771136|NCT04497987|157005907|FG001|Overall Study|Physician Decision|0|||
48771137|NCT04497987|157005906|FG000|Overall Study|Withdrawal by Subject|35|||
48771138|NCT04497987|157005907|FG001|Overall Study|Withdrawal by Subject|21|||
48771139|NCT02696096|157005908|FG000|Overall Study|ruled out at screening|1|||
48771140|NCT02696096|157005908|FG000|Overall Study|did not attend second fMRI|1|||
48771141|NCT00445328|157005911|FG000|Overall Study|Death|0|||
48771142|NCT00445328|157005912|FG001|Overall Study|Death|1|||
48771143|NCT00445328|157005911|FG000|Overall Study|Adverse Event|0|||
48771144|NCT00445328|157005912|FG001|Overall Study|Adverse Event|3|||
48771145|NCT00445328|157005911|FG000|Overall Study|Other|0|||
48771146|NCT00445328|157005912|FG001|Overall Study|Other|2|||
48771147|NCT00445328|157005911|FG000|Overall Study|Withdrawal by Subject|2|||
48771148|NCT00445328|157005912|FG001|Overall Study|Withdrawal by Subject|0|||
48771149|NCT00445328|157005911|FG000|Overall Study|Protocol Violation|1|||
48771150|NCT00445328|157005912|FG001|Overall Study|Protocol Violation|0|||
48771151|NCT00699972|157007686|FG000|Overall Study|Adverse Event|7|||
48771152|NCT00699972|157007687|FG001|Overall Study|Adverse Event|9|||
48771153|NCT00699972|157007688|FG002|Overall Study|Adverse Event|24|||
48771154|NCT00699972|157007686|FG000|Overall Study|Lost to Follow-up|0|||
48771155|NCT00699972|157007687|FG001|Overall Study|Lost to Follow-up|2|||
48771156|NCT00699972|157007688|FG002|Overall Study|Lost to Follow-up|0|||
48771157|NCT00699972|157007686|FG000|Overall Study|Withdrawal by Subject|3|||
48771158|NCT00699972|157007687|FG001|Overall Study|Withdrawal by Subject|7|||
48771159|NCT00699972|157007688|FG002|Overall Study|Withdrawal by Subject|4|||
48771160|NCT00699972|157007686|FG000|Overall Study|Lack of Efficacy|2|||
48771161|NCT00699972|157007687|FG001|Overall Study|Lack of Efficacy|0|||
48771162|NCT00699972|157007688|FG002|Overall Study|Lack of Efficacy|2|||
48771163|NCT00699972|157007686|FG000|Overall Study|Administrative/Other|3|||
48771164|NCT00699972|157007687|FG001|Overall Study|Administrative/Other|1|||
48771165|NCT00699972|157007688|FG002|Overall Study|Administrative/Other|4|||
48771166|NCT00699972|157007686|FG000|Overall Study|Randomized, Not Treated|1|||
48771167|NCT00699972|157007687|FG001|Overall Study|Randomized, Not Treated|0|||
48771168|NCT00699972|157007688|FG002|Overall Study|Randomized, Not Treated|1|||
48771169|NCT00502697|157007689|FG000|Overall Study|Withdrawal by Subject|3|||
48771170|NCT00502697|157007690|FG001|Overall Study|Withdrawal by Subject|1|||
48771171|NCT00502697|157007689|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
48771172|NCT00502697|157007690|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
48771173|NCT00502697|157007689|FG000|Overall Study|found not to meet eligibility criteria|3|||
48771174|NCT00502697|157007690|FG001|Overall Study|found not to meet eligibility criteria|4|||
48771175|NCT00502697|157007689|FG000|Overall Study|did not meet assignment criteria|4|||
48395136|NCT01014689|155639908|FG000|Overall Study|Lack of Efficacy|0|||
48395137|NCT01014689|155639909|FG001|Overall Study|Lack of Efficacy|1|||
48395138|NCT01014689|155639908|FG000|Overall Study|Adverse Event|3|||
48395139|NCT01014689|155639909|FG001|Overall Study|Adverse Event|0|||
48771176|NCT00502697|157007690|FG001|Overall Study|did not meet assignment criteria|2|||
48771177|NCT03459196|157007691|FG000|Overall Study|Subject didn't receive study catheter|2|||
48771178|NCT01888497|157007699|FG000|Washout Period 1|Withdrawal by Subject|0|||
48771179|NCT01888497|157007700|FG001|Washout Period 1|Withdrawal by Subject|0|||
48771180|NCT01888497|157007701|FG002|Washout Period 1|Withdrawal by Subject|1|||
48771181|NCT01888497|157007702|FG003|Washout Period 1|Withdrawal by Subject|1|||
48771182|NCT01888497|157007699|FG000|Washout Period 2|Adverse Event|0|||
48771183|NCT01888497|157007700|FG001|Washout Period 2|Adverse Event|0|||
48771184|NCT01888497|157007701|FG002|Washout Period 2|Adverse Event|0|||
48771185|NCT01888497|157007702|FG003|Washout Period 2|Adverse Event|1|||
48771186|NCT01888497|157007699|FG000|Washout Period 2|Withdrawal by Subject|0|||
48356038|NCT01454739|155501005|FG001|Overall Study|Protocol Violation|3|||
48356039|NCT01454739|155501004|FG000|Overall Study|Withdrawal by Subject|2|||
48356040|NCT01454739|155501005|FG001|Overall Study|Withdrawal by Subject|6|||
48356041|NCT01454739|155501004|FG000|Overall Study|Other|3|||
48356042|NCT01454739|155501005|FG001|Overall Study|Other|5|||
48356043|NCT01454739|155501004|FG000|Overall Study|Physician Decision|0|||
48356044|NCT01454739|155501005|FG001|Overall Study|Physician Decision|5|||
48356045|NCT01454739|155501004|FG000|Overall Study|Lost to Follow-up|0|||
48356046|NCT01454739|155501005|FG001|Overall Study|Lost to Follow-up|1|||
48356047|NCT01454739|155501004|FG000|Overall Study|Adverse Event|0|||
48395140|NCT01014689|155639908|FG000|Overall Study|Withdrawal by Subject|5|||
48395141|NCT01014689|155639909|FG001|Overall Study|Withdrawal by Subject|4|||
48395142|NCT01014689|155639908|FG000|Overall Study|Protocol Violation|1|||
48395143|NCT01014689|155639909|FG001|Overall Study|Protocol Violation|1|||
48395144|NCT01014689|155639908|FG000|Overall Study|Lost to Follow-up|3|||
48395145|NCT01014689|155639909|FG001|Overall Study|Lost to Follow-up|7|||
48395146|NCT01014689|155639908|FG000|Overall Study|Pregnancy|1|||
48395147|NCT01014689|155639909|FG001|Overall Study|Pregnancy|0|||
48395148|NCT04153188|155639910|FG000|Overall Study|Lost to Follow-up|1|||
48395149|NCT04153188|155639911|FG001|Overall Study|Lost to Follow-up|1|||
48395150|NCT04153188|155639910|FG000|Overall Study|Withdrawal by Subject|2|||
48395151|NCT04153188|155639911|FG001|Overall Study|Withdrawal by Subject|0|||
48395152|NCT04153188|155639910|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
48395153|NCT04153188|155639911|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
48395154|NCT04418076|155639913|FG000|Overall Study|Death|1|||
48395155|NCT04418076|155639914|FG001|Overall Study|Death|0|||
48395156|NCT04418076|155639915|FG002|Overall Study|Death|0|||
48395157|NCT04418076|155639916|FG003|Overall Study|Death|0|||
48395158|NCT04418076|155639913|FG000|Overall Study|Lost to Follow-up|2|||
48395159|NCT04418076|155639914|FG001|Overall Study|Lost to Follow-up|5|||
48395160|NCT04418076|155639915|FG002|Overall Study|Lost to Follow-up|1|||
48395161|NCT04418076|155639916|FG003|Overall Study|Lost to Follow-up|2|||
48395162|NCT04418076|155639913|FG000|Overall Study|Withdrawal by Subject|1|||
48395163|NCT04418076|155639914|FG001|Overall Study|Withdrawal by Subject|0|||
48395164|NCT04418076|155639915|FG002|Overall Study|Withdrawal by Subject|1|||
48395165|NCT04418076|155639916|FG003|Overall Study|Withdrawal by Subject|1|||
48395166|NCT04418076|155639913|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
48395167|NCT04418076|155639914|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
48395168|NCT04418076|155639915|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
48395169|NCT04418076|155639916|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
48395170|NCT01471782|155639918|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
48395171|NCT01471782|155639919|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
48395172|NCT01471782|155639920|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
48395173|NCT01471782|155639921|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
48395174|NCT01471782|155639922|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
48395175|NCT01471782|155639923|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
48395176|NCT01471782|155639918|FG000|Overall Study|Lack of Efficacy|1|||
48395177|NCT01471782|155639919|FG001|Overall Study|Lack of Efficacy|2|||
48395178|NCT01471782|155639920|FG002|Overall Study|Lack of Efficacy|1|||
48395179|NCT01471782|155639921|FG003|Overall Study|Lack of Efficacy|1|||
48395180|NCT01471782|155639922|FG004|Overall Study|Lack of Efficacy|5|||
48395181|NCT01471782|155639923|FG005|Overall Study|Lack of Efficacy|18|||
48395182|NCT01471782|155639918|FG000|Overall Study|Adverse Event|1|||
48395183|NCT01471782|155639919|FG001|Overall Study|Adverse Event|1|||
48395184|NCT01471782|155639920|FG002|Overall Study|Adverse Event|2|||
48395185|NCT01471782|155639921|FG003|Overall Study|Adverse Event|2|||
48395186|NCT01471782|155639922|FG004|Overall Study|Adverse Event|3|||
48395187|NCT01471782|155639923|FG005|Overall Study|Adverse Event|1|||
48395188|NCT01471782|155639918|FG000|Overall Study|Other|0|||
48395189|NCT01471782|155639919|FG001|Overall Study|Other|0|||
48395190|NCT01471782|155639920|FG002|Overall Study|Other|1|||
48395191|NCT01471782|155639921|FG003|Overall Study|Other|1|||
48395192|NCT01471782|155639922|FG004|Overall Study|Other|6|||
48395193|NCT01471782|155639923|FG005|Overall Study|Other|5|||
48395194|NCT01471782|155639918|FG000|Overall Study|Change of Chemotherapy|1|||
48395195|NCT01471782|155639919|FG001|Overall Study|Change of Chemotherapy|1|||
48395196|NCT01471782|155639920|FG002|Overall Study|Change of Chemotherapy|0|||
48395197|NCT01471782|155639921|FG003|Overall Study|Change of Chemotherapy|0|||
48395198|NCT01471782|155639922|FG004|Overall Study|Change of Chemotherapy|1|||
48395199|NCT01471782|155639923|FG005|Overall Study|Change of Chemotherapy|4|||
48395200|NCT01471782|155639918|FG000|Overall Study|Disease Relapse|0|||
48395201|NCT01471782|155639919|FG001|Overall Study|Disease Relapse|0|||
48395202|NCT01471782|155639920|FG002|Overall Study|Disease Relapse|0|||
48395203|NCT01471782|155639921|FG003|Overall Study|Disease Relapse|1|||
48395204|NCT01471782|155639922|FG004|Overall Study|Disease Relapse|2|||
48395205|NCT01471782|155639923|FG005|Overall Study|Disease Relapse|1|||
48395206|NCT01471782|155639918|FG000|Overall Study|Physician Decision|0|||
48395207|NCT01471782|155639919|FG001|Overall Study|Physician Decision|0|||
48395208|NCT01471782|155639920|FG002|Overall Study|Physician Decision|0|||
48395209|NCT01471782|155639921|FG003|Overall Study|Physician Decision|0|||
48395210|NCT01471782|155639922|FG004|Overall Study|Physician Decision|3|||
48395211|NCT01471782|155639923|FG005|Overall Study|Physician Decision|8|||
48395212|NCT01471782|155639918|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48395213|NCT01471782|155639919|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48395214|NCT01471782|155639920|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48395215|NCT01471782|155639921|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48395216|NCT01471782|155639922|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
48395217|NCT01471782|155639923|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
48395218|NCT01471782|155639918|FG000|Overall Study|Death|0|||
48395219|NCT01471782|155639919|FG001|Overall Study|Death|0|||
48395220|NCT01471782|155639920|FG002|Overall Study|Death|0|||
48771187|NCT01888497|157007700|FG001|Washout Period 2|Withdrawal by Subject|0|||
48771188|NCT01888497|157007701|FG002|Washout Period 2|Withdrawal by Subject|0|||
48771189|NCT01888497|157007702|FG003|Washout Period 2|Withdrawal by Subject|1|||
48771190|NCT04152447|157007703|FG000|Overall Study|Lost to Follow-up|1|||
48395221|NCT01471782|155639921|FG003|Overall Study|Death|0|||
48395222|NCT01471782|155639922|FG004|Overall Study|Death|0|||
48395223|NCT01471782|155639923|FG005|Overall Study|Death|1|||
48395224|NCT01425008|155639924|FG000|Dose Escalation Phase|Progressive Disease|2|||
48395225|NCT01425008|155639925|FG001|Dose Escalation Phase|Progressive Disease|3|||
48395226|NCT01425008|155639926|FG002|Dose Escalation Phase|Progressive Disease|2|||
48771191|NCT04152447|157007704|FG001|Overall Study|Lost to Follow-up|0|||
48771192|NCT04152447|157007703|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
48771193|NCT04152447|157007704|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
48771194|NCT04152447|157007703|FG000|Overall Study|Withdrawal by Subject|0|||
48771195|NCT04152447|157007704|FG001|Overall Study|Withdrawal by Subject|1|||
48771196|NCT04152447|157007703|FG000|Overall Study|Found ineligible after enrolling|1|||
48771197|NCT04152447|157007704|FG001|Overall Study|Found ineligible after enrolling|1|||
48771198|NCT04152447|157007703|FG000|Overall Study|Did not receive VR headset in time.|0|||
48771199|NCT04152447|157007704|FG001|Overall Study|Did not receive VR headset in time.|2|||
48771200|NCT01921829|157007705|FG000|Overall Study|Withdrawal by Subject|0|||
48771201|NCT01921829|157007706|FG001|Overall Study|Withdrawal by Subject|1|||
48771202|NCT02789176|157007707|FG000|Overall Study|Death|0|||
48771203|NCT02789176|157007708|FG001|Overall Study|Death|0|||
48771204|NCT02789176|157007709|FG002|Overall Study|Death|3|||
48771205|NCT02789176|157007710|FG003|Overall Study|Death|0|||
48771206|NCT02789176|157007707|FG000|Overall Study|Withdrawal by Subject|0|||
48771207|NCT02789176|157007708|FG001|Overall Study|Withdrawal by Subject|0|||
48771208|NCT02789176|157007709|FG002|Overall Study|Withdrawal by Subject|1|||
48771209|NCT02789176|157007710|FG003|Overall Study|Withdrawal by Subject|0|||
48771210|NCT02789176|157007707|FG000|Overall Study|Lost to Follow-up|8|||
48771211|NCT02789176|157007708|FG001|Overall Study|Lost to Follow-up|2|||
48771212|NCT02789176|157007709|FG002|Overall Study|Lost to Follow-up|6|||
48771213|NCT02789176|157007710|FG003|Overall Study|Lost to Follow-up|1|||
48771214|NCT02223767|157007711|FG000|Overall Study|Withdrawal by Subject|4|||
48771215|NCT02223767|157007712|FG001|Overall Study|Withdrawal by Subject|4|||
48771216|NCT01466270|157007715|FG000|Overall Study|Withdrawal by Subject|4|||
48771217|NCT01466270|157007716|FG001|Overall Study|Withdrawal by Subject|1|||
48771218|NCT01466270|157007715|FG000|Overall Study|Physician Decision|1|||
48771219|NCT01466270|157007716|FG001|Overall Study|Physician Decision|0|||
48771220|NCT01466270|157007715|FG000|Overall Study|Lost to Follow-up|1|||
48771221|NCT01466270|157007716|FG001|Overall Study|Lost to Follow-up|3|||
48771222|NCT01466270|157007715|FG000|Overall Study|Progression|1|||
48771223|NCT01466270|157007716|FG001|Overall Study|Progression|0|||
48771224|NCT01466270|157007715|FG000|Overall Study|Toxicity|4|||
48771225|NCT01466270|157007716|FG001|Overall Study|Toxicity|1|||
48771226|NCT01466270|157007715|FG000|Overall Study|Multiple|1|||
48771227|NCT01466270|157007716|FG001|Overall Study|Multiple|1|||
48771228|NCT01944059|157007717|FG000|Overall Study|Lost to Follow-up|1|||
48771229|NCT01944059|157007717|FG000|Overall Study|Physician Decision|3|||
48771230|NCT01944059|157007717|FG000|Overall Study|Withdrawal by Subject|1|||
48771231|NCT01944059|157007717|FG000|Overall Study|Adverse Event|2|||
48771232|NCT02365636|157007729|FG000|Overall Study|Adverse Event|3|||
48771233|NCT02365636|157007730|FG001|Overall Study|Adverse Event|3|||
48771234|NCT02365636|157007731|FG002|Overall Study|Adverse Event|2|||
48771235|NCT02365636|157007729|FG000|Overall Study|Protocol Violation|1|||
48771236|NCT02365636|157007730|FG001|Overall Study|Protocol Violation|4|||
48771237|NCT02365636|157007731|FG002|Overall Study|Protocol Violation|0|||
48771238|NCT02365636|157007729|FG000|Overall Study|Lost to Follow-up|0|||
48771239|NCT02365636|157007730|FG001|Overall Study|Lost to Follow-up|0|||
48771240|NCT02365636|157007731|FG002|Overall Study|Lost to Follow-up|1|||
48771241|NCT02365636|157007729|FG000|Overall Study|Other|2|||
48395227|NCT01425008|155639927|FG003|Dose Escalation Phase|Progressive Disease|3|||
48771242|NCT02365636|157007730|FG001|Overall Study|Other|0|||
48771243|NCT02365636|157007731|FG002|Overall Study|Other|0|||
48771244|NCT01454934|157007735|FG000|Overall Study|Clinical progression|28|||
48771245|NCT01454934|157007736|FG001|Overall Study|Clinical progression|25|||
48771246|NCT01454934|157007735|FG000|Overall Study|Other|6|||
48771247|NCT01454934|157007736|FG001|Overall Study|Other|17|||
48771248|NCT01454934|157007735|FG000|Overall Study|Adverse Event|28|||
48771249|NCT01454934|157007736|FG001|Overall Study|Adverse Event|24|||
48771250|NCT01454934|157007735|FG000|Overall Study|Withdrawn consent|2|||
48771251|NCT01454934|157007736|FG001|Overall Study|Withdrawn consent|5|||
48771252|NCT01454934|157007735|FG000|Overall Study|Withdrawal by Subject|11|||
48771253|NCT01454934|157007736|FG001|Overall Study|Withdrawal by Subject|15|||
48771254|NCT01454934|157007735|FG000|Overall Study|Disease progression|194|||
48771255|NCT01454934|157007736|FG001|Overall Study|Disease progression|181|||
48771256|NCT01454934|157007735|FG000|Overall Study|Lost to Follow-up|0|||
48771257|NCT01454934|157007736|FG001|Overall Study|Lost to Follow-up|1|||
48771258|NCT01454934|157007735|FG000|Overall Study|Not treated|1|||
48771259|NCT01454934|157007736|FG001|Overall Study|Not treated|2|||
48771260|NCT01956110|157007737|FG000|Overall Study|Protocol Violation|25|||
48771261|NCT01956110|157007738|FG001|Overall Study|Protocol Violation|11|||
48771262|NCT01956110|157007737|FG000|Overall Study|Adverse Event|9|||
48771263|NCT01956110|157007738|FG001|Overall Study|Adverse Event|10|||
48771264|NCT01956110|157007737|FG000|Overall Study|Personal reasons|1|||
48771265|NCT01956110|157007738|FG001|Overall Study|Personal reasons|1|||
48771266|NCT00701129|157007746|FG000|Overall Study|Death|2|||
48771267|NCT01782313|157007748|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
48771268|NCT01782313|157007748|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
48771269|NCT01782313|157007748|FG000|Treated Cycle 3|Progressive Disease|21|||
48771270|NCT01782313|157007748|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
48771271|NCT01782313|157007748|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
48771272|NCT01782313|157007748|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
48771273|NCT01782313|157007748|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
48771274|NCT01782313|157007748|FG000|Survival Follow up|Lost to Follow-up|1|||
48771275|NCT02932891|157007749|FG000|Overall Study|Lost to Follow-up|2|||
48771276|NCT02932891|157007749|FG000|Overall Study|HPA Suppress|2|||
48771277|NCT02583256|157007750|FG000|Overall Study|Withdrawal by Subject|0|||
48771278|NCT02583256|157007751|FG001|Overall Study|Withdrawal by Subject|1|||
48771279|NCT02583256|157007752|FG002|Overall Study|Withdrawal by Subject|1|||
48771280|NCT02583256|157007753|FG003|Overall Study|Withdrawal by Subject|0|||
48771281|NCT02583256|157007750|FG000|Overall Study|Lost to Follow-up|1|||
48771282|NCT02583256|157007751|FG001|Overall Study|Lost to Follow-up|1|||
48771283|NCT02583256|157007752|FG002|Overall Study|Lost to Follow-up|0|||
48771284|NCT02583256|157007753|FG003|Overall Study|Lost to Follow-up|1|||
48771285|NCT02583256|157007750|FG000|Overall Study|Administrative/Other|2|||
48771286|NCT02583256|157007751|FG001|Overall Study|Administrative/Other|0|||
48771287|NCT02583256|157007752|FG002|Overall Study|Administrative/Other|1|||
48771288|NCT02583256|157007753|FG003|Overall Study|Administrative/Other|2|||
48771289|NCT03019627|157007754|FG000|Overall Study|Adverse Event|8|||
48771290|NCT03019627|157007755|FG001|Overall Study|Adverse Event|0|||
48771291|NCT03019627|157007754|FG000|Overall Study|Unrelated to adverse event|1|||
48771292|NCT03019627|157007755|FG001|Overall Study|Unrelated to adverse event|3|||
48771293|NCT03019627|157007754|FG000|Overall Study|Lost to Follow-up|2|||
48771294|NCT03019627|157007755|FG001|Overall Study|Lost to Follow-up|1|||
48771295|NCT03019627|157007754|FG000|Overall Study|not compliance|2|||
48771296|NCT03019627|157007755|FG001|Overall Study|not compliance|2|||
48771297|NCT03019627|157007754|FG000|Overall Study|Other|2|||
48771298|NCT03019627|157007755|FG001|Overall Study|Other|2|||
48771299|NCT00546715|157007756|FG000|Overall Study|Withdrawal by Subject|0|||
48771300|NCT00546715|157007757|FG001|Overall Study|Withdrawal by Subject|1|||
48771301|NCT00546715|157007758|FG002|Overall Study|Withdrawal by Subject|0|||
48771302|NCT00546715|157007759|FG003|Overall Study|Withdrawal by Subject|0|||
48771303|NCT00782210|157007760|FG000|Overall Study|Adverse Event|21|||
48771304|NCT00782210|157007761|FG001|Overall Study|Adverse Event|17|||
48771305|NCT00782210|157007762|FG002|Overall Study|Adverse Event|16|||
48771306|NCT00782210|157007760|FG000|Overall Study|Lost to Follow-up|2|||
48771307|NCT00782210|157007761|FG001|Overall Study|Lost to Follow-up|1|||
48771308|NCT00782210|157007762|FG002|Overall Study|Lost to Follow-up|2|||
48771309|NCT00782210|157007760|FG000|Overall Study|Withdrawal by Subject|11|||
48771310|NCT00782210|157007761|FG001|Overall Study|Withdrawal by Subject|8|||
48771311|NCT00782210|157007762|FG002|Overall Study|Withdrawal by Subject|11|||
48771312|NCT00782210|157007760|FG000|Overall Study|Non compliance with protocol|0|||
48771313|NCT00782210|157007761|FG001|Overall Study|Non compliance with protocol|3|||
48771314|NCT00782210|157007762|FG002|Overall Study|Non compliance with protocol|2|||
48771315|NCT00782210|157007760|FG000|Overall Study|Lack of Efficacy|13|||
48771316|NCT00782210|157007761|FG001|Overall Study|Lack of Efficacy|4|||
48771317|NCT00782210|157007762|FG002|Overall Study|Lack of Efficacy|1|||
48771318|NCT00782210|157007760|FG000|Overall Study|Other reason not described above|3|||
48771319|NCT00782210|157007761|FG001|Overall Study|Other reason not described above|2|||
48771320|NCT00782210|157007762|FG002|Overall Study|Other reason not described above|3|||
48771321|NCT00654381|157007763|FG000|1st Stage|Adverse Event|3|||
48771322|NCT00654381|157007764|FG001|1st Stage|Adverse Event|3|||
48771323|NCT00654381|157007765|FG002|1st Stage|Adverse Event|3|||
48771324|NCT00654381|157007766|FG003|1st Stage|Adverse Event|3|||
48771325|NCT00654381|157007767|FG004|1st Stage|Adverse Event|2|||
48771326|NCT00654381|157007768|FG005|1st Stage|Adverse Event|1|||
48771327|NCT00654381|157007763|FG000|1st Stage|Withdrawal by Subject|0|||
48771328|NCT00654381|157007764|FG001|1st Stage|Withdrawal by Subject|0|||
48771329|NCT00654381|157007765|FG002|1st Stage|Withdrawal by Subject|0|||
48771330|NCT00654381|157007766|FG003|1st Stage|Withdrawal by Subject|1|||
48771331|NCT00654381|157007767|FG004|1st Stage|Withdrawal by Subject|0|||
48771332|NCT00654381|157007768|FG005|1st Stage|Withdrawal by Subject|1|||
48771333|NCT00654381|157007763|FG000|1st Stage|Investigator's decision|0|||
48771334|NCT00654381|157007764|FG001|1st Stage|Investigator's decision|0|||
48771335|NCT00654381|157007765|FG002|1st Stage|Investigator's decision|0|||
48771336|NCT00654381|157007766|FG003|1st Stage|Investigator's decision|1|||
48771337|NCT00654381|157007767|FG004|1st Stage|Investigator's decision|0|||
48771338|NCT00654381|157007768|FG005|1st Stage|Investigator's decision|0|||
48771339|NCT00654381|157007763|FG000|2nd Stage|Adverse Event|2|||
48771340|NCT00654381|157007764|FG001|2nd Stage|Adverse Event|0|||
48771341|NCT00654381|157007765|FG002|2nd Stage|Adverse Event|2|||
48771342|NCT00654381|157007766|FG003|2nd Stage|Adverse Event|3|||
48771343|NCT00654381|157007767|FG004|2nd Stage|Adverse Event|7|||
48771344|NCT00654381|157007768|FG005|2nd Stage|Adverse Event|2|||
48771345|NCT00654381|157007763|FG000|2nd Stage|Withdrawal by Subject|0|||
48771346|NCT00654381|157007764|FG001|2nd Stage|Withdrawal by Subject|0|||
48771347|NCT00654381|157007765|FG002|2nd Stage|Withdrawal by Subject|0|||
48771348|NCT00654381|157007766|FG003|2nd Stage|Withdrawal by Subject|0|||
48771349|NCT00654381|157007767|FG004|2nd Stage|Withdrawal by Subject|1|||
48771350|NCT00654381|157007768|FG005|2nd Stage|Withdrawal by Subject|1|||
48771351|NCT00654381|157007763|FG000|2nd Stage|Investigator's decision|0|||
48771352|NCT00654381|157007764|FG001|2nd Stage|Investigator's decision|0|||
48771353|NCT00654381|157007765|FG002|2nd Stage|Investigator's decision|1|||
48771354|NCT00654381|157007766|FG003|2nd Stage|Investigator's decision|1|||
48771355|NCT00654381|157007767|FG004|2nd Stage|Investigator's decision|0|||
48771356|NCT00654381|157007768|FG005|2nd Stage|Investigator's decision|0|||
48771357|NCT00654381|157007763|FG000|Extension Stage|Adverse Event|1|||
48771358|NCT00654381|157007764|FG001|Extension Stage|Adverse Event|2|||
48771359|NCT00654381|157007765|FG002|Extension Stage|Adverse Event|9|||
48771360|NCT00654381|157007766|FG003|Extension Stage|Adverse Event|7|||
48771361|NCT00654381|157007767|FG004|Extension Stage|Adverse Event|1|||
48771362|NCT00654381|157007768|FG005|Extension Stage|Adverse Event|1|||
48771363|NCT00654381|157007763|FG000|Extension Stage|Protocol Violation|0|||
48771364|NCT00654381|157007764|FG001|Extension Stage|Protocol Violation|0|||
48771365|NCT00654381|157007765|FG002|Extension Stage|Protocol Violation|0|||
48395228|NCT01425008|155639928|FG004|Dose Escalation Phase|Progressive Disease|5|||
48395229|NCT01425008|155639929|FG005|Dose Escalation Phase|Progressive Disease|4|||
48395230|NCT01425008|155639930|FG006|Dose Escalation Phase|Progressive Disease|0|||
48395231|NCT01425008|155639931|FG007|Dose Escalation Phase|Progressive Disease|2|||
48395232|NCT01425008|155639932|FG008|Dose Escalation Phase|Progressive Disease|6|||
48395233|NCT01425008|155639933|FG009|Dose Escalation Phase|Progressive Disease|2|||
48395234|NCT01425008|155639934|FG010|Dose Escalation Phase|Progressive Disease|0|||
48395235|NCT01425008|155639935|FG011|Dose Escalation Phase|Progressive Disease|0|||
48395236|NCT01425008|155639936|FG012|Dose Escalation Phase|Progressive Disease|0|||
48395237|NCT01425008|155639937|FG013|Dose Escalation Phase|Progressive Disease|0|||
48395238|NCT01425008|155639938|FG014|Dose Escalation Phase|Progressive Disease|0|||
48395239|NCT01425008|155639939|FG015|Dose Escalation Phase|Progressive Disease|0|||
48771366|NCT00654381|157007766|FG003|Extension Stage|Protocol Violation|1|||
48771367|NCT00654381|157007767|FG004|Extension Stage|Protocol Violation|0|||
48771368|NCT00654381|157007768|FG005|Extension Stage|Protocol Violation|0|||
48395240|NCT01425008|155639940|FG016|Dose Escalation Phase|Progressive Disease|0|||
48395241|NCT01425008|155639941|FG017|Dose Escalation Phase|Progressive Disease|0|||
48771369|NCT00654381|157007763|FG000|Extension Stage|Lack of Efficacy|0|||
48771370|NCT00654381|157007764|FG001|Extension Stage|Lack of Efficacy|0|||
48771371|NCT00654381|157007765|FG002|Extension Stage|Lack of Efficacy|1|||
48771372|NCT00654381|157007766|FG003|Extension Stage|Lack of Efficacy|0|||
48771373|NCT00654381|157007767|FG004|Extension Stage|Lack of Efficacy|0|||
48771374|NCT00654381|157007768|FG005|Extension Stage|Lack of Efficacy|0|||
48771375|NCT00654381|157007763|FG000|Extension Stage|Withdrawal by Subject|0|||
48771376|NCT00654381|157007764|FG001|Extension Stage|Withdrawal by Subject|0|||
48771377|NCT00654381|157007765|FG002|Extension Stage|Withdrawal by Subject|1|||
48771378|NCT00654381|157007766|FG003|Extension Stage|Withdrawal by Subject|1|||
48771379|NCT00654381|157007767|FG004|Extension Stage|Withdrawal by Subject|1|||
48771380|NCT00654381|157007768|FG005|Extension Stage|Withdrawal by Subject|1|||
48771381|NCT00654381|157007763|FG000|Extension Stage|Closure of the trial site|0|||
48771382|NCT00654381|157007764|FG001|Extension Stage|Closure of the trial site|0|||
48771383|NCT00654381|157007765|FG002|Extension Stage|Closure of the trial site|0|||
48771384|NCT00654381|157007766|FG003|Extension Stage|Closure of the trial site|0|||
48771385|NCT00654381|157007767|FG004|Extension Stage|Closure of the trial site|1|||
48771386|NCT00654381|157007768|FG005|Extension Stage|Closure of the trial site|1|||
48771387|NCT03852316|157007769|FG000|Overall Study|Protocol Violation|1|||
48771388|NCT03852316|157007769|FG000|Overall Study|Withdrawal by Subject|2|||
48771389|NCT03852316|157007769|FG000|Overall Study|Enrolled but Device not Utilized|1|||
48395242|NCT01425008|155639942|FG018|Dose Escalation Phase|Progressive Disease|0|||
48395243|NCT01425008|155639924|FG000|Dose Escalation Phase|Adverse Event|2|||
48395244|NCT01425008|155639925|FG001|Dose Escalation Phase|Adverse Event|0|||
48395245|NCT01425008|155639926|FG002|Dose Escalation Phase|Adverse Event|0|||
48395246|NCT01425008|155639927|FG003|Dose Escalation Phase|Adverse Event|0|||
48395247|NCT01425008|155639928|FG004|Dose Escalation Phase|Adverse Event|0|||
48395248|NCT01425008|155639929|FG005|Dose Escalation Phase|Adverse Event|2|||
48395249|NCT01425008|155639930|FG006|Dose Escalation Phase|Adverse Event|0|||
48771390|NCT01430585|157007770|FG000|Overall Study|Death|1|||
48771391|NCT01430585|157007770|FG000|Overall Study|Objective Progression or Relapse|3|||
48771392|NCT01430585|157007770|FG000|Overall Study|Study Terminated by Sponsor|3|||
48771393|NCT01430585|157007770|FG000|Overall Study|Other|7|||
48771394|NCT00850200|157007771|FG000|Overall Study|Physician Decision|2|||
48771395|NCT00850200|157007771|FG000|Overall Study|Did not recieve treatment|2|||
48771396|NCT00850200|157007771|FG000|Overall Study|Withdrawal by Subject|1|||
48771397|NCT03277261|157007782|FG000|Overall Study|Adverse Event|17|||
48771398|NCT03277261|157007783|FG001|Overall Study|Adverse Event|1|||
48395250|NCT01425008|155639931|FG007|Dose Escalation Phase|Adverse Event|0|||
48395251|NCT01425008|155639932|FG008|Dose Escalation Phase|Adverse Event|2|||
48395252|NCT01425008|155639933|FG009|Dose Escalation Phase|Adverse Event|0|||
48395253|NCT01425008|155639934|FG010|Dose Escalation Phase|Adverse Event|0|||
48395254|NCT01425008|155639935|FG011|Dose Escalation Phase|Adverse Event|0|||
48395255|NCT01425008|155639936|FG012|Dose Escalation Phase|Adverse Event|0|||
48395256|NCT01425008|155639937|FG013|Dose Escalation Phase|Adverse Event|0|||
48395257|NCT01425008|155639938|FG014|Dose Escalation Phase|Adverse Event|0|||
48395258|NCT01425008|155639939|FG015|Dose Escalation Phase|Adverse Event|0|||
48395259|NCT01425008|155639940|FG016|Dose Escalation Phase|Adverse Event|0|||
48395260|NCT01425008|155639941|FG017|Dose Escalation Phase|Adverse Event|0|||
48395261|NCT01425008|155639942|FG018|Dose Escalation Phase|Adverse Event|0|||
48395262|NCT01425008|155639924|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395263|NCT01425008|155639925|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395264|NCT01425008|155639926|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48771399|NCT03277261|157007782|FG000|Overall Study|Participant Withdrawal of Consent|6|||
48771400|NCT03277261|157007783|FG001|Overall Study|Participant Withdrawal of Consent|15|||
48771401|NCT03277261|157007782|FG000|Overall Study|Investigator / Sponsor Decision|4|||
48771402|NCT03277261|157007783|FG001|Overall Study|Investigator / Sponsor Decision|2|||
48771403|NCT03277261|157007782|FG000|Overall Study|Pregnancy|2|||
48771404|NCT03277261|157007783|FG001|Overall Study|Pregnancy|0|||
48771405|NCT03277261|157007782|FG000|Overall Study|Lost to Follow-up|2|||
48771406|NCT03277261|157007783|FG001|Overall Study|Lost to Follow-up|2|||
48771407|NCT03277261|157007782|FG000|Overall Study|Lack of Efficacy|2|||
48771408|NCT03277261|157007783|FG001|Overall Study|Lack of Efficacy|2|||
48771409|NCT03277261|157007782|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
48771410|NCT03277261|157007783|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
48771411|NCT01252290|157007784|FG000|Overall Study|Withdrawal by Subject|1|||
48771412|NCT00354172|157007787|FG000|Overall Study|Did not receive transplant|1|||
48771413|NCT01800916|157007788|FG000|Test Period 1 (1 Week)|Convex product user|0|||
48771414|NCT01800916|157007789|FG001|Test Period 1 (1 Week)|Convex product user|0|||
48771415|NCT01800916|157007790|FG002|Test Period 1 (1 Week)|Convex product user|0|||
48771416|NCT01800916|157007791|FG003|Test Period 1 (1 Week)|Convex product user|1|||
48771417|NCT01800916|157007792|FG004|Test Period 1 (1 Week)|Convex product user|0|||
48771418|NCT01800916|157007793|FG005|Test Period 1 (1 Week)|Convex product user|0|||
48771419|NCT01800916|157007794|FG006|Test Period 1 (1 Week)|Convex product user|0|||
48771420|NCT01800916|157007795|FG007|Test Period 1 (1 Week)|Convex product user|0|||
48771421|NCT01800916|157007796|FG008|Test Period 1 (1 Week)|Convex product user|0|||
48771422|NCT01800916|157007788|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
48771423|NCT01800916|157007789|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
48771424|NCT01800916|157007790|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
48771425|NCT01800916|157007791|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
48771426|NCT01800916|157007792|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
48771427|NCT01800916|157007793|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
48771428|NCT01800916|157007794|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
48771429|NCT01800916|157007795|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
48771430|NCT01800916|157007796|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
48771431|NCT03144180|157007798|FG000|Overall Study|STAT Delivery|1|||
48771432|NCT03144180|157007799|FG001|Overall Study|STAT Delivery|1|||
48771433|NCT03144180|157007798|FG000|Overall Study|Provider forgot to fill out forms|1|||
48771434|NCT03144180|157007799|FG001|Overall Study|Provider forgot to fill out forms|3|||
48395265|NCT01425008|155639927|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395266|NCT01425008|155639928|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
48395267|NCT01425008|155639929|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395268|NCT01425008|155639930|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
48395269|NCT01425008|155639931|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
48395270|NCT01425008|155639932|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
48395271|NCT01425008|155639933|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395272|NCT01425008|155639934|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395273|NCT01425008|155639935|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395274|NCT01425008|155639936|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395275|NCT01425008|155639937|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395276|NCT01425008|155639938|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395277|NCT01425008|155639939|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395278|NCT01425008|155639940|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395279|NCT01425008|155639941|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395280|NCT01425008|155639942|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48395281|NCT01425008|155639924|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48395282|NCT01425008|155639925|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48395283|NCT01425008|155639926|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48395284|NCT01425008|155639927|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48395285|NCT01425008|155639928|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
48395286|NCT01425008|155639929|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
48395287|NCT01425008|155639930|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
48771435|NCT03144180|157007798|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
48771436|NCT03144180|157007799|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
48395288|NCT01425008|155639931|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
48395289|NCT01425008|155639932|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
48395290|NCT01425008|155639933|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
48395291|NCT01425008|155639934|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
48395292|NCT01425008|155639935|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
48395293|NCT01425008|155639936|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
48395294|NCT01425008|155639937|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
48395295|NCT01425008|155639938|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
48395296|NCT01425008|155639939|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
48395297|NCT01425008|155639940|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
48395298|NCT01425008|155639941|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
48395299|NCT01425008|155639942|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
48395300|NCT01425008|155639924|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395301|NCT01425008|155639925|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395302|NCT01425008|155639926|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
48395303|NCT01425008|155639927|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395304|NCT01425008|155639928|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395305|NCT01425008|155639929|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395306|NCT01425008|155639930|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
48771437|NCT03144180|157007798|FG000|Overall Study|Scrub tech removed tube cap|0|||
48771438|NCT03144180|157007799|FG001|Overall Study|Scrub tech removed tube cap|1|||
48771439|NCT03746522|157007800|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
48771440|NCT03746522|157007801|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
48771441|NCT03746522|157007802|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
48771442|NCT03746522|157007800|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
48771443|NCT03746522|157007801|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
48771444|NCT03746522|157007802|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
48771445|NCT03746522|157007800|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
48771446|NCT03746522|157007801|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
48771447|NCT03746522|157007802|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
48771448|NCT03746522|157007800|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
48771449|NCT03746522|157007801|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
48771450|NCT03746522|157007802|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
48771451|NCT03746522|157007800|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
48771452|NCT03746522|157007801|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
48771453|NCT03746522|157007802|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
48771454|NCT02552316|157007806|FG000|Overall Study|Withdrawal by Subject|1|||
48771455|NCT02552316|157007806|FG000|Overall Study|Withdrawal due to non-compliance|1|||
48395307|NCT01425008|155639931|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395308|NCT01425008|155639932|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
48395309|NCT01425008|155639933|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
48771456|NCT00684424|157007807|FG000|Overall Study|Adverse Event|1|||
48771457|NCT00684424|157007807|FG000|Overall Study|Lost to Follow-up|2|||
48395310|NCT01425008|155639934|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395311|NCT01425008|155639935|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395312|NCT01425008|155639936|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395313|NCT01425008|155639937|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
48771458|NCT00684424|157007807|FG000|Overall Study|Other|2|||
48395314|NCT01425008|155639938|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395315|NCT01425008|155639939|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395316|NCT01425008|155639940|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395317|NCT01425008|155639941|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395318|NCT01425008|155639942|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
48395319|NCT01425008|155639924|FG000|Dose Escalation Phase|Other|0|||
48395320|NCT01425008|155639925|FG001|Dose Escalation Phase|Other|0|||
48395321|NCT01425008|155639926|FG002|Dose Escalation Phase|Other|0|||
48395322|NCT01425008|155639927|FG003|Dose Escalation Phase|Other|0|||
48395323|NCT01425008|155639928|FG004|Dose Escalation Phase|Other|0|||
48771459|NCT00353366|157007809|FG000|Overall Study|Adverse Event|8|||
48771460|NCT00353366|157007809|FG000|Overall Study|Protocol Violation|12|||
48771461|NCT00353366|157007809|FG000|Overall Study|Withdrawal by Subject|12|||
48771462|NCT00353366|157007809|FG000|Overall Study|Lost to Follow-up|92|||
48771463|NCT00353366|157007809|FG000|Overall Study|Other|19|||
48771464|NCT04116710|157007810|FG000|Overall Study|Death|4|||
48771465|NCT04116710|157007811|FG001|Overall Study|Death|6|||
48771466|NCT04116710|157007812|FG002|Overall Study|Death|3|||
48771467|NCT04116710|157007813|FG003|Overall Study|Death|1|||
48771468|NCT04116710|157007810|FG000|Overall Study|Withdrawal by Subject|0|||
48771469|NCT04116710|157007811|FG001|Overall Study|Withdrawal by Subject|0|||
48771470|NCT04116710|157007812|FG002|Overall Study|Withdrawal by Subject|0|||
48771471|NCT04116710|157007813|FG003|Overall Study|Withdrawal by Subject|1|||
48771472|NCT01109316|157007814|FG000|Study Period 1|Adverse Event|0|||
48771473|NCT01109316|157007815|FG001|Study Period 1|Adverse Event|0|||
48771474|NCT01109316|157007816|FG002|Study Period 1|Adverse Event|1|||
48771475|NCT01109316|157007817|FG003|Study Period 1|Adverse Event|0|||
48771476|NCT01109316|157007818|FG004|Study Period 1|Adverse Event|0|||
48771477|NCT01109316|157007819|FG005|Study Period 1|Adverse Event|0|||
48771478|NCT01109316|157007814|FG000|Study Period 1|Lost to Follow-up|0|||
48771479|NCT01109316|157007815|FG001|Study Period 1|Lost to Follow-up|0|||
48771480|NCT01109316|157007816|FG002|Study Period 1|Lost to Follow-up|1|||
48771481|NCT01109316|157007817|FG003|Study Period 1|Lost to Follow-up|1|||
48771482|NCT01109316|157007818|FG004|Study Period 1|Lost to Follow-up|0|||
48771483|NCT01109316|157007819|FG005|Study Period 1|Lost to Follow-up|0|||
48771484|NCT01109316|157007814|FG000|Study Period 1|Withdrawal by Subject|0|||
48771485|NCT01109316|157007815|FG001|Study Period 1|Withdrawal by Subject|0|||
48771486|NCT01109316|157007816|FG002|Study Period 1|Withdrawal by Subject|1|||
48771487|NCT01109316|157007817|FG003|Study Period 1|Withdrawal by Subject|0|||
48771488|NCT01109316|157007818|FG004|Study Period 1|Withdrawal by Subject|2|||
48771489|NCT01109316|157007819|FG005|Study Period 1|Withdrawal by Subject|0|||
48771490|NCT01109316|157007814|FG000|Study Period 1|Sponsor Decision|0|||
48771491|NCT01109316|157007815|FG001|Study Period 1|Sponsor Decision|0|||
48771492|NCT01109316|157007816|FG002|Study Period 1|Sponsor Decision|0|||
48771493|NCT01109316|157007817|FG003|Study Period 1|Sponsor Decision|0|||
48771494|NCT01109316|157007818|FG004|Study Period 1|Sponsor Decision|0|||
48771495|NCT01109316|157007819|FG005|Study Period 1|Sponsor Decision|2|||
48771496|NCT01109316|157007814|FG000|Study Period 2|Entry Criteria Not Met|0|||
48771497|NCT01109316|157007815|FG001|Study Period 2|Entry Criteria Not Met|1|||
48771498|NCT01109316|157007816|FG002|Study Period 2|Entry Criteria Not Met|0|||
48771499|NCT01109316|157007817|FG003|Study Period 2|Entry Criteria Not Met|0|||
48771500|NCT01109316|157007818|FG004|Study Period 2|Entry Criteria Not Met|0|||
48771501|NCT01109316|157007819|FG005|Study Period 2|Entry Criteria Not Met|0|||
48771502|NCT01109316|157007814|FG000|Study Period 2|Physician Decision|0|||
48771503|NCT01109316|157007815|FG001|Study Period 2|Physician Decision|0|||
48771504|NCT01109316|157007816|FG002|Study Period 2|Physician Decision|0|||
48771505|NCT01109316|157007817|FG003|Study Period 2|Physician Decision|1|||
48771506|NCT01109316|157007818|FG004|Study Period 2|Physician Decision|0|||
48771507|NCT01109316|157007819|FG005|Study Period 2|Physician Decision|0|||
48771508|NCT01109316|157007814|FG000|Study Period 2|Protocol Violation|1|||
48771509|NCT01109316|157007815|FG001|Study Period 2|Protocol Violation|0|||
48771510|NCT01109316|157007816|FG002|Study Period 2|Protocol Violation|0|||
48771511|NCT01109316|157007817|FG003|Study Period 2|Protocol Violation|0|||
48771512|NCT01109316|157007818|FG004|Study Period 2|Protocol Violation|0|||
48771513|NCT01109316|157007819|FG005|Study Period 2|Protocol Violation|0|||
48395324|NCT01425008|155639929|FG005|Dose Escalation Phase|Other|0|||
48395325|NCT01425008|155639930|FG006|Dose Escalation Phase|Other|0|||
48395326|NCT01425008|155639931|FG007|Dose Escalation Phase|Other|0|||
48395327|NCT01425008|155639932|FG008|Dose Escalation Phase|Other|1|||
48395328|NCT01425008|155639933|FG009|Dose Escalation Phase|Other|0|||
48771514|NCT01109316|157007814|FG000|Study Period 2|Withdrawal by Subject|0|||
48771515|NCT01109316|157007815|FG001|Study Period 2|Withdrawal by Subject|0|||
48771516|NCT01109316|157007816|FG002|Study Period 2|Withdrawal by Subject|1|||
48771517|NCT01109316|157007817|FG003|Study Period 2|Withdrawal by Subject|0|||
48356048|NCT01454739|155501005|FG001|Overall Study|Adverse Event|1|||
48356049|NCT01810939|155501006|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
48771518|NCT01109316|157007818|FG004|Study Period 2|Withdrawal by Subject|0|||
48771519|NCT01109316|157007819|FG005|Study Period 2|Withdrawal by Subject|1|||
48771520|NCT01109316|157007814|FG000|Study Period 3|Lost to Follow-up|0|||
48771521|NCT01109316|157007815|FG001|Study Period 3|Lost to Follow-up|0|||
48771522|NCT01109316|157007816|FG002|Study Period 3|Lost to Follow-up|0|||
48771523|NCT01109316|157007817|FG003|Study Period 3|Lost to Follow-up|0|||
48771524|NCT01109316|157007818|FG004|Study Period 3|Lost to Follow-up|1|||
48771525|NCT01109316|157007819|FG005|Study Period 3|Lost to Follow-up|0|||
48771526|NCT01109316|157007814|FG000|Study Period 3|Withdrawal by Subject|1|||
48771527|NCT01109316|157007815|FG001|Study Period 3|Withdrawal by Subject|0|||
48771528|NCT01109316|157007816|FG002|Study Period 3|Withdrawal by Subject|0|||
48771529|NCT01109316|157007817|FG003|Study Period 3|Withdrawal by Subject|0|||
48771530|NCT01109316|157007818|FG004|Study Period 3|Withdrawal by Subject|1|||
48771531|NCT01109316|157007819|FG005|Study Period 3|Withdrawal by Subject|0|||
48356050|NCT01810939|155501007|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
48356051|NCT01810939|155501008|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
48356052|NCT01810939|155501006|FG000|Part A Treatment Period|Protocol Violation|2|||
48356053|NCT01810939|155501007|FG001|Part A Treatment Period|Protocol Violation|0|||
48771532|NCT01120210|157007820|FG000|MAIN INFUSION|Adverse Event|1|||
48771533|NCT01120210|157007821|FG001|MAIN INFUSION|Adverse Event|0|||
48771534|NCT01120210|157007820|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
48771535|NCT01120210|157007821|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
48395329|NCT01425008|155639934|FG010|Dose Escalation Phase|Other|0|||
48395330|NCT01425008|155639935|FG011|Dose Escalation Phase|Other|0|||
48395331|NCT01425008|155639936|FG012|Dose Escalation Phase|Other|0|||
48395332|NCT01425008|155639937|FG013|Dose Escalation Phase|Other|0|||
48395333|NCT01425008|155639938|FG014|Dose Escalation Phase|Other|0|||
48771536|NCT02043015|157007822|FG000|Overall Study|Lost to Follow-up|4|||
48771537|NCT02043015|157007822|FG000|Overall Study|Withdrawal by Subject|4|||
48771538|NCT02043015|157007822|FG000|Overall Study|Removed once target enrollment reached|15|||
48771539|NCT02043015|157007822|FG000|Overall Study|Participant moved away from study city|4|||
48771540|NCT02043015|157007822|FG000|Overall Study|Incarceration|1|||
48771541|NCT00775437|157007823|FG000|Overall Study|Loss of efficacy|2|||
48771542|NCT00775437|157007823|FG000|Overall Study|Withdrawal by Subject|3|||
48771543|NCT00775437|157007823|FG000|Overall Study|Lost to Follow-up|1|||
48771544|NCT03075644|157007827|FG000|Overall Study|Withdrawal by Subject|1|||
48771545|NCT03075644|157007828|FG001|Overall Study|Withdrawal by Subject|1|||
48771546|NCT01205165|157007829|FG000|Overall Study|Lost to Follow-up|2|||
48771547|NCT03306264|157007830|FG000|Overall Study|Death|33|||
48771548|NCT03306264|157007831|FG001|Overall Study|Death|25|||
48771549|NCT03306264|157007832|FG002|Overall Study|Death|34|||
48771550|NCT03306264|157007833|FG003|Overall Study|Death|34|||
48771551|NCT03306264|157007830|FG000|Overall Study|Complete Consent Withdrawal|4|||
48771552|NCT03306264|157007831|FG001|Overall Study|Complete Consent Withdrawal|4|||
48771553|NCT03306264|157007832|FG002|Overall Study|Complete Consent Withdrawal|1|||
48771554|NCT03306264|157007833|FG003|Overall Study|Complete Consent Withdrawal|8|||
48771555|NCT03306264|157007830|FG000|Overall Study|Lost to Follow-up|1|||
48771556|NCT03306264|157007831|FG001|Overall Study|Lost to Follow-up|0|||
48771557|NCT03306264|157007832|FG002|Overall Study|Lost to Follow-up|1|||
48771558|NCT03306264|157007833|FG003|Overall Study|Lost to Follow-up|0|||
48771559|NCT03306264|157007830|FG000|Overall Study|Rollover to ASTX727-06|10|||
48771560|NCT03306264|157007831|FG001|Overall Study|Rollover to ASTX727-06|18|||
48771561|NCT03306264|157007832|FG002|Overall Study|Rollover to ASTX727-06|4|||
48771562|NCT03306264|157007833|FG003|Overall Study|Rollover to ASTX727-06|2|||
48771563|NCT03306264|157007830|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
48771564|NCT03306264|157007831|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
48771565|NCT03306264|157007832|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
48771566|NCT03306264|157007833|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
48771567|NCT01706250|157007838|FG000|Overall Study|Lost to Follow-up|2|||
48771568|NCT02143843|157007839|FG000|Overall Study|Adverse Event|8|||
48771569|NCT02143843|157007839|FG000|Overall Study|Lack of Efficacy|2|||
48771570|NCT02143843|157007839|FG000|Overall Study|Withdrawal by Subject|2|||
48771571|NCT03044197|157007842|FG000|Overall Study|Withdrawal by Subject|3|||
48771572|NCT03044197|157007843|FG001|Overall Study|Withdrawal by Subject|1|||
48771573|NCT01720069|157007844|FG000|Overall Study|Could not use e-diary correctly|0|||
48771574|NCT01720069|157007845|FG001|Overall Study|Could not use e-diary correctly|1|||
48771575|NCT01720069|157007846|FG002|Overall Study|Could not use e-diary correctly|1|||
48771576|NCT01720069|157007844|FG000|Overall Study|Randomised without baseline values|0|||
48771577|NCT01720069|157007845|FG001|Overall Study|Randomised without baseline values|0|||
48771578|NCT01720069|157007846|FG002|Overall Study|Randomised without baseline values|1|||
48771579|NCT01720069|157007844|FG000|Overall Study|Adverse Event|0|||
48771580|NCT01720069|157007845|FG001|Overall Study|Adverse Event|0|||
48771581|NCT01720069|157007846|FG002|Overall Study|Adverse Event|1|||
48771582|NCT01720069|157007844|FG000|Overall Study|Lack of Efficacy|0|||
48771583|NCT01720069|157007845|FG001|Overall Study|Lack of Efficacy|4|||
48771584|NCT01720069|157007846|FG002|Overall Study|Lack of Efficacy|0|||
48771585|NCT01720069|157007844|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
48771586|NCT01720069|157007845|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
48771587|NCT01720069|157007846|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
48771588|NCT01720069|157007844|FG000|Overall Study|Withdrawal by Subject|0|||
48771589|NCT01720069|157007845|FG001|Overall Study|Withdrawal by Subject|2|||
48395334|NCT01425008|155639939|FG015|Dose Escalation Phase|Other|0|||
48395335|NCT01425008|155639940|FG016|Dose Escalation Phase|Other|0|||
48395336|NCT01425008|155639941|FG017|Dose Escalation Phase|Other|0|||
48395337|NCT01425008|155639942|FG018|Dose Escalation Phase|Other|0|||
48395338|NCT01425008|155639924|FG000|Dose Expansion Phase|Progressive Disease|0|||
48395339|NCT01425008|155639925|FG001|Dose Expansion Phase|Progressive Disease|0|||
48771590|NCT01720069|157007846|FG002|Overall Study|Withdrawal by Subject|1|||
48771591|NCT01720069|157007844|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
48771592|NCT01720069|157007845|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
48771593|NCT01720069|157007846|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
48771594|NCT01720069|157007844|FG000|Overall Study|Non-compliance on using e-diary|0|||
48771595|NCT01720069|157007845|FG001|Overall Study|Non-compliance on using e-diary|0|||
48771596|NCT01720069|157007846|FG002|Overall Study|Non-compliance on using e-diary|1|||
48771597|NCT01720069|157007844|FG000|Overall Study|Lost to Follow-up|0|||
48771598|NCT01720069|157007845|FG001|Overall Study|Lost to Follow-up|0|||
48771599|NCT01720069|157007846|FG002|Overall Study|Lost to Follow-up|1|||
48771600|NCT02318693|157007847|FG000|Overall Study|Protocol Violation|0|||
48771601|NCT02318693|157007848|FG001|Overall Study|Protocol Violation|1|||
48771602|NCT00218543|157007850|FG000|Overall Study|Lost to Follow-up|8|||
48771603|NCT00218543|157007850|FG000|Overall Study|relocated|1|||
48771604|NCT00218543|157007850|FG000|Overall Study|Withdrawal by Subject|1|||
48771605|NCT00218543|157007850|FG000|Overall Study|Physician Decision|3|||
48771606|NCT00218543|157007850|FG000|Overall Study|Adverse Event|2|||
48771607|NCT01864291|157007851|FG000|Overall Study|need for revision surgery|2|||
48771608|NCT02920983|157007852|FG000|Dispense 1|Unacceptable Lens Fit|0|||
48771609|NCT02920983|157007853|FG001|Dispense 1|Unacceptable Lens Fit|0|||
48771610|NCT02920983|157007854|FG002|Dispense 1|Unacceptable Lens Fit|0|||
48771611|NCT02920983|157007855|FG003|Dispense 1|Unacceptable Lens Fit|0|||
48771612|NCT02920983|157007856|FG004|Dispense 1|Unacceptable Lens Fit|1|||
48771613|NCT02920983|157007857|FG005|Dispense 1|Unacceptable Lens Fit|0|||
48771614|NCT02920983|157007852|FG000|Dispense 2|Unscceptable lens fit|1|||
48771615|NCT02920983|157007853|FG001|Dispense 2|Unscceptable lens fit|0|||
48771616|NCT02920983|157007854|FG002|Dispense 2|Unscceptable lens fit|0|||
48771617|NCT02920983|157007855|FG003|Dispense 2|Unscceptable lens fit|0|||
48771618|NCT02920983|157007856|FG004|Dispense 2|Unscceptable lens fit|1|||
48771619|NCT02920983|157007857|FG005|Dispense 2|Unscceptable lens fit|0|||
48771620|NCT02920983|157007852|FG000|Dispense 3|Unacceptable Lens Fit|1|||
48771621|NCT02920983|157007853|FG001|Dispense 3|Unacceptable Lens Fit|1|||
48771622|NCT02920983|157007854|FG002|Dispense 3|Unacceptable Lens Fit|0|||
48771623|NCT02920983|157007855|FG003|Dispense 3|Unacceptable Lens Fit|0|||
48771624|NCT02920983|157007856|FG004|Dispense 3|Unacceptable Lens Fit|1|||
48771625|NCT02920983|157007857|FG005|Dispense 3|Unacceptable Lens Fit|0|||
48771626|NCT03256552|157009830|FG000|Overall Study|Protocol Violation|1|||
48771627|NCT03256552|157009830|FG000|Overall Study|Physician Decision|1|||
48771628|NCT03256552|157009830|FG000|Overall Study|Adverse Event|1|||
48771629|NCT03256552|157009830|FG000|Overall Study|Withdrawal by Subject|2|||
48771630|NCT04380857|157009839|FG000|Overall Study|Lost to Follow-up|3|||
48771631|NCT04380857|157009840|FG001|Overall Study|Lost to Follow-up|3|||
48771632|NCT00427635|157009841|FG000|Treatment Phase|Withdrawal by Subject|1|||
48771633|NCT00427635|157009842|FG001|Treatment Phase|Withdrawal by Subject|0|||
48771634|NCT00427635|157009841|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
48771635|NCT00427635|157009842|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
48771636|NCT03277846|157009843|FG000|Overall Study|Inpatient stay too brief|12|||
48771637|NCT03277846|157009844|FG001|Overall Study|Inpatient stay too brief|11|||
48771638|NCT02554656|157009845|FG000|Overall Study|Protocol Violation|3|||
48771639|NCT03240575|157009846|FG000|Overall Study|Adverse Event|0|||
48771640|NCT03240575|157009847|FG001|Overall Study|Adverse Event|2|||
48771641|NCT03240575|157009848|FG002|Overall Study|Adverse Event|0|||
48771642|NCT03240575|157009849|FG003|Overall Study|Adverse Event|1|||
48771643|NCT03240575|157009846|FG000|Overall Study|Withdrawal by Subject|2|||
48771644|NCT03240575|157009847|FG001|Overall Study|Withdrawal by Subject|11|||
48771645|NCT03240575|157009848|FG002|Overall Study|Withdrawal by Subject|0|||
48771646|NCT03240575|157009849|FG003|Overall Study|Withdrawal by Subject|1|||
48771647|NCT03240575|157009846|FG000|Overall Study|Other|0|||
48356054|NCT01810939|155501008|FG002|Part A Treatment Period|Protocol Violation|0|||
48356055|NCT01810939|155501006|FG000|Part A Treatment Period|Adverse Event|10|||
48356056|NCT01810939|155501007|FG001|Part A Treatment Period|Adverse Event|0|||
48356057|NCT01810939|155501008|FG002|Part A Treatment Period|Adverse Event|0|||
48356058|NCT01810939|155501006|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
48356059|NCT01810939|155501007|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
48356060|NCT01810939|155501008|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
48356061|NCT01810939|155501006|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
48356062|NCT01810939|155501007|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
48356063|NCT01810939|155501008|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
48356064|NCT01810939|155501006|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
48356065|NCT01810939|155501007|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
48356066|NCT01810939|155501008|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
48356067|NCT01810939|155501006|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
48356068|NCT01810939|155501007|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
48356069|NCT01810939|155501008|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
48771648|NCT03240575|157009847|FG001|Overall Study|Other|1|||
48771649|NCT03240575|157009848|FG002|Overall Study|Other|0|||
48771650|NCT03240575|157009849|FG003|Overall Study|Other|0|||
48771651|NCT03568942|157009850|FG000|Overall Study|Family emergency|1|||
48771652|NCT03568942|157009850|FG000|Overall Study|Lost to Follow-up|1|||
48771653|NCT02118428|157009856|FG000|Overall Study|Physician Decision|0|||
48771654|NCT02118428|157009857|FG001|Overall Study|Physician Decision|1|||
48771655|NCT02118428|157009858|FG002|Overall Study|Physician Decision|0|||
48771656|NCT02118428|157009856|FG000|Overall Study|Withdrawal by Subject|2|||
48771657|NCT02118428|157009857|FG001|Overall Study|Withdrawal by Subject|2|||
48771658|NCT02118428|157009858|FG002|Overall Study|Withdrawal by Subject|0|||
48771659|NCT02118428|157009856|FG000|Overall Study|Death|7|||
48771660|NCT02118428|157009857|FG001|Overall Study|Death|5|||
48771661|NCT02118428|157009858|FG002|Overall Study|Death|0|||
48395340|NCT01425008|155639926|FG002|Dose Expansion Phase|Progressive Disease|0|||
48395341|NCT01425008|155639927|FG003|Dose Expansion Phase|Progressive Disease|0|||
48395342|NCT01425008|155639928|FG004|Dose Expansion Phase|Progressive Disease|0|||
48395343|NCT01425008|155639929|FG005|Dose Expansion Phase|Progressive Disease|0|||
48395344|NCT01425008|155639930|FG006|Dose Expansion Phase|Progressive Disease|0|||
48395345|NCT01425008|155639931|FG007|Dose Expansion Phase|Progressive Disease|0|||
48395346|NCT01425008|155639932|FG008|Dose Expansion Phase|Progressive Disease|0|||
48395347|NCT01425008|155639933|FG009|Dose Expansion Phase|Progressive Disease|0|||
48395348|NCT01425008|155639934|FG010|Dose Expansion Phase|Progressive Disease|10|||
48395349|NCT01425008|155639935|FG011|Dose Expansion Phase|Progressive Disease|4|||
48395350|NCT01425008|155639936|FG012|Dose Expansion Phase|Progressive Disease|12|||
48395351|NCT01425008|155639937|FG013|Dose Expansion Phase|Progressive Disease|1|||
48395352|NCT01425008|155639938|FG014|Dose Expansion Phase|Progressive Disease|5|||
48395353|NCT01425008|155639939|FG015|Dose Expansion Phase|Progressive Disease|8|||
48395354|NCT01425008|155639940|FG016|Dose Expansion Phase|Progressive Disease|9|||
48395355|NCT01425008|155639941|FG017|Dose Expansion Phase|Progressive Disease|2|||
48395356|NCT01425008|155639942|FG018|Dose Expansion Phase|Progressive Disease|10|||
48395357|NCT01425008|155639924|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
48395358|NCT01425008|155639925|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
48395359|NCT01425008|155639926|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
48395360|NCT01425008|155639927|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
48395361|NCT01425008|155639928|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
48395362|NCT01425008|155639929|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
48395363|NCT01425008|155639930|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
48395364|NCT01425008|155639931|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
48395365|NCT01425008|155639932|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
48395366|NCT01425008|155639933|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
48395367|NCT01425008|155639934|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
48395368|NCT01425008|155639935|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
48395369|NCT01425008|155639936|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
48395370|NCT01425008|155639937|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
48395371|NCT01425008|155639938|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
48395372|NCT01425008|155639939|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
48395373|NCT01425008|155639940|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
48395374|NCT01425008|155639941|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
48395375|NCT01425008|155639942|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
48395376|NCT01425008|155639924|FG000|Dose Expansion Phase|Other|0|||
48395377|NCT01425008|155639925|FG001|Dose Expansion Phase|Other|0|||
48395378|NCT01425008|155639926|FG002|Dose Expansion Phase|Other|0|||
48395379|NCT01425008|155639927|FG003|Dose Expansion Phase|Other|0|||
48395380|NCT01425008|155639928|FG004|Dose Expansion Phase|Other|0|||
48395381|NCT01425008|155639929|FG005|Dose Expansion Phase|Other|0|||
48395382|NCT01425008|155639930|FG006|Dose Expansion Phase|Other|0|||
48395383|NCT01425008|155639931|FG007|Dose Expansion Phase|Other|0|||
48395384|NCT01425008|155639932|FG008|Dose Expansion Phase|Other|0|||
48395385|NCT01425008|155639933|FG009|Dose Expansion Phase|Other|0|||
48395386|NCT01425008|155639934|FG010|Dose Expansion Phase|Other|0|||
48395387|NCT01425008|155639935|FG011|Dose Expansion Phase|Other|0|||
48395388|NCT01425008|155639936|FG012|Dose Expansion Phase|Other|1|||
48395389|NCT01425008|155639937|FG013|Dose Expansion Phase|Other|0|||
48395390|NCT01425008|155639938|FG014|Dose Expansion Phase|Other|0|||
48395391|NCT01425008|155639939|FG015|Dose Expansion Phase|Other|0|||
48395392|NCT01425008|155639940|FG016|Dose Expansion Phase|Other|2|||
48395393|NCT01425008|155639941|FG017|Dose Expansion Phase|Other|0|||
48395394|NCT01425008|155639942|FG018|Dose Expansion Phase|Other|4|||
48395395|NCT01425008|155639924|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395396|NCT01425008|155639925|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395397|NCT01425008|155639926|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395398|NCT01425008|155639927|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395399|NCT01425008|155639928|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395400|NCT01425008|155639929|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395401|NCT01425008|155639930|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395402|NCT01425008|155639931|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395403|NCT01425008|155639932|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395404|NCT01425008|155639933|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395405|NCT01425008|155639934|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
48395406|NCT01425008|155639935|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
48395407|NCT01425008|155639936|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395408|NCT01425008|155639937|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395409|NCT01425008|155639938|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395410|NCT01425008|155639939|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
48395411|NCT01425008|155639940|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
48395412|NCT01425008|155639941|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
48395413|NCT01425008|155639942|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
48395414|NCT01425008|155639924|FG000|Dose Expansion Phase|Adverse Event|0|||
48395415|NCT01425008|155639925|FG001|Dose Expansion Phase|Adverse Event|0|||
48395416|NCT01425008|155639926|FG002|Dose Expansion Phase|Adverse Event|0|||
48395417|NCT01425008|155639927|FG003|Dose Expansion Phase|Adverse Event|0|||
48395418|NCT01425008|155639928|FG004|Dose Expansion Phase|Adverse Event|0|||
48395419|NCT01425008|155639929|FG005|Dose Expansion Phase|Adverse Event|0|||
48395420|NCT01425008|155639930|FG006|Dose Expansion Phase|Adverse Event|0|||
48395421|NCT01425008|155639931|FG007|Dose Expansion Phase|Adverse Event|0|||
48395422|NCT01425008|155639932|FG008|Dose Expansion Phase|Adverse Event|0|||
48395423|NCT01425008|155639933|FG009|Dose Expansion Phase|Adverse Event|0|||
48395424|NCT01425008|155639934|FG010|Dose Expansion Phase|Adverse Event|2|||
48395425|NCT01425008|155639935|FG011|Dose Expansion Phase|Adverse Event|3|||
48395426|NCT01425008|155639936|FG012|Dose Expansion Phase|Adverse Event|3|||
48395427|NCT01425008|155639937|FG013|Dose Expansion Phase|Adverse Event|0|||
48395428|NCT01425008|155639938|FG014|Dose Expansion Phase|Adverse Event|1|||
48395429|NCT01425008|155639939|FG015|Dose Expansion Phase|Adverse Event|1|||
48395430|NCT01425008|155639940|FG016|Dose Expansion Phase|Adverse Event|5|||
48395431|NCT01425008|155639941|FG017|Dose Expansion Phase|Adverse Event|0|||
48395432|NCT01425008|155639942|FG018|Dose Expansion Phase|Adverse Event|3|||
48395433|NCT01425008|155639924|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
48356070|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
48356071|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
48356072|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
48356073|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
48356074|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
48356075|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
48356076|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
48356077|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
48356078|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
48356079|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
48356080|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
48356081|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
48356082|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
48356083|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
48356084|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
48356085|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
48356086|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
48356087|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
48356088|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
48356089|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
48356090|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
48356091|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
48356092|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
48356093|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
48356094|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
48356095|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
48356096|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
48356097|NCT01810939|155501006|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
48356098|NCT01810939|155501007|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
48356099|NCT01810939|155501008|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
48356100|NCT02870972|155501012|FG000|Overall Study|Adverse Event|1|||
48356101|NCT02870972|155501013|FG001|Overall Study|Adverse Event|0|||
48356102|NCT02870972|155501014|FG002|Overall Study|Adverse Event|0|||
48356103|NCT02870972|155501015|FG003|Overall Study|Adverse Event|0|||
48356104|NCT02870972|155501016|FG004|Overall Study|Adverse Event|0|||
48356105|NCT01907906|155501017|FG000|Overall Study|Withdrawal by Subject|1|||
48356106|NCT01907906|155501018|FG001|Overall Study|Withdrawal by Subject|0|||
48356107|NCT01907906|155501017|FG000|Overall Study|Physician Decision|3|||
48356108|NCT01907906|155501018|FG001|Overall Study|Physician Decision|1|||
48356109|NCT00979953|155501019|FG000|Overall Study|Adverse Event|5|||
48356110|NCT00979953|155501020|FG001|Overall Study|Adverse Event|2|||
48356111|NCT00979953|155501021|FG002|Overall Study|Adverse Event|17|||
48356112|NCT00979953|155501022|FG003|Overall Study|Adverse Event|4|||
48356113|NCT00979953|155501019|FG000|Overall Study|Lack of Efficacy|1|||
48356114|NCT00979953|155501020|FG001|Overall Study|Lack of Efficacy|2|||
48356115|NCT00979953|155501021|FG002|Overall Study|Lack of Efficacy|0|||
48356116|NCT00979953|155501022|FG003|Overall Study|Lack of Efficacy|0|||
48395434|NCT01425008|155639925|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
48395435|NCT01425008|155639926|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
48395436|NCT01425008|155639927|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
48771662|NCT02118428|157009856|FG000|Overall Study|Lost to Follow-up|3|||
48771663|NCT02118428|157009857|FG001|Overall Study|Lost to Follow-up|1|||
48771664|NCT02118428|157009858|FG002|Overall Study|Lost to Follow-up|0|||
48771665|NCT02118428|157009856|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
48771666|NCT02118428|157009857|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
48771667|NCT02118428|157009858|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
48771668|NCT04300296|157009859|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
48771669|NCT04300296|157009860|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771670|NCT04300296|157009861|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771671|NCT04300296|157009862|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771672|NCT04300296|157009863|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771673|NCT04300296|157009864|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
48771674|NCT04300296|157009859|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771675|NCT04300296|157009860|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771676|NCT04300296|157009861|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771677|NCT04300296|157009862|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771678|NCT04300296|157009863|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
48771679|NCT04300296|157009864|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
48771680|NCT04300296|157009859|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
48771681|NCT04300296|157009860|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
48771682|NCT04300296|157009861|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
48771683|NCT04300296|157009862|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
48771684|NCT04300296|157009863|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
48771685|NCT04300296|157009864|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
48771686|NCT04300296|157009859|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
48771687|NCT04300296|157009860|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
48771688|NCT04300296|157009861|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
48771689|NCT04300296|157009862|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
48771690|NCT04300296|157009863|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
48771691|NCT04300296|157009864|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
48771692|NCT04300296|157009859|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
48771693|NCT04300296|157009860|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
48771694|NCT04300296|157009861|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
48771695|NCT04300296|157009862|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
48771696|NCT04300296|157009863|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
48771697|NCT04300296|157009864|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
48771698|NCT04300296|157009859|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771699|NCT04300296|157009860|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
48771700|NCT04300296|157009861|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771701|NCT04300296|157009862|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771702|NCT04300296|157009863|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771703|NCT04300296|157009864|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
48771704|NCT04300296|157009859|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
48771705|NCT04300296|157009860|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
48771706|NCT04300296|157009861|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
48771707|NCT04300296|157009862|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
48771708|NCT04300296|157009863|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
48771709|NCT04300296|157009864|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
48771710|NCT00424372|157009867|FG000|Overall Study|Death|1|||
48395437|NCT01425008|155639928|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
48395438|NCT01425008|155639929|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
48395439|NCT01425008|155639930|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
48395440|NCT01425008|155639931|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
48395441|NCT01425008|155639932|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
48395442|NCT01425008|155639933|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
48395443|NCT01425008|155639934|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
48771711|NCT00424372|157009867|FG000|Overall Study|Adverse Event|18|||
48771712|NCT00424372|157009867|FG000|Overall Study|Lack of Efficacy|6|||
48771713|NCT00424372|157009867|FG000|Overall Study|Withdrawal by Subject|4|||
48771714|NCT00424372|157009867|FG000|Overall Study|Protocol Violation|1|||
48771715|NCT00424372|157009867|FG000|Overall Study|Health deterioration|1|||
48771716|NCT02412631|157009870|FG000|Overall Study|Adverse Event|1|||
48771717|NCT02412631|157009871|FG001|Overall Study|Adverse Event|2|||
48771718|NCT02412631|157009870|FG000|Overall Study|Lost to Follow-up|5|||
48771719|NCT02412631|157009871|FG001|Overall Study|Lost to Follow-up|9|||
48771720|NCT02412631|157009870|FG000|Overall Study|Withdrawal by Subject|9|||
48771721|NCT02412631|157009871|FG001|Overall Study|Withdrawal by Subject|3|||
48771722|NCT02412631|157009870|FG000|Overall Study|Early stop by FDA|5|||
48771723|NCT02412631|157009871|FG001|Overall Study|Early stop by FDA|2|||
48771724|NCT02412631|157009870|FG000|Overall Study|Unspecified reason|6|||
48771725|NCT02412631|157009871|FG001|Overall Study|Unspecified reason|8|||
48771726|NCT02940691|157009872|FG000|Overall Study|Lost to Follow-up|5|||
48771727|NCT02940691|157009872|FG000|Overall Study|Incarceration|1|||
48771728|NCT02177266|157009873|FG000|Overall Study|Adverse Event|0|||
48771729|NCT02177266|157009874|FG001|Overall Study|Adverse Event|1|||
48771730|NCT02177266|157009873|FG000|Overall Study|Withdrawal by Subject|1|||
48771731|NCT02177266|157009874|FG001|Overall Study|Withdrawal by Subject|0|||
48771732|NCT03364049|157009875|FG000|Overall Study|Death|6|||
48771733|NCT03364049|157009876|FG001|Overall Study|Death|4|||
48771734|NCT03364049|157009877|FG002|Overall Study|Death|5|||
48771735|NCT03364049|157009878|FG003|Overall Study|Death|14|||
48771736|NCT03364049|157009875|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
48771737|NCT03364049|157009876|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
48771738|NCT03364049|157009877|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
48771739|NCT03364049|157009878|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
48771740|NCT03364049|157009875|FG000|Overall Study|Withdrawal by Subject|0|||
48771741|NCT03364049|157009876|FG001|Overall Study|Withdrawal by Subject|1|||
48771742|NCT03364049|157009877|FG002|Overall Study|Withdrawal by Subject|1|||
48771743|NCT03364049|157009878|FG003|Overall Study|Withdrawal by Subject|1|||
48771744|NCT00577122|157009883|FG000|Overall Study|Adverse Event|0|||
48771745|NCT00577122|157009884|FG001|Overall Study|Adverse Event|2|||
48771746|NCT00577122|157009883|FG000|Overall Study|Progression, relapse during active trt|6|||
48771747|NCT00577122|157009884|FG001|Overall Study|Progression, relapse during active trt|8|||
48771748|NCT00577122|157009883|FG000|Overall Study|Prog, refract disease during active trt|8|||
48771749|NCT00577122|157009884|FG001|Overall Study|Prog, refract disease during active trt|5|||
48771750|NCT00577122|157009883|FG000|Overall Study|Alternative Therapy|0|||
48771751|NCT00577122|157009884|FG001|Overall Study|Alternative Therapy|1|||
48771752|NCT01340976|157009885|FG000|Overall Study|Physician Decision|2|||
48771753|NCT01340976|157009886|FG001|Overall Study|Physician Decision|0|||
48771754|NCT01340976|157009887|FG002|Overall Study|Physician Decision|1|||
48771755|NCT01340976|157009888|FG003|Overall Study|Physician Decision|1|||
48771756|NCT01340976|157009889|FG004|Overall Study|Physician Decision|1|||
48771757|NCT01340976|157009890|FG005|Overall Study|Physician Decision|0|||
48771758|NCT01340976|157009885|FG000|Overall Study|Death|0|||
48771759|NCT01340976|157009886|FG001|Overall Study|Death|1|||
48771760|NCT01340976|157009887|FG002|Overall Study|Death|0|||
48771761|NCT01340976|157009888|FG003|Overall Study|Death|0|||
48771762|NCT01340976|157009889|FG004|Overall Study|Death|0|||
48771763|NCT01340976|157009890|FG005|Overall Study|Death|0|||
48771764|NCT01340976|157009885|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
48771765|NCT01340976|157009886|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771766|NCT01340976|157009887|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771767|NCT01340976|157009888|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771768|NCT01340976|157009889|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771769|NCT01340976|157009890|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
48771770|NCT01340976|157009885|FG000|Overall Study|Withdrawal by Subject|0|||
48771771|NCT01340976|157009886|FG001|Overall Study|Withdrawal by Subject|0|||
48771772|NCT01340976|157009887|FG002|Overall Study|Withdrawal by Subject|0|||
48771773|NCT01340976|157009888|FG003|Overall Study|Withdrawal by Subject|1|||
48771774|NCT01340976|157009889|FG004|Overall Study|Withdrawal by Subject|1|||
48771775|NCT01340976|157009890|FG005|Overall Study|Withdrawal by Subject|0|||
48771776|NCT01340976|157009885|FG000|Overall Study|Other anemia treatment|1|||
48771777|NCT01340976|157009886|FG001|Overall Study|Other anemia treatment|0|||
48771778|NCT01340976|157009887|FG002|Overall Study|Other anemia treatment|2|||
48771779|NCT01340976|157009888|FG003|Overall Study|Other anemia treatment|1|||
48771780|NCT01340976|157009889|FG004|Overall Study|Other anemia treatment|0|||
48771781|NCT01340976|157009890|FG005|Overall Study|Other anemia treatment|1|||
48771782|NCT01340976|157009885|FG000|Overall Study|Adverse Event|0|||
48771783|NCT01340976|157009886|FG001|Overall Study|Adverse Event|1|||
48771784|NCT01340976|157009887|FG002|Overall Study|Adverse Event|0|||
48771785|NCT01340976|157009888|FG003|Overall Study|Adverse Event|0|||
48771786|NCT01340976|157009889|FG004|Overall Study|Adverse Event|0|||
48771787|NCT01340976|157009890|FG005|Overall Study|Adverse Event|0|||
48771788|NCT02953821|157009894|FG000|Overall Study|Adverse Event|0|||
48771789|NCT02953821|157009895|FG001|Overall Study|Adverse Event|4|||
48771790|NCT02953821|157009894|FG000|Overall Study|Death|1|||
48771791|NCT02953821|157009895|FG001|Overall Study|Death|0|||
48771792|NCT02953821|157009894|FG000|Overall Study|Progressive Disease|5|||
48771793|NCT02953821|157009895|FG001|Overall Study|Progressive Disease|1|||
48771794|NCT02953821|157009894|FG000|Overall Study|Lost to Follow-up|2|||
48771795|NCT02953821|157009895|FG001|Overall Study|Lost to Follow-up|0|||
48395444|NCT01425008|155639935|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
48771796|NCT02953821|157009894|FG000|Overall Study|Physician Decision|1|||
48771797|NCT02953821|157009895|FG001|Overall Study|Physician Decision|1|||
48771798|NCT02953821|157009894|FG000|Overall Study|Withdrawal by Subject|3|||
48771799|NCT02953821|157009895|FG001|Overall Study|Withdrawal by Subject|3|||
48771800|NCT02953821|157009894|FG000|Overall Study|Change of address|0|||
48771801|NCT02953821|157009895|FG001|Overall Study|Change of address|1|||
48771802|NCT02953821|157009894|FG000|Overall Study|Lack of Efficacy|1|||
48771803|NCT02953821|157009895|FG001|Overall Study|Lack of Efficacy|0|||
48771804|NCT02953821|157009894|FG000|Overall Study|Out of state for indeterminate time|0|||
48771805|NCT02953821|157009895|FG001|Overall Study|Out of state for indeterminate time|1|||
48771806|NCT02953821|157009894|FG000|Overall Study|No improvement|0|||
48771807|NCT02953821|157009895|FG001|Overall Study|No improvement|1|||
48771808|NCT02953821|157009894|FG000|Overall Study|Refused follow-up visit|2|||
48771809|NCT02953821|157009895|FG001|Overall Study|Refused follow-up visit|1|||
48771810|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
48771811|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
48771812|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
48771813|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Death|1|||
48771814|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
48771815|NCT02840877|157009900|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
48771816|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
48771817|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Treatment failure|1|||
48771818|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
48771819|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
48771820|NCT02840877|157009900|FG000|12 Weeks to 6 Months|Death|1|||
48771821|NCT02840877|157009900|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
48771822|NCT02840877|157009900|FG000|6 Months to 18 Months|Treatment failure|7|||
48771823|NCT02840877|157009900|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
48771824|NCT02840877|157009900|FG000|6 Months to 18 Months|Moved/transferred out|6|||
48771825|NCT02840877|157009900|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
48771826|NCT02840877|157009900|FG000|6 Months to 18 Months|Death|4|||
48771827|NCT02840877|157009900|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
48771828|NCT02840877|157009900|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
48771829|NCT02840877|157009900|FG000|6 Months to 18 Months|Still in study.|14|||
48771830|NCT01743092|157009904|FG000|Overall Study|Lost to Follow-up|14|||
48771831|NCT01743092|157009905|FG001|Overall Study|Lost to Follow-up|15|||
48771832|NCT00826267|157009906|FG000|Overall Study|Other Adverse Event|1|||
48771833|NCT00826267|157009907|FG001|Overall Study|Other Adverse Event|0|||
48771834|NCT00826267|157009908|FG002|Overall Study|Other Adverse Event|0|||
48771835|NCT00414661|157009918|FG000|Overall Study|Death|2|||
48771836|NCT00414661|157009919|FG001|Overall Study|Death|5|||
48771837|NCT00414661|157009920|FG002|Overall Study|Death|0|||
48771838|NCT00414661|157009921|FG003|Overall Study|Death|0|||
48771839|NCT00414661|157009918|FG000|Overall Study|Lost to Follow-up|1|||
48771840|NCT00414661|157009919|FG001|Overall Study|Lost to Follow-up|4|||
48771841|NCT00414661|157009920|FG002|Overall Study|Lost to Follow-up|0|||
48771842|NCT00414661|157009921|FG003|Overall Study|Lost to Follow-up|1|||
48771843|NCT00414661|157009918|FG000|Overall Study|Withdrawal by Subject|5|||
48771844|NCT00414661|157009919|FG001|Overall Study|Withdrawal by Subject|2|||
48771845|NCT00414661|157009920|FG002|Overall Study|Withdrawal by Subject|2|||
48771846|NCT00414661|157009921|FG003|Overall Study|Withdrawal by Subject|2|||
48771847|NCT00414661|157009918|FG000|Overall Study|Other|6|||
48771848|NCT00414661|157009919|FG001|Overall Study|Other|3|||
48771849|NCT00414661|157009920|FG002|Overall Study|Other|0|||
48771850|NCT00414661|157009921|FG003|Overall Study|Other|0|||
48771851|NCT00357370|157009922|FG000|Cohort 2|Lack of Efficacy|0|||
48771852|NCT00357370|157009923|FG001|Cohort 2|Lack of Efficacy|2|||
48771853|NCT00357370|157009924|FG002|Cohort 2|Lack of Efficacy|1|||
48771854|NCT00357370|157009922|FG000|Cohort 2|Adverse Event|1|||
48771855|NCT00357370|157009923|FG001|Cohort 2|Adverse Event|1|||
48771856|NCT00357370|157009924|FG002|Cohort 2|Adverse Event|1|||
48771857|NCT00357370|157009922|FG000|Cohort 2|Lost to Follow-up|0|||
48771858|NCT00357370|157009923|FG001|Cohort 2|Lost to Follow-up|1|||
48771859|NCT00357370|157009924|FG002|Cohort 2|Lost to Follow-up|0|||
48771860|NCT00357370|157009922|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
48771861|NCT00357370|157009923|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
48771862|NCT00357370|157009924|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
48771863|NCT00357370|157009922|FG000|Cohort 2|Withdrawal by Subject|0|||
48771864|NCT00357370|157009923|FG001|Cohort 2|Withdrawal by Subject|2|||
48771865|NCT00357370|157009924|FG002|Cohort 2|Withdrawal by Subject|0|||
48771866|NCT03491150|157009925|FG000|Overall Study|Adverse Event|1|||
48771867|NCT03491150|157009926|FG001|Overall Study|Adverse Event|0|||
48771868|NCT03491150|157009925|FG000|Overall Study|Study Terminated by Sponsor|74|||
48771869|NCT03491150|157009926|FG001|Overall Study|Study Terminated by Sponsor|70|||
48771870|NCT03491150|157009925|FG000|Overall Study|Other|0|||
48771871|NCT03491150|157009926|FG001|Overall Study|Other|1|||
48771872|NCT03491150|157009925|FG000|Overall Study|Withdrawal by Subject|1|||
48771873|NCT03491150|157009926|FG001|Overall Study|Withdrawal by Subject|2|||
48771874|NCT01147653|157009927|FG000|Year 2|Withdrawal by Subject|2|||
48771875|NCT01147653|157009928|FG001|Year 2|Withdrawal by Subject|3|||
48771876|NCT01302392|157009931|FG000|Overall Study|Lost to Follow-up|1|||
48771877|NCT01302392|157009932|FG001|Overall Study|Lost to Follow-up|0|||
48771878|NCT01302392|157009931|FG000|Overall Study|Withdrawal by Subject|6|||
48771879|NCT01302392|157009932|FG001|Overall Study|Withdrawal by Subject|1|||
48771880|NCT02388997|157009933|FG000|Overall Study|Adverse Event|1|||
48771881|NCT02388997|157009934|FG001|Overall Study|Adverse Event|2|||
48771882|NCT02388997|157009933|FG000|Overall Study|Withdrawal by Subject|2|||
48771883|NCT02388997|157009934|FG001|Overall Study|Withdrawal by Subject|1|||
48771884|NCT02388997|157009933|FG000|Overall Study|Lung function exclusion criteria|0|||
48771885|NCT02388997|157009934|FG001|Overall Study|Lung function exclusion criteria|2|||
48771886|NCT02388997|157009933|FG000|Overall Study|Tested positive for virus during run-in|0|||
48771887|NCT02388997|157009934|FG001|Overall Study|Tested positive for virus during run-in|1|||
48771888|NCT01565291|157009935|FG000|Overall Study|Withdrawal by Subject|1|||
48771889|NCT01565291|157009936|FG001|Overall Study|Withdrawal by Subject|0|||
48771890|NCT01856543|157009943|FG000|Overall Study|Treatment discontinued|6|||
48771891|NCT01856543|157009944|FG001|Overall Study|Treatment discontinued|3|||
48771892|NCT01856543|157009943|FG000|Overall Study|Withdrawn before start|7|||
48771893|NCT01856543|157009944|FG001|Overall Study|Withdrawn before start|3|||
48771894|NCT00298831|157009947|FG000|Overall Study|Adverse Event|1|||
48771895|NCT00298831|157009947|FG000|Overall Study|Lost to Follow-up|3|||
48771896|NCT00298831|157009947|FG000|Overall Study|Withdrawal by Subject|1|||
48771897|NCT00298831|157009947|FG000|Overall Study|Participants did not receive treatment|27|||
48771898|NCT03139916|157009948|FG000|Overall Study|Withdrawal by Subject|2|||
48771899|NCT03139916|157009948|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
48771900|NCT01957475|157009949|FG000|Test Period 1|Withdrawal by Subject|1|||
48771901|NCT01957475|157009950|FG001|Test Period 1|Withdrawal by Subject|0|||
48771902|NCT01957475|157009949|FG000|Test Period 1|Other|1|||
48771903|NCT01957475|157009950|FG001|Test Period 1|Other|0|||
48771904|NCT01957475|157009949|FG000|Test Period 1|Lack of Efficacy|0|||
48771905|NCT01957475|157009950|FG001|Test Period 1|Lack of Efficacy|1|||
48771906|NCT01957475|157009949|FG000|Test Period 2|Adverse Event|1|||
48771907|NCT01957475|157009950|FG001|Test Period 2|Adverse Event|0|||
48771908|NCT00183872|157009951|FG000|Overall Study|Death|3|||
48771909|NCT00183872|157009951|FG000|Overall Study|Adverse Event|9|||
48771910|NCT00183872|157009951|FG000|Overall Study|Withdrawal by Subject|2|||
48771911|NCT00183872|157009951|FG000|Overall Study|Drug delayed more than 28 days|2|||
48771912|NCT04587193|157009952|FG000|Overall Study|Screen failure after consent|3|||
48771913|NCT04587193|157009953|FG001|Overall Study|Screen failure after consent|0|||
48771914|NCT04587193|157009952|FG000|Overall Study|Device broke during study|3|||
48771915|NCT04587193|157009953|FG001|Overall Study|Device broke during study|2|||
48771916|NCT02469610|157009954|FG000|Overall Study|Death|1|||
48771917|NCT02469610|157009955|FG001|Overall Study|Death|0|||
48771918|NCT02469610|157009954|FG000|Overall Study|Lost to Follow-up|1|||
48771919|NCT02469610|157009955|FG001|Overall Study|Lost to Follow-up|0|||
48771920|NCT02469610|157009954|FG000|Overall Study|exclusion criteria|2|||
48771921|NCT02469610|157009955|FG001|Overall Study|exclusion criteria|1|||
48771922|NCT01387607|157009956|FG000|Overall Study|Adverse Event|23|||
48771923|NCT01387607|157009957|FG001|Overall Study|Adverse Event|11|||
48771924|NCT01387607|157009956|FG000|Overall Study|Lack of Efficacy|8|||
48771925|NCT01387607|157009957|FG001|Overall Study|Lack of Efficacy|6|||
48771926|NCT01387607|157009956|FG000|Overall Study|Lost to Follow-up|2|||
48771927|NCT01387607|157009957|FG001|Overall Study|Lost to Follow-up|1|||
48771928|NCT01387607|157009956|FG000|Overall Study|No longer meets eligibility criteria|0|||
48771929|NCT01387607|157009957|FG001|Overall Study|No longer meets eligibility criteria|1|||
48771930|NCT01387607|157009956|FG000|Overall Study|Protocol Violation|1|||
48356117|NCT00979953|155501019|FG000|Overall Study|Lost to Follow-up|1|||
48356118|NCT00979953|155501020|FG001|Overall Study|Lost to Follow-up|1|||
48356119|NCT00979953|155501021|FG002|Overall Study|Lost to Follow-up|1|||
48771931|NCT01387607|157009957|FG001|Overall Study|Protocol Violation|5|||
48771932|NCT01387607|157009956|FG000|Overall Study|Withdrawal by Subject|13|||
48356120|NCT00979953|155501022|FG003|Overall Study|Lost to Follow-up|0|||
48356121|NCT00979953|155501019|FG000|Overall Study|Withdrawal by Subject|0|||
48356122|NCT00979953|155501020|FG001|Overall Study|Withdrawal by Subject|0|||
48356123|NCT00979953|155501021|FG002|Overall Study|Withdrawal by Subject|2|||
48356124|NCT00979953|155501022|FG003|Overall Study|Withdrawal by Subject|1|||
48356125|NCT00979953|155501019|FG000|Overall Study|Protocol Violation|1|||
48356126|NCT00979953|155501020|FG001|Overall Study|Protocol Violation|0|||
48395445|NCT01425008|155639936|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
48395446|NCT01425008|155639937|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
48395447|NCT01425008|155639938|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
48395448|NCT01425008|155639939|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
48395449|NCT01425008|155639940|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
48395450|NCT01425008|155639941|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
48395451|NCT01425008|155639942|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
48771933|NCT01387607|157009957|FG001|Overall Study|Withdrawal by Subject|14|||
48771934|NCT01387607|157009956|FG000|Overall Study|Other|1|||
48771935|NCT01387607|157009957|FG001|Overall Study|Other|1|||
48771936|NCT01387607|157009956|FG000|Overall Study|Randomized, not treated|3|||
48771937|NCT01387607|157009957|FG001|Overall Study|Randomized, not treated|6|||
48771938|NCT03878134|157009959|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
48771939|NCT03851016|157009960|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48771940|NCT03851016|157009961|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
48395452|NCT01425008|155639924|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395453|NCT01425008|155639925|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48771941|NCT02460224|157009962|FG000|Overall Study|Adverse Event|0|||
48771942|NCT02460224|157009963|FG001|Overall Study|Adverse Event|0|||
48395454|NCT01425008|155639926|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395455|NCT01425008|155639927|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395456|NCT01425008|155639928|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395457|NCT01425008|155639929|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48771943|NCT02460224|157009964|FG002|Overall Study|Adverse Event|0|||
48771944|NCT02460224|157009965|FG003|Overall Study|Adverse Event|0|||
48771945|NCT02460224|157009966|FG004|Overall Study|Adverse Event|0|||
48771946|NCT02460224|157009967|FG005|Overall Study|Adverse Event|0|||
48771947|NCT02460224|157009968|FG006|Overall Study|Adverse Event|1|||
48771948|NCT02460224|157009969|FG007|Overall Study|Adverse Event|0|||
48771949|NCT02460224|157009970|FG008|Overall Study|Adverse Event|0|||
48771950|NCT02460224|157009971|FG009|Overall Study|Adverse Event|0|||
48771951|NCT02460224|157009972|FG010|Overall Study|Adverse Event|0|||
48771952|NCT02460224|157009973|FG011|Overall Study|Adverse Event|0|||
48771953|NCT02460224|157009974|FG012|Overall Study|Adverse Event|1|||
48771954|NCT02460224|157009975|FG013|Overall Study|Adverse Event|0|||
48771955|NCT02460224|157009976|FG014|Overall Study|Adverse Event|0|||
48771956|NCT02460224|157009977|FG015|Overall Study|Adverse Event|0|||
48771957|NCT02460224|157009978|FG016|Overall Study|Adverse Event|1|||
48771958|NCT02460224|157009979|FG017|Overall Study|Adverse Event|0|||
48771959|NCT02460224|157009980|FG018|Overall Study|Adverse Event|1|||
48771960|NCT02460224|157009981|FG019|Overall Study|Adverse Event|0|||
48771961|NCT02460224|157009982|FG020|Overall Study|Adverse Event|1|||
48771962|NCT02460224|157009983|FG021|Overall Study|Adverse Event|1|||
48771963|NCT02460224|157009984|FG022|Overall Study|Adverse Event|1|||
48771964|NCT02460224|157009985|FG023|Overall Study|Adverse Event|0|||
48771965|NCT02460224|157009986|FG024|Overall Study|Adverse Event|0|||
48771966|NCT02460224|157009987|FG025|Overall Study|Adverse Event|0|||
48771967|NCT02460224|157009988|FG026|Overall Study|Adverse Event|11|||
48771968|NCT02460224|157009989|FG027|Overall Study|Adverse Event|1|||
48771969|NCT02460224|157009990|FG028|Overall Study|Adverse Event|6|||
48771970|NCT02460224|157009962|FG000|Overall Study|Death|0|||
48771971|NCT02460224|157009963|FG001|Overall Study|Death|0|||
48771972|NCT02460224|157009964|FG002|Overall Study|Death|0|||
48771973|NCT02460224|157009965|FG003|Overall Study|Death|0|||
48771974|NCT02460224|157009966|FG004|Overall Study|Death|0|||
48771975|NCT02460224|157009967|FG005|Overall Study|Death|2|||
48771976|NCT02460224|157009968|FG006|Overall Study|Death|1|||
48771977|NCT02460224|157009969|FG007|Overall Study|Death|0|||
48771978|NCT02460224|157009970|FG008|Overall Study|Death|0|||
48771979|NCT02460224|157009971|FG009|Overall Study|Death|1|||
48771980|NCT02460224|157009972|FG010|Overall Study|Death|0|||
48771981|NCT02460224|157009973|FG011|Overall Study|Death|0|||
48771982|NCT02460224|157009974|FG012|Overall Study|Death|0|||
48771983|NCT02460224|157009975|FG013|Overall Study|Death|1|||
48771984|NCT02460224|157009976|FG014|Overall Study|Death|0|||
48771985|NCT02460224|157009977|FG015|Overall Study|Death|0|||
48771986|NCT02460224|157009978|FG016|Overall Study|Death|2|||
48395458|NCT01425008|155639930|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48771987|NCT02460224|157009979|FG017|Overall Study|Death|1|||
48771988|NCT02460224|157009980|FG018|Overall Study|Death|0|||
48771989|NCT02460224|157009981|FG019|Overall Study|Death|2|||
48771990|NCT02460224|157009982|FG020|Overall Study|Death|0|||
48771991|NCT02460224|157009983|FG021|Overall Study|Death|0|||
48771992|NCT02460224|157009984|FG022|Overall Study|Death|0|||
48771993|NCT02460224|157009985|FG023|Overall Study|Death|0|||
48771994|NCT02460224|157009986|FG024|Overall Study|Death|1|||
48771995|NCT02460224|157009987|FG025|Overall Study|Death|1|||
48771996|NCT02460224|157009988|FG026|Overall Study|Death|5|||
48771997|NCT02460224|157009989|FG027|Overall Study|Death|0|||
48771998|NCT02460224|157009990|FG028|Overall Study|Death|1|||
48771999|NCT02460224|157009962|FG000|Overall Study|Lost to Follow-up|0|||
48772000|NCT02460224|157009963|FG001|Overall Study|Lost to Follow-up|0|||
48772001|NCT02460224|157009964|FG002|Overall Study|Lost to Follow-up|0|||
48772002|NCT02460224|157009965|FG003|Overall Study|Lost to Follow-up|0|||
48772003|NCT02460224|157009966|FG004|Overall Study|Lost to Follow-up|0|||
48772004|NCT02460224|157009967|FG005|Overall Study|Lost to Follow-up|0|||
48772005|NCT02460224|157009968|FG006|Overall Study|Lost to Follow-up|0|||
48772006|NCT02460224|157009969|FG007|Overall Study|Lost to Follow-up|0|||
48772007|NCT02460224|157009970|FG008|Overall Study|Lost to Follow-up|0|||
48772008|NCT02460224|157009971|FG009|Overall Study|Lost to Follow-up|0|||
48772009|NCT02460224|157009972|FG010|Overall Study|Lost to Follow-up|0|||
48772010|NCT02460224|157009973|FG011|Overall Study|Lost to Follow-up|0|||
48772011|NCT02460224|157009974|FG012|Overall Study|Lost to Follow-up|0|||
48772012|NCT02460224|157009975|FG013|Overall Study|Lost to Follow-up|0|||
48772013|NCT02460224|157009976|FG014|Overall Study|Lost to Follow-up|0|||
48772014|NCT02460224|157009977|FG015|Overall Study|Lost to Follow-up|0|||
48772015|NCT02460224|157009978|FG016|Overall Study|Lost to Follow-up|0|||
48772016|NCT02460224|157009979|FG017|Overall Study|Lost to Follow-up|0|||
48772017|NCT02460224|157009980|FG018|Overall Study|Lost to Follow-up|0|||
48772018|NCT02460224|157009981|FG019|Overall Study|Lost to Follow-up|0|||
48772019|NCT02460224|157009982|FG020|Overall Study|Lost to Follow-up|0|||
48772020|NCT02460224|157009983|FG021|Overall Study|Lost to Follow-up|0|||
48772021|NCT02460224|157009984|FG022|Overall Study|Lost to Follow-up|1|||
48772022|NCT02460224|157009985|FG023|Overall Study|Lost to Follow-up|0|||
48772023|NCT02460224|157009986|FG024|Overall Study|Lost to Follow-up|0|||
48772024|NCT02460224|157009987|FG025|Overall Study|Lost to Follow-up|0|||
48772025|NCT02460224|157009988|FG026|Overall Study|Lost to Follow-up|0|||
48772026|NCT02460224|157009989|FG027|Overall Study|Lost to Follow-up|0|||
48772027|NCT02460224|157009990|FG028|Overall Study|Lost to Follow-up|0|||
48772028|NCT02460224|157009962|FG000|Overall Study|Physician Decision|0|||
48772029|NCT02460224|157009963|FG001|Overall Study|Physician Decision|1|||
48772030|NCT02460224|157009964|FG002|Overall Study|Physician Decision|0|||
48772031|NCT02460224|157009965|FG003|Overall Study|Physician Decision|0|||
48772032|NCT02460224|157009966|FG004|Overall Study|Physician Decision|1|||
48772033|NCT02460224|157009967|FG005|Overall Study|Physician Decision|0|||
48772034|NCT02460224|157009968|FG006|Overall Study|Physician Decision|0|||
48772035|NCT02460224|157009969|FG007|Overall Study|Physician Decision|1|||
48772036|NCT02460224|157009970|FG008|Overall Study|Physician Decision|0|||
48772037|NCT02460224|157009971|FG009|Overall Study|Physician Decision|0|||
48772038|NCT02460224|157009972|FG010|Overall Study|Physician Decision|0|||
48772039|NCT02460224|157009973|FG011|Overall Study|Physician Decision|1|||
48772040|NCT02460224|157009974|FG012|Overall Study|Physician Decision|0|||
48772041|NCT02460224|157009975|FG013|Overall Study|Physician Decision|1|||
48772042|NCT02460224|157009976|FG014|Overall Study|Physician Decision|0|||
48772043|NCT02460224|157009977|FG015|Overall Study|Physician Decision|0|||
48772044|NCT02460224|157009978|FG016|Overall Study|Physician Decision|2|||
48772045|NCT02460224|157009979|FG017|Overall Study|Physician Decision|1|||
48772046|NCT02460224|157009980|FG018|Overall Study|Physician Decision|1|||
48772047|NCT02460224|157009981|FG019|Overall Study|Physician Decision|2|||
48772048|NCT02460224|157009982|FG020|Overall Study|Physician Decision|1|||
48772049|NCT02460224|157009983|FG021|Overall Study|Physician Decision|1|||
48772050|NCT02460224|157009984|FG022|Overall Study|Physician Decision|0|||
48772051|NCT02460224|157009985|FG023|Overall Study|Physician Decision|0|||
48772052|NCT02460224|157009986|FG024|Overall Study|Physician Decision|1|||
48772053|NCT02460224|157009987|FG025|Overall Study|Physician Decision|0|||
48772054|NCT02460224|157009988|FG026|Overall Study|Physician Decision|14|||
48772055|NCT02460224|157009989|FG027|Overall Study|Physician Decision|1|||
48772056|NCT02460224|157009990|FG028|Overall Study|Physician Decision|6|||
48772057|NCT02460224|157009962|FG000|Overall Study|Progressive disease|15|||
48772058|NCT02460224|157009963|FG001|Overall Study|Progressive disease|11|||
48772059|NCT02460224|157009964|FG002|Overall Study|Progressive disease|5|||
48772060|NCT02460224|157009965|FG003|Overall Study|Progressive disease|6|||
48772061|NCT02460224|157009966|FG004|Overall Study|Progressive disease|3|||
48772062|NCT02460224|157009967|FG005|Overall Study|Progressive disease|26|||
48772063|NCT02460224|157009968|FG006|Overall Study|Progressive disease|28|||
48772064|NCT02460224|157009969|FG007|Overall Study|Progressive disease|4|||
48772065|NCT02460224|157009970|FG008|Overall Study|Progressive disease|5|||
48772066|NCT02460224|157009971|FG009|Overall Study|Progressive disease|9|||
48772067|NCT02460224|157009972|FG010|Overall Study|Progressive disease|5|||
48772068|NCT02460224|157009973|FG011|Overall Study|Progressive disease|4|||
48772069|NCT02460224|157009974|FG012|Overall Study|Progressive disease|5|||
48772070|NCT02460224|157009975|FG013|Overall Study|Progressive disease|4|||
48772071|NCT02460224|157009976|FG014|Overall Study|Progressive disease|5|||
48772072|NCT02460224|157009977|FG015|Overall Study|Progressive disease|5|||
48772073|NCT02460224|157009978|FG016|Overall Study|Progressive disease|15|||
48772074|NCT02460224|157009979|FG017|Overall Study|Progressive disease|3|||
48772075|NCT02460224|157009980|FG018|Overall Study|Progressive disease|8|||
48772076|NCT02460224|157009981|FG019|Overall Study|Progressive disease|3|||
48772077|NCT02460224|157009982|FG020|Overall Study|Progressive disease|4|||
48772078|NCT02460224|157009983|FG021|Overall Study|Progressive disease|9|||
48772079|NCT02460224|157009984|FG022|Overall Study|Progressive disease|4|||
48772080|NCT02460224|157009985|FG023|Overall Study|Progressive disease|11|||
48772081|NCT02460224|157009986|FG024|Overall Study|Progressive disease|4|||
48772082|NCT02460224|157009987|FG025|Overall Study|Progressive disease|5|||
48772083|NCT02460224|157009988|FG026|Overall Study|Progressive disease|85|||
48772084|NCT02460224|157009989|FG027|Overall Study|Progressive disease|17|||
48772085|NCT02460224|157009990|FG028|Overall Study|Progressive disease|77|||
48772086|NCT02460224|157009962|FG000|Overall Study|Subject/guardian decision|2|||
48772087|NCT02460224|157009963|FG001|Overall Study|Subject/guardian decision|0|||
48772088|NCT02460224|157009964|FG002|Overall Study|Subject/guardian decision|1|||
48395459|NCT01425008|155639931|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395460|NCT01425008|155639932|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395461|NCT01425008|155639933|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395462|NCT01425008|155639934|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395463|NCT01425008|155639935|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395464|NCT01425008|155639936|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395465|NCT01425008|155639937|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395466|NCT01425008|155639938|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395467|NCT01425008|155639939|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395468|NCT01425008|155639940|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395469|NCT01425008|155639941|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48395470|NCT01425008|155639942|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
48395471|NCT01806779|155639943|FG000|Overall Study|Physician Decision|2|||
48395472|NCT01806779|155639944|FG001|Overall Study|Physician Decision|0|||
48395473|NCT01806779|155639945|FG002|Overall Study|Physician Decision|1|||
48395474|NCT01806779|155639943|FG000|Overall Study|Lack of Efficacy|1|||
48395475|NCT01806779|155639944|FG001|Overall Study|Lack of Efficacy|1|||
48395476|NCT01806779|155639945|FG002|Overall Study|Lack of Efficacy|0|||
48395477|NCT01806779|155639943|FG000|Overall Study|Lost to Follow-up|19|||
48395478|NCT01806779|155639944|FG001|Overall Study|Lost to Follow-up|20|||
48395479|NCT01806779|155639945|FG002|Overall Study|Lost to Follow-up|0|||
48395480|NCT01806779|155639943|FG000|Overall Study|Withdrawal by Subject|20|||
48395481|NCT01806779|155639944|FG001|Overall Study|Withdrawal by Subject|23|||
48395482|NCT01806779|155639945|FG002|Overall Study|Withdrawal by Subject|22|||
48395483|NCT00936208|155639946|FG000|Overall Study|Protocol Violation|37|||
48395484|NCT00936208|155639947|FG001|Overall Study|Protocol Violation|22|||
48395485|NCT02595450|155639950|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
48395486|NCT02595450|155639950|FG000|Overall Study|Enrolled, but not treated|8|||
48395487|NCT01934556|155639952|FG000|Overall Study|Withdrawal by Subject|0|||
48395488|NCT01934556|155639953|FG001|Overall Study|Withdrawal by Subject|1|||
48395489|NCT01934556|155639954|FG002|Overall Study|Withdrawal by Subject|1|||
48395490|NCT01934556|155639952|FG000|Overall Study|Lost to Follow-up|4|||
48395491|NCT01934556|155639953|FG001|Overall Study|Lost to Follow-up|10|||
48395492|NCT01934556|155639954|FG002|Overall Study|Lost to Follow-up|7|||
48395493|NCT01934556|155639952|FG000|Overall Study|Death|1|||
48395494|NCT01934556|155639953|FG001|Overall Study|Death|5|||
48395495|NCT01934556|155639954|FG002|Overall Study|Death|2|||
48395496|NCT00176605|155641543|FG000|Overall Study|Withdrawal by Subject|2|||
48395497|NCT01321710|155641544|FG000|Overall Study|Lost to Follow-up|4|||
48395498|NCT01321710|155641545|FG001|Overall Study|Lost to Follow-up|5|||
48395499|NCT01321710|155641546|FG002|Overall Study|Lost to Follow-up|0|||
48395500|NCT01761292|155641547|FG000|Part 1|Adverse Event|1|||
48395501|NCT01761292|155641547|FG000|Part 1|not receiving treatment in Part 1|1|||
48395502|NCT01761292|155641547|FG000|Extension 1|Withdrawal by Subject|1|||
48395503|NCT01566773|155641548|FG000|Overall Study|Protocol specified criteria|4|||
48395504|NCT01566773|155641548|FG000|Overall Study|Protocol Violation|4|||
48395505|NCT01566773|155641548|FG000|Overall Study|Withdrawal by Subject|9|||
48772089|NCT02460224|157009965|FG003|Overall Study|Subject/guardian decision|0|||
48772090|NCT02460224|157009966|FG004|Overall Study|Subject/guardian decision|2|||
48772091|NCT02460224|157009967|FG005|Overall Study|Subject/guardian decision|2|||
48772092|NCT02460224|157009968|FG006|Overall Study|Subject/guardian decision|0|||
48772093|NCT02460224|157009969|FG007|Overall Study|Subject/guardian decision|0|||
48772094|NCT02460224|157009970|FG008|Overall Study|Subject/guardian decision|1|||
48772095|NCT02460224|157009971|FG009|Overall Study|Subject/guardian decision|1|||
48772096|NCT02460224|157009972|FG010|Overall Study|Subject/guardian decision|0|||
48772097|NCT02460224|157009973|FG011|Overall Study|Subject/guardian decision|1|||
48772098|NCT02460224|157009974|FG012|Overall Study|Subject/guardian decision|0|||
48772099|NCT02460224|157009975|FG013|Overall Study|Subject/guardian decision|0|||
48772100|NCT02460224|157009976|FG014|Overall Study|Subject/guardian decision|0|||
48772101|NCT02460224|157009977|FG015|Overall Study|Subject/guardian decision|1|||
48395506|NCT01566773|155641548|FG000|Overall Study|Administrative reason|1|||
48395507|NCT01566773|155641548|FG000|Overall Study|Adverse Event|10|||
48395508|NCT01566773|155641548|FG000|Overall Study|Physician Decision|2|||
48395509|NCT01097746|155641549|FG000|Overall Study|Adverse Event|4|||
48395510|NCT01097746|155641549|FG000|Overall Study|taken off study before any treatment given|1|||
48395511|NCT02236520|155641550|FG000|Overall Study|Physician Decision|0|||
48395512|NCT02236520|155641551|FG001|Overall Study|Physician Decision|5|||
48395513|NCT02236520|155641552|FG002|Overall Study|Physician Decision|0|||
48772102|NCT02460224|157009978|FG016|Overall Study|Subject/guardian decision|0|||
48772103|NCT02460224|157009979|FG017|Overall Study|Subject/guardian decision|1|||
48772104|NCT02460224|157009980|FG018|Overall Study|Subject/guardian decision|2|||
48772105|NCT02460224|157009981|FG019|Overall Study|Subject/guardian decision|0|||
48772106|NCT02460224|157009982|FG020|Overall Study|Subject/guardian decision|0|||
48772107|NCT02460224|157009983|FG021|Overall Study|Subject/guardian decision|1|||
48772108|NCT02460224|157009984|FG022|Overall Study|Subject/guardian decision|0|||
48772109|NCT02460224|157009985|FG023|Overall Study|Subject/guardian decision|0|||
48772110|NCT02460224|157009986|FG024|Overall Study|Subject/guardian decision|0|||
48772111|NCT02460224|157009987|FG025|Overall Study|Subject/guardian decision|0|||
48772112|NCT02460224|157009988|FG026|Overall Study|Subject/guardian decision|6|||
48772113|NCT02460224|157009989|FG027|Overall Study|Subject/guardian decision|2|||
48772114|NCT02460224|157009990|FG028|Overall Study|Subject/guardian decision|3|||
48772115|NCT01600586|157009992|FG000|Overall Study|Physician Decision|3|||
48772116|NCT01600586|157009993|FG001|Overall Study|Physician Decision|3|||
48772117|NCT04055116|157009995|FG000|First Intervention|Physician Decision|2|||
48395514|NCT02236520|155641553|FG003|Overall Study|Physician Decision|0|||
48395515|NCT02236520|155641550|FG000|Overall Study|Withdrawal by Subject|1|||
48395516|NCT02236520|155641551|FG001|Overall Study|Withdrawal by Subject|0|||
48395517|NCT02236520|155641552|FG002|Overall Study|Withdrawal by Subject|0|||
48395518|NCT02236520|155641553|FG003|Overall Study|Withdrawal by Subject|1|||
48395519|NCT02236520|155641550|FG000|Overall Study|Pregnancy|1|||
48395520|NCT02236520|155641551|FG001|Overall Study|Pregnancy|0|||
48395521|NCT02236520|155641552|FG002|Overall Study|Pregnancy|0|||
48395522|NCT02236520|155641553|FG003|Overall Study|Pregnancy|0|||
48395523|NCT00390546|155641554|FG000|Overall Study|Renal impairment|1|||
48395524|NCT00390546|155641555|FG001|Overall Study|Renal impairment|0|||
48395525|NCT00390546|155641554|FG000|Overall Study|Physician Decision|5|||
48395526|NCT00390546|155641555|FG001|Overall Study|Physician Decision|5|||
48772118|NCT04055116|157009996|FG001|First Intervention|Physician Decision|7|||
48772119|NCT01898793|157009997|FG000|Overall Study|Death|2|||
48772120|NCT01898793|157009998|FG001|Overall Study|Death|1|||
48772121|NCT01898793|157009999|FG002|Overall Study|Death|4|||
48772122|NCT01898793|157010000|FG003|Overall Study|Death|0|||
48772123|NCT01898793|157010001|FG004|Overall Study|Death|0|||
48772124|NCT01898793|157010002|FG005|Overall Study|Death|0|||
48772125|NCT01898793|157010003|FG006|Overall Study|Death|0|||
48772126|NCT02908529|157010004|FG000|Overall Study|Lost to Follow-up|0|||
48772127|NCT02908529|157010005|FG001|Overall Study|Lost to Follow-up|2|||
48772128|NCT00689481|157010007|FG000|Overall Study|Adverse Event|7|||
48772129|NCT00689481|157010008|FG001|Overall Study|Adverse Event|1|||
48772130|NCT00689481|157010007|FG000|Overall Study|Lost to Follow-up|4|||
48772131|NCT00689481|157010008|FG001|Overall Study|Lost to Follow-up|3|||
48772132|NCT00689481|157010007|FG000|Overall Study|Lack of Efficacy|4|||
48772133|NCT00689481|157010008|FG001|Overall Study|Lack of Efficacy|3|||
48772134|NCT00689481|157010007|FG000|Overall Study|Non-compliance with study treatment|1|||
48772135|NCT00689481|157010008|FG001|Overall Study|Non-compliance with study treatment|1|||
48772136|NCT00689481|157010007|FG000|Overall Study|Withdrawal by Subject|8|||
48772137|NCT00689481|157010008|FG001|Overall Study|Withdrawal by Subject|4|||
48772138|NCT00689481|157010007|FG000|Overall Study|Excluded medication started during study|0|||
48772139|NCT00689481|157010008|FG001|Overall Study|Excluded medication started during study|1|||
48772140|NCT00689481|157010007|FG000|Overall Study|Subject early term, left on vacation|0|||
48772141|NCT00689481|157010008|FG001|Overall Study|Subject early term, left on vacation|1|||
48772142|NCT00512096|157010009|FG000|Overall Study|Adverse Event|2|||
48772143|NCT00512096|157010009|FG000|Overall Study|Withdrawal by Subject|2|||
48772144|NCT00512096|157010009|FG000|Overall Study|Lack of Efficacy|3|||
48772145|NCT00931307|157010013|FG000|Overall Study|Lack of Efficacy|12|||
48772146|NCT00931307|157010013|FG000|Overall Study|Biomicroscopy|1|||
48772147|NCT01069289|157010014|FG000|Overall Study|Withdrawal by Subject|15|||
48772148|NCT01069289|157010015|FG001|Overall Study|Withdrawal by Subject|26|||
48772149|NCT01069289|157010014|FG000|Overall Study|Adverse Event|21|||
48356127|NCT00979953|155501021|FG002|Overall Study|Protocol Violation|2|||
48356128|NCT00979953|155501022|FG003|Overall Study|Protocol Violation|2|||
48356129|NCT01174446|155501023|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
48356130|NCT01174446|155501024|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
48356131|NCT01174446|155501025|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
48356132|NCT01174446|155501026|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
48356133|NCT01174446|155501023|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
48356134|NCT01174446|155501024|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
48356135|NCT01174446|155501025|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
48772150|NCT01069289|157010015|FG001|Overall Study|Adverse Event|28|||
48772151|NCT01069289|157010014|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48772152|NCT01069289|157010015|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48772153|NCT01069289|157010014|FG000|Overall Study|Severe non-compliance to protocol|3|||
48772154|NCT01069289|157010015|FG001|Overall Study|Severe non-compliance to protocol|2|||
48772155|NCT01069289|157010014|FG000|Overall Study|Due to deteriorating health condition|1|||
48772156|NCT01069289|157010015|FG001|Overall Study|Due to deteriorating health condition|0|||
48772157|NCT01797536|157011391|FG000|Overall Study|Adverse Event|0|||
48772158|NCT01797536|157011392|FG001|Overall Study|Adverse Event|1|||
48772159|NCT01797536|157011393|FG002|Overall Study|Adverse Event|0|||
48395527|NCT02081534|155641556|FG000|Overall Study|Adverse Event|5|||
48395528|NCT02081534|155641557|FG001|Overall Study|Adverse Event|4|||
48395529|NCT02081534|155641558|FG002|Overall Study|Adverse Event|3|||
48395530|NCT02081534|155641559|FG003|Overall Study|Adverse Event|10|||
48395531|NCT02081534|155641560|FG004|Overall Study|Adverse Event|2|||
48395532|NCT02081534|155641561|FG005|Overall Study|Adverse Event|8|||
48395533|NCT02081534|155641562|FG006|Overall Study|Adverse Event|2|||
48395534|NCT02081534|155641556|FG000|Overall Study|Withdrawal by Subject|0|||
48395535|NCT02081534|155641557|FG001|Overall Study|Withdrawal by Subject|1|||
48395536|NCT02081534|155641558|FG002|Overall Study|Withdrawal by Subject|1|||
48395537|NCT02081534|155641559|FG003|Overall Study|Withdrawal by Subject|1|||
48395538|NCT02081534|155641560|FG004|Overall Study|Withdrawal by Subject|1|||
48395539|NCT02081534|155641561|FG005|Overall Study|Withdrawal by Subject|0|||
48395540|NCT02081534|155641562|FG006|Overall Study|Withdrawal by Subject|1|||
48395541|NCT02081534|155641556|FG000|Overall Study|Protocol Violation|0|||
48395542|NCT02081534|155641557|FG001|Overall Study|Protocol Violation|3|||
48395543|NCT02081534|155641558|FG002|Overall Study|Protocol Violation|0|||
48395544|NCT02081534|155641559|FG003|Overall Study|Protocol Violation|0|||
48395545|NCT02081534|155641560|FG004|Overall Study|Protocol Violation|0|||
48395546|NCT02081534|155641561|FG005|Overall Study|Protocol Violation|0|||
48395547|NCT02081534|155641562|FG006|Overall Study|Protocol Violation|1|||
48395548|NCT02081534|155641556|FG000|Overall Study|Lost to Follow-up|0|||
48395549|NCT02081534|155641557|FG001|Overall Study|Lost to Follow-up|0|||
48395550|NCT02081534|155641558|FG002|Overall Study|Lost to Follow-up|0|||
48395551|NCT02081534|155641559|FG003|Overall Study|Lost to Follow-up|2|||
48395552|NCT02081534|155641560|FG004|Overall Study|Lost to Follow-up|1|||
48395553|NCT02081534|155641561|FG005|Overall Study|Lost to Follow-up|1|||
48395554|NCT02081534|155641562|FG006|Overall Study|Lost to Follow-up|0|||
48395555|NCT01308008|155641563|FG000|4 Weeks|Illness, disinterest, time|9|||
48395556|NCT01308008|155641564|FG001|4 Weeks|Illness, disinterest, time|2|||
48395557|NCT01135498|155641568|FG000|Overall Study|Adverse Event|20|||
48395558|NCT01135498|155641568|FG000|Overall Study|Progressive disease|38|||
48395559|NCT01135498|155641568|FG000|Overall Study|Investigator judgement|25|||
48395560|NCT01135498|155641568|FG000|Overall Study|Withdrawal by Subject|4|||
48395561|NCT01135498|155641568|FG000|Overall Study|Death|1|||
48395562|NCT01135498|155641568|FG000|Overall Study|Ongoing at time of analysis|2|||
48395563|NCT02104583|155641569|FG000|Overall Study|New ICD or CRT-D implanted|2|||
48395564|NCT02104583|155641570|FG001|Overall Study|New ICD or CRT-D implanted|0|||
48395565|NCT02104583|155641571|FG002|Overall Study|New ICD or CRT-D implanted|1|||
48395566|NCT02104583|155641572|FG003|Overall Study|New ICD or CRT-D implanted|0|||
48395567|NCT02104583|155641573|FG004|Overall Study|New ICD or CRT-D implanted|0|||
48395568|NCT02104583|155641569|FG000|Overall Study|Death|2|||
48395569|NCT02104583|155641570|FG001|Overall Study|Death|1|||
48395570|NCT02104583|155641571|FG002|Overall Study|Death|3|||
48395571|NCT02104583|155641572|FG003|Overall Study|Death|3|||
48395572|NCT02104583|155641573|FG004|Overall Study|Death|5|||
48772160|NCT01797536|157011394|FG003|Overall Study|Adverse Event|0|||
48772161|NCT01158222|157011395|FG000|Overall Study|Not eligible for intermediate phase|17|||
48772162|NCT01470469|157011396|FG000|Overall Study|Withdrawal by Subject|4|||
48772163|NCT01470469|157011397|FG001|Overall Study|Withdrawal by Subject|6|||
48772164|NCT01470469|157011396|FG000|Overall Study|Lack of Efficacy|1|||
48772165|NCT01470469|157011397|FG001|Overall Study|Lack of Efficacy|7|||
48772166|NCT01470469|157011396|FG000|Overall Study|Adverse Event|0|||
48772167|NCT01470469|157011397|FG001|Overall Study|Adverse Event|7|||
48772168|NCT01470469|157011396|FG000|Overall Study|Lost to Follow-up|2|||
48772169|NCT01470469|157011397|FG001|Overall Study|Lost to Follow-up|2|||
48772170|NCT01470469|157011396|FG000|Overall Study|Protocol Violation|1|||
48772171|NCT01470469|157011397|FG001|Overall Study|Protocol Violation|1|||
48395573|NCT02104583|155641569|FG000|Overall Study|Subject required cardiac ablation|6|||
48395574|NCT02104583|155641570|FG001|Overall Study|Subject required cardiac ablation|4|||
48395575|NCT02104583|155641571|FG002|Overall Study|Subject required cardiac ablation|4|||
48395576|NCT02104583|155641572|FG003|Overall Study|Subject required cardiac ablation|5|||
48395577|NCT02104583|155641573|FG004|Overall Study|Subject required cardiac ablation|4|||
48395578|NCT02104583|155641569|FG000|Overall Study|Subject required prohibited medication|0|||
48395579|NCT02104583|155641570|FG001|Overall Study|Subject required prohibited medication|1|||
48395580|NCT02104583|155641571|FG002|Overall Study|Subject required prohibited medication|1|||
48772172|NCT01470469|157011396|FG000|Overall Study|Other|2|||
48395581|NCT02104583|155641572|FG003|Overall Study|Subject required prohibited medication|0|||
48395582|NCT02104583|155641573|FG004|Overall Study|Subject required prohibited medication|1|||
48395583|NCT02104583|155641569|FG000|Overall Study|Withdrew Consent|3|||
48395584|NCT02104583|155641570|FG001|Overall Study|Withdrew Consent|2|||
48395585|NCT02104583|155641571|FG002|Overall Study|Withdrew Consent|0|||
48395586|NCT02104583|155641572|FG003|Overall Study|Withdrew Consent|2|||
48395587|NCT02104583|155641573|FG004|Overall Study|Withdrew Consent|1|||
48395588|NCT02104583|155641569|FG000|Overall Study|Investigator's Discretion|1|||
48395589|NCT02104583|155641570|FG001|Overall Study|Investigator's Discretion|0|||
48772173|NCT01470469|157011397|FG001|Overall Study|Other|1|||
48772174|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
48395590|NCT02104583|155641571|FG002|Overall Study|Investigator's Discretion|0|||
48772175|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
48772176|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
48772177|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
48772178|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
48772179|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
48772180|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
48772181|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
48772182|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
48772183|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
48772184|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
48772185|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
48772186|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
48772187|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
48772188|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
48772189|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Death|5|||
48772190|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Death|0|||
48772191|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Death|2|||
48772192|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Death|0|||
48395591|NCT02104583|155641572|FG003|Overall Study|Investigator's Discretion|0|||
48772193|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Death|4|||
48772194|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
48772195|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
48772196|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
48772197|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
48772198|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
48772199|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
48772200|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
48772201|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
48772202|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
48772203|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
48772204|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
48772205|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
48772206|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
48772207|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
48772208|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
48772209|NCT01604343|157011398|FG000|Prior to W52 Administration(Through W52)|Other|15|||
48395592|NCT02104583|155641573|FG004|Overall Study|Investigator's Discretion|0|||
48772210|NCT01604343|157011399|FG001|Prior to W52 Administration(Through W52)|Other|0|||
48772211|NCT01604343|157011400|FG002|Prior to W52 Administration(Through W52)|Other|10|||
48772212|NCT01604343|157011401|FG003|Prior to W52 Administration(Through W52)|Other|0|||
48772213|NCT01604343|157011402|FG004|Prior to W52 Administration(Through W52)|Other|6|||
48772214|NCT01604343|157011398|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
48772215|NCT01604343|157011399|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
48772216|NCT01604343|157011400|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
48772217|NCT01604343|157011401|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
48772218|NCT01604343|157011402|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
48772219|NCT01604343|157011398|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
48395593|NCT02104583|155641569|FG000|Overall Study|Protocol Violation|0|||
48395594|NCT02104583|155641570|FG001|Overall Study|Protocol Violation|0|||
48395595|NCT02104583|155641571|FG002|Overall Study|Protocol Violation|1|||
48395596|NCT02104583|155641572|FG003|Overall Study|Protocol Violation|0|||
48395597|NCT02104583|155641573|FG004|Overall Study|Protocol Violation|0|||
48395598|NCT02104583|155641569|FG000|Overall Study|Adverse Event|3|||
48395599|NCT02104583|155641570|FG001|Overall Study|Adverse Event|3|||
48395600|NCT02104583|155641571|FG002|Overall Study|Adverse Event|6|||
48395601|NCT02104583|155641572|FG003|Overall Study|Adverse Event|6|||
48395602|NCT02104583|155641573|FG004|Overall Study|Adverse Event|1|||
48395603|NCT02104583|155641569|FG000|Overall Study|Lost to Follow-up|1|||
48395604|NCT02104583|155641570|FG001|Overall Study|Lost to Follow-up|0|||
48395605|NCT02104583|155641571|FG002|Overall Study|Lost to Follow-up|0|||
48395606|NCT02104583|155641572|FG003|Overall Study|Lost to Follow-up|0|||
48395607|NCT02104583|155641573|FG004|Overall Study|Lost to Follow-up|0|||
48395608|NCT02104583|155641569|FG000|Overall Study|Randomized but Never Treated|0|||
48395609|NCT02104583|155641570|FG001|Overall Study|Randomized but Never Treated|0|||
48395610|NCT02104583|155641571|FG002|Overall Study|Randomized but Never Treated|0|||
48395611|NCT02104583|155641572|FG003|Overall Study|Randomized but Never Treated|1|||
48395612|NCT02104583|155641573|FG004|Overall Study|Randomized but Never Treated|0|||
48772220|NCT01604343|157011399|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
48772221|NCT01604343|157011400|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
48772222|NCT01604343|157011401|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
48772223|NCT01604343|157011402|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
48772224|NCT01604343|157011398|FG000|Week 52 to Week 104|Adverse Event|0|||
48772225|NCT01604343|157011399|FG001|Week 52 to Week 104|Adverse Event|12|||
48772226|NCT01604343|157011400|FG002|Week 52 to Week 104|Adverse Event|26|||
48772227|NCT01604343|157011401|FG003|Week 52 to Week 104|Adverse Event|21|||
48772228|NCT01604343|157011402|FG004|Week 52 to Week 104|Adverse Event|27|||
48772229|NCT01604343|157011398|FG000|Week 52 to Week 104|Death|0|||
48772230|NCT01604343|157011399|FG001|Week 52 to Week 104|Death|4|||
48772231|NCT01604343|157011400|FG002|Week 52 to Week 104|Death|2|||
48772232|NCT01604343|157011401|FG003|Week 52 to Week 104|Death|5|||
48772233|NCT01604343|157011402|FG004|Week 52 to Week 104|Death|0|||
48772234|NCT01604343|157011398|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
48772235|NCT01604343|157011399|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
48772236|NCT01604343|157011400|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
48772237|NCT01604343|157011401|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
48772238|NCT01604343|157011402|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
48772239|NCT01604343|157011398|FG000|Week 52 to Week 104|Physician Decision|0|||
48772240|NCT01604343|157011399|FG001|Week 52 to Week 104|Physician Decision|1|||
48772241|NCT01604343|157011400|FG002|Week 52 to Week 104|Physician Decision|0|||
48772242|NCT01604343|157011401|FG003|Week 52 to Week 104|Physician Decision|0|||
48772243|NCT01604343|157011402|FG004|Week 52 to Week 104|Physician Decision|2|||
48772244|NCT01604343|157011398|FG000|Week 52 to Week 104|Pregnancy|0|||
48772245|NCT01604343|157011399|FG001|Week 52 to Week 104|Pregnancy|0|||
48772246|NCT01604343|157011400|FG002|Week 52 to Week 104|Pregnancy|1|||
48772247|NCT01604343|157011401|FG003|Week 52 to Week 104|Pregnancy|2|||
48772248|NCT01604343|157011402|FG004|Week 52 to Week 104|Pregnancy|1|||
48772249|NCT01604343|157011398|FG000|Week 52 to Week 104|Other|0|||
48772250|NCT01604343|157011399|FG001|Week 52 to Week 104|Other|11|||
48772251|NCT01604343|157011400|FG002|Week 52 to Week 104|Other|11|||
48772252|NCT01604343|157011401|FG003|Week 52 to Week 104|Other|6|||
48772253|NCT01604343|157011402|FG004|Week 52 to Week 104|Other|3|||
48772254|NCT01604343|157011398|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
48772255|NCT01604343|157011399|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
48772256|NCT01604343|157011400|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
48772257|NCT01604343|157011401|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
48772258|NCT01604343|157011402|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
48772259|NCT01604343|157011398|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
48772260|NCT01604343|157011399|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
48772261|NCT01604343|157011400|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
48772262|NCT01604343|157011401|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
48772263|NCT01604343|157011402|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
48772264|NCT01604343|157011398|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
48772265|NCT01604343|157011399|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
48772266|NCT01604343|157011400|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
48772267|NCT01604343|157011401|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
48772268|NCT01604343|157011402|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
48772269|NCT00111228|157011403|FG000|Overall Study|Withdrawal by Subject|5|||
48772270|NCT00111228|157011404|FG001|Overall Study|Withdrawal by Subject|1|||
48772271|NCT00111228|157011405|FG002|Overall Study|Withdrawal by Subject|0|||
48772272|NCT02579616|157011408|FG000|Overall Study|Participants did not receive treatment|3|||
48772273|NCT01448850|157011410|FG000|Overall Study|Death|3|||
48772274|NCT01448850|157011411|FG001|Overall Study|Death|6|||
48772275|NCT01448850|157011410|FG000|Overall Study|Withdrawal by Subject|13|||
48395613|NCT01230242|155641574|FG000|Overall Study|Physician Decision|2|||
48395614|NCT01230242|155641574|FG000|Overall Study|Withdrawal by Subject|1|||
48772276|NCT01448850|157011411|FG001|Overall Study|Withdrawal by Subject|21|||
48772277|NCT01448850|157011410|FG000|Overall Study|Lost to Follow-up|3|||
48772278|NCT01448850|157011411|FG001|Overall Study|Lost to Follow-up|1|||
48772279|NCT01448850|157011410|FG000|Overall Study|Other|15|||
48772280|NCT01448850|157011411|FG001|Overall Study|Other|12|||
48772281|NCT02465528|157011412|FG000|Overall Study|Progressive disease|0|||
48772282|NCT02465528|157011413|FG001|Overall Study|Progressive disease|2|||
48772283|NCT02465528|157011414|FG002|Overall Study|Progressive disease|9|||
48772284|NCT02465528|157011415|FG003|Overall Study|Progressive disease|4|||
48772285|NCT02465528|157011412|FG000|Overall Study|Study terminated by sponsor|1|||
48772286|NCT02465528|157011413|FG001|Overall Study|Study terminated by sponsor|2|||
48772287|NCT02465528|157011414|FG002|Overall Study|Study terminated by sponsor|0|||
48772288|NCT02465528|157011415|FG003|Overall Study|Study terminated by sponsor|0|||
48772289|NCT02465528|157011412|FG000|Overall Study|Withdrawal by Subject|0|||
48772290|NCT02465528|157011413|FG001|Overall Study|Withdrawal by Subject|0|||
48772291|NCT02465528|157011414|FG002|Overall Study|Withdrawal by Subject|2|||
48772292|NCT02465528|157011415|FG003|Overall Study|Withdrawal by Subject|0|||
48772293|NCT02465528|157011412|FG000|Overall Study|Adverse Event|0|||
48772294|NCT02465528|157011413|FG001|Overall Study|Adverse Event|0|||
48772295|NCT02465528|157011414|FG002|Overall Study|Adverse Event|0|||
48772296|NCT02465528|157011415|FG003|Overall Study|Adverse Event|1|||
48772297|NCT02465528|157011412|FG000|Overall Study|Physician Decision|0|||
48772298|NCT02465528|157011413|FG001|Overall Study|Physician Decision|0|||
48772299|NCT02465528|157011414|FG002|Overall Study|Physician Decision|1|||
48772300|NCT02465528|157011415|FG003|Overall Study|Physician Decision|0|||
48772301|NCT00086580|157011424|FG000|Treatment Period|Disease progression|9|||
48772302|NCT00086580|157011425|FG001|Treatment Period|Disease progression|8|||
48772303|NCT00086580|157011424|FG000|Treatment Period|Unable to comply with protocol|3|||
48772304|NCT00086580|157011425|FG001|Treatment Period|Unable to comply with protocol|1|||
48772305|NCT00086580|157011424|FG000|Treatment Period|Withdrawal by Subject|7|||
48772306|NCT00086580|157011425|FG001|Treatment Period|Withdrawal by Subject|8|||
48772307|NCT00086580|157011424|FG000|Treatment Period|Physician Decision|13|||
48772308|NCT00086580|157011425|FG001|Treatment Period|Physician Decision|7|||
48772309|NCT00086580|157011424|FG000|Treatment Period|AE - not treatment related|7|||
48772310|NCT00086580|157011425|FG001|Treatment Period|AE - not treatment related|7|||
48772311|NCT00086580|157011424|FG000|Treatment Period|Toxicity - treatment related|15|||
48772312|NCT00086580|157011425|FG001|Treatment Period|Toxicity - treatment related|15|||
48772313|NCT00086580|157011424|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
48772314|NCT00086580|157011425|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
48772315|NCT00086580|157011424|FG000|Treatment Period|Death|5|||
48772316|NCT00086580|157011425|FG001|Treatment Period|Death|7|||
48772317|NCT00086580|157011424|FG000|Treatment Period|Other|5|||
48772318|NCT00086580|157011425|FG001|Treatment Period|Other|3|||
48772319|NCT00086580|157011424|FG000|Follow-up Period|Disease progression|72|||
48772320|NCT00086580|157011425|FG001|Follow-up Period|Disease progression|99|||
48772321|NCT00086580|157011424|FG000|Follow-up Period|Unable to comply with protocol|5|||
48772322|NCT00086580|157011425|FG001|Follow-up Period|Unable to comply with protocol|0|||
48772323|NCT00086580|157011424|FG000|Follow-up Period|Withdrawal by Subject|6|||
48772324|NCT00086580|157011425|FG001|Follow-up Period|Withdrawal by Subject|6|||
48772325|NCT00086580|157011424|FG000|Follow-up Period|Physician Decision|0|||
48772326|NCT00086580|157011425|FG001|Follow-up Period|Physician Decision|1|||
48772327|NCT00086580|157011424|FG000|Follow-up Period|AE - not related|1|||
48772328|NCT00086580|157011425|FG001|Follow-up Period|AE - not related|0|||
48772329|NCT00086580|157011424|FG000|Follow-up Period|Death|13|||
48772330|NCT00086580|157011425|FG001|Follow-up Period|Death|7|||
48772331|NCT00086580|157011424|FG000|Follow-up Period|Other|7|||
48772332|NCT00086580|157011425|FG001|Follow-up Period|Other|6|||
48772333|NCT00086580|157011424|FG000|Observation Period|Unable to comply with protocol|1|||
48772334|NCT00086580|157011425|FG001|Observation Period|Unable to comply with protocol|1|||
48772335|NCT00086580|157011424|FG000|Observation Period|Withdrawal by Subject|4|||
48772336|NCT00086580|157011425|FG001|Observation Period|Withdrawal by Subject|2|||
48772337|NCT00086580|157011424|FG000|Observation Period|Death|33|||
48772338|NCT00086580|157011425|FG001|Observation Period|Death|55|||
48772339|NCT00086580|157011424|FG000|Observation Period|Other|8|||
48772340|NCT00086580|157011425|FG001|Observation Period|Other|7|||
48772341|NCT02126969|157011426|FG000|Overall Study|Withdrawal by Subject|1|||
48772342|NCT02126969|157011427|FG001|Overall Study|Withdrawal by Subject|2|||
48772343|NCT00767676|157011430|FG000|Overall Study|Investigator error|54|||
48772344|NCT01371656|157011431|FG000|Overall Study|Death|7|||
48772345|NCT01371656|157011432|FG001|Overall Study|Death|4|||
48772346|NCT01371656|157011431|FG000|Overall Study|Physician Decision|46|||
48772347|NCT01371656|157011432|FG001|Overall Study|Physician Decision|7|||
48772348|NCT01371656|157011431|FG000|Overall Study|Withdrawal by Subject|7|||
48772349|NCT01371656|157011432|FG001|Overall Study|Withdrawal by Subject|0|||
48772350|NCT01371656|157011431|FG000|Overall Study|Ineligible|4|||
48772351|NCT01371656|157011432|FG001|Overall Study|Ineligible|3|||
48772352|NCT02141516|157011438|FG000|Overall Study|Adverse Event|0|||
48395615|NCT01486927|155641575|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
48395616|NCT01486927|155641575|FG000|Overall Study|Physician Decision|1|||
48395617|NCT01486927|155641575|FG000|Overall Study|50 Exposure days not reached|2|||
48395618|NCT01486927|155641575|FG000|Overall Study|Withdrawal by Subject|8|||
48395619|NCT01486927|155641575|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
48772353|NCT02141516|157011439|FG001|Overall Study|Adverse Event|1|||
48772354|NCT02141516|157011440|FG002|Overall Study|Adverse Event|0|||
48772355|NCT02141516|157011438|FG000|Overall Study|Lost to Follow-up|0|||
48772356|NCT02141516|157011439|FG001|Overall Study|Lost to Follow-up|1|||
48772357|NCT02141516|157011440|FG002|Overall Study|Lost to Follow-up|0|||
48772358|NCT02141516|157011438|FG000|Overall Study|Other|0|||
48772359|NCT02141516|157011439|FG001|Overall Study|Other|3|||
48772360|NCT02141516|157011440|FG002|Overall Study|Other|0|||
48772361|NCT01559311|157011445|FG000|Overall Study|Protocol Violation|0|||
48772362|NCT01559311|157011446|FG001|Overall Study|Protocol Violation|0|||
48395620|NCT00766532|155641579|FG000|Overall Study|Protocol Violation|2|||
48395621|NCT02636582|155641580|FG000|Overall Study|Surgical Pathology|1|||
48395622|NCT02636582|155641581|FG001|Overall Study|Surgical Pathology|0|||
48395623|NCT00714285|155641584|FG000|Overall Study|Lost to Follow-up|0|||
48395624|NCT00714285|155641585|FG001|Overall Study|Lost to Follow-up|2|||
48395625|NCT00714285|155641586|FG002|Overall Study|Lost to Follow-up|0|||
48395626|NCT00714285|155641587|FG003|Overall Study|Lost to Follow-up|1|||
48395627|NCT00714285|155641584|FG000|Overall Study|Migrated/moved from study area|0|||
48395628|NCT00714285|155641585|FG001|Overall Study|Migrated/moved from study area|1|||
48395629|NCT00714285|155641586|FG002|Overall Study|Migrated/moved from study area|0|||
48395630|NCT00714285|155641587|FG003|Overall Study|Migrated/moved from study area|0|||
48395631|NCT01140451|155641588|FG000|Overall Study|Withdrawal by Subject|26|||
48395632|NCT01140451|155641589|FG001|Overall Study|Withdrawal by Subject|33|||
48395633|NCT01140451|155641588|FG000|Overall Study|Adverse Event|2|||
48395634|NCT01140451|155641589|FG001|Overall Study|Adverse Event|6|||
48395635|NCT01140451|155641588|FG000|Overall Study|Physician Decision|5|||
48395636|NCT01140451|155641589|FG001|Overall Study|Physician Decision|3|||
48395637|NCT01140451|155641588|FG000|Overall Study|Lost to Follow-up|2|||
48395638|NCT01140451|155641589|FG001|Overall Study|Lost to Follow-up|0|||
48395639|NCT01140451|155641588|FG000|Overall Study|Participants Planning Pregnancy|3|||
48395640|NCT01140451|155641589|FG001|Overall Study|Participants Planning Pregnancy|0|||
48772363|NCT01559311|157011447|FG002|Overall Study|Protocol Violation|2|||
48772364|NCT01559311|157011445|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
48772365|NCT01559311|157011446|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
48772366|NCT01559311|157011447|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
48772367|NCT01559311|157011445|FG000|Overall Study|Withdrawal by Subject|2|||
48772368|NCT01559311|157011446|FG001|Overall Study|Withdrawal by Subject|1|||
48772369|NCT01559311|157011447|FG002|Overall Study|Withdrawal by Subject|0|||
48772370|NCT01559311|157011445|FG000|Overall Study|Death|0|||
48772371|NCT01559311|157011446|FG001|Overall Study|Death|2|||
48772372|NCT01559311|157011447|FG002|Overall Study|Death|3|||
48772373|NCT01559311|157011445|FG000|Overall Study|Lost to Follow-up|0|||
48772374|NCT01559311|157011446|FG001|Overall Study|Lost to Follow-up|3|||
48772375|NCT01559311|157011447|FG002|Overall Study|Lost to Follow-up|2|||
48772376|NCT01559311|157011445|FG000|Overall Study|Adverse Event|0|||
48772377|NCT01559311|157011446|FG001|Overall Study|Adverse Event|0|||
48772378|NCT01559311|157011447|FG002|Overall Study|Adverse Event|1|||
48772379|NCT01418209|157011453|FG000|Overall Study|Withdrawal by Subject|1|||
48772380|NCT01418209|157011454|FG001|Overall Study|Withdrawal by Subject|0|||
48772381|NCT01418209|157011455|FG002|Overall Study|Withdrawal by Subject|1|||
48772382|NCT01418209|157011453|FG000|Overall Study|Did not provide hot flash diary data|1|||
48772383|NCT01418209|157011454|FG001|Overall Study|Did not provide hot flash diary data|3|||
48772384|NCT01418209|157011455|FG002|Overall Study|Did not provide hot flash diary data|3|||
48772385|NCT01603875|157011460|FG000|Overall Study|Preexisting rabies antibody|3|||
48772386|NCT01603875|157011461|FG001|Overall Study|Preexisting rabies antibody|4|||
48772387|NCT01603875|157011462|FG002|Overall Study|Preexisting rabies antibody|3|||
48772388|NCT01603875|157011460|FG000|Overall Study|Lost to Follow-up|4|||
48772389|NCT01603875|157011461|FG001|Overall Study|Lost to Follow-up|3|||
48772390|NCT01603875|157011462|FG002|Overall Study|Lost to Follow-up|6|||
48772391|NCT01603875|157011460|FG000|Overall Study|Protocol Violation|0|||
48772392|NCT01603875|157011461|FG001|Overall Study|Protocol Violation|1|||
48772393|NCT01603875|157011462|FG002|Overall Study|Protocol Violation|0|||
48772394|NCT02188485|157011469|FG000|Overall Study|Withdrawal by Subject|2|||
48772395|NCT02188485|157011470|FG001|Overall Study|Withdrawal by Subject|1|||
48772396|NCT02188485|157011469|FG000|Overall Study|PI withdrew, lack of capacity|0|||
48772397|NCT02188485|157011470|FG001|Overall Study|PI withdrew, lack of capacity|2|||
48772398|NCT00799617|157011471|FG000|Main Testosterone Trial|Randomized in error|1|||
48772399|NCT00799617|157011472|FG001|Main Testosterone Trial|Randomized in error|1|||
48772400|NCT00799617|157011471|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
48772401|NCT00799617|157011472|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
48772402|NCT00799617|157011471|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
48772403|NCT00799617|157011472|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
48772404|NCT00799617|157011471|FG000|Sexual Funtion Trial|No Baseline Data|4|||
48772405|NCT00799617|157011472|FG001|Sexual Funtion Trial|No Baseline Data|7|||
48772406|NCT00799617|157011471|FG000|Physical Function Trial|Lost to Follow-up|6|||
48772407|NCT00799617|157011472|FG001|Physical Function Trial|Lost to Follow-up|11|||
48772408|NCT00799617|157011471|FG000|Vitality Trial|Lost to Follow-up|7|||
48772409|NCT00799617|157011472|FG001|Vitality Trial|Lost to Follow-up|22|||
48772410|NCT00799617|157011471|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
48772411|NCT00799617|157011472|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
48772412|NCT00799617|157011471|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
48772413|NCT00799617|157011472|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
48772414|NCT00799617|157011471|FG000|Bone Trial|Month 12 scan not available|6|||
48772415|NCT00799617|157011472|FG001|Bone Trial|Month 12 scan not available|16|||
48772416|NCT00799617|157011471|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
48772417|NCT00799617|157011472|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
48772418|NCT00799617|157011471|FG000|Anemia Trial|Withdrawal by Subject|3|||
48772419|NCT00799617|157011472|FG001|Anemia Trial|Withdrawal by Subject|3|||
48772420|NCT04545515|157011473|FG000|Overall Study|Adverse Event|1|||
48772421|NCT04545515|157011473|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
48772422|NCT04545515|157011473|FG000|Overall Study|Commercial drug is available for participant|7|||
48772423|NCT01652716|157011474|FG000|Overall Study|Loss of glucose control|1|||
48772424|NCT01652716|157011475|FG001|Overall Study|Loss of glucose control|0|||
48772425|NCT01652716|157011474|FG000|Overall Study|Administrative|0|||
48772426|NCT01652716|157011475|FG001|Overall Study|Administrative|2|||
48772427|NCT01652716|157011474|FG000|Overall Study|Investigator decision|1|||
48772428|NCT01652716|157011475|FG001|Overall Study|Investigator decision|4|||
48772429|NCT01652716|157011474|FG000|Overall Study|Lost to Follow-up|12|||
48772430|NCT01652716|157011475|FG001|Overall Study|Lost to Follow-up|11|||
48772431|NCT01652716|157011474|FG000|Overall Study|Protocol Violation|2|||
48772432|NCT01652716|157011475|FG001|Overall Study|Protocol Violation|1|||
48772433|NCT01652716|157011474|FG000|Overall Study|Adverse Event|7|||
48772434|NCT01652716|157011475|FG001|Overall Study|Adverse Event|10|||
48772435|NCT01652716|157011474|FG000|Overall Study|Withdrawal by Subject|33|||
48772436|NCT01652716|157011475|FG001|Overall Study|Withdrawal by Subject|18|||
48772437|NCT02751983|157011476|FG000|Treatment|Stopped ACT, but Remained in study|2|||
48772438|NCT02751983|157011477|FG001|Treatment|Stopped ACT, but Remained in study|0|||
48772439|NCT02751983|157011476|FG000|Treatment|Discharged prior to beginning ACT|2|||
48772440|NCT02751983|157011477|FG001|Treatment|Discharged prior to beginning ACT|0|||
48772441|NCT02751983|157011476|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
48772442|NCT02751983|157011477|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
48772443|NCT02751983|157011476|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
48772444|NCT02751983|157011477|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
48772445|NCT02751983|157011476|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
48772446|NCT02751983|157011477|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
48772447|NCT04187196|157011478|FG000|Overall Study|Screen Failure|2|||
48772448|NCT04187196|157011479|FG001|Overall Study|Screen Failure|0|||
48772449|NCT01723228|157011480|FG000|Overall Study|Adverse Event|2|||
48772450|NCT01723228|157011481|FG001|Overall Study|Adverse Event|6|||
48772451|NCT01723228|157011480|FG000|Overall Study|Withdrawal by Subject|2|||
48772452|NCT01723228|157011481|FG001|Overall Study|Withdrawal by Subject|1|||
48772453|NCT01723228|157011480|FG000|Overall Study|Protocol Violation|0|||
48772454|NCT01723228|157011481|FG001|Overall Study|Protocol Violation|2|||
48772455|NCT01723228|157011480|FG000|Overall Study|Lost to Follow-up|2|||
48772456|NCT01723228|157011481|FG001|Overall Study|Lost to Follow-up|1|||
48772457|NCT01723228|157011480|FG000|Overall Study|Other|2|||
48772458|NCT01723228|157011481|FG001|Overall Study|Other|1|||
48772459|NCT01282216|157011482|FG000|Overall Study|Graft failure|0|||
48772460|NCT01282216|157011483|FG001|Overall Study|Graft failure|0|||
48772461|NCT01282216|157011484|FG002|Overall Study|Graft failure|3|||
48772462|NCT01282216|157011485|FG003|Overall Study|Graft failure|2|||
48772463|NCT01282216|157011482|FG000|Overall Study|Physician Decision|0|||
48772464|NCT01282216|157011483|FG001|Overall Study|Physician Decision|0|||
48772465|NCT01282216|157011484|FG002|Overall Study|Physician Decision|11|||
48772466|NCT01282216|157011485|FG003|Overall Study|Physician Decision|0|||
48772467|NCT01282216|157011482|FG000|Overall Study|Relapse|0|||
48772468|NCT01282216|157011483|FG001|Overall Study|Relapse|0|||
48772469|NCT01282216|157011484|FG002|Overall Study|Relapse|17|||
48772470|NCT01282216|157011485|FG003|Overall Study|Relapse|6|||
48772471|NCT01282216|157011482|FG000|Overall Study|Death|0|||
48772472|NCT01282216|157011483|FG001|Overall Study|Death|0|||
48772473|NCT01282216|157011484|FG002|Overall Study|Death|2|||
48772474|NCT01282216|157011485|FG003|Overall Study|Death|0|||
48772475|NCT00437034|157011486|FG000|Overall Study|Adverse Event|1|||
48772476|NCT00437034|157011486|FG000|Overall Study|Disease progression during treatment|5|||
48772477|NCT02797262|157011487|FG000|Overall Study|Withdrawal by Subject|5|||
48772478|NCT02797262|157011488|FG001|Overall Study|Withdrawal by Subject|1|||
48356136|NCT01174446|155501026|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
48356137|NCT01174446|155501023|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
48356138|NCT01174446|155501024|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
48356139|NCT01174446|155501025|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
48356140|NCT01174446|155501026|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
48356141|NCT01174446|155501023|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
48356142|NCT01174446|155501024|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
48356143|NCT01174446|155501025|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
48356144|NCT01174446|155501026|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
48356145|NCT01271504|155501027|FG000|Overall Study|Death|7|||
48356146|NCT01271504|155501028|FG001|Overall Study|Death|6|||
48356147|NCT01271504|155501029|FG002|Overall Study|Death|32|||
48356148|NCT01271504|155501030|FG003|Overall Study|Death|32|||
48395641|NCT02699892|155641593|FG000|Overall Study|Other|36|||
48395642|NCT04091087|155641596|FG000|Overall Study|Not treated|1|||
48395643|NCT04091087|155641597|FG001|Overall Study|Not treated|0|||
48395644|NCT04091087|155641596|FG000|Overall Study|Adverse Event|4|||
48395645|NCT04091087|155641597|FG001|Overall Study|Adverse Event|4|||
48395646|NCT04091087|155641596|FG000|Overall Study|Protocol Violation|0|||
48395647|NCT04091087|155641597|FG001|Overall Study|Protocol Violation|1|||
48772479|NCT02797262|157011487|FG000|Overall Study|Lost to Follow-up|10|||
48772480|NCT02797262|157011488|FG001|Overall Study|Lost to Follow-up|7|||
48772481|NCT02797262|157011487|FG000|Overall Study|Death|1|||
48772482|NCT02797262|157011488|FG001|Overall Study|Death|2|||
48772483|NCT02797262|157011487|FG000|Overall Study|Adverse Event|1|||
48772484|NCT02797262|157011488|FG001|Overall Study|Adverse Event|0|||
48772485|NCT02797262|157011487|FG000|Overall Study|COVID-19|2|||
48772486|NCT02797262|157011488|FG001|Overall Study|COVID-19|1|||
48772487|NCT02797262|157011487|FG000|Overall Study|Out-of-country|1|||
48772488|NCT02797262|157011488|FG001|Overall Study|Out-of-country|0|||
48772489|NCT01916304|157011489|FG000|Overall Study|Screening failure|17|||
48772490|NCT01282424|157011490|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
48772491|NCT01282424|157011490|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
48772492|NCT01282424|157011490|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
48772493|NCT01282424|157011490|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
48772494|NCT01282424|157011490|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
48772495|NCT01282424|157011490|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
48772496|NCT01282424|157011490|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
48772497|NCT01282424|157011490|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
48772498|NCT02553421|157011493|FG000|Overall Study|Lost to Follow-up|21|||
48772499|NCT02553421|157011494|FG001|Overall Study|Lost to Follow-up|1|||
48772500|NCT02553421|157011493|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
48772501|NCT02553421|157011494|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
48772502|NCT02553421|157011493|FG000|Overall Study|Improper Device Placement|3|||
48772503|NCT02553421|157011494|FG001|Overall Study|Improper Device Placement|0|||
48772504|NCT03337724|157011500|FG000|Overall Study|Reason not Specified|12|||
48772505|NCT03337724|157011501|FG001|Overall Study|Reason not Specified|21|||
48772506|NCT03337724|157011502|FG002|Overall Study|Reason not Specified|9|||
48772507|NCT03337724|157011503|FG003|Overall Study|Reason not Specified|9|||
48772508|NCT03337724|157011504|FG004|Overall Study|Reason not Specified|29|||
48772509|NCT03337724|157011500|FG000|Overall Study|Withdrawal by Subject|13|||
48772510|NCT03337724|157011501|FG001|Overall Study|Withdrawal by Subject|15|||
48772511|NCT03337724|157011502|FG002|Overall Study|Withdrawal by Subject|4|||
48772512|NCT03337724|157011503|FG003|Overall Study|Withdrawal by Subject|15|||
48772513|NCT03337724|157011504|FG004|Overall Study|Withdrawal by Subject|6|||
48772514|NCT03337724|157011500|FG000|Overall Study|Protocol Deviation|0|||
48772515|NCT03337724|157011501|FG001|Overall Study|Protocol Deviation|1|||
48772516|NCT03337724|157011502|FG002|Overall Study|Protocol Deviation|1|||
48772517|NCT03337724|157011503|FG003|Overall Study|Protocol Deviation|1|||
48772518|NCT03337724|157011504|FG004|Overall Study|Protocol Deviation|0|||
48772519|NCT03337724|157011500|FG000|Overall Study|Adverse Event|1|||
48772520|NCT03337724|157011501|FG001|Overall Study|Adverse Event|1|||
48772521|NCT03337724|157011502|FG002|Overall Study|Adverse Event|0|||
48772522|NCT03337724|157011503|FG003|Overall Study|Adverse Event|1|||
48772523|NCT03337724|157011504|FG004|Overall Study|Adverse Event|0|||
48772524|NCT03337724|157011500|FG000|Overall Study|Death|40|||
48772525|NCT03337724|157011501|FG001|Overall Study|Death|89|||
48772526|NCT03337724|157011502|FG002|Overall Study|Death|43|||
48772527|NCT03337724|157011503|FG003|Overall Study|Death|76|||
48772528|NCT03337724|157011504|FG004|Overall Study|Death|50|||
48772529|NCT03337724|157011500|FG000|Overall Study|Lost to Follow-up|5|||
48772530|NCT03337724|157011501|FG001|Overall Study|Lost to Follow-up|5|||
48772531|NCT03337724|157011502|FG002|Overall Study|Lost to Follow-up|4|||
48772532|NCT03337724|157011503|FG003|Overall Study|Lost to Follow-up|7|||
48772533|NCT03337724|157011504|FG004|Overall Study|Lost to Follow-up|4|||
48772534|NCT03337724|157011500|FG000|Overall Study|Physician Decision|16|||
48772535|NCT03337724|157011501|FG001|Overall Study|Physician Decision|34|||
48772536|NCT03337724|157011502|FG002|Overall Study|Physician Decision|14|||
48772537|NCT03337724|157011503|FG003|Overall Study|Physician Decision|34|||
48772538|NCT03337724|157011504|FG004|Overall Study|Physician Decision|13|||
48772539|NCT03337724|157011500|FG000|Overall Study|Progressive Disease|0|||
48772540|NCT03337724|157011501|FG001|Overall Study|Progressive Disease|2|||
48772541|NCT03337724|157011502|FG002|Overall Study|Progressive Disease|1|||
48772542|NCT03337724|157011503|FG003|Overall Study|Progressive Disease|2|||
48772543|NCT03337724|157011504|FG004|Overall Study|Progressive Disease|0|||
48772544|NCT03337724|157011500|FG000|Overall Study|Symptomatic Deterioration|0|||
48395648|NCT04091087|155641596|FG000|Overall Study|Withdrawal by Subject|5|||
48772545|NCT03337724|157011501|FG001|Overall Study|Symptomatic Deterioration|0|||
48772546|NCT03337724|157011502|FG002|Overall Study|Symptomatic Deterioration|0|||
48772547|NCT03337724|157011503|FG003|Overall Study|Symptomatic Deterioration|1|||
48395649|NCT04091087|155641597|FG001|Overall Study|Withdrawal by Subject|2|||
48772548|NCT03337724|157011504|FG004|Overall Study|Symptomatic Deterioration|0|||
48772549|NCT00773097|157011505|FG000|Overall Study|Withdrawal by Subject|1|||
48772550|NCT00773097|157011505|FG000|Overall Study|Physician Decision|6|||
48772551|NCT00080223|157011512|FG000|Overall Study|Adverse Event|23|||
48772552|NCT00080223|157011512|FG000|Overall Study|Death|21|||
48772553|NCT00080223|157011512|FG000|Overall Study|Withdrawal by Subject|13|||
48772554|NCT00080223|157011512|FG000|Overall Study|Lung Transplantation|9|||
48772555|NCT00080223|157011512|FG000|Overall Study|Non-compliance With Study Treatment|7|||
48772556|NCT00080223|157011512|FG000|Overall Study|Participant unwilling to continue|2|||
48772557|NCT00080223|157011512|FG000|Overall Study|Physician Decision|1|||
48772558|NCT02517905|157011515|FG000|Overall Study|Lost to Follow-up|4|||
48772559|NCT02517905|157011516|FG001|Overall Study|Lost to Follow-up|0|||
48772560|NCT02517905|157011515|FG000|Overall Study|Withdrawal by Subject|4|||
48772561|NCT02517905|157011516|FG001|Overall Study|Withdrawal by Subject|0|||
48772562|NCT02517905|157011515|FG000|Overall Study|Screen failure|2|||
48772563|NCT02517905|157011516|FG001|Overall Study|Screen failure|2|||
48772564|NCT01114516|157011520|FG000|Overall Study|Lost to Follow-up|2|||
48772565|NCT01114516|157011521|FG001|Overall Study|Lost to Follow-up|1|||
48772566|NCT00836875|157011523|FG000|Overall Study|Death|3|||
48772567|NCT00836875|157011524|FG001|Overall Study|Death|2|||
48772568|NCT00836875|157011523|FG000|Overall Study|Withdrawal by Subject|0|||
48772569|NCT00836875|157011524|FG001|Overall Study|Withdrawal by Subject|1|||
48772570|NCT00774995|157011525|FG000|Overall Study|Protocol Violation|0|||
48772571|NCT00774995|157011526|FG001|Overall Study|Protocol Violation|0|||
48772572|NCT00774995|157011527|FG002|Overall Study|Protocol Violation|1|||
48772573|NCT00774995|157011528|FG003|Overall Study|Protocol Violation|0|||
48772574|NCT01209624|157011529|FG000|Overall Study|Death|2|||
48772575|NCT01209624|157011529|FG000|Overall Study|Adverse Event|13|||
48772576|NCT01209624|157011529|FG000|Overall Study|Lack of Efficacy|17|||
48772577|NCT01209624|157011529|FG000|Overall Study|Lost to Follow-up|290|||
48772578|NCT01209624|157011529|FG000|Overall Study|Other|4|||
48772579|NCT03265119|157011530|FG000|Overall Study|Adverse Event|2|||
48772580|NCT03265119|157011531|FG001|Overall Study|Adverse Event|1|||
48772581|NCT03265119|157011530|FG000|Overall Study|Lack of Efficacy|3|||
48772582|NCT03265119|157011531|FG001|Overall Study|Lack of Efficacy|0|||
48772583|NCT03265119|157011530|FG000|Overall Study|Protocol Violation|1|||
48772584|NCT03265119|157011531|FG001|Overall Study|Protocol Violation|2|||
48772585|NCT03265119|157011530|FG000|Overall Study|Withdrawal by Subject|2|||
48772586|NCT03265119|157011531|FG001|Overall Study|Withdrawal by Subject|4|||
48772587|NCT03265119|157011530|FG000|Overall Study|Lost to Follow-up|1|||
48772588|NCT03265119|157011531|FG001|Overall Study|Lost to Follow-up|0|||
48772589|NCT03265119|157011530|FG000|Overall Study|Lack of Compliance|1|||
48772590|NCT03265119|157011531|FG001|Overall Study|Lack of Compliance|0|||
48797700|NCT03508843|157097052|FG000|Overall Study|Withdrawal by Subject|1|||
48797701|NCT03508843|157097052|FG000|Overall Study|technical difficulties|2|||
48797702|NCT00765843|157097054|FG000|Overall Study|Lost to Follow-up|1|||
48797703|NCT00765843|157097055|FG001|Overall Study|Lost to Follow-up|3|||
48797704|NCT00765843|157097056|FG002|Overall Study|Lost to Follow-up|2|||
48797705|NCT00765843|157097054|FG000|Overall Study|did not return to receive intervention|0|||
48797706|NCT00765843|157097055|FG001|Overall Study|did not return to receive intervention|1|||
48797707|NCT00765843|157097056|FG002|Overall Study|did not return to receive intervention|0|||
48797708|NCT00765843|157097054|FG000|Overall Study|Adverse Event|0|||
48797709|NCT00765843|157097055|FG001|Overall Study|Adverse Event|0|||
48797710|NCT00765843|157097056|FG002|Overall Study|Adverse Event|1|||
48797711|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
48356149|NCT01271504|155501027|FG000|Overall Study|Lost to Follow-up|0|||
48356150|NCT01271504|155501028|FG001|Overall Study|Lost to Follow-up|1|||
48356151|NCT01271504|155501029|FG002|Overall Study|Lost to Follow-up|3|||
48356152|NCT01271504|155501030|FG003|Overall Study|Lost to Follow-up|1|||
48356153|NCT01271504|155501027|FG000|Overall Study|Protocol Violation|0|||
48356154|NCT01271504|155501028|FG001|Overall Study|Protocol Violation|0|||
48356155|NCT01271504|155501029|FG002|Overall Study|Protocol Violation|0|||
48356156|NCT01271504|155501030|FG003|Overall Study|Protocol Violation|2|||
48356157|NCT01271504|155501027|FG000|Overall Study|Administrative Reasons|0|||
48356158|NCT01271504|155501028|FG001|Overall Study|Administrative Reasons|0|||
48356159|NCT01271504|155501029|FG002|Overall Study|Administrative Reasons|6|||
48356160|NCT01271504|155501030|FG003|Overall Study|Administrative Reasons|5|||
48356161|NCT01271504|155501027|FG000|Overall Study|Withdrawal by Subject|0|||
48356162|NCT01271504|155501028|FG001|Overall Study|Withdrawal by Subject|0|||
48356163|NCT01271504|155501029|FG002|Overall Study|Withdrawal by Subject|1|||
48356164|NCT01271504|155501030|FG003|Overall Study|Withdrawal by Subject|3|||
48356165|NCT01271504|155501027|FG000|Overall Study|Other|0|||
48356166|NCT01271504|155501028|FG001|Overall Study|Other|1|||
48356167|NCT01271504|155501029|FG002|Overall Study|Other|2|||
48356168|NCT01271504|155501030|FG003|Overall Study|Other|0|||
48356169|NCT00193479|155501031|FG000|Induction Chemotherapy|Adverse Event|2|||
48356170|NCT00193479|155501031|FG000|Induction Chemotherapy|Disease Progression|1|||
48356171|NCT00193479|155501031|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
48772591|NCT00574405|157013098|FG000|Overall Study|Withdrawal by Subject|3|||
48772592|NCT00574405|157013099|FG001|Overall Study|Withdrawal by Subject|2|||
48772593|NCT01101841|157013102|FG000|Overall Study|Adverse Event|15|||
48772594|NCT01101841|157013103|FG001|Overall Study|Adverse Event|15|||
48772595|NCT01101841|157013102|FG000|Overall Study|Lost to Follow-up|9|||
48772596|NCT01101841|157013103|FG001|Overall Study|Lost to Follow-up|3|||
48772597|NCT01101841|157013102|FG000|Overall Study|Withdrawal by Subject|21|||
48772598|NCT01101841|157013103|FG001|Overall Study|Withdrawal by Subject|40|||
48772599|NCT01101841|157013102|FG000|Overall Study|Protocol Violation|1|||
48772600|NCT01101841|157013103|FG001|Overall Study|Protocol Violation|1|||
48772601|NCT01101841|157013102|FG000|Overall Study|Physician Decision|0|||
48772602|NCT01101841|157013103|FG001|Overall Study|Physician Decision|2|||
48772603|NCT01101841|157013102|FG000|Overall Study|Lack of Efficacy|0|||
48772604|NCT01101841|157013103|FG001|Overall Study|Lack of Efficacy|2|||
48772605|NCT01101841|157013102|FG000|Overall Study|Other|0|||
48772606|NCT01101841|157013103|FG001|Overall Study|Other|1|||
48772607|NCT01101841|157013102|FG000|Overall Study|Suicidality Tracking Scale|3|||
48772608|NCT01101841|157013103|FG001|Overall Study|Suicidality Tracking Scale|1|||
48772609|NCT01101841|157013102|FG000|Overall Study|Eligibility Criteria|1|||
48772610|NCT01101841|157013103|FG001|Overall Study|Eligibility Criteria|2|||
48772611|NCT01700179|157013107|FG000|Overall Study|Physician Decision|2|||
48772612|NCT00679341|157013108|FG000|Overall Study|Disease progression|42|||
48772613|NCT00679341|157013109|FG001|Overall Study|Disease progression|36|||
48772614|NCT00679341|157013108|FG000|Overall Study|Adverse Event|5|||
48772615|NCT00679341|157013109|FG001|Overall Study|Adverse Event|6|||
48772616|NCT00679341|157013108|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
48772617|NCT00679341|157013109|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
48772618|NCT00679341|157013108|FG000|Overall Study|Death|1|||
48772619|NCT00679341|157013109|FG001|Overall Study|Death|1|||
48772620|NCT00679341|157013108|FG000|Overall Study|Other|1|||
48772621|NCT00679341|157013109|FG001|Overall Study|Other|0|||
48772622|NCT00679341|157013108|FG000|Overall Study|Physician Decision|1|||
48772623|NCT00679341|157013109|FG001|Overall Study|Physician Decision|0|||
48772624|NCT00679341|157013108|FG000|Overall Study|Not treated|0|||
48772625|NCT00679341|157013109|FG001|Overall Study|Not treated|2|||
48772626|NCT00679341|157013108|FG000|Overall Study|Physician/patient decision to withdraw|0|||
48772627|NCT00679341|157013109|FG001|Overall Study|Physician/patient decision to withdraw|6|||
48772628|NCT01207778|157013110|FG000|Overall Study|Lost to Follow-up|0|||
48772629|NCT01207778|157013111|FG001|Overall Study|Lost to Follow-up|3|||
48772630|NCT01207778|157013112|FG002|Overall Study|Lost to Follow-up|3|||
48772631|NCT01433263|157013115|FG000|Overall Study|Adverse Event|3|||
48772632|NCT01433263|157013116|FG001|Overall Study|Adverse Event|1|||
48772633|NCT01433263|157013115|FG000|Overall Study|Death|5|||
48772634|NCT01433263|157013116|FG001|Overall Study|Death|3|||
48772635|NCT01433263|157013115|FG000|Overall Study|Lost to Follow-up|0|||
48772636|NCT01433263|157013116|FG001|Overall Study|Lost to Follow-up|1|||
48772637|NCT01433263|157013115|FG000|Overall Study|Protocol Deviation|1|||
48772638|NCT01433263|157013116|FG001|Overall Study|Protocol Deviation|0|||
48772639|NCT01433263|157013115|FG000|Overall Study|Withdrawal by Subject|10|||
48772640|NCT01433263|157013116|FG001|Overall Study|Withdrawal by Subject|7|||
48772641|NCT00646204|157013117|FG000|Overall Study|Adverse Event|3|||
48772642|NCT00646204|157013118|FG001|Overall Study|Adverse Event|0|||
48772643|NCT00646204|157013117|FG000|Overall Study|Withdrawal by Subject|1|||
48772644|NCT00646204|157013118|FG001|Overall Study|Withdrawal by Subject|0|||
48772645|NCT02919670|157013124|FG000|Overall Study|Only 17 participants met compliance|43|||
48772646|NCT02919670|157013125|FG001|Overall Study|Only 17 participants met compliance|39|||
48772647|NCT00706966|157013126|FG000|Overall Study|Adverse Event|1|||
48772648|NCT01631474|157013127|FG000|Overall Study|Lost to Follow-up|8|||
48772649|NCT01631474|157013128|FG001|Overall Study|Lost to Follow-up|5|||
48772650|NCT01631474|157013129|FG002|Overall Study|Lost to Follow-up|7|||
48772651|NCT01631474|157013130|FG003|Overall Study|Lost to Follow-up|5|||
48772652|NCT01631474|157013131|FG004|Overall Study|Lost to Follow-up|5|||
48772653|NCT01631474|157013127|FG000|Overall Study|Withdrawal by Subject|4|||
48772654|NCT01631474|157013128|FG001|Overall Study|Withdrawal by Subject|4|||
48772655|NCT01631474|157013129|FG002|Overall Study|Withdrawal by Subject|2|||
48772656|NCT01631474|157013130|FG003|Overall Study|Withdrawal by Subject|6|||
48772657|NCT01631474|157013131|FG004|Overall Study|Withdrawal by Subject|5|||
48772658|NCT01631474|157013127|FG000|Overall Study|Lack of Efficacy|2|||
48772659|NCT01631474|157013128|FG001|Overall Study|Lack of Efficacy|2|||
48772660|NCT01631474|157013129|FG002|Overall Study|Lack of Efficacy|0|||
48772661|NCT01631474|157013130|FG003|Overall Study|Lack of Efficacy|0|||
48772662|NCT01631474|157013131|FG004|Overall Study|Lack of Efficacy|2|||
48772663|NCT01631474|157013127|FG000|Overall Study|Noncompliance with Study Drug|0|||
48772664|NCT01631474|157013128|FG001|Overall Study|Noncompliance with Study Drug|0|||
48772665|NCT01631474|157013129|FG002|Overall Study|Noncompliance with Study Drug|0|||
48772666|NCT01631474|157013130|FG003|Overall Study|Noncompliance with Study Drug|0|||
48772667|NCT01631474|157013131|FG004|Overall Study|Noncompliance with Study Drug|1|||
48772668|NCT01631474|157013127|FG000|Overall Study|Adverse Event|0|||
48772669|NCT01631474|157013128|FG001|Overall Study|Adverse Event|1|||
48772670|NCT01631474|157013129|FG002|Overall Study|Adverse Event|0|||
48772671|NCT01631474|157013130|FG003|Overall Study|Adverse Event|0|||
48772672|NCT01631474|157013131|FG004|Overall Study|Adverse Event|0|||
48772673|NCT00958776|157013132|FG000|Overall Study|Adverse Event|0|||
48772674|NCT00958776|157013133|FG001|Overall Study|Adverse Event|1|||
48772675|NCT00958776|157013132|FG000|Overall Study|Physician Decision|1|||
48772676|NCT00958776|157013133|FG001|Overall Study|Physician Decision|0|||
48772677|NCT00958776|157013132|FG000|Overall Study|Lost to Follow-up|2|||
48772678|NCT00958776|157013133|FG001|Overall Study|Lost to Follow-up|6|||
48772679|NCT00958776|157013132|FG000|Overall Study|Withdrawal by Subject|7|||
48772680|NCT00958776|157013133|FG001|Overall Study|Withdrawal by Subject|16|||
48772681|NCT00958776|157013132|FG000|Overall Study|Protocol Violation|1|||
48772682|NCT00958776|157013133|FG001|Overall Study|Protocol Violation|1|||
48772683|NCT00958776|157013132|FG000|Overall Study|Death|2|||
48772684|NCT00958776|157013133|FG001|Overall Study|Death|1|||
48772685|NCT00958776|157013132|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
48772686|NCT00958776|157013133|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
48772687|NCT00958776|157013132|FG000|Overall Study|Missing|1|||
48772688|NCT00958776|157013133|FG001|Overall Study|Missing|1|||
48772689|NCT00480636|157013134|FG000|Overall Study|Death|12|||
48772690|NCT00480636|157013134|FG000|Overall Study|Lost to Follow-up|4|||
48772691|NCT00480636|157013134|FG000|Overall Study|Other|2|||
48772692|NCT00480636|157013134|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
48772693|NCT00326911|157013137|FG000|Overall Study|Hospitalization prior to treatment|0|||
48772694|NCT00326911|157013138|FG001|Overall Study|Hospitalization prior to treatment|1|||
48772695|NCT00326911|157013137|FG000|Overall Study|Physician decision prior to treatment|1|||
48772696|NCT00326911|157013138|FG001|Overall Study|Physician decision prior to treatment|0|||
48772697|NCT00326911|157013137|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
48772698|NCT00326911|157013138|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
48772699|NCT00654628|157013149|FG000|6-week Active Treatment Period|Adverse Event|9|||
48772700|NCT00654628|157013149|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
48772701|NCT00654628|157013149|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
48772702|NCT00654628|157013149|FG000|6-week Active Treatment Period|Out of window period|1|||
48772703|NCT00654628|157013149|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
48772704|NCT00654628|157013149|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
48772705|NCT02684006|157013150|FG000|Overall Study|Ongoing|31|||
48772706|NCT02684006|157013151|FG001|Overall Study|Ongoing|10|||
48772707|NCT02684006|157013150|FG000|Overall Study|Other|7|||
48772708|NCT02684006|157013151|FG001|Overall Study|Other|6|||
48772709|NCT02684006|157013150|FG000|Overall Study|Protocol Violation|2|||
48772710|NCT02684006|157013151|FG001|Overall Study|Protocol Violation|1|||
48772711|NCT02684006|157013150|FG000|Overall Study|Non-compliance with study drug|1|||
48772712|NCT02684006|157013151|FG001|Overall Study|Non-compliance with study drug|1|||
48772713|NCT02684006|157013150|FG000|Overall Study|No longer meets eligibility criteria|6|||
48772714|NCT02684006|157013151|FG001|Overall Study|No longer meets eligibility criteria|2|||
48772715|NCT02684006|157013150|FG000|Overall Study|Lost to Follow-up|0|||
48772716|NCT02684006|157013151|FG001|Overall Study|Lost to Follow-up|1|||
48772717|NCT02684006|157013150|FG000|Overall Study|Death|24|||
48772718|NCT02684006|157013151|FG001|Overall Study|Death|22|||
48772719|NCT02684006|157013150|FG000|Overall Study|Global deterioration of health status|18|||
48772720|NCT02684006|157013151|FG001|Overall Study|Global deterioration of health status|20|||
48772721|NCT02684006|157013150|FG000|Overall Study|Physician Decision|14|||
48772722|NCT02684006|157013151|FG001|Overall Study|Physician Decision|9|||
48772723|NCT02684006|157013150|FG000|Overall Study|Adverse Event|74|||
48772724|NCT02684006|157013151|FG001|Overall Study|Adverse Event|65|||
48772725|NCT02684006|157013150|FG000|Overall Study|Withdrawal by Subject|29|||
48772726|NCT02684006|157013151|FG001|Overall Study|Withdrawal by Subject|41|||
48772727|NCT02684006|157013150|FG000|Overall Study|Progressive disease|236|||
48772728|NCT02684006|157013151|FG001|Overall Study|Progressive disease|266|||
48772729|NCT02399085|157013152|FG000|Overall Study|Adverse Event|16|||
48772730|NCT02399085|157013152|FG000|Overall Study|Death|2|||
48772731|NCT02399085|157013152|FG000|Overall Study|Withdrawal by Subject|8|||
48772732|NCT02399085|157013152|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
48356172|NCT00193479|155501031|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
48772733|NCT02399085|157013152|FG000|Overall Study|Physician Decision|5|||
48772734|NCT03235024|157013153|FG000|Overall Study|Adverse Event|2|||
48772735|NCT03235024|157013154|FG001|Overall Study|Adverse Event|2|||
48772736|NCT03235024|157013153|FG000|Overall Study|Death|1|||
48772737|NCT03235024|157013154|FG001|Overall Study|Death|0|||
48772738|NCT03235024|157013153|FG000|Overall Study|Lost to Follow-up|2|||
48772739|NCT03235024|157013154|FG001|Overall Study|Lost to Follow-up|5|||
48772740|NCT03235024|157013153|FG000|Overall Study|Protocol Violation|1|||
48772741|NCT03235024|157013154|FG001|Overall Study|Protocol Violation|0|||
48772742|NCT03235024|157013153|FG000|Overall Study|Withdrawal by Subject|0|||
48772743|NCT03235024|157013154|FG001|Overall Study|Withdrawal by Subject|3|||
48772744|NCT02357576|157013157|FG000|Treatment Period|Withdrawal by Subject|0|||
48772745|NCT02357576|157013158|FG001|Treatment Period|Withdrawal by Subject|1|||
48772746|NCT02357576|157013157|FG000|Treatment Period|Physician Decision|0|||
48772747|NCT02357576|157013158|FG001|Treatment Period|Physician Decision|1|||
48772748|NCT02357576|157013157|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
48772749|NCT02357576|157013158|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
48772750|NCT02357576|157013157|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
48772751|NCT02357576|157013158|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
48772752|NCT02357576|157013157|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
48772753|NCT02357576|157013158|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
48772754|NCT02357576|157013157|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
48772755|NCT02357576|157013158|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
48772756|NCT00261716|157013159|FG000|Overall Study|Withdrawal by Subject|6|||
48772757|NCT00261716|157013160|FG001|Overall Study|Withdrawal by Subject|8|||
48772758|NCT00261716|157013159|FG000|Overall Study|Lost to Follow-up|0|||
48772759|NCT00261716|157013160|FG001|Overall Study|Lost to Follow-up|2|||
48772760|NCT01988571|157013163|FG000|Overall Study|Death|3|||
48772761|NCT01988571|157013164|FG001|Overall Study|Death|1|||
48772762|NCT01988571|157013163|FG000|Overall Study|Physician Decision|2|||
48772763|NCT01988571|157013164|FG001|Overall Study|Physician Decision|1|||
48772764|NCT01988571|157013163|FG000|Overall Study|Lost to Follow-up|3|||
48772765|NCT01988571|157013164|FG001|Overall Study|Lost to Follow-up|0|||
48772766|NCT01988571|157013163|FG000|Overall Study|Withdrawal by Subject|31|||
48772767|NCT01988571|157013164|FG001|Overall Study|Withdrawal by Subject|33|||
48772768|NCT00937547|157013168|FG000|Overall Study|misdiagnosis|1|||
48772769|NCT00937547|157013169|FG001|Overall Study|misdiagnosis|6|||
48772770|NCT00937547|157013170|FG002|Overall Study|misdiagnosis|7|||
48772771|NCT00325234|157013171|FG000|Overall Study|Adverse Event|10|||
48772772|NCT00325234|157013172|FG001|Overall Study|Adverse Event|7|||
48772773|NCT00325234|157013171|FG000|Overall Study|Death due to Study Disease|1|||
48772774|NCT00325234|157013172|FG001|Overall Study|Death due to Study Disease|0|||
48772775|NCT00325234|157013171|FG000|Overall Study|Entry Criteria Not Met|1|||
48772776|NCT00325234|157013172|FG001|Overall Study|Entry Criteria Not Met|2|||
48772777|NCT00325234|157013171|FG000|Overall Study|Subject Decision|6|||
48772778|NCT00325234|157013172|FG001|Overall Study|Subject Decision|8|||
48772779|NCT00325234|157013171|FG000|Overall Study|Physician Decision|17|||
48772780|NCT00325234|157013172|FG001|Overall Study|Physician Decision|12|||
48772781|NCT00325234|157013171|FG000|Overall Study|Progressive Disease|34|||
48772782|NCT00325234|157013172|FG001|Overall Study|Progressive Disease|37|||
48772783|NCT01234467|157013173|FG000|Overall Study|Adverse Event|3|||
48772784|NCT01234467|157013173|FG000|Overall Study|Death|2|||
48772785|NCT01234467|157013173|FG000|Overall Study|Withdrawal by Subject|2|||
48772786|NCT01234467|157013173|FG000|Overall Study|Disease Progression|2|||
48772787|NCT01234467|157013173|FG000|Overall Study|Clinical deterioration|1|||
48772788|NCT01234467|157013173|FG000|Overall Study|Physician Decision|1|||
48772789|NCT01234467|157013173|FG000|Overall Study|Other complicating disease (stroke)|1|||
48772790|NCT01461096|157013174|FG000|Overall Study|Death|3|||
48772791|NCT01461096|157013175|FG001|Overall Study|Death|6|||
48772792|NCT01461096|157013174|FG000|Overall Study|Severe debilitation, unable to continue|1|||
48772793|NCT01461096|157013175|FG001|Overall Study|Severe debilitation, unable to continue|1|||
48772794|NCT01461096|157013174|FG000|Overall Study|Subj not able to get to clinic|15|||
48772795|NCT01461096|157013175|FG001|Overall Study|Subj not able to get to clinic|13|||
48772796|NCT01461096|157013174|FG000|Overall Study|Site is closing|27|||
48772797|NCT01461096|157013175|FG001|Overall Study|Site is closing|30|||
48772798|NCT01461096|157013174|FG000|Overall Study|Withdrawal by Subject|5|||
48772799|NCT01461096|157013175|FG001|Overall Study|Withdrawal by Subject|3|||
48772800|NCT01461096|157013174|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
48772801|NCT01461096|157013175|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
48772802|NCT01461096|157013174|FG000|Overall Study|Lost to Follow-up|8|||
48772803|NCT01461096|157013175|FG001|Overall Study|Lost to Follow-up|4|||
48772804|NCT02059148|157013176|FG000|Treatment 1|Protocol Violation|0|||
48772805|NCT02059148|157013177|FG001|Treatment 1|Protocol Violation|0|||
48772806|NCT02059148|157013178|FG002|Treatment 1|Protocol Violation|0|||
48772807|NCT02059148|157013179|FG003|Treatment 1|Protocol Violation|0|||
48772808|NCT02059148|157013180|FG004|Treatment 1|Protocol Violation|0|||
48772809|NCT02059148|157013181|FG005|Treatment 1|Protocol Violation|1|||
48772810|NCT00414050|157013182|FG000|Overall Study|Adverse Event|1|||
48772811|NCT00414050|157013183|FG001|Overall Study|Adverse Event|1|||
48772812|NCT00414050|157013184|FG002|Overall Study|Adverse Event|1|||
48772813|NCT00414050|157013185|FG003|Overall Study|Adverse Event|1|||
48772814|NCT00414050|157013182|FG000|Overall Study|Lost to Follow-up|2|||
48772815|NCT00414050|157013183|FG001|Overall Study|Lost to Follow-up|2|||
48772816|NCT00414050|157013184|FG002|Overall Study|Lost to Follow-up|1|||
48772817|NCT00414050|157013185|FG003|Overall Study|Lost to Follow-up|1|||
48772818|NCT00414050|157013182|FG000|Overall Study|Withdrawal by Subject|5|||
48772819|NCT00414050|157013183|FG001|Overall Study|Withdrawal by Subject|3|||
48772820|NCT00414050|157013184|FG002|Overall Study|Withdrawal by Subject|2|||
48772821|NCT00414050|157013185|FG003|Overall Study|Withdrawal by Subject|4|||
48772822|NCT00414050|157013182|FG000|Overall Study|Subject discontinued for other reason|1|||
48772823|NCT00414050|157013183|FG001|Overall Study|Subject discontinued for other reason|2|||
48772824|NCT00414050|157013184|FG002|Overall Study|Subject discontinued for other reason|2|||
48772825|NCT00414050|157013185|FG003|Overall Study|Subject discontinued for other reason|1|||
48772826|NCT00414050|157013182|FG000|Overall Study|Subject Moved|0|||
48772827|NCT00414050|157013183|FG001|Overall Study|Subject Moved|0|||
48772828|NCT00414050|157013184|FG002|Overall Study|Subject Moved|0|||
48772829|NCT00414050|157013185|FG003|Overall Study|Subject Moved|1|||
48772830|NCT00720876|157013186|FG000|Overall Study|found to be ineligible after starting tx|2|||
48772831|NCT00079274|157013187|FG000|Overall Study|Withdrawal by Subject|111|||
48772832|NCT00079274|157013188|FG001|Overall Study|Withdrawal by Subject|10|||
48772833|NCT00079274|157013189|FG002|Overall Study|Withdrawal by Subject|12|||
48772834|NCT00079274|157013190|FG003|Overall Study|Withdrawal by Subject|163|||
48772835|NCT00079274|157013191|FG004|Overall Study|Withdrawal by Subject|7|||
48772836|NCT00079274|157013192|FG005|Overall Study|Withdrawal by Subject|8|||
48772837|NCT00079274|157013193|FG006|Overall Study|Withdrawal by Subject|0|||
48772838|NCT00079274|157013187|FG000|Overall Study|Adverse Event|130|||
48772839|NCT00079274|157013188|FG001|Overall Study|Adverse Event|8|||
48772840|NCT00079274|157013189|FG002|Overall Study|Adverse Event|8|||
48772841|NCT00079274|157013190|FG003|Overall Study|Adverse Event|184|||
48772842|NCT00079274|157013191|FG004|Overall Study|Adverse Event|7|||
48772843|NCT00079274|157013192|FG005|Overall Study|Adverse Event|8|||
48772844|NCT00079274|157013193|FG006|Overall Study|Adverse Event|0|||
48772845|NCT00079274|157013187|FG000|Overall Study|Recurrence|21|||
48772846|NCT00079274|157013188|FG001|Overall Study|Recurrence|0|||
48772847|NCT00079274|157013189|FG002|Overall Study|Recurrence|1|||
48772848|NCT00079274|157013190|FG003|Overall Study|Recurrence|15|||
48772849|NCT00079274|157013191|FG004|Overall Study|Recurrence|0|||
48772850|NCT00079274|157013192|FG005|Overall Study|Recurrence|2|||
48772851|NCT00079274|157013193|FG006|Overall Study|Recurrence|0|||
48772852|NCT00079274|157013187|FG000|Overall Study|Alternate Treatment|6|||
48772853|NCT00079274|157013188|FG001|Overall Study|Alternate Treatment|1|||
48772854|NCT00079274|157013189|FG002|Overall Study|Alternate Treatment|0|||
48772855|NCT00079274|157013190|FG003|Overall Study|Alternate Treatment|3|||
48772856|NCT00079274|157013191|FG004|Overall Study|Alternate Treatment|0|||
48772857|NCT00079274|157013192|FG005|Overall Study|Alternate Treatment|0|||
48772858|NCT00079274|157013193|FG006|Overall Study|Alternate Treatment|0|||
48772859|NCT00079274|157013187|FG000|Overall Study|Other Medical Problems|6|||
48772860|NCT00079274|157013188|FG001|Overall Study|Other Medical Problems|1|||
48772861|NCT00079274|157013189|FG002|Overall Study|Other Medical Problems|0|||
48772862|NCT00079274|157013190|FG003|Overall Study|Other Medical Problems|7|||
48772863|NCT00079274|157013191|FG004|Overall Study|Other Medical Problems|0|||
48772864|NCT00079274|157013192|FG005|Overall Study|Other Medical Problems|0|||
48772865|NCT00079274|157013193|FG006|Overall Study|Other Medical Problems|0|||
48356173|NCT03853551|155501036|FG000|Overall Study|Death|2|||
48356174|NCT03853551|155501036|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
48356175|NCT00504075|155501037|FG000|Overall Study|Adverse Event|1|||
48356176|NCT00504075|155501037|FG000|Overall Study|Lost to Follow-up|5|||
48356177|NCT00504075|155501037|FG000|Overall Study|Withdrawal by Subject|1|||
48772866|NCT00079274|157013187|FG000|Overall Study|Death|4|||
48772867|NCT00079274|157013188|FG001|Overall Study|Death|0|||
48772868|NCT00079274|157013189|FG002|Overall Study|Death|1|||
48772869|NCT00079274|157013190|FG003|Overall Study|Death|15|||
48772870|NCT00079274|157013191|FG004|Overall Study|Death|0|||
48772871|NCT00079274|157013192|FG005|Overall Study|Death|0|||
48772872|NCT00079274|157013193|FG006|Overall Study|Death|0|||
48772873|NCT00079274|157013187|FG000|Overall Study|Cytogenetic resistance|0|||
48772874|NCT00079274|157013188|FG001|Overall Study|Cytogenetic resistance|0|||
48772875|NCT00079274|157013189|FG002|Overall Study|Cytogenetic resistance|0|||
48772876|NCT00079274|157013190|FG003|Overall Study|Cytogenetic resistance|2|||
48772877|NCT00079274|157013191|FG004|Overall Study|Cytogenetic resistance|0|||
48772878|NCT00079274|157013192|FG005|Overall Study|Cytogenetic resistance|0|||
48772879|NCT00079274|157013193|FG006|Overall Study|Cytogenetic resistance|0|||
48772880|NCT00079274|157013187|FG000|Overall Study|Other|43|||
48772881|NCT00079274|157013188|FG001|Overall Study|Other|7|||
48772882|NCT00079274|157013189|FG002|Overall Study|Other|5|||
48772883|NCT00079274|157013190|FG003|Overall Study|Other|55|||
48772884|NCT00079274|157013191|FG004|Overall Study|Other|1|||
48356178|NCT00504075|155501037|FG000|Overall Study|Required other therapeutic intervention|1|||
48356179|NCT02406248|155501038|FG000|Overall Study|Death|7|||
48772885|NCT00079274|157013192|FG005|Overall Study|Other|2|||
48772886|NCT00079274|157013193|FG006|Overall Study|Other|0|||
48772887|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
48772888|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772889|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772890|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772891|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772892|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772893|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
48772894|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
48772895|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772896|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772897|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772898|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772899|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772900|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
48772901|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
48772902|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772903|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772904|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772905|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772906|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772907|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
48772908|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
48772909|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772910|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772911|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772912|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772913|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772914|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
48772915|NCT01479621|157013198|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
48772916|NCT01479621|157013199|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772917|NCT01479621|157013200|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772918|NCT01479621|157013201|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772919|NCT01479621|157013202|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772920|NCT01479621|157013203|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772921|NCT01479621|157013204|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
48772922|NCT01479621|157013198|FG000|Treatment Period|Adverse Event|0|||
48772923|NCT01479621|157013199|FG001|Treatment Period|Adverse Event|0|||
48772924|NCT01479621|157013200|FG002|Treatment Period|Adverse Event|0|||
48772925|NCT01479621|157013201|FG003|Treatment Period|Adverse Event|0|||
48772926|NCT01479621|157013202|FG004|Treatment Period|Adverse Event|1|||
48772927|NCT01479621|157013203|FG005|Treatment Period|Adverse Event|2|||
48772928|NCT01479621|157013204|FG006|Treatment Period|Adverse Event|2|||
48772929|NCT01479621|157013198|FG000|Treatment Period|Withdrawal by Subject|0|||
48772930|NCT01479621|157013199|FG001|Treatment Period|Withdrawal by Subject|4|||
48772931|NCT01479621|157013200|FG002|Treatment Period|Withdrawal by Subject|2|||
48772932|NCT01479621|157013201|FG003|Treatment Period|Withdrawal by Subject|2|||
48772933|NCT01479621|157013202|FG004|Treatment Period|Withdrawal by Subject|5|||
48772934|NCT01479621|157013203|FG005|Treatment Period|Withdrawal by Subject|5|||
48772935|NCT01479621|157013204|FG006|Treatment Period|Withdrawal by Subject|1|||
48772936|NCT01479621|157013198|FG000|Treatment Period|Physician Decision|0|||
48772937|NCT01479621|157013199|FG001|Treatment Period|Physician Decision|0|||
48772938|NCT01479621|157013200|FG002|Treatment Period|Physician Decision|0|||
48772939|NCT01479621|157013201|FG003|Treatment Period|Physician Decision|0|||
48772940|NCT01479621|157013202|FG004|Treatment Period|Physician Decision|1|||
48772941|NCT01479621|157013203|FG005|Treatment Period|Physician Decision|1|||
48772942|NCT01479621|157013204|FG006|Treatment Period|Physician Decision|0|||
48772943|NCT01479621|157013198|FG000|Treatment Period|Non-compliance to study drug|0|||
48772944|NCT01479621|157013199|FG001|Treatment Period|Non-compliance to study drug|1|||
48772945|NCT01479621|157013200|FG002|Treatment Period|Non-compliance to study drug|0|||
48772946|NCT01479621|157013201|FG003|Treatment Period|Non-compliance to study drug|0|||
48772947|NCT01479621|157013202|FG004|Treatment Period|Non-compliance to study drug|0|||
48772948|NCT01479621|157013203|FG005|Treatment Period|Non-compliance to study drug|0|||
48772949|NCT01479621|157013204|FG006|Treatment Period|Non-compliance to study drug|1|||
48772950|NCT01479621|157013198|FG000|Treatment Period|Protocol Violation|0|||
48772951|NCT01479621|157013199|FG001|Treatment Period|Protocol Violation|9|||
48772952|NCT01479621|157013200|FG002|Treatment Period|Protocol Violation|6|||
48772953|NCT01479621|157013201|FG003|Treatment Period|Protocol Violation|5|||
48772954|NCT01479621|157013202|FG004|Treatment Period|Protocol Violation|2|||
48772955|NCT01479621|157013203|FG005|Treatment Period|Protocol Violation|10|||
48772956|NCT01479621|157013204|FG006|Treatment Period|Protocol Violation|6|||
48772957|NCT01479621|157013198|FG000|Treatment Period|Pregnancy|0|||
48772958|NCT01479621|157013199|FG001|Treatment Period|Pregnancy|0|||
48395650|NCT02363686|155641600|FG000|Overall Study|Withdrawal by Subject|22|||
48395651|NCT02363686|155641600|FG000|Overall Study|incomplete FEES examinations|13|||
48395652|NCT01485627|155641601|FG000|Overall Study|Patient withdrew|6|||
48395653|NCT01485627|155641602|FG001|Overall Study|Patient withdrew|5|||
48395654|NCT01485627|155641601|FG000|Overall Study|Patient died|3|||
48395655|NCT01485627|155641602|FG001|Overall Study|Patient died|1|||
48395656|NCT01485627|155641601|FG000|Overall Study|Patient lost to followup|0|||
48395657|NCT01485627|155641602|FG001|Overall Study|Patient lost to followup|1|||
48395658|NCT01485627|155641601|FG000|Overall Study|Caregiver withdrew|3|||
48395659|NCT01485627|155641602|FG001|Overall Study|Caregiver withdrew|3|||
48395660|NCT01485627|155641601|FG000|Overall Study|Caregiver lost to follow up|11|||
48395661|NCT01485627|155641602|FG001|Overall Study|Caregiver lost to follow up|12|||
48395662|NCT01485627|155641601|FG000|Overall Study|Caregiver died|1|||
48395663|NCT01485627|155641602|FG001|Overall Study|Caregiver died|0|||
48395664|NCT01485627|155641601|FG000|Overall Study|caregiver was not bereaved|42|||
48395665|NCT01485627|155641602|FG001|Overall Study|caregiver was not bereaved|35|||
48395666|NCT01709149|155641607|FG000|Open-label Lead-in Phase|Adverse Event|109|||
48395667|NCT01709149|155641608|FG001|Open-label Lead-in Phase|Adverse Event|0|||
48395668|NCT01709149|155641609|FG002|Open-label Lead-in Phase|Adverse Event|0|||
48395669|NCT01709149|155641607|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
48395670|NCT01709149|155641608|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
48395671|NCT01709149|155641609|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
48395672|NCT01709149|155641607|FG000|Open-label Lead-in Phase|Death|1|||
48395673|NCT01709149|155641608|FG001|Open-label Lead-in Phase|Death|0|||
48395674|NCT01709149|155641609|FG002|Open-label Lead-in Phase|Death|0|||
48395675|NCT01709149|155641607|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
48395676|NCT01709149|155641608|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
48395677|NCT01709149|155641609|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
48395678|NCT01709149|155641607|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
48395679|NCT01709149|155641608|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
48395680|NCT01709149|155641609|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
48395681|NCT01709149|155641607|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
48772959|NCT01479621|157013200|FG002|Treatment Period|Pregnancy|2|||
48772960|NCT01479621|157013201|FG003|Treatment Period|Pregnancy|0|||
48772961|NCT01479621|157013202|FG004|Treatment Period|Pregnancy|0|||
48772962|NCT01479621|157013203|FG005|Treatment Period|Pregnancy|0|||
48772963|NCT01479621|157013204|FG006|Treatment Period|Pregnancy|0|||
48772964|NCT01479621|157013198|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
48772965|NCT01479621|157013199|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
48772966|NCT01479621|157013200|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
48772967|NCT01479621|157013201|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
48772968|NCT01479621|157013202|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
48772969|NCT01479621|157013203|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
48772970|NCT01479621|157013204|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
48772971|NCT01479621|157013198|FG000|Treatment Period|Lost to Follow-up|0|||
48772972|NCT01479621|157013199|FG001|Treatment Period|Lost to Follow-up|0|||
48772973|NCT01479621|157013200|FG002|Treatment Period|Lost to Follow-up|1|||
48395682|NCT01709149|155641608|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
48395683|NCT01709149|155641609|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
48395684|NCT01709149|155641607|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
48395685|NCT01709149|155641608|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
48395686|NCT01709149|155641609|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
48395687|NCT01709149|155641607|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
48395688|NCT01709149|155641608|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
48395689|NCT01709149|155641609|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
48395690|NCT01709149|155641607|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
48395691|NCT01709149|155641608|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
48395692|NCT01709149|155641609|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
48395693|NCT01709149|155641607|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48395694|NCT01709149|155641608|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
48395695|NCT01709149|155641609|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
48395696|NCT01577186|155641610|FG000|Overall Study|Adverse Event|23|||
48395697|NCT01577186|155641610|FG000|Overall Study|Death|1|||
48395698|NCT01577186|155641610|FG000|Overall Study|Lost to Follow-up|28|||
48772974|NCT01479621|157013201|FG003|Treatment Period|Lost to Follow-up|0|||
48772975|NCT01479621|157013202|FG004|Treatment Period|Lost to Follow-up|2|||
48395699|NCT01577186|155641610|FG000|Overall Study|Withdrawal by Subject|35|||
48395700|NCT01577186|155641610|FG000|Overall Study|Insufficient Response|18|||
48395701|NCT01577186|155641610|FG000|Overall Study|Ineligible to Continue|15|||
48395702|NCT01577186|155641610|FG000|Overall Study|Non-Compliant|8|||
48395703|NCT01577186|155641610|FG000|Overall Study|Other|2|||
48395704|NCT02915523|155641611|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
48395705|NCT02915523|155641612|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
48395706|NCT02915523|155641613|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
48395707|NCT02915523|155641614|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
48772976|NCT01479621|157013203|FG005|Treatment Period|Lost to Follow-up|2|||
48772977|NCT01479621|157013204|FG006|Treatment Period|Lost to Follow-up|1|||
48772978|NCT01479621|157013198|FG000|Treatment Period|Met stopping criteria|0|||
48772979|NCT01479621|157013199|FG001|Treatment Period|Met stopping criteria|8|||
48772980|NCT01479621|157013200|FG002|Treatment Period|Met stopping criteria|7|||
48772981|NCT01479621|157013201|FG003|Treatment Period|Met stopping criteria|4|||
48772982|NCT01479621|157013202|FG004|Treatment Period|Met stopping criteria|9|||
48772983|NCT01479621|157013203|FG005|Treatment Period|Met stopping criteria|20|||
48772984|NCT01479621|157013204|FG006|Treatment Period|Met stopping criteria|6|||
48772985|NCT03304379|157013205|FG000|Overall Study|Protocol Violation|8|||
48772986|NCT03304379|157013206|FG001|Overall Study|Protocol Violation|10|||
48772987|NCT03304379|157013207|FG002|Overall Study|Protocol Violation|5|||
48772988|NCT03304379|157013208|FG003|Overall Study|Protocol Violation|0|||
48772989|NCT03304379|157013209|FG004|Overall Study|Protocol Violation|2|||
48772990|NCT03304379|157013205|FG000|Overall Study|Adverse Event|4|||
48772991|NCT03304379|157013206|FG001|Overall Study|Adverse Event|20|||
48772992|NCT03304379|157013207|FG002|Overall Study|Adverse Event|17|||
48772993|NCT03304379|157013208|FG003|Overall Study|Adverse Event|1|||
48772994|NCT03304379|157013209|FG004|Overall Study|Adverse Event|0|||
48772995|NCT03304379|157013205|FG000|Overall Study|Lack of Efficacy|17|||
48772996|NCT03304379|157013206|FG001|Overall Study|Lack of Efficacy|16|||
48772997|NCT03304379|157013207|FG002|Overall Study|Lack of Efficacy|20|||
48772998|NCT03304379|157013208|FG003|Overall Study|Lack of Efficacy|0|||
48772999|NCT03304379|157013209|FG004|Overall Study|Lack of Efficacy|0|||
48773000|NCT03304379|157013205|FG000|Overall Study|Physician Decision|6|||
48773001|NCT03304379|157013206|FG001|Overall Study|Physician Decision|10|||
48773002|NCT03304379|157013207|FG002|Overall Study|Physician Decision|6|||
48356180|NCT02406248|155501038|FG000|Overall Study|Withdrawal by Subject|2|||
48356181|NCT01777334|155501039|FG000|Overall Study|Adverse Event|18|||
48356182|NCT01777334|155501040|FG001|Overall Study|Adverse Event|14|||
48356183|NCT01777334|155501039|FG000|Overall Study|Lack of Efficacy|15|||
48356184|NCT01777334|155501040|FG001|Overall Study|Lack of Efficacy|29|||
48356185|NCT01777334|155501039|FG000|Overall Study|Protocol Violation|3|||
48356186|NCT01777334|155501040|FG001|Overall Study|Protocol Violation|7|||
48356187|NCT01777334|155501039|FG000|Overall Study|Lost to Follow-up|3|||
48356188|NCT01777334|155501040|FG001|Overall Study|Lost to Follow-up|2|||
48356189|NCT01777334|155501039|FG000|Overall Study|Withdrawal by Subject|14|||
48356190|NCT01777334|155501040|FG001|Overall Study|Withdrawal by Subject|11|||
48356191|NCT02417441|155501041|FG000|Overall Study|Inconclusive due to missing data|52|||
48356192|NCT02417441|155501042|FG001|Overall Study|Inconclusive due to missing data|19|||
48356193|NCT00643617|155501046|FG000|Overall Study|Death|6|||
48356194|NCT00643617|155501047|FG001|Overall Study|Death|9|||
48356195|NCT00643617|155501046|FG000|Overall Study|Lost to Follow-up|42|||
48356196|NCT00643617|155501047|FG001|Overall Study|Lost to Follow-up|51|||
48356197|NCT03933462|155501050|FG000|Overall Study|Adverse Event|2|||
48356198|NCT03933462|155501051|FG001|Overall Study|Adverse Event|0|||
48356199|NCT03126110|155501055|FG000|Phase 1|Death|2|||
48356200|NCT03126110|155501056|FG001|Phase 1|Death|2|||
48356201|NCT03126110|155501057|FG002|Phase 1|Death|4|||
48356202|NCT03126110|155501058|FG003|Phase 1|Death|3|||
48356203|NCT03126110|155501059|FG004|Phase 1|Death|4|||
48356204|NCT03126110|155501060|FG005|Phase 1|Death|4|||
48356205|NCT03126110|155501061|FG006|Phase 1|Death|3|||
48356206|NCT03126110|155501062|FG007|Phase 1|Death|4|||
48356207|NCT03126110|155501063|FG008|Phase 1|Death|5|||
48356208|NCT03126110|155501064|FG009|Phase 1|Death|2|||
48356209|NCT03126110|155501065|FG010|Phase 1|Death|6|||
48356210|NCT03126110|155501066|FG011|Phase 1|Death|0|||
48356211|NCT03126110|155501067|FG012|Phase 1|Death|0|||
48356212|NCT03126110|155501068|FG013|Phase 1|Death|0|||
48356213|NCT03126110|155501069|FG014|Phase 1|Death|0|||
48356214|NCT03126110|155501070|FG015|Phase 1|Death|0|||
48356215|NCT03126110|155501071|FG016|Phase 1|Death|0|||
48356216|NCT03126110|155501055|FG000|Phase 1|Lost to Follow-up|0|||
48356217|NCT03126110|155501056|FG001|Phase 1|Lost to Follow-up|1|||
48356218|NCT03126110|155501057|FG002|Phase 1|Lost to Follow-up|0|||
48356219|NCT03126110|155501058|FG003|Phase 1|Lost to Follow-up|0|||
48356220|NCT03126110|155501059|FG004|Phase 1|Lost to Follow-up|0|||
48356221|NCT03126110|155501060|FG005|Phase 1|Lost to Follow-up|0|||
48773003|NCT03304379|157013208|FG003|Overall Study|Physician Decision|9|||
48773004|NCT03304379|157013209|FG004|Overall Study|Physician Decision|10|||
48773005|NCT03304379|157013205|FG000|Overall Study|Withdrawal by Subject|26|||
48773006|NCT03304379|157013206|FG001|Overall Study|Withdrawal by Subject|58|||
48773007|NCT03304379|157013207|FG002|Overall Study|Withdrawal by Subject|66|||
48395708|NCT02915523|155641611|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
48395709|NCT02915523|155641612|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
48395710|NCT02915523|155641613|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
48395711|NCT02915523|155641614|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
48395712|NCT02915523|155641611|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
48395713|NCT02915523|155641612|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
48395714|NCT02915523|155641613|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
48395715|NCT02915523|155641614|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
48395716|NCT02915523|155641611|FG000|Expansion Phase (Phase 2)|Death|0|||
48395717|NCT02915523|155641612|FG001|Expansion Phase (Phase 2)|Death|0|||
48395718|NCT02915523|155641613|FG002|Expansion Phase (Phase 2)|Death|26|||
48395719|NCT02915523|155641614|FG003|Expansion Phase (Phase 2)|Death|53|||
48395720|NCT02915523|155641611|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
48395721|NCT02915523|155641612|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
48395722|NCT02915523|155641613|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
48395723|NCT02915523|155641614|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
48395724|NCT02915523|155641611|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
48395725|NCT02915523|155641612|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
48395726|NCT02915523|155641613|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
48395727|NCT02915523|155641614|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
48395728|NCT02915523|155641611|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
48395729|NCT02915523|155641612|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
48395730|NCT02915523|155641613|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
48395731|NCT02915523|155641614|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
48395732|NCT03287219|155641615|FG000|Overall Study|Protocol Violation|0|||
48395733|NCT03287219|155641616|FG001|Overall Study|Protocol Violation|2|||
48395734|NCT01118351|155641617|FG000|Overall Study|Adverse Event|3|||
48395735|NCT01118351|155641617|FG000|Overall Study|Withdrawal by Subject|1|||
48395736|NCT02919436|155641618|FG000|Overall Study|Did not undergo surgery|16|||
48773008|NCT03304379|157013208|FG003|Overall Study|Withdrawal by Subject|3|||
48773009|NCT03304379|157013209|FG004|Overall Study|Withdrawal by Subject|5|||
48773010|NCT03304379|157013205|FG000|Overall Study|Lost to Follow-up|8|||
48773011|NCT03304379|157013206|FG001|Overall Study|Lost to Follow-up|24|||
48773012|NCT03304379|157013207|FG002|Overall Study|Lost to Follow-up|35|||
48773013|NCT03304379|157013208|FG003|Overall Study|Lost to Follow-up|4|||
48773014|NCT03304379|157013209|FG004|Overall Study|Lost to Follow-up|0|||
48773015|NCT03304379|157013205|FG000|Overall Study|Death|1|||
48773016|NCT03304379|157013206|FG001|Overall Study|Death|2|||
48773017|NCT03304379|157013207|FG002|Overall Study|Death|0|||
48773018|NCT03304379|157013208|FG003|Overall Study|Death|0|||
48773019|NCT03304379|157013209|FG004|Overall Study|Death|0|||
48773020|NCT03304379|157013205|FG000|Overall Study|Other|0|||
48773021|NCT03304379|157013206|FG001|Overall Study|Other|1|||
48773022|NCT03304379|157013207|FG002|Overall Study|Other|0|||
48773023|NCT03304379|157013208|FG003|Overall Study|Other|0|||
48773024|NCT03304379|157013209|FG004|Overall Study|Other|0|||
48773025|NCT00179413|157013216|FG000|Overall Study|Adverse Event|38|||
48773026|NCT00179413|157013217|FG001|Overall Study|Adverse Event|20|||
48773027|NCT00179413|157013216|FG000|Overall Study|Withdrawal by Subject|87|||
48773028|NCT00179413|157013217|FG001|Overall Study|Withdrawal by Subject|95|||
48773029|NCT03027466|157013224|FG000|Overall Study|Opting out of the app|1869|||
48773030|NCT03027466|157013225|FG001|Overall Study|Opting out of the app|1819|||
48773031|NCT03027466|157013226|FG002|Overall Study|Opting out of the app|1743|||
48773032|NCT03027466|157013227|FG003|Overall Study|Opting out of the app|1821|||
48773033|NCT00094653|157013229|FG000|Overall Study|Death|306|||
48773034|NCT00094653|157013230|FG001|Overall Study|Death|100|||
48773035|NCT00094653|157013231|FG002|Overall Study|Death|119|||
48773036|NCT00094653|157013229|FG000|Overall Study|Subject Withdrew Consent|10|||
48773037|NCT00094653|157013230|FG001|Overall Study|Subject Withdrew Consent|2|||
48773038|NCT00094653|157013231|FG002|Overall Study|Subject Withdrew Consent|3|||
48773039|NCT00094653|157013229|FG000|Overall Study|Other|2|||
48773040|NCT00094653|157013230|FG001|Overall Study|Other|2|||
48773041|NCT00094653|157013231|FG002|Overall Study|Other|2|||
48773042|NCT00094653|157013229|FG000|Overall Study|Lost to Follow-up|3|||
48773043|NCT00094653|157013230|FG001|Overall Study|Lost to Follow-up|2|||
48395737|NCT02919436|155641619|FG001|Overall Study|Did not undergo surgery|20|||
48395738|NCT02919436|155641618|FG000|Overall Study|Enrolled before trial registration|44|||
48395739|NCT02919436|155641619|FG001|Overall Study|Enrolled before trial registration|33|||
48395740|NCT01709435|155641624|FG000|Overall Study|Adverse Event|1|||
48395741|NCT01709435|155641625|FG001|Overall Study|Adverse Event|1|||
48773044|NCT00094653|157013231|FG002|Overall Study|Lost to Follow-up|1|||
48773045|NCT00094653|157013229|FG000|Overall Study|Protocol Violation|0|||
48773046|NCT00094653|157013230|FG001|Overall Study|Protocol Violation|0|||
48773047|NCT00094653|157013231|FG002|Overall Study|Protocol Violation|1|||
48773048|NCT00458484|157013232|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
48773049|NCT00458484|157013233|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
48773050|NCT00458484|157013234|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
48773051|NCT00458484|157013235|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
48773052|NCT00458484|157013236|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
48773053|NCT00458484|157013237|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
48773054|NCT00458484|157013238|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
48773055|NCT01337297|157013239|FG000|Overall Study|They entered to single anodal tDCS|4|||
48773056|NCT01337297|157013240|FG001|Overall Study|They entered to single anodal tDCS|3|||
48773057|NCT01337297|157013239|FG000|Overall Study|Lost to Follow-up|1|||
48773058|NCT01337297|157013240|FG001|Overall Study|Lost to Follow-up|3|||
48773059|NCT02316717|157013241|FG000|Overall Study|Adverse Event|2|||
48773060|NCT02316717|157013242|FG001|Overall Study|Adverse Event|2|||
48773061|NCT02316717|157013243|FG002|Overall Study|Adverse Event|0|||
48773062|NCT02316717|157013241|FG000|Overall Study|Lost to Follow-up|1|||
48773063|NCT02316717|157013242|FG001|Overall Study|Lost to Follow-up|2|||
48773064|NCT02316717|157013243|FG002|Overall Study|Lost to Follow-up|1|||
48773065|NCT02316717|157013241|FG000|Overall Study|Non compliance|3|||
48773066|NCT02316717|157013242|FG001|Overall Study|Non compliance|1|||
48773067|NCT02316717|157013243|FG002|Overall Study|Non compliance|0|||
48773068|NCT02316717|157013241|FG000|Overall Study|Protocol Violation|2|||
48773069|NCT02316717|157013242|FG001|Overall Study|Protocol Violation|0|||
48773070|NCT02316717|157013243|FG002|Overall Study|Protocol Violation|0|||
48773071|NCT02316717|157013241|FG000|Overall Study|Withdrawal by Subject|2|||
48773072|NCT02316717|157013242|FG001|Overall Study|Withdrawal by Subject|1|||
48773073|NCT02316717|157013243|FG002|Overall Study|Withdrawal by Subject|1|||
48773074|NCT02316717|157013241|FG000|Overall Study|Death|0|||
48356222|NCT03126110|155501061|FG006|Phase 1|Lost to Follow-up|0|||
48356223|NCT03126110|155501062|FG007|Phase 1|Lost to Follow-up|0|||
48773075|NCT02316717|157013242|FG001|Overall Study|Death|0|||
48773076|NCT02316717|157013243|FG002|Overall Study|Death|1|||
48773077|NCT02316717|157013241|FG000|Overall Study|Physician Decision|0|||
48773078|NCT02316717|157013242|FG001|Overall Study|Physician Decision|1|||
48773079|NCT02316717|157013243|FG002|Overall Study|Physician Decision|0|||
48773080|NCT02316717|157013241|FG000|Overall Study|TBC|1|||
48773081|NCT02316717|157013242|FG001|Overall Study|TBC|0|||
48356224|NCT03126110|155501063|FG008|Phase 1|Lost to Follow-up|1|||
48356225|NCT03126110|155501064|FG009|Phase 1|Lost to Follow-up|0|||
48356226|NCT03126110|155501065|FG010|Phase 1|Lost to Follow-up|0|||
48356227|NCT03126110|155501066|FG011|Phase 1|Lost to Follow-up|0|||
48356228|NCT03126110|155501067|FG012|Phase 1|Lost to Follow-up|0|||
48356229|NCT03126110|155501068|FG013|Phase 1|Lost to Follow-up|0|||
48356230|NCT03126110|155501069|FG014|Phase 1|Lost to Follow-up|0|||
48356231|NCT03126110|155501070|FG015|Phase 1|Lost to Follow-up|0|||
48356232|NCT03126110|155501071|FG016|Phase 1|Lost to Follow-up|0|||
48356233|NCT03126110|155501055|FG000|Phase 1|Withdrawal by Subject|1|||
48356234|NCT03126110|155501056|FG001|Phase 1|Withdrawal by Subject|0|||
48356235|NCT03126110|155501057|FG002|Phase 1|Withdrawal by Subject|0|||
48356236|NCT03126110|155501058|FG003|Phase 1|Withdrawal by Subject|1|||
48356237|NCT03126110|155501059|FG004|Phase 1|Withdrawal by Subject|1|||
48356238|NCT03126110|155501060|FG005|Phase 1|Withdrawal by Subject|0|||
48356239|NCT03126110|155501061|FG006|Phase 1|Withdrawal by Subject|0|||
48356240|NCT03126110|155501062|FG007|Phase 1|Withdrawal by Subject|0|||
48356241|NCT03126110|155501063|FG008|Phase 1|Withdrawal by Subject|2|||
48356242|NCT03126110|155501064|FG009|Phase 1|Withdrawal by Subject|1|||
48356243|NCT03126110|155501065|FG010|Phase 1|Withdrawal by Subject|0|||
48356244|NCT03126110|155501066|FG011|Phase 1|Withdrawal by Subject|0|||
48356245|NCT03126110|155501067|FG012|Phase 1|Withdrawal by Subject|0|||
48356246|NCT03126110|155501068|FG013|Phase 1|Withdrawal by Subject|0|||
48356247|NCT03126110|155501069|FG014|Phase 1|Withdrawal by Subject|0|||
48356248|NCT03126110|155501070|FG015|Phase 1|Withdrawal by Subject|0|||
48356249|NCT03126110|155501071|FG016|Phase 1|Withdrawal by Subject|0|||
48773082|NCT02316717|157013243|FG002|Overall Study|TBC|0|||
48773083|NCT00004031|157013246|FG000|Overall Study|Adverse Event|5|||
48773084|NCT00004031|157013247|FG001|Overall Study|Adverse Event|0|||
48773085|NCT00004031|157013246|FG000|Overall Study|Refusal unrelated to adverse events|2|||
48773086|NCT00004031|157013247|FG001|Overall Study|Refusal unrelated to adverse events|11|||
48395742|NCT01709435|155641626|FG002|Overall Study|Adverse Event|1|||
48395743|NCT01709435|155641627|FG003|Overall Study|Adverse Event|0|||
48395744|NCT01709435|155641628|FG004|Overall Study|Adverse Event|0|||
48395745|NCT01709435|155641629|FG005|Overall Study|Adverse Event|1|||
48395746|NCT01709435|155641624|FG000|Overall Study|Lack of Efficacy|5|||
48773087|NCT00004031|157013246|FG000|Overall Study|Progression/relapse|9|||
48395747|NCT01709435|155641625|FG001|Overall Study|Lack of Efficacy|7|||
48395748|NCT01709435|155641626|FG002|Overall Study|Lack of Efficacy|2|||
48395749|NCT01709435|155641627|FG003|Overall Study|Lack of Efficacy|2|||
48395750|NCT01709435|155641628|FG004|Overall Study|Lack of Efficacy|6|||
48395751|NCT01709435|155641629|FG005|Overall Study|Lack of Efficacy|3|||
48395752|NCT01709435|155641624|FG000|Overall Study|Physician Decision|0|||
48395753|NCT01709435|155641625|FG001|Overall Study|Physician Decision|1|||
48395754|NCT01709435|155641626|FG002|Overall Study|Physician Decision|0|||
48395755|NCT01709435|155641627|FG003|Overall Study|Physician Decision|1|||
48395756|NCT01709435|155641628|FG004|Overall Study|Physician Decision|2|||
48395757|NCT01709435|155641629|FG005|Overall Study|Physician Decision|0|||
48395758|NCT01709435|155641624|FG000|Overall Study|Withdrawal by Subject|0|||
48395759|NCT01709435|155641625|FG001|Overall Study|Withdrawal by Subject|0|||
48395760|NCT01709435|155641626|FG002|Overall Study|Withdrawal by Subject|3|||
48395761|NCT01709435|155641627|FG003|Overall Study|Withdrawal by Subject|0|||
48395762|NCT01709435|155641628|FG004|Overall Study|Withdrawal by Subject|2|||
48395763|NCT01709435|155641629|FG005|Overall Study|Withdrawal by Subject|2|||
48395764|NCT02264990|155641630|FG000|Overall Study|Death|255|||
48395765|NCT02264990|155641631|FG001|Overall Study|Death|250|||
48395766|NCT02264990|155641630|FG000|Overall Study|Withdrawal by Subject|4|||
48773088|NCT00004031|157013247|FG001|Overall Study|Progression/relapse|4|||
48773089|NCT00004031|157013246|FG000|Overall Study|Death|3|||
48773090|NCT00004031|157013247|FG001|Overall Study|Death|1|||
48773091|NCT00004031|157013246|FG000|Overall Study|Other- not protocol specified|3|||
48773092|NCT00004031|157013247|FG001|Overall Study|Other- not protocol specified|3|||
48395767|NCT02264990|155641631|FG001|Overall Study|Withdrawal by Subject|5|||
48395768|NCT02264990|155641630|FG000|Overall Study|Lost to Follow-up|1|||
48395769|NCT02264990|155641631|FG001|Overall Study|Lost to Follow-up|3|||
48395770|NCT02264990|155641630|FG000|Overall Study|Other|0|||
48395771|NCT02264990|155641631|FG001|Overall Study|Other|1|||
48395772|NCT02429414|155641632|FG000|Overall Study|Physician Decision|0|||
48395773|NCT02429414|155641633|FG001|Overall Study|Physician Decision|1|||
48395774|NCT01604265|155641636|FG000|Overall Study|Adverse Event|1|||
48395775|NCT01604265|155641637|FG001|Overall Study|Adverse Event|0|||
48395776|NCT01604265|155641636|FG000|Overall Study|Withdrawal by Subject|1|||
48395777|NCT01604265|155641637|FG001|Overall Study|Withdrawal by Subject|0|||
48395778|NCT02182687|155641638|FG000|Overall Study|Withdrawal by Subject|4|||
48395779|NCT02182687|155641639|FG001|Overall Study|Withdrawal by Subject|0|||
48395780|NCT02182687|155641638|FG000|Overall Study|Adverse Event|1|||
48395781|NCT02182687|155641639|FG001|Overall Study|Adverse Event|0|||
48395782|NCT02182687|155641638|FG000|Overall Study|Lost to Follow-up|0|||
48395783|NCT02182687|155641639|FG001|Overall Study|Lost to Follow-up|1|||
48395784|NCT03882970|155641644|FG000|Overall Study|Adverse Event|5|||
48395785|NCT03882970|155641645|FG001|Overall Study|Adverse Event|7|||
48395786|NCT03882970|155641646|FG002|Overall Study|Adverse Event|3|||
48395787|NCT03882970|155641647|FG003|Overall Study|Adverse Event|1|||
48395788|NCT03882970|155641644|FG000|Overall Study|Death|1|||
48395789|NCT03882970|155641645|FG001|Overall Study|Death|2|||
48395790|NCT03882970|155641646|FG002|Overall Study|Death|1|||
48395791|NCT03882970|155641647|FG003|Overall Study|Death|1|||
48395792|NCT03882970|155641644|FG000|Overall Study|Lost to Follow-up|8|||
48395793|NCT03882970|155641645|FG001|Overall Study|Lost to Follow-up|9|||
48773093|NCT00004031|157013246|FG000|Overall Study|Reason under review|3|||
48773094|NCT00004031|157013247|FG001|Overall Study|Reason under review|2|||
48773095|NCT00853658|157013248|FG000|Overall Study|Death|713|||
48395794|NCT03882970|155641646|FG002|Overall Study|Lost to Follow-up|5|||
48395795|NCT03882970|155641647|FG003|Overall Study|Lost to Follow-up|5|||
48395796|NCT03882970|155641644|FG000|Overall Study|Physician Decision|0|||
48773096|NCT00853658|157013249|FG001|Overall Study|Death|768|||
48773097|NCT00853658|157013250|FG002|Overall Study|Death|753|||
48395797|NCT03882970|155641645|FG001|Overall Study|Physician Decision|2|||
48773098|NCT00853658|157013248|FG000|Overall Study|Lost to Follow-up|11|||
48395798|NCT03882970|155641646|FG002|Overall Study|Physician Decision|2|||
48395799|NCT03882970|155641647|FG003|Overall Study|Physician Decision|2|||
48395800|NCT03882970|155641644|FG000|Overall Study|Protocol Violation|2|||
48395801|NCT03882970|155641645|FG001|Overall Study|Protocol Violation|0|||
48395802|NCT03882970|155641646|FG002|Overall Study|Protocol Violation|0|||
48395803|NCT03882970|155641647|FG003|Overall Study|Protocol Violation|0|||
48395804|NCT03882970|155641644|FG000|Overall Study|Withdrawal by Subject|8|||
48395805|NCT03882970|155641645|FG001|Overall Study|Withdrawal by Subject|17|||
48773099|NCT00853658|157013249|FG001|Overall Study|Lost to Follow-up|6|||
48773100|NCT00853658|157013250|FG002|Overall Study|Lost to Follow-up|11|||
48773101|NCT00853658|157013248|FG000|Overall Study|H.A. Request|26|||
48773102|NCT00853658|157013249|FG001|Overall Study|H.A. Request|23|||
48773103|NCT00853658|157013250|FG002|Overall Study|H.A. Request|19|||
48773104|NCT00853658|157013248|FG000|Overall Study|IRB request|0|||
48773105|NCT00853658|157013249|FG001|Overall Study|IRB request|0|||
48773106|NCT00853658|157013250|FG002|Overall Study|IRB request|2|||
48773107|NCT00853658|157013248|FG000|Overall Study|Vital Status known (alive) at study end|2|||
48773108|NCT00853658|157013249|FG001|Overall Study|Vital Status known (alive) at study end|3|||
48773109|NCT00853658|157013250|FG002|Overall Study|Vital Status known (alive) at study end|3|||
48773110|NCT00853658|157013248|FG000|Overall Study|Vital Status unknown at study end|1|||
48773111|NCT00853658|157013249|FG001|Overall Study|Vital Status unknown at study end|1|||
48773112|NCT00853658|157013250|FG002|Overall Study|Vital Status unknown at study end|0|||
48773113|NCT00853658|157013248|FG000|Overall Study|Vital Status at study end N/A|8|||
48773114|NCT00853658|157013249|FG001|Overall Study|Vital Status at study end N/A|10|||
48773115|NCT00853658|157013250|FG002|Overall Study|Vital Status at study end N/A|10|||
48773116|NCT00853658|157013248|FG000|Overall Study|Patient's request|21|||
48773117|NCT00853658|157013249|FG001|Overall Study|Patient's request|17|||
48773118|NCT00853658|157013250|FG002|Overall Study|Patient's request|11|||
48773119|NCT00853658|157013248|FG000|Overall Study|Missing study completion information|5|||
48773120|NCT00853658|157013249|FG001|Overall Study|Missing study completion information|4|||
48773121|NCT00853658|157013250|FG002|Overall Study|Missing study completion information|6|||
48773122|NCT03146650|157013251|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
48773123|NCT03146650|157013251|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
48773124|NCT03146650|157013251|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
48773125|NCT03146650|157013251|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
48773126|NCT03146650|157013251|FG000|2 Year Follow-up|Death|11|||
48773127|NCT03146650|157013251|FG000|2 Year Follow-up|Still in follow-up|7|||
48773128|NCT03146650|157013251|FG000|2 Year Follow-up|Lost to Follow-up|1|||
48773129|NCT03548584|157014763|FG000|Overall Study|Lost to Follow-up|0|||
48773130|NCT03548584|157014764|FG001|Overall Study|Lost to Follow-up|0|||
48773131|NCT03548584|157014765|FG002|Overall Study|Lost to Follow-up|1|||
48773132|NCT03548584|157014763|FG000|Overall Study|Adverse Event|1|||
48773133|NCT03548584|157014764|FG001|Overall Study|Adverse Event|11|||
48773134|NCT03548584|157014765|FG002|Overall Study|Adverse Event|5|||
48773135|NCT03548584|157014763|FG000|Overall Study|Site Terminated by Sponsor|1|||
48773136|NCT03548584|157014764|FG001|Overall Study|Site Terminated by Sponsor|3|||
48773137|NCT03548584|157014765|FG002|Overall Study|Site Terminated by Sponsor|2|||
48773138|NCT03548584|157014763|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
48773139|NCT03548584|157014764|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
48773140|NCT03548584|157014765|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
48773141|NCT03548584|157014763|FG000|Overall Study|Lack of Efficacy|0|||
48773142|NCT03548584|157014764|FG001|Overall Study|Lack of Efficacy|1|||
48773143|NCT03548584|157014765|FG002|Overall Study|Lack of Efficacy|0|||
48773144|NCT03548584|157014763|FG000|Overall Study|Non-compliance with Study Drug|0|||
48773145|NCT03548584|157014764|FG001|Overall Study|Non-compliance with Study Drug|1|||
48773146|NCT03548584|157014765|FG002|Overall Study|Non-compliance with Study Drug|0|||
48773147|NCT03548584|157014763|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
48773148|NCT03548584|157014764|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
48773149|NCT03548584|157014765|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
48773150|NCT04524403|157014766|FG000|Overall Study|Withdrawal by Subject|10|||
48773151|NCT04524403|157014767|FG001|Overall Study|Withdrawal by Subject|3|||
48773152|NCT04524403|157014768|FG002|Overall Study|Withdrawal by Subject|8|||
48773153|NCT04524403|157014766|FG000|Overall Study|Lost to Follow-up|3|||
48773154|NCT04524403|157014767|FG001|Overall Study|Lost to Follow-up|4|||
48773155|NCT04524403|157014768|FG002|Overall Study|Lost to Follow-up|3|||
48773156|NCT04524403|157014766|FG000|Overall Study|Adverse Event|3|||
48773157|NCT04524403|157014767|FG001|Overall Study|Adverse Event|1|||
48395806|NCT03882970|155641646|FG002|Overall Study|Withdrawal by Subject|7|||
48395807|NCT03882970|155641647|FG003|Overall Study|Withdrawal by Subject|22|||
48395808|NCT03882970|155641644|FG000|Overall Study|Personal Reason|2|||
48395809|NCT03882970|155641645|FG001|Overall Study|Personal Reason|3|||
48395810|NCT03882970|155641646|FG002|Overall Study|Personal Reason|1|||
48395811|NCT03882970|155641647|FG003|Overall Study|Personal Reason|3|||
48395812|NCT03002155|155641648|FG000|Overall Study|Lost to Follow-up|1|||
48395813|NCT03002155|155641649|FG001|Overall Study|Lost to Follow-up|2|||
48395814|NCT03002155|155641648|FG000|Overall Study|Withdrawal by Subject|1|||
48395815|NCT03002155|155641649|FG001|Overall Study|Withdrawal by Subject|0|||
48395816|NCT03002155|155641648|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
48395817|NCT03002155|155641649|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
48395818|NCT02898259|155641650|FG000|Overall Study|Adverse Event|0|||
48395819|NCT02898259|155641651|FG001|Overall Study|Adverse Event|0|||
48395820|NCT02898259|155641652|FG002|Overall Study|Adverse Event|1|||
48395821|NCT02898259|155641653|FG003|Overall Study|Adverse Event|0|||
48395822|NCT02898259|155641654|FG004|Overall Study|Adverse Event|0|||
48395823|NCT02898259|155641650|FG000|Overall Study|Lack of Efficacy|1|||
48773158|NCT04524403|157014768|FG002|Overall Study|Adverse Event|4|||
48773159|NCT04524403|157014766|FG000|Overall Study|Non-compliant with study drug|1|||
48395824|NCT02898259|155641651|FG001|Overall Study|Lack of Efficacy|1|||
48773160|NCT04524403|157014767|FG001|Overall Study|Non-compliant with study drug|2|||
48773161|NCT04524403|157014768|FG002|Overall Study|Non-compliant with study drug|3|||
48773162|NCT04524403|157014766|FG000|Overall Study|Moved|0|||
48773163|NCT04524403|157014767|FG001|Overall Study|Moved|1|||
48773164|NCT04524403|157014768|FG002|Overall Study|Moved|0|||
48773165|NCT01707004|157014770|FG000|Overall Study|Physician Decision|3|||
48773166|NCT00589108|157014771|FG000|Overall Study|Lost to Follow-up|1|||
48773167|NCT00589108|157014772|FG001|Overall Study|Lost to Follow-up|1|||
48773168|NCT00589108|157014773|FG002|Overall Study|Lost to Follow-up|1|||
48773169|NCT00589108|157014771|FG000|Overall Study|Death|3|||
48773170|NCT00589108|157014772|FG001|Overall Study|Death|3|||
48773171|NCT00589108|157014773|FG002|Overall Study|Death|4|||
48773172|NCT00727194|157014774|FG000|Screening Period|Low QMG scores|0|||
48773173|NCT00727194|157014775|FG001|Screening Period|Low QMG scores|0|||
48773174|NCT00727194|157014776|FG002|Screening Period|Low QMG scores|6|||
48773175|NCT00727194|157014774|FG000|Screening Period|Lacked AChR antibodies|0|||
48773176|NCT00727194|157014775|FG001|Screening Period|Lacked AChR antibodies|0|||
48773177|NCT00727194|157014776|FG002|Screening Period|Lacked AChR antibodies|5|||
48773178|NCT00727194|157014774|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
48773179|NCT00727194|157014775|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
48773180|NCT00727194|157014776|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
48773181|NCT00727194|157014774|FG000|Screening Period|Severe infections|0|||
48773182|NCT00727194|157014775|FG001|Screening Period|Severe infections|0|||
48773183|NCT00727194|157014776|FG002|Screening Period|Severe infections|2|||
48773184|NCT00727194|157014774|FG000|Screening Period|History of thymoma|0|||
48773185|NCT00727194|157014775|FG001|Screening Period|History of thymoma|0|||
48773186|NCT00727194|157014776|FG002|Screening Period|History of thymoma|1|||
48773187|NCT00727194|157014774|FG000|Treatment Period 2|Lack of Efficacy|0|||
48773188|NCT00727194|157014775|FG001|Treatment Period 2|Lack of Efficacy|1|||
48773189|NCT00727194|157014776|FG002|Treatment Period 2|Lack of Efficacy|0|||
48773190|NCT02472756|157014777|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
48395825|NCT02898259|155641652|FG002|Overall Study|Lack of Efficacy|3|||
48395826|NCT02898259|155641653|FG003|Overall Study|Lack of Efficacy|0|||
48395827|NCT02898259|155641654|FG004|Overall Study|Lack of Efficacy|0|||
48773191|NCT02472756|157014777|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
48773192|NCT02472756|157014777|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
48773193|NCT02472756|157014777|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
48773194|NCT02472756|157014777|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
48773195|NCT00978731|157014779|FG000|Overall Study|Death|4|||
48773196|NCT00978731|157014780|FG001|Overall Study|Death|1|||
48773197|NCT00978731|157014781|FG002|Overall Study|Death|1|||
48773198|NCT00978731|157014782|FG003|Overall Study|Death|0|||
48773199|NCT00978731|157014779|FG000|Overall Study|Lost to Follow-up|0|||
48773200|NCT00978731|157014780|FG001|Overall Study|Lost to Follow-up|0|||
48773201|NCT00978731|157014781|FG002|Overall Study|Lost to Follow-up|0|||
48773202|NCT00978731|157014782|FG003|Overall Study|Lost to Follow-up|1|||
48773203|NCT00978731|157014779|FG000|Overall Study|Adverse Event|5|||
48395828|NCT02898259|155641650|FG000|Overall Study|Lost to Follow-up|0|||
48395829|NCT02898259|155641651|FG001|Overall Study|Lost to Follow-up|0|||
48395830|NCT02898259|155641652|FG002|Overall Study|Lost to Follow-up|1|||
48395831|NCT02898259|155641653|FG003|Overall Study|Lost to Follow-up|0|||
48395832|NCT02898259|155641654|FG004|Overall Study|Lost to Follow-up|0|||
48395833|NCT02898259|155641650|FG000|Overall Study|Transformation before study began|0|||
48395834|NCT02898259|155641651|FG001|Overall Study|Transformation before study began|0|||
48395835|NCT02898259|155641652|FG002|Overall Study|Transformation before study began|0|||
48395836|NCT02898259|155641653|FG003|Overall Study|Transformation before study began|1|||
48395837|NCT02898259|155641654|FG004|Overall Study|Transformation before study began|0|||
48395838|NCT02829138|155641663|FG000|Overall Study|Withdrawal by Subject|1|||
48395839|NCT02829138|155641664|FG001|Overall Study|Withdrawal by Subject|0|||
48395840|NCT02728830|155641669|FG000|Overall Study|Exclusionary Surgery|9|||
48395841|NCT02728830|155641669|FG000|Overall Study|Exclusionary Pathology|6|||
48395842|NCT02728830|155641669|FG000|Overall Study|Physician Decision|3|||
48395843|NCT02728830|155641669|FG000|Overall Study|Withdrawal by Subject|2|||
48395844|NCT02728830|155641669|FG000|Overall Study|Lost to Follow-up|1|||
48395845|NCT02728830|155641669|FG000|Overall Study|Exclusionary Lab Values|1|||
48395846|NCT02728830|155641669|FG000|Overall Study|Contraindicated Illness|1|||
48395847|NCT02728830|155641669|FG000|Overall Study|Language Barrier|1|||
48395848|NCT02980224|155641673|FG000|Overall Study|Adverse Event|4|||
48395849|NCT02980224|155641674|FG001|Overall Study|Adverse Event|1|||
48395850|NCT02980224|155641673|FG000|Overall Study|Withdrawal by Subject|0|||
48395851|NCT02980224|155641674|FG001|Overall Study|Withdrawal by Subject|2|||
48395852|NCT02941627|155641677|FG000|Overall Study|Death|1|||
48395853|NCT02941627|155641677|FG000|Overall Study|Surgical failure|1|||
48395854|NCT02941627|155641677|FG000|Overall Study|cholesteatoma prevented implantation|1|||
48395855|NCT00563186|155641678|FG000|Overall Study|LOS<48 hours|97|||
48395856|NCT00563186|155641679|FG001|Overall Study|LOS<48 hours|74|||
48395857|NCT00563186|155641678|FG000|Overall Study|Incomplete data|1|||
48395858|NCT00563186|155641679|FG001|Overall Study|Incomplete data|1|||
48395859|NCT00513500|155641682|FG000|Overall Study|Lost to Follow-up|35|||
48395860|NCT00513500|155641683|FG001|Overall Study|Lost to Follow-up|39|||
48395861|NCT00513500|155641682|FG000|Overall Study|Death|2|||
48395862|NCT00513500|155641683|FG001|Overall Study|Death|1|||
48395863|NCT00513500|155641682|FG000|Overall Study|Hospitalized|4|||
48395864|NCT00513500|155641683|FG001|Overall Study|Hospitalized|14|||
48395865|NCT00886600|155641684|FG000|Double-blind Monotherapy|Adverse Event|1|||
48395866|NCT00886600|155641685|FG001|Double-blind Monotherapy|Adverse Event|1|||
48395867|NCT00886600|155641686|FG002|Double-blind Monotherapy|Adverse Event|1|||
48395868|NCT00886600|155641687|FG003|Double-blind Monotherapy|Adverse Event|1|||
48395869|NCT00886600|155641684|FG000|Double-blind Monotherapy|Protocol Violation|0|||
48395870|NCT00886600|155641685|FG001|Double-blind Monotherapy|Protocol Violation|0|||
48395871|NCT00886600|155641686|FG002|Double-blind Monotherapy|Protocol Violation|0|||
48395872|NCT00886600|155641687|FG003|Double-blind Monotherapy|Protocol Violation|1|||
48395873|NCT00886600|155641684|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
48395874|NCT00886600|155641685|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
48395875|NCT00886600|155641686|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
48395876|NCT00886600|155641687|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
48395877|NCT00886600|155641684|FG000|Combination Therapy Period|Adverse Event|0|||
48395878|NCT00886600|155641685|FG001|Combination Therapy Period|Adverse Event|0|||
48395879|NCT00886600|155641686|FG002|Combination Therapy Period|Adverse Event|1|||
48395880|NCT00886600|155641687|FG003|Combination Therapy Period|Adverse Event|0|||
48395881|NCT00886600|155641684|FG000|Combination Therapy Period|Protocol Violation|0|||
48395882|NCT00886600|155641685|FG001|Combination Therapy Period|Protocol Violation|0|||
48395883|NCT00886600|155641686|FG002|Combination Therapy Period|Protocol Violation|1|||
48395884|NCT00886600|155641687|FG003|Combination Therapy Period|Protocol Violation|0|||
48395885|NCT00790907|155641688|FG000|Overall Study|Adverse Event|9|||
48773204|NCT00978731|157014780|FG001|Overall Study|Adverse Event|2|||
48773205|NCT00978731|157014781|FG002|Overall Study|Adverse Event|0|||
48773206|NCT00978731|157014782|FG003|Overall Study|Adverse Event|0|||
48773207|NCT00978731|157014779|FG000|Overall Study|Participant's request|1|||
48773208|NCT00978731|157014780|FG001|Overall Study|Participant's request|0|||
48395886|NCT00790907|155641689|FG001|Overall Study|Adverse Event|7|||
48773209|NCT00978731|157014781|FG002|Overall Study|Participant's request|0|||
48773210|NCT00978731|157014782|FG003|Overall Study|Participant's request|0|||
48773211|NCT00978731|157014779|FG000|Overall Study|Administrative reason|3|||
48773212|NCT00978731|157014780|FG001|Overall Study|Administrative reason|3|||
48773213|NCT00978731|157014781|FG002|Overall Study|Administrative reason|1|||
48773214|NCT00978731|157014782|FG003|Overall Study|Administrative reason|0|||
48773215|NCT00978731|157014779|FG000|Overall Study|Deterioration without progression|0|||
48773216|NCT00978731|157014780|FG001|Overall Study|Deterioration without progression|1|||
48773217|NCT00978731|157014781|FG002|Overall Study|Deterioration without progression|0|||
48773218|NCT00978731|157014782|FG003|Overall Study|Deterioration without progression|0|||
48773219|NCT00978731|157014779|FG000|Overall Study|Disease progression/relapse|5|||
48773220|NCT00978731|157014780|FG001|Overall Study|Disease progression/relapse|4|||
48773221|NCT00978731|157014781|FG002|Overall Study|Disease progression/relapse|2|||
48773222|NCT00978731|157014782|FG003|Overall Study|Disease progression/relapse|2|||
48773223|NCT00978731|157014779|FG000|Overall Study|Study closure|3|||
48773224|NCT00978731|157014780|FG001|Overall Study|Study closure|4|||
48773225|NCT00978731|157014781|FG002|Overall Study|Study closure|1|||
48773226|NCT00978731|157014782|FG003|Overall Study|Study closure|1|||
48773227|NCT00978731|157014779|FG000|Overall Study|No response|1|||
48773228|NCT00978731|157014780|FG001|Overall Study|No response|0|||
48773229|NCT00978731|157014781|FG002|Overall Study|No response|0|||
48773230|NCT00978731|157014782|FG003|Overall Study|No response|0|||
48773231|NCT00110266|157014783|FG000|Overall Study|Adverse Event|27|||
48773232|NCT00110266|157014783|FG000|Overall Study|Abnormal laboratory value|15|||
48773233|NCT00110266|157014783|FG000|Overall Study|Withdrawal by Subject|16|||
48773234|NCT00110266|157014783|FG000|Overall Study|Death|17|||
48773235|NCT00110266|157014783|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48773236|NCT00110266|157014783|FG000|Overall Study|Participant condition no longer requires study drug|1|||
48773237|NCT02097134|157014784|FG000|Overall Study|Physician Decision|4|||
48773238|NCT02097134|157014784|FG000|Overall Study|Non-Protocol Therapy|1|||
48773239|NCT02097134|157014784|FG000|Overall Study|Progressive Disease|3|||
48773240|NCT02097134|157014784|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
48773241|NCT02896400|157014785|FG000|1 Month Follow-up|Lost to Follow-up|7|||
48773242|NCT02896400|157014786|FG001|1 Month Follow-up|Lost to Follow-up|7|||
48773243|NCT02896400|157014787|FG002|1 Month Follow-up|Lost to Follow-up|5|||
48773244|NCT02896400|157014788|FG003|1 Month Follow-up|Lost to Follow-up|8|||
48773245|NCT02896400|157014789|FG004|1 Month Follow-up|Lost to Follow-up|9|||
48773246|NCT02896400|157014790|FG005|1 Month Follow-up|Lost to Follow-up|6|||
48773247|NCT02896400|157014791|FG006|1 Month Follow-up|Lost to Follow-up|5|||
48773248|NCT02896400|157014792|FG007|1 Month Follow-up|Lost to Follow-up|6|||
48773249|NCT02896400|157014793|FG008|1 Month Follow-up|Lost to Follow-up|4|||
48773250|NCT02896400|157014794|FG009|1 Month Follow-up|Lost to Follow-up|7|||
48773251|NCT02896400|157014795|FG010|1 Month Follow-up|Lost to Follow-up|5|||
48773252|NCT02896400|157014796|FG011|1 Month Follow-up|Lost to Follow-up|5|||
48773253|NCT02896400|157014797|FG012|1 Month Follow-up|Lost to Follow-up|3|||
48773254|NCT02896400|157014798|FG013|1 Month Follow-up|Lost to Follow-up|4|||
48773255|NCT02896400|157014799|FG014|1 Month Follow-up|Lost to Follow-up|1|||
48773256|NCT02896400|157014800|FG015|1 Month Follow-up|Lost to Follow-up|2|||
48773257|NCT02896400|157014785|FG000|1 Month Follow-up|Death|0|||
48773258|NCT02896400|157014786|FG001|1 Month Follow-up|Death|0|||
48773259|NCT02896400|157014787|FG002|1 Month Follow-up|Death|0|||
48773260|NCT02896400|157014788|FG003|1 Month Follow-up|Death|0|||
48773261|NCT02896400|157014789|FG004|1 Month Follow-up|Death|0|||
48773262|NCT02896400|157014790|FG005|1 Month Follow-up|Death|0|||
48773263|NCT02896400|157014791|FG006|1 Month Follow-up|Death|0|||
48773264|NCT02896400|157014792|FG007|1 Month Follow-up|Death|0|||
48773265|NCT02896400|157014793|FG008|1 Month Follow-up|Death|0|||
48773266|NCT02896400|157014794|FG009|1 Month Follow-up|Death|0|||
48773267|NCT02896400|157014795|FG010|1 Month Follow-up|Death|0|||
48773268|NCT02896400|157014796|FG011|1 Month Follow-up|Death|0|||
48773269|NCT02896400|157014797|FG012|1 Month Follow-up|Death|0|||
48773270|NCT02896400|157014798|FG013|1 Month Follow-up|Death|0|||
48773271|NCT02896400|157014799|FG014|1 Month Follow-up|Death|0|||
48773272|NCT02896400|157014800|FG015|1 Month Follow-up|Death|1|||
48773273|NCT02896400|157014785|FG000|3 Month Follow-up|Lost to Follow-up|6|||
48773274|NCT02896400|157014786|FG001|3 Month Follow-up|Lost to Follow-up|3|||
48773275|NCT02896400|157014787|FG002|3 Month Follow-up|Lost to Follow-up|6|||
48773276|NCT02896400|157014788|FG003|3 Month Follow-up|Lost to Follow-up|11|||
48773277|NCT02896400|157014789|FG004|3 Month Follow-up|Lost to Follow-up|12|||
48773278|NCT02896400|157014790|FG005|3 Month Follow-up|Lost to Follow-up|6|||
48773279|NCT02896400|157014791|FG006|3 Month Follow-up|Lost to Follow-up|4|||
48773280|NCT02896400|157014792|FG007|3 Month Follow-up|Lost to Follow-up|3|||
48773281|NCT02896400|157014793|FG008|3 Month Follow-up|Lost to Follow-up|6|||
48773282|NCT02896400|157014794|FG009|3 Month Follow-up|Lost to Follow-up|5|||
48773283|NCT02896400|157014795|FG010|3 Month Follow-up|Lost to Follow-up|6|||
48773284|NCT02896400|157014796|FG011|3 Month Follow-up|Lost to Follow-up|6|||
48773285|NCT02896400|157014797|FG012|3 Month Follow-up|Lost to Follow-up|3|||
48773286|NCT02896400|157014798|FG013|3 Month Follow-up|Lost to Follow-up|5|||
48773287|NCT02896400|157014799|FG014|3 Month Follow-up|Lost to Follow-up|3|||
48773288|NCT02896400|157014800|FG015|3 Month Follow-up|Lost to Follow-up|2|||
48773289|NCT02896400|157014785|FG000|3 Month Follow-up|Death|0|||
48773290|NCT02896400|157014786|FG001|3 Month Follow-up|Death|0|||
48773291|NCT02896400|157014787|FG002|3 Month Follow-up|Death|0|||
48773292|NCT02896400|157014788|FG003|3 Month Follow-up|Death|0|||
48773293|NCT02896400|157014789|FG004|3 Month Follow-up|Death|0|||
48773294|NCT02896400|157014790|FG005|3 Month Follow-up|Death|0|||
48773295|NCT02896400|157014791|FG006|3 Month Follow-up|Death|0|||
48773296|NCT02896400|157014792|FG007|3 Month Follow-up|Death|0|||
48773297|NCT02896400|157014793|FG008|3 Month Follow-up|Death|0|||
48773298|NCT02896400|157014794|FG009|3 Month Follow-up|Death|0|||
48773299|NCT02896400|157014795|FG010|3 Month Follow-up|Death|0|||
48773300|NCT02896400|157014796|FG011|3 Month Follow-up|Death|0|||
48773301|NCT02896400|157014797|FG012|3 Month Follow-up|Death|0|||
48773302|NCT02896400|157014798|FG013|3 Month Follow-up|Death|1|||
48773303|NCT02896400|157014799|FG014|3 Month Follow-up|Death|1|||
48773304|NCT02896400|157014800|FG015|3 Month Follow-up|Death|0|||
48773305|NCT02896400|157014785|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773306|NCT02896400|157014786|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773307|NCT02896400|157014787|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773308|NCT02896400|157014788|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773309|NCT02896400|157014789|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773310|NCT02896400|157014790|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773311|NCT02896400|157014791|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
48773312|NCT02896400|157014792|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
48773313|NCT02896400|157014793|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773314|NCT02896400|157014794|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773315|NCT02896400|157014795|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773316|NCT02896400|157014796|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773317|NCT02896400|157014797|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773318|NCT02896400|157014798|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
48773319|NCT02896400|157014799|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
48773320|NCT02896400|157014800|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
48773321|NCT02896400|157014785|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
48773322|NCT02896400|157014786|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
48773323|NCT02896400|157014787|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
48773324|NCT02896400|157014788|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
48773325|NCT02896400|157014789|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
48773326|NCT02896400|157014790|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
48773327|NCT02896400|157014791|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
48773328|NCT02896400|157014792|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
48773329|NCT02896400|157014793|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
48773330|NCT02896400|157014794|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
48773331|NCT02896400|157014795|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
48773332|NCT02896400|157014796|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
48773333|NCT02896400|157014797|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
48773334|NCT02896400|157014798|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
48773335|NCT02896400|157014799|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
48773336|NCT02896400|157014800|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
48773337|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Adverse Event|2|||
48773338|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Adverse Event|3|||
48773339|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Adverse Event|4|||
48773340|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Adverse Event|4|||
48773341|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
48773342|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
48773343|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
48773344|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
48773345|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
48773346|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
48773347|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
48773348|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
48395887|NCT00790907|155641690|FG002|Overall Study|Adverse Event|6|||
48395888|NCT00790907|155641688|FG000|Overall Study|Physician Decision|304|||
48395889|NCT00790907|155641689|FG001|Overall Study|Physician Decision|271|||
48395890|NCT00790907|155641690|FG002|Overall Study|Physician Decision|255|||
48773349|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
48395891|NCT00790907|155641688|FG000|Overall Study|Withdrawal by Subject|1|||
48395892|NCT00790907|155641689|FG001|Overall Study|Withdrawal by Subject|7|||
48395893|NCT00790907|155641690|FG002|Overall Study|Withdrawal by Subject|5|||
48395894|NCT00790907|155641688|FG000|Overall Study|Bleeding Event|11|||
48395895|NCT00790907|155641689|FG001|Overall Study|Bleeding Event|16|||
48395896|NCT00790907|155641690|FG002|Overall Study|Bleeding Event|21|||
48395897|NCT00790907|155641688|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
48395898|NCT00790907|155641689|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
48395899|NCT00790907|155641690|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
48395900|NCT00790907|155641688|FG000|Overall Study|Qualifying Condition Not Present|29|||
48395901|NCT00790907|155641689|FG001|Overall Study|Qualifying Condition Not Present|14|||
48773350|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
48773351|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
48773352|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
48773353|NCT00071812|157014803|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
48773354|NCT00071812|157014804|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
48773355|NCT00071812|157014805|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
48773356|NCT00071812|157014806|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
48773357|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
48773358|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
48773359|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
48773360|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
48773361|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48773362|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48773363|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48773364|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
48773365|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48773366|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48773367|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48773368|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
48773369|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48773370|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48773371|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48773372|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
48773373|NCT00071812|157014803|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48773374|NCT00071812|157014804|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48773375|NCT00071812|157014805|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
48773376|NCT00071812|157014806|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
48773377|NCT01896895|157014807|FG000|Double-blind MP|Physician Decision|0|||
48773378|NCT01896895|157014808|FG001|Double-blind MP|Physician Decision|0|||
48773379|NCT01896895|157014809|FG002|Double-blind MP|Physician Decision|1|||
48773380|NCT01896895|157014810|FG003|Double-blind MP|Physician Decision|0|||
48773381|NCT01896895|157014807|FG000|Double-blind MP|Withdrawal by Subject|0|||
48773382|NCT01896895|157014808|FG001|Double-blind MP|Withdrawal by Subject|2|||
48773383|NCT01896895|157014809|FG002|Double-blind MP|Withdrawal by Subject|1|||
48773384|NCT01896895|157014810|FG003|Double-blind MP|Withdrawal by Subject|0|||
48773385|NCT01896895|157014807|FG000|Double-blind MP|Lost to Follow-up|1|||
48773386|NCT01896895|157014808|FG001|Double-blind MP|Lost to Follow-up|0|||
48773387|NCT01896895|157014809|FG002|Double-blind MP|Lost to Follow-up|1|||
48773388|NCT01896895|157014810|FG003|Double-blind MP|Lost to Follow-up|0|||
48395902|NCT00790907|155641690|FG002|Overall Study|Qualifying Condition Not Present|16|||
48773389|NCT01589822|157014811|FG000|Overall Study|Withdrawal by Subject|1|||
48773390|NCT01589822|157014812|FG001|Overall Study|Withdrawal by Subject|2|||
48773391|NCT01589822|157014813|FG002|Overall Study|Withdrawal by Subject|0|||
48773392|NCT01589822|157014811|FG000|Overall Study|Death|1|||
48773393|NCT01589822|157014812|FG001|Overall Study|Death|0|||
48773394|NCT01589822|157014813|FG002|Overall Study|Death|0|||
48395903|NCT00790907|155641688|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
48395904|NCT00790907|155641689|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
48395905|NCT00790907|155641690|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
48773395|NCT01589822|157014811|FG000|Overall Study|Missed 90 day visit|2|||
48773396|NCT01589822|157014812|FG001|Overall Study|Missed 90 day visit|1|||
48773397|NCT01589822|157014813|FG002|Overall Study|Missed 90 day visit|1|||
48773398|NCT00596011|157014816|FG000|Overall Study|Withdrawal by Subject|2|||
48395906|NCT00790907|155641688|FG000|Overall Study|Did Not Receive Study Drug|10|||
48773399|NCT00596011|157014817|FG001|Overall Study|Withdrawal by Subject|3|||
48773400|NCT00596011|157014816|FG000|Overall Study|Adverse Event|11|||
48395907|NCT00790907|155641689|FG001|Overall Study|Did Not Receive Study Drug|0|||
48395908|NCT00790907|155641690|FG002|Overall Study|Did Not Receive Study Drug|0|||
48773401|NCT00596011|157014817|FG001|Overall Study|Adverse Event|7|||
48773402|NCT01633944|157014822|FG000|Open-label Titration Phase|Adverse Event|109|||
48773403|NCT01633944|157014823|FG001|Open-label Titration Phase|Adverse Event|0|||
48773404|NCT01633944|157014824|FG002|Open-label Titration Phase|Adverse Event|0|||
48773405|NCT01633944|157014822|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
48395909|NCT02222207|155643284|FG000|Overall Study|Death|1|||
48395910|NCT02222207|155643284|FG000|Overall Study|Other reasons|2|||
48773406|NCT01633944|157014823|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
48773407|NCT01633944|157014824|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
48773408|NCT01633944|157014822|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
48773409|NCT01633944|157014823|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
48773410|NCT01633944|157014824|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
48773411|NCT01633944|157014822|FG000|Open-label Titration Phase|Protocol Violation|24|||
48773412|NCT01633944|157014823|FG001|Open-label Titration Phase|Protocol Violation|0|||
48773413|NCT01633944|157014824|FG002|Open-label Titration Phase|Protocol Violation|0|||
48773414|NCT01633944|157014822|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
48773415|NCT01633944|157014823|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
48773416|NCT01633944|157014824|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
48773417|NCT01633944|157014822|FG000|Open-label Titration Phase|Other|68|||
48773418|NCT01633944|157014823|FG001|Open-label Titration Phase|Other|0|||
48773419|NCT01633944|157014824|FG002|Open-label Titration Phase|Other|0|||
48773420|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Adverse Event|0|||
48773421|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Adverse Event|13|||
48773422|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Adverse Event|7|||
48773423|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
48773424|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
48773425|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
48395911|NCT02222207|155643284|FG000|Overall Study|Adverse Event|1|||
48395912|NCT01982292|155643285|FG000|Overall Study|Adverse Event|2|||
48395913|NCT01982292|155643286|FG001|Overall Study|Adverse Event|0|||
48395914|NCT01982292|155643285|FG000|Overall Study|Death|1|||
48395915|NCT01982292|155643286|FG001|Overall Study|Death|0|||
48395916|NCT01982292|155643285|FG000|Overall Study|Lost to Follow-up|2|||
48395917|NCT01982292|155643286|FG001|Overall Study|Lost to Follow-up|0|||
48773426|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
48773427|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
48773428|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
48773429|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
48773430|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
48773431|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
48773432|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48773433|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
48773434|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
48773435|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
48773436|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
48773437|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
48773438|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
48773439|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
48773440|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
48773441|NCT01633944|157014822|FG000|Double-blind Treatment Phase|Other|0|||
48395918|NCT01982292|155643285|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
48395919|NCT01982292|155643286|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
48773442|NCT01633944|157014823|FG001|Double-blind Treatment Phase|Other|7|||
48773443|NCT01633944|157014824|FG002|Double-blind Treatment Phase|Other|0|||
48773444|NCT02488629|157014825|FG000|Overall Study|Lack of Efficacy|3|||
48773445|NCT02488629|157014826|FG001|Overall Study|Lack of Efficacy|1|||
48773446|NCT02488629|157014827|FG002|Overall Study|Lack of Efficacy|0|||
48773447|NCT02488629|157014828|FG003|Overall Study|Lack of Efficacy|0|||
48773448|NCT02488629|157014825|FG000|Overall Study|Withdrawal by Subject|0|||
48773449|NCT02488629|157014826|FG001|Overall Study|Withdrawal by Subject|1|||
48773450|NCT02488629|157014827|FG002|Overall Study|Withdrawal by Subject|0|||
48773451|NCT02488629|157014828|FG003|Overall Study|Withdrawal by Subject|0|||
48773452|NCT03912233|157014829|FG000|Overall Study|Adverse Event|1|||
48773453|NCT03912233|157014830|FG001|Overall Study|Adverse Event|0|||
48395920|NCT01982292|155643285|FG000|Overall Study|Protocol Deviation|1|||
48773454|NCT03912233|157014831|FG002|Overall Study|Adverse Event|0|||
48773455|NCT03912233|157014832|FG003|Overall Study|Adverse Event|0|||
48773456|NCT03912233|157014833|FG004|Overall Study|Adverse Event|0|||
48395921|NCT01982292|155643286|FG001|Overall Study|Protocol Deviation|0|||
48395922|NCT01982292|155643285|FG000|Overall Study|Patient/Guardian Decision|3|||
48773457|NCT03912233|157014834|FG005|Overall Study|Adverse Event|0|||
48773458|NCT03912233|157014829|FG000|Overall Study|Physician Decision|1|||
48773459|NCT03912233|157014830|FG001|Overall Study|Physician Decision|0|||
48773460|NCT03912233|157014831|FG002|Overall Study|Physician Decision|0|||
48773461|NCT03912233|157014832|FG003|Overall Study|Physician Decision|0|||
48773462|NCT03912233|157014833|FG004|Overall Study|Physician Decision|0|||
48773463|NCT03912233|157014834|FG005|Overall Study|Physician Decision|0|||
48773464|NCT03912233|157014829|FG000|Overall Study|Other|0|||
48773465|NCT03912233|157014830|FG001|Overall Study|Other|0|||
48395923|NCT01982292|155643286|FG001|Overall Study|Patient/Guardian Decision|1|||
48395924|NCT01982292|155643285|FG000|Overall Study|Technical Problems|2|||
48395925|NCT01982292|155643286|FG001|Overall Study|Technical Problems|0|||
48395926|NCT02187471|155643287|FG000|Overall Study|Protocol Violation|4|||
48395927|NCT02187471|155643288|FG001|Overall Study|Protocol Violation|5|||
48395928|NCT02187471|155643289|FG002|Overall Study|Protocol Violation|4|||
48395929|NCT02187471|155643290|FG003|Overall Study|Protocol Violation|4|||
48395930|NCT02187471|155643287|FG000|Overall Study|Missing|0|||
48395931|NCT02187471|155643288|FG001|Overall Study|Missing|0|||
48395932|NCT02187471|155643289|FG002|Overall Study|Missing|0|||
48395933|NCT02187471|155643290|FG003|Overall Study|Missing|1|||
48395934|NCT02187471|155643287|FG000|Overall Study|Lack of Efficacy|18|||
48773466|NCT03912233|157014831|FG002|Overall Study|Other|0|||
48773467|NCT03912233|157014832|FG003|Overall Study|Other|0|||
48773468|NCT03912233|157014833|FG004|Overall Study|Other|7|||
48773469|NCT03912233|157014834|FG005|Overall Study|Other|12|||
48773470|NCT01434823|157014835|FG000|Overall Study|Incomplete data in medical record|4|||
48773471|NCT01434823|157014836|FG001|Overall Study|Incomplete data in medical record|7|||
48773472|NCT00098839|157014839|FG000|Overall Study|Adverse Event|5|||
48773473|NCT00098839|157014840|FG001|Overall Study|Adverse Event|2|||
48395935|NCT02187471|155643288|FG001|Overall Study|Lack of Efficacy|9|||
48395936|NCT02187471|155643289|FG002|Overall Study|Lack of Efficacy|13|||
48395937|NCT02187471|155643290|FG003|Overall Study|Lack of Efficacy|11|||
48395938|NCT02187471|155643287|FG000|Overall Study|Adverse Event|24|||
48773474|NCT00098839|157014839|FG000|Overall Study|Death|1|||
48773475|NCT00098839|157014840|FG001|Overall Study|Death|2|||
48773476|NCT00098839|157014839|FG000|Overall Study|Physician Decision|4|||
48773477|NCT00098839|157014840|FG001|Overall Study|Physician Decision|14|||
48773478|NCT00098839|157014839|FG000|Overall Study|Withdrawal by Subject|1|||
48773479|NCT00098839|157014840|FG001|Overall Study|Withdrawal by Subject|0|||
48395939|NCT02187471|155643288|FG001|Overall Study|Adverse Event|34|||
48395940|NCT02187471|155643289|FG002|Overall Study|Adverse Event|44|||
48395941|NCT02187471|155643290|FG003|Overall Study|Adverse Event|36|||
48395942|NCT02187471|155643287|FG000|Overall Study|Withdrawal by Subject|23|||
48395943|NCT02187471|155643288|FG001|Overall Study|Withdrawal by Subject|29|||
48395944|NCT02187471|155643289|FG002|Overall Study|Withdrawal by Subject|22|||
48395945|NCT02187471|155643290|FG003|Overall Study|Withdrawal by Subject|24|||
48395946|NCT02187471|155643287|FG000|Overall Study|Other|7|||
48395947|NCT02187471|155643288|FG001|Overall Study|Other|5|||
48395948|NCT02187471|155643289|FG002|Overall Study|Other|3|||
48395949|NCT02187471|155643290|FG003|Overall Study|Other|4|||
48395950|NCT00522431|155643291|FG000|Overall Study|Adverse Event|5|||
48395951|NCT00522431|155643291|FG000|Overall Study|Protocol Violation|2|||
48395952|NCT00522431|155643291|FG000|Overall Study|Withdrawal by Subject|2|||
48395953|NCT00522431|155643291|FG000|Overall Study|Subject non-compliance|1|||
48395954|NCT00522431|155643291|FG000|Overall Study|Other/unknown|1|||
48395955|NCT00631371|155643292|FG000|Overall Study|Lost to Follow-up|24|||
48395956|NCT00631371|155643293|FG001|Overall Study|Lost to Follow-up|19|||
48395957|NCT00631371|155643292|FG000|Overall Study|Other reason|5|||
48395958|NCT00631371|155643293|FG001|Overall Study|Other reason|12|||
48395959|NCT00631371|155643292|FG000|Overall Study|subject request|38|||
48395960|NCT00631371|155643293|FG001|Overall Study|subject request|45|||
48395961|NCT00631371|155643292|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
48395962|NCT00631371|155643293|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
48395963|NCT00631371|155643292|FG000|Overall Study|Death|263|||
48395964|NCT00631371|155643293|FG001|Overall Study|Death|239|||
48395965|NCT00762892|155643294|FG000|Overall Study|Lost to Follow-up|2|||
48395966|NCT00762892|155643295|FG001|Overall Study|Lost to Follow-up|5|||
48395967|NCT00762892|155643294|FG000|Overall Study|Withdrawal by Subject|0|||
48395968|NCT00762892|155643295|FG001|Overall Study|Withdrawal by Subject|1|||
48773480|NCT00098839|157014839|FG000|Overall Study|Refusal of further protocol therapy|3|||
48773481|NCT00098839|157014840|FG001|Overall Study|Refusal of further protocol therapy|1|||
48773482|NCT00098839|157014839|FG000|Overall Study|Relapse|6|||
48773483|NCT00098839|157014840|FG001|Overall Study|Relapse|3|||
48773484|NCT00098839|157014839|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
48773485|NCT00098839|157014840|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
48773486|NCT00098839|157014839|FG000|Overall Study|Ineligible|2|||
48773487|NCT00098839|157014840|FG001|Overall Study|Ineligible|0|||
48773488|NCT04879745|157014842|FG000|Overall Study|Lost to Follow-up|4|||
48773489|NCT04879745|157014843|FG001|Overall Study|Lost to Follow-up|1|||
48773490|NCT02148003|157014844|FG000|Overall Study|Failed inclusion criteria|1|||
48395969|NCT00762892|155643294|FG000|Overall Study|Death|1|||
48395970|NCT00762892|155643295|FG001|Overall Study|Death|0|||
48395971|NCT00762892|155643294|FG000|Overall Study|Pregnancy|1|||
48395972|NCT00762892|155643295|FG001|Overall Study|Pregnancy|0|||
48395973|NCT00762892|155643294|FG000|Overall Study|Incarceration|1|||
48773491|NCT02148003|157014845|FG001|Overall Study|Failed inclusion criteria|0|||
48395974|NCT00762892|155643295|FG001|Overall Study|Incarceration|0|||
48395975|NCT00513409|155643299|FG000|Overall Study|Adverse Event|0|||
48395976|NCT00513409|155643300|FG001|Overall Study|Adverse Event|1|||
48395977|NCT00513409|155643299|FG000|Overall Study|Withdrawal by Subject|0|||
48395978|NCT00513409|155643300|FG001|Overall Study|Withdrawal by Subject|2|||
48395979|NCT00513409|155643299|FG000|Overall Study|Lost to Follow-up|0|||
48773492|NCT02148003|157014844|FG000|Overall Study|Met exclusion criteria|0|||
48773493|NCT02148003|157014845|FG001|Overall Study|Met exclusion criteria|1|||
48773494|NCT02148003|157014844|FG000|Overall Study|Withdrawal by Subject|0|||
48773495|NCT02148003|157014845|FG001|Overall Study|Withdrawal by Subject|1|||
48773496|NCT03192150|157014848|FG000|Overall Study|Adverse Event|14|||
48773497|NCT03192150|157014849|FG001|Overall Study|Adverse Event|12|||
48773498|NCT03192150|157014848|FG000|Overall Study|Lack of Efficacy|23|||
48773499|NCT03192150|157014849|FG001|Overall Study|Lack of Efficacy|30|||
48773500|NCT03192150|157014848|FG000|Overall Study|Lost to Follow-up|1|||
48773501|NCT03192150|157014849|FG001|Overall Study|Lost to Follow-up|1|||
48773502|NCT03192150|157014848|FG000|Overall Study|Withdrawal by Subject|4|||
48773503|NCT03192150|157014849|FG001|Overall Study|Withdrawal by Subject|2|||
48773504|NCT03192150|157014848|FG000|Overall Study|Protocol Violation|5|||
48773505|NCT03192150|157014849|FG001|Overall Study|Protocol Violation|2|||
48773506|NCT03192150|157014848|FG000|Overall Study|Surgery Canceled|6|||
48773507|NCT03192150|157014849|FG001|Overall Study|Surgery Canceled|2|||
48773508|NCT03192150|157014848|FG000|Overall Study|Other-Various Administrative Reasons|2|||
48773509|NCT03192150|157014849|FG001|Overall Study|Other-Various Administrative Reasons|5|||
48773510|NCT02178475|157014850|FG000|Overall Study|Withdrawal by Subject|7|||
48773511|NCT02178475|157014850|FG000|Overall Study|Lost to Follow-up|10|||
48773512|NCT02178475|157014850|FG000|Overall Study|Death|13|||
48773513|NCT02178475|157014850|FG000|Overall Study|Protocol-specified Criteria|99|||
48773514|NCT00779766|157014851|FG000|Month 24|Serious Adverse Event|2|||
48773515|NCT00779766|157014852|FG001|Month 24|Serious Adverse Event|3|||
48773516|NCT00779766|157014851|FG000|Month 24|Adverse Event|3|||
48773517|NCT00779766|157014852|FG001|Month 24|Adverse Event|3|||
48773518|NCT00779766|157014851|FG000|Month 24|Protocol Violation|3|||
48773519|NCT00779766|157014852|FG001|Month 24|Protocol Violation|1|||
48773520|NCT00779766|157014851|FG000|Month 24|Withdrawal by Subject|159|||
48773521|NCT00779766|157014852|FG001|Month 24|Withdrawal by Subject|127|||
48773522|NCT00779766|157014851|FG000|Month 24|Migrated/moved from study area|138|||
48773523|NCT00779766|157014852|FG001|Month 24|Migrated/moved from study area|162|||
48773524|NCT00779766|157014851|FG000|Month 24|Lost to Follow-up|9|||
48773525|NCT00779766|157014852|FG001|Month 24|Lost to Follow-up|9|||
48773526|NCT00779766|157014851|FG000|Month 24|Other|18|||
48773527|NCT00779766|157014852|FG001|Month 24|Other|27|||
48773528|NCT00779766|157014851|FG000|Month 48|Withdrawal by Subject|68|||
48773529|NCT00779766|157014852|FG001|Month 48|Withdrawal by Subject|63|||
48773530|NCT00779766|157014851|FG000|Month 48|Migrated/moved from study area|76|||
48773531|NCT00779766|157014852|FG001|Month 48|Migrated/moved from study area|75|||
48773532|NCT00779766|157014851|FG000|Month 48|Lost to Follow-up|29|||
48773533|NCT00779766|157014852|FG001|Month 48|Lost to Follow-up|30|||
48773534|NCT00779766|157014851|FG000|Month 48|Other|1|||
48773535|NCT00779766|157014852|FG001|Month 48|Other|0|||
48773536|NCT00779766|157014851|FG000|Month 72|Withdrawal by Subject|55|||
48773537|NCT00779766|157014852|FG001|Month 72|Withdrawal by Subject|71|||
48773538|NCT00779766|157014851|FG000|Month 72|Migrated/moved from study area|124|||
48773539|NCT00779766|157014852|FG001|Month 72|Migrated/moved from study area|109|||
48773540|NCT00779766|157014851|FG000|Month 72|Lost to Follow-up|6|||
48773541|NCT00779766|157014852|FG001|Month 72|Lost to Follow-up|8|||
48773542|NCT00779766|157014851|FG000|Month 72|Other|0|||
48773543|NCT00779766|157014852|FG001|Month 72|Other|1|||
48773544|NCT00617240|157014858|FG000|Overall Study|Lack of Efficacy|1|||
48773545|NCT00617240|157014859|FG001|Overall Study|Lack of Efficacy|0|||
48773546|NCT02410811|157014860|FG000|Overall Study|Withdrawal by Subject|0|||
48773547|NCT02410811|157014861|FG001|Overall Study|Withdrawal by Subject|0|||
48773548|NCT02410811|157014862|FG002|Overall Study|Withdrawal by Subject|1|||
48773549|NCT02410811|157014863|FG003|Overall Study|Withdrawal by Subject|0|||
48773550|NCT04960228|157014864|FG000|Overall Study|Withdrawal by Subject|216|||
48773551|NCT04960228|157014865|FG001|Overall Study|Withdrawal by Subject|35|||
48773552|NCT04960228|157014864|FG000|Overall Study|Failed attention check|69|||
48773553|NCT04960228|157014865|FG001|Overall Study|Failed attention check|148|||
48773554|NCT04960228|157014864|FG000|Overall Study|Flagged for response quality by Dynata|3|||
48773555|NCT04960228|157014865|FG001|Overall Study|Flagged for response quality by Dynata|3|||
48773556|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
48395980|NCT00513409|155643300|FG001|Overall Study|Lost to Follow-up|1|||
48773557|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
48773558|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
48773559|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
48773560|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
48773561|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
48773562|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
48773563|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
48773564|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
48773565|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
48395981|NCT00513409|155643299|FG000|Overall Study|Physician Decision|1|||
48395982|NCT00513409|155643300|FG001|Overall Study|Physician Decision|0|||
48395983|NCT00513409|155643299|FG000|Overall Study|Visit 3 not done|1|||
48395984|NCT00513409|155643300|FG001|Overall Study|Visit 3 not done|2|||
48395985|NCT04036708|155643301|FG000|Overall Study|Lost to Follow-up|14|||
48395986|NCT04036708|155643302|FG001|Overall Study|Lost to Follow-up|4|||
48395987|NCT04036708|155643303|FG002|Overall Study|Lost to Follow-up|14|||
48395988|NCT04036708|155643304|FG003|Overall Study|Lost to Follow-up|4|||
48395989|NCT04766021|155643305|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
48395990|NCT04766021|155643305|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
48395991|NCT01033734|155643306|FG000|Overall Study|Withdrawal by Subject|1|||
48395992|NCT03577730|155643308|FG000|Overall Study|Physician Decision|3|||
48395993|NCT03577730|155643309|FG001|Overall Study|Physician Decision|1|||
48395994|NCT03577730|155643308|FG000|Overall Study|Did not receive allocated intervention|1|||
48395995|NCT03577730|155643309|FG001|Overall Study|Did not receive allocated intervention|0|||
48395996|NCT03709654|155643310|FG000|Overall Study|Lost to Follow-up|1|||
48395997|NCT03709654|155643311|FG001|Overall Study|Lost to Follow-up|1|||
48395998|NCT03709654|155643310|FG000|Overall Study|Withdrawal by Subject|1|||
48395999|NCT03709654|155643311|FG001|Overall Study|Withdrawal by Subject|1|||
48396000|NCT03709654|155643310|FG000|Overall Study|Adverse Event|1|||
48396001|NCT03709654|155643311|FG001|Overall Study|Adverse Event|0|||
48396002|NCT00109707|155643322|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
48396003|NCT00109707|155643323|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
48396004|NCT00109707|155643324|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
48773566|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
48773567|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
48773568|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
48773569|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
48773570|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
48773571|NCT00280566|157014866|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
48773572|NCT00280566|157014867|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
48773573|NCT00280566|157014868|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
48773574|NCT00280566|157014866|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
48773575|NCT00280566|157014867|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
48773576|NCT00280566|157014868|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
48773577|NCT00280566|157014866|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
48773578|NCT00280566|157014867|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
48773579|NCT00280566|157014868|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
48773580|NCT00280566|157014866|FG000|Period 2 Double Blind|Adverse Event|0|||
48773581|NCT00280566|157014867|FG001|Period 2 Double Blind|Adverse Event|11|||
48773582|NCT00280566|157014868|FG002|Period 2 Double Blind|Adverse Event|15|||
48773583|NCT00280566|157014866|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
48773584|NCT00280566|157014867|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
48773585|NCT00280566|157014868|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
48773586|NCT00280566|157014866|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
48773587|NCT00280566|157014867|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
48773588|NCT00280566|157014868|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
48773589|NCT00280566|157014866|FG000|Period 2 Double Blind|miscellaneous|0|||
48773590|NCT00280566|157014867|FG001|Period 2 Double Blind|miscellaneous|10|||
48773591|NCT00280566|157014868|FG002|Period 2 Double Blind|miscellaneous|5|||
48773592|NCT01502644|157014869|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
48773593|NCT01502644|157014870|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
48773594|NCT01502644|157014871|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
48773595|NCT01502644|157014872|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
48773596|NCT01502644|157014869|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
48773597|NCT01502644|157014870|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
48773598|NCT01502644|157014871|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
48773599|NCT01502644|157014872|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
48773600|NCT01502644|157014869|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
48396005|NCT00109707|155643322|FG000|Overall Study|Abnormal laboratory values|1|||
48396006|NCT00109707|155643323|FG001|Overall Study|Abnormal laboratory values|0|||
48396007|NCT00109707|155643324|FG002|Overall Study|Abnormal laboratory values|0|||
48396008|NCT00109707|155643322|FG000|Overall Study|Administrative problems|2|||
48396009|NCT00109707|155643323|FG001|Overall Study|Administrative problems|0|||
48773601|NCT01502644|157014870|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
48773602|NCT01502644|157014871|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
48773603|NCT01502644|157014872|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
48773604|NCT01502644|157014869|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
48773605|NCT01502644|157014870|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
48773606|NCT01502644|157014871|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
48773607|NCT01502644|157014872|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
48773608|NCT01502644|157014869|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
48773609|NCT01502644|157014870|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
48773610|NCT01502644|157014871|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
48773611|NCT01502644|157014872|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
48773612|NCT00057746|157014875|FG000|Overall Study|Withdrawal by Subject|0|||
48773613|NCT00057746|157014876|FG001|Overall Study|Withdrawal by Subject|0|||
48773614|NCT00057746|157014877|FG002|Overall Study|Withdrawal by Subject|1|||
48773615|NCT00670228|157014880|FG000|Overall Study|Adverse Event|1|||
48773616|NCT00670228|157014881|FG001|Overall Study|Adverse Event|0|||
48773617|NCT00670228|157014880|FG000|Overall Study|Death or MACE|0|||
48773618|NCT00670228|157014881|FG001|Overall Study|Death or MACE|1|||
48773619|NCT00670228|157014880|FG000|Overall Study|Not treated|2|||
48773620|NCT00670228|157014881|FG001|Overall Study|Not treated|2|||
48773621|NCT00670228|157014880|FG000|Overall Study|Not meeting the selection criteria|2|||
48773622|NCT00670228|157014881|FG001|Overall Study|Not meeting the selection criteria|0|||
48773623|NCT01469065|157014885|FG000|Overall Study|Lack of Efficacy|0|||
48773624|NCT01469065|157014886|FG001|Overall Study|Lack of Efficacy|0|||
48773625|NCT01469065|157014887|FG002|Overall Study|Lack of Efficacy|0|||
48773626|NCT01469065|157014888|FG003|Overall Study|Lack of Efficacy|0|||
48773627|NCT01469065|157014889|FG004|Overall Study|Lack of Efficacy|1|||
48773628|NCT01469065|157014885|FG000|Overall Study|Other|0|||
48773629|NCT01469065|157014886|FG001|Overall Study|Other|1|||
48773630|NCT01469065|157014887|FG002|Overall Study|Other|0|||
48773631|NCT01469065|157014888|FG003|Overall Study|Other|0|||
48773632|NCT01469065|157014889|FG004|Overall Study|Other|0|||
48773633|NCT00785486|157014892|FG000|Midazolam Alone|Withdrawal by Subject|1|||
48773634|NCT02130765|157014895|FG000|Overall Study|Did not receive treatment|4|||
48773635|NCT02130765|157014896|FG001|Overall Study|Did not receive treatment|0|||
48773636|NCT02130765|157014897|FG002|Overall Study|Did not receive treatment|0|||
48773637|NCT02130765|157014898|FG003|Overall Study|Did not receive treatment|0|||
48773638|NCT00006184|157014899|FG000|Overall Study|Death|1|||
48773639|NCT00006184|157014900|FG001|Overall Study|Death|0|||
48773640|NCT01020019|157014913|FG000|Overall Study|Lost to Follow-up|21|||
48773641|NCT01020019|157014914|FG001|Overall Study|Lost to Follow-up|18|||
48773642|NCT01020019|157014913|FG000|Overall Study|Adverse Event|1|||
48773643|NCT01020019|157014914|FG001|Overall Study|Adverse Event|5|||
48773644|NCT01020019|157014913|FG000|Overall Study|not interested in treatment|4|||
48773645|NCT01020019|157014914|FG001|Overall Study|not interested in treatment|4|||
48773646|NCT01020019|157014913|FG000|Overall Study|moving|0|||
48773647|NCT01020019|157014914|FG001|Overall Study|moving|2|||
48773648|NCT04115358|157014915|FG000|Overall Study|exfoliation|0|||
48773649|NCT04115358|157014916|FG001|Overall Study|exfoliation|0|||
48773650|NCT04115358|157014917|FG002|Overall Study|exfoliation|1|||
48773651|NCT01440946|157014922|FG000|Overall Study|Lost to Follow-up|1|||
48396010|NCT00109707|155643324|FG002|Overall Study|Administrative problems|1|||
48396011|NCT00109707|155643322|FG000|Overall Study|Adverse Event|10|||
48396012|NCT00109707|155643323|FG001|Overall Study|Adverse Event|2|||
48396013|NCT00109707|155643324|FG002|Overall Study|Adverse Event|3|||
48396014|NCT00109707|155643322|FG000|Overall Study|Death|4|||
48396015|NCT00109707|155643323|FG001|Overall Study|Death|0|||
48396016|NCT00109707|155643324|FG002|Overall Study|Death|0|||
48396017|NCT00109707|155643322|FG000|Overall Study|Disease progression|12|||
48396018|NCT00109707|155643323|FG001|Overall Study|Disease progression|4|||
48396019|NCT00109707|155643324|FG002|Overall Study|Disease progression|3|||
48396020|NCT00109707|155643322|FG000|Overall Study|Lost to Follow-up|3|||
48396021|NCT00109707|155643323|FG001|Overall Study|Lost to Follow-up|0|||
48396022|NCT00109707|155643324|FG002|Overall Study|Lost to Follow-up|0|||
48773652|NCT01440946|157014923|FG001|Overall Study|Lost to Follow-up|1|||
48396023|NCT00109707|155643322|FG000|Overall Study|Protocol Violation|1|||
48396024|NCT00109707|155643323|FG001|Overall Study|Protocol Violation|0|||
48396025|NCT00109707|155643324|FG002|Overall Study|Protocol Violation|0|||
48773653|NCT01440946|157014922|FG000|Overall Study|Physician Decision|1|||
48773654|NCT01440946|157014923|FG001|Overall Study|Physician Decision|0|||
48773655|NCT00101101|157014928|FG000|Overall Study|never received vaccine|20|||
48773656|NCT01848990|157014933|FG000|Overall Study|Adverse Event|6|||
48773657|NCT01848990|157014934|FG001|Overall Study|Adverse Event|2|||
48773658|NCT01848990|157014935|FG002|Overall Study|Adverse Event|0|||
48773659|NCT01848990|157014933|FG000|Overall Study|Lost to Follow-up|6|||
48773660|NCT01848990|157014934|FG001|Overall Study|Lost to Follow-up|2|||
48773661|NCT01848990|157014935|FG002|Overall Study|Lost to Follow-up|2|||
48773662|NCT01848990|157014933|FG000|Overall Study|Protocol Violation|1|||
48773663|NCT01848990|157014934|FG001|Overall Study|Protocol Violation|1|||
48773664|NCT01848990|157014935|FG002|Overall Study|Protocol Violation|0|||
48773665|NCT01848990|157014933|FG000|Overall Study|Withdrawal by Subject|29|||
48773666|NCT01848990|157014934|FG001|Overall Study|Withdrawal by Subject|10|||
48773667|NCT01848990|157014935|FG002|Overall Study|Withdrawal by Subject|11|||
48773668|NCT01848990|157014933|FG000|Overall Study|Physician Decision|1|||
48773669|NCT01848990|157014934|FG001|Overall Study|Physician Decision|1|||
48773670|NCT01848990|157014935|FG002|Overall Study|Physician Decision|0|||
48396026|NCT00109707|155643322|FG000|Overall Study|Patient withdrew consent|6|||
48396027|NCT00109707|155643323|FG001|Overall Study|Patient withdrew consent|1|||
48396028|NCT00109707|155643324|FG002|Overall Study|Patient withdrew consent|0|||
48396029|NCT02199080|155643327|FG000|Overall Study|Protocol Violation|12|||
48396030|NCT02250274|155643330|FG000|Overall Study|Insufficient blood draw amount|7|||
48773671|NCT01848990|157014933|FG000|Overall Study|Non Compliance|1|||
48773672|NCT01848990|157014934|FG001|Overall Study|Non Compliance|0|||
48773673|NCT01848990|157014935|FG002|Overall Study|Non Compliance|0|||
48773674|NCT01848990|157014933|FG000|Overall Study|Death|1|||
48773675|NCT01848990|157014934|FG001|Overall Study|Death|0|||
48773676|NCT01848990|157014935|FG002|Overall Study|Death|1|||
48773677|NCT01848990|157014933|FG000|Overall Study|Other|1|||
48773678|NCT01848990|157014934|FG001|Overall Study|Other|4|||
48773679|NCT01848990|157014935|FG002|Overall Study|Other|2|||
48773680|NCT01971346|157014936|FG000|Overall Study|Protocol Violation|3|||
48773681|NCT01971346|157014936|FG000|Overall Study|Lost to Follow-up|2|||
48773682|NCT01971346|157014936|FG000|Overall Study|Withdrawal by Subject|2|||
48773683|NCT01971346|157014936|FG000|Overall Study|Physician Decision|1|||
48773684|NCT01687166|157014945|FG000|Overall Study|Attempt subject|2|||
48773685|NCT01687166|157014946|FG001|Overall Study|Attempt subject|3|||
48773686|NCT01687166|157014947|FG002|Overall Study|Attempt subject|2|||
48773687|NCT01687166|157014948|FG003|Overall Study|Attempt subject|0|||
48773688|NCT01687166|157014945|FG000|Overall Study|Did not meet eligibility criteria|4|||
48773689|NCT01687166|157014946|FG001|Overall Study|Did not meet eligibility criteria|6|||
48396031|NCT02250274|155643331|FG001|Overall Study|Insufficient blood draw amount|6|||
48773690|NCT01687166|157014947|FG002|Overall Study|Did not meet eligibility criteria|1|||
48773691|NCT01687166|157014948|FG003|Overall Study|Did not meet eligibility criteria|1|||
48773692|NCT01687166|157014945|FG000|Overall Study|Adverse Event|2|||
48773693|NCT01687166|157014946|FG001|Overall Study|Adverse Event|1|||
48773694|NCT01687166|157014947|FG002|Overall Study|Adverse Event|0|||
48773695|NCT01687166|157014948|FG003|Overall Study|Adverse Event|0|||
48773696|NCT01687166|157014945|FG000|Overall Study|Physician Decision|3|||
48773697|NCT01687166|157014946|FG001|Overall Study|Physician Decision|2|||
48773698|NCT01687166|157014947|FG002|Overall Study|Physician Decision|1|||
48773699|NCT01687166|157014948|FG003|Overall Study|Physician Decision|0|||
48773700|NCT01687166|157014945|FG000|Overall Study|Withdrawal by Subject|11|||
48773701|NCT01687166|157014946|FG001|Overall Study|Withdrawal by Subject|4|||
48773702|NCT01687166|157014947|FG002|Overall Study|Withdrawal by Subject|3|||
48773703|NCT01687166|157014948|FG003|Overall Study|Withdrawal by Subject|0|||
48773704|NCT01687166|157014945|FG000|Overall Study|Lost to Follow-up|2|||
48773705|NCT01687166|157014946|FG001|Overall Study|Lost to Follow-up|5|||
48773706|NCT01687166|157014947|FG002|Overall Study|Lost to Follow-up|1|||
48773707|NCT01687166|157014948|FG003|Overall Study|Lost to Follow-up|0|||
48773708|NCT01687166|157014945|FG000|Overall Study|Equipment/Device Availability|0|||
48773709|NCT01687166|157014946|FG001|Overall Study|Equipment/Device Availability|1|||
48773710|NCT01687166|157014947|FG002|Overall Study|Equipment/Device Availability|0|||
48773711|NCT01687166|157014948|FG003|Overall Study|Equipment/Device Availability|0|||
48773712|NCT01687166|157014945|FG000|Overall Study|Death|1|||
48773713|NCT01687166|157014946|FG001|Overall Study|Death|1|||
48773714|NCT01687166|157014947|FG002|Overall Study|Death|0|||
48773715|NCT01687166|157014948|FG003|Overall Study|Death|0|||
48773716|NCT01687166|157014945|FG000|Overall Study|Protocol Violation|1|||
48773717|NCT01687166|157014946|FG001|Overall Study|Protocol Violation|1|||
48773718|NCT01687166|157014947|FG002|Overall Study|Protocol Violation|1|||
48773719|NCT01687166|157014948|FG003|Overall Study|Protocol Violation|0|||
48773720|NCT01687166|157014945|FG000|Overall Study|Subject moved out of state|0|||
48773721|NCT01687166|157014946|FG001|Overall Study|Subject moved out of state|1|||
48773722|NCT01687166|157014947|FG002|Overall Study|Subject moved out of state|0|||
48773723|NCT01687166|157014948|FG003|Overall Study|Subject moved out of state|0|||
48773724|NCT01687166|157014945|FG000|Overall Study|Patient unable to be compliant|1|||
48773725|NCT01687166|157014946|FG001|Overall Study|Patient unable to be compliant|0|||
48773726|NCT01687166|157014947|FG002|Overall Study|Patient unable to be compliant|0|||
48773727|NCT01687166|157014948|FG003|Overall Study|Patient unable to be compliant|0|||
48773728|NCT01687166|157014945|FG000|Overall Study|Physician choice to use different device|1|||
48773729|NCT01687166|157014946|FG001|Overall Study|Physician choice to use different device|2|||
48773730|NCT01687166|157014947|FG002|Overall Study|Physician choice to use different device|4|||
48773731|NCT01687166|157014948|FG003|Overall Study|Physician choice to use different device|0|||
48773732|NCT01687166|157014945|FG000|Overall Study|Insurance|0|||
48773733|NCT01687166|157014946|FG001|Overall Study|Insurance|0|||
48773734|NCT01687166|157014947|FG002|Overall Study|Insurance|1|||
48773735|NCT01687166|157014948|FG003|Overall Study|Insurance|1|||
48773736|NCT04122443|157014949|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
48773737|NCT04122443|157014950|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
48773738|NCT04122443|157014951|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
48773739|NCT04122443|157014949|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
48773740|NCT04122443|157014950|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
48773741|NCT04122443|157014951|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
48773742|NCT01072201|157014952|FG000|Overall Study|Lost to Follow-up|0|||
48773743|NCT01072201|157014953|FG001|Overall Study|Lost to Follow-up|1|||
48773744|NCT00700011|157014954|FG000|Overall Study|Death|0|||
48773745|NCT00700011|157014955|FG001|Overall Study|Death|1|||
48773746|NCT00678561|157014956|FG000|Overall Study|Adverse Event|0|||
48773747|NCT00678561|157014957|FG001|Overall Study|Adverse Event|1|||
48773748|NCT00678561|157014958|FG002|Overall Study|Adverse Event|1|||
48773749|NCT00678561|157014959|FG003|Overall Study|Adverse Event|0|||
48773750|NCT00678561|157014960|FG004|Overall Study|Adverse Event|1|||
48773751|NCT00678561|157014961|FG005|Overall Study|Adverse Event|0|||
48773752|NCT00678561|157014962|FG006|Overall Study|Adverse Event|0|||
48773753|NCT00678561|157014963|FG007|Overall Study|Adverse Event|0|||
48773754|NCT00678561|157014956|FG000|Overall Study|Protocol Violation|0|||
48773755|NCT00678561|157014957|FG001|Overall Study|Protocol Violation|0|||
48773756|NCT00678561|157014958|FG002|Overall Study|Protocol Violation|0|||
48773757|NCT00678561|157014959|FG003|Overall Study|Protocol Violation|0|||
48773758|NCT00678561|157014960|FG004|Overall Study|Protocol Violation|1|||
48773759|NCT00678561|157014961|FG005|Overall Study|Protocol Violation|1|||
48773760|NCT00678561|157014962|FG006|Overall Study|Protocol Violation|0|||
48773761|NCT00678561|157014963|FG007|Overall Study|Protocol Violation|0|||
48773762|NCT00678561|157014956|FG000|Overall Study|Withdrawal by Subject|0|||
48773763|NCT00678561|157014957|FG001|Overall Study|Withdrawal by Subject|0|||
48773764|NCT00678561|157014958|FG002|Overall Study|Withdrawal by Subject|0|||
48773765|NCT00678561|157014959|FG003|Overall Study|Withdrawal by Subject|0|||
48773766|NCT00678561|157014960|FG004|Overall Study|Withdrawal by Subject|0|||
48773767|NCT00678561|157014961|FG005|Overall Study|Withdrawal by Subject|0|||
48773768|NCT00678561|157014962|FG006|Overall Study|Withdrawal by Subject|0|||
48773769|NCT00678561|157014963|FG007|Overall Study|Withdrawal by Subject|1|||
48773770|NCT00667342|157016648|FG000|Overall Study|Protocol Violation|1|||
48773771|NCT00667342|157016649|FG001|Overall Study|Protocol Violation|0|||
48773772|NCT00667342|157016650|FG002|Overall Study|Protocol Violation|0|||
48773773|NCT00667342|157016648|FG000|Overall Study|Withdrawal by Subject|1|||
48773774|NCT00667342|157016649|FG001|Overall Study|Withdrawal by Subject|0|||
48773775|NCT00667342|157016650|FG002|Overall Study|Withdrawal by Subject|0|||
48773776|NCT00667342|157016648|FG000|Overall Study|Physician Decision|3|||
48773777|NCT00667342|157016649|FG001|Overall Study|Physician Decision|0|||
48773778|NCT00667342|157016650|FG002|Overall Study|Physician Decision|0|||
48773779|NCT00667342|157016648|FG000|Overall Study|Relapse or tumor progression|9|||
48773780|NCT00667342|157016649|FG001|Overall Study|Relapse or tumor progression|0|||
48773781|NCT00667342|157016650|FG002|Overall Study|Relapse or tumor progression|7|||
48773782|NCT00667342|157016648|FG000|Overall Study|Adverse Event|0|||
48773783|NCT00667342|157016649|FG001|Overall Study|Adverse Event|0|||
48773784|NCT00667342|157016650|FG002|Overall Study|Adverse Event|1|||
48773785|NCT00667342|157016648|FG000|Overall Study|Ineligible|0|||
48773786|NCT00667342|157016649|FG001|Overall Study|Ineligible|0|||
48773787|NCT00667342|157016650|FG002|Overall Study|Ineligible|1|||
48773788|NCT00293384|157016651|FG000|Overall Study|Non-compliance|2|||
48773789|NCT00293384|157016651|FG000|Overall Study|Missed dosage/study drug|1|||
48773790|NCT00293384|157016651|FG000|Overall Study|Ineligible|2|||
48773791|NCT01886833|157016658|FG000|Overall Study|IgA not available from both periods|204|||
48773792|NCT01440322|157016659|FG000|Overall Study|Discomfort|2|||
48773793|NCT01440322|157016660|FG001|Overall Study|Discomfort|0|||
48773794|NCT01440322|157016659|FG000|Overall Study|Biomicroscopy|1|||
48773795|NCT01440322|157016660|FG001|Overall Study|Biomicroscopy|0|||
48773796|NCT01440322|157016659|FG000|Overall Study|Symptoms and Problems|1|||
48773797|NCT01440322|157016660|FG001|Overall Study|Symptoms and Problems|0|||
48773798|NCT01440322|157016659|FG000|Overall Study|Unacceptable Subjective Vision|1|||
48773799|NCT01440322|157016660|FG001|Overall Study|Unacceptable Subjective Vision|0|||
48773800|NCT01440322|157016659|FG000|Overall Study|Other Product Related|1|||
48773801|NCT01440322|157016660|FG001|Overall Study|Other Product Related|0|||
48773802|NCT01440322|157016659|FG000|Overall Study|Unrelated Medical Problem|0|||
48773803|NCT01440322|157016660|FG001|Overall Study|Unrelated Medical Problem|1|||
48773804|NCT01440322|157016659|FG000|Overall Study|Other Non-Product Related|1|||
48773805|NCT01440322|157016660|FG001|Overall Study|Other Non-Product Related|0|||
48773806|NCT00770120|157016668|FG000|Overall Study|Progression|31|||
48773807|NCT00770120|157016668|FG000|Overall Study|Adverse Event|11|||
48773808|NCT00770120|157016668|FG000|Overall Study|Not Protocol Specified|11|||
48773809|NCT00770120|157016668|FG000|Overall Study|Death|3|||
48773810|NCT00770120|157016668|FG000|Overall Study|Withdrawal by Subject|2|||
48773811|NCT00770120|157016668|FG000|Overall Study|Ineligible|1|||
48773812|NCT00770120|157016668|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
48773813|NCT00770120|157016668|FG000|Overall Study|Reason under Review|1|||
48773814|NCT00279708|157016669|FG000|Overall Study|Withdrawal by Subject|2|||
48773815|NCT00279708|157016670|FG001|Overall Study|Withdrawal by Subject|3|||
48773816|NCT00279708|157016669|FG000|Overall Study|Adverse Event|1|||
48773817|NCT00279708|157016670|FG001|Overall Study|Adverse Event|1|||
48773818|NCT02652624|157016671|FG000|Randomized Phase|Pregnancy|3|||
48773819|NCT02652624|157016672|FG001|Randomized Phase|Pregnancy|1|||
48773820|NCT02652624|157016671|FG000|Randomized Phase|Investigator's Discretion|0|||
48773821|NCT02652624|157016672|FG001|Randomized Phase|Investigator's Discretion|2|||
48773822|NCT02652624|157016671|FG000|Randomized Phase|Death|0|||
48773823|NCT02652624|157016672|FG001|Randomized Phase|Death|1|||
48773824|NCT02652624|157016671|FG000|Randomized Phase|Lost to Follow-up|0|||
48773825|NCT02652624|157016672|FG001|Randomized Phase|Lost to Follow-up|1|||
48773826|NCT02652624|157016671|FG000|Extension Phase|Lost to Follow-up|3|||
48773827|NCT02652624|157016672|FG001|Extension Phase|Lost to Follow-up|1|||
48773828|NCT02652624|157016671|FG000|Extension Phase|Pregnancy|1|||
48773829|NCT02652624|157016672|FG001|Extension Phase|Pregnancy|1|||
48773830|NCT02652624|157016671|FG000|Extension Phase|Adverse Event|0|||
48773831|NCT02652624|157016672|FG001|Extension Phase|Adverse Event|1|||
48773832|NCT02652624|157016671|FG000|Extension Phase|Withdrew Consent|0|||
48773833|NCT02652624|157016672|FG001|Extension Phase|Withdrew Consent|1|||
48773834|NCT00501540|157016677|FG000|Overall Study|Death|5|||
48773835|NCT03228680|157016678|FG000|Overall Study|Adverse Event|13|||
48773836|NCT03228680|157016679|FG001|Overall Study|Adverse Event|18|||
48773837|NCT03228680|157016678|FG000|Overall Study|Randomization failure|0|||
48773838|NCT03228680|157016679|FG001|Overall Study|Randomization failure|1|||
48773839|NCT03228680|157016678|FG000|Overall Study|Withdrawal by Subject|1|||
48773840|NCT03228680|157016679|FG001|Overall Study|Withdrawal by Subject|0|||
48773841|NCT03228680|157016678|FG000|Overall Study|Other|9|||
48773842|NCT03228680|157016679|FG001|Overall Study|Other|16|||
48773843|NCT01018264|157016690|FG000|Overall Study|Withdrawal by Subject|1|||
48773844|NCT01018264|157016691|FG001|Overall Study|Withdrawal by Subject|0|||
48773845|NCT01018264|157016690|FG000|Overall Study|Lost to Follow-up|0|||
48396032|NCT01277549|155643332|FG000|Overall Study|Failed to meet eligibility criteria|13|||
48396033|NCT01277549|155643333|FG001|Overall Study|Failed to meet eligibility criteria|9|||
48396034|NCT01277549|155643332|FG000|Overall Study|Withdrawal by Subject|1|||
48773846|NCT01018264|157016691|FG001|Overall Study|Lost to Follow-up|1|||
48773847|NCT00211081|157016692|FG000|Overall Study|Withdrawal by Subject|2|||
48773848|NCT00678691|157016693|FG000|Overall Study|Adverse Event|6|||
48773849|NCT00678691|157016694|FG001|Overall Study|Adverse Event|4|||
48773850|NCT03698773|157016701|FG000|Overall Study|Lost to Follow-up|2|||
48773851|NCT03698773|157016702|FG001|Overall Study|Lost to Follow-up|1|||
48773852|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
48773853|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
48773854|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
48773855|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
48773856|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
48773857|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
48773858|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
48773859|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
48773860|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
48773861|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
48773862|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
48773863|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
48773864|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
48773865|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
48773866|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
48773867|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
48773868|NCT02047110|157016703|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
48773869|NCT02047110|157016704|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
48773870|NCT02047110|157016705|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
48773871|NCT02047110|157016706|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
48773872|NCT02047110|157016703|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
48773873|NCT02047110|157016704|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
48773874|NCT02047110|157016705|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
48773875|NCT02047110|157016706|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
48773876|NCT02047110|157016703|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
48773877|NCT02047110|157016704|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
48773878|NCT02047110|157016705|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
48773879|NCT02047110|157016706|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
48773880|NCT02047110|157016703|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
48773881|NCT02047110|157016704|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
48773882|NCT02047110|157016705|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
48773883|NCT02047110|157016706|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
48773884|NCT02047110|157016703|FG000|Escape Treatment Period|Adverse Event|1|||
48773885|NCT02047110|157016704|FG001|Escape Treatment Period|Adverse Event|2|||
48773886|NCT02047110|157016705|FG002|Escape Treatment Period|Adverse Event|2|||
48773887|NCT02047110|157016706|FG003|Escape Treatment Period|Adverse Event|0|||
48773888|NCT02047110|157016703|FG000|Escape Treatment Period|Other than specified|1|||
48773889|NCT02047110|157016704|FG001|Escape Treatment Period|Other than specified|2|||
48773890|NCT02047110|157016705|FG002|Escape Treatment Period|Other than specified|0|||
48773891|NCT02047110|157016706|FG003|Escape Treatment Period|Other than specified|1|||
48773892|NCT02047110|157016703|FG000|OLE Treatment Period|Other than specified|0|||
48773893|NCT02047110|157016704|FG001|OLE Treatment Period|Other than specified|0|||
48773894|NCT02047110|157016705|FG002|OLE Treatment Period|Other than specified|1|||
48773895|NCT02047110|157016706|FG003|OLE Treatment Period|Other than specified|0|||
48773896|NCT02247349|157016707|FG000|Overall Study|Disease Progression|7|||
48773897|NCT02247349|157016708|FG001|Overall Study|Disease Progression|4|||
48773898|NCT02247349|157016709|FG002|Overall Study|Disease Progression|26|||
48773899|NCT02247349|157016710|FG003|Overall Study|Disease Progression|31|||
48773900|NCT02247349|157016711|FG004|Overall Study|Disease Progression|16|||
48773901|NCT02247349|157016712|FG005|Overall Study|Disease Progression|6|||
48773902|NCT02247349|157016707|FG000|Overall Study|Study drug toxicity|0|||
48773903|NCT02247349|157016708|FG001|Overall Study|Study drug toxicity|1|||
48773904|NCT02247349|157016709|FG002|Overall Study|Study drug toxicity|1|||
48773905|NCT02247349|157016710|FG003|Overall Study|Study drug toxicity|1|||
48773906|NCT02247349|157016711|FG004|Overall Study|Study drug toxicity|2|||
48773907|NCT02247349|157016712|FG005|Overall Study|Study drug toxicity|2|||
48773908|NCT02247349|157016707|FG000|Overall Study|Death|0|||
48773909|NCT02247349|157016708|FG001|Overall Study|Death|0|||
48773910|NCT02247349|157016709|FG002|Overall Study|Death|0|||
48773911|NCT02247349|157016710|FG003|Overall Study|Death|1|||
48773912|NCT02247349|157016711|FG004|Overall Study|Death|0|||
48773913|NCT02247349|157016712|FG005|Overall Study|Death|0|||
48773914|NCT02247349|157016707|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
48773915|NCT02247349|157016708|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
48773916|NCT02247349|157016709|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
48773917|NCT02247349|157016710|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
48773918|NCT02247349|157016711|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
48773919|NCT02247349|157016712|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
48773920|NCT02247349|157016707|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48773921|NCT02247349|157016708|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48773922|NCT02247349|157016709|FG002|Overall Study|Participant request to discontinue study treatment|1|||
48773923|NCT02247349|157016710|FG003|Overall Study|Participant request to discontinue study treatment|2|||
48773924|NCT02247349|157016711|FG004|Overall Study|Participant request to discontinue study treatment|1|||
48773925|NCT02247349|157016712|FG005|Overall Study|Participant request to discontinue study treatment|0|||
48773926|NCT02247349|157016707|FG000|Overall Study|Withdrawal by Subject|0|||
48773927|NCT02247349|157016708|FG001|Overall Study|Withdrawal by Subject|1|||
48773928|NCT02247349|157016709|FG002|Overall Study|Withdrawal by Subject|0|||
48773929|NCT02247349|157016710|FG003|Overall Study|Withdrawal by Subject|0|||
48773930|NCT02247349|157016711|FG004|Overall Study|Withdrawal by Subject|0|||
48773931|NCT02247349|157016712|FG005|Overall Study|Withdrawal by Subject|0|||
48773932|NCT02247349|157016707|FG000|Overall Study|Administrative reason by sponsor|0|||
48773933|NCT02247349|157016708|FG001|Overall Study|Administrative reason by sponsor|0|||
48773934|NCT02247349|157016709|FG002|Overall Study|Administrative reason by sponsor|0|||
48773935|NCT02247349|157016710|FG003|Overall Study|Administrative reason by sponsor|0|||
48773936|NCT02247349|157016711|FG004|Overall Study|Administrative reason by sponsor|1|||
48773937|NCT02247349|157016712|FG005|Overall Study|Administrative reason by sponsor|0|||
48773938|NCT02247349|157016707|FG000|Overall Study|Other reasons|0|||
48773939|NCT02247349|157016708|FG001|Overall Study|Other reasons|0|||
48773940|NCT02247349|157016709|FG002|Overall Study|Other reasons|1|||
48773941|NCT02247349|157016710|FG003|Overall Study|Other reasons|0|||
48773942|NCT02247349|157016711|FG004|Overall Study|Other reasons|0|||
48773943|NCT02247349|157016712|FG005|Overall Study|Other reasons|0|||
48773944|NCT02644967|157016713|FG000|Overall Study|Death|26|||
48773945|NCT02644967|157016713|FG000|Overall Study|Physician Decision|1|||
48773946|NCT02644967|157016713|FG000|Overall Study|Withdrawal by Subject|2|||
48773947|NCT02644967|157016713|FG000|Overall Study|Protocol Violation|1|||
48773948|NCT02644967|157016713|FG000|Overall Study|Progressive Disease|1|||
48773949|NCT02644967|157016713|FG000|Overall Study|Study Terminated by Sponsor|4|||
48773950|NCT00559962|157016714|FG000|Overall Study|Adverse Event|1|||
48773951|NCT00559962|157016715|FG001|Overall Study|Adverse Event|7|||
48773952|NCT00559962|157016716|FG002|Overall Study|Adverse Event|8|||
48773953|NCT00559962|157016717|FG003|Overall Study|Adverse Event|5|||
48773954|NCT00559962|157016718|FG004|Overall Study|Adverse Event|11|||
48773955|NCT00559962|157016719|FG005|Overall Study|Adverse Event|4|||
48773956|NCT00559962|157016720|FG006|Overall Study|Adverse Event|4|||
48773957|NCT00559962|157016721|FG007|Overall Study|Adverse Event|2|||
48773958|NCT00559962|157016714|FG000|Overall Study|Lost to Follow-up|0|||
48773959|NCT00559962|157016715|FG001|Overall Study|Lost to Follow-up|1|||
48773960|NCT00559962|157016716|FG002|Overall Study|Lost to Follow-up|0|||
48773961|NCT00559962|157016717|FG003|Overall Study|Lost to Follow-up|0|||
48773962|NCT00559962|157016718|FG004|Overall Study|Lost to Follow-up|0|||
48773963|NCT00559962|157016719|FG005|Overall Study|Lost to Follow-up|0|||
48773964|NCT00559962|157016720|FG006|Overall Study|Lost to Follow-up|0|||
48773965|NCT00559962|157016721|FG007|Overall Study|Lost to Follow-up|0|||
48773966|NCT00559962|157016714|FG000|Overall Study|Withdrawal by Subject|1|||
48773967|NCT00559962|157016715|FG001|Overall Study|Withdrawal by Subject|1|||
48773968|NCT00559962|157016716|FG002|Overall Study|Withdrawal by Subject|2|||
48773969|NCT00559962|157016717|FG003|Overall Study|Withdrawal by Subject|0|||
48773970|NCT00559962|157016718|FG004|Overall Study|Withdrawal by Subject|3|||
48396035|NCT01277549|155643333|FG001|Overall Study|Withdrawal by Subject|3|||
48396036|NCT01277549|155643332|FG000|Overall Study|Protocol Violation|10|||
48396037|NCT01277549|155643333|FG001|Overall Study|Protocol Violation|1|||
48396038|NCT01277549|155643332|FG000|Overall Study|Physician Decision|2|||
48396039|NCT01277549|155643333|FG001|Overall Study|Physician Decision|1|||
48396040|NCT02424253|155643334|FG000|Overall Study|Other, unspecified|1|||
48396041|NCT02424253|155643335|FG001|Overall Study|Other, unspecified|0|||
48396042|NCT02424253|155643334|FG000|Overall Study|Compliance problems|1|||
48396043|NCT02424253|155643335|FG001|Overall Study|Compliance problems|0|||
48396044|NCT02424253|155643334|FG000|Overall Study|Physician Decision|2|||
48396045|NCT02424253|155643335|FG001|Overall Study|Physician Decision|0|||
48396046|NCT02424253|155643334|FG000|Overall Study|Lack of Efficacy|0|||
48396047|NCT02424253|155643335|FG001|Overall Study|Lack of Efficacy|7|||
48396048|NCT02424253|155643334|FG000|Overall Study|Adverse Event|2|||
48773971|NCT00559962|157016719|FG005|Overall Study|Withdrawal by Subject|1|||
48773972|NCT00559962|157016720|FG006|Overall Study|Withdrawal by Subject|0|||
48773973|NCT00559962|157016721|FG007|Overall Study|Withdrawal by Subject|2|||
48773974|NCT00559962|157016714|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
48773975|NCT00559962|157016715|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
48773976|NCT00559962|157016716|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
48773977|NCT00559962|157016717|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
48773978|NCT00559962|157016718|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
48773979|NCT00559962|157016719|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
48773980|NCT00559962|157016720|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
48773981|NCT00559962|157016721|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
48773982|NCT00259857|157016723|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
48773983|NCT00259857|157016724|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
48773984|NCT00259857|157016723|FG000|24 Months Treatment|Lost to Follow-up|0|||
48773985|NCT00259857|157016724|FG001|24 Months Treatment|Lost to Follow-up|3|||
48773986|NCT03837899|157016725|FG000|Overall Study|Death|6|||
48773987|NCT03837899|157016726|FG001|Overall Study|Death|8|||
48773988|NCT03837899|157016727|FG002|Overall Study|Death|3|||
48773989|NCT03837899|157016728|FG003|Overall Study|Death|7|||
48773990|NCT03837899|157016729|FG004|Overall Study|Death|8|||
48773991|NCT03837899|157016730|FG005|Overall Study|Death|7|||
48773992|NCT03837899|157016725|FG000|Overall Study|Moved to post-trial access program|0|||
48773993|NCT03837899|157016726|FG001|Overall Study|Moved to post-trial access program|1|||
48773994|NCT03837899|157016727|FG002|Overall Study|Moved to post-trial access program|0|||
48773995|NCT03837899|157016728|FG003|Overall Study|Moved to post-trial access program|0|||
48773996|NCT03837899|157016729|FG004|Overall Study|Moved to post-trial access program|0|||
48773997|NCT03837899|157016730|FG005|Overall Study|Moved to post-trial access program|0|||
48773998|NCT03837899|157016725|FG000|Overall Study|Other|0|||
48773999|NCT03837899|157016726|FG001|Overall Study|Other|0|||
48774000|NCT03837899|157016727|FG002|Overall Study|Other|0|||
48774001|NCT03837899|157016728|FG003|Overall Study|Other|0|||
48774002|NCT03837899|157016729|FG004|Overall Study|Other|0|||
48774003|NCT03837899|157016730|FG005|Overall Study|Other|2|||
48774004|NCT03837899|157016725|FG000|Overall Study|Lost to Follow-up|0|||
48774005|NCT03837899|157016726|FG001|Overall Study|Lost to Follow-up|1|||
48774006|NCT03837899|157016727|FG002|Overall Study|Lost to Follow-up|0|||
48774007|NCT03837899|157016728|FG003|Overall Study|Lost to Follow-up|0|||
48774008|NCT03837899|157016729|FG004|Overall Study|Lost to Follow-up|0|||
48774009|NCT03837899|157016730|FG005|Overall Study|Lost to Follow-up|0|||
48774010|NCT03837899|157016725|FG000|Overall Study|Withdrawal by Subject|0|||
48774011|NCT03837899|157016726|FG001|Overall Study|Withdrawal by Subject|0|||
48774012|NCT03837899|157016727|FG002|Overall Study|Withdrawal by Subject|0|||
48774013|NCT03837899|157016728|FG003|Overall Study|Withdrawal by Subject|1|||
48774014|NCT03837899|157016729|FG004|Overall Study|Withdrawal by Subject|0|||
48774015|NCT03837899|157016730|FG005|Overall Study|Withdrawal by Subject|0|||
48774016|NCT03837899|157016725|FG000|Overall Study|Study specific discontinuation criteria|0|||
48774017|NCT03837899|157016726|FG001|Overall Study|Study specific discontinuation criteria|1|||
48774018|NCT03837899|157016727|FG002|Overall Study|Study specific discontinuation criteria|0|||
48774019|NCT03837899|157016728|FG003|Overall Study|Study specific discontinuation criteria|0|||
48774020|NCT03837899|157016729|FG004|Overall Study|Study specific discontinuation criteria|3|||
48774021|NCT03837899|157016730|FG005|Overall Study|Study specific discontinuation criteria|1|||
48774022|NCT00393939|157016731|FG000|Overall Study|Protocol Violation|1|||
48774023|NCT00393939|157016732|FG001|Overall Study|Protocol Violation|1|||
48774024|NCT00393939|157016731|FG000|Overall Study|Lost to Follow-up|2|||
48774025|NCT00393939|157016732|FG001|Overall Study|Lost to Follow-up|4|||
48774026|NCT00393939|157016731|FG000|Overall Study|Death|10|||
48774027|NCT00393939|157016732|FG001|Overall Study|Death|4|||
48774028|NCT00393939|157016731|FG000|Overall Study|Sponsor|5|||
48774029|NCT00393939|157016732|FG001|Overall Study|Sponsor|13|||
48774030|NCT00393939|157016731|FG000|Overall Study|Objective progression or relapse|239|||
48774031|NCT00393939|157016732|FG001|Overall Study|Objective progression or relapse|223|||
48774032|NCT00393939|157016731|FG000|Overall Study|Withdrawal by Subject|2|||
48774033|NCT00393939|157016732|FG001|Overall Study|Withdrawal by Subject|7|||
48774034|NCT00393939|157016731|FG000|Overall Study|Other|37|||
48774035|NCT00393939|157016732|FG001|Overall Study|Other|45|||
48774036|NCT00637195|157016733|FG000|Overall Study|Lost to Follow-up|1|||
48774037|NCT00637195|157016734|FG001|Overall Study|Lost to Follow-up|0|||
48774038|NCT00637195|157016733|FG000|Overall Study|Other|2|||
48774039|NCT00637195|157016734|FG001|Overall Study|Other|0|||
48774040|NCT00637195|157016733|FG000|Overall Study|Withdrawal by Subject|0|||
48774041|NCT00637195|157016734|FG001|Overall Study|Withdrawal by Subject|1|||
48774042|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
48774043|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
48774044|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
48774045|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
48396049|NCT02424253|155643335|FG001|Overall Study|Adverse Event|0|||
48774046|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
48774047|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
48774048|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
48774049|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
48774050|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
48774051|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
48774052|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
48774053|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
48774054|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
48774055|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
48774056|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
48774057|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
48774058|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
48774059|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
48774060|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
48774061|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
48774062|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
48774063|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
48774064|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
48774065|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
48774066|NCT04542070|157016737|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
48774067|NCT04542070|157016738|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
48396050|NCT02424253|155643334|FG000|Overall Study|Consent withdrawn by subject|4|||
48396051|NCT02424253|155643335|FG001|Overall Study|Consent withdrawn by subject|1|||
48396052|NCT02424253|155643334|FG000|Overall Study|Lost to Follow-up|1|||
48774068|NCT04542070|157016739|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
48774069|NCT04542070|157016740|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
48774070|NCT04542070|157016737|FG000|Maintenance + Extension Period|Adverse Event|10|||
48774071|NCT04542070|157016738|FG001|Maintenance + Extension Period|Adverse Event|2|||
48774072|NCT04542070|157016739|FG002|Maintenance + Extension Period|Adverse Event|0|||
48774073|NCT04542070|157016740|FG003|Maintenance + Extension Period|Adverse Event|0|||
48774074|NCT04542070|157016737|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
48774075|NCT04542070|157016738|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
48774076|NCT04542070|157016739|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
48774077|NCT04542070|157016740|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
48774078|NCT04542070|157016737|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
48774079|NCT04542070|157016738|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
48774080|NCT04542070|157016739|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
48774081|NCT04542070|157016740|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
48774082|NCT04542070|157016737|FG000|Maintenance + Extension Period|Physician Decision|1|||
48774083|NCT04542070|157016738|FG001|Maintenance + Extension Period|Physician Decision|1|||
48774084|NCT04542070|157016739|FG002|Maintenance + Extension Period|Physician Decision|0|||
48774085|NCT04542070|157016740|FG003|Maintenance + Extension Period|Physician Decision|0|||
48774086|NCT04542070|157016737|FG000|Maintenance + Extension Period|Protocol Violation|2|||
48774087|NCT04542070|157016738|FG001|Maintenance + Extension Period|Protocol Violation|5|||
48774088|NCT04542070|157016739|FG002|Maintenance + Extension Period|Protocol Violation|0|||
48774089|NCT04542070|157016740|FG003|Maintenance + Extension Period|Protocol Violation|0|||
48774090|NCT04542070|157016737|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
48774091|NCT04542070|157016738|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
48774092|NCT04542070|157016739|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
48774093|NCT04542070|157016740|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
48774094|NCT04542070|157016737|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
48774095|NCT04542070|157016738|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
48774096|NCT04542070|157016739|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
48774097|NCT04542070|157016740|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
48774098|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
48774099|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
48774100|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
48774101|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
48396053|NCT02424253|155643335|FG001|Overall Study|Lost to Follow-up|1|||
48396054|NCT00583362|155643336|FG000|Overall Study|Adverse Event|44|||
48396055|NCT00583362|155643336|FG000|Overall Study|Lack of Efficacy|22|||
48396056|NCT00583362|155643336|FG000|Overall Study|Lost to Follow-up|4|||
48396057|NCT00583362|155643336|FG000|Overall Study|Non-compliance with study drug|28|||
48396058|NCT00583362|155643336|FG000|Overall Study|Pregnancy|7|||
48396059|NCT00583362|155643336|FG000|Overall Study|Miscommunication of visit window|5|||
48396060|NCT00583362|155643336|FG000|Overall Study|Current site closed|7|||
48396061|NCT00583362|155643336|FG000|Overall Study|Subject not dosed in LBSL99|1|||
48396062|NCT00583362|155643336|FG000|Overall Study|Subject moved out of the country/state|2|||
48774102|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
48396063|NCT00583362|155643336|FG000|Overall Study|Missed visits due to staff changes|1|||
48396064|NCT00583362|155643336|FG000|Overall Study|Misunderstanding of protocol|1|||
48396065|NCT00583362|155643336|FG000|Overall Study|Behavioral problems and non-compliance|1|||
48774103|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
48774104|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
48774105|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
48774106|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
48774107|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
48774108|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
48774109|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
48774110|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
48774111|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
48774112|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
48774113|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
48396066|NCT00583362|155643336|FG000|Overall Study|Sponsor request due to missed doses|1|||
48396067|NCT00583362|155643336|FG000|Overall Study|Physician Decision|19|||
48396068|NCT00583362|155643336|FG000|Overall Study|Protocol Violation|2|||
48396069|NCT00583362|155643336|FG000|Overall Study|Withdrawal by Subject|57|||
48396070|NCT00205855|155643337|FG000|Overall Study|Only received temporary implants|16|||
48396071|NCT00205855|155643337|FG000|Overall Study|Withdrawal by Subject|5|||
48774114|NCT04542070|157016737|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
48774115|NCT04542070|157016738|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
48774116|NCT04542070|157016739|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
48774117|NCT04542070|157016740|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
48774118|NCT00550836|157016743|FG000|Overall Study|Withdrawal by Subject|3|||
48774119|NCT00550836|157016744|FG001|Overall Study|Withdrawal by Subject|9|||
48774120|NCT04085523|157016745|FG000|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774121|NCT04085523|157016746|FG001|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774122|NCT04085523|157016747|FG002|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774123|NCT04085523|157016748|FG003|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774124|NCT04085523|157016749|FG004|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
48774125|NCT04085523|157016750|FG005|Open-Label Period (Weeks 52 to 156)|Study Ongoing|57|||
48774126|NCT00715793|157016751|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
48774127|NCT00715793|157016752|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
48774128|NCT00715793|157016751|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
48774129|NCT00715793|157016752|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
48774130|NCT03194646|157016755|FG000|Overall Study|Adverse Event|24|||
48774131|NCT03194646|157016756|FG001|Overall Study|Adverse Event|25|||
48774132|NCT03194646|157016757|FG002|Overall Study|Adverse Event|14|||
48774133|NCT03194646|157016758|FG003|Overall Study|Adverse Event|17|||
48774134|NCT03194646|157016755|FG000|Overall Study|Lack of Efficacy|4|||
48774135|NCT03194646|157016756|FG001|Overall Study|Lack of Efficacy|2|||
48774136|NCT03194646|157016757|FG002|Overall Study|Lack of Efficacy|2|||
48774137|NCT03194646|157016758|FG003|Overall Study|Lack of Efficacy|12|||
48774138|NCT03194646|157016755|FG000|Overall Study|Lost to Follow-up|30|||
48774139|NCT03194646|157016756|FG001|Overall Study|Lost to Follow-up|22|||
48774140|NCT03194646|157016757|FG002|Overall Study|Lost to Follow-up|12|||
48774141|NCT03194646|157016758|FG003|Overall Study|Lost to Follow-up|35|||
48774142|NCT03194646|157016755|FG000|Overall Study|Non-compliance with study drug|4|||
48774143|NCT03194646|157016756|FG001|Overall Study|Non-compliance with study drug|0|||
48774144|NCT03194646|157016757|FG002|Overall Study|Non-compliance with study drug|1|||
48774145|NCT03194646|157016758|FG003|Overall Study|Non-compliance with study drug|1|||
48774146|NCT03194646|157016755|FG000|Overall Study|Other|89|||
48774147|NCT03194646|157016756|FG001|Overall Study|Other|68|||
48774148|NCT03194646|157016757|FG002|Overall Study|Other|34|||
48774149|NCT03194646|157016758|FG003|Overall Study|Other|31|||
48774150|NCT03194646|157016755|FG000|Overall Study|Physician Decision|7|||
48774151|NCT03194646|157016756|FG001|Overall Study|Physician Decision|9|||
48774152|NCT03194646|157016757|FG002|Overall Study|Physician Decision|5|||
48774153|NCT03194646|157016758|FG003|Overall Study|Physician Decision|4|||
48396072|NCT01318109|155643338|FG000|Overall Study|Adverse Event|0|||
48396073|NCT01318109|155643339|FG001|Overall Study|Adverse Event|2|||
48396074|NCT01318109|155643340|FG002|Overall Study|Adverse Event|0|||
48396075|NCT01318109|155643338|FG000|Overall Study|Withdrawal by Subject|1|||
48396076|NCT01318109|155643339|FG001|Overall Study|Withdrawal by Subject|0|||
48396077|NCT01318109|155643340|FG002|Overall Study|Withdrawal by Subject|0|||
48396078|NCT01318109|155643338|FG000|Overall Study|Schedule Conflict|0|||
48396079|NCT01318109|155643339|FG001|Overall Study|Schedule Conflict|1|||
48396080|NCT01318109|155643340|FG002|Overall Study|Schedule Conflict|0|||
48396081|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
48774154|NCT03194646|157016755|FG000|Overall Study|Pregnancy|4|||
48396082|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
48396083|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
48396084|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
48396085|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
48396086|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
48774155|NCT03194646|157016756|FG001|Overall Study|Pregnancy|5|||
48774156|NCT03194646|157016757|FG002|Overall Study|Pregnancy|1|||
48774157|NCT03194646|157016758|FG003|Overall Study|Pregnancy|2|||
48774158|NCT03194646|157016755|FG000|Overall Study|Protocol Violation|4|||
48774159|NCT03194646|157016756|FG001|Overall Study|Protocol Violation|2|||
48774160|NCT03194646|157016757|FG002|Overall Study|Protocol Violation|1|||
48774161|NCT03194646|157016758|FG003|Overall Study|Protocol Violation|1|||
48774162|NCT03194646|157016755|FG000|Overall Study|Site terminated by sponsor|0|||
48774163|NCT03194646|157016756|FG001|Overall Study|Site terminated by sponsor|0|||
48774164|NCT03194646|157016757|FG002|Overall Study|Site terminated by sponsor|2|||
48774165|NCT03194646|157016758|FG003|Overall Study|Site terminated by sponsor|0|||
48774166|NCT03194646|157016755|FG000|Overall Study|Study terminated by sponsor|62|||
48774167|NCT03194646|157016756|FG001|Overall Study|Study terminated by sponsor|61|||
48774168|NCT03194646|157016757|FG002|Overall Study|Study terminated by sponsor|30|||
48774169|NCT03194646|157016758|FG003|Overall Study|Study terminated by sponsor|34|||
48774170|NCT03194646|157016755|FG000|Overall Study|Withdrawal by Subject|75|||
48774171|NCT03194646|157016756|FG001|Overall Study|Withdrawal by Subject|74|||
48774172|NCT03194646|157016757|FG002|Overall Study|Withdrawal by Subject|36|||
48774173|NCT03194646|157016758|FG003|Overall Study|Withdrawal by Subject|131|||
48774174|NCT03194646|157016755|FG000|Overall Study|Missing|1|||
48774175|NCT03194646|157016756|FG001|Overall Study|Missing|0|||
48774176|NCT03194646|157016757|FG002|Overall Study|Missing|1|||
48774177|NCT03194646|157016758|FG003|Overall Study|Missing|12|||
48774178|NCT03417141|157016761|FG000|Overall Study|Withdrawal by Subject|1|||
48774179|NCT03417141|157016761|FG000|Overall Study|Protocol Violation|3|||
48774180|NCT01712984|157016769|FG000|Overall Study|Adverse Event|0|||
48774181|NCT01712984|157016770|FG001|Overall Study|Adverse Event|0|||
48774182|NCT01712984|157016771|FG002|Overall Study|Adverse Event|1|||
48774183|NCT01712984|157016769|FG000|Overall Study|Protocol Violation|2|||
48774184|NCT01712984|157016770|FG001|Overall Study|Protocol Violation|0|||
48774185|NCT01712984|157016771|FG002|Overall Study|Protocol Violation|1|||
48774186|NCT01712984|157016769|FG000|Overall Study|Lost to Follow-up|8|||
48774187|NCT01712984|157016770|FG001|Overall Study|Lost to Follow-up|10|||
48774188|NCT01712984|157016771|FG002|Overall Study|Lost to Follow-up|1|||
48774189|NCT01712984|157016769|FG000|Overall Study|Withdrawal by Subject|6|||
48774190|NCT01712984|157016770|FG001|Overall Study|Withdrawal by Subject|6|||
48774191|NCT01712984|157016771|FG002|Overall Study|Withdrawal by Subject|7|||
48774192|NCT01800903|157016772|FG000|Second Test Period|unable to catheterise|1|||
48774193|NCT01800903|157016773|FG001|Second Test Period|unable to catheterise|0|||
48774194|NCT01800903|157016774|FG002|Second Test Period|unable to catheterise|0|||
48396087|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
48396088|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
48774195|NCT01800903|157016775|FG003|Second Test Period|unable to catheterise|0|||
48774196|NCT01800903|157016776|FG004|Second Test Period|unable to catheterise|0|||
48774197|NCT01800903|157016777|FG005|Second Test Period|unable to catheterise|0|||
48774198|NCT01328002|157016781|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
48774199|NCT01328002|157016782|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
48774200|NCT01328002|157016781|FG000|Open-Label Period|Adverse Event|8|||
48774201|NCT01328002|157016782|FG001|Open-Label Period|Adverse Event|0|||
48774202|NCT01328002|157016781|FG000|Open-Label Period|Lack of Efficacy|3|||
48774203|NCT01328002|157016782|FG001|Open-Label Period|Lack of Efficacy|0|||
48774204|NCT01328002|157016781|FG000|Open-Label Period|Protocol Violation|2|||
48774205|NCT01328002|157016782|FG001|Open-Label Period|Protocol Violation|0|||
48774206|NCT01328002|157016781|FG000|Open-Label Period|Withdrawal by Subject|9|||
48774207|NCT01328002|157016782|FG001|Open-Label Period|Withdrawal by Subject|0|||
48774208|NCT01328002|157016781|FG000|Open-Label Period|Lost to Follow-up|6|||
48774209|NCT01328002|157016782|FG001|Open-Label Period|Lost to Follow-up|0|||
48774210|NCT01328002|157016781|FG000|Open-Label Period|Other Reason|2|||
48774211|NCT01328002|157016782|FG001|Open-Label Period|Other Reason|0|||
48774212|NCT01328002|157016781|FG000|Double-Blind Period|Adverse Event|1|||
48774213|NCT01328002|157016782|FG001|Double-Blind Period|Adverse Event|0|||
48774214|NCT01328002|157016781|FG000|Double-Blind Period|Lack of Efficacy|1|||
48774215|NCT01328002|157016782|FG001|Double-Blind Period|Lack of Efficacy|0|||
48774216|NCT01208233|157016786|FG000|Overall Study|Adverse Event|0|||
48774217|NCT01208233|157016787|FG001|Overall Study|Adverse Event|1|||
48774218|NCT01208233|157016788|FG002|Overall Study|Adverse Event|2|||
48774219|NCT01208233|157016789|FG003|Overall Study|Adverse Event|0|||
48774220|NCT01208233|157016790|FG004|Overall Study|Adverse Event|3|||
48774221|NCT01208233|157016791|FG005|Overall Study|Adverse Event|5|||
48774222|NCT01208233|157016786|FG000|Overall Study|Death|0|||
48774223|NCT01208233|157016787|FG001|Overall Study|Death|0|||
48774224|NCT01208233|157016788|FG002|Overall Study|Death|0|||
48774225|NCT01208233|157016789|FG003|Overall Study|Death|0|||
48774226|NCT01208233|157016790|FG004|Overall Study|Death|3|||
48774227|NCT01208233|157016791|FG005|Overall Study|Death|5|||
48774228|NCT01208233|157016786|FG000|Overall Study|Did not meet entrance criteria|2|||
48396089|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
48774229|NCT01208233|157016787|FG001|Overall Study|Did not meet entrance criteria|1|||
48396090|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
48396091|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
48396092|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
48396093|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
48396094|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
48396095|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
48396096|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
48396097|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
48396098|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
48396099|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
48396100|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
48396101|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
48396102|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
48396103|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
48396104|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
48396105|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
48396106|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
48396107|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
48396108|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
48396109|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
48396110|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
48396111|NCT00784654|155643349|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
48396112|NCT00784654|155643350|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
48774230|NCT01208233|157016788|FG002|Overall Study|Did not meet entrance criteria|1|||
48774231|NCT01208233|157016789|FG003|Overall Study|Did not meet entrance criteria|0|||
48774232|NCT01208233|157016790|FG004|Overall Study|Did not meet entrance criteria|1|||
48774233|NCT01208233|157016791|FG005|Overall Study|Did not meet entrance criteria|0|||
48774234|NCT01208233|157016786|FG000|Overall Study|Medication error without adverse event|0|||
48774235|NCT01208233|157016787|FG001|Overall Study|Medication error without adverse event|0|||
48774236|NCT01208233|157016788|FG002|Overall Study|Medication error without adverse event|0|||
48774237|NCT01208233|157016789|FG003|Overall Study|Medication error without adverse event|0|||
48774238|NCT01208233|157016790|FG004|Overall Study|Medication error without adverse event|0|||
48774239|NCT01208233|157016791|FG005|Overall Study|Medication error without adverse event|1|||
48774240|NCT01208233|157016786|FG000|Overall Study|Study terminated by sponsor|0|||
48774241|NCT01208233|157016787|FG001|Overall Study|Study terminated by sponsor|0|||
48774242|NCT01208233|157016788|FG002|Overall Study|Study terminated by sponsor|0|||
48774243|NCT01208233|157016789|FG003|Overall Study|Study terminated by sponsor|0|||
48774244|NCT01208233|157016790|FG004|Overall Study|Study terminated by sponsor|10|||
48774245|NCT01208233|157016791|FG005|Overall Study|Study terminated by sponsor|7|||
48774246|NCT01208233|157016786|FG000|Overall Study|Protocol Violation|0|||
48774247|NCT01208233|157016787|FG001|Overall Study|Protocol Violation|0|||
48774248|NCT01208233|157016788|FG002|Overall Study|Protocol Violation|0|||
48774249|NCT01208233|157016789|FG003|Overall Study|Protocol Violation|0|||
48774250|NCT01208233|157016790|FG004|Overall Study|Protocol Violation|3|||
48774251|NCT01208233|157016791|FG005|Overall Study|Protocol Violation|0|||
48774252|NCT01208233|157016786|FG000|Overall Study|Other|2|||
48774253|NCT01208233|157016787|FG001|Overall Study|Other|1|||
48774254|NCT01208233|157016788|FG002|Overall Study|Other|0|||
48774255|NCT01208233|157016789|FG003|Overall Study|Other|0|||
48774256|NCT01208233|157016790|FG004|Overall Study|Other|0|||
48774257|NCT01208233|157016791|FG005|Overall Study|Other|1|||
48774258|NCT01208233|157016786|FG000|Overall Study|Withdrawal by Subject|1|||
48774259|NCT01208233|157016787|FG001|Overall Study|Withdrawal by Subject|0|||
48774260|NCT01208233|157016788|FG002|Overall Study|Withdrawal by Subject|1|||
48774261|NCT01208233|157016789|FG003|Overall Study|Withdrawal by Subject|1|||
48774262|NCT01208233|157016790|FG004|Overall Study|Withdrawal by Subject|4|||
48774263|NCT01208233|157016791|FG005|Overall Study|Withdrawal by Subject|2|||
48774264|NCT01110239|157016794|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
48774265|NCT01110239|157016795|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
48774266|NCT01110239|157016796|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
48396113|NCT00784654|155643351|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
48396114|NCT00784654|155643349|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
48774267|NCT01110239|157016797|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
48774268|NCT01110239|157016794|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
48774269|NCT01110239|157016795|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
48774270|NCT01110239|157016796|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
48774271|NCT01110239|157016797|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
48774272|NCT03135522|157016798|FG000|Overall Study|Adverse Event|1|||
48774273|NCT03135522|157016799|FG001|Overall Study|Adverse Event|0|||
48774274|NCT00459134|157016801|FG000|Overall Study|Physician Decision|1|||
48774275|NCT00459134|157016802|FG001|Overall Study|Physician Decision|1|||
48774276|NCT00459134|157016801|FG000|Overall Study|Withdrawal by Subject|8|||
48774277|NCT00459134|157016802|FG001|Overall Study|Withdrawal by Subject|7|||
48774278|NCT00459134|157016801|FG000|Overall Study|Lost to Follow-up|6|||
48774279|NCT00459134|157016802|FG001|Overall Study|Lost to Follow-up|7|||
48774280|NCT00459134|157016801|FG000|Overall Study|Surgery|1|||
48774281|NCT00459134|157016802|FG001|Overall Study|Surgery|2|||
48774282|NCT00459134|157016801|FG000|Overall Study|Toxicity|4|||
48774283|NCT00459134|157016802|FG001|Overall Study|Toxicity|5|||
48774284|NCT00459134|157016801|FG000|Overall Study|Progression|1|||
48774285|NCT00459134|157016802|FG001|Overall Study|Progression|0|||
48774286|NCT00459134|157016801|FG000|Overall Study|Multiple Reasons|2|||
48774287|NCT00459134|157016802|FG001|Overall Study|Multiple Reasons|3|||
48774288|NCT01332149|157018705|FG000|Overall Study|Adverse Event|11|||
48774289|NCT01332149|157018706|FG001|Overall Study|Adverse Event|9|||
48774290|NCT01332149|157018705|FG000|Overall Study|Other unspecified|5|||
48774291|NCT01332149|157018706|FG001|Overall Study|Other unspecified|7|||
48774292|NCT01332149|157018705|FG000|Overall Study|Protocol Violation|1|||
48774293|NCT01332149|157018706|FG001|Overall Study|Protocol Violation|3|||
48774294|NCT01332149|157018705|FG000|Overall Study|Withdrawal by Subject|4|||
48774295|NCT01332149|157018706|FG001|Overall Study|Withdrawal by Subject|5|||
48774296|NCT01332149|157018705|FG000|Overall Study|Lost to Follow-up|1|||
48774297|NCT01332149|157018706|FG001|Overall Study|Lost to Follow-up|1|||
48774298|NCT01332149|157018705|FG000|Overall Study|Insufficient clinical response|4|||
48774299|NCT01332149|157018706|FG001|Overall Study|Insufficient clinical response|7|||
48774300|NCT01332149|157018705|FG000|Overall Study|Did not meet entrance criteria|3|||
48774301|NCT01332149|157018706|FG001|Overall Study|Did not meet entrance criteria|4|||
48774302|NCT01332149|157018705|FG000|Overall Study|Randomized but not treated|1|||
48774303|NCT01332149|157018706|FG001|Overall Study|Randomized but not treated|2|||
48774304|NCT00192075|157018711|FG000|Overall Study|Disease Progression|23|||
48774305|NCT00192075|157018712|FG001|Overall Study|Disease Progression|6|||
48774306|NCT00192075|157018711|FG000|Overall Study|Adverse Event|1|||
48774307|NCT00192075|157018712|FG001|Overall Study|Adverse Event|3|||
48774308|NCT00192075|157018711|FG000|Overall Study|Death|0|||
48774309|NCT00192075|157018712|FG001|Overall Study|Death|1|||
48774310|NCT00192075|157018711|FG000|Overall Study|Lack of Efficacy|0|||
48774311|NCT00192075|157018712|FG001|Overall Study|Lack of Efficacy|0|||
48774312|NCT00192075|157018711|FG000|Overall Study|Physician Decision|3|||
48774313|NCT00192075|157018712|FG001|Overall Study|Physician Decision|0|||
48774314|NCT00192075|157018711|FG000|Overall Study|Withdrawal by Subject|5|||
48774315|NCT00192075|157018712|FG001|Overall Study|Withdrawal by Subject|5|||
48774316|NCT00192075|157018711|FG000|Overall Study|Patient Non-Compliance|0|||
48774317|NCT00192075|157018712|FG001|Overall Study|Patient Non-Compliance|1|||
48774318|NCT00192075|157018711|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
48774319|NCT00192075|157018712|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
48774320|NCT00192075|157018711|FG000|Overall Study|Other|5|||
48774321|NCT00192075|157018712|FG001|Overall Study|Other|2|||
48774322|NCT02331446|157018715|FG000|Overall Study|Lost to Follow-up|2|||
48774323|NCT02331446|157018716|FG001|Overall Study|Lost to Follow-up|1|||
48774324|NCT02331446|157018717|FG002|Overall Study|Lost to Follow-up|0|||
48774325|NCT02331446|157018718|FG003|Overall Study|Lost to Follow-up|1|||
48774326|NCT02331446|157018715|FG000|Overall Study|Personal Problem|2|||
48774327|NCT02331446|157018716|FG001|Overall Study|Personal Problem|0|||
48774328|NCT02331446|157018717|FG002|Overall Study|Personal Problem|0|||
48774329|NCT02331446|157018718|FG003|Overall Study|Personal Problem|0|||
48774330|NCT02331446|157018715|FG000|Overall Study|Disease|0|||
48774331|NCT02331446|157018716|FG001|Overall Study|Disease|2|||
48774332|NCT02331446|157018717|FG002|Overall Study|Disease|2|||
48774333|NCT02331446|157018718|FG003|Overall Study|Disease|1|||
48774334|NCT02331446|157018715|FG000|Overall Study|Physician Decision|0|||
48774335|NCT02331446|157018716|FG001|Overall Study|Physician Decision|1|||
48774336|NCT02331446|157018717|FG002|Overall Study|Physician Decision|0|||
48774337|NCT02331446|157018718|FG003|Overall Study|Physician Decision|1|||
48774338|NCT02331446|157018715|FG000|Overall Study|Lost before baseline analysis|0|||
48774339|NCT02331446|157018716|FG001|Overall Study|Lost before baseline analysis|1|||
48774340|NCT02331446|157018717|FG002|Overall Study|Lost before baseline analysis|1|||
48774341|NCT02331446|157018718|FG003|Overall Study|Lost before baseline analysis|0|||
48774342|NCT01863446|157018722|FG000|Overall Study|Withdrawal by Subject|1|||
48774343|NCT01863446|157018723|FG001|Overall Study|Withdrawal by Subject|0|||
48774344|NCT01863446|157018724|FG002|Overall Study|Withdrawal by Subject|1|||
48774345|NCT01863446|157018725|FG003|Overall Study|Withdrawal by Subject|2|||
48774346|NCT01863446|157018722|FG000|Overall Study|Physician Decision|0|||
48774347|NCT01863446|157018723|FG001|Overall Study|Physician Decision|0|||
48774348|NCT01863446|157018724|FG002|Overall Study|Physician Decision|1|||
48774349|NCT01863446|157018725|FG003|Overall Study|Physician Decision|0|||
48774350|NCT00529386|157018728|FG000|Overall Study|Lost to Follow-up|1|||
48774351|NCT03592641|157018729|FG000|Overall Study|Withdrawal by Subject|1|||
48774352|NCT04086472|157018730|FG000|Overall Study|Lost to Follow-up|1|||
48774353|NCT04086472|157018731|FG001|Overall Study|Lost to Follow-up|0|||
48774354|NCT04086472|157018732|FG002|Overall Study|Lost to Follow-up|0|||
48774355|NCT04086472|157018733|FG003|Overall Study|Lost to Follow-up|0|||
48774356|NCT04086472|157018734|FG004|Overall Study|Lost to Follow-up|1|||
48774357|NCT04086472|157018730|FG000|Overall Study|Physician Decision|0|||
48774358|NCT04086472|157018731|FG001|Overall Study|Physician Decision|1|||
48774359|NCT04086472|157018732|FG002|Overall Study|Physician Decision|1|||
48774360|NCT04086472|157018733|FG003|Overall Study|Physician Decision|0|||
48774361|NCT04086472|157018734|FG004|Overall Study|Physician Decision|0|||
48774362|NCT04086472|157018730|FG000|Overall Study|Withdrawal by Subject|1|||
48774363|NCT04086472|157018731|FG001|Overall Study|Withdrawal by Subject|1|||
48774364|NCT04086472|157018732|FG002|Overall Study|Withdrawal by Subject|1|||
48774365|NCT04086472|157018733|FG003|Overall Study|Withdrawal by Subject|0|||
48774366|NCT04086472|157018734|FG004|Overall Study|Withdrawal by Subject|0|||
48774367|NCT04086472|157018730|FG000|Overall Study|Various reasons|2|||
48774368|NCT04086472|157018731|FG001|Overall Study|Various reasons|0|||
48396115|NCT00784654|155643350|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
48396116|NCT00784654|155643351|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
48396117|NCT00784654|155643349|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
48396118|NCT00784654|155643350|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
48396119|NCT00784654|155643351|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
48396120|NCT00784654|155643349|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48396121|NCT00784654|155643350|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
48396122|NCT00784654|155643351|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
48396123|NCT00784654|155643349|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
48396124|NCT00784654|155643350|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
48396125|NCT00784654|155643351|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
48396126|NCT00784654|155643349|FG000|Randomized Withdrawal Period|Adverse Event|0|||
48396127|NCT00784654|155643350|FG001|Randomized Withdrawal Period|Adverse Event|1|||
48396128|NCT00784654|155643351|FG002|Randomized Withdrawal Period|Adverse Event|1|||
48396129|NCT00784654|155643349|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
48396130|NCT00784654|155643350|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
48396131|NCT00784654|155643351|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
48396132|NCT00784654|155643349|FG000|Randomized Withdrawal Period|Family reasons|0|||
48396133|NCT00784654|155643350|FG001|Randomized Withdrawal Period|Family reasons|0|||
48396134|NCT00784654|155643351|FG002|Randomized Withdrawal Period|Family reasons|1|||
48396135|NCT01079182|155643352|FG000|Overall Study|Lost to Follow-up|1634|||
48396136|NCT01079182|155643352|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
48396137|NCT01079182|155643352|FG000|Overall Study|Lack of Efficacy|514|||
48396138|NCT01079182|155643352|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
48396139|NCT01079182|155643352|FG000|Overall Study|Reasons not Evaluated|271|||
48396140|NCT01026831|155643353|FG000|Overall Study|Adverse Event|4|||
48774369|NCT04086472|157018732|FG002|Overall Study|Various reasons|0|||
48774370|NCT04086472|157018733|FG003|Overall Study|Various reasons|3|||
48774371|NCT04086472|157018734|FG004|Overall Study|Various reasons|1|||
48774372|NCT03100825|157018735|FG000|Overall Study|Participant/Guardian Decision|7|||
48774373|NCT03100825|157018735|FG000|Overall Study|Physician Decision|1|||
48774374|NCT00436280|157018736|FG000|Period 1: Induction|Adverse Event|8|||
48774375|NCT00436280|157018736|FG000|Period 1: Induction|Progressive Disease|12|||
48774376|NCT00436280|157018736|FG000|Period 1: Induction|Stable Disease|6|||
48774377|NCT00436280|157018736|FG000|Period 1: Induction|Withdrawal by Subject|1|||
48774378|NCT00436280|157018736|FG000|Period 1: Induction|Death|1|||
48774379|NCT00436280|157018736|FG000|Period 2: Consolidation|Adverse Event|1|||
48774380|NCT00436280|157018736|FG000|Period 2: Consolidation|Progressive Disease|10|||
48774381|NCT00436280|157018736|FG000|Period 2: Consolidation|Stable Disease|1|||
48774382|NCT00436280|157018736|FG000|Period 2: Consolidation|Physician Decision|2|||
48774383|NCT00436280|157018736|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
48774384|NCT00436280|157018736|FG000|Period 2: Consolidation|Death|1|||
48774385|NCT00436280|157018736|FG000|Period 3: Maintenance|Adverse Event|6|||
48774386|NCT00436280|157018736|FG000|Period 3: Maintenance|Progressive Disease|12|||
48774387|NCT02103478|157018739|FG000|Overall Study|Adverse Event|0|||
48774388|NCT02103478|157018740|FG001|Overall Study|Adverse Event|0|||
48774389|NCT02103478|157018741|FG002|Overall Study|Adverse Event|1|||
48774390|NCT02103478|157018742|FG003|Overall Study|Adverse Event|1|||
48396141|NCT01026831|155643354|FG001|Overall Study|Adverse Event|3|||
48396142|NCT01026831|155643353|FG000|Overall Study|Lost to Follow-up|2|||
48396143|NCT01026831|155643354|FG001|Overall Study|Lost to Follow-up|0|||
48774391|NCT02103478|157018743|FG004|Overall Study|Adverse Event|2|||
48774392|NCT02103478|157018744|FG005|Overall Study|Adverse Event|1|||
48774393|NCT02103478|157018745|FG006|Overall Study|Adverse Event|0|||
48774394|NCT02103478|157018746|FG007|Overall Study|Adverse Event|0|||
48774395|NCT02103478|157018747|FG008|Overall Study|Adverse Event|0|||
48774396|NCT02103478|157018739|FG000|Overall Study|Death|2|||
48774397|NCT02103478|157018740|FG001|Overall Study|Death|2|||
48774398|NCT02103478|157018741|FG002|Overall Study|Death|1|||
48774399|NCT02103478|157018742|FG003|Overall Study|Death|1|||
48774400|NCT02103478|157018743|FG004|Overall Study|Death|5|||
48774401|NCT02103478|157018744|FG005|Overall Study|Death|15|||
48774402|NCT02103478|157018745|FG006|Overall Study|Death|14|||
48774403|NCT02103478|157018746|FG007|Overall Study|Death|10|||
48774404|NCT02103478|157018747|FG008|Overall Study|Death|11|||
48774405|NCT02103478|157018739|FG000|Overall Study|Progressive Disease|2|||
48774406|NCT02103478|157018740|FG001|Overall Study|Progressive Disease|1|||
48774407|NCT02103478|157018741|FG002|Overall Study|Progressive Disease|2|||
48774408|NCT02103478|157018742|FG003|Overall Study|Progressive Disease|0|||
48774409|NCT02103478|157018743|FG004|Overall Study|Progressive Disease|9|||
48774410|NCT02103478|157018744|FG005|Overall Study|Progressive Disease|1|||
48774411|NCT02103478|157018745|FG006|Overall Study|Progressive Disease|2|||
48774412|NCT02103478|157018746|FG007|Overall Study|Progressive Disease|0|||
48774413|NCT02103478|157018747|FG008|Overall Study|Progressive Disease|1|||
48774414|NCT02103478|157018739|FG000|Overall Study|Withdrawal by Subject|2|||
48774415|NCT02103478|157018740|FG001|Overall Study|Withdrawal by Subject|0|||
48774416|NCT02103478|157018741|FG002|Overall Study|Withdrawal by Subject|0|||
48774417|NCT02103478|157018742|FG003|Overall Study|Withdrawal by Subject|4|||
48396144|NCT01026831|155643353|FG000|Overall Study|Physician Decision|1|||
48774418|NCT02103478|157018743|FG004|Overall Study|Withdrawal by Subject|0|||
48774419|NCT02103478|157018744|FG005|Overall Study|Withdrawal by Subject|0|||
48774420|NCT02103478|157018745|FG006|Overall Study|Withdrawal by Subject|1|||
48774421|NCT02103478|157018746|FG007|Overall Study|Withdrawal by Subject|1|||
48774422|NCT02103478|157018747|FG008|Overall Study|Withdrawal by Subject|0|||
48774423|NCT02103478|157018739|FG000|Overall Study|Lost to Follow-up|0|||
48774424|NCT02103478|157018740|FG001|Overall Study|Lost to Follow-up|0|||
48774425|NCT02103478|157018741|FG002|Overall Study|Lost to Follow-up|0|||
48774426|NCT02103478|157018742|FG003|Overall Study|Lost to Follow-up|0|||
48774427|NCT02103478|157018743|FG004|Overall Study|Lost to Follow-up|0|||
48774428|NCT02103478|157018744|FG005|Overall Study|Lost to Follow-up|0|||
48774429|NCT02103478|157018745|FG006|Overall Study|Lost to Follow-up|0|||
48774430|NCT02103478|157018746|FG007|Overall Study|Lost to Follow-up|1|||
48774431|NCT02103478|157018747|FG008|Overall Study|Lost to Follow-up|0|||
48774432|NCT02103478|157018739|FG000|Overall Study|Other|1|||
48774433|NCT02103478|157018740|FG001|Overall Study|Other|3|||
48774434|NCT02103478|157018741|FG002|Overall Study|Other|2|||
48774435|NCT02103478|157018742|FG003|Overall Study|Other|0|||
48774436|NCT02103478|157018743|FG004|Overall Study|Other|3|||
48774437|NCT02103478|157018744|FG005|Overall Study|Other|8|||
48774438|NCT02103478|157018745|FG006|Overall Study|Other|8|||
48774439|NCT02103478|157018746|FG007|Overall Study|Other|4|||
48774440|NCT02103478|157018747|FG008|Overall Study|Other|2|||
48774441|NCT02566759|157018749|FG000|All Parts|Withdrawal by Subject|0|||
48774442|NCT02566759|157018750|FG001|All Parts|Withdrawal by Subject|1|||
48774443|NCT02566759|157018751|FG002|All Parts|Withdrawal by Subject|0|||
48774444|NCT02566759|157018752|FG003|All Parts|Withdrawal by Subject|0|||
48774445|NCT02566759|157018753|FG004|All Parts|Withdrawal by Subject|0|||
48774446|NCT02566759|157018754|FG005|All Parts|Withdrawal by Subject|0|||
48774447|NCT02566759|157018755|FG006|All Parts|Withdrawal by Subject|0|||
48774448|NCT02566759|157018756|FG007|All Parts|Withdrawal by Subject|0|||
48774449|NCT02566759|157018757|FG008|All Parts|Withdrawal by Subject|0|||
48774450|NCT02566759|157018758|FG009|All Parts|Withdrawal by Subject|0|||
48774451|NCT02566759|157018759|FG010|All Parts|Withdrawal by Subject|0|||
48774452|NCT02566759|157018760|FG011|All Parts|Withdrawal by Subject|0|||
48774453|NCT02566759|157018761|FG012|All Parts|Withdrawal by Subject|0|||
48774454|NCT02566759|157018762|FG013|All Parts|Withdrawal by Subject|0|||
48774455|NCT02566759|157018763|FG014|All Parts|Withdrawal by Subject|0|||
48774456|NCT02566759|157018764|FG015|All Parts|Withdrawal by Subject|0|||
48774457|NCT02566759|157018765|FG016|All Parts|Withdrawal by Subject|0|||
48774458|NCT02566759|157018749|FG000|All Parts|Adverse Event|0|||
48396145|NCT01026831|155643354|FG001|Overall Study|Physician Decision|1|||
48396146|NCT01026831|155643353|FG000|Overall Study|Protocol Violation|0|||
48774459|NCT02566759|157018750|FG001|All Parts|Adverse Event|0|||
48774460|NCT02566759|157018751|FG002|All Parts|Adverse Event|0|||
48774461|NCT02566759|157018752|FG003|All Parts|Adverse Event|0|||
48774462|NCT02566759|157018753|FG004|All Parts|Adverse Event|0|||
48774463|NCT02566759|157018754|FG005|All Parts|Adverse Event|0|||
48774464|NCT02566759|157018755|FG006|All Parts|Adverse Event|0|||
48774465|NCT02566759|157018756|FG007|All Parts|Adverse Event|0|||
48774466|NCT02566759|157018757|FG008|All Parts|Adverse Event|0|||
48774467|NCT02566759|157018758|FG009|All Parts|Adverse Event|0|||
48774468|NCT02566759|157018759|FG010|All Parts|Adverse Event|0|||
48774469|NCT02566759|157018760|FG011|All Parts|Adverse Event|0|||
48774470|NCT02566759|157018761|FG012|All Parts|Adverse Event|1|||
48774471|NCT02566759|157018762|FG013|All Parts|Adverse Event|3|||
48774472|NCT02566759|157018763|FG014|All Parts|Adverse Event|0|||
48774473|NCT02566759|157018764|FG015|All Parts|Adverse Event|0|||
48774474|NCT02566759|157018765|FG016|All Parts|Adverse Event|0|||
48774475|NCT02566759|157018749|FG000|All Parts|Other|0|||
48774476|NCT02566759|157018750|FG001|All Parts|Other|0|||
48774477|NCT02566759|157018751|FG002|All Parts|Other|0|||
48774478|NCT02566759|157018752|FG003|All Parts|Other|0|||
48774479|NCT02566759|157018753|FG004|All Parts|Other|0|||
48774480|NCT02566759|157018754|FG005|All Parts|Other|0|||
48774481|NCT02566759|157018755|FG006|All Parts|Other|0|||
48774482|NCT02566759|157018756|FG007|All Parts|Other|0|||
48774483|NCT02566759|157018757|FG008|All Parts|Other|0|||
48774484|NCT02566759|157018758|FG009|All Parts|Other|0|||
48774485|NCT02566759|157018759|FG010|All Parts|Other|0|||
48774486|NCT02566759|157018760|FG011|All Parts|Other|0|||
48774487|NCT02566759|157018761|FG012|All Parts|Other|0|||
48774488|NCT02566759|157018762|FG013|All Parts|Other|2|||
48774489|NCT02566759|157018763|FG014|All Parts|Other|0|||
48774490|NCT02566759|157018764|FG015|All Parts|Other|0|||
48774491|NCT02566759|157018765|FG016|All Parts|Other|0|||
48774492|NCT02566759|157018749|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774493|NCT02566759|157018750|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774494|NCT02566759|157018751|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774495|NCT02566759|157018752|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774496|NCT02566759|157018753|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774497|NCT02566759|157018754|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774498|NCT02566759|157018755|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774499|NCT02566759|157018756|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774500|NCT02566759|157018757|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774501|NCT02566759|157018758|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774502|NCT02566759|157018759|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774503|NCT02566759|157018760|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774504|NCT02566759|157018761|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774505|NCT02566759|157018762|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774506|NCT02566759|157018763|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774507|NCT02566759|157018764|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
48774508|NCT02566759|157018765|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
48774509|NCT00087568|157018766|FG000|Overall Study|Adverse Event|4|||
48774510|NCT00087568|157018767|FG001|Overall Study|Adverse Event|0|||
48774511|NCT00087568|157018766|FG000|Overall Study|Withdrawal by Subject|1|||
48774512|NCT00087568|157018767|FG001|Overall Study|Withdrawal by Subject|1|||
48774513|NCT00087568|157018766|FG000|Overall Study|Lost to Follow-up|1|||
48774514|NCT00087568|157018767|FG001|Overall Study|Lost to Follow-up|0|||
48774515|NCT00087568|157018766|FG000|Overall Study|Lack of Efficacy|24|||
48774516|NCT00087568|157018767|FG001|Overall Study|Lack of Efficacy|1|||
48774517|NCT00441337|157018768|FG000|Overall Study|Disease Progression|6|||
48774518|NCT00441337|157018769|FG001|Overall Study|Disease Progression|6|||
48774519|NCT00441337|157018770|FG002|Overall Study|Disease Progression|4|||
48774520|NCT00441337|157018771|FG003|Overall Study|Disease Progression|18|||
48774521|NCT00441337|157018768|FG000|Overall Study|Lost to Follow-up|0|||
48774522|NCT00441337|157018769|FG001|Overall Study|Lost to Follow-up|0|||
48774523|NCT00441337|157018770|FG002|Overall Study|Lost to Follow-up|0|||
48774524|NCT00441337|157018771|FG003|Overall Study|Lost to Follow-up|1|||
48774525|NCT00441337|157018768|FG000|Overall Study|Sponsor Decision|0|||
48774526|NCT00441337|157018769|FG001|Overall Study|Sponsor Decision|0|||
48774527|NCT00441337|157018770|FG002|Overall Study|Sponsor Decision|1|||
48774528|NCT00441337|157018771|FG003|Overall Study|Sponsor Decision|2|||
48774529|NCT00441337|157018768|FG000|Overall Study|Did not meet inclusion criteria|0|||
48774530|NCT00441337|157018769|FG001|Overall Study|Did not meet inclusion criteria|0|||
48774531|NCT00441337|157018770|FG002|Overall Study|Did not meet inclusion criteria|1|||
48774532|NCT00441337|157018771|FG003|Overall Study|Did not meet inclusion criteria|0|||
48774533|NCT03064126|157018774|FG000|Overall Study|Death|40|||
48774534|NCT03064126|157018775|FG001|Overall Study|Death|16|||
48774535|NCT03064126|157018776|FG002|Overall Study|Death|4|||
48396147|NCT01026831|155643354|FG001|Overall Study|Protocol Violation|2|||
48396148|NCT01026831|155643353|FG000|Overall Study|Withdrawal by Subject|7|||
48396149|NCT01026831|155643354|FG001|Overall Study|Withdrawal by Subject|5|||
48396150|NCT02255422|155643355|FG000|Overall Study|Withdrawal by Subject|0|||
48774536|NCT03064126|157018777|FG003|Overall Study|Death|2|||
48774537|NCT03064126|157018774|FG000|Overall Study|Withdrawal by Subject|17|||
48774538|NCT03064126|157018775|FG001|Overall Study|Withdrawal by Subject|9|||
48774539|NCT03064126|157018776|FG002|Overall Study|Withdrawal by Subject|0|||
48774540|NCT03064126|157018777|FG003|Overall Study|Withdrawal by Subject|2|||
48774541|NCT03064126|157018774|FG000|Overall Study|Lost to Follow-up|7|||
48774542|NCT03064126|157018775|FG001|Overall Study|Lost to Follow-up|3|||
48774543|NCT03064126|157018776|FG002|Overall Study|Lost to Follow-up|0|||
48774544|NCT03064126|157018777|FG003|Overall Study|Lost to Follow-up|0|||
48774545|NCT03064126|157018774|FG000|Overall Study|Adverse Event|2|||
48774546|NCT03064126|157018775|FG001|Overall Study|Adverse Event|0|||
48774547|NCT03064126|157018776|FG002|Overall Study|Adverse Event|0|||
48774548|NCT03064126|157018777|FG003|Overall Study|Adverse Event|0|||
48774549|NCT03064126|157018774|FG000|Overall Study|Physician Decision|3|||
48774550|NCT03064126|157018775|FG001|Overall Study|Physician Decision|0|||
48774551|NCT03064126|157018776|FG002|Overall Study|Physician Decision|0|||
48774552|NCT03064126|157018777|FG003|Overall Study|Physician Decision|0|||
48774553|NCT03064126|157018774|FG000|Overall Study|Other reason for early termination|3|||
48774554|NCT03064126|157018775|FG001|Overall Study|Other reason for early termination|2|||
48774555|NCT03064126|157018776|FG002|Overall Study|Other reason for early termination|0|||
48774556|NCT03064126|157018777|FG003|Overall Study|Other reason for early termination|0|||
48774557|NCT03064126|157018774|FG000|Overall Study|Missed Visit|3|||
48774558|NCT03064126|157018775|FG001|Overall Study|Missed Visit|1|||
48774559|NCT03064126|157018776|FG002|Overall Study|Missed Visit|0|||
48774560|NCT03064126|157018777|FG003|Overall Study|Missed Visit|0|||
48774561|NCT05074433|157018781|FG000|Overall Study|Adverse Event|0|||
48774562|NCT05074433|157018782|FG001|Overall Study|Adverse Event|2|||
48774563|NCT05074433|157018783|FG002|Overall Study|Adverse Event|0|||
48774564|NCT05074433|157018784|FG003|Overall Study|Adverse Event|1|||
48774565|NCT05074433|157018781|FG000|Overall Study|Sponsor Request|0|||
48774566|NCT05074433|157018782|FG001|Overall Study|Sponsor Request|1|||
48774567|NCT05074433|157018783|FG002|Overall Study|Sponsor Request|1|||
48774568|NCT05074433|157018784|FG003|Overall Study|Sponsor Request|0|||
48774569|NCT05074433|157018781|FG000|Overall Study|Death|1|||
48774570|NCT05074433|157018782|FG001|Overall Study|Death|0|||
48774571|NCT05074433|157018783|FG002|Overall Study|Death|0|||
48774572|NCT05074433|157018784|FG003|Overall Study|Death|0|||
48774573|NCT05074433|157018781|FG000|Overall Study|Lost to Follow-up|0|||
48774574|NCT05074433|157018782|FG001|Overall Study|Lost to Follow-up|0|||
48774575|NCT05074433|157018783|FG002|Overall Study|Lost to Follow-up|2|||
48774576|NCT05074433|157018784|FG003|Overall Study|Lost to Follow-up|0|||
48774577|NCT05074433|157018781|FG000|Overall Study|Subject Decision|8|||
48774578|NCT05074433|157018782|FG001|Overall Study|Subject Decision|6|||
48774579|NCT05074433|157018783|FG002|Overall Study|Subject Decision|4|||
48774580|NCT05074433|157018784|FG003|Overall Study|Subject Decision|5|||
48774581|NCT01859715|157018785|FG000|Overall Study|No 2nd VAS|16|||
48774582|NCT01859715|157018786|FG001|Overall Study|No 2nd VAS|8|||
48774583|NCT01859715|157018787|FG002|Overall Study|No 2nd VAS|23|||
48774584|NCT00833924|157018788|FG000|Overall Study|Death|21|||
48774585|NCT00833924|157018788|FG000|Overall Study|Conversion|2|||
48774586|NCT00833924|157018788|FG000|Overall Study|Lost to Follow-up|2|||
48774587|NCT00833924|157018788|FG000|Overall Study|Withdrawal by Subject|13|||
48774588|NCT00833924|157018788|FG000|Overall Study|In study follow-up|71|||
48774589|NCT01485861|157018791|FG000|Phase Ib|Death|1|||
48774590|NCT01485861|157018792|FG001|Phase Ib|Death|0|||
48774591|NCT01485861|157018793|FG002|Phase Ib|Death|0|||
48774592|NCT01485861|157018794|FG003|Phase Ib|Death|0|||
48774593|NCT01485861|157018795|FG004|Phase Ib|Death|0|||
48774594|NCT01485861|157018796|FG005|Phase Ib|Death|0|||
48774595|NCT01485861|157018791|FG000|Phase Ib|Physician Decision|1|||
48774596|NCT01485861|157018792|FG001|Phase Ib|Physician Decision|1|||
48774597|NCT01485861|157018793|FG002|Phase Ib|Physician Decision|0|||
48774598|NCT01485861|157018794|FG003|Phase Ib|Physician Decision|0|||
48774599|NCT01485861|157018795|FG004|Phase Ib|Physician Decision|0|||
48774600|NCT01485861|157018796|FG005|Phase Ib|Physician Decision|0|||
48774601|NCT01485861|157018791|FG000|Phase Ib|Adverse Event|0|||
48774602|NCT01485861|157018792|FG001|Phase Ib|Adverse Event|4|||
48774603|NCT01485861|157018793|FG002|Phase Ib|Adverse Event|0|||
48774604|NCT01485861|157018794|FG003|Phase Ib|Adverse Event|0|||
48774605|NCT01485861|157018795|FG004|Phase Ib|Adverse Event|0|||
48774606|NCT01485861|157018796|FG005|Phase Ib|Adverse Event|0|||
48774607|NCT01485861|157018791|FG000|Phase Ib|Progression of disease|5|||
48774608|NCT01485861|157018792|FG001|Phase Ib|Progression of disease|0|||
48774609|NCT01485861|157018793|FG002|Phase Ib|Progression of disease|0|||
48774610|NCT01485861|157018794|FG003|Phase Ib|Progression of disease|0|||
48774611|NCT01485861|157018795|FG004|Phase Ib|Progression of disease|0|||
48774612|NCT01485861|157018796|FG005|Phase Ib|Progression of disease|0|||
48774613|NCT01485861|157018791|FG000|Phase Ib|Other|3|||
48774614|NCT01485861|157018792|FG001|Phase Ib|Other|0|||
48774615|NCT01485861|157018793|FG002|Phase Ib|Other|0|||
48774616|NCT01485861|157018794|FG003|Phase Ib|Other|0|||
48774617|NCT01485861|157018795|FG004|Phase Ib|Other|0|||
48774618|NCT01485861|157018796|FG005|Phase Ib|Other|0|||
48774619|NCT01485861|157018791|FG000|Phase Ib|Withdrawal by Subject|4|||
48774620|NCT01485861|157018792|FG001|Phase Ib|Withdrawal by Subject|1|||
48774621|NCT01485861|157018793|FG002|Phase Ib|Withdrawal by Subject|0|||
48774622|NCT01485861|157018794|FG003|Phase Ib|Withdrawal by Subject|0|||
48774623|NCT01485861|157018795|FG004|Phase Ib|Withdrawal by Subject|0|||
48774624|NCT01485861|157018796|FG005|Phase Ib|Withdrawal by Subject|0|||
48774625|NCT01485861|157018791|FG000|Phase II|Death|0|||
48774626|NCT01485861|157018792|FG001|Phase II|Death|0|||
48774627|NCT01485861|157018793|FG002|Phase II|Death|67|||
48774628|NCT01485861|157018794|FG003|Phase II|Death|71|||
48774629|NCT01485861|157018795|FG004|Phase II|Death|68|||
48774630|NCT01485861|157018796|FG005|Phase II|Death|0|||
48774631|NCT01485861|157018791|FG000|Phase II|Progression of Disease|0|||
48774632|NCT01485861|157018792|FG001|Phase II|Progression of Disease|0|||
48774633|NCT01485861|157018793|FG002|Phase II|Progression of Disease|1|||
48774634|NCT01485861|157018794|FG003|Phase II|Progression of Disease|0|||
48774635|NCT01485861|157018795|FG004|Phase II|Progression of Disease|0|||
48774636|NCT01485861|157018796|FG005|Phase II|Progression of Disease|0|||
48774637|NCT01485861|157018791|FG000|Phase II|Other|0|||
48774638|NCT01485861|157018792|FG001|Phase II|Other|0|||
48774639|NCT01485861|157018793|FG002|Phase II|Other|0|||
48774640|NCT01485861|157018794|FG003|Phase II|Other|1|||
48774641|NCT01485861|157018795|FG004|Phase II|Other|0|||
48774642|NCT01485861|157018796|FG005|Phase II|Other|0|||
48774643|NCT01485861|157018791|FG000|Phase II|Withdrawal by Subject|0|||
48774644|NCT01485861|157018792|FG001|Phase II|Withdrawal by Subject|0|||
48774645|NCT01485861|157018793|FG002|Phase II|Withdrawal by Subject|6|||
48774646|NCT01485861|157018794|FG003|Phase II|Withdrawal by Subject|3|||
48774647|NCT01485861|157018795|FG004|Phase II|Withdrawal by Subject|4|||
48774648|NCT01485861|157018796|FG005|Phase II|Withdrawal by Subject|0|||
48774649|NCT01485861|157018791|FG000|Phase II|Lost to Follow-up|0|||
48774650|NCT01485861|157018792|FG001|Phase II|Lost to Follow-up|0|||
48774651|NCT01485861|157018793|FG002|Phase II|Lost to Follow-up|2|||
48774652|NCT01485861|157018794|FG003|Phase II|Lost to Follow-up|3|||
48774653|NCT01485861|157018795|FG004|Phase II|Lost to Follow-up|5|||
48774654|NCT01485861|157018796|FG005|Phase II|Lost to Follow-up|0|||
48774655|NCT01485861|157018791|FG000|Phase II|Study Ended|0|||
48774656|NCT01485861|157018792|FG001|Phase II|Study Ended|0|||
48774657|NCT01485861|157018793|FG002|Phase II|Study Ended|7|||
48774658|NCT01485861|157018794|FG003|Phase II|Study Ended|8|||
48774659|NCT01485861|157018795|FG004|Phase II|Study Ended|6|||
48774660|NCT01485861|157018796|FG005|Phase II|Study Ended|0|||
48774661|NCT01485861|157018791|FG000|Safety Phase|Death|0|||
48774662|NCT01485861|157018792|FG001|Safety Phase|Death|0|||
48774663|NCT01485861|157018793|FG002|Safety Phase|Death|0|||
48774664|NCT01485861|157018794|FG003|Safety Phase|Death|0|||
48774665|NCT01485861|157018795|FG004|Safety Phase|Death|0|||
48774666|NCT01485861|157018796|FG005|Safety Phase|Death|2|||
48774667|NCT01485861|157018791|FG000|Safety Phase|Adverse Event|0|||
48774668|NCT01485861|157018792|FG001|Safety Phase|Adverse Event|0|||
48774669|NCT01485861|157018793|FG002|Safety Phase|Adverse Event|0|||
48774670|NCT01485861|157018794|FG003|Safety Phase|Adverse Event|0|||
48774671|NCT01485861|157018795|FG004|Safety Phase|Adverse Event|0|||
48774672|NCT01485861|157018796|FG005|Safety Phase|Adverse Event|1|||
48774673|NCT01485861|157018791|FG000|Safety Phase|Other|0|||
48774674|NCT01485861|157018792|FG001|Safety Phase|Other|0|||
48774675|NCT01485861|157018793|FG002|Safety Phase|Other|0|||
48774676|NCT01485861|157018794|FG003|Safety Phase|Other|0|||
48774677|NCT01485861|157018795|FG004|Safety Phase|Other|0|||
48774678|NCT01485861|157018796|FG005|Safety Phase|Other|5|||
48774679|NCT01485861|157018791|FG000|Safety Phase|Progression of Disease|0|||
48774680|NCT01485861|157018792|FG001|Safety Phase|Progression of Disease|0|||
48774681|NCT01485861|157018793|FG002|Safety Phase|Progression of Disease|0|||
48774682|NCT01485861|157018794|FG003|Safety Phase|Progression of Disease|0|||
48774683|NCT01485861|157018795|FG004|Safety Phase|Progression of Disease|0|||
48774684|NCT01485861|157018796|FG005|Safety Phase|Progression of Disease|9|||
48774685|NCT01485861|157018791|FG000|Safety Phase|Withdrawal by Subject|0|||
48774686|NCT01485861|157018792|FG001|Safety Phase|Withdrawal by Subject|0|||
48774687|NCT01485861|157018793|FG002|Safety Phase|Withdrawal by Subject|0|||
48774688|NCT01485861|157018794|FG003|Safety Phase|Withdrawal by Subject|0|||
48774689|NCT01485861|157018795|FG004|Safety Phase|Withdrawal by Subject|0|||
48774690|NCT01485861|157018796|FG005|Safety Phase|Withdrawal by Subject|6|||
48774691|NCT01485861|157018791|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774692|NCT01485861|157018792|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774693|NCT01485861|157018793|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774694|NCT01485861|157018794|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
48774695|NCT01485861|157018795|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
48396151|NCT02255422|155643356|FG001|Overall Study|Withdrawal by Subject|0|||
48774696|NCT01485861|157018796|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
48774697|NCT01158924|157018799|FG000|Overall Study|Withdrawal by Subject|1|||
48774698|NCT01158924|157018800|FG001|Overall Study|Withdrawal by Subject|2|||
48774699|NCT01158924|157018799|FG000|Overall Study|Lost to Follow-up|0|||
48774700|NCT01158924|157018800|FG001|Overall Study|Lost to Follow-up|1|||
48774701|NCT03795922|157018801|FG000|Overall Study|Adverse Event|2|||
48774702|NCT03795922|157018802|FG001|Overall Study|Adverse Event|1|||
48774703|NCT03795922|157018801|FG000|Overall Study|Withdrawal by Subject|5|||
48774704|NCT03795922|157018802|FG001|Overall Study|Withdrawal by Subject|13|||
48774705|NCT03795922|157018801|FG000|Overall Study|Lost to Follow-up|2|||
48774706|NCT03795922|157018802|FG001|Overall Study|Lost to Follow-up|3|||
48774707|NCT03795922|157018801|FG000|Overall Study|Pregnancy|0|||
48774708|NCT03795922|157018802|FG001|Overall Study|Pregnancy|1|||
48774709|NCT03795922|157018801|FG000|Overall Study|Physician Decision|1|||
48774710|NCT03795922|157018802|FG001|Overall Study|Physician Decision|2|||
48774711|NCT03795922|157018801|FG000|Overall Study|Protocol Violation|0|||
48774712|NCT03795922|157018802|FG001|Overall Study|Protocol Violation|1|||
48774713|NCT03795922|157018801|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
48774714|NCT03795922|157018802|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
48774715|NCT01632800|157018806|FG000|Overall Study|Subject did not fit in apparatus|1|||
48774716|NCT01000051|157018808|FG000|Overall Study|Withdrawal by Subject|1|||
48774717|NCT01000051|157018809|FG001|Overall Study|Withdrawal by Subject|1|||
48774718|NCT01000051|157018808|FG000|Overall Study|Disease Progression|1|||
48774719|NCT01000051|157018809|FG001|Overall Study|Disease Progression|0|||
48774720|NCT01000051|157018808|FG000|Overall Study|Serious noncompliance|1|||
48774721|NCT01000051|157018809|FG001|Overall Study|Serious noncompliance|0|||
48774722|NCT04439240|157018810|FG000|Overall Study|Ineligible|2|||
48774723|NCT04439240|157018810|FG000|Overall Study|Never started treatment|2|||
48774724|NCT04439240|157018810|FG000|Overall Study|Adverse Event|12|||
48774725|NCT04439240|157018810|FG000|Overall Study|Death|2|||
48774726|NCT04439240|157018810|FG000|Overall Study|Disease progression|25|||
48774727|NCT04439240|157018810|FG000|Overall Study|Other diseases|2|||
48774728|NCT04439240|157018810|FG000|Overall Study|Withdrawal by Subject|3|||
48774729|NCT04439240|157018810|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
48774730|NCT04439240|157018810|FG000|Overall Study|Symptomatic decline|1|||
48774731|NCT04439240|157018810|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
48774732|NCT04439240|157018810|FG000|Overall Study|Clinical progression|1|||
48774733|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Adverse Event|41|||
48774734|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Adverse Event|24|||
48774735|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
48774736|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
48774737|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
48774738|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
48774739|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Physician Decision|0|||
48774740|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Physician Decision|6|||
48774741|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
48774742|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
48774743|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
48774744|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
48774745|NCT00673452|157018811|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
48774746|NCT00673452|157018812|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
48774747|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
48774748|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
48774749|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
48774750|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
48774751|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
48774752|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
48774753|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
48774754|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
48774755|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
48774756|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
48774757|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
48774758|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
48774759|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
48774760|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
48774761|NCT00673452|157018811|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
48774762|NCT00673452|157018812|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
48774763|NCT00813124|157018813|FG000|Overall Study|Death|2|||
48774764|NCT00813124|157018813|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
48774765|NCT00813124|157018813|FG000|Overall Study|Withdrawal by Subject|1|||
48774766|NCT00733824|157018814|FG000|Phase I|Withdrawal by Subject|1|||
48774767|NCT00733824|157018815|FG001|Phase I|Withdrawal by Subject|0|||
48774768|NCT00733824|157018816|FG002|Phase I|Withdrawal by Subject|0|||
48774769|NCT00733824|157018817|FG003|Phase I|Withdrawal by Subject|0|||
48396152|NCT02255422|155643357|FG002|Overall Study|Withdrawal by Subject|0|||
48396153|NCT02255422|155643358|FG003|Overall Study|Withdrawal by Subject|0|||
48774770|NCT00733824|157018818|FG004|Phase I|Withdrawal by Subject|0|||
48774771|NCT03773757|157018822|FG000|Overall Study|Withdrawal by Subject|2|||
48774772|NCT03773757|157018823|FG001|Overall Study|Withdrawal by Subject|4|||
48774773|NCT03056690|157018824|FG000|Overall Study|Adverse Event|3|||
48774774|NCT03056690|157018825|FG001|Overall Study|Adverse Event|2|||
48396154|NCT02255422|155643359|FG004|Overall Study|Withdrawal by Subject|0|||
48774775|NCT03056690|157018824|FG000|Overall Study|Lack of Efficacy|1|||
48774776|NCT03056690|157018825|FG001|Overall Study|Lack of Efficacy|2|||
48774777|NCT03056690|157018824|FG000|Overall Study|Lost to Follow-up|3|||
48774778|NCT03056690|157018825|FG001|Overall Study|Lost to Follow-up|2|||
48774779|NCT03056690|157018824|FG000|Overall Study|Protocol Violation|2|||
48774780|NCT03056690|157018825|FG001|Overall Study|Protocol Violation|2|||
48774781|NCT03056690|157018824|FG000|Overall Study|Withdrawal by Subject|3|||
48774782|NCT03056690|157018825|FG001|Overall Study|Withdrawal by Subject|6|||
48774783|NCT03056690|157018824|FG000|Overall Study|Non-compliance with Study Drug|1|||
48774784|NCT03056690|157018825|FG001|Overall Study|Non-compliance with Study Drug|0|||
48774785|NCT03056690|157018824|FG000|Overall Study|Miscellaneous|1|||
48774786|NCT03056690|157018825|FG001|Overall Study|Miscellaneous|2|||
48774787|NCT01585766|157018826|FG000|Overall Study|Withdrawal by Subject|0|||
48774788|NCT01585766|157018827|FG001|Overall Study|Withdrawal by Subject|1|||
48774789|NCT01585766|157018828|FG002|Overall Study|Withdrawal by Subject|1|||
48774790|NCT01585766|157018829|FG003|Overall Study|Withdrawal by Subject|0|||
48774791|NCT01585766|157018830|FG004|Overall Study|Withdrawal by Subject|0|||
48774792|NCT01585766|157018831|FG005|Overall Study|Withdrawal by Subject|0|||
48774793|NCT01585766|157018826|FG000|Overall Study|Death|0|||
48774794|NCT01585766|157018827|FG001|Overall Study|Death|1|||
48774795|NCT01585766|157018828|FG002|Overall Study|Death|0|||
48774796|NCT01585766|157018829|FG003|Overall Study|Death|0|||
48774797|NCT01585766|157018830|FG004|Overall Study|Death|0|||
48774798|NCT01585766|157018831|FG005|Overall Study|Death|0|||
48774799|NCT01585766|157018826|FG000|Overall Study|Physician Decision|0|||
48774800|NCT01585766|157018827|FG001|Overall Study|Physician Decision|0|||
48774801|NCT01585766|157018828|FG002|Overall Study|Physician Decision|1|||
48774802|NCT01585766|157018829|FG003|Overall Study|Physician Decision|0|||
48774803|NCT01585766|157018830|FG004|Overall Study|Physician Decision|0|||
48774804|NCT01585766|157018831|FG005|Overall Study|Physician Decision|0|||
48774805|NCT01701258|157018832|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
48774806|NCT01701258|157018833|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
48774807|NCT01701258|157018834|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
48774808|NCT01701258|157018835|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
48774809|NCT01701258|157018836|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
48774810|NCT01701258|157018837|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
48774811|NCT01701258|157018838|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
48774812|NCT01701258|157018839|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
48774813|NCT01701258|157018840|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
48774814|NCT01701258|157018841|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
48774815|NCT01701258|157018842|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
48774816|NCT01701258|157018843|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
48774817|NCT01701258|157018844|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
48774818|NCT01701258|157018832|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
48774819|NCT01701258|157018833|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
48774820|NCT01701258|157018834|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
48774821|NCT01701258|157018835|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
48774822|NCT01701258|157018836|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
48774823|NCT01701258|157018837|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
48774824|NCT01701258|157018838|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
48774825|NCT01701258|157018839|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
48774826|NCT01701258|157018840|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
48774827|NCT01701258|157018841|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
48774828|NCT01701258|157018842|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
48774829|NCT01701258|157018843|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
48774830|NCT01701258|157018844|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
48774831|NCT01701258|157018832|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
48774832|NCT01701258|157018833|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
48774833|NCT01701258|157018834|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
48774834|NCT01701258|157018835|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
48774835|NCT01701258|157018836|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
48774836|NCT01701258|157018837|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
48774837|NCT01701258|157018838|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
48774838|NCT01701258|157018839|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
48774839|NCT01701258|157018840|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
48774840|NCT01701258|157018841|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
48774841|NCT01701258|157018842|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
48774842|NCT01701258|157018843|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
48774843|NCT01701258|157018844|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
48774844|NCT01701258|157018832|FG000|Assessment and Scheduling|Investigator Terminated|2|||
48774845|NCT01701258|157018833|FG001|Assessment and Scheduling|Investigator Terminated|0|||
48774846|NCT01701258|157018834|FG002|Assessment and Scheduling|Investigator Terminated|0|||
48774847|NCT01701258|157018835|FG003|Assessment and Scheduling|Investigator Terminated|0|||
48774848|NCT01701258|157018836|FG004|Assessment and Scheduling|Investigator Terminated|0|||
48774849|NCT01701258|157018837|FG005|Assessment and Scheduling|Investigator Terminated|0|||
48774850|NCT01701258|157018838|FG006|Assessment and Scheduling|Investigator Terminated|0|||
48774851|NCT01701258|157018839|FG007|Assessment and Scheduling|Investigator Terminated|0|||
48774852|NCT01701258|157018840|FG008|Assessment and Scheduling|Investigator Terminated|0|||
48774853|NCT01701258|157018841|FG009|Assessment and Scheduling|Investigator Terminated|0|||
48774854|NCT01701258|157018842|FG010|Assessment and Scheduling|Investigator Terminated|0|||
48774855|NCT01701258|157018843|FG011|Assessment and Scheduling|Investigator Terminated|0|||
48774856|NCT01701258|157018844|FG012|Assessment and Scheduling|Investigator Terminated|0|||
48774857|NCT02052739|157018845|FG000|Overall Study|Withdrew due to Adverse Event|3|||
48774858|NCT02052739|157018846|FG001|Overall Study|Withdrew due to Adverse Event|0|||
48774859|NCT02052739|157018845|FG000|Overall Study|Participant Died|2|||
48774860|NCT02052739|157018846|FG001|Overall Study|Participant Died|1|||
48774861|NCT01785602|157018847|FG000|Overall Study|Withdrawal by Subject|2|||
48774862|NCT01785602|157018848|FG001|Overall Study|Withdrawal by Subject|0|||
48774863|NCT01785602|157018847|FG000|Overall Study|Lost to Follow-up|1|||
48774864|NCT01785602|157018848|FG001|Overall Study|Lost to Follow-up|1|||
48774865|NCT01785602|157018847|FG000|Overall Study|Adverse Event|3|||
48774866|NCT01785602|157018848|FG001|Overall Study|Adverse Event|5|||
48774867|NCT01785602|157018847|FG000|Overall Study|Administrative problems|7|||
48774868|NCT01785602|157018848|FG001|Overall Study|Administrative problems|3|||
48774869|NCT04251533|157018849|FG000|Overall Study|Progressive disease|33|||
48774870|NCT04251533|157018850|FG001|Overall Study|Progressive disease|29|||
48774871|NCT04251533|157018851|FG002|Overall Study|Progressive disease|22|||
48774872|NCT04251533|157018849|FG000|Overall Study|Death|5|||
48774873|NCT04251533|157018850|FG001|Overall Study|Death|1|||
48774874|NCT04251533|157018851|FG002|Overall Study|Death|3|||
48774875|NCT04251533|157018849|FG000|Overall Study|Physician Decision|3|||
48774876|NCT04251533|157018850|FG001|Overall Study|Physician Decision|2|||
48774877|NCT04251533|157018851|FG002|Overall Study|Physician Decision|4|||
48774878|NCT04251533|157018849|FG000|Overall Study|Participant decision|1|||
48774879|NCT04251533|157018850|FG001|Overall Study|Participant decision|3|||
48774880|NCT04251533|157018851|FG002|Overall Study|Participant decision|1|||
48774881|NCT04251533|157018849|FG000|Overall Study|Adverse Event|2|||
48774882|NCT04251533|157018850|FG001|Overall Study|Adverse Event|1|||
48774883|NCT04251533|157018851|FG002|Overall Study|Adverse Event|1|||
48774884|NCT00595582|157018861|FG000|Overall Study|Pilot study that PI terminated|2|||
48774885|NCT00595582|157018861|FG000|Overall Study|Lost to Follow-up|1|||
48774886|NCT00595582|157018861|FG000|Overall Study|Adverse Event|2|||
48774887|NCT00595582|157018861|FG000|Overall Study|Physician Decision|5|||
48774888|NCT00983814|157018864|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
48774889|NCT00983814|157018865|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
48774890|NCT00983814|157018866|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
48774891|NCT00983814|157018864|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
48774892|NCT00983814|157018865|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
48774893|NCT00983814|157018866|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
48774894|NCT00983814|157018864|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
48774895|NCT00983814|157018865|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
48774896|NCT00983814|157018866|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
48774897|NCT00983814|157018864|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
48774898|NCT00983814|157018865|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
48774899|NCT00983814|157018866|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
48774900|NCT00983814|157018864|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
48774901|NCT00983814|157018865|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
48774902|NCT00983814|157018866|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
48774903|NCT03779841|157018875|FG000|Randomized Population|Did Not Receive Treatment|3|||
48774904|NCT03779841|157018876|FG001|Randomized Population|Did Not Receive Treatment|1|||
48774905|NCT03779841|157018877|FG002|Randomized Population|Did Not Receive Treatment|0|||
48774906|NCT03779841|157018875|FG000|Treated (Safety) Population|Adverse Event|1|||
48774907|NCT03779841|157018876|FG001|Treated (Safety) Population|Adverse Event|1|||
48774908|NCT03779841|157018877|FG002|Treated (Safety) Population|Adverse Event|0|||
48396155|NCT02255422|155643360|FG005|Overall Study|Withdrawal by Subject|0|||
48396156|NCT02255422|155643361|FG006|Overall Study|Withdrawal by Subject|2|||
48774909|NCT03779841|157018875|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
48774910|NCT03779841|157018876|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
48774911|NCT03779841|157018877|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
48774912|NCT03779841|157018875|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
48774913|NCT03779841|157018876|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
48774914|NCT03779841|157018877|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
48774915|NCT03779841|157018875|FG000|Treated (Safety) Population|Death|1|||
48774916|NCT03779841|157018876|FG001|Treated (Safety) Population|Death|0|||
48774917|NCT03779841|157018877|FG002|Treated (Safety) Population|Death|2|||
48774918|NCT02447991|157018878|FG000|Overall Study|Withdrawn by subject - no data|0|||
48774919|NCT02447991|157018879|FG001|Overall Study|Withdrawn by subject - no data|2|||
48774920|NCT02447991|157018878|FG000|Overall Study|Withdrawn by Subject - with data|4|||
48774921|NCT02447991|157018879|FG001|Overall Study|Withdrawn by Subject - with data|4|||
48774922|NCT02447991|157018878|FG000|Overall Study|Lost to Follow-up - no data|3|||
48774923|NCT02447991|157018879|FG001|Overall Study|Lost to Follow-up - no data|6|||
48774924|NCT02447991|157018878|FG000|Overall Study|Lost to follow-up - with data|0|||
48774925|NCT02447991|157018879|FG001|Overall Study|Lost to follow-up - with data|3|||
48774926|NCT02447991|157018878|FG000|Overall Study|End of study - no treatment results|3|||
48774927|NCT02447991|157018879|FG001|Overall Study|End of study - no treatment results|6|||
48774928|NCT02447991|157018878|FG000|Overall Study|End of study - partial treatment results|0|||
48774929|NCT02447991|157018879|FG001|Overall Study|End of study - partial treatment results|9|||
48774930|NCT01581593|157019894|FG000|Overall Study|Withdrawal by Subject|1|||
48774931|NCT00779675|157019897|FG000|Treatment Period|Adverse Event|87|||
48774932|NCT00779675|157019897|FG000|Treatment Period|Treatment Failure|80|||
48774933|NCT00779675|157019897|FG000|Treatment Period|Transferred to Another Study|38|||
48774934|NCT00779675|157019897|FG000|Treatment Period|Lost to Follow-up|23|||
48774935|NCT00779675|157019897|FG000|Treatment Period|Withdrawal by Subject|46|||
48774936|NCT00779675|157019897|FG000|Treatment Period|Protocol Violation|54|||
48774937|NCT00779675|157019897|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
48774938|NCT00779675|157019897|FG000|Treatment Period|Administrative|3|||
48774939|NCT00779675|157019897|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
48774940|NCT00779675|157019897|FG000|Extended Treatment Period|Protocol Violation|13|||
48774941|NCT00779675|157019897|FG000|Extended Treatment Period|Adverse Event|6|||
48774942|NCT00779675|157019897|FG000|Extended Treatment Period|Treatment Failure|11|||
48774943|NCT00779675|157019897|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
48774944|NCT00779675|157019897|FG000|Extended Treatment Period|Lost to Follow-up|6|||
48774945|NCT01400841|157019901|FG000|Initial Study Phase (6 Months)|Death|1|||
48774946|NCT01400841|157019901|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
48774947|NCT04537806|157019904|FG000|Overall Study|Randomized but not treated|1|||
48774948|NCT04537806|157019905|FG001|Overall Study|Randomized but not treated|0|||
48396157|NCT02255422|155643355|FG000|Overall Study|Lost to Follow-up|0|||
48774949|NCT04537806|157019904|FG000|Overall Study|Adverse Event|1|||
48774950|NCT04537806|157019905|FG001|Overall Study|Adverse Event|1|||
48774951|NCT04304001|157019914|FG000|Overall Study|Lost to Follow-up|13|||
48774952|NCT04304001|157019915|FG001|Overall Study|Lost to Follow-up|9|||
48774953|NCT00705575|157019919|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48774954|NCT00705575|157019920|FG001|Overall Study|Abnormal laboratory value(s)|3|||
48774955|NCT00705575|157019919|FG000|Overall Study|Abnormal test procedure result(s)|2|||
48774956|NCT00705575|157019920|FG001|Overall Study|Abnormal test procedure result(s)|12|||
48774957|NCT00705575|157019919|FG000|Overall Study|Adverse Event|11|||
48774958|NCT00705575|157019920|FG001|Overall Study|Adverse Event|15|||
48774959|NCT00705575|157019919|FG000|Overall Study|Lost to Follow-up|3|||
48774960|NCT00705575|157019920|FG001|Overall Study|Lost to Follow-up|4|||
48774961|NCT00705575|157019919|FG000|Overall Study|Protocol Violation|2|||
48774962|NCT00705575|157019920|FG001|Overall Study|Protocol Violation|2|||
48774963|NCT00705575|157019919|FG000|Overall Study|Withdrawal by Subject|5|||
48774964|NCT00705575|157019920|FG001|Overall Study|Withdrawal by Subject|10|||
48774965|NCT00724451|157019923|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
48774966|NCT00724451|157019923|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
48774967|NCT00724451|157019923|FG000|Overall Study|Not Eligible for Treatment|431|||
48774968|NCT00724451|157019923|FG000|Overall Study|Participant Refused Treatment|89|||
48774969|NCT00724451|157019923|FG000|Overall Study|Never Started Treatment|89|||
48774970|NCT00724451|157019923|FG000|Overall Study|Unknown; No Data Sources Available|9|||
48774971|NCT00724451|157019923|FG000|Overall Study|Physician Decision|116|||
48774972|NCT00724451|157019923|FG000|Overall Study|Withdrawal by Subject|45|||
48774973|NCT00724451|157019923|FG000|Overall Study|Investigator + Participant Decision|13|||
48774974|NCT01110915|157019930|FG000|Overall Study|Death|2|||
48774975|NCT01110915|157019931|FG001|Overall Study|Death|1|||
48774976|NCT01110915|157019930|FG000|Overall Study|Lost to Follow-up|1|||
48774977|NCT01110915|157019931|FG001|Overall Study|Lost to Follow-up|0|||
48774978|NCT01110915|157019930|FG000|Overall Study|Withdrawal by Subject|7|||
48774979|NCT01110915|157019931|FG001|Overall Study|Withdrawal by Subject|1|||
48774980|NCT02948842|157019933|FG000|Overall Study|Withdrawal by Subject|4|||
48774981|NCT00578565|157019934|FG000|Overall Study|Adverse Event|3|||
48774982|NCT01649856|157019935|FG000|Overall Study|Withdrawal by Subject|14|||
48774983|NCT01649856|157019936|FG001|Overall Study|Withdrawal by Subject|14|||
48774984|NCT01649856|157019935|FG000|Overall Study|Protocol Violation|4|||
48774985|NCT01649856|157019936|FG001|Overall Study|Protocol Violation|4|||
48774986|NCT01649856|157019935|FG000|Overall Study|Treatment Failure|1|||
48774987|NCT01649856|157019936|FG001|Overall Study|Treatment Failure|1|||
48396158|NCT02255422|155643356|FG001|Overall Study|Lost to Follow-up|0|||
48774988|NCT01649856|157019935|FG000|Overall Study|Death|69|||
48774989|NCT01649856|157019936|FG001|Overall Study|Death|34|||
48774990|NCT01649856|157019935|FG000|Overall Study|Stable or Progressed Disease|5|||
48774991|NCT01649856|157019936|FG001|Overall Study|Stable or Progressed Disease|3|||
48774992|NCT01649856|157019935|FG000|Overall Study|Lost to Follow-up|20|||
48774993|NCT01649856|157019936|FG001|Overall Study|Lost to Follow-up|16|||
48774994|NCT01649856|157019935|FG000|Overall Study|Lack of Compliance|6|||
48774995|NCT01649856|157019936|FG001|Overall Study|Lack of Compliance|1|||
48774996|NCT01649856|157019935|FG000|Overall Study|Other|20|||
48774997|NCT01649856|157019936|FG001|Overall Study|Other|5|||
48774998|NCT00179647|157019937|FG000|Overall Study|Adverse Event|294|||
48774999|NCT00179647|157019937|FG000|Overall Study|Lack of Efficacy|478|||
48775000|NCT00179647|157019937|FG000|Overall Study|Withdrawal by Subject|83|||
48775001|NCT00179647|157019937|FG000|Overall Study|Lost to Follow-up|4|||
48775002|NCT00179647|157019937|FG000|Overall Study|Death|94|||
48775003|NCT00179647|157019937|FG000|Overall Study|Other|960|||
48775004|NCT02550652|157019938|FG000|Overall Study|Death|1|||
48775005|NCT02550652|157019939|FG001|Overall Study|Death|4|||
48396159|NCT02255422|155643357|FG002|Overall Study|Lost to Follow-up|1|||
48396160|NCT02255422|155643358|FG003|Overall Study|Lost to Follow-up|0|||
48396161|NCT02255422|155643359|FG004|Overall Study|Lost to Follow-up|0|||
48396162|NCT02255422|155643360|FG005|Overall Study|Lost to Follow-up|0|||
48396163|NCT02255422|155643361|FG006|Overall Study|Lost to Follow-up|0|||
48396164|NCT00730639|155643362|FG000|Overall Study|Adverse Event|3|||
48396165|NCT00730639|155643363|FG001|Overall Study|Adverse Event|0|||
48396166|NCT00730639|155643364|FG002|Overall Study|Adverse Event|9|||
48396167|NCT00730639|155643365|FG003|Overall Study|Adverse Event|8|||
48396168|NCT00730639|155643366|FG004|Overall Study|Adverse Event|23|||
48396169|NCT00730639|155643362|FG000|Overall Study|Complete Response|0|||
48396170|NCT00730639|155643363|FG001|Overall Study|Complete Response|0|||
48396171|NCT00730639|155643364|FG002|Overall Study|Complete Response|2|||
48396172|NCT00730639|155643365|FG003|Overall Study|Complete Response|2|||
48396173|NCT00730639|155643366|FG004|Overall Study|Complete Response|1|||
48396174|NCT00730639|155643362|FG000|Overall Study|Completed Maximum Cycles|0|||
48396175|NCT00730639|155643363|FG001|Overall Study|Completed Maximum Cycles|0|||
48396176|NCT00730639|155643364|FG002|Overall Study|Completed Maximum Cycles|11|||
48396177|NCT00730639|155643365|FG003|Overall Study|Completed Maximum Cycles|3|||
48396178|NCT00730639|155643366|FG004|Overall Study|Completed Maximum Cycles|6|||
48396179|NCT00730639|155643362|FG000|Overall Study|Death|0|||
48396180|NCT00730639|155643363|FG001|Overall Study|Death|0|||
48396181|NCT00730639|155643364|FG002|Overall Study|Death|0|||
48775006|NCT02550652|157019938|FG000|Overall Study|Lack of Efficacy|1|||
48775007|NCT02550652|157019939|FG001|Overall Study|Lack of Efficacy|0|||
48775008|NCT02550652|157019938|FG000|Overall Study|Withdrawal by Subject|4|||
48396182|NCT00730639|155643365|FG003|Overall Study|Death|0|||
48396183|NCT00730639|155643366|FG004|Overall Study|Death|2|||
48396184|NCT00730639|155643362|FG000|Overall Study|Disease Progression|12|||
48396185|NCT00730639|155643363|FG001|Overall Study|Disease Progression|13|||
48396186|NCT00730639|155643364|FG002|Overall Study|Disease Progression|48|||
48396187|NCT00730639|155643365|FG003|Overall Study|Disease Progression|32|||
48396188|NCT00730639|155643366|FG004|Overall Study|Disease Progression|88|||
48775009|NCT02550652|157019939|FG001|Overall Study|Withdrawal by Subject|7|||
48775010|NCT02550652|157019938|FG000|Overall Study|Post Trial Access|1|||
48396189|NCT00730639|155643362|FG000|Overall Study|non-specified|0|||
48396190|NCT00730639|155643363|FG001|Overall Study|non-specified|0|||
48396191|NCT00730639|155643364|FG002|Overall Study|non-specified|4|||
48396192|NCT00730639|155643365|FG003|Overall Study|non-specified|2|||
48396193|NCT00730639|155643366|FG004|Overall Study|non-specified|3|||
48396194|NCT00730639|155643362|FG000|Overall Study|Protocol Violation|0|||
48396195|NCT00730639|155643363|FG001|Overall Study|Protocol Violation|0|||
48396196|NCT00730639|155643364|FG002|Overall Study|Protocol Violation|1|||
48396197|NCT00730639|155643365|FG003|Overall Study|Protocol Violation|0|||
48396198|NCT00730639|155643366|FG004|Overall Study|Protocol Violation|0|||
48396199|NCT00730639|155643362|FG000|Overall Study|Withdrawal by Subject|0|||
48396200|NCT00730639|155643363|FG001|Overall Study|Withdrawal by Subject|0|||
48396201|NCT00730639|155643364|FG002|Overall Study|Withdrawal by Subject|6|||
48396202|NCT00730639|155643365|FG003|Overall Study|Withdrawal by Subject|3|||
48396203|NCT00730639|155643366|FG004|Overall Study|Withdrawal by Subject|4|||
48396204|NCT00730639|155643362|FG000|Overall Study|Treatment on-going|2|||
48396205|NCT00730639|155643363|FG001|Overall Study|Treatment on-going|5|||
48396206|NCT00730639|155643364|FG002|Overall Study|Treatment on-going|5|||
48396207|NCT00730639|155643365|FG003|Overall Study|Treatment on-going|4|||
48396208|NCT00730639|155643366|FG004|Overall Study|Treatment on-going|4|||
48775011|NCT02550652|157019939|FG001|Overall Study|Post Trial Access|0|||
48775012|NCT02550652|157019938|FG000|Overall Study|Lost to Follow-up|1|||
48775013|NCT02550652|157019939|FG001|Overall Study|Lost to Follow-up|3|||
48775014|NCT02550652|157019938|FG000|Overall Study|Physician Decision|0|||
48775015|NCT02550652|157019939|FG001|Overall Study|Physician Decision|2|||
48396209|NCT01836783|155643371|FG000|Overall Study|Withdrawal by Subject|0|||
48396210|NCT01836783|155643372|FG001|Overall Study|Withdrawal by Subject|2|||
48775016|NCT02550652|157019938|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
48775017|NCT02550652|157019939|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
48396211|NCT04942925|155643373|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
48396212|NCT04942925|155643374|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
48396213|NCT04942925|155643373|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
48396214|NCT04942925|155643374|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
48396215|NCT00159861|155643376|FG000|Core Study - 16 Weeks|Death|3|||
48775018|NCT02127307|157019940|FG000|Overall Study|Protocol Violation|36|||
48775019|NCT02127307|157019940|FG000|Overall Study|Lost to Follow-up|2|||
48775020|NCT02127307|157019940|FG000|Overall Study|Death|101|||
48396216|NCT00159861|155643377|FG001|Core Study - 16 Weeks|Death|0|||
48396217|NCT00159861|155643376|FG000|Core Study - 16 Weeks|Adverse Event|12|||
48396218|NCT00159861|155643377|FG001|Core Study - 16 Weeks|Adverse Event|6|||
48396219|NCT00159861|155643376|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
48775021|NCT02127307|157019940|FG000|Overall Study|Other than specified above|169|||
48775022|NCT00958880|157019943|FG000|Overall Study|Lost to Follow-up|2|||
48775023|NCT00958880|157019944|FG001|Overall Study|Lost to Follow-up|2|||
48775024|NCT02442830|157019946|FG000|Overall Study|Technical Failure|0|||
48775025|NCT02442830|157019947|FG001|Overall Study|Technical Failure|1|||
48775026|NCT03191903|157019951|FG000|Overall Study|Withdrawal by Subject|6|||
48775027|NCT03191903|157019952|FG001|Overall Study|Withdrawal by Subject|5|||
48775028|NCT03191903|157019953|FG002|Overall Study|Withdrawal by Subject|4|||
48775029|NCT03191903|157019951|FG000|Overall Study|Adverse Event|1|||
48775030|NCT03191903|157019952|FG001|Overall Study|Adverse Event|0|||
48775031|NCT03191903|157019953|FG002|Overall Study|Adverse Event|0|||
48775032|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
48775033|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
48775034|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
48775035|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
48775036|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
48775037|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
48775038|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
48775039|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
48775040|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
48775041|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
48775042|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
48775043|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
48775044|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
48775045|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
48775046|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
48775047|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
48775048|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
48775049|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
48775050|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
48775051|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
48775052|NCT00813761|157019954|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
48775053|NCT00813761|157019955|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
48775054|NCT00813761|157019956|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
48775055|NCT00813761|157019957|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
48775056|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
48775057|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
48775058|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
48775059|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
48775060|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
48775061|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
48775062|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
48775063|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
48775064|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
48775065|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
48775066|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
48775067|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
48775068|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
48775069|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
48775070|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
48775071|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
48775072|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
48775073|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
48775074|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
48775075|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
48775076|NCT00813761|157019954|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
48775077|NCT00813761|157019955|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
48775078|NCT00813761|157019956|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
48775079|NCT00813761|157019957|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
48775080|NCT00691210|157019958|FG000|Overall Study|Progression of Disease|0|||
48775081|NCT00691210|157019959|FG001|Overall Study|Progression of Disease|0|||
48775082|NCT00691210|157019960|FG002|Overall Study|Progression of Disease|0|||
48775083|NCT00691210|157019961|FG003|Overall Study|Progression of Disease|2|||
48775084|NCT00691210|157019962|FG004|Overall Study|Progression of Disease|0|||
48775085|NCT00691210|157019963|FG005|Overall Study|Progression of Disease|0|||
48775086|NCT00691210|157019964|FG006|Overall Study|Progression of Disease|0|||
48775087|NCT00691210|157019965|FG007|Overall Study|Progression of Disease|0|||
48775088|NCT00691210|157019958|FG000|Overall Study|Lack of Efficacy|0|||
48775089|NCT00691210|157019959|FG001|Overall Study|Lack of Efficacy|0|||
48775090|NCT00691210|157019960|FG002|Overall Study|Lack of Efficacy|0|||
48775091|NCT00691210|157019961|FG003|Overall Study|Lack of Efficacy|1|||
48775092|NCT00691210|157019962|FG004|Overall Study|Lack of Efficacy|0|||
48775093|NCT00691210|157019963|FG005|Overall Study|Lack of Efficacy|1|||
48775094|NCT00691210|157019964|FG006|Overall Study|Lack of Efficacy|0|||
48396220|NCT00159861|155643377|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
48396221|NCT00159861|155643376|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
48396222|NCT00159861|155643377|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
48396223|NCT00159861|155643376|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
48396224|NCT00159861|155643377|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
48396225|NCT00159861|155643376|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
48396226|NCT00159861|155643377|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
48396227|NCT00159861|155643376|FG000|Extension Study - up to 3 Years|Death|24|||
48396228|NCT00159861|155643377|FG001|Extension Study - up to 3 Years|Death|28|||
48396229|NCT00159861|155643376|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
48396230|NCT00159861|155643377|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
48396231|NCT00159861|155643376|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
48396232|NCT00159861|155643377|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
48396233|NCT00159861|155643376|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
48396234|NCT00159861|155643377|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
48396235|NCT00159861|155643376|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
48396236|NCT00159861|155643377|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
48396237|NCT01632566|155643379|FG000|Overall Study|Withdrawal by Subject|0|||
48396238|NCT01632566|155643380|FG001|Overall Study|Withdrawal by Subject|1|||
48396239|NCT01632566|155643381|FG002|Overall Study|Withdrawal by Subject|0|||
48396240|NCT01632566|155643382|FG003|Overall Study|Withdrawal by Subject|0|||
48396241|NCT01632566|155643383|FG004|Overall Study|Withdrawal by Subject|0|||
48396242|NCT01632566|155643379|FG000|Overall Study|Sponsor Decision|0|||
48396243|NCT01632566|155643380|FG001|Overall Study|Sponsor Decision|2|||
48775095|NCT00691210|157019965|FG007|Overall Study|Lack of Efficacy|0|||
48775096|NCT01306617|157019969|FG000|Overall Study|Adverse Event|1|||
48775097|NCT01306617|157019970|FG001|Overall Study|Adverse Event|0|||
48775098|NCT01306617|157019971|FG002|Overall Study|Adverse Event|0|||
48775099|NCT01306617|157019969|FG000|Overall Study|Virologic Failure|0|||
48775100|NCT01306617|157019970|FG001|Overall Study|Virologic Failure|0|||
48775101|NCT01306617|157019971|FG002|Overall Study|Virologic Failure|5|||
48775102|NCT01306617|157019969|FG000|Overall Study|Non-compliance|0|||
48775103|NCT01306617|157019970|FG001|Overall Study|Non-compliance|1|||
48775104|NCT01306617|157019971|FG002|Overall Study|Non-compliance|0|||
48775105|NCT01850004|157019979|FG000|Overall Study|Poor/Non-compliance|1|||
48775106|NCT01850004|157019979|FG000|Overall Study|Participant Withdrew Consent|9|||
48775107|NCT01850004|157019979|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
48775108|NCT01850004|157019979|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
48775109|NCT01850004|157019979|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
48775110|NCT01850004|157019979|FG000|Overall Study|Other Reasons|2|||
48775111|NCT01850004|157019979|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
48775112|NCT01850004|157019979|FG000|Overall Study|Maximum Clinical Benefit|4|||
48775113|NCT00428610|157019980|FG000|Overall Study|Death Due to Adverse Event|3|||
48775114|NCT00428610|157019981|FG001|Overall Study|Death Due to Adverse Event|0|||
48775115|NCT00428610|157019982|FG002|Overall Study|Death Due to Adverse Event|5|||
48775116|NCT00428610|157019980|FG000|Overall Study|Death Due to Progressive Disease|0|||
48775117|NCT00428610|157019981|FG001|Overall Study|Death Due to Progressive Disease|0|||
48775118|NCT00428610|157019982|FG002|Overall Study|Death Due to Progressive Disease|2|||
48775119|NCT00428610|157019980|FG000|Overall Study|Adverse Event|2|||
48775120|NCT00428610|157019981|FG001|Overall Study|Adverse Event|3|||
48775121|NCT00428610|157019982|FG002|Overall Study|Adverse Event|2|||
48775122|NCT00428610|157019980|FG000|Overall Study|Investigator Decision|2|||
48396244|NCT01632566|155643381|FG002|Overall Study|Sponsor Decision|9|||
48396245|NCT01632566|155643382|FG003|Overall Study|Sponsor Decision|2|||
48396246|NCT01632566|155643383|FG004|Overall Study|Sponsor Decision|2|||
48396247|NCT01100437|155643386|FG000|Titration/Stabilization|Adverse Event|0|||
48775123|NCT00428610|157019981|FG001|Overall Study|Investigator Decision|1|||
48775124|NCT00428610|157019982|FG002|Overall Study|Investigator Decision|1|||
48775125|NCT00428610|157019980|FG000|Overall Study|Progressive Disease|42|||
48775126|NCT00428610|157019981|FG001|Overall Study|Progressive Disease|14|||
48775127|NCT00428610|157019982|FG002|Overall Study|Progressive Disease|22|||
48775128|NCT00428610|157019980|FG000|Overall Study|Withdrawal by Subject|4|||
48775129|NCT00428610|157019981|FG001|Overall Study|Withdrawal by Subject|0|||
48775130|NCT00428610|157019982|FG002|Overall Study|Withdrawal by Subject|0|||
48775131|NCT04369469|157019985|FG000|Overall Study|Lost to Follow-up|2|||
48775132|NCT04369469|157019986|FG001|Overall Study|Lost to Follow-up|4|||
48775133|NCT04369469|157019985|FG000|Overall Study|Physician Decision|2|||
48775134|NCT04369469|157019986|FG001|Overall Study|Physician Decision|1|||
48775135|NCT04369469|157019985|FG000|Overall Study|Withdrawal by Subject|2|||
48775136|NCT04369469|157019986|FG001|Overall Study|Withdrawal by Subject|3|||
48775137|NCT04369469|157019985|FG000|Overall Study|Adverse Event|1|||
48775138|NCT04369469|157019986|FG001|Overall Study|Adverse Event|0|||
48775139|NCT04369469|157019985|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
48775140|NCT04369469|157019986|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
48775141|NCT04369469|157019985|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
48775142|NCT04369469|157019986|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
48775143|NCT04369469|157019985|FG000|Overall Study|Unable to Provide Consent|0|||
48775144|NCT04369469|157019986|FG001|Overall Study|Unable to Provide Consent|1|||
48775145|NCT02707640|157019994|FG000|Overall Study|Adverse Event|4|||
48775146|NCT02707640|157019995|FG001|Overall Study|Adverse Event|2|||
48396248|NCT01100437|155643387|FG001|Titration/Stabilization|Adverse Event|0|||
48396249|NCT01100437|155643388|FG002|Titration/Stabilization|Adverse Event|4|||
48396250|NCT01100437|155643386|FG000|Titration/Stabilization|Non-compliance|0|||
48396251|NCT01100437|155643387|FG001|Titration/Stabilization|Non-compliance|0|||
48396252|NCT01100437|155643388|FG002|Titration/Stabilization|Non-compliance|1|||
48396253|NCT01100437|155643386|FG000|Titration/Stabilization|Sponsor canceled study|0|||
48396254|NCT01100437|155643387|FG001|Titration/Stabilization|Sponsor canceled study|0|||
48396255|NCT01100437|155643388|FG002|Titration/Stabilization|Sponsor canceled study|1|||
48396256|NCT01100437|155643386|FG000|Maintenance|Withdrawal by Subject|0|||
48396257|NCT01100437|155643387|FG001|Maintenance|Withdrawal by Subject|0|||
48775147|NCT02707640|157019994|FG000|Overall Study|Death|1|||
48775148|NCT02707640|157019995|FG001|Overall Study|Death|2|||
48775149|NCT02707640|157019994|FG000|Overall Study|Physician Decision|2|||
48775150|NCT02707640|157019995|FG001|Overall Study|Physician Decision|0|||
48775151|NCT02707640|157019994|FG000|Overall Study|Withdrawal by Subject|0|||
48775152|NCT02707640|157019995|FG001|Overall Study|Withdrawal by Subject|1|||
48775153|NCT02707640|157019994|FG000|Overall Study|Participant's Personal Decision|1|||
48775154|NCT02707640|157019995|FG001|Overall Study|Participant's Personal Decision|2|||
48775155|NCT02707640|157019994|FG000|Overall Study|Sponsor Discretion|1|||
48775156|NCT02707640|157019995|FG001|Overall Study|Sponsor Discretion|0|||
48775157|NCT00555438|157019996|FG000|10 Days Post-operative|Death|4|||
48775158|NCT00555438|157019996|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
48775159|NCT01312467|157020000|FG000|Overall Study|Adverse Event|4|||
48775160|NCT01312467|157020000|FG000|Overall Study|Lost to Follow-up|1|||
48775161|NCT01312467|157020000|FG000|Overall Study|Withdrawal by Subject|2|||
48775162|NCT01312467|157020000|FG000|Overall Study|Deported to country of origin|1|||
48775163|NCT01312467|157020000|FG000|Overall Study|Another medical condition|1|||
48775164|NCT01312467|157020000|FG000|Overall Study|Ineligible|4|||
48775165|NCT02199691|157020001|FG000|Overall Study|Protocol Violation|3|||
48775166|NCT02199691|157020002|FG001|Overall Study|Protocol Violation|3|||
48775167|NCT02199691|157020003|FG002|Overall Study|Protocol Violation|6|||
48775168|NCT02199691|157020004|FG003|Overall Study|Protocol Violation|7|||
48775169|NCT02199691|157020001|FG000|Overall Study|Withdrawal by Subject|5|||
48775170|NCT02199691|157020002|FG001|Overall Study|Withdrawal by Subject|3|||
48775171|NCT02199691|157020003|FG002|Overall Study|Withdrawal by Subject|12|||
48775172|NCT02199691|157020004|FG003|Overall Study|Withdrawal by Subject|13|||
48775173|NCT02199691|157020001|FG000|Overall Study|Lost to Follow-up|2|||
48775174|NCT02199691|157020002|FG001|Overall Study|Lost to Follow-up|1|||
48775175|NCT02199691|157020003|FG002|Overall Study|Lost to Follow-up|9|||
48775176|NCT02199691|157020004|FG003|Overall Study|Lost to Follow-up|10|||
48775177|NCT01976845|157020007|FG000|Overall Study|Physician Decision|8|||
48775178|NCT01976845|157020008|FG001|Overall Study|Physician Decision|8|||
48775179|NCT01976845|157020009|FG002|Overall Study|Physician Decision|3|||
48775180|NCT01336738|157021798|FG000|Overall Study|Adverse Event|0|||
48396258|NCT01100437|155643388|FG002|Maintenance|Withdrawal by Subject|1|||
48396259|NCT01100437|155643386|FG000|Maintenance|Sponsor termination of study|0|||
48396260|NCT01100437|155643387|FG001|Maintenance|Sponsor termination of study|0|||
48396261|NCT01100437|155643388|FG002|Maintenance|Sponsor termination of study|1|||
48396262|NCT01358864|155643389|FG000|Overall Study|Adverse Event|0|||
48396263|NCT01358864|155643390|FG001|Overall Study|Adverse Event|6|||
48396264|NCT01358864|155643391|FG002|Overall Study|Adverse Event|9|||
48396265|NCT01358864|155643392|FG003|Overall Study|Adverse Event|0|||
48396266|NCT01358864|155643393|FG004|Overall Study|Adverse Event|4|||
48396267|NCT01358864|155643394|FG005|Overall Study|Adverse Event|8|||
48396268|NCT01358864|155643395|FG006|Overall Study|Adverse Event|12|||
48396269|NCT01358864|155643396|FG007|Overall Study|Adverse Event|7|||
48396270|NCT01358864|155643389|FG000|Overall Study|Lack of Efficacy|26|||
48396271|NCT01358864|155643390|FG001|Overall Study|Lack of Efficacy|3|||
48396272|NCT01358864|155643391|FG002|Overall Study|Lack of Efficacy|4|||
48396273|NCT01358864|155643392|FG003|Overall Study|Lack of Efficacy|19|||
48775181|NCT01336738|157021799|FG001|Overall Study|Adverse Event|3|||
48775182|NCT01336738|157021800|FG002|Overall Study|Adverse Event|2|||
48775183|NCT01336738|157021801|FG003|Overall Study|Adverse Event|1|||
48775184|NCT01336738|157021802|FG004|Overall Study|Adverse Event|3|||
48775185|NCT01336738|157021798|FG000|Overall Study|Lost to Follow-up|2|||
48775186|NCT01336738|157021799|FG001|Overall Study|Lost to Follow-up|1|||
48775187|NCT01336738|157021800|FG002|Overall Study|Lost to Follow-up|2|||
48775188|NCT01336738|157021801|FG003|Overall Study|Lost to Follow-up|2|||
48775189|NCT01336738|157021802|FG004|Overall Study|Lost to Follow-up|2|||
48396274|NCT01358864|155643393|FG004|Overall Study|Lack of Efficacy|7|||
48396275|NCT01358864|155643394|FG005|Overall Study|Lack of Efficacy|4|||
48396276|NCT01358864|155643395|FG006|Overall Study|Lack of Efficacy|49|||
48396277|NCT01358864|155643396|FG007|Overall Study|Lack of Efficacy|44|||
48396278|NCT01358864|155643389|FG000|Overall Study|Lost to Follow-up|0|||
48396279|NCT01358864|155643390|FG001|Overall Study|Lost to Follow-up|0|||
48396280|NCT01358864|155643391|FG002|Overall Study|Lost to Follow-up|1|||
48396281|NCT01358864|155643392|FG003|Overall Study|Lost to Follow-up|0|||
48396282|NCT01358864|155643393|FG004|Overall Study|Lost to Follow-up|0|||
48396283|NCT01358864|155643394|FG005|Overall Study|Lost to Follow-up|0|||
48396284|NCT01358864|155643395|FG006|Overall Study|Lost to Follow-up|0|||
48396285|NCT01358864|155643396|FG007|Overall Study|Lost to Follow-up|1|||
48396286|NCT01358864|155643389|FG000|Overall Study|Withdrawal by Subject|3|||
48396287|NCT01358864|155643390|FG001|Overall Study|Withdrawal by Subject|4|||
48396288|NCT01358864|155643391|FG002|Overall Study|Withdrawal by Subject|2|||
48396289|NCT01358864|155643392|FG003|Overall Study|Withdrawal by Subject|0|||
48396290|NCT01358864|155643393|FG004|Overall Study|Withdrawal by Subject|0|||
48396291|NCT01358864|155643394|FG005|Overall Study|Withdrawal by Subject|1|||
48396292|NCT01358864|155643395|FG006|Overall Study|Withdrawal by Subject|1|||
48396293|NCT01358864|155643396|FG007|Overall Study|Withdrawal by Subject|3|||
48396294|NCT01358864|155643389|FG000|Overall Study|Other reason not defined above|2|||
48396295|NCT01358864|155643390|FG001|Overall Study|Other reason not defined above|0|||
48396296|NCT01358864|155643391|FG002|Overall Study|Other reason not defined above|0|||
48396297|NCT01358864|155643392|FG003|Overall Study|Other reason not defined above|0|||
48396298|NCT01358864|155643393|FG004|Overall Study|Other reason not defined above|0|||
48396299|NCT01358864|155643394|FG005|Overall Study|Other reason not defined above|0|||
48396300|NCT01358864|155643395|FG006|Overall Study|Other reason not defined above|2|||
48396301|NCT01358864|155643396|FG007|Overall Study|Other reason not defined above|0|||
48396302|NCT01358864|155643389|FG000|Overall Study|Not treated|0|||
48396303|NCT01358864|155643390|FG001|Overall Study|Not treated|0|||
48775190|NCT01336738|157021798|FG000|Overall Study|Did not meet entrance criteria|0|||
48775191|NCT01336738|157021799|FG001|Overall Study|Did not meet entrance criteria|1|||
48775192|NCT01336738|157021800|FG002|Overall Study|Did not meet entrance criteria|0|||
48775193|NCT01336738|157021801|FG003|Overall Study|Did not meet entrance criteria|0|||
48775194|NCT01336738|157021802|FG004|Overall Study|Did not meet entrance criteria|0|||
48775195|NCT01336738|157021798|FG000|Overall Study|Protocol Violation|0|||
48775196|NCT01336738|157021799|FG001|Overall Study|Protocol Violation|1|||
48775197|NCT01336738|157021800|FG002|Overall Study|Protocol Violation|0|||
48775198|NCT01336738|157021801|FG003|Overall Study|Protocol Violation|0|||
48775199|NCT01336738|157021802|FG004|Overall Study|Protocol Violation|0|||
48775200|NCT01336738|157021798|FG000|Overall Study|Withdrawal by Subject|2|||
48775201|NCT01336738|157021799|FG001|Overall Study|Withdrawal by Subject|0|||
48775202|NCT01336738|157021800|FG002|Overall Study|Withdrawal by Subject|2|||
48775203|NCT01336738|157021801|FG003|Overall Study|Withdrawal by Subject|1|||
48775204|NCT01336738|157021802|FG004|Overall Study|Withdrawal by Subject|1|||
48775205|NCT01336738|157021798|FG000|Overall Study|Other|3|||
48775206|NCT01336738|157021799|FG001|Overall Study|Other|3|||
48775207|NCT01336738|157021800|FG002|Overall Study|Other|2|||
48775208|NCT01336738|157021801|FG003|Overall Study|Other|3|||
48775209|NCT01336738|157021802|FG004|Overall Study|Other|4|||
48775210|NCT03042312|157021803|FG000|Overall Study|Administrative Reason|1|||
48775211|NCT03042312|157021804|FG001|Overall Study|Administrative Reason|1|||
48775212|NCT03042312|157021803|FG000|Overall Study|Adverse Event|0|||
48775213|NCT03042312|157021804|FG001|Overall Study|Adverse Event|1|||
48775214|NCT03042312|157021803|FG000|Overall Study|Lost to Follow-up|1|||
48775215|NCT03042312|157021804|FG001|Overall Study|Lost to Follow-up|3|||
48775216|NCT03042312|157021803|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
48775217|NCT03042312|157021804|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
48396304|NCT01358864|155643391|FG002|Overall Study|Not treated|0|||
48396305|NCT01358864|155643392|FG003|Overall Study|Not treated|0|||
48396306|NCT01358864|155643393|FG004|Overall Study|Not treated|0|||
48775218|NCT03042312|157021803|FG000|Overall Study|Withdrawal by Subject|4|||
48775219|NCT03042312|157021804|FG001|Overall Study|Withdrawal by Subject|5|||
48396307|NCT01358864|155643394|FG005|Overall Study|Not treated|0|||
48396308|NCT01358864|155643395|FG006|Overall Study|Not treated|1|||
48396309|NCT01358864|155643396|FG007|Overall Study|Not treated|0|||
48396310|NCT00278993|155643403|FG000|Overall Study|Adverse Event|24|||
48775220|NCT03003520|157021813|FG000|Overall Study|Adverse Event|9|||
48775221|NCT03003520|157021814|FG001|Overall Study|Adverse Event|0|||
48775222|NCT03003520|157021813|FG000|Overall Study|Death|1|||
48775223|NCT03003520|157021814|FG001|Overall Study|Death|0|||
48775224|NCT03003520|157021813|FG000|Overall Study|Other reasons|4|||
48775225|NCT03003520|157021814|FG001|Overall Study|Other reasons|0|||
48775226|NCT03003520|157021813|FG000|Overall Study|Withdrawal by Subject|6|||
48775227|NCT03003520|157021814|FG001|Overall Study|Withdrawal by Subject|0|||
48775228|NCT03003520|157021813|FG000|Overall Study|Progressive disease|9|||
48396311|NCT00278993|155643403|FG000|Overall Study|Withdrawal by Subject|5|||
48396312|NCT00278993|155643403|FG000|Overall Study|Progressive Disease|65|||
48396313|NCT00278993|155643403|FG000|Overall Study|Physician Decision|9|||
48396314|NCT00278993|155643403|FG000|Overall Study|Not Otherwise Specified|4|||
48396315|NCT01250379|155643404|FG000|Overall Study|Death|141|||
48396316|NCT01250379|155643405|FG001|Overall Study|Death|148|||
48396317|NCT01250379|155643404|FG000|Overall Study|Withdrawal by Subject|32|||
48396318|NCT01250379|155643405|FG001|Overall Study|Withdrawal by Subject|20|||
48396319|NCT01250379|155643404|FG000|Overall Study|Physician Decision|11|||
48396320|NCT01250379|155643405|FG001|Overall Study|Physician Decision|3|||
48396321|NCT01250379|155643404|FG000|Overall Study|Protocol Violation|2|||
48396322|NCT01250379|155643405|FG001|Overall Study|Protocol Violation|8|||
48396323|NCT01250379|155643404|FG000|Overall Study|Lost to Follow-up|9|||
48396324|NCT01250379|155643405|FG001|Overall Study|Lost to Follow-up|6|||
48396325|NCT01250379|155643404|FG000|Overall Study|Adverse Event|5|||
48396326|NCT01250379|155643405|FG001|Overall Study|Adverse Event|4|||
48396327|NCT01250379|155643404|FG000|Overall Study|Other|0|||
48396328|NCT01250379|155643405|FG001|Overall Study|Other|4|||
48396329|NCT01250379|155643404|FG000|Overall Study|Participant noncompliance|2|||
48396330|NCT01250379|155643405|FG001|Overall Study|Participant noncompliance|0|||
48396331|NCT02270242|155643408|FG000|Overall Study|Withdrawal by Subject|18|||
48396332|NCT02270242|155643409|FG001|Overall Study|Withdrawal by Subject|25|||
48396333|NCT02270242|155643408|FG000|Overall Study|Lost to Follow-up|41|||
48396334|NCT02270242|155643409|FG001|Overall Study|Lost to Follow-up|27|||
48396335|NCT02270242|155643408|FG000|Overall Study|Physician Decision|0|||
48396336|NCT02270242|155643409|FG001|Overall Study|Physician Decision|1|||
48396337|NCT00644787|155643412|FG000|Period 1: Titration Phase|Adverse Event|11|||
48396338|NCT00644787|155643413|FG001|Period 1: Titration Phase|Adverse Event|0|||
48396339|NCT00644787|155643414|FG002|Period 1: Titration Phase|Adverse Event|0|||
48396340|NCT00644787|155643412|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
48396341|NCT00644787|155643413|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
48396342|NCT00644787|155643414|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
48396343|NCT00644787|155643412|FG000|Period 1: Titration Phase|Physician Decision|1|||
48775229|NCT03003520|157021814|FG001|Overall Study|Progressive disease|1|||
48775230|NCT00827372|157021815|FG000|Overall Study|Adverse Event|5|||
48775231|NCT00827372|157021815|FG000|Overall Study|Lack of Efficacy|3|||
48775232|NCT03085927|157021816|FG000|Overall Study|Withdrawal by Subject|1|||
48775233|NCT03085927|157021817|FG001|Overall Study|Withdrawal by Subject|4|||
48775234|NCT03085927|157021816|FG000|Overall Study|Lost to Follow-up|3|||
48775235|NCT03085927|157021817|FG001|Overall Study|Lost to Follow-up|1|||
48775236|NCT03085927|157021816|FG000|Overall Study|Death|1|||
48775237|NCT03085927|157021817|FG001|Overall Study|Death|0|||
48775238|NCT03085927|157021816|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
48775239|NCT03085927|157021817|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
48775240|NCT03085927|157021816|FG000|Overall Study|Dyad Became Ineligible|0|||
48775241|NCT03085927|157021817|FG001|Overall Study|Dyad Became Ineligible|1|||
48775242|NCT02565381|157021821|FG000|Overall Study|Lost to Follow-up|1|||
48775243|NCT02565381|157021822|FG001|Overall Study|Lost to Follow-up|0|||
48775244|NCT02565381|157021823|FG002|Overall Study|Lost to Follow-up|1|||
48775245|NCT03036566|157021830|FG000|Overall Study|Lost to Follow-up|3|||
48775246|NCT00672477|157021831|FG000|Overall Study|Adverse Event|10|||
48775247|NCT00672477|157021832|FG001|Overall Study|Adverse Event|7|||
48775248|NCT00672477|157021831|FG000|Overall Study|Death|7|||
48775249|NCT00672477|157021832|FG001|Overall Study|Death|11|||
48775250|NCT00672477|157021831|FG000|Overall Study|Physician Decision|2|||
48775251|NCT00672477|157021832|FG001|Overall Study|Physician Decision|0|||
48775252|NCT00672477|157021831|FG000|Overall Study|Protocol Violation|1|||
48775253|NCT00672477|157021832|FG001|Overall Study|Protocol Violation|1|||
48396344|NCT00644787|155643413|FG001|Period 1: Titration Phase|Physician Decision|0|||
48396345|NCT00644787|155643414|FG002|Period 1: Titration Phase|Physician Decision|0|||
48396346|NCT00644787|155643412|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
48396347|NCT00644787|155643413|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
48775254|NCT00672477|157021831|FG000|Overall Study|Withdrawal by Subject|5|||
48775255|NCT00672477|157021832|FG001|Overall Study|Withdrawal by Subject|3|||
48775256|NCT00672477|157021831|FG000|Overall Study|Lack of Efficacy|1|||
48775257|NCT00672477|157021832|FG001|Overall Study|Lack of Efficacy|1|||
48775258|NCT00672477|157021831|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
48775259|NCT00672477|157021832|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
48775260|NCT03986944|157021833|FG000|Overall Study|Adverse Event|1|||
48775261|NCT03986944|157021834|FG001|Overall Study|Adverse Event|2|||
48775262|NCT03986944|157021835|FG002|Overall Study|Adverse Event|3|||
48775263|NCT03986944|157021833|FG000|Overall Study|Protocol Violation|0|||
48775264|NCT03986944|157021834|FG001|Overall Study|Protocol Violation|1|||
48775265|NCT03986944|157021835|FG002|Overall Study|Protocol Violation|1|||
48775266|NCT03986944|157021833|FG000|Overall Study|Withdrawal by Subject|3|||
48775267|NCT03986944|157021834|FG001|Overall Study|Withdrawal by Subject|5|||
48775268|NCT03986944|157021835|FG002|Overall Study|Withdrawal by Subject|5|||
48775269|NCT03986944|157021833|FG000|Overall Study|Study termination|10|||
48775270|NCT03986944|157021834|FG001|Overall Study|Study termination|10|||
48775271|NCT03986944|157021835|FG002|Overall Study|Study termination|10|||
48775272|NCT03986944|157021833|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
48775273|NCT03986944|157021834|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
48775274|NCT03986944|157021835|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
48775275|NCT03986944|157021833|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
48775276|NCT03986944|157021834|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
48775277|NCT03986944|157021835|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
48775278|NCT00634647|157021839|FG000|Overall Study|death on study|3|||
48775279|NCT00634647|157021839|FG000|Overall Study|refused further treatment|3|||
48775280|NCT00634647|157021839|FG000|Overall Study|declined to participate before treatment|1|||
48775281|NCT02984020|157021840|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
48775282|NCT02984020|157021840|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
48775283|NCT02984020|157021840|FG000|Overall Study|Other significant protocol violation|2|||
48775284|NCT01529645|157021841|FG000|Overall Study|Lost to Follow-up|0|||
48775285|NCT01529645|157021842|FG001|Overall Study|Lost to Follow-up|1|||
48775286|NCT01529645|157021843|FG002|Overall Study|Lost to Follow-up|1|||
48775287|NCT01529645|157021844|FG003|Overall Study|Lost to Follow-up|1|||
48775288|NCT01529645|157021845|FG004|Overall Study|Lost to Follow-up|1|||
48775289|NCT01529645|157021846|FG005|Overall Study|Lost to Follow-up|0|||
48775290|NCT01529645|157021847|FG006|Overall Study|Lost to Follow-up|2|||
48775291|NCT01529645|157021848|FG007|Overall Study|Lost to Follow-up|0|||
48775292|NCT01529645|157021849|FG008|Overall Study|Lost to Follow-up|1|||
48775293|NCT01529645|157021850|FG009|Overall Study|Lost to Follow-up|0|||
48775294|NCT01529645|157021841|FG000|Overall Study|SAE - Premature contractions|0|||
48775295|NCT01529645|157021842|FG001|Overall Study|SAE - Premature contractions|0|||
48775296|NCT01529645|157021843|FG002|Overall Study|SAE - Premature contractions|1|||
48775297|NCT01529645|157021844|FG003|Overall Study|SAE - Premature contractions|0|||
48775298|NCT01529645|157021845|FG004|Overall Study|SAE - Premature contractions|0|||
48775299|NCT01529645|157021846|FG005|Overall Study|SAE - Premature contractions|0|||
48775300|NCT01529645|157021847|FG006|Overall Study|SAE - Premature contractions|0|||
48775301|NCT01529645|157021848|FG007|Overall Study|SAE - Premature contractions|0|||
48775302|NCT01529645|157021849|FG008|Overall Study|SAE - Premature contractions|0|||
48775303|NCT01529645|157021850|FG009|Overall Study|SAE - Premature contractions|0|||
48775304|NCT01529645|157021841|FG000|Overall Study|Withdrawal by Subject|2|||
48775305|NCT01529645|157021842|FG001|Overall Study|Withdrawal by Subject|0|||
48775306|NCT01529645|157021843|FG002|Overall Study|Withdrawal by Subject|0|||
48775307|NCT01529645|157021844|FG003|Overall Study|Withdrawal by Subject|1|||
48775308|NCT01529645|157021845|FG004|Overall Study|Withdrawal by Subject|1|||
48775309|NCT01529645|157021846|FG005|Overall Study|Withdrawal by Subject|1|||
48775310|NCT01529645|157021847|FG006|Overall Study|Withdrawal by Subject|0|||
48775311|NCT01529645|157021848|FG007|Overall Study|Withdrawal by Subject|0|||
48775312|NCT01529645|157021849|FG008|Overall Study|Withdrawal by Subject|0|||
48775313|NCT01529645|157021850|FG009|Overall Study|Withdrawal by Subject|0|||
48775314|NCT02880371|157021854|FG000|Phase 1b|Lost to Follow-up|1|||
48775315|NCT02880371|157021855|FG001|Phase 1b|Lost to Follow-up|0|||
48775316|NCT02880371|157021856|FG002|Phase 1b|Lost to Follow-up|0|||
48775317|NCT02880371|157021857|FG003|Phase 1b|Lost to Follow-up|0|||
48775318|NCT02880371|157021858|FG004|Phase 1b|Lost to Follow-up|0|||
48775319|NCT02880371|157021859|FG005|Phase 1b|Lost to Follow-up|0|||
48775320|NCT02880371|157021860|FG006|Phase 1b|Lost to Follow-up|0|||
48775321|NCT02880371|157021861|FG007|Phase 1b|Lost to Follow-up|0|||
48775322|NCT02880371|157021854|FG000|Phase 1b|Participants terminated by Sponsor|1|||
48775323|NCT02880371|157021855|FG001|Phase 1b|Participants terminated by Sponsor|0|||
48775324|NCT02880371|157021856|FG002|Phase 1b|Participants terminated by Sponsor|0|||
48775325|NCT02880371|157021857|FG003|Phase 1b|Participants terminated by Sponsor|0|||
48775326|NCT02880371|157021858|FG004|Phase 1b|Participants terminated by Sponsor|0|||
48775327|NCT02880371|157021859|FG005|Phase 1b|Participants terminated by Sponsor|0|||
48775328|NCT02880371|157021860|FG006|Phase 1b|Participants terminated by Sponsor|0|||
48775329|NCT02880371|157021861|FG007|Phase 1b|Participants terminated by Sponsor|0|||
48356250|NCT03126110|155501055|FG000|Phase 1|Safety follow-up no longer necessary|1|||
48775330|NCT02880371|157021854|FG000|Phase 1b|Withdrawal by Subject|0|||
48775331|NCT02880371|157021855|FG001|Phase 1b|Withdrawal by Subject|0|||
48775332|NCT02880371|157021856|FG002|Phase 1b|Withdrawal by Subject|1|||
48775333|NCT02880371|157021857|FG003|Phase 1b|Withdrawal by Subject|0|||
48775334|NCT02880371|157021858|FG004|Phase 1b|Withdrawal by Subject|0|||
48775335|NCT02880371|157021859|FG005|Phase 1b|Withdrawal by Subject|0|||
48775336|NCT02880371|157021860|FG006|Phase 1b|Withdrawal by Subject|0|||
48775337|NCT02880371|157021861|FG007|Phase 1b|Withdrawal by Subject|0|||
48775338|NCT02880371|157021854|FG000|Phase 1b|Death|4|||
48775339|NCT02880371|157021855|FG001|Phase 1b|Death|6|||
48775340|NCT02880371|157021856|FG002|Phase 1b|Death|5|||
48775341|NCT02880371|157021857|FG003|Phase 1b|Death|1|||
48775342|NCT02880371|157021858|FG004|Phase 1b|Death|0|||
48775343|NCT02880371|157021859|FG005|Phase 1b|Death|0|||
48775344|NCT02880371|157021860|FG006|Phase 1b|Death|0|||
48775345|NCT02880371|157021861|FG007|Phase 1b|Death|0|||
48775346|NCT02880371|157021854|FG000|Phase 1b|Enrolled but not Treated|0|||
48775347|NCT02880371|157021855|FG001|Phase 1b|Enrolled but not Treated|1|||
48775348|NCT02880371|157021856|FG002|Phase 1b|Enrolled but not Treated|0|||
48775349|NCT02880371|157021857|FG003|Phase 1b|Enrolled but not Treated|0|||
48775350|NCT02880371|157021858|FG004|Phase 1b|Enrolled but not Treated|0|||
48775351|NCT02880371|157021859|FG005|Phase 1b|Enrolled but not Treated|0|||
48775352|NCT02880371|157021860|FG006|Phase 1b|Enrolled but not Treated|0|||
48775353|NCT02880371|157021861|FG007|Phase 1b|Enrolled but not Treated|0|||
48775354|NCT02880371|157021854|FG000|Phase 2|Enrolled but not Treated|0|||
48775355|NCT02880371|157021855|FG001|Phase 2|Enrolled but not Treated|0|||
48775356|NCT02880371|157021856|FG002|Phase 2|Enrolled but not Treated|0|||
48775357|NCT02880371|157021857|FG003|Phase 2|Enrolled but not Treated|0|||
48775358|NCT02880371|157021858|FG004|Phase 2|Enrolled but not Treated|0|||
48775359|NCT02880371|157021859|FG005|Phase 2|Enrolled but not Treated|1|||
48775360|NCT02880371|157021860|FG006|Phase 2|Enrolled but not Treated|1|||
48775361|NCT02880371|157021861|FG007|Phase 2|Enrolled but not Treated|0|||
48775362|NCT02880371|157021854|FG000|Phase 2|Other|0|||
48775363|NCT02880371|157021855|FG001|Phase 2|Other|0|||
48775364|NCT02880371|157021856|FG002|Phase 2|Other|0|||
48775365|NCT02880371|157021857|FG003|Phase 2|Other|0|||
48775366|NCT02880371|157021858|FG004|Phase 2|Other|0|||
48775367|NCT02880371|157021859|FG005|Phase 2|Other|1|||
48775368|NCT02880371|157021860|FG006|Phase 2|Other|2|||
48775369|NCT02880371|157021861|FG007|Phase 2|Other|1|||
48775370|NCT02880371|157021854|FG000|Phase 2|Participants terminated by Sponsor|0|||
48775371|NCT02880371|157021855|FG001|Phase 2|Participants terminated by Sponsor|0|||
48775372|NCT02880371|157021856|FG002|Phase 2|Participants terminated by Sponsor|0|||
48775373|NCT02880371|157021857|FG003|Phase 2|Participants terminated by Sponsor|0|||
48775374|NCT02880371|157021858|FG004|Phase 2|Participants terminated by Sponsor|1|||
48775375|NCT02880371|157021859|FG005|Phase 2|Participants terminated by Sponsor|6|||
48775376|NCT02880371|157021860|FG006|Phase 2|Participants terminated by Sponsor|1|||
48775377|NCT02880371|157021861|FG007|Phase 2|Participants terminated by Sponsor|5|||
48775378|NCT02880371|157021854|FG000|Phase 2|Death|0|||
48775379|NCT02880371|157021855|FG001|Phase 2|Death|0|||
48775380|NCT02880371|157021856|FG002|Phase 2|Death|0|||
48775381|NCT02880371|157021857|FG003|Phase 2|Death|0|||
48775382|NCT02880371|157021858|FG004|Phase 2|Death|1|||
48775383|NCT02880371|157021859|FG005|Phase 2|Death|10|||
48775384|NCT02880371|157021860|FG006|Phase 2|Death|20|||
48775385|NCT02880371|157021861|FG007|Phase 2|Death|5|||
48775386|NCT02880371|157021854|FG000|Phase 2|Lost to Follow-up|0|||
48775387|NCT02880371|157021855|FG001|Phase 2|Lost to Follow-up|0|||
48775388|NCT02880371|157021856|FG002|Phase 2|Lost to Follow-up|0|||
48775389|NCT02880371|157021857|FG003|Phase 2|Lost to Follow-up|0|||
48775390|NCT02880371|157021858|FG004|Phase 2|Lost to Follow-up|0|||
48775391|NCT02880371|157021859|FG005|Phase 2|Lost to Follow-up|0|||
48775392|NCT02880371|157021860|FG006|Phase 2|Lost to Follow-up|3|||
48775393|NCT02880371|157021861|FG007|Phase 2|Lost to Follow-up|0|||
48775394|NCT02880371|157021854|FG000|Phase 2|Withdrawal by Subject|0|||
48775395|NCT02880371|157021855|FG001|Phase 2|Withdrawal by Subject|0|||
48775396|NCT02880371|157021856|FG002|Phase 2|Withdrawal by Subject|0|||
48775397|NCT02880371|157021857|FG003|Phase 2|Withdrawal by Subject|0|||
48775398|NCT02880371|157021858|FG004|Phase 2|Withdrawal by Subject|0|||
48775399|NCT02880371|157021859|FG005|Phase 2|Withdrawal by Subject|1|||
48775400|NCT02880371|157021860|FG006|Phase 2|Withdrawal by Subject|1|||
48775401|NCT02880371|157021861|FG007|Phase 2|Withdrawal by Subject|0|||
48775402|NCT02880371|157021854|FG000|Phase 2|End of Study page not completed by error|0|||
48775403|NCT02880371|157021855|FG001|Phase 2|End of Study page not completed by error|0|||
48775404|NCT02880371|157021856|FG002|Phase 2|End of Study page not completed by error|0|||
48775405|NCT02880371|157021857|FG003|Phase 2|End of Study page not completed by error|0|||
48775406|NCT02880371|157021858|FG004|Phase 2|End of Study page not completed by error|0|||
48356251|NCT03126110|155501056|FG001|Phase 1|Safety follow-up no longer necessary|0|||
48775407|NCT02880371|157021859|FG005|Phase 2|End of Study page not completed by error|1|||
48775408|NCT02880371|157021860|FG006|Phase 2|End of Study page not completed by error|0|||
48775409|NCT02880371|157021861|FG007|Phase 2|End of Study page not completed by error|0|||
48775410|NCT02649972|157021864|FG000|Overall Study|Not treated|1|||
48396348|NCT00644787|155643414|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
48396349|NCT00644787|155643412|FG000|Period 1: Titration Phase|Worsening of complications|1|||
48396350|NCT00644787|155643413|FG001|Period 1: Titration Phase|Worsening of complications|0|||
48356252|NCT03126110|155501057|FG002|Phase 1|Safety follow-up no longer necessary|0|||
48356253|NCT03126110|155501058|FG003|Phase 1|Safety follow-up no longer necessary|0|||
48356254|NCT03126110|155501059|FG004|Phase 1|Safety follow-up no longer necessary|0|||
48356255|NCT03126110|155501060|FG005|Phase 1|Safety follow-up no longer necessary|0|||
48356256|NCT03126110|155501061|FG006|Phase 1|Safety follow-up no longer necessary|0|||
48396351|NCT00644787|155643414|FG002|Period 1: Titration Phase|Worsening of complications|0|||
48775411|NCT01777997|157021868|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
48775412|NCT01777997|157021868|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
48775413|NCT01777997|157021868|FG000|Weeks 48 to 72/96 on ART|Death|1|||
48775414|NCT01777997|157021868|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
48775415|NCT00306592|157021876|FG000|Overall Study|Adverse Event|8|||
48775416|NCT00306592|157021877|FG001|Overall Study|Adverse Event|15|||
48775417|NCT00306592|157021876|FG000|Overall Study|Lost to Follow-up|1|||
48775418|NCT00306592|157021877|FG001|Overall Study|Lost to Follow-up|0|||
48775419|NCT00306592|157021876|FG000|Overall Study|Noncompliance|0|||
48775420|NCT00306592|157021877|FG001|Overall Study|Noncompliance|2|||
48775421|NCT00306592|157021876|FG000|Overall Study|Persistent Antibodies|6|||
48775422|NCT00306592|157021877|FG001|Overall Study|Persistent Antibodies|3|||
48775423|NCT00306592|157021876|FG000|Overall Study|Voluntary|10|||
48775424|NCT00306592|157021877|FG001|Overall Study|Voluntary|6|||
48775425|NCT00306592|157021876|FG000|Overall Study|Other|5|||
48775426|NCT00306592|157021877|FG001|Overall Study|Other|10|||
48775427|NCT00306592|157021876|FG000|Overall Study|Other|1|||
48775428|NCT00306592|157021877|FG001|Overall Study|Other|2|||
48775429|NCT00306592|157021876|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
48775430|NCT00306592|157021877|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
48775431|NCT01302964|157021878|FG000|Overall Study|Adverse Event|1|||
48775432|NCT01302964|157021879|FG001|Overall Study|Adverse Event|0|||
48775433|NCT04640311|157021884|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
48775434|NCT04640311|157021885|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775435|NCT04640311|157021886|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775436|NCT04640311|157021887|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775437|NCT04640311|157021888|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775438|NCT04640311|157021889|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775439|NCT04640311|157021890|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775440|NCT04640311|157021891|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775441|NCT04640311|157021892|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775442|NCT04640311|157021893|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775443|NCT04640311|157021894|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775444|NCT04640311|157021895|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775445|NCT04640311|157021896|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775446|NCT04640311|157021884|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775447|NCT04640311|157021885|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
48775448|NCT04640311|157021886|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775449|NCT04640311|157021887|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775450|NCT04640311|157021888|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775451|NCT04640311|157021889|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775452|NCT04640311|157021890|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775453|NCT04640311|157021891|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775454|NCT04640311|157021892|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775455|NCT04640311|157021893|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775456|NCT04640311|157021894|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775457|NCT04640311|157021895|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775458|NCT04640311|157021896|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
48775459|NCT04640311|157021884|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775460|NCT04640311|157021885|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
48775461|NCT04640311|157021886|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775462|NCT04640311|157021887|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775463|NCT04640311|157021888|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775464|NCT04640311|157021889|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48356257|NCT03126110|155501062|FG007|Phase 1|Safety follow-up no longer necessary|0|||
48356258|NCT03126110|155501063|FG008|Phase 1|Safety follow-up no longer necessary|0|||
48775465|NCT04640311|157021890|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775466|NCT04640311|157021891|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775467|NCT04640311|157021892|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775468|NCT04640311|157021893|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775469|NCT04640311|157021894|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775470|NCT04640311|157021895|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775471|NCT04640311|157021896|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775472|NCT04640311|157021884|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
48775473|NCT04640311|157021885|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
48775474|NCT04640311|157021886|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
48775475|NCT04640311|157021887|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775476|NCT04640311|157021888|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775477|NCT04640311|157021889|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775478|NCT04640311|157021890|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775479|NCT04640311|157021891|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775480|NCT04640311|157021892|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775481|NCT04640311|157021893|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775482|NCT04640311|157021894|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775483|NCT04640311|157021895|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775484|NCT04640311|157021896|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
48775485|NCT04640311|157021884|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775486|NCT04640311|157021885|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775487|NCT04640311|157021886|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
48775488|NCT04640311|157021887|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775489|NCT04640311|157021888|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775490|NCT04640311|157021889|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775491|NCT04640311|157021890|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775492|NCT04640311|157021891|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775493|NCT04640311|157021892|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775494|NCT04640311|157021893|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775495|NCT04640311|157021894|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775496|NCT04640311|157021895|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775497|NCT04640311|157021896|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
48775498|NCT04640311|157021884|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775499|NCT04640311|157021885|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775500|NCT04640311|157021886|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48356259|NCT03126110|155501064|FG009|Phase 1|Safety follow-up no longer necessary|0|||
48356260|NCT03126110|155501065|FG010|Phase 1|Safety follow-up no longer necessary|0|||
48356261|NCT03126110|155501066|FG011|Phase 1|Safety follow-up no longer necessary|0|||
48356262|NCT03126110|155501067|FG012|Phase 1|Safety follow-up no longer necessary|0|||
48356263|NCT03126110|155501068|FG013|Phase 1|Safety follow-up no longer necessary|0|||
48356264|NCT03126110|155501069|FG014|Phase 1|Safety follow-up no longer necessary|0|||
48396352|NCT00644787|155643412|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
48396353|NCT00644787|155643413|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
48396354|NCT00644787|155643414|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
48396355|NCT00644787|155643412|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
48396356|NCT00644787|155643413|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
48396357|NCT00644787|155643414|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
48396358|NCT00644787|155643412|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
48396359|NCT00644787|155643413|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
48396360|NCT00644787|155643414|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
48396361|NCT00644787|155643412|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
48396362|NCT00644787|155643413|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
48396363|NCT00644787|155643414|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
48430335|NCT00696657|155763707|FG007|Overall Study|Protocol Violation|0|||
48356265|NCT03126110|155501070|FG015|Phase 1|Safety follow-up no longer necessary|0|||
48356266|NCT03126110|155501071|FG016|Phase 1|Safety follow-up no longer necessary|0|||
48396364|NCT00644787|155643412|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
48396365|NCT00644787|155643413|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
48396366|NCT00644787|155643414|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
48396367|NCT00644787|155643412|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
48396368|NCT00644787|155643413|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
48396369|NCT00644787|155643414|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
48396370|NCT00644787|155643412|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
48396371|NCT00644787|155643413|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
48396372|NCT00644787|155643414|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
48396373|NCT00805480|155643415|FG000|Overall Study|Withdrawal by Subject|13|||
48396374|NCT00805480|155643416|FG001|Overall Study|Withdrawal by Subject|5|||
48396375|NCT00805480|155643417|FG002|Overall Study|Withdrawal by Subject|11|||
48396376|NCT00805480|155643418|FG003|Overall Study|Withdrawal by Subject|5|||
48396377|NCT00805480|155643415|FG000|Overall Study|Lost to Follow-up|1|||
48775501|NCT04640311|157021887|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
48775502|NCT04640311|157021888|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775503|NCT04640311|157021889|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775504|NCT04640311|157021890|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
48775505|NCT04640311|157021891|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775506|NCT04640311|157021892|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775507|NCT04640311|157021893|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775508|NCT04640311|157021894|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775509|NCT04640311|157021895|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48775510|NCT04640311|157021896|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
48396378|NCT00805480|155643416|FG001|Overall Study|Lost to Follow-up|2|||
48396379|NCT00805480|155643417|FG002|Overall Study|Lost to Follow-up|0|||
48396380|NCT00805480|155643418|FG003|Overall Study|Lost to Follow-up|0|||
48396381|NCT00805480|155643415|FG000|Overall Study|Adverse Event|0|||
48396382|NCT00805480|155643416|FG001|Overall Study|Adverse Event|0|||
48396383|NCT00805480|155643417|FG002|Overall Study|Adverse Event|1|||
48775511|NCT04640311|157021884|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775512|NCT04640311|157021885|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775513|NCT04640311|157021886|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775514|NCT04640311|157021887|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48396384|NCT00805480|155643418|FG003|Overall Study|Adverse Event|0|||
48396385|NCT00861744|155643419|FG000|Overall Study|Adverse Event|0|||
48396386|NCT00861744|155643420|FG001|Overall Study|Adverse Event|0|||
48396387|NCT00861744|155643421|FG002|Overall Study|Adverse Event|0|||
48396388|NCT00861744|155643422|FG003|Overall Study|Adverse Event|1|||
48396389|NCT00861744|155643419|FG000|Overall Study|Lost to Follow-up|7|||
48396390|NCT00861744|155643420|FG001|Overall Study|Lost to Follow-up|19|||
48396391|NCT00861744|155643421|FG002|Overall Study|Lost to Follow-up|17|||
48396392|NCT00861744|155643422|FG003|Overall Study|Lost to Follow-up|12|||
48396393|NCT00861744|155643419|FG000|Overall Study|Withdrawal by Subject|10|||
48396394|NCT00861744|155643420|FG001|Overall Study|Withdrawal by Subject|6|||
48396395|NCT00861744|155643421|FG002|Overall Study|Withdrawal by Subject|6|||
48396396|NCT00861744|155643422|FG003|Overall Study|Withdrawal by Subject|19|||
48396397|NCT00861744|155643419|FG000|Overall Study|Protocol Violation|0|||
48396398|NCT00861744|155643420|FG001|Overall Study|Protocol Violation|1|||
48396399|NCT00861744|155643421|FG002|Overall Study|Protocol Violation|0|||
48775515|NCT04640311|157021888|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775516|NCT04640311|157021889|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
48775517|NCT04640311|157021890|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775518|NCT04640311|157021891|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775519|NCT04640311|157021892|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
48775520|NCT04640311|157021893|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775521|NCT04640311|157021894|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775522|NCT04640311|157021895|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775523|NCT04640311|157021896|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
48775524|NCT04640311|157021884|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775525|NCT04640311|157021885|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775526|NCT04640311|157021886|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775527|NCT04640311|157021887|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775528|NCT04640311|157021888|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775529|NCT04640311|157021889|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775530|NCT04640311|157021890|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
48775531|NCT04640311|157021891|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775532|NCT04640311|157021892|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775533|NCT04640311|157021893|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775534|NCT04640311|157021894|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
48775535|NCT04640311|157021895|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775536|NCT04640311|157021896|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
48775537|NCT04640311|157021884|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775538|NCT04640311|157021885|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775539|NCT04640311|157021886|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775540|NCT04640311|157021887|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775541|NCT04640311|157021888|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775542|NCT04640311|157021889|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775543|NCT04640311|157021890|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775544|NCT04640311|157021891|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775545|NCT04640311|157021892|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775546|NCT04640311|157021893|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775547|NCT04640311|157021894|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775548|NCT04640311|157021895|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
48775549|NCT04640311|157021896|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
48775550|NCT04101526|157021899|FG000|Overall Study|Did not complete all sleep diary entries|0|||
48775551|NCT04101526|157021900|FG001|Overall Study|Did not complete all sleep diary entries|1|||
48775552|NCT02944578|157021901|FG000|Overall Study|Physician Decision|1|||
48775553|NCT02944578|157021902|FG001|Overall Study|Physician Decision|0|||
48775554|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
48775555|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
48775556|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
48775557|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
48775558|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
48775559|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
48775560|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
48775561|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
48775562|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
48775563|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48775564|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
48775565|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
48775566|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
48775567|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
48775568|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
48356267|NCT03126110|155501055|FG000|Phase 1|Survival follow-up no longer necessary|0|||
48356268|NCT03126110|155501056|FG001|Phase 1|Survival follow-up no longer necessary|0|||
48356269|NCT03126110|155501057|FG002|Phase 1|Survival follow-up no longer necessary|1|||
48356270|NCT03126110|155501058|FG003|Phase 1|Survival follow-up no longer necessary|0|||
48356271|NCT03126110|155501059|FG004|Phase 1|Survival follow-up no longer necessary|0|||
48356272|NCT03126110|155501060|FG005|Phase 1|Survival follow-up no longer necessary|0|||
48356273|NCT03126110|155501061|FG006|Phase 1|Survival follow-up no longer necessary|0|||
48775569|NCT01257204|157021903|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
48775570|NCT01257204|157021904|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
48775571|NCT01257204|157021905|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
48775572|NCT01257204|157021903|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
48775573|NCT01257204|157021904|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
48775574|NCT01257204|157021905|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
48775575|NCT01257204|157021903|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
48775576|NCT01257204|157021904|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
48775577|NCT01257204|157021905|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
48775578|NCT01257204|157021903|FG000|Follow-up Period (up to Week 48)|Other|0|||
48775579|NCT01257204|157021904|FG001|Follow-up Period (up to Week 48)|Other|0|||
48775580|NCT01257204|157021905|FG002|Follow-up Period (up to Week 48)|Other|5|||
48775581|NCT00145509|157021906|FG000|Overall Study|Adverse Event|10|||
48775582|NCT00145509|157021907|FG001|Overall Study|Adverse Event|3|||
48775583|NCT00145509|157021906|FG000|Overall Study|Lack of Efficacy|3|||
48775584|NCT00145509|157021907|FG001|Overall Study|Lack of Efficacy|1|||
48775585|NCT00145509|157021906|FG000|Overall Study|Lost to Follow-up|5|||
48775586|NCT00145509|157021907|FG001|Overall Study|Lost to Follow-up|9|||
48775587|NCT00145509|157021906|FG000|Overall Study|Withdrew Consent|2|||
48775588|NCT00145509|157021907|FG001|Overall Study|Withdrew Consent|7|||
48775589|NCT00145509|157021906|FG000|Overall Study|Reason not provided|2|||
48775590|NCT00145509|157021907|FG001|Overall Study|Reason not provided|1|||
48775591|NCT01481116|157021909|FG000|Overall Study|Adverse Event|26|||
48775592|NCT01481116|157021910|FG001|Overall Study|Adverse Event|26|||
48775593|NCT01481116|157021911|FG002|Overall Study|Adverse Event|42|||
48775594|NCT01481116|157021909|FG000|Overall Study|Major Protocol Deviation|3|||
48775595|NCT01481116|157021910|FG001|Overall Study|Major Protocol Deviation|7|||
48775596|NCT01481116|157021911|FG002|Overall Study|Major Protocol Deviation|1|||
48775597|NCT01481116|157021909|FG000|Overall Study|Lost to Follow-up|8|||
48775598|NCT01481116|157021910|FG001|Overall Study|Lost to Follow-up|12|||
48775599|NCT01481116|157021911|FG002|Overall Study|Lost to Follow-up|11|||
48775600|NCT01481116|157021909|FG000|Overall Study|Withdrawal by Subject|37|||
48775601|NCT01481116|157021910|FG001|Overall Study|Withdrawal by Subject|33|||
48775602|NCT01481116|157021911|FG002|Overall Study|Withdrawal by Subject|37|||
48775603|NCT01481116|157021909|FG000|Overall Study|Study Termination|730|||
48775604|NCT01481116|157021910|FG001|Overall Study|Study Termination|729|||
48775605|NCT01481116|157021911|FG002|Overall Study|Study Termination|713|||
48775606|NCT01481116|157021909|FG000|Overall Study|Pregnancy|0|||
48775607|NCT01481116|157021910|FG001|Overall Study|Pregnancy|0|||
48775608|NCT01481116|157021911|FG002|Overall Study|Pregnancy|1|||
48775609|NCT01481116|157021909|FG000|Overall Study|Lack of Efficacy|3|||
48775610|NCT01481116|157021910|FG001|Overall Study|Lack of Efficacy|3|||
48775611|NCT01481116|157021911|FG002|Overall Study|Lack of Efficacy|1|||
48775612|NCT01481116|157021909|FG000|Overall Study|Contraindications|1|||
48775613|NCT01481116|157021910|FG001|Overall Study|Contraindications|1|||
48775614|NCT01481116|157021911|FG002|Overall Study|Contraindications|0|||
48775615|NCT01481116|157021909|FG000|Overall Study|Other|1|||
48775616|NCT01481116|157021910|FG001|Overall Study|Other|1|||
48775617|NCT01481116|157021911|FG002|Overall Study|Other|0|||
48775618|NCT01481116|157021909|FG000|Overall Study|Participant Started Taking Glipizide|1|||
48775619|NCT01481116|157021910|FG001|Overall Study|Participant Started Taking Glipizide|0|||
48775620|NCT01481116|157021911|FG002|Overall Study|Participant Started Taking Glipizide|0|||
48775621|NCT01481116|157021909|FG000|Overall Study|Participant Moved Out of Area|2|||
48396400|NCT00861744|155643422|FG003|Overall Study|Protocol Violation|0|||
48396401|NCT00861744|155643419|FG000|Overall Study|Migration from study area|0|||
48396402|NCT00861744|155643420|FG001|Overall Study|Migration from study area|3|||
48396403|NCT00861744|155643421|FG002|Overall Study|Migration from study area|1|||
48396404|NCT00861744|155643422|FG003|Overall Study|Migration from study area|0|||
48775622|NCT01481116|157021910|FG001|Overall Study|Participant Moved Out of Area|0|||
48775623|NCT01481116|157021911|FG002|Overall Study|Participant Moved Out of Area|1|||
48775624|NCT01481116|157021909|FG000|Overall Study|Participant Moved Out of Country|1|||
48775625|NCT01481116|157021910|FG001|Overall Study|Participant Moved Out of Country|0|||
48775626|NCT01481116|157021911|FG002|Overall Study|Participant Moved Out of Country|1|||
48775627|NCT01481116|157021909|FG000|Overall Study|Investigator Decision|3|||
48775628|NCT01481116|157021910|FG001|Overall Study|Investigator Decision|2|||
48775629|NCT01481116|157021911|FG002|Overall Study|Investigator Decision|1|||
48775630|NCT01481116|157021909|FG000|Overall Study|Sponsor Decision|0|||
48775631|NCT01481116|157021910|FG001|Overall Study|Sponsor Decision|1|||
48775632|NCT01481116|157021911|FG002|Overall Study|Sponsor Decision|3|||
48775633|NCT01481116|157021909|FG000|Overall Study|Non-Compliant With Study Drug|0|||
48775634|NCT01481116|157021910|FG001|Overall Study|Non-Compliant With Study Drug|1|||
48775635|NCT01481116|157021911|FG002|Overall Study|Non-Compliant With Study Drug|1|||
48775636|NCT01481116|157021909|FG000|Overall Study|Investigator's Discretion|2|||
48775637|NCT01481116|157021910|FG001|Overall Study|Investigator's Discretion|0|||
48396405|NCT00861744|155643419|FG000|Overall Study|Blood draws|0|||
48396406|NCT00861744|155643420|FG001|Overall Study|Blood draws|0|||
48775638|NCT01481116|157021911|FG002|Overall Study|Investigator's Discretion|0|||
48775639|NCT01481116|157021909|FG000|Overall Study|Death|2|||
48775640|NCT01481116|157021910|FG001|Overall Study|Death|1|||
48775641|NCT01481116|157021911|FG002|Overall Study|Death|0|||
48775642|NCT01481116|157021909|FG000|Overall Study|Hypoglycemic Event|4|||
48775643|NCT01481116|157021910|FG001|Overall Study|Hypoglycemic Event|0|||
48775644|NCT01481116|157021911|FG002|Overall Study|Hypoglycemic Event|0|||
48775645|NCT02433834|157021912|FG000|Overall Study|Protocol-specified criteria|7|||
48775646|NCT02433834|157021912|FG000|Overall Study|Protocol Violation|3|||
48775647|NCT02433834|157021912|FG000|Overall Study|Lost to Follow-up|6|||
48775648|NCT02433834|157021912|FG000|Overall Study|Withdrawal by Subject|14|||
48775649|NCT02433834|157021912|FG000|Overall Study|Adverse Event|6|||
48775650|NCT02433834|157021912|FG000|Overall Study|Physician Decision|1|||
48775651|NCT00333229|157021914|FG000|Overall Study|Lack of Efficacy|0|||
48775652|NCT00333229|157021915|FG001|Overall Study|Lack of Efficacy|1|||
48775653|NCT00548808|157021918|FG000|Overall Study|Lost to Follow-up|9|||
48775654|NCT00548808|157021919|FG001|Overall Study|Lost to Follow-up|3|||
48775655|NCT00548808|157021918|FG000|Overall Study|Protocol Violation|8|||
48775656|NCT00548808|157021919|FG001|Overall Study|Protocol Violation|8|||
48775657|NCT00548808|157021918|FG000|Overall Study|Withdrawal by Subject|8|||
48775658|NCT00548808|157021919|FG001|Overall Study|Withdrawal by Subject|4|||
48775659|NCT00548808|157021918|FG000|Overall Study|Physician Decision|6|||
48775660|NCT00548808|157021919|FG001|Overall Study|Physician Decision|3|||
48775661|NCT00548808|157021918|FG000|Overall Study|Adverse Event|4|||
48775662|NCT00548808|157021919|FG001|Overall Study|Adverse Event|5|||
48775663|NCT00548808|157021918|FG000|Overall Study|Death|2|||
48775664|NCT00548808|157021919|FG001|Overall Study|Death|0|||
48775665|NCT00548808|157021918|FG000|Overall Study|Entry Criteria Not Met|2|||
48775666|NCT00548808|157021919|FG001|Overall Study|Entry Criteria Not Met|2|||
48775667|NCT00548808|157021918|FG000|Overall Study|Lack of Efficacy|2|||
48775668|NCT00548808|157021919|FG001|Overall Study|Lack of Efficacy|0|||
48775669|NCT00548808|157021918|FG000|Overall Study|Sponsor Decision|1|||
48775670|NCT00548808|157021919|FG001|Overall Study|Sponsor Decision|1|||
48775671|NCT01375049|157021920|FG000|Overall Study|Adverse Event|2|||
48775672|NCT01375049|157021920|FG000|Overall Study|Lost to Follow-up|1|||
48775673|NCT01375049|157021920|FG000|Overall Study|Withdrawal by Subject|2|||
48775674|NCT01375049|157021920|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
48775675|NCT03394391|157021921|FG000|Overall Study|Lost to Follow-up|1|||
48775676|NCT03394391|157021922|FG001|Overall Study|Lost to Follow-up|2|||
48775677|NCT00910715|157021923|FG000|Overall Study|Lost to Follow-up|22|||
48775678|NCT00910715|157021924|FG001|Overall Study|Lost to Follow-up|26|||
48775679|NCT00910715|157021925|FG002|Overall Study|Lost to Follow-up|0|||
48775680|NCT03354429|157021926|FG000|Overall Study|Withdrawal by Subject|8|||
48775681|NCT03354429|157021927|FG001|Overall Study|Withdrawal by Subject|7|||
48775682|NCT03354429|157021926|FG000|Overall Study|Lost to Follow-up|1|||
48775683|NCT03354429|157021927|FG001|Overall Study|Lost to Follow-up|0|||
48775684|NCT00912405|157021930|FG000|Overall Study|Lost to Follow-up|5|||
48775685|NCT01049919|157021943|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
48775686|NCT01049919|157021944|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
48775687|NCT01049919|157021943|FG000|Overall Study|Withdrawal by Subject|5|||
48775688|NCT01049919|157021944|FG001|Overall Study|Withdrawal by Subject|0|||
48775689|NCT01049919|157021943|FG000|Overall Study|Lost to Follow-up|6|||
48775690|NCT01049919|157021944|FG001|Overall Study|Lost to Follow-up|1|||
48775691|NCT01049919|157021943|FG000|Overall Study|Physician Decision|2|||
48775692|NCT01049919|157021944|FG001|Overall Study|Physician Decision|0|||
48775693|NCT01049919|157021943|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
48775694|NCT01049919|157021944|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
48775695|NCT01049919|157021943|FG000|Overall Study|Early study termination by sponsor.|2|||
48775696|NCT01049919|157021944|FG001|Overall Study|Early study termination by sponsor.|0|||
48775697|NCT00844545|157021945|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
48775698|NCT00844545|157021945|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
48775699|NCT00844545|157021945|FG000|Extension Treatment Period|Adverse Event|2|||
48775700|NCT00844545|157021945|FG000|Post Treatment Period|Withdrawal by Subject|1|||
48356274|NCT03126110|155501062|FG007|Phase 1|Survival follow-up no longer necessary|0|||
48775701|NCT01532687|157021949|FG000|Overall Study|Death|2|||
48775702|NCT01532687|157021950|FG001|Overall Study|Death|0|||
48775703|NCT01532687|157021949|FG000|Overall Study|Adverse Event|6|||
48775704|NCT01532687|157021950|FG001|Overall Study|Adverse Event|1|||
48775705|NCT01532687|157021949|FG000|Overall Study|Withdrawal by Subject|1|||
48356275|NCT03126110|155501063|FG008|Phase 1|Survival follow-up no longer necessary|0|||
48356276|NCT03126110|155501064|FG009|Phase 1|Survival follow-up no longer necessary|0|||
48775706|NCT01532687|157021950|FG001|Overall Study|Withdrawal by Subject|0|||
48775707|NCT01532687|157021949|FG000|Overall Study|Physician Decision|2|||
48775708|NCT01532687|157021950|FG001|Overall Study|Physician Decision|1|||
48775709|NCT01532687|157021949|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
48775710|NCT01532687|157021950|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
48775711|NCT00807092|157021951|FG000|Overall Study|Adverse Event|0|||
48775712|NCT00807092|157021952|FG001|Overall Study|Adverse Event|1|||
48775713|NCT00807092|157021951|FG000|Overall Study|Protocol Violation|0|||
48775714|NCT00807092|157021952|FG001|Overall Study|Protocol Violation|2|||
48775715|NCT00807092|157021951|FG000|Overall Study|Withdrawal by Subject|1|||
48775716|NCT00807092|157021952|FG001|Overall Study|Withdrawal by Subject|0|||
48775717|NCT00807092|157021951|FG000|Overall Study|CGMS data collection failed|0|||
48775718|NCT00807092|157021952|FG001|Overall Study|CGMS data collection failed|1|||
48775719|NCT03160703|157021953|FG000|Overall Study|Withdrawal by Subject|0|||
48775720|NCT03160703|157021954|FG001|Overall Study|Withdrawal by Subject|0|||
48775721|NCT03160703|157021955|FG002|Overall Study|Withdrawal by Subject|0|||
48775722|NCT03160703|157021956|FG003|Overall Study|Withdrawal by Subject|1|||
48775723|NCT03728582|157021957|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
48775724|NCT03728582|157021958|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
48775725|NCT03728582|157021957|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
48775726|NCT03728582|157021958|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
48775727|NCT02738775|157021959|FG000|Overall Study|Withdrawal by Subject|0|||
48775728|NCT02738775|157021960|FG001|Overall Study|Withdrawal by Subject|1|||
48775729|NCT02738775|157021961|FG002|Overall Study|Withdrawal by Subject|0|||
48775730|NCT02738775|157021962|FG003|Overall Study|Withdrawal by Subject|0|||
48775731|NCT02738775|157021963|FG004|Overall Study|Withdrawal by Subject|0|||
48775732|NCT02738775|157021964|FG005|Overall Study|Withdrawal by Subject|0|||
48775733|NCT02738775|157021959|FG000|Overall Study|Adverse Event|0|||
48775734|NCT02738775|157021960|FG001|Overall Study|Adverse Event|0|||
48775735|NCT02738775|157021961|FG002|Overall Study|Adverse Event|0|||
48775736|NCT02738775|157021962|FG003|Overall Study|Adverse Event|1|||
48775737|NCT02738775|157021963|FG004|Overall Study|Adverse Event|0|||
48775738|NCT02738775|157021964|FG005|Overall Study|Adverse Event|0|||
48396407|NCT00861744|155643421|FG002|Overall Study|Blood draws|0|||
48775739|NCT02738775|157021959|FG000|Overall Study|Pregnancy|0|||
48775740|NCT02738775|157021960|FG001|Overall Study|Pregnancy|1|||
48775741|NCT02738775|157021961|FG002|Overall Study|Pregnancy|0|||
48775742|NCT02738775|157021962|FG003|Overall Study|Pregnancy|0|||
48775743|NCT02738775|157021963|FG004|Overall Study|Pregnancy|0|||
48775744|NCT02738775|157021964|FG005|Overall Study|Pregnancy|0|||
48396408|NCT00861744|155643422|FG003|Overall Study|Blood draws|1|||
48396409|NCT01928381|155643423|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
48396410|NCT01928381|155643424|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48775745|NCT02738775|157021959|FG000|Overall Study|Missing|0|||
48775746|NCT02738775|157021960|FG001|Overall Study|Missing|0|||
48775747|NCT02738775|157021961|FG002|Overall Study|Missing|0|||
48775748|NCT02738775|157021962|FG003|Overall Study|Missing|0|||
48775749|NCT02738775|157021963|FG004|Overall Study|Missing|0|||
48775750|NCT02738775|157021964|FG005|Overall Study|Missing|1|||
48775751|NCT04808609|157021967|FG000|Overall Study|Lost to Follow-up|0|||
48775752|NCT04808609|157021968|FG001|Overall Study|Lost to Follow-up|2|||
48775753|NCT04808609|157021967|FG000|Overall Study|Administrative Withdrawal|0|||
48775754|NCT04808609|157021968|FG001|Overall Study|Administrative Withdrawal|1|||
48775755|NCT01274637|157021969|FG000|Overall Study|Withdrawal by Subject|0|||
48775756|NCT01274637|157021970|FG001|Overall Study|Withdrawal by Subject|1|||
48775757|NCT01274637|157021969|FG000|Overall Study|Lost to Follow-up|0|||
48775758|NCT01274637|157021970|FG001|Overall Study|Lost to Follow-up|1|||
48775759|NCT04096560|157021971|FG000|Overall Study|Reason not Specified|1|||
48775760|NCT04096560|157021972|FG001|Overall Study|Reason not Specified|0|||
48775761|NCT04096560|157021973|FG002|Overall Study|Reason not Specified|0|||
48775762|NCT04096560|157021974|FG003|Overall Study|Reason not Specified|0|||
48775763|NCT04096560|157021975|FG004|Overall Study|Reason not Specified|1|||
48775764|NCT04096560|157021976|FG005|Overall Study|Reason not Specified|1|||
48775765|NCT04096560|157021977|FG006|Overall Study|Reason not Specified|1|||
48775766|NCT04096560|157021978|FG007|Overall Study|Reason not Specified|0|||
48775767|NCT04096560|157021971|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775768|NCT04096560|157021972|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775769|NCT04096560|157021973|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775770|NCT04096560|157021974|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48430336|NCT00696657|155763708|FG008|Overall Study|Protocol Violation|1|||
48775771|NCT04096560|157021975|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775772|NCT04096560|157021976|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
48775773|NCT04096560|157021977|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
48775774|NCT04096560|157021978|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
48775775|NCT04096560|157021971|FG000|Overall Study|Study Terminated by Sponsor|0|||
48775776|NCT04096560|157021972|FG001|Overall Study|Study Terminated by Sponsor|0|||
48775777|NCT04096560|157021973|FG002|Overall Study|Study Terminated by Sponsor|0|||
48775778|NCT04096560|157021974|FG003|Overall Study|Study Terminated by Sponsor|5|||
48775779|NCT04096560|157021975|FG004|Overall Study|Study Terminated by Sponsor|6|||
48775780|NCT04096560|157021976|FG005|Overall Study|Study Terminated by Sponsor|4|||
48775781|NCT04096560|157021977|FG006|Overall Study|Study Terminated by Sponsor|6|||
48775782|NCT04096560|157021978|FG007|Overall Study|Study Terminated by Sponsor|1|||
48775783|NCT04096560|157021971|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775784|NCT04096560|157021972|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775785|NCT04096560|157021973|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775786|NCT04096560|157021974|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775787|NCT04096560|157021975|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775788|NCT04096560|157021976|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775789|NCT04096560|157021977|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
48775790|NCT04096560|157021978|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
48775791|NCT02047604|157021981|FG000|Overall Study|Withdrawal by Subject|0|||
48775792|NCT02047604|157021982|FG001|Overall Study|Withdrawal by Subject|0|||
48775793|NCT02047604|157021983|FG002|Overall Study|Withdrawal by Subject|0|||
48775794|NCT02047604|157021984|FG003|Overall Study|Withdrawal by Subject|0|||
48775795|NCT02047604|157021985|FG004|Overall Study|Withdrawal by Subject|1|||
48775796|NCT02047604|157021986|FG005|Overall Study|Withdrawal by Subject|1|||
48775797|NCT01692197|157021994|FG000|Overall Study|Failed Screening|3|||
48775798|NCT02120924|157021995|FG000|Overall Study|Lack of Efficacy|1|||
48775799|NCT02120924|157021996|FG001|Overall Study|Lack of Efficacy|2|||
48775800|NCT02120924|157021997|FG002|Overall Study|Lack of Efficacy|3|||
48775801|NCT02120924|157021995|FG000|Overall Study|Adverse Event|0|||
48775802|NCT02120924|157021996|FG001|Overall Study|Adverse Event|1|||
48775803|NCT02120924|157021997|FG002|Overall Study|Adverse Event|3|||
48775804|NCT02120924|157021995|FG000|Overall Study|Withdrawal by Subject|16|||
48775805|NCT02120924|157021996|FG001|Overall Study|Withdrawal by Subject|20|||
48775806|NCT02120924|157021997|FG002|Overall Study|Withdrawal by Subject|8|||
48775807|NCT02120924|157021995|FG000|Overall Study|Lost to Follow-up|14|||
48775808|NCT02120924|157021996|FG001|Overall Study|Lost to Follow-up|14|||
48775809|NCT02120924|157021997|FG002|Overall Study|Lost to Follow-up|11|||
48775810|NCT02120924|157021995|FG000|Overall Study|Pregnancy|2|||
48775811|NCT02120924|157021996|FG001|Overall Study|Pregnancy|0|||
48775812|NCT02120924|157021997|FG002|Overall Study|Pregnancy|0|||
48775813|NCT02120924|157021995|FG000|Overall Study|Protocol Violation|3|||
48775814|NCT02120924|157021996|FG001|Overall Study|Protocol Violation|7|||
48775815|NCT02120924|157021997|FG002|Overall Study|Protocol Violation|2|||
48775816|NCT02120924|157021995|FG000|Overall Study|Physician Decision|0|||
48775817|NCT02120924|157021996|FG001|Overall Study|Physician Decision|1|||
48775818|NCT02120924|157021997|FG002|Overall Study|Physician Decision|1|||
48775819|NCT02120924|157021995|FG000|Overall Study|Death|1|||
48775820|NCT02120924|157021996|FG001|Overall Study|Death|0|||
48775821|NCT02120924|157021997|FG002|Overall Study|Death|0|||
48775822|NCT02120924|157021995|FG000|Overall Study|Compliance with IP|5|||
48775823|NCT02120924|157021996|FG001|Overall Study|Compliance with IP|1|||
48775824|NCT02120924|157021997|FG002|Overall Study|Compliance with IP|1|||
48775825|NCT02770391|157021998|FG000|Overall Study|Lost to Follow-up|2|||
48775826|NCT02770391|157021998|FG000|Overall Study|Withdrawal by Subject|1|||
48775827|NCT02770391|157021998|FG000|Overall Study|Surgery delayed unevaluable|2|||
48775828|NCT02770391|157021998|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
48775829|NCT00612313|157022001|FG000|Overall Study|Withdrawal by Subject|6|||
48775830|NCT00612313|157022002|FG001|Overall Study|Withdrawal by Subject|9|||
48775831|NCT00612313|157022001|FG000|Overall Study|Lost to Follow-up|11|||
48775832|NCT00612313|157022002|FG001|Overall Study|Lost to Follow-up|4|||
48775833|NCT03952039|157022003|FG000|Overall Study|Adverse Event|22|||
48775834|NCT03952039|157022004|FG001|Overall Study|Adverse Event|8|||
48775835|NCT03952039|157022003|FG000|Overall Study|Withdrawal by Participant|17|||
48775836|NCT03952039|157022004|FG001|Overall Study|Withdrawal by Participant|12|||
48775837|NCT03952039|157022003|FG000|Overall Study|Death|13|||
48775838|NCT03952039|157022004|FG001|Overall Study|Death|6|||
48775839|NCT03952039|157022003|FG000|Overall Study|Lack of Efficacy|12|||
48775840|NCT03952039|157022004|FG001|Overall Study|Lack of Efficacy|2|||
48775841|NCT03952039|157022003|FG000|Overall Study|Physician Decision|9|||
48775842|NCT03952039|157022004|FG001|Overall Study|Physician Decision|3|||
48775843|NCT03952039|157022003|FG000|Overall Study|Progressive Disease|6|||
48775844|NCT03952039|157022004|FG001|Overall Study|Progressive Disease|4|||
48775845|NCT03952039|157022003|FG000|Overall Study|Other Reasons|12|||
48775846|NCT03952039|157022004|FG001|Overall Study|Other Reasons|4|||
48775847|NCT03370341|157023608|FG000|Overall Study|Lost to Follow-up|0|||
48775848|NCT03370341|157023609|FG001|Overall Study|Lost to Follow-up|1|||
48775849|NCT00938431|157023613|FG000|Overall Study|Adverse Event|5|||
48775850|NCT00938431|157023614|FG001|Overall Study|Adverse Event|8|||
48775851|NCT00938431|157023615|FG002|Overall Study|Adverse Event|6|||
48775852|NCT00938431|157023613|FG000|Overall Study|Lack of Efficacy|0|||
48775853|NCT00938431|157023614|FG001|Overall Study|Lack of Efficacy|1|||
48775854|NCT00938431|157023615|FG002|Overall Study|Lack of Efficacy|0|||
48775855|NCT00938431|157023613|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
48775856|NCT00938431|157023614|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
48775857|NCT00938431|157023615|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
48775858|NCT00938431|157023613|FG000|Overall Study|Dosing compliance issue|0|||
48775859|NCT00938431|157023614|FG001|Overall Study|Dosing compliance issue|0|||
48775860|NCT00938431|157023615|FG002|Overall Study|Dosing compliance issue|1|||
48775861|NCT00938431|157023613|FG000|Overall Study|Reached maximum dose early|0|||
48775862|NCT00938431|157023614|FG001|Overall Study|Reached maximum dose early|0|||
48775863|NCT00938431|157023615|FG002|Overall Study|Reached maximum dose early|1|||
48775864|NCT01816139|157023620|FG000|Overall Study|Adverse Event|6|||
48775865|NCT01816139|157023621|FG001|Overall Study|Adverse Event|8|||
48775866|NCT01816139|157023620|FG000|Overall Study|Lack of Efficacy|1|||
48775867|NCT01816139|157023621|FG001|Overall Study|Lack of Efficacy|2|||
48396411|NCT01928381|155643425|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48396412|NCT01928381|155643426|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48775868|NCT01816139|157023620|FG000|Overall Study|Lost to Follow-up|5|||
48775869|NCT01816139|157023621|FG001|Overall Study|Lost to Follow-up|3|||
48775870|NCT01816139|157023620|FG000|Overall Study|Withdrew Consent|6|||
48775871|NCT01816139|157023621|FG001|Overall Study|Withdrew Consent|4|||
48775872|NCT01816139|157023620|FG000|Overall Study|Protocol Violation|6|||
48775873|NCT01816139|157023621|FG001|Overall Study|Protocol Violation|3|||
48775874|NCT01816139|157023620|FG000|Overall Study|Reason not Specified|4|||
48775875|NCT01816139|157023621|FG001|Overall Study|Reason not Specified|2|||
48775876|NCT02212730|157023622|FG000|Overall Study|Tumor not of the required cell histology|1|||
48775877|NCT02212730|157023623|FG001|Overall Study|Tumor not of the required cell histology|0|||
48775878|NCT02212730|157023622|FG000|Overall Study|Withdrawal by Subject|1|||
48775879|NCT02212730|157023623|FG001|Overall Study|Withdrawal by Subject|0|||
48775880|NCT02212730|157023622|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
48775881|NCT02212730|157023623|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
48775882|NCT00298896|157023626|FG000|Overall Study|Death|3|||
48775883|NCT00298896|157023626|FG000|Overall Study|Physician Decision|2|||
48775884|NCT00298896|157023626|FG000|Overall Study|Intercurrent Illness|1|||
48775885|NCT00298896|157023626|FG000|Overall Study|Disease Progression|41|||
48775886|NCT00298896|157023626|FG000|Overall Study|Withdrawal by Subject|2|||
48775887|NCT00298896|157023626|FG000|Overall Study|Assigned to treatment in error|1|||
48775888|NCT04709237|157023627|FG000|Overall Study|Lost to Follow-up|1|||
48775889|NCT04709237|157023628|FG001|Overall Study|Lost to Follow-up|0|||
48775890|NCT04709237|157023629|FG002|Overall Study|Lost to Follow-up|0|||
48775891|NCT01344057|157023634|FG000|Overall Study|Premature Withdrawal|1|||
48775892|NCT00466193|157023635|FG000|Overall Study|Adverse Event|0|||
48775893|NCT00466193|157023636|FG001|Overall Study|Adverse Event|1|||
48775894|NCT00466193|157023635|FG000|Overall Study|Lost to Follow-up|2|||
48775895|NCT00466193|157023636|FG001|Overall Study|Lost to Follow-up|4|||
48775896|NCT00466193|157023635|FG000|Overall Study|Physician Decision|1|||
48775897|NCT00466193|157023636|FG001|Overall Study|Physician Decision|0|||
48775898|NCT00466193|157023635|FG000|Overall Study|Protocol Violation|1|||
48775899|NCT00466193|157023636|FG001|Overall Study|Protocol Violation|1|||
48775900|NCT00466193|157023635|FG000|Overall Study|Withdrawal by Subject|7|||
48775901|NCT00466193|157023636|FG001|Overall Study|Withdrawal by Subject|2|||
48396413|NCT01928381|155643427|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48396414|NCT01928381|155643428|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48396415|NCT01928381|155643429|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
48396416|NCT01928381|155643423|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
48396417|NCT01928381|155643424|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
48396418|NCT01928381|155643425|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
48396419|NCT01928381|155643426|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
48396420|NCT01928381|155643427|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
48396421|NCT01928381|155643428|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
48396422|NCT01928381|155643429|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
48396423|NCT01928381|155643423|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
48775902|NCT00466193|157023635|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
48775903|NCT00466193|157023636|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
48775904|NCT05044234|157023637|FG000|Overall Study|Lost to Follow-up|2|||
48775905|NCT05044234|157023638|FG001|Overall Study|Lost to Follow-up|1|||
48775906|NCT05044234|157023639|FG002|Overall Study|Lost to Follow-up|1|||
48775907|NCT05044234|157023640|FG003|Overall Study|Lost to Follow-up|2|||
48775908|NCT05044234|157023637|FG000|Overall Study|Withdrawal by Subject|6|||
48775909|NCT05044234|157023638|FG001|Overall Study|Withdrawal by Subject|4|||
48775910|NCT05044234|157023639|FG002|Overall Study|Withdrawal by Subject|5|||
48396424|NCT01928381|155643424|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
48396425|NCT01928381|155643425|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
48775911|NCT05044234|157023640|FG003|Overall Study|Withdrawal by Subject|8|||
48775912|NCT05044234|157023637|FG000|Overall Study|Study terminated by Sponsor|21|||
48775913|NCT05044234|157023638|FG001|Overall Study|Study terminated by Sponsor|21|||
48396426|NCT01928381|155643426|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
48396427|NCT01928381|155643427|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
48396428|NCT01928381|155643428|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
48396429|NCT01928381|155643429|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
48396430|NCT01928381|155643423|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
48396431|NCT01928381|155643424|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
48396432|NCT01928381|155643425|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
48396433|NCT01928381|155643426|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
48396434|NCT01928381|155643427|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
48396435|NCT01928381|155643428|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
48396436|NCT01928381|155643429|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
48775914|NCT05044234|157023639|FG002|Overall Study|Study terminated by Sponsor|20|||
48775915|NCT05044234|157023640|FG003|Overall Study|Study terminated by Sponsor|14|||
48775916|NCT05044234|157023637|FG000|Overall Study|Other, not specified|0|||
48775917|NCT05044234|157023638|FG001|Overall Study|Other, not specified|0|||
48775918|NCT05044234|157023639|FG002|Overall Study|Other, not specified|1|||
48775919|NCT05044234|157023640|FG003|Overall Study|Other, not specified|2|||
48775920|NCT05044234|157023637|FG000|Overall Study|Delayed data entry|0|||
48775921|NCT05044234|157023638|FG001|Overall Study|Delayed data entry|0|||
48775922|NCT05044234|157023639|FG002|Overall Study|Delayed data entry|0|||
48775923|NCT05044234|157023640|FG003|Overall Study|Delayed data entry|1|||
48775924|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Adverse Event|9|||
48775925|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Adverse Event|2|||
48775926|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
48775927|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
48775928|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
48775929|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
48775930|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Physician Decision|1|||
48775931|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Physician Decision|1|||
48775932|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Pregnancy|2|||
48775933|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Pregnancy|0|||
48775934|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
48775935|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
48775936|NCT02896127|157023641|FG000|COMPLETED WEEK 52|Technical problems|1|||
48775937|NCT02896127|157023642|FG001|COMPLETED WEEK 52|Technical problems|0|||
48775938|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
48775939|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
48775940|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
48775941|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
48775942|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
48775943|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
48775944|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
48775945|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
48775946|NCT02896127|157023641|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
48775947|NCT02896127|157023642|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
48775948|NCT01023659|157023643|FG000|Overall Study|Lost to Follow-up|73|||
48775949|NCT01023659|157023644|FG001|Overall Study|Lost to Follow-up|228|||
48775950|NCT01023659|157023645|FG002|Overall Study|Lost to Follow-up|99|||
48775951|NCT02477020|157023647|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
48775952|NCT02477020|157023648|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
48775953|NCT02477020|157023647|FG000|Overall Study|Voluntary Withdrawal|7|||
48775954|NCT02477020|157023648|FG001|Overall Study|Voluntary Withdrawal|16|||
48775955|NCT02477020|157023647|FG000|Overall Study|Reason not Specified|3|||
48775956|NCT02477020|157023648|FG001|Overall Study|Reason not Specified|1|||
48775957|NCT02477020|157023647|FG000|Overall Study|Lack of Efficacy|14|||
48775958|NCT02477020|157023648|FG001|Overall Study|Lack of Efficacy|5|||
48775959|NCT00451282|157023649|FG000|Overall Study|Lost to Follow-up|6|||
48775960|NCT00451282|157023650|FG001|Overall Study|Lost to Follow-up|5|||
48775961|NCT00563797|157023652|FG000|Overall Study|Lost to Follow-up|7|||
48775962|NCT00563797|157023653|FG001|Overall Study|Lost to Follow-up|2|||
48775963|NCT01276327|157023654|FG000|Overall Study|Adverse Event|1|||
48775964|NCT01276327|157023655|FG001|Overall Study|Adverse Event|3|||
48775965|NCT01276327|157023654|FG000|Overall Study|Withdrawal by Subject|1|||
48775966|NCT01276327|157023655|FG001|Overall Study|Withdrawal by Subject|0|||
48775967|NCT02809976|157023656|FG000|Overall Study|Lost to Follow-up|1|||
48775968|NCT02809976|157023656|FG000|Overall Study|Withdrawal by Subject|1|||
48775969|NCT01513291|157023657|FG000|Treatment Period|Adverse Event|8|||
48775970|NCT01513291|157023658|FG001|Treatment Period|Adverse Event|4|||
48775971|NCT01513291|157023659|FG002|Treatment Period|Adverse Event|0|||
48775972|NCT01513291|157023660|FG003|Treatment Period|Adverse Event|0|||
48775973|NCT01513291|157023661|FG004|Treatment Period|Adverse Event|0|||
48396437|NCT01928381|155643423|FG000|Part 1 - Pain Training|Protocol Violation|1|||
48396438|NCT01928381|155643424|FG001|Part 1 - Pain Training|Protocol Violation|0|||
48775974|NCT01513291|157023657|FG000|Treatment Period|Lack of Efficacy|3|||
48775975|NCT01513291|157023658|FG001|Treatment Period|Lack of Efficacy|0|||
48356277|NCT03126110|155501065|FG010|Phase 1|Survival follow-up no longer necessary|0|||
48356278|NCT03126110|155501066|FG011|Phase 1|Survival follow-up no longer necessary|0|||
48356279|NCT03126110|155501067|FG012|Phase 1|Survival follow-up no longer necessary|0|||
48356280|NCT03126110|155501068|FG013|Phase 1|Survival follow-up no longer necessary|0|||
48356281|NCT03126110|155501069|FG014|Phase 1|Survival follow-up no longer necessary|0|||
48356282|NCT03126110|155501070|FG015|Phase 1|Survival follow-up no longer necessary|0|||
48356283|NCT03126110|155501071|FG016|Phase 1|Survival follow-up no longer necessary|0|||
48356284|NCT03126110|155501055|FG000|Phase 2|Study terminated by the sponsor|0|||
48356285|NCT03126110|155501056|FG001|Phase 2|Study terminated by the sponsor|0|||
48356286|NCT03126110|155501057|FG002|Phase 2|Study terminated by the sponsor|0|||
48356287|NCT03126110|155501058|FG003|Phase 2|Study terminated by the sponsor|0|||
48356288|NCT03126110|155501059|FG004|Phase 2|Study terminated by the sponsor|0|||
48356289|NCT03126110|155501060|FG005|Phase 2|Study terminated by the sponsor|0|||
48356290|NCT03126110|155501061|FG006|Phase 2|Study terminated by the sponsor|0|||
48356291|NCT03126110|155501062|FG007|Phase 2|Study terminated by the sponsor|0|||
48356292|NCT03126110|155501063|FG008|Phase 2|Study terminated by the sponsor|0|||
48356293|NCT03126110|155501064|FG009|Phase 2|Study terminated by the sponsor|0|||
48356294|NCT03126110|155501065|FG010|Phase 2|Study terminated by the sponsor|0|||
48356295|NCT03126110|155501066|FG011|Phase 2|Study terminated by the sponsor|0|||
48356296|NCT03126110|155501067|FG012|Phase 2|Study terminated by the sponsor|0|||
48356297|NCT03126110|155501068|FG013|Phase 2|Study terminated by the sponsor|4|||
48356298|NCT03126110|155501069|FG014|Phase 2|Study terminated by the sponsor|0|||
48356299|NCT03126110|155501070|FG015|Phase 2|Study terminated by the sponsor|0|||
48356300|NCT03126110|155501071|FG016|Phase 2|Study terminated by the sponsor|0|||
48356301|NCT03126110|155501055|FG000|Phase 2|Withdrawal by Subject|0|||
48356302|NCT03126110|155501056|FG001|Phase 2|Withdrawal by Subject|0|||
48356303|NCT03126110|155501057|FG002|Phase 2|Withdrawal by Subject|0|||
48356304|NCT03126110|155501058|FG003|Phase 2|Withdrawal by Subject|0|||
48356305|NCT03126110|155501059|FG004|Phase 2|Withdrawal by Subject|0|||
48356306|NCT03126110|155501060|FG005|Phase 2|Withdrawal by Subject|0|||
48356307|NCT03126110|155501061|FG006|Phase 2|Withdrawal by Subject|0|||
48356308|NCT03126110|155501062|FG007|Phase 2|Withdrawal by Subject|0|||
48356309|NCT03126110|155501063|FG008|Phase 2|Withdrawal by Subject|0|||
48356310|NCT03126110|155501064|FG009|Phase 2|Withdrawal by Subject|0|||
48356311|NCT03126110|155501065|FG010|Phase 2|Withdrawal by Subject|0|||
48356312|NCT03126110|155501066|FG011|Phase 2|Withdrawal by Subject|1|||
48356313|NCT03126110|155501067|FG012|Phase 2|Withdrawal by Subject|3|||
48356314|NCT03126110|155501068|FG013|Phase 2|Withdrawal by Subject|3|||
48356315|NCT03126110|155501069|FG014|Phase 2|Withdrawal by Subject|2|||
48356316|NCT03126110|155501070|FG015|Phase 2|Withdrawal by Subject|1|||
48356317|NCT03126110|155501071|FG016|Phase 2|Withdrawal by Subject|0|||
48356318|NCT03126110|155501055|FG000|Phase 2|Lost to Follow-up|0|||
48356319|NCT03126110|155501056|FG001|Phase 2|Lost to Follow-up|0|||
48356320|NCT03126110|155501057|FG002|Phase 2|Lost to Follow-up|0|||
48356321|NCT03126110|155501058|FG003|Phase 2|Lost to Follow-up|0|||
48356322|NCT03126110|155501059|FG004|Phase 2|Lost to Follow-up|0|||
48356323|NCT03126110|155501060|FG005|Phase 2|Lost to Follow-up|0|||
48356324|NCT03126110|155501061|FG006|Phase 2|Lost to Follow-up|0|||
48356325|NCT03126110|155501062|FG007|Phase 2|Lost to Follow-up|0|||
48356326|NCT03126110|155501063|FG008|Phase 2|Lost to Follow-up|0|||
48356327|NCT03126110|155501064|FG009|Phase 2|Lost to Follow-up|0|||
48356328|NCT03126110|155501065|FG010|Phase 2|Lost to Follow-up|0|||
48775976|NCT01513291|157023659|FG002|Treatment Period|Lack of Efficacy|0|||
48775977|NCT01513291|157023660|FG003|Treatment Period|Lack of Efficacy|0|||
48775978|NCT01513291|157023661|FG004|Treatment Period|Lack of Efficacy|0|||
48775979|NCT01513291|157023657|FG000|Treatment Period|Lost to Follow-up|2|||
48775980|NCT01513291|157023658|FG001|Treatment Period|Lost to Follow-up|3|||
48775981|NCT01513291|157023659|FG002|Treatment Period|Lost to Follow-up|0|||
48775982|NCT01513291|157023660|FG003|Treatment Period|Lost to Follow-up|0|||
48775983|NCT01513291|157023661|FG004|Treatment Period|Lost to Follow-up|0|||
48775984|NCT01513291|157023657|FG000|Treatment Period|Physician Decision|1|||
48775985|NCT01513291|157023658|FG001|Treatment Period|Physician Decision|0|||
48356329|NCT03126110|155501066|FG011|Phase 2|Lost to Follow-up|1|||
48356330|NCT03126110|155501067|FG012|Phase 2|Lost to Follow-up|1|||
48356331|NCT03126110|155501068|FG013|Phase 2|Lost to Follow-up|1|||
48356332|NCT03126110|155501069|FG014|Phase 2|Lost to Follow-up|2|||
48356333|NCT03126110|155501070|FG015|Phase 2|Lost to Follow-up|0|||
48356334|NCT03126110|155501071|FG016|Phase 2|Lost to Follow-up|0|||
48356335|NCT03126110|155501055|FG000|Phase 2|Death|0|||
48356336|NCT03126110|155501056|FG001|Phase 2|Death|0|||
48356337|NCT03126110|155501057|FG002|Phase 2|Death|0|||
48356338|NCT03126110|155501058|FG003|Phase 2|Death|0|||
48356339|NCT03126110|155501059|FG004|Phase 2|Death|0|||
48356340|NCT03126110|155501060|FG005|Phase 2|Death|0|||
48356341|NCT03126110|155501061|FG006|Phase 2|Death|0|||
48356342|NCT03126110|155501062|FG007|Phase 2|Death|0|||
48356343|NCT03126110|155501063|FG008|Phase 2|Death|0|||
48356344|NCT03126110|155501064|FG009|Phase 2|Death|0|||
48356345|NCT03126110|155501065|FG010|Phase 2|Death|0|||
48356346|NCT03126110|155501066|FG011|Phase 2|Death|6|||
48356347|NCT03126110|155501067|FG012|Phase 2|Death|12|||
48356348|NCT03126110|155501068|FG013|Phase 2|Death|25|||
48356349|NCT03126110|155501069|FG014|Phase 2|Death|11|||
48356350|NCT03126110|155501070|FG015|Phase 2|Death|3|||
48356351|NCT03126110|155501071|FG016|Phase 2|Death|2|||
48356352|NCT03126110|155501055|FG000|Phase 2|Progressive Disease|0|||
48775986|NCT01513291|157023659|FG002|Treatment Period|Physician Decision|0|||
48775987|NCT01513291|157023660|FG003|Treatment Period|Physician Decision|0|||
48775988|NCT01513291|157023661|FG004|Treatment Period|Physician Decision|0|||
48775989|NCT01513291|157023657|FG000|Treatment Period|Protocol Violation|1|||
48775990|NCT01513291|157023658|FG001|Treatment Period|Protocol Violation|2|||
48775991|NCT01513291|157023659|FG002|Treatment Period|Protocol Violation|0|||
48775992|NCT01513291|157023660|FG003|Treatment Period|Protocol Violation|0|||
48775993|NCT01513291|157023661|FG004|Treatment Period|Protocol Violation|0|||
48775994|NCT01513291|157023657|FG000|Treatment Period|Withdrawal by Subject|8|||
48775995|NCT01513291|157023658|FG001|Treatment Period|Withdrawal by Subject|5|||
48775996|NCT01513291|157023659|FG002|Treatment Period|Withdrawal by Subject|0|||
48775997|NCT01513291|157023660|FG003|Treatment Period|Withdrawal by Subject|0|||
48775998|NCT01513291|157023661|FG004|Treatment Period|Withdrawal by Subject|0|||
48775999|NCT01513291|157023657|FG000|Treatment Period|Randomized not treated|0|||
48776000|NCT01513291|157023658|FG001|Treatment Period|Randomized not treated|2|||
48776001|NCT01513291|157023659|FG002|Treatment Period|Randomized not treated|0|||
48776002|NCT01513291|157023660|FG003|Treatment Period|Randomized not treated|0|||
48776003|NCT01513291|157023661|FG004|Treatment Period|Randomized not treated|0|||
48776004|NCT01513291|157023657|FG000|Run-out Period|Lost to Follow-up|0|||
48776005|NCT01513291|157023658|FG001|Run-out Period|Lost to Follow-up|0|||
48776006|NCT01513291|157023659|FG002|Run-out Period|Lost to Follow-up|0|||
48776007|NCT01513291|157023660|FG003|Run-out Period|Lost to Follow-up|1|||
48776008|NCT01513291|157023661|FG004|Run-out Period|Lost to Follow-up|0|||
48776009|NCT01513291|157023657|FG000|Run-out Period|Withdrawal by Subject|0|||
48776010|NCT01513291|157023658|FG001|Run-out Period|Withdrawal by Subject|0|||
48776011|NCT01513291|157023659|FG002|Run-out Period|Withdrawal by Subject|0|||
48776012|NCT01513291|157023660|FG003|Run-out Period|Withdrawal by Subject|1|||
48776013|NCT01513291|157023661|FG004|Run-out Period|Withdrawal by Subject|0|||
48776014|NCT02984995|157023665|FG000|Overall Study|Required stem cell transplant|13|||
48776015|NCT02984995|157023666|FG001|Overall Study|Required stem cell transplant|2|||
48776016|NCT02984995|157023665|FG000|Overall Study|Progressive disease|11|||
48776017|NCT02984995|157023666|FG001|Overall Study|Progressive disease|1|||
48776018|NCT02984995|157023665|FG000|Overall Study|Adverse Event|1|||
48776019|NCT02984995|157023666|FG001|Overall Study|Adverse Event|0|||
48776020|NCT04354831|157023667|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
48776021|NCT04354831|157023668|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
48776022|NCT02992899|157023669|FG000|Overall Study|Withdrawal by Subject|1|||
48776023|NCT02992899|157023670|FG001|Overall Study|Withdrawal by Subject|0|||
48776024|NCT02992899|157023669|FG000|Overall Study|Lost to Follow-up|1|||
48776025|NCT02992899|157023670|FG001|Overall Study|Lost to Follow-up|3|||
48776026|NCT01034397|157023671|FG000|Overall Study|Lack of compliance|0|||
48776027|NCT01034397|157023672|FG001|Overall Study|Lack of compliance|1|||
48776028|NCT01034397|157023671|FG000|Overall Study|Lack of Efficacy|3|||
48776029|NCT01034397|157023672|FG001|Overall Study|Lack of Efficacy|0|||
48776030|NCT01034397|157023671|FG000|Overall Study|Adverse Event|4|||
48776031|NCT01034397|157023672|FG001|Overall Study|Adverse Event|0|||
48776032|NCT01034397|157023671|FG000|Overall Study|Other|0|||
48776033|NCT01034397|157023672|FG001|Overall Study|Other|1|||
48776034|NCT04027686|157023673|FG000|Overall Study|Lost to Follow-up|2|||
48776035|NCT04027686|157023674|FG001|Overall Study|Lost to Follow-up|0|||
48776036|NCT04027686|157023673|FG000|Overall Study|Withdrawal by Subject|0|||
48776037|NCT04027686|157023674|FG001|Overall Study|Withdrawal by Subject|1|||
48776038|NCT04713748|157023675|FG000|Overall Study|Not enough kits allocated|35|||
48776039|NCT00096941|157023676|FG000|Overall Study|disease progression|3|||
48776040|NCT01611259|157023677|FG000|Overall Study|Physician Decision|1|||
48776041|NCT01611259|157023677|FG000|Overall Study|Lack of Efficacy|2|||
48776042|NCT01611259|157023677|FG000|Overall Study|Adverse Event|4|||
48776043|NCT01611259|157023677|FG000|Overall Study|Withdrawal by Subject|7|||
48776044|NCT00439140|157023681|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
48776045|NCT00439140|157023682|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
48776046|NCT00439140|157023683|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
48776047|NCT00439140|157023681|FG000|Treatment Cycle 1|Personal reasons|0|||
48776048|NCT00439140|157023682|FG001|Treatment Cycle 1|Personal reasons|2|||
48776049|NCT00439140|157023683|FG002|Treatment Cycle 1|Personal reasons|0|||
48776050|NCT00439140|157023681|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
48776051|NCT00439140|157023682|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
48776052|NCT00439140|157023683|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
48776053|NCT00439140|157023681|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
48776054|NCT00439140|157023682|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
48356353|NCT03126110|155501056|FG001|Phase 2|Progressive Disease|0|||
48356354|NCT03126110|155501057|FG002|Phase 2|Progressive Disease|0|||
48356355|NCT03126110|155501058|FG003|Phase 2|Progressive Disease|0|||
48776055|NCT00439140|157023683|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
48776056|NCT00439140|157023681|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
48776057|NCT00439140|157023682|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
48776058|NCT00439140|157023683|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
48776059|NCT02203591|157023686|FG000|Overall Study|Did not meet treatment day baseline|147|||
48776060|NCT02203591|157023687|FG001|Overall Study|Did not meet treatment day baseline|141|||
48776061|NCT02203591|157023688|FG002|Overall Study|Did not meet treatment day baseline|150|||
48776062|NCT02203591|157023689|FG003|Overall Study|Did not meet treatment day baseline|45|||
48776063|NCT02203591|157023690|FG004|Overall Study|Did not meet treatment day baseline|33|||
48776064|NCT02203591|157023691|FG005|Overall Study|Did not meet treatment day baseline|35|||
48776065|NCT02203591|157023692|FG006|Overall Study|Did not meet treatment day baseline|29|||
48776066|NCT02203591|157023693|FG007|Overall Study|Did not meet treatment day baseline|12|||
48776067|NCT02203591|157023686|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
48776068|NCT02203591|157023687|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
48776069|NCT02203591|157023688|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
48776070|NCT02203591|157023689|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
48776071|NCT02203591|157023690|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
48776072|NCT02203591|157023691|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
48776073|NCT02203591|157023692|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
48776074|NCT02203591|157023693|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
48776075|NCT00281840|157023694|FG000|Overall Study|Adverse Event|12|||
48776076|NCT00281840|157023694|FG000|Overall Study|Physician Decision|6|||
48776077|NCT00281840|157023694|FG000|Overall Study|Withdrawal by Subject|3|||
48776078|NCT00281840|157023694|FG000|Overall Study|Disease Progression|2|||
48776079|NCT00281840|157023694|FG000|Overall Study|exceed maximum delay in treatment|1|||
48776080|NCT00281840|157023694|FG000|Overall Study|Complicating Disease|1|||
48776081|NCT03921411|157023704|FG000|Overall Study|Withdrawal by Subject|1|||
48776082|NCT03921411|157023704|FG000|Overall Study|Protocol Deviation|2|||
48776083|NCT03921411|157023704|FG000|Overall Study|Enrolled, but never treated|2|||
48776084|NCT01578551|157023712|FG000|Overall Study|Adverse Event|1|||
48776085|NCT01578551|157023713|FG001|Overall Study|Adverse Event|0|||
48776086|NCT00061048|157023714|FG000|Overall Study|Adverse Event|2|||
48776087|NCT00061048|157023714|FG000|Overall Study|disease progression|20|||
48776088|NCT01632579|157023715|FG000|Washout Period|Adverse Event|1|||
48776089|NCT01632579|157023716|FG001|Washout Period|Adverse Event|0|||
48776090|NCT01632579|157023717|FG002|Washout Period|Adverse Event|0|||
48776091|NCT01632579|157023718|FG003|Washout Period|Adverse Event|0|||
48776092|NCT01632579|157023719|FG004|Washout Period|Adverse Event|0|||
48776093|NCT01632579|157023720|FG005|Washout Period|Adverse Event|0|||
48776094|NCT01632579|157023721|FG006|Washout Period|Adverse Event|0|||
48776095|NCT01632579|157023722|FG007|Washout Period|Adverse Event|0|||
48776096|NCT01632579|157023723|FG008|Washout Period|Adverse Event|0|||
48776097|NCT01632579|157023715|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
48776098|NCT01632579|157023716|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
48776099|NCT01632579|157023717|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
48776100|NCT01632579|157023718|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
48776101|NCT01632579|157023719|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
48776102|NCT01632579|157023720|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
48776103|NCT01632579|157023721|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
48776104|NCT01632579|157023722|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
48776105|NCT01632579|157023723|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
48776106|NCT00162136|157023724|FG000|Overall Study|Adverse Event|1|||
48776107|NCT00162136|157023724|FG000|Overall Study|Death|1|||
48776108|NCT00162136|157023724|FG000|Overall Study|Disease Progression/Relapse|23|||
48776109|NCT00162136|157023724|FG000|Overall Study|Investigator Request|5|||
48776110|NCT00162136|157023724|FG000|Overall Study|Study Drug Toxicity|4|||
48776111|NCT00162136|157023724|FG000|Overall Study|Withdrawal by Subject|1|||
48776112|NCT02788175|157023725|FG000|Overall Study|Protocol Violation|3|||
48776113|NCT02788175|157023725|FG000|Overall Study|Withdrawal by Subject|4|||
48776114|NCT02788175|157023725|FG000|Overall Study|Ineligible prior to study agent|6|||
48776115|NCT03930745|157023726|FG000|Overall Study|Lost to Follow-up|10|||
48776116|NCT03930745|157023727|FG001|Overall Study|Lost to Follow-up|5|||
48776117|NCT03930745|157023726|FG000|Overall Study|Withdrawal by Subject|1|||
48776118|NCT03930745|157023727|FG001|Overall Study|Withdrawal by Subject|2|||
48776119|NCT03930745|157023726|FG000|Overall Study|Protocol Violation|2|||
48776120|NCT03930745|157023727|FG001|Overall Study|Protocol Violation|2|||
48776121|NCT03930745|157023726|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
48776122|NCT03930745|157023727|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
48776123|NCT03930745|157023726|FG000|Overall Study|Adverse Event|0|||
48776124|NCT03930745|157023727|FG001|Overall Study|Adverse Event|1|||
48776125|NCT03930745|157023726|FG000|Overall Study|Pregnancy|0|||
48776126|NCT03930745|157023727|FG001|Overall Study|Pregnancy|1|||
48776127|NCT00818441|157023732|FG000|Overall Study|Death|69|||
48776128|NCT00818441|157023733|FG001|Overall Study|Death|26|||
48776129|NCT00818441|157023732|FG000|Overall Study|Other|5|||
48776130|NCT00818441|157023733|FG001|Overall Study|Other|0|||
48776131|NCT00818441|157023732|FG000|Overall Study|Lost to Follow-up|2|||
48776132|NCT00818441|157023733|FG001|Overall Study|Lost to Follow-up|1|||
48776133|NCT00818441|157023732|FG000|Overall Study|Withdrawal by Subject|2|||
48776134|NCT00818441|157023733|FG001|Overall Study|Withdrawal by Subject|0|||
48776135|NCT00818441|157023732|FG000|Overall Study|Adverse Event|0|||
48776136|NCT00818441|157023733|FG001|Overall Study|Adverse Event|1|||
48776137|NCT00818441|157023732|FG000|Overall Study|Study terminated by sponsor|11|||
48776138|NCT00818441|157023733|FG001|Overall Study|Study terminated by sponsor|2|||
48776139|NCT00829621|157023746|FG000|Overall Study|Death|1|||
48776140|NCT00829621|157023747|FG001|Overall Study|Death|0|||
48776141|NCT00829621|157023746|FG000|Overall Study|Lost to Follow-up|3|||
48776142|NCT00829621|157023747|FG001|Overall Study|Lost to Follow-up|4|||
48776143|NCT01438541|157023751|FG000|Overall Study|Physician Decision|1|||
48776144|NCT01438541|157023751|FG000|Overall Study|Withdrawal by Subject|1|||
48776145|NCT01438541|157023751|FG000|Overall Study|discharge from the hospital|5|||
48776146|NCT02091167|157023753|FG000|Overall Study|Lost to Follow-up|0|||
48776147|NCT02091167|157023754|FG001|Overall Study|Lost to Follow-up|2|||
48776148|NCT03096782|157023757|FG000|Overall Study|Death|1|||
48776149|NCT03096782|157023757|FG000|Overall Study|Participant Relapsed|1|||
48776150|NCT03662750|157023758|FG000|Overall Study|Withdrawal by Subject|1|||
48776151|NCT03823651|157023765|FG000|Overall Study|Death|5|||
48776152|NCT03823651|157023766|FG001|Overall Study|Death|0|||
48776153|NCT03823651|157023765|FG000|Overall Study|Physician Decision|1|||
48776154|NCT03823651|157023766|FG001|Overall Study|Physician Decision|0|||
48776155|NCT03823651|157023765|FG000|Overall Study|Caregiver to patient who died|0|||
48776156|NCT03823651|157023766|FG001|Overall Study|Caregiver to patient who died|5|||
48776157|NCT03823651|157023765|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
48776158|NCT03823651|157023766|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
48776159|NCT04346615|157025914|FG000|Overall Study|Lost to Follow-up|0|||
48776160|NCT04346615|157025915|FG001|Overall Study|Lost to Follow-up|2|||
48776161|NCT04346615|157025914|FG000|Overall Study|Withdrawal by Subject|1|||
48776162|NCT04346615|157025915|FG001|Overall Study|Withdrawal by Subject|0|||
48776163|NCT04346615|157025914|FG000|Overall Study|Death|5|||
48776164|NCT04346615|157025915|FG001|Overall Study|Death|1|||
48776165|NCT04346615|157025914|FG000|Overall Study|Other|0|||
48776166|NCT04346615|157025915|FG001|Overall Study|Other|2|||
48776167|NCT04346615|157025914|FG000|Overall Study|Randomized not treated|1|||
48396439|NCT01928381|155643425|FG002|Part 1 - Pain Training|Protocol Violation|0|||
48396440|NCT01928381|155643426|FG003|Part 1 - Pain Training|Protocol Violation|0|||
48396441|NCT01928381|155643427|FG004|Part 1 - Pain Training|Protocol Violation|0|||
48396442|NCT01928381|155643428|FG005|Part 1 - Pain Training|Protocol Violation|0|||
48396443|NCT01928381|155643429|FG006|Part 1 - Pain Training|Protocol Violation|0|||
48396444|NCT01928381|155643423|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
48396445|NCT01928381|155643424|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48396446|NCT01928381|155643425|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48396447|NCT01928381|155643426|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48396448|NCT01928381|155643427|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48396449|NCT01928381|155643428|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48396450|NCT01928381|155643429|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
48396451|NCT01928381|155643423|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
48396452|NCT01928381|155643424|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48396453|NCT01928381|155643425|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48396454|NCT01928381|155643426|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48396455|NCT01928381|155643427|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48396456|NCT01928381|155643428|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48396457|NCT01928381|155643429|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
48776168|NCT04346615|157025915|FG001|Overall Study|Randomized not treated|0|||
48776169|NCT00941733|157025916|FG000|Overall Study|Death|24|||
48776170|NCT00941733|157025917|FG001|Overall Study|Death|10|||
48776171|NCT00941733|157025916|FG000|Overall Study|Withdrawal by Subject|14|||
48776172|NCT00941733|157025917|FG001|Overall Study|Withdrawal by Subject|6|||
48776173|NCT00941733|157025916|FG000|Overall Study|Adverse Event|20|||
48776174|NCT00941733|157025917|FG001|Overall Study|Adverse Event|4|||
48396458|NCT01928381|155643423|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
48396459|NCT01928381|155643424|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48396460|NCT01928381|155643425|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48430337|NCT00696657|155763700|FG000|Overall Study|Lack of Efficacy|0|||
48776175|NCT00941733|157025916|FG000|Overall Study|Lost to Follow-up|1|||
48776176|NCT00941733|157025917|FG001|Overall Study|Lost to Follow-up|2|||
48776177|NCT00941733|157025916|FG000|Overall Study|Protocol Violation|15|||
48776178|NCT00941733|157025917|FG001|Overall Study|Protocol Violation|6|||
48776179|NCT00773175|157025927|FG000|Overall Study|Adverse Event|2|||
48776180|NCT00773175|157025928|FG001|Overall Study|Adverse Event|0|||
48776181|NCT00773175|157025927|FG000|Overall Study|Consent Withdrawn|0|||
48776182|NCT00773175|157025928|FG001|Overall Study|Consent Withdrawn|2|||
48776183|NCT03285646|157025929|FG000|Overall Study|Adverse Event|1|||
48776184|NCT03285646|157025930|FG001|Overall Study|Adverse Event|0|||
48776185|NCT03285646|157025929|FG000|Overall Study|Withdrawal by Subject|10|||
48776186|NCT03285646|157025930|FG001|Overall Study|Withdrawal by Subject|2|||
48776187|NCT03285646|157025929|FG000|Overall Study|Lost to Follow-up|2|||
48776188|NCT03285646|157025930|FG001|Overall Study|Lost to Follow-up|1|||
48776189|NCT03285646|157025929|FG000|Overall Study|Investigator/Sponsor Decision|0|||
48776190|NCT03285646|157025930|FG001|Overall Study|Investigator/Sponsor Decision|1|||
48776191|NCT01465802|157025932|FG000|Overall Study|Study terminated by sponsor|1|||
48776192|NCT01465802|157025933|FG001|Overall Study|Study terminated by sponsor|0|||
48776193|NCT01465802|157025934|FG002|Overall Study|Study terminated by sponsor|0|||
48776194|NCT01465802|157025935|FG003|Overall Study|Study terminated by sponsor|1|||
48776195|NCT01465802|157025936|FG004|Overall Study|Study terminated by sponsor|7|||
48776196|NCT01465802|157025932|FG000|Overall Study|Withdrawal by Subject|7|||
48776197|NCT01465802|157025933|FG001|Overall Study|Withdrawal by Subject|7|||
48776198|NCT01465802|157025934|FG002|Overall Study|Withdrawal by Subject|0|||
48776199|NCT01465802|157025935|FG003|Overall Study|Withdrawal by Subject|8|||
48776200|NCT01465802|157025936|FG004|Overall Study|Withdrawal by Subject|1|||
48776201|NCT01465802|157025932|FG000|Overall Study|Lost to Follow-up|1|||
48776202|NCT01465802|157025933|FG001|Overall Study|Lost to Follow-up|1|||
48776203|NCT01465802|157025934|FG002|Overall Study|Lost to Follow-up|0|||
48776204|NCT01465802|157025935|FG003|Overall Study|Lost to Follow-up|0|||
48776205|NCT01465802|157025936|FG004|Overall Study|Lost to Follow-up|0|||
48776206|NCT01465802|157025932|FG000|Overall Study|Reason not specified|9|||
48776207|NCT01465802|157025933|FG001|Overall Study|Reason not specified|4|||
48776208|NCT01465802|157025934|FG002|Overall Study|Reason not specified|0|||
48776209|NCT01465802|157025935|FG003|Overall Study|Reason not specified|10|||
48776210|NCT01465802|157025936|FG004|Overall Study|Reason not specified|2|||
48776211|NCT01465802|157025932|FG000|Overall Study|Death|15|||
48776212|NCT01465802|157025933|FG001|Overall Study|Death|12|||
48776213|NCT01465802|157025934|FG002|Overall Study|Death|0|||
48776214|NCT01465802|157025935|FG003|Overall Study|Death|10|||
48776215|NCT01465802|157025936|FG004|Overall Study|Death|2|||
48776216|NCT00456092|157025938|FG000|Extension Phase|Grade 2 or Greater AE|2|||
48776217|NCT00456092|157025939|FG001|Extension Phase|Grade 2 or Greater AE|2|||
48776218|NCT00456092|157025940|FG002|Extension Phase|Grade 2 or Greater AE|0|||
48776219|NCT00456092|157025941|FG003|Extension Phase|Grade 2 or Greater AE|0|||
48776220|NCT00456092|157025942|FG004|Extension Phase|Grade 2 or Greater AE|2|||
48776221|NCT00456092|157025938|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
48776222|NCT00456092|157025939|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
48776223|NCT00456092|157025940|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
48776224|NCT00456092|157025941|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
48776225|NCT00456092|157025942|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
48776226|NCT00456092|157025938|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
48776227|NCT00456092|157025939|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
48776228|NCT00456092|157025940|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
48776229|NCT00456092|157025941|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
48776230|NCT00456092|157025942|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
48776231|NCT00456092|157025938|FG000|Extension Phase|Withdrew Consent|2|||
48776232|NCT00456092|157025939|FG001|Extension Phase|Withdrew Consent|0|||
48776233|NCT00456092|157025940|FG002|Extension Phase|Withdrew Consent|0|||
48776234|NCT00456092|157025941|FG003|Extension Phase|Withdrew Consent|0|||
48776235|NCT00456092|157025942|FG004|Extension Phase|Withdrew Consent|0|||
48776236|NCT00456092|157025938|FG000|Extension Phase|Lost to Follow-up|1|||
48776237|NCT00456092|157025939|FG001|Extension Phase|Lost to Follow-up|1|||
48776238|NCT00456092|157025940|FG002|Extension Phase|Lost to Follow-up|0|||
48776239|NCT00456092|157025941|FG003|Extension Phase|Lost to Follow-up|0|||
48776240|NCT00456092|157025942|FG004|Extension Phase|Lost to Follow-up|1|||
48776241|NCT00456092|157025938|FG000|Extension Phase|Other|2|||
48776242|NCT00456092|157025939|FG001|Extension Phase|Other|0|||
48776243|NCT00456092|157025940|FG002|Extension Phase|Other|0|||
48776244|NCT00456092|157025941|FG003|Extension Phase|Other|1|||
48776245|NCT00456092|157025942|FG004|Extension Phase|Other|1|||
48356356|NCT03126110|155501059|FG004|Phase 2|Progressive Disease|0|||
48356357|NCT03126110|155501060|FG005|Phase 2|Progressive Disease|0|||
48356358|NCT03126110|155501061|FG006|Phase 2|Progressive Disease|0|||
48356359|NCT03126110|155501062|FG007|Phase 2|Progressive Disease|0|||
48356360|NCT03126110|155501063|FG008|Phase 2|Progressive Disease|0|||
48356361|NCT03126110|155501064|FG009|Phase 2|Progressive Disease|0|||
48776246|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
48776247|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
48356362|NCT03126110|155501065|FG010|Phase 2|Progressive Disease|0|||
48776248|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
48776249|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
48776250|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
48776251|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
48776252|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
48396461|NCT01928381|155643426|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48396462|NCT01928381|155643427|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48396463|NCT01928381|155643428|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48396464|NCT01928381|155643429|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
48396465|NCT01928381|155643423|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
48396466|NCT01928381|155643424|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48396467|NCT01928381|155643425|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48396468|NCT01928381|155643426|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48396469|NCT01928381|155643427|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48396470|NCT01928381|155643428|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48396471|NCT01928381|155643429|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
48396472|NCT01928381|155643423|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
48396473|NCT01928381|155643424|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
48396474|NCT01928381|155643425|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
48396475|NCT01928381|155643426|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
48396476|NCT01928381|155643427|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
48396477|NCT01928381|155643428|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
48396478|NCT01928381|155643429|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
48396479|NCT01928381|155643423|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48396480|NCT01928381|155643424|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48396481|NCT01928381|155643425|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
48396482|NCT01928381|155643426|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48396483|NCT01928381|155643427|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48396484|NCT01928381|155643428|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48396485|NCT01928381|155643429|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
48396486|NCT01928381|155643423|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
48396487|NCT01928381|155643424|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
48396488|NCT01928381|155643425|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
48396489|NCT01928381|155643426|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
48396490|NCT01928381|155643427|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
48396491|NCT01928381|155643428|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
48396492|NCT01928381|155643429|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
48396493|NCT01928381|155643423|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
48396494|NCT01928381|155643424|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
48396495|NCT01928381|155643425|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
48396496|NCT01928381|155643426|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
48396497|NCT01928381|155643427|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
48396498|NCT01928381|155643428|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
48396499|NCT01928381|155643429|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
48396500|NCT01928381|155643423|FG000|Washout First Intervention|Protocol Violation|0|||
48396501|NCT01928381|155643424|FG001|Washout First Intervention|Protocol Violation|0|||
48396502|NCT01928381|155643425|FG002|Washout First Intervention|Protocol Violation|0|||
48396503|NCT01928381|155643426|FG003|Washout First Intervention|Protocol Violation|0|||
48396504|NCT01928381|155643427|FG004|Washout First Intervention|Protocol Violation|1|||
48396505|NCT01928381|155643428|FG005|Washout First Intervention|Protocol Violation|0|||
48396506|NCT01928381|155643429|FG006|Washout First Intervention|Protocol Violation|0|||
48396507|NCT01928381|155643423|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
48396508|NCT01928381|155643424|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
48396509|NCT01928381|155643425|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
48396510|NCT01928381|155643426|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
48396511|NCT01928381|155643427|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
48776253|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
48776254|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
48776255|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
48776256|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
48776257|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
48776258|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
48776259|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
48776260|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
48776261|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
48776262|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
48776263|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
48776264|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
48776265|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
48776266|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
48776267|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
48776268|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
48776269|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
48776270|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
48776271|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
48776272|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
48776273|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
48776274|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
48776275|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
48776276|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
48776277|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
48776278|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
48776279|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
48776280|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
48776281|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
48776282|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
48776283|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
48776284|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
48776285|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
48776286|NCT00456092|157025938|FG000|Treatment Phase (12 Weeks)|Other|1|||
48776287|NCT00456092|157025939|FG001|Treatment Phase (12 Weeks)|Other|0|||
48776288|NCT00456092|157025940|FG002|Treatment Phase (12 Weeks)|Other|1|||
48776289|NCT00456092|157025941|FG003|Treatment Phase (12 Weeks)|Other|0|||
48776290|NCT00456092|157025942|FG004|Treatment Phase (12 Weeks)|Other|0|||
48776291|NCT01565993|157025945|FG000|Overall Study|Physician Decision|0|||
48776292|NCT01565993|157025946|FG001|Overall Study|Physician Decision|3|||
48776293|NCT01824303|157025947|FG000|Randomized Study|Withdrawal by Subject|1|||
48776294|NCT01824303|157025948|FG001|Randomized Study|Withdrawal by Subject|1|||
48776295|NCT01824303|157025947|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
48776296|NCT01824303|157025948|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
48776297|NCT03219333|157025949|FG000|Overall Study|Withdrawal by Subject|9|||
48776298|NCT03219333|157025950|FG001|Overall Study|Withdrawal by Subject|4|||
48776299|NCT03219333|157025949|FG000|Overall Study|Lost to Follow-up|1|||
48776300|NCT03219333|157025950|FG001|Overall Study|Lost to Follow-up|1|||
48396512|NCT01928381|155643428|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
48396513|NCT01928381|155643429|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
48396514|NCT01928381|155643423|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
48396515|NCT01928381|155643424|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
48396516|NCT01928381|155643425|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
48396517|NCT01928381|155643426|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
48396518|NCT01928381|155643427|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
48776301|NCT03219333|157025949|FG000|Overall Study|Death|104|||
48776302|NCT03219333|157025950|FG001|Overall Study|Death|72|||
48776303|NCT03219333|157025949|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
48776304|NCT03219333|157025950|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
48776305|NCT03219333|157025949|FG000|Overall Study|Other|2|||
48776306|NCT03219333|157025950|FG001|Overall Study|Other|2|||
48776307|NCT01126541|157025953|FG000|Overall Study|Adverse Event|0|||
48776308|NCT01126541|157025954|FG001|Overall Study|Adverse Event|2|||
48776309|NCT01126541|157025955|FG002|Overall Study|Adverse Event|4|||
48776310|NCT01126541|157025953|FG000|Overall Study|Death|0|||
48776311|NCT01126541|157025954|FG001|Overall Study|Death|1|||
48776312|NCT01126541|157025955|FG002|Overall Study|Death|0|||
48776313|NCT01126541|157025953|FG000|Overall Study|Lack of Efficacy|6|||
48776314|NCT01126541|157025954|FG001|Overall Study|Lack of Efficacy|1|||
48776315|NCT01126541|157025955|FG002|Overall Study|Lack of Efficacy|11|||
48776316|NCT01126541|157025953|FG000|Overall Study|Lost to Follow-up|1|||
48776317|NCT01126541|157025954|FG001|Overall Study|Lost to Follow-up|2|||
48776318|NCT01126541|157025955|FG002|Overall Study|Lost to Follow-up|2|||
48776319|NCT01126541|157025953|FG000|Overall Study|Withdrawal by Subject|2|||
48776320|NCT01126541|157025954|FG001|Overall Study|Withdrawal by Subject|5|||
48776321|NCT01126541|157025955|FG002|Overall Study|Withdrawal by Subject|6|||
48776322|NCT01126541|157025953|FG000|Overall Study|Protocol Violation|0|||
48776323|NCT01126541|157025954|FG001|Overall Study|Protocol Violation|0|||
48776324|NCT01126541|157025955|FG002|Overall Study|Protocol Violation|1|||
48776325|NCT01126541|157025953|FG000|Overall Study|Administrative reason or other|1|||
48776326|NCT01126541|157025954|FG001|Overall Study|Administrative reason or other|1|||
48776327|NCT01126541|157025955|FG002|Overall Study|Administrative reason or other|2|||
48776328|NCT02732847|157025956|FG000|Overall Study|some filled early|42|||
48776329|NCT02732847|157025957|FG001|Overall Study|some filled early|42|||
48776330|NCT02956629|157025958|FG000|Overall Study|Adverse Event|0|||
48776331|NCT02956629|157025959|FG001|Overall Study|Adverse Event|0|||
48396519|NCT01928381|155643428|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
48396520|NCT01928381|155643429|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
48396521|NCT00562588|155643433|FG000|Overall Study|Adverse Event|40|||
48396522|NCT00562588|155643434|FG001|Overall Study|Adverse Event|58|||
48396523|NCT00562588|155643433|FG000|Overall Study|Protocol Violation|30|||
48396524|NCT00562588|155643434|FG001|Overall Study|Protocol Violation|26|||
48396525|NCT00562588|155643433|FG000|Overall Study|Lost to Follow-up|12|||
48396526|NCT00562588|155643434|FG001|Overall Study|Lost to Follow-up|4|||
48396527|NCT00562588|155643433|FG000|Overall Study|Withdrawal by Subject|10|||
48396528|NCT00562588|155643434|FG001|Overall Study|Withdrawal by Subject|9|||
48396529|NCT00562588|155643433|FG000|Overall Study|Other|0|||
48396530|NCT00562588|155643434|FG001|Overall Study|Other|2|||
48396531|NCT03809611|155643435|FG000|Overall Study|Withdrawal by Subject|1|||
48396532|NCT03809611|155643436|FG001|Overall Study|Withdrawal by Subject|1|||
48776332|NCT02956629|157025960|FG002|Overall Study|Adverse Event|1|||
48776333|NCT02956629|157025961|FG003|Overall Study|Adverse Event|0|||
48396533|NCT03451773|155644576|FG000|Overall Study|Death on study|1|||
48396534|NCT03451773|155644577|FG001|Overall Study|Death on study|5|||
48396535|NCT03451773|155644576|FG000|Overall Study|Death during follow-up period|0|||
48396536|NCT03451773|155644577|FG001|Overall Study|Death during follow-up period|1|||
48396537|NCT00879229|155644579|FG000|Overall Study|Study terminated by Sponsor|13|||
48396538|NCT00879229|155644580|FG001|Overall Study|Study terminated by Sponsor|12|||
48396539|NCT00879229|155644579|FG000|Overall Study|Death|4|||
48396540|NCT00879229|155644580|FG001|Overall Study|Death|2|||
48396541|NCT00879229|155644579|FG000|Overall Study|Adverse Event|2|||
48396542|NCT00879229|155644580|FG001|Overall Study|Adverse Event|0|||
48396543|NCT00879229|155644579|FG000|Overall Study|Withdrawal by Subject|1|||
48396544|NCT00879229|155644580|FG001|Overall Study|Withdrawal by Subject|0|||
48396545|NCT00879229|155644579|FG000|Overall Study|Clinical status did not improve|1|||
48396546|NCT00879229|155644580|FG001|Overall Study|Clinical status did not improve|0|||
48396547|NCT00879229|155644579|FG000|Overall Study|Other|1|||
48396548|NCT00879229|155644580|FG001|Overall Study|Other|0|||
48396549|NCT00925015|155644583|FG000|Overall Study|Adverse Event|1|||
48396550|NCT00925015|155644584|FG001|Overall Study|Adverse Event|2|||
48396551|NCT00925015|155644585|FG002|Overall Study|Adverse Event|1|||
48396552|NCT00925015|155644583|FG000|Overall Study|Physician Decision|0|||
48396553|NCT00925015|155644584|FG001|Overall Study|Physician Decision|1|||
48396554|NCT00925015|155644585|FG002|Overall Study|Physician Decision|0|||
48396555|NCT00925015|155644583|FG000|Overall Study|Progressive Disease|7|||
48396556|NCT00925015|155644584|FG001|Overall Study|Progressive Disease|3|||
48396557|NCT00925015|155644585|FG002|Overall Study|Progressive Disease|4|||
48396558|NCT00925015|155644583|FG000|Overall Study|Withdrawal by Subject|0|||
48396559|NCT00925015|155644584|FG001|Overall Study|Withdrawal by Subject|0|||
48396560|NCT00925015|155644585|FG002|Overall Study|Withdrawal by Subject|1|||
48396561|NCT04962022|155644586|FG000|Period 1|Withdrawal by Subject|1|||
48396562|NCT04962022|155644587|FG001|Period 1|Withdrawal by Subject|0|||
48396563|NCT00732303|155644595|FG000|Overall Study|Study Terminated|2|||
48396564|NCT02590588|155644596|FG000|Overall Study|Adverse Event|1|||
48396565|NCT00763815|155644601|FG000|Overall Study|Adverse Event|14|||
48776334|NCT02956629|157025962|FG004|Overall Study|Adverse Event|0|||
48776335|NCT02956629|157025963|FG005|Overall Study|Adverse Event|0|||
48776336|NCT02956629|157025958|FG000|Overall Study|Lost to Follow-up|2|||
48776337|NCT02956629|157025959|FG001|Overall Study|Lost to Follow-up|5|||
48776338|NCT02956629|157025960|FG002|Overall Study|Lost to Follow-up|3|||
48776339|NCT02956629|157025961|FG003|Overall Study|Lost to Follow-up|1|||
48776340|NCT02956629|157025962|FG004|Overall Study|Lost to Follow-up|0|||
48776341|NCT02956629|157025963|FG005|Overall Study|Lost to Follow-up|1|||
48776342|NCT02956629|157025958|FG000|Overall Study|Withdrawal by Subject|3|||
48776343|NCT02956629|157025959|FG001|Overall Study|Withdrawal by Subject|1|||
48776344|NCT02956629|157025960|FG002|Overall Study|Withdrawal by Subject|0|||
48776345|NCT02956629|157025961|FG003|Overall Study|Withdrawal by Subject|0|||
48776346|NCT02956629|157025962|FG004|Overall Study|Withdrawal by Subject|0|||
48776347|NCT02956629|157025963|FG005|Overall Study|Withdrawal by Subject|0|||
48776348|NCT00812929|157025964|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
48776349|NCT00812929|157025965|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
48396566|NCT00763815|155644602|FG001|Overall Study|Adverse Event|29|||
48396567|NCT00763815|155644601|FG000|Overall Study|Lack of Efficacy|10|||
48396568|NCT00763815|155644602|FG001|Overall Study|Lack of Efficacy|11|||
48776350|NCT00812929|157025966|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
48776351|NCT00812929|157025967|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
48776352|NCT00812929|157025968|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
48396569|NCT00763815|155644601|FG000|Overall Study|Poor Compliance to Protocol|6|||
48396570|NCT00763815|155644602|FG001|Overall Study|Poor Compliance to Protocol|6|||
48396571|NCT00763815|155644601|FG000|Overall Study|Lost to Follow-up|2|||
48776353|NCT00812929|157025969|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
48776354|NCT00812929|157025970|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
48776355|NCT00812929|157025971|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
48776356|NCT00812929|157025972|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
48776357|NCT00812929|157025973|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
48776358|NCT00812929|157025964|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
48776359|NCT00812929|157025965|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
48776360|NCT00812929|157025966|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
48776361|NCT00812929|157025967|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
48776362|NCT00812929|157025968|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
48776363|NCT00812929|157025969|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
48776364|NCT00812929|157025970|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
48776365|NCT00812929|157025971|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
48776366|NCT00812929|157025972|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
48776367|NCT00812929|157025973|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
48776368|NCT00812929|157025964|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
48776369|NCT00812929|157025965|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
48776370|NCT00812929|157025966|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
48776371|NCT00812929|157025967|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
48776372|NCT00812929|157025968|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
48776373|NCT00812929|157025969|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
48776374|NCT00812929|157025970|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
48776375|NCT00812929|157025971|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
48776376|NCT00812929|157025972|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
48776377|NCT00812929|157025973|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
48776378|NCT01600040|157025974|FG000|Overall Study|Withdrawal by Subject|1|||
48776379|NCT00047463|157025976|FG000|Overall Study|Withdrawal by Subject|0|||
48776380|NCT00047463|157025977|FG001|Overall Study|Withdrawal by Subject|3|||
48776381|NCT00113516|157025978|FG000|Part 1|Adverse Event|6|||
48776382|NCT00113516|157025979|FG001|Part 1|Adverse Event|0|||
48776383|NCT00113516|157025978|FG000|Part 1|Death|3|||
48776384|NCT00113516|157025979|FG001|Part 1|Death|0|||
48776385|NCT00113516|157025978|FG000|Part 1|Other|3|||
48776386|NCT00113516|157025979|FG001|Part 1|Other|0|||
48776387|NCT00113516|157025978|FG000|Part 1|Withdrawal by Subject|2|||
48776388|NCT00113516|157025979|FG001|Part 1|Withdrawal by Subject|0|||
48776389|NCT00113516|157025978|FG000|Part 1|Lack of Efficacy|2|||
48776390|NCT00113516|157025979|FG001|Part 1|Lack of Efficacy|0|||
48776391|NCT00113516|157025978|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
48776392|NCT00113516|157025979|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
48776393|NCT00113516|157025978|FG000|Part 1|Laboratory Abnormality|1|||
48776394|NCT00113516|157025979|FG001|Part 1|Laboratory Abnormality|0|||
48776395|NCT00113516|157025978|FG000|Part 1|Ongoing|1|||
48776396|NCT00113516|157025979|FG001|Part 1|Ongoing|0|||
48776397|NCT00113516|157025978|FG000|Part 1|Missing|65|||
48776398|NCT00113516|157025979|FG001|Part 1|Missing|0|||
48776399|NCT00113516|157025978|FG000|Part 2|Adverse Event|0|||
48776400|NCT00113516|157025979|FG001|Part 2|Adverse Event|16|||
48776401|NCT00113516|157025978|FG000|Part 2|Death|0|||
48776402|NCT00113516|157025979|FG001|Part 2|Death|5|||
48776403|NCT00113516|157025978|FG000|Part 2|Lack of Efficacy|0|||
48776404|NCT00113516|157025979|FG001|Part 2|Lack of Efficacy|37|||
48776405|NCT00113516|157025978|FG000|Part 2|Withdrawal by Subject|0|||
48776406|NCT00113516|157025979|FG001|Part 2|Withdrawal by Subject|3|||
48776407|NCT00113516|157025978|FG000|Part 2|Other|0|||
48776408|NCT00113516|157025979|FG001|Part 2|Other|3|||
48776409|NCT00113516|157025978|FG000|Part 2|Laboratory Abnormality|0|||
48776410|NCT00113516|157025979|FG001|Part 2|Laboratory Abnormality|1|||
48776411|NCT00113516|157025978|FG000|Part 2|Ongoing|0|||
48776412|NCT00113516|157025979|FG001|Part 2|Ongoing|1|||
48776413|NCT02443298|157025980|FG000|Overall Study|Adverse Event|3|||
48776414|NCT02443298|157025981|FG001|Overall Study|Adverse Event|3|||
48776415|NCT02443298|157025980|FG000|Overall Study|Withdrawal by Subject|1|||
48776416|NCT02443298|157025981|FG001|Overall Study|Withdrawal by Subject|2|||
48776417|NCT00797667|157025984|FG000|Overall Study|Lack of Efficacy|0|||
48776418|NCT00797667|157025985|FG001|Overall Study|Lack of Efficacy|1|||
48776419|NCT00797667|157025986|FG002|Overall Study|Lack of Efficacy|0|||
48776420|NCT00797667|157025984|FG000|Overall Study|Lost to Follow-up|8|||
48776421|NCT00797667|157025985|FG001|Overall Study|Lost to Follow-up|12|||
48776422|NCT00797667|157025986|FG002|Overall Study|Lost to Follow-up|2|||
48776423|NCT00797667|157025984|FG000|Overall Study|Physician Decision|3|||
48776424|NCT00797667|157025985|FG001|Overall Study|Physician Decision|1|||
48776425|NCT00797667|157025986|FG002|Overall Study|Physician Decision|0|||
48776426|NCT00797667|157025984|FG000|Overall Study|Pregnancy|2|||
48776427|NCT00797667|157025985|FG001|Overall Study|Pregnancy|0|||
48776428|NCT00797667|157025986|FG002|Overall Study|Pregnancy|0|||
48776429|NCT00797667|157025984|FG000|Overall Study|Protocol Violation|2|||
48776430|NCT00797667|157025985|FG001|Overall Study|Protocol Violation|7|||
48776431|NCT00797667|157025986|FG002|Overall Study|Protocol Violation|0|||
48396572|NCT00763815|155644602|FG001|Overall Study|Lost to Follow-up|4|||
48396573|NCT00763815|155644601|FG000|Overall Study|Early Termination|1|||
48396574|NCT00763815|155644602|FG001|Overall Study|Early Termination|0|||
48396575|NCT00763815|155644601|FG000|Overall Study|Familial and Personal Reasons|9|||
48396576|NCT00763815|155644602|FG001|Overall Study|Familial and Personal Reasons|16|||
48396577|NCT00763815|155644601|FG000|Overall Study|Physician Decision|1|||
48396578|NCT00763815|155644602|FG001|Overall Study|Physician Decision|0|||
48396579|NCT00763815|155644601|FG000|Overall Study|Withdrawal by Subject|7|||
48396580|NCT00763815|155644602|FG001|Overall Study|Withdrawal by Subject|12|||
48396581|NCT00763815|155644601|FG000|Overall Study|Protocol Violation|2|||
48396582|NCT00763815|155644602|FG001|Overall Study|Protocol Violation|5|||
48396583|NCT00763815|155644601|FG000|Overall Study|Sponsor's Decision|0|||
48396584|NCT00763815|155644602|FG001|Overall Study|Sponsor's Decision|1|||
48396585|NCT03699007|155644603|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
48396586|NCT03699007|155644604|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
48396587|NCT03699007|155644603|FG000|6-month Follow Up|Lost to Follow-up|2|||
48396588|NCT03699007|155644604|FG001|6-month Follow Up|Lost to Follow-up|3|||
48396589|NCT00414453|155644605|FG000|Overall Study|Abnormal lab work|16|||
48396590|NCT01389752|155644608|FG000|Study Period 1|Sponsor decision|0|||
48396591|NCT01389752|155644609|FG001|Study Period 1|Sponsor decision|2|||
48396592|NCT01389752|155644608|FG000|Study Period 2|Sponsor decision|1|||
48396593|NCT01389752|155644609|FG001|Study Period 2|Sponsor decision|0|||
48396594|NCT00143455|155644612|FG000|Cohort 1|Adverse Event|8|||
48396595|NCT00143455|155644613|FG001|Cohort 1|Adverse Event|4|||
48396596|NCT00143455|155644614|FG002|Cohort 1|Adverse Event|0|||
48396597|NCT00143455|155644615|FG003|Cohort 1|Adverse Event|0|||
48396598|NCT00143455|155644612|FG000|Cohort 1|Death|5|||
48396599|NCT00143455|155644613|FG001|Cohort 1|Death|2|||
48396600|NCT00143455|155644614|FG002|Cohort 1|Death|0|||
48396601|NCT00143455|155644615|FG003|Cohort 1|Death|0|||
48396602|NCT00143455|155644612|FG000|Cohort 1|Progressive Disease|0|||
48396603|NCT00143455|155644613|FG001|Cohort 1|Progressive Disease|6|||
48396604|NCT00143455|155644614|FG002|Cohort 1|Progressive Disease|0|||
48396605|NCT00143455|155644615|FG003|Cohort 1|Progressive Disease|0|||
48396606|NCT00143455|155644612|FG000|Cohort 1|Withdrawal by Subject|1|||
48396607|NCT00143455|155644613|FG001|Cohort 1|Withdrawal by Subject|4|||
48396608|NCT00143455|155644614|FG002|Cohort 1|Withdrawal by Subject|0|||
48396609|NCT00143455|155644615|FG003|Cohort 1|Withdrawal by Subject|0|||
48396610|NCT00143455|155644612|FG000|Cohort 1|Randomized But Not Treated|0|||
48396611|NCT00143455|155644613|FG001|Cohort 1|Randomized But Not Treated|1|||
48396612|NCT00143455|155644614|FG002|Cohort 1|Randomized But Not Treated|0|||
48396613|NCT00143455|155644615|FG003|Cohort 1|Randomized But Not Treated|0|||
48396614|NCT00143455|155644612|FG000|Cohort 2|Adverse Event|0|||
48396615|NCT00143455|155644613|FG001|Cohort 2|Adverse Event|0|||
48396616|NCT00143455|155644614|FG002|Cohort 2|Adverse Event|42|||
48396617|NCT00143455|155644615|FG003|Cohort 2|Adverse Event|30|||
48396618|NCT00143455|155644612|FG000|Cohort 2|No Longer Required Study Treatment|0|||
48396619|NCT00143455|155644613|FG001|Cohort 2|No Longer Required Study Treatment|0|||
48396620|NCT00143455|155644614|FG002|Cohort 2|No Longer Required Study Treatment|1|||
48396621|NCT00143455|155644615|FG003|Cohort 2|No Longer Required Study Treatment|0|||
48396622|NCT00143455|155644612|FG000|Cohort 2|Protocol Violation|0|||
48396623|NCT00143455|155644613|FG001|Cohort 2|Protocol Violation|0|||
48396624|NCT00143455|155644614|FG002|Cohort 2|Protocol Violation|1|||
48396625|NCT00143455|155644615|FG003|Cohort 2|Protocol Violation|1|||
48396626|NCT00143455|155644612|FG000|Cohort 2|Lost to Follow-up|0|||
48396627|NCT00143455|155644613|FG001|Cohort 2|Lost to Follow-up|0|||
48396628|NCT00143455|155644614|FG002|Cohort 2|Lost to Follow-up|1|||
48396629|NCT00143455|155644615|FG003|Cohort 2|Lost to Follow-up|4|||
48396630|NCT00143455|155644612|FG000|Cohort 2|Death|0|||
48396631|NCT00143455|155644613|FG001|Cohort 2|Death|0|||
48396632|NCT00143455|155644614|FG002|Cohort 2|Death|20|||
48396633|NCT00143455|155644615|FG003|Cohort 2|Death|12|||
48396634|NCT00143455|155644612|FG000|Cohort 2|Progressive Disease|0|||
48396635|NCT00143455|155644613|FG001|Cohort 2|Progressive Disease|0|||
48396636|NCT00143455|155644614|FG002|Cohort 2|Progressive Disease|20|||
48396637|NCT00143455|155644615|FG003|Cohort 2|Progressive Disease|27|||
48396638|NCT00143455|155644612|FG000|Cohort 2|Withdrawal by Subject|0|||
48396639|NCT00143455|155644613|FG001|Cohort 2|Withdrawal by Subject|0|||
48396640|NCT00143455|155644614|FG002|Cohort 2|Withdrawal by Subject|13|||
48396641|NCT00143455|155644615|FG003|Cohort 2|Withdrawal by Subject|12|||
48396642|NCT00143455|155644612|FG000|Cohort 2|Other|0|||
48396643|NCT00143455|155644613|FG001|Cohort 2|Other|0|||
48396644|NCT00143455|155644614|FG002|Cohort 2|Other|7|||
48396645|NCT00143455|155644615|FG003|Cohort 2|Other|6|||
48396646|NCT00143455|155644612|FG000|Cohort 2|Randomized But Not Treated|0|||
48396647|NCT00143455|155644613|FG001|Cohort 2|Randomized But Not Treated|0|||
48396648|NCT00143455|155644614|FG002|Cohort 2|Randomized But Not Treated|1|||
48396649|NCT00143455|155644615|FG003|Cohort 2|Randomized But Not Treated|1|||
48396650|NCT00419380|155644618|FG000|Overall Study|Lack of Efficacy|1|||
48396651|NCT00419380|155644619|FG001|Overall Study|Lack of Efficacy|7|||
48396652|NCT00419380|155644618|FG000|Overall Study|Physician Decision|0|||
48776432|NCT00797667|157025984|FG000|Overall Study|Study Terminated by Sponsor|217|||
48776433|NCT00797667|157025985|FG001|Overall Study|Study Terminated by Sponsor|216|||
48776434|NCT00797667|157025986|FG002|Overall Study|Study Terminated by Sponsor|115|||
48776435|NCT00797667|157025984|FG000|Overall Study|Withdrawal by Subject|9|||
48776436|NCT00797667|157025985|FG001|Overall Study|Withdrawal by Subject|14|||
48776437|NCT00797667|157025986|FG002|Overall Study|Withdrawal by Subject|2|||
48776438|NCT00797667|157025984|FG000|Overall Study|Adverse Event|19|||
48776439|NCT00797667|157025985|FG001|Overall Study|Adverse Event|8|||
48776440|NCT00797667|157025986|FG002|Overall Study|Adverse Event|8|||
48776441|NCT03732248|157025991|FG000|Overall Study|Withdrawal by Subject|1|||
48776442|NCT03732248|157025992|FG001|Overall Study|Withdrawal by Subject|0|||
48776443|NCT04796610|157025993|FG000|Overall Study|Withdrawal by Subject|1|||
48776444|NCT04796610|157025994|FG001|Overall Study|Withdrawal by Subject|0|||
48776445|NCT04796610|157025995|FG002|Overall Study|Withdrawal by Subject|0|||
48776446|NCT04796610|157025996|FG003|Overall Study|Withdrawal by Subject|0|||
48776447|NCT04796610|157025993|FG000|Overall Study|Lost to Follow-up|2|||
48776448|NCT04796610|157025994|FG001|Overall Study|Lost to Follow-up|0|||
48776449|NCT04796610|157025995|FG002|Overall Study|Lost to Follow-up|1|||
48776450|NCT04796610|157025996|FG003|Overall Study|Lost to Follow-up|1|||
48776451|NCT01599650|157025997|FG000|Overall Study|Administrative issue|1|||
48776452|NCT01599650|157025998|FG001|Overall Study|Administrative issue|0|||
48776453|NCT01599650|157025999|FG002|Overall Study|Administrative issue|1|||
48776454|NCT01599650|157025997|FG000|Overall Study|Physician Decision|2|||
48776455|NCT01599650|157025998|FG001|Overall Study|Physician Decision|0|||
48776456|NCT01599650|157025999|FG002|Overall Study|Physician Decision|7|||
48776457|NCT01599650|157025997|FG000|Overall Study|Protocol Violation|0|||
48776458|NCT01599650|157025998|FG001|Overall Study|Protocol Violation|3|||
48776459|NCT01599650|157025999|FG002|Overall Study|Protocol Violation|0|||
48776460|NCT01599650|157025997|FG000|Overall Study|Death|2|||
48776461|NCT01599650|157025998|FG001|Overall Study|Death|1|||
48776462|NCT01599650|157025999|FG002|Overall Study|Death|2|||
48776463|NCT01599650|157025997|FG000|Overall Study|Lost to Follow-up|3|||
48776464|NCT01599650|157025998|FG001|Overall Study|Lost to Follow-up|3|||
48776465|NCT01599650|157025999|FG002|Overall Study|Lost to Follow-up|3|||
48776466|NCT01599650|157025997|FG000|Overall Study|Withdrawal by Subject|11|||
48776467|NCT01599650|157025998|FG001|Overall Study|Withdrawal by Subject|11|||
48776468|NCT01599650|157025999|FG002|Overall Study|Withdrawal by Subject|10|||
48776469|NCT01599650|157025997|FG000|Overall Study|Adverse Event|3|||
48776470|NCT01599650|157025998|FG001|Overall Study|Adverse Event|8|||
48776471|NCT01599650|157025999|FG002|Overall Study|Adverse Event|4|||
48776472|NCT01243944|157026000|FG000|Overall Study|Adverse Event|15|||
48776473|NCT01243944|157026001|FG001|Overall Study|Adverse Event|13|||
48776474|NCT01243944|157026000|FG000|Overall Study|Lost to Follow-up|2|||
48776475|NCT01243944|157026001|FG001|Overall Study|Lost to Follow-up|1|||
48776476|NCT01243944|157026000|FG000|Overall Study|Physician Decision|2|||
48776477|NCT01243944|157026001|FG001|Overall Study|Physician Decision|7|||
48776478|NCT01243944|157026000|FG000|Overall Study|Disease progression|12|||
48776479|NCT01243944|157026001|FG001|Overall Study|Disease progression|11|||
48776480|NCT01243944|157026000|FG000|Overall Study|Protocol deviation|1|||
48776481|NCT01243944|157026001|FG001|Overall Study|Protocol deviation|1|||
48776482|NCT01243944|157026000|FG000|Overall Study|Participant decision|10|||
48776483|NCT01243944|157026001|FG001|Overall Study|Participant decision|15|||
48776484|NCT01243944|157026000|FG000|Overall Study|Death|2|||
48776485|NCT01243944|157026001|FG001|Overall Study|Death|3|||
48776486|NCT01243944|157026000|FG000|Overall Study|Non-compliance with study treatment|1|||
48776487|NCT01243944|157026001|FG001|Overall Study|Non-compliance with study treatment|0|||
48776488|NCT03323099|157026007|FG000|Overall Study|Withdrawal by Subject|6|||
48776489|NCT03323099|157026008|FG001|Overall Study|Withdrawal by Subject|12|||
48776490|NCT03323099|157026007|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
48776491|NCT03323099|157026008|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
48776492|NCT03495908|157026013|FG000|Overall Study|Withdrawal by Subject|3|||
48776493|NCT03495908|157026014|FG001|Overall Study|Withdrawal by Subject|1|||
48776494|NCT03495908|157026013|FG000|Overall Study|Lost to Follow-up|1|||
48396653|NCT00419380|155644619|FG001|Overall Study|Physician Decision|1|||
48776495|NCT03495908|157026014|FG001|Overall Study|Lost to Follow-up|4|||
48776496|NCT03495908|157026013|FG000|Overall Study|Adverse Event|0|||
48776497|NCT03495908|157026014|FG001|Overall Study|Adverse Event|2|||
48776498|NCT03495908|157026013|FG000|Overall Study|Death|1|||
48776499|NCT03495908|157026014|FG001|Overall Study|Death|0|||
48776500|NCT03495908|157026013|FG000|Overall Study|Physician Decision|5|||
48776501|NCT03495908|157026014|FG001|Overall Study|Physician Decision|4|||
48776502|NCT03495908|157026013|FG000|Overall Study|No documented reason|0|||
48776503|NCT03495908|157026014|FG001|Overall Study|No documented reason|2|||
48776504|NCT00413413|157026015|FG000|Single-Blind|Adverse Event|0|||
48776505|NCT00413413|157026016|FG001|Single-Blind|Adverse Event|9|||
48776506|NCT00413413|157026017|FG002|Single-Blind|Adverse Event|0|||
48776507|NCT00413413|157026015|FG000|Single-Blind|Lack of Efficacy|0|||
48776508|NCT00413413|157026016|FG001|Single-Blind|Lack of Efficacy|5|||
48776509|NCT00413413|157026017|FG002|Single-Blind|Lack of Efficacy|0|||
48396654|NCT00419380|155644618|FG000|Overall Study|Lost to Follow-up|0|||
48396655|NCT00419380|155644619|FG001|Overall Study|Lost to Follow-up|1|||
48396656|NCT00419380|155644618|FG000|Overall Study|Withdrawal by Subject|0|||
48396657|NCT00419380|155644619|FG001|Overall Study|Withdrawal by Subject|1|||
48396658|NCT01181011|155644624|FG000|Overall Study|Adverse Event|2|||
48396659|NCT01181011|155644624|FG000|Overall Study|Lost to Follow-up|1|||
48396660|NCT03152019|155644625|FG000|Overall Study|Adverse Event|0|||
48396661|NCT03152019|155644626|FG001|Overall Study|Adverse Event|1|||
48396662|NCT01119248|155644627|FG000|Overall Study|Physician Decision|5|||
48396663|NCT01967550|155644628|FG000|Overall Study|Withdrawal by Subject|1|||
48396664|NCT01967550|155644629|FG001|Overall Study|Withdrawal by Subject|0|||
48396665|NCT01967550|155644628|FG000|Overall Study|Adverse Event|2|||
48396666|NCT01967550|155644629|FG001|Overall Study|Adverse Event|0|||
48396667|NCT01967550|155644628|FG000|Overall Study|Protocol Violation|2|||
48396668|NCT01967550|155644629|FG001|Overall Study|Protocol Violation|1|||
48396669|NCT01967550|155644628|FG000|Overall Study|Non Compliance|0|||
48396670|NCT01967550|155644629|FG001|Overall Study|Non Compliance|1|||
48396671|NCT04417894|155644630|FG000|Overall Study|Lost to Follow-up|3|||
48776510|NCT00413413|157026015|FG000|Single-Blind|Subject no longer requires study drug|0|||
48776511|NCT00413413|157026016|FG001|Single-Blind|Subject no longer requires study drug|151|||
48776512|NCT00413413|157026017|FG002|Single-Blind|Subject no longer requires study drug|0|||
48776513|NCT00413413|157026015|FG000|Single-Blind|Protocol Violation|0|||
48776514|NCT00413413|157026016|FG001|Single-Blind|Protocol Violation|16|||
48396672|NCT04417894|155644631|FG001|Overall Study|Lost to Follow-up|0|||
48396673|NCT04417894|155644630|FG000|Overall Study|Withdrawal by Subject|7|||
48396674|NCT04417894|155644631|FG001|Overall Study|Withdrawal by Subject|6|||
48396675|NCT04417894|155644630|FG000|Overall Study|Lack of Efficacy|3|||
48396676|NCT04417894|155644631|FG001|Overall Study|Lack of Efficacy|1|||
48396677|NCT01180660|155644632|FG000|Overall Study|Changed to open surgery|1|||
48396678|NCT01180660|155644633|FG001|Overall Study|Changed to open surgery|0|||
48396679|NCT01883635|155644634|FG000|Overall Study|Withdrawal by Subject|4|||
48396680|NCT01883635|155644635|FG001|Overall Study|Withdrawal by Subject|0|||
48396681|NCT03652662|155644636|FG000|Overall Study|Withdrawal by Subject|2|||
48396682|NCT03652662|155644637|FG001|Overall Study|Withdrawal by Subject|1|||
48396683|NCT03652662|155644636|FG000|Overall Study|Lost to Follow-up|1|||
48396684|NCT03652662|155644637|FG001|Overall Study|Lost to Follow-up|0|||
48776515|NCT00413413|157026017|FG002|Single-Blind|Protocol Violation|0|||
48776516|NCT00413413|157026015|FG000|Single-Blind|Withdrawal by Subject|0|||
48776517|NCT00413413|157026016|FG001|Single-Blind|Withdrawal by Subject|27|||
48776518|NCT00413413|157026017|FG002|Single-Blind|Withdrawal by Subject|0|||
48776519|NCT00413413|157026015|FG000|Single-Blind|Lost to Follow-up|0|||
48776520|NCT00413413|157026016|FG001|Single-Blind|Lost to Follow-up|8|||
48776521|NCT00413413|157026017|FG002|Single-Blind|Lost to Follow-up|0|||
48776522|NCT00413413|157026015|FG000|Double-Blind|Adverse Event|6|||
48776523|NCT00413413|157026016|FG001|Double-Blind|Adverse Event|0|||
48776524|NCT00413413|157026017|FG002|Double-Blind|Adverse Event|5|||
48776525|NCT00413413|157026015|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
48776526|NCT00413413|157026016|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
48776527|NCT00413413|157026017|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
48776528|NCT00413413|157026015|FG000|Double-Blind|Protocol deviation|1|||
48776529|NCT00413413|157026016|FG001|Double-Blind|Protocol deviation|2|||
48776530|NCT00413413|157026017|FG002|Double-Blind|Protocol deviation|1|||
48776531|NCT00413413|157026015|FG000|Double-Blind|Subject withdrew consent|4|||
48776532|NCT00413413|157026016|FG001|Double-Blind|Subject withdrew consent|6|||
48776533|NCT00413413|157026017|FG002|Double-Blind|Subject withdrew consent|9|||
48776534|NCT00413413|157026015|FG000|Double-Blind|Lost to Follow-up|3|||
48776535|NCT00413413|157026016|FG001|Double-Blind|Lost to Follow-up|4|||
48776536|NCT00413413|157026017|FG002|Double-Blind|Lost to Follow-up|2|||
48776537|NCT01410110|157026018|FG000|Overall Study|Withdrawal by Subject|4|||
48776538|NCT01410110|157026019|FG001|Overall Study|Withdrawal by Subject|2|||
48776539|NCT01416805|157026022|FG000|Overall Study|Lost to Follow-up|4|||
48776540|NCT01416805|157026023|FG001|Overall Study|Lost to Follow-up|4|||
48776541|NCT01732835|157026031|FG000|6-month Primary Endpoint|Did not receive device|19|||
48776542|NCT01732835|157026031|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
48776543|NCT01732835|157026031|FG000|6-month Primary Endpoint|Adverse Event|3|||
48776544|NCT01732835|157026031|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
48776545|NCT01732835|157026031|FG000|2-year Extended Follow-up|Adverse Event|3|||
48776546|NCT01732835|157026031|FG000|2-year Extended Follow-up|Death|1|||
48776547|NCT02334748|157026032|FG000|Overall Study|Adverse Event|1|||
48776548|NCT02334748|157026032|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
48776549|NCT02334748|157026032|FG000|Overall Study|Patient no longer required study drug|2|||
48396685|NCT00993928|155644640|FG000|Overall Study|Withdrawal by Subject|4|||
48396686|NCT00993928|155644641|FG001|Overall Study|Withdrawal by Subject|7|||
48776550|NCT02334748|157026032|FG000|Overall Study|Lack of Efficacy|4|||
48396687|NCT00993928|155644640|FG000|Overall Study|ineligible|1|||
48396688|NCT00993928|155644641|FG001|Overall Study|ineligible|0|||
48396689|NCT02751502|155644642|FG000|Overall Study|Lack of funding|4|||
48776551|NCT02604589|157026035|FG000|Overall Study|catheter dislodgement|0|||
48776552|NCT02604589|157026036|FG001|Overall Study|catheter dislodgement|0|||
48776553|NCT02604589|157026037|FG002|Overall Study|catheter dislodgement|1|||
48776554|NCT05061446|157026042|FG000|Overall Study|Adverse Event|2|||
48776555|NCT05061446|157026043|FG001|Overall Study|Adverse Event|0|||
48776556|NCT05061446|157026044|FG002|Overall Study|Adverse Event|0|||
48776557|NCT05061446|157026042|FG000|Overall Study|Participant no longer available due to personal reason|0|||
48776558|NCT05061446|157026043|FG001|Overall Study|Participant no longer available due to personal reason|1|||
48776559|NCT05061446|157026044|FG002|Overall Study|Participant no longer available due to personal reason|0|||
48776560|NCT04111497|157026045|FG000|Overall Study|relapse of primary disease|1|||
48776561|NCT04111497|157026045|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
48776562|NCT01767116|157026056|FG000|Overall Study|Lost to Follow-up|2|||
48776563|NCT01767116|157026057|FG001|Overall Study|Lost to Follow-up|2|||
48776564|NCT02209324|157026062|FG000|Overall Study|Adverse Event|2|||
48776565|NCT02209324|157026062|FG000|Overall Study|Lack of Efficacy|1|||
48776566|NCT02209324|157026062|FG000|Overall Study|Lost to Follow-up|1|||
48776567|NCT02209324|157026062|FG000|Overall Study|Physician Decision|3|||
48776568|NCT02209324|157026062|FG000|Overall Study|Protocol Violation|14|||
48776569|NCT02209324|157026062|FG000|Overall Study|Withdrawal by Subject|8|||
48776570|NCT02209324|157026062|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
48776571|NCT02209324|157026062|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
48776572|NCT02209324|157026062|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
48776573|NCT03511560|157026064|FG000|Overall Study|Death|0|||
48776574|NCT03511560|157026065|FG001|Overall Study|Death|1|||
48776575|NCT03511560|157026064|FG000|Overall Study|Adverse Event|0|||
48776576|NCT03511560|157026065|FG001|Overall Study|Adverse Event|2|||
48776577|NCT03511560|157026064|FG000|Overall Study|Transplant cancelled|0|||
48776578|NCT03511560|157026065|FG001|Overall Study|Transplant cancelled|1|||
48776579|NCT03511560|157026064|FG000|Overall Study|Patient switched to another drug|1|||
48776580|NCT03511560|157026065|FG001|Overall Study|Patient switched to another drug|0|||
48776581|NCT04496258|157026070|FG000|Overall Study|Withdrawal by Subject|2|||
48776582|NCT04496258|157026071|FG001|Overall Study|Withdrawal by Subject|1|||
48776583|NCT02985736|157026072|FG000|Overall Study|Lost to Follow-up|3|||
48776584|NCT03049813|157026073|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
48776585|NCT03049813|157026074|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
48776586|NCT03049813|157026075|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
48776587|NCT03049813|157026076|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
48776588|NCT03049813|157026073|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
48776589|NCT03049813|157026074|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
48776590|NCT03049813|157026075|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
48776591|NCT03049813|157026076|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
48776592|NCT03049813|157026073|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
48776593|NCT03049813|157026074|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
48776594|NCT03049813|157026075|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
48776595|NCT03049813|157026076|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
48776596|NCT03049813|157026073|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
48776597|NCT03049813|157026074|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
48776598|NCT03049813|157026075|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
48776599|NCT03049813|157026076|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
48776600|NCT01813019|157026077|FG000|Overall Study|Adverse Event|0|||
48776601|NCT01813019|157026078|FG001|Overall Study|Adverse Event|3|||
48776602|NCT01813019|157026077|FG000|Overall Study|Withdrawal by Subject|3|||
48776603|NCT01813019|157026078|FG001|Overall Study|Withdrawal by Subject|2|||
48776604|NCT01813019|157026077|FG000|Overall Study|administrative problems|2|||
48776605|NCT01813019|157026078|FG001|Overall Study|administrative problems|0|||
48776606|NCT01813019|157026077|FG000|Overall Study|Protocol Deviation|2|||
48776607|NCT01813019|157026078|FG001|Overall Study|Protocol Deviation|1|||
48776608|NCT03169153|157026081|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
48776609|NCT03169153|157026082|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
48776610|NCT03169153|157026081|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
48776611|NCT03169153|157026082|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
48776612|NCT03169153|157026081|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
48776613|NCT03169153|157026082|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
48776614|NCT03169153|157026081|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
48356363|NCT03126110|155501066|FG011|Phase 2|Progressive Disease|0|||
48356364|NCT03126110|155501067|FG012|Phase 2|Progressive Disease|0|||
48356365|NCT03126110|155501068|FG013|Phase 2|Progressive Disease|1|||
48356366|NCT03126110|155501069|FG014|Phase 2|Progressive Disease|0|||
48356367|NCT03126110|155501070|FG015|Phase 2|Progressive Disease|0|||
48356368|NCT03126110|155501071|FG016|Phase 2|Progressive Disease|0|||
48356369|NCT03126110|155501055|FG000|Phase 2|Started new treatment|0|||
48776615|NCT03169153|157026082|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
48776616|NCT00622635|157026083|FG000|Treatment Period 1|Adverse Event|0|||
48776617|NCT00622635|157026084|FG001|Treatment Period 1|Adverse Event|0|||
48776618|NCT00622635|157026085|FG002|Treatment Period 1|Adverse Event|1|||
48776619|NCT00622635|157026086|FG003|Treatment Period 1|Adverse Event|0|||
48776620|NCT00622635|157026087|FG004|Treatment Period 1|Adverse Event|0|||
48776621|NCT00622635|157026088|FG005|Treatment Period 1|Adverse Event|0|||
48776622|NCT00622635|157026083|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48776623|NCT00622635|157026084|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48776624|NCT00622635|157026085|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48776625|NCT00622635|157026086|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48776626|NCT00622635|157026087|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48776627|NCT00622635|157026088|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48776628|NCT00622635|157026083|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776629|NCT00622635|157026084|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776630|NCT00622635|157026085|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776631|NCT00622635|157026086|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776632|NCT00622635|157026087|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
48776633|NCT00622635|157026088|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
48776634|NCT00622635|157026083|FG000|Treatment Period 2|Adverse Event|1|||
48776635|NCT00622635|157026084|FG001|Treatment Period 2|Adverse Event|0|||
48776636|NCT00622635|157026085|FG002|Treatment Period 2|Adverse Event|0|||
48776637|NCT00622635|157026086|FG003|Treatment Period 2|Adverse Event|0|||
48776638|NCT00622635|157026087|FG004|Treatment Period 2|Adverse Event|0|||
48776639|NCT00622635|157026088|FG005|Treatment Period 2|Adverse Event|0|||
48776640|NCT00622635|157026083|FG000|Treatment Period 3|Adverse Event|0|||
48776641|NCT00622635|157026084|FG001|Treatment Period 3|Adverse Event|0|||
48776642|NCT00622635|157026085|FG002|Treatment Period 3|Adverse Event|0|||
48776643|NCT00622635|157026086|FG003|Treatment Period 3|Adverse Event|2|||
48776644|NCT00622635|157026087|FG004|Treatment Period 3|Adverse Event|0|||
48776645|NCT00622635|157026088|FG005|Treatment Period 3|Adverse Event|0|||
48776646|NCT00622635|157026083|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48776647|NCT00622635|157026084|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48776648|NCT00622635|157026085|FG002|Treatment Period 3|Withdrawal by Subject|0|||
48776649|NCT00622635|157026086|FG003|Treatment Period 3|Withdrawal by Subject|1|||
48776650|NCT00622635|157026087|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48776651|NCT00622635|157026088|FG005|Treatment Period 3|Withdrawal by Subject|0|||
48776652|NCT03120013|157026089|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
48776653|NCT03120013|157026090|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48776654|NCT03286140|157026091|FG000|Overall Study|Withdrawal by Subject|10|||
48776655|NCT03286140|157026092|FG001|Overall Study|Withdrawal by Subject|5|||
48776656|NCT03286140|157026091|FG000|Overall Study|Lost to Follow-up|5|||
48776657|NCT03286140|157026092|FG001|Overall Study|Lost to Follow-up|10|||
48776658|NCT03286140|157026091|FG000|Overall Study|Failure to comply|0|||
48776659|NCT03286140|157026092|FG001|Overall Study|Failure to comply|1|||
48776660|NCT04382612|157026102|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
48776661|NCT00718718|157026103|FG000|Prior to Week 12|Adverse Event|0|||
48776662|NCT00718718|157026104|FG001|Prior to Week 12|Adverse Event|0|||
48776663|NCT00718718|157026105|FG002|Prior to Week 12|Adverse Event|0|||
48776664|NCT00718718|157026106|FG003|Prior to Week 12|Adverse Event|0|||
48776665|NCT00718718|157026107|FG004|Prior to Week 12|Adverse Event|0|||
48776666|NCT00718718|157026108|FG005|Prior to Week 12|Adverse Event|0|||
48776667|NCT00718718|157026109|FG006|Prior to Week 12|Adverse Event|0|||
48776668|NCT00718718|157026110|FG007|Prior to Week 12|Adverse Event|1|||
48776669|NCT00718718|157026111|FG008|Prior to Week 12|Adverse Event|1|||
48776670|NCT00718718|157026112|FG009|Prior to Week 12|Adverse Event|0|||
48776671|NCT00718718|157026103|FG000|Prior to Week 12|Withdrawal by Subject|0|||
48776672|NCT00718718|157026104|FG001|Prior to Week 12|Withdrawal by Subject|0|||
48776673|NCT00718718|157026105|FG002|Prior to Week 12|Withdrawal by Subject|0|||
48776674|NCT00718718|157026106|FG003|Prior to Week 12|Withdrawal by Subject|0|||
48776675|NCT00718718|157026107|FG004|Prior to Week 12|Withdrawal by Subject|3|||
48776676|NCT00718718|157026108|FG005|Prior to Week 12|Withdrawal by Subject|0|||
48776677|NCT00718718|157026109|FG006|Prior to Week 12|Withdrawal by Subject|1|||
48776678|NCT00718718|157026110|FG007|Prior to Week 12|Withdrawal by Subject|1|||
48776679|NCT00718718|157026111|FG008|Prior to Week 12|Withdrawal by Subject|1|||
48776680|NCT00718718|157026112|FG009|Prior to Week 12|Withdrawal by Subject|0|||
48776681|NCT00718718|157026103|FG000|Prior to Week 12|Other|1|||
48776682|NCT00718718|157026104|FG001|Prior to Week 12|Other|0|||
48776683|NCT00718718|157026105|FG002|Prior to Week 12|Other|1|||
48776684|NCT00718718|157026106|FG003|Prior to Week 12|Other|0|||
48776685|NCT00718718|157026107|FG004|Prior to Week 12|Other|0|||
48776686|NCT00718718|157026108|FG005|Prior to Week 12|Other|0|||
48776687|NCT00718718|157026109|FG006|Prior to Week 12|Other|0|||
48776688|NCT00718718|157026110|FG007|Prior to Week 12|Other|0|||
48776689|NCT00718718|157026111|FG008|Prior to Week 12|Other|0|||
48776690|NCT00718718|157026112|FG009|Prior to Week 12|Other|0|||
48776691|NCT00718718|157026103|FG000|Week 12 to End of Study|Adverse Event|0|||
48776692|NCT00718718|157026104|FG001|Week 12 to End of Study|Adverse Event|0|||
48776693|NCT00718718|157026105|FG002|Week 12 to End of Study|Adverse Event|0|||
48776694|NCT00718718|157026106|FG003|Week 12 to End of Study|Adverse Event|0|||
48776695|NCT00718718|157026107|FG004|Week 12 to End of Study|Adverse Event|0|||
48776696|NCT00718718|157026108|FG005|Week 12 to End of Study|Adverse Event|0|||
48776697|NCT00718718|157026109|FG006|Week 12 to End of Study|Adverse Event|0|||
48776698|NCT00718718|157026110|FG007|Week 12 to End of Study|Adverse Event|1|||
48776699|NCT00718718|157026111|FG008|Week 12 to End of Study|Adverse Event|0|||
48776700|NCT00718718|157026112|FG009|Week 12 to End of Study|Adverse Event|0|||
48776701|NCT00718718|157026103|FG000|Week 12 to End of Study|Death|0|||
48776702|NCT00718718|157026104|FG001|Week 12 to End of Study|Death|0|||
48776703|NCT00718718|157026105|FG002|Week 12 to End of Study|Death|0|||
48776704|NCT00718718|157026106|FG003|Week 12 to End of Study|Death|0|||
48776705|NCT00718718|157026107|FG004|Week 12 to End of Study|Death|0|||
48776706|NCT00718718|157026108|FG005|Week 12 to End of Study|Death|1|||
48776707|NCT00718718|157026109|FG006|Week 12 to End of Study|Death|0|||
48776708|NCT00718718|157026110|FG007|Week 12 to End of Study|Death|0|||
48776709|NCT00718718|157026111|FG008|Week 12 to End of Study|Death|0|||
48776710|NCT00718718|157026112|FG009|Week 12 to End of Study|Death|0|||
48776711|NCT00718718|157026103|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
48776712|NCT00718718|157026104|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
48776713|NCT00718718|157026105|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
48776714|NCT00718718|157026106|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
48776715|NCT00718718|157026107|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
48776716|NCT00718718|157026108|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
48776717|NCT00718718|157026109|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
48776718|NCT00718718|157026110|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
48776719|NCT00718718|157026111|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
48776720|NCT00718718|157026112|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
48776721|NCT00718718|157026103|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
48776722|NCT00718718|157026104|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
48776723|NCT00718718|157026105|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
48776724|NCT00718718|157026106|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
48776725|NCT00718718|157026107|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
48776726|NCT00718718|157026108|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
48776727|NCT00718718|157026109|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
48776728|NCT00718718|157026110|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
48776729|NCT00718718|157026111|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
48776730|NCT00718718|157026112|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
48776731|NCT00718718|157026103|FG000|Week 12 to End of Study|Other|0|||
48776732|NCT00718718|157026104|FG001|Week 12 to End of Study|Other|1|||
48776733|NCT00718718|157026105|FG002|Week 12 to End of Study|Other|0|||
48776734|NCT00718718|157026106|FG003|Week 12 to End of Study|Other|1|||
48776735|NCT00718718|157026107|FG004|Week 12 to End of Study|Other|0|||
48396690|NCT00088374|155644643|FG000|Overall Study|patient did not receive any 17AAG|1|||
48396691|NCT00088374|155644643|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
48776736|NCT00718718|157026108|FG005|Week 12 to End of Study|Other|0|||
48776737|NCT00718718|157026109|FG006|Week 12 to End of Study|Other|1|||
48776738|NCT00718718|157026110|FG007|Week 12 to End of Study|Other|0|||
48776739|NCT00718718|157026111|FG008|Week 12 to End of Study|Other|0|||
48776740|NCT00718718|157026112|FG009|Week 12 to End of Study|Other|0|||
48776741|NCT03285477|157026115|FG000|Treatment and Response Assessment Period|Death|1|||
48776742|NCT03285477|157026116|FG001|Treatment and Response Assessment Period|Death|0|||
48776743|NCT03285477|157026115|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
48776744|NCT03285477|157026116|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
48776745|NCT03285477|157026115|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
48776746|NCT03285477|157026116|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
48776747|NCT03285477|157026115|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
48776748|NCT03285477|157026116|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
48776749|NCT03285477|157026115|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
48776750|NCT03285477|157026116|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
48776751|NCT00852397|157026117|FG000|Overall Study|Adverse Event|4|||
48776752|NCT00852397|157026118|FG001|Overall Study|Adverse Event|6|||
48776753|NCT00852397|157026119|FG002|Overall Study|Adverse Event|4|||
48776754|NCT00852397|157026117|FG000|Overall Study|Death|0|||
48776755|NCT00852397|157026118|FG001|Overall Study|Death|0|||
48776756|NCT00852397|157026119|FG002|Overall Study|Death|1|||
48776757|NCT00852397|157026117|FG000|Overall Study|Withdrawal by Subject|4|||
48776758|NCT00852397|157026118|FG001|Overall Study|Withdrawal by Subject|1|||
48776759|NCT00852397|157026119|FG002|Overall Study|Withdrawal by Subject|2|||
48776760|NCT00852397|157026117|FG000|Overall Study|Study terminated by sponsor|2|||
48776761|NCT00852397|157026118|FG001|Overall Study|Study terminated by sponsor|1|||
48776762|NCT00852397|157026119|FG002|Overall Study|Study terminated by sponsor|6|||
48776763|NCT00852397|157026117|FG000|Overall Study|Difficulty in study site visit|1|||
48776764|NCT00852397|157026118|FG001|Overall Study|Difficulty in study site visit|0|||
48776765|NCT00852397|157026119|FG002|Overall Study|Difficulty in study site visit|0|||
48776766|NCT00852397|157026117|FG000|Overall Study|Protocol Violation|0|||
48776767|NCT00852397|157026118|FG001|Overall Study|Protocol Violation|0|||
48776768|NCT00852397|157026119|FG002|Overall Study|Protocol Violation|1|||
48776769|NCT02556710|157028423|FG000|Overall Study|Surgical treatment|3|||
48776770|NCT02556710|157028424|FG001|Overall Study|Surgical treatment|0|||
48776771|NCT02556710|157028423|FG000|Overall Study|Required proscribed pain medication|2|||
48776772|NCT02556710|157028424|FG001|Overall Study|Required proscribed pain medication|1|||
48776773|NCT02556710|157028423|FG000|Overall Study|Lack of Efficacy|1|||
48776774|NCT02556710|157028424|FG001|Overall Study|Lack of Efficacy|0|||
48396692|NCT00852995|155644644|FG000|Overall Study|Adverse Event|1|||
48396693|NCT00852995|155644645|FG001|Overall Study|Adverse Event|0|||
48396694|NCT00852995|155644646|FG002|Overall Study|Adverse Event|4|||
48776775|NCT02556710|157028423|FG000|Overall Study|Worsening osteoarthritis|1|||
48776776|NCT02556710|157028424|FG001|Overall Study|Worsening osteoarthritis|0|||
48776777|NCT02556710|157028423|FG000|Overall Study|Moved out of state|1|||
48776778|NCT02556710|157028424|FG001|Overall Study|Moved out of state|0|||
48776779|NCT02556710|157028423|FG000|Overall Study|Missing reason|3|||
48776780|NCT02556710|157028424|FG001|Overall Study|Missing reason|1|||
48396695|NCT00852995|155644647|FG003|Overall Study|Adverse Event|0|||
48396696|NCT00852995|155644648|FG004|Overall Study|Adverse Event|0|||
48776781|NCT02556710|157028423|FG000|Overall Study|Pain as lack of efficacy|0|||
48776782|NCT02556710|157028424|FG001|Overall Study|Pain as lack of efficacy|4|||
48776783|NCT00991302|157028425|FG000|Overall Study|Death|0|||
48776784|NCT00991302|157028426|FG001|Overall Study|Death|1|||
48776785|NCT00991302|157028425|FG000|Overall Study|Lost to Follow-up|14|||
48776786|NCT00991302|157028426|FG001|Overall Study|Lost to Follow-up|12|||
48776787|NCT02383758|157028427|FG000|Overall Study|Withdrawal by Subject|0|||
48776788|NCT02383758|157028428|FG001|Overall Study|Withdrawal by Subject|2|||
48776789|NCT04258839|157028431|FG000|Overall Study|Adverse Event|2|||
48776790|NCT04258839|157028432|FG001|Overall Study|Adverse Event|4|||
48776791|NCT04258839|157028431|FG000|Overall Study|Lack of Efficacy|0|||
48776792|NCT04258839|157028432|FG001|Overall Study|Lack of Efficacy|2|||
48776793|NCT04258839|157028431|FG000|Overall Study|Lost to Follow-up|2|||
48776794|NCT04258839|157028432|FG001|Overall Study|Lost to Follow-up|0|||
48776795|NCT04258839|157028431|FG000|Overall Study|Withdrawal by Subject|1|||
48776796|NCT04258839|157028432|FG001|Overall Study|Withdrawal by Subject|2|||
48776797|NCT04258839|157028431|FG000|Overall Study|Withdrawal by Caregiver|5|||
48776798|NCT04258839|157028432|FG001|Overall Study|Withdrawal by Caregiver|6|||
48776799|NCT04258839|157028431|FG000|Overall Study|Reason not Specified|0|||
48776800|NCT04258839|157028432|FG001|Overall Study|Reason not Specified|1|||
48776801|NCT02970968|157028433|FG000|Overall Study|Withdrawal by Subject|3|||
48776802|NCT02970968|157028434|FG001|Overall Study|Withdrawal by Subject|3|||
48776803|NCT02970968|157028433|FG000|Overall Study|Adverse Event|1|||
48776804|NCT02970968|157028434|FG001|Overall Study|Adverse Event|2|||
48776805|NCT02970968|157028433|FG000|Overall Study|Lost to Follow-up|1|||
48776806|NCT02970968|157028434|FG001|Overall Study|Lost to Follow-up|1|||
48776807|NCT02970968|157028433|FG000|Overall Study|Non-Compliance|0|||
48776808|NCT02970968|157028434|FG001|Overall Study|Non-Compliance|1|||
48776809|NCT00653224|157028435|FG000|Overall Study|Adverse Event|2|||
48776810|NCT00653224|157028436|FG001|Overall Study|Adverse Event|1|||
48776811|NCT00653224|157028435|FG000|Overall Study|Lack of Efficacy|1|||
48776812|NCT00653224|157028436|FG001|Overall Study|Lack of Efficacy|2|||
48776813|NCT00653224|157028435|FG000|Overall Study|Loss of efficacy|1|||
48776814|NCT00653224|157028436|FG001|Overall Study|Loss of efficacy|0|||
48776815|NCT00653224|157028435|FG000|Overall Study|Lost to Follow-up|1|||
48396697|NCT00852995|155644644|FG000|Overall Study|Lost to Follow-up|0|||
48396698|NCT00852995|155644645|FG001|Overall Study|Lost to Follow-up|1|||
48776816|NCT00653224|157028436|FG001|Overall Study|Lost to Follow-up|0|||
48776817|NCT00653224|157028435|FG000|Overall Study|Other|2|||
48776818|NCT00653224|157028436|FG001|Overall Study|Other|4|||
48776819|NCT00646958|157028437|FG000|Overall Study|Lack of Efficacy|1|||
48776820|NCT00646958|157028438|FG001|Overall Study|Lack of Efficacy|0|||
48396699|NCT00852995|155644646|FG002|Overall Study|Lost to Follow-up|1|||
48396700|NCT00852995|155644647|FG003|Overall Study|Lost to Follow-up|0|||
48396701|NCT00852995|155644648|FG004|Overall Study|Lost to Follow-up|0|||
48396702|NCT00852995|155644644|FG000|Overall Study|Withdrawal by Subject|4|||
48396703|NCT00852995|155644645|FG001|Overall Study|Withdrawal by Subject|0|||
48396704|NCT00852995|155644646|FG002|Overall Study|Withdrawal by Subject|0|||
48396705|NCT00852995|155644647|FG003|Overall Study|Withdrawal by Subject|1|||
48396706|NCT00852995|155644648|FG004|Overall Study|Withdrawal by Subject|2|||
48396707|NCT00852995|155644644|FG000|Overall Study|Non-Compliance|0|||
48776821|NCT00646958|157028439|FG002|Overall Study|Lack of Efficacy|0|||
48776822|NCT00646958|157028437|FG000|Overall Study|Adverse Event|4|||
48776823|NCT00646958|157028438|FG001|Overall Study|Adverse Event|0|||
48776824|NCT00646958|157028439|FG002|Overall Study|Adverse Event|0|||
48776825|NCT00646958|157028437|FG000|Overall Study|Lost to Follow-up|1|||
48776826|NCT00646958|157028438|FG001|Overall Study|Lost to Follow-up|5|||
48776827|NCT00646958|157028439|FG002|Overall Study|Lost to Follow-up|7|||
48776828|NCT00646958|157028437|FG000|Overall Study|Protocol Violation|1|||
48776829|NCT00646958|157028438|FG001|Overall Study|Protocol Violation|1|||
48776830|NCT00646958|157028439|FG002|Overall Study|Protocol Violation|0|||
48776831|NCT00646958|157028437|FG000|Overall Study|Abnormal screening lab tests|1|||
48776832|NCT00646958|157028438|FG001|Overall Study|Abnormal screening lab tests|1|||
48776833|NCT00646958|157028439|FG002|Overall Study|Abnormal screening lab tests|0|||
48776834|NCT00646958|157028437|FG000|Overall Study|Withdrawal by Subject|1|||
48776835|NCT00646958|157028438|FG001|Overall Study|Withdrawal by Subject|2|||
48776836|NCT00646958|157028439|FG002|Overall Study|Withdrawal by Subject|0|||
48776837|NCT00646958|157028437|FG000|Overall Study|Did not receive study drug|2|||
48776838|NCT00646958|157028438|FG001|Overall Study|Did not receive study drug|0|||
48776839|NCT00646958|157028439|FG002|Overall Study|Did not receive study drug|2|||
48776840|NCT02293005|157028441|FG000|Overall Study|Adverse Event|2|||
48776841|NCT02293005|157028441|FG000|Overall Study|Death|4|||
48776842|NCT02293005|157028441|FG000|Overall Study|Lost to Follow-up|1|||
48776843|NCT02293005|157028441|FG000|Overall Study|Withdrawal by Subject|2|||
48776844|NCT02293005|157028441|FG000|Overall Study|Progression|17|||
48776845|NCT04982029|157028442|FG000|Overall Study|Lost to Follow-up|2|||
48776846|NCT04982029|157028443|FG001|Overall Study|Lost to Follow-up|3|||
48776847|NCT00600821|157028445|FG000|Overall Study|Death|45|||
48776848|NCT00600821|157028446|FG001|Overall Study|Death|46|||
48776849|NCT00600821|157028445|FG000|Overall Study|Lost to Follow-up|2|||
48396708|NCT00852995|155644645|FG001|Overall Study|Non-Compliance|0|||
48396709|NCT00852995|155644646|FG002|Overall Study|Non-Compliance|0|||
48776850|NCT00600821|157028446|FG001|Overall Study|Lost to Follow-up|2|||
48776851|NCT00600821|157028445|FG000|Overall Study|Withdrawal by Subject|1|||
48776852|NCT00600821|157028446|FG001|Overall Study|Withdrawal by Subject|1|||
48776853|NCT00600821|157028445|FG000|Overall Study|Terminated by sponsor|8|||
48776854|NCT00600821|157028446|FG001|Overall Study|Terminated by sponsor|6|||
48776855|NCT00600821|157028445|FG000|Overall Study|Objective progression or relapse|0|||
48776856|NCT00600821|157028446|FG001|Overall Study|Objective progression or relapse|1|||
48776857|NCT00600821|157028445|FG000|Overall Study|Randomized but not treated|0|||
48776858|NCT00600821|157028446|FG001|Overall Study|Randomized but not treated|1|||
48776859|NCT00600821|157028445|FG000|Overall Study|Other|2|||
48776860|NCT00600821|157028446|FG001|Overall Study|Other|3|||
48776861|NCT01310413|157028448|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
48776862|NCT01310413|157028449|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
48776863|NCT01310413|157028450|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
48776864|NCT01310413|157028451|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
48776865|NCT01310413|157028452|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
48776866|NCT01310413|157028453|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
48396710|NCT00852995|155644647|FG003|Overall Study|Non-Compliance|2|||
48396711|NCT00852995|155644648|FG004|Overall Study|Non-Compliance|0|||
48396712|NCT00852995|155644644|FG000|Overall Study|Progressive Disease|1|||
48396713|NCT00852995|155644645|FG001|Overall Study|Progressive Disease|0|||
48396714|NCT00852995|155644646|FG002|Overall Study|Progressive Disease|0|||
48776867|NCT01310413|157028454|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
48776868|NCT01310413|157028448|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
48776869|NCT01310413|157028449|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
48776870|NCT01310413|157028450|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
48776871|NCT01310413|157028451|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
48776872|NCT01310413|157028452|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
48776873|NCT01310413|157028453|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
48776874|NCT01310413|157028454|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
48776875|NCT01310413|157028448|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
48776876|NCT01310413|157028449|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
48776877|NCT01310413|157028450|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
48776878|NCT01310413|157028451|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
48776879|NCT01310413|157028452|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
48776880|NCT01310413|157028453|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
48776881|NCT01310413|157028454|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
48776882|NCT01310413|157028448|FG000|Day 0 to Day 385|Other|1|||
48776883|NCT01310413|157028449|FG001|Day 0 to Day 385|Other|0|||
48776884|NCT01310413|157028450|FG002|Day 0 to Day 385|Other|3|||
48776885|NCT01310413|157028451|FG003|Day 0 to Day 385|Other|0|||
48776886|NCT01310413|157028452|FG004|Day 0 to Day 385|Other|0|||
48776887|NCT01310413|157028453|FG005|Day 0 to Day 385|Other|0|||
48776888|NCT01310413|157028454|FG006|Day 0 to Day 385|Other|0|||
48776889|NCT01310413|157028448|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776890|NCT01310413|157028449|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776891|NCT01310413|157028450|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776892|NCT01310413|157028451|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776893|NCT01310413|157028452|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776894|NCT01310413|157028453|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
48776895|NCT01310413|157028454|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
48776896|NCT01310413|157028448|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
48776897|NCT01310413|157028449|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
48776898|NCT01310413|157028450|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
48776899|NCT01310413|157028451|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
48776900|NCT01310413|157028452|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
48776901|NCT01310413|157028453|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
48776902|NCT01310413|157028454|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
48776903|NCT02564471|157028455|FG000|Overall Study|Adverse Event|1|||
48776904|NCT02564471|157028456|FG001|Overall Study|Adverse Event|0|||
48776905|NCT02564471|157028457|FG002|Overall Study|Adverse Event|0|||
48776906|NCT02564471|157028458|FG003|Overall Study|Adverse Event|0|||
48776907|NCT02564471|157028455|FG000|Overall Study|Withdrawal by Subject|2|||
48776908|NCT02564471|157028456|FG001|Overall Study|Withdrawal by Subject|1|||
48776909|NCT02564471|157028457|FG002|Overall Study|Withdrawal by Subject|3|||
48776910|NCT02564471|157028458|FG003|Overall Study|Withdrawal by Subject|0|||
48776911|NCT02564471|157028455|FG000|Overall Study|Lost to Follow-up|0|||
48776912|NCT02564471|157028456|FG001|Overall Study|Lost to Follow-up|2|||
48776913|NCT02564471|157028457|FG002|Overall Study|Lost to Follow-up|0|||
48776914|NCT02564471|157028458|FG003|Overall Study|Lost to Follow-up|0|||
48776915|NCT00194012|157028459|FG000|Randomized Phase|Lack of Efficacy|8|||
48776916|NCT00194012|157028460|FG001|Randomized Phase|Lack of Efficacy|18|||
48776917|NCT00194012|157028459|FG000|Randomized Phase|Study nonadherence|2|||
48776918|NCT00194012|157028460|FG001|Randomized Phase|Study nonadherence|1|||
48776919|NCT00194012|157028459|FG000|Randomized Phase|Withdrawal by Subject|3|||
48776920|NCT00194012|157028460|FG001|Randomized Phase|Withdrawal by Subject|3|||
48776921|NCT00194012|157028459|FG000|Randomized Phase|Adverse Event|2|||
48776922|NCT00194012|157028460|FG001|Randomized Phase|Adverse Event|1|||
48776923|NCT00194012|157028459|FG000|Randomized Phase|Participant reported having a rash|1|||
48776924|NCT00194012|157028460|FG001|Randomized Phase|Participant reported having a rash|0|||
48776925|NCT00194012|157028459|FG000|Randomized Phase|Emesis and enuresis|0|||
48776926|NCT00194012|157028460|FG001|Randomized Phase|Emesis and enuresis|1|||
48776927|NCT00194012|157028459|FG000|Randomized Phase|Oral/nasal twitching|0|||
48776928|NCT00194012|157028460|FG001|Randomized Phase|Oral/nasal twitching|1|||
48776929|NCT00194012|157028459|FG000|Open Label Extension (OLE)|Weight Gain|1|||
48776930|NCT00194012|157028460|FG001|Open Label Extension (OLE)|Weight Gain|0|||
48776931|NCT00194012|157028459|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
48776932|NCT00194012|157028460|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
48776933|NCT00194012|157028459|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
48776934|NCT00194012|157028460|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
48776935|NCT00194012|157028459|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
48776936|NCT00194012|157028460|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
48776937|NCT01643473|157028461|FG000|Overall Study|Lost to Follow-up|1|||
48776938|NCT01643473|157028462|FG001|Overall Study|Lost to Follow-up|0|||
48776939|NCT00659646|157028463|FG000|Overall Study|Protocol Violation|12|||
48776940|NCT00659646|157028464|FG001|Overall Study|Protocol Violation|8|||
48776941|NCT00659646|157028463|FG000|Overall Study|Adverse Event|1|||
48776942|NCT00659646|157028464|FG001|Overall Study|Adverse Event|0|||
48776943|NCT00659646|157028463|FG000|Overall Study|Lost to Follow-up|1|||
48776944|NCT00659646|157028464|FG001|Overall Study|Lost to Follow-up|0|||
48776945|NCT00659646|157028463|FG000|Overall Study|protocol noncompliance after randomized|1|||
48776946|NCT00659646|157028464|FG001|Overall Study|protocol noncompliance after randomized|0|||
48776947|NCT02453594|157028466|FG000|Overall Study|Protocol Violation|0|||
48776948|NCT02453594|157028467|FG001|Overall Study|Protocol Violation|0|||
48776949|NCT02453594|157028468|FG002|Overall Study|Protocol Violation|1|||
48776950|NCT02453594|157028466|FG000|Overall Study|Cohort Was Closed|17|||
48396715|NCT00852995|155644647|FG003|Overall Study|Progressive Disease|2|||
48396716|NCT00852995|155644648|FG004|Overall Study|Progressive Disease|1|||
48396717|NCT00852995|155644644|FG000|Overall Study|Physician Decision|1|||
48396718|NCT00852995|155644645|FG001|Overall Study|Physician Decision|0|||
48396719|NCT00852995|155644646|FG002|Overall Study|Physician Decision|0|||
48396720|NCT00852995|155644647|FG003|Overall Study|Physician Decision|0|||
48396721|NCT00852995|155644648|FG004|Overall Study|Physician Decision|0|||
48396722|NCT00852995|155644644|FG000|Overall Study|Protocol Violation|0|||
48396723|NCT00852995|155644645|FG001|Overall Study|Protocol Violation|0|||
48396724|NCT00852995|155644646|FG002|Overall Study|Protocol Violation|0|||
48396725|NCT00852995|155644647|FG003|Overall Study|Protocol Violation|0|||
48396726|NCT00852995|155644648|FG004|Overall Study|Protocol Violation|1|||
48396727|NCT00852995|155644644|FG000|Overall Study|Moved Out of Area|1|||
48396728|NCT00852995|155644645|FG001|Overall Study|Moved Out of Area|0|||
48396729|NCT00852995|155644646|FG002|Overall Study|Moved Out of Area|0|||
48396730|NCT00852995|155644647|FG003|Overall Study|Moved Out of Area|0|||
48396731|NCT00852995|155644648|FG004|Overall Study|Moved Out of Area|0|||
48396732|NCT00498173|155644650|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
48396733|NCT00498173|155644651|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
48396734|NCT00498173|155644652|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
48396735|NCT03499028|155644653|FG000|Overall Study|Lost to Follow-up|12|||
48396736|NCT03499028|155644654|FG001|Overall Study|Lost to Follow-up|9|||
48396737|NCT03499028|155644653|FG000|Overall Study|Withdrawal by Subject|5|||
48396738|NCT03499028|155644654|FG001|Overall Study|Withdrawal by Subject|8|||
48396739|NCT03499028|155644653|FG000|Overall Study|Unplanned SNF discharge|5|||
48396740|NCT03499028|155644654|FG001|Overall Study|Unplanned SNF discharge|8|||
48396741|NCT00720109|155644655|FG000|Induction Period|Did not meet eligibility criteria|3|||
48396742|NCT00720109|155644656|FG001|Induction Period|Did not meet eligibility criteria|0|||
48396743|NCT00720109|155644657|FG002|Induction Period|Did not meet eligibility criteria|0|||
48396744|NCT00720109|155644655|FG000|Induction Period|Bone Marrow Transplant|2|||
48396745|NCT00720109|155644656|FG001|Induction Period|Bone Marrow Transplant|0|||
48396746|NCT00720109|155644657|FG002|Induction Period|Bone Marrow Transplant|0|||
48776951|NCT02453594|157028467|FG001|Overall Study|Cohort Was Closed|21|||
48776952|NCT02453594|157028468|FG002|Overall Study|Cohort Was Closed|14|||
48776953|NCT02453594|157028466|FG000|Overall Study|Death|20|||
48776954|NCT02453594|157028467|FG001|Overall Study|Death|24|||
48776955|NCT02453594|157028468|FG002|Overall Study|Death|16|||
48776956|NCT02453594|157028466|FG000|Overall Study|Lost to Follow-up|6|||
48776957|NCT02453594|157028467|FG001|Overall Study|Lost to Follow-up|14|||
48776958|NCT02453594|157028468|FG002|Overall Study|Lost to Follow-up|2|||
48776959|NCT02453594|157028466|FG000|Overall Study|Physician Decision|2|||
48776960|NCT02453594|157028467|FG001|Overall Study|Physician Decision|4|||
48776961|NCT02453594|157028468|FG002|Overall Study|Physician Decision|0|||
48776962|NCT02453594|157028466|FG000|Overall Study|Site Terminated by Sponsor|1|||
48776963|NCT02453594|157028467|FG001|Overall Study|Site Terminated by Sponsor|0|||
48776964|NCT02453594|157028468|FG002|Overall Study|Site Terminated by Sponsor|1|||
48776965|NCT02453594|157028466|FG000|Overall Study|Transitioned to Extension Study|16|||
48776966|NCT02453594|157028467|FG001|Overall Study|Transitioned to Extension Study|9|||
48776967|NCT02453594|157028468|FG002|Overall Study|Transitioned to Extension Study|16|||
48396747|NCT00720109|155644655|FG000|Induction Period|Physician Decision|1|||
48776968|NCT02453594|157028466|FG000|Overall Study|Withdrawal by Subject|7|||
48776969|NCT02453594|157028467|FG001|Overall Study|Withdrawal by Subject|9|||
48776970|NCT02453594|157028468|FG002|Overall Study|Withdrawal by Subject|11|||
48776971|NCT00587587|157028471|FG000|Overall Study|Lost to Follow-up|6|||
48776972|NCT00587587|157028472|FG001|Overall Study|Lost to Follow-up|1|||
48776973|NCT04622254|157028475|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
48396748|NCT00720109|155644656|FG001|Induction Period|Physician Decision|0|||
48396749|NCT00720109|155644657|FG002|Induction Period|Physician Decision|0|||
48396750|NCT00720109|155644655|FG000|Risk Stratification Period|Adverse Event|0|||
48430338|NCT00696657|155763701|FG001|Overall Study|Lack of Efficacy|1|||
48776974|NCT04622254|157028476|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
48776975|NCT04622254|157028477|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
48776976|NCT04622254|157028478|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
48776977|NCT04622254|157028479|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
48776978|NCT04622254|157028480|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
48776979|NCT04622254|157028475|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
48776980|NCT04622254|157028476|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
48776981|NCT04622254|157028477|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
48776982|NCT04622254|157028478|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48776983|NCT04622254|157028479|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48776984|NCT04622254|157028480|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48776985|NCT04622254|157028475|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
48776986|NCT04622254|157028476|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776987|NCT04622254|157028477|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776988|NCT04622254|157028478|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776989|NCT04622254|157028479|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776990|NCT04622254|157028480|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
48776991|NCT04622254|157028475|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48776992|NCT04622254|157028476|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
48776993|NCT04622254|157028477|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
48776994|NCT04622254|157028478|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48776995|NCT04622254|157028479|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48776996|NCT04622254|157028480|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48776997|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48776998|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48776999|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48777000|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
48777001|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48777002|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48777003|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48777004|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48777005|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48777006|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
48777007|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48777008|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
48777009|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777010|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777011|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777012|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
48777013|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777014|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48777015|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777016|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777017|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777018|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
48777019|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777020|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48777021|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48777022|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48777023|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48777024|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
48777025|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
48777026|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
48777027|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48777028|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48777029|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48777030|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
48777031|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
48777032|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
48777033|NCT04622254|157028475|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
48777034|NCT04622254|157028476|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
48777035|NCT04622254|157028477|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
48777036|NCT04622254|157028478|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
48777037|NCT04622254|157028479|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
48777038|NCT04622254|157028480|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
48777039|NCT02057757|157028481|FG000|Overall Study|Withdrawal by Subject|3|||
48777040|NCT02057757|157028482|FG001|Overall Study|Withdrawal by Subject|5|||
48777041|NCT02057757|157028481|FG000|Overall Study|Death|2|||
48777042|NCT02057757|157028482|FG001|Overall Study|Death|0|||
48777043|NCT02057757|157028481|FG000|Overall Study|Lost to Follow-up|8|||
48777044|NCT02057757|157028482|FG001|Overall Study|Lost to Follow-up|3|||
48777045|NCT02057757|157028481|FG000|Overall Study|Non-compliance|1|||
48777046|NCT02057757|157028482|FG001|Overall Study|Non-compliance|0|||
48777047|NCT03614793|157028483|FG000|Overall Study|Lost to Follow-up|1|||
48777048|NCT03614793|157028484|FG001|Overall Study|Lost to Follow-up|2|||
48777049|NCT03614793|157028483|FG000|Overall Study|Lack of Efficacy|0|||
48777050|NCT03614793|157028484|FG001|Overall Study|Lack of Efficacy|5|||
48777051|NCT03614793|157028483|FG000|Overall Study|Withdrawal by Subject|0|||
48777052|NCT03614793|157028484|FG001|Overall Study|Withdrawal by Subject|1|||
48777053|NCT03614793|157028483|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
48777054|NCT03614793|157028484|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
48777055|NCT01168999|157028485|FG000|Overall Study|Lost to Follow-up|2|||
48777056|NCT01168999|157028486|FG001|Overall Study|Lost to Follow-up|1|||
48777057|NCT01168999|157028487|FG002|Overall Study|Lost to Follow-up|0|||
48777058|NCT01168999|157028488|FG003|Overall Study|Lost to Follow-up|0|||
48777059|NCT03586869|157028489|FG000|Overall Study|Progressive Disease|3|||
48777060|NCT04116229|157028490|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
48777061|NCT04116229|157028491|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
48777062|NCT04116229|157028490|FG000|Overall Study|Scheduling not possible.|0|||
48777063|NCT04116229|157028491|FG001|Overall Study|Scheduling not possible.|1|||
48777064|NCT04394351|157028492|FG000|Part A (16 Weeks)|Adverse Event|1|||
48777065|NCT04394351|157028493|FG001|Part A (16 Weeks)|Adverse Event|0|||
48777066|NCT04394351|157028494|FG002|Part A (16 Weeks)|Adverse Event|0|||
48777067|NCT04394351|157028495|FG003|Part A (16 Weeks)|Adverse Event|0|||
48777068|NCT04394351|157028496|FG004|Part A (16 Weeks)|Adverse Event|0|||
48777069|NCT04394351|157028497|FG005|Part A (16 Weeks)|Adverse Event|0|||
48777070|NCT04394351|157028498|FG006|Part A (16 Weeks)|Adverse Event|0|||
48777071|NCT04394351|157028499|FG007|Part A (16 Weeks)|Adverse Event|0|||
48777072|NCT04394351|157028492|FG000|Part A (16 Weeks)|Physician Decision|0|||
48777073|NCT04394351|157028493|FG001|Part A (16 Weeks)|Physician Decision|1|||
48777074|NCT04394351|157028494|FG002|Part A (16 Weeks)|Physician Decision|0|||
48777075|NCT04394351|157028495|FG003|Part A (16 Weeks)|Physician Decision|0|||
48777076|NCT04394351|157028496|FG004|Part A (16 Weeks)|Physician Decision|0|||
48777077|NCT04394351|157028497|FG005|Part A (16 Weeks)|Physician Decision|0|||
48777078|NCT04394351|157028498|FG006|Part A (16 Weeks)|Physician Decision|0|||
48777079|NCT04394351|157028499|FG007|Part A (16 Weeks)|Physician Decision|0|||
48777080|NCT04394351|157028492|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777081|NCT04394351|157028493|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
48777082|NCT04394351|157028494|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777083|NCT04394351|157028495|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777084|NCT04394351|157028496|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777085|NCT04394351|157028497|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777086|NCT04394351|157028498|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777087|NCT04394351|157028499|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
48777088|NCT04394351|157028492|FG000|Part B (36 Weeks)|Adverse Event|0|||
48777089|NCT04394351|157028493|FG001|Part B (36 Weeks)|Adverse Event|0|||
48777090|NCT04394351|157028494|FG002|Part B (36 Weeks)|Adverse Event|0|||
48777091|NCT04394351|157028495|FG003|Part B (36 Weeks)|Adverse Event|0|||
48777092|NCT04394351|157028496|FG004|Part B (36 Weeks)|Adverse Event|0|||
48777093|NCT04394351|157028497|FG005|Part B (36 Weeks)|Adverse Event|0|||
48777094|NCT04394351|157028498|FG006|Part B (36 Weeks)|Adverse Event|1|||
48777095|NCT04394351|157028499|FG007|Part B (36 Weeks)|Adverse Event|0|||
48777096|NCT02461589|157028503|FG000|Overall Study|Withdrawal by Subject|5|||
48777097|NCT02461589|157028504|FG001|Overall Study|Withdrawal by Subject|1|||
48777098|NCT02461589|157028505|FG002|Overall Study|Withdrawal by Subject|3|||
48777099|NCT02461589|157028506|FG003|Overall Study|Withdrawal by Subject|2|||
48777100|NCT02461589|157028507|FG004|Overall Study|Withdrawal by Subject|1|||
48777101|NCT02461589|157028508|FG005|Overall Study|Withdrawal by Subject|2|||
48777102|NCT02461589|157028509|FG006|Overall Study|Withdrawal by Subject|1|||
48777103|NCT02461589|157028510|FG007|Overall Study|Withdrawal by Subject|3|||
48777104|NCT02461589|157028511|FG008|Overall Study|Withdrawal by Subject|3|||
48777105|NCT02461589|157028512|FG009|Overall Study|Withdrawal by Subject|1|||
48777106|NCT02461589|157028503|FG000|Overall Study|Lost to Follow-up|0|||
48777107|NCT02461589|157028504|FG001|Overall Study|Lost to Follow-up|0|||
48777108|NCT02461589|157028505|FG002|Overall Study|Lost to Follow-up|2|||
48777109|NCT02461589|157028506|FG003|Overall Study|Lost to Follow-up|3|||
48777110|NCT02461589|157028507|FG004|Overall Study|Lost to Follow-up|1|||
48777111|NCT02461589|157028508|FG005|Overall Study|Lost to Follow-up|1|||
48777112|NCT02461589|157028509|FG006|Overall Study|Lost to Follow-up|3|||
48777113|NCT02461589|157028510|FG007|Overall Study|Lost to Follow-up|1|||
48777114|NCT02461589|157028511|FG008|Overall Study|Lost to Follow-up|3|||
48777115|NCT02461589|157028512|FG009|Overall Study|Lost to Follow-up|1|||
48777116|NCT02461589|157028503|FG000|Overall Study|Death|0|||
48777117|NCT02461589|157028504|FG001|Overall Study|Death|0|||
48777118|NCT02461589|157028505|FG002|Overall Study|Death|0|||
48777119|NCT02461589|157028506|FG003|Overall Study|Death|0|||
48777120|NCT02461589|157028507|FG004|Overall Study|Death|0|||
48777121|NCT02461589|157028508|FG005|Overall Study|Death|0|||
48777122|NCT02461589|157028509|FG006|Overall Study|Death|0|||
48777123|NCT02461589|157028510|FG007|Overall Study|Death|1|||
48777124|NCT02461589|157028511|FG008|Overall Study|Death|0|||
48777125|NCT02461589|157028512|FG009|Overall Study|Death|0|||
48777126|NCT02461589|157028503|FG000|Overall Study|Unclassified|0|||
48777127|NCT02461589|157028504|FG001|Overall Study|Unclassified|0|||
48777128|NCT02461589|157028505|FG002|Overall Study|Unclassified|0|||
48777129|NCT02461589|157028506|FG003|Overall Study|Unclassified|0|||
48777130|NCT02461589|157028507|FG004|Overall Study|Unclassified|0|||
48777131|NCT02461589|157028508|FG005|Overall Study|Unclassified|0|||
48777132|NCT02461589|157028509|FG006|Overall Study|Unclassified|1|||
48777133|NCT02461589|157028510|FG007|Overall Study|Unclassified|0|||
48777134|NCT02461589|157028511|FG008|Overall Study|Unclassified|0|||
48777135|NCT02461589|157028512|FG009|Overall Study|Unclassified|2|||
48777136|NCT02461589|157028503|FG000|Overall Study|Missing follow-up information|1|||
48777137|NCT02461589|157028504|FG001|Overall Study|Missing follow-up information|1|||
48777138|NCT02461589|157028505|FG002|Overall Study|Missing follow-up information|0|||
48777139|NCT02461589|157028506|FG003|Overall Study|Missing follow-up information|0|||
48777140|NCT02461589|157028507|FG004|Overall Study|Missing follow-up information|0|||
48777141|NCT02461589|157028508|FG005|Overall Study|Missing follow-up information|0|||
48777142|NCT02461589|157028509|FG006|Overall Study|Missing follow-up information|1|||
48777143|NCT02461589|157028510|FG007|Overall Study|Missing follow-up information|0|||
48777144|NCT02461589|157028511|FG008|Overall Study|Missing follow-up information|0|||
48777145|NCT02461589|157028512|FG009|Overall Study|Missing follow-up information|0|||
48777146|NCT02461589|157028503|FG000|Overall Study|Withdrawal from trial before exposure|0|||
48777147|NCT02461589|157028504|FG001|Overall Study|Withdrawal from trial before exposure|0|||
48777148|NCT02461589|157028505|FG002|Overall Study|Withdrawal from trial before exposure|0|||
48777149|NCT02461589|157028506|FG003|Overall Study|Withdrawal from trial before exposure|0|||
48777150|NCT02461589|157028507|FG004|Overall Study|Withdrawal from trial before exposure|0|||
48777151|NCT02461589|157028508|FG005|Overall Study|Withdrawal from trial before exposure|0|||
48777152|NCT02461589|157028509|FG006|Overall Study|Withdrawal from trial before exposure|0|||
48777153|NCT02461589|157028510|FG007|Overall Study|Withdrawal from trial before exposure|0|||
48777154|NCT02461589|157028511|FG008|Overall Study|Withdrawal from trial before exposure|0|||
48777155|NCT02461589|157028512|FG009|Overall Study|Withdrawal from trial before exposure|1|||
48777156|NCT03669081|157028526|FG000|Overall Study|Data could not be validated|1|||
48777157|NCT03669081|157028527|FG001|Overall Study|Data could not be validated|1|||
48777158|NCT03217136|157028529|FG000|Overall Study|Lost to Follow-up|2|||
48777159|NCT03217136|157028530|FG001|Overall Study|Lost to Follow-up|1|||
48777160|NCT03217136|157028529|FG000|Overall Study|Site Randomized Participant in Error|0|||
48777161|NCT03217136|157028530|FG001|Overall Study|Site Randomized Participant in Error|1|||
48777162|NCT03217136|157028529|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
48777163|NCT03217136|157028530|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
48777164|NCT03217136|157028529|FG000|Overall Study|Dispensing Error|1|||
48777165|NCT03217136|157028530|FG001|Overall Study|Dispensing Error|0|||
48777166|NCT03217136|157028529|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48777167|NCT03217136|157028530|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48777168|NCT00812812|157028531|FG000|Overall Study|Adverse Event|2|||
48777169|NCT00812812|157028532|FG001|Overall Study|Adverse Event|1|||
48777170|NCT00812812|157028531|FG000|Overall Study|Lack of Efficacy|1|||
48777171|NCT00812812|157028532|FG001|Overall Study|Lack of Efficacy|0|||
48777172|NCT00812812|157028531|FG000|Overall Study|Lost to Follow-up|0|||
48777173|NCT00812812|157028532|FG001|Overall Study|Lost to Follow-up|1|||
48777174|NCT00812812|157028531|FG000|Overall Study|Withdrawal by Subject|0|||
48777175|NCT00812812|157028532|FG001|Overall Study|Withdrawal by Subject|2|||
48777176|NCT01401530|157028533|FG000|Overall Study|Disease Progression|1|||
48777177|NCT01401530|157028534|FG001|Overall Study|Disease Progression|2|||
48777178|NCT01401530|157028535|FG002|Overall Study|Disease Progression|1|||
48777179|NCT01401530|157028533|FG000|Overall Study|Adverse Event|1|||
48777180|NCT01401530|157028534|FG001|Overall Study|Adverse Event|1|||
48777181|NCT01401530|157028535|FG002|Overall Study|Adverse Event|1|||
48777182|NCT01401530|157028533|FG000|Overall Study|Participant Choice|1|||
48777183|NCT01401530|157028534|FG001|Overall Study|Participant Choice|2|||
48777184|NCT01401530|157028535|FG002|Overall Study|Participant Choice|1|||
48777185|NCT01401530|157028533|FG000|Overall Study|Physician Decision|0|||
48777186|NCT01401530|157028534|FG001|Overall Study|Physician Decision|1|||
48777187|NCT01401530|157028535|FG002|Overall Study|Physician Decision|0|||
48777188|NCT03755765|157028536|FG000|Overall Study|Withdrawal by Subject|2|||
48777189|NCT03755765|157028537|FG001|Overall Study|Withdrawal by Subject|4|||
48777190|NCT03755765|157028538|FG002|Overall Study|Withdrawal by Subject|4|||
48777191|NCT02104557|157028539|FG000|Overall Study|Adverse Event|24|||
48777192|NCT02104557|157028539|FG000|Overall Study|Lost to Follow-up|34|||
48777193|NCT02104557|157028539|FG000|Overall Study|Violated the usage and dosage|14|||
48777194|NCT02104557|157028539|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
48777195|NCT02104557|157028539|FG000|Overall Study|Administered Sayana prior to the contract|1|||
48777196|NCT02104557|157028539|FG000|Overall Study|Other|17|||
48396751|NCT00720109|155644656|FG001|Risk Stratification Period|Adverse Event|1|||
48396752|NCT00720109|155644657|FG002|Risk Stratification Period|Adverse Event|0|||
48396753|NCT00720109|155644655|FG000|Risk Stratification Period|Physician Decision|0|||
48396754|NCT00720109|155644656|FG001|Risk Stratification Period|Physician Decision|2|||
48396755|NCT00720109|155644657|FG002|Risk Stratification Period|Physician Decision|1|||
48777197|NCT02104557|157028539|FG000|Overall Study|Change to other contraception methods|5|||
48777198|NCT02104557|157028539|FG000|Overall Study|Discontinuation due to no pain|1|||
48777199|NCT02104557|157028539|FG000|Overall Study|Withdrawal consent|2|||
48777200|NCT02104557|157028539|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
48777201|NCT02104557|157028539|FG000|Overall Study|Discontinuation of contraception|9|||
48777202|NCT01046110|157028542|FG000|Overall Study|Adverse Event|9|||
48777203|NCT01046110|157028543|FG001|Overall Study|Adverse Event|2|||
48777204|NCT01046110|157028542|FG000|Overall Study|Lack of Efficacy|0|||
48777205|NCT01046110|157028543|FG001|Overall Study|Lack of Efficacy|1|||
48777206|NCT01046110|157028542|FG000|Overall Study|Protocol Violation|7|||
48777207|NCT01046110|157028543|FG001|Overall Study|Protocol Violation|12|||
48777208|NCT01046110|157028542|FG000|Overall Study|Withdrawal Criteria|3|||
48777209|NCT01046110|157028543|FG001|Overall Study|Withdrawal Criteria|5|||
48777210|NCT01046110|157028542|FG000|Overall Study|Unclassified|36|||
48777211|NCT01046110|157028543|FG001|Overall Study|Unclassified|35|||
48777212|NCT04360824|157028550|FG000|Overall Study|Withdrawal by Subject|2|||
48777213|NCT04360824|157028551|FG001|Overall Study|Withdrawal by Subject|1|||
48777214|NCT04360824|157028550|FG000|Overall Study|Did not receive assigned treatment|1|||
48777215|NCT04360824|157028551|FG001|Overall Study|Did not receive assigned treatment|3|||
48777216|NCT00718042|157028552|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777217|NCT00718042|157028553|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777218|NCT00718042|157028554|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777219|NCT00718042|157028555|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777220|NCT00718042|157028556|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
48777221|NCT00718042|157028557|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
48777222|NCT00718042|157028552|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
48777223|NCT00718042|157028553|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
48777224|NCT00718042|157028554|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
48777225|NCT00718042|157028555|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
48777226|NCT00718042|157028556|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
48777227|NCT00718042|157028557|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
48777228|NCT00718042|157028552|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
48777229|NCT00718042|157028553|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
48777230|NCT00718042|157028554|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
48777231|NCT00718042|157028555|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
48777232|NCT00718042|157028556|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
48777233|NCT00718042|157028557|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
48777234|NCT00718042|157028552|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777235|NCT00718042|157028553|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
48777236|NCT00718042|157028554|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777237|NCT00718042|157028555|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777238|NCT00718042|157028556|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777239|NCT00718042|157028557|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
48777240|NCT00718042|157028552|FG000|Donor Follow-up|Lost to Follow-up|13|||
48777241|NCT00718042|157028553|FG001|Donor Follow-up|Lost to Follow-up|0|||
48777242|NCT00718042|157028554|FG002|Donor Follow-up|Lost to Follow-up|0|||
48777243|NCT00718042|157028555|FG003|Donor Follow-up|Lost to Follow-up|0|||
48777244|NCT00718042|157028556|FG004|Donor Follow-up|Lost to Follow-up|19|||
48777245|NCT00718042|157028557|FG005|Donor Follow-up|Lost to Follow-up|0|||
48777246|NCT00304070|157028558|FG000|Overall Study|Death|0|||
48777247|NCT00304070|157028559|FG001|Overall Study|Death|0|||
48777248|NCT00304070|157028560|FG002|Overall Study|Death|3|||
48777249|NCT00304070|157028558|FG000|Overall Study|Lost to Follow-up|0|||
48777250|NCT00304070|157028559|FG001|Overall Study|Lost to Follow-up|0|||
48396756|NCT00720109|155644655|FG000|Risk Stratification Period|Bone marrow transplant|0|||
48396757|NCT00720109|155644656|FG001|Risk Stratification Period|Bone marrow transplant|9|||
48396758|NCT00720109|155644657|FG002|Risk Stratification Period|Bone marrow transplant|7|||
48396759|NCT00720109|155644655|FG000|Risk Stratification Period|Disease progression or relapse|0|||
48777251|NCT00304070|157028560|FG002|Overall Study|Lost to Follow-up|1|||
48777252|NCT00304070|157028558|FG000|Overall Study|Physician Decision|0|||
48777253|NCT00304070|157028559|FG001|Overall Study|Physician Decision|0|||
48777254|NCT00304070|157028560|FG002|Overall Study|Physician Decision|3|||
48777255|NCT00304070|157028558|FG000|Overall Study|Withdrawal by Subject|0|||
48777256|NCT00304070|157028559|FG001|Overall Study|Withdrawal by Subject|0|||
48430339|NCT00696657|155763702|FG002|Overall Study|Lack of Efficacy|0|||
48777257|NCT00304070|157028560|FG002|Overall Study|Withdrawal by Subject|1|||
48777258|NCT00304070|157028558|FG000|Overall Study|Progressive Disease|3|||
48777259|NCT00304070|157028559|FG001|Overall Study|Progressive Disease|7|||
48396760|NCT00720109|155644656|FG001|Risk Stratification Period|Disease progression or relapse|2|||
48396761|NCT00720109|155644657|FG002|Risk Stratification Period|Disease progression or relapse|0|||
48396762|NCT00720109|155644655|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
48396763|NCT00720109|155644656|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
48396764|NCT00720109|155644657|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
48396765|NCT03595553|155644658|FG000|Overall Study|Withdrawal by Subject|20|||
48396766|NCT03595553|155644659|FG001|Overall Study|Withdrawal by Subject|8|||
48396767|NCT03595553|155644658|FG000|Overall Study|Physician Decision|3|||
48396768|NCT03595553|155644659|FG001|Overall Study|Physician Decision|2|||
48396769|NCT03595553|155644658|FG000|Overall Study|Adverse Event|2|||
48396770|NCT03595553|155644659|FG001|Overall Study|Adverse Event|5|||
48396771|NCT03595553|155644658|FG000|Overall Study|Death|24|||
48396772|NCT03595553|155644659|FG001|Overall Study|Death|22|||
48396773|NCT03595553|155644658|FG000|Overall Study|Lost to Follow-up|6|||
48396774|NCT03595553|155644659|FG001|Overall Study|Lost to Follow-up|7|||
48396775|NCT03595553|155644658|FG000|Overall Study|Other as indicated in CSR|3|||
48396776|NCT03595553|155644659|FG001|Overall Study|Other as indicated in CSR|3|||
48777260|NCT00304070|157028560|FG002|Overall Study|Progressive Disease|4|||
48777261|NCT00575588|157028561|FG000|Overall Study|Adverse Event|11|||
48777262|NCT00575588|157028562|FG001|Overall Study|Adverse Event|13|||
48777263|NCT00575588|157028561|FG000|Overall Study|Withdrawal by Subject|27|||
48777264|NCT00575588|157028562|FG001|Overall Study|Withdrawal by Subject|31|||
48777265|NCT00575588|157028561|FG000|Overall Study|Lost to Follow-up|1|||
48396777|NCT03595553|155644658|FG000|Overall Study|Sponsor Decision|0|||
48396778|NCT03595553|155644659|FG001|Overall Study|Sponsor Decision|1|||
48396779|NCT00903175|155644660|FG000|Period 1 - First Line|Adverse Event|36|||
48396780|NCT00903175|155644661|FG001|Period 1 - First Line|Adverse Event|50|||
48396781|NCT00903175|155644660|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
48396782|NCT00903175|155644661|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
48777266|NCT00575588|157028562|FG001|Overall Study|Lost to Follow-up|3|||
48777267|NCT00575588|157028561|FG000|Overall Study|Death|4|||
48777268|NCT00575588|157028562|FG001|Overall Study|Death|2|||
48777269|NCT00575588|157028561|FG000|Overall Study|Incorrect enrollment|8|||
48777270|NCT00575588|157028562|FG001|Overall Study|Incorrect enrollment|4|||
48777271|NCT00575588|157028561|FG000|Overall Study|Study specific discontinuation criteria|203|||
48777272|NCT00575588|157028562|FG001|Overall Study|Study specific discontinuation criteria|218|||
48777273|NCT00575588|157028561|FG000|Overall Study|Severe non-compliance to protocol|5|||
48777274|NCT00575588|157028562|FG001|Overall Study|Severe non-compliance to protocol|7|||
48777275|NCT00575588|157028561|FG000|Overall Study|Safety reasons|2|||
48777276|NCT00575588|157028562|FG001|Overall Study|Safety reasons|1|||
48777277|NCT00575588|157028561|FG000|Overall Study|Elevated triglyceride|1|||
48777278|NCT00575588|157028562|FG001|Overall Study|Elevated triglyceride|0|||
48777279|NCT00575588|157028561|FG000|Overall Study|Patient moved|1|||
48777280|NCT00575588|157028562|FG001|Overall Study|Patient moved|3|||
48777281|NCT00575588|157028561|FG000|Overall Study|Impossible to determine HbA1c|0|||
48777282|NCT00575588|157028562|FG001|Overall Study|Impossible to determine HbA1c|1|||
48777283|NCT00377676|157028563|FG000|Overall Study|Adverse Event|498|||
48777284|NCT00377676|157028564|FG001|Overall Study|Adverse Event|107|||
48777285|NCT00377676|157028563|FG000|Overall Study|Protocol Violation|33|||
48777286|NCT00377676|157028564|FG001|Overall Study|Protocol Violation|27|||
48777287|NCT00377676|157028563|FG000|Overall Study|Death|5|||
48777288|NCT00377676|157028564|FG001|Overall Study|Death|2|||
48777289|NCT00377676|157028563|FG000|Overall Study|Withdrawal by Subject|187|||
48777290|NCT00377676|157028564|FG001|Overall Study|Withdrawal by Subject|72|||
48777291|NCT00377676|157028563|FG000|Overall Study|Lost to Follow-up|120|||
48777292|NCT00377676|157028564|FG001|Overall Study|Lost to Follow-up|56|||
48777293|NCT00377676|157028563|FG000|Overall Study|Other|118|||
48777294|NCT00377676|157028564|FG001|Overall Study|Other|58|||
48777295|NCT01412424|157028566|FG000|Core Treatment Period|Treatment Failure|24|||
48777296|NCT01412424|157028566|FG000|Core Treatment Period|Adverse Event|21|||
48777297|NCT01412424|157028566|FG000|Core Treatment Period|Patient Request|5|||
48777298|NCT01412424|157028566|FG000|Core Treatment Period|Lost to Follow-up|2|||
48777299|NCT01412424|157028566|FG000|Core Treatment Period|Sponsor Request|1|||
48777300|NCT01412424|157028566|FG000|Extension Treatment Period|Adverse Event|2|||
48396783|NCT00903175|155644660|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
48777301|NCT01412424|157028566|FG000|Extension Treatment Period|Treatment Failure|2|||
48777302|NCT01412424|157028566|FG000|Extension Treatment Period|Patient Request|2|||
48396784|NCT00903175|155644661|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
48396785|NCT00903175|155644660|FG000|Period 1 - First Line|Protocol Violation|3|||
48396786|NCT00903175|155644661|FG001|Period 1 - First Line|Protocol Violation|3|||
48396787|NCT00903175|155644660|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
48396788|NCT00903175|155644661|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
48777303|NCT03586999|157028577|FG000|Overall Study|Lack of Efficacy|2|||
48777304|NCT02664038|157028581|FG000|13 Week|Lost to Follow-up|7|||
48777305|NCT02664038|157028582|FG001|13 Week|Lost to Follow-up|14|||
48777306|NCT02664038|157028581|FG000|13 Week|Withdrawal by Subject|1|||
48777307|NCT02664038|157028582|FG001|13 Week|Withdrawal by Subject|0|||
48777308|NCT02664038|157028581|FG000|26 Week|Lost to Follow-up|5|||
48777309|NCT02664038|157028582|FG001|26 Week|Lost to Follow-up|4|||
48777310|NCT03296696|157028598|FG000|Overall Study|Started Other Antitumor Therapy|1|||
48777311|NCT03296696|157028599|FG001|Overall Study|Started Other Antitumor Therapy|2|||
48777312|NCT03296696|157028600|FG002|Overall Study|Started Other Antitumor Therapy|1|||
48777313|NCT03296696|157028601|FG003|Overall Study|Started Other Antitumor Therapy|2|||
48777314|NCT03296696|157028602|FG004|Overall Study|Started Other Antitumor Therapy|1|||
48777315|NCT03296696|157028603|FG005|Overall Study|Started Other Antitumor Therapy|1|||
48777316|NCT03296696|157028604|FG006|Overall Study|Started Other Antitumor Therapy|2|||
48777317|NCT03296696|157028605|FG007|Overall Study|Started Other Antitumor Therapy|3|||
48777318|NCT03296696|157028606|FG008|Overall Study|Started Other Antitumor Therapy|1|||
48777319|NCT03296696|157028607|FG009|Overall Study|Started Other Antitumor Therapy|0|||
48777320|NCT03296696|157028598|FG000|Overall Study|Death|0|||
48777321|NCT03296696|157028599|FG001|Overall Study|Death|1|||
48777322|NCT03296696|157028600|FG002|Overall Study|Death|1|||
48777323|NCT03296696|157028601|FG003|Overall Study|Death|2|||
48777324|NCT03296696|157028602|FG004|Overall Study|Death|2|||
48777325|NCT03296696|157028603|FG005|Overall Study|Death|3|||
48777326|NCT03296696|157028604|FG006|Overall Study|Death|1|||
48777327|NCT03296696|157028605|FG007|Overall Study|Death|2|||
48777328|NCT03296696|157028606|FG008|Overall Study|Death|0|||
48777329|NCT03296696|157028607|FG009|Overall Study|Death|0|||
48777330|NCT03296696|157028598|FG000|Overall Study|Withdrawal by Subject|0|||
48777331|NCT03296696|157028599|FG001|Overall Study|Withdrawal by Subject|0|||
48777332|NCT03296696|157028600|FG002|Overall Study|Withdrawal by Subject|1|||
48777333|NCT03296696|157028601|FG003|Overall Study|Withdrawal by Subject|0|||
48777334|NCT03296696|157028602|FG004|Overall Study|Withdrawal by Subject|1|||
48777335|NCT03296696|157028603|FG005|Overall Study|Withdrawal by Subject|0|||
48777336|NCT03296696|157028604|FG006|Overall Study|Withdrawal by Subject|0|||
48777337|NCT03296696|157028605|FG007|Overall Study|Withdrawal by Subject|0|||
48777338|NCT03296696|157028606|FG008|Overall Study|Withdrawal by Subject|0|||
48777339|NCT03296696|157028607|FG009|Overall Study|Withdrawal by Subject|1|||
48777340|NCT00699699|157028608|FG000|Overall Study|Adverse Event|36|||
48777341|NCT00699699|157028608|FG000|Overall Study|Individual different reasons|21|||
48777342|NCT01752933|157028609|FG000|Treatment|Disease Progression|3|||
48777343|NCT01752933|157028610|FG001|Treatment|Disease Progression|29|||
48777344|NCT01752933|157028609|FG000|Treatment|Withdrawal by Subject|0|||
48777345|NCT01752933|157028610|FG001|Treatment|Withdrawal by Subject|5|||
48777346|NCT01752933|157028609|FG000|Treatment|Adverse Event|1|||
48777347|NCT01752933|157028610|FG001|Treatment|Adverse Event|4|||
48777348|NCT01752933|157028609|FG000|Treatment|Physician Decision|0|||
48777349|NCT01752933|157028610|FG001|Treatment|Physician Decision|3|||
48777350|NCT01752933|157028609|FG000|Treatment|Death|0|||
48777351|NCT01752933|157028610|FG001|Treatment|Death|2|||
48777352|NCT01752933|157028609|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
48777353|NCT01752933|157028610|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
48777354|NCT01752933|157028609|FG000|Treatment|Patient noncompliant|0|||
48777355|NCT01752933|157028610|FG001|Treatment|Patient noncompliant|1|||
48777356|NCT01752933|157028609|FG000|Treatment|Patient unable to travel to appointments|0|||
48777357|NCT01752933|157028610|FG001|Treatment|Patient unable to travel to appointments|1|||
48777358|NCT01752933|157028609|FG000|Overall Study and Follow-up|Death|4|||
48777359|NCT01752933|157028610|FG001|Overall Study and Follow-up|Death|34|||
48777360|NCT01752933|157028609|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
48777361|NCT01752933|157028610|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
48777362|NCT01752933|157028609|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
48777363|NCT01752933|157028610|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
48777364|NCT01752933|157028609|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
48777365|NCT01752933|157028610|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
48777366|NCT01866709|157028616|FG000|Overall Study|Adverse Event|1|||
48777367|NCT01866709|157028617|FG001|Overall Study|Adverse Event|0|||
48777368|NCT01858194|157028618|FG000|Overall Study|Total Artificial Heart Implant|0|||
48777369|NCT01858194|157028619|FG001|Overall Study|Total Artificial Heart Implant|1|||
48777370|NCT01858194|157028618|FG000|Overall Study|Lost to Follow-up|0|||
48777371|NCT01858194|157028619|FG001|Overall Study|Lost to Follow-up|1|||
48777372|NCT01079234|157028626|FG000|Main: Week 0 to 26|Adverse Event|5|||
48777373|NCT01079234|157028627|FG001|Main: Week 0 to 26|Adverse Event|4|||
48777374|NCT01079234|157028628|FG002|Main: Week 0 to 26|Adverse Event|1|||
48777375|NCT01079234|157028629|FG003|Main: Week 0 to 26|Adverse Event|0|||
48777376|NCT01079234|157028626|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
48777377|NCT01079234|157028627|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
48777378|NCT01079234|157028628|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
48777379|NCT01079234|157028629|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
48777380|NCT01079234|157028626|FG000|Main: Week 0 to 26|Protocol Violation|6|||
48777381|NCT01079234|157028627|FG001|Main: Week 0 to 26|Protocol Violation|2|||
48777382|NCT01079234|157028628|FG002|Main: Week 0 to 26|Protocol Violation|4|||
48777383|NCT01079234|157028629|FG003|Main: Week 0 to 26|Protocol Violation|0|||
48777384|NCT01079234|157028626|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
48777385|NCT01079234|157028627|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
48777386|NCT01079234|157028628|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
48777387|NCT01079234|157028629|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
48777388|NCT01079234|157028626|FG000|Main: Week 0 to 26|Unclassified|7|||
48777389|NCT01079234|157028627|FG001|Main: Week 0 to 26|Unclassified|13|||
48777390|NCT01079234|157028628|FG002|Main: Week 0 to 26|Unclassified|4|||
48777391|NCT01079234|157028629|FG003|Main: Week 0 to 26|Unclassified|0|||
48777392|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Adverse Event|0|||
48777393|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Adverse Event|0|||
48777394|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Adverse Event|1|||
48777395|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Adverse Event|0|||
48777396|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
48777397|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
48777398|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
48777399|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
48777400|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
48777401|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
48777402|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
48777403|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
48777404|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
48777405|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
48777406|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
48777407|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
48777408|NCT01079234|157028626|FG000|Extension: Week 27 to 52|Unclassified|0|||
48777409|NCT01079234|157028627|FG001|Extension: Week 27 to 52|Unclassified|0|||
48777410|NCT01079234|157028628|FG002|Extension: Week 27 to 52|Unclassified|4|||
48777411|NCT01079234|157028629|FG003|Extension: Week 27 to 52|Unclassified|7|||
48777412|NCT00132769|157028630|FG000|Overall Study|Withdrawal by Subject|1|||
48777413|NCT00132769|157028631|FG001|Overall Study|Withdrawal by Subject|3|||
48777414|NCT00132769|157028630|FG000|Overall Study|Lack of Efficacy|7|||
48777415|NCT00132769|157028631|FG001|Overall Study|Lack of Efficacy|6|||
48777416|NCT00132769|157028630|FG000|Overall Study|Adverse Event|2|||
48777417|NCT00132769|157028631|FG001|Overall Study|Adverse Event|1|||
48777418|NCT00132769|157028630|FG000|Overall Study|Protocol Violation|1|||
48777419|NCT00132769|157028631|FG001|Overall Study|Protocol Violation|1|||
48777420|NCT03832192|157028632|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
48777421|NCT03832192|157028633|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
48777422|NCT03099382|157028634|FG000|Overall Study|Protocol Violation|2|||
48777423|NCT03099382|157028635|FG001|Overall Study|Protocol Violation|3|||
48777424|NCT00499369|157028636|FG000|Overall Study|Adverse Event|2|||
48777425|NCT00499369|157028637|FG001|Overall Study|Adverse Event|2|||
48777426|NCT00499369|157028638|FG002|Overall Study|Adverse Event|3|||
48777427|NCT00499369|157028639|FG003|Overall Study|Adverse Event|1|||
48777428|NCT00499369|157028640|FG004|Overall Study|Adverse Event|2|||
48777429|NCT00499369|157028636|FG000|Overall Study|Withdrawal by Subject|0|||
48777430|NCT00499369|157028637|FG001|Overall Study|Withdrawal by Subject|1|||
48777431|NCT00499369|157028638|FG002|Overall Study|Withdrawal by Subject|1|||
48777432|NCT00499369|157028639|FG003|Overall Study|Withdrawal by Subject|0|||
48777433|NCT00499369|157028640|FG004|Overall Study|Withdrawal by Subject|0|||
48777434|NCT00499369|157028636|FG000|Overall Study|Progression|10|||
48777435|NCT00499369|157028637|FG001|Overall Study|Progression|12|||
48777436|NCT00499369|157028638|FG002|Overall Study|Progression|9|||
48777437|NCT00499369|157028639|FG003|Overall Study|Progression|6|||
48777438|NCT00499369|157028640|FG004|Overall Study|Progression|10|||
48777439|NCT00499369|157028636|FG000|Overall Study|Death|0|||
48777440|NCT00499369|157028637|FG001|Overall Study|Death|1|||
48777441|NCT00499369|157028638|FG002|Overall Study|Death|0|||
48777442|NCT00499369|157028639|FG003|Overall Study|Death|0|||
48777443|NCT00499369|157028640|FG004|Overall Study|Death|0|||
48777444|NCT00499369|157028636|FG000|Overall Study|Not protocol specified|2|||
48777445|NCT00499369|157028637|FG001|Overall Study|Not protocol specified|0|||
48777446|NCT00499369|157028638|FG002|Overall Study|Not protocol specified|3|||
48777447|NCT00499369|157028639|FG003|Overall Study|Not protocol specified|1|||
48777448|NCT00499369|157028640|FG004|Overall Study|Not protocol specified|0|||
48777449|NCT00499369|157028636|FG000|Overall Study|Ineligible|2|||
48777450|NCT00499369|157028637|FG001|Overall Study|Ineligible|2|||
48777451|NCT00499369|157028638|FG002|Overall Study|Ineligible|1|||
48777452|NCT00499369|157028639|FG003|Overall Study|Ineligible|1|||
48777453|NCT00499369|157028640|FG004|Overall Study|Ineligible|0|||
48777454|NCT02096835|157030603|FG000|Overall Study|Withdrawal by Subject|1|||
48777455|NCT02096835|157030604|FG001|Overall Study|Withdrawal by Subject|0|||
48777456|NCT02096835|157030605|FG002|Overall Study|Withdrawal by Subject|0|||
48777457|NCT02096835|157030603|FG000|Overall Study|converted to open procedures|1|||
48777458|NCT02096835|157030604|FG001|Overall Study|converted to open procedures|0|||
48777459|NCT02096835|157030605|FG002|Overall Study|converted to open procedures|0|||
48777460|NCT02096835|157030603|FG000|Overall Study|Lost to Follow-up|1|||
48777461|NCT02096835|157030604|FG001|Overall Study|Lost to Follow-up|0|||
48777462|NCT02096835|157030605|FG002|Overall Study|Lost to Follow-up|1|||
48777463|NCT02033889|157030606|FG000|Overall Study|Adverse Event|3|||
48777464|NCT02033889|157030607|FG001|Overall Study|Adverse Event|1|||
48777465|NCT02033889|157030608|FG002|Overall Study|Adverse Event|3|||
48777466|NCT02033889|157030606|FG000|Overall Study|Death|3|||
48777467|NCT02033889|157030607|FG001|Overall Study|Death|1|||
48777468|NCT02033889|157030608|FG002|Overall Study|Death|2|||
48777469|NCT02033889|157030606|FG000|Overall Study|Excluded Medication|1|||
48777470|NCT02033889|157030607|FG001|Overall Study|Excluded Medication|1|||
48777471|NCT02033889|157030608|FG002|Overall Study|Excluded Medication|0|||
48777472|NCT02033889|157030606|FG000|Overall Study|Lost to Follow-up|8|||
48777473|NCT02033889|157030607|FG001|Overall Study|Lost to Follow-up|5|||
48777474|NCT02033889|157030608|FG002|Overall Study|Lost to Follow-up|6|||
48777475|NCT02033889|157030606|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48777476|NCT02033889|157030607|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48777477|NCT02033889|157030608|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48777478|NCT02033889|157030606|FG000|Overall Study|Physician Decision|0|||
48777479|NCT02033889|157030607|FG001|Overall Study|Physician Decision|1|||
48777480|NCT02033889|157030608|FG002|Overall Study|Physician Decision|1|||
48777481|NCT02033889|157030606|FG000|Overall Study|Participant moved|0|||
48777482|NCT02033889|157030607|FG001|Overall Study|Participant moved|1|||
48777483|NCT02033889|157030608|FG002|Overall Study|Participant moved|0|||
48777484|NCT02033889|157030606|FG000|Overall Study|Withdrawal by Subject|18|||
48777485|NCT02033889|157030607|FG001|Overall Study|Withdrawal by Subject|10|||
48777486|NCT02033889|157030608|FG002|Overall Study|Withdrawal by Subject|13|||
48777487|NCT01312909|157030610|FG000|Overall Study|Randomized but not treated|1|||
48777488|NCT01312909|157030611|FG001|Overall Study|Randomized but not treated|3|||
48777489|NCT01312909|157030612|FG002|Overall Study|Randomized but not treated|1|||
48777490|NCT01312909|157030610|FG000|Overall Study|Adverse Event|1|||
48777491|NCT01312909|157030611|FG001|Overall Study|Adverse Event|0|||
48777492|NCT01312909|157030612|FG002|Overall Study|Adverse Event|3|||
48777493|NCT01312909|157030610|FG000|Overall Study|Protocol Violation|2|||
48777494|NCT01312909|157030611|FG001|Overall Study|Protocol Violation|0|||
48777495|NCT01312909|157030612|FG002|Overall Study|Protocol Violation|2|||
48777496|NCT01312909|157030610|FG000|Overall Study|Other|9|||
48777497|NCT01312909|157030611|FG001|Overall Study|Other|6|||
48777498|NCT01312909|157030612|FG002|Overall Study|Other|11|||
48777499|NCT01312909|157030610|FG000|Overall Study|Withdrawal by Subject|8|||
48777500|NCT01312909|157030611|FG001|Overall Study|Withdrawal by Subject|10|||
48777501|NCT01312909|157030612|FG002|Overall Study|Withdrawal by Subject|7|||
48777502|NCT01312909|157030610|FG000|Overall Study|Lost to Follow-up|21|||
48777503|NCT01312909|157030611|FG001|Overall Study|Lost to Follow-up|17|||
48777504|NCT01312909|157030612|FG002|Overall Study|Lost to Follow-up|20|||
48777505|NCT01312909|157030610|FG000|Overall Study|Insufficient clinical response|0|||
48777506|NCT01312909|157030611|FG001|Overall Study|Insufficient clinical response|0|||
48777507|NCT01312909|157030612|FG002|Overall Study|Insufficient clinical response|1|||
48396789|NCT00903175|155644660|FG000|Period 1 - First Line|Administrative problems|12|||
48777508|NCT01312909|157030610|FG000|Overall Study|Entrance criteria not met|0|||
48777509|NCT01312909|157030611|FG001|Overall Study|Entrance criteria not met|0|||
48777510|NCT01312909|157030612|FG002|Overall Study|Entrance criteria not met|2|||
48777511|NCT03143829|157030615|FG000|Overall Study|Withdrawal by Subject|2|||
48777512|NCT03143829|157030616|FG001|Overall Study|Withdrawal by Subject|5|||
48777513|NCT03143829|157030615|FG000|Overall Study|Lost to Follow-up|0|||
48777514|NCT03143829|157030616|FG001|Overall Study|Lost to Follow-up|2|||
48777515|NCT03143829|157030615|FG000|Overall Study|Death|1|||
48777516|NCT03143829|157030616|FG001|Overall Study|Death|1|||
48777517|NCT03143829|157030615|FG000|Overall Study|changed treatment, no longer eligible|2|||
48777518|NCT03143829|157030616|FG001|Overall Study|changed treatment, no longer eligible|2|||
48777519|NCT02391948|157030617|FG000|6-month Assessment|Death|0|||
48777520|NCT02391948|157030618|FG001|6-month Assessment|Death|0|||
48777521|NCT02391948|157030619|FG002|6-month Assessment|Death|0|||
48777522|NCT02391948|157030620|FG003|6-month Assessment|Death|0|||
48777523|NCT02391948|157030621|FG004|6-month Assessment|Death|1|||
48777524|NCT02391948|157030617|FG000|6-month Assessment|Withdrawal by Subject|0|||
48777525|NCT02391948|157030618|FG001|6-month Assessment|Withdrawal by Subject|0|||
48777526|NCT02391948|157030619|FG002|6-month Assessment|Withdrawal by Subject|1|||
48777527|NCT02391948|157030620|FG003|6-month Assessment|Withdrawal by Subject|2|||
48777528|NCT02391948|157030621|FG004|6-month Assessment|Withdrawal by Subject|0|||
48777529|NCT02391948|157030617|FG000|6-month Assessment|Lost to Follow-up|4|||
48777530|NCT02391948|157030618|FG001|6-month Assessment|Lost to Follow-up|5|||
48777531|NCT02391948|157030619|FG002|6-month Assessment|Lost to Follow-up|2|||
48777532|NCT02391948|157030620|FG003|6-month Assessment|Lost to Follow-up|3|||
48777533|NCT02391948|157030621|FG004|6-month Assessment|Lost to Follow-up|1|||
48777534|NCT02391948|157030617|FG000|6-month Assessment|Medical issue/illness|1|||
48777535|NCT02391948|157030618|FG001|6-month Assessment|Medical issue/illness|1|||
48777536|NCT02391948|157030619|FG002|6-month Assessment|Medical issue/illness|0|||
48777537|NCT02391948|157030620|FG003|6-month Assessment|Medical issue/illness|0|||
48777538|NCT02391948|157030621|FG004|6-month Assessment|Medical issue/illness|0|||
48777539|NCT02391948|157030617|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
48777540|NCT02391948|157030618|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
48777541|NCT02391948|157030619|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
48777542|NCT02391948|157030620|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
48777543|NCT02391948|157030621|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
48777544|NCT02391948|157030617|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
48777545|NCT02391948|157030618|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
48777546|NCT02391948|157030619|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
48777547|NCT02391948|157030620|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
48777548|NCT02391948|157030621|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
48777549|NCT02391948|157030617|FG000|12-month Assessment|Death|0|||
48777550|NCT02391948|157030618|FG001|12-month Assessment|Death|0|||
48777551|NCT02391948|157030619|FG002|12-month Assessment|Death|0|||
48777552|NCT02391948|157030620|FG003|12-month Assessment|Death|1|||
48777553|NCT02391948|157030621|FG004|12-month Assessment|Death|0|||
48777554|NCT02391948|157030617|FG000|12-month Assessment|Withdrawal by Subject|1|||
48777555|NCT02391948|157030618|FG001|12-month Assessment|Withdrawal by Subject|0|||
48777556|NCT02391948|157030619|FG002|12-month Assessment|Withdrawal by Subject|0|||
48777557|NCT02391948|157030620|FG003|12-month Assessment|Withdrawal by Subject|1|||
48777558|NCT02391948|157030621|FG004|12-month Assessment|Withdrawal by Subject|0|||
48777559|NCT02391948|157030617|FG000|12-month Assessment|Lost to Follow-up|5|||
48777560|NCT02391948|157030618|FG001|12-month Assessment|Lost to Follow-up|4|||
48777561|NCT02391948|157030619|FG002|12-month Assessment|Lost to Follow-up|4|||
48777562|NCT02391948|157030620|FG003|12-month Assessment|Lost to Follow-up|4|||
48777563|NCT02391948|157030621|FG004|12-month Assessment|Lost to Follow-up|5|||
48777564|NCT02391948|157030617|FG000|12-month Assessment|Medical issue/illness|0|||
48777565|NCT02391948|157030618|FG001|12-month Assessment|Medical issue/illness|1|||
48777566|NCT02391948|157030619|FG002|12-month Assessment|Medical issue/illness|0|||
48777567|NCT02391948|157030620|FG003|12-month Assessment|Medical issue/illness|1|||
48777568|NCT02391948|157030621|FG004|12-month Assessment|Medical issue/illness|0|||
48777569|NCT02391948|157030617|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
48777570|NCT02391948|157030618|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
48777571|NCT02391948|157030619|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
48777572|NCT02391948|157030620|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
48356370|NCT03126110|155501056|FG001|Phase 2|Started new treatment|0|||
48777573|NCT02391948|157030621|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
48356371|NCT03126110|155501057|FG002|Phase 2|Started new treatment|0|||
48777574|NCT02391948|157030617|FG000|18-month Assessment|Death|0|||
48777575|NCT02391948|157030618|FG001|18-month Assessment|Death|0|||
48777576|NCT02391948|157030619|FG002|18-month Assessment|Death|0|||
48777577|NCT02391948|157030620|FG003|18-month Assessment|Death|1|||
48777578|NCT02391948|157030621|FG004|18-month Assessment|Death|1|||
48777579|NCT02391948|157030617|FG000|18-month Assessment|Withdrawal by Subject|1|||
48777580|NCT02391948|157030618|FG001|18-month Assessment|Withdrawal by Subject|0|||
48777581|NCT02391948|157030619|FG002|18-month Assessment|Withdrawal by Subject|0|||
48777582|NCT02391948|157030620|FG003|18-month Assessment|Withdrawal by Subject|1|||
48777583|NCT02391948|157030621|FG004|18-month Assessment|Withdrawal by Subject|0|||
48777584|NCT02391948|157030617|FG000|18-month Assessment|Lost to Follow-up|2|||
48777585|NCT02391948|157030618|FG001|18-month Assessment|Lost to Follow-up|6|||
48777586|NCT02391948|157030619|FG002|18-month Assessment|Lost to Follow-up|2|||
48777587|NCT02391948|157030620|FG003|18-month Assessment|Lost to Follow-up|2|||
48777588|NCT02391948|157030621|FG004|18-month Assessment|Lost to Follow-up|3|||
48777589|NCT02391948|157030617|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
48777590|NCT02391948|157030618|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
48777591|NCT02391948|157030619|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
48777592|NCT02391948|157030620|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
48777593|NCT02391948|157030621|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
48777594|NCT02391948|157030617|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
48777595|NCT02391948|157030618|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
48777596|NCT02391948|157030619|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
48777597|NCT02391948|157030620|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
48777598|NCT02391948|157030621|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
48777599|NCT02391948|157030617|FG000|24-month Assessment|Death|0|||
48777600|NCT02391948|157030618|FG001|24-month Assessment|Death|0|||
48777601|NCT02391948|157030619|FG002|24-month Assessment|Death|0|||
48777602|NCT02391948|157030620|FG003|24-month Assessment|Death|0|||
48777603|NCT02391948|157030621|FG004|24-month Assessment|Death|1|||
48777604|NCT02391948|157030617|FG000|24-month Assessment|Withdrawal by Subject|1|||
48777605|NCT02391948|157030618|FG001|24-month Assessment|Withdrawal by Subject|1|||
48777606|NCT02391948|157030619|FG002|24-month Assessment|Withdrawal by Subject|0|||
48777607|NCT02391948|157030620|FG003|24-month Assessment|Withdrawal by Subject|0|||
48777608|NCT02391948|157030621|FG004|24-month Assessment|Withdrawal by Subject|1|||
48777609|NCT02391948|157030617|FG000|24-month Assessment|Lost to Follow-up|5|||
48777610|NCT02391948|157030618|FG001|24-month Assessment|Lost to Follow-up|4|||
48777611|NCT02391948|157030619|FG002|24-month Assessment|Lost to Follow-up|0|||
48777612|NCT02391948|157030620|FG003|24-month Assessment|Lost to Follow-up|0|||
48777613|NCT02391948|157030621|FG004|24-month Assessment|Lost to Follow-up|0|||
48777614|NCT02391948|157030617|FG000|24-month Assessment|Medical issue/illness|0|||
48777615|NCT02391948|157030618|FG001|24-month Assessment|Medical issue/illness|0|||
48777616|NCT02391948|157030619|FG002|24-month Assessment|Medical issue/illness|1|||
48777617|NCT02391948|157030620|FG003|24-month Assessment|Medical issue/illness|0|||
48777618|NCT02391948|157030621|FG004|24-month Assessment|Medical issue/illness|0|||
48777619|NCT02391948|157030617|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
48777620|NCT02391948|157030618|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
48777621|NCT02391948|157030619|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
48777622|NCT02391948|157030620|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
48777623|NCT02391948|157030621|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
48777624|NCT00023673|157030622|FG000|Overall Study|Ineligible / no protocol treatment|0|||
48777625|NCT00023673|157030623|FG001|Overall Study|Ineligible / no protocol treatment|0|||
48777626|NCT00023673|157030624|FG002|Overall Study|Ineligible / no protocol treatment|0|||
48396790|NCT00903175|155644661|FG001|Period 1 - First Line|Administrative problems|13|||
48396791|NCT00903175|155644660|FG000|Period 1 - First Line|Death|17|||
48396792|NCT00903175|155644661|FG001|Period 1 - First Line|Death|10|||
48396793|NCT00903175|155644660|FG000|Period 2 - Second Line|Missing|1|||
48396794|NCT00903175|155644661|FG001|Period 2 - Second Line|Missing|0|||
48396795|NCT00903175|155644660|FG000|Period 2 - Second Line|Adverse Event|16|||
48396796|NCT00903175|155644661|FG001|Period 2 - Second Line|Adverse Event|20|||
48396797|NCT00903175|155644660|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
48396798|NCT00903175|155644661|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
48396799|NCT00903175|155644660|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
48777627|NCT00023673|157030625|FG003|Overall Study|Ineligible / no protocol treatment|1|||
48777628|NCT00023673|157030622|FG000|Overall Study|Patient withdrew consent|0|||
48777629|NCT00023673|157030623|FG001|Overall Study|Patient withdrew consent|0|||
48777630|NCT00023673|157030624|FG002|Overall Study|Patient withdrew consent|0|||
48777631|NCT00023673|157030625|FG003|Overall Study|Patient withdrew consent|1|||
48777632|NCT01040871|157030631|FG000|Overall Study|Adverse Event|6|||
48777633|NCT01040871|157030632|FG001|Overall Study|Adverse Event|2|||
48777634|NCT01040871|157030631|FG000|Overall Study|Withdrawal by Subject|2|||
48777635|NCT01040871|157030632|FG001|Overall Study|Withdrawal by Subject|0|||
48777636|NCT01040871|157030631|FG000|Overall Study|Death|1|||
48777637|NCT01040871|157030632|FG001|Overall Study|Death|3|||
48777638|NCT01040871|157030631|FG000|Overall Study|Lack of Efficacy|1|||
48396800|NCT00903175|155644661|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
48777639|NCT01040871|157030632|FG001|Overall Study|Lack of Efficacy|1|||
48777640|NCT01040871|157030631|FG000|Overall Study|drug supply issue|1|||
48777641|NCT01040871|157030632|FG001|Overall Study|drug supply issue|0|||
48777642|NCT01040871|157030631|FG000|Overall Study|Randomized and Not Treated|2|||
48777643|NCT01040871|157030632|FG001|Overall Study|Randomized and Not Treated|1|||
48777644|NCT01175824|157030633|FG000|Overall Study|Adverse Event|2|||
48777645|NCT01175824|157030634|FG001|Overall Study|Adverse Event|1|||
48777646|NCT01175824|157030633|FG000|Overall Study|Lack of Efficacy|2|||
48777647|NCT01175824|157030634|FG001|Overall Study|Lack of Efficacy|0|||
48777648|NCT01175824|157030633|FG000|Overall Study|Lost to Follow-up|0|||
48777649|NCT01175824|157030634|FG001|Overall Study|Lost to Follow-up|1|||
48777650|NCT01175824|157030633|FG000|Overall Study|Physician Decision|0|||
48777651|NCT01175824|157030634|FG001|Overall Study|Physician Decision|4|||
48777652|NCT01175824|157030633|FG000|Overall Study|Protocol Violation|2|||
48777653|NCT01175824|157030634|FG001|Overall Study|Protocol Violation|5|||
48356372|NCT03126110|155501058|FG003|Phase 2|Started new treatment|0|||
48777654|NCT01175824|157030633|FG000|Overall Study|Withdrawal by Subject|3|||
48777655|NCT01175824|157030634|FG001|Overall Study|Withdrawal by Subject|7|||
48777656|NCT01175824|157030633|FG000|Overall Study|Sponsor Decision|1|||
48777657|NCT01175824|157030634|FG001|Overall Study|Sponsor Decision|0|||
48777658|NCT01175824|157030633|FG000|Overall Study|Entry Criteria Not Met|6|||
48777659|NCT01175824|157030634|FG001|Overall Study|Entry Criteria Not Met|4|||
48777660|NCT00274716|157030635|FG000|Phase A|Other non-reported reason|4|||
48777661|NCT00274716|157030636|FG001|Phase A|Other non-reported reason|2|||
48777662|NCT00274716|157030637|FG002|Phase A|Other non-reported reason|1|||
48777663|NCT00274716|157030638|FG003|Phase A|Other non-reported reason|2|||
48777664|NCT00274716|157030639|FG004|Phase A|Other non-reported reason|0|||
48777665|NCT00274716|157030640|FG005|Phase A|Other non-reported reason|1|||
48777666|NCT00274716|157030635|FG000|Phase A|Participant moved|0|||
48777667|NCT00274716|157030636|FG001|Phase A|Participant moved|0|||
48777668|NCT00274716|157030637|FG002|Phase A|Participant moved|1|||
48777669|NCT00274716|157030638|FG003|Phase A|Participant moved|0|||
48777670|NCT00274716|157030639|FG004|Phase A|Participant moved|0|||
48777671|NCT00274716|157030640|FG005|Phase A|Participant moved|1|||
48777672|NCT00274716|157030635|FG000|Phase A|Site Terminated|0|||
48777673|NCT00274716|157030636|FG001|Phase A|Site Terminated|0|||
48777674|NCT00274716|157030637|FG002|Phase A|Site Terminated|0|||
48777675|NCT00274716|157030638|FG003|Phase A|Site Terminated|1|||
48777676|NCT00274716|157030639|FG004|Phase A|Site Terminated|0|||
48777677|NCT00274716|157030640|FG005|Phase A|Site Terminated|0|||
48777678|NCT00274716|157030635|FG000|Phase A|Protocol Violation|1|||
48777679|NCT00274716|157030636|FG001|Phase A|Protocol Violation|0|||
48777680|NCT00274716|157030637|FG002|Phase A|Protocol Violation|0|||
48777681|NCT00274716|157030638|FG003|Phase A|Protocol Violation|1|||
48777682|NCT00274716|157030639|FG004|Phase A|Protocol Violation|0|||
48777683|NCT00274716|157030640|FG005|Phase A|Protocol Violation|0|||
48777684|NCT00274716|157030635|FG000|Phase A|Met criteria for discontinuation|1|||
48777685|NCT00274716|157030636|FG001|Phase A|Met criteria for discontinuation|1|||
48777686|NCT00274716|157030637|FG002|Phase A|Met criteria for discontinuation|0|||
48777687|NCT00274716|157030638|FG003|Phase A|Met criteria for discontinuation|0|||
48777688|NCT00274716|157030639|FG004|Phase A|Met criteria for discontinuation|0|||
48777689|NCT00274716|157030640|FG005|Phase A|Met criteria for discontinuation|0|||
48777690|NCT00274716|157030635|FG000|Phase A|Withdrawal by Subject|2|||
48777691|NCT00274716|157030636|FG001|Phase A|Withdrawal by Subject|2|||
48777692|NCT00274716|157030637|FG002|Phase A|Withdrawal by Subject|1|||
48777693|NCT00274716|157030638|FG003|Phase A|Withdrawal by Subject|3|||
48777694|NCT00274716|157030639|FG004|Phase A|Withdrawal by Subject|0|||
48777695|NCT00274716|157030640|FG005|Phase A|Withdrawal by Subject|1|||
48777696|NCT00274716|157030635|FG000|Phase A|Adverse Event|2|||
48777697|NCT00274716|157030636|FG001|Phase A|Adverse Event|3|||
48777698|NCT00274716|157030637|FG002|Phase A|Adverse Event|3|||
48777699|NCT00274716|157030638|FG003|Phase A|Adverse Event|0|||
48777700|NCT00274716|157030639|FG004|Phase A|Adverse Event|2|||
48777701|NCT00274716|157030640|FG005|Phase A|Adverse Event|0|||
48777702|NCT00274716|157030635|FG000|Phase A|Completed but did not enter Phase B|1|||
48777703|NCT00274716|157030636|FG001|Phase A|Completed but did not enter Phase B|2|||
48777704|NCT00274716|157030637|FG002|Phase A|Completed but did not enter Phase B|2|||
48777705|NCT00274716|157030638|FG003|Phase A|Completed but did not enter Phase B|2|||
48777706|NCT00274716|157030639|FG004|Phase A|Completed but did not enter Phase B|1|||
48777707|NCT00274716|157030640|FG005|Phase A|Completed but did not enter Phase B|1|||
48356373|NCT03126110|155501059|FG004|Phase 2|Started new treatment|0|||
48356374|NCT03126110|155501060|FG005|Phase 2|Started new treatment|0|||
48356375|NCT03126110|155501061|FG006|Phase 2|Started new treatment|0|||
48356376|NCT03126110|155501062|FG007|Phase 2|Started new treatment|0|||
48356377|NCT03126110|155501063|FG008|Phase 2|Started new treatment|0|||
48356378|NCT03126110|155501064|FG009|Phase 2|Started new treatment|0|||
48777708|NCT00274716|157030635|FG000|Phase B|Adverse Event|0|||
48777709|NCT00274716|157030636|FG001|Phase B|Adverse Event|0|||
48356379|NCT03126110|155501065|FG010|Phase 2|Started new treatment|0|||
48777710|NCT00274716|157030637|FG002|Phase B|Adverse Event|2|||
48777711|NCT00274716|157030638|FG003|Phase B|Adverse Event|0|||
48777712|NCT00274716|157030639|FG004|Phase B|Adverse Event|0|||
48777713|NCT00274716|157030640|FG005|Phase B|Adverse Event|1|||
48777714|NCT00274716|157030635|FG000|Phase B|Protocol Violation|0|||
48777715|NCT00274716|157030636|FG001|Phase B|Protocol Violation|2|||
48777716|NCT00274716|157030637|FG002|Phase B|Protocol Violation|0|||
48777717|NCT00274716|157030638|FG003|Phase B|Protocol Violation|0|||
48777718|NCT00274716|157030639|FG004|Phase B|Protocol Violation|0|||
48396801|NCT00903175|155644660|FG000|Period 2 - Second Line|Administrative problems|19|||
48396802|NCT00903175|155644661|FG001|Period 2 - Second Line|Administrative problems|9|||
48396803|NCT00903175|155644660|FG000|Period 2 - Second Line|Death|5|||
48396804|NCT00903175|155644661|FG001|Period 2 - Second Line|Death|2|||
48396805|NCT02286947|155644662|FG000|Overall Study|Withdrawal by Subject|2|||
48396806|NCT03074474|155644665|FG000|Overall Study|Lost to Follow-up|10|||
48396807|NCT03074474|155644665|FG000|Overall Study|Withdrawal by Subject|10|||
48396808|NCT03074474|155644665|FG000|Overall Study|Death|4|||
48396809|NCT03074474|155644665|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
48396810|NCT01681433|155644666|FG000|Overall Study|Lack of Efficacy|23|||
48396811|NCT01681433|155644667|FG001|Overall Study|Lack of Efficacy|23|||
48396812|NCT01681433|155644666|FG000|Overall Study|Withdrawal by Subject|5|||
48396813|NCT01681433|155644667|FG001|Overall Study|Withdrawal by Subject|5|||
48396814|NCT01681433|155644666|FG000|Overall Study|Protocol Violation|2|||
48396815|NCT01681433|155644667|FG001|Overall Study|Protocol Violation|0|||
48396816|NCT01681433|155644666|FG000|Overall Study|Adverse Event|2|||
48396817|NCT01681433|155644667|FG001|Overall Study|Adverse Event|4|||
48396818|NCT01681433|155644666|FG000|Overall Study|Lost to Follow-up|0|||
48396819|NCT01681433|155644667|FG001|Overall Study|Lost to Follow-up|1|||
48396820|NCT02321436|155644674|FG000|Overall Study|Withdrawal by Subject|1|||
48396821|NCT02321436|155644675|FG001|Overall Study|Withdrawal by Subject|0|||
48396822|NCT02321436|155644674|FG000|Overall Study|Lost to Follow-up|0|||
48396823|NCT02321436|155644675|FG001|Overall Study|Lost to Follow-up|1|||
48396824|NCT00264238|155644676|FG000|Overall Study|Protocol Violation|1|||
48396825|NCT03124563|155644679|FG000|Overall Study|Lost to Follow-up|1|||
48396826|NCT03124563|155644680|FG001|Overall Study|Lost to Follow-up|1|||
48396827|NCT03124563|155644679|FG000|Overall Study|Withdrawal by Subject|1|||
48396828|NCT03124563|155644680|FG001|Overall Study|Withdrawal by Subject|1|||
48396829|NCT01534533|155644681|FG000|Overall Study|Lost to Follow-up|3|||
48396830|NCT01534533|155644682|FG001|Overall Study|Lost to Follow-up|0|||
48396831|NCT01534533|155644683|FG002|Overall Study|Lost to Follow-up|4|||
48396832|NCT01534533|155644684|FG003|Overall Study|Lost to Follow-up|3|||
48396833|NCT01534533|155644681|FG000|Overall Study|Withdrawal by Subject|5|||
48396834|NCT01534533|155644682|FG001|Overall Study|Withdrawal by Subject|3|||
48396835|NCT01534533|155644683|FG002|Overall Study|Withdrawal by Subject|4|||
48396836|NCT01534533|155644684|FG003|Overall Study|Withdrawal by Subject|1|||
48396837|NCT02484911|155646168|FG000|Overall Study|Withdrawal by Subject|2|||
48396838|NCT02484911|155646169|FG001|Overall Study|Withdrawal by Subject|1|||
48396839|NCT02484911|155646168|FG000|Overall Study|Protocol Violation|2|||
48396840|NCT02484911|155646169|FG001|Overall Study|Protocol Violation|1|||
48396841|NCT01148537|155646170|FG000|Overall Study|Withdrawal by Subject|1|||
48396842|NCT01148537|155646171|FG001|Overall Study|Withdrawal by Subject|0|||
48396843|NCT01148537|155646172|FG002|Overall Study|Withdrawal by Subject|2|||
48396844|NCT01148537|155646170|FG000|Overall Study|Adverse Event|2|||
48396845|NCT01148537|155646171|FG001|Overall Study|Adverse Event|0|||
48777719|NCT00274716|157030640|FG005|Phase B|Protocol Violation|0|||
48777720|NCT00274716|157030635|FG000|Phase B|Withdrawal by Subject|0|||
48777721|NCT00274716|157030636|FG001|Phase B|Withdrawal by Subject|1|||
48777722|NCT00274716|157030637|FG002|Phase B|Withdrawal by Subject|0|||
48777723|NCT00274716|157030638|FG003|Phase B|Withdrawal by Subject|0|||
48777724|NCT00274716|157030639|FG004|Phase B|Withdrawal by Subject|0|||
48777725|NCT00274716|157030640|FG005|Phase B|Withdrawal by Subject|0|||
48777726|NCT00274716|157030635|FG000|Phase B|Participant moved|1|||
48777727|NCT00274716|157030636|FG001|Phase B|Participant moved|0|||
48777728|NCT00274716|157030637|FG002|Phase B|Participant moved|0|||
48777729|NCT00274716|157030638|FG003|Phase B|Participant moved|0|||
48777730|NCT00274716|157030639|FG004|Phase B|Participant moved|0|||
48777731|NCT00274716|157030640|FG005|Phase B|Participant moved|0|||
48777732|NCT00274716|157030635|FG000|Phase B|Other non-reported reason|0|||
48396846|NCT01148537|155646172|FG002|Overall Study|Adverse Event|1|||
48396847|NCT00847912|155646173|FG000|Overall Study|Protocol Violation|6|||
48396848|NCT00847912|155646174|FG001|Overall Study|Protocol Violation|7|||
48396849|NCT00847912|155646173|FG000|Overall Study|Withdrawal by Subject|3|||
48396850|NCT00847912|155646174|FG001|Overall Study|Withdrawal by Subject|6|||
48396851|NCT00838331|155646178|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
48777733|NCT00274716|157030636|FG001|Phase B|Other non-reported reason|0|||
48777734|NCT00274716|157030637|FG002|Phase B|Other non-reported reason|1|||
48777735|NCT00274716|157030638|FG003|Phase B|Other non-reported reason|1|||
48777736|NCT00274716|157030639|FG004|Phase B|Other non-reported reason|0|||
48777737|NCT00274716|157030640|FG005|Phase B|Other non-reported reason|0|||
48396852|NCT01309659|155646179|FG000|Overall Study|Protocol Violation|0|||
48777738|NCT00274716|157030635|FG000|Phase B|Lost to Follow-up|0|||
48777739|NCT00274716|157030636|FG001|Phase B|Lost to Follow-up|1|||
48396853|NCT01309659|155646180|FG001|Overall Study|Protocol Violation|1|||
48396854|NCT00750737|155646181|FG000|Overall Study|Withdrawal by Subject|3|||
48396855|NCT00750737|155646182|FG001|Overall Study|Withdrawal by Subject|3|||
48396856|NCT02192827|155646183|FG000|Overall Study|Lost to Follow-up|25|||
48396857|NCT02192827|155646184|FG001|Overall Study|Lost to Follow-up|27|||
48396858|NCT02192827|155646183|FG000|Overall Study|Given additional steroids with admission|13|||
48396859|NCT02192827|155646184|FG001|Overall Study|Given additional steroids with admission|11|||
48396860|NCT03571646|155646188|FG000|Overall Study|Adverse Event|1|||
48396861|NCT03571646|155646189|FG001|Overall Study|Adverse Event|0|||
48396862|NCT03571646|155646188|FG000|Overall Study|Withdrawal by Subject|1|||
48396863|NCT03571646|155646189|FG001|Overall Study|Withdrawal by Subject|1|||
48396864|NCT01453855|155646190|FG000|Overall Study|Adverse Event|3|||
48396865|NCT01453855|155646191|FG001|Overall Study|Adverse Event|4|||
48396866|NCT01453855|155646190|FG000|Overall Study|Lost to Follow-up|2|||
48396867|NCT01453855|155646191|FG001|Overall Study|Lost to Follow-up|1|||
48396868|NCT01453855|155646190|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
48396869|NCT01453855|155646191|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
48396870|NCT01453855|155646190|FG000|Overall Study|Noncompliance|1|||
48396871|NCT01453855|155646191|FG001|Overall Study|Noncompliance|0|||
48396872|NCT01453855|155646190|FG000|Overall Study|Inadequate Control of IOP|1|||
48396873|NCT01453855|155646191|FG001|Overall Study|Inadequate Control of IOP|5|||
48396874|NCT01453855|155646190|FG000|Overall Study|Other|0|||
48396875|NCT01453855|155646191|FG001|Overall Study|Other|1|||
48396876|NCT01780662|155646194|FG000|Overall Study|Adverse Event|1|||
48396877|NCT01780662|155646195|FG001|Overall Study|Adverse Event|0|||
48396878|NCT01780662|155646196|FG002|Overall Study|Adverse Event|2|||
48396879|NCT01780662|155646194|FG000|Overall Study|Physician Decision|0|||
48396880|NCT01780662|155646195|FG001|Overall Study|Physician Decision|5|||
48396881|NCT01780662|155646196|FG002|Overall Study|Physician Decision|7|||
48396882|NCT01780662|155646194|FG000|Overall Study|Protocol Violation|0|||
48396883|NCT01780662|155646195|FG001|Overall Study|Protocol Violation|1|||
48396884|NCT01780662|155646196|FG002|Overall Study|Protocol Violation|0|||
48396885|NCT01780662|155646194|FG000|Overall Study|Ineligible|0|||
48396886|NCT01780662|155646195|FG001|Overall Study|Ineligible|0|||
48396887|NCT01780662|155646196|FG002|Overall Study|Ineligible|1|||
48396888|NCT00252057|155646197|FG000|Overall Study|Withdrawal by Subject|2|||
48396889|NCT00252057|155646198|FG001|Overall Study|Withdrawal by Subject|5|||
48396890|NCT00252057|155646197|FG000|Overall Study|Death|1|||
48396891|NCT00252057|155646198|FG001|Overall Study|Death|2|||
48396892|NCT00252057|155646197|FG000|Overall Study|Participant previously enrolled|0|||
48396893|NCT00252057|155646198|FG001|Overall Study|Participant previously enrolled|1|||
48396894|NCT00253630|155646199|FG000|Overall Study|ineligible|2|||
48396895|NCT01780831|155646202|FG000|Overall Study|Withdrawal by Subject|0|||
48396896|NCT01780831|155646203|FG001|Overall Study|Withdrawal by Subject|0|||
48396897|NCT01780831|155646204|FG002|Overall Study|Withdrawal by Subject|4|||
48396898|NCT01780831|155646205|FG003|Overall Study|Withdrawal by Subject|0|||
48396899|NCT01780831|155646202|FG000|Overall Study|Lost to Follow-up|0|||
48396900|NCT01780831|155646203|FG001|Overall Study|Lost to Follow-up|0|||
48396901|NCT01780831|155646204|FG002|Overall Study|Lost to Follow-up|0|||
48396902|NCT01780831|155646205|FG003|Overall Study|Lost to Follow-up|1|||
48396903|NCT01895322|155646215|FG000|Overall Study|Adverse Event|1|||
48396904|NCT01895322|155646215|FG000|Overall Study|Withdrawal by Subject|2|||
48396905|NCT01895322|155646215|FG000|Overall Study|Protocol Violation|10|||
48396906|NCT00978029|155646219|FG000|Overall Study|Adverse Event|1|||
48396907|NCT00978029|155646220|FG001|Overall Study|Adverse Event|2|||
48396908|NCT00978029|155646221|FG002|Overall Study|Adverse Event|5|||
48396909|NCT00978029|155646219|FG000|Overall Study|Withdrawal by Subject|0|||
48396910|NCT00978029|155646220|FG001|Overall Study|Withdrawal by Subject|0|||
48396911|NCT00978029|155646221|FG002|Overall Study|Withdrawal by Subject|1|||
48777740|NCT00274716|157030637|FG002|Phase B|Lost to Follow-up|0|||
48777741|NCT00274716|157030638|FG003|Phase B|Lost to Follow-up|0|||
48777742|NCT00274716|157030639|FG004|Phase B|Lost to Follow-up|0|||
48777743|NCT00274716|157030640|FG005|Phase B|Lost to Follow-up|0|||
48777744|NCT02489981|157030642|FG000|Overall Study|Adverse Event|21|||
48777745|NCT02489981|157030642|FG000|Overall Study|Insufficient effectiveness|16|||
48777746|NCT02489981|157030642|FG000|Overall Study|Improved|31|||
48396912|NCT00978029|155646219|FG000|Overall Study|Protocol Violation|0|||
48396913|NCT00978029|155646220|FG001|Overall Study|Protocol Violation|1|||
48396914|NCT00978029|155646221|FG002|Overall Study|Protocol Violation|0|||
48396915|NCT02863809|155646222|FG000|Overall Study|Adverse Event|8|||
48396916|NCT02863809|155646223|FG001|Overall Study|Adverse Event|8|||
48396917|NCT02863809|155646222|FG000|Overall Study|Withdrawal by Subject|0|||
48396918|NCT02863809|155646223|FG001|Overall Study|Withdrawal by Subject|1|||
48396919|NCT02863809|155646222|FG000|Overall Study|Lost to Follow-up|1|||
48396920|NCT02863809|155646223|FG001|Overall Study|Lost to Follow-up|1|||
48396921|NCT02863809|155646222|FG000|Overall Study|Death|1|||
48396922|NCT02863809|155646223|FG001|Overall Study|Death|0|||
48396923|NCT02918019|155646226|FG000|Overall Study|Death|0|||
48396924|NCT02918019|155646227|FG001|Overall Study|Death|0|||
48777747|NCT02489981|157030642|FG000|Overall Study|Lost to Follow-up|31|||
48396925|NCT02918019|155646228|FG002|Overall Study|Death|1|||
48396926|NCT02918019|155646229|FG003|Overall Study|Death|0|||
48396927|NCT02918019|155646226|FG000|Overall Study|Lost to Follow-up|1|||
48396928|NCT02918019|155646227|FG001|Overall Study|Lost to Follow-up|1|||
48396929|NCT02918019|155646228|FG002|Overall Study|Lost to Follow-up|0|||
48396930|NCT02918019|155646229|FG003|Overall Study|Lost to Follow-up|1|||
48396931|NCT02918019|155646226|FG000|Overall Study|Principal investigator request|0|||
48396932|NCT02918019|155646227|FG001|Overall Study|Principal investigator request|0|||
48396933|NCT02918019|155646228|FG002|Overall Study|Principal investigator request|0|||
48396934|NCT02918019|155646229|FG003|Overall Study|Principal investigator request|1|||
48396935|NCT02918019|155646226|FG000|Overall Study|Physician Decision|1|||
48396936|NCT02918019|155646227|FG001|Overall Study|Physician Decision|3|||
48396937|NCT02918019|155646228|FG002|Overall Study|Physician Decision|2|||
48396938|NCT02918019|155646229|FG003|Overall Study|Physician Decision|0|||
48396939|NCT02918019|155646226|FG000|Overall Study|Protocol deviation|1|||
48396940|NCT02918019|155646227|FG001|Overall Study|Protocol deviation|1|||
48396941|NCT02918019|155646228|FG002|Overall Study|Protocol deviation|0|||
48396942|NCT02918019|155646229|FG003|Overall Study|Protocol deviation|2|||
48396943|NCT02918019|155646226|FG000|Overall Study|Withdrawal by Subject|3|||
48396944|NCT02918019|155646227|FG001|Overall Study|Withdrawal by Subject|4|||
48396945|NCT02918019|155646228|FG002|Overall Study|Withdrawal by Subject|6|||
48396946|NCT02918019|155646229|FG003|Overall Study|Withdrawal by Subject|4|||
48396947|NCT02918019|155646226|FG000|Overall Study|Adverse Event|0|||
48396948|NCT02918019|155646227|FG001|Overall Study|Adverse Event|1|||
48396949|NCT02918019|155646228|FG002|Overall Study|Adverse Event|0|||
48396950|NCT02918019|155646229|FG003|Overall Study|Adverse Event|1|||
48777748|NCT02489981|157030642|FG000|Overall Study|Other than listed|28|||
48777749|NCT00796861|157030643|FG000|Overall Study|Withdrawal by Subject|2|||
48777750|NCT00796861|157030643|FG000|Overall Study|Death|2|||
48777751|NCT01358981|157030646|FG000|Period 1|Withdrawal by Subject|0|||
48777752|NCT01358981|157030647|FG001|Period 1|Withdrawal by Subject|0|||
48777753|NCT01358981|157030648|FG002|Period 1|Withdrawal by Subject|0|||
48777754|NCT01358981|157030649|FG003|Period 1|Withdrawal by Subject|1|||
48777755|NCT01358981|157030650|FG004|Period 1|Withdrawal by Subject|0|||
48396951|NCT02970292|155646230|FG000|Overall Study|Physician Decision|1|||
48396952|NCT02970292|155646231|FG001|Overall Study|Physician Decision|1|||
48396953|NCT02970292|155646230|FG000|Overall Study|Withdrawal by Subject|11|||
48396954|NCT02970292|155646231|FG001|Overall Study|Withdrawal by Subject|5|||
48396955|NCT02970292|155646230|FG000|Overall Study|Noncompliance with study drug|2|||
48396956|NCT02970292|155646231|FG001|Overall Study|Noncompliance with study drug|2|||
48396957|NCT02970292|155646230|FG000|Overall Study|Adverse Event|5|||
48396958|NCT02970292|155646231|FG001|Overall Study|Adverse Event|0|||
48396959|NCT02970292|155646230|FG000|Overall Study|Lack of Efficacy|1|||
48396960|NCT02970292|155646231|FG001|Overall Study|Lack of Efficacy|0|||
48396961|NCT02970292|155646230|FG000|Overall Study|Lost to Follow-up|1|||
48396962|NCT02970292|155646231|FG001|Overall Study|Lost to Follow-up|0|||
48396963|NCT02970292|155646230|FG000|Overall Study|Protocol Violation|2|||
48396964|NCT02970292|155646231|FG001|Overall Study|Protocol Violation|0|||
48396965|NCT02970292|155646230|FG000|Overall Study|Other|1|||
48396966|NCT02970292|155646231|FG001|Overall Study|Other|0|||
48396967|NCT04041284|155646236|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
48396968|NCT04041284|155646237|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
48396969|NCT04041284|155646236|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
48396970|NCT04041284|155646237|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
48396971|NCT04041284|155646236|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
48396972|NCT04041284|155646237|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
48396973|NCT04041284|155646236|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
48396974|NCT04041284|155646237|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
48396975|NCT04041284|155646236|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
48396976|NCT04041284|155646237|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
48396977|NCT04041284|155646236|FG000|DB Phase (12 Weeks)|Other than specified|1|||
48396978|NCT04041284|155646237|FG001|DB Phase (12 Weeks)|Other than specified|0|||
48777756|NCT01358981|157030651|FG005|Period 1|Withdrawal by Subject|0|||
48777757|NCT01358981|157030652|FG006|Period 1|Withdrawal by Subject|0|||
48396979|NCT04041284|155646236|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
48396980|NCT04041284|155646237|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
48396981|NCT04041284|155646236|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
48396982|NCT04041284|155646237|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
48396983|NCT04041284|155646236|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
48396984|NCT04041284|155646237|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
48396985|NCT04041284|155646236|FG000|OL Phase (12 Weeks)|Other than specified|6|||
48396986|NCT04041284|155646237|FG001|OL Phase (12 Weeks)|Other than specified|2|||
48396987|NCT02595723|155646238|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
48396988|NCT02595723|155646239|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
48396989|NCT02595723|155646240|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
48777758|NCT02370888|157030653|FG000|Overall Study|disease progression|2|||
48396990|NCT02595723|155646238|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
48777759|NCT02370888|157030653|FG000|Overall Study|did not meet chimerism criteria|6|||
48396991|NCT02595723|155646239|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
48396992|NCT02595723|155646240|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
48396993|NCT04839380|155646241|FG000|Overall Study|Withdrawal by Subject|2|||
48396994|NCT04839380|155646241|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
48396995|NCT01058096|155646246|FG000|Double-blind Treatment Phase|Adverse Event|11|||
48396996|NCT01058096|155646247|FG001|Double-blind Treatment Phase|Adverse Event|15|||
48396997|NCT01058096|155646246|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
48396998|NCT01058096|155646247|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
48396999|NCT01058096|155646246|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
48397000|NCT01058096|155646247|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
48397001|NCT01058096|155646246|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
48397002|NCT01058096|155646247|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
48397003|NCT01058096|155646246|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
48397004|NCT01058096|155646247|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
48397005|NCT01058096|155646246|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
48397006|NCT01058096|155646247|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
48397007|NCT00446511|155646253|FG000|Overall Study|Adverse Event|7|||
48397008|NCT00446511|155646254|FG001|Overall Study|Adverse Event|2|||
48397009|NCT00446511|155646255|FG002|Overall Study|Adverse Event|3|||
48397010|NCT00446511|155646256|FG003|Overall Study|Adverse Event|1|||
48397011|NCT00446511|155646253|FG000|Overall Study|Protocol Violation|0|||
48397012|NCT00446511|155646254|FG001|Overall Study|Protocol Violation|0|||
48397013|NCT00446511|155646255|FG002|Overall Study|Protocol Violation|0|||
48397014|NCT00446511|155646256|FG003|Overall Study|Protocol Violation|1|||
48397015|NCT00446511|155646253|FG000|Overall Study|Withdrawal by Subject|0|||
48397016|NCT00446511|155646254|FG001|Overall Study|Withdrawal by Subject|0|||
48397017|NCT00446511|155646255|FG002|Overall Study|Withdrawal by Subject|0|||
48397018|NCT00446511|155646256|FG003|Overall Study|Withdrawal by Subject|3|||
48397019|NCT00446511|155646253|FG000|Overall Study|Administrative Problems|3|||
48397020|NCT00446511|155646254|FG001|Overall Study|Administrative Problems|0|||
48397021|NCT00446511|155646255|FG002|Overall Study|Administrative Problems|4|||
48397022|NCT00446511|155646256|FG003|Overall Study|Administrative Problems|1|||
48397023|NCT00193063|155646259|FG000|Overall Study|Lack of Efficacy|3|||
48397024|NCT00193063|155646259|FG000|Overall Study|Adverse Event|1|||
48397025|NCT02109484|155646262|FG000|Overall Study|Lost to Follow-up|0|||
48397026|NCT02109484|155646263|FG001|Overall Study|Lost to Follow-up|0|||
48397027|NCT02109484|155646264|FG002|Overall Study|Lost to Follow-up|0|||
48397028|NCT02109484|155646265|FG003|Overall Study|Lost to Follow-up|1|||
48397029|NCT02109484|155646266|FG004|Overall Study|Lost to Follow-up|1|||
48397030|NCT02109484|155646267|FG005|Overall Study|Lost to Follow-up|0|||
48397031|NCT02109484|155646268|FG006|Overall Study|Lost to Follow-up|1|||
48397032|NCT02109484|155646269|FG007|Overall Study|Lost to Follow-up|0|||
48397033|NCT02109484|155646262|FG000|Overall Study|Withdrawal by Subject|0|||
48397034|NCT02109484|155646263|FG001|Overall Study|Withdrawal by Subject|0|||
48397035|NCT02109484|155646264|FG002|Overall Study|Withdrawal by Subject|0|||
48397036|NCT02109484|155646265|FG003|Overall Study|Withdrawal by Subject|0|||
48397037|NCT02109484|155646266|FG004|Overall Study|Withdrawal by Subject|1|||
48397038|NCT02109484|155646267|FG005|Overall Study|Withdrawal by Subject|1|||
48397039|NCT02109484|155646268|FG006|Overall Study|Withdrawal by Subject|1|||
48397040|NCT02109484|155646269|FG007|Overall Study|Withdrawal by Subject|0|||
48397041|NCT02109484|155646262|FG000|Overall Study|Physician Decision|0|||
48397042|NCT02109484|155646263|FG001|Overall Study|Physician Decision|0|||
48397043|NCT02109484|155646264|FG002|Overall Study|Physician Decision|0|||
48397044|NCT02109484|155646265|FG003|Overall Study|Physician Decision|0|||
48777760|NCT01785524|157030654|FG000|Overall Study|Withdrawal by Subject|2|||
48777761|NCT01785524|157030655|FG001|Overall Study|Withdrawal by Subject|2|||
48777762|NCT01060384|157030656|FG000|Overall Study|Withdrawal by Subject|0|||
48777763|NCT01060384|157030657|FG001|Overall Study|Withdrawal by Subject|1|||
48777764|NCT01060384|157030658|FG002|Overall Study|Withdrawal by Subject|0|||
48777765|NCT01060384|157030659|FG003|Overall Study|Withdrawal by Subject|0|||
48397045|NCT02109484|155646266|FG004|Overall Study|Physician Decision|2|||
48397046|NCT02109484|155646267|FG005|Overall Study|Physician Decision|0|||
48397047|NCT02109484|155646268|FG006|Overall Study|Physician Decision|0|||
48397048|NCT02109484|155646269|FG007|Overall Study|Physician Decision|0|||
48397049|NCT02109484|155646262|FG000|Overall Study|Death|0|||
48397050|NCT02109484|155646263|FG001|Overall Study|Death|0|||
48397051|NCT02109484|155646264|FG002|Overall Study|Death|0|||
48397052|NCT02109484|155646265|FG003|Overall Study|Death|0|||
48397053|NCT02109484|155646266|FG004|Overall Study|Death|0|||
48397054|NCT02109484|155646267|FG005|Overall Study|Death|0|||
48397055|NCT02109484|155646268|FG006|Overall Study|Death|0|||
48777766|NCT01060384|157030660|FG004|Overall Study|Withdrawal by Subject|0|||
48777767|NCT01060384|157030656|FG000|Overall Study|Death|0|||
48397056|NCT02109484|155646269|FG007|Overall Study|Death|2|||
48397057|NCT02109484|155646262|FG000|Overall Study|Moved away from study area|0|||
48397058|NCT02109484|155646263|FG001|Overall Study|Moved away from study area|0|||
48397059|NCT02109484|155646264|FG002|Overall Study|Moved away from study area|0|||
48777768|NCT01060384|157030657|FG001|Overall Study|Death|0|||
48777769|NCT01060384|157030658|FG002|Overall Study|Death|0|||
48777770|NCT01060384|157030659|FG003|Overall Study|Death|0|||
48777771|NCT01060384|157030660|FG004|Overall Study|Death|1|||
48777772|NCT01060384|157030656|FG000|Overall Study|Intercurrent illness|0|||
48777773|NCT01060384|157030657|FG001|Overall Study|Intercurrent illness|0|||
48777774|NCT01060384|157030658|FG002|Overall Study|Intercurrent illness|0|||
48777775|NCT01060384|157030659|FG003|Overall Study|Intercurrent illness|0|||
48777776|NCT01060384|157030660|FG004|Overall Study|Intercurrent illness|1|||
48777777|NCT02863354|157030664|FG000|Year 1|Lost to Follow-up|1|||
48777778|NCT02863354|157030665|FG001|Year 1|Lost to Follow-up|1|||
48777779|NCT02863354|157030664|FG000|Year 1|Withdrawal by Subject|3|||
48777780|NCT02863354|157030665|FG001|Year 1|Withdrawal by Subject|0|||
48777781|NCT02863354|157030664|FG000|Year 1|Death|0|||
48777782|NCT02863354|157030665|FG001|Year 1|Death|1|||
48777783|NCT02863354|157030664|FG000|Year 2|Lost to Follow-up|2|||
48777784|NCT02863354|157030665|FG001|Year 2|Lost to Follow-up|2|||
48777785|NCT02822794|157030666|FG000|Overall Study|Withdrew Consent|1|||
48777786|NCT02822794|157030667|FG001|Overall Study|Withdrew Consent|0|||
48777787|NCT02266381|157030668|FG000|Overall Study|Physician Decision|3|||
48777788|NCT02266381|157030669|FG001|Overall Study|Physician Decision|5|||
48777789|NCT02266381|157030670|FG002|Overall Study|Physician Decision|4|||
48397060|NCT02109484|155646265|FG003|Overall Study|Moved away from study area|0|||
48397061|NCT02109484|155646266|FG004|Overall Study|Moved away from study area|0|||
48397062|NCT02109484|155646267|FG005|Overall Study|Moved away from study area|0|||
48397063|NCT02109484|155646268|FG006|Overall Study|Moved away from study area|1|||
48397064|NCT02109484|155646269|FG007|Overall Study|Moved away from study area|1|||
48397065|NCT03298022|155646270|FG000|Overall Study|Lack of Efficacy|4|||
48397066|NCT03298022|155646270|FG000|Overall Study|Withdrawal by Subject|7|||
48397067|NCT03298022|155646270|FG000|Overall Study|Adverse Event|1|||
48397068|NCT03298022|155646270|FG000|Overall Study|disease relapse|1|||
48397069|NCT00689871|155646275|FG000|Overall Study|Lost to Follow-up|123|||
48397070|NCT00689871|155646276|FG001|Overall Study|Lost to Follow-up|13|||
48397071|NCT00689871|155646277|FG002|Overall Study|Lost to Follow-up|37|||
48397072|NCT00689871|155646278|FG003|Overall Study|Lost to Follow-up|1|||
48397073|NCT00689871|155646275|FG000|Overall Study|Explanted of All Study Devices|36|||
48397074|NCT00689871|155646276|FG001|Overall Study|Explanted of All Study Devices|25|||
48397075|NCT00689871|155646277|FG002|Overall Study|Explanted of All Study Devices|29|||
48397076|NCT00689871|155646278|FG003|Overall Study|Explanted of All Study Devices|3|||
48397077|NCT00689871|155646275|FG000|Overall Study|Withdrawal by Subject|13|||
48397078|NCT00689871|155646276|FG001|Overall Study|Withdrawal by Subject|3|||
48397079|NCT00689871|155646277|FG002|Overall Study|Withdrawal by Subject|4|||
48397080|NCT00689871|155646278|FG003|Overall Study|Withdrawal by Subject|1|||
48397081|NCT00689871|155646275|FG000|Overall Study|Death|1|||
48397082|NCT00689871|155646276|FG001|Overall Study|Death|10|||
48397083|NCT00689871|155646277|FG002|Overall Study|Death|2|||
48397084|NCT00689871|155646278|FG003|Overall Study|Death|2|||
48397085|NCT00689871|155646275|FG000|Overall Study|Physician Decision|2|||
48397086|NCT00689871|155646276|FG001|Overall Study|Physician Decision|1|||
48397087|NCT00689871|155646277|FG002|Overall Study|Physician Decision|1|||
48397088|NCT00689871|155646278|FG003|Overall Study|Physician Decision|0|||
48397089|NCT01505634|155646280|FG000|Overall Study|Withdrawal by Subject|2|||
48397090|NCT01505634|155646281|FG001|Overall Study|Withdrawal by Subject|5|||
48397091|NCT01505634|155646282|FG002|Overall Study|Withdrawal by Subject|1|||
48397092|NCT01505634|155646280|FG000|Overall Study|Physician Decision|1|||
48397093|NCT01505634|155646281|FG001|Overall Study|Physician Decision|1|||
48397094|NCT01505634|155646282|FG002|Overall Study|Physician Decision|0|||
48397095|NCT01505634|155646280|FG000|Overall Study|Adverse Event|1|||
48397096|NCT01505634|155646281|FG001|Overall Study|Adverse Event|0|||
48397097|NCT01505634|155646282|FG002|Overall Study|Adverse Event|0|||
48397098|NCT01505634|155646280|FG000|Overall Study|Insufficient supply of drug at site|1|||
48397099|NCT01505634|155646281|FG001|Overall Study|Insufficient supply of drug at site|0|||
48397100|NCT01505634|155646282|FG002|Overall Study|Insufficient supply of drug at site|0|||
48397101|NCT01505634|155646280|FG000|Overall Study|Protocol Violation|2|||
48397102|NCT01505634|155646281|FG001|Overall Study|Protocol Violation|0|||
48397103|NCT01505634|155646282|FG002|Overall Study|Protocol Violation|0|||
48397104|NCT01505634|155646280|FG000|Overall Study|Lost to Follow-up|1|||
48397105|NCT01505634|155646281|FG001|Overall Study|Lost to Follow-up|4|||
48777790|NCT03433456|157030675|FG000|Overall Study|Death|1|||
48777791|NCT03433456|157030676|FG001|Overall Study|Death|1|||
48397106|NCT01505634|155646282|FG002|Overall Study|Lost to Follow-up|4|||
48777792|NCT03433456|157030675|FG000|Overall Study|Lost to Follow-up|14|||
48777793|NCT03433456|157030676|FG001|Overall Study|Lost to Follow-up|11|||
48777794|NCT03433456|157030675|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
48777795|NCT03433456|157030676|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
48397107|NCT01505634|155646280|FG000|Overall Study|Death|1|||
48397108|NCT01505634|155646281|FG001|Overall Study|Death|0|||
48777796|NCT03251924|157030682|FG000|Overall Study|Disease Progression|6|||
48777797|NCT03251924|157030683|FG001|Overall Study|Disease Progression|6|||
48777798|NCT03251924|157030684|FG002|Overall Study|Disease Progression|7|||
48777799|NCT03251924|157030685|FG003|Overall Study|Disease Progression|8|||
48777800|NCT03251924|157030686|FG004|Overall Study|Disease Progression|8|||
48777801|NCT03251924|157030687|FG005|Overall Study|Disease Progression|7|||
48777802|NCT03251924|157030688|FG006|Overall Study|Disease Progression|6|||
48777803|NCT03251924|157030689|FG007|Overall Study|Disease Progression|10|||
48397109|NCT01505634|155646282|FG002|Overall Study|Death|0|||
48397110|NCT01505634|155646280|FG000|Overall Study|In a conflict zone|0|||
48777804|NCT03251924|157030690|FG008|Overall Study|Disease Progression|6|||
48777805|NCT03251924|157030682|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
48777806|NCT03251924|157030683|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
48397111|NCT01505634|155646281|FG001|Overall Study|In a conflict zone|0|||
48777807|NCT03251924|157030684|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
48777808|NCT03251924|157030685|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
48777809|NCT03251924|157030686|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
48777810|NCT03251924|157030687|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
48777811|NCT03251924|157030688|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
48777812|NCT03251924|157030689|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
48777813|NCT03251924|157030690|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
48777814|NCT03251924|157030682|FG000|Overall Study|Death|0|||
48777815|NCT03251924|157030683|FG001|Overall Study|Death|1|||
48777816|NCT03251924|157030684|FG002|Overall Study|Death|0|||
48777817|NCT03251924|157030685|FG003|Overall Study|Death|1|||
48777818|NCT03251924|157030686|FG004|Overall Study|Death|1|||
48777819|NCT03251924|157030687|FG005|Overall Study|Death|1|||
48777820|NCT03251924|157030688|FG006|Overall Study|Death|0|||
48777821|NCT03251924|157030689|FG007|Overall Study|Death|0|||
48777822|NCT03251924|157030690|FG008|Overall Study|Death|0|||
48777823|NCT03251924|157030682|FG000|Overall Study|Study Drug Toxicity|0|||
48777824|NCT03251924|157030683|FG001|Overall Study|Study Drug Toxicity|0|||
48777825|NCT03251924|157030684|FG002|Overall Study|Study Drug Toxicity|0|||
48777826|NCT03251924|157030685|FG003|Overall Study|Study Drug Toxicity|1|||
48777827|NCT03251924|157030686|FG004|Overall Study|Study Drug Toxicity|0|||
48777828|NCT03251924|157030687|FG005|Overall Study|Study Drug Toxicity|0|||
48777829|NCT03251924|157030688|FG006|Overall Study|Study Drug Toxicity|0|||
48777830|NCT03251924|157030689|FG007|Overall Study|Study Drug Toxicity|0|||
48777831|NCT03251924|157030690|FG008|Overall Study|Study Drug Toxicity|1|||
48777832|NCT03251924|157030682|FG000|Overall Study|Other Reasons|0|||
48777833|NCT03251924|157030683|FG001|Overall Study|Other Reasons|0|||
48777834|NCT03251924|157030684|FG002|Overall Study|Other Reasons|0|||
48777835|NCT03251924|157030685|FG003|Overall Study|Other Reasons|0|||
48777836|NCT03251924|157030686|FG004|Overall Study|Other Reasons|0|||
48777837|NCT03251924|157030687|FG005|Overall Study|Other Reasons|0|||
48777838|NCT03251924|157030688|FG006|Overall Study|Other Reasons|0|||
48777839|NCT03251924|157030689|FG007|Overall Study|Other Reasons|0|||
48777840|NCT03251924|157030690|FG008|Overall Study|Other Reasons|1|||
48397112|NCT01505634|155646282|FG002|Overall Study|In a conflict zone|1|||
48397113|NCT02846532|155646283|FG000|Overall Study|Lost to Follow-up|0|||
48397114|NCT02846532|155646284|FG001|Overall Study|Lost to Follow-up|1|||
48397115|NCT02846532|155646285|FG002|Overall Study|Lost to Follow-up|1|||
48397116|NCT02846532|155646283|FG000|Overall Study|Withdrawal by Subject|1|||
48397117|NCT02846532|155646284|FG001|Overall Study|Withdrawal by Subject|2|||
48397118|NCT02846532|155646285|FG002|Overall Study|Withdrawal by Subject|0|||
48777841|NCT03251924|157030682|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48777842|NCT03251924|157030683|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48777843|NCT03251924|157030684|FG002|Overall Study|Participant request to discontinue study treatment|0|||
48777844|NCT03251924|157030685|FG003|Overall Study|Participant request to discontinue study treatment|0|||
48777845|NCT03251924|157030686|FG004|Overall Study|Participant request to discontinue study treatment|0|||
48777846|NCT03251924|157030687|FG005|Overall Study|Participant request to discontinue study treatment|0|||
48777847|NCT03251924|157030688|FG006|Overall Study|Participant request to discontinue study treatment|0|||
48777848|NCT03251924|157030689|FG007|Overall Study|Participant request to discontinue study treatment|1|||
48777849|NCT03251924|157030690|FG008|Overall Study|Participant request to discontinue study treatment|0|||
48777850|NCT01193556|157030691|FG000|Overall Study|Study termination|26|||
48777851|NCT01193556|157030692|FG001|Overall Study|Study termination|25|||
48777852|NCT00887341|157030693|FG000|Overall Study|Refused treatment|1|||
48777853|NCT00887341|157030694|FG001|Overall Study|Refused treatment|0|||
48397119|NCT01294579|155646288|FG000|Overall Study|Disease progression|12|||
48397120|NCT01294579|155646288|FG000|Overall Study|Adverse Event|11|||
48777854|NCT00887341|157030693|FG000|Overall Study|Withdrawal by Subject|1|||
48777855|NCT00887341|157030694|FG001|Overall Study|Withdrawal by Subject|1|||
48777856|NCT00887341|157030693|FG000|Overall Study|Adverse Event|0|||
48777857|NCT00887341|157030694|FG001|Overall Study|Adverse Event|1|||
48777858|NCT00887341|157030693|FG000|Overall Study|Lost to Follow-up|0|||
48777859|NCT00887341|157030694|FG001|Overall Study|Lost to Follow-up|1|||
48777860|NCT02617589|157030695|FG000|Randomization|Request to Discontinue Study Treatment|1|||
48777861|NCT02617589|157030696|FG001|Randomization|Request to Discontinue Study Treatment|3|||
48777862|NCT02617589|157030695|FG000|Randomization|Participant Withdrew Consent|1|||
48777863|NCT02617589|157030696|FG001|Randomization|Participant Withdrew Consent|2|||
48777864|NCT02617589|157030695|FG000|Treatment|Other Reasons|3|||
48777865|NCT02617589|157030696|FG001|Treatment|Other Reasons|3|||
48777866|NCT02617589|157030695|FG000|Treatment|Poor/Non Compliance|1|||
48777867|NCT02617589|157030696|FG001|Treatment|Poor/Non Compliance|1|||
48777868|NCT02617589|157030695|FG000|Treatment|Maximum Clinical Benefit|0|||
48777869|NCT02617589|157030696|FG001|Treatment|Maximum Clinical Benefit|2|||
48777870|NCT02617589|157030695|FG000|Treatment|Participant Withdrew Consent|2|||
48777871|NCT02617589|157030696|FG001|Treatment|Participant Withdrew Consent|6|||
48777872|NCT02617589|157030695|FG000|Treatment|Participant Request to Discontinue|12|||
48777873|NCT02617589|157030696|FG001|Treatment|Participant Request to Discontinue|21|||
48777874|NCT02617589|157030695|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
48777875|NCT02617589|157030696|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
48777876|NCT02617589|157030695|FG000|Treatment|Death|1|||
48777877|NCT02617589|157030696|FG001|Treatment|Death|1|||
48777878|NCT02617589|157030695|FG000|Treatment|Study Drug Toxicity|27|||
48777879|NCT02617589|157030696|FG001|Treatment|Study Drug Toxicity|20|||
48777880|NCT02617589|157030695|FG000|Treatment|Disease Progression|216|||
48777881|NCT02617589|157030696|FG001|Treatment|Disease Progression|136|||
48777882|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
48777883|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
48777884|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
48777885|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
48777886|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
48777887|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
48777888|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
48777889|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
48777890|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
48777891|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
48777892|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
48777893|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
48777894|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
48777895|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
48397121|NCT01294579|155646288|FG000|Overall Study|Study closed/terminated|3|||
48397122|NCT01294579|155646288|FG000|Overall Study|Lost to Follow-up|1|||
48777896|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
48777897|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
48777898|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
48777899|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
48777900|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
48777901|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
48777902|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
48777903|NCT02161718|157030697|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
48777904|NCT02161718|157030698|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
48777905|NCT02161718|157030699|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
48777906|NCT02161718|157030697|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
48777907|NCT02161718|157030698|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
48777908|NCT02161718|157030699|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
48777909|NCT02161718|157030697|FG000|Post- Randomization Period|Lost to Follow-up|0|||
48777910|NCT02161718|157030698|FG001|Post- Randomization Period|Lost to Follow-up|9|||
48777911|NCT02161718|157030699|FG002|Post- Randomization Period|Lost to Follow-up|15|||
48397123|NCT01294579|155646288|FG000|Overall Study|Physician Decision|3|||
48777912|NCT02161718|157030697|FG000|Post- Randomization Period|Adverse Event|0|||
48777913|NCT02161718|157030698|FG001|Post- Randomization Period|Adverse Event|9|||
48777914|NCT02161718|157030699|FG002|Post- Randomization Period|Adverse Event|10|||
48777915|NCT02161718|157030697|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
48777916|NCT02161718|157030698|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
48777917|NCT02161718|157030699|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
48777918|NCT02161718|157030697|FG000|Post- Randomization Period|Physician Decision|0|||
48777919|NCT02161718|157030698|FG001|Post- Randomization Period|Physician Decision|2|||
48777920|NCT02161718|157030699|FG002|Post- Randomization Period|Physician Decision|4|||
48397124|NCT01294579|155646288|FG000|Overall Study|Withdrawal by Subject|5|||
48777921|NCT02161718|157030697|FG000|Post- Randomization Period|Protocol Violation|0|||
48777922|NCT02161718|157030698|FG001|Post- Randomization Period|Protocol Violation|2|||
48777923|NCT02161718|157030699|FG002|Post- Randomization Period|Protocol Violation|3|||
48777924|NCT02161718|157030697|FG000|Post- Randomization Period|Lack of Efficacy|0|||
48777925|NCT02161718|157030698|FG001|Post- Randomization Period|Lack of Efficacy|0|||
48777926|NCT02161718|157030699|FG002|Post- Randomization Period|Lack of Efficacy|1|||
48777927|NCT02161718|157030697|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
48777928|NCT02161718|157030698|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
48777929|NCT02161718|157030699|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
48777930|NCT02161718|157030697|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
48777931|NCT02161718|157030698|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
48777932|NCT02161718|157030699|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
48777933|NCT02161718|157030697|FG000|Post- Randomization Period|Relocation|0|||
48777934|NCT02161718|157030698|FG001|Post- Randomization Period|Relocation|3|||
48777935|NCT02161718|157030699|FG002|Post- Randomization Period|Relocation|0|||
48777936|NCT02138214|157030700|FG000|Overall Study|Withdrawal by Subject|0|||
48777937|NCT02138214|157030701|FG001|Overall Study|Withdrawal by Subject|1|||
48777938|NCT02138214|157030702|FG002|Overall Study|Withdrawal by Subject|0|||
48777939|NCT02138214|157030700|FG000|Overall Study|Lost to Follow-up|0|||
48777940|NCT02138214|157030701|FG001|Overall Study|Lost to Follow-up|2|||
48777941|NCT02138214|157030702|FG002|Overall Study|Lost to Follow-up|4|||
48777942|NCT02138214|157030700|FG000|Overall Study|Screen Failure|0|||
48777943|NCT02138214|157030701|FG001|Overall Study|Screen Failure|1|||
48777944|NCT02138214|157030702|FG002|Overall Study|Screen Failure|0|||
48777945|NCT01975389|157030703|FG000|Overall Study|Adverse Event|10|||
48777946|NCT01975389|157030704|FG001|Overall Study|Adverse Event|6|||
48777947|NCT01975389|157030703|FG000|Overall Study|Death|61|||
48777948|NCT01975389|157030704|FG001|Overall Study|Death|54|||
48777949|NCT01975389|157030703|FG000|Overall Study|Lost to Follow-up|81|||
48777950|NCT01975389|157030704|FG001|Overall Study|Lost to Follow-up|86|||
48777951|NCT01975389|157030703|FG000|Overall Study|Withdrawal by Subject|90|||
48777952|NCT01975389|157030704|FG001|Overall Study|Withdrawal by Subject|76|||
48777953|NCT01975389|157030703|FG000|Overall Study|Other|6|||
48777954|NCT01975389|157030704|FG001|Overall Study|Other|9|||
48777955|NCT01975389|157030703|FG000|Overall Study|Randomized, not treated|4|||
48777956|NCT01975389|157030704|FG001|Overall Study|Randomized, not treated|5|||
48777957|NCT01312961|157030705|FG000|Overall Study|Adverse Event|3|||
48777958|NCT01312961|157030706|FG001|Overall Study|Adverse Event|3|||
48777959|NCT01312961|157030705|FG000|Overall Study|Lack of Efficacy|11|||
48777960|NCT01312961|157030706|FG001|Overall Study|Lack of Efficacy|1|||
48777961|NCT01312961|157030705|FG000|Overall Study|Poor compliance to protocol|1|||
48777962|NCT01312961|157030706|FG001|Overall Study|Poor compliance to protocol|0|||
48777963|NCT01312961|157030705|FG000|Overall Study|Other than specified above|2|||
48777964|NCT01312961|157030706|FG001|Overall Study|Other than specified above|3|||
48777965|NCT03509948|157030707|FG000|Overall Study|Protocol Violation|0|||
48777966|NCT03509948|157030708|FG001|Overall Study|Protocol Violation|1|||
48777967|NCT04208412|157030709|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
48777968|NCT04208412|157030710|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
48777969|NCT04208412|157030709|FG000|Overall Study|Withdrawal by Subject|1|||
48777970|NCT04208412|157030710|FG001|Overall Study|Withdrawal by Subject|0|||
48777971|NCT04208412|157030709|FG000|Overall Study|Lost to Follow-up|0|||
48777972|NCT04208412|157030710|FG001|Overall Study|Lost to Follow-up|1|||
48777973|NCT02778204|157030711|FG000|Overall Study|Adverse Event|1|||
48777974|NCT02778204|157030712|FG001|Overall Study|Adverse Event|0|||
48777975|NCT02778204|157030713|FG002|Overall Study|Adverse Event|0|||
48777976|NCT02778204|157030714|FG003|Overall Study|Adverse Event|0|||
48777977|NCT02778204|157030711|FG000|Overall Study|Withdrawal by Subject|0|||
48777978|NCT02778204|157030712|FG001|Overall Study|Withdrawal by Subject|0|||
48777979|NCT02778204|157030713|FG002|Overall Study|Withdrawal by Subject|1|||
48777980|NCT02778204|157030714|FG003|Overall Study|Withdrawal by Subject|2|||
48777981|NCT02778204|157030711|FG000|Overall Study|Lost to Follow-up|1|||
48777982|NCT02778204|157030712|FG001|Overall Study|Lost to Follow-up|0|||
48777983|NCT02778204|157030713|FG002|Overall Study|Lost to Follow-up|2|||
48777984|NCT02778204|157030714|FG003|Overall Study|Lost to Follow-up|1|||
48777985|NCT02778204|157030711|FG000|Overall Study|Protocol Violation|0|||
48777986|NCT02778204|157030712|FG001|Overall Study|Protocol Violation|0|||
48777987|NCT02778204|157030713|FG002|Overall Study|Protocol Violation|1|||
48777988|NCT02778204|157030714|FG003|Overall Study|Protocol Violation|0|||
48777989|NCT02778204|157030711|FG000|Overall Study|Eligibility Violation|0|||
48777990|NCT02778204|157030712|FG001|Overall Study|Eligibility Violation|0|||
48777991|NCT02778204|157030713|FG002|Overall Study|Eligibility Violation|0|||
48397125|NCT02069899|155646289|FG000|Overall Study|Adverse Event|6|||
48397126|NCT02069899|155646290|FG001|Overall Study|Adverse Event|0|||
48397127|NCT02069899|155646291|FG002|Overall Study|Adverse Event|1|||
48397128|NCT02069899|155646289|FG000|Overall Study|Withdrawal by Participant|2|||
48397129|NCT02069899|155646290|FG001|Overall Study|Withdrawal by Participant|0|||
48397130|NCT02069899|155646291|FG002|Overall Study|Withdrawal by Participant|0|||
48397131|NCT02069899|155646289|FG000|Overall Study|Lost to Follow-up|1|||
48397132|NCT02069899|155646290|FG001|Overall Study|Lost to Follow-up|0|||
48397133|NCT02069899|155646291|FG002|Overall Study|Lost to Follow-up|1|||
48397134|NCT02069899|155646289|FG000|Overall Study|Other|4|||
48397135|NCT02069899|155646290|FG001|Overall Study|Other|0|||
48397136|NCT02069899|155646291|FG002|Overall Study|Other|0|||
48397137|NCT02069899|155646289|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
48397138|NCT02069899|155646290|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
48397139|NCT02069899|155646291|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
48397140|NCT02069899|155646289|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
48397141|NCT02069899|155646290|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
48397142|NCT02069899|155646291|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
48397143|NCT00640328|155646294|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48397144|NCT00640328|155646295|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
48397145|NCT00640328|155646296|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48397146|NCT00640328|155646297|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48397147|NCT00640328|155646298|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48397148|NCT00640328|155646299|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
48397149|NCT00640328|155646294|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
48397150|NCT00640328|155646295|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
48397151|NCT00640328|155646296|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
48397152|NCT00640328|155646297|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
48397153|NCT00640328|155646298|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
48397154|NCT00640328|155646299|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
48397155|NCT00640328|155646294|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48397156|NCT00640328|155646295|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48397157|NCT00640328|155646296|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
48397158|NCT00640328|155646297|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48397159|NCT00640328|155646298|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48397160|NCT00640328|155646299|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
48397161|NCT00640328|155646294|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
48430340|NCT00696657|155763703|FG003|Overall Study|Lack of Efficacy|0|||
48777992|NCT02778204|157030714|FG003|Overall Study|Eligibility Violation|1|||
48777993|NCT01978184|157030715|FG000|Overall Study|Progressive disease|5|||
48777994|NCT01978184|157030716|FG001|Overall Study|Progressive disease|5|||
48777995|NCT01978184|157030715|FG000|Overall Study|Other than PDA|2|||
48777996|NCT01978184|157030716|FG001|Overall Study|Other than PDA|2|||
48777997|NCT01978184|157030715|FG000|Overall Study|Physician Decision|0|||
48777998|NCT01978184|157030716|FG001|Overall Study|Physician Decision|3|||
48777999|NCT01978184|157030715|FG000|Overall Study|Noncompliance|1|||
48778000|NCT01978184|157030716|FG001|Overall Study|Noncompliance|2|||
48778001|NCT01978184|157030715|FG000|Overall Study|Death|1|||
48778002|NCT01978184|157030716|FG001|Overall Study|Death|0|||
48778003|NCT01978184|157030715|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
48778004|NCT01978184|157030716|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
48778005|NCT02460198|157030717|FG000|Overall Study|Adverse Event|1|||
48778006|NCT02460198|157030718|FG001|Overall Study|Adverse Event|3|||
48778007|NCT02460198|157030717|FG000|Overall Study|Death|36|||
48778008|NCT02460198|157030718|FG001|Overall Study|Death|28|||
48778009|NCT02460198|157030717|FG000|Overall Study|Lost to Follow-up|1|||
48778010|NCT02460198|157030718|FG001|Overall Study|Lost to Follow-up|1|||
48778011|NCT02460198|157030717|FG000|Overall Study|Transferred to Extension Study|15|||
48778012|NCT02460198|157030718|FG001|Overall Study|Transferred to Extension Study|15|||
48778013|NCT02460198|157030717|FG000|Overall Study|Withdrawal by Subject|2|||
48778014|NCT02460198|157030718|FG001|Overall Study|Withdrawal by Subject|4|||
48778015|NCT02460198|157030717|FG000|Overall Study|Site Terminated By Sponsor|0|||
48778016|NCT02460198|157030718|FG001|Overall Study|Site Terminated By Sponsor|1|||
48778017|NCT02460198|157030717|FG000|Overall Study|Did Not Continue on Extension Study|6|||
48778018|NCT02460198|157030718|FG001|Overall Study|Did Not Continue on Extension Study|11|||
48778019|NCT03351049|157030719|FG000|Overall Study|Withdrawal|26|||
48778020|NCT03351049|157030720|FG001|Overall Study|Withdrawal|22|||
48778021|NCT00298038|157030723|FG000|Overall Study|Lost to Follow-up|0|||
48778022|NCT00298038|157030724|FG001|Overall Study|Lost to Follow-up|1|||
48778023|NCT00298038|157030723|FG000|Overall Study|Liver Transplant|0|||
48778024|NCT00298038|157030724|FG001|Overall Study|Liver Transplant|1|||
48778025|NCT00298038|157030723|FG000|Overall Study|Protocol Violation|1|||
48778026|NCT00298038|157030724|FG001|Overall Study|Protocol Violation|3|||
48778027|NCT00298038|157030723|FG000|Overall Study|Death|6|||
48778028|NCT00298038|157030724|FG001|Overall Study|Death|3|||
48778029|NCT00298038|157030723|FG000|Overall Study|Withdrawal by Subject|6|||
48778030|NCT00298038|157030724|FG001|Overall Study|Withdrawal by Subject|9|||
48778031|NCT00298038|157030723|FG000|Overall Study|Adverse Event|8|||
48778032|NCT00298038|157030724|FG001|Overall Study|Adverse Event|7|||
48778033|NCT00298038|157030723|FG000|Overall Study|Breakthrough overt HE episode|28|||
48778034|NCT00298038|157030724|FG001|Overall Study|Breakthrough overt HE episode|69|||
48778035|NCT00298038|157030723|FG000|Overall Study|Noncompliance|1|||
48778036|NCT00298038|157030724|FG001|Overall Study|Noncompliance|0|||
48778037|NCT00298038|157030723|FG000|Overall Study|Cocaine Abuse|1|||
48778038|NCT00298038|157030724|FG001|Overall Study|Cocaine Abuse|0|||
48778039|NCT00298038|157030723|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
48778040|NCT00298038|157030724|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
48778041|NCT00503685|157030725|FG000|Overall Study|Adverse Event|0|||
48778042|NCT00503685|157030726|FG001|Overall Study|Adverse Event|0|||
48778043|NCT00503685|157030727|FG002|Overall Study|Adverse Event|2|||
48778044|NCT00503685|157030725|FG000|Overall Study|Withdrawal by Subject|0|||
48778045|NCT00503685|157030726|FG001|Overall Study|Withdrawal by Subject|1|||
48778046|NCT00503685|157030727|FG002|Overall Study|Withdrawal by Subject|0|||
48778047|NCT00503685|157030725|FG000|Overall Study|Protocol Violation|0|||
48778048|NCT00503685|157030726|FG001|Overall Study|Protocol Violation|1|||
48778049|NCT00503685|157030727|FG002|Overall Study|Protocol Violation|0|||
48778050|NCT00503685|157030725|FG000|Overall Study|Eligibility Criteria Not Met|0|||
48356380|NCT03126110|155501066|FG011|Phase 2|Started new treatment|0|||
48356381|NCT03126110|155501067|FG012|Phase 2|Started new treatment|0|||
48356382|NCT03126110|155501068|FG013|Phase 2|Started new treatment|0|||
48356383|NCT03126110|155501069|FG014|Phase 2|Started new treatment|1|||
48356384|NCT03126110|155501070|FG015|Phase 2|Started new treatment|0|||
48356385|NCT03126110|155501071|FG016|Phase 2|Started new treatment|0|||
48356386|NCT02844777|155501072|FG000|Overall Study|Withdrawal by Subject|2|||
48356387|NCT02844777|155501073|FG001|Overall Study|Withdrawal by Subject|0|||
48356388|NCT02844777|155501074|FG002|Overall Study|Withdrawal by Subject|0|||
48356389|NCT00150618|155501075|FG000|Overall Study|Adverse Event|2|||
48356390|NCT00150618|155501076|FG001|Overall Study|Adverse Event|2|||
48356391|NCT00150618|155501077|FG002|Overall Study|Adverse Event|6|||
48356392|NCT00150618|155501078|FG003|Overall Study|Adverse Event|9|||
48356393|NCT00150618|155501079|FG004|Overall Study|Adverse Event|5|||
48356394|NCT00150618|155501075|FG000|Overall Study|Withdrawal by Subject|6|||
48356395|NCT00150618|155501076|FG001|Overall Study|Withdrawal by Subject|8|||
48356396|NCT00150618|155501077|FG002|Overall Study|Withdrawal by Subject|8|||
48356397|NCT00150618|155501078|FG003|Overall Study|Withdrawal by Subject|4|||
48356398|NCT00150618|155501079|FG004|Overall Study|Withdrawal by Subject|5|||
48356399|NCT00150618|155501075|FG000|Overall Study|Lost to Follow-up|4|||
48356400|NCT00150618|155501076|FG001|Overall Study|Lost to Follow-up|1|||
48356401|NCT00150618|155501077|FG002|Overall Study|Lost to Follow-up|5|||
48356402|NCT00150618|155501078|FG003|Overall Study|Lost to Follow-up|8|||
48356403|NCT00150618|155501079|FG004|Overall Study|Lost to Follow-up|4|||
48356404|NCT00150618|155501075|FG000|Overall Study|Protocol Violation|1|||
48356405|NCT00150618|155501076|FG001|Overall Study|Protocol Violation|0|||
48356406|NCT00150618|155501077|FG002|Overall Study|Protocol Violation|0|||
48356407|NCT00150618|155501078|FG003|Overall Study|Protocol Violation|0|||
48356408|NCT00150618|155501079|FG004|Overall Study|Protocol Violation|1|||
48356409|NCT00150618|155501075|FG000|Overall Study|Lack of Efficacy|1|||
48356410|NCT00150618|155501076|FG001|Overall Study|Lack of Efficacy|4|||
48356411|NCT00150618|155501077|FG002|Overall Study|Lack of Efficacy|7|||
48356412|NCT00150618|155501078|FG003|Overall Study|Lack of Efficacy|4|||
48356413|NCT00150618|155501079|FG004|Overall Study|Lack of Efficacy|6|||
48356414|NCT00150618|155501075|FG000|Overall Study|No study meds|0|||
48356415|NCT00150618|155501076|FG001|Overall Study|No study meds|0|||
48356416|NCT00150618|155501077|FG002|Overall Study|No study meds|0|||
48356417|NCT00150618|155501078|FG003|Overall Study|No study meds|0|||
48397162|NCT00640328|155646295|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
48397163|NCT00640328|155646296|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
48397164|NCT00640328|155646297|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
48778051|NCT00503685|157030726|FG001|Overall Study|Eligibility Criteria Not Met|1|||
48778052|NCT00503685|157030727|FG002|Overall Study|Eligibility Criteria Not Met|0|||
48778053|NCT01181895|157030728|FG000|Overall Study|Adverse Event|3|||
48778054|NCT01181895|157030729|FG001|Overall Study|Adverse Event|1|||
48778055|NCT01181895|157030730|FG002|Overall Study|Adverse Event|1|||
48778056|NCT01181895|157030728|FG000|Overall Study|Lack of Efficacy|8|||
48778057|NCT01181895|157030729|FG001|Overall Study|Lack of Efficacy|9|||
48778058|NCT01181895|157030730|FG002|Overall Study|Lack of Efficacy|9|||
48778059|NCT01181895|157030728|FG000|Overall Study|Protocol Violation|2|||
48778060|NCT01181895|157030729|FG001|Overall Study|Protocol Violation|1|||
48778061|NCT01181895|157030730|FG002|Overall Study|Protocol Violation|0|||
48778062|NCT01181895|157030728|FG000|Overall Study|Lost to Follow-up|0|||
48397165|NCT00640328|155646298|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
48397166|NCT00640328|155646299|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
48778063|NCT01181895|157030729|FG001|Overall Study|Lost to Follow-up|1|||
48778064|NCT01181895|157030730|FG002|Overall Study|Lost to Follow-up|2|||
48778065|NCT01181895|157030728|FG000|Overall Study|Investigator Discretion|1|||
48778066|NCT01181895|157030729|FG001|Overall Study|Investigator Discretion|2|||
48778067|NCT01181895|157030730|FG002|Overall Study|Investigator Discretion|1|||
48778068|NCT01181895|157030728|FG000|Overall Study|Withdrawal by Subject|3|||
48778069|NCT01181895|157030729|FG001|Overall Study|Withdrawal by Subject|0|||
48778070|NCT01181895|157030730|FG002|Overall Study|Withdrawal by Subject|5|||
48778071|NCT04028388|157030734|FG000|Overall Study|Evaluations missing|3|||
48778072|NCT04028388|157030735|FG001|Overall Study|Evaluations missing|6|||
48778073|NCT04028388|157030734|FG000|Overall Study|Not started|2|||
48778074|NCT04028388|157030735|FG001|Overall Study|Not started|0|||
48778075|NCT05204134|157030736|FG000|Overall Study|Withdrawal by Subject|3|||
48778076|NCT05204134|157030736|FG000|Overall Study|Physician Decision|1|||
48778077|NCT02752048|157030739|FG000|Overall Study|Withdrawal by Subject|0|||
48778078|NCT02752048|157030740|FG001|Overall Study|Withdrawal by Subject|0|||
48778079|NCT02752048|157030741|FG002|Overall Study|Withdrawal by Subject|3|||
48778080|NCT02758236|157030749|FG000|Overall Study|Investigator discretion|43|||
48778081|NCT05789875|157030750|FG000|Overall Study|Lost to Follow-up|6|||
48778082|NCT01994395|157030751|FG000|Overall Study|Withdrawal by Subject|1|||
48778083|NCT01994395|157030752|FG001|Overall Study|Withdrawal by Subject|2|||
48778084|NCT01940705|157030757|FG000|Overall Study|Lost to Follow-up|1|||
48778085|NCT01940705|157030758|FG001|Overall Study|Lost to Follow-up|3|||
48778086|NCT01940705|157030759|FG002|Overall Study|Lost to Follow-up|2|||
48778087|NCT01940705|157030760|FG003|Overall Study|Lost to Follow-up|2|||
48778088|NCT01940705|157030757|FG000|Overall Study|Withdrawal by Subject|2|||
48778089|NCT01940705|157030758|FG001|Overall Study|Withdrawal by Subject|2|||
48778090|NCT01940705|157030759|FG002|Overall Study|Withdrawal by Subject|3|||
48778091|NCT01940705|157030760|FG003|Overall Study|Withdrawal by Subject|2|||
48778092|NCT01940705|157030757|FG000|Overall Study|Intervention not given|0|||
48778093|NCT01940705|157030758|FG001|Overall Study|Intervention not given|3|||
48778094|NCT01940705|157030759|FG002|Overall Study|Intervention not given|3|||
48778095|NCT01940705|157030760|FG003|Overall Study|Intervention not given|0|||
48778096|NCT01940705|157030757|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
48778097|NCT01940705|157030758|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
48778098|NCT01940705|157030759|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
48778099|NCT01940705|157030760|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
48778100|NCT01802411|157030763|FG000|Overall Study|Death|2|||
48778101|NCT01802411|157030764|FG001|Overall Study|Death|1|||
48778102|NCT01802411|157030763|FG000|Overall Study|Adverse Event|2|||
48778103|NCT01802411|157030764|FG001|Overall Study|Adverse Event|7|||
48778104|NCT01802411|157030763|FG000|Overall Study|Lack of Efficacy|8|||
48778105|NCT01802411|157030764|FG001|Overall Study|Lack of Efficacy|10|||
48778106|NCT01802411|157030763|FG000|Overall Study|Withdrawal by Subject|0|||
48778107|NCT01802411|157030764|FG001|Overall Study|Withdrawal by Subject|2|||
48778108|NCT01802411|157030763|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
48778109|NCT01802411|157030764|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
48778110|NCT01802411|157030763|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
48778111|NCT01802411|157030764|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
48778112|NCT01802411|157030763|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
48778113|NCT01802411|157030764|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
48778114|NCT02663128|157030765|FG000|Period 2|Physician Decision|0|||
48778115|NCT02663128|157030766|FG001|Period 2|Physician Decision|0|||
48778116|NCT02663128|157030767|FG002|Period 2|Physician Decision|0|||
48778117|NCT02663128|157030768|FG003|Period 2|Physician Decision|0|||
48778118|NCT02663128|157030769|FG004|Period 2|Physician Decision|1|||
48778119|NCT02663128|157030770|FG005|Period 2|Physician Decision|0|||
48778120|NCT01663636|157030771|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
48778121|NCT01663636|157030772|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
48778122|NCT00660010|157030775|FG000|Overall Study|Withdrawal by Subject|2|||
48778123|NCT00660010|157030775|FG000|Overall Study|Lost to Follow-up|3|||
48778124|NCT00660010|157030775|FG000|Overall Study|Adverse Event|1|||
48778125|NCT00660010|157030775|FG000|Overall Study|Noncompliance with visit schedule|3|||
48778126|NCT03864614|157030776|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
48778127|NCT03864614|157030777|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
48778128|NCT03864614|157030778|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
48778129|NCT03864614|157030779|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
48778130|NCT03864614|157030776|FG000|Overall Study|Withdrawal by Subject|72|||
48778131|NCT03864614|157030777|FG001|Overall Study|Withdrawal by Subject|100|||
48778132|NCT03864614|157030778|FG002|Overall Study|Withdrawal by Subject|1|||
48778133|NCT03864614|157030779|FG003|Overall Study|Withdrawal by Subject|21|||
48778134|NCT03864614|157030776|FG000|Overall Study|Lost to Follow-up|45|||
48778135|NCT03864614|157030777|FG001|Overall Study|Lost to Follow-up|54|||
48778136|NCT03864614|157030778|FG002|Overall Study|Lost to Follow-up|0|||
48778137|NCT03864614|157030779|FG003|Overall Study|Lost to Follow-up|9|||
48778138|NCT03864614|157030776|FG000|Overall Study|Adverse Event|42|||
48778139|NCT03864614|157030777|FG001|Overall Study|Adverse Event|30|||
48778140|NCT03864614|157030778|FG002|Overall Study|Adverse Event|1|||
48778141|NCT03864614|157030779|FG003|Overall Study|Adverse Event|9|||
48778142|NCT03864614|157030776|FG000|Overall Study|Protocol Deviation|6|||
48778143|NCT03864614|157030777|FG001|Overall Study|Protocol Deviation|26|||
48778144|NCT03864614|157030778|FG002|Overall Study|Protocol Deviation|0|||
48778145|NCT03864614|157030779|FG003|Overall Study|Protocol Deviation|1|||
48778146|NCT03864614|157030776|FG000|Overall Study|Physician Decision|7|||
48778147|NCT03864614|157030777|FG001|Overall Study|Physician Decision|10|||
48778148|NCT03864614|157030778|FG002|Overall Study|Physician Decision|1|||
48778149|NCT03864614|157030779|FG003|Overall Study|Physician Decision|5|||
48778150|NCT03864614|157030776|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
48778151|NCT03864614|157030777|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
48778152|NCT03864614|157030778|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
48778153|NCT03864614|157030779|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
48778154|NCT03864614|157030776|FG000|Overall Study|Sponsor Decision|1|||
48778155|NCT03864614|157030777|FG001|Overall Study|Sponsor Decision|2|||
48778156|NCT03864614|157030778|FG002|Overall Study|Sponsor Decision|0|||
48397167|NCT04697628|155646300|FG000|Overall Study|Withdrawal by Subject|17|||
48397168|NCT04697628|155646301|FG001|Overall Study|Withdrawal by Subject|23|||
48397169|NCT04697628|155646300|FG000|Overall Study|Lost to Follow-up|0|||
48397170|NCT04697628|155646301|FG001|Overall Study|Lost to Follow-up|4|||
48397171|NCT04697628|155646300|FG000|Overall Study|On-going in study|122|||
48397172|NCT04697628|155646301|FG001|Overall Study|On-going in study|91|||
48397173|NCT01326546|155646302|FG000|Overall Study|Lost to Follow-up|8|||
48397174|NCT01326546|155646303|FG001|Overall Study|Lost to Follow-up|7|||
48397175|NCT01326546|155646302|FG000|Overall Study|Protocol Violation|3|||
48397176|NCT01326546|155646303|FG001|Overall Study|Protocol Violation|4|||
48397177|NCT01326546|155646302|FG000|Overall Study|Pregnancy|0|||
48397178|NCT01326546|155646303|FG001|Overall Study|Pregnancy|1|||
48397179|NCT01326546|155646302|FG000|Overall Study|Adverse Event|1|||
48397180|NCT01326546|155646303|FG001|Overall Study|Adverse Event|0|||
48397181|NCT01326546|155646302|FG000|Overall Study|Withdrawal by Subject|5|||
48397182|NCT01326546|155646303|FG001|Overall Study|Withdrawal by Subject|1|||
48397183|NCT04294719|155646304|FG000|Overall Study|Withdrawal by Subject|1|||
48397184|NCT02788747|155646309|FG000|Overall Study|Adverse Event|1|||
48397185|NCT02788747|155646310|FG001|Overall Study|Adverse Event|0|||
48397186|NCT02788747|155646311|FG002|Overall Study|Adverse Event|0|||
48397187|NCT03033875|155646312|FG000|Overall Study|Withdrawal by Subject|5|||
48397188|NCT03033875|155646313|FG001|Overall Study|Withdrawal by Subject|9|||
48397189|NCT03033875|155646314|FG002|Overall Study|Withdrawal by Subject|4|||
48397190|NCT03033875|155646312|FG000|Overall Study|Other|14|||
48397191|NCT03033875|155646313|FG001|Overall Study|Other|15|||
48778157|NCT03864614|157030779|FG003|Overall Study|Sponsor Decision|0|||
48778158|NCT03864614|157030776|FG000|Overall Study|Pregnancy|0|||
48778159|NCT03864614|157030777|FG001|Overall Study|Pregnancy|1|||
48778160|NCT03864614|157030778|FG002|Overall Study|Pregnancy|0|||
48778161|NCT03864614|157030779|FG003|Overall Study|Pregnancy|0|||
48778162|NCT03864614|157030776|FG000|Overall Study|Other|7|||
48778163|NCT03864614|157030777|FG001|Overall Study|Other|9|||
48778164|NCT03864614|157030778|FG002|Overall Study|Other|1|||
48778165|NCT03864614|157030779|FG003|Overall Study|Other|4|||
48778166|NCT03864614|157030776|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
48397192|NCT03033875|155646314|FG002|Overall Study|Other|8|||
48397193|NCT03355300|155646315|FG000|Overall Study|Physician Decision|0|||
48778167|NCT03864614|157030777|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
48778168|NCT03864614|157030778|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
48397194|NCT03355300|155646316|FG001|Overall Study|Physician Decision|1|||
48778169|NCT03864614|157030779|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
48778170|NCT00533949|157032563|FG000|Overall Study|Protocol Violation|12|||
48778171|NCT00533949|157032564|FG001|Overall Study|Protocol Violation|12|||
48778172|NCT00533949|157032565|FG002|Overall Study|Protocol Violation|9|||
48778173|NCT00533949|157032566|FG003|Overall Study|Protocol Violation|9|||
48778174|NCT00533949|157032563|FG000|Overall Study|Withdrawal by Subject|3|||
48778175|NCT00533949|157032564|FG001|Overall Study|Withdrawal by Subject|2|||
48778176|NCT00533949|157032565|FG002|Overall Study|Withdrawal by Subject|1|||
48778177|NCT00533949|157032566|FG003|Overall Study|Withdrawal by Subject|1|||
48778178|NCT02573324|157032567|FG000|Overall Study|Withdrawal by Subject|26|||
48778179|NCT02573324|157032568|FG001|Overall Study|Withdrawal by Subject|23|||
48778180|NCT02573324|157032569|FG002|Overall Study|Withdrawal by Subject|3|||
48778181|NCT02573324|157032567|FG000|Overall Study|Lost to Follow-up|4|||
48778182|NCT02573324|157032568|FG001|Overall Study|Lost to Follow-up|5|||
48778183|NCT02573324|157032569|FG002|Overall Study|Lost to Follow-up|0|||
48778184|NCT02573324|157032567|FG000|Overall Study|Study Terminated by Sponsor|107|||
48778185|NCT02573324|157032568|FG001|Overall Study|Study Terminated by Sponsor|89|||
48778186|NCT02573324|157032569|FG002|Overall Study|Study Terminated by Sponsor|2|||
48778187|NCT02573324|157032567|FG000|Overall Study|Death|182|||
48778188|NCT02573324|157032568|FG001|Overall Study|Death|200|||
48778189|NCT02573324|157032569|FG002|Overall Study|Death|1|||
48778190|NCT02573324|157032567|FG000|Overall Study|Other, Not Specified|20|||
48778191|NCT02573324|157032568|FG001|Overall Study|Other, Not Specified|27|||
48778192|NCT02573324|157032569|FG002|Overall Study|Other, Not Specified|0|||
48778193|NCT02573324|157032567|FG000|Overall Study|Unknown Reason|2|||
48778194|NCT02573324|157032568|FG001|Overall Study|Unknown Reason|0|||
48778195|NCT02573324|157032569|FG002|Overall Study|Unknown Reason|0|||
48778196|NCT00612066|157032570|FG000|Overall Study|Adverse Event|1|||
48778197|NCT01677195|157032571|FG000|Overall Study|Lost to Follow-up|14|||
48778198|NCT01677195|157032572|FG001|Overall Study|Lost to Follow-up|22|||
48778199|NCT01677195|157032573|FG002|Overall Study|Lost to Follow-up|22|||
48778200|NCT01677195|157032571|FG000|Overall Study|Withdrawal by Subject|1|||
48778201|NCT01677195|157032572|FG001|Overall Study|Withdrawal by Subject|0|||
48778202|NCT01677195|157032573|FG002|Overall Study|Withdrawal by Subject|1|||
48778203|NCT01677195|157032571|FG000|Overall Study|Adverse Event|6|||
48778204|NCT01677195|157032572|FG001|Overall Study|Adverse Event|4|||
48778205|NCT01677195|157032573|FG002|Overall Study|Adverse Event|1|||
48778206|NCT01677195|157032571|FG000|Overall Study|Physician Decision|1|||
48778207|NCT01677195|157032572|FG001|Overall Study|Physician Decision|2|||
48778208|NCT01677195|157032573|FG002|Overall Study|Physician Decision|2|||
48778209|NCT01677195|157032571|FG000|Overall Study|Pregnancy|0|||
48778210|NCT01677195|157032572|FG001|Overall Study|Pregnancy|1|||
48778211|NCT01677195|157032573|FG002|Overall Study|Pregnancy|0|||
48778212|NCT01677195|157032571|FG000|Overall Study|Protocol Violation|7|||
48778213|NCT01677195|157032572|FG001|Overall Study|Protocol Violation|3|||
48778214|NCT01677195|157032573|FG002|Overall Study|Protocol Violation|4|||
48778215|NCT01519518|157032575|FG000|Overall Study|Consent not available|7|||
48778216|NCT01519518|157032576|FG001|Overall Study|Consent not available|10|||
48778217|NCT01513317|157032577|FG000|Overall Study|Withdrawal by Subject|15|||
48778218|NCT01513317|157032578|FG001|Overall Study|Withdrawal by Subject|4|||
48778219|NCT01513317|157032577|FG000|Overall Study|Death|1|||
48778220|NCT01513317|157032578|FG001|Overall Study|Death|1|||
48778221|NCT01513317|157032577|FG000|Overall Study|Study terminated by sponsor|18|||
48778222|NCT01513317|157032578|FG001|Overall Study|Study terminated by sponsor|18|||
48778223|NCT01513317|157032577|FG000|Overall Study|Other|0|||
48778224|NCT01513317|157032578|FG001|Overall Study|Other|1|||
48778225|NCT02200042|157032585|FG000|Overall Study|Withdrawal by Subject|0|||
48778226|NCT02200042|157032586|FG001|Overall Study|Withdrawal by Subject|1|||
48778227|NCT01969838|157032587|FG000|Double-blind Phase|Adverse Event|10|||
48778228|NCT01969838|157032588|FG001|Double-blind Phase|Adverse Event|4|||
48778229|NCT01969838|157032589|FG002|Double-blind Phase|Adverse Event|0|||
48778230|NCT01969838|157032590|FG003|Double-blind Phase|Adverse Event|0|||
48778231|NCT01969838|157032587|FG000|Double-blind Phase|Death|5|||
48778232|NCT01969838|157032588|FG001|Double-blind Phase|Death|2|||
48778233|NCT01969838|157032589|FG002|Double-blind Phase|Death|0|||
48778234|NCT01969838|157032590|FG003|Double-blind Phase|Death|0|||
48778235|NCT01969838|157032587|FG000|Double-blind Phase|Physician Decision|5|||
48778236|NCT01969838|157032588|FG001|Double-blind Phase|Physician Decision|1|||
48778237|NCT01969838|157032589|FG002|Double-blind Phase|Physician Decision|0|||
48778238|NCT01969838|157032590|FG003|Double-blind Phase|Physician Decision|0|||
48778239|NCT01969838|157032587|FG000|Double-blind Phase|Subject Decision|4|||
48778240|NCT01969838|157032588|FG001|Double-blind Phase|Subject Decision|2|||
48778241|NCT01969838|157032589|FG002|Double-blind Phase|Subject Decision|0|||
48778242|NCT01969838|157032590|FG003|Double-blind Phase|Subject Decision|0|||
48778243|NCT01969838|157032587|FG000|Double-blind Phase|Disease Progression|2|||
48778244|NCT01969838|157032588|FG001|Double-blind Phase|Disease Progression|0|||
48778245|NCT01969838|157032589|FG002|Double-blind Phase|Disease Progression|0|||
48778246|NCT01969838|157032590|FG003|Double-blind Phase|Disease Progression|0|||
48778247|NCT01969838|157032587|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
48778248|NCT01969838|157032588|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
48778249|NCT01969838|157032589|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
48778250|NCT01969838|157032590|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
48778251|NCT01969838|157032587|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
48778252|NCT01969838|157032588|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
48778253|NCT01969838|157032589|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
48778254|NCT01969838|157032590|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
48778255|NCT01969838|157032587|FG000|Open-label Phase|Adverse Event|0|||
48778256|NCT01969838|157032588|FG001|Open-label Phase|Adverse Event|0|||
48778257|NCT01969838|157032589|FG002|Open-label Phase|Adverse Event|37|||
48778258|NCT01969838|157032590|FG003|Open-label Phase|Adverse Event|49|||
48778259|NCT01969838|157032587|FG000|Open-label Phase|Disease Progression|0|||
48778260|NCT01969838|157032588|FG001|Open-label Phase|Disease Progression|0|||
48778261|NCT01969838|157032589|FG002|Open-label Phase|Disease Progression|26|||
48778262|NCT01969838|157032590|FG003|Open-label Phase|Disease Progression|27|||
48778263|NCT01969838|157032587|FG000|Open-label Phase|Lack of Efficacy|0|||
48778264|NCT01969838|157032588|FG001|Open-label Phase|Lack of Efficacy|0|||
48778265|NCT01969838|157032589|FG002|Open-label Phase|Lack of Efficacy|17|||
48778266|NCT01969838|157032590|FG003|Open-label Phase|Lack of Efficacy|19|||
48778267|NCT01969838|157032587|FG000|Open-label Phase|Subject Decision|0|||
48778268|NCT01969838|157032588|FG001|Open-label Phase|Subject Decision|0|||
48778269|NCT01969838|157032589|FG002|Open-label Phase|Subject Decision|14|||
48778270|NCT01969838|157032590|FG003|Open-label Phase|Subject Decision|15|||
48778271|NCT01969838|157032587|FG000|Open-label Phase|Death|0|||
48778272|NCT01969838|157032588|FG001|Open-label Phase|Death|0|||
48778273|NCT01969838|157032589|FG002|Open-label Phase|Death|13|||
48778274|NCT01969838|157032590|FG003|Open-label Phase|Death|11|||
48778275|NCT01969838|157032587|FG000|Open-label Phase|Physician Decision|0|||
48778276|NCT01969838|157032588|FG001|Open-label Phase|Physician Decision|0|||
48778277|NCT01969838|157032589|FG002|Open-label Phase|Physician Decision|9|||
48778278|NCT01969838|157032590|FG003|Open-label Phase|Physician Decision|14|||
48778279|NCT01969838|157032587|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
48778280|NCT01969838|157032588|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
48778281|NCT01969838|157032589|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
48778282|NCT01969838|157032590|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
48778283|NCT02086591|157032593|FG000|Overall Study|Adverse Event|1|||
48778284|NCT02086591|157032593|FG000|Overall Study|Withdrawal by Subject|1|||
48778285|NCT02086591|157032593|FG000|Overall Study|protocol terminated|3|||
48778286|NCT03455855|157032594|FG000|Overall Study|Lost to Follow-up|4|||
48778287|NCT03455855|157032595|FG001|Overall Study|Lost to Follow-up|2|||
48778288|NCT01774903|157032596|FG000|Overall Study|Adverse Event|7|||
48778289|NCT01774903|157032596|FG000|Overall Study|Withdrawal by Subject|2|||
48778290|NCT01774903|157032596|FG000|Overall Study|Lack of Efficacy|1|||
48778291|NCT01774903|157032596|FG000|Overall Study|Ineligible to continue the trial|1|||
48778292|NCT00961259|157032603|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
48778293|NCT00961259|157032604|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
48778294|NCT00961259|157032605|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
48778295|NCT02167035|157032608|FG000|Overall Study|Adverse Event|2|||
48778296|NCT02167035|157032609|FG001|Overall Study|Adverse Event|2|||
48778297|NCT02167035|157032608|FG000|Overall Study|Lost to Follow-up|3|||
48778298|NCT02167035|157032609|FG001|Overall Study|Lost to Follow-up|3|||
48778299|NCT02167035|157032608|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
48778300|NCT02167035|157032609|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
48778301|NCT02252081|157032610|FG000|Overall Study|Withdrawal by Subject|2|||
48778302|NCT02252081|157032611|FG001|Overall Study|Withdrawal by Subject|1|||
48778303|NCT02252081|157032610|FG000|Overall Study|Adverse Event|4|||
48778304|NCT02252081|157032611|FG001|Overall Study|Adverse Event|1|||
48778305|NCT02252081|157032610|FG000|Overall Study|non compliance & others|0|||
48778306|NCT02252081|157032611|FG001|Overall Study|non compliance & others|2|||
48778307|NCT00048724|157032617|FG000|Overall Study|Adverse Event|53|||
48778308|NCT00048724|157032618|FG001|Overall Study|Adverse Event|12|||
48778309|NCT00048724|157032617|FG000|Overall Study|Withdrawal by Subject|34|||
48778310|NCT00048724|157032618|FG001|Overall Study|Withdrawal by Subject|54|||
48778311|NCT00048724|157032617|FG000|Overall Study|Lost to Follow-up|5|||
48778312|NCT00048724|157032618|FG001|Overall Study|Lost to Follow-up|5|||
48778313|NCT00048724|157032617|FG000|Overall Study|Protocol-defined Clinical Event|17|||
48778314|NCT00048724|157032618|FG001|Overall Study|Protocol-defined Clinical Event|32|||
48778315|NCT00048724|157032617|FG000|Overall Study|Noncompliance With Protocol|4|||
48778316|NCT00048724|157032618|FG001|Overall Study|Noncompliance With Protocol|12|||
48778317|NCT00048724|157032617|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
48778318|NCT00048724|157032618|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
48778319|NCT00048724|157032617|FG000|Overall Study|Administrative|1|||
48778320|NCT00048724|157032618|FG001|Overall Study|Administrative|1|||
48778321|NCT02039427|157032619|FG000|Overall Study|Duration of surgery > 3h|1|||
48778322|NCT02039427|157032620|FG001|Overall Study|Duration of surgery > 3h|1|||
48778323|NCT02039427|157032621|FG002|Overall Study|Duration of surgery > 3h|0|||
48778324|NCT02039427|157032622|FG003|Overall Study|Duration of surgery > 3h|0|||
48778325|NCT02039427|157032619|FG000|Overall Study|Withdrawal on concent|0|||
48778326|NCT02039427|157032620|FG001|Overall Study|Withdrawal on concent|0|||
48778327|NCT02039427|157032621|FG002|Overall Study|Withdrawal on concent|0|||
48778328|NCT02039427|157032622|FG003|Overall Study|Withdrawal on concent|1|||
48778329|NCT02039427|157032619|FG000|Overall Study|Cancellation of surgery|0|||
48778330|NCT02039427|157032620|FG001|Overall Study|Cancellation of surgery|0|||
48778331|NCT02039427|157032621|FG002|Overall Study|Cancellation of surgery|1|||
48778332|NCT02039427|157032622|FG003|Overall Study|Cancellation of surgery|0|||
48778333|NCT02039427|157032619|FG000|Overall Study|Loss of follow - up|1|||
48778334|NCT02039427|157032620|FG001|Overall Study|Loss of follow - up|0|||
48778335|NCT02039427|157032621|FG002|Overall Study|Loss of follow - up|2|||
48778336|NCT02039427|157032622|FG003|Overall Study|Loss of follow - up|4|||
48778337|NCT02039427|157032619|FG000|Overall Study|Steroid Use|1|||
48778338|NCT02039427|157032620|FG001|Overall Study|Steroid Use|0|||
48778339|NCT02039427|157032621|FG002|Overall Study|Steroid Use|0|||
48778340|NCT02039427|157032622|FG003|Overall Study|Steroid Use|0|||
48778341|NCT03603964|157032623|FG000|Overall Study|Death|9|||
48778342|NCT03603964|157032623|FG000|Overall Study|Withdrawal by participant|7|||
48778343|NCT03603964|157032623|FG000|Overall Study|Study terminated by Sponsor|19|||
48778344|NCT04317586|157032624|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
48778345|NCT04317586|157032624|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
48778346|NCT01148810|157032625|FG000|Overall Study|Adverse Event|0|||
48778347|NCT01148810|157032626|FG001|Overall Study|Adverse Event|2|||
48778348|NCT01148810|157032625|FG000|Overall Study|Lack of Efficacy|0|||
48778349|NCT01148810|157032626|FG001|Overall Study|Lack of Efficacy|1|||
48778350|NCT01148810|157032625|FG000|Overall Study|Withdrawal by Subject|0|||
48778351|NCT01148810|157032626|FG001|Overall Study|Withdrawal by Subject|2|||
48778352|NCT01148810|157032625|FG000|Overall Study|Protocol Violation|1|||
48778353|NCT01148810|157032626|FG001|Overall Study|Protocol Violation|0|||
48778354|NCT00403455|157032628|FG000|Overall Study|Withdrawal by Subject|1|||
48778355|NCT03003676|157032631|FG000|Overall Study|Lack of Efficacy|5|||
48778356|NCT03003676|157032632|FG001|Overall Study|Lack of Efficacy|7|||
48778357|NCT03003676|157032631|FG000|Overall Study|Withdrawal by Subject|0|||
48778358|NCT03003676|157032632|FG001|Overall Study|Withdrawal by Subject|1|||
48778359|NCT03003676|157032631|FG000|Overall Study|Hepatitis B infection|1|||
48778360|NCT03003676|157032632|FG001|Overall Study|Hepatitis B infection|0|||
48778361|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
48778362|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
48778363|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
48778364|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
48778365|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
48778366|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
48778367|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
48778368|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
48778369|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
48778370|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
48778371|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
48778372|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
48778373|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
48778374|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
48356418|NCT00150618|155501079|FG004|Overall Study|No study meds|2|||
48778375|NCT03732638|157032633|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
48778376|NCT03732638|157032634|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
48778377|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
48778378|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
48778379|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
48778380|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
48778381|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
48778382|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
48356419|NCT00150618|155501075|FG000|Overall Study|Physician Decision|0|||
48397195|NCT03355300|155646315|FG000|Overall Study|Lack of Efficacy|2|||
48397196|NCT03355300|155646316|FG001|Overall Study|Lack of Efficacy|1|||
48778383|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
48778384|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
48778385|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
48778386|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
48778387|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
48778388|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
48778389|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
48778390|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
48778391|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
48778392|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
48778393|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
48778394|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
48778395|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
48778396|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
48778397|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
48778398|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
48778399|NCT03732638|157032633|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
48778400|NCT03732638|157032634|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
48778401|NCT03732638|157032633|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
48778402|NCT03732638|157032634|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
48778403|NCT03732638|157032633|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
48778404|NCT03732638|157032634|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
48778405|NCT03732638|157032633|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
48778406|NCT03732638|157032634|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
48778407|NCT03732638|157032633|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
48778408|NCT03732638|157032634|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
48778409|NCT03766646|157032635|FG000|Overall Study|Withdrawal by Subject|1|||
48778410|NCT03766646|157032636|FG001|Overall Study|Withdrawal by Subject|0|||
48778411|NCT03766646|157032635|FG000|Overall Study|Protocol Violation|0|||
48778412|NCT03766646|157032636|FG001|Overall Study|Protocol Violation|3|||
48778413|NCT01163682|157032640|FG000|Overall Study|Lost to Follow-up|6|||
48778414|NCT01163682|157032641|FG001|Overall Study|Lost to Follow-up|9|||
48778415|NCT00359762|157032643|FG000|Period II|Adverse Event|17|||
48778416|NCT00359762|157032644|FG001|Period II|Adverse Event|0|||
48778417|NCT00359762|157032645|FG002|Period II|Adverse Event|0|||
48778418|NCT00359762|157032646|FG003|Period II|Adverse Event|0|||
48778419|NCT00359762|157032647|FG004|Period II|Adverse Event|49|||
48778420|NCT00359762|157032643|FG000|Period II|Protocol Violation|18|||
48778421|NCT00359762|157032644|FG001|Period II|Protocol Violation|0|||
48778422|NCT00359762|157032645|FG002|Period II|Protocol Violation|0|||
48778423|NCT00359762|157032646|FG003|Period II|Protocol Violation|0|||
48778424|NCT00359762|157032647|FG004|Period II|Protocol Violation|11|||
48778425|NCT00359762|157032643|FG000|Period II|Physician Decision|17|||
48778426|NCT00359762|157032644|FG001|Period II|Physician Decision|0|||
48778427|NCT00359762|157032645|FG002|Period II|Physician Decision|0|||
48778428|NCT00359762|157032646|FG003|Period II|Physician Decision|0|||
48778429|NCT00359762|157032647|FG004|Period II|Physician Decision|23|||
48778430|NCT00359762|157032643|FG000|Period II|Death|2|||
48778431|NCT00359762|157032644|FG001|Period II|Death|0|||
48778432|NCT00359762|157032645|FG002|Period II|Death|0|||
48778433|NCT00359762|157032646|FG003|Period II|Death|0|||
48778434|NCT00359762|157032647|FG004|Period II|Death|4|||
48778435|NCT00359762|157032643|FG000|Period II|Lack of Efficacy|11|||
48778436|NCT00359762|157032644|FG001|Period II|Lack of Efficacy|0|||
48778437|NCT00359762|157032645|FG002|Period II|Lack of Efficacy|0|||
48778438|NCT00359762|157032646|FG003|Period II|Lack of Efficacy|0|||
48778439|NCT00359762|157032647|FG004|Period II|Lack of Efficacy|8|||
48778440|NCT00359762|157032643|FG000|Period II|Lost to follow up|5|||
48397197|NCT03355300|155646315|FG000|Overall Study|Other reason|1|||
48397198|NCT03355300|155646316|FG001|Overall Study|Other reason|0|||
48397199|NCT01634555|155646320|FG000|Overall Study|Adverse Event|3|||
48778441|NCT00359762|157032644|FG001|Period II|Lost to follow up|0|||
48397200|NCT01634555|155646320|FG000|Overall Study|Physician Decision|1|||
48778442|NCT00359762|157032645|FG002|Period II|Lost to follow up|0|||
48778443|NCT00359762|157032646|FG003|Period II|Lost to follow up|0|||
48778444|NCT00359762|157032647|FG004|Period II|Lost to follow up|5|||
48778445|NCT00359762|157032643|FG000|Period II|Entry Criteria Not Met|8|||
48778446|NCT00359762|157032644|FG001|Period II|Entry Criteria Not Met|0|||
48778447|NCT00359762|157032645|FG002|Period II|Entry Criteria Not Met|0|||
48778448|NCT00359762|157032646|FG003|Period II|Entry Criteria Not Met|0|||
48778449|NCT00359762|157032647|FG004|Period II|Entry Criteria Not Met|4|||
48778450|NCT00359762|157032643|FG000|Period II|Subject Decision|50|||
48778451|NCT00359762|157032644|FG001|Period II|Subject Decision|0|||
48397201|NCT01411085|155646321|FG000|Overall Study|Physician Decision|1|||
48778452|NCT00359762|157032645|FG002|Period II|Subject Decision|0|||
48778453|NCT00359762|157032646|FG003|Period II|Subject Decision|0|||
48778454|NCT00359762|157032647|FG004|Period II|Subject Decision|70|||
48778455|NCT00359762|157032643|FG000|Period III|Protocol Violation|0|||
48778456|NCT00359762|157032644|FG001|Period III|Protocol Violation|5|||
48778457|NCT00359762|157032645|FG002|Period III|Protocol Violation|3|||
48778458|NCT00359762|157032646|FG003|Period III|Protocol Violation|8|||
48778459|NCT00359762|157032647|FG004|Period III|Protocol Violation|0|||
48778460|NCT00359762|157032643|FG000|Period III|Adverse Event|0|||
48778461|NCT00359762|157032644|FG001|Period III|Adverse Event|3|||
48778462|NCT00359762|157032645|FG002|Period III|Adverse Event|4|||
48778463|NCT00359762|157032646|FG003|Period III|Adverse Event|10|||
48778464|NCT00359762|157032647|FG004|Period III|Adverse Event|0|||
48778465|NCT00359762|157032643|FG000|Period III|Physician Decision|0|||
48778466|NCT00359762|157032644|FG001|Period III|Physician Decision|5|||
48778467|NCT00359762|157032645|FG002|Period III|Physician Decision|9|||
48778468|NCT00359762|157032646|FG003|Period III|Physician Decision|15|||
48778469|NCT00359762|157032647|FG004|Period III|Physician Decision|0|||
48778470|NCT00359762|157032643|FG000|Period III|Lack of Efficacy|0|||
48778471|NCT00359762|157032644|FG001|Period III|Lack of Efficacy|7|||
48778472|NCT00359762|157032645|FG002|Period III|Lack of Efficacy|5|||
48778473|NCT00359762|157032646|FG003|Period III|Lack of Efficacy|9|||
48778474|NCT00359762|157032647|FG004|Period III|Lack of Efficacy|0|||
48778475|NCT00359762|157032643|FG000|Period III|Lost to follow up|0|||
48397202|NCT01411085|155646321|FG000|Overall Study|Protocol Violation|1|||
48397203|NCT01411085|155646321|FG000|Overall Study|Adverse Event|1|||
48397204|NCT02193074|155646324|FG000|Overall Study|Withdrawal by Subject|1|||
48397205|NCT02193074|155646325|FG001|Overall Study|Withdrawal by Subject|2|||
48397206|NCT02193074|155646324|FG000|Overall Study|Adverse Event|16|||
48397207|NCT02193074|155646325|FG001|Overall Study|Adverse Event|13|||
48397208|NCT01652885|155648174|FG000|Overall Study|Adverse Event|1|||
48397209|NCT01395394|155648175|FG000|Baseline Study Visit|Protocol Violation|1|||
48397210|NCT01395394|155648176|FG001|Baseline Study Visit|Protocol Violation|0|||
48397211|NCT01395394|155648177|FG002|Baseline Study Visit|Protocol Violation|0|||
48397212|NCT00980200|155648178|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
48778476|NCT00359762|157032644|FG001|Period III|Lost to follow up|1|||
48778477|NCT00359762|157032645|FG002|Period III|Lost to follow up|1|||
48778478|NCT00359762|157032646|FG003|Period III|Lost to follow up|2|||
48778479|NCT00359762|157032647|FG004|Period III|Lost to follow up|0|||
48778480|NCT00359762|157032643|FG000|Period III|Entry Criteria Not Met|0|||
48778481|NCT00359762|157032644|FG001|Period III|Entry Criteria Not Met|1|||
48778482|NCT00359762|157032645|FG002|Period III|Entry Criteria Not Met|0|||
48778483|NCT00359762|157032646|FG003|Period III|Entry Criteria Not Met|1|||
48397213|NCT00980200|155648179|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
48397214|NCT00980200|155648180|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
48397215|NCT00980200|155648181|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
48397216|NCT00980200|155648182|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
48397217|NCT00980200|155648178|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
48397218|NCT00980200|155648179|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
48397219|NCT00980200|155648180|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
48397220|NCT00980200|155648181|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
48397221|NCT00980200|155648182|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
48397222|NCT01736579|155648185|FG000|Overall Study|Termination of Study by Sponsor|2|||
48397223|NCT01736579|155648186|FG001|Overall Study|Termination of Study by Sponsor|2|||
48397224|NCT03468855|155648187|FG000|Overall Study|Adverse Event|2|||
48397225|NCT03468855|155648187|FG000|Overall Study|Lost to Follow-up|5|||
48397226|NCT03468855|155648187|FG000|Overall Study|Withdrawal by Subject|3|||
48397227|NCT03468855|155648187|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
48397228|NCT03368170|155648189|FG000|Overall Study|Adverse Event|2|||
48397229|NCT03368170|155648190|FG001|Overall Study|Adverse Event|1|||
48397230|NCT00666458|155648191|FG000|Overall Study|Adverse Event|8|||
48397231|NCT00666458|155648192|FG001|Overall Study|Adverse Event|7|||
48778484|NCT00359762|157032647|FG004|Period III|Entry Criteria Not Met|0|||
48778485|NCT00359762|157032643|FG000|Period III|Subject Decision|0|||
48778486|NCT00359762|157032644|FG001|Period III|Subject Decision|7|||
48778487|NCT00359762|157032645|FG002|Period III|Subject Decision|8|||
48778488|NCT00359762|157032646|FG003|Period III|Subject Decision|20|||
48778489|NCT00359762|157032647|FG004|Period III|Subject Decision|0|||
48778490|NCT00530023|157032648|FG000|Overall Study|Withdrawal by Subject|0|||
48778491|NCT00530023|157032649|FG001|Overall Study|Withdrawal by Subject|1|||
48778492|NCT04574362|157032650|FG000|Overall Study|Other|0|||
48778493|NCT04574362|157032651|FG001|Overall Study|Other|5|||
48778494|NCT04574362|157032650|FG000|Overall Study|COVID-19|0|||
48778495|NCT04574362|157032651|FG001|Overall Study|COVID-19|1|||
48397232|NCT00666458|155648191|FG000|Overall Study|Withdrawal by Subject|5|||
48397233|NCT00666458|155648192|FG001|Overall Study|Withdrawal by Subject|4|||
48778496|NCT04574362|157032650|FG000|Overall Study|Adverse Event|1|||
48778497|NCT04574362|157032651|FG001|Overall Study|Adverse Event|1|||
48778498|NCT04574362|157032650|FG000|Overall Study|Withdrawal by Subject|2|||
48778499|NCT04574362|157032651|FG001|Overall Study|Withdrawal by Subject|4|||
48778500|NCT04574362|157032650|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
48778501|NCT04574362|157032651|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
48778502|NCT04574362|157032650|FG000|Overall Study|Participant refused to come to the hospital|1|||
48778503|NCT04574362|157032651|FG001|Overall Study|Participant refused to come to the hospital|0|||
48778504|NCT04574362|157032650|FG000|Overall Study|Participant refused the visit|1|||
48778505|NCT04574362|157032651|FG001|Overall Study|Participant refused the visit|0|||
48778506|NCT04574362|157032650|FG000|Overall Study|Participant quit early because of business trip|1|||
48778507|NCT04574362|157032651|FG001|Overall Study|Participant quit early because of business trip|0|||
48778508|NCT00765245|157032653|FG000|Overall Study|disease progression|3|||
48778509|NCT00765245|157032654|FG001|Overall Study|disease progression|2|||
48778510|NCT00765245|157032653|FG000|Overall Study|Withdrawal by Subject|3|||
48778511|NCT00765245|157032654|FG001|Overall Study|Withdrawal by Subject|0|||
48778512|NCT00765245|157032653|FG000|Overall Study|Adverse Event|5|||
48778513|NCT00765245|157032654|FG001|Overall Study|Adverse Event|0|||
48778514|NCT00765245|157032653|FG000|Overall Study|Physician Decision|1|||
48778515|NCT00765245|157032654|FG001|Overall Study|Physician Decision|0|||
48397234|NCT00666458|155648191|FG000|Overall Study|Lost to Follow-up|0|||
48397235|NCT00666458|155648192|FG001|Overall Study|Lost to Follow-up|3|||
48778516|NCT00765245|157032653|FG000|Overall Study|Death|1|||
48778517|NCT00765245|157032654|FG001|Overall Study|Death|0|||
48778518|NCT04382326|157032655|FG000|Overall Study|Adverse Event, not serious|1|||
48397236|NCT00666458|155648191|FG000|Overall Study|Administrative reason by sponsor|1|||
48778519|NCT04382326|157032656|FG001|Overall Study|Adverse Event, not serious|2|||
48397237|NCT00666458|155648192|FG001|Overall Study|Administrative reason by sponsor|1|||
48397238|NCT00666458|155648191|FG000|Overall Study|Incorrect enrollment|7|||
48397239|NCT00666458|155648192|FG001|Overall Study|Incorrect enrollment|1|||
48397240|NCT00666458|155648191|FG000|Overall Study|Study specific discontinuation criteria|14|||
48778520|NCT04382326|157032655|FG000|Overall Study|Other|1|||
48778521|NCT04382326|157032656|FG001|Overall Study|Other|0|||
48778522|NCT04382326|157032655|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
48778523|NCT04382326|157032656|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
48778524|NCT04382326|157032655|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
48778525|NCT04382326|157032656|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
48778526|NCT04382326|157032655|FG000|Overall Study|Protocol Violation|29|||
48778527|NCT04382326|157032656|FG001|Overall Study|Protocol Violation|23|||
48778528|NCT04382326|157032655|FG000|Overall Study|Physician Decision|0|||
48778529|NCT04382326|157032656|FG001|Overall Study|Physician Decision|1|||
48778530|NCT04382326|157032655|FG000|Overall Study|Lost to Follow-up|48|||
48778531|NCT04382326|157032656|FG001|Overall Study|Lost to Follow-up|63|||
48778532|NCT04382326|157032655|FG000|Overall Study|Adverse Event, non-fatal|1|||
48778533|NCT04382326|157032656|FG001|Overall Study|Adverse Event, non-fatal|1|||
48778534|NCT01263873|157032657|FG000|Overall Study|One provider unable to complete numbers|1|||
48778535|NCT01263873|157032658|FG001|Overall Study|One provider unable to complete numbers|1|||
48778536|NCT04067141|157032663|FG000|First Intervention|Withdrawal by Subject|0|||
48778537|NCT04067141|157032664|FG001|First Intervention|Withdrawal by Subject|1|||
48778538|NCT04067141|157032663|FG000|Second Intervention|Adverse Event|0|||
48778539|NCT04067141|157032664|FG001|Second Intervention|Adverse Event|2|||
48778540|NCT03525834|157032665|FG000|Overall Study|Progressive disease|1|||
48778541|NCT00614939|157032668|FG000|Overall Study|Withdrawal by Subject|10|||
48778542|NCT00614939|157032669|FG001|Overall Study|Withdrawal by Subject|17|||
48778543|NCT00614939|157032668|FG000|Overall Study|Study specific discontinuation criteris|13|||
48778544|NCT00614939|157032669|FG001|Overall Study|Study specific discontinuation criteris|16|||
48778545|NCT00614939|157032668|FG000|Overall Study|Adverse Event|2|||
48778546|NCT00614939|157032669|FG001|Overall Study|Adverse Event|5|||
48778547|NCT00614939|157032668|FG000|Overall Study|Incorrect enrollment|1|||
48778548|NCT00614939|157032669|FG001|Overall Study|Incorrect enrollment|2|||
48778549|NCT00614939|157032668|FG000|Overall Study|Death|4|||
48778550|NCT00614939|157032669|FG001|Overall Study|Death|3|||
48778551|NCT00614939|157032668|FG000|Overall Study|Poor/non-compliance|4|||
48778552|NCT00614939|157032669|FG001|Overall Study|Poor/non-compliance|0|||
48778553|NCT00614939|157032668|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
48778554|NCT00614939|157032669|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
48778555|NCT02667912|157032670|FG000|Overall Study|Death|3|||
48778556|NCT02667912|157032671|FG001|Overall Study|Death|1|||
48778557|NCT02667912|157032670|FG000|Overall Study|Withdrawal by Subject|1|||
48778558|NCT02667912|157032671|FG001|Overall Study|Withdrawal by Subject|2|||
48778559|NCT02667912|157032670|FG000|Overall Study|Withdrawal by Subject|1|||
48778560|NCT02667912|157032671|FG001|Overall Study|Withdrawal by Subject|0|||
48778561|NCT00534352|157032672|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
48778562|NCT00534352|157032672|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
48778563|NCT00534352|157032672|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
48778564|NCT00534352|157032672|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
48778565|NCT00534352|157032672|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
48778566|NCT00534352|157032672|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
48778567|NCT01986829|157032675|FG000|Overall Study|Death|1|||
48778568|NCT02504866|157032676|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
48778569|NCT02504866|157032677|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
48778570|NCT02504866|157032678|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
48778571|NCT01260922|157032679|FG000|First Intervention|Withdrawal by Subject|0|||
48778572|NCT01260922|157032680|FG001|First Intervention|Withdrawal by Subject|1|||
48778573|NCT01260922|157032679|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
48778574|NCT01260922|157032680|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
48778575|NCT01260922|157032679|FG000|Second Intervention|Emesis|0|||
48778576|NCT01260922|157032680|FG001|Second Intervention|Emesis|2|||
48778577|NCT01229436|157032685|FG000|Overall Study|Withdrawal by Subject|2|||
48778578|NCT01229436|157032685|FG000|Overall Study|Lost to Follow-up|3|||
48778579|NCT01459796|157032688|FG000|Overall Study|Non compliance with protocol|2|||
48778580|NCT01459796|157032689|FG001|Overall Study|Non compliance with protocol|4|||
48778581|NCT01459796|157032688|FG000|Overall Study|Adverse Event|5|||
48778582|NCT01459796|157032689|FG001|Overall Study|Adverse Event|5|||
48778583|NCT01459796|157032688|FG000|Overall Study|Withdrawal by Subject|6|||
48778584|NCT01459796|157032689|FG001|Overall Study|Withdrawal by Subject|3|||
48778585|NCT01459796|157032688|FG000|Overall Study|Lost to Follow-up|5|||
48778586|NCT01459796|157032689|FG001|Overall Study|Lost to Follow-up|4|||
48778587|NCT01459796|157032688|FG000|Overall Study|Reason unspecified|1|||
48778588|NCT01459796|157032689|FG001|Overall Study|Reason unspecified|2|||
48778589|NCT01459796|157032688|FG000|Overall Study|Decision by the sponsor|75|||
48778590|NCT01459796|157032689|FG001|Overall Study|Decision by the sponsor|108|||
48778591|NCT02170727|157032690|FG000|Overall Study|Lost to Follow-up|1|||
48778592|NCT02170727|157032691|FG001|Overall Study|Lost to Follow-up|0|||
48778593|NCT02170727|157032690|FG000|Overall Study|Withdrawal by Subject|2|||
48778594|NCT02170727|157032691|FG001|Overall Study|Withdrawal by Subject|0|||
48778595|NCT03231371|157032694|FG000|Overall Study|Withdrawal by Subject|1|||
48778596|NCT03231371|157032694|FG000|Overall Study|chose or were ineligible to have MRI|12|||
48778597|NCT01959581|157032695|FG000|Overall Study|Lost to Follow-up|5|||
48778598|NCT03246958|157032696|FG000|Overall Study|Withdrawal by Subject|0|||
48778599|NCT03246958|157032697|FG001|Overall Study|Withdrawal by Subject|1|||
48778600|NCT03246958|157032698|FG002|Overall Study|Withdrawal by Subject|0|||
48778601|NCT03246958|157032699|FG003|Overall Study|Withdrawal by Subject|0|||
48778602|NCT03246958|157032700|FG004|Overall Study|Withdrawal by Subject|0|||
48778603|NCT03246958|157032701|FG005|Overall Study|Withdrawal by Subject|1|||
48778604|NCT03246958|157032702|FG006|Overall Study|Withdrawal by Subject|0|||
48778605|NCT03246958|157032696|FG000|Overall Study|Progression|13|||
48778606|NCT03246958|157032697|FG001|Overall Study|Progression|9|||
48778607|NCT03246958|157032698|FG002|Overall Study|Progression|3|||
48778608|NCT03246958|157032699|FG003|Overall Study|Progression|2|||
48778609|NCT03246958|157032700|FG004|Overall Study|Progression|1|||
48778610|NCT03246958|157032701|FG005|Overall Study|Progression|2|||
48778611|NCT03246958|157032702|FG006|Overall Study|Progression|1|||
48356420|NCT00150618|155501076|FG001|Overall Study|Physician Decision|2|||
48356421|NCT00150618|155501077|FG002|Overall Study|Physician Decision|0|||
48778612|NCT03246958|157032696|FG000|Overall Study|Adverse Event|2|||
48778613|NCT03246958|157032697|FG001|Overall Study|Adverse Event|2|||
48778614|NCT03246958|157032698|FG002|Overall Study|Adverse Event|0|||
48778615|NCT03246958|157032699|FG003|Overall Study|Adverse Event|1|||
48778616|NCT03246958|157032700|FG004|Overall Study|Adverse Event|1|||
48397241|NCT00666458|155648192|FG001|Overall Study|Study specific discontinuation criteria|7|||
48397242|NCT00666458|155648191|FG000|Overall Study|Severe non-compliance to the protocol|1|||
48397243|NCT00666458|155648192|FG001|Overall Study|Severe non-compliance to the protocol|1|||
48397244|NCT00666458|155648191|FG000|Overall Study|Safety reasons|1|||
48397245|NCT00666458|155648192|FG001|Overall Study|Safety reasons|0|||
48397246|NCT00666458|155648191|FG000|Overall Study|Medical history of anemia|1|||
48397247|NCT00666458|155648192|FG001|Overall Study|Medical history of anemia|0|||
48397248|NCT03311711|155648193|FG000|Overall Study|Death|1|||
48397249|NCT03311711|155648194|FG001|Overall Study|Death|0|||
48397250|NCT03311711|155648195|FG002|Overall Study|Death|0|||
48397251|NCT03311711|155648196|FG003|Overall Study|Death|0|||
48397252|NCT03311711|155648197|FG004|Overall Study|Death|0|||
48778617|NCT03246958|157032701|FG005|Overall Study|Adverse Event|0|||
48778618|NCT03246958|157032702|FG006|Overall Study|Adverse Event|2|||
48778619|NCT03246958|157032696|FG000|Overall Study|Death|0|||
48778620|NCT03246958|157032697|FG001|Overall Study|Death|1|||
48778621|NCT03246958|157032698|FG002|Overall Study|Death|0|||
48778622|NCT03246958|157032699|FG003|Overall Study|Death|0|||
48778623|NCT03246958|157032700|FG004|Overall Study|Death|0|||
48778624|NCT03246958|157032701|FG005|Overall Study|Death|0|||
48778625|NCT03246958|157032702|FG006|Overall Study|Death|0|||
48778626|NCT03246958|157032696|FG000|Overall Study|Physician Decision|0|||
48778627|NCT03246958|157032697|FG001|Overall Study|Physician Decision|0|||
48778628|NCT03246958|157032698|FG002|Overall Study|Physician Decision|0|||
48778629|NCT03246958|157032699|FG003|Overall Study|Physician Decision|1|||
48778630|NCT03246958|157032700|FG004|Overall Study|Physician Decision|0|||
48778631|NCT03246958|157032701|FG005|Overall Study|Physician Decision|0|||
48778632|NCT03246958|157032702|FG006|Overall Study|Physician Decision|0|||
48778633|NCT03246958|157032696|FG000|Overall Study|Never start treatment|1|||
48778634|NCT03246958|157032697|FG001|Overall Study|Never start treatment|0|||
48778635|NCT03246958|157032698|FG002|Overall Study|Never start treatment|0|||
48778636|NCT03246958|157032699|FG003|Overall Study|Never start treatment|0|||
48778637|NCT03246958|157032700|FG004|Overall Study|Never start treatment|0|||
48778638|NCT03246958|157032701|FG005|Overall Study|Never start treatment|0|||
48778639|NCT03246958|157032702|FG006|Overall Study|Never start treatment|0|||
48778640|NCT03246958|157032696|FG000|Overall Study|Over enrollment|0|||
48778641|NCT03246958|157032697|FG001|Overall Study|Over enrollment|2|||
48778642|NCT03246958|157032698|FG002|Overall Study|Over enrollment|0|||
48778643|NCT03246958|157032699|FG003|Overall Study|Over enrollment|0|||
48778644|NCT03246958|157032700|FG004|Overall Study|Over enrollment|0|||
48778645|NCT03246958|157032701|FG005|Overall Study|Over enrollment|0|||
48778646|NCT03246958|157032702|FG006|Overall Study|Over enrollment|0|||
48778647|NCT03880578|157032705|FG000|Overall Study|Withdrawal by Subject|0|||
48778648|NCT03880578|157032706|FG001|Overall Study|Withdrawal by Subject|3|||
48778649|NCT03880578|157032707|FG002|Overall Study|Withdrawal by Subject|1|||
48778650|NCT03880578|157032705|FG000|Overall Study|Death|0|||
48778651|NCT03880578|157032706|FG001|Overall Study|Death|1|||
48778652|NCT03880578|157032707|FG002|Overall Study|Death|0|||
48778653|NCT04632940|157032708|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
48778654|NCT04632940|157032709|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
48778655|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
48778656|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
48778657|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
48778658|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
48778659|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
48778660|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
48778661|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
48778662|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
48778663|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
48778664|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
48778665|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Other than specified|0|||
48778666|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Other than specified|1|||
48778667|NCT04632940|157032708|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
48778668|NCT04632940|157032709|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
48778669|NCT02610140|157032710|FG000|Randomization and Treatment Period|Radiological progression|23|||
48778670|NCT02610140|157032711|FG001|Randomization and Treatment Period|Radiological progression|15|||
48778671|NCT02610140|157032710|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
48397253|NCT03311711|155648198|FG005|Overall Study|Death|0|||
48778672|NCT02610140|157032711|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
48778673|NCT02610140|157032710|FG000|Randomization and Treatment Period|Protocol Violation|1|||
48778674|NCT02610140|157032711|FG001|Randomization and Treatment Period|Protocol Violation|0|||
48778675|NCT02610140|157032710|FG000|Randomization and Treatment Period|Physician Decision|0|||
48778676|NCT02610140|157032711|FG001|Randomization and Treatment Period|Physician Decision|1|||
48397254|NCT03311711|155648199|FG006|Overall Study|Death|1|||
48397255|NCT03311711|155648200|FG007|Overall Study|Death|0|||
48778677|NCT02610140|157032710|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
48778678|NCT02610140|157032711|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
48778679|NCT02610140|157032710|FG000|Randomization and Treatment Period|Death|7|||
48778680|NCT02610140|157032711|FG001|Randomization and Treatment Period|Death|1|||
48778681|NCT02610140|157032710|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
48778682|NCT02610140|157032711|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
48778683|NCT02610140|157032710|FG000|Randomization and Treatment Period|Adverse Event|44|||
48778684|NCT02610140|157032711|FG001|Randomization and Treatment Period|Adverse Event|13|||
48778685|NCT02610140|157032710|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
48778686|NCT02610140|157032711|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
48778687|NCT02610140|157032710|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
48778688|NCT02610140|157032711|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
48397256|NCT03311711|155648201|FG008|Overall Study|Death|1|||
48397257|NCT03311711|155648202|FG009|Overall Study|Death|0|||
48397258|NCT03311711|155648193|FG000|Overall Study|Death of dyad partner|0|||
48397259|NCT03311711|155648194|FG001|Overall Study|Death of dyad partner|1|||
48397260|NCT03311711|155648195|FG002|Overall Study|Death of dyad partner|0|||
48397261|NCT03311711|155648196|FG003|Overall Study|Death of dyad partner|0|||
48397262|NCT03311711|155648197|FG004|Overall Study|Death of dyad partner|0|||
48778689|NCT02610140|157032710|FG000|Randomization and Treatment Period|Not treated|3|||
48778690|NCT02610140|157032711|FG001|Randomization and Treatment Period|Not treated|10|||
48778691|NCT02610140|157032710|FG000|Safety Follow-up|Other|0|||
48778692|NCT02610140|157032711|FG001|Safety Follow-up|Other|2|||
48397263|NCT03311711|155648198|FG005|Overall Study|Death of dyad partner|0|||
48397264|NCT03311711|155648199|FG006|Overall Study|Death of dyad partner|0|||
48397265|NCT03311711|155648200|FG007|Overall Study|Death of dyad partner|1|||
48397266|NCT03311711|155648201|FG008|Overall Study|Death of dyad partner|0|||
48397267|NCT03311711|155648202|FG009|Overall Study|Death of dyad partner|1|||
48397268|NCT03311711|155648193|FG000|Overall Study|Lost to Follow-up|2|||
48397269|NCT03311711|155648194|FG001|Overall Study|Lost to Follow-up|2|||
48397270|NCT03311711|155648195|FG002|Overall Study|Lost to Follow-up|0|||
48397271|NCT03311711|155648196|FG003|Overall Study|Lost to Follow-up|0|||
48397272|NCT03311711|155648197|FG004|Overall Study|Lost to Follow-up|0|||
48397273|NCT03311711|155648198|FG005|Overall Study|Lost to Follow-up|0|||
48397274|NCT03311711|155648199|FG006|Overall Study|Lost to Follow-up|1|||
48397275|NCT03311711|155648200|FG007|Overall Study|Lost to Follow-up|1|||
48397276|NCT03311711|155648201|FG008|Overall Study|Lost to Follow-up|0|||
48397277|NCT03311711|155648202|FG009|Overall Study|Lost to Follow-up|0|||
48397278|NCT03311711|155648193|FG000|Overall Study|Withdrawal by Subject|1|||
48397279|NCT03311711|155648194|FG001|Overall Study|Withdrawal by Subject|1|||
48397280|NCT03311711|155648195|FG002|Overall Study|Withdrawal by Subject|0|||
48397281|NCT03311711|155648196|FG003|Overall Study|Withdrawal by Subject|0|||
48397282|NCT03311711|155648197|FG004|Overall Study|Withdrawal by Subject|0|||
48397283|NCT03311711|155648198|FG005|Overall Study|Withdrawal by Subject|0|||
48397284|NCT03311711|155648199|FG006|Overall Study|Withdrawal by Subject|3|||
48397285|NCT03311711|155648200|FG007|Overall Study|Withdrawal by Subject|3|||
48397286|NCT03311711|155648201|FG008|Overall Study|Withdrawal by Subject|0|||
48397287|NCT03311711|155648202|FG009|Overall Study|Withdrawal by Subject|0|||
48397288|NCT02325219|155648210|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
48397289|NCT02325219|155648211|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
48397290|NCT02325219|155648212|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
48397291|NCT02325219|155648213|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
48397292|NCT02325219|155648214|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
48397293|NCT02325219|155648210|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
48397294|NCT02325219|155648211|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
48397295|NCT02325219|155648212|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48397296|NCT02325219|155648213|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48397297|NCT02325219|155648214|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
48397298|NCT02325219|155648210|FG000|Controlled Period (Week 0 - 16)|Other|0|||
48397299|NCT02325219|155648211|FG001|Controlled Period (Week 0 - 16)|Other|0|||
48397300|NCT02325219|155648212|FG002|Controlled Period (Week 0 - 16)|Other|1|||
48397301|NCT02325219|155648213|FG003|Controlled Period (Week 0 - 16)|Other|0|||
48397302|NCT02325219|155648214|FG004|Controlled Period (Week 0 - 16)|Other|0|||
48397303|NCT02325219|155648210|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
48397304|NCT02325219|155648211|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
48778693|NCT02610140|157032710|FG000|Safety Follow-up|Lost to Follow-up|1|||
48778694|NCT02610140|157032711|FG001|Safety Follow-up|Lost to Follow-up|0|||
48397305|NCT02325219|155648212|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
48397306|NCT02325219|155648213|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
48778695|NCT02610140|157032710|FG000|Safety Follow-up|No follow-up|5|||
48778696|NCT02610140|157032711|FG001|Safety Follow-up|No follow-up|3|||
48778697|NCT02610140|157032710|FG000|Safety Follow-up|Death|12|||
48778698|NCT02610140|157032711|FG001|Safety Follow-up|Death|2|||
48397307|NCT02325219|155648214|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
48397308|NCT02325219|155648210|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
48397309|NCT02325219|155648211|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
48397310|NCT02325219|155648212|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
48397311|NCT02325219|155648213|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
48397312|NCT02325219|155648214|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
48397313|NCT02325219|155648210|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48397314|NCT02325219|155648211|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
48397315|NCT02325219|155648212|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48397316|NCT02325219|155648213|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48397317|NCT02325219|155648214|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
48397318|NCT02918864|155648215|FG000|Overall Study|Withdrawal by Subject|1|||
48397319|NCT02918864|155648216|FG001|Overall Study|Withdrawal by Subject|1|||
48397320|NCT02918864|155648215|FG000|Overall Study|Lost to Follow-up|3|||
48397321|NCT02918864|155648216|FG001|Overall Study|Lost to Follow-up|2|||
48397322|NCT00082888|155648217|FG000|Overall Study|Ineligible|1|||
48397323|NCT00082888|155648218|FG001|Overall Study|Ineligible|0|||
48397324|NCT00082888|155648219|FG002|Overall Study|Ineligible|0|||
48397325|NCT00975156|155648229|FG000|Overall Study|Protocol Violation|0|||
48397326|NCT00975156|155648230|FG001|Overall Study|Protocol Violation|1|||
48397327|NCT02646982|155648232|FG000|Overall Study|Adverse Event|1|||
48397328|NCT02646982|155648233|FG001|Overall Study|Adverse Event|1|||
48397329|NCT02646982|155648232|FG000|Overall Study|Withdrawal by Subject|2|||
48397330|NCT02646982|155648233|FG001|Overall Study|Withdrawal by Subject|1|||
48397331|NCT04169373|155648234|FG000|Week 1 to Week 14|Adverse Event|1|||
48397332|NCT04169373|155648235|FG001|Week 1 to Week 14|Adverse Event|0|||
48397333|NCT04169373|155648236|FG002|Week 1 to Week 14|Adverse Event|1|||
48397334|NCT04169373|155648237|FG003|Week 1 to Week 14|Adverse Event|2|||
48778699|NCT02610140|157032710|FG000|Safety Follow-up|Deterioration of general conditions|15|||
48778700|NCT02610140|157032711|FG001|Safety Follow-up|Deterioration of general conditions|5|||
48778701|NCT02610140|157032710|FG000|Safety Follow-up|Withdrawal by Subject|12|||
48778702|NCT02610140|157032711|FG001|Safety Follow-up|Withdrawal by Subject|12|||
48778703|NCT02610140|157032710|FG000|Active Follow-up|Progressive disease - radiological|30|||
48778704|NCT02610140|157032711|FG001|Active Follow-up|Progressive disease - radiological|22|||
48778705|NCT02610140|157032710|FG000|Active Follow-up|Death|8|||
48778706|NCT02610140|157032711|FG001|Active Follow-up|Death|1|||
48778707|NCT02610140|157032710|FG000|Active Follow-up|Withdrawal by Subject|4|||
48778708|NCT02610140|157032711|FG001|Active Follow-up|Withdrawal by Subject|0|||
48778709|NCT02610140|157032710|FG000|Active Follow-up|Progressive disease - clinical|1|||
48778710|NCT02610140|157032711|FG001|Active Follow-up|Progressive disease - clinical|2|||
48778711|NCT02610140|157032710|FG000|Active Follow-up|Deterioration of general conditions|1|||
48778712|NCT02610140|157032711|FG001|Active Follow-up|Deterioration of general conditions|0|||
48778713|NCT02610140|157032710|FG000|Active Follow-up|Ongoing but not completed|4|||
48778714|NCT02610140|157032711|FG001|Active Follow-up|Ongoing but not completed|1|||
48778715|NCT02610140|157032710|FG000|Long-term Follow-up|Death|86|||
48778716|NCT02610140|157032711|FG001|Long-term Follow-up|Death|44|||
48778717|NCT02610140|157032710|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
48778718|NCT02610140|157032711|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
48778719|NCT02610140|157032710|FG000|Long-term Follow-up|Lost to Follow-up|1|||
48778720|NCT02610140|157032711|FG001|Long-term Follow-up|Lost to Follow-up|2|||
48778721|NCT02610140|157032710|FG000|Long-term Follow-up|Ongoing but not completed|30|||
48778722|NCT02610140|157032711|FG001|Long-term Follow-up|Ongoing but not completed|17|||
48778723|NCT01827904|157032712|FG000|Main Study|Withdrawal by Subject|1|||
48778724|NCT01827904|157032713|FG001|Main Study|Withdrawal by Subject|0|||
48778725|NCT01827904|157032714|FG002|Main Study|Withdrawal by Subject|0|||
48778726|NCT01827904|157032712|FG000|Main Study|Adverse Event|1|||
48778727|NCT01827904|157032713|FG001|Main Study|Adverse Event|0|||
48778728|NCT01827904|157032714|FG002|Main Study|Adverse Event|0|||
48778729|NCT01827904|157032712|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
48778730|NCT01827904|157032713|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
48778731|NCT01827904|157032714|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
48778732|NCT01827904|157032712|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
48778733|NCT01827904|157032713|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
48778734|NCT01827904|157032714|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
48778735|NCT01827904|157032712|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
48397335|NCT04169373|155648234|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
48397336|NCT04169373|155648235|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
48397337|NCT04169373|155648236|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
48397338|NCT04169373|155648237|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
48397339|NCT04169373|155648234|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
48778736|NCT01827904|157032713|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
48778737|NCT01827904|157032714|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
48778738|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
48397340|NCT04169373|155648235|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
48397341|NCT04169373|155648236|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
48397342|NCT04169373|155648237|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
48397343|NCT04169373|155648234|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
48397344|NCT04169373|155648235|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
48397345|NCT04169373|155648236|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
48397346|NCT04169373|155648237|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
48397347|NCT04169373|155648234|FG000|Week 1 to Week 14|Other|1|||
48397348|NCT04169373|155648235|FG001|Week 1 to Week 14|Other|3|||
48397349|NCT04169373|155648236|FG002|Week 1 to Week 14|Other|3|||
48397350|NCT04169373|155648237|FG003|Week 1 to Week 14|Other|5|||
48397351|NCT04169373|155648234|FG000|Week 14 to Week 52|Adverse Event|1|||
48397352|NCT04169373|155648235|FG001|Week 14 to Week 52|Adverse Event|0|||
48397353|NCT04169373|155648236|FG002|Week 14 to Week 52|Adverse Event|0|||
48397354|NCT04169373|155648237|FG003|Week 14 to Week 52|Adverse Event|1|||
48397355|NCT04169373|155648234|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
48397356|NCT04169373|155648235|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
48397357|NCT04169373|155648236|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
48397358|NCT04169373|155648237|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
48397359|NCT04169373|155648234|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
48397360|NCT04169373|155648235|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
48397361|NCT04169373|155648236|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
48397362|NCT04169373|155648237|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
48397363|NCT04169373|155648234|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
48397364|NCT04169373|155648235|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
48397365|NCT04169373|155648236|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
48397366|NCT04169373|155648237|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
48397367|NCT04169373|155648234|FG000|Week 14 to Week 52|Other|4|||
48397368|NCT04169373|155648235|FG001|Week 14 to Week 52|Other|5|||
48397369|NCT04169373|155648236|FG002|Week 14 to Week 52|Other|4|||
48397370|NCT04169373|155648237|FG003|Week 14 to Week 52|Other|5|||
48397371|NCT04169373|155648234|FG000|Week 14 to Week 52|Ongoing|0|||
48397372|NCT04169373|155648235|FG001|Week 14 to Week 52|Ongoing|1|||
48397373|NCT04169373|155648236|FG002|Week 14 to Week 52|Ongoing|0|||
48397374|NCT04169373|155648237|FG003|Week 14 to Week 52|Ongoing|0|||
48397375|NCT01294670|155648240|FG000|Overall Study|Not treated|1|||
48397376|NCT01294670|155648241|FG001|Overall Study|Not treated|0|||
48397377|NCT01294670|155648242|FG002|Overall Study|Not treated|0|||
48397378|NCT01294670|155648243|FG003|Overall Study|Not treated|0|||
48397379|NCT01294670|155648244|FG004|Overall Study|Not treated|0|||
48397380|NCT00661531|155648245|FG000|Overall Study|Withdrawal by Subject|3|||
48397381|NCT02669017|155648247|FG000|Overall Study|Death|1|||
48397382|NCT02669017|155648248|FG001|Overall Study|Death|2|||
48397383|NCT02669017|155648249|FG002|Overall Study|Death|2|||
48397384|NCT02669017|155648250|FG003|Overall Study|Death|3|||
48397385|NCT02669017|155648251|FG004|Overall Study|Death|8|||
48397386|NCT02669017|155648252|FG005|Overall Study|Death|18|||
48397387|NCT02669017|155648253|FG006|Overall Study|Death|10|||
48397388|NCT02669017|155648254|FG007|Overall Study|Death|47|||
48397389|NCT02669017|155648255|FG008|Overall Study|Death|20|||
48397390|NCT02669017|155648247|FG000|Overall Study|Withdrawal by Subject|0|||
48397391|NCT02669017|155648248|FG001|Overall Study|Withdrawal by Subject|0|||
48397392|NCT02669017|155648249|FG002|Overall Study|Withdrawal by Subject|0|||
48397393|NCT02669017|155648250|FG003|Overall Study|Withdrawal by Subject|1|||
48397394|NCT02669017|155648251|FG004|Overall Study|Withdrawal by Subject|2|||
48397395|NCT02669017|155648252|FG005|Overall Study|Withdrawal by Subject|0|||
48397396|NCT02669017|155648253|FG006|Overall Study|Withdrawal by Subject|0|||
48397397|NCT02669017|155648254|FG007|Overall Study|Withdrawal by Subject|2|||
48397398|NCT02669017|155648255|FG008|Overall Study|Withdrawal by Subject|2|||
48397399|NCT02669017|155648247|FG000|Overall Study|Lost to Follow-up|0|||
48397400|NCT02669017|155648248|FG001|Overall Study|Lost to Follow-up|0|||
48397401|NCT02669017|155648249|FG002|Overall Study|Lost to Follow-up|0|||
48397402|NCT02669017|155648250|FG003|Overall Study|Lost to Follow-up|0|||
48397403|NCT02669017|155648251|FG004|Overall Study|Lost to Follow-up|0|||
48397404|NCT02669017|155648252|FG005|Overall Study|Lost to Follow-up|0|||
48397405|NCT02669017|155648253|FG006|Overall Study|Lost to Follow-up|0|||
48397406|NCT02669017|155648254|FG007|Overall Study|Lost to Follow-up|0|||
48397407|NCT02669017|155648255|FG008|Overall Study|Lost to Follow-up|1|||
48397408|NCT02669017|155648247|FG000|Overall Study|Miscellaneous|0|||
48397409|NCT02669017|155648248|FG001|Overall Study|Miscellaneous|0|||
48397410|NCT02669017|155648249|FG002|Overall Study|Miscellaneous|0|||
48397411|NCT02669017|155648250|FG003|Overall Study|Miscellaneous|0|||
48397412|NCT02669017|155648251|FG004|Overall Study|Miscellaneous|2|||
48397413|NCT02669017|155648252|FG005|Overall Study|Miscellaneous|1|||
48397414|NCT02669017|155648253|FG006|Overall Study|Miscellaneous|1|||
48397415|NCT02669017|155648254|FG007|Overall Study|Miscellaneous|13|||
48397416|NCT02669017|155648255|FG008|Overall Study|Miscellaneous|2|||
48778739|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
48778740|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
48778741|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
48778742|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
48778743|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
48778744|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
48778745|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
48778746|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
48778747|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
48778748|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
48778749|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
48778750|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Physician Decision|1|||
48778751|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Physician Decision|0|||
48778752|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Physician Decision|0|||
48778753|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
48778754|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
48778755|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
48778756|NCT01827904|157032712|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
48778757|NCT01827904|157032713|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
48778758|NCT01827904|157032714|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
48397417|NCT01146873|155648258|FG000|Overall Study|Transfer out|0|||
48397418|NCT01146873|155648259|FG001|Overall Study|Transfer out|6|||
48397419|NCT01379274|155648260|FG000|Overall Study|funding withdrawn|1|||
48778759|NCT03221257|157032718|FG000|Overall Study|Lost to Follow-up|0|||
48778760|NCT03221257|157032719|FG001|Overall Study|Lost to Follow-up|1|||
48778761|NCT03221257|157032718|FG000|Overall Study|Withdrawal by Subject|1|||
48778762|NCT03221257|157032719|FG001|Overall Study|Withdrawal by Subject|1|||
48778763|NCT02207829|157032720|FG000|Overall Study|Adverse Event|10|||
48397420|NCT01650636|155648261|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
48397421|NCT01650636|155648262|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
48397422|NCT01650636|155648261|FG000|Washout up to 5 Months|Physician Decision|2|||
48397423|NCT01650636|155648262|FG001|Washout up to 5 Months|Physician Decision|2|||
48397424|NCT01650636|155648261|FG000|Washout up to 5 Months|Death|1|||
48397425|NCT01650636|155648262|FG001|Washout up to 5 Months|Death|0|||
48397426|NCT01650636|155648261|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
48397427|NCT01650636|155648262|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
48397428|NCT01650636|155648261|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
48397429|NCT01650636|155648262|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
48397430|NCT01650636|155648261|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
48397431|NCT01650636|155648262|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
48397432|NCT00811135|155648263|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
48397433|NCT00811135|155648263|FG000|Overall Study|Death|3|||
48397434|NCT00811135|155648263|FG000|Overall Study|Protocol Violation|2|||
48397435|NCT00811135|155648263|FG000|Overall Study|Violation of Selection Criteria|1|||
48397436|NCT00811135|155648263|FG000|Overall Study|Refused Treatment|1|||
48397437|NCT00811135|155648263|FG000|Overall Study|Withdrawal by Subject|3|||
48397438|NCT00811135|155648263|FG000|Overall Study|Administrative/Other Unspecified|11|||
48397439|NCT00811135|155648263|FG000|Overall Study|Ongoing|59|||
48397440|NCT03655756|155648274|FG000|Overall Study|Death|1|||
48397441|NCT01263639|155648275|FG000|Overall Study|Lost to Follow-up|66|||
48397442|NCT01263639|155648276|FG001|Overall Study|Lost to Follow-up|70|||
48397443|NCT01263639|155648275|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
48397444|NCT01263639|155648276|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
48397445|NCT01965262|155648285|FG000|Second Intervention (7 Days)|Discontinued|0|||
48778764|NCT02207829|157032721|FG001|Overall Study|Adverse Event|9|||
48397446|NCT01965262|155648286|FG001|Second Intervention (7 Days)|Discontinued|1|||
48778765|NCT02207829|157032720|FG000|Overall Study|Lack of Efficacy|7|||
48778766|NCT02207829|157032721|FG001|Overall Study|Lack of Efficacy|5|||
48778767|NCT02207829|157032720|FG000|Overall Study|Lost to Follow-up|2|||
48778768|NCT02207829|157032721|FG001|Overall Study|Lost to Follow-up|2|||
48397447|NCT01965262|155648285|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
48397448|NCT01965262|155648286|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
48397449|NCT01965262|155648285|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
48397450|NCT01965262|155648286|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
48778769|NCT02207829|157032720|FG000|Overall Study|Protocol deviation|5|||
48397451|NCT03728309|155648292|FG000|Overall Study|Randomized but not Treated|0|||
48397452|NCT03728309|155648293|FG001|Overall Study|Randomized but not Treated|1|||
48397453|NCT03728309|155648292|FG000|Overall Study|Adverse Event|0|||
48397454|NCT03728309|155648293|FG001|Overall Study|Adverse Event|1|||
48397455|NCT03728309|155648292|FG000|Overall Study|Withdrawal by Subject|2|||
48397456|NCT03728309|155648293|FG001|Overall Study|Withdrawal by Subject|8|||
48397457|NCT03728309|155648292|FG000|Overall Study|Lost to Follow-up|9|||
48397458|NCT03728309|155648293|FG001|Overall Study|Lost to Follow-up|10|||
48397459|NCT03728309|155648292|FG000|Overall Study|Protocol Deviation|0|||
48397460|NCT03728309|155648293|FG001|Overall Study|Protocol Deviation|1|||
48397461|NCT03728309|155648292|FG000|Overall Study|Due to COVID|1|||
48397462|NCT03728309|155648293|FG001|Overall Study|Due to COVID|3|||
48397463|NCT01265550|155648294|FG000|Pre Randomization|Withdrawal by Subject|0|||
48397464|NCT01265550|155648295|FG001|Pre Randomization|Withdrawal by Subject|0|||
48397465|NCT01265550|155648296|FG002|Pre Randomization|Withdrawal by Subject|0|||
48397466|NCT01265550|155648297|FG003|Pre Randomization|Withdrawal by Subject|70|||
48397467|NCT01265550|155648294|FG000|Pre Randomization|Technical Exclusions|0|||
48397468|NCT01265550|155648295|FG001|Pre Randomization|Technical Exclusions|0|||
48397469|NCT01265550|155648296|FG002|Pre Randomization|Technical Exclusions|0|||
48397470|NCT01265550|155648297|FG003|Pre Randomization|Technical Exclusions|54|||
48397471|NCT01265550|155648294|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
48397472|NCT01265550|155648295|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
48397473|NCT01265550|155648296|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
48778770|NCT02207829|157032721|FG001|Overall Study|Protocol deviation|4|||
48778771|NCT02207829|157032720|FG000|Overall Study|Withdrew consent|18|||
48778772|NCT02207829|157032721|FG001|Overall Study|Withdrew consent|14|||
48778773|NCT00129259|157032722|FG000|Overall Study|Lost to Follow-up|1|||
48778774|NCT00129259|157032723|FG001|Overall Study|Lost to Follow-up|1|||
48778775|NCT00129259|157032722|FG000|Overall Study|Withdrawal by Subject|2|||
48778776|NCT00129259|157032723|FG001|Overall Study|Withdrawal by Subject|1|||
48778777|NCT00129259|157032722|FG000|Overall Study|Only available minimal phone assessments|0|||
48778778|NCT00129259|157032723|FG001|Overall Study|Only available minimal phone assessments|1|||
48778779|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778780|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778781|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778782|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778783|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778784|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778785|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778786|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778787|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778788|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778789|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778790|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
48778791|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778792|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778793|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778794|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
48778795|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48778796|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
48778797|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
48778798|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
48778799|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
48778800|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
48778801|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
48778802|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
48778803|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
48397474|NCT01265550|155648297|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
48397475|NCT01265550|155648294|FG000|Pre Randomization|Non-GERD organic disorders|0|||
48397476|NCT01265550|155648295|FG001|Pre Randomization|Non-GERD organic disorders|0|||
48397477|NCT01265550|155648296|FG002|Pre Randomization|Non-GERD organic disorders|0|||
48397478|NCT01265550|155648297|FG003|Pre Randomization|Non-GERD organic disorders|23|||
48397479|NCT01265550|155648294|FG000|Pre Randomization|Functional heartburn|0|||
48778804|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
48778805|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
48778806|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
48778807|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48778808|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48778809|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48778810|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
48397480|NCT01265550|155648295|FG001|Pre Randomization|Functional heartburn|0|||
48397481|NCT01265550|155648296|FG002|Pre Randomization|Functional heartburn|0|||
48397482|NCT01265550|155648297|FG003|Pre Randomization|Functional heartburn|99|||
48397483|NCT00408694|155648298|FG000|Overall Study|Ineligible|1|||
48397484|NCT00408694|155648298|FG000|Overall Study|No protocol treatment|1|||
48778811|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778812|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778813|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778814|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778815|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778816|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
48778817|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
48778818|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778819|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778820|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
48778821|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
48778822|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
48778823|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778824|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778825|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778826|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
48778827|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778828|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778829|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778830|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778831|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778832|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
48778833|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778834|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778835|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778836|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778837|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778838|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
48778839|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778840|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778841|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778842|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
48778843|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778844|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778845|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778846|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778847|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778848|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
48778849|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778850|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778851|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778852|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778853|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778854|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778855|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778856|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778857|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778858|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
48778859|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778860|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778861|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778862|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778863|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778864|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48397485|NCT01687712|155648302|FG000|Cycle 1|Not Biochemically Pregnant|386|||
48397486|NCT01687712|155648303|FG001|Cycle 1|Not Biochemically Pregnant|348|||
48397487|NCT01687712|155648302|FG000|Cycle 1|Early Pregnancy Loss|43|||
48778865|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778866|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778867|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
48778868|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48397488|NCT01687712|155648303|FG001|Cycle 1|Early Pregnancy Loss|60|||
48397489|NCT01687712|155648302|FG000|Cycle 1|Ectopic Pregnancy|5|||
48397490|NCT01687712|155648303|FG001|Cycle 1|Ectopic Pregnancy|5|||
48397491|NCT01687712|155648302|FG000|Cycle 1|Heterotropic Pregnancy|1|||
48397492|NCT01687712|155648303|FG001|Cycle 1|Heterotropic Pregnancy|0|||
48397493|NCT01687712|155648302|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
48397494|NCT01687712|155648303|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
48397495|NCT01687712|155648302|FG000|Cycle 1|Abortion|3|||
48397496|NCT01687712|155648303|FG001|Cycle 1|Abortion|0|||
48397497|NCT01687712|155648302|FG000|Cycle 1|Intrauterine Fetal Death|0|||
48397498|NCT01687712|155648303|FG001|Cycle 1|Intrauterine Fetal Death|1|||
48397499|NCT01687712|155648302|FG000|Cycle 1|Lost to Follow-up|1|||
48397500|NCT01687712|155648303|FG001|Cycle 1|Lost to Follow-up|1|||
48397501|NCT01687712|155648302|FG000|Cycle 2|Not Biochemically Pregnant|74|||
48397502|NCT01687712|155648303|FG001|Cycle 2|Not Biochemically Pregnant|77|||
48778869|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778870|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778871|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778872|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778873|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778874|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
48778875|NCT01609556|157032724|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
48778876|NCT01609556|157032725|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778877|NCT01609556|157032726|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778878|NCT01609556|157032727|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778879|NCT01609556|157032728|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778880|NCT01609556|157032729|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
48778881|NCT01609556|157032730|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778882|NCT01609556|157032731|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778883|NCT01609556|157032732|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778884|NCT01609556|157032733|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778885|NCT01609556|157032734|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
48778886|NCT01609556|157032735|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778887|NCT01609556|157032736|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778888|NCT01609556|157032737|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778889|NCT01609556|157032738|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778890|NCT01609556|157032739|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
48778891|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778892|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778893|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778894|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778895|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778896|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778897|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778898|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778899|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778900|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778901|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778902|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
48778903|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
48778904|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
48778905|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
48397503|NCT01687712|155648302|FG000|Cycle 2|Early Pregnancy Loss|18|||
48397504|NCT01687712|155648303|FG001|Cycle 2|Early Pregnancy Loss|16|||
48397505|NCT01687712|155648302|FG000|Cycle 2|Ectopic Pregnancy|0|||
48397506|NCT01687712|155648303|FG001|Cycle 2|Ectopic Pregnancy|1|||
48397507|NCT01687712|155648302|FG000|Cycle 2|Still Birth|1|||
48397508|NCT01687712|155648303|FG001|Cycle 2|Still Birth|0|||
48397509|NCT01687712|155648302|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
48397510|NCT01687712|155648303|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
48397511|NCT01687712|155648302|FG000|Cycle 3|Not Biochemically Pregnant|21|||
48397512|NCT01687712|155648303|FG001|Cycle 3|Not Biochemically Pregnant|22|||
48397513|NCT01687712|155648302|FG000|Cycle 3|Early Pregnancy Loss|1|||
48397514|NCT01687712|155648303|FG001|Cycle 3|Early Pregnancy Loss|2|||
48397515|NCT01687712|155648302|FG000|Cycle 3|Ectopic Pregnancy|1|||
48397516|NCT01687712|155648303|FG001|Cycle 3|Ectopic Pregnancy|0|||
48397517|NCT01687712|155648302|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
48778906|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
48778907|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48397518|NCT01687712|155648303|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
48397519|NCT02573155|155648304|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
48397520|NCT02573155|155648305|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
48778908|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48397521|NCT02573155|155648304|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
48397522|NCT02573155|155648305|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
48397523|NCT02573155|155648304|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
48397524|NCT02573155|155648305|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
48397525|NCT02573155|155648304|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
48397526|NCT02573155|155648305|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
48397527|NCT02573155|155648304|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
48778909|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778910|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778911|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778912|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778913|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778914|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778915|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778916|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778917|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48778918|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
48397528|NCT02573155|155648305|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
48778919|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
48778920|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
48778921|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
48778922|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
48778923|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778924|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778925|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778926|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778927|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778928|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778929|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778930|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778931|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778932|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778933|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778934|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
48778935|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
48397529|NCT02573155|155648304|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
48397530|NCT02573155|155648305|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
48397531|NCT02573155|155648304|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
48397532|NCT02573155|155648305|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
48397533|NCT02573155|155648304|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
48397534|NCT02573155|155648305|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
48397535|NCT00512798|155648308|FG000|Overall Study|Death|0|||
48397536|NCT00512798|155648309|FG001|Overall Study|Death|3|||
48397537|NCT00512798|155648308|FG000|Overall Study|Adverse Event|2|||
48397538|NCT00512798|155648309|FG001|Overall Study|Adverse Event|4|||
48397539|NCT00512798|155648308|FG000|Overall Study|Progression of disease|14|||
48397540|NCT00512798|155648309|FG001|Overall Study|Progression of disease|20|||
48397541|NCT00512798|155648308|FG000|Overall Study|Withdrawal by Subject|3|||
48397542|NCT00512798|155648309|FG001|Overall Study|Withdrawal by Subject|0|||
48397543|NCT03434379|155648317|FG000|Global Period|Lost to Follow-up|3|||
48397544|NCT03434379|155648318|FG001|Global Period|Lost to Follow-up|6|||
48397545|NCT03434379|155648319|FG002|Global Period|Lost to Follow-up|0|||
48397546|NCT03434379|155648320|FG003|Global Period|Lost to Follow-up|0|||
48397547|NCT03434379|155648317|FG000|Global Period|Death|115|||
48397548|NCT03434379|155648318|FG001|Global Period|Death|228|||
48397549|NCT03434379|155648319|FG002|Global Period|Death|0|||
48397550|NCT03434379|155648320|FG003|Global Period|Death|0|||
48397551|NCT03434379|155648317|FG000|Global Period|Withdrawal by Subject|20|||
48397552|NCT03434379|155648318|FG001|Global Period|Withdrawal by Subject|21|||
48397553|NCT03434379|155648319|FG002|Global Period|Withdrawal by Subject|0|||
48397554|NCT03434379|155648320|FG003|Global Period|Withdrawal by Subject|0|||
48397555|NCT03434379|155648317|FG000|Global Period|Reason Unspecified|0|||
48778936|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
48778937|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
48778938|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
48778939|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778940|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778941|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778942|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778943|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778944|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778945|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778946|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778947|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778948|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778949|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778950|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778951|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
48778952|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778953|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778954|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
48778955|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778956|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778957|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778958|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778959|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778960|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778961|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778962|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778963|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778964|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778965|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778966|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
48778967|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
48778968|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
48778969|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
48778970|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
48778971|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778972|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778973|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778974|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778975|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778976|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778977|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778978|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48397556|NCT03434379|155648318|FG001|Global Period|Reason Unspecified|1|||
48397557|NCT03434379|155648319|FG002|Global Period|Reason Unspecified|0|||
48397558|NCT03434379|155648320|FG003|Global Period|Reason Unspecified|0|||
48397559|NCT03434379|155648317|FG000|Global Period|Study Ended by Sponsor|26|||
48397560|NCT03434379|155648318|FG001|Global Period|Study Ended by Sponsor|80|||
48397561|NCT03434379|155648319|FG002|Global Period|Study Ended by Sponsor|0|||
48397562|NCT03434379|155648320|FG003|Global Period|Study Ended by Sponsor|0|||
48397563|NCT03434379|155648317|FG000|Global Period|Physician Decision|1|||
48397564|NCT03434379|155648318|FG001|Global Period|Physician Decision|0|||
48397565|NCT03434379|155648319|FG002|Global Period|Physician Decision|0|||
48397566|NCT03434379|155648320|FG003|Global Period|Physician Decision|0|||
48397567|NCT03434379|155648317|FG000|China Extension Period|Lost to Follow-up|0|||
48397568|NCT03434379|155648318|FG001|China Extension Period|Lost to Follow-up|0|||
48397569|NCT03434379|155648319|FG002|China Extension Period|Lost to Follow-up|2|||
48397570|NCT03434379|155648320|FG003|China Extension Period|Lost to Follow-up|3|||
48397571|NCT03434379|155648317|FG000|China Extension Period|Death|0|||
48397572|NCT03434379|155648318|FG001|China Extension Period|Death|0|||
48397573|NCT03434379|155648319|FG002|China Extension Period|Death|46|||
48778979|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778980|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48397574|NCT03434379|155648320|FG003|China Extension Period|Death|88|||
48397575|NCT03434379|155648317|FG000|China Extension Period|Withdrawal by Subject|0|||
48397576|NCT03434379|155648318|FG001|China Extension Period|Withdrawal by Subject|0|||
48430341|NCT00696657|155763704|FG004|Overall Study|Lack of Efficacy|0|||
48778981|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778982|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778983|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778984|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778985|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
48778986|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
48778987|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778988|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778989|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778990|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778991|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778992|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778993|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778994|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778995|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778996|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778997|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778998|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
48778999|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
48779000|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
48779001|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
48779002|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
48779003|NCT01609556|157032724|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779004|NCT01609556|157032725|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779005|NCT01609556|157032726|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779006|NCT01609556|157032727|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779007|NCT01609556|157032728|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779008|NCT01609556|157032729|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779009|NCT01609556|157032730|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779010|NCT01609556|157032731|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48397577|NCT03434379|155648319|FG002|China Extension Period|Withdrawal by Subject|8|||
48397578|NCT03434379|155648320|FG003|China Extension Period|Withdrawal by Subject|6|||
48397579|NCT03434379|155648317|FG000|China Extension Period|Study Ended by Sponsor|0|||
48397580|NCT03434379|155648318|FG001|China Extension Period|Study Ended by Sponsor|0|||
48397581|NCT03434379|155648319|FG002|China Extension Period|Study Ended by Sponsor|5|||
48779011|NCT01609556|157032732|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779012|NCT01609556|157032733|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779013|NCT01609556|157032734|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779014|NCT01609556|157032735|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779015|NCT01609556|157032736|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
48779016|NCT01609556|157032737|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779017|NCT01609556|157032738|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779018|NCT01609556|157032739|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
48779019|NCT02720484|157032743|FG000|Treatment on Study|Adverse Event|1|||
48779020|NCT02720484|157032743|FG000|Treatment on Study|Withdrawal by Subject|1|||
48779021|NCT02720484|157032743|FG000|Treatment on Study|Progressive Disease|4|||
48779022|NCT02720484|157032743|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
48779023|NCT02720484|157032743|FG000|Follow Up for 2 Years|Death|3|||
48779024|NCT02720484|157032743|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
48779025|NCT05070897|157032744|FG000|Overall Study|Protocol Violation|123|||
48779026|NCT05070897|157032745|FG001|Overall Study|Protocol Violation|68|||
48779027|NCT01968434|157032749|FG000|Overall Study|Lost to Follow-up|3|||
48779028|NCT01968434|157032750|FG001|Overall Study|Lost to Follow-up|6|||
48779029|NCT01218646|157032751|FG000|Overall Study|Adverse Event|0|||
48779030|NCT01218646|157032752|FG001|Overall Study|Adverse Event|0|||
48397582|NCT03434379|155648320|FG003|China Extension Period|Study Ended by Sponsor|36|||
48397583|NCT03064841|155648321|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
48397584|NCT03064841|155648321|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
48779031|NCT01218646|157032753|FG002|Overall Study|Adverse Event|1|||
48779032|NCT01218646|157032754|FG003|Overall Study|Adverse Event|0|||
48779033|NCT01218646|157032751|FG000|Overall Study|Lost to Follow-up|1|||
48779034|NCT01218646|157032752|FG001|Overall Study|Lost to Follow-up|0|||
48779035|NCT01218646|157032753|FG002|Overall Study|Lost to Follow-up|0|||
48779036|NCT01218646|157032754|FG003|Overall Study|Lost to Follow-up|0|||
48779037|NCT01218646|157032751|FG000|Overall Study|Protocol Violation|0|||
48779038|NCT01218646|157032752|FG001|Overall Study|Protocol Violation|0|||
48779039|NCT01218646|157032753|FG002|Overall Study|Protocol Violation|1|||
48779040|NCT01218646|157032754|FG003|Overall Study|Protocol Violation|1|||
48779041|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
48779042|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
48779043|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
48779044|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
48779045|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
48779046|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
48779047|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
48779048|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
48779049|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
48779050|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
48779051|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
48779052|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
48779053|NCT03246529|157032758|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
48779054|NCT03246529|157032759|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
48779055|NCT03246529|157032760|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
48779056|NCT03246529|157032758|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
48779057|NCT03246529|157032759|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
48779058|NCT03246529|157032760|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
48779059|NCT03246529|157032758|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
48779060|NCT03246529|157032759|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
48779061|NCT03246529|157032760|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
48779062|NCT03246529|157032758|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
48779063|NCT03246529|157032759|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
48779064|NCT03246529|157032760|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
48779065|NCT03246529|157032758|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
48779066|NCT03246529|157032759|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
48779067|NCT03246529|157032760|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
48779068|NCT02742103|157034461|FG000|Overall Study|Protocol Violation|1|||
48779069|NCT02742103|157034462|FG001|Overall Study|Protocol Violation|0|||
48779070|NCT02742103|157034461|FG000|Overall Study|Death|2|||
48779071|NCT02742103|157034462|FG001|Overall Study|Death|2|||
48779072|NCT02742103|157034461|FG000|Overall Study|Adverse Event|1|||
48779073|NCT02742103|157034462|FG001|Overall Study|Adverse Event|0|||
48779074|NCT02742103|157034461|FG000|Overall Study|Moved to another town|0|||
48779075|NCT02742103|157034462|FG001|Overall Study|Moved to another town|1|||
48779076|NCT02742103|157034461|FG000|Overall Study|Withdrawal by Subject|5|||
48779077|NCT02742103|157034462|FG001|Overall Study|Withdrawal by Subject|2|||
48779078|NCT01818336|157034463|FG000|Overall Study|Declined retest visit|0|||
48779079|NCT01818336|157034464|FG001|Overall Study|Declined retest visit|11|||
48779080|NCT01818336|157034463|FG000|Overall Study|Lost to Follow-up|0|||
48779081|NCT01818336|157034464|FG001|Overall Study|Lost to Follow-up|1|||
48779082|NCT01709318|157034465|FG000|Overall Study|Adverse Event|3|||
48779083|NCT01709318|157034466|FG001|Overall Study|Adverse Event|4|||
48779084|NCT01709318|157034467|FG002|Overall Study|Adverse Event|2|||
48779085|NCT01709318|157034468|FG003|Overall Study|Adverse Event|2|||
48779086|NCT01709318|157034469|FG004|Overall Study|Adverse Event|0|||
48779087|NCT01709318|157034470|FG005|Overall Study|Adverse Event|1|||
48779088|NCT01709318|157034471|FG006|Overall Study|Adverse Event|2|||
48779089|NCT01709318|157034465|FG000|Overall Study|Lost to Follow-up|2|||
48779090|NCT01709318|157034466|FG001|Overall Study|Lost to Follow-up|0|||
48779091|NCT01709318|157034467|FG002|Overall Study|Lost to Follow-up|0|||
48779092|NCT01709318|157034468|FG003|Overall Study|Lost to Follow-up|0|||
48779093|NCT01709318|157034469|FG004|Overall Study|Lost to Follow-up|1|||
48779094|NCT01709318|157034470|FG005|Overall Study|Lost to Follow-up|1|||
48779095|NCT01709318|157034471|FG006|Overall Study|Lost to Follow-up|1|||
48779096|NCT01709318|157034465|FG000|Overall Study|Non-compliance with Study Drug|0|||
48779097|NCT01709318|157034466|FG001|Overall Study|Non-compliance with Study Drug|2|||
48397585|NCT03064841|155648321|FG000|Overall Study|Screen failure|2|||
48397586|NCT03864653|155648324|FG000|Overall Study|Withdrawal by Subject|1|||
48397587|NCT03048422|155648325|FG000|Overall Study|Death|1|||
48397588|NCT03048422|155648326|FG001|Overall Study|Death|0|||
48397589|NCT03048422|155648327|FG002|Overall Study|Death|0|||
48397590|NCT03048422|155648325|FG000|Overall Study|Lost to Follow-up|5|||
48397591|NCT03048422|155648326|FG001|Overall Study|Lost to Follow-up|0|||
48397592|NCT03048422|155648327|FG002|Overall Study|Lost to Follow-up|1|||
48397593|NCT03048422|155648325|FG000|Overall Study|Withdrawal by Subject|5|||
48397594|NCT03048422|155648326|FG001|Overall Study|Withdrawal by Subject|7|||
48779098|NCT01709318|157034467|FG002|Overall Study|Non-compliance with Study Drug|1|||
48397595|NCT03048422|155648327|FG002|Overall Study|Withdrawal by Subject|4|||
48397596|NCT03048422|155648325|FG000|Overall Study|Moved|3|||
48779099|NCT01709318|157034468|FG003|Overall Study|Non-compliance with Study Drug|1|||
48779100|NCT01709318|157034469|FG004|Overall Study|Non-compliance with Study Drug|0|||
48397597|NCT03048422|155648326|FG001|Overall Study|Moved|2|||
48397598|NCT03048422|155648327|FG002|Overall Study|Moved|2|||
48397599|NCT03048422|155648325|FG000|Overall Study|Noncompliant with Study Requirements|2|||
48397600|NCT03048422|155648326|FG001|Overall Study|Noncompliant with Study Requirements|1|||
48397601|NCT03048422|155648327|FG002|Overall Study|Noncompliant with Study Requirements|2|||
48397602|NCT03048422|155648325|FG000|Overall Study|Not Able to Get to Clinic|1|||
48397603|NCT03048422|155648326|FG001|Overall Study|Not Able to Get to Clinic|0|||
48779101|NCT01709318|157034470|FG005|Overall Study|Non-compliance with Study Drug|0|||
48779102|NCT01709318|157034471|FG006|Overall Study|Non-compliance with Study Drug|2|||
48779103|NCT01709318|157034465|FG000|Overall Study|Physician Decision|0|||
48779104|NCT01709318|157034466|FG001|Overall Study|Physician Decision|0|||
48779105|NCT01709318|157034467|FG002|Overall Study|Physician Decision|0|||
48779106|NCT01709318|157034468|FG003|Overall Study|Physician Decision|0|||
48779107|NCT01709318|157034469|FG004|Overall Study|Physician Decision|0|||
48779108|NCT01709318|157034470|FG005|Overall Study|Physician Decision|0|||
48779109|NCT01709318|157034471|FG006|Overall Study|Physician Decision|1|||
48779110|NCT01709318|157034465|FG000|Overall Study|Pregnancy|0|||
48779111|NCT01709318|157034466|FG001|Overall Study|Pregnancy|0|||
48779112|NCT01709318|157034467|FG002|Overall Study|Pregnancy|0|||
48779113|NCT01709318|157034468|FG003|Overall Study|Pregnancy|0|||
48779114|NCT01709318|157034469|FG004|Overall Study|Pregnancy|1|||
48779115|NCT01709318|157034470|FG005|Overall Study|Pregnancy|0|||
48779116|NCT01709318|157034471|FG006|Overall Study|Pregnancy|0|||
48779117|NCT01709318|157034465|FG000|Overall Study|Protocol Violation|0|||
48779118|NCT01709318|157034466|FG001|Overall Study|Protocol Violation|0|||
48779119|NCT01709318|157034467|FG002|Overall Study|Protocol Violation|0|||
48779120|NCT01709318|157034468|FG003|Overall Study|Protocol Violation|0|||
48779121|NCT01709318|157034469|FG004|Overall Study|Protocol Violation|2|||
48779122|NCT01709318|157034470|FG005|Overall Study|Protocol Violation|0|||
48779123|NCT01709318|157034471|FG006|Overall Study|Protocol Violation|1|||
48779124|NCT01709318|157034465|FG000|Overall Study|Technical Problems|1|||
48779125|NCT01709318|157034466|FG001|Overall Study|Technical Problems|0|||
48779126|NCT01709318|157034467|FG002|Overall Study|Technical Problems|0|||
48397604|NCT03048422|155648327|FG002|Overall Study|Not Able to Get to Clinic|0|||
48397605|NCT01984268|155648328|FG000|Overall Study|Study Terminated|15|||
48397606|NCT01314716|155648329|FG000|Double-Blind Phase|Randomized but not treated|1|||
48397607|NCT01314716|155648330|FG001|Double-Blind Phase|Randomized but not treated|1|||
48397608|NCT01314716|155648329|FG000|Double-Blind Phase|Adverse Event|10|||
48397609|NCT01314716|155648330|FG001|Double-Blind Phase|Adverse Event|4|||
48397610|NCT01314716|155648329|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
48397611|NCT01314716|155648330|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
48397612|NCT01314716|155648329|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48397613|NCT01314716|155648330|FG001|Double-Blind Phase|Lost to Follow-up|1|||
48397614|NCT01314716|155648329|FG000|Double-Blind Phase|Sponsor request|1|||
48397615|NCT01314716|155648330|FG001|Double-Blind Phase|Sponsor request|2|||
48397616|NCT01314716|155648329|FG000|Double-Blind Phase|Physician Decision|0|||
48397617|NCT01314716|155648330|FG001|Double-Blind Phase|Physician Decision|1|||
48397618|NCT01314716|155648329|FG000|Open-Label Phase|Adverse Event|4|||
48397619|NCT01314716|155648330|FG001|Open-Label Phase|Adverse Event|6|||
48397620|NCT01314716|155648329|FG000|Open-Label Phase|Withdrawal by Subject|1|||
48397621|NCT01314716|155648330|FG001|Open-Label Phase|Withdrawal by Subject|2|||
48397622|NCT01314716|155648329|FG000|Open-Label Phase|Physician Decision|5|||
48397623|NCT01314716|155648330|FG001|Open-Label Phase|Physician Decision|4|||
48397624|NCT00700271|155648331|FG000|Overall Study|Adverse Event|4|||
48397625|NCT00700271|155648332|FG001|Overall Study|Adverse Event|6|||
48397626|NCT00700271|155648331|FG000|Overall Study|Protocol Violation|1|||
48397627|NCT00700271|155648332|FG001|Overall Study|Protocol Violation|0|||
48397628|NCT00700271|155648331|FG000|Overall Study|Administrative Reasons|1|||
48397629|NCT00700271|155648332|FG001|Overall Study|Administrative Reasons|0|||
48397630|NCT00700271|155648331|FG000|Overall Study|Withdrawal by Subject|6|||
48397631|NCT00700271|155648332|FG001|Overall Study|Withdrawal by Subject|4|||
48397632|NCT00700271|155648331|FG000|Overall Study|Lost to Follow-up|2|||
48397633|NCT00700271|155648332|FG001|Overall Study|Lost to Follow-up|2|||
48397634|NCT04428424|155648334|FG000|Overall Study|Does not meet entrance criteria|132|||
48779127|NCT01709318|157034468|FG003|Overall Study|Technical Problems|0|||
48779128|NCT01709318|157034469|FG004|Overall Study|Technical Problems|0|||
48779129|NCT01709318|157034470|FG005|Overall Study|Technical Problems|0|||
48779130|NCT01709318|157034471|FG006|Overall Study|Technical Problems|0|||
48779131|NCT01709318|157034465|FG000|Overall Study|Withdrawal by Subject|3|||
48779132|NCT01709318|157034466|FG001|Overall Study|Withdrawal by Subject|0|||
48779133|NCT01709318|157034467|FG002|Overall Study|Withdrawal by Subject|3|||
48397635|NCT04428424|155648334|FG000|Overall Study|Lost to Follow-up|115|||
48397636|NCT04818593|155648337|FG000|Overall Study|Low Oocyte Yield|8|||
48779134|NCT01709318|157034468|FG003|Overall Study|Withdrawal by Subject|3|||
48779135|NCT01709318|157034469|FG004|Overall Study|Withdrawal by Subject|0|||
48779136|NCT01709318|157034470|FG005|Overall Study|Withdrawal by Subject|2|||
48779137|NCT01709318|157034471|FG006|Overall Study|Withdrawal by Subject|4|||
48779138|NCT01709318|157034465|FG000|Overall Study|Other Protocol Specified Criteria|0|||
48779139|NCT01709318|157034466|FG001|Overall Study|Other Protocol Specified Criteria|1|||
48779140|NCT01709318|157034467|FG002|Overall Study|Other Protocol Specified Criteria|0|||
48779141|NCT01709318|157034468|FG003|Overall Study|Other Protocol Specified Criteria|0|||
48779142|NCT01709318|157034469|FG004|Overall Study|Other Protocol Specified Criteria|0|||
48779143|NCT01709318|157034470|FG005|Overall Study|Other Protocol Specified Criteria|0|||
48779144|NCT01709318|157034471|FG006|Overall Study|Other Protocol Specified Criteria|0|||
48397637|NCT04818593|155648338|FG001|Overall Study|Low Oocyte Yield|8|||
48397638|NCT04818593|155648337|FG000|Overall Study|Not ICSI Insemination|7|||
48397639|NCT04818593|155648338|FG001|Overall Study|Not ICSI Insemination|7|||
48397640|NCT04818593|155648337|FG000|Overall Study|Poor Sperm Quality|2|||
48397641|NCT04818593|155648338|FG001|Overall Study|Poor Sperm Quality|2|||
48397642|NCT04818593|155648337|FG000|Overall Study|Withdrawal by Subject|2|||
48397643|NCT04818593|155648338|FG001|Overall Study|Withdrawal by Subject|2|||
48397644|NCT04818593|155648337|FG000|Overall Study|Conversion to IUI due to low response|1|||
48397645|NCT04818593|155648338|FG001|Overall Study|Conversion to IUI due to low response|1|||
48397646|NCT01452152|155648339|FG000|Overall Study|Study termination by sponsor|5|||
48397647|NCT01452152|155648340|FG001|Overall Study|Study termination by sponsor|0|||
48397648|NCT01452152|155648341|FG002|Overall Study|Study termination by sponsor|4|||
48397649|NCT01908101|155649840|FG000|Overall Study|Physician Decision|1|||
48397650|NCT01908101|155649840|FG000|Overall Study|Withdrawal by Subject|1|||
48397651|NCT01908101|155649840|FG000|Overall Study|Incorrect Diagnosis|2|||
48397652|NCT01908101|155649840|FG000|Overall Study|Incorrect Starting Dose|1|||
48397653|NCT01908101|155649840|FG000|Overall Study|Did not complete the first cycle|4|||
48397654|NCT01394939|155649843|FG000|Overall Study|Adverse Event|1|||
48397655|NCT01394939|155649844|FG001|Overall Study|Adverse Event|3|||
48397656|NCT01394939|155649845|FG002|Overall Study|Adverse Event|0|||
48397657|NCT01394939|155649846|FG003|Overall Study|Adverse Event|2|||
48397658|NCT01394939|155649843|FG000|Overall Study|Death|0|||
48779145|NCT01083433|157034474|FG000|Overall Study|Lost to Follow-up|2|||
48779146|NCT01083433|157034475|FG001|Overall Study|Lost to Follow-up|1|||
48779147|NCT01083433|157034476|FG002|Overall Study|Lost to Follow-up|1|||
48779148|NCT01083433|157034474|FG000|Overall Study|Withdrawal by Subject|0|||
48779149|NCT01083433|157034475|FG001|Overall Study|Withdrawal by Subject|5|||
48779150|NCT01083433|157034476|FG002|Overall Study|Withdrawal by Subject|3|||
48779151|NCT01083433|157034474|FG000|Overall Study|Pregnancy|0|||
48779152|NCT01083433|157034475|FG001|Overall Study|Pregnancy|0|||
48779153|NCT01083433|157034476|FG002|Overall Study|Pregnancy|1|||
48779154|NCT00982319|157034479|FG000|Overall Study|Surgery date change|1|||
48779155|NCT00982319|157034480|FG001|Overall Study|Surgery date change|0|||
48779156|NCT00982319|157034479|FG000|Overall Study|Preop values out of acceptable range|1|||
48779157|NCT00982319|157034480|FG001|Overall Study|Preop values out of acceptable range|1|||
48779158|NCT00982319|157034479|FG000|Overall Study|Pregnancy|0|||
48779159|NCT00982319|157034480|FG001|Overall Study|Pregnancy|1|||
48779160|NCT02610192|157034481|FG000|Overall Study|Received other treatment|8|||
48779161|NCT02610192|157034481|FG000|Overall Study|Physician Decision|1|||
48779162|NCT01694706|157034482|FG000|Overall Study|Adverse Event|0|||
48779163|NCT01694706|157034483|FG001|Overall Study|Adverse Event|1|||
48779164|NCT01694706|157034484|FG002|Overall Study|Adverse Event|0|||
48779165|NCT01694706|157034482|FG000|Overall Study|other reason not defined above|1|||
48779166|NCT01694706|157034483|FG001|Overall Study|other reason not defined above|0|||
48779167|NCT01694706|157034484|FG002|Overall Study|other reason not defined above|0|||
48779168|NCT01324024|157034485|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
48779169|NCT01324024|157034486|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48779170|NCT00642304|157034501|FG000|Overall Study|Adverse Event|1|||
48779171|NCT00642304|157034501|FG000|Overall Study|Death|1|||
48779172|NCT00642304|157034501|FG000|Overall Study|Blood transfusion|2|||
48779173|NCT00642304|157034501|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
48779174|NCT00642304|157034501|FG000|Overall Study|Transplantation|1|||
48779175|NCT00889421|157034503|FG000|Overall Study|Lack of Efficacy|3|||
48779176|NCT04327934|157034506|FG000|Overall Study|Did not qualify|7|||
48397659|NCT01394939|155649844|FG001|Overall Study|Death|2|||
48779177|NCT04327934|157034507|FG001|Overall Study|Did not qualify|4|||
48779178|NCT04327934|157034506|FG000|Overall Study|Physician Decision|0|||
48779179|NCT04327934|157034507|FG001|Overall Study|Physician Decision|1|||
48397660|NCT01394939|155649845|FG002|Overall Study|Death|0|||
48397661|NCT01394939|155649846|FG003|Overall Study|Death|0|||
48779180|NCT01430130|157034508|FG000|Overall Study|Lost to Follow-up|1|||
48779181|NCT01430130|157034508|FG000|Overall Study|Infection on Control Side of Incision|1|||
48779182|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Adverse Event|3|||
48779183|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Adverse Event|2|||
48397662|NCT01394939|155649843|FG000|Overall Study|Physician Decision|0|||
48397663|NCT01394939|155649844|FG001|Overall Study|Physician Decision|1|||
48397664|NCT01394939|155649845|FG002|Overall Study|Physician Decision|0|||
48397665|NCT01394939|155649846|FG003|Overall Study|Physician Decision|0|||
48779184|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Adverse Event|0|||
48779185|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Adverse Event|0|||
48779186|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Adverse Event|0|||
48779187|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Adverse Event|0|||
48779188|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Adverse Event|0|||
48779189|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
48779190|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
48779191|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779192|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779193|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779194|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779195|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
48779196|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Physician Decision|1|||
48779197|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Physician Decision|0|||
48779198|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Physician Decision|0|||
48779199|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Physician Decision|0|||
48779200|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Physician Decision|0|||
48779201|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Physician Decision|0|||
48779202|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Physician Decision|0|||
48779203|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
48779204|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
48779205|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779206|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779207|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779208|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779209|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
48779210|NCT02265705|157034509|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779211|NCT02265705|157034510|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
48779212|NCT02265705|157034511|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779213|NCT02265705|157034512|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779214|NCT02265705|157034513|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779215|NCT02265705|157034514|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779216|NCT02265705|157034515|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
48779217|NCT02265705|157034509|FG000|Rescue Period|Withdrawal by Subject|0|||
48356422|NCT00150618|155501078|FG003|Overall Study|Physician Decision|0|||
48356423|NCT00150618|155501079|FG004|Overall Study|Physician Decision|1|||
48356424|NCT00150618|155501075|FG000|Overall Study|Lack of compliance|2|||
48779218|NCT02265705|157034510|FG001|Rescue Period|Withdrawal by Subject|0|||
48779219|NCT02265705|157034511|FG002|Rescue Period|Withdrawal by Subject|1|||
48779220|NCT02265705|157034512|FG003|Rescue Period|Withdrawal by Subject|0|||
48779221|NCT02265705|157034513|FG004|Rescue Period|Withdrawal by Subject|0|||
48779222|NCT02265705|157034514|FG005|Rescue Period|Withdrawal by Subject|0|||
48779223|NCT02265705|157034515|FG006|Rescue Period|Withdrawal by Subject|0|||
48779224|NCT02265705|157034509|FG000|Rescue Period|Death|0|||
48779225|NCT02265705|157034510|FG001|Rescue Period|Death|0|||
48779226|NCT02265705|157034511|FG002|Rescue Period|Death|1|||
48779227|NCT02265705|157034512|FG003|Rescue Period|Death|0|||
48779228|NCT02265705|157034513|FG004|Rescue Period|Death|0|||
48779229|NCT02265705|157034514|FG005|Rescue Period|Death|0|||
48779230|NCT02265705|157034515|FG006|Rescue Period|Death|0|||
48779231|NCT02265705|157034509|FG000|Rescue Period|Lack of Efficacy|0|||
48779232|NCT02265705|157034510|FG001|Rescue Period|Lack of Efficacy|0|||
48779233|NCT02265705|157034511|FG002|Rescue Period|Lack of Efficacy|1|||
48779234|NCT02265705|157034512|FG003|Rescue Period|Lack of Efficacy|0|||
48779235|NCT02265705|157034513|FG004|Rescue Period|Lack of Efficacy|0|||
48779236|NCT02265705|157034514|FG005|Rescue Period|Lack of Efficacy|0|||
48779237|NCT02265705|157034515|FG006|Rescue Period|Lack of Efficacy|0|||
48356425|NCT00150618|155501076|FG001|Overall Study|Lack of compliance|1|||
48356426|NCT00150618|155501077|FG002|Overall Study|Lack of compliance|1|||
48356427|NCT00150618|155501078|FG003|Overall Study|Lack of compliance|0|||
48356428|NCT00150618|155501079|FG004|Overall Study|Lack of compliance|1|||
48356429|NCT00150618|155501075|FG000|Overall Study|Abnormal ECG|1|||
48356430|NCT00150618|155501076|FG001|Overall Study|Abnormal ECG|0|||
48356431|NCT00150618|155501077|FG002|Overall Study|Abnormal ECG|0|||
48356432|NCT00150618|155501078|FG003|Overall Study|Abnormal ECG|0|||
48356433|NCT00150618|155501079|FG004|Overall Study|Abnormal ECG|0|||
48356434|NCT00150618|155501075|FG000|Overall Study|Sponsor's decision|0|||
48356435|NCT00150618|155501076|FG001|Overall Study|Sponsor's decision|0|||
48356436|NCT00150618|155501077|FG002|Overall Study|Sponsor's decision|0|||
48356437|NCT00150618|155501078|FG003|Overall Study|Sponsor's decision|1|||
48356438|NCT00150618|155501079|FG004|Overall Study|Sponsor's decision|0|||
48356439|NCT01099917|155501080|FG000|Overall Study|Adverse Event|3|||
48356440|NCT01099917|155501080|FG000|Overall Study|Not Treated|24|||
48356441|NCT02567708|155501081|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
48397666|NCT01394939|155649843|FG000|Overall Study|Withdrawal by Subject|0|||
48397667|NCT01394939|155649844|FG001|Overall Study|Withdrawal by Subject|2|||
48397668|NCT01394939|155649845|FG002|Overall Study|Withdrawal by Subject|0|||
48397669|NCT01394939|155649846|FG003|Overall Study|Withdrawal by Subject|2|||
48397670|NCT01394939|155649843|FG000|Overall Study|Others|0|||
48397671|NCT01394939|155649844|FG001|Overall Study|Others|2|||
48779238|NCT02265705|157034509|FG000|Open Label Period|Adverse Event|0|||
48779239|NCT02265705|157034510|FG001|Open Label Period|Adverse Event|0|||
48779240|NCT02265705|157034511|FG002|Open Label Period|Adverse Event|0|||
48779241|NCT02265705|157034512|FG003|Open Label Period|Adverse Event|2|||
48779242|NCT02265705|157034513|FG004|Open Label Period|Adverse Event|2|||
48779243|NCT02265705|157034514|FG005|Open Label Period|Adverse Event|0|||
48779244|NCT02265705|157034515|FG006|Open Label Period|Adverse Event|0|||
48779245|NCT02265705|157034509|FG000|Open Label Period|Physician Decision|0|||
48779246|NCT02265705|157034510|FG001|Open Label Period|Physician Decision|0|||
48779247|NCT02265705|157034511|FG002|Open Label Period|Physician Decision|0|||
48779248|NCT02265705|157034512|FG003|Open Label Period|Physician Decision|0|||
48779249|NCT02265705|157034513|FG004|Open Label Period|Physician Decision|1|||
48779250|NCT02265705|157034514|FG005|Open Label Period|Physician Decision|0|||
48779251|NCT02265705|157034515|FG006|Open Label Period|Physician Decision|0|||
48779252|NCT02265705|157034509|FG000|Open Label Period|Withdrawal by Subject|0|||
48779253|NCT02265705|157034510|FG001|Open Label Period|Withdrawal by Subject|0|||
48779254|NCT02265705|157034511|FG002|Open Label Period|Withdrawal by Subject|0|||
48779255|NCT02265705|157034512|FG003|Open Label Period|Withdrawal by Subject|0|||
48779256|NCT02265705|157034513|FG004|Open Label Period|Withdrawal by Subject|2|||
48779257|NCT02265705|157034514|FG005|Open Label Period|Withdrawal by Subject|0|||
48779258|NCT02265705|157034515|FG006|Open Label Period|Withdrawal by Subject|0|||
48779259|NCT02265705|157034509|FG000|Follow-up Period|Sponsor Decision|0|||
48779260|NCT02265705|157034510|FG001|Follow-up Period|Sponsor Decision|0|||
48779261|NCT02265705|157034511|FG002|Follow-up Period|Sponsor Decision|0|||
48779262|NCT02265705|157034512|FG003|Follow-up Period|Sponsor Decision|0|||
48779263|NCT02265705|157034513|FG004|Follow-up Period|Sponsor Decision|0|||
48779264|NCT02265705|157034514|FG005|Follow-up Period|Sponsor Decision|1|||
48779265|NCT02265705|157034515|FG006|Follow-up Period|Sponsor Decision|6|||
48779266|NCT02265705|157034509|FG000|Follow-up Period|Adverse Event|0|||
48779267|NCT02265705|157034510|FG001|Follow-up Period|Adverse Event|0|||
48779268|NCT02265705|157034511|FG002|Follow-up Period|Adverse Event|0|||
48779269|NCT02265705|157034512|FG003|Follow-up Period|Adverse Event|0|||
48779270|NCT02265705|157034513|FG004|Follow-up Period|Adverse Event|0|||
48779271|NCT02265705|157034514|FG005|Follow-up Period|Adverse Event|0|||
48779272|NCT02265705|157034515|FG006|Follow-up Period|Adverse Event|3|||
48779273|NCT02265705|157034509|FG000|Follow-up Period|Physician Decision|0|||
48779274|NCT02265705|157034510|FG001|Follow-up Period|Physician Decision|0|||
48779275|NCT02265705|157034511|FG002|Follow-up Period|Physician Decision|0|||
48779276|NCT02265705|157034512|FG003|Follow-up Period|Physician Decision|0|||
48779277|NCT02265705|157034513|FG004|Follow-up Period|Physician Decision|0|||
48779278|NCT02265705|157034514|FG005|Follow-up Period|Physician Decision|0|||
48779279|NCT02265705|157034515|FG006|Follow-up Period|Physician Decision|1|||
48779280|NCT02265705|157034509|FG000|Follow-up Period|Withdrawal by Subject|0|||
48779281|NCT02265705|157034510|FG001|Follow-up Period|Withdrawal by Subject|0|||
48779282|NCT02265705|157034511|FG002|Follow-up Period|Withdrawal by Subject|0|||
48779283|NCT02265705|157034512|FG003|Follow-up Period|Withdrawal by Subject|0|||
48779284|NCT02265705|157034513|FG004|Follow-up Period|Withdrawal by Subject|0|||
48779285|NCT02265705|157034514|FG005|Follow-up Period|Withdrawal by Subject|0|||
48779286|NCT02265705|157034515|FG006|Follow-up Period|Withdrawal by Subject|1|||
48779287|NCT03029208|157034523|FG000|Overall Study|Withdrawal by Subject|2|||
48779288|NCT03029208|157034524|FG001|Overall Study|Withdrawal by Subject|3|||
48779289|NCT03029208|157034523|FG000|Overall Study|Lost to Follow-up|0|||
48779290|NCT03029208|157034524|FG001|Overall Study|Lost to Follow-up|1|||
48779291|NCT01700946|157034525|FG000|Overall Study|Lost to Follow-up|1|||
48779292|NCT01700946|157034526|FG001|Overall Study|Lost to Follow-up|0|||
48779293|NCT01700946|157034525|FG000|Overall Study|Physician Decision|7|||
48779294|NCT01700946|157034526|FG001|Overall Study|Physician Decision|12|||
48779295|NCT01700946|157034525|FG000|Overall Study|Withdrawal by Subject|0|||
48779296|NCT01700946|157034526|FG001|Overall Study|Withdrawal by Subject|2|||
48779297|NCT01700946|157034525|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
48779298|NCT01700946|157034526|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
48779299|NCT01700946|157034525|FG000|Overall Study|Relapse|2|||
48779300|NCT01700946|157034526|FG001|Overall Study|Relapse|1|||
48397672|NCT01394939|155649845|FG002|Overall Study|Others|0|||
48779301|NCT01700946|157034525|FG000|Overall Study|Unacceptable toxicity|1|||
48397673|NCT01394939|155649846|FG003|Overall Study|Others|3|||
48779302|NCT01700946|157034526|FG001|Overall Study|Unacceptable toxicity|0|||
48779303|NCT04177108|157034527|FG000|Overall Study|Withdrawal by Subject|4|||
48779304|NCT04177108|157034528|FG001|Overall Study|Withdrawal by Subject|8|||
48779305|NCT04177108|157034529|FG002|Overall Study|Withdrawal by Subject|9|||
48779306|NCT04177108|157034530|FG003|Overall Study|Withdrawal by Subject|11|||
48779307|NCT04177108|157034531|FG004|Overall Study|Withdrawal by Subject|13|||
48779308|NCT04177108|157034527|FG000|Overall Study|Physician Decision|23|||
48779309|NCT04177108|157034528|FG001|Overall Study|Physician Decision|15|||
48779310|NCT04177108|157034529|FG002|Overall Study|Physician Decision|18|||
48779311|NCT04177108|157034530|FG003|Overall Study|Physician Decision|29|||
48779312|NCT04177108|157034531|FG004|Overall Study|Physician Decision|23|||
48779313|NCT04177108|157034527|FG000|Overall Study|Reason Not Specified|0|||
48779314|NCT04177108|157034528|FG001|Overall Study|Reason Not Specified|1|||
48779315|NCT04177108|157034529|FG002|Overall Study|Reason Not Specified|0|||
48779316|NCT04177108|157034530|FG003|Overall Study|Reason Not Specified|0|||
48779317|NCT04177108|157034531|FG004|Overall Study|Reason Not Specified|2|||
48779318|NCT04177108|157034527|FG000|Overall Study|Lost to Follow-up|0|||
48779319|NCT04177108|157034528|FG001|Overall Study|Lost to Follow-up|0|||
48779320|NCT04177108|157034529|FG002|Overall Study|Lost to Follow-up|1|||
48779321|NCT04177108|157034530|FG003|Overall Study|Lost to Follow-up|1|||
48779322|NCT04177108|157034531|FG004|Overall Study|Lost to Follow-up|1|||
48779323|NCT04177108|157034527|FG000|Overall Study|Death|16|||
48779324|NCT04177108|157034528|FG001|Overall Study|Death|19|||
48779325|NCT04177108|157034529|FG002|Overall Study|Death|13|||
48779326|NCT04177108|157034530|FG003|Overall Study|Death|17|||
48779327|NCT04177108|157034531|FG004|Overall Study|Death|18|||
48779328|NCT00382733|157034534|FG000|Overall Study|Withdrawal by Subject|0|||
48779329|NCT00382733|157034535|FG001|Overall Study|Withdrawal by Subject|1|||
48779330|NCT00382733|157034536|FG002|Overall Study|Withdrawal by Subject|0|||
48779331|NCT00382733|157034537|FG003|Overall Study|Withdrawal by Subject|0|||
48779332|NCT00382733|157034538|FG004|Overall Study|Withdrawal by Subject|0|||
48779333|NCT01458171|157034541|FG000|Overall Study|Adverse Event|1|||
48397674|NCT03670953|155649850|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
48397675|NCT03670953|155649851|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
48397676|NCT03670953|155649852|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
48397677|NCT03670953|155649853|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
48397678|NCT03670953|155649850|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
48397679|NCT03670953|155649851|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
48397680|NCT03670953|155649852|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
48397681|NCT03670953|155649853|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
48397682|NCT03670953|155649850|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
48397683|NCT03670953|155649851|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
48397684|NCT03670953|155649852|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
48397685|NCT03670953|155649853|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
48397686|NCT03670953|155649850|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
48397687|NCT03670953|155649851|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
48397688|NCT03670953|155649852|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
48397689|NCT03670953|155649853|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
48397690|NCT03670953|155649850|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
48397691|NCT03670953|155649851|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
48397692|NCT03670953|155649852|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
48397693|NCT03670953|155649853|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
48397694|NCT03670953|155649850|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
48397695|NCT03670953|155649851|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
48397696|NCT03670953|155649852|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
48397697|NCT03670953|155649853|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
48397698|NCT03670953|155649850|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
48397699|NCT03670953|155649851|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
48397700|NCT03670953|155649852|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
48397701|NCT03670953|155649853|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
48779334|NCT00153101|157034545|FG000|Overall Study|Lost to Follow-up|14|||
48779335|NCT00153101|157034546|FG001|Overall Study|Lost to Follow-up|14|||
48779336|NCT00153101|157034547|FG002|Overall Study|Lost to Follow-up|12|||
48779337|NCT00153101|157034548|FG003|Overall Study|Lost to Follow-up|5|||
48779338|NCT00153101|157034549|FG004|Overall Study|Lost to Follow-up|5|||
48779339|NCT00153101|157034545|FG000|Overall Study|Withdrawal by Subject|3|||
48397702|NCT03670953|155649850|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
48397703|NCT03670953|155649851|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
48397704|NCT03670953|155649852|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
48397705|NCT03670953|155649853|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
48397706|NCT03670953|155649850|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
48779340|NCT00153101|157034546|FG001|Overall Study|Withdrawal by Subject|4|||
48779341|NCT00153101|157034547|FG002|Overall Study|Withdrawal by Subject|3|||
48779342|NCT00153101|157034548|FG003|Overall Study|Withdrawal by Subject|3|||
48779343|NCT00153101|157034549|FG004|Overall Study|Withdrawal by Subject|5|||
48779344|NCT04798586|157034552|FG000|Overall Study|Death|2|||
48779345|NCT01696032|157034558|FG000|Overall Study|Withdrawal by Subject|0|||
48779346|NCT01696032|157034559|FG001|Overall Study|Withdrawal by Subject|0|||
48779347|NCT01696032|157034560|FG002|Overall Study|Withdrawal by Subject|1|||
48397707|NCT03670953|155649851|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
48397708|NCT03670953|155649852|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
48397709|NCT03670953|155649853|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
48397710|NCT03670953|155649850|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
48397711|NCT03670953|155649851|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
48397712|NCT03670953|155649852|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
48397713|NCT03670953|155649853|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
48397714|NCT03670953|155649850|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
48397715|NCT03670953|155649851|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
48397716|NCT03670953|155649852|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
48397717|NCT03670953|155649853|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
48397718|NCT03670953|155649850|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
48397719|NCT03670953|155649851|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
48397720|NCT03670953|155649852|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
48397721|NCT03670953|155649853|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
48397722|NCT03670953|155649850|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
48397723|NCT03670953|155649851|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
48397724|NCT03670953|155649852|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
48397725|NCT03670953|155649853|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
48397726|NCT03670953|155649850|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
48397727|NCT03670953|155649851|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
48397728|NCT03670953|155649852|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
48397729|NCT03670953|155649853|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
48397730|NCT03670953|155649850|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
48397731|NCT03670953|155649851|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
48397732|NCT03670953|155649852|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
48397733|NCT03670953|155649853|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
48397734|NCT03670953|155649850|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
48397735|NCT03670953|155649851|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
48397736|NCT03670953|155649852|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
48397737|NCT03670953|155649853|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
48397738|NCT03670953|155649850|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
48397739|NCT03670953|155649851|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
48397740|NCT03670953|155649852|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
48397741|NCT03670953|155649853|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
48397742|NCT03670953|155649850|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
48397743|NCT03670953|155649851|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
48397744|NCT03670953|155649852|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
48397745|NCT03670953|155649853|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
48397746|NCT00412750|155649855|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48397747|NCT00412750|155649856|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48397748|NCT00412750|155649857|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48397749|NCT00412750|155649855|FG000|Overall Study|Administrative problems|21|||
48397750|NCT00412750|155649856|FG001|Overall Study|Administrative problems|17|||
48397751|NCT00412750|155649857|FG002|Overall Study|Administrative problems|14|||
48397752|NCT00412750|155649855|FG000|Overall Study|Adverse Event|8|||
48397753|NCT00412750|155649856|FG001|Overall Study|Adverse Event|3|||
48397754|NCT00412750|155649857|FG002|Overall Study|Adverse Event|3|||
48397755|NCT00412750|155649855|FG000|Overall Study|Lost to Follow-up|1|||
48397756|NCT00412750|155649856|FG001|Overall Study|Lost to Follow-up|0|||
48397757|NCT00412750|155649857|FG002|Overall Study|Lost to Follow-up|1|||
48397758|NCT00412750|155649855|FG000|Overall Study|Withdrawal by Subject|0|||
48397759|NCT00412750|155649856|FG001|Overall Study|Withdrawal by Subject|1|||
48397760|NCT00412750|155649857|FG002|Overall Study|Withdrawal by Subject|2|||
48397761|NCT00412750|155649855|FG000|Overall Study|Lack of Efficacy|0|||
48397762|NCT00412750|155649856|FG001|Overall Study|Lack of Efficacy|0|||
48397763|NCT00412750|155649857|FG002|Overall Study|Lack of Efficacy|3|||
48397764|NCT02135692|155649863|FG000|Overall Study|Adverse Event|3|||
48397765|NCT02135692|155649863|FG000|Overall Study|Lack of Efficacy|2|||
48397766|NCT02135692|155649863|FG000|Overall Study|Protocol Violation|2|||
48397767|NCT02135692|155649863|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
48397768|NCT02135692|155649863|FG000|Overall Study|Product commercially available|159|||
48397769|NCT02135692|155649863|FG000|Overall Study|Study closed/terminated|153|||
48397770|NCT02135692|155649863|FG000|Overall Study|Lost to Follow-up|4|||
48779348|NCT01696032|157034561|FG003|Overall Study|Withdrawal by Subject|2|||
48779349|NCT01696032|157034558|FG000|Overall Study|Death|14|||
48779350|NCT01696032|157034559|FG001|Overall Study|Death|4|||
48779351|NCT01696032|157034560|FG002|Overall Study|Death|43|||
48779352|NCT01696032|157034561|FG003|Overall Study|Death|18|||
48397771|NCT02135692|155649863|FG000|Overall Study|Withdrawal by Subject|15|||
48779353|NCT01696032|157034558|FG000|Overall Study|Lost to Follow-up|0|||
48779354|NCT01696032|157034559|FG001|Overall Study|Lost to Follow-up|1|||
48779355|NCT01696032|157034560|FG002|Overall Study|Lost to Follow-up|0|||
48779356|NCT01696032|157034561|FG003|Overall Study|Lost to Follow-up|0|||
48779357|NCT01696032|157034558|FG000|Overall Study|Database lock|0|||
48779358|NCT01696032|157034559|FG001|Overall Study|Database lock|1|||
48779359|NCT01696032|157034560|FG002|Overall Study|Database lock|7|||
48779360|NCT01696032|157034561|FG003|Overall Study|Database lock|2|||
48779361|NCT02486406|157034562|FG000|Overall Study|Withdrew consent|1|||
48779362|NCT02486406|157034563|FG001|Overall Study|Withdrew consent|0|||
48779363|NCT02486406|157034564|FG002|Overall Study|Withdrew consent|0|||
48779364|NCT02486406|157034565|FG003|Overall Study|Withdrew consent|1|||
48779365|NCT02486406|157034562|FG000|Overall Study|Lost to Follow-up|1|||
48779366|NCT02486406|157034563|FG001|Overall Study|Lost to Follow-up|3|||
48779367|NCT02486406|157034564|FG002|Overall Study|Lost to Follow-up|1|||
48779368|NCT02486406|157034565|FG003|Overall Study|Lost to Follow-up|3|||
48779369|NCT02486406|157034562|FG000|Overall Study|Other, not specified|0|||
48779370|NCT02486406|157034563|FG001|Overall Study|Other, not specified|0|||
48779371|NCT02486406|157034564|FG002|Overall Study|Other, not specified|1|||
48779372|NCT02486406|157034565|FG003|Overall Study|Other, not specified|0|||
48779373|NCT01826825|157034566|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
48779374|NCT01826825|157034567|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
48779375|NCT00142909|157034568|FG000|Randomization|Various Reasons|7|||
48779376|NCT00142909|157034569|FG001|Randomization|Various Reasons|10|||
48779377|NCT00142909|157034568|FG000|Medications Begin|Protocol Violation|2|||
48779378|NCT00142909|157034569|FG001|Medications Begin|Protocol Violation|0|||
48779379|NCT00142909|157034568|FG000|Medications Begin|Withdrawal by Subject|5|||
48779380|NCT00142909|157034569|FG001|Medications Begin|Withdrawal by Subject|3|||
48779381|NCT00142909|157034568|FG000|Medications Begin|Withdrawal by Subject|2|||
48779382|NCT00142909|157034569|FG001|Medications Begin|Withdrawal by Subject|0|||
48779383|NCT02158039|157034570|FG000|Overall Study|Withdrawal by Subject|1|||
48779384|NCT02158039|157034570|FG000|Overall Study|Screen Failure|9|||
48779385|NCT03062891|157034579|FG000|Overall Study|Withdrawal by Subject|2|||
48779386|NCT03062891|157034580|FG001|Overall Study|Withdrawal by Subject|0|||
48779387|NCT03062891|157034579|FG000|Overall Study|Lost to Follow-up|50|||
48779388|NCT03062891|157034580|FG001|Overall Study|Lost to Follow-up|38|||
48779389|NCT02052466|157034584|FG000|Overall Study|Withdrawal by Subject|1|||
48779390|NCT02052466|157034584|FG000|Overall Study|Acromial fracture|1|||
48779391|NCT04666441|157034585|FG000|Overall Study|Lost to Follow-up|1|||
48779392|NCT04666441|157034586|FG001|Overall Study|Lost to Follow-up|4|||
48779393|NCT04666441|157034587|FG002|Overall Study|Lost to Follow-up|1|||
48779394|NCT04666441|157034588|FG003|Overall Study|Lost to Follow-up|3|||
48779395|NCT04666441|157034589|FG004|Overall Study|Lost to Follow-up|0|||
48779396|NCT04666441|157034590|FG005|Overall Study|Lost to Follow-up|2|||
48779397|NCT04666441|157034591|FG006|Overall Study|Lost to Follow-up|2|||
48779398|NCT04666441|157034592|FG007|Overall Study|Lost to Follow-up|2|||
48779399|NCT04666441|157034585|FG000|Overall Study|Subject Decision|1|||
48779400|NCT04666441|157034586|FG001|Overall Study|Subject Decision|1|||
48779401|NCT04666441|157034587|FG002|Overall Study|Subject Decision|3|||
48779402|NCT04666441|157034588|FG003|Overall Study|Subject Decision|1|||
48779403|NCT04666441|157034589|FG004|Overall Study|Subject Decision|0|||
48779404|NCT04666441|157034590|FG005|Overall Study|Subject Decision|1|||
48779405|NCT04666441|157034591|FG006|Overall Study|Subject Decision|3|||
48779406|NCT04666441|157034592|FG007|Overall Study|Subject Decision|2|||
48779407|NCT00965848|157034593|FG000|Overall Study|Protocol Violation|3|||
48779408|NCT00965848|157034594|FG001|Overall Study|Protocol Violation|0|||
48779409|NCT00965848|157034595|FG002|Overall Study|Protocol Violation|1|||
48779410|NCT00965848|157034593|FG000|Overall Study|Death|11|||
48779411|NCT00965848|157034594|FG001|Overall Study|Death|1|||
48779412|NCT00965848|157034595|FG002|Overall Study|Death|5|||
48779413|NCT00965848|157034593|FG000|Overall Study|Lost to Follow-up|0|||
48779414|NCT00965848|157034594|FG001|Overall Study|Lost to Follow-up|0|||
48779415|NCT00965848|157034595|FG002|Overall Study|Lost to Follow-up|1|||
48779416|NCT00965848|157034593|FG000|Overall Study|Withdrawal by Subject|1|||
48779417|NCT00965848|157034594|FG001|Overall Study|Withdrawal by Subject|0|||
48779418|NCT00965848|157034595|FG002|Overall Study|Withdrawal by Subject|0|||
48779419|NCT00965848|157034593|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
48779420|NCT00965848|157034594|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
48779421|NCT00965848|157034595|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
48779422|NCT00965848|157034593|FG000|Overall Study|Not Clinically Evaluable|7|||
48779423|NCT00965848|157034594|FG001|Overall Study|Not Clinically Evaluable|1|||
48779424|NCT00965848|157034595|FG002|Overall Study|Not Clinically Evaluable|1|||
48779425|NCT00965848|157034593|FG000|Overall Study|Other|5|||
48779426|NCT00965848|157034594|FG001|Overall Study|Other|0|||
48779427|NCT00965848|157034595|FG002|Overall Study|Other|1|||
48779428|NCT03149328|157034596|FG000|Overall Study|Withdrawal by Subject|30|||
48779429|NCT03149328|157034597|FG001|Overall Study|Withdrawal by Subject|26|||
48779430|NCT03149328|157034596|FG000|Overall Study|Changed Dialysis Modality|18|||
48779431|NCT03149328|157034597|FG001|Overall Study|Changed Dialysis Modality|1|||
48779432|NCT03149328|157034596|FG000|Overall Study|Transplant|9|||
48779433|NCT03149328|157034597|FG001|Overall Study|Transplant|1|||
48779434|NCT03149328|157034596|FG000|Overall Study|Lost to Follow-up|25|||
48779435|NCT03149328|157034597|FG001|Overall Study|Lost to Follow-up|16|||
48779436|NCT03149328|157034596|FG000|Overall Study|Left Study Site|1|||
48779437|NCT03149328|157034597|FG001|Overall Study|Left Study Site|2|||
48779438|NCT03149328|157034596|FG000|Overall Study|Language Barrier|1|||
48779439|NCT03149328|157034597|FG001|Overall Study|Language Barrier|0|||
48779440|NCT00927927|157034598|FG000|Overall Study|Withdrawal by Subject|0|||
48779441|NCT00927927|157034599|FG001|Overall Study|Withdrawal by Subject|0|||
48779442|NCT00927927|157034600|FG002|Overall Study|Withdrawal by Subject|0|||
48779443|NCT00927927|157034601|FG003|Overall Study|Withdrawal by Subject|0|||
48779444|NCT00927927|157034602|FG004|Overall Study|Withdrawal by Subject|0|||
48779445|NCT00927927|157034603|FG005|Overall Study|Withdrawal by Subject|0|||
48779446|NCT00927927|157034604|FG006|Overall Study|Withdrawal by Subject|0|||
48779447|NCT00927927|157034605|FG007|Overall Study|Withdrawal by Subject|2|||
48779448|NCT00927927|157034606|FG008|Overall Study|Withdrawal by Subject|0|||
48779449|NCT00927927|157034607|FG009|Overall Study|Withdrawal by Subject|0|||
48779450|NCT00927927|157034608|FG010|Overall Study|Withdrawal by Subject|0|||
48779451|NCT00927927|157034609|FG011|Overall Study|Withdrawal by Subject|2|||
48779452|NCT00927927|157034610|FG012|Overall Study|Withdrawal by Subject|0|||
48779453|NCT00927927|157034611|FG013|Overall Study|Withdrawal by Subject|0|||
48779454|NCT00927927|157034612|FG014|Overall Study|Withdrawal by Subject|0|||
48779455|NCT03403634|157034613|FG000|Overall Study|Disease progression|3|||
48779456|NCT03403634|157034613|FG000|Overall Study|Did not meet eligibility criteria|4|||
48779457|NCT01431508|157034615|FG000|Overall Study|Lack of Efficacy|1|||
48779458|NCT01431508|157034615|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
48779459|NCT01337245|157034621|FG000|Overall Study|Lost to Follow-up|1|||
48779460|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
48779461|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
48779462|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
48779463|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
48779464|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
48779465|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
48779466|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
48779467|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
48779468|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
48779469|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
48779470|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
48779471|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
48779472|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
48779473|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
48779474|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
48779475|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
48779476|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
48779477|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
48779478|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
48779479|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
48779480|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
48779481|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
48779482|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
48779483|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
48779484|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
48779485|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
48779486|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
48779487|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
48779488|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
48779489|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
48779490|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
48779491|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
48779492|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
48779493|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
48779494|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
48779495|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
48779496|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
48779497|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
48779498|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
48779499|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
48779500|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
48779501|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
48779502|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
48779503|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
48779504|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
48779505|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
48779506|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
48779507|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
48779508|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
48779509|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
48779510|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
48779511|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
48779512|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
48779513|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
48779514|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
48779515|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
48779516|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
48779517|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
48779518|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
48779519|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
48779520|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
48779521|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
48779522|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
48779523|NCT01884350|157034622|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
48779524|NCT01884350|157034623|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
48779525|NCT01884350|157034624|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
48779526|NCT00363766|157034629|FG000|Overall Study|Progressive Disease|15|||
48779527|NCT00363766|157034630|FG001|Overall Study|Progressive Disease|9|||
48779528|NCT00363766|157034629|FG000|Overall Study|Adverse Event|10|||
48779529|NCT00363766|157034630|FG001|Overall Study|Adverse Event|2|||
48779530|NCT00363766|157034629|FG000|Overall Study|Disease Related Death|1|||
48779531|NCT00363766|157034630|FG001|Overall Study|Disease Related Death|3|||
48779532|NCT00363766|157034629|FG000|Overall Study|Not Disease Related Death|3|||
48779533|NCT00363766|157034630|FG001|Overall Study|Not Disease Related Death|4|||
48779534|NCT00363766|157034629|FG000|Overall Study|Withdrawal by Subject|2|||
48779535|NCT00363766|157034630|FG001|Overall Study|Withdrawal by Subject|0|||
48779536|NCT00363766|157034629|FG000|Overall Study|Physician Decision|1|||
48779537|NCT00363766|157034630|FG001|Overall Study|Physician Decision|2|||
48779538|NCT03120624|157034631|FG000|Overall Study|Withdrawal by Subject|0|||
48779539|NCT03120624|157034632|FG001|Overall Study|Withdrawal by Subject|1|||
48779540|NCT03120624|157034633|FG002|Overall Study|Withdrawal by Subject|0|||
48779541|NCT03120624|157034634|FG003|Overall Study|Withdrawal by Subject|0|||
48779542|NCT03120624|157034635|FG004|Overall Study|Withdrawal by Subject|0|||
48779543|NCT03120624|157034636|FG005|Overall Study|Withdrawal by Subject|0|||
48779544|NCT03120624|157034637|FG006|Overall Study|Withdrawal by Subject|0|||
48779545|NCT03120624|157034638|FG007|Overall Study|Withdrawal by Subject|0|||
48779546|NCT00608829|157036374|FG000|Overall Study|Death|6|||
48779547|NCT00608829|157036374|FG000|Overall Study|Withdrawal by Subject|4|||
48779548|NCT00608829|157036374|FG000|Overall Study|Subject refuses to follow up or return.|5|||
48356442|NCT02567708|155501082|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
48356443|NCT02567708|155501081|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
48356444|NCT02567708|155501082|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
48356445|NCT02567708|155501081|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
48356446|NCT02567708|155501082|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
48356447|NCT02567708|155501081|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
48356448|NCT02567708|155501082|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
48356449|NCT01575873|155501083|FG000|Overall Study|Withdrawal by Subject|15|||
48356450|NCT01575873|155501084|FG001|Overall Study|Withdrawal by Subject|20|||
48356451|NCT01575873|155501085|FG002|Overall Study|Withdrawal by Subject|34|||
48356452|NCT01575873|155501086|FG003|Overall Study|Withdrawal by Subject|34|||
48356453|NCT01575873|155501083|FG000|Overall Study|Adverse Event|7|||
48356454|NCT01575873|155501084|FG001|Overall Study|Adverse Event|7|||
48356455|NCT01575873|155501085|FG002|Overall Study|Adverse Event|9|||
48356456|NCT01575873|155501086|FG003|Overall Study|Adverse Event|12|||
48356457|NCT01575873|155501083|FG000|Overall Study|Lost to Follow-up|1|||
48356458|NCT01575873|155501084|FG001|Overall Study|Lost to Follow-up|3|||
48356459|NCT01575873|155501085|FG002|Overall Study|Lost to Follow-up|13|||
48779549|NCT01607905|157036377|FG000|Overall Study|Withdrawal by participant|7|||
48779550|NCT01607905|157036378|FG001|Overall Study|Withdrawal by participant|2|||
48779551|NCT01607905|157036379|FG002|Overall Study|Withdrawal by participant|4|||
48779552|NCT01607905|157036380|FG003|Overall Study|Withdrawal by participant|6|||
48779553|NCT01607905|157036381|FG004|Overall Study|Withdrawal by participant|0|||
48397772|NCT01995071|155649864|FG000|Overall Study|Adverse Event|0|||
48397773|NCT01995071|155649865|FG001|Overall Study|Adverse Event|0|||
48397774|NCT01995071|155649866|FG002|Overall Study|Adverse Event|0|||
48397775|NCT01995071|155649867|FG003|Overall Study|Adverse Event|0|||
48397776|NCT01995071|155649868|FG004|Overall Study|Adverse Event|0|||
48397777|NCT01995071|155649869|FG005|Overall Study|Adverse Event|0|||
48397778|NCT01995071|155649870|FG006|Overall Study|Adverse Event|1|||
48397779|NCT01995071|155649871|FG007|Overall Study|Adverse Event|0|||
48397780|NCT01995071|155649872|FG008|Overall Study|Adverse Event|0|||
48397781|NCT01995071|155649873|FG009|Overall Study|Adverse Event|0|||
48397782|NCT01995071|155649874|FG010|Overall Study|Adverse Event|0|||
48397783|NCT01995071|155649875|FG011|Overall Study|Adverse Event|0|||
48397784|NCT01995071|155649864|FG000|Overall Study|Moved|0|||
48397785|NCT01995071|155649865|FG001|Overall Study|Moved|0|||
48397786|NCT01995071|155649866|FG002|Overall Study|Moved|1|||
48397787|NCT01995071|155649867|FG003|Overall Study|Moved|0|||
48397788|NCT01995071|155649868|FG004|Overall Study|Moved|1|||
48397789|NCT01995071|155649869|FG005|Overall Study|Moved|0|||
48397790|NCT01995071|155649870|FG006|Overall Study|Moved|0|||
48397791|NCT01995071|155649871|FG007|Overall Study|Moved|0|||
48397792|NCT01995071|155649872|FG008|Overall Study|Moved|0|||
48397793|NCT01995071|155649873|FG009|Overall Study|Moved|0|||
48397794|NCT01995071|155649874|FG010|Overall Study|Moved|1|||
48779554|NCT01607905|157036382|FG005|Overall Study|Withdrawal by participant|4|||
48779555|NCT01607905|157036383|FG006|Overall Study|Withdrawal by participant|12|||
48779556|NCT01607905|157036377|FG000|Overall Study|Incidence or severity of AEs|5|||
48779557|NCT01607905|157036378|FG001|Overall Study|Incidence or severity of AEs|1|||
48779558|NCT01607905|157036379|FG002|Overall Study|Incidence or severity of AEs|1|||
48779559|NCT01607905|157036380|FG003|Overall Study|Incidence or severity of AEs|3|||
48779560|NCT01607905|157036381|FG004|Overall Study|Incidence or severity of AEs|0|||
48779561|NCT01607905|157036382|FG005|Overall Study|Incidence or severity of AEs|2|||
48779562|NCT01607905|157036383|FG006|Overall Study|Incidence or severity of AEs|8|||
48779563|NCT01607905|157036377|FG000|Overall Study|Disease progression|44|||
48779564|NCT01607905|157036378|FG001|Overall Study|Disease progression|16|||
48779565|NCT01607905|157036379|FG002|Overall Study|Disease progression|15|||
48779566|NCT01607905|157036380|FG003|Overall Study|Disease progression|11|||
48779567|NCT01607905|157036381|FG004|Overall Study|Disease progression|6|||
48779568|NCT01607905|157036382|FG005|Overall Study|Disease progression|7|||
48779569|NCT01607905|157036383|FG006|Overall Study|Disease progression|21|||
48779570|NCT01607905|157036377|FG000|Overall Study|Non-compliance with study procedures|0|||
48779571|NCT01607905|157036378|FG001|Overall Study|Non-compliance with study procedures|0|||
48779572|NCT01607905|157036379|FG002|Overall Study|Non-compliance with study procedures|0|||
48779573|NCT01607905|157036380|FG003|Overall Study|Non-compliance with study procedures|0|||
48779574|NCT01607905|157036381|FG004|Overall Study|Non-compliance with study procedures|0|||
48779575|NCT01607905|157036382|FG005|Overall Study|Non-compliance with study procedures|0|||
48779576|NCT01607905|157036383|FG006|Overall Study|Non-compliance with study procedures|1|||
48779577|NCT01607905|157036377|FG000|Overall Study|Death|1|||
48779578|NCT01607905|157036378|FG001|Overall Study|Death|1|||
48779579|NCT01607905|157036379|FG002|Overall Study|Death|1|||
48779580|NCT01607905|157036380|FG003|Overall Study|Death|1|||
48779581|NCT01607905|157036381|FG004|Overall Study|Death|0|||
48779582|NCT01607905|157036382|FG005|Overall Study|Death|0|||
48779583|NCT01607905|157036383|FG006|Overall Study|Death|3|||
48779584|NCT01607905|157036377|FG000|Overall Study|Other treatments become available|1|||
48397795|NCT01995071|155649875|FG011|Overall Study|Moved|0|||
48397796|NCT01995071|155649864|FG000|Overall Study|Lost to Follow-up|1|||
48397797|NCT01995071|155649865|FG001|Overall Study|Lost to Follow-up|0|||
48397798|NCT01995071|155649866|FG002|Overall Study|Lost to Follow-up|0|||
48779585|NCT01607905|157036378|FG001|Overall Study|Other treatments become available|0|||
48397799|NCT01995071|155649867|FG003|Overall Study|Lost to Follow-up|0|||
48779586|NCT01607905|157036379|FG002|Overall Study|Other treatments become available|0|||
48779587|NCT01607905|157036380|FG003|Overall Study|Other treatments become available|0|||
48779588|NCT01607905|157036381|FG004|Overall Study|Other treatments become available|0|||
48779589|NCT01607905|157036382|FG005|Overall Study|Other treatments become available|0|||
48779590|NCT01607905|157036383|FG006|Overall Study|Other treatments become available|1|||
48779591|NCT01607905|157036377|FG000|Overall Study|Investigator discretion|0|||
48779592|NCT01607905|157036378|FG001|Overall Study|Investigator discretion|0|||
48779593|NCT01607905|157036379|FG002|Overall Study|Investigator discretion|0|||
48397800|NCT01995071|155649868|FG004|Overall Study|Lost to Follow-up|0|||
48397801|NCT01995071|155649869|FG005|Overall Study|Lost to Follow-up|0|||
48397802|NCT01995071|155649870|FG006|Overall Study|Lost to Follow-up|0|||
48397803|NCT01995071|155649871|FG007|Overall Study|Lost to Follow-up|1|||
48397804|NCT01995071|155649872|FG008|Overall Study|Lost to Follow-up|1|||
48779594|NCT01607905|157036380|FG003|Overall Study|Investigator discretion|0|||
48779595|NCT01607905|157036381|FG004|Overall Study|Investigator discretion|0|||
48779596|NCT01607905|157036382|FG005|Overall Study|Investigator discretion|1|||
48779597|NCT01607905|157036383|FG006|Overall Study|Investigator discretion|0|||
48779598|NCT01607905|157036377|FG000|Overall Study|Other|1|||
48779599|NCT01607905|157036378|FG001|Overall Study|Other|0|||
48779600|NCT01607905|157036379|FG002|Overall Study|Other|0|||
48779601|NCT01607905|157036380|FG003|Overall Study|Other|0|||
48779602|NCT01607905|157036381|FG004|Overall Study|Other|0|||
48779603|NCT01607905|157036382|FG005|Overall Study|Other|0|||
48779604|NCT01607905|157036383|FG006|Overall Study|Other|1|||
48779605|NCT01607905|157036377|FG000|Overall Study|Randomized but not treated|1|||
48779606|NCT01607905|157036378|FG001|Overall Study|Randomized but not treated|0|||
48779607|NCT01607905|157036379|FG002|Overall Study|Randomized but not treated|0|||
48779608|NCT01607905|157036380|FG003|Overall Study|Randomized but not treated|0|||
48779609|NCT01607905|157036381|FG004|Overall Study|Randomized but not treated|1|||
48779610|NCT01607905|157036382|FG005|Overall Study|Randomized but not treated|1|||
48397805|NCT01995071|155649873|FG009|Overall Study|Lost to Follow-up|0|||
48397806|NCT01995071|155649874|FG010|Overall Study|Lost to Follow-up|0|||
48397807|NCT01995071|155649875|FG011|Overall Study|Lost to Follow-up|0|||
48397808|NCT01995071|155649864|FG000|Overall Study|Incarcerated|0|||
48397809|NCT01995071|155649865|FG001|Overall Study|Incarcerated|0|||
48397810|NCT01995071|155649866|FG002|Overall Study|Incarcerated|0|||
48397811|NCT01995071|155649867|FG003|Overall Study|Incarcerated|0|||
48397812|NCT01995071|155649868|FG004|Overall Study|Incarcerated|0|||
48397813|NCT01995071|155649869|FG005|Overall Study|Incarcerated|0|||
48397814|NCT01995071|155649870|FG006|Overall Study|Incarcerated|0|||
48397815|NCT01995071|155649871|FG007|Overall Study|Incarcerated|1|||
48397816|NCT01995071|155649872|FG008|Overall Study|Incarcerated|0|||
48397817|NCT01995071|155649873|FG009|Overall Study|Incarcerated|0|||
48397818|NCT01995071|155649874|FG010|Overall Study|Incarcerated|0|||
48397819|NCT01995071|155649875|FG011|Overall Study|Incarcerated|0|||
48397820|NCT01339559|155649879|FG000|Overall Study|Adverse Event|92|||
48397821|NCT01339559|155649879|FG000|Overall Study|Death|5|||
48397822|NCT01339559|155649879|FG000|Overall Study|Lack of Efficacy|164|||
48397823|NCT01339559|155649879|FG000|Overall Study|Lost to Follow-up|22|||
48397824|NCT01339559|155649879|FG000|Overall Study|Subject choice|89|||
48397825|NCT01339559|155649879|FG000|Overall Study|Protocol Violation|15|||
48779611|NCT01607905|157036383|FG006|Overall Study|Randomized but not treated|0|||
48397826|NCT01339559|155649879|FG000|Overall Study|Study closure at site|1|||
48397827|NCT01339559|155649879|FG000|Overall Study|Incarcerated|2|||
48397828|NCT01339559|155649879|FG000|Overall Study|Epilepsy surgery|1|||
48397829|NCT01339559|155649879|FG000|Overall Study|Pregnancy planned|2|||
48397830|NCT01339559|155649879|FG000|Overall Study|Left the country|1|||
48779612|NCT02602288|157036384|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
48779613|NCT02602288|157036385|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
48779614|NCT02602288|157036384|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
48397831|NCT01339559|155649879|FG000|Overall Study|Investigator decision|2|||
48397832|NCT01339559|155649879|FG000|Overall Study|Patient didn't wish to continue|1|||
48397833|NCT01339559|155649879|FG000|Overall Study|PI decision|1|||
48397834|NCT01661140|155649880|FG000|Open-Label Period|Adverse Event|44|||
48779615|NCT02602288|157036385|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
48779616|NCT02602288|157036384|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
48779617|NCT02602288|157036385|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
48779618|NCT02602288|157036384|FG000|12 Month Follow-up|Lost to Follow-up|0|||
48779619|NCT02602288|157036385|FG001|12 Month Follow-up|Lost to Follow-up|4|||
48779620|NCT02602288|157036384|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
48779621|NCT02602288|157036385|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
48779622|NCT00352534|157036390|FG000|Initial Staging|Ineligible|8|||
48779623|NCT00352534|157036391|FG001|Initial Staging|Ineligible|9|||
48779624|NCT00352534|157036392|FG002|Initial Staging|Ineligible|0|||
48779625|NCT00352534|157036393|FG003|Initial Staging|Ineligible|0|||
48779626|NCT00352534|157036394|FG004|Initial Staging|Ineligible|0|||
48779627|NCT00352534|157036395|FG005|Initial Staging|Ineligible|0|||
48779628|NCT00352534|157036396|FG006|Initial Staging|Ineligible|0|||
48779629|NCT00352534|157036390|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
48779630|NCT00352534|157036391|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
48779631|NCT00352534|157036392|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
48779632|NCT00352534|157036393|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
48779633|NCT00352534|157036394|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
48779634|NCT00352534|157036395|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
48779635|NCT00352534|157036396|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
48779636|NCT00352534|157036390|FG000|Final Risk Group Assignment|Physician Decision|0|||
48779637|NCT00352534|157036391|FG001|Final Risk Group Assignment|Physician Decision|0|||
48779638|NCT00352534|157036392|FG002|Final Risk Group Assignment|Physician Decision|0|||
48779639|NCT00352534|157036393|FG003|Final Risk Group Assignment|Physician Decision|0|||
48779640|NCT00352534|157036394|FG004|Final Risk Group Assignment|Physician Decision|0|||
48779641|NCT00352534|157036395|FG005|Final Risk Group Assignment|Physician Decision|8|||
48779642|NCT00352534|157036396|FG006|Final Risk Group Assignment|Physician Decision|0|||
48779643|NCT00352534|157036390|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779644|NCT00352534|157036391|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779645|NCT00352534|157036392|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779646|NCT00352534|157036393|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779647|NCT00352534|157036394|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779648|NCT00352534|157036395|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
48779649|NCT00352534|157036396|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
48779650|NCT00352534|157036390|FG000|Final Risk Group Assignment|Ineligible|0|||
48779651|NCT00352534|157036391|FG001|Final Risk Group Assignment|Ineligible|0|||
48779652|NCT00352534|157036392|FG002|Final Risk Group Assignment|Ineligible|3|||
48779653|NCT00352534|157036393|FG003|Final Risk Group Assignment|Ineligible|1|||
48779654|NCT00352534|157036394|FG004|Final Risk Group Assignment|Ineligible|0|||
48779655|NCT00352534|157036395|FG005|Final Risk Group Assignment|Ineligible|13|||
48779656|NCT00352534|157036396|FG006|Final Risk Group Assignment|Ineligible|0|||
48779657|NCT00352534|157036390|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779658|NCT00352534|157036391|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779659|NCT00352534|157036392|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779660|NCT00352534|157036393|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779661|NCT00352534|157036394|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779662|NCT00352534|157036395|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
48779663|NCT00352534|157036396|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
48779664|NCT00352534|157036390|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779665|NCT00352534|157036391|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779666|NCT00352534|157036392|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779667|NCT00352534|157036393|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779668|NCT00352534|157036394|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48779669|NCT00352534|157036395|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
48397835|NCT01661140|155649881|FG001|Open-Label Period|Adverse Event|0|||
48779670|NCT00352534|157036396|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
48779671|NCT00352534|157036390|FG000|Final Risk Group Assignment|Death|0|||
48397836|NCT01661140|155649882|FG002|Open-Label Period|Adverse Event|0|||
48779672|NCT00352534|157036391|FG001|Final Risk Group Assignment|Death|0|||
48779673|NCT00352534|157036392|FG002|Final Risk Group Assignment|Death|0|||
48397837|NCT01661140|155649880|FG000|Open-Label Period|Protocol Violation|3|||
48397838|NCT01661140|155649881|FG001|Open-Label Period|Protocol Violation|0|||
48397839|NCT01661140|155649882|FG002|Open-Label Period|Protocol Violation|0|||
48397840|NCT01661140|155649880|FG000|Open-Label Period|Withdrawal by Subject|5|||
48397841|NCT01661140|155649881|FG001|Open-Label Period|Withdrawal by Subject|0|||
48397842|NCT01661140|155649882|FG002|Open-Label Period|Withdrawal by Subject|0|||
48397843|NCT01661140|155649880|FG000|Open-Label Period|Investigator Decision|3|||
48397844|NCT01661140|155649881|FG001|Open-Label Period|Investigator Decision|0|||
48397845|NCT01661140|155649882|FG002|Open-Label Period|Investigator Decision|0|||
48397846|NCT01661140|155649880|FG000|Open-Label Period|Death|1|||
48397847|NCT01661140|155649881|FG001|Open-Label Period|Death|0|||
48397848|NCT01661140|155649882|FG002|Open-Label Period|Death|0|||
48397849|NCT01661140|155649880|FG000|Open-Label Period|Administrative/Other|1|||
48397850|NCT01661140|155649881|FG001|Open-Label Period|Administrative/Other|0|||
48779674|NCT00352534|157036393|FG003|Final Risk Group Assignment|Death|0|||
48779675|NCT00352534|157036394|FG004|Final Risk Group Assignment|Death|0|||
48779676|NCT00352534|157036395|FG005|Final Risk Group Assignment|Death|2|||
48779677|NCT00352534|157036396|FG006|Final Risk Group Assignment|Death|0|||
48779678|NCT00924950|157036397|FG000|Overall Study|Lost to Follow-up|2|||
48779679|NCT01075321|157036398|FG000|Overall Study|Withdrawal by Subject|0|||
48779680|NCT01075321|157036399|FG001|Overall Study|Withdrawal by Subject|0|||
48779681|NCT01075321|157036400|FG002|Overall Study|Withdrawal by Subject|1|||
48779682|NCT01075321|157036401|FG003|Overall Study|Withdrawal by Subject|1|||
48779683|NCT01075321|157036398|FG000|Overall Study|Protocol Violation|0|||
48779684|NCT01075321|157036399|FG001|Overall Study|Protocol Violation|0|||
48779685|NCT01075321|157036400|FG002|Overall Study|Protocol Violation|1|||
48779686|NCT01075321|157036401|FG003|Overall Study|Protocol Violation|0|||
48779687|NCT01075321|157036398|FG000|Overall Study|Treatment Incomplete due to progression|1|||
48779688|NCT01075321|157036399|FG001|Overall Study|Treatment Incomplete due to progression|0|||
48779689|NCT01075321|157036400|FG002|Overall Study|Treatment Incomplete due to progression|0|||
48779690|NCT01075321|157036401|FG003|Overall Study|Treatment Incomplete due to progression|0|||
48779691|NCT01075321|157036398|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
48779692|NCT01075321|157036399|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
48779693|NCT01075321|157036400|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
48779694|NCT01075321|157036401|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
48779695|NCT00503841|157036402|FG000|Overall Study|All screen failures|44|||
48779696|NCT02082522|157036403|FG000|Overall Study|Sponsor termination|5|||
48779697|NCT02082522|157036404|FG001|Overall Study|Sponsor termination|3|||
48779698|NCT02082522|157036403|FG000|Overall Study|Withdrawal by Subject|2|||
48779699|NCT02082522|157036404|FG001|Overall Study|Withdrawal by Subject|4|||
48779700|NCT02082522|157036403|FG000|Overall Study|Death|1|||
48779701|NCT02082522|157036404|FG001|Overall Study|Death|0|||
48779702|NCT02082522|157036403|FG000|Overall Study|Lost to Follow-up|1|||
48779703|NCT02082522|157036404|FG001|Overall Study|Lost to Follow-up|0|||
48779704|NCT02082522|157036403|FG000|Overall Study|Physician Decision|3|||
48779705|NCT02082522|157036404|FG001|Overall Study|Physician Decision|1|||
48779706|NCT02082522|157036403|FG000|Overall Study|Disease progression|2|||
48779707|NCT02082522|157036404|FG001|Overall Study|Disease progression|2|||
48779708|NCT02082522|157036403|FG000|Overall Study|Chemotherapy change|1|||
48779709|NCT02082522|157036404|FG001|Overall Study|Chemotherapy change|3|||
48779710|NCT01575561|157036407|FG000|Overall Study|Adverse Event|9|||
48779711|NCT01575561|157036407|FG000|Overall Study|Lack of Efficacy|8|||
48779712|NCT01575561|157036407|FG000|Overall Study|Lost to Follow-up|6|||
48779713|NCT01575561|157036407|FG000|Overall Study|Protocol Violation|4|||
48779714|NCT01575561|157036407|FG000|Overall Study|Withdrawal by Subject|11|||
48779715|NCT01575561|157036407|FG000|Overall Study|administration|1|||
48779716|NCT01175382|157036408|FG000|Overall Study|Lost to Follow-up|4|||
48397851|NCT01661140|155649882|FG002|Open-Label Period|Administrative/Other|0|||
48397852|NCT01661140|155649880|FG000|Open-Label Period|Sponsor termination|16|||
48397853|NCT01661140|155649881|FG001|Open-Label Period|Sponsor termination|0|||
48397854|NCT01661140|155649882|FG002|Open-Label Period|Sponsor termination|0|||
48397855|NCT01661140|155649880|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
48397856|NCT01661140|155649881|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
48397857|NCT01661140|155649882|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
48397858|NCT01661140|155649880|FG000|Open-Label Period|Lost to Follow-up|2|||
48779717|NCT01175382|157036409|FG001|Overall Study|Lost to Follow-up|3|||
48779718|NCT01175382|157036410|FG002|Overall Study|Lost to Follow-up|1|||
48779719|NCT01175382|157036408|FG000|Overall Study|Physician Decision|0|||
48779720|NCT01175382|157036409|FG001|Overall Study|Physician Decision|1|||
48779721|NCT01175382|157036410|FG002|Overall Study|Physician Decision|0|||
48779722|NCT01175382|157036408|FG000|Overall Study|Withdrawal by Subject|0|||
48779723|NCT01175382|157036409|FG001|Overall Study|Withdrawal by Subject|0|||
48397859|NCT01661140|155649881|FG001|Open-Label Period|Lost to Follow-up|0|||
48397860|NCT01661140|155649882|FG002|Open-Label Period|Lost to Follow-up|0|||
48397861|NCT01661140|155649880|FG000|Double-Blind Period|Refused Treatment|0|||
48779724|NCT01175382|157036410|FG002|Overall Study|Withdrawal by Subject|1|||
48779725|NCT01175382|157036408|FG000|Overall Study|No longer having problem|1|||
48779726|NCT01175382|157036409|FG001|Overall Study|No longer having problem|0|||
48779727|NCT01175382|157036410|FG002|Overall Study|No longer having problem|1|||
48779728|NCT01175382|157036408|FG000|Overall Study|Unable/unwilling to attend visits|3|||
48779729|NCT01175382|157036409|FG001|Overall Study|Unable/unwilling to attend visits|1|||
48779730|NCT01175382|157036410|FG002|Overall Study|Unable/unwilling to attend visits|2|||
48779731|NCT01175382|157036408|FG000|Overall Study|Unwilling to follow protocol|0|||
48779732|NCT01175382|157036409|FG001|Overall Study|Unwilling to follow protocol|1|||
48779733|NCT01175382|157036410|FG002|Overall Study|Unwilling to follow protocol|0|||
48779734|NCT01175382|157036408|FG000|Overall Study|Unable to tolerate study meds|0|||
48779735|NCT01175382|157036409|FG001|Overall Study|Unable to tolerate study meds|1|||
48779736|NCT01175382|157036410|FG002|Overall Study|Unable to tolerate study meds|1|||
48779737|NCT00440271|157036411|FG000|Overall Study|Protocol Violation|1|||
48779738|NCT00440271|157036412|FG001|Overall Study|Protocol Violation|1|||
48779739|NCT00440271|157036411|FG000|Overall Study|Adverse Event|0|||
48779740|NCT00440271|157036412|FG001|Overall Study|Adverse Event|1|||
48779741|NCT00440271|157036411|FG000|Overall Study|Lost to Follow-up|1|||
48779742|NCT00440271|157036412|FG001|Overall Study|Lost to Follow-up|0|||
48779743|NCT00440271|157036411|FG000|Overall Study|Withdrawal by Subject|0|||
48779744|NCT00440271|157036412|FG001|Overall Study|Withdrawal by Subject|2|||
48779745|NCT00440271|157036411|FG000|Overall Study|Lack of Efficacy|0|||
48779746|NCT00440271|157036412|FG001|Overall Study|Lack of Efficacy|1|||
48779747|NCT00440271|157036411|FG000|Overall Study|Due to closure of trial|8|||
48779748|NCT00440271|157036412|FG001|Overall Study|Due to closure of trial|10|||
48779749|NCT00440271|157036411|FG000|Overall Study|Other|2|||
48779750|NCT00440271|157036412|FG001|Overall Study|Other|0|||
48779751|NCT00723801|157036413|FG000|Overall Study|Lost to Follow-up|1|||
48779752|NCT00723801|157036414|FG001|Overall Study|Lost to Follow-up|2|||
48779753|NCT00723801|157036413|FG000|Overall Study|Protocol Violation|2|||
48779754|NCT00723801|157036414|FG001|Overall Study|Protocol Violation|1|||
48779755|NCT00120042|157036415|FG000|Overall Study|all completed protocl|0|||
48779756|NCT00120042|157036416|FG001|Overall Study|all completed protocl|0|||
48779757|NCT00120042|157036417|FG002|Overall Study|all completed protocl|0|||
48779758|NCT00774787|157036418|FG000|Overall Study|Lost to Follow-up|1|||
48779759|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
48779760|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
48779761|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
48779762|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
48779763|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
48779764|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
48779765|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Death|1|||
48779766|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Death|0|||
48779767|NCT02554773|157036419|FG000|Original Dose Regimen (SAS 1)|Other|4|||
48779768|NCT02554773|157036420|FG001|Original Dose Regimen (SAS 1)|Other|0|||
48779769|NCT02554773|157036419|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
48779770|NCT02554773|157036420|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
48779771|NCT02554773|157036419|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
48779772|NCT02554773|157036420|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
48779773|NCT02554773|157036419|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
48779774|NCT02554773|157036420|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
48779775|NCT02554773|157036419|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
48779776|NCT02554773|157036420|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
48779777|NCT02496884|157036421|FG000|Overall Study|Counted twice as enrolled|2|||
48779778|NCT02496884|157036422|FG001|Overall Study|Counted twice as enrolled|0|||
48779779|NCT02496884|157036423|FG002|Overall Study|Counted twice as enrolled|0|||
48779780|NCT02496884|157036424|FG003|Overall Study|Counted twice as enrolled|0|||
48779781|NCT02496884|157036421|FG000|Overall Study|Withdrawal by Subject|0|||
48779782|NCT02496884|157036422|FG001|Overall Study|Withdrawal by Subject|3|||
48779783|NCT02496884|157036423|FG002|Overall Study|Withdrawal by Subject|0|||
48779784|NCT02496884|157036424|FG003|Overall Study|Withdrawal by Subject|0|||
48779785|NCT03348904|157036425|FG000|Overall Study|Administrative reason by the sponsor|0|||
48779786|NCT03348904|157036426|FG001|Overall Study|Administrative reason by the sponsor|1|||
48779787|NCT03348904|157036427|FG002|Overall Study|Administrative reason by the sponsor|0|||
48779788|NCT00097591|157036428|FG000|Overall Study|Withdrawal of consent|342|||
48779789|NCT00097591|157036429|FG001|Overall Study|Withdrawal of consent|323|||
48397862|NCT01661140|155649881|FG001|Double-Blind Period|Refused Treatment|0|||
48779790|NCT00097591|157036428|FG000|Overall Study|Less than 6 months on study drug|9|||
48779791|NCT00097591|157036429|FG001|Overall Study|Less than 6 months on study drug|7|||
48779792|NCT00097591|157036428|FG000|Overall Study|Unable to attend termination visit|53|||
48779793|NCT00097591|157036429|FG001|Overall Study|Unable to attend termination visit|51|||
48779794|NCT00097591|157036428|FG000|Overall Study|Lost to follow up|6|||
48397863|NCT01661140|155649882|FG002|Double-Blind Period|Refused Treatment|1|||
48779795|NCT00097591|157036429|FG001|Overall Study|Lost to follow up|10|||
48779796|NCT00097591|157036428|FG000|Overall Study|Other|0|||
48397864|NCT01661140|155649880|FG000|Double-Blind Period|Adverse Event|0|||
48779797|NCT00097591|157036429|FG001|Overall Study|Other|3|||
48779798|NCT01978119|157036440|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
48779799|NCT01978119|157036441|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
48779800|NCT01978119|157036440|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
48779801|NCT01978119|157036441|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48779802|NCT01978119|157036440|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48779803|NCT01978119|157036441|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
48779804|NCT02352493|157036442|FG000|Overall Study|Pregnancy|0|||
48779805|NCT02352493|157036443|FG001|Overall Study|Pregnancy|0|||
48779806|NCT02352493|157036444|FG002|Overall Study|Pregnancy|0|||
48779807|NCT02352493|157036445|FG003|Overall Study|Pregnancy|0|||
48779808|NCT02352493|157036446|FG004|Overall Study|Pregnancy|0|||
48779809|NCT02352493|157036447|FG005|Overall Study|Pregnancy|0|||
48779810|NCT02352493|157036448|FG006|Overall Study|Pregnancy|1|||
48779811|NCT02352493|157036449|FG007|Overall Study|Pregnancy|0|||
48779812|NCT02352493|157036450|FG008|Overall Study|Pregnancy|1|||
48779813|NCT02352493|157036451|FG009|Overall Study|Pregnancy|0|||
48779814|NCT02352493|157036452|FG010|Overall Study|Pregnancy|0|||
48779815|NCT02352493|157036453|FG011|Overall Study|Pregnancy|0|||
48779816|NCT02352493|157036454|FG012|Overall Study|Pregnancy|0|||
48779817|NCT02352493|157036455|FG013|Overall Study|Pregnancy|0|||
48779818|NCT02352493|157036456|FG014|Overall Study|Pregnancy|0|||
48779819|NCT02352493|157036457|FG015|Overall Study|Pregnancy|0|||
48779820|NCT02352493|157036458|FG016|Overall Study|Pregnancy|0|||
48779821|NCT02352493|157036459|FG017|Overall Study|Pregnancy|0|||
48779822|NCT02352493|157036442|FG000|Overall Study|Withdrawal by Subject|0|||
48779823|NCT02352493|157036443|FG001|Overall Study|Withdrawal by Subject|0|||
48779824|NCT02352493|157036444|FG002|Overall Study|Withdrawal by Subject|0|||
48779825|NCT02352493|157036445|FG003|Overall Study|Withdrawal by Subject|0|||
48779826|NCT02352493|157036446|FG004|Overall Study|Withdrawal by Subject|0|||
48779827|NCT02352493|157036447|FG005|Overall Study|Withdrawal by Subject|0|||
48779828|NCT02352493|157036448|FG006|Overall Study|Withdrawal by Subject|0|||
48779829|NCT02352493|157036449|FG007|Overall Study|Withdrawal by Subject|0|||
48779830|NCT02352493|157036450|FG008|Overall Study|Withdrawal by Subject|1|||
48779831|NCT02352493|157036451|FG009|Overall Study|Withdrawal by Subject|0|||
48779832|NCT02352493|157036452|FG010|Overall Study|Withdrawal by Subject|0|||
48779833|NCT02352493|157036453|FG011|Overall Study|Withdrawal by Subject|0|||
48779834|NCT02352493|157036454|FG012|Overall Study|Withdrawal by Subject|0|||
48779835|NCT02352493|157036455|FG013|Overall Study|Withdrawal by Subject|0|||
48779836|NCT02352493|157036456|FG014|Overall Study|Withdrawal by Subject|1|||
48779837|NCT02352493|157036457|FG015|Overall Study|Withdrawal by Subject|0|||
48779838|NCT02352493|157036458|FG016|Overall Study|Withdrawal by Subject|0|||
48779839|NCT02352493|157036459|FG017|Overall Study|Withdrawal by Subject|0|||
48779840|NCT02352493|157036442|FG000|Overall Study|Lost to Follow-up|0|||
48779841|NCT02352493|157036443|FG001|Overall Study|Lost to Follow-up|0|||
48779842|NCT02352493|157036444|FG002|Overall Study|Lost to Follow-up|0|||
48779843|NCT02352493|157036445|FG003|Overall Study|Lost to Follow-up|0|||
48779844|NCT02352493|157036446|FG004|Overall Study|Lost to Follow-up|0|||
48779845|NCT02352493|157036447|FG005|Overall Study|Lost to Follow-up|0|||
48779846|NCT02352493|157036448|FG006|Overall Study|Lost to Follow-up|0|||
48779847|NCT02352493|157036449|FG007|Overall Study|Lost to Follow-up|0|||
48779848|NCT02352493|157036450|FG008|Overall Study|Lost to Follow-up|0|||
48779849|NCT02352493|157036451|FG009|Overall Study|Lost to Follow-up|1|||
48779850|NCT02352493|157036452|FG010|Overall Study|Lost to Follow-up|0|||
48779851|NCT02352493|157036453|FG011|Overall Study|Lost to Follow-up|0|||
48779852|NCT02352493|157036454|FG012|Overall Study|Lost to Follow-up|1|||
48779853|NCT02352493|157036455|FG013|Overall Study|Lost to Follow-up|2|||
48779854|NCT02352493|157036456|FG014|Overall Study|Lost to Follow-up|0|||
48779855|NCT02352493|157036457|FG015|Overall Study|Lost to Follow-up|0|||
48779856|NCT02352493|157036458|FG016|Overall Study|Lost to Follow-up|0|||
48779857|NCT02352493|157036459|FG017|Overall Study|Lost to Follow-up|0|||
48397865|NCT01661140|155649881|FG001|Double-Blind Period|Adverse Event|16|||
48397866|NCT01661140|155649882|FG002|Double-Blind Period|Adverse Event|18|||
48397867|NCT01661140|155649880|FG000|Double-Blind Period|Protocol Violation|0|||
48397868|NCT01661140|155649881|FG001|Double-Blind Period|Protocol Violation|2|||
48397869|NCT01661140|155649882|FG002|Double-Blind Period|Protocol Violation|3|||
48397870|NCT01661140|155649880|FG000|Double-Blind Period|Withdrawal by Subject|0|||
48397871|NCT01661140|155649881|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48397872|NCT01661140|155649882|FG002|Double-Blind Period|Withdrawal by Subject|3|||
48779858|NCT02317575|157036460|FG000|Period 1|Difficulty with venous cannulation|0|||
48779859|NCT02317575|157036461|FG001|Period 1|Difficulty with venous cannulation|1|||
48779860|NCT02317575|157036462|FG002|Period 1|Difficulty with venous cannulation|0|||
48779861|NCT02317575|157036463|FG003|Period 1|Difficulty with venous cannulation|0|||
48779862|NCT02317575|157036464|FG004|Period 1|Difficulty with venous cannulation|0|||
48779863|NCT02317575|157036460|FG000|Period 1|Withdrawal by Subject|1|||
48779864|NCT02317575|157036461|FG001|Period 1|Withdrawal by Subject|0|||
48779865|NCT02317575|157036462|FG002|Period 1|Withdrawal by Subject|0|||
48779866|NCT02317575|157036463|FG003|Period 1|Withdrawal by Subject|0|||
48779867|NCT02317575|157036464|FG004|Period 1|Withdrawal by Subject|0|||
48779868|NCT02223390|157036465|FG000|Overall Study|Lost to Follow-up|9|||
48779869|NCT02223390|157036466|FG001|Overall Study|Lost to Follow-up|4|||
48779870|NCT01831089|157036467|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
48779871|NCT01831089|157036468|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
48779872|NCT01831089|157036469|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
48779873|NCT01831089|157036470|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
48779874|NCT01831089|157036471|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
48779875|NCT01831089|157036472|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
48779876|NCT01831089|157036467|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
48779877|NCT01831089|157036468|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
48779878|NCT01831089|157036469|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
48779879|NCT01831089|157036470|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
48779880|NCT01831089|157036471|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
48779881|NCT01831089|157036472|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
48779882|NCT01831089|157036467|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779883|NCT01831089|157036468|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
48779884|NCT01831089|157036469|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779885|NCT01831089|157036470|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779886|NCT01831089|157036471|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779887|NCT01831089|157036472|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
48779888|NCT01831089|157036467|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
48779889|NCT01831089|157036468|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
48779890|NCT01831089|157036469|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
48779891|NCT01831089|157036470|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
48779892|NCT01831089|157036471|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
48779893|NCT01831089|157036472|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
48779894|NCT01831089|157036467|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779895|NCT01831089|157036468|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779896|NCT01831089|157036469|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
48779897|NCT01831089|157036470|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779898|NCT01831089|157036471|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779899|NCT01831089|157036472|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
48779900|NCT01831089|157036467|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
48779901|NCT01831089|157036468|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
48779902|NCT01831089|157036469|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
48779903|NCT01831089|157036470|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
48779904|NCT01831089|157036471|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
48779905|NCT01831089|157036472|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
48779906|NCT01831089|157036467|FG000|Cohort III: Dose Level 3|Global end of study|0|||
48779907|NCT01831089|157036468|FG001|Cohort III: Dose Level 3|Global end of study|0|||
48779908|NCT01831089|157036469|FG002|Cohort III: Dose Level 3|Global end of study|1|||
48779909|NCT01831089|157036470|FG003|Cohort III: Dose Level 3|Global end of study|0|||
48779910|NCT01831089|157036471|FG004|Cohort III: Dose Level 3|Global end of study|0|||
48779911|NCT01831089|157036472|FG005|Cohort III: Dose Level 3|Global end of study|0|||
48779912|NCT01831089|157036467|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
48779913|NCT01831089|157036468|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
48779914|NCT01831089|157036469|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
48779915|NCT01831089|157036470|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
48779916|NCT01831089|157036471|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
48779917|NCT01831089|157036472|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
48779918|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
48779919|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
48779920|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
48779921|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
48397873|NCT01661140|155649880|FG000|Double-Blind Period|Investigator's Decision|0|||
48397874|NCT01661140|155649881|FG001|Double-Blind Period|Investigator's Decision|1|||
48397875|NCT01661140|155649882|FG002|Double-Blind Period|Investigator's Decision|2|||
48397876|NCT01661140|155649880|FG000|Double-Blind Period|Sponsor Termination|0|||
48397877|NCT01661140|155649881|FG001|Double-Blind Period|Sponsor Termination|14|||
48397878|NCT01661140|155649882|FG002|Double-Blind Period|Sponsor Termination|17|||
48397879|NCT01661140|155649880|FG000|Double-Blind Period|Administrative/Other|0|||
48397880|NCT01661140|155649881|FG001|Double-Blind Period|Administrative/Other|7|||
48397881|NCT01661140|155649882|FG002|Double-Blind Period|Administrative/Other|6|||
48397882|NCT00746252|155649883|FG000|Overall Study|weight gain >7.5 %|1|||
48779922|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
48779923|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
48779924|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48779925|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48779926|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48779927|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48779928|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
48779929|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
48397883|NCT00746252|155649884|FG001|Overall Study|weight gain >7.5 %|2|||
48397884|NCT01391000|155649885|FG000|Overall Study|Lost to Follow-up|2|||
48397885|NCT01391000|155649886|FG001|Overall Study|Lost to Follow-up|0|||
48779930|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Death|0|||
48779931|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Death|0|||
48779932|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Death|0|||
48779933|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Death|0|||
48779934|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Death|1|||
48779935|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Death|0|||
48779936|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Global end of study|0|||
48779937|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Global end of study|0|||
48779938|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Global end of study|0|||
48779939|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Global end of study|0|||
48779940|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Global end of study|2|||
48779941|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Global end of study|0|||
48779942|NCT01831089|157036467|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779943|NCT01831089|157036468|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779944|NCT01831089|157036469|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779945|NCT01831089|157036470|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779946|NCT01831089|157036471|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
48779947|NCT01831089|157036472|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
48779948|NCT01831089|157036467|FG000|Cohort B: Arm B|Progressive disease|0|||
48779949|NCT01831089|157036468|FG001|Cohort B: Arm B|Progressive disease|0|||
48779950|NCT01831089|157036469|FG002|Cohort B: Arm B|Progressive disease|0|||
48779951|NCT01831089|157036470|FG003|Cohort B: Arm B|Progressive disease|0|||
48779952|NCT01831089|157036471|FG004|Cohort B: Arm B|Progressive disease|0|||
48779953|NCT01831089|157036472|FG005|Cohort B: Arm B|Progressive disease|8|||
48779954|NCT01831089|157036467|FG000|Cohort B: Arm B|Physician Decision|0|||
48779955|NCT01831089|157036468|FG001|Cohort B: Arm B|Physician Decision|0|||
48779956|NCT01831089|157036469|FG002|Cohort B: Arm B|Physician Decision|0|||
48779957|NCT01831089|157036470|FG003|Cohort B: Arm B|Physician Decision|0|||
48779958|NCT01831089|157036471|FG004|Cohort B: Arm B|Physician Decision|0|||
48779959|NCT01831089|157036472|FG005|Cohort B: Arm B|Physician Decision|2|||
48779960|NCT01831089|157036467|FG000|Cohort B: Arm B|Never treated|0|||
48779961|NCT01831089|157036468|FG001|Cohort B: Arm B|Never treated|0|||
48779962|NCT01831089|157036469|FG002|Cohort B: Arm B|Never treated|0|||
48779963|NCT01831089|157036470|FG003|Cohort B: Arm B|Never treated|0|||
48779964|NCT01831089|157036471|FG004|Cohort B: Arm B|Never treated|0|||
48779965|NCT01831089|157036472|FG005|Cohort B: Arm B|Never treated|2|||
48779966|NCT01831089|157036467|FG000|Cohort B: Arm B|Adverse Event|0|||
48779967|NCT01831089|157036468|FG001|Cohort B: Arm B|Adverse Event|0|||
48779968|NCT01831089|157036469|FG002|Cohort B: Arm B|Adverse Event|0|||
48779969|NCT01831089|157036470|FG003|Cohort B: Arm B|Adverse Event|0|||
48779970|NCT01831089|157036471|FG004|Cohort B: Arm B|Adverse Event|0|||
48779971|NCT01831089|157036472|FG005|Cohort B: Arm B|Adverse Event|1|||
48779972|NCT01831089|157036467|FG000|Cohort B: Arm B|Global end of study|0|||
48779973|NCT01831089|157036468|FG001|Cohort B: Arm B|Global end of study|0|||
48779974|NCT01831089|157036469|FG002|Cohort B: Arm B|Global end of study|0|||
48779975|NCT01831089|157036470|FG003|Cohort B: Arm B|Global end of study|0|||
48779976|NCT01831089|157036471|FG004|Cohort B: Arm B|Global end of study|0|||
48779977|NCT01831089|157036472|FG005|Cohort B: Arm B|Global end of study|1|||
48779978|NCT02480621|157036485|FG000|Randomization|Withdrawal by Subject|1|||
48779979|NCT02480621|157036486|FG001|Randomization|Withdrawal by Subject|0|||
48779980|NCT02480621|157036485|FG000|Randomization|Surgeon did not give intervention|0|||
48779981|NCT02480621|157036486|FG001|Randomization|Surgeon did not give intervention|1|||
48779982|NCT02480621|157036485|FG000|Follow Up|Lost to Follow-up|4|||
48779983|NCT02480621|157036486|FG001|Follow Up|Lost to Follow-up|2|||
48779984|NCT02799082|157036488|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
48779985|NCT02799082|157036489|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
48779986|NCT02799082|157036488|FG000|Overall Study|Protocol Violation|0|||
48779987|NCT02799082|157036489|FG001|Overall Study|Protocol Violation|1|||
48779988|NCT02520531|157036493|FG000|Overall Study|Revision of study device components|2|||
48397886|NCT00789529|155649887|FG000|Overall Study|Withdrawal by Subject|0|||
48779989|NCT02520531|157036494|FG001|Overall Study|Revision of study device components|2|||
48779990|NCT02520531|157036493|FG000|Overall Study|Death|1|||
48779991|NCT02520531|157036494|FG001|Overall Study|Death|2|||
48779992|NCT02520531|157036493|FG000|Overall Study|Lost to Follow-up|1|||
48779993|NCT02520531|157036494|FG001|Overall Study|Lost to Follow-up|1|||
48779994|NCT02520531|157036493|FG000|Overall Study|Meet exclusion criterion|0|||
48779995|NCT02520531|157036494|FG001|Overall Study|Meet exclusion criterion|1|||
48397887|NCT00789529|155649888|FG001|Overall Study|Withdrawal by Subject|1|||
48397888|NCT00789529|155649887|FG000|Overall Study|Other Reason|1|||
48397889|NCT00789529|155649888|FG001|Overall Study|Other Reason|0|||
48397890|NCT04623242|155649889|FG000|Overall Study|Withdrawal by Subject|7|||
48397891|NCT04623242|155649890|FG001|Overall Study|Withdrawal by Subject|12|||
48397892|NCT04623242|155649891|FG002|Overall Study|Withdrawal by Subject|5|||
48397893|NCT04623242|155649892|FG003|Overall Study|Withdrawal by Subject|7|||
48397894|NCT04623242|155649893|FG004|Overall Study|Withdrawal by Subject|0|||
48397895|NCT04623242|155649889|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
48397896|NCT04623242|155649890|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
48397897|NCT04623242|155649891|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
48397898|NCT04623242|155649892|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
48397899|NCT04623242|155649893|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
48397900|NCT04623242|155649889|FG000|Overall Study|Subject unblinded to mutation status|0|||
48397901|NCT04623242|155649890|FG001|Overall Study|Subject unblinded to mutation status|0|||
48397902|NCT04623242|155649891|FG002|Overall Study|Subject unblinded to mutation status|0|||
48397903|NCT04623242|155649892|FG003|Overall Study|Subject unblinded to mutation status|13|||
48397904|NCT04623242|155649893|FG004|Overall Study|Subject unblinded to mutation status|0|||
48397905|NCT01262365|155649894|FG000|Overall Study|Lack of Efficacy|35|||
48397906|NCT01262365|155649895|FG001|Overall Study|Lack of Efficacy|30|||
48397907|NCT01262365|155649896|FG002|Overall Study|Lack of Efficacy|47|||
48397908|NCT01262365|155649894|FG000|Overall Study|Protocol Violation|3|||
48397909|NCT01262365|155649895|FG001|Overall Study|Protocol Violation|1|||
48397910|NCT01262365|155649896|FG002|Overall Study|Protocol Violation|1|||
48397911|NCT01262365|155649894|FG000|Overall Study|Lost to Follow-up|3|||
48779996|NCT02520531|157036493|FG000|Overall Study|Withdrawal by Subject|1|||
48779997|NCT02520531|157036494|FG001|Overall Study|Withdrawal by Subject|0|||
48779998|NCT02520531|157036493|FG000|Overall Study|Not study device|1|||
48397912|NCT01262365|155649895|FG001|Overall Study|Lost to Follow-up|7|||
48779999|NCT02520531|157036494|FG001|Overall Study|Not study device|0|||
48397913|NCT01262365|155649896|FG002|Overall Study|Lost to Follow-up|6|||
48780000|NCT03965052|157036495|FG000|Overall Study|Protocol Violation|1|||
48780001|NCT03965052|157036496|FG001|Overall Study|Protocol Violation|0|||
48780002|NCT01962974|157036502|FG000|Overall Study|Study termination|7|||
48780003|NCT02838017|157036503|FG000|Overall Study|Lost to Follow-up|14|||
48780004|NCT02838017|157036504|FG001|Overall Study|Lost to Follow-up|11|||
48780005|NCT01059617|157036509|FG000|Overall Study|Other|7|||
48780006|NCT01059617|157036510|FG001|Overall Study|Other|1|||
48780007|NCT01059617|157036511|FG002|Overall Study|Other|8|||
48780008|NCT01059617|157036512|FG003|Overall Study|Other|6|||
48780009|NCT01307501|157036513|FG000|Overall Study|Treatment Failure|1|||
48780010|NCT01307501|157036513|FG000|Overall Study|Death|20|||
48780011|NCT01307501|157036513|FG000|Overall Study|Lost to Follow-up|1|||
48397914|NCT01262365|155649894|FG000|Overall Study|Withdrawal by Subject|17|||
48397915|NCT01262365|155649895|FG001|Overall Study|Withdrawal by Subject|22|||
48397916|NCT01262365|155649896|FG002|Overall Study|Withdrawal by Subject|22|||
48397917|NCT01262365|155649894|FG000|Overall Study|Death|1|||
48397918|NCT01262365|155649895|FG001|Overall Study|Death|2|||
48397919|NCT01262365|155649896|FG002|Overall Study|Death|1|||
48397920|NCT01262365|155649894|FG000|Overall Study|Adverse Event|26|||
48397921|NCT01262365|155649895|FG001|Overall Study|Adverse Event|16|||
48397922|NCT01262365|155649896|FG002|Overall Study|Adverse Event|11|||
48397923|NCT01262365|155649894|FG000|Overall Study|sponsor decision|1|||
48397924|NCT01262365|155649895|FG001|Overall Study|sponsor decision|1|||
48397925|NCT01262365|155649896|FG002|Overall Study|sponsor decision|0|||
48397926|NCT01262365|155649894|FG000|Overall Study|Randomization error|1|||
48397927|NCT01262365|155649895|FG001|Overall Study|Randomization error|0|||
48397928|NCT01262365|155649896|FG002|Overall Study|Randomization error|2|||
48397929|NCT01262365|155649894|FG000|Overall Study|Non-compliance|1|||
48397930|NCT01262365|155649895|FG001|Overall Study|Non-compliance|0|||
48397931|NCT01262365|155649896|FG002|Overall Study|Non-compliance|2|||
48397932|NCT01262365|155649894|FG000|Overall Study|Suspected pregnancy|1|||
48397933|NCT01262365|155649895|FG001|Overall Study|Suspected pregnancy|0|||
48780012|NCT01307501|157036513|FG000|Overall Study|Starting Hospice|1|||
48780013|NCT00809757|157036514|FG000|Overall Study|Adverse Event|2|||
48397934|NCT01262365|155649896|FG002|Overall Study|Suspected pregnancy|0|||
48397935|NCT01262365|155649894|FG000|Overall Study|Patient pregnant|1|||
48780014|NCT00809757|157036515|FG001|Overall Study|Adverse Event|3|||
48780015|NCT00809757|157036516|FG002|Overall Study|Adverse Event|3|||
48780016|NCT00809757|157036514|FG000|Overall Study|Lost to Follow-up|0|||
48397936|NCT01262365|155649895|FG001|Overall Study|Patient pregnant|0|||
48780017|NCT00809757|157036515|FG001|Overall Study|Lost to Follow-up|0|||
48780018|NCT00809757|157036516|FG002|Overall Study|Lost to Follow-up|1|||
48780019|NCT00809757|157036514|FG000|Overall Study|Protocol Violation|1|||
48397937|NCT01262365|155649896|FG002|Overall Study|Patient pregnant|1|||
48397938|NCT01262365|155649894|FG000|Overall Study|Toxicity related to study drug|0|||
48780020|NCT00809757|157036515|FG001|Overall Study|Protocol Violation|1|||
48780021|NCT00809757|157036516|FG002|Overall Study|Protocol Violation|1|||
48780022|NCT00809757|157036514|FG000|Overall Study|Withdrawal by Subject|2|||
48780023|NCT00809757|157036515|FG001|Overall Study|Withdrawal by Subject|1|||
48780024|NCT00809757|157036516|FG002|Overall Study|Withdrawal by Subject|3|||
48780025|NCT00809757|157036514|FG000|Overall Study|Subject Uncooperative|1|||
48780026|NCT00809757|157036515|FG001|Overall Study|Subject Uncooperative|0|||
48780027|NCT00809757|157036516|FG002|Overall Study|Subject Uncooperative|2|||
48780028|NCT00809757|157036514|FG000|Overall Study|Noncompliance with Medication|0|||
48780029|NCT00809757|157036515|FG001|Overall Study|Noncompliance with Medication|0|||
48780030|NCT00809757|157036516|FG002|Overall Study|Noncompliance with Medication|1|||
48780031|NCT05819749|157036517|FG000|Overall Study|Lost to Follow-up|1|||
48780032|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
48780033|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780034|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780035|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780036|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780037|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48780038|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
48780039|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780040|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780041|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780042|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780043|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48780044|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
48780045|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780046|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780047|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780048|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780049|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48780050|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
48780051|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48780052|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48780053|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48780054|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48780055|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48780056|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
48780057|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780058|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780059|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780060|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780061|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48780062|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
48780063|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780064|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780065|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780066|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780067|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
48780068|NCT02139644|157038445|FG000|Run-In Period (Pre-assignment)|Other|6|||
48780069|NCT02139644|157038446|FG001|Run-In Period (Pre-assignment)|Other|0|||
48780070|NCT02139644|157038447|FG002|Run-In Period (Pre-assignment)|Other|0|||
48780071|NCT02139644|157038448|FG003|Run-In Period (Pre-assignment)|Other|0|||
48780072|NCT02139644|157038449|FG004|Run-In Period (Pre-assignment)|Other|0|||
48780073|NCT02139644|157038450|FG005|Run-In Period (Pre-assignment)|Other|0|||
48780074|NCT02139644|157038445|FG000|Treatment Period|Adverse Event|0|||
48780075|NCT02139644|157038446|FG001|Treatment Period|Adverse Event|0|||
48780076|NCT02139644|157038447|FG002|Treatment Period|Adverse Event|3|||
48780077|NCT02139644|157038448|FG003|Treatment Period|Adverse Event|2|||
48780078|NCT02139644|157038449|FG004|Treatment Period|Adverse Event|1|||
48780079|NCT02139644|157038450|FG005|Treatment Period|Adverse Event|6|||
48780080|NCT02139644|157038445|FG000|Treatment Period|Withdrawal by Subject|0|||
48780081|NCT02139644|157038446|FG001|Treatment Period|Withdrawal by Subject|0|||
48780082|NCT02139644|157038447|FG002|Treatment Period|Withdrawal by Subject|2|||
48780083|NCT02139644|157038448|FG003|Treatment Period|Withdrawal by Subject|2|||
48780084|NCT02139644|157038449|FG004|Treatment Period|Withdrawal by Subject|3|||
48780085|NCT02139644|157038450|FG005|Treatment Period|Withdrawal by Subject|2|||
48780086|NCT02139644|157038445|FG000|Treatment Period|Non-compliance|0|||
48780087|NCT02139644|157038446|FG001|Treatment Period|Non-compliance|0|||
48780088|NCT02139644|157038447|FG002|Treatment Period|Non-compliance|0|||
48780089|NCT02139644|157038448|FG003|Treatment Period|Non-compliance|1|||
48780090|NCT02139644|157038449|FG004|Treatment Period|Non-compliance|0|||
48780091|NCT02139644|157038450|FG005|Treatment Period|Non-compliance|0|||
48780092|NCT02139644|157038445|FG000|Treatment Period|Protocol Violation|0|||
48780093|NCT02139644|157038446|FG001|Treatment Period|Protocol Violation|0|||
48780094|NCT02139644|157038447|FG002|Treatment Period|Protocol Violation|0|||
48780095|NCT02139644|157038448|FG003|Treatment Period|Protocol Violation|1|||
48780096|NCT02139644|157038449|FG004|Treatment Period|Protocol Violation|1|||
48780097|NCT02139644|157038450|FG005|Treatment Period|Protocol Violation|1|||
48780098|NCT02139644|157038445|FG000|Treatment Period|Disease progression|0|||
48780099|NCT02139644|157038446|FG001|Treatment Period|Disease progression|0|||
48780100|NCT02139644|157038447|FG002|Treatment Period|Disease progression|0|||
48780101|NCT02139644|157038448|FG003|Treatment Period|Disease progression|1|||
48780102|NCT02139644|157038449|FG004|Treatment Period|Disease progression|1|||
48780103|NCT02139644|157038450|FG005|Treatment Period|Disease progression|2|||
48780104|NCT02139644|157038445|FG000|Treatment Period|Lost to Follow-up|0|||
48780105|NCT02139644|157038446|FG001|Treatment Period|Lost to Follow-up|0|||
48780106|NCT02139644|157038447|FG002|Treatment Period|Lost to Follow-up|1|||
48780107|NCT02139644|157038448|FG003|Treatment Period|Lost to Follow-up|1|||
48780108|NCT02139644|157038449|FG004|Treatment Period|Lost to Follow-up|1|||
48780109|NCT02139644|157038450|FG005|Treatment Period|Lost to Follow-up|1|||
48780110|NCT02139644|157038445|FG000|Treatment Period|Lack of Efficacy|0|||
48780111|NCT02139644|157038446|FG001|Treatment Period|Lack of Efficacy|0|||
48780112|NCT02139644|157038447|FG002|Treatment Period|Lack of Efficacy|1|||
48780113|NCT02139644|157038448|FG003|Treatment Period|Lack of Efficacy|0|||
48780114|NCT02139644|157038449|FG004|Treatment Period|Lack of Efficacy|1|||
48780115|NCT02139644|157038450|FG005|Treatment Period|Lack of Efficacy|4|||
48780116|NCT02139644|157038445|FG000|Treatment Period|Other|0|||
48780117|NCT02139644|157038446|FG001|Treatment Period|Other|3|||
48780118|NCT02139644|157038447|FG002|Treatment Period|Other|1|||
48780119|NCT02139644|157038448|FG003|Treatment Period|Other|1|||
48780120|NCT02139644|157038449|FG004|Treatment Period|Other|0|||
48780121|NCT02139644|157038450|FG005|Treatment Period|Other|1|||
48780122|NCT02066298|157038451|FG000|Overall Study|Lost to Follow-up|3|||
48780123|NCT02066298|157038452|FG001|Overall Study|Lost to Follow-up|2|||
48780124|NCT02066298|157038453|FG002|Overall Study|Lost to Follow-up|3|||
48780125|NCT02066298|157038454|FG003|Overall Study|Lost to Follow-up|2|||
48780126|NCT02066298|157038455|FG004|Overall Study|Lost to Follow-up|3|||
48780127|NCT02066298|157038456|FG005|Overall Study|Lost to Follow-up|4|||
48780128|NCT02066298|157038451|FG000|Overall Study|Withdrawal by Subject|6|||
48780129|NCT02066298|157038452|FG001|Overall Study|Withdrawal by Subject|6|||
48780130|NCT02066298|157038453|FG002|Overall Study|Withdrawal by Subject|6|||
48780131|NCT02066298|157038454|FG003|Overall Study|Withdrawal by Subject|4|||
48780132|NCT02066298|157038455|FG004|Overall Study|Withdrawal by Subject|5|||
48780133|NCT02066298|157038456|FG005|Overall Study|Withdrawal by Subject|8|||
48780134|NCT02066298|157038451|FG000|Overall Study|Physician Decision|0|||
48780135|NCT02066298|157038452|FG001|Overall Study|Physician Decision|0|||
48780136|NCT02066298|157038453|FG002|Overall Study|Physician Decision|1|||
48780137|NCT02066298|157038454|FG003|Overall Study|Physician Decision|0|||
48780138|NCT02066298|157038455|FG004|Overall Study|Physician Decision|1|||
48780139|NCT02066298|157038456|FG005|Overall Study|Physician Decision|0|||
48780140|NCT04260191|157038457|FG000|Overall Study|Decision by Sponsor|0|||
48780141|NCT04260191|157038458|FG001|Overall Study|Decision by Sponsor|1|||
48780142|NCT04260191|157038459|FG002|Overall Study|Decision by Sponsor|0|||
48780143|NCT04260191|157038457|FG000|Overall Study|Withdrawal by Subject|1|||
48780144|NCT04260191|157038458|FG001|Overall Study|Withdrawal by Subject|0|||
48780145|NCT04260191|157038459|FG002|Overall Study|Withdrawal by Subject|3|||
48780146|NCT04260191|157038457|FG000|Overall Study|Death|4|||
48780147|NCT04260191|157038458|FG001|Overall Study|Death|3|||
48780148|NCT04260191|157038459|FG002|Overall Study|Death|2|||
48780149|NCT00630877|157038462|FG000|Overall Study|Adverse Event|11|||
48780150|NCT00630877|157038463|FG001|Overall Study|Adverse Event|8|||
48780151|NCT00630877|157038464|FG002|Overall Study|Adverse Event|7|||
48780152|NCT00630877|157038462|FG000|Overall Study|Withdrawal by Subject|3|||
48780153|NCT00630877|157038463|FG001|Overall Study|Withdrawal by Subject|4|||
48780154|NCT00630877|157038464|FG002|Overall Study|Withdrawal by Subject|0|||
48780155|NCT00630877|157038462|FG000|Overall Study|Lost to Follow-up|2|||
48780156|NCT00630877|157038463|FG001|Overall Study|Lost to Follow-up|0|||
48780157|NCT00630877|157038464|FG002|Overall Study|Lost to Follow-up|0|||
48780158|NCT00630877|157038462|FG000|Overall Study|Noncompliance|2|||
48780159|NCT00630877|157038463|FG001|Overall Study|Noncompliance|3|||
48780160|NCT00630877|157038464|FG002|Overall Study|Noncompliance|1|||
48780161|NCT00630877|157038462|FG000|Overall Study|Protocol violation|1|||
48780162|NCT00630877|157038463|FG001|Overall Study|Protocol violation|0|||
48780163|NCT00630877|157038464|FG002|Overall Study|Protocol violation|1|||
48780164|NCT00630877|157038462|FG000|Overall Study|Personal reasons|0|||
48780165|NCT00630877|157038463|FG001|Overall Study|Personal reasons|0|||
48780166|NCT00630877|157038464|FG002|Overall Study|Personal reasons|1|||
48780167|NCT01913041|157038469|FG000|Overall Study|Protocol Violation|35|||
48780168|NCT01913041|157038469|FG000|Overall Study|Withdrawal by Subject|3|||
48780169|NCT01913041|157038469|FG000|Overall Study|Physician Decision|1|||
48780170|NCT01794949|157038472|FG000|Overall Study|Lost to Follow-up|1|||
48780171|NCT01794949|157038473|FG001|Overall Study|Lost to Follow-up|0|||
48397939|NCT01262365|155649895|FG001|Overall Study|Toxicity related to study drug|1|||
48397940|NCT01262365|155649896|FG002|Overall Study|Toxicity related to study drug|0|||
48397941|NCT01262365|155649894|FG000|Overall Study|Cannot tolerate the protocol|0|||
48397942|NCT01262365|155649895|FG001|Overall Study|Cannot tolerate the protocol|1|||
48397943|NCT01262365|155649896|FG002|Overall Study|Cannot tolerate the protocol|0|||
48397944|NCT01262365|155649894|FG000|Overall Study|Patient unavailable|0|||
48397945|NCT01262365|155649895|FG001|Overall Study|Patient unavailable|0|||
48397946|NCT01262365|155649896|FG002|Overall Study|Patient unavailable|1|||
48397947|NCT01368835|155649897|FG000|Overall Study|Inclusion criteria/photography quality|22|||
48397948|NCT01368835|155649897|FG000|Overall Study|Lost to Follow-up|11|||
48397949|NCT01594853|155649898|FG000|Overall Study|Withdrawal by Subject|1|||
48397950|NCT01594853|155649899|FG001|Overall Study|Withdrawal by Subject|1|||
48397951|NCT01594853|155649898|FG000|Overall Study|Lost to Follow-up|1|||
48397952|NCT01594853|155649899|FG001|Overall Study|Lost to Follow-up|1|||
48397953|NCT01594853|155649898|FG000|Overall Study|noncompliance with exercise|0|||
48397954|NCT01594853|155649899|FG001|Overall Study|noncompliance with exercise|1|||
48397955|NCT00769002|155649902|FG000|Overall Study|Study was not completed, no data|9|||
48397956|NCT00769002|155649903|FG001|Overall Study|Study was not completed, no data|9|||
48397957|NCT03776175|155649905|FG000|Treatment Period (42 Days)|Adverse Event|0|||
48397958|NCT03776175|155649906|FG001|Treatment Period (42 Days)|Adverse Event|1|||
48397959|NCT03776175|155649907|FG002|Treatment Period (42 Days)|Adverse Event|1|||
48397960|NCT03776175|155649908|FG003|Treatment Period (42 Days)|Adverse Event|0|||
48397961|NCT03776175|155649905|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
48397962|NCT03776175|155649906|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
48397963|NCT03776175|155649907|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
48780172|NCT00226941|157038474|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
48780173|NCT00226941|157038475|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
48780174|NCT00226941|157038476|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
48780175|NCT00226941|157038477|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
48397964|NCT03776175|155649908|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
48397965|NCT03776175|155649905|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
48397966|NCT03776175|155649906|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
48397967|NCT03776175|155649907|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
48780176|NCT00226941|157038474|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
48780177|NCT00226941|157038475|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
48780178|NCT00226941|157038476|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
48780179|NCT00226941|157038477|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
48780180|NCT00844194|157038482|FG000|Overall Study|Adverse Event|17|||
48780181|NCT00844194|157038483|FG001|Overall Study|Adverse Event|5|||
48780182|NCT00844194|157038482|FG000|Overall Study|Protocol Violation|1|||
48780183|NCT00844194|157038483|FG001|Overall Study|Protocol Violation|1|||
48780184|NCT00844194|157038482|FG000|Overall Study|Lost to Follow-up|1|||
48780185|NCT00844194|157038483|FG001|Overall Study|Lost to Follow-up|1|||
48780186|NCT00844194|157038482|FG000|Overall Study|Withdrawal by Subject|2|||
48780187|NCT00844194|157038483|FG001|Overall Study|Withdrawal by Subject|1|||
48780188|NCT00844194|157038482|FG000|Overall Study|Lack of Efficacy|3|||
48780189|NCT00844194|157038483|FG001|Overall Study|Lack of Efficacy|0|||
48780190|NCT00844194|157038482|FG000|Overall Study|Other reason (not specified)|1|||
48780191|NCT00844194|157038483|FG001|Overall Study|Other reason (not specified)|0|||
48780192|NCT01542528|157038484|FG000|Overall Study|Lost to Follow-up|2|||
48780193|NCT01542528|157038485|FG001|Overall Study|Lost to Follow-up|1|||
48780194|NCT01542528|157038484|FG000|Overall Study|Physician Decision|1|||
48780195|NCT01542528|157038485|FG001|Overall Study|Physician Decision|0|||
48780196|NCT01542528|157038484|FG000|Overall Study|Withdrawal by Subject|9|||
48780197|NCT01542528|157038485|FG001|Overall Study|Withdrawal by Subject|6|||
48780198|NCT05282004|157038486|FG000|Overall Study|Adverse Event|2|||
48780199|NCT01332305|157038487|FG000|Overall Study|Adverse Event|1|||
48780200|NCT01332305|157038488|FG001|Overall Study|Adverse Event|4|||
48780201|NCT01332305|157038489|FG002|Overall Study|Adverse Event|6|||
48780202|NCT01332305|157038490|FG003|Overall Study|Adverse Event|3|||
48780203|NCT01332305|157038491|FG004|Overall Study|Adverse Event|5|||
48780204|NCT01332305|157038487|FG000|Overall Study|Withdrawal by Subject|6|||
48780205|NCT01332305|157038488|FG001|Overall Study|Withdrawal by Subject|5|||
48780206|NCT01332305|157038489|FG002|Overall Study|Withdrawal by Subject|4|||
48780207|NCT01332305|157038490|FG003|Overall Study|Withdrawal by Subject|1|||
48780208|NCT01332305|157038491|FG004|Overall Study|Withdrawal by Subject|0|||
48780209|NCT01332305|157038487|FG000|Overall Study|Lost to Follow-up|0|||
48780210|NCT01332305|157038488|FG001|Overall Study|Lost to Follow-up|2|||
48780211|NCT01332305|157038489|FG002|Overall Study|Lost to Follow-up|3|||
48780212|NCT01332305|157038490|FG003|Overall Study|Lost to Follow-up|2|||
48780213|NCT01332305|157038491|FG004|Overall Study|Lost to Follow-up|3|||
48780214|NCT01332305|157038487|FG000|Overall Study|Protocol Violation|1|||
48780215|NCT01332305|157038488|FG001|Overall Study|Protocol Violation|2|||
48780216|NCT01332305|157038489|FG002|Overall Study|Protocol Violation|1|||
48780217|NCT01332305|157038490|FG003|Overall Study|Protocol Violation|0|||
48780218|NCT01332305|157038491|FG004|Overall Study|Protocol Violation|3|||
48780219|NCT01332305|157038487|FG000|Overall Study|Withdrawal by Sponsor|1|||
48780220|NCT01332305|157038488|FG001|Overall Study|Withdrawal by Sponsor|0|||
48780221|NCT01332305|157038489|FG002|Overall Study|Withdrawal by Sponsor|0|||
48780222|NCT01332305|157038490|FG003|Overall Study|Withdrawal by Sponsor|1|||
48780223|NCT01332305|157038491|FG004|Overall Study|Withdrawal by Sponsor|1|||
48780224|NCT01332305|157038487|FG000|Overall Study|Treatment Failure|1|||
48780225|NCT01332305|157038488|FG001|Overall Study|Treatment Failure|1|||
48780226|NCT01332305|157038489|FG002|Overall Study|Treatment Failure|0|||
48780227|NCT01332305|157038490|FG003|Overall Study|Treatment Failure|0|||
48780228|NCT01332305|157038491|FG004|Overall Study|Treatment Failure|0|||
48780229|NCT01332305|157038487|FG000|Overall Study|Physician Decision|0|||
48780230|NCT01332305|157038488|FG001|Overall Study|Physician Decision|0|||
48780231|NCT01332305|157038489|FG002|Overall Study|Physician Decision|0|||
48780232|NCT01332305|157038490|FG003|Overall Study|Physician Decision|1|||
48780233|NCT01332305|157038491|FG004|Overall Study|Physician Decision|0|||
48397968|NCT03776175|155649908|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
48397969|NCT03776175|155649905|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
48397970|NCT03776175|155649906|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
48397971|NCT03776175|155649907|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
48397972|NCT03776175|155649908|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
48397973|NCT03776175|155649905|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
48397974|NCT03776175|155649906|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
48397975|NCT03776175|155649907|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
48397976|NCT03776175|155649908|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
48780234|NCT01931839|157038492|FG000|Overall Study|Death|0|||
48780235|NCT01931839|157038493|FG001|Overall Study|Death|1|||
48780236|NCT01931839|157038494|FG002|Overall Study|Death|2|||
48780237|NCT01931839|157038495|FG003|Overall Study|Death|0|||
48780238|NCT01931839|157038496|FG004|Overall Study|Death|0|||
48780239|NCT01931839|157038497|FG005|Overall Study|Death|0|||
48780240|NCT01931839|157038498|FG006|Overall Study|Death|0|||
48780241|NCT01931839|157038492|FG000|Overall Study|Physician Decision|1|||
48780242|NCT01931839|157038493|FG001|Overall Study|Physician Decision|0|||
48780243|NCT01931839|157038494|FG002|Overall Study|Physician Decision|1|||
48780244|NCT01931839|157038495|FG003|Overall Study|Physician Decision|0|||
48780245|NCT01931839|157038496|FG004|Overall Study|Physician Decision|0|||
48780246|NCT01931839|157038497|FG005|Overall Study|Physician Decision|0|||
48780247|NCT01931839|157038498|FG006|Overall Study|Physician Decision|1|||
48780248|NCT01931839|157038492|FG000|Overall Study|Withdrawal of consent|0|||
48780249|NCT01931839|157038493|FG001|Overall Study|Withdrawal of consent|0|||
48780250|NCT01931839|157038494|FG002|Overall Study|Withdrawal of consent|0|||
48780251|NCT01931839|157038495|FG003|Overall Study|Withdrawal of consent|0|||
48780252|NCT01931839|157038496|FG004|Overall Study|Withdrawal of consent|1|||
48780253|NCT01931839|157038497|FG005|Overall Study|Withdrawal of consent|0|||
48780254|NCT01931839|157038498|FG006|Overall Study|Withdrawal of consent|0|||
48780255|NCT01931839|157038492|FG000|Overall Study|Adverse Event|9|||
48780256|NCT01931839|157038493|FG001|Overall Study|Adverse Event|4|||
48780257|NCT01931839|157038494|FG002|Overall Study|Adverse Event|1|||
48780258|NCT01931839|157038495|FG003|Overall Study|Adverse Event|3|||
48780259|NCT01931839|157038496|FG004|Overall Study|Adverse Event|0|||
48780260|NCT01931839|157038497|FG005|Overall Study|Adverse Event|0|||
48780261|NCT01931839|157038498|FG006|Overall Study|Adverse Event|1|||
48780262|NCT01931839|157038492|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
48780263|NCT01931839|157038493|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
48780264|NCT01931839|157038494|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
48780265|NCT01931839|157038495|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
48780266|NCT01931839|157038496|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
48780267|NCT01931839|157038497|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
48780268|NCT01931839|157038498|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
48780269|NCT01931839|157038492|FG000|Overall Study|Other non-compliance|15|||
48780270|NCT01931839|157038493|FG001|Overall Study|Other non-compliance|9|||
48780271|NCT01931839|157038494|FG002|Overall Study|Other non-compliance|12|||
48780272|NCT01931839|157038495|FG003|Overall Study|Other non-compliance|3|||
48780273|NCT01931839|157038496|FG004|Overall Study|Other non-compliance|0|||
48780274|NCT01931839|157038497|FG005|Overall Study|Other non-compliance|3|||
48780275|NCT01931839|157038498|FG006|Overall Study|Other non-compliance|0|||
48780276|NCT01931839|157038492|FG000|Overall Study|Lost to Follow-up|1|||
48780277|NCT01931839|157038493|FG001|Overall Study|Lost to Follow-up|2|||
48780278|NCT01931839|157038494|FG002|Overall Study|Lost to Follow-up|4|||
48780279|NCT01931839|157038495|FG003|Overall Study|Lost to Follow-up|5|||
48780280|NCT01931839|157038496|FG004|Overall Study|Lost to Follow-up|0|||
48780281|NCT01931839|157038497|FG005|Overall Study|Lost to Follow-up|0|||
48780282|NCT01931839|157038498|FG006|Overall Study|Lost to Follow-up|0|||
48780283|NCT01931839|157038492|FG000|Overall Study|Other|4|||
48780284|NCT01931839|157038493|FG001|Overall Study|Other|2|||
48780285|NCT01931839|157038494|FG002|Overall Study|Other|6|||
48780286|NCT01931839|157038495|FG003|Overall Study|Other|0|||
48780287|NCT01931839|157038496|FG004|Overall Study|Other|0|||
48780288|NCT01931839|157038497|FG005|Overall Study|Other|0|||
48780289|NCT01931839|157038498|FG006|Overall Study|Other|0|||
48780290|NCT03224468|157038499|FG000|Overall Study|Did not obtain MM card|53|||
48780291|NCT03224468|157038500|FG001|Overall Study|Did not obtain MM card|0|||
48780292|NCT03224468|157038499|FG000|Overall Study|Lost to Follow-up|4|||
48780293|NCT03224468|157038500|FG001|Overall Study|Lost to Follow-up|11|||
48780294|NCT03224468|157038499|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
48780295|NCT03224468|157038500|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
48780296|NCT01557946|157038501|FG000|Overall Study|Adverse Event|3|||
48780297|NCT01557946|157038502|FG001|Overall Study|Adverse Event|0|||
48780298|NCT04321460|157038503|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
48780299|NCT04321460|157038504|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
48780300|NCT01038921|157038505|FG000|Overall Study|Withdrawal by Subject|1|||
48780301|NCT01038921|157038506|FG001|Overall Study|Withdrawal by Subject|0|||
48780302|NCT01038921|157038505|FG000|Overall Study|Physician Decision|1|||
48780303|NCT01038921|157038506|FG001|Overall Study|Physician Decision|0|||
48780304|NCT01709227|157038507|FG000|Overall Study|Physician Decision|1|||
48780305|NCT01709227|157038508|FG001|Overall Study|Physician Decision|0|||
48780306|NCT01709227|157038507|FG000|Overall Study|Pleural Peritoneal communication|0|||
48780307|NCT01709227|157038508|FG001|Overall Study|Pleural Peritoneal communication|9|||
48780308|NCT00572572|157038510|FG000|Overall Study|Withdrawal by Subject|3|||
48780309|NCT00572572|157038511|FG001|Overall Study|Withdrawal by Subject|6|||
48780310|NCT01958918|157038516|FG000|Overall Study|Death|1|||
48780311|NCT01958918|157038517|FG001|Overall Study|Death|3|||
48780312|NCT01958918|157038516|FG000|Overall Study|Lost to Follow-up|4|||
48780313|NCT01958918|157038517|FG001|Overall Study|Lost to Follow-up|7|||
48780314|NCT01958918|157038516|FG000|Overall Study|Withdrawal by Subject|13|||
48780315|NCT01958918|157038517|FG001|Overall Study|Withdrawal by Subject|8|||
48780316|NCT01958918|157038516|FG000|Overall Study|Lack of Efficacy|13|||
48780317|NCT01958918|157038517|FG001|Overall Study|Lack of Efficacy|10|||
48780318|NCT01958918|157038516|FG000|Overall Study|Adverse Event|12|||
48780319|NCT01958918|157038517|FG001|Overall Study|Adverse Event|12|||
48780320|NCT01958918|157038516|FG000|Overall Study|administrative problems|0|||
48780321|NCT01958918|157038517|FG001|Overall Study|administrative problems|2|||
48780322|NCT00659269|157038518|FG000|Overall Study|Physician Decision|1|||
48780323|NCT00659269|157038519|FG001|Overall Study|Physician Decision|1|||
48780324|NCT04258020|157038520|FG000|Overall Study|Withdrawal by Subject|1|||
48780325|NCT04258020|157038521|FG001|Overall Study|Withdrawal by Subject|0|||
48780326|NCT01047683|157038522|FG000|Overall Study|Adverse Event|3|||
48780327|NCT01047683|157038523|FG001|Overall Study|Adverse Event|1|||
48780328|NCT01047683|157038524|FG002|Overall Study|Adverse Event|0|||
48780329|NCT01047683|157038522|FG000|Overall Study|Withdrew Consent|1|||
48780330|NCT01047683|157038523|FG001|Overall Study|Withdrew Consent|4|||
48780331|NCT01047683|157038524|FG002|Overall Study|Withdrew Consent|2|||
48780332|NCT01047683|157038522|FG000|Overall Study|Lost to Follow-up|0|||
48780333|NCT01047683|157038523|FG001|Overall Study|Lost to Follow-up|1|||
48780334|NCT01047683|157038524|FG002|Overall Study|Lost to Follow-up|0|||
48780335|NCT01047683|157038522|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
48780336|NCT01047683|157038523|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
48780337|NCT01047683|157038524|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
48780338|NCT03095417|157038525|FG000|Overall Study|missed|1|||
48780339|NCT03095417|157038526|FG001|Overall Study|missed|2|||
48780340|NCT03095417|157038527|FG002|Overall Study|missed|0|||
48780341|NCT03095417|157038528|FG003|Overall Study|missed|1|||
48780342|NCT03095417|157038525|FG000|Overall Study|Lost to Follow-up|2|||
48780343|NCT03095417|157038526|FG001|Overall Study|Lost to Follow-up|2|||
48780344|NCT03095417|157038527|FG002|Overall Study|Lost to Follow-up|1|||
48780345|NCT03095417|157038528|FG003|Overall Study|Lost to Follow-up|0|||
48780346|NCT03095417|157038525|FG000|Overall Study|refusal|0|||
48780347|NCT03095417|157038526|FG001|Overall Study|refusal|1|||
48780348|NCT03095417|157038527|FG002|Overall Study|refusal|0|||
48780349|NCT03095417|157038528|FG003|Overall Study|refusal|1|||
48780350|NCT03095417|157038525|FG000|Overall Study|Withdrawal by Subject|8|||
48780351|NCT03095417|157038526|FG001|Overall Study|Withdrawal by Subject|2|||
48780352|NCT03095417|157038527|FG002|Overall Study|Withdrawal by Subject|5|||
48780353|NCT03095417|157038528|FG003|Overall Study|Withdrawal by Subject|4|||
48780354|NCT03095417|157038525|FG000|Overall Study|Physician Decision|1|||
48780355|NCT03095417|157038526|FG001|Overall Study|Physician Decision|2|||
48780356|NCT03095417|157038527|FG002|Overall Study|Physician Decision|2|||
48780357|NCT03095417|157038528|FG003|Overall Study|Physician Decision|2|||
48780358|NCT03095417|157038525|FG000|Overall Study|Death|1|||
48780359|NCT03095417|157038526|FG001|Overall Study|Death|2|||
48780360|NCT03095417|157038527|FG002|Overall Study|Death|1|||
48780361|NCT03095417|157038528|FG003|Overall Study|Death|3|||
48780362|NCT02806986|157038529|FG000|Treatment Stage 1|Adverse Event|1|||
48780363|NCT02806986|157038529|FG000|Treatment Stage 2|Adverse Event|3|||
48780364|NCT02806986|157038529|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
48780365|NCT00346034|157038530|FG000|Overall Study|Adverse Event|34|||
48780366|NCT00346034|157038530|FG000|Overall Study|Lack of Efficacy|8|||
48780367|NCT00346034|157038530|FG000|Overall Study|Withdrawal by Subject|13|||
48780368|NCT00346034|157038530|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
48780369|NCT00346034|157038530|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
48780370|NCT01877421|157038531|FG000|Phase 2|Lost to Follow-up|0|||
48780371|NCT01877421|157038532|FG001|Phase 2|Lost to Follow-up|0|||
48780372|NCT01877421|157038533|FG002|Phase 2|Lost to Follow-up|0|||
48780373|NCT01877421|157038534|FG003|Phase 2|Lost to Follow-up|0|||
48780374|NCT01877421|157038535|FG004|Phase 2|Lost to Follow-up|0|||
48780375|NCT01877421|157038536|FG005|Phase 2|Lost to Follow-up|0|||
48780376|NCT01877421|157038537|FG006|Phase 2|Lost to Follow-up|1|||
48780377|NCT01877421|157038538|FG007|Phase 2|Lost to Follow-up|0|||
48780378|NCT01877421|157038539|FG008|Phase 2|Lost to Follow-up|0|||
48780379|NCT01877421|157038540|FG009|Phase 2|Lost to Follow-up|0|||
48780380|NCT01877421|157038541|FG010|Phase 2|Lost to Follow-up|0|||
48780381|NCT01877421|157038542|FG011|Phase 2|Lost to Follow-up|0|||
48780382|NCT01877421|157038543|FG012|Phase 2|Lost to Follow-up|0|||
48780383|NCT01877421|157038544|FG013|Phase 2|Lost to Follow-up|0|||
48780384|NCT01877421|157038545|FG014|Phase 2|Lost to Follow-up|0|||
48780385|NCT01877421|157038546|FG015|Phase 2|Lost to Follow-up|0|||
48780386|NCT01877421|157038547|FG016|Phase 2|Lost to Follow-up|0|||
48397977|NCT03776175|155649905|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
48397978|NCT03776175|155649906|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
48397979|NCT03776175|155649907|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
48397980|NCT03776175|155649908|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
48397981|NCT01784965|155649912|FG000|Overall Study|Withdrawal by Subject|6|||
48397982|NCT01784965|155649913|FG001|Overall Study|Withdrawal by Subject|3|||
48397983|NCT01784965|155649912|FG000|Overall Study|Adverse Event|0|||
48397984|NCT01784965|155649913|FG001|Overall Study|Adverse Event|8|||
48397985|NCT00783094|155649914|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
48397986|NCT00783094|155649915|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
48397987|NCT00783094|155649916|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
48397988|NCT00783094|155649914|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
48397989|NCT00783094|155649915|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
48397990|NCT00783094|155649916|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
48397991|NCT00783094|155649914|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
48397992|NCT00783094|155649915|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
48397993|NCT00783094|155649916|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
48397994|NCT00783094|155649914|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
48397995|NCT00783094|155649915|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
48397996|NCT00783094|155649916|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
48397997|NCT00783094|155649914|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
48397998|NCT00783094|155649915|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
48397999|NCT00783094|155649916|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
48398000|NCT00783094|155649914|FG000|Open-Label Extension Period|Adverse Event|12|||
48398001|NCT00783094|155649915|FG001|Open-Label Extension Period|Adverse Event|7|||
48398002|NCT00783094|155649916|FG002|Open-Label Extension Period|Adverse Event|16|||
48398003|NCT00783094|155649914|FG000|Open-Label Extension Period|Death|0|||
48398004|NCT00783094|155649915|FG001|Open-Label Extension Period|Death|0|||
48398005|NCT00783094|155649916|FG002|Open-Label Extension Period|Death|1|||
48398006|NCT00783094|155649914|FG000|Open-Label Extension Period|Protocol Violation|4|||
48398007|NCT00783094|155649915|FG001|Open-Label Extension Period|Protocol Violation|5|||
48398008|NCT00783094|155649916|FG002|Open-Label Extension Period|Protocol Violation|7|||
48398009|NCT00783094|155649914|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
48398010|NCT00783094|155649915|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
48398011|NCT00783094|155649916|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
48398012|NCT00783094|155649914|FG000|Open-Label Extension Period|Physician Decision|4|||
48398013|NCT00783094|155649915|FG001|Open-Label Extension Period|Physician Decision|2|||
48398014|NCT00783094|155649916|FG002|Open-Label Extension Period|Physician Decision|3|||
48398015|NCT00783094|155649914|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
48780387|NCT01877421|157038548|FG017|Phase 2|Lost to Follow-up|0|||
48780388|NCT01877421|157038531|FG000|Phase 2|Withdrawal by Subject|0|||
48398016|NCT00783094|155649915|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
48398017|NCT00783094|155649916|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
48398018|NCT03313076|155649918|FG000|Overall Study|Withdrawal by Subject|2|||
48398019|NCT03313076|155649919|FG001|Overall Study|Withdrawal by Subject|0|||
48780389|NCT01877421|157038532|FG001|Phase 2|Withdrawal by Subject|0|||
48780390|NCT01877421|157038533|FG002|Phase 2|Withdrawal by Subject|0|||
48780391|NCT01877421|157038534|FG003|Phase 2|Withdrawal by Subject|0|||
48780392|NCT01877421|157038535|FG004|Phase 2|Withdrawal by Subject|0|||
48780393|NCT01877421|157038536|FG005|Phase 2|Withdrawal by Subject|0|||
48780394|NCT01877421|157038537|FG006|Phase 2|Withdrawal by Subject|0|||
48780395|NCT01877421|157038538|FG007|Phase 2|Withdrawal by Subject|0|||
48780396|NCT01877421|157038539|FG008|Phase 2|Withdrawal by Subject|1|||
48780397|NCT01877421|157038540|FG009|Phase 2|Withdrawal by Subject|0|||
48780398|NCT01877421|157038541|FG010|Phase 2|Withdrawal by Subject|1|||
48780399|NCT01877421|157038542|FG011|Phase 2|Withdrawal by Subject|0|||
48398020|NCT03313076|155649920|FG002|Overall Study|Withdrawal by Subject|0|||
48398021|NCT03313076|155649921|FG003|Overall Study|Withdrawal by Subject|0|||
48398022|NCT03313076|155649918|FG000|Overall Study|Lost to Follow-up|0|||
48398023|NCT03313076|155649919|FG001|Overall Study|Lost to Follow-up|2|||
48398024|NCT03313076|155649920|FG002|Overall Study|Lost to Follow-up|2|||
48398025|NCT03313076|155649921|FG003|Overall Study|Lost to Follow-up|2|||
48398026|NCT00915681|155649922|FG000|Overall Study|Screening failures|46|||
48398027|NCT03031301|155649925|FG000|Overall Study|Protocol Violation|4|||
48780400|NCT01877421|157038543|FG012|Phase 2|Withdrawal by Subject|1|||
48780401|NCT01877421|157038544|FG013|Phase 2|Withdrawal by Subject|0|||
48780402|NCT01877421|157038545|FG014|Phase 2|Withdrawal by Subject|0|||
48780403|NCT01877421|157038546|FG015|Phase 2|Withdrawal by Subject|1|||
48780404|NCT01877421|157038547|FG016|Phase 2|Withdrawal by Subject|0|||
48780405|NCT01877421|157038548|FG017|Phase 2|Withdrawal by Subject|0|||
48780406|NCT01877421|157038531|FG000|Phase 2|Protocol Violation|0|||
48780407|NCT01877421|157038532|FG001|Phase 2|Protocol Violation|0|||
48780408|NCT01877421|157038533|FG002|Phase 2|Protocol Violation|0|||
48780409|NCT01877421|157038534|FG003|Phase 2|Protocol Violation|0|||
48780410|NCT01877421|157038535|FG004|Phase 2|Protocol Violation|0|||
48780411|NCT01877421|157038536|FG005|Phase 2|Protocol Violation|0|||
48780412|NCT01877421|157038537|FG006|Phase 2|Protocol Violation|0|||
48780413|NCT01877421|157038538|FG007|Phase 2|Protocol Violation|0|||
48780414|NCT01877421|157038539|FG008|Phase 2|Protocol Violation|0|||
48780415|NCT01877421|157038540|FG009|Phase 2|Protocol Violation|0|||
48780416|NCT01877421|157038541|FG010|Phase 2|Protocol Violation|1|||
48780417|NCT01877421|157038542|FG011|Phase 2|Protocol Violation|0|||
48780418|NCT01877421|157038543|FG012|Phase 2|Protocol Violation|0|||
48780419|NCT01877421|157038544|FG013|Phase 2|Protocol Violation|0|||
48780420|NCT01877421|157038545|FG014|Phase 2|Protocol Violation|0|||
48780421|NCT01877421|157038546|FG015|Phase 2|Protocol Violation|0|||
48780422|NCT01877421|157038547|FG016|Phase 2|Protocol Violation|0|||
48780423|NCT01877421|157038548|FG017|Phase 2|Protocol Violation|0|||
48780424|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
48780425|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
48780426|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
48780427|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
48780428|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
48780429|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
48780430|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
48780431|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
48780432|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
48780433|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
48780434|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
48780435|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
48780436|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
48780437|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
48780438|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
48780439|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
48398028|NCT03031301|155649926|FG001|Overall Study|Protocol Violation|8|||
48398029|NCT03031301|155649925|FG000|Overall Study|Withdrawal by Subject|7|||
48398030|NCT03031301|155649926|FG001|Overall Study|Withdrawal by Subject|4|||
48398031|NCT03031301|155649925|FG000|Overall Study|Lost to Follow-up|4|||
48780440|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
48780441|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
48780442|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
48398032|NCT03031301|155649926|FG001|Overall Study|Lost to Follow-up|12|||
48780443|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
48780444|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
48780445|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
48780446|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
48398033|NCT03031301|155649925|FG000|Overall Study|Noncompliance|1|||
48398034|NCT03031301|155649926|FG001|Overall Study|Noncompliance|3|||
48398035|NCT03031301|155649925|FG000|Overall Study|Technical issue|1|||
48398036|NCT03031301|155649926|FG001|Overall Study|Technical issue|1|||
48398037|NCT03031301|155649925|FG000|Overall Study|Adverse Event|1|||
48780447|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
48780448|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
48780449|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
48780450|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
48780451|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
48780452|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
48780453|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
48780454|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
48780455|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
48780456|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
48780457|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
48780458|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
48780459|NCT00383435|157038549|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
48780460|NCT00383435|157038550|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
48780461|NCT00383435|157038551|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
48780462|NCT00383435|157038552|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
48780463|NCT00383435|157038553|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
48780464|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
48780465|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
48780466|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
48780467|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
48780468|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
48780469|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48780470|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48780471|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48780472|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48780473|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
48780474|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
48780475|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
48780476|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
48780477|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
48780478|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
48356460|NCT01575873|155501086|FG003|Overall Study|Lost to Follow-up|5|||
48356461|NCT01575873|155501083|FG000|Overall Study|Death|3|||
48356462|NCT01575873|155501084|FG001|Overall Study|Death|2|||
48356463|NCT01575873|155501085|FG002|Overall Study|Death|8|||
48356464|NCT01575873|155501086|FG003|Overall Study|Death|9|||
48356465|NCT01575873|155501083|FG000|Overall Study|Noncompliance|1|||
48356466|NCT01575873|155501084|FG001|Overall Study|Noncompliance|2|||
48356467|NCT01575873|155501085|FG002|Overall Study|Noncompliance|4|||
48356468|NCT01575873|155501086|FG003|Overall Study|Noncompliance|3|||
48356469|NCT01575873|155501083|FG000|Overall Study|Administrative decision|1|||
48356470|NCT01575873|155501084|FG001|Overall Study|Administrative decision|1|||
48356471|NCT01575873|155501085|FG002|Overall Study|Administrative decision|1|||
48356472|NCT01575873|155501086|FG003|Overall Study|Administrative decision|0|||
48356473|NCT01575873|155501083|FG000|Overall Study|Protocol deviation|0|||
48356474|NCT01575873|155501084|FG001|Overall Study|Protocol deviation|1|||
48356475|NCT01575873|155501085|FG002|Overall Study|Protocol deviation|0|||
48356476|NCT01575873|155501086|FG003|Overall Study|Protocol deviation|1|||
48356477|NCT01575873|155501083|FG000|Overall Study|Requirement for Alternative Therapy|0|||
48356478|NCT01575873|155501084|FG001|Overall Study|Requirement for Alternative Therapy|0|||
48356479|NCT01575873|155501085|FG002|Overall Study|Requirement for Alternative Therapy|1|||
48356480|NCT01575873|155501086|FG003|Overall Study|Requirement for Alternative Therapy|1|||
48356481|NCT01575873|155501083|FG000|Overall Study|Other|0|||
48356482|NCT01575873|155501084|FG001|Overall Study|Other|0|||
48356483|NCT01575873|155501085|FG002|Overall Study|Other|4|||
48356484|NCT01575873|155501086|FG003|Overall Study|Other|2|||
48356485|NCT04936685|155501087|FG000|Overall Study|Protocol Violation|1|||
48356486|NCT04936685|155501088|FG001|Overall Study|Protocol Violation|0|||
48356487|NCT00706654|155501089|FG000|Conversion Phase|Lost to Follow-up|4|||
48356488|NCT00706654|155501090|FG001|Conversion Phase|Lost to Follow-up|0|||
48356489|NCT00706654|155501091|FG002|Conversion Phase|Lost to Follow-up|0|||
48356490|NCT00706654|155501092|FG003|Conversion Phase|Lost to Follow-up|0|||
48356491|NCT00706654|155501089|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
48356492|NCT00706654|155501090|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
48356493|NCT00706654|155501091|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
48356494|NCT00706654|155501092|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
48356495|NCT00706654|155501089|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
48356496|NCT00706654|155501090|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
48356497|NCT00706654|155501091|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
48356498|NCT00706654|155501092|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
48356499|NCT00706654|155501089|FG000|Conversion Phase|Withdrawn by Investigator|14|||
48780479|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
48780480|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
48780481|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
48780482|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
48780483|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
48780484|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48780485|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
48780486|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
48780487|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
48780488|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48780489|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
48780490|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48780491|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48780492|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48780493|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
48780494|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48780495|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48780496|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48780497|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48780498|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48780499|NCT00383435|157038549|FG000|26-Week Treatment Safety Extension|Administrative|1|||
48780500|NCT00383435|157038550|FG001|26-Week Treatment Safety Extension|Administrative|1|||
48780501|NCT00383435|157038551|FG002|26-Week Treatment Safety Extension|Administrative|0|||
48780502|NCT00383435|157038552|FG003|26-Week Treatment Safety Extension|Administrative|1|||
48780503|NCT00383435|157038553|FG004|26-Week Treatment Safety Extension|Administrative|0|||
48780504|NCT01751568|157038554|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
48780505|NCT01751568|157038555|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
48780506|NCT01751568|157038556|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
48780507|NCT04776148|157038557|FG000|Overall Study|Death|172|||
48780508|NCT04776148|157038558|FG001|Overall Study|Death|188|||
48780509|NCT04776148|157038557|FG000|Overall Study|Lost to Follow-up|0|||
48780510|NCT04776148|157038558|FG001|Overall Study|Lost to Follow-up|1|||
48780511|NCT04776148|157038557|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48780512|NCT04776148|157038558|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48780513|NCT04776148|157038557|FG000|Overall Study|Withdrawal by Subject|2|||
48780514|NCT04776148|157038558|FG001|Overall Study|Withdrawal by Subject|4|||
48780515|NCT04776148|157038557|FG000|Overall Study|Ongoing in Study|67|||
48780516|NCT04776148|157038558|FG001|Overall Study|Ongoing in Study|45|||
48780517|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
48780518|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
48780519|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
48780520|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
48780521|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
48780522|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
48780523|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
48780524|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
48780525|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
48780526|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
48780527|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
48780528|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
48780529|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
48780530|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
48780531|NCT02464969|157038561|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
48780532|NCT02464969|157038562|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
48780533|NCT02464969|157038561|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
48780534|NCT02464969|157038562|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
48780535|NCT02464969|157038561|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
48780536|NCT02464969|157038562|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
48780537|NCT02464969|157038561|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
48780538|NCT02464969|157038562|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
48780539|NCT04572633|157038563|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
48780540|NCT02606136|157038566|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
48356500|NCT00706654|155501090|FG001|Conversion Phase|Withdrawn by Investigator|0|||
48398038|NCT03031301|155649926|FG001|Overall Study|Adverse Event|0|||
48780541|NCT02606136|157038566|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
48780542|NCT02606136|157038566|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
48780543|NCT02606136|157038566|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
48780544|NCT04456699|157038567|FG000|Overall Study|Death|48|||
48780545|NCT04456699|157038568|FG001|Overall Study|Death|50|||
48780546|NCT04456699|157038569|FG002|Overall Study|Death|52|||
48780547|NCT04456699|157038567|FG000|Overall Study|Physician Decision|0|||
48780548|NCT04456699|157038568|FG001|Overall Study|Physician Decision|0|||
48780549|NCT04456699|157038569|FG002|Overall Study|Physician Decision|2|||
48780550|NCT04456699|157038567|FG000|Overall Study|Sponsor Decision|55|||
48780551|NCT04456699|157038568|FG001|Overall Study|Sponsor Decision|61|||
48780552|NCT04456699|157038569|FG002|Overall Study|Sponsor Decision|50|||
48780553|NCT04456699|157038567|FG000|Overall Study|Withdrawal by Subject|8|||
48780554|NCT04456699|157038568|FG001|Overall Study|Withdrawal by Subject|4|||
48398039|NCT01784861|155649927|FG000|Overall Study|Adverse Event|0|||
48398040|NCT01784861|155649928|FG001|Overall Study|Adverse Event|0|||
48398041|NCT01784861|155649929|FG002|Overall Study|Adverse Event|1|||
48780555|NCT04456699|157038569|FG002|Overall Study|Withdrawal by Subject|5|||
48780556|NCT04079933|157038570|FG000|Overall Study|Withdrawal by Subject|3|||
48780557|NCT04079933|157038571|FG001|Overall Study|Withdrawal by Subject|4|||
48780558|NCT04079933|157038570|FG000|Overall Study|Lost to Follow-up|0|||
48780559|NCT04079933|157038571|FG001|Overall Study|Lost to Follow-up|1|||
48780560|NCT04788147|157038572|FG000|Overall Study|Screen Failure|3|||
48780561|NCT04788147|157038573|FG001|Overall Study|Screen Failure|10|||
48780562|NCT04788147|157038572|FG000|Overall Study|Incomplete RMRS image session|2|||
48780563|NCT04788147|157038573|FG001|Overall Study|Incomplete RMRS image session|0|||
48780564|NCT00781326|157038576|FG000|Phase I|Adverse Event|1|||
48780565|NCT00781326|157038576|FG000|Phase I|Withdrawal by Subject|1|||
48780566|NCT00781326|157038576|FG000|Phase I|Physician Decision|2|||
48780567|NCT05101252|157038577|FG000|Overall Study|Unsatisfactory Test Article|1|||
48780568|NCT05101252|157038578|FG001|Overall Study|Unsatisfactory Test Article|0|||
48780569|NCT05101252|157038577|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
48780570|NCT05101252|157038578|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
48780571|NCT05101252|157038577|FG000|Overall Study|Withdrew Consent during study|0|||
48780572|NCT05101252|157038578|FG001|Overall Study|Withdrew Consent during study|1|||
48780573|NCT05101252|157038577|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
48780574|NCT05101252|157038578|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
48780575|NCT01775137|157038579|FG000|Overall Study|Death|1|||
48780576|NCT01775137|157038579|FG000|Overall Study|Protocol deviation|2|||
48780577|NCT01775137|157038579|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48780578|NCT01775137|157038579|FG000|Overall Study|Adverse Event|1|||
48780579|NCT01775137|157038579|FG000|Overall Study|Withdrawal by participants|5|||
48780580|NCT00701051|157038580|FG000|Screening|Failed Screening|40|||
48780581|NCT00701051|157038581|FG001|Screening|Failed Screening|0|||
48780582|NCT00701051|157038582|FG002|Screening|Failed Screening|0|||
48780583|NCT00701051|157038580|FG000|Screening|Time conflicts|19|||
48780584|NCT00701051|157038581|FG001|Screening|Time conflicts|0|||
48780585|NCT00701051|157038582|FG002|Screening|Time conflicts|0|||
48780586|NCT00701051|157038580|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
48780587|NCT00701051|157038581|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
48780588|NCT00701051|157038582|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
48780589|NCT00345579|157038587|FG000|Overall Study|Adverse Event|9|||
48780590|NCT00345579|157038588|FG001|Overall Study|Adverse Event|6|||
48780591|NCT00345579|157038587|FG000|Overall Study|Protocol Violation|14|||
48780592|NCT00345579|157038588|FG001|Overall Study|Protocol Violation|5|||
48780593|NCT00345579|157038587|FG000|Overall Study|Withdrawal by Subject|50|||
48780594|NCT00345579|157038588|FG001|Overall Study|Withdrawal by Subject|17|||
48780595|NCT00345579|157038587|FG000|Overall Study|Lost to Follow-up|82|||
48780596|NCT00345579|157038588|FG001|Overall Study|Lost to Follow-up|36|||
48780597|NCT00345579|157038587|FG000|Overall Study|Other|9|||
48780598|NCT00345579|157038588|FG001|Overall Study|Other|1|||
48780599|NCT01731171|157038589|FG000|Overall Study|Withdrawal by Subject|4|||
48398042|NCT01784861|155649930|FG003|Overall Study|Adverse Event|2|||
48780600|NCT01731171|157038590|FG001|Overall Study|Withdrawal by Subject|1|||
48398043|NCT01784861|155649931|FG004|Overall Study|Adverse Event|1|||
48780601|NCT01731171|157038589|FG000|Overall Study|Lost to Follow-up|3|||
48780602|NCT01731171|157038590|FG001|Overall Study|Lost to Follow-up|2|||
48780603|NCT01731171|157038589|FG000|Overall Study|Moved out of Area|0|||
48780604|NCT01731171|157038590|FG001|Overall Study|Moved out of Area|2|||
48780605|NCT01731171|157038589|FG000|Overall Study|Terminated for Lack of Adherence|0|||
48780606|NCT01731171|157038590|FG001|Overall Study|Terminated for Lack of Adherence|1|||
48780607|NCT01731171|157038589|FG000|Overall Study|Terminated for Safety Reasons|0|||
48780608|NCT01731171|157038590|FG001|Overall Study|Terminated for Safety Reasons|1|||
48780609|NCT03653429|157038594|FG000|Overall Study|Physician Decision|4|||
48780610|NCT03653429|157038595|FG001|Overall Study|Physician Decision|10|||
48780611|NCT01040130|157038596|FG000|Overall Study|Adverse Event|1|||
48780612|NCT01040130|157038597|FG001|Overall Study|Adverse Event|1|||
48780613|NCT01040130|157038598|FG002|Overall Study|Adverse Event|0|||
48780614|NCT01040130|157038599|FG003|Overall Study|Adverse Event|5|||
48780615|NCT01040130|157038600|FG004|Overall Study|Adverse Event|0|||
48780616|NCT01040130|157038601|FG005|Overall Study|Adverse Event|3|||
48780617|NCT01040130|157038596|FG000|Overall Study|Protocol Violation|0|||
48780618|NCT01040130|157038597|FG001|Overall Study|Protocol Violation|0|||
48780619|NCT01040130|157038598|FG002|Overall Study|Protocol Violation|2|||
48780620|NCT01040130|157038599|FG003|Overall Study|Protocol Violation|0|||
48780621|NCT01040130|157038600|FG004|Overall Study|Protocol Violation|0|||
48780622|NCT01040130|157038601|FG005|Overall Study|Protocol Violation|0|||
48780623|NCT01040130|157038596|FG000|Overall Study|Withdrawal by Subject|0|||
48780624|NCT01040130|157038597|FG001|Overall Study|Withdrawal by Subject|2|||
48780625|NCT01040130|157038598|FG002|Overall Study|Withdrawal by Subject|0|||
48780626|NCT01040130|157038599|FG003|Overall Study|Withdrawal by Subject|0|||
48780627|NCT01040130|157038600|FG004|Overall Study|Withdrawal by Subject|0|||
48780628|NCT01040130|157038601|FG005|Overall Study|Withdrawal by Subject|1|||
48780629|NCT01040130|157038596|FG000|Overall Study|Other reasons not listed above|2|||
48780630|NCT01040130|157038597|FG001|Overall Study|Other reasons not listed above|0|||
48780631|NCT01040130|157038598|FG002|Overall Study|Other reasons not listed above|0|||
48780632|NCT01040130|157038599|FG003|Overall Study|Other reasons not listed above|0|||
48780633|NCT01040130|157038600|FG004|Overall Study|Other reasons not listed above|0|||
48780634|NCT01040130|157038601|FG005|Overall Study|Other reasons not listed above|0|||
48780635|NCT02673697|157038602|FG000|Overall Study|Adverse Event|2|||
48780636|NCT02673697|157038603|FG001|Overall Study|Adverse Event|0|||
48780637|NCT02673697|157038602|FG000|Overall Study|Death|32|||
48780638|NCT02673697|157038603|FG001|Overall Study|Death|24|||
48780639|NCT02673697|157038602|FG000|Overall Study|Lost to Follow-up|5|||
48780640|NCT02673697|157038603|FG001|Overall Study|Lost to Follow-up|2|||
48780641|NCT02673697|157038602|FG000|Overall Study|Physician Decision|2|||
48780642|NCT02673697|157038603|FG001|Overall Study|Physician Decision|1|||
48780643|NCT02673697|157038602|FG000|Overall Study|Withdrawal by Subject|10|||
48780644|NCT02673697|157038603|FG001|Overall Study|Withdrawal by Subject|7|||
48780645|NCT02673697|157038602|FG000|Overall Study|Change subj medical status|1|||
48780646|NCT02673697|157038603|FG001|Overall Study|Change subj medical status|2|||
48780647|NCT02673697|157038602|FG000|Overall Study|Explant|10|||
48780648|NCT02673697|157038603|FG001|Overall Study|Explant|5|||
48780649|NCT02673697|157038602|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
48780650|NCT02673697|157038603|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
48780651|NCT01591681|157038606|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
48780652|NCT01591681|157038606|FG000|Overall Study|Failed to use system during run-in|1|||
48780653|NCT01723904|157038607|FG000|Overall Study|Noncompliant|3|||
48780654|NCT01723904|157038607|FG000|Overall Study|Adverse Event|5|||
48780655|NCT01723904|157038607|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
48780656|NCT00690755|157038618|FG000|Overall Study|Physician Decision|2|||
48780657|NCT00690755|157038619|FG001|Overall Study|Physician Decision|0|||
48780658|NCT00690755|157038620|FG002|Overall Study|Physician Decision|46|||
48780659|NCT00690755|157038621|FG003|Overall Study|Physician Decision|5|||
48780660|NCT00690755|157038622|FG004|Overall Study|Physician Decision|0|||
48398044|NCT01784861|155649932|FG005|Overall Study|Adverse Event|0|||
48398045|NCT01784861|155649927|FG000|Overall Study|Withdrawal by Subject|0|||
48398046|NCT01784861|155649928|FG001|Overall Study|Withdrawal by Subject|0|||
48398047|NCT01784861|155649929|FG002|Overall Study|Withdrawal by Subject|0|||
48398048|NCT01784861|155649930|FG003|Overall Study|Withdrawal by Subject|1|||
48398049|NCT01784861|155649931|FG004|Overall Study|Withdrawal by Subject|0|||
48398050|NCT01784861|155649932|FG005|Overall Study|Withdrawal by Subject|0|||
48398051|NCT01784861|155649927|FG000|Overall Study|Physician Decision|0|||
48398052|NCT01784861|155649928|FG001|Overall Study|Physician Decision|0|||
48398053|NCT01784861|155649929|FG002|Overall Study|Physician Decision|0|||
48398054|NCT01784861|155649930|FG003|Overall Study|Physician Decision|2|||
48398055|NCT01784861|155649931|FG004|Overall Study|Physician Decision|0|||
48398056|NCT01784861|155649932|FG005|Overall Study|Physician Decision|1|||
48780661|NCT00690755|157038623|FG005|Overall Study|Physician Decision|4|||
48780662|NCT00690755|157038624|FG006|Overall Study|Physician Decision|0|||
48780663|NCT03855189|157038625|FG000|Overall Study|Adverse Event|5|||
48398057|NCT01662895|155649938|FG000|Overall Study|Lost to Follow-up|0|||
48398058|NCT01662895|155649939|FG001|Overall Study|Lost to Follow-up|1|||
48780664|NCT03855189|157038626|FG001|Overall Study|Adverse Event|2|||
48780665|NCT03855189|157038627|FG002|Overall Study|Adverse Event|4|||
48780666|NCT03855189|157038625|FG000|Overall Study|Treatment Failure|1|||
48780667|NCT03855189|157038626|FG001|Overall Study|Treatment Failure|1|||
48780668|NCT03855189|157038627|FG002|Overall Study|Treatment Failure|2|||
48780669|NCT03855189|157038625|FG000|Overall Study|Noncompliance with Protocol|0|||
48780670|NCT03855189|157038626|FG001|Overall Study|Noncompliance with Protocol|1|||
48780671|NCT03855189|157038627|FG002|Overall Study|Noncompliance with Protocol|0|||
48780672|NCT03855189|157038625|FG000|Overall Study|Did Not Return|4|||
48780673|NCT03855189|157038626|FG001|Overall Study|Did Not Return|3|||
48780674|NCT03855189|157038627|FG002|Overall Study|Did Not Return|0|||
48780675|NCT00861341|157038628|FG000|Overall Study|Withdrawal by Subject|2|||
48780676|NCT01870843|157038629|FG000|Overall Study|Adverse Event|10|||
48780677|NCT01870843|157038629|FG000|Overall Study|Lost to Follow-up|24|||
48780678|NCT01870843|157038629|FG000|Overall Study|Death|1|||
48780679|NCT01870843|157038629|FG000|Overall Study|Withdrawal by Subject|18|||
48780680|NCT04095858|157038630|FG000|Overall Study|Death|1|||
48780681|NCT04095858|157038631|FG001|Overall Study|Death|0|||
48780682|NCT04095858|157038630|FG000|Overall Study|Study terminated by Sponsor|2|||
48780683|NCT04095858|157038631|FG001|Overall Study|Study terminated by Sponsor|4|||
48780684|NCT03156023|157038632|FG000|Overall Study|Withdrawal by Subject|1|||
48780685|NCT03156023|157038633|FG001|Overall Study|Withdrawal by Subject|0|||
48780686|NCT03156023|157038634|FG002|Overall Study|Withdrawal by Subject|2|||
48780687|NCT03156023|157038635|FG003|Overall Study|Withdrawal by Subject|1|||
48780688|NCT03156023|157038636|FG004|Overall Study|Withdrawal by Subject|1|||
48780689|NCT03156023|157038632|FG000|Overall Study|Lost to Follow-up|0|||
48780690|NCT03156023|157038633|FG001|Overall Study|Lost to Follow-up|0|||
48780691|NCT03156023|157038634|FG002|Overall Study|Lost to Follow-up|0|||
48780692|NCT03156023|157038635|FG003|Overall Study|Lost to Follow-up|0|||
48780693|NCT03156023|157038636|FG004|Overall Study|Lost to Follow-up|1|||
48780694|NCT01105533|157040074|FG000|Overall Study|Death|0|||
48780695|NCT01105533|157040075|FG001|Overall Study|Death|0|||
48780696|NCT01105533|157040076|FG002|Overall Study|Death|0|||
48780697|NCT01105533|157040077|FG003|Overall Study|Death|0|||
48780698|NCT01105533|157040078|FG004|Overall Study|Death|1|||
48780699|NCT01105533|157040079|FG005|Overall Study|Death|0|||
48780700|NCT01105533|157040080|FG006|Overall Study|Death|0|||
48780701|NCT01105533|157040081|FG007|Overall Study|Death|0|||
48780702|NCT01105533|157040082|FG008|Overall Study|Death|0|||
48780703|NCT01105533|157040074|FG000|Overall Study|Lack of Efficacy|1|||
48780704|NCT01105533|157040075|FG001|Overall Study|Lack of Efficacy|1|||
48780705|NCT01105533|157040076|FG002|Overall Study|Lack of Efficacy|3|||
48780706|NCT01105533|157040077|FG003|Overall Study|Lack of Efficacy|3|||
48780707|NCT01105533|157040078|FG004|Overall Study|Lack of Efficacy|4|||
48780708|NCT01105533|157040079|FG005|Overall Study|Lack of Efficacy|5|||
48780709|NCT01105533|157040080|FG006|Overall Study|Lack of Efficacy|3|||
48780710|NCT01105533|157040081|FG007|Overall Study|Lack of Efficacy|2|||
48780711|NCT01105533|157040082|FG008|Overall Study|Lack of Efficacy|9|||
48780712|NCT01105533|157040074|FG000|Overall Study|Adverse Event|0|||
48780713|NCT01105533|157040075|FG001|Overall Study|Adverse Event|0|||
48780714|NCT01105533|157040076|FG002|Overall Study|Adverse Event|0|||
48780715|NCT01105533|157040077|FG003|Overall Study|Adverse Event|0|||
48780716|NCT01105533|157040078|FG004|Overall Study|Adverse Event|1|||
48780717|NCT01105533|157040079|FG005|Overall Study|Adverse Event|2|||
48780718|NCT01105533|157040080|FG006|Overall Study|Adverse Event|2|||
48780719|NCT01105533|157040081|FG007|Overall Study|Adverse Event|0|||
48780720|NCT01105533|157040082|FG008|Overall Study|Adverse Event|1|||
48780721|NCT01105533|157040074|FG000|Overall Study|Other|0|||
48780722|NCT01105533|157040075|FG001|Overall Study|Other|0|||
48780723|NCT01105533|157040076|FG002|Overall Study|Other|0|||
48780724|NCT01105533|157040077|FG003|Overall Study|Other|0|||
48780725|NCT01105533|157040078|FG004|Overall Study|Other|1|||
48780726|NCT01105533|157040079|FG005|Overall Study|Other|0|||
48780727|NCT01105533|157040080|FG006|Overall Study|Other|3|||
48780728|NCT01105533|157040081|FG007|Overall Study|Other|1|||
48398059|NCT05098041|155649940|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
48780729|NCT01105533|157040082|FG008|Overall Study|Other|2|||
48780730|NCT01105533|157040074|FG000|Overall Study|Physician Decision|0|||
48780731|NCT01105533|157040075|FG001|Overall Study|Physician Decision|0|||
48780732|NCT01105533|157040076|FG002|Overall Study|Physician Decision|0|||
48780733|NCT01105533|157040077|FG003|Overall Study|Physician Decision|0|||
48780734|NCT01105533|157040078|FG004|Overall Study|Physician Decision|0|||
48780735|NCT01105533|157040079|FG005|Overall Study|Physician Decision|0|||
48780736|NCT01105533|157040080|FG006|Overall Study|Physician Decision|0|||
48780737|NCT01105533|157040081|FG007|Overall Study|Physician Decision|1|||
48780738|NCT01105533|157040082|FG008|Overall Study|Physician Decision|0|||
48780739|NCT03892889|157040083|FG000|Overall Study|Adverse Event|17|||
48780740|NCT03892889|157040083|FG000|Overall Study|Lack of Efficacy|1|||
48780741|NCT03892889|157040083|FG000|Overall Study|Lost to Follow-up|46|||
48780742|NCT03892889|157040083|FG000|Overall Study|Non-compliance with study drug|22|||
48780743|NCT03892889|157040083|FG000|Overall Study|Pregnancy|1|||
48780744|NCT03892889|157040083|FG000|Overall Study|Protocol Deviation|3|||
48780745|NCT03892889|157040083|FG000|Overall Study|Withdrawal by Subject|50|||
48780746|NCT03892889|157040083|FG000|Overall Study|Withdrawal by Caregiver|1|||
48780747|NCT03892889|157040083|FG000|Overall Study|Study Terminated by Sponsor|50|||
48780748|NCT03892889|157040083|FG000|Overall Study|Physician Decision|8|||
48780749|NCT03892889|157040083|FG000|Overall Study|Reason not Specified|5|||
48780750|NCT02348489|157040088|FG000|Overall Study|Death|336|||
48780751|NCT02348489|157040089|FG001|Overall Study|Death|335|||
48780752|NCT02348489|157040088|FG000|Overall Study|Withdrawal by Subject|14|||
48780753|NCT02348489|157040089|FG001|Overall Study|Withdrawal by Subject|27|||
48780754|NCT02348489|157040088|FG000|Overall Study|Lost to Follow-up|3|||
48780755|NCT02348489|157040089|FG001|Overall Study|Lost to Follow-up|5|||
48780756|NCT01933334|157040094|FG000|Overall Study|Adverse Event|5|||
48780757|NCT01933334|157040095|FG001|Overall Study|Adverse Event|1|||
48780758|NCT01933334|157040094|FG000|Overall Study|Withdrawal by Subject|0|||
48780759|NCT01933334|157040095|FG001|Overall Study|Withdrawal by Subject|1|||
48780760|NCT01923181|157040098|FG000|Overall Study|Protocol Violation|2|||
48780761|NCT01923181|157040099|FG001|Overall Study|Protocol Violation|2|||
48780762|NCT01923181|157040100|FG002|Overall Study|Protocol Violation|0|||
48780763|NCT01923181|157040101|FG003|Overall Study|Protocol Violation|2|||
48780764|NCT01923181|157040102|FG004|Overall Study|Protocol Violation|2|||
48780765|NCT01923181|157040103|FG005|Overall Study|Protocol Violation|1|||
48780766|NCT01923181|157040104|FG006|Overall Study|Protocol Violation|1|||
48780767|NCT01923181|157040105|FG007|Overall Study|Protocol Violation|2|||
48780768|NCT01923181|157040106|FG008|Overall Study|Protocol Violation|1|||
48780769|NCT01923181|157040098|FG000|Overall Study|Withdrawal by Subject|0|||
48780770|NCT01923181|157040099|FG001|Overall Study|Withdrawal by Subject|1|||
48780771|NCT01923181|157040100|FG002|Overall Study|Withdrawal by Subject|0|||
48780772|NCT01923181|157040101|FG003|Overall Study|Withdrawal by Subject|1|||
48780773|NCT01923181|157040102|FG004|Overall Study|Withdrawal by Subject|4|||
48780774|NCT01923181|157040103|FG005|Overall Study|Withdrawal by Subject|2|||
48780775|NCT01923181|157040104|FG006|Overall Study|Withdrawal by Subject|4|||
48780776|NCT01923181|157040105|FG007|Overall Study|Withdrawal by Subject|3|||
48356501|NCT00706654|155501091|FG002|Conversion Phase|Withdrawn by Investigator|0|||
48780777|NCT01923181|157040106|FG008|Overall Study|Withdrawal by Subject|1|||
48780778|NCT01923181|157040098|FG000|Overall Study|Other|1|||
48780779|NCT01923181|157040099|FG001|Overall Study|Other|0|||
48780780|NCT01923181|157040100|FG002|Overall Study|Other|0|||
48780781|NCT01923181|157040101|FG003|Overall Study|Other|1|||
48780782|NCT01923181|157040102|FG004|Overall Study|Other|0|||
48780783|NCT01923181|157040103|FG005|Overall Study|Other|0|||
48780784|NCT01923181|157040104|FG006|Overall Study|Other|0|||
48780785|NCT01923181|157040105|FG007|Overall Study|Other|0|||
48780786|NCT01923181|157040106|FG008|Overall Study|Other|0|||
48780787|NCT01923181|157040098|FG000|Overall Study|Lost to Follow-up|0|||
48780788|NCT01923181|157040099|FG001|Overall Study|Lost to Follow-up|3|||
48780789|NCT01923181|157040100|FG002|Overall Study|Lost to Follow-up|2|||
48780790|NCT01923181|157040101|FG003|Overall Study|Lost to Follow-up|1|||
48780791|NCT01923181|157040102|FG004|Overall Study|Lost to Follow-up|2|||
48356502|NCT00706654|155501092|FG003|Conversion Phase|Withdrawn by Investigator|0|||
48356503|NCT00706654|155501089|FG000|Conversion Phase|Withdrew Consent|38|||
48356504|NCT00706654|155501090|FG001|Conversion Phase|Withdrew Consent|0|||
48356505|NCT00706654|155501091|FG002|Conversion Phase|Withdrew Consent|0|||
48356506|NCT00706654|155501092|FG003|Conversion Phase|Withdrew Consent|0|||
48356507|NCT00706654|155501089|FG000|Conversion Phase|Adverse Event|18|||
48356508|NCT00706654|155501090|FG001|Conversion Phase|Adverse Event|0|||
48356509|NCT00706654|155501091|FG002|Conversion Phase|Adverse Event|0|||
48356510|NCT00706654|155501092|FG003|Conversion Phase|Adverse Event|0|||
48356511|NCT00706654|155501089|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
48356512|NCT00706654|155501090|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48356513|NCT00706654|155501091|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48356514|NCT00706654|155501092|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48356515|NCT00706654|155501089|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
48356516|NCT00706654|155501090|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48356517|NCT00706654|155501091|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48356518|NCT00706654|155501092|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48356519|NCT00706654|155501089|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
48356520|NCT00706654|155501090|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
48356521|NCT00706654|155501091|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
48780792|NCT01923181|157040103|FG005|Overall Study|Lost to Follow-up|1|||
48780793|NCT01923181|157040104|FG006|Overall Study|Lost to Follow-up|3|||
48780794|NCT01923181|157040105|FG007|Overall Study|Lost to Follow-up|3|||
48780795|NCT01923181|157040106|FG008|Overall Study|Lost to Follow-up|1|||
48780796|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
48780797|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
48780798|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
48780799|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780800|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780801|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48398060|NCT00464334|155649950|FG000|Overall Study|Adverse Event|0|||
48398061|NCT00464334|155649951|FG001|Overall Study|Adverse Event|0|||
48398062|NCT00464334|155649952|FG002|Overall Study|Adverse Event|0|||
48780802|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780803|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780804|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48780805|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
48780806|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
48780807|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
48780808|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780809|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780810|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780811|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780812|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780813|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48780814|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780815|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
48780816|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
48780817|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780818|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780819|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780820|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780821|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780822|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48780823|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
48780824|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
48780825|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
48780826|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780827|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780828|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780829|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780830|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780831|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48780832|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780833|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
48780834|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
48398063|NCT00464334|155649953|FG003|Overall Study|Adverse Event|1|||
48398064|NCT00464334|155649954|FG004|Overall Study|Adverse Event|1|||
48780835|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780836|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780837|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780838|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780839|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780840|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
48780841|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
48780842|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780843|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780844|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780845|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780846|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780847|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780848|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780849|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48780850|NCT01172938|157040107|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780851|NCT01172938|157040108|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
48780852|NCT01172938|157040109|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
48780853|NCT01172938|157040110|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780854|NCT01172938|157040111|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780855|NCT01172938|157040112|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780856|NCT01172938|157040113|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
48780857|NCT01172938|157040114|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
48398065|NCT00464334|155649955|FG005|Overall Study|Adverse Event|1|||
48780858|NCT01172938|157040115|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
48398066|NCT00464334|155649956|FG006|Overall Study|Adverse Event|0|||
48398067|NCT00464334|155649957|FG007|Overall Study|Adverse Event|0|||
48780859|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
48780860|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
48780861|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
48356522|NCT00706654|155501092|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
48356523|NCT00706654|155501089|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
48780862|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
48780863|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
48780864|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
48780865|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
48780866|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
48780867|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
48780868|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
48780869|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
48780870|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
48780871|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
48780872|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
48780873|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
48780874|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
48780875|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
48780876|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
48780877|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780878|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780879|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
48780880|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780881|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780882|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780883|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780884|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780885|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
48780886|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
48780887|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
48780888|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
48780889|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
48780890|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
48780891|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
48780892|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
48780893|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
48780894|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
48780895|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780896|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
48780897|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
48780898|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
48780899|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780900|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780901|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780902|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780903|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
48780904|NCT01172938|157040107|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780905|NCT01172938|157040108|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780906|NCT01172938|157040109|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780907|NCT01172938|157040110|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780908|NCT01172938|157040111|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780909|NCT01172938|157040112|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
48780910|NCT01172938|157040113|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
48780911|NCT01172938|157040114|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780912|NCT01172938|157040115|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
48780913|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780914|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
48780915|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
48780916|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780917|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780918|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780919|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
48780920|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
48780921|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
48780922|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780923|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
48780924|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
48780925|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780926|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780927|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780928|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780929|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
48780930|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
48780931|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780932|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780933|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
48780934|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780935|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780936|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780937|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780938|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780939|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
48780940|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780941|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
48780942|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
48780943|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780944|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780945|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780946|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
48780947|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
48780948|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
48780949|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780950|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780951|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
48780952|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780953|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780954|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780955|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780956|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780957|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
48780958|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780959|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
48780960|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
48356524|NCT00706654|155501090|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
48780961|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780962|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780963|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780964|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780965|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
48780966|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
48780967|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780968|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
48780969|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780970|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780971|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780972|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780973|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780974|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
48780975|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
48780976|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780977|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
48780978|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780979|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780980|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780981|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780982|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780983|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780984|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
48780985|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780986|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780987|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780988|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780989|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780990|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780991|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780992|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
48780993|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
48780994|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48780995|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
48780996|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
48780997|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48780998|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48780999|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48781000|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
48781001|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
48781002|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
48781003|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48781004|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
48781005|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
48781006|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48781007|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48356525|NCT00706654|155501091|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
48356526|NCT00706654|155501092|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
48356527|NCT00706654|155501089|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
48356528|NCT00706654|155501090|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48356529|NCT00706654|155501091|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48356530|NCT00706654|155501092|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48356531|NCT00706654|155501089|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
48356532|NCT00706654|155501090|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48356533|NCT00706654|155501091|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48356534|NCT00706654|155501092|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48356535|NCT00706654|155501089|FG000|Oral Stabilization Phase|Withdrew consent|55|||
48356536|NCT00706654|155501090|FG001|Oral Stabilization Phase|Withdrew consent|0|||
48356537|NCT00706654|155501091|FG002|Oral Stabilization Phase|Withdrew consent|0|||
48356538|NCT00706654|155501092|FG003|Oral Stabilization Phase|Withdrew consent|0|||
48356539|NCT00706654|155501089|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
48356540|NCT00706654|155501090|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
48356541|NCT00706654|155501091|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
48356542|NCT00706654|155501092|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
48356543|NCT00706654|155501089|FG000|Oral Stabilization Phase|Adverse Event|21|||
48356544|NCT00706654|155501090|FG001|Oral Stabilization Phase|Adverse Event|0|||
48781008|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48781009|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
48781010|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
48781011|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
48781012|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781013|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781014|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781015|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781016|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781017|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781018|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781019|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
48781020|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
48781021|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781022|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
48781023|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781024|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781025|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781026|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781027|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781028|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781029|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
48781030|NCT01172938|157040107|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781031|NCT01172938|157040108|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781032|NCT01172938|157040109|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
48781033|NCT01172938|157040110|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781034|NCT01172938|157040111|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781035|NCT01172938|157040112|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781036|NCT01172938|157040113|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781037|NCT01172938|157040114|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781038|NCT01172938|157040115|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
48781039|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781040|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
48781041|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
48781042|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781043|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781044|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781045|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781046|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
48781047|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
48781048|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781049|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
48781050|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
48781051|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781052|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781053|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781054|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
48781055|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
48781056|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
48781057|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781058|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
48781059|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
48781060|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781061|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781062|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781063|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
48781064|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
48781065|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
48781066|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781067|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781068|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
48781069|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781070|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781071|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48398068|NCT00464334|155649958|FG008|Overall Study|Adverse Event|2|||
48781072|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781073|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
48781074|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
48781075|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781076|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781077|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781078|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781079|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781080|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781081|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781082|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
48781083|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
48781084|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781085|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781086|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
48781087|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781088|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781089|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781090|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
48781091|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
48781092|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
48781093|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781094|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781095|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
48781096|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781097|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781098|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781099|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781100|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781101|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
48781102|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781103|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
48781104|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781105|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781106|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781107|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781108|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781109|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
48781110|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
48781111|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781112|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
48781113|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
48781114|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781115|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781116|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781117|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781118|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
48781119|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
48781120|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781121|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781122|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
48781123|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781124|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781125|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781126|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781127|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781128|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
48781129|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781130|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781131|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
48781132|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781133|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781134|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781135|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781136|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781137|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
48781138|NCT01172938|157040107|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781139|NCT01172938|157040108|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781140|NCT01172938|157040109|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781141|NCT01172938|157040110|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781142|NCT01172938|157040111|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781143|NCT01172938|157040112|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781144|NCT01172938|157040113|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781145|NCT01172938|157040114|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
48781146|NCT01172938|157040115|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
48781147|NCT01033747|157040116|FG000|Overall Study|Adverse Event|9|||
48781148|NCT01033747|157040117|FG001|Overall Study|Adverse Event|4|||
48781149|NCT01033747|157040116|FG000|Overall Study|Abnormal Laboratory Value|1|||
48781150|NCT01033747|157040117|FG001|Overall Study|Abnormal Laboratory Value|0|||
48781151|NCT01033747|157040116|FG000|Overall Study|Abnormal test procedure|0|||
48781152|NCT01033747|157040117|FG001|Overall Study|Abnormal test procedure|1|||
48781153|NCT01033747|157040116|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
48781154|NCT01033747|157040117|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
48781155|NCT01033747|157040116|FG000|Overall Study|Protocol Violation|1|||
48781156|NCT01033747|157040117|FG001|Overall Study|Protocol Violation|0|||
48781157|NCT01033747|157040116|FG000|Overall Study|Withdrawal by Subject|9|||
48781158|NCT01033747|157040117|FG001|Overall Study|Withdrawal by Subject|6|||
48781159|NCT01033747|157040116|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
48781160|NCT01033747|157040117|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
48781161|NCT01033747|157040116|FG000|Overall Study|Stopped at end of Extension 1|2|||
48781162|NCT01033747|157040117|FG001|Overall Study|Stopped at end of Extension 1|0|||
48781163|NCT00840970|157040122|FG000|Overall Study|Adverse Event|0|||
48781164|NCT00840970|157040123|FG001|Overall Study|Adverse Event|0|||
48781165|NCT00840970|157040124|FG002|Overall Study|Adverse Event|1|||
48781166|NCT00504829|157040125|FG000|Overall Study|Protocol Violation|6|||
48781167|NCT00504829|157040126|FG001|Overall Study|Protocol Violation|4|||
48781168|NCT00504829|157040127|FG002|Overall Study|Protocol Violation|10|||
48781169|NCT01490060|157040128|FG000|Cycle 1|Change of Treatment|0|||
48781170|NCT01490060|157040129|FG001|Cycle 1|Change of Treatment|1|||
48781171|NCT01490060|157040130|FG002|Cycle 1|Change of Treatment|1|||
48781172|NCT01490060|157040131|FG003|Cycle 1|Change of Treatment|1|||
48781173|NCT01490060|157040128|FG000|Cycle 1|Insurance Denied|0|||
48781174|NCT01490060|157040129|FG001|Cycle 1|Insurance Denied|0|||
48781175|NCT01490060|157040130|FG002|Cycle 1|Insurance Denied|2|||
48781176|NCT01490060|157040131|FG003|Cycle 1|Insurance Denied|0|||
48781177|NCT01490060|157040128|FG000|Cycle 1|Withdrawal by Subject|0|||
48781178|NCT01490060|157040129|FG001|Cycle 1|Withdrawal by Subject|0|||
48781179|NCT01490060|157040130|FG002|Cycle 1|Withdrawal by Subject|0|||
48781180|NCT01490060|157040131|FG003|Cycle 1|Withdrawal by Subject|1|||
48781181|NCT01490060|157040128|FG000|Cycle 1|Treatment at Another Facility|0|||
48781182|NCT01490060|157040129|FG001|Cycle 1|Treatment at Another Facility|0|||
48781183|NCT01490060|157040130|FG002|Cycle 1|Treatment at Another Facility|0|||
48781184|NCT01490060|157040131|FG003|Cycle 1|Treatment at Another Facility|1|||
48781185|NCT01490060|157040128|FG000|Cycle 2|Change of Treatment|1|||
48781186|NCT01490060|157040129|FG001|Cycle 2|Change of Treatment|1|||
48781187|NCT01490060|157040130|FG002|Cycle 2|Change of Treatment|0|||
48781188|NCT01490060|157040131|FG003|Cycle 2|Change of Treatment|0|||
48781189|NCT01490060|157040128|FG000|Cycle 2|Non-Compliance|0|||
48781190|NCT01490060|157040129|FG001|Cycle 2|Non-Compliance|0|||
48781191|NCT01490060|157040130|FG002|Cycle 2|Non-Compliance|1|||
48398069|NCT00464334|155649959|FG009|Overall Study|Adverse Event|1|||
48398070|NCT00464334|155649960|FG010|Overall Study|Adverse Event|2|||
48398071|NCT00464334|155649950|FG000|Overall Study|Lack of Efficacy|0|||
48398072|NCT00464334|155649951|FG001|Overall Study|Lack of Efficacy|1|||
48398073|NCT00464334|155649952|FG002|Overall Study|Lack of Efficacy|0|||
48781192|NCT01490060|157040131|FG003|Cycle 2|Non-Compliance|0|||
48781193|NCT01490060|157040128|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
48781194|NCT01490060|157040129|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
48781195|NCT01490060|157040130|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
48398074|NCT00464334|155649953|FG003|Overall Study|Lack of Efficacy|0|||
48398075|NCT00464334|155649954|FG004|Overall Study|Lack of Efficacy|0|||
48781196|NCT01490060|157040131|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
48781197|NCT04443218|157040132|FG000|Overall Study|Exited study for other reasons|9|||
48781198|NCT04443218|157040132|FG000|Overall Study|Withdrawal by Subject|1|||
48781199|NCT04443218|157040132|FG000|Overall Study|Lost to Follow-up|4|||
48781200|NCT04443218|157040132|FG000|Overall Study|Death|19|||
48781201|NCT00403546|157040138|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
48781202|NCT00403546|157040139|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
48781203|NCT00403546|157040140|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
48781204|NCT00403546|157040138|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
48781205|NCT00403546|157040139|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
48781206|NCT00403546|157040140|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
48781207|NCT00403546|157040138|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
48781208|NCT00403546|157040139|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
48781209|NCT00403546|157040140|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
48781210|NCT00403546|157040138|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
48781211|NCT00403546|157040139|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
48781212|NCT00403546|157040140|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
48781213|NCT00403546|157040138|FG000|Screening Phase|Screening Failure|22|||
48781214|NCT00403546|157040139|FG001|Screening Phase|Screening Failure|0|||
48781215|NCT00403546|157040140|FG002|Screening Phase|Screening Failure|0|||
48781216|NCT00403546|157040138|FG000|Screening Phase|Adverse Event|1|||
48781217|NCT00403546|157040139|FG001|Screening Phase|Adverse Event|0|||
48781218|NCT00403546|157040140|FG002|Screening Phase|Adverse Event|0|||
48781219|NCT00403546|157040138|FG000|Screening Phase|Terminated Prior to Randomization|5|||
48781220|NCT00403546|157040139|FG001|Screening Phase|Terminated Prior to Randomization|0|||
48781221|NCT00403546|157040140|FG002|Screening Phase|Terminated Prior to Randomization|0|||
48781222|NCT00403546|157040138|FG000|Randomized Trial|Early Terminations|0|||
48781223|NCT00403546|157040139|FG001|Randomized Trial|Early Terminations|17|||
48781224|NCT00403546|157040140|FG002|Randomized Trial|Early Terminations|16|||
48781225|NCT03207750|157040143|FG000|Overall Study|Adverse Event|3|||
48781226|NCT03207750|157040144|FG001|Overall Study|Adverse Event|2|||
48398076|NCT00464334|155649955|FG005|Overall Study|Lack of Efficacy|0|||
48781227|NCT03207750|157040143|FG000|Overall Study|Lost to Follow-up|21|||
48781228|NCT03207750|157040144|FG001|Overall Study|Lost to Follow-up|29|||
48781229|NCT03207750|157040143|FG000|Overall Study|Protocol Violation|0|||
48781230|NCT03207750|157040144|FG001|Overall Study|Protocol Violation|1|||
48781231|NCT03207750|157040143|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
48781232|NCT03207750|157040144|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
48781233|NCT03207750|157040143|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
48781234|NCT03207750|157040144|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
48781235|NCT03207750|157040143|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
48781236|NCT03207750|157040144|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
48781237|NCT03207750|157040143|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
48781238|NCT03207750|157040144|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
48781239|NCT03207750|157040143|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
48781240|NCT03207750|157040144|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
48781241|NCT03893448|157040155|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
48781242|NCT03893448|157040156|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
48781243|NCT03893448|157040155|FG000|Overall Study|Physician Decision|8|||
48781244|NCT03893448|157040156|FG001|Overall Study|Physician Decision|14|||
48781245|NCT03893448|157040155|FG000|Overall Study|Lost to Follow-up|34|||
48781246|NCT03893448|157040156|FG001|Overall Study|Lost to Follow-up|27|||
48781247|NCT03893448|157040155|FG000|Overall Study|Death|1|||
48781248|NCT03893448|157040156|FG001|Overall Study|Death|0|||
48781249|NCT00793910|157040157|FG000|Overall Study|discarded study pills|0|||
48781250|NCT00793910|157040158|FG001|Overall Study|discarded study pills|1|||
48781251|NCT00793910|157040157|FG000|Overall Study|did not pick up medications|1|||
48781252|NCT00793910|157040158|FG001|Overall Study|did not pick up medications|1|||
48781253|NCT00793910|157040157|FG000|Overall Study|ineligible based on entry criteria|2|||
48781254|NCT00793910|157040158|FG001|Overall Study|ineligible based on entry criteria|3|||
48781255|NCT00793910|157040157|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
48781256|NCT00793910|157040158|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
48781257|NCT00793910|157040157|FG000|Overall Study|Withdrawal by Subject|0|||
48781258|NCT00793910|157040158|FG001|Overall Study|Withdrawal by Subject|1|||
48781259|NCT01525082|157040162|FG000|Overall Study|Death|1|||
48781260|NCT02056301|157040164|FG000|Overall Study|Protocol Violation|1|||
48781261|NCT02056301|157040165|FG001|Overall Study|Protocol Violation|2|||
48781262|NCT02056301|157040164|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
48781263|NCT02056301|157040165|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
48781264|NCT02056301|157040164|FG000|Overall Study|Withdrawal by Subject|0|||
48781265|NCT02056301|157040165|FG001|Overall Study|Withdrawal by Subject|1|||
48781266|NCT02056301|157040164|FG000|Overall Study|Issues with epidural|0|||
48781267|NCT02056301|157040165|FG001|Overall Study|Issues with epidural|3|||
48781268|NCT01748994|157040166|FG000|Overall Study|Lost to Follow-up|8|||
48781269|NCT01748994|157040167|FG001|Overall Study|Lost to Follow-up|6|||
48781270|NCT02041429|157040171|FG000|Overall Study|Progressive Disease|2|||
48781271|NCT02041429|157040172|FG001|Overall Study|Progressive Disease|2|||
48781272|NCT02041429|157040173|FG002|Overall Study|Progressive Disease|3|||
48781273|NCT02041429|157040174|FG003|Overall Study|Progressive Disease|2|||
48781274|NCT02041429|157040171|FG000|Overall Study|Toxicity|0|||
48781275|NCT02041429|157040172|FG001|Overall Study|Toxicity|1|||
48781276|NCT02041429|157040173|FG002|Overall Study|Toxicity|4|||
48781277|NCT02041429|157040174|FG003|Overall Study|Toxicity|2|||
48781278|NCT02041429|157040171|FG000|Overall Study|Withdrawal by Subject|0|||
48781279|NCT02041429|157040172|FG001|Overall Study|Withdrawal by Subject|1|||
48781280|NCT02041429|157040173|FG002|Overall Study|Withdrawal by Subject|0|||
48781281|NCT02041429|157040174|FG003|Overall Study|Withdrawal by Subject|0|||
48781282|NCT02041429|157040171|FG000|Overall Study|On Maintenance Therapy|1|||
48781283|NCT02041429|157040172|FG001|Overall Study|On Maintenance Therapy|0|||
48781284|NCT02041429|157040173|FG002|Overall Study|On Maintenance Therapy|0|||
48781285|NCT02041429|157040174|FG003|Overall Study|On Maintenance Therapy|2|||
48781286|NCT01427712|157040175|FG000|Overall Study|Transfer to a different hospital|2|||
48781287|NCT01427712|157040175|FG000|Overall Study|Lost to Follow-up|1|||
48781288|NCT01427712|157040175|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
48781289|NCT01427712|157040175|FG000|Overall Study|Failure to visit|1|||
48781290|NCT02338362|157040176|FG000|Overall Study|Withdrawal by Subject|1|||
48781291|NCT02338362|157040177|FG001|Overall Study|Withdrawal by Subject|1|||
48781292|NCT01669343|157040179|FG000|Part A: All Patients|Withdrawal by Subject|7|||
48781293|NCT01669343|157040179|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
48781294|NCT01669343|157040179|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
48781295|NCT01669343|157040179|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
48781296|NCT01669343|157040179|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
48781297|NCT00439777|157040180|FG000|Treatment Period|Death|29|||
48781298|NCT00439777|157040181|FG001|Treatment Period|Death|21|||
48781299|NCT00439777|157040180|FG000|Treatment Period|Study terminated by sponsor|125|||
48781300|NCT00439777|157040181|FG001|Treatment Period|Study terminated by sponsor|132|||
48781301|NCT00439777|157040180|FG000|Treatment Period|Site closed by investigator|0|||
48781302|NCT00439777|157040181|FG001|Treatment Period|Site closed by investigator|1|||
48781303|NCT00439777|157040180|FG000|Treatment Period|Did not take study treatment|7|||
48781304|NCT00439777|157040181|FG001|Treatment Period|Did not take study treatment|8|||
48781305|NCT00439777|157040180|FG000|Treatment Period|Adverse Event|111|||
48781306|NCT00439777|157040181|FG001|Treatment Period|Adverse Event|92|||
48781307|NCT00439777|157040180|FG000|Treatment Period|Protocol Violation|23|||
48781308|NCT00439777|157040181|FG001|Treatment Period|Protocol Violation|30|||
48781309|NCT00439777|157040180|FG000|Treatment Period|Withdrawal by Subject|66|||
48781310|NCT00439777|157040181|FG001|Treatment Period|Withdrawal by Subject|118|||
48781311|NCT00439777|157040180|FG000|Treatment Period|Lack of Efficacy|1|||
48781312|NCT00439777|157040181|FG001|Treatment Period|Lack of Efficacy|4|||
48781313|NCT00439777|157040180|FG000|Treatment Period|Lost to Follow-up|8|||
48781314|NCT00439777|157040181|FG001|Treatment Period|Lost to Follow-up|10|||
48781315|NCT00439777|157040180|FG000|Treatment Period|Protocol driven decision point|1|||
48398077|NCT00464334|155649956|FG006|Overall Study|Lack of Efficacy|0|||
48398078|NCT00464334|155649957|FG007|Overall Study|Lack of Efficacy|0|||
48398079|NCT00464334|155649958|FG008|Overall Study|Lack of Efficacy|0|||
48781316|NCT00439777|157040181|FG001|Treatment Period|Protocol driven decision point|3|||
48781317|NCT00439777|157040180|FG000|Treatment Period|Physician Decision|7|||
48781318|NCT00439777|157040181|FG001|Treatment Period|Physician Decision|18|||
48781319|NCT00439777|157040180|FG000|Treatment Period|Clinical endpoint reached|26|||
48781320|NCT00439777|157040181|FG001|Treatment Period|Clinical endpoint reached|13|||
48781321|NCT00439777|157040180|FG000|Treatment Period|Technical problems|3|||
48781322|NCT00439777|157040181|FG001|Treatment Period|Technical problems|1|||
48781323|NCT00439777|157040180|FG000|Treatment Period|Participant convenience|12|||
48781324|NCT00439777|157040181|FG001|Treatment Period|Participant convenience|8|||
48781325|NCT00439777|157040180|FG000|Observational Period|Protocol Violation|0|||
48781326|NCT00439777|157040181|FG001|Observational Period|Protocol Violation|2|||
48781327|NCT00439777|157040180|FG000|Observational Period|Withdrawal by Subject|9|||
48781328|NCT00439777|157040181|FG001|Observational Period|Withdrawal by Subject|5|||
48781329|NCT00439777|157040180|FG000|Observational Period|Lost to Follow-up|1|||
48781330|NCT00439777|157040181|FG001|Observational Period|Lost to Follow-up|11|||
48781331|NCT00439777|157040180|FG000|Observational Period|Death|27|||
48781332|NCT00439777|157040181|FG001|Observational Period|Death|20|||
48781333|NCT00439777|157040180|FG000|Observational Period|Study terminated by sponsor|3|||
48781334|NCT00439777|157040181|FG001|Observational Period|Study terminated by sponsor|1|||
48781335|NCT00439777|157040180|FG000|Observational Period|Protocol driven decision point|0|||
48781336|NCT00439777|157040181|FG001|Observational Period|Protocol driven decision point|1|||
48781337|NCT00439777|157040180|FG000|Observational Period|Lack of Efficacy|1|||
48781338|NCT00439777|157040181|FG001|Observational Period|Lack of Efficacy|0|||
48781339|NCT00439777|157040180|FG000|Observational Period|Technical problems|0|||
48781340|NCT00439777|157040181|FG001|Observational Period|Technical problems|1|||
48398080|NCT00464334|155649959|FG009|Overall Study|Lack of Efficacy|0|||
48781341|NCT00661492|157040182|FG000|Overall Study|Adverse Event|16|||
48781342|NCT00661492|157040183|FG001|Overall Study|Adverse Event|13|||
48781343|NCT00661492|157040182|FG000|Overall Study|Disease Progression|44|||
48781344|NCT00661492|157040183|FG001|Overall Study|Disease Progression|14|||
48781345|NCT00661492|157040182|FG000|Overall Study|Patient Request|6|||
48781346|NCT00661492|157040183|FG001|Overall Study|Patient Request|1|||
48781347|NCT00661492|157040182|FG000|Overall Study|Investigator Request|1|||
48781348|NCT00661492|157040183|FG001|Overall Study|Investigator Request|0|||
48781349|NCT00661492|157040182|FG000|Overall Study|Lost to Follow-up|0|||
48781350|NCT00661492|157040183|FG001|Overall Study|Lost to Follow-up|1|||
48781351|NCT00661492|157040182|FG000|Overall Study|Other|1|||
48781352|NCT00661492|157040183|FG001|Overall Study|Other|0|||
48781353|NCT01272934|157040184|FG000|Overall Study|Adverse Event|0|||
48781354|NCT01272934|157040185|FG001|Overall Study|Adverse Event|1|||
48781355|NCT01272934|157040184|FG000|Overall Study|Abnormal Laboratory Value|0|||
48781356|NCT01272934|157040185|FG001|Overall Study|Abnormal Laboratory Value|1|||
48781357|NCT01143259|157040188|FG000|Overall Study|Withdrawal by Subject|3|||
48781358|NCT01143259|157040189|FG001|Overall Study|Withdrawal by Subject|2|||
48781359|NCT01143259|157040188|FG000|Overall Study|Protocol Violation|13|||
48781360|NCT01143259|157040189|FG001|Overall Study|Protocol Violation|9|||
48781361|NCT01143259|157040188|FG000|Overall Study|Screen Failure|7|||
48781362|NCT01143259|157040189|FG001|Overall Study|Screen Failure|9|||
48781363|NCT00835406|157040192|FG000|Period: First Intervention|Adverse Event|0|||
48781364|NCT00835406|157040193|FG001|Period: First Intervention|Adverse Event|1|||
48781365|NCT00835406|157040192|FG000|Period: First Intervention|Withdrawal by Subject|2|||
48781366|NCT00835406|157040193|FG001|Period: First Intervention|Withdrawal by Subject|0|||
48781367|NCT00835406|157040192|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
48398081|NCT00464334|155649960|FG010|Overall Study|Lack of Efficacy|0|||
48781368|NCT00835406|157040193|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
48781369|NCT03864900|157040194|FG000|Overall Study|Withdrawal by Subject|1|||
48781370|NCT03864900|157040195|FG001|Overall Study|Withdrawal by Subject|1|||
48781371|NCT03864900|157040194|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
48781372|NCT03864900|157040195|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
48781373|NCT00499889|157040197|FG000|Overall Study|Infection prior to treatment|1|||
48781374|NCT01358526|157040201|FG000|Open-label Titration Period|Adverse Event|95|||
48781375|NCT01358526|157040202|FG001|Open-label Titration Period|Adverse Event|0|||
48781376|NCT01358526|157040203|FG002|Open-label Titration Period|Adverse Event|0|||
48781377|NCT01358526|157040201|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
48781378|NCT01358526|157040202|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
48781379|NCT01358526|157040203|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
48781380|NCT01358526|157040201|FG000|Open-label Titration Period|Lost to Follow-up|25|||
48781381|NCT01358526|157040202|FG001|Open-label Titration Period|Lost to Follow-up|0|||
48781382|NCT01358526|157040203|FG002|Open-label Titration Period|Lost to Follow-up|0|||
48781383|NCT01358526|157040201|FG000|Open-label Titration Period|Lack of Efficacy|107|||
48781384|NCT01358526|157040202|FG001|Open-label Titration Period|Lack of Efficacy|0|||
48781385|NCT01358526|157040203|FG002|Open-label Titration Period|Lack of Efficacy|0|||
48781386|NCT01358526|157040201|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
48781387|NCT01358526|157040202|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
48781388|NCT01358526|157040203|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
48781389|NCT01358526|157040201|FG000|Open-label Titration Period|Administrative|8|||
48781390|NCT01358526|157040202|FG001|Open-label Titration Period|Administrative|0|||
48781391|NCT01358526|157040203|FG002|Open-label Titration Period|Administrative|0|||
48398082|NCT00464334|155649950|FG000|Overall Study|Lost to Follow-up|0|||
48781392|NCT01358526|157040201|FG000|Open-label Titration Period|Did not qualify|178|||
48398083|NCT00464334|155649951|FG001|Overall Study|Lost to Follow-up|0|||
48398084|NCT00464334|155649952|FG002|Overall Study|Lost to Follow-up|1|||
48398085|NCT00464334|155649953|FG003|Overall Study|Lost to Follow-up|0|||
48398086|NCT00464334|155649954|FG004|Overall Study|Lost to Follow-up|1|||
48398087|NCT00464334|155649955|FG005|Overall Study|Lost to Follow-up|0|||
48398088|NCT00464334|155649956|FG006|Overall Study|Lost to Follow-up|1|||
48398089|NCT00464334|155649957|FG007|Overall Study|Lost to Follow-up|0|||
48398090|NCT00464334|155649958|FG008|Overall Study|Lost to Follow-up|0|||
48398091|NCT00464334|155649959|FG009|Overall Study|Lost to Follow-up|0|||
48398092|NCT00464334|155649960|FG010|Overall Study|Lost to Follow-up|2|||
48781393|NCT01358526|157040202|FG001|Open-label Titration Period|Did not qualify|0|||
48781394|NCT01358526|157040203|FG002|Open-label Titration Period|Did not qualify|0|||
48398093|NCT00464334|155649950|FG000|Overall Study|Progressive Disease|0|||
48398094|NCT00464334|155649951|FG001|Overall Study|Progressive Disease|0|||
48781395|NCT01358526|157040201|FG000|Double-blind Phase|Adverse Event|0|||
48781396|NCT01358526|157040202|FG001|Double-blind Phase|Adverse Event|24|||
48398095|NCT00464334|155649952|FG002|Overall Study|Progressive Disease|0|||
48398096|NCT00464334|155649953|FG003|Overall Study|Progressive Disease|0|||
48398097|NCT00464334|155649954|FG004|Overall Study|Progressive Disease|0|||
48398098|NCT00464334|155649955|FG005|Overall Study|Progressive Disease|1|||
48398099|NCT00464334|155649956|FG006|Overall Study|Progressive Disease|0|||
48398100|NCT00464334|155649957|FG007|Overall Study|Progressive Disease|0|||
48781397|NCT01358526|157040203|FG002|Double-blind Phase|Adverse Event|23|||
48781398|NCT01358526|157040201|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48781399|NCT01358526|157040202|FG001|Double-blind Phase|Withdrawal by Subject|10|||
48781400|NCT01358526|157040203|FG002|Double-blind Phase|Withdrawal by Subject|8|||
48781401|NCT01358526|157040201|FG000|Double-blind Phase|Lost to Follow-up|0|||
48781402|NCT01358526|157040202|FG001|Double-blind Phase|Lost to Follow-up|4|||
48781403|NCT01358526|157040203|FG002|Double-blind Phase|Lost to Follow-up|1|||
48398101|NCT00464334|155649958|FG008|Overall Study|Progressive Disease|1|||
48398102|NCT00464334|155649959|FG009|Overall Study|Progressive Disease|0|||
48781404|NCT01358526|157040201|FG000|Double-blind Phase|Lack of Efficacy|0|||
48781405|NCT01358526|157040202|FG001|Double-blind Phase|Lack of Efficacy|31|||
48781406|NCT01358526|157040203|FG002|Double-blind Phase|Lack of Efficacy|73|||
48781407|NCT01358526|157040201|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
48781408|NCT01358526|157040202|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
48781409|NCT01358526|157040203|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
48781410|NCT01358526|157040201|FG000|Double-blind Phase|Administrative|0|||
48781411|NCT01358526|157040202|FG001|Double-blind Phase|Administrative|6|||
48781412|NCT01358526|157040203|FG002|Double-blind Phase|Administrative|10|||
48781413|NCT03394924|157040207|FG000|Overall Study|Adverse Event|0|||
48781414|NCT03394924|157040208|FG001|Overall Study|Adverse Event|5|||
48781415|NCT03394924|157040209|FG002|Overall Study|Adverse Event|0|||
48781416|NCT03394924|157040207|FG000|Overall Study|Withdrawal by Subject|2|||
48781417|NCT03394924|157040208|FG001|Overall Study|Withdrawal by Subject|0|||
48781418|NCT03394924|157040209|FG002|Overall Study|Withdrawal by Subject|0|||
48781419|NCT03394924|157040207|FG000|Overall Study|Lost to Follow-up|0|||
48781420|NCT03394924|157040208|FG001|Overall Study|Lost to Follow-up|1|||
48781421|NCT03394924|157040209|FG002|Overall Study|Lost to Follow-up|0|||
48781422|NCT03394924|157040207|FG000|Overall Study|Did not meet all inclusion criteria|1|||
48781423|NCT03394924|157040208|FG001|Overall Study|Did not meet all inclusion criteria|0|||
48781424|NCT03394924|157040209|FG002|Overall Study|Did not meet all inclusion criteria|0|||
48781425|NCT04223856|157040210|FG000|Overall Study|Progressive disease|153|||
48781426|NCT04223856|157040211|FG001|Overall Study|Progressive disease|73|||
48781427|NCT04223856|157040210|FG000|Overall Study|Adverse Event|97|||
48781428|NCT04223856|157040211|FG001|Overall Study|Adverse Event|62|||
48781429|NCT04223856|157040210|FG000|Overall Study|Physician Decision|9|||
48781430|NCT04223856|157040211|FG001|Overall Study|Physician Decision|28|||
48781431|NCT04223856|157040210|FG000|Overall Study|Withdrawal by Subject|22|||
48781432|NCT04223856|157040211|FG001|Overall Study|Withdrawal by Subject|24|||
48781433|NCT04223856|157040210|FG000|Overall Study|Other|7|||
48781434|NCT04223856|157040211|FG001|Overall Study|Other|2|||
48781435|NCT04223856|157040210|FG000|Overall Study|Randomized but not treated|2|||
48781436|NCT04223856|157040211|FG001|Overall Study|Randomized but not treated|11|||
48781437|NCT04223856|157040210|FG000|Overall Study|On-treatment|144|||
48781438|NCT04223856|157040211|FG001|Overall Study|On-treatment|0|||
48781439|NCT02349711|157042401|FG000|Overall Study|Withdrawal by Subject|2|||
48781440|NCT02349711|157042402|FG001|Overall Study|Withdrawal by Subject|1|||
48781441|NCT02349711|157042401|FG000|Overall Study|Lost to Follow-up|1|||
48781442|NCT02349711|157042402|FG001|Overall Study|Lost to Follow-up|1|||
48781443|NCT02343458|157042410|FG000|Overall Study|Adverse Event|15|||
48781444|NCT02343458|157042411|FG001|Overall Study|Adverse Event|14|||
48398103|NCT00464334|155649960|FG010|Overall Study|Progressive Disease|0|||
48398104|NCT00464334|155649950|FG000|Overall Study|Study Terminated by Sponsor|0|||
48398105|NCT00464334|155649951|FG001|Overall Study|Study Terminated by Sponsor|0|||
48398106|NCT00464334|155649952|FG002|Overall Study|Study Terminated by Sponsor|0|||
48398107|NCT00464334|155649953|FG003|Overall Study|Study Terminated by Sponsor|1|||
48398108|NCT00464334|155649954|FG004|Overall Study|Study Terminated by Sponsor|0|||
48398109|NCT00464334|155649955|FG005|Overall Study|Study Terminated by Sponsor|0|||
48398110|NCT00464334|155649956|FG006|Overall Study|Study Terminated by Sponsor|0|||
48398111|NCT00464334|155649957|FG007|Overall Study|Study Terminated by Sponsor|0|||
48398112|NCT00464334|155649958|FG008|Overall Study|Study Terminated by Sponsor|0|||
48398113|NCT00464334|155649959|FG009|Overall Study|Study Terminated by Sponsor|0|||
48398114|NCT00464334|155649960|FG010|Overall Study|Study Terminated by Sponsor|0|||
48398115|NCT00464334|155649950|FG000|Overall Study|Withdrawal by Subject|1|||
48398116|NCT00464334|155649951|FG001|Overall Study|Withdrawal by Subject|7|||
48398117|NCT00464334|155649952|FG002|Overall Study|Withdrawal by Subject|4|||
48398118|NCT00464334|155649953|FG003|Overall Study|Withdrawal by Subject|2|||
48398119|NCT00464334|155649954|FG004|Overall Study|Withdrawal by Subject|2|||
48398120|NCT00464334|155649955|FG005|Overall Study|Withdrawal by Subject|2|||
48398121|NCT00464334|155649956|FG006|Overall Study|Withdrawal by Subject|2|||
48398122|NCT00464334|155649957|FG007|Overall Study|Withdrawal by Subject|1|||
48398123|NCT00464334|155649958|FG008|Overall Study|Withdrawal by Subject|3|||
48398124|NCT00464334|155649959|FG009|Overall Study|Withdrawal by Subject|0|||
48781445|NCT02343458|157042412|FG002|Overall Study|Adverse Event|15|||
48781446|NCT02343458|157042413|FG003|Overall Study|Adverse Event|3|||
48781447|NCT02343458|157042410|FG000|Overall Study|Lack of Efficacy|3|||
48781448|NCT02343458|157042411|FG001|Overall Study|Lack of Efficacy|8|||
48781449|NCT02343458|157042412|FG002|Overall Study|Lack of Efficacy|4|||
48781450|NCT02343458|157042413|FG003|Overall Study|Lack of Efficacy|8|||
48781451|NCT02343458|157042410|FG000|Overall Study|Withdrawal by Subject|18|||
48398125|NCT00464334|155649960|FG010|Overall Study|Withdrawal by Subject|0|||
48398126|NCT00586495|155649961|FG000|Treatment Period|Adverse Event|11|||
48398127|NCT00586495|155649961|FG000|Treatment Period|Death|1|||
48398128|NCT00586495|155649961|FG000|Treatment Period|Protocol Violation|1|||
48781452|NCT02343458|157042411|FG001|Overall Study|Withdrawal by Subject|17|||
48781453|NCT02343458|157042412|FG002|Overall Study|Withdrawal by Subject|23|||
48781454|NCT02343458|157042413|FG003|Overall Study|Withdrawal by Subject|14|||
48781455|NCT02343458|157042410|FG000|Overall Study|Physician Decision|1|||
48781456|NCT02343458|157042411|FG001|Overall Study|Physician Decision|4|||
48781457|NCT02343458|157042412|FG002|Overall Study|Physician Decision|2|||
48781458|NCT02343458|157042413|FG003|Overall Study|Physician Decision|2|||
48781459|NCT02343458|157042410|FG000|Overall Study|Lost to Follow-up|5|||
48781460|NCT02343458|157042411|FG001|Overall Study|Lost to Follow-up|5|||
48781461|NCT02343458|157042412|FG002|Overall Study|Lost to Follow-up|3|||
48781462|NCT02343458|157042413|FG003|Overall Study|Lost to Follow-up|1|||
48781463|NCT02343458|157042410|FG000|Overall Study|Protocol Violation|2|||
48781464|NCT02343458|157042411|FG001|Overall Study|Protocol Violation|5|||
48781465|NCT02343458|157042412|FG002|Overall Study|Protocol Violation|2|||
48781466|NCT02343458|157042413|FG003|Overall Study|Protocol Violation|2|||
48781467|NCT02343458|157042410|FG000|Overall Study|Protocol Specified Criteria|17|||
48781468|NCT02343458|157042411|FG001|Overall Study|Protocol Specified Criteria|13|||
48781469|NCT02343458|157042412|FG002|Overall Study|Protocol Specified Criteria|14|||
48781470|NCT02343458|157042413|FG003|Overall Study|Protocol Specified Criteria|8|||
48781471|NCT01043874|157042414|FG000|Overall Study|Adverse Event|3|||
48781472|NCT01043874|157042414|FG000|Overall Study|Withdrawal by Subject|1|||
48781473|NCT01043874|157042414|FG000|Overall Study|Lack of Efficacy|1|||
48781474|NCT01043874|157042414|FG000|Overall Study|Administrative Problems|1|||
48781475|NCT01265953|157042416|FG000|Overall Study|Non compliance|5|||
48781476|NCT01265953|157042417|FG001|Overall Study|Non compliance|3|||
48781477|NCT02564198|157042418|FG000|Overall Study|Withdrawal by Subject|2|||
48781478|NCT02564198|157042419|FG001|Overall Study|Withdrawal by Subject|4|||
48781479|NCT02564198|157042420|FG002|Overall Study|Withdrawal by Subject|0|||
48781480|NCT02564198|157042418|FG000|Overall Study|Adverse Event|0|||
48781481|NCT02564198|157042419|FG001|Overall Study|Adverse Event|1|||
48781482|NCT02564198|157042420|FG002|Overall Study|Adverse Event|0|||
48781483|NCT01640301|157042423|FG000|Overall Study|Death|0|||
48781484|NCT01640301|157042424|FG001|Overall Study|Death|8|||
48781485|NCT02055352|157042425|FG000|Overall Study|Adverse Event|0|||
48781486|NCT02055352|157042426|FG001|Overall Study|Adverse Event|1|||
48781487|NCT02055352|157042425|FG000|Overall Study|Non-eligible|0|||
48781488|NCT02055352|157042426|FG001|Overall Study|Non-eligible|1|||
48781489|NCT02055352|157042425|FG000|Overall Study|Poor compliance|1|||
48781490|NCT02055352|157042426|FG001|Overall Study|Poor compliance|1|||
48781491|NCT02055352|157042425|FG000|Overall Study|Death|1|||
48781492|NCT02055352|157042426|FG001|Overall Study|Death|2|||
48781493|NCT02055352|157042425|FG000|Overall Study|Patient decision|1|||
48781494|NCT02055352|157042426|FG001|Overall Study|Patient decision|1|||
48781495|NCT02055352|157042425|FG000|Overall Study|Use of prohibited treatment|0|||
48781496|NCT02055352|157042426|FG001|Overall Study|Use of prohibited treatment|3|||
48781497|NCT02055352|157042425|FG000|Overall Study|AE, study drug would be detrimental|1|||
48781498|NCT02055352|157042426|FG001|Overall Study|AE, study drug would be detrimental|3|||
48781499|NCT02055352|157042425|FG000|Overall Study|Withdrawal of informed consent|1|||
48781500|NCT02055352|157042426|FG001|Overall Study|Withdrawal of informed consent|0|||
48781501|NCT02055352|157042425|FG000|Overall Study|Reason unknown|1|||
48781502|NCT02055352|157042426|FG001|Overall Study|Reason unknown|5|||
48781503|NCT00127608|157042427|FG000|Overall Study|VZV DNA negative|1|||
48781504|NCT00408993|157042428|FG000|Overall Study|Adverse Event|15|||
48781505|NCT00408993|157042429|FG001|Overall Study|Adverse Event|4|||
48781506|NCT00408993|157042428|FG000|Overall Study|Protocol Violation|1|||
48781507|NCT00408993|157042429|FG001|Overall Study|Protocol Violation|6|||
48781508|NCT00408993|157042428|FG000|Overall Study|Lack of Efficacy|1|||
48781509|NCT00408993|157042429|FG001|Overall Study|Lack of Efficacy|4|||
48781510|NCT00408993|157042428|FG000|Overall Study|Withdrawal by Subject|2|||
48781511|NCT00408993|157042429|FG001|Overall Study|Withdrawal by Subject|3|||
48781512|NCT02473614|157042434|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
48781513|NCT02473614|157042435|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
48781514|NCT00633984|157042436|FG000|Overall Study|Lost to Follow-up|0|||
48781515|NCT00633984|157042437|FG001|Overall Study|Lost to Follow-up|6|||
48781516|NCT00633984|157042436|FG000|Overall Study|Withdrawal by Subject|8|||
48781517|NCT00633984|157042437|FG001|Overall Study|Withdrawal by Subject|7|||
48781518|NCT00633984|157042436|FG000|Overall Study|Hospitalized|1|||
48781519|NCT00633984|157042437|FG001|Overall Study|Hospitalized|0|||
48781520|NCT04532112|157042438|FG000|Overall Study|Adverse Event|3|||
48781521|NCT04532112|157042439|FG001|Overall Study|Adverse Event|0|||
48781522|NCT02019719|157042440|FG000|Overall Study|Adverse Event|1|||
48781523|NCT02019719|157042441|FG001|Overall Study|Adverse Event|0|||
48781524|NCT02019719|157042442|FG002|Overall Study|Adverse Event|0|||
48781525|NCT02019719|157042443|FG003|Overall Study|Adverse Event|1|||
48781526|NCT02019719|157042444|FG004|Overall Study|Adverse Event|1|||
48781527|NCT02019719|157042440|FG000|Overall Study|Protocol Violation|1|||
48781528|NCT02019719|157042441|FG001|Overall Study|Protocol Violation|1|||
48781529|NCT02019719|157042442|FG002|Overall Study|Protocol Violation|0|||
48781530|NCT02019719|157042443|FG003|Overall Study|Protocol Violation|0|||
48781531|NCT02019719|157042444|FG004|Overall Study|Protocol Violation|0|||
48781532|NCT02019719|157042440|FG000|Overall Study|Protocol defined stopping criteria|2|||
48781533|NCT02019719|157042441|FG001|Overall Study|Protocol defined stopping criteria|0|||
48781534|NCT02019719|157042442|FG002|Overall Study|Protocol defined stopping criteria|0|||
48781535|NCT02019719|157042443|FG003|Overall Study|Protocol defined stopping criteria|1|||
48781536|NCT02019719|157042444|FG004|Overall Study|Protocol defined stopping criteria|1|||
48781537|NCT02019719|157042440|FG000|Overall Study|Physician Decision|2|||
48781538|NCT02019719|157042441|FG001|Overall Study|Physician Decision|0|||
48781539|NCT02019719|157042442|FG002|Overall Study|Physician Decision|0|||
48781540|NCT02019719|157042443|FG003|Overall Study|Physician Decision|0|||
48781541|NCT02019719|157042444|FG004|Overall Study|Physician Decision|0|||
48781542|NCT02031276|157042445|FG000|Period 1 Double-blind IV|Adverse Event|6|||
48781543|NCT02031276|157042446|FG001|Period 1 Double-blind IV|Adverse Event|5|||
48781544|NCT02031276|157042447|FG002|Period 1 Double-blind IV|Adverse Event|1|||
48781545|NCT02031276|157042445|FG000|Period 1 Double-blind IV|Other|0|||
48781546|NCT02031276|157042446|FG001|Period 1 Double-blind IV|Other|1|||
48781547|NCT02031276|157042447|FG002|Period 1 Double-blind IV|Other|0|||
48781548|NCT02031276|157042445|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
48781549|NCT02031276|157042446|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
48781550|NCT02031276|157042447|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
48781551|NCT02031276|157042445|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
48781552|NCT02031276|157042446|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
48781553|NCT02031276|157042447|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
48781554|NCT02031276|157042445|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
48781555|NCT02031276|157042446|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
48781556|NCT02031276|157042447|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
48781557|NCT02031276|157042445|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
48781558|NCT02031276|157042446|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
48781559|NCT02031276|157042447|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
48781560|NCT02031276|157042445|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
48781561|NCT02031276|157042446|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
48781562|NCT02031276|157042447|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
48781563|NCT02031276|157042445|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
48398129|NCT00586495|155649961|FG000|Treatment Period|Withdrawal by Subject|1|||
48781564|NCT02031276|157042446|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
48781565|NCT02031276|157042447|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
48781566|NCT02031276|157042445|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
48781567|NCT02031276|157042446|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
48781568|NCT02031276|157042447|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
48781569|NCT02530619|157042462|FG000|Registered for Study|Withdrawal by Subject|2|||
48781570|NCT02530619|157042462|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
48781571|NCT02530619|157042462|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
48781572|NCT02530619|157042462|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
48781573|NCT02530619|157042462|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
48781574|NCT02530619|157042462|FG000|Follow-up Period (6 Months)|Death|4|||
48781575|NCT02530619|157042462|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
48781576|NCT02530619|157042462|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
48781577|NCT01993719|157042467|FG000|First Drug Administration|Not treated|1|||
48781578|NCT01993719|157042468|FG001|First Drug Administration|Not treated|0|||
48781579|NCT01993719|157042469|FG002|First Drug Administration|Not treated|0|||
48398130|NCT00586495|155649961|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
48781580|NCT01993719|157042470|FG003|First Drug Administration|Not treated|0|||
48781581|NCT01993719|157042471|FG004|First Drug Administration|Not treated|0|||
48781582|NCT01992536|157042472|FG000|Overall Study|Administrative Reason|0|||
48781583|NCT01992536|157042473|FG001|Overall Study|Administrative Reason|0|||
48356545|NCT00706654|155501091|FG002|Oral Stabilization Phase|Adverse Event|0|||
48356546|NCT00706654|155501092|FG003|Oral Stabilization Phase|Adverse Event|0|||
48781584|NCT01992536|157042474|FG002|Overall Study|Administrative Reason|0|||
48781585|NCT01992536|157042475|FG003|Overall Study|Administrative Reason|0|||
48781586|NCT01992536|157042476|FG004|Overall Study|Administrative Reason|0|||
48781587|NCT01992536|157042477|FG005|Overall Study|Administrative Reason|0|||
48781588|NCT01992536|157042478|FG006|Overall Study|Administrative Reason|7|||
48781589|NCT01992536|157042479|FG007|Overall Study|Administrative Reason|0|||
48781590|NCT01992536|157042480|FG008|Overall Study|Administrative Reason|0|||
48781591|NCT01992536|157042481|FG009|Overall Study|Administrative Reason|0|||
48781592|NCT01992536|157042472|FG000|Overall Study|Lost to Follow-up|4|||
48781593|NCT01992536|157042473|FG001|Overall Study|Lost to Follow-up|2|||
48781594|NCT01992536|157042474|FG002|Overall Study|Lost to Follow-up|1|||
48781595|NCT01992536|157042475|FG003|Overall Study|Lost to Follow-up|0|||
48781596|NCT01992536|157042476|FG004|Overall Study|Lost to Follow-up|0|||
48781597|NCT01992536|157042477|FG005|Overall Study|Lost to Follow-up|1|||
48781598|NCT01992536|157042478|FG006|Overall Study|Lost to Follow-up|0|||
48781599|NCT01992536|157042479|FG007|Overall Study|Lost to Follow-up|0|||
48781600|NCT01992536|157042480|FG008|Overall Study|Lost to Follow-up|1|||
48781601|NCT01992536|157042481|FG009|Overall Study|Lost to Follow-up|1|||
48781602|NCT01992536|157042472|FG000|Overall Study|Withdrawal by Subject|0|||
48781603|NCT01992536|157042473|FG001|Overall Study|Withdrawal by Subject|1|||
48781604|NCT01992536|157042474|FG002|Overall Study|Withdrawal by Subject|0|||
48781605|NCT01992536|157042475|FG003|Overall Study|Withdrawal by Subject|2|||
48781606|NCT01992536|157042476|FG004|Overall Study|Withdrawal by Subject|0|||
48781607|NCT01992536|157042477|FG005|Overall Study|Withdrawal by Subject|0|||
48781608|NCT01992536|157042478|FG006|Overall Study|Withdrawal by Subject|0|||
48781609|NCT01992536|157042479|FG007|Overall Study|Withdrawal by Subject|0|||
48781610|NCT01992536|157042480|FG008|Overall Study|Withdrawal by Subject|0|||
48781611|NCT01992536|157042481|FG009|Overall Study|Withdrawal by Subject|0|||
48781612|NCT01762761|157042482|FG000|Overall Study|Adverse Event|15|||
48781613|NCT01762761|157042483|FG001|Overall Study|Adverse Event|17|||
48781614|NCT01762761|157042482|FG000|Overall Study|Lack of Efficacy|9|||
48781615|NCT01762761|157042483|FG001|Overall Study|Lack of Efficacy|25|||
48781616|NCT01762761|157042482|FG000|Overall Study|Protocol Violation|1|||
48781617|NCT01762761|157042483|FG001|Overall Study|Protocol Violation|1|||
48781618|NCT01762761|157042482|FG000|Overall Study|Study closed/terminated|0|||
48781619|NCT01762761|157042483|FG001|Overall Study|Study closed/terminated|2|||
48781620|NCT01762761|157042482|FG000|Overall Study|Lost to Follow-up|3|||
48781621|NCT01762761|157042483|FG001|Overall Study|Lost to Follow-up|6|||
48781622|NCT01762761|157042482|FG000|Overall Study|Physician Decision|4|||
48781623|NCT01762761|157042483|FG001|Overall Study|Physician Decision|6|||
48781624|NCT01762761|157042482|FG000|Overall Study|Withdrawal by Subject|7|||
48781625|NCT01762761|157042483|FG001|Overall Study|Withdrawal by Subject|8|||
48781626|NCT02162810|157042485|FG000|Overall Study|Protocol Violation|1|||
48781627|NCT02162810|157042486|FG001|Overall Study|Protocol Violation|0|||
48781628|NCT02162810|157042485|FG000|Overall Study|patients did not report compliance|4|||
48781629|NCT02162810|157042486|FG001|Overall Study|patients did not report compliance|1|||
48781630|NCT03295201|157042487|FG000|Overall Study|Lost to Follow-up|1|||
48781631|NCT03295201|157042488|FG001|Overall Study|Lost to Follow-up|1|||
48781632|NCT03295201|157042487|FG000|Overall Study|Hospital admission|0|||
48781633|NCT03295201|157042488|FG001|Overall Study|Hospital admission|1|||
48781634|NCT00389324|157042489|FG000|Run-In Phase|Adverse Event|1|||
48781635|NCT00389324|157042489|FG000|Run-In Phase|Lost to Follow-up|1|||
48781636|NCT00389324|157042489|FG000|Run-In Phase|Withdrawal by Subject|1|||
48781637|NCT00389324|157042489|FG000|Subcutaneous Phase|Adverse Event|2|||
48781638|NCT00389324|157042489|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
48781639|NCT00389324|157042489|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
48781640|NCT00389324|157042489|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
48356547|NCT00706654|155501089|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
48356548|NCT00706654|155501090|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48781641|NCT04726709|157042490|FG000|Overall Study|Withdrawal by Subject|2|||
48398131|NCT00586495|155649961|FG000|Treatment Period|Switch to commercial drug|10|||
48398132|NCT00586495|155649961|FG000|Follow-up|Death|40|||
48398133|NCT00586495|155649961|FG000|Follow-up|Lost to Follow-up|1|||
48398134|NCT00586495|155649961|FG000|Follow-up|Withdrawal by Subject|4|||
48398135|NCT00586495|155649961|FG000|Follow-up|Protocol driven decision point|37|||
48398136|NCT00586495|155649961|FG000|Follow-up|Switch to commercial drug|10|||
48398137|NCT00705783|155649962|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
48398138|NCT00705783|155649963|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
48398139|NCT00705783|155649964|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
48398140|NCT00705783|155649962|FG000|Conversion Phase|Lost to Follow-up|13|||
48398141|NCT00705783|155649963|FG001|Conversion Phase|Lost to Follow-up|0|||
48398142|NCT00705783|155649964|FG002|Conversion Phase|Lost to Follow-up|0|||
48398143|NCT00705783|155649962|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
48398144|NCT00705783|155649963|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
48398145|NCT00705783|155649964|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
48398146|NCT00705783|155649962|FG000|Conversion Phase|Withdrawn by Investigator|4|||
48398147|NCT00705783|155649963|FG001|Conversion Phase|Withdrawn by Investigator|0|||
48398148|NCT00705783|155649964|FG002|Conversion Phase|Withdrawn by Investigator|0|||
48398149|NCT00705783|155649962|FG000|Conversion Phase|Withdrew Consent|24|||
48398150|NCT00705783|155649963|FG001|Conversion Phase|Withdrew Consent|0|||
48398151|NCT00705783|155649964|FG002|Conversion Phase|Withdrew Consent|0|||
48398152|NCT00705783|155649962|FG000|Conversion Phase|Protocol Deviation|2|||
48398153|NCT00705783|155649963|FG001|Conversion Phase|Protocol Deviation|0|||
48398154|NCT00705783|155649964|FG002|Conversion Phase|Protocol Deviation|0|||
48398155|NCT00705783|155649962|FG000|Conversion Phase|Adverse Event|11|||
48398156|NCT00705783|155649963|FG001|Conversion Phase|Adverse Event|0|||
48398157|NCT00705783|155649964|FG002|Conversion Phase|Adverse Event|0|||
48398158|NCT00705783|155649962|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
48398159|NCT00705783|155649963|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48398160|NCT00705783|155649964|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
48398161|NCT00705783|155649962|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
48398162|NCT00705783|155649963|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48398163|NCT00705783|155649964|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
48398164|NCT00705783|155649962|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
48398165|NCT00705783|155649963|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
48398166|NCT00705783|155649964|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
48398167|NCT00705783|155649962|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
48398168|NCT00705783|155649963|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
48398169|NCT00705783|155649964|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
48398170|NCT00705783|155649962|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
48398171|NCT00705783|155649963|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48398172|NCT00705783|155649964|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
48398173|NCT00705783|155649962|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
48398174|NCT00705783|155649963|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48398175|NCT00705783|155649964|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
48398176|NCT00705783|155649962|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
48398177|NCT00705783|155649963|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
48398178|NCT00705783|155649964|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
48398179|NCT00705783|155649962|FG000|Oral Stabilization Phase|Adverse Event|14|||
48398180|NCT00705783|155649963|FG001|Oral Stabilization Phase|Adverse Event|0|||
48398181|NCT00705783|155649964|FG002|Oral Stabilization Phase|Adverse Event|0|||
48398182|NCT00705783|155649962|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
48398183|NCT00705783|155649963|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48398184|NCT00705783|155649964|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48398185|NCT00705783|155649962|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
48398186|NCT00705783|155649963|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48398187|NCT00705783|155649964|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48398188|NCT00705783|155649962|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
48781642|NCT04726709|157042491|FG001|Overall Study|Withdrawal by Subject|2|||
48398189|NCT00705783|155649963|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
48398190|NCT00705783|155649964|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
48398191|NCT00705783|155649962|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
48781643|NCT01465334|157042492|FG000|Overall Study|Disease Progression|1|||
48781644|NCT01465334|157042493|FG001|Overall Study|Disease Progression|0|||
48781645|NCT01465334|157042492|FG000|Overall Study|Adverse Event|1|||
48781646|NCT01465334|157042493|FG001|Overall Study|Adverse Event|0|||
48781647|NCT01465334|157042492|FG000|Overall Study|Richter's transformation|0|||
48398192|NCT00705783|155649963|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
48398193|NCT00705783|155649964|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
48398194|NCT00705783|155649962|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
48398195|NCT00705783|155649963|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
48398196|NCT00705783|155649964|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
48398197|NCT00705783|155649962|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
48398198|NCT00705783|155649963|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
48398199|NCT00705783|155649964|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
48398200|NCT00705783|155649962|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
48398201|NCT00705783|155649963|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
48398202|NCT00705783|155649964|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
48398203|NCT00705783|155649962|FG000|Depot Stabilization Phase|Adverse Event|17|||
48398204|NCT00705783|155649963|FG001|Depot Stabilization Phase|Adverse Event|0|||
48398205|NCT00705783|155649964|FG002|Depot Stabilization Phase|Adverse Event|0|||
48398206|NCT00705783|155649962|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
48398207|NCT00705783|155649963|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48398208|NCT00705783|155649964|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48781648|NCT01465334|157042493|FG001|Overall Study|Richter's transformation|3|||
48781649|NCT01465334|157042492|FG000|Overall Study|Refractory Disease|0|||
48781650|NCT01465334|157042493|FG001|Overall Study|Refractory Disease|3|||
48781651|NCT02117570|157042497|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
48781652|NCT02117570|157042498|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
48781653|NCT02117570|157042499|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
48781654|NCT02117570|157042497|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
48398209|NCT00705783|155649962|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
48398210|NCT00705783|155649963|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48398211|NCT00705783|155649964|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48398212|NCT00705783|155649962|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
48398213|NCT00705783|155649963|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
48398214|NCT00705783|155649964|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
48398215|NCT00705783|155649962|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
48398216|NCT00705783|155649963|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
48398217|NCT00705783|155649964|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
48398218|NCT00705783|155649962|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
48398219|NCT00705783|155649963|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
48398220|NCT00705783|155649964|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
48398221|NCT00705783|155649962|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
48398222|NCT00705783|155649963|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
48398223|NCT00705783|155649964|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
48398224|NCT00705783|155649962|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
48398225|NCT00705783|155649963|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
48398226|NCT00705783|155649964|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
48398227|NCT00705783|155649962|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
48398228|NCT00705783|155649963|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
48398229|NCT00705783|155649964|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
48398230|NCT00705783|155649962|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
48398231|NCT00705783|155649963|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
48398232|NCT00705783|155649964|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
48398233|NCT00705783|155649962|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
48398234|NCT00705783|155649963|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
48398235|NCT00705783|155649964|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
48398236|NCT00705783|155649962|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
48398237|NCT00705783|155649963|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
48398238|NCT00705783|155649964|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
48398239|NCT01297270|155649965|FG000|Overall Study|Adverse Event|19|||
48398240|NCT01297270|155649966|FG001|Overall Study|Adverse Event|32|||
48398241|NCT01297270|155649967|FG002|Overall Study|Adverse Event|5|||
48398242|NCT01297270|155649965|FG000|Overall Study|Lack of Efficacy|15|||
48398243|NCT01297270|155649966|FG001|Overall Study|Lack of Efficacy|17|||
48398244|NCT01297270|155649967|FG002|Overall Study|Lack of Efficacy|15|||
48398245|NCT01297270|155649965|FG000|Overall Study|Lost to Follow-up|1|||
48398246|NCT01297270|155649966|FG001|Overall Study|Lost to Follow-up|2|||
48781655|NCT02117570|157042498|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
48781656|NCT02117570|157042499|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
48781657|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
48781658|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
48781659|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
48398247|NCT01297270|155649967|FG002|Overall Study|Lost to Follow-up|1|||
48398248|NCT01297270|155649965|FG000|Overall Study|Protocol Violation|0|||
48398249|NCT01297270|155649966|FG001|Overall Study|Protocol Violation|2|||
48398250|NCT01297270|155649967|FG002|Overall Study|Protocol Violation|0|||
48398251|NCT01297270|155649965|FG000|Overall Study|Withdrawal by Subject|7|||
48398252|NCT01297270|155649966|FG001|Overall Study|Withdrawal by Subject|15|||
48398253|NCT01297270|155649967|FG002|Overall Study|Withdrawal by Subject|7|||
48398254|NCT01297270|155649965|FG000|Overall Study|Other reason not defined above|3|||
48398255|NCT01297270|155649966|FG001|Overall Study|Other reason not defined above|3|||
48398256|NCT01297270|155649967|FG002|Overall Study|Other reason not defined above|1|||
48398257|NCT01297270|155649965|FG000|Overall Study|Not treated|0|||
48398258|NCT01297270|155649966|FG001|Overall Study|Not treated|1|||
48398259|NCT01297270|155649967|FG002|Overall Study|Not treated|0|||
48398260|NCT03603496|155649974|FG000|Overall Study|Death|19|||
48398261|NCT03603496|155649975|FG001|Overall Study|Death|24|||
48398262|NCT03603496|155649974|FG000|Overall Study|Lost to Follow-up|141|||
48398263|NCT03603496|155649975|FG001|Overall Study|Lost to Follow-up|141|||
48398264|NCT03603496|155649974|FG000|Overall Study|Withdrawal by Subject|26|||
48398265|NCT03603496|155649975|FG001|Overall Study|Withdrawal by Subject|20|||
48398266|NCT04317274|155649980|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
48398267|NCT04317274|155649981|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
48398268|NCT04317274|155649982|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
48398269|NCT04317274|155649983|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
48398270|NCT01081795|155649984|FG000|Overall Study|Adverse Event|18|||
48398271|NCT01081795|155649985|FG001|Overall Study|Adverse Event|23|||
48398272|NCT01081795|155649986|FG002|Overall Study|Adverse Event|6|||
48398273|NCT01081795|155649984|FG000|Overall Study|Lack of Efficacy|7|||
48398274|NCT01081795|155649985|FG001|Overall Study|Lack of Efficacy|5|||
48398275|NCT01081795|155649986|FG002|Overall Study|Lack of Efficacy|19|||
48398276|NCT01081795|155649984|FG000|Overall Study|Subject's schedule|1|||
48398277|NCT01081795|155649985|FG001|Overall Study|Subject's schedule|1|||
48398278|NCT01081795|155649986|FG002|Overall Study|Subject's schedule|2|||
48398279|NCT01081795|155649984|FG000|Overall Study|Revocation of informed consent|2|||
48398280|NCT01081795|155649985|FG001|Overall Study|Revocation of informed consent|0|||
48398281|NCT01081795|155649986|FG002|Overall Study|Revocation of informed consent|0|||
48398282|NCT01081795|155649984|FG000|Overall Study|Ineligible for participation|1|||
48398283|NCT01081795|155649985|FG001|Overall Study|Ineligible for participation|0|||
48398284|NCT01081795|155649986|FG002|Overall Study|Ineligible for participation|0|||
48398285|NCT01081795|155649984|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
48781660|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
48398286|NCT01081795|155649985|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
48398287|NCT01081795|155649986|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
48398288|NCT01081795|155649984|FG000|Overall Study|Using drug with restricted days of use|2|||
48398289|NCT01081795|155649985|FG001|Overall Study|Using drug with restricted days of use|3|||
48398290|NCT01081795|155649986|FG002|Overall Study|Using drug with restricted days of use|2|||
48398291|NCT01081795|155649984|FG000|Overall Study|Other|1|||
48398292|NCT01081795|155649985|FG001|Overall Study|Other|2|||
48398293|NCT01081795|155649986|FG002|Overall Study|Other|0|||
48398294|NCT01618214|155649990|FG000|Overall Study|Adverse Event|3|||
48398295|NCT01618214|155649991|FG001|Overall Study|Adverse Event|1|||
48398296|NCT01618214|155649990|FG000|Overall Study|Lack of Efficacy|1|||
48398297|NCT01618214|155649991|FG001|Overall Study|Lack of Efficacy|1|||
48398298|NCT01618214|155649990|FG000|Overall Study|Protocol Violation|1|||
48398299|NCT01618214|155649991|FG001|Overall Study|Protocol Violation|4|||
48398300|NCT01618214|155649990|FG000|Overall Study|Withdrawal Criteria|1|||
48398301|NCT01618214|155649991|FG001|Overall Study|Withdrawal Criteria|2|||
48781661|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
48781662|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
48781663|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
48781664|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
48781665|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
48781666|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
48781667|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
48781668|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
48781669|NCT02117570|157042497|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
48781670|NCT02117570|157042498|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
48781671|NCT02117570|157042499|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
48781672|NCT00922428|157042500|FG000|Overall Study|retrospective/extremely implausible data|2|||
48781673|NCT00922428|157042500|FG000|Overall Study|no medication use or questionable use|13|||
48781674|NCT02114892|157042501|FG000|Overall Study|Lost to Follow-up|1|||
48781675|NCT02114892|157042502|FG001|Overall Study|Lost to Follow-up|2|||
48398302|NCT01618214|155649990|FG000|Overall Study|Unclassified|4|||
48398303|NCT01618214|155649991|FG001|Overall Study|Unclassified|5|||
48398304|NCT02370615|155649992|FG000|Overall Study|Adverse Event|1|||
48398305|NCT02370615|155649993|FG001|Overall Study|Adverse Event|0|||
48398306|NCT00835237|155649994|FG000|Overall Study|Lost to Follow-up|4|||
48398307|NCT00835237|155649995|FG001|Overall Study|Lost to Follow-up|0|||
48781676|NCT00680407|157042503|FG000|Overall Study|Lost to Follow-up|3|||
48781677|NCT00680407|157042504|FG001|Overall Study|Lost to Follow-up|3|||
48781678|NCT00680407|157042505|FG002|Overall Study|Lost to Follow-up|1|||
48781679|NCT00680407|157042503|FG000|Overall Study|Withdrawal by Subject|5|||
48781680|NCT00680407|157042504|FG001|Overall Study|Withdrawal by Subject|2|||
48781681|NCT00680407|157042505|FG002|Overall Study|Withdrawal by Subject|2|||
48781682|NCT00320216|157042506|FG000|Overall Study|Adverse Event|0|||
48781683|NCT00320216|157042507|FG001|Overall Study|Adverse Event|6|||
48781684|NCT00320216|157042508|FG002|Overall Study|Adverse Event|0|||
48781685|NCT00320216|157042509|FG003|Overall Study|Adverse Event|2|||
48781686|NCT00320216|157042510|FG004|Overall Study|Adverse Event|2|||
48781687|NCT00320216|157042506|FG000|Overall Study|Lack of Efficacy|6|||
48781688|NCT00320216|157042507|FG001|Overall Study|Lack of Efficacy|2|||
48781689|NCT00320216|157042508|FG002|Overall Study|Lack of Efficacy|1|||
48781690|NCT00320216|157042509|FG003|Overall Study|Lack of Efficacy|0|||
48781691|NCT00320216|157042510|FG004|Overall Study|Lack of Efficacy|1|||
48781692|NCT00320216|157042506|FG000|Overall Study|Lost to Follow-up|3|||
48781693|NCT00320216|157042507|FG001|Overall Study|Lost to Follow-up|0|||
48781694|NCT00320216|157042508|FG002|Overall Study|Lost to Follow-up|0|||
48781695|NCT00320216|157042509|FG003|Overall Study|Lost to Follow-up|0|||
48781696|NCT00320216|157042510|FG004|Overall Study|Lost to Follow-up|0|||
48781697|NCT00320216|157042506|FG000|Overall Study|Other|7|||
48781698|NCT00320216|157042507|FG001|Overall Study|Other|2|||
48781699|NCT00320216|157042508|FG002|Overall Study|Other|5|||
48781700|NCT00320216|157042509|FG003|Overall Study|Other|1|||
48781701|NCT00320216|157042510|FG004|Overall Study|Other|3|||
48781702|NCT00779246|157042511|FG000|Overall Study|Missing sufficient data for analysis|33|||
48781703|NCT00779246|157042512|FG001|Overall Study|Missing sufficient data for analysis|53|||
48781704|NCT00093145|157042513|FG000|Overall Study|Unacceptable Toxicity Only|2|||
48781705|NCT00093145|157042513|FG000|Overall Study|Physician Decision|5|||
48781706|NCT00093145|157042513|FG000|Overall Study|Withdrawal by Subject|9|||
48781707|NCT00093145|157042513|FG000|Overall Study|Other|1|||
48781708|NCT02371369|157042516|FG000|Part 1|Physician Decision|0|||
48781709|NCT02371369|157042517|FG001|Part 1|Physician Decision|3|||
48781710|NCT02371369|157042516|FG000|Part 1|Adverse Event|8|||
48781711|NCT02371369|157042517|FG001|Part 1|Adverse Event|0|||
48781712|NCT02371369|157042516|FG000|Part 1|Withdrawal by Subject|1|||
48781713|NCT02371369|157042517|FG001|Part 1|Withdrawal by Subject|6|||
48781714|NCT02371369|157042516|FG000|Part 1|Disease progression|0|||
48781715|NCT02371369|157042517|FG001|Part 1|Disease progression|1|||
48781716|NCT02371369|157042516|FG000|Part 1|Protocol Violation|0|||
48781717|NCT02371369|157042517|FG001|Part 1|Protocol Violation|1|||
48781718|NCT02371369|157042516|FG000|Part 2|Adverse Event|6|||
48781719|NCT02371369|157042517|FG001|Part 2|Adverse Event|5|||
48781720|NCT02371369|157042516|FG000|Part 2|Withdrawal by Subject|16|||
48781721|NCT02371369|157042517|FG001|Part 2|Withdrawal by Subject|6|||
48781722|NCT02371369|157042516|FG000|Part 2|Investigator decision|1|||
48781723|NCT02371369|157042517|FG001|Part 2|Investigator decision|2|||
48781724|NCT02371369|157042516|FG000|Part 2|Death|0|||
48781725|NCT02371369|157042517|FG001|Part 2|Death|1|||
48781726|NCT02371369|157042516|FG000|Part 2|Disease progression|1|||
48781727|NCT02371369|157042517|FG001|Part 2|Disease progression|0|||
48781728|NCT02371369|157042516|FG000|Part 2|Subject Noncompliance|1|||
48781729|NCT02371369|157042517|FG001|Part 2|Subject Noncompliance|0|||
48781730|NCT02371369|157042516|FG000|Part 2|Lost to Follow-up|1|||
48781731|NCT02371369|157042517|FG001|Part 2|Lost to Follow-up|1|||
48781732|NCT02371369|157042516|FG000|Part 2|Subject transitioned to commercial supply|6|||
48781733|NCT02371369|157042517|FG001|Part 2|Subject transitioned to commercial supply|4|||
48781734|NCT02371369|157042516|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
48781735|NCT02371369|157042517|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
48781736|NCT02371369|157042516|FG000|Part 2|Surgical resection of tumor|1|||
48781737|NCT02371369|157042517|FG001|Part 2|Surgical resection of tumor|1|||
48781738|NCT02371369|157042516|FG000|Part 2|Other|0|||
48781739|NCT02371369|157042517|FG001|Part 2|Other|1|||
48781740|NCT00803634|157042518|FG000|Overall Study|Withdrew Consent|1|||
48781741|NCT00803634|157042519|FG001|Overall Study|Withdrew Consent|0|||
48781742|NCT00803634|157042518|FG000|Overall Study|Lost to Follow-up|2|||
48781743|NCT00803634|157042519|FG001|Overall Study|Lost to Follow-up|3|||
48781744|NCT00803634|157042518|FG000|Overall Study|Death|3|||
48781745|NCT00803634|157042519|FG001|Overall Study|Death|2|||
48781746|NCT05077267|157042520|FG000|Treatment Period|Lost to Follow-up|0|||
48781747|NCT05077267|157042521|FG001|Treatment Period|Lost to Follow-up|1|||
48781748|NCT05077267|157042522|FG002|Treatment Period|Lost to Follow-up|0|||
48781749|NCT05077267|157042520|FG000|Treatment Period|Withdrawal by Subject|0|||
48781750|NCT05077267|157042521|FG001|Treatment Period|Withdrawal by Subject|1|||
48781751|NCT05077267|157042522|FG002|Treatment Period|Withdrawal by Subject|0|||
48781752|NCT05077267|157042520|FG000|Follow-up Period|Lost to Follow-up|0|||
48781753|NCT05077267|157042521|FG001|Follow-up Period|Lost to Follow-up|5|||
48781754|NCT05077267|157042522|FG002|Follow-up Period|Lost to Follow-up|7|||
48781755|NCT05077267|157042520|FG000|Follow-up Period|Withdrawal by Subject|0|||
48781756|NCT05077267|157042521|FG001|Follow-up Period|Withdrawal by Subject|2|||
48781757|NCT05077267|157042522|FG002|Follow-up Period|Withdrawal by Subject|5|||
48781758|NCT05077267|157042520|FG000|Follow-up Period|Study terminated by sponsor|0|||
48781759|NCT05077267|157042521|FG001|Follow-up Period|Study terminated by sponsor|27|||
48781760|NCT05077267|157042522|FG002|Follow-up Period|Study terminated by sponsor|23|||
48781761|NCT05077267|157042520|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
48781762|NCT05077267|157042521|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
48781763|NCT05077267|157042522|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
48781764|NCT05077267|157042520|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
48781765|NCT05077267|157042521|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
48781766|NCT05077267|157042522|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
48781767|NCT03238001|157042531|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
48781768|NCT03238001|157042531|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
48781769|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
48781770|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
48781771|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
48781772|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
48781773|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
48781774|NCT03238001|157042531|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
48781775|NCT01313559|157042532|FG000|Overall Study|Withdrawal by Subject|1|||
48781776|NCT01313559|157042533|FG001|Overall Study|Withdrawal by Subject|2|||
48781777|NCT01313559|157042532|FG000|Overall Study|Disease progression|1|||
48781778|NCT01313559|157042533|FG001|Overall Study|Disease progression|0|||
48781779|NCT01313559|157042532|FG000|Overall Study|Rising PSA|2|||
48781780|NCT01313559|157042533|FG001|Overall Study|Rising PSA|0|||
48781781|NCT01910519|157042537|FG000|Overall Study|Withdrawal by Subject|2|||
48781782|NCT01910519|157042538|FG001|Overall Study|Withdrawal by Subject|0|||
48781783|NCT01910519|157042537|FG000|Overall Study|Adverse Event|2|||
48781784|NCT01910519|157042538|FG001|Overall Study|Adverse Event|0|||
48356549|NCT00706654|155501091|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48781785|NCT04964089|157042539|FG000|Overall Study|Adverse Event|8|||
48781786|NCT04964089|157042540|FG001|Overall Study|Adverse Event|6|||
48781787|NCT04964089|157042539|FG000|Overall Study|Non-compliance with study schedule|1|||
48781788|NCT04964089|157042540|FG001|Overall Study|Non-compliance with study schedule|0|||
48781789|NCT04964089|157042539|FG000|Overall Study|Withdrawal by Subject|6|||
48781790|NCT04964089|157042540|FG001|Overall Study|Withdrawal by Subject|5|||
48781791|NCT04964089|157042539|FG000|Overall Study|Lost to Follow-up|1|||
48781792|NCT04964089|157042540|FG001|Overall Study|Lost to Follow-up|1|||
48781793|NCT04964089|157042539|FG000|Overall Study|Progressive disease|4|||
48781794|NCT04964089|157042540|FG001|Overall Study|Progressive disease|0|||
48781795|NCT04964089|157042539|FG000|Overall Study|Physician Decision|1|||
48781796|NCT04964089|157042540|FG001|Overall Study|Physician Decision|0|||
48781797|NCT04964089|157042539|FG000|Overall Study|Participant did not want to continue study treatment|1|||
48781798|NCT04964089|157042540|FG001|Overall Study|Participant did not want to continue study treatment|0|||
48781799|NCT04964089|157042539|FG000|Overall Study|Participant moved to different state|1|||
48781800|NCT04964089|157042540|FG001|Overall Study|Participant moved to different state|0|||
48781801|NCT04964089|157042539|FG000|Overall Study|Participant decided to discontinue|0|||
48781802|NCT04964089|157042540|FG001|Overall Study|Participant decided to discontinue|1|||
48781803|NCT04452344|157042541|FG000|Overall Study|Withdrawal by Subject|3|||
48781804|NCT04452344|157042542|FG001|Overall Study|Withdrawal by Subject|6|||
48781805|NCT04452344|157042541|FG000|Overall Study|Adverse Event|1|||
48781806|NCT04452344|157042542|FG001|Overall Study|Adverse Event|2|||
48781807|NCT04452344|157042541|FG000|Overall Study|Lost to Follow-up|2|||
48781808|NCT04452344|157042542|FG001|Overall Study|Lost to Follow-up|2|||
48781809|NCT04452344|157042541|FG000|Overall Study|No Post-Op Visit|6|||
48781810|NCT04452344|157042542|FG001|Overall Study|No Post-Op Visit|7|||
48781811|NCT00023452|157042543|FG000|Overall Study|Ineligible for Study|163|||
48781812|NCT00023452|157042544|FG001|Overall Study|Ineligible for Study|159|||
48781813|NCT00023452|157042543|FG000|Overall Study|Out of Window|129|||
48781814|NCT00023452|157042544|FG001|Overall Study|Out of Window|69|||
48781815|NCT00023452|157042543|FG000|Overall Study|Death|2|||
48781816|NCT00023452|157042544|FG001|Overall Study|Death|0|||
48781817|NCT00023452|157042543|FG000|Overall Study|Withdrawal by Subject|66|||
48781818|NCT00023452|157042544|FG001|Overall Study|Withdrawal by Subject|54|||
48781819|NCT00023452|157042543|FG000|Overall Study|Adverse Event|139|||
48781820|NCT00023452|157042544|FG001|Overall Study|Adverse Event|196|||
48781821|NCT00023452|157042543|FG000|Overall Study|Lost to Follow-up|293|||
48781822|NCT00023452|157042544|FG001|Overall Study|Lost to Follow-up|60|||
48781823|NCT00023452|157042543|FG000|Overall Study|Physician Decision|49|||
48781824|NCT00023452|157042544|FG001|Overall Study|Physician Decision|21|||
48781825|NCT00023452|157042543|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
48781826|NCT00023452|157042544|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
48781827|NCT00023452|157042543|FG000|Overall Study|Pregnant|53|||
48781828|NCT00023452|157042544|FG001|Overall Study|Pregnant|20|||
48781829|NCT00023452|157042543|FG000|Overall Study|Other|204|||
48781830|NCT00023452|157042544|FG001|Overall Study|Other|69|||
48781831|NCT01898195|157042545|FG000|Smoking Abstinence|Did not have good measurements|35|||
48781832|NCT01898195|157042546|FG001|Smoking Abstinence|Did not have good measurements|38|||
48781833|NCT01898195|157042547|FG002|Smoking Abstinence|Did not have good measurements|36|||
48781834|NCT01954017|157042550|FG000|Overall Study|Adverse Event|0|||
48781835|NCT01954017|157042551|FG001|Overall Study|Adverse Event|0|||
48781836|NCT01954017|157042552|FG002|Overall Study|Adverse Event|1|||
48781837|NCT01954017|157042550|FG000|Overall Study|Death|2|||
48781838|NCT01954017|157042551|FG001|Overall Study|Death|1|||
48781839|NCT01954017|157042552|FG002|Overall Study|Death|1|||
48781840|NCT01954017|157042550|FG000|Overall Study|Withdrawal by Subject|0|||
48781841|NCT01954017|157042551|FG001|Overall Study|Withdrawal by Subject|1|||
48781842|NCT01954017|157042552|FG002|Overall Study|Withdrawal by Subject|0|||
48781843|NCT01954017|157042550|FG000|Overall Study|Protocol Violation|0|||
48781844|NCT01954017|157042551|FG001|Overall Study|Protocol Violation|3|||
48781845|NCT01954017|157042552|FG002|Overall Study|Protocol Violation|2|||
48781846|NCT01954017|157042550|FG000|Overall Study|Necrotizing enterocolitis|1|||
48781847|NCT01954017|157042551|FG001|Overall Study|Necrotizing enterocolitis|0|||
48781848|NCT01954017|157042552|FG002|Overall Study|Necrotizing enterocolitis|1|||
48781849|NCT01954017|157042550|FG000|Overall Study|Enteral intake stopped >7 days|0|||
48781850|NCT01954017|157042551|FG001|Overall Study|Enteral intake stopped >7 days|1|||
48781851|NCT01954017|157042552|FG002|Overall Study|Enteral intake stopped >7 days|1|||
48781852|NCT01954017|157042550|FG000|Overall Study|All other reasons|2|||
48781853|NCT01954017|157042551|FG001|Overall Study|All other reasons|2|||
48781854|NCT01954017|157042552|FG002|Overall Study|All other reasons|7|||
48781855|NCT04598152|157042553|FG000|Overall Study|Lost to Follow-up|0|||
48781856|NCT04598152|157042554|FG001|Overall Study|Lost to Follow-up|1|||
48781857|NCT00932893|157042555|FG000|Overall Study|Death|115|||
48781858|NCT00932893|157042556|FG001|Overall Study|Death|24|||
48781859|NCT00932893|157042555|FG000|Overall Study|Lost to Follow-up|8|||
48781860|NCT00932893|157042556|FG001|Overall Study|Lost to Follow-up|0|||
48781861|NCT00932893|157042555|FG000|Overall Study|Withdrawal by Subject|5|||
48781862|NCT00932893|157042556|FG001|Overall Study|Withdrawal by Subject|2|||
48781863|NCT00932893|157042555|FG000|Overall Study|Other|5|||
48781864|NCT00932893|157042556|FG001|Overall Study|Other|144|||
48781865|NCT03891524|157042557|FG000|Overall Study|Death|0|||
48781866|NCT03891524|157042558|FG001|Overall Study|Death|0|||
48781867|NCT03891524|157042559|FG002|Overall Study|Death|0|||
48781868|NCT03891524|157042560|FG003|Overall Study|Death|0|||
48781869|NCT03891524|157042561|FG004|Overall Study|Death|0|||
48781870|NCT03891524|157042562|FG005|Overall Study|Death|0|||
48781871|NCT03891524|157042563|FG006|Overall Study|Death|0|||
48398308|NCT00835237|155649994|FG000|Overall Study|Withdrawal by Subject|2|||
48398309|NCT00835237|155649995|FG001|Overall Study|Withdrawal by Subject|0|||
48398310|NCT01536860|155649996|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
48398311|NCT01536860|155649997|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
48781872|NCT03891524|157042564|FG007|Overall Study|Death|1|||
48398312|NCT01536860|155649998|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
48398313|NCT00606086|155650008|FG000|Overall Study|Adverse Event|1|||
48398314|NCT00606086|155650009|FG001|Overall Study|Adverse Event|1|||
48398315|NCT00606086|155650008|FG000|Overall Study|Lost to Follow-up|4|||
48398316|NCT00606086|155650009|FG001|Overall Study|Lost to Follow-up|8|||
48398317|NCT00606086|155650008|FG000|Overall Study|Protocol Violation|1|||
48398318|NCT00606086|155650009|FG001|Overall Study|Protocol Violation|0|||
48398319|NCT00606086|155650008|FG000|Overall Study|Withdrawal by Subject|5|||
48781873|NCT03891524|157042557|FG000|Overall Study|Withdrawal by Subject|0|||
48781874|NCT03891524|157042558|FG001|Overall Study|Withdrawal by Subject|1|||
48781875|NCT03891524|157042559|FG002|Overall Study|Withdrawal by Subject|2|||
48781876|NCT03891524|157042560|FG003|Overall Study|Withdrawal by Subject|1|||
48781877|NCT03891524|157042561|FG004|Overall Study|Withdrawal by Subject|2|||
48781878|NCT03891524|157042562|FG005|Overall Study|Withdrawal by Subject|2|||
48781879|NCT03891524|157042563|FG006|Overall Study|Withdrawal by Subject|2|||
48781880|NCT03891524|157042564|FG007|Overall Study|Withdrawal by Subject|1|||
48781881|NCT03283670|157042567|FG000|Placebo Gas|Withdrawal by Subject|2|||
48781882|NCT03283670|157042567|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
48781883|NCT03283670|157042567|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
48781884|NCT02823145|157042568|FG000|Enrollment|Other|1|||
48781885|NCT02823145|157042569|FG001|Enrollment|Other|0|||
48781886|NCT02823145|157042568|FG000|Treatment|Adverse Event|0|||
48781887|NCT02823145|157042569|FG001|Treatment|Adverse Event|11|||
48781888|NCT02823145|157042568|FG000|Treatment|Death|0|||
48781889|NCT02823145|157042569|FG001|Treatment|Death|3|||
48781890|NCT02823145|157042568|FG000|Treatment|Family Decision|0|||
48781891|NCT02823145|157042569|FG001|Treatment|Family Decision|1|||
48781892|NCT02823145|157042568|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
48781893|NCT02823145|157042569|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
48781894|NCT02823145|157042568|FG000|Treatment|Lack of Efficacy|0|||
48781895|NCT02823145|157042569|FG001|Treatment|Lack of Efficacy|48|||
48781896|NCT02823145|157042568|FG000|Treatment|Non-Compliance With E-Diary|0|||
48781897|NCT02823145|157042569|FG001|Treatment|Non-Compliance With E-Diary|1|||
48781898|NCT02823145|157042568|FG000|Treatment|Physician Decision|0|||
48781899|NCT02823145|157042569|FG001|Treatment|Physician Decision|2|||
48781900|NCT02823145|157042568|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
48781901|NCT02823145|157042569|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
48781902|NCT02823145|157042568|FG000|Treatment|Subject needed to take prohibited medication|0|||
48781903|NCT02823145|157042569|FG001|Treatment|Subject needed to take prohibited medication|1|||
48781904|NCT02823145|157042568|FG000|Treatment|Subject transferred to direct access programme|0|||
48781905|NCT02823145|157042569|FG001|Treatment|Subject transferred to direct access programme|1|||
48781906|NCT02823145|157042568|FG000|Treatment|Switching to commercially available drug|0|||
48781907|NCT02823145|157042569|FG001|Treatment|Switching to commercially available drug|11|||
48781908|NCT02823145|157042568|FG000|Treatment|Transitioned to commercial supply of medication|0|||
48781909|NCT02823145|157042569|FG001|Treatment|Transitioned to commercial supply of medication|1|||
48781910|NCT02823145|157042568|FG000|Treatment|Withdrawal By Caregiver|0|||
48781911|NCT02823145|157042569|FG001|Treatment|Withdrawal By Caregiver|1|||
48781912|NCT02823145|157042568|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
48781913|NCT02823145|157042569|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
48781914|NCT02823145|157042568|FG000|Treatment|Withdrawal by Subject|0|||
48781915|NCT02823145|157042569|FG001|Treatment|Withdrawal by Subject|16|||
48781916|NCT02823145|157042568|FG000|Treatment|Reason unknown|0|||
48781917|NCT02823145|157042569|FG001|Treatment|Reason unknown|1|||
48781918|NCT03136068|157044484|FG000|Overall Study|Lost to Follow-up|1|||
48781919|NCT03136068|157044485|FG001|Overall Study|Lost to Follow-up|1|||
48781920|NCT03136068|157044484|FG000|Overall Study|Protocol Violation|1|||
48781921|NCT03136068|157044485|FG001|Overall Study|Protocol Violation|0|||
48781922|NCT00432380|157044488|FG000|Overall Study|Migrated/moved from study area|3|||
48781923|NCT00432380|157044489|FG001|Overall Study|Migrated/moved from study area|4|||
48781924|NCT00432380|157044490|FG002|Overall Study|Migrated/moved from study area|1|||
48781925|NCT00432380|157044488|FG000|Overall Study|Adverse Event|1|||
48781926|NCT00432380|157044489|FG001|Overall Study|Adverse Event|0|||
48781927|NCT00432380|157044490|FG002|Overall Study|Adverse Event|0|||
48781928|NCT01071395|157044491|FG000|Overall Study|Withdrawal by Subject|2|||
48781929|NCT01071395|157044492|FG001|Overall Study|Withdrawal by Subject|1|||
48781930|NCT01071395|157044491|FG000|Overall Study|Adverse Event|3|||
48781931|NCT01071395|157044492|FG001|Overall Study|Adverse Event|1|||
48781932|NCT02805257|157044493|FG000|Overall Study|Lost to Follow-up|7|||
48781933|NCT02805257|157044494|FG001|Overall Study|Lost to Follow-up|6|||
48781934|NCT02805257|157044493|FG000|Overall Study|Death|0|||
48781935|NCT02805257|157044494|FG001|Overall Study|Death|1|||
48398320|NCT00606086|155650009|FG001|Overall Study|Withdrawal by Subject|3|||
48781936|NCT01539291|157044495|FG000|Study GS-US-312-0116|Adverse Event|9|||
48781937|NCT01539291|157044496|FG001|Study GS-US-312-0116|Adverse Event|0|||
48781938|NCT01539291|157044497|FG002|Study GS-US-312-0116|Adverse Event|0|||
48781939|NCT01539291|157044498|FG003|Study GS-US-312-0116|Adverse Event|0|||
48781940|NCT01539291|157044495|FG000|Study GS-US-312-0116|Physician Decision|1|||
48781941|NCT01539291|157044496|FG001|Study GS-US-312-0116|Physician Decision|0|||
48781942|NCT01539291|157044497|FG002|Study GS-US-312-0116|Physician Decision|0|||
48781943|NCT01539291|157044498|FG003|Study GS-US-312-0116|Physician Decision|0|||
48781944|NCT01539291|157044495|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
48781945|NCT01539291|157044496|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
48781946|NCT01539291|157044497|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
48781947|NCT01539291|157044498|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
48781948|NCT01539291|157044495|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
48781949|NCT01539291|157044496|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
48781950|NCT01539291|157044497|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
48781951|NCT01539291|157044498|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
48781952|NCT01539291|157044495|FG000|Study GS-US-312-0116|Other|1|||
48781953|NCT01539291|157044496|FG001|Study GS-US-312-0116|Other|0|||
48781954|NCT01539291|157044497|FG002|Study GS-US-312-0116|Other|0|||
48781955|NCT01539291|157044498|FG003|Study GS-US-312-0116|Other|0|||
48781956|NCT01539291|157044495|FG000|Study GS-US-312-0117|Adverse Event|22|||
48781957|NCT01539291|157044496|FG001|Study GS-US-312-0117|Adverse Event|1|||
48781958|NCT01539291|157044497|FG002|Study GS-US-312-0117|Adverse Event|9|||
48781959|NCT01539291|157044498|FG003|Study GS-US-312-0117|Adverse Event|12|||
48781960|NCT01539291|157044495|FG000|Study GS-US-312-0117|Physician Decision|9|||
48781961|NCT01539291|157044496|FG001|Study GS-US-312-0117|Physician Decision|0|||
48781962|NCT01539291|157044497|FG002|Study GS-US-312-0117|Physician Decision|6|||
48781963|NCT01539291|157044498|FG003|Study GS-US-312-0117|Physician Decision|4|||
48781964|NCT01539291|157044495|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
48781965|NCT01539291|157044496|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
48781966|NCT01539291|157044497|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
48398321|NCT00606086|155650008|FG000|Overall Study|Non-compliance|0|||
48398322|NCT00606086|155650009|FG001|Overall Study|Non-compliance|1|||
48398323|NCT00606086|155650008|FG000|Overall Study|Randomized, not treated|1|||
48398324|NCT00606086|155650009|FG001|Overall Study|Randomized, not treated|2|||
48398325|NCT01929408|155650013|FG000|Overall Study|received HCT as initial treatment|8|||
48398326|NCT01325428|155650022|FG000|Part A|Progressive disease according to RECIST|9|||
48398327|NCT01325428|155650022|FG000|Part A|Clinical signs, symptoms of progression|2|||
48398328|NCT01325428|155650022|FG000|Part A|Other adverse event|1|||
48781967|NCT01539291|157044498|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
48356550|NCT00706654|155501092|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
48356551|NCT00706654|155501089|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
48356552|NCT00706654|155501090|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48356553|NCT00706654|155501091|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48356554|NCT00706654|155501092|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
48356555|NCT00706654|155501089|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
48356556|NCT00706654|155501090|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
48356557|NCT00706654|155501091|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
48356558|NCT00706654|155501092|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
48356559|NCT00706654|155501089|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
48356560|NCT00706654|155501090|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
48356561|NCT00706654|155501091|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
48356562|NCT00706654|155501092|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
48398329|NCT01325428|155650022|FG000|Part A|Refused continue taking trial medication|2|||
48781968|NCT01539291|157044495|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
48781969|NCT01539291|157044496|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
48781970|NCT01539291|157044497|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
48781971|NCT01539291|157044498|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
48781972|NCT01539291|157044495|FG000|Study GS-US-312-0117|Other|2|||
48781973|NCT01539291|157044496|FG001|Study GS-US-312-0117|Other|1|||
48781974|NCT01539291|157044497|FG002|Study GS-US-312-0117|Other|1|||
48781975|NCT01539291|157044498|FG003|Study GS-US-312-0117|Other|1|||
48781976|NCT01076400|157044499|FG000|Overall Study|Adverse Event|2|||
48781977|NCT01076400|157044500|FG001|Overall Study|Adverse Event|0|||
48781978|NCT01076400|157044501|FG002|Overall Study|Adverse Event|0|||
48781979|NCT01076400|157044499|FG000|Overall Study|Progressive Disease|5|||
48781980|NCT01076400|157044500|FG001|Overall Study|Progressive Disease|0|||
48781981|NCT01076400|157044501|FG002|Overall Study|Progressive Disease|0|||
48781982|NCT02766608|157044504|FG000|Overall Study|Adverse Event|27|||
48781983|NCT02766608|157044505|FG001|Overall Study|Adverse Event|22|||
48781984|NCT02766608|157044506|FG002|Overall Study|Adverse Event|17|||
48781985|NCT02766608|157044507|FG003|Overall Study|Adverse Event|13|||
48781986|NCT02766608|157044508|FG004|Overall Study|Adverse Event|12|||
48781987|NCT02766608|157044504|FG000|Overall Study|Withdrawal by Subject|21|||
48781988|NCT02766608|157044505|FG001|Overall Study|Withdrawal by Subject|20|||
48781989|NCT02766608|157044506|FG002|Overall Study|Withdrawal by Subject|24|||
48781990|NCT02766608|157044507|FG003|Overall Study|Withdrawal by Subject|13|||
48781991|NCT02766608|157044508|FG004|Overall Study|Withdrawal by Subject|10|||
48781992|NCT02766608|157044504|FG000|Overall Study|Lack of Efficacy|16|||
48781993|NCT02766608|157044505|FG001|Overall Study|Lack of Efficacy|15|||
48781994|NCT02766608|157044506|FG002|Overall Study|Lack of Efficacy|32|||
48781995|NCT02766608|157044507|FG003|Overall Study|Lack of Efficacy|8|||
48781996|NCT02766608|157044508|FG004|Overall Study|Lack of Efficacy|2|||
48781997|NCT02766608|157044504|FG000|Overall Study|Lost to Follow-up|6|||
48781998|NCT02766608|157044505|FG001|Overall Study|Lost to Follow-up|3|||
48781999|NCT02766608|157044506|FG002|Overall Study|Lost to Follow-up|5|||
48782000|NCT02766608|157044507|FG003|Overall Study|Lost to Follow-up|2|||
48782001|NCT02766608|157044508|FG004|Overall Study|Lost to Follow-up|2|||
48782002|NCT02766608|157044504|FG000|Overall Study|Physician Decision|3|||
48782003|NCT02766608|157044505|FG001|Overall Study|Physician Decision|2|||
48782004|NCT02766608|157044506|FG002|Overall Study|Physician Decision|3|||
48782005|NCT02766608|157044507|FG003|Overall Study|Physician Decision|1|||
48782006|NCT02766608|157044508|FG004|Overall Study|Physician Decision|2|||
48782007|NCT02766608|157044504|FG000|Overall Study|Protocol disc criteria|3|||
48782008|NCT02766608|157044505|FG001|Overall Study|Protocol disc criteria|3|||
48782009|NCT02766608|157044506|FG002|Overall Study|Protocol disc criteria|4|||
48782010|NCT02766608|157044507|FG003|Overall Study|Protocol disc criteria|0|||
48782011|NCT02766608|157044508|FG004|Overall Study|Protocol disc criteria|0|||
48782012|NCT02766608|157044504|FG000|Overall Study|Protocol Violation|0|||
48782013|NCT02766608|157044505|FG001|Overall Study|Protocol Violation|4|||
48782014|NCT02766608|157044506|FG002|Overall Study|Protocol Violation|4|||
48782015|NCT02766608|157044507|FG003|Overall Study|Protocol Violation|0|||
48782016|NCT02766608|157044508|FG004|Overall Study|Protocol Violation|1|||
48398330|NCT01325428|155650022|FG000|Part A|Other reason not defined above|2|||
48398331|NCT01325428|155650022|FG000|Part B|Refused continue taking trial medication|2|||
48398332|NCT01325428|155650022|FG000|Part B|Other reason not defined above|1|||
48398333|NCT03557281|155651479|FG000|Overall Study|Investigator discretion|0|||
48398334|NCT03557281|155651480|FG001|Overall Study|Investigator discretion|0|||
48398335|NCT03557281|155651481|FG002|Overall Study|Investigator discretion|1|||
48398336|NCT03557281|155651482|FG003|Overall Study|Investigator discretion|0|||
48398337|NCT03557281|155651483|FG004|Overall Study|Investigator discretion|0|||
48398338|NCT03557281|155651479|FG000|Overall Study|Withdrawal by Subject|0|||
48398339|NCT03557281|155651480|FG001|Overall Study|Withdrawal by Subject|1|||
48398340|NCT03557281|155651481|FG002|Overall Study|Withdrawal by Subject|1|||
48398341|NCT03557281|155651482|FG003|Overall Study|Withdrawal by Subject|1|||
48398342|NCT03557281|155651483|FG004|Overall Study|Withdrawal by Subject|2|||
48398343|NCT03557281|155651479|FG000|Overall Study|Randomized, but did not receive treatment|0|||
48398344|NCT03557281|155651480|FG001|Overall Study|Randomized, but did not receive treatment|0|||
48398345|NCT03557281|155651481|FG002|Overall Study|Randomized, but did not receive treatment|0|||
48398346|NCT03557281|155651482|FG003|Overall Study|Randomized, but did not receive treatment|0|||
48782017|NCT02766608|157044504|FG000|Overall Study|Administrative Reasons|3|||
48782018|NCT02766608|157044505|FG001|Overall Study|Administrative Reasons|1|||
48782019|NCT02766608|157044506|FG002|Overall Study|Administrative Reasons|1|||
48782020|NCT02766608|157044507|FG003|Overall Study|Administrative Reasons|0|||
48782021|NCT02766608|157044508|FG004|Overall Study|Administrative Reasons|0|||
48782022|NCT02239510|157044509|FG000|Overall Study|Lost to Follow-up|2|||
48782023|NCT02239510|157044510|FG001|Overall Study|Lost to Follow-up|1|||
48782024|NCT00182689|157044511|FG000|Overall Study|Adverse Event|8|||
48782025|NCT00182689|157044512|FG001|Overall Study|Adverse Event|11|||
48782026|NCT00182689|157044511|FG000|Overall Study|Withdrawal by Subject|2|||
48782027|NCT00182689|157044512|FG001|Overall Study|Withdrawal by Subject|2|||
48782028|NCT00182689|157044511|FG000|Overall Study|Progression|27|||
48782029|NCT00182689|157044512|FG001|Overall Study|Progression|29|||
48782030|NCT00182689|157044511|FG000|Overall Study|Death|1|||
48782031|NCT00182689|157044512|FG001|Overall Study|Death|0|||
48398347|NCT03557281|155651483|FG004|Overall Study|Randomized, but did not receive treatment|1|||
48398348|NCT02229552|155651484|FG000|Baseline|Withdrawal by Subject|6|||
48782032|NCT00182689|157044511|FG000|Overall Study|not protocol specified|0|||
48398349|NCT02229552|155651484|FG000|1-year Follow up|Withdrawal by Subject|7|||
48398350|NCT02229552|155651484|FG000|1-year Follow up|Lost to Follow-up|18|||
48782033|NCT00182689|157044512|FG001|Overall Study|not protocol specified|3|||
48782034|NCT00182689|157044511|FG000|Overall Study|Ineligible|1|||
48398351|NCT02229552|155651484|FG000|2-Year Follow up|Withdrawal by Subject|9|||
48398352|NCT02229552|155651484|FG000|2-Year Follow up|Lost to Follow-up|17|||
48398353|NCT04429061|155651485|FG000|Overall Study|Lost to Follow-up|62|||
48398354|NCT04429061|155651486|FG001|Overall Study|Lost to Follow-up|87|||
48398355|NCT04429061|155651485|FG000|Overall Study|Withdrawal by Subject|3|||
48782035|NCT00182689|157044512|FG001|Overall Study|Ineligible|4|||
48782036|NCT00182689|157044511|FG000|Overall Study|Never received treatment|1|||
48782037|NCT00182689|157044512|FG001|Overall Study|Never received treatment|0|||
48398356|NCT04429061|155651486|FG001|Overall Study|Withdrawal by Subject|4|||
48398357|NCT00971945|155651487|FG000|Overall Study|Progressive Disease|3|||
48398358|NCT00971945|155651487|FG000|Overall Study|Change in treatment policy|1|||
48782038|NCT02866682|157044513|FG000|Overall Study|Death|0|||
48782039|NCT02866682|157044514|FG001|Overall Study|Death|1|||
48782040|NCT02866682|157044513|FG000|Overall Study|Lost to Follow-up|0|||
48782041|NCT02866682|157044514|FG001|Overall Study|Lost to Follow-up|4|||
48782042|NCT02866682|157044513|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
48782043|NCT02866682|157044514|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
48782044|NCT02866682|157044513|FG000|Overall Study|Other|0|||
48782045|NCT02866682|157044514|FG001|Overall Study|Other|1|||
48782046|NCT03738865|157044515|FG000|Overall Study|Withdrawal by Subject|3|||
48782047|NCT03738865|157044516|FG001|Overall Study|Withdrawal by Subject|3|||
48782048|NCT03738865|157044515|FG000|Overall Study|Adverse Event|2|||
48782049|NCT03738865|157044516|FG001|Overall Study|Adverse Event|0|||
48782050|NCT03738865|157044515|FG000|Overall Study|Physician Decision|0|||
48782051|NCT03738865|157044516|FG001|Overall Study|Physician Decision|1|||
48782052|NCT04193202|157044517|FG000|Overall Study|Adverse Event|2|||
48782053|NCT04193202|157044518|FG001|Overall Study|Adverse Event|1|||
48782054|NCT04193202|157044517|FG000|Overall Study|Death|0|||
48782055|NCT04193202|157044518|FG001|Overall Study|Death|1|||
48782056|NCT04193202|157044517|FG000|Overall Study|Physician Decision|1|||
48782057|NCT04193202|157044518|FG001|Overall Study|Physician Decision|1|||
48782058|NCT04193202|157044517|FG000|Overall Study|Protocol Violation|2|||
48782059|NCT04193202|157044518|FG001|Overall Study|Protocol Violation|2|||
48782060|NCT04193202|157044517|FG000|Overall Study|Withdrawal by Subject|11|||
48782061|NCT04193202|157044518|FG001|Overall Study|Withdrawal by Subject|5|||
48782062|NCT01602315|157044519|FG000|Overall Study|Protocol Violation|0|||
48782063|NCT01602315|157044520|FG001|Overall Study|Protocol Violation|0|||
48782064|NCT01602315|157044521|FG002|Overall Study|Protocol Violation|0|||
48782065|NCT01602315|157044522|FG003|Overall Study|Protocol Violation|0|||
48782066|NCT01602315|157044523|FG004|Overall Study|Protocol Violation|0|||
48782067|NCT01602315|157044524|FG005|Overall Study|Protocol Violation|1|||
48782068|NCT01602315|157044525|FG006|Overall Study|Protocol Violation|0|||
48782069|NCT01602315|157044519|FG000|Overall Study|Physician Decision|2|||
48782070|NCT01602315|157044520|FG001|Overall Study|Physician Decision|0|||
48782071|NCT01602315|157044521|FG002|Overall Study|Physician Decision|0|||
48782072|NCT01602315|157044522|FG003|Overall Study|Physician Decision|0|||
48782073|NCT01602315|157044523|FG004|Overall Study|Physician Decision|2|||
48782074|NCT01602315|157044524|FG005|Overall Study|Physician Decision|1|||
48782075|NCT01602315|157044525|FG006|Overall Study|Physician Decision|1|||
48782076|NCT01602315|157044519|FG000|Overall Study|Disease progression|6|||
48782077|NCT01602315|157044520|FG001|Overall Study|Disease progression|3|||
48782078|NCT01602315|157044521|FG002|Overall Study|Disease progression|10|||
48782079|NCT01602315|157044522|FG003|Overall Study|Disease progression|1|||
48782080|NCT01602315|157044523|FG004|Overall Study|Disease progression|41|||
48782081|NCT01602315|157044524|FG005|Overall Study|Disease progression|12|||
48782082|NCT01602315|157044525|FG006|Overall Study|Disease progression|15|||
48782083|NCT01602315|157044519|FG000|Overall Study|Death|1|||
48782084|NCT01602315|157044520|FG001|Overall Study|Death|1|||
48782085|NCT01602315|157044521|FG002|Overall Study|Death|1|||
48782086|NCT01602315|157044522|FG003|Overall Study|Death|1|||
48782087|NCT01602315|157044523|FG004|Overall Study|Death|7|||
48782088|NCT01602315|157044524|FG005|Overall Study|Death|2|||
48782089|NCT01602315|157044525|FG006|Overall Study|Death|2|||
48782090|NCT01602315|157044519|FG000|Overall Study|Withdrawal by Subject|2|||
48782091|NCT01602315|157044520|FG001|Overall Study|Withdrawal by Subject|0|||
48782092|NCT01602315|157044521|FG002|Overall Study|Withdrawal by Subject|2|||
48782093|NCT01602315|157044522|FG003|Overall Study|Withdrawal by Subject|0|||
48782094|NCT01602315|157044523|FG004|Overall Study|Withdrawal by Subject|6|||
48398359|NCT00971945|155651487|FG000|Overall Study|Other reasons|2|||
48398360|NCT03325673|155651488|FG000|Overall Study|Adverse Event|4|||
48782095|NCT01602315|157044524|FG005|Overall Study|Withdrawal by Subject|0|||
48398361|NCT03325673|155651489|FG001|Overall Study|Adverse Event|0|||
48782096|NCT01602315|157044525|FG006|Overall Study|Withdrawal by Subject|1|||
48782097|NCT01602315|157044519|FG000|Overall Study|Adverse Event|5|||
48782098|NCT01602315|157044520|FG001|Overall Study|Adverse Event|1|||
48782099|NCT01602315|157044521|FG002|Overall Study|Adverse Event|5|||
48398362|NCT00820898|155651493|FG000|Overall Study|Inelgible - wrong primary site|1|||
48398363|NCT03189446|155651494|FG000|Overall Study|Adverse Event|2|||
48398364|NCT03189446|155651494|FG000|Overall Study|Withdrawal by Subject|2|||
48398365|NCT03189446|155651494|FG000|Overall Study|Physician Decision|1|||
48398366|NCT02830880|155651496|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
48398367|NCT02830880|155651496|FG000|Overall Study|Death|1|||
48398368|NCT02830880|155651496|FG000|Overall Study|Physician Decision|1|||
48398369|NCT02095535|155651497|FG000|Recruitment|Protocol Violation|2|||
48398370|NCT01580488|155651498|FG000|Overall Study|Withdrawal by Subject|1|||
48398371|NCT02787863|155651499|FG000|Overall Study|Death|1|||
48398372|NCT02787863|155651500|FG001|Overall Study|Death|0|||
48398373|NCT02787863|155651501|FG002|Overall Study|Death|1|||
48398374|NCT02787863|155651502|FG003|Overall Study|Death|0|||
48398375|NCT02787863|155651503|FG004|Overall Study|Death|0|||
48398376|NCT02787863|155651504|FG005|Overall Study|Death|0|||
48398377|NCT02787863|155651505|FG006|Overall Study|Death|0|||
48398378|NCT02787863|155651506|FG007|Overall Study|Death|0|||
48398379|NCT02787863|155651499|FG000|Overall Study|Withdrawal by Subject|0|||
48398380|NCT02787863|155651500|FG001|Overall Study|Withdrawal by Subject|1|||
48398381|NCT02787863|155651501|FG002|Overall Study|Withdrawal by Subject|1|||
48398382|NCT02787863|155651502|FG003|Overall Study|Withdrawal by Subject|0|||
48398383|NCT02787863|155651503|FG004|Overall Study|Withdrawal by Subject|0|||
48398384|NCT02787863|155651504|FG005|Overall Study|Withdrawal by Subject|0|||
48398385|NCT02787863|155651505|FG006|Overall Study|Withdrawal by Subject|0|||
48398386|NCT02787863|155651506|FG007|Overall Study|Withdrawal by Subject|0|||
48782100|NCT01602315|157044522|FG003|Overall Study|Adverse Event|4|||
48782101|NCT01602315|157044523|FG004|Overall Study|Adverse Event|15|||
48782102|NCT01602315|157044524|FG005|Overall Study|Adverse Event|3|||
48782103|NCT01602315|157044525|FG006|Overall Study|Adverse Event|9|||
48782104|NCT01602315|157044519|FG000|Overall Study|Subject/guardian decision|0|||
48782105|NCT01602315|157044520|FG001|Overall Study|Subject/guardian decision|0|||
48782106|NCT01602315|157044521|FG002|Overall Study|Subject/guardian decision|0|||
48782107|NCT01602315|157044522|FG003|Overall Study|Subject/guardian decision|0|||
48782108|NCT01602315|157044523|FG004|Overall Study|Subject/guardian decision|0|||
48782109|NCT01602315|157044524|FG005|Overall Study|Subject/guardian decision|0|||
48782110|NCT01602315|157044525|FG006|Overall Study|Subject/guardian decision|1|||
48782111|NCT01602315|157044519|FG000|Overall Study|Cross-over patients to combo treatment|0|||
48782112|NCT01602315|157044520|FG001|Overall Study|Cross-over patients to combo treatment|0|||
48782113|NCT01602315|157044521|FG002|Overall Study|Cross-over patients to combo treatment|0|||
48782114|NCT01602315|157044522|FG003|Overall Study|Cross-over patients to combo treatment|0|||
48782115|NCT01602315|157044523|FG004|Overall Study|Cross-over patients to combo treatment|0|||
48782116|NCT01602315|157044524|FG005|Overall Study|Cross-over patients to combo treatment|16|||
48782117|NCT01602315|157044525|FG006|Overall Study|Cross-over patients to combo treatment|0|||
48782118|NCT02660359|157044526|FG000|Overall Study|Protocol Deviation|0|||
48782119|NCT02660359|157044527|FG001|Overall Study|Protocol Deviation|0|||
48782120|NCT02660359|157044528|FG002|Overall Study|Protocol Deviation|1|||
48782121|NCT02660359|157044526|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
48782122|NCT02660359|157044527|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
48782123|NCT02660359|157044528|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
48782124|NCT02660359|157044526|FG000|Overall Study|Lack of Efficacy|1|||
48782125|NCT02660359|157044527|FG001|Overall Study|Lack of Efficacy|1|||
48782126|NCT02660359|157044528|FG002|Overall Study|Lack of Efficacy|1|||
48782127|NCT02660359|157044526|FG000|Overall Study|Adverse Event|0|||
48782128|NCT02660359|157044527|FG001|Overall Study|Adverse Event|1|||
48782129|NCT02660359|157044528|FG002|Overall Study|Adverse Event|0|||
48782130|NCT02660359|157044526|FG000|Overall Study|Other|2|||
48782131|NCT02660359|157044527|FG001|Overall Study|Other|1|||
48782132|NCT02660359|157044528|FG002|Overall Study|Other|3|||
48782133|NCT02660359|157044526|FG000|Overall Study|Withdrawal by Subject|7|||
48782134|NCT02660359|157044527|FG001|Overall Study|Withdrawal by Subject|5|||
48782135|NCT02660359|157044528|FG002|Overall Study|Withdrawal by Subject|8|||
48398387|NCT01414257|155651507|FG000|Overall Study|No Visit After First Day of Treatment|12|||
48398388|NCT01414257|155651507|FG000|Overall Study|Protocol Violation|10|||
48782136|NCT02660359|157044526|FG000|Overall Study|Lost to Follow-up|3|||
48782137|NCT02660359|157044527|FG001|Overall Study|Lost to Follow-up|3|||
48782138|NCT02660359|157044528|FG002|Overall Study|Lost to Follow-up|0|||
48782139|NCT00982020|157044530|FG000|Overall Study|Adverse Event|19|||
48782140|NCT00982020|157044531|FG001|Overall Study|Adverse Event|15|||
48398389|NCT01324232|155651508|FG000|Overall Study|Protocol Violation|0|||
48782141|NCT00982020|157044530|FG000|Overall Study|Withdrawal by Subject|11|||
48398390|NCT01324232|155651509|FG001|Overall Study|Protocol Violation|0|||
48398391|NCT01324232|155651510|FG002|Overall Study|Protocol Violation|0|||
48398392|NCT01324232|155651511|FG003|Overall Study|Protocol Violation|2|||
48398393|NCT01324232|155651508|FG000|Overall Study|Missing|0|||
48398394|NCT01324232|155651509|FG001|Overall Study|Missing|0|||
48782142|NCT00982020|157044531|FG001|Overall Study|Withdrawal by Subject|14|||
48782143|NCT00982020|157044530|FG000|Overall Study|Lost to Follow-up|5|||
48782144|NCT00982020|157044531|FG001|Overall Study|Lost to Follow-up|11|||
48782145|NCT00982020|157044530|FG000|Overall Study|Lack of Efficacy|10|||
48782146|NCT00982020|157044531|FG001|Overall Study|Lack of Efficacy|4|||
48782147|NCT00982020|157044530|FG000|Overall Study|Parent/Caregiver Decision|5|||
48782148|NCT00982020|157044531|FG001|Overall Study|Parent/Caregiver Decision|5|||
48782149|NCT00982020|157044530|FG000|Overall Study|Treatment Non-compliance|3|||
48782150|NCT00982020|157044531|FG001|Overall Study|Treatment Non-compliance|6|||
48782151|NCT00982020|157044530|FG000|Overall Study|Physician Decision|2|||
48782152|NCT00982020|157044531|FG001|Overall Study|Physician Decision|5|||
48782153|NCT00982020|157044530|FG000|Overall Study|Entry Criteria Not Met|2|||
48782154|NCT00982020|157044531|FG001|Overall Study|Entry Criteria Not Met|1|||
48782155|NCT00982020|157044530|FG000|Overall Study|Protocol Violation|0|||
48782156|NCT00982020|157044531|FG001|Overall Study|Protocol Violation|2|||
48782157|NCT00982020|157044530|FG000|Overall Study|Clinical Relapse|0|||
48782158|NCT00982020|157044531|FG001|Overall Study|Clinical Relapse|1|||
48782159|NCT00975975|157044532|FG000|Overall Study|Death|6|||
48782160|NCT01252251|157044533|FG000|Overall Study|Withdrawal by Subject|1|||
48782161|NCT02039505|157044534|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
48782162|NCT02039505|157044535|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
48398395|NCT01324232|155651510|FG002|Overall Study|Missing|1|||
48398396|NCT01324232|155651511|FG003|Overall Study|Missing|0|||
48398397|NCT01324232|155651508|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
48398398|NCT01324232|155651509|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
48398399|NCT01324232|155651510|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
48398400|NCT01324232|155651511|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
48398401|NCT01324232|155651508|FG000|Overall Study|Lack of Efficacy|2|||
48398402|NCT01324232|155651509|FG001|Overall Study|Lack of Efficacy|1|||
48398403|NCT01324232|155651510|FG002|Overall Study|Lack of Efficacy|2|||
48782163|NCT02039505|157044536|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
48782164|NCT02039505|157044537|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
48782165|NCT02039505|157044538|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
48398404|NCT01324232|155651511|FG003|Overall Study|Lack of Efficacy|2|||
48398405|NCT01324232|155651508|FG000|Overall Study|Participant Refused Medication|0|||
48398406|NCT01324232|155651509|FG001|Overall Study|Participant Refused Medication|1|||
48398407|NCT01324232|155651510|FG002|Overall Study|Participant Refused Medication|0|||
48398408|NCT01324232|155651511|FG003|Overall Study|Participant Refused Medication|0|||
48398409|NCT01324232|155651508|FG000|Overall Study|Intercurrent illness|0|||
48398410|NCT01324232|155651509|FG001|Overall Study|Intercurrent illness|0|||
48398411|NCT01324232|155651510|FG002|Overall Study|Intercurrent illness|0|||
48782166|NCT02039505|157044539|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
48782167|NCT02039505|157044540|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
48398412|NCT01324232|155651511|FG003|Overall Study|Intercurrent illness|1|||
48398413|NCT01324232|155651508|FG000|Overall Study|Adverse Event|2|||
48398414|NCT01324232|155651509|FG001|Overall Study|Adverse Event|5|||
48398415|NCT01324232|155651510|FG002|Overall Study|Adverse Event|6|||
48398416|NCT01324232|155651511|FG003|Overall Study|Adverse Event|6|||
48398417|NCT01324232|155651508|FG000|Overall Study|Withdrawal by Subject|0|||
48398418|NCT01324232|155651509|FG001|Overall Study|Withdrawal by Subject|3|||
48398419|NCT01324232|155651510|FG002|Overall Study|Withdrawal by Subject|4|||
48398420|NCT01324232|155651511|FG003|Overall Study|Withdrawal by Subject|0|||
48398421|NCT01324232|155651508|FG000|Overall Study|Lost to Follow-up|1|||
48398422|NCT01324232|155651509|FG001|Overall Study|Lost to Follow-up|0|||
48398423|NCT01324232|155651510|FG002|Overall Study|Lost to Follow-up|0|||
48398424|NCT01324232|155651511|FG003|Overall Study|Lost to Follow-up|0|||
48398425|NCT03286842|155651512|FG000|Overall Study|Patients rolled over to another study|80|||
48782168|NCT02039505|157044534|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
48782169|NCT02039505|157044535|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
48782170|NCT02039505|157044536|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
48782171|NCT02039505|157044537|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
48782172|NCT02039505|157044538|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
48398426|NCT02797808|155651513|FG000|Overall Study|Withdrawal by Subject|1|||
48398427|NCT02797808|155651514|FG001|Overall Study|Withdrawal by Subject|1|||
48782173|NCT02039505|157044539|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
48782174|NCT02039505|157044540|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
48398428|NCT02797808|155651513|FG000|Overall Study|Physician Decision|6|||
48398429|NCT02797808|155651514|FG001|Overall Study|Physician Decision|2|||
48398430|NCT03509350|155651515|FG000|Overall Study|Withdrawal by Subject|0|||
48398431|NCT03509350|155651516|FG001|Overall Study|Withdrawal by Subject|2|||
48398432|NCT00290433|155651517|FG000|Overall Study|Disease Progression|13|||
48398433|NCT00290433|155651517|FG000|Overall Study|Adverse Event|14|||
48398434|NCT00290433|155651517|FG000|Overall Study|Withdrawal by Subject|1|||
48398435|NCT00290433|155651517|FG000|Overall Study|Non-Compliance|1|||
48398436|NCT00290433|155651517|FG000|Overall Study|Congestive Heart Failure|1|||
48398437|NCT00290433|155651517|FG000|Overall Study|Transplant in CR|5|||
48398438|NCT00290433|155651517|FG000|Overall Study|Unrelated Infection/Death|1|||
48398439|NCT00797732|155651521|FG000|Overall Study|Withdrawal by Subject|3|||
48398440|NCT00797732|155651522|FG001|Overall Study|Withdrawal by Subject|3|||
48398441|NCT00797732|155651523|FG002|Overall Study|Withdrawal by Subject|0|||
48398442|NCT00797732|155651521|FG000|Overall Study|Lost to Follow-up|1|||
48398443|NCT00797732|155651522|FG001|Overall Study|Lost to Follow-up|0|||
48398444|NCT00797732|155651523|FG002|Overall Study|Lost to Follow-up|0|||
48398445|NCT00797732|155651521|FG000|Overall Study|Death|1|||
48398446|NCT00797732|155651522|FG001|Overall Study|Death|0|||
48398447|NCT00797732|155651523|FG002|Overall Study|Death|0|||
48398448|NCT00797732|155651521|FG000|Overall Study|Not meet inclusion criteria|0|||
48398449|NCT00797732|155651522|FG001|Overall Study|Not meet inclusion criteria|0|||
48398450|NCT00797732|155651523|FG002|Overall Study|Not meet inclusion criteria|7|||
48398451|NCT00797732|155651521|FG000|Overall Study|Excluded due to time constraints|0|||
48398452|NCT00797732|155651522|FG001|Overall Study|Excluded due to time constraints|0|||
48398453|NCT00797732|155651523|FG002|Overall Study|Excluded due to time constraints|24|||
48398454|NCT00797732|155651521|FG000|Overall Study|Refused to Participate|0|||
48398455|NCT00797732|155651522|FG001|Overall Study|Refused to Participate|0|||
48398456|NCT00797732|155651523|FG002|Overall Study|Refused to Participate|123|||
48398457|NCT01789970|155651524|FG000|Open-label Titration Period|Adverse Event|68|||
48398458|NCT01789970|155651525|FG001|Open-label Titration Period|Adverse Event|0|||
48398459|NCT01789970|155651526|FG002|Open-label Titration Period|Adverse Event|0|||
48398460|NCT01789970|155651524|FG000|Open-label Titration Period|Lack of Efficacy|31|||
48398461|NCT01789970|155651525|FG001|Open-label Titration Period|Lack of Efficacy|0|||
48398462|NCT01789970|155651526|FG002|Open-label Titration Period|Lack of Efficacy|0|||
48398463|NCT01789970|155651524|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
48398464|NCT01789970|155651525|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
48398465|NCT01789970|155651526|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
48398466|NCT01789970|155651524|FG000|Open-label Titration Period|Protocol Violation|18|||
48398467|NCT01789970|155651525|FG001|Open-label Titration Period|Protocol Violation|0|||
48398468|NCT01789970|155651526|FG002|Open-label Titration Period|Protocol Violation|0|||
48398469|NCT01789970|155651524|FG000|Open-label Titration Period|Lost to Follow-up|5|||
48398470|NCT01789970|155651525|FG001|Open-label Titration Period|Lost to Follow-up|0|||
48398471|NCT01789970|155651526|FG002|Open-label Titration Period|Lost to Follow-up|0|||
48398472|NCT01789970|155651524|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
48398473|NCT01789970|155651525|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
48398474|NCT01789970|155651526|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
48398475|NCT01789970|155651524|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
48782175|NCT02039505|157044534|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
48398476|NCT01789970|155651525|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
48398477|NCT01789970|155651526|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
48398478|NCT01789970|155651524|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
48398479|NCT01789970|155651525|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
48398480|NCT01789970|155651526|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
48398481|NCT01789970|155651524|FG000|Open-label Titration Period|Pregnancy|2|||
48398482|NCT01789970|155651525|FG001|Open-label Titration Period|Pregnancy|0|||
48398483|NCT01789970|155651526|FG002|Open-label Titration Period|Pregnancy|0|||
48398484|NCT01789970|155651524|FG000|Open-label Titration Period|Other|76|||
48398485|NCT01789970|155651525|FG001|Open-label Titration Period|Other|0|||
48398486|NCT01789970|155651526|FG002|Open-label Titration Period|Other|0|||
48398487|NCT01789970|155651524|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
48398488|NCT01789970|155651525|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
48398489|NCT01789970|155651526|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
48398490|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
48398491|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
48398492|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
48782176|NCT02039505|157044535|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782177|NCT02039505|157044536|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782178|NCT02039505|157044537|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782179|NCT02039505|157044538|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782180|NCT02039505|157044539|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782181|NCT02039505|157044540|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
48782182|NCT02039505|157044534|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
48398493|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
48398494|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
48398495|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
48782183|NCT02039505|157044535|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
48782184|NCT02039505|157044536|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
48398496|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
48398497|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
48398498|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
48398499|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
48398500|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
48398501|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
48398502|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
48398503|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
48398504|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
48398505|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
48398506|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
48398507|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
48398508|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
48398509|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
48398510|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
48398511|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
48398512|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
48398513|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
48398514|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
48398515|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
48398516|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
48782185|NCT02039505|157044537|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
48782186|NCT02039505|157044538|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
48782187|NCT02039505|157044539|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
48782188|NCT02039505|157044540|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
48782189|NCT02039505|157044534|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
48782190|NCT02039505|157044535|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
48398517|NCT01789970|155651524|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
48398518|NCT01789970|155651525|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
48398519|NCT01789970|155651526|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
48398520|NCT00401752|155651527|FG000|Overall Study|Adverse Event|2|||
48398521|NCT00401752|155651528|FG001|Overall Study|Adverse Event|5|||
48398522|NCT00401752|155651527|FG000|Overall Study|Withdrawal by Subject|2|||
48398523|NCT00401752|155651528|FG001|Overall Study|Withdrawal by Subject|6|||
48398524|NCT00401752|155651527|FG000|Overall Study|Lost to Follow-up|1|||
48398525|NCT00401752|155651528|FG001|Overall Study|Lost to Follow-up|4|||
48398526|NCT00401752|155651527|FG000|Overall Study|Development of any exclusion criteria|4|||
48398527|NCT00401752|155651528|FG001|Overall Study|Development of any exclusion criteria|2|||
48398528|NCT00401752|155651527|FG000|Overall Study|Physician Decision|1|||
48398529|NCT00401752|155651528|FG001|Overall Study|Physician Decision|1|||
48398530|NCT01121393|155651529|FG000|Overall Study|Progressive disease|201|||
48398531|NCT01121393|155651530|FG001|Overall Study|Progressive disease|20|||
48398532|NCT01121393|155651529|FG000|Overall Study|Other Adverse events|24|||
48398533|NCT01121393|155651530|FG001|Overall Study|Other Adverse events|45|||
48398534|NCT01121393|155651529|FG000|Overall Study|Non-compliant with protocol|0|||
48398535|NCT01121393|155651530|FG001|Overall Study|Non-compliant with protocol|3|||
48398536|NCT01121393|155651529|FG000|Overall Study|Lost to Follow-up|1|||
48398537|NCT01121393|155651530|FG001|Overall Study|Lost to Follow-up|0|||
48398538|NCT01121393|155651529|FG000|Overall Study|Refused cont. medication|7|||
48398539|NCT01121393|155651530|FG001|Overall Study|Refused cont. medication|7|||
48398540|NCT01121393|155651529|FG000|Overall Study|Not treated|3|||
48398541|NCT01121393|155651530|FG001|Overall Study|Not treated|9|||
48398542|NCT01121393|155651529|FG000|Overall Study|Other than listed|6|||
48398543|NCT01121393|155651530|FG001|Overall Study|Other than listed|0|||
48398544|NCT02706730|155651544|FG000|Overall Study|Adverse Event|3|||
48398545|NCT02706730|155651544|FG000|Overall Study|Lack of Efficacy|5|||
48398546|NCT02706730|155651544|FG000|Overall Study|Withdrawal by Subject|11|||
48398547|NCT02706730|155651544|FG000|Overall Study|Study Terminated by Sponsor|11|||
48398548|NCT02706730|155651544|FG000|Overall Study|Subject chose not to receive injection|3|||
48398549|NCT03021642|155651545|FG000|Washout Period (21 Days)|Adverse Event|1|||
48398550|NCT03021642|155651546|FG001|Washout Period (21 Days)|Adverse Event|1|||
48398551|NCT00094055|155651547|FG000|Overall Study|Adverse Event|11|||
48398552|NCT00094055|155651547|FG000|Overall Study|Death|4|||
48398553|NCT00094055|155651547|FG000|Overall Study|Lack of Efficacy|17|||
48797712|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
48398554|NCT00094055|155651547|FG000|Overall Study|Lost to Follow-up|2|||
48398555|NCT00094055|155651547|FG000|Overall Study|progressive disease|2|||
48398556|NCT00094055|155651547|FG000|Overall Study|clinical progression|1|||
48398557|NCT00094055|155651547|FG000|Overall Study|roll-over to another study|14|||
48398558|NCT00094055|155651547|FG000|Overall Study|Withdrawal by Subject|9|||
48398559|NCT00411554|155651548|FG000|Overall Study|Adverse Event|2|||
48782191|NCT02039505|157044536|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
48782192|NCT02039505|157044537|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
48782193|NCT02039505|157044538|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
48782194|NCT02039505|157044539|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
48782195|NCT02039505|157044540|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
48782196|NCT02039505|157044534|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
48782197|NCT02039505|157044535|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
48782198|NCT02039505|157044536|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
48782199|NCT02039505|157044537|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
48782200|NCT02039505|157044538|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
48782201|NCT02039505|157044539|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
48782202|NCT02039505|157044540|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
48782203|NCT02039505|157044534|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782204|NCT02039505|157044535|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782205|NCT02039505|157044536|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782206|NCT02039505|157044537|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
48782207|NCT02039505|157044538|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782208|NCT02039505|157044539|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782209|NCT02039505|157044540|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
48782210|NCT02039505|157044534|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782211|NCT02039505|157044535|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782212|NCT02039505|157044536|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782213|NCT02039505|157044537|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782214|NCT02039505|157044538|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782215|NCT02039505|157044539|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
48782216|NCT02039505|157044540|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
48782217|NCT02039505|157044534|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782218|NCT02039505|157044535|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782219|NCT02039505|157044536|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782220|NCT02039505|157044537|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782221|NCT02039505|157044538|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48782222|NCT02039505|157044539|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
48398560|NCT00411554|155651549|FG001|Overall Study|Adverse Event|4|||
48398561|NCT00411554|155651548|FG000|Overall Study|Lack of Efficacy|2|||
48398562|NCT00411554|155651549|FG001|Overall Study|Lack of Efficacy|5|||
48398563|NCT00411554|155651548|FG000|Overall Study|Withdrawal by Subject|3|||
48398564|NCT00411554|155651549|FG001|Overall Study|Withdrawal by Subject|0|||
48398565|NCT00411554|155651548|FG000|Overall Study|Patient Moved|1|||
48398566|NCT00411554|155651549|FG001|Overall Study|Patient Moved|0|||
48398567|NCT01902290|155651556|FG000|Overall Study|Withdrawal by Subject|19|||
48398568|NCT01902290|155651557|FG001|Overall Study|Withdrawal by Subject|27|||
48398569|NCT01902290|155651556|FG000|Overall Study|Lost to Follow-up|2|||
48398570|NCT01902290|155651557|FG001|Overall Study|Lost to Follow-up|2|||
48398571|NCT01902290|155651556|FG000|Overall Study|Death|1|||
48398572|NCT01902290|155651557|FG001|Overall Study|Death|0|||
48398573|NCT01902290|155651556|FG000|Overall Study|Sponsor Decision|26|||
48398574|NCT01902290|155651557|FG001|Overall Study|Sponsor Decision|24|||
48398575|NCT02161211|155651561|FG000|Overall Study|Lost to Follow-up|21|||
48398576|NCT02161211|155651562|FG001|Overall Study|Lost to Follow-up|27|||
48398577|NCT02161211|155651563|FG002|Overall Study|Lost to Follow-up|21|||
48398578|NCT02161211|155651561|FG000|Overall Study|Dropped|12|||
48398579|NCT02161211|155651562|FG001|Overall Study|Dropped|5|||
48398580|NCT02161211|155651563|FG002|Overall Study|Dropped|9|||
48398581|NCT02436876|155651564|FG000|Overall Study|Lost to Follow-up|0|||
48398582|NCT02436876|155651565|FG001|Overall Study|Lost to Follow-up|1|||
48398583|NCT02436876|155651566|FG002|Overall Study|Lost to Follow-up|1|||
48398584|NCT02436876|155651567|FG003|Overall Study|Lost to Follow-up|1|||
48398585|NCT02436876|155651564|FG000|Overall Study|Withdrawal by Subject|1|||
48398586|NCT02436876|155651565|FG001|Overall Study|Withdrawal by Subject|0|||
48398587|NCT02436876|155651566|FG002|Overall Study|Withdrawal by Subject|0|||
48398588|NCT02436876|155651567|FG003|Overall Study|Withdrawal by Subject|1|||
48398589|NCT02436876|155651564|FG000|Overall Study|Physician Decision|0|||
48782223|NCT02039505|157044540|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
48782224|NCT02039505|157044534|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48398590|NCT02436876|155651565|FG001|Overall Study|Physician Decision|2|||
48398591|NCT02436876|155651566|FG002|Overall Study|Physician Decision|1|||
48398592|NCT02436876|155651567|FG003|Overall Study|Physician Decision|0|||
48398593|NCT02436876|155651564|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
48398594|NCT02436876|155651565|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
48398595|NCT02436876|155651566|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
48398596|NCT02436876|155651567|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
48398597|NCT00075504|155651568|FG000|Overall Study|Withdrawal by Subject|9|||
48782225|NCT02039505|157044535|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782226|NCT02039505|157044536|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782227|NCT02039505|157044537|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782228|NCT02039505|157044538|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782229|NCT02039505|157044539|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
48782230|NCT02039505|157044540|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
48782231|NCT02039505|157044534|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782232|NCT02039505|157044535|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782233|NCT02039505|157044536|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782234|NCT02039505|157044537|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782235|NCT02039505|157044538|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782236|NCT02039505|157044539|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
48782237|NCT02039505|157044540|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
48782238|NCT02525133|157044550|FG000|Overall Study|Adverse Event|0|||
48782239|NCT02525133|157044551|FG001|Overall Study|Adverse Event|1|||
48782240|NCT02525133|157044550|FG000|Overall Study|Death|0|||
48782241|NCT02525133|157044551|FG001|Overall Study|Death|1|||
48782242|NCT02525133|157044550|FG000|Overall Study|did not meet randomization criteria|1|||
48782243|NCT02525133|157044551|FG001|Overall Study|did not meet randomization criteria|0|||
48782244|NCT02525133|157044550|FG000|Overall Study|Lost to Follow-up|5|||
48782245|NCT02525133|157044551|FG001|Overall Study|Lost to Follow-up|1|||
48782246|NCT02525133|157044550|FG000|Overall Study|randomized not enrolled|3|||
48782247|NCT02525133|157044551|FG001|Overall Study|randomized not enrolled|0|||
48782248|NCT02525133|157044550|FG000|Overall Study|Withdrawal by Subject|1|||
48782249|NCT02525133|157044551|FG001|Overall Study|Withdrawal by Subject|0|||
48782250|NCT01075074|157044552|FG000|Overall Study|Surgeon changed to open incisional case|1|||
48782251|NCT01075074|157044553|FG001|Overall Study|Surgeon changed to open incisional case|2|||
48782252|NCT01075074|157044554|FG002|Overall Study|Surgeon changed to open incisional case|2|||
48782253|NCT02691455|157044556|FG000|Overall Study|Withdrawal by Subject|1|||
48782254|NCT02691455|157044557|FG001|Overall Study|Withdrawal by Subject|2|||
48782255|NCT02691455|157044556|FG000|Overall Study|Lost to Follow-up|15|||
48782256|NCT02691455|157044557|FG001|Overall Study|Lost to Follow-up|15|||
48782257|NCT00009737|157044558|FG000|Overall Study|Adverse Event|112|||
48782258|NCT00009737|157044559|FG001|Overall Study|Adverse Event|75|||
48782259|NCT00009737|157044558|FG000|Overall Study|Death|4|||
48782260|NCT00009737|157044559|FG001|Overall Study|Death|6|||
48782261|NCT00009737|157044558|FG000|Overall Study|Lack of Efficacy|17|||
48782262|NCT00009737|157044559|FG001|Overall Study|Lack of Efficacy|15|||
48782263|NCT00009737|157044558|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
48782264|NCT00009737|157044559|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
48782265|NCT00009737|157044558|FG000|Overall Study|Other Protocol Violation|1|||
48782266|NCT00009737|157044559|FG001|Overall Study|Other Protocol Violation|0|||
48782267|NCT00009737|157044558|FG000|Overall Study|Refused Treatment|15|||
48782268|NCT00009737|157044559|FG001|Overall Study|Refused Treatment|16|||
48782269|NCT00009737|157044558|FG000|Overall Study|Lost to Follow-up|1|||
48782270|NCT00009737|157044559|FG001|Overall Study|Lost to Follow-up|1|||
48782271|NCT00009737|157044558|FG000|Overall Study|Administrative/Other Reasons|7|||
48782272|NCT00009737|157044559|FG001|Overall Study|Administrative/Other Reasons|1|||
48782273|NCT00803023|157044562|FG000|Overall Study|Adverse Event|5|||
48782274|NCT00803023|157044563|FG001|Overall Study|Adverse Event|4|||
48782275|NCT00803023|157044564|FG002|Overall Study|Adverse Event|8|||
48782276|NCT00803023|157044565|FG003|Overall Study|Adverse Event|6|||
48782277|NCT00803023|157044562|FG000|Overall Study|Withdrawal by Subject|0|||
48782278|NCT00803023|157044563|FG001|Overall Study|Withdrawal by Subject|2|||
48782279|NCT00803023|157044564|FG002|Overall Study|Withdrawal by Subject|0|||
48398598|NCT00075504|155651569|FG001|Overall Study|Withdrawal by Subject|7|||
48398599|NCT00927095|155651572|FG000|Overall Study|Adverse Event|3|||
48782280|NCT00803023|157044565|FG003|Overall Study|Withdrawal by Subject|0|||
48782281|NCT00803023|157044562|FG000|Overall Study|Lost to Follow-up|0|||
48782282|NCT00803023|157044563|FG001|Overall Study|Lost to Follow-up|1|||
48782283|NCT00803023|157044564|FG002|Overall Study|Lost to Follow-up|2|||
48782284|NCT00803023|157044565|FG003|Overall Study|Lost to Follow-up|1|||
48398600|NCT00927095|155651573|FG001|Overall Study|Adverse Event|1|||
48782285|NCT00803023|157044562|FG000|Overall Study|Lack of Efficacy|0|||
48782286|NCT00803023|157044563|FG001|Overall Study|Lack of Efficacy|1|||
48782287|NCT00803023|157044564|FG002|Overall Study|Lack of Efficacy|1|||
48782288|NCT00803023|157044565|FG003|Overall Study|Lack of Efficacy|1|||
48782289|NCT03465540|157044568|FG000|Overall Study|Withdrawal by Subject|0|||
48782290|NCT03465540|157044569|FG001|Overall Study|Withdrawal by Subject|0|||
48782291|NCT03465540|157044570|FG002|Overall Study|Withdrawal by Subject|1|||
48782292|NCT03465540|157044571|FG003|Overall Study|Withdrawal by Subject|1|||
48398601|NCT00927095|155651574|FG002|Overall Study|Adverse Event|0|||
48398602|NCT00927095|155651572|FG000|Overall Study|Withdrawal by Subject|2|||
48398603|NCT00927095|155651573|FG001|Overall Study|Withdrawal by Subject|1|||
48398604|NCT00927095|155651574|FG002|Overall Study|Withdrawal by Subject|1|||
48398605|NCT00927095|155651572|FG000|Overall Study|Physician Decision|1|||
48398606|NCT00927095|155651573|FG001|Overall Study|Physician Decision|2|||
48782293|NCT03465540|157044572|FG004|Overall Study|Withdrawal by Subject|1|||
48782294|NCT03465540|157044573|FG005|Overall Study|Withdrawal by Subject|0|||
48782295|NCT03465540|157044568|FG000|Overall Study|Lost to Follow-up|0|||
48782296|NCT03465540|157044569|FG001|Overall Study|Lost to Follow-up|1|||
48398607|NCT00927095|155651574|FG002|Overall Study|Physician Decision|1|||
48782297|NCT03465540|157044570|FG002|Overall Study|Lost to Follow-up|0|||
48782298|NCT03465540|157044571|FG003|Overall Study|Lost to Follow-up|0|||
48782299|NCT03465540|157044572|FG004|Overall Study|Lost to Follow-up|1|||
48782300|NCT03465540|157044573|FG005|Overall Study|Lost to Follow-up|0|||
48782301|NCT03465540|157044568|FG000|Overall Study|Death|1|||
48782302|NCT03465540|157044569|FG001|Overall Study|Death|1|||
48782303|NCT03465540|157044570|FG002|Overall Study|Death|0|||
48782304|NCT03465540|157044571|FG003|Overall Study|Death|2|||
48782305|NCT03465540|157044572|FG004|Overall Study|Death|0|||
48782306|NCT03465540|157044573|FG005|Overall Study|Death|2|||
48782307|NCT03465540|157044568|FG000|Overall Study|Protocol specified criteria|0|||
48782308|NCT03465540|157044569|FG001|Overall Study|Protocol specified criteria|2|||
48782309|NCT03465540|157044570|FG002|Overall Study|Protocol specified criteria|2|||
48782310|NCT03465540|157044571|FG003|Overall Study|Protocol specified criteria|0|||
48782311|NCT03465540|157044572|FG004|Overall Study|Protocol specified criteria|2|||
48782312|NCT03465540|157044573|FG005|Overall Study|Protocol specified criteria|0|||
48782313|NCT01519206|157044578|FG000|Overall Study|Lost to Follow-up|3|||
48782314|NCT01519206|157044578|FG000|Overall Study|Missed Visit|2|||
48782315|NCT02660944|157044580|FG000|Overall Study|Adverse Event|3|||
48782316|NCT02660944|157044581|FG001|Overall Study|Adverse Event|4|||
48782317|NCT02660944|157044580|FG000|Overall Study|Physician Decision|3|||
48782318|NCT02660944|157044581|FG001|Overall Study|Physician Decision|1|||
48782319|NCT02660944|157044580|FG000|Overall Study|Withdrawal by Subject|5|||
48782320|NCT02660944|157044581|FG001|Overall Study|Withdrawal by Subject|3|||
48782321|NCT02660944|157044580|FG000|Overall Study|Lost to Follow-up|4|||
48398608|NCT01290692|155651578|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
48398609|NCT03461757|155651583|FG000|Overall Study|Adverse Event|1|||
48782322|NCT02660944|157044581|FG001|Overall Study|Lost to Follow-up|1|||
48782323|NCT02660944|157044580|FG000|Overall Study|Subject schedule|0|||
48782324|NCT02660944|157044581|FG001|Overall Study|Subject schedule|1|||
48782325|NCT02660944|157044580|FG000|Overall Study|Exclusion criteria met|2|||
48782326|NCT02660944|157044581|FG001|Overall Study|Exclusion criteria met|0|||
48782327|NCT01343056|157044584|FG000|Overall Study|Lost to Follow-up|7|||
48782328|NCT01343056|157044585|FG001|Overall Study|Lost to Follow-up|5|||
48782329|NCT01343056|157044586|FG002|Overall Study|Lost to Follow-up|3|||
48782330|NCT01343056|157044587|FG003|Overall Study|Lost to Follow-up|9|||
48782331|NCT02647359|157044593|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
48782332|NCT02647359|157044594|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
48782333|NCT02647359|157044593|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
48782334|NCT02647359|157044594|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
48782335|NCT02647359|157044593|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
48782336|NCT02647359|157044594|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
48782337|NCT02647359|157044593|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
48782338|NCT02647359|157044594|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
48782339|NCT02647359|157044593|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
48782340|NCT02647359|157044594|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
48782341|NCT02647359|157044593|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
48782342|NCT02647359|157044594|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
48782343|NCT03646513|157044595|FG000|Overall Study|Premature study termination|4|||
48782344|NCT03634579|157044598|FG000|Overall Study|study termination|9|||
48782345|NCT03067441|157044601|FG000|Overall Study|Withdrawal by Subject|16|||
48782346|NCT03067441|157044602|FG001|Overall Study|Withdrawal by Subject|34|||
48782347|NCT03067441|157044601|FG000|Overall Study|Lost to Follow-up|7|||
48782348|NCT03067441|157044602|FG001|Overall Study|Lost to Follow-up|5|||
48782349|NCT03067441|157044601|FG000|Overall Study|Adverse Event|7|||
48782350|NCT03067441|157044602|FG001|Overall Study|Adverse Event|14|||
48782351|NCT03067441|157044601|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
48782352|NCT03067441|157044602|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
48782353|NCT03067441|157044601|FG000|Overall Study|Physician Decision|1|||
48782354|NCT03067441|157044602|FG001|Overall Study|Physician Decision|3|||
48398610|NCT03461757|155651584|FG001|Overall Study|Adverse Event|0|||
48398611|NCT03461757|155651583|FG000|Overall Study|Lost to Follow-up|13|||
48398612|NCT03461757|155651584|FG001|Overall Study|Lost to Follow-up|7|||
48782355|NCT03067441|157044601|FG000|Overall Study|Other|1|||
48782356|NCT03067441|157044602|FG001|Overall Study|Other|1|||
48782357|NCT02543346|157044603|FG000|Second Priming Visit|Withdrawal by Subject|0|||
48782358|NCT02543346|157044604|FG001|Second Priming Visit|Withdrawal by Subject|2|||
48782359|NCT02543346|157044605|FG002|Second Priming Visit|Withdrawal by Subject|2|||
48782360|NCT02543346|157044606|FG003|Second Priming Visit|Withdrawal by Subject|2|||
48782361|NCT02543346|157044603|FG000|Second Priming Visit|Adverse Event|1|||
48782362|NCT02543346|157044604|FG001|Second Priming Visit|Adverse Event|0|||
48782363|NCT02543346|157044605|FG002|Second Priming Visit|Adverse Event|0|||
48782364|NCT02543346|157044606|FG003|Second Priming Visit|Adverse Event|0|||
48782365|NCT01198600|157044614|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
48398613|NCT03461757|155651583|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
48398614|NCT03461757|155651584|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
48398615|NCT03461757|155651583|FG000|Overall Study|Non-compliance with study treatment|0|||
48398616|NCT03461757|155651584|FG001|Overall Study|Non-compliance with study treatment|1|||
48398617|NCT03461757|155651583|FG000|Overall Study|Pregnancy|2|||
48398618|NCT03461757|155651584|FG001|Overall Study|Pregnancy|0|||
48398619|NCT03461757|155651583|FG000|Overall Study|Protocol Violation|1|||
48398620|NCT03461757|155651584|FG001|Overall Study|Protocol Violation|1|||
48398621|NCT03461757|155651583|FG000|Overall Study|Withdrawal by Subject|7|||
48398622|NCT03461757|155651584|FG001|Overall Study|Withdrawal by Subject|7|||
48398623|NCT03461757|155651583|FG000|Overall Study|Other Reasons|1|||
48398624|NCT03461757|155651584|FG001|Overall Study|Other Reasons|4|||
48398625|NCT00357500|155651585|FG000|Overall Study|Adverse Event|3|||
48398626|NCT00357500|155651585|FG000|Overall Study|Withdrawal by Subject|5|||
48398627|NCT00357500|155651585|FG000|Overall Study|Progressive Disease|65|||
48398628|NCT00357500|155651585|FG000|Overall Study|Not Started Protocol Therapy|4|||
48398629|NCT02425826|155651586|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
48398630|NCT02425826|155651587|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
48398631|NCT02425826|155651588|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
48398632|NCT02425826|155651586|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
48398633|NCT02425826|155651587|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
48398634|NCT02425826|155651588|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
48398635|NCT02425826|155651586|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
48398636|NCT02425826|155651587|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
48398637|NCT02425826|155651588|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
48398638|NCT02425826|155651586|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
48398639|NCT02425826|155651587|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
48398640|NCT02425826|155651588|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
48398641|NCT02425826|155651586|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
48398642|NCT02425826|155651587|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
48398643|NCT02425826|155651588|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
48398644|NCT02425826|155651586|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
48398645|NCT02425826|155651587|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
48398646|NCT02425826|155651588|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
48398647|NCT02425826|155651586|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
48398648|NCT02425826|155651587|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
48398649|NCT02425826|155651588|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
48398650|NCT02425826|155651586|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
48398651|NCT02425826|155651587|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
48398652|NCT02425826|155651588|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
48398653|NCT02425826|155651586|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
48398654|NCT02425826|155651587|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
48398655|NCT02425826|155651588|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
48398656|NCT02425826|155651586|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
48398657|NCT02425826|155651587|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
48398658|NCT02425826|155651588|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
48398659|NCT01464307|155651590|FG000|Main Period|Death|0|||
48398660|NCT01464307|155651591|FG001|Main Period|Death|1|||
48398661|NCT01464307|155651590|FG000|Main Period|Adverse Event|6|||
48398662|NCT01464307|155651591|FG001|Main Period|Adverse Event|1|||
48398663|NCT01464307|155651590|FG000|Main Period|Lack of Efficacy|2|||
48398664|NCT01464307|155651591|FG001|Main Period|Lack of Efficacy|0|||
48398665|NCT01464307|155651590|FG000|Main Period|Withdrawal by Subject|5|||
48398666|NCT01464307|155651591|FG001|Main Period|Withdrawal by Subject|2|||
48782366|NCT01198600|157044615|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
48398667|NCT01464307|155651590|FG000|Main Period|Predefined discontinuation criteria|2|||
48398668|NCT01464307|155651591|FG001|Main Period|Predefined discontinuation criteria|1|||
48398669|NCT01464307|155651590|FG000|Open-Label Extension Period|Adverse Event|15|||
48398670|NCT01464307|155651591|FG001|Open-Label Extension Period|Adverse Event|0|||
48398671|NCT01464307|155651590|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
48398672|NCT01464307|155651591|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
48398673|NCT01464307|155651590|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
48398674|NCT01464307|155651591|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
48398675|NCT01464307|155651590|FG000|Open-Label Extension Period|Death|1|||
48398676|NCT01464307|155651591|FG001|Open-Label Extension Period|Death|0|||
48398677|NCT01464307|155651590|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
48398678|NCT01464307|155651591|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
48398679|NCT01464307|155651590|FG000|Open-Label Extension Period|Non-compliance|9|||
48398680|NCT01464307|155651591|FG001|Open-Label Extension Period|Non-compliance|0|||
48398681|NCT01464307|155651590|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
48398682|NCT01464307|155651591|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
48398683|NCT00866307|155651594|FG000|Induction|Adverse Event|5|||
48398684|NCT00866307|155651595|FG001|Induction|Adverse Event|0|||
48398685|NCT00866307|155651596|FG002|Induction|Adverse Event|0|||
48398686|NCT00866307|155651594|FG000|Induction|Death|2|||
48398687|NCT00866307|155651595|FG001|Induction|Death|0|||
48398688|NCT00866307|155651596|FG002|Induction|Death|0|||
48398689|NCT00866307|155651594|FG000|Induction|Physician Decision|5|||
48398690|NCT00866307|155651595|FG001|Induction|Physician Decision|0|||
48398691|NCT00866307|155651596|FG002|Induction|Physician Decision|0|||
48398692|NCT00866307|155651594|FG000|Induction|Progressive Disease|1|||
48398693|NCT00866307|155651595|FG001|Induction|Progressive Disease|0|||
48398694|NCT00866307|155651596|FG002|Induction|Progressive Disease|0|||
48398695|NCT00866307|155651594|FG000|Induction|Identification of Patients with Day 29 M|3|||
48398696|NCT00866307|155651595|FG001|Induction|Identification of Patients with Day 29 M|0|||
48398697|NCT00866307|155651596|FG002|Induction|Identification of Patients with Day 29 M|0|||
48398698|NCT00866307|155651594|FG000|Induction|Inadequate cytognetic samples th|1|||
48398699|NCT00866307|155651595|FG001|Induction|Inadequate cytognetic samples th|0|||
48398700|NCT00866307|155651596|FG002|Induction|Inadequate cytognetic samples th|0|||
48398701|NCT00866307|155651594|FG000|Induction|Improper post-induction consent|2|||
48398702|NCT00866307|155651595|FG001|Induction|Improper post-induction consent|0|||
48398703|NCT00866307|155651596|FG002|Induction|Improper post-induction consent|0|||
48398704|NCT00866307|155651594|FG000|Induction|Study was closed at the time|1|||
48398705|NCT00866307|155651595|FG001|Induction|Study was closed at the time|0|||
48398706|NCT00866307|155651596|FG002|Induction|Study was closed at the time|0|||
48398707|NCT00866307|155651594|FG000|Consolidation/Maintenance|Adverse Event|0|||
48398708|NCT00866307|155651595|FG001|Consolidation/Maintenance|Adverse Event|0|||
48398709|NCT00866307|155651596|FG002|Consolidation/Maintenance|Adverse Event|8|||
48398710|NCT00866307|155651594|FG000|Consolidation/Maintenance|Death|0|||
48398711|NCT00866307|155651595|FG001|Consolidation/Maintenance|Death|0|||
48398712|NCT00866307|155651596|FG002|Consolidation/Maintenance|Death|1|||
48398713|NCT00866307|155651594|FG000|Consolidation/Maintenance|Physician Decision|0|||
48398714|NCT00866307|155651595|FG001|Consolidation/Maintenance|Physician Decision|3|||
48398715|NCT00866307|155651596|FG002|Consolidation/Maintenance|Physician Decision|2|||
48398716|NCT00866307|155651594|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
48398717|NCT00866307|155651595|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
48398718|NCT00866307|155651596|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
48398719|NCT00866307|155651594|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
48398720|NCT00866307|155651595|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
48398721|NCT00866307|155651596|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
48398722|NCT00866307|155651594|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
48398723|NCT00866307|155651595|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
48398724|NCT00866307|155651596|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
48398725|NCT00866307|155651594|FG000|Consolidation/Maintenance|Therapy error|0|||
48398726|NCT00866307|155651595|FG001|Consolidation/Maintenance|Therapy error|1|||
48398727|NCT00866307|155651596|FG002|Consolidation/Maintenance|Therapy error|0|||
48398728|NCT00866307|155651594|FG000|Consolidation/Maintenance|Non-compliance|0|||
48398729|NCT00866307|155651595|FG001|Consolidation/Maintenance|Non-compliance|0|||
48398730|NCT00866307|155651596|FG002|Consolidation/Maintenance|Non-compliance|1|||
48398731|NCT00866307|155651594|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
48398732|NCT00866307|155651595|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
48398733|NCT00866307|155651596|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
48398734|NCT01344876|155651597|FG000|Overall Study|Adverse Event|0|||
48398735|NCT01344876|155651598|FG001|Overall Study|Adverse Event|0|||
48398736|NCT01344876|155651599|FG002|Overall Study|Adverse Event|0|||
48398737|NCT01344876|155651600|FG003|Overall Study|Adverse Event|0|||
48398738|NCT01344876|155651601|FG004|Overall Study|Adverse Event|1|||
48398739|NCT01344876|155651597|FG000|Overall Study|Withdrawal by Subject|0|||
48398740|NCT01344876|155651598|FG001|Overall Study|Withdrawal by Subject|0|||
48398741|NCT01344876|155651599|FG002|Overall Study|Withdrawal by Subject|1|||
48398742|NCT01344876|155651600|FG003|Overall Study|Withdrawal by Subject|0|||
48398743|NCT01344876|155651601|FG004|Overall Study|Withdrawal by Subject|0|||
48398744|NCT01344876|155651597|FG000|Overall Study|Definite progression of primary disease|1|||
48398745|NCT01344876|155651598|FG001|Overall Study|Definite progression of primary disease|0|||
48398746|NCT01344876|155651599|FG002|Overall Study|Definite progression of primary disease|0|||
48398747|NCT01344876|155651600|FG003|Overall Study|Definite progression of primary disease|3|||
48398748|NCT01344876|155651601|FG004|Overall Study|Definite progression of primary disease|0|||
48398749|NCT01031446|155651602|FG000|Overall Study|Disease Progression|38|||
48398750|NCT01031446|155651602|FG000|Overall Study|Adverse Event|9|||
48398751|NCT01031446|155651602|FG000|Overall Study|Physician Decision|4|||
48398752|NCT01031446|155651602|FG000|Overall Study|Withdrawal by Subject|3|||
48398753|NCT01031446|155651602|FG000|Overall Study|Still on treatment|1|||
48398754|NCT01564862|155651606|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
48398755|NCT01564862|155651607|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
48398756|NCT01564862|155651608|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
48398757|NCT01564862|155651606|FG000|Overall Study|Major Protocol Deviation|3|||
48398758|NCT01564862|155651607|FG001|Overall Study|Major Protocol Deviation|3|||
48398759|NCT01564862|155651608|FG002|Overall Study|Major Protocol Deviation|4|||
48398760|NCT01564862|155651606|FG000|Overall Study|Lost to Follow-up|10|||
48398761|NCT01564862|155651607|FG001|Overall Study|Lost to Follow-up|8|||
48398762|NCT01564862|155651608|FG002|Overall Study|Lost to Follow-up|6|||
48398763|NCT01564862|155651606|FG000|Overall Study|Voluntary Withdrawal|9|||
48398764|NCT01564862|155651607|FG001|Overall Study|Voluntary Withdrawal|6|||
48398765|NCT01564862|155651608|FG002|Overall Study|Voluntary Withdrawal|8|||
48398766|NCT01564862|155651606|FG000|Overall Study|Lack of Efficacy|1|||
48398767|NCT01564862|155651607|FG001|Overall Study|Lack of Efficacy|5|||
48398768|NCT01564862|155651608|FG002|Overall Study|Lack of Efficacy|6|||
48398769|NCT01564862|155651606|FG000|Overall Study|Other reason(s)|1|||
48398770|NCT01564862|155651607|FG001|Overall Study|Other reason(s)|0|||
48398771|NCT01564862|155651608|FG002|Overall Study|Other reason(s)|0|||
48398772|NCT03344003|155651609|FG000|Overall Study|Switched to alternative treatment|1|||
48398773|NCT03344003|155651610|FG001|Overall Study|Switched to alternative treatment|0|||
48398774|NCT03344003|155651609|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
48398775|NCT03344003|155651610|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
48398776|NCT00772668|155651611|FG000|Overall Study|Physician Decision|3|||
48398777|NCT01623271|155653342|FG000|Overall Study|Withdrawal by Subject|2|||
48398778|NCT01137773|155653347|FG000|Overall Study|Death|3|||
48398779|NCT01137773|155653348|FG001|Overall Study|Death|3|||
48398780|NCT01137773|155653347|FG000|Overall Study|Lost to Follow-up|6|||
48782367|NCT01198600|157044616|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
48782368|NCT01198600|157044617|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
48782369|NCT01198600|157044614|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
48782370|NCT01198600|157044615|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
48782371|NCT01198600|157044616|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
48782372|NCT01198600|157044617|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
48782373|NCT01198600|157044614|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
48782374|NCT01198600|157044615|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
48782375|NCT01198600|157044616|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
48782376|NCT01198600|157044617|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
48782377|NCT01198600|157044614|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
48782378|NCT01198600|157044615|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
48782379|NCT01198600|157044616|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
48782380|NCT01198600|157044617|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
48782381|NCT01198600|157044614|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
48782382|NCT01198600|157044615|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
48782383|NCT01198600|157044616|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
48782384|NCT01198600|157044617|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
48782385|NCT01198600|157044614|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
48782386|NCT01198600|157044615|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
48782387|NCT01198600|157044616|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
48782388|NCT01198600|157044617|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
48782389|NCT01198600|157044614|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
48782390|NCT01198600|157044615|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
48398781|NCT01137773|155653348|FG001|Overall Study|Lost to Follow-up|0|||
48398782|NCT01535729|155653349|FG000|Overall Study|Withdrawal by Subject|2|||
48398783|NCT01535729|155653349|FG000|Overall Study|Disease progression|230|||
48398784|NCT01535729|155653349|FG000|Overall Study|Discontinued treatment|25|||
48398785|NCT01535729|155653349|FG000|Overall Study|Lost to Follow-up|8|||
48398786|NCT01535729|155653349|FG000|Overall Study|Death|52|||
48398787|NCT01535729|155653349|FG000|Overall Study|Other|19|||
48398788|NCT01535729|155653349|FG000|Overall Study|Did not sign informed consent|1|||
48398789|NCT01535729|155653349|FG000|Overall Study|No previous chemotherapy|33|||
48398790|NCT01535729|155653349|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
48398791|NCT01535729|155653349|FG000|Overall Study|Protocol Violation|11|||
48398792|NCT01535729|155653349|FG000|Overall Study|Screening failure|1|||
48398793|NCT01535729|155653349|FG000|Overall Study|Not treated|9|||
48398794|NCT01535729|155653349|FG000|Overall Study|No participant record available|5|||
48398795|NCT02105454|155653352|FG000|Overall Study|Withdrawal by Subject|1|||
48398796|NCT00179309|155653355|FG000|Treatment|Toxicity|2|||
48398797|NCT00179309|155653356|FG001|Treatment|Toxicity|3|||
48398798|NCT00179309|155653355|FG000|Treatment|Withdrawal by Subject|1|||
48398799|NCT00179309|155653356|FG001|Treatment|Withdrawal by Subject|2|||
48398800|NCT00179309|155653355|FG000|Treatment|Allergy|1|||
48398801|NCT00179309|155653356|FG001|Treatment|Allergy|0|||
48398802|NCT00429858|155653357|FG000|Overall Study|Withdrawal by Subject|1|||
48398803|NCT00429858|155653357|FG000|Overall Study|Study Termination|1|||
48398804|NCT02432235|155653364|FG000|Overall Study|Death|1|||
48398805|NCT02432235|155653365|FG001|Overall Study|Death|1|||
48398806|NCT02432235|155653366|FG002|Overall Study|Death|2|||
48398807|NCT02432235|155653367|FG003|Overall Study|Death|2|||
48398808|NCT02432235|155653368|FG004|Overall Study|Death|1|||
48398809|NCT02432235|155653369|FG005|Overall Study|Death|3|||
48398810|NCT02432235|155653370|FG006|Overall Study|Death|11|||
48398811|NCT02432235|155653371|FG007|Overall Study|Death|15|||
48398812|NCT02432235|155653372|FG008|Overall Study|Death|15|||
48398813|NCT02432235|155653373|FG009|Overall Study|Death|3|||
48398814|NCT02432235|155653374|FG010|Overall Study|Death|1|||
48398815|NCT02432235|155653375|FG011|Overall Study|Death|0|||
48398816|NCT02432235|155653364|FG000|Overall Study|Withdrawal by Subject|0|||
48398817|NCT02432235|155653365|FG001|Overall Study|Withdrawal by Subject|1|||
48398818|NCT02432235|155653366|FG002|Overall Study|Withdrawal by Subject|0|||
48398819|NCT02432235|155653367|FG003|Overall Study|Withdrawal by Subject|0|||
48398820|NCT02432235|155653368|FG004|Overall Study|Withdrawal by Subject|0|||
48398821|NCT02432235|155653369|FG005|Overall Study|Withdrawal by Subject|2|||
48398822|NCT02432235|155653370|FG006|Overall Study|Withdrawal by Subject|5|||
48782391|NCT01198600|157044616|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
48782392|NCT01198600|157044617|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
48782393|NCT00968617|157044620|FG000|Overall Study|Study terminated by sponsor|6|||
48782394|NCT02308033|157044628|FG000|Overall Study|Normal Gram stain at Baseline|13|||
48782395|NCT02308033|157044629|FG001|Overall Study|Normal Gram stain at Baseline|10|||
48782396|NCT02308033|157044628|FG000|Overall Study|Positive for STD at Baseline|7|||
48782397|NCT02308033|157044629|FG001|Overall Study|Positive for STD at Baseline|4|||
48782398|NCT02308033|157044628|FG000|Overall Study|Lost to Follow-up|6|||
48782399|NCT02308033|157044629|FG001|Overall Study|Lost to Follow-up|5|||
48782400|NCT03791398|157044630|FG000|Overall Study|Progression of Disease Under Study|2|||
48782401|NCT03791398|157044631|FG001|Overall Study|Progression of Disease Under Study|0|||
48782402|NCT03791398|157044632|FG002|Overall Study|Progression of Disease Under Study|0|||
48782403|NCT00766376|157044633|FG000|Overall Study|Withdrawal by Subject|27|||
48782404|NCT03021187|157044634|FG000|Overall Study|Death|0|||
48782405|NCT03021187|157044635|FG001|Overall Study|Death|0|||
48782406|NCT03021187|157044636|FG002|Overall Study|Death|3|||
48782407|NCT03021187|157044637|FG003|Overall Study|Death|0|||
48782408|NCT03021187|157044634|FG000|Overall Study|Withdrawal by Subject|0|||
48782409|NCT03021187|157044635|FG001|Overall Study|Withdrawal by Subject|6|||
48782410|NCT03021187|157044636|FG002|Overall Study|Withdrawal by Subject|2|||
48782411|NCT03021187|157044637|FG003|Overall Study|Withdrawal by Subject|5|||
48782412|NCT03021187|157044634|FG000|Overall Study|Lost to Follow-up|10|||
48782413|NCT03021187|157044635|FG001|Overall Study|Lost to Follow-up|3|||
48782414|NCT03021187|157044636|FG002|Overall Study|Lost to Follow-up|1|||
48398823|NCT02432235|155653371|FG007|Overall Study|Withdrawal by Subject|3|||
48398824|NCT02432235|155653372|FG008|Overall Study|Withdrawal by Subject|1|||
48398825|NCT02432235|155653373|FG009|Overall Study|Withdrawal by Subject|0|||
48398826|NCT02432235|155653374|FG010|Overall Study|Withdrawal by Subject|0|||
48398827|NCT02432235|155653375|FG011|Overall Study|Withdrawal by Subject|0|||
48398828|NCT02432235|155653364|FG000|Overall Study|Lost to Follow-up|0|||
48398829|NCT02432235|155653365|FG001|Overall Study|Lost to Follow-up|0|||
48398830|NCT02432235|155653366|FG002|Overall Study|Lost to Follow-up|0|||
48782415|NCT03021187|157044637|FG003|Overall Study|Lost to Follow-up|4|||
48782416|NCT00766415|157044640|FG000|Overall Study|Withdrawal by Subject|0|||
48782417|NCT00766415|157044641|FG001|Overall Study|Withdrawal by Subject|1|||
48782418|NCT03738150|157044643|FG000|Base Study|Withdrawal by Subject|1|||
48398831|NCT02432235|155653367|FG003|Overall Study|Lost to Follow-up|0|||
48398832|NCT02432235|155653368|FG004|Overall Study|Lost to Follow-up|0|||
48398833|NCT02432235|155653369|FG005|Overall Study|Lost to Follow-up|1|||
48398834|NCT02432235|155653370|FG006|Overall Study|Lost to Follow-up|0|||
48398835|NCT02432235|155653371|FG007|Overall Study|Lost to Follow-up|0|||
48782419|NCT03738150|157044643|FG000|Extension Study|Withdrawal by Subject|1|||
48782420|NCT03832946|157044644|FG000|Overall Study|Adverse Event|3|||
48782421|NCT03832946|157044645|FG001|Overall Study|Adverse Event|1|||
48782422|NCT03832946|157044644|FG000|Overall Study|Lost to Follow-up|1|||
48782423|NCT03832946|157044645|FG001|Overall Study|Lost to Follow-up|0|||
48782424|NCT03832946|157044644|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
48782425|NCT03832946|157044645|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
48782426|NCT03832946|157044644|FG000|Overall Study|Lack of Efficacy|1|||
48782427|NCT03832946|157044645|FG001|Overall Study|Lack of Efficacy|0|||
48782428|NCT03832946|157044644|FG000|Overall Study|Withdrawal by Subject|12|||
48782429|NCT03832946|157044645|FG001|Overall Study|Withdrawal by Subject|9|||
48782430|NCT01462344|157044646|FG000|Overall Study|Withdrawal by Subject|245|||
48782431|NCT01462344|157044647|FG001|Overall Study|Withdrawal by Subject|226|||
48782432|NCT01462344|157044646|FG000|Overall Study|Adverse Event|24|||
48782433|NCT01462344|157044647|FG001|Overall Study|Adverse Event|23|||
48782434|NCT01462344|157044646|FG000|Overall Study|Asthma Exacerbation|34|||
48782435|NCT01462344|157044647|FG001|Overall Study|Asthma Exacerbation|35|||
48782436|NCT01462344|157044646|FG000|Overall Study|Lack of Efficacy|5|||
48782437|NCT01462344|157044647|FG001|Overall Study|Lack of Efficacy|6|||
48782438|NCT01462344|157044646|FG000|Overall Study|Protocol Violation|68|||
48782439|NCT01462344|157044647|FG001|Overall Study|Protocol Violation|53|||
48782440|NCT01462344|157044646|FG000|Overall Study|Lost to Follow-up|7|||
48782441|NCT01462344|157044647|FG001|Overall Study|Lost to Follow-up|7|||
48782442|NCT01003249|157044648|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48782443|NCT01003249|157044649|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
48782444|NCT01003249|157044648|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
48782445|NCT01003249|157044649|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
48782446|NCT01003249|157044648|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48782447|NCT01003249|157044649|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48782448|NCT01003249|157044648|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
48782449|NCT01003249|157044649|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
48782450|NCT03483623|157044650|FG000|Overall Study|43 complete sets achieved|1|||
48782451|NCT00560833|157044651|FG000|Overall Study|Adverse Event|16|||
48782452|NCT00560833|157044652|FG001|Overall Study|Adverse Event|10|||
48782453|NCT00560833|157044653|FG002|Overall Study|Adverse Event|25|||
48782454|NCT00560833|157044654|FG003|Overall Study|Adverse Event|23|||
48782455|NCT00560833|157044655|FG004|Overall Study|Adverse Event|35|||
48782456|NCT00560833|157044651|FG000|Overall Study|Lost to Follow-up|0|||
48782457|NCT00560833|157044652|FG001|Overall Study|Lost to Follow-up|0|||
48782458|NCT00560833|157044653|FG002|Overall Study|Lost to Follow-up|1|||
48782459|NCT00560833|157044654|FG003|Overall Study|Lost to Follow-up|0|||
48782460|NCT00560833|157044655|FG004|Overall Study|Lost to Follow-up|0|||
48782461|NCT00560833|157044651|FG000|Overall Study|Lack of Efficacy|22|||
48782462|NCT00560833|157044652|FG001|Overall Study|Lack of Efficacy|9|||
48782463|NCT00560833|157044653|FG002|Overall Study|Lack of Efficacy|6|||
48782464|NCT00560833|157044654|FG003|Overall Study|Lack of Efficacy|4|||
48782465|NCT00560833|157044655|FG004|Overall Study|Lack of Efficacy|4|||
48782466|NCT00560833|157044651|FG000|Overall Study|Participant uncooperative|5|||
48782467|NCT00560833|157044652|FG001|Overall Study|Participant uncooperative|5|||
48782468|NCT00560833|157044653|FG002|Overall Study|Participant uncooperative|4|||
48782469|NCT00560833|157044654|FG003|Overall Study|Participant uncooperative|4|||
48782470|NCT00560833|157044655|FG004|Overall Study|Participant uncooperative|2|||
48782471|NCT00560833|157044651|FG000|Overall Study|Other|1|||
48782472|NCT00560833|157044652|FG001|Overall Study|Other|1|||
48782473|NCT00560833|157044653|FG002|Overall Study|Other|3|||
48782474|NCT00560833|157044654|FG003|Overall Study|Other|0|||
48782475|NCT00560833|157044655|FG004|Overall Study|Other|0|||
48782476|NCT00560833|157044651|FG000|Overall Study|Never received drug|0|||
48782477|NCT00560833|157044652|FG001|Overall Study|Never received drug|1|||
48782478|NCT00560833|157044653|FG002|Overall Study|Never received drug|0|||
48782479|NCT00560833|157044654|FG003|Overall Study|Never received drug|0|||
48782480|NCT00560833|157044655|FG004|Overall Study|Never received drug|1|||
48782481|NCT02663817|157044667|FG000|Overall Study|Screen failure|2|||
48782482|NCT02899728|157044668|FG000|Overall Study|Withdrawal by Subject|1|||
48782483|NCT02899728|157044669|FG001|Overall Study|Withdrawal by Subject|1|||
48782484|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Adverse Event|4|||
48782485|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Adverse Event|1|||
48398836|NCT02432235|155653372|FG008|Overall Study|Lost to Follow-up|1|||
48782486|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Adverse Event|1|||
48782487|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
48782488|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
48782489|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
48782490|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Pregnancy|3|||
48398837|NCT02432235|155653373|FG009|Overall Study|Lost to Follow-up|0|||
48782491|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Pregnancy|0|||
48782492|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Pregnancy|0|||
48782493|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
48782494|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
48782495|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
48782496|NCT03328897|157046417|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
48782497|NCT03328897|157046418|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
48782498|NCT03328897|157046419|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
48782499|NCT03328897|157046417|FG000|Follow-up Epoch|Adverse Event|4|||
48782500|NCT03328897|157046418|FG001|Follow-up Epoch|Adverse Event|0|||
48782501|NCT03328897|157046419|FG002|Follow-up Epoch|Adverse Event|1|||
48782502|NCT03328897|157046417|FG000|Follow-up Epoch|Lack of Efficacy|1|||
48782503|NCT03328897|157046418|FG001|Follow-up Epoch|Lack of Efficacy|1|||
48782504|NCT03328897|157046419|FG002|Follow-up Epoch|Lack of Efficacy|1|||
48782505|NCT03328897|157046417|FG000|Follow-up Epoch|Lost to Follow-up|0|||
48782506|NCT03328897|157046418|FG001|Follow-up Epoch|Lost to Follow-up|1|||
48782507|NCT03328897|157046419|FG002|Follow-up Epoch|Lost to Follow-up|0|||
48782508|NCT03328897|157046417|FG000|Follow-up Epoch|Pregnancy|1|||
48782509|NCT03328897|157046418|FG001|Follow-up Epoch|Pregnancy|0|||
48782510|NCT03328897|157046419|FG002|Follow-up Epoch|Pregnancy|0|||
48782511|NCT03328897|157046417|FG000|Follow-up Epoch|Patient/guardian decision|2|||
48782512|NCT03328897|157046418|FG001|Follow-up Epoch|Patient/guardian decision|1|||
48782513|NCT03328897|157046419|FG002|Follow-up Epoch|Patient/guardian decision|0|||
48782514|NCT02080091|157046420|FG000|Overall Study|Study Terminated|22|||
48782515|NCT02080091|157046420|FG000|Overall Study|Death|1|||
48782516|NCT02080091|157046420|FG000|Overall Study|Withdrawal by Subject|1|||
48782517|NCT02080091|157046420|FG000|Overall Study|Other|1|||
48782518|NCT03422003|157046421|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
48782519|NCT03422003|157046422|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
48782520|NCT03422003|157046421|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
48782521|NCT03422003|157046422|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
48782522|NCT03794089|157046425|FG000|Overall Study|Lost to Follow-up|4|||
48782523|NCT03794089|157046426|FG001|Overall Study|Lost to Follow-up|1|||
48782524|NCT03794089|157046425|FG000|Overall Study|Withdrawal by Subject|2|||
48782525|NCT03794089|157046426|FG001|Overall Study|Withdrawal by Subject|0|||
48782526|NCT01639001|157046427|FG000|Overall Study|Refused further follow-up|9|||
48782527|NCT01639001|157046428|FG001|Overall Study|Refused further follow-up|12|||
48782528|NCT01639001|157046427|FG000|Overall Study|Lost to Follow-up|3|||
48398838|NCT02432235|155653374|FG010|Overall Study|Lost to Follow-up|0|||
48398839|NCT02432235|155653375|FG011|Overall Study|Lost to Follow-up|0|||
48398840|NCT02432235|155653364|FG000|Overall Study|Miscellaneous|0|||
48398841|NCT02432235|155653365|FG001|Overall Study|Miscellaneous|0|||
48398842|NCT02432235|155653366|FG002|Overall Study|Miscellaneous|0|||
48398843|NCT02432235|155653367|FG003|Overall Study|Miscellaneous|0|||
48398844|NCT02432235|155653368|FG004|Overall Study|Miscellaneous|1|||
48398845|NCT02432235|155653369|FG005|Overall Study|Miscellaneous|6|||
48398846|NCT02432235|155653370|FG006|Overall Study|Miscellaneous|2|||
48398847|NCT02432235|155653371|FG007|Overall Study|Miscellaneous|2|||
48398848|NCT02432235|155653372|FG008|Overall Study|Miscellaneous|4|||
48398849|NCT02432235|155653373|FG009|Overall Study|Miscellaneous|0|||
48398850|NCT02432235|155653374|FG010|Overall Study|Miscellaneous|0|||
48398851|NCT02432235|155653375|FG011|Overall Study|Miscellaneous|1|||
48398852|NCT03345472|155653376|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
48398853|NCT03345472|155653376|FG000|Implant to 3 Months|Physician Decision|1|||
48398854|NCT03345472|155653376|FG000|Implant to 3 Months|Adverse Event|1|||
48398855|NCT03345472|155653376|FG000|3 Months to 12 Months|Physician Decision|3|||
48398856|NCT03345472|155653376|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
48398857|NCT03345472|155653376|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
48398858|NCT03345472|155653376|FG000|3 Months to 12 Months|Adverse Event|1|||
48398859|NCT03345472|155653376|FG000|3 Months to 12 Months|Death|1|||
48398860|NCT01926782|155653377|FG000|Overall Study|Participant moved|2|||
48398861|NCT01926782|155653378|FG001|Overall Study|Participant moved|0|||
48398862|NCT01926782|155653379|FG002|Overall Study|Participant moved|1|||
48398863|NCT01926782|155653380|FG003|Overall Study|Participant moved|1|||
48782529|NCT01639001|157046428|FG001|Overall Study|Lost to Follow-up|0|||
48782530|NCT01639001|157046427|FG000|Overall Study|Death|62|||
48782531|NCT01639001|157046428|FG001|Overall Study|Death|61|||
48782532|NCT01639001|157046427|FG000|Overall Study|Randomized but not treated|0|||
48398864|NCT01926782|155653381|FG004|Overall Study|Participant moved|0|||
48398865|NCT01926782|155653382|FG005|Overall Study|Participant moved|3|||
48398866|NCT01926782|155653377|FG000|Overall Study|Physician Decision|0|||
48782533|NCT01639001|157046428|FG001|Overall Study|Randomized but not treated|2|||
48782534|NCT01639001|157046427|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
48797713|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
48398867|NCT01926782|155653378|FG001|Overall Study|Physician Decision|2|||
48782535|NCT01639001|157046428|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
48782536|NCT03811912|157046429|FG000|Overall Study|Withdrew Consent|4|||
48782537|NCT03811912|157046430|FG001|Overall Study|Withdrew Consent|2|||
48782538|NCT01438411|157046431|FG000|Overall Study|Adverse Event|8|||
48782539|NCT01438411|157046431|FG000|Overall Study|Lost to Follow-up|1|||
48782540|NCT01438411|157046431|FG000|Overall Study|Lack of Efficacy|1|||
48782541|NCT01438411|157046431|FG000|Overall Study|Withdrawal by Subject|3|||
48782542|NCT01782131|157046432|FG000|Overall Study|Death|93|||
48782543|NCT01782131|157046433|FG001|Overall Study|Death|96|||
48782544|NCT01782131|157046432|FG000|Overall Study|Lost to Follow-up|1|||
48782545|NCT01782131|157046433|FG001|Overall Study|Lost to Follow-up|3|||
48782546|NCT01782131|157046432|FG000|Overall Study|Withdrawal by Subject|10|||
48782547|NCT01782131|157046433|FG001|Overall Study|Withdrawal by Subject|10|||
48782548|NCT01782131|157046432|FG000|Overall Study|Randomized but not treated|5|||
48782549|NCT01782131|157046433|FG001|Overall Study|Randomized but not treated|5|||
48782550|NCT01782131|157046432|FG000|Overall Study|Reason not provided|0|||
48782551|NCT01782131|157046433|FG001|Overall Study|Reason not provided|1|||
48398868|NCT01926782|155653379|FG002|Overall Study|Physician Decision|1|||
48398869|NCT01926782|155653380|FG003|Overall Study|Physician Decision|1|||
48782552|NCT00796718|157046434|FG000|Overall Study|Adverse Event|2|||
48782553|NCT00796718|157046434|FG000|Overall Study|Exclusion Criteria|1|||
48398870|NCT01926782|155653381|FG004|Overall Study|Physician Decision|0|||
48398871|NCT01926782|155653382|FG005|Overall Study|Physician Decision|0|||
48398872|NCT01926782|155653377|FG000|Overall Study|Other than specified|2|||
48398873|NCT01926782|155653378|FG001|Overall Study|Other than specified|3|||
48782554|NCT00796718|157046434|FG000|Overall Study|Lost to Follow-up|5|||
48782555|NCT00796718|157046434|FG000|Overall Study|Withdrawal by Informed Consent|1|||
48782556|NCT02627677|157046435|FG000|Overall Study|Adverse event (not progressive disease)|1|||
48782557|NCT02627677|157046436|FG001|Overall Study|Adverse event (not progressive disease)|4|||
48782558|NCT02627677|157046437|FG002|Overall Study|Adverse event (not progressive disease)|1|||
48782559|NCT02627677|157046435|FG000|Overall Study|Progressive disease|1|||
48782560|NCT02627677|157046436|FG001|Overall Study|Progressive disease|3|||
48782561|NCT02627677|157046437|FG002|Overall Study|Progressive disease|0|||
48782562|NCT02627677|157046435|FG000|Overall Study|Lack of Efficacy|1|||
48782563|NCT02627677|157046436|FG001|Overall Study|Lack of Efficacy|2|||
48782564|NCT02627677|157046437|FG002|Overall Study|Lack of Efficacy|0|||
48782565|NCT02627677|157046435|FG000|Overall Study|Lost to Follow-up|0|||
48782566|NCT02627677|157046436|FG001|Overall Study|Lost to Follow-up|0|||
48782567|NCT02627677|157046437|FG002|Overall Study|Lost to Follow-up|1|||
48782568|NCT02627677|157046435|FG000|Overall Study|Pregnancy|0|||
48782569|NCT02627677|157046436|FG001|Overall Study|Pregnancy|1|||
48782570|NCT02627677|157046437|FG002|Overall Study|Pregnancy|0|||
48782571|NCT02627677|157046435|FG000|Overall Study|Study Terminated by Sponsor|5|||
48782572|NCT02627677|157046436|FG001|Overall Study|Study Terminated by Sponsor|10|||
48782573|NCT02627677|157046437|FG002|Overall Study|Study Terminated by Sponsor|6|||
48782574|NCT02627677|157046435|FG000|Overall Study|Physician Decision|0|||
48782575|NCT02627677|157046436|FG001|Overall Study|Physician Decision|0|||
48782576|NCT02627677|157046437|FG002|Overall Study|Physician Decision|2|||
48782577|NCT02627677|157046435|FG000|Overall Study|Withdrawal by Subject|2|||
48782578|NCT02627677|157046436|FG001|Overall Study|Withdrawal by Subject|1|||
48782579|NCT02627677|157046437|FG002|Overall Study|Withdrawal by Subject|1|||
48782580|NCT02627677|157046435|FG000|Overall Study|Reason not Specified|0|||
48782581|NCT02627677|157046436|FG001|Overall Study|Reason not Specified|0|||
48782582|NCT02627677|157046437|FG002|Overall Study|Reason not Specified|1|||
48782583|NCT02627677|157046435|FG000|Overall Study|Randomized but not Treated|1|||
48782584|NCT02627677|157046436|FG001|Overall Study|Randomized but not Treated|0|||
48782585|NCT02627677|157046437|FG002|Overall Study|Randomized but not Treated|0|||
48782586|NCT04329104|157046438|FG000|Efficacy Study|Withdrawal by Subject|0|||
48782587|NCT04329104|157046439|FG001|Efficacy Study|Withdrawal by Subject|0|||
48782588|NCT04329104|157046440|FG002|Efficacy Study|Withdrawal by Subject|0|||
48782589|NCT04329104|157046441|FG003|Efficacy Study|Withdrawal by Subject|5|||
48782590|NCT04329104|157046442|FG004|Efficacy Study|Withdrawal by Subject|6|||
48782591|NCT04329104|157046443|FG005|Efficacy Study|Withdrawal by Subject|8|||
48782592|NCT02886572|157046444|FG000|Overall Study|Death|8|||
48782593|NCT01153633|157046445|FG000|Overall Study|Protocol Violation|1|||
48782594|NCT01153633|157046446|FG001|Overall Study|Protocol Violation|1|||
48782595|NCT01153633|157046445|FG000|Overall Study|Therapeutic failure|3|||
48782596|NCT01153633|157046446|FG001|Overall Study|Therapeutic failure|3|||
48782597|NCT00384085|157046447|FG000|Overall Study|Adverse Event|5|||
48398874|NCT01926782|155653379|FG002|Overall Study|Other than specified|5|||
48782598|NCT00384085|157046448|FG001|Overall Study|Adverse Event|5|||
48782599|NCT00384085|157046449|FG002|Overall Study|Adverse Event|4|||
48782600|NCT00384085|157046447|FG000|Overall Study|Lack of Efficacy|0|||
48782601|NCT00384085|157046448|FG001|Overall Study|Lack of Efficacy|3|||
48782602|NCT00384085|157046449|FG002|Overall Study|Lack of Efficacy|2|||
48782603|NCT00384085|157046447|FG000|Overall Study|No longer Requires Study Treatment|1|||
48782604|NCT00384085|157046448|FG001|Overall Study|No longer Requires Study Treatment|0|||
48782605|NCT00384085|157046449|FG002|Overall Study|No longer Requires Study Treatment|1|||
48782606|NCT00384085|157046447|FG000|Overall Study|Protocol Violation|2|||
48782607|NCT00384085|157046448|FG001|Overall Study|Protocol Violation|2|||
48782608|NCT00384085|157046449|FG002|Overall Study|Protocol Violation|2|||
48782609|NCT00384085|157046447|FG000|Overall Study|Lost to Follow-up|9|||
48782610|NCT00384085|157046448|FG001|Overall Study|Lost to Follow-up|9|||
48782611|NCT00384085|157046449|FG002|Overall Study|Lost to Follow-up|10|||
48782612|NCT00384085|157046447|FG000|Overall Study|Progressive Disease|0|||
48782613|NCT00384085|157046448|FG001|Overall Study|Progressive Disease|1|||
48398875|NCT01926782|155653380|FG003|Overall Study|Other than specified|12|||
48398876|NCT01926782|155653381|FG004|Overall Study|Other than specified|4|||
48398877|NCT01926782|155653382|FG005|Overall Study|Other than specified|11|||
48398878|NCT01926782|155653377|FG000|Overall Study|Adverse Event|13|||
48398879|NCT01926782|155653378|FG001|Overall Study|Adverse Event|4|||
48398880|NCT01926782|155653379|FG002|Overall Study|Adverse Event|17|||
48398881|NCT01926782|155653380|FG003|Overall Study|Adverse Event|4|||
48398882|NCT01926782|155653381|FG004|Overall Study|Adverse Event|3|||
48398883|NCT01926782|155653382|FG005|Overall Study|Adverse Event|14|||
48398884|NCT01926782|155653377|FG000|Overall Study|Poor compliance to protocol|5|||
48398885|NCT01926782|155653378|FG001|Overall Study|Poor compliance to protocol|3|||
48398886|NCT01926782|155653379|FG002|Overall Study|Poor compliance to protocol|8|||
48398887|NCT01926782|155653380|FG003|Overall Study|Poor compliance to protocol|0|||
48398888|NCT01926782|155653381|FG004|Overall Study|Poor compliance to protocol|1|||
48398889|NCT01926782|155653382|FG005|Overall Study|Poor compliance to protocol|6|||
48398890|NCT01926782|155653377|FG000|Overall Study|Randomized and not treated|0|||
48398891|NCT01926782|155653378|FG001|Overall Study|Randomized and not treated|0|||
48398892|NCT01926782|155653379|FG002|Overall Study|Randomized and not treated|0|||
48398893|NCT01926782|155653380|FG003|Overall Study|Randomized and not treated|1|||
48398894|NCT01926782|155653381|FG004|Overall Study|Randomized and not treated|0|||
48398895|NCT01926782|155653382|FG005|Overall Study|Randomized and not treated|0|||
48398896|NCT01926782|155653377|FG000|Overall Study|Withdrawal by Subject|6|||
48398897|NCT01926782|155653378|FG001|Overall Study|Withdrawal by Subject|1|||
48398898|NCT01926782|155653379|FG002|Overall Study|Withdrawal by Subject|8|||
48398899|NCT01926782|155653380|FG003|Overall Study|Withdrawal by Subject|1|||
48398900|NCT01926782|155653381|FG004|Overall Study|Withdrawal by Subject|0|||
48398901|NCT01926782|155653382|FG005|Overall Study|Withdrawal by Subject|5|||
48398902|NCT01926782|155653377|FG000|Overall Study|Related to study drug administration|0|||
48398903|NCT01926782|155653378|FG001|Overall Study|Related to study drug administration|0|||
48398904|NCT01926782|155653379|FG002|Overall Study|Related to study drug administration|0|||
48398905|NCT01926782|155653380|FG003|Overall Study|Related to study drug administration|0|||
48398906|NCT01926782|155653381|FG004|Overall Study|Related to study drug administration|0|||
48398907|NCT01926782|155653382|FG005|Overall Study|Related to study drug administration|2|||
48398908|NCT01046877|155653387|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
48398909|NCT01046877|155653387|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
48398910|NCT02450578|155653390|FG000|Overall Study|ECG abnormality so not treated|1|||
48398911|NCT02450578|155653391|FG001|Overall Study|ECG abnormality so not treated|0|||
48398912|NCT02450578|155653392|FG002|Overall Study|ECG abnormality so not treated|0|||
48782614|NCT00384085|157046449|FG002|Overall Study|Progressive Disease|0|||
48782615|NCT00384085|157046447|FG000|Overall Study|Withdrawal by Subject|14|||
48782616|NCT00384085|157046448|FG001|Overall Study|Withdrawal by Subject|19|||
48398913|NCT02450578|155653393|FG003|Overall Study|ECG abnormality so not treated|0|||
48398914|NCT04016311|155653395|FG000|Overall Study|Withdrawal by Subject|1|||
48398915|NCT04016311|155653396|FG001|Overall Study|Withdrawal by Subject|0|||
48398916|NCT04029519|155653397|FG000|Overall Study|Protocol Violation|1|||
48398917|NCT04029519|155653397|FG000|Overall Study|Withdrawal by Subject|3|||
48398918|NCT04029519|155653397|FG000|Overall Study|Lost to Follow-up|1|||
48398919|NCT02064387|155653398|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48782617|NCT00384085|157046449|FG002|Overall Study|Withdrawal by Subject|29|||
48782618|NCT00384085|157046447|FG000|Overall Study|Patient non-compliant|4|||
48782619|NCT00384085|157046448|FG001|Overall Study|Patient non-compliant|4|||
48782620|NCT00384085|157046449|FG002|Overall Study|Patient non-compliant|5|||
48398920|NCT02064387|155653399|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48398921|NCT02064387|155653400|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48398922|NCT02064387|155653401|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48398923|NCT02064387|155653402|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48398924|NCT02064387|155653403|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48398925|NCT02064387|155653404|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48398926|NCT02064387|155653405|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
48398927|NCT02064387|155653406|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48398928|NCT02064387|155653407|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
48398929|NCT02064387|155653408|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48398930|NCT02064387|155653409|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
48782621|NCT00384085|157046447|FG000|Overall Study|Physician Decision|1|||
48782622|NCT00384085|157046448|FG001|Overall Study|Physician Decision|0|||
48782623|NCT00384085|157046449|FG002|Overall Study|Physician Decision|0|||
48782624|NCT00384085|157046447|FG000|Overall Study|Loss of site personnel|1|||
48782625|NCT00384085|157046448|FG001|Overall Study|Loss of site personnel|0|||
48782626|NCT00384085|157046449|FG002|Overall Study|Loss of site personnel|1|||
48782627|NCT00384085|157046447|FG000|Overall Study|Sponsor decision|1|||
48782628|NCT00384085|157046448|FG001|Overall Study|Sponsor decision|2|||
48782629|NCT00384085|157046449|FG002|Overall Study|Sponsor decision|1|||
48782630|NCT00384085|157046447|FG000|Overall Study|Patient moved|1|||
48782631|NCT00384085|157046448|FG001|Overall Study|Patient moved|0|||
48782632|NCT00384085|157046449|FG002|Overall Study|Patient moved|1|||
48782633|NCT00384085|157046447|FG000|Overall Study|Patient required surgery|0|||
48782634|NCT00384085|157046448|FG001|Overall Study|Patient required surgery|1|||
48782635|NCT00384085|157046449|FG002|Overall Study|Patient required surgery|0|||
48782636|NCT02318329|157046454|FG000|Overall Study|Progressive Disease|2|||
48782637|NCT02318329|157046455|FG001|Overall Study|Progressive Disease|3|||
48782638|NCT02318329|157046456|FG002|Overall Study|Progressive Disease|2|||
48782639|NCT02318329|157046457|FG003|Overall Study|Progressive Disease|3|||
48782640|NCT02318329|157046458|FG004|Overall Study|Progressive Disease|3|||
48782641|NCT02318329|157046459|FG005|Overall Study|Progressive Disease|3|||
48782642|NCT02318329|157046460|FG006|Overall Study|Progressive Disease|1|||
48782643|NCT02318329|157046461|FG007|Overall Study|Progressive Disease|1|||
48782644|NCT02318329|157046462|FG008|Overall Study|Progressive Disease|5|||
48782645|NCT02318329|157046463|FG009|Overall Study|Progressive Disease|39|||
48782646|NCT02318329|157046454|FG000|Overall Study|Death|0|||
48782647|NCT02318329|157046455|FG001|Overall Study|Death|0|||
48782648|NCT02318329|157046456|FG002|Overall Study|Death|0|||
48782649|NCT02318329|157046457|FG003|Overall Study|Death|0|||
48782650|NCT02318329|157046458|FG004|Overall Study|Death|0|||
48782651|NCT02318329|157046459|FG005|Overall Study|Death|0|||
48782652|NCT02318329|157046460|FG006|Overall Study|Death|0|||
48782653|NCT02318329|157046461|FG007|Overall Study|Death|0|||
48782654|NCT02318329|157046462|FG008|Overall Study|Death|0|||
48782655|NCT02318329|157046463|FG009|Overall Study|Death|5|||
48782656|NCT02318329|157046454|FG000|Overall Study|Lost to Follow-up|0|||
48782657|NCT02318329|157046455|FG001|Overall Study|Lost to Follow-up|0|||
48782658|NCT02318329|157046456|FG002|Overall Study|Lost to Follow-up|0|||
48782659|NCT02318329|157046457|FG003|Overall Study|Lost to Follow-up|0|||
48782660|NCT02318329|157046458|FG004|Overall Study|Lost to Follow-up|0|||
48782661|NCT02318329|157046459|FG005|Overall Study|Lost to Follow-up|0|||
48782662|NCT02318329|157046460|FG006|Overall Study|Lost to Follow-up|0|||
48782663|NCT02318329|157046461|FG007|Overall Study|Lost to Follow-up|0|||
48782664|NCT02318329|157046462|FG008|Overall Study|Lost to Follow-up|0|||
48782665|NCT02318329|157046463|FG009|Overall Study|Lost to Follow-up|1|||
48782666|NCT02318329|157046454|FG000|Overall Study|Withdrawal by Subject|0|||
48782667|NCT02318329|157046455|FG001|Overall Study|Withdrawal by Subject|0|||
48782668|NCT02318329|157046456|FG002|Overall Study|Withdrawal by Subject|0|||
48782669|NCT02318329|157046457|FG003|Overall Study|Withdrawal by Subject|0|||
48782670|NCT02318329|157046458|FG004|Overall Study|Withdrawal by Subject|0|||
48782671|NCT02318329|157046459|FG005|Overall Study|Withdrawal by Subject|0|||
48782672|NCT02318329|157046460|FG006|Overall Study|Withdrawal by Subject|0|||
48782673|NCT02318329|157046461|FG007|Overall Study|Withdrawal by Subject|0|||
48782674|NCT02318329|157046462|FG008|Overall Study|Withdrawal by Subject|0|||
48782675|NCT02318329|157046463|FG009|Overall Study|Withdrawal by Subject|6|||
48398931|NCT02064387|155653398|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48782676|NCT02318329|157046454|FG000|Overall Study|Other|1|||
48782677|NCT02318329|157046455|FG001|Overall Study|Other|1|||
48398932|NCT02064387|155653399|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48430342|NCT00696657|155763705|FG005|Overall Study|Lack of Efficacy|0|||
48782678|NCT02318329|157046456|FG002|Overall Study|Other|1|||
48782679|NCT02318329|157046457|FG003|Overall Study|Other|0|||
48782680|NCT02318329|157046458|FG004|Overall Study|Other|0|||
48782681|NCT02318329|157046459|FG005|Overall Study|Other|0|||
48782682|NCT02318329|157046460|FG006|Overall Study|Other|0|||
48782683|NCT02318329|157046461|FG007|Overall Study|Other|0|||
48782684|NCT02318329|157046462|FG008|Overall Study|Other|1|||
48782685|NCT02318329|157046463|FG009|Overall Study|Other|1|||
48782686|NCT00581945|157046468|FG000|Overall Study|Adverse Event|4|||
48782687|NCT00581945|157046469|FG001|Overall Study|Adverse Event|4|||
48782688|NCT00581945|157046468|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48782689|NCT00581945|157046469|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48782690|NCT00581945|157046468|FG000|Overall Study|Withdrawal by Subject|2|||
48782691|NCT00581945|157046469|FG001|Overall Study|Withdrawal by Subject|6|||
48782692|NCT00581945|157046468|FG000|Overall Study|Death|1|||
48782693|NCT00581945|157046469|FG001|Overall Study|Death|0|||
48782694|NCT00767000|157046474|FG000|54-week Study|Adverse Event|4|||
48782695|NCT00767000|157046475|FG001|54-week Study|Adverse Event|6|||
48782696|NCT00767000|157046476|FG002|54-week Study|Adverse Event|6|||
48782697|NCT00767000|157046477|FG003|54-week Study|Adverse Event|8|||
48356563|NCT00706654|155501089|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
48356564|NCT00706654|155501090|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
48356565|NCT00706654|155501091|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
48356566|NCT00706654|155501092|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
48356567|NCT00706654|155501089|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
48356568|NCT00706654|155501090|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
48356569|NCT00706654|155501091|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
48356570|NCT00706654|155501092|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
48356571|NCT00706654|155501089|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
48356572|NCT00706654|155501090|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
48356573|NCT00706654|155501091|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
48356574|NCT00706654|155501092|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
48356575|NCT00706654|155501089|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
48356576|NCT00706654|155501090|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
48356577|NCT00706654|155501091|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
48356578|NCT00706654|155501092|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
48356579|NCT00706654|155501089|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
48356580|NCT00706654|155501090|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
48356581|NCT00706654|155501091|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
48356582|NCT00706654|155501092|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
48356583|NCT00706654|155501089|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
48356584|NCT00706654|155501090|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
48356585|NCT00706654|155501091|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
48356586|NCT00706654|155501092|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
48356587|NCT01647542|155501093|FG000|Overall Study|Major Protocol Deviation|1|||
48356588|NCT01647542|155501094|FG001|Overall Study|Major Protocol Deviation|0|||
48356589|NCT01647542|155501095|FG002|Overall Study|Major Protocol Deviation|0|||
48356590|NCT01647542|155501093|FG000|Overall Study|Adverse Event|4|||
48356591|NCT01647542|155501094|FG001|Overall Study|Adverse Event|5|||
48356592|NCT01647542|155501095|FG002|Overall Study|Adverse Event|4|||
48356593|NCT01647542|155501093|FG000|Overall Study|Lost to Follow-up|0|||
48356594|NCT01647542|155501094|FG001|Overall Study|Lost to Follow-up|2|||
48356595|NCT01647542|155501095|FG002|Overall Study|Lost to Follow-up|2|||
48356596|NCT01647542|155501093|FG000|Overall Study|Withdrawal by Subject|6|||
48356597|NCT01647542|155501094|FG001|Overall Study|Withdrawal by Subject|4|||
48356598|NCT01647542|155501095|FG002|Overall Study|Withdrawal by Subject|0|||
48356599|NCT01647542|155501093|FG000|Overall Study|Study Termination|64|||
48356600|NCT01647542|155501094|FG001|Overall Study|Study Termination|61|||
48356601|NCT01647542|155501095|FG002|Overall Study|Study Termination|65|||
48356602|NCT01647542|155501093|FG000|Overall Study|Lack of Efficacy|1|||
48356603|NCT01647542|155501094|FG001|Overall Study|Lack of Efficacy|1|||
48356604|NCT01647542|155501095|FG002|Overall Study|Lack of Efficacy|0|||
48356605|NCT01647542|155501093|FG000|Overall Study|Death|0|||
48356606|NCT01647542|155501094|FG001|Overall Study|Death|0|||
48356607|NCT01647542|155501095|FG002|Overall Study|Death|1|||
48356608|NCT01001390|155501102|FG000|Overall Study|Failure to wear AFO device|2|||
48356609|NCT01001390|155501103|FG001|Overall Study|Failure to wear AFO device|0|||
48356610|NCT02956837|155501104|FG000|Overall Study|Serious Adverse Events|0|||
48356611|NCT02956837|155501105|FG001|Overall Study|Serious Adverse Events|1|||
48356612|NCT02956837|155501106|FG002|Overall Study|Serious Adverse Events|0|||
48356613|NCT02956837|155501107|FG003|Overall Study|Serious Adverse Events|0|||
48356614|NCT02956837|155501104|FG000|Overall Study|Withdrawal by Subject|0|||
48356615|NCT02956837|155501105|FG001|Overall Study|Withdrawal by Subject|1|||
48356616|NCT02956837|155501106|FG002|Overall Study|Withdrawal by Subject|0|||
48356617|NCT02956837|155501107|FG003|Overall Study|Withdrawal by Subject|3|||
48356618|NCT02956837|155501104|FG000|Overall Study|Lost to Follow-up|0|||
48356619|NCT02956837|155501105|FG001|Overall Study|Lost to Follow-up|1|||
48356620|NCT02956837|155501106|FG002|Overall Study|Lost to Follow-up|2|||
48356621|NCT02956837|155501107|FG003|Overall Study|Lost to Follow-up|0|||
48356622|NCT02638103|155501108|FG000|Overall Study|Adverse Event|13|||
48782698|NCT00767000|157046478|FG004|54-week Study|Adverse Event|4|||
48398933|NCT02064387|155653400|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398934|NCT02064387|155653401|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398935|NCT02064387|155653402|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398936|NCT02064387|155653403|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398937|NCT02064387|155653404|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398938|NCT02064387|155653405|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
48398939|NCT02064387|155653406|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398940|NCT02064387|155653407|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398941|NCT02064387|155653408|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398942|NCT02064387|155653409|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
48398943|NCT02064387|155653398|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398944|NCT02064387|155653399|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398945|NCT02064387|155653400|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398946|NCT02064387|155653401|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398947|NCT02064387|155653402|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398948|NCT02064387|155653403|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398949|NCT02064387|155653404|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398950|NCT02064387|155653405|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398951|NCT02064387|155653406|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
48398952|NCT02064387|155653407|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398953|NCT02064387|155653408|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398954|NCT02064387|155653409|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
48398955|NCT02064387|155653398|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
48398956|NCT02064387|155653399|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
48398957|NCT02064387|155653400|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
48398958|NCT02064387|155653401|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
48398959|NCT02064387|155653402|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
48398960|NCT02064387|155653403|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
48398961|NCT02064387|155653404|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
48398962|NCT02064387|155653405|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
48398963|NCT02064387|155653406|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
48398964|NCT02064387|155653407|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
48398965|NCT02064387|155653408|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
48398966|NCT02064387|155653409|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
48398967|NCT02064387|155653398|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398968|NCT02064387|155653399|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398969|NCT02064387|155653400|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398970|NCT02064387|155653401|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398971|NCT02064387|155653402|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398972|NCT02064387|155653403|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398973|NCT02064387|155653404|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398974|NCT02064387|155653405|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398975|NCT02064387|155653406|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48782699|NCT00767000|157046474|FG000|54-week Study|Creaninine/creatinine clearance|2|||
48782700|NCT00767000|157046475|FG001|54-week Study|Creaninine/creatinine clearance|1|||
48782701|NCT00767000|157046476|FG002|54-week Study|Creaninine/creatinine clearance|2|||
48782702|NCT00767000|157046477|FG003|54-week Study|Creaninine/creatinine clearance|2|||
48782703|NCT00767000|157046478|FG004|54-week Study|Creaninine/creatinine clearance|4|||
48782704|NCT00767000|157046474|FG000|54-week Study|Hyperglycemia|0|||
48782705|NCT00767000|157046475|FG001|54-week Study|Hyperglycemia|0|||
48782706|NCT00767000|157046476|FG002|54-week Study|Hyperglycemia|1|||
48782707|NCT00767000|157046477|FG003|54-week Study|Hyperglycemia|0|||
48782708|NCT00767000|157046478|FG004|54-week Study|Hyperglycemia|1|||
48782709|NCT00767000|157046474|FG000|54-week Study|Hypoglycemia|0|||
48782710|NCT00767000|157046475|FG001|54-week Study|Hypoglycemia|1|||
48782711|NCT00767000|157046476|FG002|54-week Study|Hypoglycemia|0|||
48782712|NCT00767000|157046477|FG003|54-week Study|Hypoglycemia|0|||
48782713|NCT00767000|157046478|FG004|54-week Study|Hypoglycemia|0|||
48782714|NCT00767000|157046474|FG000|54-week Study|Interruption of study medication|0|||
48782715|NCT00767000|157046475|FG001|54-week Study|Interruption of study medication|0|||
48782716|NCT00767000|157046476|FG002|54-week Study|Interruption of study medication|1|||
48782717|NCT00767000|157046477|FG003|54-week Study|Interruption of study medication|0|||
48782718|NCT00767000|157046478|FG004|54-week Study|Interruption of study medication|0|||
48782719|NCT00767000|157046474|FG000|54-week Study|Lack of Efficacy|2|||
48782720|NCT00767000|157046475|FG001|54-week Study|Lack of Efficacy|0|||
48398976|NCT02064387|155653407|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48398977|NCT02064387|155653408|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
48430343|NCT00696657|155763706|FG006|Overall Study|Lack of Efficacy|0|||
48782721|NCT00767000|157046476|FG002|54-week Study|Lack of Efficacy|1|||
48782722|NCT00767000|157046477|FG003|54-week Study|Lack of Efficacy|0|||
48782723|NCT00767000|157046478|FG004|54-week Study|Lack of Efficacy|5|||
48782724|NCT00767000|157046474|FG000|54-week Study|Lost to Follow-up|4|||
48782725|NCT00767000|157046475|FG001|54-week Study|Lost to Follow-up|0|||
48782726|NCT00767000|157046476|FG002|54-week Study|Lost to Follow-up|1|||
48782727|NCT00767000|157046477|FG003|54-week Study|Lost to Follow-up|4|||
48782728|NCT00767000|157046478|FG004|54-week Study|Lost to Follow-up|2|||
48782729|NCT00767000|157046474|FG000|54-week Study|Physician Decision|4|||
48782730|NCT00767000|157046475|FG001|54-week Study|Physician Decision|0|||
48782731|NCT00767000|157046476|FG002|54-week Study|Physician Decision|1|||
48782732|NCT00767000|157046477|FG003|54-week Study|Physician Decision|1|||
48782733|NCT00767000|157046478|FG004|54-week Study|Physician Decision|1|||
48782734|NCT00767000|157046474|FG000|54-week Study|Progressive disease|0|||
48782735|NCT00767000|157046475|FG001|54-week Study|Progressive disease|0|||
48356623|NCT02638103|155501109|FG001|Overall Study|Adverse Event|12|||
48356624|NCT02638103|155501110|FG002|Overall Study|Adverse Event|19|||
48356625|NCT02638103|155501111|FG003|Overall Study|Adverse Event|12|||
48356626|NCT02638103|155501108|FG000|Overall Study|Withdrawal by Subject|43|||
48356627|NCT02638103|155501109|FG001|Overall Study|Withdrawal by Subject|53|||
48356628|NCT02638103|155501110|FG002|Overall Study|Withdrawal by Subject|30|||
48356629|NCT02638103|155501111|FG003|Overall Study|Withdrawal by Subject|61|||
48356630|NCT02638103|155501108|FG000|Overall Study|Protocol Violation|1|||
48356631|NCT02638103|155501109|FG001|Overall Study|Protocol Violation|2|||
48356632|NCT02638103|155501110|FG002|Overall Study|Protocol Violation|1|||
48356633|NCT02638103|155501111|FG003|Overall Study|Protocol Violation|4|||
48356634|NCT02638103|155501108|FG000|Overall Study|Pregnancy|2|||
48356635|NCT02638103|155501109|FG001|Overall Study|Pregnancy|3|||
48356636|NCT02638103|155501110|FG002|Overall Study|Pregnancy|0|||
48356637|NCT02638103|155501111|FG003|Overall Study|Pregnancy|1|||
48356638|NCT02638103|155501108|FG000|Overall Study|Non-compliance to Study Procedures|2|||
48356639|NCT02638103|155501109|FG001|Overall Study|Non-compliance to Study Procedures|1|||
48356640|NCT02638103|155501110|FG002|Overall Study|Non-compliance to Study Procedures|1|||
48356641|NCT02638103|155501111|FG003|Overall Study|Non-compliance to Study Procedures|1|||
48356642|NCT02638103|155501108|FG000|Overall Study|Lost to Follow-up|26|||
48356643|NCT02638103|155501109|FG001|Overall Study|Lost to Follow-up|33|||
48356644|NCT02638103|155501110|FG002|Overall Study|Lost to Follow-up|20|||
48356645|NCT02638103|155501111|FG003|Overall Study|Lost to Follow-up|37|||
48356646|NCT02638103|155501108|FG000|Overall Study|Lack of Efficacy|14|||
48356647|NCT02638103|155501109|FG001|Overall Study|Lack of Efficacy|10|||
48356648|NCT02638103|155501110|FG002|Overall Study|Lack of Efficacy|12|||
48356649|NCT02638103|155501111|FG003|Overall Study|Lack of Efficacy|22|||
48356650|NCT02638103|155501108|FG000|Overall Study|Other than specified|5|||
48356651|NCT02638103|155501109|FG001|Overall Study|Other than specified|4|||
48356652|NCT02638103|155501110|FG002|Overall Study|Other than specified|2|||
48356653|NCT02638103|155501111|FG003|Overall Study|Other than specified|4|||
48356654|NCT00246090|155501112|FG000|Overall Study|Adverse Event|25|||
48356655|NCT00246090|155501112|FG000|Overall Study|Withdrawal by Subject|7|||
48356656|NCT00246090|155501112|FG000|Overall Study|Progressive Disease|212|||
48356657|NCT00246090|155501112|FG000|Overall Study|Clinical Progression|30|||
48356658|NCT00246090|155501112|FG000|Overall Study|Physician Decision|11|||
48356659|NCT00246090|155501112|FG000|Overall Study|Not Otherwise Specified|10|||
48356660|NCT03332784|155501113|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356661|NCT03332784|155501114|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
48356662|NCT03332784|155501115|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356663|NCT03332784|155501116|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356664|NCT03332784|155501117|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356665|NCT03332784|155501118|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356666|NCT03332784|155501119|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356667|NCT03332784|155501120|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356668|NCT03332784|155501121|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356669|NCT03332784|155501122|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356670|NCT03332784|155501123|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356671|NCT03332784|155501124|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356672|NCT03332784|155501125|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356673|NCT03332784|155501126|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356674|NCT03332784|155501127|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
48356675|NCT03332784|155501128|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356676|NCT03332784|155501129|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356677|NCT03332784|155501130|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356678|NCT03332784|155501131|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48782736|NCT00767000|157046476|FG002|54-week Study|Progressive disease|1|||
48782737|NCT00767000|157046477|FG003|54-week Study|Progressive disease|0|||
48782738|NCT00767000|157046478|FG004|54-week Study|Progressive disease|0|||
48782739|NCT00767000|157046474|FG000|54-week Study|Protocol Violation|0|||
48782740|NCT00767000|157046475|FG001|54-week Study|Protocol Violation|0|||
48782741|NCT00767000|157046476|FG002|54-week Study|Protocol Violation|1|||
48782742|NCT00767000|157046477|FG003|54-week Study|Protocol Violation|2|||
48782743|NCT00767000|157046478|FG004|54-week Study|Protocol Violation|0|||
48782744|NCT00767000|157046474|FG000|54-week Study|Withdrawal by Subject|2|||
48782745|NCT00767000|157046475|FG001|54-week Study|Withdrawal by Subject|3|||
48782746|NCT00767000|157046476|FG002|54-week Study|Withdrawal by Subject|5|||
48782747|NCT00767000|157046477|FG003|54-week Study|Withdrawal by Subject|11|||
48782748|NCT00767000|157046478|FG004|54-week Study|Withdrawal by Subject|13|||
48782749|NCT00767000|157046474|FG000|54-week Study|Study terminated by sponsor|90|||
48782750|NCT00767000|157046475|FG001|54-week Study|Study terminated by sponsor|102|||
48782751|NCT00767000|157046476|FG002|54-week Study|Study terminated by sponsor|89|||
48782752|NCT00767000|157046477|FG003|54-week Study|Study terminated by sponsor|196|||
48782753|NCT00767000|157046478|FG004|54-week Study|Study terminated by sponsor|194|||
48782754|NCT00767000|157046474|FG000|54-week Study|Reason not reported|0|||
48782755|NCT00767000|157046475|FG001|54-week Study|Reason not reported|0|||
48782756|NCT00767000|157046476|FG002|54-week Study|Reason not reported|0|||
48782757|NCT00767000|157046477|FG003|54-week Study|Reason not reported|1|||
48782758|NCT00767000|157046478|FG004|54-week Study|Reason not reported|0|||
48782759|NCT00767000|157046474|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
48782760|NCT00767000|157046475|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
48782761|NCT00767000|157046476|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
48782762|NCT00767000|157046477|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
48782763|NCT00767000|157046478|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
48782764|NCT02032901|157046479|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
48782765|NCT02032901|157046480|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
48782766|NCT02032901|157046479|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
48782767|NCT02032901|157046480|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
48782768|NCT01259713|157046481|FG000|Overall Study|Adverse Event|54|||
48782769|NCT01259713|157046482|FG001|Overall Study|Adverse Event|23|||
48782770|NCT01259713|157046481|FG000|Overall Study|Death Not Related to IFI|8|||
48782771|NCT01259713|157046482|FG001|Overall Study|Death Not Related to IFI|1|||
48782772|NCT01259713|157046481|FG000|Overall Study|Investigators Discretion|14|||
48782773|NCT01259713|157046482|FG001|Overall Study|Investigators Discretion|6|||
48782774|NCT01259713|157046481|FG000|Overall Study|Lack of Efficacy|2|||
48782775|NCT01259713|157046482|FG001|Overall Study|Lack of Efficacy|0|||
48782776|NCT01259713|157046481|FG000|Overall Study|Protocol Violation|5|||
48782777|NCT01259713|157046482|FG001|Overall Study|Protocol Violation|4|||
48782778|NCT01259713|157046481|FG000|Overall Study|Subject Withdrew Consent|12|||
48782779|NCT01259713|157046482|FG001|Overall Study|Subject Withdrew Consent|7|||
48782780|NCT01722331|157046483|FG000|Part 1|Adverse Event|5|||
48782781|NCT01722331|157046484|FG001|Part 1|Adverse Event|0|||
48782782|NCT01722331|157046485|FG002|Part 1|Adverse Event|0|||
48782783|NCT01722331|157046486|FG003|Part 1|Adverse Event|0|||
48356679|NCT03332784|155501132|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
48356680|NCT02920970|155501133|FG000|First Intervention|Protocol Violation|0|||
48356681|NCT02920970|155501134|FG001|First Intervention|Protocol Violation|1|||
48356682|NCT02920970|155501133|FG000|First Intervention|Adverse Event|0|||
48356683|NCT02920970|155501134|FG001|First Intervention|Adverse Event|1|||
48356684|NCT02920970|155501133|FG000|Second Intervention|Poor Lens Fit|1|||
48356685|NCT02920970|155501134|FG001|Second Intervention|Poor Lens Fit|0|||
48356686|NCT01969851|155501139|FG000|Overall Study|Adverse Event|0|||
48356687|NCT01969851|155501140|FG001|Overall Study|Adverse Event|0|||
48356688|NCT01969851|155501141|FG002|Overall Study|Adverse Event|3|||
48356689|NCT01969851|155501139|FG000|Overall Study|Lack of Efficacy|0|||
48356690|NCT01969851|155501140|FG001|Overall Study|Lack of Efficacy|3|||
48356691|NCT01969851|155501141|FG002|Overall Study|Lack of Efficacy|1|||
48356692|NCT01969851|155501139|FG000|Overall Study|Withdrawal by Subject|1|||
48356693|NCT01969851|155501140|FG001|Overall Study|Withdrawal by Subject|0|||
48356694|NCT01969851|155501141|FG002|Overall Study|Withdrawal by Subject|1|||
48356695|NCT01969851|155501139|FG000|Overall Study|No effective dose in Titration period|0|||
48356696|NCT01969851|155501140|FG001|Overall Study|No effective dose in Titration period|0|||
48356697|NCT01969851|155501141|FG002|Overall Study|No effective dose in Titration period|1|||
48356698|NCT01969851|155501139|FG000|Overall Study|Sponsor decision|0|||
48356699|NCT01969851|155501140|FG001|Overall Study|Sponsor decision|0|||
48356700|NCT01969851|155501141|FG002|Overall Study|Sponsor decision|1|||
48356701|NCT00208325|155501142|FG000|Overall Study|Death|18|||
48356702|NCT00208325|155501143|FG001|Overall Study|Death|19|||
48356703|NCT00208325|155501144|FG002|Overall Study|Death|7|||
48356704|NCT00208325|155501145|FG003|Overall Study|Death|5|||
48398978|NCT02064387|155653409|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
48782784|NCT01722331|157046487|FG004|Part 1|Adverse Event|0|||
48782785|NCT01722331|157046488|FG005|Part 1|Adverse Event|0|||
48782786|NCT01722331|157046489|FG006|Part 1|Adverse Event|0|||
48398979|NCT00749996|155653414|FG000|Overall Study|Lost to Follow-up|7|||
48398980|NCT00749996|155653415|FG001|Overall Study|Lost to Follow-up|4|||
48398981|NCT00749996|155653414|FG000|Overall Study|Withdrawal by Subject|5|||
48398982|NCT00749996|155653415|FG001|Overall Study|Withdrawal by Subject|4|||
48398983|NCT00749996|155653414|FG000|Overall Study|Protocol Violation|2|||
48398984|NCT00749996|155653415|FG001|Overall Study|Protocol Violation|3|||
48398985|NCT00749996|155653414|FG000|Overall Study|Physician Decision|2|||
48398986|NCT00749996|155653415|FG001|Overall Study|Physician Decision|0|||
48398987|NCT00749996|155653414|FG000|Overall Study|Pregnancy|0|||
48398988|NCT00749996|155653415|FG001|Overall Study|Pregnancy|2|||
48398989|NCT00749996|155653414|FG000|Overall Study|Adverse Event|1|||
48782787|NCT01722331|157046483|FG000|Part 1|Lack of Efficacy|0|||
48782788|NCT01722331|157046484|FG001|Part 1|Lack of Efficacy|0|||
48782789|NCT01722331|157046485|FG002|Part 1|Lack of Efficacy|1|||
48782790|NCT01722331|157046486|FG003|Part 1|Lack of Efficacy|0|||
48782791|NCT01722331|157046487|FG004|Part 1|Lack of Efficacy|2|||
48782792|NCT01722331|157046488|FG005|Part 1|Lack of Efficacy|0|||
48782793|NCT01722331|157046489|FG006|Part 1|Lack of Efficacy|0|||
48782794|NCT01722331|157046483|FG000|Part 1|Lost to Follow-up|1|||
48782795|NCT01722331|157046484|FG001|Part 1|Lost to Follow-up|0|||
48782796|NCT01722331|157046485|FG002|Part 1|Lost to Follow-up|2|||
48398990|NCT00749996|155653415|FG001|Overall Study|Adverse Event|0|||
48398991|NCT00749996|155653414|FG000|Overall Study|Death|1|||
48398992|NCT00749996|155653415|FG001|Overall Study|Death|0|||
48398993|NCT03436862|155653417|FG000|Overall Study|Adverse Event|4|||
48398994|NCT03436862|155653417|FG000|Overall Study|Progressive Disease|2|||
48398995|NCT01692301|155653418|FG000|Overall Study|Adverse Event|15|||
48782797|NCT01722331|157046486|FG003|Part 1|Lost to Follow-up|0|||
48782798|NCT01722331|157046487|FG004|Part 1|Lost to Follow-up|1|||
48782799|NCT01722331|157046488|FG005|Part 1|Lost to Follow-up|0|||
48782800|NCT01722331|157046489|FG006|Part 1|Lost to Follow-up|0|||
48782801|NCT01722331|157046483|FG000|Part 1|Physician Decision|0|||
48782802|NCT01722331|157046484|FG001|Part 1|Physician Decision|0|||
48782803|NCT01722331|157046485|FG002|Part 1|Physician Decision|3|||
48782804|NCT01722331|157046486|FG003|Part 1|Physician Decision|0|||
48782805|NCT01722331|157046487|FG004|Part 1|Physician Decision|1|||
48782806|NCT01722331|157046488|FG005|Part 1|Physician Decision|0|||
48782807|NCT01722331|157046489|FG006|Part 1|Physician Decision|0|||
48782808|NCT01722331|157046483|FG000|Part 1|Pregnancy|1|||
48782809|NCT01722331|157046484|FG001|Part 1|Pregnancy|0|||
48782810|NCT01722331|157046485|FG002|Part 1|Pregnancy|0|||
48782811|NCT01722331|157046486|FG003|Part 1|Pregnancy|0|||
48782812|NCT01722331|157046487|FG004|Part 1|Pregnancy|0|||
48782813|NCT01722331|157046488|FG005|Part 1|Pregnancy|0|||
48782814|NCT01722331|157046489|FG006|Part 1|Pregnancy|0|||
48782815|NCT01722331|157046483|FG000|Part 1|Progressive Disease|0|||
48782816|NCT01722331|157046484|FG001|Part 1|Progressive Disease|0|||
48782817|NCT01722331|157046485|FG002|Part 1|Progressive Disease|0|||
48782818|NCT01722331|157046486|FG003|Part 1|Progressive Disease|0|||
48782819|NCT01722331|157046487|FG004|Part 1|Progressive Disease|1|||
48782820|NCT01722331|157046488|FG005|Part 1|Progressive Disease|0|||
48782821|NCT01722331|157046489|FG006|Part 1|Progressive Disease|0|||
48782822|NCT01722331|157046483|FG000|Part 1|Protocol Violation|1|||
48782823|NCT01722331|157046484|FG001|Part 1|Protocol Violation|0|||
48782824|NCT01722331|157046485|FG002|Part 1|Protocol Violation|0|||
48782825|NCT01722331|157046486|FG003|Part 1|Protocol Violation|0|||
48782826|NCT01722331|157046487|FG004|Part 1|Protocol Violation|1|||
48782827|NCT01722331|157046488|FG005|Part 1|Protocol Violation|0|||
48782828|NCT01722331|157046489|FG006|Part 1|Protocol Violation|0|||
48782829|NCT01722331|157046483|FG000|Part 1|Withdrawal by Subject|2|||
48782830|NCT01722331|157046484|FG001|Part 1|Withdrawal by Subject|0|||
48398996|NCT01692301|155653419|FG001|Overall Study|Adverse Event|12|||
48398997|NCT01692301|155653418|FG000|Overall Study|Death|1|||
48398998|NCT01692301|155653419|FG001|Overall Study|Death|2|||
48398999|NCT01692301|155653418|FG000|Overall Study|Lack of Efficacy|0|||
48399000|NCT01692301|155653419|FG001|Overall Study|Lack of Efficacy|5|||
48782831|NCT01722331|157046485|FG002|Part 1|Withdrawal by Subject|3|||
48782832|NCT01722331|157046486|FG003|Part 1|Withdrawal by Subject|0|||
48782833|NCT01722331|157046487|FG004|Part 1|Withdrawal by Subject|3|||
48782834|NCT01722331|157046488|FG005|Part 1|Withdrawal by Subject|0|||
48782835|NCT01722331|157046489|FG006|Part 1|Withdrawal by Subject|0|||
48399001|NCT01692301|155653418|FG000|Overall Study|Non-compliance with study treatment|1|||
48399002|NCT01692301|155653419|FG001|Overall Study|Non-compliance with study treatment|2|||
48399003|NCT01692301|155653418|FG000|Overall Study|Protocol deviation|9|||
48782836|NCT01722331|157046483|FG000|Part 2|Adverse Event|3|||
48782837|NCT01722331|157046484|FG001|Part 2|Adverse Event|0|||
48782838|NCT01722331|157046485|FG002|Part 2|Adverse Event|0|||
48782839|NCT01722331|157046486|FG003|Part 2|Adverse Event|0|||
48399004|NCT01692301|155653419|FG001|Overall Study|Protocol deviation|2|||
48782840|NCT01722331|157046487|FG004|Part 2|Adverse Event|0|||
48782841|NCT01722331|157046488|FG005|Part 2|Adverse Event|1|||
48782842|NCT01722331|157046489|FG006|Part 2|Adverse Event|0|||
48782843|NCT01722331|157046483|FG000|Part 2|Lack of Efficacy|3|||
48782844|NCT01722331|157046484|FG001|Part 2|Lack of Efficacy|0|||
48782845|NCT01722331|157046485|FG002|Part 2|Lack of Efficacy|11|||
48399005|NCT01692301|155653418|FG000|Overall Study|Patient/guardian decision|16|||
48399006|NCT01692301|155653419|FG001|Overall Study|Patient/guardian decision|15|||
48399007|NCT01692301|155653418|FG000|Overall Study|Technical problems|0|||
48399008|NCT01692301|155653419|FG001|Overall Study|Technical problems|1|||
48399009|NCT01692301|155653418|FG000|Overall Study|Physician Decision|2|||
48399010|NCT01692301|155653419|FG001|Overall Study|Physician Decision|2|||
48399011|NCT01692301|155653418|FG000|Overall Study|Lost to Follow-up|1|||
48399012|NCT01692301|155653419|FG001|Overall Study|Lost to Follow-up|1|||
48399013|NCT02867995|155653427|FG000|Overall Study|Withdrawal by Subject|0|||
48399014|NCT02867995|155653428|FG001|Overall Study|Withdrawal by Subject|1|||
48399015|NCT02867995|155653427|FG000|Overall Study|Lost to Follow-up|0|||
48399016|NCT02867995|155653428|FG001|Overall Study|Lost to Follow-up|2|||
48399017|NCT02926950|155653431|FG000|Overall Study|Adverse Event|4|||
48399018|NCT02926950|155653432|FG001|Overall Study|Adverse Event|6|||
48782846|NCT01722331|157046486|FG003|Part 2|Lack of Efficacy|0|||
48782847|NCT01722331|157046487|FG004|Part 2|Lack of Efficacy|0|||
48782848|NCT01722331|157046488|FG005|Part 2|Lack of Efficacy|3|||
48782849|NCT01722331|157046489|FG006|Part 2|Lack of Efficacy|3|||
48782850|NCT01722331|157046483|FG000|Part 2|Lost to Follow-up|0|||
48782851|NCT01722331|157046484|FG001|Part 2|Lost to Follow-up|0|||
48782852|NCT01722331|157046485|FG002|Part 2|Lost to Follow-up|3|||
48782853|NCT01722331|157046486|FG003|Part 2|Lost to Follow-up|0|||
48782854|NCT01722331|157046487|FG004|Part 2|Lost to Follow-up|0|||
48782855|NCT01722331|157046488|FG005|Part 2|Lost to Follow-up|1|||
48782856|NCT01722331|157046489|FG006|Part 2|Lost to Follow-up|1|||
48782857|NCT01722331|157046483|FG000|Part 2|Non-Compliance with Study Drug|1|||
48782858|NCT01722331|157046484|FG001|Part 2|Non-Compliance with Study Drug|0|||
48782859|NCT01722331|157046485|FG002|Part 2|Non-Compliance with Study Drug|1|||
48782860|NCT01722331|157046486|FG003|Part 2|Non-Compliance with Study Drug|0|||
48782861|NCT01722331|157046487|FG004|Part 2|Non-Compliance with Study Drug|0|||
48399019|NCT02926950|155653431|FG000|Overall Study|At the participant's own request|21|||
48399020|NCT02926950|155653432|FG001|Overall Study|At the participant's own request|25|||
48782862|NCT01722331|157046488|FG005|Part 2|Non-Compliance with Study Drug|0|||
48399021|NCT02926950|155653431|FG000|Overall Study|Reason not Specified|17|||
48399022|NCT02926950|155653432|FG001|Overall Study|Reason not Specified|9|||
48399023|NCT02926950|155653431|FG000|Overall Study|Lost to Follow-up|7|||
48399024|NCT02926950|155653432|FG001|Overall Study|Lost to Follow-up|8|||
48399025|NCT01777581|155653433|FG000|Overall Study|Lost to Follow-up|1|||
48399026|NCT01777581|155653434|FG001|Overall Study|Lost to Follow-up|1|||
48399027|NCT01777581|155653433|FG000|Overall Study|Adverse Event|2|||
48399028|NCT01777581|155653434|FG001|Overall Study|Adverse Event|0|||
48782863|NCT01722331|157046489|FG006|Part 2|Non-Compliance with Study Drug|0|||
48782864|NCT01722331|157046483|FG000|Part 2|Physician Decision|0|||
48399029|NCT01777581|155653433|FG000|Overall Study|Lack of Efficacy|0|||
48399030|NCT01777581|155653434|FG001|Overall Study|Lack of Efficacy|1|||
48399031|NCT00993031|155653435|FG000|Overall Study|Death|0|||
48399032|NCT00993031|155653436|FG001|Overall Study|Death|1|||
48399033|NCT00993031|155653435|FG000|Overall Study|Physician Decision|0|||
48399034|NCT00993031|155653436|FG001|Overall Study|Physician Decision|2|||
48399035|NCT00993031|155653435|FG000|Overall Study|Withdrawal by Subject|3|||
48782865|NCT01722331|157046484|FG001|Part 2|Physician Decision|0|||
48782866|NCT01722331|157046485|FG002|Part 2|Physician Decision|2|||
48782867|NCT01722331|157046486|FG003|Part 2|Physician Decision|0|||
48782868|NCT01722331|157046487|FG004|Part 2|Physician Decision|0|||
48782869|NCT01722331|157046488|FG005|Part 2|Physician Decision|0|||
48782870|NCT01722331|157046489|FG006|Part 2|Physician Decision|0|||
48782871|NCT01722331|157046483|FG000|Part 2|Pregnancy|0|||
48782872|NCT01722331|157046484|FG001|Part 2|Pregnancy|0|||
48782873|NCT01722331|157046485|FG002|Part 2|Pregnancy|0|||
48782874|NCT01722331|157046486|FG003|Part 2|Pregnancy|0|||
48782875|NCT01722331|157046487|FG004|Part 2|Pregnancy|0|||
48782876|NCT01722331|157046488|FG005|Part 2|Pregnancy|1|||
48782877|NCT01722331|157046489|FG006|Part 2|Pregnancy|0|||
48782878|NCT01722331|157046483|FG000|Part 2|Progressive Disease|0|||
48782879|NCT01722331|157046484|FG001|Part 2|Progressive Disease|0|||
48399036|NCT00993031|155653436|FG001|Overall Study|Withdrawal by Subject|3|||
48399037|NCT00993031|155653435|FG000|Overall Study|Lost to Follow-up|19|||
48399038|NCT00993031|155653436|FG001|Overall Study|Lost to Follow-up|13|||
48782880|NCT01722331|157046485|FG002|Part 2|Progressive Disease|1|||
48399039|NCT01568593|155653437|FG000|Overall Study|Lack of Efficacy|4|||
48782881|NCT01722331|157046486|FG003|Part 2|Progressive Disease|0|||
48782882|NCT01722331|157046487|FG004|Part 2|Progressive Disease|0|||
48399040|NCT01568593|155653438|FG001|Overall Study|Lack of Efficacy|1|||
48399041|NCT01568593|155653437|FG000|Overall Study|Adverse Event|3|||
48782883|NCT01722331|157046488|FG005|Part 2|Progressive Disease|0|||
48782884|NCT01722331|157046489|FG006|Part 2|Progressive Disease|0|||
48782885|NCT01722331|157046483|FG000|Part 2|Protocol Violation|1|||
48782886|NCT01722331|157046484|FG001|Part 2|Protocol Violation|0|||
48782887|NCT01722331|157046485|FG002|Part 2|Protocol Violation|0|||
48782888|NCT01722331|157046486|FG003|Part 2|Protocol Violation|0|||
48782889|NCT01722331|157046487|FG004|Part 2|Protocol Violation|0|||
48782890|NCT01722331|157046488|FG005|Part 2|Protocol Violation|0|||
48782891|NCT01722331|157046489|FG006|Part 2|Protocol Violation|0|||
48782892|NCT01722331|157046483|FG000|Part 2|Withdrawal by Subject|5|||
48782893|NCT01722331|157046484|FG001|Part 2|Withdrawal by Subject|0|||
48782894|NCT01722331|157046485|FG002|Part 2|Withdrawal by Subject|3|||
48782895|NCT01722331|157046486|FG003|Part 2|Withdrawal by Subject|0|||
48782896|NCT01722331|157046487|FG004|Part 2|Withdrawal by Subject|0|||
48782897|NCT01722331|157046488|FG005|Part 2|Withdrawal by Subject|2|||
48782898|NCT01722331|157046489|FG006|Part 2|Withdrawal by Subject|2|||
48782899|NCT01722331|157046483|FG000|Part 2|Other Protocol Specified Criteria|6|||
48782900|NCT01722331|157046484|FG001|Part 2|Other Protocol Specified Criteria|0|||
48782901|NCT01722331|157046485|FG002|Part 2|Other Protocol Specified Criteria|10|||
48782902|NCT01722331|157046486|FG003|Part 2|Other Protocol Specified Criteria|0|||
48782903|NCT01722331|157046487|FG004|Part 2|Other Protocol Specified Criteria|0|||
48782904|NCT01722331|157046488|FG005|Part 2|Other Protocol Specified Criteria|2|||
48782905|NCT01722331|157046489|FG006|Part 2|Other Protocol Specified Criteria|1|||
48782906|NCT01722331|157046483|FG000|Part 3|Adverse Event|2|||
48782907|NCT01722331|157046484|FG001|Part 3|Adverse Event|2|||
48782908|NCT01722331|157046485|FG002|Part 3|Adverse Event|0|||
48782909|NCT01722331|157046486|FG003|Part 3|Adverse Event|1|||
48782910|NCT01722331|157046487|FG004|Part 3|Adverse Event|0|||
48782911|NCT01722331|157046488|FG005|Part 3|Adverse Event|0|||
48782912|NCT01722331|157046489|FG006|Part 3|Adverse Event|0|||
48782913|NCT01722331|157046483|FG000|Part 3|Death|1|||
48782914|NCT01722331|157046484|FG001|Part 3|Death|0|||
48782915|NCT01722331|157046485|FG002|Part 3|Death|0|||
48782916|NCT01722331|157046486|FG003|Part 3|Death|0|||
48782917|NCT01722331|157046487|FG004|Part 3|Death|0|||
48782918|NCT01722331|157046488|FG005|Part 3|Death|0|||
48399042|NCT01568593|155653438|FG001|Overall Study|Adverse Event|2|||
48782919|NCT01722331|157046489|FG006|Part 3|Death|0|||
48782920|NCT01722331|157046483|FG000|Part 3|Lack of Efficacy|1|||
48782921|NCT01722331|157046484|FG001|Part 3|Lack of Efficacy|0|||
48782922|NCT01722331|157046485|FG002|Part 3|Lack of Efficacy|0|||
48782923|NCT01722331|157046486|FG003|Part 3|Lack of Efficacy|0|||
48782924|NCT01722331|157046487|FG004|Part 3|Lack of Efficacy|0|||
48782925|NCT01722331|157046488|FG005|Part 3|Lack of Efficacy|0|||
48782926|NCT01722331|157046489|FG006|Part 3|Lack of Efficacy|0|||
48782927|NCT01722331|157046483|FG000|Part 3|Lost to Follow-up|3|||
48782928|NCT01722331|157046484|FG001|Part 3|Lost to Follow-up|4|||
48782929|NCT01722331|157046485|FG002|Part 3|Lost to Follow-up|0|||
48782930|NCT01722331|157046486|FG003|Part 3|Lost to Follow-up|0|||
48782931|NCT01722331|157046487|FG004|Part 3|Lost to Follow-up|0|||
48399043|NCT02971670|155653439|FG000|Overall Study|Withdrawal by Subject|4|||
48782932|NCT01722331|157046488|FG005|Part 3|Lost to Follow-up|1|||
48782933|NCT01722331|157046489|FG006|Part 3|Lost to Follow-up|0|||
48782934|NCT01722331|157046483|FG000|Part 3|Non-Compliance with Study Drug|0|||
48782935|NCT01722331|157046484|FG001|Part 3|Non-Compliance with Study Drug|1|||
48782936|NCT01722331|157046485|FG002|Part 3|Non-Compliance with Study Drug|0|||
48782937|NCT01722331|157046486|FG003|Part 3|Non-Compliance with Study Drug|0|||
48782938|NCT01722331|157046487|FG004|Part 3|Non-Compliance with Study Drug|0|||
48782939|NCT01722331|157046488|FG005|Part 3|Non-Compliance with Study Drug|0|||
48399044|NCT02971670|155653440|FG001|Overall Study|Withdrawal by Subject|1|||
48399045|NCT02971670|155653441|FG002|Overall Study|Withdrawal by Subject|1|||
48399046|NCT02971670|155653442|FG003|Overall Study|Withdrawal by Subject|2|||
48399047|NCT05779072|155653444|FG000|Overall Study|Lost to Follow-up|0|||
48399048|NCT05779072|155653445|FG001|Overall Study|Lost to Follow-up|1|||
48399049|NCT05779072|155653444|FG000|Overall Study|Withdrawal by Subject|1|||
48782940|NCT01722331|157046489|FG006|Part 3|Non-Compliance with Study Drug|0|||
48399050|NCT05779072|155653445|FG001|Overall Study|Withdrawal by Subject|5|||
48399051|NCT00506883|155653446|FG000|Overall Study|Lost to Follow-up|1|||
48782941|NCT01722331|157046483|FG000|Part 3|Physician Decision|1|||
48782942|NCT01722331|157046484|FG001|Part 3|Physician Decision|1|||
48782943|NCT01722331|157046485|FG002|Part 3|Physician Decision|0|||
48782944|NCT01722331|157046486|FG003|Part 3|Physician Decision|0|||
48782945|NCT01722331|157046487|FG004|Part 3|Physician Decision|0|||
48782946|NCT01722331|157046488|FG005|Part 3|Physician Decision|0|||
48782947|NCT01722331|157046489|FG006|Part 3|Physician Decision|1|||
48782948|NCT01722331|157046483|FG000|Part 3|Protocol Violation|2|||
48782949|NCT01722331|157046484|FG001|Part 3|Protocol Violation|1|||
48782950|NCT01722331|157046485|FG002|Part 3|Protocol Violation|0|||
48782951|NCT01722331|157046486|FG003|Part 3|Protocol Violation|0|||
48782952|NCT01722331|157046487|FG004|Part 3|Protocol Violation|0|||
48782953|NCT01722331|157046488|FG005|Part 3|Protocol Violation|0|||
48782954|NCT01722331|157046489|FG006|Part 3|Protocol Violation|0|||
48782955|NCT01722331|157046483|FG000|Part 3|Withdrawal by Subject|4|||
48782956|NCT01722331|157046484|FG001|Part 3|Withdrawal by Subject|7|||
48782957|NCT01722331|157046485|FG002|Part 3|Withdrawal by Subject|0|||
48782958|NCT01722331|157046486|FG003|Part 3|Withdrawal by Subject|0|||
48782959|NCT01722331|157046487|FG004|Part 3|Withdrawal by Subject|0|||
48782960|NCT01722331|157046488|FG005|Part 3|Withdrawal by Subject|2|||
48782961|NCT01722331|157046489|FG006|Part 3|Withdrawal by Subject|1|||
48782962|NCT01722331|157046483|FG000|Part 3|Other Protocol Specified Criteria|1|||
48782963|NCT01722331|157046484|FG001|Part 3|Other Protocol Specified Criteria|1|||
48782964|NCT01722331|157046485|FG002|Part 3|Other Protocol Specified Criteria|0|||
48782965|NCT01722331|157046486|FG003|Part 3|Other Protocol Specified Criteria|0|||
48782966|NCT01722331|157046487|FG004|Part 3|Other Protocol Specified Criteria|0|||
48782967|NCT01722331|157046488|FG005|Part 3|Other Protocol Specified Criteria|0|||
48782968|NCT01722331|157046489|FG006|Part 3|Other Protocol Specified Criteria|0|||
48782969|NCT02246998|157046490|FG000|Overall Study|Adverse Event|0|||
48782970|NCT02246998|157046491|FG001|Overall Study|Adverse Event|1|||
48782971|NCT02246998|157046492|FG002|Overall Study|Adverse Event|1|||
48782972|NCT02246998|157046493|FG003|Overall Study|Adverse Event|0|||
48782973|NCT02246998|157046490|FG000|Overall Study|Lost to Follow-up|1|||
48782974|NCT02246998|157046491|FG001|Overall Study|Lost to Follow-up|0|||
48782975|NCT02246998|157046492|FG002|Overall Study|Lost to Follow-up|0|||
48782976|NCT02246998|157046493|FG003|Overall Study|Lost to Follow-up|1|||
48782977|NCT02246998|157046490|FG000|Overall Study|Randomized but Never Dosed|1|||
48782978|NCT02246998|157046491|FG001|Overall Study|Randomized but Never Dosed|2|||
48782979|NCT02246998|157046492|FG002|Overall Study|Randomized but Never Dosed|2|||
48782980|NCT02246998|157046493|FG003|Overall Study|Randomized but Never Dosed|1|||
48782981|NCT01154166|157046495|FG000|Overall Study|Adverse Event|14|||
48782982|NCT01154166|157046496|FG001|Overall Study|Adverse Event|9|||
48782983|NCT01154166|157046495|FG000|Overall Study|Lost to Follow-up|1|||
48782984|NCT01154166|157046496|FG001|Overall Study|Lost to Follow-up|1|||
48782985|NCT01154166|157046495|FG000|Overall Study|Protocol Violation|4|||
48782986|NCT01154166|157046496|FG001|Overall Study|Protocol Violation|1|||
48782987|NCT01154166|157046495|FG000|Overall Study|Withdrawal by Subject|10|||
48782988|NCT01154166|157046496|FG001|Overall Study|Withdrawal by Subject|1|||
48782989|NCT01154166|157046495|FG000|Overall Study|Lack of Efficacy|3|||
48399052|NCT00506883|155653447|FG001|Overall Study|Lost to Follow-up|1|||
48399053|NCT00506883|155653448|FG002|Overall Study|Lost to Follow-up|1|||
48782990|NCT01154166|157046496|FG001|Overall Study|Lack of Efficacy|0|||
48782991|NCT01154166|157046495|FG000|Overall Study|Disease Progression|1|||
48782992|NCT01154166|157046496|FG001|Overall Study|Disease Progression|0|||
48782993|NCT01154166|157046495|FG000|Overall Study|Poor Compliance|1|||
48782994|NCT01154166|157046496|FG001|Overall Study|Poor Compliance|0|||
48782995|NCT04121962|157046497|FG000|Overall Study|Lost to Follow-up|42|||
48782996|NCT04121962|157046498|FG001|Overall Study|Lost to Follow-up|39|||
48399054|NCT00506883|155653446|FG000|Overall Study|Withdrawal by Subject|1|||
48399055|NCT00506883|155653447|FG001|Overall Study|Withdrawal by Subject|0|||
48783000|NCT03701555|157046504|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
48783001|NCT03701555|157046505|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
48399056|NCT00506883|155653448|FG002|Overall Study|Withdrawal by Subject|1|||
48783002|NCT03701555|157046506|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
48783003|NCT03701555|157046507|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
48783004|NCT03701555|157046508|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
48783005|NCT03701555|157046509|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
48783006|NCT03701555|157046510|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
48783007|NCT03701555|157046511|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
48399057|NCT00506883|155653446|FG000|Overall Study|Lack of Efficacy|0|||
48399058|NCT00506883|155653447|FG001|Overall Study|Lack of Efficacy|1|||
48399059|NCT00506883|155653448|FG002|Overall Study|Lack of Efficacy|1|||
48399060|NCT00506883|155653446|FG000|Overall Study|Other|5|||
48399061|NCT00506883|155653447|FG001|Overall Study|Other|1|||
48783008|NCT03701555|157046512|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
48783009|NCT03701555|157046513|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
48399062|NCT00506883|155653448|FG002|Overall Study|Other|1|||
48783010|NCT03701555|157046514|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
48783011|NCT03701555|157046515|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
48783012|NCT03701555|157046516|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
48783013|NCT03701555|157046517|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
48399063|NCT03713944|155653449|FG000|Study Treatment|Patient non-compliance|1|||
48399064|NCT03713944|155653449|FG000|Study Treatment|Alternative Cancer Therapy|3|||
48399065|NCT03713944|155653449|FG000|Study Treatment|Disease Progression|18|||
48399066|NCT03713944|155653449|FG000|Study Treatment|AE/Side Effects/Complications|2|||
48399067|NCT03713944|155653449|FG000|Study Treatment|Death|2|||
48399068|NCT03713944|155653449|FG000|Study Treatment|Withdrawal by Subject|1|||
48399069|NCT03713944|155653449|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
48399070|NCT03713944|155653449|FG000|Study Treatment|Symptomatic Deterioration|2|||
48399071|NCT03713944|155653449|FG000|Follow up|Withdrawal by Subject|2|||
48783014|NCT03701555|157046518|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
48783015|NCT03701555|157046519|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
48783016|NCT03701555|157046520|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
48399072|NCT03713944|155653449|FG000|Follow up|Death|11|||
48399073|NCT03713944|155653449|FG000|Follow up|Study Terminated|3|||
48783017|NCT03701555|157046521|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
48783018|NCT03701555|157046522|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
48783019|NCT03701555|157046523|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
48783020|NCT03701555|157046524|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
48783021|NCT03701555|157046525|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
48783022|NCT03701555|157046526|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
48783023|NCT03701555|157046527|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
48783024|NCT03701555|157046528|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
48399074|NCT02004873|155653450|FG000|Overall Study|Implant unsuccessful|6|||
48399075|NCT02004873|155653450|FG000|Overall Study|Awaiting 6-month visit|390|||
48399076|NCT02004873|155653450|FG000|Overall Study|Missed 6-month visit|4|||
48783025|NCT03701555|157046529|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
48783026|NCT03701555|157046530|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
48783027|NCT03701555|157046531|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
48783028|NCT03701555|157046532|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
48783029|NCT03701555|157046533|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
48783030|NCT03701555|157046534|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
48783031|NCT03701555|157046535|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
48783032|NCT03701555|157046536|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
48783033|NCT03701555|157046537|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
48783034|NCT03701555|157046538|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
48783035|NCT03701555|157046539|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
48783036|NCT03701555|157046504|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
48783037|NCT03701555|157046505|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
48783038|NCT03701555|157046506|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
48783039|NCT03701555|157046507|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
48783040|NCT03701555|157046508|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
48783041|NCT03701555|157046509|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
48783042|NCT03701555|157046510|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
48783043|NCT03701555|157046511|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
48783044|NCT03701555|157046512|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
48783045|NCT03701555|157046513|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
48783046|NCT03701555|157046514|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
48783047|NCT03701555|157046515|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
48783048|NCT03701555|157046516|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
48399077|NCT02004873|155653450|FG000|Overall Study|Death|23|||
48399078|NCT02004873|155653450|FG000|Overall Study|Withdrawal by Subject|1|||
48399079|NCT01353703|155653451|FG000|Overall Study|Migrated/moved from study area|1|||
48399080|NCT01353703|155653452|FG001|Overall Study|Migrated/moved from study area|0|||
48399081|NCT00487539|155653455|FG000|Overall Study|Adverse Event|3|||
48783049|NCT03701555|157046517|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
48783050|NCT03701555|157046518|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
48783051|NCT03701555|157046519|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
48783052|NCT03701555|157046520|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
48783053|NCT03701555|157046521|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
48783054|NCT03701555|157046522|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
48783055|NCT03701555|157046523|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
48783056|NCT03701555|157046524|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
48399082|NCT00487539|155653456|FG001|Overall Study|Adverse Event|2|||
48783057|NCT03701555|157046525|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
48783058|NCT03701555|157046526|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
48399083|NCT00487539|155653457|FG002|Overall Study|Adverse Event|1|||
48783059|NCT03701555|157046527|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
48783060|NCT03701555|157046528|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
48783061|NCT03701555|157046529|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
48783062|NCT03701555|157046530|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
48783063|NCT03701555|157046531|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
48783064|NCT03701555|157046532|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
48783065|NCT03701555|157046533|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
48783066|NCT03701555|157046534|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
48783067|NCT03701555|157046535|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
48783068|NCT03701555|157046536|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
48783069|NCT03701555|157046537|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
48783070|NCT03701555|157046538|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
48783071|NCT03701555|157046539|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
48783072|NCT03701555|157046504|FG000|Part 2 (Day 1)|Other|0|||
48783073|NCT03701555|157046505|FG001|Part 2 (Day 1)|Other|0|||
48783074|NCT03701555|157046506|FG002|Part 2 (Day 1)|Other|0|||
48783075|NCT03701555|157046507|FG003|Part 2 (Day 1)|Other|0|||
48783076|NCT03701555|157046508|FG004|Part 2 (Day 1)|Other|0|||
48783077|NCT03701555|157046509|FG005|Part 2 (Day 1)|Other|0|||
48783078|NCT03701555|157046510|FG006|Part 2 (Day 1)|Other|0|||
48783079|NCT03701555|157046511|FG007|Part 2 (Day 1)|Other|0|||
48783080|NCT03701555|157046512|FG008|Part 2 (Day 1)|Other|0|||
48783081|NCT03701555|157046513|FG009|Part 2 (Day 1)|Other|0|||
48783082|NCT03701555|157046514|FG010|Part 2 (Day 1)|Other|3|||
48783083|NCT03701555|157046515|FG011|Part 2 (Day 1)|Other|1|||
48783084|NCT03701555|157046516|FG012|Part 2 (Day 1)|Other|0|||
48783085|NCT03701555|157046517|FG013|Part 2 (Day 1)|Other|1|||
48783086|NCT03701555|157046518|FG014|Part 2 (Day 1)|Other|0|||
48783087|NCT03701555|157046519|FG015|Part 2 (Day 1)|Other|2|||
48783088|NCT03701555|157046520|FG016|Part 2 (Day 1)|Other|2|||
48783089|NCT03701555|157046521|FG017|Part 2 (Day 1)|Other|0|||
48783090|NCT03701555|157046522|FG018|Part 2 (Day 1)|Other|0|||
48783091|NCT03701555|157046523|FG019|Part 2 (Day 1)|Other|0|||
48783092|NCT03701555|157046524|FG020|Part 2 (Day 1)|Other|0|||
48783093|NCT03701555|157046525|FG021|Part 2 (Day 1)|Other|0|||
48783094|NCT03701555|157046526|FG022|Part 2 (Day 1)|Other|0|||
48783095|NCT03701555|157046527|FG023|Part 2 (Day 1)|Other|0|||
48783096|NCT03701555|157046528|FG024|Part 2 (Day 1)|Other|0|||
48783097|NCT03701555|157046529|FG025|Part 2 (Day 1)|Other|0|||
48783098|NCT03701555|157046530|FG026|Part 2 (Day 1)|Other|0|||
48783099|NCT03701555|157046531|FG027|Part 2 (Day 1)|Other|0|||
48783100|NCT03701555|157046532|FG028|Part 2 (Day 1)|Other|0|||
48783101|NCT03701555|157046533|FG029|Part 2 (Day 1)|Other|0|||
48783102|NCT03701555|157046534|FG030|Part 2 (Day 1)|Other|0|||
48783103|NCT03701555|157046535|FG031|Part 2 (Day 1)|Other|0|||
48783104|NCT03701555|157046536|FG032|Part 2 (Day 1)|Other|0|||
48783105|NCT03701555|157046537|FG033|Part 2 (Day 1)|Other|0|||
48783106|NCT03701555|157046538|FG034|Part 2 (Day 1)|Other|0|||
48783107|NCT03701555|157046539|FG035|Part 2 (Day 1)|Other|0|||
48783108|NCT03701555|157046504|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
48783109|NCT03701555|157046505|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
48783110|NCT03701555|157046506|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
48783111|NCT03701555|157046507|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
48399084|NCT00487539|155653458|FG003|Overall Study|Adverse Event|1|||
48399085|NCT00487539|155653455|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48399086|NCT00487539|155653456|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48399087|NCT00487539|155653457|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48399088|NCT00487539|155653458|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
48399089|NCT00487539|155653455|FG000|Overall Study|Other|3|||
48399090|NCT00487539|155653456|FG001|Overall Study|Other|1|||
48399091|NCT00487539|155653457|FG002|Overall Study|Other|2|||
48399092|NCT00487539|155653458|FG003|Overall Study|Other|2|||
48399093|NCT02175680|155653462|FG000|Overall Study|non-compliance|1|||
48399094|NCT02175680|155653462|FG000|Overall Study|other non-medical reason|1|||
48399095|NCT01665144|155653463|FG000|Core Part|Withdrawal by Subject|96|||
48399096|NCT01665144|155653464|FG001|Core Part|Withdrawal by Subject|77|||
48399097|NCT01665144|155653465|FG002|Core Part|Withdrawal by Subject|0|||
48783112|NCT03701555|157046508|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
48783113|NCT03701555|157046509|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
48783114|NCT03701555|157046510|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
48783115|NCT03701555|157046511|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
48783116|NCT03701555|157046512|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
48783117|NCT03701555|157046513|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
48783118|NCT03701555|157046514|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
48783119|NCT03701555|157046515|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
48783120|NCT03701555|157046516|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
48783121|NCT03701555|157046517|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
48399098|NCT01665144|155653463|FG000|Core Part|Adverse Event|45|||
48783122|NCT03701555|157046518|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
48783123|NCT03701555|157046519|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
48399099|NCT01665144|155653464|FG001|Core Part|Adverse Event|18|||
48783124|NCT03701555|157046520|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
48783125|NCT03701555|157046521|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
48783126|NCT03701555|157046522|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
48783127|NCT03701555|157046523|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
48783128|NCT03701555|157046524|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
48783129|NCT03701555|157046525|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
48783130|NCT03701555|157046526|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
48783131|NCT03701555|157046527|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
48783132|NCT03701555|157046528|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
48783133|NCT03701555|157046529|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
48783134|NCT03701555|157046530|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
48783135|NCT03701555|157046531|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
48783136|NCT03701555|157046532|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
48783137|NCT03701555|157046533|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
48783138|NCT03701555|157046534|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
48783139|NCT03701555|157046535|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
48783140|NCT03701555|157046536|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
48783141|NCT03701555|157046537|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
48783142|NCT03701555|157046538|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
48783143|NCT03701555|157046539|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
48783144|NCT03701555|157046504|FG000|Part 3 (Day 1)|Subject Decision|0|||
48783145|NCT03701555|157046505|FG001|Part 3 (Day 1)|Subject Decision|0|||
48783146|NCT03701555|157046506|FG002|Part 3 (Day 1)|Subject Decision|0|||
48783147|NCT03701555|157046507|FG003|Part 3 (Day 1)|Subject Decision|0|||
48783148|NCT03701555|157046508|FG004|Part 3 (Day 1)|Subject Decision|0|||
48783149|NCT03701555|157046509|FG005|Part 3 (Day 1)|Subject Decision|0|||
48783150|NCT03701555|157046510|FG006|Part 3 (Day 1)|Subject Decision|0|||
48783151|NCT03701555|157046511|FG007|Part 3 (Day 1)|Subject Decision|0|||
48783152|NCT03701555|157046512|FG008|Part 3 (Day 1)|Subject Decision|0|||
48783153|NCT03701555|157046513|FG009|Part 3 (Day 1)|Subject Decision|0|||
48783154|NCT03701555|157046514|FG010|Part 3 (Day 1)|Subject Decision|0|||
48783155|NCT03701555|157046515|FG011|Part 3 (Day 1)|Subject Decision|0|||
48783156|NCT03701555|157046516|FG012|Part 3 (Day 1)|Subject Decision|0|||
48783157|NCT03701555|157046517|FG013|Part 3 (Day 1)|Subject Decision|0|||
48783158|NCT03701555|157046518|FG014|Part 3 (Day 1)|Subject Decision|0|||
48783159|NCT03701555|157046519|FG015|Part 3 (Day 1)|Subject Decision|0|||
48399100|NCT01665144|155653465|FG002|Core Part|Adverse Event|0|||
48783160|NCT03701555|157046520|FG016|Part 3 (Day 1)|Subject Decision|0|||
48783161|NCT03701555|157046521|FG017|Part 3 (Day 1)|Subject Decision|0|||
48399101|NCT01665144|155653463|FG000|Core Part|Lack of Efficacy|16|||
48783162|NCT03701555|157046522|FG018|Part 3 (Day 1)|Subject Decision|0|||
48783163|NCT03701555|157046523|FG019|Part 3 (Day 1)|Subject Decision|0|||
48783164|NCT03701555|157046524|FG020|Part 3 (Day 1)|Subject Decision|0|||
48783165|NCT03701555|157046525|FG021|Part 3 (Day 1)|Subject Decision|0|||
48783166|NCT03701555|157046526|FG022|Part 3 (Day 1)|Subject Decision|0|||
48783167|NCT03701555|157046527|FG023|Part 3 (Day 1)|Subject Decision|0|||
48783168|NCT03701555|157046528|FG024|Part 3 (Day 1)|Subject Decision|0|||
48783169|NCT03701555|157046529|FG025|Part 3 (Day 1)|Subject Decision|0|||
48783170|NCT03701555|157046530|FG026|Part 3 (Day 1)|Subject Decision|1|||
48783171|NCT03701555|157046531|FG027|Part 3 (Day 1)|Subject Decision|0|||
48783172|NCT03701555|157046532|FG028|Part 3 (Day 1)|Subject Decision|0|||
48783173|NCT03701555|157046533|FG029|Part 3 (Day 1)|Subject Decision|0|||
48783174|NCT03701555|157046534|FG030|Part 3 (Day 1)|Subject Decision|0|||
48783175|NCT03701555|157046535|FG031|Part 3 (Day 1)|Subject Decision|2|||
48783176|NCT03701555|157046536|FG032|Part 3 (Day 1)|Subject Decision|1|||
48783177|NCT03701555|157046537|FG033|Part 3 (Day 1)|Subject Decision|1|||
48783178|NCT03701555|157046538|FG034|Part 3 (Day 1)|Subject Decision|0|||
48783179|NCT03701555|157046539|FG035|Part 3 (Day 1)|Subject Decision|0|||
48783180|NCT03701555|157046504|FG000|Part 3 (Day 1)|Other|0|||
48783181|NCT03701555|157046505|FG001|Part 3 (Day 1)|Other|0|||
48783182|NCT03701555|157046506|FG002|Part 3 (Day 1)|Other|0|||
48783183|NCT03701555|157046507|FG003|Part 3 (Day 1)|Other|0|||
48783184|NCT03701555|157046508|FG004|Part 3 (Day 1)|Other|0|||
48783185|NCT03701555|157046509|FG005|Part 3 (Day 1)|Other|0|||
48783186|NCT03701555|157046510|FG006|Part 3 (Day 1)|Other|0|||
48783187|NCT03701555|157046511|FG007|Part 3 (Day 1)|Other|0|||
48783188|NCT03701555|157046512|FG008|Part 3 (Day 1)|Other|0|||
48783189|NCT03701555|157046513|FG009|Part 3 (Day 1)|Other|0|||
48783190|NCT03701555|157046514|FG010|Part 3 (Day 1)|Other|0|||
48399102|NCT01665144|155653464|FG001|Core Part|Lack of Efficacy|11|||
48399103|NCT01665144|155653465|FG002|Core Part|Lack of Efficacy|0|||
48783191|NCT03701555|157046515|FG011|Part 3 (Day 1)|Other|0|||
48783192|NCT03701555|157046516|FG012|Part 3 (Day 1)|Other|0|||
48783193|NCT03701555|157046517|FG013|Part 3 (Day 1)|Other|0|||
48783194|NCT03701555|157046518|FG014|Part 3 (Day 1)|Other|0|||
48783195|NCT03701555|157046519|FG015|Part 3 (Day 1)|Other|0|||
48783196|NCT03701555|157046520|FG016|Part 3 (Day 1)|Other|0|||
48783197|NCT03701555|157046521|FG017|Part 3 (Day 1)|Other|0|||
48783198|NCT03701555|157046522|FG018|Part 3 (Day 1)|Other|0|||
48783199|NCT03701555|157046523|FG019|Part 3 (Day 1)|Other|0|||
48783200|NCT03701555|157046524|FG020|Part 3 (Day 1)|Other|0|||
48783201|NCT03701555|157046525|FG021|Part 3 (Day 1)|Other|0|||
48783202|NCT03701555|157046526|FG022|Part 3 (Day 1)|Other|0|||
48783203|NCT03701555|157046527|FG023|Part 3 (Day 1)|Other|0|||
48783204|NCT03701555|157046528|FG024|Part 3 (Day 1)|Other|1|||
48783205|NCT03701555|157046529|FG025|Part 3 (Day 1)|Other|1|||
48783206|NCT03701555|157046530|FG026|Part 3 (Day 1)|Other|0|||
48783207|NCT03701555|157046531|FG027|Part 3 (Day 1)|Other|0|||
48783208|NCT03701555|157046532|FG028|Part 3 (Day 1)|Other|0|||
48783209|NCT03701555|157046533|FG029|Part 3 (Day 1)|Other|1|||
48783210|NCT03701555|157046534|FG030|Part 3 (Day 1)|Other|1|||
48783211|NCT03701555|157046535|FG031|Part 3 (Day 1)|Other|0|||
48783212|NCT03701555|157046536|FG032|Part 3 (Day 1)|Other|1|||
48783213|NCT03701555|157046537|FG033|Part 3 (Day 1)|Other|1|||
48783214|NCT03701555|157046538|FG034|Part 3 (Day 1)|Other|0|||
48783215|NCT03701555|157046539|FG035|Part 3 (Day 1)|Other|0|||
48783216|NCT04757649|157046540|FG000|Overall Study|Withdrawal by Subject|1|||
48783217|NCT04757649|157046540|FG000|Overall Study|Adverse Event|1|||
48783218|NCT00795600|157046541|FG000|Overall Study|Adverse Event|1|||
48783219|NCT00795600|157046542|FG001|Overall Study|Adverse Event|1|||
48783220|NCT00795600|157046541|FG000|Overall Study|Protocol Violation|1|||
48783221|NCT00795600|157046542|FG001|Overall Study|Protocol Violation|2|||
48783222|NCT00795600|157046541|FG000|Overall Study|Withdrawal by Subject|1|||
48783223|NCT00795600|157046542|FG001|Overall Study|Withdrawal by Subject|0|||
48783224|NCT00795600|157046541|FG000|Overall Study|Unclassified|1|||
48783225|NCT00795600|157046542|FG001|Overall Study|Unclassified|1|||
48783226|NCT01286779|157046543|FG000|Overall Study|Withdrawal by Subject|9|||
48783227|NCT01286779|157046543|FG000|Overall Study|Protocol Violation|5|||
48783228|NCT01286779|157046543|FG000|Overall Study|Physician Decision|2|||
48783229|NCT01286779|157046543|FG000|Overall Study|Participant had scheduled surgery|1|||
48783230|NCT01286779|157046543|FG000|Overall Study|Participant moved to another country|1|||
48783231|NCT01286779|157046543|FG000|Overall Study|Discontinued by sponsor|1|||
48783232|NCT01255358|157046549|FG000|Overall Study|Adverse Event|2|||
48783233|NCT01255358|157046549|FG000|Overall Study|Protocol Violation|2|||
48783234|NCT04798781|157046550|FG000|Overall Study|Withdrawal by Subject|1|||
48783235|NCT01046643|157046551|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
48783236|NCT01046643|157046552|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
48783237|NCT01046643|157046553|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
48783238|NCT01046643|157046554|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
48783239|NCT02802345|157046555|FG000|Overall Study|Not Treated|0|||
48783240|NCT02802345|157046556|FG001|Overall Study|Not Treated|1|||
48783241|NCT02802345|157046555|FG000|Overall Study|Adverse Event|28|||
48783242|NCT02802345|157046556|FG001|Overall Study|Adverse Event|20|||
48783243|NCT02802345|157046555|FG000|Overall Study|Withdrawal by Subject|3|||
48783244|NCT02802345|157046556|FG001|Overall Study|Withdrawal by Subject|3|||
48783245|NCT02802345|157046555|FG000|Overall Study|Protocol Violation|0|||
48783246|NCT02802345|157046556|FG001|Overall Study|Protocol Violation|1|||
48783247|NCT02802345|157046555|FG000|Overall Study|Other than listed|1|||
48783248|NCT02802345|157046556|FG001|Overall Study|Other than listed|5|||
48399104|NCT01665144|155653463|FG000|Core Part|Lost to Follow-up|9|||
48399105|NCT01665144|155653464|FG001|Core Part|Lost to Follow-up|8|||
48399106|NCT01665144|155653465|FG002|Core Part|Lost to Follow-up|0|||
48399107|NCT01665144|155653463|FG000|Core Part|Physician Decision|13|||
48399108|NCT01665144|155653464|FG001|Core Part|Physician Decision|1|||
48399109|NCT01665144|155653465|FG002|Core Part|Physician Decision|0|||
48783249|NCT00022516|157046557|FG000|Overall Study|Adverse Event|0|||
48783250|NCT00022516|157046558|FG001|Overall Study|Adverse Event|59|||
48399110|NCT01665144|155653463|FG000|Core Part|Progressive disease|8|||
48399111|NCT01665144|155653464|FG001|Core Part|Progressive disease|4|||
48399112|NCT01665144|155653465|FG002|Core Part|Progressive disease|0|||
48399113|NCT01665144|155653463|FG000|Core Part|Non-compliance with study treatment|5|||
48399114|NCT01665144|155653464|FG001|Core Part|Non-compliance with study treatment|0|||
48399115|NCT01665144|155653465|FG002|Core Part|Non-compliance with study treatment|0|||
48399116|NCT01665144|155653463|FG000|Core Part|Death|3|||
48399117|NCT01665144|155653464|FG001|Core Part|Death|1|||
48399118|NCT01665144|155653465|FG002|Core Part|Death|0|||
48399119|NCT01665144|155653463|FG000|Core Part|Protocol deviation|3|||
48399120|NCT01665144|155653464|FG001|Core Part|Protocol deviation|1|||
48399121|NCT01665144|155653465|FG002|Core Part|Protocol deviation|0|||
48399122|NCT01665144|155653463|FG000|Core Part|New therapy for study indication|2|||
48783251|NCT00022516|157046557|FG000|Overall Study|Lack of Efficacy|0|||
48399123|NCT01665144|155653464|FG001|Core Part|New therapy for study indication|1|||
48399124|NCT01665144|155653465|FG002|Core Part|New therapy for study indication|0|||
48783252|NCT00022516|157046558|FG001|Overall Study|Lack of Efficacy|27|||
48783253|NCT00022516|157046557|FG000|Overall Study|Physician Decision|0|||
48783254|NCT00022516|157046558|FG001|Overall Study|Physician Decision|1|||
48783255|NCT00022516|157046557|FG000|Overall Study|Protocol Violation|1|||
48399125|NCT01665144|155653463|FG000|Core Part|Technical problems|2|||
48399126|NCT01665144|155653464|FG001|Core Part|Technical problems|0|||
48399127|NCT01665144|155653465|FG002|Core Part|Technical problems|0|||
48783256|NCT00022516|157046558|FG001|Overall Study|Protocol Violation|3|||
48783257|NCT00022516|157046557|FG000|Overall Study|Withdrawal by Subject|2|||
48783258|NCT00022516|157046558|FG001|Overall Study|Withdrawal by Subject|113|||
48783259|NCT00022516|157046557|FG000|Overall Study|Incomplete documentation|0|||
48783260|NCT00022516|157046558|FG001|Overall Study|Incomplete documentation|27|||
48783261|NCT03783923|157046564|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
48783262|NCT03783923|157046565|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
48783263|NCT03783923|157046564|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
48783264|NCT03783923|157046565|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
48783265|NCT03783923|157046564|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
48783266|NCT03783923|157046565|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
48783267|NCT03783923|157046564|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
48783268|NCT03783923|157046565|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
48783269|NCT03783923|157046564|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
48783270|NCT03783923|157046565|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
48783271|NCT01592708|157046568|FG000|Overall Study|Protocol Violation|3|||
48783272|NCT01592708|157046569|FG001|Overall Study|Protocol Violation|0|||
48783273|NCT00856583|157046570|FG000|Overall Study|Lack of Efficacy|389|||
48783274|NCT00856583|157046571|FG001|Overall Study|Lack of Efficacy|377|||
48783275|NCT00856583|157046570|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
48783276|NCT00856583|157046571|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
48783277|NCT00856583|157046570|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
48783278|NCT00856583|157046571|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
48783279|NCT00856583|157046570|FG000|Overall Study|Non-compliance|305|||
48783280|NCT00856583|157046571|FG001|Overall Study|Non-compliance|262|||
48783281|NCT00856583|157046570|FG000|Overall Study|Withdrawal by Subject|1092|||
48783282|NCT00856583|157046571|FG001|Overall Study|Withdrawal by Subject|919|||
48783283|NCT00856583|157046570|FG000|Overall Study|Physician Decision|59|||
48783284|NCT00856583|157046571|FG001|Overall Study|Physician Decision|82|||
48783285|NCT00856583|157046570|FG000|Overall Study|Pregnancy|14|||
48783286|NCT00856583|157046571|FG001|Overall Study|Pregnancy|5|||
48783287|NCT00856583|157046570|FG000|Overall Study|Other|92|||
48783288|NCT00856583|157046571|FG001|Overall Study|Other|104|||
48783289|NCT00856583|157046570|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
48783290|NCT00856583|157046571|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
48399128|NCT01665144|155653463|FG000|Extension Part|Patient/guardian decision|180|||
48399129|NCT01665144|155653464|FG001|Extension Part|Patient/guardian decision|0|||
48399130|NCT01665144|155653465|FG002|Extension Part|Patient/guardian decision|98|||
48399131|NCT01665144|155653463|FG000|Extension Part|Adverse Event|104|||
48399132|NCT01665144|155653464|FG001|Extension Part|Adverse Event|0|||
48399133|NCT01665144|155653465|FG002|Extension Part|Adverse Event|59|||
48399134|NCT01665144|155653463|FG000|Extension Part|Study closed early|42|||
48399135|NCT01665144|155653464|FG001|Extension Part|Study closed early|0|||
48399136|NCT01665144|155653465|FG002|Extension Part|Study closed early|19|||
48399137|NCT01665144|155653463|FG000|Extension Part|Progressive disease|36|||
48399138|NCT01665144|155653464|FG001|Extension Part|Progressive disease|0|||
48399139|NCT01665144|155653465|FG002|Extension Part|Progressive disease|14|||
48399140|NCT01665144|155653463|FG000|Extension Part|Lack of Efficacy|37|||
48399141|NCT01665144|155653464|FG001|Extension Part|Lack of Efficacy|0|||
48399142|NCT01665144|155653465|FG002|Extension Part|Lack of Efficacy|12|||
48399143|NCT01665144|155653463|FG000|Extension Part|Physician Decision|29|||
48399144|NCT01665144|155653464|FG001|Extension Part|Physician Decision|0|||
48399145|NCT01665144|155653465|FG002|Extension Part|Physician Decision|13|||
48399146|NCT01665144|155653463|FG000|Extension Part|Technical problems|20|||
48399147|NCT01665144|155653464|FG001|Extension Part|Technical problems|0|||
48399148|NCT01665144|155653465|FG002|Extension Part|Technical problems|8|||
48399149|NCT01665144|155653463|FG000|Extension Part|Death|20|||
48399150|NCT01665144|155653464|FG001|Extension Part|Death|0|||
48399151|NCT01665144|155653465|FG002|Extension Part|Death|4|||
48399152|NCT01665144|155653463|FG000|Extension Part|Missing|12|||
48399153|NCT01665144|155653464|FG001|Extension Part|Missing|0|||
48399154|NCT01665144|155653465|FG002|Extension Part|Missing|6|||
48399155|NCT01665144|155653463|FG000|Extension Part|Lost to Follow-up|9|||
48399156|NCT01665144|155653464|FG001|Extension Part|Lost to Follow-up|0|||
48399157|NCT01665144|155653465|FG002|Extension Part|Lost to Follow-up|5|||
48783291|NCT03694548|157046579|FG000|Part A Survey|Protocol Violation|3|||
48783292|NCT03694548|157046580|FG001|Part A Survey|Protocol Violation|3|||
48783293|NCT03694548|157046581|FG002|Part A Survey|Protocol Violation|0|||
48783294|NCT03694548|157046579|FG000|Part B Yoga Program|Protocol Violation|0|||
48783295|NCT03694548|157046580|FG001|Part B Yoga Program|Protocol Violation|0|||
48399158|NCT01665144|155653463|FG000|Extension Part|New therapy for study indication|3|||
48399159|NCT01665144|155653464|FG001|Extension Part|New therapy for study indication|0|||
48399160|NCT01665144|155653465|FG002|Extension Part|New therapy for study indication|2|||
48399161|NCT01665144|155653463|FG000|Extension Part|Protocol deviation|3|||
48399162|NCT01665144|155653464|FG001|Extension Part|Protocol deviation|0|||
48783296|NCT03694548|157046581|FG002|Part B Yoga Program|Protocol Violation|3|||
48399163|NCT01665144|155653465|FG002|Extension Part|Protocol deviation|0|||
48399164|NCT01060059|155653466|FG000|Overall Study|Adverse Event|1|||
48399165|NCT01060059|155653467|FG001|Overall Study|Adverse Event|1|||
48399166|NCT01060059|155653466|FG000|Overall Study|Death|2|||
48783297|NCT03694548|157046579|FG000|Part B Yoga Program|Did not attend intervention|0|||
48399167|NCT01060059|155653467|FG001|Overall Study|Death|3|||
48399168|NCT01060059|155653466|FG000|Overall Study|Lost to Follow-up|18|||
48783298|NCT03694548|157046580|FG001|Part B Yoga Program|Did not attend intervention|0|||
48783299|NCT03694548|157046581|FG002|Part B Yoga Program|Did not attend intervention|8|||
48783300|NCT04102501|157046582|FG000|Overall Study|Withdrawal by Subject|7|||
48783301|NCT04102501|157046583|FG001|Overall Study|Withdrawal by Subject|9|||
48783302|NCT04102501|157046582|FG000|Overall Study|Adverse Event|1|||
48783303|NCT04102501|157046583|FG001|Overall Study|Adverse Event|3|||
48783304|NCT04433767|157046586|FG000|Overall Study|Adverse Event|1|||
48783305|NCT00759109|157046587|FG000|Overall Study|Adverse Event|17|||
48399169|NCT01060059|155653467|FG001|Overall Study|Lost to Follow-up|34|||
48783306|NCT00759109|157046588|FG001|Overall Study|Adverse Event|12|||
48783307|NCT00759109|157046587|FG000|Overall Study|Inability to comply|1|||
48783308|NCT00759109|157046588|FG001|Overall Study|Inability to comply|1|||
48783309|NCT00759109|157046587|FG000|Overall Study|Withdrawal by Subject|9|||
48783310|NCT00759109|157046588|FG001|Overall Study|Withdrawal by Subject|5|||
48783311|NCT00759109|157046587|FG000|Overall Study|Death|4|||
48783312|NCT00759109|157046588|FG001|Overall Study|Death|3|||
48783313|NCT00759109|157046587|FG000|Overall Study|Lost to Follow-up|4|||
48783314|NCT00759109|157046588|FG001|Overall Study|Lost to Follow-up|6|||
48783315|NCT00759109|157046587|FG000|Overall Study|Started new therapy|2|||
48783316|NCT00759109|157046588|FG001|Overall Study|Started new therapy|6|||
48783317|NCT00759109|157046587|FG000|Overall Study|HCV RNA negative|1|||
48783318|NCT00759109|157046588|FG001|Overall Study|HCV RNA negative|0|||
48783319|NCT00759109|157046587|FG000|Overall Study|Participant moved to a different city|0|||
48783320|NCT00759109|157046588|FG001|Overall Study|Participant moved to a different city|1|||
48783321|NCT00759109|157046587|FG000|Overall Study|Participant had a liver transplant|0|||
48783322|NCT00759109|157046588|FG001|Overall Study|Participant had a liver transplant|1|||
48783323|NCT00759109|157046587|FG000|Overall Study|Lost during study|1|||
48783324|NCT00759109|157046588|FG001|Overall Study|Lost during study|0|||
48783325|NCT03165045|157046589|FG000|Visit 1|No registration after visit 1|9|||
48783326|NCT03165045|157046589|FG000|Visit 1|No treatment documented|10|||
48783327|NCT03165045|157046589|FG000|Visit 1|No visit 1|10|||
48783328|NCT03165045|157046589|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
48783329|NCT03165045|157046589|FG000|Visit 2|No available total CCQ score at all|29|||
48783330|NCT03165045|157046589|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
48783331|NCT03588572|157046590|FG000|Visitation 1|Lack of Efficacy|1|||
48783332|NCT03588572|157046591|FG001|Visitation 1|Lack of Efficacy|1|||
48783333|NCT03588572|157046590|FG000|Visitation 2|Lost to Follow-up|1|||
48783334|NCT03588572|157046591|FG001|Visitation 2|Lost to Follow-up|1|||
48783335|NCT03588572|157046590|FG000|Visitation 2|Lack of Efficacy|0|||
48783336|NCT03588572|157046591|FG001|Visitation 2|Lack of Efficacy|1|||
48783337|NCT03588572|157046590|FG000|Visitation 2|Withdrawal by Subject|1|||
48783338|NCT03588572|157046591|FG001|Visitation 2|Withdrawal by Subject|0|||
48783339|NCT03588572|157046590|FG000|Visitation 3|Lost to Follow-up|1|||
48783340|NCT03588572|157046591|FG001|Visitation 3|Lost to Follow-up|1|||
48783341|NCT03588572|157046590|FG000|Visitation 3|Physician Decision|1|||
48399170|NCT01060059|155653466|FG000|Overall Study|entry criteria not met|4|||
48399171|NCT01060059|155653467|FG001|Overall Study|entry criteria not met|3|||
48399172|NCT01060059|155653466|FG000|Overall Study|Withdrawal by Subject|35|||
48399173|NCT01060059|155653467|FG001|Overall Study|Withdrawal by Subject|23|||
48399174|NCT01060059|155653466|FG000|Overall Study|lack of glycemic control|2|||
48399175|NCT01060059|155653467|FG001|Overall Study|lack of glycemic control|1|||
48399176|NCT01060059|155653466|FG000|Overall Study|lack of compliance|5|||
48399177|NCT01060059|155653467|FG001|Overall Study|lack of compliance|2|||
48399178|NCT00903929|155653468|FG000|Overall Study|Withdrawal by Subject|0|||
48399179|NCT00903929|155653469|FG001|Overall Study|Withdrawal by Subject|0|||
48399180|NCT00903929|155653470|FG002|Overall Study|Withdrawal by Subject|1|||
48399181|NCT00903929|155653471|FG003|Overall Study|Withdrawal by Subject|2|||
48783342|NCT03588572|157046591|FG001|Visitation 3|Physician Decision|1|||
48783343|NCT03588572|157046590|FG000|Visitation 3|Withdrawal by Subject|1|||
48783344|NCT03588572|157046591|FG001|Visitation 3|Withdrawal by Subject|0|||
48783345|NCT04602624|157046594|FG000|Overall Study|Protocol Deviation|1|||
48783346|NCT04602624|157046594|FG000|Overall Study|Withdrawal by Participant|1|||
48783347|NCT00464542|157048156|FG000|Pre-treatment|Withdrawal by Subject|2|||
48783348|NCT01610700|157048157|FG000|Overall Study|Adverse Event|3|||
48399182|NCT00903929|155653468|FG000|Overall Study|Adverse Event|0|||
48399183|NCT00903929|155653469|FG001|Overall Study|Adverse Event|0|||
48399184|NCT00903929|155653470|FG002|Overall Study|Adverse Event|0|||
48399185|NCT00903929|155653471|FG003|Overall Study|Adverse Event|1|||
48783349|NCT01610700|157048158|FG001|Overall Study|Adverse Event|1|||
48783350|NCT01610700|157048157|FG000|Overall Study|Withdrawal by Subject|0|||
48783351|NCT01610700|157048158|FG001|Overall Study|Withdrawal by Subject|1|||
48783352|NCT01610700|157048157|FG000|Overall Study|subject took one dose of street cannabis|0|||
48783353|NCT01610700|157048158|FG001|Overall Study|subject took one dose of street cannabis|1|||
48783354|NCT01045447|157048161|FG000|Overall Study|Adverse Event|0|||
48783355|NCT01045447|157048162|FG001|Overall Study|Adverse Event|1|||
48783356|NCT01045447|157048161|FG000|Overall Study|Lack of Efficacy|3|||
48783357|NCT01045447|157048162|FG001|Overall Study|Lack of Efficacy|1|||
48783358|NCT01045447|157048161|FG000|Overall Study|Protocol Violation|6|||
48783359|NCT01045447|157048162|FG001|Overall Study|Protocol Violation|3|||
48783360|NCT01045447|157048161|FG000|Overall Study|Withdrawal Criteria|10|||
48783361|NCT01045447|157048162|FG001|Overall Study|Withdrawal Criteria|10|||
48783362|NCT01045447|157048161|FG000|Overall Study|Unclassified|17|||
48783363|NCT01045447|157048162|FG001|Overall Study|Unclassified|13|||
48783364|NCT00262834|157048165|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
48783365|NCT00262834|157048166|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
48783366|NCT00003457|157048167|FG000|Overall Study|Not evaluable|9|||
48783367|NCT01054729|157048168|FG000|Overall Study|Randomized but Not Treated|0|||
48783368|NCT01054729|157048169|FG001|Overall Study|Randomized but Not Treated|1|||
48783369|NCT01054729|157048170|FG002|Overall Study|Randomized but Not Treated|0|||
48783370|NCT01054729|157048171|FG003|Overall Study|Randomized but Not Treated|0|||
48783371|NCT01054729|157048168|FG000|Overall Study|Adverse Event|1|||
48783372|NCT01054729|157048169|FG001|Overall Study|Adverse Event|1|||
48783373|NCT01054729|157048170|FG002|Overall Study|Adverse Event|2|||
48783374|NCT01054729|157048171|FG003|Overall Study|Adverse Event|1|||
48783375|NCT01054729|157048168|FG000|Overall Study|Withdrawal by Subject|1|||
48783376|NCT01054729|157048169|FG001|Overall Study|Withdrawal by Subject|0|||
48783377|NCT01054729|157048170|FG002|Overall Study|Withdrawal by Subject|1|||
48783378|NCT01054729|157048171|FG003|Overall Study|Withdrawal by Subject|0|||
48783379|NCT01054729|157048168|FG000|Overall Study|Lost to Follow-up|0|||
48783380|NCT01054729|157048169|FG001|Overall Study|Lost to Follow-up|1|||
48783381|NCT01054729|157048170|FG002|Overall Study|Lost to Follow-up|0|||
48783382|NCT01054729|157048171|FG003|Overall Study|Lost to Follow-up|0|||
48783383|NCT01054729|157048168|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
48783384|NCT01054729|157048169|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
48783385|NCT01054729|157048170|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
48783386|NCT01054729|157048171|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
48783387|NCT01054729|157048168|FG000|Overall Study|Non-responder|1|||
48783388|NCT01054729|157048169|FG001|Overall Study|Non-responder|0|||
48783389|NCT01054729|157048170|FG002|Overall Study|Non-responder|1|||
48783390|NCT01054729|157048171|FG003|Overall Study|Non-responder|1|||
48783391|NCT01054729|157048168|FG000|Overall Study|PEG/RBV Non-responder|1|||
48783392|NCT01054729|157048169|FG001|Overall Study|PEG/RBV Non-responder|0|||
48783393|NCT01054729|157048170|FG002|Overall Study|PEG/RBV Non-responder|1|||
48783394|NCT01054729|157048171|FG003|Overall Study|PEG/RBV Non-responder|0|||
48783395|NCT01054729|157048168|FG000|Overall Study|Personal/Obligations|0|||
48783396|NCT01054729|157048169|FG001|Overall Study|Personal/Obligations|1|||
48783397|NCT01054729|157048170|FG002|Overall Study|Personal/Obligations|0|||
48783398|NCT01054729|157048171|FG003|Overall Study|Personal/Obligations|0|||
48783399|NCT01054729|157048168|FG000|Overall Study|Subject moved|0|||
48783400|NCT01054729|157048169|FG001|Overall Study|Subject moved|0|||
48783401|NCT01054729|157048170|FG002|Overall Study|Subject moved|1|||
48783402|NCT01054729|157048171|FG003|Overall Study|Subject moved|0|||
48783403|NCT01054729|157048168|FG000|Overall Study|Lack of Efficacy|0|||
48783404|NCT01054729|157048169|FG001|Overall Study|Lack of Efficacy|0|||
48783405|NCT01054729|157048170|FG002|Overall Study|Lack of Efficacy|0|||
48783406|NCT01054729|157048171|FG003|Overall Study|Lack of Efficacy|1|||
48783407|NCT04265755|157048175|FG000|Overall Study|Withdrawal by Subject|39|||
48783408|NCT04265755|157048175|FG000|Overall Study|Decision by sponsor|2|||
48783409|NCT04265755|157048175|FG000|Overall Study|Lost to Follow-up|11|||
48783410|NCT04265755|157048175|FG000|Overall Study|Death|1|||
48783411|NCT04535037|157048176|FG000|Overall Study|Protocol Violation|1|||
48399186|NCT01913483|155653473|FG000|Overall Study|Withdrawal by Subject|1|||
48399187|NCT01913483|155653474|FG001|Overall Study|Withdrawal by Subject|2|||
48399188|NCT01913483|155653473|FG000|Overall Study|Lost to Follow-up|6|||
48399189|NCT01913483|155653474|FG001|Overall Study|Lost to Follow-up|3|||
48399190|NCT01913483|155653473|FG000|Overall Study|Death|14|||
48399191|NCT01913483|155653474|FG001|Overall Study|Death|17|||
48399192|NCT01035905|155653477|FG000|Overall Study|Lack of Efficacy|1|||
48399193|NCT01035905|155653478|FG001|Overall Study|Lack of Efficacy|1|||
48783412|NCT04535037|157048177|FG001|Overall Study|Protocol Violation|0|||
48783413|NCT04535037|157048176|FG000|Overall Study|Withdrawal by Subject|8|||
48783414|NCT04535037|157048177|FG001|Overall Study|Withdrawal by Subject|9|||
48783415|NCT04535037|157048176|FG000|Overall Study|Migrated / moved from the study area|1|||
48783416|NCT04535037|157048177|FG001|Overall Study|Migrated / moved from the study area|4|||
48399194|NCT00091832|155653479|FG000|Overall Study|Physician Decision|1|||
48783417|NCT04535037|157048176|FG000|Overall Study|Other|2|||
48783418|NCT04535037|157048177|FG001|Overall Study|Other|5|||
48783419|NCT01854554|157048183|FG000|Overall Study|Denial of Insurance Coverage|12|||
48783420|NCT01854554|157048184|FG001|Overall Study|Denial of Insurance Coverage|0|||
48399195|NCT00091832|155653480|FG001|Overall Study|Physician Decision|0|||
48783421|NCT01854554|157048183|FG000|Overall Study|Decided to get treatment locally|1|||
48783422|NCT01854554|157048184|FG001|Overall Study|Decided to get treatment locally|5|||
48783423|NCT01854554|157048183|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
48783424|NCT01854554|157048184|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
48783425|NCT01854554|157048183|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783426|NCT01854554|157048184|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
48783427|NCT01854554|157048183|FG000|Overall Study|Progression|0|||
48783428|NCT01854554|157048184|FG001|Overall Study|Progression|1|||
48783429|NCT01854554|157048183|FG000|Overall Study|Lost to Follow-up|0|||
48783430|NCT01854554|157048184|FG001|Overall Study|Lost to Follow-up|1|||
48783431|NCT02731131|157048185|FG000|Overall Study|Psychiatric Disorder|0|||
48783432|NCT02731131|157048186|FG001|Overall Study|Psychiatric Disorder|1|||
48783433|NCT02731131|157048185|FG000|Overall Study|Refused Therapy|0|||
48783434|NCT02731131|157048186|FG001|Overall Study|Refused Therapy|1|||
48783435|NCT02819726|157048191|FG000|Part A (All Participants)|Lost to Follow-up|0|||
48783436|NCT02819726|157048192|FG001|Part A (All Participants)|Lost to Follow-up|1|||
48783437|NCT02819726|157048193|FG002|Part A (All Participants)|Lost to Follow-up|0|||
48783438|NCT02819726|157048194|FG003|Part A (All Participants)|Lost to Follow-up|0|||
48783439|NCT02819726|157048191|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
48783440|NCT02819726|157048192|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
48783441|NCT02819726|157048193|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
48783442|NCT02819726|157048194|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
48783443|NCT02819726|157048191|FG000|Part A (All Participants)|Protocol non-compliance|3|||
48783444|NCT02819726|157048192|FG001|Part A (All Participants)|Protocol non-compliance|4|||
48783445|NCT02819726|157048193|FG002|Part A (All Participants)|Protocol non-compliance|5|||
48783446|NCT02819726|157048194|FG003|Part A (All Participants)|Protocol non-compliance|0|||
48783447|NCT02819726|157048191|FG000|Part B (All Participants)|Lost to Follow-up|1|||
48783448|NCT02819726|157048192|FG001|Part B (All Participants)|Lost to Follow-up|1|||
48783449|NCT02819726|157048193|FG002|Part B (All Participants)|Lost to Follow-up|2|||
48783450|NCT02819726|157048194|FG003|Part B (All Participants)|Lost to Follow-up|2|||
48783451|NCT02819726|157048191|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
48783452|NCT02819726|157048192|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
48783453|NCT02819726|157048193|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
48783454|NCT02819726|157048194|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
48783455|NCT02819726|157048191|FG000|Part B (All Participants)|Protocol non-compliance|0|||
48783456|NCT02819726|157048192|FG001|Part B (All Participants)|Protocol non-compliance|0|||
48783457|NCT02819726|157048193|FG002|Part B (All Participants)|Protocol non-compliance|1|||
48783458|NCT02819726|157048194|FG003|Part B (All Participants)|Protocol non-compliance|0|||
48783459|NCT02536508|157048195|FG000|Overall Study|Withdrawal by Subject|18|||
48783460|NCT02536508|157048196|FG001|Overall Study|Withdrawal by Subject|13|||
48783461|NCT02536508|157048197|FG002|Overall Study|Withdrawal by Subject|7|||
48783462|NCT02536508|157048195|FG000|Overall Study|Adverse Event|14|||
48783463|NCT02536508|157048196|FG001|Overall Study|Adverse Event|13|||
48399196|NCT00091832|155653481|FG002|Overall Study|Physician Decision|0|||
48399197|NCT00091832|155653482|FG003|Overall Study|Physician Decision|0|||
48399198|NCT00091832|155653483|FG004|Overall Study|Physician Decision|0|||
48399199|NCT00091832|155653484|FG005|Overall Study|Physician Decision|0|||
48399200|NCT00091832|155653479|FG000|Overall Study|Adverse Event|0|||
48399201|NCT00091832|155653480|FG001|Overall Study|Adverse Event|0|||
48399202|NCT00091832|155653481|FG002|Overall Study|Adverse Event|0|||
48399203|NCT00091832|155653482|FG003|Overall Study|Adverse Event|1|||
48399204|NCT00091832|155653483|FG004|Overall Study|Adverse Event|3|||
48399205|NCT00091832|155653484|FG005|Overall Study|Adverse Event|0|||
48399206|NCT00091832|155653479|FG000|Overall Study|Withdrawal by Subject|4|||
48399207|NCT00091832|155653480|FG001|Overall Study|Withdrawal by Subject|5|||
48399208|NCT00091832|155653481|FG002|Overall Study|Withdrawal by Subject|0|||
48399209|NCT00091832|155653482|FG003|Overall Study|Withdrawal by Subject|1|||
48399210|NCT00091832|155653483|FG004|Overall Study|Withdrawal by Subject|3|||
48399211|NCT00091832|155653484|FG005|Overall Study|Withdrawal by Subject|1|||
48399212|NCT00091832|155653479|FG000|Overall Study|Death|6|||
48399213|NCT00091832|155653480|FG001|Overall Study|Death|4|||
48399214|NCT00091832|155653481|FG002|Overall Study|Death|5|||
48399215|NCT00091832|155653482|FG003|Overall Study|Death|8|||
48399216|NCT00091832|155653483|FG004|Overall Study|Death|5|||
48783464|NCT02536508|157048197|FG002|Overall Study|Adverse Event|6|||
48399217|NCT00091832|155653484|FG005|Overall Study|Death|6|||
48399218|NCT00091832|155653479|FG000|Overall Study|Disease Progression|2|||
48783465|NCT02536508|157048195|FG000|Overall Study|Lost to Follow-up|12|||
48783466|NCT02536508|157048196|FG001|Overall Study|Lost to Follow-up|4|||
48783467|NCT02536508|157048197|FG002|Overall Study|Lost to Follow-up|0|||
48783468|NCT02536508|157048195|FG000|Overall Study|Lack of Efficacy|3|||
48783469|NCT02536508|157048196|FG001|Overall Study|Lack of Efficacy|5|||
48783470|NCT02536508|157048197|FG002|Overall Study|Lack of Efficacy|4|||
48783471|NCT02536508|157048195|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
48399219|NCT00091832|155653480|FG001|Overall Study|Disease Progression|0|||
48399220|NCT00091832|155653481|FG002|Overall Study|Disease Progression|0|||
48399221|NCT00091832|155653482|FG003|Overall Study|Disease Progression|1|||
48399222|NCT00091832|155653483|FG004|Overall Study|Disease Progression|1|||
48399223|NCT00091832|155653484|FG005|Overall Study|Disease Progression|2|||
48783472|NCT02536508|157048196|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
48783473|NCT02536508|157048197|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
48783474|NCT02536508|157048195|FG000|Overall Study|Physician Decision|0|||
48783475|NCT02536508|157048196|FG001|Overall Study|Physician Decision|4|||
48783476|NCT02536508|157048197|FG002|Overall Study|Physician Decision|2|||
48783477|NCT02536508|157048195|FG000|Overall Study|Major Protocol Deviation|2|||
48783478|NCT02536508|157048196|FG001|Overall Study|Major Protocol Deviation|2|||
48783479|NCT02536508|157048197|FG002|Overall Study|Major Protocol Deviation|2|||
48783480|NCT02536508|157048195|FG000|Overall Study|Administrative Reasons|0|||
48783481|NCT02536508|157048196|FG001|Overall Study|Administrative Reasons|1|||
48783482|NCT02536508|157048197|FG002|Overall Study|Administrative Reasons|0|||
48783483|NCT00003498|157048198|FG000|Overall Study|Not evaluable.|4|||
48783484|NCT01055639|157048203|FG000|Overall Study|Adverse Event|0|||
48783485|NCT01055639|157048204|FG001|Overall Study|Adverse Event|1|||
48783486|NCT01055639|157048203|FG000|Overall Study|Lack of Efficacy|0|||
48783487|NCT01055639|157048204|FG001|Overall Study|Lack of Efficacy|1|||
48783488|NCT01055639|157048203|FG000|Overall Study|Lost to Follow-up|8|||
48783489|NCT01055639|157048204|FG001|Overall Study|Lost to Follow-up|11|||
48783490|NCT01055639|157048203|FG000|Overall Study|Protocol Violation|5|||
48783491|NCT01055639|157048204|FG001|Overall Study|Protocol Violation|5|||
48783492|NCT01055639|157048203|FG000|Overall Study|Withdrawal by Subject|8|||
48783493|NCT01055639|157048204|FG001|Overall Study|Withdrawal by Subject|11|||
48783494|NCT02417246|157048205|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
48783495|NCT02417246|157048206|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
48783496|NCT02417246|157048205|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
48783497|NCT02417246|157048206|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
48783498|NCT02417246|157048205|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
48783499|NCT02417246|157048206|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
48783500|NCT02417246|157048205|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
48783501|NCT02417246|157048206|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
48783502|NCT01181921|157048210|FG000|Overall Study|Lost to Follow-up|1|||
48783503|NCT04408469|157048215|FG000|Overall Study|Lost to Follow-up|6|||
48783504|NCT04408469|157048216|FG001|Overall Study|Lost to Follow-up|9|||
48783505|NCT04408469|157048215|FG000|Overall Study|Withdrawal by Subject|6|||
48783506|NCT04408469|157048216|FG001|Overall Study|Withdrawal by Subject|1|||
48783507|NCT04408469|157048215|FG000|Overall Study|Dismissal due to ineligibility|0|||
48783508|NCT04408469|157048216|FG001|Overall Study|Dismissal due to ineligibility|1|||
48783509|NCT02460991|157048222|FG000|Overall Study|Withdrawal by Subject|0|||
48783510|NCT02460991|157048223|FG001|Overall Study|Withdrawal by Subject|2|||
48783511|NCT02546544|157048224|FG000|Overall Study|Disease Progression|14|||
48783512|NCT02546544|157048224|FG000|Overall Study|Adverse Event|1|||
48783513|NCT02546544|157048224|FG000|Overall Study|Withdrawal by Subject|1|||
48783514|NCT01921348|157048225|FG000|Overall Study|Withdrawal by Subject|1|||
48783515|NCT01921348|157048226|FG001|Overall Study|Withdrawal by Subject|0|||
48783516|NCT01921348|157048225|FG000|Overall Study|Lost to Follow-up|0|||
48783517|NCT01921348|157048226|FG001|Overall Study|Lost to Follow-up|2|||
48783518|NCT03073603|157048227|FG000|Overall Study|Noncompliance|3|||
48783519|NCT03073603|157048228|FG001|Overall Study|Noncompliance|1|||
48783520|NCT03073603|157048227|FG000|Overall Study|Adverse Event|5|||
48783521|NCT03073603|157048228|FG001|Overall Study|Adverse Event|3|||
48783522|NCT03073603|157048227|FG000|Overall Study|Physician Decision|1|||
48783523|NCT03073603|157048228|FG001|Overall Study|Physician Decision|2|||
48783524|NCT03073603|157048227|FG000|Overall Study|Required treatment not allowed by protocol|1|||
48783525|NCT03073603|157048228|FG001|Overall Study|Required treatment not allowed by protocol|0|||
48783526|NCT03073603|157048227|FG000|Overall Study|Financial or insurance-related|8|||
48399224|NCT00091832|155653479|FG000|Overall Study|Ineligibility Determined|0|||
48399225|NCT00091832|155653480|FG001|Overall Study|Ineligibility Determined|0|||
48399226|NCT00091832|155653481|FG002|Overall Study|Ineligibility Determined|1|||
48399227|NCT00091832|155653482|FG003|Overall Study|Ineligibility Determined|0|||
48783527|NCT03073603|157048228|FG001|Overall Study|Financial or insurance-related|0|||
48783528|NCT03073603|157048227|FG000|Overall Study|Withdrawal by Subject|0|||
48783529|NCT03073603|157048228|FG001|Overall Study|Withdrawal by Subject|1|||
48783530|NCT03073603|157048227|FG000|Overall Study|Discontinued DMT|4|||
48783531|NCT03073603|157048228|FG001|Overall Study|Discontinued DMT|0|||
48783532|NCT03073603|157048227|FG000|Overall Study|Restarted DMT|0|||
48783533|NCT03073603|157048228|FG001|Overall Study|Restarted DMT|1|||
48783534|NCT00455195|157048229|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
48783535|NCT00455195|157048230|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
48783536|NCT00455195|157048229|FG000|Double-blind Study AGLU02704|Death|1|||
48783537|NCT00455195|157048230|FG001|Double-blind Study AGLU02704|Death|0|||
48783538|NCT00455195|157048229|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
48783539|NCT00455195|157048230|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
48783540|NCT00455195|157048229|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
48783541|NCT00455195|157048230|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
48783542|NCT03936244|157048233|FG000|Overall Study|Lost to Follow-up|5|||
48399228|NCT00091832|155653483|FG004|Overall Study|Ineligibility Determined|1|||
48399229|NCT00091832|155653484|FG005|Overall Study|Ineligibility Determined|0|||
48399230|NCT00091832|155653479|FG000|Overall Study|Lost to Follow-up|1|||
48399231|NCT00091832|155653480|FG001|Overall Study|Lost to Follow-up|0|||
48399232|NCT00091832|155653481|FG002|Overall Study|Lost to Follow-up|3|||
48399233|NCT00091832|155653482|FG003|Overall Study|Lost to Follow-up|3|||
48783543|NCT03936244|157048234|FG001|Overall Study|Lost to Follow-up|1|||
48783544|NCT03936244|157048233|FG000|Overall Study|Physician Decision|7|||
48783545|NCT03936244|157048234|FG001|Overall Study|Physician Decision|3|||
48783546|NCT01925183|157048235|FG000|Overall Study|Adverse Event|1|||
48783547|NCT01925183|157048236|FG001|Overall Study|Adverse Event|0|||
48783548|NCT01114646|157048237|FG000|Overall Study|Withdrawal by Subject|3|||
48783549|NCT01114646|157048238|FG001|Overall Study|Withdrawal by Subject|2|||
48783550|NCT01296568|157048242|FG000|Continued Access Phase|Lost to Follow-up|1|||
48783551|NCT01296568|157048242|FG000|Continued Access Phase|Withdrawal by Subject|1|||
48783552|NCT01296568|157048242|FG000|Continued Access Phase|Disease Progression|1|||
48783553|NCT02013765|157048243|FG000|Overall Study|Trial was terminated by sponsor|1|||
48783554|NCT00462384|157048244|FG000|Overall Study|Adverse Event|2|||
48783555|NCT00462384|157048244|FG000|Overall Study|Death|2|||
48783556|NCT00462384|157048244|FG000|Overall Study|Withdrawal by Subject|1|||
48783557|NCT00462384|157048244|FG000|Overall Study|Other|4|||
48783558|NCT02571452|157048246|FG000|Overall Study Treatment|Protocol Violation|0|||
48783559|NCT02571452|157048247|FG001|Overall Study Treatment|Protocol Violation|1|||
48783560|NCT02571452|157048246|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
48783561|NCT02571452|157048247|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
48783562|NCT02571452|157048246|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
48783563|NCT02571452|157048247|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
48783564|NCT04000165|157048248|FG000|Overall Study|Physician Decision|1|||
48783565|NCT04000165|157048248|FG000|Overall Study|Withdrawal by Subject|1|||
48783566|NCT02014116|157048250|FG000|Overall Study|Progressive Disease|3|||
48783567|NCT02014116|157048251|FG001|Overall Study|Progressive Disease|4|||
48783568|NCT02014116|157048252|FG002|Overall Study|Progressive Disease|2|||
48783569|NCT02014116|157048253|FG003|Overall Study|Progressive Disease|6|||
48783570|NCT02014116|157048254|FG004|Overall Study|Progressive Disease|1|||
48783571|NCT02014116|157048255|FG005|Overall Study|Progressive Disease|13|||
48783572|NCT02014116|157048256|FG006|Overall Study|Progressive Disease|1|||
48783573|NCT02014116|157048257|FG007|Overall Study|Progressive Disease|3|||
48399234|NCT00091832|155653483|FG004|Overall Study|Lost to Follow-up|2|||
48399235|NCT00091832|155653484|FG005|Overall Study|Lost to Follow-up|1|||
48399236|NCT00091832|155653479|FG000|Overall Study|Noncompliance|0|||
48399237|NCT00091832|155653480|FG001|Overall Study|Noncompliance|1|||
48399238|NCT00091832|155653481|FG002|Overall Study|Noncompliance|0|||
48399239|NCT00091832|155653482|FG003|Overall Study|Noncompliance|0|||
48399240|NCT00091832|155653483|FG004|Overall Study|Noncompliance|0|||
48399241|NCT00091832|155653484|FG005|Overall Study|Noncompliance|0|||
48399242|NCT00091832|155653479|FG000|Overall Study|Other|0|||
48399243|NCT00091832|155653480|FG001|Overall Study|Other|1|||
48399244|NCT00091832|155653481|FG002|Overall Study|Other|2|||
48399245|NCT00091832|155653482|FG003|Overall Study|Other|0|||
48399246|NCT00091832|155653483|FG004|Overall Study|Other|0|||
48399247|NCT00091832|155653484|FG005|Overall Study|Other|0|||
48399248|NCT00091832|155653479|FG000|Overall Study|Protocol Violation|0|||
48399249|NCT00091832|155653480|FG001|Overall Study|Protocol Violation|0|||
48399250|NCT00091832|155653481|FG002|Overall Study|Protocol Violation|1|||
48399251|NCT00091832|155653482|FG003|Overall Study|Protocol Violation|0|||
48399252|NCT00091832|155653483|FG004|Overall Study|Protocol Violation|0|||
48399253|NCT00091832|155653484|FG005|Overall Study|Protocol Violation|1|||
48399254|NCT01972074|155653485|FG000|Overall Study|Adverse Event|4|||
48399255|NCT01972074|155653486|FG001|Overall Study|Adverse Event|1|||
48399256|NCT01972074|155653487|FG002|Overall Study|Adverse Event|0|||
48399257|NCT01972074|155653485|FG000|Overall Study|Lack of Efficacy|1|||
48399258|NCT01972074|155653486|FG001|Overall Study|Lack of Efficacy|1|||
48399259|NCT01972074|155653487|FG002|Overall Study|Lack of Efficacy|0|||
48783574|NCT02014116|157048258|FG008|Overall Study|Progressive Disease|7|||
48783575|NCT02014116|157048250|FG000|Overall Study|Adverse Event|0|||
48783576|NCT02014116|157048251|FG001|Overall Study|Adverse Event|0|||
48783577|NCT02014116|157048252|FG002|Overall Study|Adverse Event|0|||
48783578|NCT02014116|157048253|FG003|Overall Study|Adverse Event|0|||
48399260|NCT01972074|155653485|FG000|Overall Study|Lost to Follow-up|0|||
48399261|NCT01972074|155653486|FG001|Overall Study|Lost to Follow-up|1|||
48399262|NCT01972074|155653487|FG002|Overall Study|Lost to Follow-up|1|||
48783579|NCT02014116|157048254|FG004|Overall Study|Adverse Event|1|||
48783580|NCT02014116|157048255|FG005|Overall Study|Adverse Event|0|||
48783581|NCT02014116|157048256|FG006|Overall Study|Adverse Event|0|||
48783582|NCT02014116|157048257|FG007|Overall Study|Adverse Event|1|||
48399263|NCT01972074|155653485|FG000|Overall Study|Withdrawal by Subject|1|||
48783583|NCT02014116|157048258|FG008|Overall Study|Adverse Event|0|||
48399264|NCT01972074|155653486|FG001|Overall Study|Withdrawal by Subject|1|||
48399265|NCT01972074|155653487|FG002|Overall Study|Withdrawal by Subject|1|||
48783584|NCT02014116|157048250|FG000|Overall Study|Lost to Follow-up|0|||
48783585|NCT02014116|157048251|FG001|Overall Study|Lost to Follow-up|0|||
48783586|NCT02014116|157048252|FG002|Overall Study|Lost to Follow-up|0|||
48783587|NCT02014116|157048253|FG003|Overall Study|Lost to Follow-up|0|||
48783588|NCT02014116|157048254|FG004|Overall Study|Lost to Follow-up|0|||
48783589|NCT02014116|157048255|FG005|Overall Study|Lost to Follow-up|1|||
48783590|NCT02014116|157048256|FG006|Overall Study|Lost to Follow-up|0|||
48783591|NCT02014116|157048257|FG007|Overall Study|Lost to Follow-up|0|||
48783592|NCT02014116|157048258|FG008|Overall Study|Lost to Follow-up|1|||
48783593|NCT02014116|157048250|FG000|Overall Study|Death|0|||
48783594|NCT02014116|157048251|FG001|Overall Study|Death|0|||
48783595|NCT02014116|157048252|FG002|Overall Study|Death|0|||
48783596|NCT02014116|157048253|FG003|Overall Study|Death|0|||
48783597|NCT02014116|157048254|FG004|Overall Study|Death|0|||
48783598|NCT02014116|157048255|FG005|Overall Study|Death|0|||
48783599|NCT02014116|157048256|FG006|Overall Study|Death|0|||
48783600|NCT02014116|157048257|FG007|Overall Study|Death|1|||
48783601|NCT02014116|157048258|FG008|Overall Study|Death|1|||
48783602|NCT02014116|157048250|FG000|Overall Study|Withdrawal by Subject|0|||
48783603|NCT02014116|157048251|FG001|Overall Study|Withdrawal by Subject|0|||
48783604|NCT02014116|157048252|FG002|Overall Study|Withdrawal by Subject|1|||
48783605|NCT02014116|157048253|FG003|Overall Study|Withdrawal by Subject|1|||
48783606|NCT02014116|157048254|FG004|Overall Study|Withdrawal by Subject|0|||
48783607|NCT02014116|157048255|FG005|Overall Study|Withdrawal by Subject|1|||
48783608|NCT02014116|157048256|FG006|Overall Study|Withdrawal by Subject|0|||
48783609|NCT02014116|157048257|FG007|Overall Study|Withdrawal by Subject|0|||
48783610|NCT02014116|157048258|FG008|Overall Study|Withdrawal by Subject|0|||
48783611|NCT02014116|157048250|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
48783612|NCT02014116|157048251|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
48399266|NCT01972074|155653485|FG000|Overall Study|Scanner Unavailable|0|||
48399267|NCT01972074|155653486|FG001|Overall Study|Scanner Unavailable|0|||
48399268|NCT01972074|155653487|FG002|Overall Study|Scanner Unavailable|1|||
48399269|NCT02508194|155653488|FG000|Overall Study|Death|5|||
48399270|NCT02508194|155653489|FG001|Overall Study|Death|3|||
48399271|NCT02508194|155653488|FG000|Overall Study|Lost to Follow-up|25|||
48399272|NCT02508194|155653489|FG001|Overall Study|Lost to Follow-up|18|||
48399273|NCT02508194|155653488|FG000|Overall Study|Withdrawal by Subject|20|||
48399274|NCT02508194|155653489|FG001|Overall Study|Withdrawal by Subject|18|||
48399275|NCT02508194|155653488|FG000|Overall Study|Error in Randomization|1|||
48399276|NCT02508194|155653489|FG001|Overall Study|Error in Randomization|3|||
48399277|NCT02508194|155653488|FG000|Overall Study|Principal Investigator Decision|1|||
48399278|NCT02508194|155653489|FG001|Overall Study|Principal Investigator Decision|2|||
48399279|NCT03920670|155653492|FG000|Overall Study|Protocol Violation|2|||
48399280|NCT03920670|155653493|FG001|Overall Study|Protocol Violation|2|||
48399281|NCT03920670|155653492|FG000|Overall Study|Adverse Event|1|||
48399282|NCT03920670|155653493|FG001|Overall Study|Adverse Event|0|||
48399283|NCT02937350|155653502|FG000|Overall Study|Withdrawal by Subject|0|||
48399284|NCT02937350|155653503|FG001|Overall Study|Withdrawal by Subject|1|||
48399285|NCT02937350|155653504|FG002|Overall Study|Withdrawal by Subject|0|||
48399286|NCT03354663|155655396|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
48399287|NCT03354663|155655396|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
48399288|NCT03354663|155655396|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
48399289|NCT03354663|155655396|FG000|Completed 30-day Visit|Missed Visit|1|||
48399290|NCT01049035|155655397|FG000|Overall Study|Serious adverse event|0|||
48399291|NCT01049035|155655398|FG001|Overall Study|Serious adverse event|1|||
48399292|NCT01049035|155655399|FG002|Overall Study|Serious adverse event|1|||
48399293|NCT01049035|155655400|FG003|Overall Study|Serious adverse event|2|||
48399294|NCT01049035|155655401|FG004|Overall Study|Serious adverse event|0|||
48399295|NCT01049035|155655402|FG005|Overall Study|Serious adverse event|0|||
48399296|NCT01049035|155655403|FG006|Overall Study|Serious adverse event|0|||
48399297|NCT01049035|155655397|FG000|Overall Study|Other adverse event (AE)|0|||
48783613|NCT02014116|157048252|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
48783614|NCT02014116|157048253|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
48783615|NCT02014116|157048254|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
48783616|NCT02014116|157048255|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
48783617|NCT02014116|157048256|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
48783618|NCT02014116|157048257|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
48783619|NCT02014116|157048258|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
48783620|NCT02014116|157048250|FG000|Overall Study|Physician Decision|0|||
48783621|NCT02014116|157048251|FG001|Overall Study|Physician Decision|0|||
48783622|NCT02014116|157048252|FG002|Overall Study|Physician Decision|0|||
48399298|NCT01049035|155655398|FG001|Overall Study|Other adverse event (AE)|0|||
48783623|NCT02014116|157048253|FG003|Overall Study|Physician Decision|0|||
48783624|NCT02014116|157048254|FG004|Overall Study|Physician Decision|0|||
48430344|NCT00696657|155763707|FG007|Overall Study|Lack of Efficacy|0|||
48783625|NCT02014116|157048255|FG005|Overall Study|Physician Decision|0|||
48783626|NCT02014116|157048256|FG006|Overall Study|Physician Decision|0|||
48783627|NCT02014116|157048257|FG007|Overall Study|Physician Decision|0|||
48399299|NCT01049035|155655399|FG002|Overall Study|Other adverse event (AE)|0|||
48399300|NCT01049035|155655400|FG003|Overall Study|Other adverse event (AE)|1|||
48399301|NCT01049035|155655401|FG004|Overall Study|Other adverse event (AE)|0|||
48399302|NCT01049035|155655402|FG005|Overall Study|Other adverse event (AE)|0|||
48399303|NCT01049035|155655403|FG006|Overall Study|Other adverse event (AE)|0|||
48399304|NCT01049035|155655397|FG000|Overall Study|Non-compliance with the protocol|12|||
48399305|NCT01049035|155655398|FG001|Overall Study|Non-compliance with the protocol|6|||
48399306|NCT01049035|155655399|FG002|Overall Study|Non-compliance with the protocol|14|||
48399307|NCT01049035|155655400|FG003|Overall Study|Non-compliance with the protocol|5|||
48399308|NCT01049035|155655401|FG004|Overall Study|Non-compliance with the protocol|3|||
48399309|NCT01049035|155655402|FG005|Overall Study|Non-compliance with the protocol|4|||
48399310|NCT01049035|155655403|FG006|Overall Study|Non-compliance with the protocol|10|||
48399311|NCT01049035|155655397|FG000|Overall Study|Lost to Follow-up|5|||
48399312|NCT01049035|155655398|FG001|Overall Study|Lost to Follow-up|4|||
48399313|NCT01049035|155655399|FG002|Overall Study|Lost to Follow-up|4|||
48399314|NCT01049035|155655400|FG003|Overall Study|Lost to Follow-up|1|||
48399315|NCT01049035|155655401|FG004|Overall Study|Lost to Follow-up|0|||
48399316|NCT01049035|155655402|FG005|Overall Study|Lost to Follow-up|3|||
48399317|NCT01049035|155655403|FG006|Overall Study|Lost to Follow-up|3|||
48399318|NCT01049035|155655397|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
48399319|NCT01049035|155655398|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
48399320|NCT01049035|155655399|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
48399321|NCT01049035|155655400|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
48399322|NCT01049035|155655401|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
48399323|NCT01049035|155655402|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
48399324|NCT01049035|155655403|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
48399325|NCT02239939|155655406|FG000|Overall Study|Adverse Event|1|||
48399326|NCT02239939|155655407|FG001|Overall Study|Adverse Event|0|||
48399327|NCT02239939|155655406|FG000|Overall Study|Withdrawal by Subject|1|||
48399328|NCT02239939|155655407|FG001|Overall Study|Withdrawal by Subject|1|||
48399329|NCT02239939|155655406|FG000|Overall Study|Lost to Follow-up|0|||
48399330|NCT02239939|155655407|FG001|Overall Study|Lost to Follow-up|1|||
48399331|NCT04312009|155655413|FG000|Overall Study|Withdrawal by Subject|2|||
48399332|NCT04312009|155655414|FG001|Overall Study|Withdrawal by Subject|1|||
48399333|NCT01192022|155655415|FG000|Overall Study|Withdrawal of Consent|3|||
48399334|NCT01192022|155655416|FG001|Overall Study|Withdrawal of Consent|1|||
48399335|NCT01192022|155655417|FG002|Overall Study|Withdrawal of Consent|0|||
48399336|NCT01192022|155655418|FG003|Overall Study|Withdrawal of Consent|0|||
48399337|NCT01192022|155655419|FG004|Overall Study|Withdrawal of Consent|0|||
48399338|NCT01192022|155655415|FG000|Overall Study|Lost to Follow-up|4|||
48399339|NCT01192022|155655416|FG001|Overall Study|Lost to Follow-up|2|||
48399340|NCT01192022|155655417|FG002|Overall Study|Lost to Follow-up|1|||
48399341|NCT01192022|155655418|FG003|Overall Study|Lost to Follow-up|1|||
48399342|NCT01192022|155655419|FG004|Overall Study|Lost to Follow-up|0|||
48399343|NCT01192022|155655415|FG000|Overall Study|Adverse Event|1|||
48399344|NCT01192022|155655416|FG001|Overall Study|Adverse Event|0|||
48399345|NCT01192022|155655417|FG002|Overall Study|Adverse Event|0|||
48783628|NCT02014116|157048258|FG008|Overall Study|Physician Decision|1|||
48783629|NCT00437489|157048269|FG000|Overall Study|Study terminated by sponsor|23|||
48783630|NCT00437489|157048270|FG001|Overall Study|Study terminated by sponsor|21|||
48783631|NCT00437489|157048269|FG000|Overall Study|Lost to Follow-up|0|||
48783632|NCT00437489|157048270|FG001|Overall Study|Lost to Follow-up|1|||
48783633|NCT04934670|157048271|FG000|Overall Study|Death|4|||
48783634|NCT04934670|157048272|FG001|Overall Study|Death|0|||
48783635|NCT04934670|157048271|FG000|Overall Study|Lost to Follow-up|1|||
48399346|NCT01192022|155655418|FG003|Overall Study|Adverse Event|0|||
48399347|NCT01192022|155655419|FG004|Overall Study|Adverse Event|0|||
48399348|NCT01192022|155655415|FG000|Overall Study|Fatal Adverse Event|4|||
48399349|NCT01192022|155655416|FG001|Overall Study|Fatal Adverse Event|6|||
48399350|NCT01192022|155655417|FG002|Overall Study|Fatal Adverse Event|0|||
48399351|NCT01192022|155655418|FG003|Overall Study|Fatal Adverse Event|0|||
48399352|NCT01192022|155655419|FG004|Overall Study|Fatal Adverse Event|1|||
48399353|NCT01192022|155655415|FG000|Overall Study|Physician withdrew-patient hardship|1|||
48399354|NCT01192022|155655416|FG001|Overall Study|Physician withdrew-patient hardship|0|||
48399355|NCT01192022|155655417|FG002|Overall Study|Physician withdrew-patient hardship|0|||
48399356|NCT01192022|155655418|FG003|Overall Study|Physician withdrew-patient hardship|0|||
48399357|NCT01192022|155655419|FG004|Overall Study|Physician withdrew-patient hardship|0|||
48399358|NCT01192022|155655415|FG000|Overall Study|Patient too sick from chemotherapy|0|||
48399359|NCT01192022|155655416|FG001|Overall Study|Patient too sick from chemotherapy|1|||
48783636|NCT04934670|157048272|FG001|Overall Study|Lost to Follow-up|4|||
48399360|NCT01192022|155655417|FG002|Overall Study|Patient too sick from chemotherapy|0|||
48399361|NCT01192022|155655418|FG003|Overall Study|Patient too sick from chemotherapy|0|||
48399362|NCT01192022|155655419|FG004|Overall Study|Patient too sick from chemotherapy|0|||
48399363|NCT01192022|155655415|FG000|Overall Study|Patient needed surgery|0|||
48399364|NCT01192022|155655416|FG001|Overall Study|Patient needed surgery|1|||
48783637|NCT00099983|157048281|FG000|Overall Study|Lost to Follow-up|2|||
48399365|NCT01192022|155655417|FG002|Overall Study|Patient needed surgery|0|||
48399366|NCT01192022|155655418|FG003|Overall Study|Patient needed surgery|0|||
48399367|NCT01192022|155655419|FG004|Overall Study|Patient needed surgery|0|||
48399368|NCT01192022|155655415|FG000|Overall Study|Parents did not allow all follow up|0|||
48399369|NCT01192022|155655416|FG001|Overall Study|Parents did not allow all follow up|0|||
48399370|NCT01192022|155655417|FG002|Overall Study|Parents did not allow all follow up|0|||
48399371|NCT01192022|155655418|FG003|Overall Study|Parents did not allow all follow up|1|||
48399372|NCT01192022|155655419|FG004|Overall Study|Parents did not allow all follow up|0|||
48399373|NCT00623480|155655423|FG000|Overall Study|Lost to Follow-up|0|||
48399374|NCT00623480|155655424|FG001|Overall Study|Lost to Follow-up|1|||
48399375|NCT00623480|155655423|FG000|Overall Study|Withdrawal by Subject|2|||
48399376|NCT00623480|155655424|FG001|Overall Study|Withdrawal by Subject|4|||
48399377|NCT00623480|155655423|FG000|Overall Study|Lack of Efficacy|1|||
48399378|NCT00623480|155655424|FG001|Overall Study|Lack of Efficacy|0|||
48399379|NCT00623480|155655423|FG000|Overall Study|Non-compliant with study medication|4|||
48399380|NCT00623480|155655424|FG001|Overall Study|Non-compliant with study medication|0|||
48399381|NCT00623480|155655423|FG000|Overall Study|Protocol Violation|0|||
48399382|NCT00623480|155655424|FG001|Overall Study|Protocol Violation|1|||
48399383|NCT00623480|155655423|FG000|Overall Study|Site closed by sponsor|0|||
48399384|NCT00623480|155655424|FG001|Overall Study|Site closed by sponsor|1|||
48399385|NCT00781456|155655425|FG000|Overall Study|Adverse Event|3|||
48399386|NCT00781456|155655426|FG001|Overall Study|Adverse Event|3|||
48399387|NCT00781456|155655425|FG000|Overall Study|Withdrawal by Subject|3|||
48399388|NCT00781456|155655426|FG001|Overall Study|Withdrawal by Subject|5|||
48399389|NCT00781456|155655425|FG000|Overall Study|Protocol Violation|4|||
48399390|NCT00781456|155655426|FG001|Overall Study|Protocol Violation|1|||
48399391|NCT00781456|155655425|FG000|Overall Study|Noncompliance With Protocol|1|||
48399392|NCT00781456|155655426|FG001|Overall Study|Noncompliance With Protocol|1|||
48399393|NCT00781456|155655425|FG000|Overall Study|Lost to Follow-up|10|||
48399394|NCT00781456|155655426|FG001|Overall Study|Lost to Follow-up|5|||
48399395|NCT00781456|155655425|FG000|Overall Study|Other Reason, Unknown|0|||
48399396|NCT00781456|155655426|FG001|Overall Study|Other Reason, Unknown|1|||
48399397|NCT01902966|155655427|FG000|Overall Study|Death|1|||
48399398|NCT01902966|155655427|FG000|Overall Study|Physician Decision|1|||
48399399|NCT01902966|155655427|FG000|Overall Study|Withdrawal by Subject|1|||
48399400|NCT00711100|155655436|FG000|Overall Study|Lack of Efficacy|5|||
48399401|NCT00711100|155655436|FG000|Overall Study|Withdrawal by Subject|8|||
48399402|NCT03548558|155655437|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
48399403|NCT03548558|155655438|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
48399404|NCT03548558|155655439|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
48399405|NCT03548558|155655440|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
48399406|NCT03548558|155655441|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
48399407|NCT03548558|155655442|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
48399408|NCT03548558|155655443|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
48399409|NCT03548558|155655437|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
48399410|NCT03548558|155655438|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
48783638|NCT00099983|157048282|FG001|Overall Study|Lost to Follow-up|3|||
48783639|NCT00099983|157048281|FG000|Overall Study|Missing Source Documents|14|||
48783640|NCT00099983|157048282|FG001|Overall Study|Missing Source Documents|15|||
48783641|NCT00099983|157048281|FG000|Overall Study|Withdrawal by Subject|3|||
48783642|NCT00099983|157048282|FG001|Overall Study|Withdrawal by Subject|2|||
48783643|NCT00099983|157048281|FG000|Overall Study|Adverse Event|1|||
48783644|NCT00099983|157048282|FG001|Overall Study|Adverse Event|1|||
48783645|NCT00099983|157048281|FG000|Overall Study|Lack of Efficacy|0|||
48783646|NCT00099983|157048282|FG001|Overall Study|Lack of Efficacy|1|||
48783647|NCT00099983|157048281|FG000|Overall Study|Unable to return for appointments|1|||
48783648|NCT00099983|157048282|FG001|Overall Study|Unable to return for appointments|1|||
48783649|NCT00099983|157048281|FG000|Overall Study|Moved|1|||
48783650|NCT00099983|157048282|FG001|Overall Study|Moved|0|||
48783651|NCT00099983|157048281|FG000|Overall Study|Other psychiatric problem|1|||
48783652|NCT00099983|157048282|FG001|Overall Study|Other psychiatric problem|0|||
48783653|NCT00099983|157048281|FG000|Overall Study|Incarcerated|0|||
48783654|NCT00099983|157048282|FG001|Overall Study|Incarcerated|1|||
48783655|NCT00099983|157048281|FG000|Overall Study|Intolerant of burden of visits|0|||
48783656|NCT00099983|157048282|FG001|Overall Study|Intolerant of burden of visits|1|||
48783657|NCT00099983|157048281|FG000|Overall Study|Other issue|1|||
48783658|NCT00099983|157048282|FG001|Overall Study|Other issue|0|||
48399411|NCT03548558|155655439|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
48783659|NCT02641080|157048283|FG000|Overall Study|Physician Decision|2|||
48783660|NCT02641080|157048284|FG001|Overall Study|Physician Decision|0|||
48783661|NCT02641080|157048283|FG000|Overall Study|Withdrawal by Subject|0|||
48783662|NCT02641080|157048284|FG001|Overall Study|Withdrawal by Subject|1|||
48783663|NCT02641080|157048283|FG000|Overall Study|Rehab Center denied use of pumps|0|||
48399412|NCT03548558|155655440|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
48783664|NCT02641080|157048284|FG001|Overall Study|Rehab Center denied use of pumps|3|||
48399413|NCT03548558|155655441|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
48399414|NCT03548558|155655442|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
48399415|NCT03548558|155655443|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
48399416|NCT03548558|155655437|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
48399417|NCT03548558|155655438|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
48399418|NCT03548558|155655439|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
48399419|NCT03548558|155655440|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
48399420|NCT03548558|155655441|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
48399421|NCT03548558|155655442|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
48783665|NCT02641080|157048283|FG000|Overall Study|Lost to Follow-up|0|||
48783666|NCT02641080|157048284|FG001|Overall Study|Lost to Follow-up|3|||
48399422|NCT03548558|155655443|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
48399423|NCT03548558|155655437|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
48399424|NCT03548558|155655438|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
48399425|NCT03548558|155655439|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
48399426|NCT03548558|155655440|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
48399427|NCT03548558|155655441|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
48399428|NCT03548558|155655442|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
48399429|NCT03548558|155655443|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
48399430|NCT03548558|155655437|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
48399431|NCT03548558|155655438|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
48399432|NCT03548558|155655439|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
48399433|NCT03548558|155655440|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
48399434|NCT03548558|155655441|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
48399435|NCT03548558|155655442|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
48399436|NCT03548558|155655443|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
48399437|NCT03548558|155655437|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
48399438|NCT03548558|155655438|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
48399439|NCT03548558|155655439|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
48783667|NCT00965523|157048285|FG000|Study 221|Progressive Disease|4|||
48783668|NCT00965523|157048285|FG000|Study 221|Physician Decision|3|||
48783669|NCT00965523|157048285|FG000|Study 224|Progressive Disease|5|||
48783670|NCT00965523|157048285|FG000|Study 224|Physician Decision|1|||
48783671|NCT01136291|157048289|FG000|Overall Study|Lost to Follow-up|1|||
48783672|NCT01136291|157048290|FG001|Overall Study|Lost to Follow-up|1|||
48783673|NCT04773587|157048291|FG000|Overall Study|Lost to Follow-up|11|||
48783674|NCT04773587|157048292|FG001|Overall Study|Lost to Follow-up|3|||
48783675|NCT04773587|157048291|FG000|Overall Study|Adverse Event|6|||
48783676|NCT04773587|157048292|FG001|Overall Study|Adverse Event|3|||
48783677|NCT04773587|157048291|FG000|Overall Study|Lack of Efficacy|5|||
48783678|NCT04773587|157048292|FG001|Overall Study|Lack of Efficacy|2|||
48783679|NCT04773587|157048291|FG000|Overall Study|Withdrawal by Subject|4|||
48783680|NCT04773587|157048292|FG001|Overall Study|Withdrawal by Subject|5|||
48783681|NCT04773587|157048291|FG000|Overall Study|Noncompliance|1|||
48783682|NCT04773587|157048292|FG001|Overall Study|Noncompliance|0|||
48783683|NCT04773587|157048291|FG000|Overall Study|Protocol Violation|1|||
48783684|NCT04773587|157048292|FG001|Overall Study|Protocol Violation|0|||
48783685|NCT04773587|157048291|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
48783686|NCT04773587|157048292|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
48783687|NCT00724971|157048293|FG000|Overall Study|Adverse Event|5|||
48783688|NCT00724971|157048293|FG000|Overall Study|Withdrawal by Subject|1|||
48783689|NCT02194621|157048294|FG000|Overall Study|6 withdrew prior to randomization|2|||
48783690|NCT02194621|157048295|FG001|Overall Study|6 withdrew prior to randomization|2|||
48783691|NCT02194621|157048296|FG002|Overall Study|6 withdrew prior to randomization|2|||
48783692|NCT02194621|157048294|FG000|Overall Study|Withdrawal by Subject|4|||
48783693|NCT02194621|157048295|FG001|Overall Study|Withdrawal by Subject|4|||
48783694|NCT02194621|157048296|FG002|Overall Study|Withdrawal by Subject|7|||
48783695|NCT02345512|157048304|FG000|Overall Study|Adverse Event|1|||
48783696|NCT02345512|157048304|FG000|Overall Study|Withdrawal by Subject|1|||
48783697|NCT00253864|157048305|FG000|Overall Study|Lost to Follow-up|5|||
48783698|NCT00253864|157048306|FG001|Overall Study|Lost to Follow-up|8|||
48783699|NCT00659334|157048307|FG000|Overall Study|Screen Failure|8|||
48783700|NCT00659334|157048308|FG001|Overall Study|Screen Failure|5|||
48783701|NCT00659334|157048309|FG002|Overall Study|Screen Failure|0|||
48783702|NCT00659334|157048310|FG003|Overall Study|Screen Failure|0|||
48783703|NCT00659334|157048311|FG004|Overall Study|Screen Failure|0|||
48783704|NCT00659334|157048312|FG005|Overall Study|Screen Failure|0|||
48783705|NCT00659334|157048313|FG006|Overall Study|Screen Failure|1|||
48783706|NCT01410448|157048314|FG000|Overall Study|No conversion to everolimus|0|||
48783707|NCT01410448|157048315|FG001|Overall Study|No conversion to everolimus|24|||
48783708|NCT01410448|157048314|FG000|Overall Study|Graft loss|4|||
48783709|NCT01410448|157048315|FG001|Overall Study|Graft loss|1|||
48399440|NCT03548558|155655440|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
48399441|NCT03548558|155655441|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
48399442|NCT03548558|155655442|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
48399443|NCT03548558|155655443|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
48399444|NCT02792842|155655444|FG000|Overall Study|Adverse Event|4|||
48399445|NCT02792842|155655445|FG001|Overall Study|Adverse Event|2|||
48399446|NCT02792842|155655446|FG002|Overall Study|Adverse Event|3|||
48399447|NCT02792842|155655444|FG000|Overall Study|Withdrawal by Subject|0|||
48399448|NCT02792842|155655445|FG001|Overall Study|Withdrawal by Subject|1|||
48399449|NCT02792842|155655446|FG002|Overall Study|Withdrawal by Subject|2|||
48399450|NCT02792842|155655444|FG000|Overall Study|Lost to Follow-up|0|||
48399451|NCT02792842|155655445|FG001|Overall Study|Lost to Follow-up|0|||
48399452|NCT02792842|155655446|FG002|Overall Study|Lost to Follow-up|1|||
48399453|NCT02792842|155655444|FG000|Overall Study|Schedule delay|0|||
48399454|NCT02792842|155655445|FG001|Overall Study|Schedule delay|1|||
48783710|NCT01410448|157048314|FG000|Overall Study|Administrative issues|2|||
48783711|NCT01410448|157048315|FG001|Overall Study|Administrative issues|1|||
48356705|NCT00208325|155501142|FG000|Overall Study|Withdrawal by Subject|0|||
48356706|NCT00208325|155501143|FG001|Overall Study|Withdrawal by Subject|1|||
48356707|NCT00208325|155501144|FG002|Overall Study|Withdrawal by Subject|0|||
48356708|NCT00208325|155501145|FG003|Overall Study|Withdrawal by Subject|0|||
48356709|NCT00208325|155501142|FG000|Overall Study|Revision|4|||
48356710|NCT00208325|155501143|FG001|Overall Study|Revision|1|||
48356711|NCT00208325|155501144|FG002|Overall Study|Revision|0|||
48356712|NCT00208325|155501145|FG003|Overall Study|Revision|4|||
48356713|NCT00208325|155501142|FG000|Overall Study|Lost to Follow-up|1|||
48356714|NCT00208325|155501143|FG001|Overall Study|Lost to Follow-up|0|||
48783712|NCT01410448|157048314|FG000|Overall Study|Lost to Follow-up|1|||
48783713|NCT01410448|157048315|FG001|Overall Study|Lost to Follow-up|0|||
48783714|NCT01410448|157048314|FG000|Overall Study|Withdrawal by Subject|3|||
48783715|NCT01410448|157048315|FG001|Overall Study|Withdrawal by Subject|2|||
48783716|NCT01410448|157048314|FG000|Overall Study|Protocol Violation|0|||
48783717|NCT01410448|157048315|FG001|Overall Study|Protocol Violation|4|||
48783718|NCT01410448|157048314|FG000|Overall Study|Death|2|||
48783719|NCT01410448|157048315|FG001|Overall Study|Death|3|||
48783720|NCT01308580|157048316|FG000|Overall Study|Lost to Follow-up|12|||
48783721|NCT01308580|157048317|FG001|Overall Study|Lost to Follow-up|7|||
48783722|NCT03712917|157048323|FG000|Overall Study|Pregnancy|0|||
48783723|NCT03712917|157048324|FG001|Overall Study|Pregnancy|0|||
48783724|NCT03712917|157048325|FG002|Overall Study|Pregnancy|1|||
48783725|NCT03712917|157048323|FG000|Overall Study|Adverse Event|0|||
48783726|NCT03712917|157048324|FG001|Overall Study|Adverse Event|4|||
48783727|NCT03712917|157048325|FG002|Overall Study|Adverse Event|3|||
48783728|NCT03712917|157048323|FG000|Overall Study|Lost to Follow-up|9|||
48783729|NCT03712917|157048324|FG001|Overall Study|Lost to Follow-up|4|||
48783730|NCT03712917|157048325|FG002|Overall Study|Lost to Follow-up|5|||
48783731|NCT00110617|157048326|FG000|Overall Study|Adverse Event|2|||
48783732|NCT00110617|157048327|FG001|Overall Study|Adverse Event|4|||
48783733|NCT00110617|157048326|FG000|Overall Study|Abnormal Laboratory Value|4|||
48783734|NCT00110617|157048327|FG001|Overall Study|Abnormal Laboratory Value|2|||
48783735|NCT00110617|157048326|FG000|Overall Study|Lack of Efficacy|1|||
48783736|NCT00110617|157048327|FG001|Overall Study|Lack of Efficacy|0|||
48783737|NCT00110617|157048326|FG000|Overall Study|Patient no longer requires study drug|1|||
48356715|NCT00208325|155501144|FG002|Overall Study|Lost to Follow-up|2|||
48356716|NCT00208325|155501145|FG003|Overall Study|Lost to Follow-up|0|||
48356717|NCT00208325|155501142|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
48399455|NCT02792842|155655446|FG002|Overall Study|Schedule delay|1|||
48399456|NCT02018822|155655455|FG000|Overall Study|filling replaced by crown|0|||
48399457|NCT02018822|155655456|FG001|Overall Study|filling replaced by crown|1|||
48783738|NCT00110617|157048327|FG001|Overall Study|Patient no longer requires study drug|0|||
48783739|NCT00110617|157048326|FG000|Overall Study|Protocol Violation|5|||
48783740|NCT00110617|157048327|FG001|Overall Study|Protocol Violation|0|||
48783741|NCT00110617|157048326|FG000|Overall Study|Withdrawal by Subject|10|||
48783742|NCT00110617|157048327|FG001|Overall Study|Withdrawal by Subject|4|||
48356718|NCT00208325|155501143|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
48356719|NCT00208325|155501144|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
48356720|NCT00208325|155501145|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
48399458|NCT02018822|155655457|FG002|Overall Study|filling replaced by crown|0|||
48783743|NCT00110617|157048326|FG000|Overall Study|Lost to Follow-up|9|||
48783744|NCT00110617|157048327|FG001|Overall Study|Lost to Follow-up|1|||
48783745|NCT00110617|157048326|FG000|Overall Study|Administrative problems|6|||
48783746|NCT00110617|157048327|FG001|Overall Study|Administrative problems|5|||
48783747|NCT00110617|157048326|FG000|Overall Study|Death|1|||
48783748|NCT00110617|157048327|FG001|Overall Study|Death|1|||
48783749|NCT00110617|157048326|FG000|Overall Study|Did not receive study drug|0|||
48783750|NCT00110617|157048327|FG001|Overall Study|Did not receive study drug|12|||
48783751|NCT00618514|157049990|FG000|Overall Study|Lost to Follow-up|11|||
48783752|NCT00618514|157049991|FG001|Overall Study|Lost to Follow-up|12|||
48399459|NCT02018822|155655455|FG000|Overall Study|Physician Decision|0|||
48399460|NCT02018822|155655456|FG001|Overall Study|Physician Decision|1|||
48399461|NCT02018822|155655457|FG002|Overall Study|Physician Decision|1|||
48399462|NCT02018822|155655455|FG000|Overall Study|Lost to Follow-up|6|||
48399463|NCT02018822|155655456|FG001|Overall Study|Lost to Follow-up|6|||
48399464|NCT02018822|155655457|FG002|Overall Study|Lost to Follow-up|5|||
48399465|NCT00264875|155655458|FG000|Overall Study|Adverse Event|6|||
48399466|NCT00264875|155655458|FG000|Overall Study|Lost to Follow-up|6|||
48399467|NCT00264875|155655458|FG000|Overall Study|Protocol Violation|11|||
48399468|NCT00264875|155655458|FG000|Overall Study|Withdrawal by Subject|7|||
48399469|NCT00283595|155655459|FG000|Overall Study|Withdrawal by Subject|1|||
48399470|NCT00283595|155655460|FG001|Overall Study|Withdrawal by Subject|2|||
48399471|NCT00845728|155655465|FG000|Overall Study|Abnormal laboratory value (s)|2|||
48399472|NCT00845728|155655466|FG001|Overall Study|Abnormal laboratory value (s)|2|||
48399473|NCT00845728|155655465|FG000|Overall Study|Patient's inability to use the device|4|||
48399474|NCT00845728|155655466|FG001|Overall Study|Patient's inability to use the device|6|||
48399475|NCT00845728|155655465|FG000|Overall Study|Abnormal test procedure result (s)|7|||
48399476|NCT00845728|155655466|FG001|Overall Study|Abnormal test procedure result (s)|2|||
48399477|NCT00845728|155655465|FG000|Overall Study|Lost to Follow-up|22|||
48399478|NCT00845728|155655466|FG001|Overall Study|Lost to Follow-up|13|||
48399479|NCT00845728|155655465|FG000|Overall Study|Death|24|||
48399480|NCT00845728|155655466|FG001|Overall Study|Death|26|||
48399481|NCT00845728|155655465|FG000|Overall Study|Administrative Problems|34|||
48399482|NCT00845728|155655466|FG001|Overall Study|Administrative Problems|26|||
48399483|NCT00845728|155655465|FG000|Overall Study|Protocol Violation|36|||
48399484|NCT00845728|155655466|FG001|Overall Study|Protocol Violation|24|||
48399485|NCT00845728|155655465|FG000|Overall Study|Lack of Efficacy|51|||
48399486|NCT00845728|155655466|FG001|Overall Study|Lack of Efficacy|39|||
48399487|NCT00845728|155655465|FG000|Overall Study|Adverse Event|101|||
48399488|NCT00845728|155655466|FG001|Overall Study|Adverse Event|96|||
48399489|NCT00845728|155655465|FG000|Overall Study|Withdrawal by Subject|105|||
48399490|NCT00845728|155655466|FG001|Overall Study|Withdrawal by Subject|108|||
48399491|NCT03529773|155655467|FG000|Overall Study|Adverse Event|0|||
48399492|NCT03529773|155655468|FG001|Overall Study|Adverse Event|0|||
48399493|NCT03529773|155655469|FG002|Overall Study|Adverse Event|0|||
48399494|NCT03529773|155655470|FG003|Overall Study|Adverse Event|0|||
48399495|NCT03529773|155655471|FG004|Overall Study|Adverse Event|0|||
48399496|NCT03529773|155655472|FG005|Overall Study|Adverse Event|0|||
48399497|NCT03529773|155655473|FG006|Overall Study|Adverse Event|0|||
48399498|NCT03529773|155655474|FG007|Overall Study|Adverse Event|0|||
48399499|NCT03529773|155655475|FG008|Overall Study|Adverse Event|0|||
48399500|NCT03529773|155655476|FG009|Overall Study|Adverse Event|0|||
48399501|NCT03529773|155655477|FG010|Overall Study|Adverse Event|0|||
48399502|NCT03529773|155655478|FG011|Overall Study|Adverse Event|0|||
48399503|NCT03529773|155655479|FG012|Overall Study|Adverse Event|0|||
48399504|NCT03529773|155655480|FG013|Overall Study|Adverse Event|0|||
48399505|NCT03529773|155655481|FG014|Overall Study|Adverse Event|0|||
48399506|NCT03529773|155655482|FG015|Overall Study|Adverse Event|0|||
48399507|NCT03529773|155655483|FG016|Overall Study|Adverse Event|0|||
48399508|NCT03529773|155655484|FG017|Overall Study|Adverse Event|0|||
48399509|NCT03529773|155655485|FG018|Overall Study|Adverse Event|0|||
48399510|NCT03529773|155655486|FG019|Overall Study|Adverse Event|0|||
48399511|NCT03529773|155655487|FG020|Overall Study|Adverse Event|0|||
48399512|NCT03529773|155655488|FG021|Overall Study|Adverse Event|0|||
48399513|NCT03529773|155655489|FG022|Overall Study|Adverse Event|0|||
48399514|NCT03529773|155655490|FG023|Overall Study|Adverse Event|0|||
48399515|NCT03529773|155655491|FG024|Overall Study|Adverse Event|0|||
48399516|NCT03529773|155655492|FG025|Overall Study|Adverse Event|0|||
48399517|NCT03529773|155655493|FG026|Overall Study|Adverse Event|0|||
48783753|NCT00618514|157049992|FG002|Overall Study|Lost to Follow-up|4|||
48399518|NCT03529773|155655494|FG027|Overall Study|Adverse Event|0|||
48399519|NCT03529773|155655495|FG028|Overall Study|Adverse Event|0|||
48783754|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
48783755|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
48399520|NCT03529773|155655496|FG029|Overall Study|Adverse Event|0|||
48399521|NCT03529773|155655497|FG030|Overall Study|Adverse Event|1|||
48399522|NCT03529773|155655498|FG031|Overall Study|Adverse Event|0|||
48399523|NCT03529773|155655499|FG032|Overall Study|Adverse Event|0|||
48399524|NCT03529773|155655500|FG033|Overall Study|Adverse Event|0|||
48399525|NCT03529773|155655501|FG034|Overall Study|Adverse Event|0|||
48399526|NCT03529773|155655502|FG035|Overall Study|Adverse Event|1|||
48399527|NCT03529773|155655503|FG036|Overall Study|Adverse Event|0|||
48399528|NCT03529773|155655504|FG037|Overall Study|Adverse Event|0|||
48399529|NCT03529773|155655505|FG038|Overall Study|Adverse Event|1|||
48399530|NCT03529773|155655506|FG039|Overall Study|Adverse Event|1|||
48399531|NCT03529773|155655467|FG000|Overall Study|Death|0|||
48399532|NCT03529773|155655468|FG001|Overall Study|Death|0|||
48399533|NCT03529773|155655469|FG002|Overall Study|Death|0|||
48399534|NCT03529773|155655470|FG003|Overall Study|Death|0|||
48399535|NCT03529773|155655471|FG004|Overall Study|Death|0|||
48399536|NCT03529773|155655472|FG005|Overall Study|Death|0|||
48399537|NCT03529773|155655473|FG006|Overall Study|Death|0|||
48399538|NCT03529773|155655474|FG007|Overall Study|Death|0|||
48399539|NCT03529773|155655475|FG008|Overall Study|Death|0|||
48399540|NCT03529773|155655476|FG009|Overall Study|Death|0|||
48399541|NCT03529773|155655477|FG010|Overall Study|Death|0|||
48399542|NCT03529773|155655478|FG011|Overall Study|Death|0|||
48399543|NCT03529773|155655479|FG012|Overall Study|Death|1|||
48783756|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
48783757|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
48783758|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Adverse Event|5|||
48783759|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Adverse Event|3|||
48783760|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Adverse Event|4|||
48783761|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Adverse Event|10|||
48783762|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
48783763|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
48783764|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
48783765|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
48783766|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
48783767|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
48783768|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
48783769|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
48783770|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Pregnancy|5|||
48783771|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Pregnancy|0|||
48783772|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Pregnancy|3|||
48783773|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Pregnancy|2|||
48783774|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Non-compliance|1|||
48783775|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Non-compliance|4|||
48399544|NCT03529773|155655480|FG013|Overall Study|Death|0|||
48399545|NCT03529773|155655481|FG014|Overall Study|Death|0|||
48399546|NCT03529773|155655482|FG015|Overall Study|Death|0|||
48399547|NCT03529773|155655483|FG016|Overall Study|Death|0|||
48399548|NCT03529773|155655484|FG017|Overall Study|Death|0|||
48783776|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Non-compliance|0|||
48783777|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Non-compliance|3|||
48783778|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Other|0|||
48783779|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Other|3|||
48783780|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Other|3|||
48783781|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Other|1|||
48783782|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
48783783|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
48783784|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
48783785|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
48783786|NCT01760954|157049993|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
48783787|NCT01760954|157049994|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
48783788|NCT01760954|157049995|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
48783789|NCT01760954|157049996|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
48783790|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
48783791|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
48783792|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
48783793|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
48783794|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
48783795|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
48783796|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
48783797|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
48783798|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
48783799|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
48399549|NCT03529773|155655485|FG018|Overall Study|Death|0|||
48399550|NCT03529773|155655486|FG019|Overall Study|Death|1|||
48399551|NCT03529773|155655487|FG020|Overall Study|Death|0|||
48399552|NCT03529773|155655488|FG021|Overall Study|Death|0|||
48399553|NCT03529773|155655489|FG022|Overall Study|Death|1|||
48399554|NCT03529773|155655490|FG023|Overall Study|Death|0|||
48399555|NCT03529773|155655491|FG024|Overall Study|Death|0|||
48399556|NCT03529773|155655492|FG025|Overall Study|Death|0|||
48399557|NCT03529773|155655493|FG026|Overall Study|Death|0|||
48399558|NCT03529773|155655494|FG027|Overall Study|Death|0|||
48399559|NCT03529773|155655495|FG028|Overall Study|Death|0|||
48399560|NCT03529773|155655496|FG029|Overall Study|Death|0|||
48399561|NCT03529773|155655497|FG030|Overall Study|Death|0|||
48399562|NCT03529773|155655498|FG031|Overall Study|Death|0|||
48399563|NCT03529773|155655499|FG032|Overall Study|Death|0|||
48399564|NCT03529773|155655500|FG033|Overall Study|Death|1|||
48399565|NCT03529773|155655501|FG034|Overall Study|Death|1|||
48399566|NCT03529773|155655502|FG035|Overall Study|Death|0|||
48399567|NCT03529773|155655503|FG036|Overall Study|Death|1|||
48399568|NCT03529773|155655504|FG037|Overall Study|Death|0|||
48399569|NCT03529773|155655505|FG038|Overall Study|Death|0|||
48399570|NCT03529773|155655506|FG039|Overall Study|Death|0|||
48399571|NCT03529773|155655467|FG000|Overall Study|Lost to Follow-up|0|||
48399572|NCT03529773|155655468|FG001|Overall Study|Lost to Follow-up|0|||
48399573|NCT03529773|155655469|FG002|Overall Study|Lost to Follow-up|1|||
48399574|NCT03529773|155655470|FG003|Overall Study|Lost to Follow-up|0|||
48399575|NCT03529773|155655471|FG004|Overall Study|Lost to Follow-up|1|||
48399576|NCT03529773|155655472|FG005|Overall Study|Lost to Follow-up|1|||
48399577|NCT03529773|155655473|FG006|Overall Study|Lost to Follow-up|0|||
48399578|NCT03529773|155655474|FG007|Overall Study|Lost to Follow-up|0|||
48399579|NCT03529773|155655475|FG008|Overall Study|Lost to Follow-up|0|||
48399580|NCT03529773|155655476|FG009|Overall Study|Lost to Follow-up|0|||
48399581|NCT03529773|155655477|FG010|Overall Study|Lost to Follow-up|0|||
48399582|NCT03529773|155655478|FG011|Overall Study|Lost to Follow-up|0|||
48399583|NCT03529773|155655479|FG012|Overall Study|Lost to Follow-up|0|||
48399584|NCT03529773|155655480|FG013|Overall Study|Lost to Follow-up|1|||
48399585|NCT03529773|155655481|FG014|Overall Study|Lost to Follow-up|4|||
48399586|NCT03529773|155655482|FG015|Overall Study|Lost to Follow-up|1|||
48399587|NCT03529773|155655483|FG016|Overall Study|Lost to Follow-up|1|||
48399588|NCT03529773|155655484|FG017|Overall Study|Lost to Follow-up|0|||
48399589|NCT03529773|155655485|FG018|Overall Study|Lost to Follow-up|1|||
48399590|NCT03529773|155655486|FG019|Overall Study|Lost to Follow-up|1|||
48399591|NCT03529773|155655487|FG020|Overall Study|Lost to Follow-up|2|||
48399592|NCT03529773|155655488|FG021|Overall Study|Lost to Follow-up|4|||
48399593|NCT03529773|155655489|FG022|Overall Study|Lost to Follow-up|3|||
48399594|NCT03529773|155655490|FG023|Overall Study|Lost to Follow-up|4|||
48399595|NCT03529773|155655491|FG024|Overall Study|Lost to Follow-up|3|||
48399596|NCT03529773|155655492|FG025|Overall Study|Lost to Follow-up|5|||
48399597|NCT03529773|155655493|FG026|Overall Study|Lost to Follow-up|5|||
48399598|NCT03529773|155655494|FG027|Overall Study|Lost to Follow-up|0|||
48399599|NCT03529773|155655495|FG028|Overall Study|Lost to Follow-up|0|||
48399600|NCT03529773|155655496|FG029|Overall Study|Lost to Follow-up|0|||
48399601|NCT03529773|155655497|FG030|Overall Study|Lost to Follow-up|1|||
48399602|NCT03529773|155655498|FG031|Overall Study|Lost to Follow-up|0|||
48399603|NCT03529773|155655499|FG032|Overall Study|Lost to Follow-up|0|||
48399604|NCT03529773|155655500|FG033|Overall Study|Lost to Follow-up|1|||
48399605|NCT03529773|155655501|FG034|Overall Study|Lost to Follow-up|1|||
48399606|NCT03529773|155655502|FG035|Overall Study|Lost to Follow-up|0|||
48399607|NCT03529773|155655503|FG036|Overall Study|Lost to Follow-up|0|||
48783800|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
48783801|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
48783802|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
48783803|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
48783804|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
48783805|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
48783806|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
48783807|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
48783808|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
48783809|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
48783810|NCT01760954|157049993|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
48783811|NCT01760954|157049994|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
48399608|NCT03529773|155655504|FG037|Overall Study|Lost to Follow-up|3|||
48399609|NCT03529773|155655505|FG038|Overall Study|Lost to Follow-up|1|||
48399610|NCT03529773|155655506|FG039|Overall Study|Lost to Follow-up|1|||
48783812|NCT01760954|157049995|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
48783813|NCT01760954|157049996|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
48783814|NCT03564496|157049997|FG000|Overall Study|Withdrawal by Subject|1|||
48783815|NCT03564496|157049998|FG001|Overall Study|Withdrawal by Subject|1|||
48783816|NCT03564496|157049999|FG002|Overall Study|Withdrawal by Subject|0|||
48783817|NCT03564496|157049997|FG000|Overall Study|Screen failure|0|||
48783818|NCT03564496|157049998|FG001|Overall Study|Screen failure|3|||
48783819|NCT03564496|157049999|FG002|Overall Study|Screen failure|0|||
48783820|NCT02696850|157050001|FG000|Overall Study|Withdrawal by Subject|3|||
48399611|NCT03529773|155655467|FG000|Overall Study|No longer meets eligibility criteria|0|||
48399612|NCT03529773|155655468|FG001|Overall Study|No longer meets eligibility criteria|0|||
48399613|NCT03529773|155655469|FG002|Overall Study|No longer meets eligibility criteria|0|||
48399614|NCT03529773|155655470|FG003|Overall Study|No longer meets eligibility criteria|0|||
48399615|NCT03529773|155655471|FG004|Overall Study|No longer meets eligibility criteria|0|||
48399616|NCT03529773|155655472|FG005|Overall Study|No longer meets eligibility criteria|0|||
48399617|NCT03529773|155655473|FG006|Overall Study|No longer meets eligibility criteria|0|||
48399618|NCT03529773|155655474|FG007|Overall Study|No longer meets eligibility criteria|0|||
48430345|NCT00696657|155763708|FG008|Overall Study|Lack of Efficacy|0|||
48399619|NCT03529773|155655475|FG008|Overall Study|No longer meets eligibility criteria|0|||
48399620|NCT03529773|155655476|FG009|Overall Study|No longer meets eligibility criteria|0|||
48399621|NCT03529773|155655477|FG010|Overall Study|No longer meets eligibility criteria|0|||
48399622|NCT03529773|155655478|FG011|Overall Study|No longer meets eligibility criteria|0|||
48399623|NCT03529773|155655479|FG012|Overall Study|No longer meets eligibility criteria|0|||
48399624|NCT03529773|155655480|FG013|Overall Study|No longer meets eligibility criteria|0|||
48399625|NCT03529773|155655481|FG014|Overall Study|No longer meets eligibility criteria|0|||
48399626|NCT03529773|155655482|FG015|Overall Study|No longer meets eligibility criteria|0|||
48399627|NCT03529773|155655483|FG016|Overall Study|No longer meets eligibility criteria|0|||
48399628|NCT03529773|155655484|FG017|Overall Study|No longer meets eligibility criteria|0|||
48399629|NCT03529773|155655485|FG018|Overall Study|No longer meets eligibility criteria|0|||
48399630|NCT03529773|155655486|FG019|Overall Study|No longer meets eligibility criteria|0|||
48399631|NCT03529773|155655487|FG020|Overall Study|No longer meets eligibility criteria|0|||
48399632|NCT03529773|155655488|FG021|Overall Study|No longer meets eligibility criteria|0|||
48783821|NCT02696850|157050002|FG001|Overall Study|Withdrawal by Subject|3|||
48783822|NCT02696850|157050001|FG000|Overall Study|Lost to Follow-up|8|||
48783823|NCT02696850|157050002|FG001|Overall Study|Lost to Follow-up|5|||
48783824|NCT02621606|157050005|FG000|Overall Study|Withdrawal by Subject|0|||
48783825|NCT02621606|157050006|FG001|Overall Study|Withdrawal by Subject|1|||
48783826|NCT02621606|157050007|FG002|Overall Study|Withdrawal by Subject|0|||
48783827|NCT04820673|157050009|FG000|Overall Study|Adverse Event|6|||
48783828|NCT04820673|157050009|FG000|Overall Study|Due to Lack of Effectiveness|1|||
48783829|NCT04820673|157050009|FG000|Overall Study|Pregnancy|1|||
48783830|NCT04820673|157050009|FG000|Overall Study|Voluntary Withdrawal|20|||
48783831|NCT04820673|157050009|FG000|Overall Study|Lost to Follow-up|10|||
48783832|NCT04001829|157050010|FG000|Overall Study|Never start protocol therapy|5|||
48783833|NCT04001829|157050011|FG001|Overall Study|Never start protocol therapy|5|||
48783834|NCT04001829|157050010|FG000|Overall Study|Adverse Event|11|||
48783835|NCT04001829|157050011|FG001|Overall Study|Adverse Event|7|||
48783836|NCT04001829|157050010|FG000|Overall Study|Alternative therapy|1|||
48783837|NCT04001829|157050011|FG001|Overall Study|Alternative therapy|2|||
48783838|NCT04001829|157050010|FG000|Overall Study|Disease progression/relapse|2|||
48783839|NCT04001829|157050011|FG001|Overall Study|Disease progression/relapse|1|||
48783840|NCT04001829|157050010|FG000|Overall Study|Other complicating disease|1|||
48783841|NCT04001829|157050011|FG001|Overall Study|Other complicating disease|0|||
48783842|NCT04001829|157050010|FG000|Overall Study|Withdrawal by Subject|1|||
48783843|NCT04001829|157050011|FG001|Overall Study|Withdrawal by Subject|4|||
48783844|NCT04001829|157050010|FG000|Overall Study|Ineligible|2|||
48783845|NCT04001829|157050011|FG001|Overall Study|Ineligible|2|||
48783846|NCT04001829|157050010|FG000|Overall Study|Reason missing due to delinquent data|1|||
48783847|NCT04001829|157050011|FG001|Overall Study|Reason missing due to delinquent data|0|||
48783848|NCT00086346|157050012|FG000|Randomization|Did not receive test article|4|||
48783849|NCT00086346|157050013|FG001|Randomization|Did not receive test article|4|||
48783850|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Adverse Event|94|||
48783851|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Adverse Event|11|||
48783852|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
48783853|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
48783854|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
48783855|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
48783856|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
48783857|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
48399633|NCT03529773|155655489|FG022|Overall Study|No longer meets eligibility criteria|1|||
48399634|NCT03529773|155655490|FG023|Overall Study|No longer meets eligibility criteria|0|||
48399635|NCT03529773|155655491|FG024|Overall Study|No longer meets eligibility criteria|0|||
48399636|NCT03529773|155655492|FG025|Overall Study|No longer meets eligibility criteria|0|||
48399637|NCT03529773|155655493|FG026|Overall Study|No longer meets eligibility criteria|0|||
48399638|NCT03529773|155655494|FG027|Overall Study|No longer meets eligibility criteria|0|||
48399639|NCT03529773|155655495|FG028|Overall Study|No longer meets eligibility criteria|0|||
48399640|NCT03529773|155655496|FG029|Overall Study|No longer meets eligibility criteria|0|||
48399641|NCT03529773|155655497|FG030|Overall Study|No longer meets eligibility criteria|0|||
48783858|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
48783859|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
48783860|NCT00086346|157050012|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
48783861|NCT00086346|157050013|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
48783862|NCT04495374|157050014|FG000|Overall Study|Protocol Violation|2|||
48783863|NCT04495374|157050015|FG001|Overall Study|Protocol Violation|1|||
48783864|NCT00353704|157050016|FG000|Overall Study|Protocol Violation|3|||
48783865|NCT00353704|157050017|FG001|Overall Study|Protocol Violation|1|||
48783866|NCT02807948|157050018|FG000|Overall Study|Physician Decision|1|||
48783867|NCT02807948|157050019|FG001|Overall Study|Physician Decision|0|||
48783868|NCT01303627|157050021|FG000|Overall Study|the failure while performing URS|0|||
48783869|NCT01303627|157050022|FG001|Overall Study|the failure while performing URS|1|||
48783870|NCT02416791|157050023|FG000|6 Months|Lost to Follow-up|0|||
48783871|NCT02416791|157050024|FG001|6 Months|Lost to Follow-up|0|||
48783872|NCT02416791|157050025|FG002|6 Months|Lost to Follow-up|1|||
48783873|NCT00406029|157050034|FG000|Overall Study|Adverse Event|12|||
48783874|NCT00406029|157050035|FG001|Overall Study|Adverse Event|2|||
48783875|NCT00406029|157050036|FG002|Overall Study|Adverse Event|5|||
48783876|NCT00406029|157050037|FG003|Overall Study|Adverse Event|10|||
48783877|NCT00406029|157050038|FG004|Overall Study|Adverse Event|7|||
48783878|NCT00406029|157050034|FG000|Overall Study|Withdrawal by Subject|3|||
48783879|NCT00406029|157050035|FG001|Overall Study|Withdrawal by Subject|4|||
48399642|NCT03529773|155655498|FG031|Overall Study|No longer meets eligibility criteria|0|||
48399643|NCT03529773|155655499|FG032|Overall Study|No longer meets eligibility criteria|0|||
48399644|NCT03529773|155655500|FG033|Overall Study|No longer meets eligibility criteria|0|||
48399645|NCT03529773|155655501|FG034|Overall Study|No longer meets eligibility criteria|0|||
48399646|NCT03529773|155655502|FG035|Overall Study|No longer meets eligibility criteria|0|||
48399647|NCT03529773|155655503|FG036|Overall Study|No longer meets eligibility criteria|0|||
48399648|NCT03529773|155655504|FG037|Overall Study|No longer meets eligibility criteria|0|||
48399649|NCT03529773|155655505|FG038|Overall Study|No longer meets eligibility criteria|1|||
48399650|NCT03529773|155655506|FG039|Overall Study|No longer meets eligibility criteria|0|||
48399651|NCT03529773|155655467|FG000|Overall Study|Other|0|||
48399652|NCT03529773|155655468|FG001|Overall Study|Other|0|||
48399653|NCT03529773|155655469|FG002|Overall Study|Other|0|||
48783880|NCT00406029|157050036|FG002|Overall Study|Withdrawal by Subject|2|||
48399654|NCT03529773|155655470|FG003|Overall Study|Other|0|||
48399655|NCT03529773|155655471|FG004|Overall Study|Other|0|||
48399656|NCT03529773|155655472|FG005|Overall Study|Other|0|||
48399657|NCT03529773|155655473|FG006|Overall Study|Other|0|||
48399658|NCT03529773|155655474|FG007|Overall Study|Other|0|||
48399659|NCT03529773|155655475|FG008|Overall Study|Other|0|||
48399660|NCT03529773|155655476|FG009|Overall Study|Other|0|||
48399661|NCT03529773|155655477|FG010|Overall Study|Other|0|||
48783881|NCT00406029|157050037|FG003|Overall Study|Withdrawal by Subject|2|||
48399662|NCT03529773|155655478|FG011|Overall Study|Other|0|||
48399663|NCT03529773|155655479|FG012|Overall Study|Other|1|||
48399664|NCT03529773|155655480|FG013|Overall Study|Other|0|||
48399665|NCT03529773|155655481|FG014|Overall Study|Other|2|||
48399666|NCT03529773|155655482|FG015|Overall Study|Other|0|||
48399667|NCT03529773|155655483|FG016|Overall Study|Other|0|||
48399668|NCT03529773|155655484|FG017|Overall Study|Other|3|||
48783882|NCT00406029|157050038|FG004|Overall Study|Withdrawal by Subject|0|||
48783883|NCT00406029|157050034|FG000|Overall Study|Protocol Violation|1|||
48783884|NCT00406029|157050035|FG001|Overall Study|Protocol Violation|2|||
48783885|NCT00406029|157050036|FG002|Overall Study|Protocol Violation|0|||
48783886|NCT00406029|157050037|FG003|Overall Study|Protocol Violation|2|||
48783887|NCT00406029|157050038|FG004|Overall Study|Protocol Violation|0|||
48783888|NCT00406029|157050034|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783889|NCT00406029|157050035|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783890|NCT00406029|157050036|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
48783891|NCT00406029|157050037|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783892|NCT00406029|157050038|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
48783893|NCT00406029|157050034|FG000|Overall Study|Randomized in Error|0|||
48783894|NCT00406029|157050035|FG001|Overall Study|Randomized in Error|0|||
48783895|NCT00406029|157050036|FG002|Overall Study|Randomized in Error|2|||
48783896|NCT00406029|157050037|FG003|Overall Study|Randomized in Error|3|||
48783897|NCT00406029|157050038|FG004|Overall Study|Randomized in Error|1|||
48783898|NCT02519504|157050042|FG000|Overall Study|Protocol Violation|6|||
48783899|NCT02519504|157050043|FG001|Overall Study|Protocol Violation|5|||
48783900|NCT02519504|157050042|FG000|Overall Study|Ineligible for direct testing|12|||
48783901|NCT02519504|157050043|FG001|Overall Study|Ineligible for direct testing|12|||
48783902|NCT02519504|157050042|FG000|Overall Study|Did not participate in direct testing|95|||
48783903|NCT02519504|157050043|FG001|Overall Study|Did not participate in direct testing|86|||
48399669|NCT03529773|155655485|FG018|Overall Study|Other|0|||
48399670|NCT03529773|155655486|FG019|Overall Study|Other|0|||
48399671|NCT03529773|155655487|FG020|Overall Study|Other|1|||
48399672|NCT03529773|155655488|FG021|Overall Study|Other|0|||
48783904|NCT00856856|157050044|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
48399673|NCT03529773|155655489|FG022|Overall Study|Other|1|||
48399674|NCT03529773|155655490|FG023|Overall Study|Other|0|||
48399675|NCT03529773|155655491|FG024|Overall Study|Other|3|||
48399676|NCT03529773|155655492|FG025|Overall Study|Other|2|||
48783905|NCT00856856|157050044|FG000|4-year Clinical Follow-up|Missed visit|1|||
48783906|NCT02473952|157050049|FG000|Overall Study|Adverse Event|2|||
48783907|NCT02473952|157050050|FG001|Overall Study|Adverse Event|2|||
48783908|NCT02473952|157050049|FG000|Overall Study|Withdrawal by Subject|0|||
48783909|NCT02473952|157050050|FG001|Overall Study|Withdrawal by Subject|6|||
48783910|NCT01205685|157050051|FG000|Overall Study|Disease Progression|10|||
48783911|NCT01205685|157050051|FG000|Overall Study|Withdrawal by Subject|1|||
48783912|NCT03349710|157050052|FG000|Treatment Period|Death|0|||
48783913|NCT03349710|157050053|FG001|Treatment Period|Death|0|||
48783914|NCT03349710|157050054|FG002|Treatment Period|Death|1|||
48783915|NCT03349710|157050055|FG003|Treatment Period|Death|0|||
48783916|NCT03349710|157050052|FG000|Treatment Period|Disease Progression|0|||
48783917|NCT03349710|157050053|FG001|Treatment Period|Disease Progression|2|||
48783918|NCT03349710|157050054|FG002|Treatment Period|Disease Progression|0|||
48783919|NCT03349710|157050055|FG003|Treatment Period|Disease Progression|1|||
48783920|NCT03349710|157050052|FG000|Treatment Period|Study Drug Toxicity|1|||
48783921|NCT03349710|157050053|FG001|Treatment Period|Study Drug Toxicity|0|||
48783922|NCT03349710|157050054|FG002|Treatment Period|Study Drug Toxicity|1|||
48783923|NCT03349710|157050055|FG003|Treatment Period|Study Drug Toxicity|1|||
48783924|NCT03349710|157050052|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
48783925|NCT03349710|157050053|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
48783926|NCT03349710|157050054|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
48783927|NCT03349710|157050055|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
48783928|NCT03349710|157050052|FG000|Treatment Period|admin reason by sponsor|0|||
48783929|NCT03349710|157050053|FG001|Treatment Period|admin reason by sponsor|7|||
48783930|NCT03349710|157050054|FG002|Treatment Period|admin reason by sponsor|0|||
48783931|NCT03349710|157050055|FG003|Treatment Period|admin reason by sponsor|19|||
48783932|NCT03349710|157050052|FG000|Treatment Period|Other Reason|2|||
48783933|NCT03349710|157050053|FG001|Treatment Period|Other Reason|0|||
48783934|NCT03349710|157050054|FG002|Treatment Period|Other Reason|2|||
48783935|NCT03349710|157050055|FG003|Treatment Period|Other Reason|1|||
48783936|NCT03349710|157050052|FG000|Treatment Period|completed|6|||
48783937|NCT03349710|157050053|FG001|Treatment Period|completed|0|||
48783938|NCT03349710|157050054|FG002|Treatment Period|completed|18|||
48783939|NCT03349710|157050055|FG003|Treatment Period|completed|1|||
48783940|NCT03349710|157050052|FG000|Treatment Period|participant request to discontinue|0|||
48399677|NCT03529773|155655493|FG026|Overall Study|Other|2|||
48399678|NCT03529773|155655494|FG027|Overall Study|Other|0|||
48399679|NCT03529773|155655495|FG028|Overall Study|Other|0|||
48399680|NCT03529773|155655496|FG029|Overall Study|Other|0|||
48783941|NCT03349710|157050053|FG001|Treatment Period|participant request to discontinue|0|||
48783942|NCT03349710|157050054|FG002|Treatment Period|participant request to discontinue|4|||
48783943|NCT03349710|157050055|FG003|Treatment Period|participant request to discontinue|0|||
48783944|NCT03349710|157050052|FG000|Treatment Period|participant withdrew consent|1|||
48783945|NCT03349710|157050053|FG001|Treatment Period|participant withdrew consent|0|||
48783946|NCT03349710|157050054|FG002|Treatment Period|participant withdrew consent|0|||
48783947|NCT03349710|157050055|FG003|Treatment Period|participant withdrew consent|0|||
48783948|NCT02159482|157050056|FG000|Overall Study|Withdrawal by Subject|2|||
48783949|NCT02159482|157050056|FG000|Overall Study|Physician Decision|3|||
48783950|NCT01202773|157050059|FG000|Overall Study|Adverse Event|4|||
48783951|NCT01202773|157050060|FG001|Overall Study|Adverse Event|5|||
48783952|NCT01202773|157050061|FG002|Overall Study|Adverse Event|5|||
48783953|NCT01202773|157050059|FG000|Overall Study|Lack of Efficacy|5|||
48783954|NCT01202773|157050060|FG001|Overall Study|Lack of Efficacy|4|||
48783955|NCT01202773|157050061|FG002|Overall Study|Lack of Efficacy|9|||
48783956|NCT01202773|157050059|FG000|Overall Study|Entry Criteria Not Met|2|||
48783957|NCT01202773|157050060|FG001|Overall Study|Entry Criteria Not Met|0|||
48783958|NCT01202773|157050061|FG002|Overall Study|Entry Criteria Not Met|1|||
48783959|NCT01202773|157050059|FG000|Overall Study|Lost to Follow-up|1|||
48783960|NCT01202773|157050060|FG001|Overall Study|Lost to Follow-up|2|||
48783961|NCT01202773|157050061|FG002|Overall Study|Lost to Follow-up|2|||
48783962|NCT01202773|157050059|FG000|Overall Study|Withdrawal by Subject|13|||
48783963|NCT01202773|157050060|FG001|Overall Study|Withdrawal by Subject|6|||
48399681|NCT03529773|155655497|FG030|Overall Study|Other|0|||
48399682|NCT03529773|155655498|FG031|Overall Study|Other|0|||
48399683|NCT03529773|155655499|FG032|Overall Study|Other|0|||
48783964|NCT01202773|157050061|FG002|Overall Study|Withdrawal by Subject|5|||
48783965|NCT01202773|157050059|FG000|Overall Study|Physician Decision|2|||
48783966|NCT01202773|157050060|FG001|Overall Study|Physician Decision|0|||
48399684|NCT03529773|155655500|FG033|Overall Study|Other|0|||
48783967|NCT01202773|157050061|FG002|Overall Study|Physician Decision|0|||
48783968|NCT01202773|157050059|FG000|Overall Study|Protocol Violation|11|||
48783969|NCT01202773|157050060|FG001|Overall Study|Protocol Violation|6|||
48783970|NCT01202773|157050061|FG002|Overall Study|Protocol Violation|10|||
48399685|NCT03529773|155655501|FG034|Overall Study|Other|1|||
48399686|NCT03529773|155655502|FG035|Overall Study|Other|1|||
48783971|NCT01202773|157050059|FG000|Overall Study|Sponsor Decision|19|||
48783972|NCT01202773|157050060|FG001|Overall Study|Sponsor Decision|20|||
48783973|NCT01202773|157050061|FG002|Overall Study|Sponsor Decision|23|||
48783974|NCT03434119|157050068|FG000|Overall Study|Randomized but not treated|1|||
48783975|NCT03434119|157050069|FG001|Overall Study|Randomized but not treated|0|||
48783976|NCT03434119|157050068|FG000|Overall Study|Adverse Event|1|||
48399687|NCT03529773|155655503|FG036|Overall Study|Other|0|||
48399688|NCT03529773|155655504|FG037|Overall Study|Other|0|||
48399689|NCT03529773|155655505|FG038|Overall Study|Other|0|||
48399690|NCT03529773|155655506|FG039|Overall Study|Other|0|||
48399691|NCT03529773|155655467|FG000|Overall Study|Physician Decision|0|||
48399692|NCT03529773|155655468|FG001|Overall Study|Physician Decision|0|||
48399693|NCT03529773|155655469|FG002|Overall Study|Physician Decision|0|||
48399694|NCT03529773|155655470|FG003|Overall Study|Physician Decision|0|||
48399695|NCT03529773|155655471|FG004|Overall Study|Physician Decision|0|||
48399696|NCT03529773|155655472|FG005|Overall Study|Physician Decision|0|||
48399697|NCT03529773|155655473|FG006|Overall Study|Physician Decision|0|||
48399698|NCT03529773|155655474|FG007|Overall Study|Physician Decision|0|||
48399699|NCT03529773|155655475|FG008|Overall Study|Physician Decision|0|||
48399700|NCT03529773|155655476|FG009|Overall Study|Physician Decision|0|||
48399701|NCT03529773|155655477|FG010|Overall Study|Physician Decision|0|||
48399702|NCT03529773|155655478|FG011|Overall Study|Physician Decision|0|||
48399703|NCT03529773|155655479|FG012|Overall Study|Physician Decision|0|||
48399704|NCT03529773|155655480|FG013|Overall Study|Physician Decision|0|||
48399705|NCT03529773|155655481|FG014|Overall Study|Physician Decision|0|||
48783977|NCT03434119|157050069|FG001|Overall Study|Adverse Event|0|||
48783978|NCT03434119|157050068|FG000|Overall Study|Poor Compliance to Protocol|0|||
48783979|NCT03434119|157050069|FG001|Overall Study|Poor Compliance to Protocol|1|||
48783980|NCT03434119|157050068|FG000|Overall Study|Study Terminated by Sponsor|91|||
48783981|NCT03434119|157050069|FG001|Overall Study|Study Terminated by Sponsor|102|||
48783982|NCT03434119|157050068|FG000|Overall Study|Withdrawal by Subject|7|||
48783983|NCT03434119|157050069|FG001|Overall Study|Withdrawal by Subject|5|||
48783984|NCT03434119|157050068|FG000|Overall Study|Other than specified|7|||
48783985|NCT03434119|157050069|FG001|Overall Study|Other than specified|5|||
48783986|NCT00148343|157050077|FG000|Overall Study|Withdrawal by Subject|12|||
48783987|NCT00148343|157050078|FG001|Overall Study|Withdrawal by Subject|7|||
48783988|NCT00148343|157050077|FG000|Overall Study|Physician Decision|3|||
48783989|NCT00148343|157050078|FG001|Overall Study|Physician Decision|4|||
48783990|NCT00736996|157050082|FG000|Overall Study|Lost to Follow-up|1|||
48783991|NCT00736996|157050083|FG001|Overall Study|Lost to Follow-up|9|||
48783992|NCT00736996|157050084|FG002|Overall Study|Lost to Follow-up|2|||
48783993|NCT00941603|157050085|FG000|Overall Study|Adverse Event|10|||
48783994|NCT00941603|157050086|FG001|Overall Study|Adverse Event|15|||
48783995|NCT00941603|157050087|FG002|Overall Study|Adverse Event|5|||
48783996|NCT00941603|157050088|FG003|Overall Study|Adverse Event|1|||
48783997|NCT00941603|157050089|FG004|Overall Study|Adverse Event|4|||
48783998|NCT00941603|157050090|FG005|Overall Study|Adverse Event|0|||
48783999|NCT00941603|157050085|FG000|Overall Study|Lost to Follow-up|0|||
48784000|NCT00941603|157050086|FG001|Overall Study|Lost to Follow-up|0|||
48784001|NCT00941603|157050087|FG002|Overall Study|Lost to Follow-up|0|||
48784002|NCT00941603|157050088|FG003|Overall Study|Lost to Follow-up|1|||
48784003|NCT00941603|157050089|FG004|Overall Study|Lost to Follow-up|0|||
48784004|NCT00941603|157050090|FG005|Overall Study|Lost to Follow-up|2|||
48784005|NCT00941603|157050085|FG000|Overall Study|Withdrawal by Subject|0|||
48784006|NCT00941603|157050086|FG001|Overall Study|Withdrawal by Subject|0|||
48784007|NCT00941603|157050087|FG002|Overall Study|Withdrawal by Subject|0|||
48784008|NCT00941603|157050088|FG003|Overall Study|Withdrawal by Subject|2|||
48784009|NCT00941603|157050089|FG004|Overall Study|Withdrawal by Subject|0|||
48784010|NCT00941603|157050090|FG005|Overall Study|Withdrawal by Subject|1|||
48784011|NCT00941603|157050085|FG000|Overall Study|Protocol Violation|0|||
48784012|NCT00941603|157050086|FG001|Overall Study|Protocol Violation|1|||
48784013|NCT00941603|157050087|FG002|Overall Study|Protocol Violation|0|||
48784014|NCT00941603|157050088|FG003|Overall Study|Protocol Violation|0|||
48784015|NCT00941603|157050089|FG004|Overall Study|Protocol Violation|0|||
48784016|NCT00941603|157050090|FG005|Overall Study|Protocol Violation|0|||
48784017|NCT00941603|157050085|FG000|Overall Study|Did not meet protocol eligibility|1|||
48784018|NCT00941603|157050086|FG001|Overall Study|Did not meet protocol eligibility|0|||
48784019|NCT00941603|157050087|FG002|Overall Study|Did not meet protocol eligibility|0|||
48399706|NCT03529773|155655482|FG015|Overall Study|Physician Decision|0|||
48399707|NCT03529773|155655483|FG016|Overall Study|Physician Decision|0|||
48399708|NCT03529773|155655484|FG017|Overall Study|Physician Decision|0|||
48399709|NCT03529773|155655485|FG018|Overall Study|Physician Decision|0|||
48399710|NCT03529773|155655486|FG019|Overall Study|Physician Decision|1|||
48784020|NCT00941603|157050088|FG003|Overall Study|Did not meet protocol eligibility|0|||
48784021|NCT00941603|157050089|FG004|Overall Study|Did not meet protocol eligibility|0|||
48399711|NCT03529773|155655487|FG020|Overall Study|Physician Decision|1|||
48784022|NCT00941603|157050090|FG005|Overall Study|Did not meet protocol eligibility|0|||
48784023|NCT00583557|157050091|FG000|Overall Study|Withdrawal by Subject|18|||
48784024|NCT00583557|157050091|FG000|Overall Study|Adverse Event|9|||
48784025|NCT00583557|157050091|FG000|Overall Study|Lack of Efficacy|31|||
48784026|NCT00583557|157050091|FG000|Overall Study|Lack of Compliance|5|||
48784027|NCT00583557|157050091|FG000|Overall Study|Other|5|||
48784028|NCT00583557|157050091|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
48399712|NCT03529773|155655488|FG021|Overall Study|Physician Decision|0|||
48399713|NCT03529773|155655489|FG022|Overall Study|Physician Decision|0|||
48399714|NCT03529773|155655490|FG023|Overall Study|Physician Decision|0|||
48399715|NCT03529773|155655491|FG024|Overall Study|Physician Decision|0|||
48399716|NCT03529773|155655492|FG025|Overall Study|Physician Decision|0|||
48399717|NCT03529773|155655493|FG026|Overall Study|Physician Decision|0|||
48399718|NCT03529773|155655494|FG027|Overall Study|Physician Decision|0|||
48399719|NCT03529773|155655495|FG028|Overall Study|Physician Decision|0|||
48399720|NCT03529773|155655496|FG029|Overall Study|Physician Decision|0|||
48399721|NCT03529773|155655497|FG030|Overall Study|Physician Decision|0|||
48399722|NCT03529773|155655498|FG031|Overall Study|Physician Decision|0|||
48399723|NCT03529773|155655499|FG032|Overall Study|Physician Decision|0|||
48399724|NCT03529773|155655500|FG033|Overall Study|Physician Decision|0|||
48399725|NCT03529773|155655501|FG034|Overall Study|Physician Decision|0|||
48399726|NCT03529773|155655502|FG035|Overall Study|Physician Decision|0|||
48399727|NCT03529773|155655503|FG036|Overall Study|Physician Decision|0|||
48399728|NCT03529773|155655504|FG037|Overall Study|Physician Decision|0|||
48399729|NCT03529773|155655505|FG038|Overall Study|Physician Decision|0|||
48399730|NCT03529773|155655506|FG039|Overall Study|Physician Decision|0|||
48399731|NCT03529773|155655467|FG000|Overall Study|Protocol Violation|0|||
48399732|NCT03529773|155655468|FG001|Overall Study|Protocol Violation|0|||
48399733|NCT03529773|155655469|FG002|Overall Study|Protocol Violation|0|||
48399734|NCT03529773|155655470|FG003|Overall Study|Protocol Violation|0|||
48399735|NCT03529773|155655471|FG004|Overall Study|Protocol Violation|0|||
48399736|NCT03529773|155655472|FG005|Overall Study|Protocol Violation|0|||
48399737|NCT03529773|155655473|FG006|Overall Study|Protocol Violation|0|||
48399738|NCT03529773|155655474|FG007|Overall Study|Protocol Violation|0|||
48399739|NCT03529773|155655475|FG008|Overall Study|Protocol Violation|0|||
48399740|NCT03529773|155655476|FG009|Overall Study|Protocol Violation|0|||
48399741|NCT03529773|155655477|FG010|Overall Study|Protocol Violation|0|||
48399742|NCT03529773|155655478|FG011|Overall Study|Protocol Violation|0|||
48399743|NCT03529773|155655479|FG012|Overall Study|Protocol Violation|0|||
48399744|NCT03529773|155655480|FG013|Overall Study|Protocol Violation|0|||
48399745|NCT03529773|155655481|FG014|Overall Study|Protocol Violation|0|||
48399746|NCT03529773|155655482|FG015|Overall Study|Protocol Violation|0|||
48399747|NCT03529773|155655483|FG016|Overall Study|Protocol Violation|0|||
48399748|NCT03529773|155655484|FG017|Overall Study|Protocol Violation|0|||
48399749|NCT03529773|155655485|FG018|Overall Study|Protocol Violation|0|||
48399750|NCT03529773|155655486|FG019|Overall Study|Protocol Violation|0|||
48399751|NCT03529773|155655487|FG020|Overall Study|Protocol Violation|0|||
48399752|NCT03529773|155655488|FG021|Overall Study|Protocol Violation|0|||
48399753|NCT03529773|155655489|FG022|Overall Study|Protocol Violation|0|||
48399754|NCT03529773|155655490|FG023|Overall Study|Protocol Violation|0|||
48399755|NCT03529773|155655491|FG024|Overall Study|Protocol Violation|0|||
48399756|NCT03529773|155655492|FG025|Overall Study|Protocol Violation|0|||
48399757|NCT03529773|155655493|FG026|Overall Study|Protocol Violation|0|||
48399758|NCT03529773|155655494|FG027|Overall Study|Protocol Violation|0|||
48399759|NCT03529773|155655495|FG028|Overall Study|Protocol Violation|0|||
48399760|NCT03529773|155655496|FG029|Overall Study|Protocol Violation|0|||
48399761|NCT03529773|155655497|FG030|Overall Study|Protocol Violation|1|||
48399762|NCT03529773|155655498|FG031|Overall Study|Protocol Violation|0|||
48399763|NCT03529773|155655499|FG032|Overall Study|Protocol Violation|0|||
48399764|NCT03529773|155655500|FG033|Overall Study|Protocol Violation|0|||
48399765|NCT03529773|155655501|FG034|Overall Study|Protocol Violation|0|||
48399766|NCT03529773|155655502|FG035|Overall Study|Protocol Violation|0|||
48399767|NCT03529773|155655503|FG036|Overall Study|Protocol Violation|0|||
48399768|NCT03529773|155655504|FG037|Overall Study|Protocol Violation|0|||
48399769|NCT03529773|155655505|FG038|Overall Study|Protocol Violation|0|||
48399770|NCT03529773|155655506|FG039|Overall Study|Protocol Violation|0|||
48399771|NCT03529773|155655467|FG000|Overall Study|Withdrawal by Subject|0|||
48399772|NCT03529773|155655468|FG001|Overall Study|Withdrawal by Subject|0|||
48399773|NCT03529773|155655469|FG002|Overall Study|Withdrawal by Subject|0|||
48399774|NCT03529773|155655470|FG003|Overall Study|Withdrawal by Subject|0|||
48399775|NCT03529773|155655471|FG004|Overall Study|Withdrawal by Subject|0|||
48399776|NCT03529773|155655472|FG005|Overall Study|Withdrawal by Subject|0|||
48399777|NCT03529773|155655473|FG006|Overall Study|Withdrawal by Subject|0|||
48399778|NCT03529773|155655474|FG007|Overall Study|Withdrawal by Subject|1|||
48399779|NCT03529773|155655475|FG008|Overall Study|Withdrawal by Subject|0|||
48399780|NCT03529773|155655476|FG009|Overall Study|Withdrawal by Subject|1|||
48399781|NCT03529773|155655477|FG010|Overall Study|Withdrawal by Subject|1|||
48399782|NCT03529773|155655478|FG011|Overall Study|Withdrawal by Subject|0|||
48399783|NCT03529773|155655479|FG012|Overall Study|Withdrawal by Subject|0|||
48399784|NCT03529773|155655480|FG013|Overall Study|Withdrawal by Subject|0|||
48399785|NCT03529773|155655481|FG014|Overall Study|Withdrawal by Subject|0|||
48399786|NCT03529773|155655482|FG015|Overall Study|Withdrawal by Subject|3|||
48399787|NCT03529773|155655483|FG016|Overall Study|Withdrawal by Subject|0|||
48399788|NCT03529773|155655484|FG017|Overall Study|Withdrawal by Subject|2|||
48399789|NCT03529773|155655485|FG018|Overall Study|Withdrawal by Subject|3|||
48399790|NCT03529773|155655486|FG019|Overall Study|Withdrawal by Subject|1|||
48399791|NCT03529773|155655487|FG020|Overall Study|Withdrawal by Subject|3|||
48399792|NCT03529773|155655488|FG021|Overall Study|Withdrawal by Subject|1|||
48399793|NCT03529773|155655489|FG022|Overall Study|Withdrawal by Subject|1|||
48399794|NCT03529773|155655490|FG023|Overall Study|Withdrawal by Subject|2|||
48399795|NCT03529773|155655491|FG024|Overall Study|Withdrawal by Subject|2|||
48399796|NCT03529773|155655492|FG025|Overall Study|Withdrawal by Subject|4|||
48399797|NCT03529773|155655493|FG026|Overall Study|Withdrawal by Subject|2|||
48399798|NCT03529773|155655494|FG027|Overall Study|Withdrawal by Subject|1|||
48399799|NCT03529773|155655495|FG028|Overall Study|Withdrawal by Subject|1|||
48399800|NCT03529773|155655496|FG029|Overall Study|Withdrawal by Subject|0|||
48399801|NCT03529773|155655497|FG030|Overall Study|Withdrawal by Subject|0|||
48399802|NCT03529773|155655498|FG031|Overall Study|Withdrawal by Subject|0|||
48399803|NCT03529773|155655499|FG032|Overall Study|Withdrawal by Subject|0|||
48399804|NCT03529773|155655500|FG033|Overall Study|Withdrawal by Subject|0|||
48399805|NCT03529773|155655501|FG034|Overall Study|Withdrawal by Subject|1|||
48784029|NCT01131312|157050092|FG000|Overall Study|Lost to Follow-up|425|||
48784030|NCT01131312|157050093|FG001|Overall Study|Lost to Follow-up|229|||
48784031|NCT01131312|157050094|FG002|Overall Study|Lost to Follow-up|351|||
48784032|NCT02401672|157050097|FG000|Overall Study|Withdrawal by Subject|1|||
48784033|NCT02401672|157050098|FG001|Overall Study|Withdrawal by Subject|3|||
48784034|NCT04389840|157050101|FG000|Overall Study|Adverse Event|0|||
48784035|NCT04389840|157050102|FG001|Overall Study|Adverse Event|0|||
48784036|NCT04389840|157050103|FG002|Overall Study|Adverse Event|0|||
48784037|NCT04389840|157050104|FG003|Overall Study|Adverse Event|1|||
48784038|NCT04389840|157050105|FG004|Overall Study|Adverse Event|0|||
48784039|NCT04389840|157050106|FG005|Overall Study|Adverse Event|0|||
48784040|NCT04389840|157050101|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
48399806|NCT03529773|155655502|FG035|Overall Study|Withdrawal by Subject|2|||
48399807|NCT03529773|155655503|FG036|Overall Study|Withdrawal by Subject|0|||
48399808|NCT03529773|155655504|FG037|Overall Study|Withdrawal by Subject|2|||
48399809|NCT03529773|155655505|FG038|Overall Study|Withdrawal by Subject|1|||
48399810|NCT03529773|155655506|FG039|Overall Study|Withdrawal by Subject|1|||
48399811|NCT03529773|155655467|FG000|Overall Study|Screen Failure|0|||
48399812|NCT03529773|155655468|FG001|Overall Study|Screen Failure|0|||
48399813|NCT03529773|155655469|FG002|Overall Study|Screen Failure|0|||
48399814|NCT03529773|155655470|FG003|Overall Study|Screen Failure|0|||
48399815|NCT03529773|155655471|FG004|Overall Study|Screen Failure|0|||
48399816|NCT03529773|155655472|FG005|Overall Study|Screen Failure|0|||
48399817|NCT03529773|155655473|FG006|Overall Study|Screen Failure|0|||
48399818|NCT03529773|155655474|FG007|Overall Study|Screen Failure|0|||
48399819|NCT03529773|155655475|FG008|Overall Study|Screen Failure|0|||
48399820|NCT03529773|155655476|FG009|Overall Study|Screen Failure|0|||
48399821|NCT03529773|155655477|FG010|Overall Study|Screen Failure|0|||
48399822|NCT03529773|155655478|FG011|Overall Study|Screen Failure|0|||
48399823|NCT03529773|155655479|FG012|Overall Study|Screen Failure|0|||
48784041|NCT04389840|157050102|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
48784042|NCT04389840|157050103|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
48784043|NCT04389840|157050104|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
48784044|NCT04389840|157050105|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
48784045|NCT04389840|157050106|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
48784046|NCT04389840|157050101|FG000|Overall Study|Death|0|||
48784047|NCT04389840|157050102|FG001|Overall Study|Death|1|||
48784048|NCT04389840|157050103|FG002|Overall Study|Death|0|||
48784049|NCT04389840|157050104|FG003|Overall Study|Death|0|||
48784050|NCT04389840|157050105|FG004|Overall Study|Death|0|||
48784051|NCT04389840|157050106|FG005|Overall Study|Death|0|||
48784052|NCT03321019|157050107|FG000|Overall Study|Withdrawal by Subject|0|||
48784053|NCT03321019|157050108|FG001|Overall Study|Withdrawal by Subject|6|||
48784054|NCT03321019|157050107|FG000|Overall Study|Lost to Follow-up|0|||
48784055|NCT03321019|157050108|FG001|Overall Study|Lost to Follow-up|22|||
48784056|NCT00709722|157050110|FG000|Overall Study|Adverse Event|1|||
48784057|NCT03359096|157050111|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
48784058|NCT03359096|157050112|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
48784059|NCT03359096|157050111|FG000|First Intervention (4 Weeks)|Death|1|||
48784060|NCT03359096|157050112|FG001|First Intervention (4 Weeks)|Death|0|||
48784061|NCT03359096|157050111|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
48399824|NCT03529773|155655480|FG013|Overall Study|Screen Failure|0|||
48399825|NCT03529773|155655481|FG014|Overall Study|Screen Failure|0|||
48399826|NCT03529773|155655482|FG015|Overall Study|Screen Failure|0|||
48399827|NCT03529773|155655483|FG016|Overall Study|Screen Failure|0|||
48399828|NCT03529773|155655484|FG017|Overall Study|Screen Failure|0|||
48399829|NCT03529773|155655485|FG018|Overall Study|Screen Failure|0|||
48399830|NCT03529773|155655486|FG019|Overall Study|Screen Failure|0|||
48399831|NCT03529773|155655487|FG020|Overall Study|Screen Failure|0|||
48784062|NCT03359096|157050112|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
48784063|NCT02007577|157050114|FG000|Overall Study|Adverse Event|1|||
48784064|NCT02007577|157050115|FG001|Overall Study|Adverse Event|0|||
48784065|NCT02007577|157050114|FG000|Overall Study|Withdrawal by Subject|0|||
48399832|NCT03529773|155655488|FG021|Overall Study|Screen Failure|0|||
48399833|NCT03529773|155655489|FG022|Overall Study|Screen Failure|0|||
48399834|NCT03529773|155655490|FG023|Overall Study|Screen Failure|0|||
48399835|NCT03529773|155655491|FG024|Overall Study|Screen Failure|0|||
48399836|NCT03529773|155655492|FG025|Overall Study|Screen Failure|0|||
48399837|NCT03529773|155655493|FG026|Overall Study|Screen Failure|0|||
48399838|NCT03529773|155655494|FG027|Overall Study|Screen Failure|0|||
48399839|NCT03529773|155655495|FG028|Overall Study|Screen Failure|0|||
48399840|NCT03529773|155655496|FG029|Overall Study|Screen Failure|0|||
48399841|NCT03529773|155655497|FG030|Overall Study|Screen Failure|0|||
48399842|NCT03529773|155655498|FG031|Overall Study|Screen Failure|0|||
48784066|NCT02007577|157050115|FG001|Overall Study|Withdrawal by Subject|1|||
48399843|NCT03529773|155655499|FG032|Overall Study|Screen Failure|0|||
48399844|NCT03529773|155655500|FG033|Overall Study|Screen Failure|0|||
48399845|NCT03529773|155655501|FG034|Overall Study|Screen Failure|0|||
48399846|NCT03529773|155655502|FG035|Overall Study|Screen Failure|0|||
48399847|NCT03529773|155655503|FG036|Overall Study|Screen Failure|1|||
48399848|NCT03529773|155655504|FG037|Overall Study|Screen Failure|1|||
48784067|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
48784068|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
48784069|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
48784070|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
48784071|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
48784072|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
48784073|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
48784074|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
48784075|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Other|0|||
48784076|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Other|1|||
48784077|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Other|0|||
48784078|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Other|0|||
48784079|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
48784080|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
48784081|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
48784082|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
48784083|NCT05799495|157050119|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
48399849|NCT03529773|155655505|FG038|Overall Study|Screen Failure|0|||
48399850|NCT03529773|155655506|FG039|Overall Study|Screen Failure|1|||
48399851|NCT03529773|155655467|FG000|Overall Study|Randomized but not vaccinated|0|||
48399852|NCT03529773|155655468|FG001|Overall Study|Randomized but not vaccinated|0|||
48399853|NCT03529773|155655469|FG002|Overall Study|Randomized but not vaccinated|0|||
48399854|NCT03529773|155655470|FG003|Overall Study|Randomized but not vaccinated|0|||
48399855|NCT03529773|155655471|FG004|Overall Study|Randomized but not vaccinated|0|||
48399856|NCT03529773|155655472|FG005|Overall Study|Randomized but not vaccinated|0|||
48399857|NCT03529773|155655473|FG006|Overall Study|Randomized but not vaccinated|0|||
48399858|NCT03529773|155655474|FG007|Overall Study|Randomized but not vaccinated|0|||
48399859|NCT03529773|155655475|FG008|Overall Study|Randomized but not vaccinated|0|||
48399860|NCT03529773|155655476|FG009|Overall Study|Randomized but not vaccinated|0|||
48399861|NCT03529773|155655477|FG010|Overall Study|Randomized but not vaccinated|0|||
48399862|NCT03529773|155655478|FG011|Overall Study|Randomized but not vaccinated|0|||
48399863|NCT03529773|155655479|FG012|Overall Study|Randomized but not vaccinated|0|||
48399864|NCT03529773|155655480|FG013|Overall Study|Randomized but not vaccinated|0|||
48399865|NCT03529773|155655481|FG014|Overall Study|Randomized but not vaccinated|0|||
48399866|NCT03529773|155655482|FG015|Overall Study|Randomized but not vaccinated|0|||
48399867|NCT03529773|155655483|FG016|Overall Study|Randomized but not vaccinated|0|||
48399868|NCT03529773|155655484|FG017|Overall Study|Randomized but not vaccinated|1|||
48399869|NCT03529773|155655485|FG018|Overall Study|Randomized but not vaccinated|0|||
48399870|NCT03529773|155655486|FG019|Overall Study|Randomized but not vaccinated|0|||
48399871|NCT03529773|155655487|FG020|Overall Study|Randomized but not vaccinated|0|||
48399872|NCT03529773|155655488|FG021|Overall Study|Randomized but not vaccinated|0|||
48399873|NCT03529773|155655489|FG022|Overall Study|Randomized but not vaccinated|0|||
48399874|NCT03529773|155655490|FG023|Overall Study|Randomized but not vaccinated|0|||
48784084|NCT05799495|157050120|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
48784085|NCT05799495|157050121|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
48784086|NCT05799495|157050122|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
48784087|NCT05799495|157050119|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48784088|NCT05799495|157050120|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48784089|NCT05799495|157050121|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
48784090|NCT05799495|157050122|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
48784091|NCT00214136|157050123|FG000|Overall Study|Death|5|||
48784092|NCT01024387|157050124|FG000|Overall Study|Radiographic Progression|29|||
48784093|NCT01024387|157050124|FG000|Overall Study|Symptomatic Progression|10|||
48784094|NCT01024387|157050124|FG000|Overall Study|Physician Decision|5|||
48784095|NCT01024387|157050124|FG000|Overall Study|Withdrawal by Subject|5|||
48784096|NCT01024387|157050124|FG000|Overall Study|Death|2|||
48399875|NCT03529773|155655491|FG024|Overall Study|Randomized but not vaccinated|0|||
48399876|NCT03529773|155655492|FG025|Overall Study|Randomized but not vaccinated|0|||
48399877|NCT03529773|155655493|FG026|Overall Study|Randomized but not vaccinated|0|||
48399878|NCT03529773|155655494|FG027|Overall Study|Randomized but not vaccinated|1|||
48399879|NCT03529773|155655495|FG028|Overall Study|Randomized but not vaccinated|0|||
48399880|NCT03529773|155655496|FG029|Overall Study|Randomized but not vaccinated|0|||
48399881|NCT03529773|155655497|FG030|Overall Study|Randomized but not vaccinated|0|||
48399882|NCT03529773|155655498|FG031|Overall Study|Randomized but not vaccinated|0|||
48399883|NCT03529773|155655499|FG032|Overall Study|Randomized but not vaccinated|0|||
48399884|NCT03529773|155655500|FG033|Overall Study|Randomized but not vaccinated|0|||
48784097|NCT01024387|157050124|FG000|Overall Study|Prolonged Treatment Delay|1|||
48784098|NCT01024387|157050124|FG000|Overall Study|Adverse Event|3|||
48784099|NCT01024387|157050124|FG000|Overall Study|Other|5|||
48784100|NCT04287920|157050125|FG000|Overall Study|Lost to Follow-up|1|||
48784101|NCT04287920|157050126|FG001|Overall Study|Lost to Follow-up|1|||
48784102|NCT04287920|157050125|FG000|Overall Study|Withdrawal by Subject|0|||
48784103|NCT04287920|157050126|FG001|Overall Study|Withdrawal by Subject|3|||
48784104|NCT01226745|157050127|FG000|Overall Study|Did not complete schedule of assessments|8|||
48784105|NCT01226745|157050128|FG001|Overall Study|Did not complete schedule of assessments|3|||
48784106|NCT01226745|157050129|FG002|Overall Study|Did not complete schedule of assessments|6|||
48784107|NCT01226745|157050130|FG003|Overall Study|Did not complete schedule of assessments|0|||
48784108|NCT01226745|157050131|FG004|Overall Study|Did not complete schedule of assessments|0|||
48784109|NCT01226745|157050132|FG005|Overall Study|Did not complete schedule of assessments|1|||
48784110|NCT01226745|157050127|FG000|Overall Study|Lost to Follow-up|2|||
48784111|NCT01226745|157050128|FG001|Overall Study|Lost to Follow-up|6|||
48399885|NCT03529773|155655501|FG034|Overall Study|Randomized but not vaccinated|0|||
48399886|NCT03529773|155655502|FG035|Overall Study|Randomized but not vaccinated|0|||
48399887|NCT03529773|155655503|FG036|Overall Study|Randomized but not vaccinated|0|||
48399888|NCT03529773|155655504|FG037|Overall Study|Randomized but not vaccinated|0|||
48399889|NCT03529773|155655505|FG038|Overall Study|Randomized but not vaccinated|0|||
48399890|NCT03529773|155655506|FG039|Overall Study|Randomized but not vaccinated|0|||
48399891|NCT01496066|155655508|FG000|Overall Study|Lost to Follow-up|8|||
48399892|NCT01496066|155655509|FG001|Overall Study|Lost to Follow-up|5|||
48399893|NCT01496066|155655508|FG000|Overall Study|Explant|3|||
48399894|NCT01496066|155655509|FG001|Overall Study|Explant|0|||
48399895|NCT01496066|155655508|FG000|Overall Study|Death|1|||
48399896|NCT01496066|155655509|FG001|Overall Study|Death|4|||
48399897|NCT03237065|155655510|FG000|Overall Study|Adverse Event|0|||
48399898|NCT03237065|155655511|FG001|Overall Study|Adverse Event|2|||
48399899|NCT03237065|155655510|FG000|Overall Study|Protocol Violation|0|||
48399900|NCT03237065|155655511|FG001|Overall Study|Protocol Violation|1|||
48399901|NCT03237065|155655510|FG000|Overall Study|Withdrawal by Subject|3|||
48399902|NCT03237065|155655511|FG001|Overall Study|Withdrawal by Subject|0|||
48399903|NCT03237065|155655510|FG000|Overall Study|Lost to Follow-up|1|||
48399904|NCT03237065|155655511|FG001|Overall Study|Lost to Follow-up|0|||
48399905|NCT03237065|155655510|FG000|Overall Study|Unable to obtain venous access|0|||
48399906|NCT03237065|155655511|FG001|Overall Study|Unable to obtain venous access|1|||
48399907|NCT00267748|155655512|FG000|Non-randomized Period|Progressive disease|10|||
48399908|NCT00267748|155655513|FG001|Non-randomized Period|Progressive disease|0|||
48399909|NCT00267748|155655514|FG002|Non-randomized Period|Progressive disease|0|||
48399910|NCT00267748|155655512|FG000|Non-randomized Period|Adverse Event|8|||
48399911|NCT00267748|155655513|FG001|Non-randomized Period|Adverse Event|0|||
48399912|NCT00267748|155655514|FG002|Non-randomized Period|Adverse Event|0|||
48399913|NCT00267748|155655512|FG000|Non-randomized Period|Death|1|||
48399914|NCT00267748|155655513|FG001|Non-randomized Period|Death|0|||
48399915|NCT00267748|155655514|FG002|Non-randomized Period|Death|0|||
48399916|NCT00267748|155655512|FG000|Non-randomized Period|Participant not willing to participate|1|||
48399917|NCT00267748|155655513|FG001|Non-randomized Period|Participant not willing to participate|0|||
48399918|NCT00267748|155655514|FG002|Non-randomized Period|Participant not willing to participate|0|||
48399919|NCT00267748|155655512|FG000|Non-randomized Period|Other|3|||
48399920|NCT00267748|155655513|FG001|Non-randomized Period|Other|0|||
48399921|NCT00267748|155655514|FG002|Non-randomized Period|Other|0|||
48784112|NCT01226745|157050129|FG002|Overall Study|Lost to Follow-up|6|||
48784113|NCT01226745|157050130|FG003|Overall Study|Lost to Follow-up|1|||
48784114|NCT01226745|157050131|FG004|Overall Study|Lost to Follow-up|1|||
48399922|NCT00267748|155655512|FG000|Randomized Period|Death|0|||
48399923|NCT00267748|155655513|FG001|Randomized Period|Death|2|||
48399924|NCT00267748|155655514|FG002|Randomized Period|Death|3|||
48399925|NCT00267748|155655512|FG000|Randomized Period|Adverse Event|0|||
48399926|NCT00267748|155655513|FG001|Randomized Period|Adverse Event|23|||
48399927|NCT00267748|155655514|FG002|Randomized Period|Adverse Event|25|||
48399928|NCT00267748|155655512|FG000|Randomized Period|Global deterioration of health status|0|||
48399929|NCT00267748|155655513|FG001|Randomized Period|Global deterioration of health status|6|||
48399930|NCT00267748|155655514|FG002|Randomized Period|Global deterioration of health status|7|||
48784115|NCT01226745|157050132|FG005|Overall Study|Lost to Follow-up|2|||
48399931|NCT00267748|155655512|FG000|Randomized Period|Lost to Follow-up|0|||
48399932|NCT00267748|155655513|FG001|Randomized Period|Lost to Follow-up|1|||
48399933|NCT00267748|155655514|FG002|Randomized Period|Lost to Follow-up|0|||
48399934|NCT00267748|155655512|FG000|Randomized Period|Objective progression or relapse|0|||
48399935|NCT00267748|155655513|FG001|Randomized Period|Objective progression or relapse|77|||
48399936|NCT00267748|155655514|FG002|Randomized Period|Objective progression or relapse|86|||
48399937|NCT00267748|155655512|FG000|Randomized Period|Withdrawal by Subject|0|||
48399938|NCT00267748|155655513|FG001|Randomized Period|Withdrawal by Subject|9|||
48399939|NCT00267748|155655514|FG002|Randomized Period|Withdrawal by Subject|2|||
48784116|NCT01226745|157050127|FG000|Overall Study|Death|1|||
48784117|NCT01226745|157050128|FG001|Overall Study|Death|0|||
48784118|NCT01226745|157050129|FG002|Overall Study|Death|0|||
48784119|NCT01226745|157050130|FG003|Overall Study|Death|0|||
48784120|NCT01226745|157050131|FG004|Overall Study|Death|0|||
48784121|NCT01226745|157050132|FG005|Overall Study|Death|1|||
48784122|NCT01226745|157050127|FG000|Overall Study|Other|6|||
48784123|NCT01226745|157050128|FG001|Overall Study|Other|7|||
48784124|NCT01226745|157050129|FG002|Overall Study|Other|8|||
48784125|NCT01226745|157050130|FG003|Overall Study|Other|4|||
48784126|NCT01226745|157050131|FG004|Overall Study|Other|3|||
48784127|NCT01226745|157050132|FG005|Overall Study|Other|1|||
48784128|NCT04307186|157050133|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
48784129|NCT04307186|157050133|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
48784130|NCT04307186|157050133|FG000|Washout 3-14 Days|Progressive disease|1|||
48399940|NCT00267748|155655512|FG000|Randomized Period|Other|0|||
48399941|NCT00267748|155655513|FG001|Randomized Period|Other|9|||
48399942|NCT00267748|155655514|FG002|Randomized Period|Other|6|||
48399943|NCT00267748|155655512|FG000|Randomized Period|randomized but not treated|0|||
48399944|NCT00267748|155655513|FG001|Randomized Period|randomized but not treated|0|||
48399945|NCT00267748|155655514|FG002|Randomized Period|randomized but not treated|3|||
48399946|NCT03245450|155655515|FG000|Overall Study|Radiological disease progression|3|||
48399947|NCT03245450|155655516|FG001|Overall Study|Radiological disease progression|3|||
48399948|NCT03245450|155655517|FG002|Overall Study|Radiological disease progression|2|||
48399949|NCT03245450|155655518|FG003|Overall Study|Radiological disease progression|2|||
48399950|NCT03245450|155655519|FG004|Overall Study|Radiological disease progression|7|||
48399951|NCT03245450|155655520|FG005|Overall Study|Radiological disease progression|6|||
48399952|NCT03245450|155655521|FG006|Overall Study|Radiological disease progression|6|||
48399953|NCT03245450|155655515|FG000|Overall Study|Clinical disease progression|0|||
48399954|NCT03245450|155655516|FG001|Overall Study|Clinical disease progression|0|||
48399955|NCT03245450|155655517|FG002|Overall Study|Clinical disease progression|1|||
48399956|NCT03245450|155655518|FG003|Overall Study|Clinical disease progression|0|||
48399957|NCT03245450|155655519|FG004|Overall Study|Clinical disease progression|0|||
48399958|NCT03245450|155655520|FG005|Overall Study|Clinical disease progression|2|||
48399959|NCT03245450|155655521|FG006|Overall Study|Clinical disease progression|0|||
48399960|NCT03245450|155655515|FG000|Overall Study|Other|0|||
48399961|NCT03245450|155655516|FG001|Overall Study|Other|0|||
48399962|NCT03245450|155655517|FG002|Overall Study|Other|0|||
48399963|NCT03245450|155655518|FG003|Overall Study|Other|1|||
48399964|NCT03245450|155655519|FG004|Overall Study|Other|1|||
48399965|NCT03245450|155655520|FG005|Overall Study|Other|1|||
48399966|NCT03245450|155655521|FG006|Overall Study|Other|1|||
48399967|NCT03245450|155655515|FG000|Overall Study|Withdrawal by Subject|0|||
48399968|NCT03245450|155655516|FG001|Overall Study|Withdrawal by Subject|1|||
48399969|NCT03245450|155655517|FG002|Overall Study|Withdrawal by Subject|0|||
48399970|NCT03245450|155655518|FG003|Overall Study|Withdrawal by Subject|0|||
48399971|NCT03245450|155655519|FG004|Overall Study|Withdrawal by Subject|0|||
48399972|NCT03245450|155655520|FG005|Overall Study|Withdrawal by Subject|0|||
48399973|NCT03245450|155655521|FG006|Overall Study|Withdrawal by Subject|0|||
48399974|NCT03245450|155655515|FG000|Overall Study|Adverse Event|0|||
48399975|NCT03245450|155655516|FG001|Overall Study|Adverse Event|0|||
48399976|NCT03245450|155655517|FG002|Overall Study|Adverse Event|0|||
48784131|NCT04307186|157050133|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
48784132|NCT04307186|157050133|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
48784133|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
48784134|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
48399977|NCT03245450|155655518|FG003|Overall Study|Adverse Event|0|||
48399978|NCT03245450|155655519|FG004|Overall Study|Adverse Event|1|||
48399979|NCT03245450|155655520|FG005|Overall Study|Adverse Event|0|||
48399980|NCT03245450|155655521|FG006|Overall Study|Adverse Event|2|||
48399981|NCT02268058|155655522|FG000|Overall Study|Protocol Violation|1|||
48399982|NCT02268058|155655523|FG001|Overall Study|Protocol Violation|0|||
48399983|NCT02268058|155655524|FG002|Overall Study|Protocol Violation|0|||
48399984|NCT02268058|155655525|FG003|Overall Study|Protocol Violation|0|||
48399985|NCT00705939|155655527|FG000|Overall Study|Protocol Violation|0|||
48399986|NCT00705939|155655528|FG001|Overall Study|Protocol Violation|0|||
48784135|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
48784136|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
48784137|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
48784138|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
48784139|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
48784140|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
48784141|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
48784142|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
48784143|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
48784144|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
48784145|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
48784146|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
48784147|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
48784148|NCT00355082|157050134|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
48784149|NCT00355082|157050135|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
48784150|NCT00355082|157050136|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
48784151|NCT00355082|157050134|FG000|Continuation Phase|Adverse Event|2|||
48784152|NCT00355082|157050135|FG001|Continuation Phase|Adverse Event|0|||
48784153|NCT00355082|157050136|FG002|Continuation Phase|Adverse Event|1|||
48784154|NCT00355082|157050134|FG000|Continuation Phase|Lost to Follow-up|2|||
48784155|NCT00355082|157050135|FG001|Continuation Phase|Lost to Follow-up|0|||
48784156|NCT00355082|157050136|FG002|Continuation Phase|Lost to Follow-up|1|||
48784157|NCT00355082|157050134|FG000|Continuation Phase|Protocol Violation|1|||
48784158|NCT00355082|157050135|FG001|Continuation Phase|Protocol Violation|0|||
48784159|NCT00355082|157050136|FG002|Continuation Phase|Protocol Violation|1|||
48784160|NCT00355082|157050134|FG000|Continuation Phase|Withdrawal by Subject|4|||
48784161|NCT00355082|157050135|FG001|Continuation Phase|Withdrawal by Subject|0|||
48784162|NCT00355082|157050136|FG002|Continuation Phase|Withdrawal by Subject|0|||
48784163|NCT00355082|157050134|FG000|Continuation Phase|Lack of Efficacy|5|||
48784164|NCT00355082|157050135|FG001|Continuation Phase|Lack of Efficacy|0|||
48784165|NCT00355082|157050136|FG002|Continuation Phase|Lack of Efficacy|0|||
48784166|NCT00355082|157050134|FG000|Continuation Phase|Site Closed by Sponsor|8|||
48784167|NCT00355082|157050135|FG001|Continuation Phase|Site Closed by Sponsor|0|||
48784168|NCT00355082|157050136|FG002|Continuation Phase|Site Closed by Sponsor|0|||
48784169|NCT00355082|157050134|FG000|Continuation Phase|Scheduling Error|1|||
48399987|NCT00705939|155655529|FG002|Overall Study|Protocol Violation|1|||
48784170|NCT00355082|157050135|FG001|Continuation Phase|Scheduling Error|0|||
48784171|NCT00355082|157050136|FG002|Continuation Phase|Scheduling Error|0|||
48784172|NCT00355082|157050134|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
48784173|NCT00355082|157050135|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
48784174|NCT00355082|157050136|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
48784175|NCT01808313|157050137|FG000|Overall Study|Adverse Event|5|||
48784176|NCT01808313|157050137|FG000|Overall Study|Protocol Violation|2|||
48784177|NCT01808313|157050137|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48784178|NCT01808313|157050137|FG000|Overall Study|Lost to Follow-up|1|||
48784179|NCT01808313|157050137|FG000|Overall Study|Physician Decision|1|||
48784180|NCT00710424|157050150|FG000|Overall Study|Adverse Event|30|||
48784181|NCT00710424|157050151|FG001|Overall Study|Adverse Event|12|||
48784182|NCT00710424|157050150|FG000|Overall Study|Lack of Efficacy|4|||
48784183|NCT00710424|157050151|FG001|Overall Study|Lack of Efficacy|5|||
48784184|NCT00710424|157050150|FG000|Overall Study|Withdrawal by Subject|5|||
48784185|NCT00710424|157050151|FG001|Overall Study|Withdrawal by Subject|3|||
48784186|NCT00710424|157050150|FG000|Overall Study|Lost to Follow-up|0|||
48784187|NCT00710424|157050151|FG001|Overall Study|Lost to Follow-up|1|||
48784188|NCT00710424|157050150|FG000|Overall Study|Refused medication, no side effects|1|||
48784189|NCT00710424|157050151|FG001|Overall Study|Refused medication, no side effects|0|||
48784190|NCT00710424|157050150|FG000|Overall Study|Non-compliance with stable analgesia|1|||
48784191|NCT00710424|157050151|FG001|Overall Study|Non-compliance with stable analgesia|0|||
48784192|NCT00710424|157050150|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
48784193|NCT00710424|157050151|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
48784194|NCT00710424|157050150|FG000|Overall Study|Subject thought medication changed|1|||
48784195|NCT00710424|157050151|FG001|Overall Study|Subject thought medication changed|0|||
48784196|NCT00710424|157050150|FG000|Overall Study|Ceased treatment due to travel|1|||
48784197|NCT00710424|157050151|FG001|Overall Study|Ceased treatment due to travel|0|||
48784198|NCT00710424|157050150|FG000|Overall Study|Subject preferred paracetamol|0|||
48784199|NCT00710424|157050151|FG001|Overall Study|Subject preferred paracetamol|1|||
48784200|NCT00710424|157050150|FG000|Overall Study|Felt good so stopped treatment|0|||
48784201|NCT00710424|157050151|FG001|Overall Study|Felt good so stopped treatment|1|||
48784202|NCT03859323|157051639|FG000|Overall Study|Lost to Follow-up|0|||
48784203|NCT03859323|157051640|FG001|Overall Study|Lost to Follow-up|0|||
48784204|NCT03859323|157051641|FG002|Overall Study|Lost to Follow-up|0|||
48784205|NCT03859323|157051642|FG003|Overall Study|Lost to Follow-up|0|||
48784206|NCT03859323|157051643|FG004|Overall Study|Lost to Follow-up|0|||
48784207|NCT03859323|157051644|FG005|Overall Study|Lost to Follow-up|0|||
48784208|NCT03859323|157051645|FG006|Overall Study|Lost to Follow-up|1|||
48399988|NCT00705939|155655527|FG000|Overall Study|Withdrawal by Subject|0|||
48399989|NCT00705939|155655528|FG001|Overall Study|Withdrawal by Subject|1|||
48399990|NCT00705939|155655529|FG002|Overall Study|Withdrawal by Subject|3|||
48784209|NCT03859323|157051646|FG007|Overall Study|Lost to Follow-up|0|||
48784210|NCT03859323|157051647|FG008|Overall Study|Lost to Follow-up|0|||
48784211|NCT03859323|157051648|FG009|Overall Study|Lost to Follow-up|0|||
48784212|NCT03859323|157051649|FG010|Overall Study|Lost to Follow-up|0|||
48784213|NCT03859323|157051650|FG011|Overall Study|Lost to Follow-up|0|||
48784214|NCT03859323|157051651|FG012|Overall Study|Lost to Follow-up|0|||
48784215|NCT03859323|157051639|FG000|Overall Study|Withdrawal by Subject|0|||
48784216|NCT03859323|157051640|FG001|Overall Study|Withdrawal by Subject|0|||
48784217|NCT03859323|157051641|FG002|Overall Study|Withdrawal by Subject|1|||
48784218|NCT03859323|157051642|FG003|Overall Study|Withdrawal by Subject|0|||
48784219|NCT03859323|157051643|FG004|Overall Study|Withdrawal by Subject|0|||
48784220|NCT03859323|157051644|FG005|Overall Study|Withdrawal by Subject|1|||
48784221|NCT03859323|157051645|FG006|Overall Study|Withdrawal by Subject|0|||
48784222|NCT03859323|157051646|FG007|Overall Study|Withdrawal by Subject|0|||
48784223|NCT03859323|157051647|FG008|Overall Study|Withdrawal by Subject|0|||
48784224|NCT03859323|157051648|FG009|Overall Study|Withdrawal by Subject|1|||
48784225|NCT03859323|157051649|FG010|Overall Study|Withdrawal by Subject|1|||
48784226|NCT03859323|157051650|FG011|Overall Study|Withdrawal by Subject|2|||
48784227|NCT03859323|157051651|FG012|Overall Study|Withdrawal by Subject|1|||
48784228|NCT03859323|157051639|FG000|Overall Study|Pregnancy|0|||
48784229|NCT03859323|157051640|FG001|Overall Study|Pregnancy|0|||
48784230|NCT03859323|157051641|FG002|Overall Study|Pregnancy|0|||
48784231|NCT03859323|157051642|FG003|Overall Study|Pregnancy|0|||
48784232|NCT03859323|157051643|FG004|Overall Study|Pregnancy|0|||
48784233|NCT03859323|157051644|FG005|Overall Study|Pregnancy|0|||
48784234|NCT03859323|157051645|FG006|Overall Study|Pregnancy|0|||
48784235|NCT03859323|157051646|FG007|Overall Study|Pregnancy|0|||
48784236|NCT03859323|157051647|FG008|Overall Study|Pregnancy|0|||
48784237|NCT03859323|157051648|FG009|Overall Study|Pregnancy|1|||
48784238|NCT03859323|157051649|FG010|Overall Study|Pregnancy|0|||
48784239|NCT03859323|157051650|FG011|Overall Study|Pregnancy|0|||
48784240|NCT03859323|157051651|FG012|Overall Study|Pregnancy|0|||
48784241|NCT01432366|157051655|FG000|Overall Study|Non-Responder|7|||
48784242|NCT01432366|157051655|FG000|Overall Study|Adverse Event|8|||
48784243|NCT01432366|157051655|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
48784244|NCT01432366|157051655|FG000|Overall Study|Pregnancy|1|||
48784245|NCT01432366|157051655|FG000|Overall Study|Lost to Follow-up|13|||
48784246|NCT01432366|157051655|FG000|Overall Study|Lack of Efficacy|1|||
48784247|NCT01432366|157051655|FG000|Overall Study|Site Closed|20|||
48784248|NCT01432366|157051655|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
48784249|NCT01432366|157051655|FG000|Overall Study|Other|14|||
48784250|NCT01917526|157051659|FG000|Overall Study|Protocol Violation|1|||
48784251|NCT01917526|157051660|FG001|Overall Study|Protocol Violation|1|||
48784252|NCT03131648|157051664|FG000|Initial Treatment Period|Not dosed|2|||
48784253|NCT03131648|157051665|FG001|Initial Treatment Period|Not dosed|2|||
48784254|NCT03131648|157051666|FG002|Initial Treatment Period|Not dosed|0|||
48784255|NCT03131648|157051667|FG003|Initial Treatment Period|Not dosed|0|||
48784256|NCT03131648|157051668|FG004|Initial Treatment Period|Not dosed|0|||
48784257|NCT03131648|157051669|FG005|Initial Treatment Period|Not dosed|0|||
48784258|NCT03131648|157051670|FG006|Initial Treatment Period|Not dosed|0|||
48784259|NCT03131648|157051671|FG007|Initial Treatment Period|Not dosed|0|||
48784260|NCT03131648|157051664|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
48784261|NCT03131648|157051665|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
48784262|NCT03131648|157051666|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784263|NCT03131648|157051667|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784264|NCT03131648|157051668|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784265|NCT03131648|157051669|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784266|NCT03131648|157051670|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784267|NCT03131648|157051671|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
48784268|NCT03131648|157051664|FG000|Open-label Treatment|Discontinued IMP|0|||
48784269|NCT03131648|157051665|FG001|Open-label Treatment|Discontinued IMP|0|||
48784270|NCT03131648|157051666|FG002|Open-label Treatment|Discontinued IMP|0|||
48784271|NCT03131648|157051667|FG003|Open-label Treatment|Discontinued IMP|0|||
48784272|NCT03131648|157051668|FG004|Open-label Treatment|Discontinued IMP|0|||
48784273|NCT03131648|157051669|FG005|Open-label Treatment|Discontinued IMP|0|||
48784274|NCT03131648|157051670|FG006|Open-label Treatment|Discontinued IMP|112|||
48784275|NCT03131648|157051671|FG007|Open-label Treatment|Discontinued IMP|0|||
48784276|NCT03131648|157051664|FG000|Open-label Treatment|Completed Week 50|0|||
48784277|NCT03131648|157051665|FG001|Open-label Treatment|Completed Week 50|0|||
48784278|NCT03131648|157051666|FG002|Open-label Treatment|Completed Week 50|0|||
48784279|NCT03131648|157051667|FG003|Open-label Treatment|Completed Week 50|0|||
48784280|NCT03131648|157051668|FG004|Open-label Treatment|Completed Week 50|0|||
48784281|NCT03131648|157051669|FG005|Open-label Treatment|Completed Week 50|0|||
48399991|NCT00705939|155655527|FG000|Overall Study|Physician Decision|0|||
48399992|NCT00705939|155655528|FG001|Overall Study|Physician Decision|1|||
48399993|NCT00705939|155655529|FG002|Overall Study|Physician Decision|0|||
48399994|NCT01537211|155655530|FG000|Overall Study|Lost to Follow-up|0|||
48399995|NCT01537211|155655531|FG001|Overall Study|Lost to Follow-up|1|||
48399996|NCT00797823|155655532|FG000|First Period (Initial Randomization)|Physician Decision|1|||
48399997|NCT00797823|155655533|FG001|First Period (Initial Randomization)|Physician Decision|0|||
48399998|NCT00797823|155655534|FG002|First Period (Initial Randomization)|Physician Decision|0|||
48399999|NCT01707693|155655535|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
48400000|NCT01707693|155655536|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
48400001|NCT01707693|155655535|FG000|Overall Study Allocation|Protocol Violation|4|||
48400002|NCT01707693|155655536|FG001|Overall Study Allocation|Protocol Violation|3|||
48400003|NCT01707693|155655535|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
48400004|NCT01707693|155655536|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
48400005|NCT01707693|155655535|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
48400006|NCT01707693|155655536|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
48400007|NCT00391222|155655538|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
48400008|NCT00391222|155655539|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
48400009|NCT00391222|155655540|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
48400010|NCT00391222|155655541|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
48400011|NCT00391222|155655538|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
48400012|NCT00391222|155655539|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
48400013|NCT00391222|155655540|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
48400014|NCT00391222|155655541|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
48400015|NCT00391222|155655538|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
48400016|NCT00391222|155655539|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
48400017|NCT00391222|155655540|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
48400018|NCT00391222|155655541|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
48400019|NCT00391222|155655538|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
48400020|NCT00391222|155655539|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
48400021|NCT00391222|155655540|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
48400022|NCT00391222|155655541|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
48400023|NCT00391222|155655538|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
48400024|NCT00391222|155655539|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
48400025|NCT00391222|155655540|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
48400026|NCT00391222|155655541|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
48784282|NCT03131648|157051670|FG006|Open-label Treatment|Completed Week 50|6|||
48784283|NCT03131648|157051671|FG007|Open-label Treatment|Completed Week 50|0|||
48784284|NCT03131648|157051664|FG000|Maintenance Treatment Period|Not dosed|0|||
48784285|NCT03131648|157051665|FG001|Maintenance Treatment Period|Not dosed|0|||
48784286|NCT03131648|157051666|FG002|Maintenance Treatment Period|Not dosed|3|||
48784287|NCT03131648|157051667|FG003|Maintenance Treatment Period|Not dosed|2|||
48784288|NCT03131648|157051668|FG004|Maintenance Treatment Period|Not dosed|1|||
48784289|NCT03131648|157051669|FG005|Maintenance Treatment Period|Not dosed|0|||
48784290|NCT03131648|157051670|FG006|Maintenance Treatment Period|Not dosed|0|||
48784291|NCT03131648|157051671|FG007|Maintenance Treatment Period|Not dosed|0|||
48784292|NCT03131648|157051664|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
48784293|NCT03131648|157051665|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
48784294|NCT03131648|157051666|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
48784295|NCT03131648|157051667|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
48784296|NCT03131648|157051668|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
48784297|NCT03131648|157051669|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
48784298|NCT03131648|157051670|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
48784299|NCT03131648|157051671|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
48784300|NCT03131648|157051664|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48784301|NCT03131648|157051665|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48784302|NCT03131648|157051666|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
48784303|NCT03131648|157051667|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
48784304|NCT03131648|157051668|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
48784305|NCT03131648|157051669|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
48784306|NCT03131648|157051670|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48784307|NCT03131648|157051671|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
48784308|NCT03131648|157051664|FG000|Maintenance Treatment Period|Completed Week 50|0|||
48400027|NCT00391222|155655538|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
48400028|NCT00391222|155655539|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
48400029|NCT00391222|155655540|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
48784309|NCT03131648|157051665|FG001|Maintenance Treatment Period|Completed Week 50|0|||
48784310|NCT03131648|157051666|FG002|Maintenance Treatment Period|Completed Week 50|0|||
48784311|NCT03131648|157051667|FG003|Maintenance Treatment Period|Completed Week 50|0|||
48400030|NCT00391222|155655541|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
48400031|NCT00391222|155655538|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
48400032|NCT00391222|155655539|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
48400033|NCT00391222|155655540|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
48400034|NCT00391222|155655541|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
48400035|NCT00391222|155655538|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
48400036|NCT00391222|155655539|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
48784312|NCT03131648|157051668|FG004|Maintenance Treatment Period|Completed Week 50|1|||
48784313|NCT03131648|157051669|FG005|Maintenance Treatment Period|Completed Week 50|0|||
48784314|NCT03131648|157051670|FG006|Maintenance Treatment Period|Completed Week 50|0|||
48784315|NCT03131648|157051671|FG007|Maintenance Treatment Period|Completed Week 50|0|||
48784316|NCT03131648|157051664|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784317|NCT03131648|157051665|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784318|NCT03131648|157051666|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784319|NCT03131648|157051667|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784320|NCT03131648|157051668|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784321|NCT03131648|157051669|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784322|NCT03131648|157051670|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
48784323|NCT03131648|157051671|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
48784324|NCT01753193|157051676|FG000|Overall Study|Withdrawal by Subject|23|||
48784325|NCT01753193|157051676|FG000|Overall Study|Lost to Follow-up|6|||
48784326|NCT01753193|157051676|FG000|Overall Study|Death|1|||
48784327|NCT01753193|157051676|FG000|Overall Study|Other|16|||
48784328|NCT02682264|157051677|FG000|Overall Study|Withdrawal by Subject|56|||
48784329|NCT02682264|157051678|FG001|Overall Study|Withdrawal by Subject|45|||
48784330|NCT02682264|157051677|FG000|Overall Study|Lost to Follow-up|49|||
48784331|NCT02682264|157051678|FG001|Overall Study|Lost to Follow-up|41|||
48784332|NCT02682264|157051677|FG000|Overall Study|Lack of Efficacy|14|||
48784333|NCT02682264|157051678|FG001|Overall Study|Lack of Efficacy|16|||
48784334|NCT02682264|157051677|FG000|Overall Study|Withdrawal by Parent|6|||
48784335|NCT02682264|157051678|FG001|Overall Study|Withdrawal by Parent|7|||
48784336|NCT02682264|157051677|FG000|Overall Study|Adverse Event|9|||
48784337|NCT02682264|157051678|FG001|Overall Study|Adverse Event|0|||
48784338|NCT02682264|157051677|FG000|Overall Study|Noncompliance with study drug|1|||
48784339|NCT02682264|157051678|FG001|Overall Study|Noncompliance with study drug|4|||
48784340|NCT02682264|157051677|FG000|Overall Study|Pregnancy|1|||
48784341|NCT02682264|157051678|FG001|Overall Study|Pregnancy|2|||
48784342|NCT02682264|157051677|FG000|Overall Study|Recovery|1|||
48784343|NCT02682264|157051678|FG001|Overall Study|Recovery|2|||
48784344|NCT02682264|157051677|FG000|Overall Study|Progressive Disease|1|||
48784345|NCT02682264|157051678|FG001|Overall Study|Progressive Disease|0|||
48784346|NCT02682264|157051677|FG000|Overall Study|Technical Problems|0|||
48784347|NCT02682264|157051678|FG001|Overall Study|Technical Problems|1|||
48784348|NCT02682264|157051677|FG000|Overall Study|Moved abroad and unable to continue|0|||
48784349|NCT02682264|157051678|FG001|Overall Study|Moved abroad and unable to continue|3|||
48784350|NCT02682264|157051677|FG000|Overall Study|Stopped test article application|0|||
48784351|NCT02682264|157051678|FG001|Overall Study|Stopped test article application|1|||
48784352|NCT00971048|157051679|FG000|Overall Study|Protocol Violation|1|||
48784353|NCT00971048|157051680|FG001|Overall Study|Protocol Violation|2|||
48784354|NCT00971048|157051681|FG002|Overall Study|Protocol Violation|0|||
48784355|NCT00971048|157051682|FG003|Overall Study|Protocol Violation|1|||
48784356|NCT00971048|157051679|FG000|Overall Study|Adverse Event|0|||
48784357|NCT00971048|157051680|FG001|Overall Study|Adverse Event|0|||
48784358|NCT00971048|157051681|FG002|Overall Study|Adverse Event|1|||
48784359|NCT00971048|157051682|FG003|Overall Study|Adverse Event|0|||
48784360|NCT00971048|157051679|FG000|Overall Study|Physician Decision|0|||
48784361|NCT00971048|157051680|FG001|Overall Study|Physician Decision|0|||
48784362|NCT00971048|157051681|FG002|Overall Study|Physician Decision|0|||
48784363|NCT00971048|157051682|FG003|Overall Study|Physician Decision|1|||
48784364|NCT02843568|157051683|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
48784365|NCT02843568|157051684|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
48400037|NCT00391222|155655540|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
48400038|NCT00391222|155655541|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
48400039|NCT00391222|155655538|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
48400040|NCT00391222|155655539|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
48784366|NCT02843568|157051683|FG000|Overall Study|Death|3|||
48784367|NCT02843568|157051684|FG001|Overall Study|Death|3|||
48784368|NCT02843568|157051683|FG000|Overall Study|Withdrawal by Subject|1|||
48784369|NCT02843568|157051684|FG001|Overall Study|Withdrawal by Subject|1|||
48784370|NCT02843568|157051683|FG000|Overall Study|Lost to Follow-up|2|||
48784371|NCT02843568|157051684|FG001|Overall Study|Lost to Follow-up|0|||
48784372|NCT03879798|157051685|FG000|Overall Study|Adverse Event|0|||
48784373|NCT03879798|157051686|FG001|Overall Study|Adverse Event|0|||
48784374|NCT03879798|157051687|FG002|Overall Study|Adverse Event|0|||
48784375|NCT03879798|157051688|FG003|Overall Study|Adverse Event|0|||
48400041|NCT00391222|155655540|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
48400042|NCT00391222|155655541|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
48400043|NCT00391222|155655538|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
48400044|NCT00391222|155655539|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
48400045|NCT00391222|155655540|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
48400046|NCT00391222|155655541|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
48400047|NCT00391222|155655538|FG000|Period III (Double-Blind Treatment)|Other|6|||
48400048|NCT00391222|155655539|FG001|Period III (Double-Blind Treatment)|Other|1|||
48400049|NCT00391222|155655540|FG002|Period III (Double-Blind Treatment)|Other|6|||
48784376|NCT03879798|157051689|FG004|Overall Study|Adverse Event|0|||
48784377|NCT03879798|157051690|FG005|Overall Study|Adverse Event|1|||
48784378|NCT03879798|157051685|FG000|Overall Study|Lack of Efficacy|0|||
48784379|NCT03879798|157051686|FG001|Overall Study|Lack of Efficacy|0|||
48784380|NCT03879798|157051687|FG002|Overall Study|Lack of Efficacy|0|||
48784381|NCT03879798|157051688|FG003|Overall Study|Lack of Efficacy|0|||
48784382|NCT03879798|157051689|FG004|Overall Study|Lack of Efficacy|0|||
48784383|NCT03879798|157051690|FG005|Overall Study|Lack of Efficacy|1|||
48784384|NCT03879798|157051685|FG000|Overall Study|Withdrawal by Subject|0|||
48784385|NCT03879798|157051686|FG001|Overall Study|Withdrawal by Subject|0|||
48784386|NCT03879798|157051687|FG002|Overall Study|Withdrawal by Subject|0|||
48784387|NCT03879798|157051688|FG003|Overall Study|Withdrawal by Subject|0|||
48784388|NCT03879798|157051689|FG004|Overall Study|Withdrawal by Subject|0|||
48784389|NCT03879798|157051690|FG005|Overall Study|Withdrawal by Subject|1|||
48784390|NCT05348681|157051692|FG000|Overall Study|Study terminated by Sponsor|8|||
48784391|NCT05348681|157051693|FG001|Overall Study|Study terminated by Sponsor|3|||
48784392|NCT05348681|157051692|FG000|Overall Study|Withdrawal by Subject|1|||
48784393|NCT05348681|157051693|FG001|Overall Study|Withdrawal by Subject|1|||
48784394|NCT05348681|157051692|FG000|Overall Study|Lost to Follow-up|1|||
48784395|NCT05348681|157051693|FG001|Overall Study|Lost to Follow-up|1|||
48784396|NCT05348681|157051692|FG000|Overall Study|Adverse Event|1|||
48784397|NCT05348681|157051693|FG001|Overall Study|Adverse Event|0|||
48784398|NCT05348681|157051692|FG000|Overall Study|Other|2|||
48784399|NCT05348681|157051693|FG001|Overall Study|Other|1|||
48784400|NCT02493361|157051694|FG000|Overall Study|Withdrawal by Subject|3|||
48784401|NCT02219932|157051696|FG000|Overall Study|Other|5|||
48784402|NCT02219932|157051697|FG001|Overall Study|Other|11|||
48784403|NCT02219932|157051696|FG000|Overall Study|Death|1|||
48784404|NCT02219932|157051697|FG001|Overall Study|Death|1|||
48784405|NCT02219932|157051696|FG000|Overall Study|Investigator Decision|0|||
48784406|NCT02219932|157051697|FG001|Overall Study|Investigator Decision|1|||
48784407|NCT02219932|157051696|FG000|Overall Study|Consent Withdrawn|11|||
48784408|NCT02219932|157051697|FG001|Overall Study|Consent Withdrawn|7|||
48784409|NCT02219932|157051696|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
48784410|NCT02219932|157051697|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
48784411|NCT02219932|157051696|FG000|Overall Study|Protocol Violation|10|||
48784412|NCT02219932|157051697|FG001|Overall Study|Protocol Violation|6|||
48784413|NCT02219932|157051696|FG000|Overall Study|Pregnancy|1|||
48784414|NCT02219932|157051697|FG001|Overall Study|Pregnancy|0|||
48784415|NCT02219932|157051696|FG000|Overall Study|Lost to Follow-up|4|||
48400050|NCT00391222|155655541|FG003|Period III (Double-Blind Treatment)|Other|0|||
48400051|NCT04849780|155655542|FG000|Period 1|Covid-19 Related|1|||
48400052|NCT04849780|155655543|FG001|Period 1|Covid-19 Related|0|||
48400053|NCT04849780|155655542|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
48400054|NCT04849780|155655543|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
48400055|NCT04849780|155655542|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
48400056|NCT04849780|155655543|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
48400057|NCT00725075|155655544|FG000|Overall Study|Use of Excluded Medication|0|||
48784416|NCT02219932|157051697|FG001|Overall Study|Lost to Follow-up|2|||
48784417|NCT02219932|157051696|FG000|Overall Study|Adverse Event|23|||
48784418|NCT02219932|157051697|FG001|Overall Study|Adverse Event|21|||
48784419|NCT03321981|157051700|FG000|Overall Study|Progressive Disease (PD)|15|||
48400058|NCT00725075|155655545|FG001|Overall Study|Use of Excluded Medication|1|||
48400059|NCT00725075|155655546|FG002|Overall Study|Use of Excluded Medication|0|||
48784420|NCT03321981|157051701|FG001|Overall Study|Progressive Disease (PD)|30|||
48784421|NCT03321981|157051702|FG002|Overall Study|Progressive Disease (PD)|47|||
48784422|NCT03321981|157051700|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
48784423|NCT03321981|157051701|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
48784424|NCT03321981|157051702|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
48784425|NCT03321981|157051700|FG000|Overall Study|Adverse Event|0|||
48784426|NCT03321981|157051701|FG001|Overall Study|Adverse Event|0|||
48784427|NCT03321981|157051702|FG002|Overall Study|Adverse Event|2|||
48784428|NCT03321981|157051700|FG000|Overall Study|symptomatic deterioration|0|||
48784429|NCT03321981|157051701|FG001|Overall Study|symptomatic deterioration|1|||
48400060|NCT00725075|155655544|FG000|Overall Study|Protocol Violation|0|||
48400061|NCT00725075|155655545|FG001|Overall Study|Protocol Violation|0|||
48400062|NCT00725075|155655546|FG002|Overall Study|Protocol Violation|1|||
48784430|NCT03321981|157051702|FG002|Overall Study|symptomatic deterioration|1|||
48784431|NCT03321981|157051700|FG000|Overall Study|Lack of compliance|0|||
48784432|NCT03321981|157051701|FG001|Overall Study|Lack of compliance|1|||
48784433|NCT03321981|157051702|FG002|Overall Study|Lack of compliance|0|||
48784434|NCT03321981|157051700|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
48784435|NCT03321981|157051701|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
48784436|NCT03321981|157051702|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
48784437|NCT03321981|157051700|FG000|Overall Study|Death|0|||
48784438|NCT03321981|157051701|FG001|Overall Study|Death|1|||
48784439|NCT03321981|157051702|FG002|Overall Study|Death|0|||
48784440|NCT03321981|157051700|FG000|Overall Study|Subject withdrawal of investigational product|0|||
48784441|NCT03321981|157051701|FG001|Overall Study|Subject withdrawal of investigational product|1|||
48784442|NCT03321981|157051702|FG002|Overall Study|Subject withdrawal of investigational product|0|||
48784443|NCT03321981|157051700|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
48784444|NCT03321981|157051701|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
48784445|NCT03321981|157051702|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
48784446|NCT03321981|157051700|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
48784447|NCT03321981|157051701|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
48784448|NCT03321981|157051702|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
48784449|NCT00096135|157051710|FG000|Overall Study|Physician Decision|20|||
48784450|NCT00096135|157051711|FG001|Overall Study|Physician Decision|4|||
48784451|NCT00096135|157051710|FG000|Overall Study|Refusal of further protocol therapy|4|||
48784452|NCT00096135|157051711|FG001|Overall Study|Refusal of further protocol therapy|1|||
48784453|NCT00096135|157051710|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
48784454|NCT00096135|157051711|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
48784455|NCT00096135|157051710|FG000|Overall Study|Other, specify|15|||
48784456|NCT00096135|157051711|FG001|Overall Study|Other, specify|3|||
48784457|NCT00096135|157051710|FG000|Overall Study|Ineligible|2|||
48784458|NCT00096135|157051711|FG001|Overall Study|Ineligible|0|||
48784459|NCT00968669|157051714|FG000|Overall Study|Lost to Follow-up|5|||
48784460|NCT00968669|157051715|FG001|Overall Study|Lost to Follow-up|2|||
48784461|NCT00968669|157051716|FG002|Overall Study|Lost to Follow-up|1|||
48784462|NCT00968669|157051717|FG003|Overall Study|Lost to Follow-up|4|||
48784463|NCT00968669|157051714|FG000|Overall Study|Withdrawal by Subject|9|||
48784464|NCT00968669|157051715|FG001|Overall Study|Withdrawal by Subject|7|||
48784465|NCT00968669|157051716|FG002|Overall Study|Withdrawal by Subject|5|||
48784466|NCT00968669|157051717|FG003|Overall Study|Withdrawal by Subject|3|||
48784467|NCT00968669|157051714|FG000|Overall Study|Pregnancy|0|||
48784468|NCT00968669|157051715|FG001|Overall Study|Pregnancy|0|||
48784469|NCT00968669|157051716|FG002|Overall Study|Pregnancy|2|||
48784470|NCT00968669|157051717|FG003|Overall Study|Pregnancy|0|||
48784471|NCT00968669|157051714|FG000|Overall Study|AE|1|||
48784472|NCT00968669|157051715|FG001|Overall Study|AE|0|||
48784473|NCT00968669|157051716|FG002|Overall Study|AE|0|||
48784474|NCT00968669|157051717|FG003|Overall Study|AE|0|||
48784475|NCT00968669|157051714|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
48784476|NCT00968669|157051715|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
48784477|NCT00968669|157051716|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
48784478|NCT00968669|157051717|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
48784479|NCT00968669|157051714|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
48784480|NCT00968669|157051715|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
48784481|NCT00968669|157051716|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
48784482|NCT00968669|157051717|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
48784483|NCT00968669|157051714|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
48784484|NCT00968669|157051715|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
48784485|NCT00968669|157051716|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
48784486|NCT00968669|157051717|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
48784487|NCT00968669|157051714|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
48784488|NCT00968669|157051715|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
48784489|NCT00968669|157051716|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
48784490|NCT00968669|157051717|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
48784491|NCT00968669|157051714|FG000|Overall Study|EARLY WITHDRAWAL|0|||
48784492|NCT00968669|157051715|FG001|Overall Study|EARLY WITHDRAWAL|1|||
48400063|NCT00725075|155655544|FG000|Overall Study|Lost to Follow-up|1|||
48400064|NCT00725075|155655545|FG001|Overall Study|Lost to Follow-up|0|||
48400065|NCT00725075|155655546|FG002|Overall Study|Lost to Follow-up|0|||
48784493|NCT00968669|157051716|FG002|Overall Study|EARLY WITHDRAWAL|0|||
48430346|NCT00696657|155763700|FG000|Overall Study|Withdrawal criteria|1|||
48784494|NCT00968669|157051717|FG003|Overall Study|EARLY WITHDRAWAL|0|||
48784495|NCT00968669|157051714|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
48784496|NCT00968669|157051715|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
48784497|NCT00968669|157051716|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
48784498|NCT00968669|157051717|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
48784499|NCT00968669|157051714|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
48784500|NCT00968669|157051715|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
48784501|NCT00968669|157051716|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
48784502|NCT00968669|157051717|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
48784503|NCT00968669|157051714|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
48784504|NCT00968669|157051715|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
48784505|NCT00968669|157051716|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
48784506|NCT00968669|157051717|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
48784507|NCT00968669|157051714|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
48784508|NCT00968669|157051715|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
48784509|NCT00968669|157051716|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
48784510|NCT00968669|157051717|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
48784511|NCT00968669|157051714|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
48784512|NCT00968669|157051715|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
48784513|NCT00968669|157051716|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
48784514|NCT00968669|157051717|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
48784515|NCT00968669|157051714|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
48784516|NCT00968669|157051715|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
48784517|NCT00968669|157051716|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
48784518|NCT00968669|157051717|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
48784519|NCT00968669|157051714|FG000|Overall Study|SPONSOR DECISION|0|||
48784520|NCT00968669|157051715|FG001|Overall Study|SPONSOR DECISION|1|||
48784521|NCT00968669|157051716|FG002|Overall Study|SPONSOR DECISION|0|||
48784522|NCT00968669|157051717|FG003|Overall Study|SPONSOR DECISION|0|||
48784523|NCT00968669|157051714|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
48784524|NCT00968669|157051715|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
48784525|NCT00968669|157051716|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
48784526|NCT00968669|157051717|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
48784527|NCT00968669|157051714|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
48784528|NCT00968669|157051715|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
48784529|NCT00968669|157051716|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
48784530|NCT00968669|157051717|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
48784531|NCT00968669|157051714|FG000|Overall Study|SUBJECT INCARCERATED|0|||
48784532|NCT00968669|157051715|FG001|Overall Study|SUBJECT INCARCERATED|1|||
48784533|NCT00968669|157051716|FG002|Overall Study|SUBJECT INCARCERATED|0|||
48784534|NCT00968669|157051717|FG003|Overall Study|SUBJECT INCARCERATED|0|||
48784535|NCT00968669|157051714|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
48784536|NCT00968669|157051715|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
48784537|NCT00968669|157051716|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
48784538|NCT00968669|157051717|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
48784539|NCT00968669|157051714|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
48784540|NCT00968669|157051715|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
48784541|NCT00968669|157051716|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
48784542|NCT00968669|157051717|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
48784543|NCT01109992|157051723|FG000|Overall Study|Withdrawal by Subject|0|||
48784544|NCT01109992|157051724|FG001|Overall Study|Withdrawal by Subject|1|||
48784545|NCT01109992|157051723|FG000|Overall Study|Movement during rest scan.|0|||
48784546|NCT01109992|157051724|FG001|Overall Study|Movement during rest scan.|1|||
48784547|NCT03538626|157051730|FG000|Overall Study|Withdrawal by Subject|0|||
48784548|NCT03538626|157051731|FG001|Overall Study|Withdrawal by Subject|1|||
48784549|NCT03538626|157051732|FG002|Overall Study|Withdrawal by Subject|0|||
48784550|NCT03538626|157051733|FG003|Overall Study|Withdrawal by Subject|0|||
48784551|NCT03538626|157051734|FG004|Overall Study|Withdrawal by Subject|0|||
48784552|NCT03538626|157051735|FG005|Overall Study|Withdrawal by Subject|0|||
48784553|NCT03538626|157051736|FG006|Overall Study|Withdrawal by Subject|0|||
48784554|NCT03538626|157051737|FG007|Overall Study|Withdrawal by Subject|0|||
48784555|NCT03538626|157051730|FG000|Overall Study|Lost to Follow-up|0|||
48784556|NCT03538626|157051731|FG001|Overall Study|Lost to Follow-up|0|||
48784557|NCT03538626|157051732|FG002|Overall Study|Lost to Follow-up|0|||
48784558|NCT03538626|157051733|FG003|Overall Study|Lost to Follow-up|0|||
48784559|NCT03538626|157051734|FG004|Overall Study|Lost to Follow-up|0|||
48784560|NCT03538626|157051735|FG005|Overall Study|Lost to Follow-up|0|||
48784561|NCT03538626|157051736|FG006|Overall Study|Lost to Follow-up|1|||
48784562|NCT03538626|157051737|FG007|Overall Study|Lost to Follow-up|0|||
48784563|NCT00345397|157051750|FG000|Overall Study|Death|1|||
48784564|NCT04266028|157051753|FG000|Overall Study|Adverse Event|0|||
48784565|NCT04266028|157051754|FG001|Overall Study|Adverse Event|0|||
48784566|NCT04266028|157051755|FG002|Overall Study|Adverse Event|1|||
48784567|NCT04266028|157051756|FG003|Overall Study|Adverse Event|0|||
48784568|NCT04266028|157051757|FG004|Overall Study|Adverse Event|1|||
48784569|NCT04266028|157051758|FG005|Overall Study|Adverse Event|0|||
48784570|NCT04266028|157051759|FG006|Overall Study|Adverse Event|2|||
48784571|NCT04266028|157051760|FG007|Overall Study|Adverse Event|0|||
48784572|NCT04266028|157051753|FG000|Overall Study|temporary halt of the study|0|||
48784573|NCT04266028|157051754|FG001|Overall Study|temporary halt of the study|0|||
48784574|NCT04266028|157051755|FG002|Overall Study|temporary halt of the study|0|||
48784575|NCT04266028|157051756|FG003|Overall Study|temporary halt of the study|0|||
48784576|NCT04266028|157051757|FG004|Overall Study|temporary halt of the study|0|||
48784577|NCT04266028|157051758|FG005|Overall Study|temporary halt of the study|0|||
48784578|NCT04266028|157051759|FG006|Overall Study|temporary halt of the study|2|||
48784579|NCT04266028|157051760|FG007|Overall Study|temporary halt of the study|1|||
48784580|NCT04266028|157051753|FG000|Overall Study|Onset of birch pollen season|0|||
48784581|NCT04266028|157051754|FG001|Overall Study|Onset of birch pollen season|0|||
48784582|NCT04266028|157051755|FG002|Overall Study|Onset of birch pollen season|0|||
48784583|NCT04266028|157051756|FG003|Overall Study|Onset of birch pollen season|0|||
48784584|NCT04266028|157051757|FG004|Overall Study|Onset of birch pollen season|1|||
48784585|NCT04266028|157051758|FG005|Overall Study|Onset of birch pollen season|0|||
48784586|NCT04266028|157051759|FG006|Overall Study|Onset of birch pollen season|0|||
48784587|NCT04266028|157051760|FG007|Overall Study|Onset of birch pollen season|0|||
48784588|NCT01178853|157051762|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
48784589|NCT01178853|157051763|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
48784590|NCT01178853|157051762|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
48784591|NCT01178853|157051763|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
48784592|NCT01178853|157051762|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
48400066|NCT00725075|155655544|FG000|Overall Study|Withdrawal by Subject|4|||
48784593|NCT01178853|157051763|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
48784594|NCT01178853|157051762|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
48784595|NCT01178853|157051763|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
48784596|NCT01178853|157051762|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
48784597|NCT01178853|157051763|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
48784598|NCT01682837|157051764|FG000|Baseline|Withdrawal by Subject|5|||
48784599|NCT04558346|157051775|FG000|Overall Study|Withdrawal by Subject|2|||
48784600|NCT04558346|157051776|FG001|Overall Study|Withdrawal by Subject|0|||
48400067|NCT00725075|155655545|FG001|Overall Study|Withdrawal by Subject|5|||
48400068|NCT00725075|155655546|FG002|Overall Study|Withdrawal by Subject|4|||
48400069|NCT00725075|155655544|FG000|Overall Study|Adverse Event|2|||
48400070|NCT00725075|155655545|FG001|Overall Study|Adverse Event|1|||
48400071|NCT00725075|155655546|FG002|Overall Study|Adverse Event|1|||
48784601|NCT04558346|157051775|FG000|Overall Study|Lost to Follow-up|0|||
48784602|NCT04558346|157051776|FG001|Overall Study|Lost to Follow-up|1|||
48784603|NCT04558346|157051775|FG000|Overall Study|Adverse Event|0|||
48784604|NCT04558346|157051776|FG001|Overall Study|Adverse Event|1|||
48784605|NCT02715765|157051777|FG000|Overall Study|Study Termination|3|||
48784606|NCT02715765|157051778|FG001|Overall Study|Study Termination|0|||
48784607|NCT02715765|157051779|FG002|Overall Study|Study Termination|0|||
48784608|NCT02331134|157051780|FG000|Overall Study|Withdrawal by Subject|1|||
48784609|NCT03086447|157051783|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48784610|NCT03086447|157051784|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
48784611|NCT03086447|157051783|FG000|Overall Study|Lost Lens|2|||
48784612|NCT03086447|157051784|FG001|Overall Study|Lost Lens|5|||
48784613|NCT03086447|157051783|FG000|Overall Study|Product quality complaint|0|||
48784614|NCT03086447|157051784|FG001|Overall Study|Product quality complaint|1|||
48784615|NCT03086447|157051783|FG000|Overall Study|Lens Damage|1|||
48784616|NCT03086447|157051784|FG001|Overall Study|Lens Damage|6|||
48784617|NCT03086447|157051783|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
48784618|NCT03086447|157051784|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
48784619|NCT03086447|157051783|FG000|Overall Study|Test Article No Longer Available|1|||
48784620|NCT03086447|157051784|FG001|Overall Study|Test Article No Longer Available|0|||
48784621|NCT03086447|157051783|FG000|Overall Study|Protocol Violation|2|||
48784622|NCT03086447|157051784|FG001|Overall Study|Protocol Violation|4|||
48784623|NCT03086447|157051783|FG000|Overall Study|Lost to Follow-up|0|||
48784624|NCT03086447|157051784|FG001|Overall Study|Lost to Follow-up|1|||
48784625|NCT03086447|157051783|FG000|Overall Study|Adverse Event|3|||
48784626|NCT03086447|157051784|FG001|Overall Study|Adverse Event|0|||
48784627|NCT03086447|157051783|FG000|Overall Study|Lens Discomfort|2|||
48784628|NCT03086447|157051784|FG001|Overall Study|Lens Discomfort|1|||
48784629|NCT03346759|157051787|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
48784630|NCT03346759|157051788|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
48784631|NCT03346759|157051787|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
48784632|NCT03346759|157051788|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
48400072|NCT00725075|155655544|FG000|Overall Study|Worsening of Disease|2|||
48400073|NCT00725075|155655545|FG001|Overall Study|Worsening of Disease|1|||
48784633|NCT03346759|157051787|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
48784634|NCT03346759|157051788|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
48784635|NCT02863991|157051789|FG000|Overall Study|Death|0|||
48784636|NCT02863991|157051790|FG001|Overall Study|Death|3|||
48784637|NCT02863991|157051789|FG000|Overall Study|Lack of Efficacy|0|||
48784638|NCT02863991|157051790|FG001|Overall Study|Lack of Efficacy|1|||
48784639|NCT02863991|157051789|FG000|Overall Study|Study Terminated|2|||
48784640|NCT02863991|157051790|FG001|Overall Study|Study Terminated|8|||
48784641|NCT00364858|157051792|FG000|Overall Study|Adverse Event|1|||
48784642|NCT00364858|157051793|FG001|Overall Study|Adverse Event|5|||
48784643|NCT00364858|157051792|FG000|Overall Study|Withdrawal by Subject|1|||
48784644|NCT00364858|157051793|FG001|Overall Study|Withdrawal by Subject|1|||
48784645|NCT00364858|157051792|FG000|Overall Study|Pregnancy|1|||
48784646|NCT00364858|157051793|FG001|Overall Study|Pregnancy|1|||
48784647|NCT00364858|157051792|FG000|Overall Study|Clinical failure|2|||
48784648|NCT00364858|157051793|FG001|Overall Study|Clinical failure|13|||
48784649|NCT00364858|157051792|FG000|Overall Study|Discontinuation at baseline|1|||
48784650|NCT00364858|157051793|FG001|Overall Study|Discontinuation at baseline|0|||
48784651|NCT00364858|157051792|FG000|Overall Study|Non-compliant|1|||
48784652|NCT00364858|157051793|FG001|Overall Study|Non-compliant|0|||
48784653|NCT00364858|157051792|FG000|Overall Study|Return to Q2 regimen|0|||
48784654|NCT00364858|157051793|FG001|Overall Study|Return to Q2 regimen|1|||
48784655|NCT00364858|157051792|FG000|Overall Study|Clinical baseline issue|0|||
48784656|NCT00364858|157051793|FG001|Overall Study|Clinical baseline issue|1|||
48784657|NCT02132611|157051794|FG000|Overall Study|Death|2|||
48784658|NCT02005471|157051796|FG000|Main Study|Adverse Event|0|||
48784659|NCT02005471|157051797|FG001|Main Study|Adverse Event|1|||
48784660|NCT02005471|157051798|FG002|Main Study|Adverse Event|0|||
48784661|NCT02005471|157051799|FG003|Main Study|Adverse Event|0|||
48784662|NCT02005471|157051796|FG000|Main Study|Death|83|||
48784663|NCT02005471|157051797|FG001|Main Study|Death|52|||
48784664|NCT02005471|157051798|FG002|Main Study|Death|0|||
48784665|NCT02005471|157051799|FG003|Main Study|Death|0|||
48784666|NCT02005471|157051796|FG000|Main Study|Lost to Follow-up|4|||
48400074|NCT00725075|155655546|FG002|Overall Study|Worsening of Disease|2|||
48400075|NCT00725075|155655544|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
48400076|NCT00725075|155655545|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
48400077|NCT00725075|155655546|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
48400078|NCT00725075|155655544|FG000|Overall Study|Other|1|||
48400079|NCT00725075|155655545|FG001|Overall Study|Other|0|||
48400080|NCT00725075|155655546|FG002|Overall Study|Other|0|||
48400081|NCT03984305|155655547|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
48400082|NCT03984305|155655548|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
48400083|NCT03984305|155655547|FG000|Overall Study|Withdrawal by Subject|3|||
48400084|NCT03984305|155655548|FG001|Overall Study|Withdrawal by Subject|3|||
48400085|NCT03984305|155655547|FG000|Overall Study|Lost to Follow-up|1|||
48400086|NCT03984305|155655548|FG001|Overall Study|Lost to Follow-up|0|||
48400087|NCT02979431|155655549|FG000|Overall Study|Parent/guardian withdrew consent|2|||
48400088|NCT02979431|155655550|FG001|Overall Study|Parent/guardian withdrew consent|1|||
48400089|NCT02979431|155655551|FG002|Overall Study|Parent/guardian withdrew consent|1|||
48400090|NCT02979431|155655552|FG003|Overall Study|Parent/guardian withdrew consent|1|||
48400091|NCT02979431|155655549|FG000|Overall Study|Randomized but received no study drug|1|||
48400092|NCT02979431|155655550|FG001|Overall Study|Randomized but received no study drug|1|||
48400093|NCT02979431|155655551|FG002|Overall Study|Randomized but received no study drug|0|||
48400094|NCT02979431|155655552|FG003|Overall Study|Randomized but received no study drug|0|||
48400095|NCT02979431|155655549|FG000|Overall Study|Adverse Event|0|||
48400096|NCT02979431|155655550|FG001|Overall Study|Adverse Event|0|||
48400097|NCT02979431|155655551|FG002|Overall Study|Adverse Event|1|||
48400098|NCT02979431|155655552|FG003|Overall Study|Adverse Event|0|||
48400099|NCT02979431|155655549|FG000|Overall Study|Subject left country after Day14|1|||
48400100|NCT02979431|155655550|FG001|Overall Study|Subject left country after Day14|0|||
48400101|NCT02979431|155655551|FG002|Overall Study|Subject left country after Day14|0|||
48400102|NCT02979431|155655552|FG003|Overall Study|Subject left country after Day14|0|||
48400103|NCT00796315|155655553|FG000|Overall Study|Protocol Violation|0|||
48400104|NCT00796315|155655554|FG001|Overall Study|Protocol Violation|1|||
48400105|NCT00796315|155655555|FG002|Overall Study|Protocol Violation|0|||
48400106|NCT02799069|155655557|FG000|Overall Study|Adverse Event|0|||
48400107|NCT02799069|155655558|FG001|Overall Study|Adverse Event|2|||
48400108|NCT02799069|155655559|FG002|Overall Study|Adverse Event|2|||
48400109|NCT02799069|155655557|FG000|Overall Study|Lack of Efficacy|2|||
48784667|NCT02005471|157051797|FG001|Main Study|Lost to Follow-up|5|||
48784668|NCT02005471|157051798|FG002|Main Study|Lost to Follow-up|0|||
48784669|NCT02005471|157051799|FG003|Main Study|Lost to Follow-up|0|||
48784670|NCT02005471|157051796|FG000|Main Study|Physician Decision|3|||
48400110|NCT02799069|155655558|FG001|Overall Study|Lack of Efficacy|0|||
48400111|NCT02799069|155655559|FG002|Overall Study|Lack of Efficacy|0|||
48400112|NCT02799069|155655557|FG000|Overall Study|Lost to Follow-up|1|||
48400113|NCT02799069|155655558|FG001|Overall Study|Lost to Follow-up|1|||
48400114|NCT02799069|155655559|FG002|Overall Study|Lost to Follow-up|0|||
48400115|NCT02799069|155655557|FG000|Overall Study|Withdrawal by Subject|4|||
48400116|NCT02799069|155655558|FG001|Overall Study|Withdrawal by Subject|4|||
48784671|NCT02005471|157051797|FG001|Main Study|Physician Decision|1|||
48784672|NCT02005471|157051798|FG002|Main Study|Physician Decision|0|||
48784673|NCT02005471|157051799|FG003|Main Study|Physician Decision|0|||
48784674|NCT02005471|157051796|FG000|Main Study|Withdrawal by Subject|26|||
48784675|NCT02005471|157051797|FG001|Main Study|Withdrawal by Subject|11|||
48784676|NCT02005471|157051798|FG002|Main Study|Withdrawal by Subject|0|||
48784677|NCT02005471|157051799|FG003|Main Study|Withdrawal by Subject|0|||
48784678|NCT02005471|157051796|FG000|Main Study|Reason not Specified|0|||
48784679|NCT02005471|157051797|FG001|Main Study|Reason not Specified|6|||
48784680|NCT02005471|157051798|FG002|Main Study|Reason not Specified|0|||
48784681|NCT02005471|157051799|FG003|Main Study|Reason not Specified|0|||
48784682|NCT02005471|157051796|FG000|Main Study|Randomized but not Dosed|8|||
48784683|NCT02005471|157051797|FG001|Main Study|Randomized but not Dosed|0|||
48784684|NCT02005471|157051798|FG002|Main Study|Randomized but not Dosed|0|||
48784685|NCT02005471|157051799|FG003|Main Study|Randomized but not Dosed|0|||
48784686|NCT02005471|157051796|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
48784687|NCT02005471|157051797|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
48784688|NCT02005471|157051798|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
48784689|NCT02005471|157051799|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
48784690|NCT02005471|157051796|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
48784691|NCT02005471|157051797|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
48784692|NCT02005471|157051798|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
48784693|NCT02005471|157051799|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
48784694|NCT02005471|157051796|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
48784695|NCT02005471|157051797|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
48784696|NCT02005471|157051798|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
48784697|NCT02005471|157051799|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
48784698|NCT00898677|157051800|FG000|Overall Study|Adverse Event|0|||
48784699|NCT00898677|157051801|FG001|Overall Study|Adverse Event|0|||
48784700|NCT00898677|157051802|FG002|Overall Study|Adverse Event|1|||
48784701|NCT00898677|157051803|FG003|Overall Study|Adverse Event|0|||
48784702|NCT00898677|157051800|FG000|Overall Study|Lost to Follow-up|0|||
48784703|NCT00898677|157051801|FG001|Overall Study|Lost to Follow-up|0|||
48784704|NCT00898677|157051802|FG002|Overall Study|Lost to Follow-up|2|||
48784705|NCT00898677|157051803|FG003|Overall Study|Lost to Follow-up|0|||
48784706|NCT00898677|157051800|FG000|Overall Study|Protocol Violation|1|||
48784707|NCT00898677|157051801|FG001|Overall Study|Protocol Violation|1|||
48400117|NCT02799069|155655559|FG002|Overall Study|Withdrawal by Subject|3|||
48400118|NCT02799069|155655557|FG000|Overall Study|Protocol Violation|1|||
48400119|NCT02799069|155655558|FG001|Overall Study|Protocol Violation|0|||
48400120|NCT02799069|155655559|FG002|Overall Study|Protocol Violation|2|||
48400121|NCT03979274|155655560|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48400122|NCT03979274|155655561|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48400123|NCT02301403|155655562|FG000|Overall Study|Withdrawal by Subject|28|||
48400124|NCT02301403|155655563|FG001|Overall Study|Withdrawal by Subject|41|||
48400125|NCT01816243|155655564|FG000|Overall Study|Adverse Event|6|||
48400126|NCT01816243|155655564|FG000|Overall Study|Lost to Follow-up|1|||
48400127|NCT01816243|155655564|FG000|Overall Study|Lack of Efficacy|1|||
48400128|NCT01816243|155655564|FG000|Overall Study|Not eligible for the study|1|||
48400129|NCT01816243|155655564|FG000|Overall Study|Amputation|3|||
48400130|NCT01446419|155655565|FG000|Overall Study|Death|1|||
48400131|NCT01446419|155655566|FG001|Overall Study|Death|0|||
48400132|NCT01446419|155655565|FG000|Overall Study|Withdrawal by Subject|1|||
48400133|NCT01446419|155655566|FG001|Overall Study|Withdrawal by Subject|1|||
48400134|NCT01446419|155655565|FG000|Overall Study|Terminated per protocol|3|||
48400135|NCT01446419|155655566|FG001|Overall Study|Terminated per protocol|0|||
48400136|NCT00464178|155655567|FG000|Overall Study|Protocol Violation|1|||
48400137|NCT00464178|155655567|FG000|Overall Study|Withdrawal by Subject|1|||
48784708|NCT00898677|157051802|FG002|Overall Study|Protocol Violation|2|||
48784709|NCT00898677|157051803|FG003|Overall Study|Protocol Violation|0|||
48784710|NCT00898677|157051800|FG000|Overall Study|Withdrawal by Subject|0|||
48784711|NCT00898677|157051801|FG001|Overall Study|Withdrawal by Subject|0|||
48784712|NCT00898677|157051802|FG002|Overall Study|Withdrawal by Subject|0|||
48784713|NCT00898677|157051803|FG003|Overall Study|Withdrawal by Subject|1|||
48400138|NCT00915343|155655568|FG000|Part B - Open Label Period|Treatment switch|0|||
48784714|NCT00898677|157051800|FG000|Overall Study|Not Treated: Adverse Event|0|||
48400139|NCT00915343|155655569|FG001|Part B - Open Label Period|Treatment switch|0|||
48400140|NCT00915343|155655570|FG002|Part B - Open Label Period|Treatment switch|1|||
48784715|NCT00898677|157051801|FG001|Overall Study|Not Treated: Adverse Event|2|||
48784716|NCT00898677|157051802|FG002|Overall Study|Not Treated: Adverse Event|1|||
48784717|NCT00898677|157051803|FG003|Overall Study|Not Treated: Adverse Event|0|||
48784718|NCT00898677|157051800|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
48784719|NCT00898677|157051801|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
48784720|NCT00898677|157051802|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
48784721|NCT00898677|157051803|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
48784722|NCT00898677|157051800|FG000|Overall Study|Not Treated: Pregnancy|0|||
48784723|NCT00898677|157051801|FG001|Overall Study|Not Treated: Pregnancy|0|||
48784724|NCT00898677|157051802|FG002|Overall Study|Not Treated: Pregnancy|1|||
48784725|NCT00898677|157051803|FG003|Overall Study|Not Treated: Pregnancy|0|||
48784726|NCT00898677|157051800|FG000|Overall Study|Not Treated: Protocol Violation|2|||
48784727|NCT00898677|157051801|FG001|Overall Study|Not Treated: Protocol Violation|0|||
48784728|NCT00898677|157051802|FG002|Overall Study|Not Treated: Protocol Violation|2|||
48784729|NCT00898677|157051803|FG003|Overall Study|Not Treated: Protocol Violation|0|||
48784730|NCT00898677|157051800|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
48784731|NCT00898677|157051801|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
48784732|NCT00898677|157051802|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
48784733|NCT00898677|157051803|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
48784734|NCT00898677|157051800|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
48784735|NCT00898677|157051801|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
48784736|NCT00898677|157051802|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
48784737|NCT00898677|157051803|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
48784738|NCT00898677|157051800|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
48784739|NCT00898677|157051801|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
48784740|NCT00898677|157051802|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
48784741|NCT00898677|157051803|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
48784742|NCT00898677|157051800|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
48784743|NCT00898677|157051801|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
48784744|NCT00898677|157051802|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
48400141|NCT00915343|155655568|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
48400142|NCT00915343|155655569|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
48400143|NCT00915343|155655570|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
48400144|NCT03434977|155655573|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
48400145|NCT03434977|155655574|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
48400146|NCT01462266|155655576|FG000|Overall Study|Adverse Event|7|||
48784745|NCT00898677|157051803|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
48784746|NCT00898677|157051800|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
48784747|NCT00898677|157051801|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
48784748|NCT00898677|157051802|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
48784749|NCT00898677|157051803|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
48784750|NCT00898677|157051800|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
48784751|NCT00898677|157051801|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
48400147|NCT01462266|155655577|FG001|Overall Study|Adverse Event|6|||
48400148|NCT01462266|155655576|FG000|Overall Study|Death|2|||
48784752|NCT00898677|157051802|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
48784753|NCT00898677|157051803|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
48784754|NCT00898677|157051800|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
48784755|NCT00898677|157051801|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
48784756|NCT00898677|157051802|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
48784757|NCT00898677|157051803|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
48784758|NCT03387852|157051804|FG000|Overall Study|Adverse event (AE)|3|||
48784759|NCT03387852|157051805|FG001|Overall Study|Adverse event (AE)|0|||
48784760|NCT03387852|157051806|FG002|Overall Study|Adverse event (AE)|2|||
48784761|NCT03387852|157051807|FG003|Overall Study|Adverse event (AE)|0|||
48784762|NCT03387852|157051804|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
48784763|NCT03387852|157051805|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
48784764|NCT03387852|157051806|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
48784765|NCT03387852|157051807|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
48784766|NCT03387852|157051804|FG000|Overall Study|Withdrawal by participant|1|||
48784767|NCT03387852|157051805|FG001|Overall Study|Withdrawal by participant|1|||
48784768|NCT03387852|157051806|FG002|Overall Study|Withdrawal by participant|3|||
48784769|NCT03387852|157051807|FG003|Overall Study|Withdrawal by participant|2|||
48784770|NCT03387852|157051804|FG000|Overall Study|Other- Unspecified|1|||
48784771|NCT03387852|157051805|FG001|Overall Study|Other- Unspecified|1|||
48784772|NCT03387852|157051806|FG002|Overall Study|Other- Unspecified|2|||
48784773|NCT03387852|157051807|FG003|Overall Study|Other- Unspecified|1|||
48784774|NCT03387852|157051804|FG000|Overall Study|Poor compliance to protocol|0|||
48784775|NCT03387852|157051805|FG001|Overall Study|Poor compliance to protocol|0|||
48784776|NCT03387852|157051806|FG002|Overall Study|Poor compliance to protocol|0|||
48784777|NCT03387852|157051807|FG003|Overall Study|Poor compliance to protocol|1|||
48784778|NCT03387852|157051804|FG000|Overall Study|Randomized and not treated|0|||
48784779|NCT03387852|157051805|FG001|Overall Study|Randomized and not treated|0|||
48784780|NCT03387852|157051806|FG002|Overall Study|Randomized and not treated|0|||
48784781|NCT03387852|157051807|FG003|Overall Study|Randomized and not treated|1|||
48784782|NCT02730819|157051811|FG000|Overall Study|Lost to Follow-up|9|||
48784783|NCT02763384|157051812|FG000|Overall Study|Physician Decision|1|||
48784784|NCT02763384|157051812|FG000|Overall Study|Rapid decline - went on hospice|1|||
48784785|NCT02121847|157051813|FG000|Overall Study|Administrative Reasons|1|||
48784786|NCT02121847|157051813|FG000|Overall Study|Adverse Event|2|||
48784787|NCT02535065|157051814|FG000|Overall Study|Death|13|||
48784788|NCT02535065|157051814|FG000|Overall Study|Lost to Follow-up|1|||
48784789|NCT02535065|157051814|FG000|Overall Study|Withdrawal by Subject|6|||
48784790|NCT01329029|157051815|FG000|Overall Study|Withdrawal by Subject|117|||
48784791|NCT01329029|157051816|FG001|Overall Study|Withdrawal by Subject|87|||
48784792|NCT01329029|157051815|FG000|Overall Study|Adverse Event|82|||
48784793|NCT01329029|157051816|FG001|Overall Study|Adverse Event|29|||
48784794|NCT01329029|157051815|FG000|Overall Study|Death|16|||
48784795|NCT01329029|157051816|FG001|Overall Study|Death|19|||
48784796|NCT01329029|157051815|FG000|Overall Study|Other|14|||
48784797|NCT01329029|157051816|FG001|Overall Study|Other|20|||
48784798|NCT01329029|157051815|FG000|Overall Study|COPD Exacerbation|11|||
48784799|NCT01329029|157051816|FG001|Overall Study|COPD Exacerbation|18|||
48784800|NCT01329029|157051815|FG000|Overall Study|Physician Decision|16|||
48784801|NCT01329029|157051816|FG001|Overall Study|Physician Decision|13|||
48784802|NCT01329029|157051815|FG000|Overall Study|Lost to Follow-up|8|||
48784803|NCT01329029|157051816|FG001|Overall Study|Lost to Follow-up|5|||
48784804|NCT01329029|157051815|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
48784805|NCT01329029|157051816|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
48784806|NCT02352948|157051817|FG000|Overall Study|Death|47|||
48784807|NCT02352948|157051818|FG001|Overall Study|Death|48|||
48784808|NCT02352948|157051819|FG002|Overall Study|Death|114|||
48784809|NCT02352948|157051820|FG003|Overall Study|Death|74|||
48784810|NCT02352948|157051821|FG004|Overall Study|Death|77|||
48784811|NCT02352948|157051822|FG005|Overall Study|Death|44|||
48784812|NCT02352948|157051817|FG000|Overall Study|Lost to Follow-up|1|||
48784813|NCT02352948|157051818|FG001|Overall Study|Lost to Follow-up|0|||
48784814|NCT02352948|157051819|FG002|Overall Study|Lost to Follow-up|2|||
48784815|NCT02352948|157051820|FG003|Overall Study|Lost to Follow-up|1|||
48784816|NCT02352948|157051821|FG004|Overall Study|Lost to Follow-up|2|||
48784817|NCT02352948|157051822|FG005|Overall Study|Lost to Follow-up|1|||
48784818|NCT02352948|157051817|FG000|Overall Study|Withdrawal by Subject|1|||
48784819|NCT02352948|157051818|FG001|Overall Study|Withdrawal by Subject|10|||
48784820|NCT02352948|157051819|FG002|Overall Study|Withdrawal by Subject|11|||
48784821|NCT02352948|157051820|FG003|Overall Study|Withdrawal by Subject|23|||
48784822|NCT02352948|157051821|FG004|Overall Study|Withdrawal by Subject|9|||
48784823|NCT02352948|157051822|FG005|Overall Study|Withdrawal by Subject|4|||
48784824|NCT02352948|157051817|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48784825|NCT02352948|157051818|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48784826|NCT02352948|157051819|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
48784827|NCT02352948|157051820|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
48784828|NCT02352948|157051821|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
48784829|NCT02352948|157051822|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
48784830|NCT02352948|157051817|FG000|Overall Study|Other|0|||
48784831|NCT02352948|157051818|FG001|Overall Study|Other|0|||
48784832|NCT02352948|157051819|FG002|Overall Study|Other|2|||
48784833|NCT02352948|157051820|FG003|Overall Study|Other|0|||
48784834|NCT02352948|157051821|FG004|Overall Study|Other|0|||
48784835|NCT02352948|157051822|FG005|Overall Study|Other|0|||
48784836|NCT01337089|157053332|FG000|Overall Study|Adverse Event|237|||
48784837|NCT01337089|157053332|FG000|Overall Study|Withdrawal by Subject|129|||
48784838|NCT01337089|157053332|FG000|Overall Study|Withdrawal by Investigator|33|||
48784839|NCT01337089|157053332|FG000|Overall Study|Met Withdrawal Criteria|3|||
48784840|NCT01337089|157053332|FG000|Overall Study|Lost to Follow-up|2|||
48784841|NCT03778294|157053333|FG000|Overall Study|Death|1|||
48784842|NCT03778294|157053333|FG000|Overall Study|Issues with insurance|1|||
48784843|NCT03778294|157053333|FG000|Overall Study|disease progression before treatment|2|||
48784844|NCT04419493|157053335|FG000|Wash-out After Period 1|Adverse Event|1|||
48784845|NCT04419493|157053336|FG001|Wash-out After Period 1|Adverse Event|2|||
48784846|NCT04419493|157053337|FG002|Wash-out After Period 1|Adverse Event|1|||
48784847|NCT04419493|157053338|FG003|Wash-out After Period 1|Adverse Event|0|||
48784848|NCT00524134|157053339|FG000|Overall Study|Withdrawal by Subject|1|||
48784849|NCT00524134|157053339|FG000|Overall Study|Physician Decision|1|||
48784850|NCT00970502|157053340|FG000|Overall Study|Withdrawal by Subject|1|||
48784851|NCT01627249|157053341|FG000|Overall Study|Death|3|||
48784852|NCT01627249|157053342|FG001|Overall Study|Death|5|||
48784853|NCT01627249|157053343|FG002|Overall Study|Death|3|||
48784854|NCT01627249|157053341|FG000|Overall Study|Withdrawal by Subject|12|||
48784855|NCT01627249|157053342|FG001|Overall Study|Withdrawal by Subject|6|||
48784856|NCT01627249|157053343|FG002|Overall Study|Withdrawal by Subject|9|||
48784857|NCT01627249|157053341|FG000|Overall Study|Missed Visit|1|||
48784858|NCT01627249|157053342|FG001|Overall Study|Missed Visit|1|||
48784859|NCT01627249|157053343|FG002|Overall Study|Missed Visit|0|||
48784860|NCT00201006|157053344|FG000|Overall Study|Withdrawal by Subject|7|||
48784861|NCT00201006|157053345|FG001|Overall Study|Withdrawal by Subject|2|||
48784862|NCT00201006|157053346|FG002|Overall Study|Withdrawal by Subject|3|||
48784863|NCT00201006|157053344|FG000|Overall Study|Adverse Event|1|||
48784864|NCT00201006|157053345|FG001|Overall Study|Adverse Event|0|||
48784865|NCT00201006|157053346|FG002|Overall Study|Adverse Event|1|||
48784866|NCT02707055|157053347|FG000|Phase 1|Withdrawal by Subject|1|||
48784867|NCT02707055|157053348|FG001|Phase 1|Withdrawal by Subject|2|||
48784868|NCT02707055|157053347|FG000|Phase 1|Physician Decision|0|||
48784869|NCT02707055|157053348|FG001|Phase 1|Physician Decision|1|||
48784870|NCT02707055|157053347|FG000|Phase 2|Adverse Event|1|||
48784871|NCT02707055|157053348|FG001|Phase 2|Adverse Event|2|||
48784872|NCT03266588|157053349|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
48784873|NCT03266588|157053350|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
48784874|NCT03266588|157053351|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
48784875|NCT03266588|157053349|FG000|Observational Period|Withdrawal by Subject|44|||
48784876|NCT03266588|157053350|FG001|Observational Period|Withdrawal by Subject|22|||
48784877|NCT03266588|157053351|FG002|Observational Period|Withdrawal by Subject|13|||
48784878|NCT03266588|157053349|FG000|Observational Period|Non-compliance|18|||
48784879|NCT03266588|157053350|FG001|Observational Period|Non-compliance|12|||
48784880|NCT03266588|157053351|FG002|Observational Period|Non-compliance|10|||
48784881|NCT03266588|157053349|FG000|Observational Period|Lost to Follow-up|8|||
48784882|NCT03266588|157053350|FG001|Observational Period|Lost to Follow-up|12|||
48784883|NCT03266588|157053351|FG002|Observational Period|Lost to Follow-up|4|||
48784884|NCT03266588|157053349|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
48784885|NCT03266588|157053350|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
48784886|NCT03266588|157053351|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
48784887|NCT03266588|157053349|FG000|Observational Period|Protocol Deviation|1|||
48784888|NCT03266588|157053350|FG001|Observational Period|Protocol Deviation|0|||
48784889|NCT03266588|157053351|FG002|Observational Period|Protocol Deviation|0|||
48784890|NCT03266588|157053349|FG000|Observational Period|Other Reasons|3|||
48784891|NCT03266588|157053350|FG001|Observational Period|Other Reasons|0|||
48784892|NCT03266588|157053351|FG002|Observational Period|Other Reasons|1|||
48784893|NCT03266588|157053349|FG000|Long-term Treatment Period|Adverse Event|33|||
48784894|NCT03266588|157053350|FG001|Long-term Treatment Period|Adverse Event|17|||
48784895|NCT03266588|157053351|FG002|Long-term Treatment Period|Adverse Event|8|||
48784896|NCT03266588|157053349|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
48784897|NCT03266588|157053350|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
48784898|NCT03266588|157053351|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
48784899|NCT03266588|157053349|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
48784900|NCT03266588|157053350|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
48784901|NCT03266588|157053351|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
48784902|NCT03266588|157053349|FG000|Long-term Treatment Period|Non-Compliance|126|||
48784903|NCT03266588|157053350|FG001|Long-term Treatment Period|Non-Compliance|57|||
48784904|NCT03266588|157053351|FG002|Long-term Treatment Period|Non-Compliance|7|||
48784905|NCT03266588|157053349|FG000|Long-term Treatment Period|Pregnancy|11|||
48784906|NCT03266588|157053350|FG001|Long-term Treatment Period|Pregnancy|5|||
48784907|NCT03266588|157053351|FG002|Long-term Treatment Period|Pregnancy|0|||
48400149|NCT01462266|155655577|FG001|Overall Study|Death|1|||
48784908|NCT03266588|157053349|FG000|Long-term Treatment Period|Protocol Deviation|17|||
48784909|NCT03266588|157053350|FG001|Long-term Treatment Period|Protocol Deviation|10|||
48784910|NCT03266588|157053351|FG002|Long-term Treatment Period|Protocol Deviation|4|||
48784911|NCT03266588|157053349|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
48784912|NCT03266588|157053350|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
48784913|NCT03266588|157053351|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
48784914|NCT03266588|157053349|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
48784915|NCT03266588|157053350|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
48784916|NCT03266588|157053351|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
48400150|NCT01462266|155655576|FG000|Overall Study|Lack of Efficacy|0|||
48400151|NCT01462266|155655577|FG001|Overall Study|Lack of Efficacy|2|||
48400152|NCT01462266|155655576|FG000|Overall Study|Lost to Follow-up|4|||
48784917|NCT03266588|157053349|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
48784918|NCT03266588|157053350|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
48784919|NCT03266588|157053351|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
48784920|NCT03266588|157053349|FG000|Long-term Treatment Period|Other Reasons|5|||
48784921|NCT03266588|157053350|FG001|Long-term Treatment Period|Other Reasons|0|||
48784922|NCT03266588|157053351|FG002|Long-term Treatment Period|Other Reasons|0|||
48784923|NCT03266588|157053349|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
48784924|NCT03266588|157053350|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
48784925|NCT03266588|157053351|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
48784926|NCT02244944|157053353|FG000|Overall Study|Withdrawal by Subject|1|||
48784927|NCT02244944|157053353|FG000|Overall Study|Study Terminated|1|||
48784928|NCT01750268|157053354|FG000|Overall Study|Lost to Follow-up|0|||
48784929|NCT01750268|157053355|FG001|Overall Study|Lost to Follow-up|2|||
48400153|NCT01462266|155655577|FG001|Overall Study|Lost to Follow-up|3|||
48400154|NCT01462266|155655576|FG000|Overall Study|Non-compliance with study drug|3|||
48400155|NCT01462266|155655577|FG001|Overall Study|Non-compliance with study drug|0|||
48400156|NCT01462266|155655576|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
48400157|NCT01462266|155655577|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
48400158|NCT01462266|155655576|FG000|Overall Study|Physician Decision|2|||
48400159|NCT01462266|155655577|FG001|Overall Study|Physician Decision|5|||
48400160|NCT01462266|155655576|FG000|Overall Study|Protocol Violation|1|||
48400161|NCT01462266|155655577|FG001|Overall Study|Protocol Violation|3|||
48400162|NCT01462266|155655576|FG000|Overall Study|Withdrawal by Subject|7|||
48400163|NCT01462266|155655577|FG001|Overall Study|Withdrawal by Subject|2|||
48400164|NCT01462266|155655576|FG000|Overall Study|Screen failure|1|||
48400165|NCT01462266|155655577|FG001|Overall Study|Screen failure|1|||
48400166|NCT00546052|155655578|FG000|Overall Study|Adverse Event|47|||
48400167|NCT00546052|155655578|FG000|Overall Study|Lost to Follow-up|144|||
48400168|NCT00546052|155655578|FG000|Overall Study|Protocol Violation|9|||
48400169|NCT00546052|155655578|FG000|Overall Study|Withdrawal by Subject|20|||
48400170|NCT00546052|155655578|FG000|Overall Study|Non Compliance|7|||
48400171|NCT01489527|155655579|FG000|Overall Study|Pregnancy|9|||
48400172|NCT01489527|155655580|FG001|Overall Study|Pregnancy|14|||
48400173|NCT01489527|155655579|FG000|Overall Study|Participant moved|6|||
48400174|NCT01489527|155655580|FG001|Overall Study|Participant moved|7|||
48400175|NCT01489527|155655579|FG000|Overall Study|Withdrawal by Subject|0|||
48400176|NCT01489527|155655580|FG001|Overall Study|Withdrawal by Subject|4|||
48400177|NCT01489527|155655579|FG000|Overall Study|Lost to Follow-up|5|||
48400178|NCT01489527|155655580|FG001|Overall Study|Lost to Follow-up|1|||
48400179|NCT01489527|155655579|FG000|Overall Study|Procedures|1|||
48400180|NCT01489527|155655580|FG001|Overall Study|Procedures|0|||
48400181|NCT01489527|155655579|FG000|Overall Study|Not compliant|1|||
48400182|NCT01489527|155655580|FG001|Overall Study|Not compliant|0|||
48400183|NCT04899232|155655581|FG000|Screening Period|Physician Decision|1|||
48400184|NCT04899232|155655582|FG001|Screening Period|Physician Decision|0|||
48400185|NCT04899232|155655583|FG002|Screening Period|Physician Decision|0|||
48400186|NCT04899232|155655581|FG000|Screening Period|Withdrawal by Subject|1|||
48400187|NCT04899232|155655582|FG001|Screening Period|Withdrawal by Subject|0|||
48400188|NCT04899232|155655583|FG002|Screening Period|Withdrawal by Subject|0|||
48400189|NCT04899232|155655581|FG000|Screening Period|Participant discharged before receiving intervention|3|||
48400190|NCT04899232|155655582|FG001|Screening Period|Participant discharged before receiving intervention|0|||
48400191|NCT04899232|155655583|FG002|Screening Period|Participant discharged before receiving intervention|0|||
48400192|NCT01738971|155655587|FG000|Overall Study|Lost to Follow-up|19|||
48400193|NCT01738971|155655588|FG001|Overall Study|Lost to Follow-up|30|||
48400194|NCT01738971|155655589|FG002|Overall Study|Lost to Follow-up|17|||
48784930|NCT01750268|157053354|FG000|Overall Study|Physician Decision|0|||
48784931|NCT01750268|157053355|FG001|Overall Study|Physician Decision|3|||
48784932|NCT01750268|157053354|FG000|Overall Study|Withdrawal by Subject|2|||
48784933|NCT01750268|157053355|FG001|Overall Study|Withdrawal by Subject|0|||
48784934|NCT00966940|157053359|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
48784935|NCT00966940|157053360|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
48784936|NCT00966940|157053359|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
48784937|NCT00966940|157053360|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
48784938|NCT03087591|157053364|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
48784939|NCT03087591|157053364|FG000|Overall Study|Withdrawal by Subject|1|||
48784940|NCT01073618|157053365|FG000|Overall Study|Death|208|||
48784941|NCT01073618|157053365|FG000|Overall Study|Adverse Event|19|||
48784942|NCT01073618|157053365|FG000|Overall Study|Other|80|||
48784943|NCT03725982|157053366|FG000|First Intervention|Withdrawal by Subject|0|||
48784944|NCT03725982|157053367|FG001|First Intervention|Withdrawal by Subject|1|||
48400195|NCT03505021|155655590|FG000|Overall Study|Protocol Violation|1|||
48400196|NCT03505021|155655591|FG001|Overall Study|Protocol Violation|0|||
48400197|NCT03505021|155655590|FG000|Overall Study|Death|9|||
48400198|NCT03505021|155655591|FG001|Overall Study|Death|8|||
48400199|NCT03505021|155655590|FG000|Overall Study|Consent withdrawn by subject|6|||
48400200|NCT03505021|155655591|FG001|Overall Study|Consent withdrawn by subject|1|||
48784945|NCT03725982|157053366|FG000|First Intervention|Physician Decision|1|||
48784946|NCT03725982|157053367|FG001|First Intervention|Physician Decision|1|||
48784947|NCT04743908|157053368|FG000|Overall Study|Death|1|||
48784948|NCT04743908|157053369|FG001|Overall Study|Death|0|||
48400201|NCT03505021|155655590|FG000|Overall Study|Lost to Follow-up|5|||
48400202|NCT03505021|155655591|FG001|Overall Study|Lost to Follow-up|3|||
48400203|NCT03505021|155655590|FG000|Overall Study|Adverse Event|26|||
48400204|NCT03505021|155655591|FG001|Overall Study|Adverse Event|9|||
48784949|NCT04743908|157053368|FG000|Overall Study|Lost to Follow-up|181|||
48400205|NCT03505021|155655590|FG000|Overall Study|Disease progression|33|||
48784950|NCT04743908|157053369|FG001|Overall Study|Lost to Follow-up|180|||
48784951|NCT04743908|157053368|FG000|Overall Study|Withdrawal by Subject|1|||
48784952|NCT04743908|157053369|FG001|Overall Study|Withdrawal by Subject|2|||
48784953|NCT02044510|157053370|FG000|Overall Study|Adverse Event|1|||
48784954|NCT02044510|157053371|FG001|Overall Study|Adverse Event|2|||
48784955|NCT02979535|157053372|FG000|Overall Study|Non compliance with the protocol|78|||
48784956|NCT02979535|157053373|FG001|Overall Study|Non compliance with the protocol|82|||
48784957|NCT02979535|157053372|FG000|Overall Study|Consent withdrawn by participant|11|||
48784958|NCT02979535|157053373|FG001|Overall Study|Consent withdrawn by participant|18|||
48784959|NCT02979535|157053372|FG000|Overall Study|Lost to Follow-up|6|||
48784960|NCT02979535|157053373|FG001|Overall Study|Lost to Follow-up|1|||
48784961|NCT00512135|157053374|FG000|Overall Study|Not Treated|5|||
48784962|NCT00512135|157053374|FG000|Overall Study|Lack of Efficacy|2|||
48784963|NCT00512135|157053374|FG000|Overall Study|Adverse Event|6|||
48784964|NCT00512135|157053374|FG000|Overall Study|Withdrawal by Subject|22|||
48784965|NCT00512135|157053374|FG000|Overall Study|Lost to Follow-up|27|||
48784966|NCT00512135|157053374|FG000|Overall Study|Other|22|||
48784967|NCT01343082|157053375|FG000|The run-in Period|Not meeting criteria|3|||
48784968|NCT01343082|157053376|FG001|The run-in Period|Not meeting criteria|4|||
48784969|NCT01343082|157053377|FG002|The run-in Period|Not meeting criteria|5|||
48784970|NCT01343082|157053375|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
48784971|NCT01343082|157053376|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
48784972|NCT01343082|157053377|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
48784973|NCT01343082|157053375|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
48784974|NCT01343082|157053376|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
48784975|NCT01343082|157053377|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
48784976|NCT01343082|157053375|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
48784977|NCT01343082|157053376|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
48784978|NCT01343082|157053377|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
48784979|NCT01343082|157053375|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
48784980|NCT01343082|157053376|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
48784981|NCT01343082|157053377|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
48784982|NCT00467870|157053378|FG000|Overall Study|Adverse Event|13|||
48784983|NCT00467870|157053379|FG001|Overall Study|Adverse Event|9|||
48784984|NCT00467870|157053380|FG002|Overall Study|Adverse Event|1|||
48784985|NCT00467870|157053381|FG003|Overall Study|Adverse Event|15|||
48784986|NCT00467870|157053382|FG004|Overall Study|Adverse Event|15|||
48784987|NCT00467870|157053383|FG005|Overall Study|Adverse Event|1|||
48784988|NCT00467870|157053378|FG000|Overall Study|Protocol Violation|2|||
48784989|NCT00467870|157053379|FG001|Overall Study|Protocol Violation|1|||
48784990|NCT00467870|157053380|FG002|Overall Study|Protocol Violation|1|||
48784991|NCT00467870|157053381|FG003|Overall Study|Protocol Violation|2|||
48784992|NCT00467870|157053382|FG004|Overall Study|Protocol Violation|0|||
48784993|NCT00467870|157053383|FG005|Overall Study|Protocol Violation|0|||
48784994|NCT00467870|157053378|FG000|Overall Study|Withdrawal by Subject|14|||
48784995|NCT00467870|157053379|FG001|Overall Study|Withdrawal by Subject|21|||
48784996|NCT00467870|157053380|FG002|Overall Study|Withdrawal by Subject|0|||
48784997|NCT00467870|157053381|FG003|Overall Study|Withdrawal by Subject|9|||
48784998|NCT00467870|157053382|FG004|Overall Study|Withdrawal by Subject|10|||
48784999|NCT00467870|157053383|FG005|Overall Study|Withdrawal by Subject|1|||
48785000|NCT00467870|157053378|FG000|Overall Study|Lost to Follow-up|5|||
48785001|NCT00467870|157053379|FG001|Overall Study|Lost to Follow-up|3|||
48785002|NCT00467870|157053380|FG002|Overall Study|Lost to Follow-up|1|||
48785003|NCT00467870|157053381|FG003|Overall Study|Lost to Follow-up|1|||
48785004|NCT00467870|157053382|FG004|Overall Study|Lost to Follow-up|3|||
48785005|NCT00467870|157053383|FG005|Overall Study|Lost to Follow-up|0|||
48785006|NCT00467870|157053378|FG000|Overall Study|Subject Non-compliance|3|||
48785007|NCT00467870|157053379|FG001|Overall Study|Subject Non-compliance|4|||
48785008|NCT00467870|157053380|FG002|Overall Study|Subject Non-compliance|0|||
48785009|NCT00467870|157053381|FG003|Overall Study|Subject Non-compliance|1|||
48785010|NCT00467870|157053382|FG004|Overall Study|Subject Non-compliance|5|||
48785011|NCT00467870|157053383|FG005|Overall Study|Subject Non-compliance|0|||
48785012|NCT00467870|157053378|FG000|Overall Study|Other/Unknown|8|||
48785013|NCT00467870|157053379|FG001|Overall Study|Other/Unknown|5|||
48785014|NCT00467870|157053380|FG002|Overall Study|Other/Unknown|1|||
48785015|NCT00467870|157053381|FG003|Overall Study|Other/Unknown|5|||
48785016|NCT00467870|157053382|FG004|Overall Study|Other/Unknown|4|||
48785017|NCT00467870|157053383|FG005|Overall Study|Other/Unknown|0|||
48785018|NCT02624804|157053384|FG000|Overall Study|Screen Failure|5|||
48785019|NCT02613481|157053385|FG000|Overall Study|Lost to Follow-up|7|||
48785020|NCT02613481|157053385|FG000|Overall Study|Withdrawal by Subject|2|||
48785021|NCT02348216|157053386|FG000|Overall Study|Death|5|||
48400206|NCT03505021|155655591|FG001|Overall Study|Disease progression|17|||
48785022|NCT02348216|157053387|FG001|Overall Study|Death|53|||
48785023|NCT02348216|157053388|FG002|Overall Study|Death|11|||
48785024|NCT02348216|157053389|FG003|Overall Study|Death|20|||
48785025|NCT02348216|157053390|FG004|Overall Study|Death|16|||
48785026|NCT02348216|157053391|FG005|Overall Study|Death|32|||
48785027|NCT02348216|157053392|FG006|Overall Study|Death|17|||
48785028|NCT02348216|157053386|FG000|Overall Study|Full consent withdrawal|0|||
48785029|NCT02348216|157053387|FG001|Overall Study|Full consent withdrawal|0|||
48785030|NCT02348216|157053388|FG002|Overall Study|Full consent withdrawal|0|||
48785031|NCT02348216|157053389|FG003|Overall Study|Full consent withdrawal|1|||
48785032|NCT02348216|157053390|FG004|Overall Study|Full consent withdrawal|3|||
48785033|NCT02348216|157053391|FG005|Overall Study|Full consent withdrawal|0|||
48785034|NCT02348216|157053392|FG006|Overall Study|Full consent withdrawal|3|||
48785035|NCT02348216|157053386|FG000|Overall Study|Lost to Follow-up|0|||
48785036|NCT02348216|157053387|FG001|Overall Study|Lost to Follow-up|5|||
48785037|NCT02348216|157053388|FG002|Overall Study|Lost to Follow-up|2|||
48785038|NCT02348216|157053389|FG003|Overall Study|Lost to Follow-up|0|||
48785039|NCT02348216|157053390|FG004|Overall Study|Lost to Follow-up|1|||
48785040|NCT02348216|157053391|FG005|Overall Study|Lost to Follow-up|1|||
48785041|NCT02348216|157053392|FG006|Overall Study|Lost to Follow-up|1|||
48785042|NCT02348216|157053386|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
48785043|NCT02348216|157053387|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
48785044|NCT02348216|157053388|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
48785045|NCT02348216|157053389|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
48785046|NCT02348216|157053390|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
48785047|NCT02348216|157053391|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
48785048|NCT02348216|157053392|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
48785049|NCT02348216|157053386|FG000|Overall Study|Reason not specified|2|||
48785050|NCT02348216|157053387|FG001|Overall Study|Reason not specified|19|||
48785051|NCT02348216|157053388|FG002|Overall Study|Reason not specified|11|||
48785052|NCT02348216|157053389|FG003|Overall Study|Reason not specified|17|||
48785053|NCT02348216|157053390|FG004|Overall Study|Reason not specified|21|||
48785054|NCT02348216|157053391|FG005|Overall Study|Reason not specified|17|||
48785055|NCT02348216|157053392|FG006|Overall Study|Reason not specified|19|||
48785056|NCT00562159|157053393|FG000|Overall Study|Adverse Event|11|||
48785057|NCT00562159|157053394|FG001|Overall Study|Adverse Event|8|||
48785058|NCT00562159|157053393|FG000|Overall Study|Lost to Follow-up|5|||
48400207|NCT03505021|155655590|FG000|Overall Study|Other|11|||
48400208|NCT03505021|155655591|FG001|Overall Study|Other|5|||
48400209|NCT03505021|155655590|FG000|Overall Study|Personal reason|21|||
48400210|NCT03505021|155655591|FG001|Overall Study|Personal reason|12|||
48400211|NCT00105443|155657682|FG000|Double-Blind Treatment|Adverse Event|1|||
48400212|NCT00105443|155657683|FG001|Double-Blind Treatment|Adverse Event|0|||
48785059|NCT00562159|157053394|FG001|Overall Study|Lost to Follow-up|4|||
48785060|NCT00562159|157053393|FG000|Overall Study|Withdrawal by Subject|9|||
48400213|NCT00105443|155657684|FG002|Double-Blind Treatment|Adverse Event|0|||
48400214|NCT00105443|155657685|FG003|Double-Blind Treatment|Adverse Event|0|||
48400215|NCT00105443|155657682|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
48400216|NCT00105443|155657683|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
48400217|NCT00105443|155657684|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
48785061|NCT00562159|157053394|FG001|Overall Study|Withdrawal by Subject|8|||
48400218|NCT00105443|155657685|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
48400219|NCT00105443|155657682|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
48400220|NCT00105443|155657683|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
48400221|NCT00105443|155657684|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
48400222|NCT00105443|155657685|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
48400223|NCT00105443|155657682|FG000|Double-Blind Treatment|Physician Decision|1|||
48400224|NCT00105443|155657683|FG001|Double-Blind Treatment|Physician Decision|0|||
48400225|NCT00105443|155657684|FG002|Double-Blind Treatment|Physician Decision|2|||
48785062|NCT00562159|157053393|FG000|Overall Study|Protocol Violation|12|||
48785063|NCT00562159|157053394|FG001|Overall Study|Protocol Violation|12|||
48785064|NCT00562159|157053393|FG000|Overall Study|Did not meet protocol eligibility|1|||
48785065|NCT00562159|157053394|FG001|Overall Study|Did not meet protocol eligibility|1|||
48400226|NCT00105443|155657685|FG003|Double-Blind Treatment|Physician Decision|0|||
48400227|NCT00105443|155657682|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
48400228|NCT00105443|155657683|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
48785066|NCT00434057|157053397|FG000|Overall Study|Withdrawal by Subject|1|||
48785067|NCT01233817|157053406|FG000|Overall Study|Lost to Follow-up|1|||
48785068|NCT01233817|157053406|FG000|Overall Study|Withdrawal by Subject|2|||
48785069|NCT00599326|157053408|FG000|Overall Study|Lost to Follow-up|1|||
48785070|NCT00599326|157053408|FG000|Overall Study|Noncompliant|1|||
48785071|NCT03105362|157053415|FG000|Overall Study|Withdrawal by Subject|1|||
48785072|NCT03105362|157053415|FG000|Overall Study|Lost to Follow-up|1|||
48785073|NCT00144339|157053416|FG000|Overall Study|Adverse Event|746|||
48785074|NCT00144339|157053417|FG001|Overall Study|Adverse Event|627|||
48785075|NCT00144339|157053416|FG000|Overall Study|Protocol Violation|75|||
48785076|NCT00144339|157053417|FG001|Overall Study|Protocol Violation|48|||
48785077|NCT00144339|157053416|FG000|Overall Study|Withdrawal by Subject|403|||
48785078|NCT00144339|157053417|FG001|Overall Study|Withdrawal by Subject|300|||
48785079|NCT00144339|157053416|FG000|Overall Study|Lost to Follow-up|76|||
48785080|NCT00144339|157053417|FG001|Overall Study|Lost to Follow-up|64|||
48785081|NCT00144339|157053416|FG000|Overall Study|Other|58|||
48785082|NCT00144339|157053417|FG001|Overall Study|Other|60|||
48785083|NCT00305058|157053418|FG000|Overall Study|Participant too young|1|||
48785084|NCT00305058|157053419|FG001|Overall Study|Participant too young|0|||
48785085|NCT00305058|157053418|FG000|Overall Study|Missing data collection instrument|3|||
48785086|NCT00305058|157053419|FG001|Overall Study|Missing data collection instrument|2|||
48785087|NCT00305058|157053418|FG000|Overall Study|Missing outcome data|3|||
48785088|NCT00305058|157053419|FG001|Overall Study|Missing outcome data|2|||
48785089|NCT00586105|157053424|FG000|Overall Study|Adverse Event|4|||
48785090|NCT00586105|157053424|FG000|Overall Study|Death|2|||
48785091|NCT00586105|157053424|FG000|Overall Study|Protocol Violation|1|||
48785092|NCT00586105|157053424|FG000|Overall Study|Withdrawal by Subject|3|||
48785093|NCT00586105|157053424|FG000|Overall Study|Disease progression|19|||
48785094|NCT00586105|157053424|FG000|Overall Study|Switched to commercial drug|9|||
48785095|NCT00586105|157053424|FG000|Overall Study|Reason not reported|1|||
48785096|NCT01435577|157053425|FG000|Overall Study|Adverse Event|10|||
48785097|NCT01435577|157053426|FG001|Overall Study|Adverse Event|0|||
48785098|NCT01435577|157053425|FG000|Overall Study|Lack of Efficacy|7|||
48785099|NCT01435577|157053426|FG001|Overall Study|Lack of Efficacy|51|||
48785100|NCT01435577|157053425|FG000|Overall Study|Alternative treatment started|0|||
48785101|NCT01435577|157053426|FG001|Overall Study|Alternative treatment started|1|||
48785102|NCT01220557|157053431|FG000|Overall Study|Lost to Follow-up|5|||
48785103|NCT01220557|157053432|FG001|Overall Study|Lost to Follow-up|3|||
48785104|NCT01220557|157053431|FG000|Overall Study|attended less than 6 lessons|1|||
48785105|NCT01220557|157053432|FG001|Overall Study|attended less than 6 lessons|2|||
48785106|NCT02911948|157053434|FG000|Overall Study|Protocol Violation|0|||
48785107|NCT02911948|157053435|FG001|Overall Study|Protocol Violation|1|||
48400229|NCT00105443|155657684|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
48400230|NCT00105443|155657685|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
48400231|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
48400232|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
48400233|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
48400234|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
48400235|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
48400236|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
48400237|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
48400238|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
48400239|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
48400240|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
48400241|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
48400242|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
48400243|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
48400244|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
48400245|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
48400246|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
48400247|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
48400248|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
48400249|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
48785108|NCT02911948|157053434|FG000|Overall Study|Withdrawal by Subject|0|||
48785109|NCT02911948|157053435|FG001|Overall Study|Withdrawal by Subject|2|||
48785110|NCT02911948|157053434|FG000|Overall Study|Lack of Efficacy|0|||
48785111|NCT02911948|157053435|FG001|Overall Study|Lack of Efficacy|1|||
48785112|NCT02911948|157053434|FG000|Overall Study|Unclassified|0|||
48785113|NCT02911948|157053435|FG001|Overall Study|Unclassified|3|||
48785114|NCT03867734|157053436|FG000|Overall Study|Lost to Follow-up|2|||
48785115|NCT02265237|157053437|FG000|As Treated (Overall Study)|Adverse Event|1|||
48400250|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
48785116|NCT02265237|157053438|FG001|As Treated (Overall Study)|Adverse Event|1|||
48785117|NCT02265237|157053439|FG002|As Treated (Overall Study)|Adverse Event|0|||
48785118|NCT02265237|157053440|FG003|As Treated (Overall Study)|Adverse Event|0|||
48785119|NCT02265237|157053437|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
48785120|NCT02265237|157053438|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
48785121|NCT02265237|157053439|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
48400251|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
48400252|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
48400253|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
48400254|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
48400255|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
48400256|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
48400257|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
48400258|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
48400259|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
48400260|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
48400261|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
48400262|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
48400263|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
48400264|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
48400265|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
48400266|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
48400267|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
48400268|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
48785122|NCT02265237|157053440|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
48785123|NCT02265237|157053437|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
48785124|NCT02265237|157053438|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
48785125|NCT02265237|157053439|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
48785126|NCT02265237|157053440|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
48785127|NCT02265237|157053437|FG000|As Treated (Overall Study)|Other|2|||
48785128|NCT02265237|157053438|FG001|As Treated (Overall Study)|Other|0|||
48785129|NCT02265237|157053439|FG002|As Treated (Overall Study)|Other|3|||
48785130|NCT02265237|157053440|FG003|As Treated (Overall Study)|Other|1|||
48785131|NCT01458574|157053442|FG000|Overall Study|Adverse Event|5|||
48785132|NCT01458574|157053443|FG001|Overall Study|Adverse Event|9|||
48785133|NCT01458574|157053444|FG002|Overall Study|Adverse Event|7|||
48785134|NCT01458574|157053442|FG000|Overall Study|Lack of Efficacy|70|||
48785135|NCT01458574|157053443|FG001|Overall Study|Lack of Efficacy|53|||
48785136|NCT01458574|157053444|FG002|Overall Study|Lack of Efficacy|132|||
48785137|NCT01458574|157053442|FG000|Overall Study|Lost to Follow-up|3|||
48785138|NCT01458574|157053443|FG001|Overall Study|Lost to Follow-up|2|||
48785139|NCT01458574|157053444|FG002|Overall Study|Lost to Follow-up|1|||
48785140|NCT01458574|157053442|FG000|Overall Study|Pregnancy|1|||
48785141|NCT01458574|157053443|FG001|Overall Study|Pregnancy|1|||
48785142|NCT01458574|157053444|FG002|Overall Study|Pregnancy|0|||
48785143|NCT01458574|157053442|FG000|Overall Study|Protocol Violation|0|||
48785144|NCT01458574|157053443|FG001|Overall Study|Protocol Violation|1|||
48785145|NCT01458574|157053444|FG002|Overall Study|Protocol Violation|0|||
48785146|NCT01458574|157053442|FG000|Overall Study|Withdrawal by Subject|6|||
48785147|NCT01458574|157053443|FG001|Overall Study|Withdrawal by Subject|3|||
48785148|NCT01458574|157053444|FG002|Overall Study|Withdrawal by Subject|5|||
48785149|NCT01458574|157053442|FG000|Overall Study|Other|2|||
48785150|NCT01458574|157053443|FG001|Overall Study|Other|1|||
48785151|NCT01458574|157053444|FG002|Overall Study|Other|0|||
48785152|NCT01458574|157053442|FG000|Overall Study|Randomized but not treated|0|||
48785153|NCT01458574|157053443|FG001|Overall Study|Randomized but not treated|1|||
48785154|NCT01458574|157053444|FG002|Overall Study|Randomized but not treated|0|||
48785155|NCT04782323|157053445|FG000|Overall Study|Death|1|||
48785156|NCT04782323|157053446|FG001|Overall Study|Death|0|||
48785157|NCT04782323|157053447|FG002|Overall Study|Death|0|||
48785158|NCT04782323|157053448|FG003|Overall Study|Death|0|||
48785159|NCT04782323|157053449|FG004|Overall Study|Death|1|||
48785160|NCT04782323|157053450|FG005|Overall Study|Death|1|||
48785161|NCT04782323|157053451|FG006|Overall Study|Death|1|||
48785162|NCT04782323|157053452|FG007|Overall Study|Death|0|||
48785163|NCT04782323|157053445|FG000|Overall Study|Withdrawal by Subject|0|||
48785164|NCT04782323|157053446|FG001|Overall Study|Withdrawal by Subject|0|||
48785165|NCT04782323|157053447|FG002|Overall Study|Withdrawal by Subject|1|||
48785166|NCT04782323|157053448|FG003|Overall Study|Withdrawal by Subject|0|||
48785167|NCT04782323|157053449|FG004|Overall Study|Withdrawal by Subject|0|||
48785168|NCT04782323|157053450|FG005|Overall Study|Withdrawal by Subject|1|||
48785169|NCT04782323|157053451|FG006|Overall Study|Withdrawal by Subject|0|||
48785170|NCT04782323|157053452|FG007|Overall Study|Withdrawal by Subject|1|||
48785171|NCT04782323|157053445|FG000|Overall Study|Lost to Follow-up|0|||
48785172|NCT04782323|157053446|FG001|Overall Study|Lost to Follow-up|1|||
48785173|NCT04782323|157053447|FG002|Overall Study|Lost to Follow-up|1|||
48785174|NCT04782323|157053448|FG003|Overall Study|Lost to Follow-up|0|||
48785175|NCT04782323|157053449|FG004|Overall Study|Lost to Follow-up|0|||
48785176|NCT04782323|157053450|FG005|Overall Study|Lost to Follow-up|1|||
48785177|NCT04782323|157053451|FG006|Overall Study|Lost to Follow-up|1|||
48785178|NCT04782323|157053452|FG007|Overall Study|Lost to Follow-up|2|||
48785179|NCT04782323|157053445|FG000|Overall Study|randomization in error|1|||
48785180|NCT04782323|157053446|FG001|Overall Study|randomization in error|0|||
48785181|NCT04782323|157053447|FG002|Overall Study|randomization in error|0|||
48785182|NCT04782323|157053448|FG003|Overall Study|randomization in error|0|||
48785183|NCT04782323|157053449|FG004|Overall Study|randomization in error|0|||
48785184|NCT04782323|157053450|FG005|Overall Study|randomization in error|0|||
48785185|NCT04782323|157053451|FG006|Overall Study|randomization in error|0|||
48785186|NCT04782323|157053452|FG007|Overall Study|randomization in error|0|||
48785187|NCT01617629|157053455|FG000|Overall Study|Death|2|||
48785188|NCT01617629|157053455|FG000|Overall Study|Investigator's Clinical Judgement|1|||
48785189|NCT01617629|157053455|FG000|Overall Study|Reason Not Specified|1|||
48785190|NCT01617629|157053455|FG000|Overall Study|Participant Withdrew Consent|2|||
48785191|NCT00558285|157053456|FG000|Overall Study|Adverse Event|1|||
48785192|NCT00558285|157053457|FG001|Overall Study|Adverse Event|1|||
48785193|NCT00558285|157053458|FG002|Overall Study|Adverse Event|4|||
48785194|NCT00558285|157053459|FG003|Overall Study|Adverse Event|1|||
48785195|NCT00558285|157053460|FG004|Overall Study|Adverse Event|2|||
48785196|NCT00558285|157053456|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48785197|NCT00558285|157053457|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48785198|NCT00558285|157053458|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48785199|NCT00558285|157053459|FG003|Overall Study|Abnormal test procedure result(s)|0|||
48785200|NCT00558285|157053460|FG004|Overall Study|Abnormal test procedure result(s)|0|||
48785201|NCT00558285|157053456|FG000|Overall Study|Subject withdrew consent|2|||
48785202|NCT00558285|157053457|FG001|Overall Study|Subject withdrew consent|0|||
48400269|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
48400270|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
48400271|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
48400272|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
48400273|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
48400274|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
48400275|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
48400276|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
48400277|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
48400278|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
48400279|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
48785203|NCT00558285|157053458|FG002|Overall Study|Subject withdrew consent|1|||
48785204|NCT00558285|157053459|FG003|Overall Study|Subject withdrew consent|1|||
48785205|NCT00558285|157053460|FG004|Overall Study|Subject withdrew consent|1|||
48785206|NCT00558285|157053456|FG000|Overall Study|Lost to Follow-up|1|||
48785207|NCT00558285|157053457|FG001|Overall Study|Lost to Follow-up|1|||
48785208|NCT00558285|157053458|FG002|Overall Study|Lost to Follow-up|0|||
48785209|NCT00558285|157053459|FG003|Overall Study|Lost to Follow-up|0|||
48785210|NCT00558285|157053460|FG004|Overall Study|Lost to Follow-up|0|||
48785211|NCT00558285|157053456|FG000|Overall Study|Administrative problems|0|||
48785212|NCT00558285|157053457|FG001|Overall Study|Administrative problems|0|||
48785213|NCT00558285|157053458|FG002|Overall Study|Administrative problems|0|||
48785214|NCT00558285|157053459|FG003|Overall Study|Administrative problems|1|||
48785215|NCT00558285|157053460|FG004|Overall Study|Administrative problems|1|||
48785216|NCT00558285|157053456|FG000|Overall Study|Protocol deviation|1|||
48785217|NCT00558285|157053457|FG001|Overall Study|Protocol deviation|1|||
48785218|NCT00558285|157053458|FG002|Overall Study|Protocol deviation|0|||
48785219|NCT00558285|157053459|FG003|Overall Study|Protocol deviation|1|||
48785220|NCT00558285|157053460|FG004|Overall Study|Protocol deviation|0|||
48785221|NCT03478891|157053461|FG000|Overall Study|Enrolled, but product never administered|0|||
48785222|NCT03478891|157053462|FG001|Overall Study|Enrolled, but product never administered|0|||
48785223|NCT03478891|157053463|FG002|Overall Study|Enrolled, but product never administered|1|||
48785224|NCT03478891|157053461|FG000|Overall Study|Moved from area|0|||
48785225|NCT03478891|157053462|FG001|Overall Study|Moved from area|0|||
48785226|NCT03478891|157053463|FG002|Overall Study|Moved from area|1|||
48785227|NCT03478891|157053461|FG000|Overall Study|Lost to Follow-up|1|||
48785228|NCT03478891|157053462|FG001|Overall Study|Lost to Follow-up|0|||
48785229|NCT03478891|157053463|FG002|Overall Study|Lost to Follow-up|1|||
48785230|NCT01174342|157053464|FG000|Overall Study|Conversion to cesarean section|4|||
48785231|NCT01773226|157055611|FG000|Overall Study|Withdrawal by Subject|1|||
48785232|NCT03985423|157055617|FG000|Overall Study|Adverse Event|1|||
48400280|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
48785233|NCT03985423|157055617|FG000|Overall Study|Death|2|||
48785234|NCT03985423|157055617|FG000|Overall Study|Physician Decision|1|||
48785235|NCT03985423|157055617|FG000|Overall Study|Withdrawal by Subject|2|||
48785236|NCT03985423|157055617|FG000|Overall Study|Lack of insurance and citizenship|1|||
48785237|NCT00724282|157055618|FG000|Overall Study|Withdrawal by Subject|3|||
48785238|NCT00724282|157055618|FG000|Overall Study|Physician Decision|1|||
48785239|NCT00993447|157055619|FG000|Overall Study|Withdrawal by Subject|23|||
48785240|NCT00993447|157055620|FG001|Overall Study|Withdrawal by Subject|8|||
48785241|NCT00993447|157055619|FG000|Overall Study|Protocol Violation|12|||
48785242|NCT00993447|157055620|FG001|Overall Study|Protocol Violation|8|||
48785243|NCT00993447|157055619|FG000|Overall Study|Lost to Follow-up|1|||
48785244|NCT00993447|157055620|FG001|Overall Study|Lost to Follow-up|3|||
48785245|NCT00993447|157055619|FG000|Overall Study|Adverse Event|1|||
48785246|NCT00993447|157055620|FG001|Overall Study|Adverse Event|0|||
48785247|NCT00129987|157055623|FG000|1st Educational Session|Withdrawal by Subject|141|||
48785248|NCT00129987|157055624|FG001|1st Educational Session|Withdrawal by Subject|109|||
48785249|NCT00129987|157055623|FG000|1 Year|Withdrawal by Subject|32|||
48785250|NCT00129987|157055624|FG001|1 Year|Withdrawal by Subject|21|||
48785251|NCT04401579|157055625|FG000|Overall Study|Death|23|||
48785252|NCT04401579|157055626|FG001|Overall Study|Death|36|||
48785253|NCT04401579|157055625|FG000|Overall Study|Lost to Follow-up|40|||
48785254|NCT04401579|157055626|FG001|Overall Study|Lost to Follow-up|41|||
48785255|NCT04401579|157055625|FG000|Overall Study|Withdrawal by Subject|8|||
48785256|NCT04401579|157055626|FG001|Overall Study|Withdrawal by Subject|16|||
48785257|NCT04401579|157055625|FG000|Overall Study|Physician Decision|1|||
48785258|NCT04401579|157055626|FG001|Overall Study|Physician Decision|2|||
48785259|NCT04401579|157055625|FG000|Overall Study|Became ineligible after enrollment|1|||
48785260|NCT04401579|157055626|FG001|Overall Study|Became ineligible after enrollment|1|||
48785261|NCT04401579|157055625|FG000|Overall Study|Enrolled but treatment not administered|7|||
48785262|NCT04401579|157055626|FG001|Overall Study|Enrolled but treatment not administered|9|||
48785263|NCT04401579|157055625|FG000|Overall Study|Adverse Event|2|||
48785264|NCT04401579|157055626|FG001|Overall Study|Adverse Event|1|||
48785265|NCT04401579|157055625|FG000|Overall Study|Scheduling error|1|||
48785266|NCT04401579|157055626|FG001|Overall Study|Scheduling error|2|||
48785267|NCT04401579|157055625|FG000|Overall Study|Transferred to another hospital|1|||
48785268|NCT04401579|157055626|FG001|Overall Study|Transferred to another hospital|2|||
48785269|NCT03836053|157055627|FG000|Overall Study|Protocol-specified criteria|0|||
48785270|NCT03836053|157055628|FG001|Overall Study|Protocol-specified criteria|2|||
48785271|NCT03836053|157055629|FG002|Overall Study|Protocol-specified criteria|1|||
48785272|NCT03836053|157055627|FG000|Overall Study|Death|1|||
48785273|NCT03836053|157055628|FG001|Overall Study|Death|6|||
48785274|NCT03836053|157055629|FG002|Overall Study|Death|4|||
48785275|NCT03836053|157055627|FG000|Overall Study|Withdrawal of consent from study|0|||
48785276|NCT03836053|157055628|FG001|Overall Study|Withdrawal of consent from study|0|||
48785277|NCT03836053|157055629|FG002|Overall Study|Withdrawal of consent from study|1|||
48785278|NCT03836053|157055627|FG000|Overall Study|Decision by sponsor|0|||
48785279|NCT03836053|157055628|FG001|Overall Study|Decision by sponsor|2|||
48785280|NCT03836053|157055629|FG002|Overall Study|Decision by sponsor|4|||
48785281|NCT01863680|157055633|FG000|Overall Study|Adverse Event|17|||
48785282|NCT01863680|157055633|FG000|Overall Study|Risk of OHSS|17|||
48785283|NCT01863680|157055633|FG000|Overall Study|Spontaneous pregnancy|2|||
48785284|NCT01863680|157055633|FG000|Overall Study|Withdrawal by Subject|1|||
48785285|NCT01863680|157055633|FG000|Overall Study|Did not undergo IVF/ET|14|||
48785286|NCT01863680|157055633|FG000|Overall Study|Other|6|||
48785287|NCT00566228|157055638|FG000|Overall Study|Withdrawal by Subject|1|||
48785288|NCT00566228|157055639|FG001|Overall Study|Withdrawal by Subject|0|||
48785289|NCT00566228|157055638|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
48785290|NCT00566228|157055639|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
48785291|NCT00566228|157055638|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
48785292|NCT00566228|157055639|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
48785293|NCT00566228|157055638|FG000|Overall Study|progressed before infusion could occur|0|||
48785294|NCT00566228|157055639|FG001|Overall Study|progressed before infusion could occur|1|||
48785295|NCT01159938|157055640|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
48785296|NCT01159938|157055641|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
48785297|NCT01159938|157055642|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
48785298|NCT01159938|157055643|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
48785299|NCT01159938|157055644|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
48785300|NCT02646423|157055647|FG000|Overall Study|Adverse Event|5|||
48785301|NCT02646423|157055648|FG001|Overall Study|Adverse Event|7|||
48785302|NCT02646423|157055647|FG000|Overall Study|Ineligible|2|||
48785303|NCT02646423|157055648|FG001|Overall Study|Ineligible|1|||
48785304|NCT02548962|157055654|FG000|Overall Study|Withdrawal by Subject|1|||
48785305|NCT02548962|157055655|FG001|Overall Study|Withdrawal by Subject|0|||
48785306|NCT00823719|157055656|FG000|Overall Study|Adverse Event|1|||
48785307|NCT00823719|157055657|FG001|Overall Study|Adverse Event|2|||
48785308|NCT00823719|157055656|FG000|Overall Study|Physician Decision|1|||
48785309|NCT00823719|157055657|FG001|Overall Study|Physician Decision|4|||
48785310|NCT00823719|157055656|FG000|Overall Study|Withdrawal by Subject|0|||
48785311|NCT00823719|157055657|FG001|Overall Study|Withdrawal by Subject|1|||
48785312|NCT00823719|157055656|FG000|Overall Study|Disease Progression|4|||
48785313|NCT00823719|157055657|FG001|Overall Study|Disease Progression|4|||
48785314|NCT02696317|157055658|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
48785315|NCT02696317|157055659|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
48785316|NCT02696317|157055658|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
48785317|NCT02696317|157055659|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
48785318|NCT00237744|157055660|FG000|Overall Study|Withdrawal by Subject|3|||
48785319|NCT00237744|157055661|FG001|Overall Study|Withdrawal by Subject|1|||
48785320|NCT00237744|157055662|FG002|Overall Study|Withdrawal by Subject|0|||
48785321|NCT00563784|157055665|FG000|Overall Study|Withdrawal by Subject|2|||
48785322|NCT00563784|157055665|FG000|Overall Study|Screen Failures|20|||
48785323|NCT02828111|157055666|FG000|Overall Study|Withdrawal by Subject|0|||
48785324|NCT02828111|157055667|FG001|Overall Study|Withdrawal by Subject|0|||
48785325|NCT02828111|157055668|FG002|Overall Study|Withdrawal by Subject|2|||
48785326|NCT02828111|157055669|FG003|Overall Study|Withdrawal by Subject|0|||
48785327|NCT02828111|157055670|FG004|Overall Study|Withdrawal by Subject|0|||
48785328|NCT02828111|157055666|FG000|Overall Study|Lost to Follow-up|0|||
48785329|NCT02828111|157055667|FG001|Overall Study|Lost to Follow-up|0|||
48785330|NCT02828111|157055668|FG002|Overall Study|Lost to Follow-up|0|||
48785331|NCT02828111|157055669|FG003|Overall Study|Lost to Follow-up|1|||
48785332|NCT02828111|157055670|FG004|Overall Study|Lost to Follow-up|1|||
48785333|NCT02528214|157055671|FG000|Overall Study|Protocol Violation|0|||
48785334|NCT02528214|157055672|FG001|Overall Study|Protocol Violation|1|||
48785335|NCT02528214|157055671|FG000|Overall Study|Adverse Event|0|||
48785336|NCT02528214|157055672|FG001|Overall Study|Adverse Event|1|||
48785337|NCT02528214|157055671|FG000|Overall Study|Other than specified above|0|||
48785338|NCT02528214|157055672|FG001|Overall Study|Other than specified above|1|||
48785339|NCT00407537|157055673|FG000|Overall Study|Death|5|||
48785340|NCT00407537|157055674|FG001|Overall Study|Death|2|||
48785341|NCT00407537|157055673|FG000|Overall Study|Adverse Event|36|||
48785342|NCT00407537|157055674|FG001|Overall Study|Adverse Event|0|||
48785343|NCT00407537|157055673|FG000|Overall Study|Lost to Follow-up|12|||
48785344|NCT00407537|157055674|FG001|Overall Study|Lost to Follow-up|19|||
48785345|NCT00407537|157055673|FG000|Overall Study|Other|6|||
48785346|NCT00407537|157055674|FG001|Overall Study|Other|7|||
48785347|NCT00407537|157055673|FG000|Overall Study|Withdrawal by Subject|34|||
48785348|NCT00407537|157055674|FG001|Overall Study|Withdrawal by Subject|16|||
48785349|NCT01026974|157055676|FG000|Overall Study|Withdrawal by Subject|0|||
48785350|NCT01026974|157055677|FG001|Overall Study|Withdrawal by Subject|1|||
48785351|NCT01026974|157055678|FG002|Overall Study|Withdrawal by Subject|7|||
48785352|NCT01026974|157055679|FG003|Overall Study|Withdrawal by Subject|2|||
48785353|NCT01026974|157055676|FG000|Overall Study|Lost to Follow-up|1|||
48785354|NCT01026974|157055677|FG001|Overall Study|Lost to Follow-up|1|||
48785355|NCT01026974|157055678|FG002|Overall Study|Lost to Follow-up|4|||
48785356|NCT01026974|157055679|FG003|Overall Study|Lost to Follow-up|0|||
48785357|NCT01026974|157055676|FG000|Overall Study|Adverse Event|0|||
48785358|NCT01026974|157055677|FG001|Overall Study|Adverse Event|0|||
48785359|NCT01026974|157055678|FG002|Overall Study|Adverse Event|0|||
48785360|NCT01026974|157055679|FG003|Overall Study|Adverse Event|1|||
48785361|NCT01026974|157055676|FG000|Overall Study|Inappropriate enrollment|0|||
48785362|NCT01026974|157055677|FG001|Overall Study|Inappropriate enrollment|0|||
48785363|NCT01026974|157055678|FG002|Overall Study|Inappropriate enrollment|1|||
48785364|NCT01026974|157055679|FG003|Overall Study|Inappropriate enrollment|0|||
48785365|NCT02864082|157055680|FG000|Overall Study|Adverse Event|1|||
48785366|NCT02864082|157055681|FG001|Overall Study|Adverse Event|1|||
48785367|NCT02864082|157055680|FG000|Overall Study|Lost to Follow-up|0|||
48785368|NCT02864082|157055681|FG001|Overall Study|Lost to Follow-up|1|||
48785369|NCT02864082|157055680|FG000|Overall Study|Withdrawal by Subject|2|||
48785370|NCT02864082|157055681|FG001|Overall Study|Withdrawal by Subject|2|||
48785371|NCT04179032|157055682|FG000|Part B (Up to Week 52)|Adverse Event|1|||
48785372|NCT04179032|157055682|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
48785373|NCT04179032|157055682|FG000|Access Extension Phase|Ongoing|11|||
48785374|NCT00817089|157055683|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
48785375|NCT00817089|157055684|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
48785376|NCT00817089|157055685|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
48785377|NCT00817089|157055686|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
48785378|NCT00817089|157055683|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
48785379|NCT00817089|157055684|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
48785380|NCT00817089|157055685|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
48785381|NCT00817089|157055686|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
48785382|NCT04667117|157055687|FG000|Investigational Period|Lost to Follow-up|0|||
48785383|NCT04667117|157055688|FG001|Investigational Period|Lost to Follow-up|0|||
48785384|NCT04667117|157055689|FG002|Investigational Period|Lost to Follow-up|1|||
48785385|NCT04667117|157055687|FG000|Investigational Period|Protocol Deviation|0|||
48785386|NCT04667117|157055688|FG001|Investigational Period|Protocol Deviation|1|||
48785387|NCT04667117|157055689|FG002|Investigational Period|Protocol Deviation|0|||
48785388|NCT04667117|157055687|FG000|Extension Period|Lost to Follow-up|1|||
48400281|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
48785389|NCT04667117|157055688|FG001|Extension Period|Lost to Follow-up|0|||
48785390|NCT04667117|157055689|FG002|Extension Period|Lost to Follow-up|0|||
48785391|NCT00874029|157055690|FG000|Overall Study|Withdrawal by Subject|10|||
48785392|NCT00874029|157055690|FG000|Overall Study|Pregnancy|4|||
48785393|NCT00874029|157055690|FG000|Overall Study|Physician Decision|1|||
48785394|NCT00874029|157055690|FG000|Overall Study|Adverse Event|1|||
48785395|NCT00874029|157055690|FG000|Overall Study|Lost to Follow-up|5|||
48785396|NCT02328326|157055694|FG000|Overall Study|Withdrawal by Subject|10|||
48785397|NCT02328326|157055695|FG001|Overall Study|Withdrawal by Subject|3|||
48785398|NCT02328326|157055694|FG000|Overall Study|Death|2|||
48785399|NCT02328326|157055695|FG001|Overall Study|Death|1|||
48785400|NCT02328326|157055694|FG000|Overall Study|Lost to Follow-up|10|||
48785401|NCT02328326|157055695|FG001|Overall Study|Lost to Follow-up|4|||
48785402|NCT02252211|157055696|FG000|Overall Study|Adverse Event|0|||
48785403|NCT02252211|157055697|FG001|Overall Study|Adverse Event|1|||
48785404|NCT02252211|157055698|FG002|Overall Study|Adverse Event|0|||
48785405|NCT02252211|157055696|FG000|Overall Study|Progressive disease|3|||
48785406|NCT02252211|157055697|FG001|Overall Study|Progressive disease|2|||
48785407|NCT02252211|157055698|FG002|Overall Study|Progressive disease|0|||
48785408|NCT02252211|157055696|FG000|Overall Study|Withdrawal by Subject|1|||
48785409|NCT02252211|157055697|FG001|Overall Study|Withdrawal by Subject|0|||
48785410|NCT02252211|157055698|FG002|Overall Study|Withdrawal by Subject|0|||
48785411|NCT02252211|157055696|FG000|Overall Study|Serious Adverse Event During Screening|1|||
48785412|NCT02252211|157055697|FG001|Overall Study|Serious Adverse Event During Screening|0|||
48785413|NCT02252211|157055698|FG002|Overall Study|Serious Adverse Event During Screening|1|||
48785414|NCT01953926|157055699|FG000|Overall Study|Withdrawal by Subject|23|||
48785415|NCT01953926|157055700|FG001|Overall Study|Withdrawal by Subject|3|||
48785416|NCT01953926|157055701|FG002|Overall Study|Withdrawal by Subject|3|||
48785417|NCT01953926|157055702|FG003|Overall Study|Withdrawal by Subject|5|||
48785418|NCT01953926|157055703|FG004|Overall Study|Withdrawal by Subject|6|||
48785419|NCT01953926|157055704|FG005|Overall Study|Withdrawal by Subject|0|||
48785420|NCT01953926|157055705|FG006|Overall Study|Withdrawal by Subject|1|||
48785421|NCT01953926|157055699|FG000|Overall Study|Physician Decision|1|||
48785422|NCT01953926|157055700|FG001|Overall Study|Physician Decision|0|||
48785423|NCT01953926|157055701|FG002|Overall Study|Physician Decision|0|||
48785424|NCT01953926|157055702|FG003|Overall Study|Physician Decision|0|||
48785425|NCT01953926|157055703|FG004|Overall Study|Physician Decision|2|||
48785426|NCT01953926|157055704|FG005|Overall Study|Physician Decision|0|||
48785427|NCT01953926|157055705|FG006|Overall Study|Physician Decision|0|||
48785428|NCT01953926|157055699|FG000|Overall Study|Lost to Follow-up|18|||
48785429|NCT01953926|157055700|FG001|Overall Study|Lost to Follow-up|3|||
48785430|NCT01953926|157055701|FG002|Overall Study|Lost to Follow-up|0|||
48785431|NCT01953926|157055702|FG003|Overall Study|Lost to Follow-up|5|||
48785432|NCT01953926|157055703|FG004|Overall Study|Lost to Follow-up|3|||
48400282|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
48400283|NCT00105443|155657682|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
48400284|NCT00105443|155657683|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
48400285|NCT00105443|155657684|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
48400286|NCT00105443|155657685|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
48400287|NCT02164981|155657686|FG000|Started|Withdrawal by Subject|2|||
48400288|NCT02164981|155657687|FG001|Started|Withdrawal by Subject|1|||
48400289|NCT02164981|155657688|FG002|Started|Withdrawal by Subject|0|||
48400290|NCT02164981|155657686|FG000|Started|Protocol Violation|2|||
48400291|NCT02164981|155657687|FG001|Started|Protocol Violation|0|||
48400292|NCT02164981|155657688|FG002|Started|Protocol Violation|0|||
48400293|NCT02164981|155657686|FG000|Started|Adverse Event|1|||
48400294|NCT02164981|155657687|FG001|Started|Adverse Event|2|||
48400295|NCT02164981|155657688|FG002|Started|Adverse Event|0|||
48400296|NCT02164981|155657686|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
48400297|NCT02164981|155657687|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
48400298|NCT02164981|155657688|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
48400299|NCT02164981|155657686|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
48785433|NCT01953926|157055704|FG005|Overall Study|Lost to Follow-up|0|||
48785434|NCT01953926|157055705|FG006|Overall Study|Lost to Follow-up|0|||
48785435|NCT01953926|157055699|FG000|Overall Study|Protocol Violation|1|||
48785436|NCT01953926|157055700|FG001|Overall Study|Protocol Violation|0|||
48785437|NCT01953926|157055701|FG002|Overall Study|Protocol Violation|0|||
48785438|NCT01953926|157055702|FG003|Overall Study|Protocol Violation|0|||
48785439|NCT01953926|157055703|FG004|Overall Study|Protocol Violation|0|||
48785440|NCT01953926|157055704|FG005|Overall Study|Protocol Violation|0|||
48785441|NCT01953926|157055705|FG006|Overall Study|Protocol Violation|0|||
48785442|NCT01953926|157055699|FG000|Overall Study|Other, Disease progression|2|||
48785443|NCT01953926|157055700|FG001|Overall Study|Other, Disease progression|1|||
48785444|NCT01953926|157055701|FG002|Overall Study|Other, Disease progression|0|||
48785445|NCT01953926|157055702|FG003|Overall Study|Other, Disease progression|0|||
48785446|NCT01953926|157055703|FG004|Overall Study|Other, Disease progression|1|||
48785447|NCT01953926|157055704|FG005|Overall Study|Other, Disease progression|0|||
48785448|NCT01953926|157055705|FG006|Overall Study|Other, Disease progression|0|||
48785449|NCT01953926|157055699|FG000|Overall Study|Discontinuation of study by sponsor|41|||
48785450|NCT01953926|157055700|FG001|Overall Study|Discontinuation of study by sponsor|7|||
48785451|NCT01953926|157055701|FG002|Overall Study|Discontinuation of study by sponsor|5|||
48785452|NCT01953926|157055702|FG003|Overall Study|Discontinuation of study by sponsor|12|||
48785453|NCT01953926|157055703|FG004|Overall Study|Discontinuation of study by sponsor|46|||
48785454|NCT01953926|157055704|FG005|Overall Study|Discontinuation of study by sponsor|5|||
48785455|NCT01953926|157055705|FG006|Overall Study|Discontinuation of study by sponsor|6|||
48785456|NCT01953926|157055699|FG000|Overall Study|Not Treated|1|||
48785457|NCT01953926|157055700|FG001|Overall Study|Not Treated|0|||
48785458|NCT01953926|157055701|FG002|Overall Study|Not Treated|1|||
48785459|NCT01953926|157055702|FG003|Overall Study|Not Treated|0|||
48785460|NCT01953926|157055703|FG004|Overall Study|Not Treated|0|||
48785461|NCT01953926|157055704|FG005|Overall Study|Not Treated|0|||
48785462|NCT01953926|157055705|FG006|Overall Study|Not Treated|0|||
48785463|NCT02310750|157055709|FG000|HP Period 1|Lost to Follow-up|0|||
48785464|NCT02310750|157055710|FG001|HP Period 1|Lost to Follow-up|0|||
48785465|NCT02310750|157055711|FG002|HP Period 1|Lost to Follow-up|0|||
48785466|NCT02310750|157055712|FG003|HP Period 1|Lost to Follow-up|0|||
48785467|NCT02310750|157055713|FG004|HP Period 1|Lost to Follow-up|0|||
48785468|NCT02310750|157055714|FG005|HP Period 1|Lost to Follow-up|0|||
48785469|NCT02310750|157055715|FG006|HP Period 1|Lost to Follow-up|1|||
48785470|NCT02310750|157055716|FG007|HP Period 1|Lost to Follow-up|0|||
48785471|NCT02310750|157055717|FG008|HP Period 1|Lost to Follow-up|0|||
48785472|NCT02310750|157055718|FG009|HP Period 1|Lost to Follow-up|0|||
48785473|NCT02310750|157055719|FG010|HP Period 1|Lost to Follow-up|0|||
48785474|NCT02310750|157055720|FG011|HP Period 1|Lost to Follow-up|0|||
48785475|NCT02310750|157055721|FG012|HP Period 1|Lost to Follow-up|0|||
48785476|NCT02310750|157055722|FG013|HP Period 1|Lost to Follow-up|0|||
48785477|NCT02310750|157055723|FG014|HP Period 1|Lost to Follow-up|0|||
48785478|NCT02310750|157055724|FG015|HP Period 1|Lost to Follow-up|0|||
48785479|NCT02310750|157055709|FG000|HP Period 1|Withdrawal by Subject|1|||
48785480|NCT02310750|157055710|FG001|HP Period 1|Withdrawal by Subject|0|||
48785481|NCT02310750|157055711|FG002|HP Period 1|Withdrawal by Subject|0|||
48785482|NCT02310750|157055712|FG003|HP Period 1|Withdrawal by Subject|1|||
48785483|NCT02310750|157055713|FG004|HP Period 1|Withdrawal by Subject|0|||
48785484|NCT02310750|157055714|FG005|HP Period 1|Withdrawal by Subject|0|||
48785485|NCT02310750|157055715|FG006|HP Period 1|Withdrawal by Subject|0|||
48785486|NCT02310750|157055716|FG007|HP Period 1|Withdrawal by Subject|0|||
48785487|NCT02310750|157055717|FG008|HP Period 1|Withdrawal by Subject|0|||
48785488|NCT02310750|157055718|FG009|HP Period 1|Withdrawal by Subject|0|||
48785489|NCT02310750|157055719|FG010|HP Period 1|Withdrawal by Subject|0|||
48785490|NCT02310750|157055720|FG011|HP Period 1|Withdrawal by Subject|0|||
48785491|NCT02310750|157055721|FG012|HP Period 1|Withdrawal by Subject|0|||
48785492|NCT02310750|157055722|FG013|HP Period 1|Withdrawal by Subject|0|||
48785493|NCT02310750|157055723|FG014|HP Period 1|Withdrawal by Subject|0|||
48785494|NCT02310750|157055724|FG015|HP Period 1|Withdrawal by Subject|0|||
48785495|NCT02310750|157055709|FG000|HP Washout 1|Lost to Follow-up|0|||
48785496|NCT02310750|157055710|FG001|HP Washout 1|Lost to Follow-up|0|||
48785497|NCT02310750|157055711|FG002|HP Washout 1|Lost to Follow-up|1|||
48785498|NCT02310750|157055712|FG003|HP Washout 1|Lost to Follow-up|1|||
48785499|NCT02310750|157055713|FG004|HP Washout 1|Lost to Follow-up|2|||
48785500|NCT02310750|157055714|FG005|HP Washout 1|Lost to Follow-up|2|||
48785501|NCT02310750|157055715|FG006|HP Washout 1|Lost to Follow-up|3|||
48785502|NCT02310750|157055716|FG007|HP Washout 1|Lost to Follow-up|0|||
48785503|NCT02310750|157055717|FG008|HP Washout 1|Lost to Follow-up|0|||
48785504|NCT02310750|157055718|FG009|HP Washout 1|Lost to Follow-up|0|||
48785505|NCT02310750|157055719|FG010|HP Washout 1|Lost to Follow-up|0|||
48785506|NCT02310750|157055720|FG011|HP Washout 1|Lost to Follow-up|0|||
48785507|NCT02310750|157055721|FG012|HP Washout 1|Lost to Follow-up|0|||
48785508|NCT02310750|157055722|FG013|HP Washout 1|Lost to Follow-up|0|||
48785509|NCT02310750|157055723|FG014|HP Washout 1|Lost to Follow-up|0|||
48785510|NCT02310750|157055724|FG015|HP Washout 1|Lost to Follow-up|0|||
48785511|NCT02310750|157055709|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785512|NCT02310750|157055710|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785513|NCT02310750|157055711|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785514|NCT02310750|157055712|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
48785515|NCT02310750|157055713|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785516|NCT02310750|157055714|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
48785517|NCT02310750|157055715|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785518|NCT02310750|157055716|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785519|NCT02310750|157055717|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
48785520|NCT02310750|157055718|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
48785521|NCT02310750|157055719|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785522|NCT02310750|157055720|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785523|NCT02310750|157055721|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785524|NCT02310750|157055722|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785525|NCT02310750|157055723|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785526|NCT02310750|157055724|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
48785527|NCT02310750|157055709|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785528|NCT02310750|157055710|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785529|NCT02310750|157055711|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48400300|NCT02164981|155657687|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
48400301|NCT02164981|155657688|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
48400302|NCT02164981|155657686|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
48400303|NCT02164981|155657687|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
48400304|NCT02164981|155657688|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
48400305|NCT01157078|155657690|FG000|Overall Study|Withdrawal by Subject|12|||
48400306|NCT01157078|155657691|FG001|Overall Study|Withdrawal by Subject|14|||
48400307|NCT01157078|155657690|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48400308|NCT01157078|155657691|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48400309|NCT01157078|155657690|FG000|Overall Study|Adverse Event|6|||
48400310|NCT01157078|155657691|FG001|Overall Study|Adverse Event|6|||
48400311|NCT01157078|155657690|FG000|Overall Study|Severe non-compliance to protocol|2|||
48400312|NCT01157078|155657691|FG001|Overall Study|Severe non-compliance to protocol|4|||
48785530|NCT02310750|157055712|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785531|NCT02310750|157055713|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785532|NCT02310750|157055714|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785533|NCT02310750|157055715|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785534|NCT02310750|157055716|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785535|NCT02310750|157055717|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785536|NCT02310750|157055718|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
48785537|NCT02310750|157055719|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785538|NCT02310750|157055720|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785539|NCT02310750|157055721|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785540|NCT02310750|157055722|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785541|NCT02310750|157055723|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785542|NCT02310750|157055724|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
48785543|NCT02310750|157055709|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785544|NCT02310750|157055710|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785545|NCT02310750|157055711|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785546|NCT02310750|157055712|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785547|NCT02310750|157055713|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785548|NCT02310750|157055714|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785549|NCT02310750|157055715|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785550|NCT02310750|157055716|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
48785551|NCT02310750|157055717|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
48785552|NCT02310750|157055718|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
48785553|NCT02310750|157055719|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785554|NCT02310750|157055720|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785555|NCT02310750|157055721|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785556|NCT02310750|157055722|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785557|NCT02310750|157055723|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785558|NCT02310750|157055724|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
48785559|NCT02310750|157055709|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785560|NCT02310750|157055710|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785561|NCT02310750|157055711|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785562|NCT02310750|157055712|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785563|NCT02310750|157055713|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785564|NCT02310750|157055714|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785565|NCT02310750|157055715|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785566|NCT02310750|157055716|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
48785567|NCT02310750|157055717|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
48785568|NCT02310750|157055718|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785569|NCT02310750|157055719|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785570|NCT02310750|157055720|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785571|NCT02310750|157055721|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785572|NCT02310750|157055722|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785573|NCT02310750|157055723|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48400313|NCT01157078|155657690|FG000|Overall Study|Condition under investigation worsened|0|||
48400314|NCT01157078|155657691|FG001|Overall Study|Condition under investigation worsened|1|||
48785574|NCT02310750|157055724|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
48785575|NCT02310750|157055709|FG000|HP Washout 2|Lost to Follow-up|0|||
48785576|NCT02310750|157055710|FG001|HP Washout 2|Lost to Follow-up|0|||
48785577|NCT02310750|157055711|FG002|HP Washout 2|Lost to Follow-up|0|||
48785578|NCT02310750|157055712|FG003|HP Washout 2|Lost to Follow-up|0|||
48785579|NCT02310750|157055713|FG004|HP Washout 2|Lost to Follow-up|1|||
48785580|NCT02310750|157055714|FG005|HP Washout 2|Lost to Follow-up|0|||
48785581|NCT02310750|157055715|FG006|HP Washout 2|Lost to Follow-up|7|||
48785582|NCT02310750|157055716|FG007|HP Washout 2|Lost to Follow-up|0|||
48785583|NCT02310750|157055717|FG008|HP Washout 2|Lost to Follow-up|0|||
48785584|NCT02310750|157055718|FG009|HP Washout 2|Lost to Follow-up|0|||
48785585|NCT02310750|157055719|FG010|HP Washout 2|Lost to Follow-up|0|||
48785586|NCT02310750|157055720|FG011|HP Washout 2|Lost to Follow-up|0|||
48785587|NCT02310750|157055721|FG012|HP Washout 2|Lost to Follow-up|0|||
48785588|NCT02310750|157055722|FG013|HP Washout 2|Lost to Follow-up|0|||
48785589|NCT02310750|157055723|FG014|HP Washout 2|Lost to Follow-up|0|||
48785590|NCT02310750|157055724|FG015|HP Washout 2|Lost to Follow-up|0|||
48785591|NCT00288587|157055729|FG000|Overall Study|Death|4|||
48785592|NCT00288587|157055730|FG001|Overall Study|Death|4|||
48785593|NCT00288587|157055729|FG000|Overall Study|Transplant|0|||
48785594|NCT00288587|157055730|FG001|Overall Study|Transplant|3|||
48785595|NCT00288587|157055729|FG000|Overall Study|Adverse Event|0|||
48785596|NCT00288587|157055730|FG001|Overall Study|Adverse Event|1|||
48785597|NCT00288587|157055729|FG000|Overall Study|Physician Decision|0|||
48785598|NCT00288587|157055730|FG001|Overall Study|Physician Decision|2|||
48785599|NCT00288587|157055729|FG000|Overall Study|Severe Aortic Stenosis|1|||
48785600|NCT00288587|157055730|FG001|Overall Study|Severe Aortic Stenosis|0|||
48785601|NCT04323436|157055733|FG000|Overall Study|Adverse Event|7|||
48785602|NCT04323436|157055734|FG001|Overall Study|Adverse Event|0|||
48785603|NCT04323436|157055735|FG002|Overall Study|Adverse Event|0|||
48785604|NCT04323436|157055733|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
48785605|NCT04323436|157055734|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
48785606|NCT04323436|157055735|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
48785607|NCT04323436|157055733|FG000|Overall Study|Death|1|||
48785608|NCT04323436|157055734|FG001|Overall Study|Death|0|||
48785609|NCT04323436|157055735|FG002|Overall Study|Death|0|||
48785610|NCT04323436|157055733|FG000|Overall Study|Physician Decision|2|||
48785611|NCT04323436|157055734|FG001|Overall Study|Physician Decision|0|||
48785612|NCT04323436|157055735|FG002|Overall Study|Physician Decision|0|||
48785613|NCT04323436|157055733|FG000|Overall Study|Progressive disease|10|||
48400315|NCT01157078|155657690|FG000|Overall Study|Lack of Efficacy|2|||
48400316|NCT01157078|155657691|FG001|Overall Study|Lack of Efficacy|0|||
48785614|NCT04323436|157055734|FG001|Overall Study|Progressive disease|0|||
48785615|NCT04323436|157055735|FG002|Overall Study|Progressive disease|0|||
48785616|NCT04323436|157055733|FG000|Overall Study|Subject decision|3|||
48785617|NCT04323436|157055734|FG001|Overall Study|Subject decision|0|||
48785618|NCT04323436|157055735|FG002|Overall Study|Subject decision|0|||
48785619|NCT01344460|157055736|FG000|Overall Study|Withdrawal by Subject|1|||
48785620|NCT01344460|157055736|FG000|Overall Study|Lost to Follow-up|2|||
48785621|NCT02276482|157055737|FG000|Overall Study|Adverse Event|1|||
48785622|NCT02276482|157055738|FG001|Overall Study|Adverse Event|0|||
48785623|NCT02276482|157055737|FG000|Overall Study|Withdrawal by Subject|1|||
48785624|NCT02276482|157055738|FG001|Overall Study|Withdrawal by Subject|0|||
48785625|NCT02276482|157055737|FG000|Overall Study|Gram-negative infection|1|||
48785626|NCT02276482|157055738|FG001|Overall Study|Gram-negative infection|0|||
48785627|NCT02276482|157055737|FG000|Overall Study|Reason not specified|0|||
48785628|NCT02276482|157055738|FG001|Overall Study|Reason not specified|1|||
48785629|NCT00506493|157055739|FG000|Overall Study|Death|6|||
48400317|NCT01157078|155657690|FG000|Overall Study|Study-specific withdrawal criteria|2|||
48785630|NCT00506493|157055739|FG000|Overall Study|Withdrawal by Subject|5|||
48785631|NCT02653482|157055743|FG000|Overall Study|Death|1|||
48785632|NCT02653482|157055744|FG001|Overall Study|Death|1|||
48785633|NCT03230916|157055745|FG000|Overall Study|Withdrawal by Subject|0|||
48400318|NCT01157078|155657691|FG001|Overall Study|Study-specific withdrawal criteria|2|||
48785634|NCT03230916|157055746|FG001|Overall Study|Withdrawal by Subject|0|||
48785635|NCT03230916|157055747|FG002|Overall Study|Withdrawal by Subject|0|||
48785636|NCT03230916|157055748|FG003|Overall Study|Withdrawal by Subject|0|||
48400319|NCT01157078|155657690|FG000|Overall Study|Lost to Follow-up|7|||
48785637|NCT03230916|157055749|FG004|Overall Study|Withdrawal by Subject|0|||
48785638|NCT03230916|157055750|FG005|Overall Study|Withdrawal by Subject|1|||
48785639|NCT03230916|157055751|FG006|Overall Study|Withdrawal by Subject|0|||
48785640|NCT03230916|157055752|FG007|Overall Study|Withdrawal by Subject|0|||
48785641|NCT03230916|157055753|FG008|Overall Study|Withdrawal by Subject|0|||
48785642|NCT03230916|157055754|FG009|Overall Study|Withdrawal by Subject|0|||
48785643|NCT03230916|157055755|FG010|Overall Study|Withdrawal by Subject|0|||
48785644|NCT05132699|157055756|FG000|Overall Study|Withdrawal by Subject|3|||
48785645|NCT05132699|157055757|FG001|Overall Study|Withdrawal by Subject|0|||
48400320|NCT01157078|155657691|FG001|Overall Study|Lost to Follow-up|5|||
48785646|NCT01404312|157057453|FG000|Overall Study|Death|21|||
48785647|NCT01404312|157057454|FG001|Overall Study|Death|27|||
48785648|NCT01404312|157057453|FG000|Overall Study|Withdrawal by Subject|15|||
48785649|NCT01404312|157057454|FG001|Overall Study|Withdrawal by Subject|18|||
48785650|NCT01404312|157057453|FG000|Overall Study|Participant Unable to get to clinic|93|||
48785651|NCT01404312|157057454|FG001|Overall Study|Participant Unable to get to clinic|103|||
48785652|NCT01404312|157057453|FG000|Overall Study|Lost to Follow-up|115|||
48785653|NCT01404312|157057454|FG001|Overall Study|Lost to Follow-up|111|||
48785654|NCT01404312|157057453|FG000|Overall Study|Site closed|22|||
48785655|NCT01404312|157057454|FG001|Overall Study|Site closed|21|||
48785656|NCT01404312|157057453|FG000|Overall Study|Participant not willing to adhere to req|31|||
48785657|NCT01404312|157057454|FG001|Overall Study|Participant not willing to adhere to req|29|||
48785658|NCT01404312|157057453|FG000|Overall Study|Severe debilitation, unable to continue|1|||
48785659|NCT01404312|157057454|FG001|Overall Study|Severe debilitation, unable to continue|2|||
48785660|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
48785661|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
48785662|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
48785663|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
48785664|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
48785665|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
48785666|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
48785667|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
48785668|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
48785669|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
48785670|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
48785671|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
48785672|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
48785673|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
48785674|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
48785675|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
48785676|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
48785677|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
48785678|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
48785679|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
48785680|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
48785681|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
48785682|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
48785683|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
48785684|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785685|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785686|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785687|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785688|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785689|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48400321|NCT01157078|155657690|FG000|Overall Study|Other|2|||
48400322|NCT01157078|155657691|FG001|Overall Study|Other|4|||
48400323|NCT02600507|155657694|FG000|Overall Study|Adverse Event|3|||
48400324|NCT02600507|155657695|FG001|Overall Study|Adverse Event|15|||
48400325|NCT02600507|155657696|FG002|Overall Study|Adverse Event|5|||
48400326|NCT02600507|155657694|FG000|Overall Study|Lack of Efficacy|3|||
48400327|NCT02600507|155657695|FG001|Overall Study|Lack of Efficacy|8|||
48400328|NCT02600507|155657696|FG002|Overall Study|Lack of Efficacy|5|||
48400329|NCT02600507|155657694|FG000|Overall Study|Lost to Follow-up|3|||
48400330|NCT02600507|155657695|FG001|Overall Study|Lost to Follow-up|5|||
48400331|NCT02600507|155657696|FG002|Overall Study|Lost to Follow-up|2|||
48400332|NCT02600507|155657694|FG000|Overall Study|Protocol Violation|12|||
48400333|NCT02600507|155657695|FG001|Overall Study|Protocol Violation|4|||
48400334|NCT02600507|155657696|FG002|Overall Study|Protocol Violation|4|||
48400335|NCT02600507|155657694|FG000|Overall Study|Physician Decision|1|||
48400336|NCT02600507|155657695|FG001|Overall Study|Physician Decision|0|||
48400337|NCT02600507|155657696|FG002|Overall Study|Physician Decision|1|||
48400338|NCT02600507|155657694|FG000|Overall Study|Withdrawal by Subject|7|||
48400339|NCT02600507|155657695|FG001|Overall Study|Withdrawal by Subject|11|||
48400340|NCT02600507|155657696|FG002|Overall Study|Withdrawal by Subject|7|||
48400341|NCT02600507|155657694|FG000|Overall Study|Other|0|||
48785690|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785691|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48400342|NCT02600507|155657695|FG001|Overall Study|Other|1|||
48785692|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785693|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785694|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785695|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785696|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785697|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785698|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785699|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
48785700|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785701|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785702|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
48785703|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
48785704|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
48785705|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785706|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48400343|NCT02600507|155657696|FG002|Overall Study|Other|1|||
48400344|NCT04541004|155657697|FG000|Overall Study|Adverse Event|2|||
48785707|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785708|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785709|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785710|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785711|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785712|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48400345|NCT00706134|155657698|FG000|Overall Study|Adverse Event|8|||
48400346|NCT00706134|155657699|FG001|Overall Study|Adverse Event|7|||
48400347|NCT00706134|155657700|FG002|Overall Study|Adverse Event|2|||
48400348|NCT00706134|155657701|FG003|Overall Study|Adverse Event|3|||
48400349|NCT00706134|155657698|FG000|Overall Study|Lost to Follow-up|0|||
48400350|NCT00706134|155657699|FG001|Overall Study|Lost to Follow-up|1|||
48400351|NCT00706134|155657700|FG002|Overall Study|Lost to Follow-up|0|||
48400352|NCT00706134|155657701|FG003|Overall Study|Lost to Follow-up|0|||
48400353|NCT00706134|155657698|FG000|Overall Study|Protocol Violation|0|||
48400354|NCT00706134|155657699|FG001|Overall Study|Protocol Violation|6|||
48400355|NCT00706134|155657700|FG002|Overall Study|Protocol Violation|0|||
48400356|NCT00706134|155657701|FG003|Overall Study|Protocol Violation|3|||
48400357|NCT00706134|155657698|FG000|Overall Study|Withdrawal by Subject|1|||
48400358|NCT00706134|155657699|FG001|Overall Study|Withdrawal by Subject|2|||
48400359|NCT00706134|155657700|FG002|Overall Study|Withdrawal by Subject|1|||
48400360|NCT00706134|155657701|FG003|Overall Study|Withdrawal by Subject|0|||
48400361|NCT00706134|155657698|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
48400362|NCT00706134|155657699|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
48400363|NCT00706134|155657700|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
48400364|NCT00706134|155657701|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
48400365|NCT00706134|155657698|FG000|Overall Study|Did not meet study criteria|2|||
48400366|NCT00706134|155657699|FG001|Overall Study|Did not meet study criteria|0|||
48400367|NCT00706134|155657700|FG002|Overall Study|Did not meet study criteria|0|||
48400368|NCT00706134|155657701|FG003|Overall Study|Did not meet study criteria|0|||
48400369|NCT03691974|155657702|FG000|Overall Study|Physician Decision|1|||
48400370|NCT03691974|155657703|FG001|Overall Study|Physician Decision|0|||
48785713|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785714|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785715|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785716|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785717|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785718|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785719|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
48785720|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
48785721|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
48785722|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
48785723|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
48785724|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
48785725|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
48785726|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
48400371|NCT03691974|155657702|FG000|Overall Study|Adverse Event|1|||
48400372|NCT03691974|155657703|FG001|Overall Study|Adverse Event|0|||
48400373|NCT03691974|155657702|FG000|Overall Study|Withdrawal by Subject|11|||
48400374|NCT03691974|155657703|FG001|Overall Study|Withdrawal by Subject|9|||
48400375|NCT03691974|155657702|FG000|Overall Study|Protocol Violation|1|||
48785727|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
48785728|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
48785729|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
48400376|NCT03691974|155657703|FG001|Overall Study|Protocol Violation|0|||
48785730|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
48785731|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
48785732|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
48785733|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
48785734|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
48785735|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
48785736|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
48785737|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
48785738|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
48785739|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
48785740|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
48785741|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785742|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785743|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785744|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785745|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785746|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785747|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785748|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785749|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785750|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785751|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785752|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785753|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785754|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785755|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785756|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785757|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785758|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785759|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
48785760|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
48785761|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
48785762|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785763|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
48785764|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
48785765|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785766|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785767|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785768|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785769|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785770|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785771|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785772|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785773|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785774|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785775|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785776|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785777|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785778|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785779|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
48785780|NCT01490632|157057456|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785781|NCT01490632|157057457|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785782|NCT01490632|157057458|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785783|NCT01490632|157057459|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785784|NCT01490632|157057460|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
48785785|NCT01490632|157057461|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785786|NCT01490632|157057462|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785787|NCT01490632|157057463|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785788|NCT01490632|157057464|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785789|NCT01490632|157057465|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785790|NCT01490632|157057466|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785791|NCT01490632|157057467|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785792|NCT01490632|157057468|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785793|NCT01490632|157057469|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785794|NCT01490632|157057470|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785795|NCT01490632|157057471|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48797714|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
48785796|NCT01490632|157057472|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785797|NCT01490632|157057473|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785798|NCT01490632|157057474|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785799|NCT01490632|157057475|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
48785800|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785801|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785802|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785803|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785804|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785805|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
48785806|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
48785807|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785808|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785809|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
48785810|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
48785811|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
48785812|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785813|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785814|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785815|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785816|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785817|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785818|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785819|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
48785820|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785821|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785822|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785823|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785824|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785825|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785826|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
48785827|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785828|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
48785829|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
48785830|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
48785831|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785832|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785833|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785834|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785835|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785836|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785837|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785838|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785839|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
48785840|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785841|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785842|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785843|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785844|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785845|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785846|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
48785847|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785848|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48400377|NCT03691974|155657702|FG000|Overall Study|Lost to Follow-up|8|||
48400378|NCT03691974|155657703|FG001|Overall Study|Lost to Follow-up|7|||
48400379|NCT00691483|155657706|FG000|Overall Study|Adverse Event|14|||
48400380|NCT00691483|155657707|FG001|Overall Study|Adverse Event|6|||
48400381|NCT00691483|155657706|FG000|Overall Study|Lost to Follow-up|17|||
48400382|NCT00691483|155657707|FG001|Overall Study|Lost to Follow-up|10|||
48400383|NCT00691483|155657706|FG000|Overall Study|Withdrawal by Subject|24|||
48785849|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
48785850|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785851|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785852|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48400384|NCT00691483|155657707|FG001|Overall Study|Withdrawal by Subject|7|||
48400385|NCT00691483|155657706|FG000|Overall Study|Other known cause|6|||
48400386|NCT00691483|155657707|FG001|Overall Study|Other known cause|1|||
48400387|NCT00691483|155657706|FG000|Overall Study|Randomized by not treated|7|||
48785853|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785854|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785855|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785856|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785857|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785858|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785859|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
48785860|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785861|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785862|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785863|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785864|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785865|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785866|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
48785867|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785868|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785869|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785870|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785871|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785872|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785873|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785874|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785875|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785876|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785877|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785878|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785879|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
48785880|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785881|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785882|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785883|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785884|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785885|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
48785886|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785887|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785888|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785889|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785890|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785891|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785892|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785893|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785894|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785895|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785896|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785897|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785898|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785899|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
48785900|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785901|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785902|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785903|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48400388|NCT00691483|155657707|FG001|Overall Study|Randomized by not treated|1|||
48400389|NCT00049673|155657708|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
48400390|NCT00049673|155657709|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
48400391|NCT03927105|155657710|FG000|Overall Study|Death|1|||
48400392|NCT03927105|155657710|FG000|Overall Study|In observation for potential re-treatment|2|||
48785904|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785905|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785906|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
48785907|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785908|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
48785909|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785910|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
48785911|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
48785912|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48426303|NCT00064662|155749535|FG000|Overall Study|Administratively withdrawn|2|||
48785913|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785914|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785915|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785916|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785917|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785918|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785919|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
48785920|NCT01490632|157057456|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785921|NCT01490632|157057457|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785922|NCT01490632|157057458|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785923|NCT01490632|157057459|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785924|NCT01490632|157057460|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785925|NCT01490632|157057461|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
48785926|NCT01490632|157057462|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
48785927|NCT01490632|157057463|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
48785928|NCT01490632|157057464|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
48785929|NCT01490632|157057465|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
48785930|NCT01490632|157057466|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
48785931|NCT01490632|157057467|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
48785932|NCT01490632|157057468|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785933|NCT01490632|157057469|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785934|NCT01490632|157057470|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785935|NCT01490632|157057471|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785936|NCT01490632|157057472|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785937|NCT01490632|157057473|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785938|NCT01490632|157057474|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785939|NCT01490632|157057475|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
48785940|NCT01490632|157057456|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785941|NCT01490632|157057457|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785942|NCT01490632|157057458|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785943|NCT01490632|157057459|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785944|NCT01490632|157057460|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785945|NCT01490632|157057461|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785946|NCT01490632|157057462|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785947|NCT01490632|157057463|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785948|NCT01490632|157057464|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785949|NCT01490632|157057465|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785950|NCT01490632|157057466|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785951|NCT01490632|157057467|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785952|NCT01490632|157057468|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785953|NCT01490632|157057469|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785954|NCT01490632|157057470|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
48785955|NCT01490632|157057471|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
48785956|NCT01490632|157057472|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785957|NCT01490632|157057473|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785958|NCT01490632|157057474|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785959|NCT01490632|157057475|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
48785960|NCT01490632|157057456|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785961|NCT01490632|157057457|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785962|NCT01490632|157057458|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785963|NCT01490632|157057459|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785964|NCT01490632|157057460|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785965|NCT01490632|157057461|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785966|NCT01490632|157057462|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785967|NCT01490632|157057463|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785968|NCT01490632|157057464|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785969|NCT01490632|157057465|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785970|NCT01490632|157057466|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785971|NCT01490632|157057467|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785972|NCT01490632|157057468|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785973|NCT01490632|157057469|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
48785974|NCT01490632|157057470|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785975|NCT01490632|157057471|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785976|NCT01490632|157057472|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785977|NCT01490632|157057473|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785978|NCT01490632|157057474|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48785979|NCT01490632|157057475|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
48400393|NCT03927105|155657710|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
48400394|NCT00817531|155657712|FG000|Overall Study|Adverse Event|1|||
48400395|NCT00817531|155657712|FG000|Overall Study|Lack of Efficacy|1|||
48400396|NCT00812214|155657716|FG000|Overall Study|Lost to Follow-up|3|||
48400397|NCT00812214|155657717|FG001|Overall Study|Lost to Follow-up|1|||
48400398|NCT01659320|155657720|FG000|Overall Study|Withdrawal by Subject|2|||
48400399|NCT01659320|155657720|FG000|Overall Study|Physician Decision|1|||
48400400|NCT00590590|155657721|FG000|Overall Study|Lack of Efficacy|1|||
48400401|NCT00590590|155657722|FG001|Overall Study|Lack of Efficacy|2|||
48400402|NCT00590590|155657723|FG002|Overall Study|Lack of Efficacy|0|||
48400403|NCT00590590|155657721|FG000|Overall Study|Adverse Event|1|||
48400404|NCT00590590|155657722|FG001|Overall Study|Adverse Event|0|||
48400405|NCT00590590|155657723|FG002|Overall Study|Adverse Event|0|||
48400406|NCT00590590|155657721|FG000|Overall Study|Protocol Violation|0|||
48400407|NCT00590590|155657722|FG001|Overall Study|Protocol Violation|0|||
48400408|NCT00590590|155657723|FG002|Overall Study|Protocol Violation|2|||
48400409|NCT00590590|155657721|FG000|Overall Study|Lost to Follow-up|4|||
48400410|NCT00590590|155657722|FG001|Overall Study|Lost to Follow-up|1|||
48400411|NCT00590590|155657723|FG002|Overall Study|Lost to Follow-up|2|||
48400412|NCT00590590|155657721|FG000|Overall Study|Withdrawal by Subject|0|||
48400413|NCT00590590|155657722|FG001|Overall Study|Withdrawal by Subject|1|||
48400414|NCT00590590|155657723|FG002|Overall Study|Withdrawal by Subject|1|||
48400415|NCT00590590|155657721|FG000|Overall Study|Did not complete due to study closure|1|||
48400416|NCT00590590|155657722|FG001|Overall Study|Did not complete due to study closure|1|||
48400417|NCT00590590|155657723|FG002|Overall Study|Did not complete due to study closure|1|||
48400418|NCT00590590|155657721|FG000|Overall Study|Did not complete study|0|||
48400419|NCT00590590|155657722|FG001|Overall Study|Did not complete study|1|||
48785980|NCT01490632|157057456|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785981|NCT01490632|157057457|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785982|NCT01490632|157057458|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785983|NCT01490632|157057459|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785984|NCT01490632|157057460|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785985|NCT01490632|157057461|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785986|NCT01490632|157057462|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785987|NCT01490632|157057463|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785988|NCT01490632|157057464|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785989|NCT01490632|157057465|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785990|NCT01490632|157057466|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785991|NCT01490632|157057467|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785992|NCT01490632|157057468|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785993|NCT01490632|157057469|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785994|NCT01490632|157057470|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
48785995|NCT01490632|157057471|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
48785996|NCT01490632|157057472|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785997|NCT01490632|157057473|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785998|NCT01490632|157057474|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48785999|NCT01490632|157057475|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
48786000|NCT01490632|157057456|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786001|NCT01490632|157057457|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786002|NCT01490632|157057458|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786003|NCT01490632|157057459|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786004|NCT01490632|157057460|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786005|NCT01490632|157057461|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786006|NCT01490632|157057462|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786007|NCT01490632|157057463|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786008|NCT01490632|157057464|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48400420|NCT00590590|155657723|FG002|Overall Study|Did not complete study|0|||
48400421|NCT00132132|155657724|FG000|Overall Study|Lost to Follow-up|7|||
48400422|NCT00132132|155657725|FG001|Overall Study|Lost to Follow-up|2|||
48400423|NCT01870401|155657726|FG000|Overall Study|Death|48|||
48400424|NCT01870401|155657727|FG001|Overall Study|Death|24|||
48400425|NCT01870401|155657726|FG000|Overall Study|Withdrawal by Subject|39|||
48400426|NCT01870401|155657727|FG001|Overall Study|Withdrawal by Subject|26|||
48786009|NCT01490632|157057465|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786010|NCT01490632|157057466|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786011|NCT01490632|157057467|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786012|NCT01490632|157057468|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
48786013|NCT01490632|157057469|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
48786014|NCT01490632|157057470|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
48786015|NCT01490632|157057471|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
48786016|NCT01490632|157057472|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786017|NCT01490632|157057473|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786018|NCT01490632|157057474|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786019|NCT01490632|157057475|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
48786020|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
48786021|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
48786022|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
48786023|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
48786024|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
48786025|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
48786026|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
48786027|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
48786028|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
48786029|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
48786030|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
48786031|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
48786032|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
48786033|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
48786034|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
48786035|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
48786036|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
48786037|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
48786038|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
48786039|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
48786040|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Death|0|||
48786041|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Death|0|||
48786042|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Death|0|||
48786043|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Death|0|||
48786044|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Death|0|||
48786045|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Death|0|||
48786046|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Death|0|||
48786047|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Death|0|||
48786048|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Death|0|||
48786049|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Death|0|||
48786050|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Death|0|||
48786051|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Death|0|||
48786052|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Death|0|||
48786053|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Death|0|||
48400427|NCT01870401|155657726|FG000|Overall Study|Lost to Follow-up|19|||
48400428|NCT01870401|155657727|FG001|Overall Study|Lost to Follow-up|14|||
48400429|NCT01870401|155657726|FG000|Overall Study|Other|9|||
48786054|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Death|0|||
48400430|NCT01870401|155657727|FG001|Overall Study|Other|7|||
48786055|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Death|0|||
48786056|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Death|0|||
48786057|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Death|0|||
48786058|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Death|1|||
48786059|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Death|0|||
48786060|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786061|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786062|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786063|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786064|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786065|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786066|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786067|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786068|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786069|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786070|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786071|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786072|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786073|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786074|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786075|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48400431|NCT01870401|155657726|FG000|Overall Study|On-going in the Study|35|||
48786076|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
48786077|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
48786078|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
48786079|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
48786080|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786081|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786082|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786083|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786084|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786085|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786086|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786087|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786088|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786089|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786090|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786091|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786092|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786093|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786094|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786095|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786096|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786097|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786098|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
48786099|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
48786100|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
48786101|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
48786102|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
48786103|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
48786104|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
48786105|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
48786106|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
48786107|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
48786108|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
48786109|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
48786110|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
48786111|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
48786112|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
48786113|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
48786114|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
48786115|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
48786116|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
48786117|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
48786118|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
48786119|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
48786120|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
48786121|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
48786122|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
48786123|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
48786124|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
48786125|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
48786126|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
48786127|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
48786128|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
48786129|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
48786130|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
48786131|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
48786132|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
48786133|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
48786134|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
48786135|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
48786136|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
48786137|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
48786138|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
48786139|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
48786140|NCT01490632|157057456|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786141|NCT01490632|157057457|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786142|NCT01490632|157057458|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786143|NCT01490632|157057459|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786144|NCT01490632|157057460|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786145|NCT01490632|157057461|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786146|NCT01490632|157057462|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786147|NCT01490632|157057463|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786148|NCT01490632|157057464|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786149|NCT01490632|157057465|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786150|NCT01490632|157057466|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786151|NCT01490632|157057467|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786152|NCT01490632|157057468|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786153|NCT01490632|157057469|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786154|NCT01490632|157057470|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48400432|NCT01870401|155657727|FG001|Overall Study|On-going in the Study|25|||
48400433|NCT01745146|155657728|FG000|Overall Study|Withdrawal by Subject|1|||
48400434|NCT01745146|155657729|FG001|Overall Study|Withdrawal by Subject|3|||
48786155|NCT01490632|157057471|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786156|NCT01490632|157057472|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
48786157|NCT01490632|157057473|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
48786158|NCT01490632|157057474|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
48786159|NCT01490632|157057475|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
48786160|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
48786161|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
48786162|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
48786163|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
48786164|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Death|235|||
48786165|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Death|167|||
48786166|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Death|1|||
48786167|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Death|0|||
48786168|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
48786169|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
48786170|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
48786171|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
48786172|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
48786173|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
48786174|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
48786175|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
48786176|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Other|1|||
48786177|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Other|2|||
48786178|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Other|0|||
48786179|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Other|0|||
48786180|NCT00673049|157057476|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
48786181|NCT00673049|157057477|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
48786182|NCT00673049|157057478|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
48786183|NCT00673049|157057479|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
48786184|NCT00673049|157057476|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
48400435|NCT01745146|155657728|FG000|Overall Study|Lost to Follow-up|2|||
48400436|NCT01745146|155657729|FG001|Overall Study|Lost to Follow-up|0|||
48786185|NCT00673049|157057477|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
48786186|NCT00673049|157057478|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
48786187|NCT00673049|157057479|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
48786188|NCT00673049|157057476|FG000|After Progression on Erlotinib|Death|0|||
48786189|NCT00673049|157057477|FG001|After Progression on Erlotinib|Death|0|||
48786190|NCT00673049|157057478|FG002|After Progression on Erlotinib|Death|0|||
48786191|NCT00673049|157057479|FG003|After Progression on Erlotinib|Death|71|||
48786192|NCT00673049|157057476|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
48786193|NCT00673049|157057477|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
48786194|NCT00673049|157057478|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
48786195|NCT00673049|157057479|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
48786196|NCT00673049|157057476|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
48786197|NCT00673049|157057477|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
48786198|NCT00673049|157057478|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
48786199|NCT00673049|157057479|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
48786200|NCT00673049|157057476|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
48786201|NCT00673049|157057477|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
48786202|NCT00673049|157057478|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
48786203|NCT00673049|157057479|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
48786204|NCT04837482|157057480|FG000|Period 2|Withdrawal by Subject|0|||
48786205|NCT04837482|157057481|FG001|Period 2|Withdrawal by Subject|1|||
48786206|NCT01197950|157057490|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
48786207|NCT01197950|157057491|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
48797715|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
48786208|NCT01197950|157057492|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
48786209|NCT01793792|157057503|FG000|Overall Study|Death|5|||
48786210|NCT01793792|157057503|FG000|Overall Study|Lost to Follow-up|5|||
48786211|NCT01793792|157057503|FG000|Overall Study|Withdrawal by Subject|1|||
48786212|NCT01793792|157057503|FG000|Overall Study|Device Not Implanted|1|||
48786213|NCT01248884|157057504|FG000|Overall Study|Withdrawal by Subject|1|||
48400437|NCT02684981|155657730|FG000|Overall Study|Permanently discontinued the treatment|157|||
48400438|NCT02684981|155657731|FG001|Overall Study|Permanently discontinued the treatment|161|||
48400439|NCT02684981|155657732|FG002|Overall Study|Permanently discontinued the treatment|110|||
48400440|NCT02684981|155657730|FG000|Overall Study|Other|83|||
48400441|NCT02684981|155657731|FG001|Overall Study|Other|49|||
48400442|NCT02684981|155657732|FG002|Overall Study|Other|17|||
48400443|NCT00452699|155657733|FG000|Overall Study|Adverse Event|10|||
48400444|NCT00452699|155657734|FG001|Overall Study|Adverse Event|3|||
48786214|NCT01248884|157057505|FG001|Overall Study|Withdrawal by Subject|3|||
48786215|NCT01248884|157057506|FG002|Overall Study|Withdrawal by Subject|1|||
48786216|NCT01248884|157057504|FG000|Overall Study|Adverse Event|1|||
48786217|NCT01248884|157057505|FG001|Overall Study|Adverse Event|0|||
48786218|NCT01248884|157057506|FG002|Overall Study|Adverse Event|0|||
48786219|NCT04479618|157057507|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
48786220|NCT04479618|157057508|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
48786221|NCT04479618|157057509|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
48786222|NCT04479618|157057507|FG000|Overall Study|Lack of Efficacy|1|||
48786223|NCT04479618|157057508|FG001|Overall Study|Lack of Efficacy|0|||
48786224|NCT04479618|157057509|FG002|Overall Study|Lack of Efficacy|0|||
48786225|NCT04479618|157057507|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
48786226|NCT04479618|157057508|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
48786227|NCT04479618|157057509|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
48786228|NCT04479618|157057507|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
48786229|NCT04479618|157057508|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
48786230|NCT04479618|157057509|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
48786231|NCT04479618|157057507|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
48786232|NCT04479618|157057508|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
48786233|NCT04479618|157057509|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
48786234|NCT04479618|157057507|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
48786235|NCT04479618|157057508|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
48786236|NCT04479618|157057509|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
48786237|NCT04969250|157057515|FG000|Overall Study|Protocol Violation|0|||
48786238|NCT04969250|157057516|FG001|Overall Study|Protocol Violation|2|||
48786239|NCT04969250|157057517|FG002|Overall Study|Protocol Violation|3|||
48786240|NCT04969250|157057518|FG003|Overall Study|Protocol Violation|8|||
48786241|NCT04969250|157057515|FG000|Overall Study|Withdrawal by Subject|0|||
48786242|NCT04969250|157057516|FG001|Overall Study|Withdrawal by Subject|1|||
48400445|NCT00452699|155657733|FG000|Overall Study|Lack of Efficacy|6|||
48400446|NCT00452699|155657734|FG001|Overall Study|Lack of Efficacy|4|||
48400447|NCT00452699|155657733|FG000|Overall Study|Lost to Follow-up|6|||
48400448|NCT00452699|155657734|FG001|Overall Study|Lost to Follow-up|9|||
48400449|NCT00452699|155657733|FG000|Overall Study|Protocol Violation|21|||
48786243|NCT04969250|157057517|FG002|Overall Study|Withdrawal by Subject|0|||
48400450|NCT00452699|155657734|FG001|Overall Study|Protocol Violation|25|||
48400451|NCT00452699|155657733|FG000|Overall Study|Withdrawal by Subject|26|||
48400452|NCT00452699|155657734|FG001|Overall Study|Withdrawal by Subject|25|||
48400453|NCT00452699|155657733|FG000|Overall Study|Other|12|||
48400454|NCT00452699|155657734|FG001|Overall Study|Other|7|||
48400455|NCT02921971|155657735|FG000|Overall Study|Adverse Event|1|||
48400456|NCT02921971|155657736|FG001|Overall Study|Adverse Event|2|||
48400457|NCT02921971|155657735|FG000|Overall Study|Lack of Efficacy|3|||
48400458|NCT02921971|155657736|FG001|Overall Study|Lack of Efficacy|1|||
48400459|NCT02921971|155657735|FG000|Overall Study|Other than specified above|2|||
48400460|NCT02921971|155657736|FG001|Overall Study|Other than specified above|1|||
48400461|NCT00326898|155657737|FG000|Overall Study|Disease progression|52|||
48400462|NCT00326898|155657738|FG001|Overall Study|Disease progression|54|||
48400463|NCT00326898|155657739|FG002|Overall Study|Disease progression|102|||
48400464|NCT00326898|155657737|FG000|Overall Study|Adverse Event|124|||
48400465|NCT00326898|155657738|FG001|Overall Study|Adverse Event|128|||
48400466|NCT00326898|155657739|FG002|Overall Study|Adverse Event|33|||
48400467|NCT00326898|155657737|FG000|Overall Study|Death|2|||
48400468|NCT00326898|155657738|FG001|Overall Study|Death|0|||
48400469|NCT00326898|155657739|FG002|Overall Study|Death|0|||
48400470|NCT00326898|155657737|FG000|Overall Study|Withdrawal by Subject|134|||
48786244|NCT04969250|157057518|FG003|Overall Study|Withdrawal by Subject|0|||
48786245|NCT03647501|157057519|FG000|Overall Study|Lost to Follow-up|1|||
48786246|NCT03647501|157057520|FG001|Overall Study|Lost to Follow-up|1|||
48786247|NCT03647501|157057519|FG000|Overall Study|Withdrawal by Subject|0|||
48786248|NCT03647501|157057520|FG001|Overall Study|Withdrawal by Subject|1|||
48786249|NCT02079805|157057521|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48786250|NCT02079805|157057522|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48786251|NCT02079805|157057521|FG000|Overall Study|Voluntary Withdrawal|0|||
48786252|NCT02079805|157057522|FG001|Overall Study|Voluntary Withdrawal|1|||
48786253|NCT03447769|157057523|FG000|Overall Study|Progressive disease|138|||
48786254|NCT03447769|157057524|FG001|Overall Study|Progressive disease|148|||
48786255|NCT03447769|157057523|FG000|Overall Study|Study terminated by Sponsor|60|||
48786256|NCT03447769|157057524|FG001|Overall Study|Study terminated by Sponsor|44|||
48786257|NCT03447769|157057523|FG000|Overall Study|Adverse Event|34|||
48786258|NCT03447769|157057524|FG001|Overall Study|Adverse Event|31|||
48786259|NCT03447769|157057523|FG000|Overall Study|Patient decision|27|||
48786260|NCT03447769|157057524|FG001|Overall Study|Patient decision|27|||
48786261|NCT03447769|157057523|FG000|Overall Study|Protocol deviation|4|||
48786262|NCT03447769|157057524|FG001|Overall Study|Protocol deviation|6|||
48786263|NCT03447769|157057523|FG000|Overall Study|Death|2|||
48786264|NCT03447769|157057524|FG001|Overall Study|Death|7|||
48786265|NCT03447769|157057523|FG000|Overall Study|Technical problems|1|||
48786266|NCT03447769|157057524|FG001|Overall Study|Technical problems|0|||
48786267|NCT03447769|157057523|FG000|Overall Study|Lost to Follow-up|0|||
48786268|NCT03447769|157057524|FG001|Overall Study|Lost to Follow-up|1|||
48786269|NCT03447769|157057523|FG000|Overall Study|Physician Decision|13|||
48786270|NCT03447769|157057524|FG001|Overall Study|Physician Decision|5|||
48786271|NCT03759873|157057526|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
48786272|NCT03759873|157057527|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
48786273|NCT03759873|157057528|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
48786274|NCT03759873|157057529|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
48786275|NCT03759873|157057526|FG000|Overall Study|Moved outside eligible area|0|||
48400471|NCT00326898|155657738|FG001|Overall Study|Withdrawal by Subject|128|||
48400472|NCT00326898|155657739|FG002|Overall Study|Withdrawal by Subject|32|||
48400473|NCT00326898|155657737|FG000|Overall Study|Alternative therapy|1|||
48400474|NCT00326898|155657738|FG001|Overall Study|Alternative therapy|0|||
48400475|NCT00326898|155657739|FG002|Overall Study|Alternative therapy|0|||
48400476|NCT00326898|155657737|FG000|Overall Study|Other complicating disease|5|||
48400477|NCT00326898|155657738|FG001|Overall Study|Other complicating disease|5|||
48400478|NCT00326898|155657739|FG002|Overall Study|Other complicating disease|4|||
48400479|NCT00326898|155657737|FG000|Overall Study|Other/Missing/Unknown|33|||
48400480|NCT00326898|155657738|FG001|Overall Study|Other/Missing/Unknown|28|||
48400481|NCT00326898|155657739|FG002|Overall Study|Other/Missing/Unknown|32|||
48400482|NCT00493870|155657741|FG000|Overall Study|Lost to Follow-up|12|||
48400483|NCT00493870|155657742|FG001|Overall Study|Lost to Follow-up|15|||
48400484|NCT03733392|155657743|FG000|Overall Study|Withdrawal by Subject|11|||
48400485|NCT03733392|155657744|FG001|Overall Study|Withdrawal by Subject|1|||
48400486|NCT03733392|155657743|FG000|Overall Study|Death|1|||
48400487|NCT03733392|155657744|FG001|Overall Study|Death|0|||
48400488|NCT03733392|155657743|FG000|Overall Study|Lost to Follow-up|5|||
48400489|NCT03733392|155657744|FG001|Overall Study|Lost to Follow-up|0|||
48400490|NCT03733392|155657743|FG000|Overall Study|Protocol Violation|0|||
48400491|NCT03733392|155657744|FG001|Overall Study|Protocol Violation|1|||
48400492|NCT03733392|155657743|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
48400493|NCT03733392|155657744|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
48400494|NCT03733392|155657743|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
48786276|NCT03759873|157057527|FG001|Overall Study|Moved outside eligible area|2|||
48786277|NCT03759873|157057528|FG002|Overall Study|Moved outside eligible area|0|||
48786278|NCT03759873|157057529|FG003|Overall Study|Moved outside eligible area|0|||
48786279|NCT03759873|157057526|FG000|Overall Study|Withdrawal by Subject|0|||
48400495|NCT03733392|155657744|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
48400496|NCT03733392|155657743|FG000|Overall Study|Patient Non-Compliance|2|||
48400497|NCT03733392|155657744|FG001|Overall Study|Patient Non-Compliance|1|||
48400498|NCT03733392|155657743|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
48786280|NCT03759873|157057527|FG001|Overall Study|Withdrawal by Subject|0|||
48786281|NCT03759873|157057528|FG002|Overall Study|Withdrawal by Subject|1|||
48786282|NCT03759873|157057529|FG003|Overall Study|Withdrawal by Subject|0|||
48786283|NCT03579563|157057530|FG000|Overall Study|Lost to Follow-up|0|||
48786284|NCT03579563|157057531|FG001|Overall Study|Lost to Follow-up|0|||
48786285|NCT03579563|157057532|FG002|Overall Study|Lost to Follow-up|0|||
48786286|NCT03579563|157057533|FG003|Overall Study|Lost to Follow-up|0|||
48786287|NCT03579563|157057534|FG004|Overall Study|Lost to Follow-up|1|||
48400499|NCT03733392|155657744|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
48400500|NCT03733392|155657743|FG000|Overall Study|Withdrawal prior to procedure|5|||
48400501|NCT03733392|155657744|FG001|Overall Study|Withdrawal prior to procedure|2|||
48786288|NCT03579563|157057535|FG005|Overall Study|Lost to Follow-up|0|||
48786289|NCT03579563|157057530|FG000|Overall Study|Lack of Efficacy|1|||
48786290|NCT03579563|157057531|FG001|Overall Study|Lack of Efficacy|1|||
48786291|NCT03579563|157057532|FG002|Overall Study|Lack of Efficacy|4|||
48786292|NCT03579563|157057533|FG003|Overall Study|Lack of Efficacy|1|||
48786293|NCT03579563|157057534|FG004|Overall Study|Lack of Efficacy|2|||
48786294|NCT03579563|157057535|FG005|Overall Study|Lack of Efficacy|3|||
48786295|NCT03579563|157057530|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
48786296|NCT03579563|157057531|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
48786297|NCT03579563|157057532|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
48786298|NCT03579563|157057533|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
48786299|NCT03579563|157057534|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
48786300|NCT03579563|157057535|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
48786301|NCT03579563|157057530|FG000|Overall Study|Time/distance concern|0|||
48786302|NCT03579563|157057531|FG001|Overall Study|Time/distance concern|0|||
48786303|NCT03579563|157057532|FG002|Overall Study|Time/distance concern|1|||
48786304|NCT03579563|157057533|FG003|Overall Study|Time/distance concern|0|||
48786305|NCT03579563|157057534|FG004|Overall Study|Time/distance concern|0|||
48786306|NCT03579563|157057535|FG005|Overall Study|Time/distance concern|1|||
48786307|NCT03579563|157057530|FG000|Overall Study|COVID shutdown|2|||
48786308|NCT03579563|157057531|FG001|Overall Study|COVID shutdown|3|||
48786309|NCT03579563|157057532|FG002|Overall Study|COVID shutdown|4|||
48786310|NCT03579563|157057533|FG003|Overall Study|COVID shutdown|3|||
48786311|NCT03579563|157057534|FG004|Overall Study|COVID shutdown|1|||
48786312|NCT03579563|157057535|FG005|Overall Study|COVID shutdown|2|||
48786313|NCT03579563|157057530|FG000|Overall Study|Protocol administration error|1|||
48786314|NCT03579563|157057531|FG001|Overall Study|Protocol administration error|0|||
48786315|NCT03579563|157057532|FG002|Overall Study|Protocol administration error|1|||
48786316|NCT03579563|157057533|FG003|Overall Study|Protocol administration error|0|||
48786317|NCT03579563|157057534|FG004|Overall Study|Protocol administration error|1|||
48786318|NCT03579563|157057535|FG005|Overall Study|Protocol administration error|5|||
48786319|NCT04139317|157057536|FG000|Overall Study|Adverse Event|10|||
48786320|NCT04139317|157057537|FG001|Overall Study|Adverse Event|2|||
48786321|NCT04139317|157057536|FG000|Overall Study|Death|6|||
48786322|NCT04139317|157057537|FG001|Overall Study|Death|4|||
48786323|NCT04139317|157057536|FG000|Overall Study|Lost to Follow-up|1|||
48786324|NCT04139317|157057537|FG001|Overall Study|Lost to Follow-up|0|||
48786325|NCT04139317|157057536|FG000|Overall Study|Physician Decision|3|||
48786326|NCT04139317|157057537|FG001|Overall Study|Physician Decision|1|||
48786327|NCT04139317|157057536|FG000|Overall Study|Progressive Disease|19|||
48786328|NCT04139317|157057537|FG001|Overall Study|Progressive Disease|9|||
48786329|NCT04139317|157057536|FG000|Overall Study|Subject Decision|2|||
48786330|NCT04139317|157057537|FG001|Overall Study|Subject Decision|2|||
48786331|NCT00511004|157057538|FG000|Overall Study|Lost to Follow-up|0|||
48786332|NCT00511004|157057539|FG001|Overall Study|Lost to Follow-up|0|||
48786333|NCT00511004|157057540|FG002|Overall Study|Lost to Follow-up|4|||
48786334|NCT01568047|157057541|FG000|Overall Study|Ineligibility|1|||
48786335|NCT01568047|157057542|FG001|Overall Study|Ineligibility|0|||
48786336|NCT01568047|157057543|FG002|Overall Study|Ineligibility|0|||
48786337|NCT01568047|157057544|FG003|Overall Study|Ineligibility|0|||
48786338|NCT01568047|157057541|FG000|Overall Study|Withdrawal by Subject|0|||
48786339|NCT01568047|157057542|FG001|Overall Study|Withdrawal by Subject|1|||
48786340|NCT01568047|157057543|FG002|Overall Study|Withdrawal by Subject|0|||
48786341|NCT01568047|157057544|FG003|Overall Study|Withdrawal by Subject|0|||
48786342|NCT01568047|157057541|FG000|Overall Study|Adverse Event|0|||
48786343|NCT01568047|157057542|FG001|Overall Study|Adverse Event|0|||
48786344|NCT01568047|157057543|FG002|Overall Study|Adverse Event|1|||
48786345|NCT01568047|157057544|FG003|Overall Study|Adverse Event|1|||
48786346|NCT02043782|157057545|FG000|Period 1|Adverse Event|0|||
48786347|NCT02043782|157057546|FG001|Period 1|Adverse Event|0|||
48786348|NCT02043782|157057547|FG002|Period 1|Adverse Event|1|||
48786349|NCT02043782|157057548|FG003|Period 1|Adverse Event|0|||
48786350|NCT02043782|157057549|FG004|Period 1|Adverse Event|0|||
48786351|NCT02043782|157057550|FG005|Period 1|Adverse Event|0|||
48786352|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
48786353|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
48786354|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
48786355|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
48786356|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
48786357|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
48786358|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
48786359|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
48786360|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
48786361|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
48786362|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
48786363|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
48786364|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
48786365|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
48786366|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
48786367|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
48786368|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
48786369|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
48786370|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
48786371|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
48786372|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
48786373|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
48786374|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
48786375|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
48786376|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
48786377|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
48786378|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
48786379|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
48786380|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
48786381|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
48786382|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
48786383|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
48786384|NCT04818346|157057551|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
48786385|NCT04818346|157057552|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
48786386|NCT04818346|157057553|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
48786387|NCT04818346|157057554|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
48786388|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
48786389|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
48786390|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
48786391|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
48786392|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
48786393|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
48786394|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
48786395|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
48786396|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
48786397|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
48786398|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
48786399|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
48786400|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
48786401|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
48786402|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
48786403|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
48786404|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
48786405|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
48786406|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
48786407|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
48786408|NCT04818346|157057551|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
48786409|NCT04818346|157057552|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
48786410|NCT04818346|157057553|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
48786411|NCT04818346|157057554|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
48786412|NCT01985126|157057559|FG000|Overall Study|Death|15|||
48786413|NCT01985126|157057560|FG001|Overall Study|Death|69|||
48786414|NCT01985126|157057559|FG000|Overall Study|Lost to Follow-up|0|||
48786415|NCT01985126|157057560|FG001|Overall Study|Lost to Follow-up|8|||
48786416|NCT01985126|157057559|FG000|Overall Study|Study Terminated By Sponsor|1|||
48786417|NCT01985126|157057560|FG001|Overall Study|Study Terminated By Sponsor|22|||
48786418|NCT01985126|157057559|FG000|Overall Study|Withdrawal by Subject|2|||
48786419|NCT01985126|157057560|FG001|Overall Study|Withdrawal by Subject|7|||
48786420|NCT01434602|157057561|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
48786421|NCT01434602|157057562|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
48786422|NCT01434602|157057563|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
48786423|NCT01434602|157057564|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
48786424|NCT01434602|157057565|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
48786425|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
48786426|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
48786427|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
48786428|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
48786429|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
48786430|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
48786431|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
48786432|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
48786433|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
48786434|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
48786435|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
48786436|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
48786437|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
48786438|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
48786439|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
48786440|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
48786441|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
48786442|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
48786443|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
48786444|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
48786445|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
48786446|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
48786447|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
48786448|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
48786449|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
48786450|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
48786451|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
48786452|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
48786453|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
48786454|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
48786455|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
48786456|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
48786457|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
48786458|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
48786459|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
48786460|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
48786461|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
48786462|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
48786463|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
48786464|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
48786465|NCT01434602|157057561|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
48786466|NCT01434602|157057562|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
48786467|NCT01434602|157057563|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
48786468|NCT01434602|157057564|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
48786469|NCT01434602|157057565|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
48786470|NCT00380068|157057568|FG000|Overall Study|Adverse Event|40|||
48786471|NCT00380068|157057568|FG000|Overall Study|Withdrawal by Subject|10|||
48786472|NCT00380068|157057568|FG000|Overall Study|Not compliant|6|||
48786473|NCT00380068|157057568|FG000|Overall Study|Lost to Follow-up|1|||
48786474|NCT00380068|157057568|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
48786475|NCT00380068|157057568|FG000|Overall Study|Lung transplant|3|||
48786476|NCT00380068|157057568|FG000|Overall Study|Physician Decision|2|||
48786477|NCT00380068|157057568|FG000|Overall Study|Partipant moved away|1|||
48786478|NCT00380068|157057568|FG000|Overall Study|Lack of Efficacy|5|||
48786479|NCT03301051|157057569|FG000|Overall Study|Adverse Event|0|||
48786480|NCT03301051|157057570|FG001|Overall Study|Adverse Event|4|||
48786481|NCT03301051|157057569|FG000|Overall Study|Withdrawal by Subject|59|||
48400502|NCT05594173|155657747|FG000|Overall Study|Adverse Event|1|||
48400503|NCT05594173|155657747|FG000|Overall Study|COVID-19 Pandemic|2|||
48400504|NCT00883337|155657748|FG000|Core Treatment Period|Adverse Event|9|||
48400505|NCT00883337|155657749|FG001|Core Treatment Period|Adverse Event|12|||
48786482|NCT03301051|157057570|FG001|Overall Study|Withdrawal by Subject|65|||
48786483|NCT03301051|157057569|FG000|Overall Study|Lost to Follow-up|263|||
48786484|NCT03301051|157057570|FG001|Overall Study|Lost to Follow-up|282|||
48786485|NCT03301051|157057569|FG000|Overall Study|Protocol Violation|1|||
48786486|NCT03301051|157057570|FG001|Overall Study|Protocol Violation|3|||
48786487|NCT03301051|157057569|FG000|Overall Study|Physician Decision|1|||
48786488|NCT03301051|157057570|FG001|Overall Study|Physician Decision|3|||
48786489|NCT03301051|157057569|FG000|Overall Study|Death|1|||
48786490|NCT03301051|157057570|FG001|Overall Study|Death|1|||
48786491|NCT03301051|157057569|FG000|Overall Study|Miscellaneous|8|||
48786492|NCT03301051|157057570|FG001|Overall Study|Miscellaneous|4|||
48786493|NCT03301051|157057569|FG000|Overall Study|Randomized, not vaccinated|13|||
48786494|NCT03301051|157057570|FG001|Overall Study|Randomized, not vaccinated|10|||
48786495|NCT01165281|157057582|FG000|Overall Study|Adverse Event|12|||
48786496|NCT01165281|157057583|FG001|Overall Study|Adverse Event|14|||
48786497|NCT01165281|157057582|FG000|Overall Study|Death|3|||
48786498|NCT01165281|157057583|FG001|Overall Study|Death|4|||
48786499|NCT01165281|157057582|FG000|Overall Study|Lack of Efficacy|4|||
48786500|NCT01165281|157057583|FG001|Overall Study|Lack of Efficacy|1|||
48786501|NCT01165281|157057582|FG000|Overall Study|Lost to Follow-up|0|||
48786502|NCT01165281|157057583|FG001|Overall Study|Lost to Follow-up|1|||
48786503|NCT01165281|157057582|FG000|Overall Study|Physician Decision|8|||
48786504|NCT01165281|157057583|FG001|Overall Study|Physician Decision|1|||
48786505|NCT01165281|157057582|FG000|Overall Study|Protocol Violation|6|||
48786506|NCT01165281|157057583|FG001|Overall Study|Protocol Violation|5|||
48786507|NCT01165281|157057582|FG000|Overall Study|Withdrawal by Subject|8|||
48786508|NCT01165281|157057583|FG001|Overall Study|Withdrawal by Subject|7|||
48786509|NCT01165281|157057582|FG000|Overall Study|Noncompliance with Study Drug|1|||
48786510|NCT01165281|157057583|FG001|Overall Study|Noncompliance with Study Drug|4|||
48786511|NCT01165281|157057582|FG000|Overall Study|Progressive Disease|10|||
48786512|NCT01165281|157057583|FG001|Overall Study|Progressive Disease|14|||
48786513|NCT01165281|157057582|FG000|Overall Study|Other|6|||
48786514|NCT01165281|157057583|FG001|Overall Study|Other|0|||
48786515|NCT00714168|157057584|FG000|Overall Study|Pregnancy|5|||
48786516|NCT00714168|157057585|FG001|Overall Study|Pregnancy|4|||
48786517|NCT00714168|157057584|FG000|Overall Study|Lost to Follow-up|32|||
48786518|NCT00714168|157057585|FG001|Overall Study|Lost to Follow-up|50|||
48786519|NCT00714168|157057584|FG000|Overall Study|Relocation|4|||
48786520|NCT00714168|157057585|FG001|Overall Study|Relocation|3|||
48786521|NCT00714168|157057584|FG000|Overall Study|Non-study medical condition|3|||
48786522|NCT00714168|157057585|FG001|Overall Study|Non-study medical condition|2|||
48786523|NCT04764396|157057591|FG000|Overall Study|Physician Decision|1|||
48786524|NCT04764396|157057592|FG001|Overall Study|Physician Decision|0|||
48786525|NCT01669122|157057594|FG000|Period I|Lost to Follow-up|1|||
48786526|NCT01669122|157057594|FG000|Washout Period II|Protocol Violation|2|||
48786527|NCT02075593|157057596|FG000|Overall Study|Withdrawal by Subject|1|||
48786528|NCT01389973|157057597|FG000|Overall Study|Lost to Follow-up|1|||
48786529|NCT01389973|157057597|FG000|Overall Study|Trial Stopped by Sponsor|9|||
48786530|NCT01389973|157057597|FG000|Overall Study|Other|10|||
48786531|NCT01962493|157057598|FG000|Overall Study|Adverse Event|1|||
48786532|NCT01962493|157057599|FG001|Overall Study|Adverse Event|2|||
48786533|NCT01962493|157057598|FG000|Overall Study|Protocol Violation|0|||
48786534|NCT01962493|157057599|FG001|Overall Study|Protocol Violation|1|||
48786535|NCT01962493|157057598|FG000|Overall Study|Withdrawal by Subject|4|||
48786536|NCT01962493|157057599|FG001|Overall Study|Withdrawal by Subject|2|||
48786537|NCT03776136|157057600|FG000|Overall Study|Death|85|||
48786538|NCT03776136|157057600|FG000|Overall Study|Withdrawal by Subject|3|||
48786539|NCT03776136|157057600|FG000|Overall Study|Sponsor Decision|15|||
48786540|NCT00613951|157057601|FG000|Overall Study|Adverse Event|1|||
48786541|NCT00613951|157057602|FG001|Overall Study|Adverse Event|0|||
48786542|NCT00613951|157057603|FG002|Overall Study|Adverse Event|1|||
48786543|NCT00613951|157057601|FG000|Overall Study|Lack of Efficacy|0|||
48786544|NCT00613951|157057602|FG001|Overall Study|Lack of Efficacy|1|||
48786545|NCT00613951|157057603|FG002|Overall Study|Lack of Efficacy|1|||
48786546|NCT00613951|157057601|FG000|Overall Study|Protocol Violation|1|||
48786547|NCT00613951|157057602|FG001|Overall Study|Protocol Violation|1|||
48786548|NCT00613951|157057603|FG002|Overall Study|Protocol Violation|1|||
48786549|NCT00613951|157057601|FG000|Overall Study|Unclassified|5|||
48786550|NCT00613951|157057602|FG001|Overall Study|Unclassified|3|||
48786551|NCT00613951|157057603|FG002|Overall Study|Unclassified|2|||
48786552|NCT00655980|157057606|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
48786553|NCT00655980|157057607|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
48786554|NCT00655980|157057608|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
48786555|NCT00936390|157057611|FG000|Overall Study|Protocol Violation|21|||
48786556|NCT00936390|157057612|FG001|Overall Study|Protocol Violation|25|||
48786557|NCT04348604|157057613|FG000|Week 8|Withdrawal by Subject|1|||
48786558|NCT04348604|157057614|FG001|Week 8|Withdrawal by Subject|1|||
48786559|NCT04348604|157057613|FG000|Week 8|Lost to Follow-up|1|||
48786560|NCT04348604|157057614|FG001|Week 8|Lost to Follow-up|2|||
48786561|NCT04348604|157057613|FG000|Week 8|Suspended|0|||
48786562|NCT04348604|157057614|FG001|Week 8|Suspended|1|||
48786563|NCT04348604|157057613|FG000|Week 12|Lost to Follow-up|1|||
48786564|NCT04348604|157057614|FG001|Week 12|Lost to Follow-up|2|||
48786565|NCT04348604|157057613|FG000|Week 12|Withdrawal by Subject|1|||
48786566|NCT04348604|157057614|FG001|Week 12|Withdrawal by Subject|0|||
48786567|NCT04348604|157057613|FG000|Week 24|Lost to Follow-up|2|||
48786568|NCT04348604|157057614|FG001|Week 24|Lost to Follow-up|1|||
48786569|NCT02459574|157057615|FG000|Overall Study|Withdrawal by Subject|6|||
48786570|NCT02459574|157057616|FG001|Overall Study|Withdrawal by Subject|6|||
48786571|NCT02459574|157057617|FG002|Overall Study|Withdrawal by Subject|2|||
48786572|NCT02459574|157057615|FG000|Overall Study|Lost to Follow-up|1|||
48786573|NCT02459574|157057616|FG001|Overall Study|Lost to Follow-up|1|||
48786574|NCT02459574|157057617|FG002|Overall Study|Lost to Follow-up|0|||
48786575|NCT02459574|157057615|FG000|Overall Study|Death|0|||
48786576|NCT02459574|157057616|FG001|Overall Study|Death|1|||
48786577|NCT02459574|157057617|FG002|Overall Study|Death|0|||
48786578|NCT05245864|157057618|FG000|Overall Study|Withdrawal by Subject|1|||
48786579|NCT05245864|157057619|FG001|Overall Study|Withdrawal by Subject|1|||
48786580|NCT03690869|157057622|FG000|Overall Study|Adverse Event|0|||
48786581|NCT03690869|157057623|FG001|Overall Study|Adverse Event|0|||
48786582|NCT03690869|157057624|FG002|Overall Study|Adverse Event|0|||
48786583|NCT03690869|157057625|FG003|Overall Study|Adverse Event|1|||
48786584|NCT03690869|157057626|FG004|Overall Study|Adverse Event|0|||
48786585|NCT03690869|157057627|FG005|Overall Study|Adverse Event|0|||
48786586|NCT03690869|157057628|FG006|Overall Study|Adverse Event|0|||
48786587|NCT03690869|157057629|FG007|Overall Study|Adverse Event|1|||
48786588|NCT03690869|157057630|FG008|Overall Study|Adverse Event|0|||
48786589|NCT03690869|157057631|FG009|Overall Study|Adverse Event|1|||
48786590|NCT03690869|157057622|FG000|Overall Study|Death|1|||
48786591|NCT03690869|157057623|FG001|Overall Study|Death|1|||
48786592|NCT03690869|157057624|FG002|Overall Study|Death|1|||
48786593|NCT03690869|157057625|FG003|Overall Study|Death|4|||
48786594|NCT03690869|157057626|FG004|Overall Study|Death|2|||
48786595|NCT03690869|157057627|FG005|Overall Study|Death|5|||
48786596|NCT03690869|157057628|FG006|Overall Study|Death|3|||
48786597|NCT03690869|157057629|FG007|Overall Study|Death|2|||
48786598|NCT03690869|157057630|FG008|Overall Study|Death|0|||
48786599|NCT03690869|157057631|FG009|Overall Study|Death|3|||
48786600|NCT03690869|157057622|FG000|Overall Study|Lost to Follow-up|0|||
48786601|NCT03690869|157057623|FG001|Overall Study|Lost to Follow-up|0|||
48786602|NCT03690869|157057624|FG002|Overall Study|Lost to Follow-up|1|||
48786603|NCT03690869|157057625|FG003|Overall Study|Lost to Follow-up|0|||
48786604|NCT03690869|157057626|FG004|Overall Study|Lost to Follow-up|0|||
48786605|NCT03690869|157057627|FG005|Overall Study|Lost to Follow-up|0|||
48786606|NCT03690869|157057628|FG006|Overall Study|Lost to Follow-up|0|||
48786607|NCT03690869|157057629|FG007|Overall Study|Lost to Follow-up|0|||
48786608|NCT03690869|157057630|FG008|Overall Study|Lost to Follow-up|0|||
48786609|NCT03690869|157057631|FG009|Overall Study|Lost to Follow-up|0|||
48786610|NCT03690869|157057622|FG000|Overall Study|Other Treatment|1|||
48786611|NCT03690869|157057623|FG001|Overall Study|Other Treatment|1|||
48786612|NCT03690869|157057624|FG002|Overall Study|Other Treatment|1|||
48786613|NCT03690869|157057625|FG003|Overall Study|Other Treatment|2|||
48786614|NCT03690869|157057626|FG004|Overall Study|Other Treatment|3|||
48786615|NCT03690869|157057627|FG005|Overall Study|Other Treatment|1|||
48786616|NCT03690869|157057628|FG006|Overall Study|Other Treatment|2|||
48786617|NCT03690869|157057629|FG007|Overall Study|Other Treatment|7|||
48786618|NCT03690869|157057630|FG008|Overall Study|Other Treatment|0|||
48786619|NCT03690869|157057631|FG009|Overall Study|Other Treatment|3|||
48786620|NCT03690869|157057622|FG000|Overall Study|Physician Decision|0|||
48786621|NCT03690869|157057623|FG001|Overall Study|Physician Decision|1|||
48786622|NCT03690869|157057624|FG002|Overall Study|Physician Decision|0|||
48786623|NCT03690869|157057625|FG003|Overall Study|Physician Decision|0|||
48786624|NCT03690869|157057626|FG004|Overall Study|Physician Decision|0|||
48786625|NCT03690869|157057627|FG005|Overall Study|Physician Decision|0|||
48786626|NCT03690869|157057628|FG006|Overall Study|Physician Decision|0|||
48786627|NCT03690869|157057629|FG007|Overall Study|Physician Decision|0|||
48786628|NCT03690869|157057630|FG008|Overall Study|Physician Decision|0|||
48786629|NCT03690869|157057631|FG009|Overall Study|Physician Decision|0|||
48786630|NCT03690869|157057622|FG000|Overall Study|Progressive Disease|1|||
48786631|NCT03690869|157057623|FG001|Overall Study|Progressive Disease|2|||
48786632|NCT03690869|157057624|FG002|Overall Study|Progressive Disease|0|||
48786633|NCT03690869|157057625|FG003|Overall Study|Progressive Disease|1|||
48786634|NCT03690869|157057626|FG004|Overall Study|Progressive Disease|0|||
48786635|NCT03690869|157057627|FG005|Overall Study|Progressive Disease|0|||
48786636|NCT03690869|157057628|FG006|Overall Study|Progressive Disease|0|||
48786637|NCT03690869|157057629|FG007|Overall Study|Progressive Disease|0|||
48786638|NCT03690869|157057630|FG008|Overall Study|Progressive Disease|1|||
48786639|NCT03690869|157057631|FG009|Overall Study|Progressive Disease|1|||
48786640|NCT03690869|157057622|FG000|Overall Study|Subject Decision|0|||
48786641|NCT03690869|157057623|FG001|Overall Study|Subject Decision|0|||
48786642|NCT03690869|157057624|FG002|Overall Study|Subject Decision|0|||
48786643|NCT03690869|157057625|FG003|Overall Study|Subject Decision|1|||
48786644|NCT03690869|157057626|FG004|Overall Study|Subject Decision|0|||
48786645|NCT03690869|157057627|FG005|Overall Study|Subject Decision|0|||
48786646|NCT03690869|157057628|FG006|Overall Study|Subject Decision|0|||
48786647|NCT03690869|157057629|FG007|Overall Study|Subject Decision|1|||
48786648|NCT03690869|157057630|FG008|Overall Study|Subject Decision|0|||
48786649|NCT03690869|157057631|FG009|Overall Study|Subject Decision|0|||
48786650|NCT03870763|157059012|FG000|Overall Study|Study terminated by sponsor|0|||
48786651|NCT03870763|157059013|FG001|Overall Study|Study terminated by sponsor|2|||
48786652|NCT03870763|157059014|FG002|Overall Study|Study terminated by sponsor|0|||
48786653|NCT03870763|157059012|FG000|Overall Study|Withdrawal by Subject|0|||
48786654|NCT03870763|157059013|FG001|Overall Study|Withdrawal by Subject|1|||
48786655|NCT03870763|157059014|FG002|Overall Study|Withdrawal by Subject|0|||
48786656|NCT03870763|157059012|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
48786657|NCT03870763|157059013|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
48786658|NCT03870763|157059014|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
48786659|NCT03521635|157059017|FG000|Overall Study|Adverse Event|1|||
48786660|NCT03521635|157059018|FG001|Overall Study|Adverse Event|1|||
48786661|NCT03521635|157059017|FG000|Overall Study|Refused to complete study visit|1|||
48786662|NCT03521635|157059018|FG001|Overall Study|Refused to complete study visit|0|||
48786663|NCT03521635|157059017|FG000|Overall Study|Refused to continue trial medication|2|||
48786664|NCT03521635|157059018|FG001|Overall Study|Refused to continue trial medication|2|||
48786665|NCT03521635|157059017|FG000|Overall Study|Lost to Follow-up|0|||
48786666|NCT03521635|157059018|FG001|Overall Study|Lost to Follow-up|1|||
48786667|NCT03521635|157059017|FG000|Overall Study|Meet exclusion criteria|0|||
48786668|NCT03521635|157059018|FG001|Overall Study|Meet exclusion criteria|1|||
48786669|NCT03521635|157059017|FG000|Overall Study|Patient not taken study medicine|0|||
48786670|NCT03521635|157059018|FG001|Overall Study|Patient not taken study medicine|1|||
48786671|NCT03727750|157059021|FG000|Overall Study|Death|45|||
48786672|NCT03727750|157059021|FG000|Overall Study|Withdrawal by Subject|2|||
48786673|NCT03727750|157059021|FG000|Overall Study|Lost to Follow-up|1|||
48786674|NCT03727750|157059021|FG000|Overall Study|Other|1|||
48786675|NCT02099838|157059022|FG000|Overall Study|Death|1|||
48786676|NCT02099838|157059023|FG001|Overall Study|Death|0|||
48786677|NCT02099838|157059022|FG000|Overall Study|Lost to Follow-up|3|||
48786678|NCT02099838|157059023|FG001|Overall Study|Lost to Follow-up|1|||
48786679|NCT02099838|157059022|FG000|Overall Study|Withdrawal by Subject|0|||
48786680|NCT02099838|157059023|FG001|Overall Study|Withdrawal by Subject|1|||
48786681|NCT01227889|157059024|FG000|Randomized Phase (RP)|Adverse Event|13|||
48786682|NCT01227889|157059025|FG001|Randomized Phase (RP)|Adverse Event|0|||
48786683|NCT01227889|157059024|FG000|Randomized Phase (RP)|Physician Decision|13|||
48786684|NCT01227889|157059025|FG001|Randomized Phase (RP)|Physician Decision|5|||
48786685|NCT01227889|157059024|FG000|Randomized Phase (RP)|Progressive Disease|135|||
48786686|NCT01227889|157059025|FG001|Randomized Phase (RP)|Progressive Disease|52|||
48786687|NCT01227889|157059024|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
48786688|NCT01227889|157059025|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
48786689|NCT01227889|157059024|FG000|Randomized Phase (RP)|Missing|1|||
48786690|NCT01227889|157059025|FG001|Randomized Phase (RP)|Missing|3|||
48786691|NCT01227889|157059024|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
48786692|NCT01227889|157059025|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
48786693|NCT01227889|157059024|FG000|Crossover Phase|Adverse Event|0|||
48786694|NCT01227889|157059025|FG001|Crossover Phase|Adverse Event|1|||
48786695|NCT01227889|157059024|FG000|Crossover Phase|Physician Decision|0|||
48786696|NCT01227889|157059025|FG001|Crossover Phase|Physician Decision|3|||
48786697|NCT01227889|157059024|FG000|Crossover Phase|Progressive Disease|0|||
48786698|NCT01227889|157059025|FG001|Crossover Phase|Progressive Disease|31|||
48786699|NCT01227889|157059024|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
48786700|NCT01227889|157059025|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
48786701|NCT01227889|157059024|FG000|Crossover Phase|Withdrawal by Subject|0|||
48786702|NCT01227889|157059025|FG001|Crossover Phase|Withdrawal by Subject|1|||
48786703|NCT03268811|157059026|FG000|Overall Study|Adverse Event|0|||
48786704|NCT03268811|157059027|FG001|Overall Study|Adverse Event|1|||
48786705|NCT00254982|157059028|FG000|Overall Study|Other|2|||
48786706|NCT00254982|157059029|FG001|Overall Study|Other|1|||
48786707|NCT00254982|157059028|FG000|Overall Study|Lack of Efficacy|5|||
48786708|NCT00254982|157059029|FG001|Overall Study|Lack of Efficacy|3|||
48786709|NCT00254982|157059028|FG000|Overall Study|Lost to Follow-up|5|||
48786710|NCT00254982|157059029|FG001|Overall Study|Lost to Follow-up|3|||
48786711|NCT00254982|157059028|FG000|Overall Study|Adverse Event|18|||
48786712|NCT00254982|157059029|FG001|Overall Study|Adverse Event|16|||
48786713|NCT00254982|157059028|FG000|Overall Study|Withdrawal by Subject|1|||
48786714|NCT00254982|157059029|FG001|Overall Study|Withdrawal by Subject|1|||
48786715|NCT00254982|157059028|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
48786716|NCT00254982|157059029|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
48786717|NCT00254982|157059028|FG000|Overall Study|Protocol deviation|1|||
48786718|NCT00254982|157059029|FG001|Overall Study|Protocol deviation|1|||
48786719|NCT00254982|157059028|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
48786720|NCT00254982|157059029|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
48786721|NCT00254982|157059028|FG000|Overall Study|Malignancy|0|||
48786722|NCT00254982|157059029|FG001|Overall Study|Malignancy|2|||
48786723|NCT00254982|157059028|FG000|Overall Study|Opportunistic infection|1|||
48786724|NCT00254982|157059029|FG001|Overall Study|Opportunistic infection|0|||
48786725|NCT00254982|157059028|FG000|Overall Study|Abnormal liver function tests|2|||
48786726|NCT00254982|157059029|FG001|Overall Study|Abnormal liver function tests|1|||
48786727|NCT01308749|157059035|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
48786728|NCT01308749|157059036|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
48786729|NCT01308749|157059035|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
48786730|NCT01308749|157059036|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
48786731|NCT01308749|157059035|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
48786732|NCT01308749|157059036|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
48786733|NCT02553330|157059037|FG000|Overall Study|Study Terminated by Sponsor|2|||
48786734|NCT02553330|157059038|FG001|Overall Study|Study Terminated by Sponsor|13|||
48786735|NCT02553330|157059039|FG002|Overall Study|Study Terminated by Sponsor|12|||
48786736|NCT02553330|157059037|FG000|Overall Study|Withdrawal by Subject|3|||
48786737|NCT02553330|157059038|FG001|Overall Study|Withdrawal by Subject|19|||
48786738|NCT02553330|157059039|FG002|Overall Study|Withdrawal by Subject|21|||
48786739|NCT02553330|157059037|FG000|Overall Study|Other|0|||
48786740|NCT02553330|157059038|FG001|Overall Study|Other|1|||
48786741|NCT02553330|157059039|FG002|Overall Study|Other|0|||
48786742|NCT02553330|157059037|FG000|Overall Study|Non compliance to study treatment|0|||
48786743|NCT02553330|157059038|FG001|Overall Study|Non compliance to study treatment|1|||
48786744|NCT02553330|157059039|FG002|Overall Study|Non compliance to study treatment|0|||
48786745|NCT02553330|157059037|FG000|Overall Study|Adverse Event|0|||
48786746|NCT02553330|157059038|FG001|Overall Study|Adverse Event|1|||
48786747|NCT02553330|157059039|FG002|Overall Study|Adverse Event|0|||
48786748|NCT02553330|157059037|FG000|Overall Study|Lost to Follow-up|0|||
48786749|NCT02553330|157059038|FG001|Overall Study|Lost to Follow-up|4|||
48786750|NCT02553330|157059039|FG002|Overall Study|Lost to Follow-up|4|||
48786751|NCT02896855|157059043|FG000|Overall Study|Death|50|||
48786752|NCT02896855|157059044|FG001|Overall Study|Death|40|||
48786753|NCT02896855|157059043|FG000|Overall Study|Lost to Follow-up|15|||
48786754|NCT02896855|157059044|FG001|Overall Study|Lost to Follow-up|9|||
48786755|NCT02896855|157059043|FG000|Overall Study|Withdrawal by Subject|7|||
48786756|NCT02896855|157059044|FG001|Overall Study|Withdrawal by Subject|4|||
48786757|NCT00448539|157059045|FG000|Overall Study|Medication non-compliance|4|||
48786758|NCT00448539|157059046|FG001|Overall Study|Medication non-compliance|1|||
48786759|NCT00448539|157059045|FG000|Overall Study|Protocol Violation|1|||
48786760|NCT00448539|157059046|FG001|Overall Study|Protocol Violation|0|||
48786761|NCT00448539|157059045|FG000|Overall Study|Request of the investigator or sponsor|67|||
48786762|NCT00448539|157059046|FG001|Overall Study|Request of the investigator or sponsor|54|||
48786763|NCT00448539|157059045|FG000|Overall Study|Withdrawal by Subject|20|||
48786764|NCT00448539|157059046|FG001|Overall Study|Withdrawal by Subject|24|||
48786765|NCT00448539|157059045|FG000|Overall Study|Diary non-compliance|1|||
48786766|NCT00448539|157059046|FG001|Overall Study|Diary non-compliance|0|||
48786767|NCT00448539|157059045|FG000|Overall Study|Adverse Event|9|||
48786768|NCT00448539|157059046|FG001|Overall Study|Adverse Event|26|||
48786769|NCT00448539|157059045|FG000|Overall Study|Lack of Efficacy|27|||
48786770|NCT00448539|157059046|FG001|Overall Study|Lack of Efficacy|40|||
48786771|NCT00448539|157059045|FG000|Overall Study|Miscellaneous|2|||
48786772|NCT00448539|157059046|FG001|Overall Study|Miscellaneous|1|||
48786773|NCT00448539|157059045|FG000|Overall Study|Change of meds|2|||
48786774|NCT00448539|157059046|FG001|Overall Study|Change of meds|3|||
48786775|NCT00448539|157059045|FG000|Overall Study|Lost to Follow-up|1|||
48786776|NCT00448539|157059046|FG001|Overall Study|Lost to Follow-up|3|||
48786777|NCT04862143|157059047|FG000|Overall Study|Adverse Event|1|||
48786778|NCT04862143|157059047|FG000|Overall Study|Study terminated by sponsor|1|||
48786779|NCT01666002|157059051|FG000|Overall Study|Lost to Follow-up|5|||
48786780|NCT01666002|157059052|FG001|Overall Study|Lost to Follow-up|0|||
48786781|NCT04955639|157059053|FG000|Overall Study|Withdrawal by Subject|2|||
48786782|NCT04955639|157059054|FG001|Overall Study|Withdrawal by Subject|2|||
48786783|NCT04955639|157059053|FG000|Overall Study|Week 26 survey not completed|2|||
48786784|NCT04955639|157059054|FG001|Overall Study|Week 26 survey not completed|2|||
48786785|NCT02479412|157059057|FG000|Overall Study|Adverse Event|0|||
48786786|NCT02479412|157059058|FG001|Overall Study|Adverse Event|0|||
48786787|NCT02479412|157059059|FG002|Overall Study|Adverse Event|1|||
48786788|NCT02479412|157059060|FG003|Overall Study|Adverse Event|0|||
48786789|NCT02479412|157059061|FG004|Overall Study|Adverse Event|0|||
48786790|NCT02479412|157059062|FG005|Overall Study|Adverse Event|0|||
48786791|NCT02479412|157059063|FG006|Overall Study|Adverse Event|0|||
48786792|NCT02479412|157059064|FG007|Overall Study|Adverse Event|0|||
48786793|NCT02479412|157059065|FG008|Overall Study|Adverse Event|0|||
48786794|NCT02479412|157059057|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48786795|NCT02479412|157059058|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48786796|NCT02479412|157059059|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48786797|NCT02479412|157059060|FG003|Overall Study|Study-specific withdrawal criteria|1|||
48786798|NCT02479412|157059061|FG004|Overall Study|Study-specific withdrawal criteria|0|||
48786799|NCT02479412|157059062|FG005|Overall Study|Study-specific withdrawal criteria|0|||
48786800|NCT02479412|157059063|FG006|Overall Study|Study-specific withdrawal criteria|0|||
48786801|NCT02479412|157059064|FG007|Overall Study|Study-specific withdrawal criteria|1|||
48786802|NCT02479412|157059065|FG008|Overall Study|Study-specific withdrawal criteria|1|||
48786803|NCT02479412|157059057|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
48786804|NCT02479412|157059058|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
48786805|NCT02479412|157059059|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
48786806|NCT02479412|157059060|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
48786807|NCT02479412|157059061|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
48786808|NCT02479412|157059062|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
48786809|NCT02479412|157059063|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
48786810|NCT02479412|157059064|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
48786811|NCT02479412|157059065|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
48786812|NCT03305016|157059068|FG000|Overall Study|Withdrawal by Subject|2|||
48786813|NCT03579459|157059071|FG000|Overall Study|Adverse Event|7|||
48786814|NCT03579459|157059072|FG001|Overall Study|Adverse Event|6|||
48786815|NCT03579459|157059073|FG002|Overall Study|Adverse Event|2|||
48786816|NCT03579459|157059074|FG003|Overall Study|Adverse Event|6|||
48786817|NCT03579459|157059071|FG000|Overall Study|Death|1|||
48786818|NCT03579459|157059072|FG001|Overall Study|Death|0|||
48786819|NCT03579459|157059073|FG002|Overall Study|Death|1|||
48786820|NCT03579459|157059074|FG003|Overall Study|Death|2|||
48786821|NCT03579459|157059071|FG000|Overall Study|Lost to Follow-up|6|||
48786822|NCT03579459|157059072|FG001|Overall Study|Lost to Follow-up|2|||
48786823|NCT03579459|157059073|FG002|Overall Study|Lost to Follow-up|4|||
48786824|NCT03579459|157059074|FG003|Overall Study|Lost to Follow-up|1|||
48786825|NCT03579459|157059071|FG000|Overall Study|Physician Decision|0|||
48786826|NCT03579459|157059072|FG001|Overall Study|Physician Decision|1|||
48786827|NCT03579459|157059073|FG002|Overall Study|Physician Decision|0|||
48786828|NCT03579459|157059074|FG003|Overall Study|Physician Decision|1|||
48786829|NCT03579459|157059071|FG000|Overall Study|Protocol Violation|1|||
48786830|NCT03579459|157059072|FG001|Overall Study|Protocol Violation|2|||
48786831|NCT03579459|157059073|FG002|Overall Study|Protocol Violation|3|||
48786832|NCT03579459|157059074|FG003|Overall Study|Protocol Violation|5|||
48786833|NCT03579459|157059071|FG000|Overall Study|Withdrawal by Subject|12|||
48786834|NCT03579459|157059072|FG001|Overall Study|Withdrawal by Subject|8|||
48786835|NCT03579459|157059073|FG002|Overall Study|Withdrawal by Subject|11|||
48786836|NCT03579459|157059074|FG003|Overall Study|Withdrawal by Subject|8|||
48786837|NCT03579459|157059071|FG000|Overall Study|Medication error without associated adverse event|2|||
48786838|NCT03579459|157059072|FG001|Overall Study|Medication error without associated adverse event|1|||
48786839|NCT03579459|157059073|FG002|Overall Study|Medication error without associated adverse event|1|||
48786840|NCT03579459|157059074|FG003|Overall Study|Medication error without associated adverse event|0|||
48786841|NCT03579459|157059071|FG000|Overall Study|Other|0|||
48786842|NCT03579459|157059072|FG001|Overall Study|Other|1|||
48786843|NCT03579459|157059073|FG002|Overall Study|Other|1|||
48786844|NCT03579459|157059074|FG003|Overall Study|Other|0|||
48786845|NCT03579459|157059071|FG000|Overall Study|Randomized not vaccinated|0|||
48786846|NCT03579459|157059072|FG001|Overall Study|Randomized not vaccinated|2|||
48786847|NCT03579459|157059073|FG002|Overall Study|Randomized not vaccinated|0|||
48786848|NCT03579459|157059074|FG003|Overall Study|Randomized not vaccinated|1|||
48786849|NCT03043664|157059075|FG000|Overall Study|Lost to Follow-up|1|||
48400506|NCT00883337|155657750|FG002|Core Treatment Period|Adverse Event|22|||
48786850|NCT03713593|157059077|FG000|Overall Study|Participants Ongoing|140|||
48786851|NCT03713593|157059078|FG001|Overall Study|Participants Ongoing|114|||
48400507|NCT00883337|155657748|FG000|Core Treatment Period|Lack of Efficacy|7|||
48400508|NCT00883337|155657749|FG001|Core Treatment Period|Lack of Efficacy|4|||
48786852|NCT03713593|157059077|FG000|Overall Study|Withdrawal by Subject|3|||
48786853|NCT03713593|157059078|FG001|Overall Study|Withdrawal by Subject|6|||
48786854|NCT03713593|157059077|FG000|Overall Study|Death|252|||
48786855|NCT03713593|157059078|FG001|Overall Study|Death|279|||
48786856|NCT02975882|157059079|FG000|Overall Study|Adverse Event|1|||
48786857|NCT02975882|157059080|FG001|Overall Study|Adverse Event|2|||
48786858|NCT02975882|157059081|FG002|Overall Study|Adverse Event|1|||
48786859|NCT02975882|157059082|FG003|Overall Study|Adverse Event|1|||
48786860|NCT02975882|157059079|FG000|Overall Study|Death|0|||
48786861|NCT02975882|157059080|FG001|Overall Study|Death|1|||
48786862|NCT02975882|157059081|FG002|Overall Study|Death|0|||
48786863|NCT02975882|157059082|FG003|Overall Study|Death|0|||
48786864|NCT02975882|157059079|FG000|Overall Study|Lack of Efficacy|3|||
48786865|NCT02975882|157059080|FG001|Overall Study|Lack of Efficacy|7|||
48786866|NCT02975882|157059081|FG002|Overall Study|Lack of Efficacy|4|||
48786867|NCT02975882|157059082|FG003|Overall Study|Lack of Efficacy|3|||
48786868|NCT02975882|157059079|FG000|Overall Study|Physician Decision|0|||
48786869|NCT02975882|157059080|FG001|Overall Study|Physician Decision|2|||
48786870|NCT02975882|157059081|FG002|Overall Study|Physician Decision|4|||
48786871|NCT02975882|157059082|FG003|Overall Study|Physician Decision|2|||
48786872|NCT02975882|157059079|FG000|Overall Study|Ineligible|0|||
48786873|NCT02975882|157059080|FG001|Overall Study|Ineligible|1|||
48786874|NCT02975882|157059081|FG002|Overall Study|Ineligible|0|||
48786875|NCT02975882|157059082|FG003|Overall Study|Ineligible|0|||
48786876|NCT02515773|157059083|FG000|Overall Study|Withdrawal by Subject|12|||
48786877|NCT02515773|157059084|FG001|Overall Study|Withdrawal by Subject|2|||
48786878|NCT02515773|157059083|FG000|Overall Study|Lost to Follow-up|119|||
48786879|NCT02515773|157059084|FG001|Overall Study|Lost to Follow-up|126|||
48786880|NCT02515773|157059083|FG000|Overall Study|Discharged from Clinic Services|53|||
48786881|NCT02515773|157059084|FG001|Overall Study|Discharged from Clinic Services|84|||
48786882|NCT02515773|157059083|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
48786883|NCT02515773|157059084|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
48786884|NCT02515773|157059083|FG000|Overall Study|Follow-up at non-study site|8|||
48786885|NCT02515773|157059084|FG001|Overall Study|Follow-up at non-study site|16|||
48786886|NCT02515773|157059083|FG000|Overall Study|Moved from area|9|||
48786887|NCT02515773|157059084|FG001|Overall Study|Moved from area|14|||
48786888|NCT04642638|157059090|FG000|Overall Study|Withdrawal by Subject|23|||
48786889|NCT04642638|157059091|FG001|Overall Study|Withdrawal by Subject|29|||
48786890|NCT04642638|157059092|FG002|Overall Study|Withdrawal by Subject|9|||
48786891|NCT04642638|157059093|FG003|Overall Study|Withdrawal by Subject|7|||
48786892|NCT04642638|157059094|FG004|Overall Study|Withdrawal by Subject|61|||
48400509|NCT00883337|155657750|FG002|Core Treatment Period|Lack of Efficacy|2|||
48400510|NCT00883337|155657748|FG000|Core Treatment Period|Lost to Follow-up|1|||
48786893|NCT04642638|157059095|FG005|Overall Study|Withdrawal by Subject|27|||
48786894|NCT04642638|157059090|FG000|Overall Study|Lost to Follow-up|17|||
48786895|NCT04642638|157059091|FG001|Overall Study|Lost to Follow-up|18|||
48786896|NCT04642638|157059092|FG002|Overall Study|Lost to Follow-up|5|||
48786897|NCT04642638|157059093|FG003|Overall Study|Lost to Follow-up|5|||
48786898|NCT04642638|157059094|FG004|Overall Study|Lost to Follow-up|6|||
48786899|NCT04642638|157059095|FG005|Overall Study|Lost to Follow-up|3|||
48786900|NCT04642638|157059090|FG000|Overall Study|Adverse Event|0|||
48786901|NCT04642638|157059091|FG001|Overall Study|Adverse Event|0|||
48400511|NCT00883337|155657749|FG001|Core Treatment Period|Lost to Follow-up|1|||
48400512|NCT00883337|155657750|FG002|Core Treatment Period|Lost to Follow-up|0|||
48400513|NCT00883337|155657748|FG000|Core Treatment Period|Withdrawal by Subject|2|||
48400514|NCT00883337|155657749|FG001|Core Treatment Period|Withdrawal by Subject|2|||
48400515|NCT00883337|155657750|FG002|Core Treatment Period|Withdrawal by Subject|6|||
48400516|NCT00883337|155657748|FG000|Core Treatment Period|Wish to be pregnant|1|||
48400517|NCT00883337|155657749|FG001|Core Treatment Period|Wish to be pregnant|2|||
48400518|NCT00883337|155657750|FG002|Core Treatment Period|Wish to be pregnant|1|||
48400519|NCT00883337|155657748|FG000|Core Treatment Period|Poor compliance to protocol|0|||
48400520|NCT00883337|155657749|FG001|Core Treatment Period|Poor compliance to protocol|0|||
48400521|NCT00883337|155657750|FG002|Core Treatment Period|Poor compliance to protocol|1|||
48400522|NCT00883337|155657748|FG000|Core Treatment Period|Other than above|0|||
48400523|NCT00883337|155657749|FG001|Core Treatment Period|Other than above|1|||
48400524|NCT00883337|155657750|FG002|Core Treatment Period|Other than above|1|||
48400525|NCT00883337|155657748|FG000|Extension Treatment Period|Adverse Event|8|||
48400526|NCT00883337|155657749|FG001|Extension Treatment Period|Adverse Event|5|||
48400527|NCT00883337|155657750|FG002|Extension Treatment Period|Adverse Event|5|||
48400528|NCT00883337|155657748|FG000|Extension Treatment Period|Lack of Efficacy|8|||
48400529|NCT00883337|155657749|FG001|Extension Treatment Period|Lack of Efficacy|8|||
48400530|NCT00883337|155657750|FG002|Extension Treatment Period|Lack of Efficacy|8|||
48400531|NCT00883337|155657748|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
48400532|NCT00883337|155657749|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
48400533|NCT00883337|155657750|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
48400534|NCT00883337|155657748|FG000|Extension Treatment Period|Lost to Follow-up|1|||
48400535|NCT00883337|155657749|FG001|Extension Treatment Period|Lost to Follow-up|0|||
48400536|NCT00883337|155657750|FG002|Extension Treatment Period|Lost to Follow-up|0|||
48400537|NCT00883337|155657748|FG000|Extension Treatment Period|Other than above|10|||
48400538|NCT00883337|155657749|FG001|Extension Treatment Period|Other than above|9|||
48400539|NCT00883337|155657750|FG002|Extension Treatment Period|Other than above|5|||
48400540|NCT02615990|155657751|FG000|Overall Study|study terminated|1|||
48400541|NCT02615990|155657752|FG001|Overall Study|study terminated|1|||
48400542|NCT00130832|155657753|FG000|Overall Study|Adverse Event|1|||
48400543|NCT00130832|155657754|FG001|Overall Study|Adverse Event|1|||
48400544|NCT00130832|155657753|FG000|Overall Study|Lost to Follow-up|1|||
48400545|NCT00130832|155657754|FG001|Overall Study|Lost to Follow-up|2|||
48400546|NCT00130832|155657753|FG000|Overall Study|Protocol Violation|6|||
48400547|NCT00130832|155657754|FG001|Overall Study|Protocol Violation|8|||
48400548|NCT00130832|155657753|FG000|Overall Study|Withdrawal by Subject|6|||
48400549|NCT00130832|155657754|FG001|Overall Study|Withdrawal by Subject|1|||
48400550|NCT00130832|155657753|FG000|Overall Study|Moved|2|||
48400551|NCT00130832|155657754|FG001|Overall Study|Moved|2|||
48400552|NCT00130832|155657753|FG000|Overall Study|Other|0|||
48400553|NCT00130832|155657754|FG001|Overall Study|Other|3|||
48400554|NCT02944448|155657755|FG000|Overall Study|Adverse Event|37|||
48786902|NCT04642638|157059092|FG002|Overall Study|Adverse Event|1|||
48786903|NCT04642638|157059093|FG003|Overall Study|Adverse Event|0|||
48786904|NCT04642638|157059094|FG004|Overall Study|Adverse Event|10|||
48400555|NCT02944448|155657756|FG001|Overall Study|Adverse Event|6|||
48400556|NCT02944448|155657755|FG000|Overall Study|Lack of Efficacy|8|||
48400557|NCT02944448|155657756|FG001|Overall Study|Lack of Efficacy|5|||
48400558|NCT02944448|155657755|FG000|Overall Study|Lost to Follow-up|3|||
48786905|NCT04642638|157059095|FG005|Overall Study|Adverse Event|3|||
48786906|NCT04642638|157059090|FG000|Overall Study|Reason Not Specified|1|||
48786907|NCT04642638|157059091|FG001|Overall Study|Reason Not Specified|4|||
48400559|NCT02944448|155657756|FG001|Overall Study|Lost to Follow-up|1|||
48400560|NCT02944448|155657755|FG000|Overall Study|Protocol Violation|25|||
48400561|NCT02944448|155657756|FG001|Overall Study|Protocol Violation|7|||
48400562|NCT02944448|155657755|FG000|Overall Study|Withdrawal by Subject|14|||
48400563|NCT02944448|155657756|FG001|Overall Study|Withdrawal by Subject|4|||
48400564|NCT02944448|155657755|FG000|Overall Study|Sponsor did not supply drug in time|0|||
48400565|NCT02944448|155657756|FG001|Overall Study|Sponsor did not supply drug in time|1|||
48400566|NCT02944448|155657755|FG000|Overall Study|Noncompliant with dosing|1|||
48400567|NCT02944448|155657756|FG001|Overall Study|Noncompliant with dosing|0|||
48400568|NCT02944448|155657755|FG000|Overall Study|Abnormal laboratory values|1|||
48400569|NCT02944448|155657756|FG001|Overall Study|Abnormal laboratory values|0|||
48400570|NCT03468309|155657757|FG000|Overall Study|Lost to Follow-up|4|||
48400571|NCT03468309|155657757|FG000|Overall Study|Withdrawal by Subject|2|||
48400572|NCT02889796|155657758|FG000|Overall Study|Withdrew Consent|18|||
48400573|NCT02889796|155657759|FG001|Overall Study|Withdrew Consent|29|||
48400574|NCT02889796|155657760|FG002|Overall Study|Withdrew Consent|20|||
48786908|NCT04642638|157059092|FG002|Overall Study|Reason Not Specified|0|||
48786909|NCT04642638|157059093|FG003|Overall Study|Reason Not Specified|0|||
48400575|NCT02889796|155657761|FG003|Overall Study|Withdrew Consent|1|||
48786910|NCT04642638|157059094|FG004|Overall Study|Reason Not Specified|38|||
48786911|NCT04642638|157059095|FG005|Overall Study|Reason Not Specified|16|||
48786912|NCT04642638|157059090|FG000|Overall Study|Physician Decision|0|||
48786913|NCT04642638|157059091|FG001|Overall Study|Physician Decision|0|||
48786914|NCT04642638|157059092|FG002|Overall Study|Physician Decision|0|||
48786915|NCT04642638|157059093|FG003|Overall Study|Physician Decision|0|||
48786916|NCT04642638|157059094|FG004|Overall Study|Physician Decision|2|||
48786917|NCT04642638|157059095|FG005|Overall Study|Physician Decision|1|||
48786918|NCT04642638|157059090|FG000|Overall Study|Protocol Deviation|0|||
48786919|NCT04642638|157059091|FG001|Overall Study|Protocol Deviation|0|||
48400576|NCT02889796|155657762|FG004|Overall Study|Withdrew Consent|2|||
48400577|NCT02889796|155657763|FG005|Overall Study|Withdrew Consent|35|||
48400578|NCT02889796|155657758|FG000|Overall Study|Investigator's Discretion|10|||
48400579|NCT02889796|155657759|FG001|Overall Study|Investigator's Discretion|9|||
48400580|NCT02889796|155657760|FG002|Overall Study|Investigator's Discretion|10|||
48786920|NCT04642638|157059092|FG002|Overall Study|Protocol Deviation|0|||
48786921|NCT04642638|157059093|FG003|Overall Study|Protocol Deviation|0|||
48786922|NCT04642638|157059094|FG004|Overall Study|Protocol Deviation|1|||
48786923|NCT04642638|157059095|FG005|Overall Study|Protocol Deviation|3|||
48786924|NCT04642638|157059090|FG000|Overall Study|Study Terminated|0|||
48786925|NCT04642638|157059091|FG001|Overall Study|Study Terminated|0|||
48786926|NCT04642638|157059092|FG002|Overall Study|Study Terminated|0|||
48786927|NCT04642638|157059093|FG003|Overall Study|Study Terminated|0|||
48786928|NCT04642638|157059094|FG004|Overall Study|Study Terminated|484|||
48786929|NCT04642638|157059095|FG005|Overall Study|Study Terminated|250|||
48400581|NCT02889796|155657761|FG003|Overall Study|Investigator's Discretion|3|||
48786930|NCT04642638|157059090|FG000|Overall Study|Pregnancy|0|||
48786931|NCT04642638|157059091|FG001|Overall Study|Pregnancy|0|||
48786932|NCT04642638|157059092|FG002|Overall Study|Pregnancy|0|||
48786933|NCT04642638|157059093|FG003|Overall Study|Pregnancy|0|||
48786934|NCT04642638|157059094|FG004|Overall Study|Pregnancy|1|||
48786935|NCT04642638|157059095|FG005|Overall Study|Pregnancy|0|||
48786936|NCT00990652|157059096|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
48786937|NCT00990652|157059096|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
48786938|NCT00553267|157059097|FG000|Overall Study|Adverse Event|8|||
48786939|NCT00553267|157059098|FG001|Overall Study|Adverse Event|10|||
48786940|NCT00553267|157059099|FG002|Overall Study|Adverse Event|5|||
48786941|NCT00553267|157059097|FG000|Overall Study|Non compliant with protocol|3|||
48786942|NCT00553267|157059098|FG001|Overall Study|Non compliant with protocol|3|||
48786943|NCT00553267|157059099|FG002|Overall Study|Non compliant with protocol|2|||
48400582|NCT02889796|155657762|FG004|Overall Study|Investigator's Discretion|0|||
48786944|NCT00553267|157059097|FG000|Overall Study|Lost to Follow-up|0|||
48786945|NCT00553267|157059098|FG001|Overall Study|Lost to Follow-up|0|||
48786946|NCT00553267|157059099|FG002|Overall Study|Lost to Follow-up|1|||
48786947|NCT00553267|157059097|FG000|Overall Study|Consent withdrawn|2|||
48786948|NCT00553267|157059098|FG001|Overall Study|Consent withdrawn|3|||
48786949|NCT00553267|157059099|FG002|Overall Study|Consent withdrawn|1|||
48786950|NCT00553267|157059097|FG000|Overall Study|Specified category|1|||
48786951|NCT00553267|157059098|FG001|Overall Study|Specified category|2|||
48786952|NCT00553267|157059099|FG002|Overall Study|Specified category|1|||
48400583|NCT02889796|155657763|FG005|Overall Study|Investigator's Discretion|15|||
48400584|NCT02889796|155657758|FG000|Overall Study|Adverse Event|17|||
48786953|NCT01944046|157059105|FG000|Randomized to DB|Adverse Event|5|||
48786954|NCT01944046|157059106|FG001|Randomized to DB|Adverse Event|2|||
48786955|NCT01944046|157059105|FG000|Randomized to DB|Clinical Worsening|3|||
48786956|NCT01944046|157059106|FG001|Randomized to DB|Clinical Worsening|2|||
48786957|NCT01944046|157059105|FG000|Randomized to DB|Lost to Follow-up|3|||
48786958|NCT01944046|157059106|FG001|Randomized to DB|Lost to Follow-up|3|||
48786959|NCT01944046|157059105|FG000|Randomized to DB|Withdrawal by Subject|2|||
48786960|NCT01944046|157059106|FG001|Randomized to DB|Withdrawal by Subject|4|||
48786961|NCT01944046|157059105|FG000|Randomized to DB|Physician Decision|1|||
48400585|NCT02889796|155657759|FG001|Overall Study|Adverse Event|8|||
48786962|NCT01944046|157059106|FG001|Randomized to DB|Physician Decision|2|||
48786963|NCT01944046|157059105|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
48786964|NCT01944046|157059106|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
48786965|NCT01944046|157059105|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
48786966|NCT01944046|157059106|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
48786967|NCT01944046|157059105|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
48786968|NCT01944046|157059106|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
48786969|NCT01944046|157059105|FG000|Open Label Eligible and Consented|Adverse Event|6|||
48786970|NCT01944046|157059106|FG001|Open Label Eligible and Consented|Adverse Event|1|||
48786971|NCT01944046|157059105|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
48786972|NCT01944046|157059106|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
48786973|NCT01944046|157059105|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
48786974|NCT01944046|157059106|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
48786975|NCT02937545|157059108|FG000|Overall Study|Withdrawal by Subject|1|||
48786976|NCT02937545|157059109|FG001|Overall Study|Withdrawal by Subject|2|||
48786977|NCT02937545|157059110|FG002|Overall Study|Withdrawal by Subject|6|||
48786978|NCT02937545|157059111|FG003|Overall Study|Withdrawal by Subject|7|||
48786979|NCT02937545|157059108|FG000|Overall Study|Lost to Follow-up|1|||
48786980|NCT02937545|157059109|FG001|Overall Study|Lost to Follow-up|0|||
48786981|NCT02937545|157059110|FG002|Overall Study|Lost to Follow-up|0|||
48786982|NCT02937545|157059111|FG003|Overall Study|Lost to Follow-up|0|||
48786983|NCT02504294|157059112|FG000|Overall Study|Adverse Event|15|||
48786984|NCT02504294|157059113|FG001|Overall Study|Adverse Event|12|||
48786985|NCT02504294|157059112|FG000|Overall Study|Withdrawal by Subject|7|||
48786986|NCT02504294|157059113|FG001|Overall Study|Withdrawal by Subject|1|||
48786987|NCT02504294|157059112|FG000|Overall Study|Protocol Violation|27|||
48786988|NCT02504294|157059113|FG001|Overall Study|Protocol Violation|26|||
48786989|NCT02504294|157059112|FG000|Overall Study|Physician Decision|1|||
48786990|NCT02504294|157059113|FG001|Overall Study|Physician Decision|2|||
48786991|NCT02504294|157059112|FG000|Overall Study|Lost to Follow-up|6|||
48786992|NCT02504294|157059113|FG001|Overall Study|Lost to Follow-up|7|||
48786993|NCT01934218|157059123|FG000|Double-blind Phase|Adverse Event|8|||
48786994|NCT01934218|157059124|FG001|Double-blind Phase|Adverse Event|8|||
48786995|NCT01934218|157059123|FG000|Double-blind Phase|Lack of Efficacy|6|||
48786996|NCT01934218|157059124|FG001|Double-blind Phase|Lack of Efficacy|7|||
48786997|NCT01934218|157059123|FG000|Double-blind Phase|Lost to Follow-up|7|||
48786998|NCT01934218|157059124|FG001|Double-blind Phase|Lost to Follow-up|14|||
48786999|NCT01934218|157059123|FG000|Double-blind Phase|Physician Decision|1|||
48787000|NCT01934218|157059124|FG001|Double-blind Phase|Physician Decision|2|||
48787001|NCT01934218|157059123|FG000|Double-blind Phase|Protocol Violation|4|||
48787002|NCT01934218|157059124|FG001|Double-blind Phase|Protocol Violation|0|||
48787003|NCT01934218|157059123|FG000|Double-blind Phase|Withdrawal by Subject|16|||
48787004|NCT01934218|157059124|FG001|Double-blind Phase|Withdrawal by Subject|13|||
48787005|NCT01934218|157059123|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
48787006|NCT01934218|157059124|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
48787007|NCT01934218|157059123|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
48787008|NCT01934218|157059124|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
48787009|NCT01934218|157059123|FG000|Open-Label Phase|Adverse Event|2|||
48787010|NCT01934218|157059124|FG001|Open-Label Phase|Adverse Event|4|||
48787011|NCT01934218|157059123|FG000|Open-Label Phase|Lack of Efficacy|1|||
48787012|NCT01934218|157059124|FG001|Open-Label Phase|Lack of Efficacy|4|||
48787013|NCT01934218|157059123|FG000|Open-Label Phase|Lost to Follow-up|4|||
48787014|NCT01934218|157059124|FG001|Open-Label Phase|Lost to Follow-up|2|||
48787015|NCT01934218|157059123|FG000|Open-Label Phase|Physician Decision|1|||
48787016|NCT01934218|157059124|FG001|Open-Label Phase|Physician Decision|0|||
48787017|NCT01934218|157059123|FG000|Open-Label Phase|Protocol Violation|1|||
48787018|NCT01934218|157059124|FG001|Open-Label Phase|Protocol Violation|0|||
48787019|NCT01934218|157059123|FG000|Open-Label Phase|Withdrawal by Subject|13|||
48787020|NCT01934218|157059124|FG001|Open-Label Phase|Withdrawal by Subject|11|||
48787021|NCT01934218|157059123|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
48787022|NCT01934218|157059124|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
48787023|NCT01934218|157059123|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
48787024|NCT01934218|157059124|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
48787025|NCT01365494|157059128|FG000|Overall Study|Adverse Event|1|||
48787026|NCT01365494|157059129|FG001|Overall Study|Adverse Event|0|||
48787027|NCT01365494|157059128|FG000|Overall Study|Withdrawal by Subject|0|||
48787028|NCT01365494|157059129|FG001|Overall Study|Withdrawal by Subject|1|||
48787029|NCT01365494|157059128|FG000|Overall Study|Lost to Follow-up|1|||
48787030|NCT01365494|157059129|FG001|Overall Study|Lost to Follow-up|2|||
48787031|NCT02648698|157061018|FG000|Overall Study|Protocol Violation|1|||
48787032|NCT02648698|157061019|FG001|Overall Study|Protocol Violation|5|||
48787033|NCT00116805|157061020|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
48787034|NCT00116805|157061021|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
48787035|NCT00116805|157061020|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
48787036|NCT00116805|157061021|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
48787037|NCT00116805|157061020|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
48400586|NCT02889796|155657760|FG002|Overall Study|Adverse Event|8|||
48400587|NCT02889796|155657761|FG003|Overall Study|Adverse Event|4|||
48400588|NCT02889796|155657762|FG004|Overall Study|Adverse Event|1|||
48400589|NCT02889796|155657763|FG005|Overall Study|Adverse Event|7|||
48400590|NCT02889796|155657758|FG000|Overall Study|Lost to Follow-up|5|||
48400591|NCT02889796|155657759|FG001|Overall Study|Lost to Follow-up|7|||
48787038|NCT00116805|157061021|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
48787039|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
48787040|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
48787041|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
48787042|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
48787043|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
48787044|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
48787045|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
48787046|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
48787047|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
48787048|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
48400592|NCT02889796|155657760|FG002|Overall Study|Lost to Follow-up|2|||
48400593|NCT02889796|155657761|FG003|Overall Study|Lost to Follow-up|0|||
48356721|NCT00208325|155501142|FG000|Overall Study|Does not wish to Continue in Study|5|||
48356722|NCT00208325|155501143|FG001|Overall Study|Does not wish to Continue in Study|8|||
48356723|NCT00208325|155501144|FG002|Overall Study|Does not wish to Continue in Study|3|||
48356724|NCT00208325|155501145|FG003|Overall Study|Does not wish to Continue in Study|2|||
48356725|NCT00208325|155501142|FG000|Overall Study|Other|2|||
48356726|NCT00208325|155501143|FG001|Overall Study|Other|1|||
48356727|NCT00208325|155501144|FG002|Overall Study|Other|1|||
48356728|NCT00208325|155501145|FG003|Overall Study|Other|0|||
48356729|NCT00208325|155501142|FG000|Overall Study|Mis-Randomized|17|||
48356730|NCT00208325|155501143|FG001|Overall Study|Mis-Randomized|20|||
48356731|NCT00208325|155501144|FG002|Overall Study|Mis-Randomized|0|||
48356732|NCT00208325|155501145|FG003|Overall Study|Mis-Randomized|0|||
48356733|NCT00108745|155501146|FG000|Overall Study|Withdrawal by Subject|19|||
48356734|NCT00108745|155501147|FG001|Overall Study|Withdrawal by Subject|12|||
48356735|NCT00108745|155501148|FG002|Overall Study|Withdrawal by Subject|12|||
48356736|NCT00108745|155501146|FG000|Overall Study|Never Treated|8|||
48356737|NCT00108745|155501147|FG001|Overall Study|Never Treated|10|||
48356738|NCT00108745|155501148|FG002|Overall Study|Never Treated|12|||
48356739|NCT00108745|155501146|FG000|Overall Study|Ineligible|7|||
48356740|NCT00108745|155501147|FG001|Overall Study|Ineligible|13|||
48356741|NCT00108745|155501148|FG002|Overall Study|Ineligible|13|||
48356742|NCT03238963|155501149|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
48356743|NCT03238963|155501150|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
48356744|NCT03238963|155501149|FG000|Overall Study|Withdrawal by Subject|1|||
48356745|NCT03238963|155501150|FG001|Overall Study|Withdrawal by Subject|1|||
48356746|NCT03238963|155501149|FG000|Overall Study|Lost to Follow-up|1|||
48356747|NCT03238963|155501150|FG001|Overall Study|Lost to Follow-up|0|||
48356748|NCT03238963|155501149|FG000|Overall Study|Protocol Violation|1|||
48356749|NCT03238963|155501150|FG001|Overall Study|Protocol Violation|1|||
48356750|NCT03238963|155501149|FG000|Overall Study|Adverse Event|1|||
48356751|NCT03238963|155501150|FG001|Overall Study|Adverse Event|0|||
48356752|NCT01495598|155501154|FG000|Overall Study|Death during follow up period|2|||
48356753|NCT01495598|155501154|FG000|Overall Study|Death on study|1|||
48356754|NCT01495598|155501154|FG000|Overall Study|Lost to Follow-up|3|||
48356755|NCT01495598|155501154|FG000|Overall Study|Physician Decision|8|||
48356756|NCT01213524|155501156|FG000|Baseline|Withdrawal by Subject|5|||
48356757|NCT01213524|155501156|FG000|Baseline|high breath alcohol levels|1|||
48356758|NCT01213524|155501156|FG000|Baseline|Physician Decision|1|||
48356759|NCT01213524|155501156|FG000|Session 2|Withdrawal by Subject|5|||
48356760|NCT01213524|155501156|FG000|Session 3|Withdrawal by Subject|4|||
48356761|NCT01213524|155501156|FG000|Session 4|Physician Decision|1|||
48356762|NCT01213524|155501156|FG000|Session 4|Withdrawal by Subject|2|||
48356763|NCT02671500|155501157|FG000|Overall Study|Lack of Efficacy|12|||
48356764|NCT02671500|155501157|FG000|Overall Study|Lost to Follow-up|2|||
48356765|NCT03551691|155501158|FG000|Overall Study|Withdrawal by Subject|3|||
48356766|NCT03551691|155501159|FG001|Overall Study|Withdrawal by Subject|3|||
48356767|NCT04411056|155503483|FG000|Overall Study|surgery cancelled|1|||
48356768|NCT04411056|155503484|FG001|Overall Study|surgery cancelled|0|||
48356769|NCT04411056|155503483|FG000|Overall Study|Equipment problem during intubation|0|||
48787049|NCT00116805|157061020|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
48787050|NCT00116805|157061021|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
48787051|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
48787052|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
48787053|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
48787054|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
48787055|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
48787056|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
48356770|NCT04411056|155503484|FG001|Overall Study|Equipment problem during intubation|1|||
48356771|NCT00903760|155503487|FG000|Overall Study|Disease Progression/Death|8|||
48356772|NCT00903760|155503488|FG001|Overall Study|Disease Progression/Death|6|||
48356773|NCT00903760|155503487|FG000|Overall Study|Stem Cell Transplant|8|||
48356774|NCT00903760|155503488|FG001|Overall Study|Stem Cell Transplant|4|||
48356775|NCT00903760|155503487|FG000|Overall Study|Physician Decision|1|||
48356776|NCT00903760|155503488|FG001|Overall Study|Physician Decision|2|||
48356777|NCT00903760|155503487|FG000|Overall Study|Death|0|||
48356778|NCT00903760|155503488|FG001|Overall Study|Death|1|||
48356779|NCT00903760|155503487|FG000|Overall Study|Lost to Follow-up|1|||
48356780|NCT00903760|155503488|FG001|Overall Study|Lost to Follow-up|0|||
48787057|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
48787058|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
48787059|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
48787060|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
48787061|NCT00116805|157061020|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
48787062|NCT00116805|157061021|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
48787063|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
48787064|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
48787065|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
48787066|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
48787067|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
48787068|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
48787069|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
48787070|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
48787071|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
48787072|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
48787073|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
48787074|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
48787075|NCT00116805|157061020|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
48787076|NCT00116805|157061021|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
48787077|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
48787078|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
48787079|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
48787080|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
48787081|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
48787082|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
48787083|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
48787084|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
48787085|NCT00116805|157061020|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
48787086|NCT00116805|157061021|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
48787087|NCT00116805|157061020|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
48787088|NCT00116805|157061021|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
48787089|NCT00116805|157061020|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
48787090|NCT00116805|157061021|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
48787091|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
48787092|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
48787093|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
48787094|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
48787095|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
48787096|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
48787097|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
48787098|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
48787099|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
48787100|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
48787101|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
48787102|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
48787103|NCT00116805|157061020|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
48787104|NCT00116805|157061021|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
48787105|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
48787106|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
48787107|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
48787108|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
48787109|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
48787110|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
48787111|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
48787112|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
48787113|NCT00116805|157061020|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
48787114|NCT00116805|157061021|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
48787115|NCT00116805|157061020|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
48787116|NCT00116805|157061021|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
48787117|NCT00116805|157061020|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
48787118|NCT00116805|157061021|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
48787119|NCT00116805|157061020|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
48787120|NCT00116805|157061021|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
48787121|NCT00116805|157061020|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
48787122|NCT00116805|157061021|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
48787123|NCT02053350|157061022|FG000|Overall Study|Withdrawal by Subject|1|||
48787124|NCT02053350|157061022|FG000|Overall Study|Adverse Event|4|||
48787125|NCT00317772|157061023|FG000|Overall Study|Adverse Event|0|||
48787126|NCT00317772|157061024|FG001|Overall Study|Adverse Event|0|||
48787127|NCT00317772|157061025|FG002|Overall Study|Adverse Event|0|||
48787128|NCT00317772|157061026|FG003|Overall Study|Adverse Event|2|||
48787129|NCT00317772|157061023|FG000|Overall Study|Disease Progression|2|||
48787130|NCT00317772|157061024|FG001|Overall Study|Disease Progression|2|||
48787131|NCT00317772|157061025|FG002|Overall Study|Disease Progression|1|||
48787132|NCT00317772|157061026|FG003|Overall Study|Disease Progression|7|||
48787133|NCT01159691|157061027|FG000|Overall Study|Lost to Follow-up|2|||
48787134|NCT01159691|157061027|FG000|Overall Study|Unknown reasons|1|||
48787135|NCT01159691|157061027|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
48787136|NCT01159691|157061027|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
48787137|NCT01159691|157061027|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
48787138|NCT01159691|157061027|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
48787139|NCT01159691|157061027|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
48787140|NCT01159691|157061027|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
48787141|NCT03019536|157061031|FG000|Overall Study|Withdrawal by Subject|1|||
48787142|NCT03019536|157061032|FG001|Overall Study|Withdrawal by Subject|1|||
48787143|NCT03019536|157061033|FG002|Overall Study|Withdrawal by Subject|0|||
48787144|NCT03019536|157061031|FG000|Overall Study|Adverse Event|0|||
48787145|NCT03019536|157061032|FG001|Overall Study|Adverse Event|0|||
48787146|NCT03019536|157061033|FG002|Overall Study|Adverse Event|2|||
48787147|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Adverse Event|5|||
48787148|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Adverse Event|8|||
48787149|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Adverse Event|4|||
48787150|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Adverse Event|8|||
48787151|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
48787152|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
48787153|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
48787154|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
48787155|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
48787156|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
48787157|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
48787158|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
48787159|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Physician Decision|1|||
48787160|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Physician Decision|0|||
48787161|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Physician Decision|0|||
48787162|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Physician Decision|0|||
48787163|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
48787164|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
48787165|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
48787166|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
48787167|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Pregnancy|0|||
48787168|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Pregnancy|1|||
48787169|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Pregnancy|0|||
48787170|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Pregnancy|0|||
48400594|NCT02889796|155657762|FG004|Overall Study|Lost to Follow-up|2|||
48400595|NCT02889796|155657763|FG005|Overall Study|Lost to Follow-up|6|||
48400596|NCT02889796|155657758|FG000|Overall Study|Protocol Violation|0|||
48400597|NCT02889796|155657759|FG001|Overall Study|Protocol Violation|1|||
48400598|NCT02889796|155657760|FG002|Overall Study|Protocol Violation|3|||
48787171|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
48787172|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
48787173|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
48787174|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
48787175|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Death|0|||
48787176|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Death|1|||
48787177|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Death|0|||
48787178|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Death|0|||
48787179|NCT00071487|157061038|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
48787180|NCT00071487|157061039|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
48787181|NCT00071487|157061040|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
48400599|NCT02889796|155657761|FG003|Overall Study|Protocol Violation|0|||
48400600|NCT02889796|155657762|FG004|Overall Study|Protocol Violation|0|||
48787182|NCT00071487|157061041|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
48787183|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
48787184|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
48787185|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
48787186|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
48400601|NCT02889796|155657763|FG005|Overall Study|Protocol Violation|4|||
48787187|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48787188|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48787189|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
48787190|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
48787191|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48787192|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48787193|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48787194|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
48787195|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
48787196|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
48787197|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
48787198|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
48787199|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48787200|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48787201|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
48787202|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
48787203|NCT00071487|157061038|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48787204|NCT00071487|157061039|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48787205|NCT00071487|157061040|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
48787206|NCT00071487|157061041|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
48787207|NCT00352365|157061042|FG000|Induction Therapy|Adverse Event|7|||
48787208|NCT00352365|157061042|FG000|Induction Therapy|Progression/Relapse|8|||
48787209|NCT00352365|157061042|FG000|Induction Therapy|Death|7|||
48787210|NCT00352365|157061042|FG000|Induction Therapy|Not protocol specified|1|||
48787211|NCT00352365|157061042|FG000|Induction Therapy|Not eligible|3|||
48787212|NCT00352365|157061042|FG000|Induction Therapy|Death before starting protocol therapy|1|||
48787213|NCT00352365|157061042|FG000|Maintenance Therapy|Progression/Relapse|3|||
48787214|NCT00352365|157061042|FG000|Maintenance Therapy|Death|2|||
48787215|NCT00352365|157061042|FG000|Maintenance Therapy|Not protocol specified|3|||
48787216|NCT00352365|157061042|FG000|Maintenance Therapy|Not eligible|4|||
48787217|NCT00987467|157061043|FG000|Overall Study|Lost to Follow-up|2|||
48787218|NCT01517802|157061049|FG000|Overall Study|Death|1|||
48787219|NCT02590354|157061050|FG000|Phase 1|Active hepatitis B or C infection|1|||
48787220|NCT02590354|157061050|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
48787221|NCT02590354|157061050|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
48787222|NCT02590354|157061050|FG000|Phase 1|Subject does not want to participate|20|||
48787223|NCT02590354|157061050|FG000|Phase 1|Lost to Follow-up|1|||
48787224|NCT02590354|157061050|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
48787225|NCT00996996|157061051|FG000|Overall Study|Progressive Disease|10|||
48787226|NCT00996996|157061051|FG000|Overall Study|Non-compliance|8|||
48787227|NCT00996996|157061051|FG000|Overall Study|Lost to Follow-up|9|||
48787228|NCT00996996|157061051|FG000|Overall Study|Death|5|||
48787229|NCT00996996|157061051|FG000|Overall Study|Did Not Receive Study Medications|1|||
48787230|NCT04831736|157061054|FG000|Overall Study|Withdrawal by Subject|0|||
48787231|NCT04831736|157061055|FG001|Overall Study|Withdrawal by Subject|1|||
48787232|NCT01659021|157061069|FG000|Main Study|Adverse Event|2|||
48787233|NCT01659021|157061070|FG001|Main Study|Adverse Event|3|||
48787234|NCT01659021|157061069|FG000|Main Study|Lost to Follow-up|1|||
48787235|NCT01659021|157061070|FG001|Main Study|Lost to Follow-up|0|||
48787236|NCT01659021|157061069|FG000|Main Study|Unknown Reasons|2|||
48787237|NCT01659021|157061070|FG001|Main Study|Unknown Reasons|1|||
48787238|NCT01659021|157061069|FG000|Main Study|Physician Decision|34|||
48787239|NCT01659021|157061070|FG001|Main Study|Physician Decision|16|||
48787240|NCT01659021|157061069|FG000|Main Study|Withdrawal by Subject|19|||
48787241|NCT01659021|157061070|FG001|Main Study|Withdrawal by Subject|16|||
48787242|NCT01659021|157061069|FG000|Main Study|Study Terminated by Sponsor|16|||
48787243|NCT01659021|157061070|FG001|Main Study|Study Terminated by Sponsor|1|||
48787244|NCT01659021|157061069|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
48787245|NCT01659021|157061070|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
48787246|NCT01659021|157061069|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
48787247|NCT01659021|157061070|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
48787248|NCT03551938|157061071|FG000|3-Month Follow Up|Lost to Follow-up|39|||
48787249|NCT03551938|157061072|FG001|3-Month Follow Up|Lost to Follow-up|38|||
48787250|NCT03551938|157061071|FG000|6-Month Follow Up|Lost to Follow-up|46|||
48787251|NCT03551938|157061072|FG001|6-Month Follow Up|Lost to Follow-up|42|||
48787252|NCT03551938|157061071|FG000|9-Month Follow Up|Lost to Follow-up|44|||
48787253|NCT03551938|157061072|FG001|9-Month Follow Up|Lost to Follow-up|43|||
48787254|NCT02103439|157061073|FG000|Overall Study|Adverse Event|0|||
48787255|NCT02103439|157061074|FG001|Overall Study|Adverse Event|2|||
48787256|NCT02103439|157061073|FG000|Overall Study|Withdrawal by Subject|3|||
48787257|NCT02103439|157061074|FG001|Overall Study|Withdrawal by Subject|1|||
48787258|NCT01343368|157061075|FG000|Overall Study|Death|1|||
48787259|NCT01343368|157061076|FG001|Overall Study|Death|0|||
48787260|NCT01343368|157061075|FG000|Overall Study|Lost to Follow-up|1|||
48787261|NCT01343368|157061076|FG001|Overall Study|Lost to Follow-up|0|||
48787262|NCT02511431|157061077|FG000|Treatment|Lost to Follow-up|0|||
48787263|NCT02511431|157061078|FG001|Treatment|Lost to Follow-up|0|||
48787264|NCT02511431|157061079|FG002|Treatment|Lost to Follow-up|1|||
48400602|NCT02889796|155657758|FG000|Overall Study|Non-compliance With Study Drug|0|||
48400603|NCT02889796|155657759|FG001|Overall Study|Non-compliance With Study Drug|2|||
48400604|NCT02889796|155657760|FG002|Overall Study|Non-compliance With Study Drug|0|||
48400605|NCT02889796|155657761|FG003|Overall Study|Non-compliance With Study Drug|0|||
48400606|NCT02889796|155657762|FG004|Overall Study|Non-compliance With Study Drug|1|||
48400607|NCT02889796|155657763|FG005|Overall Study|Non-compliance With Study Drug|2|||
48400608|NCT02889796|155657758|FG000|Overall Study|Death|1|||
48400609|NCT02889796|155657759|FG001|Overall Study|Death|1|||
48400610|NCT02889796|155657760|FG002|Overall Study|Death|0|||
48400611|NCT02889796|155657761|FG003|Overall Study|Death|1|||
48400612|NCT02889796|155657762|FG004|Overall Study|Death|0|||
48400613|NCT02889796|155657763|FG005|Overall Study|Death|1|||
48400614|NCT02889796|155657758|FG000|Overall Study|Pregnancy|0|||
48400615|NCT02889796|155657759|FG001|Overall Study|Pregnancy|1|||
48400616|NCT02889796|155657760|FG002|Overall Study|Pregnancy|1|||
48400617|NCT02889796|155657761|FG003|Overall Study|Pregnancy|0|||
48400618|NCT02889796|155657762|FG004|Overall Study|Pregnancy|0|||
48400619|NCT02889796|155657763|FG005|Overall Study|Pregnancy|0|||
48400620|NCT02889796|155657758|FG000|Overall Study|Randomized but not Dosed|2|||
48400621|NCT02889796|155657759|FG001|Overall Study|Randomized but not Dosed|0|||
48400622|NCT02889796|155657760|FG002|Overall Study|Randomized but not Dosed|0|||
48400623|NCT02889796|155657761|FG003|Overall Study|Randomized but not Dosed|0|||
48400624|NCT02889796|155657762|FG004|Overall Study|Randomized but not Dosed|0|||
48400625|NCT02889796|155657763|FG005|Overall Study|Randomized but not Dosed|2|||
48400626|NCT00488982|155657764|FG000|Course 1|Physician Decision|0|||
48400627|NCT00488982|155657765|FG001|Course 1|Physician Decision|2|||
48400628|NCT00488982|155657766|FG002|Course 1|Physician Decision|4|||
48400629|NCT00488982|155657764|FG000|Course 1|Withdrawal by Subject|0|||
48400630|NCT00488982|155657765|FG001|Course 1|Withdrawal by Subject|8|||
48400631|NCT00488982|155657766|FG002|Course 1|Withdrawal by Subject|2|||
48400632|NCT00488982|155657764|FG000|Course 1|nonprotocol therapy|0|||
48400633|NCT00488982|155657765|FG001|Course 1|nonprotocol therapy|2|||
48400634|NCT00488982|155657766|FG002|Course 1|nonprotocol therapy|2|||
48400635|NCT00488982|155657764|FG000|Course 1|Adverse Event|0|||
48400636|NCT00488982|155657765|FG001|Course 1|Adverse Event|0|||
48400637|NCT00488982|155657766|FG002|Course 1|Adverse Event|6|||
48400638|NCT01678144|155657767|FG000|Stage 1: MAR Classic|Adverse Event|1|||
48400639|NCT02631200|155657768|FG000|First Period|Death|1|||
48400640|NCT02631200|155657769|FG001|First Period|Death|2|||
48400641|NCT02631200|155657768|FG000|First Period|Patient ill-health|2|||
48400642|NCT02631200|155657769|FG001|First Period|Patient ill-health|4|||
48400643|NCT02631200|155657768|FG000|First Period|Withdrawal by Subject|4|||
48400644|NCT02631200|155657769|FG001|First Period|Withdrawal by Subject|1|||
48787265|NCT02511431|157061080|FG003|Treatment|Lost to Follow-up|0|||
48787266|NCT02511431|157061081|FG004|Treatment|Lost to Follow-up|0|||
48787267|NCT02511431|157061082|FG005|Treatment|Lost to Follow-up|1|||
48787268|NCT01369342|157061083|FG000|Overall Study|Withdrawal by Subject|7|||
48787269|NCT01369342|157061084|FG001|Overall Study|Withdrawal by Subject|7|||
48787270|NCT01369342|157061085|FG002|Overall Study|Withdrawal by Subject|2|||
48787271|NCT01369342|157061083|FG000|Overall Study|Lost to Follow-up|5|||
48787272|NCT01369342|157061084|FG001|Overall Study|Lost to Follow-up|2|||
48787273|NCT01369342|157061085|FG002|Overall Study|Lost to Follow-up|1|||
48787274|NCT01369342|157061083|FG000|Overall Study|Not Treated|1|||
48787275|NCT01369342|157061084|FG001|Overall Study|Not Treated|0|||
48400645|NCT02631200|155657768|FG000|Deferred Period|Death|0|||
48400646|NCT02631200|155657769|FG001|Deferred Period|Death|1|||
48400647|NCT02631200|155657768|FG000|Deferred Period|Received kidney transplant|0|||
48400648|NCT02631200|155657769|FG001|Deferred Period|Received kidney transplant|1|||
48400649|NCT02631200|155657768|FG000|Deferred Period|Withdrawal by Subject|0|||
48400650|NCT02631200|155657769|FG001|Deferred Period|Withdrawal by Subject|2|||
48400651|NCT02631200|155657768|FG000|Deferred Period|Lost to Follow-up|0|||
48400652|NCT02631200|155657769|FG001|Deferred Period|Lost to Follow-up|1|||
48400653|NCT01978093|155657772|FG000|Overall Study|Death|1|||
48400654|NCT01978093|155657773|FG001|Overall Study|Death|0|||
48400655|NCT01978093|155657772|FG000|Overall Study|Adverse Event|0|||
48400656|NCT01978093|155657773|FG001|Overall Study|Adverse Event|5|||
48787276|NCT01369342|157061085|FG002|Overall Study|Not Treated|0|||
48787277|NCT00321854|157061086|FG000|Overall Study|Adverse Event|41|||
48787278|NCT00321854|157061087|FG001|Overall Study|Adverse Event|43|||
48787279|NCT00321854|157061086|FG000|Overall Study|Lack of Efficacy|9|||
48787280|NCT00321854|157061087|FG001|Overall Study|Lack of Efficacy|14|||
48400657|NCT01978093|155657772|FG000|Overall Study|Protocol Violation|8|||
48400658|NCT01978093|155657773|FG001|Overall Study|Protocol Violation|2|||
48400659|NCT01978093|155657772|FG000|Overall Study|Withdrawal by Subject|29|||
48400660|NCT01978093|155657773|FG001|Overall Study|Withdrawal by Subject|25|||
48400661|NCT01978093|155657772|FG000|Overall Study|Lost to Follow-up|11|||
48400662|NCT01978093|155657773|FG001|Overall Study|Lost to Follow-up|15|||
48787281|NCT00321854|157061086|FG000|Overall Study|Protocol Violation|6|||
48787282|NCT00321854|157061087|FG001|Overall Study|Protocol Violation|5|||
48787283|NCT00321854|157061086|FG000|Overall Study|Lost to Follow-up|0|||
48787284|NCT00321854|157061087|FG001|Overall Study|Lost to Follow-up|2|||
48787285|NCT00321854|157061086|FG000|Overall Study|Withdrawal by Subject|6|||
48787286|NCT00321854|157061087|FG001|Overall Study|Withdrawal by Subject|17|||
48787287|NCT00321854|157061086|FG000|Overall Study|Other|1|||
48787288|NCT00321854|157061087|FG001|Overall Study|Other|1|||
48787289|NCT00413153|157061090|FG000|Overall Study|Withdrawal by Subject|1|||
48787290|NCT00413153|157061091|FG001|Overall Study|Withdrawal by Subject|1|||
48787291|NCT00413153|157061090|FG000|Overall Study|Adverse Event|1|||
48787292|NCT00413153|157061091|FG001|Overall Study|Adverse Event|0|||
48787293|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
48787294|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
48787295|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
48787296|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
48787297|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
48787298|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
48787299|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
48787300|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
48787301|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
48787302|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
48787303|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
48787304|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
48787305|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
48787306|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
48787307|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
48787308|NCT01571362|157061092|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
48787309|NCT01571362|157061093|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
48787310|NCT01571362|157061094|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
48787311|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48787312|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
48787313|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
48787314|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48787315|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
48787316|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
48787317|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48787318|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Adverse Event|9|||
48787319|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Adverse Event|14|||
48787320|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48787321|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
48787322|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
48787323|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
48787324|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
48787325|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
48787326|NCT01571362|157061092|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
48787327|NCT01571362|157061093|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
48787328|NCT01571362|157061094|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
48787329|NCT03667053|157061098|FG000|Overall Study|Withdrawal by Subject|1|||
48787330|NCT03667053|157061099|FG001|Overall Study|Withdrawal by Subject|0|||
48787331|NCT03667053|157061100|FG002|Overall Study|Withdrawal by Subject|0|||
48787332|NCT01127178|157061102|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
48787333|NCT01127178|157061103|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
48787334|NCT01127178|157061102|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
48787335|NCT01127178|157061103|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
48787336|NCT01127178|157061102|FG000|Dose Escalation: Treatment Phase|Other|2|||
48787337|NCT01127178|157061103|FG001|Dose Escalation: Treatment Phase|Other|0|||
48787338|NCT01127178|157061102|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
48787339|NCT01127178|157061103|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
48787340|NCT01127178|157061102|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
48787341|NCT01127178|157061103|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
48787342|NCT01127178|157061102|FG000|Dose Escalation: Extension Phase|Other|1|||
48787343|NCT01127178|157061103|FG001|Dose Escalation: Extension Phase|Other|0|||
48787344|NCT04971395|157061106|FG000|Overall Study|Withdrawal by Subject|0|||
48787345|NCT04971395|157061107|FG001|Overall Study|Withdrawal by Subject|1|||
48787346|NCT04971395|157061108|FG002|Overall Study|Withdrawal by Subject|0|||
48787347|NCT03264989|157061109|FG000|Overall Study|Lost to Follow-up|1|||
48787348|NCT03264989|157061110|FG001|Overall Study|Lost to Follow-up|0|||
48787349|NCT03264989|157061109|FG000|Overall Study|New Therapy for study Indication|1|||
48787350|NCT03264989|157061110|FG001|Overall Study|New Therapy for study Indication|0|||
48787351|NCT03264989|157061109|FG000|Overall Study|Protocol Violation|0|||
48787352|NCT03264989|157061110|FG001|Overall Study|Protocol Violation|1|||
48787353|NCT03264989|157061109|FG000|Overall Study|Patient decision|13|||
48787354|NCT03264989|157061110|FG001|Overall Study|Patient decision|0|||
48787355|NCT03264989|157061109|FG000|Overall Study|Physician Decision|6|||
48787356|NCT03264989|157061110|FG001|Overall Study|Physician Decision|4|||
48787357|NCT03264989|157061109|FG000|Overall Study|Adverse Event|2|||
48787358|NCT03264989|157061110|FG001|Overall Study|Adverse Event|1|||
48787359|NCT03264989|157061109|FG000|Overall Study|Death|1|||
48787360|NCT03264989|157061110|FG001|Overall Study|Death|1|||
48787361|NCT03264989|157061109|FG000|Overall Study|Pregnancy|2|||
48787362|NCT03264989|157061110|FG001|Overall Study|Pregnancy|0|||
48787363|NCT03264989|157061109|FG000|Overall Study|End of Study|19|||
48787364|NCT03264989|157061110|FG001|Overall Study|End of Study|5|||
48787365|NCT04185298|157061111|FG000|Overall Study|Lost to Follow-up|1|||
48787366|NCT04185298|157061112|FG001|Overall Study|Lost to Follow-up|3|||
48787367|NCT04185298|157061111|FG000|Overall Study|Withdrawal by Subject|0|||
48787368|NCT04185298|157061112|FG001|Overall Study|Withdrawal by Subject|3|||
48787369|NCT01310036|157061121|FG000|Overall Study|Administrative/other|10|||
48787370|NCT01310036|157061121|FG000|Overall Study|Withdrew Consent|11|||
48787371|NCT01310036|157061121|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
48787372|NCT01310036|157061121|FG000|Overall Study|Progression of Disease|164|||
48787373|NCT01310036|157061121|FG000|Overall Study|Death|1|||
48787374|NCT01310036|157061121|FG000|Overall Study|Adverse event or intercurrent illness|12|||
48787375|NCT01175668|157061122|FG000|Overall Study|Withdrawal by Subject|2|||
48787376|NCT01175668|157061123|FG001|Overall Study|Withdrawal by Subject|0|||
48787377|NCT04575467|157061126|FG000|Overall Study|Adverse Event|0|||
48787378|NCT04575467|157061127|FG001|Overall Study|Adverse Event|1|||
48787379|NCT04575467|157061128|FG002|Overall Study|Adverse Event|0|||
48787380|NCT04575467|157061129|FG003|Overall Study|Adverse Event|0|||
48787381|NCT03085810|157061130|FG000|Main Study|Withdrawal by Subject|77|||
48787382|NCT03085810|157061131|FG001|Main Study|Withdrawal by Subject|0|||
48787383|NCT03085810|157061132|FG002|Main Study|Withdrawal by Subject|0|||
48787384|NCT03085810|157061130|FG000|Main Study|Terminated By Sponsor|14|||
48787385|NCT03085810|157061131|FG001|Main Study|Terminated By Sponsor|0|||
48787386|NCT03085810|157061132|FG002|Main Study|Terminated By Sponsor|0|||
48787387|NCT03085810|157061130|FG000|Main Study|Protocol Violation|15|||
48787388|NCT03085810|157061131|FG001|Main Study|Protocol Violation|0|||
48787389|NCT03085810|157061132|FG002|Main Study|Protocol Violation|0|||
48787390|NCT03085810|157061130|FG000|Main Study|Physician Decision|13|||
48787391|NCT03085810|157061131|FG001|Main Study|Physician Decision|0|||
48787392|NCT03085810|157061132|FG002|Main Study|Physician Decision|0|||
48787393|NCT03085810|157061130|FG000|Main Study|Lost to Follow-up|17|||
48787394|NCT03085810|157061131|FG001|Main Study|Lost to Follow-up|0|||
48787395|NCT03085810|157061132|FG002|Main Study|Lost to Follow-up|0|||
48787396|NCT03085810|157061130|FG000|Main Study|Adverse Event|25|||
48787397|NCT03085810|157061131|FG001|Main Study|Adverse Event|0|||
48787398|NCT03085810|157061132|FG002|Main Study|Adverse Event|0|||
48400663|NCT01978093|155657772|FG000|Overall Study|Migrated/moved from study area|11|||
48400664|NCT01978093|155657773|FG001|Overall Study|Migrated/moved from study area|13|||
48400665|NCT01978093|155657772|FG000|Overall Study|Loss of kaiser coverage|4|||
48787399|NCT03085810|157061130|FG000|Main Study|Pregnancy|7|||
48787400|NCT03085810|157061131|FG001|Main Study|Pregnancy|0|||
48787401|NCT03085810|157061132|FG002|Main Study|Pregnancy|0|||
48787402|NCT03085810|157061130|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
48787403|NCT03085810|157061131|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
48787404|NCT03085810|157061132|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
48787405|NCT03085810|157061130|FG000|Main Study|Lack of Efficacy|10|||
48787406|NCT03085810|157061131|FG001|Main Study|Lack of Efficacy|0|||
48787407|NCT03085810|157061132|FG002|Main Study|Lack of Efficacy|0|||
48787408|NCT03085810|157061130|FG000|Main Study|Death|12|||
48787409|NCT03085810|157061131|FG001|Main Study|Death|0|||
48787410|NCT03085810|157061132|FG002|Main Study|Death|0|||
48787411|NCT03085810|157061130|FG000|Main Study|Disease progression|1|||
48787412|NCT03085810|157061131|FG001|Main Study|Disease progression|0|||
48400666|NCT01978093|155657773|FG001|Overall Study|Loss of kaiser coverage|10|||
48400667|NCT01978093|155657772|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
48787413|NCT03085810|157061132|FG002|Main Study|Disease progression|0|||
48787414|NCT03085810|157061130|FG000|Main Study|Site Closure|3|||
48787415|NCT03085810|157061131|FG001|Main Study|Site Closure|0|||
48787416|NCT03085810|157061132|FG002|Main Study|Site Closure|0|||
48787417|NCT03085810|157061130|FG000|Main Study|Planned pregnancy|17|||
48787418|NCT03085810|157061131|FG001|Main Study|Planned pregnancy|0|||
48787419|NCT03085810|157061132|FG002|Main Study|Planned pregnancy|0|||
48787420|NCT03085810|157061130|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
48787421|NCT03085810|157061131|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
48787422|NCT03085810|157061132|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
48787423|NCT03085810|157061130|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
48787424|NCT03085810|157061131|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
48787425|NCT03085810|157061132|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
48787426|NCT03085810|157061130|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
48787427|NCT03085810|157061131|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
48787428|NCT03085810|157061132|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
48787429|NCT03085810|157061130|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
48787430|NCT03085810|157061131|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
48787431|NCT03085810|157061132|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
48787432|NCT00784043|157061135|FG000|Overall Study|Withdrawal by Subject|8|||
48787433|NCT00784043|157061136|FG001|Overall Study|Withdrawal by Subject|5|||
48787434|NCT00784043|157061135|FG000|Overall Study|Protocol Terminated|23|||
48787435|NCT00784043|157061136|FG001|Overall Study|Protocol Terminated|1|||
48787436|NCT02415400|157061137|FG000|Overall Study|Adverse Event|0|||
48787437|NCT02415400|157061138|FG001|Overall Study|Adverse Event|1|||
48787438|NCT02415400|157061139|FG002|Overall Study|Adverse Event|1|||
48787439|NCT02415400|157061140|FG003|Overall Study|Adverse Event|2|||
48787440|NCT02415400|157061137|FG000|Overall Study|Participant request to stop therapy|4|||
48787441|NCT02415400|157061138|FG001|Overall Study|Participant request to stop therapy|3|||
48787442|NCT02415400|157061139|FG002|Overall Study|Participant request to stop therapy|8|||
48787443|NCT02415400|157061140|FG003|Overall Study|Participant request to stop therapy|6|||
48787444|NCT02415400|157061137|FG000|Overall Study|Participant withdrew consent|14|||
48787445|NCT02415400|157061138|FG001|Overall Study|Participant withdrew consent|12|||
48787446|NCT02415400|157061139|FG002|Overall Study|Participant withdrew consent|30|||
48787447|NCT02415400|157061140|FG003|Overall Study|Participant withdrew consent|21|||
48787448|NCT02415400|157061137|FG000|Overall Study|Death|39|||
48787449|NCT02415400|157061138|FG001|Overall Study|Death|41|||
48787450|NCT02415400|157061139|FG002|Overall Study|Death|35|||
48787451|NCT02415400|157061140|FG003|Overall Study|Death|42|||
48787452|NCT02415400|157061137|FG000|Overall Study|Lost to Follow-up|3|||
48787453|NCT02415400|157061138|FG001|Overall Study|Lost to Follow-up|3|||
48787454|NCT02415400|157061139|FG002|Overall Study|Lost to Follow-up|2|||
48787455|NCT02415400|157061140|FG003|Overall Study|Lost to Follow-up|5|||
48787456|NCT02415400|157061137|FG000|Overall Study|Poor/Non-Compliance|0|||
48787457|NCT02415400|157061138|FG001|Overall Study|Poor/Non-Compliance|1|||
48787458|NCT02415400|157061139|FG002|Overall Study|Poor/Non-Compliance|3|||
48787459|NCT02415400|157061140|FG003|Overall Study|Poor/Non-Compliance|4|||
48787460|NCT02415400|157061137|FG000|Overall Study|Participant no longer meets criteria|2|||
48787461|NCT02415400|157061138|FG001|Overall Study|Participant no longer meets criteria|0|||
48787462|NCT02415400|157061139|FG002|Overall Study|Participant no longer meets criteria|0|||
48787463|NCT02415400|157061140|FG003|Overall Study|Participant no longer meets criteria|1|||
48787464|NCT02415400|157061137|FG000|Overall Study|Participant doesn't answer phone|1|||
48787465|NCT02415400|157061138|FG001|Overall Study|Participant doesn't answer phone|0|||
48787466|NCT02415400|157061139|FG002|Overall Study|Participant doesn't answer phone|0|||
48787467|NCT02415400|157061140|FG003|Overall Study|Participant doesn't answer phone|0|||
48787468|NCT02415400|157061137|FG000|Overall Study|Participant wanted home visits|1|||
48787469|NCT02415400|157061138|FG001|Overall Study|Participant wanted home visits|0|||
48787470|NCT02415400|157061139|FG002|Overall Study|Participant wanted home visits|0|||
48787471|NCT02415400|157061140|FG003|Overall Study|Participant wanted home visits|0|||
48787472|NCT02415400|157061137|FG000|Overall Study|Randomized in error|2|||
48787473|NCT02415400|157061138|FG001|Overall Study|Randomized in error|0|||
48787474|NCT02415400|157061139|FG002|Overall Study|Randomized in error|0|||
48787475|NCT02415400|157061140|FG003|Overall Study|Randomized in error|0|||
48787476|NCT02415400|157061137|FG000|Overall Study|No study drug on site|0|||
48787477|NCT02415400|157061138|FG001|Overall Study|No study drug on site|1|||
48787478|NCT02415400|157061139|FG002|Overall Study|No study drug on site|0|||
48787479|NCT02415400|157061140|FG003|Overall Study|No study drug on site|0|||
48787480|NCT02415400|157061137|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
48787481|NCT02415400|157061138|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
48787482|NCT02415400|157061139|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
48787483|NCT02415400|157061140|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
48787484|NCT02415400|157061137|FG000|Overall Study|Coagulation values cannot be set|0|||
48787485|NCT02415400|157061138|FG001|Overall Study|Coagulation values cannot be set|0|||
48787486|NCT02415400|157061139|FG002|Overall Study|Coagulation values cannot be set|1|||
48787487|NCT02415400|157061140|FG003|Overall Study|Coagulation values cannot be set|0|||
48787488|NCT02415400|157061137|FG000|Overall Study|State regulations prevent participation|0|||
48787489|NCT02415400|157061138|FG001|Overall Study|State regulations prevent participation|0|||
48787490|NCT02415400|157061139|FG002|Overall Study|State regulations prevent participation|1|||
48787491|NCT02415400|157061140|FG003|Overall Study|State regulations prevent participation|0|||
48787492|NCT02415400|157061137|FG000|Overall Study|Poor treatment monitoring|0|||
48787493|NCT02415400|157061138|FG001|Overall Study|Poor treatment monitoring|0|||
48787494|NCT02415400|157061139|FG002|Overall Study|Poor treatment monitoring|1|||
48787495|NCT02415400|157061140|FG003|Overall Study|Poor treatment monitoring|0|||
48787496|NCT02415400|157061137|FG000|Overall Study|Participant in jail|0|||
48787497|NCT02415400|157061138|FG001|Overall Study|Participant in jail|0|||
48787498|NCT02415400|157061139|FG002|Overall Study|Participant in jail|1|||
48787499|NCT02415400|157061140|FG003|Overall Study|Participant in jail|0|||
48787500|NCT02415400|157061137|FG000|Overall Study|Investigator decision|0|||
48787501|NCT02415400|157061138|FG001|Overall Study|Investigator decision|0|||
48787502|NCT02415400|157061139|FG002|Overall Study|Investigator decision|1|||
48787503|NCT02415400|157061140|FG003|Overall Study|Investigator decision|1|||
48787504|NCT02415400|157061137|FG000|Overall Study|Site closure; participant won't transfer|0|||
48787505|NCT02415400|157061138|FG001|Overall Study|Site closure; participant won't transfer|0|||
48787506|NCT02415400|157061139|FG002|Overall Study|Site closure; participant won't transfer|0|||
48787507|NCT02415400|157061140|FG003|Overall Study|Site closure; participant won't transfer|1|||
48787508|NCT02105948|157061144|FG000|Overall Study|Adverse Event|10|||
48787509|NCT02105948|157061145|FG001|Overall Study|Adverse Event|7|||
48787510|NCT02105948|157061146|FG002|Overall Study|Adverse Event|11|||
48400668|NCT01978093|155657773|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
48400669|NCT01978093|155657772|FG000|Overall Study|Mother lost custody of child|0|||
48400670|NCT01978093|155657773|FG001|Overall Study|Mother lost custody of child|1|||
48787511|NCT02105948|157061147|FG003|Overall Study|Adverse Event|11|||
48787512|NCT02105948|157061144|FG000|Overall Study|Lack of Efficacy|0|||
48787513|NCT02105948|157061145|FG001|Overall Study|Lack of Efficacy|1|||
48787514|NCT02105948|157061146|FG002|Overall Study|Lack of Efficacy|3|||
48787515|NCT02105948|157061147|FG003|Overall Study|Lack of Efficacy|2|||
48787516|NCT02105948|157061144|FG000|Overall Study|Lost to Follow-up|0|||
48787517|NCT02105948|157061145|FG001|Overall Study|Lost to Follow-up|0|||
48787518|NCT02105948|157061146|FG002|Overall Study|Lost to Follow-up|2|||
48787519|NCT02105948|157061147|FG003|Overall Study|Lost to Follow-up|1|||
48787520|NCT02105948|157061144|FG000|Overall Study|Physician Decision|2|||
48787521|NCT02105948|157061145|FG001|Overall Study|Physician Decision|2|||
48787522|NCT02105948|157061146|FG002|Overall Study|Physician Decision|2|||
48787523|NCT02105948|157061147|FG003|Overall Study|Physician Decision|2|||
48787524|NCT02105948|157061144|FG000|Overall Study|Withdrawal by Subject|15|||
48787525|NCT02105948|157061145|FG001|Overall Study|Withdrawal by Subject|10|||
48787526|NCT02105948|157061146|FG002|Overall Study|Withdrawal by Subject|10|||
48787527|NCT02105948|157061147|FG003|Overall Study|Withdrawal by Subject|11|||
48787528|NCT01650259|157061152|FG000|Overall Study|Improvement|105|||
48787529|NCT01650259|157061153|FG001|Overall Study|Improvement|0|||
48787530|NCT01650259|157061152|FG000|Overall Study|Adverse Event|127|||
48787531|NCT01650259|157061153|FG001|Overall Study|Adverse Event|0|||
48787532|NCT01650259|157061152|FG000|Overall Study|Lack of Efficacy|143|||
48787533|NCT01650259|157061153|FG001|Overall Study|Lack of Efficacy|0|||
48787534|NCT01650259|157061152|FG000|Overall Study|Lost to Follow-up|435|||
48787535|NCT01650259|157061153|FG001|Overall Study|Lost to Follow-up|0|||
48787536|NCT01650259|157061152|FG000|Overall Study|Patients had no visit after entry|70|||
48787537|NCT01650259|157061153|FG001|Overall Study|Patients had no visit after entry|0|||
48787538|NCT01650259|157061152|FG000|Overall Study|CRF not collected|98|||
48787539|NCT01650259|157061153|FG001|Overall Study|CRF not collected|82|||
48787540|NCT01650259|157061152|FG000|Overall Study|Not treated|1|||
48787541|NCT01650259|157061153|FG001|Overall Study|Not treated|7|||
48787542|NCT01650259|157061152|FG000|Overall Study|Other than listed|64|||
48787543|NCT01650259|157061153|FG001|Overall Study|Other than listed|146|||
48787544|NCT00936858|157061154|FG000|Overall Study|Death|3|||
48787545|NCT00936858|157061154|FG000|Overall Study|Progression|29|||
48787546|NCT00936858|157061154|FG000|Overall Study|Withdrawal by Subject|5|||
48787547|NCT00936858|157061154|FG000|Overall Study|Adverse Event|1|||
48787548|NCT00936858|157061154|FG000|Overall Study|Physician Decision|7|||
48787549|NCT00936858|157061154|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
48787550|NCT00936858|157061154|FG000|Overall Study|Lost to Follow-up|1|||
48787551|NCT04615273|157061157|FG000|Overall Study|Withdrawal by Subject|3|||
48787552|NCT04615273|157061158|FG001|Overall Study|Withdrawal by Subject|1|||
48787553|NCT04615273|157061159|FG002|Overall Study|Withdrawal by Subject|2|||
48787554|NCT04615273|157061157|FG000|Overall Study|Adverse Event|1|||
48787555|NCT04615273|157061158|FG001|Overall Study|Adverse Event|0|||
48787556|NCT04615273|157061159|FG002|Overall Study|Adverse Event|1|||
48787557|NCT04615273|157061157|FG000|Overall Study|Lost to Follow-up|0|||
48787558|NCT04615273|157061158|FG001|Overall Study|Lost to Follow-up|1|||
48787559|NCT04615273|157061159|FG002|Overall Study|Lost to Follow-up|0|||
48787560|NCT04615273|157061157|FG000|Overall Study|Physician Decision|0|||
48787561|NCT04615273|157061158|FG001|Overall Study|Physician Decision|0|||
48787562|NCT04615273|157061159|FG002|Overall Study|Physician Decision|1|||
48787563|NCT04615273|157061157|FG000|Overall Study|Other|0|||
48787564|NCT04615273|157061158|FG001|Overall Study|Other|1|||
48400671|NCT01978093|155657772|FG000|Overall Study|Child was in care of grandmother|0|||
48400672|NCT01978093|155657773|FG001|Overall Study|Child was in care of grandmother|1|||
48400673|NCT01978093|155657772|FG000|Overall Study|N/A for vaccine administration|0|||
48400674|NCT01978093|155657773|FG001|Overall Study|N/A for vaccine administration|1|||
48400675|NCT03124784|155657774|FG000|Overall Study|Adverse Event|1|||
48400676|NCT03124784|155657774|FG000|Overall Study|Computer/Equip Malfunction|1|||
48400677|NCT04677712|155657780|FG000|Overall Study|Lost to Follow-up|0|||
48400678|NCT04677712|155657781|FG001|Overall Study|Lost to Follow-up|1|||
48400679|NCT04677712|155657782|FG002|Overall Study|Lost to Follow-up|0|||
48400680|NCT04677712|155657783|FG003|Overall Study|Lost to Follow-up|0|||
48400681|NCT04677712|155657784|FG004|Overall Study|Lost to Follow-up|0|||
48400682|NCT04677712|155657785|FG005|Overall Study|Lost to Follow-up|0|||
48400683|NCT00424827|155657791|FG000|Overall Study|Adverse Event|1|||
48400684|NCT02469090|155657792|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
48400685|NCT02469090|155657793|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
48787565|NCT04615273|157061159|FG002|Overall Study|Other|0|||
48787566|NCT04615273|157061157|FG000|Overall Study|Randomized but not treated|1|||
48787567|NCT04615273|157061158|FG001|Overall Study|Randomized but not treated|3|||
48787568|NCT04615273|157061159|FG002|Overall Study|Randomized but not treated|1|||
48787569|NCT00435370|157061165|FG000|Overall Study|Adverse Event|8|||
48787570|NCT00435370|157061166|FG001|Overall Study|Adverse Event|8|||
48787571|NCT00435370|157061165|FG000|Overall Study|Withdrawal by Subject|10|||
48787572|NCT00435370|157061166|FG001|Overall Study|Withdrawal by Subject|10|||
48787573|NCT00435370|157061165|FG000|Overall Study|Antipsychotic medication changed|4|||
48787574|NCT00435370|157061166|FG001|Overall Study|Antipsychotic medication changed|2|||
48787575|NCT03277313|157061169|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
48787576|NCT03277313|157061170|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
48787577|NCT03277313|157061169|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
48787578|NCT03277313|157061170|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
48787579|NCT03277313|157061169|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
48787580|NCT03277313|157061170|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
48787581|NCT03277313|157061169|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
48787582|NCT03277313|157061170|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
48787583|NCT03277313|157061169|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
48787584|NCT03277313|157061170|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
48787585|NCT01965834|157061171|FG000|Overall Study|Lack of Efficacy|4|||
48787586|NCT03943095|157061174|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
48787587|NCT03943095|157061175|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
48787588|NCT03943095|157061174|FG000|Overall Study|Withdrawal by Subject|1|||
48787589|NCT03943095|157061175|FG001|Overall Study|Withdrawal by Subject|0|||
48787590|NCT04571619|157061176|FG000|Phase 1|Death|22|||
48787591|NCT04571619|157061177|FG001|Phase 1|Death|18|||
48787592|NCT04571619|157061176|FG000|Phase 1|Withdrawal by Subject|7|||
48787593|NCT04571619|157061177|FG001|Phase 1|Withdrawal by Subject|2|||
48787594|NCT04571619|157061176|FG000|Phase 2|Death|13|||
48787595|NCT04571619|157061177|FG001|Phase 2|Death|16|||
48787596|NCT04571619|157061176|FG000|Phase 2|Withdrawal by Subject|6|||
48787597|NCT04571619|157061177|FG001|Phase 2|Withdrawal by Subject|4|||
48400686|NCT02469090|155657794|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
48400687|NCT02469090|155657792|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
48400688|NCT02469090|155657793|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
48787598|NCT02493127|157061179|FG000|Overall Study|Lost to Follow-up|1|||
48787599|NCT02493127|157061180|FG001|Overall Study|Lost to Follow-up|1|||
48787600|NCT01660906|157061181|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
48787601|NCT02096900|157061187|FG000|Overall Study|Did not receive medication|3|||
48787602|NCT02096900|157061188|FG001|Overall Study|Did not receive medication|1|||
48787603|NCT02096900|157061187|FG000|Overall Study|Surgery cancelled- medication received|1|||
48787604|NCT02096900|157061188|FG001|Overall Study|Surgery cancelled- medication received|1|||
48787605|NCT03896516|157063449|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
48787606|NCT03896516|157063450|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
48787607|NCT03896516|157063449|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
48787608|NCT03896516|157063450|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
48787609|NCT03896516|157063449|FG000|Washout Period|Physician Decision|3|||
48400689|NCT02469090|155657794|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
48787610|NCT03896516|157063450|FG001|Washout Period|Physician Decision|1|||
48787611|NCT03896516|157063449|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
48787612|NCT03896516|157063450|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
48787613|NCT02605954|157063451|FG000|Overall Study|Adverse Event|5|||
48787614|NCT02605954|157063452|FG001|Overall Study|Adverse Event|1|||
48787615|NCT02605954|157063451|FG000|Overall Study|Investigator's Discretion|1|||
48787616|NCT02605954|157063452|FG001|Overall Study|Investigator's Discretion|0|||
48787617|NCT02605954|157063451|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48787618|NCT02605954|157063452|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48787619|NCT02605954|157063451|FG000|Overall Study|Withdrew Consent|2|||
48787620|NCT02605954|157063452|FG001|Overall Study|Withdrew Consent|2|||
48787621|NCT02605954|157063451|FG000|Overall Study|Lost to Follow-up|3|||
48787622|NCT02605954|157063452|FG001|Overall Study|Lost to Follow-up|0|||
48787623|NCT02605954|157063451|FG000|Overall Study|Randomized but not treated|0|||
48787624|NCT02605954|157063452|FG001|Overall Study|Randomized but not treated|1|||
48787625|NCT04739956|157063480|FG000|Overall Study|Withdrawal by Subject|1|||
48787626|NCT04739956|157063481|FG001|Overall Study|Withdrawal by Subject|1|||
48787627|NCT05794243|157063482|FG000|Overall Study|Withdrawal by Subject|1|||
48787628|NCT05794243|157063483|FG001|Overall Study|Withdrawal by Subject|0|||
48787629|NCT05794243|157063484|FG002|Overall Study|Withdrawal by Subject|1|||
48787630|NCT05794243|157063482|FG000|Overall Study|Physician Decision|0|||
48787631|NCT05794243|157063483|FG001|Overall Study|Physician Decision|3|||
48787632|NCT05794243|157063484|FG002|Overall Study|Physician Decision|1|||
48787633|NCT03150173|157063485|FG000|Overall Study|Lost to Follow-up|13|||
48787634|NCT03150173|157063486|FG001|Overall Study|Lost to Follow-up|5|||
48787635|NCT03133546|157063487|FG000|Overall Study|Death|46|||
48787636|NCT03133546|157063488|FG001|Overall Study|Death|43|||
48787637|NCT03133546|157063487|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
48787638|NCT03133546|157063488|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
48787639|NCT04979442|157063489|FG000|Overall Study|Death|43|||
48787640|NCT04979442|157063490|FG001|Overall Study|Death|30|||
48787641|NCT04979442|157063489|FG000|Overall Study|Withdrawal by Subject|8|||
48787642|NCT04979442|157063490|FG001|Overall Study|Withdrawal by Subject|13|||
48787643|NCT04979442|157063489|FG000|Overall Study|Physician Decision|1|||
48787644|NCT04979442|157063490|FG001|Overall Study|Physician Decision|1|||
48787645|NCT04979442|157063489|FG000|Overall Study|Lost to Follow-up|0|||
48787646|NCT04979442|157063490|FG001|Overall Study|Lost to Follow-up|2|||
48787647|NCT04979442|157063489|FG000|Overall Study|do not want to continue|0|||
48787648|NCT04979442|157063490|FG001|Overall Study|do not want to continue|1|||
48787649|NCT00833989|157063494|FG000|Overall Study|Physician Decision|0|||
48787650|NCT00833989|157063495|FG001|Overall Study|Physician Decision|0|||
48787651|NCT00833989|157063496|FG002|Overall Study|Physician Decision|0|||
48787652|NCT00833989|157063497|FG003|Overall Study|Physician Decision|1|||
48787653|NCT00833989|157063494|FG000|Overall Study|Withdrawal by Subject|3|||
48787654|NCT00833989|157063495|FG001|Overall Study|Withdrawal by Subject|0|||
48787655|NCT00833989|157063496|FG002|Overall Study|Withdrawal by Subject|1|||
48787656|NCT00833989|157063497|FG003|Overall Study|Withdrawal by Subject|1|||
48787657|NCT01949480|157063498|FG000|Overall Study|Physician Decision|5|||
48787658|NCT01949480|157063499|FG001|Overall Study|Physician Decision|8|||
48787659|NCT04053764|157063500|FG000|Overall Study|Withdrawal by Subject|6|||
48787660|NCT04053764|157063501|FG001|Overall Study|Withdrawal by Subject|2|||
48787661|NCT04053764|157063500|FG000|Overall Study|Physician Decision|2|||
48787662|NCT04053764|157063501|FG001|Overall Study|Physician Decision|1|||
48787663|NCT04053764|157063500|FG000|Overall Study|Adverse Event|1|||
48787664|NCT04053764|157063501|FG001|Overall Study|Adverse Event|0|||
48787665|NCT04053764|157063500|FG000|Overall Study|Pregnancy|1|||
48787666|NCT04053764|157063501|FG001|Overall Study|Pregnancy|0|||
48787667|NCT03998618|157063502|FG000|Overall Study|Death|7|||
48787668|NCT03998618|157063503|FG001|Overall Study|Death|11|||
48787669|NCT03998618|157063502|FG000|Overall Study|hospice enrollment|3|||
48787670|NCT03998618|157063503|FG001|Overall Study|hospice enrollment|3|||
48787671|NCT03998618|157063502|FG000|Overall Study|Not feeling well/health problems|3|||
48787672|NCT03998618|157063503|FG001|Overall Study|Not feeling well/health problems|5|||
48787673|NCT03998618|157063502|FG000|Overall Study|Lost to Follow-up|6|||
48787674|NCT03998618|157063503|FG001|Overall Study|Lost to Follow-up|6|||
48787675|NCT03998618|157063502|FG000|Overall Study|Withdrawal by Subject|0|||
48787676|NCT03998618|157063503|FG001|Overall Study|Withdrawal by Subject|4|||
48787677|NCT01910129|157063508|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
48787678|NCT01910129|157063509|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
48787679|NCT01910129|157063510|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
48787680|NCT01910129|157063508|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
48787681|NCT01910129|157063509|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
48787682|NCT01910129|157063510|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
48787683|NCT04313634|157063511|FG000|Overall Study|Adverse Event|2|||
48787684|NCT04313634|157063512|FG001|Overall Study|Adverse Event|2|||
48787685|NCT04313634|157063513|FG002|Overall Study|Adverse Event|0|||
48400690|NCT02469090|155657792|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
48787686|NCT04313634|157063511|FG000|Overall Study|Withdrawal by Subject|1|||
48787687|NCT04313634|157063512|FG001|Overall Study|Withdrawal by Subject|0|||
48787688|NCT04313634|157063513|FG002|Overall Study|Withdrawal by Subject|1|||
48787689|NCT04313634|157063511|FG000|Overall Study|Protocol Violation|0|||
48787690|NCT04313634|157063512|FG001|Overall Study|Protocol Violation|0|||
48787691|NCT04313634|157063513|FG002|Overall Study|Protocol Violation|1|||
48787692|NCT00319098|157063514|FG000|Overall Study|Serious adverse event|3|||
48787693|NCT00319098|157063515|FG001|Overall Study|Serious adverse event|0|||
48787694|NCT00319098|157063514|FG000|Overall Study|Adverse Event|20|||
48787695|NCT00319098|157063515|FG001|Overall Study|Adverse Event|1|||
48787696|NCT00319098|157063514|FG000|Overall Study|Withdrawal by Subject|37|||
48787697|NCT00319098|157063515|FG001|Overall Study|Withdrawal by Subject|8|||
48787698|NCT00319098|157063514|FG000|Overall Study|Migrated/moved from study area|2|||
48787699|NCT00319098|157063515|FG001|Overall Study|Migrated/moved from study area|1|||
48787700|NCT00319098|157063514|FG000|Overall Study|Lost to Follow-up|37|||
48787701|NCT00319098|157063515|FG001|Overall Study|Lost to Follow-up|13|||
48787702|NCT00319098|157063514|FG000|Overall Study|Others|33|||
48787703|NCT00319098|157063515|FG001|Overall Study|Others|8|||
48787704|NCT00319098|157063514|FG000|Overall Study|Protocol Violation|3|||
48787705|NCT00319098|157063515|FG001|Overall Study|Protocol Violation|1|||
48787706|NCT03585244|157063518|FG000|Overall Study|Withdrawal by Subject|15|||
48787707|NCT06281548|157063519|FG000|Overall Study|Lost to Follow-up|3|||
48787708|NCT01618838|157063520|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
48787709|NCT00700401|157063525|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
48787710|NCT00700401|157063525|FG000|Overall Study|Adverse Event|5|||
48787711|NCT00700401|157063525|FG000|Overall Study|Refused Treatment|2|||
48787712|NCT00700401|157063525|FG000|Overall Study|Lost to Follow-up|1|||
48787713|NCT00700401|157063525|FG000|Overall Study|Treatment never started|1|||
48787714|NCT00700401|157063525|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
48787715|NCT00700401|157063525|FG000|Overall Study|Withdrawal by Subject|2|||
48787716|NCT02717507|157063526|FG000|Overall Study|Lost to Follow-up|5|||
48787717|NCT02717507|157063527|FG001|Overall Study|Lost to Follow-up|8|||
48787718|NCT02717507|157063526|FG000|Overall Study|Pregnancy|1|||
48787719|NCT02717507|157063527|FG001|Overall Study|Pregnancy|1|||
48787720|NCT02717507|157063526|FG000|Overall Study|Protocol Violation|2|||
48787721|NCT02717507|157063527|FG001|Overall Study|Protocol Violation|2|||
48787722|NCT02717507|157063526|FG000|Overall Study|Withdrawal by Subject|20|||
48787723|NCT02717507|157063527|FG001|Overall Study|Withdrawal by Subject|20|||
48787724|NCT02717507|157063526|FG000|Overall Study|Relapse|1|||
48787725|NCT02717507|157063527|FG001|Overall Study|Relapse|1|||
48787726|NCT02717507|157063526|FG000|Overall Study|Cardiac Event|2|||
48787727|NCT02717507|157063527|FG001|Overall Study|Cardiac Event|6|||
48787728|NCT00295750|157063528|FG000|Overall Study|Adverse Event|19|||
48787729|NCT00295750|157063529|FG001|Overall Study|Adverse Event|15|||
48787730|NCT00295750|157063530|FG002|Overall Study|Adverse Event|12|||
48787731|NCT00295750|157063528|FG000|Overall Study|Lack of Efficacy|1|||
48787732|NCT00295750|157063529|FG001|Overall Study|Lack of Efficacy|1|||
48787733|NCT00295750|157063530|FG002|Overall Study|Lack of Efficacy|0|||
48787734|NCT00295750|157063528|FG000|Overall Study|Lost to Follow-up|1|||
48787735|NCT00295750|157063529|FG001|Overall Study|Lost to Follow-up|4|||
48787736|NCT00295750|157063530|FG002|Overall Study|Lost to Follow-up|1|||
48787737|NCT00295750|157063528|FG000|Overall Study|Taking prohibited therapy|2|||
48787738|NCT00295750|157063529|FG001|Overall Study|Taking prohibited therapy|3|||
48787739|NCT00295750|157063530|FG002|Overall Study|Taking prohibited therapy|2|||
48787740|NCT00295750|157063528|FG000|Overall Study|Administrative errors|2|||
48787741|NCT00295750|157063529|FG001|Overall Study|Administrative errors|4|||
48787742|NCT00295750|157063530|FG002|Overall Study|Administrative errors|5|||
48787743|NCT00295750|157063528|FG000|Overall Study|Trial drug errors|1|||
48787744|NCT00295750|157063529|FG001|Overall Study|Trial drug errors|1|||
48787745|NCT00295750|157063530|FG002|Overall Study|Trial drug errors|0|||
48787746|NCT00295750|157063528|FG000|Overall Study|Disease progression|2|||
48787747|NCT00295750|157063529|FG001|Overall Study|Disease progression|1|||
48787748|NCT00295750|157063530|FG002|Overall Study|Disease progression|0|||
48787749|NCT00295750|157063528|FG000|Overall Study|Personal reasons|0|||
48787750|NCT00295750|157063529|FG001|Overall Study|Personal reasons|1|||
48787751|NCT00295750|157063530|FG002|Overall Study|Personal reasons|0|||
48787752|NCT00295750|157063528|FG000|Overall Study|Randomized but never received trial drug|4|||
48787753|NCT00295750|157063529|FG001|Overall Study|Randomized but never received trial drug|3|||
48787754|NCT00295750|157063530|FG002|Overall Study|Randomized but never received trial drug|3|||
48787755|NCT00295750|157063528|FG000|Overall Study|Withdrawal by Subject|9|||
48787756|NCT00295750|157063529|FG001|Overall Study|Withdrawal by Subject|4|||
48787757|NCT00295750|157063530|FG002|Overall Study|Withdrawal by Subject|7|||
48787758|NCT00295750|157063528|FG000|Overall Study|Protocol Violation|2|||
48787759|NCT00295750|157063529|FG001|Overall Study|Protocol Violation|4|||
48787760|NCT00295750|157063530|FG002|Overall Study|Protocol Violation|2|||
48787761|NCT03835533|157063541|FG000|Overall Study|Death|5|||
48787762|NCT03835533|157063542|FG001|Overall Study|Death|10|||
48430347|NCT00696657|155763701|FG001|Overall Study|Withdrawal criteria|3|||
48787763|NCT03835533|157063543|FG002|Overall Study|Death|9|||
48787764|NCT03835533|157063541|FG000|Overall Study|Withdrawal by Subject|2|||
48787765|NCT03835533|157063542|FG001|Overall Study|Withdrawal by Subject|2|||
48787766|NCT03835533|157063543|FG002|Overall Study|Withdrawal by Subject|2|||
48787767|NCT03835533|157063541|FG000|Overall Study|Lost to Follow-up|1|||
48787768|NCT03835533|157063542|FG001|Overall Study|Lost to Follow-up|0|||
48787769|NCT03835533|157063543|FG002|Overall Study|Lost to Follow-up|0|||
48787770|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
48787771|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
48787772|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
48787773|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
48787774|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
48787775|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
48787776|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
48787777|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
48787778|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
48787779|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
48787780|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
48787781|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
48787782|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
48787783|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
48787784|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
48787785|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48787786|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48787787|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48787788|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48787789|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48787790|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
48787791|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
48787792|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
48787793|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
48787794|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
48787795|NCT03152552|157063544|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
48787796|NCT03152552|157063545|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
48787797|NCT03152552|157063546|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
48787798|NCT03152552|157063547|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
48787799|NCT03152552|157063548|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
48787800|NCT03152552|157063544|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
48787801|NCT03152552|157063545|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
48787802|NCT03152552|157063546|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
48787803|NCT03152552|157063547|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
48787804|NCT03152552|157063548|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
48787805|NCT04757753|157063552|FG000|Overall Study|Lost to Follow-up|7|||
48787806|NCT04757753|157063553|FG001|Overall Study|Lost to Follow-up|7|||
48787807|NCT04757753|157063552|FG000|Overall Study|Withdrawal by Subject|0|||
48787808|NCT04757753|157063553|FG001|Overall Study|Withdrawal by Subject|3|||
48787809|NCT04757753|157063552|FG000|Overall Study|Endodontic treatment failure|1|||
48787810|NCT04757753|157063553|FG001|Overall Study|Endodontic treatment failure|2|||
48787811|NCT04757753|157063552|FG000|Overall Study|Tooth fracture/extraction|3|||
48787812|NCT04757753|157063553|FG001|Overall Study|Tooth fracture/extraction|0|||
48787813|NCT03249090|157063554|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
48787814|NCT03249090|157063555|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
48787815|NCT03249090|157063554|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
48787816|NCT03249090|157063555|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
48787817|NCT03249090|157063554|FG000|3 Month Time Point|Voluntary withdrawal|6|||
48787818|NCT03249090|157063555|FG001|3 Month Time Point|Voluntary withdrawal|3|||
48787819|NCT03249090|157063554|FG000|3 Month Time Point|Changed oncology practice|4|||
48787820|NCT03249090|157063555|FG001|3 Month Time Point|Changed oncology practice|2|||
48787821|NCT03249090|157063554|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
48787822|NCT03249090|157063555|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
48787823|NCT03249090|157063554|FG000|12 Month Time Point|Voluntary withdrawal|35|||
48787824|NCT03249090|157063555|FG001|12 Month Time Point|Voluntary withdrawal|4|||
48787825|NCT03249090|157063554|FG000|12 Month Time Point|Changed oncology practice|20|||
48787826|NCT03249090|157063555|FG001|12 Month Time Point|Changed oncology practice|9|||
48787827|NCT02717611|157063556|FG000|Overall Study|Death|13|||
48787828|NCT02717611|157063556|FG000|Overall Study|Withdrawal by Subject|6|||
48787829|NCT02717611|157063556|FG000|Overall Study|Active, not recruiting|40|||
48400691|NCT02469090|155657793|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
48787830|NCT02717611|157063556|FG000|Overall Study|Complicating disease|1|||
48787831|NCT02372409|157063557|FG000|Overall Study|Lost to Follow-up|1|||
48787832|NCT02372409|157063558|FG001|Overall Study|Lost to Follow-up|0|||
48787833|NCT02372409|157063557|FG000|Overall Study|Disease progression|1|||
48787834|NCT02372409|157063558|FG001|Overall Study|Disease progression|1|||
48787835|NCT04157348|157063559|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
48787836|NCT04157348|157063560|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
48787837|NCT04157348|157063559|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
48787838|NCT04157348|157063560|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
48787839|NCT04157348|157063559|FG000|Double-blind Treatment Period|Adverse Event|0|||
48787840|NCT04157348|157063560|FG001|Double-blind Treatment Period|Adverse Event|1|||
48787841|NCT04157348|157063559|FG000|Open-label Extension Period|Adverse Event|1|||
48787842|NCT04157348|157063560|FG001|Open-label Extension Period|Adverse Event|1|||
48787843|NCT04157348|157063559|FG000|Open-label Extension Period|Death|0|||
48787844|NCT04157348|157063560|FG001|Open-label Extension Period|Death|1|||
48787845|NCT04157348|157063559|FG000|Open-label Extension Period|Lack of Efficacy|2|||
48787846|NCT04157348|157063560|FG001|Open-label Extension Period|Lack of Efficacy|2|||
48787847|NCT04157348|157063559|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
48787848|NCT04157348|157063560|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
48787849|NCT04157348|157063559|FG000|Open-label Extension Period|Ongoing|60|||
48787850|NCT04157348|157063560|FG001|Open-label Extension Period|Ongoing|57|||
48787851|NCT04157348|157063559|FG000|Open-label Extension Period|other reasons|1|||
48787852|NCT04157348|157063560|FG001|Open-label Extension Period|other reasons|1|||
48787853|NCT03325712|157063565|FG000|Overall Study|Protocol Violation|0|||
48787854|NCT03325712|157063566|FG001|Overall Study|Protocol Violation|0|||
48787855|NCT03325712|157063567|FG002|Overall Study|Protocol Violation|0|||
48400692|NCT02469090|155657794|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
48400693|NCT02469090|155657792|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
48400694|NCT02469090|155657793|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
48400695|NCT02469090|155657794|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
48400696|NCT02469090|155657792|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
48400697|NCT02469090|155657793|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
48400698|NCT02469090|155657794|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
48400699|NCT02469090|155657792|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
48400700|NCT02469090|155657793|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
48400701|NCT02469090|155657794|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
48400702|NCT02469090|155657792|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
48400703|NCT02469090|155657793|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
48400704|NCT02469090|155657794|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
48400705|NCT02469090|155657792|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
48400706|NCT02469090|155657793|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
48400707|NCT02469090|155657794|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
48400708|NCT00957008|155657798|FG000|Overall Study|Withdrawal by Subject|13|||
48400709|NCT00957008|155657799|FG001|Overall Study|Withdrawal by Subject|10|||
48400710|NCT00957008|155657800|FG002|Overall Study|Withdrawal by Subject|12|||
48400711|NCT00957008|155657801|FG003|Overall Study|Withdrawal by Subject|16|||
48400712|NCT00957008|155657798|FG000|Overall Study|Lost to Follow-up|3|||
48400713|NCT00957008|155657799|FG001|Overall Study|Lost to Follow-up|1|||
48787856|NCT03325712|157063568|FG003|Overall Study|Protocol Violation|0|||
48787857|NCT03325712|157063569|FG004|Overall Study|Protocol Violation|1|||
48787858|NCT03325712|157063570|FG005|Overall Study|Protocol Violation|0|||
48787859|NCT03325712|157063571|FG006|Overall Study|Protocol Violation|0|||
48787860|NCT03325712|157063572|FG007|Overall Study|Protocol Violation|0|||
48787861|NCT03325712|157063565|FG000|Overall Study|Adverse Event|0|||
48787862|NCT03325712|157063566|FG001|Overall Study|Adverse Event|0|||
48787863|NCT03325712|157063567|FG002|Overall Study|Adverse Event|0|||
48787864|NCT03325712|157063568|FG003|Overall Study|Adverse Event|0|||
48787865|NCT03325712|157063569|FG004|Overall Study|Adverse Event|1|||
48787866|NCT03325712|157063570|FG005|Overall Study|Adverse Event|0|||
48787867|NCT03325712|157063571|FG006|Overall Study|Adverse Event|0|||
48787868|NCT03325712|157063572|FG007|Overall Study|Adverse Event|0|||
48787869|NCT03550313|157063573|FG000|Overall Study|Adverse Event|0|||
48787870|NCT03550313|157063574|FG001|Overall Study|Adverse Event|1|||
48787871|NCT03550313|157063575|FG002|Overall Study|Adverse Event|0|||
48787872|NCT03550313|157063573|FG000|Overall Study|Lost to Follow-up|5|||
48787873|NCT03550313|157063574|FG001|Overall Study|Lost to Follow-up|7|||
48787874|NCT03550313|157063575|FG002|Overall Study|Lost to Follow-up|12|||
48787875|NCT03550313|157063573|FG000|Overall Study|Study terminated by sponsor|44|||
48400714|NCT00957008|155657800|FG002|Overall Study|Lost to Follow-up|3|||
48400715|NCT00957008|155657801|FG003|Overall Study|Lost to Follow-up|4|||
48400716|NCT00957008|155657798|FG000|Overall Study|Physician Decision|1|||
48400717|NCT00957008|155657799|FG001|Overall Study|Physician Decision|0|||
48400718|NCT00957008|155657800|FG002|Overall Study|Physician Decision|1|||
48400719|NCT00957008|155657801|FG003|Overall Study|Physician Decision|1|||
48400720|NCT00957008|155657798|FG000|Overall Study|Relocated; Family conflict|4|||
48787876|NCT03550313|157063574|FG001|Overall Study|Study terminated by sponsor|37|||
48787877|NCT03550313|157063575|FG002|Overall Study|Study terminated by sponsor|48|||
48787878|NCT03550313|157063573|FG000|Overall Study|No longer met eligibility criteria|3|||
48400721|NCT00957008|155657799|FG001|Overall Study|Relocated; Family conflict|1|||
48400722|NCT00957008|155657800|FG002|Overall Study|Relocated; Family conflict|1|||
48400723|NCT00957008|155657801|FG003|Overall Study|Relocated; Family conflict|3|||
48400724|NCT01425203|155657802|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
48400725|NCT01425203|155657803|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
48400726|NCT01425203|155657804|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
48400727|NCT01425203|155657802|FG000|Treatment Phase|Failure at futility timepoint|8|||
48400728|NCT01425203|155657803|FG001|Treatment Phase|Failure at futility timepoint|27|||
48400729|NCT01425203|155657804|FG002|Treatment Phase|Failure at futility timepoint|0|||
48400730|NCT01425203|155657802|FG000|Treatment Phase|Other virologic failure criteria|5|||
48400731|NCT01425203|155657803|FG001|Treatment Phase|Other virologic failure criteria|3|||
48400732|NCT01425203|155657804|FG002|Treatment Phase|Other virologic failure criteria|0|||
48400733|NCT01425203|155657802|FG000|Treatment Phase|Unidentified reasons|11|||
48400734|NCT01425203|155657803|FG001|Treatment Phase|Unidentified reasons|5|||
48400735|NCT01425203|155657804|FG002|Treatment Phase|Unidentified reasons|0|||
48400736|NCT01425203|155657802|FG000|Treatment Phase|Did not receive treatment|0|||
48400737|NCT01425203|155657803|FG001|Treatment Phase|Did not receive treatment|1|||
48400738|NCT01425203|155657804|FG002|Treatment Phase|Did not receive treatment|0|||
48400739|NCT01425203|155657802|FG000|Crossover Phase|Failure at futility timepoint|0|||
48400740|NCT01425203|155657803|FG001|Crossover Phase|Failure at futility timepoint|0|||
48400741|NCT01425203|155657804|FG002|Crossover Phase|Failure at futility timepoint|3|||
48400742|NCT01425203|155657802|FG000|Crossover Phase|Other virologic failure criteria|0|||
48400743|NCT01425203|155657803|FG001|Crossover Phase|Other virologic failure criteria|0|||
48400744|NCT01425203|155657804|FG002|Crossover Phase|Other virologic failure criteria|3|||
48400745|NCT02559687|155657805|FG000|Overall Study|Death|112|||
48400746|NCT02559687|155657805|FG000|Overall Study|Sponsor Decision|5|||
48400747|NCT02559687|155657805|FG000|Overall Study|Withdrawal by Subject|4|||
48400748|NCT02926209|155657806|FG000|Study Cohort|Poor Bowel Preparation|1|||
48400749|NCT02926209|155657807|FG001|Study Cohort|Poor Bowel Preparation|0|||
48400750|NCT01098071|155657809|FG000|Overall Study|Surgery (adenoidectomy)|2|||
48400751|NCT01098071|155657809|FG000|Overall Study|Lost to Follow-up|13|||
48400752|NCT01857869|155657814|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
48787879|NCT03550313|157063574|FG001|Overall Study|No longer met eligibility criteria|5|||
48787880|NCT03550313|157063575|FG002|Overall Study|No longer met eligibility criteria|6|||
48787881|NCT03550313|157063573|FG000|Overall Study|Withdrawal by parent/guardian|20|||
48787882|NCT03550313|157063574|FG001|Overall Study|Withdrawal by parent/guardian|18|||
48787883|NCT03550313|157063575|FG002|Overall Study|Withdrawal by parent/guardian|26|||
48787884|NCT03550313|157063573|FG000|Overall Study|Other|4|||
48787885|NCT03550313|157063574|FG001|Overall Study|Other|2|||
48787886|NCT03550313|157063575|FG002|Overall Study|Other|2|||
48787887|NCT03550313|157063573|FG000|Overall Study|Randomized but not vaccinated|3|||
48787888|NCT03550313|157063574|FG001|Overall Study|Randomized but not vaccinated|23|||
48787889|NCT03550313|157063575|FG002|Overall Study|Randomized but not vaccinated|2|||
48787890|NCT03550313|157063573|FG000|Overall Study|Sites terminated due to quality issues|18|||
48787891|NCT03550313|157063574|FG001|Overall Study|Sites terminated due to quality issues|17|||
48787892|NCT03550313|157063575|FG002|Overall Study|Sites terminated due to quality issues|18|||
48787893|NCT04656847|157063576|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
48787894|NCT00839072|157063577|FG000|First Intervention Period|Withdrawal by Subject|1|||
48787895|NCT00839072|157063578|FG001|First Intervention Period|Withdrawal by Subject|0|||
48787896|NCT00839072|157063577|FG000|First Intervention Period|Adverse Event|1|||
48787897|NCT00839072|157063578|FG001|First Intervention Period|Adverse Event|1|||
48787898|NCT00839072|157063577|FG000|Second Intervention Period|Withdrawal by Subject|1|||
48787899|NCT00839072|157063578|FG001|Second Intervention Period|Withdrawal by Subject|0|||
48787900|NCT01297062|157063580|FG000|Overall Study|Adverse Event|2|||
48787901|NCT01297062|157063581|FG001|Overall Study|Adverse Event|0|||
48787902|NCT01297062|157063582|FG002|Overall Study|Adverse Event|1|||
48787903|NCT01297062|157063583|FG003|Overall Study|Adverse Event|0|||
48787904|NCT01297062|157063584|FG004|Overall Study|Adverse Event|0|||
48787905|NCT01297062|157063585|FG005|Overall Study|Adverse Event|0|||
48787906|NCT01297062|157063586|FG006|Overall Study|Adverse Event|0|||
48787907|NCT01297062|157063580|FG000|Overall Study|Physician Decision|1|||
48400753|NCT01857869|155657815|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
48400754|NCT01857869|155657816|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
48400755|NCT01857869|155657817|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
48400756|NCT01857869|155657818|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
48787908|NCT01297062|157063581|FG001|Overall Study|Physician Decision|0|||
48787909|NCT01297062|157063582|FG002|Overall Study|Physician Decision|1|||
48787910|NCT01297062|157063583|FG003|Overall Study|Physician Decision|0|||
48787911|NCT01297062|157063584|FG004|Overall Study|Physician Decision|0|||
48787912|NCT01297062|157063585|FG005|Overall Study|Physician Decision|0|||
48787913|NCT01297062|157063586|FG006|Overall Study|Physician Decision|6|||
48787914|NCT01297062|157063580|FG000|Overall Study|Protocol Violation|0|||
48787915|NCT01297062|157063581|FG001|Overall Study|Protocol Violation|0|||
48787916|NCT01297062|157063582|FG002|Overall Study|Protocol Violation|0|||
48787917|NCT01297062|157063583|FG003|Overall Study|Protocol Violation|0|||
48787918|NCT01297062|157063584|FG004|Overall Study|Protocol Violation|1|||
48787919|NCT01297062|157063585|FG005|Overall Study|Protocol Violation|0|||
48787920|NCT01297062|157063586|FG006|Overall Study|Protocol Violation|0|||
48787921|NCT01297062|157063580|FG000|Overall Study|Subject Decision|1|||
48787922|NCT01297062|157063581|FG001|Overall Study|Subject Decision|1|||
48787923|NCT01297062|157063582|FG002|Overall Study|Subject Decision|0|||
48787924|NCT01297062|157063583|FG003|Overall Study|Subject Decision|1|||
48787925|NCT01297062|157063584|FG004|Overall Study|Subject Decision|1|||
48787926|NCT01297062|157063585|FG005|Overall Study|Subject Decision|1|||
48787927|NCT01297062|157063586|FG006|Overall Study|Subject Decision|2|||
48787928|NCT01196975|157063587|FG000|Overall Study|Adverse Event|2|||
48787929|NCT01196975|157063588|FG001|Overall Study|Adverse Event|2|||
48787930|NCT01196975|157063589|FG002|Overall Study|Adverse Event|0|||
48787931|NCT01196975|157063590|FG003|Overall Study|Adverse Event|0|||
48787932|NCT01196975|157063591|FG004|Overall Study|Adverse Event|2|||
48787933|NCT01196975|157063587|FG000|Overall Study|Withdrawal by Subject|2|||
48787934|NCT01196975|157063588|FG001|Overall Study|Withdrawal by Subject|1|||
48787935|NCT01196975|157063589|FG002|Overall Study|Withdrawal by Subject|0|||
48787936|NCT01196975|157063590|FG003|Overall Study|Withdrawal by Subject|1|||
48787937|NCT01196975|157063591|FG004|Overall Study|Withdrawal by Subject|0|||
48787938|NCT01196975|157063587|FG000|Overall Study|Lost to Follow-up|11|||
48787939|NCT01196975|157063588|FG001|Overall Study|Lost to Follow-up|6|||
48787940|NCT01196975|157063589|FG002|Overall Study|Lost to Follow-up|5|||
48787941|NCT01196975|157063590|FG003|Overall Study|Lost to Follow-up|5|||
48787942|NCT01196975|157063591|FG004|Overall Study|Lost to Follow-up|11|||
48787943|NCT01664078|157063594|FG000|Overall Study|Death|9|||
48787944|NCT01664078|157063594|FG000|Overall Study|Withdrawal by Subject|4|||
48787945|NCT01664078|157063594|FG000|Overall Study|Lost to Follow-up|2|||
48787946|NCT01664078|157063594|FG000|Overall Study|missed 5 year visit|1|||
48787947|NCT01664078|157063594|FG000|Overall Study|Other|53|||
48787948|NCT03743038|157063595|FG000|Overall Study|Physician Decision|1|||
48787949|NCT03674177|157063596|FG000|Overall Study|Lost to Follow-up|2|||
48787950|NCT03674177|157063597|FG001|Overall Study|Lost to Follow-up|1|||
48787951|NCT03674177|157063598|FG002|Overall Study|Lost to Follow-up|0|||
48787952|NCT03674177|157063599|FG003|Overall Study|Lost to Follow-up|2|||
48787953|NCT00360529|157063603|FG000|Overall Study|Adverse Event|10|||
48787954|NCT00360529|157063604|FG001|Overall Study|Adverse Event|23|||
48787955|NCT00360529|157063605|FG002|Overall Study|Adverse Event|33|||
48787956|NCT00360529|157063603|FG000|Overall Study|Protocol Violation|3|||
48787957|NCT00360529|157063604|FG001|Overall Study|Protocol Violation|3|||
48787958|NCT00360529|157063605|FG002|Overall Study|Protocol Violation|11|||
48787959|NCT00360529|157063603|FG000|Overall Study|Lost to Follow-up|14|||
48787960|NCT00360529|157063604|FG001|Overall Study|Lost to Follow-up|10|||
48787961|NCT00360529|157063605|FG002|Overall Study|Lost to Follow-up|13|||
48787962|NCT00360529|157063603|FG000|Overall Study|Withdrawal by Subject|22|||
48787963|NCT00360529|157063604|FG001|Overall Study|Withdrawal by Subject|14|||
48787964|NCT00360529|157063605|FG002|Overall Study|Withdrawal by Subject|18|||
48787965|NCT00360529|157063603|FG000|Overall Study|Lack of Efficacy|8|||
48787966|NCT00360529|157063604|FG001|Overall Study|Lack of Efficacy|6|||
48787967|NCT00360529|157063605|FG002|Overall Study|Lack of Efficacy|5|||
48787968|NCT00360529|157063603|FG000|Overall Study|Reason discontinued not explained above|4|||
48787969|NCT00360529|157063604|FG001|Overall Study|Reason discontinued not explained above|9|||
48787970|NCT00360529|157063605|FG002|Overall Study|Reason discontinued not explained above|11|||
48787971|NCT00744653|157063606|FG000|Overall Study|antineoplastic treatment|11|||
48787972|NCT00744653|157063606|FG000|Overall Study|Death|1|||
48787973|NCT00744653|157063606|FG000|Overall Study|Lost to Follow-up|1|||
48787974|NCT00744653|157063606|FG000|Overall Study|Physician Decision|3|||
48787975|NCT03826667|157063607|FG000|Overall Study|Protocol deviation|21|||
48787976|NCT00808808|157063609|FG000|Overall Study|Vaccinated; survey not completed|131|||
48787977|NCT00808808|157063610|FG001|Overall Study|Vaccinated; survey not completed|169|||
48787978|NCT00808808|157063611|FG002|Overall Study|Vaccinated; survey not completed|302|||
48787979|NCT00808808|157063609|FG000|Overall Study|Employee was not vaccinated.|2686|||
48787980|NCT00808808|157063610|FG001|Overall Study|Employee was not vaccinated.|2268|||
48787981|NCT00808808|157063611|FG002|Overall Study|Employee was not vaccinated.|2255|||
48787982|NCT02012491|157063613|FG000|Overall Study|Lost to Follow-up|1|||
48787983|NCT02012491|157063614|FG001|Overall Study|Lost to Follow-up|0|||
48787984|NCT02012491|157063613|FG000|Overall Study|Protocol Violation|0|||
48400757|NCT01857869|155657819|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
48400758|NCT01857869|155657820|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
48787985|NCT02012491|157063614|FG001|Overall Study|Protocol Violation|1|||
48787986|NCT02012491|157063613|FG000|Overall Study|Withdrawal by Subject|1|||
48787987|NCT02012491|157063614|FG001|Overall Study|Withdrawal by Subject|0|||
48787988|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
48787989|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
48787990|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
48787991|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
48787992|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
48787993|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
48787994|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
48787995|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
48787996|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
48787997|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
48787998|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
48787999|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
48788000|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
48788001|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
48788002|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
48788003|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
48788004|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
48788005|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
48788006|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
48788007|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
48788008|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
48788009|NCT01781572|157063617|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
48788010|NCT01781572|157063618|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
48788011|NCT01781572|157063619|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
48788012|NCT01781572|157063617|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
48788013|NCT01781572|157063618|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
48788014|NCT01781572|157063619|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
48788015|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
48788016|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
48788017|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
48788018|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
48788019|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
48400759|NCT01857869|155657821|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
48400760|NCT01857869|155657822|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
48788020|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
48788021|NCT01781572|157063617|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
48788022|NCT01781572|157063618|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
48788023|NCT01781572|157063619|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
48788024|NCT01781572|157063617|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
48788025|NCT01781572|157063618|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
48788026|NCT01781572|157063619|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
48788027|NCT01781572|157063617|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
48788028|NCT01781572|157063618|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
48788029|NCT01781572|157063619|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
48788030|NCT01781572|157063617|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
48788031|NCT01781572|157063618|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
48788032|NCT01781572|157063619|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
48788033|NCT01781572|157063617|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
48788034|NCT01781572|157063618|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
48400761|NCT01857869|155657823|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
48400762|NCT01857869|155657814|FG000|Primary/Challenge Phase|Pregnancy|1|||
48400763|NCT01857869|155657815|FG001|Primary/Challenge Phase|Pregnancy|0|||
48400764|NCT01857869|155657816|FG002|Primary/Challenge Phase|Pregnancy|0|||
48400765|NCT01857869|155657817|FG003|Primary/Challenge Phase|Pregnancy|0|||
48400766|NCT01857869|155657818|FG004|Primary/Challenge Phase|Pregnancy|0|||
48400767|NCT01857869|155657819|FG005|Primary/Challenge Phase|Pregnancy|0|||
48400768|NCT01857869|155657820|FG006|Primary/Challenge Phase|Pregnancy|0|||
48400769|NCT01857869|155657821|FG007|Primary/Challenge Phase|Pregnancy|0|||
48788035|NCT01781572|157063619|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
48788036|NCT01781572|157063617|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
48788037|NCT01781572|157063618|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
48788038|NCT01781572|157063619|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
48788039|NCT01781572|157063617|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
48788040|NCT01781572|157063618|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
48788041|NCT01781572|157063619|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
48788042|NCT05557942|157063623|FG000|Overall Study|Death|0|||
48788043|NCT05557942|157063624|FG001|Overall Study|Death|0|||
48400770|NCT01857869|155657822|FG008|Primary/Challenge Phase|Pregnancy|0|||
48400771|NCT01857869|155657823|FG009|Primary/Challenge Phase|Pregnancy|0|||
48400772|NCT01857869|155657814|FG000|Primary/Challenge Phase|Protocol Violation|1|||
48430348|NCT00696657|155763702|FG002|Overall Study|Withdrawal criteria|2|||
48788044|NCT05557942|157063625|FG002|Overall Study|Death|0|||
48788045|NCT05557942|157063626|FG003|Overall Study|Death|2|||
48788046|NCT05557942|157063627|FG004|Overall Study|Death|1|||
48788047|NCT05557942|157063628|FG005|Overall Study|Death|1|||
48788048|NCT05557942|157063623|FG000|Overall Study|Physician Decision|1|||
48788049|NCT05557942|157063624|FG001|Overall Study|Physician Decision|1|||
48788050|NCT05557942|157063625|FG002|Overall Study|Physician Decision|2|||
48788051|NCT05557942|157063626|FG003|Overall Study|Physician Decision|3|||
48356781|NCT00903760|155503487|FG000|Overall Study|Withdrawal by Subject|1|||
48356782|NCT00903760|155503488|FG001|Overall Study|Withdrawal by Subject|2|||
48356783|NCT00903760|155503487|FG000|Overall Study|Off treatment for long period|0|||
48356784|NCT00903760|155503488|FG001|Overall Study|Off treatment for long period|1|||
48788052|NCT05557942|157063627|FG004|Overall Study|Physician Decision|0|||
48788053|NCT05557942|157063628|FG005|Overall Study|Physician Decision|2|||
48788054|NCT05557942|157063623|FG000|Overall Study|Study terminated by sponsor|17|||
48788055|NCT05557942|157063624|FG001|Overall Study|Study terminated by sponsor|17|||
48788056|NCT05557942|157063625|FG002|Overall Study|Study terminated by sponsor|14|||
48788057|NCT05557942|157063626|FG003|Overall Study|Study terminated by sponsor|40|||
48788058|NCT05557942|157063627|FG004|Overall Study|Study terminated by sponsor|45|||
48788059|NCT05557942|157063628|FG005|Overall Study|Study terminated by sponsor|37|||
48788060|NCT05557942|157063623|FG000|Overall Study|Protocol Violation|0|||
48788061|NCT05557942|157063624|FG001|Overall Study|Protocol Violation|0|||
48788062|NCT05557942|157063625|FG002|Overall Study|Protocol Violation|0|||
48356785|NCT02388347|155503489|FG000|Overall Study|Withdrawal by Subject|0|||
48356786|NCT02388347|155503490|FG001|Overall Study|Withdrawal by Subject|0|||
48356787|NCT02388347|155503491|FG002|Overall Study|Withdrawal by Subject|1|||
48356788|NCT02388347|155503492|FG003|Overall Study|Withdrawal by Subject|0|||
48356789|NCT02388347|155503493|FG004|Overall Study|Withdrawal by Subject|0|||
48356790|NCT02473965|155503495|FG000|Overall Study|Adverse Event|6|||
48356791|NCT02473965|155503496|FG001|Overall Study|Adverse Event|4|||
48356792|NCT02473965|155503495|FG000|Overall Study|MG worsening|4|||
48356793|NCT02473965|155503496|FG001|Overall Study|MG worsening|1|||
48400773|NCT01857869|155657815|FG001|Primary/Challenge Phase|Protocol Violation|0|||
48400774|NCT01857869|155657816|FG002|Primary/Challenge Phase|Protocol Violation|0|||
48400775|NCT01857869|155657817|FG003|Primary/Challenge Phase|Protocol Violation|0|||
48788063|NCT05557942|157063626|FG003|Overall Study|Protocol Violation|0|||
48788064|NCT05557942|157063627|FG004|Overall Study|Protocol Violation|0|||
48788065|NCT05557942|157063628|FG005|Overall Study|Protocol Violation|1|||
48788066|NCT05557942|157063623|FG000|Overall Study|Withdrawal by Subject|0|||
48788067|NCT05557942|157063624|FG001|Overall Study|Withdrawal by Subject|0|||
48788068|NCT05557942|157063625|FG002|Overall Study|Withdrawal by Subject|0|||
48788069|NCT05557942|157063626|FG003|Overall Study|Withdrawal by Subject|0|||
48788070|NCT05557942|157063627|FG004|Overall Study|Withdrawal by Subject|2|||
48788071|NCT05557942|157063628|FG005|Overall Study|Withdrawal by Subject|0|||
48788072|NCT02693665|157063629|FG000|Overall Study|Death|3|||
48788073|NCT02693665|157063630|FG001|Overall Study|Death|2|||
48788074|NCT02693665|157063629|FG000|Overall Study|Lost to Follow-up|7|||
48788075|NCT02693665|157063630|FG001|Overall Study|Lost to Follow-up|3|||
48788076|NCT02693665|157063629|FG000|Overall Study|Protocol Violation|1|||
48788077|NCT02693665|157063630|FG001|Overall Study|Protocol Violation|0|||
48788078|NCT02693665|157063629|FG000|Overall Study|Withdrawal by Subject|2|||
48788079|NCT02693665|157063630|FG001|Overall Study|Withdrawal by Subject|0|||
48788080|NCT02693665|157063629|FG000|Overall Study|patient wanted to leave it behind|1|||
48788081|NCT02693665|157063630|FG001|Overall Study|patient wanted to leave it behind|0|||
48788082|NCT02693665|157063629|FG000|Overall Study|anxiety|1|||
48788083|NCT02693665|157063630|FG001|Overall Study|anxiety|0|||
48788084|NCT02693665|157063629|FG000|Overall Study|family issues|1|||
48788085|NCT02693665|157063630|FG001|Overall Study|family issues|0|||
48788086|NCT02693665|157063629|FG000|Overall Study|no reason given|1|||
48788087|NCT02693665|157063630|FG001|Overall Study|no reason given|0|||
48788088|NCT04304833|157063631|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
48788089|NCT04304833|157063632|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
48788090|NCT03972488|157063634|FG000|Overall Study|Progressive disease|42|||
48788091|NCT03972488|157063635|FG001|Overall Study|Progressive disease|44|||
48788092|NCT03972488|157063634|FG000|Overall Study|Physician Decision|13|||
48788093|NCT03972488|157063635|FG001|Overall Study|Physician Decision|7|||
48788094|NCT03972488|157063634|FG000|Overall Study|Adverse Event|8|||
48788095|NCT03972488|157063635|FG001|Overall Study|Adverse Event|1|||
48788096|NCT03972488|157063634|FG000|Overall Study|Death|4|||
48788097|NCT03972488|157063635|FG001|Overall Study|Death|4|||
48788098|NCT03972488|157063634|FG000|Overall Study|Withdrawal by Subject|3|||
48788099|NCT03972488|157063635|FG001|Overall Study|Withdrawal by Subject|4|||
48788100|NCT03972488|157063634|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
48788101|NCT03972488|157063635|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
48788102|NCT00626522|157065901|FG000|Overall Study|Protocol Violation|0|||
48788103|NCT00626522|157065902|FG001|Overall Study|Protocol Violation|0|||
48788104|NCT00626522|157065903|FG002|Overall Study|Protocol Violation|0|||
48788105|NCT00626522|157065904|FG003|Overall Study|Protocol Violation|0|||
48788106|NCT00626522|157065905|FG004|Overall Study|Protocol Violation|1|||
48788107|NCT00626522|157065906|FG005|Overall Study|Protocol Violation|0|||
48788108|NCT00626522|157065901|FG000|Overall Study|Adverse Event|2|||
48788109|NCT00626522|157065902|FG001|Overall Study|Adverse Event|1|||
48788110|NCT00626522|157065903|FG002|Overall Study|Adverse Event|2|||
48788111|NCT00626522|157065904|FG003|Overall Study|Adverse Event|0|||
48788112|NCT00626522|157065905|FG004|Overall Study|Adverse Event|1|||
48788113|NCT00626522|157065906|FG005|Overall Study|Adverse Event|1|||
48788114|NCT00626522|157065901|FG000|Overall Study|Withdrawal by Subject|2|||
48788115|NCT00626522|157065902|FG001|Overall Study|Withdrawal by Subject|5|||
48356794|NCT02473965|155503495|FG000|Overall Study|Withdrawal by Subject|2|||
48356795|NCT02473965|155503496|FG001|Overall Study|Withdrawal by Subject|3|||
48788116|NCT00626522|157065903|FG002|Overall Study|Withdrawal by Subject|5|||
48788117|NCT00626522|157065904|FG003|Overall Study|Withdrawal by Subject|0|||
48788118|NCT00626522|157065905|FG004|Overall Study|Withdrawal by Subject|4|||
48788119|NCT00626522|157065906|FG005|Overall Study|Withdrawal by Subject|1|||
48788120|NCT00626522|157065901|FG000|Overall Study|COPD exacerbation|0|||
48788121|NCT00626522|157065902|FG001|Overall Study|COPD exacerbation|0|||
48788122|NCT00626522|157065903|FG002|Overall Study|COPD exacerbation|0|||
48788123|NCT00626522|157065904|FG003|Overall Study|COPD exacerbation|1|||
48788124|NCT00626522|157065905|FG004|Overall Study|COPD exacerbation|1|||
48788125|NCT00626522|157065906|FG005|Overall Study|COPD exacerbation|0|||
48788126|NCT00626522|157065901|FG000|Overall Study|Lost to Follow-up|0|||
48788127|NCT00626522|157065902|FG001|Overall Study|Lost to Follow-up|1|||
48788128|NCT00626522|157065903|FG002|Overall Study|Lost to Follow-up|0|||
48788129|NCT00626522|157065904|FG003|Overall Study|Lost to Follow-up|0|||
48788130|NCT00626522|157065905|FG004|Overall Study|Lost to Follow-up|0|||
48788131|NCT00626522|157065906|FG005|Overall Study|Lost to Follow-up|0|||
48788132|NCT00626522|157065901|FG000|Overall Study|Inconsistent reason reported|1|||
48788133|NCT00626522|157065902|FG001|Overall Study|Inconsistent reason reported|0|||
48788134|NCT00626522|157065903|FG002|Overall Study|Inconsistent reason reported|0|||
48788135|NCT00626522|157065904|FG003|Overall Study|Inconsistent reason reported|0|||
48788136|NCT00626522|157065905|FG004|Overall Study|Inconsistent reason reported|0|||
48788137|NCT00626522|157065906|FG005|Overall Study|Inconsistent reason reported|0|||
48788138|NCT00626522|157065901|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
48788139|NCT00626522|157065902|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
48788140|NCT00626522|157065903|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
48788141|NCT00626522|157065904|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
48356796|NCT02473965|155503495|FG000|Overall Study|Physician Decision|0|||
48788142|NCT00626522|157065905|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
48788143|NCT00626522|157065906|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
48788144|NCT01412944|157065907|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788145|NCT01412944|157065908|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788146|NCT01412944|157065909|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
48788147|NCT01412944|157065910|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788148|NCT01412944|157065911|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788149|NCT01412944|157065912|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
48788150|NCT01412944|157065907|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788151|NCT01412944|157065908|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788152|NCT01412944|157065909|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788153|NCT01412944|157065910|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788154|NCT01412944|157065911|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
48788155|NCT01412944|157065912|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
48788156|NCT01412944|157065907|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788157|NCT01412944|157065908|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788158|NCT01412944|157065909|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788159|NCT01412944|157065910|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788160|NCT01412944|157065911|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
48788161|NCT01412944|157065912|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
48788162|NCT01412944|157065907|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
48788163|NCT01412944|157065908|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788164|NCT01412944|157065909|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788165|NCT01412944|157065910|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788166|NCT01412944|157065911|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788167|NCT01412944|157065912|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
48788168|NCT01412944|157065907|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
48788169|NCT01412944|157065908|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
48788170|NCT01412944|157065909|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
48788171|NCT01412944|157065910|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
48788172|NCT01412944|157065911|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
48788173|NCT01412944|157065912|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
48788174|NCT01412944|157065907|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788175|NCT01412944|157065908|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
48788176|NCT01412944|157065909|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788177|NCT01412944|157065910|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788178|NCT01412944|157065911|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788179|NCT01412944|157065912|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
48788180|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788181|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788182|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
48788183|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
48788184|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
48788185|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788186|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Adverse Event|0|||
48788187|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Adverse Event|0|||
48788188|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Adverse Event|0|||
48788189|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Adverse Event|0|||
48788190|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Adverse Event|1|||
48788191|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Adverse Event|0|||
48788192|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
48788193|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
48788194|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
48788195|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
48788196|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
48788197|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
48788198|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788199|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788200|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788201|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788202|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788203|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
48400776|NCT01857869|155657818|FG004|Primary/Challenge Phase|Protocol Violation|0|||
48788204|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788205|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788206|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788207|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788208|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
48788209|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788210|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
48788211|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
48788212|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788213|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788214|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788215|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
48788216|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
48788217|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
48788218|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
48788219|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
48788220|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
48788221|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
48788222|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788223|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
48788224|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788225|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788226|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788227|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
48788228|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788229|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
48788230|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788231|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788232|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788233|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
48788234|NCT01412944|157065907|FG000|Entire: IV + Maintenance|Adverse Event|0|||
48788235|NCT01412944|157065908|FG001|Entire: IV + Maintenance|Adverse Event|1|||
48788236|NCT01412944|157065909|FG002|Entire: IV + Maintenance|Adverse Event|0|||
48788237|NCT01412944|157065910|FG003|Entire: IV + Maintenance|Adverse Event|0|||
48788238|NCT01412944|157065911|FG004|Entire: IV + Maintenance|Adverse Event|0|||
48788239|NCT01412944|157065912|FG005|Entire: IV + Maintenance|Adverse Event|0|||
48788240|NCT00360308|157065913|FG000|Overall Study|Adverse Event|15|||
48788241|NCT00360308|157065914|FG001|Overall Study|Adverse Event|14|||
48788242|NCT00360308|157065915|FG002|Overall Study|Adverse Event|25|||
48788243|NCT00360308|157065913|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
48788244|NCT00360308|157065914|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
48788245|NCT00360308|157065915|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
48788246|NCT00360308|157065913|FG000|Overall Study|Protocol Violation|2|||
48788247|NCT00360308|157065914|FG001|Overall Study|Protocol Violation|1|||
48788248|NCT00360308|157065915|FG002|Overall Study|Protocol Violation|2|||
48788249|NCT00360308|157065913|FG000|Overall Study|Withdrawal by Subject|11|||
48788250|NCT00360308|157065914|FG001|Overall Study|Withdrawal by Subject|7|||
48788251|NCT00360308|157065915|FG002|Overall Study|Withdrawal by Subject|14|||
48788252|NCT00360308|157065913|FG000|Overall Study|Lack of Efficacy|3|||
48788253|NCT00360308|157065914|FG001|Overall Study|Lack of Efficacy|0|||
48788254|NCT00360308|157065915|FG002|Overall Study|Lack of Efficacy|2|||
48788255|NCT00360308|157065913|FG000|Overall Study|Other|2|||
48788256|NCT00360308|157065914|FG001|Overall Study|Other|1|||
48788257|NCT00360308|157065915|FG002|Overall Study|Other|1|||
48788258|NCT00360308|157065913|FG000|Overall Study|Study termination by sponsor|43|||
48788259|NCT00360308|157065914|FG001|Overall Study|Study termination by sponsor|55|||
48788260|NCT00360308|157065915|FG002|Overall Study|Study termination by sponsor|44|||
48788261|NCT00377819|157065919|FG000|Overall Study|Adverse Event|2|||
48788262|NCT00377819|157065920|FG001|Overall Study|Adverse Event|3|||
48788263|NCT00377819|157065919|FG000|Overall Study|Withdrawal by Subject|10|||
48788264|NCT00377819|157065920|FG001|Overall Study|Withdrawal by Subject|4|||
48788265|NCT00377819|157065919|FG000|Overall Study|Death|0|||
48788266|NCT00377819|157065920|FG001|Overall Study|Death|1|||
48788267|NCT00377819|157065919|FG000|Overall Study|Lost to Follow-up|0|||
48788268|NCT00377819|157065920|FG001|Overall Study|Lost to Follow-up|1|||
48788269|NCT00377819|157065919|FG000|Overall Study|Protocol Violation|1|||
48788270|NCT00377819|157065920|FG001|Overall Study|Protocol Violation|1|||
48788271|NCT01914926|157065921|FG000|Overall Study|Adverse Event|1|||
48788272|NCT01914926|157065922|FG001|Overall Study|Adverse Event|0|||
48788273|NCT01914926|157065921|FG000|Overall Study|uncooperative, agitated and removed|0|||
48788274|NCT01914926|157065922|FG001|Overall Study|uncooperative, agitated and removed|1|||
48788275|NCT00321919|157065923|FG000|Overall Study|Adverse Event|17|||
48788276|NCT00321919|157065924|FG001|Overall Study|Adverse Event|10|||
48788277|NCT00321919|157065923|FG000|Overall Study|Death|21|||
48788278|NCT00321919|157065924|FG001|Overall Study|Death|17|||
48788279|NCT00321919|157065923|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48788280|NCT00321919|157065924|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48788281|NCT00321919|157065923|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48788282|NCT00321919|157065924|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48788283|NCT00321919|157065923|FG000|Overall Study|Refused Treatment|23|||
48788284|NCT00321919|157065924|FG001|Overall Study|Refused Treatment|14|||
48788285|NCT00321919|157065923|FG000|Overall Study|Other Protocol Violation|2|||
48788286|NCT00321919|157065924|FG001|Overall Study|Other Protocol Violation|3|||
48788287|NCT00321919|157065923|FG000|Overall Study|Failure to Return|3|||
48788288|NCT00321919|157065924|FG001|Overall Study|Failure to Return|1|||
48788289|NCT00321919|157065923|FG000|Overall Study|Other withdrawal reason|7|||
48788290|NCT00321919|157065924|FG001|Overall Study|Other withdrawal reason|6|||
48788291|NCT02148250|157065927|FG000|Screening|Withdrawal by Subject|5|||
48788292|NCT02148250|157065928|FG001|Screening|Withdrawal by Subject|0|||
48788293|NCT02508311|157065931|FG000|Overall Study|Withdrawal by Subject|1|||
48788294|NCT02508311|157065932|FG001|Overall Study|Withdrawal by Subject|0|||
48788295|NCT02169674|157065933|FG000|Overall Study|Withdrawal by Subject|2|||
48788296|NCT02169674|157065934|FG001|Overall Study|Withdrawal by Subject|1|||
48788297|NCT02169674|157065933|FG000|Overall Study|Seroprotected|30|||
48788298|NCT02169674|157065934|FG001|Overall Study|Seroprotected|76|||
48788299|NCT02169674|157065933|FG000|Overall Study|Lost to Follow-up|0|||
48788300|NCT02169674|157065934|FG001|Overall Study|Lost to Follow-up|1|||
48788301|NCT02370602|157065935|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48788302|NCT02370602|157065936|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48788303|NCT02370602|157065937|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48788304|NCT02370602|157065938|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
48788305|NCT02370602|157065939|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
48788306|NCT02370602|157065940|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
48788307|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
48788308|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
48788309|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
48788310|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
48788311|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
48788312|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
48788313|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
48788314|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
48788315|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
48788316|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
48788317|NCT00695903|157065941|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
48788318|NCT00695903|157065942|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
48788319|NCT00695903|157065941|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
48788320|NCT00695903|157065942|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
48788321|NCT00695903|157065941|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
48788322|NCT00695903|157065942|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
48788323|NCT00695903|157065941|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
48788324|NCT00695903|157065942|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
48788325|NCT04137380|157065950|FG000|Overall Study|Physician Decision|0|||
48788326|NCT04137380|157065951|FG001|Overall Study|Physician Decision|0|||
48788327|NCT04137380|157065952|FG002|Overall Study|Physician Decision|0|||
48788328|NCT04137380|157065953|FG003|Overall Study|Physician Decision|1|||
48788329|NCT04137380|157065954|FG004|Overall Study|Physician Decision|0|||
48788330|NCT04137380|157065955|FG005|Overall Study|Physician Decision|0|||
48788331|NCT04137380|157065956|FG006|Overall Study|Physician Decision|0|||
48788332|NCT01613248|157065957|FG000|Overall Study|Adverse Event|0|||
48788333|NCT01613248|157065958|FG001|Overall Study|Adverse Event|0|||
48788334|NCT01613248|157065959|FG002|Overall Study|Adverse Event|0|||
48788335|NCT01613248|157065960|FG003|Overall Study|Adverse Event|1|||
48788336|NCT01613248|157065961|FG004|Overall Study|Adverse Event|0|||
48788337|NCT01613248|157065962|FG005|Overall Study|Adverse Event|0|||
48788338|NCT01613248|157065957|FG000|Overall Study|Withdrawal by Subject|3|||
48788339|NCT01613248|157065958|FG001|Overall Study|Withdrawal by Subject|2|||
48788340|NCT01613248|157065959|FG002|Overall Study|Withdrawal by Subject|2|||
48788341|NCT01613248|157065960|FG003|Overall Study|Withdrawal by Subject|5|||
48788342|NCT01613248|157065961|FG004|Overall Study|Withdrawal by Subject|0|||
48788343|NCT01613248|157065962|FG005|Overall Study|Withdrawal by Subject|1|||
48788344|NCT01613248|157065957|FG000|Overall Study|Lost to Follow-up|5|||
48788345|NCT01613248|157065958|FG001|Overall Study|Lost to Follow-up|7|||
48788346|NCT01613248|157065959|FG002|Overall Study|Lost to Follow-up|4|||
48788347|NCT01613248|157065960|FG003|Overall Study|Lost to Follow-up|8|||
48788348|NCT01613248|157065961|FG004|Overall Study|Lost to Follow-up|4|||
48788349|NCT01613248|157065962|FG005|Overall Study|Lost to Follow-up|2|||
48788350|NCT01613248|157065957|FG000|Overall Study|Study Terminated by Sponsor|4|||
48788351|NCT01613248|157065958|FG001|Overall Study|Study Terminated by Sponsor|6|||
48788352|NCT01613248|157065959|FG002|Overall Study|Study Terminated by Sponsor|8|||
48788353|NCT01613248|157065960|FG003|Overall Study|Study Terminated by Sponsor|8|||
48788354|NCT01613248|157065961|FG004|Overall Study|Study Terminated by Sponsor|9|||
48788355|NCT01613248|157065962|FG005|Overall Study|Study Terminated by Sponsor|11|||
48788356|NCT01613248|157065957|FG000|Overall Study|Physician Decision|8|||
48788357|NCT01613248|157065958|FG001|Overall Study|Physician Decision|8|||
48788358|NCT01613248|157065959|FG002|Overall Study|Physician Decision|9|||
48788359|NCT01613248|157065960|FG003|Overall Study|Physician Decision|4|||
48788360|NCT01613248|157065961|FG004|Overall Study|Physician Decision|7|||
48788361|NCT01613248|157065962|FG005|Overall Study|Physician Decision|6|||
48788362|NCT01613248|157065957|FG000|Overall Study|Lack of Qualifying Event|9|||
48788363|NCT01613248|157065958|FG001|Overall Study|Lack of Qualifying Event|11|||
48788364|NCT01613248|157065959|FG002|Overall Study|Lack of Qualifying Event|10|||
48788365|NCT01613248|157065960|FG003|Overall Study|Lack of Qualifying Event|11|||
48788366|NCT01613248|157065961|FG004|Overall Study|Lack of Qualifying Event|15|||
48788367|NCT01613248|157065962|FG005|Overall Study|Lack of Qualifying Event|18|||
48788368|NCT01613248|157065957|FG000|Overall Study|Pregnancy|0|||
48788369|NCT01613248|157065958|FG001|Overall Study|Pregnancy|0|||
48788370|NCT01613248|157065959|FG002|Overall Study|Pregnancy|0|||
48788371|NCT01613248|157065960|FG003|Overall Study|Pregnancy|1|||
48788372|NCT01613248|157065961|FG004|Overall Study|Pregnancy|0|||
48788373|NCT01613248|157065962|FG005|Overall Study|Pregnancy|0|||
48788374|NCT00121238|157065963|FG000|Overall Study|disease progression before intervention|1|||
48788375|NCT00121238|157065963|FG000|Overall Study|Protocol Violation|2|||
48788376|NCT03056755|157065964|FG000|Treatment- Core Phase|Progressive disease|89|||
48788377|NCT03056755|157065965|FG001|Treatment- Core Phase|Progressive disease|88|||
48788378|NCT03056755|157065966|FG002|Treatment- Core Phase|Progressive disease|90|||
48788379|NCT03056755|157065964|FG000|Treatment- Core Phase|Adverse Event|20|||
48788380|NCT03056755|157065965|FG001|Treatment- Core Phase|Adverse Event|14|||
48788381|NCT03056755|157065966|FG002|Treatment- Core Phase|Adverse Event|13|||
48788382|NCT03056755|157065964|FG000|Treatment- Core Phase|Physician Decision|7|||
48788383|NCT03056755|157065965|FG001|Treatment- Core Phase|Physician Decision|13|||
48788384|NCT03056755|157065966|FG002|Treatment- Core Phase|Physician Decision|5|||
48788385|NCT03056755|157065964|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
48788386|NCT03056755|157065965|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
48788387|NCT03056755|157065966|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
48788388|NCT03056755|157065964|FG000|Treatment- Core Phase|Death|3|||
48788389|NCT03056755|157065965|FG001|Treatment- Core Phase|Death|2|||
48788390|NCT03056755|157065966|FG002|Treatment- Core Phase|Death|4|||
48788391|NCT03056755|157065964|FG000|Treatment- Core Phase|Protocol deviation|1|||
48788392|NCT03056755|157065965|FG001|Treatment- Core Phase|Protocol deviation|1|||
48788393|NCT03056755|157065966|FG002|Treatment- Core Phase|Protocol deviation|0|||
48400777|NCT01857869|155657819|FG005|Primary/Challenge Phase|Protocol Violation|0|||
48400778|NCT01857869|155657820|FG006|Primary/Challenge Phase|Protocol Violation|0|||
48400779|NCT01857869|155657821|FG007|Primary/Challenge Phase|Protocol Violation|0|||
48400780|NCT01857869|155657822|FG008|Primary/Challenge Phase|Protocol Violation|0|||
48400781|NCT01857869|155657823|FG009|Primary/Challenge Phase|Protocol Violation|0|||
48400782|NCT01857869|155657814|FG000|Primary/Challenge Phase|Other|1|||
48400783|NCT01857869|155657815|FG001|Primary/Challenge Phase|Other|1|||
48400784|NCT01857869|155657816|FG002|Primary/Challenge Phase|Other|0|||
48400785|NCT01857869|155657817|FG003|Primary/Challenge Phase|Other|0|||
48400786|NCT01857869|155657818|FG004|Primary/Challenge Phase|Other|0|||
48400787|NCT01857869|155657819|FG005|Primary/Challenge Phase|Other|0|||
48400788|NCT01857869|155657820|FG006|Primary/Challenge Phase|Other|0|||
48400789|NCT01857869|155657821|FG007|Primary/Challenge Phase|Other|0|||
48400790|NCT01857869|155657822|FG008|Primary/Challenge Phase|Other|0|||
48400791|NCT01857869|155657823|FG009|Primary/Challenge Phase|Other|0|||
48400792|NCT01857869|155657814|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48400793|NCT01857869|155657815|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48788394|NCT03056755|157065964|FG000|Treatment- Core Phase|Technical problems|1|||
48788395|NCT03056755|157065965|FG001|Treatment- Core Phase|Technical problems|0|||
48788396|NCT03056755|157065966|FG002|Treatment- Core Phase|Technical problems|0|||
48788397|NCT03056755|157065964|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
48788398|NCT03056755|157065965|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
48788399|NCT03056755|157065966|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
48788400|NCT03056755|157065964|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
48788401|NCT03056755|157065965|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
48788402|NCT03056755|157065966|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
48788403|NCT03056755|157065964|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
48788404|NCT03056755|157065965|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
48788405|NCT03056755|157065966|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
48400794|NCT01857869|155657816|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48788406|NCT03056755|157065964|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
48788407|NCT03056755|157065965|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
48788408|NCT03056755|157065966|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
48788409|NCT05554237|157065969|FG000|Part 2 (7 Days)|Adverse Event|0|||
48400795|NCT01857869|155657817|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
48400796|NCT01857869|155657818|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48400797|NCT01857869|155657819|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48430349|NCT00696657|155763703|FG003|Overall Study|Withdrawal criteria|2|||
48788410|NCT05554237|157065970|FG001|Part 2 (7 Days)|Adverse Event|0|||
48788411|NCT05554237|157065971|FG002|Part 2 (7 Days)|Adverse Event|0|||
48788412|NCT05554237|157065972|FG003|Part 2 (7 Days)|Adverse Event|0|||
48788413|NCT05554237|157065973|FG004|Part 2 (7 Days)|Adverse Event|2|||
48788414|NCT05554237|157065974|FG005|Part 2 (7 Days)|Adverse Event|0|||
48788415|NCT05554237|157065975|FG006|Part 2 (7 Days)|Adverse Event|0|||
48788416|NCT05554237|157065976|FG007|Part 2 (7 Days)|Adverse Event|0|||
48788417|NCT05554237|157065977|FG008|Part 2 (7 Days)|Adverse Event|0|||
48788418|NCT05554237|157065978|FG009|Part 2 (7 Days)|Adverse Event|1|||
48788419|NCT05554237|157065979|FG010|Part 2 (7 Days)|Adverse Event|0|||
48788420|NCT05554237|157065980|FG011|Part 2 (7 Days)|Adverse Event|0|||
48788421|NCT05554237|157065981|FG012|Part 2 (7 Days)|Adverse Event|1|||
48788422|NCT05554237|157065982|FG013|Part 2 (7 Days)|Adverse Event|0|||
48788423|NCT03720795|157065986|FG000|Phase 1|Lost to Follow-up|4|||
48788424|NCT03720795|157065986|FG000|Phase 1|Withdrawal by Subject|6|||
48788425|NCT03720795|157065986|FG000|Phase 1|Protocol Violation|1|||
48788426|NCT03720795|157065986|FG000|Phase 1|Other|1|||
48788427|NCT03720795|157065986|FG000|Phase 2|Lost to Follow-up|5|||
48788428|NCT03720795|157065986|FG000|Phase 2|Withdrawal by Subject|10|||
48788429|NCT03720795|157065986|FG000|Phase 2|Protocol Violation|2|||
48788430|NCT03720795|157065986|FG000|3 Month Follow Up|Lost to Follow-up|2|||
48788431|NCT01306162|157065991|FG000|Period 1|Adverse Event|0|||
48788432|NCT01306162|157065992|FG001|Period 1|Adverse Event|0|||
48788433|NCT01306162|157065993|FG002|Period 1|Adverse Event|0|||
48788434|NCT01306162|157065994|FG003|Period 1|Adverse Event|1|||
48788435|NCT01306162|157065991|FG000|Washout 1|Non-compliance to protocol|0|||
48788436|NCT01306162|157065992|FG001|Washout 1|Non-compliance to protocol|1|||
48788437|NCT01306162|157065993|FG002|Washout 1|Non-compliance to protocol|0|||
48788438|NCT01306162|157065994|FG003|Washout 1|Non-compliance to protocol|0|||
48788439|NCT01556438|157065995|FG000|Overall Study|Adverse Event|4|||
48788440|NCT01556438|157065996|FG001|Overall Study|Adverse Event|2|||
48788441|NCT01556438|157065995|FG000|Overall Study|Sponsor Decision|0|||
48788442|NCT01556438|157065996|FG001|Overall Study|Sponsor Decision|2|||
48788443|NCT01556438|157065995|FG000|Overall Study|Progressive Disease|0|||
48788444|NCT01556438|157065996|FG001|Overall Study|Progressive Disease|6|||
48788445|NCT01556438|157065995|FG000|Overall Study|Death|0|||
48788446|NCT01556438|157065996|FG001|Overall Study|Death|1|||
48788447|NCT00092131|157065997|FG000|Treatment Period I|Adverse Event|1|||
48788448|NCT00092131|157065998|FG001|Treatment Period I|Adverse Event|0|||
48788449|NCT00092131|157065997|FG000|Treatment Period II|Adverse Event|0|||
48788450|NCT00092131|157065998|FG001|Treatment Period II|Adverse Event|1|||
48788451|NCT01660763|157065999|FG000|Overall Study|Lack of Efficacy|45|||
48788452|NCT01660763|157066000|FG001|Overall Study|Lack of Efficacy|50|||
48788453|NCT01660763|157065999|FG000|Overall Study|Adverse Event|22|||
48788454|NCT01660763|157066000|FG001|Overall Study|Adverse Event|7|||
48788455|NCT01660763|157065999|FG000|Overall Study|Protocol Violation|1|||
48788456|NCT01660763|157066000|FG001|Overall Study|Protocol Violation|0|||
48788457|NCT01660763|157065999|FG000|Overall Study|Withdrawal by Subject|4|||
48788458|NCT01660763|157066000|FG001|Overall Study|Withdrawal by Subject|0|||
48788459|NCT01660763|157065999|FG000|Overall Study|Patient ready for early discharge|28|||
48788460|NCT01660763|157066000|FG001|Overall Study|Patient ready for early discharge|4|||
48788461|NCT04709419|157066003|FG000|Overall Study|Physician Decision|1|||
48788462|NCT04709419|157066004|FG001|Overall Study|Physician Decision|0|||
48788463|NCT03034577|157066005|FG000|Overall Study|Withdrawal by Subject|6|||
48788464|NCT03034577|157066006|FG001|Overall Study|Withdrawal by Subject|9|||
48788465|NCT03034577|157066005|FG000|Overall Study|Lost to Follow-up|25|||
48788466|NCT03034577|157066006|FG001|Overall Study|Lost to Follow-up|26|||
48788467|NCT03358472|157066007|FG000|Overall Study|Death|6|||
48788468|NCT03358472|157066008|FG001|Overall Study|Death|3|||
48788469|NCT03358472|157066009|FG002|Overall Study|Death|10|||
48788470|NCT03358472|157066007|FG000|Overall Study|Physician Decision|0|||
48788471|NCT03358472|157066008|FG001|Overall Study|Physician Decision|1|||
48356797|NCT02473965|155503496|FG001|Overall Study|Physician Decision|2|||
48356798|NCT01183390|155503497|FG000|First Intervention|Adverse Event|0|||
48356799|NCT01183390|155503498|FG001|First Intervention|Adverse Event|1|||
48356800|NCT00487825|155503502|FG000|Overall Study|Adverse Event|2|||
48788472|NCT03358472|157066009|FG002|Overall Study|Physician Decision|0|||
48788473|NCT03358472|157066007|FG000|Overall Study|Withdrawal by Subject|0|||
48788474|NCT03358472|157066008|FG001|Overall Study|Withdrawal by Subject|0|||
48788475|NCT03358472|157066009|FG002|Overall Study|Withdrawal by Subject|1|||
48788476|NCT03358472|157066007|FG000|Overall Study|On-going at clinical cut off date|9|||
48788477|NCT03358472|157066008|FG001|Overall Study|On-going at clinical cut off date|6|||
48788478|NCT03358472|157066009|FG002|Overall Study|On-going at clinical cut off date|5|||
48788479|NCT00490646|157066010|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
48788480|NCT00490646|157066011|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
48788481|NCT00490646|157066010|FG000|Overall Study|Never Treated (had an adverse event)|1|||
48788482|NCT00490646|157066011|FG001|Overall Study|Never Treated (had an adverse event)|0|||
48788483|NCT00490646|157066010|FG000|Overall Study|Never Treated (withdrew consent)|0|||
48356801|NCT00487825|155503503|FG001|Overall Study|Adverse Event|2|||
48788484|NCT00490646|157066011|FG001|Overall Study|Never Treated (withdrew consent)|1|||
48788485|NCT01453595|157066015|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48788486|NCT01453595|157066016|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48788487|NCT01453595|157066017|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48788488|NCT02130193|157066018|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
48788489|NCT02130193|157066019|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
48788490|NCT02130193|157066020|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
48788491|NCT02130193|157066018|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
48788492|NCT02130193|157066019|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
48788493|NCT02130193|157066020|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
48788494|NCT02130193|157066018|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
48788495|NCT02130193|157066019|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
48788496|NCT02130193|157066020|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
48788497|NCT02130193|157066018|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
48788498|NCT02130193|157066019|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
48788499|NCT02130193|157066020|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
48788500|NCT01218438|157066021|FG000|Epoch 1|Physician Decision|2|||
48788501|NCT01218438|157066021|FG000|Epoch 1|Adverse Event|1|||
48788502|NCT01218438|157066021|FG000|Epoch 3|Withdrawal by Subject|3|||
48788503|NCT01218438|157066021|FG000|Epoch 3|Adverse Event|1|||
48788504|NCT01218438|157066021|FG000|Epoch 4|Physician Decision|1|||
48788505|NCT01218438|157066021|FG000|Epoch 4|Withdrawal by Subject|2|||
48788506|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
48788507|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
48788508|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
48788509|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788510|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788511|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788512|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788513|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788514|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48788515|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
48788516|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
48788517|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
48788518|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788519|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788520|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788521|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788522|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788523|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48788524|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
48788525|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
48788526|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
48788527|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788528|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788529|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788530|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788531|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788532|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48788533|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48788534|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788535|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
48788536|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788537|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788538|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788539|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788540|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788541|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48788542|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788543|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788544|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
48400798|NCT01857869|155657820|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48788545|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788546|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48400799|NCT01857869|155657821|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48400800|NCT01857869|155657822|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48788547|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48400801|NCT01857869|155657823|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
48400802|NCT01857869|155657814|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48400803|NCT01857869|155657815|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48400804|NCT01857869|155657816|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48400805|NCT01857869|155657817|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
48400806|NCT01857869|155657818|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48400807|NCT01857869|155657819|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48400808|NCT01857869|155657820|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48400809|NCT01857869|155657821|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48788548|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788549|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788550|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48788551|NCT01212770|157066024|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
48788552|NCT01212770|157066025|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
48788553|NCT01212770|157066026|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
48788554|NCT01212770|157066027|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788555|NCT01212770|157066028|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788556|NCT01212770|157066029|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788557|NCT01212770|157066030|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788558|NCT01212770|157066031|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788559|NCT01212770|157066032|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
48788560|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788561|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
48788562|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
48788563|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
48788564|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788565|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788566|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
48788567|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788568|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
48788569|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
48788570|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
48788571|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
48788572|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
48788573|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
48788574|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
48788575|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
48788576|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
48788577|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
48788578|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
48788579|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
48788580|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
48788581|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
48788582|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
48788583|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
48788584|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
48788585|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
48788586|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
48788587|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788588|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788589|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
48788590|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788591|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788592|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788593|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788594|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788595|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
48788596|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788597|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788598|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788599|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
48788600|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788601|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788602|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788603|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788604|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
48788605|NCT01212770|157066024|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788606|NCT01212770|157066025|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788607|NCT01212770|157066026|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
48788608|NCT01212770|157066027|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
48788609|NCT01212770|157066028|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788610|NCT01212770|157066029|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48400810|NCT01857869|155657822|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48400811|NCT01857869|155657823|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
48400812|NCT01999582|155657826|FG000|Overall Study|Withdrawal by Subject|0|||
48400813|NCT01999582|155657827|FG001|Overall Study|Withdrawal by Subject|0|||
48400814|NCT01999582|155657828|FG002|Overall Study|Withdrawal by Subject|0|||
48400815|NCT01999582|155657829|FG003|Overall Study|Withdrawal by Subject|1|||
48400816|NCT01999582|155657830|FG004|Overall Study|Withdrawal by Subject|0|||
48400817|NCT01999582|155657831|FG005|Overall Study|Withdrawal by Subject|0|||
48400818|NCT01999582|155657826|FG000|Overall Study|Adverse Event|0|||
48400819|NCT01999582|155657827|FG001|Overall Study|Adverse Event|0|||
48400820|NCT01999582|155657828|FG002|Overall Study|Adverse Event|3|||
48400821|NCT01999582|155657829|FG003|Overall Study|Adverse Event|0|||
48400822|NCT01999582|155657830|FG004|Overall Study|Adverse Event|1|||
48400823|NCT01999582|155657831|FG005|Overall Study|Adverse Event|0|||
48400824|NCT01999582|155657826|FG000|Overall Study|Other Reasons|1|||
48788611|NCT01212770|157066030|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788612|NCT01212770|157066031|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788613|NCT01212770|157066032|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
48788614|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788615|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
48788616|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
48788617|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788618|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788619|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788620|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788621|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48788622|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
48788623|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788624|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
48788625|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
48788626|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788627|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788628|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788629|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48788630|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
48788631|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
48788632|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788633|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
48788634|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788635|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788636|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788637|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788638|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788639|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788640|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
48788641|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788642|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
48788643|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
48788644|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788645|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788646|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788647|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48788648|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
48788649|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
48400825|NCT01999582|155657827|FG001|Overall Study|Other Reasons|0|||
48400826|NCT01999582|155657828|FG002|Overall Study|Other Reasons|3|||
48788650|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788651|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
48400827|NCT01999582|155657829|FG003|Overall Study|Other Reasons|1|||
48400828|NCT01999582|155657830|FG004|Overall Study|Other Reasons|1|||
48400829|NCT01999582|155657831|FG005|Overall Study|Other Reasons|2|||
48788652|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
48788653|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788654|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788655|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788656|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
48788657|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
48788658|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
48788659|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788660|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
48788661|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48788662|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788663|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788664|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788665|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788666|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48788667|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48788668|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788669|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
48788670|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
48788671|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788672|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788673|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788674|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48788675|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
48788676|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
48788677|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788678|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
48788679|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
48788680|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788681|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788682|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788683|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48788684|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
48788685|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
48788686|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48400830|NCT01999582|155657826|FG000|Overall Study|Protocol Violation|1|||
48400831|NCT01999582|155657827|FG001|Overall Study|Protocol Violation|0|||
48400832|NCT01999582|155657828|FG002|Overall Study|Protocol Violation|0|||
48400833|NCT01999582|155657829|FG003|Overall Study|Protocol Violation|0|||
48788687|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
48788688|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
48788689|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48788690|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48788691|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48788692|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48788693|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48788694|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
48788695|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788696|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
48788697|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788698|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788699|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788700|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788701|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788702|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788703|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48788704|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788705|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788706|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788707|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788708|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788709|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788710|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788711|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
48788712|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
48788713|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788714|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
48400834|NCT01999582|155657830|FG004|Overall Study|Protocol Violation|0|||
48788715|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48788716|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788717|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788718|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788719|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48788720|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48788721|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48788722|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788723|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
48788724|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
48788725|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788726|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788727|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788728|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788729|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48788730|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
48788731|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788732|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
48788733|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
48788734|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788735|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788736|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788737|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788738|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
48788739|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48788740|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788741|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
48788742|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
48788743|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788744|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788745|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788746|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788747|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
48788748|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
48788749|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788750|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
48788751|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
48788752|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788753|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788754|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788755|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788756|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788757|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48788758|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788759|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788760|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
48788761|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788762|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788763|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788764|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788765|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788766|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48788767|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788768|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
48788769|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788770|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788771|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788772|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788773|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788774|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48788775|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
48788776|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
48788777|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
48788778|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
48788779|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
48788780|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
48788781|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
48788782|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
48788783|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
48788784|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
48788785|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788786|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788787|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
48788788|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788789|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788790|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788791|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788792|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788793|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48788794|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788795|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788796|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
48788797|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788798|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788799|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788800|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788801|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48788802|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
48788803|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788804|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788805|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
48788806|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788807|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788808|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788809|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788810|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788811|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48788812|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788813|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
48788814|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48788815|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788816|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48400835|NCT01999582|155657831|FG005|Overall Study|Protocol Violation|1|||
48400836|NCT01999582|155657826|FG000|Overall Study|Lack of Efficacy|1|||
48400837|NCT01999582|155657827|FG001|Overall Study|Lack of Efficacy|3|||
48788817|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788818|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788819|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48788820|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48788821|NCT01212770|157066024|FG000|Long-term Safety Phase (Year 5)|Death|0|||
48788822|NCT01212770|157066025|FG001|Long-term Safety Phase (Year 5)|Death|0|||
48788823|NCT01212770|157066026|FG002|Long-term Safety Phase (Year 5)|Death|0|||
48788824|NCT01212770|157066027|FG003|Long-term Safety Phase (Year 5)|Death|0|||
48788825|NCT01212770|157066028|FG004|Long-term Safety Phase (Year 5)|Death|0|||
48788826|NCT01212770|157066029|FG005|Long-term Safety Phase (Year 5)|Death|0|||
48788827|NCT01212770|157066030|FG006|Long-term Safety Phase (Year 5)|Death|0|||
48788828|NCT01212770|157066031|FG007|Long-term Safety Phase (Year 5)|Death|1|||
48788829|NCT01212770|157066032|FG008|Long-term Safety Phase (Year 5)|Death|0|||
48788830|NCT00722761|157066036|FG000|Overall Study|Lost to Follow-up|1|||
48788831|NCT00722761|157066037|FG001|Overall Study|Lost to Follow-up|4|||
48788832|NCT00722761|157066036|FG000|Overall Study|Withdrawal by Subject|5|||
48788833|NCT00722761|157066037|FG001|Overall Study|Withdrawal by Subject|2|||
48788834|NCT03276676|157066038|FG000|Overall Study|Withdrawal by Subject|2|||
48788835|NCT03276676|157066039|FG001|Overall Study|Withdrawal by Subject|1|||
48788836|NCT01128413|157066040|FG000|Overall Study|Withdrawal by Subject|1|||
48788837|NCT01128413|157066041|FG001|Overall Study|Withdrawal by Subject|0|||
48788838|NCT01128413|157066040|FG000|Overall Study|NICOM Monitor Problems|2|||
48788839|NCT01128413|157066041|FG001|Overall Study|NICOM Monitor Problems|1|||
48788840|NCT01128413|157066040|FG000|Overall Study|Pt made DNR|1|||
48788841|NCT01128413|157066041|FG001|Overall Study|Pt made DNR|0|||
48788842|NCT00045110|157066042|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
48788843|NCT00045110|157066043|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
48788844|NCT00045110|157066044|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
48788845|NCT00045110|157066042|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
48788846|NCT00045110|157066043|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
48788847|NCT00045110|157066044|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
48788848|NCT00045110|157066042|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
48788849|NCT00045110|157066043|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
48788850|NCT00045110|157066044|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
48788851|NCT01864564|157066045|FG000|Overall Study|Lost to Follow-up|17|||
48788852|NCT01864564|157066046|FG001|Overall Study|Lost to Follow-up|23|||
48788853|NCT01864564|157066045|FG000|Overall Study|Withdrawal by Subject|20|||
48788854|NCT01864564|157066046|FG001|Overall Study|Withdrawal by Subject|11|||
48788855|NCT01864564|157066045|FG000|Overall Study|Protocol Violation|0|||
48788856|NCT01864564|157066046|FG001|Overall Study|Protocol Violation|27|||
48788857|NCT01864564|157066045|FG000|Overall Study|not reported|0|||
48788858|NCT01864564|157066046|FG001|Overall Study|not reported|34|||
48788859|NCT04154787|157066047|FG000|Overall Study|Adverse Event|0|||
48788860|NCT04154787|157066048|FG001|Overall Study|Adverse Event|1|||
48788861|NCT04154787|157066049|FG002|Overall Study|Adverse Event|0|||
48788862|NCT04154787|157066047|FG000|Overall Study|Patient Requires Other Treatment|0|||
48788863|NCT04154787|157066048|FG001|Overall Study|Patient Requires Other Treatment|1|||
48788864|NCT04154787|157066049|FG002|Overall Study|Patient Requires Other Treatment|0|||
48788865|NCT04154787|157066047|FG000|Overall Study|Study Terminated By Sponsor|0|||
48788866|NCT04154787|157066048|FG001|Overall Study|Study Terminated By Sponsor|6|||
48788867|NCT04154787|157066049|FG002|Overall Study|Study Terminated By Sponsor|1|||
48788868|NCT04154787|157066047|FG000|Overall Study|Subject Decision|0|||
48788869|NCT04154787|157066048|FG001|Overall Study|Subject Decision|1|||
48788870|NCT04154787|157066049|FG002|Overall Study|Subject Decision|0|||
48788871|NCT04154787|157066047|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
48788872|NCT04154787|157066048|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
48788873|NCT04154787|157066049|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
48788874|NCT02010060|157066050|FG000|Overall Study|Lost to Follow-up|1|||
48788875|NCT02010060|157066051|FG001|Overall Study|Lost to Follow-up|2|||
48788876|NCT02010060|157066052|FG002|Overall Study|Lost to Follow-up|2|||
48788877|NCT02010060|157066050|FG000|Overall Study|Injury|0|||
48788878|NCT02010060|157066051|FG001|Overall Study|Injury|1|||
48788879|NCT02010060|157066052|FG002|Overall Study|Injury|0|||
48788880|NCT02097108|157066065|FG000|Overall Study|Adverse Event|1|||
48788881|NCT02097108|157066065|FG000|Overall Study|patient was abroad for 6 months|1|||
48788882|NCT02412137|157066068|FG000|Overall Study|Withdrawal by Subject|2|||
48788883|NCT02412137|157066069|FG001|Overall Study|Withdrawal by Subject|0|||
48788884|NCT02412137|157066068|FG000|Overall Study|Lost to Follow-up|21|||
48788885|NCT02412137|157066069|FG001|Overall Study|Lost to Follow-up|14|||
48788886|NCT02412137|157066068|FG000|Overall Study|Physician Decision|28|||
48788887|NCT02412137|157066069|FG001|Overall Study|Physician Decision|9|||
48788888|NCT01170026|157067721|FG000|Overall Study|Lost to Follow-up|4|||
48788889|NCT01170026|157067722|FG001|Overall Study|Lost to Follow-up|2|||
48788890|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
48788891|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
48788892|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
48788893|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
48788894|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
48788895|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
48788896|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
48788897|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
48788898|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
48788899|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
48788900|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
48788901|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
48788902|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788903|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788904|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788905|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
48788906|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788907|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
48788908|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
48788909|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
48788910|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
48788911|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788912|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788913|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788914|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788915|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788916|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
48788917|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
48788918|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
48788919|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
48788920|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788921|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788922|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788923|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788924|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788925|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
48788926|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
48788927|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
48788928|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
48788929|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788930|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788931|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788932|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
48788933|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788934|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
48788935|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
48788936|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788937|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788938|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788939|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788940|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788941|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788942|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788943|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
48788944|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788945|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
48788946|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788947|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788948|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788949|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788950|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788951|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788952|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788953|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788954|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788955|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
48788956|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788957|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788958|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788959|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788960|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788961|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
48788962|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
48788963|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788964|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788965|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788966|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788967|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788968|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788969|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788970|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
48788971|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
48788972|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788973|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788974|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788975|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788976|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788977|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788978|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788979|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
48788980|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
48788981|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788982|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788983|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788984|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788985|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788986|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788987|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788988|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
48788989|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788990|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
48788991|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
48788992|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788993|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788994|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788995|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788996|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788997|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
48788998|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
48788999|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
48789000|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789001|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789002|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789003|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789004|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789005|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789006|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
48789007|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48356802|NCT00487825|155503502|FG000|Overall Study|Lack of Efficacy|1|||
48356803|NCT00487825|155503503|FG001|Overall Study|Lack of Efficacy|1|||
48356804|NCT00487825|155503502|FG000|Overall Study|Other|3|||
48356805|NCT00487825|155503503|FG001|Overall Study|Other|2|||
48356806|NCT02358668|155503504|FG000|Overall Study|Adverse Event|2|||
48356807|NCT02358668|155503505|FG001|Overall Study|Adverse Event|0|||
48356808|NCT02358668|155503506|FG002|Overall Study|Adverse Event|0|||
48356809|NCT02358668|155503504|FG000|Overall Study|Withdrawal by Subject|0|||
48356810|NCT02358668|155503505|FG001|Overall Study|Withdrawal by Subject|1|||
48356811|NCT02358668|155503506|FG002|Overall Study|Withdrawal by Subject|0|||
48789008|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
48789009|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789010|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789011|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789012|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789013|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789014|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789015|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
48789016|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789017|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
48400838|NCT01999582|155657828|FG002|Overall Study|Lack of Efficacy|0|||
48789018|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789019|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789020|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789021|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789022|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789023|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789024|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
48789025|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789026|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789027|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
48789028|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789029|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789030|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789031|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789032|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789033|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
48789034|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789035|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789036|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
48789037|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789038|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789039|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789040|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789041|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789042|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
48789043|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789044|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789045|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
48789046|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789047|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789048|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789049|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789050|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789051|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
48789052|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789053|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789054|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789055|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789056|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789057|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48400839|NCT01999582|155657829|FG003|Overall Study|Lack of Efficacy|1|||
48400840|NCT01999582|155657830|FG004|Overall Study|Lack of Efficacy|0|||
48400841|NCT01999582|155657831|FG005|Overall Study|Lack of Efficacy|0|||
48400842|NCT02239263|155657832|FG000|Overall Study|Protocol Violation|6|||
48400843|NCT02347176|155657833|FG000|Overall Study|Lost to Follow-up|2|||
48400844|NCT02347176|155657834|FG001|Overall Study|Lost to Follow-up|3|||
48400845|NCT02347176|155657835|FG002|Overall Study|Lost to Follow-up|1|||
48400846|NCT02347176|155657836|FG003|Overall Study|Lost to Follow-up|1|||
48400847|NCT02347176|155657833|FG000|Overall Study|Withdrawal by Subject|9|||
48400848|NCT02347176|155657834|FG001|Overall Study|Withdrawal by Subject|5|||
48400849|NCT02347176|155657835|FG002|Overall Study|Withdrawal by Subject|5|||
48400850|NCT02347176|155657836|FG003|Overall Study|Withdrawal by Subject|3|||
48400851|NCT02347176|155657833|FG000|Overall Study|Other|1|||
48400852|NCT02347176|155657834|FG001|Overall Study|Other|2|||
48400853|NCT02347176|155657835|FG002|Overall Study|Other|2|||
48400854|NCT02347176|155657836|FG003|Overall Study|Other|0|||
48400855|NCT02435849|155657840|FG000|Overall Study|Death|23|||
48400856|NCT02435849|155657841|FG001|Overall Study|Death|0|||
48400857|NCT02435849|155657840|FG000|Overall Study|Lack of Efficacy|10|||
48400858|NCT02435849|155657841|FG001|Overall Study|Lack of Efficacy|0|||
48400859|NCT02435849|155657840|FG000|Overall Study|New therapy for study indication|8|||
48400860|NCT02435849|155657841|FG001|Overall Study|New therapy for study indication|0|||
48400861|NCT02435849|155657840|FG000|Overall Study|Subject/guardian decision|5|||
48400862|NCT02435849|155657841|FG001|Overall Study|Subject/guardian decision|1|||
48400863|NCT02435849|155657840|FG000|Overall Study|Lost to Follow-up|1|||
48400864|NCT02435849|155657841|FG001|Overall Study|Lost to Follow-up|0|||
48400865|NCT02435849|155657840|FG000|Overall Study|Physician Decision|1|||
48789058|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
48789059|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789060|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
48789061|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
48789062|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
48789063|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789064|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789065|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789066|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789067|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789068|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789069|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
48789070|NCT03598790|157067723|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789071|NCT03598790|157067724|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789072|NCT03598790|157067725|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
48789073|NCT03598790|157067726|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789074|NCT03598790|157067727|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789075|NCT03598790|157067728|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789076|NCT03598790|157067729|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789077|NCT03598790|157067730|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789078|NCT03598790|157067731|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
48789079|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789080|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789081|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789082|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
48789083|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
48789084|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
48789085|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789086|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789087|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
48789088|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789089|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789090|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789091|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
48789092|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789093|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48400866|NCT02435849|155657841|FG001|Overall Study|Physician Decision|0|||
48400867|NCT00293579|155657842|FG000|Overall Study|Withdrawal by Subject|1|||
48400868|NCT03099707|155657843|FG000|Overall Study|Withdrawal by Subject|0|||
48400869|NCT03099707|155657844|FG001|Overall Study|Withdrawal by Subject|3|||
48400870|NCT03099707|155657843|FG000|Overall Study|Lost to Follow-up|0|||
48400871|NCT03099707|155657844|FG001|Overall Study|Lost to Follow-up|1|||
48789094|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789095|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789096|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
48789097|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789098|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789099|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789100|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
48789101|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789102|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789103|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789104|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789105|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
48789106|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789107|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789108|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789109|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
48789110|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
48789111|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789112|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789113|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789114|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
48789115|NCT03598790|157067723|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789116|NCT03598790|157067724|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789117|NCT03598790|157067725|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789118|NCT03598790|157067726|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
48789119|NCT03598790|157067727|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789120|NCT03598790|157067728|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789121|NCT03598790|157067729|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789122|NCT03598790|157067730|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789123|NCT03598790|157067731|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
48789124|NCT00377234|157067740|FG000|Overall Study|Adverse Event|14|||
48789125|NCT00377234|157067741|FG001|Overall Study|Adverse Event|17|||
48789126|NCT00377234|157067740|FG000|Overall Study|Withdrawal by Subject|11|||
48789127|NCT00377234|157067741|FG001|Overall Study|Withdrawal by Subject|9|||
48789128|NCT00377234|157067740|FG000|Overall Study|Lost to Follow-up|4|||
48789129|NCT00377234|157067741|FG001|Overall Study|Lost to Follow-up|2|||
48789130|NCT00377234|157067740|FG000|Overall Study|Administrative|2|||
48400872|NCT02302963|155657845|FG000|Overall Study|Withdrawal by Subject|2|||
48400873|NCT02302963|155657846|FG001|Overall Study|Withdrawal by Subject|1|||
48400874|NCT02302963|155657845|FG000|Overall Study|Steroid injection|0|||
48400875|NCT02302963|155657846|FG001|Overall Study|Steroid injection|1|||
48789131|NCT00377234|157067741|FG001|Overall Study|Administrative|1|||
48789132|NCT00377234|157067740|FG000|Overall Study|Not assigned|3|||
48789133|NCT00377234|157067741|FG001|Overall Study|Not assigned|2|||
48789134|NCT01585103|157067742|FG000|Overall Study|Unable to swallow Cytosponge|6|||
48789135|NCT02564523|157067743|FG000|Overall Study|Withdrawal by Subject|3|||
48789136|NCT02564523|157067744|FG001|Overall Study|Withdrawal by Subject|0|||
48789137|NCT02564523|157067745|FG002|Overall Study|Withdrawal by Subject|1|||
48789138|NCT02564523|157067746|FG003|Overall Study|Withdrawal by Subject|0|||
48789139|NCT02564523|157067747|FG004|Overall Study|Withdrawal by Subject|1|||
48789140|NCT02564523|157067748|FG005|Overall Study|Withdrawal by Subject|0|||
48789141|NCT02564523|157067749|FG006|Overall Study|Withdrawal by Subject|1|||
48789142|NCT02564523|157067750|FG007|Overall Study|Withdrawal by Subject|0|||
48789143|NCT02564523|157067751|FG008|Overall Study|Withdrawal by Subject|0|||
48789144|NCT02564523|157067752|FG009|Overall Study|Withdrawal by Subject|0|||
48789145|NCT02564523|157067753|FG010|Overall Study|Withdrawal by Subject|1|||
48789146|NCT02564523|157067754|FG011|Overall Study|Withdrawal by Subject|0|||
48789147|NCT02564523|157067755|FG012|Overall Study|Withdrawal by Subject|1|||
48789148|NCT02564523|157067756|FG013|Overall Study|Withdrawal by Subject|0|||
48400876|NCT02302963|155657845|FG000|Overall Study|Physician Decision|1|||
48400877|NCT02302963|155657846|FG001|Overall Study|Physician Decision|0|||
48400878|NCT02361216|155657849|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
48789149|NCT02564523|157067757|FG014|Overall Study|Withdrawal by Subject|0|||
48789150|NCT02564523|157067758|FG015|Overall Study|Withdrawal by Subject|0|||
48789151|NCT02564523|157067759|FG016|Overall Study|Withdrawal by Subject|0|||
48400879|NCT02361216|155657850|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
48400880|NCT02361216|155657849|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
48789152|NCT02564523|157067760|FG017|Overall Study|Withdrawal by Subject|0|||
48789153|NCT02564523|157067743|FG000|Overall Study|Adverse Event|0|||
48789154|NCT02564523|157067744|FG001|Overall Study|Adverse Event|0|||
48789155|NCT02564523|157067745|FG002|Overall Study|Adverse Event|0|||
48789156|NCT02564523|157067746|FG003|Overall Study|Adverse Event|0|||
48789157|NCT02564523|157067747|FG004|Overall Study|Adverse Event|0|||
48789158|NCT02564523|157067748|FG005|Overall Study|Adverse Event|0|||
48789159|NCT02564523|157067749|FG006|Overall Study|Adverse Event|0|||
48789160|NCT02564523|157067750|FG007|Overall Study|Adverse Event|0|||
48789161|NCT02564523|157067751|FG008|Overall Study|Adverse Event|0|||
48789162|NCT02564523|157067752|FG009|Overall Study|Adverse Event|0|||
48789163|NCT02564523|157067753|FG010|Overall Study|Adverse Event|0|||
48789164|NCT02564523|157067754|FG011|Overall Study|Adverse Event|0|||
48789165|NCT02564523|157067755|FG012|Overall Study|Adverse Event|0|||
48789166|NCT02564523|157067756|FG013|Overall Study|Adverse Event|0|||
48789167|NCT02564523|157067757|FG014|Overall Study|Adverse Event|0|||
48789168|NCT02564523|157067758|FG015|Overall Study|Adverse Event|0|||
48789169|NCT02564523|157067759|FG016|Overall Study|Adverse Event|0|||
48789170|NCT02564523|157067760|FG017|Overall Study|Adverse Event|1|||
48789171|NCT02564523|157067743|FG000|Overall Study|Death|0|||
48789172|NCT02564523|157067744|FG001|Overall Study|Death|0|||
48789173|NCT02564523|157067745|FG002|Overall Study|Death|0|||
48789174|NCT02564523|157067746|FG003|Overall Study|Death|0|||
48789175|NCT02564523|157067747|FG004|Overall Study|Death|0|||
48789176|NCT02564523|157067748|FG005|Overall Study|Death|0|||
48789177|NCT02564523|157067749|FG006|Overall Study|Death|1|||
48789178|NCT02564523|157067750|FG007|Overall Study|Death|0|||
48789179|NCT02564523|157067751|FG008|Overall Study|Death|0|||
48789180|NCT02564523|157067752|FG009|Overall Study|Death|0|||
48789181|NCT02564523|157067753|FG010|Overall Study|Death|1|||
48789182|NCT02564523|157067754|FG011|Overall Study|Death|0|||
48789183|NCT02564523|157067755|FG012|Overall Study|Death|0|||
48789184|NCT02564523|157067756|FG013|Overall Study|Death|0|||
48789185|NCT02564523|157067757|FG014|Overall Study|Death|0|||
48789186|NCT02564523|157067758|FG015|Overall Study|Death|0|||
48789187|NCT02564523|157067759|FG016|Overall Study|Death|0|||
48789188|NCT02564523|157067760|FG017|Overall Study|Death|0|||
48789189|NCT02564523|157067743|FG000|Overall Study|Lost to Follow-up|2|||
48789190|NCT02564523|157067744|FG001|Overall Study|Lost to Follow-up|1|||
48789191|NCT02564523|157067745|FG002|Overall Study|Lost to Follow-up|4|||
48789192|NCT02564523|157067746|FG003|Overall Study|Lost to Follow-up|0|||
48789193|NCT02564523|157067747|FG004|Overall Study|Lost to Follow-up|1|||
48789194|NCT02564523|157067748|FG005|Overall Study|Lost to Follow-up|0|||
48789195|NCT02564523|157067749|FG006|Overall Study|Lost to Follow-up|1|||
48789196|NCT02564523|157067750|FG007|Overall Study|Lost to Follow-up|0|||
48789197|NCT02564523|157067751|FG008|Overall Study|Lost to Follow-up|0|||
48789198|NCT02564523|157067752|FG009|Overall Study|Lost to Follow-up|0|||
48789199|NCT02564523|157067753|FG010|Overall Study|Lost to Follow-up|0|||
48789200|NCT02564523|157067754|FG011|Overall Study|Lost to Follow-up|1|||
48789201|NCT02564523|157067755|FG012|Overall Study|Lost to Follow-up|1|||
48789202|NCT02564523|157067756|FG013|Overall Study|Lost to Follow-up|0|||
48789203|NCT02564523|157067757|FG014|Overall Study|Lost to Follow-up|0|||
48789204|NCT02564523|157067758|FG015|Overall Study|Lost to Follow-up|0|||
48789205|NCT02564523|157067759|FG016|Overall Study|Lost to Follow-up|0|||
48789206|NCT02564523|157067760|FG017|Overall Study|Lost to Follow-up|0|||
48789207|NCT02564523|157067743|FG000|Overall Study|Physician Decision|0|||
48789208|NCT02564523|157067744|FG001|Overall Study|Physician Decision|0|||
48789209|NCT02564523|157067745|FG002|Overall Study|Physician Decision|0|||
48789210|NCT02564523|157067746|FG003|Overall Study|Physician Decision|0|||
48789211|NCT02564523|157067747|FG004|Overall Study|Physician Decision|1|||
48789212|NCT02564523|157067748|FG005|Overall Study|Physician Decision|0|||
48789213|NCT02564523|157067749|FG006|Overall Study|Physician Decision|0|||
48789214|NCT02564523|157067750|FG007|Overall Study|Physician Decision|0|||
48789215|NCT02564523|157067751|FG008|Overall Study|Physician Decision|0|||
48789216|NCT02564523|157067752|FG009|Overall Study|Physician Decision|0|||
48789217|NCT02564523|157067753|FG010|Overall Study|Physician Decision|1|||
48789218|NCT02564523|157067754|FG011|Overall Study|Physician Decision|0|||
48789219|NCT02564523|157067755|FG012|Overall Study|Physician Decision|0|||
48356812|NCT03246347|155503507|FG000|Overall Study|On Study|23|||
48356813|NCT02419417|155503508|FG000|Overall Study|Disease progression|5|||
48356814|NCT02419417|155503509|FG001|Overall Study|Disease progression|4|||
48356815|NCT02419417|155503510|FG002|Overall Study|Disease progression|13|||
48356816|NCT02419417|155503511|FG003|Overall Study|Disease progression|10|||
48356817|NCT02419417|155503512|FG004|Overall Study|Disease progression|10|||
48356818|NCT02419417|155503513|FG005|Overall Study|Disease progression|3|||
48356819|NCT02419417|155503514|FG006|Overall Study|Disease progression|4|||
48356820|NCT02419417|155503515|FG007|Overall Study|Disease progression|5|||
48356821|NCT02419417|155503516|FG008|Overall Study|Disease progression|13|||
48789220|NCT02564523|157067756|FG013|Overall Study|Physician Decision|0|||
48789221|NCT02564523|157067757|FG014|Overall Study|Physician Decision|0|||
48789222|NCT02564523|157067758|FG015|Overall Study|Physician Decision|0|||
48356822|NCT02419417|155503517|FG009|Overall Study|Disease progression|9|||
48789223|NCT02564523|157067759|FG016|Overall Study|Physician Decision|0|||
48789224|NCT02564523|157067760|FG017|Overall Study|Physician Decision|0|||
48789225|NCT02564523|157067743|FG000|Overall Study|Protocol Violation|2|||
48789226|NCT02564523|157067744|FG001|Overall Study|Protocol Violation|2|||
48789227|NCT02564523|157067745|FG002|Overall Study|Protocol Violation|5|||
48789228|NCT02564523|157067746|FG003|Overall Study|Protocol Violation|0|||
48789229|NCT02564523|157067747|FG004|Overall Study|Protocol Violation|1|||
48789230|NCT02564523|157067748|FG005|Overall Study|Protocol Violation|0|||
48789231|NCT02564523|157067749|FG006|Overall Study|Protocol Violation|0|||
48789232|NCT02564523|157067750|FG007|Overall Study|Protocol Violation|0|||
48789233|NCT02564523|157067751|FG008|Overall Study|Protocol Violation|0|||
48789234|NCT02564523|157067752|FG009|Overall Study|Protocol Violation|0|||
48789235|NCT02564523|157067753|FG010|Overall Study|Protocol Violation|0|||
48789236|NCT02564523|157067754|FG011|Overall Study|Protocol Violation|0|||
48789237|NCT02564523|157067755|FG012|Overall Study|Protocol Violation|0|||
48789238|NCT02564523|157067756|FG013|Overall Study|Protocol Violation|0|||
48789239|NCT02564523|157067757|FG014|Overall Study|Protocol Violation|0|||
48789240|NCT02564523|157067758|FG015|Overall Study|Protocol Violation|0|||
48789241|NCT02564523|157067759|FG016|Overall Study|Protocol Violation|0|||
48789242|NCT02564523|157067760|FG017|Overall Study|Protocol Violation|0|||
48789243|NCT02564523|157067743|FG000|Overall Study|Other|3|||
48789244|NCT02564523|157067744|FG001|Overall Study|Other|0|||
48789245|NCT02564523|157067745|FG002|Overall Study|Other|0|||
48789246|NCT02564523|157067746|FG003|Overall Study|Other|1|||
48789247|NCT02564523|157067747|FG004|Overall Study|Other|0|||
48789248|NCT02564523|157067748|FG005|Overall Study|Other|0|||
48789249|NCT02564523|157067749|FG006|Overall Study|Other|0|||
48789250|NCT02564523|157067750|FG007|Overall Study|Other|0|||
48789251|NCT02564523|157067751|FG008|Overall Study|Other|0|||
48789252|NCT02564523|157067752|FG009|Overall Study|Other|0|||
48789253|NCT02564523|157067753|FG010|Overall Study|Other|0|||
48789254|NCT02564523|157067754|FG011|Overall Study|Other|0|||
48789255|NCT02564523|157067755|FG012|Overall Study|Other|0|||
48789256|NCT02564523|157067756|FG013|Overall Study|Other|0|||
48789257|NCT02564523|157067757|FG014|Overall Study|Other|0|||
48789258|NCT02564523|157067758|FG015|Overall Study|Other|0|||
48789259|NCT02564523|157067759|FG016|Overall Study|Other|0|||
48789260|NCT02564523|157067760|FG017|Overall Study|Other|0|||
48789261|NCT02097472|157067764|FG000|Received Vaccination 2|Adverse Event|0|||
48789262|NCT02097472|157067765|FG001|Received Vaccination 2|Adverse Event|0|||
48789263|NCT02097472|157067766|FG002|Received Vaccination 2|Adverse Event|0|||
48789264|NCT02097472|157067767|FG003|Received Vaccination 2|Adverse Event|0|||
48789265|NCT02097472|157067768|FG004|Received Vaccination 2|Adverse Event|0|||
48789266|NCT02097472|157067769|FG005|Received Vaccination 2|Adverse Event|0|||
48789267|NCT02097472|157067770|FG006|Received Vaccination 2|Adverse Event|1|||
48789268|NCT02097472|157067771|FG007|Received Vaccination 2|Adverse Event|0|||
48789269|NCT01221597|157067772|FG000|Overall Study|Adverse Event|4|||
48789270|NCT01221597|157067773|FG001|Overall Study|Adverse Event|1|||
48789271|NCT01221597|157067772|FG000|Overall Study|Withdrawal by Subject|20|||
48789272|NCT01221597|157067773|FG001|Overall Study|Withdrawal by Subject|6|||
48789273|NCT01221597|157067772|FG000|Overall Study|Lost to Follow-up|6|||
48789274|NCT01221597|157067773|FG001|Overall Study|Lost to Follow-up|5|||
48789275|NCT01221597|157067772|FG000|Overall Study|Protocol Violation|1|||
48789276|NCT01221597|157067773|FG001|Overall Study|Protocol Violation|0|||
48789277|NCT01221597|157067772|FG000|Overall Study|Other|3|||
48789278|NCT01221597|157067773|FG001|Overall Study|Other|4|||
48789279|NCT01221597|157067772|FG000|Overall Study|Death|2|||
48789280|NCT01221597|157067773|FG001|Overall Study|Death|0|||
48789281|NCT03643952|157067774|FG000|Overall Study|Lack of Efficacy|1|||
48789282|NCT02592330|157067778|FG000|Overall Study|Withdrawal by Subject|1|||
48789283|NCT02592330|157067779|FG001|Overall Study|Withdrawal by Subject|0|||
48789284|NCT02592330|157067778|FG000|Overall Study|Failed Biopsy|1|||
48789285|NCT02592330|157067779|FG001|Overall Study|Failed Biopsy|0|||
48789286|NCT01854827|157067780|FG000|Overall Study|Death|1|||
48789287|NCT01491854|157067781|FG000|Overall Study|mainly due to premature termination|93|||
48789288|NCT01491854|157067781|FG000|Overall Study|Death|1|||
48789289|NCT01491854|157067781|FG000|Overall Study|Withdrawal by Subject|3|||
48789290|NCT01491854|157067781|FG000|Overall Study|Lost to Follow-up|33|||
48789291|NCT02347761|157067784|FG000|All Collected|Death|1|||
48789292|NCT02347761|157067785|FG001|All Collected|Death|0|||
48789293|NCT02347761|157067786|FG002|All Collected|Death|0|||
48789294|NCT02347761|157067784|FG000|All Collected|Lost to Follow-up|3|||
48789295|NCT02347761|157067785|FG001|All Collected|Lost to Follow-up|2|||
48789296|NCT02347761|157067786|FG002|All Collected|Lost to Follow-up|3|||
48789297|NCT02347761|157067784|FG000|All Collected|Withdrawal by Subject|11|||
48789298|NCT02347761|157067785|FG001|All Collected|Withdrawal by Subject|11|||
48789299|NCT02347761|157067786|FG002|All Collected|Withdrawal by Subject|22|||
48789300|NCT02347761|157067784|FG000|All Collected|invetigator disretion|2|||
48789301|NCT02347761|157067785|FG001|All Collected|invetigator disretion|0|||
48789302|NCT02347761|157067786|FG002|All Collected|invetigator disretion|0|||
48789303|NCT02347761|157067784|FG000|All Collected|instillation site pain|0|||
48789304|NCT02347761|157067785|FG001|All Collected|instillation site pain|0|||
48789305|NCT02347761|157067786|FG002|All Collected|instillation site pain|1|||
48789306|NCT02347761|157067784|FG000|All Collected|exacerbation of COPD|0|||
48789307|NCT02347761|157067785|FG001|All Collected|exacerbation of COPD|0|||
48789308|NCT02347761|157067786|FG002|All Collected|exacerbation of COPD|1|||
48789309|NCT02347761|157067784|FG000|All Collected|moved/travel|0|||
48789310|NCT02347761|157067785|FG001|All Collected|moved/travel|1|||
48789311|NCT02347761|157067786|FG002|All Collected|moved/travel|0|||
48789312|NCT02347761|157067784|FG000|On Study Treatment|Lack of Efficacy|2|||
48789313|NCT02347761|157067785|FG001|On Study Treatment|Lack of Efficacy|3|||
48789314|NCT02347761|157067786|FG002|On Study Treatment|Lack of Efficacy|4|||
48789315|NCT02347761|157067784|FG000|On Study Treatment|non-compliance with study medication|0|||
48789316|NCT02347761|157067785|FG001|On Study Treatment|non-compliance with study medication|0|||
48789317|NCT02347761|157067786|FG002|On Study Treatment|non-compliance with study medication|2|||
48789318|NCT02347761|157067784|FG000|On Study Treatment|Withdrawal by Subject|7|||
48789319|NCT02347761|157067785|FG001|On Study Treatment|Withdrawal by Subject|3|||
48789320|NCT02347761|157067786|FG002|On Study Treatment|Withdrawal by Subject|5|||
48789321|NCT02347761|157067784|FG000|On Study Treatment|move/travel|2|||
48789322|NCT02347761|157067785|FG001|On Study Treatment|move/travel|6|||
48789323|NCT02347761|157067786|FG002|On Study Treatment|move/travel|5|||
48789324|NCT02347761|157067784|FG000|On Study Treatment|dissastisfaction with device|2|||
48789325|NCT02347761|157067785|FG001|On Study Treatment|dissastisfaction with device|1|||
48789326|NCT02347761|157067786|FG002|On Study Treatment|dissastisfaction with device|4|||
48789327|NCT02347761|157067784|FG000|On Study Treatment|Lost to Follow-up|2|||
48789328|NCT02347761|157067785|FG001|On Study Treatment|Lost to Follow-up|1|||
48789329|NCT02347761|157067786|FG002|On Study Treatment|Lost to Follow-up|1|||
48789330|NCT02347761|157067784|FG000|On Study Treatment|investigator discretion|2|||
48789331|NCT02347761|157067785|FG001|On Study Treatment|investigator discretion|0|||
48789332|NCT02347761|157067786|FG002|On Study Treatment|investigator discretion|0|||
48789333|NCT02347761|157067784|FG000|On Study Treatment|durg not working|0|||
48789334|NCT02347761|157067785|FG001|On Study Treatment|durg not working|1|||
48789335|NCT02347761|157067786|FG002|On Study Treatment|durg not working|1|||
48789336|NCT02347761|157067784|FG000|On Study Treatment|Adverse Event|10|||
48789337|NCT02347761|157067785|FG001|On Study Treatment|Adverse Event|8|||
48789338|NCT02347761|157067786|FG002|On Study Treatment|Adverse Event|20|||
48789339|NCT01380327|157067787|FG000|Overall Study|Lost to Follow-up|0|||
48789340|NCT01380327|157067788|FG001|Overall Study|Lost to Follow-up|1|||
48789341|NCT01380327|157067789|FG002|Overall Study|Lost to Follow-up|1|||
48789342|NCT01380327|157067787|FG000|Overall Study|Protocol Violation|3|||
48789343|NCT01380327|157067788|FG001|Overall Study|Protocol Violation|2|||
48356823|NCT02419417|155503518|FG010|Overall Study|Disease progression|0|||
48356824|NCT02419417|155503508|FG000|Overall Study|Study drug toxicity|0|||
48356825|NCT02419417|155503509|FG001|Overall Study|Study drug toxicity|0|||
48356826|NCT02419417|155503510|FG002|Overall Study|Study drug toxicity|0|||
48356827|NCT02419417|155503511|FG003|Overall Study|Study drug toxicity|0|||
48356828|NCT02419417|155503512|FG004|Overall Study|Study drug toxicity|1|||
48789344|NCT01380327|157067789|FG002|Overall Study|Protocol Violation|3|||
48789345|NCT01380327|157067787|FG000|Overall Study|Withdrawal by Subject|0|||
48789346|NCT01380327|157067788|FG001|Overall Study|Withdrawal by Subject|0|||
48789347|NCT01380327|157067789|FG002|Overall Study|Withdrawal by Subject|1|||
48789348|NCT01380327|157067787|FG000|Overall Study|Housing situation precluded ability to k|0|||
48789349|NCT01380327|157067788|FG001|Overall Study|Housing situation precluded ability to k|0|||
48789350|NCT01380327|157067789|FG002|Overall Study|Housing situation precluded ability to k|1|||
48789351|NCT01380327|157067787|FG000|Overall Study|Questionable onset of epilepsy|0|||
48789352|NCT01380327|157067788|FG001|Overall Study|Questionable onset of epilepsy|0|||
48789353|NCT01380327|157067789|FG002|Overall Study|Questionable onset of epilepsy|1|||
48789354|NCT00476476|157067790|FG000|Overall Study|Adverse Event|2|||
48789355|NCT00476476|157067791|FG001|Overall Study|Adverse Event|7|||
48356829|NCT02419417|155503513|FG005|Overall Study|Study drug toxicity|0|||
48356830|NCT02419417|155503514|FG006|Overall Study|Study drug toxicity|0|||
48356831|NCT02419417|155503515|FG007|Overall Study|Study drug toxicity|0|||
48356832|NCT02419417|155503516|FG008|Overall Study|Study drug toxicity|0|||
48356833|NCT02419417|155503517|FG009|Overall Study|Study drug toxicity|0|||
48356834|NCT02419417|155503518|FG010|Overall Study|Study drug toxicity|0|||
48356835|NCT02419417|155503508|FG000|Overall Study|Adverse event unrelated to study drug|0|||
48356836|NCT02419417|155503509|FG001|Overall Study|Adverse event unrelated to study drug|0|||
48356837|NCT02419417|155503510|FG002|Overall Study|Adverse event unrelated to study drug|0|||
48356838|NCT02419417|155503511|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48356839|NCT02419417|155503512|FG004|Overall Study|Adverse event unrelated to study drug|2|||
48356840|NCT02419417|155503513|FG005|Overall Study|Adverse event unrelated to study drug|1|||
48356841|NCT02419417|155503514|FG006|Overall Study|Adverse event unrelated to study drug|0|||
48356842|NCT02419417|155503515|FG007|Overall Study|Adverse event unrelated to study drug|1|||
48356843|NCT02419417|155503516|FG008|Overall Study|Adverse event unrelated to study drug|0|||
48789356|NCT00476476|157067790|FG000|Overall Study|Progressive Disease|0|||
48789357|NCT00476476|157067791|FG001|Overall Study|Progressive Disease|17|||
48789358|NCT01540851|157067792|FG000|Overall Study|Lost to Follow-up|14|||
48400881|NCT02361216|155657850|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
48400882|NCT02361216|155657849|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
48400883|NCT02361216|155657850|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
48789359|NCT01540851|157067793|FG001|Overall Study|Lost to Follow-up|15|||
48789360|NCT01540851|157067792|FG000|Overall Study|Withdrawal by Subject|7|||
48789361|NCT01540851|157067793|FG001|Overall Study|Withdrawal by Subject|3|||
48789362|NCT00937924|157067796|FG000|Overall Study|Lost to Follow-up|44|||
48789363|NCT00937924|157067797|FG001|Overall Study|Lost to Follow-up|44|||
48789364|NCT00937924|157067798|FG002|Overall Study|Lost to Follow-up|41|||
48789365|NCT04515576|157067801|FG000|Overall Study|Withdrawal by Subject|0|||
48789366|NCT04515576|157067802|FG001|Overall Study|Withdrawal by Subject|0|||
48789367|NCT04515576|157067803|FG002|Overall Study|Withdrawal by Subject|0|||
48789368|NCT04515576|157067804|FG003|Overall Study|Withdrawal by Subject|0|||
48789369|NCT04515576|157067805|FG004|Overall Study|Withdrawal by Subject|0|||
48789370|NCT04515576|157067806|FG005|Overall Study|Withdrawal by Subject|1|||
48789371|NCT03850678|157067807|FG000|Overall Study|Withdrawal by Subject|3|||
48789372|NCT03850678|157067808|FG001|Overall Study|Withdrawal by Subject|0|||
48789373|NCT03850678|157067807|FG000|Overall Study|Experimenter Error|1|||
48789374|NCT03850678|157067808|FG001|Overall Study|Experimenter Error|1|||
48789375|NCT03850678|157067807|FG000|Overall Study|Did Not Condition To Experiment|7|||
48789376|NCT03850678|157067808|FG001|Overall Study|Did Not Condition To Experiment|2|||
48789377|NCT00099437|157067814|FG000|Overall Study|Lost to Follow-up|30|||
48789378|NCT00099437|157067815|FG001|Overall Study|Lost to Follow-up|33|||
48789379|NCT00099437|157067814|FG000|Overall Study|Death|293|||
48789380|NCT00099437|157067815|FG001|Overall Study|Death|261|||
48789381|NCT00099437|157067814|FG000|Overall Study|Withdrawal by Subject|6|||
48789382|NCT00099437|157067815|FG001|Overall Study|Withdrawal by Subject|10|||
48789383|NCT00099437|157067814|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
48789384|NCT00099437|157067815|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
48789385|NCT04973254|157067816|FG000|Overall Study|Not adherent|0|||
48789386|NCT04973254|157067817|FG001|Overall Study|Not adherent|1|||
48789387|NCT04973254|157067818|FG002|Overall Study|Not adherent|0|||
48789388|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
48789389|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
48789390|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
48789391|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
48789392|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
48789393|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
48789394|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
48789395|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
48789396|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
48789397|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
48789398|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
48789399|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
48789400|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
48789401|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
48789402|NCT02288247|157067819|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
48789403|NCT02288247|157067820|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
48789404|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
48789405|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
48789406|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
48789407|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
48789408|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
48789409|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
48789410|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
48789411|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
48789412|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
48789413|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
48789414|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
48789415|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
48789416|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
48789417|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
48789418|NCT02288247|157067819|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
48789419|NCT02288247|157067820|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
48789420|NCT01672801|157067823|FG000|Overall Study|Screen Failure|0|||
48789421|NCT01672801|157067824|FG001|Overall Study|Screen Failure|1|||
48789422|NCT01362140|157067825|FG000|Overall Study|Noncompliance|1|||
48789423|NCT01362140|157067826|FG001|Overall Study|Noncompliance|0|||
48789424|NCT01362140|157067825|FG000|Overall Study|Adverse Event|2|||
48789425|NCT01362140|157067826|FG001|Overall Study|Adverse Event|2|||
48789426|NCT01362140|157067825|FG000|Overall Study|Withdrawal by Subject|3|||
48789427|NCT01362140|157067826|FG001|Overall Study|Withdrawal by Subject|3|||
48789428|NCT01362140|157067825|FG000|Overall Study|Administrative Decision|0|||
48789429|NCT01362140|157067826|FG001|Overall Study|Administrative Decision|1|||
48400884|NCT02361216|155657849|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
48789430|NCT01362140|157067825|FG000|Overall Study|Death|2|||
48789431|NCT01362140|157067826|FG001|Overall Study|Death|1|||
48789432|NCT01362140|157067825|FG000|Overall Study|Other|1|||
48789433|NCT01362140|157067826|FG001|Overall Study|Other|1|||
48789434|NCT01362140|157067825|FG000|Overall Study|Protocol-specified Criteria|1|||
48789435|NCT01362140|157067826|FG001|Overall Study|Protocol-specified Criteria|2|||
48789436|NCT01362140|157067825|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
48789437|NCT01362140|157067826|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
48789438|NCT05553808|157067827|FG000|Overall Study|Death|25|||
48789439|NCT05553808|157067828|FG001|Overall Study|Death|62|||
48789440|NCT05553808|157067827|FG000|Overall Study|Site Closed|6|||
48789441|NCT05553808|157067828|FG001|Overall Study|Site Closed|6|||
48789442|NCT05553808|157067827|FG000|Overall Study|Lost to Follow-up|1|||
48789443|NCT05553808|157067828|FG001|Overall Study|Lost to Follow-up|0|||
48789444|NCT05553808|157067827|FG000|Overall Study|Withdrawal by Subject|3|||
48789445|NCT05553808|157067828|FG001|Overall Study|Withdrawal by Subject|2|||
48789446|NCT02734212|157067830|FG000|Overall Study|Lost to Follow-up|5|||
48789447|NCT02734212|157067831|FG001|Overall Study|Lost to Follow-up|10|||
48789448|NCT01764945|157067837|FG000|Overall Study|Adverse Event|0|||
48789449|NCT01764945|157067838|FG001|Overall Study|Adverse Event|1|||
48789450|NCT01764945|157067839|FG002|Overall Study|Adverse Event|0|||
48789451|NCT01764945|157067840|FG003|Overall Study|Adverse Event|0|||
48789452|NCT01764945|157067841|FG004|Overall Study|Adverse Event|0|||
48789453|NCT01764945|157067842|FG005|Overall Study|Adverse Event|0|||
48789454|NCT01764945|157067843|FG006|Overall Study|Adverse Event|1|||
48789455|NCT01764945|157067844|FG007|Overall Study|Adverse Event|0|||
48789456|NCT02576067|157067856|FG000|Overall Study|Death|0|||
48789457|NCT02576067|157067857|FG001|Overall Study|Death|1|||
48789458|NCT02576067|157067856|FG000|Overall Study|Lack of Efficacy|1|||
48789459|NCT02576067|157067857|FG001|Overall Study|Lack of Efficacy|0|||
48789460|NCT02576067|157067856|FG000|Overall Study|Lost to Follow-up|11|||
48789461|NCT02576067|157067857|FG001|Overall Study|Lost to Follow-up|0|||
48789462|NCT02576067|157067856|FG000|Overall Study|Withdrawal by Subject|11|||
48789463|NCT02576067|157067857|FG001|Overall Study|Withdrawal by Subject|2|||
48789464|NCT02576067|157067856|FG000|Overall Study|study closure of main CIRT trial)|0|||
48789465|NCT02576067|157067857|FG001|Overall Study|study closure of main CIRT trial)|8|||
48789466|NCT02576067|157067856|FG000|Overall Study|not randomized, failed run-in|7|||
48789467|NCT02576067|157067857|FG001|Overall Study|not randomized, failed run-in|0|||
48789468|NCT02576067|157067856|FG000|Overall Study|screen failure/ re-enrolled|0|||
48789469|NCT02576067|157067857|FG001|Overall Study|screen failure/ re-enrolled|25|||
48789470|NCT02576067|157067856|FG000|Overall Study|Physician Decision|4|||
48789471|NCT02576067|157067857|FG001|Overall Study|Physician Decision|0|||
48789472|NCT00622167|157067858|FG000|Overall Study|Did not meet angiographic criteria|20|||
48789473|NCT03336619|157067859|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
48789474|NCT03336619|157067860|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
48789475|NCT03336619|157067859|FG000|Overall Study|Withdrawal by Subject|17|||
48789476|NCT03336619|157067860|FG001|Overall Study|Withdrawal by Subject|16|||
48789477|NCT03336619|157067859|FG000|Overall Study|Adverse Event|2|||
48789478|NCT03336619|157067860|FG001|Overall Study|Adverse Event|5|||
48789479|NCT03336619|157067859|FG000|Overall Study|Physician Decision|3|||
48789480|NCT03336619|157067860|FG001|Overall Study|Physician Decision|0|||
48789481|NCT00627705|157067863|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
48789482|NCT00627705|157067864|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
48789483|NCT00627705|157067863|FG000|Overall Study|Adverse Event|1|||
48789484|NCT00627705|157067864|FG001|Overall Study|Adverse Event|0|||
48789485|NCT00627705|157067863|FG000|Overall Study|Withdrawal by Subject|0|||
48789486|NCT00627705|157067864|FG001|Overall Study|Withdrawal by Subject|2|||
48789487|NCT00627705|157067863|FG000|Overall Study|Lost to Follow-up|0|||
48789488|NCT00627705|157067864|FG001|Overall Study|Lost to Follow-up|1|||
48789489|NCT02625623|157067866|FG000|Overall Study|Participants randomized but not treated|9|||
48789490|NCT02625623|157067867|FG001|Overall Study|Participants randomized but not treated|1|||
48789491|NCT01371851|157067868|FG000|Overall Study|Lost to Follow-up|5|||
48789492|NCT01371851|157067869|FG001|Overall Study|Lost to Follow-up|8|||
48789493|NCT01371851|157067868|FG000|Overall Study|was arrested and put in jail|0|||
48789494|NCT01371851|157067869|FG001|Overall Study|was arrested and put in jail|1|||
48789495|NCT01371851|157067868|FG000|Overall Study|non study related adverse event|1|||
48789496|NCT01371851|157067869|FG001|Overall Study|non study related adverse event|0|||
48789497|NCT01371851|157067868|FG000|Overall Study|Blood Pressure outside study parameters|2|||
48789498|NCT01371851|157067869|FG001|Overall Study|Blood Pressure outside study parameters|0|||
48789499|NCT02137369|157067871|FG000|Overall Study|Withdrawal by Subject|3|||
48789500|NCT02137369|157067872|FG001|Overall Study|Withdrawal by Subject|2|||
48789501|NCT02137369|157067871|FG000|Overall Study|Adverse Event|2|||
48789502|NCT02137369|157067872|FG001|Overall Study|Adverse Event|0|||
48789503|NCT02137369|157067871|FG000|Overall Study|Lost to Follow-up|1|||
48789504|NCT02137369|157067872|FG001|Overall Study|Lost to Follow-up|0|||
48789505|NCT02137369|157067871|FG000|Overall Study|Moved away|2|||
48789506|NCT02137369|157067872|FG001|Overall Study|Moved away|0|||
48789507|NCT05608629|157067874|FG000|Overall Study|Lost to Follow-up|2|||
48789508|NCT01667432|157067877|FG000|Overall Study|Premature Study Termination|26|||
48789509|NCT01667432|157067877|FG000|Overall Study|Failure to Return|10|||
48789510|NCT01667432|157067877|FG000|Overall Study|Moved to Another Center|3|||
48356844|NCT02419417|155503517|FG009|Overall Study|Adverse event unrelated to study drug|0|||
48356845|NCT02419417|155503518|FG010|Overall Study|Adverse event unrelated to study drug|0|||
48356846|NCT02419417|155503508|FG000|Overall Study|Participant request to discontinue|0|||
48356847|NCT02419417|155503509|FG001|Overall Study|Participant request to discontinue|0|||
48356848|NCT02419417|155503510|FG002|Overall Study|Participant request to discontinue|0|||
48356849|NCT02419417|155503511|FG003|Overall Study|Participant request to discontinue|0|||
48356850|NCT02419417|155503512|FG004|Overall Study|Participant request to discontinue|0|||
48356851|NCT02419417|155503513|FG005|Overall Study|Participant request to discontinue|0|||
48356852|NCT02419417|155503514|FG006|Overall Study|Participant request to discontinue|0|||
48356853|NCT02419417|155503515|FG007|Overall Study|Participant request to discontinue|0|||
48356854|NCT02419417|155503516|FG008|Overall Study|Participant request to discontinue|0|||
48356855|NCT02419417|155503517|FG009|Overall Study|Participant request to discontinue|1|||
48356856|NCT02419417|155503518|FG010|Overall Study|Participant request to discontinue|0|||
48356857|NCT02419417|155503508|FG000|Overall Study|Withdrawal by Subject|0|||
48356858|NCT02419417|155503509|FG001|Overall Study|Withdrawal by Subject|0|||
48356859|NCT02419417|155503510|FG002|Overall Study|Withdrawal by Subject|0|||
48356860|NCT02419417|155503511|FG003|Overall Study|Withdrawal by Subject|0|||
48356861|NCT02419417|155503512|FG004|Overall Study|Withdrawal by Subject|0|||
48356862|NCT02419417|155503513|FG005|Overall Study|Withdrawal by Subject|0|||
48356863|NCT02419417|155503514|FG006|Overall Study|Withdrawal by Subject|0|||
48356864|NCT02419417|155503515|FG007|Overall Study|Withdrawal by Subject|0|||
48356865|NCT02419417|155503516|FG008|Overall Study|Withdrawal by Subject|0|||
48356866|NCT02419417|155503517|FG009|Overall Study|Withdrawal by Subject|0|||
48356867|NCT02419417|155503518|FG010|Overall Study|Withdrawal by Subject|1|||
48356868|NCT02568397|155503519|FG000|Period 2|Withdrawal by Subject|0|||
48789511|NCT01667432|157067877|FG000|Overall Study|Lost to Follow-up|3|||
48789512|NCT01667432|157067877|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
48356869|NCT02568397|155503520|FG001|Period 2|Withdrawal by Subject|1|||
48789513|NCT01667432|157067877|FG000|Overall Study|Insufficient Therapeutic Response|4|||
48789514|NCT01667432|157067877|FG000|Overall Study|Adverse Event|1|||
48789515|NCT01667432|157067877|FG000|Overall Study|Protocol Deviation|2|||
48789516|NCT01667432|157067877|FG000|Overall Study|Principal Investigator Decision|1|||
48789517|NCT01667432|157067877|FG000|Overall Study|Reason Not Specified|2|||
48789518|NCT01667432|157067877|FG000|Overall Study|Missing Information|4|||
48789519|NCT03077724|157067878|FG000|Overall Study|Lost to Follow-up|5|||
48789520|NCT03077724|157067879|FG001|Overall Study|Lost to Follow-up|1|||
48789521|NCT03077724|157067878|FG000|Overall Study|Withdrawal by Subject|3|||
48789522|NCT03077724|157067879|FG001|Overall Study|Withdrawal by Subject|1|||
48789523|NCT02269670|157067880|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
48789524|NCT04707768|157067887|FG000|Overall Study|Adverse Event|9|||
48789525|NCT04707768|157067888|FG001|Overall Study|Adverse Event|18|||
48789526|NCT04707768|157067889|FG002|Overall Study|Adverse Event|3|||
48789527|NCT04707768|157067887|FG000|Overall Study|Investigator's Discretion|8|||
48789528|NCT04707768|157067888|FG001|Overall Study|Investigator's Discretion|4|||
48789529|NCT04707768|157067889|FG002|Overall Study|Investigator's Discretion|3|||
48789530|NCT04707768|157067887|FG000|Overall Study|Withdrawal by Subject|6|||
48789531|NCT04707768|157067888|FG001|Overall Study|Withdrawal by Subject|8|||
48789532|NCT04707768|157067889|FG002|Overall Study|Withdrawal by Subject|2|||
48789533|NCT04707768|157067887|FG000|Overall Study|Lack of Efficacy|1|||
48789534|NCT04707768|157067888|FG001|Overall Study|Lack of Efficacy|3|||
48789535|NCT04707768|157067889|FG002|Overall Study|Lack of Efficacy|0|||
48789536|NCT04707768|157067887|FG000|Overall Study|Lost to Follow-up|0|||
48789537|NCT04707768|157067888|FG001|Overall Study|Lost to Follow-up|0|||
48789538|NCT04707768|157067889|FG002|Overall Study|Lost to Follow-up|3|||
48789539|NCT04707768|157067887|FG000|Overall Study|Death|13|||
48789540|NCT04707768|157067888|FG001|Overall Study|Death|11|||
48789541|NCT04707768|157067889|FG002|Overall Study|Death|13|||
48789542|NCT04707768|157067887|FG000|Overall Study|Protocol Violation|2|||
48789543|NCT04707768|157067888|FG001|Overall Study|Protocol Violation|1|||
48789544|NCT04707768|157067889|FG002|Overall Study|Protocol Violation|0|||
48789545|NCT04707768|157067887|FG000|Overall Study|Non Compliance with Study Drug|1|||
48789546|NCT04707768|157067888|FG001|Overall Study|Non Compliance with Study Drug|0|||
48789547|NCT04707768|157067889|FG002|Overall Study|Non Compliance with Study Drug|0|||
48789548|NCT04707768|157067887|FG000|Overall Study|Transplant|4|||
48789549|NCT04707768|157067888|FG001|Overall Study|Transplant|4|||
48789550|NCT04707768|157067889|FG002|Overall Study|Transplant|8|||
48789551|NCT04707768|157067887|FG000|Overall Study|Other|9|||
48789552|NCT04707768|157067888|FG001|Overall Study|Other|5|||
48789553|NCT04707768|157067889|FG002|Overall Study|Other|2|||
48789554|NCT02489500|157069728|FG000|Overall Study|Death|1|||
48789555|NCT02489500|157069729|FG001|Overall Study|Death|1|||
48789556|NCT03912259|157069732|FG000|Overall Study|Adverse Event (AE)|2|||
48789557|NCT03912259|157069733|FG001|Overall Study|Adverse Event (AE)|4|||
48789558|NCT03912259|157069732|FG000|Overall Study|Lack of Efficacy|4|||
48789559|NCT03912259|157069733|FG001|Overall Study|Lack of Efficacy|1|||
48789560|NCT03912259|157069732|FG000|Overall Study|Withdrawal by Subject|11|||
48789561|NCT03912259|157069733|FG001|Overall Study|Withdrawal by Subject|1|||
48789562|NCT02091726|157069734|FG000|Overall Study|Lost to Follow-up|6|||
48789563|NCT04786444|157069735|FG000|Overall Study|Withdrawal by Subject|4|||
48789564|NCT04786444|157069736|FG001|Overall Study|Withdrawal by Subject|7|||
48789565|NCT04786444|157069737|FG002|Overall Study|Withdrawal by Subject|2|||
48789566|NCT04786444|157069735|FG000|Overall Study|Lost to Follow-up|11|||
48789567|NCT04786444|157069736|FG001|Overall Study|Lost to Follow-up|9|||
48789568|NCT04786444|157069737|FG002|Overall Study|Lost to Follow-up|10|||
48789569|NCT04786444|157069735|FG000|Overall Study|Subject would like to become pregnant|0|||
48789570|NCT04786444|157069736|FG001|Overall Study|Subject would like to become pregnant|1|||
48789571|NCT04786444|157069737|FG002|Overall Study|Subject would like to become pregnant|0|||
48789572|NCT01054820|157069738|FG000|Overall Study|Withdrawal by Subject|2|||
48789573|NCT02462876|157069739|FG000|Overall Study|Death|3|||
48789574|NCT02462876|157069739|FG000|Overall Study|Lost to Follow-up|7|||
48400885|NCT02361216|155657850|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
48400886|NCT02361216|155657849|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
48400887|NCT02361216|155657850|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
48400888|NCT02361216|155657849|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
48789575|NCT02462876|157069739|FG000|Overall Study|Surgical Bypass|9|||
48789576|NCT02462876|157069739|FG000|Overall Study|Amputation Above the Metatarsals|1|||
48789577|NCT02462876|157069739|FG000|Overall Study|36 months follow-up visit missed|1|||
48789578|NCT02462876|157069739|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
48400889|NCT02361216|155657850|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
48789579|NCT02462876|157069739|FG000|Overall Study|Patient did not come back to the vascular department|1|||
48789580|NCT02462876|157069739|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
48789581|NCT02462876|157069739|FG000|Overall Study|Patient refused to come back|1|||
48789582|NCT02462876|157069739|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
48789583|NCT02462876|157069739|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
48789584|NCT01217073|157069740|FG000|Base Period|Adverse Event|1|||
48789585|NCT01217073|157069741|FG001|Base Period|Adverse Event|0|||
48789586|NCT01217073|157069742|FG002|Base Period|Adverse Event|1|||
48789587|NCT01217073|157069743|FG003|Base Period|Adverse Event|0|||
48789588|NCT01217073|157069744|FG004|Base Period|Adverse Event|4|||
48789589|NCT01217073|157069745|FG005|Base Period|Adverse Event|1|||
48789590|NCT01217073|157069746|FG006|Base Period|Adverse Event|0|||
48789591|NCT01217073|157069747|FG007|Base Period|Adverse Event|0|||
48789592|NCT01217073|157069740|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
48789593|NCT01217073|157069741|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789594|NCT01217073|157069742|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789595|NCT01217073|157069743|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789596|NCT01217073|157069744|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789597|NCT01217073|157069745|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789598|NCT01217073|157069746|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789599|NCT01217073|157069747|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
48789600|NCT01217073|157069740|FG000|Base Period|Excluded medication|0|||
48789601|NCT01217073|157069741|FG001|Base Period|Excluded medication|0|||
48789602|NCT01217073|157069742|FG002|Base Period|Excluded medication|0|||
48789603|NCT01217073|157069743|FG003|Base Period|Excluded medication|0|||
48789604|NCT01217073|157069744|FG004|Base Period|Excluded medication|1|||
48789605|NCT01217073|157069745|FG005|Base Period|Excluded medication|0|||
48789606|NCT01217073|157069746|FG006|Base Period|Excluded medication|0|||
48400890|NCT03110900|155657851|FG000|Overall Study|Sponsor withdrew|1|||
48400891|NCT03110900|155657852|FG001|Overall Study|Sponsor withdrew|1|||
48400892|NCT00490568|155660140|FG000|Overall Study|Adverse Event|116|||
48400893|NCT00490568|155660140|FG000|Overall Study|Lost to Follow-up|13|||
48400894|NCT00490568|155660140|FG000|Overall Study|Protocol Violation|45|||
48400895|NCT00490568|155660140|FG000|Overall Study|Withdrawal by Subject|135|||
48789607|NCT01217073|157069747|FG007|Base Period|Excluded medication|0|||
48789608|NCT01217073|157069740|FG000|Base Period|Lack of Efficacy|0|||
48400896|NCT00490568|155660140|FG000|Overall Study|Still in the study at termination|974|||
48400897|NCT00490568|155660140|FG000|Overall Study|Other|1|||
48400898|NCT00490568|155660140|FG000|Overall Study|Exclusion criteria met|1|||
48400899|NCT00490568|155660140|FG000|Overall Study|Caregiver related|20|||
48400900|NCT00490568|155660140|FG000|Overall Study|Abnormal ECG|25|||
48400901|NCT00490568|155660140|FG000|Overall Study|Participant refused follow-up|9|||
48400902|NCT00490568|155660140|FG000|Overall Study|Legal representative withdrew consent|1|||
48400903|NCT00490568|155660140|FG000|Overall Study|Disease progression|4|||
48400904|NCT00490568|155660140|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
48400905|NCT00490568|155660140|FG000|Overall Study|Investigator decision|3|||
48400906|NCT00490568|155660140|FG000|Overall Study|Non-Compliance|7|||
48400907|NCT00490568|155660140|FG000|Overall Study|Efficacy related|3|||
48400908|NCT00490568|155660140|FG000|Overall Study|Participant died|1|||
48789609|NCT01217073|157069741|FG001|Base Period|Lack of Efficacy|0|||
48789610|NCT01217073|157069742|FG002|Base Period|Lack of Efficacy|0|||
48789611|NCT01217073|157069743|FG003|Base Period|Lack of Efficacy|0|||
48789612|NCT01217073|157069744|FG004|Base Period|Lack of Efficacy|0|||
48789613|NCT01217073|157069745|FG005|Base Period|Lack of Efficacy|1|||
48789614|NCT01217073|157069746|FG006|Base Period|Lack of Efficacy|0|||
48789615|NCT01217073|157069747|FG007|Base Period|Lack of Efficacy|0|||
48789616|NCT01217073|157069740|FG000|Base Period|Lost to Follow-up|0|||
48789617|NCT01217073|157069741|FG001|Base Period|Lost to Follow-up|0|||
48789618|NCT01217073|157069742|FG002|Base Period|Lost to Follow-up|1|||
48789619|NCT01217073|157069743|FG003|Base Period|Lost to Follow-up|1|||
48789620|NCT01217073|157069744|FG004|Base Period|Lost to Follow-up|3|||
48789621|NCT01217073|157069745|FG005|Base Period|Lost to Follow-up|0|||
48789622|NCT01217073|157069746|FG006|Base Period|Lost to Follow-up|0|||
48789623|NCT01217073|157069747|FG007|Base Period|Lost to Follow-up|0|||
48789624|NCT01217073|157069740|FG000|Base Period|Physician Decision|0|||
48400909|NCT00490568|155660140|FG000|Overall Study|Participant withdrawal due to surgery|1|||
48789625|NCT01217073|157069741|FG001|Base Period|Physician Decision|0|||
48789626|NCT01217073|157069742|FG002|Base Period|Physician Decision|0|||
48789627|NCT01217073|157069743|FG003|Base Period|Physician Decision|0|||
48789628|NCT01217073|157069744|FG004|Base Period|Physician Decision|1|||
48400910|NCT01964352|155660142|FG000|Overall Study|Adverse Event|13|||
48400911|NCT01964352|155660143|FG001|Overall Study|Adverse Event|3|||
48400912|NCT01964352|155660144|FG002|Overall Study|Adverse Event|4|||
48789629|NCT01217073|157069745|FG005|Base Period|Physician Decision|0|||
48789630|NCT01217073|157069746|FG006|Base Period|Physician Decision|0|||
48789631|NCT01217073|157069747|FG007|Base Period|Physician Decision|0|||
48789632|NCT01217073|157069740|FG000|Base Period|Protocol Violation|1|||
48789633|NCT01217073|157069741|FG001|Base Period|Protocol Violation|0|||
48789634|NCT01217073|157069742|FG002|Base Period|Protocol Violation|0|||
48789635|NCT01217073|157069743|FG003|Base Period|Protocol Violation|0|||
48789636|NCT01217073|157069744|FG004|Base Period|Protocol Violation|1|||
48400913|NCT01964352|155660145|FG003|Overall Study|Adverse Event|3|||
48789637|NCT01217073|157069745|FG005|Base Period|Protocol Violation|2|||
48789638|NCT01217073|157069746|FG006|Base Period|Protocol Violation|0|||
48789639|NCT01217073|157069747|FG007|Base Period|Protocol Violation|0|||
48789640|NCT01217073|157069740|FG000|Base Period|Withdrawal by Subject|4|||
48789641|NCT01217073|157069741|FG001|Base Period|Withdrawal by Subject|5|||
48789642|NCT01217073|157069742|FG002|Base Period|Withdrawal by Subject|5|||
48789643|NCT01217073|157069743|FG003|Base Period|Withdrawal by Subject|1|||
48789644|NCT01217073|157069744|FG004|Base Period|Withdrawal by Subject|5|||
48789645|NCT01217073|157069745|FG005|Base Period|Withdrawal by Subject|5|||
48789646|NCT01217073|157069746|FG006|Base Period|Withdrawal by Subject|0|||
48789647|NCT01217073|157069747|FG007|Base Period|Withdrawal by Subject|0|||
48789648|NCT01217073|157069740|FG000|Extension Period|Adverse Event|0|||
48789649|NCT01217073|157069741|FG001|Extension Period|Adverse Event|0|||
48789650|NCT01217073|157069742|FG002|Extension Period|Adverse Event|0|||
48789651|NCT01217073|157069743|FG003|Extension Period|Adverse Event|0|||
48789652|NCT01217073|157069744|FG004|Extension Period|Adverse Event|0|||
48789653|NCT01217073|157069745|FG005|Extension Period|Adverse Event|0|||
48586930|NCT00772005|156341480|FG001|Overall Study|Non-compliance with drug administration|0|||
48400914|NCT01964352|155660142|FG000|Overall Study|Lack of Efficacy|6|||
48400915|NCT01964352|155660143|FG001|Overall Study|Lack of Efficacy|0|||
48400916|NCT01964352|155660144|FG002|Overall Study|Lack of Efficacy|0|||
48400917|NCT01964352|155660145|FG003|Overall Study|Lack of Efficacy|0|||
48400918|NCT01964352|155660142|FG000|Overall Study|Protocol Violation|2|||
48400919|NCT01964352|155660143|FG001|Overall Study|Protocol Violation|4|||
48400920|NCT01964352|155660144|FG002|Overall Study|Protocol Violation|0|||
48400921|NCT01964352|155660145|FG003|Overall Study|Protocol Violation|2|||
48400922|NCT01964352|155660142|FG000|Overall Study|Lost to Follow-up|1|||
48400923|NCT01964352|155660143|FG001|Overall Study|Lost to Follow-up|0|||
48400924|NCT01964352|155660144|FG002|Overall Study|Lost to Follow-up|0|||
48400925|NCT01964352|155660145|FG003|Overall Study|Lost to Follow-up|1|||
48400926|NCT01964352|155660142|FG000|Overall Study|Withdrawal by Subject|4|||
48400927|NCT01964352|155660143|FG001|Overall Study|Withdrawal by Subject|2|||
48400928|NCT01964352|155660144|FG002|Overall Study|Withdrawal by Subject|1|||
48400929|NCT01964352|155660145|FG003|Overall Study|Withdrawal by Subject|0|||
48400930|NCT01964352|155660142|FG000|Overall Study|Other than stated above|0|||
48400931|NCT01964352|155660143|FG001|Overall Study|Other than stated above|2|||
48400932|NCT01964352|155660144|FG002|Overall Study|Other than stated above|1|||
48586931|NCT00772005|156341481|FG002|Overall Study|Non-compliance with drug administration|1|||
48586932|NCT00772005|156341482|FG003|Overall Study|Non-compliance with drug administration|1|||
48789654|NCT01217073|157069746|FG006|Extension Period|Adverse Event|19|||
48789655|NCT01217073|157069747|FG007|Extension Period|Adverse Event|5|||
48789656|NCT01217073|157069740|FG000|Extension Period|ALT/AST|0|||
48789657|NCT01217073|157069741|FG001|Extension Period|ALT/AST|0|||
48789658|NCT01217073|157069742|FG002|Extension Period|ALT/AST|0|||
48789659|NCT01217073|157069743|FG003|Extension Period|ALT/AST|0|||
48789660|NCT01217073|157069744|FG004|Extension Period|ALT/AST|0|||
48789661|NCT01217073|157069745|FG005|Extension Period|ALT/AST|0|||
48789662|NCT01217073|157069746|FG006|Extension Period|ALT/AST|2|||
48789663|NCT01217073|157069747|FG007|Extension Period|ALT/AST|0|||
48789664|NCT01217073|157069740|FG000|Extension Period|Contraindication to study medication|0|||
48789665|NCT01217073|157069741|FG001|Extension Period|Contraindication to study medication|0|||
48789666|NCT01217073|157069742|FG002|Extension Period|Contraindication to study medication|0|||
48789667|NCT01217073|157069743|FG003|Extension Period|Contraindication to study medication|0|||
48789668|NCT01217073|157069744|FG004|Extension Period|Contraindication to study medication|0|||
48789669|NCT01217073|157069745|FG005|Extension Period|Contraindication to study medication|0|||
48789670|NCT01217073|157069746|FG006|Extension Period|Contraindication to study medication|1|||
48400933|NCT01964352|155660145|FG003|Overall Study|Other than stated above|2|||
48789671|NCT01217073|157069747|FG007|Extension Period|Contraindication to study medication|0|||
48789672|NCT01217073|157069740|FG000|Extension Period|Creatinine/eGFR|0|||
48789673|NCT01217073|157069741|FG001|Extension Period|Creatinine/eGFR|0|||
48789674|NCT01217073|157069742|FG002|Extension Period|Creatinine/eGFR|0|||
48789675|NCT01217073|157069743|FG003|Extension Period|Creatinine/eGFR|0|||
48789676|NCT01217073|157069744|FG004|Extension Period|Creatinine/eGFR|0|||
48789677|NCT01217073|157069745|FG005|Extension Period|Creatinine/eGFR|0|||
48789678|NCT01217073|157069746|FG006|Extension Period|Creatinine/eGFR|11|||
48789679|NCT01217073|157069747|FG007|Extension Period|Creatinine/eGFR|1|||
48789680|NCT01217073|157069740|FG000|Extension Period|Death|0|||
48400934|NCT03657043|155660146|FG000|Overall Study|Withdrawal by Subject|1|||
48400935|NCT03657043|155660147|FG001|Overall Study|Withdrawal by Subject|1|||
48400936|NCT03657043|155660148|FG002|Overall Study|Withdrawal by Subject|0|||
48400937|NCT03657043|155660149|FG003|Overall Study|Withdrawal by Subject|0|||
48789681|NCT01217073|157069741|FG001|Extension Period|Death|0|||
48400938|NCT03657043|155660150|FG004|Overall Study|Withdrawal by Subject|4|||
48789682|NCT01217073|157069742|FG002|Extension Period|Death|0|||
48789683|NCT01217073|157069743|FG003|Extension Period|Death|0|||
48400939|NCT03657043|155660146|FG000|Overall Study|Study closure by Sponsor|0|||
48400940|NCT03657043|155660147|FG001|Overall Study|Study closure by Sponsor|2|||
48789684|NCT01217073|157069744|FG004|Extension Period|Death|0|||
48789685|NCT01217073|157069745|FG005|Extension Period|Death|0|||
48789686|NCT01217073|157069746|FG006|Extension Period|Death|1|||
48789687|NCT01217073|157069747|FG007|Extension Period|Death|0|||
48789688|NCT01217073|157069740|FG000|Extension Period|Excluded medication|0|||
48789689|NCT01217073|157069741|FG001|Extension Period|Excluded medication|0|||
48789690|NCT01217073|157069742|FG002|Extension Period|Excluded medication|0|||
48789691|NCT01217073|157069743|FG003|Extension Period|Excluded medication|0|||
48789692|NCT01217073|157069744|FG004|Extension Period|Excluded medication|0|||
48789693|NCT01217073|157069745|FG005|Extension Period|Excluded medication|0|||
48789694|NCT01217073|157069746|FG006|Extension Period|Excluded medication|2|||
48789695|NCT01217073|157069747|FG007|Extension Period|Excluded medication|0|||
48789696|NCT01217073|157069740|FG000|Extension Period|Lack of Efficacy|0|||
48789697|NCT01217073|157069741|FG001|Extension Period|Lack of Efficacy|0|||
48789698|NCT01217073|157069742|FG002|Extension Period|Lack of Efficacy|0|||
48789699|NCT01217073|157069743|FG003|Extension Period|Lack of Efficacy|0|||
48789700|NCT01217073|157069744|FG004|Extension Period|Lack of Efficacy|0|||
48789701|NCT01217073|157069745|FG005|Extension Period|Lack of Efficacy|0|||
48789702|NCT01217073|157069746|FG006|Extension Period|Lack of Efficacy|3|||
48789703|NCT01217073|157069747|FG007|Extension Period|Lack of Efficacy|0|||
48789704|NCT01217073|157069740|FG000|Extension Period|Lost to Follow-up|0|||
48789705|NCT01217073|157069741|FG001|Extension Period|Lost to Follow-up|0|||
48789706|NCT01217073|157069742|FG002|Extension Period|Lost to Follow-up|0|||
48789707|NCT01217073|157069743|FG003|Extension Period|Lost to Follow-up|0|||
48789708|NCT01217073|157069744|FG004|Extension Period|Lost to Follow-up|0|||
48789709|NCT01217073|157069745|FG005|Extension Period|Lost to Follow-up|0|||
48789710|NCT01217073|157069746|FG006|Extension Period|Lost to Follow-up|9|||
48789711|NCT01217073|157069747|FG007|Extension Period|Lost to Follow-up|1|||
48789712|NCT01217073|157069740|FG000|Extension Period|Non-compliance with study drug|0|||
48789713|NCT01217073|157069741|FG001|Extension Period|Non-compliance with study drug|0|||
48789714|NCT01217073|157069742|FG002|Extension Period|Non-compliance with study drug|0|||
48789715|NCT01217073|157069743|FG003|Extension Period|Non-compliance with study drug|0|||
48789716|NCT01217073|157069744|FG004|Extension Period|Non-compliance with study drug|0|||
48789717|NCT01217073|157069745|FG005|Extension Period|Non-compliance with study drug|0|||
48789718|NCT01217073|157069746|FG006|Extension Period|Non-compliance with study drug|0|||
48789719|NCT01217073|157069747|FG007|Extension Period|Non-compliance with study drug|1|||
48789720|NCT01217073|157069740|FG000|Extension Period|Physician Decision|0|||
48789721|NCT01217073|157069741|FG001|Extension Period|Physician Decision|0|||
48789722|NCT01217073|157069742|FG002|Extension Period|Physician Decision|0|||
48789723|NCT01217073|157069743|FG003|Extension Period|Physician Decision|0|||
48789724|NCT01217073|157069744|FG004|Extension Period|Physician Decision|0|||
48789725|NCT01217073|157069745|FG005|Extension Period|Physician Decision|0|||
48789726|NCT01217073|157069746|FG006|Extension Period|Physician Decision|4|||
48789727|NCT01217073|157069747|FG007|Extension Period|Physician Decision|1|||
48789728|NCT01217073|157069740|FG000|Extension Period|Protocol Violation|0|||
48789729|NCT01217073|157069741|FG001|Extension Period|Protocol Violation|0|||
48789730|NCT01217073|157069742|FG002|Extension Period|Protocol Violation|0|||
48789731|NCT01217073|157069743|FG003|Extension Period|Protocol Violation|0|||
48789732|NCT01217073|157069744|FG004|Extension Period|Protocol Violation|0|||
48789733|NCT01217073|157069745|FG005|Extension Period|Protocol Violation|0|||
48789734|NCT01217073|157069746|FG006|Extension Period|Protocol Violation|2|||
48789735|NCT01217073|157069747|FG007|Extension Period|Protocol Violation|1|||
48789736|NCT01217073|157069740|FG000|Extension Period|Site discontinued study participation|0|||
48789737|NCT01217073|157069741|FG001|Extension Period|Site discontinued study participation|0|||
48789738|NCT01217073|157069742|FG002|Extension Period|Site discontinued study participation|0|||
48789739|NCT01217073|157069743|FG003|Extension Period|Site discontinued study participation|0|||
48789740|NCT01217073|157069744|FG004|Extension Period|Site discontinued study participation|0|||
48789741|NCT01217073|157069745|FG005|Extension Period|Site discontinued study participation|0|||
48789742|NCT01217073|157069746|FG006|Extension Period|Site discontinued study participation|7|||
48789743|NCT01217073|157069747|FG007|Extension Period|Site discontinued study participation|2|||
48789744|NCT01217073|157069740|FG000|Extension Period|Withdrawal by Subject|0|||
48789745|NCT01217073|157069741|FG001|Extension Period|Withdrawal by Subject|0|||
48789746|NCT01217073|157069742|FG002|Extension Period|Withdrawal by Subject|0|||
48789747|NCT01217073|157069743|FG003|Extension Period|Withdrawal by Subject|0|||
48789748|NCT01217073|157069744|FG004|Extension Period|Withdrawal by Subject|0|||
48789749|NCT01217073|157069745|FG005|Extension Period|Withdrawal by Subject|0|||
48789750|NCT01217073|157069746|FG006|Extension Period|Withdrawal by Subject|30|||
48789751|NCT01217073|157069747|FG007|Extension Period|Withdrawal by Subject|8|||
48789752|NCT02301143|157069748|FG000|Induction Period|Enrolled But Not Treated|1|||
48789753|NCT02301143|157069749|FG001|Induction Period|Enrolled But Not Treated|0|||
48789754|NCT02301143|157069748|FG000|Induction Period|Death|1|||
48789755|NCT02301143|157069749|FG001|Induction Period|Death|0|||
48789756|NCT02301143|157069748|FG000|Induction Period|Adverse Event|22|||
48789757|NCT02301143|157069749|FG001|Induction Period|Adverse Event|0|||
48789758|NCT02301143|157069748|FG000|Induction Period|Progressive Disease|8|||
48789759|NCT02301143|157069749|FG001|Induction Period|Progressive Disease|0|||
48789760|NCT02301143|157069748|FG000|Induction Period|Withdrawal by Subject|3|||
48789761|NCT02301143|157069749|FG001|Induction Period|Withdrawal by Subject|0|||
48789762|NCT02301143|157069748|FG000|Induction Period|Noncompliance with Study Drug|1|||
48789763|NCT02301143|157069749|FG001|Induction Period|Noncompliance with Study Drug|0|||
48789764|NCT02301143|157069748|FG000|Induction Period|Physician Decision|4|||
48789765|NCT02301143|157069749|FG001|Induction Period|Physician Decision|0|||
48789766|NCT02301143|157069748|FG000|Induction Period|Symptomatic Deterioration|2|||
48789767|NCT02301143|157069749|FG001|Induction Period|Symptomatic Deterioration|0|||
48789768|NCT02301143|157069748|FG000|Induction Period|Protocol Violation|2|||
48789769|NCT02301143|157069749|FG001|Induction Period|Protocol Violation|0|||
48789770|NCT02301143|157069748|FG000|Induction Period|Other|1|||
48789771|NCT02301143|157069749|FG001|Induction Period|Other|0|||
48789772|NCT02301143|157069748|FG000|Investigator's Choice|Adverse Event|0|||
48789773|NCT02301143|157069749|FG001|Investigator's Choice|Adverse Event|3|||
48789774|NCT02301143|157069748|FG000|Investigator's Choice|Progressive Disease|0|||
48789775|NCT02301143|157069749|FG001|Investigator's Choice|Progressive Disease|3|||
48789776|NCT02301143|157069748|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
48789777|NCT02301143|157069749|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
48789778|NCT02301143|157069748|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
48789779|NCT02301143|157069749|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
48789780|NCT02301143|157069748|FG000|Investigator's Choice|Other|0|||
48789781|NCT02301143|157069749|FG001|Investigator's Choice|Other|1|||
48789782|NCT02301143|157069748|FG000|Investigator's Choice|Unresectable Surgery|0|||
48789783|NCT02301143|157069749|FG001|Investigator's Choice|Unresectable Surgery|1|||
48789784|NCT04066114|157069752|FG000|Overall Study|Adverse Event|1|||
48789785|NCT04066114|157069753|FG001|Overall Study|Adverse Event|0|||
48789786|NCT04066114|157069754|FG002|Overall Study|Adverse Event|0|||
48789787|NCT04066114|157069752|FG000|Overall Study|Withdrawal by Subject|1|||
48789788|NCT04066114|157069753|FG001|Overall Study|Withdrawal by Subject|0|||
48789789|NCT04066114|157069754|FG002|Overall Study|Withdrawal by Subject|0|||
48789790|NCT04066114|157069752|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
48789791|NCT04066114|157069753|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
48789792|NCT04066114|157069754|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
48789793|NCT00726752|157069757|FG000|Overall Study|Lack of Efficacy|6|||
48789794|NCT04447404|157069758|FG000|Overall Study|Death|2|||
48400941|NCT03657043|155660148|FG002|Overall Study|Study closure by Sponsor|0|||
48400942|NCT03657043|155660149|FG003|Overall Study|Study closure by Sponsor|0|||
48789795|NCT04447404|157069759|FG001|Overall Study|Death|0|||
48789796|NCT01816594|157069762|FG000|Overall Study|Local Progress|0|||
48789797|NCT01816594|157069763|FG001|Overall Study|Local Progress|2|||
48789798|NCT01816594|157069762|FG000|Overall Study|Adverse Event|9|||
48789799|NCT01816594|157069763|FG001|Overall Study|Adverse Event|0|||
48789800|NCT01816594|157069762|FG000|Overall Study|Withdrawal by Subject|1|||
48789801|NCT01816594|157069763|FG001|Overall Study|Withdrawal by Subject|0|||
48789802|NCT01816594|157069762|FG000|Overall Study|Physician Decision|1|||
48789803|NCT01816594|157069763|FG001|Overall Study|Physician Decision|0|||
48789804|NCT02862106|157069768|FG000|Overall Study|Adverse Event|4|||
48789805|NCT02862106|157069769|FG001|Overall Study|Adverse Event|0|||
48400943|NCT03657043|155660150|FG004|Overall Study|Study closure by Sponsor|17|||
48400944|NCT03657043|155660146|FG000|Overall Study|Lost to Follow-up|0|||
48789806|NCT02862106|157069768|FG000|Overall Study|Protocol Violation|16|||
48789807|NCT02862106|157069769|FG001|Overall Study|Protocol Violation|1|||
48789808|NCT02862106|157069768|FG000|Overall Study|Lost to Follow-up|15|||
48789809|NCT02862106|157069769|FG001|Overall Study|Lost to Follow-up|5|||
48789810|NCT02862106|157069768|FG000|Overall Study|Withdrawal by Subject|2|||
48789811|NCT02862106|157069769|FG001|Overall Study|Withdrawal by Subject|0|||
48789812|NCT02862106|157069768|FG000|Overall Study|Subjects moved to other city|1|||
48789813|NCT02862106|157069769|FG001|Overall Study|Subjects moved to other city|0|||
48789814|NCT00487162|157069770|FG000|Overall Study|Adverse Event|0|||
48789815|NCT00487162|157069771|FG001|Overall Study|Adverse Event|1|||
48789816|NCT00487162|157069770|FG000|Overall Study|Physician Decision|0|||
48789817|NCT00487162|157069771|FG001|Overall Study|Physician Decision|1|||
48789818|NCT00487162|157069770|FG000|Overall Study|Withdrawal by Subject|2|||
48789819|NCT00487162|157069771|FG001|Overall Study|Withdrawal by Subject|3|||
48789820|NCT01814371|157069772|FG000|Overall Study|Lost to Follow-up|30|||
48789821|NCT01814371|157069773|FG001|Overall Study|Lost to Follow-up|27|||
48789822|NCT03593655|157069776|FG000|First Product Use Period|Withdrawal by Subject|1|||
48789823|NCT03593655|157069777|FG001|First Product Use Period|Withdrawal by Subject|1|||
48789824|NCT03593655|157069776|FG000|First Product Use Period|Lost to Follow-up|1|||
48789825|NCT03593655|157069777|FG001|First Product Use Period|Lost to Follow-up|3|||
48789826|NCT03593655|157069776|FG000|Second Product Use Period|Withdrawal by Subject|1|||
48789827|NCT03593655|157069777|FG001|Second Product Use Period|Withdrawal by Subject|1|||
48789828|NCT03593655|157069776|FG000|Second Product Use Period|Lost to Follow-up|1|||
48789829|NCT03593655|157069777|FG001|Second Product Use Period|Lost to Follow-up|0|||
48789830|NCT03593655|157069776|FG000|Third Product Use Period|Lost to Follow-up|1|||
48789831|NCT03593655|157069777|FG001|Third Product Use Period|Lost to Follow-up|2|||
48789832|NCT03593655|157069776|FG000|Third Product Use Period|Physician Decision|0|||
48789833|NCT03593655|157069777|FG001|Third Product Use Period|Physician Decision|1|||
48789834|NCT03593655|157069776|FG000|Third Product Use Period|Withdrawal by Subject|0|||
48789835|NCT03593655|157069777|FG001|Third Product Use Period|Withdrawal by Subject|1|||
48789836|NCT05046795|157069778|FG000|Overall Study|Adverse Event|13|||
48789837|NCT05046795|157069779|FG001|Overall Study|Adverse Event|15|||
48356870|NCT02568397|155503519|FG000|Period 2|Physician Decision|0|||
48789838|NCT05046795|157069778|FG000|Overall Study|Withdrawal by Subject|4|||
48789839|NCT05046795|157069779|FG001|Overall Study|Withdrawal by Subject|7|||
48789840|NCT05046795|157069778|FG000|Overall Study|Physician Decision|1|||
48789841|NCT05046795|157069779|FG001|Overall Study|Physician Decision|2|||
48789842|NCT05046795|157069778|FG000|Overall Study|Protocol Violation|1|||
48789843|NCT05046795|157069779|FG001|Overall Study|Protocol Violation|2|||
48789844|NCT05046795|157069778|FG000|Overall Study|Death|1|||
48789845|NCT05046795|157069779|FG001|Overall Study|Death|0|||
48789846|NCT05046795|157069778|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
48789847|NCT05046795|157069779|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
48789848|NCT03923959|157069780|FG000|Overall Study|Death|16|||
48789849|NCT03923959|157069781|FG001|Overall Study|Death|12|||
48789850|NCT03923959|157069780|FG000|Overall Study|Lost to Follow-up|56|||
48789851|NCT03923959|157069781|FG001|Overall Study|Lost to Follow-up|56|||
48789852|NCT03923959|157069780|FG000|Overall Study|Withdrawal by Subject|1|||
48789853|NCT03923959|157069781|FG001|Overall Study|Withdrawal by Subject|1|||
48789854|NCT03923959|157069780|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
48789855|NCT03923959|157069781|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
48789856|NCT03526250|157069787|FG000|Overall Study|Adverse Event|4|||
48789857|NCT03526250|157069787|FG000|Overall Study|Progressive Disease|16|||
48789858|NCT03526250|157069787|FG000|Overall Study|No Treatment|3|||
48789859|NCT00782340|157069788|FG000|Open Label Titration|Adverse Event|12|||
48789860|NCT00782340|157069789|FG001|Open Label Titration|Adverse Event|0|||
48789861|NCT00782340|157069790|FG002|Open Label Titration|Adverse Event|0|||
48789862|NCT00782340|157069788|FG000|Open Label Titration|Treatment failure|50|||
48789863|NCT00782340|157069789|FG001|Open Label Titration|Treatment failure|0|||
48789864|NCT00782340|157069790|FG002|Open Label Titration|Treatment failure|0|||
48789865|NCT00782340|157069788|FG000|Open Label Titration|Protocol Violation|5|||
48789866|NCT00782340|157069789|FG001|Open Label Titration|Protocol Violation|0|||
48789867|NCT00782340|157069790|FG002|Open Label Titration|Protocol Violation|0|||
48789868|NCT00782340|157069788|FG000|Open Label Titration|Withdrawal by Subject|5|||
48789869|NCT00782340|157069789|FG001|Open Label Titration|Withdrawal by Subject|0|||
48789870|NCT00782340|157069790|FG002|Open Label Titration|Withdrawal by Subject|0|||
48789871|NCT00782340|157069788|FG000|Open Label Titration|Enrollment capped|16|||
48789872|NCT00782340|157069789|FG001|Open Label Titration|Enrollment capped|0|||
48789873|NCT00782340|157069790|FG002|Open Label Titration|Enrollment capped|0|||
48789874|NCT00782340|157069788|FG000|Open Label Titration|Did not meet responder criteria|2|||
48789875|NCT00782340|157069789|FG001|Open Label Titration|Did not meet responder criteria|0|||
48789876|NCT00782340|157069790|FG002|Open Label Titration|Did not meet responder criteria|0|||
48789877|NCT00782340|157069788|FG000|Open Label Titration|Lost to Follow-up|5|||
48789878|NCT00782340|157069789|FG001|Open Label Titration|Lost to Follow-up|0|||
48789879|NCT00782340|157069790|FG002|Open Label Titration|Lost to Follow-up|0|||
48789880|NCT00782340|157069788|FG000|Open Label Titration|Randomized in error|6|||
48789881|NCT00782340|157069789|FG001|Open Label Titration|Randomized in error|0|||
48789882|NCT00782340|157069790|FG002|Open Label Titration|Randomized in error|0|||
48789883|NCT04171999|157069791|FG000|Overall Study|deemed ineligible after randomization|2|||
48789884|NCT04171999|157069792|FG001|Overall Study|deemed ineligible after randomization|1|||
48789885|NCT02959437|157069795|FG000|Overall Study|Death|33|||
48789886|NCT02959437|157069796|FG001|Overall Study|Death|3|||
48789887|NCT02959437|157069797|FG002|Overall Study|Death|0|||
48789888|NCT02959437|157069798|FG003|Overall Study|Death|0|||
48789889|NCT02959437|157069795|FG000|Overall Study|Lost to Follow-up|3|||
48789890|NCT02959437|157069796|FG001|Overall Study|Lost to Follow-up|1|||
48789891|NCT02959437|157069797|FG002|Overall Study|Lost to Follow-up|0|||
48789892|NCT02959437|157069798|FG003|Overall Study|Lost to Follow-up|0|||
48356871|NCT02568397|155503520|FG001|Period 2|Physician Decision|1|||
48356872|NCT04843579|155503521|FG000|Overall Study|Adverse Event|1|||
48356873|NCT04843579|155503521|FG000|Overall Study|Disease Progression|1|||
48789893|NCT02959437|157069795|FG000|Overall Study|Withdrawal by Subject|11|||
48789894|NCT02959437|157069796|FG001|Overall Study|Withdrawal by Subject|3|||
48356874|NCT01443403|155503522|FG000|Overall Study|Adverse Event|1|||
48789895|NCT02959437|157069797|FG002|Overall Study|Withdrawal by Subject|0|||
48789896|NCT02959437|157069798|FG003|Overall Study|Withdrawal by Subject|0|||
48789897|NCT02959437|157069795|FG000|Overall Study|Progressive Disease|9|||
48789898|NCT02959437|157069796|FG001|Overall Study|Progressive Disease|1|||
48789899|NCT02959437|157069797|FG002|Overall Study|Progressive Disease|0|||
48789900|NCT02959437|157069798|FG003|Overall Study|Progressive Disease|0|||
48400945|NCT03657043|155660147|FG001|Overall Study|Lost to Follow-up|0|||
48400946|NCT03657043|155660148|FG002|Overall Study|Lost to Follow-up|0|||
48400947|NCT03657043|155660149|FG003|Overall Study|Lost to Follow-up|0|||
48400948|NCT03657043|155660150|FG004|Overall Study|Lost to Follow-up|4|||
48400949|NCT03657043|155660146|FG000|Overall Study|Death|6|||
48400950|NCT03657043|155660147|FG001|Overall Study|Death|5|||
48400951|NCT03657043|155660148|FG002|Overall Study|Death|0|||
48400952|NCT03657043|155660149|FG003|Overall Study|Death|0|||
48400953|NCT03657043|155660150|FG004|Overall Study|Death|53|||
48400954|NCT03657043|155660146|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
48400955|NCT03657043|155660147|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
48400956|NCT03657043|155660148|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
48400957|NCT03657043|155660149|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
48789901|NCT02959437|157069795|FG000|Overall Study|Study Terminated by Sponsor|4|||
48789902|NCT02959437|157069796|FG001|Overall Study|Study Terminated by Sponsor|0|||
48789903|NCT02959437|157069797|FG002|Overall Study|Study Terminated by Sponsor|0|||
48789904|NCT02959437|157069798|FG003|Overall Study|Study Terminated by Sponsor|0|||
48789905|NCT02959437|157069795|FG000|Overall Study|Other Unspecified|2|||
48789906|NCT02959437|157069796|FG001|Overall Study|Other Unspecified|0|||
48789907|NCT02959437|157069797|FG002|Overall Study|Other Unspecified|0|||
48789908|NCT02959437|157069798|FG003|Overall Study|Other Unspecified|0|||
48789909|NCT05671653|157069804|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
48789910|NCT05671653|157069805|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
48789911|NCT05671653|157069806|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
48789912|NCT05671653|157069807|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
48789913|NCT05671653|157069808|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
48789914|NCT05671653|157069809|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
48789915|NCT05671653|157069810|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
48789916|NCT05671653|157069811|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
48789917|NCT05671653|157069812|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
48789918|NCT05671653|157069813|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
48789919|NCT05671653|157069814|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
48789920|NCT05671653|157069815|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
48789921|NCT05671653|157069816|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
48789922|NCT05671653|157069804|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789923|NCT05671653|157069805|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789924|NCT05671653|157069806|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789925|NCT05671653|157069807|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789926|NCT05671653|157069808|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48356875|NCT01443403|155503523|FG001|Overall Study|Adverse Event|1|||
48356876|NCT01443403|155503524|FG002|Overall Study|Adverse Event|4|||
48356877|NCT01443403|155503525|FG003|Overall Study|Adverse Event|5|||
48356878|NCT01443403|155503522|FG000|Overall Study|Withdrawal by Subject|0|||
48356879|NCT01443403|155503523|FG001|Overall Study|Withdrawal by Subject|1|||
48356880|NCT01443403|155503524|FG002|Overall Study|Withdrawal by Subject|2|||
48356881|NCT01443403|155503525|FG003|Overall Study|Withdrawal by Subject|1|||
48356882|NCT01443403|155503522|FG000|Overall Study|Lost to Follow-up|0|||
48356883|NCT01443403|155503523|FG001|Overall Study|Lost to Follow-up|0|||
48356884|NCT01443403|155503524|FG002|Overall Study|Lost to Follow-up|0|||
48356885|NCT01443403|155503525|FG003|Overall Study|Lost to Follow-up|1|||
48356886|NCT01443403|155503522|FG000|Overall Study|Protocol Violation|2|||
48356887|NCT01443403|155503523|FG001|Overall Study|Protocol Violation|1|||
48356888|NCT01443403|155503524|FG002|Overall Study|Protocol Violation|1|||
48356889|NCT01443403|155503525|FG003|Overall Study|Protocol Violation|1|||
48356890|NCT01443403|155503522|FG000|Overall Study|Use of Prohibited Treatment|2|||
48356891|NCT01443403|155503523|FG001|Overall Study|Use of Prohibited Treatment|3|||
48356892|NCT01443403|155503524|FG002|Overall Study|Use of Prohibited Treatment|0|||
48356893|NCT01443403|155503525|FG003|Overall Study|Use of Prohibited Treatment|0|||
48356894|NCT01443403|155503522|FG000|Overall Study|Other - Miscellaneous|1|||
48356895|NCT01443403|155503523|FG001|Overall Study|Other - Miscellaneous|0|||
48356896|NCT01443403|155503524|FG002|Overall Study|Other - Miscellaneous|0|||
48430350|NCT00696657|155763704|FG004|Overall Study|Withdrawal criteria|0|||
48789927|NCT05671653|157069809|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
48789928|NCT05671653|157069810|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48356897|NCT01443403|155503525|FG003|Overall Study|Other - Miscellaneous|1|||
48356898|NCT01367847|155503526|FG000|Overall Study|Withdrawal by Subject|2|||
48356899|NCT01367847|155503527|FG001|Overall Study|Withdrawal by Subject|2|||
48356900|NCT01439867|155503528|FG000|Overall Study|Non-compliance|0|||
48356901|NCT01439867|155503529|FG001|Overall Study|Non-compliance|1|||
48356902|NCT01439867|155503528|FG000|Overall Study|Withdrawal by Subject|1|||
48789929|NCT05671653|157069811|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789930|NCT05671653|157069812|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789931|NCT05671653|157069813|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789932|NCT05671653|157069814|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789933|NCT05671653|157069815|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789934|NCT05671653|157069816|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
48789935|NCT05671653|157069804|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789936|NCT05671653|157069805|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789937|NCT05671653|157069806|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789938|NCT05671653|157069807|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789939|NCT05671653|157069808|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789940|NCT05671653|157069809|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
48789941|NCT05671653|157069810|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789942|NCT05671653|157069811|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789943|NCT05671653|157069812|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789944|NCT05671653|157069813|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789945|NCT05671653|157069814|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789946|NCT05671653|157069815|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789947|NCT05671653|157069816|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
48789948|NCT05671653|157069804|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789949|NCT05671653|157069805|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789950|NCT05671653|157069806|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789951|NCT05671653|157069807|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789952|NCT05671653|157069808|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789953|NCT05671653|157069809|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789954|NCT05671653|157069810|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789955|NCT05671653|157069811|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789956|NCT05671653|157069812|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
48789957|NCT05671653|157069813|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789958|NCT05671653|157069814|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48400958|NCT03657043|155660150|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
48400959|NCT03657043|155660146|FG000|Overall Study|Adverse Event|0|||
48400960|NCT03657043|155660147|FG001|Overall Study|Adverse Event|0|||
48400961|NCT03657043|155660148|FG002|Overall Study|Adverse Event|0|||
48400962|NCT03657043|155660149|FG003|Overall Study|Adverse Event|0|||
48400963|NCT03657043|155660150|FG004|Overall Study|Adverse Event|2|||
48400964|NCT03657043|155660146|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
48400965|NCT03657043|155660147|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
48400966|NCT03657043|155660148|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
48400967|NCT03657043|155660149|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
48789959|NCT05671653|157069815|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789960|NCT05671653|157069816|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
48789961|NCT05671653|157069804|FG000|Cohort 2 Period 2|Adverse Event|0|||
48789962|NCT05671653|157069805|FG001|Cohort 2 Period 2|Adverse Event|0|||
48789963|NCT05671653|157069806|FG002|Cohort 2 Period 2|Adverse Event|0|||
48789964|NCT05671653|157069807|FG003|Cohort 2 Period 2|Adverse Event|0|||
48789965|NCT05671653|157069808|FG004|Cohort 2 Period 2|Adverse Event|0|||
48789966|NCT05671653|157069809|FG005|Cohort 2 Period 2|Adverse Event|0|||
48400968|NCT03657043|155660150|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
48789967|NCT05671653|157069810|FG006|Cohort 2 Period 2|Adverse Event|0|||
48789968|NCT05671653|157069811|FG007|Cohort 2 Period 2|Adverse Event|0|||
48789969|NCT05671653|157069812|FG008|Cohort 2 Period 2|Adverse Event|0|||
48789970|NCT05671653|157069813|FG009|Cohort 2 Period 2|Adverse Event|0|||
48789971|NCT05671653|157069814|FG010|Cohort 2 Period 2|Adverse Event|1|||
48789972|NCT05671653|157069815|FG011|Cohort 2 Period 2|Adverse Event|0|||
48789973|NCT05671653|157069816|FG012|Cohort 2 Period 2|Adverse Event|0|||
48789974|NCT05671653|157069804|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
48789975|NCT05671653|157069805|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
48789976|NCT05671653|157069806|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
48789977|NCT05671653|157069807|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
48789978|NCT05671653|157069808|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
48789979|NCT05671653|157069809|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
48789980|NCT05671653|157069810|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
48789981|NCT05671653|157069811|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
48789982|NCT05671653|157069812|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
48789983|NCT05671653|157069813|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
48789984|NCT05671653|157069814|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
48789985|NCT05671653|157069815|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
48789986|NCT05671653|157069816|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
48789987|NCT05671653|157069804|FG000|Cohort 2 Period 2|Pregnancy|0|||
48789988|NCT05671653|157069805|FG001|Cohort 2 Period 2|Pregnancy|0|||
48789989|NCT05671653|157069806|FG002|Cohort 2 Period 2|Pregnancy|0|||
48789990|NCT05671653|157069807|FG003|Cohort 2 Period 2|Pregnancy|0|||
48789991|NCT05671653|157069808|FG004|Cohort 2 Period 2|Pregnancy|0|||
48789992|NCT05671653|157069809|FG005|Cohort 2 Period 2|Pregnancy|0|||
48789993|NCT05671653|157069810|FG006|Cohort 2 Period 2|Pregnancy|0|||
48789994|NCT05671653|157069811|FG007|Cohort 2 Period 2|Pregnancy|0|||
48789995|NCT05671653|157069812|FG008|Cohort 2 Period 2|Pregnancy|0|||
48789996|NCT05671653|157069813|FG009|Cohort 2 Period 2|Pregnancy|0|||
48789997|NCT05671653|157069814|FG010|Cohort 2 Period 2|Pregnancy|1|||
48789998|NCT05671653|157069815|FG011|Cohort 2 Period 2|Pregnancy|0|||
48789999|NCT05671653|157069816|FG012|Cohort 2 Period 2|Pregnancy|0|||
48790000|NCT05671653|157069804|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790001|NCT05671653|157069805|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790002|NCT05671653|157069806|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790003|NCT05671653|157069807|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790004|NCT05671653|157069808|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790005|NCT05671653|157069809|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790006|NCT05671653|157069810|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790007|NCT05671653|157069811|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790008|NCT05671653|157069812|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790009|NCT05671653|157069813|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790010|NCT05671653|157069814|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
48790011|NCT05671653|157069815|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790012|NCT05671653|157069816|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
48790013|NCT05671653|157069804|FG000|Cohort 2 Period 2|Other|0|||
48790014|NCT05671653|157069805|FG001|Cohort 2 Period 2|Other|0|||
48790015|NCT05671653|157069806|FG002|Cohort 2 Period 2|Other|0|||
48790016|NCT05671653|157069807|FG003|Cohort 2 Period 2|Other|0|||
48790017|NCT05671653|157069808|FG004|Cohort 2 Period 2|Other|0|||
48790018|NCT05671653|157069809|FG005|Cohort 2 Period 2|Other|0|||
48790019|NCT05671653|157069810|FG006|Cohort 2 Period 2|Other|0|||
48356903|NCT01439867|155503529|FG001|Overall Study|Withdrawal by Subject|2|||
48790020|NCT05671653|157069811|FG007|Cohort 2 Period 2|Other|0|||
48790021|NCT05671653|157069812|FG008|Cohort 2 Period 2|Other|0|||
48356904|NCT01439867|155503528|FG000|Overall Study|Administrative Decision|4|||
48356905|NCT01439867|155503529|FG001|Overall Study|Administrative Decision|5|||
48790022|NCT05671653|157069813|FG009|Cohort 2 Period 2|Other|0|||
48790023|NCT05671653|157069814|FG010|Cohort 2 Period 2|Other|1|||
48790024|NCT05671653|157069815|FG011|Cohort 2 Period 2|Other|0|||
48790025|NCT05671653|157069816|FG012|Cohort 2 Period 2|Other|0|||
48356906|NCT01439867|155503528|FG000|Overall Study|Protocol-specified Criteria|1|||
48790026|NCT05671653|157069804|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790027|NCT05671653|157069805|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790028|NCT05671653|157069806|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790029|NCT05671653|157069807|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790030|NCT05671653|157069808|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790031|NCT05671653|157069809|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790032|NCT05671653|157069810|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790033|NCT05671653|157069811|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790034|NCT05671653|157069812|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790035|NCT05671653|157069813|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790036|NCT05671653|157069814|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790037|NCT05671653|157069815|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
48790038|NCT05671653|157069816|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
48790039|NCT00688636|157069817|FG000|Overall Study|Adverse Event|2|||
48790040|NCT00688636|157069818|FG001|Overall Study|Adverse Event|1|||
48790041|NCT01572727|157069819|FG000|Overall Study|Adverse Event|43|||
48790042|NCT01572727|157069820|FG001|Overall Study|Adverse Event|15|||
48790043|NCT01572727|157069819|FG000|Overall Study|Lost to Follow-up|1|||
48790044|NCT01572727|157069820|FG001|Overall Study|Lost to Follow-up|1|||
48790045|NCT01572727|157069819|FG000|Overall Study|Physician Decision|23|||
48790046|NCT01572727|157069820|FG001|Overall Study|Physician Decision|9|||
48790047|NCT01572727|157069819|FG000|Overall Study|Progressive disease|59|||
48790048|NCT01572727|157069820|FG001|Overall Study|Progressive disease|82|||
48790049|NCT01572727|157069819|FG000|Overall Study|Protocol Violation|0|||
48790050|NCT01572727|157069820|FG001|Overall Study|Protocol Violation|1|||
48790051|NCT01572727|157069819|FG000|Overall Study|Study terminated by sponsor|61|||
48790052|NCT01572727|157069820|FG001|Overall Study|Study terminated by sponsor|83|||
48790053|NCT01572727|157069819|FG000|Overall Study|Parent/guardian decision|14|||
48790054|NCT01572727|157069820|FG001|Overall Study|Parent/guardian decision|9|||
48790055|NCT01572727|157069819|FG000|Overall Study|Death|2|||
48790056|NCT01572727|157069820|FG001|Overall Study|Death|2|||
48790057|NCT01572727|157069819|FG000|Overall Study|Untreated|4|||
48400969|NCT03657043|155660146|FG000|Overall Study|Withdrawal - declined follow-up|0|||
48400970|NCT03657043|155660147|FG001|Overall Study|Withdrawal - declined follow-up|0|||
48400971|NCT03657043|155660148|FG002|Overall Study|Withdrawal - declined follow-up|0|||
48400972|NCT03657043|155660149|FG003|Overall Study|Withdrawal - declined follow-up|0|||
48400973|NCT03657043|155660150|FG004|Overall Study|Withdrawal - declined follow-up|1|||
48400974|NCT02356562|155660151|FG000|Overall Study|Withdrawal by Subject|0|||
48400975|NCT02356562|155660152|FG001|Overall Study|Withdrawal by Subject|1|||
48400976|NCT02356562|155660151|FG000|Overall Study|Re-entered treatment in a previous study|1|||
48400977|NCT02356562|155660152|FG001|Overall Study|Re-entered treatment in a previous study|0|||
48400978|NCT02356562|155660151|FG000|Overall Study|site closure|1|||
48400979|NCT02356562|155660152|FG001|Overall Study|site closure|0|||
48400980|NCT02814565|155660155|FG000|Overall Study|Lack of Efficacy|0|||
48400981|NCT02814565|155660156|FG001|Overall Study|Lack of Efficacy|1|||
48400982|NCT02814565|155660155|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
48400983|NCT02814565|155660156|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
48400984|NCT01391507|155660159|FG000|Overall Study|Death|0|||
48400985|NCT01391507|155660160|FG001|Overall Study|Death|0|||
48400986|NCT01391507|155660161|FG002|Overall Study|Death|0|||
48400987|NCT01391507|155660162|FG003|Overall Study|Death|1|||
48400988|NCT01391507|155660159|FG000|Overall Study|Adverse Event|1|||
48400989|NCT01391507|155660160|FG001|Overall Study|Adverse Event|1|||
48400990|NCT01391507|155660161|FG002|Overall Study|Adverse Event|2|||
48400991|NCT01391507|155660162|FG003|Overall Study|Adverse Event|2|||
48400992|NCT01391507|155660159|FG000|Overall Study|Withdrawal by Subject|1|||
48400993|NCT01391507|155660160|FG001|Overall Study|Withdrawal by Subject|2|||
48400994|NCT01391507|155660161|FG002|Overall Study|Withdrawal by Subject|1|||
48400995|NCT01391507|155660162|FG003|Overall Study|Withdrawal by Subject|1|||
48400996|NCT01391507|155660159|FG000|Overall Study|Lack of Efficacy|0|||
48400997|NCT01391507|155660160|FG001|Overall Study|Lack of Efficacy|0|||
48400998|NCT01391507|155660161|FG002|Overall Study|Lack of Efficacy|0|||
48400999|NCT01391507|155660162|FG003|Overall Study|Lack of Efficacy|1|||
48401000|NCT01391507|155660159|FG000|Overall Study|Protocol Violation|2|||
48790058|NCT01572727|157069820|FG001|Overall Study|Untreated|7|||
48790059|NCT02384954|157069823|FG000|Phase 1|Progressive Disease|2|||
48790060|NCT02384954|157069824|FG001|Phase 1|Progressive Disease|0|||
48401001|NCT01391507|155660160|FG001|Overall Study|Protocol Violation|1|||
48401002|NCT01391507|155660161|FG002|Overall Study|Protocol Violation|1|||
48401003|NCT01391507|155660162|FG003|Overall Study|Protocol Violation|2|||
48401004|NCT00209339|155660163|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
48401005|NCT00209339|155660163|FG000|At 12 Months Follow-up|Death|1|||
48790061|NCT02384954|157069825|FG002|Phase 1|Progressive Disease|1|||
48790062|NCT02384954|157069826|FG003|Phase 1|Progressive Disease|1|||
48401006|NCT00209339|155660163|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
48790063|NCT02384954|157069827|FG004|Phase 1|Progressive Disease|0|||
48790064|NCT02384954|157069828|FG005|Phase 1|Progressive Disease|0|||
48401007|NCT00209339|155660163|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
48430351|NCT00696657|155763705|FG005|Overall Study|Withdrawal criteria|0|||
48790065|NCT02384954|157069829|FG006|Phase 1|Progressive Disease|0|||
48790066|NCT02384954|157069830|FG007|Phase 1|Progressive Disease|0|||
48790067|NCT02384954|157069831|FG008|Phase 1|Progressive Disease|0|||
48790068|NCT02384954|157069823|FG000|Phase 1|Adverse Event|0|||
48790069|NCT02384954|157069824|FG001|Phase 1|Adverse Event|0|||
48790070|NCT02384954|157069825|FG002|Phase 1|Adverse Event|1|||
48790071|NCT02384954|157069826|FG003|Phase 1|Adverse Event|0|||
48790072|NCT02384954|157069827|FG004|Phase 1|Adverse Event|0|||
48790073|NCT02384954|157069828|FG005|Phase 1|Adverse Event|0|||
48790074|NCT02384954|157069829|FG006|Phase 1|Adverse Event|0|||
48790075|NCT02384954|157069830|FG007|Phase 1|Adverse Event|0|||
48790076|NCT02384954|157069831|FG008|Phase 1|Adverse Event|0|||
48790077|NCT02384954|157069823|FG000|Phase 2|Progressive Disease|0|||
48790078|NCT02384954|157069824|FG001|Phase 2|Progressive Disease|0|||
48790079|NCT02384954|157069825|FG002|Phase 2|Progressive Disease|0|||
48790080|NCT02384954|157069826|FG003|Phase 2|Progressive Disease|0|||
48790081|NCT02384954|157069827|FG004|Phase 2|Progressive Disease|0|||
48790082|NCT02384954|157069828|FG005|Phase 2|Progressive Disease|0|||
48790083|NCT02384954|157069829|FG006|Phase 2|Progressive Disease|0|||
48790084|NCT02384954|157069830|FG007|Phase 2|Progressive Disease|1|||
48790085|NCT02384954|157069831|FG008|Phase 2|Progressive Disease|2|||
48790086|NCT02384954|157069823|FG000|Phase 2|Adverse Event|0|||
48356907|NCT01439867|155503529|FG001|Overall Study|Protocol-specified Criteria|0|||
48790087|NCT02384954|157069824|FG001|Phase 2|Adverse Event|0|||
48790088|NCT02384954|157069825|FG002|Phase 2|Adverse Event|0|||
48790089|NCT02384954|157069826|FG003|Phase 2|Adverse Event|0|||
48790090|NCT02384954|157069827|FG004|Phase 2|Adverse Event|0|||
48790091|NCT02384954|157069828|FG005|Phase 2|Adverse Event|0|||
48790092|NCT02384954|157069829|FG006|Phase 2|Adverse Event|0|||
48790093|NCT02384954|157069830|FG007|Phase 2|Adverse Event|1|||
48790094|NCT02384954|157069831|FG008|Phase 2|Adverse Event|1|||
48790095|NCT02384954|157069823|FG000|Phase 2|Failure to meet continuation criteria|0|||
48790096|NCT02384954|157069824|FG001|Phase 2|Failure to meet continuation criteria|0|||
48790097|NCT02384954|157069825|FG002|Phase 2|Failure to meet continuation criteria|0|||
48790098|NCT02384954|157069826|FG003|Phase 2|Failure to meet continuation criteria|0|||
48790099|NCT02384954|157069827|FG004|Phase 2|Failure to meet continuation criteria|0|||
48790100|NCT02384954|157069828|FG005|Phase 2|Failure to meet continuation criteria|0|||
48790101|NCT02384954|157069829|FG006|Phase 2|Failure to meet continuation criteria|0|||
48790102|NCT02384954|157069830|FG007|Phase 2|Failure to meet continuation criteria|1|||
48790103|NCT02384954|157069831|FG008|Phase 2|Failure to meet continuation criteria|0|||
48790104|NCT01474681|157069832|FG000|Overall Study|Death|0|||
48790105|NCT01474681|157069833|FG001|Overall Study|Death|3|||
48790106|NCT01474681|157069834|FG002|Overall Study|Death|2|||
48790107|NCT01474681|157069835|FG003|Overall Study|Death|6|||
48790108|NCT01328574|157069836|FG000|Overall Study|Refused further treatment|1|||
48790109|NCT05073458|157069838|FG000|24-week Double-blind Period|Adverse Event|1|||
48790110|NCT05073458|157069839|FG001|24-week Double-blind Period|Adverse Event|0|||
48790111|NCT05073458|157069838|FG000|24-week Double-blind Period|Physician Decision|1|||
48790112|NCT05073458|157069839|FG001|24-week Double-blind Period|Physician Decision|0|||
48790113|NCT05073458|157069838|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
48790114|NCT05073458|157069839|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
48790115|NCT05073458|157069838|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
48790116|NCT05073458|157069839|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
48790117|NCT05073458|157069838|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
48790118|NCT05073458|157069839|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
48790119|NCT05073458|157069838|FG000|24-week Open-label Period|Adverse Event|1|||
48790120|NCT05073458|157069839|FG001|24-week Open-label Period|Adverse Event|2|||
48790121|NCT03150056|157069840|FG000|Overall Study|Withdrawal by Subject|0|||
48790122|NCT03150056|157069841|FG001|Overall Study|Withdrawal by Subject|0|||
48790123|NCT03150056|157069842|FG002|Overall Study|Withdrawal by Subject|0|||
48790124|NCT03150056|157069843|FG003|Overall Study|Withdrawal by Subject|0|||
48790125|NCT03150056|157069844|FG004|Overall Study|Withdrawal by Subject|0|||
48790126|NCT03150056|157069845|FG005|Overall Study|Withdrawal by Subject|2|||
48790127|NCT03150056|157069840|FG000|Overall Study|Study terminated by Sponsor|1|||
48790128|NCT03150056|157069841|FG001|Overall Study|Study terminated by Sponsor|3|||
48790129|NCT03150056|157069842|FG002|Overall Study|Study terminated by Sponsor|1|||
48790130|NCT03150056|157069843|FG003|Overall Study|Study terminated by Sponsor|1|||
48790131|NCT03150056|157069844|FG004|Overall Study|Study terminated by Sponsor|5|||
48790132|NCT03150056|157069845|FG005|Overall Study|Study terminated by Sponsor|6|||
48790133|NCT03150056|157069840|FG000|Overall Study|Death|9|||
48790134|NCT03150056|157069841|FG001|Overall Study|Death|2|||
48790135|NCT03150056|157069842|FG002|Overall Study|Death|2|||
48356908|NCT01888874|155503530|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
48790136|NCT03150056|157069843|FG003|Overall Study|Death|7|||
48790137|NCT03150056|157069844|FG004|Overall Study|Death|8|||
48790138|NCT03150056|157069845|FG005|Overall Study|Death|10|||
48790139|NCT02952924|157069848|FG000|Overall Study|Protocol Violation|0|||
48790140|NCT02952924|157069849|FG001|Overall Study|Protocol Violation|0|||
48401008|NCT00209339|155660163|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
48401009|NCT00209339|155660163|FG000|At 24 Months Follow-up|Death|1|||
48401010|NCT00209339|155660163|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
48401011|NCT00209339|155660163|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
48401012|NCT00209339|155660163|FG000|At 4 Years Follow-up|Death|1|||
48401013|NCT00209339|155660163|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
48401014|NCT00209339|155660163|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
48401015|NCT00209339|155660163|FG000|At 5 Years Follow-up|Death|1|||
48401016|NCT01239160|155660169|FG000|Overall Study|Lost to Follow-up|3|||
48401017|NCT01239160|155660170|FG001|Overall Study|Lost to Follow-up|5|||
48401018|NCT01239160|155660171|FG002|Overall Study|Lost to Follow-up|0|||
48401019|NCT01239160|155660169|FG000|Overall Study|Withdrawal by Subject|17|||
48401020|NCT01239160|155660170|FG001|Overall Study|Withdrawal by Subject|6|||
48401021|NCT01239160|155660171|FG002|Overall Study|Withdrawal by Subject|2|||
48401022|NCT01239160|155660169|FG000|Overall Study|Physician Decision|5|||
48401023|NCT01239160|155660170|FG001|Overall Study|Physician Decision|7|||
48401024|NCT01239160|155660171|FG002|Overall Study|Physician Decision|2|||
48401025|NCT01239160|155660169|FG000|Overall Study|Early Termination Due to Study Closure|0|||
48790141|NCT02952924|157069850|FG002|Overall Study|Protocol Violation|0|||
48790142|NCT02952924|157069851|FG003|Overall Study|Protocol Violation|0|||
48401026|NCT01239160|155660170|FG001|Overall Study|Early Termination Due to Study Closure|1|||
48790143|NCT02952924|157069852|FG004|Overall Study|Protocol Violation|0|||
48790144|NCT02952924|157069853|FG005|Overall Study|Protocol Violation|0|||
48790145|NCT02952924|157069854|FG006|Overall Study|Protocol Violation|0|||
48790146|NCT02952924|157069855|FG007|Overall Study|Protocol Violation|0|||
48401027|NCT01239160|155660171|FG002|Overall Study|Early Termination Due to Study Closure|6|||
48401028|NCT02275338|155660173|FG000|Overall Study|Adverse Event|15|||
48401029|NCT02275338|155660173|FG000|Overall Study|Lack of Efficacy|3|||
48401030|NCT02275338|155660173|FG000|Overall Study|Withdrawal by Subject|4|||
48790147|NCT02952924|157069856|FG008|Overall Study|Protocol Violation|0|||
48790148|NCT02952924|157069857|FG009|Overall Study|Protocol Violation|0|||
48790149|NCT02952924|157069858|FG010|Overall Study|Protocol Violation|0|||
48790150|NCT02952924|157069859|FG011|Overall Study|Protocol Violation|0|||
48790151|NCT02952924|157069860|FG012|Overall Study|Protocol Violation|0|||
48790152|NCT02952924|157069861|FG013|Overall Study|Protocol Violation|0|||
48790153|NCT02952924|157069862|FG014|Overall Study|Protocol Violation|0|||
48790154|NCT02952924|157069863|FG015|Overall Study|Protocol Violation|0|||
48790155|NCT02952924|157069864|FG016|Overall Study|Protocol Violation|0|||
48790156|NCT02952924|157069865|FG017|Overall Study|Protocol Violation|0|||
48790157|NCT02952924|157069866|FG018|Overall Study|Protocol Violation|0|||
48790158|NCT02952924|157069867|FG019|Overall Study|Protocol Violation|1|||
48790159|NCT02952924|157069868|FG020|Overall Study|Protocol Violation|0|||
48790160|NCT02952924|157069869|FG021|Overall Study|Protocol Violation|0|||
48790161|NCT02952924|157069848|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
48790162|NCT02952924|157069849|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
48790163|NCT02952924|157069850|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
48790164|NCT02952924|157069851|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
48790165|NCT02952924|157069852|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
48790166|NCT02952924|157069853|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
48790167|NCT02952924|157069854|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
48790168|NCT02952924|157069855|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
48790169|NCT02952924|157069856|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
48790170|NCT02952924|157069857|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
48790171|NCT02952924|157069858|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
48790172|NCT02952924|157069859|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
48790173|NCT02952924|157069860|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
48790174|NCT02952924|157069861|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
48790175|NCT02952924|157069862|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
48790176|NCT02952924|157069863|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
48790177|NCT02952924|157069864|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
48790178|NCT02952924|157069865|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
48356909|NCT01888874|155503531|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
48356910|NCT01888874|155503532|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
48356911|NCT01888874|155503533|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
48356912|NCT01888874|155503534|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
48356913|NCT01888874|155503535|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
48356914|NCT01888874|155503536|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
48356915|NCT01888874|155503530|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
48356916|NCT01888874|155503531|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
48401031|NCT02275338|155660173|FG000|Overall Study|Disease progression (death)|1|||
48356917|NCT01888874|155503532|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
48790179|NCT02952924|157069866|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
48790180|NCT02952924|157069867|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
48790181|NCT02952924|157069868|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
48790182|NCT02952924|157069869|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
48790183|NCT02952924|157069848|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790184|NCT02952924|157069849|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790185|NCT02952924|157069850|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790186|NCT02952924|157069851|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790187|NCT02952924|157069852|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790188|NCT02952924|157069853|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790189|NCT02952924|157069854|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790190|NCT02952924|157069855|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790191|NCT02952924|157069856|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790192|NCT02952924|157069857|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
48401032|NCT02275338|155660173|FG000|Overall Study|Ineligible to start Phase 2|4|||
48790193|NCT02952924|157069858|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790194|NCT02952924|157069859|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
48401033|NCT02275338|155660173|FG000|Overall Study|Reason not specified|5|||
48401034|NCT02275338|155660173|FG000|Overall Study|Does not meet entry criteria|1|||
48401035|NCT00382993|155660174|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
48401036|NCT00382993|155660175|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
48401037|NCT00382993|155660174|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
48401038|NCT00382993|155660175|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
48401039|NCT00382993|155660174|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
48401040|NCT00382993|155660175|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
48401041|NCT00382993|155660174|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
48401042|NCT00382993|155660175|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
48401043|NCT00382993|155660174|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
48401044|NCT00382993|155660175|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
48401045|NCT00382993|155660174|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
48401046|NCT00382993|155660175|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
48401047|NCT00382993|155660174|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
48401048|NCT00382993|155660175|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
48790195|NCT02952924|157069860|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790196|NCT02952924|157069861|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790197|NCT02952924|157069862|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790198|NCT02952924|157069863|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790199|NCT02952924|157069864|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790200|NCT02952924|157069865|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790201|NCT02952924|157069866|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790202|NCT02952924|157069867|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790203|NCT02952924|157069868|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
48790204|NCT02952924|157069869|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
48790205|NCT02952924|157069848|FG000|Overall Study|Noncompliance with study drug|0|||
48790206|NCT02952924|157069849|FG001|Overall Study|Noncompliance with study drug|0|||
48790207|NCT02952924|157069850|FG002|Overall Study|Noncompliance with study drug|0|||
48790208|NCT02952924|157069851|FG003|Overall Study|Noncompliance with study drug|0|||
48790209|NCT02952924|157069852|FG004|Overall Study|Noncompliance with study drug|0|||
48790210|NCT02952924|157069853|FG005|Overall Study|Noncompliance with study drug|0|||
48790211|NCT02952924|157069854|FG006|Overall Study|Noncompliance with study drug|0|||
48790212|NCT02952924|157069855|FG007|Overall Study|Noncompliance with study drug|0|||
48790213|NCT02952924|157069856|FG008|Overall Study|Noncompliance with study drug|0|||
48790214|NCT02952924|157069857|FG009|Overall Study|Noncompliance with study drug|0|||
48790215|NCT02952924|157069858|FG010|Overall Study|Noncompliance with study drug|0|||
48790216|NCT02952924|157069859|FG011|Overall Study|Noncompliance with study drug|0|||
48790217|NCT02952924|157069860|FG012|Overall Study|Noncompliance with study drug|0|||
48790218|NCT02952924|157069861|FG013|Overall Study|Noncompliance with study drug|0|||
48790219|NCT02952924|157069862|FG014|Overall Study|Noncompliance with study drug|0|||
48790220|NCT02952924|157069863|FG015|Overall Study|Noncompliance with study drug|0|||
48790221|NCT02952924|157069864|FG016|Overall Study|Noncompliance with study drug|0|||
48790222|NCT02952924|157069865|FG017|Overall Study|Noncompliance with study drug|0|||
48790223|NCT02952924|157069866|FG018|Overall Study|Noncompliance with study drug|0|||
48790224|NCT02952924|157069867|FG019|Overall Study|Noncompliance with study drug|0|||
48790225|NCT02952924|157069868|FG020|Overall Study|Noncompliance with study drug|0|||
48790226|NCT02952924|157069869|FG021|Overall Study|Noncompliance with study drug|1|||
48790227|NCT01581281|157069871|FG000|Overall Study|Early Study Closure|15|||
48790228|NCT01581281|157069872|FG001|Overall Study|Early Study Closure|6|||
48790229|NCT01581281|157069873|FG002|Overall Study|Early Study Closure|12|||
48790230|NCT02081846|157069875|FG000|Overall Study|Withdrawal by Subject|1|||
48790231|NCT02081846|157069876|FG001|Overall Study|Withdrawal by Subject|0|||
48790232|NCT02081846|157069875|FG000|Overall Study|invalid consent|1|||
48790233|NCT02081846|157069876|FG001|Overall Study|invalid consent|0|||
48790234|NCT01939028|157069877|FG000|Overall Study|Withdrawal by Subject|5|||
48790235|NCT01939028|157069877|FG000|Overall Study|Physician Decision|7|||
48790236|NCT03282227|157069878|FG000|Overall Study|Exposure Goals Achieved|60|||
48790237|NCT03282227|157069878|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
48790238|NCT03282227|157069878|FG000|Overall Study|Adverse Event|15|||
48790239|NCT03282227|157069878|FG000|Overall Study|Lost to Follow-up|21|||
48790240|NCT03282227|157069878|FG000|Overall Study|Withdrawal by Subject|20|||
48790241|NCT03282227|157069878|FG000|Overall Study|Lack of Efficacy|12|||
48790242|NCT03282227|157069878|FG000|Overall Study|Sponsor decision|3|||
48790243|NCT03282227|157069878|FG000|Overall Study|Physician Decision|2|||
48790244|NCT03282227|157069878|FG000|Overall Study|Pregnancy|2|||
48790245|NCT03282227|157069878|FG000|Overall Study|Other|1|||
48790246|NCT02232893|157069879|FG000|Overall Study|Withdrawal by Subject|4|||
48790247|NCT02232893|157069880|FG001|Overall Study|Withdrawal by Subject|1|||
48790248|NCT02232893|157069879|FG000|Overall Study|Adverse Event|0|||
48790249|NCT02232893|157069880|FG001|Overall Study|Adverse Event|1|||
48790250|NCT02232893|157069879|FG000|Overall Study|Sponsor request early termination|0|||
48790251|NCT02232893|157069880|FG001|Overall Study|Sponsor request early termination|1|||
48790252|NCT02232893|157069879|FG000|Overall Study|Developed exclusion criteria|0|||
48790253|NCT02232893|157069880|FG001|Overall Study|Developed exclusion criteria|1|||
48790254|NCT02232893|157069879|FG000|Overall Study|Other|0|||
48790255|NCT02232893|157069880|FG001|Overall Study|Other|3|||
48790256|NCT03273946|157069881|FG000|Overall Study|Withdrawal by Subject|5|||
48790257|NCT03273946|157069881|FG000|Overall Study|Unwillingness of the guardian|1|||
48790258|NCT03273946|157069881|FG000|Overall Study|Participant refused to use the drug|2|||
48790259|NCT03273946|157069881|FG000|Overall Study|Participant relative refused to use drug|1|||
48790260|NCT02293538|157069883|FG000|Overall Study|Adverse Event|0|||
48790261|NCT02293538|157069884|FG001|Overall Study|Adverse Event|1|||
48790262|NCT02293538|157069883|FG000|Overall Study|Lost to Follow-up|1|||
48790263|NCT02293538|157069884|FG001|Overall Study|Lost to Follow-up|0|||
48790264|NCT02293538|157069883|FG000|Overall Study|Withdrawal by Subject|0|||
48790265|NCT02293538|157069884|FG001|Overall Study|Withdrawal by Subject|1|||
48790266|NCT03342638|157069885|FG000|Overall Study|Withdrawal by Subject|1|||
48790267|NCT03342638|157069886|FG001|Overall Study|Withdrawal by Subject|0|||
48790268|NCT03342638|157069885|FG000|Overall Study|Physician Decision|0|||
48790269|NCT03342638|157069886|FG001|Overall Study|Physician Decision|1|||
48790270|NCT04498390|157069889|FG000|Overall Study|Adverse Event|0|||
48790271|NCT04498390|157069890|FG001|Overall Study|Adverse Event|0|||
48790272|NCT04498390|157069891|FG002|Overall Study|Adverse Event|1|||
48790273|NCT04498390|157069892|FG003|Overall Study|Adverse Event|0|||
48790274|NCT04498390|157069893|FG004|Overall Study|Adverse Event|0|||
48790275|NCT04498390|157069889|FG000|Overall Study|Withdrawal by Subject|0|||
48790276|NCT04498390|157069890|FG001|Overall Study|Withdrawal by Subject|0|||
48790277|NCT04498390|157069891|FG002|Overall Study|Withdrawal by Subject|0|||
48790278|NCT04498390|157069892|FG003|Overall Study|Withdrawal by Subject|1|||
48790279|NCT04498390|157069893|FG004|Overall Study|Withdrawal by Subject|0|||
48790280|NCT04177758|157069899|FG000|Overall Study|Lost to Follow-up|19|||
48790281|NCT04177758|157069900|FG001|Overall Study|Lost to Follow-up|11|||
48790282|NCT01475136|157069904|FG000|Overall Study|Sponsor Decision|0|||
48790283|NCT01475136|157069905|FG001|Overall Study|Sponsor Decision|1|||
48790284|NCT01475136|157069906|FG002|Overall Study|Sponsor Decision|0|||
48790285|NCT01475136|157069907|FG003|Overall Study|Sponsor Decision|0|||
48790286|NCT01475136|157069904|FG000|Overall Study|Entry Criteria Not Met|0|||
48790287|NCT01475136|157069905|FG001|Overall Study|Entry Criteria Not Met|2|||
48790288|NCT01475136|157069906|FG002|Overall Study|Entry Criteria Not Met|3|||
48790289|NCT01475136|157069907|FG003|Overall Study|Entry Criteria Not Met|1|||
48790290|NCT01475136|157069904|FG000|Overall Study|Withdrawal by Subject|0|||
48790291|NCT01475136|157069905|FG001|Overall Study|Withdrawal by Subject|0|||
48790292|NCT01475136|157069906|FG002|Overall Study|Withdrawal by Subject|0|||
48790293|NCT01475136|157069907|FG003|Overall Study|Withdrawal by Subject|2|||
48790294|NCT01475136|157069904|FG000|Overall Study|Adverse Event|1|||
48790295|NCT01475136|157069905|FG001|Overall Study|Adverse Event|0|||
48790296|NCT01475136|157069906|FG002|Overall Study|Adverse Event|0|||
48790297|NCT01475136|157069907|FG003|Overall Study|Adverse Event|1|||
48790298|NCT01475136|157069904|FG000|Overall Study|Death|0|||
48790299|NCT01475136|157069905|FG001|Overall Study|Death|0|||
48790300|NCT01475136|157069906|FG002|Overall Study|Death|0|||
48790301|NCT01475136|157069907|FG003|Overall Study|Death|1|||
48790302|NCT00791765|157071371|FG000|Weeks 1 to 12|Adverse Event|0|||
48790303|NCT00791765|157071372|FG001|Weeks 1 to 12|Adverse Event|1|||
48790304|NCT00791765|157071371|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
48790305|NCT00791765|157071372|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
48790306|NCT00791765|157071371|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
48790307|NCT00791765|157071372|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
48790308|NCT00791765|157071371|FG000|Weeks 1 to 12|Physician Decision|1|||
48790309|NCT00791765|157071372|FG001|Weeks 1 to 12|Physician Decision|0|||
48790310|NCT00791765|157071371|FG000|Weeks 1 to 12|Disease progression|3|||
48790311|NCT00791765|157071372|FG001|Weeks 1 to 12|Disease progression|0|||
48790312|NCT00791765|157071371|FG000|Weeks 1 to 12|Ineligibility determined|0|||
48790313|NCT00791765|157071372|FG001|Weeks 1 to 12|Ineligibility determined|3|||
48790314|NCT00791765|157071371|FG000|Weeks 13 to 24|Protocol deviation|2|||
48790315|NCT00791765|157071372|FG001|Weeks 13 to 24|Protocol deviation|0|||
48790316|NCT00791765|157071371|FG000|Weeks 13 to 24|Adverse Event|0|||
48790317|NCT00791765|157071372|FG001|Weeks 13 to 24|Adverse Event|3|||
48790318|NCT00791765|157071371|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
48790319|NCT00791765|157071372|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
48790320|NCT00791765|157071371|FG000|Weeks 13 to 24|Disease progression|0|||
48356918|NCT01888874|155503533|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
48356919|NCT01888874|155503534|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
48356920|NCT01888874|155503535|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
48356921|NCT01888874|155503536|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
48356922|NCT01888874|155503530|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48356923|NCT01888874|155503531|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48356924|NCT01888874|155503532|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48356925|NCT01888874|155503533|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48356926|NCT01888874|155503534|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48356927|NCT01888874|155503535|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
48356928|NCT01888874|155503536|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
48356929|NCT01888874|155503530|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
48356930|NCT01888874|155503531|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
48356931|NCT01888874|155503532|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
48356932|NCT01888874|155503533|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
48356933|NCT01888874|155503534|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
48356934|NCT01888874|155503535|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
48356935|NCT01888874|155503536|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
48356936|NCT01888874|155503530|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48356937|NCT01888874|155503531|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48356938|NCT01888874|155503532|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48356939|NCT01888874|155503533|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48356940|NCT01888874|155503534|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
48356941|NCT01888874|155503535|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48356942|NCT01888874|155503536|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48356943|NCT01888874|155503530|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48356944|NCT01888874|155503531|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
48356945|NCT01888874|155503532|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48356946|NCT01888874|155503533|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48356947|NCT01888874|155503534|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48356948|NCT01888874|155503535|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48356949|NCT01888874|155503536|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
48356950|NCT01888874|155503530|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48356951|NCT01888874|155503531|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
48356952|NCT01888874|155503532|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48356953|NCT01888874|155503533|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48356954|NCT01888874|155503534|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48356955|NCT01888874|155503535|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
48356956|NCT01888874|155503536|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
48356957|NCT01888874|155503530|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
48356958|NCT01888874|155503531|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
48356959|NCT01888874|155503532|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
48356960|NCT01888874|155503533|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48356961|NCT01888874|155503534|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
48356962|NCT01888874|155503535|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48356963|NCT01888874|155503536|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48356964|NCT01888874|155503530|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48790321|NCT00791765|157071372|FG001|Weeks 13 to 24|Disease progression|1|||
48790322|NCT00791765|157071371|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
48790323|NCT00791765|157071372|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
48790324|NCT00791765|157071371|FG000|Weeks 13 to 24|Other|0|||
48790325|NCT00791765|157071372|FG001|Weeks 13 to 24|Other|1|||
48790326|NCT01682460|157071373|FG000|Overall Study|Withdrawal by Subject|2|||
48790327|NCT01682460|157071373|FG000|Overall Study|Did not meet inclusion criteria|2|||
48790328|NCT00920426|157071374|FG000|ITZ111451|Adverse Event|1|||
48790329|NCT00920426|157071375|FG001|ITZ111451|Adverse Event|0|||
48790330|NCT00920426|157071376|FG002|ITZ111451|Adverse Event|0|||
48790331|NCT00920426|157071377|FG003|ITZ111451|Adverse Event|0|||
48790332|NCT01292603|157071378|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790333|NCT01292603|157071379|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790334|NCT01292603|157071380|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790335|NCT01292603|157071381|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
48790336|NCT01292603|157071382|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790337|NCT01292603|157071383|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
48790338|NCT01292603|157071378|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
48790339|NCT01292603|157071379|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
48790340|NCT01292603|157071380|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
48790341|NCT01292603|157071381|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
48790342|NCT01292603|157071382|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
48790343|NCT01292603|157071383|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
48790344|NCT01292603|157071378|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790345|NCT01292603|157071379|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790346|NCT01292603|157071380|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790347|NCT01292603|157071381|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
48790348|NCT01292603|157071382|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790349|NCT01292603|157071383|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
48790350|NCT01292603|157071378|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790351|NCT01292603|157071379|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790352|NCT01292603|157071380|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790353|NCT01292603|157071381|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
48790354|NCT01292603|157071382|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790355|NCT01292603|157071383|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
48790356|NCT01292603|157071378|FG000|Part 1: Regular Follow-Up Period|Death|3|||
48790357|NCT01292603|157071379|FG001|Part 1: Regular Follow-Up Period|Death|1|||
48790358|NCT01292603|157071380|FG002|Part 1: Regular Follow-Up Period|Death|3|||
48790359|NCT01292603|157071381|FG003|Part 1: Regular Follow-Up Period|Death|1|||
48790360|NCT01292603|157071382|FG004|Part 1: Regular Follow-Up Period|Death|0|||
48790361|NCT01292603|157071383|FG005|Part 1: Regular Follow-Up Period|Death|0|||
48790362|NCT01292603|157071378|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
48790363|NCT01292603|157071379|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
48790364|NCT01292603|157071380|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
48790365|NCT01292603|157071381|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
48790366|NCT01292603|157071382|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
48790367|NCT01292603|157071383|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
48790368|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Death|0|||
48790369|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Death|0|||
48790370|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Death|0|||
48790371|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Death|0|||
48790372|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Death|1|||
48790373|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Death|0|||
48790374|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790375|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790376|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790377|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790378|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
48790379|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
48790380|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
48790381|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
48790382|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
48790383|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
48790384|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
48356965|NCT01888874|155503531|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48356966|NCT01888874|155503532|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48356967|NCT01888874|155503533|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48356968|NCT01888874|155503534|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
48356969|NCT01888874|155503535|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48430352|NCT00696657|155763706|FG006|Overall Study|Withdrawal criteria|1|||
48790385|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
48790386|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
48790387|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
48790388|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
48790389|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
48790390|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
48790391|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
48790392|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
48790393|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
48790394|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
48790395|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
48790396|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
48790397|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
48790398|NCT01292603|157071378|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790399|NCT01292603|157071379|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790400|NCT01292603|157071380|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790401|NCT01292603|157071381|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790402|NCT01292603|157071382|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
48790403|NCT01292603|157071383|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
48790404|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Death|0|||
48790405|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Death|0|||
48790406|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Death|0|||
48790407|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Death|0|||
48790408|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Death|6|||
48790409|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Death|3|||
48790410|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
48790411|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
48790412|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
48790413|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
48790414|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
48790415|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
48790416|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
48790417|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
48790418|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
48790419|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
48790420|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
48790421|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
48790422|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790423|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790424|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790425|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790426|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
48790427|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
48790428|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
48356970|NCT01888874|155503536|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
48356971|NCT01888874|155503530|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48356972|NCT01888874|155503531|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48356973|NCT01888874|155503532|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
48356974|NCT01888874|155503533|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48356975|NCT01888874|155503534|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48356976|NCT01888874|155503535|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
48356977|NCT01888874|155503536|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
48356978|NCT01888874|155503530|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48356979|NCT01888874|155503531|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48356980|NCT01888874|155503532|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
48356981|NCT01888874|155503533|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48356982|NCT01888874|155503534|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48356983|NCT01888874|155503535|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48356984|NCT01888874|155503536|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
48356985|NCT01888874|155503530|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
48356986|NCT01888874|155503531|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
48356987|NCT01888874|155503532|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
48356988|NCT01888874|155503533|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
48356989|NCT01888874|155503534|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
48356990|NCT01888874|155503535|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
48356991|NCT01888874|155503536|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
48356992|NCT01888874|155503530|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48790429|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
48790430|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
48790431|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
48586933|NCT00269477|156341485|FG000|Overall Study|Protocol Violation|5|||
48586934|NCT00269477|156341486|FG001|Overall Study|Protocol Violation|5|||
48586935|NCT00269477|156341487|FG002|Overall Study|Protocol Violation|1|||
48586936|NCT00269477|156341488|FG003|Overall Study|Protocol Violation|0|||
48586937|NCT00269477|156341485|FG000|Overall Study|Missed post-vaccination blood draw|0|||
48586938|NCT00269477|156341486|FG001|Overall Study|Missed post-vaccination blood draw|1|||
48586939|NCT00269477|156341487|FG002|Overall Study|Missed post-vaccination blood draw|0|||
48586940|NCT00269477|156341488|FG003|Overall Study|Missed post-vaccination blood draw|0|||
48586941|NCT00568334|156341491|FG000|Overall Study|Withdrawal by Subject|0|||
48586942|NCT00568334|156341492|FG001|Overall Study|Withdrawal by Subject|1|||
48586943|NCT00568334|156341491|FG000|Overall Study|Lost to Follow-up|1|||
48586944|NCT00568334|156341492|FG001|Overall Study|Lost to Follow-up|0|||
48586945|NCT01897571|156341493|FG000|Overall Study|Lost to Follow-up|3|||
48586946|NCT01897571|156341494|FG001|Overall Study|Lost to Follow-up|0|||
48586947|NCT01897571|156341495|FG002|Overall Study|Lost to Follow-up|0|||
48586948|NCT01897571|156341496|FG003|Overall Study|Lost to Follow-up|0|||
48586949|NCT01897571|156341497|FG004|Overall Study|Lost to Follow-up|2|||
48586950|NCT01897571|156341498|FG005|Overall Study|Lost to Follow-up|0|||
48586951|NCT01897571|156341499|FG006|Overall Study|Lost to Follow-up|0|||
48586952|NCT01897571|156341500|FG007|Overall Study|Lost to Follow-up|0|||
48586953|NCT01897571|156341501|FG008|Overall Study|Lost to Follow-up|1|||
48586954|NCT01897571|156341502|FG009|Overall Study|Lost to Follow-up|2|||
48586955|NCT01897571|156341503|FG010|Overall Study|Lost to Follow-up|4|||
48586956|NCT01897571|156341493|FG000|Overall Study|Withdrawal by Subject|0|||
48586957|NCT01897571|156341494|FG001|Overall Study|Withdrawal by Subject|0|||
48586958|NCT01897571|156341495|FG002|Overall Study|Withdrawal by Subject|0|||
48586959|NCT01897571|156341496|FG003|Overall Study|Withdrawal by Subject|0|||
48586960|NCT01897571|156341497|FG004|Overall Study|Withdrawal by Subject|0|||
48586961|NCT01897571|156341498|FG005|Overall Study|Withdrawal by Subject|0|||
48586962|NCT01897571|156341499|FG006|Overall Study|Withdrawal by Subject|0|||
48586963|NCT01897571|156341500|FG007|Overall Study|Withdrawal by Subject|1|||
48586964|NCT01897571|156341501|FG008|Overall Study|Withdrawal by Subject|4|||
48586965|NCT01897571|156341502|FG009|Overall Study|Withdrawal by Subject|3|||
48586966|NCT01897571|156341503|FG010|Overall Study|Withdrawal by Subject|1|||
48586967|NCT01897571|156341493|FG000|Overall Study|Other|1|||
48586968|NCT01897571|156341494|FG001|Overall Study|Other|0|||
48586969|NCT01897571|156341495|FG002|Overall Study|Other|0|||
48586970|NCT01897571|156341496|FG003|Overall Study|Other|3|||
48586971|NCT01897571|156341497|FG004|Overall Study|Other|3|||
48586972|NCT01897571|156341498|FG005|Overall Study|Other|4|||
48586973|NCT01897571|156341499|FG006|Overall Study|Other|7|||
48586974|NCT01897571|156341500|FG007|Overall Study|Other|0|||
48586975|NCT01897571|156341501|FG008|Overall Study|Other|0|||
48356993|NCT01888874|155503531|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
48356994|NCT01888874|155503532|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48356995|NCT01888874|155503533|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48356996|NCT01888874|155503534|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48356997|NCT01888874|155503535|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
48356998|NCT01888874|155503536|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
48356999|NCT03768336|155503537|FG000|Overall Study|Lost to Follow-up|3|||
48357000|NCT03768336|155503538|FG001|Overall Study|Lost to Follow-up|2|||
48357001|NCT03768336|155503537|FG000|Overall Study|Became Ineligible|2|||
48357002|NCT03768336|155503538|FG001|Overall Study|Became Ineligible|0|||
48357003|NCT03768336|155503537|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
48357004|NCT03768336|155503538|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
48357005|NCT03768336|155503537|FG000|Overall Study|Missed final survey (post-treatment|0|||
48357006|NCT03768336|155503538|FG001|Overall Study|Missed final survey (post-treatment|1|||
48357007|NCT03258723|155503539|FG000|Overall Study|COVID Interruption of study|54|||
48357008|NCT03258723|155503539|FG000|Overall Study|Lost to Follow-up|8|||
48357009|NCT02000622|155503541|FG000|Overall Study|Withdrawal by Subject|5|||
48357010|NCT02000622|155503542|FG001|Overall Study|Withdrawal by Subject|7|||
48357011|NCT02000622|155503541|FG000|Overall Study|Lost to Follow-up|4|||
48357012|NCT02000622|155503542|FG001|Overall Study|Lost to Follow-up|0|||
48357013|NCT02000622|155503541|FG000|Overall Study|Death|159|||
48357014|NCT02000622|155503542|FG001|Overall Study|Death|73|||
48357015|NCT02000622|155503541|FG000|Overall Study|Withdrawn due to site closure|1|||
48357016|NCT02000622|155503542|FG001|Overall Study|Withdrawn due to site closure|0|||
48357017|NCT01234883|155503543|FG000|Overall Study|Early treatment release|8|||
48357018|NCT01234883|155503544|FG001|Overall Study|Early treatment release|10|||
48357019|NCT01234883|155503543|FG000|Overall Study|Parent/guardian withdrew consent|1|||
48357020|NCT01234883|155503544|FG001|Overall Study|Parent/guardian withdrew consent|2|||
48357021|NCT01234883|155503543|FG000|Overall Study|Technical difficulties with IV infusion|0|||
48357022|NCT01234883|155503544|FG001|Overall Study|Technical difficulties with IV infusion|1|||
48357023|NCT01234883|155503543|FG000|Overall Study|Inclusion/exclusion failure|1|||
48401049|NCT00382993|155660174|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
48401050|NCT00382993|155660175|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
48401051|NCT00382993|155660174|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
48401052|NCT00382993|155660175|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
48401053|NCT00382993|155660174|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
48401054|NCT00382993|155660175|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
48401055|NCT01100944|155660176|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
48401056|NCT01100944|155660177|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
48401057|NCT01100944|155660178|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
48401058|NCT01100944|155660176|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
48401059|NCT01100944|155660177|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
48401060|NCT01100944|155660178|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
48401061|NCT01100944|155660176|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
48401062|NCT01100944|155660177|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
48401063|NCT01100944|155660178|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
48401064|NCT01100944|155660176|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
48401065|NCT01100944|155660177|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
48401066|NCT01100944|155660178|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
48401067|NCT01665807|155660198|FG000|Overall Study|Withdrawal by Subject|2|||
48401068|NCT01665807|155660199|FG001|Overall Study|Withdrawal by Subject|0|||
48401069|NCT01665807|155660200|FG002|Overall Study|Withdrawal by Subject|1|||
48401070|NCT01847885|155660203|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
48401071|NCT01847885|155660204|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
48586976|NCT01897571|156341502|FG009|Overall Study|Other|0|||
48586977|NCT01897571|156341503|FG010|Overall Study|Other|0|||
48586978|NCT01897571|156341493|FG000|Overall Study|Enrolled in rollover study|0|||
48586979|NCT01897571|156341494|FG001|Overall Study|Enrolled in rollover study|0|||
48401072|NCT01847885|155660205|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
48586980|NCT01897571|156341495|FG002|Overall Study|Enrolled in rollover study|0|||
48586981|NCT01897571|156341496|FG003|Overall Study|Enrolled in rollover study|0|||
48586982|NCT01897571|156341497|FG004|Overall Study|Enrolled in rollover study|0|||
48586983|NCT01897571|156341498|FG005|Overall Study|Enrolled in rollover study|0|||
48586984|NCT01897571|156341499|FG006|Overall Study|Enrolled in rollover study|0|||
48586985|NCT01897571|156341500|FG007|Overall Study|Enrolled in rollover study|9|||
48586986|NCT01897571|156341501|FG008|Overall Study|Enrolled in rollover study|7|||
48586987|NCT01897571|156341502|FG009|Overall Study|Enrolled in rollover study|9|||
48586988|NCT01897571|156341503|FG010|Overall Study|Enrolled in rollover study|1|||
48586989|NCT01897571|156341493|FG000|Overall Study|Death|2|||
48586990|NCT01897571|156341494|FG001|Overall Study|Death|2|||
48586991|NCT01897571|156341495|FG002|Overall Study|Death|3|||
48586992|NCT01897571|156341496|FG003|Overall Study|Death|6|||
48586993|NCT01897571|156341497|FG004|Overall Study|Death|7|||
48586994|NCT01897571|156341498|FG005|Overall Study|Death|9|||
48586995|NCT01897571|156341499|FG006|Overall Study|Death|5|||
48586996|NCT01897571|156341500|FG007|Overall Study|Death|22|||
48586997|NCT01897571|156341501|FG008|Overall Study|Death|23|||
48586998|NCT01897571|156341502|FG009|Overall Study|Death|129|||
48586999|NCT01897571|156341503|FG010|Overall Study|Death|59|||
48587000|NCT01256385|156341505|FG000|Overall Study|Physician Decision|1|||
48587001|NCT01256385|156341506|FG001|Overall Study|Physician Decision|1|||
48587002|NCT01256385|156341505|FG000|Overall Study|Withdrawal by Subject|2|||
48587003|NCT01256385|156341506|FG001|Overall Study|Withdrawal by Subject|2|||
48790432|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
48790433|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
48790434|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
48790435|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
48790436|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
48790437|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
48790438|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
48790439|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
48790440|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
48790441|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
48790442|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
48790443|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
48790444|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
48790445|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
48790446|NCT01292603|157071378|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
48790447|NCT01292603|157071379|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
48790448|NCT01292603|157071380|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
48790449|NCT01292603|157071381|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
48790450|NCT01292603|157071382|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
48790451|NCT01292603|157071383|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
48790452|NCT01292603|157071378|FG000|Overall Survival Status|Death|3|||
48790453|NCT01292603|157071379|FG001|Overall Survival Status|Death|1|||
48790454|NCT01292603|157071380|FG002|Overall Survival Status|Death|3|||
48790455|NCT01292603|157071381|FG003|Overall Survival Status|Death|1|||
48790456|NCT01292603|157071382|FG004|Overall Survival Status|Death|16|||
48790457|NCT01292603|157071383|FG005|Overall Survival Status|Death|10|||
48790458|NCT01808690|157071384|FG000|Overall Study|Withdrawal by Subject|1|||
48790459|NCT01808690|157071385|FG001|Overall Study|Withdrawal by Subject|2|||
48790460|NCT03586648|157071390|FG000|Period 1|Withdrawal by Subject|0|||
48790461|NCT03586648|157071391|FG001|Period 1|Withdrawal by Subject|1|||
48790462|NCT03586648|157071390|FG000|Period 1|Lost to Follow-up|1|||
48790463|NCT03586648|157071391|FG001|Period 1|Lost to Follow-up|1|||
48790464|NCT03586648|157071390|FG000|Period 1|Adverse Event|1|||
48790465|NCT03586648|157071391|FG001|Period 1|Adverse Event|0|||
48790466|NCT03586648|157071390|FG000|Period 1|Study related symptoms or complaints|2|||
48790467|NCT03586648|157071391|FG001|Period 1|Study related symptoms or complaints|1|||
48790468|NCT03586648|157071390|FG000|Period 1|Physician Decision|0|||
48790469|NCT03586648|157071391|FG001|Period 1|Physician Decision|1|||
48790470|NCT03586648|157071390|FG000|Period 2|Adverse Event|1|||
48790471|NCT03586648|157071391|FG001|Period 2|Adverse Event|0|||
48790472|NCT02041195|157071392|FG000|Overall Study|Adverse Event|1|||
48790473|NCT02041195|157071393|FG001|Overall Study|Adverse Event|2|||
48790474|NCT02041195|157071394|FG002|Overall Study|Adverse Event|0|||
48790475|NCT02041195|157071395|FG003|Overall Study|Adverse Event|0|||
48790476|NCT02041195|157071396|FG004|Overall Study|Adverse Event|0|||
48790477|NCT02041195|157071397|FG005|Overall Study|Adverse Event|0|||
48587004|NCT04702997|156341507|FG000|Overall Study|Withdrawal by Subject|1|||
48587005|NCT04702997|156341508|FG001|Overall Study|Withdrawal by Subject|1|||
48587006|NCT01797094|156341509|FG000|Overall Study|Adverse Event|1|||
48587007|NCT01797094|156341510|FG001|Overall Study|Adverse Event|1|||
48587008|NCT01797094|156341509|FG000|Overall Study|Personal Reasons|4|||
48587009|NCT01797094|156341510|FG001|Overall Study|Personal Reasons|0|||
48587010|NCT01797094|156341509|FG000|Overall Study|Protocol Violation|0|||
48587011|NCT01797094|156341510|FG001|Overall Study|Protocol Violation|1|||
48587012|NCT01797094|156341509|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48587013|NCT01797094|156341510|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48587014|NCT00401960|156341511|FG000|Overall Study|Lost to Follow-up|3|||
48587015|NCT00401960|156341512|FG001|Overall Study|Lost to Follow-up|0|||
48587016|NCT00401960|156341511|FG000|Overall Study|Death|2|||
48587017|NCT00401960|156341512|FG001|Overall Study|Death|0|||
48587018|NCT02649426|156341515|FG000|Overall Study|Follow-up on going|1|||
48587019|NCT02649426|156341516|FG001|Overall Study|Follow-up on going|26|||
48587020|NCT02649426|156341517|FG002|Overall Study|Follow-up on going|28|||
48587021|NCT02649426|156341518|FG003|Overall Study|Follow-up on going|31|||
48587022|NCT01440569|156341519|FG000|Main Study|Enrolled but not treated|1|||
48587023|NCT01440569|156341520|FG001|Main Study|Enrolled but not treated|0|||
48587024|NCT01440569|156341519|FG000|Main Study|Adverse Event|9|||
48587025|NCT01440569|156341520|FG001|Main Study|Adverse Event|0|||
48587026|NCT01440569|156341519|FG000|Main Study|Pregnancy|1|||
48587027|NCT01440569|156341520|FG001|Main Study|Pregnancy|0|||
48587028|NCT01440569|156341519|FG000|Main Study|Investigator's Discretion|1|||
48587029|NCT01440569|156341520|FG001|Main Study|Investigator's Discretion|1|||
48587030|NCT01440569|156341519|FG000|Main Study|Withdrew Consent|7|||
48587031|NCT01440569|156341520|FG001|Main Study|Withdrew Consent|1|||
48587032|NCT01440569|156341519|FG000|Main Study|Lost to Follow-up|13|||
48587033|NCT01440569|156341520|FG001|Main Study|Lost to Follow-up|2|||
48587034|NCT01440569|156341519|FG000|Main Study|Subject Non-Compliance|3|||
48587035|NCT01440569|156341520|FG001|Main Study|Subject Non-Compliance|0|||
48587036|NCT01440569|156341519|FG000|Main Study|Protocol Violation|1|||
48587037|NCT01440569|156341520|FG001|Main Study|Protocol Violation|0|||
48587038|NCT01440569|156341519|FG000|Open-Label Rollover Phase|Adverse Event|3|||
48587039|NCT01440569|156341520|FG001|Open-Label Rollover Phase|Adverse Event|0|||
48401073|NCT01847885|155660203|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
48401074|NCT01847885|155660204|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
48587040|NCT01440569|156341519|FG000|Open-Label Rollover Phase|Pregnancy|1|||
48587041|NCT01440569|156341520|FG001|Open-Label Rollover Phase|Pregnancy|0|||
48790478|NCT02041195|157071398|FG006|Overall Study|Adverse Event|3|||
48790479|NCT02041195|157071399|FG007|Overall Study|Adverse Event|0|||
48790480|NCT02041195|157071392|FG000|Overall Study|Withdrawal by Subject|1|||
48790481|NCT02041195|157071393|FG001|Overall Study|Withdrawal by Subject|0|||
48790482|NCT02041195|157071394|FG002|Overall Study|Withdrawal by Subject|0|||
48790483|NCT02041195|157071395|FG003|Overall Study|Withdrawal by Subject|0|||
48790484|NCT02041195|157071396|FG004|Overall Study|Withdrawal by Subject|0|||
48790485|NCT02041195|157071397|FG005|Overall Study|Withdrawal by Subject|0|||
48790486|NCT02041195|157071398|FG006|Overall Study|Withdrawal by Subject|4|||
48587042|NCT01440569|156341519|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
48587043|NCT01440569|156341520|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
48587044|NCT01440569|156341519|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
48587045|NCT01440569|156341520|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
48790487|NCT02041195|157071399|FG007|Overall Study|Withdrawal by Subject|3|||
48790488|NCT02041195|157071392|FG000|Overall Study|Unable to comply with study visits|0|||
48790489|NCT02041195|157071393|FG001|Overall Study|Unable to comply with study visits|1|||
48790490|NCT02041195|157071394|FG002|Overall Study|Unable to comply with study visits|0|||
48790491|NCT02041195|157071395|FG003|Overall Study|Unable to comply with study visits|0|||
48790492|NCT02041195|157071396|FG004|Overall Study|Unable to comply with study visits|1|||
48790493|NCT02041195|157071397|FG005|Overall Study|Unable to comply with study visits|0|||
48790494|NCT02041195|157071398|FG006|Overall Study|Unable to comply with study visits|0|||
48790495|NCT02041195|157071399|FG007|Overall Study|Unable to comply with study visits|0|||
48790496|NCT02395120|157071400|FG000|Overall Study|Missed follow-up dental exam|57|||
48790497|NCT02395120|157071401|FG001|Overall Study|Missed follow-up dental exam|62|||
48790498|NCT02395120|157071402|FG002|Overall Study|Missed follow-up dental exam|6|||
48790499|NCT02395120|157071403|FG003|Overall Study|Missed follow-up dental exam|6|||
48790500|NCT02395120|157071404|FG004|Overall Study|Missed follow-up dental exam|51|||
48790501|NCT00907153|157071411|FG000|Overall Study|Lost to Follow-up|1|||
48790502|NCT00907153|157071412|FG001|Overall Study|Lost to Follow-up|1|||
48790503|NCT00907153|157071411|FG000|Overall Study|Withdrawal by Subject|1|||
48790504|NCT00907153|157071412|FG001|Overall Study|Withdrawal by Subject|3|||
48790505|NCT01780298|157071413|FG000|Overall Study|Physician Decision|1|||
48790506|NCT01780298|157071414|FG001|Overall Study|Physician Decision|5|||
48790507|NCT01780298|157071415|FG002|Overall Study|Physician Decision|1|||
48790508|NCT01780298|157071416|FG003|Overall Study|Physician Decision|1|||
48790509|NCT01780298|157071413|FG000|Overall Study|Subject not matched|1|||
48790510|NCT01780298|157071414|FG001|Overall Study|Subject not matched|0|||
48790511|NCT01780298|157071415|FG002|Overall Study|Subject not matched|1|||
48790512|NCT01780298|157071416|FG003|Overall Study|Subject not matched|0|||
48790513|NCT01780298|157071413|FG000|Overall Study|Adverse Event|0|||
48790514|NCT01780298|157071414|FG001|Overall Study|Adverse Event|0|||
48790515|NCT01780298|157071415|FG002|Overall Study|Adverse Event|2|||
48790516|NCT01780298|157071416|FG003|Overall Study|Adverse Event|0|||
48790517|NCT01983293|157071417|FG000|Overall Study|Withdrawal by Subject|29|||
48790518|NCT01983293|157071418|FG001|Overall Study|Withdrawal by Subject|15|||
48790519|NCT01983293|157071417|FG000|Overall Study|Missing 12-month visit|3|||
48790520|NCT01983293|157071418|FG001|Overall Study|Missing 12-month visit|3|||
48790521|NCT01983293|157071417|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
48790522|NCT01983293|157071418|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
48790523|NCT01349569|157071419|FG000|Overall Study|Lack of Efficacy|4|||
48790524|NCT03581305|157071420|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
48790525|NCT03581305|157071421|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
48790526|NCT03581305|157071420|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
48790527|NCT03581305|157071421|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
48790528|NCT03581305|157071420|FG000|Serotonergic Study|Withdrawal by Subject|5|||
48790529|NCT03581305|157071421|FG001|Serotonergic Study|Withdrawal by Subject|1|||
48790530|NCT01747772|157071422|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
48790531|NCT03147248|157071423|FG000|Overall Study|Adverse Event|0|||
48790532|NCT03147248|157071424|FG001|Overall Study|Adverse Event|2|||
48790533|NCT03147248|157071425|FG002|Overall Study|Adverse Event|2|||
48790534|NCT03147248|157071426|FG003|Overall Study|Adverse Event|2|||
48790535|NCT03147248|157071427|FG004|Overall Study|Adverse Event|6|||
48790536|NCT03147248|157071428|FG005|Overall Study|Adverse Event|11|||
48790537|NCT03147248|157071423|FG000|Overall Study|Disease progression|1|||
48790538|NCT03147248|157071424|FG001|Overall Study|Disease progression|0|||
48790539|NCT03147248|157071425|FG002|Overall Study|Disease progression|0|||
48790540|NCT03147248|157071426|FG003|Overall Study|Disease progression|0|||
48790541|NCT03147248|157071427|FG004|Overall Study|Disease progression|0|||
48790542|NCT03147248|157071428|FG005|Overall Study|Disease progression|2|||
48790543|NCT03147248|157071423|FG000|Overall Study|Withdrawal by Subject|0|||
48790544|NCT03147248|157071424|FG001|Overall Study|Withdrawal by Subject|0|||
48790545|NCT03147248|157071425|FG002|Overall Study|Withdrawal by Subject|0|||
48790546|NCT03147248|157071426|FG003|Overall Study|Withdrawal by Subject|0|||
48790547|NCT03147248|157071427|FG004|Overall Study|Withdrawal by Subject|12|||
48790548|NCT03147248|157071428|FG005|Overall Study|Withdrawal by Subject|9|||
48790549|NCT03147248|157071423|FG000|Overall Study|Protocol Violation|0|||
48790550|NCT03147248|157071424|FG001|Overall Study|Protocol Violation|0|||
48790551|NCT03147248|157071425|FG002|Overall Study|Protocol Violation|0|||
48790552|NCT03147248|157071426|FG003|Overall Study|Protocol Violation|0|||
48790553|NCT03147248|157071427|FG004|Overall Study|Protocol Violation|2|||
48357024|NCT01234883|155503544|FG001|Overall Study|Inclusion/exclusion failure|0|||
48790554|NCT03147248|157071428|FG005|Overall Study|Protocol Violation|0|||
48790555|NCT03147248|157071423|FG000|Overall Study|Lost to Follow-up|0|||
48790556|NCT03147248|157071424|FG001|Overall Study|Lost to Follow-up|0|||
48790557|NCT03147248|157071425|FG002|Overall Study|Lost to Follow-up|0|||
48790558|NCT03147248|157071426|FG003|Overall Study|Lost to Follow-up|0|||
48790559|NCT03147248|157071427|FG004|Overall Study|Lost to Follow-up|2|||
48790560|NCT03147248|157071428|FG005|Overall Study|Lost to Follow-up|0|||
48790561|NCT03147248|157071423|FG000|Overall Study|Pregnancy|0|||
48790562|NCT03147248|157071424|FG001|Overall Study|Pregnancy|0|||
48790563|NCT03147248|157071425|FG002|Overall Study|Pregnancy|0|||
48790564|NCT03147248|157071426|FG003|Overall Study|Pregnancy|0|||
48790565|NCT03147248|157071427|FG004|Overall Study|Pregnancy|1|||
48790566|NCT03147248|157071428|FG005|Overall Study|Pregnancy|0|||
48790567|NCT03147248|157071423|FG000|Overall Study|Death|0|||
48790568|NCT03147248|157071424|FG001|Overall Study|Death|0|||
48790569|NCT03147248|157071425|FG002|Overall Study|Death|0|||
48790570|NCT03147248|157071426|FG003|Overall Study|Death|0|||
48790571|NCT03147248|157071427|FG004|Overall Study|Death|0|||
48790572|NCT03147248|157071428|FG005|Overall Study|Death|4|||
48790573|NCT03147248|157071423|FG000|Overall Study|Physician Decision|0|||
48790574|NCT03147248|157071424|FG001|Overall Study|Physician Decision|0|||
48790575|NCT03147248|157071425|FG002|Overall Study|Physician Decision|0|||
48790576|NCT03147248|157071426|FG003|Overall Study|Physician Decision|0|||
48790577|NCT03147248|157071427|FG004|Overall Study|Physician Decision|2|||
48790578|NCT03147248|157071428|FG005|Overall Study|Physician Decision|4|||
48790579|NCT03147248|157071423|FG000|Overall Study|Prolonged Dosing Interval|0|||
48790580|NCT03147248|157071424|FG001|Overall Study|Prolonged Dosing Interval|0|||
48790581|NCT03147248|157071425|FG002|Overall Study|Prolonged Dosing Interval|0|||
48790582|NCT03147248|157071426|FG003|Overall Study|Prolonged Dosing Interval|0|||
48790583|NCT03147248|157071427|FG004|Overall Study|Prolonged Dosing Interval|1|||
48790584|NCT03147248|157071428|FG005|Overall Study|Prolonged Dosing Interval|1|||
48790585|NCT02780388|157071437|FG000|Overall Study|Lost to Follow-up|0|||
48790586|NCT02780388|157071438|FG001|Overall Study|Lost to Follow-up|1|||
48790587|NCT02780388|157071439|FG002|Overall Study|Lost to Follow-up|0|||
48790588|NCT02780388|157071440|FG003|Overall Study|Lost to Follow-up|0|||
48790589|NCT02780388|157071441|FG004|Overall Study|Lost to Follow-up|0|||
48790590|NCT02780388|157071437|FG000|Overall Study|Withdrawal by Subject|1|||
48790591|NCT02780388|157071438|FG001|Overall Study|Withdrawal by Subject|1|||
48790592|NCT02780388|157071439|FG002|Overall Study|Withdrawal by Subject|0|||
48790593|NCT02780388|157071440|FG003|Overall Study|Withdrawal by Subject|0|||
48790594|NCT02780388|157071441|FG004|Overall Study|Withdrawal by Subject|0|||
48790595|NCT03832010|157071446|FG000|Overall Study|Withdrawal by Subject|2|||
48790596|NCT03832010|157071447|FG001|Overall Study|Withdrawal by Subject|1|||
48587046|NCT01440569|156341519|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
48587047|NCT01440569|156341520|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
48587048|NCT01440569|156341519|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
48587049|NCT01440569|156341520|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
48587050|NCT01440569|156341519|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
48587051|NCT01440569|156341520|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
48587052|NCT00467558|156341524|FG000|Overall Study|Lost to Follow-up|2|||
48587053|NCT00467558|156341525|FG001|Overall Study|Lost to Follow-up|0|||
48587054|NCT00856843|156341531|FG000|Overall Study|Withdrawal by Subject|1|||
48587055|NCT00856843|156341532|FG001|Overall Study|Withdrawal by Subject|5|||
48587056|NCT00856843|156341531|FG000|Overall Study|Lack of Efficacy|1|||
48587057|NCT00856843|156341532|FG001|Overall Study|Lack of Efficacy|0|||
48587058|NCT00938587|156341537|FG000|Overall Study|Adverse Event|2|||
48587059|NCT00938587|156341538|FG001|Overall Study|Adverse Event|0|||
48587060|NCT00938587|156341539|FG002|Overall Study|Adverse Event|0|||
48587061|NCT00938587|156341540|FG003|Overall Study|Adverse Event|2|||
48587062|NCT00938587|156341537|FG000|Overall Study|Did not meet entrance criteria|0|||
48790597|NCT03832010|157071448|FG002|Overall Study|Withdrawal by Subject|0|||
48790598|NCT03832010|157071446|FG000|Overall Study|Lost to Follow-up|2|||
48790599|NCT03832010|157071447|FG001|Overall Study|Lost to Follow-up|1|||
48790600|NCT03832010|157071448|FG002|Overall Study|Lost to Follow-up|1|||
48790601|NCT00838110|157071449|FG000|Overall Study|Death|0|||
48790602|NCT00838110|157071450|FG001|Overall Study|Death|0|||
48790603|NCT00838110|157071451|FG002|Overall Study|Death|1|||
48790604|NCT00838110|157071452|FG003|Overall Study|Death|2|||
48790605|NCT00838110|157071449|FG000|Overall Study|Adverse Event|11|||
48790606|NCT00838110|157071450|FG001|Overall Study|Adverse Event|10|||
48790607|NCT00838110|157071451|FG002|Overall Study|Adverse Event|8|||
48790608|NCT00838110|157071452|FG003|Overall Study|Adverse Event|7|||
48790609|NCT00838110|157071449|FG000|Overall Study|Withdrawal by Subject|5|||
48790610|NCT00838110|157071450|FG001|Overall Study|Withdrawal by Subject|6|||
48357025|NCT02270671|155503547|FG000|Overall Study|Withdrawal by Subject|1|||
48357026|NCT02270671|155503548|FG001|Overall Study|Withdrawal by Subject|1|||
48357027|NCT02270671|155503547|FG000|Overall Study|Protocol Violation|0|||
48790611|NCT00838110|157071451|FG002|Overall Study|Withdrawal by Subject|3|||
48790612|NCT00838110|157071452|FG003|Overall Study|Withdrawal by Subject|4|||
48790613|NCT00838110|157071449|FG000|Overall Study|Other|3|||
48790614|NCT00838110|157071450|FG001|Overall Study|Other|3|||
48790615|NCT00838110|157071451|FG002|Overall Study|Other|3|||
48790616|NCT00838110|157071452|FG003|Overall Study|Other|2|||
48790617|NCT00838110|157071449|FG000|Overall Study|Protocol Violation|0|||
48401075|NCT01847885|155660205|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
48401076|NCT01847885|155660203|FG000|Initial Enrollment (Consented)|Screen failure|39|||
48790618|NCT00838110|157071450|FG001|Overall Study|Protocol Violation|2|||
48790619|NCT00838110|157071451|FG002|Overall Study|Protocol Violation|1|||
48790620|NCT00838110|157071452|FG003|Overall Study|Protocol Violation|1|||
48790621|NCT00838110|157071449|FG000|Overall Study|Lost to Follow-up|3|||
48790622|NCT00838110|157071450|FG001|Overall Study|Lost to Follow-up|0|||
48790623|NCT00838110|157071451|FG002|Overall Study|Lost to Follow-up|0|||
48790624|NCT00838110|157071452|FG003|Overall Study|Lost to Follow-up|0|||
48790625|NCT00838110|157071449|FG000|Overall Study|Did not meet eligibility criteria|0|||
48790626|NCT00838110|157071450|FG001|Overall Study|Did not meet eligibility criteria|0|||
48790627|NCT00838110|157071451|FG002|Overall Study|Did not meet eligibility criteria|1|||
48790628|NCT00838110|157071452|FG003|Overall Study|Did not meet eligibility criteria|2|||
48790629|NCT00838110|157071449|FG000|Overall Study|Randomized but not treated|0|||
48790630|NCT00838110|157071450|FG001|Overall Study|Randomized but not treated|1|||
48790631|NCT00838110|157071451|FG002|Overall Study|Randomized but not treated|0|||
48790632|NCT00838110|157071452|FG003|Overall Study|Randomized but not treated|0|||
48790633|NCT02388724|157071463|FG000|Overall Study|Reason not Specified|0|||
48790634|NCT02388724|157071464|FG001|Overall Study|Reason not Specified|1|||
48790635|NCT02388724|157071463|FG000|Overall Study|Major Protocol Deviation|3|||
48790636|NCT02388724|157071464|FG001|Overall Study|Major Protocol Deviation|3|||
48790637|NCT02388724|157071463|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
48790638|NCT02388724|157071464|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
48790639|NCT02388724|157071463|FG000|Overall Study|Voluntary Withdrawal|6|||
48790640|NCT02388724|157071464|FG001|Overall Study|Voluntary Withdrawal|5|||
48790641|NCT02388724|157071463|FG000|Overall Study|Randomized but not Treated|0|||
48790642|NCT02388724|157071464|FG001|Overall Study|Randomized but not Treated|2|||
48790643|NCT01549613|157071471|FG000|Overall Study|Lost to Follow-up|11|||
48790644|NCT01549613|157071472|FG001|Overall Study|Lost to Follow-up|11|||
48790645|NCT03166618|157071476|FG000|Overall Study|Study was Terminated|0|||
48790646|NCT03166618|157071477|FG001|Overall Study|Study was Terminated|1|||
48790647|NCT04717596|157071478|FG000|Overall Study|Withdrawal by Subject|4|||
48790648|NCT03555396|157071479|FG000|Overall Study|Death|3|||
48790649|NCT03555396|157071480|FG001|Overall Study|Death|1|||
48790650|NCT03555396|157071479|FG000|Overall Study|Lost to Follow-up|0|||
48790651|NCT03555396|157071480|FG001|Overall Study|Lost to Follow-up|2|||
48790652|NCT02647658|157071481|FG000|Overall Study|Consent refusal|15|||
48790653|NCT02647658|157071482|FG001|Overall Study|Consent refusal|24|||
48790654|NCT00784810|157071485|FG000|Overall Study|Adverse Event|32|||
48790655|NCT00784810|157071486|FG001|Overall Study|Adverse Event|20|||
48790656|NCT00784810|157071485|FG000|Overall Study|Lack of Efficacy|14|||
48790657|NCT00784810|157071486|FG001|Overall Study|Lack of Efficacy|11|||
48790658|NCT00784810|157071485|FG000|Overall Study|Withdrawal by Subject|11|||
48790659|NCT00784810|157071486|FG001|Overall Study|Withdrawal by Subject|9|||
48790660|NCT00784810|157071485|FG000|Overall Study|Administrative|5|||
48790661|NCT00784810|157071486|FG001|Overall Study|Administrative|8|||
48790662|NCT00784810|157071485|FG000|Overall Study|Lost to Follow-up|1|||
48790663|NCT00784810|157071486|FG001|Overall Study|Lost to Follow-up|1|||
48790664|NCT03568318|157071488|FG000|Overall Study|Adverse Event|3|||
48790665|NCT03568318|157071489|FG001|Overall Study|Adverse Event|1|||
48790666|NCT03568318|157071490|FG002|Overall Study|Adverse Event|1|||
48790667|NCT03568318|157071491|FG003|Overall Study|Adverse Event|0|||
48790668|NCT03568318|157071492|FG004|Overall Study|Adverse Event|1|||
48790669|NCT03568318|157071493|FG005|Overall Study|Adverse Event|0|||
48790670|NCT03568318|157071488|FG000|Overall Study|Withdrawal by Subject|6|||
48790671|NCT03568318|157071489|FG001|Overall Study|Withdrawal by Subject|5|||
48790672|NCT03568318|157071490|FG002|Overall Study|Withdrawal by Subject|2|||
48790673|NCT03568318|157071491|FG003|Overall Study|Withdrawal by Subject|1|||
48587063|NCT00938587|156341538|FG001|Overall Study|Did not meet entrance criteria|0|||
48587064|NCT00938587|156341539|FG002|Overall Study|Did not meet entrance criteria|1|||
48587065|NCT00938587|156341540|FG003|Overall Study|Did not meet entrance criteria|0|||
48587066|NCT00938587|156341537|FG000|Overall Study|Withdrawal by Subject|1|||
48587067|NCT00938587|156341538|FG001|Overall Study|Withdrawal by Subject|1|||
48587068|NCT00938587|156341539|FG002|Overall Study|Withdrawal by Subject|0|||
48587069|NCT00938587|156341540|FG003|Overall Study|Withdrawal by Subject|0|||
48587070|NCT03677934|156341541|FG000|Overall Study|Adverse Event|1|||
48587071|NCT03677934|156341542|FG001|Overall Study|Adverse Event|1|||
48587072|NCT03677934|156341541|FG000|Overall Study|Death|8|||
48587073|NCT03677934|156341542|FG001|Overall Study|Death|4|||
48401077|NCT01847885|155660204|FG001|Initial Enrollment (Consented)|Screen failure|0|||
48587074|NCT03677934|156341541|FG000|Overall Study|Lost to Follow-up|3|||
48587075|NCT03677934|156341542|FG001|Overall Study|Lost to Follow-up|0|||
48587076|NCT03677934|156341541|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48587077|NCT03677934|156341542|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48587078|NCT03677934|156341541|FG000|Overall Study|Physician Decision|0|||
48587079|NCT03677934|156341542|FG001|Overall Study|Physician Decision|1|||
48587080|NCT03677934|156341541|FG000|Overall Study|Withdrawal by Subject|1|||
48587081|NCT03677934|156341542|FG001|Overall Study|Withdrawal by Subject|7|||
48587082|NCT00957905|156341543|FG000|Part B|Not Treated|0|||
48790674|NCT03568318|157071492|FG004|Overall Study|Withdrawal by Subject|0|||
48790675|NCT03568318|157071493|FG005|Overall Study|Withdrawal by Subject|0|||
48790676|NCT03568318|157071488|FG000|Overall Study|Lost to Follow-up|3|||
48790677|NCT03568318|157071489|FG001|Overall Study|Lost to Follow-up|2|||
48790678|NCT03568318|157071490|FG002|Overall Study|Lost to Follow-up|2|||
48790679|NCT03568318|157071491|FG003|Overall Study|Lost to Follow-up|2|||
48790680|NCT03568318|157071492|FG004|Overall Study|Lost to Follow-up|1|||
48790681|NCT03568318|157071493|FG005|Overall Study|Lost to Follow-up|0|||
48790682|NCT03568318|157071488|FG000|Overall Study|Other|3|||
48357028|NCT02270671|155503548|FG001|Overall Study|Protocol Violation|1|||
48790683|NCT03568318|157071489|FG001|Overall Study|Other|1|||
48790684|NCT03568318|157071490|FG002|Overall Study|Other|3|||
48790685|NCT03568318|157071491|FG003|Overall Study|Other|0|||
48401078|NCT01847885|155660205|FG002|Initial Enrollment (Consented)|Screen failure|0|||
48401079|NCT01847885|155660203|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
48401080|NCT01847885|155660204|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
48401081|NCT01847885|155660205|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
48401082|NCT01847885|155660203|FG000|Randomization|Protocol Violation|0|||
48401083|NCT01847885|155660204|FG001|Randomization|Protocol Violation|1|||
48401084|NCT01847885|155660205|FG002|Randomization|Protocol Violation|0|||
48401085|NCT01847885|155660203|FG000|Randomization|Withdrawal by Subject|0|||
48401086|NCT01847885|155660204|FG001|Randomization|Withdrawal by Subject|0|||
48401087|NCT01847885|155660205|FG002|Randomization|Withdrawal by Subject|2|||
48401088|NCT01847885|155660203|FG000|Randomization|Screen Failure|0|||
48401089|NCT01847885|155660204|FG001|Randomization|Screen Failure|3|||
48401090|NCT01847885|155660205|FG002|Randomization|Screen Failure|0|||
48401091|NCT02574637|155660208|FG000|Double-blind Period|Adverse Event|1|||
48401092|NCT02574637|155660209|FG001|Double-blind Period|Adverse Event|0|||
48401093|NCT02574637|155660210|FG002|Double-blind Period|Adverse Event|0|||
48401094|NCT02574637|155660211|FG003|Double-blind Period|Adverse Event|0|||
48401095|NCT02574637|155660212|FG004|Double-blind Period|Adverse Event|0|||
48401096|NCT02574637|155660213|FG005|Double-blind Period|Adverse Event|0|||
48401097|NCT02574637|155660214|FG006|Double-blind Period|Adverse Event|0|||
48401098|NCT02574637|155660215|FG007|Double-blind Period|Adverse Event|0|||
48401099|NCT02574637|155660216|FG008|Double-blind Period|Adverse Event|0|||
48401100|NCT02574637|155660217|FG009|Double-blind Period|Adverse Event|0|||
48401101|NCT02574637|155660208|FG000|Double-blind Period|Lack of Efficacy|0|||
48401102|NCT02574637|155660209|FG001|Double-blind Period|Lack of Efficacy|0|||
48401103|NCT02574637|155660210|FG002|Double-blind Period|Lack of Efficacy|2|||
48401104|NCT02574637|155660211|FG003|Double-blind Period|Lack of Efficacy|0|||
48401105|NCT02574637|155660212|FG004|Double-blind Period|Lack of Efficacy|0|||
48401106|NCT02574637|155660213|FG005|Double-blind Period|Lack of Efficacy|0|||
48401107|NCT02574637|155660214|FG006|Double-blind Period|Lack of Efficacy|0|||
48401108|NCT02574637|155660215|FG007|Double-blind Period|Lack of Efficacy|0|||
48401109|NCT02574637|155660216|FG008|Double-blind Period|Lack of Efficacy|0|||
48401110|NCT02574637|155660217|FG009|Double-blind Period|Lack of Efficacy|0|||
48401111|NCT02574637|155660208|FG000|Double-blind Period|Protocol Deviation|1|||
48401112|NCT02574637|155660209|FG001|Double-blind Period|Protocol Deviation|0|||
48401113|NCT02574637|155660210|FG002|Double-blind Period|Protocol Deviation|0|||
48401114|NCT02574637|155660211|FG003|Double-blind Period|Protocol Deviation|0|||
48401115|NCT02574637|155660212|FG004|Double-blind Period|Protocol Deviation|0|||
48401116|NCT02574637|155660213|FG005|Double-blind Period|Protocol Deviation|0|||
48401117|NCT02574637|155660214|FG006|Double-blind Period|Protocol Deviation|0|||
48401118|NCT02574637|155660215|FG007|Double-blind Period|Protocol Deviation|0|||
48401119|NCT02574637|155660216|FG008|Double-blind Period|Protocol Deviation|0|||
48790686|NCT03568318|157071492|FG004|Overall Study|Other|0|||
48790687|NCT03568318|157071493|FG005|Overall Study|Other|0|||
48790688|NCT03568318|157071488|FG000|Overall Study|Ongoing at Time of Analysis|5|||
48401120|NCT02574637|155660217|FG009|Double-blind Period|Protocol Deviation|0|||
48401121|NCT02574637|155660208|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
48401122|NCT02574637|155660209|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
48790689|NCT03568318|157071489|FG001|Overall Study|Ongoing at Time of Analysis|3|||
48790690|NCT03568318|157071490|FG002|Overall Study|Ongoing at Time of Analysis|2|||
48790691|NCT03568318|157071491|FG003|Overall Study|Ongoing at Time of Analysis|1|||
48790692|NCT03568318|157071492|FG004|Overall Study|Ongoing at Time of Analysis|0|||
48790693|NCT03568318|157071493|FG005|Overall Study|Ongoing at Time of Analysis|0|||
48790694|NCT01358968|157071495|FG000|Period 2|Adverse Event|0|||
48790695|NCT01358968|157071496|FG001|Period 2|Adverse Event|1|||
48790696|NCT01358968|157071497|FG002|Period 2|Adverse Event|0|||
48790697|NCT01358968|157071498|FG003|Period 2|Adverse Event|0|||
48790698|NCT01358968|157071495|FG000|Continued Access Phase|Progression of Disease|0|||
48790699|NCT01358968|157071496|FG001|Continued Access Phase|Progression of Disease|0|||
48790700|NCT01358968|157071497|FG002|Continued Access Phase|Progression of Disease|8|||
48790701|NCT01358968|157071498|FG003|Continued Access Phase|Progression of Disease|4|||
48790702|NCT01358968|157071495|FG000|Continued Access Phase|Protocol Violation|0|||
48790703|NCT01358968|157071496|FG001|Continued Access Phase|Protocol Violation|0|||
48790704|NCT01358968|157071497|FG002|Continued Access Phase|Protocol Violation|0|||
48790705|NCT01358968|157071498|FG003|Continued Access Phase|Protocol Violation|2|||
48790706|NCT01358968|157071495|FG000|Continued Access Phase|Withdrawal by Subject|0|||
48790707|NCT01358968|157071496|FG001|Continued Access Phase|Withdrawal by Subject|0|||
48790708|NCT01358968|157071497|FG002|Continued Access Phase|Withdrawal by Subject|3|||
48790709|NCT01358968|157071498|FG003|Continued Access Phase|Withdrawal by Subject|0|||
48790710|NCT01358968|157071495|FG000|Continued Access Phase|Death|0|||
48790711|NCT01358968|157071496|FG001|Continued Access Phase|Death|0|||
48790712|NCT01358968|157071497|FG002|Continued Access Phase|Death|1|||
48790713|NCT01358968|157071498|FG003|Continued Access Phase|Death|1|||
48790714|NCT05224050|157071502|FG000|Overall Study|Withdrawal by Subject|9|||
48790715|NCT05224050|157071502|FG000|Overall Study|Lost to Follow-up|3|||
48790716|NCT01640808|157071503|FG000|Overall Study|Unable to continue dynamic CT|14|||
48401123|NCT02574637|155660210|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
48401124|NCT02574637|155660211|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
48790717|NCT01640808|157071504|FG001|Overall Study|Unable to continue dynamic CT|4|||
48790718|NCT01640808|157071503|FG000|Overall Study|Withdrawal by Subject|12|||
48790719|NCT01640808|157071504|FG001|Overall Study|Withdrawal by Subject|4|||
48790720|NCT01640808|157071503|FG000|Overall Study|Lost to Follow-up|4|||
48790721|NCT01640808|157071504|FG001|Overall Study|Lost to Follow-up|0|||
48790722|NCT01640808|157071503|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
48790723|NCT01640808|157071504|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
48790724|NCT01640808|157071503|FG000|Overall Study|Administration of anticancer drugs|2|||
48790725|NCT01640808|157071504|FG001|Overall Study|Administration of anticancer drugs|1|||
48790726|NCT01640808|157071503|FG000|Overall Study|Physician Decision|19|||
48790727|NCT01640808|157071504|FG001|Overall Study|Physician Decision|5|||
48790728|NCT01640808|157071503|FG000|Overall Study|Randomized but not treated|4|||
48790729|NCT01640808|157071504|FG001|Overall Study|Randomized but not treated|2|||
48790730|NCT02273141|157071510|FG000|Overall Study|Adverse Event|0|||
48790731|NCT02273141|157071511|FG001|Overall Study|Adverse Event|1|||
48790732|NCT02273141|157071510|FG000|Overall Study|Lost to Follow-up|1|||
48790733|NCT02273141|157071511|FG001|Overall Study|Lost to Follow-up|3|||
48790734|NCT02273141|157071510|FG000|Overall Study|Withdrawal by Subject|10|||
48790735|NCT02273141|157071511|FG001|Overall Study|Withdrawal by Subject|15|||
48790736|NCT02273141|157071510|FG000|Overall Study|Various|6|||
48790737|NCT02273141|157071511|FG001|Overall Study|Various|6|||
48790744|NCT02372396|157071517|FG000|Overall Study|Lost to Follow-up|7|||
48790745|NCT02372396|157071518|FG001|Overall Study|Lost to Follow-up|9|||
48790746|NCT00522275|157071523|FG000|Overall Study|Adverse Event|35|||
48790747|NCT00522275|157071523|FG000|Overall Study|Lack of Efficacy|80|||
48790748|NCT00522275|157071523|FG000|Overall Study|Subject withdrew consent|16|||
48790749|NCT00522275|157071523|FG000|Overall Study|Protocol deviation|1|||
48790750|NCT00522275|157071523|FG000|Overall Study|Unsatisfactory compliance|11|||
48790751|NCT00522275|157071523|FG000|Overall Study|Lost to Follow-up|8|||
48790752|NCT00522275|157071523|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
48790753|NCT00522275|157071523|FG000|Overall Study|Other: Subject is pregnant|2|||
48790754|NCT00522275|157071523|FG000|Overall Study|Other: Subject relocated|2|||
48790755|NCT00522275|157071523|FG000|Overall Study|Other: Subject arrested|1|||
48790756|NCT00522275|157071523|FG000|Overall Study|Other: Site / clinic closed|4|||
48790757|NCT00522275|157071523|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
48790758|NCT00522275|157071523|FG000|Overall Study|Other: Sponsor request|2|||
48790759|NCT00522275|157071523|FG000|Overall Study|Other: Subject ran out of medication|1|||
48790760|NCT00522275|157071523|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
48790761|NCT02341417|157071524|FG000|Overall Study|Withdrawal by Subject|0|||
48790762|NCT02341417|157071525|FG001|Overall Study|Withdrawal by Subject|2|||
48790763|NCT02341417|157071526|FG002|Overall Study|Withdrawal by Subject|0|||
48790764|NCT02341417|157071524|FG000|Overall Study|Decision by sponsor|2|||
48790765|NCT02341417|157071525|FG001|Overall Study|Decision by sponsor|0|||
48790766|NCT02341417|157071526|FG002|Overall Study|Decision by sponsor|0|||
48790767|NCT02341417|157071524|FG000|Overall Study|Death|0|||
48790768|NCT02341417|157071525|FG001|Overall Study|Death|0|||
48790769|NCT02341417|157071526|FG002|Overall Study|Death|1|||
48790770|NCT04403698|157071527|FG000|Overall Study|Adverse Event|1|||
48790771|NCT04403698|157071528|FG001|Overall Study|Adverse Event|1|||
48790772|NCT04403698|157071527|FG000|Overall Study|Lost to Follow-up|1|||
48790773|NCT04403698|157071528|FG001|Overall Study|Lost to Follow-up|0|||
48790774|NCT04403698|157071527|FG000|Overall Study|Protocol Violation|0|||
48790775|NCT04403698|157071528|FG001|Overall Study|Protocol Violation|1|||
48790776|NCT04899349|157071534|FG000|Overall Study|Study terminated by Sponsor|2|||
48790777|NCT04899349|157071535|FG001|Overall Study|Study terminated by Sponsor|0|||
48790778|NCT02300220|157071536|FG000|Overall Study|Lost to Follow-up|1|||
48790779|NCT02300220|157071537|FG001|Overall Study|Lost to Follow-up|2|||
48790780|NCT02300220|157071536|FG000|Overall Study|Death|1|||
48790781|NCT02300220|157071537|FG001|Overall Study|Death|1|||
48790782|NCT02300220|157071536|FG000|Overall Study|Adverse Event|1|||
48790783|NCT02300220|157071537|FG001|Overall Study|Adverse Event|1|||
48401125|NCT02574637|155660212|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
48430353|NCT00696657|155763707|FG007|Overall Study|Withdrawal criteria|1|||
48790784|NCT02300220|157071536|FG000|Overall Study|Protocol Violation|1|||
48790785|NCT02300220|157071537|FG001|Overall Study|Protocol Violation|0|||
48790786|NCT02300220|157071536|FG000|Overall Study|Withdrawal by Subject|0|||
48790787|NCT02300220|157071537|FG001|Overall Study|Withdrawal by Subject|2|||
48790788|NCT02300220|157071536|FG000|Overall Study|Did not tolerate IMP|0|||
48790789|NCT02300220|157071537|FG001|Overall Study|Did not tolerate IMP|1|||
48401126|NCT02574637|155660213|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
48401127|NCT02574637|155660214|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
48401128|NCT02574637|155660215|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
48401129|NCT02574637|155660216|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
48401130|NCT02574637|155660217|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
48401131|NCT02574637|155660208|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
48401132|NCT02574637|155660209|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
48401133|NCT02574637|155660210|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
48401134|NCT02574637|155660211|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
48401135|NCT02574637|155660212|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
48401136|NCT02574637|155660213|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
48790790|NCT03069482|157074061|FG000|Overall Study|Lost to Follow-up|0|||
48790791|NCT03069482|157074062|FG001|Overall Study|Lost to Follow-up|1|||
48790792|NCT03069482|157074061|FG000|Overall Study|Physician Decision|1|||
48790793|NCT03069482|157074062|FG001|Overall Study|Physician Decision|0|||
48790794|NCT00251745|157074063|FG000|Overall Study|Adverse Event|7|||
48790795|NCT00251745|157074064|FG001|Overall Study|Adverse Event|9|||
48790796|NCT00251745|157074065|FG002|Overall Study|Adverse Event|11|||
48790797|NCT00251745|157074063|FG000|Overall Study|Lost to Follow-up|4|||
48790798|NCT00251745|157074064|FG001|Overall Study|Lost to Follow-up|2|||
48790799|NCT00251745|157074065|FG002|Overall Study|Lost to Follow-up|5|||
48790800|NCT00251745|157074063|FG000|Overall Study|Withdrawal by Subject|13|||
48790801|NCT00251745|157074064|FG001|Overall Study|Withdrawal by Subject|7|||
48790802|NCT00251745|157074065|FG002|Overall Study|Withdrawal by Subject|3|||
48790803|NCT00251745|157074063|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
48790804|NCT00251745|157074064|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
48790805|NCT00251745|157074065|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
48790806|NCT00251745|157074063|FG000|Overall Study|Lack of Efficacy|3|||
48790807|NCT00251745|157074064|FG001|Overall Study|Lack of Efficacy|0|||
48790808|NCT00251745|157074065|FG002|Overall Study|Lack of Efficacy|0|||
48790809|NCT00251745|157074063|FG000|Overall Study|Noncompliant|0|||
48790810|NCT00251745|157074064|FG001|Overall Study|Noncompliant|2|||
48790811|NCT00251745|157074065|FG002|Overall Study|Noncompliant|2|||
48790812|NCT00251745|157074063|FG000|Overall Study|Pregnancy|0|||
48790813|NCT00251745|157074064|FG001|Overall Study|Pregnancy|1|||
48790814|NCT00251745|157074065|FG002|Overall Study|Pregnancy|0|||
48790815|NCT00251745|157074063|FG000|Overall Study|Per Subject Request|0|||
48790816|NCT00251745|157074064|FG001|Overall Study|Per Subject Request|0|||
48790817|NCT00251745|157074065|FG002|Overall Study|Per Subject Request|1|||
48790818|NCT00251745|157074063|FG000|Overall Study|Per Investigator Request|1|||
48790819|NCT00251745|157074064|FG001|Overall Study|Per Investigator Request|0|||
48790820|NCT00251745|157074065|FG002|Overall Study|Per Investigator Request|0|||
48790821|NCT00489970|157074066|FG000|Persistence Year 9|Lost to Follow-up|2|||
48790822|NCT00489970|157074067|FG001|Persistence Year 9|Lost to Follow-up|2|||
48790823|NCT00489970|157074068|FG002|Persistence Year 9|Lost to Follow-up|3|||
48790824|NCT00489970|157074066|FG000|Persistence Year 9|Other|1|||
48790825|NCT00489970|157074067|FG001|Persistence Year 9|Other|0|||
48790826|NCT00489970|157074068|FG002|Persistence Year 9|Other|2|||
48790827|NCT02891187|157074069|FG000|Overall Study|Lost to Follow-up|1|||
48790828|NCT02891187|157074070|FG001|Overall Study|Lost to Follow-up|2|||
48790829|NCT03320070|157074073|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
48790830|NCT03320070|157074074|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
48790831|NCT03320070|157074073|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
48790832|NCT03320070|157074074|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
48790833|NCT03320070|157074073|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
48790834|NCT03320070|157074074|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
48790835|NCT03320070|157074073|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
48790836|NCT03320070|157074074|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
48790837|NCT03320070|157074073|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
48790838|NCT03320070|157074074|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
48790839|NCT03320070|157074073|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
48790840|NCT03320070|157074074|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
48790841|NCT01880424|157074078|FG000|Overall Study|Adverse Event|7|||
48790842|NCT01880424|157074079|FG001|Overall Study|Adverse Event|6|||
48790843|NCT01880424|157074078|FG000|Overall Study|Lack of Efficacy|1|||
48790844|NCT01880424|157074079|FG001|Overall Study|Lack of Efficacy|4|||
48790845|NCT01880424|157074078|FG000|Overall Study|Lost to Follow-up|3|||
48790846|NCT01880424|157074079|FG001|Overall Study|Lost to Follow-up|2|||
48790847|NCT01880424|157074078|FG000|Overall Study|Protocol Violation|11|||
48790848|NCT01880424|157074079|FG001|Overall Study|Protocol Violation|13|||
48790849|NCT01880424|157074078|FG000|Overall Study|Withdrawal by Subject|10|||
48790850|NCT01880424|157074079|FG001|Overall Study|Withdrawal by Subject|30|||
48790851|NCT01880424|157074078|FG000|Overall Study|Other|1|||
48790852|NCT01880424|157074079|FG001|Overall Study|Other|0|||
48790853|NCT01275625|157074080|FG000|Overall Study|Death|1|||
48790854|NCT01275625|157074080|FG000|Overall Study|Lack of Efficacy|2|||
48790855|NCT01275625|157074080|FG000|Overall Study|Lost to Follow-up|1|||
48790856|NCT01275625|157074080|FG000|Overall Study|Withdrawal by Subject|3|||
48790857|NCT01275625|157074080|FG000|Overall Study|Protocol Violation|1|||
48790858|NCT01275625|157074080|FG000|Overall Study|Adverse Event|4|||
48790859|NCT01275625|157074080|FG000|Overall Study|Other|1|||
48790860|NCT02062632|157074083|FG000|Overall Study|No treatment data|1|||
48790861|NCT05403801|157074084|FG000|Overall Study|Withdrawal by Subject|2|||
48790866|NCT02105116|157074087|FG000|Overall Study|not eligible for step 2 of trial|5|||
48790867|NCT02105116|157074087|FG000|Overall Study|Death|1|||
48790868|NCT00263666|157074088|FG000|Overall Study|Adverse Event|6|||
48790869|NCT00263666|157074089|FG001|Overall Study|Adverse Event|8|||
48790870|NCT00263666|157074088|FG000|Overall Study|Lost to Follow-up|1|||
48790871|NCT00263666|157074089|FG001|Overall Study|Lost to Follow-up|2|||
48790872|NCT00263666|157074088|FG000|Overall Study|Withdrawal by Subject|0|||
48790873|NCT00263666|157074089|FG001|Overall Study|Withdrawal by Subject|1|||
48790874|NCT00896168|157074090|FG000|Overall Study|Adverse Event|4|||
48790875|NCT00896168|157074091|FG001|Overall Study|Adverse Event|7|||
48790876|NCT00896168|157074090|FG000|Overall Study|Treatment failure|8|||
48790877|NCT00896168|157074091|FG001|Overall Study|Treatment failure|10|||
48790878|NCT00896168|157074090|FG000|Overall Study|Lost to Follow-up|1|||
48790879|NCT00896168|157074091|FG001|Overall Study|Lost to Follow-up|1|||
48790880|NCT00896168|157074090|FG000|Overall Study|Other|1|||
48790881|NCT00896168|157074091|FG001|Overall Study|Other|1|||
48790882|NCT00902304|157074092|FG000|Overall Study|Adverse Event|4|||
48790883|NCT00902304|157074093|FG001|Overall Study|Adverse Event|10|||
48790884|NCT00902304|157074094|FG002|Overall Study|Adverse Event|25|||
48790885|NCT00902304|157074092|FG000|Overall Study|Investigator discretion|3|||
48790886|NCT00902304|157074093|FG001|Overall Study|Investigator discretion|5|||
48790887|NCT00902304|157074094|FG002|Overall Study|Investigator discretion|13|||
48790888|NCT00902304|157074092|FG000|Overall Study|Lost to Follow-up|7|||
48790889|NCT00902304|157074093|FG001|Overall Study|Lost to Follow-up|7|||
48790890|NCT00902304|157074094|FG002|Overall Study|Lost to Follow-up|7|||
48790891|NCT00902304|157074092|FG000|Overall Study|Protocol Violation|9|||
48790892|NCT00902304|157074093|FG001|Overall Study|Protocol Violation|18|||
48790893|NCT00902304|157074094|FG002|Overall Study|Protocol Violation|20|||
48790894|NCT00902304|157074092|FG000|Overall Study|Withdrawal by Subject|32|||
48790895|NCT00902304|157074093|FG001|Overall Study|Withdrawal by Subject|22|||
48790896|NCT00902304|157074094|FG002|Overall Study|Withdrawal by Subject|43|||
48790897|NCT00902304|157074092|FG000|Overall Study|includes pregnancy|3|||
48790898|NCT00902304|157074093|FG001|Overall Study|includes pregnancy|9|||
48790899|NCT00902304|157074094|FG002|Overall Study|includes pregnancy|2|||
48790900|NCT01262651|157074099|FG000|Overall Study|Adverse Event|40|||
48790901|NCT01262651|157074100|FG001|Overall Study|Adverse Event|35|||
48790902|NCT01262651|157074099|FG000|Overall Study|Withdrawal by Subject|15|||
48790903|NCT01262651|157074100|FG001|Overall Study|Withdrawal by Subject|11|||
48790904|NCT01262651|157074099|FG000|Overall Study|Withdrawal by Investigator|2|||
48790905|NCT01262651|157074100|FG001|Overall Study|Withdrawal by Investigator|2|||
48790906|NCT01262651|157074099|FG000|Overall Study|Met Withdrawal Criteria|1|||
48790907|NCT01262651|157074100|FG001|Overall Study|Met Withdrawal Criteria|0|||
48790908|NCT03162224|157074104|FG000|Overall Study|Death|4|||
48790909|NCT03162224|157074105|FG001|Overall Study|Death|5|||
48790910|NCT03162224|157074106|FG002|Overall Study|Death|8|||
48790911|NCT03162224|157074104|FG000|Overall Study|Withdrawal by Subject|1|||
48401137|NCT02574637|155660214|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
48790912|NCT03162224|157074105|FG001|Overall Study|Withdrawal by Subject|0|||
48790913|NCT03162224|157074106|FG002|Overall Study|Withdrawal by Subject|1|||
48790914|NCT03162224|157074104|FG000|Overall Study|Lost to Follow-up|0|||
48790915|NCT03162224|157074105|FG001|Overall Study|Lost to Follow-up|1|||
48790916|NCT03162224|157074106|FG002|Overall Study|Lost to Follow-up|0|||
48790917|NCT03162224|157074104|FG000|Overall Study|Other|6|||
48790918|NCT03162224|157074105|FG001|Overall Study|Other|2|||
48790919|NCT03162224|157074106|FG002|Overall Study|Other|1|||
48790920|NCT05021640|157074107|FG000|Overall Study|Lost to Follow-up|0|||
48790921|NCT05021640|157074108|FG001|Overall Study|Lost to Follow-up|0|||
48790922|NCT05021640|157074109|FG002|Overall Study|Lost to Follow-up|0|||
48790923|NCT05021640|157074110|FG003|Overall Study|Lost to Follow-up|0|||
48790924|NCT05021640|157074111|FG004|Overall Study|Lost to Follow-up|1|||
48790925|NCT02566031|157074112|FG000|Overall Study|Patient/guardian decision|14|||
48790926|NCT02566031|157074113|FG001|Overall Study|Patient/guardian decision|7|||
48790927|NCT02566031|157074112|FG000|Overall Study|Protocol deviation|2|||
48790928|NCT02566031|157074113|FG001|Overall Study|Protocol deviation|3|||
48790929|NCT02566031|157074112|FG000|Overall Study|Adverse Event|3|||
48790930|NCT02566031|157074113|FG001|Overall Study|Adverse Event|1|||
48790931|NCT02566031|157074112|FG000|Overall Study|Lost to Follow-up|1|||
48790932|NCT02566031|157074113|FG001|Overall Study|Lost to Follow-up|1|||
48790933|NCT03204279|157074114|FG000|Overall Study|Withdrawal by Subject|0|||
48790934|NCT03204279|157074115|FG001|Overall Study|Withdrawal by Subject|1|||
48790935|NCT02277106|157074116|FG000|Stage 2|Adverse Event|0|||
48790936|NCT02277106|157074117|FG001|Stage 2|Adverse Event|0|||
48790937|NCT02277106|157074118|FG002|Stage 2|Adverse Event|1|||
48790938|NCT01064739|157074119|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
48790939|NCT04827212|157074122|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
48790940|NCT04827212|157074123|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
48790941|NCT04827212|157074122|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
48790942|NCT04827212|157074123|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
48790943|NCT03058679|157074126|FG000|Baseline to Week 6|Lost to Follow-up|3|||
48790944|NCT03058679|157074127|FG001|Baseline to Week 6|Lost to Follow-up|2|||
48790945|NCT03058679|157074126|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
48790946|NCT03058679|157074127|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
48790947|NCT03058679|157074126|FG000|Baseline to Week 6|Adverse Event|6|||
48790948|NCT03058679|157074127|FG001|Baseline to Week 6|Adverse Event|6|||
48790949|NCT03058679|157074126|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
48790950|NCT03058679|157074127|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
48790951|NCT03058679|157074126|FG000|Baseline to Week 6|Difficulty following the diet|0|||
48790952|NCT03058679|157074127|FG001|Baseline to Week 6|Difficulty following the diet|2|||
48790953|NCT03058679|157074126|FG000|Baseline to Week 6|Physician Decision|1|||
48790954|NCT03058679|157074127|FG001|Baseline to Week 6|Physician Decision|0|||
48790955|NCT03058679|157074126|FG000|Week 6 to Week 12|Change in medication|5|||
48790956|NCT03058679|157074127|FG001|Week 6 to Week 12|Change in medication|7|||
48790957|NCT03058679|157074126|FG000|Week 6 to Week 12|Adverse Event|4|||
48790958|NCT03058679|157074127|FG001|Week 6 to Week 12|Adverse Event|3|||
48790959|NCT03058679|157074126|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
48790960|NCT03058679|157074127|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
48790961|NCT03058679|157074126|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
48790962|NCT03058679|157074127|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
48790963|NCT01260350|157074130|FG000|Overall Study|Lack of Efficacy|0|||
48790964|NCT01260350|157074131|FG001|Overall Study|Lack of Efficacy|0|||
48790965|NCT01260350|157074132|FG002|Overall Study|Lack of Efficacy|0|||
48790966|NCT01260350|157074133|FG003|Overall Study|Lack of Efficacy|0|||
48790967|NCT01260350|157074134|FG004|Overall Study|Lack of Efficacy|0|||
48790968|NCT01260350|157074135|FG005|Overall Study|Lack of Efficacy|0|||
48790969|NCT01260350|157074136|FG006|Overall Study|Lack of Efficacy|0|||
48790970|NCT01260350|157074137|FG007|Overall Study|Lack of Efficacy|0|||
48790971|NCT01260350|157074138|FG008|Overall Study|Lack of Efficacy|0|||
48790972|NCT01260350|157074139|FG009|Overall Study|Lack of Efficacy|0|||
48790973|NCT01260350|157074140|FG010|Overall Study|Lack of Efficacy|0|||
48790974|NCT01260350|157074141|FG011|Overall Study|Lack of Efficacy|0|||
48790975|NCT01260350|157074142|FG012|Overall Study|Lack of Efficacy|0|||
48790976|NCT01260350|157074143|FG013|Overall Study|Lack of Efficacy|0|||
48790977|NCT01260350|157074144|FG014|Overall Study|Lack of Efficacy|0|||
48790978|NCT01260350|157074145|FG015|Overall Study|Lack of Efficacy|0|||
48790979|NCT01260350|157074146|FG016|Overall Study|Lack of Efficacy|0|||
48790980|NCT01260350|157074147|FG017|Overall Study|Lack of Efficacy|1|||
48790981|NCT01260350|157074148|FG018|Overall Study|Lack of Efficacy|0|||
48790982|NCT01260350|157074149|FG019|Overall Study|Lack of Efficacy|0|||
48790983|NCT01260350|157074150|FG020|Overall Study|Lack of Efficacy|3|||
48790984|NCT01260350|157074151|FG021|Overall Study|Lack of Efficacy|0|||
48790985|NCT01260350|157074130|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790986|NCT01260350|157074131|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790987|NCT01260350|157074132|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790988|NCT01260350|157074133|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790989|NCT01260350|157074134|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790990|NCT01260350|157074135|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790991|NCT01260350|157074136|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790992|NCT01260350|157074137|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790993|NCT01260350|157074138|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
48790994|NCT01260350|157074139|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790995|NCT01260350|157074140|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790996|NCT01260350|157074141|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790997|NCT01260350|157074142|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790998|NCT01260350|157074143|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48790999|NCT01260350|157074144|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791000|NCT01260350|157074145|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791001|NCT01260350|157074146|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791002|NCT01260350|157074147|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791003|NCT01260350|157074148|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48401138|NCT02574637|155660215|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
48791004|NCT01260350|157074149|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791005|NCT01260350|157074150|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791006|NCT01260350|157074151|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
48791007|NCT03834779|157074154|FG000|Overall Study|Death|1|||
48401139|NCT02574637|155660216|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
48401140|NCT02574637|155660217|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
48401141|NCT02574637|155660208|FG000|Double-blind Period|Reason Not Specified|0|||
48401142|NCT02574637|155660209|FG001|Double-blind Period|Reason Not Specified|0|||
48401143|NCT02574637|155660210|FG002|Double-blind Period|Reason Not Specified|0|||
48401144|NCT02574637|155660211|FG003|Double-blind Period|Reason Not Specified|1|||
48401145|NCT02574637|155660212|FG004|Double-blind Period|Reason Not Specified|0|||
48401146|NCT02574637|155660213|FG005|Double-blind Period|Reason Not Specified|0|||
48401147|NCT02574637|155660214|FG006|Double-blind Period|Reason Not Specified|0|||
48401148|NCT02574637|155660215|FG007|Double-blind Period|Reason Not Specified|0|||
48401149|NCT02574637|155660216|FG008|Double-blind Period|Reason Not Specified|0|||
48791008|NCT03834779|157074155|FG001|Overall Study|Death|2|||
48791009|NCT03834779|157074154|FG000|Overall Study|Lost to Follow-up|6|||
48791010|NCT03834779|157074155|FG001|Overall Study|Lost to Follow-up|4|||
48791011|NCT02530671|157074156|FG000|Overall Study|Lost to Follow-up|2|||
48791012|NCT02530671|157074157|FG001|Overall Study|Lost to Follow-up|0|||
48791013|NCT02530671|157074156|FG000|Overall Study|Withdrawal by Subject|1|||
48791014|NCT02530671|157074157|FG001|Overall Study|Withdrawal by Subject|0|||
48791015|NCT05178316|157074158|FG000|Overall Study|Adverse Event|5|||
48401150|NCT02574637|155660217|FG009|Double-blind Period|Reason Not Specified|0|||
48401151|NCT02574637|155660208|FG000|Open-label (OL) Period|Adverse Event|0|||
48401152|NCT02574637|155660209|FG001|Open-label (OL) Period|Adverse Event|0|||
48401153|NCT02574637|155660210|FG002|Open-label (OL) Period|Adverse Event|0|||
48791016|NCT05178316|157074159|FG001|Overall Study|Adverse Event|4|||
48791017|NCT05178316|157074160|FG002|Overall Study|Adverse Event|9|||
48791018|NCT05178316|157074158|FG000|Overall Study|Enrolled in Error|1|||
48791019|NCT05178316|157074159|FG001|Overall Study|Enrolled in Error|2|||
48791020|NCT05178316|157074160|FG002|Overall Study|Enrolled in Error|1|||
48791021|NCT05178316|157074158|FG000|Overall Study|Lost to Follow-up|3|||
48791022|NCT05178316|157074159|FG001|Overall Study|Lost to Follow-up|15|||
48791023|NCT05178316|157074160|FG002|Overall Study|Lost to Follow-up|11|||
48791024|NCT05178316|157074158|FG000|Overall Study|Noncompliance|1|||
48791025|NCT05178316|157074159|FG001|Overall Study|Noncompliance|3|||
48587083|NCT00957905|156341544|FG001|Part B|Not Treated|1|||
48587084|NCT00957905|156341543|FG000|Part B|Physician Decision|0|||
48401154|NCT02574637|155660211|FG003|Open-label (OL) Period|Adverse Event|0|||
48401155|NCT02574637|155660212|FG004|Open-label (OL) Period|Adverse Event|0|||
48401156|NCT02574637|155660213|FG005|Open-label (OL) Period|Adverse Event|0|||
48401157|NCT02574637|155660214|FG006|Open-label (OL) Period|Adverse Event|0|||
48587085|NCT00957905|156341544|FG001|Part B|Physician Decision|1|||
48587086|NCT00957905|156341543|FG000|Part B|Death|0|||
48587087|NCT00957905|156341544|FG001|Part B|Death|1|||
48791026|NCT05178316|157074160|FG002|Overall Study|Noncompliance|1|||
48587088|NCT00957905|156341543|FG000|Part B|Protocol Violation|0|||
48587089|NCT00957905|156341544|FG001|Part B|Protocol Violation|1|||
48587090|NCT02083653|156341545|FG000|Overall Study|Randomized but not Treated|0|||
48587091|NCT02083653|156341546|FG001|Overall Study|Randomized but not Treated|2|||
48587092|NCT02083653|156341547|FG002|Overall Study|Randomized but not Treated|7|||
48587093|NCT02083653|156341545|FG000|Overall Study|Adverse Event|12|||
48587094|NCT02083653|156341546|FG001|Overall Study|Adverse Event|5|||
48587095|NCT02083653|156341547|FG002|Overall Study|Adverse Event|4|||
48587096|NCT02083653|156341545|FG000|Overall Study|Lost to Follow-up|1|||
48587097|NCT02083653|156341546|FG001|Overall Study|Lost to Follow-up|0|||
48587098|NCT02083653|156341547|FG002|Overall Study|Lost to Follow-up|0|||
48587099|NCT02083653|156341545|FG000|Overall Study|Death|2|||
48587100|NCT02083653|156341546|FG001|Overall Study|Death|2|||
48587101|NCT02083653|156341547|FG002|Overall Study|Death|2|||
48587102|NCT02083653|156341545|FG000|Overall Study|Progressive Disease|65|||
48587103|NCT02083653|156341546|FG001|Overall Study|Progressive Disease|73|||
48587104|NCT02083653|156341547|FG002|Overall Study|Progressive Disease|63|||
48587105|NCT02083653|156341545|FG000|Overall Study|Withdrawal by Subject|2|||
48587106|NCT02083653|156341546|FG001|Overall Study|Withdrawal by Subject|1|||
48587107|NCT02083653|156341547|FG002|Overall Study|Withdrawal by Subject|2|||
48587108|NCT02083653|156341545|FG000|Overall Study|Other Events|0|||
48587109|NCT02083653|156341546|FG001|Overall Study|Other Events|2|||
48587110|NCT02083653|156341547|FG002|Overall Study|Other Events|2|||
48587111|NCT02083653|156341545|FG000|Overall Study|Reason Missing|0|||
48587112|NCT02083653|156341546|FG001|Overall Study|Reason Missing|0|||
48587113|NCT02083653|156341547|FG002|Overall Study|Reason Missing|4|||
48587114|NCT01333956|156341564|FG000|Overall Study|Lost to Follow-up|1|||
48587115|NCT01333956|156341565|FG001|Overall Study|Lost to Follow-up|2|||
48587116|NCT01333956|156341566|FG002|Overall Study|Lost to Follow-up|0|||
48587117|NCT01333956|156341567|FG003|Overall Study|Lost to Follow-up|1|||
48587118|NCT01333956|156341564|FG000|Overall Study|Unable to complete study procedure|1|||
48587119|NCT01333956|156341565|FG001|Overall Study|Unable to complete study procedure|0|||
48587120|NCT01333956|156341566|FG002|Overall Study|Unable to complete study procedure|0|||
48587121|NCT01333956|156341567|FG003|Overall Study|Unable to complete study procedure|1|||
48587122|NCT01333956|156341564|FG000|Overall Study|Withdrawal by Subject|0|||
48587123|NCT01333956|156341565|FG001|Overall Study|Withdrawal by Subject|2|||
48587124|NCT01333956|156341566|FG002|Overall Study|Withdrawal by Subject|1|||
48587125|NCT01333956|156341567|FG003|Overall Study|Withdrawal by Subject|0|||
48587126|NCT02073656|156341568|FG000|Primary Study|Lost to Follow-up|6|||
48587127|NCT02073656|156341568|FG000|Primary Study|Death|1|||
48587128|NCT02073656|156341568|FG000|Primary Study|Withdrew Consent|1|||
48587129|NCT03383692|156341575|FG000|Overall Study|Progressive disease as per RECIST|3|||
48587130|NCT03383692|156341576|FG001|Overall Study|Progressive disease as per RECIST|3|||
48587131|NCT03383692|156341575|FG000|Overall Study|Clinical progression|0|||
48587132|NCT03383692|156341576|FG001|Overall Study|Clinical progression|1|||
48587133|NCT03383692|156341575|FG000|Overall Study|Adverse Event|3|||
48587134|NCT03383692|156341576|FG001|Overall Study|Adverse Event|0|||
48587135|NCT02839876|156341579|FG000|Overall Study|Protocol Violation|10|||
48587136|NCT02839876|156341580|FG001|Overall Study|Protocol Violation|11|||
48587137|NCT03373461|156341590|FG000|Part 2|Adverse Event|0|||
48587138|NCT03373461|156341591|FG001|Part 2|Adverse Event|1|||
48587139|NCT03373461|156341592|FG002|Part 2|Adverse Event|0|||
48587140|NCT03373461|156341593|FG003|Part 2|Adverse Event|0|||
48587141|NCT03373461|156341594|FG004|Part 2|Adverse Event|1|||
48587142|NCT02333383|156341595|FG000|Overall Study|Adalimumab discontinuation|21|||
48587143|NCT02333383|156341595|FG000|Overall Study|Lost to Follow-up|15|||
48587144|NCT02333383|156341595|FG000|Overall Study|Withdrawal by Subject|3|||
48587145|NCT02333383|156341595|FG000|Overall Study|Transfer to another hospital|2|||
48587146|NCT01573754|156341598|FG000|Overall Study|Noncompliance or remission not achieved|3|||
48587147|NCT01573754|156341599|FG001|Overall Study|Noncompliance or remission not achieved|15|||
48587148|NCT00829829|156341603|FG000|Overall Study|Protocol Violation|0|||
48587149|NCT00829829|156341604|FG001|Overall Study|Protocol Violation|3|||
48587150|NCT00829829|156341605|FG002|Overall Study|Protocol Violation|0|||
48587151|NCT00829829|156341603|FG000|Overall Study|Adverse Event|4|||
48587152|NCT00829829|156341604|FG001|Overall Study|Adverse Event|4|||
48587153|NCT00829829|156341605|FG002|Overall Study|Adverse Event|3|||
48587154|NCT00829829|156341603|FG000|Overall Study|Withdrawal by Subject|8|||
48587155|NCT00829829|156341604|FG001|Overall Study|Withdrawal by Subject|4|||
48587156|NCT00829829|156341605|FG002|Overall Study|Withdrawal by Subject|2|||
48587157|NCT00829829|156341603|FG000|Overall Study|Decision by the Sponsor|1|||
48587158|NCT00829829|156341604|FG001|Overall Study|Decision by the Sponsor|0|||
48587159|NCT00829829|156341605|FG002|Overall Study|Decision by the Sponsor|2|||
48587160|NCT00829829|156341603|FG000|Overall Study|Lost to Follow-up|7|||
48587161|NCT00829829|156341604|FG001|Overall Study|Lost to Follow-up|3|||
48587162|NCT00829829|156341605|FG002|Overall Study|Lost to Follow-up|3|||
48587163|NCT00829829|156341603|FG000|Overall Study|Other than specified above|2|||
48587164|NCT00829829|156341604|FG001|Overall Study|Other than specified above|2|||
48791027|NCT05178316|157074158|FG000|Overall Study|Other|0|||
48791028|NCT05178316|157074159|FG001|Overall Study|Other|1|||
48791029|NCT05178316|157074160|FG002|Overall Study|Other|0|||
48791030|NCT05178316|157074158|FG000|Overall Study|Physician Decision|0|||
48791031|NCT05178316|157074159|FG001|Overall Study|Physician Decision|3|||
48791032|NCT05178316|157074160|FG002|Overall Study|Physician Decision|2|||
48791033|NCT05178316|157074158|FG000|Overall Study|Protocol deviation|1|||
48791034|NCT05178316|157074159|FG001|Overall Study|Protocol deviation|0|||
48791035|NCT05178316|157074160|FG002|Overall Study|Protocol deviation|1|||
48791036|NCT05178316|157074158|FG000|Overall Study|Sponsor decision|1|||
48791037|NCT05178316|157074159|FG001|Overall Study|Sponsor decision|0|||
48791038|NCT05178316|157074160|FG002|Overall Study|Sponsor decision|1|||
48791039|NCT05178316|157074158|FG000|Overall Study|Withdrawal by Subject|5|||
48791040|NCT05178316|157074159|FG001|Overall Study|Withdrawal by Subject|11|||
48791041|NCT05178316|157074160|FG002|Overall Study|Withdrawal by Subject|5|||
48791042|NCT00418886|157074161|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
48791043|NCT00418886|157074162|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
48791044|NCT00418886|157074161|FG000|Randomized Period|Death|122|||
48791045|NCT00418886|157074162|FG001|Randomized Period|Death|147|||
48791046|NCT00418886|157074161|FG000|Randomized Period|Withdrawal by Subject|9|||
48791047|NCT00418886|157074162|FG001|Randomized Period|Withdrawal by Subject|10|||
48791048|NCT00418886|157074161|FG000|Randomized Period|Lost to Follow-up|4|||
48791049|NCT00418886|157074162|FG001|Randomized Period|Lost to Follow-up|6|||
48791050|NCT00418886|157074161|FG000|Randomized Period|withdrawn due to other reason|1|||
48791051|NCT00418886|157074162|FG001|Randomized Period|withdrawn due to other reason|0|||
48791052|NCT00418886|157074161|FG000|Randomized Period|randomised but no treatment received|0|||
48791053|NCT00418886|157074162|FG001|Randomized Period|randomised but no treatment received|1|||
48791054|NCT01343407|157074163|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
48791055|NCT01343407|157074164|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
48791056|NCT01343407|157074165|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
48791057|NCT01343407|157074166|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
48791058|NCT01343407|157074167|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
48791059|NCT01343407|157074168|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
48587165|NCT00829829|156341605|FG002|Overall Study|Other than specified above|1|||
48791060|NCT01343407|157074163|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791061|NCT01343407|157074164|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791062|NCT01343407|157074165|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
48791063|NCT01343407|157074166|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791064|NCT01343407|157074167|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791065|NCT01343407|157074168|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
48791066|NCT03950739|157074169|FG000|Treatment Phase|Adverse Event|2|||
48791067|NCT03950739|157074169|FG000|Optional Extension Phase|Death|1|||
48791068|NCT03950739|157074169|FG000|Optional Extension Phase|Progressive Disease|5|||
48791069|NCT03950739|157074169|FG000|Optional Extension Phase|Adverse Event|7|||
48791070|NCT03950739|157074169|FG000|Optional Extension Phase|Lost to Follow-up|2|||
48791071|NCT03950739|157074169|FG000|Optional Extension Phase|Site Closure|2|||
48791072|NCT03950739|157074169|FG000|Optional Extension Phase|Pregnancy|1|||
48791073|NCT01972841|157074170|FG000|Overall Study|Randomized but Never Received Treatment|2|||
48791074|NCT01972841|157074171|FG001|Overall Study|Randomized but Never Received Treatment|5|||
48791075|NCT01972841|157074172|FG002|Overall Study|Randomized but Never Received Treatment|4|||
48791076|NCT01972841|157074173|FG003|Overall Study|Randomized but Never Received Treatment|2|||
48791077|NCT01972841|157074174|FG004|Overall Study|Randomized but Never Received Treatment|6|||
48791078|NCT01972841|157074175|FG005|Overall Study|Randomized but Never Received Treatment|13|||
48791079|NCT01972841|157074170|FG000|Overall Study|Adverse Event|13|||
48791080|NCT01972841|157074171|FG001|Overall Study|Adverse Event|8|||
48791081|NCT01972841|157074172|FG002|Overall Study|Adverse Event|12|||
48587166|NCT02984267|156341606|FG000|Overall Study|Protocol Violation|1|||
48791082|NCT01972841|157074173|FG003|Overall Study|Adverse Event|9|||
48791083|NCT01972841|157074174|FG004|Overall Study|Adverse Event|21|||
48791084|NCT01972841|157074175|FG005|Overall Study|Adverse Event|26|||
48791085|NCT01972841|157074170|FG000|Overall Study|Lack of Efficacy|1|||
48791086|NCT01972841|157074171|FG001|Overall Study|Lack of Efficacy|0|||
48791087|NCT01972841|157074172|FG002|Overall Study|Lack of Efficacy|0|||
48791088|NCT01972841|157074173|FG003|Overall Study|Lack of Efficacy|2|||
48791089|NCT01972841|157074174|FG004|Overall Study|Lack of Efficacy|4|||
48791090|NCT01972841|157074175|FG005|Overall Study|Lack of Efficacy|1|||
48791091|NCT01972841|157074170|FG000|Overall Study|Lost to Follow-up|4|||
48791092|NCT01972841|157074171|FG001|Overall Study|Lost to Follow-up|2|||
48791093|NCT01972841|157074172|FG002|Overall Study|Lost to Follow-up|4|||
48791094|NCT01972841|157074173|FG003|Overall Study|Lost to Follow-up|2|||
48791095|NCT01972841|157074174|FG004|Overall Study|Lost to Follow-up|9|||
48791096|NCT01972841|157074175|FG005|Overall Study|Lost to Follow-up|3|||
48791097|NCT01972841|157074170|FG000|Overall Study|Protocol Violation|2|||
48791098|NCT01972841|157074171|FG001|Overall Study|Protocol Violation|2|||
48791099|NCT01972841|157074172|FG002|Overall Study|Protocol Violation|3|||
48791100|NCT01972841|157074173|FG003|Overall Study|Protocol Violation|5|||
48791101|NCT01972841|157074174|FG004|Overall Study|Protocol Violation|9|||
48791102|NCT01972841|157074175|FG005|Overall Study|Protocol Violation|4|||
48791103|NCT01972841|157074170|FG000|Overall Study|Withdrawal by participants|21|||
48791104|NCT01972841|157074171|FG001|Overall Study|Withdrawal by participants|27|||
48791105|NCT01972841|157074172|FG002|Overall Study|Withdrawal by participants|23|||
48791106|NCT01972841|157074173|FG003|Overall Study|Withdrawal by participants|16|||
48791107|NCT01972841|157074174|FG004|Overall Study|Withdrawal by participants|33|||
48791108|NCT01972841|157074175|FG005|Overall Study|Withdrawal by participants|34|||
48791109|NCT01972841|157074170|FG000|Overall Study|Miscellaneous|0|||
48791110|NCT01972841|157074171|FG001|Overall Study|Miscellaneous|0|||
48791111|NCT01972841|157074172|FG002|Overall Study|Miscellaneous|4|||
48791112|NCT01972841|157074173|FG003|Overall Study|Miscellaneous|1|||
48791113|NCT01972841|157074174|FG004|Overall Study|Miscellaneous|0|||
48791114|NCT01972841|157074175|FG005|Overall Study|Miscellaneous|4|||
48791115|NCT01972841|157074170|FG000|Overall Study|Did not have end of treatment page|0|||
48791116|NCT01972841|157074171|FG001|Overall Study|Did not have end of treatment page|0|||
48791117|NCT01972841|157074172|FG002|Overall Study|Did not have end of treatment page|0|||
48791118|NCT01972841|157074173|FG003|Overall Study|Did not have end of treatment page|0|||
48791119|NCT01972841|157074174|FG004|Overall Study|Did not have end of treatment page|1|||
48791120|NCT01972841|157074175|FG005|Overall Study|Did not have end of treatment page|0|||
48791121|NCT04526704|157074177|FG000|Overall Study|Adverse Event|1|||
48791122|NCT04526704|157074178|FG001|Overall Study|Adverse Event|0|||
48791123|NCT04526704|157074177|FG000|Overall Study|Physician Decision|1|||
48791124|NCT04526704|157074178|FG001|Overall Study|Physician Decision|0|||
48791125|NCT04526704|157074177|FG000|Overall Study|Withdrawal by Subject|2|||
48791126|NCT04526704|157074178|FG001|Overall Study|Withdrawal by Subject|0|||
48791127|NCT05453773|157074179|FG000|Overall Study|Withdrawal by Subject|3|||
48791128|NCT05453773|157074179|FG000|Overall Study|Lost to Follow-up|3|||
48791129|NCT05453773|157074179|FG000|Overall Study|Difficult Blood Draw|3|||
48791130|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
48791131|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
48791132|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
48791133|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
48791134|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
48791135|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
48791136|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
48791137|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
48791138|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
48791139|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
48791140|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
48791141|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
48791142|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
48791143|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
48791144|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
48791145|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
48791146|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
48791147|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
48791148|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
48791149|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
48791150|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
48791151|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
48401158|NCT02574637|155660215|FG007|Open-label (OL) Period|Adverse Event|0|||
48401159|NCT02574637|155660216|FG008|Open-label (OL) Period|Adverse Event|1|||
48401160|NCT02574637|155660217|FG009|Open-label (OL) Period|Adverse Event|0|||
48401161|NCT02574637|155660208|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
48791152|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
48791153|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
48791154|NCT01715805|157074181|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
48791155|NCT01715805|157074182|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
48791156|NCT01715805|157074183|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
48791157|NCT01715805|157074184|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
48791158|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
48791159|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
48791160|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
48791161|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
48791162|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
48791163|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
48791164|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
48791165|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
48791166|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
48791167|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
48791168|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
48791169|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
48791170|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
48791171|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
48791172|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
48791173|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
48791174|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
48791175|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
48791176|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
48791177|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
48791178|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
48791179|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
48791180|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
48791181|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
48791182|NCT01715805|157074181|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
48791183|NCT01715805|157074182|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
48791184|NCT01715805|157074183|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
48791185|NCT01715805|157074184|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
48791186|NCT04313881|157074185|FG000|Overall Study|Death|138|||
48791187|NCT04313881|157074186|FG001|Overall Study|Death|126|||
48791188|NCT04313881|157074185|FG000|Overall Study|Study terminated by sponsor|108|||
48791189|NCT04313881|157074186|FG001|Overall Study|Study terminated by sponsor|129|||
48791190|NCT04313881|157074185|FG000|Overall Study|Consent withdrawn|19|||
48791191|NCT04313881|157074186|FG001|Overall Study|Consent withdrawn|15|||
48791192|NCT04313881|157074185|FG000|Overall Study|Reason not Specified|3|||
48791193|NCT04313881|157074186|FG001|Overall Study|Reason not Specified|1|||
48791194|NCT02534909|157074191|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
48791195|NCT01454583|157074193|FG000|1st Year|Lost to Follow-up|1057|||
48791196|NCT01454583|157074194|FG001|1st Year|Lost to Follow-up|318|||
48791197|NCT01454583|157074195|FG002|1st Year|Lost to Follow-up|180|||
48791198|NCT01454583|157074193|FG000|2nd Year|Lost to Follow-up|3965|||
48791199|NCT01454583|157074194|FG001|2nd Year|Lost to Follow-up|1049|||
48791200|NCT01454583|157074195|FG002|2nd Year|Lost to Follow-up|737|||
48791201|NCT01454583|157074193|FG000|3rd Year|Lost to Follow-up|1959|||
48791202|NCT01454583|157074194|FG001|3rd Year|Lost to Follow-up|512|||
48791203|NCT01454583|157074195|FG002|3rd Year|Lost to Follow-up|297|||
48791204|NCT02491671|157074196|FG000|Overall Study|Adverse Event|6|||
48791205|NCT02491671|157074197|FG001|Overall Study|Adverse Event|8|||
48791206|NCT02491671|157074196|FG000|Overall Study|Death|0|||
48791207|NCT02491671|157074197|FG001|Overall Study|Death|2|||
48791208|NCT02491671|157074196|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
48791209|NCT02491671|157074197|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
48791210|NCT01090453|157074198|FG000|Overall Study|Withdrawal by Subject|1|||
48791211|NCT01090453|157074199|FG001|Overall Study|Withdrawal by Subject|2|||
48791212|NCT01090453|157074198|FG000|Overall Study|Lost to Follow-up|7|||
48791213|NCT01090453|157074199|FG001|Overall Study|Lost to Follow-up|7|||
48791214|NCT01090453|157074198|FG000|Overall Study|Non serious AEs|1|||
48791215|NCT01090453|157074199|FG001|Overall Study|Non serious AEs|0|||
48791216|NCT01090453|157074198|FG000|Overall Study|Protocol Violation|2|||
48791217|NCT01090453|157074199|FG001|Overall Study|Protocol Violation|0|||
48791218|NCT01090453|157074198|FG000|Overall Study|Other|2|||
48791219|NCT01090453|157074199|FG001|Overall Study|Other|4|||
48791220|NCT01090453|157074198|FG000|Overall Study|Eligibility Criteria|0|||
48791221|NCT01090453|157074199|FG001|Overall Study|Eligibility Criteria|1|||
48791222|NCT03964454|157074202|FG000|Overall Study|Lost to Follow-up|13|||
48791223|NCT03964454|157074203|FG001|Overall Study|Lost to Follow-up|7|||
48791224|NCT03964454|157074202|FG000|Overall Study|Withdrawal by Subject|4|||
48791225|NCT03964454|157074203|FG001|Overall Study|Withdrawal by Subject|11|||
48791226|NCT01302119|157074204|FG000|Overall Study|Withdrawal by Subject|30|||
48791227|NCT01302119|157074205|FG001|Overall Study|Withdrawal by Subject|20|||
48791228|NCT01302119|157074204|FG000|Overall Study|Lost to Follow-up|10|||
48791229|NCT01302119|157074205|FG001|Overall Study|Lost to Follow-up|4|||
48791230|NCT01302119|157074204|FG000|Overall Study|Adverse Event|2|||
48791231|NCT01302119|157074205|FG001|Overall Study|Adverse Event|1|||
48791232|NCT01302119|157074204|FG000|Overall Study|Non-compliance|4|||
48791233|NCT01302119|157074205|FG001|Overall Study|Non-compliance|2|||
48791234|NCT01302119|157074204|FG000|Overall Study|Non-specific|4|||
48791235|NCT01302119|157074205|FG001|Overall Study|Non-specific|1|||
48791236|NCT01300546|157074212|FG000|Overall Study|Withdrawal by Subject|1|||
48791237|NCT01300546|157074213|FG001|Overall Study|Withdrawal by Subject|0|||
48791238|NCT01300546|157074212|FG000|Overall Study|Lost to Follow-up|0|||
48791239|NCT01300546|157074213|FG001|Overall Study|Lost to Follow-up|2|||
48791240|NCT01300546|157074212|FG000|Overall Study|Lack of Efficacy|0|||
48791241|NCT01300546|157074213|FG001|Overall Study|Lack of Efficacy|3|||
48791242|NCT01300546|157074212|FG000|Overall Study|Adverse Event|0|||
48791243|NCT01300546|157074213|FG001|Overall Study|Adverse Event|1|||
48791244|NCT01909934|157074217|FG000|Overall Study|Ongoing|23|||
48791245|NCT01909934|157074217|FG000|Overall Study|Withdrawal by Subject|3|||
48791246|NCT01909934|157074217|FG000|Overall Study|Lost to Follow-up|1|||
48791247|NCT01909934|157074217|FG000|Overall Study|Withdrawal of Informed Consent|1|||
48791248|NCT01909934|157074217|FG000|Overall Study|Death|22|||
48791249|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
48791250|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
48791251|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
48791252|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48791253|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48791254|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
48791255|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791256|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791257|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
48791258|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791259|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791260|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
48791261|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
48791262|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
48791263|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
48791264|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
48791265|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
48791266|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
48791267|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
48791268|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
48791269|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
48791270|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48791271|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48791272|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
48791273|NCT04988308|157074218|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
48791274|NCT04988308|157074219|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
48791275|NCT04988308|157074220|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
48791276|NCT04988308|157074221|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
48791277|NCT04988308|157074222|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
48791278|NCT04988308|157074223|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
48791279|NCT04988308|157074218|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48791280|NCT04988308|157074219|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48791281|NCT04988308|157074220|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
48791282|NCT04988308|157074221|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
48791283|NCT04988308|157074222|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
48791284|NCT04988308|157074223|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
48791285|NCT04988308|157074218|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48791286|NCT04988308|157074219|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48791287|NCT04988308|157074220|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
48401162|NCT02574637|155660209|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
48401163|NCT02574637|155660210|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
48401164|NCT02574637|155660211|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
48401165|NCT02574637|155660212|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
48401166|NCT02574637|155660213|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
48401167|NCT02574637|155660214|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
48791288|NCT04988308|157074221|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
48791289|NCT04988308|157074222|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
48791290|NCT04988308|157074223|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
48791291|NCT04988308|157074218|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48791292|NCT04988308|157074219|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48791293|NCT04988308|157074220|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
48791294|NCT04988308|157074221|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
48791295|NCT04988308|157074222|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
48791296|NCT04988308|157074223|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
48791297|NCT04988308|157074218|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
48791298|NCT04988308|157074219|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
48791299|NCT04988308|157074220|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
48791300|NCT04988308|157074221|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
48791301|NCT04988308|157074222|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
48791302|NCT04988308|157074223|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
48791303|NCT04302350|157074225|FG000|Overall Study|Physician Decision|1|||
48791304|NCT04302350|157074226|FG001|Overall Study|Physician Decision|1|||
48791305|NCT04302350|157074227|FG002|Overall Study|Physician Decision|2|||
48791306|NCT04302350|157074225|FG000|Overall Study|Lack of Efficacy|1|||
48791307|NCT04302350|157074226|FG001|Overall Study|Lack of Efficacy|1|||
48791308|NCT04302350|157074227|FG002|Overall Study|Lack of Efficacy|4|||
48791309|NCT04302350|157074225|FG000|Overall Study|Adverse Event|0|||
48791310|NCT04302350|157074226|FG001|Overall Study|Adverse Event|1|||
48791311|NCT04302350|157074227|FG002|Overall Study|Adverse Event|2|||
48791312|NCT02313428|157074228|FG000|Overall Study|Lost to Follow-up|1|||
48791313|NCT02313428|157074229|FG001|Overall Study|Lost to Follow-up|1|||
48791314|NCT04482647|157074230|FG000|Overall Study|Time constraints|2|||
48791315|NCT04482647|157074230|FG000|Overall Study|Health issues|1|||
48791316|NCT04482647|157074230|FG000|Overall Study|Death in the family|1|||
48791317|NCT04482647|157074230|FG000|Overall Study|Disliked the intervention|1|||
48791318|NCT04482647|157074230|FG000|Overall Study|No reasons specified|7|||
48791319|NCT04537923|157076982|FG000|Overall Study|Adverse Event|2|||
48791320|NCT04537923|157076983|FG001|Overall Study|Adverse Event|1|||
48791321|NCT04537923|157076984|FG002|Overall Study|Adverse Event|2|||
48791322|NCT04537923|157076985|FG003|Overall Study|Adverse Event|4|||
48791323|NCT04537923|157076982|FG000|Overall Study|Death|3|||
48791324|NCT04537923|157076983|FG001|Overall Study|Death|3|||
48791325|NCT04537923|157076984|FG002|Overall Study|Death|1|||
48791326|NCT04537923|157076985|FG003|Overall Study|Death|11|||
48791327|NCT04537923|157076982|FG000|Overall Study|Lost to Follow-up|1|||
48791328|NCT04537923|157076983|FG001|Overall Study|Lost to Follow-up|2|||
48791329|NCT04537923|157076984|FG002|Overall Study|Lost to Follow-up|1|||
48791330|NCT04537923|157076985|FG003|Overall Study|Lost to Follow-up|6|||
48791331|NCT04537923|157076982|FG000|Overall Study|Physician Decision|1|||
48791332|NCT04537923|157076983|FG001|Overall Study|Physician Decision|0|||
48791333|NCT04537923|157076984|FG002|Overall Study|Physician Decision|2|||
48791334|NCT04537923|157076985|FG003|Overall Study|Physician Decision|5|||
48791335|NCT04537923|157076982|FG000|Overall Study|Pregnancy|1|||
48791336|NCT04537923|157076983|FG001|Overall Study|Pregnancy|0|||
48791337|NCT04537923|157076984|FG002|Overall Study|Pregnancy|0|||
48791338|NCT04537923|157076985|FG003|Overall Study|Pregnancy|0|||
48791339|NCT04537923|157076982|FG000|Overall Study|Withdrawal by Subject|4|||
48791340|NCT04537923|157076983|FG001|Overall Study|Withdrawal by Subject|4|||
48791341|NCT04537923|157076984|FG002|Overall Study|Withdrawal by Subject|4|||
48791342|NCT04537923|157076985|FG003|Overall Study|Withdrawal by Subject|58|||
48791343|NCT04537923|157076982|FG000|Overall Study|Missed study visits|2|||
48791344|NCT04537923|157076983|FG001|Overall Study|Missed study visits|0|||
48791345|NCT04537923|157076984|FG002|Overall Study|Missed study visits|0|||
48791346|NCT04537923|157076985|FG003|Overall Study|Missed study visits|3|||
48791347|NCT04537923|157076982|FG000|Overall Study|Sponsor's decision|0|||
48791348|NCT04537923|157076983|FG001|Overall Study|Sponsor's decision|0|||
48791349|NCT04537923|157076984|FG002|Overall Study|Sponsor's decision|1|||
48791350|NCT04537923|157076985|FG003|Overall Study|Sponsor's decision|1|||
48791351|NCT04537923|157076982|FG000|Overall Study|Safety reasons|1|||
48791352|NCT04537923|157076983|FG001|Overall Study|Safety reasons|0|||
48791353|NCT04537923|157076984|FG002|Overall Study|Safety reasons|0|||
48791354|NCT04537923|157076985|FG003|Overall Study|Safety reasons|0|||
48791355|NCT05349617|157076990|FG000|Overall Study|Death|1|||
48791356|NCT05349617|157076991|FG001|Overall Study|Death|1|||
48791357|NCT05349617|157076990|FG000|Overall Study|Lost to Follow-up|3|||
48791358|NCT05349617|157076991|FG001|Overall Study|Lost to Follow-up|8|||
48791359|NCT05349617|157076990|FG000|Overall Study|Withdrawal by Subject|2|||
48791360|NCT05349617|157076991|FG001|Overall Study|Withdrawal by Subject|10|||
48791361|NCT00674986|157076992|FG000|Overall Study|Adverse Event|2|||
48791362|NCT00674986|157076993|FG001|Overall Study|Adverse Event|1|||
48791363|NCT00674986|157076992|FG000|Overall Study|Subject withdrew consent|12|||
48791364|NCT00674986|157076993|FG001|Overall Study|Subject withdrew consent|19|||
48791365|NCT00674986|157076992|FG000|Overall Study|Lost to Follow-up|25|||
48791366|NCT00674986|157076993|FG001|Overall Study|Lost to Follow-up|53|||
48791367|NCT00674986|157076992|FG000|Overall Study|Other reasons|4|||
48791368|NCT00674986|157076993|FG001|Overall Study|Other reasons|8|||
48791369|NCT01912612|157076996|FG000|Overall Study|Adverse Event|4|||
48791370|NCT01912612|157076997|FG001|Overall Study|Adverse Event|0|||
48791371|NCT01912612|157076998|FG002|Overall Study|Adverse Event|0|||
48791372|NCT01912612|157076996|FG000|Overall Study|Withdrew consent|1|||
48791373|NCT01912612|157076997|FG001|Overall Study|Withdrew consent|0|||
48791374|NCT01912612|157076998|FG002|Overall Study|Withdrew consent|0|||
48791375|NCT01912612|157076996|FG000|Overall Study|Study design change|0|||
48791376|NCT01912612|157076997|FG001|Overall Study|Study design change|0|||
48791377|NCT01912612|157076998|FG002|Overall Study|Study design change|3|||
48791378|NCT01588184|157076999|FG000|Overall Study|Death|1|||
48791379|NCT01588184|157077000|FG001|Overall Study|Death|0|||
48791380|NCT01588184|157077001|FG002|Overall Study|Death|0|||
48791381|NCT01588184|157077002|FG003|Overall Study|Death|1|||
48791382|NCT01588184|157077003|FG004|Overall Study|Death|1|||
48791383|NCT01588184|157077004|FG005|Overall Study|Death|1|||
48791384|NCT01588184|157076999|FG000|Overall Study|Withdrawal by Subject|2|||
48791385|NCT01588184|157077000|FG001|Overall Study|Withdrawal by Subject|4|||
48791386|NCT01588184|157077001|FG002|Overall Study|Withdrawal by Subject|0|||
48791387|NCT01588184|157077002|FG003|Overall Study|Withdrawal by Subject|1|||
48791388|NCT01588184|157077003|FG004|Overall Study|Withdrawal by Subject|0|||
48791389|NCT01588184|157077004|FG005|Overall Study|Withdrawal by Subject|0|||
48791390|NCT01588184|157076999|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
48791391|NCT01588184|157077000|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
48791392|NCT01588184|157077001|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
48791393|NCT01588184|157077002|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
48791394|NCT01588184|157077003|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
48791395|NCT01588184|157077004|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
48791396|NCT01588184|157076999|FG000|Overall Study|multiple reasons|0|||
48791397|NCT01588184|157077000|FG001|Overall Study|multiple reasons|3|||
48791398|NCT01588184|157077001|FG002|Overall Study|multiple reasons|0|||
48791399|NCT01588184|157077002|FG003|Overall Study|multiple reasons|1|||
48791400|NCT01588184|157077003|FG004|Overall Study|multiple reasons|0|||
48791401|NCT01588184|157077004|FG005|Overall Study|multiple reasons|0|||
48791402|NCT01140880|157077005|FG000|Overall Study|Death|0|||
48791403|NCT01140880|157077006|FG001|Overall Study|Death|1|||
48791404|NCT01140880|157077005|FG000|Overall Study|Withdrawal by Subject|6|||
48791405|NCT01140880|157077006|FG001|Overall Study|Withdrawal by Subject|3|||
48791406|NCT01140880|157077005|FG000|Overall Study|Lost to Follow-up|8|||
48791407|NCT01140880|157077006|FG001|Overall Study|Lost to Follow-up|10|||
48791408|NCT01140880|157077005|FG000|Overall Study|Protocol Violation|0|||
48791409|NCT01140880|157077006|FG001|Overall Study|Protocol Violation|30|||
48791410|NCT02844946|157077013|FG000|Overall Study|Lost to Follow-up|7|||
48791411|NCT02844946|157077014|FG001|Overall Study|Lost to Follow-up|0|||
48791412|NCT01605617|157077015|FG000|First Intervention|Adverse Event|0|||
48791413|NCT01605617|157077016|FG001|First Intervention|Adverse Event|1|||
48791414|NCT01605617|157077015|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
48791415|NCT01605617|157077016|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
48791416|NCT00868439|157077017|FG000|Overall Study|Adverse Event|4|||
48791417|NCT00868439|157077018|FG001|Overall Study|Adverse Event|3|||
48791418|NCT00868439|157077017|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
48791419|NCT00868439|157077018|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
48791420|NCT00868439|157077017|FG000|Overall Study|Death|0|||
48791421|NCT00868439|157077018|FG001|Overall Study|Death|1|||
48791422|NCT00868439|157077017|FG000|Overall Study|Protocol Violation|1|||
48791423|NCT00868439|157077018|FG001|Overall Study|Protocol Violation|1|||
48791424|NCT00868439|157077017|FG000|Overall Study|Physician Decision|1|||
48791425|NCT00868439|157077018|FG001|Overall Study|Physician Decision|0|||
48791426|NCT00868439|157077017|FG000|Overall Study|Withdrawal by Subject|0|||
48791427|NCT00868439|157077018|FG001|Overall Study|Withdrawal by Subject|1|||
48791428|NCT04903288|157077019|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
48791429|NCT04903288|157077019|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
48791430|NCT04903288|157077019|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
48791431|NCT04903288|157077019|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
48791432|NCT03241745|157077023|FG000|Overall Study|Adverse Event|7|||
48791433|NCT03241745|157077023|FG000|Overall Study|Death|1|||
48791434|NCT03241745|157077023|FG000|Overall Study|Withdrawal by Subject|5|||
48791435|NCT03241745|157077023|FG000|Overall Study|Treatment delay >28 days|2|||
48791436|NCT03241745|157077023|FG000|Overall Study|Lack of Efficacy|14|||
48791437|NCT04391023|157077033|FG000|Overall Study|Withdrawal by Subject|2|||
48791438|NCT04391023|157077034|FG001|Overall Study|Withdrawal by Subject|2|||
48791439|NCT02085408|157077039|FG000|Step 1: Induction|Disease Progression|19|||
48791440|NCT02085408|157077040|FG001|Step 1: Induction|Disease Progression|19|||
48791441|NCT02085408|157077039|FG000|Step 1: Induction|Adverse Event|18|||
48791442|NCT02085408|157077040|FG001|Step 1: Induction|Adverse Event|17|||
48791443|NCT02085408|157077039|FG000|Step 1: Induction|Death|33|||
48791444|NCT02085408|157077040|FG001|Step 1: Induction|Death|30|||
48791445|NCT02085408|157077039|FG000|Step 1: Induction|Withdrawal by Subject|16|||
48791446|NCT02085408|157077040|FG001|Step 1: Induction|Withdrawal by Subject|8|||
48791447|NCT02085408|157077039|FG000|Step 1: Induction|Alternative Therapy|15|||
48791448|NCT02085408|157077040|FG001|Step 1: Induction|Alternative Therapy|19|||
48791449|NCT02085408|157077039|FG000|Step 1: Induction|Complicating Disease|2|||
48791450|NCT02085408|157077040|FG001|Step 1: Induction|Complicating Disease|3|||
48791451|NCT02085408|157077039|FG000|Step 1: Induction|Other|27|||
48791452|NCT02085408|157077040|FG001|Step 1: Induction|Other|39|||
48791453|NCT02085408|157077039|FG000|Step 1: Induction|Never started treatment|6|||
48791454|NCT02085408|157077040|FG001|Step 1: Induction|Never started treatment|4|||
48791455|NCT02085408|157077039|FG000|Step 2: Consolidation|Disease Progression|5|||
48791456|NCT02085408|157077040|FG001|Step 2: Consolidation|Disease Progression|20|||
48791457|NCT02085408|157077039|FG000|Step 2: Consolidation|Adverse Event|9|||
48791458|NCT02085408|157077040|FG001|Step 2: Consolidation|Adverse Event|8|||
48791459|NCT02085408|157077039|FG000|Step 2: Consolidation|Death|4|||
48791460|NCT02085408|157077040|FG001|Step 2: Consolidation|Death|3|||
48791461|NCT02085408|157077039|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
48791462|NCT02085408|157077040|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
48791463|NCT02085408|157077039|FG000|Step 2: Consolidation|Alternative Therapy|9|||
48791464|NCT02085408|157077040|FG001|Step 2: Consolidation|Alternative Therapy|3|||
48791465|NCT02085408|157077039|FG000|Step 2: Consolidation|Complicating Disease|0|||
48791466|NCT02085408|157077040|FG001|Step 2: Consolidation|Complicating Disease|2|||
48791467|NCT02085408|157077039|FG000|Step 2: Consolidation|Other|6|||
48791468|NCT02085408|157077040|FG001|Step 2: Consolidation|Other|6|||
48791469|NCT02085408|157077039|FG000|Step 2: Consolidation|Never started treatment|4|||
48791470|NCT02085408|157077040|FG001|Step 2: Consolidation|Never started treatment|3|||
48791471|NCT02085408|157077039|FG000|Step 3: Maintenance|Disease Progression|13|||
48791472|NCT02085408|157077040|FG001|Step 3: Maintenance|Disease Progression|11|||
48791473|NCT02085408|157077039|FG000|Step 3: Maintenance|Adverse Event|2|||
48791474|NCT02085408|157077040|FG001|Step 3: Maintenance|Adverse Event|4|||
48791475|NCT02085408|157077039|FG000|Step 3: Maintenance|Death|1|||
48791476|NCT02085408|157077040|FG001|Step 3: Maintenance|Death|2|||
48791477|NCT02085408|157077039|FG000|Step 3: Maintenance|Alternative Therapy|1|||
48791478|NCT02085408|157077040|FG001|Step 3: Maintenance|Alternative Therapy|1|||
48791479|NCT02085408|157077039|FG000|Step 3: Maintenance|Complicating Disease|0|||
48791480|NCT02085408|157077040|FG001|Step 3: Maintenance|Complicating Disease|1|||
48791481|NCT02085408|157077039|FG000|Step 3: Maintenance|Other|3|||
48791482|NCT02085408|157077040|FG001|Step 3: Maintenance|Other|2|||
48791483|NCT02085408|157077039|FG000|Step 3: Maintenance|Never started treatment|5|||
48791484|NCT02085408|157077040|FG001|Step 3: Maintenance|Never started treatment|1|||
48791485|NCT04233216|157077041|FG000|Overall Study|Lost to Follow-up|1|||
48791486|NCT04233216|157077042|FG001|Overall Study|Lost to Follow-up|0|||
48791487|NCT04233216|157077043|FG002|Overall Study|Lost to Follow-up|2|||
48791488|NCT04233216|157077044|FG003|Overall Study|Lost to Follow-up|0|||
48791489|NCT04233216|157077041|FG000|Overall Study|Physician Decision|0|||
48791490|NCT04233216|157077042|FG001|Overall Study|Physician Decision|3|||
48791491|NCT04233216|157077043|FG002|Overall Study|Physician Decision|0|||
48791492|NCT04233216|157077044|FG003|Overall Study|Physician Decision|2|||
48791493|NCT04233216|157077041|FG000|Overall Study|Withdrawal by Subject|0|||
48791494|NCT04233216|157077042|FG001|Overall Study|Withdrawal by Subject|2|||
48791495|NCT04233216|157077043|FG002|Overall Study|Withdrawal by Subject|1|||
48791496|NCT04233216|157077044|FG003|Overall Study|Withdrawal by Subject|0|||
48791497|NCT00715429|157077046|FG000|Overall Study|Did not complete the study diary|0|||
48791498|NCT00715429|157077047|FG001|Overall Study|Did not complete the study diary|1|||
48791499|NCT00492284|157077048|FG000|Overall Study|Adverse Event|0|||
48791500|NCT00492284|157077049|FG001|Overall Study|Adverse Event|1|||
48791501|NCT00492284|157077050|FG002|Overall Study|Adverse Event|1|||
48791502|NCT00492284|157077051|FG003|Overall Study|Adverse Event|2|||
48791503|NCT00492284|157077048|FG000|Overall Study|Lost to Follow-up|0|||
48791504|NCT00492284|157077049|FG001|Overall Study|Lost to Follow-up|0|||
48791505|NCT00492284|157077050|FG002|Overall Study|Lost to Follow-up|3|||
48791506|NCT00492284|157077051|FG003|Overall Study|Lost to Follow-up|1|||
48791507|NCT00492284|157077048|FG000|Overall Study|Death|0|||
48791508|NCT00492284|157077049|FG001|Overall Study|Death|3|||
48791509|NCT00492284|157077050|FG002|Overall Study|Death|2|||
48791510|NCT00492284|157077051|FG003|Overall Study|Death|5|||
48791511|NCT00492284|157077048|FG000|Overall Study|Withdrawal by Subject|1|||
48791512|NCT00492284|157077049|FG001|Overall Study|Withdrawal by Subject|0|||
48791513|NCT00492284|157077050|FG002|Overall Study|Withdrawal by Subject|0|||
48401168|NCT02574637|155660215|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
48401169|NCT02574637|155660216|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
48401170|NCT02574637|155660217|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
48401171|NCT02574637|155660208|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48401172|NCT02574637|155660209|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48401173|NCT02574637|155660210|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48401174|NCT02574637|155660211|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48401175|NCT02574637|155660212|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48401176|NCT02574637|155660213|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
48401177|NCT02574637|155660214|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
48401178|NCT02574637|155660215|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
48401179|NCT02574637|155660216|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
48401180|NCT02574637|155660217|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
48401181|NCT01212185|155660219|FG000|Overall Study|Protocol Violation|2|||
48401182|NCT01212185|155660220|FG001|Overall Study|Protocol Violation|1|||
48401183|NCT04823949|155660221|FG000|Overall Study|Withdrawal by Subject|0|||
48401184|NCT04823949|155660222|FG001|Overall Study|Withdrawal by Subject|4|||
48401185|NCT04823949|155660221|FG000|Overall Study|Physician Decision|0|||
48401186|NCT04823949|155660222|FG001|Overall Study|Physician Decision|1|||
48401187|NCT02474082|155660225|FG000|Overall Study|Adverse Event|2|||
48401188|NCT02474082|155660226|FG001|Overall Study|Adverse Event|32|||
48401189|NCT02474082|155660225|FG000|Overall Study|Withdrawal of informed consent|1|||
48401190|NCT02474082|155660226|FG001|Overall Study|Withdrawal of informed consent|11|||
48401191|NCT02474082|155660225|FG000|Overall Study|Lost to Follow-up|2|||
48401192|NCT02474082|155660226|FG001|Overall Study|Lost to Follow-up|2|||
48401193|NCT02474082|155660225|FG000|Overall Study|Dose tapering not achieved|0|||
48401194|NCT02474082|155660226|FG001|Overall Study|Dose tapering not achieved|4|||
48401195|NCT02474082|155660225|FG000|Overall Study|Participant/guardian decision|1|||
48401196|NCT02474082|155660226|FG001|Overall Study|Participant/guardian decision|2|||
48401197|NCT02474082|155660225|FG000|Overall Study|Non-compliance with study treatment|0|||
48401198|NCT02474082|155660226|FG001|Overall Study|Non-compliance with study treatment|2|||
48401199|NCT02474082|155660225|FG000|Overall Study|Protocol deviation|0|||
48401200|NCT02474082|155660226|FG001|Overall Study|Protocol deviation|1|||
48401201|NCT01463098|155660231|FG000|Part A (11 Days)|Participant Choice|2|||
48401202|NCT01463098|155660232|FG001|Part A (11 Days)|Participant Choice|0|||
48401203|NCT01463098|155660233|FG002|Part A (11 Days)|Participant Choice|0|||
48791514|NCT00492284|157077051|FG003|Overall Study|Withdrawal by Subject|2|||
48791515|NCT03695172|157077054|FG000|Overall Study|Withdrawal by Subject|1|||
48791516|NCT03695172|157077055|FG001|Overall Study|Withdrawal by Subject|1|||
48791517|NCT03695172|157077056|FG002|Overall Study|Withdrawal by Subject|0|||
48791518|NCT03624504|157077057|FG000|Overall Study|Unsuccessful Implant|1|||
48791519|NCT00727272|157077058|FG000|Washout Period A|Adverse Event|0|||
48791520|NCT00727272|157077059|FG001|Washout Period A|Adverse Event|0|||
48791521|NCT00727272|157077060|FG002|Washout Period A|Adverse Event|1|||
48791522|NCT00727272|157077058|FG000|Washout Period B|Withdrawal by Subject|0|||
48791523|NCT00727272|157077059|FG001|Washout Period B|Withdrawal by Subject|0|||
48791524|NCT00727272|157077060|FG002|Washout Period B|Withdrawal by Subject|1|||
48791525|NCT02834780|157077061|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
48791526|NCT02834780|157077062|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
48791527|NCT02834780|157077063|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
48791528|NCT02834780|157077064|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
48791529|NCT02834780|157077065|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
48791530|NCT02834780|157077066|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
48791531|NCT02834780|157077067|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
48791532|NCT02834780|157077068|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
48791533|NCT02834780|157077069|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
48791534|NCT02834780|157077070|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
48791535|NCT02834780|157077071|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
48791536|NCT02834780|157077072|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
48791537|NCT02834780|157077073|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
48791538|NCT02834780|157077061|FG000|Overall Study|Withdrawal by Subject|0|||
48791539|NCT02834780|157077062|FG001|Overall Study|Withdrawal by Subject|0|||
48791540|NCT02834780|157077063|FG002|Overall Study|Withdrawal by Subject|1|||
48791541|NCT02834780|157077064|FG003|Overall Study|Withdrawal by Subject|0|||
48791542|NCT02834780|157077065|FG004|Overall Study|Withdrawal by Subject|0|||
48791543|NCT02834780|157077066|FG005|Overall Study|Withdrawal by Subject|0|||
48791544|NCT02834780|157077067|FG006|Overall Study|Withdrawal by Subject|0|||
48401204|NCT01463098|155660234|FG003|Part A (11 Days)|Participant Choice|0|||
48791545|NCT02834780|157077068|FG007|Overall Study|Withdrawal by Subject|0|||
48791546|NCT02834780|157077069|FG008|Overall Study|Withdrawal by Subject|0|||
48791547|NCT02834780|157077070|FG009|Overall Study|Withdrawal by Subject|0|||
48791548|NCT02834780|157077071|FG010|Overall Study|Withdrawal by Subject|1|||
48791549|NCT02834780|157077072|FG011|Overall Study|Withdrawal by Subject|0|||
48791550|NCT02834780|157077073|FG012|Overall Study|Withdrawal by Subject|0|||
48791551|NCT02834780|157077061|FG000|Overall Study|Adverse Event|0|||
48791552|NCT02834780|157077062|FG001|Overall Study|Adverse Event|0|||
48791553|NCT02834780|157077063|FG002|Overall Study|Adverse Event|0|||
48791554|NCT02834780|157077064|FG003|Overall Study|Adverse Event|0|||
48791555|NCT02834780|157077065|FG004|Overall Study|Adverse Event|1|||
48791556|NCT02834780|157077066|FG005|Overall Study|Adverse Event|0|||
48791557|NCT02834780|157077067|FG006|Overall Study|Adverse Event|1|||
48791558|NCT02834780|157077068|FG007|Overall Study|Adverse Event|1|||
48791559|NCT02834780|157077069|FG008|Overall Study|Adverse Event|0|||
48791560|NCT02834780|157077070|FG009|Overall Study|Adverse Event|2|||
48791561|NCT02834780|157077071|FG010|Overall Study|Adverse Event|0|||
48791562|NCT02834780|157077072|FG011|Overall Study|Adverse Event|3|||
48791563|NCT02834780|157077073|FG012|Overall Study|Adverse Event|2|||
48791564|NCT02834780|157077061|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791565|NCT02834780|157077062|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
48791566|NCT02834780|157077063|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
48791567|NCT02834780|157077064|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791568|NCT02834780|157077065|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791569|NCT02834780|157077066|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791570|NCT02834780|157077067|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791571|NCT02834780|157077068|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
48791572|NCT02834780|157077069|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
48791573|NCT02834780|157077070|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
48791574|NCT02834780|157077071|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
48791575|NCT02834780|157077072|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
48791576|NCT02834780|157077073|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
48791577|NCT02834780|157077061|FG000|Overall Study|Other|1|||
48791578|NCT02834780|157077062|FG001|Overall Study|Other|0|||
48791579|NCT02834780|157077063|FG002|Overall Study|Other|1|||
48791580|NCT02834780|157077064|FG003|Overall Study|Other|2|||
48791581|NCT02834780|157077065|FG004|Overall Study|Other|0|||
48791582|NCT02834780|157077066|FG005|Overall Study|Other|0|||
48791583|NCT02834780|157077067|FG006|Overall Study|Other|0|||
48791584|NCT02834780|157077068|FG007|Overall Study|Other|0|||
48791585|NCT02834780|157077069|FG008|Overall Study|Other|0|||
48791586|NCT02834780|157077070|FG009|Overall Study|Other|0|||
48791587|NCT02834780|157077071|FG010|Overall Study|Other|0|||
48791588|NCT02834780|157077072|FG011|Overall Study|Other|0|||
48791589|NCT02834780|157077073|FG012|Overall Study|Other|1|||
48791590|NCT03449030|157077074|FG000|Overall Study|Withdrawal by Subject|0|||
48791591|NCT03449030|157077075|FG001|Overall Study|Withdrawal by Subject|0|||
48791592|NCT03449030|157077076|FG002|Overall Study|Withdrawal by Subject|0|||
48791593|NCT03449030|157077077|FG003|Overall Study|Withdrawal by Subject|1|||
48791594|NCT03449030|157077078|FG004|Overall Study|Withdrawal by Subject|1|||
48791595|NCT03449030|157077079|FG005|Overall Study|Withdrawal by Subject|1|||
48791596|NCT03449030|157077080|FG006|Overall Study|Withdrawal by Subject|1|||
48791597|NCT03449030|157077081|FG007|Overall Study|Withdrawal by Subject|2|||
48791598|NCT03449030|157077082|FG008|Overall Study|Withdrawal by Subject|0|||
48791599|NCT03449030|157077083|FG009|Overall Study|Withdrawal by Subject|0|||
48791600|NCT03449030|157077074|FG000|Overall Study|Symptomatic Deterioration|0|||
48791601|NCT03449030|157077075|FG001|Overall Study|Symptomatic Deterioration|1|||
48791602|NCT03449030|157077076|FG002|Overall Study|Symptomatic Deterioration|0|||
48791603|NCT03449030|157077077|FG003|Overall Study|Symptomatic Deterioration|0|||
48791604|NCT03449030|157077078|FG004|Overall Study|Symptomatic Deterioration|0|||
48791605|NCT03449030|157077079|FG005|Overall Study|Symptomatic Deterioration|1|||
48791606|NCT03449030|157077080|FG006|Overall Study|Symptomatic Deterioration|1|||
48791607|NCT03449030|157077081|FG007|Overall Study|Symptomatic Deterioration|0|||
48791608|NCT03449030|157077082|FG008|Overall Study|Symptomatic Deterioration|2|||
48791609|NCT03449030|157077083|FG009|Overall Study|Symptomatic Deterioration|0|||
48791610|NCT03449030|157077074|FG000|Overall Study|Progressive Disease|1|||
48791611|NCT03449030|157077075|FG001|Overall Study|Progressive Disease|0|||
48791612|NCT03449030|157077076|FG002|Overall Study|Progressive Disease|1|||
48401205|NCT01463098|155660235|FG004|Part A (11 Days)|Participant Choice|0|||
48401206|NCT01463098|155660236|FG005|Part A (11 Days)|Participant Choice|0|||
48791613|NCT03449030|157077077|FG003|Overall Study|Progressive Disease|4|||
48791614|NCT03449030|157077078|FG004|Overall Study|Progressive Disease|5|||
48791615|NCT03449030|157077079|FG005|Overall Study|Progressive Disease|3|||
48791616|NCT03449030|157077080|FG006|Overall Study|Progressive Disease|0|||
48791617|NCT03449030|157077081|FG007|Overall Study|Progressive Disease|1|||
48791618|NCT03449030|157077082|FG008|Overall Study|Progressive Disease|1|||
48401207|NCT01463098|155660237|FG006|Part A (11 Days)|Participant Choice|0|||
48791619|NCT03449030|157077083|FG009|Overall Study|Progressive Disease|1|||
48791620|NCT03449030|157077074|FG000|Overall Study|Adverse Event|0|||
48791621|NCT03449030|157077075|FG001|Overall Study|Adverse Event|0|||
48791622|NCT03449030|157077076|FG002|Overall Study|Adverse Event|0|||
48791623|NCT03449030|157077077|FG003|Overall Study|Adverse Event|0|||
48791624|NCT03449030|157077078|FG004|Overall Study|Adverse Event|0|||
48791625|NCT03449030|157077079|FG005|Overall Study|Adverse Event|2|||
48791626|NCT03449030|157077080|FG006|Overall Study|Adverse Event|0|||
48791627|NCT03449030|157077081|FG007|Overall Study|Adverse Event|0|||
48791628|NCT03449030|157077082|FG008|Overall Study|Adverse Event|0|||
48791629|NCT03449030|157077083|FG009|Overall Study|Adverse Event|0|||
48791630|NCT03449030|157077074|FG000|Overall Study|Death|0|||
48791631|NCT03449030|157077075|FG001|Overall Study|Death|0|||
48791632|NCT03449030|157077076|FG002|Overall Study|Death|0|||
48791633|NCT03449030|157077077|FG003|Overall Study|Death|0|||
48791634|NCT03449030|157077078|FG004|Overall Study|Death|1|||
48791635|NCT03449030|157077079|FG005|Overall Study|Death|0|||
48791636|NCT03449030|157077080|FG006|Overall Study|Death|0|||
48791637|NCT03449030|157077081|FG007|Overall Study|Death|0|||
48791638|NCT03449030|157077082|FG008|Overall Study|Death|0|||
48791639|NCT03449030|157077083|FG009|Overall Study|Death|0|||
48791640|NCT02270450|157077084|FG000|Overall Study|Refusal unrelated to adverse event|3|||
48791641|NCT02270450|157077085|FG001|Overall Study|Refusal unrelated to adverse event|1|||
48791642|NCT02270450|157077086|FG002|Overall Study|Refusal unrelated to adverse event|5|||
48791643|NCT02270450|157077087|FG003|Overall Study|Refusal unrelated to adverse event|14|||
48791644|NCT02270450|157077084|FG000|Overall Study|Progression/relapse|1|||
48791645|NCT02270450|157077085|FG001|Overall Study|Progression/relapse|2|||
48791646|NCT02270450|157077086|FG002|Overall Study|Progression/relapse|4|||
48791647|NCT02270450|157077087|FG003|Overall Study|Progression/relapse|9|||
48791648|NCT02270450|157077084|FG000|Overall Study|Death|19|||
48791649|NCT02270450|157077085|FG001|Overall Study|Death|19|||
48791650|NCT02270450|157077086|FG002|Overall Study|Death|31|||
48791651|NCT02270450|157077087|FG003|Overall Study|Death|59|||
48791652|NCT03595904|157077092|FG000|Overall Study|Protocol Violation|3|||
48791653|NCT03595904|157077093|FG001|Overall Study|Protocol Violation|1|||
48791654|NCT03595904|157077092|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
48791655|NCT03595904|157077093|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
48791656|NCT03595904|157077092|FG000|Overall Study|Insurance complications|1|||
48791657|NCT03595904|157077093|FG001|Overall Study|Insurance complications|0|||
48791658|NCT03595904|157077092|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
48791659|NCT03595904|157077093|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
48791660|NCT03182868|157077096|FG000|Overall Study|Protocol Violation|3|||
48791661|NCT03182868|157077097|FG001|Overall Study|Protocol Violation|0|||
48791662|NCT03182868|157077098|FG002|Overall Study|Protocol Violation|4|||
48791663|NCT03182868|157077099|FG003|Overall Study|Protocol Violation|1|||
48791664|NCT03182868|157077100|FG004|Overall Study|Protocol Violation|8|||
48791665|NCT01587651|157077104|FG000|Overall Study|Adverse Event|0|||
48791666|NCT01587651|157077105|FG001|Overall Study|Adverse Event|1|||
48791667|NCT01587651|157077106|FG002|Overall Study|Adverse Event|0|||
48791668|NCT01587651|157077104|FG000|Overall Study|Protocol Violation|0|||
48791669|NCT01587651|157077105|FG001|Overall Study|Protocol Violation|1|||
48791670|NCT01587651|157077106|FG002|Overall Study|Protocol Violation|1|||
48791671|NCT01587651|157077104|FG000|Overall Study|Withdrawal by Subject|0|||
48791672|NCT01587651|157077105|FG001|Overall Study|Withdrawal by Subject|1|||
48791673|NCT01587651|157077106|FG002|Overall Study|Withdrawal by Subject|0|||
48791674|NCT00518115|157077113|FG000|Overall Study|Adverse Event|6|||
48791675|NCT00518115|157077114|FG001|Overall Study|Adverse Event|1|||
48791676|NCT00518115|157077115|FG002|Overall Study|Adverse Event|5|||
48791677|NCT00518115|157077116|FG003|Overall Study|Adverse Event|6|||
48791678|NCT00518115|157077117|FG004|Overall Study|Adverse Event|5|||
48791679|NCT00518115|157077118|FG005|Overall Study|Adverse Event|5|||
48791680|NCT00518115|157077119|FG006|Overall Study|Adverse Event|5|||
48791681|NCT00518115|157077120|FG007|Overall Study|Adverse Event|10|||
48791682|NCT00518115|157077121|FG008|Overall Study|Adverse Event|2|||
48791683|NCT00518115|157077122|FG009|Overall Study|Adverse Event|9|||
48791684|NCT00518115|157077113|FG000|Overall Study|Lost to Follow-up|0|||
48791685|NCT00518115|157077114|FG001|Overall Study|Lost to Follow-up|0|||
48791686|NCT00518115|157077115|FG002|Overall Study|Lost to Follow-up|2|||
48401208|NCT01463098|155660238|FG007|Part A (11 Days)|Participant Choice|0|||
48401209|NCT01463098|155660239|FG008|Part A (11 Days)|Participant Choice|1|||
48401210|NCT01463098|155660240|FG009|Part A (11 Days)|Participant Choice|0|||
48791687|NCT00518115|157077116|FG003|Overall Study|Lost to Follow-up|3|||
48791688|NCT00518115|157077117|FG004|Overall Study|Lost to Follow-up|1|||
48401211|NCT01463098|155660241|FG010|Part A (11 Days)|Participant Choice|0|||
48791689|NCT00518115|157077118|FG005|Overall Study|Lost to Follow-up|3|||
48791690|NCT00518115|157077119|FG006|Overall Study|Lost to Follow-up|0|||
48791691|NCT00518115|157077120|FG007|Overall Study|Lost to Follow-up|1|||
48791692|NCT00518115|157077121|FG008|Overall Study|Lost to Follow-up|1|||
48791693|NCT00518115|157077122|FG009|Overall Study|Lost to Follow-up|1|||
48791694|NCT00518115|157077113|FG000|Overall Study|Protocol Violation|1|||
48791695|NCT00518115|157077114|FG001|Overall Study|Protocol Violation|3|||
48791696|NCT00518115|157077115|FG002|Overall Study|Protocol Violation|1|||
48791697|NCT00518115|157077116|FG003|Overall Study|Protocol Violation|0|||
48791698|NCT00518115|157077117|FG004|Overall Study|Protocol Violation|0|||
48791699|NCT00518115|157077118|FG005|Overall Study|Protocol Violation|0|||
48791700|NCT00518115|157077119|FG006|Overall Study|Protocol Violation|0|||
48791701|NCT00518115|157077120|FG007|Overall Study|Protocol Violation|0|||
48791702|NCT00518115|157077121|FG008|Overall Study|Protocol Violation|0|||
48791703|NCT00518115|157077122|FG009|Overall Study|Protocol Violation|0|||
48791704|NCT00518115|157077113|FG000|Overall Study|Withdrawal by Subject|1|||
48791705|NCT00518115|157077114|FG001|Overall Study|Withdrawal by Subject|1|||
48791706|NCT00518115|157077115|FG002|Overall Study|Withdrawal by Subject|5|||
48791707|NCT00518115|157077116|FG003|Overall Study|Withdrawal by Subject|0|||
48791708|NCT00518115|157077117|FG004|Overall Study|Withdrawal by Subject|2|||
48791709|NCT00518115|157077118|FG005|Overall Study|Withdrawal by Subject|1|||
48791710|NCT00518115|157077119|FG006|Overall Study|Withdrawal by Subject|0|||
48791711|NCT00518115|157077120|FG007|Overall Study|Withdrawal by Subject|2|||
48791712|NCT00518115|157077121|FG008|Overall Study|Withdrawal by Subject|1|||
48791713|NCT00518115|157077122|FG009|Overall Study|Withdrawal by Subject|3|||
48791714|NCT00518115|157077113|FG000|Overall Study|Lack of Efficacy|1|||
48791715|NCT00518115|157077114|FG001|Overall Study|Lack of Efficacy|0|||
48791716|NCT00518115|157077115|FG002|Overall Study|Lack of Efficacy|1|||
48791717|NCT00518115|157077116|FG003|Overall Study|Lack of Efficacy|1|||
48791718|NCT00518115|157077117|FG004|Overall Study|Lack of Efficacy|0|||
48791719|NCT00518115|157077118|FG005|Overall Study|Lack of Efficacy|0|||
48357029|NCT02270671|155503547|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
48791720|NCT00518115|157077119|FG006|Overall Study|Lack of Efficacy|0|||
48791721|NCT00518115|157077120|FG007|Overall Study|Lack of Efficacy|1|||
48791722|NCT00518115|157077121|FG008|Overall Study|Lack of Efficacy|0|||
48791723|NCT00518115|157077122|FG009|Overall Study|Lack of Efficacy|0|||
48791724|NCT00518115|157077113|FG000|Overall Study|Non-Compliance|1|||
48791725|NCT00518115|157077114|FG001|Overall Study|Non-Compliance|0|||
48791726|NCT00518115|157077115|FG002|Overall Study|Non-Compliance|1|||
48791727|NCT00518115|157077116|FG003|Overall Study|Non-Compliance|0|||
48791728|NCT00518115|157077117|FG004|Overall Study|Non-Compliance|1|||
48791729|NCT00518115|157077118|FG005|Overall Study|Non-Compliance|1|||
48791730|NCT00518115|157077119|FG006|Overall Study|Non-Compliance|1|||
48791731|NCT00518115|157077120|FG007|Overall Study|Non-Compliance|1|||
48791732|NCT00518115|157077121|FG008|Overall Study|Non-Compliance|0|||
48791733|NCT00518115|157077122|FG009|Overall Study|Non-Compliance|1|||
48791734|NCT00518115|157077113|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
48791735|NCT00518115|157077114|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
48791736|NCT00518115|157077115|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791737|NCT00518115|157077116|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791738|NCT00518115|157077117|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791739|NCT00518115|157077118|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
48791740|NCT00518115|157077119|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791741|NCT00518115|157077120|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791742|NCT00518115|157077121|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791743|NCT00518115|157077122|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
48791744|NCT00518115|157077113|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
48791745|NCT00518115|157077114|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791746|NCT00518115|157077115|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791747|NCT00518115|157077116|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791748|NCT00518115|157077117|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791749|NCT00518115|157077118|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791750|NCT00518115|157077119|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791751|NCT00518115|157077120|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791752|NCT00518115|157077121|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791753|NCT00518115|157077122|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
48791754|NCT00518115|157077113|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791755|NCT00518115|157077114|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791756|NCT00518115|157077115|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
48791757|NCT00518115|157077116|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791758|NCT00518115|157077117|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791759|NCT00518115|157077118|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791760|NCT00518115|157077119|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791761|NCT00518115|157077120|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791762|NCT00518115|157077121|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
48791763|NCT00518115|157077122|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
48791764|NCT00518115|157077113|FG000|Overall Study|Wrong Monotherapy Administered|0|||
48791765|NCT00518115|157077114|FG001|Overall Study|Wrong Monotherapy Administered|0|||
48791766|NCT00518115|157077115|FG002|Overall Study|Wrong Monotherapy Administered|1|||
48791767|NCT00518115|157077116|FG003|Overall Study|Wrong Monotherapy Administered|0|||
48791768|NCT00518115|157077117|FG004|Overall Study|Wrong Monotherapy Administered|0|||
48791769|NCT00518115|157077118|FG005|Overall Study|Wrong Monotherapy Administered|0|||
48791770|NCT00518115|157077119|FG006|Overall Study|Wrong Monotherapy Administered|1|||
48791771|NCT00518115|157077120|FG007|Overall Study|Wrong Monotherapy Administered|0|||
48791772|NCT00518115|157077121|FG008|Overall Study|Wrong Monotherapy Administered|0|||
48791773|NCT00518115|157077122|FG009|Overall Study|Wrong Monotherapy Administered|0|||
48791774|NCT00518115|157077113|FG000|Overall Study|Violation of Exclusion Criteria|0|||
48791775|NCT00518115|157077114|FG001|Overall Study|Violation of Exclusion Criteria|0|||
48791776|NCT00518115|157077115|FG002|Overall Study|Violation of Exclusion Criteria|0|||
48791777|NCT00518115|157077116|FG003|Overall Study|Violation of Exclusion Criteria|1|||
48791778|NCT00518115|157077117|FG004|Overall Study|Violation of Exclusion Criteria|0|||
48791779|NCT00518115|157077118|FG005|Overall Study|Violation of Exclusion Criteria|0|||
48791780|NCT00518115|157077119|FG006|Overall Study|Violation of Exclusion Criteria|1|||
48791781|NCT00518115|157077120|FG007|Overall Study|Violation of Exclusion Criteria|0|||
48791782|NCT00518115|157077121|FG008|Overall Study|Violation of Exclusion Criteria|0|||
48791783|NCT00518115|157077122|FG009|Overall Study|Violation of Exclusion Criteria|0|||
48791784|NCT00518115|157077113|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
48791785|NCT00518115|157077114|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
48791786|NCT00518115|157077115|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
48791787|NCT00518115|157077116|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
48791788|NCT00518115|157077117|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
48791789|NCT00518115|157077118|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
48791790|NCT00518115|157077119|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
48791791|NCT00518115|157077120|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
48791792|NCT00518115|157077121|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
48791793|NCT00518115|157077122|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
48791794|NCT00518115|157077113|FG000|Overall Study|Withdrew Consent|0|||
48791795|NCT00518115|157077114|FG001|Overall Study|Withdrew Consent|0|||
48791796|NCT00518115|157077115|FG002|Overall Study|Withdrew Consent|0|||
48791797|NCT00518115|157077116|FG003|Overall Study|Withdrew Consent|0|||
48791798|NCT00518115|157077117|FG004|Overall Study|Withdrew Consent|0|||
48791799|NCT00518115|157077118|FG005|Overall Study|Withdrew Consent|1|||
48791800|NCT00518115|157077119|FG006|Overall Study|Withdrew Consent|0|||
48791801|NCT00518115|157077120|FG007|Overall Study|Withdrew Consent|0|||
48791802|NCT00518115|157077121|FG008|Overall Study|Withdrew Consent|0|||
48791803|NCT00518115|157077122|FG009|Overall Study|Withdrew Consent|0|||
48791804|NCT00518115|157077113|FG000|Overall Study|Moved Out of State|0|||
48791805|NCT00518115|157077114|FG001|Overall Study|Moved Out of State|0|||
48791806|NCT00518115|157077115|FG002|Overall Study|Moved Out of State|0|||
48791807|NCT00518115|157077116|FG003|Overall Study|Moved Out of State|0|||
48791808|NCT00518115|157077117|FG004|Overall Study|Moved Out of State|0|||
48791809|NCT00518115|157077118|FG005|Overall Study|Moved Out of State|0|||
48791810|NCT00518115|157077119|FG006|Overall Study|Moved Out of State|0|||
48791811|NCT00518115|157077120|FG007|Overall Study|Moved Out of State|0|||
48791812|NCT00518115|157077121|FG008|Overall Study|Moved Out of State|0|||
48791813|NCT00518115|157077122|FG009|Overall Study|Moved Out of State|1|||
48791814|NCT00047879|157077123|FG000|Overall Study|Progressive disease|4|||
48791815|NCT00047879|157077124|FG001|Overall Study|Progressive disease|3|||
48791816|NCT02291614|157077125|FG000|Overall Study|Lost to Follow-up|0|||
48791817|NCT02291614|157077126|FG001|Overall Study|Lost to Follow-up|0|||
48791818|NCT02291614|157077127|FG002|Overall Study|Lost to Follow-up|0|||
48791819|NCT02291614|157077128|FG003|Overall Study|Lost to Follow-up|0|||
48791820|NCT02291614|157077129|FG004|Overall Study|Lost to Follow-up|0|||
48791821|NCT02291614|157077130|FG005|Overall Study|Lost to Follow-up|0|||
48791822|NCT02291614|157077131|FG006|Overall Study|Lost to Follow-up|0|||
48791823|NCT02291614|157077132|FG007|Overall Study|Lost to Follow-up|1|||
48791824|NCT02291614|157077133|FG008|Overall Study|Lost to Follow-up|0|||
48791825|NCT02291614|157077134|FG009|Overall Study|Lost to Follow-up|0|||
48791826|NCT02291614|157077135|FG010|Overall Study|Lost to Follow-up|0|||
48791827|NCT02291614|157077125|FG000|Overall Study|Withdrawal by Subject|0|||
48791828|NCT02291614|157077126|FG001|Overall Study|Withdrawal by Subject|1|||
48791829|NCT02291614|157077127|FG002|Overall Study|Withdrawal by Subject|0|||
48791830|NCT02291614|157077128|FG003|Overall Study|Withdrawal by Subject|0|||
48692358|NCT03982199|156722581|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
48692359|NCT00057863|156722582|FG000|Overall Study|Death|1|||
48692360|NCT00057863|156722582|FG000|Overall Study|Withdrawal by Subject|2|||
48692361|NCT02090426|156722583|FG000|Overall Study|Lost to Follow-up|12|||
48692362|NCT02090426|156722584|FG001|Overall Study|Lost to Follow-up|6|||
48692363|NCT00953667|156722589|FG000|Overall Study|Lost to Follow-up|11|||
48692364|NCT00953667|156722589|FG000|Overall Study|Physician Decision|35|||
48692365|NCT00953667|156722589|FG000|Overall Study|Withdrawal by Subject|63|||
48692366|NCT00953667|156722589|FG000|Overall Study|Adverse Event|10|||
48692367|NCT00953667|156722589|FG000|Overall Study|poor venous access,unable to draw blood|4|||
48692368|NCT00703014|156722590|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
48692369|NCT00703014|156722591|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
48692370|NCT00703014|156722592|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
48692371|NCT00703014|156722593|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
48692372|NCT00703014|156722590|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
48692373|NCT00703014|156722591|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
48692374|NCT00703014|156722592|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
48692375|NCT00703014|156722593|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
48692376|NCT04999839|156722594|FG000|Overall Study|Adverse Event|1|||
48692377|NCT04999839|156722595|FG001|Overall Study|Adverse Event|1|||
48692378|NCT04999839|156722596|FG002|Overall Study|Adverse Event|1|||
48692379|NCT04999839|156722597|FG003|Overall Study|Adverse Event|1|||
48692380|NCT04999839|156722598|FG004|Overall Study|Adverse Event|1|||
48692381|NCT04999839|156722594|FG000|Overall Study|Lost to Follow-up|2|||
48692382|NCT04999839|156722595|FG001|Overall Study|Lost to Follow-up|0|||
48692383|NCT04999839|156722596|FG002|Overall Study|Lost to Follow-up|2|||
48692384|NCT04999839|156722597|FG003|Overall Study|Lost to Follow-up|4|||
48692385|NCT04999839|156722598|FG004|Overall Study|Lost to Follow-up|1|||
48692386|NCT04999839|156722594|FG000|Overall Study|Withdrawal by Subject|6|||
48692387|NCT04999839|156722595|FG001|Overall Study|Withdrawal by Subject|5|||
48692388|NCT04999839|156722596|FG002|Overall Study|Withdrawal by Subject|3|||
48692389|NCT04999839|156722597|FG003|Overall Study|Withdrawal by Subject|2|||
48692390|NCT04999839|156722598|FG004|Overall Study|Withdrawal by Subject|2|||
48692391|NCT04999839|156722594|FG000|Overall Study|Lack of Efficacy|0|||
48692392|NCT04999839|156722595|FG001|Overall Study|Lack of Efficacy|1|||
48692393|NCT04999839|156722596|FG002|Overall Study|Lack of Efficacy|0|||
48692394|NCT04999839|156722597|FG003|Overall Study|Lack of Efficacy|0|||
48692395|NCT04999839|156722598|FG004|Overall Study|Lack of Efficacy|0|||
48692396|NCT04999839|156722594|FG000|Overall Study|Physician Decision|0|||
48692397|NCT04999839|156722595|FG001|Overall Study|Physician Decision|0|||
48692398|NCT04999839|156722596|FG002|Overall Study|Physician Decision|0|||
48692399|NCT04999839|156722597|FG003|Overall Study|Physician Decision|0|||
48692400|NCT04999839|156722598|FG004|Overall Study|Physician Decision|1|||
48692401|NCT04999839|156722594|FG000|Overall Study|Sponsor request|0|||
48692402|NCT04999839|156722595|FG001|Overall Study|Sponsor request|1|||
48692403|NCT04999839|156722596|FG002|Overall Study|Sponsor request|0|||
48692404|NCT04999839|156722597|FG003|Overall Study|Sponsor request|0|||
48692405|NCT04999839|156722598|FG004|Overall Study|Sponsor request|0|||
48692406|NCT04999839|156722594|FG000|Overall Study|Other|0|||
48692407|NCT04999839|156722595|FG001|Overall Study|Other|0|||
48692408|NCT04999839|156722596|FG002|Overall Study|Other|1|||
48791831|NCT02291614|157077129|FG004|Overall Study|Withdrawal by Subject|0|||
48357030|NCT02270671|155503548|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
48357031|NCT02270671|155503547|FG000|Overall Study|Lost to Follow-up|2|||
48791832|NCT02291614|157077130|FG005|Overall Study|Withdrawal by Subject|0|||
48791833|NCT02291614|157077131|FG006|Overall Study|Withdrawal by Subject|0|||
48791834|NCT02291614|157077132|FG007|Overall Study|Withdrawal by Subject|0|||
48791835|NCT02291614|157077133|FG008|Overall Study|Withdrawal by Subject|0|||
48791836|NCT02291614|157077134|FG009|Overall Study|Withdrawal by Subject|2|||
48791837|NCT02291614|157077135|FG010|Overall Study|Withdrawal by Subject|2|||
48791838|NCT02291614|157077125|FG000|Overall Study|Decision by sponsor|0|||
48791839|NCT02291614|157077126|FG001|Overall Study|Decision by sponsor|0|||
48791840|NCT02291614|157077127|FG002|Overall Study|Decision by sponsor|0|||
48791841|NCT02291614|157077128|FG003|Overall Study|Decision by sponsor|1|||
48791842|NCT02291614|157077129|FG004|Overall Study|Decision by sponsor|0|||
48791843|NCT02291614|157077130|FG005|Overall Study|Decision by sponsor|0|||
48791844|NCT02291614|157077131|FG006|Overall Study|Decision by sponsor|0|||
48791845|NCT02291614|157077132|FG007|Overall Study|Decision by sponsor|0|||
48791846|NCT02291614|157077133|FG008|Overall Study|Decision by sponsor|0|||
48791847|NCT02291614|157077134|FG009|Overall Study|Decision by sponsor|0|||
48791848|NCT02291614|157077135|FG010|Overall Study|Decision by sponsor|0|||
48791849|NCT02291614|157077125|FG000|Overall Study|Death|0|||
48791850|NCT02291614|157077126|FG001|Overall Study|Death|0|||
48791851|NCT02291614|157077127|FG002|Overall Study|Death|1|||
48791852|NCT02291614|157077128|FG003|Overall Study|Death|0|||
48791853|NCT02291614|157077129|FG004|Overall Study|Death|1|||
48791854|NCT02291614|157077130|FG005|Overall Study|Death|1|||
48791855|NCT02291614|157077131|FG006|Overall Study|Death|1|||
48692409|NCT04999839|156722597|FG003|Overall Study|Other|0|||
48357032|NCT02270671|155503548|FG001|Overall Study|Lost to Follow-up|1|||
48357033|NCT02563548|155503549|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
48692410|NCT04999839|156722598|FG004|Overall Study|Other|0|||
48692411|NCT00982735|156722601|FG000|Overall Study|Lost to Follow-up|6|||
48692412|NCT00982735|156722601|FG000|Overall Study|Patient ineligible for trial|224|||
48692413|NCT00292942|156722603|FG000|Overall Study|Withdrawal by Subject|0|||
48692414|NCT00292942|156722604|FG001|Overall Study|Withdrawal by Subject|0|||
48692415|NCT00292942|156722605|FG002|Overall Study|Withdrawal by Subject|1|||
48692416|NCT00292942|156722606|FG003|Overall Study|Withdrawal by Subject|0|||
48692417|NCT00292942|156722603|FG000|Overall Study|Adverse Event|0|||
48692418|NCT00292942|156722604|FG001|Overall Study|Adverse Event|0|||
48692419|NCT00292942|156722605|FG002|Overall Study|Adverse Event|0|||
48692420|NCT00292942|156722606|FG003|Overall Study|Adverse Event|1|||
48692421|NCT00112736|156722612|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
48692422|NCT00112736|156722613|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
48692423|NCT02021565|156722614|FG000|Baseline Through Intervention|Death|0|||
48692424|NCT02021565|156722615|FG001|Baseline Through Intervention|Death|1|||
48692425|NCT02021565|156722614|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
48692426|NCT02021565|156722615|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
48692427|NCT02021565|156722614|FG000|Baseline Through Intervention|Protocol Violation|0|||
48692428|NCT02021565|156722615|FG001|Baseline Through Intervention|Protocol Violation|7|||
48692429|NCT02021565|156722614|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
48692430|NCT02021565|156722615|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
48692431|NCT02021565|156722614|FG000|3-month Follow-up|Death|3|||
48692432|NCT02021565|156722615|FG001|3-month Follow-up|Death|0|||
48692433|NCT02021565|156722614|FG000|3-month Follow-up|Withdrawal by Subject|4|||
48692434|NCT02021565|156722615|FG001|3-month Follow-up|Withdrawal by Subject|0|||
48692435|NCT02021565|156722614|FG000|3-month Follow-up|Protocol Violation|3|||
48692436|NCT02021565|156722615|FG001|3-month Follow-up|Protocol Violation|2|||
48692437|NCT02735239|156724492|FG000|Overall Study|Adverse Event|0|||
48692438|NCT02735239|156724493|FG001|Overall Study|Adverse Event|0|||
48692439|NCT02735239|156724494|FG002|Overall Study|Adverse Event|4|||
48692440|NCT02735239|156724495|FG003|Overall Study|Adverse Event|0|||
48692441|NCT02735239|156724496|FG004|Overall Study|Adverse Event|0|||
48692442|NCT02735239|156724497|FG005|Overall Study|Adverse Event|0|||
48692443|NCT02735239|156724492|FG000|Overall Study|Death|1|||
48692444|NCT02735239|156724493|FG001|Overall Study|Death|1|||
48692445|NCT02735239|156724494|FG002|Overall Study|Death|0|||
48692446|NCT02735239|156724495|FG003|Overall Study|Death|0|||
48692447|NCT02735239|156724496|FG004|Overall Study|Death|0|||
48692448|NCT02735239|156724497|FG005|Overall Study|Death|0|||
48692449|NCT02735239|156724492|FG000|Overall Study|Physician Decision|0|||
48692450|NCT02735239|156724493|FG001|Overall Study|Physician Decision|0|||
48692451|NCT02735239|156724494|FG002|Overall Study|Physician Decision|1|||
48692452|NCT02735239|156724495|FG003|Overall Study|Physician Decision|0|||
48692453|NCT02735239|156724496|FG004|Overall Study|Physician Decision|0|||
48692454|NCT02735239|156724497|FG005|Overall Study|Physician Decision|0|||
48692455|NCT02735239|156724492|FG000|Overall Study|Progressive disease|3|||
48692456|NCT02735239|156724493|FG001|Overall Study|Progressive disease|1|||
48692457|NCT02735239|156724494|FG002|Overall Study|Progressive disease|3|||
48692458|NCT02735239|156724495|FG003|Overall Study|Progressive disease|0|||
48692459|NCT02735239|156724496|FG004|Overall Study|Progressive disease|0|||
48692460|NCT02735239|156724497|FG005|Overall Study|Progressive disease|2|||
48692461|NCT02735239|156724492|FG000|Overall Study|Withdrawal by Subject|0|||
48692462|NCT02735239|156724493|FG001|Overall Study|Withdrawal by Subject|1|||
48692463|NCT02735239|156724494|FG002|Overall Study|Withdrawal by Subject|0|||
48692464|NCT02735239|156724495|FG003|Overall Study|Withdrawal by Subject|0|||
48692465|NCT02735239|156724496|FG004|Overall Study|Withdrawal by Subject|0|||
48692466|NCT02735239|156724497|FG005|Overall Study|Withdrawal by Subject|0|||
48692467|NCT03287791|156724500|FG000|Overall Study|Insufficient Therapeutic Response|0|||
48692468|NCT03287791|156724501|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48692469|NCT03287791|156724502|FG002|Overall Study|Insufficient Therapeutic Response|1|||
48692470|NCT03287791|156724500|FG000|Overall Study|Adverse Event|0|||
48692471|NCT03287791|156724501|FG001|Overall Study|Adverse Event|4|||
48692472|NCT03287791|156724502|FG002|Overall Study|Adverse Event|3|||
48692473|NCT03287791|156724500|FG000|Overall Study|Withdrawal by Subject|12|||
48692474|NCT03287791|156724501|FG001|Overall Study|Withdrawal by Subject|12|||
48692475|NCT03287791|156724502|FG002|Overall Study|Withdrawal by Subject|17|||
48692476|NCT03287791|156724500|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
48692477|NCT03287791|156724501|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
48692478|NCT03287791|156724502|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
48692479|NCT03287791|156724500|FG000|Overall Study|Lost to Follow-up|8|||
48692480|NCT03287791|156724501|FG001|Overall Study|Lost to Follow-up|14|||
48692481|NCT03287791|156724502|FG002|Overall Study|Lost to Follow-up|11|||
48791856|NCT02291614|157077132|FG007|Overall Study|Death|0|||
48791857|NCT02291614|157077133|FG008|Overall Study|Death|0|||
48791858|NCT02291614|157077134|FG009|Overall Study|Death|0|||
48791859|NCT02291614|157077135|FG010|Overall Study|Death|0|||
48791860|NCT03298451|157077137|FG000|Overall Study|Death|275|||
48791861|NCT03298451|157077138|FG001|Overall Study|Death|260|||
48791862|NCT03298451|157077139|FG002|Overall Study|Death|122|||
48791863|NCT03298451|157077140|FG003|Overall Study|Death|280|||
48791864|NCT03298451|157077137|FG000|Overall Study|Lost to Follow-up|1|||
48791865|NCT03298451|157077138|FG001|Overall Study|Lost to Follow-up|1|||
48791866|NCT03298451|157077139|FG002|Overall Study|Lost to Follow-up|0|||
48791867|NCT03298451|157077140|FG003|Overall Study|Lost to Follow-up|7|||
48791868|NCT03298451|157077137|FG000|Overall Study|Withdrawal by Subject|9|||
48791869|NCT03298451|157077138|FG001|Overall Study|Withdrawal by Subject|7|||
48791870|NCT03298451|157077139|FG002|Overall Study|Withdrawal by Subject|1|||
48791871|NCT03298451|157077140|FG003|Overall Study|Withdrawal by Subject|20|||
48791872|NCT01565707|157077141|FG000|Overall Study|Adverse Event|1|||
48791873|NCT01565707|157077142|FG001|Overall Study|Adverse Event|6|||
48791874|NCT01565707|157077143|FG002|Overall Study|Adverse Event|2|||
48357034|NCT02563548|155503550|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
48357035|NCT02563548|155503551|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
48791875|NCT01565707|157077144|FG003|Overall Study|Adverse Event|1|||
48791876|NCT01565707|157077141|FG000|Overall Study|Lost to Follow-up|1|||
48791877|NCT01565707|157077142|FG001|Overall Study|Lost to Follow-up|0|||
48791878|NCT01565707|157077143|FG002|Overall Study|Lost to Follow-up|0|||
48791879|NCT01565707|157077144|FG003|Overall Study|Lost to Follow-up|0|||
48791880|NCT01565707|157077141|FG000|Overall Study|Protocol Violation|1|||
48791881|NCT01565707|157077142|FG001|Overall Study|Protocol Violation|0|||
48791882|NCT01565707|157077143|FG002|Overall Study|Protocol Violation|0|||
48791883|NCT01565707|157077144|FG003|Overall Study|Protocol Violation|1|||
48791884|NCT01565707|157077141|FG000|Overall Study|Withdrawal by Subject|3|||
48791885|NCT01565707|157077142|FG001|Overall Study|Withdrawal by Subject|1|||
48791886|NCT01565707|157077143|FG002|Overall Study|Withdrawal by Subject|1|||
48791887|NCT01565707|157077144|FG003|Overall Study|Withdrawal by Subject|1|||
48791888|NCT01565707|157077141|FG000|Overall Study|Randomized but not evaluable|2|||
48791889|NCT01565707|157077142|FG001|Overall Study|Randomized but not evaluable|0|||
48791890|NCT01565707|157077143|FG002|Overall Study|Randomized but not evaluable|0|||
48791891|NCT01565707|157077144|FG003|Overall Study|Randomized but not evaluable|0|||
48791892|NCT01565707|157077141|FG000|Overall Study|Miscellaneous|1|||
48791893|NCT01565707|157077142|FG001|Overall Study|Miscellaneous|1|||
48791894|NCT01565707|157077143|FG002|Overall Study|Miscellaneous|0|||
48791895|NCT01565707|157077144|FG003|Overall Study|Miscellaneous|2|||
48791896|NCT02298192|157077154|FG000|Overall Study|Unclassified|3|||
48791897|NCT02298192|157077155|FG001|Overall Study|Unclassified|2|||
48791898|NCT02298192|157077154|FG000|Overall Study|Withdrawal criteria|2|||
48791899|NCT02298192|157077155|FG001|Overall Study|Withdrawal criteria|0|||
48791900|NCT02298192|157077154|FG000|Overall Study|Withdrawal by Subject|6|||
48791901|NCT02298192|157077155|FG001|Overall Study|Withdrawal by Subject|1|||
48791902|NCT02298192|157077154|FG000|Overall Study|Lost to Follow-up|2|||
48791903|NCT02298192|157077155|FG001|Overall Study|Lost to Follow-up|1|||
48791904|NCT02298192|157077154|FG000|Overall Study|Adverse Event|6|||
48791905|NCT02298192|157077155|FG001|Overall Study|Adverse Event|2|||
48791906|NCT00374322|157077156|FG000|Overall Study|Lost to Follow-up|92|||
48791907|NCT00374322|157077157|FG001|Overall Study|Lost to Follow-up|90|||
48791908|NCT00374322|157077156|FG000|Overall Study|Protocol Violation|8|||
48791909|NCT00374322|157077157|FG001|Overall Study|Protocol Violation|3|||
48791910|NCT00374322|157077156|FG000|Overall Study|Withdrawal by Subject|235|||
48791911|NCT00374322|157077157|FG001|Overall Study|Withdrawal by Subject|167|||
48791912|NCT00374322|157077156|FG000|Overall Study|Sponsor Terminated Study|866|||
48791913|NCT00374322|157077157|FG001|Overall Study|Sponsor Terminated Study|990|||
48791914|NCT00374322|157077156|FG000|Overall Study|Physician Decision|36|||
48791915|NCT00374322|157077157|FG001|Overall Study|Physician Decision|32|||
48791916|NCT00374322|157077156|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
48791917|NCT00374322|157077157|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
48791918|NCT00374322|157077156|FG000|Overall Study|Sponsor Decision|2|||
48791919|NCT00374322|157077157|FG001|Overall Study|Sponsor Decision|3|||
48791920|NCT00374322|157077156|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
48791921|NCT00374322|157077157|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
48791922|NCT00374322|157077156|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
48791923|NCT00374322|157077157|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
48791924|NCT00374322|157077156|FG000|Overall Study|Severe Toxicity|1|||
48791925|NCT00374322|157077157|FG001|Overall Study|Severe Toxicity|0|||
48430354|NCT00696657|155763708|FG008|Overall Study|Withdrawal criteria|2|||
48791926|NCT00374322|157077156|FG000|Overall Study|Site Closed|2|||
48791927|NCT00374322|157077157|FG001|Overall Study|Site Closed|2|||
48791928|NCT00374322|157077156|FG000|Overall Study|Participant Changed Physician|1|||
48791929|NCT00374322|157077157|FG001|Overall Study|Participant Changed Physician|0|||
48791930|NCT00374322|157077156|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
48401212|NCT01463098|155660242|FG011|Part A (11 Days)|Participant Choice|0|||
48401213|NCT01463098|155660243|FG012|Part A (11 Days)|Participant Choice|0|||
48401214|NCT01463098|155660244|FG013|Part A (11 Days)|Participant Choice|0|||
48791931|NCT00374322|157077157|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
48791932|NCT00374322|157077156|FG000|Overall Study|Noncompliance with Study Requirements|0|||
48791933|NCT00374322|157077157|FG001|Overall Study|Noncompliance with Study Requirements|1|||
48791934|NCT00374322|157077156|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
48791935|NCT00374322|157077157|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
48791936|NCT00374322|157077156|FG000|Overall Study|Did Not Receive Study Medication|8|||
48791937|NCT00374322|157077157|FG001|Overall Study|Did Not Receive Study Medication|6|||
48791938|NCT01178086|157077158|FG000|Overall Study|Participant refusal|7|||
48791939|NCT01178086|157077158|FG000|Overall Study|Physician Decision|44|||
48791940|NCT01178086|157077158|FG000|Overall Study|Switch to other CLL therapy|113|||
48791941|NCT01178086|157077158|FG000|Overall Study|Death|59|||
48791942|NCT01178086|157077158|FG000|Overall Study|Other unspecified|89|||
48791943|NCT01178086|157077158|FG000|Overall Study|Excluded from EAS|20|||
48791944|NCT00058123|157077161|FG000|Overall Study|Wrong histology|9|||
48791945|NCT00058123|157077161|FG000|Overall Study|Received >3 prior treatments|1|||
48791946|NCT00234065|157077169|FG000|Overall Study|Adverse Event|268|||
48791947|NCT00234065|157077170|FG001|Overall Study|Adverse Event|166|||
48791948|NCT00234065|157077169|FG000|Overall Study|Withdrawal by Subject|73|||
48791949|NCT00234065|157077170|FG001|Overall Study|Withdrawal by Subject|56|||
48791950|NCT00234065|157077169|FG000|Overall Study|Physician Decision|23|||
48791951|NCT00234065|157077170|FG001|Overall Study|Physician Decision|22|||
48791952|NCT00234065|157077169|FG000|Overall Study|Not Classified|111|||
48791953|NCT00234065|157077170|FG001|Overall Study|Not Classified|112|||
48791954|NCT00126438|157077171|FG000|Overall Study|Withdrawal due to adverse event|1|||
48791955|NCT00126438|157077172|FG001|Overall Study|Withdrawal due to adverse event|0|||
48791956|NCT00126438|157077171|FG000|Overall Study|Lost to Follow-up|22|||
48791957|NCT00126438|157077172|FG001|Overall Study|Lost to Follow-up|0|||
48401215|NCT01463098|155660231|FG000|Part A (11 Days)|Lost to Follow-up|0|||
48791958|NCT00126438|157077171|FG000|Overall Study|Protocol Violation|8|||
48791959|NCT00126438|157077172|FG001|Overall Study|Protocol Violation|8|||
48791960|NCT00126438|157077171|FG000|Overall Study|Withdrawal by Subject|3|||
48791961|NCT00126438|157077172|FG001|Overall Study|Withdrawal by Subject|2|||
48791962|NCT05374421|157077173|FG000|Overall Study|Withdrawal by Subject|3|||
48791963|NCT05374421|157077174|FG001|Overall Study|Withdrawal by Subject|4|||
48791964|NCT02477618|157077185|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
48791965|NCT02477618|157077186|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
48791966|NCT02477618|157077185|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
48791967|NCT02477618|157077186|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
48791968|NCT02477618|157077185|FG000|Overall Study|Adverse Event|1|||
48791969|NCT02477618|157077186|FG001|Overall Study|Adverse Event|1|||
48791970|NCT02477618|157077185|FG000|Overall Study|Transferred Away from Study Site|1|||
48791971|NCT02477618|157077186|FG001|Overall Study|Transferred Away from Study Site|0|||
48791972|NCT02477618|157077185|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
48791973|NCT02477618|157077186|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
48791974|NCT03053050|157077189|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
48791975|NCT03053050|157077190|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
48791976|NCT03053050|157077191|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
48791977|NCT03053050|157077192|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
48791978|NCT03053050|157077189|FG000|Randomized Phase|Withdrew Consent|16|||
48791979|NCT03053050|157077190|FG001|Randomized Phase|Withdrew Consent|8|||
48791980|NCT03053050|157077191|FG002|Randomized Phase|Withdrew Consent|9|||
48791981|NCT03053050|157077192|FG003|Randomized Phase|Withdrew Consent|0|||
48791982|NCT03053050|157077189|FG000|Randomized Phase|Investigator's Discretion|6|||
48791983|NCT03053050|157077190|FG001|Randomized Phase|Investigator's Discretion|6|||
48791984|NCT03053050|157077191|FG002|Randomized Phase|Investigator's Discretion|3|||
48791985|NCT03053050|157077192|FG003|Randomized Phase|Investigator's Discretion|0|||
48791986|NCT03053050|157077189|FG000|Randomized Phase|Lost to Follow-up|5|||
48791987|NCT03053050|157077190|FG001|Randomized Phase|Lost to Follow-up|1|||
48401216|NCT01463098|155660232|FG001|Part A (11 Days)|Lost to Follow-up|0|||
48401217|NCT01463098|155660233|FG002|Part A (11 Days)|Lost to Follow-up|0|||
48401218|NCT01463098|155660234|FG003|Part A (11 Days)|Lost to Follow-up|0|||
48791988|NCT03053050|157077191|FG002|Randomized Phase|Lost to Follow-up|1|||
48791989|NCT03053050|157077192|FG003|Randomized Phase|Lost to Follow-up|0|||
48791990|NCT03053050|157077189|FG000|Randomized Phase|Adverse Event|0|||
48791991|NCT03053050|157077190|FG001|Randomized Phase|Adverse Event|1|||
48791992|NCT03053050|157077191|FG002|Randomized Phase|Adverse Event|0|||
48791993|NCT03053050|157077192|FG003|Randomized Phase|Adverse Event|0|||
48791994|NCT03053050|157077189|FG000|Randomized Phase|Randomized but Never Treated|2|||
48791995|NCT03053050|157077190|FG001|Randomized Phase|Randomized but Never Treated|2|||
48791996|NCT03053050|157077191|FG002|Randomized Phase|Randomized but Never Treated|2|||
48401219|NCT01463098|155660235|FG004|Part A (11 Days)|Lost to Follow-up|1|||
48401220|NCT01463098|155660236|FG005|Part A (11 Days)|Lost to Follow-up|0|||
48401221|NCT01463098|155660237|FG006|Part A (11 Days)|Lost to Follow-up|0|||
48791997|NCT03053050|157077192|FG003|Randomized Phase|Randomized but Never Treated|0|||
48791998|NCT03053050|157077189|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
48791999|NCT03053050|157077190|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
48792000|NCT03053050|157077191|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
48792001|NCT03053050|157077192|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
48792002|NCT03053050|157077189|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
48792003|NCT03053050|157077190|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
48792004|NCT03053050|157077191|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
48792005|NCT03053050|157077192|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
48792006|NCT03053050|157077189|FG000|Open-label Phase|Withdrew Consent|0|||
48792007|NCT03053050|157077190|FG001|Open-label Phase|Withdrew Consent|0|||
48792008|NCT03053050|157077191|FG002|Open-label Phase|Withdrew Consent|0|||
48792009|NCT03053050|157077192|FG003|Open-label Phase|Withdrew Consent|6|||
48792010|NCT03053050|157077189|FG000|Open-label Phase|Investigator's Discretion|0|||
48792011|NCT03053050|157077190|FG001|Open-label Phase|Investigator's Discretion|0|||
48792012|NCT03053050|157077191|FG002|Open-label Phase|Investigator's Discretion|0|||
48792013|NCT03053050|157077192|FG003|Open-label Phase|Investigator's Discretion|4|||
48792014|NCT05239039|157077193|FG000|Overall Study|Withdrawal by Subject|0|||
48792015|NCT05239039|157077194|FG001|Overall Study|Withdrawal by Subject|1|||
48792016|NCT02492100|157079178|FG000|Overall Study|Death|1|||
48792017|NCT05706506|157079179|FG000|Overall Study|Adverse Event|1|||
48792018|NCT05706506|157079179|FG000|Overall Study|Withdrawal by Subject|4|||
48792019|NCT05706506|157079179|FG000|Overall Study|Lost to Follow-up|2|||
48792020|NCT05706506|157079179|FG000|Overall Study|Inadvertent Enrolment|12|||
48792021|NCT05706506|157079179|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
48792022|NCT05706506|157079179|FG000|Overall Study|Participant Moved Out of State|1|||
48792023|NCT03656562|157079180|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
48792024|NCT03656562|157079181|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
48792025|NCT03656562|157079182|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
48792026|NCT03656562|157079183|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
48792027|NCT03656562|157079180|FG000|Overall Study|Physician Decision|1|||
48792028|NCT03656562|157079181|FG001|Overall Study|Physician Decision|2|||
48792029|NCT03656562|157079182|FG002|Overall Study|Physician Decision|0|||
48792030|NCT03656562|157079183|FG003|Overall Study|Physician Decision|0|||
48792031|NCT03656562|157079180|FG000|Overall Study|Subject Decision|3|||
48792032|NCT03656562|157079181|FG001|Overall Study|Subject Decision|5|||
48792033|NCT03656562|157079182|FG002|Overall Study|Subject Decision|0|||
48792034|NCT03656562|157079183|FG003|Overall Study|Subject Decision|2|||
48792035|NCT02473250|157079184|FG000|Overall Study|Lost to Follow-up|10|||
48792036|NCT02473250|157079184|FG000|Overall Study|Physician Decision|5|||
48792037|NCT02473250|157079184|FG000|Overall Study|Did not tolerate medication washout|3|||
48792038|NCT02473250|157079184|FG000|Overall Study|Antidepressant effect of divalproex|2|||
48792039|NCT03575052|157079185|FG000|Overall Study|Adverse Event|6|||
48792040|NCT03575052|157079186|FG001|Overall Study|Adverse Event|10|||
48792041|NCT03575052|157079185|FG000|Overall Study|Not further specified|5|||
48792042|NCT03575052|157079186|FG001|Overall Study|Not further specified|7|||
48792043|NCT03575052|157079185|FG000|Overall Study|Withdrawal by Subject|5|||
48792044|NCT03575052|157079186|FG001|Overall Study|Withdrawal by Subject|6|||
48792045|NCT03575052|157079185|FG000|Overall Study|Lost to Follow-up|3|||
48792046|NCT03575052|157079186|FG001|Overall Study|Lost to Follow-up|0|||
48792047|NCT03575052|157079185|FG000|Overall Study|Death|2|||
48792048|NCT03575052|157079186|FG001|Overall Study|Death|1|||
48792049|NCT03575052|157079185|FG000|Overall Study|Lack of Efficacy|2|||
48792050|NCT03575052|157079186|FG001|Overall Study|Lack of Efficacy|1|||
48792051|NCT03575052|157079185|FG000|Overall Study|Study drug noncompliance|1|||
48792052|NCT03575052|157079186|FG001|Overall Study|Study drug noncompliance|2|||
48792053|NCT03575052|157079185|FG000|Overall Study|Protocol Violation|0|||
48792054|NCT03575052|157079186|FG001|Overall Study|Protocol Violation|2|||
48792055|NCT03575052|157079185|FG000|Overall Study|Physician Decision|1|||
48792056|NCT03575052|157079186|FG001|Overall Study|Physician Decision|0|||
48792057|NCT03822533|157079188|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
48792058|NCT03822533|157079189|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
48792059|NCT03822533|157079188|FG000|3 Month Follow-up|Lost to Follow-up|2|||
48792060|NCT03822533|157079189|FG001|3 Month Follow-up|Lost to Follow-up|2|||
48792061|NCT03822533|157079188|FG000|6 Month Follow-up|Lost to Follow-up|3|||
48792062|NCT03822533|157079189|FG001|6 Month Follow-up|Lost to Follow-up|0|||
48792063|NCT03822533|157079188|FG000|12 Month Follow-up|Lost to Follow-up|2|||
48792064|NCT03822533|157079189|FG001|12 Month Follow-up|Lost to Follow-up|3|||
48792065|NCT03822533|157079188|FG000|12 Month Follow-up|Pregnancy|0|||
48792066|NCT03822533|157079189|FG001|12 Month Follow-up|Pregnancy|1|||
48792067|NCT03822533|157079188|FG000|12 Month Follow-up|Surgery|2|||
48792068|NCT03822533|157079189|FG001|12 Month Follow-up|Surgery|0|||
48792069|NCT03822533|157079188|FG000|12 Month Follow-up|Wrong address|1|||
48401222|NCT01463098|155660238|FG007|Part A (11 Days)|Lost to Follow-up|0|||
48401223|NCT01463098|155660239|FG008|Part A (11 Days)|Lost to Follow-up|0|||
48401224|NCT01463098|155660240|FG009|Part A (11 Days)|Lost to Follow-up|0|||
48401225|NCT01463098|155660241|FG010|Part A (11 Days)|Lost to Follow-up|0|||
48401226|NCT01463098|155660242|FG011|Part A (11 Days)|Lost to Follow-up|0|||
48401227|NCT01463098|155660243|FG012|Part A (11 Days)|Lost to Follow-up|0|||
48401228|NCT01463098|155660244|FG013|Part A (11 Days)|Lost to Follow-up|0|||
48401229|NCT01463098|155660231|FG000|Part B (11 Days)|Participant Choice|0|||
48401230|NCT01463098|155660232|FG001|Part B (11 Days)|Participant Choice|0|||
48792070|NCT03822533|157079189|FG001|12 Month Follow-up|Wrong address|0|||
48792071|NCT03822533|157079188|FG000|12 Month Follow-up|No symptoms|1|||
48792072|NCT03822533|157079189|FG001|12 Month Follow-up|No symptoms|0|||
48792073|NCT03822533|157079188|FG000|12 Month Follow-up|Changed primary care center|0|||
48792074|NCT03822533|157079189|FG001|12 Month Follow-up|Changed primary care center|1|||
48792075|NCT01990950|157079192|FG000|Overall Study|Death|3|||
48792076|NCT01990950|157079192|FG000|Overall Study|Lost to Follow-up|2|||
48792077|NCT01990950|157079192|FG000|Overall Study|Withdrawal by Subject|6|||
48792078|NCT03484702|157079193|FG000|Treatment Period|Death|3|||
48792079|NCT03484702|157079194|FG001|Treatment Period|Death|1|||
48792080|NCT03484702|157079195|FG002|Treatment Period|Death|0|||
48792081|NCT03484702|157079196|FG003|Treatment Period|Death|0|||
48792082|NCT03484702|157079197|FG004|Treatment Period|Death|0|||
48792083|NCT03484702|157079198|FG005|Treatment Period|Death|0|||
48792084|NCT03484702|157079193|FG000|Treatment Period|Adverse Event|1|||
48792085|NCT03484702|157079194|FG001|Treatment Period|Adverse Event|0|||
48792086|NCT03484702|157079195|FG002|Treatment Period|Adverse Event|0|||
48792087|NCT03484702|157079196|FG003|Treatment Period|Adverse Event|0|||
48792088|NCT03484702|157079197|FG004|Treatment Period|Adverse Event|0|||
48792089|NCT03484702|157079198|FG005|Treatment Period|Adverse Event|0|||
48792090|NCT03484702|157079193|FG000|Treatment Period|Participant Withdrew from Study|0|||
48792091|NCT03484702|157079194|FG001|Treatment Period|Participant Withdrew from Study|1|||
48792092|NCT03484702|157079195|FG002|Treatment Period|Participant Withdrew from Study|0|||
48792093|NCT03484702|157079196|FG003|Treatment Period|Participant Withdrew from Study|0|||
48792094|NCT03484702|157079197|FG004|Treatment Period|Participant Withdrew from Study|0|||
48792095|NCT03484702|157079198|FG005|Treatment Period|Participant Withdrew from Study|0|||
48792096|NCT03484702|157079193|FG000|Treatment Period|Physician Decision|0|||
48792097|NCT03484702|157079194|FG001|Treatment Period|Physician Decision|1|||
48792098|NCT03484702|157079195|FG002|Treatment Period|Physician Decision|0|||
48792099|NCT03484702|157079196|FG003|Treatment Period|Physician Decision|0|||
48792100|NCT03484702|157079197|FG004|Treatment Period|Physician Decision|0|||
48792101|NCT03484702|157079198|FG005|Treatment Period|Physician Decision|1|||
48792102|NCT01830595|157079201|FG000|First Period|Withdrawal by Subject|1|||
48792103|NCT01830595|157079202|FG001|First Period|Withdrawal by Subject|3|||
48792104|NCT01830595|157079201|FG000|Washout|Withdrawal by Subject|2|||
48792105|NCT01830595|157079202|FG001|Washout|Withdrawal by Subject|2|||
48792106|NCT04154956|157079205|FG000|Overall Study|Death|109|||
48792107|NCT04154956|157079206|FG001|Overall Study|Death|110|||
48792108|NCT04154956|157079205|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
48792109|NCT04154956|157079206|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
48792110|NCT04154956|157079205|FG000|Overall Study|Withdrawal by Subject|1|||
48792111|NCT04154956|157079206|FG001|Overall Study|Withdrawal by Subject|7|||
48792112|NCT04154956|157079205|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
48792113|NCT04154956|157079206|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
48792114|NCT05374837|157079207|FG000|Overall Study|Lost to Follow-up|17|||
48792115|NCT05374837|157079208|FG001|Overall Study|Lost to Follow-up|18|||
48792116|NCT00676715|157079209|FG000|Treatment Period (TP)|Adverse Event|0|||
48792117|NCT00676715|157079210|FG001|Treatment Period (TP)|Adverse Event|3|||
48792118|NCT00676715|157079211|FG002|Treatment Period (TP)|Adverse Event|2|||
48792119|NCT00676715|157079212|FG003|Treatment Period (TP)|Adverse Event|2|||
48792120|NCT00676715|157079209|FG000|Treatment Period (TP)|Death|0|||
48792121|NCT00676715|157079210|FG001|Treatment Period (TP)|Death|0|||
48792122|NCT00676715|157079211|FG002|Treatment Period (TP)|Death|1|||
48792123|NCT00676715|157079212|FG003|Treatment Period (TP)|Death|0|||
48792124|NCT00676715|157079209|FG000|Treatment Period (TP)|Failure to return|1|||
48792125|NCT00676715|157079210|FG001|Treatment Period (TP)|Failure to return|0|||
48792126|NCT00676715|157079211|FG002|Treatment Period (TP)|Failure to return|0|||
48792127|NCT00676715|157079212|FG003|Treatment Period (TP)|Failure to return|0|||
48792128|NCT00676715|157079209|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
48401231|NCT01463098|155660233|FG002|Part B (11 Days)|Participant Choice|0|||
48401232|NCT01463098|155660234|FG003|Part B (11 Days)|Participant Choice|0|||
48792129|NCT00676715|157079210|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
48792130|NCT00676715|157079211|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
48792131|NCT00676715|157079212|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
48792132|NCT00676715|157079209|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
48792133|NCT00676715|157079210|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
48792134|NCT00676715|157079211|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
48792135|NCT00676715|157079212|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
48792136|NCT00676715|157079209|FG000|Treatment Period (TP)|Withdrew consent|3|||
48792137|NCT00676715|157079210|FG001|Treatment Period (TP)|Withdrew consent|3|||
48792138|NCT00676715|157079211|FG002|Treatment Period (TP)|Withdrew consent|3|||
48792139|NCT00676715|157079212|FG003|Treatment Period (TP)|Withdrew consent|3|||
48792140|NCT00676715|157079209|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
48792141|NCT00676715|157079210|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
48792142|NCT00676715|157079211|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
48792143|NCT00676715|157079212|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
48792144|NCT00676715|157079209|FG000|Treatment Period (TP)|Administrative|0|||
48792145|NCT00676715|157079210|FG001|Treatment Period (TP)|Administrative|0|||
48792146|NCT00676715|157079211|FG002|Treatment Period (TP)|Administrative|0|||
48792147|NCT00676715|157079212|FG003|Treatment Period (TP)|Administrative|1|||
48792148|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
48792149|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
48792150|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
48792151|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
48792152|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
48792153|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
48792154|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
48792155|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
48792156|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
48792157|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
48792158|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
48792159|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
48792160|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
48792161|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
48792162|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
48792163|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
48792164|NCT00676715|157079209|FG000|Treatment-free Period (TFP)|Death|1|||
48792165|NCT00676715|157079210|FG001|Treatment-free Period (TFP)|Death|1|||
48792166|NCT00676715|157079211|FG002|Treatment-free Period (TFP)|Death|1|||
48792167|NCT00676715|157079212|FG003|Treatment-free Period (TFP)|Death|0|||
48792168|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Reason not provided|3|||
48792169|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Reason not provided|4|||
48792170|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Reason not provided|1|||
48792171|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Reason not provided|4|||
48792172|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
48792173|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
48792174|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
48792175|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
48792176|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
48792177|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
48792178|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
48792179|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
48792180|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Adverse Event|0|||
48792181|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Adverse Event|3|||
48792182|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Adverse Event|1|||
48792183|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Adverse Event|0|||
48792184|NCT00676715|157079209|FG000|Open Label Extension (OLE)|Death|2|||
48792185|NCT00676715|157079210|FG001|Open Label Extension (OLE)|Death|0|||
48792186|NCT00676715|157079211|FG002|Open Label Extension (OLE)|Death|2|||
48792187|NCT00676715|157079212|FG003|Open Label Extension (OLE)|Death|2|||
48792188|NCT02506153|157079213|FG000|Overall Study|Adverse Event|359|||
48792189|NCT02506153|157079214|FG001|Overall Study|Adverse Event|114|||
48792190|NCT02506153|157079213|FG000|Overall Study|Refused unrelated to adverse event|127|||
48792191|NCT02506153|157079214|FG001|Overall Study|Refused unrelated to adverse event|18|||
48792192|NCT02506153|157079213|FG000|Overall Study|Progression/relapse|91|||
48792193|NCT02506153|157079214|FG001|Overall Study|Progression/relapse|136|||
48792194|NCT02506153|157079213|FG000|Overall Study|Death|2|||
48792195|NCT02506153|157079214|FG001|Overall Study|Death|1|||
48792196|NCT02506153|157079213|FG000|Overall Study|Other - not protocol specified|23|||
48792197|NCT02506153|157079214|FG001|Overall Study|Other - not protocol specified|12|||
48792198|NCT03905655|157079216|FG000|Overall Study|Adverse Event|1|||
48792199|NCT03905655|157079217|FG001|Overall Study|Adverse Event|0|||
48792200|NCT03905655|157079218|FG002|Overall Study|Adverse Event|1|||
48587167|NCT02984267|156341607|FG001|Overall Study|Protocol Violation|0|||
48587168|NCT02984267|156341606|FG000|Overall Study|Withdrawal by Subject|0|||
48792201|NCT03905655|157079219|FG003|Overall Study|Adverse Event|1|||
48792202|NCT03117738|157079222|FG000|Overall Study|Withdrawal by Subject|3|||
48792203|NCT03117738|157079223|FG001|Overall Study|Withdrawal by Subject|1|||
48792204|NCT03117738|157079222|FG000|Overall Study|Lost to Follow-up|1|||
48587169|NCT02984267|156341607|FG001|Overall Study|Withdrawal by Subject|1|||
48792205|NCT03117738|157079223|FG001|Overall Study|Lost to Follow-up|4|||
48792206|NCT01669629|157079224|FG000|Period 1|protocol deviation|1|||
48792207|NCT01669629|157079225|FG001|Period 1|protocol deviation|2|||
48792208|NCT01754467|157079226|FG000|Overall Study|Lost to Follow-up|1|||
48792209|NCT02794285|157079227|FG000|Overall Study|Adverse Event|11|||
48792210|NCT02794285|157079228|FG001|Overall Study|Adverse Event|4|||
48792211|NCT02794285|157079229|FG002|Overall Study|Adverse Event|5|||
48792212|NCT02794285|157079230|FG003|Overall Study|Adverse Event|8|||
48792213|NCT02794285|157079227|FG000|Overall Study|Condition Under Investigation Improved|1|||
48792214|NCT02794285|157079228|FG001|Overall Study|Condition Under Investigation Improved|0|||
48401233|NCT01463098|155660235|FG004|Part B (11 Days)|Participant Choice|0|||
48792215|NCT02794285|157079229|FG002|Overall Study|Condition Under Investigation Improved|0|||
48792216|NCT02794285|157079230|FG003|Overall Study|Condition Under Investigation Improved|0|||
48792217|NCT02794285|157079227|FG000|Overall Study|Condition Under Investigation Worsened|0|||
48792218|NCT02794285|157079228|FG001|Overall Study|Condition Under Investigation Worsened|2|||
48792219|NCT02794285|157079229|FG002|Overall Study|Condition Under Investigation Worsened|1|||
48401234|NCT01463098|155660236|FG005|Part B (11 Days)|Participant Choice|0|||
48401235|NCT01463098|155660237|FG006|Part B (11 Days)|Participant Choice|0|||
48792220|NCT02794285|157079230|FG003|Overall Study|Condition Under Investigation Worsened|0|||
48792221|NCT02794285|157079227|FG000|Overall Study|Death|2|||
48792222|NCT02794285|157079228|FG001|Overall Study|Death|1|||
48792223|NCT02794285|157079229|FG002|Overall Study|Death|2|||
48792224|NCT02794285|157079230|FG003|Overall Study|Death|0|||
48792225|NCT02794285|157079227|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
48792226|NCT02794285|157079228|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
48792227|NCT02794285|157079229|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
48792228|NCT02794285|157079230|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
48792229|NCT02794285|157079227|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
48792230|NCT02794285|157079228|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
48792231|NCT02794285|157079229|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
48792232|NCT02794285|157079230|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
48792233|NCT02794285|157079227|FG000|Overall Study|Lack of Efficacy|10|||
48792234|NCT02794285|157079228|FG001|Overall Study|Lack of Efficacy|6|||
48792235|NCT02794285|157079229|FG002|Overall Study|Lack of Efficacy|3|||
48401236|NCT01463098|155660238|FG007|Part B (11 Days)|Participant Choice|0|||
48401237|NCT01463098|155660239|FG008|Part B (11 Days)|Participant Choice|0|||
48792236|NCT02794285|157079230|FG003|Overall Study|Lack of Efficacy|3|||
48792237|NCT02794285|157079227|FG000|Overall Study|Lost to Follow-up|5|||
48792238|NCT02794285|157079228|FG001|Overall Study|Lost to Follow-up|6|||
48792239|NCT02794285|157079229|FG002|Overall Study|Lost to Follow-up|3|||
48792240|NCT02794285|157079230|FG003|Overall Study|Lost to Follow-up|1|||
48792241|NCT02794285|157079227|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
48792242|NCT02794285|157079228|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
48792243|NCT02794285|157079229|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
48792244|NCT02794285|157079230|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
48792245|NCT02794285|157079227|FG000|Overall Study|Withdrawal by Subject|38|||
48792246|NCT02794285|157079228|FG001|Overall Study|Withdrawal by Subject|29|||
48792247|NCT02794285|157079229|FG002|Overall Study|Withdrawal by Subject|20|||
48792248|NCT02794285|157079230|FG003|Overall Study|Withdrawal by Subject|12|||
48792249|NCT02794285|157079227|FG000|Overall Study|Missing|1|||
48792250|NCT02794285|157079228|FG001|Overall Study|Missing|0|||
48792251|NCT02794285|157079229|FG002|Overall Study|Missing|0|||
48792252|NCT02794285|157079230|FG003|Overall Study|Missing|0|||
48792253|NCT02794285|157079227|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
48792254|NCT02794285|157079228|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
48792255|NCT02794285|157079229|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
48792256|NCT02794285|157079230|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
48792257|NCT02794285|157079227|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
48792258|NCT02794285|157079228|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
48792259|NCT02794285|157079229|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
48792260|NCT02794285|157079230|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
48792261|NCT03252587|157079231|FG000|Overall Study|Adverse Event|3|||
48792262|NCT03252587|157079232|FG001|Overall Study|Adverse Event|8|||
48792263|NCT03252587|157079233|FG002|Overall Study|Adverse Event|6|||
48792264|NCT03252587|157079234|FG003|Overall Study|Adverse Event|12|||
48792265|NCT03252587|157079231|FG000|Overall Study|Lack of Efficacy|7|||
48792266|NCT03252587|157079232|FG001|Overall Study|Lack of Efficacy|2|||
48792267|NCT03252587|157079233|FG002|Overall Study|Lack of Efficacy|2|||
48792268|NCT03252587|157079234|FG003|Overall Study|Lack of Efficacy|4|||
48792269|NCT03252587|157079231|FG000|Overall Study|Lost to Follow-up|2|||
48792270|NCT03252587|157079232|FG001|Overall Study|Lost to Follow-up|0|||
48792271|NCT03252587|157079233|FG002|Overall Study|Lost to Follow-up|0|||
48792272|NCT03252587|157079234|FG003|Overall Study|Lost to Follow-up|2|||
48792273|NCT03252587|157079231|FG000|Overall Study|Pregnancy|2|||
48357036|NCT02563548|155503552|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
48357037|NCT02563548|155503553|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
48357038|NCT02563548|155503554|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
48357039|NCT02563548|155503549|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
48357040|NCT02563548|155503550|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
48357041|NCT02563548|155503551|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
48357042|NCT02563548|155503552|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
48357043|NCT02563548|155503553|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
48357044|NCT02563548|155503554|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
48357045|NCT02563548|155503549|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48357046|NCT02563548|155503550|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48357047|NCT02563548|155503551|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
48357048|NCT02563548|155503552|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48357049|NCT02563548|155503553|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48357050|NCT02563548|155503554|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
48357051|NCT02563548|155503549|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
48357052|NCT02563548|155503550|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
48357053|NCT02563548|155503551|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
48357054|NCT02563548|155503552|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
48357055|NCT02563548|155503553|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
48357056|NCT02563548|155503554|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
48357057|NCT02563548|155503549|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
48357058|NCT02563548|155503550|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
48357059|NCT02563548|155503551|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
48357060|NCT02563548|155503552|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
48357061|NCT02563548|155503553|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
48357062|NCT02563548|155503554|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
48357063|NCT02563548|155503549|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
48357064|NCT02563548|155503550|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
48357065|NCT02563548|155503551|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
48792274|NCT03252587|157079232|FG001|Overall Study|Pregnancy|1|||
48792275|NCT03252587|157079233|FG002|Overall Study|Pregnancy|0|||
48792276|NCT03252587|157079234|FG003|Overall Study|Pregnancy|1|||
48792277|NCT03252587|157079231|FG000|Overall Study|Withdrawal by Subject|8|||
48792278|NCT03252587|157079232|FG001|Overall Study|Withdrawal by Subject|4|||
48792279|NCT03252587|157079233|FG002|Overall Study|Withdrawal by Subject|4|||
48792280|NCT03252587|157079234|FG003|Overall Study|Withdrawal by Subject|4|||
48792281|NCT03252587|157079231|FG000|Overall Study|Other Reasons|2|||
48401238|NCT01463098|155660240|FG009|Part B (11 Days)|Participant Choice|0|||
48792282|NCT03252587|157079232|FG001|Overall Study|Other Reasons|5|||
48401239|NCT01463098|155660241|FG010|Part B (11 Days)|Participant Choice|0|||
48401240|NCT01463098|155660242|FG011|Part B (11 Days)|Participant Choice|1|||
48401241|NCT01463098|155660243|FG012|Part B (11 Days)|Participant Choice|0|||
48401242|NCT01463098|155660244|FG013|Part B (11 Days)|Participant Choice|0|||
48401243|NCT05099640|155660245|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
48401244|NCT05099640|155660246|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
48401245|NCT05099640|155660247|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
48792283|NCT03252587|157079233|FG002|Overall Study|Other Reasons|5|||
48792284|NCT03252587|157079234|FG003|Overall Study|Other Reasons|4|||
48792285|NCT00325468|157079246|FG000|Overall Study|Adverse Event|1|||
48792286|NCT00325468|157079247|FG001|Overall Study|Adverse Event|1|||
48792287|NCT00325468|157079248|FG002|Overall Study|Adverse Event|0|||
48792288|NCT00325468|157079249|FG003|Overall Study|Adverse Event|5|||
48792289|NCT00325468|157079250|FG004|Overall Study|Adverse Event|1|||
48792290|NCT00325468|157079246|FG000|Overall Study|Death|2|||
48792291|NCT00325468|157079247|FG001|Overall Study|Death|0|||
48792292|NCT00325468|157079248|FG002|Overall Study|Death|2|||
48792293|NCT00325468|157079249|FG003|Overall Study|Death|4|||
48792294|NCT00325468|157079250|FG004|Overall Study|Death|0|||
48792295|NCT00325468|157079246|FG000|Overall Study|Lost to Follow-up|0|||
48792296|NCT00325468|157079247|FG001|Overall Study|Lost to Follow-up|0|||
48792297|NCT00325468|157079248|FG002|Overall Study|Lost to Follow-up|1|||
48792298|NCT00325468|157079249|FG003|Overall Study|Lost to Follow-up|2|||
48792299|NCT00325468|157079250|FG004|Overall Study|Lost to Follow-up|2|||
48792300|NCT00325468|157079246|FG000|Overall Study|Physician Decision|1|||
48792301|NCT00325468|157079247|FG001|Overall Study|Physician Decision|1|||
48792302|NCT00325468|157079248|FG002|Overall Study|Physician Decision|0|||
48792303|NCT00325468|157079249|FG003|Overall Study|Physician Decision|1|||
48792304|NCT00325468|157079250|FG004|Overall Study|Physician Decision|0|||
48792305|NCT00325468|157079246|FG000|Overall Study|Withdrawal by Subject|3|||
48792306|NCT00325468|157079247|FG001|Overall Study|Withdrawal by Subject|1|||
48792307|NCT00325468|157079248|FG002|Overall Study|Withdrawal by Subject|0|||
48792308|NCT00325468|157079249|FG003|Overall Study|Withdrawal by Subject|14|||
48792309|NCT00325468|157079250|FG004|Overall Study|Withdrawal by Subject|4|||
48792310|NCT00325468|157079246|FG000|Overall Study|site closure etc|4|||
48792311|NCT00325468|157079247|FG001|Overall Study|site closure etc|2|||
48792312|NCT00325468|157079248|FG002|Overall Study|site closure etc|1|||
48792313|NCT00325468|157079249|FG003|Overall Study|site closure etc|8|||
48792314|NCT00325468|157079250|FG004|Overall Study|site closure etc|1|||
48792315|NCT01654549|157079251|FG000|Overall Study|H.pylori eradication not successful|0|||
48792316|NCT01654549|157079252|FG001|Overall Study|H.pylori eradication not successful|1|||
48792317|NCT03732209|157079253|FG000|Overall Study|Lost to Follow-up|4|||
48792318|NCT03732209|157079254|FG001|Overall Study|Lost to Follow-up|4|||
48792319|NCT03732209|157079253|FG000|Overall Study|Withdrawal by Subject|8|||
48792320|NCT03732209|157079254|FG001|Overall Study|Withdrawal by Subject|9|||
48792321|NCT00594854|157079267|FG000|Overall Study|Study terminated|7|||
48792322|NCT00594854|157079268|FG001|Overall Study|Study terminated|10|||
48792323|NCT04867369|157079269|FG000|Overall Study|Withdrawal by Subject|1|||
48792324|NCT04867369|157079270|FG001|Overall Study|Withdrawal by Subject|0|||
48792325|NCT04382404|157079271|FG000|Overall Study|Adverse Event|1|||
48792326|NCT04382404|157079271|FG000|Overall Study|Lost to Follow-up|2|||
48792327|NCT04936035|157079273|FG000|Overall Study|Adverse Event|0|||
48792328|NCT04936035|157079274|FG001|Overall Study|Adverse Event|1|||
48792329|NCT04936035|157079275|FG002|Overall Study|Adverse Event|0|||
48792330|NCT04936035|157079276|FG003|Overall Study|Adverse Event|0|||
48792331|NCT04936035|157079277|FG004|Overall Study|Adverse Event|0|||
48792332|NCT04936035|157079273|FG000|Overall Study|Death|0|||
48792333|NCT04936035|157079274|FG001|Overall Study|Death|0|||
48792334|NCT04936035|157079275|FG002|Overall Study|Death|0|||
48792335|NCT04936035|157079276|FG003|Overall Study|Death|1|||
48401246|NCT05099640|155660245|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
48792336|NCT04936035|157079277|FG004|Overall Study|Death|0|||
48792337|NCT04936035|157079273|FG000|Overall Study|Lost to Follow-up|0|||
48792338|NCT04936035|157079274|FG001|Overall Study|Lost to Follow-up|1|||
48792339|NCT04936035|157079275|FG002|Overall Study|Lost to Follow-up|1|||
48792340|NCT04936035|157079276|FG003|Overall Study|Lost to Follow-up|2|||
48792341|NCT04936035|157079277|FG004|Overall Study|Lost to Follow-up|1|||
48792342|NCT04936035|157079273|FG000|Overall Study|Physician Decision|0|||
48792343|NCT04936035|157079274|FG001|Overall Study|Physician Decision|1|||
48792344|NCT04936035|157079275|FG002|Overall Study|Physician Decision|0|||
48792345|NCT04936035|157079276|FG003|Overall Study|Physician Decision|0|||
48792346|NCT04936035|157079277|FG004|Overall Study|Physician Decision|0|||
48792347|NCT04936035|157079273|FG000|Overall Study|Protocol Deviation|0|||
48792348|NCT04936035|157079274|FG001|Overall Study|Protocol Deviation|0|||
48792349|NCT04936035|157079275|FG002|Overall Study|Protocol Deviation|1|||
48792350|NCT04936035|157079276|FG003|Overall Study|Protocol Deviation|0|||
48792351|NCT04936035|157079277|FG004|Overall Study|Protocol Deviation|0|||
48792352|NCT04936035|157079273|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
48792353|NCT04936035|157079274|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
48792354|NCT04936035|157079275|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
48792355|NCT04936035|157079276|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
48792356|NCT04936035|157079277|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
48792357|NCT04936035|157079273|FG000|Overall Study|Reason Unknown|0|||
48792358|NCT04936035|157079274|FG001|Overall Study|Reason Unknown|0|||
48792359|NCT04936035|157079275|FG002|Overall Study|Reason Unknown|0|||
48792360|NCT04936035|157079276|FG003|Overall Study|Reason Unknown|0|||
48792361|NCT04936035|157079277|FG004|Overall Study|Reason Unknown|1|||
48792362|NCT04936035|157079273|FG000|Overall Study|Withdrawal by Subject|1|||
48792363|NCT04936035|157079274|FG001|Overall Study|Withdrawal by Subject|0|||
48792364|NCT04936035|157079275|FG002|Overall Study|Withdrawal by Subject|0|||
48792365|NCT04936035|157079276|FG003|Overall Study|Withdrawal by Subject|0|||
48792366|NCT04936035|157079277|FG004|Overall Study|Withdrawal by Subject|0|||
48792367|NCT04936035|157079273|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
48792368|NCT04936035|157079274|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
48792369|NCT04936035|157079275|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
48792370|NCT04936035|157079276|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
48792371|NCT04936035|157079277|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
48792372|NCT04936035|157079273|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
48792373|NCT04936035|157079274|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
48792374|NCT04936035|157079275|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
48792375|NCT04936035|157079276|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
48792376|NCT04936035|157079277|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
48792377|NCT04936035|157079273|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
48792378|NCT04936035|157079274|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
48792379|NCT04936035|157079275|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
48792380|NCT04936035|157079276|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
48792381|NCT04936035|157079277|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
48792382|NCT03996473|157079278|FG000|Treatment Assignment|Withdrawal by Subject|1|||
48792383|NCT03996473|157079278|FG000|Treatment Assignment|Progressive disease|6|||
48792384|NCT03996473|157079278|FG000|Treatment Assignment|Study drug never administered|1|||
48792385|NCT03996473|157079278|FG000|Active Follow-up|Death|1|||
48792386|NCT03996473|157079278|FG000|Long-term Follow-up|Death|5|||
48792387|NCT00070499|157079279|FG000|Overall Study|Adverse Event|6|||
48792388|NCT00070499|157079280|FG001|Overall Study|Adverse Event|6|||
48792389|NCT00070499|157079281|FG002|Overall Study|Adverse Event|19|||
48792390|NCT00070499|157079282|FG003|Overall Study|Adverse Event|15|||
48792391|NCT00070499|157079279|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
48792392|NCT00070499|157079280|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
48792393|NCT00070499|157079281|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
48792394|NCT00070499|157079282|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
48792395|NCT00070499|157079279|FG000|Overall Study|Progression/relapse|4|||
48792396|NCT00070499|157079280|FG001|Overall Study|Progression/relapse|2|||
48792397|NCT00070499|157079281|FG002|Overall Study|Progression/relapse|1|||
48792398|NCT00070499|157079282|FG003|Overall Study|Progression/relapse|4|||
48792399|NCT00070499|157079279|FG000|Overall Study|Death|1|||
48792400|NCT00070499|157079280|FG001|Overall Study|Death|1|||
48792401|NCT00070499|157079281|FG002|Overall Study|Death|1|||
48792402|NCT00070499|157079282|FG003|Overall Study|Death|2|||
48792403|NCT00070499|157079279|FG000|Overall Study|Other - not protocol specified|7|||
48792404|NCT00070499|157079280|FG001|Overall Study|Other - not protocol specified|3|||
48792405|NCT00070499|157079281|FG002|Overall Study|Other - not protocol specified|12|||
48792406|NCT00070499|157079282|FG003|Overall Study|Other - not protocol specified|20|||
48792407|NCT00070499|157079279|FG000|Overall Study|Still on protocol treatment|10|||
48792408|NCT00070499|157079280|FG001|Overall Study|Still on protocol treatment|4|||
48792409|NCT00070499|157079281|FG002|Overall Study|Still on protocol treatment|79|||
48792410|NCT00070499|157079282|FG003|Overall Study|Still on protocol treatment|57|||
48401247|NCT05099640|155660246|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
48401248|NCT05099640|155660247|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
48792411|NCT00070499|157079279|FG000|Overall Study|Did not start treatment|1|||
48792412|NCT00070499|157079280|FG001|Overall Study|Did not start treatment|0|||
48792413|NCT00070499|157079281|FG002|Overall Study|Did not start treatment|0|||
48792414|NCT00070499|157079282|FG003|Overall Study|Did not start treatment|2|||
48792415|NCT00070499|157079279|FG000|Overall Study|Not eligible|2|||
48792416|NCT00070499|157079280|FG001|Overall Study|Not eligible|5|||
48792417|NCT00070499|157079281|FG002|Overall Study|Not eligible|3|||
48792418|NCT00070499|157079282|FG003|Overall Study|Not eligible|2|||
48792419|NCT05569252|157079283|FG000|Overall Study|Adverse event (central vision loss)|1|||
48792420|NCT05569252|157079284|FG001|Overall Study|Adverse event (central vision loss)|0|||
48792421|NCT05569252|157079285|FG002|Overall Study|Adverse event (central vision loss)|0|||
48792422|NCT05569252|157079286|FG003|Overall Study|Adverse event (central vision loss)|0|||
48792423|NCT02923180|157079293|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
48792424|NCT02923180|157079293|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
48792425|NCT04293055|157079294|FG000|Overall Study|Lost to Follow-up|1|||
48792426|NCT04293055|157079295|FG001|Overall Study|Lost to Follow-up|1|||
48792427|NCT04293055|157079294|FG000|Overall Study|Did not trigger randomization|6|||
48792428|NCT04293055|157079295|FG001|Overall Study|Did not trigger randomization|5|||
48792429|NCT05071053|157079296|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|2|||
48792430|NCT05071053|157079296|FG000|Overall Study|Progressive disease|28|||
48792431|NCT05071053|157079296|FG000|Overall Study|Adverse Event|5|||
48792432|NCT06390839|157079297|FG000|Overall Study|Ineligible|2|||
48792433|NCT06390839|157079297|FG000|Overall Study|Never start protocol therapy|3|||
48792434|NCT06390839|157079297|FG000|Overall Study|Adverse Event|1|||
48792435|NCT06390839|157079297|FG000|Overall Study|Alternative therapy|2|||
48792436|NCT06390839|157079297|FG000|Overall Study|Death|3|||
48792437|NCT06390839|157079297|FG000|Overall Study|Disease progression|28|||
48792438|NCT06390839|157079297|FG000|Overall Study|Withdrawal by Subject|2|||
48792439|NCT06390839|157079297|FG000|Overall Study|Complicating disease|1|||
48792440|NCT06390839|157079297|FG000|Overall Study|Noncompliance|1|||
48792441|NCT01381692|157079298|FG000|Overall Study|Adverse Event|1|||
48792442|NCT01381692|157079299|FG001|Overall Study|Adverse Event|0|||
48792443|NCT01381692|157079300|FG002|Overall Study|Adverse Event|0|||
48792444|NCT01381692|157079301|FG003|Overall Study|Adverse Event|0|||
48792445|NCT01381692|157079302|FG004|Overall Study|Adverse Event|0|||
48792446|NCT01381692|157079303|FG005|Overall Study|Adverse Event|0|||
48792447|NCT03315455|157079304|FG000|Overall Study|Ongoing in the Study|13|||
48792448|NCT03315455|157079305|FG001|Overall Study|Ongoing in the Study|24|||
48792449|NCT03315455|157079306|FG002|Overall Study|Ongoing in the Study|17|||
48792450|NCT03315455|157079307|FG003|Overall Study|Ongoing in the Study|15|||
48792451|NCT03315455|157079304|FG000|Overall Study|Withdrawal by Subject|0|||
48792452|NCT03315455|157079305|FG001|Overall Study|Withdrawal by Subject|1|||
48792453|NCT03315455|157079306|FG002|Overall Study|Withdrawal by Subject|0|||
48792454|NCT03315455|157079307|FG003|Overall Study|Withdrawal by Subject|0|||
48792455|NCT04575051|157079310|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
48792456|NCT04575051|157079311|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
48792457|NCT04575051|157079312|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
48792458|NCT04575051|157079313|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
48792459|NCT04575051|157079314|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
48792460|NCT04575051|157079310|FG000|Time Period 1|Missing follow up|1|||
48792461|NCT04575051|157079311|FG001|Time Period 1|Missing follow up|3|||
48792462|NCT04575051|157079312|FG002|Time Period 1|Missing follow up|1|||
48792463|NCT04575051|157079313|FG003|Time Period 1|Missing follow up|3|||
48792464|NCT04575051|157079314|FG004|Time Period 1|Missing follow up|2|||
48792465|NCT04575051|157079310|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
48792466|NCT04575051|157079311|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
48792467|NCT04575051|157079312|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
48792468|NCT04575051|157079313|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
48792469|NCT04575051|157079314|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
48792470|NCT04575051|157079310|FG000|Time Period 2|Missing follow up|1|||
48792471|NCT04575051|157079311|FG001|Time Period 2|Missing follow up|8|||
48792472|NCT04575051|157079312|FG002|Time Period 2|Missing follow up|7|||
48792473|NCT04575051|157079313|FG003|Time Period 2|Missing follow up|0|||
48792474|NCT04575051|157079314|FG004|Time Period 2|Missing follow up|1|||
48792475|NCT04575051|157079310|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
48792476|NCT04575051|157079311|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
48792477|NCT04575051|157079312|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
48792478|NCT04575051|157079313|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
48792479|NCT04575051|157079314|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
48792480|NCT04575051|157079310|FG000|Time Period 3|Missing follow up|8|||
48792481|NCT04575051|157079311|FG001|Time Period 3|Missing follow up|6|||
48792482|NCT04575051|157079312|FG002|Time Period 3|Missing follow up|4|||
48792483|NCT04575051|157079313|FG003|Time Period 3|Missing follow up|3|||
48792484|NCT04575051|157079314|FG004|Time Period 3|Missing follow up|0|||
48792485|NCT04575051|157079310|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
48792486|NCT04575051|157079311|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
48792487|NCT04575051|157079312|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
48792488|NCT04575051|157079313|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
48792489|NCT04575051|157079314|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
48792490|NCT04575051|157079310|FG000|Time Period 4|Missing follow up|17|||
48792491|NCT04575051|157079311|FG001|Time Period 4|Missing follow up|3|||
48792492|NCT04575051|157079312|FG002|Time Period 4|Missing follow up|4|||
48792493|NCT04575051|157079313|FG003|Time Period 4|Missing follow up|2|||
48792494|NCT04575051|157079314|FG004|Time Period 4|Missing follow up|1|||
48792495|NCT04575051|157079310|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
48792496|NCT04575051|157079311|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
48792497|NCT04575051|157079312|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
48792498|NCT04575051|157079313|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
48792499|NCT04575051|157079314|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
48792500|NCT04575051|157079310|FG000|Time Period 5|Missing follow up|11|||
48792501|NCT04575051|157079311|FG001|Time Period 5|Missing follow up|8|||
48792502|NCT04575051|157079312|FG002|Time Period 5|Missing follow up|12|||
48792503|NCT04575051|157079313|FG003|Time Period 5|Missing follow up|3|||
48792504|NCT04575051|157079314|FG004|Time Period 5|Missing follow up|11|||
48792505|NCT00529399|157079315|FG000|Overall Study|Lost to Follow-up|1|||
48792506|NCT00529399|157079316|FG001|Overall Study|Lost to Follow-up|0|||
48792507|NCT00529399|157079317|FG002|Overall Study|Lost to Follow-up|1|||
48792508|NCT00529399|157079315|FG000|Overall Study|Withdrawal by Subject|1|||
48792509|NCT00529399|157079316|FG001|Overall Study|Withdrawal by Subject|0|||
48401249|NCT05099640|155660245|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
48401250|NCT05099640|155660246|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
48792510|NCT00529399|157079317|FG002|Overall Study|Withdrawal by Subject|1|||
48792511|NCT00529399|157079315|FG000|Overall Study|Non-compliant|0|||
48792512|NCT00529399|157079316|FG001|Overall Study|Non-compliant|1|||
48792513|NCT00529399|157079317|FG002|Overall Study|Non-compliant|0|||
48792514|NCT04393441|157079329|FG000|Overall Study|Adverse Event|0|||
48792515|NCT04393441|157079330|FG001|Overall Study|Adverse Event|3|||
48792516|NCT04393441|157079329|FG000|Overall Study|Withdrawal by Subject|5|||
48792517|NCT04393441|157079330|FG001|Overall Study|Withdrawal by Subject|7|||
48792518|NCT04393441|157079329|FG000|Overall Study|Lost to Follow-up|0|||
48792519|NCT04393441|157079330|FG001|Overall Study|Lost to Follow-up|2|||
48792520|NCT04393441|157079329|FG000|Overall Study|Protocol Deviation|2|||
48792521|NCT04393441|157079330|FG001|Overall Study|Protocol Deviation|1|||
48792522|NCT04393441|157079329|FG000|Overall Study|Reason not Specified|1|||
48792523|NCT04393441|157079330|FG001|Overall Study|Reason not Specified|1|||
48401251|NCT05099640|155660247|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
48401252|NCT05099640|155660245|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
48401253|NCT05099640|155660246|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
48401254|NCT05099640|155660247|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
48401255|NCT05099640|155660245|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
48401256|NCT05099640|155660246|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
48401257|NCT05099640|155660247|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
48401258|NCT05099640|155660245|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
48401259|NCT05099640|155660246|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
48401260|NCT05099640|155660247|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
48401261|NCT02462473|155660248|FG000|Overall Study|Death|1|||
48401262|NCT02462473|155660248|FG000|Overall Study|Other|3|||
48792524|NCT02363738|157079331|FG000|Overall Study|Adverse Event|5|||
48401263|NCT00953758|155660255|FG000|Overall Study|Death|2|||
48401264|NCT00953758|155660256|FG001|Overall Study|Death|0|||
48401265|NCT00953758|155660257|FG002|Overall Study|Death|1|||
48792525|NCT02363738|157079332|FG001|Overall Study|Adverse Event|2|||
48792526|NCT02363738|157079331|FG000|Overall Study|Lack of Efficacy|1|||
48792527|NCT02363738|157079332|FG001|Overall Study|Lack of Efficacy|2|||
48792528|NCT02363738|157079331|FG000|Overall Study|Lost to Follow-up|2|||
48792529|NCT02363738|157079332|FG001|Overall Study|Lost to Follow-up|1|||
48401266|NCT00953758|155660258|FG003|Overall Study|Death|1|||
48401267|NCT00953758|155660259|FG004|Overall Study|Death|1|||
48401268|NCT00953758|155660260|FG005|Overall Study|Death|1|||
48792530|NCT02187991|157079333|FG000|Overall Study|Adverse Event|13|||
48792531|NCT02187991|157079334|FG001|Overall Study|Adverse Event|14|||
48792532|NCT02187991|157079335|FG002|Overall Study|Adverse Event|3|||
48792533|NCT02187991|157079336|FG003|Overall Study|Adverse Event|2|||
48792534|NCT02187991|157079333|FG000|Overall Study|Withdrawal by Subject|9|||
48792535|NCT02187991|157079334|FG001|Overall Study|Withdrawal by Subject|6|||
48792536|NCT02187991|157079335|FG002|Overall Study|Withdrawal by Subject|3|||
48792537|NCT02187991|157079336|FG003|Overall Study|Withdrawal by Subject|2|||
48792538|NCT02187991|157079333|FG000|Overall Study|Physician Decision|4|||
48792539|NCT02187991|157079334|FG001|Overall Study|Physician Decision|4|||
48792540|NCT02187991|157079335|FG002|Overall Study|Physician Decision|0|||
48792541|NCT02187991|157079336|FG003|Overall Study|Physician Decision|2|||
48792542|NCT02187991|157079333|FG000|Overall Study|Other, unrelated complication|7|||
48792543|NCT02187991|157079334|FG001|Overall Study|Other, unrelated complication|1|||
48792544|NCT02187991|157079335|FG002|Overall Study|Other, unrelated complication|1|||
48792545|NCT02187991|157079336|FG003|Overall Study|Other, unrelated complication|2|||
48792546|NCT02187991|157079333|FG000|Overall Study|Death|1|||
48792547|NCT02187991|157079334|FG001|Overall Study|Death|3|||
48792548|NCT02187991|157079335|FG002|Overall Study|Death|0|||
48792549|NCT02187991|157079336|FG003|Overall Study|Death|0|||
48792550|NCT01392560|157079337|FG000|Overall Study|Adverse Event|2|||
48792551|NCT01392560|157079337|FG000|Overall Study|not entered|8|||
48792552|NCT01392560|157079337|FG000|Overall Study|discontinued during placebo run-in|2|||
48792553|NCT02576678|157079339|FG000|Overall Study|Adverse Event|0|||
48792554|NCT02576678|157079340|FG001|Overall Study|Adverse Event|0|||
48792555|NCT02576678|157079341|FG002|Overall Study|Adverse Event|2|||
48792556|NCT02576678|157079339|FG000|Overall Study|Withdrawal by Subject|3|||
48792557|NCT02576678|157079340|FG001|Overall Study|Withdrawal by Subject|1|||
48792558|NCT02576678|157079341|FG002|Overall Study|Withdrawal by Subject|2|||
48792559|NCT02576678|157079339|FG000|Overall Study|Lost to Follow-up|0|||
48792560|NCT02576678|157079340|FG001|Overall Study|Lost to Follow-up|0|||
48792561|NCT02576678|157079341|FG002|Overall Study|Lost to Follow-up|1|||
48792562|NCT02576678|157079339|FG000|Overall Study|Miscellaneous|2|||
48792563|NCT02576678|157079340|FG001|Overall Study|Miscellaneous|0|||
48792564|NCT02576678|157079341|FG002|Overall Study|Miscellaneous|0|||
48792565|NCT03687086|157079342|FG000|Overall Study|Withdrawal by Subject|3|||
48792566|NCT03687086|157079343|FG001|Overall Study|Withdrawal by Subject|4|||
48792567|NCT03687086|157079342|FG000|Overall Study|Lost to Follow-up|1|||
48792568|NCT03687086|157079343|FG001|Overall Study|Lost to Follow-up|1|||
48792569|NCT03687086|157079342|FG000|Overall Study|Death|1|||
48792570|NCT03687086|157079343|FG001|Overall Study|Death|0|||
48792571|NCT03687086|157079342|FG000|Overall Study|Incomplete assessment|0|||
48792572|NCT03687086|157079343|FG001|Overall Study|Incomplete assessment|2|||
48792573|NCT02363946|157079347|FG000|Overall Study|Lost to Follow-up|0|||
48792574|NCT02363946|157079348|FG001|Overall Study|Lost to Follow-up|0|||
48792575|NCT02363946|157079349|FG002|Overall Study|Lost to Follow-up|0|||
48792576|NCT02363946|157079350|FG003|Overall Study|Lost to Follow-up|0|||
48792577|NCT02363946|157079351|FG004|Overall Study|Lost to Follow-up|0|||
48792578|NCT02363946|157079352|FG005|Overall Study|Lost to Follow-up|0|||
48792579|NCT02363946|157079353|FG006|Overall Study|Lost to Follow-up|0|||
48792580|NCT02363946|157079354|FG007|Overall Study|Lost to Follow-up|1|||
48792581|NCT02363946|157079355|FG008|Overall Study|Lost to Follow-up|0|||
48792582|NCT02363946|157079356|FG009|Overall Study|Lost to Follow-up|0|||
48792583|NCT02363946|157079357|FG010|Overall Study|Lost to Follow-up|0|||
48792584|NCT02363946|157079358|FG011|Overall Study|Lost to Follow-up|0|||
48792585|NCT02363946|157079359|FG012|Overall Study|Lost to Follow-up|0|||
48792586|NCT00113568|157079360|FG000|Overall Study|Adverse Event|97|||
48792587|NCT00113568|157079360|FG000|Overall Study|Death|1|||
48792588|NCT00113568|157079360|FG000|Overall Study|Lack of Efficacy|30|||
48792589|NCT00113568|157079360|FG000|Overall Study|Lost to Follow-up|156|||
48792590|NCT00113568|157079360|FG000|Overall Study|Protocol Violation|32|||
48792591|NCT00113568|157079360|FG000|Overall Study|Withdrawal by Subject|117|||
48792592|NCT00113568|157079360|FG000|Overall Study|Other|112|||
48792593|NCT00989287|157079362|FG000|Overall Study|Adverse Event|1|||
48792594|NCT00989287|157079363|FG001|Overall Study|Adverse Event|0|||
48792595|NCT00989287|157079362|FG000|Overall Study|Lost to Follow-up|0|||
48792596|NCT00989287|157079363|FG001|Overall Study|Lost to Follow-up|1|||
48792597|NCT00729833|157079364|FG000|Overall Study|Death|5|||
48792598|NCT00729833|157079365|FG001|Overall Study|Death|1|||
48792599|NCT00729833|157079366|FG002|Overall Study|Death|3|||
48792600|NCT00729833|157079367|FG003|Overall Study|Death|5|||
48792601|NCT00729833|157079364|FG000|Overall Study|Study Terminated by Sponsor|0|||
48792602|NCT00729833|157079365|FG001|Overall Study|Study Terminated by Sponsor|0|||
48792603|NCT00729833|157079366|FG002|Overall Study|Study Terminated by Sponsor|1|||
48792604|NCT00729833|157079367|FG003|Overall Study|Study Terminated by Sponsor|0|||
48792605|NCT00729833|157079364|FG000|Overall Study|Lost to Follow-up|1|||
48792606|NCT00729833|157079365|FG001|Overall Study|Lost to Follow-up|0|||
48792607|NCT00729833|157079366|FG002|Overall Study|Lost to Follow-up|0|||
48792608|NCT00729833|157079367|FG003|Overall Study|Lost to Follow-up|0|||
48792609|NCT00729833|157079364|FG000|Overall Study|Withdrawal by Subject|3|||
48401269|NCT00953758|155660261|FG006|Overall Study|Death|1|||
48401270|NCT00953758|155660262|FG007|Overall Study|Death|3|||
48401271|NCT00953758|155660263|FG008|Overall Study|Death|1|||
48792610|NCT00729833|157079365|FG001|Overall Study|Withdrawal by Subject|1|||
48792611|NCT00729833|157079366|FG002|Overall Study|Withdrawal by Subject|3|||
48792612|NCT00729833|157079367|FG003|Overall Study|Withdrawal by Subject|0|||
48792613|NCT00729833|157079364|FG000|Overall Study|Unspecified Reasons|11|||
48792614|NCT00729833|157079365|FG001|Overall Study|Unspecified Reasons|5|||
48792615|NCT00729833|157079366|FG002|Overall Study|Unspecified Reasons|5|||
48792616|NCT00729833|157079367|FG003|Overall Study|Unspecified Reasons|1|||
48792617|NCT00417079|157079368|FG000|Overall Study|Disease progression|267|||
48792618|NCT00417079|157079369|FG001|Overall Study|Disease progression|180|||
48792619|NCT00417079|157079368|FG000|Overall Study|Adverse Event|32|||
48792620|NCT00417079|157079369|FG001|Overall Study|Adverse Event|67|||
48792621|NCT00417079|157079368|FG000|Overall Study|Non-compliance to protocol|0|||
48792622|NCT00417079|157079369|FG001|Overall Study|Non-compliance to protocol|1|||
48792623|NCT00417079|157079368|FG000|Overall Study|Lost to Follow-up|2|||
48792624|NCT00417079|157079369|FG001|Overall Study|Lost to Follow-up|0|||
48792625|NCT00417079|157079368|FG000|Overall Study|Withdrawal by Subject|17|||
48792626|NCT00417079|157079369|FG001|Overall Study|Withdrawal by Subject|8|||
48792627|NCT00417079|157079368|FG000|Overall Study|Not treated|6|||
48792628|NCT00417079|157079369|FG001|Overall Study|Not treated|7|||
48792629|NCT00417079|157079368|FG000|Overall Study|Screened failure|2|||
48792630|NCT00417079|157079369|FG001|Overall Study|Screened failure|1|||
48792631|NCT00417079|157079368|FG000|Overall Study|Investigator's decision|1|||
48792632|NCT00417079|157079369|FG001|Overall Study|Investigator's decision|4|||
48792633|NCT00417079|157079368|FG000|Overall Study|Non-confirmed Disease progression|1|||
48792634|NCT00417079|157079369|FG001|Overall Study|Non-confirmed Disease progression|1|||
48792635|NCT00417079|157079368|FG000|Overall Study|Clinical deterioration|1|||
48792636|NCT00417079|157079369|FG001|Overall Study|Clinical deterioration|0|||
48792637|NCT00417079|157079368|FG000|Overall Study|Screening error|2|||
48792638|NCT00417079|157079369|FG001|Overall Study|Screening error|1|||
48792639|NCT00417079|157079368|FG000|Overall Study|Withdrawal by subject's family|0|||
48792640|NCT00417079|157079369|FG001|Overall Study|Withdrawal by subject's family|1|||
48792641|NCT00417079|157079368|FG000|Overall Study|Patient unable to come to the clinic|0|||
48792642|NCT00417079|157079369|FG001|Overall Study|Patient unable to come to the clinic|1|||
48792643|NCT00417079|157079368|FG000|Overall Study|abnormal liver function tests|0|||
48792644|NCT00417079|157079369|FG001|Overall Study|abnormal liver function tests|1|||
48792645|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
48792646|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
48792647|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
48792648|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
48792649|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
48792650|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
48792651|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
48792652|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
48792653|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
48792654|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
48792655|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
48792656|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
48792657|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
48792658|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
48792659|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
48792660|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
48792661|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
48792662|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
48792663|NCT00833638|157079374|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
48792664|NCT00833638|157079375|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
48792665|NCT00833638|157079376|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
48792666|NCT00833638|157079374|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
48792667|NCT00833638|157079375|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
48792668|NCT00833638|157079376|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
48792669|NCT00833638|157079374|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
48792670|NCT00833638|157079375|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
48792671|NCT00833638|157079376|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
48792672|NCT03969719|157079377|FG000|Overall Study|Other reasons not specified|1|||
48792673|NCT03969719|157079378|FG001|Overall Study|Other reasons not specified|1|||
48792674|NCT03969719|157079379|FG002|Overall Study|Other reasons not specified|3|||
48792675|NCT03969719|157079377|FG000|Overall Study|Withdrawal by Subject|2|||
48792676|NCT03969719|157079378|FG001|Overall Study|Withdrawal by Subject|3|||
48792677|NCT03969719|157079379|FG002|Overall Study|Withdrawal by Subject|2|||
48401272|NCT00953758|155660264|FG009|Overall Study|Death|0|||
48401273|NCT00953758|155660255|FG000|Overall Study|Participant refused further follow-up|0|||
48401274|NCT00953758|155660256|FG001|Overall Study|Participant refused further follow-up|0|||
48401275|NCT00953758|155660257|FG002|Overall Study|Participant refused further follow-up|1|||
48401276|NCT00953758|155660258|FG003|Overall Study|Participant refused further follow-up|0|||
48401277|NCT00953758|155660259|FG004|Overall Study|Participant refused further follow-up|3|||
48401278|NCT00953758|155660260|FG005|Overall Study|Participant refused further follow-up|0|||
48401279|NCT00953758|155660261|FG006|Overall Study|Participant refused further follow-up|0|||
48401280|NCT00953758|155660262|FG007|Overall Study|Participant refused further follow-up|0|||
48401281|NCT00953758|155660263|FG008|Overall Study|Participant refused further follow-up|1|||
48401282|NCT00953758|155660264|FG009|Overall Study|Participant refused further follow-up|0|||
48401283|NCT00953758|155660255|FG000|Overall Study|Lost to Follow-up|0|||
48401284|NCT00953758|155660256|FG001|Overall Study|Lost to Follow-up|0|||
48401285|NCT00953758|155660257|FG002|Overall Study|Lost to Follow-up|0|||
48401286|NCT00953758|155660258|FG003|Overall Study|Lost to Follow-up|1|||
48401287|NCT00953758|155660259|FG004|Overall Study|Lost to Follow-up|0|||
48401288|NCT00953758|155660260|FG005|Overall Study|Lost to Follow-up|0|||
48401289|NCT00953758|155660261|FG006|Overall Study|Lost to Follow-up|0|||
48401290|NCT00953758|155660262|FG007|Overall Study|Lost to Follow-up|1|||
48401291|NCT00953758|155660263|FG008|Overall Study|Lost to Follow-up|0|||
48401292|NCT00953758|155660264|FG009|Overall Study|Lost to Follow-up|1|||
48401293|NCT00953758|155660255|FG000|Overall Study|Physician Decision|0|||
48792678|NCT03969719|157079377|FG000|Overall Study|Protocol Violation|1|||
48792679|NCT03969719|157079378|FG001|Overall Study|Protocol Violation|2|||
48792680|NCT03969719|157079379|FG002|Overall Study|Protocol Violation|0|||
48792681|NCT03969719|157079377|FG000|Overall Study|Adverse Event|0|||
48792682|NCT03969719|157079378|FG001|Overall Study|Adverse Event|2|||
48792683|NCT03969719|157079379|FG002|Overall Study|Adverse Event|0|||
48792684|NCT03969719|157079377|FG000|Overall Study|Lost to Follow-up|0|||
48792685|NCT03969719|157079378|FG001|Overall Study|Lost to Follow-up|1|||
48792686|NCT03969719|157079379|FG002|Overall Study|Lost to Follow-up|0|||
48792687|NCT02527798|157080875|FG000|Overall Study|Physician Decision|1|||
48792688|NCT02527798|157080876|FG001|Overall Study|Physician Decision|0|||
48792689|NCT02527798|157080877|FG002|Overall Study|Physician Decision|1|||
48792690|NCT02527798|157080878|FG003|Overall Study|Physician Decision|1|||
48792691|NCT02527798|157080879|FG004|Overall Study|Physician Decision|0|||
48792692|NCT02527798|157080880|FG005|Overall Study|Physician Decision|0|||
48792693|NCT02527798|157080875|FG000|Overall Study|Death|0|||
48792694|NCT02527798|157080876|FG001|Overall Study|Death|0|||
48401294|NCT00953758|155660256|FG001|Overall Study|Physician Decision|0|||
48401295|NCT00953758|155660257|FG002|Overall Study|Physician Decision|0|||
48401296|NCT00953758|155660258|FG003|Overall Study|Physician Decision|0|||
48401297|NCT00953758|155660259|FG004|Overall Study|Physician Decision|1|||
48401298|NCT00953758|155660260|FG005|Overall Study|Physician Decision|0|||
48401299|NCT00953758|155660261|FG006|Overall Study|Physician Decision|0|||
48401300|NCT00953758|155660262|FG007|Overall Study|Physician Decision|0|||
48401301|NCT00953758|155660263|FG008|Overall Study|Physician Decision|0|||
48401302|NCT00953758|155660264|FG009|Overall Study|Physician Decision|0|||
48401303|NCT00953758|155660255|FG000|Overall Study|Disease progression|0|||
48792695|NCT02527798|157080877|FG002|Overall Study|Death|1|||
48792696|NCT02527798|157080878|FG003|Overall Study|Death|0|||
48792697|NCT02527798|157080879|FG004|Overall Study|Death|0|||
48792698|NCT02527798|157080880|FG005|Overall Study|Death|0|||
48792699|NCT02527798|157080875|FG000|Overall Study|Withdrawal by Subject|0|||
48792700|NCT02527798|157080876|FG001|Overall Study|Withdrawal by Subject|1|||
48792701|NCT02527798|157080877|FG002|Overall Study|Withdrawal by Subject|2|||
48792702|NCT02527798|157080878|FG003|Overall Study|Withdrawal by Subject|0|||
48792703|NCT02527798|157080879|FG004|Overall Study|Withdrawal by Subject|0|||
48792704|NCT02527798|157080880|FG005|Overall Study|Withdrawal by Subject|0|||
48792705|NCT02527798|157080875|FG000|Overall Study|Reason undisclosed|1|||
48792706|NCT02527798|157080876|FG001|Overall Study|Reason undisclosed|0|||
48792707|NCT02527798|157080877|FG002|Overall Study|Reason undisclosed|1|||
48792708|NCT02527798|157080878|FG003|Overall Study|Reason undisclosed|0|||
48792709|NCT02527798|157080879|FG004|Overall Study|Reason undisclosed|0|||
48401304|NCT00953758|155660256|FG001|Overall Study|Disease progression|0|||
48401305|NCT00953758|155660257|FG002|Overall Study|Disease progression|0|||
48401306|NCT00953758|155660258|FG003|Overall Study|Disease progression|0|||
48792710|NCT02527798|157080880|FG005|Overall Study|Reason undisclosed|0|||
48792711|NCT02527798|157080875|FG000|Overall Study|Did not receive intervention|1|||
48792712|NCT02527798|157080876|FG001|Overall Study|Did not receive intervention|1|||
48401307|NCT00953758|155660259|FG004|Overall Study|Disease progression|1|||
48401308|NCT00953758|155660260|FG005|Overall Study|Disease progression|0|||
48401309|NCT00953758|155660261|FG006|Overall Study|Disease progression|0|||
48401310|NCT00953758|155660262|FG007|Overall Study|Disease progression|0|||
48401311|NCT00953758|155660263|FG008|Overall Study|Disease progression|0|||
48401312|NCT00953758|155660264|FG009|Overall Study|Disease progression|0|||
48792713|NCT02527798|157080877|FG002|Overall Study|Did not receive intervention|0|||
48792714|NCT02527798|157080878|FG003|Overall Study|Did not receive intervention|0|||
48401313|NCT00953758|155660255|FG000|Overall Study|Participant went for transplant|0|||
48401314|NCT00953758|155660256|FG001|Overall Study|Participant went for transplant|0|||
48401315|NCT00953758|155660257|FG002|Overall Study|Participant went for transplant|0|||
48401316|NCT00953758|155660258|FG003|Overall Study|Participant went for transplant|0|||
48401317|NCT00953758|155660259|FG004|Overall Study|Participant went for transplant|0|||
48401318|NCT00953758|155660260|FG005|Overall Study|Participant went for transplant|0|||
48401319|NCT00953758|155660261|FG006|Overall Study|Participant went for transplant|0|||
48401320|NCT00953758|155660262|FG007|Overall Study|Participant went for transplant|0|||
48401321|NCT00953758|155660263|FG008|Overall Study|Participant went for transplant|1|||
48401322|NCT00953758|155660264|FG009|Overall Study|Participant went for transplant|0|||
48401323|NCT02556255|155660265|FG000|Overall Study|Lost to Follow-up|4|||
48401324|NCT00744874|155660266|FG000|Overall Study|Lost to Follow-up|1|||
48401325|NCT00744874|155660266|FG000|Overall Study|Withdrawal by Subject|1|||
48401326|NCT00744874|155660266|FG000|Overall Study|Study Device not available at procedure|1|||
48401327|NCT00744874|155660266|FG000|Overall Study|Unable to accomodate schedule|1|||
48401328|NCT03115151|155660269|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
48792715|NCT02527798|157080879|FG004|Overall Study|Did not receive intervention|0|||
48792716|NCT02527798|157080880|FG005|Overall Study|Did not receive intervention|0|||
48792717|NCT02526693|157080883|FG000|Overall Study|Physician Decision|3|||
48792718|NCT02526693|157080884|FG001|Overall Study|Physician Decision|1|||
48401329|NCT03115151|155660270|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
48401330|NCT03115151|155660269|FG000|Overall Study|Epidural catheter removal|1|||
48792719|NCT03750552|157080887|FG000|Overall Study|Adverse Event|5|||
48792720|NCT03750552|157080888|FG001|Overall Study|Adverse Event|1|||
48792721|NCT03750552|157080887|FG000|Overall Study|Withdrawal by Subject|1|||
48792722|NCT03750552|157080888|FG001|Overall Study|Withdrawal by Subject|1|||
48792723|NCT03750552|157080887|FG000|Overall Study|Other|2|||
48792724|NCT03750552|157080888|FG001|Overall Study|Other|0|||
48792725|NCT02367911|157080889|FG000|Overall Study|Withdrawal by Subject|3|||
48792726|NCT02367911|157080890|FG001|Overall Study|Withdrawal by Subject|2|||
48792727|NCT02367911|157080889|FG000|Overall Study|Lost to Follow-up|2|||
48792728|NCT02367911|157080890|FG001|Overall Study|Lost to Follow-up|2|||
48792729|NCT00773968|157080891|FG000|Overall Study|Adverse Event|2|||
48792730|NCT00773968|157080891|FG000|Overall Study|Death|1|||
48792731|NCT00773968|157080891|FG000|Overall Study|Failure to Return|2|||
48792732|NCT00773968|157080891|FG000|Overall Study|Lack of Efficacy|3|||
48792733|NCT00773968|157080891|FG000|Overall Study|Protocol Violation|1|||
48792734|NCT00773968|157080891|FG000|Overall Study|Withdrawal by Subject|11|||
48792735|NCT00773968|157080891|FG000|Overall Study|Screen Failure|17|||
48792736|NCT00773968|157080891|FG000|Overall Study|Other|8|||
48792737|NCT01003899|157080893|FG000|Overall Study|Other Adverse Event|8|||
48792738|NCT01003899|157080893|FG000|Overall Study|Not entered|4|||
48792739|NCT01003899|157080893|FG000|Overall Study|Not treated|1|||
48792740|NCT01003899|157080893|FG000|Overall Study|Progressive disease|34|||
48792741|NCT02522494|157080894|FG000|Overall Study|Lost to Follow-up|6|||
48792742|NCT02522494|157080895|FG001|Overall Study|Lost to Follow-up|2|||
48792743|NCT02522494|157080894|FG000|Overall Study|Withdrawal by Subject|1|||
48792744|NCT02522494|157080895|FG001|Overall Study|Withdrawal by Subject|0|||
48792745|NCT02522494|157080894|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
48792746|NCT02522494|157080895|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
48792747|NCT02522494|157080894|FG000|Overall Study|Participant did not watch the video|1|||
48792748|NCT02522494|157080895|FG001|Overall Study|Participant did not watch the video|0|||
48792749|NCT02522494|157080894|FG000|Overall Study|Death|0|||
48792750|NCT02522494|157080895|FG001|Overall Study|Death|1|||
48792751|NCT00328510|157080896|FG000|Overall Study|Gag disorder, could not use frame|4|||
48792752|NCT00328510|157080897|FG001|Overall Study|Gag disorder, could not use frame|0|||
48792753|NCT00328510|157080896|FG000|Overall Study|Dentition problems, could not use frame|1|||
48792754|NCT00328510|157080897|FG001|Overall Study|Dentition problems, could not use frame|0|||
48792755|NCT00328510|157080896|FG000|Overall Study|Withdrawal by Subject|4|||
48792756|NCT00328510|157080897|FG001|Overall Study|Withdrawal by Subject|2|||
48792757|NCT00328510|157080896|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
48792758|NCT00328510|157080897|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
48792759|NCT00328510|157080896|FG000|Overall Study|Treatment changed to a single fraction|1|||
48792760|NCT00328510|157080897|FG001|Overall Study|Treatment changed to a single fraction|1|||
48792761|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
48792762|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
48792763|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
48792764|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792765|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792766|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792767|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792768|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792769|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792770|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792771|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792772|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792773|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792774|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
48792775|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
48792776|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
48792777|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
48792778|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792779|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792780|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792781|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792782|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792783|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792784|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792785|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792786|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792787|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792788|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
48792789|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
48792790|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
48792791|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
48792792|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792793|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792794|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792795|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792796|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792797|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792798|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792799|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792800|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792801|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792802|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
48792803|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
48792804|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
48792805|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
48792806|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792807|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792808|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792809|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792810|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792811|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792812|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792813|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792814|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792815|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792816|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
48792817|NCT02349295|157080899|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792818|NCT02349295|157080900|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
48792819|NCT02349295|157080901|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
48792820|NCT02349295|157080902|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792821|NCT02349295|157080903|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792822|NCT02349295|157080904|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792823|NCT02349295|157080905|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792824|NCT02349295|157080906|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792825|NCT02349295|157080907|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792826|NCT02349295|157080908|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792827|NCT02349295|157080909|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792828|NCT02349295|157080910|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792829|NCT02349295|157080911|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48401331|NCT03115151|155660270|FG001|Overall Study|Epidural catheter removal|0|||
48401332|NCT03115151|155660269|FG000|Overall Study|Withdrawal by Subject|0|||
48401333|NCT03115151|155660270|FG001|Overall Study|Withdrawal by Subject|1|||
48401334|NCT03115151|155660269|FG000|Overall Study|Intervention not received according to the protocol.|1|||
48792830|NCT02349295|157080912|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
48792831|NCT02349295|157080899|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
48792832|NCT02349295|157080900|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
48792833|NCT02349295|157080901|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
48792834|NCT02349295|157080902|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
48792835|NCT02349295|157080903|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
48792836|NCT02349295|157080904|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
48792837|NCT02349295|157080905|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
48792838|NCT02349295|157080906|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
48792839|NCT02349295|157080907|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
48792840|NCT02349295|157080908|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
48792841|NCT02349295|157080909|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
48792842|NCT02349295|157080910|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
48792843|NCT02349295|157080911|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
48792844|NCT02349295|157080912|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
48792845|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792846|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792847|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792848|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792849|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792850|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792851|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792852|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
48792853|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
48792854|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
48792855|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
48792856|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792857|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792858|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
48792859|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792860|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792861|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792862|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792863|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792864|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792865|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792866|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
48792867|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
48792868|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
48792869|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
48792870|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792871|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792872|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
48792873|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792874|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792875|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792876|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792877|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792878|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792879|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792880|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
48792881|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792882|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
48792883|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792884|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792885|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792886|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
48792887|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
48792888|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
48792889|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
48792890|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
48792891|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
48792892|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
48401335|NCT03115151|155660270|FG001|Overall Study|Intervention not received according to the protocol.|1|||
48401336|NCT03115151|155660269|FG000|Overall Study|Physician Decision|1|||
48401337|NCT03115151|155660270|FG001|Overall Study|Physician Decision|0|||
48401338|NCT03115151|155660269|FG000|Overall Study|Randomization not applied|1|||
48401339|NCT03115151|155660270|FG001|Overall Study|Randomization not applied|1|||
48792893|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
48792894|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
48792895|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
48792896|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
48792897|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
48792898|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
48792899|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
48792900|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
48792901|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792902|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792903|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792904|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792905|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792906|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792907|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792908|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
48792909|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
48792910|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
48792911|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
48792912|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792913|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792914|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
48792915|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792916|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792917|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792918|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792919|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792920|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792921|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792922|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
48792923|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
48792924|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792925|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792926|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792927|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792928|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
48792929|NCT02349295|157080899|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792930|NCT02349295|157080900|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792931|NCT02349295|157080901|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792932|NCT02349295|157080902|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792933|NCT02349295|157080903|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792934|NCT02349295|157080904|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792935|NCT02349295|157080905|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792936|NCT02349295|157080906|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
48792937|NCT02349295|157080907|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
48792938|NCT02349295|157080908|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792939|NCT02349295|157080909|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792940|NCT02349295|157080910|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792941|NCT02349295|157080911|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792942|NCT02349295|157080912|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
48792943|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792944|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792945|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792946|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792947|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792948|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792949|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792950|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792951|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792952|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48401340|NCT03403205|155660274|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
48401341|NCT03403205|155660275|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
48792953|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
48792954|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
48792955|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
48792956|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
48792957|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792958|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792959|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792960|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792961|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792962|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792963|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792964|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792965|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792966|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48401342|NCT03403205|155660276|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
48401343|NCT03403205|155660277|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
48401344|NCT03403205|155660278|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48401345|NCT03403205|155660279|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48401346|NCT03403205|155660274|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
48401347|NCT03403205|155660275|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48401348|NCT03403205|155660276|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
48401349|NCT03403205|155660277|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48401350|NCT03403205|155660278|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48401351|NCT03403205|155660279|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48401352|NCT03403205|155660274|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
48401353|NCT03403205|155660275|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
48401354|NCT03403205|155660276|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
48401355|NCT03403205|155660277|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
48401356|NCT03403205|155660278|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
48401357|NCT03403205|155660279|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
48401358|NCT03403205|155660274|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
48401359|NCT03403205|155660275|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
48401360|NCT03403205|155660276|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
48401361|NCT03403205|155660277|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
48401362|NCT03403205|155660278|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
48401363|NCT03403205|155660279|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
48401364|NCT03403205|155660274|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
48401365|NCT03403205|155660275|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48401366|NCT03403205|155660276|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48401367|NCT03403205|155660277|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48401368|NCT03403205|155660278|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48401369|NCT03403205|155660279|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
48792967|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792968|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
48792969|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
48792970|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
48792971|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792972|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792973|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792974|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792975|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792976|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792977|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792978|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792979|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792980|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792981|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792982|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
48792983|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
48401370|NCT03403205|155660274|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48401371|NCT03403205|155660275|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
48401372|NCT03403205|155660276|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48792984|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
48792985|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792986|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792987|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792988|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792989|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792990|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792991|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48401373|NCT03403205|155660277|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48401374|NCT03403205|155660278|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48792992|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792993|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792994|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792995|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792996|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
48792997|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792998|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
48792999|NCT02349295|157080899|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793000|NCT02349295|157080900|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793001|NCT02349295|157080901|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793002|NCT02349295|157080902|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793003|NCT02349295|157080903|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793004|NCT02349295|157080904|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793005|NCT02349295|157080905|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793006|NCT02349295|157080906|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793007|NCT02349295|157080907|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793008|NCT02349295|157080908|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793009|NCT02349295|157080909|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48401375|NCT03403205|155660279|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
48401376|NCT03403205|155660274|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
48401377|NCT03403205|155660275|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
48401378|NCT03403205|155660276|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
48401379|NCT03403205|155660277|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
48401380|NCT03403205|155660278|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
48401381|NCT03403205|155660279|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
48793010|NCT02349295|157080910|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
48793011|NCT02349295|157080911|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793012|NCT02349295|157080912|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
48793013|NCT02863926|157080913|FG000|Overall Study|Physician Decision|1|||
48793014|NCT02863926|157080914|FG001|Overall Study|Physician Decision|0|||
48793015|NCT02863926|157080913|FG000|Overall Study|Lost to Follow-up|1|||
48793016|NCT02863926|157080914|FG001|Overall Study|Lost to Follow-up|1|||
48793017|NCT00739648|157080915|FG000|Overall Study|Adverse Event|3|||
48793018|NCT00739648|157080916|FG001|Overall Study|Adverse Event|15|||
48793019|NCT00739648|157080915|FG000|Overall Study|Withdrawal by Subject|13|||
48793020|NCT00739648|157080916|FG001|Overall Study|Withdrawal by Subject|25|||
48793021|NCT00739648|157080915|FG000|Overall Study|Lost to Follow-up|4|||
48793022|NCT00739648|157080916|FG001|Overall Study|Lost to Follow-up|7|||
48793023|NCT00739648|157080915|FG000|Overall Study|Death|2|||
48793024|NCT00739648|157080916|FG001|Overall Study|Death|0|||
48793025|NCT00739648|157080915|FG000|Overall Study|Do not know|4|||
48793026|NCT00739648|157080916|FG001|Overall Study|Do not know|6|||
48793027|NCT03422250|157080917|FG000|Intervention|Adverse Event|0|||
48793028|NCT03422250|157080918|FG001|Intervention|Adverse Event|1|||
48793029|NCT03422250|157080919|FG002|Intervention|Adverse Event|0|||
48793030|NCT03422250|157080920|FG003|Intervention|Adverse Event|1|||
48793031|NCT03422250|157080917|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
48793032|NCT03422250|157080918|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
48793033|NCT03422250|157080919|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
48793034|NCT03422250|157080920|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
48793035|NCT03422250|157080917|FG000|Follow-up|Withdrawal by Subject|0|||
48793036|NCT03422250|157080918|FG001|Follow-up|Withdrawal by Subject|0|||
48793037|NCT03422250|157080919|FG002|Follow-up|Withdrawal by Subject|0|||
48793038|NCT03422250|157080920|FG003|Follow-up|Withdrawal by Subject|1|||
48793039|NCT03422250|157080917|FG000|Follow-up|Adverse Event|0|||
48793040|NCT03422250|157080918|FG001|Follow-up|Adverse Event|0|||
48793041|NCT03422250|157080919|FG002|Follow-up|Adverse Event|0|||
48793042|NCT03422250|157080920|FG003|Follow-up|Adverse Event|1|||
48793043|NCT02216123|157080922|FG000|Overall Study|Lost to Follow-up|4|||
48793044|NCT02216123|157080923|FG001|Overall Study|Lost to Follow-up|2|||
48793045|NCT02216123|157080922|FG000|Overall Study|Withdrawal by Subject|2|||
48793046|NCT02216123|157080923|FG001|Overall Study|Withdrawal by Subject|0|||
48793047|NCT02239679|157080924|FG000|Overall Study|Lost to Follow-up|1|||
48793048|NCT02239679|157080925|FG001|Overall Study|Lost to Follow-up|0|||
48793049|NCT02239679|157080926|FG002|Overall Study|Lost to Follow-up|0|||
48793050|NCT02239679|157080924|FG000|Overall Study|Withdrawal by Subject|2|||
48793051|NCT02239679|157080925|FG001|Overall Study|Withdrawal by Subject|3|||
48793052|NCT02239679|157080926|FG002|Overall Study|Withdrawal by Subject|1|||
48793053|NCT01786512|157080928|FG000|Overall Study|Lost to Follow-up|0|||
48793054|NCT01786512|157080929|FG001|Overall Study|Lost to Follow-up|0|||
48793055|NCT01786512|157080930|FG002|Overall Study|Lost to Follow-up|0|||
48793056|NCT01786512|157080931|FG003|Overall Study|Lost to Follow-up|0|||
48793057|NCT01786512|157080932|FG004|Overall Study|Lost to Follow-up|0|||
48793058|NCT01786512|157080933|FG005|Overall Study|Lost to Follow-up|0|||
48793059|NCT01786512|157080934|FG006|Overall Study|Lost to Follow-up|0|||
48793060|NCT01786512|157080935|FG007|Overall Study|Lost to Follow-up|0|||
48793061|NCT01786512|157080936|FG008|Overall Study|Lost to Follow-up|0|||
48793062|NCT01786512|157080937|FG009|Overall Study|Lost to Follow-up|1|||
48793063|NCT01786512|157080938|FG010|Overall Study|Lost to Follow-up|0|||
48793064|NCT01786512|157080928|FG000|Overall Study|Decision by sponsor|0|||
48793065|NCT01786512|157080929|FG001|Overall Study|Decision by sponsor|0|||
48793066|NCT01786512|157080930|FG002|Overall Study|Decision by sponsor|0|||
48793067|NCT01786512|157080931|FG003|Overall Study|Decision by sponsor|0|||
48793068|NCT01786512|157080932|FG004|Overall Study|Decision by sponsor|0|||
48793069|NCT01786512|157080933|FG005|Overall Study|Decision by sponsor|0|||
48793070|NCT01786512|157080934|FG006|Overall Study|Decision by sponsor|0|||
48793071|NCT01786512|157080935|FG007|Overall Study|Decision by sponsor|0|||
48793072|NCT01786512|157080936|FG008|Overall Study|Decision by sponsor|0|||
48793073|NCT01786512|157080937|FG009|Overall Study|Decision by sponsor|0|||
48793074|NCT01786512|157080938|FG010|Overall Study|Decision by sponsor|2|||
48793075|NCT01786512|157080928|FG000|Overall Study|Withdrawal by Subject|0|||
48793076|NCT01786512|157080929|FG001|Overall Study|Withdrawal by Subject|1|||
48793077|NCT01786512|157080930|FG002|Overall Study|Withdrawal by Subject|0|||
48793078|NCT01786512|157080931|FG003|Overall Study|Withdrawal by Subject|0|||
48793079|NCT01786512|157080932|FG004|Overall Study|Withdrawal by Subject|0|||
48793080|NCT01786512|157080933|FG005|Overall Study|Withdrawal by Subject|0|||
48793081|NCT01786512|157080934|FG006|Overall Study|Withdrawal by Subject|1|||
48793082|NCT01786512|157080935|FG007|Overall Study|Withdrawal by Subject|0|||
48793083|NCT01786512|157080936|FG008|Overall Study|Withdrawal by Subject|0|||
48793084|NCT01786512|157080937|FG009|Overall Study|Withdrawal by Subject|3|||
48793085|NCT01786512|157080938|FG010|Overall Study|Withdrawal by Subject|7|||
48793086|NCT01786512|157080928|FG000|Overall Study|Death|0|||
48793087|NCT01786512|157080929|FG001|Overall Study|Death|0|||
48793088|NCT01786512|157080930|FG002|Overall Study|Death|0|||
48793089|NCT01786512|157080931|FG003|Overall Study|Death|0|||
48793090|NCT01786512|157080932|FG004|Overall Study|Death|0|||
48793091|NCT01786512|157080933|FG005|Overall Study|Death|0|||
48793092|NCT01786512|157080934|FG006|Overall Study|Death|0|||
48793093|NCT01786512|157080935|FG007|Overall Study|Death|0|||
48793094|NCT01786512|157080936|FG008|Overall Study|Death|4|||
48793095|NCT01786512|157080937|FG009|Overall Study|Death|1|||
48793096|NCT01786512|157080938|FG010|Overall Study|Death|3|||
48793097|NCT03137303|157080939|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
48793098|NCT03137303|157080940|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
48793099|NCT03137303|157080939|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
48793100|NCT03137303|157080940|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
48793101|NCT03137303|157080939|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
48793102|NCT03137303|157080940|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
48793103|NCT03137303|157080939|FG000|T3: 9-month Follow-up|Death|1|||
48793104|NCT03137303|157080940|FG001|T3: 9-month Follow-up|Death|0|||
48793105|NCT03137303|157080939|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
48793106|NCT03137303|157080940|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
48793107|NCT03137303|157080939|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
48793108|NCT03137303|157080940|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
48793109|NCT03137303|157080939|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
48793110|NCT03137303|157080940|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
48793111|NCT00760929|157080941|FG000|Overall Study|Adverse Event|2|||
48793112|NCT00760929|157080942|FG001|Overall Study|Adverse Event|0|||
48793113|NCT00760929|157080943|FG002|Overall Study|Adverse Event|6|||
48793114|NCT00760929|157080944|FG003|Overall Study|Adverse Event|10|||
48793115|NCT00760929|157080941|FG000|Overall Study|Lack of Efficacy|0|||
48793116|NCT00760929|157080942|FG001|Overall Study|Lack of Efficacy|2|||
48793117|NCT00760929|157080943|FG002|Overall Study|Lack of Efficacy|1|||
48793118|NCT00760929|157080944|FG003|Overall Study|Lack of Efficacy|0|||
48793119|NCT00760929|157080941|FG000|Overall Study|Withdrawal by Subject|1|||
48793120|NCT00760929|157080942|FG001|Overall Study|Withdrawal by Subject|0|||
48793121|NCT00760929|157080943|FG002|Overall Study|Withdrawal by Subject|9|||
48793122|NCT00760929|157080944|FG003|Overall Study|Withdrawal by Subject|1|||
48793123|NCT00760929|157080941|FG000|Overall Study|Lost to Follow-up|0|||
48793124|NCT00760929|157080942|FG001|Overall Study|Lost to Follow-up|0|||
48793125|NCT00760929|157080943|FG002|Overall Study|Lost to Follow-up|1|||
48793126|NCT00760929|157080944|FG003|Overall Study|Lost to Follow-up|0|||
48793127|NCT00760929|157080941|FG000|Overall Study|Progression of Disease|21|||
48793128|NCT00760929|157080942|FG001|Overall Study|Progression of Disease|26|||
48793129|NCT00760929|157080943|FG002|Overall Study|Progression of Disease|38|||
48793130|NCT00760929|157080944|FG003|Overall Study|Progression of Disease|42|||
48793131|NCT00760929|157080941|FG000|Overall Study|Other|2|||
48793132|NCT00760929|157080942|FG001|Overall Study|Other|0|||
48793133|NCT00760929|157080943|FG002|Overall Study|Other|2|||
48793134|NCT00760929|157080944|FG003|Overall Study|Other|1|||
48793135|NCT00760929|157080941|FG000|Overall Study|Death|0|||
48793136|NCT00760929|157080942|FG001|Overall Study|Death|0|||
48793137|NCT00760929|157080943|FG002|Overall Study|Death|1|||
48793138|NCT00760929|157080944|FG003|Overall Study|Death|0|||
48793139|NCT00760929|157080941|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
48793140|NCT00760929|157080942|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
48793141|NCT00760929|157080943|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
48793142|NCT00760929|157080944|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
48793143|NCT04060355|157080946|FG000|Overall Study|Lost to Follow-up|41|||
48793144|NCT00574080|157080947|FG000|Overall Study|Death|10|||
48793145|NCT00574080|157080948|FG001|Overall Study|Death|10|||
48793146|NCT03966157|157080949|FG000|Overall Study|Physician Decision|1|||
48793147|NCT03966157|157080950|FG001|Overall Study|Physician Decision|0|||
48793148|NCT01597050|157080951|FG000|Overall Study|Withdrawal by Subject|1|||
48793149|NCT01597050|157080952|FG001|Overall Study|Withdrawal by Subject|0|||
48793150|NCT02065336|157080953|FG000|Extension Phase|Study Terminated by Sponsor|0|||
48793151|NCT02065336|157080954|FG001|Extension Phase|Study Terminated by Sponsor|0|||
48793152|NCT02065336|157080955|FG002|Extension Phase|Study Terminated by Sponsor|0|||
48793153|NCT02065336|157080956|FG003|Extension Phase|Study Terminated by Sponsor|0|||
48793154|NCT02065336|157080957|FG004|Extension Phase|Study Terminated by Sponsor|0|||
48793155|NCT02065336|157080958|FG005|Extension Phase|Study Terminated by Sponsor|0|||
48793156|NCT02065336|157080959|FG006|Extension Phase|Study Terminated by Sponsor|0|||
48793157|NCT02065336|157080960|FG007|Extension Phase|Study Terminated by Sponsor|0|||
48793158|NCT02065336|157080961|FG008|Extension Phase|Study Terminated by Sponsor|2|||
48793159|NCT02065336|157080962|FG009|Extension Phase|Study Terminated by Sponsor|8|||
48793160|NCT02278328|157080966|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
48793161|NCT02278328|157080967|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
48793162|NCT02278328|157080968|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
48793163|NCT02278328|157080966|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
48793164|NCT02278328|157080967|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
48793165|NCT02278328|157080968|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
48793166|NCT02278328|157080966|FG000|Neuropsych Screening|incomplete consent|0|||
48793167|NCT02278328|157080967|FG001|Neuropsych Screening|incomplete consent|0|||
48793168|NCT02278328|157080968|FG002|Neuropsych Screening|incomplete consent|2|||
48793169|NCT04794803|157080970|FG000|Overall Study|Death|1|||
48793170|NCT04794803|157080971|FG001|Overall Study|Death|3|||
48793171|NCT04794803|157080970|FG000|Overall Study|Lost to Follow-up|2|||
48793172|NCT04794803|157080971|FG001|Overall Study|Lost to Follow-up|2|||
48793173|NCT04794803|157080970|FG000|Overall Study|Withdrawal by Subject|1|||
48793174|NCT04794803|157080971|FG001|Overall Study|Withdrawal by Subject|0|||
48793175|NCT04794803|157080970|FG000|Overall Study|Physician Decision|1|||
48793176|NCT04794803|157080971|FG001|Overall Study|Physician Decision|1|||
48793177|NCT04794803|157080970|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
48793178|NCT04794803|157080971|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
48793179|NCT04794803|157080970|FG000|Overall Study|Refused to continue the treatment|1|||
48793180|NCT04794803|157080971|FG001|Overall Study|Refused to continue the treatment|0|||
48793181|NCT04794803|157080970|FG000|Overall Study|Patient admitted to ICU|0|||
48793182|NCT04794803|157080971|FG001|Overall Study|Patient admitted to ICU|1|||
48793183|NCT01388816|157080972|FG000|Overall Study|Adverse Event|0|||
48793184|NCT01388816|157080973|FG001|Overall Study|Adverse Event|2|||
48793185|NCT01388816|157080974|FG002|Overall Study|Adverse Event|0|||
48793186|NCT01388816|157080975|FG003|Overall Study|Adverse Event|0|||
48793187|NCT01388816|157080972|FG000|Overall Study|Lost to Follow-up|0|||
48793188|NCT01388816|157080973|FG001|Overall Study|Lost to Follow-up|1|||
48793189|NCT01388816|157080974|FG002|Overall Study|Lost to Follow-up|0|||
48793190|NCT01388816|157080975|FG003|Overall Study|Lost to Follow-up|0|||
48793191|NCT01388816|157080972|FG000|Overall Study|Withdrawal by Subject|2|||
48793192|NCT01388816|157080973|FG001|Overall Study|Withdrawal by Subject|1|||
48793193|NCT01388816|157080974|FG002|Overall Study|Withdrawal by Subject|1|||
48793194|NCT01388816|157080975|FG003|Overall Study|Withdrawal by Subject|0|||
48793195|NCT01388816|157080972|FG000|Overall Study|Protocol Violation|0|||
48793196|NCT01388816|157080973|FG001|Overall Study|Protocol Violation|0|||
48793197|NCT01388816|157080974|FG002|Overall Study|Protocol Violation|2|||
48793198|NCT01388816|157080975|FG003|Overall Study|Protocol Violation|0|||
48793199|NCT01995461|157080978|FG000|Overall Study|Death|1|||
48793200|NCT01995461|157080978|FG000|Overall Study|Lost to Follow-up|2|||
48793201|NCT01995461|157080978|FG000|Overall Study|Withdrawal by Subject|2|||
48793202|NCT03240692|157080982|FG000|Overall Study|Physician Decision|1|||
48793203|NCT03240692|157080982|FG000|Overall Study|Withdrawal by Subject|1|||
48793204|NCT01857531|157080983|FG000|Overall Study|Withdrawal by Subject|4|||
48793205|NCT01775904|157080986|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
48793206|NCT01775904|157080986|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
48793207|NCT02820623|157080987|FG000|Overall Study|Withdrawal by Subject|1|||
48793208|NCT02820623|157080988|FG001|Overall Study|Withdrawal by Subject|3|||
48793209|NCT02820623|157080989|FG002|Overall Study|Withdrawal by Subject|3|||
48793210|NCT02820623|157080987|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
48793211|NCT02820623|157080988|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
48793212|NCT02820623|157080989|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
48793213|NCT02820623|157080987|FG000|Overall Study|Therapist unable to enroll clients|1|||
48793214|NCT02820623|157080988|FG001|Overall Study|Therapist unable to enroll clients|1|||
48793215|NCT02820623|157080989|FG002|Overall Study|Therapist unable to enroll clients|3|||
48793216|NCT02820623|157080987|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
48793217|NCT02820623|157080988|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
48793218|NCT02820623|157080989|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
48793219|NCT00617344|157080990|FG000|Overall Study|Serious adverse event|1|||
48793220|NCT00617344|157080991|FG001|Overall Study|Serious adverse event|0|||
48793221|NCT00617344|157080992|FG002|Overall Study|Serious adverse event|0|||
48793222|NCT00617344|157080990|FG000|Overall Study|Other Adverse Event|1|||
48793223|NCT00617344|157080991|FG001|Overall Study|Other Adverse Event|1|||
48793224|NCT00617344|157080992|FG002|Overall Study|Other Adverse Event|0|||
48793225|NCT00617344|157080990|FG000|Overall Study|Protocol Violation|10|||
48793226|NCT00617344|157080991|FG001|Overall Study|Protocol Violation|8|||
48793227|NCT00617344|157080992|FG002|Overall Study|Protocol Violation|5|||
48793228|NCT00617344|157080990|FG000|Overall Study|Lost to Follow-up|5|||
48793229|NCT00617344|157080991|FG001|Overall Study|Lost to Follow-up|4|||
48793230|NCT00617344|157080992|FG002|Overall Study|Lost to Follow-up|1|||
48793231|NCT00617344|157080990|FG000|Overall Study|Withdrawal by Subject|8|||
48793232|NCT00617344|157080991|FG001|Overall Study|Withdrawal by Subject|9|||
48793233|NCT00617344|157080992|FG002|Overall Study|Withdrawal by Subject|2|||
48793234|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
48793235|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
48793236|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
48793237|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
48793238|NCT00983073|157080993|FG000|Titration and Optimal Dose Period|Other reason|4|||
48793239|NCT00983073|157080993|FG000|Maintenance Period|Adverse Event|5|||
48793240|NCT00983073|157080993|FG000|Maintenance Period|Withdrawal by Subject|2|||
48793241|NCT00983073|157080993|FG000|Maintenance Period|Lack of Efficacy|2|||
48793242|NCT00983073|157080993|FG000|Maintenance Period|Other Reason|7|||
48793243|NCT00636610|157080998|FG000|Overall Study|Adverse Event|4|||
48793244|NCT00636610|157080999|FG001|Overall Study|Adverse Event|4|||
48793245|NCT00636610|157080998|FG000|Overall Study|Death|6|||
48793246|NCT00636610|157080999|FG001|Overall Study|Death|3|||
48793247|NCT00636610|157080998|FG000|Overall Study|Physician decision to withdraw patient|15|||
48793248|NCT00636610|157080999|FG001|Overall Study|Physician decision to withdraw patient|9|||
48793249|NCT00636610|157080998|FG000|Overall Study|Subject decision to withdraw|15|||
48793250|NCT00636610|157080999|FG001|Overall Study|Subject decision to withdraw|11|||
48793251|NCT00636610|157080998|FG000|Overall Study|Disease progression - radiographic|41|||
48793252|NCT00636610|157080999|FG001|Overall Study|Disease progression - radiographic|51|||
48793253|NCT00636610|157080998|FG000|Overall Study|Disease progression - clinical|8|||
48793254|NCT00636610|157080999|FG001|Overall Study|Disease progression - clinical|3|||
48793255|NCT00636610|157080998|FG000|Overall Study|Reason for discontinuation not available|3|||
48793256|NCT00636610|157080999|FG001|Overall Study|Reason for discontinuation not available|2|||
48793257|NCT03762473|157081000|FG000|Overall Study|Death|1|||
48793258|NCT03762473|157081001|FG001|Overall Study|Death|0|||
48793259|NCT00941330|157081004|FG000|Overall Study|Other|1|||
48793260|NCT00941330|157081005|FG001|Overall Study|Other|0|||
48793261|NCT00941330|157081004|FG000|Overall Study|Physician Decision|0|||
48793262|NCT00941330|157081005|FG001|Overall Study|Physician Decision|2|||
48793263|NCT00818753|157081006|FG000|Overall Study|Protocol Violation|1|||
48793264|NCT00818753|157081007|FG001|Overall Study|Protocol Violation|0|||
48793265|NCT00818753|157081008|FG002|Overall Study|Protocol Violation|0|||
48793266|NCT00818753|157081006|FG000|Overall Study|Other reason (not specified)|0|||
48401382|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
48401383|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
48793267|NCT00818753|157081007|FG001|Overall Study|Other reason (not specified)|0|||
48793268|NCT00818753|157081008|FG002|Overall Study|Other reason (not specified)|1|||
48793269|NCT00818753|157081006|FG000|Overall Study|Randomised and not treated|2|||
48793270|NCT00818753|157081007|FG001|Overall Study|Randomised and not treated|0|||
48793271|NCT00818753|157081008|FG002|Overall Study|Randomised and not treated|0|||
48793272|NCT00725296|157081010|FG000|Overall Study|Adverse Event|11|||
48793273|NCT00725296|157081010|FG000|Overall Study|Lack of Efficacy|7|||
48793274|NCT00725296|157081010|FG000|Overall Study|Withdrawal by Subject|3|||
48793275|NCT00725296|157081010|FG000|Overall Study|Non-Compliance|2|||
48793276|NCT00725296|157081010|FG000|Overall Study|Lost to Follow-up|1|||
48793277|NCT00725296|157081010|FG000|Overall Study|Other|38|||
48793278|NCT00657618|157081013|FG000|Overall Study|Adverse Event|32|||
48793279|NCT00657618|157081013|FG000|Overall Study|Withdrawal by Subject|8|||
48793280|NCT00657618|157081013|FG000|Overall Study|negative for leishmaniasis|2|||
48793281|NCT00657618|157081013|FG000|Overall Study|didn't start due to schedule conflicts|1|||
48793282|NCT04980300|157081016|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
48793283|NCT04980300|157081017|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
48793284|NCT04980300|157081016|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
48793285|NCT04980300|157081017|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
48793286|NCT04980300|157081016|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
48793287|NCT04980300|157081017|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
48793288|NCT04980300|157081016|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
48793289|NCT04980300|157081017|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
48793290|NCT04940624|157081019|FG000|Overall Study|Adverse Event|4|||
48793291|NCT04940624|157081020|FG001|Overall Study|Adverse Event|11|||
48793292|NCT04940624|157081019|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
48793293|NCT04940624|157081020|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
48793294|NCT04940624|157081019|FG000|Overall Study|Physician Decision|1|||
48793295|NCT04940624|157081020|FG001|Overall Study|Physician Decision|0|||
48793296|NCT04940624|157081019|FG000|Overall Study|Lost to Follow-up|1|||
48793297|NCT04940624|157081020|FG001|Overall Study|Lost to Follow-up|0|||
48793298|NCT04940624|157081019|FG000|Overall Study|Reason Not Specified|1|||
48793299|NCT04940624|157081020|FG001|Overall Study|Reason Not Specified|0|||
48793300|NCT00423176|157082149|FG000|Overall Study|Adverse Event|4|||
48793301|NCT00423176|157082150|FG001|Overall Study|Adverse Event|6|||
48793302|NCT00423176|157082149|FG000|Overall Study|Treatment Failure|1|||
48793303|NCT00423176|157082150|FG001|Overall Study|Treatment Failure|6|||
48793304|NCT00423176|157082149|FG000|Overall Study|Lost to Follow-up|4|||
48793305|NCT00423176|157082150|FG001|Overall Study|Lost to Follow-up|7|||
48793306|NCT00423176|157082149|FG000|Overall Study|Withdrawal by Subject|4|||
48793307|NCT00423176|157082150|FG001|Overall Study|Withdrawal by Subject|3|||
48793308|NCT00423176|157082149|FG000|Overall Study|Protocol Violation|1|||
48793309|NCT00423176|157082150|FG001|Overall Study|Protocol Violation|3|||
48793310|NCT00423176|157082149|FG000|Overall Study|Did not meet protocol eligibility|2|||
48793311|NCT00423176|157082150|FG001|Overall Study|Did not meet protocol eligibility|4|||
48793312|NCT05072080|157082151|FG000|Overall Study|Death|0|||
48793313|NCT05072080|157082152|FG001|Overall Study|Death|0|||
48793314|NCT05072080|157082153|FG002|Overall Study|Death|1|||
48793315|NCT05072080|157082154|FG003|Overall Study|Death|0|||
48793316|NCT05072080|157082151|FG000|Overall Study|Lost to Follow-up|65|||
48793317|NCT05072080|157082152|FG001|Overall Study|Lost to Follow-up|70|||
48793318|NCT05072080|157082153|FG002|Overall Study|Lost to Follow-up|58|||
48793319|NCT05072080|157082154|FG003|Overall Study|Lost to Follow-up|23|||
48793320|NCT05072080|157082151|FG000|Overall Study|Physician Decision|2|||
48793321|NCT05072080|157082152|FG001|Overall Study|Physician Decision|1|||
48793322|NCT05072080|157082153|FG002|Overall Study|Physician Decision|1|||
48793323|NCT05072080|157082154|FG003|Overall Study|Physician Decision|0|||
48793324|NCT05072080|157082151|FG000|Overall Study|Withdrawal by Subject|45|||
48793325|NCT05072080|157082152|FG001|Overall Study|Withdrawal by Subject|30|||
48793326|NCT05072080|157082153|FG002|Overall Study|Withdrawal by Subject|27|||
48793327|NCT05072080|157082154|FG003|Overall Study|Withdrawal by Subject|7|||
48793328|NCT05072080|157082151|FG000|Overall Study|Sponsor Decision|0|||
48793329|NCT05072080|157082152|FG001|Overall Study|Sponsor Decision|1|||
48793330|NCT05072080|157082153|FG002|Overall Study|Sponsor Decision|0|||
48793331|NCT05072080|157082154|FG003|Overall Study|Sponsor Decision|0|||
48401384|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
48793332|NCT05072080|157082151|FG000|Overall Study|Subject moved|1|||
48793333|NCT05072080|157082152|FG001|Overall Study|Subject moved|3|||
48793334|NCT05072080|157082153|FG002|Overall Study|Subject moved|5|||
48430355|NCT00696657|155763700|FG000|Overall Study|Unclassified|0|||
48793335|NCT05072080|157082154|FG003|Overall Study|Subject moved|2|||
48793336|NCT05072080|157082151|FG000|Overall Study|Withdrawal by parent|0|||
48793337|NCT05072080|157082152|FG001|Overall Study|Withdrawal by parent|0|||
48793338|NCT05072080|157082153|FG002|Overall Study|Withdrawal by parent|1|||
48793339|NCT05072080|157082154|FG003|Overall Study|Withdrawal by parent|0|||
48793340|NCT05072080|157082151|FG000|Overall Study|Subject was deployed|0|||
48793341|NCT05072080|157082152|FG001|Overall Study|Subject was deployed|1|||
48793342|NCT05072080|157082153|FG002|Overall Study|Subject was deployed|0|||
48793343|NCT05072080|157082154|FG003|Overall Study|Subject was deployed|0|||
48793344|NCT05072080|157082151|FG000|Overall Study|Subject left site without receiving dose|0|||
48793345|NCT05072080|157082152|FG001|Overall Study|Subject left site without receiving dose|1|||
48793346|NCT05072080|157082153|FG002|Overall Study|Subject left site without receiving dose|0|||
48793347|NCT05072080|157082154|FG003|Overall Study|Subject left site without receiving dose|0|||
48793348|NCT05072080|157082151|FG000|Overall Study|Subject incarcerated|0|||
48793349|NCT05072080|157082152|FG001|Overall Study|Subject incarcerated|1|||
48793350|NCT05072080|157082153|FG002|Overall Study|Subject incarcerated|0|||
48793351|NCT05072080|157082154|FG003|Overall Study|Subject incarcerated|1|||
48793352|NCT05072080|157082151|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
48793353|NCT05072080|157082152|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
48793354|NCT05072080|157082153|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
48793355|NCT05072080|157082154|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
48793356|NCT05072080|157082151|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
48793357|NCT05072080|157082152|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
48793358|NCT05072080|157082153|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
48793359|NCT05072080|157082154|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
48793360|NCT03763708|157082155|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
48793361|NCT03763708|157082156|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793362|NCT03763708|157082157|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793363|NCT03763708|157082158|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793364|NCT03763708|157082159|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793365|NCT03763708|157082160|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793366|NCT03763708|157082161|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793367|NCT03763708|157082162|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793368|NCT03763708|157082163|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
48793369|NCT03763708|157082155|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793370|NCT03763708|157082156|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793371|NCT03763708|157082157|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
48793372|NCT03763708|157082158|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793373|NCT03763708|157082159|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793374|NCT03763708|157082160|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793375|NCT03763708|157082161|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793376|NCT03763708|157082162|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793377|NCT03763708|157082163|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
48793378|NCT03763708|157082155|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793379|NCT03763708|157082156|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793380|NCT03763708|157082157|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793381|NCT03763708|157082158|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
48793382|NCT03763708|157082159|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793383|NCT03763708|157082160|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793384|NCT03763708|157082161|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793385|NCT03763708|157082162|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793386|NCT03763708|157082163|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
48793387|NCT03763708|157082155|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793388|NCT03763708|157082156|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793389|NCT03763708|157082157|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793390|NCT03763708|157082158|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793391|NCT03763708|157082159|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
48793392|NCT03763708|157082160|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793393|NCT03763708|157082161|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793394|NCT03763708|157082162|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793395|NCT03763708|157082163|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
48793396|NCT03763708|157082155|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793397|NCT03763708|157082156|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793398|NCT03763708|157082157|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793399|NCT03763708|157082158|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793400|NCT03763708|157082159|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793401|NCT03763708|157082160|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
48793402|NCT03763708|157082161|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793403|NCT03763708|157082162|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793404|NCT03763708|157082163|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
48793405|NCT03763708|157082155|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793406|NCT03763708|157082156|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793407|NCT03763708|157082157|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793408|NCT03763708|157082158|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793409|NCT03763708|157082159|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793410|NCT03763708|157082160|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793411|NCT03763708|157082161|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
48793412|NCT03763708|157082162|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793413|NCT03763708|157082163|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
48793414|NCT03763708|157082155|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
48793415|NCT03763708|157082156|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
48793416|NCT03763708|157082157|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
48793417|NCT03763708|157082158|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
48793418|NCT03763708|157082159|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
48793419|NCT03763708|157082160|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
48793420|NCT03763708|157082161|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
48793421|NCT03763708|157082162|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
48793422|NCT03763708|157082163|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
48793423|NCT03763708|157082155|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
48793424|NCT03763708|157082156|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
48793425|NCT03763708|157082157|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
48793426|NCT03763708|157082158|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
48793427|NCT03763708|157082159|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
48793428|NCT03763708|157082160|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
48793429|NCT03763708|157082161|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
48793430|NCT03763708|157082162|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
48793431|NCT03763708|157082163|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
48793432|NCT03763708|157082155|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
48793433|NCT03763708|157082156|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
48401385|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
48401386|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
48401387|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
48401388|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
48401389|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
48401390|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
48401391|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
48401392|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
48401393|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
48401394|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Death|1|||
48793434|NCT03763708|157082157|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
48793435|NCT03763708|157082158|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
48793436|NCT03763708|157082159|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
48793437|NCT03763708|157082160|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
48793438|NCT03763708|157082161|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
48793439|NCT03763708|157082162|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
48793440|NCT03763708|157082163|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
48793441|NCT03768505|157082165|FG000|Overall Study|sponsor decision|76|||
48793442|NCT03768505|157082165|FG000|Overall Study|Death|35|||
48793443|NCT03768505|157082165|FG000|Overall Study|Other -Various|30|||
48793444|NCT03768505|157082165|FG000|Overall Study|Withdrawal by Subject|22|||
48793445|NCT03768505|157082165|FG000|Overall Study|Lost to Follow-up|6|||
48793446|NCT03896035|157082168|FG000|Overall Study|Lost to Follow-up|2|||
48793447|NCT03896035|157082169|FG001|Overall Study|Lost to Follow-up|6|||
48793448|NCT03896035|157082168|FG000|Overall Study|Withdrawal by Subject|0|||
48793449|NCT03896035|157082169|FG001|Overall Study|Withdrawal by Subject|1|||
48401395|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Death|0|||
48401396|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Death|0|||
48401397|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Death|0|||
48793450|NCT03896035|157082168|FG000|Overall Study|Health/family health issues during COVID|0|||
48793451|NCT03896035|157082169|FG001|Overall Study|Health/family health issues during COVID|4|||
48793452|NCT00827918|157082179|FG000|Overall Study|Adverse Event|4|||
48793453|NCT00827918|157082180|FG001|Overall Study|Adverse Event|0|||
48793454|NCT00827918|157082181|FG002|Overall Study|Adverse Event|0|||
48401398|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Death|0|||
48401399|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Death|0|||
48401400|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
48401401|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48401402|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48401403|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48401404|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48401405|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
48401406|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
48401407|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
48401408|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
48401409|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
48401410|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
48401411|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
48401412|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
48401413|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48401414|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48401415|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48401416|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48401417|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
48401418|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
48401419|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
48401420|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
48401421|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
48401422|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
48401423|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
48401424|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
48401425|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
48793455|NCT00827918|157082179|FG000|Overall Study|Lack of Efficacy|16|||
48793456|NCT00827918|157082180|FG001|Overall Study|Lack of Efficacy|4|||
48793457|NCT00827918|157082181|FG002|Overall Study|Lack of Efficacy|15|||
48793458|NCT00827918|157082179|FG000|Overall Study|Physician Decision|1|||
48793459|NCT00827918|157082180|FG001|Overall Study|Physician Decision|0|||
48793460|NCT00827918|157082181|FG002|Overall Study|Physician Decision|0|||
48401426|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
48793461|NCT00827918|157082179|FG000|Overall Study|Pregnancy|0|||
48793462|NCT00827918|157082180|FG001|Overall Study|Pregnancy|1|||
48793463|NCT00827918|157082181|FG002|Overall Study|Pregnancy|0|||
48793464|NCT00827918|157082179|FG000|Overall Study|Progressive Disease|1|||
48793465|NCT00827918|157082180|FG001|Overall Study|Progressive Disease|1|||
48793466|NCT00827918|157082181|FG002|Overall Study|Progressive Disease|0|||
48793467|NCT00827918|157082179|FG000|Overall Study|Protocol Violation|0|||
48793468|NCT00827918|157082180|FG001|Overall Study|Protocol Violation|1|||
48793469|NCT00827918|157082181|FG002|Overall Study|Protocol Violation|0|||
48793470|NCT00827918|157082179|FG000|Overall Study|Withdrawal by Subject|6|||
48793471|NCT00827918|157082180|FG001|Overall Study|Withdrawal by Subject|2|||
48793472|NCT00827918|157082181|FG002|Overall Study|Withdrawal by Subject|6|||
48793473|NCT01302847|157082182|FG000|Overall Study|Death|0|||
48793474|NCT01302847|157082183|FG001|Overall Study|Death|1|||
48793475|NCT01302847|157082184|FG002|Overall Study|Death|0|||
48793476|NCT01302847|157082185|FG003|Overall Study|Death|0|||
48793477|NCT01302847|157082186|FG004|Overall Study|Death|0|||
48793478|NCT01302847|157082187|FG005|Overall Study|Death|1|||
48793479|NCT01302847|157082188|FG006|Overall Study|Death|1|||
48793480|NCT01302847|157082189|FG007|Overall Study|Death|0|||
48793481|NCT01302847|157082182|FG000|Overall Study|Pregnancy|2|||
48793482|NCT01302847|157082183|FG001|Overall Study|Pregnancy|0|||
48793483|NCT01302847|157082184|FG002|Overall Study|Pregnancy|0|||
48793484|NCT01302847|157082185|FG003|Overall Study|Pregnancy|0|||
48793485|NCT01302847|157082186|FG004|Overall Study|Pregnancy|0|||
48793486|NCT01302847|157082187|FG005|Overall Study|Pregnancy|0|||
48793487|NCT01302847|157082188|FG006|Overall Study|Pregnancy|0|||
48793488|NCT01302847|157082189|FG007|Overall Study|Pregnancy|0|||
48793489|NCT01302847|157082182|FG000|Overall Study|Virologic failure|0|||
48793490|NCT01302847|157082183|FG001|Overall Study|Virologic failure|2|||
48793491|NCT01302847|157082184|FG002|Overall Study|Virologic failure|0|||
48793492|NCT01302847|157082185|FG003|Overall Study|Virologic failure|2|||
48793493|NCT01302847|157082186|FG004|Overall Study|Virologic failure|1|||
48793494|NCT01302847|157082187|FG005|Overall Study|Virologic failure|3|||
48793495|NCT01302847|157082188|FG006|Overall Study|Virologic failure|1|||
48793496|NCT01302847|157082189|FG007|Overall Study|Virologic failure|2|||
48793497|NCT01302847|157082182|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48793498|NCT01302847|157082183|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48793499|NCT01302847|157082184|FG002|Overall Study|Severe debilitation, unable to continue|0|||
48793500|NCT01302847|157082185|FG003|Overall Study|Severe debilitation, unable to continue|0|||
48793501|NCT01302847|157082186|FG004|Overall Study|Severe debilitation, unable to continue|0|||
48793502|NCT01302847|157082187|FG005|Overall Study|Severe debilitation, unable to continue|1|||
48793503|NCT01302847|157082188|FG006|Overall Study|Severe debilitation, unable to continue|1|||
48793504|NCT01302847|157082189|FG007|Overall Study|Severe debilitation, unable to continue|0|||
48793505|NCT01302847|157082182|FG000|Overall Study|Not able to get to clinic|1|||
48793506|NCT01302847|157082183|FG001|Overall Study|Not able to get to clinic|1|||
48793507|NCT01302847|157082184|FG002|Overall Study|Not able to get to clinic|0|||
48793508|NCT01302847|157082185|FG003|Overall Study|Not able to get to clinic|0|||
48793509|NCT01302847|157082186|FG004|Overall Study|Not able to get to clinic|0|||
48793510|NCT01302847|157082187|FG005|Overall Study|Not able to get to clinic|0|||
48793511|NCT01302847|157082188|FG006|Overall Study|Not able to get to clinic|0|||
48793512|NCT01302847|157082189|FG007|Overall Study|Not able to get to clinic|0|||
48793513|NCT01302847|157082182|FG000|Overall Study|Site closing|2|||
48793514|NCT01302847|157082183|FG001|Overall Study|Site closing|2|||
48793515|NCT01302847|157082184|FG002|Overall Study|Site closing|0|||
48793516|NCT01302847|157082185|FG003|Overall Study|Site closing|0|||
48793517|NCT01302847|157082186|FG004|Overall Study|Site closing|0|||
48793518|NCT01302847|157082187|FG005|Overall Study|Site closing|0|||
48793519|NCT01302847|157082188|FG006|Overall Study|Site closing|0|||
48793520|NCT01302847|157082189|FG007|Overall Study|Site closing|0|||
48793521|NCT01302847|157082182|FG000|Overall Study|Withdrawal by Subject|1|||
48793522|NCT01302847|157082183|FG001|Overall Study|Withdrawal by Subject|0|||
48793523|NCT01302847|157082184|FG002|Overall Study|Withdrawal by Subject|0|||
48793524|NCT01302847|157082185|FG003|Overall Study|Withdrawal by Subject|0|||
48793525|NCT01302847|157082186|FG004|Overall Study|Withdrawal by Subject|1|||
48793526|NCT01302847|157082187|FG005|Overall Study|Withdrawal by Subject|0|||
48793527|NCT01302847|157082188|FG006|Overall Study|Withdrawal by Subject|0|||
48793528|NCT01302847|157082189|FG007|Overall Study|Withdrawal by Subject|1|||
48793529|NCT01302847|157082182|FG000|Overall Study|Not willing to adhere to requirements|5|||
48793530|NCT01302847|157082183|FG001|Overall Study|Not willing to adhere to requirements|0|||
48793531|NCT01302847|157082184|FG002|Overall Study|Not willing to adhere to requirements|1|||
48793532|NCT01302847|157082185|FG003|Overall Study|Not willing to adhere to requirements|0|||
48793533|NCT01302847|157082186|FG004|Overall Study|Not willing to adhere to requirements|0|||
48793534|NCT01302847|157082187|FG005|Overall Study|Not willing to adhere to requirements|0|||
48793535|NCT01302847|157082188|FG006|Overall Study|Not willing to adhere to requirements|0|||
48793536|NCT01302847|157082189|FG007|Overall Study|Not willing to adhere to requirements|2|||
48793537|NCT01302847|157082182|FG000|Overall Study|Site unable to contact participant|2|||
48793538|NCT01302847|157082183|FG001|Overall Study|Site unable to contact participant|1|||
48793539|NCT01302847|157082184|FG002|Overall Study|Site unable to contact participant|0|||
48793540|NCT01302847|157082185|FG003|Overall Study|Site unable to contact participant|0|||
48793541|NCT01302847|157082186|FG004|Overall Study|Site unable to contact participant|0|||
48793542|NCT01302847|157082187|FG005|Overall Study|Site unable to contact participant|0|||
48793543|NCT01302847|157082188|FG006|Overall Study|Site unable to contact participant|2|||
48793544|NCT01302847|157082189|FG007|Overall Study|Site unable to contact participant|0|||
48793545|NCT04871529|157082190|FG000|Overall Study|Withdrawal by Subject|0|||
48401427|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
48401428|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
48401429|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
48401430|NCT03403205|155660274|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
48401431|NCT03403205|155660275|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
48401432|NCT03403205|155660276|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
48401433|NCT03403205|155660277|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
48793546|NCT04871529|157082191|FG001|Overall Study|Withdrawal by Subject|1|||
48793547|NCT04871529|157082190|FG000|Overall Study|Death|0|||
48793548|NCT04871529|157082191|FG001|Overall Study|Death|1|||
48793549|NCT04871529|157082190|FG000|Overall Study|Not protocol specified|0|||
48793550|NCT04871529|157082191|FG001|Overall Study|Not protocol specified|1|||
48793551|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
48793552|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
48793553|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
48793554|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
48793555|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
48793556|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
48793557|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
48793558|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
48793559|NCT00679939|157082196|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
48793560|NCT00679939|157082197|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
48793561|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
48793562|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
48793563|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
48401434|NCT03403205|155660278|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
48793564|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
48793565|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
48793566|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
48793567|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
48793568|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
48793569|NCT00679939|157082196|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
48793570|NCT00679939|157082197|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
48793571|NCT02962908|157082198|FG000|Overall Study|Lost to Follow-up|0|||
48793572|NCT02962908|157082199|FG001|Overall Study|Lost to Follow-up|3|||
48793573|NCT02962908|157082200|FG002|Overall Study|Lost to Follow-up|0|||
48793574|NCT02962908|157082201|FG003|Overall Study|Lost to Follow-up|1|||
48793575|NCT02962908|157082198|FG000|Overall Study|Withdrawal by Subject|0|||
48793576|NCT02962908|157082199|FG001|Overall Study|Withdrawal by Subject|3|||
48793577|NCT02962908|157082200|FG002|Overall Study|Withdrawal by Subject|0|||
48793578|NCT02962908|157082201|FG003|Overall Study|Withdrawal by Subject|2|||
48793579|NCT02962908|157082198|FG000|Overall Study|Protocol Violation|0|||
48793580|NCT02962908|157082199|FG001|Overall Study|Protocol Violation|1|||
48793581|NCT02962908|157082200|FG002|Overall Study|Protocol Violation|0|||
48793582|NCT02962908|157082201|FG003|Overall Study|Protocol Violation|0|||
48793583|NCT02962908|157082198|FG000|Overall Study|Physician Decision|0|||
48793584|NCT02962908|157082199|FG001|Overall Study|Physician Decision|1|||
48793585|NCT02962908|157082200|FG002|Overall Study|Physician Decision|0|||
48793586|NCT02962908|157082201|FG003|Overall Study|Physician Decision|0|||
48793587|NCT03543254|157082202|FG000|Overall Study|Lost to Follow-up|1|||
48793588|NCT00707031|157082203|FG000|Overall Study|Adverse Event|45|||
48793589|NCT00707031|157082204|FG001|Overall Study|Adverse Event|45|||
48793590|NCT00707031|157082203|FG000|Overall Study|Lack of Efficacy|19|||
48793591|NCT00707031|157082204|FG001|Overall Study|Lack of Efficacy|6|||
48793592|NCT00707031|157082203|FG000|Overall Study|Lost to Follow-up|2|||
48793593|NCT00707031|157082204|FG001|Overall Study|Lost to Follow-up|1|||
48793594|NCT00707031|157082203|FG000|Overall Study|Protocol Violation|1|||
48793595|NCT00707031|157082204|FG001|Overall Study|Protocol Violation|0|||
48793596|NCT00707031|157082203|FG000|Overall Study|Withdrawal by Subject|7|||
48793597|NCT00707031|157082204|FG001|Overall Study|Withdrawal by Subject|8|||
48793598|NCT00707031|157082203|FG000|Overall Study|Poor Compliance to Protocol|7|||
48793599|NCT00707031|157082204|FG001|Overall Study|Poor Compliance to Protocol|13|||
48793600|NCT00707031|157082203|FG000|Overall Study|Familial or Personal Reasons|12|||
48793601|NCT00707031|157082204|FG001|Overall Study|Familial or Personal Reasons|15|||
48793602|NCT00707031|157082203|FG000|Overall Study|Serious Noncompliance|2|||
48793603|NCT00707031|157082204|FG001|Overall Study|Serious Noncompliance|3|||
48793604|NCT00707031|157082203|FG000|Overall Study|Sponsor Decision|9|||
48793605|NCT00707031|157082204|FG001|Overall Study|Sponsor Decision|8|||
48793606|NCT03221387|157082205|FG000|Overall Study|Lost to Follow-up|1|||
48793607|NCT03221387|157082205|FG000|Overall Study|Lung transplant|1|||
48793608|NCT02085252|157082206|FG000|Overall Study|Withdrawal of Consent|1|||
48793609|NCT02085252|157082207|FG001|Overall Study|Withdrawal of Consent|0|||
48793610|NCT02085252|157082206|FG000|Overall Study|Adverse Event|0|||
48793611|NCT02085252|157082207|FG001|Overall Study|Adverse Event|1|||
48793612|NCT02085252|157082206|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
48793613|NCT02085252|157082207|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
48793614|NCT02085252|157082206|FG000|Overall Study|Reason Not Specified|0|||
48793615|NCT02085252|157082207|FG001|Overall Study|Reason Not Specified|1|||
48793616|NCT02085252|157082206|FG000|Overall Study|Reason Unknown|0|||
48793617|NCT02085252|157082207|FG001|Overall Study|Reason Unknown|1|||
48793618|NCT04068831|157082208|FG000|Overall Study|Disease Progression|10|||
48793619|NCT04068831|157082209|FG001|Overall Study|Disease Progression|8|||
48793620|NCT00677365|157082212|FG000|Overall Study|Adverse Event|2|||
48793621|NCT00677365|157082213|FG001|Overall Study|Adverse Event|1|||
48793622|NCT00677365|157082214|FG002|Overall Study|Adverse Event|1|||
48793623|NCT00677365|157082215|FG003|Overall Study|Adverse Event|2|||
48793624|NCT00677365|157082212|FG000|Overall Study|Withdrawal by Subject|0|||
48793625|NCT00677365|157082213|FG001|Overall Study|Withdrawal by Subject|0|||
48793626|NCT00677365|157082214|FG002|Overall Study|Withdrawal by Subject|1|||
48793627|NCT00677365|157082215|FG003|Overall Study|Withdrawal by Subject|0|||
48793628|NCT00677365|157082212|FG000|Overall Study|Other reason|0|||
48793629|NCT00677365|157082213|FG001|Overall Study|Other reason|0|||
48793630|NCT00677365|157082214|FG002|Overall Study|Other reason|0|||
48793631|NCT00677365|157082215|FG003|Overall Study|Other reason|1|||
48793632|NCT02858895|157082218|FG000|Overall Study|Disease progression|31|||
48793633|NCT02858895|157082218|FG000|Overall Study|Death|2|||
48793634|NCT02858895|157082218|FG000|Overall Study|Adverse Event|1|||
48793635|NCT02858895|157082218|FG000|Overall Study|Withdrawal by Subject|3|||
48793636|NCT02858895|157082218|FG000|Overall Study|hospice,|1|||
48793637|NCT02858895|157082218|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
48793638|NCT05073133|157082225|FG000|Overall Study|Death|2|||
48793639|NCT04795245|157082230|FG000|Overall Study|Unkown reason|7|||
48793640|NCT04795245|157082230|FG000|Overall Study|Death|17|||
48793641|NCT04795245|157082230|FG000|Overall Study|Other than listed|19|||
48793642|NCT04795245|157082230|FG000|Overall Study|Adverse Event|143|||
48793643|NCT04795245|157082230|FG000|Overall Study|Progressive disease|512|||
48793644|NCT04795245|157082230|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
48793645|NCT04866017|157082231|FG000|Overall Study|Study Terminated by Sponsor|13|||
48793646|NCT04866017|157082232|FG001|Overall Study|Study Terminated by Sponsor|14|||
48793647|NCT04866017|157082233|FG002|Overall Study|Study Terminated by Sponsor|13|||
48793648|NCT04866017|157082231|FG000|Overall Study|Death|8|||
48793649|NCT04866017|157082232|FG001|Overall Study|Death|4|||
48793650|NCT04866017|157082233|FG002|Overall Study|Death|8|||
48793651|NCT04866017|157082231|FG000|Overall Study|Withdrawal by Subject|1|||
48793652|NCT04866017|157082232|FG001|Overall Study|Withdrawal by Subject|0|||
48793653|NCT04866017|157082233|FG002|Overall Study|Withdrawal by Subject|1|||
48793654|NCT04866017|157082231|FG000|Overall Study|Physician Decision|0|||
48793655|NCT04866017|157082232|FG001|Overall Study|Physician Decision|1|||
48793656|NCT04866017|157082233|FG002|Overall Study|Physician Decision|0|||
48793657|NCT04046549|157082234|FG000|Overall Study|Adverse Event|1|||
48793658|NCT04046549|157082234|FG000|Overall Study|Physician Decision|1|||
48793659|NCT04046549|157082234|FG000|Overall Study|Withdrawal by Subject|3|||
48793660|NCT04046549|157082234|FG000|Overall Study|Other, Not Specified|5|||
48793661|NCT03141359|157082235|FG000|Overall Study|Death|32|||
48793662|NCT03141359|157082235|FG000|Overall Study|Still On Study (in follow up)|29|||
48793663|NCT01261611|157083329|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
48793664|NCT01261611|157083330|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
48793665|NCT01261611|157083331|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
48793666|NCT01261611|157083329|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
48793667|NCT01261611|157083330|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
48793668|NCT01261611|157083331|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
48793669|NCT01261611|157083329|FG000|Treatment Cycle 1|Adverse Event|0|||
48793670|NCT01261611|157083330|FG001|Treatment Cycle 1|Adverse Event|1|||
48793671|NCT01261611|157083331|FG002|Treatment Cycle 1|Adverse Event|0|||
48793672|NCT01261611|157083329|FG000|Treatment Cycle 1|Protocol Violation|0|||
48793673|NCT01261611|157083330|FG001|Treatment Cycle 1|Protocol Violation|0|||
48401435|NCT03403205|155660279|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
48793674|NCT01261611|157083331|FG002|Treatment Cycle 1|Protocol Violation|2|||
48793675|NCT01261611|157083329|FG000|Treatment Cycle 2|Completed study|4|||
48793676|NCT01261611|157083330|FG001|Treatment Cycle 2|Completed study|0|||
48793677|NCT01261611|157083331|FG002|Treatment Cycle 2|Completed study|0|||
48793678|NCT01261611|157083329|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
48793679|NCT01261611|157083330|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
48793680|NCT01261611|157083331|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
48793681|NCT01261611|157083329|FG000|Treatment Cycle 2|Adverse Event|1|||
48793682|NCT01261611|157083330|FG001|Treatment Cycle 2|Adverse Event|0|||
48401436|NCT02111993|155660280|FG000|Overall Study|Physician Decision|5|||
48793683|NCT01261611|157083331|FG002|Treatment Cycle 2|Adverse Event|0|||
48793684|NCT01261611|157083329|FG000|Treatment Cycle 2|Protocol Violation|2|||
48793685|NCT01261611|157083330|FG001|Treatment Cycle 2|Protocol Violation|0|||
48793686|NCT01261611|157083331|FG002|Treatment Cycle 2|Protocol Violation|0|||
48401437|NCT02111993|155660281|FG001|Overall Study|Physician Decision|4|||
48401438|NCT01422239|155660284|FG000|Overall Study|Lost to Follow-up|4|||
48793687|NCT01261611|157083329|FG000|Treatment Cycle 2|Not otherwise specified|2|||
48793688|NCT01261611|157083330|FG001|Treatment Cycle 2|Not otherwise specified|0|||
48793689|NCT01261611|157083331|FG002|Treatment Cycle 2|Not otherwise specified|0|||
48793690|NCT01261611|157083329|FG000|Treatment Cycle 3|Completed study|24|||
48793691|NCT01261611|157083330|FG001|Treatment Cycle 3|Completed study|0|||
48793692|NCT01261611|157083331|FG002|Treatment Cycle 3|Completed study|0|||
48793693|NCT01261611|157083329|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
48793694|NCT01261611|157083330|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
48793695|NCT01261611|157083331|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
48793696|NCT01261611|157083329|FG000|Treatment Cycle 3|Adverse Event|1|||
48793697|NCT01261611|157083330|FG001|Treatment Cycle 3|Adverse Event|0|||
48793698|NCT01261611|157083331|FG002|Treatment Cycle 3|Adverse Event|0|||
48793699|NCT01261611|157083329|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
48793700|NCT01261611|157083330|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
48793701|NCT01261611|157083331|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
48793702|NCT01261611|157083329|FG000|Treatment Cycle 4|Completed study|87|||
48793703|NCT01261611|157083330|FG001|Treatment Cycle 4|Completed study|0|||
48793704|NCT01261611|157083331|FG002|Treatment Cycle 4|Completed study|0|||
48793705|NCT01261611|157083329|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
48793706|NCT01261611|157083330|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
48793707|NCT01261611|157083331|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
48793708|NCT01261611|157083329|FG000|Treatment Cycle 4|Adverse Event|1|||
48793709|NCT01261611|157083330|FG001|Treatment Cycle 4|Adverse Event|0|||
48793710|NCT01261611|157083331|FG002|Treatment Cycle 4|Adverse Event|0|||
48793711|NCT01261611|157083329|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
48793712|NCT01261611|157083330|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
48793713|NCT01261611|157083331|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
48793714|NCT01261611|157083329|FG000|Treatment Cycle 4|Not otherwise specified|3|||
48793715|NCT01261611|157083330|FG001|Treatment Cycle 4|Not otherwise specified|0|||
48793716|NCT01261611|157083331|FG002|Treatment Cycle 4|Not otherwise specified|0|||
48793717|NCT01261611|157083329|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
48793718|NCT01261611|157083330|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
48793719|NCT01261611|157083331|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
48793720|NCT01261611|157083329|FG000|Treatment Cycle 5|Adverse Event|1|||
48793721|NCT01261611|157083330|FG001|Treatment Cycle 5|Adverse Event|0|||
48793722|NCT01261611|157083331|FG002|Treatment Cycle 5|Adverse Event|0|||
48793723|NCT01261611|157083329|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
48793724|NCT01261611|157083330|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
48793725|NCT01261611|157083331|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
48793726|NCT02621931|157083335|FG000|Overall Study|Death|0|||
48793727|NCT02621931|157083336|FG001|Overall Study|Death|1|||
48793728|NCT02621931|157083337|FG002|Overall Study|Death|0|||
48793729|NCT02621931|157083335|FG000|Overall Study|Adverse Event|8|||
48793730|NCT02621931|157083336|FG001|Overall Study|Adverse Event|5|||
48793731|NCT02621931|157083337|FG002|Overall Study|Adverse Event|7|||
48793732|NCT02621931|157083335|FG000|Overall Study|Withdrawal by Subject|12|||
48793733|NCT02621931|157083336|FG001|Overall Study|Withdrawal by Subject|10|||
48793734|NCT02621931|157083337|FG002|Overall Study|Withdrawal by Subject|11|||
48793735|NCT02621931|157083335|FG000|Overall Study|Protocol Violation|2|||
48793736|NCT02621931|157083336|FG001|Overall Study|Protocol Violation|2|||
48793737|NCT02621931|157083337|FG002|Overall Study|Protocol Violation|2|||
48793738|NCT02621931|157083335|FG000|Overall Study|Pregnancy|2|||
48793739|NCT02621931|157083336|FG001|Overall Study|Pregnancy|0|||
48793740|NCT02621931|157083337|FG002|Overall Study|Pregnancy|0|||
48793741|NCT02621931|157083335|FG000|Overall Study|Noncompliance to study procedures|0|||
48793742|NCT02621931|157083336|FG001|Overall Study|Noncompliance to study procedures|1|||
48793743|NCT02621931|157083337|FG002|Overall Study|Noncompliance to study procedures|2|||
48793744|NCT02621931|157083335|FG000|Overall Study|Lost to Follow-up|8|||
48793745|NCT02621931|157083336|FG001|Overall Study|Lost to Follow-up|7|||
48793746|NCT02621931|157083337|FG002|Overall Study|Lost to Follow-up|10|||
48793747|NCT02621931|157083335|FG000|Overall Study|Lack of Efficacy|0|||
48793748|NCT02621931|157083336|FG001|Overall Study|Lack of Efficacy|0|||
48793749|NCT02621931|157083337|FG002|Overall Study|Lack of Efficacy|1|||
48793750|NCT02621931|157083335|FG000|Overall Study|Other|1|||
48793751|NCT02621931|157083336|FG001|Overall Study|Other|1|||
48793752|NCT02621931|157083337|FG002|Overall Study|Other|3|||
48793753|NCT00074282|157083338|FG000|Step 1|Adverse Event|32|||
48793754|NCT00074282|157083339|FG001|Step 1|Adverse Event|0|||
48793755|NCT00074282|157083340|FG002|Step 1|Adverse Event|0|||
48793756|NCT00074282|157083338|FG000|Step 1|Death|6|||
48793757|NCT00074282|157083339|FG001|Step 1|Death|0|||
48793758|NCT00074282|157083340|FG002|Step 1|Death|0|||
48793759|NCT00074282|157083338|FG000|Step 1|Withdrawal by Subject|7|||
48793760|NCT00074282|157083339|FG001|Step 1|Withdrawal by Subject|0|||
48793761|NCT00074282|157083340|FG002|Step 1|Withdrawal by Subject|0|||
48793762|NCT00074282|157083338|FG000|Step 1|Disease progression|2|||
48793763|NCT00074282|157083339|FG001|Step 1|Disease progression|0|||
48793764|NCT00074282|157083340|FG002|Step 1|Disease progression|0|||
48401439|NCT01422239|155660285|FG001|Overall Study|Lost to Follow-up|3|||
48401440|NCT03167073|155660286|FG000|Overall Study|Stillbirth|1|||
48401441|NCT03167073|155660287|FG001|Overall Study|Stillbirth|0|||
48401442|NCT01627860|155660288|FG000|Overall Study|Adverse Event|9|||
48401443|NCT01627860|155660289|FG001|Overall Study|Adverse Event|4|||
48401444|NCT01627860|155660288|FG000|Overall Study|Withdrawal by Subject|2|||
48401445|NCT01627860|155660289|FG001|Overall Study|Withdrawal by Subject|1|||
48401446|NCT01627860|155660288|FG000|Overall Study|Seizure frequency doubled|0|||
48401447|NCT01627860|155660289|FG001|Overall Study|Seizure frequency doubled|1|||
48401448|NCT01627860|155660288|FG000|Overall Study|Protocol Violation|1|||
48401449|NCT01627860|155660289|FG001|Overall Study|Protocol Violation|0|||
48401450|NCT00044512|155660290|FG000|Follow Up|Lost to Follow-up|2|||
48401451|NCT02551159|155660293|FG000|Overall Study|Death|352|||
48401452|NCT02551159|155660294|FG001|Overall Study|Death|174|||
48401453|NCT02551159|155660295|FG002|Overall Study|Death|161|||
48401454|NCT02551159|155660293|FG000|Overall Study|Withdrawal by Subject|8|||
48401455|NCT02551159|155660294|FG001|Overall Study|Withdrawal by Subject|5|||
48401456|NCT02551159|155660295|FG002|Overall Study|Withdrawal by Subject|16|||
48401457|NCT02551159|155660293|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
48401458|NCT02551159|155660294|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
48401459|NCT02551159|155660295|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
48401460|NCT00268242|155660296|FG000|Overall Study|Death|1|||
48401461|NCT02695628|155660303|FG000|Overall Study|Withdrawal by Subject|1|||
48401462|NCT01110200|155660304|FG000|Overall Study|Adverse Event|28|||
48401463|NCT01110200|155660305|FG001|Overall Study|Adverse Event|28|||
48401464|NCT01110200|155660304|FG000|Overall Study|Withdrawal by Subject|25|||
48401465|NCT01110200|155660305|FG001|Overall Study|Withdrawal by Subject|32|||
48401466|NCT01110200|155660304|FG000|Overall Study|Lack of Efficacy|16|||
48401467|NCT01110200|155660305|FG001|Overall Study|Lack of Efficacy|25|||
48401468|NCT01110200|155660304|FG000|Overall Study|Protocol Violation|14|||
48401469|NCT01110200|155660305|FG001|Overall Study|Protocol Violation|12|||
48401470|NCT01110200|155660304|FG000|Overall Study|Physician Decision|13|||
48401471|NCT01110200|155660305|FG001|Overall Study|Physician Decision|17|||
48401472|NCT01110200|155660304|FG000|Overall Study|Lost to Follow-up|10|||
48401473|NCT01110200|155660305|FG001|Overall Study|Lost to Follow-up|7|||
48401474|NCT00516737|155660310|FG000|Overall Study|Lost to Follow-up|2|||
48401475|NCT00516737|155660311|FG001|Overall Study|Lost to Follow-up|0|||
48401476|NCT00516737|155660310|FG000|Overall Study|Physician Decision|0|||
48401477|NCT00516737|155660311|FG001|Overall Study|Physician Decision|1|||
48401478|NCT00516737|155660310|FG000|Overall Study|Withdrawal by Subject|0|||
48401479|NCT00516737|155660311|FG001|Overall Study|Withdrawal by Subject|1|||
48401480|NCT00516737|155660310|FG000|Overall Study|Lack of Qualifying Event|9|||
48401481|NCT00516737|155660311|FG001|Overall Study|Lack of Qualifying Event|6|||
48401482|NCT01920711|155660312|FG000|Overall Study|Death|347|||
48401483|NCT01920711|155660313|FG001|Overall Study|Death|356|||
48401484|NCT01920711|155660312|FG000|Overall Study|Lost to Follow-up|13|||
48401485|NCT01920711|155660313|FG001|Overall Study|Lost to Follow-up|14|||
48401486|NCT01920711|155660312|FG000|Overall Study|Withdrawal by Subject|4|||
48401487|NCT01920711|155660313|FG001|Overall Study|Withdrawal by Subject|3|||
48401488|NCT00511355|155660317|FG000|Overall Study|Adverse Event|4|||
48401489|NCT00511355|155660318|FG001|Overall Study|Adverse Event|4|||
48401490|NCT00511355|155660317|FG000|Overall Study|Pregnancy Wish|1|||
48401491|NCT00511355|155660318|FG001|Overall Study|Pregnancy Wish|0|||
48401492|NCT00511355|155660317|FG000|Overall Study|Lost to Follow-up|2|||
48401493|NCT00511355|155660318|FG001|Overall Study|Lost to Follow-up|1|||
48401494|NCT00511355|155660317|FG000|Overall Study|Other Reason|0|||
48401495|NCT00511355|155660318|FG001|Overall Study|Other Reason|1|||
48401496|NCT00511355|155660317|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
48401497|NCT00511355|155660318|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
48401498|NCT00511355|155660317|FG000|Overall Study|Withdrawal of informed consent|0|||
48401499|NCT00511355|155660318|FG001|Overall Study|Withdrawal of informed consent|1|||
48401500|NCT00511355|155660317|FG000|Overall Study|Other reason pre-treatment|0|||
48401501|NCT00511355|155660318|FG001|Overall Study|Other reason pre-treatment|1|||
48401502|NCT00603915|155660319|FG000|Overall Study|Physician Decision|1|||
48401503|NCT00454805|155660320|FG000|Overall Study|Withdrawal by Subject|9|||
48401504|NCT00454805|155660321|FG001|Overall Study|Withdrawal by Subject|2|||
48401505|NCT00454805|155660320|FG000|Overall Study|Death|0|||
48401506|NCT00454805|155660321|FG001|Overall Study|Death|2|||
48401507|NCT00454805|155660320|FG000|Overall Study|Disease progression|16|||
48401508|NCT00454805|155660321|FG001|Overall Study|Disease progression|19|||
48401509|NCT00454805|155660320|FG000|Overall Study|In order to begin radiotherapy|1|||
48401510|NCT00454805|155660321|FG001|Overall Study|In order to begin radiotherapy|0|||
48401511|NCT01609842|155660331|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
48401512|NCT01609842|155660332|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
48401513|NCT01356589|155660333|FG000|Overall Study|Enrolled, but not treated|3|||
48401514|NCT01356589|155660333|FG000|Overall Study|Dose data not recorded|2|||
48401515|NCT00803179|155660334|FG000|Overall Study|Lost to Follow-up|3|||
48401516|NCT02482129|155660337|FG000|Overall Study|Adverse Event-prior to treatment|0|||
48401517|NCT02482129|155660338|FG001|Overall Study|Adverse Event-prior to treatment|1|||
48401518|NCT02482129|155660337|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
48401519|NCT02482129|155660338|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
48401520|NCT02482129|155660337|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
48401521|NCT02482129|155660338|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
48401522|NCT02482129|155660337|FG000|Overall Study|Criteria not met-prior to treatment|1|||
48401523|NCT02482129|155660338|FG001|Overall Study|Criteria not met-prior to treatment|0|||
48401524|NCT02482129|155660337|FG000|Overall Study|Adverse Event|1|||
48401525|NCT02482129|155660338|FG001|Overall Study|Adverse Event|0|||
48401526|NCT02482129|155660337|FG000|Overall Study|Withdrawal by Subject|2|||
48401527|NCT02482129|155660338|FG001|Overall Study|Withdrawal by Subject|0|||
48401528|NCT02482129|155660337|FG000|Overall Study|Criteria not met|1|||
48401529|NCT02482129|155660338|FG001|Overall Study|Criteria not met|0|||
48401530|NCT05478525|155661690|FG000|Overall Study|Withdrawal by Subject|0|||
48401531|NCT05478525|155661691|FG001|Overall Study|Withdrawal by Subject|1|||
48401532|NCT05478525|155661692|FG002|Overall Study|Withdrawal by Subject|2|||
48401533|NCT05478525|155661693|FG003|Overall Study|Withdrawal by Subject|0|||
48401534|NCT05478525|155661690|FG000|Overall Study|COVID-19 Infection|2|||
48401535|NCT05478525|155661691|FG001|Overall Study|COVID-19 Infection|0|||
48401536|NCT05478525|155661692|FG002|Overall Study|COVID-19 Infection|1|||
48401537|NCT05478525|155661693|FG003|Overall Study|COVID-19 Infection|1|||
48401538|NCT03358875|155661696|FG000|Overall Study|Death|409|||
48401539|NCT03358875|155661697|FG001|Overall Study|Death|223|||
48793765|NCT00074282|157083338|FG000|Step 1|Alternative therapy|2|||
48793766|NCT00074282|157083339|FG001|Step 1|Alternative therapy|0|||
48793767|NCT00074282|157083340|FG002|Step 1|Alternative therapy|0|||
48793768|NCT00074282|157083338|FG000|Step 1|Other complicating disease|2|||
48793769|NCT00074282|157083339|FG001|Step 1|Other complicating disease|0|||
48793770|NCT00074282|157083340|FG002|Step 1|Other complicating disease|0|||
48793771|NCT00074282|157083338|FG000|Step 1|Physician Decision|1|||
48793772|NCT00074282|157083339|FG001|Step 1|Physician Decision|0|||
48401540|NCT03358875|155661696|FG000|Overall Study|Study Closed by Sponsor|66|||
48401541|NCT03358875|155661697|FG001|Overall Study|Study Closed by Sponsor|29|||
48401542|NCT03358875|155661696|FG000|Overall Study|Withdrawal by Subject|13|||
48401543|NCT03358875|155661697|FG001|Overall Study|Withdrawal by Subject|16|||
48401544|NCT03358875|155661696|FG000|Overall Study|Lost to Follow-up|13|||
48401545|NCT03358875|155661697|FG001|Overall Study|Lost to Follow-up|2|||
48401546|NCT03358875|155661696|FG000|Overall Study|Miscellaneous|33|||
48401547|NCT03358875|155661697|FG001|Overall Study|Miscellaneous|0|||
48793773|NCT00074282|157083340|FG002|Step 1|Physician Decision|0|||
48793774|NCT00074282|157083338|FG000|Step 1|Ineligible|4|||
48401548|NCT03358875|155661696|FG000|Overall Study|Remained on Study|1|||
48401549|NCT03358875|155661697|FG001|Overall Study|Remained on Study|0|||
48401550|NCT04523207|155661698|FG000|Overall Study|Adverse Event|5|||
48401551|NCT04523207|155661699|FG001|Overall Study|Adverse Event|1|||
48401552|NCT04523207|155661698|FG000|Overall Study|Lost to Follow-up|2|||
48401553|NCT04523207|155661699|FG001|Overall Study|Lost to Follow-up|0|||
48401554|NCT04523207|155661698|FG000|Overall Study|Withdrawal by Subject|2|||
48793775|NCT00074282|157083339|FG001|Step 1|Ineligible|0|||
48793776|NCT00074282|157083340|FG002|Step 1|Ineligible|0|||
48793777|NCT00074282|157083338|FG000|Step 1|Never started treatment|2|||
48793778|NCT00074282|157083339|FG001|Step 1|Never started treatment|0|||
48793779|NCT00074282|157083340|FG002|Step 1|Never started treatment|0|||
48793780|NCT00074282|157083338|FG000|Step 2|Adverse Event|0|||
48793781|NCT00074282|157083339|FG001|Step 2|Adverse Event|2|||
48793782|NCT00074282|157083340|FG002|Step 2|Adverse Event|12|||
48793783|NCT00074282|157083338|FG000|Step 2|Disease progression|0|||
48793784|NCT00074282|157083339|FG001|Step 2|Disease progression|0|||
48793785|NCT00074282|157083340|FG002|Step 2|Disease progression|5|||
48793786|NCT00074282|157083338|FG000|Step 2|Death|0|||
48793787|NCT00074282|157083339|FG001|Step 2|Death|0|||
48793788|NCT00074282|157083340|FG002|Step 2|Death|3|||
48793789|NCT00074282|157083338|FG000|Step 2|Withdrawal by Subject|0|||
48793790|NCT00074282|157083339|FG001|Step 2|Withdrawal by Subject|0|||
48793791|NCT00074282|157083340|FG002|Step 2|Withdrawal by Subject|2|||
48793792|NCT00074282|157083338|FG000|Step 2|Physician Decision|0|||
48401555|NCT04523207|155661699|FG001|Overall Study|Withdrawal by Subject|0|||
48401556|NCT04523207|155661698|FG000|Overall Study|Progressive Disease|2|||
48401557|NCT04523207|155661699|FG001|Overall Study|Progressive Disease|1|||
48401558|NCT04523207|155661698|FG000|Overall Study|Other|7|||
48401559|NCT04523207|155661699|FG001|Overall Study|Other|1|||
48401560|NCT02489318|155661700|FG000|Randomized|Withdrawal by Subject|0|||
48401561|NCT02489318|155661701|FG001|Randomized|Withdrawal by Subject|1|||
48401562|NCT02489318|155661700|FG000|Treated|Adverse Event|19|||
48401563|NCT02489318|155661701|FG001|Treated|Adverse Event|62|||
48401564|NCT02489318|155661700|FG000|Treated|Death|13|||
48401565|NCT02489318|155661701|FG001|Treated|Death|11|||
48793793|NCT00074282|157083339|FG001|Step 2|Physician Decision|0|||
48793794|NCT00074282|157083340|FG002|Step 2|Physician Decision|1|||
48793795|NCT00074282|157083338|FG000|Step 2|Ineligible|0|||
48793796|NCT00074282|157083339|FG001|Step 2|Ineligible|0|||
48793797|NCT00074282|157083340|FG002|Step 2|Ineligible|1|||
48401566|NCT02489318|155661700|FG000|Treated|Physician Decision|4|||
48401567|NCT02489318|155661701|FG001|Treated|Physician Decision|6|||
48401568|NCT02489318|155661700|FG000|Treated|Protocol Violation|1|||
48401569|NCT02489318|155661701|FG001|Treated|Protocol Violation|2|||
48401570|NCT02489318|155661700|FG000|Treated|Withdrawal by Subject|37|||
48401571|NCT02489318|155661701|FG001|Treated|Withdrawal by Subject|36|||
48401572|NCT02489318|155661700|FG000|Treated|Other: Progressive Disease|245|||
48401573|NCT02489318|155661701|FG001|Treated|Other: Progressive Disease|138|||
48793798|NCT02811861|157083345|FG000|Overall Study|Radiological Disease Progression|123|||
48793799|NCT02811861|157083346|FG001|Overall Study|Radiological Disease Progression|97|||
48793800|NCT02811861|157083347|FG002|Overall Study|Radiological Disease Progression|174|||
48793801|NCT02811861|157083345|FG000|Overall Study|Clinical Disease Progression|20|||
48793802|NCT02811861|157083346|FG001|Overall Study|Clinical Disease Progression|19|||
48793803|NCT02811861|157083347|FG002|Overall Study|Clinical Disease Progression|22|||
48793804|NCT02811861|157083345|FG000|Overall Study|Adverse Event|63|||
48793805|NCT02811861|157083346|FG001|Overall Study|Adverse Event|60|||
48793806|NCT02811861|157083347|FG002|Overall Study|Adverse Event|41|||
48793807|NCT02811861|157083345|FG000|Overall Study|Lost to Follow-up|0|||
48793808|NCT02811861|157083346|FG001|Overall Study|Lost to Follow-up|0|||
48793809|NCT02811861|157083347|FG002|Overall Study|Lost to Follow-up|1|||
48793810|NCT02811861|157083345|FG000|Overall Study|Subject Choice|29|||
48793811|NCT02811861|157083346|FG001|Overall Study|Subject Choice|17|||
48793812|NCT02811861|157083347|FG002|Overall Study|Subject Choice|23|||
48793813|NCT02811861|157083345|FG000|Overall Study|Withdrawal by Subject|4|||
48793814|NCT02811861|157083346|FG001|Overall Study|Withdrawal by Subject|4|||
48793815|NCT02811861|157083347|FG002|Overall Study|Withdrawal by Subject|9|||
48793816|NCT02811861|157083345|FG000|Overall Study|Other|4|||
48793817|NCT02811861|157083346|FG001|Overall Study|Other|13|||
48793818|NCT02811861|157083347|FG002|Overall Study|Other|3|||
48793819|NCT02811861|157083345|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
48793820|NCT02811861|157083346|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
48793821|NCT02811861|157083347|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
48793822|NCT02811861|157083345|FG000|Overall Study|Randomized but not treated|2|||
48793823|NCT02811861|157083346|FG001|Overall Study|Randomized but not treated|3|||
48793824|NCT02811861|157083347|FG002|Overall Study|Randomized but not treated|17|||
48793825|NCT02925455|157083348|FG000|Overall Study|Withdrawal by Subject|2|||
48793826|NCT02925455|157083349|FG001|Overall Study|Withdrawal by Subject|0|||
48793827|NCT03461003|157083358|FG000|Overall Study|Lost to Follow-up|2|||
48793828|NCT03461003|157083359|FG001|Overall Study|Lost to Follow-up|2|||
48793829|NCT03461003|157083358|FG000|Overall Study|Withdrawal by Subject|3|||
48793830|NCT03461003|157083359|FG001|Overall Study|Withdrawal by Subject|1|||
48793831|NCT00605293|157083360|FG000|Overall Study|Death|2|||
48793832|NCT00605293|157083361|FG001|Overall Study|Death|1|||
48793833|NCT00605293|157083360|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48793834|NCT00605293|157083361|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48793835|NCT00605293|157083360|FG000|Overall Study|Adverse Event|1|||
48793836|NCT00605293|157083361|FG001|Overall Study|Adverse Event|0|||
48793837|NCT00605293|157083360|FG000|Overall Study|Holidays Dialysis Out|1|||
48793838|NCT00605293|157083361|FG001|Overall Study|Holidays Dialysis Out|0|||
48793839|NCT00605293|157083360|FG000|Overall Study|Blood Transfusion|7|||
48793840|NCT00605293|157083361|FG001|Overall Study|Blood Transfusion|1|||
48793841|NCT00605293|157083360|FG000|Overall Study|Renal Transplantation|3|||
48793842|NCT00605293|157083361|FG001|Overall Study|Renal Transplantation|1|||
48793843|NCT00605293|157083360|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
48793844|NCT00605293|157083361|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
48401574|NCT02489318|155661700|FG000|Treated|Other|0|||
48793845|NCT00605293|157083360|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
48793846|NCT00605293|157083361|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
48793847|NCT00605293|157083360|FG000|Overall Study|Principal Investigator Decision|0|||
48793848|NCT00605293|157083361|FG001|Overall Study|Principal Investigator Decision|1|||
48793849|NCT02119416|157083362|FG000|Overall Study|Protocol Violation|1|||
48793850|NCT02119416|157083363|FG001|Overall Study|Protocol Violation|1|||
48793851|NCT02119416|157083364|FG002|Overall Study|Protocol Violation|1|||
48793852|NCT02119416|157083362|FG000|Overall Study|wrong pubertal stage|1|||
48793853|NCT02119416|157083363|FG001|Overall Study|wrong pubertal stage|0|||
48793854|NCT02119416|157083364|FG002|Overall Study|wrong pubertal stage|1|||
48793855|NCT01692782|157083365|FG000|Overall Study|Adverse Event|12|||
48401575|NCT02489318|155661701|FG001|Treated|Other|2|||
48793856|NCT01692782|157083366|FG001|Overall Study|Adverse Event|32|||
48793857|NCT01692782|157083367|FG002|Overall Study|Adverse Event|2|||
48793858|NCT01692782|157083365|FG000|Overall Study|Lack of Efficacy|1|||
48401576|NCT02489318|155661700|FG000|Treated|Ongoing|0|||
48401577|NCT02489318|155661701|FG001|Treated|Ongoing|267|||
48401578|NCT04833777|155661702|FG000|Overall Study|Lost to Follow-up|1|||
48793859|NCT01692782|157083366|FG001|Overall Study|Lack of Efficacy|2|||
48793860|NCT01692782|157083367|FG002|Overall Study|Lack of Efficacy|0|||
48793861|NCT01692782|157083365|FG000|Overall Study|Lost to Follow-up|2|||
48401579|NCT04833777|155661703|FG001|Overall Study|Lost to Follow-up|0|||
48793862|NCT01692782|157083366|FG001|Overall Study|Lost to Follow-up|7|||
48793863|NCT01692782|157083367|FG002|Overall Study|Lost to Follow-up|1|||
48793864|NCT01692782|157083365|FG000|Overall Study|Pregnancy|1|||
48793865|NCT01692782|157083366|FG001|Overall Study|Pregnancy|0|||
48793866|NCT01692782|157083367|FG002|Overall Study|Pregnancy|0|||
48793867|NCT01692782|157083365|FG000|Overall Study|Protocol Violation|1|||
48401580|NCT01171898|155661704|FG000|Overall Study|Death|0|||
48401581|NCT01171898|155661705|FG001|Overall Study|Death|0|||
48793868|NCT01692782|157083366|FG001|Overall Study|Protocol Violation|0|||
48793869|NCT01692782|157083367|FG002|Overall Study|Protocol Violation|2|||
48793870|NCT01692782|157083365|FG000|Overall Study|Non-complance with study drug|0|||
48793871|NCT01692782|157083366|FG001|Overall Study|Non-complance with study drug|4|||
48793872|NCT01692782|157083367|FG002|Overall Study|Non-complance with study drug|1|||
48793873|NCT01692782|157083365|FG000|Overall Study|Non-compliant with study visits|0|||
48793874|NCT01692782|157083366|FG001|Overall Study|Non-compliant with study visits|0|||
48793875|NCT01692782|157083367|FG002|Overall Study|Non-compliant with study visits|1|||
48793876|NCT01692782|157083365|FG000|Overall Study|SAE not related to study drug|0|||
48793877|NCT01692782|157083366|FG001|Overall Study|SAE not related to study drug|1|||
48401582|NCT01171898|155661706|FG002|Overall Study|Death|2|||
48793878|NCT01692782|157083367|FG002|Overall Study|SAE not related to study drug|0|||
48793879|NCT01692782|157083365|FG000|Overall Study|Withdrawal by Subject|3|||
48793880|NCT01692782|157083366|FG001|Overall Study|Withdrawal by Subject|10|||
48793881|NCT01692782|157083367|FG002|Overall Study|Withdrawal by Subject|3|||
48793882|NCT03575325|157083368|FG000|Overall Study|Death|1|||
48793883|NCT02192502|157083369|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
48793884|NCT02192502|157083370|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
48793885|NCT02192502|157083369|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
48793886|NCT02192502|157083370|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
48793887|NCT02192502|157083369|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
48793888|NCT02192502|157083370|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
48793889|NCT00696111|157083374|FG000|Overall Study|Withdrawal by Subject|17|||
48793890|NCT04330638|157083375|FG000|Overall Study|Adverse Event|9|||
48793891|NCT04330638|157083376|FG001|Overall Study|Adverse Event|10|||
48793892|NCT04330638|157083377|FG002|Overall Study|Adverse Event|15|||
48793893|NCT04330638|157083378|FG003|Overall Study|Adverse Event|6|||
48793894|NCT04330638|157083379|FG004|Overall Study|Adverse Event|10|||
48793895|NCT04330638|157083380|FG005|Overall Study|Adverse Event|5|||
48793896|NCT04330638|157083375|FG000|Overall Study|Other|2|||
48793897|NCT04330638|157083376|FG001|Overall Study|Other|2|||
48793898|NCT04330638|157083377|FG002|Overall Study|Other|5|||
48793899|NCT04330638|157083378|FG003|Overall Study|Other|1|||
48793900|NCT04330638|157083379|FG004|Overall Study|Other|3|||
48793901|NCT04330638|157083380|FG005|Overall Study|Other|2|||
48793902|NCT04330638|157083375|FG000|Overall Study|Withdrawal by Subject|4|||
48793903|NCT04330638|157083376|FG001|Overall Study|Withdrawal by Subject|0|||
48793904|NCT04330638|157083377|FG002|Overall Study|Withdrawal by Subject|0|||
48793905|NCT04330638|157083378|FG003|Overall Study|Withdrawal by Subject|0|||
48793906|NCT04330638|157083379|FG004|Overall Study|Withdrawal by Subject|0|||
48793907|NCT04330638|157083380|FG005|Overall Study|Withdrawal by Subject|0|||
48793908|NCT04330638|157083375|FG000|Overall Study|Lost to Follow-up|3|||
48793909|NCT04330638|157083376|FG001|Overall Study|Lost to Follow-up|2|||
48793910|NCT04330638|157083377|FG002|Overall Study|Lost to Follow-up|3|||
48793911|NCT04330638|157083378|FG003|Overall Study|Lost to Follow-up|2|||
48793912|NCT04330638|157083379|FG004|Overall Study|Lost to Follow-up|3|||
48793913|NCT04330638|157083380|FG005|Overall Study|Lost to Follow-up|0|||
48793914|NCT04435665|157083391|FG000|Overall Study|Lost to Follow-up|0|||
48793915|NCT04435665|157083392|FG001|Overall Study|Lost to Follow-up|0|||
48793916|NCT04435665|157083393|FG002|Overall Study|Lost to Follow-up|0|||
48401583|NCT01171898|155661707|FG003|Overall Study|Death|0|||
48401584|NCT01171898|155661704|FG000|Overall Study|Lost to Follow-up|0|||
48401585|NCT01171898|155661705|FG001|Overall Study|Lost to Follow-up|1|||
48401586|NCT01171898|155661706|FG002|Overall Study|Lost to Follow-up|1|||
48401587|NCT01171898|155661707|FG003|Overall Study|Lost to Follow-up|1|||
48401588|NCT01171898|155661704|FG000|Overall Study|Withdrawal by Subject|1|||
48401589|NCT01171898|155661705|FG001|Overall Study|Withdrawal by Subject|4|||
48793917|NCT04435665|157083394|FG003|Overall Study|Lost to Follow-up|1|||
48793918|NCT00419263|157083398|FG000|Overall Study|Lost to Follow-up|2|||
48793919|NCT00419263|157083399|FG001|Overall Study|Lost to Follow-up|1|||
48793920|NCT00419263|157083400|FG002|Overall Study|Lost to Follow-up|1|||
48793921|NCT00419263|157083398|FG000|Overall Study|Randomized in Error, Not Treated|1|||
48793922|NCT00419263|157083399|FG001|Overall Study|Randomized in Error, Not Treated|1|||
48793923|NCT00419263|157083400|FG002|Overall Study|Randomized in Error, Not Treated|0|||
48793924|NCT00419263|157083398|FG000|Overall Study|Adverse Event|0|||
48793925|NCT00419263|157083399|FG001|Overall Study|Adverse Event|0|||
48793926|NCT00419263|157083400|FG002|Overall Study|Adverse Event|1|||
48793927|NCT00419263|157083398|FG000|Overall Study|Withdrawal by Subject|0|||
48793928|NCT00419263|157083399|FG001|Overall Study|Withdrawal by Subject|0|||
48793929|NCT00419263|157083400|FG002|Overall Study|Withdrawal by Subject|1|||
48793930|NCT05045625|157083401|FG000|Overall Study|Lost to Follow-up|3|||
48793931|NCT01041638|157083402|FG000|Overall Study|Adverse Event|4|||
48793932|NCT01041638|157083402|FG000|Overall Study|Death|1|||
48793933|NCT01041638|157083402|FG000|Overall Study|Lack of Efficacy|7|||
48401590|NCT01171898|155661706|FG002|Overall Study|Withdrawal by Subject|6|||
48401591|NCT01171898|155661707|FG003|Overall Study|Withdrawal by Subject|3|||
48430356|NCT00696657|155763701|FG001|Overall Study|Unclassified|1|||
48793934|NCT01041638|157083402|FG000|Overall Study|Physician Decision|4|||
48793935|NCT01041638|157083402|FG000|Overall Study|Withdrawal by Subject|11|||
48793936|NCT01777854|157083405|FG000|Overall Study|Physician Decision|3|||
48793937|NCT01777854|157083406|FG001|Overall Study|Physician Decision|3|||
48793938|NCT03792126|157083407|FG000|Overall Study|Adverse Event|1|||
48793939|NCT03792126|157083408|FG001|Overall Study|Adverse Event|2|||
48793940|NCT03792126|157083407|FG000|Overall Study|Death|0|||
48793941|NCT03792126|157083408|FG001|Overall Study|Death|1|||
48793942|NCT03792126|157083407|FG000|Overall Study|Lost to Follow-up|1|||
48793943|NCT03792126|157083408|FG001|Overall Study|Lost to Follow-up|0|||
48793944|NCT03792126|157083407|FG000|Overall Study|Withdrawal by Subject|0|||
48793945|NCT03792126|157083408|FG001|Overall Study|Withdrawal by Subject|1|||
48793946|NCT03792126|157083407|FG000|Overall Study|COVID-19 Restrictions|1|||
48793947|NCT03792126|157083408|FG001|Overall Study|COVID-19 Restrictions|3|||
48793948|NCT03792126|157083407|FG000|Overall Study|Symptoms resolved|0|||
48793949|NCT03792126|157083408|FG001|Overall Study|Symptoms resolved|3|||
48793950|NCT04322682|157083413|FG000|Overall Study|Withdrawal by Subject|33|||
48793951|NCT04322682|157083414|FG001|Overall Study|Withdrawal by Subject|47|||
48793952|NCT04322682|157083413|FG000|Overall Study|Death|5|||
48793953|NCT04322682|157083414|FG001|Overall Study|Death|9|||
48793954|NCT04322682|157083413|FG000|Overall Study|Lost to Follow-up|4|||
48793955|NCT04322682|157083414|FG001|Overall Study|Lost to Follow-up|8|||
48793956|NCT04322682|157083413|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
48793957|NCT04322682|157083414|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
48793958|NCT02638948|157083415|FG000|Overall Study|Withdrawal by Subject|4|||
48793959|NCT02638948|157083416|FG001|Overall Study|Withdrawal by Subject|5|||
48793960|NCT02638948|157083417|FG002|Overall Study|Withdrawal by Subject|3|||
48793961|NCT02638948|157083418|FG003|Overall Study|Withdrawal by Subject|1|||
48793962|NCT02638948|157083415|FG000|Overall Study|Administrative Reason by Sponsor|0|||
48793963|NCT02638948|157083416|FG001|Overall Study|Administrative Reason by Sponsor|1|||
48793964|NCT02638948|157083417|FG002|Overall Study|Administrative Reason by Sponsor|0|||
48793965|NCT02638948|157083418|FG003|Overall Study|Administrative Reason by Sponsor|4|||
48793966|NCT02638948|157083415|FG000|Overall Study|Adverse Event|0|||
48793967|NCT02638948|157083416|FG001|Overall Study|Adverse Event|0|||
48793968|NCT02638948|157083417|FG002|Overall Study|Adverse Event|1|||
48793969|NCT02638948|157083418|FG003|Overall Study|Adverse Event|1|||
48793970|NCT02638948|157083415|FG000|Overall Study|Lack of Efficacy|1|||
48793971|NCT02638948|157083416|FG001|Overall Study|Lack of Efficacy|1|||
48793972|NCT02638948|157083417|FG002|Overall Study|Lack of Efficacy|0|||
48793973|NCT02638948|157083418|FG003|Overall Study|Lack of Efficacy|0|||
48793974|NCT02638948|157083415|FG000|Overall Study|Lost to Follow-up|0|||
48793975|NCT02638948|157083416|FG001|Overall Study|Lost to Follow-up|0|||
48793976|NCT02638948|157083417|FG002|Overall Study|Lost to Follow-up|1|||
48793977|NCT02638948|157083418|FG003|Overall Study|Lost to Follow-up|1|||
48793978|NCT02638948|157083415|FG000|Overall Study|Poor/Non-Compliance|0|||
48793979|NCT02638948|157083416|FG001|Overall Study|Poor/Non-Compliance|2|||
48793980|NCT02638948|157083417|FG002|Overall Study|Poor/Non-Compliance|1|||
48793981|NCT02638948|157083418|FG003|Overall Study|Poor/Non-Compliance|0|||
48793982|NCT02638948|157083415|FG000|Overall Study|Participant no longer met study criteria|0|||
48793983|NCT02638948|157083416|FG001|Overall Study|Participant no longer met study criteria|1|||
48793984|NCT02638948|157083417|FG002|Overall Study|Participant no longer met study criteria|0|||
48793985|NCT02638948|157083418|FG003|Overall Study|Participant no longer met study criteria|0|||
48793986|NCT02638948|157083415|FG000|Overall Study|Other than specified above|4|||
48793987|NCT02638948|157083416|FG001|Overall Study|Other than specified above|1|||
48793988|NCT02638948|157083417|FG002|Overall Study|Other than specified above|1|||
48793989|NCT02638948|157083418|FG003|Overall Study|Other than specified above|1|||
48793990|NCT03085485|157083420|FG000|Overall Study|Death|1|||
48793991|NCT03085485|157083421|FG001|Overall Study|Death|0|||
48793992|NCT03085485|157083420|FG000|Overall Study|Lost to Follow-up|1|||
48793993|NCT03085485|157083421|FG001|Overall Study|Lost to Follow-up|0|||
48793994|NCT01022762|157083422|FG000|Overall Study|Adverse Event|3|||
48793995|NCT01022762|157083423|FG001|Overall Study|Adverse Event|1|||
48793996|NCT01022762|157083422|FG000|Overall Study|Lack of Efficacy|0|||
48793997|NCT01022762|157083423|FG001|Overall Study|Lack of Efficacy|1|||
48793998|NCT01022762|157083422|FG000|Overall Study|Protocol Violation|7|||
48793999|NCT01022762|157083423|FG001|Overall Study|Protocol Violation|6|||
48794000|NCT01022762|157083422|FG000|Overall Study|Unclassified|12|||
48794001|NCT01022762|157083423|FG001|Overall Study|Unclassified|20|||
48794002|NCT00605280|157083424|FG000|Year 1|Protocol Violation|0|||
48794003|NCT00605280|157083425|FG001|Year 1|Protocol Violation|0|||
48794004|NCT00605280|157083426|FG002|Year 1|Protocol Violation|0|||
48794005|NCT00605280|157083427|FG003|Year 1|Protocol Violation|1|||
48794006|NCT00605280|157083424|FG000|Year 1|Adverse Event|3|||
48794007|NCT00605280|157083425|FG001|Year 1|Adverse Event|1|||
48794008|NCT00605280|157083426|FG002|Year 1|Adverse Event|1|||
48794009|NCT00605280|157083427|FG003|Year 1|Adverse Event|5|||
48794010|NCT00605280|157083424|FG000|Year 1|Physician Decision|7|||
48794011|NCT00605280|157083425|FG001|Year 1|Physician Decision|4|||
48794012|NCT00605280|157083426|FG002|Year 1|Physician Decision|0|||
48794013|NCT00605280|157083427|FG003|Year 1|Physician Decision|6|||
48794014|NCT00605280|157083424|FG000|Year 1|Withdrawal by Subject|2|||
48794015|NCT00605280|157083425|FG001|Year 1|Withdrawal by Subject|4|||
48794016|NCT00605280|157083426|FG002|Year 1|Withdrawal by Subject|0|||
48794017|NCT00605280|157083427|FG003|Year 1|Withdrawal by Subject|4|||
48794018|NCT00605280|157083424|FG000|Year 1|Other|2|||
48794019|NCT00605280|157083425|FG001|Year 1|Other|1|||
48794020|NCT00605280|157083426|FG002|Year 1|Other|0|||
48794021|NCT00605280|157083427|FG003|Year 1|Other|1|||
48794022|NCT00605280|157083424|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
48794023|NCT00605280|157083425|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
48794024|NCT00605280|157083426|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
48794025|NCT00605280|157083427|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
48794026|NCT00605280|157083424|FG000|Year 2|Adverse Event|4|||
48794027|NCT00605280|157083425|FG001|Year 2|Adverse Event|0|||
48794028|NCT00605280|157083426|FG002|Year 2|Adverse Event|2|||
48794029|NCT00605280|157083427|FG003|Year 2|Adverse Event|4|||
48794030|NCT00605280|157083424|FG000|Year 2|Physician Decision|11|||
48794031|NCT00605280|157083425|FG001|Year 2|Physician Decision|6|||
48401592|NCT01171898|155661704|FG000|Overall Study|Terminated by Sponsor|1|||
48794032|NCT00605280|157083426|FG002|Year 2|Physician Decision|4|||
48794033|NCT00605280|157083427|FG003|Year 2|Physician Decision|11|||
48794034|NCT00605280|157083424|FG000|Year 2|Withdrawal by Subject|4|||
48794035|NCT00605280|157083425|FG001|Year 2|Withdrawal by Subject|0|||
48794036|NCT00605280|157083426|FG002|Year 2|Withdrawal by Subject|0|||
48794037|NCT00605280|157083427|FG003|Year 2|Withdrawal by Subject|4|||
48794038|NCT00605280|157083424|FG000|Year 2|Other|1|||
48794039|NCT00605280|157083425|FG001|Year 2|Other|0|||
48794040|NCT00605280|157083426|FG002|Year 2|Other|0|||
48794041|NCT00605280|157083427|FG003|Year 2|Other|1|||
48794042|NCT00605280|157083424|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
48794043|NCT00605280|157083425|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
48794044|NCT00605280|157083426|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
48794045|NCT00605280|157083427|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
48794046|NCT00605280|157083424|FG000|Year 3 Extension|Adverse Event|2|||
48794047|NCT00605280|157083425|FG001|Year 3 Extension|Adverse Event|0|||
48794048|NCT00605280|157083426|FG002|Year 3 Extension|Adverse Event|0|||
48794049|NCT00605280|157083427|FG003|Year 3 Extension|Adverse Event|2|||
48794050|NCT00605280|157083424|FG000|Year 3 Extension|Physician Decision|0|||
48794051|NCT00605280|157083425|FG001|Year 3 Extension|Physician Decision|0|||
48794052|NCT00605280|157083426|FG002|Year 3 Extension|Physician Decision|0|||
48794053|NCT00605280|157083427|FG003|Year 3 Extension|Physician Decision|2|||
48794054|NCT00605280|157083424|FG000|Year 3 Extension|Withdrawal by Subject|2|||
48794055|NCT00605280|157083425|FG001|Year 3 Extension|Withdrawal by Subject|0|||
48794056|NCT00605280|157083426|FG002|Year 3 Extension|Withdrawal by Subject|0|||
48794057|NCT00605280|157083427|FG003|Year 3 Extension|Withdrawal by Subject|5|||
48794058|NCT00605280|157083424|FG000|Year 3 Extension|Other|2|||
48794059|NCT00605280|157083425|FG001|Year 3 Extension|Other|0|||
48794060|NCT00605280|157083426|FG002|Year 3 Extension|Other|0|||
48794061|NCT00605280|157083427|FG003|Year 3 Extension|Other|0|||
48794062|NCT00605280|157083424|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
48794063|NCT00605280|157083425|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
48794064|NCT00605280|157083426|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
48794065|NCT00605280|157083427|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
48794066|NCT04891419|157083428|FG000|Overall Study|Withdrawal by Subject|4|||
48794067|NCT04891419|157083429|FG001|Overall Study|Withdrawal by Subject|0|||
48794068|NCT04891419|157083428|FG000|Overall Study|Lost to Follow-up|1|||
48794069|NCT04891419|157083429|FG001|Overall Study|Lost to Follow-up|3|||
48794070|NCT00802074|157083430|FG000|Overall Study|Adverse Event|1|||
48794071|NCT00802074|157083431|FG001|Overall Study|Adverse Event|1|||
48794072|NCT00802074|157083432|FG002|Overall Study|Adverse Event|1|||
48794073|NCT00802074|157083433|FG003|Overall Study|Adverse Event|0|||
48401593|NCT01171898|155661705|FG001|Overall Study|Terminated by Sponsor|0|||
48401594|NCT01171898|155661706|FG002|Overall Study|Terminated by Sponsor|0|||
48401595|NCT01171898|155661707|FG003|Overall Study|Terminated by Sponsor|0|||
48401596|NCT01171898|155661704|FG000|Overall Study|Ongoing|1|||
48794074|NCT00802074|157083434|FG004|Overall Study|Adverse Event|0|||
48401597|NCT01171898|155661705|FG001|Overall Study|Ongoing|9|||
48794075|NCT00802074|157083435|FG005|Overall Study|Adverse Event|0|||
48794076|NCT00802074|157083430|FG000|Overall Study|Withdrawal by Subject|1|||
48794077|NCT00802074|157083431|FG001|Overall Study|Withdrawal by Subject|0|||
48794078|NCT00802074|157083432|FG002|Overall Study|Withdrawal by Subject|0|||
48794079|NCT00802074|157083433|FG003|Overall Study|Withdrawal by Subject|0|||
48794080|NCT00802074|157083434|FG004|Overall Study|Withdrawal by Subject|0|||
48794081|NCT00802074|157083435|FG005|Overall Study|Withdrawal by Subject|0|||
48794082|NCT00127101|157083436|FG000|Base Protocol|Adverse Event|0|||
48794083|NCT00127101|157083437|FG001|Base Protocol|Adverse Event|2|||
48794084|NCT00127101|157083438|FG002|Base Protocol|Adverse Event|1|||
48794085|NCT00127101|157083439|FG003|Base Protocol|Adverse Event|0|||
48794086|NCT00127101|157083440|FG004|Base Protocol|Adverse Event|0|||
48794087|NCT00127101|157083441|FG005|Base Protocol|Adverse Event|0|||
48794088|NCT00127101|157083436|FG000|Base Protocol|Lack of Efficacy|1|||
48794089|NCT00127101|157083437|FG001|Base Protocol|Lack of Efficacy|0|||
48401598|NCT01171898|155661706|FG002|Overall Study|Ongoing|3|||
48401599|NCT01171898|155661707|FG003|Overall Study|Ongoing|0|||
48401600|NCT01171898|155661704|FG000|Overall Study|Other|1|||
48401601|NCT01171898|155661705|FG001|Overall Study|Other|5|||
48401602|NCT01171898|155661706|FG002|Overall Study|Other|0|||
48401603|NCT01171898|155661707|FG003|Overall Study|Other|2|||
48401604|NCT05418296|155661708|FG000|Overall Study|Withdrawal by Subject|4|||
48401605|NCT05418296|155661709|FG001|Overall Study|Withdrawal by Subject|1|||
48401606|NCT03548051|155661710|FG000|Overall Study|Death|1|||
48401607|NCT03548051|155661711|FG001|Overall Study|Death|1|||
48401608|NCT03548051|155661710|FG000|Overall Study|Withdrawal by Subject|1|||
48401609|NCT03548051|155661711|FG001|Overall Study|Withdrawal by Subject|0|||
48401610|NCT01514682|155661714|FG000|Overall Study|Withdrawal by Subject|2|||
48401611|NCT01514682|155661715|FG001|Overall Study|Withdrawal by Subject|3|||
48401612|NCT01514682|155661714|FG000|Overall Study|Physician Decision|4|||
48401613|NCT01514682|155661715|FG001|Overall Study|Physician Decision|3|||
48401614|NCT03847987|155661716|FG000|Overall Study|Lost to Follow-up|1|||
48401615|NCT03847987|155661717|FG001|Overall Study|Lost to Follow-up|0|||
48401616|NCT03847987|155661716|FG000|Overall Study|Adverse Event|2|||
48401617|NCT03847987|155661717|FG001|Overall Study|Adverse Event|0|||
48401618|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
48401619|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
48401620|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
48401621|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
48401622|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
48401623|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
48401624|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
48401625|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
48401626|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
48401627|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
48794090|NCT00127101|157083438|FG002|Base Protocol|Lack of Efficacy|0|||
48794091|NCT00127101|157083439|FG003|Base Protocol|Lack of Efficacy|0|||
48794092|NCT00127101|157083440|FG004|Base Protocol|Lack of Efficacy|2|||
48794093|NCT00127101|157083441|FG005|Base Protocol|Lack of Efficacy|0|||
48794094|NCT00127101|157083436|FG000|Base Protocol|Withdrawal by Subject|1|||
48794095|NCT00127101|157083437|FG001|Base Protocol|Withdrawal by Subject|2|||
48794096|NCT00127101|157083438|FG002|Base Protocol|Withdrawal by Subject|1|||
48794097|NCT00127101|157083439|FG003|Base Protocol|Withdrawal by Subject|0|||
48794098|NCT00127101|157083440|FG004|Base Protocol|Withdrawal by Subject|0|||
48794099|NCT00127101|157083441|FG005|Base Protocol|Withdrawal by Subject|1|||
48794100|NCT00127101|157083436|FG000|Continuation Phase|Adverse Event|0|||
48794101|NCT00127101|157083437|FG001|Continuation Phase|Adverse Event|0|||
48794102|NCT00127101|157083438|FG002|Continuation Phase|Adverse Event|0|||
48794103|NCT00127101|157083439|FG003|Continuation Phase|Adverse Event|0|||
48794104|NCT00127101|157083440|FG004|Continuation Phase|Adverse Event|1|||
48794105|NCT00127101|157083441|FG005|Continuation Phase|Adverse Event|1|||
48794106|NCT00127101|157083436|FG000|Continuation Phase|Lack of Efficacy|0|||
48794107|NCT00127101|157083437|FG001|Continuation Phase|Lack of Efficacy|0|||
48794108|NCT00127101|157083438|FG002|Continuation Phase|Lack of Efficacy|0|||
48794109|NCT00127101|157083439|FG003|Continuation Phase|Lack of Efficacy|0|||
48794110|NCT00127101|157083440|FG004|Continuation Phase|Lack of Efficacy|0|||
48794111|NCT00127101|157083441|FG005|Continuation Phase|Lack of Efficacy|1|||
48794112|NCT00127101|157083436|FG000|Continuation Phase|Withdrawal by Subject|0|||
48794113|NCT00127101|157083437|FG001|Continuation Phase|Withdrawal by Subject|0|||
48401628|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
48401629|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
48794114|NCT00127101|157083438|FG002|Continuation Phase|Withdrawal by Subject|1|||
48794115|NCT00127101|157083439|FG003|Continuation Phase|Withdrawal by Subject|0|||
48794116|NCT00127101|157083440|FG004|Continuation Phase|Withdrawal by Subject|2|||
48794117|NCT00127101|157083441|FG005|Continuation Phase|Withdrawal by Subject|1|||
48794118|NCT00843167|157083442|FG000|Treatment Period|Adverse Event|1|||
48794119|NCT00843167|157083443|FG001|Treatment Period|Adverse Event|5|||
48794120|NCT00843167|157083442|FG000|Treatment Period|Withdrawal by Subject|2|||
48794121|NCT00843167|157083443|FG001|Treatment Period|Withdrawal by Subject|3|||
48794122|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
48794123|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
48794124|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
48401630|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
48401631|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
48401632|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
48401633|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
48401634|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
48401635|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
48401636|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
48401637|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
48401638|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
48401639|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
48401640|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
48401641|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
48401642|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
48401643|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
48401644|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
48401645|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
48401646|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
48401647|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
48401648|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
48401649|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
48401650|NCT03605680|155661718|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
48401651|NCT03605680|155661719|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
48401652|NCT03605680|155661720|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
48401653|NCT03605680|155661721|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
48401654|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
48401655|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
48401656|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
48401657|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
48401658|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
48401659|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
48401660|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
48401661|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
48401662|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48401663|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48401664|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
48401665|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
48401666|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
48401667|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
48401668|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
48401669|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
48401670|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
48401671|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
48401672|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
48794125|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
48794126|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
48794127|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
48794128|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
48794129|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
48401673|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
48401674|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
48401675|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
48401676|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
48401677|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
48401678|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
48401679|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
48401680|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
48401681|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
48794130|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
48794131|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
48794132|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
48794133|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
48794134|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
48794135|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
48794136|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
48794137|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
48794138|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
48794139|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
48794140|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
48794141|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
48794142|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
48794143|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
48794144|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
48794145|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
48794146|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
48794147|NCT01662310|157083444|FG000|Run-In or Stabilization Phase|Other|1|||
48794148|NCT01662310|157083445|FG001|Run-In or Stabilization Phase|Other|0|||
48794149|NCT01662310|157083446|FG002|Run-In or Stabilization Phase|Other|0|||
48794150|NCT01662310|157083447|FG003|Run-In or Stabilization Phase|Other|0|||
48794151|NCT01662310|157083448|FG004|Run-In or Stabilization Phase|Other|0|||
48794152|NCT01662310|157083444|FG000|Double-Blind Phase|Adverse Event|0|||
48794153|NCT01662310|157083445|FG001|Double-Blind Phase|Adverse Event|0|||
48794154|NCT01662310|157083446|FG002|Double-Blind Phase|Adverse Event|1|||
48794155|NCT01662310|157083447|FG003|Double-Blind Phase|Adverse Event|0|||
48794156|NCT01662310|157083448|FG004|Double-Blind Phase|Adverse Event|0|||
48794157|NCT01662310|157083444|FG000|Double-Blind Phase|Lost to Follow-up|0|||
48794158|NCT01662310|157083445|FG001|Double-Blind Phase|Lost to Follow-up|3|||
48794159|NCT01662310|157083446|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48794160|NCT01662310|157083447|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48794161|NCT01662310|157083448|FG004|Double-Blind Phase|Lost to Follow-up|0|||
48794162|NCT01662310|157083444|FG000|Double-Blind Phase|Pregnancy|0|||
48794163|NCT01662310|157083445|FG001|Double-Blind Phase|Pregnancy|2|||
48794164|NCT01662310|157083446|FG002|Double-Blind Phase|Pregnancy|0|||
48794165|NCT01662310|157083447|FG003|Double-Blind Phase|Pregnancy|0|||
48794166|NCT01662310|157083448|FG004|Double-Blind Phase|Pregnancy|0|||
48794167|NCT01662310|157083444|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
48794168|NCT01662310|157083445|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
48794169|NCT01662310|157083446|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
48794170|NCT01662310|157083447|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
48794171|NCT01662310|157083448|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
48794172|NCT01662310|157083444|FG000|Double-Blind Phase|Other|0|||
48794173|NCT01662310|157083445|FG001|Double-Blind Phase|Other|0|||
48794174|NCT01662310|157083446|FG002|Double-Blind Phase|Other|1|||
48794175|NCT01662310|157083447|FG003|Double-Blind Phase|Other|0|||
48794176|NCT01662310|157083448|FG004|Double-Blind Phase|Other|0|||
48794177|NCT01662310|157083444|FG000|Double-Blind Phase|Randomized but not treated|0|||
48794178|NCT01662310|157083445|FG001|Double-Blind Phase|Randomized but not treated|1|||
48794179|NCT01662310|157083446|FG002|Double-Blind Phase|Randomized but not treated|0|||
48794180|NCT01662310|157083447|FG003|Double-Blind Phase|Randomized but not treated|0|||
48794181|NCT01662310|157083448|FG004|Double-Blind Phase|Randomized but not treated|0|||
48794182|NCT01662310|157083444|FG000|Open-Label Extension Phase|Adverse Event|0|||
48794183|NCT01662310|157083445|FG001|Open-Label Extension Phase|Adverse Event|0|||
48794184|NCT01662310|157083446|FG002|Open-Label Extension Phase|Adverse Event|0|||
48794185|NCT01662310|157083447|FG003|Open-Label Extension Phase|Adverse Event|3|||
48794186|NCT01662310|157083448|FG004|Open-Label Extension Phase|Adverse Event|0|||
48794187|NCT01662310|157083444|FG000|Open-Label Extension Phase|Death|0|||
48794188|NCT01662310|157083445|FG001|Open-Label Extension Phase|Death|0|||
48794189|NCT01662310|157083446|FG002|Open-Label Extension Phase|Death|0|||
48794190|NCT01662310|157083447|FG003|Open-Label Extension Phase|Death|1|||
48794191|NCT01662310|157083448|FG004|Open-Label Extension Phase|Death|0|||
48794192|NCT01662310|157083444|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
48794193|NCT01662310|157083445|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
48794194|NCT01662310|157083446|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
48794195|NCT01662310|157083447|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
48794196|NCT01662310|157083448|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
48794197|NCT01662310|157083444|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
48794198|NCT01662310|157083445|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
48794199|NCT01662310|157083446|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
48794200|NCT01662310|157083447|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
48794201|NCT01662310|157083448|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
48794202|NCT01662310|157083444|FG000|Open-Label Extension Phase|Pregnancy|0|||
48794203|NCT01662310|157083445|FG001|Open-Label Extension Phase|Pregnancy|0|||
48401682|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
48401683|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
48401684|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
48401685|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
48401686|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
48401687|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
48401688|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
48794204|NCT01662310|157083446|FG002|Open-Label Extension Phase|Pregnancy|0|||
48794205|NCT01662310|157083447|FG003|Open-Label Extension Phase|Pregnancy|1|||
48794206|NCT01662310|157083448|FG004|Open-Label Extension Phase|Pregnancy|0|||
48794207|NCT01662310|157083444|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
48794208|NCT01662310|157083445|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
48794209|NCT01662310|157083446|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
48794210|NCT01662310|157083447|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
48794211|NCT01662310|157083448|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
48794212|NCT05012163|157083451|FG000|Overall Study|Protocol Violation|0|||
48794213|NCT05012163|157083452|FG001|Overall Study|Protocol Violation|0|||
48794214|NCT05012163|157083453|FG002|Overall Study|Protocol Violation|1|||
48794215|NCT05012163|157083454|FG003|Overall Study|Protocol Violation|1|||
48794216|NCT03355326|157083457|FG000|Overall Study|Protocol Violation|3|||
48794217|NCT03355326|157083458|FG001|Overall Study|Protocol Violation|3|||
48794218|NCT03493542|157083460|FG000|Base Study|Withdrawal by Subject|0|||
48794219|NCT03493542|157083461|FG001|Base Study|Withdrawal by Subject|4|||
48794220|NCT03493542|157083462|FG002|Base Study|Withdrawal by Subject|0|||
48794221|NCT03493542|157083460|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
48794222|NCT03493542|157083461|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
48794223|NCT03493542|157083462|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
48794224|NCT03493542|157083460|FG000|Extension Study|Withdrawal by Subject|0|||
48794225|NCT03493542|157083461|FG001|Extension Study|Withdrawal by Subject|0|||
48794226|NCT03493542|157083462|FG002|Extension Study|Withdrawal by Subject|25|||
48794227|NCT04368429|157084965|FG000|Overall Study|Adverse Event|1|||
48794228|NCT04368429|157084966|FG001|Overall Study|Adverse Event|0|||
48794229|NCT00608582|157084967|FG000|Overall Study|Lost to Follow-up|2|||
48794230|NCT00608582|157084968|FG001|Overall Study|Lost to Follow-up|0|||
48794231|NCT00608582|157084967|FG000|Overall Study|No Best Response in Phase 1 located|1|||
48794232|NCT00608582|157084968|FG001|Overall Study|No Best Response in Phase 1 located|1|||
48794233|NCT00608582|157084967|FG000|Overall Study|Illicit Drug Use|1|||
48794234|NCT00608582|157084968|FG001|Overall Study|Illicit Drug Use|0|||
48794235|NCT00608582|157084967|FG000|Overall Study|Early stage Design Change|0|||
48794236|NCT00608582|157084968|FG001|Overall Study|Early stage Design Change|3|||
48794237|NCT00156065|157084970|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
48794238|NCT00156065|157084971|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
48794239|NCT00156065|157084972|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
48794240|NCT00156065|157084970|FG000|Overall Study|Adverse Event|8|||
48794241|NCT00156065|157084971|FG001|Overall Study|Adverse Event|11|||
48794242|NCT00156065|157084972|FG002|Overall Study|Adverse Event|4|||
48401689|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
48401690|NCT03605680|155661718|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
48401691|NCT03605680|155661719|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
48401692|NCT03605680|155661720|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
48401693|NCT03605680|155661721|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
48401694|NCT00647556|155661722|FG000|Overall Study|Adverse Event|0|||
48401695|NCT00647556|155661723|FG001|Overall Study|Adverse Event|1|||
48401696|NCT00647556|155661722|FG000|Overall Study|Lost to Follow-up|1|||
48794243|NCT00156065|157084970|FG000|Overall Study|Lack of Efficacy|2|||
48794244|NCT00156065|157084971|FG001|Overall Study|Lack of Efficacy|9|||
48794245|NCT00156065|157084972|FG002|Overall Study|Lack of Efficacy|3|||
48794246|NCT00156065|157084970|FG000|Overall Study|Withdrawal by Subject|13|||
48794247|NCT00156065|157084971|FG001|Overall Study|Withdrawal by Subject|26|||
48794248|NCT00156065|157084972|FG002|Overall Study|Withdrawal by Subject|16|||
48794249|NCT00156065|157084970|FG000|Overall Study|Lost to Follow-up|5|||
48794250|NCT00156065|157084971|FG001|Overall Study|Lost to Follow-up|7|||
48794251|NCT00156065|157084972|FG002|Overall Study|Lost to Follow-up|1|||
48794252|NCT00156065|157084970|FG000|Overall Study|Other|2|||
48794253|NCT00156065|157084971|FG001|Overall Study|Other|9|||
48794254|NCT00156065|157084972|FG002|Overall Study|Other|3|||
48794255|NCT04546581|157084975|FG000|Overall Study|Adverse Event|9|||
48794256|NCT04546581|157084976|FG001|Overall Study|Adverse Event|3|||
48794257|NCT04546581|157084975|FG000|Overall Study|Physician Decision|0|||
48794258|NCT04546581|157084976|FG001|Overall Study|Physician Decision|1|||
48794259|NCT04546581|157084975|FG000|Overall Study|Protocol Violation|1|||
48794260|NCT04546581|157084976|FG001|Overall Study|Protocol Violation|2|||
48794261|NCT04546581|157084975|FG000|Overall Study|Withdrawal by Subject|3|||
48794262|NCT04546581|157084976|FG001|Overall Study|Withdrawal by Subject|7|||
48794263|NCT01798927|157084977|FG000|Overall Study|Withdrawal by Subject|1|||
48794264|NCT01928719|157084978|FG000|Overall Study|Lost to Follow-up|26|||
48794265|NCT01928719|157084979|FG001|Overall Study|Lost to Follow-up|11|||
48794266|NCT01928719|157084978|FG000|Overall Study|Withdrawal by Subject|22|||
48794267|NCT01928719|157084979|FG001|Overall Study|Withdrawal by Subject|7|||
48794268|NCT01928719|157084978|FG000|Overall Study|Protocol Violation|3|||
48794269|NCT01928719|157084979|FG001|Overall Study|Protocol Violation|1|||
48794270|NCT01928719|157084978|FG000|Overall Study|Adverse Event|1|||
48794271|NCT01928719|157084979|FG001|Overall Study|Adverse Event|0|||
48794272|NCT02280044|157084980|FG000|Overall Study|Planned alternate|0|||
48794273|NCT02280044|157084981|FG001|Overall Study|Planned alternate|2|||
48794274|NCT02207816|157084987|FG000|Overall Study|Serious Adverse Event|0|||
48794275|NCT02207816|157084988|FG001|Overall Study|Serious Adverse Event|5|||
48794276|NCT02207816|157084989|FG002|Overall Study|Serious Adverse Event|2|||
48794277|NCT02207816|157084987|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
48794278|NCT02207816|157084988|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
48794279|NCT02207816|157084989|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
48794280|NCT02207816|157084987|FG000|Overall Study|Withdrawal by Subject|4|||
48794281|NCT02207816|157084988|FG001|Overall Study|Withdrawal by Subject|9|||
48794282|NCT02207816|157084989|FG002|Overall Study|Withdrawal by Subject|7|||
48794283|NCT02207816|157084987|FG000|Overall Study|Migrated/Moved From Study Area|41|||
48794284|NCT02207816|157084988|FG001|Overall Study|Migrated/Moved From Study Area|60|||
48794285|NCT02207816|157084989|FG002|Overall Study|Migrated/Moved From Study Area|51|||
48794286|NCT02207816|157084987|FG000|Overall Study|Lost to Follow-up|3|||
48794287|NCT02207816|157084988|FG001|Overall Study|Lost to Follow-up|9|||
48794288|NCT02207816|157084989|FG002|Overall Study|Lost to Follow-up|1|||
48794289|NCT02207816|157084987|FG000|Overall Study|Other|1|||
48794290|NCT02207816|157084988|FG001|Overall Study|Other|2|||
48794291|NCT02207816|157084989|FG002|Overall Study|Other|4|||
48794292|NCT04004611|157084992|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794293|NCT04004611|157084993|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794294|NCT04004611|157084994|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794295|NCT04004611|157084995|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794296|NCT04004611|157084996|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794297|NCT04004611|157084997|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48401697|NCT00647556|155661723|FG001|Overall Study|Lost to Follow-up|0|||
48401698|NCT00647556|155661722|FG000|Overall Study|Protocol Violation|0|||
48794298|NCT04004611|157084998|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794299|NCT04004611|157084999|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
48794300|NCT04004611|157085000|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
48794301|NCT04004611|157084992|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794302|NCT04004611|157084993|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794303|NCT04004611|157084994|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794304|NCT04004611|157084995|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794305|NCT04004611|157084996|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794306|NCT04004611|157084997|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
48794307|NCT04004611|157084998|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
48794308|NCT04004611|157084999|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
48794309|NCT04004611|157085000|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
48794310|NCT04004611|157084992|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794311|NCT04004611|157084993|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794312|NCT04004611|157084994|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794313|NCT04004611|157084995|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794314|NCT04004611|157084996|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
48794315|NCT04004611|157084997|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794316|NCT04004611|157084998|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794317|NCT04004611|157084999|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794318|NCT04004611|157085000|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
48794319|NCT04004611|157084992|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
48794320|NCT04004611|157084993|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
48794321|NCT04004611|157084994|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
48401699|NCT00647556|155661723|FG001|Overall Study|Protocol Violation|1|||
48794322|NCT04004611|157084995|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
48794323|NCT04004611|157084996|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
48794324|NCT04004611|157084997|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
48794325|NCT04004611|157084998|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
48794326|NCT04004611|157084999|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
48794327|NCT04004611|157085000|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
48794328|NCT04004611|157084992|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
48794329|NCT04004611|157084993|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794330|NCT04004611|157084994|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
48794331|NCT04004611|157084995|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794332|NCT04004611|157084996|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794333|NCT04004611|157084997|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794334|NCT04004611|157084998|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794335|NCT04004611|157084999|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794336|NCT04004611|157085000|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
48794337|NCT04004611|157084992|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794338|NCT04004611|157084993|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
48794339|NCT04004611|157084994|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794340|NCT04004611|157084995|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794341|NCT04004611|157084996|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794342|NCT04004611|157084997|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794343|NCT04004611|157084998|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794344|NCT04004611|157084999|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794345|NCT04004611|157085000|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
48794346|NCT01292928|157085003|FG000|Overall Study|Death|8|||
48794347|NCT01292928|157085003|FG000|Overall Study|Withdrawal by Subject|8|||
48401700|NCT00647556|155661722|FG000|Overall Study|Withdrawal by Subject|1|||
48401701|NCT00647556|155661723|FG001|Overall Study|Withdrawal by Subject|0|||
48401702|NCT00647556|155661722|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
48401703|NCT00647556|155661723|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
48401704|NCT00527605|155661725|FG000|Overall Study|Adverse Event|3|||
48401705|NCT00527605|155661726|FG001|Overall Study|Adverse Event|0|||
48401706|NCT00527605|155661725|FG000|Overall Study|Withdrawal by Subject|3|||
48401707|NCT00527605|155661726|FG001|Overall Study|Withdrawal by Subject|7|||
48401708|NCT00527605|155661725|FG000|Overall Study|Lost to Follow-up|6|||
48401709|NCT00527605|155661726|FG001|Overall Study|Lost to Follow-up|2|||
48401710|NCT00527605|155661725|FG000|Overall Study|Protocol Violation|1|||
48401711|NCT00527605|155661726|FG001|Overall Study|Protocol Violation|2|||
48401712|NCT00763139|155661732|FG000|Overall Study|Adverse Event|4|||
48401713|NCT00763139|155661733|FG001|Overall Study|Adverse Event|2|||
48401714|NCT00763139|155661732|FG000|Overall Study|Withdrawal by Subject|0|||
48794348|NCT01292928|157085003|FG000|Overall Study|Lost to Follow-up|6|||
48794349|NCT01292928|157085003|FG000|Overall Study|Physician Decision|2|||
48794350|NCT04263311|157085004|FG000|Overall Study|Lost to Follow-up|1|||
48794351|NCT04263311|157085005|FG001|Overall Study|Lost to Follow-up|2|||
48794352|NCT04263311|157085006|FG002|Overall Study|Lost to Follow-up|0|||
48794353|NCT04263311|157085004|FG000|Overall Study|Health Issues|1|||
48794354|NCT04263311|157085005|FG001|Overall Study|Health Issues|0|||
48794355|NCT04263311|157085006|FG002|Overall Study|Health Issues|0|||
48794356|NCT04263311|157085004|FG000|Overall Study|Left the country|1|||
48794357|NCT04263311|157085005|FG001|Overall Study|Left the country|0|||
48794358|NCT04263311|157085006|FG002|Overall Study|Left the country|0|||
48794359|NCT04263311|157085004|FG000|Overall Study|Unable to maintain time commitment|1|||
48794360|NCT04263311|157085005|FG001|Overall Study|Unable to maintain time commitment|0|||
48794361|NCT04263311|157085006|FG002|Overall Study|Unable to maintain time commitment|0|||
48794362|NCT04263311|157085004|FG000|Overall Study|No longer interested|1|||
48794363|NCT04263311|157085005|FG001|Overall Study|No longer interested|0|||
48794364|NCT04263311|157085006|FG002|Overall Study|No longer interested|0|||
48794365|NCT04263311|157085004|FG000|Overall Study|Ineligible post consent|0|||
48794366|NCT04263311|157085005|FG001|Overall Study|Ineligible post consent|0|||
48794367|NCT04263311|157085006|FG002|Overall Study|Ineligible post consent|5|||
48794368|NCT01059565|157085007|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
48794369|NCT01059565|157085008|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
48794370|NCT01059565|157085007|FG000|24-Week Randomized Phase|Adverse Event|5|||
48794371|NCT01059565|157085008|FG001|24-Week Randomized Phase|Adverse Event|0|||
48794372|NCT01059565|157085007|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
48794373|NCT01059565|157085008|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
48794374|NCT01059565|157085007|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
48794375|NCT01059565|157085008|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
48794376|NCT01059565|157085007|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
48794377|NCT01059565|157085008|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
48794378|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Adverse Event|2|||
48794379|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Adverse Event|0|||
48794380|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
48794381|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
48794382|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
48794383|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
48794384|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
48794385|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
48794386|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
48794387|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
48794388|NCT01059565|157085007|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
48794389|NCT01059565|157085008|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
48794390|NCT03927950|157085014|FG000|Overall Study|Adverse Event|9|||
48794391|NCT03945188|157085017|FG000|Overall Study|Protocol Violation|1|||
48794392|NCT03945188|157085018|FG001|Overall Study|Protocol Violation|0|||
48794393|NCT03945188|157085017|FG000|Overall Study|Disease worsening|79|||
48794394|NCT03945188|157085018|FG001|Overall Study|Disease worsening|73|||
48794395|NCT03945188|157085017|FG000|Overall Study|Physician Decision|2|||
48794396|NCT03945188|157085018|FG001|Overall Study|Physician Decision|2|||
48794397|NCT03945188|157085017|FG000|Overall Study|Lack of Efficacy|7|||
48794398|NCT03945188|157085018|FG001|Overall Study|Lack of Efficacy|4|||
48794399|NCT03945188|157085017|FG000|Overall Study|Pregnancy|2|||
48794400|NCT03945188|157085018|FG001|Overall Study|Pregnancy|0|||
48794401|NCT03945188|157085017|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
48794402|NCT03945188|157085018|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
48794403|NCT03945188|157085017|FG000|Overall Study|Adverse Event|10|||
48794404|NCT03945188|157085018|FG001|Overall Study|Adverse Event|5|||
48794405|NCT03945188|157085017|FG000|Overall Study|Other|2|||
48794406|NCT03945188|157085018|FG001|Overall Study|Other|2|||
48794407|NCT03945188|157085017|FG000|Overall Study|Lost to Follow-up|1|||
48794408|NCT03945188|157085018|FG001|Overall Study|Lost to Follow-up|2|||
48794409|NCT02219048|157085019|FG000|Overall Study|Adverse Event|2|||
48794410|NCT02219048|157085020|FG001|Overall Study|Adverse Event|5|||
48794411|NCT02219048|157085019|FG000|Overall Study|No longer meets eligibility criteria|1|||
48794412|NCT02219048|157085020|FG001|Overall Study|No longer meets eligibility criteria|0|||
48794413|NCT02219048|157085019|FG000|Overall Study|Study terminated by sponsor|16|||
48794414|NCT02219048|157085020|FG001|Overall Study|Study terminated by sponsor|15|||
48794415|NCT02219048|157085019|FG000|Overall Study|Withdrawal by Subject|2|||
48357066|NCT02563548|155503552|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
48357067|NCT02563548|155503553|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
48357068|NCT02563548|155503554|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
48357069|NCT02563548|155503549|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48430357|NCT00696657|155763702|FG002|Overall Study|Unclassified|3|||
48401715|NCT00763139|155661733|FG001|Overall Study|Withdrawal by Subject|1|||
48401716|NCT00763139|155661732|FG000|Overall Study|med change not allowed by protocol|1|||
48401717|NCT00763139|155661733|FG001|Overall Study|med change not allowed by protocol|0|||
48794416|NCT02219048|157085020|FG001|Overall Study|Withdrawal by Subject|0|||
48794417|NCT02219048|157085019|FG000|Overall Study|Other|0|||
48794418|NCT02219048|157085020|FG001|Overall Study|Other|1|||
48794419|NCT02015676|157085021|FG000|Overall Study|Adverse Event|2|||
48794420|NCT02015676|157085022|FG001|Overall Study|Adverse Event|18|||
48794421|NCT02015676|157085023|FG002|Overall Study|Adverse Event|0|||
48794422|NCT02015676|157085021|FG000|Overall Study|Lack of Efficacy|2|||
48794423|NCT02015676|157085022|FG001|Overall Study|Lack of Efficacy|4|||
48794424|NCT02015676|157085023|FG002|Overall Study|Lack of Efficacy|0|||
48794425|NCT02015676|157085021|FG000|Overall Study|Protocol Violation|1|||
48794426|NCT02015676|157085022|FG001|Overall Study|Protocol Violation|0|||
48794427|NCT02015676|157085023|FG002|Overall Study|Protocol Violation|0|||
48794428|NCT02015676|157085021|FG000|Overall Study|Withdrawal by Subject|1|||
48794429|NCT02015676|157085022|FG001|Overall Study|Withdrawal by Subject|7|||
48794430|NCT02015676|157085023|FG002|Overall Study|Withdrawal by Subject|1|||
48794431|NCT02015676|157085021|FG000|Overall Study|Administrative reasons|0|||
48794432|NCT02015676|157085022|FG001|Overall Study|Administrative reasons|3|||
48794433|NCT02015676|157085023|FG002|Overall Study|Administrative reasons|1|||
48794434|NCT02015676|157085021|FG000|Overall Study|Death|0|||
48794435|NCT02015676|157085022|FG001|Overall Study|Death|1|||
48794436|NCT02015676|157085023|FG002|Overall Study|Death|0|||
48794437|NCT02015676|157085021|FG000|Overall Study|Disease progression|3|||
48794438|NCT02015676|157085022|FG001|Overall Study|Disease progression|1|||
48794439|NCT02015676|157085023|FG002|Overall Study|Disease progression|1|||
48794440|NCT00952367|157085024|FG000|Overall Study|Withdrawal by Subject|2|||
48794441|NCT00952367|157085024|FG000|Overall Study|Noncoordination|1|||
48794442|NCT00952367|157085024|FG000|Overall Study|Protocol Violation|3|||
48794443|NCT03625570|157085028|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
48794444|NCT03625570|157085029|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
48794445|NCT03625570|157085028|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
48794446|NCT03625570|157085029|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
48794447|NCT03625570|157085028|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
48794448|NCT03625570|157085029|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
48794449|NCT04728347|157085030|FG000|Overall Study|Sponsor decision|0|||
48794450|NCT04728347|157085031|FG001|Overall Study|Sponsor decision|0|||
48794451|NCT04728347|157085032|FG002|Overall Study|Sponsor decision|1|||
48794452|NCT04728347|157085033|FG003|Overall Study|Sponsor decision|0|||
48794453|NCT03644186|157085034|FG000|Overall Study|Withdrawal by Subject|1|||
48794454|NCT03644186|157085035|FG001|Overall Study|Withdrawal by Subject|1|||
48794455|NCT03853109|157085036|FG000|Overall Study|Withdrawal by Subject|0|||
48794456|NCT03853109|157085037|FG001|Overall Study|Withdrawal by Subject|0|||
48794457|NCT03853109|157085038|FG002|Overall Study|Withdrawal by Subject|1|||
48794458|NCT03853109|157085039|FG003|Overall Study|Withdrawal by Subject|2|||
48794459|NCT03853109|157085040|FG004|Overall Study|Withdrawal by Subject|1|||
48794460|NCT03853109|157085041|FG005|Overall Study|Withdrawal by Subject|4|||
48794461|NCT03853109|157085042|FG006|Overall Study|Withdrawal by Subject|5|||
48794462|NCT03853109|157085043|FG007|Overall Study|Withdrawal by Subject|3|||
48794463|NCT03853109|157085036|FG000|Overall Study|Decision by Sponsor|0|||
48794464|NCT03853109|157085037|FG001|Overall Study|Decision by Sponsor|0|||
48794465|NCT03853109|157085038|FG002|Overall Study|Decision by Sponsor|1|||
48794466|NCT03853109|157085039|FG003|Overall Study|Decision by Sponsor|0|||
48794467|NCT03853109|157085040|FG004|Overall Study|Decision by Sponsor|1|||
48794468|NCT03853109|157085041|FG005|Overall Study|Decision by Sponsor|1|||
48794469|NCT03853109|157085042|FG006|Overall Study|Decision by Sponsor|10|||
48794470|NCT03853109|157085043|FG007|Overall Study|Decision by Sponsor|2|||
48794471|NCT03853109|157085036|FG000|Overall Study|Lost to Follow-up|0|||
48794472|NCT03853109|157085037|FG001|Overall Study|Lost to Follow-up|0|||
48794473|NCT03853109|157085038|FG002|Overall Study|Lost to Follow-up|0|||
48794474|NCT03853109|157085039|FG003|Overall Study|Lost to Follow-up|0|||
48794475|NCT03853109|157085040|FG004|Overall Study|Lost to Follow-up|1|||
48794476|NCT03853109|157085041|FG005|Overall Study|Lost to Follow-up|3|||
48794477|NCT03853109|157085042|FG006|Overall Study|Lost to Follow-up|0|||
48794478|NCT03853109|157085043|FG007|Overall Study|Lost to Follow-up|0|||
48794479|NCT03853109|157085036|FG000|Overall Study|Death|2|||
48794480|NCT03853109|157085037|FG001|Overall Study|Death|5|||
48794481|NCT03853109|157085038|FG002|Overall Study|Death|8|||
48794482|NCT03853109|157085039|FG003|Overall Study|Death|10|||
48794483|NCT03853109|157085040|FG004|Overall Study|Death|3|||
48794484|NCT03853109|157085041|FG005|Overall Study|Death|20|||
48794485|NCT03853109|157085042|FG006|Overall Study|Death|10|||
48794486|NCT03853109|157085043|FG007|Overall Study|Death|5|||
48794487|NCT00651664|157085050|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
48794488|NCT00651664|157085051|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
48794489|NCT00651664|157085052|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
48794490|NCT00651664|157085053|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
48794491|NCT00651664|157085054|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
48794492|NCT00651664|157085055|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
48794493|NCT00651664|157085056|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
48794494|NCT00651664|157085057|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
48794495|NCT00651664|157085058|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
48794496|NCT00651664|157085059|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
48794497|NCT00651664|157085050|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794498|NCT00651664|157085051|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794499|NCT00651664|157085052|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794500|NCT00651664|157085053|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794501|NCT00651664|157085054|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
48794502|NCT00651664|157085055|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
48794503|NCT00651664|157085056|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794504|NCT00651664|157085057|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
48794505|NCT00651664|157085058|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
48794506|NCT00651664|157085059|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
48794507|NCT00651664|157085050|FG000|Overall Study|Progressive Disease|3|||
48794508|NCT00651664|157085051|FG001|Overall Study|Progressive Disease|3|||
48794509|NCT00651664|157085052|FG002|Overall Study|Progressive Disease|3|||
48794510|NCT00651664|157085053|FG003|Overall Study|Progressive Disease|12|||
48794511|NCT00651664|157085054|FG004|Overall Study|Progressive Disease|4|||
48794512|NCT00651664|157085055|FG005|Overall Study|Progressive Disease|1|||
48794513|NCT00651664|157085056|FG006|Overall Study|Progressive Disease|3|||
48794514|NCT00651664|157085057|FG007|Overall Study|Progressive Disease|6|||
48794515|NCT00651664|157085058|FG008|Overall Study|Progressive Disease|5|||
48794516|NCT00651664|157085059|FG009|Overall Study|Progressive Disease|5|||
48794517|NCT00651664|157085050|FG000|Overall Study|Patient Declined Further Treatment|0|||
48794518|NCT00651664|157085051|FG001|Overall Study|Patient Declined Further Treatment|0|||
48794519|NCT00651664|157085052|FG002|Overall Study|Patient Declined Further Treatment|0|||
48794520|NCT00651664|157085053|FG003|Overall Study|Patient Declined Further Treatment|1|||
48794521|NCT00651664|157085054|FG004|Overall Study|Patient Declined Further Treatment|1|||
48794522|NCT00651664|157085055|FG005|Overall Study|Patient Declined Further Treatment|1|||
48794523|NCT00651664|157085056|FG006|Overall Study|Patient Declined Further Treatment|0|||
48794524|NCT00651664|157085057|FG007|Overall Study|Patient Declined Further Treatment|0|||
48794525|NCT00651664|157085058|FG008|Overall Study|Patient Declined Further Treatment|0|||
48794526|NCT00651664|157085059|FG009|Overall Study|Patient Declined Further Treatment|1|||
48794527|NCT00651664|157085050|FG000|Overall Study|Symptomatic Deterioration|0|||
48794528|NCT00651664|157085051|FG001|Overall Study|Symptomatic Deterioration|0|||
48794529|NCT00651664|157085052|FG002|Overall Study|Symptomatic Deterioration|0|||
48794530|NCT00651664|157085053|FG003|Overall Study|Symptomatic Deterioration|1|||
48794531|NCT00651664|157085054|FG004|Overall Study|Symptomatic Deterioration|0|||
48794532|NCT00651664|157085055|FG005|Overall Study|Symptomatic Deterioration|0|||
48794533|NCT00651664|157085056|FG006|Overall Study|Symptomatic Deterioration|1|||
48794534|NCT00651664|157085057|FG007|Overall Study|Symptomatic Deterioration|0|||
48794535|NCT00651664|157085058|FG008|Overall Study|Symptomatic Deterioration|1|||
48794536|NCT00651664|157085059|FG009|Overall Study|Symptomatic Deterioration|0|||
48794537|NCT00651664|157085050|FG000|Overall Study|Reason not Specified|0|||
48794538|NCT00651664|157085051|FG001|Overall Study|Reason not Specified|0|||
48794539|NCT00651664|157085052|FG002|Overall Study|Reason not Specified|0|||
48794540|NCT00651664|157085053|FG003|Overall Study|Reason not Specified|0|||
48794541|NCT00651664|157085054|FG004|Overall Study|Reason not Specified|0|||
48794542|NCT00651664|157085055|FG005|Overall Study|Reason not Specified|0|||
48794543|NCT00651664|157085056|FG006|Overall Study|Reason not Specified|1|||
48794544|NCT00651664|157085057|FG007|Overall Study|Reason not Specified|0|||
48794545|NCT00651664|157085058|FG008|Overall Study|Reason not Specified|0|||
48794546|NCT00651664|157085059|FG009|Overall Study|Reason not Specified|0|||
48794547|NCT02765412|157085060|FG000|Overall Study|Death|482|||
48794548|NCT02765412|157085061|FG001|Overall Study|Death|855|||
48794549|NCT03206203|157085062|FG000|Treatment|Death|38|||
48794550|NCT03206203|157085063|FG001|Treatment|Death|26|||
48794551|NCT03206203|157085064|FG002|Treatment|Death|0|||
48794552|NCT03206203|157085062|FG000|Treatment|Withdrawal by Subject|1|||
48794553|NCT03206203|157085063|FG001|Treatment|Withdrawal by Subject|0|||
48794554|NCT03206203|157085064|FG002|Treatment|Withdrawal by Subject|0|||
48794555|NCT03206203|157085062|FG000|Treatment|Lost to Follow-up|4|||
48794556|NCT03206203|157085063|FG001|Treatment|Lost to Follow-up|0|||
48794557|NCT03206203|157085064|FG002|Treatment|Lost to Follow-up|0|||
48794558|NCT03206203|157085062|FG000|Treatment|N/A in Follow-Up|8|||
48794559|NCT03206203|157085063|FG001|Treatment|N/A in Follow-Up|1|||
48794560|NCT03206203|157085064|FG002|Treatment|N/A in Follow-Up|0|||
48794561|NCT03206203|157085062|FG000|Treatment|Disease progression|0|||
48794562|NCT03206203|157085063|FG001|Treatment|Disease progression|1|||
48794563|NCT03206203|157085064|FG002|Treatment|Disease progression|0|||
48794564|NCT03206203|157085062|FG000|Treatment|Refused follow-up|0|||
48794565|NCT03206203|157085063|FG001|Treatment|Refused follow-up|1|||
48794566|NCT03206203|157085064|FG002|Treatment|Refused follow-up|0|||
48794567|NCT03206203|157085062|FG000|Treatment|Cross over to Arm 1|0|||
48794568|NCT03206203|157085063|FG001|Treatment|Cross over to Arm 1|19|||
48794569|NCT03206203|157085064|FG002|Treatment|Cross over to Arm 1|0|||
48794570|NCT03206203|157085062|FG000|Optional Cross-Over|Death|0|||
48794571|NCT03206203|157085063|FG001|Optional Cross-Over|Death|0|||
48794572|NCT03206203|157085064|FG002|Optional Cross-Over|Death|14|||
48794573|NCT03206203|157085062|FG000|Optional Cross-Over|Refused follow-up|0|||
48794574|NCT03206203|157085063|FG001|Optional Cross-Over|Refused follow-up|0|||
48794575|NCT03206203|157085064|FG002|Optional Cross-Over|Refused follow-up|2|||
48794576|NCT00951483|157085065|FG000|Overall Study|Physician Decision|4|||
48794577|NCT00951483|157085066|FG001|Overall Study|Physician Decision|0|||
48794578|NCT00951483|157085065|FG000|Overall Study|Withdrawal by Subject|15|||
48794579|NCT00951483|157085066|FG001|Overall Study|Withdrawal by Subject|0|||
48794580|NCT03565887|157085069|FG000|Overall Study|Adverse Event|1|||
48794581|NCT03565887|157085070|FG001|Overall Study|Adverse Event|0|||
48794582|NCT03565887|157085069|FG000|Overall Study|Withdrawal by Subject|0|||
48794583|NCT03565887|157085070|FG001|Overall Study|Withdrawal by Subject|2|||
48794584|NCT01152580|157085071|FG000|Overall Study|Withdrawal by Subject|0|||
48794585|NCT01152580|157085072|FG001|Overall Study|Withdrawal by Subject|1|||
48794586|NCT02677116|157085078|FG000|Overall Study|Adverse Event|0|||
48794587|NCT02677116|157085079|FG001|Overall Study|Adverse Event|1|||
48794588|NCT02677116|157085080|FG002|Overall Study|Adverse Event|0|||
48794589|NCT02677116|157085081|FG003|Overall Study|Adverse Event|0|||
48794590|NCT02677116|157085082|FG004|Overall Study|Adverse Event|0|||
48794591|NCT02677116|157085083|FG005|Overall Study|Adverse Event|1|||
48794592|NCT02677116|157085084|FG006|Overall Study|Adverse Event|1|||
48794593|NCT02677116|157085085|FG007|Overall Study|Adverse Event|0|||
48794594|NCT02677116|157085086|FG008|Overall Study|Adverse Event|0|||
48794595|NCT02677116|157085078|FG000|Overall Study|Physician Decision|0|||
48794596|NCT02677116|157085079|FG001|Overall Study|Physician Decision|2|||
48794597|NCT02677116|157085080|FG002|Overall Study|Physician Decision|3|||
48794598|NCT02677116|157085081|FG003|Overall Study|Physician Decision|2|||
48794599|NCT02677116|157085082|FG004|Overall Study|Physician Decision|1|||
48794600|NCT02677116|157085083|FG005|Overall Study|Physician Decision|3|||
48794601|NCT02677116|157085084|FG006|Overall Study|Physician Decision|1|||
48794602|NCT02677116|157085085|FG007|Overall Study|Physician Decision|1|||
48794603|NCT02677116|157085086|FG008|Overall Study|Physician Decision|2|||
48794604|NCT02677116|157085078|FG000|Overall Study|Withdrawal by parent or guardian|2|||
48794605|NCT02677116|157085079|FG001|Overall Study|Withdrawal by parent or guardian|1|||
48794606|NCT02677116|157085080|FG002|Overall Study|Withdrawal by parent or guardian|0|||
48794607|NCT02677116|157085081|FG003|Overall Study|Withdrawal by parent or guardian|1|||
48794608|NCT02677116|157085082|FG004|Overall Study|Withdrawal by parent or guardian|0|||
48401718|NCT04316585|155661734|FG000|Overall Study|Adverse Event|2|||
48401719|NCT04316585|155661735|FG001|Overall Study|Adverse Event|1|||
48794609|NCT02677116|157085083|FG005|Overall Study|Withdrawal by parent or guardian|0|||
48794610|NCT02677116|157085084|FG006|Overall Study|Withdrawal by parent or guardian|2|||
48794611|NCT02677116|157085085|FG007|Overall Study|Withdrawal by parent or guardian|1|||
48794612|NCT02677116|157085086|FG008|Overall Study|Withdrawal by parent or guardian|0|||
48794613|NCT02677116|157085078|FG000|Overall Study|Withdrawal by Subject|1|||
48794614|NCT02677116|157085079|FG001|Overall Study|Withdrawal by Subject|0|||
48794615|NCT02677116|157085080|FG002|Overall Study|Withdrawal by Subject|0|||
48794616|NCT02677116|157085081|FG003|Overall Study|Withdrawal by Subject|0|||
48794617|NCT02677116|157085082|FG004|Overall Study|Withdrawal by Subject|0|||
48794618|NCT02677116|157085083|FG005|Overall Study|Withdrawal by Subject|0|||
48794619|NCT02677116|157085084|FG006|Overall Study|Withdrawal by Subject|0|||
48401720|NCT04316585|155661734|FG000|Overall Study|Lost to Follow-up|1|||
48401721|NCT04316585|155661735|FG001|Overall Study|Lost to Follow-up|0|||
48401722|NCT04316585|155661734|FG000|Overall Study|Withdrawal by Subject|2|||
48401723|NCT04316585|155661735|FG001|Overall Study|Withdrawal by Subject|3|||
48401724|NCT04316585|155661734|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
48401725|NCT04316585|155661735|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
48401726|NCT04316585|155661734|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
48794620|NCT02677116|157085085|FG007|Overall Study|Withdrawal by Subject|0|||
48794621|NCT02677116|157085086|FG008|Overall Study|Withdrawal by Subject|0|||
48794622|NCT02660827|157085087|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
48401727|NCT04316585|155661735|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
48401728|NCT01363986|155661738|FG000|Overall Study|Disease progression|1|||
48401729|NCT00223496|155661742|FG000|Overall Study|screen failure|9|||
48401730|NCT00223496|155661742|FG000|Overall Study|Lost to Follow-up|4|||
48401731|NCT00223496|155661742|FG000|Overall Study|Lack of Efficacy|6|||
48401732|NCT00223496|155661742|FG000|Overall Study|Withdrawal by Subject|1|||
48401733|NCT00223496|155661742|FG000|Overall Study|Physician Decision|2|||
48401734|NCT00713700|155661743|FG000|Overall Study|Lost to Follow-up|3|||
48401735|NCT00713700|155661743|FG000|Overall Study|Withdrawal by Subject|1|||
48401736|NCT01701674|155661746|FG000|Overall Study|Unable to safely complete treatment|1|||
48401737|NCT03752619|155661747|FG000|Overall Study|Lost to Follow-up|2|||
48401738|NCT03752619|155661748|FG001|Overall Study|Lost to Follow-up|1|||
48401739|NCT03752619|155661747|FG000|Overall Study|Withdrawal by Subject|1|||
48401740|NCT03752619|155661748|FG001|Overall Study|Withdrawal by Subject|1|||
48401741|NCT03752619|155661747|FG000|Overall Study|Adverse Event|0|||
48401742|NCT03752619|155661748|FG001|Overall Study|Adverse Event|1|||
48401743|NCT04072822|155661749|FG000|Treatment|Adverse Event|9|||
48401744|NCT04072822|155661750|FG001|Treatment|Adverse Event|5|||
48401745|NCT04072822|155661749|FG000|Treatment|Met Stopping Criteria|13|||
48401746|NCT04072822|155661750|FG001|Treatment|Met Stopping Criteria|24|||
48401747|NCT04072822|155661749|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
48401748|NCT04072822|155661750|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
48401749|NCT04072822|155661749|FG000|Treatment|Withdrawal by Subject|0|||
48401750|NCT04072822|155661750|FG001|Treatment|Withdrawal by Subject|2|||
48401751|NCT04072822|155661749|FG000|Treatment|Death|0|||
48401752|NCT04072822|155661750|FG001|Treatment|Death|2|||
48401753|NCT04072822|155661749|FG000|Treatment|Lost to Follow-up|11|||
48401754|NCT04072822|155661750|FG001|Treatment|Lost to Follow-up|3|||
48794623|NCT02660827|157085087|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
48794624|NCT02660827|157085087|FG000|From Study to End of Continued Access|Adverse Event|3|||
48794625|NCT02660827|157085087|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
48794626|NCT02660827|157085087|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
48794627|NCT02660827|157085087|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
48794628|NCT02660827|157085087|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
48794629|NCT02660827|157085087|FG000|Period 2: Continued Access Period|Adverse Event|3|||
48794630|NCT03265600|157085088|FG000|Overall Study|Lost to Follow-up|17|||
48794631|NCT03265600|157085089|FG001|Overall Study|Lost to Follow-up|5|||
48794632|NCT03265600|157085088|FG000|Overall Study|Withdrawal by Subject|4|||
48794633|NCT03265600|157085089|FG001|Overall Study|Withdrawal by Subject|2|||
48794634|NCT03265600|157085088|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
48794635|NCT03265600|157085089|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
48794636|NCT00535730|157085090|FG000|Overall Study|Adverse Event|1|||
48794637|NCT00535730|157085091|FG001|Overall Study|Adverse Event|1|||
48794638|NCT00535730|157085090|FG000|Overall Study|Lost to Follow-up|0|||
48794639|NCT00535730|157085091|FG001|Overall Study|Lost to Follow-up|1|||
48794640|NCT00535730|157085090|FG000|Overall Study|Physician Decision|0|||
48794641|NCT00535730|157085091|FG001|Overall Study|Physician Decision|1|||
48794642|NCT00535730|157085090|FG000|Overall Study|Protocol Violation|1|||
48794643|NCT00535730|157085091|FG001|Overall Study|Protocol Violation|0|||
48794644|NCT00535730|157085090|FG000|Overall Study|Withdrawal by Subject|0|||
48794645|NCT00535730|157085091|FG001|Overall Study|Withdrawal by Subject|4|||
48794646|NCT00765388|157085098|FG000|Period 1|Lack of Efficacy|1|||
48794647|NCT00765388|157085099|FG001|Period 1|Lack of Efficacy|2|||
48794648|NCT00765388|157085098|FG000|Period 1|Lost to Follow-up|0|||
48794649|NCT00765388|157085099|FG001|Period 1|Lost to Follow-up|1|||
48794650|NCT00765388|157085098|FG000|Period 1|Herpes Zoster|0|||
48794651|NCT00765388|157085099|FG001|Period 1|Herpes Zoster|1|||
48794652|NCT00765388|157085098|FG000|Period 1|Hip operation|0|||
48794653|NCT00765388|157085099|FG001|Period 1|Hip operation|1|||
48794654|NCT01988779|157085100|FG000|Overall Study|Withdrawal by Subject|2|||
48401755|NCT04072822|155661749|FG000|Treatment|Physician Decision|1|||
48401756|NCT04072822|155661750|FG001|Treatment|Physician Decision|0|||
48401757|NCT04072822|155661749|FG000|Treatment|Other|7|||
48794655|NCT01988779|157085101|FG001|Overall Study|Withdrawal by Subject|2|||
48794656|NCT01988779|157085100|FG000|Overall Study|Protocol Violation|1|||
48794657|NCT01988779|157085101|FG001|Overall Study|Protocol Violation|0|||
48794658|NCT04072159|157085102|FG000|Overall Study|Lost to Follow-up|6|||
48401758|NCT04072822|155661750|FG001|Treatment|Other|9|||
48401759|NCT04072822|155661749|FG000|Follow-up|Withdrawal by Subject|1|||
48401760|NCT04072822|155661750|FG001|Follow-up|Withdrawal by Subject|0|||
48401761|NCT04072822|155661749|FG000|Follow-up|Lost to Follow-up|5|||
48401762|NCT04072822|155661750|FG001|Follow-up|Lost to Follow-up|4|||
48401763|NCT03701399|155661751|FG000|Overall Study|Adverse Event|3|||
48401764|NCT03701399|155661752|FG001|Overall Study|Adverse Event|5|||
48401765|NCT03701399|155661751|FG000|Overall Study|Withdrawal by Subject|6|||
48401766|NCT03701399|155661752|FG001|Overall Study|Withdrawal by Subject|3|||
48401767|NCT03701399|155661751|FG000|Overall Study|Investigators decision|1|||
48401768|NCT03701399|155661752|FG001|Overall Study|Investigators decision|2|||
48401769|NCT03701399|155661751|FG000|Overall Study|Lost to Follow-up|1|||
48401770|NCT03701399|155661752|FG001|Overall Study|Lost to Follow-up|2|||
48401771|NCT03701399|155661751|FG000|Overall Study|Death|1|||
48401772|NCT03701399|155661752|FG001|Overall Study|Death|1|||
48401773|NCT03701399|155661751|FG000|Overall Study|Randomized but not treated|1|||
48401774|NCT03701399|155661752|FG001|Overall Study|Randomized but not treated|0|||
48401775|NCT01842542|155661755|FG000|Overall Study|Withdrawal by Subject|2|||
48401776|NCT01842542|155661755|FG000|Overall Study|Lack of Efficacy|1|||
48794659|NCT04072159|157085103|FG001|Overall Study|Lost to Follow-up|6|||
48794660|NCT04072159|157085102|FG000|Overall Study|Withdrawal by Subject|2|||
48794661|NCT04072159|157085103|FG001|Overall Study|Withdrawal by Subject|0|||
48794662|NCT04450264|157086197|FG000|Overall Study|Incomplete survey|13|||
48794663|NCT04450264|157086198|FG001|Overall Study|Incomplete survey|19|||
48794664|NCT01738984|157086199|FG000|Overall Study|Pregnancy|4|||
48794665|NCT01738984|157086200|FG001|Overall Study|Pregnancy|0|||
48794666|NCT01738984|157086199|FG000|Overall Study|Withdrawal by Subject|1|||
48794667|NCT01738984|157086200|FG001|Overall Study|Withdrawal by Subject|0|||
48794668|NCT01738984|157086199|FG000|Overall Study|Lost to Follow-up|59|||
48794669|NCT01738984|157086200|FG001|Overall Study|Lost to Follow-up|39|||
48794670|NCT01625897|157086201|FG000|Overall Study|Adverse Event|27|||
48794671|NCT01625897|157086202|FG001|Overall Study|Adverse Event|10|||
48794672|NCT01625897|157086201|FG000|Overall Study|Physician Decision|0|||
48794673|NCT01625897|157086202|FG001|Overall Study|Physician Decision|1|||
48401777|NCT01842542|155661755|FG000|Overall Study|Protocol Non-compliance|2|||
48401778|NCT01842542|155661755|FG000|Overall Study|Lost to Follow-up|1|||
48401779|NCT01562548|155661763|FG000|Overall Study|Lost to Follow-up|0|||
48794674|NCT01625897|157086201|FG000|Overall Study|Withdrawal by Subject|25|||
48794675|NCT01625897|157086202|FG001|Overall Study|Withdrawal by Subject|3|||
48794676|NCT04050865|157086203|FG000|Overall Study|Adverse Event|1|||
48794677|NCT04050865|157086204|FG001|Overall Study|Adverse Event|0|||
48794678|NCT04050865|157086203|FG000|Overall Study|no insert|1|||
48794679|NCT04050865|157086204|FG001|Overall Study|no insert|0|||
48794680|NCT04050865|157086203|FG000|Overall Study|Only 1 insert|2|||
48794681|NCT04050865|157086204|FG001|Overall Study|Only 1 insert|3|||
48794682|NCT04050865|157086203|FG000|Overall Study|Physician Decision|0|||
48794683|NCT04050865|157086204|FG001|Overall Study|Physician Decision|1|||
48794684|NCT04050865|157086203|FG000|Overall Study|Withdrawal by Subject|0|||
48794685|NCT04050865|157086204|FG001|Overall Study|Withdrawal by Subject|1|||
48794686|NCT03597568|157086205|FG000|Overall Study|Withdrawal by Subject|1|||
48794687|NCT03597568|157086206|FG001|Overall Study|Withdrawal by Subject|1|||
48794688|NCT03597568|157086205|FG000|Overall Study|Unable to analyze vascular data|1|||
48794689|NCT03597568|157086206|FG001|Overall Study|Unable to analyze vascular data|1|||
48794690|NCT01471054|157086210|FG000|Overall Study|Study terminated prematurely|4|||
48794691|NCT01471054|157086211|FG001|Overall Study|Study terminated prematurely|0|||
48794692|NCT00686166|157086212|FG000|Overall Study|Adverse Event|7|||
48794693|NCT00686166|157086212|FG000|Overall Study|Withdrawal by Subject|1|||
48794694|NCT00686166|157086212|FG000|Overall Study|Progression/Relapse|1|||
48794695|NCT00686166|157086212|FG000|Overall Study|Death|1|||
48794696|NCT00686166|157086212|FG000|Overall Study|Not Protocol Specified|1|||
48794697|NCT00686166|157086212|FG000|Overall Study|Ineligible|5|||
48794698|NCT00686166|157086212|FG000|Overall Study|Did not begin protocol therapy|4|||
48794699|NCT03318523|157086213|FG000|PC Period: Up to Year 1|Adverse Event|1|||
48794700|NCT03318523|157086214|FG001|PC Period: Up to Year 1|Adverse Event|0|||
48794701|NCT03318523|157086215|FG002|PC Period: Up to Year 1|Adverse Event|2|||
48794702|NCT03318523|157086216|FG003|PC Period: Up to Year 1|Adverse Event|0|||
48794703|NCT03318523|157086217|FG004|PC Period: Up to Year 1|Adverse Event|0|||
48794704|NCT03318523|157086218|FG005|PC Period: Up to Year 1|Adverse Event|0|||
48794705|NCT03318523|157086219|FG006|PC Period: Up to Year 1|Adverse Event|0|||
48794706|NCT03318523|157086220|FG007|PC Period: Up to Year 1|Adverse Event|0|||
48794707|NCT03318523|157086221|FG008|PC Period: Up to Year 1|Adverse Event|0|||
48794708|NCT03318523|157086222|FG009|PC Period: Up to Year 1|Adverse Event|0|||
48794709|NCT03318523|157086213|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
48794710|NCT03318523|157086214|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
48794711|NCT03318523|157086215|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794712|NCT03318523|157086216|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
48794713|NCT03318523|157086217|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794714|NCT03318523|157086218|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794715|NCT03318523|157086219|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794716|NCT03318523|157086220|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794717|NCT03318523|157086221|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794718|NCT03318523|157086222|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
48794719|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794720|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794721|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794722|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794723|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
48794724|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794725|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48357070|NCT02563548|155503550|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48357071|NCT02563548|155503551|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48357072|NCT02563548|155503552|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48357073|NCT02563548|155503553|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
48357074|NCT02563548|155503554|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
48357075|NCT02563548|155503549|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
48357076|NCT02563548|155503550|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
48357077|NCT02563548|155503551|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
48357078|NCT02563548|155503552|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
48357079|NCT02563548|155503553|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
48357080|NCT02563548|155503554|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
48357081|NCT02563548|155503549|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48357082|NCT02563548|155503550|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48357083|NCT02563548|155503551|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48357084|NCT02563548|155503552|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48357085|NCT02563548|155503553|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
48357086|NCT02563548|155503554|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
48357087|NCT02563548|155503549|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48357088|NCT02563548|155503550|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48357089|NCT02563548|155503551|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48357090|NCT02563548|155503552|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48794726|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
48794727|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
48794728|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
48794729|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48794730|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48794731|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48401780|NCT01562548|155661764|FG001|Overall Study|Lost to Follow-up|0|||
48401781|NCT01562548|155661765|FG002|Overall Study|Lost to Follow-up|1|||
48401782|NCT01562548|155661766|FG003|Overall Study|Lost to Follow-up|0|||
48401783|NCT01587079|155661767|FG000|Overall Study|Protocol-specified criteria|9|||
48401784|NCT01587079|155661767|FG000|Overall Study|Protocol Violation|5|||
48401785|NCT01587079|155661767|FG000|Overall Study|Lost to Follow-up|2|||
48401786|NCT01587079|155661767|FG000|Overall Study|Physician Decision|2|||
48401787|NCT01587079|155661767|FG000|Overall Study|Withdrawal by Subject|7|||
48401788|NCT01587079|155661767|FG000|Overall Study|Adverse Event|14|||
48401789|NCT01294800|155661768|FG000|Overall Study|Adverse Event|7|||
48401790|NCT01294800|155661769|FG001|Overall Study|Adverse Event|6|||
48401791|NCT01294800|155661770|FG002|Overall Study|Adverse Event|12|||
48401792|NCT01294800|155661771|FG003|Overall Study|Adverse Event|5|||
48401793|NCT01294800|155661768|FG000|Overall Study|Subject Withdrew Consent|2|||
48401794|NCT01294800|155661769|FG001|Overall Study|Subject Withdrew Consent|2|||
48401795|NCT01294800|155661770|FG002|Overall Study|Subject Withdrew Consent|2|||
48401796|NCT01294800|155661771|FG003|Overall Study|Subject Withdrew Consent|11|||
48401797|NCT01294800|155661768|FG000|Overall Study|Lost to Follow-up|0|||
48401798|NCT01294800|155661769|FG001|Overall Study|Lost to Follow-up|0|||
48401799|NCT01294800|155661770|FG002|Overall Study|Lost to Follow-up|1|||
48401800|NCT01294800|155661771|FG003|Overall Study|Lost to Follow-up|0|||
48401801|NCT01294800|155661768|FG000|Overall Study|Non-compliance With Protocol|0|||
48401802|NCT01294800|155661769|FG001|Overall Study|Non-compliance With Protocol|1|||
48401803|NCT01294800|155661770|FG002|Overall Study|Non-compliance With Protocol|1|||
48401804|NCT01294800|155661771|FG003|Overall Study|Non-compliance With Protocol|0|||
48401805|NCT01294800|155661768|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
48401806|NCT01294800|155661769|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
48401807|NCT01294800|155661770|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
48401808|NCT01294800|155661771|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
48401809|NCT03870555|155661776|FG000|Period 3 (2 Days)|Adverse Event|1|||
48401810|NCT03870555|155661777|FG001|Period 3 (2 Days)|Adverse Event|0|||
48401811|NCT03870555|155661778|FG002|Period 3 (2 Days)|Adverse Event|0|||
48401812|NCT01097863|155661779|FG000|Overall Study|Discomfort|1|||
48401813|NCT01097863|155661780|FG001|Overall Study|Discomfort|0|||
48401814|NCT01097863|155661781|FG002|Overall Study|Discomfort|1|||
48401815|NCT01097863|155661779|FG000|Overall Study|Did not return for final visit|0|||
48401816|NCT01097863|155661780|FG001|Overall Study|Did not return for final visit|0|||
48794732|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48401817|NCT01097863|155661781|FG002|Overall Study|Did not return for final visit|1|||
48794733|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
48794734|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48794735|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
48794736|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
48794737|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
48794738|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
48794739|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794740|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794741|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794742|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48401818|NCT00352105|155661782|FG000|Overall Study|Death|5|||
48401819|NCT00352105|155661782|FG000|Overall Study|Withdrawal by Subject|5|||
48401820|NCT00352105|155661782|FG000|Overall Study|Lack of Efficacy|9|||
48401821|NCT00352105|155661782|FG000|Overall Study|Adverse Event|19|||
48401822|NCT00352105|155661782|FG000|Overall Study|Protocol Violation|2|||
48401823|NCT02526550|155661783|FG000|Overall Study|Lost to Follow-up|1|||
48401824|NCT02025010|155661793|FG000|Overall Study|Symptomatic or radiographic progression|36|||
48401825|NCT02025010|155661793|FG000|Overall Study|Adverse Event|6|||
48401826|NCT02025010|155661793|FG000|Overall Study|Physician Decision|7|||
48794743|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48401827|NCT02025010|155661793|FG000|Overall Study|Withdrawal by Subject|3|||
48401828|NCT02025010|155661793|FG000|Overall Study|Intercurrent illness|3|||
48401829|NCT02025010|155661793|FG000|Overall Study|Patients still on treatment|3|||
48401830|NCT02025010|155661793|FG000|Overall Study|Never initiate the treatment|2|||
48401831|NCT03463044|155661794|FG000|Overall Study|Lost to Follow-up|0|||
48401832|NCT03463044|155661795|FG001|Overall Study|Lost to Follow-up|0|||
48401833|NCT03463044|155661796|FG002|Overall Study|Lost to Follow-up|0|||
48401834|NCT03463044|155661797|FG003|Overall Study|Lost to Follow-up|0|||
48794744|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
48794745|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794746|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794747|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794748|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
48794749|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794750|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794751|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794752|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794753|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794754|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794755|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794756|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794757|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
48794758|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
48794759|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
48794760|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
48794761|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
48794762|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
48794763|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
48794764|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
48794765|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
48794766|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
48794767|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
48794768|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
48794769|NCT03318523|157086213|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794770|NCT03318523|157086214|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794771|NCT03318523|157086215|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794772|NCT03318523|157086216|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794773|NCT03318523|157086217|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
48794774|NCT03318523|157086218|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794775|NCT03318523|157086219|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794776|NCT03318523|157086220|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
48794777|NCT03318523|157086221|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
48794778|NCT03318523|157086222|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
48794779|NCT03031938|157086223|FG000|Overall Study|Death|1|||
48794780|NCT03031938|157086224|FG001|Overall Study|Death|0|||
48401835|NCT03463044|155661798|FG004|Overall Study|Lost to Follow-up|0|||
48401836|NCT03463044|155661799|FG005|Overall Study|Lost to Follow-up|0|||
48794781|NCT00454051|157086225|FG000|Overall Study|Adverse Event|1|||
48794782|NCT00454051|157086226|FG001|Overall Study|Adverse Event|2|||
48794783|NCT00454051|157086225|FG000|Overall Study|Withdrawal by Subject|1|||
48794784|NCT00454051|157086226|FG001|Overall Study|Withdrawal by Subject|0|||
48794785|NCT00454051|157086225|FG000|Overall Study|Protocol Violation|1|||
48794786|NCT00454051|157086226|FG001|Overall Study|Protocol Violation|1|||
48794787|NCT02261493|157086227|FG000|Overall Study|Noncompliance|0|||
48794788|NCT02261493|157086228|FG001|Overall Study|Noncompliance|0|||
48794789|NCT02261493|157086229|FG002|Overall Study|Noncompliance|2|||
48794790|NCT02261493|157086227|FG000|Overall Study|Physician Decision|0|||
48794791|NCT02261493|157086228|FG001|Overall Study|Physician Decision|1|||
48794792|NCT02261493|157086229|FG002|Overall Study|Physician Decision|0|||
48794793|NCT02261493|157086227|FG000|Overall Study|Undisclosed alcohol abuse|0|||
48794794|NCT02261493|157086228|FG001|Overall Study|Undisclosed alcohol abuse|1|||
48794795|NCT02261493|157086229|FG002|Overall Study|Undisclosed alcohol abuse|0|||
48794796|NCT02261493|157086227|FG000|Overall Study|Protocol Violation|1|||
48794797|NCT02261493|157086228|FG001|Overall Study|Protocol Violation|0|||
48794798|NCT02261493|157086229|FG002|Overall Study|Protocol Violation|0|||
48401837|NCT03463044|155661800|FG006|Overall Study|Lost to Follow-up|0|||
48401838|NCT03463044|155661801|FG007|Overall Study|Lost to Follow-up|1|||
48401839|NCT03463044|155661802|FG008|Overall Study|Lost to Follow-up|0|||
48401840|NCT05907174|155661803|FG000|3-Month Assessment|Withdrawal by Subject|0|||
48794799|NCT02261493|157086227|FG000|Overall Study|Personal Reasons|14|||
48794800|NCT02261493|157086228|FG001|Overall Study|Personal Reasons|14|||
48794801|NCT02261493|157086229|FG002|Overall Study|Personal Reasons|16|||
48794802|NCT02261493|157086227|FG000|Overall Study|Lost to Follow-up|14|||
48401841|NCT05907174|155661804|FG001|3-Month Assessment|Withdrawal by Subject|0|||
48401842|NCT05907174|155661805|FG002|3-Month Assessment|Withdrawal by Subject|0|||
48401843|NCT05907174|155661806|FG003|3-Month Assessment|Withdrawal by Subject|1|||
48401844|NCT05907174|155661803|FG000|3-Month Assessment|Lost to Follow-up|1|||
48401845|NCT05907174|155661804|FG001|3-Month Assessment|Lost to Follow-up|1|||
48794803|NCT02261493|157086228|FG001|Overall Study|Lost to Follow-up|27|||
48794804|NCT02261493|157086229|FG002|Overall Study|Lost to Follow-up|8|||
48794805|NCT02261493|157086227|FG000|Overall Study|Pregnancy|1|||
48794806|NCT02261493|157086228|FG001|Overall Study|Pregnancy|2|||
48794807|NCT02261493|157086229|FG002|Overall Study|Pregnancy|0|||
48794808|NCT02261493|157086227|FG000|Overall Study|Lack of Efficacy|0|||
48794809|NCT02261493|157086228|FG001|Overall Study|Lack of Efficacy|1|||
48794810|NCT02261493|157086229|FG002|Overall Study|Lack of Efficacy|0|||
48794811|NCT02261493|157086227|FG000|Overall Study|Adverse Event|0|||
48794812|NCT02261493|157086228|FG001|Overall Study|Adverse Event|1|||
48794813|NCT02261493|157086229|FG002|Overall Study|Adverse Event|0|||
48794814|NCT01984684|157086234|FG000|Overall Study|Lost to Follow-up|25|||
48794815|NCT01984684|157086235|FG001|Overall Study|Lost to Follow-up|24|||
48794816|NCT01984684|157086234|FG000|Overall Study|Adverse Event|8|||
48794817|NCT01984684|157086235|FG001|Overall Study|Adverse Event|12|||
48794818|NCT01984684|157086234|FG000|Overall Study|Withdrawal by Subject|9|||
48794819|NCT01984684|157086235|FG001|Overall Study|Withdrawal by Subject|9|||
48794820|NCT01984684|157086234|FG000|Overall Study|Lack of Efficacy|3|||
48794821|NCT01984684|157086235|FG001|Overall Study|Lack of Efficacy|6|||
48794822|NCT01984684|157086234|FG000|Overall Study|Physician Decision|4|||
48794823|NCT01984684|157086235|FG001|Overall Study|Physician Decision|2|||
48794824|NCT01984684|157086234|FG000|Overall Study|Protocol Violation|4|||
48794825|NCT01984684|157086235|FG001|Overall Study|Protocol Violation|2|||
48794826|NCT01984684|157086234|FG000|Overall Study|Death|0|||
48794827|NCT01984684|157086235|FG001|Overall Study|Death|1|||
48794828|NCT01984684|157086234|FG000|Overall Study|Noncompliance with study drug|2|||
48401846|NCT05907174|155661805|FG002|3-Month Assessment|Lost to Follow-up|1|||
48401847|NCT05907174|155661806|FG003|3-Month Assessment|Lost to Follow-up|1|||
48401848|NCT05907174|155661803|FG000|6-Month Assessment|Death|0|||
48401849|NCT05907174|155661804|FG001|6-Month Assessment|Death|0|||
48401850|NCT05907174|155661805|FG002|6-Month Assessment|Death|3|||
48401851|NCT05907174|155661806|FG003|6-Month Assessment|Death|0|||
48401852|NCT05907174|155661803|FG000|6-Month Assessment|Withdrawal by Subject|0|||
48401853|NCT05907174|155661804|FG001|6-Month Assessment|Withdrawal by Subject|0|||
48401854|NCT05907174|155661805|FG002|6-Month Assessment|Withdrawal by Subject|1|||
48401855|NCT05907174|155661806|FG003|6-Month Assessment|Withdrawal by Subject|1|||
48401856|NCT05907174|155661803|FG000|6-Month Assessment|Lost to Follow-up|0|||
48401857|NCT05907174|155661804|FG001|6-Month Assessment|Lost to Follow-up|1|||
48401858|NCT05907174|155661805|FG002|6-Month Assessment|Lost to Follow-up|1|||
48401859|NCT05907174|155661806|FG003|6-Month Assessment|Lost to Follow-up|1|||
48401860|NCT04730739|155661807|FG000|Overall Study|Death|1|||
48401861|NCT02733159|155661808|FG000|Overall Study|Adverse Event|1|||
48401862|NCT02733159|155661808|FG000|Overall Study|Lack of disease progression|1|||
48401863|NCT01298323|155661809|FG000|Overall Study|Adverse Event|2|||
48401864|NCT01298323|155661810|FG001|Overall Study|Adverse Event|4|||
48401865|NCT01298323|155661809|FG000|Overall Study|Death|11|||
48401866|NCT01298323|155661810|FG001|Overall Study|Death|16|||
48401867|NCT01298323|155661809|FG000|Overall Study|Lost to Follow-up|1|||
48401868|NCT01298323|155661810|FG001|Overall Study|Lost to Follow-up|0|||
48401869|NCT01298323|155661809|FG000|Overall Study|Withdrawal by Subject|6|||
48401870|NCT01298323|155661810|FG001|Overall Study|Withdrawal by Subject|3|||
48401871|NCT01298323|155661809|FG000|Overall Study|Protocol Violation|1|||
48401872|NCT01298323|155661810|FG001|Overall Study|Protocol Violation|0|||
48794829|NCT01984684|157086235|FG001|Overall Study|Noncompliance with study drug|1|||
48794830|NCT01984684|157086234|FG000|Overall Study|Subject incarcerated|1|||
48794831|NCT01984684|157086235|FG001|Overall Study|Subject incarcerated|0|||
48794832|NCT01984684|157086234|FG000|Overall Study|Study drug not available at site|1|||
48794833|NCT01984684|157086235|FG001|Overall Study|Study drug not available at site|1|||
48794834|NCT01984684|157086234|FG000|Overall Study|Subject had inadequate IV access|0|||
48794835|NCT01984684|157086235|FG001|Overall Study|Subject had inadequate IV access|1|||
48794836|NCT03152526|157086236|FG000|Overall Study|Withdrawal by Subject|0|||
48794837|NCT03152526|157086237|FG001|Overall Study|Withdrawal by Subject|1|||
48794838|NCT00512070|157086238|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
48401873|NCT01298323|155661809|FG000|Overall Study|Other|10|||
48401874|NCT01298323|155661810|FG001|Overall Study|Other|9|||
48401875|NCT01298323|155661809|FG000|Overall Study|Ongoing|55|||
48794839|NCT00512070|157086239|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
48401876|NCT01298323|155661810|FG001|Overall Study|Ongoing|55|||
48401877|NCT01298323|155661809|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
48794840|NCT00512070|157086240|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
48794841|NCT00512070|157086238|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
48794842|NCT00512070|157086239|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
48794843|NCT00512070|157086240|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
48794844|NCT04307004|157086241|FG000|Randomization 1|Withdrawal by Subject|25|||
48794845|NCT04307004|157086242|FG001|Randomization 1|Withdrawal by Subject|26|||
48401878|NCT01298323|155661810|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
48794846|NCT04307004|157086243|FG002|Randomization 1|Withdrawal by Subject|0|||
48794847|NCT04307004|157086244|FG003|Randomization 1|Withdrawal by Subject|0|||
48794848|NCT04307004|157086241|FG000|Randomization 2|Withdrawal by Subject|0|||
48794849|NCT04307004|157086242|FG001|Randomization 2|Withdrawal by Subject|0|||
48794850|NCT04307004|157086243|FG002|Randomization 2|Withdrawal by Subject|28|||
48794851|NCT04307004|157086244|FG003|Randomization 2|Withdrawal by Subject|23|||
48794852|NCT04702568|157086256|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
48794853|NCT04702568|157086257|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
48794854|NCT04702568|157086256|FG000|Overall Study|Pregnancy|1|||
48401879|NCT04678856|155661811|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
48401880|NCT04678856|155661812|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
48401881|NCT04678856|155661811|FG000|Overall Study|Withdrawal by Subject|5|||
48401882|NCT04678856|155661812|FG001|Overall Study|Withdrawal by Subject|1|||
48794855|NCT04702568|157086257|FG001|Overall Study|Pregnancy|0|||
48794856|NCT04702568|157086256|FG000|Overall Study|Bone marrow transplant|1|||
48794857|NCT04702568|157086257|FG001|Overall Study|Bone marrow transplant|0|||
48794858|NCT04702568|157086256|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
48794859|NCT04702568|157086257|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
48794860|NCT04702568|157086256|FG000|Overall Study|Withdrawal by Subject|0|||
48794861|NCT04702568|157086257|FG001|Overall Study|Withdrawal by Subject|2|||
48794862|NCT02395042|157086258|FG000|Treatment 1 Period|Adverse Event|1|||
48794863|NCT02395042|157086259|FG001|Treatment 1 Period|Adverse Event|3|||
48794864|NCT02395042|157086260|FG002|Treatment 1 Period|Adverse Event|1|||
48794865|NCT02395042|157086258|FG000|Treatment 1 Period|Lack of Efficacy|1|||
48794866|NCT02395042|157086259|FG001|Treatment 1 Period|Lack of Efficacy|1|||
48794867|NCT02395042|157086260|FG002|Treatment 1 Period|Lack of Efficacy|0|||
48794868|NCT02395042|157086258|FG000|Treatment 1 Period|Lost to Follow-up|1|||
48794869|NCT02395042|157086259|FG001|Treatment 1 Period|Lost to Follow-up|0|||
48794870|NCT02395042|157086260|FG002|Treatment 1 Period|Lost to Follow-up|0|||
48794871|NCT02395042|157086258|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
48794872|NCT02395042|157086259|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
48794873|NCT02395042|157086260|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
48794874|NCT02395042|157086258|FG000|Treatment 2 Period|Lack of Efficacy|1|||
48794875|NCT02395042|157086259|FG001|Treatment 2 Period|Lack of Efficacy|1|||
48794876|NCT02395042|157086260|FG002|Treatment 2 Period|Lack of Efficacy|0|||
48794877|NCT04485039|157086261|FG000|TPOXX Only|Adverse Event|2|||
48794878|NCT04485039|157086261|FG000|TPOXX Only|Physician Decision|1|||
48794879|NCT04485039|157086261|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
48794880|NCT04485039|157086261|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
48794881|NCT01483924|157086262|FG000|Overall Study|Withdrawal by Subject|2|||
48794882|NCT01483924|157086263|FG001|Overall Study|Withdrawal by Subject|0|||
48794883|NCT01483924|157086264|FG002|Overall Study|Withdrawal by Subject|0|||
48794884|NCT01483924|157086265|FG003|Overall Study|Withdrawal by Subject|1|||
48794885|NCT01483924|157086266|FG004|Overall Study|Withdrawal by Subject|1|||
48794886|NCT01483924|157086262|FG000|Overall Study|Adverse Event|0|||
48794887|NCT01483924|157086263|FG001|Overall Study|Adverse Event|0|||
48794888|NCT01483924|157086264|FG002|Overall Study|Adverse Event|1|||
48794889|NCT01483924|157086265|FG003|Overall Study|Adverse Event|1|||
48794890|NCT01483924|157086266|FG004|Overall Study|Adverse Event|0|||
48794891|NCT01483924|157086262|FG000|Overall Study|Non-compliance|0|||
48794892|NCT01483924|157086263|FG001|Overall Study|Non-compliance|0|||
48794893|NCT01483924|157086264|FG002|Overall Study|Non-compliance|0|||
48794894|NCT01483924|157086265|FG003|Overall Study|Non-compliance|1|||
48794895|NCT01483924|157086266|FG004|Overall Study|Non-compliance|1|||
48794896|NCT01483924|157086262|FG000|Overall Study|Sponsor concern over ECG result|0|||
48794897|NCT01483924|157086263|FG001|Overall Study|Sponsor concern over ECG result|0|||
48794898|NCT01483924|157086264|FG002|Overall Study|Sponsor concern over ECG result|0|||
48794899|NCT01483924|157086265|FG003|Overall Study|Sponsor concern over ECG result|1|||
48794900|NCT01483924|157086266|FG004|Overall Study|Sponsor concern over ECG result|0|||
48794901|NCT01596582|157086267|FG000|Overall Study|Deemed ineligible after study visit|3|||
48794902|NCT01596582|157086268|FG001|Overall Study|Deemed ineligible after study visit|6|||
48794903|NCT01596582|157086267|FG000|Overall Study|Missing all outcome data|1|||
48794904|NCT01596582|157086268|FG001|Overall Study|Missing all outcome data|1|||
48794905|NCT00695669|157086279|FG000|Overall Study|Adverse Event|0|||
48794906|NCT00695669|157086280|FG001|Overall Study|Adverse Event|0|||
48794907|NCT00695669|157086281|FG002|Overall Study|Adverse Event|2|||
48794908|NCT00695669|157086282|FG003|Overall Study|Adverse Event|0|||
48794909|NCT00695669|157086279|FG000|Overall Study|Lost to Follow-up|4|||
48794910|NCT00695669|157086280|FG001|Overall Study|Lost to Follow-up|4|||
48794911|NCT00695669|157086281|FG002|Overall Study|Lost to Follow-up|1|||
48794912|NCT00695669|157086282|FG003|Overall Study|Lost to Follow-up|4|||
48794913|NCT02191267|157086283|FG000|Overall Study|Withdrawal by Subject|1|||
48794914|NCT02191267|157086284|FG001|Overall Study|Withdrawal by Subject|0|||
48794915|NCT02191267|157086285|FG002|Overall Study|Withdrawal by Subject|0|||
48794916|NCT00528775|157086288|FG000|Overall Study|Other not specified|1|||
48794917|NCT01018394|157086289|FG000|Overall Study|Withdrawal by Subject|5|||
48794918|NCT01018394|157086290|FG001|Overall Study|Withdrawal by Subject|5|||
48794919|NCT01018394|157086289|FG000|Overall Study|Lost to Follow-up|4|||
48794920|NCT01018394|157086290|FG001|Overall Study|Lost to Follow-up|3|||
48794921|NCT05576155|157086291|FG000|Overall Study|Withdrawal by Subject|1|||
48794922|NCT05576155|157086292|FG001|Overall Study|Withdrawal by Subject|1|||
48794923|NCT04625725|157086295|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
48794924|NCT04625725|157086296|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794925|NCT04625725|157086297|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794926|NCT04625725|157086298|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794927|NCT04625725|157086299|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794928|NCT04625725|157086300|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
48794929|NCT04625725|157086295|FG000|Provent Main Study|Withdrawal by Subject|242|||
48794930|NCT04625725|157086296|FG001|Provent Main Study|Withdrawal by Subject|144|||
48794931|NCT04625725|157086297|FG002|Provent Main Study|Withdrawal by Subject|0|||
48794932|NCT04625725|157086298|FG003|Provent Main Study|Withdrawal by Subject|0|||
48794933|NCT04625725|157086299|FG004|Provent Main Study|Withdrawal by Subject|0|||
48794934|NCT04625725|157086300|FG005|Provent Main Study|Withdrawal by Subject|0|||
48794935|NCT04625725|157086295|FG000|Provent Main Study|Physician Decision|5|||
48794936|NCT04625725|157086296|FG001|Provent Main Study|Physician Decision|0|||
48794937|NCT04625725|157086297|FG002|Provent Main Study|Physician Decision|0|||
48794938|NCT04625725|157086298|FG003|Provent Main Study|Physician Decision|0|||
48794939|NCT04625725|157086299|FG004|Provent Main Study|Physician Decision|0|||
48794940|NCT04625725|157086300|FG005|Provent Main Study|Physician Decision|0|||
48794941|NCT04625725|157086295|FG000|Provent Main Study|Protocol Violation|1|||
48794942|NCT04625725|157086296|FG001|Provent Main Study|Protocol Violation|0|||
48794943|NCT04625725|157086297|FG002|Provent Main Study|Protocol Violation|0|||
48794944|NCT04625725|157086298|FG003|Provent Main Study|Protocol Violation|0|||
48794945|NCT04625725|157086299|FG004|Provent Main Study|Protocol Violation|0|||
48794946|NCT04625725|157086300|FG005|Provent Main Study|Protocol Violation|0|||
48794947|NCT04625725|157086295|FG000|Provent Main Study|Lost to Follow-up|357|||
48794948|NCT04625725|157086296|FG001|Provent Main Study|Lost to Follow-up|200|||
48794949|NCT04625725|157086297|FG002|Provent Main Study|Lost to Follow-up|0|||
48794950|NCT04625725|157086298|FG003|Provent Main Study|Lost to Follow-up|0|||
48794951|NCT04625725|157086299|FG004|Provent Main Study|Lost to Follow-up|0|||
48794952|NCT04625725|157086300|FG005|Provent Main Study|Lost to Follow-up|0|||
48794953|NCT04625725|157086295|FG000|Provent Main Study|Death|22|||
48794954|NCT04625725|157086296|FG001|Provent Main Study|Death|10|||
48794955|NCT04625725|157086297|FG002|Provent Main Study|Death|0|||
48794956|NCT04625725|157086298|FG003|Provent Main Study|Death|0|||
48794957|NCT04625725|157086299|FG004|Provent Main Study|Death|0|||
48794958|NCT04625725|157086300|FG005|Provent Main Study|Death|0|||
48794959|NCT04625725|157086295|FG000|Provent Main Study|Adverse Event|2|||
48794960|NCT04625725|157086296|FG001|Provent Main Study|Adverse Event|1|||
48794961|NCT04625725|157086297|FG002|Provent Main Study|Adverse Event|0|||
48794962|NCT04625725|157086298|FG003|Provent Main Study|Adverse Event|0|||
48794963|NCT04625725|157086299|FG004|Provent Main Study|Adverse Event|0|||
48794964|NCT04625725|157086300|FG005|Provent Main Study|Adverse Event|0|||
48794965|NCT04625725|157086295|FG000|Provent Main Study|Participants dosed in sub-study|310|||
48794966|NCT04625725|157086296|FG001|Provent Main Study|Participants dosed in sub-study|193|||
48794967|NCT04625725|157086297|FG002|Provent Main Study|Participants dosed in sub-study|0|||
48794968|NCT04625725|157086298|FG003|Provent Main Study|Participants dosed in sub-study|0|||
48794969|NCT04625725|157086299|FG004|Provent Main Study|Participants dosed in sub-study|0|||
48794970|NCT04625725|157086300|FG005|Provent Main Study|Participants dosed in sub-study|0|||
48794971|NCT04625725|157086295|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
48794972|NCT04625725|157086296|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
48794973|NCT04625725|157086297|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
48794974|NCT04625725|157086298|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
48794975|NCT04625725|157086299|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
48794976|NCT04625725|157086300|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
48794977|NCT04625725|157086295|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
48401883|NCT05076266|155661816|FG000|Overall Study|Survey not complete - Participant refusal|2|||
48401884|NCT05076266|155661817|FG001|Overall Study|Survey not complete - Participant refusal|0|||
48401885|NCT05425420|155661818|FG000|Overall Study|Physician Decision|1|||
48401886|NCT05425420|155661818|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
48794978|NCT04625725|157086296|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
48794979|NCT04625725|157086297|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
48794980|NCT04625725|157086298|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
48794981|NCT04625725|157086299|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
48794982|NCT04625725|157086300|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
48794983|NCT04625725|157086295|FG000|Provent Main Study|INCARCERATION|3|||
48794984|NCT04625725|157086296|FG001|Provent Main Study|INCARCERATION|0|||
48794985|NCT04625725|157086297|FG002|Provent Main Study|INCARCERATION|0|||
48794986|NCT04625725|157086298|FG003|Provent Main Study|INCARCERATION|0|||
48794987|NCT04625725|157086299|FG004|Provent Main Study|INCARCERATION|0|||
48794988|NCT04625725|157086300|FG005|Provent Main Study|INCARCERATION|0|||
48794989|NCT04625725|157086295|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
48794990|NCT04625725|157086296|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
48794991|NCT04625725|157086297|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
48794992|NCT04625725|157086298|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
48794993|NCT04625725|157086299|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
48794994|NCT04625725|157086300|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
48794995|NCT04625725|157086295|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
48794996|NCT04625725|157086296|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
48794997|NCT04625725|157086297|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
48794998|NCT04625725|157086298|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
48794999|NCT04625725|157086299|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
48795000|NCT04625725|157086300|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
48795001|NCT04625725|157086295|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
48795002|NCT04625725|157086296|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
48795003|NCT04625725|157086297|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
48795004|NCT04625725|157086298|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
48795005|NCT04625725|157086299|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
48795006|NCT04625725|157086300|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
48795007|NCT04625725|157086295|FG000|Provent Main Study|MISSING REASON|0|||
48795008|NCT04625725|157086296|FG001|Provent Main Study|MISSING REASON|1|||
48795009|NCT04625725|157086297|FG002|Provent Main Study|MISSING REASON|0|||
48795010|NCT04625725|157086298|FG003|Provent Main Study|MISSING REASON|0|||
48795011|NCT04625725|157086299|FG004|Provent Main Study|MISSING REASON|0|||
48795012|NCT04625725|157086300|FG005|Provent Main Study|MISSING REASON|0|||
48795013|NCT04625725|157086295|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795014|NCT04625725|157086296|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795015|NCT04625725|157086297|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795016|NCT04625725|157086298|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
48795017|NCT04625725|157086299|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795018|NCT04625725|157086300|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
48795019|NCT04625725|157086295|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795020|NCT04625725|157086296|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795021|NCT04625725|157086297|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
48795022|NCT04625725|157086298|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795023|NCT04625725|157086299|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795024|NCT04625725|157086300|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
48795025|NCT04625725|157086295|FG000|Provent Sub Study|Lost to Follow-up|0|||
48795026|NCT04625725|157086296|FG001|Provent Sub Study|Lost to Follow-up|0|||
48795027|NCT04625725|157086297|FG002|Provent Sub Study|Lost to Follow-up|20|||
48795028|NCT04625725|157086298|FG003|Provent Sub Study|Lost to Follow-up|10|||
48795029|NCT04625725|157086299|FG004|Provent Sub Study|Lost to Follow-up|6|||
48795030|NCT04625725|157086300|FG005|Provent Sub Study|Lost to Follow-up|4|||
48795031|NCT04625725|157086295|FG000|Provent Sub Study|Death|0|||
48795032|NCT04625725|157086296|FG001|Provent Sub Study|Death|0|||
48795033|NCT04625725|157086297|FG002|Provent Sub Study|Death|8|||
48795034|NCT04625725|157086298|FG003|Provent Sub Study|Death|5|||
48795035|NCT04625725|157086299|FG004|Provent Sub Study|Death|0|||
48795036|NCT04625725|157086300|FG005|Provent Sub Study|Death|1|||
48795037|NCT04625725|157086295|FG000|Provent Sub Study|Adverse Event|0|||
48795038|NCT04625725|157086296|FG001|Provent Sub Study|Adverse Event|0|||
48795039|NCT04625725|157086297|FG002|Provent Sub Study|Adverse Event|0|||
48795040|NCT04625725|157086298|FG003|Provent Sub Study|Adverse Event|0|||
48795041|NCT04625725|157086299|FG004|Provent Sub Study|Adverse Event|0|||
48795042|NCT04625725|157086300|FG005|Provent Sub Study|Adverse Event|1|||
48795043|NCT04625725|157086295|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48795044|NCT04625725|157086296|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48401887|NCT03733899|155662845|FG000|Period 1|Protocol Violation|0|||
48401888|NCT03733899|155662846|FG001|Period 1|Protocol Violation|0|||
48401889|NCT03733899|155662847|FG002|Period 1|Protocol Violation|0|||
48401890|NCT03733899|155662848|FG003|Period 1|Protocol Violation|0|||
48401891|NCT03733899|155662849|FG004|Period 1|Protocol Violation|0|||
48401892|NCT03733899|155662850|FG005|Period 1|Protocol Violation|1|||
48401893|NCT03733899|155662845|FG000|Period 2|Unscuccessful Treatment|0|||
48401894|NCT03733899|155662846|FG001|Period 2|Unscuccessful Treatment|1|||
48401895|NCT03733899|155662847|FG002|Period 2|Unscuccessful Treatment|0|||
48401896|NCT03733899|155662848|FG003|Period 2|Unscuccessful Treatment|0|||
48401897|NCT03733899|155662849|FG004|Period 2|Unscuccessful Treatment|0|||
48401898|NCT03733899|155662850|FG005|Period 2|Unscuccessful Treatment|0|||
48795045|NCT04625725|157086297|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48795046|NCT04625725|157086298|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48795047|NCT04625725|157086299|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
48795048|NCT04625725|157086300|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
48795049|NCT04625725|157086295|FG000|Provent Sub Study|Withdrawal by Subject|0|||
48795050|NCT04625725|157086296|FG001|Provent Sub Study|Withdrawal by Subject|0|||
48795051|NCT04625725|157086297|FG002|Provent Sub Study|Withdrawal by Subject|11|||
48795052|NCT04625725|157086298|FG003|Provent Sub Study|Withdrawal by Subject|13|||
48795053|NCT04625725|157086299|FG004|Provent Sub Study|Withdrawal by Subject|5|||
48795054|NCT04625725|157086300|FG005|Provent Sub Study|Withdrawal by Subject|6|||
48795055|NCT04625725|157086295|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795056|NCT04625725|157086296|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795057|NCT04625725|157086297|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795058|NCT04625725|157086298|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795059|NCT04625725|157086299|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
48795060|NCT04625725|157086300|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
48795061|NCT01297959|157086302|FG000|Overall Study|Adverse Event|0|||
48795062|NCT01297959|157086303|FG001|Overall Study|Adverse Event|1|||
48795063|NCT01297959|157086302|FG000|Overall Study|Protocol Violation|2|||
48795064|NCT01297959|157086303|FG001|Overall Study|Protocol Violation|1|||
48795065|NCT01297959|157086302|FG000|Overall Study|Withdrawal by Subject|5|||
48795066|NCT01297959|157086303|FG001|Overall Study|Withdrawal by Subject|4|||
48795067|NCT01297959|157086302|FG000|Overall Study|Physician Decision|0|||
48795068|NCT01297959|157086303|FG001|Overall Study|Physician Decision|1|||
48795069|NCT01297959|157086302|FG000|Overall Study|Unrelated medical illness / complication|0|||
48795070|NCT01297959|157086303|FG001|Overall Study|Unrelated medical illness / complication|2|||
48795071|NCT01297959|157086302|FG000|Overall Study|Other|13|||
48795072|NCT01297959|157086303|FG001|Overall Study|Other|7|||
48795073|NCT00829387|157086304|FG000|Overall Study|Withdrawal by Subject|2|||
48795074|NCT00829387|157086305|FG001|Overall Study|Withdrawal by Subject|3|||
48795075|NCT00829387|157086304|FG000|Overall Study|Disqualified by PI|1|||
48795076|NCT00829387|157086305|FG001|Overall Study|Disqualified by PI|0|||
48795077|NCT03657277|157086312|FG000|Overall Study|Physician Decision|2|||
48795078|NCT03657277|157086312|FG000|Overall Study|Lost to Follow-up|1|||
48795079|NCT03657277|157086312|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
48795080|NCT02626780|157086313|FG000|Overall Study|Withdrawal by Subject|3|||
48795081|NCT05318287|157086314|FG000|Overall Study|Lost to Follow-up|8|||
48795082|NCT05338333|157086315|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
48795083|NCT05338333|157086316|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
48795084|NCT05112900|157086317|FG000|Overall Study|Withdrawal by Subject|960|||
48795085|NCT05112900|157086318|FG001|Overall Study|Withdrawal by Subject|921|||
48795086|NCT05112900|157086319|FG002|Overall Study|Withdrawal by Subject|968|||
48795087|NCT04573881|157086320|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
48795088|NCT01925950|157088198|FG000|Part 2|Withdrawal by Subject|1|||
48795089|NCT01925950|157088199|FG001|Part 2|Withdrawal by Subject|0|||
48795090|NCT00725452|157088203|FG000|Overall Study|Adverse Event|3|||
48795091|NCT00725452|157088203|FG000|Overall Study|Lack of Efficacy|2|||
48795092|NCT00725452|157088203|FG000|Overall Study|Reason not specified|1|||
48795093|NCT00725452|157088203|FG000|Overall Study|Physician Decision|1|||
48795094|NCT00725452|157088203|FG000|Overall Study|Withdrawal by Subject|3|||
48401899|NCT03733899|155662845|FG000|Period 3|Withdrawal by Subject|1|||
48795095|NCT00725452|157088203|FG000|Overall Study|Lost to Follow-up|1|||
48795096|NCT00713648|157088204|FG000|Overall Study|Adverse Event|1|||
48795097|NCT00713648|157088204|FG000|Overall Study|Unclassified|2|||
48795098|NCT00713648|157088204|FG000|Overall Study|According to Protocol|2|||
48401900|NCT03733899|155662846|FG001|Period 3|Withdrawal by Subject|0|||
48401901|NCT03733899|155662847|FG002|Period 3|Withdrawal by Subject|0|||
48401902|NCT03733899|155662848|FG003|Period 3|Withdrawal by Subject|0|||
48401903|NCT03733899|155662849|FG004|Period 3|Withdrawal by Subject|0|||
48401904|NCT03733899|155662850|FG005|Period 3|Withdrawal by Subject|0|||
48795099|NCT00713648|157088204|FG000|Overall Study|Development of antibodies|3|||
48795100|NCT02633800|157088205|FG000|Overall Study|Death|3|||
48795101|NCT02633800|157088206|FG001|Overall Study|Death|3|||
48795102|NCT02633800|157088205|FG000|Overall Study|Reason not provided|1|||
48795103|NCT02633800|157088206|FG001|Overall Study|Reason not provided|0|||
48795104|NCT02633800|157088205|FG000|Overall Study|Radiologic(al) progression|23|||
48795105|NCT02633800|157088206|FG001|Overall Study|Radiologic(al) progression|23|||
48795106|NCT02633800|157088205|FG000|Overall Study|Clinical progression|3|||
48795107|NCT02633800|157088206|FG001|Overall Study|Clinical progression|6|||
48795108|NCT02633800|157088205|FG000|Overall Study|Study terminated by sponsor|6|||
48795109|NCT02633800|157088206|FG001|Overall Study|Study terminated by sponsor|5|||
48795110|NCT02633800|157088205|FG000|Overall Study|Adverse event, non-fatal|7|||
48795111|NCT02633800|157088206|FG001|Overall Study|Adverse event, non-fatal|2|||
48795112|NCT02633800|157088205|FG000|Overall Study|Withdrawal by Subject|0|||
48795113|NCT02633800|157088206|FG001|Overall Study|Withdrawal by Subject|3|||
48795114|NCT02633800|157088205|FG000|Overall Study|Patient Request|1|||
48795115|NCT02633800|157088206|FG001|Overall Study|Patient Request|1|||
48795116|NCT01615328|157088207|FG000|Overall Study|Lost to Follow-up|3|||
48795117|NCT01615328|157088208|FG001|Overall Study|Lost to Follow-up|5|||
48795118|NCT00746590|157088209|FG000|Overall Study|Death|1|||
48795119|NCT00464815|157088212|FG000|Overall Study|Withdrawal by Subject|6|||
48795120|NCT00464815|157088213|FG001|Overall Study|Withdrawal by Subject|3|||
48795121|NCT05054374|157088216|FG000|Overall Study|Withdrawal by Subject|1|||
48795122|NCT05054374|157088217|FG001|Overall Study|Withdrawal by Subject|0|||
48795123|NCT05054374|157088218|FG002|Overall Study|Withdrawal by Subject|0|||
48795124|NCT05054374|157088219|FG003|Overall Study|Withdrawal by Subject|0|||
48795125|NCT05054374|157088216|FG000|Overall Study|Progressive Disease|5|||
48795126|NCT05054374|157088217|FG001|Overall Study|Progressive Disease|0|||
48795127|NCT05054374|157088218|FG002|Overall Study|Progressive Disease|0|||
48795128|NCT05054374|157088219|FG003|Overall Study|Progressive Disease|0|||
48795129|NCT00558428|157088220|FG000|Overall Study|Adverse Event|6|||
48795130|NCT00558428|157088221|FG001|Overall Study|Adverse Event|22|||
48795131|NCT00558428|157088222|FG002|Overall Study|Adverse Event|3|||
48795132|NCT00558428|157088223|FG003|Overall Study|Adverse Event|4|||
48795133|NCT00558428|157088220|FG000|Overall Study|Lost to Follow-up|0|||
48795134|NCT00558428|157088221|FG001|Overall Study|Lost to Follow-up|1|||
48795135|NCT00558428|157088222|FG002|Overall Study|Lost to Follow-up|0|||
48795136|NCT00558428|157088223|FG003|Overall Study|Lost to Follow-up|0|||
48795137|NCT00558428|157088220|FG000|Overall Study|Lack of Efficacy|0|||
48795138|NCT00558428|157088221|FG001|Overall Study|Lack of Efficacy|0|||
48795139|NCT00558428|157088222|FG002|Overall Study|Lack of Efficacy|1|||
48795140|NCT00558428|157088223|FG003|Overall Study|Lack of Efficacy|2|||
48795141|NCT00558428|157088220|FG000|Overall Study|Non compliant with protocol|1|||
48795142|NCT00558428|157088221|FG001|Overall Study|Non compliant with protocol|0|||
48795143|NCT00558428|157088222|FG002|Overall Study|Non compliant with protocol|0|||
48795144|NCT00558428|157088223|FG003|Overall Study|Non compliant with protocol|3|||
48795145|NCT00558428|157088220|FG000|Overall Study|Consent withdrawn|2|||
48795146|NCT00558428|157088221|FG001|Overall Study|Consent withdrawn|1|||
48795147|NCT00558428|157088222|FG002|Overall Study|Consent withdrawn|0|||
48795148|NCT00558428|157088223|FG003|Overall Study|Consent withdrawn|1|||
48795149|NCT00558428|157088220|FG000|Overall Study|Other|3|||
48795150|NCT00558428|157088221|FG001|Overall Study|Other|0|||
48795151|NCT00558428|157088222|FG002|Overall Study|Other|0|||
48795152|NCT00558428|157088223|FG003|Overall Study|Other|1|||
48795153|NCT00530855|157088227|FG000|Overall Study|Lack of Efficacy|20|||
48795154|NCT00530855|157088227|FG000|Overall Study|Withdrawal by Subject|30|||
48795155|NCT00530855|157088227|FG000|Overall Study|Fatal Serious AE|3|||
48795156|NCT00530855|157088227|FG000|Overall Study|Non Fatal Serious AE|7|||
48795157|NCT00530855|157088227|FG000|Overall Study|Non Fatal Non Serious AE|12|||
48795158|NCT00530855|157088227|FG000|Overall Study|Protocol Violation|3|||
48795159|NCT00530855|157088227|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
48795160|NCT00530855|157088227|FG000|Overall Study|Lost to Follow-up|9|||
48795161|NCT00530855|157088227|FG000|Overall Study|Other reason for premature termination|17|||
48795162|NCT00626028|157088228|FG000|Overall Study|Adverse Event|1|||
48795163|NCT00626028|157088229|FG001|Overall Study|Adverse Event|1|||
48795164|NCT00626028|157088228|FG000|Overall Study|Device Failure|0|||
48795165|NCT00626028|157088229|FG001|Overall Study|Device Failure|1|||
48795166|NCT00626028|157088228|FG000|Overall Study|Physician Decision|2|||
48795167|NCT00626028|157088229|FG001|Overall Study|Physician Decision|1|||
48795168|NCT00626028|157088228|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
48795169|NCT00626028|157088229|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
48795170|NCT00831779|157088236|FG000|Overall Study|Lost to Follow-up|1|||
48795171|NCT00831779|157088237|FG001|Overall Study|Lost to Follow-up|0|||
48795172|NCT00831779|157088236|FG000|Overall Study|No longer met criteria|0|||
48795173|NCT00831779|157088237|FG001|Overall Study|No longer met criteria|1|||
48795174|NCT00130533|157088242|FG000|Overall Study|Withdrawal by Subject|33|||
48795175|NCT00130533|157088243|FG001|Overall Study|Withdrawal by Subject|6|||
48795176|NCT00130533|157088242|FG000|Overall Study|Adverse Event|34|||
48795177|NCT00130533|157088243|FG001|Overall Study|Adverse Event|1|||
48795178|NCT00130533|157088242|FG000|Overall Study|Disease relapse|9|||
48795179|NCT00130533|157088243|FG001|Overall Study|Disease relapse|13|||
48795180|NCT00130533|157088242|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
48795181|NCT00130533|157088243|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
48795182|NCT00130533|157088242|FG000|Overall Study|Death|4|||
48795183|NCT00130533|157088243|FG001|Overall Study|Death|2|||
48795184|NCT00130533|157088242|FG000|Overall Study|Protocol Violation|5|||
48795185|NCT00130533|157088243|FG001|Overall Study|Protocol Violation|1|||
48795186|NCT00130533|157088242|FG000|Overall Study|Lost to Follow-up|1|||
48795187|NCT00130533|157088243|FG001|Overall Study|Lost to Follow-up|1|||
48795188|NCT00130533|157088242|FG000|Overall Study|Sponsor´s decision|2|||
48795189|NCT00130533|157088243|FG001|Overall Study|Sponsor´s decision|0|||
48795190|NCT00130533|157088242|FG000|Overall Study|Second Primary Malignancy|0|||
48795191|NCT00130533|157088243|FG001|Overall Study|Second Primary Malignancy|1|||
48795192|NCT00130533|157088242|FG000|Overall Study|Other|12|||
48795193|NCT00130533|157088243|FG001|Overall Study|Other|5|||
48795194|NCT00515502|157088246|FG000|Treatment Period 1|Adverse Event|0|||
48795195|NCT00515502|157088247|FG001|Treatment Period 1|Adverse Event|0|||
48795196|NCT00515502|157088248|FG002|Treatment Period 1|Adverse Event|0|||
48795197|NCT00515502|157088249|FG003|Treatment Period 1|Adverse Event|0|||
48795198|NCT00515502|157088250|FG004|Treatment Period 1|Adverse Event|0|||
48795199|NCT00515502|157088251|FG005|Treatment Period 1|Adverse Event|0|||
48795200|NCT00515502|157088252|FG006|Treatment Period 1|Adverse Event|1|||
48795201|NCT00515502|157088253|FG007|Treatment Period 1|Adverse Event|0|||
48795202|NCT00515502|157088254|FG008|Treatment Period 1|Adverse Event|1|||
48795203|NCT00515502|157088255|FG009|Treatment Period 1|Adverse Event|0|||
48795204|NCT00515502|157088256|FG010|Treatment Period 1|Adverse Event|0|||
48795205|NCT00515502|157088257|FG011|Treatment Period 1|Adverse Event|1|||
48795206|NCT00515502|157088246|FG000|Treatment Period 2|Adverse Event|0|||
48401905|NCT01823679|155662851|FG000|Overall Study|Death|1|||
48401906|NCT04300231|155662852|FG000|Overall Study|Protocol Violation|4|||
48401907|NCT04300231|155662853|FG001|Overall Study|Protocol Violation|3|||
48401908|NCT04300231|155662854|FG002|Overall Study|Protocol Violation|0|||
48401909|NCT04300231|155662855|FG003|Overall Study|Protocol Violation|2|||
48401910|NCT01408147|155662856|FG000|Overall Study|Withdrawal by Subject|0|||
48401911|NCT01408147|155662857|FG001|Overall Study|Withdrawal by Subject|1|||
48401912|NCT01042600|155662858|FG000|Overall Study|Ineligible|1|||
48401913|NCT01042600|155662859|FG001|Overall Study|Ineligible|0|||
48401914|NCT02787850|155662860|FG000|Overall Study|Withdrawal by Subject|0|||
48401915|NCT02787850|155662861|FG001|Overall Study|Withdrawal by Subject|1|||
48401916|NCT00494091|155662864|FG000|Overall Study|Death|5|||
48401917|NCT00494091|155662865|FG001|Overall Study|Death|54|||
48795207|NCT00515502|157088247|FG001|Treatment Period 2|Adverse Event|1|||
48795208|NCT00515502|157088248|FG002|Treatment Period 2|Adverse Event|0|||
48401918|NCT00494091|155662864|FG000|Overall Study|Lost to Follow-up|0|||
48795209|NCT00515502|157088249|FG003|Treatment Period 2|Adverse Event|0|||
48795210|NCT00515502|157088250|FG004|Treatment Period 2|Adverse Event|0|||
48795211|NCT00515502|157088251|FG005|Treatment Period 2|Adverse Event|0|||
48795212|NCT00515502|157088252|FG006|Treatment Period 2|Adverse Event|0|||
48795213|NCT00515502|157088253|FG007|Treatment Period 2|Adverse Event|0|||
48795214|NCT00515502|157088254|FG008|Treatment Period 2|Adverse Event|0|||
48795215|NCT00515502|157088255|FG009|Treatment Period 2|Adverse Event|0|||
48795216|NCT00515502|157088256|FG010|Treatment Period 2|Adverse Event|0|||
48795217|NCT00515502|157088257|FG011|Treatment Period 2|Adverse Event|0|||
48795218|NCT01059175|157088258|FG000|Overall Study|Death|17|||
48795219|NCT01059175|157088259|FG001|Overall Study|Death|17|||
48795220|NCT01059175|157088258|FG000|Overall Study|Adverse Event|4|||
48795221|NCT01059175|157088259|FG001|Overall Study|Adverse Event|2|||
48795222|NCT01059175|157088258|FG000|Overall Study|Lost to Follow-up|0|||
48795223|NCT01059175|157088259|FG001|Overall Study|Lost to Follow-up|1|||
48795224|NCT02525874|157088263|FG000|Overall Study|Other|1|||
48795225|NCT02525874|157088263|FG000|Overall Study|Investigator Decision|1|||
48401919|NCT00494091|155662865|FG001|Overall Study|Lost to Follow-up|4|||
48401920|NCT00494091|155662864|FG000|Overall Study|Other|1|||
48401921|NCT00494091|155662865|FG001|Overall Study|Other|11|||
48401922|NCT00494091|155662864|FG000|Overall Study|Withdrawal by Subject|0|||
48401923|NCT00494091|155662865|FG001|Overall Study|Withdrawal by Subject|7|||
48401924|NCT03718143|155662866|FG000|Overall Study|Death|1|||
48401925|NCT03718143|155662867|FG001|Overall Study|Death|0|||
48795226|NCT02525874|157088263|FG000|Overall Study|Consent withdrawn|22|||
48795227|NCT02525874|157088263|FG000|Overall Study|Non-compliance with study drug|3|||
48795228|NCT02525874|157088263|FG000|Overall Study|Adverse Event|17|||
48795229|NCT02525874|157088263|FG000|Overall Study|Lost to Follow-up|7|||
48401926|NCT03718143|155662868|FG002|Overall Study|Death|0|||
48795230|NCT02525874|157088263|FG000|Overall Study|Disease progression, defined by protocol|2|||
48795231|NCT02525874|157088263|FG000|Overall Study|Disease relapse|4|||
48795232|NCT02525874|157088263|FG000|Overall Study|Alternative Treatment for MS|2|||
48795233|NCT02525874|157088263|FG000|Overall Study|New lesions in Brain|1|||
48795234|NCT03263429|157088268|FG000|Overall Study|Withdrawal by Subject|0|||
48795235|NCT03263429|157088269|FG001|Overall Study|Withdrawal by Subject|1|||
48795236|NCT03263429|157088270|FG002|Overall Study|Withdrawal by Subject|0|||
48795237|NCT03263429|157088268|FG000|Overall Study|Follow-Up Period Completed|0|||
48795238|NCT03263429|157088269|FG001|Overall Study|Follow-Up Period Completed|2|||
48795239|NCT03263429|157088270|FG002|Overall Study|Follow-Up Period Completed|0|||
48795240|NCT03263429|157088268|FG000|Overall Study|Death|3|||
48795241|NCT03263429|157088269|FG001|Overall Study|Death|5|||
48795242|NCT03263429|157088270|FG002|Overall Study|Death|16|||
48401927|NCT03718143|155662866|FG000|Overall Study|Progression of Disease|1|||
48401928|NCT03718143|155662867|FG001|Overall Study|Progression of Disease|0|||
48401929|NCT03718143|155662868|FG002|Overall Study|Progression of Disease|0|||
48401930|NCT03718143|155662866|FG000|Overall Study|Withdrawal of Informed Consent|1|||
48401931|NCT03718143|155662867|FG001|Overall Study|Withdrawal of Informed Consent|2|||
48401932|NCT03718143|155662868|FG002|Overall Study|Withdrawal of Informed Consent|1|||
48401933|NCT04161131|155662871|FG000|Overall Study|Ineligible|2|||
48401934|NCT04161131|155662871|FG000|Overall Study|Lost to Follow-up|4|||
48401935|NCT02721355|155662872|FG000|Overall Study|Lost to Follow-up|6|||
48401936|NCT02721355|155662873|FG001|Overall Study|Lost to Follow-up|1|||
48401937|NCT00356278|155662874|FG000|Overall Study|Withdrawal by Subject|25|||
48401938|NCT00356278|155662875|FG001|Overall Study|Withdrawal by Subject|15|||
48401939|NCT00356278|155662876|FG002|Overall Study|Withdrawal by Subject|19|||
48401940|NCT02927769|155662878|FG000|Induction Phase|Study drug toxicity|1|||
48401941|NCT02927769|155662879|FG001|Induction Phase|Study drug toxicity|1|||
48401942|NCT02927769|155662878|FG000|Induction Phase|Disease progression|0|||
48795243|NCT03263429|157088268|FG000|Overall Study|Participant unable to return|0|||
48795244|NCT03263429|157088269|FG001|Overall Study|Participant unable to return|0|||
48795245|NCT03263429|157088270|FG002|Overall Study|Participant unable to return|1|||
48795246|NCT03263429|157088268|FG000|Overall Study|Study Closed|0|||
48795247|NCT03263429|157088269|FG001|Overall Study|Study Closed|0|||
48795248|NCT03263429|157088270|FG002|Overall Study|Study Closed|1|||
48795249|NCT04530448|157088271|FG000|Overall Study|Physician Decision|3|||
48795250|NCT04530448|157088272|FG001|Overall Study|Physician Decision|0|||
48795251|NCT04838262|157088296|FG000|Overall Study|Withdrawal by Subject|9|||
48795252|NCT04838262|157088297|FG001|Overall Study|Withdrawal by Subject|4|||
48795253|NCT01618162|157088298|FG000|Overall Study|Protocol Violation|13|||
48795254|NCT01618162|157088299|FG001|Overall Study|Protocol Violation|10|||
48795255|NCT01618162|157088298|FG000|Overall Study|Adverse Event|9|||
48795256|NCT01618162|157088299|FG001|Overall Study|Adverse Event|2|||
48795257|NCT01618162|157088298|FG000|Overall Study|Withdrawal Criteria|2|||
48795258|NCT01618162|157088299|FG001|Overall Study|Withdrawal Criteria|10|||
48795259|NCT01618162|157088298|FG000|Overall Study|Unclassified|14|||
48795260|NCT01618162|157088299|FG001|Overall Study|Unclassified|13|||
48795261|NCT03321396|157088300|FG000|Overall Study|Physician Decision|1|||
48795262|NCT01970982|157088306|FG000|Overall Study|Withdrawal by Subject|0|||
48401943|NCT02927769|155662879|FG001|Induction Phase|Disease progression|1|||
48401944|NCT02927769|155662878|FG000|Intensification Phase|Study drug toxicity|1|||
48795263|NCT01970982|157088307|FG001|Overall Study|Withdrawal by Subject|0|||
48795264|NCT01970982|157088308|FG002|Overall Study|Withdrawal by Subject|2|||
48795265|NCT05130970|157088313|FG000|Overall Study|Adverse Event|1|||
48401945|NCT02927769|155662879|FG001|Intensification Phase|Study drug toxicity|0|||
48401946|NCT05633953|155662881|FG000|Overall Study|Adverse Event|7|||
48795266|NCT05130970|157088314|FG001|Overall Study|Adverse Event|1|||
48795267|NCT05130970|157088313|FG000|Overall Study|Death|0|||
48795268|NCT05130970|157088314|FG001|Overall Study|Death|1|||
48795269|NCT05130970|157088313|FG000|Overall Study|Lost to Follow-up|0|||
48795270|NCT05130970|157088314|FG001|Overall Study|Lost to Follow-up|1|||
48795271|NCT05130970|157088313|FG000|Overall Study|Physician Decision|0|||
48795272|NCT05130970|157088314|FG001|Overall Study|Physician Decision|1|||
48795273|NCT05130970|157088313|FG000|Overall Study|Withdrawal by Subject|1|||
48795274|NCT05130970|157088314|FG001|Overall Study|Withdrawal by Subject|1|||
48795275|NCT02975934|157088317|FG000|Treatment Phase|Ongoing at data-analysis|33|||
48795276|NCT02975934|157088318|FG001|Treatment Phase|Ongoing at data-analysis|5|||
48795277|NCT02975934|157088317|FG000|Treatment Phase|Discontinued prior to study drug|0|||
48795278|NCT02975934|157088318|FG001|Treatment Phase|Discontinued prior to study drug|5|||
48795279|NCT02975934|157088317|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
48795280|NCT02975934|157088318|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
48795281|NCT04435366|157088319|FG000|Year 1 (12 Months)|Adverse Event|3|||
48795282|NCT04435366|157088320|FG001|Year 1 (12 Months)|Adverse Event|0|||
48795283|NCT04435366|157088321|FG002|Year 1 (12 Months)|Adverse Event|2|||
48795284|NCT04435366|157088319|FG000|Year 1 (12 Months)|Death|2|||
48795285|NCT04435366|157088320|FG001|Year 1 (12 Months)|Death|0|||
48795286|NCT04435366|157088321|FG002|Year 1 (12 Months)|Death|1|||
48795287|NCT04435366|157088319|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
48795288|NCT04435366|157088320|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
48795289|NCT04435366|157088321|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
48795290|NCT04435366|157088319|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
48795291|NCT04435366|157088320|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
48795292|NCT04435366|157088321|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
48795293|NCT04435366|157088319|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
48795294|NCT04435366|157088320|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
48795295|NCT04435366|157088321|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
48795296|NCT04435366|157088319|FG000|Year 1 (12 Months)|Not treated|0|||
48795297|NCT04435366|157088320|FG001|Year 1 (12 Months)|Not treated|0|||
48795298|NCT04435366|157088321|FG002|Year 1 (12 Months)|Not treated|1|||
48795299|NCT04435366|157088319|FG000|Year 2 (12 Months)|Death|1|||
48795300|NCT04435366|157088320|FG001|Year 2 (12 Months)|Death|4|||
48795301|NCT04435366|157088321|FG002|Year 2 (12 Months)|Death|6|||
48795302|NCT04435366|157088319|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
48795303|NCT04435366|157088320|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
48795304|NCT04435366|157088321|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
48795305|NCT04435366|157088319|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
48795306|NCT04435366|157088320|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
48795307|NCT04435366|157088321|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
48795308|NCT04435366|157088319|FG000|Year 2 (12 Months)|Adverse Event|2|||
48795309|NCT04435366|157088320|FG001|Year 2 (12 Months)|Adverse Event|1|||
48795310|NCT04435366|157088321|FG002|Year 2 (12 Months)|Adverse Event|6|||
48795311|NCT04495179|157088322|FG000|Overall Study|Lost to Follow-up|0|||
48795312|NCT04495179|157088323|FG001|Overall Study|Lost to Follow-up|1|||
48795313|NCT04495179|157088322|FG000|Overall Study|Withdrawal by Subject|2|||
48795314|NCT04495179|157088323|FG001|Overall Study|Withdrawal by Subject|4|||
48795315|NCT04495179|157088322|FG000|Overall Study|Study terminated by sponsor|0|||
48795316|NCT04495179|157088323|FG001|Overall Study|Study terminated by sponsor|18|||
48795317|NCT04495179|157088322|FG000|Overall Study|Death|0|||
48795318|NCT04495179|157088323|FG001|Overall Study|Death|4|||
48795319|NCT04495179|157088322|FG000|Overall Study|Adverse Event|0|||
48795320|NCT04495179|157088323|FG001|Overall Study|Adverse Event|1|||
48795321|NCT03707977|157088326|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
48795322|NCT03707977|157088327|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
48795323|NCT03707977|157088328|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
48795324|NCT03707977|157088326|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
48795325|NCT03707977|157088327|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
48795326|NCT03707977|157088328|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
48795327|NCT02618967|157088329|FG000|Overall Study|Lost to Follow-up|0|||
48795328|NCT02618967|157088330|FG001|Overall Study|Lost to Follow-up|0|||
48795329|NCT02618967|157088331|FG002|Overall Study|Lost to Follow-up|1|||
48795330|NCT02618967|157088332|FG003|Overall Study|Lost to Follow-up|0|||
48795331|NCT02618967|157088333|FG004|Overall Study|Lost to Follow-up|2|||
48795332|NCT02618967|157088334|FG005|Overall Study|Lost to Follow-up|0|||
48795333|NCT02618967|157088335|FG006|Overall Study|Lost to Follow-up|0|||
48795334|NCT02618967|157088336|FG007|Overall Study|Lost to Follow-up|0|||
48795335|NCT02618967|157088329|FG000|Overall Study|Withdrawal by Subject|1|||
48795336|NCT02618967|157088330|FG001|Overall Study|Withdrawal by Subject|0|||
48795337|NCT02618967|157088331|FG002|Overall Study|Withdrawal by Subject|0|||
48795338|NCT02618967|157088332|FG003|Overall Study|Withdrawal by Subject|0|||
48795339|NCT02618967|157088333|FG004|Overall Study|Withdrawal by Subject|0|||
48795340|NCT02618967|157088334|FG005|Overall Study|Withdrawal by Subject|0|||
48795341|NCT02618967|157088335|FG006|Overall Study|Withdrawal by Subject|0|||
48795342|NCT02618967|157088336|FG007|Overall Study|Withdrawal by Subject|0|||
48795343|NCT02061202|157088338|FG000|Overall Study|Lost to Follow-up|1|||
48795344|NCT02061202|157088339|FG001|Overall Study|Lost to Follow-up|1|||
48795345|NCT04212091|157088340|FG000|Overall Study|Lost to Follow-up|0|||
48795346|NCT04212091|157088341|FG001|Overall Study|Lost to Follow-up|0|||
48795347|NCT04212091|157088342|FG002|Overall Study|Lost to Follow-up|0|||
48795348|NCT04212091|157088343|FG003|Overall Study|Lost to Follow-up|0|||
48795349|NCT04212091|157088344|FG004|Overall Study|Lost to Follow-up|1|||
48795350|NCT04212091|157088345|FG005|Overall Study|Lost to Follow-up|1|||
48795351|NCT04212091|157088340|FG000|Overall Study|Participant unable to adhere to visit|0|||
48795352|NCT04212091|157088341|FG001|Overall Study|Participant unable to adhere to visit|0|||
48795353|NCT04212091|157088342|FG002|Overall Study|Participant unable to adhere to visit|0|||
48795354|NCT04212091|157088343|FG003|Overall Study|Participant unable to adhere to visit|0|||
48795355|NCT04212091|157088344|FG004|Overall Study|Participant unable to adhere to visit|1|||
48795356|NCT04212091|157088345|FG005|Overall Study|Participant unable to adhere to visit|0|||
48795357|NCT03492281|157088348|FG000|Overall Study|Withdrawal by Subject|21|||
48795358|NCT03492281|157088349|FG001|Overall Study|Withdrawal by Subject|14|||
48795359|NCT03492281|157088350|FG002|Overall Study|Withdrawal by Subject|13|||
48795360|NCT03492281|157088348|FG000|Overall Study|Lost to Follow-up|14|||
48795361|NCT03492281|157088349|FG001|Overall Study|Lost to Follow-up|15|||
48795362|NCT03492281|157088350|FG002|Overall Study|Lost to Follow-up|10|||
48795363|NCT03492281|157088348|FG000|Overall Study|Adverse Event|6|||
48795364|NCT03492281|157088349|FG001|Overall Study|Adverse Event|8|||
48795365|NCT03492281|157088350|FG002|Overall Study|Adverse Event|13|||
48795366|NCT03492281|157088348|FG000|Overall Study|Lack of Efficacy|3|||
48795367|NCT03492281|157088349|FG001|Overall Study|Lack of Efficacy|0|||
48795368|NCT03492281|157088350|FG002|Overall Study|Lack of Efficacy|1|||
48795369|NCT03492281|157088348|FG000|Overall Study|Physician Decision|1|||
48795370|NCT03492281|157088349|FG001|Overall Study|Physician Decision|0|||
48795371|NCT03492281|157088350|FG002|Overall Study|Physician Decision|3|||
48795372|NCT03492281|157088348|FG000|Overall Study|Protocol Violation|0|||
48795373|NCT03492281|157088349|FG001|Overall Study|Protocol Violation|2|||
48795374|NCT03492281|157088350|FG002|Overall Study|Protocol Violation|1|||
48795375|NCT03492281|157088348|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
48795376|NCT03492281|157088349|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
48795377|NCT03492281|157088350|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
48795378|NCT03492281|157088348|FG000|Overall Study|Death|0|||
48795379|NCT03492281|157088349|FG001|Overall Study|Death|0|||
48795380|NCT03492281|157088350|FG002|Overall Study|Death|1|||
48795381|NCT03492281|157088348|FG000|Overall Study|Captured as Other in Database|8|||
48795382|NCT03492281|157088349|FG001|Overall Study|Captured as Other in Database|6|||
48795383|NCT03492281|157088350|FG002|Overall Study|Captured as Other in Database|3|||
48795384|NCT01506193|157088351|FG000|Overall Study|Protocol Violation|1|||
48795385|NCT01506193|157088352|FG001|Overall Study|Protocol Violation|0|||
48795386|NCT01506193|157088353|FG002|Overall Study|Protocol Violation|1|||
48795387|NCT01506193|157088351|FG000|Overall Study|Migrated/moved from study area|0|||
48795388|NCT01506193|157088352|FG001|Overall Study|Migrated/moved from study area|0|||
48795389|NCT01506193|157088353|FG002|Overall Study|Migrated/moved from study area|1|||
48795390|NCT01506193|157088351|FG000|Overall Study|Adverse event, non-fatal|0|||
48795391|NCT01506193|157088352|FG001|Overall Study|Adverse event, non-fatal|0|||
48795392|NCT01506193|157088353|FG002|Overall Study|Adverse event, non-fatal|1|||
48795393|NCT01506193|157088351|FG000|Overall Study|Withdrawal by Subject|5|||
48795394|NCT01506193|157088352|FG001|Overall Study|Withdrawal by Subject|1|||
48795395|NCT01506193|157088353|FG002|Overall Study|Withdrawal by Subject|8|||
48795396|NCT01506193|157088351|FG000|Overall Study|Lost to Follow-up|8|||
48795397|NCT01506193|157088352|FG001|Overall Study|Lost to Follow-up|3|||
48795398|NCT01506193|157088353|FG002|Overall Study|Lost to Follow-up|3|||
48795399|NCT02199028|157088354|FG000|Week 1|Adverse Event|1|||
48795400|NCT02199028|157088355|FG001|Week 1|Adverse Event|0|||
48795401|NCT02199028|157088354|FG000|Week 3|Adverse Event|1|||
48795402|NCT02199028|157088355|FG001|Week 3|Adverse Event|0|||
48795403|NCT00862134|157088357|FG000|Overall Study|Death|1|||
48795404|NCT00862134|157088358|FG001|Overall Study|Death|0|||
48795405|NCT00862134|157088357|FG000|Overall Study|Physician Decision|0|||
48795406|NCT00862134|157088358|FG001|Overall Study|Physician Decision|1|||
48795407|NCT00862134|157088357|FG000|Overall Study|Withdrawal by Subject|1|||
48795408|NCT00862134|157088358|FG001|Overall Study|Withdrawal by Subject|2|||
48795409|NCT00862134|157088357|FG000|Overall Study|Sponsor terminated study|5|||
48795410|NCT00862134|157088358|FG001|Overall Study|Sponsor terminated study|7|||
48795411|NCT00862134|157088357|FG000|Overall Study|Adverse Event|2|||
48795412|NCT00862134|157088358|FG001|Overall Study|Adverse Event|2|||
48795413|NCT00862134|157088357|FG000|Overall Study|Withdrew prior to dosing|2|||
48795414|NCT00862134|157088358|FG001|Overall Study|Withdrew prior to dosing|0|||
48795415|NCT00765674|157088359|FG000|Overall Study|Adverse Event|7|||
48795416|NCT00765674|157088360|FG001|Overall Study|Adverse Event|2|||
48795417|NCT00765674|157088361|FG002|Overall Study|Adverse Event|8|||
48795418|NCT00765674|157088362|FG003|Overall Study|Adverse Event|11|||
48795419|NCT00765674|157088359|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
48795420|NCT00765674|157088360|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
48795421|NCT00765674|157088361|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
48795422|NCT00765674|157088362|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
48795423|NCT00765674|157088359|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
48795424|NCT00765674|157088360|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
48795425|NCT00765674|157088361|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
48795426|NCT00765674|157088362|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
48795427|NCT00765674|157088359|FG000|Overall Study|Lack of Efficacy|2|||
48795428|NCT00765674|157088360|FG001|Overall Study|Lack of Efficacy|3|||
48795429|NCT00765674|157088361|FG002|Overall Study|Lack of Efficacy|1|||
48795430|NCT00765674|157088362|FG003|Overall Study|Lack of Efficacy|2|||
48795431|NCT00765674|157088359|FG000|Overall Study|Protocol Violation|2|||
48795432|NCT00765674|157088360|FG001|Overall Study|Protocol Violation|0|||
48795433|NCT00765674|157088361|FG002|Overall Study|Protocol Violation|1|||
48795434|NCT00765674|157088362|FG003|Overall Study|Protocol Violation|0|||
48795435|NCT00765674|157088359|FG000|Overall Study|Withdrawal by Subject|5|||
48795436|NCT00765674|157088360|FG001|Overall Study|Withdrawal by Subject|7|||
48795437|NCT00765674|157088361|FG002|Overall Study|Withdrawal by Subject|3|||
48795438|NCT00765674|157088362|FG003|Overall Study|Withdrawal by Subject|8|||
48795439|NCT00765674|157088359|FG000|Overall Study|Lost to Follow-up|4|||
48795440|NCT00765674|157088360|FG001|Overall Study|Lost to Follow-up|6|||
48795441|NCT00765674|157088361|FG002|Overall Study|Lost to Follow-up|2|||
48795442|NCT00765674|157088362|FG003|Overall Study|Lost to Follow-up|1|||
48795443|NCT00765674|157088359|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
48795444|NCT00765674|157088360|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
48795445|NCT00765674|157088361|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
48795446|NCT00765674|157088362|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
48795447|NCT03015402|157088363|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48795448|NCT03015402|157088364|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
48795449|NCT03015402|157088363|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
48795450|NCT03015402|157088364|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
48795451|NCT03213158|157088365|FG000|Overall Study|Withdrawal by Subject|1|||
48795452|NCT03213158|157088365|FG000|Overall Study|Physician Decision|2|||
48795453|NCT00587964|157088366|FG000|Overall Study|Withdrawal by Subject|1|||
48795454|NCT00587964|157088366|FG000|Overall Study|Lost to Follow-up|1|||
48795455|NCT00587964|157088366|FG000|Overall Study|Patient found to be ineligible|1|||
48795456|NCT00587964|157088366|FG000|Overall Study|Patient did not receive intervention|5|||
48795457|NCT00587964|157088366|FG000|Overall Study|Progression of Disease|4|||
48795458|NCT03311373|157088370|FG000|Overall Study|Adverse Event|1|||
48795459|NCT03311373|157088370|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
48795460|NCT03311373|157088370|FG000|Overall Study|Lost to Follow-up|1|||
48795461|NCT03311373|157088370|FG000|Overall Study|Physician Decision|1|||
48795462|NCT03311373|157088370|FG000|Overall Study|Withdrawal by Subject|3|||
48795463|NCT01239030|157088371|FG000|Double Blind|Adverse Event|0|||
48795464|NCT01239030|157088372|FG001|Double Blind|Adverse Event|1|||
48795465|NCT01239030|157088373|FG002|Double Blind|Adverse Event|0|||
48795466|NCT01239030|157088374|FG003|Double Blind|Adverse Event|2|||
48795467|NCT01239030|157088375|FG004|Double Blind|Adverse Event|0|||
48795468|NCT01239030|157088371|FG000|Double Blind|Withdrawal by Subject|0|||
48795469|NCT01239030|157088372|FG001|Double Blind|Withdrawal by Subject|1|||
48795470|NCT01239030|157088373|FG002|Double Blind|Withdrawal by Subject|1|||
48795471|NCT01239030|157088374|FG003|Double Blind|Withdrawal by Subject|0|||
48795472|NCT01239030|157088375|FG004|Double Blind|Withdrawal by Subject|1|||
48795473|NCT01239030|157088371|FG000|Double Blind|Lost to Follow-up|1|||
48795474|NCT01239030|157088372|FG001|Double Blind|Lost to Follow-up|1|||
48795475|NCT01239030|157088373|FG002|Double Blind|Lost to Follow-up|0|||
48795476|NCT01239030|157088374|FG003|Double Blind|Lost to Follow-up|0|||
48795477|NCT01239030|157088375|FG004|Double Blind|Lost to Follow-up|0|||
48795478|NCT01239030|157088371|FG000|Double Blind|Physician Decision|0|||
48795479|NCT01239030|157088372|FG001|Double Blind|Physician Decision|1|||
48795480|NCT01239030|157088373|FG002|Double Blind|Physician Decision|0|||
48795481|NCT01239030|157088374|FG003|Double Blind|Physician Decision|0|||
48795482|NCT01239030|157088375|FG004|Double Blind|Physician Decision|0|||
48795483|NCT01239030|157088371|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
48795484|NCT01239030|157088372|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
48795485|NCT01239030|157088373|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
48795486|NCT01239030|157088374|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
48795487|NCT01239030|157088375|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
48795488|NCT01239030|157088371|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
48795489|NCT01239030|157088372|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
48795490|NCT01239030|157088373|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
48795491|NCT01239030|157088374|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
48795492|NCT01239030|157088375|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
48795493|NCT01239030|157088371|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
48795494|NCT01239030|157088372|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
48795495|NCT01239030|157088373|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
48795496|NCT01239030|157088374|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
48795497|NCT01239030|157088375|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
48795498|NCT01239030|157088371|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
48795499|NCT01239030|157088372|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
48795500|NCT01239030|157088373|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
48795501|NCT01239030|157088374|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
48795502|NCT01239030|157088375|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
48795503|NCT02077166|157088376|FG000|Overall Study|Death|6|||
48795504|NCT02077166|157088377|FG001|Overall Study|Death|7|||
48795505|NCT02077166|157088378|FG002|Overall Study|Death|5|||
48795506|NCT02077166|157088379|FG003|Overall Study|Death|6|||
48795507|NCT02077166|157088380|FG004|Overall Study|Death|4|||
48795508|NCT02077166|157088381|FG005|Overall Study|Death|32|||
48795509|NCT02077166|157088382|FG006|Overall Study|Death|22|||
48795510|NCT02077166|157088376|FG000|Overall Study|Study Closure by Sponsor|3|||
48795511|NCT02077166|157088377|FG001|Overall Study|Study Closure by Sponsor|0|||
48795512|NCT02077166|157088378|FG002|Overall Study|Study Closure by Sponsor|2|||
48795513|NCT02077166|157088379|FG003|Overall Study|Study Closure by Sponsor|2|||
48795514|NCT02077166|157088380|FG004|Overall Study|Study Closure by Sponsor|2|||
48795515|NCT02077166|157088381|FG005|Overall Study|Study Closure by Sponsor|12|||
48795516|NCT02077166|157088382|FG006|Overall Study|Study Closure by Sponsor|4|||
48795517|NCT02077166|157088376|FG000|Overall Study|Lost to Follow-up|0|||
48795518|NCT02077166|157088377|FG001|Overall Study|Lost to Follow-up|0|||
48795519|NCT02077166|157088378|FG002|Overall Study|Lost to Follow-up|0|||
48795520|NCT02077166|157088379|FG003|Overall Study|Lost to Follow-up|0|||
48795521|NCT02077166|157088380|FG004|Overall Study|Lost to Follow-up|0|||
48795522|NCT02077166|157088381|FG005|Overall Study|Lost to Follow-up|1|||
48795523|NCT02077166|157088382|FG006|Overall Study|Lost to Follow-up|0|||
48795524|NCT02077166|157088376|FG000|Overall Study|Withdrawal by Subject|3|||
48795525|NCT02077166|157088377|FG001|Overall Study|Withdrawal by Subject|0|||
48795526|NCT02077166|157088378|FG002|Overall Study|Withdrawal by Subject|1|||
48795527|NCT02077166|157088379|FG003|Overall Study|Withdrawal by Subject|1|||
48795528|NCT02077166|157088380|FG004|Overall Study|Withdrawal by Subject|1|||
48795529|NCT02077166|157088381|FG005|Overall Study|Withdrawal by Subject|3|||
48795530|NCT02077166|157088382|FG006|Overall Study|Withdrawal by Subject|0|||
48795531|NCT02077166|157088376|FG000|Overall Study|Other, Not Specified|0|||
48795532|NCT02077166|157088377|FG001|Overall Study|Other, Not Specified|0|||
48795533|NCT02077166|157088378|FG002|Overall Study|Other, Not Specified|1|||
48795534|NCT02077166|157088379|FG003|Overall Study|Other, Not Specified|0|||
48795535|NCT02077166|157088380|FG004|Overall Study|Other, Not Specified|1|||
48795536|NCT02077166|157088381|FG005|Overall Study|Other, Not Specified|7|||
48795537|NCT02077166|157088382|FG006|Overall Study|Other, Not Specified|8|||
48795538|NCT03832595|157088383|FG000|Overall Study|Death|142|||
48795539|NCT03832595|157088384|FG001|Overall Study|Death|130|||
48795540|NCT03832595|157088383|FG000|Overall Study|Medical management without dialysis|37|||
48795541|NCT03832595|157088384|FG001|Overall Study|Medical management without dialysis|1|||
48795542|NCT01338025|157088385|FG000|Overall Study|Unexpected closure of study|10|||
48795543|NCT01338025|157088386|FG001|Overall Study|Unexpected closure of study|9|||
48795544|NCT01338025|157088385|FG000|Overall Study|Withdrawal by Subject|0|||
48795545|NCT01338025|157088386|FG001|Overall Study|Withdrawal by Subject|2|||
48795546|NCT01338025|157088385|FG000|Overall Study|Found ineligible after starting|1|||
48795547|NCT01338025|157088386|FG001|Overall Study|Found ineligible after starting|0|||
48795548|NCT04602728|157088389|FG000|Overall Study|Lost to Follow-up|4|||
48795549|NCT04602728|157088390|FG001|Overall Study|Lost to Follow-up|4|||
48795550|NCT04508699|157088393|FG000|Overall Study|Lack of Efficacy|2|||
48795551|NCT04508699|157088394|FG001|Overall Study|Lack of Efficacy|15|||
48795552|NCT04508699|157088393|FG000|Overall Study|Withdrawal by Subject|0|||
48795553|NCT04508699|157088394|FG001|Overall Study|Withdrawal by Subject|2|||
48795554|NCT00136955|157090027|FG000|Overall Study|Adverse Event|8|||
48795555|NCT00136955|157090027|FG000|Overall Study|Lost to Follow-up|1|||
48795556|NCT00136955|157090027|FG000|Overall Study|Withdrawal by Subject|2|||
48795557|NCT00136955|157090027|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
48795558|NCT00955357|157090032|FG000|Titration Phase|Adverse Event|9|||
48795559|NCT00955357|157090033|FG001|Titration Phase|Adverse Event|46|||
48795560|NCT00955357|157090032|FG000|Titration Phase|Lack of Efficacy|0|||
48795561|NCT00955357|157090033|FG001|Titration Phase|Lack of Efficacy|2|||
48795562|NCT00955357|157090032|FG000|Titration Phase|Protocol Violation|3|||
48795563|NCT00955357|157090033|FG001|Titration Phase|Protocol Violation|7|||
48795564|NCT00955357|157090032|FG000|Titration Phase|Lost to Follow-up|1|||
48795565|NCT00955357|157090033|FG001|Titration Phase|Lost to Follow-up|3|||
48795566|NCT00955357|157090032|FG000|Titration Phase|Withdrawal by Subject|3|||
48795567|NCT00955357|157090033|FG001|Titration Phase|Withdrawal by Subject|5|||
48795568|NCT00955357|157090032|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
48795569|NCT00955357|157090033|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
48795570|NCT00955357|157090032|FG000|Titration Phase|Study medication not tolerated|0|||
48795571|NCT00955357|157090033|FG001|Titration Phase|Study medication not tolerated|1|||
48795572|NCT00955357|157090032|FG000|Titration Phase|Non compliance to study procedures|0|||
48795573|NCT00955357|157090033|FG001|Titration Phase|Non compliance to study procedures|1|||
48795574|NCT00955357|157090032|FG000|Maintenance Phase|Adverse Event|3|||
48795575|NCT00955357|157090033|FG001|Maintenance Phase|Adverse Event|23|||
48795576|NCT00955357|157090032|FG000|Maintenance Phase|Lack of Efficacy|0|||
48795577|NCT00955357|157090033|FG001|Maintenance Phase|Lack of Efficacy|4|||
48795578|NCT00955357|157090032|FG000|Maintenance Phase|Protocol Violation|2|||
48795579|NCT00955357|157090033|FG001|Maintenance Phase|Protocol Violation|6|||
48795580|NCT00955357|157090032|FG000|Maintenance Phase|Lost to Follow-up|2|||
48795581|NCT00955357|157090033|FG001|Maintenance Phase|Lost to Follow-up|7|||
48795582|NCT00955357|157090032|FG000|Maintenance Phase|Withdrawal by Subject|4|||
48795583|NCT00955357|157090033|FG001|Maintenance Phase|Withdrawal by Subject|4|||
48795584|NCT00955357|157090032|FG000|Maintenance Phase|Patient moving out of area|0|||
48795585|NCT00955357|157090033|FG001|Maintenance Phase|Patient moving out of area|1|||
48795586|NCT00955357|157090032|FG000|Maintenance Phase|Non compliance to study procedures|1|||
48795587|NCT00955357|157090033|FG001|Maintenance Phase|Non compliance to study procedures|0|||
48795588|NCT02985866|157090034|FG000|Overall Study|Poor CGM data|1|||
48795589|NCT02985866|157090035|FG001|Overall Study|Poor CGM data|1|||
48795590|NCT00447057|157090036|FG000|Overall Study|Adverse Event|4|||
48795591|NCT00447057|157090037|FG001|Overall Study|Adverse Event|10|||
48795592|NCT00447057|157090038|FG002|Overall Study|Adverse Event|0|||
48795593|NCT00447057|157090039|FG003|Overall Study|Adverse Event|3|||
48795594|NCT00447057|157090036|FG000|Overall Study|Death due to study disease|6|||
48795595|NCT00447057|157090037|FG001|Overall Study|Death due to study disease|4|||
48795596|NCT00447057|157090038|FG002|Overall Study|Death due to study disease|1|||
48795597|NCT00447057|157090039|FG003|Overall Study|Death due to study disease|1|||
48795598|NCT00447057|157090036|FG000|Overall Study|Lost to Follow-up|0|||
48795599|NCT00447057|157090037|FG001|Overall Study|Lost to Follow-up|1|||
48795600|NCT00447057|157090038|FG002|Overall Study|Lost to Follow-up|0|||
48795601|NCT00447057|157090039|FG003|Overall Study|Lost to Follow-up|0|||
48795602|NCT00447057|157090036|FG000|Overall Study|Entry criteria not met|1|||
48795603|NCT00447057|157090037|FG001|Overall Study|Entry criteria not met|1|||
48795604|NCT00447057|157090038|FG002|Overall Study|Entry criteria not met|0|||
48795605|NCT00447057|157090039|FG003|Overall Study|Entry criteria not met|0|||
48795606|NCT00447057|157090036|FG000|Overall Study|Protocol Violation|0|||
48795607|NCT00447057|157090037|FG001|Overall Study|Protocol Violation|1|||
48795608|NCT00447057|157090038|FG002|Overall Study|Protocol Violation|0|||
48795609|NCT00447057|157090039|FG003|Overall Study|Protocol Violation|0|||
48795610|NCT00447057|157090036|FG000|Overall Study|Withdrawal by Subject|4|||
48795611|NCT00447057|157090037|FG001|Overall Study|Withdrawal by Subject|5|||
48795612|NCT00447057|157090038|FG002|Overall Study|Withdrawal by Subject|1|||
48795613|NCT00447057|157090039|FG003|Overall Study|Withdrawal by Subject|1|||
48795614|NCT00447057|157090036|FG000|Overall Study|Physician Decision|9|||
48795615|NCT00447057|157090037|FG001|Overall Study|Physician Decision|6|||
48795616|NCT00447057|157090038|FG002|Overall Study|Physician Decision|3|||
48795617|NCT00447057|157090039|FG003|Overall Study|Physician Decision|1|||
48795618|NCT00447057|157090036|FG000|Overall Study|Sponsor decision|1|||
48795619|NCT00447057|157090037|FG001|Overall Study|Sponsor decision|1|||
48795620|NCT00447057|157090038|FG002|Overall Study|Sponsor decision|0|||
48795621|NCT00447057|157090039|FG003|Overall Study|Sponsor decision|0|||
48795622|NCT00447057|157090036|FG000|Overall Study|Progressive disease|58|||
48795623|NCT00447057|157090037|FG001|Overall Study|Progressive disease|43|||
48795624|NCT00447057|157090038|FG002|Overall Study|Progressive disease|13|||
48795625|NCT00447057|157090039|FG003|Overall Study|Progressive disease|18|||
48795626|NCT00447057|157090036|FG000|Overall Study|Death due to adverse event|0|||
48795627|NCT00447057|157090037|FG001|Overall Study|Death due to adverse event|0|||
48401947|NCT05633953|155662881|FG000|Overall Study|Death|30|||
48401948|NCT05633953|155662881|FG000|Overall Study|Lost to Follow-up|1|||
48401949|NCT05633953|155662881|FG000|Overall Study|Osilodrostat discontinued|4|||
48401950|NCT05633953|155662881|FG000|Overall Study|Physician Decision|1|||
48401951|NCT05633953|155662881|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
48401952|NCT05633953|155662881|FG000|Overall Study|Progressive disease|2|||
48401953|NCT05956002|155662885|FG000|Treatment Period 3|Adverse Event|0|||
48401954|NCT05956002|155662886|FG001|Treatment Period 3|Adverse Event|0|||
48795628|NCT00447057|157090038|FG002|Overall Study|Death due to adverse event|1|||
48795629|NCT00447057|157090039|FG003|Overall Study|Death due to adverse event|2|||
48795630|NCT00447057|157090036|FG000|Overall Study|Death, study drug related|0|||
48795631|NCT00447057|157090037|FG001|Overall Study|Death, study drug related|1|||
48795632|NCT00447057|157090038|FG002|Overall Study|Death, study drug related|0|||
48795633|NCT00447057|157090039|FG003|Overall Study|Death, study drug related|0|||
48795634|NCT00160680|157090040|FG000|Overall Study|Adverse Event|0|||
48795635|NCT00160680|157090041|FG001|Overall Study|Adverse Event|1|||
48795636|NCT00160680|157090040|FG000|Overall Study|Lack of Efficacy|2|||
48795637|NCT00160680|157090041|FG001|Overall Study|Lack of Efficacy|1|||
48795638|NCT00160680|157090040|FG000|Overall Study|Lost to Follow-up|3|||
48795639|NCT00160680|157090041|FG001|Overall Study|Lost to Follow-up|2|||
48795640|NCT00160680|157090040|FG000|Overall Study|Withdrawal by Subject|4|||
48795641|NCT00160680|157090041|FG001|Overall Study|Withdrawal by Subject|9|||
48795642|NCT00951041|157090044|FG000|Overall Study|Withdrawal by Subject|1|||
48795643|NCT00951041|157090045|FG001|Overall Study|Withdrawal by Subject|1|||
48795644|NCT00951041|157090044|FG000|Overall Study|Lost to Follow-up|1|||
48795645|NCT00951041|157090045|FG001|Overall Study|Lost to Follow-up|0|||
48795646|NCT00951041|157090044|FG000|Overall Study|Other|3|||
48795647|NCT00951041|157090045|FG001|Overall Study|Other|0|||
48795648|NCT02131272|157090046|FG000|Overall Study|Withdrawal by parent|0|||
48795649|NCT02131272|157090047|FG001|Overall Study|Withdrawal by parent|1|||
48795650|NCT02131272|157090046|FG000|Overall Study|Withdrawal by Subject|0|||
48795651|NCT02131272|157090047|FG001|Overall Study|Withdrawal by Subject|1|||
48795652|NCT02131272|157090046|FG000|Overall Study|Withdrawal Criteria|1|||
48795653|NCT02131272|157090047|FG001|Overall Study|Withdrawal Criteria|0|||
48795654|NCT00381940|157090050|FG000|Overall Study|Lack of Efficacy|3|||
48795655|NCT00381940|157090050|FG000|Overall Study|Protocol Violation|1|||
48795656|NCT00381940|157090050|FG000|Overall Study|Ineligible|1|||
48795657|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
48795658|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
48795659|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
48795660|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
48795661|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
48795662|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
48795663|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
48795664|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
48795665|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
48795666|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
48795667|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
48795668|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
48795669|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
48795670|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
48795671|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
48795672|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
48401955|NCT05956002|155662887|FG002|Treatment Period 3|Adverse Event|1|||
48795673|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
48795674|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
48795675|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
48795676|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
48795677|NCT04162769|157090051|FG000|Double-blind Treatment (12-Week)|Other|0|||
48795678|NCT04162769|157090052|FG001|Double-blind Treatment (12-Week)|Other|1|||
48795679|NCT04162769|157090053|FG002|Double-blind Treatment (12-Week)|Other|1|||
48401956|NCT05956002|155662888|FG003|Treatment Period 3|Adverse Event|0|||
48401957|NCT03338790|155662894|FG000|Overall Study|Disease Progression|65|||
48401958|NCT03338790|155662895|FG001|Overall Study|Disease Progression|43|||
48401959|NCT03338790|155662896|FG002|Overall Study|Disease Progression|50|||
48401960|NCT03338790|155662897|FG003|Overall Study|Disease Progression|37|||
48401961|NCT03338790|155662894|FG000|Overall Study|Study Drug Toxicity|9|||
48401962|NCT03338790|155662895|FG001|Overall Study|Study Drug Toxicity|8|||
48401963|NCT03338790|155662896|FG002|Overall Study|Study Drug Toxicity|15|||
48401964|NCT03338790|155662897|FG003|Overall Study|Study Drug Toxicity|0|||
48401965|NCT03338790|155662894|FG000|Overall Study|Death|1|||
48401966|NCT03338790|155662895|FG001|Overall Study|Death|1|||
48401967|NCT03338790|155662896|FG002|Overall Study|Death|1|||
48401968|NCT03338790|155662897|FG003|Overall Study|Death|0|||
48401969|NCT03338790|155662894|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
48401970|NCT03338790|155662895|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
48401971|NCT03338790|155662896|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
48401972|NCT03338790|155662897|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
48401973|NCT03338790|155662894|FG000|Overall Study|Participant request to discontinue study treatment|3|||
48401974|NCT03338790|155662895|FG001|Overall Study|Participant request to discontinue study treatment|3|||
48401975|NCT03338790|155662896|FG002|Overall Study|Participant request to discontinue study treatment|2|||
48401976|NCT03338790|155662897|FG003|Overall Study|Participant request to discontinue study treatment|1|||
48795680|NCT04162769|157090054|FG003|Double-blind Treatment (12-Week)|Other|0|||
48795681|NCT04162769|157090051|FG000|OLE Period (52-Week)|Adverse Event|0|||
48795682|NCT04162769|157090052|FG001|OLE Period (52-Week)|Adverse Event|0|||
48795683|NCT04162769|157090053|FG002|OLE Period (52-Week)|Adverse Event|0|||
48795684|NCT04162769|157090054|FG003|OLE Period (52-Week)|Adverse Event|5|||
48795685|NCT04162769|157090051|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
48795686|NCT04162769|157090052|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
48795687|NCT04162769|157090053|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
48401977|NCT03338790|155662894|FG000|Overall Study|Poor/non-compliance|0|||
48401978|NCT03338790|155662895|FG001|Overall Study|Poor/non-compliance|1|||
48795688|NCT04162769|157090054|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
48795689|NCT04162769|157090051|FG000|OLE Period (52-Week)|Physician Decision|0|||
48795690|NCT04162769|157090052|FG001|OLE Period (52-Week)|Physician Decision|0|||
48795691|NCT04162769|157090053|FG002|OLE Period (52-Week)|Physician Decision|0|||
48795692|NCT04162769|157090054|FG003|OLE Period (52-Week)|Physician Decision|1|||
48401979|NCT03338790|155662896|FG002|Overall Study|Poor/non-compliance|0|||
48401980|NCT03338790|155662897|FG003|Overall Study|Poor/non-compliance|0|||
48401981|NCT03338790|155662894|FG000|Overall Study|Participant withdrew consent|1|||
48401982|NCT03338790|155662895|FG001|Overall Study|Participant withdrew consent|0|||
48401983|NCT03338790|155662896|FG002|Overall Study|Participant withdrew consent|1|||
48401984|NCT03338790|155662897|FG003|Overall Study|Participant withdrew consent|1|||
48401985|NCT03338790|155662894|FG000|Overall Study|Other reasons|0|||
48401986|NCT03338790|155662895|FG001|Overall Study|Other reasons|5|||
48401987|NCT03338790|155662896|FG002|Overall Study|Other reasons|0|||
48401988|NCT03338790|155662897|FG003|Overall Study|Other reasons|2|||
48401989|NCT03338790|155662894|FG000|Overall Study|Not reported|0|||
48401990|NCT03338790|155662895|FG001|Overall Study|Not reported|0|||
48401991|NCT03338790|155662896|FG002|Overall Study|Not reported|1|||
48401992|NCT03338790|155662897|FG003|Overall Study|Not reported|0|||
48401993|NCT03338790|155662894|FG000|Overall Study|Completed treatment period|1|||
48401994|NCT03338790|155662895|FG001|Overall Study|Completed treatment period|2|||
48795693|NCT04162769|157090051|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
48795694|NCT04162769|157090052|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
48795695|NCT04162769|157090053|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
48795696|NCT04162769|157090054|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
48795697|NCT04162769|157090051|FG000|OLE Period (52-Week)|Protocol deviation|0|||
48795698|NCT04162769|157090052|FG001|OLE Period (52-Week)|Protocol deviation|0|||
48795699|NCT04162769|157090053|FG002|OLE Period (52-Week)|Protocol deviation|0|||
48795700|NCT04162769|157090054|FG003|OLE Period (52-Week)|Protocol deviation|2|||
48795701|NCT01688466|157090055|FG000|Overall Study|Withdrawal by Subject|2|||
48795702|NCT01688466|157090056|FG001|Overall Study|Withdrawal by Subject|1|||
48795703|NCT01688466|157090055|FG000|Overall Study|Death|0|||
48795704|NCT01688466|157090056|FG001|Overall Study|Death|1|||
48795705|NCT01688466|157090055|FG000|Overall Study|Adverse Event|0|||
48795706|NCT01688466|157090056|FG001|Overall Study|Adverse Event|4|||
48795707|NCT01688466|157090055|FG000|Overall Study|Not evaluable|0|||
48795708|NCT01688466|157090056|FG001|Overall Study|Not evaluable|1|||
48795709|NCT02732938|157090059|FG000|Overall Study|Death|0|||
48795710|NCT02732938|157090060|FG001|Overall Study|Death|11|||
48795711|NCT02732938|157090061|FG002|Overall Study|Death|0|||
48795712|NCT02732938|157090059|FG000|Overall Study|Randomized but did not receive treatment|0|||
48795713|NCT02732938|157090060|FG001|Overall Study|Randomized but did not receive treatment|1|||
48795714|NCT02732938|157090061|FG002|Overall Study|Randomized but did not receive treatment|0|||
48795715|NCT02732938|157090059|FG000|Overall Study|Refused further follow-up|1|||
48795716|NCT02732938|157090060|FG001|Overall Study|Refused further follow-up|0|||
48795717|NCT02732938|157090061|FG002|Overall Study|Refused further follow-up|0|||
48795718|NCT02732938|157090059|FG000|Overall Study|Study terminated by sponsor|3|||
48795719|NCT02732938|157090060|FG001|Overall Study|Study terminated by sponsor|6|||
48795720|NCT02732938|157090061|FG002|Overall Study|Study terminated by sponsor|0|||
48795721|NCT01040260|157090062|FG000|Overall Study|Withdrawal by Subject|12|||
48795722|NCT01040260|157090063|FG001|Overall Study|Withdrawal by Subject|6|||
48795723|NCT01040260|157090062|FG000|Overall Study|Lost to Follow-up|3|||
48795724|NCT01040260|157090063|FG001|Overall Study|Lost to Follow-up|5|||
48795725|NCT04124926|157090064|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
48795726|NCT04124926|157090065|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
48795727|NCT04124926|157090066|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
48795728|NCT04124926|157090067|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
48795729|NCT04124926|157090068|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
48795730|NCT04124926|157090064|FG000|Healing Phase|Protocol Violation|0|||
48795731|NCT04124926|157090065|FG001|Healing Phase|Protocol Violation|1|||
48795732|NCT04124926|157090066|FG002|Healing Phase|Protocol Violation|0|||
48401995|NCT03338790|155662896|FG002|Overall Study|Completed treatment period|0|||
48401996|NCT03338790|155662897|FG003|Overall Study|Completed treatment period|0|||
48795733|NCT04124926|157090067|FG003|Healing Phase|Protocol Violation|0|||
48795734|NCT04124926|157090068|FG004|Healing Phase|Protocol Violation|0|||
48401997|NCT05784662|155662898|FG000|Overall Study|Lost to Follow-up|21|||
48795735|NCT04124926|157090064|FG000|Healing Phase|Lost to Follow-up|5|||
48795736|NCT04124926|157090065|FG001|Healing Phase|Lost to Follow-up|4|||
48795737|NCT04124926|157090066|FG002|Healing Phase|Lost to Follow-up|0|||
48795738|NCT04124926|157090067|FG003|Healing Phase|Lost to Follow-up|0|||
48795739|NCT04124926|157090068|FG004|Healing Phase|Lost to Follow-up|0|||
48795740|NCT04124926|157090064|FG000|Healing Phase|Voluntary Withdrawal|10|||
48795741|NCT04124926|157090065|FG001|Healing Phase|Voluntary Withdrawal|7|||
48401998|NCT05784662|155662899|FG001|Overall Study|Lost to Follow-up|17|||
48401999|NCT03665597|155662900|FG000|Period 1|Adverse Event|1|||
48402000|NCT03665597|155662901|FG001|Period 1|Adverse Event|0|||
48402001|NCT03665597|155662902|FG002|Period 1|Adverse Event|0|||
48402002|NCT03665597|155662903|FG003|Period 1|Adverse Event|1|||
48402003|NCT03665597|155662904|FG004|Period 1|Adverse Event|0|||
48402004|NCT03665597|155662905|FG005|Period 1|Adverse Event|0|||
48402005|NCT03665597|155662906|FG006|Period 1|Adverse Event|0|||
48402006|NCT03665597|155662900|FG000|Period 1|Screen Failure|0|||
48402007|NCT03665597|155662901|FG001|Period 1|Screen Failure|0|||
48402008|NCT03665597|155662902|FG002|Period 1|Screen Failure|0|||
48402009|NCT03665597|155662903|FG003|Period 1|Screen Failure|1|||
48402010|NCT03665597|155662904|FG004|Period 1|Screen Failure|0|||
48402011|NCT03665597|155662905|FG005|Period 1|Screen Failure|0|||
48402012|NCT03665597|155662906|FG006|Period 1|Screen Failure|0|||
48402013|NCT03665597|155662900|FG000|Period 1|Death|0|||
48402014|NCT03665597|155662901|FG001|Period 1|Death|0|||
48402015|NCT03665597|155662902|FG002|Period 1|Death|0|||
48402016|NCT03665597|155662903|FG003|Period 1|Death|0|||
48402017|NCT03665597|155662904|FG004|Period 1|Death|0|||
48402018|NCT03665597|155662905|FG005|Period 1|Death|0|||
48795742|NCT04124926|157090066|FG002|Healing Phase|Voluntary Withdrawal|0|||
48795743|NCT04124926|157090067|FG003|Healing Phase|Voluntary Withdrawal|0|||
48795744|NCT04124926|157090068|FG004|Healing Phase|Voluntary Withdrawal|0|||
48795745|NCT04124926|157090064|FG000|Healing Phase|Withdrawal of Consent|5|||
48795746|NCT04124926|157090065|FG001|Healing Phase|Withdrawal of Consent|3|||
48795747|NCT04124926|157090066|FG002|Healing Phase|Withdrawal of Consent|0|||
48795748|NCT04124926|157090067|FG003|Healing Phase|Withdrawal of Consent|0|||
48795749|NCT04124926|157090068|FG004|Healing Phase|Withdrawal of Consent|0|||
48795750|NCT04124926|157090064|FG000|Healing Phase|Miscellaneous|8|||
48795751|NCT04124926|157090065|FG001|Healing Phase|Miscellaneous|7|||
48795752|NCT04124926|157090066|FG002|Healing Phase|Miscellaneous|0|||
48795753|NCT04124926|157090067|FG003|Healing Phase|Miscellaneous|0|||
48795754|NCT04124926|157090068|FG004|Healing Phase|Miscellaneous|0|||
48795755|NCT04124926|157090064|FG000|Healing Phase|Randomized but not Treated|0|||
48795756|NCT04124926|157090065|FG001|Healing Phase|Randomized but not Treated|3|||
48795757|NCT04124926|157090066|FG002|Healing Phase|Randomized but not Treated|0|||
48795758|NCT04124926|157090067|FG003|Healing Phase|Randomized but not Treated|0|||
48795759|NCT04124926|157090068|FG004|Healing Phase|Randomized but not Treated|0|||
48795760|NCT04124926|157090064|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
48795761|NCT04124926|157090065|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
48795762|NCT04124926|157090066|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
48795763|NCT04124926|157090067|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
48795764|NCT04124926|157090068|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
48795765|NCT04124926|157090064|FG000|Maintenance Phase|Protocol Violation|0|||
48795766|NCT04124926|157090065|FG001|Maintenance Phase|Protocol Violation|0|||
48795767|NCT04124926|157090066|FG002|Maintenance Phase|Protocol Violation|3|||
48795768|NCT04124926|157090067|FG003|Maintenance Phase|Protocol Violation|0|||
48795769|NCT04124926|157090068|FG004|Maintenance Phase|Protocol Violation|0|||
48795770|NCT04124926|157090064|FG000|Maintenance Phase|Lost to Follow-up|0|||
48795771|NCT04124926|157090065|FG001|Maintenance Phase|Lost to Follow-up|0|||
48795772|NCT04124926|157090066|FG002|Maintenance Phase|Lost to Follow-up|7|||
48795773|NCT04124926|157090067|FG003|Maintenance Phase|Lost to Follow-up|8|||
48795774|NCT04124926|157090068|FG004|Maintenance Phase|Lost to Follow-up|9|||
48795775|NCT04124926|157090064|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
48795776|NCT04124926|157090065|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
48795777|NCT04124926|157090066|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
48795778|NCT04124926|157090067|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
48795779|NCT04124926|157090068|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
48795780|NCT04124926|157090064|FG000|Maintenance Phase|Pregnancy|0|||
48795781|NCT04124926|157090065|FG001|Maintenance Phase|Pregnancy|0|||
48795782|NCT04124926|157090066|FG002|Maintenance Phase|Pregnancy|0|||
48795783|NCT04124926|157090067|FG003|Maintenance Phase|Pregnancy|1|||
48795784|NCT04124926|157090068|FG004|Maintenance Phase|Pregnancy|0|||
48795785|NCT04124926|157090064|FG000|Maintenance Phase|Lack of Efficacy|0|||
48795786|NCT04124926|157090065|FG001|Maintenance Phase|Lack of Efficacy|0|||
48795787|NCT04124926|157090066|FG002|Maintenance Phase|Lack of Efficacy|0|||
48795788|NCT04124926|157090067|FG003|Maintenance Phase|Lack of Efficacy|0|||
48795789|NCT04124926|157090068|FG004|Maintenance Phase|Lack of Efficacy|1|||
48795790|NCT04124926|157090064|FG000|Maintenance Phase|Withdrawal of Consent|0|||
48795791|NCT04124926|157090065|FG001|Maintenance Phase|Withdrawal of Consent|0|||
48795792|NCT04124926|157090066|FG002|Maintenance Phase|Withdrawal of Consent|5|||
48795793|NCT04124926|157090067|FG003|Maintenance Phase|Withdrawal of Consent|5|||
48795794|NCT04124926|157090068|FG004|Maintenance Phase|Withdrawal of Consent|5|||
48795795|NCT04124926|157090064|FG000|Maintenance Phase|Miscellaneous|0|||
48795796|NCT04124926|157090065|FG001|Maintenance Phase|Miscellaneous|0|||
48795797|NCT04124926|157090066|FG002|Maintenance Phase|Miscellaneous|1|||
48795798|NCT04124926|157090067|FG003|Maintenance Phase|Miscellaneous|2|||
48795799|NCT04124926|157090068|FG004|Maintenance Phase|Miscellaneous|4|||
48402019|NCT03665597|155662906|FG006|Period 1|Death|45|||
48402020|NCT03665597|155662900|FG000|Period 1|Withdrawal by Subject|0|||
48402021|NCT03665597|155662901|FG001|Period 1|Withdrawal by Subject|0|||
48402022|NCT03665597|155662902|FG002|Period 1|Withdrawal by Subject|0|||
48402023|NCT03665597|155662903|FG003|Period 1|Withdrawal by Subject|0|||
48402024|NCT03665597|155662904|FG004|Period 1|Withdrawal by Subject|0|||
48402025|NCT03665597|155662905|FG005|Period 1|Withdrawal by Subject|0|||
48402026|NCT03665597|155662906|FG006|Period 1|Withdrawal by Subject|5|||
48402027|NCT03665597|155662900|FG000|Period 2|Adverse Event|0|||
48402028|NCT03665597|155662901|FG001|Period 2|Adverse Event|0|||
48402029|NCT03665597|155662902|FG002|Period 2|Adverse Event|0|||
48402030|NCT03665597|155662903|FG003|Period 2|Adverse Event|0|||
48795800|NCT04124926|157090064|FG000|Maintenance Phase|Randomized but not Treated|0|||
48795801|NCT04124926|157090065|FG001|Maintenance Phase|Randomized but not Treated|0|||
48795802|NCT04124926|157090066|FG002|Maintenance Phase|Randomized but not Treated|2|||
48795803|NCT04124926|157090067|FG003|Maintenance Phase|Randomized but not Treated|2|||
48795804|NCT04124926|157090068|FG004|Maintenance Phase|Randomized but not Treated|0|||
48795805|NCT00338884|157090069|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
48795806|NCT00338884|157090069|FG000|Overall Study|Adverse Event|14|||
48795807|NCT00338884|157090069|FG000|Overall Study|Death|8|||
48795808|NCT00338884|157090069|FG000|Overall Study|Other|4|||
48795809|NCT00338884|157090069|FG000|Overall Study|Global Deterioration of Health Status|3|||
48795810|NCT00338884|157090069|FG000|Overall Study|Withdrawal by Subject|3|||
48795811|NCT00338884|157090069|FG000|Overall Study|Lost to Follow-up|1|||
48795812|NCT00338884|157090069|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
48795813|NCT04764448|157090071|FG000|Overall Study|Study terminated by sponsor|2|||
48795814|NCT04764448|157090072|FG001|Overall Study|Study terminated by sponsor|2|||
48795815|NCT04764448|157090073|FG002|Overall Study|Study terminated by sponsor|5|||
48795816|NCT04764448|157090071|FG000|Overall Study|Withdrawal by Subject|3|||
48795817|NCT04764448|157090072|FG001|Overall Study|Withdrawal by Subject|3|||
48795818|NCT04764448|157090073|FG002|Overall Study|Withdrawal by Subject|1|||
48795819|NCT05711641|157090074|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
48795820|NCT05711641|157090075|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
48795821|NCT05711641|157090074|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
48795822|NCT05711641|157090075|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
48795823|NCT02243605|157090077|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
48795824|NCT02243605|157090078|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
48795825|NCT02243605|157090077|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
48795826|NCT02243605|157090078|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
48795827|NCT02243605|157090077|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
48795828|NCT02243605|157090078|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
48402031|NCT03665597|155662904|FG004|Period 2|Adverse Event|0|||
48402032|NCT03665597|155662905|FG005|Period 2|Adverse Event|1|||
48402033|NCT03665597|155662906|FG006|Period 2|Adverse Event|0|||
48402034|NCT03665597|155662900|FG000|Period 3|Adverse Event|0|||
48795829|NCT02243605|157090077|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
48795830|NCT02243605|157090078|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
48795831|NCT02243605|157090077|FG000|Stage 2 - Final Analysis Population|Progression|0|||
48795832|NCT02243605|157090078|FG001|Stage 2 - Final Analysis Population|Progression|1|||
48795833|NCT02477111|157090079|FG000|Overall Study|Death|28|||
48795834|NCT02477111|157090079|FG000|Overall Study|Withdrawal by Subject|19|||
48795835|NCT02477111|157090079|FG000|Overall Study|Lost to Follow-up|4|||
48795836|NCT01618864|157090082|FG000|Overall Study|Withdrawal by Subject|2|||
48795837|NCT01618864|157090082|FG000|Overall Study|Lost to Follow-up|2|||
48795838|NCT03178266|157090086|FG000|Overall Study|Death|0|||
48795839|NCT03178266|157090087|FG001|Overall Study|Death|1|||
48795840|NCT03178266|157090086|FG000|Overall Study|Disont. Early|0|||
48795841|NCT03178266|157090087|FG001|Overall Study|Disont. Early|1|||
48795842|NCT03178266|157090086|FG000|Overall Study|Withdrawal by Subject|0|||
48795843|NCT03178266|157090087|FG001|Overall Study|Withdrawal by Subject|2|||
48795844|NCT01749982|157090090|FG000|Overall Study|Physician Decision|0|||
48795845|NCT01749982|157090091|FG001|Overall Study|Physician Decision|0|||
48795846|NCT01749982|157090092|FG002|Overall Study|Physician Decision|0|||
48795847|NCT01749982|157090093|FG003|Overall Study|Physician Decision|1|||
48795848|NCT01749982|157090090|FG000|Overall Study|Lost to Follow-up|0|||
48795849|NCT01749982|157090091|FG001|Overall Study|Lost to Follow-up|0|||
48795850|NCT01749982|157090092|FG002|Overall Study|Lost to Follow-up|0|||
48795851|NCT01749982|157090093|FG003|Overall Study|Lost to Follow-up|1|||
48795852|NCT01749982|157090090|FG000|Overall Study|Withdrawal by Subject|0|||
48795853|NCT01749982|157090091|FG001|Overall Study|Withdrawal by Subject|0|||
48795854|NCT01749982|157090092|FG002|Overall Study|Withdrawal by Subject|0|||
48795855|NCT01749982|157090093|FG003|Overall Study|Withdrawal by Subject|1|||
48795856|NCT00262821|157090095|FG000|Overall Study|Ineligible - wrong stage|0|||
48795857|NCT00262821|157090096|FG001|Overall Study|Ineligible - wrong stage|3|||
48795858|NCT00262821|157090095|FG000|Overall Study|Ineligible - wrong cell type|2|||
48795859|NCT00262821|157090096|FG001|Overall Study|Ineligible - wrong cell type|2|||
48795860|NCT00262821|157090095|FG000|Overall Study|Ineligible - wrong primary|0|||
48795861|NCT00262821|157090096|FG001|Overall Study|Ineligible - wrong primary|1|||
48795862|NCT00262821|157090095|FG000|Overall Study|Ineligible - inadequate pathology|1|||
48795863|NCT00262821|157090096|FG001|Overall Study|Ineligible - inadequate pathology|3|||
48795864|NCT00262821|157090095|FG000|Overall Study|Ineligible - elevated creatinine|0|||
48795865|NCT00262821|157090096|FG001|Overall Study|Ineligible - elevated creatinine|2|||
48795866|NCT00262821|157090095|FG000|Overall Study|Ineligible - required test not done|1|||
48795867|NCT00262821|157090096|FG001|Overall Study|Ineligible - required test not done|4|||
48795868|NCT00262821|157090095|FG000|Overall Study|Inevaluable - inadequate data|0|||
48402035|NCT03665597|155662901|FG001|Period 3|Adverse Event|1|||
48402036|NCT03665597|155662902|FG002|Period 3|Adverse Event|0|||
48402037|NCT03665597|155662903|FG003|Period 3|Adverse Event|0|||
48402038|NCT03665597|155662904|FG004|Period 3|Adverse Event|0|||
48402039|NCT03665597|155662905|FG005|Period 3|Adverse Event|0|||
48795869|NCT00262821|157090096|FG001|Overall Study|Inevaluable - inadequate data|4|||
48795870|NCT01881126|157090097|FG000|Overall Study|Non-compliance|1|||
48795871|NCT01881126|157090098|FG001|Overall Study|Non-compliance|1|||
48795872|NCT01881126|157090097|FG000|Overall Study|Adverse Event|0|||
48795873|NCT01881126|157090098|FG001|Overall Study|Adverse Event|1|||
48795874|NCT04672941|157090099|FG000|Overall Study|Investigator decision|1|||
48795875|NCT04672941|157090099|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
48795876|NCT04672941|157090099|FG000|Overall Study|COVID-19 related but no adverse event|1|||
48795877|NCT04672941|157090099|FG000|Overall Study|Adverse Event|2|||
48795878|NCT04672941|157090099|FG000|Overall Study|Lost to Follow-up|2|||
48795879|NCT00584727|157090103|FG000|First Intervention|Discontinuation|0|||
48402040|NCT03665597|155662906|FG006|Period 3|Adverse Event|0|||
48402041|NCT03665597|155662900|FG000|Period 3|Death|0|||
48795880|NCT00584727|157090104|FG001|First Intervention|Discontinuation|0|||
48795881|NCT00584727|157090105|FG002|First Intervention|Discontinuation|1|||
48795882|NCT00584727|157090106|FG003|First Intervention|Discontinuation|0|||
48795883|NCT00584727|157090107|FG004|First Intervention|Discontinuation|0|||
48795884|NCT00584727|157090108|FG005|First Intervention|Discontinuation|0|||
48795885|NCT00584727|157090103|FG000|Third Intervention|Protocol Violation|0|||
48795886|NCT00584727|157090104|FG001|Third Intervention|Protocol Violation|0|||
48795887|NCT00584727|157090105|FG002|Third Intervention|Protocol Violation|1|||
48795888|NCT00584727|157090106|FG003|Third Intervention|Protocol Violation|0|||
48795889|NCT00584727|157090107|FG004|Third Intervention|Protocol Violation|4|||
48795890|NCT00584727|157090108|FG005|Third Intervention|Protocol Violation|2|||
48795891|NCT01328080|157090109|FG000|Overall Study|Lost to Follow-up|5|||
48795892|NCT02657031|157090110|FG000|Overall Study|Adverse Event|1|||
48795893|NCT02657031|157090111|FG001|Overall Study|Adverse Event|2|||
48795894|NCT00313820|157090115|FG000|Assigned to Treatment|Other|1|||
48795895|NCT00313820|157090116|FG001|Assigned to Treatment|Other|0|||
48795896|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
48795897|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
48795898|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
48795899|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
48795900|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
48795901|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
48795902|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
48795903|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
48795904|NCT00313820|157090115|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
48795905|NCT00313820|157090116|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
48795906|NCT00265889|157090117|FG000|Overall Study|Physician Decision|1|||
48795907|NCT00265889|157090117|FG000|Overall Study|Protocol Violation|1|||
48795908|NCT00265889|157090117|FG000|Overall Study|Insurance denied the request|3|||
48795909|NCT03519854|157090121|FG000|Overall Study|Technical Error|0|||
48795910|NCT03519854|157090122|FG001|Overall Study|Technical Error|0|||
48795911|NCT03519854|157090123|FG002|Overall Study|Technical Error|1|||
48795912|NCT03519854|157090124|FG003|Overall Study|Technical Error|0|||
48795913|NCT03519854|157090125|FG004|Overall Study|Technical Error|0|||
48795914|NCT03519854|157090126|FG005|Overall Study|Technical Error|0|||
48795915|NCT03519854|157090127|FG006|Overall Study|Technical Error|0|||
48795916|NCT03519854|157090128|FG007|Overall Study|Technical Error|0|||
48795917|NCT03519854|157090129|FG008|Overall Study|Technical Error|0|||
48795918|NCT03519854|157090130|FG009|Overall Study|Technical Error|0|||
48795919|NCT03519854|157090131|FG010|Overall Study|Technical Error|0|||
48795920|NCT03519854|157090132|FG011|Overall Study|Technical Error|0|||
48795921|NCT03519854|157090133|FG012|Overall Study|Technical Error|0|||
48795922|NCT03519854|157090134|FG013|Overall Study|Technical Error|0|||
48795923|NCT03519854|157090135|FG014|Overall Study|Technical Error|0|||
48795924|NCT03519854|157090136|FG015|Overall Study|Technical Error|0|||
48795925|NCT03519854|157090137|FG016|Overall Study|Technical Error|0|||
48795926|NCT03519854|157090138|FG017|Overall Study|Technical Error|0|||
48795927|NCT00553696|157090141|FG000|Overall Study|Adverse Event|2|||
48795928|NCT00553696|157090142|FG001|Overall Study|Adverse Event|4|||
48795929|NCT00553696|157090143|FG002|Overall Study|Adverse Event|0|||
48795930|NCT00553696|157090144|FG003|Overall Study|Adverse Event|1|||
48795931|NCT00553696|157090141|FG000|Overall Study|Global deterioration of health status|0|||
48402042|NCT03665597|155662901|FG001|Period 3|Death|0|||
48402043|NCT03665597|155662902|FG002|Period 3|Death|0|||
48402044|NCT03665597|155662903|FG003|Period 3|Death|0|||
48402045|NCT03665597|155662904|FG004|Period 3|Death|1|||
48795932|NCT00553696|157090142|FG001|Overall Study|Global deterioration of health status|2|||
48402046|NCT03665597|155662905|FG005|Period 3|Death|0|||
48402047|NCT03665597|155662906|FG006|Period 3|Death|0|||
48402048|NCT03665597|155662900|FG000|Period 4|Adverse Event|2|||
48402049|NCT03665597|155662901|FG001|Period 4|Adverse Event|2|||
48402050|NCT03665597|155662902|FG002|Period 4|Adverse Event|2|||
48402051|NCT03665597|155662903|FG003|Period 4|Adverse Event|2|||
48402052|NCT03665597|155662904|FG004|Period 4|Adverse Event|1|||
48402053|NCT03665597|155662905|FG005|Period 4|Adverse Event|0|||
48402054|NCT03665597|155662906|FG006|Period 4|Adverse Event|0|||
48402055|NCT03665597|155662900|FG000|Period 4|Death|0|||
48402056|NCT03665597|155662901|FG001|Period 4|Death|0|||
48402057|NCT03665597|155662902|FG002|Period 4|Death|2|||
48402058|NCT03665597|155662903|FG003|Period 4|Death|0|||
48402059|NCT03665597|155662904|FG004|Period 4|Death|0|||
48402060|NCT03665597|155662905|FG005|Period 4|Death|0|||
48795933|NCT00553696|157090143|FG002|Overall Study|Global deterioration of health status|0|||
48402061|NCT03665597|155662906|FG006|Period 4|Death|0|||
48402062|NCT03665597|155662900|FG000|Period 4|Physician Decision|1|||
48402063|NCT03665597|155662901|FG001|Period 4|Physician Decision|2|||
48402064|NCT03665597|155662902|FG002|Period 4|Physician Decision|0|||
48402065|NCT03665597|155662903|FG003|Period 4|Physician Decision|0|||
48402066|NCT03665597|155662904|FG004|Period 4|Physician Decision|0|||
48402067|NCT03665597|155662905|FG005|Period 4|Physician Decision|0|||
48402068|NCT03665597|155662906|FG006|Period 4|Physician Decision|0|||
48402069|NCT04633122|155662907|FG000|Overall Study|Remained on treatment|19|||
48795934|NCT00553696|157090144|FG003|Overall Study|Global deterioration of health status|0|||
48795935|NCT00553696|157090141|FG000|Overall Study|Objective progression or relapse|2|||
48795936|NCT00553696|157090142|FG001|Overall Study|Objective progression or relapse|9|||
48795937|NCT00553696|157090143|FG002|Overall Study|Objective progression or relapse|6|||
48795938|NCT00553696|157090144|FG003|Overall Study|Objective progression or relapse|0|||
48795939|NCT00553696|157090141|FG000|Overall Study|Withdrawal by Subject|0|||
48795940|NCT00553696|157090142|FG001|Overall Study|Withdrawal by Subject|1|||
48795941|NCT00553696|157090143|FG002|Overall Study|Withdrawal by Subject|0|||
48795942|NCT00553696|157090144|FG003|Overall Study|Withdrawal by Subject|0|||
48795943|NCT02747238|157090145|FG000|Overall Study|Lack of Efficacy|0|||
48795944|NCT02747238|157090146|FG001|Overall Study|Lack of Efficacy|1|||
48795945|NCT02747238|157090145|FG000|Overall Study|Data lost|3|||
48795946|NCT02747238|157090146|FG001|Overall Study|Data lost|5|||
48795947|NCT00951275|157090150|FG000|Overall Study|Administrative Reason|1|||
48402070|NCT04633122|155662908|FG001|Overall Study|Remained on treatment|14|||
48795948|NCT00951275|157090150|FG000|Overall Study|Adverse Event|7|||
48402071|NCT04633122|155662907|FG000|Overall Study|Survival follow-up stopped|22|||
48402072|NCT04633122|155662908|FG001|Overall Study|Survival follow-up stopped|25|||
48402073|NCT03694418|155662909|FG000|Overall Study|Lost to Follow-up|115|||
48795949|NCT00951275|157090150|FG000|Overall Study|Withdrawal by Subject|4|||
48795950|NCT00951275|157090150|FG000|Overall Study|Protocol Violation|1|||
48795951|NCT01298999|157090151|FG000|Overall Study|Physician Decision|0|||
48795952|NCT01298999|157090152|FG001|Overall Study|Physician Decision|1|||
48795953|NCT01298999|157090151|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
48795954|NCT01298999|157090152|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
48795955|NCT00803452|157090153|FG000|Overall Study|Adverse Event|0|||
48795956|NCT00803452|157090154|FG001|Overall Study|Adverse Event|2|||
48795957|NCT00803452|157090153|FG000|Overall Study|Lost to Follow-up|0|||
48795958|NCT00803452|157090154|FG001|Overall Study|Lost to Follow-up|3|||
48795959|NCT02816138|157090155|FG000|Overall Study|Adverse Event|1|||
48795960|NCT02693743|157090156|FG000|Overall Study|Physician Decision|1|||
48795961|NCT02693743|157090157|FG001|Overall Study|Physician Decision|0|||
48795962|NCT04157517|157090158|FG000|Overall Study|Death|1|||
48795963|NCT04157517|157090159|FG001|Overall Study|Death|2|||
48795964|NCT04157517|157090160|FG002|Overall Study|Death|2|||
48795965|NCT04157517|157090161|FG003|Overall Study|Death|3|||
48795966|NCT04157517|157090162|FG004|Overall Study|Death|3|||
48795967|NCT04157517|157090163|FG005|Overall Study|Death|4|||
48795968|NCT04157517|157090164|FG006|Overall Study|Death|1|||
48795969|NCT04157517|157090165|FG007|Overall Study|Death|2|||
48795970|NCT04157517|157090166|FG008|Overall Study|Death|4|||
48795971|NCT04157517|157090167|FG009|Overall Study|Death|0|||
48795972|NCT04157517|157090158|FG000|Overall Study|Withdrawal by Subject|1|||
48795973|NCT04157517|157090159|FG001|Overall Study|Withdrawal by Subject|1|||
48795974|NCT04157517|157090160|FG002|Overall Study|Withdrawal by Subject|1|||
48795975|NCT04157517|157090161|FG003|Overall Study|Withdrawal by Subject|0|||
48795976|NCT04157517|157090162|FG004|Overall Study|Withdrawal by Subject|0|||
48795977|NCT04157517|157090163|FG005|Overall Study|Withdrawal by Subject|1|||
48795978|NCT04157517|157090164|FG006|Overall Study|Withdrawal by Subject|0|||
48795979|NCT04157517|157090165|FG007|Overall Study|Withdrawal by Subject|0|||
48795980|NCT04157517|157090166|FG008|Overall Study|Withdrawal by Subject|1|||
48795981|NCT04157517|157090167|FG009|Overall Study|Withdrawal by Subject|0|||
48795982|NCT04157517|157090158|FG000|Overall Study|Other|1|||
48795983|NCT04157517|157090159|FG001|Overall Study|Other|0|||
48795984|NCT04157517|157090160|FG002|Overall Study|Other|0|||
48795985|NCT04157517|157090161|FG003|Overall Study|Other|0|||
48795986|NCT04157517|157090162|FG004|Overall Study|Other|0|||
48795987|NCT04157517|157090163|FG005|Overall Study|Other|1|||
48795988|NCT04157517|157090164|FG006|Overall Study|Other|2|||
48795989|NCT04157517|157090165|FG007|Overall Study|Other|7|||
48795990|NCT04157517|157090166|FG008|Overall Study|Other|7|||
48795991|NCT04157517|157090167|FG009|Overall Study|Other|0|||
48795992|NCT00924287|157091413|FG000|Overall Study|Death|1|||
48795993|NCT02030015|157091417|FG000|Overall Study|Withdrawal by Subject|3|||
48795994|NCT02030015|157091417|FG000|Overall Study|Death|13|||
48795995|NCT01258608|157091418|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
48795996|NCT01258608|157091419|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
48795997|NCT01258608|157091418|FG000|Overall Study|Clinical progression|1|||
48795998|NCT01258608|157091419|FG001|Overall Study|Clinical progression|0|||
48795999|NCT01258608|157091418|FG000|Overall Study|Sponsor decision|0|||
48796000|NCT01258608|157091419|FG001|Overall Study|Sponsor decision|1|||
48796001|NCT01258608|157091418|FG000|Overall Study|Physician Decision|6|||
48796002|NCT01258608|157091419|FG001|Overall Study|Physician Decision|1|||
48796003|NCT01258608|157091418|FG000|Overall Study|Lost to Follow-up|0|||
48796004|NCT01258608|157091419|FG001|Overall Study|Lost to Follow-up|1|||
48796005|NCT01258608|157091418|FG000|Overall Study|Lack of compliance|1|||
48796006|NCT01258608|157091419|FG001|Overall Study|Lack of compliance|0|||
48796007|NCT01258608|157091418|FG000|Overall Study|Lack of Efficacy|0|||
48796008|NCT01258608|157091419|FG001|Overall Study|Lack of Efficacy|1|||
48796009|NCT01258608|157091418|FG000|Overall Study|Adverse Event|6|||
48796010|NCT01258608|157091419|FG001|Overall Study|Adverse Event|10|||
48796011|NCT01258608|157091418|FG000|Overall Study|Withdrawal by Subject|6|||
48796012|NCT01258608|157091419|FG001|Overall Study|Withdrawal by Subject|5|||
48796013|NCT01332227|157091420|FG000|Overall Study|Adverse Event|4|||
48796014|NCT01332227|157091421|FG001|Overall Study|Adverse Event|1|||
48796015|NCT01332227|157091420|FG000|Overall Study|Withdrawal by Subject|5|||
48796016|NCT01332227|157091421|FG001|Overall Study|Withdrawal by Subject|1|||
48796017|NCT01332227|157091420|FG000|Overall Study|Lost to Follow-up|2|||
48796018|NCT01332227|157091421|FG001|Overall Study|Lost to Follow-up|0|||
48796019|NCT01332227|157091420|FG000|Overall Study|Lack of Efficacy|3|||
48796020|NCT01332227|157091421|FG001|Overall Study|Lack of Efficacy|1|||
48796021|NCT01332227|157091420|FG000|Overall Study|Poor compliance/noncompliance|1|||
48796022|NCT01332227|157091421|FG001|Overall Study|Poor compliance/noncompliance|1|||
48796023|NCT01332227|157091420|FG000|Overall Study|Patient moved from area|1|||
48796024|NCT01332227|157091421|FG001|Overall Study|Patient moved from area|0|||
48796025|NCT01332227|157091420|FG000|Overall Study|Patient began prohibited medication|0|||
48796026|NCT01332227|157091421|FG001|Overall Study|Patient began prohibited medication|1|||
48402074|NCT03694418|155662910|FG001|Overall Study|Lost to Follow-up|23|||
48402075|NCT03694418|155662911|FG002|Overall Study|Lost to Follow-up|12|||
48402076|NCT03694418|155662912|FG003|Overall Study|Lost to Follow-up|12|||
48402077|NCT03694418|155662913|FG004|Overall Study|Lost to Follow-up|13|||
48402078|NCT05399459|155662914|FG000|Overall Study|Randomized but not treated|29|||
48402079|NCT05399459|155662915|FG001|Overall Study|Randomized but not treated|30|||
48402080|NCT05399459|155662916|FG002|Overall Study|Randomized but not treated|38|||
48402081|NCT05399459|155662914|FG000|Overall Study|Lost to Follow-up|1|||
48402082|NCT05399459|155662915|FG001|Overall Study|Lost to Follow-up|0|||
48402083|NCT05399459|155662916|FG002|Overall Study|Lost to Follow-up|0|||
48402084|NCT00774345|155662919|FG000|Pre-treatment|Other reasons|2|||
48402085|NCT00774345|155662920|FG001|Pre-treatment|Other reasons|0|||
48402086|NCT00774345|155662919|FG000|Treatment|Adverse Event|61|||
48402087|NCT00774345|155662920|FG001|Treatment|Adverse Event|15|||
48402088|NCT00774345|155662919|FG000|Treatment|Progressive Disease without histologic transformation|51|||
48402089|NCT00774345|155662920|FG001|Treatment|Progressive Disease without histologic transformation|111|||
48402090|NCT00774345|155662919|FG000|Treatment|Progressive Disease with histologic transformation|4|||
48402091|NCT00774345|155662920|FG001|Treatment|Progressive Disease with histologic transformation|2|||
48402092|NCT00774345|155662919|FG000|Treatment|Withdrawal by Subject|5|||
48402093|NCT00774345|155662920|FG001|Treatment|Withdrawal by Subject|2|||
48402094|NCT00774345|155662919|FG000|Treatment|Lost to Follow-up|1|||
48402095|NCT00774345|155662920|FG001|Treatment|Lost to Follow-up|1|||
48402096|NCT00774345|155662919|FG000|Treatment|Death|4|||
48402097|NCT00774345|155662920|FG001|Treatment|Death|0|||
48402098|NCT00774345|155662919|FG000|Treatment|Other Reasons|32|||
48796027|NCT02943408|157091424|FG000|Overall Study|Lost to Follow-up|7|||
48796028|NCT02943408|157091425|FG001|Overall Study|Lost to Follow-up|1|||
48796029|NCT02943408|157091424|FG000|Overall Study|Withdrawal by Subject|0|||
48796030|NCT02943408|157091425|FG001|Overall Study|Withdrawal by Subject|1|||
48796031|NCT00886340|157091433|FG000|Overall Study|Withdrawal by Subject|0|||
48796032|NCT00886340|157091434|FG001|Overall Study|Withdrawal by Subject|7|||
48796033|NCT02338154|157091435|FG000|Overall Study|Death|46|||
48402099|NCT00774345|155662920|FG001|Treatment|Other Reasons|26|||
48402100|NCT01127165|155662923|FG000|Overall Study|Adverse Event|2|||
48402101|NCT01127165|155662924|FG001|Overall Study|Adverse Event|2|||
48402102|NCT01127165|155662923|FG000|Overall Study|Lack of Efficacy|10|||
48402103|NCT01127165|155662924|FG001|Overall Study|Lack of Efficacy|8|||
48402104|NCT01127165|155662923|FG000|Overall Study|Lost to Follow-up|3|||
48402105|NCT01127165|155662924|FG001|Overall Study|Lost to Follow-up|5|||
48402106|NCT01127165|155662923|FG000|Overall Study|Withdrawal by Subject|1|||
48402107|NCT01127165|155662924|FG001|Overall Study|Withdrawal by Subject|3|||
48402108|NCT01127165|155662923|FG000|Overall Study|Protocol Violation|0|||
48402109|NCT01127165|155662924|FG001|Overall Study|Protocol Violation|1|||
48402110|NCT02387580|155662926|FG000|Overall Study|Withdrawal by Subject|0|||
48402111|NCT02387580|155662927|FG001|Overall Study|Withdrawal by Subject|0|||
48402112|NCT02387580|155662928|FG002|Overall Study|Withdrawal by Subject|0|||
48402113|NCT02387580|155662929|FG003|Overall Study|Withdrawal by Subject|1|||
48402114|NCT02387580|155662930|FG004|Overall Study|Withdrawal by Subject|0|||
48402115|NCT02387580|155662931|FG005|Overall Study|Withdrawal by Subject|0|||
48402116|NCT01580397|155662932|FG000|Overall Study|Lack of Efficacy|14|||
48402117|NCT04745676|155662933|FG000|Overall Study|Death|1|||
48402118|NCT04745676|155662934|FG001|Overall Study|Death|0|||
48402119|NCT04745676|155662935|FG002|Overall Study|Death|0|||
48402120|NCT04589650|155662940|FG000|Overall Study|Subject decision|6|||
48402121|NCT04589650|155662941|FG001|Overall Study|Subject decision|2|||
48402122|NCT04589650|155662942|FG002|Overall Study|Subject decision|2|||
48796034|NCT02338154|157091435|FG000|Overall Study|Valve Implant Failure|17|||
48796035|NCT02338154|157091435|FG000|Overall Study|Valve Explant|11|||
48796036|NCT02338154|157091435|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
48796037|NCT02338154|157091435|FG000|Overall Study|Lost to Follow-up|8|||
48796038|NCT02338154|157091435|FG000|Overall Study|Other Reason|3|||
48796039|NCT02338154|157091435|FG000|Overall Study|Patients Without Exit Form|47|||
48796040|NCT02338154|157091435|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
48796041|NCT02822222|157091436|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
48796042|NCT02822222|157091437|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
48402123|NCT04589650|155662943|FG003|Overall Study|Subject decision|0|||
48402124|NCT04589650|155662944|FG004|Overall Study|Subject decision|0|||
48402125|NCT04589650|155662945|FG005|Overall Study|Subject decision|0|||
48402126|NCT04589650|155662940|FG000|Overall Study|Adverse Event|3|||
48402127|NCT04589650|155662941|FG001|Overall Study|Adverse Event|1|||
48402128|NCT04589650|155662942|FG002|Overall Study|Adverse Event|1|||
48402129|NCT04589650|155662943|FG003|Overall Study|Adverse Event|1|||
48796043|NCT00440531|157091438|FG000|Overall Study|Adverse Event|1|||
48402130|NCT04589650|155662944|FG004|Overall Study|Adverse Event|0|||
48402131|NCT04589650|155662945|FG005|Overall Study|Adverse Event|1|||
48402132|NCT04589650|155662940|FG000|Overall Study|Physician Decision|1|||
48402133|NCT04589650|155662941|FG001|Overall Study|Physician Decision|1|||
48402134|NCT04589650|155662942|FG002|Overall Study|Physician Decision|0|||
48796044|NCT00440531|157091439|FG001|Overall Study|Adverse Event|0|||
48796045|NCT00440531|157091440|FG002|Overall Study|Adverse Event|2|||
48796046|NCT00440531|157091438|FG000|Overall Study|Withdrawal by Subject|2|||
48796047|NCT00440531|157091439|FG001|Overall Study|Withdrawal by Subject|0|||
48796048|NCT00440531|157091440|FG002|Overall Study|Withdrawal by Subject|0|||
48796049|NCT00440531|157091438|FG000|Overall Study|Protocol Violation|1|||
48796050|NCT00440531|157091439|FG001|Overall Study|Protocol Violation|2|||
48796051|NCT00440531|157091440|FG002|Overall Study|Protocol Violation|0|||
48796052|NCT00440531|157091438|FG000|Overall Study|Lost to Follow-up|4|||
48796053|NCT00440531|157091439|FG001|Overall Study|Lost to Follow-up|3|||
48796054|NCT00440531|157091440|FG002|Overall Study|Lost to Follow-up|5|||
48796055|NCT00440531|157091438|FG000|Overall Study|see pre-assignment details|2|||
48796056|NCT00440531|157091439|FG001|Overall Study|see pre-assignment details|0|||
48796057|NCT00440531|157091440|FG002|Overall Study|see pre-assignment details|0|||
48796058|NCT03561090|157091449|FG000|Overall Study|Adverse Event|11|||
48796059|NCT03561090|157091450|FG001|Overall Study|Adverse Event|7|||
48796060|NCT03561090|157091449|FG000|Overall Study|Non-Compliance With Study Drug|2|||
48796061|NCT03561090|157091450|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48796062|NCT03561090|157091449|FG000|Overall Study|Protocol Violation|2|||
48796063|NCT03561090|157091450|FG001|Overall Study|Protocol Violation|2|||
48796064|NCT03561090|157091449|FG000|Overall Study|Withdrawal by Subject|7|||
48796065|NCT03561090|157091450|FG001|Overall Study|Withdrawal by Subject|7|||
48796066|NCT03561090|157091449|FG000|Overall Study|Lost to Follow-up|7|||
48796067|NCT03561090|157091450|FG001|Overall Study|Lost to Follow-up|2|||
48402135|NCT04589650|155662943|FG003|Overall Study|Physician Decision|0|||
48402136|NCT04589650|155662944|FG004|Overall Study|Physician Decision|0|||
48402137|NCT04589650|155662945|FG005|Overall Study|Physician Decision|0|||
48796068|NCT03561090|157091449|FG000|Overall Study|Study Terminated by Sponsor|10|||
48796069|NCT03561090|157091450|FG001|Overall Study|Study Terminated by Sponsor|15|||
48796070|NCT03561090|157091449|FG000|Overall Study|Randomized by Mistake|1|||
48796071|NCT03561090|157091450|FG001|Overall Study|Randomized by Mistake|1|||
48796072|NCT03561090|157091449|FG000|Overall Study|Other Not Specified|0|||
48402138|NCT04589650|155662940|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48402139|NCT04589650|155662941|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48402140|NCT04589650|155662942|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48402141|NCT04589650|155662943|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48402142|NCT04589650|155662944|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
48402143|NCT04589650|155662945|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
48402144|NCT04589650|155662940|FG000|Overall Study|Death|0|||
48402145|NCT04589650|155662941|FG001|Overall Study|Death|0|||
48402146|NCT04589650|155662942|FG002|Overall Study|Death|0|||
48402147|NCT04589650|155662943|FG003|Overall Study|Death|1|||
48402148|NCT04589650|155662944|FG004|Overall Study|Death|0|||
48402149|NCT04589650|155662945|FG005|Overall Study|Death|0|||
48402150|NCT04589650|155662940|FG000|Overall Study|Guardian Decision|0|||
48796073|NCT03561090|157091450|FG001|Overall Study|Other Not Specified|2|||
48796074|NCT01270347|157091457|FG000|Core Phase|Adverse Event|1|||
48796075|NCT01270347|157091458|FG001|Core Phase|Adverse Event|6|||
48796076|NCT01270347|157091457|FG000|Core Phase|Withdrawal by Subject|1|||
48796077|NCT01270347|157091458|FG001|Core Phase|Withdrawal by Subject|2|||
48796078|NCT01270347|157091457|FG000|Core Phase|Lost to Follow-up|0|||
48796079|NCT01270347|157091458|FG001|Core Phase|Lost to Follow-up|1|||
48796080|NCT01270347|157091457|FG000|Core Phase|Miscellaneous|8|||
48796081|NCT01270347|157091458|FG001|Core Phase|Miscellaneous|14|||
48796082|NCT01270347|157091457|FG000|Extension Phase|Adverse Event|1|||
48796083|NCT01270347|157091458|FG001|Extension Phase|Adverse Event|3|||
48796084|NCT01270347|157091457|FG000|Extension Phase|Withdrawal by Subject|3|||
48796085|NCT01270347|157091458|FG001|Extension Phase|Withdrawal by Subject|4|||
48796086|NCT01270347|157091457|FG000|Extension Phase|Miscellaneous|2|||
48796087|NCT01270347|157091458|FG001|Extension Phase|Miscellaneous|2|||
48796088|NCT02612311|157091459|FG000|Overall Study|Adverse Event|16|||
48796089|NCT02612311|157091460|FG001|Overall Study|Adverse Event|12|||
48796090|NCT02612311|157091461|FG002|Overall Study|Adverse Event|7|||
48796091|NCT02612311|157091462|FG003|Overall Study|Adverse Event|13|||
48796092|NCT02612311|157091459|FG000|Overall Study|Death|29|||
48796093|NCT02612311|157091460|FG001|Overall Study|Death|10|||
48402151|NCT04589650|155662941|FG001|Overall Study|Guardian Decision|0|||
48402152|NCT04589650|155662942|FG002|Overall Study|Guardian Decision|0|||
48402153|NCT04589650|155662943|FG003|Overall Study|Guardian Decision|1|||
48796094|NCT02612311|157091461|FG002|Overall Study|Death|11|||
48796095|NCT02612311|157091462|FG003|Overall Study|Death|11|||
48796096|NCT02612311|157091459|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
48796097|NCT02612311|157091460|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
48796098|NCT02612311|157091461|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
48796099|NCT02612311|157091462|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
48796100|NCT02612311|157091459|FG000|Overall Study|Investigator's Decision|11|||
48402154|NCT04589650|155662944|FG004|Overall Study|Guardian Decision|0|||
48402155|NCT04589650|155662945|FG005|Overall Study|Guardian Decision|0|||
48402156|NCT00687362|155664474|FG000|Overall Study|Protocol Violation|2|||
48402157|NCT00687362|155664474|FG000|Overall Study|Withdrawal by Subject|1|||
48402158|NCT01882907|155664475|FG000|Overall Study|Adverse Event|3|||
48402159|NCT01882907|155664476|FG001|Overall Study|Adverse Event|1|||
48402160|NCT01882907|155664475|FG000|Overall Study|Lack of Efficacy|0|||
48402161|NCT01882907|155664476|FG001|Overall Study|Lack of Efficacy|3|||
48402162|NCT01882907|155664475|FG000|Overall Study|Lost to Follow-up|1|||
48402163|NCT01882907|155664476|FG001|Overall Study|Lost to Follow-up|4|||
48402164|NCT01882907|155664475|FG000|Overall Study|Protocol Violation|10|||
48402165|NCT01882907|155664476|FG001|Overall Study|Protocol Violation|14|||
48402166|NCT01882907|155664475|FG000|Overall Study|Withdrawal by Subject|0|||
48402167|NCT01882907|155664476|FG001|Overall Study|Withdrawal by Subject|6|||
48402168|NCT05019131|155664477|FG000|Overall Study|Lost to Follow-up|0|||
48402169|NCT05019131|155664478|FG001|Overall Study|Lost to Follow-up|3|||
48402170|NCT02513329|155664479|FG000|Overall Study|Lost to Follow-up|5|||
48402171|NCT02513329|155664480|FG001|Overall Study|Lost to Follow-up|2|||
48402172|NCT02083380|155664481|FG000|Overall Study|Lack of Efficacy|68|||
48402173|NCT02083380|155664482|FG001|Overall Study|Lack of Efficacy|79|||
48402174|NCT02083380|155664483|FG002|Overall Study|Lack of Efficacy|64|||
48402175|NCT02083380|155664481|FG000|Overall Study|Withdrawal by Subject|9|||
48402176|NCT02083380|155664482|FG001|Overall Study|Withdrawal by Subject|3|||
48796101|NCT02612311|157091460|FG001|Overall Study|Investigator's Decision|15|||
48796102|NCT02612311|157091461|FG002|Overall Study|Investigator's Decision|6|||
48796103|NCT02612311|157091462|FG003|Overall Study|Investigator's Decision|6|||
48796104|NCT02612311|157091459|FG000|Overall Study|Lack of Efficacy|0|||
48796105|NCT02612311|157091460|FG001|Overall Study|Lack of Efficacy|0|||
48796106|NCT02612311|157091461|FG002|Overall Study|Lack of Efficacy|1|||
48796107|NCT02612311|157091462|FG003|Overall Study|Lack of Efficacy|1|||
48796108|NCT02612311|157091459|FG000|Overall Study|Lost to Follow-up|2|||
48796109|NCT02612311|157091460|FG001|Overall Study|Lost to Follow-up|2|||
48796110|NCT02612311|157091461|FG002|Overall Study|Lost to Follow-up|1|||
48796111|NCT02612311|157091462|FG003|Overall Study|Lost to Follow-up|2|||
48796112|NCT02612311|157091459|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
48796113|NCT02612311|157091460|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
48796114|NCT02612311|157091461|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
48796115|NCT02612311|157091462|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
48796116|NCT02612311|157091459|FG000|Overall Study|Site Terminated by Sponsor|29|||
48796117|NCT02612311|157091460|FG001|Overall Study|Site Terminated by Sponsor|12|||
48796118|NCT02612311|157091461|FG002|Overall Study|Site Terminated by Sponsor|13|||
48796119|NCT02612311|157091462|FG003|Overall Study|Site Terminated by Sponsor|5|||
48796120|NCT02612311|157091459|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
48402177|NCT02083380|155664483|FG002|Overall Study|Withdrawal by Subject|7|||
48402178|NCT02083380|155664481|FG000|Overall Study|Physician Decision|1|||
48402179|NCT02083380|155664482|FG001|Overall Study|Physician Decision|6|||
48402180|NCT02083380|155664483|FG002|Overall Study|Physician Decision|3|||
48402181|NCT02083380|155664481|FG000|Overall Study|Adverse Event|0|||
48402182|NCT02083380|155664482|FG001|Overall Study|Adverse Event|0|||
48402183|NCT02083380|155664483|FG002|Overall Study|Adverse Event|1|||
48402184|NCT02083380|155664481|FG000|Overall Study|Lost to Follow-up|5|||
48402185|NCT02083380|155664482|FG001|Overall Study|Lost to Follow-up|3|||
48796121|NCT02612311|157091460|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
48796122|NCT02612311|157091461|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
48796123|NCT02612311|157091462|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
48796124|NCT02612311|157091459|FG000|Overall Study|Reason Not Specified|3|||
48796125|NCT02612311|157091460|FG001|Overall Study|Reason Not Specified|7|||
48796126|NCT02612311|157091461|FG002|Overall Study|Reason Not Specified|4|||
48796127|NCT02612311|157091462|FG003|Overall Study|Reason Not Specified|5|||
48796128|NCT02612311|157091459|FG000|Overall Study|Unknown/Missing|10|||
48796129|NCT02612311|157091460|FG001|Overall Study|Unknown/Missing|13|||
48796130|NCT02612311|157091461|FG002|Overall Study|Unknown/Missing|4|||
48796131|NCT02612311|157091462|FG003|Overall Study|Unknown/Missing|0|||
48796132|NCT02612311|157091459|FG000|Overall Study|Non-Compliance with Study|1|||
48796133|NCT02612311|157091460|FG001|Overall Study|Non-Compliance with Study|0|||
48796134|NCT02612311|157091461|FG002|Overall Study|Non-Compliance with Study|0|||
48796135|NCT02612311|157091462|FG003|Overall Study|Non-Compliance with Study|0|||
48796136|NCT02862457|157091465|FG000|Overall Study|Death|1|||
48402186|NCT02083380|155664483|FG002|Overall Study|Lost to Follow-up|3|||
48402187|NCT02083380|155664481|FG000|Overall Study|Other|8|||
48402188|NCT02083380|155664482|FG001|Overall Study|Other|4|||
48402189|NCT02083380|155664483|FG002|Overall Study|Other|6|||
48402190|NCT00168831|155664484|FG000|Overall Study|Adverse Event|36|||
48402191|NCT00168831|155664485|FG001|Overall Study|Adverse Event|47|||
48402192|NCT00168831|155664486|FG002|Overall Study|Adverse Event|74|||
48796137|NCT02862457|157091466|FG001|Overall Study|Death|3|||
48796138|NCT02862457|157091467|FG002|Overall Study|Death|2|||
48796139|NCT02862457|157091468|FG003|Overall Study|Death|3|||
48796140|NCT02862457|157091469|FG004|Overall Study|Death|0|||
48796141|NCT02862457|157091470|FG005|Overall Study|Death|2|||
48796142|NCT02862457|157091471|FG006|Overall Study|Death|1|||
48796143|NCT02862457|157091465|FG000|Overall Study|Lost to Follow-up|1|||
48796144|NCT02862457|157091466|FG001|Overall Study|Lost to Follow-up|0|||
48796145|NCT02862457|157091467|FG002|Overall Study|Lost to Follow-up|0|||
48796146|NCT02862457|157091468|FG003|Overall Study|Lost to Follow-up|1|||
48796147|NCT02862457|157091469|FG004|Overall Study|Lost to Follow-up|0|||
48796148|NCT02862457|157091470|FG005|Overall Study|Lost to Follow-up|0|||
48796149|NCT02862457|157091471|FG006|Overall Study|Lost to Follow-up|0|||
48796150|NCT02862457|157091465|FG000|Overall Study|Withdrawal by Subject|0|||
48796151|NCT02862457|157091466|FG001|Overall Study|Withdrawal by Subject|0|||
48796152|NCT02862457|157091467|FG002|Overall Study|Withdrawal by Subject|1|||
48796153|NCT02862457|157091468|FG003|Overall Study|Withdrawal by Subject|0|||
48796154|NCT02862457|157091469|FG004|Overall Study|Withdrawal by Subject|0|||
48796155|NCT02862457|157091470|FG005|Overall Study|Withdrawal by Subject|1|||
48796156|NCT02862457|157091471|FG006|Overall Study|Withdrawal by Subject|0|||
48796157|NCT00743366|157091473|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
48796158|NCT00743366|157091474|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
48796159|NCT01799265|157091475|FG000|Overall Study|Lost to Follow-up|1|||
48796160|NCT01799265|157091476|FG001|Overall Study|Lost to Follow-up|0|||
48796161|NCT01799265|157091475|FG000|Overall Study|Protocol Violation|2|||
48796162|NCT01799265|157091476|FG001|Overall Study|Protocol Violation|1|||
48796163|NCT01799265|157091475|FG000|Overall Study|inadequate sleep study|0|||
48402193|NCT00168831|155664484|FG000|Overall Study|Lost to Follow-up|5|||
48402194|NCT00168831|155664485|FG001|Overall Study|Lost to Follow-up|6|||
48402195|NCT00168831|155664486|FG002|Overall Study|Lost to Follow-up|4|||
48402196|NCT00168831|155664484|FG000|Overall Study|Withdrawal by Subject|7|||
48402197|NCT00168831|155664485|FG001|Overall Study|Withdrawal by Subject|14|||
48402198|NCT00168831|155664486|FG002|Overall Study|Withdrawal by Subject|19|||
48402199|NCT00168831|155664484|FG000|Overall Study|Protocol Violation|6|||
48402200|NCT00168831|155664485|FG001|Overall Study|Protocol Violation|11|||
48402201|NCT00168831|155664486|FG002|Overall Study|Protocol Violation|11|||
48402202|NCT00168831|155664484|FG000|Overall Study|Other|6|||
48402203|NCT00168831|155664485|FG001|Overall Study|Other|3|||
48402204|NCT00168831|155664486|FG002|Overall Study|Other|6|||
48402205|NCT02450487|155664487|FG000|Overall Study|Lost to Follow-up|3|||
48402206|NCT01790048|155664488|FG000|Overall Study|Incorrect Age|9|||
48402207|NCT01790048|155664489|FG001|Overall Study|Incorrect Age|14|||
48402208|NCT01790048|155664488|FG000|Overall Study|data entry error|0|||
48402209|NCT01790048|155664489|FG001|Overall Study|data entry error|1|||
48402210|NCT01790048|155664488|FG000|Overall Study|Other|0|||
48402211|NCT01790048|155664489|FG001|Overall Study|Other|2|||
48402212|NCT01790048|155664488|FG000|Overall Study|SAM at Enrollment|2|||
48402213|NCT01790048|155664489|FG001|Overall Study|SAM at Enrollment|0|||
48402214|NCT01790048|155664488|FG000|Overall Study|Measurement error|1|||
48402215|NCT01790048|155664489|FG001|Overall Study|Measurement error|0|||
48402216|NCT01289015|155664490|FG000|Overall Study|Protocol Violation|12|||
48402217|NCT01289015|155664491|FG001|Overall Study|Protocol Violation|9|||
48402218|NCT01289015|155664490|FG000|Overall Study|Adverse Event|3|||
48402219|NCT01289015|155664491|FG001|Overall Study|Adverse Event|0|||
48402220|NCT01289015|155664490|FG000|Overall Study|Lost to Follow-up|33|||
48402221|NCT01289015|155664491|FG001|Overall Study|Lost to Follow-up|17|||
48796164|NCT01799265|157091476|FG001|Overall Study|inadequate sleep study|2|||
48796165|NCT00003298|157091477|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
48796166|NCT00003298|157091477|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
48796167|NCT00003298|157091477|FG000|Surgery|Unresectable at surgery|3|||
48796168|NCT00003298|157091477|FG000|Surgery|Progression before surgery|2|||
48796169|NCT00003298|157091477|FG000|Surgery|Unevaluable and off study|2|||
48796170|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
48796171|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
48796172|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
48796173|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
48796174|NCT00003298|157091477|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
48796175|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
48796176|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
48796177|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
48796178|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
48796179|NCT00003298|157091477|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
48796180|NCT00514735|157091478|FG000|Overall Study|Withdrawal by Subject|13|||
48796181|NCT00514735|157091479|FG001|Overall Study|Withdrawal by Subject|5|||
48796182|NCT00514735|157091478|FG000|Overall Study|Death|1|||
48796183|NCT00514735|157091479|FG001|Overall Study|Death|0|||
48796184|NCT00514735|157091478|FG000|Overall Study|Lost to Follow-up|0|||
48796185|NCT00514735|157091479|FG001|Overall Study|Lost to Follow-up|1|||
48796186|NCT00335322|157091480|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
48796187|NCT00335322|157091481|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
48796188|NCT00335322|157091482|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
48796189|NCT02308748|157091485|FG000|Period 1|Withdrawal by Subject|0|||
48796190|NCT02308748|157091486|FG001|Period 1|Withdrawal by Subject|0|||
48796191|NCT02308748|157091487|FG002|Period 1|Withdrawal by Subject|1|||
48796192|NCT02308748|157091488|FG003|Period 1|Withdrawal by Subject|0|||
48796193|NCT02308748|157091489|FG004|Period 1|Withdrawal by Subject|0|||
48796194|NCT02308748|157091490|FG005|Period 1|Withdrawal by Subject|0|||
48796195|NCT02308748|157091491|FG006|Period 1|Withdrawal by Subject|0|||
48796196|NCT02308748|157091492|FG007|Period 1|Withdrawal by Subject|0|||
48796197|NCT02308748|157091493|FG008|Period 1|Withdrawal by Subject|0|||
48796198|NCT02308748|157091494|FG009|Period 1|Withdrawal by Subject|0|||
48796199|NCT02308748|157091485|FG000|Period 2|Adverse Event|0|||
48796200|NCT02308748|157091486|FG001|Period 2|Adverse Event|0|||
48796201|NCT02308748|157091487|FG002|Period 2|Adverse Event|0|||
48796202|NCT02308748|157091488|FG003|Period 2|Adverse Event|0|||
48796203|NCT02308748|157091489|FG004|Period 2|Adverse Event|0|||
48796204|NCT02308748|157091490|FG005|Period 2|Adverse Event|0|||
48796205|NCT02308748|157091491|FG006|Period 2|Adverse Event|0|||
48796206|NCT02308748|157091492|FG007|Period 2|Adverse Event|1|||
48796207|NCT02308748|157091493|FG008|Period 2|Adverse Event|0|||
48796208|NCT02308748|157091494|FG009|Period 2|Adverse Event|0|||
48796209|NCT02308748|157091485|FG000|Period 3|Protocol Violation|0|||
48796210|NCT02308748|157091486|FG001|Period 3|Protocol Violation|0|||
48796211|NCT02308748|157091487|FG002|Period 3|Protocol Violation|0|||
48796212|NCT02308748|157091488|FG003|Period 3|Protocol Violation|0|||
48796213|NCT02308748|157091489|FG004|Period 3|Protocol Violation|0|||
48796214|NCT02308748|157091490|FG005|Period 3|Protocol Violation|0|||
48796215|NCT02308748|157091491|FG006|Period 3|Protocol Violation|0|||
48796216|NCT02308748|157091492|FG007|Period 3|Protocol Violation|0|||
48796217|NCT02308748|157091493|FG008|Period 3|Protocol Violation|0|||
48796218|NCT02308748|157091494|FG009|Period 3|Protocol Violation|1|||
48796219|NCT02308748|157091485|FG000|Period 5|Adverse Event|1|||
48796220|NCT02308748|157091486|FG001|Period 5|Adverse Event|0|||
48796221|NCT02308748|157091487|FG002|Period 5|Adverse Event|0|||
48796222|NCT02308748|157091488|FG003|Period 5|Adverse Event|0|||
48796223|NCT02308748|157091489|FG004|Period 5|Adverse Event|0|||
48796224|NCT02308748|157091490|FG005|Period 5|Adverse Event|0|||
48796225|NCT02308748|157091491|FG006|Period 5|Adverse Event|0|||
48796226|NCT02308748|157091492|FG007|Period 5|Adverse Event|0|||
48796227|NCT02308748|157091493|FG008|Period 5|Adverse Event|1|||
48796228|NCT02308748|157091494|FG009|Period 5|Adverse Event|0|||
48796229|NCT03364751|157091495|FG000|Overall Study|Withdrawal by Subject|1|||
48796230|NCT03364751|157091496|FG001|Overall Study|Withdrawal by Subject|0|||
48796231|NCT03364751|157091497|FG002|Overall Study|Withdrawal by Subject|0|||
48796232|NCT03364751|157091498|FG003|Overall Study|Withdrawal by Subject|0|||
48796233|NCT03364751|157091495|FG000|Overall Study|Lost to Follow-up|0|||
48796234|NCT03364751|157091496|FG001|Overall Study|Lost to Follow-up|1|||
48796235|NCT03364751|157091497|FG002|Overall Study|Lost to Follow-up|0|||
48796236|NCT03364751|157091498|FG003|Overall Study|Lost to Follow-up|0|||
48796237|NCT02975973|157091499|FG000|Overall Study|Adverse Event|1|||
48796238|NCT02975973|157091500|FG001|Overall Study|Adverse Event|1|||
48402222|NCT01289015|155664490|FG000|Overall Study|Withdrawal by Subject|17|||
48402223|NCT01289015|155664491|FG001|Overall Study|Withdrawal by Subject|8|||
48402224|NCT01289015|155664490|FG000|Overall Study|Disease progression|1|||
48402225|NCT01289015|155664491|FG001|Overall Study|Disease progression|0|||
48402226|NCT01289015|155664490|FG000|Overall Study|Negative baseline culture and others|33|||
48402227|NCT01289015|155664491|FG001|Overall Study|Negative baseline culture and others|20|||
48402228|NCT01186367|155664492|FG000|Overall Study|Lost to Follow-up|7|||
48796239|NCT02975973|157091501|FG002|Overall Study|Adverse Event|1|||
48796240|NCT02975973|157091502|FG003|Overall Study|Adverse Event|0|||
48796241|NCT00675766|157091507|FG000|Overall Study|Lost to Follow-up|6|||
48796242|NCT00675766|157091508|FG001|Overall Study|Lost to Follow-up|5|||
48796243|NCT00675766|157091509|FG002|Overall Study|Lost to Follow-up|21|||
48796244|NCT00675766|157091510|FG003|Overall Study|Lost to Follow-up|26|||
48796245|NCT02515279|157091511|FG000|Overall Study|Adverse Event|7|||
48796246|NCT02515279|157091511|FG000|Overall Study|Lack of Efficacy|31|||
48796247|NCT02515279|157091511|FG000|Overall Study|Lost to Follow-up|9|||
48796248|NCT02515279|157091511|FG000|Overall Study|Withdrawal by Subject|18|||
48796249|NCT02515279|157091511|FG000|Overall Study|End-of-treatment visit not attended|17|||
48796250|NCT02515279|157091511|FG000|Overall Study|Other|22|||
48796251|NCT03583554|157091512|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
48796252|NCT03583554|157091513|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
48796253|NCT03583554|157091514|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
48796254|NCT01800968|157091516|FG000|Overall Study|Death|23|||
48796255|NCT01800968|157091517|FG001|Overall Study|Death|16|||
48796256|NCT01800968|157091516|FG000|Overall Study|Lost to Follow-up|5|||
48796257|NCT01800968|157091517|FG001|Overall Study|Lost to Follow-up|7|||
48796258|NCT01800968|157091516|FG000|Overall Study|Withdrawal by Subject|7|||
48796259|NCT01800968|157091517|FG001|Overall Study|Withdrawal by Subject|9|||
48796260|NCT01800968|157091516|FG000|Overall Study|Physician Decision|1|||
48796261|NCT01800968|157091517|FG001|Overall Study|Physician Decision|0|||
48796262|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
48796263|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
48796264|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|disease progression|58|||
48796265|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|disease progression|47|||
48796266|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Death|3|||
48796267|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Death|6|||
48796268|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
48796269|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
48796270|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
48796271|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
48796272|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
48796273|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
48796274|NCT02472964|157091518|FG000|Part 1 (up to Week 24)|Other|2|||
48796275|NCT02472964|157091519|FG001|Part 1 (up to Week 24)|Other|1|||
48796276|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
48796277|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
48796278|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
48796279|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
48796280|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Death|0|||
48796281|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Death|1|||
48796282|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
48796283|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
48796284|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
48796285|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
48796286|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
48796287|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
48796288|NCT02472964|157091518|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
48796289|NCT02472964|157091519|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
48796290|NCT00322348|157091530|FG000|Overall Study|Adverse Event|0|||
48796291|NCT00322348|157091531|FG001|Overall Study|Adverse Event|1|||
48796292|NCT00322348|157091530|FG000|Overall Study|Withdrawal by Subject|1|||
48796293|NCT00322348|157091531|FG001|Overall Study|Withdrawal by Subject|4|||
48796294|NCT00322348|157091530|FG000|Overall Study|Lost to Follow-up|1|||
48357091|NCT02563548|155503553|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
48357092|NCT02563548|155503554|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
48357093|NCT02563548|155503549|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48357094|NCT02563548|155503550|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48357095|NCT02563548|155503551|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48357096|NCT02563548|155503552|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48357097|NCT02563548|155503553|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
48357098|NCT02563548|155503554|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
48357099|NCT02563548|155503549|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48357100|NCT02563548|155503550|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48357101|NCT02563548|155503551|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48357102|NCT02563548|155503552|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48357103|NCT02563548|155503553|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
48357104|NCT02563548|155503554|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
48357105|NCT00847626|155503557|FG000|Overall Study|Adverse Event|10|||
48357106|NCT00847626|155503558|FG001|Overall Study|Adverse Event|10|||
48357107|NCT00847626|155503559|FG002|Overall Study|Adverse Event|6|||
48357108|NCT00847626|155503560|FG003|Overall Study|Adverse Event|19|||
48357109|NCT00847626|155503561|FG004|Overall Study|Adverse Event|11|||
48357110|NCT00847626|155503562|FG005|Overall Study|Adverse Event|22|||
48357111|NCT00847626|155503563|FG006|Overall Study|Adverse Event|4|||
48357112|NCT00847626|155503564|FG007|Overall Study|Adverse Event|6|||
48357113|NCT00847626|155503565|FG008|Overall Study|Adverse Event|3|||
48357114|NCT00847626|155503566|FG009|Overall Study|Adverse Event|6|||
48357115|NCT00847626|155503567|FG010|Overall Study|Adverse Event|6|||
48357116|NCT00847626|155503557|FG000|Overall Study|Protocol Violation|2|||
48357117|NCT00847626|155503558|FG001|Overall Study|Protocol Violation|1|||
48357118|NCT00847626|155503559|FG002|Overall Study|Protocol Violation|2|||
48357119|NCT00847626|155503560|FG003|Overall Study|Protocol Violation|1|||
48357120|NCT00847626|155503561|FG004|Overall Study|Protocol Violation|1|||
48357121|NCT00847626|155503562|FG005|Overall Study|Protocol Violation|1|||
48357122|NCT00847626|155503563|FG006|Overall Study|Protocol Violation|1|||
48357123|NCT00847626|155503564|FG007|Overall Study|Protocol Violation|1|||
48357124|NCT00847626|155503565|FG008|Overall Study|Protocol Violation|0|||
48357125|NCT00847626|155503566|FG009|Overall Study|Protocol Violation|1|||
48357126|NCT00847626|155503567|FG010|Overall Study|Protocol Violation|1|||
48357127|NCT00847626|155503557|FG000|Overall Study|Lost to Follow-up|0|||
48357128|NCT00847626|155503558|FG001|Overall Study|Lost to Follow-up|1|||
48357129|NCT00847626|155503559|FG002|Overall Study|Lost to Follow-up|1|||
48357130|NCT00847626|155503560|FG003|Overall Study|Lost to Follow-up|1|||
48357131|NCT00847626|155503561|FG004|Overall Study|Lost to Follow-up|0|||
48357132|NCT00847626|155503562|FG005|Overall Study|Lost to Follow-up|3|||
48357133|NCT00847626|155503563|FG006|Overall Study|Lost to Follow-up|1|||
48357134|NCT00847626|155503564|FG007|Overall Study|Lost to Follow-up|3|||
48357135|NCT00847626|155503565|FG008|Overall Study|Lost to Follow-up|1|||
48357136|NCT00847626|155503566|FG009|Overall Study|Lost to Follow-up|0|||
48357137|NCT00847626|155503567|FG010|Overall Study|Lost to Follow-up|1|||
48357138|NCT00847626|155503557|FG000|Overall Study|Withdrawal by Subject|5|||
48357139|NCT00847626|155503558|FG001|Overall Study|Withdrawal by Subject|5|||
48357140|NCT00847626|155503559|FG002|Overall Study|Withdrawal by Subject|3|||
48402229|NCT01186367|155664493|FG001|Overall Study|Lost to Follow-up|4|||
48402230|NCT01186367|155664494|FG002|Overall Study|Lost to Follow-up|7|||
48357141|NCT00847626|155503560|FG003|Overall Study|Withdrawal by Subject|8|||
48357142|NCT00847626|155503561|FG004|Overall Study|Withdrawal by Subject|12|||
48357143|NCT00847626|155503562|FG005|Overall Study|Withdrawal by Subject|9|||
48357144|NCT00847626|155503563|FG006|Overall Study|Withdrawal by Subject|8|||
48357145|NCT00847626|155503564|FG007|Overall Study|Withdrawal by Subject|4|||
48357146|NCT00847626|155503565|FG008|Overall Study|Withdrawal by Subject|4|||
48357147|NCT00847626|155503566|FG009|Overall Study|Withdrawal by Subject|5|||
48357148|NCT00847626|155503567|FG010|Overall Study|Withdrawal by Subject|2|||
48357149|NCT00847626|155503557|FG000|Overall Study|Lack of Efficacy|3|||
48357150|NCT00847626|155503558|FG001|Overall Study|Lack of Efficacy|1|||
48357151|NCT00847626|155503559|FG002|Overall Study|Lack of Efficacy|0|||
48357152|NCT00847626|155503560|FG003|Overall Study|Lack of Efficacy|1|||
48357153|NCT00847626|155503561|FG004|Overall Study|Lack of Efficacy|2|||
48357154|NCT00847626|155503562|FG005|Overall Study|Lack of Efficacy|0|||
48357155|NCT00847626|155503563|FG006|Overall Study|Lack of Efficacy|6|||
48357156|NCT00847626|155503564|FG007|Overall Study|Lack of Efficacy|2|||
48357157|NCT00847626|155503565|FG008|Overall Study|Lack of Efficacy|5|||
48402231|NCT01186367|155664492|FG000|Overall Study|Did not receive study treatment|0|||
48402232|NCT01186367|155664493|FG001|Overall Study|Did not receive study treatment|1|||
48402233|NCT01186367|155664494|FG002|Overall Study|Did not receive study treatment|0|||
48402234|NCT04987320|155664495|FG000|Overall Study|Withdrawal by Subject|0|||
48402235|NCT04987320|155664496|FG001|Overall Study|Withdrawal by Subject|1|||
48402236|NCT05533632|155664497|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
48402237|NCT05533632|155664497|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
48402238|NCT05533632|155664497|FG000|Overall Study|Lost to Follow-up|1|||
48402239|NCT05533632|155664497|FG000|Overall Study|Withdrawal by Subject|4|||
48402240|NCT05533632|155664497|FG000|Overall Study|Adverse Event|4|||
48402241|NCT00584194|155664498|FG000|Overall Study|Other|135|||
48402242|NCT01340209|155664500|FG000|Overall Study|Adverse Event|1|||
48402243|NCT01340209|155664501|FG001|Overall Study|Adverse Event|1|||
48402244|NCT01340209|155664502|FG002|Overall Study|Adverse Event|2|||
48402245|NCT01340209|155664500|FG000|Overall Study|Protocol Violation|1|||
48402246|NCT01340209|155664501|FG001|Overall Study|Protocol Violation|2|||
48402247|NCT01340209|155664502|FG002|Overall Study|Protocol Violation|1|||
48402248|NCT01340209|155664500|FG000|Overall Study|Withdrawal by Subject|0|||
48402249|NCT01340209|155664501|FG001|Overall Study|Withdrawal by Subject|0|||
48402250|NCT01340209|155664502|FG002|Overall Study|Withdrawal by Subject|1|||
48402251|NCT01340209|155664500|FG000|Overall Study|Other reason not defined above|3|||
48402252|NCT01340209|155664501|FG001|Overall Study|Other reason not defined above|5|||
48402253|NCT01340209|155664502|FG002|Overall Study|Other reason not defined above|4|||
48402254|NCT00608985|155664503|FG000|Overall Study|Adverse Event|2|||
48402255|NCT00608985|155664504|FG001|Overall Study|Adverse Event|7|||
48402256|NCT00608985|155664505|FG002|Overall Study|Adverse Event|4|||
48402257|NCT00608985|155664506|FG003|Overall Study|Adverse Event|6|||
48402258|NCT00608985|155664503|FG000|Overall Study|Administrative/Other|7|||
48402259|NCT00608985|155664504|FG001|Overall Study|Administrative/Other|4|||
48402260|NCT00608985|155664505|FG002|Overall Study|Administrative/Other|1|||
48402261|NCT00608985|155664506|FG003|Overall Study|Administrative/Other|2|||
48402262|NCT00608985|155664503|FG000|Overall Study|Withdrawal of Consent|5|||
48402263|NCT00608985|155664504|FG001|Overall Study|Withdrawal of Consent|1|||
48402264|NCT00608985|155664505|FG002|Overall Study|Withdrawal of Consent|1|||
48402265|NCT00608985|155664506|FG003|Overall Study|Withdrawal of Consent|1|||
48402266|NCT00608985|155664503|FG000|Overall Study|Lost to Follow-up|2|||
48402267|NCT00608985|155664504|FG001|Overall Study|Lost to Follow-up|1|||
48402268|NCT00608985|155664505|FG002|Overall Study|Lost to Follow-up|0|||
48402269|NCT00608985|155664506|FG003|Overall Study|Lost to Follow-up|0|||
48402270|NCT02809833|155664507|FG000|Overall Study|Death|3|||
48402271|NCT02809833|155664507|FG000|Overall Study|Intolerance|54|||
48402272|NCT02809833|155664507|FG000|Overall Study|Lack of Efficacy|89|||
48402273|NCT02809833|155664507|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
48402274|NCT02809833|155664507|FG000|Overall Study|Noncompliance|1|||
48402275|NCT02809833|155664507|FG000|Overall Study|Withdrawal by Subject|34|||
48402276|NCT02809833|155664507|FG000|Overall Study|Lost to Follow-up|35|||
48402277|NCT02809833|155664507|FG000|Overall Study|Adverse Event (AE)|24|||
48402278|NCT02809833|155664507|FG000|Overall Study|Other|5|||
48402279|NCT02809833|155664507|FG000|Overall Study|Missing Information|52|||
48402280|NCT03665285|155664508|FG000|Overall Study|Started New Anticancer Treatment|1|||
48357158|NCT00847626|155503566|FG009|Overall Study|Lack of Efficacy|1|||
48357159|NCT00847626|155503567|FG010|Overall Study|Lack of Efficacy|7|||
48357160|NCT00847626|155503557|FG000|Overall Study|Other|1|||
48357161|NCT00847626|155503558|FG001|Overall Study|Other|5|||
48402281|NCT03665285|155664509|FG001|Overall Study|Started New Anticancer Treatment|1|||
48402282|NCT03665285|155664510|FG002|Overall Study|Started New Anticancer Treatment|2|||
48402283|NCT03665285|155664511|FG003|Overall Study|Started New Anticancer Treatment|4|||
48402284|NCT03665285|155664512|FG004|Overall Study|Started New Anticancer Treatment|1|||
48402285|NCT03665285|155664513|FG005|Overall Study|Started New Anticancer Treatment|1|||
48402286|NCT03665285|155664514|FG006|Overall Study|Started New Anticancer Treatment|2|||
48402287|NCT03665285|155664515|FG007|Overall Study|Started New Anticancer Treatment|15|||
48402288|NCT03665285|155664516|FG008|Overall Study|Started New Anticancer Treatment|1|||
48402289|NCT03665285|155664508|FG000|Overall Study|Disease Progression|0|||
48402290|NCT03665285|155664509|FG001|Overall Study|Disease Progression|0|||
48402291|NCT03665285|155664510|FG002|Overall Study|Disease Progression|3|||
48402292|NCT03665285|155664511|FG003|Overall Study|Disease Progression|1|||
48402293|NCT03665285|155664512|FG004|Overall Study|Disease Progression|0|||
48402294|NCT03665285|155664513|FG005|Overall Study|Disease Progression|0|||
48402295|NCT03665285|155664514|FG006|Overall Study|Disease Progression|0|||
48402296|NCT03665285|155664515|FG007|Overall Study|Disease Progression|7|||
48402297|NCT03665285|155664516|FG008|Overall Study|Disease Progression|1|||
48402298|NCT03665285|155664508|FG000|Overall Study|Hospice|0|||
48402299|NCT03665285|155664509|FG001|Overall Study|Hospice|0|||
48402300|NCT03665285|155664510|FG002|Overall Study|Hospice|0|||
48402301|NCT03665285|155664511|FG003|Overall Study|Hospice|0|||
48402302|NCT03665285|155664512|FG004|Overall Study|Hospice|0|||
48402303|NCT03665285|155664513|FG005|Overall Study|Hospice|0|||
48402304|NCT03665285|155664514|FG006|Overall Study|Hospice|0|||
48402305|NCT03665285|155664515|FG007|Overall Study|Hospice|2|||
48402306|NCT03665285|155664516|FG008|Overall Study|Hospice|0|||
48402307|NCT03665285|155664508|FG000|Overall Study|Withdrawal by Subject|0|||
48402308|NCT03665285|155664509|FG001|Overall Study|Withdrawal by Subject|0|||
48402309|NCT03665285|155664510|FG002|Overall Study|Withdrawal by Subject|0|||
48402310|NCT03665285|155664511|FG003|Overall Study|Withdrawal by Subject|0|||
48402311|NCT03665285|155664512|FG004|Overall Study|Withdrawal by Subject|1|||
48402312|NCT03665285|155664513|FG005|Overall Study|Withdrawal by Subject|0|||
48402313|NCT03665285|155664514|FG006|Overall Study|Withdrawal by Subject|0|||
48402314|NCT03665285|155664515|FG007|Overall Study|Withdrawal by Subject|2|||
48402315|NCT03665285|155664516|FG008|Overall Study|Withdrawal by Subject|0|||
48402316|NCT03665285|155664508|FG000|Overall Study|Physician Decision|0|||
48402317|NCT03665285|155664509|FG001|Overall Study|Physician Decision|0|||
48402318|NCT03665285|155664510|FG002|Overall Study|Physician Decision|0|||
48402319|NCT03665285|155664511|FG003|Overall Study|Physician Decision|0|||
48402320|NCT03665285|155664512|FG004|Overall Study|Physician Decision|0|||
48402321|NCT03665285|155664513|FG005|Overall Study|Physician Decision|0|||
48402322|NCT03665285|155664514|FG006|Overall Study|Physician Decision|0|||
48402323|NCT03665285|155664515|FG007|Overall Study|Physician Decision|2|||
48357162|NCT00847626|155503559|FG002|Overall Study|Other|4|||
48402324|NCT03665285|155664516|FG008|Overall Study|Physician Decision|0|||
48402325|NCT01400451|155664517|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
48402326|NCT01400451|155664518|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
48402327|NCT01400451|155664519|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
48402328|NCT01400451|155664517|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
48402329|NCT01400451|155664518|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
48402330|NCT01400451|155664519|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
48402331|NCT01400451|155664517|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
48402332|NCT01400451|155664518|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
48402333|NCT01400451|155664519|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
48402334|NCT01400451|155664517|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
48402335|NCT01400451|155664518|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
48402336|NCT01400451|155664519|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
48402337|NCT01400451|155664517|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
48402338|NCT01400451|155664518|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
48402339|NCT01400451|155664519|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
48402340|NCT01162421|155664520|FG000|Overall Study|Did not receive study drug|2|||
48402341|NCT01162421|155664521|FG001|Overall Study|Did not receive study drug|1|||
48402342|NCT01162421|155664520|FG000|Overall Study|Adverse Event|2|||
48402343|NCT01162421|155664521|FG001|Overall Study|Adverse Event|5|||
48402344|NCT01162421|155664520|FG000|Overall Study|Lost to Follow-up|0|||
48402345|NCT01162421|155664521|FG001|Overall Study|Lost to Follow-up|2|||
48402346|NCT01162421|155664520|FG000|Overall Study|Lack of Efficacy|2|||
48402347|NCT01162421|155664521|FG001|Overall Study|Lack of Efficacy|2|||
48402348|NCT01162421|155664520|FG000|Overall Study|Other|2|||
48402349|NCT01162421|155664521|FG001|Overall Study|Other|3|||
48402350|NCT01946204|155664522|FG000|Overall Study|Death|38|||
48402351|NCT01946204|155664523|FG001|Overall Study|Death|59|||
48402352|NCT01946204|155664522|FG000|Overall Study|Withdrawal by Subject|37|||
48402353|NCT01946204|155664523|FG001|Overall Study|Withdrawal by Subject|50|||
48402354|NCT01946204|155664522|FG000|Overall Study|Lost to Follow-up|3|||
48402355|NCT01946204|155664523|FG001|Overall Study|Lost to Follow-up|7|||
48402356|NCT01946204|155664522|FG000|Overall Study|Ongoing|316|||
48402357|NCT01946204|155664523|FG001|Overall Study|Ongoing|687|||
48402358|NCT01946204|155664522|FG000|Overall Study|Other|7|||
48402359|NCT01946204|155664523|FG001|Overall Study|Other|3|||
48402360|NCT01844895|155664524|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
48402361|NCT01844895|155664524|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
48402362|NCT01844895|155664524|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
48402363|NCT01844895|155664524|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
48402364|NCT01844895|155664524|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
48402365|NCT01844895|155664524|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
48402366|NCT01844895|155664524|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
48402367|NCT00428597|155664525|FG000|Overall Study|Randomized but not treated|3|||
48402368|NCT00428597|155664526|FG001|Overall Study|Randomized but not treated|3|||
48402369|NCT00428597|155664525|FG000|Overall Study|Objective Progression or Relapse|19|||
48402370|NCT00428597|155664526|FG001|Overall Study|Objective Progression or Relapse|47|||
48402371|NCT00428597|155664525|FG000|Overall Study|Study Terminated by Sponsor|41|||
48402372|NCT00428597|155664526|FG001|Overall Study|Study Terminated by Sponsor|16|||
48402373|NCT00428597|155664525|FG000|Overall Study|Adverse Event|15|||
48402374|NCT00428597|155664526|FG001|Overall Study|Adverse Event|7|||
48402375|NCT00428597|155664525|FG000|Overall Study|Global Deterioration of Health Status|1|||
48402376|NCT00428597|155664526|FG001|Overall Study|Global Deterioration of Health Status|5|||
48402377|NCT00428597|155664525|FG000|Overall Study|Protocol Violation|2|||
48402378|NCT00428597|155664526|FG001|Overall Study|Protocol Violation|1|||
48402379|NCT00428597|155664525|FG000|Overall Study|Withdrawal by Subject|2|||
48402380|NCT00428597|155664526|FG001|Overall Study|Withdrawal by Subject|1|||
48402381|NCT00428597|155664525|FG000|Overall Study|Other|1|||
48402382|NCT00428597|155664526|FG001|Overall Study|Other|1|||
48402383|NCT00428597|155664525|FG000|Overall Study|Lost to Follow-up|0|||
48402384|NCT00428597|155664526|FG001|Overall Study|Lost to Follow-up|1|||
48402385|NCT00428597|155664525|FG000|Overall Study|Pregnancy|1|||
48402386|NCT00428597|155664526|FG001|Overall Study|Pregnancy|0|||
48402387|NCT00428597|155664525|FG000|Overall Study|Death|1|||
48402388|NCT00428597|155664526|FG001|Overall Study|Death|3|||
48402389|NCT00950742|155664527|FG000|Overall Study|Other Adverse Event|1|||
48402390|NCT00950742|155664528|FG001|Overall Study|Other Adverse Event|0|||
48402391|NCT00950742|155664527|FG000|Overall Study|Withdrawal by Subject|3|||
48402392|NCT00950742|155664528|FG001|Overall Study|Withdrawal by Subject|0|||
48402393|NCT00950742|155664527|FG000|Overall Study|Progressive Disease|6|||
48402394|NCT00950742|155664528|FG001|Overall Study|Progressive Disease|2|||
48402395|NCT00950742|155664527|FG000|Overall Study|Dose limiting toxicity|6|||
48402396|NCT00950742|155664528|FG001|Overall Study|Dose limiting toxicity|0|||
48402397|NCT03691935|155664529|FG000|Overall Study|Physician Decision|2|||
48402398|NCT03691935|155664530|FG001|Overall Study|Physician Decision|1|||
48402399|NCT03691935|155664529|FG000|Overall Study|Adverse Event|3|||
48402400|NCT03691935|155664530|FG001|Overall Study|Adverse Event|0|||
48402401|NCT04875195|155664531|FG000|Overall Study|Death|9|||
48402402|NCT04875195|155664532|FG001|Overall Study|Death|3|||
48402403|NCT04875195|155664531|FG000|Overall Study|Withdrawal by Subject|2|||
48402404|NCT04875195|155664532|FG001|Overall Study|Withdrawal by Subject|1|||
48402405|NCT04875195|155664531|FG000|Overall Study|Ongoing in study|49|||
48402406|NCT04875195|155664532|FG001|Overall Study|Ongoing in study|2|||
48402407|NCT03625115|155664533|FG000|Overall Study|Withdrawal by Subject|4|||
48402408|NCT03625115|155664534|FG001|Overall Study|Withdrawal by Subject|7|||
48402409|NCT03625115|155664533|FG000|Overall Study|Lost to Follow-up|17|||
48402410|NCT03625115|155664534|FG001|Overall Study|Lost to Follow-up|24|||
48402411|NCT05184452|155664535|FG000|Overall Study|Lost to Follow-up|0|||
48402412|NCT05184452|155664536|FG001|Overall Study|Lost to Follow-up|0|||
48402413|NCT05184452|155664537|FG002|Overall Study|Lost to Follow-up|0|||
48402414|NCT05184452|155664538|FG003|Overall Study|Lost to Follow-up|0|||
48402415|NCT05184452|155664539|FG004|Overall Study|Lost to Follow-up|0|||
48402416|NCT05184452|155664540|FG005|Overall Study|Lost to Follow-up|2|||
48402417|NCT05184452|155664541|FG006|Overall Study|Lost to Follow-up|0|||
48402418|NCT05184452|155664542|FG007|Overall Study|Lost to Follow-up|0|||
48402419|NCT05184452|155664543|FG008|Overall Study|Lost to Follow-up|0|||
48402420|NCT05184452|155664544|FG009|Overall Study|Lost to Follow-up|1|||
48402421|NCT05184452|155664535|FG000|Overall Study|Withdrawal by Subject|0|||
48402422|NCT05184452|155664536|FG001|Overall Study|Withdrawal by Subject|0|||
48402423|NCT05184452|155664537|FG002|Overall Study|Withdrawal by Subject|0|||
48402424|NCT05184452|155664538|FG003|Overall Study|Withdrawal by Subject|0|||
48402425|NCT05184452|155664539|FG004|Overall Study|Withdrawal by Subject|0|||
48402426|NCT05184452|155664540|FG005|Overall Study|Withdrawal by Subject|1|||
48402427|NCT05184452|155664541|FG006|Overall Study|Withdrawal by Subject|0|||
48402428|NCT05184452|155664542|FG007|Overall Study|Withdrawal by Subject|0|||
48402429|NCT05184452|155664543|FG008|Overall Study|Withdrawal by Subject|0|||
48402430|NCT05184452|155664544|FG009|Overall Study|Withdrawal by Subject|1|||
48402431|NCT05290493|155664545|FG000|Overall Study|Withdrawal by Subject|2|||
48402432|NCT05290493|155664546|FG001|Overall Study|Withdrawal by Subject|2|||
48402433|NCT05290493|155664545|FG000|Overall Study|Adverse Event|1|||
48402434|NCT05290493|155664546|FG001|Overall Study|Adverse Event|0|||
48402435|NCT04325828|155664547|FG000|Overall Study|Ongoing|26|||
48402436|NCT02447848|155664550|FG000|Overall Study|Patient discharged|3|||
48402437|NCT02447848|155664550|FG000|Overall Study|Lack of Efficacy|4|||
48402438|NCT02447848|155664550|FG000|Overall Study|Withdrawal by Subject|4|||
48402439|NCT01877083|155664551|FG000|Treatment Phase|Disease Progression|10|||
48402440|NCT01877083|155664551|FG000|Treatment Phase|Clinical Progression|1|||
48402441|NCT01877083|155664551|FG000|Treatment Phase|Adverse Event|6|||
48402442|NCT01877083|155664551|FG000|Treatment Phase|Withdrawal by Subject|2|||
48402443|NCT01877083|155664551|FG000|Treatment Phase|Lost to Follow-up|1|||
48402444|NCT01877083|155664551|FG000|Extension Phase|Disease Progression|3|||
48402445|NCT01877083|155664551|FG000|Extension Phase|Adverse Event|2|||
48402446|NCT00865020|155664554|FG000|Overall Study|Withdrawal by Subject|22|||
48402447|NCT00865020|155664555|FG001|Overall Study|Withdrawal by Subject|16|||
48402448|NCT00865020|155664554|FG000|Overall Study|Adverse Event|9|||
48402449|NCT00865020|155664555|FG001|Overall Study|Adverse Event|14|||
48402450|NCT00865020|155664554|FG000|Overall Study|Abnormal test procedure result(s)|6|||
48402451|NCT00865020|155664555|FG001|Overall Study|Abnormal test procedure result(s)|8|||
48402452|NCT00865020|155664554|FG000|Overall Study|Lost to Follow-up|6|||
48402453|NCT00865020|155664555|FG001|Overall Study|Lost to Follow-up|4|||
48402454|NCT00865020|155664554|FG000|Overall Study|Protocol deviation|4|||
48402455|NCT00865020|155664555|FG001|Overall Study|Protocol deviation|1|||
48402456|NCT00865020|155664554|FG000|Overall Study|Administrative problems|0|||
48402457|NCT00865020|155664555|FG001|Overall Study|Administrative problems|2|||
48402458|NCT00865020|155664554|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48402459|NCT00865020|155664555|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48402460|NCT00865020|155664554|FG000|Overall Study|Death|0|||
48402461|NCT00865020|155664555|FG001|Overall Study|Death|1|||
48402462|NCT00865020|155664554|FG000|Overall Study|Randomized but discontinued|2|||
48402463|NCT00865020|155664555|FG001|Overall Study|Randomized but discontinued|4|||
48402464|NCT01582308|155664560|FG000|Period 1|Withdrawal by Subject|0|||
48402465|NCT01582308|155664561|FG001|Period 1|Withdrawal by Subject|0|||
48402466|NCT01582308|155664562|FG002|Period 1|Withdrawal by Subject|0|||
48402467|NCT01582308|155664563|FG003|Period 1|Withdrawal by Subject|0|||
48402468|NCT01582308|155664564|FG004|Period 1|Withdrawal by Subject|0|||
48402469|NCT01582308|155664565|FG005|Period 1|Withdrawal by Subject|0|||
48402470|NCT01582308|155664566|FG006|Period 1|Withdrawal by Subject|1|||
48402471|NCT01582308|155664567|FG007|Period 1|Withdrawal by Subject|0|||
48402472|NCT01582308|155664568|FG008|Period 1|Withdrawal by Subject|0|||
48402473|NCT01582308|155664569|FG009|Period 1|Withdrawal by Subject|0|||
48402474|NCT01582308|155664560|FG000|10-day Washout Following Period 1|Physician Decision|0|||
48402475|NCT01582308|155664561|FG001|10-day Washout Following Period 1|Physician Decision|0|||
48402476|NCT01582308|155664562|FG002|10-day Washout Following Period 1|Physician Decision|0|||
48402477|NCT01582308|155664563|FG003|10-day Washout Following Period 1|Physician Decision|0|||
48402478|NCT01582308|155664564|FG004|10-day Washout Following Period 1|Physician Decision|1|||
48402479|NCT01582308|155664565|FG005|10-day Washout Following Period 1|Physician Decision|0|||
48402480|NCT01582308|155664566|FG006|10-day Washout Following Period 1|Physician Decision|0|||
48402481|NCT01582308|155664567|FG007|10-day Washout Following Period 1|Physician Decision|0|||
48402482|NCT01582308|155664568|FG008|10-day Washout Following Period 1|Physician Decision|0|||
48402483|NCT01582308|155664569|FG009|10-day Washout Following Period 1|Physician Decision|0|||
48402484|NCT01582308|155664560|FG000|Period 4|Physician Decision|1|||
48402485|NCT01582308|155664561|FG001|Period 4|Physician Decision|0|||
48402486|NCT01582308|155664562|FG002|Period 4|Physician Decision|0|||
48402487|NCT01582308|155664563|FG003|Period 4|Physician Decision|0|||
48402488|NCT01582308|155664564|FG004|Period 4|Physician Decision|0|||
48402489|NCT01582308|155664565|FG005|Period 4|Physician Decision|1|||
48402490|NCT01582308|155664566|FG006|Period 4|Physician Decision|0|||
48402491|NCT01582308|155664567|FG007|Period 4|Physician Decision|0|||
48402492|NCT01582308|155664568|FG008|Period 4|Physician Decision|0|||
48402493|NCT01582308|155664569|FG009|Period 4|Physician Decision|1|||
48402494|NCT04739800|155664570|FG000|Overall Study|Adverse Event|2|||
48402495|NCT04739800|155664571|FG001|Overall Study|Adverse Event|1|||
48402496|NCT04739800|155664572|FG002|Overall Study|Adverse Event|4|||
48402497|NCT04739800|155664573|FG003|Overall Study|Adverse Event|5|||
48402498|NCT04739800|155664570|FG000|Overall Study|Never Treated|2|||
48402499|NCT04739800|155664571|FG001|Overall Study|Never Treated|0|||
48402500|NCT04739800|155664572|FG002|Overall Study|Never Treated|1|||
48402501|NCT04739800|155664573|FG003|Overall Study|Never Treated|1|||
48402502|NCT04739800|155664570|FG000|Overall Study|On Treatment|5|||
48402503|NCT04739800|155664571|FG001|Overall Study|On Treatment|9|||
48402504|NCT04739800|155664572|FG002|Overall Study|On Treatment|9|||
48402505|NCT04739800|155664573|FG003|Overall Study|On Treatment|9|||
48402506|NCT04739800|155664570|FG000|Overall Study|Symptomatic Deterioration|1|||
48402507|NCT04739800|155664571|FG001|Overall Study|Symptomatic Deterioration|1|||
48430358|NCT00696657|155763703|FG003|Overall Study|Unclassified|2|||
48402508|NCT04739800|155664572|FG002|Overall Study|Symptomatic Deterioration|3|||
48402509|NCT04739800|155664573|FG003|Overall Study|Symptomatic Deterioration|0|||
48402510|NCT04739800|155664570|FG000|Overall Study|Withdrawal by Subject|1|||
48402511|NCT04739800|155664571|FG001|Overall Study|Withdrawal by Subject|2|||
48402512|NCT04739800|155664572|FG002|Overall Study|Withdrawal by Subject|1|||
48402513|NCT04739800|155664573|FG003|Overall Study|Withdrawal by Subject|3|||
48402514|NCT04739800|155664570|FG000|Overall Study|Other Reason|1|||
48402515|NCT04739800|155664571|FG001|Overall Study|Other Reason|3|||
48402516|NCT04739800|155664572|FG002|Overall Study|Other Reason|5|||
48402517|NCT04739800|155664573|FG003|Overall Study|Other Reason|4|||
48402518|NCT02779855|155664574|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
48402519|NCT02779855|155664575|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
48402520|NCT02779855|155664576|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
48402521|NCT04675034|155664577|FG000|Overall Study|Lost to Follow-up|1|||
48402522|NCT04675034|155664578|FG001|Overall Study|Lost to Follow-up|1|||
48402523|NCT04675034|155664579|FG002|Overall Study|Lost to Follow-up|0|||
48402524|NCT04675034|155664580|FG003|Overall Study|Lost to Follow-up|2|||
48402525|NCT04675034|155664581|FG004|Overall Study|Lost to Follow-up|0|||
48402526|NCT04675034|155664577|FG000|Overall Study|Protocol Violation|1|||
48402527|NCT04675034|155664578|FG001|Overall Study|Protocol Violation|0|||
48402528|NCT04675034|155664579|FG002|Overall Study|Protocol Violation|0|||
48402529|NCT04675034|155664580|FG003|Overall Study|Protocol Violation|1|||
48402530|NCT04675034|155664581|FG004|Overall Study|Protocol Violation|3|||
48402531|NCT04675034|155664577|FG000|Overall Study|Withdrawal by Subject|9|||
48402532|NCT04675034|155664578|FG001|Overall Study|Withdrawal by Subject|3|||
48402533|NCT04675034|155664579|FG002|Overall Study|Withdrawal by Subject|4|||
48402534|NCT04675034|155664580|FG003|Overall Study|Withdrawal by Subject|8|||
48402535|NCT04675034|155664581|FG004|Overall Study|Withdrawal by Subject|6|||
48402536|NCT02711553|155664582|FG000|Overall Study|Withdrawal by Subject|2|||
48402537|NCT02711553|155664583|FG001|Overall Study|Withdrawal by Subject|1|||
48402538|NCT02711553|155664584|FG002|Overall Study|Withdrawal by Subject|1|||
48402539|NCT02711553|155664585|FG003|Overall Study|Withdrawal by Subject|0|||
48402540|NCT02711553|155664582|FG000|Overall Study|Lost to Follow-up|3|||
48402541|NCT02711553|155664583|FG001|Overall Study|Lost to Follow-up|3|||
48402542|NCT02711553|155664584|FG002|Overall Study|Lost to Follow-up|6|||
48402543|NCT02711553|155664585|FG003|Overall Study|Lost to Follow-up|3|||
48402544|NCT02711553|155664582|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
48402545|NCT02711553|155664583|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
48402546|NCT02711553|155664584|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
48402547|NCT02711553|155664585|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
48402548|NCT01396005|155666138|FG000|Overall Study|Withdrawal by Subject|0|||
48402549|NCT01396005|155666139|FG001|Overall Study|Withdrawal by Subject|1|||
48402550|NCT01396005|155666138|FG000|Overall Study|Non-compliance with protocol|0|||
48402551|NCT01396005|155666139|FG001|Overall Study|Non-compliance with protocol|1|||
48402552|NCT01777152|155666142|FG000|Overall Study|Withdrawal by Subject|22|||
48402553|NCT01777152|155666143|FG001|Overall Study|Withdrawal by Subject|16|||
48402554|NCT01777152|155666142|FG000|Overall Study|Lost to Follow-up|3|||
48402555|NCT01777152|155666143|FG001|Overall Study|Lost to Follow-up|5|||
48402556|NCT01777152|155666142|FG000|Overall Study|Death|68|||
48402557|NCT01777152|155666143|FG001|Overall Study|Death|89|||
48402558|NCT01777152|155666142|FG000|Overall Study|Not eligible, no study drug received|1|||
48402559|NCT01777152|155666143|FG001|Overall Study|Not eligible, no study drug received|0|||
48402560|NCT01777152|155666142|FG000|Overall Study|Change of diagnosis|1|||
48402561|NCT01777152|155666143|FG001|Overall Study|Change of diagnosis|0|||
48402562|NCT01496885|155666144|FG000|Overall Study|Lost to Follow-up|13|||
48402563|NCT01496885|155666144|FG000|Overall Study|Withdrawal by Subject|7|||
48402564|NCT01496885|155666144|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
48402565|NCT01496885|155666144|FG000|Overall Study|Death|1|||
48402566|NCT03273166|155666145|FG000|Overall Study|Withdrawn prior to Completion|31|||
48402567|NCT01285908|155666151|FG000|Baseline Measurement|unable to insert catheter|1|||
48402568|NCT01285908|155666152|FG001|Baseline Measurement|unable to insert catheter|0|||
48402569|NCT01285908|155666153|FG002|Baseline Measurement|unable to insert catheter|0|||
48402570|NCT01285908|155666151|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
48402571|NCT01285908|155666152|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
48402572|NCT01285908|155666153|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
48402573|NCT01285908|155666151|FG000|Baseline Measurement|unable to tolerate procedure|1|||
48402574|NCT01285908|155666152|FG001|Baseline Measurement|unable to tolerate procedure|0|||
48402575|NCT01285908|155666153|FG002|Baseline Measurement|unable to tolerate procedure|0|||
48402576|NCT01903837|155666158|FG000|Part A|Withdrawal by Subject|4|||
48402577|NCT01903837|155666159|FG001|Part A|Withdrawal by Subject|9|||
48402578|NCT01903837|155666160|FG002|Part A|Withdrawal by Subject|8|||
48402579|NCT01903837|155666161|FG003|Part A|Withdrawal by Subject|5|||
48402580|NCT01903837|155666158|FG000|Part A|Adverse Event|3|||
48402581|NCT01903837|155666159|FG001|Part A|Adverse Event|6|||
48402582|NCT01903837|155666160|FG002|Part A|Adverse Event|9|||
48402583|NCT01903837|155666161|FG003|Part A|Adverse Event|6|||
48402584|NCT01903837|155666158|FG000|Part A|Lost to Follow-up|9|||
48402585|NCT01903837|155666159|FG001|Part A|Lost to Follow-up|7|||
48402586|NCT01903837|155666160|FG002|Part A|Lost to Follow-up|7|||
48402587|NCT01903837|155666161|FG003|Part A|Lost to Follow-up|2|||
48402588|NCT01903837|155666158|FG000|Part A|Non-compliance with study drug|1|||
48402589|NCT01903837|155666159|FG001|Part A|Non-compliance with study drug|4|||
48402590|NCT01903837|155666160|FG002|Part A|Non-compliance with study drug|4|||
48402591|NCT01903837|155666161|FG003|Part A|Non-compliance with study drug|0|||
48402592|NCT01903837|155666158|FG000|Part A|Physician Decision|1|||
48402593|NCT01903837|155666159|FG001|Part A|Physician Decision|1|||
48402594|NCT01903837|155666160|FG002|Part A|Physician Decision|0|||
48402595|NCT01903837|155666161|FG003|Part A|Physician Decision|0|||
48402596|NCT01903837|155666158|FG000|Part A|Protocol Violation|1|||
48402597|NCT01903837|155666159|FG001|Part A|Protocol Violation|1|||
48402598|NCT01903837|155666160|FG002|Part A|Protocol Violation|0|||
48402599|NCT01903837|155666161|FG003|Part A|Protocol Violation|0|||
48402600|NCT01903837|155666158|FG000|Part B|Lost to Follow-up|0|||
48402601|NCT01903837|155666159|FG001|Part B|Lost to Follow-up|3|||
48402602|NCT01903837|155666160|FG002|Part B|Lost to Follow-up|3|||
48402603|NCT01903837|155666161|FG003|Part B|Lost to Follow-up|4|||
48402604|NCT01903837|155666158|FG000|Part B|Withdrawal by Subject|1|||
48402605|NCT01903837|155666159|FG001|Part B|Withdrawal by Subject|2|||
48402606|NCT01903837|155666160|FG002|Part B|Withdrawal by Subject|0|||
48402607|NCT01903837|155666161|FG003|Part B|Withdrawal by Subject|3|||
48402608|NCT01903837|155666158|FG000|Part B|Adverse Event|3|||
48402609|NCT01903837|155666159|FG001|Part B|Adverse Event|0|||
48402610|NCT01903837|155666160|FG002|Part B|Adverse Event|2|||
48402611|NCT01903837|155666161|FG003|Part B|Adverse Event|0|||
48402612|NCT01903837|155666158|FG000|Part B|Non-compliance with study drug|2|||
48402613|NCT01903837|155666159|FG001|Part B|Non-compliance with study drug|0|||
48402614|NCT01903837|155666160|FG002|Part B|Non-compliance with study drug|0|||
48402615|NCT01903837|155666161|FG003|Part B|Non-compliance with study drug|1|||
48402616|NCT01903837|155666158|FG000|Part B|Incarceration|2|||
48402617|NCT01903837|155666159|FG001|Part B|Incarceration|0|||
48402618|NCT01903837|155666160|FG002|Part B|Incarceration|0|||
48402619|NCT01903837|155666161|FG003|Part B|Incarceration|1|||
48402620|NCT01903837|155666158|FG000|Part B|Physician Decision|1|||
48402621|NCT01903837|155666159|FG001|Part B|Physician Decision|0|||
48402622|NCT01903837|155666160|FG002|Part B|Physician Decision|0|||
48402623|NCT01903837|155666161|FG003|Part B|Physician Decision|2|||
48402624|NCT01903837|155666158|FG000|Part B|Lack of Efficacy|0|||
48402625|NCT01903837|155666159|FG001|Part B|Lack of Efficacy|1|||
48402626|NCT01903837|155666160|FG002|Part B|Lack of Efficacy|0|||
48402627|NCT01903837|155666161|FG003|Part B|Lack of Efficacy|0|||
48402628|NCT02706873|155666162|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
48402629|NCT02706873|155666163|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
48402630|NCT02706873|155666164|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
48402631|NCT02706873|155666165|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
48402632|NCT02706873|155666162|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
48402633|NCT02706873|155666163|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
48402634|NCT02706873|155666164|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
48402635|NCT02706873|155666165|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
48402636|NCT02706873|155666162|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
48402637|NCT02706873|155666163|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
48402638|NCT02706873|155666164|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
48402639|NCT02706873|155666165|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
48402640|NCT02706873|155666162|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
48402641|NCT02706873|155666163|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
48357163|NCT00847626|155503560|FG003|Overall Study|Other|1|||
48402642|NCT02706873|155666164|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
48402643|NCT02706873|155666165|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
48402644|NCT02706873|155666162|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
48402645|NCT02706873|155666163|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
48402646|NCT02706873|155666164|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
48402647|NCT02706873|155666165|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
48402648|NCT02706873|155666162|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
48402649|NCT02706873|155666163|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
48402650|NCT02706873|155666164|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
48402651|NCT02706873|155666165|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
48402652|NCT02706873|155666162|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
48402653|NCT02706873|155666163|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
48402654|NCT02706873|155666164|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
48402655|NCT02706873|155666165|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
48402656|NCT02706873|155666162|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
48402657|NCT02706873|155666163|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
48402658|NCT02706873|155666164|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
48402659|NCT02706873|155666165|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
48402660|NCT02706873|155666162|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
48402661|NCT02706873|155666163|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
48402662|NCT02706873|155666164|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
48402663|NCT02706873|155666165|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
48402664|NCT02706873|155666162|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
48402665|NCT02706873|155666163|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
48402666|NCT02706873|155666164|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
48402667|NCT02706873|155666165|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
48402668|NCT02706873|155666162|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
48402669|NCT02706873|155666163|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
48402670|NCT02706873|155666164|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
48402671|NCT02706873|155666165|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
48402672|NCT02706873|155666162|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
48402673|NCT02706873|155666163|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
48402674|NCT02706873|155666164|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
48402675|NCT02706873|155666165|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
48402676|NCT02706873|155666162|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
48402677|NCT02706873|155666163|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
48402678|NCT02706873|155666164|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
48402679|NCT02706873|155666165|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
48402680|NCT02599961|155666166|FG000|Overall Study|Withdrawal by Subject|1|||
48402681|NCT02599961|155666166|FG000|Overall Study|Subject Non-Compliance|2|||
48402682|NCT02599961|155666166|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
48402683|NCT02599961|155666166|FG000|Overall Study|Other, Not Specified|3|||
48402684|NCT04142983|155666167|FG000|Overall Study|Lost to Follow-up|73|||
48402685|NCT04142983|155666167|FG000|Overall Study|Withdrawal by Subject|10|||
48402686|NCT04142983|155666167|FG000|Overall Study|Physician Decision|1|||
48402687|NCT04142983|155666167|FG000|Overall Study|Adverse Event|1|||
48402688|NCT04142983|155666167|FG000|Overall Study|No longer eligible|4|||
48402689|NCT04142983|155666167|FG000|Overall Study|Screen Failure|10|||
48402690|NCT03948178|155666169|FG000|Overall Study|Protocol Violation|1|||
48402691|NCT03948178|155666169|FG000|Overall Study|Lost to Follow-up|2|||
48402692|NCT03948178|155666169|FG000|Overall Study|Withdrawal by Subject|2|||
48402693|NCT03948178|155666169|FG000|Overall Study|Reason not known|2|||
48402694|NCT03948178|155666169|FG000|Overall Study|Personal reason|14|||
48402695|NCT03948178|155666169|FG000|Overall Study|Disease progression|30|||
48402696|NCT03948178|155666169|FG000|Overall Study|Adverse Event|12|||
48402697|NCT03948178|155666169|FG000|Overall Study|Sponsor terminated study|164|||
48402698|NCT00197054|155666170|FG000|Overall Study|Withdrawal by Subject|9|||
48402699|NCT00197054|155666171|FG001|Overall Study|Withdrawal by Subject|3|||
48402700|NCT00197054|155666172|FG002|Overall Study|Withdrawal by Subject|3|||
48402701|NCT00197054|155666170|FG000|Overall Study|Moved from area|7|||
48402702|NCT00197054|155666171|FG001|Overall Study|Moved from area|14|||
48402703|NCT00197054|155666172|FG002|Overall Study|Moved from area|9|||
48402704|NCT00197054|155666170|FG000|Overall Study|Lost to Follow-up|1|||
48402705|NCT00197054|155666171|FG001|Overall Study|Lost to Follow-up|4|||
48402706|NCT00197054|155666172|FG002|Overall Study|Lost to Follow-up|0|||
48402707|NCT00684515|155666173|FG000|Overall Study|Adverse Event|3|||
48402708|NCT00684515|155666174|FG001|Overall Study|Adverse Event|3|||
48402709|NCT00684515|155666175|FG002|Overall Study|Adverse Event|1|||
48402710|NCT00684515|155666173|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
48402711|NCT00684515|155666174|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
48402712|NCT00684515|155666175|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
48402713|NCT00191451|155666176|FG000|Overall Study|Withdrawal by Subject|2|||
48402714|NCT00191451|155666177|FG001|Overall Study|Withdrawal by Subject|3|||
48402715|NCT00191451|155666178|FG002|Overall Study|Withdrawal by Subject|5|||
48402716|NCT00191451|155666176|FG000|Overall Study|Physician Decision|2|||
48402717|NCT00191451|155666177|FG001|Overall Study|Physician Decision|9|||
48402718|NCT00191451|155666178|FG002|Overall Study|Physician Decision|6|||
48402719|NCT00191451|155666176|FG000|Overall Study|Sponsor Decision|1|||
48402720|NCT00191451|155666177|FG001|Overall Study|Sponsor Decision|0|||
48402721|NCT00191451|155666178|FG002|Overall Study|Sponsor Decision|0|||
48402722|NCT00191451|155666176|FG000|Overall Study|Ineligible|0|||
48402723|NCT00191451|155666177|FG001|Overall Study|Ineligible|1|||
48402724|NCT00191451|155666178|FG002|Overall Study|Ineligible|0|||
48402725|NCT00191451|155666176|FG000|Overall Study|Reason Not Specified|2|||
48402726|NCT00191451|155666177|FG001|Overall Study|Reason Not Specified|1|||
48402727|NCT00191451|155666178|FG002|Overall Study|Reason Not Specified|3|||
48402728|NCT00272987|155666181|FG000|Overall Study|Adverse Event|1|||
48402729|NCT00272987|155666182|FG001|Overall Study|Adverse Event|0|||
48402730|NCT00272987|155666183|FG002|Overall Study|Adverse Event|0|||
48402731|NCT00272987|155666181|FG000|Overall Study|Lost to Follow-up|3|||
48402732|NCT00272987|155666182|FG001|Overall Study|Lost to Follow-up|1|||
48402733|NCT00272987|155666183|FG002|Overall Study|Lost to Follow-up|1|||
48402734|NCT00272987|155666181|FG000|Overall Study|Withdrawal by Subject|1|||
48402735|NCT00272987|155666182|FG001|Overall Study|Withdrawal by Subject|0|||
48402736|NCT00272987|155666183|FG002|Overall Study|Withdrawal by Subject|3|||
48402737|NCT00272987|155666181|FG000|Overall Study|Sponsor Terminated study|0|||
48402738|NCT00272987|155666182|FG001|Overall Study|Sponsor Terminated study|1|||
48402739|NCT00272987|155666183|FG002|Overall Study|Sponsor Terminated study|1|||
48402740|NCT00272987|155666181|FG000|Overall Study|Disease progression|1|||
48402741|NCT00272987|155666182|FG001|Overall Study|Disease progression|1|||
48402742|NCT00272987|155666183|FG002|Overall Study|Disease progression|2|||
48402743|NCT00272987|155666181|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
48402744|NCT00272987|155666182|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
48402745|NCT00272987|155666183|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
48402746|NCT00272987|155666181|FG000|Overall Study|Death|1|||
48402747|NCT00272987|155666182|FG001|Overall Study|Death|0|||
48402748|NCT00272987|155666183|FG002|Overall Study|Death|0|||
48402749|NCT00662792|155666184|FG000|Period 1|Personal Reasons|0|||
48402750|NCT00662792|155666185|FG001|Period 1|Personal Reasons|0|||
48402751|NCT00662792|155666186|FG002|Period 1|Personal Reasons|1|||
48402752|NCT00662792|155666187|FG003|Period 1|Personal Reasons|0|||
48402753|NCT00662792|155666184|FG000|Period 1|Refused continuing medication|0|||
48402754|NCT00662792|155666185|FG001|Period 1|Refused continuing medication|1|||
48402755|NCT00662792|155666186|FG002|Period 1|Refused continuing medication|1|||
48402756|NCT00662792|155666187|FG003|Period 1|Refused continuing medication|0|||
48402757|NCT00662792|155666184|FG000|Period 1|Lost to Follow-up|1|||
48402758|NCT00662792|155666185|FG001|Period 1|Lost to Follow-up|0|||
48402759|NCT00662792|155666186|FG002|Period 1|Lost to Follow-up|0|||
48402760|NCT00662792|155666187|FG003|Period 1|Lost to Follow-up|0|||
48402761|NCT00662792|155666184|FG000|Period 1|Other adverse event (AE)|0|||
48402762|NCT00662792|155666185|FG001|Period 1|Other adverse event (AE)|2|||
48402763|NCT00662792|155666186|FG002|Period 1|Other adverse event (AE)|0|||
48402764|NCT00662792|155666187|FG003|Period 1|Other adverse event (AE)|0|||
48402765|NCT00662792|155666184|FG000|Period 1|Worsening of disease under study (AE)|1|||
48402766|NCT00662792|155666185|FG001|Period 1|Worsening of disease under study (AE)|3|||
48402767|NCT00662792|155666186|FG002|Period 1|Worsening of disease under study (AE)|2|||
48402768|NCT00662792|155666187|FG003|Period 1|Worsening of disease under study (AE)|0|||
48402769|NCT00662792|155666184|FG000|Period 1|Not treated|0|||
48402770|NCT00662792|155666185|FG001|Period 1|Not treated|1|||
48402771|NCT00662792|155666186|FG002|Period 1|Not treated|0|||
48402772|NCT00662792|155666187|FG003|Period 1|Not treated|0|||
48402773|NCT00662792|155666184|FG000|Period 2|Worsening of disease under study|1|||
48402774|NCT00662792|155666185|FG001|Period 2|Worsening of disease under study|0|||
48402775|NCT00662792|155666186|FG002|Period 2|Worsening of disease under study|0|||
48402776|NCT00662792|155666187|FG003|Period 2|Worsening of disease under study|3|||
48402777|NCT00662792|155666184|FG000|Period 3|Refused continuing medication|1|||
48402778|NCT00662792|155666185|FG001|Period 3|Refused continuing medication|0|||
48402779|NCT00662792|155666186|FG002|Period 3|Refused continuing medication|1|||
48402780|NCT00662792|155666187|FG003|Period 3|Refused continuing medication|0|||
48402781|NCT00662792|155666184|FG000|Period 3|Other adverse event (AE)|0|||
48402782|NCT00662792|155666185|FG001|Period 3|Other adverse event (AE)|0|||
48402783|NCT00662792|155666186|FG002|Period 3|Other adverse event (AE)|1|||
48402784|NCT00662792|155666187|FG003|Period 3|Other adverse event (AE)|1|||
48402785|NCT00662792|155666184|FG000|Period 4|Refused continuing medication|0|||
48402786|NCT00662792|155666185|FG001|Period 4|Refused continuing medication|1|||
48402787|NCT00662792|155666186|FG002|Period 4|Refused continuing medication|0|||
48402788|NCT00662792|155666187|FG003|Period 4|Refused continuing medication|0|||
48402789|NCT00662792|155666184|FG000|Period 4|Other adverse event (AE)|1|||
48402790|NCT00662792|155666185|FG001|Period 4|Other adverse event (AE)|0|||
48402791|NCT00662792|155666186|FG002|Period 4|Other adverse event (AE)|0|||
48402792|NCT00662792|155666187|FG003|Period 4|Other adverse event (AE)|0|||
48402793|NCT00662792|155666184|FG000|Period 4|Worsening of disease under study (AE)|0|||
48402794|NCT00662792|155666185|FG001|Period 4|Worsening of disease under study (AE)|0|||
48402795|NCT00662792|155666186|FG002|Period 4|Worsening of disease under study (AE)|0|||
48402796|NCT00662792|155666187|FG003|Period 4|Worsening of disease under study (AE)|1|||
48402797|NCT02499029|155666191|FG000|Overall Study|Lost to Follow-up|2|||
48402798|NCT02499029|155666192|FG001|Overall Study|Lost to Follow-up|2|||
48402799|NCT02499029|155666191|FG000|Overall Study|Physician Decision|2|||
48402800|NCT02499029|155666192|FG001|Overall Study|Physician Decision|1|||
48402801|NCT02499029|155666191|FG000|Overall Study|Death|1|||
48402802|NCT02499029|155666192|FG001|Overall Study|Death|0|||
48402803|NCT00699907|155666194|FG000|Overall Study|Withdrawal by Subject|2|||
48402804|NCT00699907|155666195|FG001|Overall Study|Withdrawal by Subject|1|||
48402805|NCT00699907|155666196|FG002|Overall Study|Withdrawal by Subject|0|||
48402806|NCT00699907|155666194|FG000|Overall Study|No usable sample|0|||
48402807|NCT00699907|155666195|FG001|Overall Study|No usable sample|9|||
48402808|NCT00699907|155666196|FG002|Overall Study|No usable sample|8|||
48402809|NCT00661271|155666197|FG000|Overall Study|Lost to Follow-up|28|||
48402810|NCT00661271|155666198|FG001|Overall Study|Lost to Follow-up|25|||
48402811|NCT00430508|155666199|FG000|Overall Study|Adverse Event|2|||
48402812|NCT00430508|155666200|FG001|Overall Study|Adverse Event|3|||
48402813|NCT00430508|155666201|FG002|Overall Study|Adverse Event|5|||
48402814|NCT00430508|155666202|FG003|Overall Study|Adverse Event|3|||
48402815|NCT00430508|155666199|FG000|Overall Study|Withdrawal by Subject|0|||
48402816|NCT00430508|155666200|FG001|Overall Study|Withdrawal by Subject|1|||
48402817|NCT00430508|155666201|FG002|Overall Study|Withdrawal by Subject|1|||
48402818|NCT00430508|155666202|FG003|Overall Study|Withdrawal by Subject|1|||
48402819|NCT00430508|155666199|FG000|Overall Study|responder at visit 4|0|||
48402820|NCT00430508|155666200|FG001|Overall Study|responder at visit 4|0|||
48402821|NCT00430508|155666201|FG002|Overall Study|responder at visit 4|2|||
48402822|NCT00430508|155666202|FG003|Overall Study|responder at visit 4|0|||
48402823|NCT00430508|155666199|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
48402824|NCT00430508|155666200|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
48402825|NCT00430508|155666201|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
48402826|NCT00430508|155666202|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
48402827|NCT00430508|155666199|FG000|Overall Study|Other|1|||
48402828|NCT00430508|155666200|FG001|Overall Study|Other|1|||
48402829|NCT00430508|155666201|FG002|Overall Study|Other|3|||
48402830|NCT00430508|155666202|FG003|Overall Study|Other|0|||
48402831|NCT01164722|155666206|FG000|Overall Study|Adverse Event|0|||
48402832|NCT01164722|155666207|FG001|Overall Study|Adverse Event|1|||
48402833|NCT01164722|155666206|FG000|Overall Study|Withdrawal by Subject|3|||
48402834|NCT01164722|155666207|FG001|Overall Study|Withdrawal by Subject|4|||
48402835|NCT01164722|155666206|FG000|Overall Study|Lost to Follow-up|3|||
48402836|NCT01164722|155666207|FG001|Overall Study|Lost to Follow-up|6|||
48402837|NCT01164722|155666206|FG000|Overall Study|met protocol criteria for non-treatment|11|||
48402838|NCT01164722|155666207|FG001|Overall Study|met protocol criteria for non-treatment|1|||
48402839|NCT01164722|155666206|FG000|Overall Study|enrolled on other study, concomitant med|1|||
48402840|NCT01164722|155666207|FG001|Overall Study|enrolled on other study, concomitant med|3|||
48402841|NCT00999908|155666208|FG000|Treatment Period 1|Subject withdrew consent|2|||
48402842|NCT00999908|155666209|FG001|Treatment Period 1|Subject withdrew consent|0|||
48402843|NCT00999908|155666210|FG002|Treatment Period 1|Subject withdrew consent|0|||
48402844|NCT00999908|155666208|FG000|Treatment Period 2|Protocol Violation|1|||
48402845|NCT00999908|155666209|FG001|Treatment Period 2|Protocol Violation|0|||
48402846|NCT00999908|155666210|FG002|Treatment Period 2|Protocol Violation|0|||
48402847|NCT02568046|155666211|FG000|Overall Study|Adverse Event|0|||
48402848|NCT02568046|155666212|FG001|Overall Study|Adverse Event|1|||
48402849|NCT02568046|155666211|FG000|Overall Study|Death|2|||
48402850|NCT02568046|155666212|FG001|Overall Study|Death|0|||
48402851|NCT02568046|155666211|FG000|Overall Study|Progressive Disease|1|||
48402852|NCT02568046|155666212|FG001|Overall Study|Progressive Disease|0|||
48402853|NCT02568046|155666211|FG000|Overall Study|Withdrawal by Subject|2|||
48402854|NCT02568046|155666212|FG001|Overall Study|Withdrawal by Subject|1|||
48402855|NCT02568046|155666211|FG000|Overall Study|Other Events|0|||
48402856|NCT02568046|155666212|FG001|Overall Study|Other Events|1|||
48402857|NCT04673786|155666215|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
48402858|NCT04673786|155666216|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
48402859|NCT04673786|155666217|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
48402860|NCT04673786|155666215|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
48402861|NCT04673786|155666216|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
48402862|NCT04673786|155666217|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
48430359|NCT00696657|155763704|FG004|Overall Study|Unclassified|4|||
48402863|NCT04673786|155666215|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
48402864|NCT04673786|155666216|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
48402865|NCT04673786|155666217|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
48402866|NCT04673786|155666215|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
48402867|NCT04673786|155666216|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
48402868|NCT04673786|155666217|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
48402869|NCT04673786|155666215|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
48402870|NCT04673786|155666216|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
48402871|NCT04673786|155666217|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
48402872|NCT04673786|155666215|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
48402873|NCT04673786|155666216|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
48402874|NCT04673786|155666217|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
48402875|NCT00262873|155666218|FG000|Overall Study|Adverse Event|3|||
48402876|NCT00262873|155666218|FG000|Overall Study|Withdrawal by Subject|5|||
48402877|NCT04327388|155666219|FG000|Overall Study|Adverse Event|17|||
48402878|NCT04327388|155666220|FG001|Overall Study|Adverse Event|18|||
48402879|NCT04327388|155666221|FG002|Overall Study|Adverse Event|9|||
48402880|NCT04327388|155666219|FG000|Overall Study|Other|1|||
48402881|NCT04327388|155666220|FG001|Overall Study|Other|2|||
48402882|NCT04327388|155666221|FG002|Overall Study|Other|0|||
48402883|NCT04327388|155666219|FG000|Overall Study|Randomized and not treated|2|||
48402884|NCT04327388|155666220|FG001|Overall Study|Randomized and not treated|0|||
48402885|NCT04327388|155666221|FG002|Overall Study|Randomized and not treated|2|||
48402886|NCT00626093|155666232|FG000|Overall Study|Lost to Follow-up|5|||
48402887|NCT00626093|155666232|FG000|Overall Study|Death|1|||
48402888|NCT00626093|155666232|FG000|Overall Study|Physician Decision|4|||
48402889|NCT00626093|155666232|FG000|Overall Study|Withdrawal by Subject|6|||
48402890|NCT00626093|155666232|FG000|Overall Study|Protocol Violation|1|||
48402891|NCT00626093|155666232|FG000|Overall Study|One of the required devices not implante|6|||
48402892|NCT03891901|155666233|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
48402893|NCT03891901|155666234|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48402894|NCT03891901|155666235|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48402895|NCT03891901|155666236|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48402896|NCT03891901|155666237|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48402897|NCT03891901|155666238|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48402898|NCT03891901|155666239|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48402899|NCT03891901|155666240|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48402900|NCT03891901|155666241|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
48402901|NCT03891901|155666233|FG000|Overall Study|Adverse Event|2|||
48402902|NCT03891901|155666234|FG001|Overall Study|Adverse Event|2|||
48402903|NCT03891901|155666235|FG002|Overall Study|Adverse Event|0|||
48402904|NCT03891901|155666236|FG003|Overall Study|Adverse Event|0|||
48402905|NCT03891901|155666237|FG004|Overall Study|Adverse Event|0|||
48402906|NCT03891901|155666238|FG005|Overall Study|Adverse Event|0|||
48402907|NCT03891901|155666239|FG006|Overall Study|Adverse Event|0|||
48402908|NCT03891901|155666240|FG007|Overall Study|Adverse Event|0|||
48402909|NCT03891901|155666241|FG008|Overall Study|Adverse Event|0|||
48402910|NCT03891901|155666233|FG000|Overall Study|Poor venous access|1|||
48402911|NCT03891901|155666234|FG001|Overall Study|Poor venous access|0|||
48402912|NCT03891901|155666235|FG002|Overall Study|Poor venous access|0|||
48402913|NCT03891901|155666236|FG003|Overall Study|Poor venous access|0|||
48402914|NCT03891901|155666237|FG004|Overall Study|Poor venous access|0|||
48402915|NCT03891901|155666238|FG005|Overall Study|Poor venous access|0|||
48402916|NCT03891901|155666239|FG006|Overall Study|Poor venous access|0|||
48402917|NCT03891901|155666240|FG007|Overall Study|Poor venous access|0|||
48402918|NCT03891901|155666241|FG008|Overall Study|Poor venous access|0|||
48402919|NCT03891901|155666233|FG000|Overall Study|Withdrawal by Subject|0|||
48402920|NCT03891901|155666234|FG001|Overall Study|Withdrawal by Subject|2|||
48402921|NCT03891901|155666235|FG002|Overall Study|Withdrawal by Subject|0|||
48402922|NCT03891901|155666236|FG003|Overall Study|Withdrawal by Subject|0|||
48402923|NCT03891901|155666237|FG004|Overall Study|Withdrawal by Subject|0|||
48402924|NCT03891901|155666238|FG005|Overall Study|Withdrawal by Subject|0|||
48402925|NCT03891901|155666239|FG006|Overall Study|Withdrawal by Subject|0|||
48402926|NCT03891901|155666240|FG007|Overall Study|Withdrawal by Subject|0|||
48402927|NCT03891901|155666241|FG008|Overall Study|Withdrawal by Subject|0|||
48402928|NCT00911989|155666242|FG000|Overall Study|Adverse Event|1|||
48402929|NCT02445586|155666243|FG000|Overall Study|Death|14|||
48402930|NCT02445586|155666243|FG000|Overall Study|Withdrawal by Subject|13|||
48402931|NCT02445586|155666243|FG000|Overall Study|Disease Progression|10|||
48402932|NCT02445586|155666243|FG000|Overall Study|Protocol Violation|1|||
48402933|NCT02445586|155666243|FG000|Overall Study|Medical Condition|1|||
48402934|NCT01145066|155666249|FG000|Overall Study|To resume NSAIDs|2|||
48402935|NCT01145066|155666250|FG001|Overall Study|To resume NSAIDs|2|||
48402936|NCT01145066|155666251|FG002|Overall Study|To resume NSAIDs|1|||
48402937|NCT01145066|155666249|FG000|Overall Study|Non-related surgery|0|||
48402938|NCT01145066|155666250|FG001|Overall Study|Non-related surgery|0|||
48402939|NCT01145066|155666251|FG002|Overall Study|Non-related surgery|1|||
48402940|NCT01145066|155666249|FG000|Overall Study|Withdrawal by Subject|0|||
48402941|NCT01145066|155666250|FG001|Overall Study|Withdrawal by Subject|0|||
48402942|NCT01145066|155666251|FG002|Overall Study|Withdrawal by Subject|2|||
48402943|NCT01145066|155666249|FG000|Overall Study|To start new med|1|||
48402944|NCT01145066|155666250|FG001|Overall Study|To start new med|0|||
48402945|NCT01145066|155666251|FG002|Overall Study|To start new med|0|||
48430360|NCT00696657|155763705|FG005|Overall Study|Unclassified|2|||
48357164|NCT00847626|155503561|FG004|Overall Study|Other|2|||
48357165|NCT00847626|155503562|FG005|Overall Study|Other|2|||
48357166|NCT00847626|155503563|FG006|Overall Study|Other|2|||
48357167|NCT00847626|155503564|FG007|Overall Study|Other|3|||
48357168|NCT00847626|155503565|FG008|Overall Study|Other|1|||
48357169|NCT00847626|155503566|FG009|Overall Study|Other|1|||
48357170|NCT00847626|155503567|FG010|Overall Study|Other|3|||
48402946|NCT01145066|155666249|FG000|Overall Study|problems swallowing capsule|1|||
48402947|NCT01145066|155666250|FG001|Overall Study|problems swallowing capsule|0|||
48402948|NCT01145066|155666251|FG002|Overall Study|problems swallowing capsule|0|||
48402949|NCT01145066|155666249|FG000|Overall Study|Abdominal discomfort|0|||
48402950|NCT01145066|155666250|FG001|Overall Study|Abdominal discomfort|1|||
48402951|NCT01145066|155666251|FG002|Overall Study|Abdominal discomfort|0|||
48402952|NCT01145066|155666249|FG000|Overall Study|Low platelet count|0|||
48402953|NCT01145066|155666250|FG001|Overall Study|Low platelet count|1|||
48402954|NCT01145066|155666251|FG002|Overall Study|Low platelet count|0|||
48402955|NCT00217087|155666252|FG000|Overall Study|decided to have esophagectomy|1|||
48402956|NCT00217087|155666253|FG001|Overall Study|decided to have esophagectomy|2|||
48402957|NCT00217087|155666252|FG000|Overall Study|completed less than 12 months return|10|||
48402958|NCT00217087|155666253|FG001|Overall Study|completed less than 12 months return|18|||
48402959|NCT02474329|155666254|FG000|Overall Study|Withdraw or did not contribute data.|13|||
48402960|NCT00695565|155666255|FG000|Overall Study|Lost to Follow-up|4|||
48402961|NCT00695565|155666256|FG001|Overall Study|Lost to Follow-up|4|||
48402962|NCT00695565|155666255|FG000|Overall Study|Adverse Event|3|||
48402963|NCT00695565|155666256|FG001|Overall Study|Adverse Event|1|||
48402964|NCT00695565|155666255|FG000|Overall Study|Protocol Violation|3|||
48402965|NCT00695565|155666256|FG001|Overall Study|Protocol Violation|1|||
48402966|NCT00695565|155666255|FG000|Overall Study|Withdrawal by Subject|1|||
48402967|NCT00695565|155666256|FG001|Overall Study|Withdrawal by Subject|1|||
48402968|NCT00695565|155666255|FG000|Overall Study|Lack of Efficacy|1|||
48402969|NCT00695565|155666256|FG001|Overall Study|Lack of Efficacy|1|||
48402970|NCT00695565|155666255|FG000|Overall Study|Subject did not follow instructions|1|||
48402971|NCT00695565|155666256|FG001|Overall Study|Subject did not follow instructions|1|||
48402972|NCT01106846|155666257|FG000|Overall Study|Change in surgical procedure|0|||
48402973|NCT01106846|155666258|FG001|Overall Study|Change in surgical procedure|1|||
48402974|NCT02419508|155666267|FG000|Overall Study|Adverse Event|9|||
48402975|NCT02419508|155666268|FG001|Overall Study|Adverse Event|3|||
48402976|NCT02419508|155666267|FG000|Overall Study|Withdrawal by Subject|1|||
48402977|NCT02419508|155666268|FG001|Overall Study|Withdrawal by Subject|0|||
48402978|NCT02419508|155666267|FG000|Overall Study|Other - Reason not specified|0|||
48402979|NCT02419508|155666268|FG001|Overall Study|Other - Reason not specified|1|||
48402980|NCT01445678|155666271|FG000|Overall Study|Adverse Event|12|||
48402981|NCT01445678|155666272|FG001|Overall Study|Adverse Event|8|||
48402982|NCT01445678|155666271|FG000|Overall Study|Lack of Efficacy|0|||
48402983|NCT01445678|155666272|FG001|Overall Study|Lack of Efficacy|2|||
48402984|NCT01445678|155666271|FG000|Overall Study|Lost to Follow-up|8|||
48402985|NCT01445678|155666272|FG001|Overall Study|Lost to Follow-up|5|||
48402986|NCT01445678|155666271|FG000|Overall Study|Protocol Violation|1|||
48402987|NCT01445678|155666272|FG001|Overall Study|Protocol Violation|1|||
48402988|NCT01445678|155666271|FG000|Overall Study|Withdrawal by Subject|9|||
48402989|NCT01445678|155666272|FG001|Overall Study|Withdrawal by Subject|5|||
48402990|NCT01583374|155666276|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
48402991|NCT01583374|155666277|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
48402992|NCT01583374|155666278|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
48402993|NCT01583374|155666279|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48402994|NCT01583374|155666280|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48402995|NCT01583374|155666281|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48402996|NCT01583374|155666282|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48402997|NCT01583374|155666283|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48402998|NCT01583374|155666284|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
48402999|NCT01583374|155666276|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
48403000|NCT01583374|155666277|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
48403001|NCT01583374|155666278|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
48403002|NCT01583374|155666279|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48403003|NCT01583374|155666280|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48403004|NCT01583374|155666281|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48403005|NCT01583374|155666282|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48403006|NCT01583374|155666283|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48403007|NCT01583374|155666284|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
48403008|NCT01583374|155666276|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
48403009|NCT01583374|155666277|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
48403010|NCT01583374|155666278|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48403011|NCT01583374|155666279|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48403012|NCT01583374|155666280|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48403013|NCT01583374|155666281|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48403014|NCT01583374|155666282|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48403015|NCT01583374|155666283|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48403016|NCT01583374|155666284|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
48403017|NCT01583374|155666276|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
48403018|NCT01583374|155666277|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
48403019|NCT01583374|155666278|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
48403020|NCT01583374|155666279|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48403021|NCT01583374|155666280|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48403022|NCT01583374|155666281|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48403023|NCT01583374|155666282|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48403024|NCT01583374|155666283|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48403025|NCT01583374|155666284|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
48403026|NCT01583374|155666276|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
48403027|NCT01583374|155666277|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
48403028|NCT01583374|155666278|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48403029|NCT01583374|155666279|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48403030|NCT01583374|155666280|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48403031|NCT01583374|155666281|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48403032|NCT01583374|155666282|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48403033|NCT01583374|155666283|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48403034|NCT01583374|155666284|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
48403035|NCT01583374|155666276|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48403036|NCT01583374|155666277|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48403037|NCT01583374|155666278|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
48403038|NCT01583374|155666279|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48403039|NCT01583374|155666280|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48403040|NCT01583374|155666281|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48403041|NCT01583374|155666282|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48403042|NCT01583374|155666283|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48403043|NCT01583374|155666284|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
48403044|NCT01583374|155666276|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
48403045|NCT01583374|155666277|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
48403046|NCT01583374|155666278|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
48403047|NCT01583374|155666279|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
48403048|NCT01583374|155666280|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
48403049|NCT01583374|155666281|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
48403050|NCT01583374|155666282|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
48403051|NCT01583374|155666283|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
48403052|NCT01583374|155666284|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
48403053|NCT01583374|155666276|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48403054|NCT01583374|155666277|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48403055|NCT01583374|155666278|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48403056|NCT01583374|155666279|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48403057|NCT01583374|155666280|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48403058|NCT01583374|155666281|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48403059|NCT01583374|155666282|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48403060|NCT01583374|155666283|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
48403061|NCT01583374|155666284|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
48403062|NCT01583374|155666276|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
48403063|NCT01583374|155666277|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48403064|NCT01583374|155666278|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
48403065|NCT01583374|155666279|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
48403066|NCT01583374|155666280|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48403067|NCT01583374|155666281|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48403068|NCT01583374|155666282|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
48403069|NCT01583374|155666283|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
48403070|NCT01583374|155666284|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
48403071|NCT01583374|155666276|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
48403072|NCT01583374|155666277|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
48403073|NCT01583374|155666278|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
48403074|NCT01583374|155666279|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
48403075|NCT01583374|155666280|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
48403076|NCT01583374|155666281|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
48403077|NCT01583374|155666282|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
48403078|NCT01583374|155666283|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
48403079|NCT01583374|155666284|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
48403080|NCT01583374|155666276|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48403081|NCT01583374|155666277|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
48403082|NCT01583374|155666278|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
48403083|NCT01583374|155666279|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48403084|NCT01583374|155666280|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
48403085|NCT01583374|155666281|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48403086|NCT01583374|155666282|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48403087|NCT01583374|155666283|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48403088|NCT01583374|155666284|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
48403089|NCT01583374|155666276|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48430361|NCT00696657|155763706|FG006|Overall Study|Unclassified|0|||
48403090|NCT01583374|155666277|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48403091|NCT01583374|155666278|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
48403092|NCT01583374|155666279|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48403093|NCT01583374|155666280|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
48403094|NCT01583374|155666281|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
48403095|NCT01583374|155666282|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48403096|NCT01583374|155666283|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48403097|NCT01583374|155666284|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
48403098|NCT01583374|155666276|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
48403099|NCT01583374|155666277|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
48403100|NCT01583374|155666278|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
48403101|NCT01583374|155666279|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
48403102|NCT01583374|155666280|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
48403103|NCT01583374|155666281|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
48403104|NCT01583374|155666282|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
48403105|NCT01583374|155666283|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
48403106|NCT01583374|155666284|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
48403107|NCT01583374|155666276|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
48403108|NCT01583374|155666277|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
48403109|NCT01583374|155666278|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
48403110|NCT01583374|155666279|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
48403111|NCT01583374|155666280|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
48403112|NCT01583374|155666281|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
48403113|NCT01583374|155666282|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
48403114|NCT01583374|155666283|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
48403115|NCT01583374|155666284|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
48403116|NCT01583374|155666276|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48403117|NCT01583374|155666277|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48403118|NCT01583374|155666278|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48403119|NCT01583374|155666279|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48403120|NCT01583374|155666280|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
48403121|NCT01583374|155666281|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48430362|NCT00696657|155763707|FG007|Overall Study|Unclassified|0|||
48403122|NCT01583374|155666282|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
48403123|NCT01583374|155666283|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
48403124|NCT01583374|155666284|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
48403125|NCT01583374|155666276|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
48403126|NCT01583374|155666277|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
48403127|NCT01583374|155666278|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
48403128|NCT01583374|155666279|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
48403129|NCT01583374|155666280|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
48403130|NCT01583374|155666281|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
48403131|NCT01583374|155666282|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
48403132|NCT01583374|155666283|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
48403133|NCT01583374|155666284|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
48403134|NCT01583374|155666276|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
48403135|NCT01583374|155666277|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
48403136|NCT01583374|155666278|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
48403137|NCT01583374|155666279|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
48403138|NCT01583374|155666280|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
48403139|NCT01583374|155666281|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
48403140|NCT01583374|155666282|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
48403141|NCT01583374|155666283|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
48403142|NCT01583374|155666284|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
48403143|NCT01583374|155666276|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48403144|NCT01583374|155666277|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
48403145|NCT01583374|155666278|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48403146|NCT01583374|155666279|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
48403147|NCT01583374|155666280|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
48403148|NCT01583374|155666281|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48403149|NCT01583374|155666282|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
48403150|NCT01583374|155666283|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48403151|NCT01583374|155666284|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
48403152|NCT01583374|155666276|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
48403153|NCT01583374|155666277|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
48403154|NCT01583374|155666278|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
48403155|NCT01583374|155666279|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
48403156|NCT01583374|155666280|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
48403157|NCT01583374|155666281|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
48403158|NCT01583374|155666282|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
48403159|NCT01583374|155666283|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
48403160|NCT01583374|155666284|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
48403161|NCT01459614|155666285|FG000|Overall Study|Adverse Event|1|||
48403162|NCT01459614|155666286|FG001|Overall Study|Adverse Event|0|||
48403163|NCT02531646|155666289|FG000|Overall Study|equip. image processing issue|5|||
48403164|NCT02531646|155666290|FG001|Overall Study|equip. image processing issue|1|||
48403165|NCT02531646|155666291|FG002|Overall Study|equip. image processing issue|0|||
48403166|NCT02831673|155668418|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
48403167|NCT02831673|155668419|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
48403168|NCT02831673|155668420|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
48403169|NCT02831673|155668421|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
48403170|NCT02831673|155668422|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
48403171|NCT02831673|155668418|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
48403172|NCT02831673|155668419|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
48403173|NCT02831673|155668420|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
48403174|NCT02831673|155668421|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
48403175|NCT02831673|155668422|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
48403176|NCT02831673|155668418|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
48403177|NCT02831673|155668419|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
48403178|NCT02831673|155668420|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
48403179|NCT02831673|155668421|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
48403180|NCT02831673|155668422|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
48403181|NCT02831673|155668418|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
48403182|NCT02831673|155668419|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
48403183|NCT02831673|155668420|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
48403184|NCT02831673|155668421|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
48430363|NCT00696657|155763708|FG008|Overall Study|Unclassified|1|||
48403185|NCT02831673|155668422|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
48403186|NCT02831673|155668418|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
48403187|NCT02831673|155668419|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
48403188|NCT02831673|155668420|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
48403189|NCT02831673|155668421|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
48403190|NCT02831673|155668422|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
48403191|NCT02831673|155668418|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
48403192|NCT02831673|155668419|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
48403193|NCT02831673|155668420|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
48403194|NCT02831673|155668421|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
48403195|NCT02831673|155668422|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
48403196|NCT02831673|155668418|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
48403197|NCT02831673|155668419|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
48403198|NCT02831673|155668420|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
48403199|NCT02831673|155668421|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
48403200|NCT02831673|155668422|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
48403201|NCT02831673|155668418|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
48403202|NCT02831673|155668419|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
48403203|NCT02831673|155668420|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
48403204|NCT02831673|155668421|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
48403205|NCT02831673|155668422|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
48403206|NCT02831673|155668418|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48403207|NCT02831673|155668419|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48403208|NCT02831673|155668420|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
48403209|NCT02831673|155668421|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
48403210|NCT02831673|155668422|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
48403211|NCT02831673|155668418|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48403212|NCT02831673|155668419|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48403213|NCT02831673|155668420|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
48403214|NCT02831673|155668421|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
48403215|NCT02831673|155668422|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
48403216|NCT02831673|155668418|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48403217|NCT02831673|155668419|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48403218|NCT02831673|155668420|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48403219|NCT02831673|155668421|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
48403220|NCT02831673|155668422|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
48403221|NCT02831673|155668418|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
48403222|NCT02831673|155668419|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
48403223|NCT02831673|155668420|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
48403224|NCT02831673|155668421|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
48403225|NCT02831673|155668422|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
48403226|NCT02831673|155668418|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48403227|NCT02831673|155668419|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48403228|NCT02831673|155668420|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
48403229|NCT02831673|155668421|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
48403230|NCT02831673|155668422|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
48403231|NCT02831673|155668418|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48403232|NCT02831673|155668419|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48403233|NCT02831673|155668420|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
48403234|NCT02831673|155668421|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
48403235|NCT02831673|155668422|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
48403236|NCT02831673|155668418|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48403237|NCT02831673|155668419|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48403238|NCT02831673|155668420|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
48403239|NCT02831673|155668421|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
48403240|NCT02831673|155668422|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
48403241|NCT02831673|155668418|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
48403242|NCT02831673|155668419|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
48403243|NCT02831673|155668420|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
48403244|NCT02831673|155668421|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
48403245|NCT02831673|155668422|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
48403246|NCT02831673|155668418|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48403247|NCT02831673|155668419|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48403248|NCT02831673|155668420|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48403249|NCT02831673|155668421|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
48403250|NCT02831673|155668422|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
48403251|NCT02831673|155668418|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48357171|NCT00203047|155503568|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
48357172|NCT00203047|155503569|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
48357173|NCT00203047|155503568|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
48357174|NCT00203047|155503569|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
48357175|NCT00203047|155503568|FG000|Overall Study|Withdrawal by Subject|13|||
48357176|NCT00203047|155503569|FG001|Overall Study|Withdrawal by Subject|47|||
48357177|NCT00203047|155503568|FG000|Overall Study|Teva requested participant withdrawal|1|||
48430364|NCT00696657|155763700|FG000|Overall Study|Adverse Event|0|||
48403252|NCT02831673|155668419|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48403253|NCT02831673|155668420|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48403254|NCT02831673|155668421|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
48403255|NCT02831673|155668422|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
48403256|NCT02831673|155668418|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48403257|NCT02831673|155668419|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48403258|NCT02831673|155668420|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48403259|NCT02831673|155668421|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
48403260|NCT02831673|155668422|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
48403261|NCT02831673|155668418|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48403262|NCT02831673|155668419|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48403263|NCT02831673|155668420|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48403264|NCT02831673|155668421|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
48403265|NCT02831673|155668422|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
48403266|NCT00477165|155668423|FG000|Overall Study|Adverse Event|7|||
48403267|NCT00477165|155668424|FG001|Overall Study|Adverse Event|2|||
48403268|NCT00621504|155668426|FG000|Overall Study|Adverse Event|1|||
48403269|NCT00621504|155668427|FG001|Overall Study|Adverse Event|3|||
48403270|NCT00621504|155668426|FG000|Overall Study|At the request of sponsor/investigator|1|||
48403271|NCT00621504|155668427|FG001|Overall Study|At the request of sponsor/investigator|0|||
48403272|NCT00621504|155668426|FG000|Overall Study|Withdrew consent|9|||
48403273|NCT00621504|155668427|FG001|Overall Study|Withdrew consent|6|||
48403274|NCT00621504|155668426|FG000|Overall Study|Lost to Follow-up|8|||
48403275|NCT00621504|155668427|FG001|Overall Study|Lost to Follow-up|10|||
48403276|NCT00621504|155668426|FG000|Overall Study|Other|1|||
48403277|NCT00621504|155668427|FG001|Overall Study|Other|0|||
48403278|NCT00621504|155668426|FG000|Overall Study|Death|6|||
48403279|NCT00621504|155668427|FG001|Overall Study|Death|6|||
48403280|NCT03178487|155668428|FG000|Period 1|Adverse Event|1|||
48403281|NCT03178487|155668429|FG001|Period 1|Adverse Event|2|||
48403282|NCT03178487|155668428|FG000|Period 1|Withdrawal by Subject|2|||
48403283|NCT03178487|155668429|FG001|Period 1|Withdrawal by Subject|1|||
48403284|NCT03178487|155668428|FG000|Period 1|Lost to Follow-up|1|||
48403285|NCT03178487|155668429|FG001|Period 1|Lost to Follow-up|0|||
48403286|NCT03178487|155668428|FG000|Period 1|Other|0|||
48403287|NCT03178487|155668429|FG001|Period 1|Other|1|||
48403288|NCT03178487|155668428|FG000|Period 2|Adverse Event|4|||
48403289|NCT03178487|155668429|FG001|Period 2|Adverse Event|4|||
48403290|NCT03178487|155668428|FG000|Period 2|Withdrawal by Subject|6|||
48403291|NCT03178487|155668429|FG001|Period 2|Withdrawal by Subject|6|||
48403292|NCT03178487|155668428|FG000|Period 2|Lost to Follow-up|2|||
48403293|NCT03178487|155668429|FG001|Period 2|Lost to Follow-up|2|||
48403294|NCT03178487|155668428|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
48403295|NCT03178487|155668429|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
48403296|NCT03178487|155668428|FG000|Period 2|Other|8|||
48403297|NCT03178487|155668429|FG001|Period 2|Other|7|||
48403298|NCT04093531|155668430|FG000|Overall Study|failed screening|4|||
48403299|NCT02062658|155668431|FG000|Overall Study|Withdrawal by Subject|1|||
48403300|NCT02062658|155668431|FG000|Overall Study|Lack of Efficacy|1|||
48403301|NCT02475655|155668436|FG000|Overall Study|Lost to Follow-up|0|||
48403302|NCT02475655|155668437|FG001|Overall Study|Lost to Follow-up|1|||
48403303|NCT00323557|155668444|FG000|Overall Study|Physician Decision|1|||
48403304|NCT00323557|155668445|FG001|Overall Study|Physician Decision|0|||
48403305|NCT03555266|155668446|FG000|Overall Study|Protocol Violation|6|||
48403306|NCT03555266|155668447|FG001|Overall Study|Protocol Violation|4|||
48403307|NCT02614079|155668448|FG000|Overall Study|Withdrawal by Subject|1|||
48403308|NCT00523991|155668452|FG000|Overall Study|Adverse Event|6|||
48403309|NCT00523991|155668453|FG001|Overall Study|Adverse Event|5|||
48403310|NCT00523991|155668452|FG000|Overall Study|Protocol Violation|1|||
48403311|NCT00523991|155668453|FG001|Overall Study|Protocol Violation|4|||
48403312|NCT00523991|155668452|FG000|Overall Study|Lost to Follow-up|4|||
48403313|NCT00523991|155668453|FG001|Overall Study|Lost to Follow-up|1|||
48430365|NCT00696657|155763701|FG001|Overall Study|Adverse Event|0|||
48403314|NCT00523991|155668452|FG000|Overall Study|Withdrawal by Subject|7|||
48403315|NCT00523991|155668453|FG001|Overall Study|Withdrawal by Subject|17|||
48403316|NCT00523991|155668452|FG000|Overall Study|Other reason (not specified)|3|||
48403317|NCT00523991|155668453|FG001|Overall Study|Other reason (not specified)|0|||
48403318|NCT03261531|155668454|FG000|Overall Study|Withdrawal by Subject|4|||
48403319|NCT01142726|155668455|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
48403320|NCT01142726|155668456|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
48403321|NCT01142726|155668457|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
48403322|NCT01142726|155668455|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
48403323|NCT01142726|155668456|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
48403324|NCT01142726|155668457|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
48403325|NCT01142726|155668455|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
48692482|NCT03287791|156724500|FG000|Overall Study|Protocol Violation|7|||
48692483|NCT03287791|156724501|FG001|Overall Study|Protocol Violation|2|||
48692484|NCT03287791|156724502|FG002|Overall Study|Protocol Violation|1|||
48692485|NCT03287791|156724500|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
48692486|NCT03287791|156724501|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
48692487|NCT03287791|156724502|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
48692488|NCT03287791|156724500|FG000|Overall Study|Too much time between 2 visits|0|||
48692489|NCT03287791|156724501|FG001|Overall Study|Too much time between 2 visits|1|||
48692490|NCT03287791|156724502|FG002|Overall Study|Too much time between 2 visits|0|||
48692491|NCT03287791|156724500|FG000|Overall Study|Non-compliance|0|||
48692492|NCT03287791|156724501|FG001|Overall Study|Non-compliance|1|||
48692493|NCT03287791|156724502|FG002|Overall Study|Non-compliance|0|||
48692494|NCT03287791|156724500|FG000|Overall Study|Did not meet inclusion criteria|1|||
48692495|NCT03287791|156724501|FG001|Overall Study|Did not meet inclusion criteria|0|||
48692496|NCT03287791|156724502|FG002|Overall Study|Did not meet inclusion criteria|0|||
48692497|NCT00453154|156724503|FG000|Double BIind Maintenance|Adverse Event|0|||
48692498|NCT00453154|156724504|FG001|Double BIind Maintenance|Adverse Event|0|||
48692499|NCT00453154|156724505|FG002|Double BIind Maintenance|Adverse Event|3|||
48403326|NCT01142726|155668456|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
48403327|NCT01142726|155668457|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
48403328|NCT01142726|155668455|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
48430366|NCT00696657|155763702|FG002|Overall Study|Adverse Event|3|||
48403329|NCT01142726|155668456|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
48403330|NCT01142726|155668457|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
48403331|NCT01142726|155668455|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
48403332|NCT01142726|155668456|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
48403333|NCT01142726|155668457|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
48403334|NCT01142726|155668455|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
48403335|NCT01142726|155668456|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
48403336|NCT01142726|155668457|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
48403337|NCT01142726|155668455|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
48403338|NCT01142726|155668456|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
48403339|NCT01142726|155668457|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
48403340|NCT01142726|155668455|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
48403341|NCT01142726|155668456|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
48403342|NCT01142726|155668457|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
48403343|NCT01142726|155668455|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
48403344|NCT01142726|155668456|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
48403345|NCT01142726|155668457|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
48403346|NCT01142726|155668455|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
48403347|NCT01142726|155668456|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
48403348|NCT01142726|155668457|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
48403349|NCT01142726|155668455|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
48403350|NCT01142726|155668456|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
48403351|NCT01142726|155668457|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
48403352|NCT01142726|155668455|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
48403353|NCT01142726|155668456|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
48403354|NCT01142726|155668457|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
48403355|NCT01142726|155668455|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
48403356|NCT01142726|155668456|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
48403357|NCT01142726|155668457|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
48403358|NCT01142726|155668455|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
48403359|NCT01142726|155668456|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
48403360|NCT01142726|155668457|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
48403361|NCT01142726|155668455|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
48403362|NCT01142726|155668456|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
48403363|NCT01142726|155668457|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
48403364|NCT01142726|155668455|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
48403365|NCT01142726|155668456|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
48403366|NCT01142726|155668457|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
48403367|NCT01731678|155668458|FG000|Overall Study|Withdrawal by Subject|3|||
48403368|NCT01731678|155668458|FG000|Overall Study|Did not meet inclusion criteria|1|||
48403369|NCT01731678|155668458|FG000|Overall Study|RMT too high, making TMS difficult|3|||
48403370|NCT01834729|155668461|FG000|Overall Study|Did not return bowel diaries|0|||
48403371|NCT01834729|155668462|FG001|Overall Study|Did not return bowel diaries|0|||
48403372|NCT01834729|155668463|FG002|Overall Study|Did not return bowel diaries|3|||
48403373|NCT01834729|155668464|FG003|Overall Study|Did not return bowel diaries|0|||
48403374|NCT01834729|155668461|FG000|Overall Study|Withdrawal by Subject|1|||
48403375|NCT01834729|155668462|FG001|Overall Study|Withdrawal by Subject|1|||
48403376|NCT01834729|155668463|FG002|Overall Study|Withdrawal by Subject|0|||
48403377|NCT01834729|155668464|FG003|Overall Study|Withdrawal by Subject|0|||
48403378|NCT01834729|155668461|FG000|Overall Study|Adverse Event|0|||
48403379|NCT01834729|155668462|FG001|Overall Study|Adverse Event|0|||
48403380|NCT01834729|155668463|FG002|Overall Study|Adverse Event|0|||
48403381|NCT01834729|155668464|FG003|Overall Study|Adverse Event|2|||
48403382|NCT00288080|155668465|FG000|Overall Study|Withdrawal by Subject|1|||
48403383|NCT00288080|155668466|FG001|Overall Study|Withdrawal by Subject|3|||
48403384|NCT00288080|155668465|FG000|Overall Study|Protocol Violation|25|||
48403385|NCT00288080|155668466|FG001|Overall Study|Protocol Violation|20|||
48403386|NCT01543087|155668467|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
48403387|NCT01543087|155668468|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
48403388|NCT01543087|155668469|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
48403389|NCT01543087|155668470|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
48403390|NCT01543087|155668471|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
48403391|NCT01543087|155668472|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
48403392|NCT01543087|155668467|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
48403393|NCT01543087|155668468|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
48403394|NCT01543087|155668469|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
48403395|NCT01543087|155668470|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
48403396|NCT01543087|155668471|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
48403397|NCT01543087|155668472|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
48403398|NCT01543087|155668467|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
48403399|NCT01543087|155668468|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
48403400|NCT01543087|155668469|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
48403401|NCT01543087|155668470|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
48403402|NCT01543087|155668471|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
48403403|NCT01543087|155668472|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
48403404|NCT01543087|155668467|FG000|Stage 1 (48 Months)|Other than specified|5|||
48403405|NCT01543087|155668468|FG001|Stage 1 (48 Months)|Other than specified|0|||
48403406|NCT01543087|155668469|FG002|Stage 1 (48 Months)|Other than specified|9|||
48403407|NCT01543087|155668470|FG003|Stage 1 (48 Months)|Other than specified|0|||
48403408|NCT01543087|155668471|FG004|Stage 1 (48 Months)|Other than specified|0|||
48403409|NCT01543087|155668472|FG005|Stage 1 (48 Months)|Other than specified|0|||
48403410|NCT01543087|155668467|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
48403411|NCT01543087|155668468|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
48403412|NCT01543087|155668469|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
48403413|NCT01543087|155668470|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
48403414|NCT01543087|155668471|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
48403415|NCT01543087|155668472|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
48403416|NCT01543087|155668467|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
48403417|NCT01543087|155668468|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
48403418|NCT01543087|155668469|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
48403419|NCT01543087|155668470|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
48403420|NCT01543087|155668471|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
48403421|NCT01543087|155668472|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
48403422|NCT01543087|155668467|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
48403423|NCT01543087|155668468|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
48403424|NCT01543087|155668469|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
48403425|NCT01543087|155668470|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
48403426|NCT01543087|155668471|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
48403427|NCT01543087|155668472|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
48403428|NCT00379795|155668473|FG000|Overall Study|Death|31|||
48403429|NCT00379795|155668474|FG001|Overall Study|Death|8|||
48403430|NCT00379795|155668475|FG002|Overall Study|Death|6|||
48403431|NCT00379795|155668476|FG003|Overall Study|Death|4|||
48403432|NCT00379795|155668477|FG004|Overall Study|Death|7|||
48403433|NCT00379795|155668473|FG000|Overall Study|Adverse Event|17|||
48403434|NCT00379795|155668474|FG001|Overall Study|Adverse Event|3|||
48403435|NCT00379795|155668475|FG002|Overall Study|Adverse Event|3|||
48403436|NCT00379795|155668476|FG003|Overall Study|Adverse Event|1|||
48403437|NCT00379795|155668477|FG004|Overall Study|Adverse Event|4|||
48403438|NCT00379795|155668473|FG000|Overall Study|Lost to Follow-up|8|||
48403439|NCT00379795|155668474|FG001|Overall Study|Lost to Follow-up|1|||
48403440|NCT00379795|155668475|FG002|Overall Study|Lost to Follow-up|2|||
48403441|NCT00379795|155668476|FG003|Overall Study|Lost to Follow-up|1|||
48403442|NCT00379795|155668477|FG004|Overall Study|Lost to Follow-up|4|||
48403443|NCT00379795|155668473|FG000|Overall Study|Physician Decision|25|||
48403444|NCT00379795|155668474|FG001|Overall Study|Physician Decision|0|||
48403445|NCT00379795|155668475|FG002|Overall Study|Physician Decision|2|||
48403446|NCT00379795|155668476|FG003|Overall Study|Physician Decision|2|||
48403447|NCT00379795|155668477|FG004|Overall Study|Physician Decision|2|||
48430367|NCT00696657|155763703|FG003|Overall Study|Adverse Event|7|||
48403448|NCT00379795|155668473|FG000|Overall Study|Withdrawal by Subject|94|||
48403449|NCT00379795|155668474|FG001|Overall Study|Withdrawal by Subject|11|||
48403450|NCT00379795|155668475|FG002|Overall Study|Withdrawal by Subject|19|||
48796295|NCT00322348|157091531|FG001|Overall Study|Lost to Follow-up|0|||
48403451|NCT00379795|155668476|FG003|Overall Study|Withdrawal by Subject|7|||
48796296|NCT00322348|157091530|FG000|Overall Study|Death|0|||
48796297|NCT00322348|157091531|FG001|Overall Study|Death|2|||
48796298|NCT00322348|157091530|FG000|Overall Study|Disease Progression|30|||
48796299|NCT00322348|157091531|FG001|Overall Study|Disease Progression|25|||
48796300|NCT00322348|157091530|FG000|Overall Study|Reasons not specified|5|||
48796301|NCT00322348|157091531|FG001|Overall Study|Reasons not specified|1|||
48796302|NCT04958109|157091532|FG000|Overall Study|Withdrawal by Subject|0|||
48796303|NCT04958109|157091533|FG001|Overall Study|Withdrawal by Subject|1|||
48796304|NCT04958109|157091532|FG000|Overall Study|Lost to Follow-up|0|||
48796305|NCT04958109|157091533|FG001|Overall Study|Lost to Follow-up|1|||
48796306|NCT01292239|157091536|FG000|Overall Study|Other|1|||
48796307|NCT01292239|157091537|FG001|Overall Study|Other|1|||
48796308|NCT01292239|157091536|FG000|Overall Study|Withdrawal by Subject|3|||
48796309|NCT01292239|157091537|FG001|Overall Study|Withdrawal by Subject|6|||
48796310|NCT01939548|157091541|FG000|Overall Study|Non compliance|0|||
48796311|NCT01939548|157091542|FG001|Overall Study|Non compliance|2|||
48796312|NCT01939548|157091543|FG002|Overall Study|Non compliance|0|||
48796313|NCT01939548|157091541|FG000|Overall Study|Study Terminated by Sponsor|17|||
48796314|NCT01939548|157091542|FG001|Overall Study|Study Terminated by Sponsor|19|||
48796315|NCT01939548|157091543|FG002|Overall Study|Study Terminated by Sponsor|12|||
48796316|NCT01939548|157091541|FG000|Overall Study|Insufficient Clinical Response|1|||
48796317|NCT01939548|157091542|FG001|Overall Study|Insufficient Clinical Response|0|||
48796318|NCT01939548|157091543|FG002|Overall Study|Insufficient Clinical Response|0|||
48796319|NCT01939548|157091541|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
48796320|NCT01939548|157091542|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
48796321|NCT01939548|157091543|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
48796322|NCT01939548|157091541|FG000|Overall Study|Withdrawal by Subject|4|||
48796323|NCT01939548|157091542|FG001|Overall Study|Withdrawal by Subject|4|||
48796324|NCT01939548|157091543|FG002|Overall Study|Withdrawal by Subject|1|||
48796325|NCT01939548|157091541|FG000|Overall Study|Protocol Violation|7|||
48796326|NCT01939548|157091542|FG001|Overall Study|Protocol Violation|6|||
48796327|NCT01939548|157091543|FG002|Overall Study|Protocol Violation|5|||
48796328|NCT01939548|157091541|FG000|Overall Study|Lost to Follow-up|5|||
48796329|NCT01939548|157091542|FG001|Overall Study|Lost to Follow-up|5|||
48796330|NCT01939548|157091543|FG002|Overall Study|Lost to Follow-up|3|||
48796331|NCT01939548|157091541|FG000|Overall Study|Adverse Event|2|||
48796332|NCT01939548|157091542|FG001|Overall Study|Adverse Event|9|||
48796333|NCT01939548|157091543|FG002|Overall Study|Adverse Event|7|||
48796334|NCT01939548|157091541|FG000|Overall Study|Death|0|||
48796335|NCT01939548|157091542|FG001|Overall Study|Death|0|||
48796336|NCT01939548|157091543|FG002|Overall Study|Death|1|||
48796337|NCT01939548|157091541|FG000|Overall Study|Participant dropped|0|||
48796338|NCT01939548|157091542|FG001|Overall Study|Participant dropped|0|||
48796339|NCT01939548|157091543|FG002|Overall Study|Participant dropped|1|||
48796340|NCT01939548|157091541|FG000|Overall Study|Participant unwilling to continue|0|||
48796341|NCT01939548|157091542|FG001|Overall Study|Participant unwilling to continue|1|||
48796342|NCT01939548|157091543|FG002|Overall Study|Participant unwilling to continue|0|||
48796343|NCT01939548|157091541|FG000|Overall Study|Participant withdrew consent|0|||
48796344|NCT01939548|157091542|FG001|Overall Study|Participant withdrew consent|2|||
48796345|NCT01939548|157091543|FG002|Overall Study|Participant withdrew consent|0|||
48796346|NCT01939548|157091541|FG000|Overall Study|Did not complete follow-up|0|||
48796347|NCT01939548|157091542|FG001|Overall Study|Did not complete follow-up|1|||
48796348|NCT01939548|157091543|FG002|Overall Study|Did not complete follow-up|0|||
48796349|NCT01400503|157091549|FG000|Overall Study|Withdrawal by Subject|1|||
48796350|NCT01400503|157091549|FG000|Overall Study|Study Terminated by Sponsor|58|||
48796351|NCT01400503|157091549|FG000|Overall Study|Other|1|||
48796352|NCT00344461|157091552|FG000|Overall Study|Adverse Event|6|||
48796353|NCT00344461|157091552|FG000|Overall Study|Death|1|||
48796354|NCT00344461|157091552|FG000|Overall Study|Lack of Efficacy|2|||
48796355|NCT00344461|157091552|FG000|Overall Study|Lost to Follow-up|2|||
48796356|NCT00344461|157091552|FG000|Overall Study|Physician Decision|2|||
48796357|NCT00344461|157091552|FG000|Overall Study|Protocol Violation|6|||
48796358|NCT00344461|157091552|FG000|Overall Study|Withdrawal by Subject|2|||
48796359|NCT01261338|157091556|FG000|Overall Study|Withdrawal by Subject|3|||
48796360|NCT01261338|157091557|FG001|Overall Study|Withdrawal by Subject|2|||
48796361|NCT01515748|157091560|FG000|Overall Study|Withdrawal by Subject|32|||
48796362|NCT01515748|157091561|FG001|Overall Study|Withdrawal by Subject|41|||
48796363|NCT01515748|157091560|FG000|Overall Study|Lost to Follow-up|2|||
48796364|NCT01515748|157091561|FG001|Overall Study|Lost to Follow-up|4|||
48796365|NCT01515748|157091560|FG000|Overall Study|Other than specified above|5|||
48403452|NCT00379795|155668477|FG004|Overall Study|Withdrawal by Subject|14|||
48403453|NCT00379795|155668473|FG000|Overall Study|Subject non-compliance|7|||
48403454|NCT00379795|155668474|FG001|Overall Study|Subject non-compliance|2|||
48403455|NCT00379795|155668475|FG002|Overall Study|Subject non-compliance|0|||
48403456|NCT00379795|155668476|FG003|Overall Study|Subject non-compliance|0|||
48403457|NCT00379795|155668477|FG004|Overall Study|Subject non-compliance|1|||
48403458|NCT00379795|155668473|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
48403459|NCT00379795|155668474|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
48403460|NCT00379795|155668475|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
48403461|NCT00379795|155668476|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
48403462|NCT00379795|155668477|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
48403463|NCT00379795|155668473|FG000|Overall Study|Subjects condition mandated intervention|34|||
48403464|NCT00379795|155668474|FG001|Overall Study|Subjects condition mandated intervention|9|||
48403465|NCT00379795|155668475|FG002|Overall Study|Subjects condition mandated intervention|7|||
48403466|NCT00379795|155668476|FG003|Overall Study|Subjects condition mandated intervention|5|||
48403467|NCT00379795|155668477|FG004|Overall Study|Subjects condition mandated intervention|7|||
48403468|NCT00379795|155668473|FG000|Overall Study|Sponsor's decision|257|||
48403469|NCT00379795|155668474|FG001|Overall Study|Sponsor's decision|17|||
48403470|NCT00379795|155668475|FG002|Overall Study|Sponsor's decision|54|||
48403471|NCT00379795|155668476|FG003|Overall Study|Sponsor's decision|47|||
48403472|NCT00379795|155668477|FG004|Overall Study|Sponsor's decision|10|||
48403473|NCT03175549|155668478|FG000|Overall Study|Lost to Follow-up|2|||
48403474|NCT03175549|155668479|FG001|Overall Study|Lost to Follow-up|2|||
48403475|NCT03175549|155668478|FG000|Overall Study|Medication non-compliance|2|||
48403476|NCT03175549|155668479|FG001|Overall Study|Medication non-compliance|2|||
48403477|NCT02486757|155668480|FG000|Overall Study|Lost to Follow-up|1|||
48403478|NCT02793232|155668481|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48403479|NCT02793232|155668482|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48403480|NCT02793232|155668483|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48403481|NCT02793232|155668484|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48403482|NCT02793232|155668485|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
48403483|NCT02793232|155668486|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48403484|NCT02793232|155668487|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
48403485|NCT02793232|155668488|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48403486|NCT02793232|155668489|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
48403487|NCT02682901|155668490|FG000|Overall Study|Adverse Event|10|||
48403488|NCT02682901|155668491|FG001|Overall Study|Adverse Event|3|||
48403489|NCT02682901|155668490|FG000|Overall Study|Lack of Efficacy|0|||
48403490|NCT02682901|155668491|FG001|Overall Study|Lack of Efficacy|1|||
48403491|NCT01235962|155668492|FG000|Overall Study|Withdrawal by Subject|20|||
48403492|NCT01235962|155668493|FG001|Overall Study|Withdrawal by Subject|19|||
48403493|NCT01235962|155668494|FG002|Overall Study|Withdrawal by Subject|62|||
48403494|NCT01235962|155668495|FG003|Overall Study|Withdrawal by Subject|49|||
48403495|NCT01235962|155668492|FG000|Overall Study|Lost to Follow-up|21|||
48403496|NCT01235962|155668493|FG001|Overall Study|Lost to Follow-up|16|||
48403497|NCT01235962|155668494|FG002|Overall Study|Lost to Follow-up|47|||
48403498|NCT01235962|155668495|FG003|Overall Study|Lost to Follow-up|32|||
48403499|NCT01235962|155668492|FG000|Overall Study|Physician Decision|5|||
48403500|NCT01235962|155668493|FG001|Overall Study|Physician Decision|0|||
48403501|NCT01235962|155668494|FG002|Overall Study|Physician Decision|9|||
48403502|NCT01235962|155668495|FG003|Overall Study|Physician Decision|5|||
48403503|NCT01486199|155668496|FG000|Two Year Period Between Study Days|Physician Decision|1|||
48403504|NCT01486199|155668497|FG001|Two Year Period Between Study Days|Physician Decision|0|||
48403505|NCT03694925|155668498|FG000|Overall Study|Inadequate laboratory testing|0|||
48403506|NCT03694925|155668499|FG001|Overall Study|Inadequate laboratory testing|3|||
48403507|NCT03694925|155668500|FG002|Overall Study|Inadequate laboratory testing|0|||
48403508|NCT03604445|155668503|FG000|Overall Study|Death|0|||
48403509|NCT03604445|155668504|FG001|Overall Study|Death|0|||
48403510|NCT03604445|155668505|FG002|Overall Study|Death|0|||
48403511|NCT03604445|155668506|FG003|Overall Study|Death|0|||
48403512|NCT03604445|155668507|FG004|Overall Study|Death|0|||
48403513|NCT03604445|155668508|FG005|Overall Study|Death|0|||
48403514|NCT03604445|155668509|FG006|Overall Study|Death|0|||
48403515|NCT03604445|155668510|FG007|Overall Study|Death|0|||
48403516|NCT03604445|155668511|FG008|Overall Study|Death|1|||
48403517|NCT03604445|155668503|FG000|Overall Study|Withdrawal by Subject|0|||
48403518|NCT03604445|155668504|FG001|Overall Study|Withdrawal by Subject|0|||
48403519|NCT03604445|155668505|FG002|Overall Study|Withdrawal by Subject|0|||
48403520|NCT03604445|155668506|FG003|Overall Study|Withdrawal by Subject|0|||
48692500|NCT00453154|156724506|FG003|Double BIind Maintenance|Adverse Event|12|||
48403521|NCT03604445|155668507|FG004|Overall Study|Withdrawal by Subject|0|||
48403522|NCT03604445|155668508|FG005|Overall Study|Withdrawal by Subject|0|||
48403523|NCT03604445|155668509|FG006|Overall Study|Withdrawal by Subject|1|||
48403524|NCT03604445|155668510|FG007|Overall Study|Withdrawal by Subject|0|||
48403525|NCT03604445|155668511|FG008|Overall Study|Withdrawal by Subject|0|||
48403526|NCT03604445|155668503|FG000|Overall Study|Missing visit|0|||
48403527|NCT03604445|155668504|FG001|Overall Study|Missing visit|0|||
48403528|NCT03604445|155668505|FG002|Overall Study|Missing visit|0|||
48403529|NCT03604445|155668506|FG003|Overall Study|Missing visit|0|||
48403530|NCT03604445|155668507|FG004|Overall Study|Missing visit|0|||
48403531|NCT03604445|155668508|FG005|Overall Study|Missing visit|1|||
48403532|NCT03604445|155668509|FG006|Overall Study|Missing visit|0|||
48403533|NCT03604445|155668510|FG007|Overall Study|Missing visit|1|||
48403534|NCT03604445|155668511|FG008|Overall Study|Missing visit|0|||
48403535|NCT03604445|155668503|FG000|Overall Study|Adverse Event|0|||
48403536|NCT03604445|155668504|FG001|Overall Study|Adverse Event|0|||
48403537|NCT03604445|155668505|FG002|Overall Study|Adverse Event|0|||
48403538|NCT03604445|155668506|FG003|Overall Study|Adverse Event|1|||
48403539|NCT03604445|155668507|FG004|Overall Study|Adverse Event|0|||
48403540|NCT03604445|155668508|FG005|Overall Study|Adverse Event|0|||
48403541|NCT03604445|155668509|FG006|Overall Study|Adverse Event|0|||
48403542|NCT03604445|155668510|FG007|Overall Study|Adverse Event|0|||
48403543|NCT03604445|155668511|FG008|Overall Study|Adverse Event|1|||
48403544|NCT04178772|155668518|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
48403545|NCT04178772|155668518|FG000|Overall Study|study terminated early due to COVID-19|7|||
48403546|NCT01276236|155668522|FG000|Overall Study|Lack of Efficacy|2|||
48403547|NCT01276236|155668522|FG000|Overall Study|Withdrawal by Subject|4|||
48403548|NCT01327651|155668523|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
48403549|NCT01327651|155668524|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
48403550|NCT01327651|155668525|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
48403551|NCT01327651|155668526|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
48403552|NCT01327651|155668527|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
48403553|NCT01327651|155668528|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
48403554|NCT01327651|155668529|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
48403555|NCT01327651|155668530|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
48403556|NCT01327651|155668531|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
48403557|NCT01327651|155668523|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
48403558|NCT01327651|155668524|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48403559|NCT01327651|155668525|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48403560|NCT01327651|155668526|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48403561|NCT01327651|155668527|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48403562|NCT01327651|155668528|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48403563|NCT01327651|155668529|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48403564|NCT01327651|155668530|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48403565|NCT01327651|155668531|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
48403566|NCT01327651|155668523|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
48403567|NCT01327651|155668524|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
48403568|NCT01327651|155668525|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
48403569|NCT01327651|155668526|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
48403570|NCT01327651|155668527|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
48403571|NCT01327651|155668528|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
48403572|NCT01327651|155668529|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
48403573|NCT01327651|155668530|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
48403574|NCT01327651|155668531|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
48403575|NCT01327651|155668523|FG000|Post Study Follow-up|Lost to Follow-up|0|||
48403576|NCT01327651|155668524|FG001|Post Study Follow-up|Lost to Follow-up|1|||
48403577|NCT01327651|155668525|FG002|Post Study Follow-up|Lost to Follow-up|1|||
48403578|NCT01327651|155668526|FG003|Post Study Follow-up|Lost to Follow-up|0|||
48403579|NCT01327651|155668527|FG004|Post Study Follow-up|Lost to Follow-up|0|||
48403580|NCT01327651|155668528|FG005|Post Study Follow-up|Lost to Follow-up|0|||
48403581|NCT01327651|155668529|FG006|Post Study Follow-up|Lost to Follow-up|4|||
48403582|NCT01327651|155668530|FG007|Post Study Follow-up|Lost to Follow-up|1|||
48403583|NCT01327651|155668531|FG008|Post Study Follow-up|Lost to Follow-up|2|||
48403584|NCT01890421|155668534|FG000|Overall Study|Adverse Event|1|||
48403585|NCT01890421|155668534|FG000|Overall Study|Other reason|10|||
48403586|NCT03310970|155668535|FG000|Overall Study|Withdrawal by Subject|0|||
48403587|NCT03310970|155668536|FG001|Overall Study|Withdrawal by Subject|1|||
48403588|NCT01614093|155668539|FG000|Overall Study|Withdrawal by Subject|1|||
48403589|NCT00848354|155668540|FG000|Phase 1|Adverse Event|5|||
48403590|NCT00848354|155668541|FG001|Phase 1|Adverse Event|4|||
48403591|NCT00848354|155668540|FG000|Phase 1|Discontinuation of study by sponsor|2|||
48403592|NCT00848354|155668541|FG001|Phase 1|Discontinuation of study by sponsor|1|||
48403593|NCT00848354|155668540|FG000|Phase 1|Failed to return|0|||
48403594|NCT00848354|155668541|FG001|Phase 1|Failed to return|1|||
48403595|NCT00848354|155668540|FG000|Phase 1|Lost to Follow-up|1|||
48403596|NCT00848354|155668541|FG001|Phase 1|Lost to Follow-up|1|||
48403597|NCT00848354|155668540|FG000|Phase 1|Unspecified Reason|1|||
48403598|NCT00848354|155668541|FG001|Phase 1|Unspecified Reason|1|||
48403599|NCT00848354|155668540|FG000|Phase 1|Protocol Violation|1|||
48403600|NCT00848354|155668541|FG001|Phase 1|Protocol Violation|1|||
48403601|NCT00848354|155668540|FG000|Phase 1|Withdrawal by Subject|2|||
48403602|NCT00848354|155668541|FG001|Phase 1|Withdrawal by Subject|4|||
48403603|NCT00848354|155668540|FG000|Phase 1|Lack of Efficacy|0|||
48403604|NCT00848354|155668541|FG001|Phase 1|Lack of Efficacy|1|||
48403605|NCT00848354|155668540|FG000|Phase 2 Year 1|Adverse Event|7|||
48403606|NCT00848354|155668541|FG001|Phase 2 Year 1|Adverse Event|2|||
48403607|NCT00848354|155668540|FG000|Phase 2 Year 1|Death|1|||
48403608|NCT00848354|155668541|FG001|Phase 2 Year 1|Death|0|||
48403609|NCT00848354|155668540|FG000|Phase 2 Year 1|Failed to Return|1|||
48357178|NCT00203047|155503569|FG001|Overall Study|Teva requested participant withdrawal|1|||
48357179|NCT00203047|155503568|FG000|Overall Study|Physician Decision|8|||
48357180|NCT00203047|155503569|FG001|Overall Study|Physician Decision|7|||
48357181|NCT00203047|155503568|FG000|Overall Study|Non-compliance|4|||
48357182|NCT00203047|155503569|FG001|Overall Study|Non-compliance|8|||
48357183|NCT00203047|155503568|FG000|Overall Study|Protocol Violation|1|||
48357184|NCT00203047|155503569|FG001|Overall Study|Protocol Violation|0|||
48357185|NCT00203047|155503568|FG000|Overall Study|Lost to Follow-up|11|||
48357186|NCT00203047|155503569|FG001|Overall Study|Lost to Follow-up|5|||
48357187|NCT00203047|155503568|FG000|Overall Study|Adverse Event|8|||
48357188|NCT00203047|155503569|FG001|Overall Study|Adverse Event|18|||
48403610|NCT00848354|155668541|FG001|Phase 2 Year 1|Failed to Return|1|||
48403611|NCT00848354|155668540|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
48403612|NCT00848354|155668541|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
48403613|NCT00848354|155668540|FG000|Phase 2 Year 1|Unspecified Reason|3|||
48403614|NCT00848354|155668541|FG001|Phase 2 Year 1|Unspecified Reason|0|||
48403615|NCT00848354|155668540|FG000|Phase 2 Year 1|Protocol Violation|4|||
48403616|NCT00848354|155668541|FG001|Phase 2 Year 1|Protocol Violation|1|||
48403617|NCT00848354|155668540|FG000|Phase 2 Year 1|Subject Request|1|||
48403618|NCT00848354|155668541|FG001|Phase 2 Year 1|Subject Request|2|||
48403619|NCT00848354|155668540|FG000|Phase 2 Year 2|Adverse Event|12|||
48403620|NCT00848354|155668541|FG001|Phase 2 Year 2|Adverse Event|2|||
48403621|NCT00848354|155668540|FG000|Phase 2 Year 2|Death|2|||
48403622|NCT00848354|155668541|FG001|Phase 2 Year 2|Death|0|||
48403623|NCT00848354|155668540|FG000|Phase 2 Year 2|Failed to return|3|||
48403624|NCT00848354|155668541|FG001|Phase 2 Year 2|Failed to return|0|||
48403625|NCT00848354|155668540|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
48403626|NCT00848354|155668541|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
48403627|NCT00848354|155668540|FG000|Phase 2 Year 2|Unspecified Reason|1|||
48403628|NCT00848354|155668541|FG001|Phase 2 Year 2|Unspecified Reason|0|||
48403629|NCT00848354|155668540|FG000|Phase 2 Year 2|Protocol Violation|1|||
48403630|NCT00848354|155668541|FG001|Phase 2 Year 2|Protocol Violation|1|||
48403631|NCT00848354|155668540|FG000|Phase 2 Year 2|Subject Request|1|||
48403632|NCT00848354|155668541|FG001|Phase 2 Year 2|Subject Request|1|||
48403633|NCT00848354|155668540|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
48403634|NCT00848354|155668541|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
48403635|NCT01282229|155668545|FG000|Overall Study|Protocol Violation|2|||
48403636|NCT03208231|155668548|FG000|Overall Study|Death|1|||
48403637|NCT03208231|155668549|FG001|Overall Study|Death|2|||
48403638|NCT03208231|155668548|FG000|Overall Study|Moved and unable to get to clinic|1|||
48403639|NCT03208231|155668549|FG001|Overall Study|Moved and unable to get to clinic|0|||
48403640|NCT03208231|155668548|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
48403641|NCT03208231|155668549|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
48403642|NCT02154087|155668550|FG000|Overall Study|Study Termination|1|||
48403643|NCT01724528|155668555|FG000|Overall Study|Death|3|||
48403644|NCT01724528|155668556|FG001|Overall Study|Death|0|||
48403645|NCT01724528|155668555|FG000|Overall Study|Withdrawal by Subject|0|||
48403646|NCT01724528|155668556|FG001|Overall Study|Withdrawal by Subject|2|||
48403647|NCT01724528|155668555|FG000|Overall Study|Protocol Violation|0|||
48403648|NCT01724528|155668556|FG001|Overall Study|Protocol Violation|1|||
48403649|NCT01724528|155668555|FG000|Overall Study|Patient refused to attend last visit|1|||
48403650|NCT01724528|155668556|FG001|Overall Study|Patient refused to attend last visit|0|||
48403651|NCT00654498|155668562|FG000|Overall Study|Not Treated|1|||
48403652|NCT00654498|155668563|FG001|Overall Study|Not Treated|0|||
48403653|NCT00654498|155668562|FG000|Overall Study|Adverse Event|6|||
48403654|NCT00654498|155668563|FG001|Overall Study|Adverse Event|1|||
48403655|NCT00654498|155668562|FG000|Overall Study|Protocol Violation|1|||
48403656|NCT00654498|155668563|FG001|Overall Study|Protocol Violation|1|||
48403657|NCT00654498|155668562|FG000|Overall Study|Lost to Follow-up|1|||
48403658|NCT00654498|155668563|FG001|Overall Study|Lost to Follow-up|5|||
48403659|NCT00654498|155668562|FG000|Overall Study|Withdrawal by Subject|1|||
48403660|NCT00654498|155668563|FG001|Overall Study|Withdrawal by Subject|0|||
48403661|NCT00654498|155668562|FG000|Overall Study|Other reason not defined above|4|||
48403662|NCT00654498|155668563|FG001|Overall Study|Other reason not defined above|5|||
48403663|NCT01292057|155668565|FG000|Overall Study|Protocol Violation|1|||
48403664|NCT01292057|155668566|FG001|Overall Study|Protocol Violation|1|||
48403665|NCT01292057|155668565|FG000|Overall Study|Lost to Follow-up|1|||
48403666|NCT01292057|155668566|FG001|Overall Study|Lost to Follow-up|1|||
48403667|NCT00500682|155668569|FG000|Overall Study|Adverse Event|37|||
48403668|NCT00500682|155668570|FG001|Overall Study|Adverse Event|29|||
48403669|NCT00500682|155668569|FG000|Overall Study|Death|25|||
48403670|NCT00500682|155668570|FG001|Overall Study|Death|16|||
48403671|NCT00500682|155668569|FG000|Overall Study|Lost to Follow-up|11|||
48403672|NCT00500682|155668570|FG001|Overall Study|Lost to Follow-up|11|||
48403673|NCT00500682|155668569|FG000|Overall Study|Physician Decision|6|||
48403674|NCT00500682|155668570|FG001|Overall Study|Physician Decision|10|||
48403675|NCT00500682|155668569|FG000|Overall Study|Pregnancy|2|||
48403676|NCT00500682|155668570|FG001|Overall Study|Pregnancy|0|||
48403677|NCT00500682|155668569|FG000|Overall Study|Protocol Violation|1|||
48403678|NCT00500682|155668570|FG001|Overall Study|Protocol Violation|3|||
48403679|NCT00500682|155668569|FG000|Overall Study|Withdrawal by Subject|80|||
48403680|NCT00500682|155668570|FG001|Overall Study|Withdrawal by Subject|74|||
48403681|NCT00500682|155668569|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
48403682|NCT00500682|155668570|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
48357189|NCT00203047|155503568|FG000|Overall Study|Death|1|||
48357190|NCT00203047|155503569|FG001|Overall Study|Death|2|||
48357191|NCT00203047|155503568|FG000|Overall Study|Pregnancy|3|||
48357192|NCT00203047|155503569|FG001|Overall Study|Pregnancy|0|||
48357193|NCT00203047|155503568|FG000|Overall Study|Other|5|||
48357194|NCT00203047|155503569|FG001|Overall Study|Other|5|||
48357195|NCT03057847|155503570|FG000|Overall Study|Lost to Follow-up|16|||
48357196|NCT00340704|155503571|FG000|PK Study|Adverse Event|0|||
48357197|NCT00340704|155503572|FG001|PK Study|Adverse Event|1|||
48357198|NCT00340704|155503573|FG002|PK Study|Adverse Event|0|||
48357199|NCT00340704|155503574|FG003|PK Study|Adverse Event|0|||
48357200|NCT00340704|155503575|FG004|PK Study|Adverse Event|0|||
48357201|NCT00340704|155503576|FG005|PK Study|Adverse Event|0|||
48357202|NCT00340704|155503577|FG006|PK Study|Adverse Event|0|||
48357203|NCT00340704|155503578|FG007|PK Study|Adverse Event|0|||
48357204|NCT00340704|155503579|FG008|PK Study|Adverse Event|0|||
48357205|NCT00340704|155503571|FG000|PK Study|Not treated|0|||
48357206|NCT00340704|155503572|FG001|PK Study|Not treated|0|||
48357207|NCT00340704|155503573|FG002|PK Study|Not treated|1|||
48357208|NCT00340704|155503574|FG003|PK Study|Not treated|0|||
48357209|NCT00340704|155503575|FG004|PK Study|Not treated|0|||
48357210|NCT00340704|155503576|FG005|PK Study|Not treated|0|||
48357211|NCT00340704|155503577|FG006|PK Study|Not treated|0|||
48357212|NCT00340704|155503578|FG007|PK Study|Not treated|0|||
48357213|NCT00340704|155503579|FG008|PK Study|Not treated|0|||
48357214|NCT00340704|155503571|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48357215|NCT00340704|155503572|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48403683|NCT01182428|155668573|FG000|Overall Study|Physician Decision|1|||
48403684|NCT01182428|155668574|FG001|Overall Study|Physician Decision|0|||
48403685|NCT01182428|155668573|FG000|Overall Study|Lost to Follow-up|9|||
48403686|NCT01182428|155668574|FG001|Overall Study|Lost to Follow-up|1|||
48403687|NCT01182428|155668573|FG000|Overall Study|Withdrawal by Subject|1|||
48403688|NCT01182428|155668574|FG001|Overall Study|Withdrawal by Subject|0|||
48403689|NCT01227902|155669630|FG000|Overall Study|Adverse Event|12|||
48403690|NCT01227902|155669631|FG001|Overall Study|Adverse Event|8|||
48403691|NCT01227902|155669632|FG002|Overall Study|Adverse Event|11|||
48403692|NCT01227902|155669633|FG003|Overall Study|Adverse Event|4|||
48403693|NCT01227902|155669630|FG000|Overall Study|Lack of Efficacy|1|||
48403694|NCT01227902|155669631|FG001|Overall Study|Lack of Efficacy|2|||
48403695|NCT01227902|155669632|FG002|Overall Study|Lack of Efficacy|2|||
48403696|NCT01227902|155669633|FG003|Overall Study|Lack of Efficacy|1|||
48403697|NCT01227902|155669630|FG000|Overall Study|Protocol Violation|1|||
48357216|NCT00340704|155503573|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48357217|NCT00340704|155503574|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
48357218|NCT00340704|155503575|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
48357219|NCT00340704|155503576|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48357220|NCT00340704|155503577|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
48357221|NCT00340704|155503578|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
48357222|NCT00340704|155503579|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
48357223|NCT00340704|155503571|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48357224|NCT00340704|155503572|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48357225|NCT00340704|155503573|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48357226|NCT00340704|155503574|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48357227|NCT00340704|155503575|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48357228|NCT00340704|155503576|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
48357229|NCT00340704|155503577|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48357230|NCT00340704|155503578|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48357231|NCT00340704|155503579|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
48403698|NCT01227902|155669631|FG001|Overall Study|Protocol Violation|0|||
48403699|NCT01227902|155669632|FG002|Overall Study|Protocol Violation|0|||
48403700|NCT01227902|155669633|FG003|Overall Study|Protocol Violation|0|||
48403701|NCT01227902|155669630|FG000|Overall Study|Lost to Follow-up|0|||
48403702|NCT01227902|155669631|FG001|Overall Study|Lost to Follow-up|0|||
48403703|NCT01227902|155669632|FG002|Overall Study|Lost to Follow-up|1|||
48403704|NCT01227902|155669633|FG003|Overall Study|Lost to Follow-up|2|||
48403705|NCT01227902|155669630|FG000|Overall Study|Physician Decision|0|||
48403706|NCT01227902|155669631|FG001|Overall Study|Physician Decision|1|||
48403707|NCT01227902|155669632|FG002|Overall Study|Physician Decision|1|||
48403708|NCT01227902|155669633|FG003|Overall Study|Physician Decision|0|||
48403709|NCT01227902|155669630|FG000|Overall Study|Withdrawal by Subject|4|||
48403710|NCT01227902|155669631|FG001|Overall Study|Withdrawal by Subject|2|||
48403711|NCT01227902|155669632|FG002|Overall Study|Withdrawal by Subject|4|||
48403712|NCT01227902|155669633|FG003|Overall Study|Withdrawal by Subject|3|||
48403713|NCT02068547|155669634|FG000|Overall Study|Lost to Follow-up|3|||
48403714|NCT02068547|155669635|FG001|Overall Study|Lost to Follow-up|3|||
48403715|NCT02068547|155669634|FG000|Overall Study|Physician Decision|1|||
48403716|NCT02068547|155669635|FG001|Overall Study|Physician Decision|0|||
48403717|NCT03047980|155669636|FG000|Overall Study|Adverse Event|1|||
48403718|NCT02627495|155669637|FG000|Overall Study|Withdrawal by Subject|4|||
48403719|NCT00874120|155669638|FG000|First Intervention|Adverse Event|0|||
48403720|NCT00874120|155669639|FG001|First Intervention|Adverse Event|1|||
48403721|NCT00874120|155669638|FG000|First Intervention|Withdrawal by Subject|2|||
48403722|NCT00874120|155669639|FG001|First Intervention|Withdrawal by Subject|0|||
48403723|NCT00874120|155669638|FG000|First Intervention|Lost to Follow-up|0|||
48403724|NCT00874120|155669639|FG001|First Intervention|Lost to Follow-up|1|||
48403725|NCT00874120|155669638|FG000|First Intervention|Protocol Violation|3|||
48403726|NCT00874120|155669639|FG001|First Intervention|Protocol Violation|0|||
48403727|NCT00874120|155669638|FG000|First Intervention|positive drug test|1|||
48403728|NCT00874120|155669639|FG001|First Intervention|positive drug test|0|||
48403729|NCT00874120|155669638|FG000|Second Intervention|Withdrawal by Subject|1|||
48403730|NCT00874120|155669639|FG001|Second Intervention|Withdrawal by Subject|0|||
48403731|NCT00874120|155669638|FG000|Second Intervention|Protocol Violation|1|||
48403732|NCT00874120|155669639|FG001|Second Intervention|Protocol Violation|0|||
48403733|NCT00482014|155669640|FG000|Overall Study|Withdrawal by Subject|1|||
48403734|NCT00482014|155669641|FG001|Overall Study|Withdrawal by Subject|2|||
48403735|NCT00482014|155669642|FG002|Overall Study|Withdrawal by Subject|3|||
48403736|NCT00482014|155669643|FG003|Overall Study|Withdrawal by Subject|4|||
48403737|NCT00482014|155669640|FG000|Overall Study|Adverse Event|3|||
48403738|NCT00482014|155669641|FG001|Overall Study|Adverse Event|0|||
48403739|NCT00482014|155669642|FG002|Overall Study|Adverse Event|2|||
48403740|NCT00482014|155669643|FG003|Overall Study|Adverse Event|8|||
48403741|NCT00482014|155669640|FG000|Overall Study|Death|1|||
48403742|NCT00482014|155669641|FG001|Overall Study|Death|2|||
48403743|NCT00482014|155669642|FG002|Overall Study|Death|1|||
48403744|NCT00482014|155669643|FG003|Overall Study|Death|4|||
48403745|NCT00482014|155669640|FG000|Overall Study|Lack of Efficacy|1|||
48403746|NCT00482014|155669641|FG001|Overall Study|Lack of Efficacy|0|||
48403747|NCT00482014|155669642|FG002|Overall Study|Lack of Efficacy|4|||
48403748|NCT00482014|155669643|FG003|Overall Study|Lack of Efficacy|6|||
48403749|NCT00482014|155669640|FG000|Overall Study|Sponsor Decision|1|||
48403750|NCT00482014|155669641|FG001|Overall Study|Sponsor Decision|2|||
48403751|NCT00482014|155669642|FG002|Overall Study|Sponsor Decision|1|||
48403752|NCT00482014|155669643|FG003|Overall Study|Sponsor Decision|1|||
48403753|NCT03839459|155669648|FG000|Overall Study|Withdrawal by Subject|2|||
48403754|NCT03839459|155669648|FG000|Overall Study|progression of disease|3|||
48403755|NCT01430442|155669650|FG000|Overall Study|Subject Withdrew Consent|3|||
48403756|NCT01430442|155669651|FG001|Overall Study|Subject Withdrew Consent|0|||
48403757|NCT01430442|155669652|FG002|Overall Study|Subject Withdrew Consent|1|||
48403758|NCT01430442|155669653|FG003|Overall Study|Subject Withdrew Consent|0|||
48403759|NCT01430442|155669654|FG004|Overall Study|Subject Withdrew Consent|2|||
48403760|NCT01430442|155669655|FG005|Overall Study|Subject Withdrew Consent|1|||
48403761|NCT01430442|155669656|FG006|Overall Study|Subject Withdrew Consent|5|||
48403762|NCT01430442|155669657|FG007|Overall Study|Subject Withdrew Consent|2|||
48403763|NCT01430442|155669650|FG000|Overall Study|Lost to Follow-up|2|||
48403764|NCT01430442|155669651|FG001|Overall Study|Lost to Follow-up|0|||
48403765|NCT01430442|155669652|FG002|Overall Study|Lost to Follow-up|1|||
48403766|NCT01430442|155669653|FG003|Overall Study|Lost to Follow-up|2|||
48403767|NCT01430442|155669654|FG004|Overall Study|Lost to Follow-up|2|||
48403768|NCT01430442|155669655|FG005|Overall Study|Lost to Follow-up|1|||
48403769|NCT01430442|155669656|FG006|Overall Study|Lost to Follow-up|5|||
48403770|NCT01430442|155669657|FG007|Overall Study|Lost to Follow-up|1|||
48403771|NCT01430442|155669650|FG000|Overall Study|Pregnancy|1|||
48403772|NCT01430442|155669651|FG001|Overall Study|Pregnancy|0|||
48403773|NCT01430442|155669652|FG002|Overall Study|Pregnancy|0|||
48403774|NCT01430442|155669653|FG003|Overall Study|Pregnancy|0|||
48403775|NCT01430442|155669654|FG004|Overall Study|Pregnancy|0|||
48403776|NCT01430442|155669655|FG005|Overall Study|Pregnancy|1|||
48403777|NCT01430442|155669656|FG006|Overall Study|Pregnancy|0|||
48403778|NCT01430442|155669657|FG007|Overall Study|Pregnancy|0|||
48403779|NCT01430442|155669650|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
48403780|NCT01430442|155669651|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
48403781|NCT01430442|155669652|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
48403782|NCT01430442|155669653|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
48403783|NCT01430442|155669654|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
48403784|NCT01430442|155669655|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
48403785|NCT01430442|155669656|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
48403786|NCT01430442|155669657|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
48403787|NCT00272038|155669659|FG000|Overall Study|withdrew before they received 2 cycles|7|||
48403788|NCT02740478|155669663|FG000|Overall Study|Withdrawal by Subject|1|||
48403789|NCT01592760|155669664|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
48403790|NCT01592760|155669665|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
48403791|NCT01592760|155669666|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
48403792|NCT02549339|155669667|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
48403793|NCT02549339|155669668|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
48357232|NCT00340704|155503571|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48357233|NCT00340704|155503572|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48357234|NCT00340704|155503573|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48357235|NCT00340704|155503574|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48357236|NCT00340704|155503575|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
48357237|NCT00340704|155503576|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
48357238|NCT00340704|155503577|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48357239|NCT00340704|155503578|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48357240|NCT00340704|155503579|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
48357241|NCT00340704|155503571|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48357242|NCT00340704|155503572|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48357243|NCT00340704|155503573|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48357244|NCT00340704|155503574|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48357245|NCT00340704|155503575|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
48357246|NCT00340704|155503576|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
48357247|NCT00340704|155503577|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
48357248|NCT00340704|155503578|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
48403794|NCT02549339|155669667|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
48403795|NCT02549339|155669668|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
48403796|NCT02549339|155669667|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
48403797|NCT02549339|155669668|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
48403798|NCT02549339|155669667|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
48403799|NCT02549339|155669668|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
48403800|NCT02549339|155669667|FG000|12-month Follow-up|Lack of Efficacy|0|||
48403801|NCT02549339|155669668|FG001|12-month Follow-up|Lack of Efficacy|2|||
48403802|NCT02549339|155669667|FG000|12-month Follow-up|Withdrawal by Subject|8|||
48403803|NCT02549339|155669668|FG001|12-month Follow-up|Withdrawal by Subject|3|||
48403804|NCT02549339|155669667|FG000|12-month Follow-up|Lost to Follow-up|1|||
48403805|NCT02549339|155669668|FG001|12-month Follow-up|Lost to Follow-up|3|||
48403806|NCT02549339|155669667|FG000|12-month Follow-up|Other|0|||
48403807|NCT02549339|155669668|FG001|12-month Follow-up|Other|3|||
48403808|NCT00559507|155669672|FG000|Overall Study|Not treated, patient ineligible|3|||
48403809|NCT01407926|155669676|FG000|Overall Study|Lost to Follow-up|55|||
48403810|NCT03472560|155669677|FG000|Overall Study|Subject transfer to continuation protocol|0|||
48403811|NCT03472560|155669678|FG001|Overall Study|Subject transfer to continuation protocol|1|||
48692501|NCT00453154|156724503|FG000|Double BIind Maintenance|Death|0|||
48403812|NCT03472560|155669677|FG000|Overall Study|Withdrawal by Subject|4|||
48403813|NCT03472560|155669678|FG001|Overall Study|Withdrawal by Subject|0|||
48357249|NCT00340704|155503579|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
48357250|NCT04071301|155503580|FG000|Overall Study|Withdrawal by Subject|6|||
48357251|NCT04071301|155503580|FG000|Overall Study|Death|1|||
48357252|NCT02879383|155503583|FG000|First 24 Weeks|Physician Decision|0|||
48357253|NCT02879383|155503584|FG001|First 24 Weeks|Physician Decision|1|||
48357254|NCT02879383|155503585|FG002|First 24 Weeks|Physician Decision|0|||
48357255|NCT02879383|155503586|FG003|First 24 Weeks|Physician Decision|0|||
48357256|NCT02125279|155503589|FG000|Overall Study|Lack of Efficacy|2|||
48357257|NCT02125279|155503589|FG000|Overall Study|Withdrawal by Subject|6|||
48357258|NCT02125279|155503589|FG000|Overall Study|Protocol Violation|1|||
48357259|NCT02125279|155503589|FG000|Overall Study|Lost to Follow-up|4|||
48357260|NCT00968526|155503590|FG000|Overall Study|Adverse Event|2|||
48357261|NCT00968526|155503591|FG001|Overall Study|Adverse Event|0|||
48357262|NCT00968526|155503590|FG000|Overall Study|Migrated/moved from study area|1|||
48357263|NCT00968526|155503591|FG001|Overall Study|Migrated/moved from study area|0|||
48357264|NCT00945672|155503592|FG000|Overall Study|Withdrawal by Subject|0|||
48357265|NCT00945672|155503593|FG001|Overall Study|Withdrawal by Subject|0|||
48357266|NCT00945672|155503594|FG002|Overall Study|Withdrawal by Subject|0|||
48357267|NCT00945672|155503595|FG003|Overall Study|Withdrawal by Subject|1|||
48357268|NCT01240915|155503600|FG000|Overall Study|Adverse Event|0|||
48357269|NCT01240915|155503601|FG001|Overall Study|Adverse Event|0|||
48357270|NCT01240915|155503602|FG002|Overall Study|Adverse Event|0|||
48357271|NCT01240915|155503603|FG003|Overall Study|Adverse Event|1|||
48357272|NCT01240915|155503604|FG004|Overall Study|Adverse Event|0|||
48357273|NCT01240915|155503605|FG005|Overall Study|Adverse Event|2|||
48357274|NCT01240915|155503606|FG006|Overall Study|Adverse Event|0|||
48357275|NCT01240915|155503607|FG007|Overall Study|Adverse Event|0|||
48357276|NCT01240915|155503608|FG008|Overall Study|Adverse Event|1|||
48357277|NCT01240915|155503600|FG000|Overall Study|Lost to Follow-up|0|||
48357278|NCT01240915|155503601|FG001|Overall Study|Lost to Follow-up|0|||
48357279|NCT01240915|155503602|FG002|Overall Study|Lost to Follow-up|0|||
48692502|NCT00453154|156724504|FG001|Double BIind Maintenance|Death|0|||
48357280|NCT01240915|155503603|FG003|Overall Study|Lost to Follow-up|0|||
48357281|NCT01240915|155503604|FG004|Overall Study|Lost to Follow-up|1|||
48357282|NCT01240915|155503605|FG005|Overall Study|Lost to Follow-up|1|||
48357283|NCT01240915|155503606|FG006|Overall Study|Lost to Follow-up|0|||
48357284|NCT01240915|155503607|FG007|Overall Study|Lost to Follow-up|1|||
48357285|NCT01240915|155503608|FG008|Overall Study|Lost to Follow-up|1|||
48357286|NCT01240915|155503600|FG000|Overall Study|Withdrawal by Subject|2|||
48357287|NCT01240915|155503601|FG001|Overall Study|Withdrawal by Subject|1|||
48357288|NCT01240915|155503602|FG002|Overall Study|Withdrawal by Subject|0|||
48357289|NCT01240915|155503603|FG003|Overall Study|Withdrawal by Subject|2|||
48357290|NCT01240915|155503604|FG004|Overall Study|Withdrawal by Subject|0|||
48403814|NCT03472560|155669677|FG000|Overall Study|Progressive disease|24|||
48403815|NCT03472560|155669678|FG001|Overall Study|Progressive disease|8|||
48403816|NCT03472560|155669677|FG000|Overall Study|Physician Decision|1|||
48403817|NCT03472560|155669678|FG001|Overall Study|Physician Decision|0|||
48403818|NCT03472560|155669677|FG000|Overall Study|Death|7|||
48403819|NCT03472560|155669678|FG001|Overall Study|Death|4|||
48403820|NCT03472560|155669677|FG000|Overall Study|Adverse Event|5|||
48403821|NCT03472560|155669678|FG001|Overall Study|Adverse Event|3|||
48403822|NCT03472560|155669677|FG000|Overall Study|Global deterioration of health status|0|||
48403823|NCT03472560|155669678|FG001|Overall Study|Global deterioration of health status|4|||
48403824|NCT01534676|155669679|FG000|Overall Study|Study closed due to poor enrollment|2|||
48403825|NCT01534676|155669680|FG001|Overall Study|Study closed due to poor enrollment|1|||
48403826|NCT02479802|155669682|FG000|Overall Study|Lost to Follow-up|1|||
48403827|NCT02479802|155669682|FG000|Overall Study|Adverse Event|1|||
48403828|NCT02415712|155669683|FG000|Overall Study|Protocol Violation|16|||
48403829|NCT03011333|155669688|FG000|Overall Study|Lost to Follow-up|0|||
48403830|NCT03011333|155669689|FG001|Overall Study|Lost to Follow-up|1|||
48403831|NCT03011333|155669690|FG002|Overall Study|Lost to Follow-up|0|||
48403832|NCT03011333|155669691|FG003|Overall Study|Lost to Follow-up|1|||
48403833|NCT03011333|155669692|FG004|Overall Study|Lost to Follow-up|4|||
48403834|NCT03011333|155669693|FG005|Overall Study|Lost to Follow-up|4|||
48403835|NCT03011333|155669694|FG006|Overall Study|Lost to Follow-up|5|||
48403836|NCT03033745|155669697|FG000|Overall Study|Protocol Violation|0|||
48403837|NCT03033745|155669698|FG001|Overall Study|Protocol Violation|0|||
48403838|NCT03033745|155669699|FG002|Overall Study|Protocol Violation|1|||
48403839|NCT03033745|155669697|FG000|Overall Study|Adverse Event|1|||
48403840|NCT03033745|155669698|FG001|Overall Study|Adverse Event|0|||
48403841|NCT03033745|155669699|FG002|Overall Study|Adverse Event|1|||
48403842|NCT03033745|155669697|FG000|Overall Study|Withdrawal by Subject|0|||
48403843|NCT03033745|155669698|FG001|Overall Study|Withdrawal by Subject|1|||
48403844|NCT03033745|155669699|FG002|Overall Study|Withdrawal by Subject|0|||
48403845|NCT00343512|155669700|FG000|Overall Study|Withdrawal by Subject|2|||
48403846|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
48403847|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
48403848|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
48403849|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
48403850|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
48403851|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
48403852|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
48403853|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
48403854|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
48403855|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
48403856|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
48403857|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
48403858|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
48403859|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
48403860|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
48403861|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
48403862|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
48430368|NCT00696657|155763704|FG004|Overall Study|Adverse Event|6|||
48403863|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
48403864|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
48403865|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
48403866|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
48357291|NCT01240915|155503605|FG005|Overall Study|Withdrawal by Subject|4|||
48357292|NCT01240915|155503606|FG006|Overall Study|Withdrawal by Subject|2|||
48357293|NCT01240915|155503607|FG007|Overall Study|Withdrawal by Subject|3|||
48357294|NCT01240915|155503608|FG008|Overall Study|Withdrawal by Subject|3|||
48357295|NCT01240915|155503600|FG000|Overall Study|Other|0|||
48357296|NCT01240915|155503601|FG001|Overall Study|Other|0|||
48357297|NCT01240915|155503602|FG002|Overall Study|Other|0|||
48357298|NCT01240915|155503603|FG003|Overall Study|Other|0|||
48357299|NCT01240915|155503604|FG004|Overall Study|Other|2|||
48357300|NCT01240915|155503605|FG005|Overall Study|Other|0|||
48357301|NCT01240915|155503606|FG006|Overall Study|Other|0|||
48357302|NCT01240915|155503607|FG007|Overall Study|Other|0|||
48357303|NCT01240915|155503608|FG008|Overall Study|Other|0|||
48357304|NCT01240915|155503600|FG000|Overall Study|Insufficient Clinical Response|0|||
48357305|NCT01240915|155503601|FG001|Overall Study|Insufficient Clinical Response|0|||
48357306|NCT01240915|155503602|FG002|Overall Study|Insufficient Clinical Response|0|||
48403867|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
48357307|NCT01240915|155503603|FG003|Overall Study|Insufficient Clinical Response|0|||
48403868|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
48403869|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
48403870|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Death|2|||
48403871|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Death|1|||
48403872|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Death|2|||
48403873|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Graft loss|0|||
48403874|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Graft loss|2|||
48403875|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Graft loss|0|||
48403876|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
48403877|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
48403878|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
48403879|NCT01114529|155669702|FG000|Completed Study Medication at Month 24|Missing|2|||
48403880|NCT01114529|155669703|FG001|Completed Study Medication at Month 24|Missing|0|||
48403881|NCT01114529|155669704|FG002|Completed Study Medication at Month 24|Missing|0|||
48403882|NCT01114529|155669702|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
48403883|NCT01114529|155669703|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
48403884|NCT01114529|155669704|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
48403885|NCT01114529|155669702|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
48403886|NCT01114529|155669703|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
48403887|NCT01114529|155669704|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
48403888|NCT01114529|155669702|FG000|Completed Study Phase at Month 24|Death|8|||
48403889|NCT01114529|155669703|FG001|Completed Study Phase at Month 24|Death|5|||
48403890|NCT01114529|155669704|FG002|Completed Study Phase at Month 24|Death|4|||
48403891|NCT01114529|155669702|FG000|Completed Study Phase at Month 24|Other|2|||
48403892|NCT01114529|155669703|FG001|Completed Study Phase at Month 24|Other|0|||
48403893|NCT01114529|155669704|FG002|Completed Study Phase at Month 24|Other|0|||
48403894|NCT01114529|155669702|FG000|Completed Study Phase at Month 24|Missing|2|||
48403895|NCT01114529|155669703|FG001|Completed Study Phase at Month 24|Missing|0|||
48403896|NCT01114529|155669704|FG002|Completed Study Phase at Month 24|Missing|0|||
48403897|NCT00331409|155669705|FG000|Overall Study|Lack of Efficacy|4|||
48403898|NCT03222349|155669706|FG000|Overall Study|Treatment B not done|5|||
48403899|NCT03222349|155669707|FG001|Overall Study|Treatment B not done|0|||
48403900|NCT03222349|155669706|FG000|Overall Study|Lost to Follow-up|1|||
48403901|NCT03222349|155669707|FG001|Overall Study|Lost to Follow-up|2|||
48403902|NCT03222349|155669706|FG000|Overall Study|Withdrawal by Subject|1|||
48403903|NCT03222349|155669707|FG001|Overall Study|Withdrawal by Subject|0|||
48403904|NCT03222349|155669706|FG000|Overall Study|Treatment A not done|0|||
48403905|NCT03222349|155669707|FG001|Overall Study|Treatment A not done|5|||
48403906|NCT03222349|155669706|FG000|Overall Study|Study terminated by sponsor|1|||
48403907|NCT03222349|155669707|FG001|Overall Study|Study terminated by sponsor|0|||
48403908|NCT03847610|155669710|FG000|Overall Study|Withdrawal by Subject|1|||
48403909|NCT00087646|155669711|FG000|Overall Study|Adverse Event|37|||
48403910|NCT00087646|155669712|FG001|Overall Study|Adverse Event|6|||
48403911|NCT00087646|155669713|FG002|Overall Study|Adverse Event|18|||
48403912|NCT00087646|155669714|FG003|Overall Study|Adverse Event|20|||
48403913|NCT00087646|155669711|FG000|Overall Study|Death|0|||
48403914|NCT00087646|155669712|FG001|Overall Study|Death|1|||
48403915|NCT00087646|155669713|FG002|Overall Study|Death|0|||
48403916|NCT00087646|155669714|FG003|Overall Study|Death|0|||
48403917|NCT00087646|155669711|FG000|Overall Study|Withdrawal by Subject|6|||
48403918|NCT00087646|155669712|FG001|Overall Study|Withdrawal by Subject|1|||
48403919|NCT00087646|155669713|FG002|Overall Study|Withdrawal by Subject|2|||
48403920|NCT00087646|155669714|FG003|Overall Study|Withdrawal by Subject|2|||
48403921|NCT00087646|155669711|FG000|Overall Study|Insufficient therapeutic response|64|||
48403922|NCT00087646|155669712|FG001|Overall Study|Insufficient therapeutic response|24|||
48403923|NCT00087646|155669713|FG002|Overall Study|Insufficient therapeutic response|38|||
48403924|NCT00087646|155669714|FG003|Overall Study|Insufficient therapeutic response|51|||
48403925|NCT00087646|155669711|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
48403926|NCT00087646|155669712|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
48403927|NCT00087646|155669713|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
48403928|NCT00087646|155669714|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
48403929|NCT00087646|155669711|FG000|Overall Study|Failure to Return|5|||
48403930|NCT00087646|155669712|FG001|Overall Study|Failure to Return|2|||
48403931|NCT00087646|155669713|FG002|Overall Study|Failure to Return|2|||
48403932|NCT00087646|155669714|FG003|Overall Study|Failure to Return|3|||
48403933|NCT00087646|155669711|FG000|Overall Study|Administrative/Other|6|||
48403934|NCT00087646|155669712|FG001|Overall Study|Administrative/Other|1|||
48403935|NCT00087646|155669713|FG002|Overall Study|Administrative/Other|1|||
48403936|NCT00087646|155669714|FG003|Overall Study|Administrative/Other|2|||
48403937|NCT00087646|155669711|FG000|Overall Study|Other Protocol Violation|3|||
48403938|NCT00087646|155669712|FG001|Overall Study|Other Protocol Violation|1|||
48403939|NCT00087646|155669713|FG002|Overall Study|Other Protocol Violation|0|||
48403940|NCT00087646|155669714|FG003|Overall Study|Other Protocol Violation|0|||
48403941|NCT00087646|155669711|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48403942|NCT00087646|155669712|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
48403943|NCT00087646|155669713|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
48403944|NCT00087646|155669714|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
48403945|NCT00820755|155669715|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
48403946|NCT00820755|155669716|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
48403947|NCT00820755|155669717|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
48403948|NCT00820755|155669715|FG000|Period 1: Combination Therapy Phase|Death|28|||
48403949|NCT00820755|155669716|FG001|Period 1: Combination Therapy Phase|Death|0|||
48403950|NCT00820755|155669717|FG002|Period 1: Combination Therapy Phase|Death|0|||
48403951|NCT00820755|155669715|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
48403952|NCT00820755|155669716|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
48403953|NCT00820755|155669717|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
48403954|NCT00820755|155669715|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
48403955|NCT00820755|155669716|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
48403956|NCT00820755|155669717|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
48403957|NCT00820755|155669715|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
48403958|NCT00820755|155669716|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
48403959|NCT00820755|155669717|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
48403960|NCT00820755|155669715|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
48403961|NCT00820755|155669716|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
48403962|NCT00820755|155669717|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
48403963|NCT00820755|155669715|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
48403964|NCT00820755|155669716|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
48403965|NCT00820755|155669717|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
48403966|NCT00820755|155669715|FG000|Period 1: Combination Therapy Phase|Other|11|||
48403967|NCT00820755|155669716|FG001|Period 1: Combination Therapy Phase|Other|0|||
48403968|NCT00820755|155669717|FG002|Period 1: Combination Therapy Phase|Other|0|||
48403969|NCT00820755|155669715|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
48403970|NCT00820755|155669716|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
48403971|NCT00820755|155669717|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
48403972|NCT01445769|155669719|FG000|Overall Study|Consent Withdrawn|2|||
48403973|NCT01445769|155669719|FG000|Overall Study|Disease Progression|1|||
48403974|NCT01445769|155669719|FG000|Overall Study|Lost to Follow-up|5|||
48403975|NCT01405053|155669722|FG000|Overall Study|Adverse Event|3|||
48403976|NCT01405053|155669723|FG001|Overall Study|Adverse Event|0|||
48403977|NCT01405053|155669722|FG000|Overall Study|Lost to Follow-up|0|||
48403978|NCT01405053|155669723|FG001|Overall Study|Lost to Follow-up|1|||
48403979|NCT01405053|155669722|FG000|Overall Study|Participant choice|2|||
48403980|NCT01405053|155669723|FG001|Overall Study|Participant choice|1|||
48403981|NCT01405053|155669722|FG000|Overall Study|Inadequate therapeutic effect|2|||
48403982|NCT01405053|155669723|FG001|Overall Study|Inadequate therapeutic effect|1|||
48403983|NCT01405053|155669722|FG000|Overall Study|Withdrawal by Subject|3|||
48403984|NCT01405053|155669723|FG001|Overall Study|Withdrawal by Subject|4|||
48403985|NCT01405053|155669722|FG000|Overall Study|Other|0|||
48403986|NCT01405053|155669723|FG001|Overall Study|Other|1|||
48403987|NCT01014585|155669730|FG000|Overall Study|Adverse Event|0|||
48403988|NCT01014585|155669731|FG001|Overall Study|Adverse Event|2|||
48403989|NCT01014585|155669732|FG002|Overall Study|Adverse Event|0|||
48403990|NCT01014585|155669733|FG003|Overall Study|Adverse Event|3|||
48403991|NCT01014585|155669730|FG000|Overall Study|Withdrawal by Subject|2|||
48403992|NCT01014585|155669731|FG001|Overall Study|Withdrawal by Subject|0|||
48403993|NCT01014585|155669732|FG002|Overall Study|Withdrawal by Subject|1|||
48403994|NCT01014585|155669733|FG003|Overall Study|Withdrawal by Subject|3|||
48403995|NCT01014585|155669730|FG000|Overall Study|Lost to Follow-up|0|||
48403996|NCT01014585|155669731|FG001|Overall Study|Lost to Follow-up|0|||
48403997|NCT01014585|155669732|FG002|Overall Study|Lost to Follow-up|0|||
48403998|NCT01014585|155669733|FG003|Overall Study|Lost to Follow-up|2|||
48403999|NCT01014585|155669730|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
48404000|NCT01014585|155669731|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
48404001|NCT01014585|155669732|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
48404002|NCT01014585|155669733|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
48404003|NCT02154425|155669734|FG000|Screening Period|Adverse Event|1|||
48404004|NCT02817087|155669735|FG000|Overall Study|Withdrawal by Subject|2|||
48404005|NCT02817087|155669736|FG001|Overall Study|Withdrawal by Subject|0|||
48404006|NCT01465659|155669741|FG000|Completed 1 Cycle of Treatment|Death|0|||
48404007|NCT01465659|155669742|FG001|Completed 1 Cycle of Treatment|Death|1|||
48430369|NCT00696657|155763705|FG005|Overall Study|Adverse Event|9|||
48404008|NCT01465659|155669743|FG002|Completed 1 Cycle of Treatment|Death|0|||
48404009|NCT01465659|155669744|FG003|Completed 1 Cycle of Treatment|Death|0|||
48404010|NCT01465659|155669741|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
48404011|NCT01465659|155669742|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
48404012|NCT01465659|155669743|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
48404013|NCT01465659|155669744|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
48404014|NCT01465659|155669741|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
48404015|NCT01465659|155669742|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
48404016|NCT01465659|155669743|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
48404017|NCT01465659|155669744|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
48404018|NCT01465659|155669741|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
48404019|NCT01465659|155669742|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
48404020|NCT01465659|155669743|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
48404021|NCT01465659|155669744|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
48404022|NCT01465659|155669741|FG000|Completed Follow for 1 Year|Death|6|||
48404023|NCT01465659|155669742|FG001|Completed Follow for 1 Year|Death|3|||
48404024|NCT01465659|155669743|FG002|Completed Follow for 1 Year|Death|2|||
48404025|NCT01465659|155669744|FG003|Completed Follow for 1 Year|Death|4|||
48404026|NCT02658812|155669745|FG000|Overall Study|Disease Progression|7|||
48404027|NCT02658812|155669745|FG000|Overall Study|Unrelated to study treatment|1|||
48404028|NCT02658812|155669745|FG000|Overall Study|Adverse Event|1|||
48404029|NCT01194440|155669746|FG000|Baseline (First Dose)|Reason not specified|4|||
48404030|NCT01194440|155669746|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
48404031|NCT01194440|155669746|FG000|Baseline (First Dose)|Change in therapy|1|||
48404032|NCT01194440|155669746|FG000|Baseline (First Dose)|Adverse Event|1|||
48404033|NCT01194440|155669746|FG000|6-months (2nd Dose)|Change in therapy|4|||
48404034|NCT00686647|155669753|FG000|Overall Study|Lost to Follow-up|1|||
48404035|NCT00686647|155669753|FG000|Overall Study|Death|1|||
48404036|NCT01116544|155669756|FG000|Overall Study|Protocol Violation|1|||
48404037|NCT01116544|155669757|FG001|Overall Study|Protocol Violation|0|||
48430370|NCT00696657|155763706|FG006|Overall Study|Adverse Event|14|||
48357308|NCT01240915|155503604|FG004|Overall Study|Insufficient Clinical Response|1|||
48357309|NCT01240915|155503605|FG005|Overall Study|Insufficient Clinical Response|3|||
48357310|NCT01240915|155503606|FG006|Overall Study|Insufficient Clinical Response|6|||
48357311|NCT01240915|155503607|FG007|Overall Study|Insufficient Clinical Response|0|||
48357312|NCT01240915|155503608|FG008|Overall Study|Insufficient Clinical Response|3|||
48357313|NCT02947100|155503609|FG000|Overall Study|study terminated early|3|||
48357314|NCT02947100|155503609|FG000|Overall Study|did not meet inclusion criteria|1|||
48357315|NCT00822770|155503610|FG000|Overall Study|Not treated|1|||
48357316|NCT00822770|155503611|FG001|Overall Study|Not treated|0|||
48357317|NCT00822770|155503610|FG000|Overall Study|Complication/Incomplete treatment|1|||
48357318|NCT00822770|155503611|FG001|Overall Study|Complication/Incomplete treatment|0|||
48357319|NCT00822770|155503610|FG000|Overall Study|Death|1|||
48357320|NCT00822770|155503611|FG001|Overall Study|Death|1|||
48357321|NCT02472145|155503612|FG000|Overall Study|Death|10|||
48357322|NCT02472145|155503613|FG001|Overall Study|Death|101|||
48357323|NCT02472145|155503614|FG002|Overall Study|Death|99|||
48357324|NCT02472145|155503612|FG000|Overall Study|Lost to Follow-up|0|||
48357325|NCT02472145|155503613|FG001|Overall Study|Lost to Follow-up|1|||
48357326|NCT02472145|155503614|FG002|Overall Study|Lost to Follow-up|0|||
48357327|NCT02472145|155503612|FG000|Overall Study|Withdrawal by Subject|0|||
48357328|NCT02472145|155503613|FG001|Overall Study|Withdrawal by Subject|9|||
48357329|NCT02472145|155503614|FG002|Overall Study|Withdrawal by Subject|13|||
48357330|NCT02472145|155503612|FG000|Overall Study|Sponsor decision|0|||
48357331|NCT02472145|155503613|FG001|Overall Study|Sponsor decision|3|||
48357332|NCT02472145|155503614|FG002|Overall Study|Sponsor decision|2|||
48357333|NCT02472145|155503612|FG000|Overall Study|Other|0|||
48357334|NCT02472145|155503613|FG001|Overall Study|Other|45|||
48357335|NCT02472145|155503614|FG002|Overall Study|Other|43|||
48357336|NCT01031628|155503615|FG000|Overall Study|Study terminated early|0|||
48357337|NCT01031628|155503616|FG001|Overall Study|Study terminated early|1|||
48357338|NCT01031628|155503617|FG002|Overall Study|Study terminated early|3|||
48357339|NCT01031628|155503618|FG003|Overall Study|Study terminated early|0|||
48357340|NCT03080493|155503619|FG000|Overall Study|Did not provide NRS pain results|1|||
48357341|NCT03080493|155503620|FG001|Overall Study|Did not provide NRS pain results|0|||
48404038|NCT01116544|155669756|FG000|Overall Study|Withdrawal by Subject|1|||
48404039|NCT01116544|155669757|FG001|Overall Study|Withdrawal by Subject|1|||
48404040|NCT01986062|155669763|FG000|Overall Study|Lost to Follow-up|1|||
48404041|NCT01986062|155669764|FG001|Overall Study|Lost to Follow-up|0|||
48404042|NCT01986062|155669763|FG000|Overall Study|Withdrawal by Subject|0|||
48404043|NCT01986062|155669764|FG001|Overall Study|Withdrawal by Subject|1|||
48404044|NCT02320487|155669768|FG000|Overall Study|Reason not Specified|1|||
48404045|NCT02320487|155669768|FG000|Overall Study|Physician Decision|5|||
48404046|NCT02320487|155669768|FG000|Overall Study|Withdrawal by Subject|1|||
48404047|NCT02320487|155669768|FG000|Overall Study|Death|3|||
48404048|NCT02320487|155669768|FG000|Overall Study|Adverse Event|11|||
48404049|NCT00150592|155673001|FG000|Overall Study|Adverse Event|4|||
48357342|NCT03080493|155503619|FG000|Overall Study|Adverse Event|0|||
48357343|NCT03080493|155503620|FG001|Overall Study|Adverse Event|1|||
48357344|NCT03080493|155503619|FG000|Overall Study|Randomization error (parity group)|0|||
48357345|NCT03080493|155503620|FG001|Overall Study|Randomization error (parity group)|1|||
48357346|NCT00490698|155503623|FG000|Overall Study|Withdrawal by Subject|1|||
48357347|NCT00490698|155503623|FG000|Overall Study|Disease Progression|7|||
48357348|NCT00490698|155503623|FG000|Overall Study|Physician Decision|2|||
48357349|NCT01040169|155503624|FG000|Overall Study|Lost to Follow-up|3|||
48357350|NCT01040169|155503625|FG001|Overall Study|Lost to Follow-up|8|||
48357351|NCT03682185|155503628|FG000|Overall Study|Lost to Follow-up|4|||
48357352|NCT03682185|155503629|FG001|Overall Study|Lost to Follow-up|7|||
48357353|NCT03682185|155503630|FG002|Overall Study|Lost to Follow-up|4|||
48357354|NCT03682185|155503631|FG003|Overall Study|Lost to Follow-up|7|||
48357355|NCT03682185|155503632|FG004|Overall Study|Lost to Follow-up|1|||
48357356|NCT03682185|155503628|FG000|Overall Study|Withdrawal by Subject|7|||
48357357|NCT03682185|155503629|FG001|Overall Study|Withdrawal by Subject|3|||
48357358|NCT03682185|155503630|FG002|Overall Study|Withdrawal by Subject|7|||
48357359|NCT03682185|155503631|FG003|Overall Study|Withdrawal by Subject|3|||
48404050|NCT00150592|155673002|FG001|Overall Study|Adverse Event|1|||
48357360|NCT03682185|155503632|FG004|Overall Study|Withdrawal by Subject|0|||
48357361|NCT00350727|155503633|FG000|Phase I: Dose Escalation|Adverse Event|4|||
48404051|NCT00150592|155673001|FG000|Overall Study|Protocol Violation|1|||
48404052|NCT00150592|155673002|FG001|Overall Study|Protocol Violation|0|||
48404053|NCT00150592|155673001|FG000|Overall Study|Withdrawal by Subject|1|||
48404054|NCT00150592|155673002|FG001|Overall Study|Withdrawal by Subject|2|||
48404055|NCT00150592|155673001|FG000|Overall Study|Non-compliance|1|||
48404056|NCT00150592|155673002|FG001|Overall Study|Non-compliance|0|||
48404057|NCT00880893|155673003|FG000|Overall Study|Protocol Violation|13|||
48404058|NCT00880893|155673004|FG001|Overall Study|Protocol Violation|1|||
48404059|NCT00880893|155673003|FG000|Overall Study|Withdrawal by Subject|15|||
48404060|NCT00880893|155673004|FG001|Overall Study|Withdrawal by Subject|11|||
48404061|NCT00880893|155673003|FG000|Overall Study|Lost to Follow-up|76|||
48404062|NCT00880893|155673004|FG001|Overall Study|Lost to Follow-up|33|||
48404063|NCT00880893|155673003|FG000|Overall Study|Serious adverse event|3|||
48404064|NCT00880893|155673004|FG001|Overall Study|Serious adverse event|0|||
48404065|NCT01783678|155673012|FG000|Overall Study|Randomized but Not Treated|0|||
48404066|NCT01783678|155673013|FG001|Overall Study|Randomized but Not Treated|0|||
48404067|NCT01783678|155673014|FG002|Overall Study|Randomized but Not Treated|0|||
48404068|NCT01783678|155673015|FG003|Overall Study|Randomized but Not Treated|1|||
48404069|NCT01783678|155673016|FG004|Overall Study|Randomized but Not Treated|0|||
48404070|NCT01783678|155673017|FG005|Overall Study|Randomized but Not Treated|0|||
48404071|NCT01783678|155673012|FG000|Overall Study|Lack of Efficacy|1|||
48404072|NCT01783678|155673013|FG001|Overall Study|Lack of Efficacy|13|||
48404073|NCT01783678|155673014|FG002|Overall Study|Lack of Efficacy|1|||
48404074|NCT01783678|155673015|FG003|Overall Study|Lack of Efficacy|3|||
48404075|NCT01783678|155673016|FG004|Overall Study|Lack of Efficacy|6|||
48404076|NCT01783678|155673017|FG005|Overall Study|Lack of Efficacy|5|||
48404077|NCT01783678|155673012|FG000|Overall Study|Lost to Follow-up|0|||
48404078|NCT01783678|155673013|FG001|Overall Study|Lost to Follow-up|4|||
48404079|NCT01783678|155673014|FG002|Overall Study|Lost to Follow-up|0|||
48404080|NCT01783678|155673015|FG003|Overall Study|Lost to Follow-up|2|||
48404081|NCT01783678|155673016|FG004|Overall Study|Lost to Follow-up|1|||
48404082|NCT01783678|155673017|FG005|Overall Study|Lost to Follow-up|0|||
48404083|NCT01783678|155673012|FG000|Overall Study|Withdrew Consent|1|||
48404084|NCT01783678|155673013|FG001|Overall Study|Withdrew Consent|1|||
48404085|NCT01783678|155673014|FG002|Overall Study|Withdrew Consent|0|||
48404086|NCT01783678|155673015|FG003|Overall Study|Withdrew Consent|2|||
48404087|NCT01783678|155673016|FG004|Overall Study|Withdrew Consent|0|||
48404088|NCT01783678|155673017|FG005|Overall Study|Withdrew Consent|0|||
48404089|NCT02543528|155673018|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
48404090|NCT02543528|155673019|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
48404091|NCT02543528|155673020|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
48404092|NCT02543528|155673021|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
48404093|NCT02543528|155673022|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
48404094|NCT02543528|155673018|FG000|Adaptation Period|Lens Handling Difficultes|0|||
48404095|NCT02543528|155673019|FG001|Adaptation Period|Lens Handling Difficultes|0|||
48404096|NCT02543528|155673020|FG002|Adaptation Period|Lens Handling Difficultes|0|||
48404097|NCT02543528|155673021|FG003|Adaptation Period|Lens Handling Difficultes|0|||
48404098|NCT02543528|155673022|FG004|Adaptation Period|Lens Handling Difficultes|8|||
48404099|NCT02543528|155673018|FG000|Adaptation Period|Lost to Follow-up|0|||
48404100|NCT02543528|155673019|FG001|Adaptation Period|Lost to Follow-up|0|||
48404101|NCT02543528|155673020|FG002|Adaptation Period|Lost to Follow-up|0|||
48404102|NCT02543528|155673021|FG003|Adaptation Period|Lost to Follow-up|0|||
48404103|NCT02543528|155673022|FG004|Adaptation Period|Lost to Follow-up|14|||
48404104|NCT02543528|155673018|FG000|Adaptation Period|Adverse Event|0|||
48404105|NCT02543528|155673019|FG001|Adaptation Period|Adverse Event|0|||
48404106|NCT02543528|155673020|FG002|Adaptation Period|Adverse Event|0|||
48404107|NCT02543528|155673021|FG003|Adaptation Period|Adverse Event|0|||
48404108|NCT02543528|155673022|FG004|Adaptation Period|Adverse Event|2|||
48404109|NCT02543528|155673018|FG000|Extended Wear Period|Adverse Event|17|||
48404110|NCT02543528|155673019|FG001|Extended Wear Period|Adverse Event|11|||
48404111|NCT02543528|155673020|FG002|Extended Wear Period|Adverse Event|16|||
48404112|NCT02543528|155673021|FG003|Extended Wear Period|Adverse Event|3|||
48404113|NCT02543528|155673022|FG004|Extended Wear Period|Adverse Event|0|||
48404114|NCT02543528|155673018|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
48404115|NCT02543528|155673019|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
48404116|NCT02543528|155673020|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
48404117|NCT02543528|155673021|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
48404118|NCT02543528|155673022|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
48404119|NCT02543528|155673018|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
48404120|NCT02543528|155673019|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
48404121|NCT02543528|155673020|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
48404122|NCT02543528|155673021|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
48404123|NCT02543528|155673022|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
48404124|NCT02543528|155673018|FG000|Extended Wear Period|Lost to Follow-up|0|||
48404125|NCT02543528|155673019|FG001|Extended Wear Period|Lost to Follow-up|1|||
48404126|NCT02543528|155673020|FG002|Extended Wear Period|Lost to Follow-up|2|||
48404127|NCT02543528|155673021|FG003|Extended Wear Period|Lost to Follow-up|1|||
48404128|NCT02543528|155673022|FG004|Extended Wear Period|Lost to Follow-up|0|||
48404129|NCT02543528|155673018|FG000|Extended Wear Period|Withdrawal by Subject|10|||
48404130|NCT02543528|155673019|FG001|Extended Wear Period|Withdrawal by Subject|9|||
48404131|NCT02543528|155673020|FG002|Extended Wear Period|Withdrawal by Subject|4|||
48404132|NCT02543528|155673021|FG003|Extended Wear Period|Withdrawal by Subject|5|||
48404133|NCT02543528|155673022|FG004|Extended Wear Period|Withdrawal by Subject|0|||
48404134|NCT03686397|155673023|FG000|Overall Study|Lack of Efficacy|3|||
48404135|NCT03686397|155673024|FG001|Overall Study|Lack of Efficacy|5|||
48404136|NCT03686397|155673023|FG000|Overall Study|Adverse Event|0|||
48404137|NCT03686397|155673024|FG001|Overall Study|Adverse Event|1|||
48404138|NCT03686397|155673023|FG000|Overall Study|Protocol Violation|0|||
48404139|NCT03686397|155673024|FG001|Overall Study|Protocol Violation|1|||
48404140|NCT03686397|155673023|FG000|Overall Study|Withdrawal by Subject|0|||
48404141|NCT03686397|155673024|FG001|Overall Study|Withdrawal by Subject|1|||
48404142|NCT03686397|155673023|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
48404143|NCT03686397|155673024|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
48404144|NCT00328627|155673025|FG000|Overall Study|Hyperglycemic Rescue|41|||
48404145|NCT00328627|155673026|FG001|Overall Study|Hyperglycemic Rescue|18|||
48404146|NCT00328627|155673027|FG002|Overall Study|Hyperglycemic Rescue|16|||
48404147|NCT00328627|155673028|FG003|Overall Study|Hyperglycemic Rescue|13|||
48404148|NCT00328627|155673029|FG004|Overall Study|Hyperglycemic Rescue|6|||
48404149|NCT00328627|155673030|FG005|Overall Study|Hyperglycemic Rescue|5|||
48404150|NCT00328627|155673031|FG006|Overall Study|Hyperglycemic Rescue|19|||
48404151|NCT00328627|155673032|FG007|Overall Study|Hyperglycemic Rescue|6|||
48404152|NCT00328627|155673033|FG008|Overall Study|Hyperglycemic Rescue|6|||
48404153|NCT00328627|155673034|FG009|Overall Study|Hyperglycemic Rescue|11|||
48404154|NCT00328627|155673035|FG010|Overall Study|Hyperglycemic Rescue|3|||
48404155|NCT00328627|155673036|FG011|Overall Study|Hyperglycemic Rescue|2|||
48404156|NCT00328627|155673025|FG000|Overall Study|Adverse Event|3|||
48404157|NCT00328627|155673026|FG001|Overall Study|Adverse Event|1|||
48404158|NCT00328627|155673027|FG002|Overall Study|Adverse Event|2|||
48404159|NCT00328627|155673028|FG003|Overall Study|Adverse Event|3|||
48404160|NCT00328627|155673029|FG004|Overall Study|Adverse Event|1|||
48404161|NCT00328627|155673030|FG005|Overall Study|Adverse Event|2|||
48404162|NCT00328627|155673031|FG006|Overall Study|Adverse Event|1|||
48404163|NCT00328627|155673032|FG007|Overall Study|Adverse Event|2|||
48404164|NCT00328627|155673033|FG008|Overall Study|Adverse Event|0|||
48404165|NCT00328627|155673034|FG009|Overall Study|Adverse Event|7|||
48404166|NCT00328627|155673035|FG010|Overall Study|Adverse Event|5|||
48404167|NCT00328627|155673036|FG011|Overall Study|Adverse Event|4|||
48404168|NCT00328627|155673025|FG000|Overall Study|Protocol Violation|2|||
48404169|NCT00328627|155673026|FG001|Overall Study|Protocol Violation|2|||
48404170|NCT00328627|155673027|FG002|Overall Study|Protocol Violation|2|||
48404171|NCT00328627|155673028|FG003|Overall Study|Protocol Violation|8|||
48404172|NCT00328627|155673029|FG004|Overall Study|Protocol Violation|5|||
48404173|NCT00328627|155673030|FG005|Overall Study|Protocol Violation|5|||
48404174|NCT00328627|155673031|FG006|Overall Study|Protocol Violation|6|||
48404175|NCT00328627|155673032|FG007|Overall Study|Protocol Violation|2|||
48404176|NCT00328627|155673033|FG008|Overall Study|Protocol Violation|1|||
48404177|NCT00328627|155673034|FG009|Overall Study|Protocol Violation|4|||
48404178|NCT00328627|155673035|FG010|Overall Study|Protocol Violation|6|||
48404179|NCT00328627|155673036|FG011|Overall Study|Protocol Violation|2|||
48404180|NCT00328627|155673025|FG000|Overall Study|Lost to Follow-up|4|||
48404181|NCT00328627|155673026|FG001|Overall Study|Lost to Follow-up|2|||
48404182|NCT00328627|155673027|FG002|Overall Study|Lost to Follow-up|2|||
48404183|NCT00328627|155673028|FG003|Overall Study|Lost to Follow-up|4|||
48404184|NCT00328627|155673029|FG004|Overall Study|Lost to Follow-up|0|||
48404185|NCT00328627|155673030|FG005|Overall Study|Lost to Follow-up|2|||
48404186|NCT00328627|155673031|FG006|Overall Study|Lost to Follow-up|3|||
48404187|NCT00328627|155673032|FG007|Overall Study|Lost to Follow-up|0|||
48404188|NCT00328627|155673033|FG008|Overall Study|Lost to Follow-up|3|||
48404189|NCT00328627|155673034|FG009|Overall Study|Lost to Follow-up|2|||
48404190|NCT00328627|155673035|FG010|Overall Study|Lost to Follow-up|0|||
48404191|NCT00328627|155673036|FG011|Overall Study|Lost to Follow-up|1|||
48404192|NCT00328627|155673025|FG000|Overall Study|Withdrawal by Subject|5|||
48404193|NCT00328627|155673026|FG001|Overall Study|Withdrawal by Subject|4|||
48404194|NCT00328627|155673027|FG002|Overall Study|Withdrawal by Subject|5|||
48404195|NCT00328627|155673028|FG003|Overall Study|Withdrawal by Subject|6|||
48404196|NCT00328627|155673029|FG004|Overall Study|Withdrawal by Subject|2|||
48404197|NCT00328627|155673030|FG005|Overall Study|Withdrawal by Subject|5|||
48404198|NCT00328627|155673031|FG006|Overall Study|Withdrawal by Subject|4|||
48404199|NCT00328627|155673032|FG007|Overall Study|Withdrawal by Subject|4|||
48404200|NCT00328627|155673033|FG008|Overall Study|Withdrawal by Subject|4|||
48404201|NCT00328627|155673034|FG009|Overall Study|Withdrawal by Subject|5|||
48404202|NCT00328627|155673035|FG010|Overall Study|Withdrawal by Subject|2|||
48404203|NCT00328627|155673036|FG011|Overall Study|Withdrawal by Subject|7|||
48404204|NCT00328627|155673025|FG000|Overall Study|Pregnancy|0|||
48404205|NCT00328627|155673026|FG001|Overall Study|Pregnancy|1|||
48404206|NCT00328627|155673027|FG002|Overall Study|Pregnancy|0|||
48404207|NCT00328627|155673028|FG003|Overall Study|Pregnancy|0|||
48404208|NCT00328627|155673029|FG004|Overall Study|Pregnancy|0|||
48404209|NCT00328627|155673030|FG005|Overall Study|Pregnancy|0|||
48404210|NCT00328627|155673031|FG006|Overall Study|Pregnancy|0|||
48404211|NCT00328627|155673032|FG007|Overall Study|Pregnancy|0|||
48404212|NCT00328627|155673033|FG008|Overall Study|Pregnancy|0|||
48404213|NCT00328627|155673034|FG009|Overall Study|Pregnancy|0|||
48404214|NCT00328627|155673035|FG010|Overall Study|Pregnancy|0|||
48404215|NCT00328627|155673036|FG011|Overall Study|Pregnancy|0|||
48404216|NCT00328627|155673025|FG000|Overall Study|Physician Decision|4|||
48404217|NCT00328627|155673026|FG001|Overall Study|Physician Decision|3|||
48404218|NCT00328627|155673027|FG002|Overall Study|Physician Decision|1|||
48404219|NCT00328627|155673028|FG003|Overall Study|Physician Decision|2|||
48404220|NCT00328627|155673029|FG004|Overall Study|Physician Decision|1|||
48404221|NCT00328627|155673030|FG005|Overall Study|Physician Decision|1|||
48404222|NCT00328627|155673031|FG006|Overall Study|Physician Decision|1|||
48404223|NCT00328627|155673032|FG007|Overall Study|Physician Decision|0|||
48404224|NCT00328627|155673033|FG008|Overall Study|Physician Decision|3|||
48404225|NCT00328627|155673034|FG009|Overall Study|Physician Decision|2|||
48404226|NCT00328627|155673035|FG010|Overall Study|Physician Decision|1|||
48404227|NCT00328627|155673036|FG011|Overall Study|Physician Decision|0|||
48404228|NCT00328627|155673025|FG000|Overall Study|Other|0|||
48404229|NCT00328627|155673026|FG001|Overall Study|Other|0|||
48404230|NCT00328627|155673027|FG002|Overall Study|Other|0|||
48404231|NCT00328627|155673028|FG003|Overall Study|Other|1|||
48404232|NCT00328627|155673029|FG004|Overall Study|Other|0|||
48404233|NCT00328627|155673030|FG005|Overall Study|Other|0|||
48404234|NCT00328627|155673031|FG006|Overall Study|Other|1|||
48404235|NCT00328627|155673032|FG007|Overall Study|Other|0|||
48404236|NCT00328627|155673033|FG008|Overall Study|Other|0|||
48404237|NCT00328627|155673034|FG009|Overall Study|Other|1|||
48404238|NCT00328627|155673035|FG010|Overall Study|Other|1|||
48404239|NCT00328627|155673036|FG011|Overall Study|Other|0|||
48404240|NCT04682405|155673039|FG000|Overall Study|Adverse Event|0|||
48404241|NCT04682405|155673040|FG001|Overall Study|Adverse Event|1|||
48404242|NCT04002310|155673041|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
48404243|NCT04002310|155673042|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
48404244|NCT04002310|155673043|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
48404245|NCT04002310|155673044|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
48404246|NCT04002310|155673045|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
48404247|NCT00112905|155673046|FG000|Overall Study|Adverse Event|4|||
48404248|NCT00112905|155673046|FG000|Overall Study|Death|1|||
48404249|NCT00112905|155673046|FG000|Overall Study|Ineligibility|5|||
48404250|NCT00112905|155673046|FG000|Overall Study|Alternative treatment|1|||
48404251|NCT00112905|155673046|FG000|Overall Study|performance status was deteiorating|1|||
48404252|NCT01765673|155673047|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
48404253|NCT05162066|155673059|FG000|Overall Study|Adverse Event|1|||
48404254|NCT05162066|155673060|FG001|Overall Study|Adverse Event|0|||
48404255|NCT05162066|155673061|FG002|Overall Study|Adverse Event|0|||
48404256|NCT05162066|155673059|FG000|Overall Study|Perceived lack of efficacy|1|||
48404257|NCT05162066|155673060|FG001|Overall Study|Perceived lack of efficacy|0|||
48404258|NCT05162066|155673061|FG002|Overall Study|Perceived lack of efficacy|0|||
48404259|NCT01072344|155673062|FG000|Overall Study|Relasped-reached end point|7|||
48404260|NCT01072344|155673063|FG001|Overall Study|Relasped-reached end point|12|||
48404261|NCT01072344|155673062|FG000|Overall Study|Protocol Violation|1|||
48404262|NCT01072344|155673063|FG001|Overall Study|Protocol Violation|2|||
48404263|NCT01072344|155673062|FG000|Overall Study|Lost to Follow-up|3|||
48404264|NCT01072344|155673063|FG001|Overall Study|Lost to Follow-up|4|||
48404265|NCT02605642|155673064|FG000|Overall Study|Other|11|||
48404266|NCT02605642|155673065|FG001|Overall Study|Other|1|||
48404267|NCT02605642|155673064|FG000|Overall Study|Participant non-compliance|2|||
48404268|NCT02605642|155673065|FG001|Overall Study|Participant non-compliance|4|||
48404269|NCT02605642|155673064|FG000|Overall Study|Physician Decision|10|||
48404270|NCT02605642|155673065|FG001|Overall Study|Physician Decision|0|||
48404271|NCT02605642|155673064|FG000|Overall Study|Lost to Follow-up|12|||
48404272|NCT02605642|155673065|FG001|Overall Study|Lost to Follow-up|1|||
48404273|NCT02605642|155673064|FG000|Overall Study|Adverse Event|14|||
48404274|NCT02605642|155673065|FG001|Overall Study|Adverse Event|2|||
48404275|NCT02605642|155673064|FG000|Overall Study|Withdrawal by Subject|23|||
48404276|NCT02605642|155673065|FG001|Overall Study|Withdrawal by Subject|2|||
48404277|NCT02605642|155673064|FG000|Overall Study|Lack of response|24|||
48404278|NCT02605642|155673065|FG001|Overall Study|Lack of response|11|||
48404279|NCT02111564|155673066|FG000|Overall Study|Death|109|||
48404280|NCT02111564|155673067|FG001|Overall Study|Death|120|||
48404281|NCT02111564|155673066|FG000|Overall Study|Lost to Follow-up|2|||
48404282|NCT02111564|155673067|FG001|Overall Study|Lost to Follow-up|3|||
48404283|NCT02111564|155673066|FG000|Overall Study|Withdrawal by Subject|20|||
48404284|NCT02111564|155673067|FG001|Overall Study|Withdrawal by Subject|20|||
48404285|NCT02354703|155673068|FG000|Overall Study|Withdrawal by Subject|1|||
48404286|NCT02354703|155673069|FG001|Overall Study|Withdrawal by Subject|1|||
48404287|NCT02354703|155673070|FG002|Overall Study|Withdrawal by Subject|1|||
48404288|NCT02354703|155673071|FG003|Overall Study|Withdrawal by Subject|1|||
48404289|NCT02354703|155673068|FG000|Overall Study|Lost to Follow-up|2|||
48404290|NCT02354703|155673069|FG001|Overall Study|Lost to Follow-up|7|||
48404291|NCT02354703|155673070|FG002|Overall Study|Lost to Follow-up|9|||
48404292|NCT02354703|155673071|FG003|Overall Study|Lost to Follow-up|2|||
48404293|NCT02354703|155673068|FG000|Overall Study|Adverse Event|0|||
48404294|NCT02354703|155673069|FG001|Overall Study|Adverse Event|0|||
48404295|NCT02354703|155673070|FG002|Overall Study|Adverse Event|1|||
48404296|NCT02354703|155673071|FG003|Overall Study|Adverse Event|0|||
48404297|NCT00122135|155673072|FG000|Overall Study|Withdrawal by Subject|3|||
48404298|NCT00122135|155673073|FG001|Overall Study|Withdrawal by Subject|0|||
48404299|NCT00700180|155673078|FG000|Overall Study|Death|99|||
48404300|NCT00700180|155673079|FG001|Overall Study|Death|114|||
48404301|NCT00700180|155673078|FG000|Overall Study|Alive on treatment|5|||
48404302|NCT00700180|155673079|FG001|Overall Study|Alive on treatment|3|||
48404303|NCT00700180|155673078|FG000|Overall Study|Alive in follow-up|46|||
48404304|NCT00700180|155673079|FG001|Overall Study|Alive in follow-up|27|||
48404305|NCT00700180|155673078|FG000|Overall Study|Lost to Follow-up|4|||
48404306|NCT00700180|155673079|FG001|Overall Study|Lost to Follow-up|5|||
48404307|NCT02468648|155673082|FG000|Overall Study|Death|1|||
48404308|NCT02634580|155673083|FG000|Double-blind Treatment Period|Subject Request|1|||
48404309|NCT02634580|155673084|FG001|Double-blind Treatment Period|Subject Request|0|||
48404310|NCT02634580|155673085|FG002|Double-blind Treatment Period|Subject Request|1|||
48404311|NCT02634580|155673086|FG003|Double-blind Treatment Period|Subject Request|1|||
48404312|NCT02634580|155673083|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
48404313|NCT02634580|155673084|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
48404314|NCT02634580|155673085|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
48404315|NCT02634580|155673086|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
48404316|NCT03757988|155673087|FG000|Overall Study|Withdrawal by Subject|1|||
48404317|NCT04418765|155673096|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
48404318|NCT04418765|155673097|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
48404319|NCT04418765|155673098|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
48404320|NCT04418765|155673096|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
48404321|NCT04418765|155673097|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
48404322|NCT04418765|155673098|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
48404323|NCT04418765|155673096|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
48404324|NCT04418765|155673097|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
48404325|NCT04418765|155673098|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
48404326|NCT04418765|155673096|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
48404327|NCT04418765|155673097|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
48404328|NCT04418765|155673098|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
48404329|NCT04418765|155673096|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
48404330|NCT04418765|155673097|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
48404331|NCT04418765|155673098|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
48404332|NCT04418765|155673096|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
48404333|NCT04418765|155673097|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
48404334|NCT04418765|155673098|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
48404335|NCT04418765|155673096|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
48404336|NCT04418765|155673097|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
48404337|NCT04418765|155673098|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
48404338|NCT04418765|155673096|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
48404339|NCT04418765|155673097|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
48404340|NCT04418765|155673098|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
48430371|NCT00696657|155763707|FG007|Overall Study|Adverse Event|2|||
48404341|NCT04418765|155673096|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
48404342|NCT04418765|155673097|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
48404343|NCT04418765|155673098|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
48404344|NCT04418765|155673096|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
48404345|NCT04418765|155673097|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
48404346|NCT04418765|155673098|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
48404347|NCT04418765|155673096|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
48404348|NCT04418765|155673097|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
48404349|NCT04418765|155673098|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
48404350|NCT04418765|155673096|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
48404351|NCT04418765|155673097|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
48404352|NCT04418765|155673098|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
48404353|NCT04418765|155673096|FG000|Extension Period (48 Weeks)|Other than specified|0|||
48404354|NCT04418765|155673097|FG001|Extension Period (48 Weeks)|Other than specified|5|||
48404355|NCT04418765|155673098|FG002|Extension Period (48 Weeks)|Other than specified|2|||
48404356|NCT04372927|155673100|FG000|Overall Study|Death|1|||
48404357|NCT02217566|155673125|FG000|Overall Study|Lost to Follow-up|2|||
48404358|NCT02217566|155673125|FG000|Overall Study|Death|3|||
48404359|NCT02217566|155673125|FG000|Overall Study|Early study termination|6|||
48404360|NCT01639833|155673126|FG000|Overall Study|Death|4|||
48404361|NCT01639833|155673127|FG001|Overall Study|Death|2|||
48404362|NCT01639833|155673126|FG000|Overall Study|Withdrawal by Subject|2|||
48404363|NCT01639833|155673127|FG001|Overall Study|Withdrawal by Subject|2|||
48404364|NCT00684957|155673128|FG000|Overall Study|Withdrawal by Subject|1|||
48404365|NCT00684957|155673129|FG001|Overall Study|Withdrawal by Subject|1|||
48404366|NCT00684957|155673128|FG000|Overall Study|Lost to Follow-up|1|||
48404367|NCT00684957|155673129|FG001|Overall Study|Lost to Follow-up|0|||
48404368|NCT01699087|155673130|FG000|Overall Study|Lost to Follow-up|7|||
48404369|NCT01699087|155673130|FG000|Overall Study|Screen failure (prior to treatment)|15|||
48404370|NCT01699087|155673130|FG000|Overall Study|Unable to make future visits|2|||
48404371|NCT02623335|155673131|FG000|Overall Study|Death|8|||
48404372|NCT02623335|155673132|FG001|Overall Study|Death|7|||
48404373|NCT02623335|155673131|FG000|Overall Study|Lost to Follow-up|15|||
48404374|NCT02623335|155673132|FG001|Overall Study|Lost to Follow-up|23|||
48404375|NCT02623335|155673131|FG000|Overall Study|Withdrawal by Subject|2|||
48404376|NCT02623335|155673132|FG001|Overall Study|Withdrawal by Subject|5|||
48404377|NCT02623335|155673131|FG000|Overall Study|Protocol Violation|2|||
48404378|NCT02623335|155673132|FG001|Overall Study|Protocol Violation|1|||
48404379|NCT00090545|155673133|FG000|Overall Study|Disease progression on study|21|||
48404380|NCT00090545|155673134|FG001|Overall Study|Disease progression on study|17|||
48404381|NCT00090545|155673133|FG000|Overall Study|Refused further treatment|1|||
48404382|NCT00090545|155673134|FG001|Overall Study|Refused further treatment|4|||
48404383|NCT00090545|155673133|FG000|Overall Study|Death|0|||
48404384|NCT00090545|155673134|FG001|Overall Study|Death|1|||
48404385|NCT00090545|155673133|FG000|Overall Study|Adverse Event|0|||
48404386|NCT00090545|155673134|FG001|Overall Study|Adverse Event|2|||
48404387|NCT02769624|155673135|FG000|Overall Study|Lost to Follow-up|0|||
48404388|NCT02769624|155673136|FG001|Overall Study|Lost to Follow-up|1|||
48404389|NCT02629159|155673144|FG000|Overall Study|Adverse Event|17|||
48404390|NCT02629159|155673145|FG001|Overall Study|Adverse Event|20|||
48404391|NCT02629159|155673146|FG002|Overall Study|Adverse Event|22|||
48404392|NCT02629159|155673144|FG000|Overall Study|Withdrawal by Subject|22|||
48404393|NCT02629159|155673145|FG001|Overall Study|Withdrawal by Subject|11|||
48404394|NCT02629159|155673146|FG002|Overall Study|Withdrawal by Subject|15|||
48404395|NCT02629159|155673144|FG000|Overall Study|Lost to Follow-up|7|||
48404396|NCT02629159|155673145|FG001|Overall Study|Lost to Follow-up|4|||
48404397|NCT02629159|155673146|FG002|Overall Study|Lost to Follow-up|5|||
48404398|NCT02629159|155673144|FG000|Overall Study|Lack of Efficacy|4|||
48404399|NCT02629159|155673145|FG001|Overall Study|Lack of Efficacy|0|||
48404400|NCT02629159|155673146|FG002|Overall Study|Lack of Efficacy|1|||
48404401|NCT02629159|155673144|FG000|Overall Study|Other|6|||
48404402|NCT02629159|155673145|FG001|Overall Study|Other|4|||
48404403|NCT02629159|155673146|FG002|Overall Study|Other|8|||
48404404|NCT00243659|155673147|FG000|Overall Study|Withdrawal by Subject|1|||
48404405|NCT00243659|155673148|FG001|Overall Study|Withdrawal by Subject|1|||
48404406|NCT00243659|155673147|FG000|Overall Study|Protocol Violation|1|||
48404407|NCT00243659|155673148|FG001|Overall Study|Protocol Violation|2|||
48404408|NCT01375764|155673150|FG000|Overall Study|Lost to Follow-up|0|||
48404409|NCT01375764|155673151|FG001|Overall Study|Lost to Follow-up|1|||
48404410|NCT01375764|155673152|FG002|Overall Study|Lost to Follow-up|0|||
48404411|NCT01375764|155673153|FG003|Overall Study|Lost to Follow-up|0|||
48404412|NCT01375764|155673154|FG004|Overall Study|Lost to Follow-up|0|||
48404413|NCT01375764|155673150|FG000|Overall Study|Withdrawal by Subject|2|||
48404414|NCT01375764|155673151|FG001|Overall Study|Withdrawal by Subject|0|||
48404415|NCT01375764|155673152|FG002|Overall Study|Withdrawal by Subject|0|||
48404416|NCT01375764|155673153|FG003|Overall Study|Withdrawal by Subject|0|||
48404417|NCT01375764|155673154|FG004|Overall Study|Withdrawal by Subject|1|||
48404418|NCT01375764|155673150|FG000|Overall Study|Other|0|||
48404419|NCT01375764|155673151|FG001|Overall Study|Other|0|||
48404420|NCT01375764|155673152|FG002|Overall Study|Other|0|||
48404421|NCT01375764|155673153|FG003|Overall Study|Other|1|||
48404422|NCT01375764|155673154|FG004|Overall Study|Other|0|||
48404423|NCT02867761|155673155|FG000|Overall Study|Participant withdrawn by investigator|0|||
48404424|NCT02867761|155673156|FG001|Overall Study|Participant withdrawn by investigator|1|||
48404425|NCT02867761|155673155|FG000|Overall Study|Lost to Follow-up|25|||
48404426|NCT02867761|155673156|FG001|Overall Study|Lost to Follow-up|18|||
48404427|NCT02867761|155673155|FG000|Overall Study|Unable to complete protocol|3|||
48404428|NCT02867761|155673156|FG001|Overall Study|Unable to complete protocol|7|||
48404429|NCT04506294|155673157|FG000|Overall Study|Lost to Follow-up|70|||
48404430|NCT04506294|155673158|FG001|Overall Study|Lost to Follow-up|20|||
48404431|NCT04506294|155673157|FG000|Overall Study|Withdrawal by Subject|16|||
48404432|NCT04506294|155673158|FG001|Overall Study|Withdrawal by Subject|2|||
48404433|NCT02317562|155673162|FG000|Overall Study|Physician Decision|1|||
48404434|NCT02317562|155673162|FG000|Overall Study|early termination of the study|8|||
48404435|NCT02317562|155673162|FG000|Overall Study|Lack of Efficacy|4|||
48404436|NCT02317562|155673162|FG000|Overall Study|Withdrawal by Subject|1|||
48404437|NCT02319044|155673163|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
48404438|NCT02319044|155673164|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
48404439|NCT02319044|155673165|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
48404440|NCT02319044|155673163|FG000|Overall Study|Withdrawal by Subject|3|||
48404441|NCT02319044|155673164|FG001|Overall Study|Withdrawal by Subject|3|||
48404442|NCT02319044|155673165|FG002|Overall Study|Withdrawal by Subject|6|||
48404443|NCT02319044|155673163|FG000|Overall Study|Condition under investigation worsened|100|||
48404444|NCT02319044|155673164|FG001|Overall Study|Condition under investigation worsened|50|||
48404445|NCT02319044|155673165|FG002|Overall Study|Condition under investigation worsened|46|||
48404446|NCT02319044|155673163|FG000|Overall Study|Adverse Event|17|||
48404447|NCT02319044|155673164|FG001|Overall Study|Adverse Event|2|||
48404448|NCT02319044|155673165|FG002|Overall Study|Adverse Event|8|||
48404449|NCT02319044|155673163|FG000|Overall Study|Study specific discontinuation criteria|2|||
48404450|NCT02319044|155673164|FG001|Overall Study|Study specific discontinuation criteria|2|||
48404451|NCT02319044|155673165|FG002|Overall Study|Study specific discontinuation criteria|1|||
48404452|NCT02319044|155673163|FG000|Overall Study|Not treated|0|||
48404453|NCT02319044|155673164|FG001|Overall Study|Not treated|2|||
48404454|NCT02319044|155673165|FG002|Overall Study|Not treated|2|||
48404455|NCT03551743|155673166|FG000|Overall Study|Adverse Event|1|||
48404456|NCT03551743|155673167|FG001|Overall Study|Adverse Event|0|||
48404457|NCT03551743|155673168|FG002|Overall Study|Adverse Event|0|||
48404458|NCT03551743|155673169|FG003|Overall Study|Adverse Event|0|||
48404459|NCT03551743|155673166|FG000|Overall Study|Withdrawal by Subject|1|||
48404460|NCT03551743|155673167|FG001|Overall Study|Withdrawal by Subject|0|||
48404461|NCT03551743|155673168|FG002|Overall Study|Withdrawal by Subject|0|||
48404462|NCT03551743|155673169|FG003|Overall Study|Withdrawal by Subject|0|||
48404463|NCT01512264|155673170|FG000|Overall Study|Lost to Follow-up|0|||
48404464|NCT01512264|155673171|FG001|Overall Study|Lost to Follow-up|0|||
48404465|NCT01512264|155673172|FG002|Overall Study|Lost to Follow-up|0|||
48404466|NCT01512264|155673173|FG003|Overall Study|Lost to Follow-up|1|||
48404467|NCT02026063|155673177|FG000|Overall Study|Physician Decision|0|||
48404468|NCT02026063|155673178|FG001|Overall Study|Physician Decision|10|||
48404469|NCT02026063|155673177|FG000|Overall Study|Noncompliance with Study Drug|1|||
48404470|NCT02026063|155673178|FG001|Overall Study|Noncompliance with Study Drug|1|||
48404471|NCT02026063|155673177|FG000|Overall Study|Withdrawal of Consent|1|||
48404472|NCT02026063|155673178|FG001|Overall Study|Withdrawal of Consent|6|||
48404473|NCT02026063|155673177|FG000|Overall Study|Adverse Event|5|||
48404474|NCT02026063|155673178|FG001|Overall Study|Adverse Event|20|||
48404475|NCT02026063|155673177|FG000|Overall Study|Lack of Efficacy|0|||
48404476|NCT02026063|155673178|FG001|Overall Study|Lack of Efficacy|4|||
48404477|NCT02026063|155673177|FG000|Overall Study|Lost to Follow-up|0|||
48404478|NCT02026063|155673178|FG001|Overall Study|Lost to Follow-up|1|||
48404479|NCT02026063|155673177|FG000|Overall Study|Reason not Specified|2|||
48404480|NCT02026063|155673178|FG001|Overall Study|Reason not Specified|7|||
48404481|NCT02183519|155673180|FG000|Overall Study|computer error|3|||
48404482|NCT02183519|155673181|FG001|Overall Study|computer error|0|||
48404483|NCT02183519|155673180|FG000|Overall Study|Did not respond to cough inducter|0|||
48404484|NCT02183519|155673181|FG001|Overall Study|Did not respond to cough inducter|3|||
48404485|NCT02899156|155673182|FG000|Overall Study|Death|1|||
48404486|NCT02899156|155673183|FG001|Overall Study|Death|0|||
48404487|NCT02899156|155673182|FG000|Overall Study|Physician Decision|0|||
48404488|NCT02899156|155673183|FG001|Overall Study|Physician Decision|1|||
48404489|NCT02901431|155673184|FG000|PK Part|Adverse Event|0|||
48404490|NCT02901431|155673185|FG001|PK Part|Adverse Event|1|||
48404491|NCT02901431|155673186|FG002|PK Part|Adverse Event|0|||
48404492|NCT02901431|155673187|FG003|PK Part|Adverse Event|0|||
48404493|NCT02901431|155673188|FG004|PK Part|Adverse Event|0|||
48404494|NCT02901431|155673189|FG005|PK Part|Adverse Event|0|||
48404495|NCT02901431|155673190|FG006|PK Part|Adverse Event|0|||
48404496|NCT02901431|155673191|FG007|PK Part|Adverse Event|0|||
48404497|NCT02901431|155673192|FG008|PK Part|Adverse Event|0|||
48404498|NCT02901431|155673193|FG009|PK Part|Adverse Event|0|||
48404499|NCT02901431|155673194|FG010|PK Part|Adverse Event|0|||
48404500|NCT02901431|155673195|FG011|PK Part|Adverse Event|0|||
48404501|NCT02901431|155673196|FG012|PK Part|Adverse Event|0|||
48404502|NCT02901431|155673184|FG000|PK Part|Lost to Follow-up|0|||
48404503|NCT02901431|155673185|FG001|PK Part|Lost to Follow-up|0|||
48404504|NCT02901431|155673186|FG002|PK Part|Lost to Follow-up|1|||
48404505|NCT02901431|155673187|FG003|PK Part|Lost to Follow-up|0|||
48404506|NCT02901431|155673188|FG004|PK Part|Lost to Follow-up|0|||
48404507|NCT02901431|155673189|FG005|PK Part|Lost to Follow-up|0|||
48404508|NCT02901431|155673190|FG006|PK Part|Lost to Follow-up|0|||
48404509|NCT02901431|155673191|FG007|PK Part|Lost to Follow-up|0|||
48404510|NCT02901431|155673192|FG008|PK Part|Lost to Follow-up|0|||
48404511|NCT02901431|155673193|FG009|PK Part|Lost to Follow-up|0|||
48404512|NCT02901431|155673194|FG010|PK Part|Lost to Follow-up|0|||
48404513|NCT02901431|155673195|FG011|PK Part|Lost to Follow-up|0|||
48404514|NCT02901431|155673196|FG012|PK Part|Lost to Follow-up|0|||
48404515|NCT02901431|155673184|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
48404516|NCT02901431|155673185|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404517|NCT02901431|155673186|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404518|NCT02901431|155673187|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404519|NCT02901431|155673188|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404520|NCT02901431|155673189|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404521|NCT02901431|155673190|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404522|NCT02901431|155673191|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404523|NCT02901431|155673192|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404524|NCT02901431|155673193|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404525|NCT02901431|155673194|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404526|NCT02901431|155673195|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48404527|NCT02901431|155673196|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
48796366|NCT01515748|157091561|FG001|Overall Study|Other than specified above|10|||
48796367|NCT04197713|157091562|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
48796368|NCT04197713|157091563|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
48796369|NCT04981678|157091568|FG000|Overall Study|Lost to Follow-up|0|||
48796370|NCT04981678|157091569|FG001|Overall Study|Lost to Follow-up|1|||
48796371|NCT01791725|157093641|FG000|Overall Study|Withdrawal by Subject|0|||
48796372|NCT01791725|157093642|FG001|Overall Study|Withdrawal by Subject|1|||
48796373|NCT01791725|157093643|FG002|Overall Study|Withdrawal by Subject|0|||
48796374|NCT03393000|157093646|FG000|Overall Study|Death|11|||
48796375|NCT03393000|157093646|FG000|Overall Study|Withdrawal by Subject|2|||
48796376|NCT03393000|157093646|FG000|Overall Study|Physician Decision|1|||
48796377|NCT01773070|157093647|FG000|Overall Study|Withdrawal by Subject|24|||
48796378|NCT01773070|157093647|FG000|Overall Study|Lost to Follow-up|39|||
48796379|NCT01773070|157093647|FG000|Overall Study|Other|15|||
48796380|NCT01773070|157093647|FG000|Overall Study|Death (unrelated to study procedures)|3|||
48796381|NCT01559844|157093648|FG000|Overall Study|Consent Withdrawn|7|||
48796382|NCT01559844|157093648|FG000|Overall Study|Death|5|||
48796383|NCT01559844|157093648|FG000|Overall Study|Efficacy Failure|10|||
48796384|NCT01559844|157093648|FG000|Overall Study|No Longer A Transplant Candidate|3|||
48796385|NCT02181803|157093649|FG000|Overall Study|Withdrawal by Subject|0|||
48796386|NCT02181803|157093650|FG001|Overall Study|Withdrawal by Subject|2|||
48796387|NCT02181803|157093651|FG002|Overall Study|Withdrawal by Subject|0|||
48796388|NCT02181803|157093652|FG003|Overall Study|Withdrawal by Subject|0|||
48796389|NCT02181803|157093653|FG004|Overall Study|Withdrawal by Subject|0|||
48796390|NCT02181803|157093654|FG005|Overall Study|Withdrawal by Subject|0|||
48796391|NCT02181803|157093655|FG006|Overall Study|Withdrawal by Subject|0|||
48796392|NCT02181803|157093656|FG007|Overall Study|Withdrawal by Subject|0|||
48796393|NCT02181803|157093657|FG008|Overall Study|Withdrawal by Subject|0|||
48796394|NCT02181803|157093649|FG000|Overall Study|Physician Decision|0|||
48796395|NCT02181803|157093650|FG001|Overall Study|Physician Decision|0|||
48796396|NCT02181803|157093651|FG002|Overall Study|Physician Decision|0|||
48796397|NCT02181803|157093652|FG003|Overall Study|Physician Decision|1|||
48796398|NCT02181803|157093653|FG004|Overall Study|Physician Decision|0|||
48796399|NCT02181803|157093654|FG005|Overall Study|Physician Decision|0|||
48796400|NCT02181803|157093655|FG006|Overall Study|Physician Decision|0|||
48796401|NCT02181803|157093656|FG007|Overall Study|Physician Decision|1|||
48404528|NCT02901431|155673184|FG000|PK Part|Pending dose confirmation|0|||
48404529|NCT02901431|155673185|FG001|PK Part|Pending dose confirmation|1|||
48404530|NCT02901431|155673186|FG002|PK Part|Pending dose confirmation|0|||
48404531|NCT02901431|155673187|FG003|PK Part|Pending dose confirmation|0|||
48404532|NCT02901431|155673188|FG004|PK Part|Pending dose confirmation|0|||
48404533|NCT02901431|155673189|FG005|PK Part|Pending dose confirmation|0|||
48796402|NCT02181803|157093657|FG008|Overall Study|Physician Decision|0|||
48796403|NCT02181803|157093649|FG000|Overall Study|Adverse Event|0|||
48404534|NCT02901431|155673190|FG006|PK Part|Pending dose confirmation|0|||
48404535|NCT02901431|155673191|FG007|PK Part|Pending dose confirmation|0|||
48404536|NCT02901431|155673192|FG008|PK Part|Pending dose confirmation|0|||
48404537|NCT02901431|155673193|FG009|PK Part|Pending dose confirmation|0|||
48404538|NCT02901431|155673194|FG010|PK Part|Pending dose confirmation|0|||
48404539|NCT02901431|155673195|FG011|PK Part|Pending dose confirmation|0|||
48404540|NCT02901431|155673196|FG012|PK Part|Pending dose confirmation|0|||
48404541|NCT02901431|155673184|FG000|PK Part|8 weeks of treatment ran out|2|||
48404542|NCT02901431|155673185|FG001|PK Part|8 weeks of treatment ran out|0|||
48404543|NCT02901431|155673186|FG002|PK Part|8 weeks of treatment ran out|0|||
48404544|NCT02901431|155673187|FG003|PK Part|8 weeks of treatment ran out|0|||
48404545|NCT02901431|155673188|FG004|PK Part|8 weeks of treatment ran out|0|||
48404546|NCT02901431|155673189|FG005|PK Part|8 weeks of treatment ran out|0|||
48404547|NCT02901431|155673190|FG006|PK Part|8 weeks of treatment ran out|0|||
48404548|NCT02901431|155673191|FG007|PK Part|8 weeks of treatment ran out|0|||
48404549|NCT02901431|155673192|FG008|PK Part|8 weeks of treatment ran out|0|||
48404550|NCT02901431|155673193|FG009|PK Part|8 weeks of treatment ran out|0|||
48404551|NCT02901431|155673194|FG010|PK Part|8 weeks of treatment ran out|0|||
48404552|NCT02901431|155673195|FG011|PK Part|8 weeks of treatment ran out|0|||
48404553|NCT02901431|155673196|FG012|PK Part|8 weeks of treatment ran out|0|||
48404554|NCT02901431|155673184|FG000|PK Part|Stopped treatment after 8 weeks|1|||
48404555|NCT02901431|155673185|FG001|PK Part|Stopped treatment after 8 weeks|0|||
48404556|NCT02901431|155673186|FG002|PK Part|Stopped treatment after 8 weeks|1|||
48404557|NCT02901431|155673187|FG003|PK Part|Stopped treatment after 8 weeks|0|||
48404558|NCT02901431|155673188|FG004|PK Part|Stopped treatment after 8 weeks|0|||
48404559|NCT02901431|155673189|FG005|PK Part|Stopped treatment after 8 weeks|0|||
48404560|NCT02901431|155673190|FG006|PK Part|Stopped treatment after 8 weeks|0|||
48404561|NCT02901431|155673191|FG007|PK Part|Stopped treatment after 8 weeks|0|||
48404562|NCT02901431|155673192|FG008|PK Part|Stopped treatment after 8 weeks|0|||
48404563|NCT02901431|155673193|FG009|PK Part|Stopped treatment after 8 weeks|0|||
48404564|NCT02901431|155673194|FG010|PK Part|Stopped treatment after 8 weeks|0|||
48404565|NCT02901431|155673195|FG011|PK Part|Stopped treatment after 8 weeks|0|||
48404566|NCT02901431|155673196|FG012|PK Part|Stopped treatment after 8 weeks|0|||
48404567|NCT02901431|155673184|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
48404568|NCT02901431|155673185|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404569|NCT02901431|155673186|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
48404570|NCT02901431|155673187|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404571|NCT02901431|155673188|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404572|NCT02901431|155673189|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404573|NCT02901431|155673190|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404574|NCT02901431|155673191|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404575|NCT02901431|155673192|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404576|NCT02901431|155673193|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404577|NCT02901431|155673194|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404578|NCT02901431|155673195|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404579|NCT02901431|155673196|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
48404580|NCT02901431|155673184|FG000|PK Part|Discontinued per Sponsor|0|||
48404581|NCT02901431|155673185|FG001|PK Part|Discontinued per Sponsor|3|||
48404582|NCT02901431|155673186|FG002|PK Part|Discontinued per Sponsor|0|||
48404583|NCT02901431|155673187|FG003|PK Part|Discontinued per Sponsor|0|||
48404584|NCT02901431|155673188|FG004|PK Part|Discontinued per Sponsor|0|||
48404585|NCT02901431|155673189|FG005|PK Part|Discontinued per Sponsor|0|||
48404586|NCT02901431|155673190|FG006|PK Part|Discontinued per Sponsor|0|||
48404587|NCT02901431|155673191|FG007|PK Part|Discontinued per Sponsor|0|||
48404588|NCT02901431|155673192|FG008|PK Part|Discontinued per Sponsor|0|||
48404589|NCT02901431|155673193|FG009|PK Part|Discontinued per Sponsor|0|||
48404590|NCT02901431|155673194|FG010|PK Part|Discontinued per Sponsor|0|||
48404591|NCT02901431|155673195|FG011|PK Part|Discontinued per Sponsor|0|||
48404592|NCT02901431|155673196|FG012|PK Part|Discontinued per Sponsor|0|||
48404593|NCT02901431|155673184|FG000|PK Part|Withdrawal by Subject|1|||
48404594|NCT02901431|155673185|FG001|PK Part|Withdrawal by Subject|1|||
48404595|NCT02901431|155673186|FG002|PK Part|Withdrawal by Subject|3|||
48796404|NCT02181803|157093650|FG001|Overall Study|Adverse Event|2|||
48796405|NCT02181803|157093651|FG002|Overall Study|Adverse Event|0|||
48796406|NCT02181803|157093652|FG003|Overall Study|Adverse Event|1|||
48796407|NCT02181803|157093653|FG004|Overall Study|Adverse Event|0|||
48796408|NCT02181803|157093654|FG005|Overall Study|Adverse Event|0|||
48796409|NCT02181803|157093655|FG006|Overall Study|Adverse Event|1|||
48796410|NCT02181803|157093656|FG007|Overall Study|Adverse Event|0|||
48796411|NCT02181803|157093657|FG008|Overall Study|Adverse Event|0|||
48796412|NCT01514448|157093658|FG000|Overall Study|Death|7|||
48796413|NCT01514448|157093659|FG001|Overall Study|Death|8|||
48796414|NCT01514448|157093658|FG000|Overall Study|Withdrawal by Subject|2|||
48796415|NCT01514448|157093659|FG001|Overall Study|Withdrawal by Subject|0|||
48796416|NCT01514448|157093658|FG000|Overall Study|Lost to Follow-up|2|||
48796417|NCT01514448|157093659|FG001|Overall Study|Lost to Follow-up|0|||
48796418|NCT01514448|157093658|FG000|Overall Study|New Cancer Therapy|1|||
48796419|NCT01514448|157093659|FG001|Overall Study|New Cancer Therapy|0|||
48796420|NCT03151005|157093665|FG000|Overall Study|Lost to Follow-up|5|||
48796421|NCT03151005|157093666|FG001|Overall Study|Lost to Follow-up|5|||
48796422|NCT02723864|157093669|FG000|Overall Study|Refused further treatment|1|||
48796423|NCT02723864|157093670|FG001|Overall Study|Refused further treatment|0|||
48796424|NCT02723864|157093671|FG002|Overall Study|Refused further treatment|0|||
48796425|NCT02723864|157093672|FG003|Overall Study|Refused further treatment|0|||
48796426|NCT02723864|157093673|FG004|Overall Study|Refused further treatment|1|||
48796427|NCT02723864|157093674|FG005|Overall Study|Refused further treatment|2|||
48796428|NCT02723864|157093675|FG006|Overall Study|Refused further treatment|0|||
48796429|NCT02723864|157093669|FG000|Overall Study|Exceed treatment hold time|0|||
48796430|NCT02723864|157093670|FG001|Overall Study|Exceed treatment hold time|1|||
48796431|NCT02723864|157093671|FG002|Overall Study|Exceed treatment hold time|0|||
48796432|NCT02723864|157093672|FG003|Overall Study|Exceed treatment hold time|0|||
48796433|NCT02723864|157093673|FG004|Overall Study|Exceed treatment hold time|0|||
48796434|NCT02723864|157093674|FG005|Overall Study|Exceed treatment hold time|0|||
48796435|NCT02723864|157093675|FG006|Overall Study|Exceed treatment hold time|0|||
48796436|NCT02723864|157093669|FG000|Overall Study|Clinical progression|0|||
48796437|NCT02723864|157093670|FG001|Overall Study|Clinical progression|0|||
48796438|NCT02723864|157093671|FG002|Overall Study|Clinical progression|1|||
48796439|NCT02723864|157093672|FG003|Overall Study|Clinical progression|0|||
48796440|NCT02723864|157093673|FG004|Overall Study|Clinical progression|0|||
48796441|NCT02723864|157093674|FG005|Overall Study|Clinical progression|3|||
48796442|NCT02723864|157093675|FG006|Overall Study|Clinical progression|1|||
48796443|NCT02723864|157093669|FG000|Overall Study|Physician Decision|0|||
48796444|NCT02723864|157093670|FG001|Overall Study|Physician Decision|0|||
48796445|NCT02723864|157093671|FG002|Overall Study|Physician Decision|0|||
48796446|NCT02723864|157093672|FG003|Overall Study|Physician Decision|0|||
48796447|NCT02723864|157093673|FG004|Overall Study|Physician Decision|0|||
48357362|NCT00350727|155503634|FG001|Phase I: Dose Escalation|Adverse Event|0|||
48357363|NCT00350727|155503635|FG002|Phase I: Dose Escalation|Adverse Event|0|||
48357364|NCT00350727|155503633|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
48796448|NCT02723864|157093674|FG005|Overall Study|Physician Decision|0|||
48796449|NCT02723864|157093675|FG006|Overall Study|Physician Decision|1|||
48357365|NCT00350727|155503634|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
48357366|NCT00350727|155503635|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
48357367|NCT00350727|155503633|FG000|Phase I: Dose Escalation|Death|1|||
48357368|NCT00350727|155503634|FG001|Phase I: Dose Escalation|Death|0|||
48357369|NCT00350727|155503635|FG002|Phase I: Dose Escalation|Death|0|||
48357370|NCT00350727|155503633|FG000|Phase I: Dose Escalation|Physician Decision|1|||
48357371|NCT00350727|155503634|FG001|Phase I: Dose Escalation|Physician Decision|0|||
48357372|NCT00350727|155503635|FG002|Phase I: Dose Escalation|Physician Decision|0|||
48357373|NCT00350727|155503633|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
48357374|NCT00350727|155503634|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
48357375|NCT00350727|155503635|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
48357376|NCT00350727|155503633|FG000|Phase II|Disease Progression|0|||
48357377|NCT00350727|155503634|FG001|Phase II|Disease Progression|15|||
48357378|NCT00350727|155503635|FG002|Phase II|Disease Progression|16|||
48357379|NCT00350727|155503633|FG000|Phase II|Clinical Deterioration|0|||
48357380|NCT00350727|155503634|FG001|Phase II|Clinical Deterioration|1|||
48357381|NCT00350727|155503635|FG002|Phase II|Clinical Deterioration|0|||
48357382|NCT00350727|155503633|FG000|Phase II|Withdrawal by Subject|0|||
48357383|NCT00350727|155503634|FG001|Phase II|Withdrawal by Subject|2|||
48357384|NCT00350727|155503635|FG002|Phase II|Withdrawal by Subject|1|||
48357385|NCT00350727|155503633|FG000|Phase II|Adverse Event|0|||
48357386|NCT00350727|155503634|FG001|Phase II|Adverse Event|1|||
48357387|NCT00350727|155503635|FG002|Phase II|Adverse Event|1|||
48357388|NCT00350727|155503633|FG000|Phase II|Death|0|||
48357389|NCT00350727|155503634|FG001|Phase II|Death|0|||
48357390|NCT00350727|155503635|FG002|Phase II|Death|2|||
48357391|NCT00350727|155503633|FG000|Phase II|Sponsor Terminated Study|0|||
48357392|NCT00350727|155503634|FG001|Phase II|Sponsor Terminated Study|0|||
48357393|NCT00350727|155503635|FG002|Phase II|Sponsor Terminated Study|1|||
48357394|NCT00350727|155503633|FG000|Phase II|Enrolled in Rollover Study|0|||
48357395|NCT00350727|155503634|FG001|Phase II|Enrolled in Rollover Study|0|||
48357396|NCT00350727|155503635|FG002|Phase II|Enrolled in Rollover Study|1|||
48357397|NCT01825798|155503645|FG000|Overall Study|Adverse Event|1|||
48357398|NCT01825798|155503646|FG001|Overall Study|Adverse Event|5|||
48357399|NCT01825798|155503645|FG000|Overall Study|Lost to Follow-up|1|||
48357400|NCT01825798|155503646|FG001|Overall Study|Lost to Follow-up|0|||
48357401|NCT00971997|155504866|FG000|Overall Study|Adverse Event|2|||
48357402|NCT00971997|155504866|FG000|Overall Study|Death|1|||
48357403|NCT00971997|155504866|FG000|Overall Study|Protocol Violation|4|||
48357404|NCT00971997|155504866|FG000|Overall Study|Withdrawal by Subject|5|||
48357405|NCT00971997|155504866|FG000|Overall Study|Physician Decision|7|||
48357406|NCT02808975|155504867|FG000|Overall Study|Adverse Event|3|||
48357407|NCT02808975|155504868|FG001|Overall Study|Adverse Event|4|||
48357408|NCT02808975|155504867|FG000|Overall Study|Withdrew consent|9|||
48357409|NCT02808975|155504868|FG001|Overall Study|Withdrew consent|8|||
48796450|NCT02723864|157093669|FG000|Overall Study|Changes in patient condition|0|||
48796451|NCT02723864|157093670|FG001|Overall Study|Changes in patient condition|0|||
48796452|NCT02723864|157093671|FG002|Overall Study|Changes in patient condition|0|||
48796453|NCT02723864|157093672|FG003|Overall Study|Changes in patient condition|0|||
48796454|NCT02723864|157093673|FG004|Overall Study|Changes in patient condition|0|||
48796455|NCT02723864|157093674|FG005|Overall Study|Changes in patient condition|1|||
48796456|NCT02723864|157093675|FG006|Overall Study|Changes in patient condition|0|||
48796457|NCT02723864|157093669|FG000|Overall Study|Patient choice|0|||
48796458|NCT02723864|157093670|FG001|Overall Study|Patient choice|0|||
48796459|NCT02723864|157093671|FG002|Overall Study|Patient choice|0|||
48796460|NCT02723864|157093672|FG003|Overall Study|Patient choice|0|||
48796461|NCT02723864|157093673|FG004|Overall Study|Patient choice|0|||
48796462|NCT02723864|157093674|FG005|Overall Study|Patient choice|1|||
48796463|NCT02723864|157093675|FG006|Overall Study|Patient choice|0|||
48796464|NCT02723864|157093669|FG000|Overall Study|Adverse Event|0|||
48796465|NCT02723864|157093670|FG001|Overall Study|Adverse Event|0|||
48796466|NCT02723864|157093671|FG002|Overall Study|Adverse Event|0|||
48796467|NCT02723864|157093672|FG003|Overall Study|Adverse Event|0|||
48796468|NCT02723864|157093673|FG004|Overall Study|Adverse Event|0|||
48796469|NCT02723864|157093674|FG005|Overall Study|Adverse Event|1|||
48796470|NCT02723864|157093675|FG006|Overall Study|Adverse Event|0|||
48796471|NCT02723864|157093669|FG000|Overall Study|Started new treatment|0|||
48796472|NCT02723864|157093670|FG001|Overall Study|Started new treatment|0|||
48796473|NCT02723864|157093671|FG002|Overall Study|Started new treatment|0|||
48796474|NCT02723864|157093672|FG003|Overall Study|Started new treatment|0|||
48796475|NCT02723864|157093673|FG004|Overall Study|Started new treatment|0|||
48796476|NCT02723864|157093674|FG005|Overall Study|Started new treatment|1|||
48796477|NCT02723864|157093675|FG006|Overall Study|Started new treatment|0|||
48357410|NCT02808975|155504867|FG000|Overall Study|Lost to Follow-up|4|||
48404596|NCT02901431|155673187|FG003|PK Part|Withdrawal by Subject|0|||
48404597|NCT02901431|155673188|FG004|PK Part|Withdrawal by Subject|0|||
48404598|NCT02901431|155673189|FG005|PK Part|Withdrawal by Subject|0|||
48404599|NCT02901431|155673190|FG006|PK Part|Withdrawal by Subject|0|||
48404600|NCT02901431|155673191|FG007|PK Part|Withdrawal by Subject|0|||
48404601|NCT02901431|155673192|FG008|PK Part|Withdrawal by Subject|0|||
48404602|NCT02901431|155673193|FG009|PK Part|Withdrawal by Subject|0|||
48404603|NCT02901431|155673194|FG010|PK Part|Withdrawal by Subject|0|||
48404604|NCT02901431|155673195|FG011|PK Part|Withdrawal by Subject|0|||
48404605|NCT02901431|155673196|FG012|PK Part|Withdrawal by Subject|0|||
48404606|NCT02901431|155673184|FG000|Main Treatment Part|Adverse Event|0|||
48404607|NCT02901431|155673185|FG001|Main Treatment Part|Adverse Event|0|||
48404608|NCT02901431|155673186|FG002|Main Treatment Part|Adverse Event|0|||
48404609|NCT02901431|155673187|FG003|Main Treatment Part|Adverse Event|3|||
48404610|NCT02901431|155673188|FG004|Main Treatment Part|Adverse Event|3|||
48404611|NCT02901431|155673189|FG005|Main Treatment Part|Adverse Event|4|||
48404612|NCT02901431|155673190|FG006|Main Treatment Part|Adverse Event|1|||
48404613|NCT02901431|155673191|FG007|Main Treatment Part|Adverse Event|0|||
48404614|NCT02901431|155673192|FG008|Main Treatment Part|Adverse Event|0|||
48404615|NCT02901431|155673193|FG009|Main Treatment Part|Adverse Event|0|||
48404616|NCT02901431|155673194|FG010|Main Treatment Part|Adverse Event|0|||
48404617|NCT02901431|155673195|FG011|Main Treatment Part|Adverse Event|0|||
48404618|NCT02901431|155673196|FG012|Main Treatment Part|Adverse Event|0|||
48404619|NCT02901431|155673184|FG000|Main Treatment Part|Lack of Efficacy|0|||
48404620|NCT02901431|155673185|FG001|Main Treatment Part|Lack of Efficacy|0|||
48404621|NCT02901431|155673186|FG002|Main Treatment Part|Lack of Efficacy|0|||
48404622|NCT02901431|155673187|FG003|Main Treatment Part|Lack of Efficacy|1|||
48404623|NCT02901431|155673188|FG004|Main Treatment Part|Lack of Efficacy|0|||
48404624|NCT02901431|155673189|FG005|Main Treatment Part|Lack of Efficacy|0|||
48404625|NCT02901431|155673190|FG006|Main Treatment Part|Lack of Efficacy|0|||
48404626|NCT02901431|155673191|FG007|Main Treatment Part|Lack of Efficacy|0|||
48404627|NCT02901431|155673192|FG008|Main Treatment Part|Lack of Efficacy|0|||
48404628|NCT02901431|155673193|FG009|Main Treatment Part|Lack of Efficacy|0|||
48404629|NCT02901431|155673194|FG010|Main Treatment Part|Lack of Efficacy|0|||
48404630|NCT02901431|155673195|FG011|Main Treatment Part|Lack of Efficacy|0|||
48404631|NCT02901431|155673196|FG012|Main Treatment Part|Lack of Efficacy|0|||
48404632|NCT02901431|155673184|FG000|Main Treatment Part|Lost to Follow-up|0|||
48404633|NCT02901431|155673185|FG001|Main Treatment Part|Lost to Follow-up|0|||
48404634|NCT02901431|155673186|FG002|Main Treatment Part|Lost to Follow-up|0|||
48404635|NCT02901431|155673187|FG003|Main Treatment Part|Lost to Follow-up|3|||
48404636|NCT02901431|155673188|FG004|Main Treatment Part|Lost to Follow-up|1|||
48404637|NCT02901431|155673189|FG005|Main Treatment Part|Lost to Follow-up|2|||
48404638|NCT02901431|155673190|FG006|Main Treatment Part|Lost to Follow-up|3|||
48404639|NCT02901431|155673191|FG007|Main Treatment Part|Lost to Follow-up|0|||
48404640|NCT02901431|155673192|FG008|Main Treatment Part|Lost to Follow-up|0|||
48404641|NCT02901431|155673193|FG009|Main Treatment Part|Lost to Follow-up|0|||
48404642|NCT02901431|155673194|FG010|Main Treatment Part|Lost to Follow-up|0|||
48404643|NCT02901431|155673195|FG011|Main Treatment Part|Lost to Follow-up|0|||
48404644|NCT02901431|155673196|FG012|Main Treatment Part|Lost to Follow-up|0|||
48404645|NCT02901431|155673184|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
48404646|NCT02901431|155673185|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
48404647|NCT02901431|155673186|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
48404648|NCT02901431|155673187|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
48404649|NCT02901431|155673188|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
48404650|NCT02901431|155673189|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
48404651|NCT02901431|155673190|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
48404652|NCT02901431|155673191|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
48404653|NCT02901431|155673192|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
48404654|NCT02901431|155673193|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
48404655|NCT02901431|155673194|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
48404656|NCT02901431|155673195|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
48404657|NCT02901431|155673196|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
48404658|NCT02901431|155673184|FG000|Main Treatment Part|Physician Decision|0|||
48404659|NCT02901431|155673185|FG001|Main Treatment Part|Physician Decision|0|||
48404660|NCT02901431|155673186|FG002|Main Treatment Part|Physician Decision|0|||
48404661|NCT02901431|155673187|FG003|Main Treatment Part|Physician Decision|1|||
48404662|NCT02901431|155673188|FG004|Main Treatment Part|Physician Decision|0|||
48404663|NCT02901431|155673189|FG005|Main Treatment Part|Physician Decision|0|||
48404664|NCT02901431|155673190|FG006|Main Treatment Part|Physician Decision|1|||
48404665|NCT02901431|155673191|FG007|Main Treatment Part|Physician Decision|0|||
48404666|NCT02901431|155673192|FG008|Main Treatment Part|Physician Decision|0|||
48404667|NCT02901431|155673193|FG009|Main Treatment Part|Physician Decision|0|||
48404668|NCT02901431|155673194|FG010|Main Treatment Part|Physician Decision|0|||
48404669|NCT02901431|155673195|FG011|Main Treatment Part|Physician Decision|0|||
48404670|NCT02901431|155673196|FG012|Main Treatment Part|Physician Decision|0|||
48404671|NCT02901431|155673184|FG000|Main Treatment Part|Withdrawal by Subject|0|||
48404672|NCT02901431|155673185|FG001|Main Treatment Part|Withdrawal by Subject|0|||
48404673|NCT02901431|155673186|FG002|Main Treatment Part|Withdrawal by Subject|0|||
48404674|NCT02901431|155673187|FG003|Main Treatment Part|Withdrawal by Subject|18|||
48404675|NCT02901431|155673188|FG004|Main Treatment Part|Withdrawal by Subject|3|||
48404676|NCT02901431|155673189|FG005|Main Treatment Part|Withdrawal by Subject|5|||
48404677|NCT02901431|155673190|FG006|Main Treatment Part|Withdrawal by Subject|6|||
48404678|NCT02901431|155673191|FG007|Main Treatment Part|Withdrawal by Subject|0|||
48404679|NCT02901431|155673192|FG008|Main Treatment Part|Withdrawal by Subject|0|||
48404680|NCT02901431|155673193|FG009|Main Treatment Part|Withdrawal by Subject|0|||
48404681|NCT02901431|155673194|FG010|Main Treatment Part|Withdrawal by Subject|0|||
48404682|NCT02901431|155673195|FG011|Main Treatment Part|Withdrawal by Subject|0|||
48404683|NCT02901431|155673196|FG012|Main Treatment Part|Withdrawal by Subject|0|||
48404684|NCT02901431|155673184|FG000|Open Label Part|Adverse Event|0|||
48404685|NCT02901431|155673185|FG001|Open Label Part|Adverse Event|0|||
48404686|NCT02901431|155673186|FG002|Open Label Part|Adverse Event|0|||
48404687|NCT02901431|155673187|FG003|Open Label Part|Adverse Event|0|||
48404688|NCT02901431|155673188|FG004|Open Label Part|Adverse Event|0|||
48404689|NCT02901431|155673189|FG005|Open Label Part|Adverse Event|0|||
48404690|NCT02901431|155673190|FG006|Open Label Part|Adverse Event|0|||
48404691|NCT02901431|155673191|FG007|Open Label Part|Adverse Event|0|||
48404692|NCT02901431|155673192|FG008|Open Label Part|Adverse Event|4|||
48404693|NCT02901431|155673193|FG009|Open Label Part|Adverse Event|4|||
48404694|NCT02901431|155673194|FG010|Open Label Part|Adverse Event|0|||
48404695|NCT02901431|155673195|FG011|Open Label Part|Adverse Event|4|||
48404696|NCT02901431|155673196|FG012|Open Label Part|Adverse Event|1|||
48404697|NCT02901431|155673184|FG000|Open Label Part|Lost to Follow-up|0|||
48404698|NCT02901431|155673185|FG001|Open Label Part|Lost to Follow-up|0|||
48404699|NCT02901431|155673186|FG002|Open Label Part|Lost to Follow-up|0|||
48404700|NCT02901431|155673187|FG003|Open Label Part|Lost to Follow-up|0|||
48404701|NCT02901431|155673188|FG004|Open Label Part|Lost to Follow-up|0|||
48404702|NCT02901431|155673189|FG005|Open Label Part|Lost to Follow-up|0|||
48404703|NCT02901431|155673190|FG006|Open Label Part|Lost to Follow-up|0|||
48404704|NCT02901431|155673191|FG007|Open Label Part|Lost to Follow-up|0|||
48404705|NCT02901431|155673192|FG008|Open Label Part|Lost to Follow-up|2|||
48404706|NCT02901431|155673193|FG009|Open Label Part|Lost to Follow-up|2|||
48404707|NCT02901431|155673194|FG010|Open Label Part|Lost to Follow-up|1|||
48404708|NCT02901431|155673195|FG011|Open Label Part|Lost to Follow-up|1|||
48404709|NCT02901431|155673196|FG012|Open Label Part|Lost to Follow-up|1|||
48404710|NCT02901431|155673184|FG000|Open Label Part|Physician Decision|0|||
48404711|NCT02901431|155673185|FG001|Open Label Part|Physician Decision|0|||
48404712|NCT02901431|155673186|FG002|Open Label Part|Physician Decision|0|||
48404713|NCT02901431|155673187|FG003|Open Label Part|Physician Decision|0|||
48404714|NCT02901431|155673188|FG004|Open Label Part|Physician Decision|0|||
48404715|NCT02901431|155673189|FG005|Open Label Part|Physician Decision|0|||
48404716|NCT02901431|155673190|FG006|Open Label Part|Physician Decision|0|||
48404717|NCT02901431|155673191|FG007|Open Label Part|Physician Decision|0|||
48404718|NCT02901431|155673192|FG008|Open Label Part|Physician Decision|1|||
48404719|NCT02901431|155673193|FG009|Open Label Part|Physician Decision|1|||
48404720|NCT02901431|155673194|FG010|Open Label Part|Physician Decision|0|||
48404721|NCT02901431|155673195|FG011|Open Label Part|Physician Decision|0|||
48404722|NCT02901431|155673196|FG012|Open Label Part|Physician Decision|0|||
48404723|NCT02901431|155673184|FG000|Open Label Part|Study Terminated By Sponsor|0|||
48404724|NCT02901431|155673185|FG001|Open Label Part|Study Terminated By Sponsor|0|||
48404725|NCT02901431|155673186|FG002|Open Label Part|Study Terminated By Sponsor|0|||
48404726|NCT02901431|155673187|FG003|Open Label Part|Study Terminated By Sponsor|0|||
48404727|NCT02901431|155673188|FG004|Open Label Part|Study Terminated By Sponsor|0|||
48404728|NCT02901431|155673189|FG005|Open Label Part|Study Terminated By Sponsor|0|||
48404729|NCT02901431|155673190|FG006|Open Label Part|Study Terminated By Sponsor|0|||
48404730|NCT02901431|155673191|FG007|Open Label Part|Study Terminated By Sponsor|0|||
48404731|NCT02901431|155673192|FG008|Open Label Part|Study Terminated By Sponsor|35|||
48404732|NCT02901431|155673193|FG009|Open Label Part|Study Terminated By Sponsor|12|||
48404733|NCT02901431|155673194|FG010|Open Label Part|Study Terminated By Sponsor|21|||
48404734|NCT02901431|155673195|FG011|Open Label Part|Study Terminated By Sponsor|31|||
48404735|NCT02901431|155673196|FG012|Open Label Part|Study Terminated By Sponsor|0|||
48404736|NCT02901431|155673184|FG000|Open Label Part|Withdrawal by Subject|0|||
48404737|NCT02901431|155673185|FG001|Open Label Part|Withdrawal by Subject|0|||
48404738|NCT02901431|155673186|FG002|Open Label Part|Withdrawal by Subject|0|||
48404739|NCT02901431|155673187|FG003|Open Label Part|Withdrawal by Subject|0|||
48404740|NCT02901431|155673188|FG004|Open Label Part|Withdrawal by Subject|0|||
48404741|NCT02901431|155673189|FG005|Open Label Part|Withdrawal by Subject|0|||
48404742|NCT02901431|155673190|FG006|Open Label Part|Withdrawal by Subject|0|||
48404743|NCT02901431|155673191|FG007|Open Label Part|Withdrawal by Subject|0|||
48404744|NCT02901431|155673192|FG008|Open Label Part|Withdrawal by Subject|6|||
48404745|NCT02901431|155673193|FG009|Open Label Part|Withdrawal by Subject|5|||
48404746|NCT02901431|155673194|FG010|Open Label Part|Withdrawal by Subject|7|||
48404747|NCT02901431|155673195|FG011|Open Label Part|Withdrawal by Subject|3|||
48404748|NCT02901431|155673196|FG012|Open Label Part|Withdrawal by Subject|1|||
48404749|NCT00413959|155673200|FG000|Overall Study|Pt had only one cycle.|1|||
48404750|NCT02307370|155673204|FG000|Overall Study|Death|5|||
48404751|NCT02307370|155673204|FG000|Overall Study|Lost to Follow-up|1|||
48404752|NCT02307370|155673204|FG000|Overall Study|Withdrawal by Subject|1|||
48404753|NCT02307370|155673204|FG000|Overall Study|Declined Addendum ICF|6|||
48404754|NCT02307370|155673204|FG000|Overall Study|No response during telephone contact|5|||
48404755|NCT02307370|155673204|FG000|Overall Study|Protocol Violation|1|||
48404756|NCT02425098|155673205|FG000|Overall Study|Lost to Follow-up|7|||
48404757|NCT02425098|155673206|FG001|Overall Study|Lost to Follow-up|7|||
48404758|NCT02425098|155673205|FG000|Overall Study|Withdrawal by Subject|4|||
48404759|NCT02425098|155673206|FG001|Overall Study|Withdrawal by Subject|8|||
48404760|NCT02425098|155673205|FG000|Overall Study|Pregnancy|2|||
48404761|NCT02425098|155673206|FG001|Overall Study|Pregnancy|0|||
48404762|NCT02425098|155673205|FG000|Overall Study|Reason not Specified|0|||
48404763|NCT02425098|155673206|FG001|Overall Study|Reason not Specified|1|||
48404764|NCT00429585|155673207|FG000|Overall Study|Death|1|||
48404765|NCT00429585|155673208|FG001|Overall Study|Death|0|||
48404766|NCT00429585|155673207|FG000|Overall Study|Lost to Follow-up|27|||
48404767|NCT00429585|155673208|FG001|Overall Study|Lost to Follow-up|20|||
48404768|NCT00429585|155673207|FG000|Overall Study|Physician Decision|2|||
48404769|NCT00429585|155673208|FG001|Overall Study|Physician Decision|0|||
48404770|NCT00821678|155673209|FG000|Overall Study|Withdrawal by Subject|8|||
48404771|NCT00821678|155673210|FG001|Overall Study|Withdrawal by Subject|0|||
48404772|NCT00821678|155673209|FG000|Overall Study|Lost to Follow-up|13|||
48404773|NCT00821678|155673210|FG001|Overall Study|Lost to Follow-up|12|||
48404774|NCT00821678|155673209|FG000|Overall Study|Death|0|||
48404775|NCT00821678|155673210|FG001|Overall Study|Death|2|||
48404776|NCT05048719|155675015|FG000|Overall Study|Withdrawal by Subject|2|||
48404777|NCT05048719|155675016|FG001|Overall Study|Withdrawal by Subject|1|||
48404778|NCT05048719|155675017|FG002|Overall Study|Withdrawal by Subject|3|||
48404779|NCT05048719|155675018|FG003|Overall Study|Withdrawal by Subject|1|||
48404780|NCT05048719|155675019|FG004|Overall Study|Withdrawal by Subject|0|||
48404781|NCT05048719|155675020|FG005|Overall Study|Withdrawal by Subject|2|||
48404782|NCT05048719|155675021|FG006|Overall Study|Withdrawal by Subject|1|||
48404783|NCT05048719|155675022|FG007|Overall Study|Withdrawal by Subject|1|||
48404784|NCT05048719|155675023|FG008|Overall Study|Withdrawal by Subject|0|||
48404785|NCT05048719|155675015|FG000|Overall Study|Death|1|||
48404786|NCT05048719|155675016|FG001|Overall Study|Death|0|||
48404787|NCT05048719|155675017|FG002|Overall Study|Death|0|||
48404788|NCT05048719|155675018|FG003|Overall Study|Death|0|||
48404789|NCT05048719|155675019|FG004|Overall Study|Death|0|||
48404790|NCT05048719|155675020|FG005|Overall Study|Death|0|||
48404791|NCT05048719|155675021|FG006|Overall Study|Death|0|||
48404792|NCT05048719|155675022|FG007|Overall Study|Death|0|||
48404793|NCT05048719|155675023|FG008|Overall Study|Death|0|||
48404794|NCT05048719|155675015|FG000|Overall Study|Adverse Event|0|||
48404795|NCT05048719|155675016|FG001|Overall Study|Adverse Event|1|||
48404796|NCT05048719|155675017|FG002|Overall Study|Adverse Event|2|||
48404797|NCT05048719|155675018|FG003|Overall Study|Adverse Event|0|||
48404798|NCT05048719|155675019|FG004|Overall Study|Adverse Event|1|||
48404799|NCT05048719|155675020|FG005|Overall Study|Adverse Event|0|||
48404800|NCT05048719|155675021|FG006|Overall Study|Adverse Event|0|||
48404801|NCT05048719|155675022|FG007|Overall Study|Adverse Event|0|||
48404802|NCT05048719|155675023|FG008|Overall Study|Adverse Event|0|||
48404803|NCT05048719|155675015|FG000|Overall Study|Lost to Follow-up|0|||
48404804|NCT05048719|155675016|FG001|Overall Study|Lost to Follow-up|0|||
48404805|NCT05048719|155675017|FG002|Overall Study|Lost to Follow-up|1|||
48404806|NCT05048719|155675018|FG003|Overall Study|Lost to Follow-up|3|||
48404807|NCT05048719|155675019|FG004|Overall Study|Lost to Follow-up|1|||
48404808|NCT05048719|155675020|FG005|Overall Study|Lost to Follow-up|1|||
48404809|NCT05048719|155675021|FG006|Overall Study|Lost to Follow-up|1|||
48404810|NCT05048719|155675022|FG007|Overall Study|Lost to Follow-up|1|||
48404811|NCT05048719|155675023|FG008|Overall Study|Lost to Follow-up|0|||
48404812|NCT05048719|155675015|FG000|Overall Study|Physician Decision|0|||
48404813|NCT05048719|155675016|FG001|Overall Study|Physician Decision|0|||
48404814|NCT05048719|155675017|FG002|Overall Study|Physician Decision|0|||
48404815|NCT05048719|155675018|FG003|Overall Study|Physician Decision|0|||
48404816|NCT05048719|155675019|FG004|Overall Study|Physician Decision|0|||
48404817|NCT05048719|155675020|FG005|Overall Study|Physician Decision|0|||
48404818|NCT05048719|155675021|FG006|Overall Study|Physician Decision|0|||
48404819|NCT05048719|155675022|FG007|Overall Study|Physician Decision|1|||
48404820|NCT05048719|155675023|FG008|Overall Study|Physician Decision|1|||
48404821|NCT05048719|155675015|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
48404822|NCT05048719|155675016|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48404823|NCT05048719|155675017|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48404824|NCT05048719|155675018|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48404825|NCT05048719|155675019|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48404826|NCT05048719|155675020|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48404827|NCT05048719|155675021|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48404828|NCT05048719|155675022|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48404829|NCT05048719|155675023|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
48404830|NCT05048719|155675015|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48404831|NCT05048719|155675016|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
48404832|NCT05048719|155675017|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48404833|NCT05048719|155675018|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48404834|NCT05048719|155675019|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48404835|NCT05048719|155675020|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48404836|NCT05048719|155675021|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48404837|NCT05048719|155675022|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48404838|NCT05048719|155675023|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
48430372|NCT00696657|155763708|FG008|Overall Study|Adverse Event|5|||
48404839|NCT05048719|155675015|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48404840|NCT05048719|155675016|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
48404841|NCT05048719|155675017|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48404842|NCT05048719|155675018|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48404843|NCT05048719|155675019|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48404844|NCT05048719|155675020|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48404845|NCT05048719|155675021|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48404846|NCT05048719|155675022|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48404847|NCT05048719|155675023|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
48404848|NCT05048719|155675015|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48404849|NCT05048719|155675016|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48404850|NCT05048719|155675017|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48404851|NCT05048719|155675018|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
48404852|NCT05048719|155675019|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48404853|NCT05048719|155675020|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48404854|NCT05048719|155675021|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48404855|NCT05048719|155675022|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48404856|NCT05048719|155675023|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
48404857|NCT05048719|155675015|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48404858|NCT05048719|155675016|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48404859|NCT05048719|155675017|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48404860|NCT05048719|155675018|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48404861|NCT05048719|155675019|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48404862|NCT05048719|155675020|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
48404863|NCT05048719|155675021|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48404864|NCT05048719|155675022|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48404865|NCT05048719|155675023|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
48404866|NCT02324270|155675024|FG000|Overall Study|Withdrawal by Subject|0|||
48404867|NCT02324270|155675025|FG001|Overall Study|Withdrawal by Subject|1|||
48404868|NCT02324270|155675026|FG002|Overall Study|Withdrawal by Subject|0|||
48404869|NCT02324270|155675024|FG000|Overall Study|Lost to Follow-up|4|||
48404870|NCT02324270|155675025|FG001|Overall Study|Lost to Follow-up|3|||
48404871|NCT02324270|155675026|FG002|Overall Study|Lost to Follow-up|4|||
48404872|NCT02324270|155675024|FG000|Overall Study|Protocol Violation|0|||
48404873|NCT02324270|155675025|FG001|Overall Study|Protocol Violation|1|||
48404874|NCT02324270|155675026|FG002|Overall Study|Protocol Violation|1|||
48404875|NCT02324270|155675024|FG000|Overall Study|Non Compliance with Study Drug|1|||
48404876|NCT02324270|155675025|FG001|Overall Study|Non Compliance with Study Drug|2|||
48404877|NCT02324270|155675026|FG002|Overall Study|Non Compliance with Study Drug|0|||
48404878|NCT00605085|155675028|FG000|Overall Study|Withdrawal by Subject|8|||
48404879|NCT00605085|155675029|FG001|Overall Study|Withdrawal by Subject|5|||
48404880|NCT00605085|155675028|FG000|Overall Study|Adverse Event|9|||
48404881|NCT00605085|155675029|FG001|Overall Study|Adverse Event|5|||
48404882|NCT00605085|155675028|FG000|Overall Study|Pregnancy|2|||
48404883|NCT00605085|155675029|FG001|Overall Study|Pregnancy|0|||
48404884|NCT00605085|155675028|FG000|Overall Study|Protocol Violation|3|||
48404885|NCT00605085|155675029|FG001|Overall Study|Protocol Violation|2|||
48404886|NCT00605085|155675028|FG000|Overall Study|Lost to Follow-up|10|||
48404887|NCT00605085|155675029|FG001|Overall Study|Lost to Follow-up|5|||
48404888|NCT00605085|155675028|FG000|Overall Study|administrative reasons|18|||
48404889|NCT00605085|155675029|FG001|Overall Study|administrative reasons|8|||
48404890|NCT02546986|155675030|FG000|Treatment Period|Progressive Disease|20|||
48404891|NCT02546986|155675031|FG001|Treatment Period|Progressive Disease|22|||
48404892|NCT02546986|155675030|FG000|Treatment Period|Adverse Event|14|||
48404893|NCT02546986|155675031|FG001|Treatment Period|Adverse Event|6|||
48404894|NCT02546986|155675030|FG000|Treatment Period|Symptomatic Deterioration|4|||
48404895|NCT02546986|155675031|FG001|Treatment Period|Symptomatic Deterioration|3|||
48796478|NCT02723864|157093669|FG000|Overall Study|Switched to alternative treatment|0|||
48404896|NCT02546986|155675030|FG000|Treatment Period|Death|3|||
48404897|NCT02546986|155675031|FG001|Treatment Period|Death|4|||
48404898|NCT02546986|155675030|FG000|Treatment Period|Physician Decision|1|||
48404899|NCT02546986|155675031|FG001|Treatment Period|Physician Decision|2|||
48404900|NCT02546986|155675030|FG000|Treatment Period|Protocol Violation|1|||
48404901|NCT02546986|155675031|FG001|Treatment Period|Protocol Violation|0|||
48404902|NCT02546986|155675030|FG000|Treatment Period|Withdrawal by Subject|1|||
48796479|NCT02723864|157093670|FG001|Overall Study|Switched to alternative treatment|0|||
48796480|NCT02723864|157093671|FG002|Overall Study|Switched to alternative treatment|0|||
48796481|NCT02723864|157093672|FG003|Overall Study|Switched to alternative treatment|0|||
48796482|NCT02723864|157093673|FG004|Overall Study|Switched to alternative treatment|0|||
48796483|NCT02723864|157093674|FG005|Overall Study|Switched to alternative treatment|1|||
48796484|NCT02723864|157093675|FG006|Overall Study|Switched to alternative treatment|0|||
48796485|NCT02723864|157093669|FG000|Overall Study|Late determination of ineligibility|0|||
48796486|NCT02723864|157093670|FG001|Overall Study|Late determination of ineligibility|0|||
48796487|NCT02723864|157093671|FG002|Overall Study|Late determination of ineligibility|0|||
48796488|NCT02723864|157093672|FG003|Overall Study|Late determination of ineligibility|0|||
48796489|NCT02723864|157093673|FG004|Overall Study|Late determination of ineligibility|0|||
48796490|NCT02723864|157093674|FG005|Overall Study|Late determination of ineligibility|1|||
48796491|NCT02723864|157093675|FG006|Overall Study|Late determination of ineligibility|0|||
48796492|NCT02548455|157093676|FG000|Overall Study|Withdrawal by Subject|27|||
48796493|NCT02548455|157093676|FG000|Overall Study|Death|26|||
48796494|NCT02548455|157093676|FG000|Overall Study|Lost to Follow-up|14|||
48796495|NCT02548455|157093676|FG000|Overall Study|Visit not completed|173|||
48796496|NCT04528069|157093677|FG000|Overall Study|Adverse Event|1|||
48796497|NCT04528069|157093677|FG000|Overall Study|Lost to Follow-up|1|||
48796498|NCT04528069|157093677|FG000|Overall Study|Patient Unable to Come|1|||
48796499|NCT04528069|157093677|FG000|Overall Study|Patient Unable to Attend|1|||
48796500|NCT01137474|157093678|FG000|Overall Study|Adverse Event|3|||
48796501|NCT01137474|157093679|FG001|Overall Study|Adverse Event|5|||
48796502|NCT01137474|157093680|FG002|Overall Study|Adverse Event|1|||
48796503|NCT01137474|157093681|FG003|Overall Study|Adverse Event|3|||
48796504|NCT01137474|157093678|FG000|Overall Study|Withdrawal by Subject|7|||
48796505|NCT01137474|157093679|FG001|Overall Study|Withdrawal by Subject|2|||
48796506|NCT01137474|157093680|FG002|Overall Study|Withdrawal by Subject|6|||
48796507|NCT01137474|157093681|FG003|Overall Study|Withdrawal by Subject|9|||
48796508|NCT01137474|157093678|FG000|Overall Study|No longer met study criteria|6|||
48796509|NCT01137474|157093679|FG001|Overall Study|No longer met study criteria|1|||
48404903|NCT02546986|155675031|FG001|Treatment Period|Withdrawal by Subject|1|||
48404904|NCT02546986|155675030|FG000|Treatment Period|Non-compliance with Study Drug|0|||
48404905|NCT02546986|155675031|FG001|Treatment Period|Non-compliance with Study Drug|1|||
48404906|NCT02546986|155675030|FG000|Treatment Period|Study Terminated by Sponsor|0|||
48404907|NCT02546986|155675031|FG001|Treatment Period|Study Terminated by Sponsor|1|||
48404908|NCT02546986|155675030|FG000|Treatment Period|Miscellaneous|7|||
48404909|NCT02546986|155675031|FG001|Treatment Period|Miscellaneous|9|||
48404910|NCT02546986|155675030|FG000|Survival Follow-Up Phase|Missing Status|3|||
48404911|NCT02546986|155675031|FG001|Survival Follow-Up Phase|Missing Status|5|||
48404912|NCT02546986|155675030|FG000|Survival Follow-Up Phase|Death|18|||
48404913|NCT02546986|155675031|FG001|Survival Follow-Up Phase|Death|12|||
48404914|NCT02546986|155675030|FG000|Survival Follow-Up Phase|Alive|13|||
48404915|NCT02546986|155675031|FG001|Survival Follow-Up Phase|Alive|16|||
48404916|NCT02546986|155675030|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
48796510|NCT01137474|157093680|FG002|Overall Study|No longer met study criteria|0|||
48796511|NCT01137474|157093681|FG003|Overall Study|No longer met study criteria|5|||
48796512|NCT01137474|157093678|FG000|Overall Study|Lost to Follow-up|5|||
48796513|NCT01137474|157093679|FG001|Overall Study|Lost to Follow-up|1|||
48796514|NCT01137474|157093680|FG002|Overall Study|Lost to Follow-up|0|||
48796515|NCT01137474|157093681|FG003|Overall Study|Lost to Follow-up|2|||
48796516|NCT01137474|157093678|FG000|Overall Study|Lack of Efficacy|0|||
48796517|NCT01137474|157093679|FG001|Overall Study|Lack of Efficacy|0|||
48796518|NCT01137474|157093680|FG002|Overall Study|Lack of Efficacy|0|||
48796519|NCT01137474|157093681|FG003|Overall Study|Lack of Efficacy|2|||
48796520|NCT01137474|157093678|FG000|Overall Study|Other|3|||
48796521|NCT01137474|157093679|FG001|Overall Study|Other|1|||
48796522|NCT01137474|157093680|FG002|Overall Study|Other|0|||
48796523|NCT01137474|157093681|FG003|Overall Study|Other|0|||
48796524|NCT01137474|157093678|FG000|Overall Study|Pregnancy|0|||
48796525|NCT01137474|157093679|FG001|Overall Study|Pregnancy|1|||
48796526|NCT01137474|157093680|FG002|Overall Study|Pregnancy|0|||
48796527|NCT01137474|157093681|FG003|Overall Study|Pregnancy|0|||
48796528|NCT01137474|157093678|FG000|Overall Study|Administrative reason by sponsor|0|||
48796529|NCT01137474|157093679|FG001|Overall Study|Administrative reason by sponsor|1|||
48796530|NCT01137474|157093680|FG002|Overall Study|Administrative reason by sponsor|0|||
48796531|NCT01137474|157093681|FG003|Overall Study|Administrative reason by sponsor|0|||
48796532|NCT04683926|157093683|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
48796533|NCT04683926|157093684|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
48796534|NCT04683926|157093685|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
48796535|NCT04683926|157093686|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
48796536|NCT04385368|157093688|FG000|Overall Study|Death|5|||
48796537|NCT04385368|157093689|FG001|Overall Study|Death|5|||
48796538|NCT04385368|157093688|FG000|Overall Study|Physician Decision|3|||
48796539|NCT04385368|157093689|FG001|Overall Study|Physician Decision|0|||
48796540|NCT04385368|157093688|FG000|Overall Study|Withdrawal by Subject|4|||
48796541|NCT04385368|157093689|FG001|Overall Study|Withdrawal by Subject|3|||
48796542|NCT04052204|157093690|FG000|Overall Study|Death|1|||
48796543|NCT04052204|157093691|FG001|Overall Study|Death|0|||
48796544|NCT04052204|157093692|FG002|Overall Study|Death|0|||
48796545|NCT04052204|157093690|FG000|Overall Study|Progressive disease|1|||
48796546|NCT04052204|157093691|FG001|Overall Study|Progressive disease|0|||
48796547|NCT04052204|157093692|FG002|Overall Study|Progressive disease|0|||
48357411|NCT02808975|155504868|FG001|Overall Study|Lost to Follow-up|6|||
48404917|NCT02546986|155675031|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
48404918|NCT02002975|155675034|FG000|Overall Study|Case Report Forms Uncollected|135|||
48404919|NCT02002975|155675034|FG000|Overall Study|Protocol Deviation|437|||
48404920|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
48404921|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
48404922|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
48404923|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
48404924|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
48404925|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
48404926|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
48404927|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
48404928|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
48404929|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
48404930|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
48404931|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
48404932|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
48404933|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
48404934|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
48404935|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
48404936|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
48404937|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
48404938|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
48404939|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
48404940|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
48404941|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
48404942|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
48404943|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
48404944|NCT04660643|155675035|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
48404945|NCT04660643|155675036|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
48404946|NCT04660643|155675037|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
48404947|NCT04660643|155675035|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
48404948|NCT04660643|155675036|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
48404949|NCT04660643|155675037|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
48404950|NCT04660643|155675035|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
48404951|NCT04660643|155675036|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
48404952|NCT04660643|155675037|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
48404953|NCT04660643|155675035|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
48404954|NCT04660643|155675036|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
48404955|NCT04660643|155675037|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
48404956|NCT04660643|155675035|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
48404957|NCT04660643|155675036|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
48404958|NCT04660643|155675037|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
48404959|NCT04660643|155675035|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
48404960|NCT04660643|155675036|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
48404961|NCT04660643|155675037|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
48404962|NCT04660643|155675035|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
48404963|NCT04660643|155675036|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
48404964|NCT04660643|155675037|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
48404965|NCT04660643|155675035|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
48404966|NCT04660643|155675036|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
48404967|NCT04660643|155675037|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
48404968|NCT03988907|155675038|FG000|Overall Study|Unable to complete visit|0|||
48404969|NCT03988907|155675039|FG001|Overall Study|Unable to complete visit|1|||
48404970|NCT02810964|155675040|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
48404971|NCT02810964|155675041|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
48404972|NCT02810964|155675040|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
48404973|NCT02810964|155675041|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
48404974|NCT02810964|155675040|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
48404975|NCT02810964|155675041|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
48404976|NCT02810964|155675040|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
48404977|NCT02810964|155675041|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
48404978|NCT01641939|155675043|FG000|Overall Study|Death|90|||
48404979|NCT01641939|155675044|FG001|Overall Study|Death|187|||
48404980|NCT01641939|155675045|FG002|Overall Study|Death|61|||
48404981|NCT01641939|155675043|FG000|Overall Study|Lost to Follow-up|3|||
48404982|NCT01641939|155675044|FG001|Overall Study|Lost to Follow-up|2|||
48404983|NCT01641939|155675045|FG002|Overall Study|Lost to Follow-up|1|||
48404984|NCT01641939|155675043|FG000|Overall Study|Withdrawal by Subject|14|||
48404985|NCT01641939|155675044|FG001|Overall Study|Withdrawal by Subject|11|||
48404986|NCT01641939|155675045|FG002|Overall Study|Withdrawal by Subject|5|||
48404987|NCT01641939|155675043|FG000|Overall Study|Study Terminated by Sponsor|10|||
48404988|NCT01641939|155675044|FG001|Overall Study|Study Terminated by Sponsor|28|||
48404989|NCT01641939|155675045|FG002|Overall Study|Study Terminated by Sponsor|3|||
48404990|NCT04356183|155675046|FG000|Overall Study|Lost to Follow-up|1|||
48404991|NCT04356183|155675047|FG001|Overall Study|Lost to Follow-up|0|||
48404992|NCT04356183|155675046|FG000|Overall Study|Withdrawal by Subject|1|||
48404993|NCT04356183|155675047|FG001|Overall Study|Withdrawal by Subject|1|||
48404994|NCT00772629|155675048|FG000|Overall Study|Subject was not vaccinated|1|||
48404995|NCT00772629|155675049|FG001|Overall Study|Subject was not vaccinated|0|||
48404996|NCT03905863|155675053|FG000|Overall Study|Adverse Event|2|||
48404997|NCT03905863|155675054|FG001|Overall Study|Adverse Event|4|||
48404998|NCT03905863|155675053|FG000|Overall Study|Withdrawal by Subject|2|||
48404999|NCT03905863|155675054|FG001|Overall Study|Withdrawal by Subject|2|||
48405000|NCT03905863|155675053|FG000|Overall Study|Physician Decision|0|||
48405001|NCT03905863|155675054|FG001|Overall Study|Physician Decision|3|||
48405002|NCT03905863|155675053|FG000|Overall Study|Lost to Follow-up|1|||
48405003|NCT03905863|155675054|FG001|Overall Study|Lost to Follow-up|0|||
48405004|NCT03905863|155675053|FG000|Overall Study|Protocol Violation|0|||
48405005|NCT03905863|155675054|FG001|Overall Study|Protocol Violation|2|||
48405006|NCT03905863|155675053|FG000|Overall Study|Death|0|||
48405007|NCT03905863|155675054|FG001|Overall Study|Death|1|||
48405008|NCT03269344|155675057|FG000|Overall Study|Protocol Violation|4|||
48405009|NCT03269344|155675058|FG001|Overall Study|Protocol Violation|3|||
48405010|NCT01613326|155675059|FG000|Overall Study|Adverse Event|7|||
48405011|NCT01613326|155675060|FG001|Overall Study|Adverse Event|5|||
48405012|NCT01613326|155675059|FG000|Overall Study|Withdrawal by Subject|3|||
48405013|NCT01613326|155675060|FG001|Overall Study|Withdrawal by Subject|4|||
48405014|NCT01613326|155675059|FG000|Overall Study|Abnormal test procedure result(s)|2|||
48405015|NCT01613326|155675060|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48405016|NCT01613326|155675059|FG000|Overall Study|inability to use device|1|||
48405017|NCT01613326|155675060|FG001|Overall Study|inability to use device|0|||
48405018|NCT01613326|155675059|FG000|Overall Study|Lack of Efficacy|0|||
48405019|NCT01613326|155675060|FG001|Overall Study|Lack of Efficacy|1|||
48405020|NCT01613326|155675059|FG000|Overall Study|Lost to Follow-up|0|||
48405021|NCT01613326|155675060|FG001|Overall Study|Lost to Follow-up|1|||
48405022|NCT01613326|155675059|FG000|Overall Study|Administrative|0|||
48405023|NCT01613326|155675060|FG001|Overall Study|Administrative|2|||
48405024|NCT01613326|155675059|FG000|Overall Study|Protocol Violation|0|||
48405025|NCT01613326|155675060|FG001|Overall Study|Protocol Violation|1|||
48405026|NCT03118297|155675061|FG000|Overall Study|Lost to Follow-up|0|||
48405027|NCT03118297|155675062|FG001|Overall Study|Lost to Follow-up|2|||
48405028|NCT00763321|155675071|FG000|Open-label Period|Adverse Event|24|||
48405029|NCT00763321|155675072|FG001|Open-label Period|Adverse Event|0|||
48405030|NCT00763321|155675073|FG002|Open-label Period|Adverse Event|0|||
48405031|NCT00763321|155675071|FG000|Open-label Period|Lost to Follow-up|14|||
48405032|NCT00763321|155675072|FG001|Open-label Period|Lost to Follow-up|0|||
48405033|NCT00763321|155675073|FG002|Open-label Period|Lost to Follow-up|0|||
48405034|NCT00763321|155675071|FG000|Open-label Period|Withdrawal by Subject|7|||
48405035|NCT00763321|155675072|FG001|Open-label Period|Withdrawal by Subject|0|||
48405036|NCT00763321|155675073|FG002|Open-label Period|Withdrawal by Subject|0|||
48405037|NCT00763321|155675071|FG000|Open-label Period|Subject noncompliant|7|||
48405038|NCT00763321|155675072|FG001|Open-label Period|Subject noncompliant|0|||
48405039|NCT00763321|155675073|FG002|Open-label Period|Subject noncompliant|0|||
48405040|NCT00763321|155675071|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
48405041|NCT00763321|155675072|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
48405042|NCT00763321|155675073|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
48405043|NCT00763321|155675071|FG000|Open-label Period|Lack of Efficacy|2|||
48405044|NCT00763321|155675072|FG001|Open-label Period|Lack of Efficacy|0|||
48405045|NCT00763321|155675073|FG002|Open-label Period|Lack of Efficacy|0|||
48405046|NCT00763321|155675071|FG000|Open-label Period|Other|4|||
48405047|NCT00763321|155675072|FG001|Open-label Period|Other|0|||
48405048|NCT00763321|155675073|FG002|Open-label Period|Other|0|||
48405049|NCT00763321|155675071|FG000|Double-blind Period|Lack of Efficacy|0|||
48405050|NCT00763321|155675072|FG001|Double-blind Period|Lack of Efficacy|9|||
48405051|NCT00763321|155675073|FG002|Double-blind Period|Lack of Efficacy|17|||
48405052|NCT00763321|155675071|FG000|Double-blind Period|Adverse Event|0|||
48405053|NCT00763321|155675072|FG001|Double-blind Period|Adverse Event|4|||
48405054|NCT00763321|155675073|FG002|Double-blind Period|Adverse Event|4|||
48405055|NCT00763321|155675071|FG000|Double-blind Period|Lost to Follow-up|0|||
48405056|NCT00763321|155675072|FG001|Double-blind Period|Lost to Follow-up|4|||
48405057|NCT00763321|155675073|FG002|Double-blind Period|Lost to Follow-up|2|||
48405058|NCT00763321|155675071|FG000|Double-blind Period|Withdrawal by Subject|0|||
48405059|NCT00763321|155675072|FG001|Double-blind Period|Withdrawal by Subject|2|||
48405060|NCT00763321|155675073|FG002|Double-blind Period|Withdrawal by Subject|3|||
48405061|NCT00763321|155675071|FG000|Double-blind Period|Other|0|||
48405062|NCT00763321|155675072|FG001|Double-blind Period|Other|2|||
48405063|NCT00763321|155675073|FG002|Double-blind Period|Other|3|||
48405064|NCT01017952|155675074|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
48405065|NCT01017952|155675075|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48405066|NCT01017952|155675076|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48405067|NCT01017952|155675077|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48405068|NCT01017952|155675078|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48405069|NCT01017952|155675074|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
48405070|NCT01017952|155675075|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
48405071|NCT01017952|155675076|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
48405072|NCT01017952|155675077|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
48405073|NCT01017952|155675078|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
48405074|NCT01017952|155675074|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
48405075|NCT01017952|155675075|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
48405076|NCT01017952|155675076|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
48405077|NCT01017952|155675077|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
48405078|NCT01017952|155675078|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
48405079|NCT01017952|155675074|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
48405080|NCT01017952|155675075|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48405081|NCT01017952|155675076|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48405082|NCT01017952|155675077|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48405083|NCT01017952|155675078|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48405084|NCT01017952|155675074|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
48405085|NCT01017952|155675075|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
48405086|NCT01017952|155675076|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
48405087|NCT01017952|155675077|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
48405088|NCT01017952|155675078|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
48405089|NCT01017952|155675074|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
48405090|NCT01017952|155675075|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48405091|NCT01017952|155675076|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48405092|NCT01017952|155675077|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48405093|NCT01017952|155675078|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48405094|NCT01017952|155675074|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
48405095|NCT01017952|155675075|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
48405096|NCT01017952|155675076|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
48405097|NCT01017952|155675077|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
48405098|NCT01017952|155675078|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
48405099|NCT01017952|155675074|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48405100|NCT01017952|155675075|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
48405101|NCT01017952|155675076|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
48405102|NCT01017952|155675077|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
48405103|NCT01017952|155675078|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
48405104|NCT01017952|155675074|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
48405105|NCT01017952|155675075|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
48405106|NCT01017952|155675076|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
48405107|NCT01017952|155675077|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
48405108|NCT01017952|155675078|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
48405109|NCT01017952|155675074|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
48405110|NCT01017952|155675075|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
48405111|NCT01017952|155675076|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
48405112|NCT01017952|155675077|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
48405113|NCT01017952|155675078|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
48405114|NCT01017952|155675074|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48405115|NCT01017952|155675075|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
48405116|NCT01017952|155675076|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
48430815|NCT02273050|155765233|FG002|Overall Study|Adverse Event|3|||
48405117|NCT01017952|155675077|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
48405118|NCT01017952|155675078|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
48405119|NCT01017952|155675074|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48405120|NCT01017952|155675075|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
48405121|NCT01017952|155675076|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
48405122|NCT01017952|155675077|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48405123|NCT01017952|155675078|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48405124|NCT01017952|155675074|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48405125|NCT01017952|155675075|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
48405126|NCT01017952|155675076|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
48405127|NCT01017952|155675077|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
48405128|NCT01017952|155675078|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
48405129|NCT01017952|155675074|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
48405130|NCT01017952|155675075|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
48405131|NCT01017952|155675076|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
48405132|NCT01017952|155675077|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
48405133|NCT01017952|155675078|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
48405134|NCT01064167|155675079|FG000|Overall Study|Protocol Violation|14|||
48405135|NCT01064167|155675080|FG001|Overall Study|Protocol Violation|15|||
48405136|NCT03804684|155675081|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
48405137|NCT03804684|155675082|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
48405138|NCT01298492|155675083|FG000|Overall Study|Death|2|||
48405139|NCT01298492|155675083|FG000|Overall Study|Insufficient Clinical Response|22|||
48405140|NCT01298492|155675083|FG000|Overall Study|Lost to Follow-up|12|||
48405141|NCT01298492|155675083|FG000|Overall Study|Withdrawal by Subject|47|||
48405142|NCT01298492|155675083|FG000|Overall Study|Other (Unspecified)|7|||
48405143|NCT01298492|155675083|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
48405144|NCT01298492|155675083|FG000|Overall Study|Protocol Violation|2|||
48405145|NCT01298492|155675083|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
48405146|NCT01298492|155675083|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
48405147|NCT02340663|155675085|FG000|Overall Study|Lost to Follow-up|1|||
48405148|NCT02340663|155675086|FG001|Overall Study|Lost to Follow-up|0|||
48405149|NCT02340663|155675085|FG000|Overall Study|Protocol Violation|1|||
48405150|NCT02340663|155675086|FG001|Overall Study|Protocol Violation|0|||
48405151|NCT02340663|155675085|FG000|Overall Study|Withdrawal by Subject|3|||
48405152|NCT02340663|155675086|FG001|Overall Study|Withdrawal by Subject|1|||
48405153|NCT01078805|155675087|FG000|Overall Study|Clinically significant abnormal lab|5|||
48405154|NCT01078805|155675087|FG000|Overall Study|Death|134|||
48405155|NCT01078805|155675087|FG000|Overall Study|Lost to Follow-up|676|||
48405156|NCT01078805|155675087|FG000|Overall Study|Physician Decision|169|||
48405157|NCT01078805|155675087|FG000|Overall Study|Serious adverse event|26|||
48405158|NCT01078805|155675087|FG000|Overall Study|Sponsor decision|46|||
48405159|NCT01078805|155675087|FG000|Overall Study|Withdrawal by Subject|739|||
48405160|NCT01078805|155675087|FG000|Overall Study|Other|173|||
48405161|NCT01078805|155675087|FG000|Overall Study|Didn't take study drug|82|||
48405162|NCT01656434|155675091|FG000|Overall Study|Adverse Event|199|||
48405163|NCT01656434|155675092|FG001|Overall Study|Adverse Event|63|||
48405164|NCT01656434|155675091|FG000|Overall Study|Enrollment terminated at trial site|2|||
48405165|NCT01656434|155675092|FG001|Overall Study|Enrollment terminated at trial site|0|||
48405166|NCT01656434|155675091|FG000|Overall Study|Lost to Follow-up|309|||
48405167|NCT01656434|155675092|FG001|Overall Study|Lost to Follow-up|76|||
48405168|NCT01656434|155675091|FG000|Overall Study|Site discontinued study participation|24|||
48405169|NCT01656434|155675092|FG001|Overall Study|Site discontinued study participation|9|||
48405170|NCT01656434|155675091|FG000|Overall Study|Screen failure|2|||
48405171|NCT01656434|155675092|FG001|Overall Study|Screen failure|0|||
48405172|NCT01656434|155675091|FG000|Overall Study|Protocol Violation|7|||
48405173|NCT01656434|155675092|FG001|Overall Study|Protocol Violation|0|||
48405174|NCT01656434|155675091|FG000|Overall Study|Pregnancy wish|18|||
48405175|NCT01656434|155675092|FG001|Overall Study|Pregnancy wish|6|||
48405176|NCT01656434|155675091|FG000|Overall Study|Pregnancy|45|||
48405177|NCT01656434|155675092|FG001|Overall Study|Pregnancy|10|||
48405178|NCT01656434|155675091|FG000|Overall Study|Physician Decision|7|||
48405179|NCT01656434|155675092|FG001|Overall Study|Physician Decision|2|||
48405180|NCT01656434|155675091|FG000|Overall Study|Non-compliance with study drug|48|||
48405181|NCT01656434|155675092|FG001|Overall Study|Non-compliance with study drug|9|||
48405182|NCT01656434|155675091|FG000|Overall Study|Study terminated by sponsor|1501|||
48405183|NCT01656434|155675092|FG001|Overall Study|Study terminated by sponsor|348|||
48405184|NCT01656434|155675091|FG000|Overall Study|Participant discontinued; drug related|13|||
48405185|NCT01656434|155675092|FG001|Overall Study|Participant discontinued; drug related|4|||
48405186|NCT01656434|155675091|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
48405187|NCT01656434|155675092|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
48405188|NCT01656434|155675091|FG000|Overall Study|Non-compliance with protocol|39|||
48405189|NCT01656434|155675092|FG001|Overall Study|Non-compliance with protocol|15|||
48405190|NCT01656434|155675091|FG000|Overall Study|Participant moved|40|||
48405191|NCT01656434|155675092|FG001|Overall Study|Participant moved|12|||
48405192|NCT01656434|155675091|FG000|Overall Study|Participant withdrew consent|28|||
48405193|NCT01656434|155675092|FG001|Overall Study|Participant withdrew consent|9|||
48405194|NCT01656434|155675091|FG000|Overall Study|Withdrawal by Subject|64|||
48405195|NCT01656434|155675092|FG001|Overall Study|Withdrawal by Subject|7|||
48405196|NCT03213366|155675093|FG000|Overall Study|Lost to Follow-up|9|||
48405197|NCT03213366|155675094|FG001|Overall Study|Lost to Follow-up|4|||
48405198|NCT02292771|155675095|FG000|Overall Study|Withdrawal by Subject|2|||
48405199|NCT02292771|155675096|FG001|Overall Study|Withdrawal by Subject|1|||
48405200|NCT02292771|155675095|FG000|Overall Study|Lost to Follow-up|2|||
48405201|NCT02292771|155675096|FG001|Overall Study|Lost to Follow-up|1|||
48405202|NCT02532855|155675099|FG000|Overall Study|Lost to Follow-up|4|||
48405203|NCT02532855|155675100|FG001|Overall Study|Lost to Follow-up|3|||
48405204|NCT02532855|155675099|FG000|Overall Study|Withdrawal by Subject|4|||
48405205|NCT02532855|155675100|FG001|Overall Study|Withdrawal by Subject|8|||
48405206|NCT00713219|155675109|FG000|Overall Study|Death|1|||
48405207|NCT00713219|155675109|FG000|Overall Study|Protocol Violation|1|||
48405208|NCT00508391|155675110|FG000|First Treatment|Withdrawal by Subject|6|||
48405209|NCT00508391|155675111|FG001|First Treatment|Withdrawal by Subject|3|||
48405210|NCT00508391|155675110|FG000|Second Treatment|Withdrawal by Subject|2|||
48405211|NCT00508391|155675111|FG001|Second Treatment|Withdrawal by Subject|0|||
48405212|NCT01557166|155675119|FG000|Overall Study|Adverse Event|20|||
48405213|NCT01557166|155675120|FG001|Overall Study|Adverse Event|6|||
48405214|NCT01557166|155675119|FG000|Overall Study|Lack of Efficacy|2|||
48405215|NCT01557166|155675120|FG001|Overall Study|Lack of Efficacy|1|||
48405216|NCT01557166|155675119|FG000|Overall Study|Protocol Violation|8|||
48405217|NCT01557166|155675120|FG001|Overall Study|Protocol Violation|5|||
48405218|NCT01557166|155675119|FG000|Overall Study|Withdrawn consent|12|||
48405219|NCT01557166|155675120|FG001|Overall Study|Withdrawn consent|20|||
48405220|NCT01557166|155675119|FG000|Overall Study|Target dose not tolerated|1|||
48405221|NCT01557166|155675120|FG001|Overall Study|Target dose not tolerated|0|||
48405222|NCT01557166|155675119|FG000|Overall Study|Psychiatric disorder|1|||
48405223|NCT01557166|155675120|FG001|Overall Study|Psychiatric disorder|0|||
48405224|NCT01557166|155675119|FG000|Overall Study|Unclassified|2|||
48405225|NCT01557166|155675120|FG001|Overall Study|Unclassified|5|||
48405226|NCT03742037|155675121|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48405227|NCT03742037|155675122|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
48405228|NCT03742037|155675123|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48405229|NCT03742037|155675124|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48405230|NCT03742037|155675125|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48405231|NCT03742037|155675126|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48405232|NCT03742037|155675127|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
48405233|NCT03742037|155675121|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
48405234|NCT03742037|155675122|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
48405235|NCT03742037|155675123|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
48405236|NCT03742037|155675124|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
48405237|NCT03742037|155675125|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
48405238|NCT03742037|155675126|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
48405239|NCT03742037|155675127|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
48405240|NCT03742037|155675121|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
48405241|NCT03742037|155675122|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
48405242|NCT03742037|155675123|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
48405243|NCT03742037|155675124|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
48430816|NCT02273050|155765231|FG000|Overall Study|Death|0|||
48405244|NCT03742037|155675125|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
48405245|NCT03742037|155675126|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
48405246|NCT03742037|155675127|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
48405247|NCT03742037|155675121|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48405248|NCT03742037|155675122|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
48405249|NCT03742037|155675123|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48405250|NCT03742037|155675124|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48405251|NCT03742037|155675125|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48405252|NCT03742037|155675126|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
48405253|NCT03742037|155675127|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
48405254|NCT03742037|155675121|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
48405255|NCT03742037|155675122|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
48405256|NCT03742037|155675123|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
48405257|NCT03742037|155675124|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
48405258|NCT03742037|155675125|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
48405259|NCT03742037|155675126|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
48405260|NCT03742037|155675127|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
48405261|NCT03742037|155675121|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48405262|NCT03742037|155675122|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48405263|NCT03742037|155675123|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48405264|NCT03742037|155675124|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48405265|NCT03742037|155675125|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48405266|NCT03742037|155675126|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
48405267|NCT03742037|155675127|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
48405268|NCT03742037|155675121|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
48405269|NCT03742037|155675122|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
48405270|NCT03742037|155675123|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
48405271|NCT03742037|155675124|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
48405272|NCT03742037|155675125|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
48405273|NCT03742037|155675126|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
48405274|NCT03742037|155675127|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
48405275|NCT03742037|155675121|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48405276|NCT03742037|155675122|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48405277|NCT03742037|155675123|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48405278|NCT03742037|155675124|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48405279|NCT03742037|155675125|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48405280|NCT03742037|155675126|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
48405281|NCT03742037|155675127|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
48405282|NCT03742037|155675121|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
48405283|NCT03742037|155675122|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
48405284|NCT03742037|155675123|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
48405285|NCT03742037|155675124|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
48405286|NCT03742037|155675125|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
48405287|NCT03742037|155675126|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
48405288|NCT03742037|155675127|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
48405289|NCT03742037|155675121|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
48405290|NCT03742037|155675122|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
48405291|NCT03742037|155675123|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
48405292|NCT03742037|155675124|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
48405293|NCT03742037|155675125|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
48405294|NCT03742037|155675126|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
48405295|NCT03742037|155675127|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
48405296|NCT03742037|155675121|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48405297|NCT03742037|155675122|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
48405298|NCT03742037|155675123|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
48405299|NCT03742037|155675124|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48405300|NCT03742037|155675125|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48405301|NCT03742037|155675126|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48405302|NCT03742037|155675127|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
48405303|NCT03742037|155675121|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
48405304|NCT03742037|155675122|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48405305|NCT03742037|155675123|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48405306|NCT03742037|155675124|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48405307|NCT03742037|155675125|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48405308|NCT03742037|155675126|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
48405309|NCT03742037|155675127|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
48405310|NCT03742037|155675121|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
48405311|NCT03742037|155675122|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
48405312|NCT03742037|155675123|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
48405313|NCT03742037|155675124|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
48405314|NCT03742037|155675125|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
48405315|NCT03742037|155675126|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
48405316|NCT03742037|155675127|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
48405317|NCT03742037|155675121|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
48405318|NCT03742037|155675122|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
48405319|NCT03742037|155675123|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
48405320|NCT03742037|155675124|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
48405321|NCT03742037|155675125|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
48405322|NCT03742037|155675126|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
48405323|NCT03742037|155675127|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
48405324|NCT03742037|155675121|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48430817|NCT02273050|155765232|FG001|Overall Study|Death|0|||
48796548|NCT04052204|157093690|FG000|Overall Study|Other|1|||
48796549|NCT04052204|157093691|FG001|Overall Study|Other|0|||
48796550|NCT04052204|157093692|FG002|Overall Study|Other|0|||
48796551|NCT02384759|157093693|FG000|Overall Study|Patients not treated|3|||
48796552|NCT02384759|157093694|FG001|Overall Study|Patients not treated|2|||
48796553|NCT01433354|157093695|FG000|Overall Study|Adverse Event|6|||
48796554|NCT01433354|157093695|FG000|Overall Study|Lost to Follow-up|1|||
48796555|NCT01433354|157093695|FG000|Overall Study|Administrative problems|90|||
48796556|NCT01433354|157093695|FG000|Overall Study|Protocol Violation|2|||
48796557|NCT01433354|157093695|FG000|Overall Study|Lack of Efficacy|17|||
48796558|NCT01433354|157093695|FG000|Overall Study|Subject Withdrew Consent|3|||
48796559|NCT04570436|157093711|FG000|Overall Study|Adverse Event|0|||
48796560|NCT04570436|157093712|FG001|Overall Study|Adverse Event|0|||
48796561|NCT04570436|157093713|FG002|Overall Study|Adverse Event|1|||
48796562|NCT04570436|157093714|FG003|Overall Study|Adverse Event|0|||
48796563|NCT04570436|157093715|FG004|Overall Study|Adverse Event|0|||
48796564|NCT04570436|157093716|FG005|Overall Study|Adverse Event|0|||
48796565|NCT04570436|157093717|FG006|Overall Study|Adverse Event|0|||
48796566|NCT04570436|157093718|FG007|Overall Study|Adverse Event|0|||
48796567|NCT04570436|157093719|FG008|Overall Study|Adverse Event|0|||
48796568|NCT04570436|157093720|FG009|Overall Study|Adverse Event|0|||
48796569|NCT04570436|157093711|FG000|Overall Study|Physician Decision|1|||
48796570|NCT04570436|157093712|FG001|Overall Study|Physician Decision|0|||
48796571|NCT04570436|157093713|FG002|Overall Study|Physician Decision|0|||
48796572|NCT04570436|157093714|FG003|Overall Study|Physician Decision|0|||
48796573|NCT04570436|157093715|FG004|Overall Study|Physician Decision|0|||
48796574|NCT04570436|157093716|FG005|Overall Study|Physician Decision|0|||
48796575|NCT04570436|157093717|FG006|Overall Study|Physician Decision|0|||
48796576|NCT04570436|157093718|FG007|Overall Study|Physician Decision|0|||
48796577|NCT04570436|157093719|FG008|Overall Study|Physician Decision|0|||
48796578|NCT04570436|157093720|FG009|Overall Study|Physician Decision|0|||
48796579|NCT00224874|157093721|FG000|Overall Study|Withdrawal by Subject|0|||
48796580|NCT00224874|157093722|FG001|Overall Study|Withdrawal by Subject|0|||
48796581|NCT00224874|157093723|FG002|Overall Study|Withdrawal by Subject|1|||
48796582|NCT00224874|157093724|FG003|Overall Study|Withdrawal by Subject|0|||
48405325|NCT03742037|155675122|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48405326|NCT03742037|155675123|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
48405327|NCT03742037|155675124|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48405328|NCT03742037|155675125|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48405329|NCT03742037|155675126|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48405330|NCT03742037|155675127|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
48405331|NCT00573794|155675128|FG000|Overall Study|Adverse Event|81|||
48405332|NCT00573794|155675128|FG000|Overall Study|Withdrew Consent|90|||
48405333|NCT00573794|155675128|FG000|Overall Study|Lost to Follow-up|13|||
48405334|NCT00573794|155675128|FG000|Overall Study|Protocol Violation|6|||
48405335|NCT00573794|155675128|FG000|Overall Study|Lack of Efficacy|94|||
48405336|NCT00573794|155675128|FG000|Overall Study|Other|46|||
48405337|NCT01988090|155675129|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
48405338|NCT01988090|155675130|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
48405339|NCT01988090|155675129|FG000|Start Treament After Randomization|Protocol Violation|0|||
48405340|NCT01988090|155675130|FG001|Start Treament After Randomization|Protocol Violation|1|||
48405341|NCT01988090|155675129|FG000|Complete Study After Start|Withdrawal by Subject|2|||
48405342|NCT01988090|155675130|FG001|Complete Study After Start|Withdrawal by Subject|0|||
48405343|NCT01988090|155675129|FG000|Complete Study After Start|Protocol Violation|1|||
48405344|NCT01988090|155675130|FG001|Complete Study After Start|Protocol Violation|1|||
48405345|NCT03687502|155675134|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
48405346|NCT03687502|155675134|FG000|Overall Study|Lumason not available|1|||
48405347|NCT00486278|155675138|FG000|Overall Study|Adverse Event|5|||
48405348|NCT00486278|155675138|FG000|Overall Study|Withdrawal by Subject|2|||
48405349|NCT00486278|155675138|FG000|Overall Study|Physician Decision|2|||
48405350|NCT01725750|155675139|FG000|Overall Study|Adverse Event|1|||
48405351|NCT01725750|155675140|FG001|Overall Study|Adverse Event|0|||
48405352|NCT01725750|155675139|FG000|Overall Study|Lost to Follow-up|1|||
48405353|NCT01725750|155675140|FG001|Overall Study|Lost to Follow-up|1|||
48405354|NCT01725750|155675139|FG000|Overall Study|Withdrawal by Subject|0|||
48405355|NCT01725750|155675140|FG001|Overall Study|Withdrawal by Subject|9|||
48405356|NCT02542072|155675141|FG000|First Intervention (1 Month)|Adverse Event|1|||
48405357|NCT02542072|155675142|FG001|First Intervention (1 Month)|Adverse Event|1|||
48405358|NCT02542072|155675141|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
48405359|NCT02542072|155675142|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
48405360|NCT02542072|155675141|FG000|First Intervention (1 Month)|Lens discomfort|1|||
48405361|NCT02542072|155675142|FG001|First Intervention (1 Month)|Lens discomfort|2|||
48405362|NCT02542072|155675141|FG000|First Intervention (1 Month)|Protocol Violation|1|||
48405363|NCT02542072|155675142|FG001|First Intervention (1 Month)|Protocol Violation|0|||
48405364|NCT02542072|155675141|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
48405365|NCT02542072|155675142|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
48405366|NCT02542072|155675141|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
48405367|NCT02542072|155675142|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
48405368|NCT00630331|155675147|FG000|Overall Study|Death|2|||
48405369|NCT00630331|155675148|FG001|Overall Study|Death|1|||
48405370|NCT00630331|155675149|FG002|Overall Study|Death|1|||
48405371|NCT00630331|155675147|FG000|Overall Study|Adverse Event|1|||
48405372|NCT00630331|155675148|FG001|Overall Study|Adverse Event|0|||
48405373|NCT00630331|155675149|FG002|Overall Study|Adverse Event|0|||
48405374|NCT00630331|155675147|FG000|Overall Study|Withdrawal by Subject|12|||
48405375|NCT00630331|155675148|FG001|Overall Study|Withdrawal by Subject|7|||
48405376|NCT00630331|155675149|FG002|Overall Study|Withdrawal by Subject|5|||
48405377|NCT00630331|155675147|FG000|Overall Study|Lost to Follow-up|175|||
48405378|NCT00630331|155675148|FG001|Overall Study|Lost to Follow-up|143|||
48405379|NCT00630331|155675149|FG002|Overall Study|Lost to Follow-up|170|||
48405380|NCT00630331|155675147|FG000|Overall Study|Inappropriate enrollment|3|||
48405381|NCT00630331|155675148|FG001|Overall Study|Inappropriate enrollment|6|||
48405382|NCT00630331|155675149|FG002|Overall Study|Inappropriate enrollment|3|||
48405383|NCT00630331|155675147|FG000|Overall Study|Unable to classify|9|||
48405384|NCT00630331|155675148|FG001|Overall Study|Unable to classify|4|||
48405385|NCT00630331|155675149|FG002|Overall Study|Unable to classify|3|||
48405386|NCT00630331|155675147|FG000|Overall Study|Protocol Violation|4|||
48405387|NCT00630331|155675148|FG001|Overall Study|Protocol Violation|5|||
48405388|NCT00630331|155675149|FG002|Overall Study|Protocol Violation|6|||
48405389|NCT01827384|155675150|FG000|Overall Study|Switched to alternative treatment|0|||
48405390|NCT01827384|155675151|FG001|Overall Study|Switched to alternative treatment|0|||
48405391|NCT01827384|155675152|FG002|Overall Study|Switched to alternative treatment|0|||
48405392|NCT01827384|155675153|FG003|Overall Study|Switched to alternative treatment|0|||
48405393|NCT01827384|155675154|FG004|Overall Study|Switched to alternative treatment|0|||
48405394|NCT01827384|155675155|FG005|Overall Study|Switched to alternative treatment|0|||
48405395|NCT01827384|155675156|FG006|Overall Study|Switched to alternative treatment|0|||
48405396|NCT01827384|155675157|FG007|Overall Study|Switched to alternative treatment|0|||
48405397|NCT01827384|155675158|FG008|Overall Study|Switched to alternative treatment|0|||
48405398|NCT01827384|155675159|FG009|Overall Study|Switched to alternative treatment|0|||
48405399|NCT01827384|155675160|FG010|Overall Study|Switched to alternative treatment|0|||
48405400|NCT01827384|155675161|FG011|Overall Study|Switched to alternative treatment|0|||
48405401|NCT01827384|155675162|FG012|Overall Study|Switched to alternative treatment|0|||
48796583|NCT03280121|157093725|FG000|Overall Study|Physician Decision|1|||
48796584|NCT03280121|157093725|FG000|Overall Study|Lost to Follow-up|1|||
48796585|NCT03280121|157093725|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
48796586|NCT00911534|157093728|FG000|Overall Study|Adverse Event|4|||
48796587|NCT00911534|157093729|FG001|Overall Study|Adverse Event|4|||
48796588|NCT00911534|157093728|FG000|Overall Study|Lost to Follow-up|2|||
48796589|NCT00911534|157093729|FG001|Overall Study|Lost to Follow-up|4|||
48796590|NCT00911534|157093728|FG000|Overall Study|Withdrawal by Subject|2|||
48796591|NCT00911534|157093729|FG001|Overall Study|Withdrawal by Subject|1|||
48796592|NCT00911534|157093728|FG000|Overall Study|Lack of Efficacy|4|||
48796593|NCT00911534|157093729|FG001|Overall Study|Lack of Efficacy|1|||
48796594|NCT00911534|157093728|FG000|Overall Study|Withdrawal of consent|1|||
48796595|NCT00911534|157093729|FG001|Overall Study|Withdrawal of consent|4|||
48796596|NCT00911534|157093728|FG000|Overall Study|Other|2|||
48796597|NCT00911534|157093729|FG001|Overall Study|Other|2|||
48796598|NCT02807558|157093735|FG000|Overall Study|Consent withdrawn by participant|4|||
48796599|NCT02807558|157093736|FG001|Overall Study|Consent withdrawn by participant|0|||
48796600|NCT02807558|157093737|FG002|Overall Study|Consent withdrawn by participant|4|||
48796601|NCT02807558|157093738|FG003|Overall Study|Consent withdrawn by participant|2|||
48796602|NCT02807558|157093739|FG004|Overall Study|Consent withdrawn by participant|1|||
48796603|NCT02807558|157093740|FG005|Overall Study|Consent withdrawn by participant|0|||
48796604|NCT02807558|157093735|FG000|Overall Study|Non-compliance with Study Drug|0|||
48796605|NCT02807558|157093736|FG001|Overall Study|Non-compliance with Study Drug|0|||
48796606|NCT02807558|157093737|FG002|Overall Study|Non-compliance with Study Drug|1|||
48796607|NCT02807558|157093738|FG003|Overall Study|Non-compliance with Study Drug|0|||
48796608|NCT02807558|157093739|FG004|Overall Study|Non-compliance with Study Drug|0|||
48796609|NCT02807558|157093740|FG005|Overall Study|Non-compliance with Study Drug|0|||
48796610|NCT02807558|157093735|FG000|Overall Study|Adverse Event|0|||
48796611|NCT02807558|157093736|FG001|Overall Study|Adverse Event|0|||
48796612|NCT02807558|157093737|FG002|Overall Study|Adverse Event|9|||
48796613|NCT02807558|157093738|FG003|Overall Study|Adverse Event|0|||
48796614|NCT02807558|157093739|FG004|Overall Study|Adverse Event|0|||
48796615|NCT02807558|157093740|FG005|Overall Study|Adverse Event|0|||
48796616|NCT02807558|157093735|FG000|Overall Study|Death|23|||
48796617|NCT02807558|157093736|FG001|Overall Study|Death|2|||
48796618|NCT02807558|157093737|FG002|Overall Study|Death|3|||
48796619|NCT02807558|157093738|FG003|Overall Study|Death|43|||
48796620|NCT02807558|157093739|FG004|Overall Study|Death|24|||
48796621|NCT02807558|157093740|FG005|Overall Study|Death|15|||
48796622|NCT02807558|157093735|FG000|Overall Study|Progressive Disease|0|||
48796623|NCT02807558|157093736|FG001|Overall Study|Progressive Disease|0|||
48796624|NCT02807558|157093737|FG002|Overall Study|Progressive Disease|1|||
48796625|NCT02807558|157093738|FG003|Overall Study|Progressive Disease|0|||
48796626|NCT02807558|157093739|FG004|Overall Study|Progressive Disease|0|||
48796627|NCT02807558|157093740|FG005|Overall Study|Progressive Disease|0|||
48796628|NCT02807558|157093735|FG000|Overall Study|Other than specified|1|||
48796629|NCT02807558|157093736|FG001|Overall Study|Other than specified|0|||
48796630|NCT02807558|157093737|FG002|Overall Study|Other than specified|2|||
48796631|NCT02807558|157093738|FG003|Overall Study|Other than specified|0|||
48796632|NCT02807558|157093739|FG004|Overall Study|Other than specified|1|||
48796633|NCT02807558|157093740|FG005|Overall Study|Other than specified|1|||
48796634|NCT02807558|157093735|FG000|Overall Study|Lack of Efficacy|0|||
48796635|NCT02807558|157093736|FG001|Overall Study|Lack of Efficacy|0|||
48796636|NCT02807558|157093737|FG002|Overall Study|Lack of Efficacy|9|||
48796637|NCT02807558|157093738|FG003|Overall Study|Lack of Efficacy|0|||
48796638|NCT02807558|157093739|FG004|Overall Study|Lack of Efficacy|0|||
48796639|NCT02807558|157093740|FG005|Overall Study|Lack of Efficacy|0|||
48796640|NCT01994954|157093745|FG000|Overall Study|Death|1|||
48796641|NCT01994954|157093746|FG001|Overall Study|Death|0|||
48796642|NCT01994954|157093745|FG000|Overall Study|Withdrawal by Subject|9|||
48796643|NCT01994954|157093746|FG001|Overall Study|Withdrawal by Subject|14|||
48796644|NCT01994954|157093745|FG000|Overall Study|Physician Decision|2|||
48796645|NCT01994954|157093746|FG001|Overall Study|Physician Decision|2|||
48796646|NCT01994954|157093745|FG000|Overall Study|Lost to Follow-up|8|||
48796647|NCT01994954|157093746|FG001|Overall Study|Lost to Follow-up|10|||
48796648|NCT01994954|157093745|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
48796649|NCT01994954|157093746|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
48796650|NCT04198805|157093747|FG000|Overall Study|Death|0|||
48796651|NCT04198805|157093748|FG001|Overall Study|Death|0|||
48796652|NCT04198805|157093749|FG002|Overall Study|Death|0|||
48796653|NCT04198805|157093750|FG003|Overall Study|Death|1|||
48796654|NCT04198805|157093747|FG000|Overall Study|Early Termination|8|||
48796655|NCT04198805|157093748|FG001|Overall Study|Early Termination|4|||
48796656|NCT04198805|157093749|FG002|Overall Study|Early Termination|6|||
48405402|NCT01827384|155675163|FG013|Overall Study|Switched to alternative treatment|2|||
48796657|NCT04198805|157093750|FG003|Overall Study|Early Termination|9|||
48796658|NCT00683644|157093751|FG000|Overall Study|Withdrawal by Subject|4|||
48796659|NCT00683644|157093752|FG001|Overall Study|Withdrawal by Subject|2|||
48796660|NCT00683644|157093751|FG000|Overall Study|Lost to Follow-up|1|||
48796661|NCT00683644|157093752|FG001|Overall Study|Lost to Follow-up|4|||
48796662|NCT00683644|157093751|FG000|Overall Study|Adverse Event|1|||
48796663|NCT00683644|157093752|FG001|Overall Study|Adverse Event|2|||
48796664|NCT00683644|157093751|FG000|Overall Study|Low copper, other health problems,|7|||
48796665|NCT00683644|157093752|FG001|Overall Study|Low copper, other health problems,|6|||
48796666|NCT01441102|157093753|FG000|Overall Study|Adverse Event|1|||
48796667|NCT01441102|157093753|FG000|Overall Study|Withdrawal by Subject|2|||
48796668|NCT04084314|157093755|FG000|Overall Study|Subject/guardian decision|91|||
48796669|NCT04084314|157093755|FG000|Overall Study|Adverse Event|24|||
48796670|NCT04084314|157093755|FG000|Overall Study|Lost to Follow-up|19|||
48796671|NCT04084314|157093755|FG000|Overall Study|New therapy for study indication|9|||
48796672|NCT04084314|157093755|FG000|Overall Study|Pregnancy|9|||
48796673|NCT04084314|157093755|FG000|Overall Study|Withdrawal of informed consent|8|||
48796674|NCT04084314|157093755|FG000|Overall Study|Physician Decision|4|||
48796675|NCT04084314|157093755|FG000|Overall Study|Protocol Deviation|3|||
48796676|NCT01218126|157093756|FG000|Overall Study|Adverse Event|8|||
48796677|NCT01218126|157093757|FG001|Overall Study|Adverse Event|10|||
48796678|NCT01218126|157093758|FG002|Overall Study|Adverse Event|12|||
48796679|NCT01218126|157093759|FG003|Overall Study|Adverse Event|16|||
48796680|NCT01218126|157093756|FG000|Overall Study|Lack of Efficacy|7|||
48796681|NCT01218126|157093757|FG001|Overall Study|Lack of Efficacy|2|||
48796682|NCT01218126|157093758|FG002|Overall Study|Lack of Efficacy|2|||
48796683|NCT01218126|157093759|FG003|Overall Study|Lack of Efficacy|6|||
48796684|NCT01218126|157093756|FG000|Overall Study|Protocol Violation|5|||
48796685|NCT01218126|157093757|FG001|Overall Study|Protocol Violation|2|||
48796686|NCT01218126|157093758|FG002|Overall Study|Protocol Violation|2|||
48796687|NCT01218126|157093759|FG003|Overall Study|Protocol Violation|3|||
48796688|NCT01218126|157093756|FG000|Overall Study|Protocol-defined stopping criteria|1|||
48796689|NCT01218126|157093757|FG001|Overall Study|Protocol-defined stopping criteria|1|||
48796690|NCT01218126|157093758|FG002|Overall Study|Protocol-defined stopping criteria|0|||
48796691|NCT01218126|157093759|FG003|Overall Study|Protocol-defined stopping criteria|0|||
48796692|NCT01218126|157093756|FG000|Overall Study|Lost to Follow-up|0|||
48796693|NCT01218126|157093757|FG001|Overall Study|Lost to Follow-up|0|||
48796694|NCT01218126|157093758|FG002|Overall Study|Lost to Follow-up|0|||
48796695|NCT01218126|157093759|FG003|Overall Study|Lost to Follow-up|2|||
48796696|NCT01218126|157093756|FG000|Overall Study|Physician Decision|1|||
48796697|NCT01218126|157093757|FG001|Overall Study|Physician Decision|2|||
48796698|NCT01218126|157093758|FG002|Overall Study|Physician Decision|4|||
48796699|NCT01218126|157093759|FG003|Overall Study|Physician Decision|2|||
48796700|NCT01218126|157093756|FG000|Overall Study|Withdrawal by Subject|2|||
48796701|NCT01218126|157093757|FG001|Overall Study|Withdrawal by Subject|5|||
48796702|NCT01218126|157093758|FG002|Overall Study|Withdrawal by Subject|4|||
48796703|NCT01218126|157093759|FG003|Overall Study|Withdrawal by Subject|6|||
48796704|NCT00810264|157093761|FG000|Overall Study|Lost to Follow-up|191|||
48796705|NCT00810264|157093761|FG000|Overall Study|Withdrawal by subject or physician|721|||
48796706|NCT00810264|157093761|FG000|Overall Study|Death|641|||
48796707|NCT01830127|157093762|FG000|Overall Study|Adverse Event|1|||
48796708|NCT01830127|157093763|FG001|Overall Study|Adverse Event|6|||
48796709|NCT01830127|157093762|FG000|Overall Study|Lack of Efficacy|3|||
48796710|NCT01830127|157093763|FG001|Overall Study|Lack of Efficacy|0|||
48796711|NCT01830127|157093762|FG000|Overall Study|Withdrawal by Subject|1|||
48796712|NCT01830127|157093763|FG001|Overall Study|Withdrawal by Subject|1|||
48796713|NCT01830127|157093762|FG000|Overall Study|Other reason not defined above|0|||
48796714|NCT01830127|157093763|FG001|Overall Study|Other reason not defined above|2|||
48796715|NCT00500903|157093774|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
48796716|NCT00500903|157093775|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
48796717|NCT00500903|157093776|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
48796718|NCT00500903|157093774|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
48796719|NCT00500903|157093775|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
48796720|NCT00500903|157093776|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48796721|NCT00500903|157093774|FG000|Overall Study|Progressive Disease|41|||
48796722|NCT00500903|157093775|FG001|Overall Study|Progressive Disease|2|||
48796723|NCT00500903|157093776|FG002|Overall Study|Progressive Disease|15|||
48796724|NCT00500903|157093774|FG000|Overall Study|Patient Declined Further Treatment|0|||
48796725|NCT00500903|157093775|FG001|Overall Study|Patient Declined Further Treatment|0|||
48796726|NCT00500903|157093776|FG002|Overall Study|Patient Declined Further Treatment|3|||
48796727|NCT00500903|157093774|FG000|Overall Study|Symptomatic Deterioration|2|||
48796728|NCT00500903|157093775|FG001|Overall Study|Symptomatic Deterioration|0|||
48796729|NCT00500903|157093776|FG002|Overall Study|Symptomatic Deterioration|0|||
48796730|NCT00500903|157093774|FG000|Overall Study|Reason Not Specified|10|||
48796731|NCT00500903|157093775|FG001|Overall Study|Reason Not Specified|0|||
48796732|NCT00500903|157093776|FG002|Overall Study|Reason Not Specified|2|||
48796733|NCT00698646|157093780|FG000|Overall Study|Adverse Event|8|||
48405403|NCT01827384|155675150|FG000|Overall Study|Disease progression before treatment|0|||
48357412|NCT02808975|155504867|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
48357413|NCT02808975|155504868|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
48357414|NCT02808975|155504867|FG000|Overall Study|Other, not specified|5|||
48357415|NCT02808975|155504868|FG001|Overall Study|Other, not specified|1|||
48357416|NCT00790400|155504871|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
48357417|NCT00790400|155504872|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
48357418|NCT00790400|155504871|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
48357419|NCT00790400|155504872|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
48357420|NCT00790400|155504871|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
48357421|NCT00790400|155504872|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
48357422|NCT00790400|155504871|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
48357423|NCT00790400|155504872|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
48357424|NCT00790400|155504871|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
48405404|NCT01827384|155675151|FG001|Overall Study|Disease progression before treatment|0|||
48405405|NCT01827384|155675152|FG002|Overall Study|Disease progression before treatment|0|||
48405406|NCT01827384|155675153|FG003|Overall Study|Disease progression before treatment|0|||
48405407|NCT01827384|155675154|FG004|Overall Study|Disease progression before treatment|0|||
48405408|NCT01827384|155675155|FG005|Overall Study|Disease progression before treatment|0|||
48405409|NCT01827384|155675156|FG006|Overall Study|Disease progression before treatment|0|||
48405410|NCT01827384|155675157|FG007|Overall Study|Disease progression before treatment|0|||
48405411|NCT01827384|155675158|FG008|Overall Study|Disease progression before treatment|0|||
48405412|NCT01827384|155675159|FG009|Overall Study|Disease progression before treatment|0|||
48405413|NCT01827384|155675160|FG010|Overall Study|Disease progression before treatment|0|||
48405414|NCT01827384|155675161|FG011|Overall Study|Disease progression before treatment|0|||
48405415|NCT01827384|155675162|FG012|Overall Study|Disease progression before treatment|0|||
48405416|NCT01827384|155675163|FG013|Overall Study|Disease progression before treatment|4|||
48405417|NCT01827384|155675150|FG000|Overall Study|Ineligible|0|||
48405418|NCT01827384|155675151|FG001|Overall Study|Ineligible|0|||
48405419|NCT01827384|155675152|FG002|Overall Study|Ineligible|0|||
48405420|NCT01827384|155675153|FG003|Overall Study|Ineligible|0|||
48405421|NCT01827384|155675154|FG004|Overall Study|Ineligible|0|||
48405422|NCT01827384|155675155|FG005|Overall Study|Ineligible|0|||
48405423|NCT01827384|155675156|FG006|Overall Study|Ineligible|0|||
48405424|NCT01827384|155675157|FG007|Overall Study|Ineligible|0|||
48405425|NCT01827384|155675158|FG008|Overall Study|Ineligible|0|||
48405426|NCT01827384|155675159|FG009|Overall Study|Ineligible|0|||
48405427|NCT01827384|155675160|FG010|Overall Study|Ineligible|0|||
48405428|NCT01827384|155675161|FG011|Overall Study|Ineligible|0|||
48405429|NCT01827384|155675162|FG012|Overall Study|Ineligible|0|||
48405430|NCT01827384|155675163|FG013|Overall Study|Ineligible|19|||
48405431|NCT01827384|155675150|FG000|Overall Study|Participant died before treatment|0|||
48405432|NCT01827384|155675151|FG001|Overall Study|Participant died before treatment|0|||
48405433|NCT01827384|155675152|FG002|Overall Study|Participant died before treatment|0|||
48405434|NCT01827384|155675153|FG003|Overall Study|Participant died before treatment|0|||
48405435|NCT01827384|155675154|FG004|Overall Study|Participant died before treatment|0|||
48405436|NCT01827384|155675155|FG005|Overall Study|Participant died before treatment|0|||
48405437|NCT01827384|155675156|FG006|Overall Study|Participant died before treatment|0|||
48405438|NCT01827384|155675157|FG007|Overall Study|Participant died before treatment|0|||
48405439|NCT01827384|155675158|FG008|Overall Study|Participant died before treatment|0|||
48405440|NCT01827384|155675159|FG009|Overall Study|Participant died before treatment|0|||
48405441|NCT01827384|155675160|FG010|Overall Study|Participant died before treatment|0|||
48405442|NCT01827384|155675161|FG011|Overall Study|Participant died before treatment|0|||
48405443|NCT01827384|155675162|FG012|Overall Study|Participant died before treatment|0|||
48405444|NCT01827384|155675163|FG013|Overall Study|Participant died before treatment|5|||
48405445|NCT01827384|155675150|FG000|Overall Study|Insufficient tumor cells|0|||
48405446|NCT01827384|155675151|FG001|Overall Study|Insufficient tumor cells|0|||
48405447|NCT01827384|155675152|FG002|Overall Study|Insufficient tumor cells|0|||
48405448|NCT01827384|155675153|FG003|Overall Study|Insufficient tumor cells|0|||
48405449|NCT01827384|155675154|FG004|Overall Study|Insufficient tumor cells|0|||
48405450|NCT01827384|155675155|FG005|Overall Study|Insufficient tumor cells|0|||
48405451|NCT01827384|155675156|FG006|Overall Study|Insufficient tumor cells|0|||
48405452|NCT01827384|155675157|FG007|Overall Study|Insufficient tumor cells|0|||
48405453|NCT01827384|155675158|FG008|Overall Study|Insufficient tumor cells|0|||
48405454|NCT01827384|155675159|FG009|Overall Study|Insufficient tumor cells|0|||
48405455|NCT01827384|155675160|FG010|Overall Study|Insufficient tumor cells|0|||
48405456|NCT01827384|155675161|FG011|Overall Study|Insufficient tumor cells|0|||
48405457|NCT01827384|155675162|FG012|Overall Study|Insufficient tumor cells|0|||
48405458|NCT01827384|155675163|FG013|Overall Study|Insufficient tumor cells|13|||
48405459|NCT01827384|155675150|FG000|Overall Study|No actionable mutation|0|||
48405460|NCT01827384|155675151|FG001|Overall Study|No actionable mutation|0|||
48405461|NCT01827384|155675152|FG002|Overall Study|No actionable mutation|0|||
48405462|NCT01827384|155675153|FG003|Overall Study|No actionable mutation|0|||
48405463|NCT01827384|155675154|FG004|Overall Study|No actionable mutation|0|||
48405464|NCT01827384|155675155|FG005|Overall Study|No actionable mutation|0|||
48405465|NCT01827384|155675156|FG006|Overall Study|No actionable mutation|0|||
48405466|NCT01827384|155675157|FG007|Overall Study|No actionable mutation|0|||
48405467|NCT01827384|155675158|FG008|Overall Study|No actionable mutation|0|||
48405468|NCT01827384|155675159|FG009|Overall Study|No actionable mutation|0|||
48405469|NCT01827384|155675160|FG010|Overall Study|No actionable mutation|0|||
48405470|NCT01827384|155675161|FG011|Overall Study|No actionable mutation|0|||
48405471|NCT01827384|155675162|FG012|Overall Study|No actionable mutation|0|||
48405472|NCT01827384|155675163|FG013|Overall Study|No actionable mutation|73|||
48405473|NCT01827384|155675150|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
48405474|NCT01827384|155675151|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
48405475|NCT01827384|155675152|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
48405476|NCT01827384|155675153|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
48405477|NCT01827384|155675154|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
48405478|NCT01827384|155675155|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
48405479|NCT01827384|155675156|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
48405480|NCT01827384|155675157|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
48405481|NCT01827384|155675158|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
48405482|NCT01827384|155675159|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
48405483|NCT01827384|155675160|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
48405484|NCT01827384|155675161|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
48430818|NCT02273050|155765233|FG002|Overall Study|Death|1|||
48405485|NCT01827384|155675162|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
48405486|NCT01827384|155675163|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
48405487|NCT03136107|155675171|FG000|Overall Study|Other (Not specified)|1|||
48405488|NCT03313050|155675177|FG000|Stage 2: 12 Months|Adverse Event|0|||
48405489|NCT03313050|155675178|FG001|Stage 2: 12 Months|Adverse Event|0|||
48405490|NCT03313050|155675179|FG002|Stage 2: 12 Months|Adverse Event|0|||
48405491|NCT03313050|155675180|FG003|Stage 2: 12 Months|Adverse Event|1|||
48405492|NCT03313050|155675177|FG000|Stage 2: 12 Months|Death|0|||
48405493|NCT03313050|155675178|FG001|Stage 2: 12 Months|Death|0|||
48405494|NCT03313050|155675179|FG002|Stage 2: 12 Months|Death|3|||
48405495|NCT03313050|155675180|FG003|Stage 2: 12 Months|Death|0|||
48405496|NCT03313050|155675177|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
48405497|NCT03313050|155675178|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
48405498|NCT03313050|155675179|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
48405499|NCT03313050|155675180|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
48405500|NCT03313050|155675177|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
48405501|NCT03313050|155675178|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
48405502|NCT03313050|155675179|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
48405503|NCT03313050|155675180|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
48405504|NCT03313050|155675177|FG000|Stage 2: 12 Months|Protocol deviation|0|||
48405505|NCT03313050|155675178|FG001|Stage 2: 12 Months|Protocol deviation|0|||
48405506|NCT03313050|155675179|FG002|Stage 2: 12 Months|Protocol deviation|7|||
48405507|NCT03313050|155675180|FG003|Stage 2: 12 Months|Protocol deviation|7|||
48405508|NCT03313050|155675177|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
48405509|NCT03313050|155675178|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
48405510|NCT03313050|155675179|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
48405511|NCT03313050|155675180|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
48405512|NCT03313050|155675177|FG000|Stage 2: 12 Months|Other|0|||
48405513|NCT03313050|155675178|FG001|Stage 2: 12 Months|Other|0|||
48405514|NCT03313050|155675179|FG002|Stage 2: 12 Months|Other|0|||
48405515|NCT03313050|155675180|FG003|Stage 2: 12 Months|Other|1|||
48405516|NCT01291017|155675181|FG000|Overall Study|Lost to Follow-up|2|||
48405517|NCT01291017|155675181|FG000|Overall Study|Withdrawal by Subject|3|||
48405518|NCT02847598|155675182|FG000|Overall Study|Adverse Event|0|||
48405519|NCT02847598|155675183|FG001|Overall Study|Adverse Event|0|||
48405520|NCT02847598|155675184|FG002|Overall Study|Adverse Event|0|||
48405521|NCT02847598|155675185|FG003|Overall Study|Adverse Event|0|||
48405522|NCT02847598|155675186|FG004|Overall Study|Adverse Event|0|||
48405523|NCT02847598|155675187|FG005|Overall Study|Adverse Event|0|||
48405524|NCT02847598|155675188|FG006|Overall Study|Adverse Event|0|||
48405525|NCT02847598|155675189|FG007|Overall Study|Adverse Event|1|||
48405526|NCT02847598|155675182|FG000|Overall Study|Consent withdrawn|2|||
48405527|NCT02847598|155675183|FG001|Overall Study|Consent withdrawn|0|||
48405528|NCT02847598|155675184|FG002|Overall Study|Consent withdrawn|0|||
48405529|NCT02847598|155675185|FG003|Overall Study|Consent withdrawn|4|||
48405530|NCT02847598|155675186|FG004|Overall Study|Consent withdrawn|3|||
48405531|NCT02847598|155675187|FG005|Overall Study|Consent withdrawn|2|||
48405532|NCT02847598|155675188|FG006|Overall Study|Consent withdrawn|1|||
48405533|NCT02847598|155675189|FG007|Overall Study|Consent withdrawn|3|||
48405534|NCT02847598|155675182|FG000|Overall Study|Death|3|||
48405535|NCT02847598|155675183|FG001|Overall Study|Death|0|||
48405536|NCT02847598|155675184|FG002|Overall Study|Death|0|||
48405537|NCT02847598|155675185|FG003|Overall Study|Death|0|||
48405538|NCT02847598|155675186|FG004|Overall Study|Death|0|||
48405539|NCT02847598|155675187|FG005|Overall Study|Death|0|||
48405540|NCT02847598|155675188|FG006|Overall Study|Death|0|||
48405541|NCT02847598|155675189|FG007|Overall Study|Death|0|||
48405542|NCT02847598|155675182|FG000|Overall Study|Lost to Follow-up|0|||
48405543|NCT02847598|155675183|FG001|Overall Study|Lost to Follow-up|0|||
48405544|NCT02847598|155675184|FG002|Overall Study|Lost to Follow-up|0|||
48405545|NCT02847598|155675185|FG003|Overall Study|Lost to Follow-up|0|||
48405546|NCT02847598|155675186|FG004|Overall Study|Lost to Follow-up|0|||
48405547|NCT02847598|155675187|FG005|Overall Study|Lost to Follow-up|1|||
48405548|NCT02847598|155675188|FG006|Overall Study|Lost to Follow-up|1|||
48405549|NCT02847598|155675189|FG007|Overall Study|Lost to Follow-up|0|||
48405550|NCT01916980|155676570|FG000|Overall Study|Adverse Event|4|||
48405551|NCT01916980|155676571|FG001|Overall Study|Adverse Event|2|||
48405552|NCT01916980|155676570|FG000|Overall Study|Lack of Efficacy|2|||
48405553|NCT01916980|155676571|FG001|Overall Study|Lack of Efficacy|2|||
48405554|NCT01916980|155676570|FG000|Overall Study|Withdrawal by Subject|1|||
48405555|NCT01916980|155676571|FG001|Overall Study|Withdrawal by Subject|0|||
48405556|NCT00568555|155676572|FG000|Overall Study|Withdrawal by Subject|1|||
48405557|NCT00568555|155676573|FG001|Overall Study|Withdrawal by Subject|1|||
48587170|NCT02685072|156341608|FG000|Treatment Period|Lost to Follow-up|12|||
48587171|NCT02685072|156341609|FG001|Treatment Period|Lost to Follow-up|6|||
48587172|NCT02685072|156341608|FG000|Treatment Period|Withdrawal by Subject|1|||
48587173|NCT02685072|156341609|FG001|Treatment Period|Withdrawal by Subject|3|||
48587174|NCT02685072|156341608|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
48587175|NCT02685072|156341609|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
48587176|NCT01907217|156341610|FG000|Overall Study|Withdrawal by Subject|0|||
48587177|NCT01907217|156341611|FG001|Overall Study|Withdrawal by Subject|2|||
48587178|NCT01810783|156343150|FG000|Overall Study|Adverse Event|32|||
48587179|NCT01810783|156343150|FG000|Overall Study|Withdrawal by Subject|22|||
48587180|NCT01810783|156343150|FG000|Overall Study|Lack of Efficacy|12|||
48587181|NCT01810783|156343150|FG000|Overall Study|Lost to Follow-up|10|||
48587182|NCT01810783|156343150|FG000|Overall Study|Protocol Violation|5|||
48587183|NCT01810783|156343150|FG000|Overall Study|Non-compliance with IMP|4|||
48405573|NCT00618748|155676584|FG000|Overall Study|Adverse Event|4|||
48405574|NCT00618748|155676585|FG001|Overall Study|Adverse Event|3|||
48405575|NCT00618748|155676586|FG002|Overall Study|Adverse Event|8|||
48405576|NCT00618748|155676584|FG000|Overall Study|Physician Decision|3|||
48405577|NCT00618748|155676585|FG001|Overall Study|Physician Decision|1|||
48405578|NCT00618748|155676586|FG002|Overall Study|Physician Decision|1|||
48405579|NCT00618748|155676584|FG000|Overall Study|Withdrawal by Subject|4|||
48405580|NCT00618748|155676585|FG001|Overall Study|Withdrawal by Subject|1|||
48405581|NCT00618748|155676586|FG002|Overall Study|Withdrawal by Subject|5|||
48405582|NCT00860158|155676587|FG000|Overall Study|Study Terminated|1|||
48405583|NCT00200850|155676588|FG000|Overall Study|relocation|1|||
48405584|NCT00200850|155676589|FG001|Overall Study|relocation|0|||
48405585|NCT00200850|155676590|FG002|Overall Study|relocation|1|||
48405586|NCT00200850|155676588|FG000|Overall Study|too busy|1|||
48405587|NCT00200850|155676589|FG001|Overall Study|too busy|0|||
48405588|NCT00200850|155676590|FG002|Overall Study|too busy|0|||
48405589|NCT00200850|155676588|FG000|Overall Study|Pregnancy|0|||
48405590|NCT00200850|155676589|FG001|Overall Study|Pregnancy|0|||
48405591|NCT00200850|155676590|FG002|Overall Study|Pregnancy|1|||
48405592|NCT00200850|155676588|FG000|Overall Study|Poor adherence|0|||
48405593|NCT00200850|155676589|FG001|Overall Study|Poor adherence|0|||
48405594|NCT00200850|155676590|FG002|Overall Study|Poor adherence|1|||
48405595|NCT00200850|155676588|FG000|Overall Study|optic neuritis|0|||
48405596|NCT00200850|155676589|FG001|Overall Study|optic neuritis|0|||
48405597|NCT00200850|155676590|FG002|Overall Study|optic neuritis|1|||
48405598|NCT00200850|155676588|FG000|Overall Study|Adverse Event|1|||
48405599|NCT00200850|155676589|FG001|Overall Study|Adverse Event|1|||
48405600|NCT00200850|155676590|FG002|Overall Study|Adverse Event|2|||
48405601|NCT01449708|155676591|FG000|Overall Study|Protocol Violation|0|||
48405602|NCT01449708|155676592|FG001|Overall Study|Protocol Violation|1|||
48405603|NCT01449708|155676591|FG000|Overall Study|surgical complication|1|||
48405604|NCT01449708|155676592|FG001|Overall Study|surgical complication|2|||
48405605|NCT01449708|155676591|FG000|Overall Study|respiratory failure|1|||
48405606|NCT01449708|155676592|FG001|Overall Study|respiratory failure|0|||
48405607|NCT04162210|155676593|FG000|Overall Study|Lost to Follow-up|4|||
48405608|NCT04162210|155676594|FG001|Overall Study|Lost to Follow-up|1|||
48405609|NCT04162210|155676593|FG000|Overall Study|Withdrawal by Subject|17|||
48405610|NCT04162210|155676594|FG001|Overall Study|Withdrawal by Subject|9|||
48405611|NCT04162210|155676593|FG000|Overall Study|Ongoing|113|||
48405612|NCT04162210|155676594|FG001|Overall Study|Ongoing|59|||
48405613|NCT03980938|155676597|FG000|Treatment Period 1|Study Terminated|1|||
48405614|NCT03980938|155676598|FG001|Treatment Period 1|Study Terminated|1|||
48405615|NCT03980938|155676597|FG000|Treatment Period 2|Study Terminated|2|||
48405616|NCT03980938|155676598|FG001|Treatment Period 2|Study Terminated|2|||
48405617|NCT02118792|155676599|FG000|Overall Study|Withdrawal by Subject|6|||
48405618|NCT02118792|155676600|FG001|Overall Study|Withdrawal by Subject|3|||
48405619|NCT02118792|155676599|FG000|Overall Study|Lost to Follow-up|4|||
48405620|NCT02118792|155676600|FG001|Overall Study|Lost to Follow-up|4|||
48405621|NCT02118792|155676599|FG000|Overall Study|Adverse Event|5|||
48405622|NCT02118792|155676600|FG001|Overall Study|Adverse Event|4|||
48405623|NCT02118792|155676599|FG000|Overall Study|Withdrawal by parent/guardian|14|||
48405624|NCT02118792|155676600|FG001|Overall Study|Withdrawal by parent/guardian|20|||
48405625|NCT02118792|155676599|FG000|Overall Study|Other|1|||
48405626|NCT02118792|155676600|FG001|Overall Study|Other|6|||
48405627|NCT02118792|155676599|FG000|Overall Study|Randomised but not treated|1|||
48405628|NCT02118792|155676600|FG001|Overall Study|Randomised but not treated|0|||
48405629|NCT02908880|155676601|FG000|Overall Study|Lost to Follow-up|4|||
48405630|NCT02908880|155676601|FG000|Overall Study|Explantation of the device|1|||
48405631|NCT02908880|155676601|FG000|Overall Study|Withdrawal by Subject|17|||
48405632|NCT02908880|155676601|FG000|Overall Study|Death|5|||
48405633|NCT00469612|155676602|FG000|Overall Study|Study terminated before data collected|2|||
48405634|NCT00469612|155676603|FG001|Overall Study|Study terminated before data collected|0|||
48405635|NCT01885000|155676604|FG000|Overall Study|Adverse Event|1|||
48405636|NCT01885000|155676605|FG001|Overall Study|Adverse Event|0|||
48405637|NCT01885000|155676604|FG000|Overall Study|Withdrawal by Subject|1|||
48405638|NCT01885000|155676605|FG001|Overall Study|Withdrawal by Subject|1|||
48405639|NCT01885000|155676604|FG000|Overall Study|Protocol Violation|0|||
48405640|NCT01885000|155676605|FG001|Overall Study|Protocol Violation|1|||
48405641|NCT03446885|155676607|FG000|Overall Study|Lost to Follow-up|1|||
48405642|NCT03446885|155676608|FG001|Overall Study|Lost to Follow-up|0|||
48405643|NCT03446885|155676607|FG000|Overall Study|Did not complete entire visit|1|||
48405644|NCT03446885|155676608|FG001|Overall Study|Did not complete entire visit|0|||
48405645|NCT01337973|155676609|FG000|Overall Study|Lost to Follow-up|2|||
48405646|NCT01337973|155676610|FG001|Overall Study|Lost to Follow-up|4|||
48405647|NCT01337973|155676611|FG002|Overall Study|Lost to Follow-up|3|||
48405648|NCT01337973|155676609|FG000|Overall Study|Death|1|||
48405649|NCT01337973|155676610|FG001|Overall Study|Death|2|||
48405650|NCT01337973|155676611|FG002|Overall Study|Death|1|||
48405651|NCT01337973|155676609|FG000|Overall Study|Withdrawal by Subject|10|||
48405652|NCT01337973|155676610|FG001|Overall Study|Withdrawal by Subject|8|||
48405653|NCT01337973|155676611|FG002|Overall Study|Withdrawal by Subject|4|||
48405654|NCT01337973|155676609|FG000|Overall Study|missing data on primary outcome|3|||
48405655|NCT01337973|155676610|FG001|Overall Study|missing data on primary outcome|1|||
48405656|NCT01337973|155676611|FG002|Overall Study|missing data on primary outcome|3|||
48405657|NCT04269395|155676613|FG000|Overall Study|Lost to Follow-up|1|||
48405658|NCT04269395|155676614|FG001|Overall Study|Lost to Follow-up|0|||
48405659|NCT04269395|155676613|FG000|Overall Study|Study terminated by Sponsor|13|||
48405660|NCT04269395|155676614|FG001|Overall Study|Study terminated by Sponsor|10|||
48405661|NCT00584233|155676615|FG000|Overall Study|Withdrawal by Subject|5|||
48405662|NCT00584233|155676615|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
48405663|NCT00159432|155676616|FG000|Overall Study|Adverse Event|1|||
48405664|NCT00159432|155676616|FG000|Overall Study|Death|1|||
48405665|NCT00159432|155676616|FG000|Overall Study|Lack of Efficacy|8|||
48405666|NCT00841763|155676619|FG000|Overall Study|Withdrawal by Subject|60|||
48405667|NCT00841763|155676620|FG001|Overall Study|Withdrawal by Subject|17|||
48405668|NCT00841763|155676621|FG002|Overall Study|Withdrawal by Subject|4|||
48405669|NCT00841763|155676622|FG003|Overall Study|Withdrawal by Subject|1|||
48405670|NCT00841763|155676619|FG000|Overall Study|Adverse Event|9|||
48405671|NCT00841763|155676620|FG001|Overall Study|Adverse Event|10|||
48405672|NCT00841763|155676621|FG002|Overall Study|Adverse Event|3|||
48405673|NCT00841763|155676622|FG003|Overall Study|Adverse Event|2|||
48357425|NCT00790400|155504872|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
48405674|NCT00841763|155676619|FG000|Overall Study|Lost to Follow-up|63|||
48405675|NCT00841763|155676620|FG001|Overall Study|Lost to Follow-up|25|||
48405676|NCT00841763|155676621|FG002|Overall Study|Lost to Follow-up|0|||
48405677|NCT00841763|155676622|FG003|Overall Study|Lost to Follow-up|0|||
48405678|NCT00841763|155676619|FG000|Overall Study|Protocol Violation|20|||
48405679|NCT00841763|155676620|FG001|Overall Study|Protocol Violation|3|||
48405680|NCT00841763|155676621|FG002|Overall Study|Protocol Violation|1|||
48405681|NCT00841763|155676622|FG003|Overall Study|Protocol Violation|0|||
48405682|NCT00841763|155676619|FG000|Overall Study|Administrative Reasons|3|||
48405683|NCT00841763|155676620|FG001|Overall Study|Administrative Reasons|1|||
48405684|NCT00841763|155676621|FG002|Overall Study|Administrative Reasons|0|||
48405685|NCT00841763|155676622|FG003|Overall Study|Administrative Reasons|0|||
48405686|NCT00841763|155676619|FG000|Overall Study|Unable to Classify|7|||
48405687|NCT00841763|155676620|FG001|Overall Study|Unable to Classify|1|||
48405688|NCT00841763|155676621|FG002|Overall Study|Unable to Classify|0|||
48405689|NCT00841763|155676622|FG003|Overall Study|Unable to Classify|0|||
48405690|NCT01764633|155676623|FG000|Overall Study|Withdrawal by Subject|105|||
48405691|NCT01764633|155676624|FG001|Overall Study|Withdrawal by Subject|88|||
48405692|NCT01764633|155676623|FG000|Overall Study|Lost to Follow-up|13|||
48405693|NCT01764633|155676624|FG001|Overall Study|Lost to Follow-up|5|||
48405694|NCT01441063|155676625|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
48405695|NCT01441063|155676625|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
48405696|NCT00493038|155676626|FG000|Treatment|Adverse Event|8|||
48405697|NCT00493038|155676627|FG001|Treatment|Adverse Event|4|||
48405698|NCT00493038|155676626|FG000|Treatment|Lost to Follow-up|5|||
48405699|NCT00493038|155676627|FG001|Treatment|Lost to Follow-up|3|||
48405700|NCT00493038|155676626|FG000|Treatment|Withdrawal by Subject|11|||
48405701|NCT00493038|155676627|FG001|Treatment|Withdrawal by Subject|12|||
48405702|NCT00493038|155676626|FG000|Treatment|Other|0|||
48405703|NCT00493038|155676627|FG001|Treatment|Other|1|||
48405704|NCT00493038|155676626|FG000|Follow-up|Lost to Follow-up|1|||
48405705|NCT00493038|155676627|FG001|Follow-up|Lost to Follow-up|0|||
48405706|NCT00704964|155676628|FG000|Overall Study|Not completed on time|328|||
48405707|NCT02161562|155676629|FG000|Overall Study|Withdrawal by Subject|5|||
48405708|NCT02161562|155676630|FG001|Overall Study|Withdrawal by Subject|8|||
48405709|NCT02161562|155676629|FG000|Overall Study|Protocol Violation|9|||
48405710|NCT02161562|155676630|FG001|Overall Study|Protocol Violation|4|||
48405711|NCT02161562|155676629|FG000|Overall Study|Pregnancy|1|||
48405712|NCT02161562|155676630|FG001|Overall Study|Pregnancy|2|||
48405713|NCT02161562|155676629|FG000|Overall Study|Lost to Follow-up|3|||
48405714|NCT02161562|155676630|FG001|Overall Study|Lost to Follow-up|1|||
48405715|NCT02161562|155676629|FG000|Overall Study|Lack of Efficacy|4|||
48405716|NCT02161562|155676630|FG001|Overall Study|Lack of Efficacy|1|||
48405717|NCT02161562|155676629|FG000|Overall Study|Adverse Event|1|||
48405718|NCT02161562|155676630|FG001|Overall Study|Adverse Event|1|||
48405719|NCT02161562|155676629|FG000|Overall Study|Participant moved back to home country|1|||
48405720|NCT02161562|155676630|FG001|Overall Study|Participant moved back to home country|0|||
48405721|NCT02161562|155676629|FG000|Overall Study|Withdrew due to being out of the country|1|||
48405722|NCT02161562|155676630|FG001|Overall Study|Withdrew due to being out of the country|0|||
48405723|NCT02161562|155676629|FG000|Overall Study|Participant moved out of province|1|||
48405724|NCT02161562|155676630|FG001|Overall Study|Participant moved out of province|0|||
48405725|NCT04607733|155676635|FG000|Overall Study|Lost to Follow-up|1|||
48405726|NCT04607733|155676636|FG001|Overall Study|Lost to Follow-up|0|||
48405727|NCT04607733|155676637|FG002|Overall Study|Lost to Follow-up|0|||
48405728|NCT04607733|155676638|FG003|Overall Study|Lost to Follow-up|1|||
48405729|NCT04607733|155676639|FG004|Overall Study|Lost to Follow-up|1|||
48405730|NCT04607733|155676640|FG005|Overall Study|Lost to Follow-up|0|||
48405731|NCT04607733|155676635|FG000|Overall Study|Withdrawal by Subject|0|||
48405732|NCT04607733|155676636|FG001|Overall Study|Withdrawal by Subject|0|||
48405733|NCT04607733|155676637|FG002|Overall Study|Withdrawal by Subject|0|||
48405734|NCT04607733|155676638|FG003|Overall Study|Withdrawal by Subject|0|||
48405735|NCT04607733|155676639|FG004|Overall Study|Withdrawal by Subject|1|||
48405736|NCT04607733|155676640|FG005|Overall Study|Withdrawal by Subject|0|||
48405737|NCT00577993|155676641|FG000|Overall Study|Adverse Event|1|||
48405738|NCT00577993|155676642|FG001|Overall Study|Adverse Event|0|||
48405739|NCT00577993|155676643|FG002|Overall Study|Adverse Event|0|||
48405740|NCT00577993|155676641|FG000|Overall Study|Death|0|||
48405741|NCT00577993|155676642|FG001|Overall Study|Death|1|||
48405742|NCT00577993|155676643|FG002|Overall Study|Death|1|||
48405743|NCT00577993|155676641|FG000|Overall Study|Lack of Efficacy|0|||
48405744|NCT00577993|155676642|FG001|Overall Study|Lack of Efficacy|1|||
48405745|NCT00577993|155676643|FG002|Overall Study|Lack of Efficacy|0|||
48405746|NCT00577993|155676641|FG000|Overall Study|Protocol Violation|2|||
48405747|NCT00577993|155676642|FG001|Overall Study|Protocol Violation|3|||
48405748|NCT00577993|155676643|FG002|Overall Study|Protocol Violation|0|||
48405749|NCT00577993|155676641|FG000|Overall Study|Withdrawal by Subject|1|||
48405750|NCT00577993|155676642|FG001|Overall Study|Withdrawal by Subject|0|||
48405751|NCT00577993|155676643|FG002|Overall Study|Withdrawal by Subject|2|||
48405752|NCT00577993|155676641|FG000|Overall Study|Conversion|2|||
48405753|NCT00577993|155676642|FG001|Overall Study|Conversion|5|||
48405754|NCT00577993|155676643|FG002|Overall Study|Conversion|0|||
48405755|NCT00577993|155676641|FG000|Overall Study|Uninsured|1|||
48405756|NCT00577993|155676642|FG001|Overall Study|Uninsured|0|||
48405757|NCT00577993|155676643|FG002|Overall Study|Uninsured|0|||
48405758|NCT03683394|155676648|FG000|Overall Study|Withdrawal by Subject|4|||
48405759|NCT03683394|155676649|FG001|Overall Study|Withdrawal by Subject|8|||
48405760|NCT03683394|155676648|FG000|Overall Study|Lost to Follow-up|7|||
48405761|NCT03683394|155676649|FG001|Overall Study|Lost to Follow-up|0|||
48405762|NCT03683394|155676648|FG000|Overall Study|Death|3|||
48405763|NCT03683394|155676649|FG001|Overall Study|Death|1|||
48405764|NCT00441545|155676650|FG000|First Intervention|Adverse Event|6|||
48405765|NCT00441545|155676651|FG001|First Intervention|Adverse Event|5|||
48405766|NCT00441545|155676650|FG000|First Intervention|Protocol Violation|2|||
48405767|NCT00441545|155676651|FG001|First Intervention|Protocol Violation|2|||
48405768|NCT00441545|155676650|FG000|First Intervention|Withdrawal by Subject|3|||
48405769|NCT00441545|155676651|FG001|First Intervention|Withdrawal by Subject|3|||
48405770|NCT00441545|155676650|FG000|First Intervention|Kidney transplant|1|||
48405771|NCT00441545|155676651|FG001|First Intervention|Kidney transplant|1|||
48405772|NCT00441545|155676650|FG000|First Intervention|Lack of Efficacy|2|||
48405773|NCT00441545|155676651|FG001|First Intervention|Lack of Efficacy|0|||
48405774|NCT00441545|155676650|FG000|First Intervention|Subject exceeded safety criteria|0|||
48405775|NCT00441545|155676651|FG001|First Intervention|Subject exceeded safety criteria|1|||
48405776|NCT00441545|155676650|FG000|First Intervention|Subject met an exclusionary criteria|1|||
48405777|NCT00441545|155676651|FG001|First Intervention|Subject met an exclusionary criteria|0|||
48405778|NCT00441545|155676650|FG000|First Intervention|Extended hospitalization|1|||
48405779|NCT00441545|155676651|FG001|First Intervention|Extended hospitalization|0|||
48405780|NCT00441545|155676650|FG000|First Intervention|Site error|1|||
48405781|NCT00441545|155676651|FG001|First Intervention|Site error|0|||
48405782|NCT00441545|155676650|FG000|First Intervention|Sponsor's request|1|||
48405783|NCT00441545|155676651|FG001|First Intervention|Sponsor's request|0|||
48405784|NCT00441545|155676650|FG000|Second Intervention|Adverse Event|5|||
48405785|NCT00441545|155676651|FG001|Second Intervention|Adverse Event|2|||
48405786|NCT00441545|155676650|FG000|Second Intervention|Protocol Violation|4|||
48405787|NCT00441545|155676651|FG001|Second Intervention|Protocol Violation|1|||
48405788|NCT00441545|155676650|FG000|Second Intervention|Withdrawal by Subject|1|||
48405789|NCT00441545|155676651|FG001|Second Intervention|Withdrawal by Subject|1|||
48405790|NCT00441545|155676650|FG000|Second Intervention|Kidney Transplant|1|||
48405791|NCT00441545|155676651|FG001|Second Intervention|Kidney Transplant|1|||
48405792|NCT00441545|155676650|FG000|Second Intervention|Lack of Efficacy|0|||
48405793|NCT00441545|155676651|FG001|Second Intervention|Lack of Efficacy|1|||
48405794|NCT00441545|155676650|FG000|Second Intervention|Subject exceeded safety criteria|1|||
48405795|NCT00441545|155676651|FG001|Second Intervention|Subject exceeded safety criteria|0|||
48405796|NCT00441545|155676650|FG000|Second Intervention|Subject moved|0|||
48405797|NCT00441545|155676651|FG001|Second Intervention|Subject moved|1|||
48405798|NCT00706030|155676653|FG000|Overall Study|Disease Progression|4|||
48405799|NCT00706030|155676654|FG001|Overall Study|Disease Progression|6|||
48405800|NCT00706030|155676655|FG002|Overall Study|Disease Progression|46|||
48405801|NCT00706030|155676656|FG003|Overall Study|Disease Progression|12|||
48405802|NCT00706030|155676653|FG000|Overall Study|Adverse Event|1|||
48405803|NCT00706030|155676654|FG001|Overall Study|Adverse Event|0|||
48405804|NCT00706030|155676655|FG002|Overall Study|Adverse Event|4|||
48405805|NCT00706030|155676656|FG003|Overall Study|Adverse Event|2|||
48405806|NCT00706030|155676653|FG000|Overall Study|Withdrawal by Subject|1|||
48405807|NCT00706030|155676654|FG001|Overall Study|Withdrawal by Subject|0|||
48405808|NCT00706030|155676655|FG002|Overall Study|Withdrawal by Subject|2|||
48405809|NCT00706030|155676656|FG003|Overall Study|Withdrawal by Subject|0|||
48405810|NCT00706030|155676653|FG000|Overall Study|Physician Decision|0|||
48405811|NCT00706030|155676654|FG001|Overall Study|Physician Decision|0|||
48405812|NCT00706030|155676655|FG002|Overall Study|Physician Decision|2|||
48405813|NCT00706030|155676656|FG003|Overall Study|Physician Decision|0|||
48405814|NCT00706030|155676653|FG000|Overall Study|Not recorded|0|||
48405815|NCT00706030|155676654|FG001|Overall Study|Not recorded|0|||
48405816|NCT00706030|155676655|FG002|Overall Study|Not recorded|2|||
48405817|NCT00706030|155676656|FG003|Overall Study|Not recorded|0|||
48405818|NCT00706030|155676653|FG000|Overall Study|Protocol Violation|0|||
48405819|NCT00706030|155676654|FG001|Overall Study|Protocol Violation|0|||
48405820|NCT00706030|155676655|FG002|Overall Study|Protocol Violation|1|||
48405821|NCT00706030|155676656|FG003|Overall Study|Protocol Violation|1|||
48405822|NCT00706030|155676653|FG000|Overall Study|Failed to return|0|||
48405823|NCT00706030|155676654|FG001|Overall Study|Failed to return|0|||
48405824|NCT00706030|155676655|FG002|Overall Study|Failed to return|1|||
48405825|NCT00706030|155676656|FG003|Overall Study|Failed to return|0|||
48405826|NCT00706030|155676653|FG000|Overall Study|Symptomatic Deterioration|0|||
48405827|NCT00706030|155676654|FG001|Overall Study|Symptomatic Deterioration|0|||
48405828|NCT00706030|155676655|FG002|Overall Study|Symptomatic Deterioration|1|||
48405829|NCT00706030|155676656|FG003|Overall Study|Symptomatic Deterioration|0|||
48405830|NCT00706030|155676653|FG000|Overall Study|No treatment received|0|||
48405831|NCT00706030|155676654|FG001|Overall Study|No treatment received|0|||
48405832|NCT00706030|155676655|FG002|Overall Study|No treatment received|0|||
48405833|NCT00706030|155676656|FG003|Overall Study|No treatment received|1|||
48405834|NCT00706030|155676653|FG000|Overall Study|Death|0|||
48405835|NCT00706030|155676654|FG001|Overall Study|Death|0|||
48405836|NCT00706030|155676655|FG002|Overall Study|Death|1|||
48405837|NCT00706030|155676656|FG003|Overall Study|Death|0|||
48405838|NCT02058147|155676660|FG000|Overall Study|Randomized but not treated|0|||
48405839|NCT02058147|155676661|FG001|Overall Study|Randomized but not treated|0|||
48405840|NCT02058147|155676662|FG002|Overall Study|Randomized but not treated|1|||
48405841|NCT02058147|155676660|FG000|Overall Study|Adverse Event|12|||
48405842|NCT02058147|155676661|FG001|Overall Study|Adverse Event|9|||
48405843|NCT02058147|155676662|FG002|Overall Study|Adverse Event|21|||
48405844|NCT02058147|155676660|FG000|Overall Study|Lack of Efficacy|1|||
48405845|NCT02058147|155676661|FG001|Overall Study|Lack of Efficacy|0|||
48405846|NCT02058147|155676662|FG002|Overall Study|Lack of Efficacy|3|||
48405847|NCT02058147|155676660|FG000|Overall Study|Poor compliance to protocol|8|||
48405848|NCT02058147|155676661|FG001|Overall Study|Poor compliance to protocol|9|||
48405849|NCT02058147|155676662|FG002|Overall Study|Poor compliance to protocol|4|||
48405850|NCT02058147|155676660|FG000|Overall Study|Other than specified|8|||
48405851|NCT02058147|155676661|FG001|Overall Study|Other than specified|9|||
48405852|NCT02058147|155676662|FG002|Overall Study|Other than specified|0|||
48405853|NCT02471716|155676667|FG000|Overall Study|Withdrawal by Subject|0|||
48405854|NCT02471716|155676668|FG001|Overall Study|Withdrawal by Subject|1|||
48405855|NCT02471716|155676669|FG002|Overall Study|Withdrawal by Subject|0|||
48405856|NCT02471716|155676670|FG003|Overall Study|Withdrawal by Subject|2|||
48405857|NCT02471716|155676671|FG004|Overall Study|Withdrawal by Subject|5|||
48405858|NCT02471716|155676667|FG000|Overall Study|Study Terminiated by sponsor|0|||
48405859|NCT02471716|155676668|FG001|Overall Study|Study Terminiated by sponsor|0|||
48405860|NCT02471716|155676669|FG002|Overall Study|Study Terminiated by sponsor|0|||
48405861|NCT02471716|155676670|FG003|Overall Study|Study Terminiated by sponsor|1|||
48405862|NCT02471716|155676671|FG004|Overall Study|Study Terminiated by sponsor|0|||
48405863|NCT02471716|155676667|FG000|Overall Study|Lost to Follow-up|0|||
48405864|NCT02471716|155676668|FG001|Overall Study|Lost to Follow-up|0|||
48405865|NCT02471716|155676669|FG002|Overall Study|Lost to Follow-up|0|||
48405866|NCT02471716|155676670|FG003|Overall Study|Lost to Follow-up|3|||
48405867|NCT02471716|155676671|FG004|Overall Study|Lost to Follow-up|2|||
48405868|NCT02471716|155676667|FG000|Overall Study|Death|0|||
48405869|NCT02471716|155676668|FG001|Overall Study|Death|0|||
48405870|NCT02471716|155676669|FG002|Overall Study|Death|0|||
48405871|NCT02471716|155676670|FG003|Overall Study|Death|1|||
48405872|NCT02471716|155676671|FG004|Overall Study|Death|0|||
48405873|NCT02471716|155676667|FG000|Overall Study|Other|0|||
48405874|NCT02471716|155676668|FG001|Overall Study|Other|0|||
48405875|NCT02471716|155676669|FG002|Overall Study|Other|0|||
48405876|NCT02471716|155676670|FG003|Overall Study|Other|8|||
48405877|NCT02471716|155676671|FG004|Overall Study|Other|9|||
48405878|NCT00130286|155676672|FG000|Overall Study|Withdrawal by Subject|0|||
48405879|NCT00130286|155676673|FG001|Overall Study|Withdrawal by Subject|1|||
48405880|NCT00130286|155676674|FG002|Overall Study|Withdrawal by Subject|2|||
48405881|NCT00130286|155676675|FG003|Overall Study|Withdrawal by Subject|2|||
48405882|NCT00130286|155676672|FG000|Overall Study|Adverse Event|0|||
48405883|NCT00130286|155676673|FG001|Overall Study|Adverse Event|0|||
48405884|NCT00130286|155676674|FG002|Overall Study|Adverse Event|2|||
48405885|NCT00130286|155676675|FG003|Overall Study|Adverse Event|0|||
48405886|NCT00130286|155676672|FG000|Overall Study|Missing lab specimens|0|||
48405887|NCT00130286|155676673|FG001|Overall Study|Missing lab specimens|2|||
48405888|NCT00130286|155676674|FG002|Overall Study|Missing lab specimens|0|||
48405889|NCT00130286|155676675|FG003|Overall Study|Missing lab specimens|0|||
48405890|NCT02665286|155676687|FG000|Overall Study|Lost to Follow-up|3|||
48405891|NCT02665286|155676688|FG001|Overall Study|Lost to Follow-up|2|||
48405892|NCT02665286|155676689|FG002|Overall Study|Lost to Follow-up|1|||
48405893|NCT01818297|155676699|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
48405894|NCT01818297|155676700|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
48405895|NCT01818297|155676699|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
48405896|NCT01818297|155676700|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
48405897|NCT01818297|155676699|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
48405898|NCT01818297|155676700|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
48405899|NCT00854828|155676701|FG000|Overall Study|Death|1|||
48405900|NCT00854828|155676702|FG001|Overall Study|Death|0|||
48405901|NCT00854828|155676703|FG002|Overall Study|Death|0|||
48405902|NCT00854828|155676704|FG003|Overall Study|Death|0|||
48405903|NCT00854828|155676701|FG000|Overall Study|Withdrawal by Subject|1|||
48405904|NCT00854828|155676702|FG001|Overall Study|Withdrawal by Subject|1|||
48405905|NCT00854828|155676703|FG002|Overall Study|Withdrawal by Subject|0|||
48405906|NCT00854828|155676704|FG003|Overall Study|Withdrawal by Subject|9|||
48405907|NCT00854828|155676701|FG000|Overall Study|Missed 24mo visit|1|||
48405908|NCT00854828|155676702|FG001|Overall Study|Missed 24mo visit|1|||
48405909|NCT00854828|155676703|FG002|Overall Study|Missed 24mo visit|8|||
48405910|NCT00854828|155676704|FG003|Overall Study|Missed 24mo visit|8|||
48405911|NCT01931059|155676705|FG000|Day 1|Pregnancy|0|||
48405912|NCT01931059|155676706|FG001|Day 1|Pregnancy|1|||
48405913|NCT01931059|155676705|FG000|Day3|Lost to Follow-up|1|||
48405914|NCT01931059|155676706|FG001|Day3|Lost to Follow-up|0|||
48796734|NCT00698646|157093781|FG001|Overall Study|Adverse Event|7|||
48796735|NCT00698646|157093782|FG002|Overall Study|Adverse Event|8|||
48796736|NCT00698646|157093780|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
48796737|NCT00698646|157093781|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
48796738|NCT00698646|157093782|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
48796739|NCT00698646|157093780|FG000|Overall Study|Protocol Deviation|6|||
48796740|NCT00698646|157093781|FG001|Overall Study|Protocol Deviation|2|||
48796741|NCT00698646|157093782|FG002|Overall Study|Protocol Deviation|3|||
48796742|NCT00698646|157093780|FG000|Overall Study|Withdrawal by Subject|10|||
48796743|NCT00698646|157093781|FG001|Overall Study|Withdrawal by Subject|11|||
48796744|NCT00698646|157093782|FG002|Overall Study|Withdrawal by Subject|8|||
48796745|NCT00698646|157093780|FG000|Overall Study|Lost to Follow-up|0|||
48796746|NCT00698646|157093781|FG001|Overall Study|Lost to Follow-up|0|||
48796747|NCT00698646|157093782|FG002|Overall Study|Lost to Follow-up|2|||
48796748|NCT00698646|157093780|FG000|Overall Study|Administrative problems|1|||
48796749|NCT00698646|157093781|FG001|Overall Study|Administrative problems|0|||
48796750|NCT00698646|157093782|FG002|Overall Study|Administrative problems|1|||
48796751|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
48796752|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
48796753|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
48796754|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
48405915|NCT01015833|155676707|FG000|Overall Study|Death|1|||
48405916|NCT01015833|155676708|FG001|Overall Study|Death|0|||
48405917|NCT01015833|155676707|FG000|Overall Study|Withdrawal by Subject|3|||
48405918|NCT01015833|155676708|FG001|Overall Study|Withdrawal by Subject|2|||
48796755|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
48796756|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
48796757|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
48796758|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
48796759|NCT02332590|157093783|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
48796760|NCT02332590|157093784|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
48796761|NCT02332590|157093783|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
48796762|NCT02332590|157093784|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
48796763|NCT02332590|157093783|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
48796764|NCT02332590|157093784|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
48796765|NCT02332590|157093783|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
48796766|NCT02332590|157093784|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
48796767|NCT02332590|157093783|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
48796768|NCT02332590|157093784|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
48796769|NCT00981084|157093792|FG000|Post Intervention (Data Analysis)|poor effort|1|||
48796770|NCT00981084|157093793|FG001|Post Intervention (Data Analysis)|poor effort|1|||
48796771|NCT00981084|157093792|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
48796772|NCT00981084|157093793|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
48796773|NCT01112579|157093794|FG000|Overall Study|Missed Visit|1|||
48796774|NCT01112579|157093795|FG001|Overall Study|Missed Visit|1|||
48796775|NCT01112579|157093794|FG000|Overall Study|Death|0|||
48796776|NCT01112579|157093795|FG001|Overall Study|Death|2|||
48796777|NCT01951625|157093798|FG000|Treatment Period|Protocol Violation|2|||
48796778|NCT01951625|157093799|FG001|Treatment Period|Protocol Violation|0|||
48796779|NCT01951625|157093800|FG002|Treatment Period|Protocol Violation|1|||
48796780|NCT01951625|157093801|FG003|Treatment Period|Protocol Violation|3|||
48796781|NCT01951625|157093802|FG004|Treatment Period|Protocol Violation|2|||
48796782|NCT01951625|157093798|FG000|Treatment Period|Physician Decision|0|||
48796783|NCT01951625|157093799|FG001|Treatment Period|Physician Decision|0|||
48796784|NCT01951625|157093800|FG002|Treatment Period|Physician Decision|0|||
48796785|NCT01951625|157093801|FG003|Treatment Period|Physician Decision|0|||
48796786|NCT01951625|157093802|FG004|Treatment Period|Physician Decision|1|||
48796787|NCT01951625|157093798|FG000|Treatment Period|Protocol driven decision point|0|||
48796788|NCT01951625|157093799|FG001|Treatment Period|Protocol driven decision point|5|||
48796789|NCT01951625|157093800|FG002|Treatment Period|Protocol driven decision point|0|||
48796790|NCT01951625|157093801|FG003|Treatment Period|Protocol driven decision point|2|||
48796791|NCT01951625|157093802|FG004|Treatment Period|Protocol driven decision point|1|||
48796792|NCT01951625|157093798|FG000|Treatment Period|Non compliance with study drug|1|||
48796793|NCT01951625|157093799|FG001|Treatment Period|Non compliance with study drug|2|||
48796794|NCT01951625|157093800|FG002|Treatment Period|Non compliance with study drug|2|||
48796795|NCT01951625|157093801|FG003|Treatment Period|Non compliance with study drug|0|||
48796796|NCT01951625|157093802|FG004|Treatment Period|Non compliance with study drug|0|||
48796797|NCT01951625|157093798|FG000|Treatment Period|Death|3|||
48796798|NCT01951625|157093799|FG001|Treatment Period|Death|2|||
48796799|NCT01951625|157093800|FG002|Treatment Period|Death|2|||
48796800|NCT01951625|157093801|FG003|Treatment Period|Death|1|||
48796801|NCT01951625|157093802|FG004|Treatment Period|Death|2|||
48796802|NCT01951625|157093798|FG000|Treatment Period|Adverse Event|7|||
48796803|NCT01951625|157093799|FG001|Treatment Period|Adverse Event|10|||
48796804|NCT01951625|157093800|FG002|Treatment Period|Adverse Event|9|||
48796805|NCT01951625|157093801|FG003|Treatment Period|Adverse Event|8|||
48796806|NCT01951625|157093802|FG004|Treatment Period|Adverse Event|8|||
48796807|NCT01951625|157093798|FG000|Treatment Period|Withdrawal by Subject|5|||
48796808|NCT01951625|157093799|FG001|Treatment Period|Withdrawal by Subject|2|||
48796809|NCT01951625|157093800|FG002|Treatment Period|Withdrawal by Subject|1|||
48796810|NCT01951625|157093801|FG003|Treatment Period|Withdrawal by Subject|7|||
48796811|NCT01951625|157093802|FG004|Treatment Period|Withdrawal by Subject|3|||
48796812|NCT01951625|157093798|FG000|Treatment Period|Lost to Follow-up|1|||
48796813|NCT01951625|157093799|FG001|Treatment Period|Lost to Follow-up|0|||
48796814|NCT01951625|157093800|FG002|Treatment Period|Lost to Follow-up|0|||
48796815|NCT01951625|157093801|FG003|Treatment Period|Lost to Follow-up|1|||
48796816|NCT01951625|157093802|FG004|Treatment Period|Lost to Follow-up|0|||
48796817|NCT01951625|157093798|FG000|Follow Up Period|Non-compliance with study drug|1|||
48796818|NCT01951625|157093799|FG001|Follow Up Period|Non-compliance with study drug|0|||
48796819|NCT01951625|157093800|FG002|Follow Up Period|Non-compliance with study drug|0|||
48796820|NCT01951625|157093801|FG003|Follow Up Period|Non-compliance with study drug|0|||
48796821|NCT01951625|157093802|FG004|Follow Up Period|Non-compliance with study drug|0|||
48796822|NCT01951625|157093798|FG000|Follow Up Period|Death|1|||
48796823|NCT01951625|157093799|FG001|Follow Up Period|Death|3|||
48796824|NCT01951625|157093800|FG002|Follow Up Period|Death|2|||
48796825|NCT01951625|157093801|FG003|Follow Up Period|Death|2|||
48405919|NCT01015833|155676707|FG000|Overall Study|Adverse Event|0|||
48405920|NCT01015833|155676708|FG001|Overall Study|Adverse Event|1|||
48405921|NCT01015833|155676707|FG000|Overall Study|Physician Decision|2|||
48405922|NCT01015833|155676708|FG001|Overall Study|Physician Decision|0|||
48405923|NCT01015833|155676707|FG000|Overall Study|Symptomatic deterioration|0|||
48405924|NCT01015833|155676708|FG001|Overall Study|Symptomatic deterioration|1|||
48405925|NCT01015833|155676707|FG000|Overall Study|Other|5|||
48405926|NCT01015833|155676708|FG001|Overall Study|Other|1|||
48405927|NCT01015833|155676707|FG000|Overall Study|Motor Vehicle Accidents|1|||
48405928|NCT01015833|155676708|FG001|Overall Study|Motor Vehicle Accidents|0|||
48405929|NCT01015833|155676707|FG000|Overall Study|Did not start treatment|1|||
48405930|NCT01015833|155676708|FG001|Overall Study|Did not start treatment|0|||
48405931|NCT03308188|155676712|FG000|Overall Study|Withdrawal by Subject|0|||
48405932|NCT03308188|155676713|FG001|Overall Study|Withdrawal by Subject|3|||
48405933|NCT03308188|155676712|FG000|Overall Study|Death|0|||
48405934|NCT03308188|155676713|FG001|Overall Study|Death|1|||
48405935|NCT01791855|155676714|FG000|Overall Study|Adverse Event|0|||
48405936|NCT01791855|155676715|FG001|Overall Study|Adverse Event|0|||
48405937|NCT01791855|155676716|FG002|Overall Study|Adverse Event|0|||
48405938|NCT01791855|155676717|FG003|Overall Study|Adverse Event|1|||
48405939|NCT01791855|155676714|FG000|Overall Study|Randomized, not treated|0|||
48405940|NCT01791855|155676715|FG001|Overall Study|Randomized, not treated|1|||
48405941|NCT01791855|155676716|FG002|Overall Study|Randomized, not treated|0|||
48405942|NCT01791855|155676717|FG003|Overall Study|Randomized, not treated|0|||
48405943|NCT00481065|155676718|FG000|Overall Study|Adverse event or death|1|||
48405944|NCT00481065|155676719|FG001|Overall Study|Adverse event or death|1|||
48405945|NCT00481065|155676720|FG002|Overall Study|Adverse event or death|3|||
48405946|NCT00481065|155676721|FG003|Overall Study|Adverse event or death|0|||
48405947|NCT00481065|155676722|FG004|Overall Study|Adverse event or death|2|||
48405948|NCT00481065|155676723|FG005|Overall Study|Adverse event or death|0|||
48405949|NCT00481065|155676724|FG006|Overall Study|Adverse event or death|1|||
48405950|NCT00481065|155676725|FG007|Overall Study|Adverse event or death|1|||
48405951|NCT00481065|155676718|FG000|Overall Study|Withdrawal by Subject|11|||
48405952|NCT00481065|155676719|FG001|Overall Study|Withdrawal by Subject|12|||
48405953|NCT00481065|155676720|FG002|Overall Study|Withdrawal by Subject|7|||
48405954|NCT00481065|155676721|FG003|Overall Study|Withdrawal by Subject|11|||
48405955|NCT00481065|155676722|FG004|Overall Study|Withdrawal by Subject|13|||
48405956|NCT00481065|155676723|FG005|Overall Study|Withdrawal by Subject|12|||
48405957|NCT00481065|155676724|FG006|Overall Study|Withdrawal by Subject|9|||
48405958|NCT00481065|155676725|FG007|Overall Study|Withdrawal by Subject|10|||
48405959|NCT00481065|155676718|FG000|Overall Study|Lost to Follow-up|4|||
48405960|NCT00481065|155676719|FG001|Overall Study|Lost to Follow-up|2|||
48405961|NCT00481065|155676720|FG002|Overall Study|Lost to Follow-up|4|||
48405962|NCT00481065|155676721|FG003|Overall Study|Lost to Follow-up|3|||
48405963|NCT00481065|155676722|FG004|Overall Study|Lost to Follow-up|3|||
48405964|NCT00481065|155676723|FG005|Overall Study|Lost to Follow-up|3|||
48405965|NCT00481065|155676724|FG006|Overall Study|Lost to Follow-up|2|||
48405966|NCT00481065|155676725|FG007|Overall Study|Lost to Follow-up|5|||
48405967|NCT00481065|155676718|FG000|Overall Study|Inappropriate enrollment|4|||
48405968|NCT00481065|155676719|FG001|Overall Study|Inappropriate enrollment|0|||
48405969|NCT00481065|155676720|FG002|Overall Study|Inappropriate enrollment|2|||
48405970|NCT00481065|155676721|FG003|Overall Study|Inappropriate enrollment|0|||
48405971|NCT00481065|155676722|FG004|Overall Study|Inappropriate enrollment|2|||
48405972|NCT00481065|155676723|FG005|Overall Study|Inappropriate enrollment|1|||
48405973|NCT00481065|155676724|FG006|Overall Study|Inappropriate enrollment|0|||
48405974|NCT00481065|155676725|FG007|Overall Study|Inappropriate enrollment|1|||
48405975|NCT00481065|155676718|FG000|Overall Study|Administrative reason|0|||
48405976|NCT00481065|155676719|FG001|Overall Study|Administrative reason|0|||
48405977|NCT00481065|155676720|FG002|Overall Study|Administrative reason|0|||
48405978|NCT00481065|155676721|FG003|Overall Study|Administrative reason|0|||
48405979|NCT00481065|155676722|FG004|Overall Study|Administrative reason|0|||
48405980|NCT00481065|155676723|FG005|Overall Study|Administrative reason|2|||
48405981|NCT00481065|155676724|FG006|Overall Study|Administrative reason|1|||
48405982|NCT00481065|155676725|FG007|Overall Study|Administrative reason|0|||
48405983|NCT00481065|155676718|FG000|Overall Study|Protocol Violation|2|||
48405984|NCT00481065|155676719|FG001|Overall Study|Protocol Violation|1|||
48405985|NCT00481065|155676720|FG002|Overall Study|Protocol Violation|1|||
48405986|NCT00481065|155676721|FG003|Overall Study|Protocol Violation|1|||
48405987|NCT00481065|155676722|FG004|Overall Study|Protocol Violation|2|||
48405988|NCT00481065|155676723|FG005|Overall Study|Protocol Violation|6|||
48405989|NCT00481065|155676724|FG006|Overall Study|Protocol Violation|3|||
48405990|NCT00481065|155676725|FG007|Overall Study|Protocol Violation|2|||
48405991|NCT00481065|155676718|FG000|Overall Study|Unable to classify|0|||
48405992|NCT00481065|155676719|FG001|Overall Study|Unable to classify|1|||
48405993|NCT00481065|155676720|FG002|Overall Study|Unable to classify|2|||
48405994|NCT00481065|155676721|FG003|Overall Study|Unable to classify|0|||
48405995|NCT00481065|155676722|FG004|Overall Study|Unable to classify|1|||
48405996|NCT00481065|155676723|FG005|Overall Study|Unable to classify|0|||
48405997|NCT00481065|155676724|FG006|Overall Study|Unable to classify|0|||
48405998|NCT00481065|155676725|FG007|Overall Study|Unable to classify|0|||
48405999|NCT03887130|155676732|FG000|Overall Study|Progressive disease|23|||
48406000|NCT03887130|155676733|FG001|Overall Study|Progressive disease|14|||
48406001|NCT03887130|155676734|FG002|Overall Study|Progressive disease|7|||
48406002|NCT03887130|155676732|FG000|Overall Study|Protocol Violation|3|||
48406003|NCT03887130|155676733|FG001|Overall Study|Protocol Violation|1|||
48406004|NCT03887130|155676734|FG002|Overall Study|Protocol Violation|2|||
48406005|NCT03887130|155676732|FG000|Overall Study|Drug related toxicity|7|||
48406006|NCT03887130|155676733|FG001|Overall Study|Drug related toxicity|7|||
48406007|NCT03887130|155676734|FG002|Overall Study|Drug related toxicity|13|||
48406008|NCT03887130|155676732|FG000|Overall Study|Non drug related toxicity|3|||
48406009|NCT03887130|155676733|FG001|Overall Study|Non drug related toxicity|0|||
48406010|NCT03887130|155676734|FG002|Overall Study|Non drug related toxicity|0|||
48406011|NCT03887130|155676732|FG000|Overall Study|Death|2|||
48406012|NCT03887130|155676733|FG001|Overall Study|Death|2|||
48406013|NCT03887130|155676734|FG002|Overall Study|Death|1|||
48406014|NCT03887130|155676732|FG000|Overall Study|Withdrawal by Subject|7|||
48406015|NCT03887130|155676733|FG001|Overall Study|Withdrawal by Subject|6|||
48406016|NCT03887130|155676734|FG002|Overall Study|Withdrawal by Subject|11|||
48406017|NCT03887130|155676732|FG000|Overall Study|other reason|6|||
48406018|NCT03887130|155676733|FG001|Overall Study|other reason|20|||
48406019|NCT03887130|155676734|FG002|Overall Study|other reason|17|||
48406020|NCT03828487|155676735|FG000|Overall Study|Physician Decision|1|||
48406021|NCT00930059|155678449|FG000|Overall Study|Death|1|||
48406022|NCT00930059|155678450|FG001|Overall Study|Death|0|||
48406023|NCT00930059|155678449|FG000|Overall Study|Did not meet entrance criteria|1|||
48406024|NCT00930059|155678450|FG001|Overall Study|Did not meet entrance criteria|1|||
48406025|NCT00930059|155678449|FG000|Overall Study|Withdrawal by Subject|3|||
48406026|NCT00930059|155678450|FG001|Overall Study|Withdrawal by Subject|4|||
48406027|NCT00930059|155678449|FG000|Overall Study|Other|1|||
48406028|NCT00930059|155678450|FG001|Overall Study|Other|0|||
48406029|NCT00930059|155678449|FG000|Overall Study|1 site terminated by sponsor|1|||
48406030|NCT00930059|155678450|FG001|Overall Study|1 site terminated by sponsor|1|||
48406031|NCT00930059|155678449|FG000|Overall Study|Adverse Event|1|||
48406032|NCT00930059|155678450|FG001|Overall Study|Adverse Event|6|||
48406033|NCT02049944|155678452|FG000|Overall Study|Protocol Violation|2|||
48406034|NCT01761266|155678453|FG000|Overall Study|Death|415|||
48406035|NCT01761266|155678454|FG001|Overall Study|Death|402|||
48406036|NCT01761266|155678453|FG000|Overall Study|Lost to Follow-up|8|||
48406037|NCT01761266|155678454|FG001|Overall Study|Lost to Follow-up|12|||
48406038|NCT01761266|155678453|FG000|Overall Study|Withdrawal by Subject|14|||
48406039|NCT01761266|155678454|FG001|Overall Study|Withdrawal by Subject|10|||
48406040|NCT01761266|155678453|FG000|Overall Study|Sponsor Decision|41|||
48406041|NCT01761266|155678454|FG001|Overall Study|Sponsor Decision|52|||
48406042|NCT01284114|155678455|FG000|Overall Study|viral infection|1|||
48406043|NCT01284114|155678455|FG000|Overall Study|From the results of ALLTITUDE study|1|||
48406044|NCT01284114|155678455|FG000|Overall Study|Symptomatic hypotension|1|||
48406045|NCT01284114|155678455|FG000|Overall Study|dizziness|1|||
48406046|NCT00598975|155678456|FG000|Overall Study|Adverse Event|1|||
48406047|NCT00598975|155678457|FG001|Overall Study|Adverse Event|1|||
48406048|NCT00598975|155678456|FG000|Overall Study|Brain metastases|1|||
48406049|NCT00598975|155678457|FG001|Overall Study|Brain metastases|0|||
48406050|NCT00598975|155678456|FG000|Overall Study|Withdrawal by Subject|1|||
48406051|NCT00598975|155678457|FG001|Overall Study|Withdrawal by Subject|1|||
48406052|NCT00598975|155678456|FG000|Overall Study|Withdrawal of consent|0|||
48406053|NCT00598975|155678457|FG001|Overall Study|Withdrawal of consent|1|||
48406054|NCT00598975|155678456|FG000|Overall Study|Disease progression|8|||
48406055|NCT00598975|155678457|FG001|Overall Study|Disease progression|3|||
48406056|NCT00598975|155678456|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
48406057|NCT00598975|155678457|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
48406058|NCT02554929|155678463|FG000|Overall Study|Lost to Follow-up|4|||
48406059|NCT02554929|155678464|FG001|Overall Study|Lost to Follow-up|4|||
48406060|NCT02554929|155678463|FG000|Overall Study|Withdrawal by Subject|2|||
48406061|NCT02554929|155678464|FG001|Overall Study|Withdrawal by Subject|8|||
48406062|NCT01178138|155678465|FG000|Overall Study|Lost to Follow-up|8|||
48406063|NCT01178138|155678465|FG000|Overall Study|Withdrawal by Subject|7|||
48406064|NCT01178138|155678465|FG000|Overall Study|Physician Decision|8|||
48406065|NCT03786432|155678466|FG000|Overall Study|Screen Failure after consent|1|||
48406066|NCT03786432|155678466|FG000|Overall Study|Lost to Follow-up|4|||
48406067|NCT03786432|155678466|FG000|Overall Study|did not complete 12 month CT scan|1|||
48406068|NCT01354028|155678469|FG000|Overall Study|Physician Decision|0|||
48406069|NCT01354028|155678470|FG001|Overall Study|Physician Decision|2|||
48406070|NCT01354028|155678469|FG000|Overall Study|Discharged before study start|2|||
48406071|NCT01354028|155678470|FG001|Overall Study|Discharged before study start|2|||
48406072|NCT01354028|155678469|FG000|Overall Study|No quiet alert state|0|||
48406073|NCT01354028|155678470|FG001|Overall Study|No quiet alert state|1|||
48406074|NCT00264004|155678471|FG000|Overall Study|Adverse Event|2|||
48406075|NCT00264004|155678472|FG001|Overall Study|Adverse Event|3|||
48406076|NCT00264004|155678473|FG002|Overall Study|Adverse Event|6|||
48406077|NCT00264004|155678474|FG003|Overall Study|Adverse Event|4|||
48406078|NCT00264004|155678471|FG000|Overall Study|Withdrawal by Subject|0|||
48406079|NCT00264004|155678472|FG001|Overall Study|Withdrawal by Subject|1|||
48431199|NCT01599754|155765345|FG001|Overall Study|Death|33|||
48406080|NCT00264004|155678473|FG002|Overall Study|Withdrawal by Subject|2|||
48406081|NCT00264004|155678474|FG003|Overall Study|Withdrawal by Subject|2|||
48406082|NCT00264004|155678471|FG000|Overall Study|Other|2|||
48406083|NCT00264004|155678472|FG001|Overall Study|Other|2|||
48406084|NCT00264004|155678473|FG002|Overall Study|Other|0|||
48406085|NCT00264004|155678474|FG003|Overall Study|Other|3|||
48431200|NCT01599754|155765344|FG000|Overall Study|Adverse Event|3|||
48406086|NCT00264004|155678471|FG000|Overall Study|Development study specific disc. crit.|1|||
48406087|NCT00264004|155678472|FG001|Overall Study|Development study specific disc. crit.|0|||
48406088|NCT00264004|155678473|FG002|Overall Study|Development study specific disc. crit.|1|||
48406089|NCT00264004|155678474|FG003|Overall Study|Development study specific disc. crit.|0|||
48406090|NCT00264004|155678471|FG000|Overall Study|Cond. under inv. worsened|9|||
48406091|NCT00264004|155678472|FG001|Overall Study|Cond. under inv. worsened|5|||
48406092|NCT00264004|155678473|FG002|Overall Study|Cond. under inv. worsened|3|||
48406093|NCT00264004|155678474|FG003|Overall Study|Cond. under inv. worsened|4|||
48406094|NCT00264004|155678471|FG000|Overall Study|Not treated|3|||
48406095|NCT00264004|155678472|FG001|Overall Study|Not treated|0|||
48406096|NCT00264004|155678473|FG002|Overall Study|Not treated|2|||
48406097|NCT00264004|155678474|FG003|Overall Study|Not treated|2|||
48406098|NCT03705793|155678483|FG000|Overall Study|Lost to Follow-up|3|||
48406099|NCT03705793|155678484|FG001|Overall Study|Lost to Follow-up|4|||
48406100|NCT03705793|155678483|FG000|Overall Study|Withdrawal by Subject|2|||
48406101|NCT03705793|155678484|FG001|Overall Study|Withdrawal by Subject|1|||
48406102|NCT01637142|155678486|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
48406103|NCT02222714|155678493|FG000|Overall Study|Death|0|||
48406104|NCT02222714|155678494|FG001|Overall Study|Death|2|||
48406105|NCT02222714|155678495|FG002|Overall Study|Death|3|||
48406106|NCT02222714|155678496|FG003|Overall Study|Death|4|||
48406107|NCT02222714|155678497|FG004|Overall Study|Death|6|||
48406108|NCT02222714|155678493|FG000|Overall Study|Withdrawal by Subject|0|||
48406109|NCT02222714|155678494|FG001|Overall Study|Withdrawal by Subject|0|||
48406110|NCT02222714|155678495|FG002|Overall Study|Withdrawal by Subject|1|||
48406111|NCT02222714|155678496|FG003|Overall Study|Withdrawal by Subject|0|||
48406112|NCT02222714|155678497|FG004|Overall Study|Withdrawal by Subject|1|||
48406113|NCT00648167|155678498|FG000|Overall Study|Adverse Event|6|||
48406114|NCT00648167|155678498|FG000|Overall Study|unable to swallow tablets|1|||
48406115|NCT02296242|155678499|FG000|Overall Study|Death|1|||
48406116|NCT02296242|155678500|FG001|Overall Study|Death|1|||
48406117|NCT02296242|155678501|FG002|Overall Study|Death|1|||
48406118|NCT02296242|155678502|FG003|Overall Study|Death|1|||
48406119|NCT02296242|155678503|FG004|Overall Study|Death|1|||
48406120|NCT02296242|155678499|FG000|Overall Study|Withdrawal by Subject|0|||
48357426|NCT00790400|155504871|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
48357427|NCT00790400|155504872|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
48357428|NCT00790400|155504871|FG000|Double-blind Period (Core Phase)|Death|1|||
48357429|NCT00790400|155504872|FG001|Double-blind Period (Core Phase)|Death|0|||
48357430|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
48357431|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
48357432|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
48357433|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
48357434|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
48357435|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
48357436|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
48357437|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
48357438|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
48357439|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
48357440|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|Death|1|||
48357441|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|Death|0|||
48357442|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
48357443|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
48357444|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
48357445|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
48357446|NCT00790400|155504871|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
48357447|NCT00790400|155504872|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
48357448|NCT00078338|155504873|FG000|Overall Study|Adverse Event|31|||
48357449|NCT00078338|155504874|FG001|Overall Study|Adverse Event|24|||
48357450|NCT00078338|155504873|FG000|Overall Study|Lost to Follow-up|17|||
48357451|NCT00078338|155504874|FG001|Overall Study|Lost to Follow-up|2|||
48357452|NCT00078338|155504873|FG000|Overall Study|Protocol Violation|2|||
48357453|NCT00078338|155504874|FG001|Overall Study|Protocol Violation|2|||
48357454|NCT00078338|155504873|FG000|Overall Study|Disease Progression|4|||
48357455|NCT00078338|155504874|FG001|Overall Study|Disease Progression|7|||
48357456|NCT00078338|155504873|FG000|Overall Study|Other|28|||
48357457|NCT00078338|155504874|FG001|Overall Study|Other|16|||
48357458|NCT00078338|155504873|FG000|Overall Study|Subjects randomized, but not treated|3|||
48357459|NCT00078338|155504874|FG001|Overall Study|Subjects randomized, but not treated|3|||
48357460|NCT01245140|155504875|FG000|Overall Study|Adverse Event|1|||
48357461|NCT01245140|155504876|FG001|Overall Study|Adverse Event|3|||
48357462|NCT01245140|155504875|FG000|Overall Study|Lack of Efficacy|2|||
48357463|NCT01245140|155504876|FG001|Overall Study|Lack of Efficacy|4|||
48357464|NCT01245140|155504875|FG000|Overall Study|Protocol Violation|0|||
48357465|NCT01245140|155504876|FG001|Overall Study|Protocol Violation|1|||
48357466|NCT01245140|155504875|FG000|Overall Study|Withdrawal by Subject|0|||
48406121|NCT02296242|155678500|FG001|Overall Study|Withdrawal by Subject|0|||
48406122|NCT02296242|155678501|FG002|Overall Study|Withdrawal by Subject|1|||
48406123|NCT02296242|155678502|FG003|Overall Study|Withdrawal by Subject|1|||
48406124|NCT02296242|155678503|FG004|Overall Study|Withdrawal by Subject|3|||
48406125|NCT02296242|155678499|FG000|Overall Study|Disease Progression|1|||
48406126|NCT02296242|155678500|FG001|Overall Study|Disease Progression|3|||
48406127|NCT02296242|155678501|FG002|Overall Study|Disease Progression|2|||
48406128|NCT02296242|155678502|FG003|Overall Study|Disease Progression|8|||
48406129|NCT02296242|155678503|FG004|Overall Study|Disease Progression|11|||
48406130|NCT02296242|155678499|FG000|Overall Study|Unacceptable Toxicity|0|||
48406131|NCT02296242|155678500|FG001|Overall Study|Unacceptable Toxicity|0|||
48406132|NCT02296242|155678501|FG002|Overall Study|Unacceptable Toxicity|0|||
48406133|NCT02296242|155678502|FG003|Overall Study|Unacceptable Toxicity|0|||
48406134|NCT02296242|155678503|FG004|Overall Study|Unacceptable Toxicity|1|||
48406135|NCT02296242|155678499|FG000|Overall Study|Patient Condition Changed|0|||
48406136|NCT02296242|155678500|FG001|Overall Study|Patient Condition Changed|0|||
48406137|NCT02296242|155678501|FG002|Overall Study|Patient Condition Changed|2|||
48406138|NCT02296242|155678502|FG003|Overall Study|Patient Condition Changed|0|||
48406139|NCT02296242|155678503|FG004|Overall Study|Patient Condition Changed|1|||
48406140|NCT02296242|155678499|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
48406141|NCT02296242|155678500|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
48406142|NCT02296242|155678501|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
48406143|NCT02296242|155678502|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
48406144|NCT02296242|155678503|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
48406145|NCT02296242|155678499|FG000|Overall Study|Lost to Follow-up|1|||
48406146|NCT02296242|155678500|FG001|Overall Study|Lost to Follow-up|0|||
48406147|NCT02296242|155678501|FG002|Overall Study|Lost to Follow-up|0|||
48406148|NCT02296242|155678502|FG003|Overall Study|Lost to Follow-up|0|||
48406149|NCT02296242|155678503|FG004|Overall Study|Lost to Follow-up|0|||
48406150|NCT02296242|155678499|FG000|Overall Study|Need for Hydroxyurea|2|||
48406151|NCT02296242|155678500|FG001|Overall Study|Need for Hydroxyurea|0|||
48406152|NCT02296242|155678501|FG002|Overall Study|Need for Hydroxyurea|0|||
48406153|NCT02296242|155678502|FG003|Overall Study|Need for Hydroxyurea|0|||
48406154|NCT02296242|155678503|FG004|Overall Study|Need for Hydroxyurea|0|||
48406155|NCT02296242|155678499|FG000|Overall Study|Screened for Other Protocol|0|||
48406156|NCT02296242|155678500|FG001|Overall Study|Screened for Other Protocol|1|||
48406157|NCT02296242|155678501|FG002|Overall Study|Screened for Other Protocol|0|||
48406158|NCT02296242|155678502|FG003|Overall Study|Screened for Other Protocol|0|||
48406159|NCT02296242|155678503|FG004|Overall Study|Screened for Other Protocol|0|||
48406160|NCT02296242|155678499|FG000|Overall Study|Physician Decision|0|||
48406161|NCT02296242|155678500|FG001|Overall Study|Physician Decision|1|||
48406162|NCT02296242|155678501|FG002|Overall Study|Physician Decision|0|||
48406163|NCT02296242|155678502|FG003|Overall Study|Physician Decision|1|||
48406164|NCT02296242|155678503|FG004|Overall Study|Physician Decision|0|||
48406165|NCT02296242|155678499|FG000|Overall Study|Alternative Treatment|0|||
48406166|NCT02296242|155678500|FG001|Overall Study|Alternative Treatment|0|||
48406167|NCT02296242|155678501|FG002|Overall Study|Alternative Treatment|0|||
48406168|NCT02296242|155678502|FG003|Overall Study|Alternative Treatment|1|||
48406169|NCT02296242|155678503|FG004|Overall Study|Alternative Treatment|0|||
48357467|NCT01245140|155504876|FG001|Overall Study|Withdrawal by Subject|1|||
48357468|NCT01245140|155504875|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
48357469|NCT01245140|155504876|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
48357470|NCT02615509|155504879|FG000|Overall Study|Lost to Follow-up|134|||
48357471|NCT02615509|155504879|FG000|Overall Study|Death|4|||
48357472|NCT02615509|155504879|FG000|Overall Study|Withdrawal by Subject|8|||
48357473|NCT01592045|155504882|FG000|Overall Study|Disease Progression|1|||
48357474|NCT01592045|155504883|FG001|Overall Study|Disease Progression|1|||
48357475|NCT01592045|155504882|FG000|Overall Study|Adverse Event|1|||
48357476|NCT01592045|155504883|FG001|Overall Study|Adverse Event|1|||
48357477|NCT01592045|155504882|FG000|Overall Study|Withdrawal by Subject|1|||
48357478|NCT01592045|155504883|FG001|Overall Study|Withdrawal by Subject|0|||
48357479|NCT01592045|155504882|FG000|Overall Study|Moved out of country|2|||
48357480|NCT01592045|155504883|FG001|Overall Study|Moved out of country|0|||
48357481|NCT03994731|155504884|FG000|Pegloticase + IMM Period|Death|2|||
48357482|NCT03994731|155504885|FG001|Pegloticase + IMM Period|Death|0|||
48357483|NCT03994731|155504884|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
48357484|NCT03994731|155504885|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
48357485|NCT03994731|155504884|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
48357486|NCT03994731|155504885|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
48357487|NCT01252355|155504893|FG000|Overall Study|Adverse Event|9|||
48357488|NCT01252355|155504894|FG001|Overall Study|Adverse Event|17|||
48357489|NCT01252355|155504895|FG002|Overall Study|Adverse Event|22|||
48357490|NCT01252355|155504893|FG000|Overall Study|Lack of Efficacy|6|||
48357491|NCT01252355|155504894|FG001|Overall Study|Lack of Efficacy|4|||
48357492|NCT01252355|155504895|FG002|Overall Study|Lack of Efficacy|2|||
48357493|NCT01252355|155504893|FG000|Overall Study|Lost to Follow-up|0|||
48357494|NCT01252355|155504894|FG001|Overall Study|Lost to Follow-up|0|||
48357495|NCT01252355|155504895|FG002|Overall Study|Lost to Follow-up|1|||
48357496|NCT01252355|155504893|FG000|Overall Study|Poor Compliance to Protocol|1|||
48357497|NCT01252355|155504894|FG001|Overall Study|Poor Compliance to Protocol|1|||
48406170|NCT02296242|155678499|FG000|Overall Study|Adverse Event|0|||
48406171|NCT02296242|155678500|FG001|Overall Study|Adverse Event|0|||
48406172|NCT02296242|155678501|FG002|Overall Study|Adverse Event|0|||
48406173|NCT02296242|155678502|FG003|Overall Study|Adverse Event|1|||
48406174|NCT02296242|155678503|FG004|Overall Study|Adverse Event|0|||
48406175|NCT02296242|155678499|FG000|Overall Study|Lack of Efficacy|0|||
48406176|NCT02296242|155678500|FG001|Overall Study|Lack of Efficacy|0|||
48406177|NCT02296242|155678501|FG002|Overall Study|Lack of Efficacy|0|||
48406178|NCT02296242|155678502|FG003|Overall Study|Lack of Efficacy|0|||
48406179|NCT02296242|155678503|FG004|Overall Study|Lack of Efficacy|3|||
48406180|NCT00634569|155678510|FG000|Overall Study|Withdrawal by Subject|0|||
48406181|NCT00634569|155678511|FG001|Overall Study|Withdrawal by Subject|4|||
48406182|NCT00634569|155678510|FG000|Overall Study|Physician Decision|0|||
48406183|NCT00634569|155678511|FG001|Overall Study|Physician Decision|1|||
48406184|NCT00070941|155678515|FG000|Overall Study|Adverse Event|10|||
48406185|NCT00070941|155678516|FG001|Overall Study|Adverse Event|8|||
48406186|NCT00070941|155678517|FG002|Overall Study|Adverse Event|4|||
48406187|NCT00756938|155678518|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
48406188|NCT00756938|155678519|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
48406189|NCT00756938|155678520|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
48406190|NCT00756938|155678521|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
48406191|NCT00756938|155678518|FG000|12-week Base Study|Protocol Violation|0|||
48406192|NCT00756938|155678519|FG001|12-week Base Study|Protocol Violation|0|||
48406193|NCT00756938|155678520|FG002|12-week Base Study|Protocol Violation|1|||
48406194|NCT00756938|155678521|FG003|12-week Base Study|Protocol Violation|0|||
48406195|NCT00756938|155678518|FG000|12-week Base Study|Lost to Follow-up|1|||
48406196|NCT00756938|155678519|FG001|12-week Base Study|Lost to Follow-up|0|||
48406197|NCT00756938|155678520|FG002|12-week Base Study|Lost to Follow-up|0|||
48406198|NCT00756938|155678521|FG003|12-week Base Study|Lost to Follow-up|0|||
48406199|NCT00756938|155678518|FG000|Optional Extension|Lack of Efficacy|0|||
48406200|NCT00756938|155678519|FG001|Optional Extension|Lack of Efficacy|0|||
48406201|NCT00756938|155678520|FG002|Optional Extension|Lack of Efficacy|0|||
48406202|NCT00756938|155678521|FG003|Optional Extension|Lack of Efficacy|1|||
48406203|NCT00756938|155678518|FG000|Optional Extension|End of Study|0|||
48406204|NCT00756938|155678519|FG001|Optional Extension|End of Study|0|||
48406205|NCT00756938|155678520|FG002|Optional Extension|End of Study|0|||
48406206|NCT00756938|155678521|FG003|Optional Extension|End of Study|11|||
48406207|NCT00756938|155678518|FG000|Optional Extension|Protocol-specific criteria met|0|||
48406208|NCT00756938|155678519|FG001|Optional Extension|Protocol-specific criteria met|0|||
48406209|NCT00756938|155678520|FG002|Optional Extension|Protocol-specific criteria met|0|||
48406210|NCT00756938|155678521|FG003|Optional Extension|Protocol-specific criteria met|9|||
48406211|NCT00756938|155678518|FG000|Optional Extension|Physician Decision|0|||
48406212|NCT00756938|155678519|FG001|Optional Extension|Physician Decision|0|||
48406213|NCT00756938|155678520|FG002|Optional Extension|Physician Decision|0|||
48406214|NCT00756938|155678521|FG003|Optional Extension|Physician Decision|3|||
48406215|NCT00756938|155678518|FG000|Optional Extension|Lost to Follow-up|0|||
48406216|NCT00756938|155678519|FG001|Optional Extension|Lost to Follow-up|0|||
48406217|NCT00756938|155678520|FG002|Optional Extension|Lost to Follow-up|0|||
48406218|NCT00756938|155678521|FG003|Optional Extension|Lost to Follow-up|1|||
48406219|NCT00756938|155678518|FG000|Optional Extension|Protocol Violation|0|||
48406220|NCT00756938|155678519|FG001|Optional Extension|Protocol Violation|0|||
48406221|NCT00756938|155678520|FG002|Optional Extension|Protocol Violation|0|||
48406222|NCT00756938|155678521|FG003|Optional Extension|Protocol Violation|1|||
48406223|NCT00756938|155678518|FG000|Optional Extension|Withdrawal by Subject|0|||
48406224|NCT00756938|155678519|FG001|Optional Extension|Withdrawal by Subject|0|||
48406225|NCT00756938|155678520|FG002|Optional Extension|Withdrawal by Subject|0|||
48406226|NCT00756938|155678521|FG003|Optional Extension|Withdrawal by Subject|10|||
48406227|NCT00756938|155678518|FG000|Optional Extension|Adverse Event|0|||
48406228|NCT00756938|155678519|FG001|Optional Extension|Adverse Event|0|||
48406229|NCT00756938|155678520|FG002|Optional Extension|Adverse Event|0|||
48406230|NCT00756938|155678521|FG003|Optional Extension|Adverse Event|1|||
48406231|NCT00110019|155678522|FG000|Overall Study|Lack of Efficacy|253|||
48406232|NCT00110019|155678523|FG001|Overall Study|Lack of Efficacy|285|||
48406233|NCT00110019|155678522|FG000|Overall Study|Adverse Event|61|||
48406234|NCT00110019|155678523|FG001|Overall Study|Adverse Event|40|||
48406235|NCT00110019|155678522|FG000|Overall Study|Death|13|||
48406236|NCT00110019|155678523|FG001|Overall Study|Death|15|||
48406237|NCT00110019|155678522|FG000|Overall Study|Withdrawal by Subject|21|||
48406238|NCT00110019|155678523|FG001|Overall Study|Withdrawal by Subject|9|||
48406239|NCT00110019|155678522|FG000|Overall Study|alternative therapy|5|||
48406240|NCT00110019|155678523|FG001|Overall Study|alternative therapy|1|||
48406241|NCT00110019|155678522|FG000|Overall Study|complicating disease|1|||
48406242|NCT00110019|155678523|FG001|Overall Study|complicating disease|1|||
48406243|NCT00110019|155678522|FG000|Overall Study|symptom deterioration|13|||
48406244|NCT00110019|155678523|FG001|Overall Study|symptom deterioration|16|||
48406245|NCT00110019|155678522|FG000|Overall Study|Not start protocol therapy|17|||
48406246|NCT00110019|155678523|FG001|Overall Study|Not start protocol therapy|16|||
48406247|NCT00110019|155678522|FG000|Overall Study|other reasons|22|||
48406248|NCT00110019|155678523|FG001|Overall Study|other reasons|30|||
48406249|NCT00939692|155678524|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
48406250|NCT00939692|155678525|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
48406251|NCT00939692|155678524|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
48406252|NCT00939692|155678525|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
48406253|NCT01262976|155678526|FG000|Up to Month 2|Serious Adverse Event|0|||
48406254|NCT01262976|155678527|FG001|Up to Month 2|Serious Adverse Event|0|||
48406255|NCT01262976|155678528|FG002|Up to Month 2|Serious Adverse Event|1|||
48406256|NCT01262976|155678529|FG003|Up to Month 2|Serious Adverse Event|0|||
48406257|NCT01262976|155678530|FG004|Up to Month 2|Serious Adverse Event|0|||
48406258|NCT01262976|155678531|FG005|Up to Month 2|Serious Adverse Event|0|||
48406259|NCT01262976|155678526|FG000|Up to Month 2|Withdrawal by Subject|1|||
48406260|NCT01262976|155678527|FG001|Up to Month 2|Withdrawal by Subject|0|||
48406261|NCT01262976|155678528|FG002|Up to Month 2|Withdrawal by Subject|0|||
48406262|NCT01262976|155678529|FG003|Up to Month 2|Withdrawal by Subject|0|||
48406263|NCT01262976|155678530|FG004|Up to Month 2|Withdrawal by Subject|0|||
48406264|NCT01262976|155678531|FG005|Up to Month 2|Withdrawal by Subject|0|||
48406265|NCT01262976|155678526|FG000|Up to Month 2|Migrated/moved from study area|0|||
48406266|NCT01262976|155678527|FG001|Up to Month 2|Migrated/moved from study area|1|||
48406267|NCT01262976|155678528|FG002|Up to Month 2|Migrated/moved from study area|0|||
48406268|NCT01262976|155678529|FG003|Up to Month 2|Migrated/moved from study area|0|||
48406269|NCT01262976|155678530|FG004|Up to Month 2|Migrated/moved from study area|1|||
48406270|NCT01262976|155678531|FG005|Up to Month 2|Migrated/moved from study area|1|||
48406271|NCT01262976|155678526|FG000|Up to Month 2|Lost to Follow-up|1|||
48406272|NCT01262976|155678527|FG001|Up to Month 2|Lost to Follow-up|0|||
48406273|NCT01262976|155678528|FG002|Up to Month 2|Lost to Follow-up|0|||
48406274|NCT01262976|155678529|FG003|Up to Month 2|Lost to Follow-up|1|||
48406275|NCT01262976|155678530|FG004|Up to Month 2|Lost to Follow-up|1|||
48406276|NCT01262976|155678531|FG005|Up to Month 2|Lost to Follow-up|1|||
48406277|NCT01262976|155678526|FG000|Up to Month 2|Other|1|||
48406278|NCT01262976|155678527|FG001|Up to Month 2|Other|0|||
48406279|NCT01262976|155678528|FG002|Up to Month 2|Other|0|||
48406280|NCT01262976|155678529|FG003|Up to Month 2|Other|1|||
48406281|NCT01262976|155678530|FG004|Up to Month 2|Other|0|||
48406282|NCT01262976|155678531|FG005|Up to Month 2|Other|2|||
48406283|NCT01262976|155678526|FG000|Up to Month 7|Serious Adverse Event|0|||
48406284|NCT01262976|155678527|FG001|Up to Month 7|Serious Adverse Event|0|||
48406285|NCT01262976|155678528|FG002|Up to Month 7|Serious Adverse Event|2|||
48406286|NCT01262976|155678529|FG003|Up to Month 7|Serious Adverse Event|0|||
48406287|NCT01262976|155678530|FG004|Up to Month 7|Serious Adverse Event|0|||
48406288|NCT01262976|155678531|FG005|Up to Month 7|Serious Adverse Event|0|||
48406289|NCT01262976|155678526|FG000|Up to Month 7|Withdrawal by Subject|1|||
48406290|NCT01262976|155678527|FG001|Up to Month 7|Withdrawal by Subject|0|||
48406291|NCT01262976|155678528|FG002|Up to Month 7|Withdrawal by Subject|0|||
48406292|NCT01262976|155678529|FG003|Up to Month 7|Withdrawal by Subject|0|||
48406293|NCT01262976|155678530|FG004|Up to Month 7|Withdrawal by Subject|0|||
48406294|NCT01262976|155678531|FG005|Up to Month 7|Withdrawal by Subject|0|||
48406295|NCT01262976|155678526|FG000|Up to Month 7|Migrated/moved from study area|0|||
48406296|NCT01262976|155678527|FG001|Up to Month 7|Migrated/moved from study area|0|||
48406297|NCT01262976|155678528|FG002|Up to Month 7|Migrated/moved from study area|1|||
48406298|NCT01262976|155678529|FG003|Up to Month 7|Migrated/moved from study area|3|||
48406299|NCT01262976|155678530|FG004|Up to Month 7|Migrated/moved from study area|1|||
48406300|NCT01262976|155678531|FG005|Up to Month 7|Migrated/moved from study area|1|||
48406301|NCT01262976|155678526|FG000|Up to Month 7|Lost to Follow-up|1|||
48406302|NCT01262976|155678527|FG001|Up to Month 7|Lost to Follow-up|0|||
48406303|NCT01262976|155678528|FG002|Up to Month 7|Lost to Follow-up|1|||
48406304|NCT01262976|155678529|FG003|Up to Month 7|Lost to Follow-up|3|||
48406305|NCT01262976|155678530|FG004|Up to Month 7|Lost to Follow-up|1|||
48406306|NCT01262976|155678531|FG005|Up to Month 7|Lost to Follow-up|3|||
48406307|NCT01262976|155678526|FG000|Up to Month 7|Other|3|||
48406308|NCT01262976|155678527|FG001|Up to Month 7|Other|0|||
48406309|NCT01262976|155678528|FG002|Up to Month 7|Other|2|||
48406310|NCT01262976|155678529|FG003|Up to Month 7|Other|0|||
48406311|NCT01262976|155678530|FG004|Up to Month 7|Other|0|||
48406312|NCT01262976|155678531|FG005|Up to Month 7|Other|0|||
48406313|NCT01262976|155678526|FG000|Up to Year 1|Serious Adverse Event|0|||
48406314|NCT01262976|155678527|FG001|Up to Year 1|Serious Adverse Event|0|||
48406315|NCT01262976|155678528|FG002|Up to Year 1|Serious Adverse Event|2|||
48406316|NCT01262976|155678529|FG003|Up to Year 1|Serious Adverse Event|0|||
48406317|NCT01262976|155678530|FG004|Up to Year 1|Serious Adverse Event|0|||
48406318|NCT01262976|155678531|FG005|Up to Year 1|Serious Adverse Event|0|||
48406319|NCT01262976|155678526|FG000|Up to Year 1|Withdrawal by Subject|1|||
48406320|NCT01262976|155678527|FG001|Up to Year 1|Withdrawal by Subject|0|||
48406321|NCT01262976|155678528|FG002|Up to Year 1|Withdrawal by Subject|0|||
48406322|NCT01262976|155678529|FG003|Up to Year 1|Withdrawal by Subject|0|||
48406323|NCT01262976|155678530|FG004|Up to Year 1|Withdrawal by Subject|0|||
48406324|NCT01262976|155678531|FG005|Up to Year 1|Withdrawal by Subject|0|||
48406325|NCT01262976|155678526|FG000|Up to Year 1|Migrated/moved from study area|1|||
48406326|NCT01262976|155678527|FG001|Up to Year 1|Migrated/moved from study area|0|||
48406327|NCT01262976|155678528|FG002|Up to Year 1|Migrated/moved from study area|0|||
48406328|NCT01262976|155678529|FG003|Up to Year 1|Migrated/moved from study area|3|||
48406329|NCT01262976|155678530|FG004|Up to Year 1|Migrated/moved from study area|3|||
48406330|NCT01262976|155678531|FG005|Up to Year 1|Migrated/moved from study area|2|||
48406331|NCT01262976|155678526|FG000|Up to Year 1|Lost to Follow-up|4|||
48406332|NCT01262976|155678527|FG001|Up to Year 1|Lost to Follow-up|0|||
48406333|NCT01262976|155678528|FG002|Up to Year 1|Lost to Follow-up|0|||
48406334|NCT01262976|155678529|FG003|Up to Year 1|Lost to Follow-up|1|||
48406335|NCT01262976|155678530|FG004|Up to Year 1|Lost to Follow-up|6|||
48406336|NCT01262976|155678531|FG005|Up to Year 1|Lost to Follow-up|5|||
48406337|NCT01262976|155678526|FG000|Up to Year 1|Other|3|||
48406338|NCT01262976|155678527|FG001|Up to Year 1|Other|1|||
48406339|NCT01262976|155678528|FG002|Up to Year 1|Other|0|||
48406340|NCT01262976|155678529|FG003|Up to Year 1|Other|0|||
48406341|NCT01262976|155678530|FG004|Up to Year 1|Other|2|||
48406342|NCT01262976|155678531|FG005|Up to Year 1|Other|1|||
48406343|NCT01262976|155678526|FG000|Up to Year 1|Subjects with unknown completion status|0|||
48406344|NCT01262976|155678527|FG001|Up to Year 1|Subjects with unknown completion status|0|||
48406345|NCT01262976|155678528|FG002|Up to Year 1|Subjects with unknown completion status|1|||
48406346|NCT01262976|155678529|FG003|Up to Year 1|Subjects with unknown completion status|0|||
48406347|NCT01262976|155678530|FG004|Up to Year 1|Subjects with unknown completion status|0|||
48406348|NCT01262976|155678531|FG005|Up to Year 1|Subjects with unknown completion status|1|||
48406349|NCT01262976|155678526|FG000|Up to Year 2|Serious Adverse Event|0|||
48406350|NCT01262976|155678527|FG001|Up to Year 2|Serious Adverse Event|0|||
48406351|NCT01262976|155678528|FG002|Up to Year 2|Serious Adverse Event|2|||
48406352|NCT01262976|155678529|FG003|Up to Year 2|Serious Adverse Event|0|||
48406353|NCT01262976|155678530|FG004|Up to Year 2|Serious Adverse Event|0|||
48406354|NCT01262976|155678531|FG005|Up to Year 2|Serious Adverse Event|0|||
48406355|NCT01262976|155678526|FG000|Up to Year 2|Withdrawal by Subject|1|||
48406356|NCT01262976|155678527|FG001|Up to Year 2|Withdrawal by Subject|0|||
48406357|NCT01262976|155678528|FG002|Up to Year 2|Withdrawal by Subject|0|||
48406358|NCT01262976|155678529|FG003|Up to Year 2|Withdrawal by Subject|0|||
48406359|NCT01262976|155678530|FG004|Up to Year 2|Withdrawal by Subject|0|||
48406360|NCT01262976|155678531|FG005|Up to Year 2|Withdrawal by Subject|0|||
48406361|NCT01262976|155678526|FG000|Up to Year 2|Migrated/moved from study area|0|||
48406362|NCT01262976|155678527|FG001|Up to Year 2|Migrated/moved from study area|0|||
48406363|NCT01262976|155678528|FG002|Up to Year 2|Migrated/moved from study area|0|||
48406364|NCT01262976|155678529|FG003|Up to Year 2|Migrated/moved from study area|2|||
48406365|NCT01262976|155678530|FG004|Up to Year 2|Migrated/moved from study area|1|||
48406366|NCT01262976|155678531|FG005|Up to Year 2|Migrated/moved from study area|2|||
48406367|NCT01262976|155678526|FG000|Up to Year 2|Lost to Follow-up|1|||
48406368|NCT01262976|155678527|FG001|Up to Year 2|Lost to Follow-up|1|||
48406369|NCT01262976|155678528|FG002|Up to Year 2|Lost to Follow-up|2|||
48406370|NCT01262976|155678529|FG003|Up to Year 2|Lost to Follow-up|2|||
48406371|NCT01262976|155678530|FG004|Up to Year 2|Lost to Follow-up|3|||
48406372|NCT01262976|155678531|FG005|Up to Year 2|Lost to Follow-up|3|||
48406373|NCT01262976|155678526|FG000|Up to Year 2|Subjects with unknown completion status|0|||
48406374|NCT01262976|155678527|FG001|Up to Year 2|Subjects with unknown completion status|0|||
48406375|NCT01262976|155678528|FG002|Up to Year 2|Subjects with unknown completion status|1|||
48406376|NCT01262976|155678529|FG003|Up to Year 2|Subjects with unknown completion status|0|||
48406377|NCT01262976|155678530|FG004|Up to Year 2|Subjects with unknown completion status|0|||
48406378|NCT01262976|155678531|FG005|Up to Year 2|Subjects with unknown completion status|0|||
48406379|NCT01262976|155678526|FG000|Up to Year 2|Other|3|||
48406380|NCT01262976|155678527|FG001|Up to Year 2|Other|0|||
48406381|NCT01262976|155678528|FG002|Up to Year 2|Other|0|||
48406382|NCT01262976|155678529|FG003|Up to Year 2|Other|0|||
48406383|NCT01262976|155678530|FG004|Up to Year 2|Other|0|||
48406384|NCT01262976|155678531|FG005|Up to Year 2|Other|0|||
48406385|NCT01262976|155678526|FG000|Up to Year 3|Serious Adverse Event|0|||
48406386|NCT01262976|155678527|FG001|Up to Year 3|Serious Adverse Event|0|||
48406387|NCT01262976|155678528|FG002|Up to Year 3|Serious Adverse Event|2|||
48406388|NCT01262976|155678529|FG003|Up to Year 3|Serious Adverse Event|0|||
48406389|NCT01262976|155678530|FG004|Up to Year 3|Serious Adverse Event|0|||
48406390|NCT01262976|155678531|FG005|Up to Year 3|Serious Adverse Event|0|||
48406391|NCT01262976|155678526|FG000|Up to Year 3|Withdrawal by Subject|1|||
48406392|NCT01262976|155678527|FG001|Up to Year 3|Withdrawal by Subject|0|||
48406393|NCT01262976|155678528|FG002|Up to Year 3|Withdrawal by Subject|0|||
48406394|NCT01262976|155678529|FG003|Up to Year 3|Withdrawal by Subject|0|||
48406395|NCT01262976|155678530|FG004|Up to Year 3|Withdrawal by Subject|0|||
48406396|NCT01262976|155678531|FG005|Up to Year 3|Withdrawal by Subject|0|||
48406397|NCT01262976|155678526|FG000|Up to Year 3|Migrated/moved from study area|0|||
48406398|NCT01262976|155678527|FG001|Up to Year 3|Migrated/moved from study area|0|||
48406399|NCT01262976|155678528|FG002|Up to Year 3|Migrated/moved from study area|0|||
48406400|NCT01262976|155678529|FG003|Up to Year 3|Migrated/moved from study area|2|||
48406401|NCT01262976|155678530|FG004|Up to Year 3|Migrated/moved from study area|1|||
48406402|NCT01262976|155678531|FG005|Up to Year 3|Migrated/moved from study area|1|||
48406403|NCT01262976|155678526|FG000|Up to Year 3|Lost to Follow-up|2|||
48406404|NCT01262976|155678527|FG001|Up to Year 3|Lost to Follow-up|2|||
48406405|NCT01262976|155678528|FG002|Up to Year 3|Lost to Follow-up|4|||
48406406|NCT01262976|155678529|FG003|Up to Year 3|Lost to Follow-up|3|||
48406407|NCT01262976|155678530|FG004|Up to Year 3|Lost to Follow-up|1|||
48406408|NCT01262976|155678531|FG005|Up to Year 3|Lost to Follow-up|3|||
48406409|NCT01262976|155678526|FG000|Up to Year 3|Subjects with unknown completion status|0|||
48406410|NCT01262976|155678527|FG001|Up to Year 3|Subjects with unknown completion status|0|||
48406411|NCT01262976|155678528|FG002|Up to Year 3|Subjects with unknown completion status|1|||
48406412|NCT01262976|155678529|FG003|Up to Year 3|Subjects with unknown completion status|0|||
48406413|NCT01262976|155678530|FG004|Up to Year 3|Subjects with unknown completion status|0|||
48406414|NCT01262976|155678531|FG005|Up to Year 3|Subjects with unknown completion status|0|||
48406415|NCT01262976|155678526|FG000|Up to Year 3|Other|3|||
48406416|NCT01262976|155678527|FG001|Up to Year 3|Other|0|||
48406417|NCT01262976|155678528|FG002|Up to Year 3|Other|0|||
48406418|NCT01262976|155678529|FG003|Up to Year 3|Other|0|||
48406419|NCT01262976|155678530|FG004|Up to Year 3|Other|0|||
48406420|NCT01262976|155678531|FG005|Up to Year 3|Other|0|||
48406421|NCT00448708|155678533|FG000|Overall Study|Death|21|||
48406422|NCT00448708|155678534|FG001|Overall Study|Death|17|||
48406423|NCT00448708|155678533|FG000|Overall Study|Withdrawal by Subject|8|||
48406424|NCT00448708|155678534|FG001|Overall Study|Withdrawal by Subject|4|||
48406425|NCT00448708|155678533|FG000|Overall Study|Lost to Follow-up|6|||
48406426|NCT00448708|155678534|FG001|Overall Study|Lost to Follow-up|8|||
48406427|NCT00448708|155678533|FG000|Overall Study|not listed|0|||
48406428|NCT00448708|155678534|FG001|Overall Study|not listed|2|||
48406429|NCT01925209|155678535|FG000|Treatment Epoch|Physician Decision|1|||
48406430|NCT01925209|155678536|FG001|Treatment Epoch|Physician Decision|0|||
48406431|NCT01925209|155678537|FG002|Treatment Epoch|Physician Decision|0|||
48406432|NCT01925209|155678538|FG003|Treatment Epoch|Physician Decision|0|||
48406433|NCT01925209|155678535|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
48406434|NCT01925209|155678536|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
48406435|NCT01925209|155678537|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
48406436|NCT01925209|155678538|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
48406437|NCT01925209|155678535|FG000|Treatment Epoch|Death|1|||
48406438|NCT01925209|155678536|FG001|Treatment Epoch|Death|0|||
48406439|NCT01925209|155678537|FG002|Treatment Epoch|Death|0|||
48406440|NCT01925209|155678538|FG003|Treatment Epoch|Death|0|||
48406441|NCT01925209|155678535|FG000|Treatment Epoch|Protocol deviation|0|||
48406442|NCT01925209|155678536|FG001|Treatment Epoch|Protocol deviation|0|||
48406443|NCT01925209|155678537|FG002|Treatment Epoch|Protocol deviation|1|||
48406444|NCT01925209|155678538|FG003|Treatment Epoch|Protocol deviation|1|||
48406445|NCT01925209|155678535|FG000|Treatment Epoch|Withdrawal by Subject|4|||
48406446|NCT01925209|155678536|FG001|Treatment Epoch|Withdrawal by Subject|3|||
48406447|NCT01925209|155678537|FG002|Treatment Epoch|Withdrawal by Subject|3|||
48406448|NCT01925209|155678538|FG003|Treatment Epoch|Withdrawal by Subject|2|||
48406449|NCT01925209|155678535|FG000|Treatment Epoch|Adverse Event|3|||
48406450|NCT01925209|155678536|FG001|Treatment Epoch|Adverse Event|5|||
48406451|NCT01925209|155678537|FG002|Treatment Epoch|Adverse Event|3|||
48406452|NCT01925209|155678538|FG003|Treatment Epoch|Adverse Event|1|||
48406453|NCT01925209|155678535|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
48406454|NCT01925209|155678536|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
48406455|NCT01925209|155678537|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
48406456|NCT01925209|155678538|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
48406457|NCT01925209|155678535|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
48406458|NCT01925209|155678536|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
48406459|NCT01925209|155678537|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
48406460|NCT01925209|155678538|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
48406461|NCT01925209|155678535|FG000|Follow-up|Adverse Event|1|||
48406462|NCT01925209|155678536|FG001|Follow-up|Adverse Event|4|||
48406463|NCT01925209|155678537|FG002|Follow-up|Adverse Event|0|||
48406464|NCT01925209|155678538|FG003|Follow-up|Adverse Event|1|||
48406465|NCT01925209|155678535|FG000|Follow-up|Physician Decision|0|||
48406466|NCT01925209|155678536|FG001|Follow-up|Physician Decision|0|||
48406467|NCT01925209|155678537|FG002|Follow-up|Physician Decision|1|||
48406468|NCT01925209|155678538|FG003|Follow-up|Physician Decision|0|||
48406469|NCT01925209|155678535|FG000|Follow-up|Non-compliance with study treatment|0|||
48406470|NCT01925209|155678536|FG001|Follow-up|Non-compliance with study treatment|0|||
48406471|NCT01925209|155678537|FG002|Follow-up|Non-compliance with study treatment|0|||
48406472|NCT01925209|155678538|FG003|Follow-up|Non-compliance with study treatment|1|||
48406473|NCT01925209|155678535|FG000|Follow-up|Withdrawal by Subject|0|||
48406474|NCT01925209|155678536|FG001|Follow-up|Withdrawal by Subject|2|||
48406475|NCT01925209|155678537|FG002|Follow-up|Withdrawal by Subject|0|||
48406476|NCT01925209|155678538|FG003|Follow-up|Withdrawal by Subject|2|||
48406477|NCT01700192|155678546|FG000|Overall Study|Adverse Event|73|||
48406478|NCT01700192|155678547|FG001|Overall Study|Adverse Event|18|||
48406479|NCT01700192|155678546|FG000|Overall Study|Lack of Efficacy|1|||
48406480|NCT01700192|155678547|FG001|Overall Study|Lack of Efficacy|0|||
48406481|NCT01700192|155678546|FG000|Overall Study|Lost to Follow-up|42|||
48406482|NCT01700192|155678547|FG001|Overall Study|Lost to Follow-up|29|||
48406483|NCT01700192|155678546|FG000|Overall Study|Noncompliance with study drug|0|||
48406484|NCT01700192|155678547|FG001|Overall Study|Noncompliance with study drug|5|||
48406485|NCT01700192|155678546|FG000|Overall Study|Physician Decision|2|||
48406486|NCT01700192|155678547|FG001|Overall Study|Physician Decision|3|||
48406487|NCT01700192|155678546|FG000|Overall Study|Pregnancy|1|||
48406488|NCT01700192|155678547|FG001|Overall Study|Pregnancy|4|||
48406489|NCT01700192|155678546|FG000|Overall Study|Progressive disease|1|||
48406490|NCT01700192|155678547|FG001|Overall Study|Progressive disease|0|||
48406491|NCT01700192|155678546|FG000|Overall Study|Protocol Violation|3|||
48406492|NCT01700192|155678547|FG001|Overall Study|Protocol Violation|4|||
48406493|NCT01700192|155678546|FG000|Overall Study|Technical problems|0|||
48406494|NCT01700192|155678547|FG001|Overall Study|Technical problems|1|||
48406495|NCT01700192|155678546|FG000|Overall Study|Withdrawal by Subject|56|||
48406496|NCT01700192|155678547|FG001|Overall Study|Withdrawal by Subject|64|||
48406497|NCT01700192|155678546|FG000|Overall Study|Never received study drug|1|||
48406498|NCT01700192|155678547|FG001|Overall Study|Never received study drug|0|||
48406499|NCT01703858|155678548|FG000|Overall Study|Withdrawal by Subject|0|||
48406500|NCT01703858|155678549|FG001|Overall Study|Withdrawal by Subject|1|||
48406501|NCT01703858|155678550|FG002|Overall Study|Withdrawal by Subject|0|||
48406502|NCT01500057|155678551|FG000|Overall Study|Lost to Follow-up|6|||
48406503|NCT01500057|155678552|FG001|Overall Study|Lost to Follow-up|4|||
48406504|NCT00792298|155678558|FG000|Treatment Period 1|Adverse Event|0|||
48406505|NCT00792298|155678559|FG001|Treatment Period 1|Adverse Event|1|||
48406506|NCT00792298|155678560|FG002|Treatment Period 1|Adverse Event|0|||
48406507|NCT00792298|155678561|FG003|Treatment Period 1|Adverse Event|1|||
48406508|NCT00792298|155678562|FG004|Treatment Period 1|Adverse Event|0|||
48406509|NCT00792298|155678563|FG005|Treatment Period 1|Adverse Event|1|||
48406510|NCT00792298|155678564|FG006|Treatment Period 1|Adverse Event|1|||
48406511|NCT00792298|155678565|FG007|Treatment Period 1|Adverse Event|0|||
48406512|NCT00792298|155678558|FG000|Treatment Period 1|Lack of Efficacy|0|||
48406513|NCT00792298|155678559|FG001|Treatment Period 1|Lack of Efficacy|0|||
48406514|NCT00792298|155678560|FG002|Treatment Period 1|Lack of Efficacy|1|||
48406515|NCT00792298|155678561|FG003|Treatment Period 1|Lack of Efficacy|0|||
48406516|NCT00792298|155678562|FG004|Treatment Period 1|Lack of Efficacy|0|||
48406517|NCT00792298|155678563|FG005|Treatment Period 1|Lack of Efficacy|0|||
48406518|NCT00792298|155678564|FG006|Treatment Period 1|Lack of Efficacy|0|||
48406519|NCT00792298|155678565|FG007|Treatment Period 1|Lack of Efficacy|0|||
48406520|NCT00792298|155678558|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48406521|NCT00792298|155678559|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48406522|NCT00792298|155678560|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48406523|NCT00792298|155678561|FG003|Treatment Period 1|Withdrawal by Subject|2|||
48406524|NCT00792298|155678562|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48406525|NCT00792298|155678563|FG005|Treatment Period 1|Withdrawal by Subject|2|||
48406526|NCT00792298|155678564|FG006|Treatment Period 1|Withdrawal by Subject|1|||
48406527|NCT00792298|155678565|FG007|Treatment Period 1|Withdrawal by Subject|0|||
48406528|NCT00792298|155678558|FG000|Treatment Period 1|Lost to Follow-up|0|||
48406529|NCT00792298|155678559|FG001|Treatment Period 1|Lost to Follow-up|0|||
48406530|NCT00792298|155678560|FG002|Treatment Period 1|Lost to Follow-up|0|||
48406531|NCT00792298|155678561|FG003|Treatment Period 1|Lost to Follow-up|0|||
48406532|NCT00792298|155678562|FG004|Treatment Period 1|Lost to Follow-up|0|||
48406533|NCT00792298|155678563|FG005|Treatment Period 1|Lost to Follow-up|0|||
48406534|NCT00792298|155678564|FG006|Treatment Period 1|Lost to Follow-up|1|||
48406535|NCT00792298|155678565|FG007|Treatment Period 1|Lost to Follow-up|0|||
48406536|NCT00792298|155678558|FG000|Treatment Period 1|Physician Decision|0|||
48406537|NCT00792298|155678559|FG001|Treatment Period 1|Physician Decision|0|||
48406538|NCT00792298|155678560|FG002|Treatment Period 1|Physician Decision|0|||
48406539|NCT00792298|155678561|FG003|Treatment Period 1|Physician Decision|1|||
48406540|NCT00792298|155678562|FG004|Treatment Period 1|Physician Decision|0|||
48406541|NCT00792298|155678563|FG005|Treatment Period 1|Physician Decision|0|||
48406542|NCT00792298|155678564|FG006|Treatment Period 1|Physician Decision|1|||
48406543|NCT00792298|155678565|FG007|Treatment Period 1|Physician Decision|0|||
48406544|NCT00792298|155678558|FG000|Treatment Period 1|Protocol Violation|0|||
48406545|NCT00792298|155678559|FG001|Treatment Period 1|Protocol Violation|0|||
48406546|NCT00792298|155678560|FG002|Treatment Period 1|Protocol Violation|0|||
48406547|NCT00792298|155678561|FG003|Treatment Period 1|Protocol Violation|0|||
48406548|NCT00792298|155678562|FG004|Treatment Period 1|Protocol Violation|0|||
48406549|NCT00792298|155678563|FG005|Treatment Period 1|Protocol Violation|0|||
48406550|NCT00792298|155678564|FG006|Treatment Period 1|Protocol Violation|0|||
48406551|NCT00792298|155678565|FG007|Treatment Period 1|Protocol Violation|1|||
48406552|NCT00792298|155678558|FG000|Washout|Adverse Event|0|||
48406553|NCT00792298|155678559|FG001|Washout|Adverse Event|0|||
48406554|NCT00792298|155678560|FG002|Washout|Adverse Event|0|||
48406555|NCT00792298|155678561|FG003|Washout|Adverse Event|0|||
48406556|NCT00792298|155678562|FG004|Washout|Adverse Event|0|||
48406557|NCT00792298|155678563|FG005|Washout|Adverse Event|1|||
48406558|NCT00792298|155678564|FG006|Washout|Adverse Event|0|||
48406559|NCT00792298|155678565|FG007|Washout|Adverse Event|0|||
48406560|NCT00792298|155678558|FG000|Washout|Withdrawal by Subject|0|||
48406561|NCT00792298|155678559|FG001|Washout|Withdrawal by Subject|0|||
48406562|NCT00792298|155678560|FG002|Washout|Withdrawal by Subject|1|||
48406563|NCT00792298|155678561|FG003|Washout|Withdrawal by Subject|0|||
48406564|NCT00792298|155678562|FG004|Washout|Withdrawal by Subject|0|||
48406565|NCT00792298|155678563|FG005|Washout|Withdrawal by Subject|1|||
48406566|NCT00792298|155678564|FG006|Washout|Withdrawal by Subject|0|||
48406567|NCT00792298|155678565|FG007|Washout|Withdrawal by Subject|0|||
48406568|NCT00792298|155678558|FG000|Treatment Period 2|Lack of Efficacy|0|||
48406569|NCT00792298|155678559|FG001|Treatment Period 2|Lack of Efficacy|0|||
48406570|NCT00792298|155678560|FG002|Treatment Period 2|Lack of Efficacy|0|||
48406571|NCT00792298|155678561|FG003|Treatment Period 2|Lack of Efficacy|0|||
48406572|NCT00792298|155678562|FG004|Treatment Period 2|Lack of Efficacy|1|||
48406573|NCT00792298|155678563|FG005|Treatment Period 2|Lack of Efficacy|0|||
48406574|NCT00792298|155678564|FG006|Treatment Period 2|Lack of Efficacy|0|||
48406575|NCT00792298|155678565|FG007|Treatment Period 2|Lack of Efficacy|0|||
48406576|NCT00792298|155678558|FG000|Treatment Period 2|Physician Decision|0|||
48406577|NCT00792298|155678559|FG001|Treatment Period 2|Physician Decision|0|||
48406578|NCT00792298|155678560|FG002|Treatment Period 2|Physician Decision|0|||
48406579|NCT00792298|155678561|FG003|Treatment Period 2|Physician Decision|0|||
48406580|NCT00792298|155678562|FG004|Treatment Period 2|Physician Decision|0|||
48406581|NCT00792298|155678563|FG005|Treatment Period 2|Physician Decision|0|||
48406582|NCT00792298|155678564|FG006|Treatment Period 2|Physician Decision|1|||
48406583|NCT00792298|155678565|FG007|Treatment Period 2|Physician Decision|0|||
48406584|NCT00792298|155678558|FG000|Treatment Period 2|Pregnancy|0|||
48406585|NCT00792298|155678559|FG001|Treatment Period 2|Pregnancy|0|||
48406586|NCT00792298|155678560|FG002|Treatment Period 2|Pregnancy|1|||
48406587|NCT00792298|155678561|FG003|Treatment Period 2|Pregnancy|0|||
48406588|NCT00792298|155678562|FG004|Treatment Period 2|Pregnancy|0|||
48406589|NCT00792298|155678563|FG005|Treatment Period 2|Pregnancy|0|||
48406590|NCT00792298|155678564|FG006|Treatment Period 2|Pregnancy|0|||
48406591|NCT00792298|155678565|FG007|Treatment Period 2|Pregnancy|0|||
48406592|NCT00792298|155678558|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48406593|NCT00792298|155678559|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48406594|NCT00792298|155678560|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48406595|NCT00792298|155678561|FG003|Treatment Period 2|Withdrawal by Subject|2|||
48406596|NCT00792298|155678562|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48406597|NCT00792298|155678563|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48406598|NCT00792298|155678564|FG006|Treatment Period 2|Withdrawal by Subject|0|||
48406599|NCT00792298|155678565|FG007|Treatment Period 2|Withdrawal by Subject|2|||
48406600|NCT00354601|155678567|FG000|Overall Study|Protocol Violation|1|||
48406601|NCT00354601|155678567|FG000|Overall Study|progression|1|||
48406602|NCT00666926|155678569|FG000|Overall Study|Adverse Event|0|||
48406603|NCT00666926|155678570|FG001|Overall Study|Adverse Event|0|||
48406604|NCT00666926|155678571|FG002|Overall Study|Adverse Event|0|||
48406605|NCT00666926|155678572|FG003|Overall Study|Adverse Event|0|||
48406606|NCT00666926|155678573|FG004|Overall Study|Adverse Event|0|||
48406607|NCT00666926|155678574|FG005|Overall Study|Adverse Event|0|||
48406608|NCT00666926|155678575|FG006|Overall Study|Adverse Event|0|||
48406609|NCT00666926|155678576|FG007|Overall Study|Adverse Event|0|||
48406610|NCT00666926|155678577|FG008|Overall Study|Adverse Event|0|||
48406611|NCT00666926|155678578|FG009|Overall Study|Adverse Event|2|||
48406612|NCT00666926|155678579|FG010|Overall Study|Adverse Event|2|||
48406613|NCT00666926|155678580|FG011|Overall Study|Adverse Event|2|||
48406614|NCT00666926|155678581|FG012|Overall Study|Adverse Event|0|||
48406615|NCT00666926|155678582|FG013|Overall Study|Adverse Event|1|||
48406616|NCT00666926|155678583|FG014|Overall Study|Adverse Event|0|||
48406617|NCT00666926|155678584|FG015|Overall Study|Adverse Event|0|||
48406618|NCT00666926|155678569|FG000|Overall Study|Laboratory abnormality|0|||
48406619|NCT00666926|155678570|FG001|Overall Study|Laboratory abnormality|0|||
48406620|NCT00666926|155678571|FG002|Overall Study|Laboratory abnormality|0|||
48406621|NCT00666926|155678572|FG003|Overall Study|Laboratory abnormality|0|||
48406622|NCT00666926|155678573|FG004|Overall Study|Laboratory abnormality|0|||
48406623|NCT00666926|155678574|FG005|Overall Study|Laboratory abnormality|0|||
48406624|NCT00666926|155678575|FG006|Overall Study|Laboratory abnormality|0|||
48406625|NCT00666926|155678576|FG007|Overall Study|Laboratory abnormality|0|||
48406626|NCT00666926|155678577|FG008|Overall Study|Laboratory abnormality|0|||
48406627|NCT00666926|155678578|FG009|Overall Study|Laboratory abnormality|0|||
48406628|NCT00666926|155678579|FG010|Overall Study|Laboratory abnormality|1|||
48406629|NCT00666926|155678580|FG011|Overall Study|Laboratory abnormality|0|||
48406630|NCT00666926|155678581|FG012|Overall Study|Laboratory abnormality|0|||
48406631|NCT00666926|155678582|FG013|Overall Study|Laboratory abnormality|0|||
48406632|NCT00666926|155678583|FG014|Overall Study|Laboratory abnormality|0|||
48406633|NCT00666926|155678584|FG015|Overall Study|Laboratory abnormality|1|||
48406634|NCT00666926|155678569|FG000|Overall Study|Lack of Efficacy|0|||
48406635|NCT00666926|155678570|FG001|Overall Study|Lack of Efficacy|0|||
48406636|NCT00666926|155678571|FG002|Overall Study|Lack of Efficacy|0|||
48406637|NCT00666926|155678572|FG003|Overall Study|Lack of Efficacy|0|||
48406638|NCT00666926|155678573|FG004|Overall Study|Lack of Efficacy|0|||
48406639|NCT00666926|155678574|FG005|Overall Study|Lack of Efficacy|1|||
48406640|NCT00666926|155678575|FG006|Overall Study|Lack of Efficacy|0|||
48406641|NCT00666926|155678576|FG007|Overall Study|Lack of Efficacy|0|||
48406642|NCT00666926|155678577|FG008|Overall Study|Lack of Efficacy|0|||
48406643|NCT00666926|155678578|FG009|Overall Study|Lack of Efficacy|0|||
48406644|NCT00666926|155678579|FG010|Overall Study|Lack of Efficacy|0|||
48406645|NCT00666926|155678580|FG011|Overall Study|Lack of Efficacy|1|||
48406646|NCT00666926|155678581|FG012|Overall Study|Lack of Efficacy|0|||
48406647|NCT00666926|155678582|FG013|Overall Study|Lack of Efficacy|0|||
48406648|NCT00666926|155678583|FG014|Overall Study|Lack of Efficacy|0|||
48406649|NCT00666926|155678584|FG015|Overall Study|Lack of Efficacy|0|||
48406650|NCT00666926|155678569|FG000|Overall Study|Lost to Follow-up|0|||
48406651|NCT00666926|155678570|FG001|Overall Study|Lost to Follow-up|0|||
48406652|NCT00666926|155678571|FG002|Overall Study|Lost to Follow-up|0|||
48406653|NCT00666926|155678572|FG003|Overall Study|Lost to Follow-up|1|||
48406654|NCT00666926|155678573|FG004|Overall Study|Lost to Follow-up|0|||
48406655|NCT00666926|155678574|FG005|Overall Study|Lost to Follow-up|0|||
48406656|NCT00666926|155678575|FG006|Overall Study|Lost to Follow-up|0|||
48406657|NCT00666926|155678576|FG007|Overall Study|Lost to Follow-up|0|||
48406658|NCT00666926|155678577|FG008|Overall Study|Lost to Follow-up|0|||
48406659|NCT00666926|155678578|FG009|Overall Study|Lost to Follow-up|0|||
48406660|NCT00666926|155678579|FG010|Overall Study|Lost to Follow-up|0|||
48406661|NCT00666926|155678580|FG011|Overall Study|Lost to Follow-up|0|||
48406662|NCT00666926|155678581|FG012|Overall Study|Lost to Follow-up|0|||
48406663|NCT00666926|155678582|FG013|Overall Study|Lost to Follow-up|0|||
48406664|NCT00666926|155678583|FG014|Overall Study|Lost to Follow-up|0|||
48406665|NCT00666926|155678584|FG015|Overall Study|Lost to Follow-up|0|||
48406666|NCT00666926|155678569|FG000|Overall Study|Other|2|||
48406667|NCT00666926|155678570|FG001|Overall Study|Other|4|||
48406668|NCT00666926|155678571|FG002|Overall Study|Other|3|||
48406669|NCT00666926|155678572|FG003|Overall Study|Other|3|||
48406670|NCT00666926|155678573|FG004|Overall Study|Other|3|||
48406671|NCT00666926|155678574|FG005|Overall Study|Other|3|||
48406672|NCT00666926|155678575|FG006|Overall Study|Other|4|||
48406673|NCT00666926|155678576|FG007|Overall Study|Other|0|||
48406674|NCT00666926|155678577|FG008|Overall Study|Other|3|||
48406675|NCT00666926|155678578|FG009|Overall Study|Other|5|||
48406676|NCT00666926|155678579|FG010|Overall Study|Other|3|||
48406677|NCT00666926|155678580|FG011|Overall Study|Other|26|||
48406678|NCT00666926|155678581|FG012|Overall Study|Other|3|||
48406679|NCT00666926|155678582|FG013|Overall Study|Other|2|||
48406680|NCT00666926|155678583|FG014|Overall Study|Other|4|||
48406681|NCT00666926|155678584|FG015|Overall Study|Other|4|||
48406682|NCT00666926|155678569|FG000|Overall Study|Withdrawal by Subject|0|||
48406683|NCT00666926|155678570|FG001|Overall Study|Withdrawal by Subject|0|||
48406684|NCT00666926|155678571|FG002|Overall Study|Withdrawal by Subject|0|||
48406685|NCT00666926|155678572|FG003|Overall Study|Withdrawal by Subject|0|||
48406686|NCT00666926|155678573|FG004|Overall Study|Withdrawal by Subject|0|||
48406687|NCT00666926|155678574|FG005|Overall Study|Withdrawal by Subject|0|||
48406688|NCT00666926|155678575|FG006|Overall Study|Withdrawal by Subject|0|||
48406689|NCT00666926|155678576|FG007|Overall Study|Withdrawal by Subject|1|||
48406690|NCT00666926|155678577|FG008|Overall Study|Withdrawal by Subject|0|||
48406691|NCT00666926|155678578|FG009|Overall Study|Withdrawal by Subject|3|||
48406692|NCT00666926|155678579|FG010|Overall Study|Withdrawal by Subject|0|||
48406693|NCT00666926|155678580|FG011|Overall Study|Withdrawal by Subject|3|||
48406694|NCT00666926|155678581|FG012|Overall Study|Withdrawal by Subject|0|||
48406695|NCT00666926|155678582|FG013|Overall Study|Withdrawal by Subject|1|||
48406696|NCT00666926|155678583|FG014|Overall Study|Withdrawal by Subject|3|||
48406697|NCT00666926|155678584|FG015|Overall Study|Withdrawal by Subject|3|||
48406698|NCT00666926|155678569|FG000|Overall Study|Death|0|||
48406699|NCT00666926|155678570|FG001|Overall Study|Death|0|||
48406700|NCT00666926|155678571|FG002|Overall Study|Death|0|||
48406701|NCT00666926|155678572|FG003|Overall Study|Death|0|||
48406702|NCT00666926|155678573|FG004|Overall Study|Death|0|||
48406703|NCT00666926|155678574|FG005|Overall Study|Death|0|||
48406704|NCT00666926|155678575|FG006|Overall Study|Death|0|||
48406705|NCT00666926|155678576|FG007|Overall Study|Death|0|||
48406706|NCT00666926|155678577|FG008|Overall Study|Death|0|||
48406707|NCT00666926|155678578|FG009|Overall Study|Death|0|||
48406708|NCT00666926|155678579|FG010|Overall Study|Death|0|||
48406709|NCT00666926|155678580|FG011|Overall Study|Death|1|||
48406710|NCT00666926|155678581|FG012|Overall Study|Death|0|||
48406711|NCT00666926|155678582|FG013|Overall Study|Death|0|||
48406712|NCT00666926|155678583|FG014|Overall Study|Death|0|||
48406713|NCT00666926|155678584|FG015|Overall Study|Death|0|||
48357498|NCT01252355|155504895|FG002|Overall Study|Poor Compliance to Protocol|1|||
48357499|NCT01252355|155504893|FG000|Overall Study|Progressive Disease|2|||
48357500|NCT01252355|155504894|FG001|Overall Study|Progressive Disease|0|||
48357501|NCT01252355|155504895|FG002|Overall Study|Progressive Disease|0|||
48357502|NCT01252355|155504893|FG000|Overall Study|Sponsor Early Termination of Study|149|||
48357503|NCT01252355|155504894|FG001|Overall Study|Sponsor Early Termination of Study|149|||
48357504|NCT01252355|155504895|FG002|Overall Study|Sponsor Early Termination of Study|146|||
48357505|NCT01252355|155504893|FG000|Overall Study|Randomized but not Treated|2|||
48357506|NCT01252355|155504894|FG001|Overall Study|Randomized but not Treated|0|||
48357507|NCT01252355|155504895|FG002|Overall Study|Randomized but not Treated|0|||
48357508|NCT01252355|155504893|FG000|Overall Study|Other Than Above|8|||
48357509|NCT01252355|155504894|FG001|Overall Study|Other Than Above|7|||
48357510|NCT01252355|155504895|FG002|Overall Study|Other Than Above|7|||
48357511|NCT00955708|155504896|FG000|Overall Study|Death|269|||
48357512|NCT00955708|155504896|FG000|Overall Study|Lost to Follow-up|72|||
48357513|NCT00955708|155504896|FG000|Overall Study|Physician Decision|36|||
48357514|NCT00955708|155504896|FG000|Overall Study|Protocol Violation|134|||
48357515|NCT00955708|155504896|FG000|Overall Study|Registry Conclusion|186|||
48357516|NCT00955708|155504896|FG000|Overall Study|Product removed from service|94|||
48357517|NCT00955708|155504896|FG000|Overall Study|Patient Refused to participate further|116|||
48357518|NCT00955708|155504896|FG000|Overall Study|Closure of study location|60|||
48357519|NCT00955708|155504896|FG000|Overall Study|Patient changed care provider/moved|91|||
48357520|NCT01736540|155504897|FG000|Overall Study|Did not complete scan within 45 days|2|||
48357521|NCT01736540|155504897|FG000|Overall Study|Death|1|||
48357522|NCT01736540|155504897|FG000|Overall Study|Abnormal test procedure|1|||
48406714|NCT02883244|155678585|FG000|Overall Study|Lost to Follow-up|0|||
48406715|NCT02883244|155678586|FG001|Overall Study|Lost to Follow-up|1|||
48406716|NCT00330187|155678587|FG000|Overall Study|Lost to Follow-up|12|||
48406717|NCT00330187|155678588|FG001|Overall Study|Lost to Follow-up|13|||
48406718|NCT00330187|155678589|FG002|Overall Study|Lost to Follow-up|14|||
48406719|NCT00330187|155678590|FG003|Overall Study|Lost to Follow-up|10|||
48406720|NCT00330187|155678587|FG000|Overall Study|Withdrawal by Subject|8|||
48406721|NCT00330187|155678588|FG001|Overall Study|Withdrawal by Subject|5|||
48406722|NCT00330187|155678589|FG002|Overall Study|Withdrawal by Subject|4|||
48406723|NCT00330187|155678590|FG003|Overall Study|Withdrawal by Subject|4|||
48406724|NCT01225562|155678593|FG000|Overall Study|Withdrawal by Subject|52|||
48406725|NCT01225562|155678594|FG001|Overall Study|Withdrawal by Subject|50|||
48406726|NCT01225562|155678595|FG002|Overall Study|Withdrawal by Subject|52|||
48406727|NCT01225562|155678593|FG000|Overall Study|Lost to Follow-up|3|||
48406728|NCT01225562|155678594|FG001|Overall Study|Lost to Follow-up|6|||
48406729|NCT01225562|155678595|FG002|Overall Study|Lost to Follow-up|1|||
48406730|NCT00364182|155678597|FG000|First Intervention|Secondary prophylaxis|1|||
48406731|NCT00364182|155678598|FG001|First Intervention|Secondary prophylaxis|0|||
48406732|NCT00364182|155678599|FG002|First Intervention|Secondary prophylaxis|0|||
48406733|NCT00364182|155678597|FG000|First Intervention|Withdrawal by Subject|2|||
48357523|NCT01736540|155504897|FG000|Overall Study|Withdrawal by Subject|5|||
48357524|NCT01736540|155504897|FG000|Overall Study|Protocol Violation|1|||
48406734|NCT00364182|155678598|FG001|First Intervention|Withdrawal by Subject|0|||
48406735|NCT00364182|155678599|FG002|First Intervention|Withdrawal by Subject|0|||
48406736|NCT00364182|155678597|FG000|Second Intervention|non-compliance|0|||
48406737|NCT00364182|155678598|FG001|Second Intervention|non-compliance|1|||
48406738|NCT00364182|155678599|FG002|Second Intervention|non-compliance|1|||
48406739|NCT00364182|155678597|FG000|Second Intervention|Protocol Violation|0|||
48431201|NCT01599754|155765345|FG001|Overall Study|Adverse Event|2|||
48406740|NCT00364182|155678598|FG001|Second Intervention|Protocol Violation|1|||
48406741|NCT00364182|155678599|FG002|Second Intervention|Protocol Violation|0|||
48406742|NCT00364182|155678597|FG000|Second Intervention|Adverse Event|0|||
48406743|NCT00364182|155678598|FG001|Second Intervention|Adverse Event|0|||
48406744|NCT00364182|155678599|FG002|Second Intervention|Adverse Event|1|||
48406745|NCT00364182|155678597|FG000|Third Intervention|non-compliance|0|||
48406746|NCT00364182|155678598|FG001|Third Intervention|non-compliance|1|||
48406747|NCT00364182|155678599|FG002|Third Intervention|non-compliance|0|||
48406748|NCT00364182|155678597|FG000|Third Intervention|Lost to Follow-up|0|||
48406749|NCT00364182|155678598|FG001|Third Intervention|Lost to Follow-up|0|||
48406750|NCT00364182|155678599|FG002|Third Intervention|Lost to Follow-up|1|||
48406751|NCT03336502|155678600|FG000|Overall Study|Physician Decision|0|||
48406752|NCT03336502|155678601|FG001|Overall Study|Physician Decision|1|||
48357525|NCT01736540|155504897|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
48357526|NCT01736540|155504897|FG000|Overall Study|No show for MRI appointment|1|||
48406753|NCT03336502|155678600|FG000|Overall Study|Prohibited Drugs|1|||
48406754|NCT03336502|155678601|FG001|Overall Study|Prohibited Drugs|1|||
48406755|NCT03336502|155678600|FG000|Overall Study|Death|1|||
48406756|NCT03336502|155678601|FG001|Overall Study|Death|2|||
48406757|NCT03336502|155678600|FG000|Overall Study|Adverse Event|2|||
48406758|NCT03336502|155678601|FG001|Overall Study|Adverse Event|5|||
48406759|NCT01133171|155678605|FG000|Overall Study|Withdrawal by Subject|1|||
48406760|NCT01133171|155678606|FG001|Overall Study|Withdrawal by Subject|2|||
48406761|NCT01133171|155678607|FG002|Overall Study|Withdrawal by Subject|0|||
48406762|NCT03969888|155678608|FG000|Overall Study|Never Received Study Drug|0|||
48406763|NCT03969888|155678609|FG001|Overall Study|Never Received Study Drug|0|||
48406764|NCT03969888|155678610|FG002|Overall Study|Never Received Study Drug|1|||
48406765|NCT03969888|155678611|FG003|Overall Study|Never Received Study Drug|0|||
48406766|NCT03969888|155678612|FG004|Overall Study|Never Received Study Drug|0|||
48406767|NCT03969888|155678613|FG005|Overall Study|Never Received Study Drug|0|||
48406768|NCT03969888|155678614|FG006|Overall Study|Never Received Study Drug|1|||
48406769|NCT03969888|155678615|FG007|Overall Study|Never Received Study Drug|0|||
48406770|NCT03969888|155678608|FG000|Overall Study|Reason Not Specified|0|||
48406771|NCT03969888|155678609|FG001|Overall Study|Reason Not Specified|0|||
48406772|NCT03969888|155678610|FG002|Overall Study|Reason Not Specified|0|||
48406773|NCT03969888|155678611|FG003|Overall Study|Reason Not Specified|0|||
48406774|NCT03969888|155678612|FG004|Overall Study|Reason Not Specified|0|||
48406775|NCT03969888|155678613|FG005|Overall Study|Reason Not Specified|0|||
48406776|NCT03969888|155678614|FG006|Overall Study|Reason Not Specified|0|||
48406777|NCT03969888|155678615|FG007|Overall Study|Reason Not Specified|1|||
48406778|NCT00291551|155678618|FG000|Overall Study|Death|7|||
48406779|NCT00291551|155678618|FG000|Overall Study|Withdrawal by Subject|6|||
48426304|NCT00064662|155749536|FG001|Overall Study|Administratively withdrawn|2|||
48426305|NCT00933335|155749546|FG000|Overall Study|Lost to Follow-up|1|||
48426306|NCT00933335|155749547|FG001|Overall Study|Lost to Follow-up|3|||
48426307|NCT00933335|155749546|FG000|Overall Study|Withdrawal by Subject|0|||
48426308|NCT00933335|155749547|FG001|Overall Study|Withdrawal by Subject|1|||
48426309|NCT00933335|155749546|FG000|Overall Study|Progressive Disease|0|||
48406780|NCT02322710|155680075|FG000|Overall Study|No efficacy assessment post-baseline|0|||
48406781|NCT02322710|155680076|FG001|Overall Study|No efficacy assessment post-baseline|1|||
48406782|NCT02322710|155680075|FG000|Overall Study|Protocol Violation|20|||
48406783|NCT02322710|155680076|FG001|Overall Study|Protocol Violation|25|||
48406784|NCT02894840|155680077|FG000|Overall Study|Lost to Follow-up|1|||
48406785|NCT02894840|155680078|FG001|Overall Study|Lost to Follow-up|0|||
48406786|NCT02894840|155680079|FG002|Overall Study|Lost to Follow-up|3|||
48406787|NCT02894840|155680080|FG003|Overall Study|Lost to Follow-up|0|||
48406788|NCT01871090|155680087|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
48406789|NCT01871090|155680088|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
48406790|NCT01871090|155680087|FG000|Overall Study|Interrogation not completed correctly|1|||
48406791|NCT01871090|155680088|FG001|Overall Study|Interrogation not completed correctly|0|||
48406792|NCT01871090|155680087|FG000|Overall Study|Subject Non-Compliance|0|||
48406793|NCT01871090|155680088|FG001|Overall Study|Subject Non-Compliance|1|||
48406794|NCT01707030|155680092|FG000|Overall Study|Death|1|||
48406795|NCT01707030|155680093|FG001|Overall Study|Death|1|||
48406796|NCT01707030|155680092|FG000|Overall Study|Withdrawal by Subject|2|||
48406797|NCT01707030|155680093|FG001|Overall Study|Withdrawal by Subject|3|||
48406798|NCT01707030|155680092|FG000|Overall Study|Lost to Follow-up|8|||
48406799|NCT01707030|155680093|FG001|Overall Study|Lost to Follow-up|13|||
48406800|NCT03569202|155680094|FG000|Part 3|Physician Decision|1|||
48406801|NCT03569202|155680095|FG001|Part 3|Physician Decision|0|||
48406802|NCT03569202|155680094|FG000|Part 3|Other|1|||
48406803|NCT03569202|155680095|FG001|Part 3|Other|1|||
48406804|NCT01668654|155680096|FG000|Overall Study|Study Closed/Terminated|3|||
48406805|NCT01668654|155680096|FG000|Overall Study|Withdrawal by Subject|1|||
48406806|NCT04557384|155680097|FG000|Overall Study|Study Terminated by Sponsor|1|||
48406807|NCT04557384|155680097|FG000|Overall Study|Death|1|||
48406808|NCT03806127|155680098|FG000|Overall Study|Withdrawal by Subject|4|||
48406809|NCT03806127|155680099|FG001|Overall Study|Withdrawal by Subject|5|||
48406810|NCT03806127|155680098|FG000|Overall Study|Protocol Violation|3|||
48406811|NCT03806127|155680099|FG001|Overall Study|Protocol Violation|1|||
48406812|NCT03806127|155680098|FG000|Overall Study|Adverse Event|3|||
48406813|NCT03806127|155680099|FG001|Overall Study|Adverse Event|0|||
48406814|NCT03806127|155680098|FG000|Overall Study|Unable to Complete Procedures|0|||
48406815|NCT03806127|155680099|FG001|Overall Study|Unable to Complete Procedures|1|||
48406816|NCT03806127|155680098|FG000|Overall Study|Pregnancy|0|||
48406817|NCT03806127|155680099|FG001|Overall Study|Pregnancy|1|||
48406818|NCT03806127|155680098|FG000|Overall Study|Lost to Follow-up|5|||
48406819|NCT03806127|155680099|FG001|Overall Study|Lost to Follow-up|1|||
48406820|NCT03806127|155680098|FG000|Overall Study|Physician Decision|1|||
48406821|NCT03806127|155680099|FG001|Overall Study|Physician Decision|1|||
48406822|NCT03806127|155680098|FG000|Overall Study|Could Not Come Due to Covid|1|||
48406823|NCT03806127|155680099|FG001|Overall Study|Could Not Come Due to Covid|0|||
48406824|NCT03806127|155680098|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
48406825|NCT03806127|155680099|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
48406826|NCT03806127|155680098|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
48406827|NCT03806127|155680099|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
48406828|NCT03806127|155680098|FG000|Overall Study|Covid 19 Restrictions|2|||
48406829|NCT03806127|155680099|FG001|Overall Study|Covid 19 Restrictions|0|||
48406830|NCT03806127|155680098|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
48406831|NCT03806127|155680099|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
48406832|NCT03806127|155680098|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
48406833|NCT03806127|155680099|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
48406834|NCT01622569|155680103|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
48406835|NCT01622569|155680104|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
48406836|NCT01622569|155680105|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
48406837|NCT01622569|155680106|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
48406838|NCT01622569|155680103|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
48406839|NCT01622569|155680104|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
48406840|NCT01622569|155680105|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
48406841|NCT01622569|155680106|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
48406842|NCT01622569|155680103|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
48406843|NCT01622569|155680104|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
48406844|NCT01622569|155680105|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
48406845|NCT01622569|155680106|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
48406846|NCT01622569|155680103|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48406847|NCT01622569|155680104|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
48406848|NCT01622569|155680105|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
48406849|NCT01622569|155680106|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
48406850|NCT01622569|155680103|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
48406851|NCT01622569|155680104|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
48406852|NCT01622569|155680105|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
48406853|NCT01622569|155680106|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
48406854|NCT01622569|155680103|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
48406855|NCT01622569|155680104|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
48406856|NCT01622569|155680105|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
48406857|NCT01622569|155680106|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
48406858|NCT01622569|155680103|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
48406859|NCT01622569|155680104|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
48406860|NCT01622569|155680105|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
48406861|NCT01622569|155680106|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
48406862|NCT01622569|155680103|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48406863|NCT01622569|155680104|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48406864|NCT01622569|155680105|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
48406865|NCT01622569|155680106|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
48406866|NCT04173741|155680108|FG000|Overall Study|IVC measurement cannot be done|1|||
48406867|NCT04173741|155680109|FG001|Overall Study|IVC measurement cannot be done|1|||
48406868|NCT03634800|155680110|FG000|Overall Study|Adverse Event|1|||
48406869|NCT03634800|155680110|FG000|Overall Study|Disease Progression|4|||
48406870|NCT03634800|155680110|FG000|Overall Study|Withdrawal by Subject|1|||
48406871|NCT02167945|155680112|FG000|Overall Study|Adverse Event|16|||
48406872|NCT02167945|155680112|FG000|Overall Study|Withdrew Consent|42|||
48406873|NCT02167945|155680112|FG000|Overall Study|Lost to Follow-up|122|||
48406874|NCT02167945|155680112|FG000|Overall Study|COVID-19 logistical restrictions|6|||
48406875|NCT02167945|155680112|FG000|Overall Study|Other, not specified|63|||
48406876|NCT00624520|155680114|FG000|Overall Study|Withdrawal by Subject|12|||
48406877|NCT00624520|155680115|FG001|Overall Study|Withdrawal by Subject|7|||
48406878|NCT00624520|155680114|FG000|Overall Study|Death|0|||
48406879|NCT00624520|155680115|FG001|Overall Study|Death|1|||
48406880|NCT03075163|155680118|FG000|Overall Study|not eligible for treatment limb|138|||
48406881|NCT03075163|155680119|FG001|Overall Study|not eligible for treatment limb|138|||
48406882|NCT03882424|155680120|FG000|Overall Study|Lost to Follow-up|3|||
48357527|NCT01736540|155504897|FG000|Overall Study|Unable to make MRI appointment|3|||
48357528|NCT02993523|155504904|FG000|Overall Study|Withdrew Consent|0|||
48357529|NCT02993523|155504905|FG001|Overall Study|Withdrew Consent|0|||
48406883|NCT03882424|155680121|FG001|Overall Study|Lost to Follow-up|0|||
48406884|NCT03882424|155680122|FG002|Overall Study|Lost to Follow-up|0|||
48406885|NCT03882424|155680120|FG000|Overall Study|schedule conflict|1|||
48406886|NCT03882424|155680121|FG001|Overall Study|schedule conflict|0|||
48406887|NCT03882424|155680122|FG002|Overall Study|schedule conflict|0|||
48406888|NCT01451645|155680125|FG000|Overall Study|Protocol Violation|1|||
48406889|NCT01451645|155680126|FG001|Overall Study|Protocol Violation|0|||
48406890|NCT01451645|155680125|FG000|Overall Study|Adverse Event|0|||
48406891|NCT01451645|155680126|FG001|Overall Study|Adverse Event|3|||
48406892|NCT01451645|155680125|FG000|Overall Study|Withdrawal by Subject|4|||
48406893|NCT01451645|155680126|FG001|Overall Study|Withdrawal by Subject|2|||
48406894|NCT01451645|155680125|FG000|Overall Study|Lost to Follow-up|4|||
48406895|NCT01451645|155680126|FG001|Overall Study|Lost to Follow-up|3|||
48406896|NCT00946309|155680128|FG000|Overall Study|Protocol Violation|1|||
48406897|NCT00946309|155680129|FG001|Overall Study|Protocol Violation|0|||
48406898|NCT00946309|155680128|FG000|Overall Study|Lost to Follow-up|0|||
48406899|NCT00946309|155680129|FG001|Overall Study|Lost to Follow-up|1|||
48406900|NCT00946309|155680128|FG000|Overall Study|Procedure cancelled/discontinued|0|||
48406901|NCT00946309|155680129|FG001|Overall Study|Procedure cancelled/discontinued|3|||
48406902|NCT00584870|155680131|FG000|Overall Study|Adverse Event|4|||
48406903|NCT00584870|155680132|FG001|Overall Study|Adverse Event|3|||
48406904|NCT00584870|155680133|FG002|Overall Study|Adverse Event|2|||
48406905|NCT00584870|155680131|FG000|Overall Study|Lost to Follow-up|4|||
48406906|NCT00584870|155680132|FG001|Overall Study|Lost to Follow-up|1|||
48406907|NCT00584870|155680133|FG002|Overall Study|Lost to Follow-up|1|||
48406908|NCT00584870|155680131|FG000|Overall Study|Lack of Efficacy|7|||
48406909|NCT00584870|155680132|FG001|Overall Study|Lack of Efficacy|14|||
48406910|NCT00584870|155680133|FG002|Overall Study|Lack of Efficacy|8|||
48406911|NCT00584870|155680131|FG000|Overall Study|Withdrawal by Subject|10|||
48406912|NCT00584870|155680132|FG001|Overall Study|Withdrawal by Subject|5|||
48406913|NCT00584870|155680133|FG002|Overall Study|Withdrawal by Subject|3|||
48406914|NCT00584870|155680131|FG000|Overall Study|Protocol Violation|1|||
48406915|NCT00584870|155680132|FG001|Overall Study|Protocol Violation|1|||
48406916|NCT00584870|155680133|FG002|Overall Study|Protocol Violation|2|||
48406917|NCT00584870|155680131|FG000|Overall Study|Did not met entrance criteria|1|||
48406918|NCT00584870|155680132|FG001|Overall Study|Did not met entrance criteria|0|||
48406919|NCT00584870|155680133|FG002|Overall Study|Did not met entrance criteria|0|||
48406920|NCT00584870|155680131|FG000|Overall Study|Other|2|||
48406921|NCT00584870|155680132|FG001|Overall Study|Other|0|||
48406922|NCT00584870|155680133|FG002|Overall Study|Other|0|||
48406923|NCT00584870|155680131|FG000|Overall Study|Randomized but not treated|0|||
48406924|NCT00584870|155680132|FG001|Overall Study|Randomized but not treated|1|||
48406925|NCT00584870|155680133|FG002|Overall Study|Randomized but not treated|2|||
48406926|NCT04957290|155680134|FG000|Overall Study|Progressive disease|3|||
48406927|NCT04957290|155680135|FG001|Overall Study|Progressive disease|3|||
48406928|NCT04957290|155680136|FG002|Overall Study|Progressive disease|2|||
48406929|NCT04957290|155680137|FG003|Overall Study|Progressive disease|0|||
48406930|NCT04957290|155680138|FG004|Overall Study|Progressive disease|0|||
48406931|NCT04957290|155680139|FG005|Overall Study|Progressive disease|0|||
48406932|NCT04957290|155680134|FG000|Overall Study|Withdrawal by Subject|1|||
48406933|NCT04957290|155680135|FG001|Overall Study|Withdrawal by Subject|0|||
48406934|NCT04957290|155680136|FG002|Overall Study|Withdrawal by Subject|1|||
48406935|NCT04957290|155680137|FG003|Overall Study|Withdrawal by Subject|0|||
48406936|NCT04957290|155680138|FG004|Overall Study|Withdrawal by Subject|0|||
48406937|NCT04957290|155680139|FG005|Overall Study|Withdrawal by Subject|0|||
48406938|NCT04957290|155680134|FG000|Overall Study|Death|0|||
48406939|NCT04957290|155680135|FG001|Overall Study|Death|2|||
48406940|NCT04957290|155680136|FG002|Overall Study|Death|1|||
48406941|NCT04957290|155680137|FG003|Overall Study|Death|0|||
48406942|NCT04957290|155680138|FG004|Overall Study|Death|0|||
48406943|NCT04957290|155680139|FG005|Overall Study|Death|0|||
48406944|NCT04957290|155680134|FG000|Overall Study|non compliance with study drug|0|||
48406945|NCT04957290|155680135|FG001|Overall Study|non compliance with study drug|1|||
48406946|NCT04957290|155680136|FG002|Overall Study|non compliance with study drug|0|||
48406947|NCT04957290|155680137|FG003|Overall Study|non compliance with study drug|0|||
48406948|NCT04957290|155680138|FG004|Overall Study|non compliance with study drug|0|||
48406949|NCT04957290|155680139|FG005|Overall Study|non compliance with study drug|0|||
48406950|NCT04957290|155680134|FG000|Overall Study|none specified.|0|||
48406951|NCT04957290|155680135|FG001|Overall Study|none specified.|1|||
48406952|NCT04957290|155680136|FG002|Overall Study|none specified.|2|||
48406953|NCT04957290|155680137|FG003|Overall Study|none specified.|0|||
48406954|NCT04957290|155680138|FG004|Overall Study|none specified.|0|||
48406955|NCT04957290|155680139|FG005|Overall Study|none specified.|0|||
48406956|NCT04957290|155680134|FG000|Overall Study|unacceptable toxicity|0|||
48406957|NCT04957290|155680135|FG001|Overall Study|unacceptable toxicity|0|||
48406958|NCT04957290|155680136|FG002|Overall Study|unacceptable toxicity|1|||
48406959|NCT04957290|155680137|FG003|Overall Study|unacceptable toxicity|0|||
48406960|NCT04957290|155680138|FG004|Overall Study|unacceptable toxicity|0|||
48406961|NCT04957290|155680139|FG005|Overall Study|unacceptable toxicity|0|||
48406962|NCT04957290|155680134|FG000|Overall Study|Adverse Event|0|||
48406963|NCT04957290|155680135|FG001|Overall Study|Adverse Event|0|||
48406964|NCT04957290|155680136|FG002|Overall Study|Adverse Event|1|||
48406965|NCT04957290|155680137|FG003|Overall Study|Adverse Event|0|||
48406966|NCT04957290|155680138|FG004|Overall Study|Adverse Event|0|||
48406967|NCT04957290|155680139|FG005|Overall Study|Adverse Event|0|||
48406968|NCT04957290|155680134|FG000|Overall Study|study terminated by sponsor|0|||
48406969|NCT04957290|155680135|FG001|Overall Study|study terminated by sponsor|0|||
48406970|NCT04957290|155680136|FG002|Overall Study|study terminated by sponsor|2|||
48406971|NCT04957290|155680137|FG003|Overall Study|study terminated by sponsor|0|||
48406972|NCT04957290|155680138|FG004|Overall Study|study terminated by sponsor|0|||
48406973|NCT04957290|155680139|FG005|Overall Study|study terminated by sponsor|0|||
48406974|NCT03682120|155680140|FG000|Overall Study|Lost to Follow-up|11|||
48406975|NCT03682120|155680141|FG001|Overall Study|Lost to Follow-up|4|||
48406976|NCT03682120|155680142|FG002|Overall Study|Lost to Follow-up|5|||
48406977|NCT03682120|155680143|FG003|Overall Study|Lost to Follow-up|2|||
48406978|NCT03682120|155680140|FG000|Overall Study|Physician Decision|1|||
48406979|NCT03682120|155680141|FG001|Overall Study|Physician Decision|0|||
48406980|NCT03682120|155680142|FG002|Overall Study|Physician Decision|0|||
48406981|NCT03682120|155680143|FG003|Overall Study|Physician Decision|0|||
48406982|NCT03682120|155680140|FG000|Overall Study|Withdrawal by Subject|1|||
48406983|NCT03682120|155680141|FG001|Overall Study|Withdrawal by Subject|2|||
48406984|NCT03682120|155680142|FG002|Overall Study|Withdrawal by Subject|3|||
48406985|NCT03682120|155680143|FG003|Overall Study|Withdrawal by Subject|0|||
48406986|NCT03682120|155680140|FG000|Overall Study|Death|0|||
48406987|NCT03682120|155680141|FG001|Overall Study|Death|1|||
48406988|NCT03682120|155680142|FG002|Overall Study|Death|0|||
48406989|NCT03682120|155680143|FG003|Overall Study|Death|0|||
48406990|NCT03682120|155680140|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
48406991|NCT03682120|155680141|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
48406992|NCT03682120|155680142|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
48406993|NCT03682120|155680143|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
48406994|NCT01469000|155680144|FG000|Overall Study|Withdrawal by Subject|16|||
48406995|NCT01469000|155680145|FG001|Overall Study|Withdrawal by Subject|3|||
48406996|NCT01469000|155680144|FG000|Overall Study|Sponsor Decision|4|||
48406997|NCT01469000|155680145|FG001|Overall Study|Sponsor Decision|1|||
48406998|NCT00996203|155680146|FG000|Overall Study|Adverse Event|3|||
48406999|NCT00996203|155680146|FG000|Overall Study|Lost to Follow-up|1|||
48407000|NCT00996203|155680146|FG000|Overall Study|Lack of Efficacy|1|||
48407001|NCT00996203|155680146|FG000|Overall Study|Protocol Violation|2|||
48407002|NCT00578643|155680148|FG000|Overall Study|Death|1|||
48407003|NCT00578643|155680148|FG000|Overall Study|Lost to Follow-up|1|||
48407004|NCT03529409|155680149|FG000|Randomized|Lost to Follow-up|0|||
48407005|NCT03529409|155680150|FG001|Randomized|Lost to Follow-up|0|||
48407006|NCT03529409|155680151|FG002|Randomized|Lost to Follow-up|4|||
48407007|NCT03529409|155680149|FG000|Randomized|Excluded|0|||
48407008|NCT03529409|155680150|FG001|Randomized|Excluded|0|||
48407009|NCT03529409|155680151|FG002|Randomized|Excluded|1|||
48407010|NCT03529409|155680149|FG000|Post-treatment Assessment|Death|1|||
48407011|NCT03529409|155680150|FG001|Post-treatment Assessment|Death|0|||
48407012|NCT03529409|155680151|FG002|Post-treatment Assessment|Death|0|||
48407013|NCT03529409|155680149|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
48407014|NCT03529409|155680150|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
48407015|NCT03529409|155680151|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
48407016|NCT03529409|155680149|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
48407017|NCT03529409|155680150|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
48407018|NCT03529409|155680151|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
48407019|NCT03529409|155680149|FG000|Follow-up Assessment|Death|1|||
48407020|NCT03529409|155680150|FG001|Follow-up Assessment|Death|0|||
48407021|NCT03529409|155680151|FG002|Follow-up Assessment|Death|0|||
48407022|NCT03529409|155680149|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
48407023|NCT03529409|155680150|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
48407024|NCT03529409|155680151|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
48407025|NCT02497001|155680152|FG000|Overall Study|Lost to Follow-up|10|||
48407026|NCT02497001|155680153|FG001|Overall Study|Lost to Follow-up|2|||
48407027|NCT02497001|155680154|FG002|Overall Study|Lost to Follow-up|0|||
48407028|NCT02497001|155680155|FG003|Overall Study|Lost to Follow-up|2|||
48407029|NCT02497001|155680152|FG000|Overall Study|Adverse Event|28|||
48407030|NCT02497001|155680153|FG001|Overall Study|Adverse Event|30|||
48407031|NCT02497001|155680154|FG002|Overall Study|Adverse Event|11|||
48407032|NCT02497001|155680155|FG003|Overall Study|Adverse Event|11|||
48407033|NCT02497001|155680152|FG000|Overall Study|Withdrawal by Subject|14|||
48407034|NCT02497001|155680153|FG001|Overall Study|Withdrawal by Subject|37|||
48407035|NCT02497001|155680154|FG002|Overall Study|Withdrawal by Subject|19|||
48407036|NCT02497001|155680155|FG003|Overall Study|Withdrawal by Subject|15|||
48407037|NCT02497001|155680152|FG000|Overall Study|Physician Decision|5|||
48407038|NCT02497001|155680153|FG001|Overall Study|Physician Decision|11|||
48407039|NCT02497001|155680154|FG002|Overall Study|Physician Decision|5|||
48407040|NCT02497001|155680155|FG003|Overall Study|Physician Decision|1|||
48407041|NCT02497001|155680152|FG000|Overall Study|subjects that were not treated|1|||
48407042|NCT02497001|155680153|FG001|Overall Study|subjects that were not treated|2|||
48407043|NCT02497001|155680154|FG002|Overall Study|subjects that were not treated|2|||
48407044|NCT02497001|155680155|FG003|Overall Study|subjects that were not treated|1|||
48407045|NCT02497001|155680152|FG000|Overall Study|Major Protocol Deviation|3|||
48407046|NCT02497001|155680153|FG001|Overall Study|Major Protocol Deviation|4|||
48407047|NCT02497001|155680154|FG002|Overall Study|Major Protocol Deviation|4|||
48407048|NCT02497001|155680155|FG003|Overall Study|Major Protocol Deviation|4|||
48407049|NCT02497001|155680152|FG000|Overall Study|Lack of Efficacy|10|||
48407050|NCT02497001|155680153|FG001|Overall Study|Lack of Efficacy|16|||
48407051|NCT02497001|155680154|FG002|Overall Study|Lack of Efficacy|6|||
48407052|NCT02497001|155680155|FG003|Overall Study|Lack of Efficacy|6|||
48407053|NCT02497001|155680152|FG000|Overall Study|Protocol Violation|3|||
48407054|NCT02497001|155680153|FG001|Overall Study|Protocol Violation|1|||
48407055|NCT02497001|155680154|FG002|Overall Study|Protocol Violation|3|||
48407056|NCT02497001|155680155|FG003|Overall Study|Protocol Violation|1|||
48407057|NCT05299073|155680158|FG000|Overall Study|Withdrawal by Subject|0|||
48407058|NCT05299073|155680159|FG001|Overall Study|Withdrawal by Subject|0|||
48407059|NCT05299073|155680160|FG002|Overall Study|Withdrawal by Subject|1|||
48407060|NCT05299073|155680158|FG000|Overall Study|Adverse Event|0|||
48407061|NCT05299073|155680159|FG001|Overall Study|Adverse Event|1|||
48407062|NCT05299073|155680160|FG002|Overall Study|Adverse Event|0|||
48407063|NCT05299073|155680158|FG000|Overall Study|Lost to Follow-up|0|||
48407064|NCT05299073|155680159|FG001|Overall Study|Lost to Follow-up|1|||
48407065|NCT05299073|155680160|FG002|Overall Study|Lost to Follow-up|0|||
48407066|NCT00705263|155680161|FG000|Overall Study|Withdrawal by Subject|2|||
48407067|NCT01752023|155680162|FG000|Overall Study|Physician Decision|2|||
48407068|NCT01752023|155680163|FG001|Overall Study|Physician Decision|1|||
48407069|NCT01795547|155680164|FG000|Overall Study|Adverse Event|16|||
48407070|NCT01795547|155680165|FG001|Overall Study|Adverse Event|27|||
48407071|NCT01795547|155680164|FG000|Overall Study|Lack of Efficacy|8|||
48407072|NCT01795547|155680165|FG001|Overall Study|Lack of Efficacy|3|||
48407073|NCT01795547|155680164|FG000|Overall Study|Protocol Violation|6|||
48407074|NCT01795547|155680165|FG001|Overall Study|Protocol Violation|4|||
48407075|NCT01795547|155680164|FG000|Overall Study|Lost to Follow-up|2|||
48407076|NCT01795547|155680165|FG001|Overall Study|Lost to Follow-up|5|||
48407077|NCT01795547|155680164|FG000|Overall Study|Withdrawal of consent|7|||
48407078|NCT01795547|155680165|FG001|Overall Study|Withdrawal of consent|12|||
48407079|NCT01795547|155680164|FG000|Overall Study|Not Treated|4|||
48407080|NCT01795547|155680165|FG001|Overall Study|Not Treated|10|||
48407081|NCT01795547|155680164|FG000|Overall Study|Non-compliance with IMP|1|||
48407082|NCT01795547|155680165|FG001|Overall Study|Non-compliance with IMP|1|||
48407083|NCT01795547|155680164|FG000|Overall Study|Others|4|||
48407084|NCT01795547|155680165|FG001|Overall Study|Others|1|||
48407085|NCT01795547|155680164|FG000|Overall Study|Not stated|0|||
48407086|NCT01795547|155680165|FG001|Overall Study|Not stated|1|||
48407087|NCT03430986|155680166|FG000|24-week Control Period|Adverse Event|1|||
48407088|NCT03430986|155680167|FG001|24-week Control Period|Adverse Event|0|||
48407089|NCT03430986|155680166|FG000|24-week Control Period|Lost to Follow-up|2|||
48407090|NCT03430986|155680167|FG001|24-week Control Period|Lost to Follow-up|2|||
48407091|NCT03430986|155680166|FG000|24-week Control Period|Withdrawal by Participant|5|||
48407092|NCT03430986|155680167|FG001|24-week Control Period|Withdrawal by Participant|0|||
48407093|NCT03430986|155680166|FG000|24-week Control Period|Protocol Deviation|0|||
48407094|NCT03430986|155680167|FG001|24-week Control Period|Protocol Deviation|2|||
48407095|NCT03430986|155680166|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
48407096|NCT03430986|155680167|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
48407097|NCT03430986|155680166|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
48407098|NCT03430986|155680167|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
48407099|NCT01412957|155680168|FG000|Overall Study|Withdrawal by Subject|6|||
48407100|NCT01412957|155680169|FG001|Overall Study|Withdrawal by Subject|22|||
48407101|NCT01412957|155680168|FG000|Overall Study|Lost to Follow-up|7|||
48407102|NCT01412957|155680169|FG001|Overall Study|Lost to Follow-up|2|||
48407103|NCT01412957|155680168|FG000|Overall Study|Death|136|||
48407104|NCT01412957|155680169|FG001|Overall Study|Death|133|||
48407105|NCT01813890|155680174|FG000|Overall Study|Adverse Event|0|||
48407106|NCT01813890|155680175|FG001|Overall Study|Adverse Event|3|||
48407107|NCT01813890|155680176|FG002|Overall Study|Adverse Event|4|||
48407108|NCT01813890|155680174|FG000|Overall Study|Lack of Efficacy|9|||
48407109|NCT01813890|155680175|FG001|Overall Study|Lack of Efficacy|1|||
48407110|NCT01813890|155680176|FG002|Overall Study|Lack of Efficacy|2|||
48407111|NCT01870739|155680179|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
48407112|NCT01870739|155680180|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
48407113|NCT01870739|155680179|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
48407114|NCT01870739|155680180|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
48407115|NCT01870739|155680179|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
48407116|NCT01870739|155680180|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
48407117|NCT01870739|155680179|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
48407118|NCT01870739|155680180|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
48407119|NCT01870739|155680179|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
48407120|NCT01870739|155680180|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
48407121|NCT01870739|155680179|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
48407122|NCT01870739|155680180|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
48407123|NCT01870739|155680179|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
48407124|NCT01870739|155680180|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
48407125|NCT03538743|155680181|FG000|Overall Study|Adverse Event|0|||
48407126|NCT03538743|155680182|FG001|Overall Study|Adverse Event|0|||
48407127|NCT03538743|155680183|FG002|Overall Study|Adverse Event|1|||
48407128|NCT03538743|155680184|FG003|Overall Study|Adverse Event|1|||
48407129|NCT03538743|155680185|FG004|Overall Study|Adverse Event|0|||
48407130|NCT03538743|155680186|FG005|Overall Study|Adverse Event|0|||
48407131|NCT03538743|155680187|FG006|Overall Study|Adverse Event|0|||
48407132|NCT03538743|155680188|FG007|Overall Study|Adverse Event|0|||
48407133|NCT03538743|155680189|FG008|Overall Study|Adverse Event|0|||
48407134|NCT03538743|155680181|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
48407135|NCT03538743|155680182|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
48407136|NCT03538743|155680183|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
48407137|NCT03538743|155680184|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
48407138|NCT03538743|155680185|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
48407139|NCT03538743|155680186|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
48407140|NCT03538743|155680187|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
48407141|NCT03538743|155680188|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
48407142|NCT03538743|155680189|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
48407143|NCT03538743|155680181|FG000|Overall Study|Withdrawal by Subject|0|||
48407144|NCT03538743|155680182|FG001|Overall Study|Withdrawal by Subject|0|||
48407145|NCT03538743|155680183|FG002|Overall Study|Withdrawal by Subject|0|||
48407146|NCT03538743|155680184|FG003|Overall Study|Withdrawal by Subject|1|||
48407147|NCT03538743|155680185|FG004|Overall Study|Withdrawal by Subject|0|||
48407148|NCT03538743|155680186|FG005|Overall Study|Withdrawal by Subject|0|||
48407149|NCT03538743|155680187|FG006|Overall Study|Withdrawal by Subject|0|||
48407150|NCT03538743|155680188|FG007|Overall Study|Withdrawal by Subject|0|||
48407151|NCT03538743|155680189|FG008|Overall Study|Withdrawal by Subject|0|||
48407152|NCT04640766|155680190|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
48407153|NCT01565980|155680192|FG000|Overall Study|Death|1|||
48407154|NCT01565980|155680193|FG001|Overall Study|Death|0|||
48407155|NCT01565980|155680192|FG000|Overall Study|Lost to Follow-up|1|||
48407156|NCT01565980|155680193|FG001|Overall Study|Lost to Follow-up|0|||
48407157|NCT01565980|155680192|FG000|Overall Study|health complications|1|||
48407158|NCT01565980|155680193|FG001|Overall Study|health complications|1|||
48407159|NCT01565980|155680192|FG000|Overall Study|stopped medical treatment|1|||
48407160|NCT01565980|155680193|FG001|Overall Study|stopped medical treatment|0|||
48407161|NCT01565980|155680192|FG000|Overall Study|Withdrawal by Subject|0|||
48407162|NCT01565980|155680193|FG001|Overall Study|Withdrawal by Subject|3|||
48407163|NCT01976806|155680203|FG000|Overall Study|Lost to Follow-up|1|||
48407164|NCT01976806|155680204|FG001|Overall Study|Lost to Follow-up|4|||
48407165|NCT01976806|155680203|FG000|Overall Study|Adverse Event|1|||
48407166|NCT01976806|155680204|FG001|Overall Study|Adverse Event|1|||
48407167|NCT01976806|155680203|FG000|Overall Study|Withdrawal by Subject|1|||
48407168|NCT01976806|155680204|FG001|Overall Study|Withdrawal by Subject|1|||
48407169|NCT03665038|155680208|FG000|Overall Study|Lost to Follow-up|0|||
48407170|NCT03665038|155680209|FG001|Overall Study|Lost to Follow-up|0|||
48407171|NCT03665038|155680210|FG002|Overall Study|Lost to Follow-up|1|||
48407172|NCT02848833|155680217|FG000|Overall Study|subject who are duplicated|1|||
48407173|NCT02848833|155680217|FG000|Overall Study|have not taken the study drug|11|||
48407174|NCT02848833|155680217|FG000|Overall Study|follow-up failure|6|||
48407175|NCT02848833|155680217|FG000|Overall Study|Protocol Violation|119|||
48407176|NCT02404103|155682274|FG000|Overall Study|Adverse Event|1|||
48407177|NCT02404103|155682275|FG001|Overall Study|Adverse Event|0|||
48407178|NCT02404103|155682274|FG000|Overall Study|Lost to Follow-up|3|||
48407179|NCT02404103|155682275|FG001|Overall Study|Lost to Follow-up|3|||
48407180|NCT00542997|155682278|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
48407181|NCT00542997|155682278|FG000|Wash in / Wash Out Period|Adverse Event|3|||
48407182|NCT00542997|155682278|FG000|Efficacy Period|Adverse Event|3|||
48407183|NCT01662440|155682279|FG000|Overall Study|Adverse Event|1|||
48407184|NCT01662440|155682280|FG001|Overall Study|Adverse Event|0|||
48407185|NCT01662440|155682281|FG002|Overall Study|Adverse Event|0|||
48407186|NCT01662440|155682282|FG003|Overall Study|Adverse Event|1|||
48407187|NCT01662440|155682279|FG000|Overall Study|Death|0|||
48407188|NCT01662440|155682280|FG001|Overall Study|Death|1|||
48407189|NCT01662440|155682281|FG002|Overall Study|Death|0|||
48407190|NCT01662440|155682282|FG003|Overall Study|Death|0|||
48407191|NCT01662440|155682279|FG000|Overall Study|Lost to Follow-up|2|||
48407192|NCT01662440|155682280|FG001|Overall Study|Lost to Follow-up|2|||
48407193|NCT01662440|155682281|FG002|Overall Study|Lost to Follow-up|4|||
48407194|NCT01662440|155682282|FG003|Overall Study|Lost to Follow-up|1|||
48407195|NCT01662440|155682279|FG000|Overall Study|Subject moved to another country.|0|||
48407196|NCT01662440|155682280|FG001|Overall Study|Subject moved to another country.|1|||
48407197|NCT01662440|155682281|FG002|Overall Study|Subject moved to another country.|0|||
48407198|NCT01662440|155682282|FG003|Overall Study|Subject moved to another country.|0|||
48357530|NCT02993523|155504906|FG002|Overall Study|Withdrew Consent|2|||
48357531|NCT02993523|155504907|FG003|Overall Study|Withdrew Consent|9|||
48357532|NCT02993523|155504908|FG004|Overall Study|Withdrew Consent|0|||
48357533|NCT02993523|155504904|FG000|Overall Study|Lost to Follow-up|0|||
48357534|NCT02993523|155504905|FG001|Overall Study|Lost to Follow-up|0|||
48357535|NCT02993523|155504906|FG002|Overall Study|Lost to Follow-up|3|||
48357536|NCT02993523|155504907|FG003|Overall Study|Lost to Follow-up|6|||
48357537|NCT02993523|155504908|FG004|Overall Study|Lost to Follow-up|0|||
48357538|NCT02993523|155504904|FG000|Overall Study|Death|1|||
48357539|NCT02993523|155504905|FG001|Overall Study|Death|1|||
48357540|NCT02993523|155504906|FG002|Overall Study|Death|138|||
48357541|NCT02993523|155504907|FG003|Overall Study|Death|222|||
48357542|NCT02993523|155504908|FG004|Overall Study|Death|6|||
48357543|NCT02993523|155504904|FG000|Overall Study|Reason not Specified|0|||
48357544|NCT02993523|155504905|FG001|Overall Study|Reason not Specified|0|||
48357545|NCT02993523|155504906|FG002|Overall Study|Reason not Specified|1|||
48357546|NCT02993523|155504907|FG003|Overall Study|Reason not Specified|1|||
48357547|NCT02993523|155504908|FG004|Overall Study|Reason not Specified|0|||
48357548|NCT00790205|155504909|FG000|Overall Study|Lost to Follow-up|61|||
48357549|NCT00790205|155504910|FG001|Overall Study|Lost to Follow-up|71|||
48357550|NCT00790205|155504909|FG000|Overall Study|Withdrawal by Subject|299|||
48357551|NCT00790205|155504910|FG001|Overall Study|Withdrawal by Subject|363|||
48357552|NCT01712061|155504911|FG000|Overall Study|Adverse Event|4|||
48357553|NCT01712061|155504912|FG001|Overall Study|Adverse Event|9|||
48407199|NCT01662440|155682279|FG000|Overall Study|Protocol Violation|1|||
48407200|NCT01662440|155682280|FG001|Overall Study|Protocol Violation|0|||
48407201|NCT01662440|155682281|FG002|Overall Study|Protocol Violation|0|||
48407202|NCT01662440|155682282|FG003|Overall Study|Protocol Violation|0|||
48407203|NCT01662440|155682279|FG000|Overall Study|Withdrawal by Subject|5|||
48407204|NCT01662440|155682280|FG001|Overall Study|Withdrawal by Subject|2|||
48407205|NCT01662440|155682281|FG002|Overall Study|Withdrawal by Subject|2|||
48407206|NCT01662440|155682282|FG003|Overall Study|Withdrawal by Subject|2|||
48407207|NCT01602341|155682285|FG000|Overall Study|Adverse Event|0|||
48407208|NCT01602341|155682286|FG001|Overall Study|Adverse Event|1|||
48407209|NCT02152345|155682287|FG000|Overall Study|Case Cancellations|2|||
48407210|NCT02152345|155682288|FG001|Overall Study|Case Cancellations|4|||
48407211|NCT02152345|155682287|FG000|Overall Study|Withdrawal by Subject|2|||
48407212|NCT02152345|155682288|FG001|Overall Study|Withdrawal by Subject|1|||
48407213|NCT03064763|155682291|FG000|Overall Study|Lost to Follow-up|1|||
48407214|NCT03064763|155682291|FG000|Overall Study|Death|8|||
48407215|NCT01583179|155682293|FG000|Overall Study|Screen failure|1|||
48407216|NCT01583179|155682294|FG001|Overall Study|Screen failure|2|||
48407217|NCT01652287|155682295|FG000|Overall Study|Withdrawal by Subject|2|||
48407218|NCT01652287|155682296|FG001|Overall Study|Withdrawal by Subject|0|||
48407219|NCT01307033|155682304|FG000|8-week Double-blind Period|Adverse Event|2|||
48407220|NCT01307033|155682305|FG001|8-week Double-blind Period|Adverse Event|0|||
48407221|NCT01307033|155682306|FG002|8-week Double-blind Period|Adverse Event|0|||
48407222|NCT01307033|155682307|FG003|8-week Double-blind Period|Adverse Event|0|||
48407223|NCT01307033|155682304|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
48407224|NCT01307033|155682305|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
48407225|NCT01307033|155682306|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
48407226|NCT01307033|155682307|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
48407227|NCT01307033|155682304|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
48407228|NCT01307033|155682305|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
48407229|NCT01307033|155682306|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
48407230|NCT01307033|155682307|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
48407231|NCT01307033|155682304|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
48407232|NCT01307033|155682305|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
48407233|NCT01307033|155682306|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
48407234|NCT01307033|155682307|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
48407235|NCT01307033|155682304|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
48407236|NCT01307033|155682305|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
48407237|NCT01307033|155682306|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
48426310|NCT00933335|155749547|FG001|Overall Study|Progressive Disease|11|||
48407238|NCT01307033|155682307|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
48407239|NCT01307033|155682304|FG000|44-week Open-label Extension|Adverse Event|0|||
48407240|NCT01307033|155682305|FG001|44-week Open-label Extension|Adverse Event|0|||
48407241|NCT01307033|155682306|FG002|44-week Open-label Extension|Adverse Event|2|||
48407242|NCT01307033|155682307|FG003|44-week Open-label Extension|Adverse Event|1|||
48407243|NCT01307033|155682304|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
48407244|NCT01307033|155682305|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
48407245|NCT01307033|155682306|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
48407246|NCT01307033|155682307|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
48407247|NCT01307033|155682304|FG000|44-week Open-label Extension|Physician Decision|0|||
48407248|NCT01307033|155682305|FG001|44-week Open-label Extension|Physician Decision|0|||
48407249|NCT01307033|155682306|FG002|44-week Open-label Extension|Physician Decision|1|||
48407250|NCT01307033|155682307|FG003|44-week Open-label Extension|Physician Decision|0|||
48407251|NCT01307033|155682304|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
48407252|NCT01307033|155682305|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
48407253|NCT01307033|155682306|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
48407254|NCT01307033|155682307|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
48407255|NCT01307033|155682304|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
48407256|NCT01307033|155682305|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
48407257|NCT01307033|155682306|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
48407258|NCT01307033|155682307|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
48407259|NCT01307033|155682304|FG000|44-week Open-label Extension|Death|0|||
48407260|NCT01307033|155682305|FG001|44-week Open-label Extension|Death|0|||
48407261|NCT01307033|155682306|FG002|44-week Open-label Extension|Death|0|||
48407262|NCT01307033|155682307|FG003|44-week Open-label Extension|Death|1|||
48407263|NCT01934140|155682308|FG000|Persistence Phase (Year 6-10)|Other|24|||
48407264|NCT01934140|155682309|FG001|Persistence Phase (Year 6-10)|Other|6|||
48407265|NCT01934140|155682308|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
48407266|NCT01934140|155682309|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
48407267|NCT01934140|155682308|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
48407268|NCT01934140|155682309|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
48407269|NCT01934140|155682308|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
48407270|NCT01934140|155682309|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
48407271|NCT01934140|155682308|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
48407272|NCT01934140|155682309|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
48407273|NCT01934140|155682308|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
48407274|NCT01934140|155682309|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
48407275|NCT01934140|155682308|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
48407276|NCT01934140|155682309|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
48407277|NCT01934140|155682308|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
48407278|NCT01934140|155682309|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
48407279|NCT01231555|155682310|FG000|Overall Study|Study terminated|8|||
48407280|NCT01231555|155682311|FG001|Overall Study|Study terminated|5|||
48407281|NCT01231555|155682312|FG002|Overall Study|Study terminated|8|||
48407282|NCT01231555|155682310|FG000|Overall Study|Withdrawal by Subject|0|||
48407283|NCT01231555|155682311|FG001|Overall Study|Withdrawal by Subject|2|||
48407284|NCT01231555|155682312|FG002|Overall Study|Withdrawal by Subject|0|||
48407285|NCT04167345|155682316|FG000|Overall Study|Other|1|||
48407286|NCT04167345|155682317|FG001|Overall Study|Other|1|||
48407287|NCT04167345|155682318|FG002|Overall Study|Other|0|||
48407288|NCT04167345|155682319|FG003|Overall Study|Other|0|||
48407289|NCT04167345|155682320|FG004|Overall Study|Other|0|||
48407290|NCT01461044|155682321|FG000|Overall Study|Death|58|||
48407291|NCT01461044|155682322|FG001|Overall Study|Death|35|||
48407292|NCT01461044|155682321|FG000|Overall Study|Lost to Follow-up|12|||
48407293|NCT01461044|155682322|FG001|Overall Study|Lost to Follow-up|5|||
48407294|NCT00699348|155682323|FG000|Overall Study|Death|6|||
48407295|NCT00699348|155682323|FG000|Overall Study|Adverse Event|15|||
48407296|NCT00699348|155682323|FG000|Overall Study|Withdrawal by Subject|11|||
48407297|NCT00699348|155682323|FG000|Overall Study|Protocol Violation|10|||
48407298|NCT00699348|155682323|FG000|Overall Study|Lack of Efficacy|8|||
48407299|NCT00699348|155682323|FG000|Overall Study|Failure to return|1|||
48407300|NCT00699348|155682323|FG000|Overall Study|Blood transfusion|24|||
48431432|NCT00002663|155767267|FG003|Overall Study|Other|0|||
48407301|NCT00699348|155682323|FG000|Overall Study|Renal transplantation|10|||
48407302|NCT00699348|155682323|FG000|Overall Study|Other|5|||
48407303|NCT00805740|155682326|FG000|Overall Study|Death|7|||
48407304|NCT00805740|155682327|FG001|Overall Study|Death|4|||
48407305|NCT00805740|155682326|FG000|Overall Study|Withdrawal by Subject|1|||
48407306|NCT00805740|155682327|FG001|Overall Study|Withdrawal by Subject|0|||
48407307|NCT00805740|155682326|FG000|Overall Study|Lost to Follow-up|1|||
48407308|NCT00805740|155682327|FG001|Overall Study|Lost to Follow-up|0|||
48407309|NCT00805740|155682326|FG000|Overall Study|Randomized, but not treated|2|||
48407310|NCT00805740|155682327|FG001|Overall Study|Randomized, but not treated|0|||
48407311|NCT00669617|155682328|FG000|Period 1|Withdrawal by Subject|0|||
48407312|NCT00669617|155682329|FG001|Period 1|Withdrawal by Subject|0|||
48407313|NCT00669617|155682330|FG002|Period 1|Withdrawal by Subject|1|||
48407314|NCT00669617|155682331|FG003|Period 1|Withdrawal by Subject|0|||
48407315|NCT00669617|155682332|FG004|Period 1|Withdrawal by Subject|0|||
48407316|NCT00669617|155682328|FG000|Period 1|Protocol Deviation|0|||
48407317|NCT00669617|155682329|FG001|Period 1|Protocol Deviation|0|||
48407318|NCT00669617|155682330|FG002|Period 1|Protocol Deviation|0|||
48407319|NCT00669617|155682331|FG003|Period 1|Protocol Deviation|0|||
48407320|NCT00669617|155682332|FG004|Period 1|Protocol Deviation|1|||
48407321|NCT00669617|155682328|FG000|Period 3|Lost to Follow-up|1|||
48407322|NCT00669617|155682329|FG001|Period 3|Lost to Follow-up|0|||
48407323|NCT00669617|155682330|FG002|Period 3|Lost to Follow-up|0|||
48407324|NCT00669617|155682331|FG003|Period 3|Lost to Follow-up|0|||
48407325|NCT00669617|155682332|FG004|Period 3|Lost to Follow-up|0|||
48407326|NCT02723201|155682336|FG000|Second Intervention Period|Protocol Violation|1|||
48407327|NCT02723201|155682337|FG001|Second Intervention Period|Protocol Violation|0|||
48407328|NCT02723201|155682338|FG002|Second Intervention Period|Protocol Violation|0|||
48407329|NCT02723201|155682336|FG000|Second Intervention Period|Adverse Event|1|||
48407330|NCT02723201|155682337|FG001|Second Intervention Period|Adverse Event|0|||
48407331|NCT02723201|155682338|FG002|Second Intervention Period|Adverse Event|0|||
48407332|NCT01084551|155682339|FG000|Overall Study|Adverse Event|2|||
48407333|NCT01084551|155682340|FG001|Overall Study|Adverse Event|9|||
48407334|NCT01084551|155682341|FG002|Overall Study|Adverse Event|4|||
48407335|NCT01084551|155682339|FG000|Overall Study|Lack of Efficacy|2|||
48407336|NCT01084551|155682340|FG001|Overall Study|Lack of Efficacy|0|||
48407337|NCT01084551|155682341|FG002|Overall Study|Lack of Efficacy|1|||
48407338|NCT01084551|155682339|FG000|Overall Study|Withdrawal by Subject|2|||
48407339|NCT01084551|155682340|FG001|Overall Study|Withdrawal by Subject|1|||
48407340|NCT01084551|155682341|FG002|Overall Study|Withdrawal by Subject|0|||
48407341|NCT01084551|155682339|FG000|Overall Study|Protocol Violation|2|||
48407342|NCT01084551|155682340|FG001|Overall Study|Protocol Violation|4|||
48407343|NCT01084551|155682341|FG002|Overall Study|Protocol Violation|0|||
48407344|NCT01084551|155682339|FG000|Overall Study|Lost to Follow-up|0|||
48407345|NCT01084551|155682340|FG001|Overall Study|Lost to Follow-up|0|||
48407346|NCT01084551|155682341|FG002|Overall Study|Lost to Follow-up|3|||
48407347|NCT01084551|155682339|FG000|Overall Study|Physician Decision|1|||
48407348|NCT01084551|155682340|FG001|Overall Study|Physician Decision|0|||
48407349|NCT01084551|155682341|FG002|Overall Study|Physician Decision|0|||
48407350|NCT02397473|155682344|FG000|Treatment Phase|Adverse Event|1|||
48407351|NCT02397473|155682345|FG001|Treatment Phase|Adverse Event|2|||
48407352|NCT02397473|155682344|FG000|Treatment Phase|Lack of Efficacy|8|||
48407353|NCT02397473|155682345|FG001|Treatment Phase|Lack of Efficacy|1|||
48407354|NCT02397473|155682344|FG000|Treatment Phase|Lost to Follow-up|1|||
48407355|NCT02397473|155682345|FG001|Treatment Phase|Lost to Follow-up|0|||
48407356|NCT02397473|155682344|FG000|Treatment Phase|Withdrawal by Subject|2|||
48407357|NCT02397473|155682345|FG001|Treatment Phase|Withdrawal by Subject|1|||
48407358|NCT02397473|155682344|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
48407359|NCT02397473|155682345|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
48407360|NCT02397473|155682344|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
48407361|NCT02397473|155682345|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
48407362|NCT02397473|155682344|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
48407363|NCT02397473|155682345|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
48407364|NCT02397473|155682344|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
48407365|NCT02397473|155682345|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
48407366|NCT02397473|155682344|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
48407367|NCT02397473|155682345|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
48407368|NCT02024971|155682346|FG000|Overall Study|Data Not Available|30|||
48407369|NCT02024971|155682346|FG000|Overall Study|Lost to Follow-up|6|||
48407370|NCT01467492|155682347|FG000|Overall Study|Withdrawal by Subject|6|||
48407371|NCT01467492|155682348|FG001|Overall Study|Withdrawal by Subject|4|||
48407372|NCT01467492|155682347|FG000|Overall Study|Study Terminated by Sponsor|6|||
48407373|NCT01467492|155682348|FG001|Overall Study|Study Terminated by Sponsor|4|||
48407374|NCT01467492|155682347|FG000|Overall Study|Adverse Event|4|||
48407375|NCT01467492|155682348|FG001|Overall Study|Adverse Event|3|||
48407376|NCT01467492|155682347|FG000|Overall Study|Lost to Follow-up|3|||
48407377|NCT01467492|155682348|FG001|Overall Study|Lost to Follow-up|2|||
48407378|NCT01467492|155682347|FG000|Overall Study|Undefined|2|||
48407379|NCT01467492|155682348|FG001|Overall Study|Undefined|0|||
48407380|NCT01467492|155682347|FG000|Overall Study|Enrolled But Not Treated|1|||
48407381|NCT01467492|155682348|FG001|Overall Study|Enrolled But Not Treated|0|||
48407382|NCT02009878|155682351|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
48407383|NCT02009878|155682352|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
48407384|NCT02009878|155682353|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
48407385|NCT01482910|155682354|FG000|Overall Study|Adverse Event|6|||
48407386|NCT01482910|155682355|FG001|Overall Study|Adverse Event|5|||
48407387|NCT01482910|155682354|FG000|Overall Study|Lost to Follow-up|0|||
48407388|NCT01482910|155682355|FG001|Overall Study|Lost to Follow-up|1|||
48407389|NCT01482910|155682354|FG000|Overall Study|Protocol Violation|1|||
48407390|NCT01482910|155682355|FG001|Overall Study|Protocol Violation|1|||
48407391|NCT01482910|155682354|FG000|Overall Study|Withdrawal by Subject|7|||
48407392|NCT01482910|155682355|FG001|Overall Study|Withdrawal by Subject|2|||
48407393|NCT01482910|155682354|FG000|Overall Study|Death|1|||
48407394|NCT01482910|155682355|FG001|Overall Study|Death|0|||
48407395|NCT04428411|155682357|FG000|Overall Study|Lost to Follow-up|114|||
48407396|NCT00440726|155682358|FG000|Phase 1|Dose-Limiting Toxicity|0|||
48407397|NCT00440726|155682359|FG001|Phase 1|Dose-Limiting Toxicity|1|||
48407398|NCT00440726|155682360|FG002|Phase 1|Dose-Limiting Toxicity|0|||
48407399|NCT00440726|155682358|FG000|Phase 1|Physician Decision|1|||
48407400|NCT00440726|155682359|FG001|Phase 1|Physician Decision|0|||
48407401|NCT00440726|155682360|FG002|Phase 1|Physician Decision|0|||
48407402|NCT00440726|155682358|FG000|Phase 2|Death|0|||
48407403|NCT00440726|155682359|FG001|Phase 2|Death|0|||
48407404|NCT00440726|155682360|FG002|Phase 2|Death|1|||
48407405|NCT00440726|155682358|FG000|Phase 2|Adverse Event|0|||
48407406|NCT00440726|155682359|FG001|Phase 2|Adverse Event|0|||
48407407|NCT00440726|155682360|FG002|Phase 2|Adverse Event|1|||
48407408|NCT01163786|155682361|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
48407409|NCT01163786|155682361|FG000|Treatment With Bortezomib|Adverse Event|2|||
48407410|NCT01163786|155682361|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
48407411|NCT00132730|155682362|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
48407412|NCT00132730|155682363|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
48407413|NCT00132730|155682364|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
48407414|NCT00132730|155682365|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
48407415|NCT00132730|155682366|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
48407416|NCT00132730|155682367|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
48407417|NCT00132730|155682362|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
48407418|NCT00132730|155682363|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
48407419|NCT00132730|155682364|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
48407420|NCT00132730|155682365|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
48407421|NCT00132730|155682366|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
48407422|NCT00132730|155682367|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
48407423|NCT00132730|155682362|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
48407424|NCT00132730|155682363|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
48407425|NCT00132730|155682364|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
48407426|NCT00132730|155682365|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
48407427|NCT00132730|155682366|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
48407428|NCT00132730|155682367|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
48407429|NCT00132730|155682362|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
48407430|NCT00132730|155682363|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
48407431|NCT00132730|155682364|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
48407432|NCT00132730|155682365|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
48407433|NCT00132730|155682366|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
48407434|NCT00132730|155682367|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
48407435|NCT00132730|155682362|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
48407436|NCT00132730|155682363|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
48407437|NCT00132730|155682364|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
48407438|NCT00132730|155682365|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
48357554|NCT01712061|155504913|FG002|Overall Study|Adverse Event|5|||
48357555|NCT01712061|155504911|FG000|Overall Study|Death|0|||
48357556|NCT01712061|155504912|FG001|Overall Study|Death|0|||
48357557|NCT01712061|155504913|FG002|Overall Study|Death|1|||
48357558|NCT01712061|155504911|FG000|Overall Study|Lost to Follow-up|1|||
48357559|NCT01712061|155504912|FG001|Overall Study|Lost to Follow-up|0|||
48357560|NCT01712061|155504913|FG002|Overall Study|Lost to Follow-up|1|||
48357561|NCT01712061|155504911|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
48357562|NCT01712061|155504912|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
48357563|NCT01712061|155504913|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
48357564|NCT01712061|155504911|FG000|Overall Study|Medication Error Without Associated AE|0|||
48357565|NCT01712061|155504912|FG001|Overall Study|Medication Error Without Associated AE|1|||
48357566|NCT01712061|155504913|FG002|Overall Study|Medication Error Without Associated AE|0|||
48357567|NCT01712061|155504911|FG000|Overall Study|Withdrawal by Subject|1|||
48357568|NCT01712061|155504912|FG001|Overall Study|Withdrawal by Subject|7|||
48357569|NCT01712061|155504913|FG002|Overall Study|Withdrawal by Subject|1|||
48357570|NCT01712061|155504911|FG000|Overall Study|Other|0|||
48357571|NCT01712061|155504912|FG001|Overall Study|Other|3|||
48357572|NCT01712061|155504913|FG002|Overall Study|Other|0|||
48357573|NCT02593123|155504914|FG000|Overall Study|Physician Decision|2|||
48357574|NCT02593123|155504915|FG001|Overall Study|Physician Decision|1|||
48357575|NCT02593123|155504914|FG000|Overall Study|Relapse|1|||
48357576|NCT02593123|155504915|FG001|Overall Study|Relapse|1|||
48357577|NCT01081886|155504917|FG000|Overall Study|Study termination|11|||
48357578|NCT01081886|155504918|FG001|Overall Study|Study termination|13|||
48357579|NCT01371825|155504923|FG000|Overall Study|Death|4|||
48357580|NCT00879775|155504924|FG000|Overall Study|Lost to Follow-up|2|||
48357581|NCT00879775|155504925|FG001|Overall Study|Lost to Follow-up|1|||
48357582|NCT02614183|155504926|FG000|Double Blind Treatment Phase|Adverse Event|10|||
48357583|NCT02614183|155504927|FG001|Double Blind Treatment Phase|Adverse Event|9|||
48357584|NCT02614183|155504928|FG002|Double Blind Treatment Phase|Adverse Event|7|||
48357585|NCT02614183|155504926|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
48357586|NCT02614183|155504927|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
48357587|NCT02614183|155504928|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
48357588|NCT02614183|155504926|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
48357589|NCT02614183|155504927|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
48357590|NCT02614183|155504928|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
48407439|NCT00132730|155682366|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
48407440|NCT00132730|155682367|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
48407441|NCT00132730|155682362|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48407442|NCT00132730|155682363|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48407443|NCT00132730|155682364|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48407444|NCT00132730|155682365|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
48407445|NCT00132730|155682366|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48407446|NCT00132730|155682367|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
48407447|NCT00132730|155682362|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
48407448|NCT00132730|155682363|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
48407449|NCT00132730|155682364|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
48407450|NCT00132730|155682365|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
48407451|NCT00132730|155682366|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
48407452|NCT00132730|155682367|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
48407453|NCT00132730|155682362|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
48407454|NCT00132730|155682363|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
48407455|NCT00132730|155682364|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
48407456|NCT00132730|155682365|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
48407457|NCT00132730|155682366|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
48407458|NCT00132730|155682367|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
48407459|NCT00132730|155682362|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48407460|NCT00132730|155682363|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48407461|NCT00132730|155682364|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48407462|NCT00132730|155682365|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48407463|NCT00132730|155682366|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
48407464|NCT00132730|155682367|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
48407465|NCT00132730|155682362|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48407466|NCT00132730|155682363|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48407467|NCT00132730|155682364|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48407468|NCT00132730|155682365|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48407469|NCT00132730|155682366|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
48407470|NCT00132730|155682367|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
48407471|NCT00132730|155682362|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48407472|NCT00132730|155682363|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48407473|NCT00132730|155682364|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48407474|NCT00132730|155682365|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48407475|NCT00132730|155682366|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
48407476|NCT00132730|155682367|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
48407477|NCT00132730|155682362|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
48407478|NCT00132730|155682363|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
48407479|NCT00132730|155682364|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
48407480|NCT00132730|155682365|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
48407481|NCT00132730|155682366|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
48407482|NCT00132730|155682367|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
48407483|NCT01192347|155682368|FG000|Overall Study|Death|3|||
48407484|NCT01192347|155682368|FG000|Overall Study|Lost to Follow-up|3|||
48407485|NCT01192347|155682368|FG000|Overall Study|Withdrawal by Subject|1|||
48407486|NCT01192347|155682368|FG000|Overall Study|Adverse Event|1|||
48407487|NCT01192347|155682368|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
48407488|NCT01192347|155682368|FG000|Overall Study|Patient seen in different hospital|1|||
48407489|NCT01192347|155682368|FG000|Overall Study|Patient not visiting hospital regularly|1|||
48407490|NCT01192347|155682368|FG000|Overall Study|Patient did not show up for visits|1|||
48407491|NCT02771522|155682369|FG000|Overall Study|Lost to Follow-up|3|||
48407492|NCT02771522|155682369|FG000|Overall Study|Withdrawal by Subject|2|||
48407493|NCT02771522|155682369|FG000|Overall Study|No white spot lesions|3|||
48407494|NCT03739528|155682370|FG000|Overall Study|Not treated|8|||
48407495|NCT03739528|155682371|FG001|Overall Study|Not treated|12|||
48407496|NCT03739528|155682370|FG000|Overall Study|Treatment and study discontinued|6|||
48407497|NCT03739528|155682371|FG001|Overall Study|Treatment and study discontinued|2|||
48407498|NCT03739528|155682370|FG000|Overall Study|Treatment discontinued + study completed|1|||
48407499|NCT03739528|155682371|FG001|Overall Study|Treatment discontinued + study completed|3|||
48407500|NCT00559273|155682372|FG000|Correction Period (20 Weeks)|Death|3|||
48407501|NCT00559273|155682373|FG001|Correction Period (20 Weeks)|Death|4|||
48407502|NCT00559273|155682372|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
48407503|NCT00559273|155682373|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
48407504|NCT00559273|155682372|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
48407505|NCT00559273|155682373|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
48407506|NCT00559273|155682372|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
48407507|NCT00559273|155682373|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
48407508|NCT00559273|155682372|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
48407509|NCT00559273|155682373|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
48407510|NCT00559273|155682372|FG000|Evaluation Period (8 Weeks)|Death|1|||
48407511|NCT00559273|155682373|FG001|Evaluation Period (8 Weeks)|Death|3|||
48407512|NCT00559273|155682372|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
48407513|NCT00559273|155682373|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
48407514|NCT00559273|155682372|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
48407515|NCT00559273|155682373|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
48407516|NCT00559273|155682372|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
48407517|NCT00559273|155682373|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
48407518|NCT04276207|155682374|FG000|Period 1|Withdrawal by Subject|0|||
48407519|NCT04276207|155682375|FG001|Period 1|Withdrawal by Subject|1|||
48407520|NCT05655377|155682376|FG000|Overall Study|Withdrawal by Subject|2|||
48407521|NCT01109940|155682377|FG000|Overall Study|Administrative problems|2|||
48407522|NCT01109940|155682378|FG001|Overall Study|Administrative problems|0|||
48407523|NCT01109940|155682379|FG002|Overall Study|Administrative problems|0|||
48407524|NCT01109940|155682380|FG003|Overall Study|Administrative problems|0|||
48407525|NCT01109940|155682377|FG000|Overall Study|Serious Adverse Event|2|||
48407526|NCT01109940|155682378|FG001|Overall Study|Serious Adverse Event|1|||
48407527|NCT01109940|155682379|FG002|Overall Study|Serious Adverse Event|0|||
48407528|NCT01109940|155682380|FG003|Overall Study|Serious Adverse Event|0|||
48407529|NCT01109940|155682377|FG000|Overall Study|Lost to Follow-up|1|||
48407530|NCT01109940|155682378|FG001|Overall Study|Lost to Follow-up|0|||
48407531|NCT01109940|155682379|FG002|Overall Study|Lost to Follow-up|0|||
48407532|NCT01109940|155682380|FG003|Overall Study|Lost to Follow-up|0|||
48407533|NCT01109940|155682377|FG000|Overall Study|Patient withdrew consent|1|||
48407534|NCT01109940|155682378|FG001|Overall Study|Patient withdrew consent|1|||
48407535|NCT01109940|155682379|FG002|Overall Study|Patient withdrew consent|0|||
48407536|NCT01109940|155682380|FG003|Overall Study|Patient withdrew consent|0|||
48407537|NCT01109940|155682377|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48407538|NCT01109940|155682378|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48407539|NCT01109940|155682379|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
48407540|NCT01109940|155682380|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48407541|NCT03653390|155682381|FG000|Overall Study|Lost to Follow-up|12|||
48407542|NCT03653390|155682382|FG001|Overall Study|Lost to Follow-up|8|||
48407543|NCT03653390|155682383|FG002|Overall Study|Lost to Follow-up|7|||
48407544|NCT03653390|155682381|FG000|Overall Study|Withdrawal by Subject|6|||
48407545|NCT03653390|155682382|FG001|Overall Study|Withdrawal by Subject|1|||
48407546|NCT03653390|155682383|FG002|Overall Study|Withdrawal by Subject|1|||
48407547|NCT03653390|155682381|FG000|Overall Study|Death|1|||
48407548|NCT03653390|155682382|FG001|Overall Study|Death|0|||
48407549|NCT03653390|155682383|FG002|Overall Study|Death|0|||
48407550|NCT03653390|155682381|FG000|Overall Study|Paper Survey Lost|1|||
48407551|NCT03653390|155682382|FG001|Overall Study|Paper Survey Lost|0|||
48407552|NCT03653390|155682383|FG002|Overall Study|Paper Survey Lost|0|||
48407553|NCT04451330|155682384|FG000|Overall Study|Adverse Event|1|||
48407554|NCT04451330|155682385|FG001|Overall Study|Adverse Event|2|||
48407555|NCT04451330|155682384|FG000|Overall Study|Lost to Follow-up|5|||
48407556|NCT04451330|155682385|FG001|Overall Study|Lost to Follow-up|0|||
48407557|NCT04451330|155682384|FG000|Overall Study|Withdrawal by Subject|3|||
48407558|NCT04451330|155682385|FG001|Overall Study|Withdrawal by Subject|1|||
48407559|NCT04451330|155682384|FG000|Overall Study|Withdrawal by parent/guardian|1|||
48407560|NCT04451330|155682385|FG001|Overall Study|Withdrawal by parent/guardian|0|||
48407561|NCT04451330|155682384|FG000|Overall Study|Other than specified|0|||
48407562|NCT04451330|155682385|FG001|Overall Study|Other than specified|1|||
48407563|NCT02690194|155682388|FG000|Overall Study|Withdrawal by Subject|1|||
48407564|NCT02690194|155682389|FG001|Overall Study|Withdrawal by Subject|4|||
48407565|NCT02690194|155682390|FG002|Overall Study|Withdrawal by Subject|0|||
48407566|NCT03624946|155682391|FG000|Overall Study|Lost to Follow-up|0|||
48407567|NCT03624946|155682392|FG001|Overall Study|Lost to Follow-up|1|||
48407568|NCT01987908|155682393|FG000|Placebo Lead-in Period|Adverse Event|2|||
48407569|NCT01987908|155682394|FG001|Placebo Lead-in Period|Adverse Event|0|||
48407570|NCT01987908|155682395|FG002|Placebo Lead-in Period|Adverse Event|0|||
48407571|NCT01987908|155682393|FG000|Placebo Lead-in Period|Physician Decision|2|||
48407572|NCT01987908|155682394|FG001|Placebo Lead-in Period|Physician Decision|0|||
48407573|NCT01987908|155682395|FG002|Placebo Lead-in Period|Physician Decision|0|||
48407574|NCT01987908|155682393|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
48407575|NCT01987908|155682394|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
48407576|NCT01987908|155682395|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
48407577|NCT01987908|155682393|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
48407578|NCT01987908|155682394|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
48407579|NCT01987908|155682395|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
48407580|NCT01987908|155682393|FG000|Treatment Period|Adverse Event|0|||
48407581|NCT01987908|155682394|FG001|Treatment Period|Adverse Event|1|||
48407582|NCT01987908|155682395|FG002|Treatment Period|Adverse Event|1|||
48407583|NCT01987908|155682393|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
48407584|NCT01987908|155682394|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
48407585|NCT01987908|155682395|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
48407586|NCT01987908|155682393|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
48407587|NCT01987908|155682394|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
48407588|NCT01987908|155682395|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
48407589|NCT00556426|155682396|FG000|Overall Study|Withdrawal by Subject|3|||
48407590|NCT00556426|155682396|FG000|Overall Study|Death|6|||
48407591|NCT00236080|155682397|FG000|Overall Study|Adverse Event|0|||
48407592|NCT00236080|155682398|FG001|Overall Study|Adverse Event|0|||
48407593|NCT00236080|155682399|FG002|Overall Study|Adverse Event|3|||
48407594|NCT00236080|155682400|FG003|Overall Study|Adverse Event|1|||
48407595|NCT00236080|155682401|FG004|Overall Study|Adverse Event|0|||
48407596|NCT00236080|155682397|FG000|Overall Study|Lost to Follow-up|0|||
48407597|NCT00236080|155682398|FG001|Overall Study|Lost to Follow-up|1|||
48692503|NCT00453154|156724505|FG002|Double BIind Maintenance|Death|2|||
48407598|NCT00236080|155682399|FG002|Overall Study|Lost to Follow-up|0|||
48407599|NCT00236080|155682400|FG003|Overall Study|Lost to Follow-up|0|||
48407600|NCT00236080|155682401|FG004|Overall Study|Lost to Follow-up|0|||
48407601|NCT00236080|155682397|FG000|Overall Study|Physician Decision|1|||
48407602|NCT00236080|155682398|FG001|Overall Study|Physician Decision|0|||
48407603|NCT00236080|155682399|FG002|Overall Study|Physician Decision|1|||
48407604|NCT00236080|155682400|FG003|Overall Study|Physician Decision|1|||
48407605|NCT00236080|155682401|FG004|Overall Study|Physician Decision|1|||
48407606|NCT00236080|155682397|FG000|Overall Study|Withdrawal by Subject|1|||
48407607|NCT00236080|155682398|FG001|Overall Study|Withdrawal by Subject|0|||
48407608|NCT00236080|155682399|FG002|Overall Study|Withdrawal by Subject|0|||
48407609|NCT00236080|155682400|FG003|Overall Study|Withdrawal by Subject|0|||
48407610|NCT00236080|155682401|FG004|Overall Study|Withdrawal by Subject|0|||
48407611|NCT00236080|155682397|FG000|Overall Study|Miscellaneous|0|||
48407612|NCT00236080|155682398|FG001|Overall Study|Miscellaneous|0|||
48407613|NCT00236080|155682399|FG002|Overall Study|Miscellaneous|1|||
48407614|NCT00236080|155682400|FG003|Overall Study|Miscellaneous|0|||
48407615|NCT00236080|155682401|FG004|Overall Study|Miscellaneous|0|||
48407616|NCT02400255|155682402|FG000|Overall Study|Relapse|4|||
48407617|NCT02400255|155682403|FG001|Overall Study|Relapse|1|||
48407618|NCT02400255|155682404|FG002|Overall Study|Relapse|1|||
48407619|NCT02400255|155682405|FG003|Overall Study|Relapse|2|||
48407620|NCT02400255|155682402|FG000|Overall Study|Adverse Event|6|||
48407621|NCT02400255|155682403|FG001|Overall Study|Adverse Event|3|||
48407622|NCT02400255|155682404|FG002|Overall Study|Adverse Event|0|||
48407623|NCT02400255|155682405|FG003|Overall Study|Adverse Event|0|||
48407624|NCT02400255|155682402|FG000|Overall Study|Physician Decision|6|||
48407625|NCT02400255|155682403|FG001|Overall Study|Physician Decision|0|||
48407626|NCT02400255|155682404|FG002|Overall Study|Physician Decision|0|||
48407627|NCT02400255|155682405|FG003|Overall Study|Physician Decision|0|||
48407628|NCT02400255|155682402|FG000|Overall Study|Loss of insurance|1|||
48407629|NCT02400255|155682403|FG001|Overall Study|Loss of insurance|0|||
48407630|NCT02400255|155682404|FG002|Overall Study|Loss of insurance|0|||
48407631|NCT02400255|155682405|FG003|Overall Study|Loss of insurance|0|||
48407632|NCT00944034|155682406|FG000|Overall Study|Inappropriate enrollment|0|||
48407633|NCT00944034|155682407|FG001|Overall Study|Inappropriate enrollment|1|||
48407634|NCT00944034|155682408|FG002|Overall Study|Inappropriate enrollment|0|||
48407635|NCT00944034|155682409|FG003|Overall Study|Inappropriate enrollment|1|||
48407636|NCT00944034|155682410|FG004|Overall Study|Inappropriate enrollment|2|||
48407637|NCT00944034|155682411|FG005|Overall Study|Inappropriate enrollment|1|||
48407638|NCT00944034|155682412|FG006|Overall Study|Inappropriate enrollment|0|||
48407639|NCT00944034|155682413|FG007|Overall Study|Inappropriate enrollment|0|||
48407640|NCT00944034|155682414|FG008|Overall Study|Inappropriate enrollment|1|||
48407641|NCT00944034|155682415|FG009|Overall Study|Inappropriate enrollment|1|||
48407642|NCT00944034|155682416|FG010|Overall Study|Inappropriate enrollment|0|||
48407643|NCT00944034|155682417|FG011|Overall Study|Inappropriate enrollment|0|||
48407644|NCT00944034|155682406|FG000|Overall Study|Withdrawal by Subject|3|||
48407645|NCT00944034|155682407|FG001|Overall Study|Withdrawal by Subject|2|||
48407646|NCT00944034|155682408|FG002|Overall Study|Withdrawal by Subject|6|||
48407647|NCT00944034|155682409|FG003|Overall Study|Withdrawal by Subject|2|||
48407648|NCT00944034|155682410|FG004|Overall Study|Withdrawal by Subject|5|||
48407649|NCT00944034|155682411|FG005|Overall Study|Withdrawal by Subject|8|||
48407650|NCT00944034|155682412|FG006|Overall Study|Withdrawal by Subject|2|||
48407651|NCT00944034|155682413|FG007|Overall Study|Withdrawal by Subject|2|||
48407652|NCT00944034|155682414|FG008|Overall Study|Withdrawal by Subject|3|||
48407653|NCT00944034|155682415|FG009|Overall Study|Withdrawal by Subject|4|||
48407654|NCT00944034|155682416|FG010|Overall Study|Withdrawal by Subject|0|||
48407655|NCT00944034|155682417|FG011|Overall Study|Withdrawal by Subject|4|||
48407656|NCT00944034|155682406|FG000|Overall Study|Lost to Follow-up|0|||
48407657|NCT00944034|155682407|FG001|Overall Study|Lost to Follow-up|4|||
48407658|NCT00944034|155682408|FG002|Overall Study|Lost to Follow-up|2|||
48407659|NCT00944034|155682409|FG003|Overall Study|Lost to Follow-up|0|||
48407660|NCT00944034|155682410|FG004|Overall Study|Lost to Follow-up|5|||
48407661|NCT00944034|155682411|FG005|Overall Study|Lost to Follow-up|7|||
48407662|NCT00944034|155682412|FG006|Overall Study|Lost to Follow-up|0|||
48407663|NCT00944034|155682413|FG007|Overall Study|Lost to Follow-up|1|||
48407664|NCT00944034|155682414|FG008|Overall Study|Lost to Follow-up|5|||
48407665|NCT00944034|155682415|FG009|Overall Study|Lost to Follow-up|1|||
48407666|NCT00944034|155682416|FG010|Overall Study|Lost to Follow-up|1|||
48407667|NCT00944034|155682417|FG011|Overall Study|Lost to Follow-up|0|||
48407668|NCT00944034|155682406|FG000|Overall Study|Death|0|||
48407669|NCT00944034|155682407|FG001|Overall Study|Death|0|||
48407670|NCT00944034|155682408|FG002|Overall Study|Death|1|||
48407671|NCT00944034|155682409|FG003|Overall Study|Death|0|||
48407672|NCT00944034|155682410|FG004|Overall Study|Death|0|||
48407673|NCT00944034|155682411|FG005|Overall Study|Death|0|||
48407674|NCT00944034|155682412|FG006|Overall Study|Death|0|||
48407675|NCT00944034|155682413|FG007|Overall Study|Death|0|||
48407676|NCT00944034|155682414|FG008|Overall Study|Death|0|||
48407677|NCT00944034|155682415|FG009|Overall Study|Death|0|||
48407678|NCT00944034|155682416|FG010|Overall Study|Death|0|||
48407679|NCT00944034|155682417|FG011|Overall Study|Death|0|||
48407680|NCT00944034|155682406|FG000|Overall Study|Protocol Violation|2|||
48407681|NCT00944034|155682407|FG001|Overall Study|Protocol Violation|0|||
48407682|NCT00944034|155682408|FG002|Overall Study|Protocol Violation|0|||
48407683|NCT00944034|155682409|FG003|Overall Study|Protocol Violation|1|||
48407684|NCT00944034|155682410|FG004|Overall Study|Protocol Violation|2|||
48407685|NCT00944034|155682411|FG005|Overall Study|Protocol Violation|3|||
48407686|NCT00944034|155682412|FG006|Overall Study|Protocol Violation|0|||
48407687|NCT00944034|155682413|FG007|Overall Study|Protocol Violation|1|||
48407688|NCT00944034|155682414|FG008|Overall Study|Protocol Violation|1|||
48407689|NCT00944034|155682415|FG009|Overall Study|Protocol Violation|4|||
48407690|NCT00944034|155682416|FG010|Overall Study|Protocol Violation|0|||
48407691|NCT00944034|155682417|FG011|Overall Study|Protocol Violation|0|||
48407692|NCT00944034|155682406|FG000|Overall Study|Unable to classify|0|||
48407693|NCT00944034|155682407|FG001|Overall Study|Unable to classify|0|||
48407694|NCT00944034|155682408|FG002|Overall Study|Unable to classify|0|||
48407695|NCT00944034|155682409|FG003|Overall Study|Unable to classify|0|||
48407696|NCT00944034|155682410|FG004|Overall Study|Unable to classify|0|||
48407697|NCT00944034|155682411|FG005|Overall Study|Unable to classify|1|||
48407698|NCT00944034|155682412|FG006|Overall Study|Unable to classify|1|||
48407699|NCT00944034|155682413|FG007|Overall Study|Unable to classify|1|||
48407700|NCT00944034|155682414|FG008|Overall Study|Unable to classify|0|||
48407701|NCT00944034|155682415|FG009|Overall Study|Unable to classify|0|||
48407702|NCT00944034|155682416|FG010|Overall Study|Unable to classify|0|||
48407703|NCT00944034|155682417|FG011|Overall Study|Unable to classify|0|||
48407704|NCT00944034|155682406|FG000|Overall Study|Administrative reason|0|||
48407705|NCT00944034|155682407|FG001|Overall Study|Administrative reason|0|||
48407706|NCT00944034|155682408|FG002|Overall Study|Administrative reason|0|||
48407707|NCT00944034|155682409|FG003|Overall Study|Administrative reason|0|||
48407708|NCT00944034|155682410|FG004|Overall Study|Administrative reason|0|||
48407709|NCT00944034|155682411|FG005|Overall Study|Administrative reason|0|||
48407710|NCT00944034|155682412|FG006|Overall Study|Administrative reason|1|||
48407711|NCT00944034|155682413|FG007|Overall Study|Administrative reason|0|||
48407712|NCT00944034|155682414|FG008|Overall Study|Administrative reason|0|||
48407713|NCT00944034|155682415|FG009|Overall Study|Administrative reason|0|||
48407714|NCT00944034|155682416|FG010|Overall Study|Administrative reason|0|||
48407715|NCT00944034|155682417|FG011|Overall Study|Administrative reason|0|||
48407716|NCT00510276|155682418|FG000|Acute Double-Blind Phase|Adverse Event|21|||
48407717|NCT00510276|155682419|FG001|Acute Double-Blind Phase|Adverse Event|6|||
48407718|NCT00510276|155682418|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
48407719|NCT00510276|155682419|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
48407720|NCT00510276|155682418|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
48407721|NCT00510276|155682419|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
48407722|NCT00510276|155682418|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
48407723|NCT00510276|155682419|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
48407724|NCT00510276|155682418|FG000|Acute Double-Blind Phase|Physician Decision|0|||
48407725|NCT00510276|155682419|FG001|Acute Double-Blind Phase|Physician Decision|3|||
48407726|NCT00510276|155682418|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
48407727|NCT00510276|155682419|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
48407728|NCT00510276|155682418|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
48407729|NCT00510276|155682419|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
48407730|NCT00510276|155682418|FG000|Acute Double-Blind Phase|Subject Decision|26|||
48407731|NCT00510276|155682419|FG001|Acute Double-Blind Phase|Subject Decision|28|||
48407732|NCT00510276|155682418|FG000|Extension Open-Label Phase|Adverse Event|9|||
48407733|NCT00510276|155682419|FG001|Extension Open-Label Phase|Adverse Event|18|||
48407734|NCT00510276|155682418|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
48407735|NCT00510276|155682419|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
48407736|NCT00510276|155682418|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
48407737|NCT00510276|155682419|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
48407738|NCT00510276|155682418|FG000|Extension Open-Label Phase|Physician Decision|2|||
48407739|NCT00510276|155682419|FG001|Extension Open-Label Phase|Physician Decision|3|||
48407740|NCT00510276|155682418|FG000|Extension Open-Label Phase|Protocol Violation|0|||
48407741|NCT00510276|155682419|FG001|Extension Open-Label Phase|Protocol Violation|1|||
48407742|NCT00510276|155682418|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
48407743|NCT00510276|155682419|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
48407744|NCT00510276|155682418|FG000|Extension Open-Label Phase|Subject Decision|7|||
48407745|NCT00510276|155682419|FG001|Extension Open-Label Phase|Subject Decision|9|||
48407746|NCT01961544|155682420|FG000|Overall Study|Protocol Violation|1|||
48407747|NCT01961544|155682420|FG000|Overall Study|Withdrawal by Subject|7|||
48407748|NCT01961544|155682420|FG000|Overall Study|Adverse Event|1|||
48407749|NCT01961544|155682420|FG000|Overall Study|Physician Decision|2|||
48407750|NCT01961544|155682420|FG000|Overall Study|Poor Tolerance|1|||
48407751|NCT01961544|155682420|FG000|Overall Study|Aggravation of Steral Pain|1|||
48407752|NCT03543410|155682423|FG000|Overall Study|Adverse Event|10|||
48407753|NCT03543410|155682424|FG001|Overall Study|Adverse Event|8|||
48407754|NCT03543410|155682425|FG002|Overall Study|Adverse Event|2|||
48407755|NCT03543410|155682423|FG000|Overall Study|Lack of Efficacy|0|||
48407756|NCT03543410|155682424|FG001|Overall Study|Lack of Efficacy|1|||
48407757|NCT03543410|155682425|FG002|Overall Study|Lack of Efficacy|0|||
48407758|NCT03543410|155682423|FG000|Overall Study|Lost to Follow-up|0|||
48407759|NCT03543410|155682424|FG001|Overall Study|Lost to Follow-up|1|||
48407760|NCT03543410|155682425|FG002|Overall Study|Lost to Follow-up|0|||
48407761|NCT03543410|155682423|FG000|Overall Study|Withdrawal by Subject|5|||
48407762|NCT03543410|155682424|FG001|Overall Study|Withdrawal by Subject|2|||
48407763|NCT03543410|155682425|FG002|Overall Study|Withdrawal by Subject|8|||
48407764|NCT03543410|155682423|FG000|Overall Study|Protocol Violation|0|||
48407765|NCT03543410|155682424|FG001|Overall Study|Protocol Violation|1|||
48407766|NCT03543410|155682425|FG002|Overall Study|Protocol Violation|0|||
48407767|NCT03543410|155682423|FG000|Overall Study|Due to COVID-19|4|||
48407768|NCT03543410|155682424|FG001|Overall Study|Due to COVID-19|0|||
48407769|NCT03543410|155682425|FG002|Overall Study|Due to COVID-19|2|||
48407770|NCT03543410|155682423|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
48407771|NCT03543410|155682424|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
48407772|NCT03543410|155682425|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
48407773|NCT03543410|155682423|FG000|Overall Study|Not Due to COVID-19|2|||
48407774|NCT03543410|155682424|FG001|Overall Study|Not Due to COVID-19|0|||
48407775|NCT03543410|155682425|FG002|Overall Study|Not Due to COVID-19|1|||
48407776|NCT02435914|155682426|FG000|Overall Study|Ocular Adverse Event|1|||
48407777|NCT02435914|155682427|FG001|Overall Study|Ocular Adverse Event|0|||
48407778|NCT02435914|155682428|FG002|Overall Study|Ocular Adverse Event|0|||
48407779|NCT02435914|155682429|FG003|Overall Study|Ocular Adverse Event|0|||
48407780|NCT02435914|155682426|FG000|Overall Study|Withdrawal by Subject|0|||
48407781|NCT02435914|155682427|FG001|Overall Study|Withdrawal by Subject|1|||
48407782|NCT02435914|155682428|FG002|Overall Study|Withdrawal by Subject|0|||
48407783|NCT02435914|155682429|FG003|Overall Study|Withdrawal by Subject|0|||
48407784|NCT02435914|155682426|FG000|Overall Study|Other Miscellaneous Reason|0|||
48407785|NCT02435914|155682427|FG001|Overall Study|Other Miscellaneous Reason|0|||
48407786|NCT02435914|155682428|FG002|Overall Study|Other Miscellaneous Reason|1|||
48407787|NCT02435914|155682429|FG003|Overall Study|Other Miscellaneous Reason|0|||
48407788|NCT01318122|155682430|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48407789|NCT01318122|155682431|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
48407790|NCT01318122|155682432|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
48407791|NCT01318122|155682433|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
48407792|NCT01318122|155682430|FG000|Enrolled - Long-Term Extension Study|Other|1|||
48407793|NCT01318122|155682431|FG001|Enrolled - Long-Term Extension Study|Other|0|||
48407794|NCT01318122|155682432|FG002|Enrolled - Long-Term Extension Study|Other|0|||
48407795|NCT01318122|155682433|FG003|Enrolled - Long-Term Extension Study|Other|0|||
48407796|NCT01318122|155682430|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
48407797|NCT01318122|155682431|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
48407798|NCT01318122|155682432|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
48407799|NCT01318122|155682433|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
48407800|NCT01318122|155682430|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
48407801|NCT01318122|155682431|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48407802|NCT01318122|155682432|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48407803|NCT01318122|155682433|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
48407804|NCT01318122|155682430|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
48407805|NCT01318122|155682431|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
48407806|NCT01318122|155682432|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
48407807|NCT01318122|155682433|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
48407808|NCT01318122|155682430|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48407809|NCT01318122|155682431|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
48407810|NCT01318122|155682432|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
48407811|NCT01318122|155682433|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
48407812|NCT00880256|155682436|FG000|Overall Study|Lost to Follow-up|28|||
48407813|NCT04082663|155682452|FG000|Overall Study|Adverse Event|6|||
48407814|NCT04082663|155682452|FG000|Overall Study|Lost to Follow-up|1|||
48407815|NCT01497262|155682453|FG000|Overall Study|Abnormal Lab Values|4|||
48407816|NCT01497262|155682453|FG000|Overall Study|Abnormal Test Procedure Result|1|||
48407817|NCT01497262|155682453|FG000|Overall Study|Physician Decision|1|||
48407818|NCT01497262|155682453|FG000|Overall Study|Withdrawal by Subject|2|||
48407819|NCT01497262|155682453|FG000|Overall Study|Adverse Event|2|||
48407820|NCT01497262|155682453|FG000|Overall Study|Protocol Violation|1|||
48407821|NCT03898063|155682454|FG000|Overall Study|Withdrawal by Subject|10|||
48407822|NCT03898063|155682455|FG001|Overall Study|Withdrawal by Subject|8|||
48407823|NCT02440581|155682456|FG000|Overall Study|Death|0|||
48407824|NCT02440581|155682457|FG001|Overall Study|Death|0|||
48407825|NCT02440581|155682458|FG002|Overall Study|Death|7|||
48407826|NCT02440581|155682459|FG003|Overall Study|Death|5|||
48407827|NCT02440581|155682456|FG000|Overall Study|Transplanted|1|||
48407828|NCT02440581|155682457|FG001|Overall Study|Transplanted|0|||
48407829|NCT02440581|155682458|FG002|Overall Study|Transplanted|3|||
48407830|NCT02440581|155682459|FG003|Overall Study|Transplanted|2|||
48407831|NCT02440581|155682456|FG000|Overall Study|Withdrawal by Subject|4|||
48407832|NCT02440581|155682457|FG001|Overall Study|Withdrawal by Subject|11|||
48407833|NCT02440581|155682458|FG002|Overall Study|Withdrawal by Subject|3|||
48407834|NCT02440581|155682459|FG003|Overall Study|Withdrawal by Subject|7|||
48407835|NCT04373460|155682460|FG000|Overall Study|Did not receive tranfusion|18|||
48407836|NCT04373460|155682461|FG001|Overall Study|Did not receive tranfusion|26|||
48407837|NCT05032950|155682462|FG000|Overall Study|Adverse Event|0|||
48407838|NCT05032950|155682463|FG001|Overall Study|Adverse Event|0|||
48407839|NCT05032950|155682464|FG002|Overall Study|Adverse Event|1|||
48407840|NCT05032950|155682465|FG003|Overall Study|Adverse Event|1|||
48407841|NCT05032950|155682466|FG004|Overall Study|Adverse Event|0|||
48407842|NCT05032950|155682467|FG005|Overall Study|Adverse Event|0|||
48407843|NCT02116621|155682470|FG000|Baseline|Withdrawal by Subject|0|||
48407844|NCT02116621|155682471|FG001|Baseline|Withdrawal by Subject|4|||
48407845|NCT02116621|155682470|FG000|Three Month Follow-up|Death|1|||
48407846|NCT02116621|155682471|FG001|Three Month Follow-up|Death|1|||
48407847|NCT02116621|155682470|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
48407848|NCT02116621|155682471|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
48407849|NCT02116621|155682470|FG000|Three Month Follow-up|Lost to Follow-up|0|||
48407850|NCT02116621|155682471|FG001|Three Month Follow-up|Lost to Follow-up|1|||
48407851|NCT02116621|155682470|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
48407852|NCT02116621|155682471|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
48407853|NCT02116621|155682470|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
48407854|NCT02116621|155682471|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
48407855|NCT02116621|155682470|FG000|Six Month Follow-up|Lost to Follow-up|2|||
48407856|NCT02116621|155682471|FG001|Six Month Follow-up|Lost to Follow-up|1|||
48407857|NCT02116621|155682470|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
48407858|NCT02116621|155682471|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
48407859|NCT02116621|155682470|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
48407860|NCT02116621|155682471|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
48407861|NCT02116621|155682470|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
48407862|NCT02116621|155682471|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
48407863|NCT02116621|155682470|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
48407864|NCT02116621|155682471|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
48407865|NCT02116621|155682470|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
48407866|NCT02116621|155682471|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
48407867|NCT01275222|155682472|FG000|Phase l by Treatment|Adverse Event|1|||
48407868|NCT01275222|155682473|FG001|Phase l by Treatment|Adverse Event|4|||
48407869|NCT01275222|155682474|FG002|Phase l by Treatment|Adverse Event|2|||
48407870|NCT01275222|155682475|FG003|Phase l by Treatment|Adverse Event|3|||
48407871|NCT01275222|155682476|FG004|Phase l by Treatment|Adverse Event|0|||
48407872|NCT01275222|155682477|FG005|Phase l by Treatment|Adverse Event|0|||
48407873|NCT01275222|155682472|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48407874|NCT01275222|155682473|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48407875|NCT01275222|155682474|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
48407876|NCT01275222|155682475|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48407877|NCT01275222|155682476|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48407878|NCT01275222|155682477|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
48407879|NCT01275222|155682472|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48407880|NCT01275222|155682473|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48407881|NCT01275222|155682474|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48407882|NCT01275222|155682475|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
48407883|NCT01275222|155682476|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48407884|NCT01275222|155682477|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
48407885|NCT01275222|155682472|FG000|Phase l by Treatment|Disease progression|12|||
48407886|NCT01275222|155682473|FG001|Phase l by Treatment|Disease progression|8|||
48407887|NCT01275222|155682474|FG002|Phase l by Treatment|Disease progression|2|||
48407888|NCT01275222|155682475|FG003|Phase l by Treatment|Disease progression|5|||
48407889|NCT01275222|155682476|FG004|Phase l by Treatment|Disease progression|0|||
48407890|NCT01275222|155682477|FG005|Phase l by Treatment|Disease progression|0|||
48407891|NCT01275222|155682472|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
48407892|NCT01275222|155682473|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
48407893|NCT01275222|155682474|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
48407894|NCT01275222|155682475|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
48407895|NCT01275222|155682476|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
48407896|NCT01275222|155682477|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
48407897|NCT01275222|155682472|FG000|Phase l by Treatment|Death|0|||
48407898|NCT01275222|155682473|FG001|Phase l by Treatment|Death|1|||
48407899|NCT01275222|155682474|FG002|Phase l by Treatment|Death|0|||
48407900|NCT01275222|155682475|FG003|Phase l by Treatment|Death|1|||
48407901|NCT01275222|155682476|FG004|Phase l by Treatment|Death|0|||
48407902|NCT01275222|155682477|FG005|Phase l by Treatment|Death|0|||
48407903|NCT01275222|155682472|FG000|Phase ll by Stratum|Adverse Event|0|||
48407904|NCT01275222|155682473|FG001|Phase ll by Stratum|Adverse Event|0|||
48407905|NCT01275222|155682474|FG002|Phase ll by Stratum|Adverse Event|0|||
48407906|NCT01275222|155682475|FG003|Phase ll by Stratum|Adverse Event|0|||
48407907|NCT01275222|155682476|FG004|Phase ll by Stratum|Adverse Event|2|||
48407908|NCT01275222|155682477|FG005|Phase ll by Stratum|Adverse Event|10|||
48407909|NCT01275222|155682472|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
48407910|NCT01275222|155682473|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
48407911|NCT01275222|155682474|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
48407912|NCT01275222|155682475|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
48407913|NCT01275222|155682476|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
48407914|NCT01275222|155682477|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
48407915|NCT01275222|155682472|FG000|Phase ll by Stratum|Disease progression|0|||
48407916|NCT01275222|155682473|FG001|Phase ll by Stratum|Disease progression|0|||
48407917|NCT01275222|155682474|FG002|Phase ll by Stratum|Disease progression|0|||
48407918|NCT01275222|155682475|FG003|Phase ll by Stratum|Disease progression|0|||
48407919|NCT01275222|155682476|FG004|Phase ll by Stratum|Disease progression|23|||
48407920|NCT01275222|155682477|FG005|Phase ll by Stratum|Disease progression|31|||
48407921|NCT01275222|155682472|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
48407922|NCT01275222|155682473|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
48407923|NCT01275222|155682474|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
48407924|NCT01275222|155682475|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
48407925|NCT01275222|155682476|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
48407926|NCT01275222|155682477|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
48407927|NCT01275222|155682472|FG000|Phase ll by Stratum|Death|0|||
48407928|NCT01275222|155682473|FG001|Phase ll by Stratum|Death|0|||
48407929|NCT01275222|155682474|FG002|Phase ll by Stratum|Death|0|||
48407930|NCT01275222|155682475|FG003|Phase ll by Stratum|Death|0|||
48407931|NCT01275222|155682476|FG004|Phase ll by Stratum|Death|1|||
48407932|NCT01275222|155682477|FG005|Phase ll by Stratum|Death|1|||
48407933|NCT02495948|155682478|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
48407934|NCT02495948|155682479|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
48407935|NCT02495948|155682478|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
48431433|NCT00002663|155767268|FG004|Overall Study|Other|0|||
48407936|NCT02495948|155682479|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
48407937|NCT00490542|155682480|FG000|Overall Study|Lost to Follow-up|3|||
48407938|NCT00490542|155682481|FG001|Overall Study|Lost to Follow-up|0|||
48407939|NCT00490542|155682480|FG000|Overall Study|Adverse Event|3|||
48407940|NCT00490542|155682481|FG001|Overall Study|Adverse Event|3|||
48407941|NCT00490542|155682480|FG000|Overall Study|Lack of Efficacy|1|||
48407942|NCT00490542|155682481|FG001|Overall Study|Lack of Efficacy|1|||
48407943|NCT04343651|155682482|FG000|Overall Study|Physician Decision|2|||
48407944|NCT04343651|155682483|FG001|Overall Study|Physician Decision|1|||
48407945|NCT04343651|155682482|FG000|Overall Study|Lost to Follow-up|2|||
48407946|NCT04343651|155682483|FG001|Overall Study|Lost to Follow-up|1|||
48407947|NCT04343651|155682482|FG000|Overall Study|Protocol Violation|4|||
48407948|NCT04343651|155682483|FG001|Overall Study|Protocol Violation|6|||
48407949|NCT04343651|155682482|FG000|Overall Study|Missing|3|||
48407950|NCT04343651|155682483|FG001|Overall Study|Missing|9|||
48407951|NCT04343651|155682482|FG000|Overall Study|Withdrawal by Subject|0|||
48407952|NCT04343651|155682483|FG001|Overall Study|Withdrawal by Subject|4|||
48407953|NCT04343651|155682482|FG000|Overall Study|Death|0|||
48407954|NCT04343651|155682483|FG001|Overall Study|Death|1|||
48407955|NCT04343651|155682482|FG000|Overall Study|Did not start treatment|1|||
48407956|NCT04343651|155682483|FG001|Overall Study|Did not start treatment|1|||
48407957|NCT04343651|155682482|FG000|Overall Study|Patient did not complete visits 3-6|0|||
48407958|NCT04343651|155682483|FG001|Overall Study|Patient did not complete visits 3-6|1|||
48407959|NCT02078219|155682484|FG000|Overall Study|Other|2|||
48407960|NCT02078219|155682485|FG001|Overall Study|Other|2|||
48407961|NCT02078219|155682486|FG002|Overall Study|Other|3|||
48407962|NCT02078219|155682487|FG003|Overall Study|Other|0|||
48407963|NCT02078219|155682488|FG004|Overall Study|Other|1|||
48407964|NCT02078219|155682484|FG000|Overall Study|Withdrawal by Subject|0|||
48407965|NCT02078219|155682485|FG001|Overall Study|Withdrawal by Subject|1|||
48407966|NCT02078219|155682486|FG002|Overall Study|Withdrawal by Subject|0|||
48407967|NCT02078219|155682487|FG003|Overall Study|Withdrawal by Subject|1|||
48407968|NCT02078219|155682488|FG004|Overall Study|Withdrawal by Subject|1|||
48407969|NCT02078219|155682484|FG000|Overall Study|Protocol Violation|0|||
48407970|NCT02078219|155682485|FG001|Overall Study|Protocol Violation|0|||
48407971|NCT02078219|155682486|FG002|Overall Study|Protocol Violation|0|||
48407972|NCT02078219|155682487|FG003|Overall Study|Protocol Violation|1|||
48407973|NCT02078219|155682488|FG004|Overall Study|Protocol Violation|0|||
48407974|NCT02078219|155682484|FG000|Overall Study|Death|0|||
48407975|NCT02078219|155682485|FG001|Overall Study|Death|0|||
48407976|NCT02078219|155682486|FG002|Overall Study|Death|0|||
48407977|NCT02078219|155682487|FG003|Overall Study|Death|1|||
48407978|NCT02078219|155682488|FG004|Overall Study|Death|0|||
48407979|NCT02078219|155682484|FG000|Overall Study|Adverse Event|1|||
48407980|NCT02078219|155682485|FG001|Overall Study|Adverse Event|1|||
48407981|NCT02078219|155682486|FG002|Overall Study|Adverse Event|3|||
48407982|NCT02078219|155682487|FG003|Overall Study|Adverse Event|1|||
48407983|NCT02078219|155682488|FG004|Overall Study|Adverse Event|0|||
48407984|NCT02382133|155682492|FG000|Overall Study|Death|22|||
48407985|NCT02382133|155682492|FG000|Overall Study|transfer out of ICU|4|||
48407986|NCT02382133|155682492|FG000|Overall Study|Physician Decision|2|||
48407987|NCT02382133|155682492|FG000|Overall Study|arterial catheter loss|4|||
48407988|NCT02382133|155682492|FG000|Overall Study|pressure injury both sites|1|||
48407989|NCT00275561|155682493|FG000|Overall Study|Withdrawal by Subject|0|||
48407990|NCT00275561|155682494|FG001|Overall Study|Withdrawal by Subject|1|||
48407991|NCT00275561|155682493|FG000|Overall Study|Travel|1|||
48407992|NCT00275561|155682494|FG001|Overall Study|Travel|1|||
48407993|NCT00275561|155682493|FG000|Overall Study|Scheduling|1|||
48407994|NCT00275561|155682494|FG001|Overall Study|Scheduling|2|||
48407995|NCT00275561|155682493|FG000|Overall Study|Family Issues|0|||
48407996|NCT00275561|155682494|FG001|Overall Study|Family Issues|2|||
48407997|NCT02527707|155684224|FG000|Overall Study|Adverse Event|1|||
48407998|NCT02527707|155684224|FG000|Overall Study|Adverse Event|1|||
48407999|NCT00546364|155684225|FG000|Overall Study|Disease progression|5|||
48408000|NCT00546364|155684226|FG001|Overall Study|Disease progression|11|||
48408001|NCT00546364|155684227|FG002|Overall Study|Disease progression|8|||
48408002|NCT00546364|155684225|FG000|Overall Study|Completed and off treatment|1|||
48408003|NCT00546364|155684226|FG001|Overall Study|Completed and off treatment|0|||
48408004|NCT00546364|155684227|FG002|Overall Study|Completed and off treatment|2|||
48408005|NCT00546364|155684225|FG000|Overall Study|Administrative reason by sponsor|1|||
48408006|NCT00546364|155684226|FG001|Overall Study|Administrative reason by sponsor|0|||
48408007|NCT00546364|155684227|FG002|Overall Study|Administrative reason by sponsor|0|||
48408008|NCT00546364|155684225|FG000|Overall Study|Poor compliance/noncompliance|0|||
48408009|NCT00546364|155684226|FG001|Overall Study|Poor compliance/noncompliance|0|||
48408010|NCT00546364|155684227|FG002|Overall Study|Poor compliance/noncompliance|1|||
48408011|NCT00546364|155684225|FG000|Overall Study|No longer meets study criteria|1|||
48408012|NCT00546364|155684226|FG001|Overall Study|No longer meets study criteria|1|||
48408013|NCT00546364|155684227|FG002|Overall Study|No longer meets study criteria|0|||
48408014|NCT00546364|155684225|FG000|Overall Study|Withdrawal by Subject|5|||
48408015|NCT00546364|155684226|FG001|Overall Study|Withdrawal by Subject|6|||
48408016|NCT00546364|155684227|FG002|Overall Study|Withdrawal by Subject|3|||
48408017|NCT00546364|155684225|FG000|Overall Study|Prior taxotere|1|||
48408018|NCT00546364|155684226|FG001|Overall Study|Prior taxotere|0|||
48408019|NCT00546364|155684227|FG002|Overall Study|Prior taxotere|0|||
48408020|NCT00546364|155684225|FG000|Overall Study|Mixed response|1|||
48408021|NCT00546364|155684226|FG001|Overall Study|Mixed response|0|||
48408022|NCT00546364|155684227|FG002|Overall Study|Mixed response|0|||
48408023|NCT00546364|155684225|FG000|Overall Study|Palliative treatment|1|||
48408024|NCT00546364|155684226|FG001|Overall Study|Palliative treatment|0|||
48408025|NCT00546364|155684227|FG002|Overall Study|Palliative treatment|1|||
48408026|NCT00546364|155684225|FG000|Overall Study|Target lesions resected|1|||
48408027|NCT00546364|155684226|FG001|Overall Study|Target lesions resected|0|||
48408028|NCT00546364|155684227|FG002|Overall Study|Target lesions resected|0|||
48408029|NCT00546364|155684225|FG000|Overall Study|Physician Decision|0|||
48408030|NCT00546364|155684226|FG001|Overall Study|Physician Decision|0|||
48408031|NCT00546364|155684227|FG002|Overall Study|Physician Decision|1|||
48408032|NCT00546364|155684225|FG000|Overall Study|Sponsor decision|0|||
48408033|NCT00546364|155684226|FG001|Overall Study|Sponsor decision|0|||
48408034|NCT00546364|155684227|FG002|Overall Study|Sponsor decision|1|||
48408035|NCT00403260|155684228|FG000|Overall Study|Adverse Event|5|||
48408036|NCT00403260|155684229|FG001|Overall Study|Adverse Event|4|||
48408037|NCT00403260|155684228|FG000|Overall Study|Withdrawal by Subject|5|||
48408038|NCT00403260|155684229|FG001|Overall Study|Withdrawal by Subject|6|||
48408039|NCT00403260|155684228|FG000|Overall Study|Lost to Follow-up|49|||
48408040|NCT00403260|155684229|FG001|Overall Study|Lost to Follow-up|25|||
48408041|NCT00403260|155684228|FG000|Overall Study|Re-appearance of P. falciparum|34|||
48408042|NCT00403260|155684229|FG001|Overall Study|Re-appearance of P. falciparum|25|||
48408043|NCT00403260|155684228|FG000|Overall Study|P. vivax infection|26|||
48408044|NCT00403260|155684229|FG001|Overall Study|P. vivax infection|4|||
48408045|NCT00403260|155684228|FG000|Overall Study|Mixed infection with P. vivax|2|||
48408046|NCT00403260|155684229|FG001|Overall Study|Mixed infection with P. vivax|0|||
48408047|NCT00403260|155684228|FG000|Overall Study|Mixed infection with P. falciparum|1|||
48408048|NCT00403260|155684229|FG001|Overall Study|Mixed infection with P. falciparum|0|||
48408049|NCT00403260|155684228|FG000|Overall Study|P. vivax infection at screening|1|||
48408050|NCT00403260|155684229|FG001|Overall Study|P. vivax infection at screening|0|||
48408051|NCT00403260|155684228|FG000|Overall Study|P. ovale infection|1|||
48408052|NCT00403260|155684229|FG001|Overall Study|P. ovale infection|0|||
48408053|NCT00403260|155684228|FG000|Overall Study|Gametocyte re-appearance|1|||
48408054|NCT00403260|155684229|FG001|Overall Study|Gametocyte re-appearance|1|||
48408055|NCT00403260|155684228|FG000|Overall Study|Withdrawn from study accidentally|0|||
48408056|NCT00403260|155684229|FG001|Overall Study|Withdrawn from study accidentally|1|||
48408057|NCT00544869|155684230|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
48408058|NCT00544869|155684231|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
48408059|NCT00544869|155684232|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
48408060|NCT00544869|155684230|FG000|Overall Study|Adverse Event|6|||
48408061|NCT00544869|155684231|FG001|Overall Study|Adverse Event|1|||
48408062|NCT00544869|155684232|FG002|Overall Study|Adverse Event|0|||
48408063|NCT00544869|155684230|FG000|Overall Study|Lack of Efficacy|1|||
48408064|NCT00544869|155684231|FG001|Overall Study|Lack of Efficacy|1|||
48408065|NCT00544869|155684232|FG002|Overall Study|Lack of Efficacy|0|||
48408066|NCT00544869|155684230|FG000|Overall Study|Physician Decision|2|||
48408067|NCT00544869|155684231|FG001|Overall Study|Physician Decision|0|||
48408068|NCT00544869|155684232|FG002|Overall Study|Physician Decision|0|||
48408069|NCT00771472|155684233|FG000|Overall Study|Physician Decision|2|||
48408070|NCT00771472|155684234|FG001|Overall Study|Physician Decision|3|||
48408071|NCT00771472|155684233|FG000|Overall Study|Progressive Disease|3|||
48408072|NCT00771472|155684234|FG001|Overall Study|Progressive Disease|1|||
48408073|NCT00771472|155684233|FG000|Overall Study|Protocol Violation|1|||
48408074|NCT00771472|155684234|FG001|Overall Study|Protocol Violation|0|||
48408075|NCT01790503|155684239|FG000|Overall Study|Adverse Event|1|||
48408076|NCT01790503|155684240|FG001|Overall Study|Adverse Event|0|||
48408077|NCT01790503|155684241|FG002|Overall Study|Adverse Event|0|||
48408078|NCT01790503|155684242|FG003|Overall Study|Adverse Event|0|||
48408079|NCT01790503|155684243|FG004|Overall Study|Adverse Event|0|||
48408080|NCT01790503|155684244|FG005|Overall Study|Adverse Event|2|||
48408081|NCT01790503|155684245|FG006|Overall Study|Adverse Event|0|||
48408082|NCT01790503|155684246|FG007|Overall Study|Adverse Event|0|||
48408083|NCT01790503|155684247|FG008|Overall Study|Adverse Event|2|||
48408084|NCT01790503|155684248|FG009|Overall Study|Adverse Event|4|||
48408085|NCT01790503|155684249|FG010|Overall Study|Adverse Event|7|||
48408086|NCT01790503|155684239|FG000|Overall Study|Withdrawal by Subject|0|||
48408087|NCT01790503|155684240|FG001|Overall Study|Withdrawal by Subject|0|||
48408088|NCT01790503|155684241|FG002|Overall Study|Withdrawal by Subject|1|||
48408089|NCT01790503|155684242|FG003|Overall Study|Withdrawal by Subject|1|||
48408090|NCT01790503|155684243|FG004|Overall Study|Withdrawal by Subject|1|||
48408091|NCT01790503|155684244|FG005|Overall Study|Withdrawal by Subject|2|||
48408092|NCT01790503|155684245|FG006|Overall Study|Withdrawal by Subject|1|||
48408093|NCT01790503|155684246|FG007|Overall Study|Withdrawal by Subject|0|||
48408094|NCT01790503|155684247|FG008|Overall Study|Withdrawal by Subject|0|||
48408095|NCT01790503|155684248|FG009|Overall Study|Withdrawal by Subject|0|||
48408096|NCT01790503|155684249|FG010|Overall Study|Withdrawal by Subject|1|||
48408097|NCT01790503|155684239|FG000|Overall Study|Disease progression|2|||
48408098|NCT01790503|155684240|FG001|Overall Study|Disease progression|1|||
48408099|NCT01790503|155684241|FG002|Overall Study|Disease progression|0|||
48408100|NCT01790503|155684242|FG003|Overall Study|Disease progression|1|||
48408101|NCT01790503|155684243|FG004|Overall Study|Disease progression|2|||
48408102|NCT01790503|155684244|FG005|Overall Study|Disease progression|1|||
48408103|NCT01790503|155684245|FG006|Overall Study|Disease progression|0|||
48408104|NCT01790503|155684246|FG007|Overall Study|Disease progression|1|||
48408105|NCT01790503|155684247|FG008|Overall Study|Disease progression|0|||
48408106|NCT01790503|155684248|FG009|Overall Study|Disease progression|17|||
48408107|NCT01790503|155684249|FG010|Overall Study|Disease progression|7|||
48408108|NCT01790503|155684239|FG000|Overall Study|Protocol Violation|0|||
48408109|NCT01790503|155684240|FG001|Overall Study|Protocol Violation|0|||
48408110|NCT01790503|155684241|FG002|Overall Study|Protocol Violation|0|||
48408111|NCT01790503|155684242|FG003|Overall Study|Protocol Violation|0|||
48408112|NCT01790503|155684243|FG004|Overall Study|Protocol Violation|0|||
48408113|NCT01790503|155684244|FG005|Overall Study|Protocol Violation|0|||
48408114|NCT01790503|155684245|FG006|Overall Study|Protocol Violation|0|||
48408115|NCT01790503|155684246|FG007|Overall Study|Protocol Violation|0|||
48408116|NCT01790503|155684247|FG008|Overall Study|Protocol Violation|0|||
48408117|NCT01790503|155684248|FG009|Overall Study|Protocol Violation|1|||
48408118|NCT01790503|155684249|FG010|Overall Study|Protocol Violation|0|||
48408119|NCT01790503|155684239|FG000|Overall Study|Physician Decision|0|||
48408120|NCT01790503|155684240|FG001|Overall Study|Physician Decision|0|||
48408121|NCT01790503|155684241|FG002|Overall Study|Physician Decision|0|||
48408122|NCT01790503|155684242|FG003|Overall Study|Physician Decision|0|||
48408123|NCT01790503|155684243|FG004|Overall Study|Physician Decision|0|||
48408124|NCT01790503|155684244|FG005|Overall Study|Physician Decision|0|||
48408125|NCT01790503|155684245|FG006|Overall Study|Physician Decision|0|||
48408126|NCT01790503|155684246|FG007|Overall Study|Physician Decision|0|||
48408127|NCT01790503|155684247|FG008|Overall Study|Physician Decision|0|||
48408128|NCT01790503|155684248|FG009|Overall Study|Physician Decision|1|||
48408129|NCT01790503|155684249|FG010|Overall Study|Physician Decision|1|||
48408130|NCT01790503|155684239|FG000|Overall Study|Death|0|||
48408131|NCT01790503|155684240|FG001|Overall Study|Death|0|||
48408132|NCT01790503|155684241|FG002|Overall Study|Death|0|||
48408133|NCT01790503|155684242|FG003|Overall Study|Death|0|||
48408134|NCT01790503|155684243|FG004|Overall Study|Death|0|||
48408135|NCT01790503|155684244|FG005|Overall Study|Death|0|||
48408136|NCT01790503|155684245|FG006|Overall Study|Death|0|||
48408137|NCT01790503|155684246|FG007|Overall Study|Death|0|||
48408138|NCT01790503|155684247|FG008|Overall Study|Death|0|||
48408139|NCT01790503|155684248|FG009|Overall Study|Death|1|||
48408140|NCT01790503|155684249|FG010|Overall Study|Death|0|||
48408141|NCT01790503|155684239|FG000|Overall Study|Non Compliance|0|||
48408142|NCT01790503|155684240|FG001|Overall Study|Non Compliance|0|||
48408143|NCT01790503|155684241|FG002|Overall Study|Non Compliance|0|||
48408144|NCT01790503|155684242|FG003|Overall Study|Non Compliance|0|||
48408145|NCT01790503|155684243|FG004|Overall Study|Non Compliance|1|||
48408146|NCT01790503|155684244|FG005|Overall Study|Non Compliance|0|||
48408147|NCT01790503|155684245|FG006|Overall Study|Non Compliance|0|||
48408148|NCT01790503|155684246|FG007|Overall Study|Non Compliance|0|||
48408149|NCT01790503|155684247|FG008|Overall Study|Non Compliance|0|||
48408150|NCT01790503|155684248|FG009|Overall Study|Non Compliance|0|||
48408151|NCT01790503|155684249|FG010|Overall Study|Non Compliance|0|||
48408152|NCT01790503|155684239|FG000|Overall Study|Other|0|||
48408153|NCT01790503|155684240|FG001|Overall Study|Other|0|||
48408154|NCT01790503|155684241|FG002|Overall Study|Other|0|||
48408155|NCT01790503|155684242|FG003|Overall Study|Other|0|||
48408156|NCT01790503|155684243|FG004|Overall Study|Other|1|||
48408157|NCT01790503|155684244|FG005|Overall Study|Other|0|||
48408158|NCT01790503|155684245|FG006|Overall Study|Other|0|||
48408159|NCT01790503|155684246|FG007|Overall Study|Other|0|||
48408160|NCT01790503|155684247|FG008|Overall Study|Other|1|||
48408161|NCT01790503|155684248|FG009|Overall Study|Other|2|||
48408162|NCT01790503|155684249|FG010|Overall Study|Other|0|||
48408163|NCT02631538|155684253|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
48408164|NCT02631538|155684254|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
48408165|NCT02631538|155684255|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
48408166|NCT02631538|155684256|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
48408167|NCT02631538|155684253|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
48408168|NCT02631538|155684254|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
48408169|NCT02631538|155684255|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
48408170|NCT02631538|155684256|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
48408171|NCT02631538|155684253|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
48408172|NCT02631538|155684254|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
48408173|NCT02631538|155684255|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
48408174|NCT02631538|155684256|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
48408175|NCT02631538|155684253|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
48431434|NCT00002663|155767269|FG005|Overall Study|Other|1|||
48408176|NCT02631538|155684254|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
48408177|NCT02631538|155684255|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
48408178|NCT02631538|155684256|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
48408179|NCT02631538|155684253|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
48408180|NCT02631538|155684254|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
48408181|NCT02631538|155684255|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
48408182|NCT02631538|155684256|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
48408183|NCT02631538|155684253|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
48408184|NCT02631538|155684254|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
48408185|NCT02631538|155684255|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
48408186|NCT02631538|155684256|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
48408187|NCT01046695|155684258|FG000|Overall Study|Subject had a pacemaker|0|||
48408188|NCT01046695|155684259|FG001|Overall Study|Subject had a pacemaker|1|||
48408189|NCT01046695|155684258|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
48408190|NCT01046695|155684259|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
48408191|NCT01528787|155684261|FG000|Overall Study|Withdrawal by Subject|0|||
48408192|NCT01528787|155684262|FG001|Overall Study|Withdrawal by Subject|0|||
48408193|NCT01528787|155684263|FG002|Overall Study|Withdrawal by Subject|0|||
48408194|NCT01528787|155684264|FG003|Overall Study|Withdrawal by Subject|1|||
48408195|NCT01528787|155684261|FG000|Overall Study|Family Emergency|0|||
48408196|NCT01528787|155684262|FG001|Overall Study|Family Emergency|0|||
48408197|NCT01528787|155684263|FG002|Overall Study|Family Emergency|1|||
48408198|NCT01528787|155684264|FG003|Overall Study|Family Emergency|0|||
48408199|NCT00189462|155684268|FG000|Overall Study|Lack of Efficacy|5|||
48408200|NCT00189462|155684269|FG001|Overall Study|Lack of Efficacy|1|||
48408201|NCT00189462|155684268|FG000|Overall Study|Lost to Follow-up|18|||
48408202|NCT00189462|155684269|FG001|Overall Study|Lost to Follow-up|20|||
48408203|NCT01262625|155684270|FG000|Overall Study|Administrative Error|1|||
48408204|NCT01262625|155684271|FG001|Overall Study|Administrative Error|1|||
48408205|NCT01262625|155684270|FG000|Overall Study|Site Closed|1|||
48408206|NCT01262625|155684271|FG001|Overall Study|Site Closed|0|||
48408207|NCT01869348|155684272|FG000|Overall Study|Withdrawal by Subject|1|||
48408208|NCT01869348|155684273|FG001|Overall Study|Withdrawal by Subject|1|||
48408209|NCT00441792|155684284|FG000|Overall Study|Lost to Follow-up|0|||
48408210|NCT00441792|155684285|FG001|Overall Study|Lost to Follow-up|2|||
48408211|NCT03403192|155684286|FG000|Overall Study|Lost to Follow-up|1|||
48408212|NCT03403192|155684287|FG001|Overall Study|Lost to Follow-up|2|||
48408213|NCT03403192|155684288|FG002|Overall Study|Lost to Follow-up|0|||
48408214|NCT03403192|155684289|FG003|Overall Study|Lost to Follow-up|0|||
48408215|NCT03403192|155684286|FG000|Overall Study|Unable to respond|0|||
48408216|NCT03403192|155684287|FG001|Overall Study|Unable to respond|1|||
48408217|NCT03403192|155684288|FG002|Overall Study|Unable to respond|0|||
48408218|NCT03403192|155684289|FG003|Overall Study|Unable to respond|0|||
48408219|NCT03403192|155684286|FG000|Overall Study|Incomplete|3|||
48408220|NCT03403192|155684287|FG001|Overall Study|Incomplete|1|||
48408221|NCT03403192|155684288|FG002|Overall Study|Incomplete|3|||
48408222|NCT03403192|155684289|FG003|Overall Study|Incomplete|6|||
48408223|NCT01551693|155684290|FG000|Overall Study|Disease Progression|1|||
48408224|NCT01551693|155684291|FG001|Overall Study|Disease Progression|0|||
48408225|NCT01551693|155684290|FG000|Overall Study|Adverse Event|0|||
48408226|NCT01551693|155684291|FG001|Overall Study|Adverse Event|1|||
48357591|NCT02614183|155504926|FG000|Double Blind Treatment Phase|Physician Decision|7|||
48357592|NCT02614183|155504927|FG001|Double Blind Treatment Phase|Physician Decision|3|||
48408227|NCT01551693|155684290|FG000|Overall Study|Withdrawal by Subject|0|||
48408228|NCT01551693|155684291|FG001|Overall Study|Withdrawal by Subject|1|||
48408229|NCT03093155|155684292|FG000|Overall Study|Not Eligible|1|||
48408230|NCT03093155|155684293|FG001|Overall Study|Not Eligible|0|||
48408231|NCT03093155|155684292|FG000|Overall Study|Withdrawal by Subject|0|||
48408232|NCT03093155|155684293|FG001|Overall Study|Withdrawal by Subject|1|||
48408233|NCT02902120|155684296|FG000|Overall Study|Lack of Efficacy|1|||
48408234|NCT01670994|155684299|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
48408235|NCT01670994|155684300|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
48408236|NCT01670994|155684299|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
48408237|NCT01670994|155684300|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
48408238|NCT01670994|155684299|FG000|Overall Study|Patient experienced DLT|0|||
48408239|NCT01670994|155684300|FG001|Overall Study|Patient experienced DLT|1|||
48408240|NCT03446456|155684301|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
48408241|NCT03446456|155684302|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
48408242|NCT03446456|155684301|FG000|Overall Study|Lost to Follow-up|1|||
48408243|NCT03446456|155684302|FG001|Overall Study|Lost to Follow-up|3|||
48408244|NCT03446456|155684301|FG000|Overall Study|Participant failed the toxicology test|1|||
48408245|NCT03446456|155684302|FG001|Overall Study|Participant failed the toxicology test|0|||
48408246|NCT03446456|155684301|FG000|Overall Study|Break down of the experimental equipment|1|||
48408247|NCT03446456|155684302|FG001|Overall Study|Break down of the experimental equipment|0|||
48408248|NCT01360645|155684303|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
48408249|NCT01360645|155684304|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
48408250|NCT01360645|155684305|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
48408251|NCT01360645|155684306|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
48408252|NCT01360645|155684303|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
48408253|NCT01360645|155684304|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
48408254|NCT01360645|155684305|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
48408255|NCT01360645|155684306|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
48408256|NCT01360645|155684303|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
48408257|NCT01360645|155684304|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
48408258|NCT01360645|155684305|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
48408259|NCT01360645|155684306|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
48408260|NCT01360645|155684303|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
48408261|NCT01360645|155684304|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
48408262|NCT01360645|155684305|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
48408263|NCT01360645|155684306|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
48408264|NCT01360645|155684303|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
48408265|NCT01360645|155684304|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
48408266|NCT01360645|155684305|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
48408267|NCT01360645|155684306|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
48408268|NCT01360645|155684303|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
48408269|NCT01360645|155684304|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
48408270|NCT01360645|155684305|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
48408271|NCT01360645|155684306|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
48408272|NCT01360645|155684303|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
48408273|NCT01360645|155684304|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
48408274|NCT01360645|155684305|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
48408275|NCT01360645|155684306|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
48408276|NCT01360645|155684303|FG000|Phase B (6 Weeks)|Adverse Event|0|||
48408277|NCT01360645|155684304|FG001|Phase B (6 Weeks)|Adverse Event|6|||
48408278|NCT01360645|155684305|FG002|Phase B (6 Weeks)|Adverse Event|0|||
48408279|NCT01360645|155684306|FG003|Phase B (6 Weeks)|Adverse Event|0|||
48408280|NCT01360645|155684303|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
48408281|NCT01360645|155684304|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
48408282|NCT01360645|155684305|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
48408283|NCT01360645|155684306|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
48408284|NCT01360645|155684303|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
48408285|NCT01360645|155684304|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
48408286|NCT01360645|155684305|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
48408287|NCT01360645|155684306|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
48408288|NCT01360645|155684303|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
48408289|NCT01360645|155684304|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
48408290|NCT01360645|155684305|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
48408291|NCT01360645|155684306|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
48408292|NCT01360645|155684303|FG000|Phase A+|Lost to Follow-up|0|||
48408293|NCT01360645|155684304|FG001|Phase A+|Lost to Follow-up|0|||
48408294|NCT01360645|155684305|FG002|Phase A+|Lost to Follow-up|0|||
48408295|NCT01360645|155684306|FG003|Phase A+|Lost to Follow-up|7|||
48408296|NCT01360645|155684303|FG000|Phase A+|Adverse Event|0|||
48408297|NCT01360645|155684304|FG001|Phase A+|Adverse Event|0|||
48408298|NCT01360645|155684305|FG002|Phase A+|Adverse Event|0|||
48408299|NCT01360645|155684306|FG003|Phase A+|Adverse Event|2|||
48408300|NCT01360645|155684303|FG000|Phase A+|Met Withdrawal Criteria|0|||
48408301|NCT01360645|155684304|FG001|Phase A+|Met Withdrawal Criteria|0|||
48408302|NCT01360645|155684305|FG002|Phase A+|Met Withdrawal Criteria|0|||
48408303|NCT01360645|155684306|FG003|Phase A+|Met Withdrawal Criteria|4|||
48408304|NCT01360645|155684303|FG000|Phase A+|Physician Decision|0|||
48408305|NCT01360645|155684304|FG001|Phase A+|Physician Decision|0|||
48408306|NCT01360645|155684305|FG002|Phase A+|Physician Decision|0|||
48408307|NCT01360645|155684306|FG003|Phase A+|Physician Decision|2|||
48408308|NCT01360645|155684303|FG000|Phase A+|Withdrawal by Subject|0|||
48408309|NCT01360645|155684304|FG001|Phase A+|Withdrawal by Subject|0|||
48408310|NCT01360645|155684305|FG002|Phase A+|Withdrawal by Subject|0|||
48408311|NCT01360645|155684306|FG003|Phase A+|Withdrawal by Subject|5|||
48408312|NCT01360645|155684303|FG000|Phase A+|Protocol Deviation|0|||
48408313|NCT01360645|155684304|FG001|Phase A+|Protocol Deviation|0|||
48408314|NCT01360645|155684305|FG002|Phase A+|Protocol Deviation|0|||
48408315|NCT01360645|155684306|FG003|Phase A+|Protocol Deviation|4|||
48408316|NCT03183128|155684307|FG000|Overall Study|Adverse Event|1|||
48408317|NCT03183128|155684308|FG001|Overall Study|Adverse Event|2|||
48408318|NCT03183128|155684307|FG000|Overall Study|Withdrawal by Subject|1|||
48408319|NCT03183128|155684308|FG001|Overall Study|Withdrawal by Subject|8|||
48408320|NCT03183128|155684307|FG000|Overall Study|Protocol Violation|2|||
48408321|NCT03183128|155684308|FG001|Overall Study|Protocol Violation|0|||
48408322|NCT03183128|155684307|FG000|Overall Study|Lack of Efficacy|4|||
48408323|NCT03183128|155684308|FG001|Overall Study|Lack of Efficacy|27|||
48408324|NCT03183128|155684307|FG000|Overall Study|Lost to Follow-up|1|||
48408325|NCT03183128|155684308|FG001|Overall Study|Lost to Follow-up|0|||
48408326|NCT03183128|155684307|FG000|Overall Study|Death|2|||
48408327|NCT03183128|155684308|FG001|Overall Study|Death|0|||
48408328|NCT03183128|155684307|FG000|Overall Study|Physician Decision|1|||
48408329|NCT03183128|155684308|FG001|Overall Study|Physician Decision|0|||
48408330|NCT01900002|155684311|FG000|Overall Study|Withdrawal by Subject|2|||
48408331|NCT01900002|155684311|FG000|Overall Study|ineligible for Y-90|4|||
48408332|NCT00888238|155684314|FG000|Washout Period After Period 2|Adverse Event|0|||
48408333|NCT00888238|155684315|FG001|Washout Period After Period 2|Adverse Event|0|||
48408334|NCT00888238|155684316|FG002|Washout Period After Period 2|Adverse Event|1|||
48408335|NCT02251912|155684317|FG000|Overall Study|Withdrawal by Subject|2|||
48408336|NCT02251912|155684318|FG001|Overall Study|Withdrawal by Subject|3|||
48408337|NCT02251912|155684317|FG000|Overall Study|Adverse Event|0|||
48408338|NCT02251912|155684318|FG001|Overall Study|Adverse Event|2|||
48408339|NCT02601573|155684320|FG000|Overall Study|Lost to Follow-up|0|||
48408340|NCT02601573|155684321|FG001|Overall Study|Lost to Follow-up|3|||
48408341|NCT02601573|155684322|FG002|Overall Study|Lost to Follow-up|1|||
48408342|NCT02601573|155684323|FG003|Overall Study|Lost to Follow-up|0|||
48408343|NCT02601573|155684324|FG004|Overall Study|Lost to Follow-up|2|||
48408344|NCT02601573|155684320|FG000|Overall Study|Withdrawal by Subject|0|||
48408345|NCT02601573|155684321|FG001|Overall Study|Withdrawal by Subject|1|||
48587184|NCT01810783|156343150|FG000|Overall Study|Adminstrative or other reason(s)|23|||
48587185|NCT01810783|156343150|FG000|Overall Study|Enrolled, not treated|1|||
48796826|NCT01951625|157093802|FG004|Follow Up Period|Death|1|||
48796827|NCT01951625|157093798|FG000|Follow Up Period|Logistical difficulties|1|||
48796828|NCT01951625|157093799|FG001|Follow Up Period|Logistical difficulties|2|||
48796829|NCT01951625|157093800|FG002|Follow Up Period|Logistical difficulties|0|||
48796830|NCT01951625|157093801|FG003|Follow Up Period|Logistical difficulties|0|||
48796831|NCT01951625|157093802|FG004|Follow Up Period|Logistical difficulties|0|||
48796832|NCT01951625|157093798|FG000|Follow Up Period|Adverse Event|0|||
48796833|NCT01951625|157093799|FG001|Follow Up Period|Adverse Event|3|||
48796834|NCT01951625|157093800|FG002|Follow Up Period|Adverse Event|2|||
48796835|NCT01951625|157093801|FG003|Follow Up Period|Adverse Event|3|||
48796836|NCT01951625|157093802|FG004|Follow Up Period|Adverse Event|5|||
48796837|NCT01951625|157093798|FG000|Follow Up Period|Withdrawal by Subject|4|||
48796838|NCT01951625|157093799|FG001|Follow Up Period|Withdrawal by Subject|1|||
48796839|NCT01951625|157093800|FG002|Follow Up Period|Withdrawal by Subject|0|||
48796840|NCT01951625|157093801|FG003|Follow Up Period|Withdrawal by Subject|5|||
48796841|NCT01951625|157093802|FG004|Follow Up Period|Withdrawal by Subject|3|||
48796842|NCT01951625|157093798|FG000|Follow Up Period|Lost to Follow-up|1|||
48796843|NCT01951625|157093799|FG001|Follow Up Period|Lost to Follow-up|0|||
48796844|NCT01951625|157093800|FG002|Follow Up Period|Lost to Follow-up|0|||
48796845|NCT01951625|157093801|FG003|Follow Up Period|Lost to Follow-up|1|||
48796846|NCT01951625|157093802|FG004|Follow Up Period|Lost to Follow-up|1|||
48408346|NCT02601573|155684322|FG002|Overall Study|Withdrawal by Subject|0|||
48408347|NCT02601573|155684323|FG003|Overall Study|Withdrawal by Subject|1|||
48796847|NCT03750006|157093803|FG000|Overall Study|Withdrawal by Subject|8|||
48796848|NCT03750006|157093803|FG000|Overall Study|COVID PANDEMIC|11|||
48796849|NCT01592370|157093804|FG000|Overall Study|Disease Progression|62|||
48796850|NCT01592370|157093805|FG001|Overall Study|Disease Progression|16|||
48408348|NCT02601573|155684324|FG004|Overall Study|Withdrawal by Subject|0|||
48408349|NCT02921425|155684325|FG000|Overall Study|Protocol Violation|9|||
48408350|NCT00611247|155684326|FG000|Overall Study|Death|1|||
48408351|NCT00611247|155684327|FG001|Overall Study|Death|5|||
48408352|NCT00611247|155684326|FG000|Overall Study|Lack of Efficacy|1|||
48408353|NCT00611247|155684327|FG001|Overall Study|Lack of Efficacy|16|||
48408354|NCT03168867|155684328|FG000|Overall Study|Withdrawal by Subject|1|||
48408355|NCT03168867|155684329|FG001|Overall Study|Withdrawal by Subject|5|||
48408356|NCT01107444|155684330|FG000|Overall Study|Withdrawal by Subject|8|||
48408357|NCT01107444|155684331|FG001|Overall Study|Withdrawal by Subject|12|||
48408358|NCT01107444|155684330|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
48408359|NCT01107444|155684331|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
48408360|NCT01384292|155684334|FG000|Part B|Severe non-compliance to protocol|1|||
48408361|NCT01384292|155684335|FG001|Part B|Severe non-compliance to protocol|0|||
48408362|NCT01384292|155684336|FG002|Part B|Severe non-compliance to protocol|0|||
48408363|NCT02266433|155684338|FG000|Overall Study|Lost to Follow-up|54|||
48408364|NCT02266433|155684339|FG001|Overall Study|Lost to Follow-up|46|||
48408365|NCT02266433|155684338|FG000|Overall Study|Withdrawal by Subject|5|||
48408366|NCT02266433|155684339|FG001|Overall Study|Withdrawal by Subject|7|||
48408367|NCT01948830|155684340|FG000|Overall Study|Physician Decision|1|||
48408368|NCT01948830|155684341|FG001|Overall Study|Physician Decision|3|||
48408369|NCT01948830|155684340|FG000|Overall Study|Protocol deviation|1|||
48408370|NCT01948830|155684341|FG001|Overall Study|Protocol deviation|2|||
48408371|NCT01948830|155684340|FG000|Overall Study|Lost to Follow-up|5|||
48408372|NCT01948830|155684341|FG001|Overall Study|Lost to Follow-up|4|||
48408373|NCT01948830|155684340|FG000|Overall Study|Withdrawal by Subject|14|||
48408374|NCT01948830|155684341|FG001|Overall Study|Withdrawal by Subject|17|||
48408375|NCT01948830|155684340|FG000|Overall Study|Adverse Event|9|||
48408376|NCT01948830|155684341|FG001|Overall Study|Adverse Event|2|||
48408377|NCT01948830|155684340|FG000|Overall Study|Death|3|||
48408378|NCT01948830|155684341|FG001|Overall Study|Death|4|||
48408379|NCT01285349|155684342|FG000|Overall Study|Lost to Follow-up|27|||
48408380|NCT01285349|155684343|FG001|Overall Study|Lost to Follow-up|20|||
48408381|NCT01285349|155684344|FG002|Overall Study|Lost to Follow-up|27|||
48408382|NCT01273064|155684347|FG000|Overall Study|Adverse Event|5|||
48408383|NCT01273064|155684348|FG001|Overall Study|Adverse Event|1|||
48408384|NCT01273064|155684349|FG002|Overall Study|Adverse Event|3|||
48408385|NCT01273064|155684350|FG003|Overall Study|Adverse Event|2|||
48408386|NCT01273064|155684351|FG004|Overall Study|Adverse Event|1|||
48408387|NCT01273064|155684347|FG000|Overall Study|Withdrawal by Subject|4|||
48408388|NCT01273064|155684348|FG001|Overall Study|Withdrawal by Subject|2|||
48408389|NCT01273064|155684349|FG002|Overall Study|Withdrawal by Subject|2|||
48408390|NCT01273064|155684350|FG003|Overall Study|Withdrawal by Subject|2|||
48408391|NCT01273064|155684351|FG004|Overall Study|Withdrawal by Subject|0|||
48796851|NCT01592370|157093806|FG002|Overall Study|Disease Progression|52|||
48796852|NCT01592370|157093807|FG003|Overall Study|Disease Progression|3|||
48796853|NCT01592370|157093808|FG004|Overall Study|Disease Progression|3|||
48796854|NCT01592370|157093809|FG005|Overall Study|Disease Progression|31|||
48796855|NCT01592370|157093810|FG006|Overall Study|Disease Progression|14|||
48796856|NCT01592370|157093804|FG000|Overall Study|Study Drug Toxicity|14|||
48796857|NCT01592370|157093805|FG001|Overall Study|Study Drug Toxicity|3|||
48796858|NCT01592370|157093806|FG002|Overall Study|Study Drug Toxicity|0|||
48796859|NCT01592370|157093807|FG003|Overall Study|Study Drug Toxicity|0|||
48796860|NCT01592370|157093808|FG004|Overall Study|Study Drug Toxicity|0|||
48796861|NCT01592370|157093809|FG005|Overall Study|Study Drug Toxicity|0|||
48796862|NCT01592370|157093810|FG006|Overall Study|Study Drug Toxicity|1|||
48796863|NCT01592370|157093804|FG000|Overall Study|AE unrelated to study drug|4|||
48796864|NCT01592370|157093805|FG001|Overall Study|AE unrelated to study drug|3|||
48796865|NCT01592370|157093806|FG002|Overall Study|AE unrelated to study drug|0|||
48796866|NCT01592370|157093807|FG003|Overall Study|AE unrelated to study drug|0|||
48796867|NCT01592370|157093808|FG004|Overall Study|AE unrelated to study drug|0|||
48796868|NCT01592370|157093809|FG005|Overall Study|AE unrelated to study drug|0|||
48796869|NCT01592370|157093810|FG006|Overall Study|AE unrelated to study drug|1|||
48796870|NCT01592370|157093804|FG000|Overall Study|Request to discontinue study treatment|5|||
48796871|NCT01592370|157093805|FG001|Overall Study|Request to discontinue study treatment|0|||
48796872|NCT01592370|157093806|FG002|Overall Study|Request to discontinue study treatment|2|||
48796873|NCT01592370|157093807|FG003|Overall Study|Request to discontinue study treatment|0|||
48796874|NCT01592370|157093808|FG004|Overall Study|Request to discontinue study treatment|1|||
48796875|NCT01592370|157093809|FG005|Overall Study|Request to discontinue study treatment|2|||
48796876|NCT01592370|157093810|FG006|Overall Study|Request to discontinue study treatment|0|||
48796877|NCT01592370|157093804|FG000|Overall Study|Withdrew consent|1|||
48408392|NCT01273064|155684347|FG000|Overall Study|Study Termination|13|||
48408393|NCT01273064|155684348|FG001|Overall Study|Study Termination|27|||
48408394|NCT01273064|155684349|FG002|Overall Study|Study Termination|26|||
48408395|NCT01273064|155684350|FG003|Overall Study|Study Termination|16|||
48408396|NCT01273064|155684351|FG004|Overall Study|Study Termination|8|||
48408397|NCT01273064|155684347|FG000|Overall Study|Lost to Follow-up|1|||
48408398|NCT01273064|155684348|FG001|Overall Study|Lost to Follow-up|0|||
48408399|NCT01273064|155684349|FG002|Overall Study|Lost to Follow-up|0|||
48408400|NCT01273064|155684350|FG003|Overall Study|Lost to Follow-up|0|||
48408401|NCT01273064|155684351|FG004|Overall Study|Lost to Follow-up|0|||
48408402|NCT01273064|155684347|FG000|Overall Study|Physician Decision|0|||
48408403|NCT01273064|155684348|FG001|Overall Study|Physician Decision|0|||
48408404|NCT01273064|155684349|FG002|Overall Study|Physician Decision|0|||
48408405|NCT01273064|155684350|FG003|Overall Study|Physician Decision|0|||
48408406|NCT01273064|155684351|FG004|Overall Study|Physician Decision|1|||
48408407|NCT02452762|155684353|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
48408408|NCT02452762|155684354|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
48796878|NCT01592370|157093805|FG001|Overall Study|Withdrew consent|2|||
48796879|NCT01592370|157093806|FG002|Overall Study|Withdrew consent|1|||
48796880|NCT01592370|157093807|FG003|Overall Study|Withdrew consent|1|||
48796881|NCT01592370|157093808|FG004|Overall Study|Withdrew consent|0|||
48796882|NCT01592370|157093809|FG005|Overall Study|Withdrew consent|0|||
48796883|NCT01592370|157093810|FG006|Overall Study|Withdrew consent|0|||
48796884|NCT01592370|157093804|FG000|Overall Study|Maximum clinical benefit|11|||
48796885|NCT01592370|157093805|FG001|Overall Study|Maximum clinical benefit|1|||
48796886|NCT01592370|157093806|FG002|Overall Study|Maximum clinical benefit|7|||
48796887|NCT01592370|157093807|FG003|Overall Study|Maximum clinical benefit|1|||
48796888|NCT01592370|157093808|FG004|Overall Study|Maximum clinical benefit|0|||
48796889|NCT01592370|157093809|FG005|Overall Study|Maximum clinical benefit|0|||
48796890|NCT01592370|157093810|FG006|Overall Study|Maximum clinical benefit|0|||
48796891|NCT01592370|157093804|FG000|Overall Study|No longer meets study criteria|1|||
48796892|NCT01592370|157093805|FG001|Overall Study|No longer meets study criteria|0|||
48796893|NCT01592370|157093806|FG002|Overall Study|No longer meets study criteria|0|||
48796894|NCT01592370|157093807|FG003|Overall Study|No longer meets study criteria|0|||
48796895|NCT01592370|157093808|FG004|Overall Study|No longer meets study criteria|0|||
48796896|NCT01592370|157093809|FG005|Overall Study|No longer meets study criteria|0|||
48796897|NCT01592370|157093810|FG006|Overall Study|No longer meets study criteria|0|||
48796898|NCT01592370|157093804|FG000|Overall Study|Other Reasons|6|||
48796899|NCT01592370|157093805|FG001|Overall Study|Other Reasons|0|||
48796900|NCT01592370|157093806|FG002|Overall Study|Other Reasons|10|||
48796901|NCT01592370|157093807|FG003|Overall Study|Other Reasons|0|||
48796902|NCT01592370|157093808|FG004|Overall Study|Other Reasons|0|||
48408409|NCT02452762|155684353|FG000|Overall Study|Withdrawal by Subject|1|||
48408410|NCT02452762|155684354|FG001|Overall Study|Withdrawal by Subject|0|||
48408411|NCT03595280|155684356|FG000|Overall Study|Lost to Follow-up|6|||
48796903|NCT01592370|157093809|FG005|Overall Study|Other Reasons|1|||
48796904|NCT01592370|157093810|FG006|Overall Study|Other Reasons|0|||
48796905|NCT03535337|157093811|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
48796906|NCT03535337|157093812|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
48796907|NCT03535337|157093813|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
48796908|NCT03535337|157093814|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
48796909|NCT03535337|157093815|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
48796910|NCT03535337|157093816|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
48796911|NCT03535337|157093817|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
48796912|NCT03535337|157093818|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
48796913|NCT03535337|157093819|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
48796914|NCT03535337|157093820|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
48796915|NCT04918784|157095211|FG000|Overall Study|Amputation - no longer eligible|1|||
48796916|NCT04918784|157095212|FG001|Overall Study|Amputation - no longer eligible|2|||
48796917|NCT04918784|157095211|FG000|Overall Study|Death|1|||
48796918|NCT04918784|157095212|FG001|Overall Study|Death|0|||
48796919|NCT04918784|157095211|FG000|Overall Study|patient non-compliance|3|||
48796920|NCT04918784|157095212|FG001|Overall Study|patient non-compliance|1|||
48796921|NCT04918784|157095211|FG000|Overall Study|Adverse Event|1|||
48796922|NCT04918784|157095212|FG001|Overall Study|Adverse Event|0|||
48796923|NCT01877408|157095213|FG000|Overall Study|Lost to Follow-up|0|||
48796924|NCT01877408|157095214|FG001|Overall Study|Lost to Follow-up|2|||
48796925|NCT04120233|157095217|FG000|Overall Study|Adverse Event|0|||
48796926|NCT04120233|157095218|FG001|Overall Study|Adverse Event|0|||
48796927|NCT04120233|157095219|FG002|Overall Study|Adverse Event|0|||
48796928|NCT04120233|157095220|FG003|Overall Study|Adverse Event|0|||
48796929|NCT04120233|157095221|FG004|Overall Study|Adverse Event|1|||
48796930|NCT04120233|157095222|FG005|Overall Study|Adverse Event|0|||
48796931|NCT00175825|157095223|FG000|Overall Study|Adverse Event|3|||
48796932|NCT00175825|157095224|FG001|Overall Study|Adverse Event|2|||
48796933|NCT00175825|157095225|FG002|Overall Study|Adverse Event|1|||
48796934|NCT00175825|157095226|FG003|Overall Study|Adverse Event|1|||
48796935|NCT00175825|157095223|FG000|Overall Study|Lost to Follow-up|1|||
48796936|NCT00175825|157095224|FG001|Overall Study|Lost to Follow-up|2|||
48796937|NCT00175825|157095225|FG002|Overall Study|Lost to Follow-up|0|||
48796938|NCT00175825|157095226|FG003|Overall Study|Lost to Follow-up|0|||
48796939|NCT00175825|157095223|FG000|Overall Study|Withdrawal by Subject|1|||
48796940|NCT00175825|157095224|FG001|Overall Study|Withdrawal by Subject|0|||
48796941|NCT00175825|157095225|FG002|Overall Study|Withdrawal by Subject|0|||
48796942|NCT00175825|157095226|FG003|Overall Study|Withdrawal by Subject|0|||
48796943|NCT00857207|157095227|FG000|Overall Study|Withdrawal by Subject|13|||
48796944|NCT00857207|157095228|FG001|Overall Study|Withdrawal by Subject|0|||
48796945|NCT00857207|157095227|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
48796946|NCT00857207|157095228|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
48796947|NCT00857207|157095227|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
48796948|NCT00857207|157095228|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
48796949|NCT04205630|157095232|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
48796950|NCT04205630|157095232|FG000|Overall Study|Disease clinical progression|7|||
48796951|NCT04205630|157095232|FG000|Overall Study|Withdrawal by Subject|2|||
48796952|NCT04205630|157095232|FG000|Overall Study|Adverse Event|17|||
48796953|NCT04205630|157095232|FG000|Overall Study|Other|1|||
48796954|NCT04791761|157095235|FG000|Overall Study|Lost to Follow-up|8|||
48796955|NCT04791761|157095236|FG001|Overall Study|Lost to Follow-up|6|||
48796956|NCT04791761|157095237|FG002|Overall Study|Lost to Follow-up|10|||
48796957|NCT04791761|157095235|FG000|Overall Study|Withdrawal by Subject|0|||
48796958|NCT04791761|157095236|FG001|Overall Study|Withdrawal by Subject|1|||
48796959|NCT04791761|157095237|FG002|Overall Study|Withdrawal by Subject|1|||
48796960|NCT04791761|157095235|FG000|Overall Study|Protocol Violation|0|||
48796961|NCT04791761|157095236|FG001|Overall Study|Protocol Violation|1|||
48796962|NCT04791761|157095237|FG002|Overall Study|Protocol Violation|1|||
48796963|NCT03224182|157095238|FG000|Overall Study|Study Drug Not Instilled|6|||
48796964|NCT03224182|157095239|FG001|Overall Study|Study Drug Not Instilled|1|||
48796965|NCT03224182|157095238|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
48796966|NCT03224182|157095239|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
48796967|NCT03224182|157095238|FG000|Overall Study|Withdrew of Consent|4|||
48796968|NCT03224182|157095239|FG001|Overall Study|Withdrew of Consent|2|||
48796969|NCT03224182|157095238|FG000|Overall Study|Investigator Decision|3|||
48796970|NCT03224182|157095239|FG001|Overall Study|Investigator Decision|1|||
48796971|NCT03224182|157095238|FG000|Overall Study|Sponsor Decision|26|||
48796972|NCT03224182|157095239|FG001|Overall Study|Sponsor Decision|12|||
48796973|NCT03224182|157095238|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
48796974|NCT03224182|157095239|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
48796975|NCT03224182|157095238|FG000|Overall Study|Lost to Follow-up|1|||
48796976|NCT03224182|157095239|FG001|Overall Study|Lost to Follow-up|0|||
48796977|NCT03224182|157095238|FG000|Overall Study|Participant Had Recurrence|11|||
48796978|NCT03224182|157095239|FG001|Overall Study|Participant Had Recurrence|5|||
48796979|NCT03224182|157095238|FG000|Overall Study|Death|0|||
48796980|NCT03224182|157095239|FG001|Overall Study|Death|1|||
48796981|NCT03224182|157095238|FG000|Overall Study|Reason not Specified|3|||
48796982|NCT03224182|157095239|FG001|Overall Study|Reason not Specified|3|||
48796983|NCT03224182|157095238|FG000|Overall Study|Other|1|||
48796984|NCT03224182|157095239|FG001|Overall Study|Other|0|||
48796985|NCT02481310|157095240|FG000|Follow up|Still in follow up|0|||
48796986|NCT02481310|157095241|FG001|Follow up|Still in follow up|3|||
48796987|NCT02481310|157095242|FG002|Follow up|Still in follow up|0|||
48796988|NCT00833560|157095243|FG000|Overall Study|Toxicity|13|||
48796989|NCT00833560|157095243|FG000|Overall Study|Adverse Event|11|||
48796990|NCT00833560|157095243|FG000|Overall Study|Protocol Violation|6|||
48796991|NCT00833560|157095243|FG000|Overall Study|Lack of Efficacy|4|||
48796992|NCT00833560|157095243|FG000|Overall Study|Death|2|||
48796993|NCT00833560|157095243|FG000|Overall Study|Pregression of other disease|1|||
48796994|NCT00833560|157095243|FG000|Overall Study|Other|5|||
48796995|NCT02008890|157095244|FG000|Period 1|Withdrawal by Subject|7|||
48796996|NCT02008890|157095245|FG001|Period 1|Withdrawal by Subject|7|||
48796997|NCT02008890|157095246|FG002|Period 1|Withdrawal by Subject|5|||
48796998|NCT02008890|157095247|FG003|Period 1|Withdrawal by Subject|0|||
48796999|NCT02008890|157095248|FG004|Period 1|Withdrawal by Subject|0|||
48797000|NCT02008890|157095244|FG000|Period 1|Pregnancy|1|||
48797001|NCT02008890|157095245|FG001|Period 1|Pregnancy|0|||
48797002|NCT02008890|157095246|FG002|Period 1|Pregnancy|0|||
48797003|NCT02008890|157095247|FG003|Period 1|Pregnancy|0|||
48797004|NCT02008890|157095248|FG004|Period 1|Pregnancy|0|||
48797005|NCT02008890|157095244|FG000|Period 1|Physician Decision|1|||
48797006|NCT02008890|157095245|FG001|Period 1|Physician Decision|0|||
48797007|NCT02008890|157095246|FG002|Period 1|Physician Decision|1|||
48797008|NCT02008890|157095247|FG003|Period 1|Physician Decision|0|||
48797009|NCT02008890|157095248|FG004|Period 1|Physician Decision|0|||
48797010|NCT02008890|157095244|FG000|Period 1|Adverse Event|6|||
48797011|NCT02008890|157095245|FG001|Period 1|Adverse Event|8|||
48797012|NCT02008890|157095246|FG002|Period 1|Adverse Event|6|||
48797013|NCT02008890|157095247|FG003|Period 1|Adverse Event|0|||
48797014|NCT02008890|157095248|FG004|Period 1|Adverse Event|0|||
48797015|NCT02008890|157095244|FG000|Period 2|Adverse Event|12|||
48797016|NCT02008890|157095245|FG001|Period 2|Adverse Event|7|||
48797017|NCT02008890|157095246|FG002|Period 2|Adverse Event|0|||
48797018|NCT02008890|157095247|FG003|Period 2|Adverse Event|5|||
48797019|NCT02008890|157095248|FG004|Period 2|Adverse Event|5|||
48797020|NCT02008890|157095244|FG000|Period 2|Withdrawal by Subject|11|||
48797021|NCT02008890|157095245|FG001|Period 2|Withdrawal by Subject|8|||
48797022|NCT02008890|157095246|FG002|Period 2|Withdrawal by Subject|0|||
48797023|NCT02008890|157095247|FG003|Period 2|Withdrawal by Subject|7|||
48797024|NCT02008890|157095248|FG004|Period 2|Withdrawal by Subject|2|||
48797025|NCT02008890|157095244|FG000|Period 2|Physician Decision|4|||
48797026|NCT02008890|157095245|FG001|Period 2|Physician Decision|0|||
48797027|NCT02008890|157095246|FG002|Period 2|Physician Decision|0|||
48797028|NCT02008890|157095247|FG003|Period 2|Physician Decision|2|||
48797029|NCT02008890|157095248|FG004|Period 2|Physician Decision|1|||
48797030|NCT02008890|157095244|FG000|Period 2|Lost to Follow-up|0|||
48797031|NCT02008890|157095245|FG001|Period 2|Lost to Follow-up|0|||
48797032|NCT02008890|157095246|FG002|Period 2|Lost to Follow-up|1|||
48797033|NCT02008890|157095247|FG003|Period 2|Lost to Follow-up|0|||
48797034|NCT02008890|157095248|FG004|Period 2|Lost to Follow-up|0|||
48797035|NCT02008890|157095244|FG000|Extension Period|Withdrawal by Subject|3|||
48797036|NCT02008890|157095245|FG001|Extension Period|Withdrawal by Subject|2|||
48797037|NCT02008890|157095246|FG002|Extension Period|Withdrawal by Subject|0|||
48797038|NCT02008890|157095247|FG003|Extension Period|Withdrawal by Subject|4|||
48797039|NCT02008890|157095248|FG004|Extension Period|Withdrawal by Subject|2|||
48797040|NCT02008890|157095244|FG000|Extension Period|Lost to Follow-up|1|||
48797041|NCT02008890|157095245|FG001|Extension Period|Lost to Follow-up|0|||
48797042|NCT02008890|157095246|FG002|Extension Period|Lost to Follow-up|0|||
48797043|NCT02008890|157095247|FG003|Extension Period|Lost to Follow-up|0|||
48797044|NCT02008890|157095248|FG004|Extension Period|Lost to Follow-up|0|||
48797045|NCT02008890|157095244|FG000|Extension Period|Adverse Event|1|||
48797046|NCT02008890|157095245|FG001|Extension Period|Adverse Event|3|||
48797047|NCT02008890|157095246|FG002|Extension Period|Adverse Event|0|||
48797048|NCT02008890|157095247|FG003|Extension Period|Adverse Event|0|||
48797049|NCT02008890|157095248|FG004|Extension Period|Adverse Event|2|||
48797050|NCT00643916|157095249|FG000|Overall Study|Protocol Violation|0|||
48797051|NCT00643916|157095250|FG001|Overall Study|Protocol Violation|1|||
48797052|NCT00643916|157095251|FG002|Overall Study|Protocol Violation|1|||
48797053|NCT00643916|157095252|FG003|Overall Study|Protocol Violation|1|||
48797054|NCT00643916|157095253|FG004|Overall Study|Protocol Violation|0|||
48797055|NCT00643916|157095254|FG005|Overall Study|Protocol Violation|0|||
48797056|NCT00643916|157095249|FG000|Overall Study|Lost to Follow-up|0|||
48797057|NCT00643916|157095250|FG001|Overall Study|Lost to Follow-up|1|||
48797058|NCT00643916|157095251|FG002|Overall Study|Lost to Follow-up|0|||
48797059|NCT00643916|157095252|FG003|Overall Study|Lost to Follow-up|0|||
48797060|NCT00643916|157095253|FG004|Overall Study|Lost to Follow-up|0|||
48797061|NCT00643916|157095254|FG005|Overall Study|Lost to Follow-up|0|||
48797062|NCT00643916|157095249|FG000|Overall Study|Withdrawal by Subject|2|||
48797063|NCT00643916|157095250|FG001|Overall Study|Withdrawal by Subject|2|||
48797064|NCT00643916|157095251|FG002|Overall Study|Withdrawal by Subject|2|||
48797065|NCT00643916|157095252|FG003|Overall Study|Withdrawal by Subject|1|||
48797066|NCT00643916|157095253|FG004|Overall Study|Withdrawal by Subject|0|||
48797067|NCT00643916|157095254|FG005|Overall Study|Withdrawal by Subject|1|||
48797068|NCT00643916|157095249|FG000|Overall Study|Not Vaccinated|2|||
48797069|NCT00643916|157095250|FG001|Overall Study|Not Vaccinated|2|||
48797070|NCT00643916|157095251|FG002|Overall Study|Not Vaccinated|3|||
48797071|NCT00643916|157095252|FG003|Overall Study|Not Vaccinated|0|||
48797072|NCT00643916|157095253|FG004|Overall Study|Not Vaccinated|2|||
48797073|NCT00643916|157095254|FG005|Overall Study|Not Vaccinated|0|||
48797074|NCT00499031|157095256|FG000|Overall Study|Improper pre-protocol treatment|1|||
48797075|NCT00499031|157095256|FG000|Overall Study|Required test not done|1|||
48797076|NCT00499031|157095256|FG000|Overall Study|Never treated|1|||
48797077|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
48797078|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
48797079|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
48797080|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
48797081|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
48797082|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
48797083|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
48797084|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
48797085|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Other|18|||
48797086|NCT02565914|157095260|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
48797087|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
48797088|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Other|1|||
48797089|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
48797090|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
48797091|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
48797092|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
48797093|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
48797094|NCT02565914|157095260|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
48797095|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
48797096|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
48797097|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
48797098|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
48797099|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
48797100|NCT02565914|157095260|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
48797101|NCT02450331|157095261|FG000|Overall Study|Death|162|||
48797102|NCT02450331|157095262|FG001|Overall Study|Death|171|||
48797103|NCT02450331|157095261|FG000|Overall Study|Lost to Follow-up|14|||
48797104|NCT02450331|157095262|FG001|Overall Study|Lost to Follow-up|12|||
48797105|NCT02450331|157095261|FG000|Overall Study|Withdrawal by Subject|55|||
48797106|NCT02450331|157095262|FG001|Overall Study|Withdrawal by Subject|44|||
48797107|NCT02450331|157095261|FG000|Overall Study|Non-specified other|1|||
48797108|NCT02450331|157095262|FG001|Overall Study|Non-specified other|1|||
48797109|NCT03581981|157095263|FG000|Overall Study|Withdrawal by Subject|12|||
48797110|NCT03581981|157095264|FG001|Overall Study|Withdrawal by Subject|13|||
48797111|NCT03581981|157095263|FG000|Overall Study|Physician Decision|1|||
48797112|NCT03581981|157095264|FG001|Overall Study|Physician Decision|2|||
48797113|NCT03581981|157095263|FG000|Overall Study|Lost to Follow-up|0|||
48797114|NCT03581981|157095264|FG001|Overall Study|Lost to Follow-up|4|||
48797115|NCT02047045|157095267|FG000|Baseline|Withdrawal by Subject|3|||
48797116|NCT02047045|157095268|FG001|Baseline|Withdrawal by Subject|2|||
48797117|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
48408412|NCT03595280|155684357|FG001|Overall Study|Lost to Follow-up|9|||
48408413|NCT03595280|155684358|FG002|Overall Study|Lost to Follow-up|15|||
48408414|NCT02675075|155684362|FG000|Overall Study|Lost to Follow-up|3|||
48408415|NCT02675075|155684363|FG001|Overall Study|Lost to Follow-up|0|||
48408416|NCT02292212|155684372|FG000|ViE Phase|Withdrawal by Subject|1|||
48408417|NCT02292212|155684372|FG000|ViE Phase|Protocol Violation|2|||
48408418|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408419|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408420|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408421|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
48408422|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408423|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
48408424|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48797118|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
48797119|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
48797120|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
48797121|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
48797122|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
48797123|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
48797124|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
48797125|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
48797126|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
48797127|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
48797128|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
48797129|NCT02047045|157095267|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
48797130|NCT02047045|157095268|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
48797131|NCT02047045|157095267|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
48797132|NCT02047045|157095268|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
48797133|NCT00082173|157095269|FG000|Overall Study|Withdrawal by Subject|3|||
48797134|NCT00082173|157095270|FG001|Overall Study|Withdrawal by Subject|5|||
48797135|NCT00082173|157095269|FG000|Overall Study|Lost to Follow-up|1|||
48797136|NCT00082173|157095270|FG001|Overall Study|Lost to Follow-up|0|||
48797137|NCT00082173|157095269|FG000|Overall Study|Adverse Event|1|||
48797138|NCT00082173|157095270|FG001|Overall Study|Adverse Event|0|||
48797139|NCT00082173|157095269|FG000|Overall Study|Culture negative or resistant at baselin|5|||
48797140|NCT00082173|157095270|FG001|Overall Study|Culture negative or resistant at baselin|6|||
48797141|NCT04465357|157095271|FG000|Overall Study|Adverse Event|2|||
48797142|NCT04465357|157095271|FG000|Overall Study|Lack of Efficacy|1|||
48797143|NCT04465357|157095271|FG000|Overall Study|Lost to Follow-up|2|||
48797144|NCT04465357|157095271|FG000|Overall Study|Withdrawal by Subject|6|||
48797145|NCT04465357|157095271|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
48797146|NCT03214367|157095272|FG000|Lead-in Period|Withdrawal by Subject|50|||
48797147|NCT03214367|157095273|FG001|Lead-in Period|Withdrawal by Subject|0|||
48797148|NCT03214367|157095274|FG002|Lead-in Period|Withdrawal by Subject|0|||
48797149|NCT03214367|157095275|FG003|Lead-in Period|Withdrawal by Subject|0|||
48797150|NCT03214367|157095276|FG004|Lead-in Period|Withdrawal by Subject|2|||
48797151|NCT03214367|157095277|FG005|Lead-in Period|Withdrawal by Subject|0|||
48797152|NCT03214367|157095278|FG006|Lead-in Period|Withdrawal by Subject|0|||
48797153|NCT03214367|157095279|FG007|Lead-in Period|Withdrawal by Subject|0|||
48797154|NCT03214367|157095272|FG000|Lead-in Period|Adverse Event|3|||
48797155|NCT03214367|157095273|FG001|Lead-in Period|Adverse Event|0|||
48797156|NCT03214367|157095274|FG002|Lead-in Period|Adverse Event|0|||
48797157|NCT03214367|157095275|FG003|Lead-in Period|Adverse Event|0|||
48797158|NCT03214367|157095276|FG004|Lead-in Period|Adverse Event|0|||
48797159|NCT03214367|157095277|FG005|Lead-in Period|Adverse Event|0|||
48797160|NCT03214367|157095278|FG006|Lead-in Period|Adverse Event|0|||
48797161|NCT03214367|157095279|FG007|Lead-in Period|Adverse Event|0|||
48797162|NCT03214367|157095272|FG000|Lead-in Period|Lost to Follow-up|12|||
48797163|NCT03214367|157095273|FG001|Lead-in Period|Lost to Follow-up|0|||
48797164|NCT03214367|157095274|FG002|Lead-in Period|Lost to Follow-up|0|||
48797165|NCT03214367|157095275|FG003|Lead-in Period|Lost to Follow-up|0|||
48797166|NCT03214367|157095276|FG004|Lead-in Period|Lost to Follow-up|0|||
48797167|NCT03214367|157095277|FG005|Lead-in Period|Lost to Follow-up|0|||
48797168|NCT03214367|157095278|FG006|Lead-in Period|Lost to Follow-up|0|||
48797169|NCT03214367|157095279|FG007|Lead-in Period|Lost to Follow-up|0|||
48797170|NCT03214367|157095272|FG000|Lead-in Period|Sponsor Decision|11|||
48797171|NCT03214367|157095273|FG001|Lead-in Period|Sponsor Decision|0|||
48797172|NCT03214367|157095274|FG002|Lead-in Period|Sponsor Decision|0|||
48797173|NCT03214367|157095275|FG003|Lead-in Period|Sponsor Decision|0|||
48797174|NCT03214367|157095276|FG004|Lead-in Period|Sponsor Decision|0|||
48797175|NCT03214367|157095277|FG005|Lead-in Period|Sponsor Decision|0|||
48797176|NCT03214367|157095278|FG006|Lead-in Period|Sponsor Decision|0|||
48797177|NCT03214367|157095279|FG007|Lead-in Period|Sponsor Decision|0|||
48408425|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408426|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408427|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408428|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408429|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408430|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408431|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408432|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408433|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408434|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408435|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48431435|NCT00002663|155767270|FG006|Overall Study|Other|1|||
48797178|NCT03214367|157095272|FG000|Lead-in Period|Physician Decision|12|||
48797179|NCT03214367|157095273|FG001|Lead-in Period|Physician Decision|0|||
48797180|NCT03214367|157095274|FG002|Lead-in Period|Physician Decision|0|||
48797181|NCT03214367|157095275|FG003|Lead-in Period|Physician Decision|0|||
48797182|NCT03214367|157095276|FG004|Lead-in Period|Physician Decision|0|||
48797183|NCT03214367|157095277|FG005|Lead-in Period|Physician Decision|0|||
48797184|NCT03214367|157095278|FG006|Lead-in Period|Physician Decision|0|||
48797185|NCT03214367|157095279|FG007|Lead-in Period|Physician Decision|0|||
48797186|NCT03214367|157095272|FG000|Lead-in Period|Protocol Violation|5|||
48797187|NCT03214367|157095273|FG001|Lead-in Period|Protocol Violation|0|||
48797188|NCT03214367|157095274|FG002|Lead-in Period|Protocol Violation|0|||
48797189|NCT03214367|157095275|FG003|Lead-in Period|Protocol Violation|0|||
48797190|NCT03214367|157095276|FG004|Lead-in Period|Protocol Violation|0|||
48797191|NCT03214367|157095277|FG005|Lead-in Period|Protocol Violation|0|||
48797192|NCT03214367|157095278|FG006|Lead-in Period|Protocol Violation|0|||
48797193|NCT03214367|157095279|FG007|Lead-in Period|Protocol Violation|0|||
48797194|NCT03214367|157095272|FG000|Lead-in Period|Treatment Interruption|1|||
48797195|NCT03214367|157095273|FG001|Lead-in Period|Treatment Interruption|0|||
48797196|NCT03214367|157095274|FG002|Lead-in Period|Treatment Interruption|0|||
48797197|NCT03214367|157095275|FG003|Lead-in Period|Treatment Interruption|0|||
48797198|NCT03214367|157095276|FG004|Lead-in Period|Treatment Interruption|0|||
48797199|NCT03214367|157095277|FG005|Lead-in Period|Treatment Interruption|0|||
48797200|NCT03214367|157095278|FG006|Lead-in Period|Treatment Interruption|0|||
48797201|NCT03214367|157095279|FG007|Lead-in Period|Treatment Interruption|0|||
48797202|NCT03214367|157095272|FG000|Treatment Period|Adverse Event|0|||
48797203|NCT03214367|157095273|FG001|Treatment Period|Adverse Event|1|||
48797204|NCT03214367|157095274|FG002|Treatment Period|Adverse Event|4|||
48797205|NCT03214367|157095275|FG003|Treatment Period|Adverse Event|2|||
48797206|NCT03214367|157095276|FG004|Treatment Period|Adverse Event|0|||
48797207|NCT03214367|157095277|FG005|Treatment Period|Adverse Event|0|||
48797208|NCT03214367|157095278|FG006|Treatment Period|Adverse Event|0|||
48797209|NCT03214367|157095279|FG007|Treatment Period|Adverse Event|0|||
48797210|NCT03214367|157095272|FG000|Treatment Period|Death|0|||
48797211|NCT03214367|157095273|FG001|Treatment Period|Death|1|||
48797212|NCT03214367|157095274|FG002|Treatment Period|Death|1|||
48797213|NCT03214367|157095275|FG003|Treatment Period|Death|1|||
48797214|NCT03214367|157095276|FG004|Treatment Period|Death|0|||
48408436|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408437|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408438|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408439|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48797215|NCT03214367|157095277|FG005|Treatment Period|Death|0|||
48408440|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
48408441|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48408442|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
48408443|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48408444|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
48797216|NCT03214367|157095278|FG006|Treatment Period|Death|0|||
48797217|NCT03214367|157095279|FG007|Treatment Period|Death|0|||
48797218|NCT03214367|157095272|FG000|Treatment Period|Lost to Follow-up|0|||
48797219|NCT03214367|157095273|FG001|Treatment Period|Lost to Follow-up|5|||
48797220|NCT03214367|157095274|FG002|Treatment Period|Lost to Follow-up|3|||
48797221|NCT03214367|157095275|FG003|Treatment Period|Lost to Follow-up|2|||
48797222|NCT03214367|157095276|FG004|Treatment Period|Lost to Follow-up|0|||
48797223|NCT03214367|157095277|FG005|Treatment Period|Lost to Follow-up|2|||
48797224|NCT03214367|157095278|FG006|Treatment Period|Lost to Follow-up|1|||
48797225|NCT03214367|157095279|FG007|Treatment Period|Lost to Follow-up|0|||
48797226|NCT03214367|157095272|FG000|Treatment Period|Sponsor Decision|0|||
48797227|NCT03214367|157095273|FG001|Treatment Period|Sponsor Decision|3|||
48797228|NCT03214367|157095274|FG002|Treatment Period|Sponsor Decision|0|||
48797229|NCT03214367|157095275|FG003|Treatment Period|Sponsor Decision|0|||
48797230|NCT03214367|157095276|FG004|Treatment Period|Sponsor Decision|0|||
48797231|NCT03214367|157095277|FG005|Treatment Period|Sponsor Decision|0|||
48797232|NCT03214367|157095278|FG006|Treatment Period|Sponsor Decision|0|||
48797233|NCT03214367|157095279|FG007|Treatment Period|Sponsor Decision|0|||
48797234|NCT03214367|157095272|FG000|Treatment Period|Physician Decision|0|||
48797235|NCT03214367|157095273|FG001|Treatment Period|Physician Decision|1|||
48797236|NCT03214367|157095274|FG002|Treatment Period|Physician Decision|2|||
48408445|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48408446|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48408447|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
48408448|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48797237|NCT03214367|157095275|FG003|Treatment Period|Physician Decision|0|||
48797238|NCT03214367|157095276|FG004|Treatment Period|Physician Decision|0|||
48797239|NCT03214367|157095277|FG005|Treatment Period|Physician Decision|0|||
48797240|NCT03214367|157095278|FG006|Treatment Period|Physician Decision|0|||
48797241|NCT03214367|157095279|FG007|Treatment Period|Physician Decision|0|||
48797242|NCT03214367|157095272|FG000|Treatment Period|Protocol Violation|0|||
48797243|NCT03214367|157095273|FG001|Treatment Period|Protocol Violation|3|||
48797244|NCT03214367|157095274|FG002|Treatment Period|Protocol Violation|0|||
48797245|NCT03214367|157095275|FG003|Treatment Period|Protocol Violation|0|||
48797246|NCT03214367|157095276|FG004|Treatment Period|Protocol Violation|0|||
48797247|NCT03214367|157095277|FG005|Treatment Period|Protocol Violation|0|||
48797248|NCT03214367|157095278|FG006|Treatment Period|Protocol Violation|0|||
48797249|NCT03214367|157095279|FG007|Treatment Period|Protocol Violation|0|||
48797250|NCT03214367|157095272|FG000|Treatment Period|Withdrawal by Subject|0|||
48797251|NCT03214367|157095273|FG001|Treatment Period|Withdrawal by Subject|20|||
48408449|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408450|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408451|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408452|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408453|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408454|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408455|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408456|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408457|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408458|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408459|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408460|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408461|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408462|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408463|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
48408464|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
48408465|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
48408466|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
48408467|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
48408468|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
48408469|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
48408470|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
48408471|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
48408472|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408473|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408474|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408475|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408476|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408477|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408478|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408479|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408480|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408481|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408482|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408483|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408484|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408485|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48408486|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
48797252|NCT03214367|157095274|FG002|Treatment Period|Withdrawal by Subject|23|||
48797253|NCT03214367|157095275|FG003|Treatment Period|Withdrawal by Subject|14|||
48797254|NCT03214367|157095276|FG004|Treatment Period|Withdrawal by Subject|0|||
48797255|NCT03214367|157095277|FG005|Treatment Period|Withdrawal by Subject|1|||
48797256|NCT03214367|157095278|FG006|Treatment Period|Withdrawal by Subject|1|||
48797257|NCT03214367|157095279|FG007|Treatment Period|Withdrawal by Subject|1|||
48797258|NCT04402866|157095280|FG000|Overall Study|Discontinued Prior to Treatment|0|||
48797259|NCT04402866|157095281|FG001|Overall Study|Discontinued Prior to Treatment|0|||
48797260|NCT04402866|157095282|FG002|Overall Study|Discontinued Prior to Treatment|0|||
48797261|NCT04402866|157095283|FG003|Overall Study|Discontinued Prior to Treatment|0|||
48797262|NCT04402866|157095284|FG004|Overall Study|Discontinued Prior to Treatment|2|||
48797263|NCT04402866|157095285|FG005|Overall Study|Discontinued Prior to Treatment|3|||
48797264|NCT04402866|157095280|FG000|Overall Study|Adverse Event|2|||
48797265|NCT04402866|157095281|FG001|Overall Study|Adverse Event|1|||
48797266|NCT04402866|157095282|FG002|Overall Study|Adverse Event|0|||
48797267|NCT04402866|157095283|FG003|Overall Study|Adverse Event|0|||
48797268|NCT04402866|157095284|FG004|Overall Study|Adverse Event|13|||
48797269|NCT04402866|157095285|FG005|Overall Study|Adverse Event|8|||
48797270|NCT04402866|157095280|FG000|Overall Study|Miscellaneous|0|||
48408487|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48797271|NCT04402866|157095281|FG001|Overall Study|Miscellaneous|0|||
48797272|NCT04402866|157095282|FG002|Overall Study|Miscellaneous|1|||
48797273|NCT04402866|157095283|FG003|Overall Study|Miscellaneous|0|||
48797274|NCT04402866|157095284|FG004|Overall Study|Miscellaneous|0|||
48797275|NCT04402866|157095285|FG005|Overall Study|Miscellaneous|0|||
48797276|NCT04402866|157095280|FG000|Overall Study|Lost to Follow-up|0|||
48797277|NCT04402866|157095281|FG001|Overall Study|Lost to Follow-up|0|||
48797278|NCT04402866|157095282|FG002|Overall Study|Lost to Follow-up|0|||
48797279|NCT04402866|157095283|FG003|Overall Study|Lost to Follow-up|0|||
48797280|NCT04402866|157095284|FG004|Overall Study|Lost to Follow-up|0|||
48408488|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408489|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
48408490|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408491|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
48408492|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408493|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408494|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48797281|NCT04402866|157095285|FG005|Overall Study|Lost to Follow-up|1|||
48797282|NCT04402866|157095280|FG000|Overall Study|Withdrawal by Subject|0|||
48797283|NCT04402866|157095281|FG001|Overall Study|Withdrawal by Subject|0|||
48797284|NCT04402866|157095282|FG002|Overall Study|Withdrawal by Subject|0|||
48797285|NCT04402866|157095283|FG003|Overall Study|Withdrawal by Subject|0|||
48797286|NCT04402866|157095284|FG004|Overall Study|Withdrawal by Subject|0|||
48797287|NCT04402866|157095285|FG005|Overall Study|Withdrawal by Subject|2|||
48797288|NCT04020341|157095286|FG000|Overall Study|Adverse Event|8|||
48797289|NCT04020341|157095287|FG001|Overall Study|Adverse Event|6|||
48797290|NCT04020341|157095286|FG000|Overall Study|Lost to Follow-up|8|||
48797291|NCT04020341|157095287|FG001|Overall Study|Lost to Follow-up|2|||
48797292|NCT04020341|157095286|FG000|Overall Study|Withdrawal by Subject|16|||
48797293|NCT04020341|157095287|FG001|Overall Study|Withdrawal by Subject|16|||
48797294|NCT04020341|157095286|FG000|Overall Study|Participant not able to swallow the tablet|1|||
48797295|NCT04020341|157095287|FG001|Overall Study|Participant not able to swallow the tablet|0|||
48797296|NCT04020341|157095286|FG000|Overall Study|Physician Decision|0|||
48797297|NCT04020341|157095287|FG001|Overall Study|Physician Decision|2|||
48797298|NCT04020341|157095286|FG000|Overall Study|Protocol Deviation|0|||
48797299|NCT04020341|157095287|FG001|Overall Study|Protocol Deviation|2|||
48797300|NCT05763628|157095288|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
48797301|NCT05763628|157095289|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
48408495|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408496|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408497|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408498|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408499|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408500|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408501|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408502|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408503|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408504|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408505|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408506|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408507|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408508|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408509|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
48408510|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
48408511|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408512|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408513|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
48408514|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408515|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408516|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408517|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408518|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408519|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408520|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408521|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408522|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408523|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408524|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408525|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408526|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48431436|NCT00002663|155767271|FG007|Overall Study|Other|0|||
48797302|NCT05763628|157095288|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
48797303|NCT05763628|157095289|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
48797304|NCT05763628|157095288|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
48797305|NCT05763628|157095289|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
48797306|NCT02123108|157095295|FG000|Overall Study|Death|2|||
48797307|NCT02123108|157095296|FG001|Overall Study|Death|3|||
48797308|NCT02013622|157095298|FG000|Overall Study|Lost to Follow-up|10|||
48797309|NCT02013622|157095298|FG000|Overall Study|Adverse Event|3|||
48408527|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408528|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48797310|NCT02013622|157095298|FG000|Overall Study|Met Withdrawal Criteria|3|||
48797311|NCT02013622|157095298|FG000|Overall Study|Withdrawal by Subject|6|||
48797312|NCT02013622|157095298|FG000|Overall Study|Protocol Deviation|1|||
48797313|NCT02013622|157095298|FG000|Overall Study|Lack of Efficacy|1|||
48797314|NCT00645164|157095305|FG000|Overall Study|Lost to Follow-up|2|||
48797315|NCT00645164|157095305|FG000|Overall Study|Withdrawal by Subject|4|||
48797316|NCT00645164|157095305|FG000|Overall Study|Protocol Violation|1|||
48797317|NCT00162370|157095306|FG000|Efficacy Population|Lost to Follow-up|51|||
48797318|NCT00569582|157095307|FG000|Overall Study|Withdrawal by Subject|5|||
48797319|NCT00569582|157095307|FG000|Overall Study|Death|2|||
48797320|NCT00569582|157095307|FG000|Overall Study|Adverse Event|7|||
48797321|NCT00569582|157095307|FG000|Overall Study|Subject was too ill to travel.|1|||
48797322|NCT00569582|157095307|FG000|Overall Study|Subject was non-compliant.|1|||
48797323|NCT01533493|157095308|FG000|Overall Study|Adverse Event|2|||
48797324|NCT01533493|157095309|FG001|Overall Study|Adverse Event|1|||
48797325|NCT01533493|157095308|FG000|Overall Study|Withdrawal by Subject|1|||
48797326|NCT01533493|157095309|FG001|Overall Study|Withdrawal by Subject|2|||
48797327|NCT01533493|157095308|FG000|Overall Study|Lost to Follow-up|2|||
48797328|NCT01533493|157095309|FG001|Overall Study|Lost to Follow-up|0|||
48797329|NCT01967732|157095313|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
48797330|NCT01967732|157095314|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
48797331|NCT01967732|157095315|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
48797332|NCT01967732|157095316|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
48797333|NCT01967732|157095313|FG000|First Intervention (Day 1)|Poor venous access|0|||
48797334|NCT01967732|157095314|FG001|First Intervention (Day 1)|Poor venous access|1|||
48797335|NCT01967732|157095315|FG002|First Intervention (Day 1)|Poor venous access|0|||
48797336|NCT01967732|157095316|FG003|First Intervention (Day 1)|Poor venous access|0|||
48797337|NCT00701038|157095317|FG000|Overall Study|study amended pilot group of patients|4|||
48797338|NCT00701038|157095318|FG001|Overall Study|study amended pilot group of patients|4|||
48797339|NCT03371940|157095319|FG000|Overall Study|Withdrawal by Subject|8|||
48797340|NCT03371940|157095320|FG001|Overall Study|Withdrawal by Subject|1|||
48797341|NCT03371940|157095321|FG002|Overall Study|Withdrawal by Subject|3|||
48797342|NCT03371940|157095322|FG003|Overall Study|Withdrawal by Subject|4|||
48797343|NCT05099926|157095323|FG000|Overall Study|Lost to Follow-up|1|||
48797344|NCT03923933|157095324|FG000|Overall Study|Lost to Follow-up|1|||
48797345|NCT03923933|157095325|FG001|Overall Study|Lost to Follow-up|0|||
48408529|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408530|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408531|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408532|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
48408533|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408534|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408535|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
48408536|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408537|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408538|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408539|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408540|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408541|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408542|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408543|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408544|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408545|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408546|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408547|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408548|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408549|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408550|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408551|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408552|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408553|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408554|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48797346|NCT03923933|157095324|FG000|Overall Study|Withdrawal by Subject|0|||
48797347|NCT03923933|157095325|FG001|Overall Study|Withdrawal by Subject|1|||
48797348|NCT01813474|157095326|FG000|Overall Study|Withdrawal by Subject|0|||
48797349|NCT01813474|157095327|FG001|Overall Study|Withdrawal by Subject|0|||
48797350|NCT01813474|157095328|FG002|Overall Study|Withdrawal by Subject|1|||
48797351|NCT01813474|157095326|FG000|Overall Study|Adverse Event|1|||
48797352|NCT01813474|157095327|FG001|Overall Study|Adverse Event|1|||
48797353|NCT01813474|157095328|FG002|Overall Study|Adverse Event|0|||
48797354|NCT01813474|157095326|FG000|Overall Study|Lack of Efficacy|2|||
48797355|NCT01813474|157095327|FG001|Overall Study|Lack of Efficacy|6|||
48797356|NCT01813474|157095328|FG002|Overall Study|Lack of Efficacy|9|||
48797357|NCT01813474|157095326|FG000|Overall Study|Death|0|||
48797358|NCT01813474|157095327|FG001|Overall Study|Death|0|||
48797359|NCT01813474|157095328|FG002|Overall Study|Death|1|||
48797360|NCT00316082|157095329|FG000|Overall Study|Lack of Efficacy|2|||
48408555|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
48408556|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408557|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408558|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
48408559|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408560|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408561|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408562|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408563|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408564|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408565|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408566|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408567|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408568|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408569|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408570|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408571|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408572|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408573|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408574|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408575|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408576|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408577|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408578|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
48408579|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48797361|NCT00316082|157095330|FG001|Overall Study|Lack of Efficacy|3|||
48797362|NCT00316082|157095331|FG002|Overall Study|Lack of Efficacy|3|||
48797363|NCT00316082|157095332|FG003|Overall Study|Lack of Efficacy|4|||
48797364|NCT00316082|157095333|FG004|Overall Study|Lack of Efficacy|6|||
48797365|NCT00316082|157095329|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
48797366|NCT00316082|157095330|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
48797367|NCT00316082|157095331|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
48797368|NCT00316082|157095332|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
48797369|NCT00316082|157095333|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
48797370|NCT00316082|157095329|FG000|Overall Study|Lost to Follow-up|7|||
48797371|NCT00316082|157095330|FG001|Overall Study|Lost to Follow-up|6|||
48797372|NCT00316082|157095331|FG002|Overall Study|Lost to Follow-up|7|||
48797373|NCT00316082|157095332|FG003|Overall Study|Lost to Follow-up|8|||
48797374|NCT00316082|157095333|FG004|Overall Study|Lost to Follow-up|6|||
48797375|NCT00316082|157095329|FG000|Overall Study|Poor/noncompliance|6|||
48797376|NCT00316082|157095330|FG001|Overall Study|Poor/noncompliance|1|||
48797377|NCT00316082|157095331|FG002|Overall Study|Poor/noncompliance|4|||
48797378|NCT00316082|157095332|FG003|Overall Study|Poor/noncompliance|1|||
48797379|NCT00316082|157095333|FG004|Overall Study|Poor/noncompliance|4|||
48797380|NCT00316082|157095329|FG000|Overall Study|Adverse Event|4|||
48797381|NCT00316082|157095330|FG001|Overall Study|Adverse Event|2|||
48797382|NCT00316082|157095331|FG002|Overall Study|Adverse Event|5|||
48797383|NCT00316082|157095332|FG003|Overall Study|Adverse Event|1|||
48797384|NCT00316082|157095333|FG004|Overall Study|Adverse Event|3|||
48797385|NCT00316082|157095329|FG000|Overall Study|Subject no longer meets study criteria|3|||
48797386|NCT00316082|157095330|FG001|Overall Study|Subject no longer meets study criteria|1|||
48797387|NCT00316082|157095331|FG002|Overall Study|Subject no longer meets study criteria|2|||
48797388|NCT00316082|157095332|FG003|Overall Study|Subject no longer meets study criteria|2|||
48797389|NCT00316082|157095333|FG004|Overall Study|Subject no longer meets study criteria|1|||
48797390|NCT00316082|157095329|FG000|Overall Study|Physician Decision|1|||
48431437|NCT00002663|155767272|FG008|Overall Study|Other|0|||
48797391|NCT00316082|157095330|FG001|Overall Study|Physician Decision|1|||
48797392|NCT00316082|157095331|FG002|Overall Study|Physician Decision|2|||
48797393|NCT00316082|157095332|FG003|Overall Study|Physician Decision|1|||
48797394|NCT00316082|157095333|FG004|Overall Study|Physician Decision|1|||
48797395|NCT00316082|157095329|FG000|Overall Study|Death|0|||
48797396|NCT00316082|157095330|FG001|Overall Study|Death|0|||
48797397|NCT00316082|157095331|FG002|Overall Study|Death|1|||
48797398|NCT00316082|157095332|FG003|Overall Study|Death|0|||
48797399|NCT00316082|157095333|FG004|Overall Study|Death|0|||
48797400|NCT00316082|157095329|FG000|Overall Study|Administrative reason by sponsor|0|||
48797401|NCT00316082|157095330|FG001|Overall Study|Administrative reason by sponsor|0|||
48797402|NCT00316082|157095331|FG002|Overall Study|Administrative reason by sponsor|1|||
48797403|NCT00316082|157095332|FG003|Overall Study|Administrative reason by sponsor|0|||
48797404|NCT00316082|157095333|FG004|Overall Study|Administrative reason by sponsor|0|||
48408580|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408581|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408582|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
48408583|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408584|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408585|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408586|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408587|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408588|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408589|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408590|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408591|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408592|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408593|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408594|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408595|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408596|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408597|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408598|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408599|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408600|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408601|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
48408602|NCT00896532|155684373|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408603|NCT00896532|155684374|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
48408604|NCT00896532|155684375|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408605|NCT00896532|155684376|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
48408606|NCT00896532|155684377|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
48408607|NCT00896532|155684378|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408608|NCT00896532|155684379|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408609|NCT00896532|155684380|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408610|NCT00896532|155684381|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408611|NCT00896532|155684382|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408612|NCT00896532|155684383|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408613|NCT00896532|155684384|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408614|NCT00896532|155684385|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408615|NCT00896532|155684386|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408616|NCT00896532|155684387|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408617|NCT00896532|155684388|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408618|NCT00896532|155684389|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408619|NCT00896532|155684390|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408620|NCT00896532|155684391|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408621|NCT00896532|155684392|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408622|NCT00896532|155684393|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408623|NCT00896532|155684394|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408624|NCT00896532|155684395|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
48408625|NCT00896532|155684373|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408626|NCT00896532|155684374|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408627|NCT00896532|155684375|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408628|NCT00896532|155684376|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408629|NCT00896532|155684377|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408630|NCT00896532|155684378|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408631|NCT00896532|155684379|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408632|NCT00896532|155684380|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408633|NCT00896532|155684381|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
48408634|NCT00896532|155684382|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48431438|NCT00002663|155767273|FG009|Overall Study|Other|0|||
48797405|NCT00540124|157095335|FG000|Overall Study|Adverse Event|0|||
48797406|NCT00540124|157095336|FG001|Overall Study|Adverse Event|2|||
48797407|NCT00540124|157095337|FG002|Overall Study|Adverse Event|1|||
48797408|NCT00540124|157095335|FG000|Overall Study|Entry Criteria Not Met|2|||
48797409|NCT00540124|157095336|FG001|Overall Study|Entry Criteria Not Met|0|||
48797410|NCT00540124|157095337|FG002|Overall Study|Entry Criteria Not Met|0|||
48797411|NCT00540124|157095335|FG000|Overall Study|Lack of Efficacy|1|||
48797412|NCT00540124|157095336|FG001|Overall Study|Lack of Efficacy|0|||
48797413|NCT00540124|157095337|FG002|Overall Study|Lack of Efficacy|0|||
48797414|NCT00540124|157095335|FG000|Overall Study|Withdrawal by Subject|1|||
48797415|NCT00540124|157095336|FG001|Overall Study|Withdrawal by Subject|1|||
48797416|NCT00540124|157095337|FG002|Overall Study|Withdrawal by Subject|0|||
48797417|NCT01569438|157095338|FG000|Overall Study|Lack of Efficacy|1|||
48797418|NCT01569438|157095339|FG001|Overall Study|Lack of Efficacy|2|||
48797419|NCT01569438|157095338|FG000|Overall Study|Withdrawal by Subject|0|||
48408635|NCT00896532|155684383|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48797420|NCT01569438|157095339|FG001|Overall Study|Withdrawal by Subject|3|||
48797421|NCT01569438|157095338|FG000|Overall Study|Adverse Event|2|||
48408636|NCT00896532|155684384|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408637|NCT00896532|155684385|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408638|NCT00896532|155684386|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408639|NCT00896532|155684387|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408640|NCT00896532|155684388|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408641|NCT00896532|155684389|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408642|NCT00896532|155684390|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408643|NCT00896532|155684391|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408644|NCT00896532|155684392|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408645|NCT00896532|155684393|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408646|NCT00896532|155684394|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408647|NCT00896532|155684395|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
48408648|NCT00896532|155684373|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408649|NCT00896532|155684374|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408650|NCT00896532|155684375|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408651|NCT00896532|155684376|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408652|NCT00896532|155684377|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408653|NCT00896532|155684378|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408654|NCT00896532|155684379|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408655|NCT00896532|155684380|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408656|NCT00896532|155684381|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408657|NCT00896532|155684382|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408658|NCT00896532|155684383|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408659|NCT00896532|155684384|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408660|NCT00896532|155684385|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
48408661|NCT00896532|155684386|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408662|NCT00896532|155684387|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408663|NCT00896532|155684388|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408664|NCT00896532|155684389|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408665|NCT00896532|155684390|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408666|NCT00896532|155684391|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408667|NCT00896532|155684392|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408668|NCT00896532|155684393|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408669|NCT00896532|155684394|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408670|NCT00896532|155684395|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
48408671|NCT00896532|155684373|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408672|NCT00896532|155684374|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408673|NCT00896532|155684375|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408674|NCT00896532|155684376|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408675|NCT00896532|155684377|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408676|NCT00896532|155684378|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408677|NCT00896532|155684379|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408678|NCT00896532|155684380|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408679|NCT00896532|155684381|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408680|NCT00896532|155684382|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408681|NCT00896532|155684383|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
48408682|NCT00896532|155684384|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48797422|NCT01569438|157095339|FG001|Overall Study|Adverse Event|15|||
48797423|NCT01569438|157095338|FG000|Overall Study|Protocol Violation|2|||
48797424|NCT01569438|157095339|FG001|Overall Study|Protocol Violation|0|||
48797425|NCT01569438|157095338|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
48797426|NCT01569438|157095339|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
48408683|NCT00896532|155684385|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
48408684|NCT00896532|155684386|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408685|NCT00896532|155684387|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408686|NCT00896532|155684388|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408687|NCT00896532|155684389|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408688|NCT00896532|155684390|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408689|NCT00896532|155684391|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408690|NCT00896532|155684392|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408691|NCT00896532|155684393|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408692|NCT00896532|155684394|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408693|NCT00896532|155684395|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
48408694|NCT00896532|155684373|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408695|NCT00896532|155684374|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408696|NCT00896532|155684375|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408697|NCT00896532|155684376|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408698|NCT00896532|155684377|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408699|NCT00896532|155684378|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408700|NCT00896532|155684379|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408701|NCT00896532|155684380|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408702|NCT00896532|155684381|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408703|NCT00896532|155684382|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408704|NCT00896532|155684383|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408705|NCT00896532|155684384|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48797427|NCT01569438|157095338|FG000|Overall Study|Sponsor/Physician decision|1|||
48797428|NCT01569438|157095339|FG001|Overall Study|Sponsor/Physician decision|1|||
48797429|NCT01569438|157095338|FG000|Overall Study|Unable to adhere to study schedule|0|||
48797430|NCT01569438|157095339|FG001|Overall Study|Unable to adhere to study schedule|1|||
48797431|NCT03599349|157095340|FG000|Overall Study|Lost to Follow-up|1|||
48797432|NCT00504426|157095341|FG000|Overall Study|Adverse Event|0|||
48797433|NCT00504426|157095342|FG001|Overall Study|Adverse Event|0|||
48797434|NCT00504426|157095343|FG002|Overall Study|Adverse Event|2|||
48797435|NCT00504426|157095344|FG003|Overall Study|Adverse Event|0|||
48797436|NCT00504426|157095341|FG000|Overall Study|Protocol Violation|1|||
48797437|NCT00504426|157095342|FG001|Overall Study|Protocol Violation|1|||
48797438|NCT00504426|157095343|FG002|Overall Study|Protocol Violation|2|||
48797439|NCT00504426|157095344|FG003|Overall Study|Protocol Violation|0|||
48797440|NCT00504426|157095341|FG000|Overall Study|Withdrawal by Subject|2|||
48797441|NCT00504426|157095342|FG001|Overall Study|Withdrawal by Subject|0|||
48797442|NCT00504426|157095343|FG002|Overall Study|Withdrawal by Subject|0|||
48797443|NCT00504426|157095344|FG003|Overall Study|Withdrawal by Subject|0|||
48797444|NCT00450411|157095351|FG000|Overall Study|Protocol Violation|6|||
48797445|NCT00450411|157095351|FG000|Overall Study|No protocol treatment|2|||
48797446|NCT02778100|157095355|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
48797447|NCT02778100|157095356|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
48797448|NCT00686881|157095361|FG000|Overall Study|Withdrawal by Subject|11|||
48797449|NCT00686881|157095362|FG001|Overall Study|Withdrawal by Subject|18|||
48797450|NCT00686881|157095361|FG000|Overall Study|Lost to Follow-up|0|||
48797451|NCT00686881|157095362|FG001|Overall Study|Lost to Follow-up|1|||
48797452|NCT00686881|157095361|FG000|Overall Study|Treatment-related adverse event|10|||
48797453|NCT00686881|157095362|FG001|Overall Study|Treatment-related adverse event|9|||
48797454|NCT00686881|157095361|FG000|Overall Study|Met discontinuation criteria|5|||
48797455|NCT00686881|157095362|FG001|Overall Study|Met discontinuation criteria|0|||
48797456|NCT00686881|157095361|FG000|Overall Study|Onset of malignant tumor|11|||
48797457|NCT00686881|157095362|FG001|Overall Study|Onset of malignant tumor|11|||
48797458|NCT00686881|157095361|FG000|Overall Study|Lack of Efficacy|4|||
48408706|NCT00896532|155684385|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
48408707|NCT00896532|155684386|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
48408708|NCT00896532|155684387|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408709|NCT00896532|155684388|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408710|NCT00896532|155684389|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48797459|NCT00686881|157095362|FG001|Overall Study|Lack of Efficacy|3|||
48797460|NCT00686881|157095361|FG000|Overall Study|Physician Decision|1|||
48408711|NCT00896532|155684390|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48797461|NCT00686881|157095362|FG001|Overall Study|Physician Decision|0|||
48431439|NCT00002663|155767264|FG000|Overall Study|Physician Decision|0|||
48797462|NCT00686881|157095361|FG000|Overall Study|Circumstances of site|1|||
48797463|NCT00686881|157095362|FG001|Overall Study|Circumstances of site|1|||
48797464|NCT00686881|157095361|FG000|Overall Study|Did not meet protocol eligibility|1|||
48797465|NCT00686881|157095362|FG001|Overall Study|Did not meet protocol eligibility|0|||
48797466|NCT00686881|157095361|FG000|Overall Study|Irregular visits|1|||
48797467|NCT00686881|157095362|FG001|Overall Study|Irregular visits|0|||
48797468|NCT00686881|157095361|FG000|Overall Study|Study discontinuation|35|||
48797469|NCT00686881|157095362|FG001|Overall Study|Study discontinuation|32|||
48797470|NCT00686881|157095361|FG000|Overall Study|Never received study drug|2|||
48797471|NCT00686881|157095362|FG001|Overall Study|Never received study drug|6|||
48797472|NCT00671931|157095363|FG000|Overall Study|Physician Decision|1|||
48797473|NCT00671931|157095364|FG001|Overall Study|Physician Decision|0|||
48797474|NCT00671931|157095365|FG002|Overall Study|Physician Decision|0|||
48797475|NCT00671931|157095366|FG003|Overall Study|Physician Decision|2|||
48797476|NCT00671931|157095367|FG004|Overall Study|Physician Decision|1|||
48797477|NCT02925676|157095368|FG000|Overall Study|Withdrawal by Subject|1|||
48797478|NCT00541450|157095372|FG000|Phase A|Adverse Event|3|||
48797479|NCT00541450|157095373|FG001|Phase A|Adverse Event|0|||
48797480|NCT00541450|157095372|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
48797481|NCT00541450|157095373|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
48797482|NCT00541450|157095372|FG000|Phase A|Hyperglycemia|0|||
48797483|NCT00541450|157095373|FG001|Phase A|Hyperglycemia|1|||
48797484|NCT00541450|157095372|FG000|Phase A|Lost to Follow-up|6|||
48797485|NCT00541450|157095373|FG001|Phase A|Lost to Follow-up|4|||
48797486|NCT00541450|157095372|FG000|Phase A|Physician Decision|2|||
48797487|NCT00541450|157095373|FG001|Phase A|Physician Decision|0|||
48797488|NCT00541450|157095372|FG000|Phase A|Protocol Violation|2|||
48797489|NCT00541450|157095373|FG001|Phase A|Protocol Violation|3|||
48408712|NCT00896532|155684391|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408713|NCT00896532|155684392|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408714|NCT00896532|155684393|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408715|NCT00896532|155684394|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408716|NCT00896532|155684395|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
48408717|NCT00896532|155684373|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
48408718|NCT00896532|155684374|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
48408719|NCT00896532|155684375|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
48408720|NCT00896532|155684376|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
48408721|NCT00896532|155684377|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
48408722|NCT00896532|155684378|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
48408723|NCT00896532|155684379|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
48408724|NCT00896532|155684380|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
48408725|NCT00896532|155684381|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
48408726|NCT00896532|155684382|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
48408727|NCT00896532|155684383|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
48408728|NCT00896532|155684384|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
48408729|NCT00896532|155684385|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
48408730|NCT00896532|155684386|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
48408731|NCT00896532|155684387|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
48408732|NCT00896532|155684388|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
48408733|NCT00896532|155684389|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
48408734|NCT00896532|155684390|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
48408735|NCT00896532|155684391|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
48408736|NCT00896532|155684392|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
48408737|NCT00896532|155684393|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
48408738|NCT00896532|155684394|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
48408739|NCT00896532|155684395|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
48408740|NCT00896532|155684373|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408741|NCT00896532|155684374|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408742|NCT00896532|155684375|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408743|NCT00896532|155684376|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408744|NCT00896532|155684377|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408745|NCT00896532|155684378|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408746|NCT00896532|155684379|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408747|NCT00896532|155684380|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408748|NCT00896532|155684381|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408749|NCT00896532|155684382|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408750|NCT00896532|155684383|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408751|NCT00896532|155684384|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408752|NCT00896532|155684385|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408753|NCT00896532|155684386|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408754|NCT00896532|155684387|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408755|NCT00896532|155684388|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
48797490|NCT00541450|157095372|FG000|Phase A|Withdrawal by Subject|7|||
48797491|NCT00541450|157095373|FG001|Phase A|Withdrawal by Subject|7|||
48797492|NCT00541450|157095372|FG000|Phase B|Adverse Event|6|||
48797493|NCT00541450|157095373|FG001|Phase B|Adverse Event|6|||
48797494|NCT00541450|157095372|FG000|Phase B|Hyperglycemia|10|||
48797495|NCT00541450|157095373|FG001|Phase B|Hyperglycemia|9|||
48797496|NCT00541450|157095372|FG000|Phase B|Lost to Follow-up|6|||
48797497|NCT00541450|157095373|FG001|Phase B|Lost to Follow-up|4|||
48797498|NCT00541450|157095372|FG000|Phase B|Physician Decision|4|||
48797499|NCT00541450|157095373|FG001|Phase B|Physician Decision|2|||
48797500|NCT00541450|157095372|FG000|Phase B|Pregnancy|0|||
48797501|NCT00541450|157095373|FG001|Phase B|Pregnancy|1|||
48797502|NCT00541450|157095372|FG000|Phase B|Protocol Violation|3|||
48797503|NCT00541450|157095373|FG001|Phase B|Protocol Violation|3|||
48797504|NCT00541450|157095372|FG000|Phase B|Withdrawal by Subject|8|||
48797505|NCT00541450|157095373|FG001|Phase B|Withdrawal by Subject|6|||
48797506|NCT01951638|157095379|FG000|Treatment Period|Protocol Violation|0|||
48797507|NCT01951638|157095380|FG001|Treatment Period|Protocol Violation|0|||
48797508|NCT01951638|157095381|FG002|Treatment Period|Protocol Violation|0|||
48797509|NCT01951638|157095382|FG003|Treatment Period|Protocol Violation|2|||
48797510|NCT01951638|157095383|FG004|Treatment Period|Protocol Violation|0|||
48797511|NCT01951638|157095379|FG000|Treatment Period|Protocol-driven decision point|1|||
48797512|NCT01951638|157095380|FG001|Treatment Period|Protocol-driven decision point|3|||
48797513|NCT01951638|157095381|FG002|Treatment Period|Protocol-driven decision point|0|||
48797514|NCT01951638|157095382|FG003|Treatment Period|Protocol-driven decision point|0|||
48797515|NCT01951638|157095383|FG004|Treatment Period|Protocol-driven decision point|0|||
48797516|NCT01951638|157095379|FG000|Treatment Period|Logistical difficulties|0|||
48797517|NCT01951638|157095380|FG001|Treatment Period|Logistical difficulties|1|||
48797518|NCT01951638|157095381|FG002|Treatment Period|Logistical difficulties|1|||
48797519|NCT01951638|157095382|FG003|Treatment Period|Logistical difficulties|0|||
48797520|NCT01951638|157095383|FG004|Treatment Period|Logistical difficulties|0|||
48797521|NCT01951638|157095379|FG000|Treatment Period|Withdrawal by Subject|9|||
48797522|NCT01951638|157095380|FG001|Treatment Period|Withdrawal by Subject|6|||
48797523|NCT01951638|157095381|FG002|Treatment Period|Withdrawal by Subject|4|||
48797524|NCT01951638|157095382|FG003|Treatment Period|Withdrawal by Subject|5|||
48797525|NCT01951638|157095383|FG004|Treatment Period|Withdrawal by Subject|4|||
48797526|NCT01951638|157095379|FG000|Treatment Period|Death|0|||
48797527|NCT01951638|157095380|FG001|Treatment Period|Death|0|||
48797528|NCT01951638|157095381|FG002|Treatment Period|Death|0|||
48797529|NCT01951638|157095382|FG003|Treatment Period|Death|3|||
48797530|NCT01951638|157095383|FG004|Treatment Period|Death|1|||
48797531|NCT01951638|157095379|FG000|Treatment Period|Adverse Event|3|||
48797532|NCT01951638|157095380|FG001|Treatment Period|Adverse Event|4|||
48797533|NCT01951638|157095381|FG002|Treatment Period|Adverse Event|8|||
48797534|NCT01951638|157095382|FG003|Treatment Period|Adverse Event|6|||
48797535|NCT01951638|157095383|FG004|Treatment Period|Adverse Event|5|||
48797536|NCT01951638|157095379|FG000|Follow-up Period|Protocol Violation|0|||
48357593|NCT02614183|155504928|FG002|Double Blind Treatment Phase|Physician Decision|2|||
48357594|NCT02614183|155504926|FG000|Double Blind Treatment Phase|Pregnancy|2|||
48357595|NCT02614183|155504927|FG001|Double Blind Treatment Phase|Pregnancy|1|||
48357596|NCT02614183|155504928|FG002|Double Blind Treatment Phase|Pregnancy|3|||
48357597|NCT02614183|155504926|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
48357598|NCT02614183|155504927|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
48357599|NCT02614183|155504928|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
48357600|NCT02614183|155504926|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
48357601|NCT02614183|155504927|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
48357602|NCT02614183|155504928|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
48357603|NCT02614183|155504926|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
48357604|NCT02614183|155504927|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
48357605|NCT02614183|155504928|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
48357606|NCT02614183|155504926|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
48357607|NCT02614183|155504927|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
48357608|NCT02614183|155504928|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
48357609|NCT02614183|155504926|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
48357610|NCT02614183|155504927|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
48357611|NCT02614183|155504928|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
48357612|NCT02614183|155504926|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
48357613|NCT02614183|155504927|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
48357614|NCT02614183|155504928|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
48797537|NCT01951638|157095380|FG001|Follow-up Period|Protocol Violation|0|||
48797538|NCT01951638|157095381|FG002|Follow-up Period|Protocol Violation|0|||
48797539|NCT01951638|157095382|FG003|Follow-up Period|Protocol Violation|1|||
48797540|NCT01951638|157095383|FG004|Follow-up Period|Protocol Violation|0|||
48797541|NCT01951638|157095379|FG000|Follow-up Period|Logistical difficulties|0|||
48797542|NCT01951638|157095380|FG001|Follow-up Period|Logistical difficulties|2|||
48797543|NCT01951638|157095381|FG002|Follow-up Period|Logistical difficulties|0|||
48797544|NCT01951638|157095382|FG003|Follow-up Period|Logistical difficulties|0|||
48797545|NCT01951638|157095383|FG004|Follow-up Period|Logistical difficulties|1|||
48797546|NCT01951638|157095379|FG000|Follow-up Period|Withdrawal by Subject|1|||
48797547|NCT01951638|157095380|FG001|Follow-up Period|Withdrawal by Subject|5|||
48797548|NCT01951638|157095381|FG002|Follow-up Period|Withdrawal by Subject|2|||
48797549|NCT01951638|157095382|FG003|Follow-up Period|Withdrawal by Subject|1|||
48797550|NCT01951638|157095383|FG004|Follow-up Period|Withdrawal by Subject|2|||
48797551|NCT01951638|157095379|FG000|Follow-up Period|Lost to Follow-up|0|||
48797552|NCT01951638|157095380|FG001|Follow-up Period|Lost to Follow-up|1|||
48797553|NCT01951638|157095381|FG002|Follow-up Period|Lost to Follow-up|0|||
48797554|NCT01951638|157095382|FG003|Follow-up Period|Lost to Follow-up|1|||
48797555|NCT01951638|157095383|FG004|Follow-up Period|Lost to Follow-up|0|||
48797556|NCT01951638|157095379|FG000|Follow-up Period|Death|1|||
48797557|NCT01951638|157095380|FG001|Follow-up Period|Death|0|||
48797558|NCT01951638|157095381|FG002|Follow-up Period|Death|1|||
48797559|NCT01951638|157095382|FG003|Follow-up Period|Death|4|||
48797560|NCT01951638|157095383|FG004|Follow-up Period|Death|1|||
48797561|NCT01951638|157095379|FG000|Follow-up Period|Adverse Event|0|||
48797562|NCT01951638|157095380|FG001|Follow-up Period|Adverse Event|1|||
48797563|NCT01951638|157095381|FG002|Follow-up Period|Adverse Event|2|||
48797564|NCT01951638|157095382|FG003|Follow-up Period|Adverse Event|1|||
48797565|NCT01951638|157095383|FG004|Follow-up Period|Adverse Event|1|||
48797566|NCT03360942|157095386|FG000|Overall Study|Device explanted|2|||
48797567|NCT03360942|157095386|FG000|Overall Study|Study closure|1|||
48797568|NCT03360942|157095386|FG000|Overall Study|Withdrawal by Subject|2|||
48797569|NCT03703466|157095387|FG000|Overall Study|Death|2|||
48797570|NCT03703466|157095388|FG001|Overall Study|Death|1|||
48797571|NCT03703466|157095389|FG002|Overall Study|Death|0|||
48797572|NCT03703466|157095387|FG000|Overall Study|Withdrawal by Subject|0|||
48797573|NCT03703466|157095388|FG001|Overall Study|Withdrawal by Subject|3|||
48797574|NCT03703466|157095389|FG002|Overall Study|Withdrawal by Subject|0|||
48797575|NCT03703466|157095387|FG000|Overall Study|Completed < 3 Cycles|2|||
48797576|NCT03703466|157095388|FG001|Overall Study|Completed < 3 Cycles|2|||
48797577|NCT03703466|157095389|FG002|Overall Study|Completed < 3 Cycles|2|||
48797578|NCT02120027|157096998|FG000|Overall Study|Adverse Event|4|||
48797579|NCT02120027|157096999|FG001|Overall Study|Adverse Event|5|||
48797580|NCT02120027|157096998|FG000|Overall Study|Lack of Efficacy|3|||
48797581|NCT02120027|157096999|FG001|Overall Study|Lack of Efficacy|5|||
48797582|NCT02120027|157096998|FG000|Overall Study|Lost to Follow-up|5|||
48797583|NCT02120027|157096999|FG001|Overall Study|Lost to Follow-up|13|||
48797584|NCT02120027|157096998|FG000|Overall Study|Other|4|||
48797585|NCT02120027|157096999|FG001|Overall Study|Other|0|||
48797586|NCT02120027|157096998|FG000|Overall Study|Physician Decision|4|||
48797587|NCT02120027|157096999|FG001|Overall Study|Physician Decision|3|||
48797588|NCT02120027|157096998|FG000|Overall Study|Protocol Violation|18|||
48797589|NCT02120027|157096999|FG001|Overall Study|Protocol Violation|21|||
48797590|NCT02120027|157096998|FG000|Overall Study|Study terminated by Sponsor|45|||
48797591|NCT02120027|157096999|FG001|Overall Study|Study terminated by Sponsor|47|||
48797592|NCT02120027|157096998|FG000|Overall Study|Withdrawal by Subject|33|||
48797593|NCT02120027|157096999|FG001|Overall Study|Withdrawal by Subject|25|||
48797594|NCT02701985|157097000|FG000|Overall Study|Withdrawal by Subject|1|||
48797595|NCT02701985|157097001|FG001|Overall Study|Withdrawal by Subject|1|||
48797596|NCT02701985|157097000|FG000|Overall Study|Lost to Follow-up|1|||
48797597|NCT02701985|157097001|FG001|Overall Study|Lost to Follow-up|0|||
48408756|NCT00896532|155684389|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
48408757|NCT00896532|155684390|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408758|NCT00896532|155684391|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408759|NCT00896532|155684392|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408760|NCT00896532|155684393|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408761|NCT00896532|155684394|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408762|NCT00896532|155684395|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
48408763|NCT00896532|155684373|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408764|NCT00896532|155684374|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408765|NCT00896532|155684375|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408766|NCT00896532|155684376|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408767|NCT00896532|155684377|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408768|NCT00896532|155684378|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408769|NCT00896532|155684379|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408770|NCT00896532|155684380|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408771|NCT00896532|155684381|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408772|NCT00896532|155684382|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408773|NCT00896532|155684383|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408774|NCT00896532|155684384|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408775|NCT00896532|155684385|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408776|NCT00896532|155684386|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408777|NCT00896532|155684387|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408778|NCT00896532|155684388|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
48408779|NCT00896532|155684389|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
48408780|NCT00896532|155684390|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
48408781|NCT00896532|155684391|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408782|NCT00896532|155684392|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408783|NCT00896532|155684393|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408784|NCT00896532|155684394|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408785|NCT00896532|155684395|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
48408786|NCT00896532|155684373|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408787|NCT00896532|155684374|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408788|NCT00896532|155684375|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408789|NCT00896532|155684376|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408790|NCT00896532|155684377|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408791|NCT00896532|155684378|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408792|NCT00896532|155684379|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408793|NCT00896532|155684380|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408794|NCT00896532|155684381|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408795|NCT00896532|155684382|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408796|NCT00896532|155684383|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408797|NCT00896532|155684384|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408798|NCT00896532|155684385|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408799|NCT00896532|155684386|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408800|NCT00896532|155684387|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408801|NCT00896532|155684388|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408802|NCT00896532|155684389|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
48408803|NCT00896532|155684390|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408804|NCT00896532|155684391|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408805|NCT00896532|155684392|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408806|NCT00896532|155684393|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408807|NCT00896532|155684394|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48408808|NCT00896532|155684395|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
48797598|NCT02701985|157097000|FG000|Overall Study|Death|1|||
48797599|NCT02701985|157097001|FG001|Overall Study|Death|0|||
48797600|NCT02701985|157097000|FG000|Overall Study|Adverse Event|0|||
48797601|NCT02701985|157097001|FG001|Overall Study|Adverse Event|5|||
48408809|NCT00896532|155684373|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
48408810|NCT00896532|155684374|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
48408811|NCT00896532|155684375|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
48408812|NCT00896532|155684376|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
48408813|NCT00896532|155684377|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
48408814|NCT00896532|155684378|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
48408815|NCT00896532|155684379|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
48408816|NCT00896532|155684380|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
48797602|NCT00999466|157097006|FG000|Main Part|Withdrawal by Subject|0|||
48797603|NCT00999466|157097007|FG001|Main Part|Withdrawal by Subject|0|||
48797604|NCT00999466|157097008|FG002|Main Part|Withdrawal by Subject|2|||
48797605|NCT00999466|157097006|FG000|Main Part|Adverse Event|0|||
48797606|NCT00999466|157097007|FG001|Main Part|Adverse Event|4|||
48797607|NCT00999466|157097008|FG002|Main Part|Adverse Event|2|||
48797608|NCT03409666|157097013|FG000|Overall Study|Physician Decision|0|||
48797609|NCT03409666|157097014|FG001|Overall Study|Physician Decision|1|||
48797610|NCT03409666|157097013|FG000|Overall Study|Protocol Violation|0|||
48797611|NCT03409666|157097014|FG001|Overall Study|Protocol Violation|3|||
48797612|NCT02184611|157097018|FG000|Overall Study|Lack of Efficacy|11|||
48797613|NCT02184611|157097019|FG001|Overall Study|Lack of Efficacy|15|||
48797614|NCT02184611|157097018|FG000|Overall Study|Withdrawal by Subject|5|||
48797615|NCT02184611|157097019|FG001|Overall Study|Withdrawal by Subject|6|||
48797616|NCT02184611|157097018|FG000|Overall Study|Adverse Event|4|||
48797617|NCT02184611|157097019|FG001|Overall Study|Adverse Event|5|||
48797618|NCT02184611|157097018|FG000|Overall Study|Protocol Violation|1|||
48797619|NCT02184611|157097019|FG001|Overall Study|Protocol Violation|1|||
48797620|NCT02184611|157097018|FG000|Overall Study|Protocol defined stopping criteria|0|||
48797621|NCT02184611|157097019|FG001|Overall Study|Protocol defined stopping criteria|1|||
48797622|NCT02366910|157097023|FG000|Overall Study|Withdrawal by Subject|2|||
48797623|NCT02366910|157097023|FG000|Overall Study|Screen Failure|3|||
48797624|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
48797625|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
48797626|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
48797627|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
48797628|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
48797629|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
48797630|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
48797631|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
48797632|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
48797633|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
48797634|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
48797635|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
48797636|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
48797637|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
48797638|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
48797639|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
48797640|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
48797641|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
48797642|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
48797643|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
48797644|NCT00549757|157097028|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
48797645|NCT00549757|157097029|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
48797646|NCT00549757|157097028|FG000|Extension Period (in Average 9 Months)|Death|143|||
48797647|NCT00549757|157097029|FG001|Extension Period (in Average 9 Months)|Death|136|||
48797648|NCT00549757|157097028|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
48797649|NCT00549757|157097029|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
48797650|NCT00549757|157097028|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
48797651|NCT00549757|157097029|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
48797652|NCT00549757|157097028|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
48797653|NCT00549757|157097029|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
48797654|NCT03813238|157097033|FG000|Overall Study|Adverse Event|0|||
48797655|NCT03813238|157097034|FG001|Overall Study|Adverse Event|6|||
48797656|NCT03813238|157097033|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48797657|NCT03813238|157097034|FG001|Overall Study|Withdrawal by parent/guardian|2|||
48797658|NCT03813238|157097033|FG000|Overall Study|Lost to Follow-up|0|||
48797659|NCT03813238|157097034|FG001|Overall Study|Lost to Follow-up|1|||
48797660|NCT03813238|157097033|FG000|Overall Study|Other than specified|1|||
48797661|NCT03813238|157097034|FG001|Overall Study|Other than specified|2|||
48797662|NCT03489304|157097035|FG000|Overall Study|Lost to Follow-up|4|||
48797663|NCT05159622|157097036|FG000|Overall Study|Lost to Follow-up|4|||
48797664|NCT05159622|157097037|FG001|Overall Study|Lost to Follow-up|5|||
48797665|NCT02080871|157097038|FG000|Overall Study|Death|1|||
48797666|NCT02080871|157097038|FG000|Overall Study|Lost to Follow-up|1|||
48797667|NCT01410474|157097039|FG000|Overall Study|Withdrawal by Subject|0|||
48408817|NCT00896532|155684381|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
48408818|NCT00896532|155684382|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
48408819|NCT00896532|155684383|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
48408820|NCT00896532|155684384|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
48408821|NCT00896532|155684385|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
48408822|NCT00896532|155684386|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
48408823|NCT00896532|155684387|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
48408824|NCT00896532|155684388|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
48408825|NCT00896532|155684389|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
48408826|NCT00896532|155684390|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
48408827|NCT00896532|155684391|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
48408828|NCT00896532|155684392|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
48408829|NCT00896532|155684393|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
48408830|NCT00896532|155684394|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
48408831|NCT00896532|155684395|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
48408832|NCT00896532|155684373|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408833|NCT00896532|155684374|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408834|NCT00896532|155684375|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408835|NCT00896532|155684376|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408836|NCT00896532|155684377|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408837|NCT00896532|155684378|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408838|NCT00896532|155684379|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408839|NCT00896532|155684380|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408840|NCT00896532|155684381|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408841|NCT00896532|155684382|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408842|NCT00896532|155684383|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408843|NCT00896532|155684384|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408844|NCT00896532|155684385|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408845|NCT00896532|155684386|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408846|NCT00896532|155684387|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408847|NCT00896532|155684388|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408848|NCT00896532|155684389|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
48408849|NCT00896532|155684390|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408850|NCT00896532|155684391|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408851|NCT00896532|155684392|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408852|NCT00896532|155684393|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408853|NCT00896532|155684394|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408854|NCT00896532|155684395|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
48408855|NCT00896532|155684373|FG000|Months 48-72: Follow-on Phase|Death|0|||
48408856|NCT00896532|155684374|FG001|Months 48-72: Follow-on Phase|Death|0|||
48692504|NCT00453154|156724506|FG003|Double BIind Maintenance|Death|1|||
48692505|NCT00453154|156724503|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
48692506|NCT00453154|156724504|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
48692507|NCT00453154|156724505|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
48692508|NCT00453154|156724506|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
48692509|NCT00453154|156724503|FG000|Double BIind Maintenance|Progression|0|||
48692510|NCT00453154|156724504|FG001|Double BIind Maintenance|Progression|0|||
48692511|NCT00453154|156724505|FG002|Double BIind Maintenance|Progression|29|||
48692512|NCT00453154|156724506|FG003|Double BIind Maintenance|Progression|26|||
48408857|NCT00896532|155684375|FG002|Months 48-72: Follow-on Phase|Death|0|||
48408858|NCT00896532|155684376|FG003|Months 48-72: Follow-on Phase|Death|0|||
48408859|NCT00896532|155684377|FG004|Months 48-72: Follow-on Phase|Death|0|||
48408860|NCT00896532|155684378|FG005|Months 48-72: Follow-on Phase|Death|0|||
48408861|NCT00896532|155684379|FG006|Months 48-72: Follow-on Phase|Death|0|||
48408862|NCT00896532|155684380|FG007|Months 48-72: Follow-on Phase|Death|0|||
48408863|NCT00896532|155684381|FG008|Months 48-72: Follow-on Phase|Death|0|||
48408864|NCT00896532|155684382|FG009|Months 48-72: Follow-on Phase|Death|0|||
48408865|NCT00896532|155684383|FG010|Months 48-72: Follow-on Phase|Death|0|||
48408866|NCT00896532|155684384|FG011|Months 48-72: Follow-on Phase|Death|0|||
48408867|NCT00896532|155684385|FG012|Months 48-72: Follow-on Phase|Death|0|||
48408868|NCT00896532|155684386|FG013|Months 48-72: Follow-on Phase|Death|0|||
48408869|NCT00896532|155684387|FG014|Months 48-72: Follow-on Phase|Death|0|||
48408870|NCT00896532|155684388|FG015|Months 48-72: Follow-on Phase|Death|0|||
48408871|NCT00896532|155684389|FG016|Months 48-72: Follow-on Phase|Death|0|||
48408872|NCT00896532|155684390|FG017|Months 48-72: Follow-on Phase|Death|0|||
48408873|NCT00896532|155684391|FG018|Months 48-72: Follow-on Phase|Death|1|||
48408874|NCT00896532|155684392|FG019|Months 48-72: Follow-on Phase|Death|0|||
48357615|NCT02614183|155504926|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
48357616|NCT02614183|155504927|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
48357617|NCT02614183|155504928|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
48357618|NCT05262751|155504929|FG000|Washout Period 2|Adverse Event|1|||
48357619|NCT05262751|155504930|FG001|Washout Period 2|Adverse Event|0|||
48408875|NCT00896532|155684393|FG020|Months 48-72: Follow-on Phase|Death|0|||
48408876|NCT00896532|155684394|FG021|Months 48-72: Follow-on Phase|Death|0|||
48408877|NCT00896532|155684395|FG022|Months 48-72: Follow-on Phase|Death|0|||
48408878|NCT00896532|155684373|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408879|NCT00896532|155684374|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408880|NCT00896532|155684375|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408881|NCT00896532|155684376|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408882|NCT00896532|155684377|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408883|NCT00896532|155684378|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408884|NCT00896532|155684379|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408885|NCT00896532|155684380|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408886|NCT00896532|155684381|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408887|NCT00896532|155684382|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408888|NCT00896532|155684383|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408889|NCT00896532|155684384|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408890|NCT00896532|155684385|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408891|NCT00896532|155684386|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408892|NCT00896532|155684387|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408893|NCT00896532|155684388|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408894|NCT00896532|155684389|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408895|NCT00896532|155684390|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408896|NCT00896532|155684391|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408897|NCT00896532|155684392|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408898|NCT00896532|155684393|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408899|NCT00896532|155684394|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
48408900|NCT00896532|155684395|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
48408901|NCT00896532|155684373|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408902|NCT00896532|155684374|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408903|NCT00896532|155684375|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408904|NCT00896532|155684376|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408905|NCT00896532|155684377|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408906|NCT00896532|155684378|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408907|NCT00896532|155684379|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408908|NCT00896532|155684380|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408909|NCT00896532|155684381|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408910|NCT00896532|155684382|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408911|NCT00896532|155684383|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408912|NCT00896532|155684384|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408913|NCT00896532|155684385|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408914|NCT00896532|155684386|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408915|NCT00896532|155684387|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408916|NCT00896532|155684388|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408917|NCT00896532|155684389|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408918|NCT00896532|155684390|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48431440|NCT00002663|155767265|FG001|Overall Study|Physician Decision|0|||
48408919|NCT00896532|155684391|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48408920|NCT00896532|155684392|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48357620|NCT05262751|155504931|FG002|Washout Period 2|Adverse Event|0|||
48357621|NCT05262751|155504932|FG003|Washout Period 2|Adverse Event|0|||
48357622|NCT05262751|155504933|FG004|Washout Period 2|Adverse Event|0|||
48357623|NCT05262751|155504934|FG005|Washout Period 2|Adverse Event|0|||
48357624|NCT05262751|155504929|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
48357625|NCT05262751|155504930|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
48357626|NCT05262751|155504931|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
48357627|NCT05262751|155504932|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
48357628|NCT05262751|155504933|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
48357629|NCT05262751|155504934|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
48357630|NCT03819634|155504935|FG000|Overall Study|Physician Decision|2|||
48357631|NCT01261000|155504936|FG000|Overall Study|Screen failure|1|||
48357632|NCT03690427|155504937|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
48357633|NCT03690427|155504938|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
48357634|NCT01727505|155504939|FG000|First 24 Hours|Adverse Event|0|||
48408921|NCT00896532|155684393|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48431441|NCT00002663|155767266|FG002|Overall Study|Physician Decision|0|||
48587186|NCT01492101|156343151|FG000|Overall Study|Death|323|||
48587187|NCT01492101|156343152|FG001|Overall Study|Death|322|||
48587188|NCT01492101|156343151|FG000|Overall Study|Withdrawal by Subject|14|||
48587189|NCT01492101|156343152|FG001|Overall Study|Withdrawal by Subject|18|||
48587190|NCT01492101|156343151|FG000|Overall Study|Lost to Follow-up|0|||
48408922|NCT00896532|155684394|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
48408923|NCT00896532|155684395|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
48357635|NCT01727505|155504940|FG001|First 24 Hours|Adverse Event|1|||
48357636|NCT01727505|155504939|FG000|Second 24 Hours|Missing data|0|||
48357637|NCT01727505|155504940|FG001|Second 24 Hours|Missing data|1|||
48357638|NCT00504777|155504941|FG000|Overall Study|Adverse Event|1|||
48357639|NCT02878603|155504943|FG000|Overall Study|Lost to Follow-up|4|||
48357640|NCT02878603|155504944|FG001|Overall Study|Lost to Follow-up|1|||
48357641|NCT02878603|155504943|FG000|Overall Study|Withdrawal by Subject|1|||
48357642|NCT02878603|155504944|FG001|Overall Study|Withdrawal by Subject|1|||
48408924|NCT01176916|155684396|FG000|Overall Study|Adverse Event|61|||
48357643|NCT02878603|155504943|FG000|Overall Study|Death|1|||
48408925|NCT01176916|155684396|FG000|Overall Study|Death|1|||
48408926|NCT01176916|155684396|FG000|Overall Study|Lost to Follow-up|15|||
48408927|NCT01176916|155684396|FG000|Overall Study|Objective progression or relapse|17|||
48408928|NCT01176916|155684396|FG000|Overall Study|Protocol Violation|24|||
48408929|NCT01176916|155684396|FG000|Overall Study|Withdrawal by Subject|37|||
48408930|NCT01176916|155684396|FG000|Overall Study|Other|6|||
48408931|NCT01176916|155684396|FG000|Overall Study|Withdrawal prior to Treatment|6|||
48408932|NCT00631137|155684397|FG000|Overall Study|Withdrawal by Subject|1|||
48408933|NCT00631137|155684398|FG001|Overall Study|Withdrawal by Subject|0|||
48408934|NCT01671280|155684400|FG000|Overall Study|Withdrawal by Subject|2|||
48408935|NCT00848120|155684401|FG000|Overall Study|Adverse Event|1|||
48408936|NCT00560755|155684402|FG000|Overall Study|Protocol Violation|15|||
48408937|NCT00560755|155684402|FG000|Overall Study|Withdrawal by Subject|26|||
48408938|NCT00560755|155684402|FG000|Overall Study|Lost to Follow-up|9|||
48408939|NCT00560755|155684402|FG000|Overall Study|Adverse Event|8|||
48408940|NCT00560755|155684402|FG000|Overall Study|Physician Decision|2|||
48408941|NCT00769119|155684406|FG000|Overall Study|Voluntary discontinuation|0|||
48408942|NCT00769119|155684407|FG001|Overall Study|Voluntary discontinuation|2|||
48408943|NCT00769119|155684406|FG000|Overall Study|Adverse Event|1|||
48408944|NCT00769119|155684407|FG001|Overall Study|Adverse Event|1|||
48408945|NCT00769119|155684406|FG000|Overall Study|Disallowed medication|1|||
48408946|NCT00769119|155684407|FG001|Overall Study|Disallowed medication|0|||
48408947|NCT03094195|155684410|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
48408948|NCT03094195|155684411|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
48408949|NCT03094195|155684412|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
48408950|NCT03094195|155684413|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48408951|NCT03094195|155684414|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48408952|NCT03094195|155684415|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48408953|NCT03094195|155684416|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48408954|NCT03094195|155684417|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
48408955|NCT03094195|155684410|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
48408956|NCT03094195|155684411|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
48408957|NCT03094195|155684412|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
48408958|NCT03094195|155684413|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48408959|NCT03094195|155684414|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48408960|NCT03094195|155684415|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48408961|NCT03094195|155684416|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48408962|NCT03094195|155684417|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
48408963|NCT03094195|155684410|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48408964|NCT03094195|155684411|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48408965|NCT03094195|155684412|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
48408966|NCT03094195|155684413|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48408967|NCT03094195|155684414|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48408968|NCT03094195|155684415|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48408969|NCT03094195|155684416|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48408970|NCT03094195|155684417|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
48408971|NCT03094195|155684410|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48408972|NCT03094195|155684411|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
48408973|NCT03094195|155684412|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
48408974|NCT03094195|155684413|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48408975|NCT03094195|155684414|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48408976|NCT03094195|155684415|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48408977|NCT03094195|155684416|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48408978|NCT03094195|155684417|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
48408979|NCT01961115|155684418|FG000|Overall Study|Disease Progression|1|||
48408980|NCT01961115|155684419|FG001|Overall Study|Disease Progression|0|||
48408981|NCT01961115|155684420|FG002|Overall Study|Disease Progression|3|||
48408982|NCT01961115|155684418|FG000|Overall Study|Adverse Event|1|||
48408983|NCT01961115|155684419|FG001|Overall Study|Adverse Event|0|||
48408984|NCT01961115|155684420|FG002|Overall Study|Adverse Event|1|||
48408985|NCT01439945|155684427|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
48408986|NCT01439945|155684428|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
48408987|NCT01439945|155684429|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
48408988|NCT01439945|155684430|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
48408989|NCT01439945|155684427|FG000|Double-Blind Treatment Phase|Ineligible|1|||
48408990|NCT01439945|155684428|FG001|Double-Blind Treatment Phase|Ineligible|2|||
48408991|NCT01439945|155684429|FG002|Double-Blind Treatment Phase|Ineligible|0|||
48408992|NCT01439945|155684430|FG003|Double-Blind Treatment Phase|Ineligible|1|||
48408993|NCT01651780|155684431|FG000|Overall Study|Physician decision: No 30-day visit|2|||
48408994|NCT01651780|155684432|FG001|Overall Study|Physician decision: No 30-day visit|1|||
48408995|NCT01651780|155684431|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
48408996|NCT01651780|155684432|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
48408997|NCT01651780|155684431|FG000|Overall Study|Withdrawal by Subject|2|||
48408998|NCT01651780|155684432|FG001|Overall Study|Withdrawal by Subject|0|||
48408999|NCT01651780|155684431|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
48409000|NCT01651780|155684432|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
48409001|NCT01651780|155684431|FG000|Overall Study|Lost to Follow-up|1|||
48409002|NCT01651780|155684432|FG001|Overall Study|Lost to Follow-up|2|||
48409003|NCT01651780|155684431|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
48409004|NCT01651780|155684432|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
48409005|NCT02959814|155684433|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
48409006|NCT02959814|155684433|FG000|Overall Study|Excluded based on anatomical criteria|2|||
48409007|NCT02959814|155684433|FG000|Overall Study|Protocol Violation|7|||
48409008|NCT02959814|155684433|FG000|Overall Study|FFR not measured|2|||
48409009|NCT02959814|155684433|FG000|Overall Study|In-procedure QFR not computed|6|||
48409010|NCT02959814|155684433|FG000|Overall Study|Excluded by FFR core-lab|24|||
48409011|NCT01444300|155684435|FG000|Overall Study|Adverse Event|4|||
48409012|NCT01444300|155684436|FG001|Overall Study|Adverse Event|0|||
48409013|NCT05224544|155684437|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
48409014|NCT05224544|155684438|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
48409015|NCT01468311|155684445|FG000|Overall Study|mobilization failure|1|||
48409016|NCT01468311|155684445|FG000|Overall Study|Withdrawal by Subject|1|||
48409017|NCT01671345|155684446|FG000|Overall Study|Lost to Follow-up|10|||
48409018|NCT01671345|155684447|FG001|Overall Study|Lost to Follow-up|6|||
48409019|NCT01671345|155684446|FG000|Overall Study|visit with non-participating physician|3|||
48409020|NCT01671345|155684447|FG001|Overall Study|visit with non-participating physician|3|||
48409021|NCT01299766|155686249|FG000|Overall Study|Death|5|||
48409022|NCT01299766|155686250|FG001|Overall Study|Death|4|||
48409023|NCT01299766|155686249|FG000|Overall Study|Withdrawal by Subject|29|||
48409024|NCT01299766|155686250|FG001|Overall Study|Withdrawal by Subject|19|||
48409025|NCT00388947|155686251|FG000|Overall Study|Protocol Violation|47|||
48409026|NCT03038308|155686252|FG000|Overall Study|Surgical resection|1|||
48409027|NCT03038308|155686252|FG000|Overall Study|Withdrawal by Subject|2|||
48409028|NCT03038308|155686252|FG000|Overall Study|Lost to Follow-up|1|||
48409029|NCT00619502|155686264|FG000|Overall Study|Lost to Follow-up|8|||
48409030|NCT00619502|155686265|FG001|Overall Study|Lost to Follow-up|10|||
48409031|NCT01777763|155686266|FG000|Overall Study|Adverse Event|2|||
48409032|NCT01777763|155686267|FG001|Overall Study|Adverse Event|32|||
48409033|NCT01777763|155686266|FG000|Overall Study|Protocol Violation|1|||
48409034|NCT01777763|155686267|FG001|Overall Study|Protocol Violation|7|||
48409035|NCT01777763|155686266|FG000|Overall Study|Withdrawal by Subject|0|||
48409036|NCT01777763|155686267|FG001|Overall Study|Withdrawal by Subject|2|||
48409037|NCT01777763|155686266|FG000|Overall Study|Treatment Failure|1|||
48409038|NCT01777763|155686267|FG001|Overall Study|Treatment Failure|6|||
48409039|NCT00132041|155686270|FG000|Baseline|Ineligible|6|||
48409040|NCT00132041|155686270|FG000|3 Months Post Ablation|Transplant|1|||
48409041|NCT00132041|155686270|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
48409042|NCT00132041|155686270|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
48409043|NCT00132041|155686270|FG000|6 Months Post Ablation|Death|2|||
48409044|NCT00132041|155686270|FG000|6 Months Post Ablation|Transplant|6|||
48409045|NCT00132041|155686270|FG000|9 Months Post Ablation|Death|1|||
48409046|NCT00132041|155686270|FG000|9 Months Post Ablation|Transplant|1|||
48409047|NCT00132041|155686270|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
48409048|NCT00132041|155686270|FG000|12 Months Post Ablation|Death|1|||
48409049|NCT00132041|155686270|FG000|12 Months Post Ablation|Transplant|1|||
48409050|NCT00132041|155686270|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
48409051|NCT00132041|155686270|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
48409052|NCT00132041|155686270|FG000|15 Months Post Ablation|Death|1|||
48409053|NCT00132041|155686270|FG000|15 Months Post Ablation|Transplant|5|||
48409054|NCT00132041|155686270|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
48409055|NCT00132041|155686270|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
48409056|NCT00132041|155686270|FG000|18 Months Post Ablation|Transplant|1|||
48409057|NCT00132041|155686270|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
48409058|NCT00132041|155686270|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
48409059|NCT03969875|155686271|FG000|Overall Study|did not receive allocated intervention|3|||
48409060|NCT03969875|155686272|FG001|Overall Study|did not receive allocated intervention|3|||
48409061|NCT03969875|155686273|FG002|Overall Study|did not receive allocated intervention|4|||
48409062|NCT03969875|155686271|FG000|Overall Study|Protocol Violation|4|||
48409063|NCT03969875|155686272|FG001|Overall Study|Protocol Violation|2|||
48409064|NCT03969875|155686273|FG002|Overall Study|Protocol Violation|2|||
48409065|NCT02971202|155686276|FG000|Overall Study|Pregnancy|1|||
48409066|NCT02971202|155686277|FG001|Overall Study|Pregnancy|0|||
48409067|NCT02971202|155686278|FG002|Overall Study|Pregnancy|0|||
48409068|NCT02971202|155686276|FG000|Overall Study|screen fail after consent|1|||
48409069|NCT02971202|155686277|FG001|Overall Study|screen fail after consent|0|||
48409070|NCT02971202|155686278|FG002|Overall Study|screen fail after consent|1|||
48409071|NCT03588741|155686279|FG000|Overall Study|Withdrawal by Subject|1|||
48409072|NCT01946178|155686280|FG000|Overall Study|Pregnancy|1|||
48409073|NCT01946178|155686280|FG000|Overall Study|Lost to Follow-up|1|||
48409074|NCT02421887|155686281|FG000|Overall Study|Lost to Follow-up|5|||
48409075|NCT02421887|155686282|FG001|Overall Study|Lost to Follow-up|0|||
48409076|NCT02421887|155686281|FG000|Overall Study|Withdrawal by Subject|8|||
48409077|NCT02421887|155686282|FG001|Overall Study|Withdrawal by Subject|5|||
48409078|NCT02421887|155686281|FG000|Overall Study|Physician Decision|2|||
48409079|NCT02421887|155686282|FG001|Overall Study|Physician Decision|4|||
48409080|NCT02421887|155686281|FG000|Overall Study|Adverse Event|2|||
48409081|NCT02421887|155686282|FG001|Overall Study|Adverse Event|0|||
48409082|NCT00491179|155686283|FG000|Overall Study|Adverse Event|5|||
48409083|NCT00491179|155686284|FG001|Overall Study|Adverse Event|1|||
48409084|NCT00491179|155686283|FG000|Overall Study|Withdrawal by Subject|2|||
48409085|NCT00491179|155686284|FG001|Overall Study|Withdrawal by Subject|1|||
48409086|NCT00988247|155686285|FG000|Overall Study|Adverse Event|17|||
48409087|NCT00988247|155686286|FG001|Overall Study|Adverse Event|3|||
48409088|NCT00988247|155686285|FG000|Overall Study|Withdrawal by Subject|44|||
48409089|NCT00988247|155686286|FG001|Overall Study|Withdrawal by Subject|13|||
48409090|NCT00988247|155686285|FG000|Overall Study|Pregnancy|1|||
48409091|NCT00988247|155686286|FG001|Overall Study|Pregnancy|2|||
48409092|NCT00988247|155686285|FG000|Overall Study|Lost to Follow-up|11|||
48409093|NCT00988247|155686286|FG001|Overall Study|Lost to Follow-up|2|||
48409094|NCT00988247|155686285|FG000|Overall Study|Protocol Violation|4|||
48409095|NCT00988247|155686286|FG001|Overall Study|Protocol Violation|5|||
48409096|NCT00988247|155686285|FG000|Overall Study|Sponsor requested withdrawal|3|||
48409097|NCT00988247|155686286|FG001|Overall Study|Sponsor requested withdrawal|1|||
48409098|NCT00988247|155686285|FG000|Overall Study|Other|3|||
48409099|NCT00988247|155686286|FG001|Overall Study|Other|0|||
48409100|NCT01703000|155686287|FG000|Overall Study|Death|1|||
48409101|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48357644|NCT02878603|155504944|FG001|Overall Study|Death|0|||
48357645|NCT02878603|155504943|FG000|Overall Study|Physician Decision|0|||
48357646|NCT02878603|155504944|FG001|Overall Study|Physician Decision|3|||
48357647|NCT00416195|155504945|FG000|Overall Study|Adverse Event|1|||
48357648|NCT00416195|155504946|FG001|Overall Study|Adverse Event|2|||
48357649|NCT00416195|155504945|FG000|Overall Study|Protocol Violation|1|||
48357650|NCT00416195|155504946|FG001|Overall Study|Protocol Violation|1|||
48357651|NCT00416195|155504945|FG000|Overall Study|Other|0|||
48357652|NCT00416195|155504946|FG001|Overall Study|Other|1|||
48357653|NCT04674189|155504948|FG000|Overall Study|Adverse Event|0|||
48357654|NCT04674189|155504949|FG001|Overall Study|Adverse Event|0|||
48357655|NCT04674189|155504950|FG002|Overall Study|Adverse Event|1|||
48357656|NCT04674189|155504948|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
48357657|NCT04674189|155504949|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
48357658|NCT04674189|155504950|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
48357659|NCT04674189|155504948|FG000|Overall Study|Physician Decision|1|||
48357660|NCT04674189|155504949|FG001|Overall Study|Physician Decision|0|||
48357661|NCT04674189|155504950|FG002|Overall Study|Physician Decision|0|||
48357662|NCT04674189|155504948|FG000|Overall Study|Withdrawal by Participant|83|||
48357663|NCT04674189|155504949|FG001|Overall Study|Withdrawal by Participant|71|||
48357664|NCT04674189|155504950|FG002|Overall Study|Withdrawal by Participant|142|||
48357665|NCT04674189|155504948|FG000|Overall Study|Lost to Follow-up|55|||
48357666|NCT04674189|155504949|FG001|Overall Study|Lost to Follow-up|53|||
48357667|NCT04674189|155504950|FG002|Overall Study|Lost to Follow-up|44|||
48357668|NCT04674189|155504948|FG000|Overall Study|Miscellaneous|27|||
48357669|NCT04674189|155504949|FG001|Overall Study|Miscellaneous|23|||
48357670|NCT04674189|155504950|FG002|Overall Study|Miscellaneous|207|||
48357671|NCT04674189|155504948|FG000|Overall Study|Did Not Receive Treatment|3|||
48357672|NCT04674189|155504949|FG001|Overall Study|Did Not Receive Treatment|1|||
48357673|NCT04674189|155504950|FG002|Overall Study|Did Not Receive Treatment|2|||
48357674|NCT01564277|155504951|FG000|Overall Study|Protocol Violation|0|||
48357675|NCT01564277|155504952|FG001|Overall Study|Protocol Violation|1|||
48357676|NCT01564277|155504951|FG000|Overall Study|Physician Decision|1|||
48357677|NCT01564277|155504952|FG001|Overall Study|Physician Decision|0|||
48357678|NCT01637077|155504953|FG000|Overall Study|Cancel|1|||
48357679|NCT01637077|155504954|FG001|Overall Study|Cancel|1|||
48357680|NCT01637077|155504953|FG000|Overall Study|Withdrawal by Subject|1|||
48357681|NCT01637077|155504954|FG001|Overall Study|Withdrawal by Subject|0|||
48357682|NCT01637077|155504953|FG000|Overall Study|No cycle 1 questionnaire data|2|||
48357683|NCT01637077|155504954|FG001|Overall Study|No cycle 1 questionnaire data|0|||
48357684|NCT01572740|155504955|FG000|Overall Study|Adverse Event|1|||
48357685|NCT01572740|155504956|FG001|Overall Study|Adverse Event|1|||
48357686|NCT01572740|155504955|FG000|Overall Study|Withdrawal by Subject|1|||
48357687|NCT01572740|155504956|FG001|Overall Study|Withdrawal by Subject|1|||
48357688|NCT01572740|155504955|FG000|Overall Study|unclassified|4|||
48357689|NCT01572740|155504956|FG001|Overall Study|unclassified|3|||
48357690|NCT00401258|155504959|FG000|Overall Study|Adverse Event|7|||
48357691|NCT00757627|155504960|FG000|Overall Study|Adverse Event|15|||
48357692|NCT00757627|155504960|FG000|Overall Study|Lack of Efficacy|10|||
48357693|NCT00757627|155504960|FG000|Overall Study|Lost to Follow-up|28|||
48357694|NCT00757627|155504960|FG000|Overall Study|Withdrawal by Subject|27|||
48357695|NCT00757627|155504960|FG000|Overall Study|Other|1|||
48357696|NCT02336425|155504962|FG000|Overall Study|Study terminated.|2|||
48357697|NCT02336425|155504963|FG001|Overall Study|Study terminated.|2|||
48409102|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
48409103|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409104|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409105|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409106|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
48409107|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
48409108|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
48409109|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
48409110|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
48409111|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48409112|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48409113|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48357698|NCT02336425|155504964|FG002|Overall Study|Study terminated.|3|||
48357699|NCT02336425|155504965|FG003|Overall Study|Study terminated.|3|||
48357700|NCT01067846|155504966|FG000|Overall Study|Lost to Follow-up|17|||
48357701|NCT01067846|155504967|FG001|Overall Study|Lost to Follow-up|19|||
48357702|NCT01067846|155504966|FG000|Overall Study|Withdrawal by Subject|1|||
48357703|NCT01067846|155504967|FG001|Overall Study|Withdrawal by Subject|0|||
48357704|NCT01067846|155504966|FG000|Overall Study|participation in other tx study|1|||
48357705|NCT01067846|155504967|FG001|Overall Study|participation in other tx study|0|||
48357706|NCT02833077|155504969|FG000|Overall Study|Adverse Event|1|||
48357707|NCT02833077|155504970|FG001|Overall Study|Adverse Event|2|||
48357708|NCT02833077|155504969|FG000|Overall Study|Lost to Follow-up|10|||
48357709|NCT02833077|155504970|FG001|Overall Study|Lost to Follow-up|1|||
48357710|NCT02833077|155504969|FG000|Overall Study|Personal Reasons|6|||
48357711|NCT02833077|155504970|FG001|Overall Study|Personal Reasons|4|||
48357712|NCT02833077|155504969|FG000|Overall Study|Protocol Deviation|0|||
48357713|NCT02833077|155504970|FG001|Overall Study|Protocol Deviation|1|||
48357714|NCT01782690|155504971|FG000|Overall Study|Not reported|7|||
48357715|NCT01782690|155504971|FG000|Overall Study|Toxicity of gemcitabine|1|||
48357716|NCT01782690|155504971|FG000|Overall Study|Toxicity of erlotinib|1|||
48409114|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48409115|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48409116|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
48409117|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
48409118|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
48409119|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
48409120|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
48409121|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409122|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409123|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48357717|NCT01782690|155504971|FG000|Overall Study|Lost to Follow-up|31|||
48357718|NCT01782690|155504971|FG000|Overall Study|Withdrawal of informed consent|2|||
48357719|NCT01782690|155504971|FG000|Overall Study|Absent rash|9|||
48357720|NCT01782690|155504971|FG000|Overall Study|Physician Decision|13|||
48357721|NCT01782690|155504971|FG000|Overall Study|Patient's wish|21|||
48357722|NCT01782690|155504971|FG000|Overall Study|Tumor progression|74|||
48357723|NCT01782690|155504971|FG000|Overall Study|Death|133|||
48357724|NCT01782690|155504971|FG000|Overall Study|Study completion unknown|7|||
48357725|NCT00277095|155504972|FG000|Overall Study|Death|2|||
48357726|NCT00277095|155504972|FG000|Overall Study|Explanted|7|||
48357727|NCT00277095|155504972|FG000|Overall Study|Lost to Follow-up|2|||
48357728|NCT00277095|155504972|FG000|Overall Study|Missed Follow-up|9|||
48357729|NCT00277095|155504972|FG000|Overall Study|Physician Decision|1|||
48357730|NCT02592876|155504975|FG000|Overall Study|Withdrawal by Subject|3|||
48357731|NCT02592876|155504976|FG001|Overall Study|Withdrawal by Subject|3|||
48357732|NCT02592876|155504975|FG000|Overall Study|Study Termination by Sponsor|32|||
48357733|NCT02592876|155504976|FG001|Overall Study|Study Termination by Sponsor|27|||
48357734|NCT02592876|155504975|FG000|Overall Study|Lost to Follow-up|0|||
48357735|NCT02592876|155504976|FG001|Overall Study|Lost to Follow-up|1|||
48357736|NCT02592876|155504975|FG000|Overall Study|Death|6|||
48357737|NCT02592876|155504976|FG001|Overall Study|Death|9|||
48357738|NCT01638390|155506215|FG000|Overall Study|screening failures|21|||
48357739|NCT00078377|155506216|FG000|Overall Study|Adverse Event|2|||
48357740|NCT00078377|155506217|FG001|Overall Study|Adverse Event|5|||
48357741|NCT00078377|155506218|FG002|Overall Study|Adverse Event|1|||
48357742|NCT00078377|155506216|FG000|Overall Study|Lack of Efficacy|2|||
48357743|NCT00078377|155506217|FG001|Overall Study|Lack of Efficacy|0|||
48357744|NCT00078377|155506218|FG002|Overall Study|Lack of Efficacy|2|||
48357745|NCT00078377|155506216|FG000|Overall Study|Lost to Follow-up|0|||
48357746|NCT00078377|155506217|FG001|Overall Study|Lost to Follow-up|1|||
48357747|NCT00078377|155506218|FG002|Overall Study|Lost to Follow-up|1|||
48357748|NCT00078377|155506216|FG000|Overall Study|Physician Decision|2|||
48357749|NCT00078377|155506217|FG001|Overall Study|Physician Decision|0|||
48357750|NCT00078377|155506218|FG002|Overall Study|Physician Decision|0|||
48357751|NCT00078377|155506216|FG000|Overall Study|Withdrawal by Subject|3|||
48357752|NCT00078377|155506217|FG001|Overall Study|Withdrawal by Subject|4|||
48357753|NCT00078377|155506218|FG002|Overall Study|Withdrawal by Subject|4|||
48357754|NCT00078377|155506216|FG000|Overall Study|Miscellaneous|2|||
48357755|NCT00078377|155506217|FG001|Overall Study|Miscellaneous|6|||
48357756|NCT00078377|155506218|FG002|Overall Study|Miscellaneous|1|||
48357757|NCT00129935|155506219|FG000|Overall Study|Adverse Event|18|||
48357758|NCT00129935|155506220|FG001|Overall Study|Adverse Event|56|||
48357759|NCT00129935|155506219|FG000|Overall Study|Death|1|||
48357760|NCT00129935|155506220|FG001|Overall Study|Death|1|||
48357761|NCT00129935|155506219|FG000|Overall Study|Withdrawal by Subject|7|||
48357762|NCT00129935|155506220|FG001|Overall Study|Withdrawal by Subject|20|||
48357763|NCT00129935|155506219|FG000|Overall Study|Protocol Violation|0|||
48357764|NCT00129935|155506220|FG001|Overall Study|Protocol Violation|4|||
48357765|NCT00129935|155506219|FG000|Overall Study|Physician Decision|3|||
48357766|NCT00129935|155506220|FG001|Overall Study|Physician Decision|4|||
48357767|NCT00129935|155506219|FG000|Overall Study|Recurrence|1|||
48357768|NCT00129935|155506220|FG001|Overall Study|Recurrence|3|||
48357769|NCT00129935|155506219|FG000|Overall Study|Second primary|0|||
48357770|NCT00129935|155506220|FG001|Overall Study|Second primary|1|||
48357771|NCT00129935|155506219|FG000|Overall Study|Other|3|||
48357772|NCT00129935|155506220|FG001|Overall Study|Other|2|||
48357773|NCT00129935|155506219|FG000|Overall Study|Crossed to the other arm|2|||
48357774|NCT00129935|155506220|FG001|Overall Study|Crossed to the other arm|1|||
48357775|NCT00129935|155506219|FG000|Overall Study|Incorrect study treatment|1|||
48357776|NCT00129935|155506220|FG001|Overall Study|Incorrect study treatment|0|||
48357777|NCT02354651|155506221|FG000|Overall Study|Withdrawal by Subject|2|||
48357778|NCT02354651|155506221|FG000|Overall Study|Physician Decision|1|||
48357779|NCT01381575|155506225|FG000|Overall Study|Serious Adverse Event|1|||
48357780|NCT01381575|155506226|FG001|Overall Study|Serious Adverse Event|0|||
48357781|NCT01381575|155506227|FG002|Overall Study|Serious Adverse Event|0|||
48409124|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
48409125|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409126|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
48409127|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
48409128|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48409129|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48409130|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48409131|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
48409132|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
48409133|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
48409134|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
48409135|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
48409136|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48409137|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
48409138|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
48409139|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
48409140|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48409141|NCT00289913|155686289|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
48409142|NCT00289913|155686290|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48409143|NCT00289913|155686291|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
48409144|NCT00289913|155686292|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48409145|NCT00289913|155686293|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48409146|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409147|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409148|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
48409149|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409150|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409151|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
48409152|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
48409153|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
48409154|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
48409155|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
48409156|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
48409157|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
48409158|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
48409159|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
48409160|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
48409161|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
48409162|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
48431442|NCT00002663|155767267|FG003|Overall Study|Physician Decision|0|||
48409163|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
48409164|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48409165|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48409166|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
48409167|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409168|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
48409169|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409170|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409171|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48409172|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
48409173|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
48409174|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
48409175|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
48409176|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
48409177|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
48409178|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
48409179|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
48409180|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
48409181|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
48409182|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
48409183|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
48409184|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
48409185|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
48409186|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
48409187|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
48409188|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
48409189|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
48409190|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
48431443|NCT00002663|155767268|FG004|Overall Study|Physician Decision|1|||
48409191|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
48409192|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
48409193|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
48409194|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
48409195|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
48409196|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
48409197|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
48409198|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
48409199|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
48409200|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
48409201|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
48409202|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
48409203|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
48409204|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
48409205|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
48409206|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
48409207|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
48409208|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
48409209|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
48409210|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
48409211|NCT00289913|155686289|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
48409212|NCT00289913|155686290|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
48409213|NCT00289913|155686291|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
48409214|NCT00289913|155686292|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
48409215|NCT00289913|155686293|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
48409216|NCT00289913|155686289|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409217|NCT00289913|155686290|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
48409218|NCT00289913|155686291|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409219|NCT00289913|155686292|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409220|NCT00289913|155686293|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
48409221|NCT00289913|155686289|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
48409222|NCT00289913|155686290|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
48409223|NCT00289913|155686291|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
48409224|NCT00289913|155686292|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
48409225|NCT00289913|155686293|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
48409226|NCT00289913|155686289|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48409227|NCT00289913|155686290|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48409228|NCT00289913|155686291|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48409229|NCT00289913|155686292|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
48409230|NCT00289913|155686293|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
48409231|NCT00289913|155686289|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409232|NCT00289913|155686290|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409233|NCT00289913|155686291|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409234|NCT00289913|155686292|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
48409235|NCT00289913|155686293|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
48409236|NCT00289913|155686289|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
48409237|NCT00289913|155686290|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
48409238|NCT00289913|155686291|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
48409239|NCT00289913|155686292|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
48409240|NCT00289913|155686293|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
48409241|NCT00289913|155686289|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48409242|NCT00289913|155686290|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
48409243|NCT00289913|155686291|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
48409244|NCT00289913|155686292|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48409245|NCT00289913|155686293|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
48409246|NCT00289913|155686289|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
48409247|NCT00289913|155686290|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
48409248|NCT00289913|155686291|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
48409249|NCT00289913|155686292|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
48409250|NCT00289913|155686293|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
48431444|NCT00002663|155767269|FG005|Overall Study|Physician Decision|0|||
48692513|NCT00453154|156724503|FG000|Double BIind Maintenance|Medical Issues|0|||
48692514|NCT00453154|156724504|FG001|Double BIind Maintenance|Medical Issues|0|||
48692515|NCT00453154|156724505|FG002|Double BIind Maintenance|Medical Issues|3|||
48692516|NCT00453154|156724506|FG003|Double BIind Maintenance|Medical Issues|1|||
48692517|NCT00453154|156724503|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
48692518|NCT00453154|156724504|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
48692519|NCT00453154|156724505|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
48692520|NCT00453154|156724506|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
48692521|NCT01451723|156724507|FG000|Overall Study|study halted|6|||
48692522|NCT01451723|156724508|FG001|Overall Study|study halted|5|||
48692523|NCT04540913|156724511|FG000|Overall Study|Withdrawal by Subject|14|||
48692524|NCT04540913|156724512|FG001|Overall Study|Withdrawal by Subject|3|||
48692525|NCT01755234|156724519|FG000|Overall Study|Lost to Follow-up|11|||
48692526|NCT01755234|156724520|FG001|Overall Study|Lost to Follow-up|6|||
48692527|NCT01755234|156724519|FG000|Overall Study|Change in surgical case|2|||
48357782|NCT01381575|155506225|FG000|Overall Study|Non-Serious Adverse Event|0|||
48409251|NCT00289913|155686289|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48409252|NCT00289913|155686290|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
48409253|NCT00289913|155686291|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48409254|NCT00289913|155686292|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48409255|NCT00289913|155686293|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
48409256|NCT02522767|155686296|FG000|Double-blind|Withdrawal by Subject|8|||
48409257|NCT02522767|155686297|FG001|Double-blind|Withdrawal by Subject|11|||
48409258|NCT02522767|155686296|FG000|Double-blind|Lost to Follow-up|1|||
48409259|NCT02522767|155686297|FG001|Double-blind|Lost to Follow-up|0|||
48409260|NCT02522767|155686296|FG000|Double-blind|Adverse Event|1|||
48409261|NCT02522767|155686297|FG001|Double-blind|Adverse Event|10|||
48409262|NCT02522767|155686296|FG000|Double-blind|Protocol Violation|0|||
48409263|NCT02522767|155686297|FG001|Double-blind|Protocol Violation|1|||
48409264|NCT02522767|155686296|FG000|Double-blind|Lack of Efficacy|0|||
48409265|NCT02522767|155686297|FG001|Double-blind|Lack of Efficacy|2|||
48409266|NCT02522767|155686296|FG000|Double-blind|Protocol Deviation|1|||
48409267|NCT02522767|155686297|FG001|Double-blind|Protocol Deviation|0|||
48409268|NCT02522767|155686296|FG000|Open-label|Withdrawal by Subject|2|||
48409269|NCT02522767|155686297|FG001|Open-label|Withdrawal by Subject|3|||
48409270|NCT02522767|155686296|FG000|Open-label|Lost to Follow-up|0|||
48409271|NCT02522767|155686297|FG001|Open-label|Lost to Follow-up|1|||
48409272|NCT02522767|155686296|FG000|Open-label|Adverse Event|2|||
48409273|NCT02522767|155686297|FG001|Open-label|Adverse Event|1|||
48409274|NCT02522767|155686296|FG000|Open-label|Lack of Efficacy|1|||
48409275|NCT02522767|155686297|FG001|Open-label|Lack of Efficacy|1|||
48409276|NCT02522767|155686296|FG000|Open-label|Protocol Violation|0|||
48409277|NCT02522767|155686297|FG001|Open-label|Protocol Violation|1|||
48409278|NCT00434967|155686299|FG000|Overall Study|Adverse Event|2|||
48409279|NCT00434967|155686300|FG001|Overall Study|Adverse Event|4|||
48409280|NCT00434967|155686301|FG002|Overall Study|Adverse Event|3|||
48409281|NCT00434967|155686302|FG003|Overall Study|Adverse Event|3|||
48409282|NCT00434967|155686299|FG000|Overall Study|Lost to Follow-up|0|||
48409283|NCT00434967|155686300|FG001|Overall Study|Lost to Follow-up|0|||
48409284|NCT00434967|155686301|FG002|Overall Study|Lost to Follow-up|1|||
48409285|NCT00434967|155686302|FG003|Overall Study|Lost to Follow-up|0|||
48409286|NCT00434967|155686299|FG000|Overall Study|Withdrawal by Subject|2|||
48409287|NCT00434967|155686300|FG001|Overall Study|Withdrawal by Subject|2|||
48409288|NCT00434967|155686301|FG002|Overall Study|Withdrawal by Subject|4|||
48409289|NCT00434967|155686302|FG003|Overall Study|Withdrawal by Subject|6|||
48409290|NCT00434967|155686299|FG000|Overall Study|Randomized in error|0|||
48409291|NCT00434967|155686300|FG001|Overall Study|Randomized in error|0|||
48409292|NCT00434967|155686301|FG002|Overall Study|Randomized in error|0|||
48409293|NCT00434967|155686302|FG003|Overall Study|Randomized in error|1|||
48409294|NCT00434967|155686299|FG000|Overall Study|Protocol Violation|0|||
48409295|NCT00434967|155686300|FG001|Overall Study|Protocol Violation|1|||
48409296|NCT00434967|155686301|FG002|Overall Study|Protocol Violation|0|||
48409297|NCT00434967|155686302|FG003|Overall Study|Protocol Violation|1|||
48409298|NCT00434967|155686299|FG000|Overall Study|Physician Decision|1|||
48409299|NCT00434967|155686300|FG001|Overall Study|Physician Decision|1|||
48409300|NCT00434967|155686301|FG002|Overall Study|Physician Decision|1|||
48409301|NCT00434967|155686302|FG003|Overall Study|Physician Decision|0|||
48409302|NCT00434967|155686299|FG000|Overall Study|Patient Disposition Challenges|2|||
48409303|NCT00434967|155686300|FG001|Overall Study|Patient Disposition Challenges|0|||
48409304|NCT00434967|155686301|FG002|Overall Study|Patient Disposition Challenges|0|||
48409305|NCT00434967|155686302|FG003|Overall Study|Patient Disposition Challenges|3|||
48409306|NCT02494596|155686303|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48409307|NCT02494596|155686304|FG001|Overall Study|Insufficient Therapeutic Response|3|||
48409308|NCT02494596|155686305|FG002|Overall Study|Insufficient Therapeutic Response|1|||
48409309|NCT02494596|155686303|FG000|Overall Study|Adverse Event|0|||
48409310|NCT02494596|155686304|FG001|Overall Study|Adverse Event|1|||
48409311|NCT02494596|155686305|FG002|Overall Study|Adverse Event|0|||
48409312|NCT02494596|155686303|FG000|Overall Study|Refused Treatment|0|||
48409313|NCT02494596|155686304|FG001|Overall Study|Refused Treatment|1|||
48409314|NCT02494596|155686305|FG002|Overall Study|Refused Treatment|0|||
48409315|NCT01169779|155686306|FG000|Overall Study|Adverse Event|3|||
48409316|NCT01169779|155686307|FG001|Overall Study|Adverse Event|11|||
48409317|NCT01169779|155686306|FG000|Overall Study|Lack of Efficacy|1|||
48409318|NCT01169779|155686307|FG001|Overall Study|Lack of Efficacy|0|||
48409319|NCT01169779|155686306|FG000|Overall Study|Protocol Violation|1|||
48409320|NCT01169779|155686307|FG001|Overall Study|Protocol Violation|1|||
48409321|NCT01169779|155686306|FG000|Overall Study|Withdrawal by Subject|3|||
48409322|NCT01169779|155686307|FG001|Overall Study|Withdrawal by Subject|2|||
48409323|NCT01169779|155686306|FG000|Overall Study|Familial and personal reasons|3|||
48409324|NCT01169779|155686307|FG001|Overall Study|Familial and personal reasons|3|||
48409325|NCT00214461|155686313|FG000|Overall Study|Adverse Event|0|||
48409326|NCT00214461|155686314|FG001|Overall Study|Adverse Event|0|||
48409327|NCT00214461|155686315|FG002|Overall Study|Adverse Event|1|||
48409328|NCT00214461|155686316|FG003|Overall Study|Adverse Event|1|||
48409329|NCT00214461|155686313|FG000|Overall Study|Withdrawal by Subject|0|||
48409330|NCT00214461|155686314|FG001|Overall Study|Withdrawal by Subject|0|||
48409331|NCT00214461|155686315|FG002|Overall Study|Withdrawal by Subject|1|||
48409332|NCT00214461|155686316|FG003|Overall Study|Withdrawal by Subject|0|||
48409333|NCT00643994|155686320|FG000|Overall Study|Death|24|||
48409334|NCT00643994|155686320|FG000|Overall Study|Lost to Follow-up|72|||
48409335|NCT00400400|155686321|FG000|Overall Study|Adverse Event|9|||
48409336|NCT00400400|155686322|FG001|Overall Study|Adverse Event|8|||
48409337|NCT00400400|155686321|FG000|Overall Study|Protocol Violation|2|||
48409338|NCT00400400|155686322|FG001|Overall Study|Protocol Violation|0|||
48409339|NCT00400400|155686321|FG000|Overall Study|Withdrawal by Subject|1|||
48409340|NCT00400400|155686322|FG001|Overall Study|Withdrawal by Subject|3|||
48409341|NCT00400400|155686321|FG000|Overall Study|Administrative Problem|1|||
48409342|NCT00400400|155686322|FG001|Overall Study|Administrative Problem|0|||
48409343|NCT00400400|155686321|FG000|Overall Study|Lost to Follow-up|0|||
48409344|NCT00400400|155686322|FG001|Overall Study|Lost to Follow-up|1|||
48409345|NCT00400400|155686321|FG000|Overall Study|Did not receive study drug|1|||
48409346|NCT00400400|155686322|FG001|Overall Study|Did not receive study drug|3|||
48409347|NCT01688050|155686323|FG000|Overall Study|Death|7|||
48409348|NCT01688050|155686323|FG000|Overall Study|Conversion to open repair|1|||
48409349|NCT01688050|155686323|FG000|Overall Study|Lost to Follow-up|13|||
48409350|NCT01688050|155686323|FG000|Overall Study|Withdrawal by Subject|10|||
48409351|NCT00927368|155686324|FG000|Overall Study|enrollment in another study|1|||
48409352|NCT00927368|155686325|FG001|Overall Study|enrollment in another study|1|||
48409353|NCT00927368|155686326|FG002|Overall Study|enrollment in another study|2|||
48409354|NCT00927368|155686324|FG000|Overall Study|Lost to Follow-up|4|||
48409355|NCT00927368|155686325|FG001|Overall Study|Lost to Follow-up|0|||
48409356|NCT00927368|155686326|FG002|Overall Study|Lost to Follow-up|0|||
48409357|NCT00927368|155686324|FG000|Overall Study|equipment failure|1|||
48409358|NCT00927368|155686325|FG001|Overall Study|equipment failure|0|||
48409359|NCT00927368|155686326|FG002|Overall Study|equipment failure|0|||
48409360|NCT00927368|155686324|FG000|Overall Study|ineligible post randomization|0|||
48409361|NCT00927368|155686325|FG001|Overall Study|ineligible post randomization|3|||
48409362|NCT00927368|155686326|FG002|Overall Study|ineligible post randomization|1|||
48409363|NCT00927368|155686324|FG000|Overall Study|cancellation of surgery|0|||
48409364|NCT00927368|155686325|FG001|Overall Study|cancellation of surgery|1|||
48409365|NCT00927368|155686326|FG002|Overall Study|cancellation of surgery|2|||
48409366|NCT00257010|155686327|FG000|Overall Study|Lack of Efficacy|11|||
48409367|NCT00257010|155686327|FG000|Overall Study|Lost to Follow-up|53|||
48409368|NCT00257010|155686327|FG000|Overall Study|Withdrawal by Subject|34|||
48409369|NCT00257010|155686327|FG000|Overall Study|Adverse Event|10|||
48409370|NCT00257010|155686327|FG000|Overall Study|various|11|||
48409371|NCT00257010|155686327|FG000|Overall Study|no headache reported|9|||
48409372|NCT02624492|155686328|FG000|Overall Study|Adverse Event|2|||
48409373|NCT02624492|155686329|FG001|Overall Study|Adverse Event|2|||
48409374|NCT02624492|155686330|FG002|Overall Study|Adverse Event|2|||
48409375|NCT02624492|155686328|FG000|Overall Study|Progressive disease|0|||
48409376|NCT02624492|155686329|FG001|Overall Study|Progressive disease|2|||
48409377|NCT02624492|155686330|FG002|Overall Study|Progressive disease|3|||
48409378|NCT00364689|155686332|FG000|Overall Study|Lost to Follow-up|1|||
48409379|NCT01554579|155686338|FG000|Overall Study|Adverse Event|6|||
48409380|NCT01554579|155686339|FG001|Overall Study|Adverse Event|25|||
48409381|NCT01554579|155686338|FG000|Overall Study|Lack of Efficacy|2|||
48409382|NCT01554579|155686339|FG001|Overall Study|Lack of Efficacy|1|||
48409383|NCT01554579|155686338|FG000|Overall Study|Withdrawal by Subject|2|||
48409384|NCT01554579|155686339|FG001|Overall Study|Withdrawal by Subject|1|||
48409385|NCT00094757|155686340|FG000|Overall Study|Adverse Event|11|||
48409386|NCT00094757|155686341|FG001|Overall Study|Adverse Event|9|||
48357783|NCT01381575|155506226|FG001|Overall Study|Non-Serious Adverse Event|0|||
48409387|NCT00094757|155686342|FG002|Overall Study|Adverse Event|6|||
48409388|NCT00094757|155686340|FG000|Overall Study|Lack of Efficacy|11|||
48409389|NCT00094757|155686341|FG001|Overall Study|Lack of Efficacy|15|||
48409390|NCT00094757|155686342|FG002|Overall Study|Lack of Efficacy|8|||
48409391|NCT00094757|155686340|FG000|Overall Study|Lost to Follow-up|3|||
48409392|NCT00094757|155686341|FG001|Overall Study|Lost to Follow-up|5|||
48409393|NCT00094757|155686342|FG002|Overall Study|Lost to Follow-up|6|||
48409394|NCT00094757|155686340|FG000|Overall Study|Patient Moved|2|||
48409395|NCT00094757|155686341|FG001|Overall Study|Patient Moved|1|||
48409396|NCT00094757|155686342|FG002|Overall Study|Patient Moved|1|||
48409397|NCT00094757|155686340|FG000|Overall Study|Protocol Violation|8|||
48409398|NCT00094757|155686341|FG001|Overall Study|Protocol Violation|5|||
48409399|NCT00094757|155686342|FG002|Overall Study|Protocol Violation|3|||
48409400|NCT00094757|155686340|FG000|Overall Study|Withdrawal by Subject|14|||
48409401|NCT00094757|155686341|FG001|Overall Study|Withdrawal by Subject|21|||
48409402|NCT00094757|155686342|FG002|Overall Study|Withdrawal by Subject|5|||
48409403|NCT00094757|155686340|FG000|Overall Study|Other|3|||
48409404|NCT00094757|155686341|FG001|Overall Study|Other|3|||
48409405|NCT00094757|155686342|FG002|Overall Study|Other|1|||
48409406|NCT00094757|155686340|FG000|Overall Study|Protocol specified discontinuation|1|||
48409407|NCT00094757|155686341|FG001|Overall Study|Protocol specified discontinuation|3|||
48409408|NCT00094757|155686342|FG002|Overall Study|Protocol specified discontinuation|0|||
48409409|NCT01808612|155686343|FG000|Treatment Period|Adverse Event|8|||
48409410|NCT01808612|155686344|FG001|Treatment Period|Adverse Event|4|||
48409411|NCT01808612|155686345|FG002|Treatment Period|Adverse Event|3|||
48357784|NCT01381575|155506227|FG002|Overall Study|Non-Serious Adverse Event|1|||
48357785|NCT01381575|155506225|FG000|Overall Study|Protocol Violation|0|||
48357786|NCT01381575|155506226|FG001|Overall Study|Protocol Violation|1|||
48357787|NCT01381575|155506227|FG002|Overall Study|Protocol Violation|1|||
48357788|NCT01381575|155506225|FG000|Overall Study|Withdrawal by Subject|15|||
48357789|NCT01381575|155506226|FG001|Overall Study|Withdrawal by Subject|9|||
48357790|NCT01381575|155506227|FG002|Overall Study|Withdrawal by Subject|7|||
48357791|NCT01381575|155506225|FG000|Overall Study|Migrated/moved from study area|2|||
48357792|NCT01381575|155506226|FG001|Overall Study|Migrated/moved from study area|12|||
48357793|NCT01381575|155506227|FG002|Overall Study|Migrated/moved from study area|2|||
48357794|NCT01381575|155506225|FG000|Overall Study|Lost to Follow-up|8|||
48357795|NCT01381575|155506226|FG001|Overall Study|Lost to Follow-up|17|||
48357796|NCT01381575|155506227|FG002|Overall Study|Lost to Follow-up|9|||
48357797|NCT00725712|155506228|FG000|Overall Study|Withdrawal by Subject|2|||
48357798|NCT00725712|155506229|FG001|Overall Study|Withdrawal by Subject|1|||
48357799|NCT00725712|155506228|FG000|Overall Study|Protocol Violation|1|||
48357800|NCT00725712|155506229|FG001|Overall Study|Protocol Violation|0|||
48357801|NCT00725712|155506228|FG000|Overall Study|Progressive disease|37|||
48409412|NCT01808612|155686343|FG000|Treatment Period|Lost to Follow-up|2|||
48357802|NCT00725712|155506229|FG001|Overall Study|Progressive disease|16|||
48357803|NCT00725712|155506228|FG000|Overall Study|Clinical progression not based on RECIST|0|||
48409413|NCT01808612|155686344|FG001|Treatment Period|Lost to Follow-up|2|||
48409414|NCT01808612|155686345|FG002|Treatment Period|Lost to Follow-up|1|||
48357804|NCT00725712|155506229|FG001|Overall Study|Clinical progression not based on RECIST|3|||
48409415|NCT01808612|155686343|FG000|Treatment Period|Protocol Violation|1|||
48409416|NCT01808612|155686344|FG001|Treatment Period|Protocol Violation|0|||
48409417|NCT01808612|155686345|FG002|Treatment Period|Protocol Violation|0|||
48409418|NCT01808612|155686343|FG000|Treatment Period|Withdrawal by Subject|1|||
48409419|NCT01808612|155686344|FG001|Treatment Period|Withdrawal by Subject|0|||
48409420|NCT01808612|155686345|FG002|Treatment Period|Withdrawal by Subject|4|||
48409421|NCT01808612|155686343|FG000|Treatment Period|Physician Decision|1|||
48409422|NCT01808612|155686344|FG001|Treatment Period|Physician Decision|0|||
48409423|NCT01808612|155686345|FG002|Treatment Period|Physician Decision|4|||
48409424|NCT01808612|155686343|FG000|Treatment Period|Sponsor Decision|1|||
48409425|NCT01808612|155686344|FG001|Treatment Period|Sponsor Decision|0|||
48409426|NCT01808612|155686345|FG002|Treatment Period|Sponsor Decision|0|||
48409427|NCT01808612|155686343|FG000|Treatment Period|Lack of Efficacy|1|||
48409428|NCT01808612|155686344|FG001|Treatment Period|Lack of Efficacy|1|||
48409429|NCT01808612|155686345|FG002|Treatment Period|Lack of Efficacy|2|||
48409430|NCT01808612|155686343|FG000|Discontinuation Period|Adverse Event|1|||
48409431|NCT01808612|155686344|FG001|Discontinuation Period|Adverse Event|0|||
48409432|NCT01808612|155686345|FG002|Discontinuation Period|Adverse Event|0|||
48409433|NCT01808612|155686343|FG000|Discontinuation Period|Physician Decision|1|||
48409434|NCT01808612|155686344|FG001|Discontinuation Period|Physician Decision|0|||
48409435|NCT01808612|155686345|FG002|Discontinuation Period|Physician Decision|0|||
48409436|NCT01808612|155686343|FG000|Discontinuation Period|Lost to Follow-up|0|||
48409437|NCT01808612|155686344|FG001|Discontinuation Period|Lost to Follow-up|1|||
48409438|NCT01808612|155686345|FG002|Discontinuation Period|Lost to Follow-up|0|||
48409439|NCT02796755|155686349|FG000|Overall Study|Adverse Event|2|||
48409440|NCT02796755|155686350|FG001|Overall Study|Adverse Event|0|||
48409441|NCT00045032|155686351|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
48409442|NCT00045032|155686352|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
48409443|NCT00045032|155686353|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
48409444|NCT00045032|155686351|FG000|Overall Study|Death|22|||
48409445|NCT00045032|155686352|FG001|Overall Study|Death|24|||
48409446|NCT00045032|155686353|FG002|Overall Study|Death|17|||
48409447|NCT00045032|155686351|FG000|Overall Study|Insufficient Therapeutic Response|542|||
48409448|NCT00045032|155686352|FG001|Overall Study|Insufficient Therapeutic Response|437|||
48409449|NCT00045032|155686353|FG002|Overall Study|Insufficient Therapeutic Response|445|||
48409450|NCT00045032|155686351|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
48409451|NCT00045032|155686352|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
48409452|NCT00045032|155686353|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
48409453|NCT00045032|155686351|FG000|Overall Study|Other Protocol Violation|2|||
48409454|NCT00045032|155686352|FG001|Overall Study|Other Protocol Violation|0|||
48409455|NCT00045032|155686353|FG002|Overall Study|Other Protocol Violation|1|||
48409456|NCT00045032|155686351|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
48409457|NCT00045032|155686352|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
48409458|NCT00045032|155686353|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
48409459|NCT00045032|155686351|FG000|Overall Study|Failure to Return|57|||
48409460|NCT00045032|155686352|FG001|Overall Study|Failure to Return|62|||
48409461|NCT00045032|155686353|FG002|Overall Study|Failure to Return|61|||
48409462|NCT00045032|155686351|FG000|Overall Study|Other|93|||
48409463|NCT00045032|155686352|FG001|Overall Study|Other|84|||
48409464|NCT00045032|155686353|FG002|Overall Study|Other|105|||
48409465|NCT01214044|155686355|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
48409466|NCT01214044|155686355|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
48409467|NCT01214044|155686355|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
48409468|NCT01214044|155686355|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
48409469|NCT01214044|155686355|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
48409470|NCT01214044|155686355|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
48409471|NCT02731742|155686356|FG000|Overall Study|Death|1|||
48409472|NCT02731742|155686357|FG001|Overall Study|Death|2|||
48409473|NCT02731742|155686358|FG002|Overall Study|Death|5|||
48409474|NCT02731742|155686359|FG003|Overall Study|Death|0|||
48409475|NCT02731742|155686356|FG000|Overall Study|Physician Decision|0|||
48409476|NCT02731742|155686357|FG001|Overall Study|Physician Decision|0|||
48409477|NCT02731742|155686358|FG002|Overall Study|Physician Decision|0|||
48409478|NCT02731742|155686359|FG003|Overall Study|Physician Decision|1|||
48409479|NCT02731742|155686356|FG000|Overall Study|Study Terminated by Sponsor|2|||
48409480|NCT02731742|155686357|FG001|Overall Study|Study Terminated by Sponsor|1|||
48409481|NCT02731742|155686358|FG002|Overall Study|Study Terminated by Sponsor|1|||
48409482|NCT02731742|155686359|FG003|Overall Study|Study Terminated by Sponsor|1|||
48409483|NCT04134494|155686360|FG000|Overall Study|Lost to Follow-up|2|||
48409484|NCT00773279|155686361|FG000|Period 1|Adverse Event|2|||
48409485|NCT00773279|155686362|FG001|Period 1|Adverse Event|1|||
48409486|NCT00773279|155686361|FG000|Period 1|Lack of Efficacy|0|||
48409487|NCT00773279|155686362|FG001|Period 1|Lack of Efficacy|2|||
48409488|NCT00773279|155686361|FG000|Period 1|Unclassified|5|||
48409489|NCT00773279|155686362|FG001|Period 1|Unclassified|1|||
48409490|NCT00773279|155686361|FG000|Period 2|Adverse Event|0|||
48409491|NCT00773279|155686362|FG001|Period 2|Adverse Event|1|||
48409492|NCT00773279|155686361|FG000|Period 2|Lack of Efficacy|1|||
48409493|NCT00773279|155686362|FG001|Period 2|Lack of Efficacy|0|||
48409494|NCT00773279|155686361|FG000|Period 2|Protocol Violation|0|||
48409495|NCT00773279|155686362|FG001|Period 2|Protocol Violation|3|||
48409496|NCT00773279|155686361|FG000|Period 2|Unclassified|2|||
48409497|NCT00773279|155686362|FG001|Period 2|Unclassified|2|||
48409498|NCT02211261|155686363|FG000|Overall Study|Withdrawal by Subject|0|||
48409499|NCT02211261|155686364|FG001|Overall Study|Withdrawal by Subject|0|||
48409500|NCT02211261|155686365|FG002|Overall Study|Withdrawal by Subject|1|||
48409501|NCT02211261|155686366|FG003|Overall Study|Withdrawal by Subject|0|||
48409502|NCT02211261|155686367|FG004|Overall Study|Withdrawal by Subject|2|||
48357805|NCT00725712|155506228|FG000|Overall Study|Adverse Event|5|||
48357806|NCT00725712|155506229|FG001|Overall Study|Adverse Event|5|||
48357807|NCT00725712|155506228|FG000|Overall Study|Death|2|||
48357808|NCT00725712|155506229|FG001|Overall Study|Death|0|||
48357809|NCT00725712|155506228|FG000|Overall Study|Other: Death|1|||
48357810|NCT00725712|155506229|FG001|Overall Study|Other: Death|0|||
48357811|NCT00725712|155506228|FG000|Overall Study|Hospitalized, unable to continue|0|||
48357812|NCT00725712|155506229|FG001|Overall Study|Hospitalized, unable to continue|1|||
48357813|NCT00132678|155506230|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
48357814|NCT00132678|155506231|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
48357815|NCT00132678|155506232|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
48357816|NCT00132678|155506230|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
48357817|NCT00132678|155506231|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
48357818|NCT00132678|155506232|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
48357819|NCT00132678|155506230|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
48357820|NCT00132678|155506231|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
48357821|NCT00132678|155506232|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
48357822|NCT00132678|155506230|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
48357823|NCT00132678|155506231|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
48431445|NCT00002663|155767270|FG006|Overall Study|Physician Decision|0|||
48409503|NCT02211261|155686368|FG005|Overall Study|Withdrawal by Subject|0|||
48409504|NCT02211261|155686369|FG006|Overall Study|Withdrawal by Subject|0|||
48409505|NCT02211261|155686370|FG007|Overall Study|Withdrawal by Subject|0|||
48409506|NCT02211261|155686371|FG008|Overall Study|Withdrawal by Subject|0|||
48409507|NCT02211261|155686372|FG009|Overall Study|Withdrawal by Subject|0|||
48409508|NCT02211261|155686373|FG010|Overall Study|Withdrawal by Subject|0|||
48409509|NCT02211261|155686363|FG000|Overall Study|Other|0|||
48409510|NCT02211261|155686364|FG001|Overall Study|Other|0|||
48409511|NCT02211261|155686365|FG002|Overall Study|Other|0|||
48409512|NCT02211261|155686366|FG003|Overall Study|Other|0|||
48409513|NCT02211261|155686367|FG004|Overall Study|Other|0|||
48409514|NCT02211261|155686368|FG005|Overall Study|Other|1|||
48409515|NCT02211261|155686369|FG006|Overall Study|Other|0|||
48409516|NCT02211261|155686370|FG007|Overall Study|Other|0|||
48409517|NCT02211261|155686371|FG008|Overall Study|Other|0|||
48409518|NCT02211261|155686372|FG009|Overall Study|Other|2|||
48409519|NCT02211261|155686373|FG010|Overall Study|Other|0|||
48409520|NCT02211261|155686363|FG000|Overall Study|Lost to Follow-up|0|||
48409521|NCT02211261|155686364|FG001|Overall Study|Lost to Follow-up|0|||
48409522|NCT02211261|155686365|FG002|Overall Study|Lost to Follow-up|0|||
48409523|NCT02211261|155686366|FG003|Overall Study|Lost to Follow-up|0|||
48409524|NCT02211261|155686367|FG004|Overall Study|Lost to Follow-up|0|||
48409525|NCT02211261|155686368|FG005|Overall Study|Lost to Follow-up|0|||
48409526|NCT02211261|155686369|FG006|Overall Study|Lost to Follow-up|0|||
48409527|NCT02211261|155686370|FG007|Overall Study|Lost to Follow-up|1|||
48409528|NCT02211261|155686371|FG008|Overall Study|Lost to Follow-up|0|||
48409529|NCT02211261|155686372|FG009|Overall Study|Lost to Follow-up|0|||
48409530|NCT02211261|155686373|FG010|Overall Study|Lost to Follow-up|0|||
48409531|NCT01737931|155686374|FG000|Overall Study|Withdrawal by Subject|0|||
48409532|NCT01737931|155686375|FG001|Overall Study|Withdrawal by Subject|1|||
48409533|NCT01737931|155686376|FG002|Overall Study|Withdrawal by Subject|1|||
48409534|NCT01737931|155686374|FG000|Overall Study|Physician Decision|0|||
48409535|NCT01737931|155686375|FG001|Overall Study|Physician Decision|1|||
48409536|NCT01737931|155686376|FG002|Overall Study|Physician Decision|0|||
48409537|NCT04336163|155686377|FG000|Overall Study|Lost to Follow-up|55|||
48409538|NCT04336163|155686378|FG001|Overall Study|Lost to Follow-up|0|||
48409539|NCT01481896|155686388|FG000|Overall Study|Lost to Follow-up|12|||
48409540|NCT01227967|155686389|FG000|Overall Study|Protocol Violation|3|||
48409541|NCT01227967|155686390|FG001|Overall Study|Protocol Violation|1|||
48409542|NCT01227967|155686389|FG000|Overall Study|Death|0|||
48409543|NCT01227967|155686390|FG001|Overall Study|Death|1|||
48409544|NCT01227967|155686389|FG000|Overall Study|Lost to Follow-up|8|||
48409545|NCT01227967|155686390|FG001|Overall Study|Lost to Follow-up|3|||
48409546|NCT01227967|155686389|FG000|Overall Study|Withdrawal by Subject|4|||
48409547|NCT01227967|155686390|FG001|Overall Study|Withdrawal by Subject|3|||
48409548|NCT01227967|155686389|FG000|Overall Study|Physician Decision|0|||
48409549|NCT01227967|155686390|FG001|Overall Study|Physician Decision|1|||
48409550|NCT01227967|155686389|FG000|Overall Study|Never Started Treatment|0|||
48409551|NCT01227967|155686390|FG001|Overall Study|Never Started Treatment|4|||
48409552|NCT01227967|155686389|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
48409553|NCT01227967|155686390|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
48409554|NCT00480857|155686391|FG000|Overall Study|Lack of Efficacy|2|||
48409555|NCT02149810|155686392|FG000|Overall Study|Physician Decision|1|||
48409556|NCT02149810|155686393|FG001|Overall Study|Physician Decision|2|||
48409557|NCT02149810|155686392|FG000|Overall Study|Lost to Follow-up|2|||
48409558|NCT02149810|155686393|FG001|Overall Study|Lost to Follow-up|1|||
48409559|NCT02149810|155686392|FG000|Overall Study|Withdrawal by Subject|5|||
48409560|NCT02149810|155686393|FG001|Overall Study|Withdrawal by Subject|1|||
48409561|NCT01959165|155686395|FG000|Overall Study|Adverse Event|0|||
48409562|NCT01959165|155686396|FG001|Overall Study|Adverse Event|0|||
48409563|NCT01959165|155686397|FG002|Overall Study|Adverse Event|0|||
48409564|NCT01959165|155686398|FG003|Overall Study|Adverse Event|1|||
48409565|NCT01959165|155686395|FG000|Overall Study|Lack of Efficacy|1|||
48409566|NCT01959165|155686396|FG001|Overall Study|Lack of Efficacy|0|||
48409567|NCT01959165|155686397|FG002|Overall Study|Lack of Efficacy|0|||
48409568|NCT01959165|155686398|FG003|Overall Study|Lack of Efficacy|0|||
48409569|NCT01959165|155686395|FG000|Overall Study|overdose|0|||
48409570|NCT01959165|155686396|FG001|Overall Study|overdose|0|||
48409571|NCT01959165|155686397|FG002|Overall Study|overdose|0|||
48409572|NCT01959165|155686398|FG003|Overall Study|overdose|1|||
48409573|NCT01959165|155686395|FG000|Overall Study|Welfare recipient|0|||
48409574|NCT01959165|155686396|FG001|Overall Study|Welfare recipient|1|||
48409575|NCT01959165|155686397|FG002|Overall Study|Welfare recipient|0|||
48409576|NCT01959165|155686398|FG003|Overall Study|Welfare recipient|0|||
48409577|NCT03686969|155686399|FG000|Overall Study|Study terminated|1|||
48409578|NCT03686969|155686400|FG001|Overall Study|Study terminated|0|||
48409579|NCT00772447|155686401|FG000|Overall Study|Withdrawal by Subject|9|||
48409580|NCT00772447|155686402|FG001|Overall Study|Withdrawal by Subject|5|||
48409581|NCT00772447|155686401|FG000|Overall Study|Physician Decision|4|||
48409582|NCT00772447|155686402|FG001|Overall Study|Physician Decision|8|||
48409583|NCT00772447|155686401|FG000|Overall Study|Lost to Follow-up|2|||
48409584|NCT00772447|155686402|FG001|Overall Study|Lost to Follow-up|4|||
48409585|NCT00772447|155686401|FG000|Overall Study|incorrect enrolment|3|||
48409586|NCT00772447|155686402|FG001|Overall Study|incorrect enrolment|4|||
48409587|NCT00772447|155686401|FG000|Overall Study|Protocol Violation|0|||
48409588|NCT00772447|155686402|FG001|Overall Study|Protocol Violation|1|||
48409589|NCT00772447|155686401|FG000|Overall Study|all others|2|||
48409590|NCT00772447|155686402|FG001|Overall Study|all others|2|||
48409591|NCT00927563|155686417|FG000|Overall Study|Lost to Follow-up|1|||
48409592|NCT00927563|155686417|FG000|Overall Study|Withdrawal by Subject|1|||
48409593|NCT01957137|155686418|FG000|Randomized Portion|Adverse Event|1|||
48409594|NCT01957137|155686418|FG000|Randomized Portion|Withdrawal by Subject|1|||
48409595|NCT02949830|155686421|FG000|Overall Study|Adverse Event|1|||
48409596|NCT02949830|155686421|FG000|Overall Study|Withdrawal by Subject|1|||
48409597|NCT01468987|155686422|FG000|Overall Study|Adverse Event|12|||
48409598|NCT01468987|155686423|FG001|Overall Study|Adverse Event|9|||
48409599|NCT01468987|155686422|FG000|Overall Study|Death|4|||
48409600|NCT01468987|155686423|FG001|Overall Study|Death|1|||
48409601|NCT01468987|155686422|FG000|Overall Study|Lost to Follow-up|10|||
48409602|NCT01468987|155686423|FG001|Overall Study|Lost to Follow-up|5|||
48357824|NCT00132678|155506232|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
48357825|NCT00132678|155506230|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
48357826|NCT00132678|155506231|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
48357827|NCT00132678|155506232|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
48357828|NCT00132678|155506230|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
48357829|NCT00132678|155506231|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
48357830|NCT00132678|155506232|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
48357831|NCT00132678|155506230|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
48357832|NCT00132678|155506231|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
48357833|NCT00132678|155506232|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
48357834|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Death|2|||
48409603|NCT01468987|155686422|FG000|Overall Study|Protocol Violation|8|||
48409604|NCT01468987|155686423|FG001|Overall Study|Protocol Violation|2|||
48409605|NCT01468987|155686422|FG000|Overall Study|Withdrawal by Subject|28|||
48409606|NCT01468987|155686423|FG001|Overall Study|Withdrawal by Subject|28|||
48409607|NCT01468987|155686422|FG000|Overall Study|Physician Decision|8|||
48409608|NCT01468987|155686423|FG001|Overall Study|Physician Decision|15|||
48409609|NCT01468987|155686422|FG000|Overall Study|Sponsor Decision|1|||
48409610|NCT01468987|155686423|FG001|Overall Study|Sponsor Decision|0|||
48409611|NCT00700804|155686424|FG000|Overall Study|Withdrawal by Subject|1|||
48409612|NCT00700804|155686425|FG001|Overall Study|Withdrawal by Subject|2|||
48409613|NCT00700804|155686424|FG000|Overall Study|Protocol Violation|1|||
48409614|NCT00700804|155686425|FG001|Overall Study|Protocol Violation|1|||
48409615|NCT00700804|155686424|FG000|Overall Study|Loose Stools|1|||
48409616|NCT00700804|155686425|FG001|Overall Study|Loose Stools|1|||
48409617|NCT02764541|155686426|FG000|Overall Study|Withdrawal by Subject|0|||
48409618|NCT02764541|155686427|FG001|Overall Study|Withdrawal by Subject|0|||
48409619|NCT02764541|155686428|FG002|Overall Study|Withdrawal by Subject|0|||
48409620|NCT02764541|155686429|FG003|Overall Study|Withdrawal by Subject|0|||
48409621|NCT02764541|155686430|FG004|Overall Study|Withdrawal by Subject|1|||
48409622|NCT02764541|155686431|FG005|Overall Study|Withdrawal by Subject|1|||
48409623|NCT02764541|155686432|FG006|Overall Study|Withdrawal by Subject|0|||
48409624|NCT02764541|155686433|FG007|Overall Study|Withdrawal by Subject|1|||
48409625|NCT02764541|155686426|FG000|Overall Study|Adverse Event|1|||
48409626|NCT02764541|155686427|FG001|Overall Study|Adverse Event|0|||
48409627|NCT02764541|155686428|FG002|Overall Study|Adverse Event|0|||
48409628|NCT02764541|155686429|FG003|Overall Study|Adverse Event|0|||
48409629|NCT02764541|155686430|FG004|Overall Study|Adverse Event|0|||
48409630|NCT02764541|155686431|FG005|Overall Study|Adverse Event|0|||
48409631|NCT02764541|155686432|FG006|Overall Study|Adverse Event|1|||
48409632|NCT02764541|155686433|FG007|Overall Study|Adverse Event|0|||
48409633|NCT02764541|155686426|FG000|Overall Study|Metastasis|1|||
48409634|NCT02764541|155686427|FG001|Overall Study|Metastasis|0|||
48409635|NCT02764541|155686428|FG002|Overall Study|Metastasis|0|||
48409636|NCT02764541|155686429|FG003|Overall Study|Metastasis|0|||
48409637|NCT02764541|155686430|FG004|Overall Study|Metastasis|0|||
48409638|NCT02764541|155686431|FG005|Overall Study|Metastasis|0|||
48409639|NCT02764541|155686432|FG006|Overall Study|Metastasis|0|||
48409640|NCT02764541|155686433|FG007|Overall Study|Metastasis|0|||
48409641|NCT02764541|155686426|FG000|Overall Study|Disease progression|1|||
48409642|NCT02764541|155686427|FG001|Overall Study|Disease progression|1|||
48409643|NCT02764541|155686428|FG002|Overall Study|Disease progression|0|||
48409644|NCT02764541|155686429|FG003|Overall Study|Disease progression|0|||
48409645|NCT02764541|155686430|FG004|Overall Study|Disease progression|0|||
48409646|NCT02764541|155686431|FG005|Overall Study|Disease progression|0|||
48409647|NCT02764541|155686432|FG006|Overall Study|Disease progression|0|||
48409648|NCT02764541|155686433|FG007|Overall Study|Disease progression|1|||
48409649|NCT02764541|155686426|FG000|Overall Study|Protocol Violation|0|||
48409650|NCT02764541|155686427|FG001|Overall Study|Protocol Violation|0|||
48409651|NCT02764541|155686428|FG002|Overall Study|Protocol Violation|0|||
48409652|NCT02764541|155686429|FG003|Overall Study|Protocol Violation|1|||
48409653|NCT02764541|155686430|FG004|Overall Study|Protocol Violation|0|||
48409654|NCT02764541|155686431|FG005|Overall Study|Protocol Violation|1|||
48409655|NCT02764541|155686432|FG006|Overall Study|Protocol Violation|0|||
48409656|NCT02764541|155686433|FG007|Overall Study|Protocol Violation|0|||
48409657|NCT02764541|155686426|FG000|Overall Study|Physician Decision|0|||
48409658|NCT02764541|155686427|FG001|Overall Study|Physician Decision|0|||
48409659|NCT02764541|155686428|FG002|Overall Study|Physician Decision|0|||
48409660|NCT02764541|155686429|FG003|Overall Study|Physician Decision|1|||
48409661|NCT02764541|155686430|FG004|Overall Study|Physician Decision|0|||
48409662|NCT02764541|155686431|FG005|Overall Study|Physician Decision|0|||
48409663|NCT02764541|155686432|FG006|Overall Study|Physician Decision|0|||
48409664|NCT02764541|155686433|FG007|Overall Study|Physician Decision|1|||
48409665|NCT02764541|155686426|FG000|Overall Study|Three Cycles completed before surgery|0|||
48409666|NCT02764541|155686427|FG001|Overall Study|Three Cycles completed before surgery|0|||
48409667|NCT02764541|155686428|FG002|Overall Study|Three Cycles completed before surgery|0|||
48409668|NCT02764541|155686429|FG003|Overall Study|Three Cycles completed before surgery|1|||
48409669|NCT02764541|155686430|FG004|Overall Study|Three Cycles completed before surgery|0|||
48409670|NCT02764541|155686431|FG005|Overall Study|Three Cycles completed before surgery|0|||
48409671|NCT02764541|155686432|FG006|Overall Study|Three Cycles completed before surgery|0|||
48409672|NCT02764541|155686433|FG007|Overall Study|Three Cycles completed before surgery|0|||
48409673|NCT02764541|155686426|FG000|Overall Study|Patient Compliance|0|||
48409674|NCT02764541|155686427|FG001|Overall Study|Patient Compliance|0|||
48409675|NCT02764541|155686428|FG002|Overall Study|Patient Compliance|1|||
48409676|NCT02764541|155686429|FG003|Overall Study|Patient Compliance|0|||
48409677|NCT02764541|155686430|FG004|Overall Study|Patient Compliance|0|||
48409678|NCT02764541|155686431|FG005|Overall Study|Patient Compliance|0|||
48409679|NCT02764541|155686432|FG006|Overall Study|Patient Compliance|0|||
48409680|NCT02764541|155686433|FG007|Overall Study|Patient Compliance|0|||
48409681|NCT02764541|155686426|FG000|Overall Study|Death|0|||
48409682|NCT02764541|155686427|FG001|Overall Study|Death|0|||
48409683|NCT02764541|155686428|FG002|Overall Study|Death|0|||
48409684|NCT02764541|155686429|FG003|Overall Study|Death|0|||
48409685|NCT02764541|155686430|FG004|Overall Study|Death|0|||
48409686|NCT02764541|155686431|FG005|Overall Study|Death|0|||
48409687|NCT02764541|155686432|FG006|Overall Study|Death|1|||
48409688|NCT02764541|155686433|FG007|Overall Study|Death|0|||
48409689|NCT02764541|155686426|FG000|Overall Study|Insurance reasons|0|||
48409690|NCT02764541|155686427|FG001|Overall Study|Insurance reasons|0|||
48409691|NCT02764541|155686428|FG002|Overall Study|Insurance reasons|0|||
48409692|NCT02764541|155686429|FG003|Overall Study|Insurance reasons|0|||
48409693|NCT02764541|155686430|FG004|Overall Study|Insurance reasons|0|||
48409694|NCT02764541|155686431|FG005|Overall Study|Insurance reasons|0|||
48409695|NCT02764541|155686432|FG006|Overall Study|Insurance reasons|1|||
48409696|NCT02764541|155686433|FG007|Overall Study|Insurance reasons|0|||
48409697|NCT00768898|155688339|FG000|Overall Study|Unrelated injury|1|||
48409698|NCT00768898|155688339|FG000|Overall Study|Headache|1|||
48409699|NCT00667576|155688341|FG000|Overall Study|Withdrawal by Subject|1|||
48409700|NCT00667576|155688342|FG001|Overall Study|Withdrawal by Subject|0|||
48409701|NCT00667576|155688343|FG002|Overall Study|Withdrawal by Subject|1|||
48409702|NCT00667576|155688344|FG003|Overall Study|Withdrawal by Subject|1|||
48409703|NCT00667576|155688345|FG004|Overall Study|Withdrawal by Subject|1|||
48409704|NCT00667576|155688341|FG000|Overall Study|Adverse Event|1|||
48409705|NCT00667576|155688342|FG001|Overall Study|Adverse Event|1|||
48409706|NCT00667576|155688343|FG002|Overall Study|Adverse Event|0|||
48409707|NCT00667576|155688344|FG003|Overall Study|Adverse Event|0|||
48409708|NCT00667576|155688345|FG004|Overall Study|Adverse Event|0|||
48409709|NCT00667576|155688341|FG000|Overall Study|Lost to Follow-up|0|||
48409710|NCT00667576|155688342|FG001|Overall Study|Lost to Follow-up|0|||
48409711|NCT00667576|155688343|FG002|Overall Study|Lost to Follow-up|1|||
48409712|NCT00667576|155688344|FG003|Overall Study|Lost to Follow-up|0|||
48409713|NCT00667576|155688345|FG004|Overall Study|Lost to Follow-up|0|||
48409714|NCT00667576|155688341|FG000|Overall Study|Protocol Violation|0|||
48409715|NCT00667576|155688342|FG001|Overall Study|Protocol Violation|0|||
48409716|NCT00667576|155688343|FG002|Overall Study|Protocol Violation|0|||
48409717|NCT00667576|155688344|FG003|Overall Study|Protocol Violation|1|||
48409718|NCT00667576|155688345|FG004|Overall Study|Protocol Violation|0|||
48409719|NCT00667576|155688341|FG000|Overall Study|Physician Decision|0|||
48409720|NCT00667576|155688342|FG001|Overall Study|Physician Decision|0|||
48409721|NCT00667576|155688343|FG002|Overall Study|Physician Decision|0|||
48409722|NCT00667576|155688344|FG003|Overall Study|Physician Decision|1|||
48409723|NCT00667576|155688345|FG004|Overall Study|Physician Decision|0|||
48409724|NCT00667576|155688341|FG000|Overall Study|Missed Visit|0|||
48409725|NCT00667576|155688342|FG001|Overall Study|Missed Visit|0|||
48409726|NCT00667576|155688343|FG002|Overall Study|Missed Visit|0|||
48409727|NCT00667576|155688344|FG003|Overall Study|Missed Visit|1|||
48409728|NCT00667576|155688345|FG004|Overall Study|Missed Visit|0|||
48409729|NCT00483327|155688348|FG000|Overall Study|Adverse Event|1|||
48409730|NCT00483327|155688348|FG000|Overall Study|Withdrawal by Subject|3|||
48409731|NCT00483327|155688348|FG000|Overall Study|Lost to Follow-up|4|||
48409732|NCT00483327|155688348|FG000|Overall Study|Patient Non Compliance|2|||
48409733|NCT00670007|155688349|FG000|Overall Study|Drug abuse|1|||
48409734|NCT00670007|155688349|FG000|Overall Study|Lung transplant|1|||
48409735|NCT00670007|155688349|FG000|Overall Study|Travel/Vacation|1|||
48409736|NCT00670007|155688349|FG000|Overall Study|Adverse event, serious fatal|1|||
48409737|NCT00670007|155688349|FG000|Overall Study|Adverse Event|1|||
48409738|NCT00670007|155688349|FG000|Overall Study|Withdrawal by Subject|4|||
48409739|NCT01171820|155688350|FG000|Overall Study|Death|3|||
48409740|NCT01171820|155688351|FG001|Overall Study|Death|3|||
48409741|NCT01171820|155688350|FG000|Overall Study|Lost to Follow-up|0|||
48409742|NCT01171820|155688351|FG001|Overall Study|Lost to Follow-up|1|||
48409743|NCT01171820|155688350|FG000|Overall Study|Withdrawal by Subject|2|||
48409744|NCT01171820|155688351|FG001|Overall Study|Withdrawal by Subject|0|||
48409745|NCT01171820|155688350|FG000|Overall Study|Physician Decision|0|||
48409746|NCT01171820|155688351|FG001|Overall Study|Physician Decision|1|||
48409747|NCT01171820|155688350|FG000|Overall Study|1-Year Missed Visit|1|||
48409748|NCT01171820|155688351|FG001|Overall Study|1-Year Missed Visit|1|||
48409749|NCT00984204|155688352|FG000|Overall Study|Death|1|||
48409750|NCT00984204|155688352|FG000|Overall Study|Lost to Follow-up|4|||
48409751|NCT00984204|155688352|FG000|Overall Study|Lack of Efficacy|10|||
48409752|NCT00947531|155688353|FG000|Overall Study|Withdrawal by Subject|10|||
48409753|NCT00947531|155688354|FG001|Overall Study|Withdrawal by Subject|7|||
48409754|NCT00947531|155688353|FG000|Overall Study|Administrative Reason|0|||
48409755|NCT00947531|155688354|FG001|Overall Study|Administrative Reason|1|||
48409756|NCT00947531|155688353|FG000|Overall Study|Adverse Event|2|||
48409757|NCT00947531|155688354|FG001|Overall Study|Adverse Event|2|||
48409758|NCT00947531|155688353|FG000|Overall Study|Lack of Efficacy|1|||
48409759|NCT00947531|155688354|FG001|Overall Study|Lack of Efficacy|0|||
48409760|NCT00947531|155688353|FG000|Overall Study|Other|1|||
48409761|NCT00947531|155688354|FG001|Overall Study|Other|1|||
48409762|NCT02327260|155688355|FG000|Overall Study|Lost to Follow-up|2|||
48409763|NCT02327260|155688356|FG001|Overall Study|Lost to Follow-up|3|||
48409764|NCT02327260|155688357|FG002|Overall Study|Lost to Follow-up|2|||
48409765|NCT02327260|155688355|FG000|Overall Study|invalid phone number|1|||
48409766|NCT02327260|155688356|FG001|Overall Study|invalid phone number|1|||
48409767|NCT02327260|155688357|FG002|Overall Study|invalid phone number|0|||
48409768|NCT02327260|155688355|FG000|Overall Study|non-adherence to protocol|2|||
48409769|NCT02327260|155688356|FG001|Overall Study|non-adherence to protocol|0|||
48409770|NCT02327260|155688357|FG002|Overall Study|non-adherence to protocol|0|||
48409771|NCT02327260|155688355|FG000|Overall Study|cognitive concerns|1|||
48409772|NCT02327260|155688356|FG001|Overall Study|cognitive concerns|0|||
48409773|NCT02327260|155688357|FG002|Overall Study|cognitive concerns|0|||
48409774|NCT00688909|155688358|FG000|Overall Study|Adverse Event|28|||
48409775|NCT00688909|155688358|FG000|Overall Study|Patient withdrew consent|2|||
48409776|NCT00688909|155688358|FG000|Overall Study|Administrative problems|1|||
48409777|NCT00688909|155688358|FG000|Overall Study|Protocol Violation|2|||
48409778|NCT01268293|155688359|FG000|Overall Study|Disease progression|7|||
48409779|NCT01268293|155688359|FG000|Overall Study|Adverse Event|1|||
48409780|NCT01268293|155688359|FG000|Overall Study|Subject choice|1|||
48409781|NCT00716976|155688360|FG000|Overall Study|Adverse Event|2|||
48409782|NCT00716976|155688361|FG001|Overall Study|Adverse Event|0|||
48409783|NCT00716976|155688360|FG000|Overall Study|Death|1|||
48409784|NCT00716976|155688361|FG001|Overall Study|Death|0|||
48409785|NCT00716976|155688360|FG000|Overall Study|Physician Decision|2|||
48409786|NCT00716976|155688361|FG001|Overall Study|Physician Decision|2|||
48409787|NCT00716976|155688360|FG000|Overall Study|Withdrawal by Subject|5|||
48409788|NCT00716976|155688361|FG001|Overall Study|Withdrawal by Subject|1|||
48409789|NCT00716976|155688360|FG000|Overall Study|Premature discontinuation cisplatin|5|||
48409790|NCT00716976|155688361|FG001|Overall Study|Premature discontinuation cisplatin|4|||
48409791|NCT00716976|155688360|FG000|Overall Study|Radiation during protocol|1|||
48409792|NCT00716976|155688361|FG001|Overall Study|Radiation during protocol|0|||
48409793|NCT00716976|155688360|FG000|Overall Study|Ineligibles|4|||
48409794|NCT00716976|155688361|FG001|Overall Study|Ineligibles|2|||
48409795|NCT02804763|155688362|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
48409796|NCT02804763|155688363|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
48409797|NCT02804763|155688364|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
48409798|NCT02804763|155688365|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
48409799|NCT02804763|155688362|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
48409800|NCT02804763|155688363|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
48409801|NCT02804763|155688364|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
48409802|NCT02804763|155688365|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
48409803|NCT02804763|155688362|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
48409804|NCT02804763|155688363|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
48409805|NCT02804763|155688364|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
48409806|NCT02804763|155688365|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
48409807|NCT02804763|155688362|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
48409808|NCT02804763|155688363|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
48409809|NCT02804763|155688364|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
48409810|NCT02804763|155688365|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
48409811|NCT02804763|155688362|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
48409812|NCT02804763|155688363|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
48409813|NCT02804763|155688364|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
48409814|NCT02804763|155688365|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
48409815|NCT02804763|155688362|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
48409816|NCT02804763|155688363|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
48409817|NCT02804763|155688364|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
48409818|NCT02804763|155688365|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
48409819|NCT01445535|155688376|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
48409820|NCT01445535|155688377|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
48409821|NCT01445535|155688378|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
48409822|NCT01445535|155688379|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
48409823|NCT01445535|155688376|FG000|Overall Study|Disease progression|1|||
48409824|NCT01445535|155688377|FG001|Overall Study|Disease progression|0|||
48409825|NCT01445535|155688378|FG002|Overall Study|Disease progression|1|||
48409826|NCT01445535|155688379|FG003|Overall Study|Disease progression|0|||
48409827|NCT01445535|155688376|FG000|Overall Study|PI discretion|0|||
48409828|NCT01445535|155688377|FG001|Overall Study|PI discretion|0|||
48409829|NCT01445535|155688378|FG002|Overall Study|PI discretion|0|||
48409830|NCT01445535|155688379|FG003|Overall Study|PI discretion|1|||
48409831|NCT00600171|155688380|FG000|Overall Study|Adverse Event|0|||
48409832|NCT00600171|155688381|FG001|Overall Study|Adverse Event|1|||
48409833|NCT00600171|155688382|FG002|Overall Study|Adverse Event|0|||
48409834|NCT00600171|155688383|FG003|Overall Study|Adverse Event|0|||
48409835|NCT00600171|155688384|FG004|Overall Study|Adverse Event|1|||
48409836|NCT00600171|155688385|FG005|Overall Study|Adverse Event|0|||
48409837|NCT00600171|155688380|FG000|Overall Study|Lack of Efficacy|9|||
48409838|NCT00600171|155688381|FG001|Overall Study|Lack of Efficacy|12|||
48409839|NCT00600171|155688382|FG002|Overall Study|Lack of Efficacy|3|||
48409840|NCT00600171|155688383|FG003|Overall Study|Lack of Efficacy|5|||
48409841|NCT00600171|155688384|FG004|Overall Study|Lack of Efficacy|4|||
48409842|NCT00600171|155688385|FG005|Overall Study|Lack of Efficacy|0|||
48409843|NCT00600171|155688380|FG000|Overall Study|Protocol Violation|1|||
48409844|NCT00600171|155688381|FG001|Overall Study|Protocol Violation|2|||
48409845|NCT00600171|155688382|FG002|Overall Study|Protocol Violation|0|||
48409846|NCT00600171|155688383|FG003|Overall Study|Protocol Violation|1|||
48409847|NCT00600171|155688384|FG004|Overall Study|Protocol Violation|0|||
48409848|NCT00600171|155688385|FG005|Overall Study|Protocol Violation|0|||
48409849|NCT00600171|155688380|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
48409850|NCT00600171|155688381|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48409851|NCT00600171|155688382|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
48409852|NCT00600171|155688383|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
48409853|NCT00600171|155688384|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
48409854|NCT00600171|155688385|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
48409855|NCT00600171|155688380|FG000|Overall Study|Withdrawal by Subject|3|||
48409856|NCT00600171|155688381|FG001|Overall Study|Withdrawal by Subject|0|||
48409857|NCT00600171|155688382|FG002|Overall Study|Withdrawal by Subject|0|||
48409858|NCT00600171|155688383|FG003|Overall Study|Withdrawal by Subject|1|||
48409859|NCT00600171|155688384|FG004|Overall Study|Withdrawal by Subject|1|||
48409860|NCT00600171|155688385|FG005|Overall Study|Withdrawal by Subject|1|||
48409861|NCT00600171|155688380|FG000|Overall Study|Physician Decision|0|||
48409862|NCT00600171|155688381|FG001|Overall Study|Physician Decision|1|||
48409863|NCT00600171|155688382|FG002|Overall Study|Physician Decision|0|||
48409864|NCT00600171|155688383|FG003|Overall Study|Physician Decision|1|||
48409865|NCT00600171|155688384|FG004|Overall Study|Physician Decision|0|||
48409866|NCT00600171|155688385|FG005|Overall Study|Physician Decision|2|||
48409867|NCT00600171|155688380|FG000|Overall Study|Lost to Follow-up|0|||
48409868|NCT00600171|155688381|FG001|Overall Study|Lost to Follow-up|0|||
48409869|NCT00600171|155688382|FG002|Overall Study|Lost to Follow-up|0|||
48409870|NCT00600171|155688383|FG003|Overall Study|Lost to Follow-up|1|||
48409871|NCT00600171|155688384|FG004|Overall Study|Lost to Follow-up|0|||
48409872|NCT00600171|155688385|FG005|Overall Study|Lost to Follow-up|0|||
48409873|NCT02720757|155688386|FG000|Overall Study|Other reason|5|||
48409874|NCT02720757|155688386|FG000|Overall Study|Loss of contact|4|||
48409875|NCT02720757|155688386|FG000|Overall Study|Informed consent withdrawal|1|||
48409876|NCT02720757|155688386|FG000|Overall Study|Patients wish to withdraw|2|||
48409877|NCT02720757|155688386|FG000|Overall Study|Missing|3|||
48409878|NCT02720757|155688386|FG000|Overall Study|General exclusion|3|||
48409879|NCT00454779|155688388|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
48409880|NCT00454779|155688389|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
48409881|NCT00454779|155688388|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
48409882|NCT00454779|155688389|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
48409883|NCT00454779|155688388|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
48409884|NCT00454779|155688389|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
48409885|NCT00454779|155688388|FG000|First-line Treatment Phase|Protocol Violation|0|||
48409886|NCT00454779|155688389|FG001|First-line Treatment Phase|Protocol Violation|1|||
48409887|NCT00454779|155688388|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
48431446|NCT00002663|155767271|FG007|Overall Study|Physician Decision|0|||
48409888|NCT00454779|155688389|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
48409889|NCT00454779|155688388|FG000|First-line Treatment Phase|Ongoing|1|||
48409890|NCT00454779|155688389|FG001|First-line Treatment Phase|Ongoing|0|||
48409891|NCT00454779|155688388|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
48409892|NCT00454779|155688389|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
48409893|NCT00454779|155688388|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
48409894|NCT00454779|155688389|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
48409895|NCT00454779|155688388|FG000|Second-line Treatment Phase|Ongoing|0|||
48409896|NCT00454779|155688389|FG001|Second-line Treatment Phase|Ongoing|1|||
48409897|NCT02908100|155688390|FG000|Overall Study|Adverse Event|7|||
48409898|NCT02908100|155688391|FG001|Overall Study|Adverse Event|6|||
48409899|NCT02908100|155688392|FG002|Overall Study|Adverse Event|9|||
48409900|NCT02908100|155688390|FG000|Overall Study|Death|2|||
48409901|NCT02908100|155688391|FG001|Overall Study|Death|0|||
48409902|NCT02908100|155688392|FG002|Overall Study|Death|0|||
48409903|NCT02908100|155688390|FG000|Overall Study|Lack of Efficacy|2|||
48409904|NCT02908100|155688391|FG001|Overall Study|Lack of Efficacy|3|||
48409905|NCT02908100|155688392|FG002|Overall Study|Lack of Efficacy|3|||
48409906|NCT02908100|155688390|FG000|Overall Study|Lost to Follow-up|0|||
48409907|NCT02908100|155688391|FG001|Overall Study|Lost to Follow-up|1|||
48409908|NCT02908100|155688392|FG002|Overall Study|Lost to Follow-up|2|||
48409909|NCT02908100|155688390|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48409910|NCT02908100|155688391|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48409911|NCT02908100|155688392|FG002|Overall Study|Non-Compliance With Study Drug|2|||
48409912|NCT02908100|155688390|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
48409913|NCT02908100|155688391|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
48409914|NCT02908100|155688392|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
48409915|NCT02908100|155688390|FG000|Overall Study|Physician Decision|0|||
48409916|NCT02908100|155688391|FG001|Overall Study|Physician Decision|1|||
48409917|NCT02908100|155688392|FG002|Overall Study|Physician Decision|0|||
48409918|NCT02908100|155688390|FG000|Overall Study|Pregnancy|1|||
48409919|NCT02908100|155688391|FG001|Overall Study|Pregnancy|2|||
48409920|NCT02908100|155688392|FG002|Overall Study|Pregnancy|0|||
48409921|NCT02908100|155688390|FG000|Overall Study|Withdrawal by Subject|8|||
48409922|NCT02908100|155688391|FG001|Overall Study|Withdrawal by Subject|7|||
48409923|NCT02908100|155688392|FG002|Overall Study|Withdrawal by Subject|5|||
48409924|NCT02908100|155688390|FG000|Overall Study|Randomised in Error|1|||
48409925|NCT02908100|155688391|FG001|Overall Study|Randomised in Error|0|||
48409926|NCT02908100|155688392|FG002|Overall Study|Randomised in Error|0|||
48409927|NCT04684420|155688393|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48409928|NCT04684420|155688394|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
48409929|NCT04684420|155688395|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
48409930|NCT04684420|155688396|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
48409931|NCT04684420|155688393|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
48409932|NCT04684420|155688394|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
48409933|NCT04684420|155688395|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
48409934|NCT04684420|155688396|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
48409935|NCT04303000|155688397|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
48409936|NCT04303000|155688398|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
48409937|NCT04303000|155688399|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
48409938|NCT00888355|155688402|FG000|Overall Study|Adverse Event|10|||
48409939|NCT00888355|155688403|FG001|Overall Study|Adverse Event|0|||
48409940|NCT00888355|155688404|FG002|Overall Study|Adverse Event|3|||
48409941|NCT00888355|155688405|FG003|Overall Study|Adverse Event|3|||
48409942|NCT00888355|155688402|FG000|Overall Study|Lack of Efficacy|9|||
48409943|NCT00888355|155688403|FG001|Overall Study|Lack of Efficacy|2|||
48409944|NCT00888355|155688404|FG002|Overall Study|Lack of Efficacy|5|||
48409945|NCT00888355|155688405|FG003|Overall Study|Lack of Efficacy|2|||
48409946|NCT00888355|155688402|FG000|Overall Study|Lost to Follow-up|0|||
48409947|NCT00888355|155688403|FG001|Overall Study|Lost to Follow-up|2|||
48409948|NCT00888355|155688404|FG002|Overall Study|Lost to Follow-up|2|||
48409949|NCT00888355|155688405|FG003|Overall Study|Lost to Follow-up|0|||
48409950|NCT00888355|155688402|FG000|Overall Study|Protocol Violation|3|||
48409951|NCT00888355|155688403|FG001|Overall Study|Protocol Violation|2|||
48409952|NCT00888355|155688404|FG002|Overall Study|Protocol Violation|1|||
48409953|NCT00888355|155688405|FG003|Overall Study|Protocol Violation|2|||
48409954|NCT00888355|155688402|FG000|Overall Study|Withdrawal by Subject|0|||
48409955|NCT00888355|155688403|FG001|Overall Study|Withdrawal by Subject|3|||
48409956|NCT00888355|155688404|FG002|Overall Study|Withdrawal by Subject|1|||
48409957|NCT00888355|155688405|FG003|Overall Study|Withdrawal by Subject|3|||
48409958|NCT00331006|155688406|FG000|Screening Phase|Withdrawal by Subject|1|||
48409959|NCT00331006|155688406|FG000|Screening Phase|enrollment halted|1|||
48409960|NCT00331006|155688406|FG000|Screening Phase|Lost to Follow-up|1|||
48409961|NCT00331006|155688406|FG000|Screening Phase|Ineligible for treatment phase|4|||
48409962|NCT00331006|155688406|FG000|Treatment Phase|Withdrawal by Subject|1|||
48409963|NCT00331006|155688406|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
48409964|NCT00331006|155688406|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
48409965|NCT03603652|155688407|FG000|Overall Study|Death|2|||
48409966|NCT01879410|155688415|FG000|Overall Study|Adverse Event|9|||
48409967|NCT01879410|155688416|FG001|Overall Study|Adverse Event|14|||
48409968|NCT01879410|155688415|FG000|Overall Study|Lack of Efficacy|4|||
48409969|NCT01879410|155688416|FG001|Overall Study|Lack of Efficacy|6|||
48409970|NCT01879410|155688415|FG000|Overall Study|Protocol Violation|1|||
48409971|NCT01879410|155688416|FG001|Overall Study|Protocol Violation|7|||
48409972|NCT01879410|155688415|FG000|Overall Study|Lost to Follow-up|2|||
48409973|NCT01879410|155688416|FG001|Overall Study|Lost to Follow-up|1|||
48409974|NCT01879410|155688415|FG000|Overall Study|Withdrawal by Subject|7|||
48409975|NCT01879410|155688416|FG001|Overall Study|Withdrawal by Subject|8|||
48409976|NCT01879410|155688415|FG000|Overall Study|Randomised in Error|1|||
48409977|NCT01879410|155688416|FG001|Overall Study|Randomised in Error|2|||
48409978|NCT01824979|155688418|FG000|Overall Study|Withdrawal by Subject|5|||
48409979|NCT01824979|155688419|FG001|Overall Study|Withdrawal by Subject|0|||
48409980|NCT01824979|155688418|FG000|Overall Study|Physician Decision|2|||
48409981|NCT01824979|155688419|FG001|Overall Study|Physician Decision|0|||
48409982|NCT01824979|155688418|FG000|Overall Study|Protocol Violation|6|||
48409983|NCT01824979|155688419|FG001|Overall Study|Protocol Violation|13|||
48409984|NCT00802360|155688428|FG000|Overall Study|Stimulation failure|4|||
48409985|NCT00802360|155688429|FG001|Overall Study|Stimulation failure|0|||
48409986|NCT00802360|155688430|FG002|Overall Study|Stimulation failure|3|||
48409987|NCT00802360|155688431|FG003|Overall Study|Stimulation failure|3|||
48409988|NCT00802360|155688428|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
48409989|NCT00802360|155688429|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
48409990|NCT00802360|155688430|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
48409991|NCT00802360|155688431|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
48409992|NCT00802360|155688428|FG000|Overall Study|Cycle cancelled|0|||
48409993|NCT00802360|155688429|FG001|Overall Study|Cycle cancelled|1|||
48409994|NCT00802360|155688430|FG002|Overall Study|Cycle cancelled|1|||
48409995|NCT00802360|155688431|FG003|Overall Study|Cycle cancelled|1|||
48409996|NCT00802360|155688428|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
48409997|NCT00802360|155688429|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
48409998|NCT00802360|155688430|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
48409999|NCT00802360|155688431|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
48410000|NCT00802360|155688428|FG000|Overall Study|No positive serum pregnancy|17|||
48410001|NCT00802360|155688429|FG001|Overall Study|No positive serum pregnancy|20|||
48431447|NCT00002663|155767272|FG008|Overall Study|Physician Decision|1|||
48357835|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Death|0|||
48357836|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Death|0|||
48357837|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
48357838|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
48357839|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
48357840|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
48357841|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
48357842|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
48357843|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
48357844|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
48357845|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
48357846|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
48357847|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
48357848|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
48357849|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
48357850|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
48357851|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
48410002|NCT00802360|155688430|FG002|Overall Study|No positive serum pregnancy|14|||
48410003|NCT00802360|155688431|FG003|Overall Study|No positive serum pregnancy|10|||
48410004|NCT00802360|155688428|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
48410005|NCT00802360|155688429|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48410006|NCT00802360|155688430|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
48410007|NCT00802360|155688431|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
48410008|NCT00802360|155688428|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
48410009|NCT00802360|155688429|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
48410010|NCT00802360|155688430|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
48410011|NCT00802360|155688431|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
48410012|NCT00802360|155688428|FG000|Overall Study|Other|2|||
48410013|NCT00802360|155688429|FG001|Overall Study|Other|3|||
48410014|NCT00802360|155688430|FG002|Overall Study|Other|6|||
48410015|NCT00802360|155688431|FG003|Overall Study|Other|3|||
48410016|NCT01756456|155688432|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
48410017|NCT01756456|155688433|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
48410018|NCT01756456|155688434|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
48410019|NCT01756456|155688435|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
48410020|NCT01756456|155688436|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
48410021|NCT01756456|155688437|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
48410022|NCT01756456|155688432|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
48410023|NCT01756456|155688433|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
48410024|NCT01756456|155688434|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
48410025|NCT01756456|155688435|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
48410026|NCT01756456|155688436|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
48410027|NCT01756456|155688437|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
48410028|NCT01756456|155688432|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48410029|NCT01756456|155688433|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
48410030|NCT01756456|155688434|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48410031|NCT01756456|155688435|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48410032|NCT01756456|155688436|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48410033|NCT01756456|155688437|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
48410034|NCT01756456|155688432|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
48410035|NCT01756456|155688433|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
48410036|NCT01756456|155688434|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
48410037|NCT01756456|155688435|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
48410038|NCT01756456|155688436|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
48410039|NCT01756456|155688437|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
48410040|NCT01756456|155688432|FG000|Treatment Period: Phase I/II|Other causes|0|||
48410041|NCT01756456|155688433|FG001|Treatment Period: Phase I/II|Other causes|0|||
48410042|NCT01756456|155688434|FG002|Treatment Period: Phase I/II|Other causes|0|||
48410043|NCT01756456|155688435|FG003|Treatment Period: Phase I/II|Other causes|1|||
48410044|NCT01756456|155688436|FG004|Treatment Period: Phase I/II|Other causes|2|||
48410045|NCT01756456|155688437|FG005|Treatment Period: Phase I/II|Other causes|2|||
48410046|NCT01756456|155688432|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
48410047|NCT01756456|155688433|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
48410048|NCT01756456|155688434|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
48410049|NCT01756456|155688435|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
48410050|NCT01756456|155688436|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
48410051|NCT01756456|155688437|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
48410052|NCT01756456|155688432|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48410053|NCT01756456|155688433|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
48410054|NCT01756456|155688434|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48410055|NCT01756456|155688435|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48410056|NCT01756456|155688436|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48410057|NCT01756456|155688437|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
48410058|NCT01756456|155688432|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48410059|NCT01756456|155688433|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48410060|NCT01756456|155688434|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48410061|NCT01756456|155688435|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48410062|NCT01756456|155688436|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
48410063|NCT01756456|155688437|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
48410064|NCT01756456|155688432|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
48410065|NCT01756456|155688433|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
48410066|NCT01756456|155688434|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
48410067|NCT01756456|155688435|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
48410068|NCT01756456|155688436|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
48410069|NCT01756456|155688437|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
48410070|NCT01756456|155688432|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
48410071|NCT01756456|155688433|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
48410072|NCT01756456|155688434|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
48410073|NCT01756456|155688435|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
48410074|NCT01756456|155688436|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
48410075|NCT01756456|155688437|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
48410076|NCT01756456|155688432|FG000|Follow Up Period Phase I/II|Other causes|0|||
48410077|NCT01756456|155688433|FG001|Follow Up Period Phase I/II|Other causes|0|||
48410078|NCT01756456|155688434|FG002|Follow Up Period Phase I/II|Other causes|0|||
48410079|NCT01756456|155688435|FG003|Follow Up Period Phase I/II|Other causes|1|||
48410080|NCT01756456|155688436|FG004|Follow Up Period Phase I/II|Other causes|3|||
48410081|NCT01756456|155688437|FG005|Follow Up Period Phase I/II|Other causes|5|||
48410082|NCT02908516|155688438|FG000|Overall Study|Study Terminated|3|||
48410083|NCT02908516|155688439|FG001|Overall Study|Study Terminated|3|||
48410084|NCT01573910|155688442|FG000|Overall Study|Adverse Event|4|||
48357852|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
48357853|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
48357854|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
48357855|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
48357856|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
48357857|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
48357858|NCT00132678|155506230|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
48357859|NCT00132678|155506231|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
48357860|NCT00132678|155506232|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
48357861|NCT00132678|155506230|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
48357862|NCT00132678|155506231|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
48357863|NCT00132678|155506232|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
48357864|NCT00132678|155506230|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
48357865|NCT00132678|155506231|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
48357866|NCT00132678|155506232|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
48357867|NCT00132678|155506230|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
48357868|NCT00132678|155506231|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
48357869|NCT00132678|155506232|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
48357870|NCT00132678|155506230|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
48357871|NCT00132678|155506231|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
48357872|NCT00132678|155506232|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
48357873|NCT00132678|155506230|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
48357874|NCT00132678|155506231|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
48357875|NCT00132678|155506232|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
48357876|NCT00132678|155506230|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
48357877|NCT00132678|155506231|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
48357878|NCT00132678|155506232|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
48357879|NCT00132678|155506230|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
48357880|NCT00132678|155506231|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
48357881|NCT00132678|155506232|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
48357882|NCT03896581|155506235|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
48357883|NCT03896581|155506236|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
48357884|NCT03896581|155506235|FG000|Overall Study|Withdrawal by Subject|4|||
48357885|NCT03896581|155506236|FG001|Overall Study|Withdrawal by Subject|1|||
48357886|NCT03896581|155506235|FG000|Overall Study|Lost to Follow-up|1|||
48357887|NCT03896581|155506236|FG001|Overall Study|Lost to Follow-up|0|||
48357888|NCT03896581|155506235|FG000|Overall Study|Lack of Efficacy|2|||
48357889|NCT03896581|155506236|FG001|Overall Study|Lack of Efficacy|1|||
48357890|NCT03896581|155506235|FG000|Overall Study|Adverse event, non-fatal|0|||
48357891|NCT03896581|155506236|FG001|Overall Study|Adverse event, non-fatal|2|||
48357892|NCT02522728|155506237|FG000|Overall Study|Withdrawal by Subject|6|||
48357893|NCT02522728|155506238|FG001|Overall Study|Withdrawal by Subject|6|||
48357894|NCT02522728|155506237|FG000|Overall Study|Death|4|||
48357895|NCT02522728|155506238|FG001|Overall Study|Death|3|||
48357896|NCT02522728|155506237|FG000|Overall Study|Adverse Event|2|||
48357897|NCT02522728|155506238|FG001|Overall Study|Adverse Event|1|||
48357898|NCT02522728|155506237|FG000|Overall Study|Did not receive randomized study device|0|||
48357899|NCT02522728|155506238|FG001|Overall Study|Did not receive randomized study device|1|||
48357900|NCT03019640|155506239|FG000|Overall Study|Screen Failures|4|||
48357901|NCT03019640|155506239|FG000|Overall Study|Adverse Event|3|||
48357902|NCT03019640|155506239|FG000|Overall Study|Participant Relapsed|1|||
48357903|NCT02609672|155506240|FG000|Overall Study|Lost to Follow-up|3|||
48357904|NCT02609672|155506241|FG001|Overall Study|Lost to Follow-up|1|||
48357905|NCT01154140|155506242|FG000|Overall Study|Death|71|||
48357906|NCT01154140|155506243|FG001|Overall Study|Death|81|||
48357907|NCT01154140|155506242|FG000|Overall Study|Lost to Follow-up|4|||
48357908|NCT01154140|155506243|FG001|Overall Study|Lost to Follow-up|5|||
48357909|NCT01154140|155506242|FG000|Overall Study|Withdrawal by Subject|12|||
48357910|NCT01154140|155506243|FG001|Overall Study|Withdrawal by Subject|13|||
48357911|NCT01154140|155506242|FG000|Overall Study|Other|3|||
48357912|NCT01154140|155506243|FG001|Overall Study|Other|1|||
48357913|NCT01154140|155506242|FG000|Overall Study|Randomized but not treated|1|||
48357914|NCT01154140|155506243|FG001|Overall Study|Randomized but not treated|2|||
48357915|NCT01424813|155506244|FG000|Overall Study|Withdrawal by Subject|3|||
48357916|NCT01424813|155506245|FG001|Overall Study|Withdrawal by Subject|0|||
48357917|NCT01424813|155506244|FG000|Overall Study|Protocol Violation|1|||
48357918|NCT01424813|155506245|FG001|Overall Study|Protocol Violation|0|||
48357919|NCT01424813|155506244|FG000|Overall Study|Other|1|||
48357920|NCT01424813|155506245|FG001|Overall Study|Other|2|||
48357921|NCT01358331|155506246|FG000|Overall Study|Lost to Follow-up|0|||
48357922|NCT01358331|155506247|FG001|Overall Study|Lost to Follow-up|0|||
48357923|NCT01358331|155506248|FG002|Overall Study|Lost to Follow-up|0|||
48357924|NCT01358331|155506249|FG003|Overall Study|Lost to Follow-up|1|||
48410085|NCT01573910|155688443|FG001|Overall Study|Adverse Event|4|||
48410086|NCT01573910|155688442|FG000|Overall Study|Lost to Follow-up|2|||
48410087|NCT01573910|155688443|FG001|Overall Study|Lost to Follow-up|1|||
48410088|NCT01573910|155688442|FG000|Overall Study|Withdrawal by Subject|0|||
48410089|NCT01573910|155688443|FG001|Overall Study|Withdrawal by Subject|1|||
48410090|NCT01573910|155688442|FG000|Overall Study|Protocol Violation|3|||
48410091|NCT01573910|155688443|FG001|Overall Study|Protocol Violation|0|||
48410092|NCT01573910|155688442|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
48410093|NCT01573910|155688443|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
48410094|NCT00473876|155688444|FG000|Overall Study|Lost to Follow-up|3|||
48410095|NCT00473876|155688445|FG001|Overall Study|Lost to Follow-up|1|||
48410096|NCT00974220|155688449|FG000|Treatment Period 1|Adverse Event|2|||
48410097|NCT00974220|155688450|FG001|Treatment Period 1|Adverse Event|1|||
48410098|NCT00974220|155688449|FG000|Treatment Period 1|noncompliant subjects|0|||
48410099|NCT00974220|155688450|FG001|Treatment Period 1|noncompliant subjects|1|||
48410100|NCT00712348|155688456|FG000|Overall Study|Withdrawal by Subject|1|||
48410101|NCT02411747|155688457|FG000|Overall Study|Withdrawal by Subject|1|||
48410102|NCT02411747|155688458|FG001|Overall Study|Withdrawal by Subject|0|||
48410103|NCT02411747|155688457|FG000|Overall Study|Protocol Violation|2|||
48410104|NCT02411747|155688458|FG001|Overall Study|Protocol Violation|4|||
48410105|NCT02305563|155688464|FG000|Treatment Period|Disease progression|0|||
48410106|NCT02305563|155688465|FG001|Treatment Period|Disease progression|0|||
48410107|NCT02305563|155688466|FG002|Treatment Period|Disease progression|15|||
48410108|NCT02305563|155688467|FG003|Treatment Period|Disease progression|6|||
48410109|NCT02305563|155688468|FG004|Treatment Period|Disease progression|6|||
48410110|NCT02305563|155688464|FG000|Treatment Period|Study drug toxicity|0|||
48410111|NCT02305563|155688465|FG001|Treatment Period|Study drug toxicity|0|||
48410112|NCT02305563|155688466|FG002|Treatment Period|Study drug toxicity|0|||
48410113|NCT02305563|155688467|FG003|Treatment Period|Study drug toxicity|1|||
48410114|NCT02305563|155688468|FG004|Treatment Period|Study drug toxicity|2|||
48410115|NCT02305563|155688464|FG000|Treatment Period|Death|0|||
48410116|NCT02305563|155688465|FG001|Treatment Period|Death|0|||
48410117|NCT02305563|155688466|FG002|Treatment Period|Death|1|||
48410118|NCT02305563|155688467|FG003|Treatment Period|Death|2|||
48410119|NCT02305563|155688468|FG004|Treatment Period|Death|1|||
48410120|NCT02305563|155688464|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
48410121|NCT02305563|155688465|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
48410122|NCT02305563|155688466|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
48410123|NCT02305563|155688467|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
48410124|NCT02305563|155688468|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
48410125|NCT02305563|155688464|FG000|Treatment Period|Participant request to stop therapy|0|||
48410126|NCT02305563|155688465|FG001|Treatment Period|Participant request to stop therapy|2|||
48410127|NCT02305563|155688466|FG002|Treatment Period|Participant request to stop therapy|0|||
48410128|NCT02305563|155688467|FG003|Treatment Period|Participant request to stop therapy|1|||
48410129|NCT02305563|155688468|FG004|Treatment Period|Participant request to stop therapy|0|||
48410130|NCT02305563|155688464|FG000|Treatment Period|Participant withdrew consent|0|||
48410131|NCT02305563|155688465|FG001|Treatment Period|Participant withdrew consent|0|||
48410132|NCT02305563|155688466|FG002|Treatment Period|Participant withdrew consent|1|||
48410133|NCT02305563|155688467|FG003|Treatment Period|Participant withdrew consent|1|||
48410134|NCT02305563|155688468|FG004|Treatment Period|Participant withdrew consent|1|||
48410135|NCT02305563|155688464|FG000|Treatment Period|Maximum clinical benefit|0|||
48410136|NCT02305563|155688465|FG001|Treatment Period|Maximum clinical benefit|0|||
48410137|NCT02305563|155688466|FG002|Treatment Period|Maximum clinical benefit|0|||
48410138|NCT02305563|155688467|FG003|Treatment Period|Maximum clinical benefit|0|||
48410139|NCT02305563|155688468|FG004|Treatment Period|Maximum clinical benefit|1|||
48410140|NCT02305563|155688464|FG000|Treatment Period|Poor/non-compliance|0|||
48410141|NCT02305563|155688465|FG001|Treatment Period|Poor/non-compliance|0|||
48410142|NCT02305563|155688466|FG002|Treatment Period|Poor/non-compliance|0|||
48410143|NCT02305563|155688467|FG003|Treatment Period|Poor/non-compliance|0|||
48410144|NCT02305563|155688468|FG004|Treatment Period|Poor/non-compliance|1|||
48410145|NCT02305563|155688464|FG000|Treatment Period|Administrative reason by Sponsor|0|||
48410146|NCT02305563|155688465|FG001|Treatment Period|Administrative reason by Sponsor|0|||
48410147|NCT02305563|155688466|FG002|Treatment Period|Administrative reason by Sponsor|0|||
48410148|NCT02305563|155688467|FG003|Treatment Period|Administrative reason by Sponsor|0|||
48410149|NCT02305563|155688468|FG004|Treatment Period|Administrative reason by Sponsor|1|||
48410150|NCT02305563|155688464|FG000|Treatment Period|other reason|2|||
48410151|NCT02305563|155688465|FG001|Treatment Period|other reason|0|||
48410152|NCT02305563|155688466|FG002|Treatment Period|other reason|2|||
48410153|NCT02305563|155688467|FG003|Treatment Period|other reason|2|||
48410154|NCT02305563|155688468|FG004|Treatment Period|other reason|1|||
48410155|NCT02305563|155688464|FG000|Treatment Period|Randomized but not treated|0|||
48410156|NCT02305563|155688465|FG001|Treatment Period|Randomized but not treated|0|||
48410157|NCT02305563|155688466|FG002|Treatment Period|Randomized but not treated|0|||
48410158|NCT02305563|155688467|FG003|Treatment Period|Randomized but not treated|0|||
48410159|NCT02305563|155688468|FG004|Treatment Period|Randomized but not treated|2|||
48410160|NCT02305563|155688464|FG000|Treatment Period|added ULO, then disease progression|0|||
48410161|NCT02305563|155688465|FG001|Treatment Period|added ULO, then disease progression|0|||
48410162|NCT02305563|155688466|FG002|Treatment Period|added ULO, then disease progression|0|||
48410163|NCT02305563|155688467|FG003|Treatment Period|added ULO, then disease progression|0|||
48410164|NCT02305563|155688468|FG004|Treatment Period|added ULO, then disease progression|4|||
48410165|NCT02305563|155688464|FG000|Treatment Period|added ULO; then other reason|0|||
48410166|NCT02305563|155688465|FG001|Treatment Period|added ULO; then other reason|0|||
48410167|NCT02305563|155688466|FG002|Treatment Period|added ULO; then other reason|0|||
48410168|NCT02305563|155688467|FG003|Treatment Period|added ULO; then other reason|0|||
48410169|NCT02305563|155688468|FG004|Treatment Period|added ULO; then other reason|1|||
48410170|NCT02305563|155688464|FG000|Treatment Period|added ULO, then request to stop|0|||
48410171|NCT02305563|155688465|FG001|Treatment Period|added ULO, then request to stop|0|||
48410172|NCT02305563|155688466|FG002|Treatment Period|added ULO, then request to stop|0|||
48410173|NCT02305563|155688467|FG003|Treatment Period|added ULO, then request to stop|0|||
48410174|NCT02305563|155688468|FG004|Treatment Period|added ULO, then request to stop|1|||
48410175|NCT02305563|155688464|FG000|Follow-up Period|Death|0|||
48410176|NCT02305563|155688465|FG001|Follow-up Period|Death|0|||
48410177|NCT02305563|155688466|FG002|Follow-up Period|Death|5|||
48410178|NCT02305563|155688467|FG003|Follow-up Period|Death|4|||
48410179|NCT02305563|155688468|FG004|Follow-up Period|Death|7|||
48410180|NCT02305563|155688464|FG000|Follow-up Period|Participant withdrew consent|0|||
48410181|NCT02305563|155688465|FG001|Follow-up Period|Participant withdrew consent|0|||
48410182|NCT02305563|155688466|FG002|Follow-up Period|Participant withdrew consent|2|||
48410183|NCT02305563|155688467|FG003|Follow-up Period|Participant withdrew consent|1|||
48410184|NCT02305563|155688468|FG004|Follow-up Period|Participant withdrew consent|0|||
48410185|NCT02305563|155688464|FG000|Follow-up Period|other reason|0|||
48410186|NCT02305563|155688465|FG001|Follow-up Period|other reason|0|||
48410187|NCT02305563|155688466|FG002|Follow-up Period|other reason|0|||
48410188|NCT02305563|155688467|FG003|Follow-up Period|other reason|0|||
48410189|NCT02305563|155688468|FG004|Follow-up Period|other reason|1|||
48410190|NCT02305563|155688464|FG000|Follow-up Period|Followup no longer required per protocol|3|||
48410191|NCT02305563|155688465|FG001|Follow-up Period|Followup no longer required per protocol|3|||
48410192|NCT02305563|155688466|FG002|Follow-up Period|Followup no longer required per protocol|4|||
48410193|NCT02305563|155688467|FG003|Follow-up Period|Followup no longer required per protocol|1|||
48410194|NCT02305563|155688468|FG004|Follow-up Period|Followup no longer required per protocol|4|||
48410195|NCT00054132|155688469|FG000|Overall Study|Not Treated|1|||
48410196|NCT01290887|155688470|FG000|Overall Study|Adverse Event|6|||
48410197|NCT01290887|155688471|FG001|Overall Study|Adverse Event|11|||
48410198|NCT01290887|155688470|FG000|Overall Study|Lack of Efficacy|4|||
48410199|NCT01290887|155688471|FG001|Overall Study|Lack of Efficacy|5|||
48410200|NCT01290887|155688470|FG000|Overall Study|Withdrawal by Subject|26|||
48410201|NCT01290887|155688471|FG001|Overall Study|Withdrawal by Subject|32|||
48410202|NCT01290887|155688470|FG000|Overall Study|Protocol Violation|2|||
48410203|NCT01290887|155688471|FG001|Overall Study|Protocol Violation|1|||
48410204|NCT01290887|155688470|FG000|Overall Study|Lost to Follow-up|4|||
48410205|NCT01290887|155688471|FG001|Overall Study|Lost to Follow-up|4|||
48410206|NCT01290887|155688470|FG000|Overall Study|Non-compliance to study procedures|0|||
48410207|NCT01290887|155688471|FG001|Overall Study|Non-compliance to study procedures|1|||
48410208|NCT01290887|155688470|FG000|Overall Study|Non-compliance to study medications|1|||
48410209|NCT01290887|155688471|FG001|Overall Study|Non-compliance to study medications|0|||
48410210|NCT01290887|155688470|FG000|Overall Study|Sponsor closure of study|420|||
48410211|NCT01290887|155688471|FG001|Overall Study|Sponsor closure of study|476|||
48410212|NCT01290887|155688470|FG000|Overall Study|Other|3|||
48410213|NCT01290887|155688471|FG001|Overall Study|Other|6|||
48410214|NCT04223609|155688479|FG000|Overall Study|Adverse Event|0|||
48410215|NCT04223609|155688480|FG001|Overall Study|Adverse Event|1|||
48410216|NCT04223609|155688479|FG000|Overall Study|Missed last visit|0|||
48410217|NCT04223609|155688480|FG001|Overall Study|Missed last visit|1|||
48410218|NCT01661790|155688482|FG000|Overall Study|Lost to Follow-up|0|||
48410219|NCT01661790|155688483|FG001|Overall Study|Lost to Follow-up|2|||
48410220|NCT01990261|155688484|FG000|Overall Study|Death Before Treatment Start|2|||
48410221|NCT01990261|155688484|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
48410222|NCT01990261|155688484|FG000|Overall Study|Death From other Causes|1|||
48410223|NCT01990261|155688484|FG000|Overall Study|Disease Progression (PD)|8|||
48410224|NCT01990261|155688484|FG000|Overall Study|PD Before Treatment Start|1|||
48410225|NCT01990261|155688484|FG000|Overall Study|Dossier not Approved|1|||
48410226|NCT01990261|155688484|FG000|Overall Study|Lost to Follow-up|2|||
48410227|NCT01245673|155688485|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
48410228|NCT02853760|155688486|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
48410229|NCT02853760|155688487|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
48410230|NCT02853760|155688488|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
48410231|NCT02853760|155688489|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
48410232|NCT02853760|155688490|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
48410233|NCT02853760|155688491|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
48410234|NCT00355121|155688492|FG000|Overall Study|Did not receive study vaccine|1|||
48410235|NCT00355121|155688493|FG001|Overall Study|Did not receive study vaccine|0|||
48410236|NCT00355121|155688494|FG002|Overall Study|Did not receive study vaccine|1|||
48410237|NCT00355121|155688492|FG000|Overall Study|Adverse Event|0|||
48410238|NCT00355121|155688493|FG001|Overall Study|Adverse Event|1|||
48410239|NCT00355121|155688494|FG002|Overall Study|Adverse Event|0|||
48410240|NCT00355121|155688492|FG000|Overall Study|Protocol Violation|7|||
48410241|NCT00355121|155688493|FG001|Overall Study|Protocol Violation|9|||
48410242|NCT00355121|155688494|FG002|Overall Study|Protocol Violation|1|||
48410243|NCT00355121|155688492|FG000|Overall Study|Lost to Follow-up|4|||
48410244|NCT00355121|155688493|FG001|Overall Study|Lost to Follow-up|7|||
48410245|NCT00355121|155688494|FG002|Overall Study|Lost to Follow-up|1|||
48410246|NCT00355121|155688492|FG000|Overall Study|Withdrawal by Subject|9|||
48410247|NCT00355121|155688493|FG001|Overall Study|Withdrawal by Subject|10|||
48410248|NCT00355121|155688494|FG002|Overall Study|Withdrawal by Subject|2|||
48410249|NCT00355121|155688492|FG000|Overall Study|Serious adverse events|0|||
48410250|NCT00355121|155688493|FG001|Overall Study|Serious adverse events|2|||
48410251|NCT00355121|155688494|FG002|Overall Study|Serious adverse events|0|||
48410252|NCT00655928|155688504|FG000|Overall Study|Withdrawal by Subject|2|||
48410253|NCT00655928|155688505|FG001|Overall Study|Withdrawal by Subject|1|||
48410254|NCT00655928|155688504|FG000|Overall Study|Physician Decision|1|||
48410255|NCT00655928|155688505|FG001|Overall Study|Physician Decision|1|||
48410256|NCT03636906|155688506|FG000|Overall Study|Adverse Event|0|||
48410257|NCT03636906|155688507|FG001|Overall Study|Adverse Event|0|||
48410258|NCT03636906|155688508|FG002|Overall Study|Adverse Event|1|||
48410259|NCT03636906|155688506|FG000|Overall Study|Lost to Follow-up|1|||
48410260|NCT03636906|155688507|FG001|Overall Study|Lost to Follow-up|0|||
48410261|NCT03636906|155688508|FG002|Overall Study|Lost to Follow-up|0|||
48410262|NCT03636906|155688506|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
48410263|NCT03636906|155688507|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
48410264|NCT03636906|155688508|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
48410265|NCT03636906|155688506|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
48410266|NCT03636906|155688507|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48410267|NCT03636906|155688508|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
48410268|NCT03636906|155688506|FG000|Overall Study|Other|0|||
48410269|NCT03636906|155688507|FG001|Overall Study|Other|0|||
48410270|NCT03636906|155688508|FG002|Overall Study|Other|1|||
48410271|NCT02363478|155690612|FG000|Overall Study|Lost to Follow-up|4|||
48410272|NCT02363478|155690612|FG000|Overall Study|Adverse Event|4|||
48410273|NCT00680836|155690613|FG000|Overall Study|Withdrawal by Subject|3|||
48410274|NCT00680836|155690614|FG001|Overall Study|Withdrawal by Subject|0|||
48410275|NCT00680836|155690613|FG000|Overall Study|Lost to Follow-up|3|||
48410276|NCT00680836|155690614|FG001|Overall Study|Lost to Follow-up|1|||
48410277|NCT00680836|155690613|FG000|Overall Study|Physician Decision|2|||
48410278|NCT00680836|155690614|FG001|Overall Study|Physician Decision|1|||
48410279|NCT03160560|155690615|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
48410280|NCT03160560|155690616|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48410281|NCT03160560|155690617|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48410282|NCT03160560|155690618|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
48410283|NCT03160560|155690615|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
48410284|NCT03160560|155690616|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48410285|NCT03160560|155690617|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48410286|NCT03160560|155690618|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48410287|NCT04187092|155690619|FG000|Overall Study|Lost to Follow-up|1|||
48410288|NCT04187092|155690620|FG001|Overall Study|Lost to Follow-up|1|||
48410289|NCT04187092|155690619|FG000|Overall Study|Withdrawal by Subject|1|||
48410290|NCT04187092|155690620|FG001|Overall Study|Withdrawal by Subject|1|||
48410291|NCT04187092|155690619|FG000|Overall Study|Adverse Event|0|||
48410292|NCT04187092|155690620|FG001|Overall Study|Adverse Event|1|||
48410293|NCT01341457|155690629|FG000|Overall Study|Adverse Event|2|||
48410294|NCT01341457|155690630|FG001|Overall Study|Adverse Event|0|||
48410295|NCT01254669|155690633|FG000|Overall Study|Withdrawal by Subject|0|||
48410296|NCT01254669|155690634|FG001|Overall Study|Withdrawal by Subject|1|||
48410297|NCT01254669|155690633|FG000|Overall Study|time constraint|2|||
48410298|NCT01254669|155690634|FG001|Overall Study|time constraint|2|||
48410299|NCT01254669|155690633|FG000|Overall Study|called to clinic during intervention|1|||
48410300|NCT01254669|155690634|FG001|Overall Study|called to clinic during intervention|1|||
48410301|NCT02367521|155690635|FG000|Overall Study|severe headache after intervention|2|||
48410302|NCT02367521|155690636|FG001|Overall Study|severe headache after intervention|0|||
48410303|NCT02367521|155690635|FG000|Overall Study|unable to find transportation|2|||
48410304|NCT02367521|155690636|FG001|Overall Study|unable to find transportation|0|||
48410305|NCT00103012|155690637|FG000|Overall Study|Withdrawal by Subject|2|||
48410306|NCT00103012|155690638|FG001|Overall Study|Withdrawal by Subject|1|||
48410307|NCT00103012|155690639|FG002|Overall Study|Withdrawal by Subject|2|||
48410308|NCT00103012|155690637|FG000|Overall Study|Pregnancy|1|||
48410309|NCT00103012|155690638|FG001|Overall Study|Pregnancy|0|||
48410310|NCT00103012|155690639|FG002|Overall Study|Pregnancy|0|||
48410311|NCT00103012|155690637|FG000|Overall Study|Adverse Event|0|||
48410312|NCT00103012|155690638|FG001|Overall Study|Adverse Event|0|||
48410313|NCT00103012|155690639|FG002|Overall Study|Adverse Event|1|||
48410314|NCT00103012|155690637|FG000|Overall Study|Subject non-compliant with medications|0|||
48410315|NCT00103012|155690638|FG001|Overall Study|Subject non-compliant with medications|0|||
48410316|NCT00103012|155690639|FG002|Overall Study|Subject non-compliant with medications|1|||
48410317|NCT00420511|155690640|FG000|Overall Study|Adverse Event|1|||
48410318|NCT00420511|155690641|FG001|Overall Study|Adverse Event|1|||
48410319|NCT00420511|155690640|FG000|Overall Study|Lost to Follow-up|1|||
48410320|NCT00420511|155690641|FG001|Overall Study|Lost to Follow-up|0|||
48410321|NCT03902080|155690642|FG000|Overall Study|Adverse Event|17|||
48410322|NCT03902080|155690643|FG001|Overall Study|Adverse Event|15|||
48410323|NCT03902080|155690642|FG000|Overall Study|Withdrawal by Subject|28|||
48410324|NCT03902080|155690643|FG001|Overall Study|Withdrawal by Subject|35|||
48410325|NCT03902080|155690642|FG000|Overall Study|Lost to Follow-up|6|||
48410326|NCT03902080|155690643|FG001|Overall Study|Lost to Follow-up|7|||
48410327|NCT03902080|155690642|FG000|Overall Study|Other|3|||
48410328|NCT03902080|155690643|FG001|Overall Study|Other|5|||
48410329|NCT03902080|155690642|FG000|Overall Study|Non compliance|4|||
48410330|NCT03902080|155690643|FG001|Overall Study|Non compliance|3|||
48410331|NCT03902080|155690642|FG000|Overall Study|Physician Decision|5|||
48410332|NCT03902080|155690643|FG001|Overall Study|Physician Decision|1|||
48410333|NCT03902080|155690642|FG000|Overall Study|Protocol Violation|3|||
48410334|NCT03902080|155690643|FG001|Overall Study|Protocol Violation|3|||
48410335|NCT03902080|155690642|FG000|Overall Study|Lack of Efficacy|1|||
48410336|NCT03902080|155690643|FG001|Overall Study|Lack of Efficacy|3|||
48410337|NCT03902080|155690642|FG000|Overall Study|Withdrawn prior to dosing|0|||
48410338|NCT03902080|155690643|FG001|Overall Study|Withdrawn prior to dosing|1|||
48410339|NCT03575104|155690644|FG000|Overall Study|Adverse Event|4|||
48410340|NCT03575104|155690645|FG001|Overall Study|Adverse Event|3|||
48410341|NCT03575104|155690646|FG002|Overall Study|Adverse Event|4|||
48410342|NCT03575104|155690644|FG000|Overall Study|Withdrawal by Subject|13|||
48410343|NCT03575104|155690645|FG001|Overall Study|Withdrawal by Subject|16|||
48410344|NCT03575104|155690646|FG002|Overall Study|Withdrawal by Subject|11|||
48410345|NCT03575104|155690644|FG000|Overall Study|Other reasons|6|||
48410346|NCT03575104|155690645|FG001|Overall Study|Other reasons|8|||
48410347|NCT03575104|155690646|FG002|Overall Study|Other reasons|6|||
48410348|NCT03575104|155690644|FG000|Overall Study|Lost to Follow-up|1|||
48410349|NCT03575104|155690645|FG001|Overall Study|Lost to Follow-up|2|||
48410350|NCT03575104|155690646|FG002|Overall Study|Lost to Follow-up|1|||
48410351|NCT00463476|155690647|FG000|Overall Study|Withdrawal by Subject|1|||
48410352|NCT00463476|155690648|FG001|Overall Study|Withdrawal by Subject|2|||
48410353|NCT00463476|155690647|FG000|Overall Study|Lost to Follow-up|1|||
48410354|NCT00463476|155690648|FG001|Overall Study|Lost to Follow-up|1|||
48410355|NCT01505894|155690650|FG000|Overall Study|Adverse Event|1|||
48410356|NCT01505894|155690651|FG001|Overall Study|Adverse Event|0|||
48410357|NCT01505894|155690652|FG002|Overall Study|Adverse Event|0|||
48410358|NCT01505894|155690653|FG003|Overall Study|Adverse Event|0|||
48410359|NCT01505894|155690654|FG004|Overall Study|Adverse Event|0|||
48410360|NCT01505894|155690655|FG005|Overall Study|Adverse Event|0|||
48410361|NCT01505894|155690656|FG006|Overall Study|Adverse Event|0|||
48410362|NCT01505894|155690657|FG007|Overall Study|Adverse Event|0|||
48410363|NCT01505894|155690658|FG008|Overall Study|Adverse Event|0|||
48410364|NCT01505894|155690650|FG000|Overall Study|Other than specified|0|||
48410365|NCT01505894|155690651|FG001|Overall Study|Other than specified|0|||
48410366|NCT01505894|155690652|FG002|Overall Study|Other than specified|0|||
48410367|NCT01505894|155690653|FG003|Overall Study|Other than specified|0|||
48410368|NCT01505894|155690654|FG004|Overall Study|Other than specified|1|||
48410369|NCT01505894|155690655|FG005|Overall Study|Other than specified|0|||
48410370|NCT01505894|155690656|FG006|Overall Study|Other than specified|0|||
48410371|NCT01505894|155690657|FG007|Overall Study|Other than specified|0|||
48410372|NCT01505894|155690658|FG008|Overall Study|Other than specified|0|||
48410373|NCT03823391|155690659|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
48410374|NCT03823391|155690660|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
48410375|NCT03823391|155690659|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
48410376|NCT03823391|155690660|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
48410377|NCT02661594|155690661|FG000|Overall Study|Protocol Violation|1|||
48410378|NCT02661594|155690662|FG001|Overall Study|Protocol Violation|0|||
48410379|NCT02661594|155690663|FG002|Overall Study|Protocol Violation|1|||
48410380|NCT02661594|155690664|FG003|Overall Study|Protocol Violation|0|||
48410381|NCT01279057|155690665|FG000|Overall Study|Adverse Event|1|||
48410382|NCT01279057|155690666|FG001|Overall Study|Adverse Event|0|||
48410383|NCT01279057|155690667|FG002|Overall Study|Adverse Event|1|||
48410384|NCT01279057|155690665|FG000|Overall Study|Insufficient therapeutic response|0|||
48410385|NCT01279057|155690666|FG001|Overall Study|Insufficient therapeutic response|0|||
48410386|NCT01279057|155690667|FG002|Overall Study|Insufficient therapeutic response|1|||
48410387|NCT01279057|155690665|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
48410388|NCT01279057|155690666|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
48410389|NCT01279057|155690667|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
48410390|NCT01279057|155690665|FG000|Overall Study|Withdrew consent|2|||
48410391|NCT01279057|155690666|FG001|Overall Study|Withdrew consent|0|||
48410392|NCT01279057|155690667|FG002|Overall Study|Withdrew consent|1|||
48410393|NCT01279057|155690665|FG000|Overall Study|Pregnancy|0|||
48410394|NCT01279057|155690666|FG001|Overall Study|Pregnancy|1|||
48410395|NCT01279057|155690667|FG002|Overall Study|Pregnancy|0|||
48410396|NCT01279057|155690665|FG000|Overall Study|Other|3|||
48410397|NCT01279057|155690666|FG001|Overall Study|Other|3|||
48410398|NCT01279057|155690667|FG002|Overall Study|Other|0|||
48410399|NCT01485614|155690668|FG000|Randomization|Not Treated|1|||
48410400|NCT01485614|155690669|FG001|Randomization|Not Treated|0|||
48410401|NCT01485614|155690670|FG002|Randomization|Not Treated|0|||
48410402|NCT01485614|155690671|FG003|Randomization|Not Treated|0|||
48410403|NCT01485614|155690668|FG000|Weeks 0-20|Lost to Follow-up|2|||
48410404|NCT01485614|155690669|FG001|Weeks 0-20|Lost to Follow-up|0|||
48410405|NCT01485614|155690670|FG002|Weeks 0-20|Lost to Follow-up|0|||
48410406|NCT01485614|155690671|FG003|Weeks 0-20|Lost to Follow-up|0|||
48410407|NCT01485614|155690668|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
48410408|NCT01485614|155690669|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
48410409|NCT01485614|155690670|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
48410410|NCT01485614|155690671|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
48410411|NCT01485614|155690668|FG000|Weeks 0-20|Withdrawal by Subject|3|||
48410412|NCT01485614|155690669|FG001|Weeks 0-20|Withdrawal by Subject|2|||
48410413|NCT01485614|155690670|FG002|Weeks 0-20|Withdrawal by Subject|1|||
48410414|NCT01485614|155690671|FG003|Weeks 0-20|Withdrawal by Subject|0|||
48410415|NCT01485614|155690668|FG000|Weeks 20-54|Lost to Follow-up|4|||
48410416|NCT01485614|155690669|FG001|Weeks 20-54|Lost to Follow-up|3|||
48410417|NCT01485614|155690670|FG002|Weeks 20-54|Lost to Follow-up|1|||
48410418|NCT01485614|155690671|FG003|Weeks 20-54|Lost to Follow-up|0|||
48410419|NCT01485614|155690668|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
48410420|NCT01485614|155690669|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
48410421|NCT01485614|155690670|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
48410422|NCT01485614|155690671|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
48410423|NCT01485614|155690668|FG000|Weeks 20-54|Withdrawal by Subject|5|||
48410424|NCT01485614|155690669|FG001|Weeks 20-54|Withdrawal by Subject|3|||
48410425|NCT01485614|155690670|FG002|Weeks 20-54|Withdrawal by Subject|0|||
48410426|NCT01485614|155690671|FG003|Weeks 20-54|Withdrawal by Subject|0|||
48410427|NCT00191854|155690672|FG000|Overall Study|Death|26|||
48410428|NCT00191854|155690673|FG001|Overall Study|Death|23|||
48410429|NCT00191854|155690674|FG002|Overall Study|Death|29|||
48410430|NCT00191854|155690672|FG000|Overall Study|Lost to Follow-up|7|||
48410431|NCT00191854|155690673|FG001|Overall Study|Lost to Follow-up|5|||
48410432|NCT00191854|155690674|FG002|Overall Study|Lost to Follow-up|5|||
48410433|NCT00191854|155690672|FG000|Overall Study|Withdrawal by Subject|4|||
48410434|NCT00191854|155690673|FG001|Overall Study|Withdrawal by Subject|2|||
48410435|NCT00191854|155690674|FG002|Overall Study|Withdrawal by Subject|3|||
48410436|NCT00191854|155690672|FG000|Overall Study|Sponsor Decision|0|||
48410437|NCT00191854|155690673|FG001|Overall Study|Sponsor Decision|0|||
48410438|NCT00191854|155690674|FG002|Overall Study|Sponsor Decision|1|||
48410439|NCT00191854|155690672|FG000|Overall Study|Screen Failure|0|||
48410440|NCT00191854|155690673|FG001|Overall Study|Screen Failure|0|||
48410441|NCT00191854|155690674|FG002|Overall Study|Screen Failure|1|||
48410442|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
48410443|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
48410444|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
48410445|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
48410446|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
48410447|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
48410448|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
48410449|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
48410450|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
48410451|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
48410452|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
48410453|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
48410454|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
48410455|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
48410456|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
48410457|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
48410458|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
48410459|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
48410460|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
48410461|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
48410462|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
48410463|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
48410464|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
48410465|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
48410466|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
48410467|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
48410468|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
48410469|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
48410470|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
48410471|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
48410472|NCT00849017|155690675|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
48410473|NCT00849017|155690676|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
48410474|NCT00849017|155690677|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
48410475|NCT00849017|155690675|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
48410476|NCT00849017|155690676|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
48410477|NCT00849017|155690677|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
48357925|NCT01358331|155506250|FG004|Overall Study|Lost to Follow-up|0|||
48357926|NCT01358331|155506251|FG005|Overall Study|Lost to Follow-up|0|||
48357927|NCT01358331|155506246|FG000|Overall Study|Withdrawal by Subject|0|||
48357928|NCT01358331|155506247|FG001|Overall Study|Withdrawal by Subject|0|||
48357929|NCT01358331|155506248|FG002|Overall Study|Withdrawal by Subject|0|||
48357930|NCT01358331|155506249|FG003|Overall Study|Withdrawal by Subject|1|||
48357931|NCT01358331|155506250|FG004|Overall Study|Withdrawal by Subject|1|||
48357932|NCT01358331|155506251|FG005|Overall Study|Withdrawal by Subject|1|||
48357933|NCT01358331|155506246|FG000|Overall Study|Adverse Events|1|||
48357934|NCT01358331|155506247|FG001|Overall Study|Adverse Events|1|||
48357935|NCT01358331|155506248|FG002|Overall Study|Adverse Events|1|||
48357936|NCT01358331|155506249|FG003|Overall Study|Adverse Events|0|||
48357937|NCT01358331|155506250|FG004|Overall Study|Adverse Events|1|||
48357938|NCT01358331|155506251|FG005|Overall Study|Adverse Events|5|||
48357939|NCT01358331|155506246|FG000|Overall Study|Symptomatic Deterioration|0|||
48357940|NCT01358331|155506247|FG001|Overall Study|Symptomatic Deterioration|0|||
48357941|NCT01358331|155506248|FG002|Overall Study|Symptomatic Deterioration|0|||
48357942|NCT01358331|155506249|FG003|Overall Study|Symptomatic Deterioration|0|||
48357943|NCT01358331|155506250|FG004|Overall Study|Symptomatic Deterioration|1|||
48357944|NCT01358331|155506251|FG005|Overall Study|Symptomatic Deterioration|0|||
48357945|NCT01358331|155506246|FG000|Overall Study|Participants did not wish to continue|0|||
48357946|NCT01358331|155506247|FG001|Overall Study|Participants did not wish to continue|0|||
48357947|NCT01358331|155506248|FG002|Overall Study|Participants did not wish to continue|0|||
48357948|NCT01358331|155506249|FG003|Overall Study|Participants did not wish to continue|0|||
48357949|NCT01358331|155506250|FG004|Overall Study|Participants did not wish to continue|1|||
48431448|NCT00002663|155767273|FG009|Overall Study|Physician Decision|1|||
48410478|NCT00849017|155690675|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
48410479|NCT00849017|155690676|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
48410480|NCT00849017|155690677|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
48410481|NCT00849017|155690675|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
48410482|NCT00849017|155690676|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
48410483|NCT00849017|155690677|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
48410484|NCT00849017|155690675|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
48410485|NCT00849017|155690676|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
48410486|NCT00849017|155690677|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
48410487|NCT00849017|155690675|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
48410488|NCT00849017|155690676|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
48410489|NCT00849017|155690677|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
48410490|NCT00849017|155690675|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
48410491|NCT00849017|155690676|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
48410492|NCT00849017|155690677|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
48410493|NCT00849017|155690675|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
48410494|NCT00849017|155690676|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
48357950|NCT01358331|155506251|FG005|Overall Study|Participants did not wish to continue|0|||
48357951|NCT01358331|155506246|FG000|Overall Study|Progress of disease under investigation|1|||
48357952|NCT01358331|155506247|FG001|Overall Study|Progress of disease under investigation|2|||
48357953|NCT01358331|155506248|FG002|Overall Study|Progress of disease under investigation|3|||
48357954|NCT01358331|155506249|FG003|Overall Study|Progress of disease under investigation|1|||
48357955|NCT01358331|155506250|FG004|Overall Study|Progress of disease under investigation|3|||
48357956|NCT01358331|155506251|FG005|Overall Study|Progress of disease under investigation|0|||
48357957|NCT01417104|155506252|FG000|Overall Study|Withdrawal by Subject|5|||
48357958|NCT01417104|155506253|FG001|Overall Study|Withdrawal by Subject|1|||
48357959|NCT01417104|155506252|FG000|Overall Study|Failure to make contact|0|||
48357960|NCT01417104|155506253|FG001|Overall Study|Failure to make contact|1|||
48357961|NCT01417104|155506252|FG000|Overall Study|Adverse Event|1|||
48357962|NCT01417104|155506253|FG001|Overall Study|Adverse Event|0|||
48357963|NCT00513708|155506254|FG000|Overall Study|Lost to Follow-up|4|||
48357964|NCT00513708|155506255|FG001|Overall Study|Lost to Follow-up|4|||
48357965|NCT00513708|155506256|FG002|Overall Study|Lost to Follow-up|4|||
48357966|NCT00953615|155506260|FG000|Overall Study|Adverse Event|1|||
48357967|NCT01110408|155506267|FG000|Overall Study|Protocol Violation|1|||
48357968|NCT01110408|155506268|FG001|Overall Study|Protocol Violation|0|||
48357969|NCT01038427|155506271|FG000|Overall Study|Lost to follow up|1|||
48357970|NCT01038427|155506272|FG001|Overall Study|Lost to follow up|1|||
48357971|NCT01038427|155506273|FG002|Overall Study|Lost to follow up|0|||
48357972|NCT01038427|155506271|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
48357973|NCT01038427|155506272|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
48357974|NCT01038427|155506273|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
48357975|NCT01038427|155506271|FG000|Overall Study|Withdrew consent|0|||
48357976|NCT01038427|155506272|FG001|Overall Study|Withdrew consent|0|||
48357977|NCT01038427|155506273|FG002|Overall Study|Withdrew consent|1|||
48410495|NCT00849017|155690677|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
48410496|NCT00849017|155690675|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
48410497|NCT00849017|155690676|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
48410498|NCT00849017|155690677|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
48410499|NCT03502187|155690678|FG000|Overall Study|Withdrawal by Subject|4|||
48410500|NCT03502187|155690679|FG001|Overall Study|Withdrawal by Subject|3|||
48410501|NCT03502187|155690680|FG002|Overall Study|Withdrawal by Subject|3|||
48410502|NCT03502187|155690678|FG000|Overall Study|Lost to Follow-up|5|||
48410503|NCT03502187|155690679|FG001|Overall Study|Lost to Follow-up|4|||
48410504|NCT03502187|155690680|FG002|Overall Study|Lost to Follow-up|5|||
48410505|NCT02658448|155690681|FG000|Overall Study|Lost to Follow-up|1|||
48410506|NCT01323478|155690682|FG000|Overall Study|Adverse Event|7|||
48410507|NCT01323478|155690682|FG000|Overall Study|Lack of Efficacy|4|||
48410508|NCT01323478|155690682|FG000|Overall Study|Non-compliance With Study Product|3|||
48410509|NCT01323478|155690682|FG000|Overall Study|Protocol Violation|1|||
48410510|NCT01323478|155690682|FG000|Overall Study|Withdrawal of Consent|1|||
48410511|NCT01323478|155690682|FG000|Overall Study|Administrative or Other Reasons|8|||
48410512|NCT03370770|155690689|FG000|Overall Study|Patient was followed in another hospital center|1|||
48410513|NCT03370770|155690689|FG000|Overall Study|Progressive Disease|98|||
48410514|NCT03370770|155690689|FG000|Overall Study|Adverse Event|2|||
48410515|NCT03370770|155690689|FG000|Overall Study|Death|5|||
48410516|NCT00234039|155690693|FG000|Overall Study|Adverse Event|2|||
48410517|NCT00234039|155690693|FG000|Overall Study|Progression/relapse|34|||
48410518|NCT00234039|155690693|FG000|Overall Study|Other - Not Protocol Specified|3|||
48410519|NCT00234039|155690693|FG000|Overall Study|Ineligible|9|||
48410520|NCT00234039|155690693|FG000|Overall Study|No Protocol Treatment Received|2|||
48410521|NCT03072160|155690696|FG000|Overall Study|Adverse Event|3|||
48410522|NCT03072160|155690697|FG001|Overall Study|Adverse Event|1|||
48410523|NCT03072160|155690696|FG000|Overall Study|Refused further treatment|6|||
48410524|NCT03072160|155690697|FG001|Overall Study|Refused further treatment|1|||
48410525|NCT03072160|155690696|FG000|Overall Study|Physician Decision|1|||
48410526|NCT03072160|155690697|FG001|Overall Study|Physician Decision|0|||
48410527|NCT03072160|155690696|FG000|Overall Study|Disease progression on study|1|||
48410528|NCT03072160|155690697|FG001|Overall Study|Disease progression on study|1|||
48410529|NCT03072160|155690696|FG000|Overall Study|No contact|0|||
48410530|NCT03072160|155690697|FG001|Overall Study|No contact|1|||
48410531|NCT02688647|155690698|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
48410532|NCT02688647|155690699|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
48431449|NCT00002663|155767264|FG000|Overall Study|Adverse Event|0|||
48357978|NCT01038427|155506271|FG000|Overall Study|Adverse Event|2|||
48410533|NCT02688647|155690698|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
48410534|NCT02688647|155690699|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
48410535|NCT02688647|155690698|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
48410536|NCT02688647|155690699|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
48410537|NCT02688647|155690698|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
48410538|NCT02688647|155690699|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
48410539|NCT02688647|155690698|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
48410540|NCT02688647|155690699|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
48410541|NCT02688647|155690698|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
48410542|NCT02688647|155690699|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
48410543|NCT02688647|155690698|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
48410544|NCT02688647|155690699|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
48410545|NCT03118947|155690700|FG000|Overall Study|Adverse Event|7|||
48410546|NCT03118947|155690700|FG000|Overall Study|Death|3|||
48410547|NCT03118947|155690700|FG000|Overall Study|Lack of Efficacy|4|||
48410548|NCT03118947|155690700|FG000|Overall Study|Non-compliance with study drug|1|||
48410549|NCT03118947|155690700|FG000|Overall Study|Protocol Violation|2|||
48410550|NCT03118947|155690700|FG000|Overall Study|Withdrawal by Subject|3|||
48410551|NCT03118947|155690700|FG000|Overall Study|Withdrawal by caregiver|3|||
48410552|NCT03118947|155690700|FG000|Overall Study|Change in patient's living situation|4|||
48410553|NCT03118947|155690700|FG000|Overall Study|Lost to Follow-up|2|||
48410554|NCT00675025|155690703|FG000|Overall Study|Study Terminated by Sponsor|38|||
48410555|NCT00675025|155690704|FG001|Overall Study|Study Terminated by Sponsor|42|||
48410556|NCT00675025|155690703|FG000|Overall Study|Adverse Event|6|||
48410557|NCT00675025|155690704|FG001|Overall Study|Adverse Event|11|||
48410558|NCT00675025|155690703|FG000|Overall Study|Lost to Follow-up|6|||
48410559|NCT00675025|155690704|FG001|Overall Study|Lost to Follow-up|4|||
48410560|NCT00675025|155690703|FG000|Overall Study|Withdrawal by Subject|4|||
48410561|NCT00675025|155690704|FG001|Overall Study|Withdrawal by Subject|6|||
48410562|NCT03433781|155690705|FG000|Overall Study|Progression of Disease|1|||
48410563|NCT03433781|155690706|FG001|Overall Study|Progression of Disease|0|||
48410564|NCT03433781|155690707|FG002|Overall Study|Progression of Disease|0|||
48410565|NCT03433781|155690705|FG000|Overall Study|Physician Decision|0|||
48410566|NCT03433781|155690706|FG001|Overall Study|Physician Decision|1|||
48410567|NCT03433781|155690707|FG002|Overall Study|Physician Decision|0|||
48410568|NCT02487108|155690711|FG000|Overall Study|Adverse Event|1|||
48410569|NCT02487108|155690712|FG001|Overall Study|Adverse Event|6|||
48410570|NCT02487108|155690713|FG002|Overall Study|Adverse Event|12|||
48410571|NCT02487108|155690714|FG003|Overall Study|Adverse Event|6|||
48410572|NCT02487108|155690711|FG000|Overall Study|Withdrawal by Subject|8|||
48410573|NCT02487108|155690712|FG001|Overall Study|Withdrawal by Subject|5|||
48410574|NCT02487108|155690713|FG002|Overall Study|Withdrawal by Subject|5|||
48410575|NCT02487108|155690714|FG003|Overall Study|Withdrawal by Subject|0|||
48410576|NCT02487108|155690711|FG000|Overall Study|Non-compliance to study medication|3|||
48410577|NCT02487108|155690712|FG001|Overall Study|Non-compliance to study medication|2|||
48410578|NCT02487108|155690713|FG002|Overall Study|Non-compliance to study medication|5|||
48410579|NCT02487108|155690714|FG003|Overall Study|Non-compliance to study medication|4|||
48410580|NCT02487108|155690711|FG000|Overall Study|Protocol Violation|1|||
48410581|NCT02487108|155690712|FG001|Overall Study|Protocol Violation|1|||
48410582|NCT02487108|155690713|FG002|Overall Study|Protocol Violation|2|||
48410583|NCT02487108|155690714|FG003|Overall Study|Protocol Violation|0|||
48410584|NCT02487108|155690711|FG000|Overall Study|Non-compliance to study procedures|0|||
48410585|NCT02487108|155690712|FG001|Overall Study|Non-compliance to study procedures|0|||
48410586|NCT02487108|155690713|FG002|Overall Study|Non-compliance to study procedures|0|||
48410587|NCT02487108|155690714|FG003|Overall Study|Non-compliance to study procedures|1|||
48410588|NCT02487108|155690711|FG000|Overall Study|Other than specified|3|||
48410589|NCT02487108|155690712|FG001|Overall Study|Other than specified|2|||
48410590|NCT02487108|155690713|FG002|Overall Study|Other than specified|2|||
48410591|NCT02487108|155690714|FG003|Overall Study|Other than specified|0|||
48410592|NCT01570244|155690715|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
48410593|NCT04258579|155690720|FG000|Overall Study|Withdrawal by Subject|7|||
48410594|NCT04258579|155690720|FG000|Overall Study|Lost to Follow-up|3|||
48410595|NCT04258579|155690720|FG000|Overall Study|Protocol Violation|2|||
48410596|NCT04258579|155690720|FG000|Overall Study|Adverse Event|1|||
48410597|NCT03157531|155690721|FG000|Overall Study|Death|2|||
48410598|NCT03157531|155690721|FG000|Overall Study|Lost to Follow-up|4|||
48410599|NCT01756274|155690722|FG000|Overall Study|Protocol Violation|2|||
48410600|NCT01756274|155690722|FG000|Overall Study|Laboratory error|1|||
48410601|NCT01818726|155690729|FG000|Overall Study|Administrative reasons|5|||
48410602|NCT01818726|155690730|FG001|Overall Study|Administrative reasons|1|||
48410603|NCT01818726|155690729|FG000|Overall Study|Withdrawal by Subject|0|||
48410604|NCT01818726|155690730|FG001|Overall Study|Withdrawal by Subject|1|||
48410605|NCT01818726|155690729|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
48410606|NCT01818726|155690730|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
48410607|NCT03158220|155690739|FG000|Overall Study|Screen Failure|0|||
48410608|NCT03158220|155690740|FG001|Overall Study|Screen Failure|1|||
48410609|NCT03158220|155690739|FG000|Overall Study|Withdrawal by Subject|8|||
48410610|NCT03158220|155690740|FG001|Overall Study|Withdrawal by Subject|9|||
48410611|NCT03158220|155690739|FG000|Overall Study|Status unknown|0|||
48410612|NCT03158220|155690740|FG001|Overall Study|Status unknown|1|||
48410613|NCT03158220|155690739|FG000|Overall Study|Lost to Follow-up|8|||
48410614|NCT03158220|155690740|FG001|Overall Study|Lost to Follow-up|5|||
48410615|NCT03158220|155690739|FG000|Overall Study|Physician Decision|1|||
48410616|NCT03158220|155690740|FG001|Overall Study|Physician Decision|0|||
48410617|NCT00818259|155690743|FG000|Part I|Withdrawal by Subject|1|||
48410618|NCT00818259|155690744|FG001|Part I|Withdrawal by Subject|0|||
48410619|NCT00818259|155690745|FG002|Part I|Withdrawal by Subject|0|||
48410620|NCT00818259|155690746|FG003|Part I|Withdrawal by Subject|0|||
48410621|NCT00818259|155690747|FG004|Part I|Withdrawal by Subject|0|||
48410622|NCT00818259|155690748|FG005|Part I|Withdrawal by Subject|0|||
48410623|NCT00818259|155690749|FG006|Part I|Withdrawal by Subject|0|||
48410624|NCT00818259|155690750|FG007|Part I|Withdrawal by Subject|0|||
48410625|NCT00818259|155690751|FG008|Part I|Withdrawal by Subject|0|||
48410626|NCT00818259|155690743|FG000|Part II|Physician Decision|0|||
48410627|NCT00818259|155690744|FG001|Part II|Physician Decision|0|||
48410628|NCT00818259|155690745|FG002|Part II|Physician Decision|1|||
48410629|NCT00818259|155690746|FG003|Part II|Physician Decision|0|||
48410630|NCT00818259|155690747|FG004|Part II|Physician Decision|0|||
48410631|NCT00818259|155690748|FG005|Part II|Physician Decision|0|||
48410632|NCT00818259|155690749|FG006|Part II|Physician Decision|0|||
48410633|NCT00818259|155690750|FG007|Part II|Physician Decision|0|||
48410634|NCT00818259|155690751|FG008|Part II|Physician Decision|0|||
48410635|NCT00818259|155690743|FG000|Part II|Lack of Efficacy|0|||
48410636|NCT00818259|155690744|FG001|Part II|Lack of Efficacy|0|||
48410637|NCT00818259|155690745|FG002|Part II|Lack of Efficacy|0|||
48410638|NCT00818259|155690746|FG003|Part II|Lack of Efficacy|1|||
48410639|NCT00818259|155690747|FG004|Part II|Lack of Efficacy|0|||
48410640|NCT00818259|155690748|FG005|Part II|Lack of Efficacy|0|||
48410641|NCT00818259|155690749|FG006|Part II|Lack of Efficacy|0|||
48410642|NCT00818259|155690750|FG007|Part II|Lack of Efficacy|0|||
48410643|NCT00818259|155690751|FG008|Part II|Lack of Efficacy|0|||
48410644|NCT00818259|155690743|FG000|Part II|Not Treated|0|||
48410645|NCT00818259|155690744|FG001|Part II|Not Treated|0|||
48410646|NCT00818259|155690745|FG002|Part II|Not Treated|0|||
48410647|NCT00818259|155690746|FG003|Part II|Not Treated|1|||
48410648|NCT00818259|155690747|FG004|Part II|Not Treated|0|||
48410649|NCT00818259|155690748|FG005|Part II|Not Treated|0|||
48410650|NCT00818259|155690749|FG006|Part II|Not Treated|0|||
48410651|NCT00818259|155690750|FG007|Part II|Not Treated|0|||
48410652|NCT00818259|155690751|FG008|Part II|Not Treated|0|||
48410653|NCT00818259|155690743|FG000|Part IV|Physician Decision|0|||
48410654|NCT00818259|155690744|FG001|Part IV|Physician Decision|0|||
48410655|NCT00818259|155690745|FG002|Part IV|Physician Decision|0|||
48410656|NCT00818259|155690746|FG003|Part IV|Physician Decision|0|||
48410657|NCT00818259|155690747|FG004|Part IV|Physician Decision|0|||
48410658|NCT00818259|155690748|FG005|Part IV|Physician Decision|1|||
48410659|NCT00818259|155690749|FG006|Part IV|Physician Decision|0|||
48410660|NCT00818259|155690750|FG007|Part IV|Physician Decision|0|||
48410661|NCT00818259|155690751|FG008|Part IV|Physician Decision|0|||
48410662|NCT00818259|155690743|FG000|Part V|Adverse Event|0|||
48410663|NCT00818259|155690744|FG001|Part V|Adverse Event|0|||
48410664|NCT00818259|155690745|FG002|Part V|Adverse Event|0|||
48410665|NCT00818259|155690746|FG003|Part V|Adverse Event|0|||
48410666|NCT00818259|155690747|FG004|Part V|Adverse Event|0|||
48410667|NCT00818259|155690748|FG005|Part V|Adverse Event|0|||
48410668|NCT00818259|155690749|FG006|Part V|Adverse Event|0|||
48410669|NCT00818259|155690750|FG007|Part V|Adverse Event|1|||
48410670|NCT00818259|155690751|FG008|Part V|Adverse Event|0|||
48410671|NCT01506882|155690752|FG000|Overall Study|Lack of Efficacy|4|||
48410672|NCT01506882|155690753|FG001|Overall Study|Lack of Efficacy|3|||
48410673|NCT01506882|155690752|FG000|Overall Study|Lost to Follow-up|1|||
48410674|NCT01506882|155690753|FG001|Overall Study|Lost to Follow-up|0|||
48410675|NCT01506882|155690752|FG000|Overall Study|Withdrawal by Subject|9|||
48410676|NCT01506882|155690753|FG001|Overall Study|Withdrawal by Subject|3|||
48410677|NCT01506882|155690752|FG000|Overall Study|SAE, non-fatal|2|||
48410678|NCT01506882|155690753|FG001|Overall Study|SAE, non-fatal|0|||
48410679|NCT01506882|155690752|FG000|Overall Study|AE, non-serious non-fatal|3|||
48410680|NCT01506882|155690753|FG001|Overall Study|AE, non-serious non-fatal|1|||
48410681|NCT01506882|155690752|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
48410682|NCT01506882|155690753|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48410683|NCT01506882|155690752|FG000|Overall Study|Other Reason|2|||
48410684|NCT01506882|155690753|FG001|Overall Study|Other Reason|0|||
48410685|NCT02597062|155690754|FG000|Overall Study|Ineligible|1|||
48410686|NCT01929135|155690755|FG000|Overall Study|Lost to Follow-up|1|||
48410687|NCT01929135|155690756|FG001|Overall Study|Lost to Follow-up|1|||
48410688|NCT03372941|155690757|FG000|Overall Study|Lost to Follow-up|2|||
48410689|NCT03372941|155690758|FG001|Overall Study|Lost to Follow-up|4|||
48410690|NCT02117687|155690759|FG000|Overall Study|Lost to Follow-up|0|||
48410691|NCT02117687|155690760|FG001|Overall Study|Lost to Follow-up|1|||
48410692|NCT02117687|155690759|FG000|Overall Study|Adverse Event|0|||
48410693|NCT02117687|155690760|FG001|Overall Study|Adverse Event|2|||
48410694|NCT02117687|155690759|FG000|Overall Study|Other Reasons|1|||
48410695|NCT02117687|155690760|FG001|Overall Study|Other Reasons|1|||
48410696|NCT04698629|155690763|FG000|Overall Study|Adverse Event|1|||
48410697|NCT01955707|155690765|FG000|Overall Study|Adverse Event|1|||
48410698|NCT01955707|155690766|FG001|Overall Study|Adverse Event|2|||
48410699|NCT01955707|155690765|FG000|Overall Study|Lost to Follow-up|2|||
48410700|NCT01955707|155690766|FG001|Overall Study|Lost to Follow-up|1|||
48410701|NCT01955707|155690765|FG000|Overall Study|Withdrawal by Subject|0|||
48410702|NCT01955707|155690766|FG001|Overall Study|Withdrawal by Subject|3|||
48410703|NCT01955707|155690765|FG000|Overall Study|Death|13|||
48410704|NCT01955707|155690766|FG001|Overall Study|Death|14|||
48410705|NCT01955707|155690765|FG000|Overall Study|Other|4|||
48410706|NCT01955707|155690766|FG001|Overall Study|Other|2|||
48410707|NCT01237951|155690767|FG000|Overall Study|Death|1|||
48410708|NCT02970929|155690768|FG000|Overall Study|Adverse Event|18|||
48410709|NCT02970929|155690768|FG000|Overall Study|Lack of Efficacy|8|||
48410710|NCT02970929|155690768|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
48410711|NCT02970929|155690768|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
48410712|NCT02970929|155690768|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
48410713|NCT02970929|155690768|FG000|Overall Study|LOST TO FOLLOWUP|6|||
48410714|NCT02970929|155690768|FG000|Overall Study|MOVED OUT OF STATE|1|||
48410715|NCT02970929|155690768|FG000|Overall Study|Withdrawal by Subject|16|||
48410716|NCT01817790|155690769|FG000|Overall Study|Adverse Event|0|||
48410717|NCT01817790|155690770|FG001|Overall Study|Adverse Event|2|||
48410718|NCT01817790|155690769|FG000|Overall Study|Lost to Follow-up|0|||
48410719|NCT01817790|155690770|FG001|Overall Study|Lost to Follow-up|1|||
48410720|NCT01817790|155690769|FG000|Overall Study|Protocol Violation|2|||
48410721|NCT01817790|155690770|FG001|Overall Study|Protocol Violation|1|||
48410722|NCT01817790|155690769|FG000|Overall Study|Withdrawal by Subject|1|||
48410723|NCT01817790|155690770|FG001|Overall Study|Withdrawal by Subject|3|||
48410724|NCT01817790|155690769|FG000|Overall Study|Other: Could not attend appointment|1|||
48410725|NCT01817790|155690770|FG001|Overall Study|Other: Could not attend appointment|1|||
48410726|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
48410727|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
48410728|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
48410729|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
48410730|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
48410731|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
48410732|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
48410733|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
48410734|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
48410735|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
48410736|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
48410737|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
48410738|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
48410739|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
48410740|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
48410741|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
48410742|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
48410743|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
48410744|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
48410745|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48410746|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48410747|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48410748|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48410749|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
48410750|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
48410751|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
48410752|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
48410753|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
48410754|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
48410755|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
48410756|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
48410757|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
48410758|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
48410759|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
48410760|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
48410761|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
48410762|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
48410763|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
48410764|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
48410765|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
48410766|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
48357979|NCT01038427|155506272|FG001|Overall Study|Adverse Event|2|||
48357980|NCT01038427|155506273|FG002|Overall Study|Adverse Event|1|||
48357981|NCT01038427|155506271|FG000|Overall Study|Enrolled in error|0|||
48357982|NCT01038427|155506272|FG001|Overall Study|Enrolled in error|1|||
48357983|NCT01038427|155506273|FG002|Overall Study|Enrolled in error|1|||
48357984|NCT01038427|155506271|FG000|Overall Study|Other|0|||
48357985|NCT01038427|155506272|FG001|Overall Study|Other|2|||
48357986|NCT01038427|155506273|FG002|Overall Study|Other|0|||
48357987|NCT01827046|155506276|FG000|Overall Study|Lost to Follow-up|1|||
48357988|NCT01827046|155506277|FG001|Overall Study|Lost to Follow-up|5|||
48357989|NCT01827046|155506276|FG000|Overall Study|Withdrawal by Subject|0|||
48357990|NCT01827046|155506277|FG001|Overall Study|Withdrawal by Subject|4|||
48357991|NCT00604708|155506279|FG000|Overall Study|Withdrawal by Subject|9|||
48357992|NCT00604708|155506280|FG001|Overall Study|Withdrawal by Subject|10|||
48357993|NCT00604708|155506279|FG000|Overall Study|Protocol Violation|2|||
48357994|NCT00604708|155506280|FG001|Overall Study|Protocol Violation|8|||
48357995|NCT00604708|155506279|FG000|Overall Study|Lost to Follow-up|5|||
48357996|NCT00604708|155506280|FG001|Overall Study|Lost to Follow-up|5|||
48357997|NCT00604708|155506279|FG000|Overall Study|administrative reasons|9|||
48357998|NCT00604708|155506280|FG001|Overall Study|administrative reasons|11|||
48357999|NCT00604708|155506279|FG000|Overall Study|Adverse Event|6|||
48358000|NCT00604708|155506280|FG001|Overall Study|Adverse Event|6|||
48358001|NCT02202785|155506282|FG000|Overall Study|Study Terminated by Sponsor|1|||
48358002|NCT02202785|155506283|FG001|Overall Study|Study Terminated by Sponsor|6|||
48358003|NCT02202785|155506284|FG002|Overall Study|Study Terminated by Sponsor|4|||
48358004|NCT02202785|155506282|FG000|Overall Study|Withdrawal by Subject|0|||
48358005|NCT02202785|155506283|FG001|Overall Study|Withdrawal by Subject|1|||
48358006|NCT02202785|155506284|FG002|Overall Study|Withdrawal by Subject|0|||
48358007|NCT02202785|155506282|FG000|Overall Study|Lost to Follow-up|0|||
48358008|NCT02202785|155506283|FG001|Overall Study|Lost to Follow-up|1|||
48358009|NCT02202785|155506284|FG002|Overall Study|Lost to Follow-up|0|||
48358010|NCT02202785|155506282|FG000|Overall Study|Reason not Specified|10|||
48358011|NCT02202785|155506283|FG001|Overall Study|Reason not Specified|7|||
48358012|NCT02202785|155506284|FG002|Overall Study|Reason not Specified|13|||
48358013|NCT01327846|155506290|FG000|Core Phase|Subject decision (vital status: missing)|1|||
48358014|NCT01327846|155506291|FG001|Core Phase|Subject decision (vital status: missing)|2|||
48358015|NCT01327846|155506292|FG002|Core Phase|Subject decision (vital status: missing)|2|||
48358016|NCT01327846|155506293|FG003|Core Phase|Subject decision (vital status: missing)|1|||
48358017|NCT01327846|155506290|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
48358018|NCT01327846|155506291|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
48358019|NCT01327846|155506292|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
48358020|NCT01327846|155506293|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
48358021|NCT01327846|155506290|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
48358022|NCT01327846|155506291|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
48358023|NCT01327846|155506292|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
48358024|NCT01327846|155506293|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
48358025|NCT01327846|155506290|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
48358026|NCT01327846|155506291|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
48358027|NCT01327846|155506292|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
48358028|NCT01327846|155506293|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
48358029|NCT01327846|155506290|FG000|Core Phase|Lost to Follow-up|3|||
48358030|NCT01327846|155506291|FG001|Core Phase|Lost to Follow-up|3|||
48358031|NCT01327846|155506292|FG002|Core Phase|Lost to Follow-up|4|||
48358032|NCT01327846|155506293|FG003|Core Phase|Lost to Follow-up|5|||
48358033|NCT01327846|155506290|FG000|Extension Phase|Study terminated by sponsor|1073|||
48358034|NCT01327846|155506291|FG001|Extension Phase|Study terminated by sponsor|1124|||
48358035|NCT01327846|155506292|FG002|Extension Phase|Study terminated by sponsor|1067|||
48358036|NCT01327846|155506293|FG003|Extension Phase|Study terminated by sponsor|1660|||
48358037|NCT01327846|155506290|FG000|Extension Phase|Withdrawal by Subject|20|||
48358038|NCT01327846|155506291|FG001|Extension Phase|Withdrawal by Subject|13|||
48358039|NCT01327846|155506292|FG002|Extension Phase|Withdrawal by Subject|19|||
48358040|NCT01327846|155506293|FG003|Extension Phase|Withdrawal by Subject|37|||
48358041|NCT01327846|155506290|FG000|Extension Phase|Lost to Follow-up|4|||
48358042|NCT01327846|155506291|FG001|Extension Phase|Lost to Follow-up|3|||
48358043|NCT01327846|155506292|FG002|Extension Phase|Lost to Follow-up|4|||
48358044|NCT01327846|155506293|FG003|Extension Phase|Lost to Follow-up|7|||
48358045|NCT01327846|155506290|FG000|Extension Phase|Technical Problems|2|||
48358046|NCT01327846|155506291|FG001|Extension Phase|Technical Problems|4|||
48358047|NCT01327846|155506292|FG002|Extension Phase|Technical Problems|2|||
48358048|NCT01327846|155506293|FG003|Extension Phase|Technical Problems|2|||
48358049|NCT01250509|155506296|FG000|Overall Study|Lost to Follow-up|5|||
48358050|NCT01250509|155506297|FG001|Overall Study|Lost to Follow-up|2|||
48358051|NCT02807883|155506300|FG000|Overall Study|Withdrawal by Subject|2|||
48410767|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
48410768|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
48410769|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
48410770|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
48410771|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
48410772|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
48410773|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
48410774|NCT01707992|155690771|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
48410775|NCT01707992|155690772|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
48410776|NCT01707992|155690773|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
48410777|NCT01707992|155690774|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
48410778|NCT01707992|155690775|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
48410779|NCT01707992|155690776|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
48410780|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
48410781|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
48410782|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
48410783|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
48410784|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
48410785|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
48410786|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
48410787|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
48410788|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
48410789|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
48410790|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
48410791|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
48410792|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
48410793|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
48410794|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
48410795|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
48410796|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
48410797|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
48410798|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
48410799|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
48410800|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
48410801|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
48410802|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
48410803|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
48410804|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
48410805|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
48410806|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
48410807|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
48410808|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
48410809|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
48410810|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Death|0|||
48410811|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Death|0|||
48410812|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Death|0|||
48410813|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Death|2|||
48410814|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Death|0|||
48410815|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Death|0|||
48410816|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
48410817|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
48410818|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
48410819|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
48410820|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
48410821|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
48410822|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
48410823|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
48410824|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
48410825|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
48410826|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
48410827|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
48410828|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
48410829|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
48410830|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
48431450|NCT00002663|155767265|FG001|Overall Study|Adverse Event|0|||
48410831|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
48410832|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
48410833|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
48410834|NCT01707992|155690771|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48410835|NCT01707992|155690772|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48410836|NCT01707992|155690773|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48410837|NCT01707992|155690774|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48410838|NCT01707992|155690775|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
48410839|NCT01707992|155690776|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
48410840|NCT02654002|155690781|FG000|Overall Study|Adverse Event|0|||
48410841|NCT02654002|155690782|FG001|Overall Study|Adverse Event|0|||
48410842|NCT02654002|155690783|FG002|Overall Study|Adverse Event|0|||
48410843|NCT02654002|155690784|FG003|Overall Study|Adverse Event|0|||
48410844|NCT02654002|155690785|FG004|Overall Study|Adverse Event|0|||
48410845|NCT02654002|155690786|FG005|Overall Study|Adverse Event|0|||
48410846|NCT02654002|155690787|FG006|Overall Study|Adverse Event|1|||
48410847|NCT02654002|155690788|FG007|Overall Study|Adverse Event|0|||
48410848|NCT02654002|155690789|FG008|Overall Study|Adverse Event|0|||
48410849|NCT02654002|155690781|FG000|Overall Study|Withdrew Consent|0|||
48410850|NCT02654002|155690782|FG001|Overall Study|Withdrew Consent|0|||
48410851|NCT02654002|155690783|FG002|Overall Study|Withdrew Consent|0|||
48410852|NCT02654002|155690784|FG003|Overall Study|Withdrew Consent|0|||
48410853|NCT02654002|155690785|FG004|Overall Study|Withdrew Consent|0|||
48410854|NCT02654002|155690786|FG005|Overall Study|Withdrew Consent|1|||
48410855|NCT02654002|155690787|FG006|Overall Study|Withdrew Consent|0|||
48410856|NCT02654002|155690788|FG007|Overall Study|Withdrew Consent|1|||
48410857|NCT02654002|155690789|FG008|Overall Study|Withdrew Consent|0|||
48410858|NCT00891202|155690790|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
48410859|NCT00891202|155690791|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
48410860|NCT00891202|155690792|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
48410861|NCT00891202|155690793|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
48410862|NCT00891202|155690790|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
48410863|NCT00891202|155690791|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
48410864|NCT00891202|155690792|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
48410865|NCT00891202|155690793|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
48410866|NCT00891202|155690790|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
48410867|NCT00891202|155690791|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
48410868|NCT00891202|155690792|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
48410869|NCT00891202|155690793|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
48410870|NCT00891202|155690790|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
48410871|NCT00891202|155690791|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
48410872|NCT00891202|155690792|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
48410873|NCT00891202|155690793|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
48410874|NCT04429022|155690795|FG000|Overall Study|Protocol Violation|18|||
48410875|NCT04429022|155690796|FG001|Overall Study|Protocol Violation|1|||
48410876|NCT00684177|155690801|FG000|Overall Study|Adverse Event|4|||
48410877|NCT00684177|155690802|FG001|Overall Study|Adverse Event|3|||
48410878|NCT00684177|155690801|FG000|Overall Study|Lack of Efficacy|10|||
48410879|NCT00684177|155690802|FG001|Overall Study|Lack of Efficacy|15|||
48410880|NCT00684177|155690801|FG000|Overall Study|Protocol Violation|1|||
48410881|NCT00684177|155690802|FG001|Overall Study|Protocol Violation|0|||
48410882|NCT00684177|155690801|FG000|Overall Study|Lost to Follow-up|2|||
48410883|NCT00684177|155690802|FG001|Overall Study|Lost to Follow-up|1|||
48410884|NCT00684177|155690801|FG000|Overall Study|Physician Decision|2|||
48410885|NCT00684177|155690802|FG001|Overall Study|Physician Decision|0|||
48410886|NCT00684177|155690801|FG000|Overall Study|Withdrawal by Subject|1|||
48410887|NCT00684177|155690802|FG001|Overall Study|Withdrawal by Subject|2|||
48410888|NCT00684177|155690801|FG000|Overall Study|Other|1|||
48410889|NCT00684177|155690802|FG001|Overall Study|Other|2|||
48410890|NCT01446809|155690803|FG000|Overall Study|Adverse Event|0|||
48410891|NCT01446809|155690804|FG001|Overall Study|Adverse Event|0|||
48410892|NCT01446809|155690805|FG002|Overall Study|Adverse Event|1|||
48410893|NCT01446809|155690803|FG000|Overall Study|Failure to complete study procedures|0|||
48410894|NCT01446809|155690804|FG001|Overall Study|Failure to complete study procedures|0|||
48410895|NCT01446809|155690805|FG002|Overall Study|Failure to complete study procedures|1|||
48410896|NCT03521791|155692273|FG000|Overall Study|Protocol Violation|7|||
48410897|NCT03521791|155692274|FG001|Overall Study|Protocol Violation|17|||
48410898|NCT02090855|155692275|FG000|Overall Study|no evaluable Standard of Truth results|2|||
48410899|NCT03968419|155692282|FG000|Treatment Period|Adverse Event|0|||
48410900|NCT03968419|155692283|FG001|Treatment Period|Adverse Event|0|||
48410901|NCT03968419|155692284|FG002|Treatment Period|Adverse Event|1|||
48410902|NCT03968419|155692282|FG000|Safety Follow-up Period|Death|3|||
48410903|NCT03968419|155692283|FG001|Safety Follow-up Period|Death|2|||
48410904|NCT03968419|155692284|FG002|Safety Follow-up Period|Death|1|||
48410905|NCT03968419|155692282|FG000|Safety Follow-up Period|Subject Decision|2|||
48410906|NCT03968419|155692283|FG001|Safety Follow-up Period|Subject Decision|1|||
48410907|NCT03968419|155692284|FG002|Safety Follow-up Period|Subject Decision|0|||
48410908|NCT03609619|155692291|FG000|Overall Study|Adverse Event|1|||
48410909|NCT03609619|155692292|FG001|Overall Study|Adverse Event|0|||
48410910|NCT03609619|155692291|FG000|Overall Study|Lack of Efficacy|1|||
48410911|NCT03609619|155692292|FG001|Overall Study|Lack of Efficacy|2|||
48410912|NCT03609619|155692291|FG000|Overall Study|Protocol Violation|5|||
48410913|NCT03609619|155692292|FG001|Overall Study|Protocol Violation|0|||
48410914|NCT03609619|155692291|FG000|Overall Study|Withdrawal by Subject|2|||
48410915|NCT03609619|155692292|FG001|Overall Study|Withdrawal by Subject|3|||
48410916|NCT03609619|155692291|FG000|Overall Study|Lost to Follow-up|1|||
48410917|NCT03609619|155692292|FG001|Overall Study|Lost to Follow-up|1|||
48410918|NCT00167245|155692293|FG000|Overall Study|Lost to Follow-up|20|||
48410919|NCT00167245|155692294|FG001|Overall Study|Lost to Follow-up|31|||
48410920|NCT00167245|155692293|FG000|Overall Study|Withdrawal by Subject|5|||
48410921|NCT00167245|155692294|FG001|Overall Study|Withdrawal by Subject|8|||
48410922|NCT00167245|155692293|FG000|Overall Study|Incarcerated|3|||
48410923|NCT00167245|155692294|FG001|Overall Study|Incarcerated|2|||
48410924|NCT00167245|155692293|FG000|Overall Study|Drowsy|1|||
48410925|NCT00167245|155692294|FG001|Overall Study|Drowsy|0|||
48410926|NCT00956943|155692295|FG000|Overall Study|Lost to Follow-up|9|||
48410927|NCT00956943|155692296|FG001|Overall Study|Lost to Follow-up|10|||
48410928|NCT00809328|155692297|FG000|Overall Study|Lack of Efficacy|18|||
48410929|NCT00809328|155692297|FG000|Overall Study|Adverse Event|6|||
48410930|NCT00809328|155692297|FG000|Overall Study|Protocol Violation|3|||
48410931|NCT00809328|155692297|FG000|Overall Study|Withdrawal by Subject|2|||
48410932|NCT02597855|155692300|FG000|Overall Study|Lost to Follow-up|2|||
48410933|NCT02597855|155692301|FG001|Overall Study|Lost to Follow-up|1|||
48410934|NCT02472847|155692302|FG000|Overall Study|Withdrawal by Subject|1|||
48410935|NCT02472847|155692303|FG001|Overall Study|Withdrawal by Subject|5|||
48410936|NCT00008385|155692304|FG000|Overall Study|Off treatment reasons not reported|79|||
48410937|NCT00008385|155692305|FG001|Overall Study|Off treatment reasons not reported|70|||
48410938|NCT00008385|155692304|FG000|Overall Study|Progressive disease|52|||
48410939|NCT00008385|155692305|FG001|Overall Study|Progressive disease|117|||
48410940|NCT00008385|155692304|FG000|Overall Study|Adverse Event|8|||
48410941|NCT00008385|155692305|FG001|Overall Study|Adverse Event|20|||
48410942|NCT00008385|155692304|FG000|Overall Study|Death|12|||
48410943|NCT00008385|155692305|FG001|Overall Study|Death|18|||
48410944|NCT00008385|155692304|FG000|Overall Study|Withdrawal by Subject|67|||
48410945|NCT00008385|155692305|FG001|Overall Study|Withdrawal by Subject|157|||
48410946|NCT00008385|155692304|FG000|Overall Study|Start non-protocol therapy|3|||
48410947|NCT00008385|155692305|FG001|Overall Study|Start non-protocol therapy|1|||
48410948|NCT00008385|155692304|FG000|Overall Study|Other complicating disease|17|||
48410949|NCT00008385|155692305|FG001|Overall Study|Other complicating disease|30|||
48410950|NCT00008385|155692304|FG000|Overall Study|Maximum dose reached|0|||
48410951|NCT00008385|155692305|FG001|Overall Study|Maximum dose reached|2|||
48410952|NCT00008385|155692304|FG000|Overall Study|Other|105|||
48410953|NCT00008385|155692305|FG001|Overall Study|Other|212|||
48410954|NCT00008385|155692304|FG000|Overall Study|Not start protocol therapy|44|||
48410955|NCT00008385|155692305|FG001|Overall Study|Not start protocol therapy|175|||
48410956|NCT00582556|155692306|FG000|Overall Study|Withdrawal by Subject|0|||
48410957|NCT00582556|155692307|FG001|Overall Study|Withdrawal by Subject|1|||
48410958|NCT00582556|155692308|FG002|Overall Study|Withdrawal by Subject|1|||
48410959|NCT00582556|155692306|FG000|Overall Study|Physician Decision|0|||
48410960|NCT00582556|155692307|FG001|Overall Study|Physician Decision|0|||
48410961|NCT00582556|155692308|FG002|Overall Study|Physician Decision|1|||
48410962|NCT00430755|155692317|FG000|Overall Study|Withdrawal by Subject|53|||
48410963|NCT00332709|155692318|FG000|Overall Study|Adverse Event|11|||
48410964|NCT00332709|155692319|FG001|Overall Study|Adverse Event|14|||
48410965|NCT00332709|155692318|FG000|Overall Study|Withdrawal by Subject|2|||
48410966|NCT00332709|155692319|FG001|Overall Study|Withdrawal by Subject|3|||
48410967|NCT00332709|155692318|FG000|Overall Study|Lost to Follow-up|2|||
48410968|NCT00332709|155692319|FG001|Overall Study|Lost to Follow-up|0|||
48410969|NCT00332709|155692318|FG000|Overall Study|Administrative Problems|0|||
48410970|NCT00332709|155692319|FG001|Overall Study|Administrative Problems|3|||
48410971|NCT00332709|155692318|FG000|Overall Study|Abnormal test procedure result|1|||
48410972|NCT00332709|155692319|FG001|Overall Study|Abnormal test procedure result|0|||
48410973|NCT05425563|155692320|FG000|Overall Study|Withdrawal by Subject|17|||
48410974|NCT01001702|155692321|FG000|Overall Study|Lost to Follow-up|7|||
48410975|NCT01001702|155692321|FG000|Overall Study|Adverse Event|7|||
48410976|NCT01001702|155692321|FG000|Overall Study|Sponsor Discontinued Study|4|||
48410977|NCT01001702|155692321|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
48410978|NCT01001702|155692321|FG000|Overall Study|Investigator withdrew Subject|10|||
48410979|NCT01001702|155692321|FG000|Overall Study|Withdrawal by Subject|19|||
48410980|NCT01001702|155692321|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
48410981|NCT03480802|155692322|FG000|Overall Study|Lost to Follow-up|5|||
48410982|NCT03480802|155692323|FG001|Overall Study|Lost to Follow-up|1|||
48410983|NCT03480802|155692322|FG000|Overall Study|Withdrawal by Subject|2|||
48410984|NCT03480802|155692323|FG001|Overall Study|Withdrawal by Subject|1|||
48410985|NCT03480802|155692322|FG000|Overall Study|Relocated|0|||
48410986|NCT03480802|155692323|FG001|Overall Study|Relocated|1|||
48410987|NCT00254566|155692330|FG000|Overall Study|Death|1|||
48410988|NCT00254566|155692331|FG001|Overall Study|Death|0|||
48410989|NCT00254566|155692330|FG000|Overall Study|Adverse Event|5|||
48410990|NCT00254566|155692331|FG001|Overall Study|Adverse Event|4|||
48410991|NCT00254566|155692330|FG000|Overall Study|Lack of Efficacy|12|||
48410992|NCT00254566|155692331|FG001|Overall Study|Lack of Efficacy|9|||
48410993|NCT00254566|155692330|FG000|Overall Study|Other|1|||
48410994|NCT00254566|155692331|FG001|Overall Study|Other|5|||
48410995|NCT00254566|155692330|FG000|Overall Study|Withdrawal by Subject|5|||
48410996|NCT00254566|155692331|FG001|Overall Study|Withdrawal by Subject|6|||
48410997|NCT00254566|155692330|FG000|Overall Study|Lost to Follow-up|7|||
48410998|NCT00254566|155692331|FG001|Overall Study|Lost to Follow-up|2|||
48410999|NCT00059202|155692332|FG000|Overall Study|Withdrawal by Subject|5|||
48411000|NCT00059202|155692333|FG001|Overall Study|Withdrawal by Subject|9|||
48411001|NCT00059202|155692332|FG000|Overall Study|Protocol Violation|1|||
48411002|NCT00059202|155692333|FG001|Overall Study|Protocol Violation|3|||
48411003|NCT00059202|155692332|FG000|Overall Study|drug toxicity|0|||
48411004|NCT00059202|155692333|FG001|Overall Study|drug toxicity|3|||
48411005|NCT00548548|155692336|FG000|Overall Study|Death|345|||
48411006|NCT00548548|155692337|FG001|Overall Study|Death|348|||
48411007|NCT00548548|155692336|FG000|Overall Study|Lost to Follow-up|17|||
48411008|NCT00548548|155692337|FG001|Overall Study|Lost to Follow-up|18|||
48411009|NCT01940484|155692338|FG000|Overall Study|Withdrawal by Subject|3|||
48411010|NCT01940484|155692338|FG000|Overall Study|Underwent transplantation|4|||
48411011|NCT01940484|155692338|FG000|Overall Study|Death|2|||
48411012|NCT01940484|155692338|FG000|Overall Study|Adverse Event|1|||
48411013|NCT01705691|155692339|FG000|Overall Study|Death|1|||
48411014|NCT01705691|155692340|FG001|Overall Study|Death|2|||
48411015|NCT01705691|155692339|FG000|Overall Study|Withdrawal by Subject|1|||
48411016|NCT01705691|155692340|FG001|Overall Study|Withdrawal by Subject|2|||
48411017|NCT01705691|155692339|FG000|Overall Study|Lost to Follow-up|1|||
48411018|NCT01705691|155692340|FG001|Overall Study|Lost to Follow-up|1|||
48411019|NCT01705691|155692339|FG000|Overall Study|Other|0|||
48411020|NCT01705691|155692340|FG001|Overall Study|Other|1|||
48411021|NCT00603239|155692341|FG000|Overall Study|Adverse Event|4|||
48411022|NCT00603239|155692342|FG001|Overall Study|Adverse Event|1|||
48411023|NCT00603239|155692341|FG000|Overall Study|Entry criteria not met|0|||
48411024|NCT00603239|155692342|FG001|Overall Study|Entry criteria not met|1|||
48411025|NCT00603239|155692341|FG000|Overall Study|Loss of glucose control|3|||
48411026|NCT00603239|155692342|FG001|Overall Study|Loss of glucose control|0|||
48411027|NCT00603239|155692341|FG000|Overall Study|Lost to Follow-up|2|||
48411028|NCT00603239|155692342|FG001|Overall Study|Lost to Follow-up|1|||
48411029|NCT00603239|155692341|FG000|Overall Study|Physician Decision|2|||
48411030|NCT00603239|155692342|FG001|Overall Study|Physician Decision|0|||
48411031|NCT00603239|155692341|FG000|Overall Study|Protocol Violation|2|||
48411032|NCT00603239|155692342|FG001|Overall Study|Protocol Violation|0|||
48411033|NCT00603239|155692341|FG000|Overall Study|Subject decision|2|||
48411034|NCT00603239|155692342|FG001|Overall Study|Subject decision|1|||
48411035|NCT01354132|155692343|FG000|Randomization|Physician Decision|1|||
48411036|NCT01354132|155692344|FG001|Randomization|Physician Decision|0|||
48411037|NCT01354132|155692343|FG000|Randomization|Withdrawal by Subject|0|||
48411038|NCT01354132|155692344|FG001|Randomization|Withdrawal by Subject|1|||
48411039|NCT01354132|155692343|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
48411040|NCT01354132|155692344|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
48411041|NCT01354132|155692343|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
48411042|NCT01354132|155692344|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
48411043|NCT01354132|155692343|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
48411044|NCT01354132|155692344|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
48411045|NCT01256177|155692347|FG000|Overall Study|Withdrawal by Subject|23|||
48411046|NCT01256177|155692348|FG001|Overall Study|Withdrawal by Subject|22|||
48411047|NCT01256177|155692347|FG000|Overall Study|Lost to Follow-up|2|||
48411048|NCT01256177|155692348|FG001|Overall Study|Lost to Follow-up|2|||
48411049|NCT01256177|155692347|FG000|Overall Study|Adverse Event|8|||
48411050|NCT01256177|155692348|FG001|Overall Study|Adverse Event|9|||
48411051|NCT01256177|155692347|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
48411052|NCT01256177|155692348|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
48411053|NCT01256177|155692347|FG000|Overall Study|Condition under Investigation Worsened|1|||
48411054|NCT01256177|155692348|FG001|Overall Study|Condition under Investigation Worsened|0|||
48411055|NCT01256177|155692347|FG000|Overall Study|Lack of Efficacy|11|||
48411056|NCT01256177|155692348|FG001|Overall Study|Lack of Efficacy|2|||
48411057|NCT01256177|155692347|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
48411058|NCT01256177|155692348|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
48411059|NCT00553462|155692353|FG000|Overall Study|Adverse Event|4|||
48411060|NCT00553462|155692353|FG000|Overall Study|Progression|4|||
48411061|NCT00553462|155692353|FG000|Overall Study|Withdrawal by Subject|5|||
48411062|NCT00553462|155692353|FG000|Overall Study|Physician Decision|1|||
48411063|NCT02789657|155692354|FG000|Overall Study|Withdrawal by Subject|2|||
48411064|NCT02789657|155692355|FG001|Overall Study|Withdrawal by Subject|0|||
48411065|NCT02789657|155692356|FG002|Overall Study|Withdrawal by Subject|0|||
48411066|NCT02789657|155692357|FG003|Overall Study|Withdrawal by Subject|0|||
48411067|NCT01728779|155692358|FG000|Overall Study|Withdrawal by Subject|1|||
48411068|NCT01679002|155692359|FG000|Overall Study|Adverse Event|1|||
48411069|NCT01679002|155692360|FG001|Overall Study|Adverse Event|1|||
48411070|NCT01679002|155692361|FG002|Overall Study|Adverse Event|0|||
48411071|NCT00110994|155692362|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
48411072|NCT00110994|155692363|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
48411073|NCT00110994|155692362|FG000|Double-blind (DB) Treatment|Death|1|||
48411074|NCT00110994|155692363|FG001|Double-blind (DB) Treatment|Death|0|||
48411075|NCT00110994|155692362|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
48411076|NCT00110994|155692363|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
48411077|NCT00110994|155692362|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
48411078|NCT00110994|155692363|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
48411079|NCT00110994|155692362|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
48411080|NCT00110994|155692363|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
48411081|NCT00110994|155692362|FG000|Double-blind (DB) Treatment|other reasons|2|||
48411082|NCT00110994|155692363|FG001|Double-blind (DB) Treatment|other reasons|3|||
48411083|NCT00110994|155692362|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
48411084|NCT00110994|155692363|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
48411085|NCT00110994|155692362|FG000|Active Follow-up|Other reasons|0|||
48411086|NCT00110994|155692363|FG001|Active Follow-up|Other reasons|2|||
48411087|NCT00110994|155692362|FG000|Long Term Follow-up|Death|19|||
48411088|NCT00110994|155692363|FG001|Long Term Follow-up|Death|17|||
48411089|NCT01596257|155692365|FG000|Overall Study|Inadequate Collection|23|||
48411090|NCT01596257|155692366|FG001|Overall Study|Inadequate Collection|19|||
48411091|NCT02772757|155692367|FG000|Overall Study|Withdrawal by Subject|1|||
48411092|NCT02772757|155692368|FG001|Overall Study|Withdrawal by Subject|0|||
48411093|NCT02772757|155692369|FG002|Overall Study|Withdrawal by Subject|1|||
48411094|NCT02772757|155692367|FG000|Overall Study|Protocol Violation|0|||
48411095|NCT02772757|155692368|FG001|Overall Study|Protocol Violation|0|||
48411096|NCT02772757|155692369|FG002|Overall Study|Protocol Violation|1|||
48411097|NCT02772757|155692367|FG000|Overall Study|Physician Decision|0|||
48411098|NCT02772757|155692368|FG001|Overall Study|Physician Decision|3|||
48411099|NCT02772757|155692369|FG002|Overall Study|Physician Decision|3|||
48411100|NCT03486392|155692372|FG000|Overall Study|Lost to Follow-up|0|||
48692528|NCT01755234|156724520|FG001|Overall Study|Change in surgical case|1|||
48692529|NCT01755234|156724519|FG000|Overall Study|case cancelled|1|||
48692530|NCT01755234|156724520|FG001|Overall Study|case cancelled|0|||
48692531|NCT01755234|156724519|FG000|Overall Study|Withdrawal by Subject|0|||
48692532|NCT01755234|156724520|FG001|Overall Study|Withdrawal by Subject|1|||
48692533|NCT01755234|156724519|FG000|Overall Study|unblinded|1|||
48358052|NCT00846807|155506313|FG000|Overall Study|Adverse Event|270|||
48358053|NCT00846807|155506313|FG000|Overall Study|Lost to Follow-up|94|||
48692534|NCT01755234|156724520|FG001|Overall Study|unblinded|0|||
48692535|NCT02322281|156724523|FG000|Overall Study|Progressive Disease|42|||
48358054|NCT00846807|155506313|FG000|Overall Study|Withdrawal by Subject|56|||
48358055|NCT00846807|155506313|FG000|Overall Study|Non compliant with European label|7|||
48358056|NCT00846807|155506313|FG000|Overall Study|Switch to other anticoagulants|89|||
48358057|NCT00846807|155506313|FG000|Overall Study|No prescription after hospital discharge|56|||
48358058|NCT00846807|155506313|FG000|Overall Study|Other|60|||
48358059|NCT00996606|155506314|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
48358060|NCT00996606|155506314|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48358061|NCT00996606|155506314|FG000|Overall Study|Protocol Violation|1|||
48358062|NCT00996606|155506314|FG000|Overall Study|Withdrawal by Subject|3|||
48358063|NCT00972322|155506315|FG000|Overall Study|Adverse Event|2|||
48358064|NCT00972322|155506316|FG001|Overall Study|Adverse Event|1|||
48358065|NCT00972322|155506315|FG000|Overall Study|Positive drug screen|0|||
48358066|NCT00972322|155506316|FG001|Overall Study|Positive drug screen|1|||
48358067|NCT00972322|155506315|FG000|Overall Study|Lost to Follow-up|0|||
48358068|NCT00972322|155506316|FG001|Overall Study|Lost to Follow-up|1|||
48358069|NCT00972322|155506315|FG000|Overall Study|Consistently high glucose values|1|||
48358070|NCT00972322|155506316|FG001|Overall Study|Consistently high glucose values|0|||
48358071|NCT00607724|155506325|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
48358072|NCT00607724|155506326|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
48358073|NCT00607724|155506327|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
48358074|NCT00607724|155506328|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
48358075|NCT00607724|155506329|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
48358076|NCT00607724|155506330|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
48358077|NCT00607724|155506331|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
48358078|NCT00607724|155506325|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
48358079|NCT00607724|155506326|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
48358080|NCT00607724|155506327|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
48358081|NCT00607724|155506328|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
48358082|NCT00607724|155506329|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
48358083|NCT00607724|155506330|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
48358084|NCT00607724|155506331|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
48358085|NCT00607724|155506325|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
48358086|NCT00607724|155506326|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
48358087|NCT00607724|155506327|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
48358088|NCT00607724|155506328|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
48358089|NCT00607724|155506329|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
48358090|NCT00607724|155506330|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
48358091|NCT00607724|155506331|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
48358092|NCT00607724|155506325|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
48358093|NCT00607724|155506326|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
48358094|NCT00607724|155506327|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
48358095|NCT00607724|155506328|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
48358096|NCT00607724|155506329|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
48358097|NCT00607724|155506330|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
48358098|NCT00607724|155506331|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
48358099|NCT00607724|155506325|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48358100|NCT00607724|155506326|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48358101|NCT00607724|155506327|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48358102|NCT00607724|155506328|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
48358103|NCT00607724|155506329|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48358104|NCT00607724|155506330|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48358105|NCT00607724|155506331|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
48358106|NCT01241604|155506332|FG000|Screening Period|Screen Failure|3|||
48358107|NCT01241604|155506333|FG001|Screening Period|Screen Failure|0|||
48358108|NCT01241604|155506334|FG002|Screening Period|Screen Failure|0|||
48358109|NCT03548220|155506335|FG000|Overall Study|Lost to Follow-up|1|||
48358110|NCT03548220|155506336|FG001|Overall Study|Lost to Follow-up|0|||
48358111|NCT03548220|155506337|FG002|Overall Study|Lost to Follow-up|0|||
48358112|NCT03548220|155506338|FG003|Overall Study|Lost to Follow-up|0|||
48358113|NCT00611975|155506339|FG000|Overall Study|Withdrawal by Subject|3|||
48358114|NCT00611975|155506340|FG001|Overall Study|Withdrawal by Subject|7|||
48358115|NCT00611975|155506339|FG000|Overall Study|Pregnancy|2|||
48358116|NCT00611975|155506340|FG001|Overall Study|Pregnancy|1|||
48358117|NCT01435772|155506341|FG000|Overall Study|Adverse Event|1|||
48358118|NCT01435772|155506342|FG001|Overall Study|Adverse Event|0|||
48358119|NCT01435772|155506343|FG002|Overall Study|Adverse Event|2|||
48358120|NCT01435772|155506341|FG000|Overall Study|Withdrawal by Subject|0|||
48358121|NCT01435772|155506342|FG001|Overall Study|Withdrawal by Subject|1|||
48358122|NCT01435772|155506343|FG002|Overall Study|Withdrawal by Subject|3|||
48358123|NCT01435772|155506341|FG000|Overall Study|Other - study termination|2|||
48358124|NCT01435772|155506342|FG001|Overall Study|Other - study termination|2|||
48411101|NCT03486392|155692373|FG001|Overall Study|Lost to Follow-up|0|||
48411102|NCT03486392|155692374|FG002|Overall Study|Lost to Follow-up|8|||
48411103|NCT03486392|155692375|FG003|Overall Study|Lost to Follow-up|5|||
48411104|NCT03486392|155692376|FG004|Overall Study|Lost to Follow-up|2|||
48411105|NCT03486392|155692372|FG000|Overall Study|Withdrawal by Subject|3|||
48411106|NCT03486392|155692373|FG001|Overall Study|Withdrawal by Subject|0|||
48411107|NCT03486392|155692374|FG002|Overall Study|Withdrawal by Subject|6|||
48411108|NCT03486392|155692375|FG003|Overall Study|Withdrawal by Subject|4|||
48411109|NCT03486392|155692376|FG004|Overall Study|Withdrawal by Subject|1|||
48411110|NCT03486392|155692372|FG000|Overall Study|Death|0|||
48411111|NCT03486392|155692373|FG001|Overall Study|Death|0|||
48411112|NCT03486392|155692374|FG002|Overall Study|Death|0|||
48411113|NCT03486392|155692375|FG003|Overall Study|Death|0|||
48411114|NCT03486392|155692376|FG004|Overall Study|Death|1|||
48411115|NCT01147926|155692378|FG000|Overall Study|Subject Withdrew Consent|9|||
48358125|NCT01435772|155506343|FG002|Overall Study|Other - study termination|10|||
48358126|NCT01008553|155507338|FG000|Period 1 (Titration Period)|Physician Decision|2|||
48358127|NCT01008553|155507339|FG001|Period 1 (Titration Period)|Physician Decision|0|||
48358128|NCT01008553|155507340|FG002|Period 1 (Titration Period)|Physician Decision|0|||
48358129|NCT01008553|155507338|FG000|Period 1 (Titration Period)|Adverse Event|33|||
48358130|NCT01008553|155507339|FG001|Period 1 (Titration Period)|Adverse Event|0|||
48358131|NCT01008553|155507340|FG002|Period 1 (Titration Period)|Adverse Event|0|||
48358132|NCT01008553|155507338|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
48411116|NCT01147926|155692379|FG001|Overall Study|Subject Withdrew Consent|10|||
48411117|NCT01147926|155692378|FG000|Overall Study|Adverse Event|7|||
48358133|NCT01008553|155507339|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
48411118|NCT01147926|155692379|FG001|Overall Study|Adverse Event|6|||
48411119|NCT01147926|155692378|FG000|Overall Study|Subject Non-Compliant|5|||
48411120|NCT01147926|155692379|FG001|Overall Study|Subject Non-Compliant|4|||
48411121|NCT01147926|155692378|FG000|Overall Study|Principal investigator left hospital|1|||
48411122|NCT01147926|155692379|FG001|Overall Study|Principal investigator left hospital|3|||
48411123|NCT01147926|155692378|FG000|Overall Study|Selection criteria not met|3|||
48411124|NCT01147926|155692379|FG001|Overall Study|Selection criteria not met|1|||
48411125|NCT01147926|155692378|FG000|Overall Study|Lost to Follow-up|0|||
48411126|NCT01147926|155692379|FG001|Overall Study|Lost to Follow-up|2|||
48411127|NCT01147926|155692378|FG000|Overall Study|Sponsor's Decision|0|||
48411128|NCT01147926|155692379|FG001|Overall Study|Sponsor's Decision|1|||
48411129|NCT01147926|155692378|FG000|Overall Study|Lack of Efficacy|1|||
48411130|NCT01147926|155692379|FG001|Overall Study|Lack of Efficacy|0|||
48411131|NCT01147926|155692378|FG000|Overall Study|Too busy, no time for study|1|||
48411132|NCT01147926|155692379|FG001|Overall Study|Too busy, no time for study|0|||
48411133|NCT01147926|155692378|FG000|Overall Study|Went on holiday|0|||
48411134|NCT01147926|155692379|FG001|Overall Study|Went on holiday|1|||
48411135|NCT01147926|155692378|FG000|Overall Study|Colonoscopy result|0|||
48411136|NCT01147926|155692379|FG001|Overall Study|Colonoscopy result|1|||
48411137|NCT01727258|155692380|FG000|Overall Study|Adverse Event|0|||
48411138|NCT01727258|155692381|FG001|Overall Study|Adverse Event|2|||
48411139|NCT01727258|155692382|FG002|Overall Study|Adverse Event|0|||
48411140|NCT01727258|155692380|FG000|Overall Study|Noncompliance with Study Drug|0|||
48411141|NCT01727258|155692381|FG001|Overall Study|Noncompliance with Study Drug|0|||
48411142|NCT01727258|155692382|FG002|Overall Study|Noncompliance with Study Drug|1|||
48411143|NCT01727258|155692380|FG000|Overall Study|Withdrawal by Subject|1|||
48411144|NCT01727258|155692381|FG001|Overall Study|Withdrawal by Subject|1|||
48411145|NCT01727258|155692382|FG002|Overall Study|Withdrawal by Subject|0|||
48411146|NCT01727258|155692380|FG000|Overall Study|Lost to Follow-up|1|||
48411147|NCT01727258|155692381|FG001|Overall Study|Lost to Follow-up|0|||
48411148|NCT01727258|155692382|FG002|Overall Study|Lost to Follow-up|0|||
48411149|NCT01763164|155692385|FG000|Treatment Phase|Participant/Guardian decision|26|||
48411150|NCT01763164|155692386|FG001|Treatment Phase|Participant/Guardian decision|14|||
48411151|NCT01763164|155692385|FG000|Treatment Phase|Protocol Violation|1|||
48411152|NCT01763164|155692386|FG001|Treatment Phase|Protocol Violation|1|||
48411153|NCT01763164|155692385|FG000|Treatment Phase|Progressive Disease|142|||
48411154|NCT01763164|155692386|FG001|Treatment Phase|Progressive Disease|76|||
48411155|NCT01763164|155692385|FG000|Treatment Phase|Physician Decision|24|||
48411156|NCT01763164|155692386|FG001|Treatment Phase|Physician Decision|13|||
48411157|NCT01763164|155692385|FG000|Treatment Phase|Death|10|||
48411158|NCT01763164|155692386|FG001|Treatment Phase|Death|1|||
48411159|NCT01763164|155692385|FG000|Treatment Phase|Adverse Event|66|||
48411160|NCT01763164|155692386|FG001|Treatment Phase|Adverse Event|8|||
48411161|NCT01763164|155692385|FG000|Treatment Phase|Randomized but not Treated|0|||
48411162|NCT01763164|155692386|FG001|Treatment Phase|Randomized but not Treated|19|||
48411163|NCT01763164|155692385|FG000|Treatment Phase|Other|0|||
48358134|NCT01008553|155507340|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
48358135|NCT01008553|155507338|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
48358136|NCT01008553|155507339|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
48358137|NCT01008553|155507340|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
48358138|NCT01008553|155507338|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
48358139|NCT01008553|155507339|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
48358140|NCT01008553|155507340|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
48358141|NCT01008553|155507338|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
48358142|NCT01008553|155507339|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
48358143|NCT01008553|155507340|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
48358144|NCT01008553|155507338|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
48358145|NCT01008553|155507339|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
48358146|NCT01008553|155507340|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
48358147|NCT01008553|155507338|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
48358148|NCT01008553|155507339|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
48358149|NCT01008553|155507340|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
48358150|NCT01008553|155507338|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
48358151|NCT01008553|155507339|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
48411164|NCT01763164|155692386|FG001|Treatment Phase|Other|1|||
48411165|NCT01763164|155692385|FG000|Follow up Phase|New therapy for study indication|12|||
48411166|NCT01763164|155692386|FG001|Follow up Phase|New therapy for study indication|3|||
48411167|NCT01763164|155692385|FG000|Follow up Phase|Death|21|||
48411168|NCT01763164|155692386|FG001|Follow up Phase|Death|4|||
48411169|NCT01763164|155692385|FG000|Follow up Phase|Subject/guardian decision|9|||
48411170|NCT01763164|155692386|FG001|Follow up Phase|Subject/guardian decision|2|||
48411171|NCT01763164|155692385|FG000|Follow up Phase|Progressive disease|127|||
48411172|NCT01763164|155692386|FG001|Follow up Phase|Progressive disease|62|||
48411173|NCT01763164|155692385|FG000|Follow up Phase|Physician Decision|10|||
48411174|NCT01763164|155692386|FG001|Follow up Phase|Physician Decision|3|||
48411175|NCT01763164|155692385|FG000|Follow up Phase|Lost to Follow-up|1|||
48411176|NCT01763164|155692386|FG001|Follow up Phase|Lost to Follow-up|0|||
48358152|NCT01008553|155507340|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
48358153|NCT01008553|155507338|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
48358154|NCT01008553|155507339|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
48358155|NCT01008553|155507340|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
48358156|NCT01008553|155507338|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
48358157|NCT01008553|155507339|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
48358158|NCT01008553|155507340|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
48358159|NCT01008553|155507338|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
48358160|NCT01008553|155507339|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
48358161|NCT01008553|155507340|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
48358162|NCT01008553|155507338|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
48358163|NCT01008553|155507339|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
48358164|NCT01008553|155507340|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
48358165|NCT01008553|155507338|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
48358166|NCT01008553|155507339|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
48358167|NCT01008553|155507340|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
48358168|NCT03563716|155507344|FG000|Overall Study|Death|20|||
48358169|NCT03563716|155507345|FG001|Overall Study|Death|14|||
48358170|NCT03563716|155507344|FG000|Overall Study|Withdrawal by Subject|3|||
48358171|NCT03563716|155507345|FG001|Overall Study|Withdrawal by Subject|3|||
48358172|NCT03563716|155507344|FG000|Overall Study|Still on Study|45|||
48358173|NCT03563716|155507345|FG001|Overall Study|Still on Study|50|||
48358174|NCT05816551|155507348|FG000|Overall Study|Withdrawal by Subject|0|||
48358175|NCT05816551|155507349|FG001|Overall Study|Withdrawal by Subject|1|||
48358176|NCT05816551|155507348|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
48358177|NCT05816551|155507349|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
48358178|NCT04783935|155507352|FG000|Overall Study|Withdrawal by Subject|6|||
48358179|NCT04783935|155507352|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
48358180|NCT04783935|155507352|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
48358181|NCT04783935|155507352|FG000|Overall Study|Lost to Follow-up|3|||
48358182|NCT04783935|155507352|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
48358183|NCT05273749|155507353|FG000|Overall Study|Adverse Event|14|||
48358184|NCT05273749|155507354|FG001|Overall Study|Adverse Event|8|||
48358185|NCT05273749|155507353|FG000|Overall Study|Lack of Efficacy|2|||
48358186|NCT05273749|155507354|FG001|Overall Study|Lack of Efficacy|8|||
48358187|NCT05273749|155507353|FG000|Overall Study|Physician Decision|0|||
48358188|NCT05273749|155507354|FG001|Overall Study|Physician Decision|2|||
48358189|NCT05273749|155507353|FG000|Overall Study|Withdrawal by Subject|14|||
48358190|NCT05273749|155507354|FG001|Overall Study|Withdrawal by Subject|16|||
48358191|NCT05273749|155507353|FG000|Overall Study|Lost to Follow-up|10|||
48358192|NCT05273749|155507354|FG001|Overall Study|Lost to Follow-up|10|||
48358193|NCT05273749|155507353|FG000|Overall Study|Pregnancy|1|||
48358194|NCT05273749|155507354|FG001|Overall Study|Pregnancy|0|||
48358195|NCT05273749|155507353|FG000|Overall Study|Non-Compliance|3|||
48358196|NCT05273749|155507354|FG001|Overall Study|Non-Compliance|2|||
48358197|NCT05273749|155507353|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
48358198|NCT05273749|155507354|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
48358199|NCT01594827|155507357|FG000|Overall Study|Adverse Event|1|||
48358200|NCT01594827|155507358|FG001|Overall Study|Adverse Event|0|||
48358201|NCT01594827|155507357|FG000|Overall Study|Physician Decision|3|||
48358202|NCT01594827|155507358|FG001|Overall Study|Physician Decision|0|||
48358203|NCT01736189|155507359|FG000|Overall Study|Violation of registration criteria|41|||
48358204|NCT01736189|155507359|FG000|Overall Study|Protocol Violation|4|||
48358205|NCT01736189|155507359|FG000|Overall Study|Criteria and protocol violations|1|||
48358206|NCT04179500|155507360|FG000|Treatment|Withdrawal by Subject|1|||
48358207|NCT04179500|155507360|FG000|Treatment|Adverse Event|2|||
48358208|NCT04179500|155507360|FG000|Treatment|pyrazinamide resistance|1|||
48358209|NCT03274453|155507370|FG000|Overall Study|Lost to Follow-up|2|||
48358210|NCT03274453|155507371|FG001|Overall Study|Lost to Follow-up|5|||
48358211|NCT03274453|155507372|FG002|Overall Study|Lost to Follow-up|4|||
48358212|NCT03274453|155507373|FG003|Overall Study|Lost to Follow-up|1|||
48358213|NCT03274453|155507370|FG000|Overall Study|Physician Decision|2|||
48358214|NCT03274453|155507371|FG001|Overall Study|Physician Decision|0|||
48358215|NCT03274453|155507372|FG002|Overall Study|Physician Decision|0|||
48358216|NCT03274453|155507373|FG003|Overall Study|Physician Decision|3|||
48358217|NCT03274453|155507370|FG000|Overall Study|Surgery Cancelled|0|||
48358218|NCT03274453|155507371|FG001|Overall Study|Surgery Cancelled|1|||
48358219|NCT03274453|155507372|FG002|Overall Study|Surgery Cancelled|0|||
48358220|NCT03274453|155507373|FG003|Overall Study|Surgery Cancelled|0|||
48358221|NCT01661205|155507379|FG000|Overall Study|Physician Decision|2|||
48411177|NCT01763164|155692385|FG000|Follow up Phase|Adverse Event|17|||
48411178|NCT01763164|155692386|FG001|Follow up Phase|Adverse Event|1|||
48411179|NCT00074958|155692392|FG000|Overall Study|Adverse Event|1|||
48411180|NCT00675597|155692393|FG000|Overall Study|Withdrawal by Subject|3|||
48411181|NCT01709331|155692394|FG000|Overall Study|Adverse Event|1|||
48411182|NCT03896295|155692398|FG000|Overall Study|Adverse Event|0|||
48411183|NCT03896295|155692399|FG001|Overall Study|Adverse Event|1|||
48411184|NCT03896295|155692398|FG000|Overall Study|COVID-19|7|||
48411185|NCT03896295|155692399|FG001|Overall Study|COVID-19|29|||
48411186|NCT02604264|155692403|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
48411187|NCT02604264|155692404|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
48411188|NCT01412229|155692408|FG000|Overall Study|Physician Decision|1|||
48411189|NCT00787787|155692409|FG000|Overall Study|Lack of Efficacy|4|||
48411190|NCT00787787|155692409|FG000|Overall Study|Adverse Event|3|||
48411191|NCT00151892|155692417|FG000|Overall Study|Lack of Efficacy|50|||
48411192|NCT00151892|155692418|FG001|Overall Study|Lack of Efficacy|57|||
48411193|NCT00151892|155692417|FG000|Overall Study|Patient request|10|||
48411194|NCT00151892|155692418|FG001|Overall Study|Patient request|7|||
48411195|NCT00151892|155692417|FG000|Overall Study|Lost to Follow-up|5|||
48411196|NCT00151892|155692418|FG001|Overall Study|Lost to Follow-up|10|||
48411197|NCT00151892|155692417|FG000|Overall Study|Adverse Event|6|||
48411198|NCT00151892|155692418|FG001|Overall Study|Adverse Event|3|||
48411199|NCT00151892|155692417|FG000|Overall Study|Protocol Violation|3|||
48411200|NCT00151892|155692418|FG001|Overall Study|Protocol Violation|3|||
48411201|NCT00151892|155692417|FG000|Overall Study|Non-compliance|0|||
48411202|NCT00151892|155692418|FG001|Overall Study|Non-compliance|1|||
48411203|NCT00151892|155692417|FG000|Overall Study|Pregnancy|0|||
48411204|NCT00151892|155692418|FG001|Overall Study|Pregnancy|1|||
48411205|NCT00151892|155692417|FG000|Overall Study|Did not return for a visit|1|||
48411206|NCT00151892|155692418|FG001|Overall Study|Did not return for a visit|0|||
48411207|NCT00151892|155692417|FG000|Overall Study|Used prohibited corticosteroids|1|||
48411208|NCT00151892|155692418|FG001|Overall Study|Used prohibited corticosteroids|0|||
48411209|NCT00151892|155692417|FG000|Overall Study|Lack of study medication at center|0|||
48411210|NCT00151892|155692418|FG001|Overall Study|Lack of study medication at center|1|||
48411211|NCT02502864|155692419|FG000|Overall Study|Withdrawal by Subject|1|||
48411212|NCT02770807|155692420|FG000|Overall Study|Adverse Event|3|||
48411213|NCT02770807|155692421|FG001|Overall Study|Adverse Event|3|||
48411214|NCT02770807|155692422|FG002|Overall Study|Adverse Event|1|||
48411215|NCT02770807|155692420|FG000|Overall Study|Withdrawal by Subject|7|||
48411216|NCT02770807|155692421|FG001|Overall Study|Withdrawal by Subject|3|||
48411217|NCT02770807|155692422|FG002|Overall Study|Withdrawal by Subject|4|||
48411218|NCT02770807|155692420|FG000|Overall Study|Other|0|||
48411219|NCT02770807|155692421|FG001|Overall Study|Other|1|||
48411220|NCT02770807|155692422|FG002|Overall Study|Other|0|||
48411221|NCT02770807|155692420|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
48411222|NCT02770807|155692421|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
48411223|NCT02770807|155692422|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
48411224|NCT02770807|155692420|FG000|Overall Study|Physician Decision|0|||
48411225|NCT02770807|155692421|FG001|Overall Study|Physician Decision|0|||
48411226|NCT02770807|155692422|FG002|Overall Study|Physician Decision|1|||
48411227|NCT02949128|155694857|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
48411228|NCT02949128|155694857|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
48411229|NCT02949128|155694857|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
48411230|NCT02949128|155694857|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
48411231|NCT02949128|155694857|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
48411232|NCT02949128|155694857|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
48411233|NCT02949128|155694857|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
48411234|NCT02949128|155694857|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
48411235|NCT02949128|155694857|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
48411236|NCT02949128|155694857|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
48411237|NCT00925600|155694861|FG000|Overall Study|Withdrawal by Subject|16|||
48411238|NCT00925600|155694862|FG001|Overall Study|Withdrawal by Subject|14|||
48411239|NCT00925600|155694861|FG000|Overall Study|Death|4|||
48411240|NCT00925600|155694862|FG001|Overall Study|Death|3|||
48411241|NCT00925600|155694861|FG000|Overall Study|Lost to Follow-up|2|||
48411242|NCT00925600|155694862|FG001|Overall Study|Lost to Follow-up|2|||
48411243|NCT00925600|155694861|FG000|Overall Study|Disease Progression|1|||
48411244|NCT00925600|155694862|FG001|Overall Study|Disease Progression|3|||
48411245|NCT00925600|155694861|FG000|Overall Study|Administrative Decision|1|||
48411246|NCT00925600|155694862|FG001|Overall Study|Administrative Decision|1|||
48411247|NCT00925600|155694861|FG000|Overall Study|Noncompliance|2|||
48411248|NCT00925600|155694862|FG001|Overall Study|Noncompliance|0|||
48411249|NCT00925600|155694861|FG000|Overall Study|Ineligibility Determined|2|||
48411250|NCT00925600|155694862|FG001|Overall Study|Ineligibility Determined|0|||
48411251|NCT00925600|155694861|FG000|Overall Study|Protocol Deviation|0|||
48411252|NCT00925600|155694862|FG001|Overall Study|Protocol Deviation|1|||
48411253|NCT00925600|155694861|FG000|Overall Study|Requirement for Alternative Therapy|0|||
48411254|NCT00925600|155694862|FG001|Overall Study|Requirement for Alternative Therapy|1|||
48411255|NCT00925600|155694861|FG000|Overall Study|Other|3|||
48411256|NCT00925600|155694862|FG001|Overall Study|Other|1|||
48411257|NCT00925600|155694861|FG000|Overall Study|Adverse Event|1|||
48411258|NCT00925600|155694862|FG001|Overall Study|Adverse Event|2|||
48411259|NCT00935883|155694863|FG000|Treatment Period|Physician Decision|1|||
48411260|NCT00935883|155694864|FG001|Treatment Period|Physician Decision|0|||
48411261|NCT00935883|155694863|FG000|Treatment Period|Withdrawal by Subject|0|||
48411262|NCT00935883|155694864|FG001|Treatment Period|Withdrawal by Subject|2|||
48411263|NCT01974817|155694865|FG000|Overall Study|Death|4|||
48411264|NCT01974817|155694865|FG000|Overall Study|Lost to Follow-up|2|||
48411265|NCT01974817|155694865|FG000|Overall Study|Protocol Violation|2|||
48411266|NCT03593915|155694866|FG000|Overall Study|Adverse Event|0|||
48411267|NCT03593915|155694867|FG001|Overall Study|Adverse Event|0|||
48411268|NCT03593915|155694868|FG002|Overall Study|Adverse Event|0|||
48411269|NCT03593915|155694869|FG003|Overall Study|Adverse Event|1|||
48411270|NCT03593915|155694870|FG004|Overall Study|Adverse Event|0|||
48411271|NCT03593915|155694871|FG005|Overall Study|Adverse Event|0|||
48411272|NCT03593915|155694866|FG000|Overall Study|Physician Decision|0|||
48411273|NCT03593915|155694867|FG001|Overall Study|Physician Decision|0|||
48411274|NCT03593915|155694868|FG002|Overall Study|Physician Decision|0|||
48411275|NCT03593915|155694869|FG003|Overall Study|Physician Decision|0|||
48411276|NCT03593915|155694870|FG004|Overall Study|Physician Decision|0|||
48411277|NCT03593915|155694871|FG005|Overall Study|Physician Decision|1|||
48411278|NCT01246206|155694873|FG000|Overall Study|Patient did not receive study regiments.|1|||
48411279|NCT01097629|155694874|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
48411280|NCT01097629|155694875|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
48411281|NCT01097629|155694876|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
48411282|NCT01097629|155694877|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48411283|NCT01097629|155694878|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48411284|NCT01097629|155694879|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48411285|NCT01097629|155694880|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48411286|NCT01097629|155694881|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48411287|NCT01097629|155694874|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
48411288|NCT01097629|155694875|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
48411289|NCT01097629|155694876|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
48411290|NCT01097629|155694877|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48411291|NCT01097629|155694878|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48411292|NCT01097629|155694879|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48411293|NCT01097629|155694880|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48411294|NCT01097629|155694881|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48411295|NCT01097629|155694874|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
48411296|NCT01097629|155694875|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
48411297|NCT01097629|155694876|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
48411298|NCT01097629|155694877|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48411299|NCT01097629|155694878|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48411300|NCT01097629|155694879|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48411301|NCT01097629|155694880|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48411302|NCT01097629|155694881|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48411303|NCT01097629|155694874|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
48411304|NCT01097629|155694875|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
48411305|NCT01097629|155694876|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
48411306|NCT01097629|155694877|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48411307|NCT01097629|155694878|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48411308|NCT01097629|155694879|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48358222|NCT05875142|155507380|FG000|Overall Study|Lost to Follow-up|0|||
48358223|NCT05875142|155507381|FG001|Overall Study|Lost to Follow-up|1|||
48358224|NCT05875142|155507382|FG002|Overall Study|Lost to Follow-up|1|||
48358225|NCT01939353|155507383|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
48358226|NCT01939353|155507383|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
48358227|NCT01939353|155507383|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
48358228|NCT01939353|155507383|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
48358229|NCT01939353|155507383|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
48358230|NCT01689857|155507386|FG000|Overall Study|Lost to Follow-up|5|||
48358231|NCT01689857|155507387|FG001|Overall Study|Lost to Follow-up|2|||
48358232|NCT01730378|155507388|FG000|Overall Study|Lost to Follow-up|1|||
48358233|NCT01730378|155507389|FG001|Overall Study|Lost to Follow-up|0|||
48358234|NCT00983853|155507390|FG000|Overall Study|Lost to Follow-up|1|||
48358235|NCT00983853|155507391|FG001|Overall Study|Lost to Follow-up|1|||
48358236|NCT00983853|155507392|FG002|Overall Study|Lost to Follow-up|2|||
48358237|NCT00983853|155507393|FG003|Overall Study|Lost to Follow-up|2|||
48358238|NCT00983853|155507394|FG004|Overall Study|Lost to Follow-up|2|||
48358239|NCT00983853|155507395|FG005|Overall Study|Lost to Follow-up|1|||
48358240|NCT00983853|155507390|FG000|Overall Study|Withdrawal by Subject|0|||
48358241|NCT00983853|155507391|FG001|Overall Study|Withdrawal by Subject|0|||
48358242|NCT00983853|155507392|FG002|Overall Study|Withdrawal by Subject|1|||
48358243|NCT00983853|155507393|FG003|Overall Study|Withdrawal by Subject|0|||
48358244|NCT00983853|155507394|FG004|Overall Study|Withdrawal by Subject|1|||
48358245|NCT00983853|155507395|FG005|Overall Study|Withdrawal by Subject|0|||
48358246|NCT00983853|155507390|FG000|Overall Study|Unable to come to study follow-up visits|0|||
48358247|NCT00983853|155507391|FG001|Overall Study|Unable to come to study follow-up visits|1|||
48358248|NCT00983853|155507392|FG002|Overall Study|Unable to come to study follow-up visits|0|||
48358249|NCT00983853|155507393|FG003|Overall Study|Unable to come to study follow-up visits|0|||
48358250|NCT00983853|155507394|FG004|Overall Study|Unable to come to study follow-up visits|0|||
48358251|NCT00983853|155507395|FG005|Overall Study|Unable to come to study follow-up visits|0|||
48358262|NCT00737477|155507400|FG000|Overall Study|Adverse Event|9|||
48358263|NCT00737477|155507400|FG000|Overall Study|Death|9|||
48358264|NCT00737477|155507400|FG000|Overall Study|Treatment Refusal|1|||
48358265|NCT00737477|155507400|FG000|Overall Study|Withdrawal by Subject|1|||
48358266|NCT00737477|155507400|FG000|Overall Study|Renal Transplantation|10|||
48358267|NCT00737477|155507400|FG000|Overall Study|Other|4|||
48358268|NCT01370655|155507401|FG000|Period 1|Adverse Event|2|||
48358269|NCT01370655|155507402|FG001|Period 1|Adverse Event|0|||
48358270|NCT01370655|155507403|FG002|Period 1|Adverse Event|0|||
48358271|NCT01370655|155507404|FG003|Period 1|Adverse Event|0|||
48358272|NCT01370655|155507405|FG004|Period 1|Adverse Event|0|||
48358273|NCT01370655|155507406|FG005|Period 1|Adverse Event|0|||
48358274|NCT01370655|155507407|FG006|Period 1|Adverse Event|1|||
48358275|NCT01370655|155507408|FG007|Period 1|Adverse Event|0|||
48358276|NCT01370655|155507409|FG008|Period 1|Adverse Event|0|||
48358277|NCT01370655|155507410|FG009|Period 1|Adverse Event|0|||
48358278|NCT01370655|155507411|FG010|Period 1|Adverse Event|0|||
48358279|NCT01370655|155507412|FG011|Period 1|Adverse Event|0|||
48358280|NCT01370655|155507401|FG000|Period 2|Adverse Event|0|||
48358281|NCT01370655|155507402|FG001|Period 2|Adverse Event|0|||
48358282|NCT01370655|155507403|FG002|Period 2|Adverse Event|1|||
48358283|NCT01370655|155507404|FG003|Period 2|Adverse Event|0|||
48411309|NCT01097629|155694880|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48411310|NCT01097629|155694881|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48411311|NCT01097629|155694874|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
48411312|NCT01097629|155694875|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
48411313|NCT01097629|155694876|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
48411314|NCT01097629|155694877|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48411315|NCT01097629|155694878|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48411316|NCT01097629|155694879|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48411317|NCT01097629|155694880|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48411318|NCT01097629|155694881|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48411319|NCT01097629|155694874|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
48411320|NCT01097629|155694875|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
48411321|NCT01097629|155694876|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48411322|NCT01097629|155694877|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48411323|NCT01097629|155694878|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48411324|NCT01097629|155694879|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48411325|NCT01097629|155694880|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48411326|NCT01097629|155694881|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48411327|NCT01097629|155694874|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
48411328|NCT01097629|155694875|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
48411329|NCT01097629|155694876|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
48411330|NCT01097629|155694877|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48411331|NCT01097629|155694878|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48411332|NCT01097629|155694879|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48411333|NCT01097629|155694880|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48411334|NCT01097629|155694881|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48411335|NCT01097629|155694874|FG000|DB RO Phase|Withdrawal by Subject|0|||
48411336|NCT01097629|155694875|FG001|DB RO Phase|Withdrawal by Subject|0|||
48411337|NCT01097629|155694876|FG002|DB RO Phase|Withdrawal by Subject|0|||
48411338|NCT01097629|155694877|FG003|DB RO Phase|Withdrawal by Subject|0|||
48411339|NCT01097629|155694878|FG004|DB RO Phase|Withdrawal by Subject|0|||
48411340|NCT01097629|155694879|FG005|DB RO Phase|Withdrawal by Subject|0|||
48411341|NCT01097629|155694880|FG006|DB RO Phase|Withdrawal by Subject|0|||
48411342|NCT01097629|155694881|FG007|DB RO Phase|Withdrawal by Subject|1|||
48411343|NCT01097629|155694874|FG000|DB RO Phase|Protocol Violation|0|||
48411344|NCT01097629|155694875|FG001|DB RO Phase|Protocol Violation|0|||
48411345|NCT01097629|155694876|FG002|DB RO Phase|Protocol Violation|0|||
48411346|NCT01097629|155694877|FG003|DB RO Phase|Protocol Violation|1|||
48411347|NCT01097629|155694878|FG004|DB RO Phase|Protocol Violation|0|||
48411348|NCT01097629|155694879|FG005|DB RO Phase|Protocol Violation|1|||
48411349|NCT01097629|155694880|FG006|DB RO Phase|Protocol Violation|1|||
48411350|NCT01097629|155694881|FG007|DB RO Phase|Protocol Violation|0|||
48411351|NCT01097629|155694874|FG000|DB RO Phase|Lost to Follow-up|0|||
48411352|NCT01097629|155694875|FG001|DB RO Phase|Lost to Follow-up|0|||
48411353|NCT01097629|155694876|FG002|DB RO Phase|Lost to Follow-up|0|||
48411354|NCT01097629|155694877|FG003|DB RO Phase|Lost to Follow-up|0|||
48411355|NCT01097629|155694878|FG004|DB RO Phase|Lost to Follow-up|0|||
48411356|NCT01097629|155694879|FG005|DB RO Phase|Lost to Follow-up|0|||
48411357|NCT01097629|155694880|FG006|DB RO Phase|Lost to Follow-up|2|||
48411358|NCT01097629|155694881|FG007|DB RO Phase|Lost to Follow-up|0|||
48411359|NCT02613208|155694882|FG000|Overall Study|Withdrawal by Subject|1|||
48411360|NCT02613208|155694882|FG000|Overall Study|Change of address|2|||
48411361|NCT02613208|155694882|FG000|Overall Study|Physician Decision|2|||
48411362|NCT02613208|155694882|FG000|Overall Study|Lost to Follow-up|5|||
48411363|NCT02613208|155694882|FG000|Overall Study|Death|37|||
48411364|NCT02663895|155694883|FG000|Overall Study|Adverse Event|3|||
48411365|NCT02663895|155694883|FG000|Overall Study|Physician Decision|2|||
48411366|NCT02663895|155694883|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
48411367|NCT02663895|155694883|FG000|Overall Study|Withdrawal by Subject|1|||
48411368|NCT02911688|155694884|FG000|Washout|Lost to Follow-up|1|||
48411369|NCT02911688|155694885|FG001|Washout|Lost to Follow-up|1|||
48411370|NCT02911688|155694884|FG000|Washout|Withdrawal by Subject|0|||
48411371|NCT02911688|155694885|FG001|Washout|Withdrawal by Subject|1|||
48411372|NCT00804687|155694886|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
48411373|NCT00804687|155694887|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
48411374|NCT00804687|155694888|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
48411375|NCT00804687|155694889|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
48411376|NCT00804687|155694890|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
48411377|NCT00804687|155694891|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
48411378|NCT00804687|155694886|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
48411379|NCT00804687|155694887|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
48411380|NCT00804687|155694888|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
48411381|NCT00804687|155694889|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
48411382|NCT00804687|155694890|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
48411383|NCT00804687|155694891|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
48411384|NCT00804687|155694886|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
48411385|NCT00804687|155694887|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
48411386|NCT00804687|155694888|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
48411387|NCT00804687|155694889|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
48411388|NCT00804687|155694890|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
48411389|NCT00804687|155694891|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
48411390|NCT00804687|155694886|FG000|Period 5: Treatment Period|Positive drug test|1|||
48411391|NCT00804687|155694887|FG001|Period 5: Treatment Period|Positive drug test|0|||
48411392|NCT00804687|155694888|FG002|Period 5: Treatment Period|Positive drug test|0|||
48411393|NCT00804687|155694889|FG003|Period 5: Treatment Period|Positive drug test|0|||
48411394|NCT00804687|155694890|FG004|Period 5: Treatment Period|Positive drug test|0|||
48411395|NCT00804687|155694891|FG005|Period 5: Treatment Period|Positive drug test|0|||
48411396|NCT01524991|155694892|FG000|Overall Study|Adverse Event|12|||
48411397|NCT01524991|155694892|FG000|Overall Study|Death|1|||
48411398|NCT01524991|155694892|FG000|Overall Study|Disease ProgressionDu|17|||
48411399|NCT01524991|155694892|FG000|Overall Study|Other complicating disease|1|||
48411400|NCT01524991|155694892|FG000|Overall Study|Withdrawal by Subject|2|||
48411401|NCT01524991|155694892|FG000|Overall Study|Symptomatic Deterioration|1|||
48411402|NCT01773421|155694893|FG000|Treatment Phase|Other|0|||
48411403|NCT01773421|155694894|FG001|Treatment Phase|Other|0|||
48411404|NCT01773421|155694895|FG002|Treatment Phase|Other|2|||
48411405|NCT01773421|155694896|FG003|Treatment Phase|Other|0|||
48411406|NCT01773421|155694897|FG004|Treatment Phase|Other|0|||
48411407|NCT01773421|155694898|FG005|Treatment Phase|Other|0|||
48411408|NCT01773421|155694899|FG006|Treatment Phase|Other|0|||
48411409|NCT01773421|155694893|FG000|Treatment Phase|Adverse Event|0|||
48411410|NCT01773421|155694894|FG001|Treatment Phase|Adverse Event|0|||
48411411|NCT01773421|155694895|FG002|Treatment Phase|Adverse Event|3|||
48411412|NCT01773421|155694896|FG003|Treatment Phase|Adverse Event|1|||
48411413|NCT01773421|155694897|FG004|Treatment Phase|Adverse Event|0|||
48411414|NCT01773421|155694898|FG005|Treatment Phase|Adverse Event|0|||
48411415|NCT01773421|155694899|FG006|Treatment Phase|Adverse Event|0|||
48411416|NCT01773421|155694893|FG000|Treatment Phase|Withdrawal by Subject|0|||
48411417|NCT01773421|155694894|FG001|Treatment Phase|Withdrawal by Subject|0|||
48411418|NCT01773421|155694895|FG002|Treatment Phase|Withdrawal by Subject|1|||
48411419|NCT01773421|155694896|FG003|Treatment Phase|Withdrawal by Subject|1|||
48411420|NCT01773421|155694897|FG004|Treatment Phase|Withdrawal by Subject|0|||
48411421|NCT01773421|155694898|FG005|Treatment Phase|Withdrawal by Subject|0|||
48411422|NCT01773421|155694899|FG006|Treatment Phase|Withdrawal by Subject|0|||
48411423|NCT01773421|155694893|FG000|Extension Phase|Other|0|||
48411424|NCT01773421|155694894|FG001|Extension Phase|Other|0|||
48411425|NCT01773421|155694895|FG002|Extension Phase|Other|0|||
48411426|NCT01773421|155694896|FG003|Extension Phase|Other|0|||
48411427|NCT01773421|155694897|FG004|Extension Phase|Other|1|||
48411428|NCT01773421|155694898|FG005|Extension Phase|Other|2|||
48411429|NCT01773421|155694899|FG006|Extension Phase|Other|0|||
48411430|NCT01773421|155694893|FG000|Extension Phase|Adverse Event|0|||
48411431|NCT01773421|155694894|FG001|Extension Phase|Adverse Event|0|||
48411432|NCT01773421|155694895|FG002|Extension Phase|Adverse Event|0|||
48411433|NCT01773421|155694896|FG003|Extension Phase|Adverse Event|0|||
48411434|NCT01773421|155694897|FG004|Extension Phase|Adverse Event|2|||
48411435|NCT01773421|155694898|FG005|Extension Phase|Adverse Event|0|||
48411436|NCT01773421|155694899|FG006|Extension Phase|Adverse Event|0|||
48411437|NCT00808444|155694902|FG000|Overall Study|Withdrawal by Subject|1|||
48411438|NCT00808444|155694903|FG001|Overall Study|Withdrawal by Subject|0|||
48411439|NCT00808444|155694902|FG000|Overall Study|Lost to Follow-up|0|||
48411440|NCT00808444|155694903|FG001|Overall Study|Lost to Follow-up|1|||
48411441|NCT03502330|155694904|FG000|Overall Study|Adverse Event|2|||
48411442|NCT03502330|155694905|FG001|Overall Study|Adverse Event|1|||
48411443|NCT03502330|155694906|FG002|Overall Study|Adverse Event|0|||
48411444|NCT03502330|155694907|FG003|Overall Study|Adverse Event|0|||
48411445|NCT03502330|155694908|FG004|Overall Study|Adverse Event|1|||
48411446|NCT03502330|155694909|FG005|Overall Study|Adverse Event|0|||
48411447|NCT03502330|155694910|FG006|Overall Study|Adverse Event|1|||
48411448|NCT03502330|155694911|FG007|Overall Study|Adverse Event|1|||
48411449|NCT03502330|155694912|FG008|Overall Study|Adverse Event|0|||
48411450|NCT03502330|155694904|FG000|Overall Study|Lack of Efficacy|1|||
48411451|NCT03502330|155694905|FG001|Overall Study|Lack of Efficacy|5|||
48411452|NCT03502330|155694906|FG002|Overall Study|Lack of Efficacy|3|||
48411453|NCT03502330|155694907|FG003|Overall Study|Lack of Efficacy|5|||
48411454|NCT03502330|155694908|FG004|Overall Study|Lack of Efficacy|1|||
48411455|NCT03502330|155694909|FG005|Overall Study|Lack of Efficacy|5|||
48411456|NCT03502330|155694910|FG006|Overall Study|Lack of Efficacy|5|||
48411457|NCT03502330|155694911|FG007|Overall Study|Lack of Efficacy|6|||
48411458|NCT03502330|155694912|FG008|Overall Study|Lack of Efficacy|0|||
48411459|NCT03502330|155694904|FG000|Overall Study|Physician Decision|0|||
48411460|NCT03502330|155694905|FG001|Overall Study|Physician Decision|0|||
48411461|NCT03502330|155694906|FG002|Overall Study|Physician Decision|0|||
48411462|NCT03502330|155694907|FG003|Overall Study|Physician Decision|0|||
48411463|NCT03502330|155694908|FG004|Overall Study|Physician Decision|1|||
48411464|NCT03502330|155694909|FG005|Overall Study|Physician Decision|0|||
48411465|NCT03502330|155694910|FG006|Overall Study|Physician Decision|0|||
48411466|NCT03502330|155694911|FG007|Overall Study|Physician Decision|0|||
48411467|NCT03502330|155694912|FG008|Overall Study|Physician Decision|0|||
48411468|NCT03502330|155694904|FG000|Overall Study|Withdrawal by Subject|0|||
48411469|NCT03502330|155694905|FG001|Overall Study|Withdrawal by Subject|0|||
48411470|NCT03502330|155694906|FG002|Overall Study|Withdrawal by Subject|0|||
48411471|NCT03502330|155694907|FG003|Overall Study|Withdrawal by Subject|0|||
48411472|NCT03502330|155694908|FG004|Overall Study|Withdrawal by Subject|0|||
48411473|NCT03502330|155694909|FG005|Overall Study|Withdrawal by Subject|1|||
48411474|NCT03502330|155694910|FG006|Overall Study|Withdrawal by Subject|0|||
48411475|NCT03502330|155694911|FG007|Overall Study|Withdrawal by Subject|1|||
48411476|NCT03502330|155694912|FG008|Overall Study|Withdrawal by Subject|0|||
48411477|NCT03502330|155694904|FG000|Overall Study|Death|0|||
48411478|NCT03502330|155694905|FG001|Overall Study|Death|0|||
48411479|NCT03502330|155694906|FG002|Overall Study|Death|0|||
48411480|NCT03502330|155694907|FG003|Overall Study|Death|0|||
48411481|NCT03502330|155694908|FG004|Overall Study|Death|0|||
48411482|NCT03502330|155694909|FG005|Overall Study|Death|0|||
48411483|NCT03502330|155694910|FG006|Overall Study|Death|2|||
48411484|NCT03502330|155694911|FG007|Overall Study|Death|0|||
48411485|NCT03502330|155694912|FG008|Overall Study|Death|0|||
48411486|NCT00365989|155694916|FG000|Overall Study|Withdrawal by Subject|1|||
48358284|NCT01370655|155507405|FG004|Period 2|Adverse Event|1|||
48358285|NCT01370655|155507406|FG005|Period 2|Adverse Event|0|||
48358286|NCT01370655|155507407|FG006|Period 2|Adverse Event|0|||
48358287|NCT01370655|155507408|FG007|Period 2|Adverse Event|1|||
48358288|NCT01370655|155507409|FG008|Period 2|Adverse Event|0|||
48358289|NCT01370655|155507410|FG009|Period 2|Adverse Event|0|||
48358290|NCT01370655|155507411|FG010|Period 2|Adverse Event|0|||
48358291|NCT01370655|155507412|FG011|Period 2|Adverse Event|0|||
48358292|NCT01370655|155507401|FG000|Period 2|met protocol specified stopping criteria|0|||
48358293|NCT01370655|155507402|FG001|Period 2|met protocol specified stopping criteria|0|||
48358294|NCT01370655|155507403|FG002|Period 2|met protocol specified stopping criteria|1|||
48358295|NCT01370655|155507404|FG003|Period 2|met protocol specified stopping criteria|0|||
48358296|NCT01370655|155507405|FG004|Period 2|met protocol specified stopping criteria|0|||
48358297|NCT01370655|155507406|FG005|Period 2|met protocol specified stopping criteria|0|||
48411487|NCT00365989|155694916|FG000|Overall Study|Non-compliance|1|||
48411488|NCT05499520|155694917|FG000|Overall Study|Lost to Follow-up|0|||
48411489|NCT05499520|155694918|FG001|Overall Study|Lost to Follow-up|0|||
48411490|NCT05499520|155694919|FG002|Overall Study|Lost to Follow-up|38|||
48411491|NCT05499520|155694920|FG003|Overall Study|Lost to Follow-up|41|||
48411492|NCT05499520|155694921|FG004|Overall Study|Lost to Follow-up|46|||
48411493|NCT05499520|155694922|FG005|Overall Study|Lost to Follow-up|0|||
48411494|NCT05499520|155694923|FG006|Overall Study|Lost to Follow-up|31|||
48411495|NCT05499520|155694924|FG007|Overall Study|Lost to Follow-up|45|||
48411496|NCT05499520|155694925|FG008|Overall Study|Lost to Follow-up|42|||
48411497|NCT05499520|155694926|FG009|Overall Study|Lost to Follow-up|0|||
48411498|NCT05499520|155694927|FG010|Overall Study|Lost to Follow-up|0|||
48411499|NCT05499520|155694928|FG011|Overall Study|Lost to Follow-up|37|||
48411500|NCT05499520|155694929|FG012|Overall Study|Lost to Follow-up|53|||
48411501|NCT05499520|155694930|FG013|Overall Study|Lost to Follow-up|49|||
48411502|NCT05499520|155694931|FG014|Overall Study|Lost to Follow-up|0|||
48411503|NCT05499520|155694932|FG015|Overall Study|Lost to Follow-up|36|||
48411504|NCT05499520|155694933|FG016|Overall Study|Lost to Follow-up|58|||
48411505|NCT05499520|155694934|FG017|Overall Study|Lost to Follow-up|53|||
48411506|NCT00605267|155694935|FG000|Overall Study|Adverse Event|0|||
48411507|NCT00605267|155694936|FG001|Overall Study|Adverse Event|1|||
48411508|NCT00605267|155694935|FG000|Overall Study|Lack of Efficacy|1|||
48411509|NCT00605267|155694936|FG001|Overall Study|Lack of Efficacy|5|||
48411510|NCT00605267|155694935|FG000|Overall Study|Withdrawal by Subject|2|||
48411511|NCT00605267|155694936|FG001|Overall Study|Withdrawal by Subject|3|||
48411512|NCT02939131|155694937|FG000|Overall Study|Unable to get to clinic|6|||
48411513|NCT02939131|155694938|FG001|Overall Study|Unable to get to clinic|4|||
48411514|NCT02939131|155694937|FG000|Overall Study|Lost to Follow-up|2|||
48411515|NCT02939131|155694938|FG001|Overall Study|Lost to Follow-up|4|||
48358298|NCT01370655|155507407|FG006|Period 2|met protocol specified stopping criteria|1|||
48358299|NCT01370655|155507408|FG007|Period 2|met protocol specified stopping criteria|0|||
48358300|NCT01370655|155507409|FG008|Period 2|met protocol specified stopping criteria|1|||
48358301|NCT01370655|155507410|FG009|Period 2|met protocol specified stopping criteria|0|||
48358302|NCT01370655|155507411|FG010|Period 2|met protocol specified stopping criteria|1|||
48358303|NCT01370655|155507412|FG011|Period 2|met protocol specified stopping criteria|0|||
48358304|NCT01370655|155507401|FG000|Period 2|Withdrawal by Subject|0|||
48358305|NCT01370655|155507402|FG001|Period 2|Withdrawal by Subject|0|||
48358306|NCT01370655|155507403|FG002|Period 2|Withdrawal by Subject|0|||
48358307|NCT01370655|155507404|FG003|Period 2|Withdrawal by Subject|0|||
48358308|NCT01370655|155507405|FG004|Period 2|Withdrawal by Subject|0|||
48358309|NCT01370655|155507406|FG005|Period 2|Withdrawal by Subject|0|||
48358310|NCT01370655|155507407|FG006|Period 2|Withdrawal by Subject|0|||
48358311|NCT01370655|155507408|FG007|Period 2|Withdrawal by Subject|0|||
48358312|NCT01370655|155507409|FG008|Period 2|Withdrawal by Subject|1|||
48358313|NCT01370655|155507410|FG009|Period 2|Withdrawal by Subject|0|||
48358314|NCT01370655|155507411|FG010|Period 2|Withdrawal by Subject|0|||
48358315|NCT01370655|155507412|FG011|Period 2|Withdrawal by Subject|0|||
48358316|NCT00581477|155507413|FG000|Overall Study|Physician Decision|2|||
48358317|NCT02979249|155507414|FG000|Overall Study|Lost to Follow-up|2|||
48358318|NCT02979249|155507414|FG000|Overall Study|Withdrawal by Subject|4|||
48358319|NCT01080326|155507415|FG000|Overall Study|Patient deterioration prior to procedure|3|||
48358320|NCT01080326|155507415|FG000|Overall Study|Surgeon decision|1|||
48358321|NCT02975102|155507416|FG000|Overall Study|Adverse Event|2|||
48358322|NCT02975102|155507417|FG001|Overall Study|Adverse Event|1|||
48358323|NCT04276051|155507420|FG000|Overall Study|Lost to Follow-up|0|||
48358324|NCT04276051|155507421|FG001|Overall Study|Lost to Follow-up|1|||
48358325|NCT04276051|155507420|FG000|Overall Study|Physician Decision|0|||
48411516|NCT02939131|155694937|FG000|Overall Study|severe debilitation|1|||
48411517|NCT02939131|155694938|FG001|Overall Study|severe debilitation|0|||
48411518|NCT02939131|155694937|FG000|Overall Study|Other|0|||
48411519|NCT02939131|155694938|FG001|Overall Study|Other|1|||
48411520|NCT02939131|155694937|FG000|Overall Study|not willing to adhere to protocol|2|||
48411521|NCT02939131|155694938|FG001|Overall Study|not willing to adhere to protocol|0|||
48411522|NCT00793793|155694939|FG000|Overall Study|Adverse Event|0|||
48411523|NCT00793793|155694940|FG001|Overall Study|Adverse Event|0|||
48411524|NCT00793793|155694941|FG002|Overall Study|Adverse Event|1|||
48411525|NCT00793793|155694942|FG003|Overall Study|Adverse Event|1|||
48411526|NCT00793793|155694943|FG004|Overall Study|Adverse Event|0|||
48411527|NCT00793793|155694944|FG005|Overall Study|Adverse Event|1|||
48411528|NCT00793793|155694945|FG006|Overall Study|Adverse Event|2|||
48411529|NCT00793793|155694946|FG007|Overall Study|Adverse Event|0|||
48411530|NCT00793793|155694947|FG008|Overall Study|Adverse Event|0|||
48411531|NCT00793793|155694948|FG009|Overall Study|Adverse Event|0|||
48411532|NCT00793793|155694949|FG010|Overall Study|Adverse Event|0|||
48411533|NCT00793793|155694950|FG011|Overall Study|Adverse Event|2|||
48411534|NCT00793793|155694939|FG000|Overall Study|Protocol Violation|0|||
48411535|NCT00793793|155694940|FG001|Overall Study|Protocol Violation|0|||
48411536|NCT00793793|155694941|FG002|Overall Study|Protocol Violation|0|||
48411537|NCT00793793|155694942|FG003|Overall Study|Protocol Violation|1|||
48411538|NCT00793793|155694943|FG004|Overall Study|Protocol Violation|0|||
48411539|NCT00793793|155694944|FG005|Overall Study|Protocol Violation|0|||
48411540|NCT00793793|155694945|FG006|Overall Study|Protocol Violation|0|||
48411541|NCT00793793|155694946|FG007|Overall Study|Protocol Violation|0|||
48411542|NCT00793793|155694947|FG008|Overall Study|Protocol Violation|0|||
48411543|NCT00793793|155694948|FG009|Overall Study|Protocol Violation|0|||
48411544|NCT00793793|155694949|FG010|Overall Study|Protocol Violation|0|||
48411545|NCT00793793|155694950|FG011|Overall Study|Protocol Violation|0|||
48411546|NCT00793793|155694939|FG000|Overall Study|Lost to Follow-up|0|||
48411547|NCT00793793|155694940|FG001|Overall Study|Lost to Follow-up|0|||
48411548|NCT00793793|155694941|FG002|Overall Study|Lost to Follow-up|1|||
48411549|NCT00793793|155694942|FG003|Overall Study|Lost to Follow-up|0|||
48411550|NCT00793793|155694943|FG004|Overall Study|Lost to Follow-up|0|||
48411551|NCT00793793|155694944|FG005|Overall Study|Lost to Follow-up|0|||
48411552|NCT00793793|155694945|FG006|Overall Study|Lost to Follow-up|0|||
48411553|NCT00793793|155694946|FG007|Overall Study|Lost to Follow-up|0|||
48411554|NCT00793793|155694947|FG008|Overall Study|Lost to Follow-up|1|||
48411555|NCT00793793|155694948|FG009|Overall Study|Lost to Follow-up|3|||
48411556|NCT00793793|155694949|FG010|Overall Study|Lost to Follow-up|1|||
48411557|NCT00793793|155694950|FG011|Overall Study|Lost to Follow-up|0|||
48411558|NCT00793793|155694939|FG000|Overall Study|Withdrawal by Subject|0|||
48411559|NCT00793793|155694940|FG001|Overall Study|Withdrawal by Subject|0|||
48411560|NCT00793793|155694941|FG002|Overall Study|Withdrawal by Subject|0|||
48411561|NCT00793793|155694942|FG003|Overall Study|Withdrawal by Subject|0|||
48411562|NCT00793793|155694943|FG004|Overall Study|Withdrawal by Subject|1|||
48411563|NCT00793793|155694944|FG005|Overall Study|Withdrawal by Subject|0|||
48411564|NCT00793793|155694945|FG006|Overall Study|Withdrawal by Subject|0|||
48411565|NCT00793793|155694946|FG007|Overall Study|Withdrawal by Subject|0|||
48411566|NCT00793793|155694947|FG008|Overall Study|Withdrawal by Subject|1|||
48411567|NCT00793793|155694948|FG009|Overall Study|Withdrawal by Subject|0|||
48411568|NCT00793793|155694949|FG010|Overall Study|Withdrawal by Subject|0|||
48411569|NCT00793793|155694950|FG011|Overall Study|Withdrawal by Subject|0|||
48411570|NCT00793793|155694939|FG000|Overall Study|reason not specified|0|||
48411571|NCT00793793|155694940|FG001|Overall Study|reason not specified|1|||
48411572|NCT00793793|155694941|FG002|Overall Study|reason not specified|0|||
48411573|NCT00793793|155694942|FG003|Overall Study|reason not specified|1|||
48411574|NCT00793793|155694943|FG004|Overall Study|reason not specified|1|||
48411575|NCT00793793|155694944|FG005|Overall Study|reason not specified|1|||
48411576|NCT00793793|155694945|FG006|Overall Study|reason not specified|2|||
48411577|NCT00793793|155694946|FG007|Overall Study|reason not specified|0|||
48411578|NCT00793793|155694947|FG008|Overall Study|reason not specified|7|||
48411579|NCT00793793|155694948|FG009|Overall Study|reason not specified|6|||
48411580|NCT00793793|155694949|FG010|Overall Study|reason not specified|2|||
48411581|NCT00793793|155694950|FG011|Overall Study|reason not specified|4|||
48411582|NCT00840827|155694951|FG000|Overall Study|Adverse Event|1|||
48411583|NCT00840827|155694951|FG000|Overall Study|Lack of Efficacy|4|||
48411584|NCT00840827|155694951|FG000|Overall Study|Physician Decision|1|||
48411585|NCT02159807|155694952|FG000|Overall Study|Adverse Event|0|||
48411586|NCT02159807|155694953|FG001|Overall Study|Adverse Event|0|||
48411587|NCT02159807|155694954|FG002|Overall Study|Adverse Event|1|||
48411588|NCT02159807|155694952|FG000|Overall Study|No CSF|1|||
48411589|NCT02159807|155694953|FG001|Overall Study|No CSF|1|||
48411590|NCT02159807|155694954|FG002|Overall Study|No CSF|1|||
48411591|NCT02159807|155694952|FG000|Overall Study|elevated blood pressure|0|||
48411592|NCT02159807|155694953|FG001|Overall Study|elevated blood pressure|0|||
48411593|NCT02159807|155694954|FG002|Overall Study|elevated blood pressure|1|||
48411594|NCT01552902|155694956|FG000|Overall Study|Adverse Event|1|||
48411595|NCT01552902|155694957|FG001|Overall Study|Adverse Event|15|||
48411596|NCT01552902|155694958|FG002|Overall Study|Adverse Event|14|||
48411597|NCT01552902|155694956|FG000|Overall Study|Protocol Violation|3|||
48411598|NCT01552902|155694957|FG001|Overall Study|Protocol Violation|3|||
48411599|NCT01552902|155694958|FG002|Overall Study|Protocol Violation|3|||
48411600|NCT01552902|155694956|FG000|Overall Study|Lack of Efficacy|4|||
48411601|NCT01552902|155694957|FG001|Overall Study|Lack of Efficacy|3|||
48411602|NCT01552902|155694958|FG002|Overall Study|Lack of Efficacy|1|||
48411603|NCT01552902|155694956|FG000|Overall Study|Withdrawal by Subject|1|||
48411604|NCT01552902|155694957|FG001|Overall Study|Withdrawal by Subject|9|||
48411605|NCT01552902|155694958|FG002|Overall Study|Withdrawal by Subject|6|||
48411606|NCT01552902|155694956|FG000|Overall Study|Lost to Follow-up|1|||
48411607|NCT01552902|155694957|FG001|Overall Study|Lost to Follow-up|3|||
48411608|NCT01552902|155694958|FG002|Overall Study|Lost to Follow-up|6|||
48411609|NCT01552902|155694956|FG000|Overall Study|Other|3|||
48411610|NCT01552902|155694957|FG001|Overall Study|Other|4|||
48411611|NCT01552902|155694958|FG002|Overall Study|Other|3|||
48411612|NCT00950170|155694959|FG000|Overall Study|Parent/Legal Guardian Request|1|||
48411613|NCT00950170|155694959|FG000|Overall Study|Adverse Event|2|||
48411614|NCT00950170|155694959|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
48411615|NCT01848145|155694963|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
48411616|NCT01848145|155694963|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
48411617|NCT01848145|155694963|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
48411618|NCT01848145|155694963|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
48411619|NCT01848145|155694963|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
48411620|NCT01848145|155694963|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
48411621|NCT01848145|155694963|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
48411622|NCT04067518|155694964|FG000|Overall Study|Adverse Event|1|||
48411623|NCT04067518|155694965|FG001|Overall Study|Adverse Event|3|||
48411624|NCT04067518|155694964|FG000|Overall Study|Screen failures|0|||
48411625|NCT04067518|155694965|FG001|Overall Study|Screen failures|1|||
48411626|NCT04067518|155694964|FG000|Overall Study|Enrolled but not treated|0|||
48411627|NCT04067518|155694965|FG001|Overall Study|Enrolled but not treated|1|||
48411628|NCT04426695|155694966|FG000|Overall Study|Death|2|||
48411629|NCT04426695|155694967|FG001|Overall Study|Death|0|||
48411630|NCT04426695|155694968|FG002|Overall Study|Death|1|||
48411631|NCT04426695|155694969|FG003|Overall Study|Death|27|||
48411632|NCT04426695|155694970|FG004|Overall Study|Death|25|||
48411633|NCT04426695|155694971|FG005|Overall Study|Death|21|||
48411634|NCT04426695|155694972|FG006|Overall Study|Death|42|||
48411635|NCT04426695|155694973|FG007|Overall Study|Death|23|||
48411636|NCT04426695|155694974|FG008|Overall Study|Death|37|||
48411637|NCT04426695|155694975|FG009|Overall Study|Death|14|||
48411638|NCT04426695|155694976|FG010|Overall Study|Death|8|||
48411639|NCT04426695|155694977|FG011|Overall Study|Death|7|||
48411640|NCT04426695|155694978|FG012|Overall Study|Death|13|||
48411641|NCT04426695|155694979|FG013|Overall Study|Death|25|||
48411642|NCT04426695|155694980|FG014|Overall Study|Death|19|||
48411643|NCT04426695|155694981|FG015|Overall Study|Death|7|||
48411644|NCT04426695|155694982|FG016|Overall Study|Death|8|||
48411645|NCT04426695|155694983|FG017|Overall Study|Death|4|||
48411646|NCT04426695|155694966|FG000|Overall Study|Lost to Follow-up|2|||
48411647|NCT04426695|155694967|FG001|Overall Study|Lost to Follow-up|4|||
48411648|NCT04426695|155694968|FG002|Overall Study|Lost to Follow-up|1|||
48411649|NCT04426695|155694969|FG003|Overall Study|Lost to Follow-up|19|||
48411650|NCT04426695|155694970|FG004|Overall Study|Lost to Follow-up|10|||
48411651|NCT04426695|155694971|FG005|Overall Study|Lost to Follow-up|14|||
48411652|NCT04426695|155694972|FG006|Overall Study|Lost to Follow-up|5|||
48411653|NCT04426695|155694973|FG007|Overall Study|Lost to Follow-up|14|||
48358326|NCT04276051|155507421|FG001|Overall Study|Physician Decision|1|||
48358327|NCT04276051|155507420|FG000|Overall Study|Withdrawal by Subject|1|||
48358328|NCT04276051|155507421|FG001|Overall Study|Withdrawal by Subject|1|||
48358329|NCT01912404|155507422|FG000|Overall Study|Due to personal reasons|1|||
48358330|NCT01912404|155507423|FG001|Overall Study|Due to personal reasons|0|||
48358331|NCT02269423|155507424|FG000|Overall Study|Discontinued due to change in residence|0|||
48358332|NCT02269423|155507425|FG001|Overall Study|Discontinued due to change in residence|1|||
48358333|NCT02269423|155507426|FG002|Overall Study|Discontinued due to change in residence|0|||
48358334|NCT02269423|155507427|FG003|Overall Study|Discontinued due to change in residence|1|||
48411654|NCT04426695|155694974|FG008|Overall Study|Lost to Follow-up|10|||
48358335|NCT02389764|155507429|FG000|Overall Study|Lack of Efficacy|9|||
48411655|NCT04426695|155694975|FG009|Overall Study|Lost to Follow-up|11|||
48411656|NCT04426695|155694976|FG010|Overall Study|Lost to Follow-up|12|||
48411657|NCT04426695|155694977|FG011|Overall Study|Lost to Follow-up|6|||
48411658|NCT04426695|155694978|FG012|Overall Study|Lost to Follow-up|2|||
48411659|NCT04426695|155694979|FG013|Overall Study|Lost to Follow-up|2|||
48358336|NCT00780559|155507430|FG000|Overall Study|Lost to Follow-up|2|||
48358337|NCT00780559|155507431|FG001|Overall Study|Lost to Follow-up|7|||
48358338|NCT00780559|155507430|FG000|Overall Study|Death|1|||
48358339|NCT00780559|155507431|FG001|Overall Study|Death|0|||
48358340|NCT04676763|155507432|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
48358341|NCT04676763|155507433|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
48358342|NCT04676763|155507434|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
48358343|NCT04676763|155507432|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
48358344|NCT04676763|155507433|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
48358345|NCT04676763|155507434|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
48358346|NCT04676763|155507432|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
48411660|NCT04426695|155694980|FG014|Overall Study|Lost to Follow-up|2|||
48411661|NCT04426695|155694981|FG015|Overall Study|Lost to Follow-up|0|||
48411662|NCT04426695|155694982|FG016|Overall Study|Lost to Follow-up|0|||
48411663|NCT04426695|155694983|FG017|Overall Study|Lost to Follow-up|0|||
48411664|NCT04426695|155694966|FG000|Overall Study|Participant Decision|1|||
48411665|NCT04426695|155694967|FG001|Overall Study|Participant Decision|2|||
48411666|NCT04426695|155694968|FG002|Overall Study|Participant Decision|2|||
48411667|NCT04426695|155694969|FG003|Overall Study|Participant Decision|12|||
48411668|NCT04426695|155694970|FG004|Overall Study|Participant Decision|18|||
48411669|NCT04426695|155694971|FG005|Overall Study|Participant Decision|22|||
48411670|NCT04426695|155694972|FG006|Overall Study|Participant Decision|13|||
48411671|NCT04426695|155694973|FG007|Overall Study|Participant Decision|13|||
48411672|NCT04426695|155694974|FG008|Overall Study|Participant Decision|10|||
48411673|NCT04426695|155694975|FG009|Overall Study|Participant Decision|15|||
48411674|NCT04426695|155694976|FG010|Overall Study|Participant Decision|16|||
48411675|NCT04426695|155694977|FG011|Overall Study|Participant Decision|17|||
48411676|NCT04426695|155694978|FG012|Overall Study|Participant Decision|2|||
48411677|NCT04426695|155694979|FG013|Overall Study|Participant Decision|1|||
48411678|NCT04426695|155694980|FG014|Overall Study|Participant Decision|2|||
48411679|NCT04426695|155694981|FG015|Overall Study|Participant Decision|0|||
48411680|NCT04426695|155694982|FG016|Overall Study|Participant Decision|0|||
48411681|NCT04426695|155694983|FG017|Overall Study|Participant Decision|0|||
48411682|NCT04426695|155694966|FG000|Overall Study|Adverse Event|0|||
48411683|NCT04426695|155694967|FG001|Overall Study|Adverse Event|0|||
48411684|NCT04426695|155694968|FG002|Overall Study|Adverse Event|0|||
48411685|NCT04426695|155694969|FG003|Overall Study|Adverse Event|0|||
48411686|NCT04426695|155694970|FG004|Overall Study|Adverse Event|0|||
48411687|NCT04426695|155694971|FG005|Overall Study|Adverse Event|0|||
48411688|NCT04426695|155694972|FG006|Overall Study|Adverse Event|0|||
48411689|NCT04426695|155694973|FG007|Overall Study|Adverse Event|1|||
48411690|NCT04426695|155694974|FG008|Overall Study|Adverse Event|0|||
48411691|NCT04426695|155694975|FG009|Overall Study|Adverse Event|0|||
48411692|NCT04426695|155694976|FG010|Overall Study|Adverse Event|1|||
48411693|NCT04426695|155694977|FG011|Overall Study|Adverse Event|1|||
48411694|NCT04426695|155694978|FG012|Overall Study|Adverse Event|0|||
48411695|NCT04426695|155694979|FG013|Overall Study|Adverse Event|0|||
48411696|NCT04426695|155694980|FG014|Overall Study|Adverse Event|0|||
48411697|NCT04426695|155694981|FG015|Overall Study|Adverse Event|0|||
48411698|NCT04426695|155694982|FG016|Overall Study|Adverse Event|0|||
48411699|NCT04426695|155694983|FG017|Overall Study|Adverse Event|0|||
48411700|NCT04426695|155694966|FG000|Overall Study|Sponsor Request|0|||
48411701|NCT04426695|155694967|FG001|Overall Study|Sponsor Request|0|||
48411702|NCT04426695|155694968|FG002|Overall Study|Sponsor Request|0|||
48411703|NCT04426695|155694969|FG003|Overall Study|Sponsor Request|0|||
48411704|NCT04426695|155694970|FG004|Overall Study|Sponsor Request|0|||
48411705|NCT04426695|155694971|FG005|Overall Study|Sponsor Request|0|||
48411706|NCT04426695|155694972|FG006|Overall Study|Sponsor Request|1|||
48411707|NCT04426695|155694973|FG007|Overall Study|Sponsor Request|0|||
48411708|NCT04426695|155694974|FG008|Overall Study|Sponsor Request|0|||
48411709|NCT04426695|155694975|FG009|Overall Study|Sponsor Request|0|||
48411710|NCT04426695|155694976|FG010|Overall Study|Sponsor Request|0|||
48411711|NCT04426695|155694977|FG011|Overall Study|Sponsor Request|0|||
48411712|NCT04426695|155694978|FG012|Overall Study|Sponsor Request|0|||
48411713|NCT04426695|155694979|FG013|Overall Study|Sponsor Request|0|||
48411714|NCT04426695|155694980|FG014|Overall Study|Sponsor Request|0|||
48411715|NCT04426695|155694981|FG015|Overall Study|Sponsor Request|0|||
48411716|NCT04426695|155694982|FG016|Overall Study|Sponsor Request|0|||
48411717|NCT04426695|155694983|FG017|Overall Study|Sponsor Request|0|||
48411718|NCT04426695|155694966|FG000|Overall Study|Physician Decision|0|||
48411719|NCT04426695|155694967|FG001|Overall Study|Physician Decision|0|||
48411720|NCT04426695|155694968|FG002|Overall Study|Physician Decision|0|||
48411721|NCT04426695|155694969|FG003|Overall Study|Physician Decision|0|||
48411722|NCT04426695|155694970|FG004|Overall Study|Physician Decision|0|||
48411723|NCT04426695|155694971|FG005|Overall Study|Physician Decision|0|||
48411724|NCT04426695|155694972|FG006|Overall Study|Physician Decision|0|||
48411725|NCT04426695|155694973|FG007|Overall Study|Physician Decision|0|||
48411726|NCT04426695|155694974|FG008|Overall Study|Physician Decision|0|||
48411727|NCT04426695|155694975|FG009|Overall Study|Physician Decision|1|||
48411728|NCT04426695|155694976|FG010|Overall Study|Physician Decision|0|||
48411729|NCT04426695|155694977|FG011|Overall Study|Physician Decision|0|||
48411730|NCT04426695|155694978|FG012|Overall Study|Physician Decision|1|||
48411731|NCT04426695|155694979|FG013|Overall Study|Physician Decision|0|||
48411732|NCT04426695|155694980|FG014|Overall Study|Physician Decision|0|||
48411733|NCT04426695|155694981|FG015|Overall Study|Physician Decision|0|||
48411734|NCT04426695|155694982|FG016|Overall Study|Physician Decision|0|||
48411735|NCT04426695|155694983|FG017|Overall Study|Physician Decision|0|||
48411736|NCT04426695|155694966|FG000|Overall Study|Randomized but Never Treated|3|||
48411737|NCT04426695|155694967|FG001|Overall Study|Randomized but Never Treated|1|||
48411738|NCT04426695|155694968|FG002|Overall Study|Randomized but Never Treated|0|||
48411739|NCT04426695|155694969|FG003|Overall Study|Randomized but Never Treated|4|||
48411740|NCT04426695|155694970|FG004|Overall Study|Randomized but Never Treated|5|||
48411741|NCT04426695|155694971|FG005|Overall Study|Randomized but Never Treated|5|||
48411742|NCT04426695|155694972|FG006|Overall Study|Randomized but Never Treated|4|||
48411743|NCT04426695|155694973|FG007|Overall Study|Randomized but Never Treated|6|||
48411744|NCT04426695|155694974|FG008|Overall Study|Randomized but Never Treated|6|||
48411745|NCT04426695|155694975|FG009|Overall Study|Randomized but Never Treated|3|||
48411746|NCT04426695|155694976|FG010|Overall Study|Randomized but Never Treated|3|||
48411747|NCT04426695|155694977|FG011|Overall Study|Randomized but Never Treated|6|||
48411748|NCT04426695|155694978|FG012|Overall Study|Randomized but Never Treated|1|||
48411749|NCT04426695|155694979|FG013|Overall Study|Randomized but Never Treated|2|||
48411750|NCT04426695|155694980|FG014|Overall Study|Randomized but Never Treated|0|||
48411751|NCT04426695|155694981|FG015|Overall Study|Randomized but Never Treated|0|||
48411752|NCT04426695|155694982|FG016|Overall Study|Randomized but Never Treated|0|||
48411753|NCT04426695|155694983|FG017|Overall Study|Randomized but Never Treated|0|||
48411754|NCT00179959|155694986|FG000|Overall Study|Lost to Follow-up|3|||
48411755|NCT00179959|155694987|FG001|Overall Study|Lost to Follow-up|1|||
48411756|NCT00179959|155694986|FG000|Overall Study|Withdrawal by Subject|3|||
48411757|NCT00179959|155694987|FG001|Overall Study|Withdrawal by Subject|2|||
48358347|NCT04676763|155507433|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
48358348|NCT04676763|155507434|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
48358349|NCT00694109|155507436|FG000|Overall Study|Physician Decision|3|||
48358350|NCT00694109|155507436|FG000|Overall Study|Adverse Event|74|||
48358351|NCT00694109|155507436|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
48411758|NCT01552681|155694988|FG000|Overall Study|Withdrawal by Subject|4|||
48411759|NCT01552681|155694989|FG001|Overall Study|Withdrawal by Subject|0|||
48411760|NCT01552681|155694988|FG000|Overall Study|Physician Decision|1|||
48411761|NCT01552681|155694989|FG001|Overall Study|Physician Decision|0|||
48411762|NCT01552681|155694988|FG000|Overall Study|Subject moved away|0|||
48411763|NCT01552681|155694989|FG001|Overall Study|Subject moved away|1|||
48411764|NCT00849667|155694998|FG000|Overall Study|Withdrawal by Subject|16|||
48411765|NCT00849667|155694999|FG001|Overall Study|Withdrawal by Subject|33|||
48411766|NCT00849667|155695000|FG002|Overall Study|Withdrawal by Subject|35|||
48411767|NCT00849667|155694998|FG000|Overall Study|Lost to Follow-up|8|||
48411768|NCT00849667|155694999|FG001|Overall Study|Lost to Follow-up|8|||
48411769|NCT00849667|155695000|FG002|Overall Study|Lost to Follow-up|8|||
48411770|NCT00849667|155694998|FG000|Overall Study|Adverse Event|1|||
48411771|NCT00849667|155694999|FG001|Overall Study|Adverse Event|2|||
48411772|NCT00849667|155695000|FG002|Overall Study|Adverse Event|0|||
48411773|NCT00849667|155694998|FG000|Overall Study|Other|18|||
48411774|NCT00849667|155694999|FG001|Overall Study|Other|19|||
48411775|NCT00849667|155695000|FG002|Overall Study|Other|18|||
48411776|NCT00849667|155694998|FG000|Overall Study|Progressive disease|119|||
48411777|NCT00849667|155694999|FG001|Overall Study|Progressive disease|100|||
48411778|NCT00849667|155695000|FG002|Overall Study|Progressive disease|112|||
48411779|NCT00849667|155694998|FG000|Overall Study|Sponsor decision|208|||
48411780|NCT00849667|155694999|FG001|Overall Study|Sponsor decision|204|||
48411781|NCT00849667|155695000|FG002|Overall Study|Sponsor decision|190|||
48411782|NCT00849667|155694998|FG000|Overall Study|Investigator discretion|0|||
48411783|NCT00849667|155694999|FG001|Overall Study|Investigator discretion|0|||
48411784|NCT00849667|155695000|FG002|Overall Study|Investigator discretion|1|||
48411785|NCT00531960|155695005|FG000|Overall Study|Adverse Event|5|||
48411786|NCT00531960|155695006|FG001|Overall Study|Adverse Event|4|||
48411787|NCT00531960|155695005|FG000|Overall Study|Death|3|||
48411788|NCT00531960|155695006|FG001|Overall Study|Death|2|||
48411789|NCT00531960|155695005|FG000|Overall Study|Lack of Efficacy|42|||
48411790|NCT00531960|155695006|FG001|Overall Study|Lack of Efficacy|41|||
48411791|NCT00531960|155695005|FG000|Overall Study|Violation of Selection Criteria|2|||
48411792|NCT00531960|155695006|FG001|Overall Study|Violation of Selection Criteria|0|||
48411793|NCT00531960|155695005|FG000|Overall Study|Refused Treatment|5|||
48411794|NCT00531960|155695006|FG001|Overall Study|Refused Treatment|6|||
48411795|NCT00531960|155695005|FG000|Overall Study|Other|4|||
48411796|NCT00531960|155695006|FG001|Overall Study|Other|10|||
48411797|NCT00501228|155695020|FG000|Overall Study|Withdrawal by Subject|1|||
48411798|NCT00934102|155695022|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
48411799|NCT00934102|155695023|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
48411800|NCT00934102|155695024|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
48411801|NCT02318784|155695025|FG000|Overall Study|Adverse Event|13|||
48411802|NCT02318784|155695025|FG000|Overall Study|Death|2|||
48411803|NCT02318784|155695025|FG000|Overall Study|Progressive Disease|37|||
48411804|NCT02318784|155695025|FG000|Overall Study|Withdrawal by Subject|10|||
48411805|NCT00781365|155695034|FG000|Overall Study|Withdrawal by Subject|13|||
48411806|NCT00781365|155695035|FG001|Overall Study|Withdrawal by Subject|8|||
48411807|NCT00781365|155695034|FG000|Overall Study|Did Not Attend Visit|20|||
48411808|NCT00781365|155695035|FG001|Overall Study|Did Not Attend Visit|28|||
48411809|NCT00781365|155695034|FG000|Overall Study|Language barrier|1|||
48411810|NCT00781365|155695035|FG001|Overall Study|Language barrier|0|||
48411811|NCT01960855|155695037|FG000|Overall Study|Subject noncompliant|1|||
48411812|NCT01960855|155695038|FG001|Overall Study|Subject noncompliant|0|||
48411813|NCT01960855|155695039|FG002|Overall Study|Subject noncompliant|0|||
48411814|NCT01960855|155695040|FG003|Overall Study|Subject noncompliant|0|||
48411815|NCT01960855|155695041|FG004|Overall Study|Subject noncompliant|0|||
48411816|NCT01960855|155695037|FG000|Overall Study|Adverse Event|2|||
48411817|NCT01960855|155695038|FG001|Overall Study|Adverse Event|0|||
48411818|NCT01960855|155695039|FG002|Overall Study|Adverse Event|6|||
48411819|NCT01960855|155695040|FG003|Overall Study|Adverse Event|2|||
48411820|NCT01960855|155695041|FG004|Overall Study|Adverse Event|2|||
48411821|NCT01960855|155695037|FG000|Overall Study|Lack of Efficacy|1|||
48411822|NCT01960855|155695038|FG001|Overall Study|Lack of Efficacy|1|||
48411823|NCT01960855|155695039|FG002|Overall Study|Lack of Efficacy|0|||
48411824|NCT01960855|155695040|FG003|Overall Study|Lack of Efficacy|0|||
48411825|NCT01960855|155695041|FG004|Overall Study|Lack of Efficacy|0|||
48411826|NCT01960855|155695037|FG000|Overall Study|Other|2|||
48411827|NCT01960855|155695038|FG001|Overall Study|Other|1|||
48411828|NCT01960855|155695039|FG002|Overall Study|Other|1|||
48411829|NCT01960855|155695040|FG003|Overall Study|Other|1|||
48358352|NCT00694109|155507436|FG000|Overall Study|Lack of Efficacy|2|||
48358353|NCT00694109|155507436|FG000|Overall Study|Withdrawal by Subject|13|||
48358354|NCT00694109|155507436|FG000|Overall Study|Pregnancy|1|||
48358355|NCT00694109|155507436|FG000|Overall Study|Enrolled but not treated|1|||
48358356|NCT00694109|155507436|FG000|Overall Study|Other|2|||
48358357|NCT00694109|155507436|FG000|Overall Study|Consented but no additional treatment|3|||
48358358|NCT01420237|155507439|FG000|Overall Study|Death|13|||
48358359|NCT01420237|155507439|FG000|Overall Study|Withdrawal by Subject|41|||
48358360|NCT01420237|155507439|FG000|Overall Study|Lost to Follow-up|32|||
48358361|NCT01420237|155507439|FG000|Overall Study|Adverse Event|10|||
48358362|NCT01420237|155507439|FG000|Overall Study|Investigative Site Termination|43|||
48358363|NCT01420237|155507439|FG000|Overall Study|Censored because study device not implanted|21|||
48411830|NCT01960855|155695041|FG004|Overall Study|Other|0|||
48358364|NCT01420237|155507439|FG000|Overall Study|Censored because surgery not performed|2|||
48358365|NCT01420237|155507439|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
48358366|NCT01420237|155507439|FG000|Overall Study|Sponsor terminated study early|127|||
48358367|NCT05034328|155507442|FG000|Overall Study|Protocol Violation|1|||
48358368|NCT05034328|155507443|FG001|Overall Study|Protocol Violation|0|||
48358369|NCT05034328|155507442|FG000|Overall Study|Lost to Follow-up|0|||
48358370|NCT05034328|155507443|FG001|Overall Study|Lost to Follow-up|10|||
48358371|NCT01246999|155508204|FG000|Overall Study|Lost to Follow-up|0|||
48358372|NCT01246999|155508205|FG001|Overall Study|Lost to Follow-up|1|||
48358373|NCT01246999|155508206|FG002|Overall Study|Lost to Follow-up|0|||
48358374|NCT01246999|155508207|FG003|Overall Study|Lost to Follow-up|0|||
48358375|NCT01246999|155508204|FG000|Overall Study|Withdrawal by Subject|0|||
48358376|NCT01246999|155508205|FG001|Overall Study|Withdrawal by Subject|0|||
48358377|NCT01246999|155508206|FG002|Overall Study|Withdrawal by Subject|0|||
48358378|NCT01246999|155508207|FG003|Overall Study|Withdrawal by Subject|2|||
48358379|NCT01240551|155508208|FG000|Overall Study|Refused further treatment|3|||
48358380|NCT01240551|155508209|FG001|Overall Study|Refused further treatment|2|||
48358381|NCT01240551|155508208|FG000|Overall Study|Lost to Follow-up|1|||
48358382|NCT01240551|155508209|FG001|Overall Study|Lost to Follow-up|1|||
48358383|NCT04869982|155508214|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
48358384|NCT04869982|155508215|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
48358385|NCT04869982|155508214|FG000|Overall Study|Migrated / moved from the study area|1|||
48358386|NCT04869982|155508215|FG001|Overall Study|Migrated / moved from the study area|1|||
48358387|NCT04869982|155508214|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
48358388|NCT04869982|155508215|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
48358389|NCT04869982|155508214|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
48358390|NCT04869982|155508215|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
48358391|NCT04869982|155508214|FG000|Overall Study|Solicited adverse event|2|||
48358392|NCT04869982|155508215|FG001|Overall Study|Solicited adverse event|1|||
48358393|NCT04247542|155508216|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
48358394|NCT04247542|155508217|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
48358395|NCT04247542|155508218|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
48358396|NCT04247542|155508216|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
48358397|NCT04247542|155508217|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
48358398|NCT04247542|155508218|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
48358399|NCT04842643|155508219|FG000|Overall Study|Physician Decision|1|||
48358400|NCT04842643|155508219|FG000|Overall Study|Other|1|||
48358401|NCT05592418|155508222|FG000|Overall Study|Adverse Event|1|||
48358402|NCT05592418|155508223|FG001|Overall Study|Adverse Event|0|||
48358403|NCT05592418|155508222|FG000|Overall Study|Lost to Follow-up|1|||
48358404|NCT05592418|155508223|FG001|Overall Study|Lost to Follow-up|3|||
48358405|NCT05592418|155508222|FG000|Overall Study|Withdrawal by Subject|2|||
48358406|NCT05592418|155508223|FG001|Overall Study|Withdrawal by Subject|7|||
48358407|NCT01016262|155508224|FG000|Double-blind Phase|Adverse Event|0|||
48358408|NCT01016262|155508225|FG001|Double-blind Phase|Adverse Event|0|||
48358409|NCT01016262|155508226|FG002|Double-blind Phase|Adverse Event|1|||
48358410|NCT01016262|155508227|FG003|Double-blind Phase|Adverse Event|0|||
48358411|NCT01016262|155508228|FG004|Double-blind Phase|Adverse Event|0|||
48358412|NCT01016262|155508229|FG005|Double-blind Phase|Adverse Event|0|||
48358413|NCT01016262|155508224|FG000|Double-blind Phase|Lack of Efficacy|1|||
48358414|NCT01016262|155508225|FG001|Double-blind Phase|Lack of Efficacy|0|||
48358415|NCT01016262|155508226|FG002|Double-blind Phase|Lack of Efficacy|5|||
48358416|NCT01016262|155508227|FG003|Double-blind Phase|Lack of Efficacy|0|||
48358417|NCT01016262|155508228|FG004|Double-blind Phase|Lack of Efficacy|0|||
48358418|NCT01016262|155508229|FG005|Double-blind Phase|Lack of Efficacy|0|||
48358419|NCT01016262|155508224|FG000|Double-blind Phase|Disease Progression|0|||
48358420|NCT01016262|155508225|FG001|Double-blind Phase|Disease Progression|1|||
48358421|NCT01016262|155508226|FG002|Double-blind Phase|Disease Progression|2|||
48358422|NCT01016262|155508227|FG003|Double-blind Phase|Disease Progression|0|||
48358423|NCT01016262|155508228|FG004|Double-blind Phase|Disease Progression|0|||
48358424|NCT01016262|155508229|FG005|Double-blind Phase|Disease Progression|0|||
48358425|NCT01016262|155508224|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
48358426|NCT01016262|155508225|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
48358427|NCT01016262|155508226|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
48358428|NCT01016262|155508227|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
48358429|NCT01016262|155508228|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
48358430|NCT01016262|155508229|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
48358431|NCT01016262|155508224|FG000|Open-Label Phase|Adverse Event|0|||
48358432|NCT01016262|155508225|FG001|Open-Label Phase|Adverse Event|0|||
48358433|NCT01016262|155508226|FG002|Open-Label Phase|Adverse Event|0|||
48358434|NCT01016262|155508227|FG003|Open-Label Phase|Adverse Event|1|||
48358435|NCT01016262|155508228|FG004|Open-Label Phase|Adverse Event|0|||
48358436|NCT01016262|155508229|FG005|Open-Label Phase|Adverse Event|0|||
48411831|NCT01960855|155695037|FG000|Overall Study|Consent withdrawn by subject|3|||
48411832|NCT01960855|155695038|FG001|Overall Study|Consent withdrawn by subject|1|||
48411833|NCT01960855|155695039|FG002|Overall Study|Consent withdrawn by subject|2|||
48411834|NCT01960855|155695040|FG003|Overall Study|Consent withdrawn by subject|1|||
48411835|NCT01960855|155695041|FG004|Overall Study|Consent withdrawn by subject|1|||
48411836|NCT01960855|155695037|FG000|Overall Study|Lost to Follow-up|2|||
48411837|NCT01960855|155695038|FG001|Overall Study|Lost to Follow-up|1|||
48411838|NCT01960855|155695039|FG002|Overall Study|Lost to Follow-up|0|||
48411839|NCT01960855|155695040|FG003|Overall Study|Lost to Follow-up|0|||
48411840|NCT01960855|155695041|FG004|Overall Study|Lost to Follow-up|2|||
48411841|NCT02649634|155695042|FG000|Overall Study|Withdrawal by Subject|3|||
48411842|NCT02649634|155695043|FG001|Overall Study|Withdrawal by Subject|5|||
48411843|NCT02649634|155695042|FG000|Overall Study|Lost to Follow-up|0|||
48411844|NCT02649634|155695043|FG001|Overall Study|Lost to Follow-up|1|||
48411845|NCT03367871|155695044|FG000|Overall Study|Lost to Follow-up|1|||
48411846|NCT00763009|155695046|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
48411847|NCT00607048|155695047|FG000|Overall Study|Adverse Event|0|||
48411848|NCT00607048|155695048|FG001|Overall Study|Adverse Event|1|||
48411849|NCT00607048|155695049|FG002|Overall Study|Adverse Event|0|||
48411850|NCT00607048|155695050|FG003|Overall Study|Adverse Event|0|||
48411851|NCT00607048|155695051|FG004|Overall Study|Adverse Event|4|||
48411852|NCT00607048|155695052|FG005|Overall Study|Adverse Event|0|||
48411853|NCT00607048|155695047|FG000|Overall Study|Global deterioration of health|1|||
48411854|NCT00607048|155695048|FG001|Overall Study|Global deterioration of health|0|||
48411855|NCT00607048|155695049|FG002|Overall Study|Global deterioration of health|0|||
48411856|NCT00607048|155695050|FG003|Overall Study|Global deterioration of health|0|||
48411857|NCT00607048|155695051|FG004|Overall Study|Global deterioration of health|0|||
48411858|NCT00607048|155695052|FG005|Overall Study|Global deterioration of health|0|||
48411859|NCT00607048|155695047|FG000|Overall Study|Objective disease progression - relapse|1|||
48411860|NCT00607048|155695048|FG001|Overall Study|Objective disease progression - relapse|2|||
48411861|NCT00607048|155695049|FG002|Overall Study|Objective disease progression - relapse|4|||
48411862|NCT00607048|155695050|FG003|Overall Study|Objective disease progression - relapse|2|||
48411863|NCT00607048|155695051|FG004|Overall Study|Objective disease progression - relapse|2|||
48411864|NCT00607048|155695052|FG005|Overall Study|Objective disease progression - relapse|2|||
48411865|NCT00607048|155695047|FG000|Overall Study|Withdrawal by Subject|0|||
48411866|NCT00607048|155695048|FG001|Overall Study|Withdrawal by Subject|0|||
48411867|NCT00607048|155695049|FG002|Overall Study|Withdrawal by Subject|0|||
48411868|NCT00607048|155695050|FG003|Overall Study|Withdrawal by Subject|1|||
48411869|NCT00607048|155695051|FG004|Overall Study|Withdrawal by Subject|0|||
48411870|NCT00607048|155695052|FG005|Overall Study|Withdrawal by Subject|2|||
48411871|NCT00607048|155695047|FG000|Overall Study|Other|1|||
48411872|NCT00607048|155695048|FG001|Overall Study|Other|1|||
48411873|NCT00607048|155695049|FG002|Overall Study|Other|0|||
48411874|NCT00607048|155695050|FG003|Overall Study|Other|0|||
48411875|NCT00607048|155695051|FG004|Overall Study|Other|0|||
48411876|NCT00607048|155695052|FG005|Overall Study|Other|1|||
48358437|NCT01016262|155508224|FG000|Open-Label Phase|Lost to Follow-up|0|||
48358438|NCT01016262|155508225|FG001|Open-Label Phase|Lost to Follow-up|0|||
48358439|NCT01016262|155508226|FG002|Open-Label Phase|Lost to Follow-up|0|||
48358440|NCT01016262|155508227|FG003|Open-Label Phase|Lost to Follow-up|0|||
48358441|NCT01016262|155508228|FG004|Open-Label Phase|Lost to Follow-up|1|||
48358442|NCT01016262|155508229|FG005|Open-Label Phase|Lost to Follow-up|0|||
48358443|NCT01016262|155508224|FG000|Open-Label Phase|Lack of Efficacy|0|||
48358444|NCT01016262|155508225|FG001|Open-Label Phase|Lack of Efficacy|0|||
48358445|NCT01016262|155508226|FG002|Open-Label Phase|Lack of Efficacy|0|||
48358446|NCT01016262|155508227|FG003|Open-Label Phase|Lack of Efficacy|1|||
48358447|NCT01016262|155508228|FG004|Open-Label Phase|Lack of Efficacy|0|||
48358448|NCT01016262|155508229|FG005|Open-Label Phase|Lack of Efficacy|0|||
48358449|NCT01016262|155508224|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
48358450|NCT01016262|155508225|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
48358451|NCT01016262|155508226|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
48358452|NCT01016262|155508227|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
48358453|NCT01016262|155508228|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
48358454|NCT01016262|155508229|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
48411877|NCT02013544|155695053|FG000|Overall Study|Adverse Event|5|||
48411878|NCT02013544|155695054|FG001|Overall Study|Adverse Event|5|||
48411879|NCT02013544|155695053|FG000|Overall Study|Lost to Follow-up|2|||
48411880|NCT02013544|155695054|FG001|Overall Study|Lost to Follow-up|3|||
48411881|NCT02013544|155695053|FG000|Overall Study|Withdrawal by Subject|2|||
48411882|NCT02013544|155695054|FG001|Overall Study|Withdrawal by Subject|8|||
48411883|NCT02013544|155695053|FG000|Overall Study|Physician Decision|0|||
48411884|NCT02013544|155695054|FG001|Overall Study|Physician Decision|1|||
48358455|NCT03812029|155508230|FG000|Overall Study|Protocol Violation|1|||
48358456|NCT03812029|155508231|FG001|Overall Study|Protocol Violation|0|||
48358457|NCT03812029|155508232|FG002|Overall Study|Protocol Violation|0|||
48358458|NCT03812029|155508233|FG003|Overall Study|Protocol Violation|1|||
48358459|NCT03812029|155508234|FG004|Overall Study|Protocol Violation|0|||
48358460|NCT03812029|155508230|FG000|Overall Study|Withdrawal by Subject|1|||
48358461|NCT03812029|155508231|FG001|Overall Study|Withdrawal by Subject|0|||
48358462|NCT03812029|155508232|FG002|Overall Study|Withdrawal by Subject|0|||
48358463|NCT03812029|155508233|FG003|Overall Study|Withdrawal by Subject|2|||
48358464|NCT03812029|155508234|FG004|Overall Study|Withdrawal by Subject|2|||
48358465|NCT03812029|155508230|FG000|Overall Study|Stopping rules|0|||
48358466|NCT03812029|155508231|FG001|Overall Study|Stopping rules|1|||
48358467|NCT03812029|155508232|FG002|Overall Study|Stopping rules|0|||
48358468|NCT03812029|155508233|FG003|Overall Study|Stopping rules|0|||
48358469|NCT03812029|155508234|FG004|Overall Study|Stopping rules|0|||
48358470|NCT03812029|155508230|FG000|Overall Study|Adverse Event|0|||
48358471|NCT03812029|155508231|FG001|Overall Study|Adverse Event|9|||
48358472|NCT03812029|155508232|FG002|Overall Study|Adverse Event|0|||
48358473|NCT03812029|155508233|FG003|Overall Study|Adverse Event|3|||
48358474|NCT03812029|155508234|FG004|Overall Study|Adverse Event|5|||
48358475|NCT03812029|155508230|FG000|Overall Study|Lost to Follow-up|0|||
48358476|NCT03812029|155508231|FG001|Overall Study|Lost to Follow-up|0|||
48358477|NCT03812029|155508232|FG002|Overall Study|Lost to Follow-up|0|||
48358478|NCT03812029|155508233|FG003|Overall Study|Lost to Follow-up|0|||
48358479|NCT03812029|155508234|FG004|Overall Study|Lost to Follow-up|3|||
48358480|NCT03361306|155508235|FG000|Overall Study|Death|5|||
48358481|NCT03361306|155508235|FG000|Overall Study|Still On Study (on study treatment)|3|||
48411885|NCT02013544|155695053|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
48411886|NCT02013544|155695054|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
48358482|NCT03361306|155508235|FG000|Overall Study|Still On Study (in follow up)|7|||
48358483|NCT00667394|155508236|FG000|Overall Study|Adverse Event|3|||
48358484|NCT00667394|155508237|FG001|Overall Study|Adverse Event|0|||
48358485|NCT00667394|155508236|FG000|Overall Study|Progressive disease|1|||
48358486|NCT00667394|155508237|FG001|Overall Study|Progressive disease|0|||
48358487|NCT04924660|155508238|FG000|United States|Death|29|||
48358488|NCT04924660|155508239|FG001|United States|Death|32|||
48358489|NCT04924660|155508240|FG002|United States|Death|34|||
48411887|NCT03663166|155695057|FG000|Overall Study|Withdrawal by Subject|1|||
48411888|NCT01413958|155695058|FG000|Overall Study|Lost to Follow-up|0|||
48411889|NCT01413958|155695059|FG001|Overall Study|Lost to Follow-up|1|||
48411890|NCT01614964|155695060|FG000|Overall Study|Withdrawal by Subject|2|||
48411891|NCT01614964|155695061|FG001|Overall Study|Withdrawal by Subject|0|||
48411892|NCT01614964|155695060|FG000|Overall Study|Lost to Follow-up|3|||
48411893|NCT01614964|155695061|FG001|Overall Study|Lost to Follow-up|0|||
48411894|NCT02700984|155695062|FG000|Overall Study|Death|2|||
48411895|NCT02700984|155695063|FG001|Overall Study|Death|1|||
48358490|NCT04924660|155508241|FG003|United States|Death|25|||
48358491|NCT04924660|155508242|FG004|United States|Death|26|||
48358492|NCT04924660|155508243|FG005|United States|Death|23|||
48358493|NCT04924660|155508238|FG000|United States|Lost to Follow-up|15|||
48358494|NCT04924660|155508239|FG001|United States|Lost to Follow-up|10|||
48358495|NCT04924660|155508240|FG002|United States|Lost to Follow-up|13|||
48358496|NCT04924660|155508241|FG003|United States|Lost to Follow-up|5|||
48358497|NCT04924660|155508242|FG004|United States|Lost to Follow-up|19|||
48358498|NCT04924660|155508243|FG005|United States|Lost to Follow-up|20|||
48358499|NCT04924660|155508238|FG000|United States|Withdrawal by Subject|8|||
48358500|NCT04924660|155508239|FG001|United States|Withdrawal by Subject|3|||
48358501|NCT04924660|155508240|FG002|United States|Withdrawal by Subject|3|||
48358502|NCT04924660|155508241|FG003|United States|Withdrawal by Subject|3|||
48358503|NCT04924660|155508242|FG004|United States|Withdrawal by Subject|8|||
48358504|NCT04924660|155508243|FG005|United States|Withdrawal by Subject|4|||
48358505|NCT04924660|155508238|FG000|Spain|Death|0|||
48358506|NCT04924660|155508239|FG001|Spain|Death|0|||
48358507|NCT04924660|155508240|FG002|Spain|Death|0|||
48358508|NCT04924660|155508241|FG003|Spain|Death|0|||
48358509|NCT04924660|155508242|FG004|Spain|Death|0|||
48358510|NCT04924660|155508243|FG005|Spain|Death|2|||
48358511|NCT04924660|155508238|FG000|Spain|Lost to Follow-up|0|||
48358512|NCT04924660|155508239|FG001|Spain|Lost to Follow-up|0|||
48358513|NCT04924660|155508240|FG002|Spain|Lost to Follow-up|0|||
48358514|NCT04924660|155508241|FG003|Spain|Lost to Follow-up|0|||
48358515|NCT04924660|155508242|FG004|Spain|Lost to Follow-up|1|||
48411896|NCT02700984|155695062|FG000|Overall Study|Lost to Follow-up|2|||
48411897|NCT02700984|155695063|FG001|Overall Study|Lost to Follow-up|1|||
48358516|NCT04924660|155508243|FG005|Spain|Lost to Follow-up|0|||
48358517|NCT04924660|155508238|FG000|Brazil|Death|0|||
48358518|NCT04924660|155508239|FG001|Brazil|Death|0|||
48358519|NCT04924660|155508240|FG002|Brazil|Death|0|||
48358520|NCT04924660|155508241|FG003|Brazil|Death|0|||
48358521|NCT04924660|155508242|FG004|Brazil|Death|1|||
48358522|NCT04924660|155508243|FG005|Brazil|Death|0|||
48358523|NCT04924660|155508238|FG000|Italy|Lost to Follow-up|0|||
48358524|NCT04924660|155508239|FG001|Italy|Lost to Follow-up|0|||
48358525|NCT04924660|155508240|FG002|Italy|Lost to Follow-up|0|||
48358526|NCT04924660|155508241|FG003|Italy|Lost to Follow-up|0|||
48358527|NCT04924660|155508242|FG004|Italy|Lost to Follow-up|0|||
48411898|NCT02700984|155695062|FG000|Overall Study|Physician Decision|0|||
48358528|NCT04924660|155508243|FG005|Italy|Lost to Follow-up|1|||
48358529|NCT04924660|155508238|FG000|South Africa|Death|0|||
48358530|NCT04924660|155508239|FG001|South Africa|Death|0|||
48358531|NCT04924660|155508240|FG002|South Africa|Death|0|||
48358532|NCT04924660|155508241|FG003|South Africa|Death|0|||
48358533|NCT04924660|155508242|FG004|South Africa|Death|0|||
48358534|NCT04924660|155508243|FG005|South Africa|Death|1|||
48358535|NCT04924660|155508238|FG000|South Africa|Lost to Follow-up|0|||
48358536|NCT04924660|155508239|FG001|South Africa|Lost to Follow-up|0|||
48358537|NCT04924660|155508240|FG002|South Africa|Lost to Follow-up|0|||
48358538|NCT04924660|155508241|FG003|South Africa|Lost to Follow-up|0|||
48358539|NCT04924660|155508242|FG004|South Africa|Lost to Follow-up|0|||
48358540|NCT04924660|155508243|FG005|South Africa|Lost to Follow-up|1|||
48358541|NCT04993677|155508245|FG000|Overall Study|Lost to Follow-up|1|||
48358542|NCT04993677|155508246|FG001|Overall Study|Lost to Follow-up|0|||
48358543|NCT04993677|155508247|FG002|Overall Study|Lost to Follow-up|0|||
48358544|NCT04993677|155508248|FG003|Overall Study|Lost to Follow-up|0|||
48358545|NCT04993677|155508245|FG000|Overall Study|Death|11|||
48358546|NCT04993677|155508246|FG001|Overall Study|Death|8|||
48358547|NCT04993677|155508247|FG002|Overall Study|Death|3|||
48358548|NCT04993677|155508248|FG003|Overall Study|Death|1|||
48358549|NCT04993677|155508245|FG000|Overall Study|Subject withdrawal of consent|4|||
48358550|NCT04993677|155508246|FG001|Overall Study|Subject withdrawal of consent|3|||
48358551|NCT04993677|155508247|FG002|Overall Study|Subject withdrawal of consent|0|||
48358552|NCT04993677|155508248|FG003|Overall Study|Subject withdrawal of consent|2|||
48358553|NCT04993677|155508245|FG000|Overall Study|Study termination by sponsor|3|||
48358554|NCT04993677|155508246|FG001|Overall Study|Study termination by sponsor|22|||
48358555|NCT04993677|155508247|FG002|Overall Study|Study termination by sponsor|3|||
48358556|NCT04993677|155508248|FG003|Overall Study|Study termination by sponsor|3|||
48358557|NCT04993677|155508245|FG000|Overall Study|Other|2|||
48358558|NCT04993677|155508246|FG001|Overall Study|Other|2|||
48358559|NCT04993677|155508247|FG002|Overall Study|Other|3|||
48358560|NCT04993677|155508248|FG003|Overall Study|Other|2|||
48358561|NCT01931098|155508249|FG000|Overall Study|Withdrawal by Subject|0|||
48358562|NCT01931098|155508250|FG001|Overall Study|Withdrawal by Subject|1|||
48358563|NCT01931098|155508249|FG000|Overall Study|Enrolled in different protocol|0|||
48358564|NCT01931098|155508250|FG001|Overall Study|Enrolled in different protocol|1|||
48358565|NCT01931098|155508249|FG000|Overall Study|Unable to begin trmt:active infection|0|||
48358566|NCT01931098|155508250|FG001|Overall Study|Unable to begin trmt:active infection|1|||
48358567|NCT01931098|155508249|FG000|Overall Study|Refused further treatment|0|||
48358568|NCT01931098|155508250|FG001|Overall Study|Refused further treatment|1|||
48358569|NCT04149704|155508253|FG000|Three Month Follow-up|Death|2|||
48358570|NCT04149704|155508254|FG001|Three Month Follow-up|Death|0|||
48358571|NCT04149704|155508255|FG002|Three Month Follow-up|Death|0|||
48358572|NCT04149704|155508256|FG003|Three Month Follow-up|Death|0|||
48358573|NCT04149704|155508253|FG000|Three Month Follow-up|Lost to Follow-up|1|||
48358574|NCT04149704|155508254|FG001|Three Month Follow-up|Lost to Follow-up|4|||
48358575|NCT04149704|155508255|FG002|Three Month Follow-up|Lost to Follow-up|5|||
48358576|NCT04149704|155508256|FG003|Three Month Follow-up|Lost to Follow-up|5|||
48358577|NCT04149704|155508253|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
48358578|NCT04149704|155508254|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
48358579|NCT04149704|155508255|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
48358580|NCT04149704|155508256|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
48358581|NCT04149704|155508253|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
48358582|NCT04149704|155508254|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
48358583|NCT04149704|155508255|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
48358584|NCT04149704|155508256|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
48358585|NCT03101462|155508257|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
48358586|NCT03101462|155508258|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
48358587|NCT01594970|155508259|FG000|Overall Study|Non-Adverse Event Related|4|||
48358588|NCT01594970|155508260|FG001|Overall Study|Non-Adverse Event Related|5|||
48358589|NCT01594970|155508261|FG002|Overall Study|Non-Adverse Event Related|6|||
48358590|NCT01594970|155508259|FG000|Overall Study|Adverse Event|17|||
48358591|NCT01594970|155508260|FG001|Overall Study|Adverse Event|23|||
48358592|NCT01594970|155508261|FG002|Overall Study|Adverse Event|23|||
48358593|NCT01594970|155508259|FG000|Overall Study|Lost to Follow-up|54|||
48358594|NCT01594970|155508260|FG001|Overall Study|Lost to Follow-up|54|||
48358595|NCT01594970|155508261|FG002|Overall Study|Lost to Follow-up|37|||
48358596|NCT03192475|155508264|FG000|Overall Study|Death|0|||
48358597|NCT03192475|155508265|FG001|Overall Study|Death|1|||
48358598|NCT03192475|155508264|FG000|Overall Study|Lost to Follow-up|13|||
48358599|NCT03192475|155508265|FG001|Overall Study|Lost to Follow-up|8|||
48358600|NCT01989169|155508269|FG000|Period 2|Adverse Event|0|||
48358601|NCT01989169|155508270|FG001|Period 2|Adverse Event|1|||
48358602|NCT05583578|155508273|FG000|Overall Study|Withdrawal by Subject|2|||
48358603|NCT05583578|155508274|FG001|Overall Study|Withdrawal by Subject|0|||
48358604|NCT03924635|155508275|FG000|Overall Study|Withdrawal by Subject|2|||
48358605|NCT03924635|155508276|FG001|Overall Study|Withdrawal by Subject|4|||
48358606|NCT04294641|155508277|FG000|Overall Study|Screen failure|4|||
48358607|NCT04685135|155508278|FG000|Overall Study|Death|126|||
48358608|NCT04685135|155508279|FG001|Overall Study|Death|53|||
48358609|NCT04685135|155508278|FG000|Overall Study|Withdrawal by Subject|12|||
48358610|NCT04685135|155508279|FG001|Overall Study|Withdrawal by Subject|16|||
48358611|NCT03547271|155508280|FG000|Overall Study|Adverse Event|1|||
48358612|NCT03547271|155508281|FG001|Overall Study|Adverse Event|1|||
48358613|NCT03547271|155508282|FG002|Overall Study|Adverse Event|0|||
48358614|NCT03547271|155508283|FG003|Overall Study|Adverse Event|0|||
48358615|NCT03547271|155508280|FG000|Overall Study|Protocol deviation|5|||
48358616|NCT03547271|155508281|FG001|Overall Study|Protocol deviation|7|||
48358617|NCT03547271|155508282|FG002|Overall Study|Protocol deviation|3|||
48358618|NCT03547271|155508283|FG003|Overall Study|Protocol deviation|0|||
48358619|NCT03547271|155508280|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
48358620|NCT03547271|155508281|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
48358621|NCT03547271|155508282|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
48358622|NCT03547271|155508283|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
48358623|NCT03547271|155508280|FG000|Overall Study|Lost to Follow-up|3|||
48358624|NCT03547271|155508281|FG001|Overall Study|Lost to Follow-up|3|||
48358625|NCT03547271|155508282|FG002|Overall Study|Lost to Follow-up|1|||
48358626|NCT03547271|155508283|FG003|Overall Study|Lost to Follow-up|0|||
48358627|NCT03073941|155509557|FG000|Overall Study|Received non-study device intraoperatively|0|||
48358628|NCT03073941|155509558|FG001|Overall Study|Received non-study device intraoperatively|2|||
48358629|NCT03073941|155509557|FG000|Overall Study|Death|1|||
48358630|NCT03073941|155509558|FG001|Overall Study|Death|0|||
48358631|NCT03073941|155509557|FG000|Overall Study|Withdrawal by Subject|1|||
48358632|NCT03073941|155509558|FG001|Overall Study|Withdrawal by Subject|3|||
48358633|NCT03073941|155509557|FG000|Overall Study|Lost to Follow-up|5|||
48358634|NCT03073941|155509558|FG001|Overall Study|Lost to Follow-up|4|||
48358635|NCT03073941|155509557|FG000|Overall Study|Adverse Event|4|||
48358636|NCT03073941|155509558|FG001|Overall Study|Adverse Event|2|||
48358637|NCT03073941|155509557|FG000|Overall Study|Met an exclusion criterion|0|||
48358638|NCT03073941|155509558|FG001|Overall Study|Met an exclusion criterion|1|||
48358639|NCT00667459|155509563|FG000|Overall Study|Death|0|||
48358640|NCT00667459|155509564|FG001|Overall Study|Death|2|||
48358641|NCT00667459|155509563|FG000|Overall Study|Lost to Follow-up|8|||
48358642|NCT00667459|155509564|FG001|Overall Study|Lost to Follow-up|43|||
48358643|NCT02797522|155509565|FG000|Overall Study|Study Terminated by Sponsor|0|||
48358644|NCT02797522|155509566|FG001|Overall Study|Study Terminated by Sponsor|0|||
48358645|NCT02797522|155509567|FG002|Overall Study|Study Terminated by Sponsor|0|||
48358646|NCT02797522|155509568|FG003|Overall Study|Study Terminated by Sponsor|0|||
48358647|NCT02797522|155509569|FG004|Overall Study|Study Terminated by Sponsor|0|||
48358648|NCT02797522|155509570|FG005|Overall Study|Study Terminated by Sponsor|0|||
48358649|NCT02797522|155509571|FG006|Overall Study|Study Terminated by Sponsor|0|||
48358650|NCT02797522|155509572|FG007|Overall Study|Study Terminated by Sponsor|4|||
48358651|NCT02797522|155509573|FG008|Overall Study|Study Terminated by Sponsor|2|||
48358652|NCT02797522|155509574|FG009|Overall Study|Study Terminated by Sponsor|4|||
48358653|NCT02797522|155509575|FG010|Overall Study|Study Terminated by Sponsor|1|||
48358654|NCT03838731|155509576|FG000|Overall Study|Pregnancy|0|||
48358655|NCT03838731|155509577|FG001|Overall Study|Pregnancy|1|||
48358656|NCT03838731|155509576|FG000|Overall Study|Withdrawal of consent|1|||
48358657|NCT03838731|155509577|FG001|Overall Study|Withdrawal of consent|0|||
48358658|NCT04878354|155509578|FG000|Overall Study|Adverse Event|4|||
48358659|NCT04878354|155509579|FG001|Overall Study|Adverse Event|13|||
48358660|NCT04878354|155509578|FG000|Overall Study|Withdrawal by Subject|14|||
48358661|NCT04878354|155509579|FG001|Overall Study|Withdrawal by Subject|12|||
48358662|NCT04878354|155509578|FG000|Overall Study|Lost to Follow-up|4|||
48358663|NCT04878354|155509579|FG001|Overall Study|Lost to Follow-up|1|||
48358664|NCT04878354|155509578|FG000|Overall Study|Lack of Efficacy|1|||
48358665|NCT04878354|155509579|FG001|Overall Study|Lack of Efficacy|0|||
48358666|NCT04878354|155509578|FG000|Overall Study|Protocol Violation|0|||
48411899|NCT02700984|155695063|FG001|Overall Study|Physician Decision|1|||
48411900|NCT02700984|155695062|FG000|Overall Study|Withdrawal by Subject|8|||
48411901|NCT02700984|155695063|FG001|Overall Study|Withdrawal by Subject|9|||
48411902|NCT02700984|155695062|FG000|Overall Study|Reason not specified|3|||
48358667|NCT04878354|155509579|FG001|Overall Study|Protocol Violation|1|||
48358668|NCT04878354|155509578|FG000|Overall Study|"Reason stated as other in CRF"|2|||
48358669|NCT04878354|155509579|FG001|Overall Study|"Reason stated as other in CRF"|3|||
48358670|NCT05307783|155509580|FG000|Overall Study|Death|7|||
48358671|NCT05307783|155509580|FG000|Overall Study|Lost to Follow-up|4|||
48358672|NCT02728076|155509582|FG000|Overall Study|Physician Decision|4|||
48358673|NCT00527787|155509583|FG000|Overall Study|Adverse Event|14|||
48358674|NCT00527787|155509584|FG001|Overall Study|Adverse Event|24|||
48358675|NCT00527787|155509583|FG000|Overall Study|Withdrawal by Subject|13|||
48358676|NCT00527787|155509584|FG001|Overall Study|Withdrawal by Subject|25|||
48358677|NCT00527787|155509583|FG000|Overall Study|Lost to Follow-up|5|||
48358678|NCT00527787|155509584|FG001|Overall Study|Lost to Follow-up|2|||
48358679|NCT00527787|155509583|FG000|Overall Study|Duodenal Ulcer|1|||
48358680|NCT00527787|155509584|FG001|Overall Study|Duodenal Ulcer|10|||
48358681|NCT00527787|155509583|FG000|Overall Study|misc|5|||
48358682|NCT00527787|155509584|FG001|Overall Study|misc|2|||
48358683|NCT02312557|155509585|FG000|Overall Study|Survival follow-up|4|||
48358684|NCT03106753|155509590|FG000|Overall Study|Withdrawal by Subject|0|||
48358685|NCT03106753|155509591|FG001|Overall Study|Withdrawal by Subject|1|||
48358686|NCT01735175|155509596|FG000|Overall Study|Withdrawal by Subject|9|||
48358687|NCT01735175|155509597|FG001|Overall Study|Withdrawal by Subject|2|||
48358688|NCT01735175|155509596|FG000|Overall Study|Lost to Follow-up|4|||
48358689|NCT01735175|155509597|FG001|Overall Study|Lost to Follow-up|2|||
48358690|NCT01735175|155509596|FG000|Overall Study|Death|3|||
48358691|NCT01735175|155509597|FG001|Overall Study|Death|2|||
48358692|NCT01735175|155509596|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
48358693|NCT01735175|155509597|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
48358694|NCT05877976|155509607|FG000|Overall Study|Lost to Follow-up|31|||
48358695|NCT02844816|155509624|FG000|Overall Study|No protocol treatment received|5|||
48358696|NCT02844816|155509625|FG001|Overall Study|No protocol treatment received|1|||
48358697|NCT02844816|155509624|FG000|Overall Study|Ineligible|22|||
48358698|NCT02844816|155509625|FG001|Overall Study|Ineligible|15|||
48358699|NCT02844816|155509624|FG000|Overall Study|Participant refusal|5|||
48358700|NCT02844816|155509625|FG001|Overall Study|Participant refusal|5|||
48358701|NCT02844816|155509624|FG000|Overall Study|Adverse Event|5|||
48358702|NCT02844816|155509625|FG001|Overall Study|Adverse Event|4|||
48358703|NCT02844816|155509624|FG000|Overall Study|Death|0|||
48358704|NCT02844816|155509625|FG001|Overall Study|Death|1|||
48358705|NCT02844816|155509624|FG000|Overall Study|Disease progression/recurrence|50|||
48358706|NCT02844816|155509625|FG001|Overall Study|Disease progression/recurrence|24|||
48358707|NCT02844816|155509624|FG000|Overall Study|Physician Decision|1|||
48358708|NCT02844816|155509625|FG001|Overall Study|Physician Decision|1|||
48358709|NCT05645757|155509626|FG000|Overall Study|Enrolled but treatment not administered|0|||
48358710|NCT05645757|155509627|FG001|Overall Study|Enrolled but treatment not administered|0|||
48358711|NCT05645757|155509628|FG002|Overall Study|Enrolled but treatment not administered|0|||
48358712|NCT05645757|155509629|FG003|Overall Study|Enrolled but treatment not administered|0|||
48358713|NCT05645757|155509630|FG004|Overall Study|Enrolled but treatment not administered|1|||
48358714|NCT05645757|155509631|FG005|Overall Study|Enrolled but treatment not administered|1|||
48358715|NCT05645757|155509632|FG006|Overall Study|Enrolled but treatment not administered|0|||
48358716|NCT05645757|155509633|FG007|Overall Study|Enrolled but treatment not administered|0|||
48358717|NCT00539591|155509634|FG000|Overall Study|Toxicity|3|||
48358718|NCT00539591|155509635|FG001|Overall Study|Toxicity|0|||
48358719|NCT00539591|155509636|FG002|Overall Study|Toxicity|0|||
48358720|NCT00539591|155509634|FG000|Overall Study|Disease progression|2|||
48358721|NCT00539591|155509635|FG001|Overall Study|Disease progression|2|||
48358722|NCT00539591|155509636|FG002|Overall Study|Disease progression|3|||
48358723|NCT04471246|155509637|FG000|Overall Study|Lost to Follow-up|2|||
48358724|NCT04471246|155509638|FG001|Overall Study|Lost to Follow-up|2|||
48358725|NCT02626455|155509639|FG000|Overall Study|Other|1|||
48358726|NCT02626455|155509640|FG001|Overall Study|Other|1|||
48358727|NCT02626455|155509641|FG002|Overall Study|Other|0|||
48358728|NCT02626455|155509642|FG003|Overall Study|Other|0|||
48358729|NCT02626455|155509643|FG004|Overall Study|Other|0|||
48358730|NCT02626455|155509644|FG005|Overall Study|Other|17|||
48358731|NCT02626455|155509645|FG006|Overall Study|Other|23|||
48358732|NCT02626455|155509639|FG000|Overall Study|Withdrawal by Subject|1|||
48358733|NCT02626455|155509640|FG001|Overall Study|Withdrawal by Subject|0|||
48358734|NCT02626455|155509641|FG002|Overall Study|Withdrawal by Subject|0|||
48358735|NCT02626455|155509642|FG003|Overall Study|Withdrawal by Subject|0|||
48358736|NCT02626455|155509643|FG004|Overall Study|Withdrawal by Subject|0|||
48358737|NCT02626455|155509644|FG005|Overall Study|Withdrawal by Subject|10|||
48358738|NCT02626455|155509645|FG006|Overall Study|Withdrawal by Subject|6|||
48358739|NCT02626455|155509639|FG000|Overall Study|Physician Decision|0|||
48358740|NCT02626455|155509640|FG001|Overall Study|Physician Decision|2|||
48358741|NCT02626455|155509641|FG002|Overall Study|Physician Decision|2|||
48358742|NCT02626455|155509642|FG003|Overall Study|Physician Decision|2|||
48358743|NCT02626455|155509643|FG004|Overall Study|Physician Decision|1|||
48358744|NCT02626455|155509644|FG005|Overall Study|Physician Decision|10|||
48358745|NCT02626455|155509645|FG006|Overall Study|Physician Decision|3|||
48358746|NCT02626455|155509639|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48358747|NCT02626455|155509640|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48358748|NCT02626455|155509641|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48358749|NCT02626455|155509642|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48358750|NCT02626455|155509643|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48358751|NCT02626455|155509644|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
48358752|NCT02626455|155509645|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
48358753|NCT02626455|155509639|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48358754|NCT02626455|155509640|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48358755|NCT02626455|155509641|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48411903|NCT02700984|155695063|FG001|Overall Study|Reason not specified|2|||
48411904|NCT02393209|155695064|FG000|Overall Study|Study Terminated by Sponsor|1|||
48411905|NCT02393209|155695065|FG001|Overall Study|Study Terminated by Sponsor|1|||
48411906|NCT02393209|155695066|FG002|Overall Study|Study Terminated by Sponsor|0|||
48411907|NCT02393209|155695067|FG003|Overall Study|Study Terminated by Sponsor|0|||
48411908|NCT02393209|155695064|FG000|Overall Study|Withdrawal by Patient|1|||
48411909|NCT02393209|155695065|FG001|Overall Study|Withdrawal by Patient|0|||
48411910|NCT02393209|155695066|FG002|Overall Study|Withdrawal by Patient|0|||
48411911|NCT02393209|155695067|FG003|Overall Study|Withdrawal by Patient|0|||
48411912|NCT02393209|155695064|FG000|Overall Study|Death|2|||
48411913|NCT02393209|155695065|FG001|Overall Study|Death|2|||
48411914|NCT02393209|155695066|FG002|Overall Study|Death|0|||
48411915|NCT02393209|155695067|FG003|Overall Study|Death|0|||
48411916|NCT02393209|155695064|FG000|Overall Study|Death due to Disease Progression|2|||
48411917|NCT02393209|155695065|FG001|Overall Study|Death due to Disease Progression|2|||
48411918|NCT02393209|155695066|FG002|Overall Study|Death due to Disease Progression|0|||
48411919|NCT02393209|155695067|FG003|Overall Study|Death due to Disease Progression|0|||
48411920|NCT02393209|155695064|FG000|Overall Study|Death from Legionella Infection|0|||
48411921|NCT02393209|155695065|FG001|Overall Study|Death from Legionella Infection|1|||
48411922|NCT02393209|155695066|FG002|Overall Study|Death from Legionella Infection|0|||
48411923|NCT02393209|155695067|FG003|Overall Study|Death from Legionella Infection|0|||
48411924|NCT02393209|155695064|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
48411925|NCT02393209|155695065|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
48411926|NCT02393209|155695066|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
48411927|NCT02393209|155695067|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
48411928|NCT02393209|155695064|FG000|Overall Study|Lost to Follow-up|0|||
48411929|NCT02393209|155695065|FG001|Overall Study|Lost to Follow-up|1|||
48411930|NCT02393209|155695066|FG002|Overall Study|Lost to Follow-up|0|||
48411931|NCT02393209|155695067|FG003|Overall Study|Lost to Follow-up|0|||
48411932|NCT00642642|155695072|FG000|Treatment & Follow Up|Adverse Event|2|||
48411933|NCT00642642|155695072|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
48411934|NCT00642642|155695072|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
48411935|NCT01805180|155696844|FG000|Lead-in Donor Phase|screen failure|1|||
48411936|NCT01805180|155696845|FG001|Lead-in Donor Phase|screen failure|0|||
48358756|NCT02626455|155509642|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48358757|NCT02626455|155509643|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48358758|NCT02626455|155509644|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
48358759|NCT02626455|155509645|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
48358760|NCT02626455|155509639|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48358761|NCT02626455|155509640|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48358762|NCT02626455|155509641|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48358763|NCT02626455|155509642|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48358764|NCT02626455|155509643|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
48358765|NCT02626455|155509644|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
48358766|NCT02626455|155509645|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
48358767|NCT02626455|155509639|FG000|Overall Study|Patient decision|0|||
48358768|NCT02626455|155509640|FG001|Overall Study|Patient decision|1|||
48358769|NCT02626455|155509641|FG002|Overall Study|Patient decision|0|||
48358770|NCT02626455|155509642|FG003|Overall Study|Patient decision|0|||
48358771|NCT02626455|155509643|FG004|Overall Study|Patient decision|1|||
48358772|NCT02626455|155509644|FG005|Overall Study|Patient decision|36|||
48358773|NCT02626455|155509645|FG006|Overall Study|Patient decision|22|||
48358774|NCT02626455|155509639|FG000|Overall Study|Protocol Violation|0|||
48358775|NCT02626455|155509640|FG001|Overall Study|Protocol Violation|0|||
48358776|NCT02626455|155509641|FG002|Overall Study|Protocol Violation|0|||
48358777|NCT02626455|155509642|FG003|Overall Study|Protocol Violation|0|||
48358778|NCT02626455|155509643|FG004|Overall Study|Protocol Violation|0|||
48358779|NCT02626455|155509644|FG005|Overall Study|Protocol Violation|0|||
48358780|NCT02626455|155509645|FG006|Overall Study|Protocol Violation|1|||
48358781|NCT02626455|155509639|FG000|Overall Study|Progressive disease - radiological progression|0|||
48358782|NCT02626455|155509640|FG001|Overall Study|Progressive disease - radiological progression|0|||
48358783|NCT02626455|155509641|FG002|Overall Study|Progressive disease - radiological progression|0|||
48358784|NCT02626455|155509642|FG003|Overall Study|Progressive disease - radiological progression|0|||
48358785|NCT02626455|155509643|FG004|Overall Study|Progressive disease - radiological progression|0|||
48358786|NCT02626455|155509644|FG005|Overall Study|Progressive disease - radiological progression|11|||
48358787|NCT02626455|155509645|FG006|Overall Study|Progressive disease - radiological progression|22|||
48358788|NCT02626455|155509639|FG000|Overall Study|Progressive disease - clinical progression|0|||
48358789|NCT02626455|155509640|FG001|Overall Study|Progressive disease - clinical progression|0|||
48358790|NCT02626455|155509641|FG002|Overall Study|Progressive disease - clinical progression|0|||
48358791|NCT02626455|155509642|FG003|Overall Study|Progressive disease - clinical progression|0|||
48358792|NCT02626455|155509643|FG004|Overall Study|Progressive disease - clinical progression|0|||
48358793|NCT02626455|155509644|FG005|Overall Study|Progressive disease - clinical progression|1|||
48358794|NCT02626455|155509645|FG006|Overall Study|Progressive disease - clinical progression|2|||
48358795|NCT02626455|155509639|FG000|Overall Study|Lost to Follow-up|0|||
48358796|NCT02626455|155509640|FG001|Overall Study|Lost to Follow-up|0|||
48358797|NCT02626455|155509641|FG002|Overall Study|Lost to Follow-up|0|||
48358798|NCT02626455|155509642|FG003|Overall Study|Lost to Follow-up|0|||
48358799|NCT02626455|155509643|FG004|Overall Study|Lost to Follow-up|0|||
48358800|NCT02626455|155509644|FG005|Overall Study|Lost to Follow-up|1|||
48358801|NCT02626455|155509645|FG006|Overall Study|Lost to Follow-up|0|||
48358802|NCT02626455|155509639|FG000|Overall Study|AE not associated with clinical disease progression|1|||
48358803|NCT02626455|155509640|FG001|Overall Study|AE not associated with clinical disease progression|1|||
48358804|NCT02626455|155509641|FG002|Overall Study|AE not associated with clinical disease progression|0|||
48358805|NCT02626455|155509642|FG003|Overall Study|AE not associated with clinical disease progression|2|||
48358806|NCT02626455|155509643|FG004|Overall Study|AE not associated with clinical disease progression|1|||
48358807|NCT02626455|155509644|FG005|Overall Study|AE not associated with clinical disease progression|65|||
48358808|NCT02626455|155509645|FG006|Overall Study|AE not associated with clinical disease progression|21|||
48358809|NCT02626455|155509639|FG000|Overall Study|AE associated with clinical disease progression|0|||
48358810|NCT02626455|155509640|FG001|Overall Study|AE associated with clinical disease progression|0|||
48358811|NCT02626455|155509641|FG002|Overall Study|AE associated with clinical disease progression|0|||
48358812|NCT02626455|155509642|FG003|Overall Study|AE associated with clinical disease progression|0|||
48358813|NCT02626455|155509643|FG004|Overall Study|AE associated with clinical disease progression|0|||
48358814|NCT02626455|155509644|FG005|Overall Study|AE associated with clinical disease progression|1|||
48358815|NCT02626455|155509645|FG006|Overall Study|AE associated with clinical disease progression|2|||
48358816|NCT02626455|155509639|FG000|Overall Study|Study intervention never administered|0|||
48358817|NCT02626455|155509640|FG001|Overall Study|Study intervention never administered|0|||
48358818|NCT02626455|155509641|FG002|Overall Study|Study intervention never administered|0|||
48358819|NCT02626455|155509642|FG003|Overall Study|Study intervention never administered|0|||
48358820|NCT02626455|155509643|FG004|Overall Study|Study intervention never administered|0|||
48358821|NCT02626455|155509644|FG005|Overall Study|Study intervention never administered|1|||
48358822|NCT02626455|155509645|FG006|Overall Study|Study intervention never administered|3|||
48358823|NCT02240238|155509646|FG000|Phase 1|Adverse Event|0|||
48358824|NCT02240238|155509647|FG001|Phase 1|Adverse Event|0|||
48358825|NCT02240238|155509648|FG002|Phase 1|Adverse Event|0|||
48358826|NCT02240238|155509649|FG003|Phase 1|Adverse Event|0|||
48358827|NCT02240238|155509650|FG004|Phase 1|Adverse Event|0|||
48358828|NCT02240238|155509651|FG005|Phase 1|Adverse Event|0|||
48358829|NCT02240238|155509652|FG006|Phase 1|Adverse Event|3|||
48358830|NCT02240238|155509653|FG007|Phase 1|Adverse Event|1|||
48358831|NCT02240238|155509654|FG008|Phase 1|Adverse Event|0|||
48358832|NCT02240238|155509655|FG009|Phase 1|Adverse Event|0|||
48358833|NCT02240238|155509656|FG010|Phase 1|Adverse Event|0|||
48358834|NCT02240238|155509657|FG011|Phase 1|Adverse Event|0|||
48358835|NCT02240238|155509646|FG000|Phase 1|Death|0|||
48358836|NCT02240238|155509647|FG001|Phase 1|Death|0|||
48358837|NCT02240238|155509648|FG002|Phase 1|Death|0|||
48358838|NCT02240238|155509649|FG003|Phase 1|Death|0|||
48358839|NCT02240238|155509650|FG004|Phase 1|Death|0|||
48358840|NCT02240238|155509651|FG005|Phase 1|Death|1|||
48358841|NCT02240238|155509652|FG006|Phase 1|Death|0|||
48358842|NCT02240238|155509653|FG007|Phase 1|Death|0|||
48358843|NCT02240238|155509654|FG008|Phase 1|Death|0|||
48358844|NCT02240238|155509655|FG009|Phase 1|Death|0|||
48358845|NCT02240238|155509656|FG010|Phase 1|Death|0|||
48358846|NCT02240238|155509657|FG011|Phase 1|Death|0|||
48358847|NCT02240238|155509646|FG000|Phase 1|Sponsor termination|0|||
48358848|NCT02240238|155509647|FG001|Phase 1|Sponsor termination|0|||
48358849|NCT02240238|155509648|FG002|Phase 1|Sponsor termination|0|||
48358850|NCT02240238|155509649|FG003|Phase 1|Sponsor termination|0|||
48358851|NCT02240238|155509650|FG004|Phase 1|Sponsor termination|0|||
48358852|NCT02240238|155509651|FG005|Phase 1|Sponsor termination|1|||
48358853|NCT02240238|155509652|FG006|Phase 1|Sponsor termination|0|||
48358854|NCT02240238|155509653|FG007|Phase 1|Sponsor termination|0|||
48358855|NCT02240238|155509654|FG008|Phase 1|Sponsor termination|0|||
48358856|NCT02240238|155509655|FG009|Phase 1|Sponsor termination|0|||
48358857|NCT02240238|155509656|FG010|Phase 1|Sponsor termination|0|||
48358858|NCT02240238|155509657|FG011|Phase 1|Sponsor termination|0|||
48358859|NCT02240238|155509646|FG000|Phase 1|Withdrawal by Subject|0|||
48358860|NCT02240238|155509647|FG001|Phase 1|Withdrawal by Subject|0|||
48358861|NCT02240238|155509648|FG002|Phase 1|Withdrawal by Subject|0|||
48358862|NCT02240238|155509649|FG003|Phase 1|Withdrawal by Subject|0|||
48358863|NCT02240238|155509650|FG004|Phase 1|Withdrawal by Subject|0|||
48358864|NCT02240238|155509651|FG005|Phase 1|Withdrawal by Subject|2|||
48358865|NCT02240238|155509652|FG006|Phase 1|Withdrawal by Subject|0|||
48358866|NCT02240238|155509653|FG007|Phase 1|Withdrawal by Subject|0|||
48358867|NCT02240238|155509654|FG008|Phase 1|Withdrawal by Subject|0|||
48358868|NCT02240238|155509655|FG009|Phase 1|Withdrawal by Subject|0|||
48358869|NCT02240238|155509656|FG010|Phase 1|Withdrawal by Subject|0|||
48358870|NCT02240238|155509657|FG011|Phase 1|Withdrawal by Subject|0|||
48358871|NCT02240238|155509646|FG000|Phase 1|Physician Decision|0|||
48358872|NCT02240238|155509647|FG001|Phase 1|Physician Decision|0|||
48358873|NCT02240238|155509648|FG002|Phase 1|Physician Decision|0|||
48358874|NCT02240238|155509649|FG003|Phase 1|Physician Decision|0|||
48358875|NCT02240238|155509650|FG004|Phase 1|Physician Decision|0|||
48358876|NCT02240238|155509651|FG005|Phase 1|Physician Decision|2|||
48358877|NCT02240238|155509652|FG006|Phase 1|Physician Decision|0|||
48358878|NCT02240238|155509653|FG007|Phase 1|Physician Decision|0|||
48358879|NCT02240238|155509654|FG008|Phase 1|Physician Decision|0|||
48358880|NCT02240238|155509655|FG009|Phase 1|Physician Decision|0|||
48358881|NCT02240238|155509656|FG010|Phase 1|Physician Decision|0|||
48358882|NCT02240238|155509657|FG011|Phase 1|Physician Decision|0|||
48358883|NCT02240238|155509646|FG000|Phase 2|Adverse Event|0|||
48358884|NCT02240238|155509647|FG001|Phase 2|Adverse Event|0|||
48358885|NCT02240238|155509648|FG002|Phase 2|Adverse Event|0|||
48358886|NCT02240238|155509649|FG003|Phase 2|Adverse Event|0|||
48358887|NCT02240238|155509650|FG004|Phase 2|Adverse Event|0|||
48358888|NCT02240238|155509651|FG005|Phase 2|Adverse Event|0|||
48358889|NCT02240238|155509652|FG006|Phase 2|Adverse Event|0|||
48358890|NCT02240238|155509653|FG007|Phase 2|Adverse Event|0|||
48358891|NCT02240238|155509654|FG008|Phase 2|Adverse Event|0|||
48358892|NCT02240238|155509655|FG009|Phase 2|Adverse Event|7|||
48358893|NCT02240238|155509656|FG010|Phase 2|Adverse Event|14|||
48358894|NCT02240238|155509657|FG011|Phase 2|Adverse Event|2|||
48358895|NCT02240238|155509646|FG000|Phase 2|Death|0|||
48358896|NCT02240238|155509647|FG001|Phase 2|Death|0|||
48358897|NCT02240238|155509648|FG002|Phase 2|Death|0|||
48358898|NCT02240238|155509649|FG003|Phase 2|Death|0|||
48358899|NCT02240238|155509650|FG004|Phase 2|Death|0|||
48358900|NCT02240238|155509651|FG005|Phase 2|Death|0|||
48358901|NCT02240238|155509652|FG006|Phase 2|Death|0|||
48358902|NCT02240238|155509653|FG007|Phase 2|Death|0|||
48358903|NCT02240238|155509654|FG008|Phase 2|Death|0|||
48358904|NCT02240238|155509655|FG009|Phase 2|Death|3|||
48358905|NCT02240238|155509656|FG010|Phase 2|Death|2|||
48358906|NCT02240238|155509657|FG011|Phase 2|Death|1|||
48358907|NCT02240238|155509646|FG000|Phase 2|Disease progression|0|||
48358908|NCT02240238|155509647|FG001|Phase 2|Disease progression|0|||
48358909|NCT02240238|155509648|FG002|Phase 2|Disease progression|0|||
48358910|NCT02240238|155509649|FG003|Phase 2|Disease progression|0|||
48358911|NCT02240238|155509650|FG004|Phase 2|Disease progression|0|||
48358912|NCT02240238|155509651|FG005|Phase 2|Disease progression|0|||
48358913|NCT02240238|155509652|FG006|Phase 2|Disease progression|0|||
48358914|NCT02240238|155509653|FG007|Phase 2|Disease progression|0|||
48358915|NCT02240238|155509654|FG008|Phase 2|Disease progression|0|||
48358916|NCT02240238|155509655|FG009|Phase 2|Disease progression|5|||
48358917|NCT02240238|155509656|FG010|Phase 2|Disease progression|11|||
48358918|NCT02240238|155509657|FG011|Phase 2|Disease progression|1|||
48358919|NCT02240238|155509646|FG000|Phase 2|Withdrawal by Subject|0|||
48358920|NCT02240238|155509647|FG001|Phase 2|Withdrawal by Subject|0|||
48358921|NCT02240238|155509648|FG002|Phase 2|Withdrawal by Subject|0|||
48358922|NCT02240238|155509649|FG003|Phase 2|Withdrawal by Subject|0|||
48358923|NCT02240238|155509650|FG004|Phase 2|Withdrawal by Subject|0|||
48358924|NCT02240238|155509651|FG005|Phase 2|Withdrawal by Subject|0|||
48358925|NCT02240238|155509652|FG006|Phase 2|Withdrawal by Subject|0|||
48358926|NCT02240238|155509653|FG007|Phase 2|Withdrawal by Subject|0|||
48358927|NCT02240238|155509654|FG008|Phase 2|Withdrawal by Subject|0|||
48358928|NCT02240238|155509655|FG009|Phase 2|Withdrawal by Subject|1|||
48358929|NCT02240238|155509656|FG010|Phase 2|Withdrawal by Subject|1|||
48358930|NCT02240238|155509657|FG011|Phase 2|Withdrawal by Subject|0|||
48358931|NCT02240238|155509646|FG000|Phase 2|Physician Decision|0|||
48358932|NCT02240238|155509647|FG001|Phase 2|Physician Decision|0|||
48358933|NCT02240238|155509648|FG002|Phase 2|Physician Decision|0|||
48358934|NCT02240238|155509649|FG003|Phase 2|Physician Decision|0|||
48358935|NCT02240238|155509650|FG004|Phase 2|Physician Decision|0|||
48358936|NCT02240238|155509651|FG005|Phase 2|Physician Decision|0|||
48358937|NCT02240238|155509652|FG006|Phase 2|Physician Decision|0|||
48358938|NCT02240238|155509653|FG007|Phase 2|Physician Decision|0|||
48358939|NCT02240238|155509654|FG008|Phase 2|Physician Decision|0|||
48358940|NCT02240238|155509655|FG009|Phase 2|Physician Decision|1|||
48358941|NCT02240238|155509656|FG010|Phase 2|Physician Decision|3|||
48358942|NCT02240238|155509657|FG011|Phase 2|Physician Decision|0|||
48358943|NCT02240238|155509646|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358944|NCT02240238|155509647|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358945|NCT02240238|155509648|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358946|NCT02240238|155509649|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358947|NCT02240238|155509650|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48411937|NCT01805180|155696846|FG002|Lead-in Donor Phase|screen failure|0|||
48411938|NCT01400932|155696847|FG000|Overall Study|Adverse Event|10|||
48411939|NCT01400932|155696848|FG001|Overall Study|Adverse Event|5|||
48411940|NCT01400932|155696847|FG000|Overall Study|Lack of Efficacy|0|||
48411941|NCT01400932|155696848|FG001|Overall Study|Lack of Efficacy|3|||
48411942|NCT01400932|155696847|FG000|Overall Study|Withdrawal by Subject|2|||
48411943|NCT01400932|155696848|FG001|Overall Study|Withdrawal by Subject|6|||
48411944|NCT01400932|155696847|FG000|Overall Study|Lost to Follow-up|1|||
48411945|NCT01400932|155696848|FG001|Overall Study|Lost to Follow-up|0|||
48411946|NCT01400932|155696847|FG000|Overall Study|Protocol Deviation|0|||
48358948|NCT02240238|155509651|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358949|NCT02240238|155509652|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358950|NCT02240238|155509653|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358951|NCT02240238|155509654|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358952|NCT02240238|155509655|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
48358953|NCT02240238|155509656|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358954|NCT02240238|155509657|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
48358955|NCT02240238|155509646|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358956|NCT02240238|155509647|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358957|NCT02240238|155509648|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358958|NCT02240238|155509649|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358959|NCT02240238|155509650|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358960|NCT02240238|155509651|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358961|NCT02240238|155509652|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358962|NCT02240238|155509653|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358963|NCT02240238|155509654|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358964|NCT02240238|155509655|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
48358965|NCT02240238|155509656|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358966|NCT02240238|155509657|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
48358967|NCT02240238|155509646|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358968|NCT02240238|155509647|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358969|NCT02240238|155509648|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358970|NCT02240238|155509649|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358971|NCT02240238|155509650|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358972|NCT02240238|155509651|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358973|NCT02240238|155509652|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358974|NCT02240238|155509653|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358975|NCT02240238|155509654|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358976|NCT02240238|155509655|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358977|NCT02240238|155509656|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
48358978|NCT02240238|155509657|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
48358979|NCT02240238|155509646|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358980|NCT02240238|155509647|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358981|NCT02240238|155509648|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358982|NCT02240238|155509649|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358983|NCT02240238|155509650|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358984|NCT02240238|155509651|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358985|NCT02240238|155509652|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358986|NCT02240238|155509653|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358987|NCT02240238|155509654|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358988|NCT02240238|155509655|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358989|NCT02240238|155509656|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
48358990|NCT02240238|155509657|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
48358991|NCT02240238|155509646|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48358992|NCT02240238|155509647|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48358993|NCT02240238|155509648|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48358994|NCT02240238|155509649|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48358995|NCT02240238|155509650|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48358996|NCT02240238|155509651|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48358997|NCT02240238|155509652|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48358998|NCT02240238|155509653|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48358999|NCT02240238|155509654|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48359000|NCT02240238|155509655|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48411947|NCT01400932|155696848|FG001|Overall Study|Protocol Deviation|1|||
48411948|NCT01400932|155696847|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48411949|NCT01400932|155696848|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
48411950|NCT00832819|155696849|FG000|Overall Study|Adverse Event|0|||
48411951|NCT00832819|155696850|FG001|Overall Study|Adverse Event|1|||
48411952|NCT00832819|155696851|FG002|Overall Study|Adverse Event|0|||
48411953|NCT00832819|155696849|FG000|Overall Study|Protocol Violation|0|||
48411954|NCT00832819|155696850|FG001|Overall Study|Protocol Violation|0|||
48411955|NCT00832819|155696851|FG002|Overall Study|Protocol Violation|1|||
48411956|NCT02304926|155696852|FG000|Overall Study|Lost to Follow-up|2|||
48411957|NCT02304926|155696853|FG001|Overall Study|Lost to Follow-up|1|||
48359001|NCT02240238|155509656|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
48359002|NCT02240238|155509657|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
48359003|NCT02240238|155509646|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359004|NCT02240238|155509647|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359005|NCT02240238|155509648|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359006|NCT02240238|155509649|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359007|NCT02240238|155509650|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359008|NCT02240238|155509651|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359009|NCT02240238|155509652|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359010|NCT02240238|155509653|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359011|NCT02240238|155509654|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359012|NCT02240238|155509655|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359013|NCT02240238|155509656|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
48359014|NCT02240238|155509657|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
48359015|NCT02240238|155509646|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359016|NCT02240238|155509647|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359017|NCT02240238|155509648|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359018|NCT02240238|155509649|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359019|NCT02240238|155509650|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359020|NCT02240238|155509651|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359021|NCT02240238|155509652|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359022|NCT02240238|155509653|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359023|NCT02240238|155509654|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359024|NCT02240238|155509655|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359025|NCT02240238|155509656|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
48359026|NCT02240238|155509657|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
48359027|NCT02240238|155509646|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359028|NCT02240238|155509647|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359029|NCT02240238|155509648|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359030|NCT02240238|155509649|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359031|NCT02240238|155509650|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359032|NCT02240238|155509651|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359033|NCT02240238|155509652|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359034|NCT02240238|155509653|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359035|NCT02240238|155509654|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359036|NCT02240238|155509655|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359037|NCT02240238|155509656|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
48359038|NCT02240238|155509657|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
48359039|NCT03626220|155509658|FG000|Overall Study|Withdrawal by Subject|2|||
48359040|NCT03626220|155509659|FG001|Overall Study|Withdrawal by Subject|0|||
48359041|NCT00681668|155509660|FG000|Overall Study|Protocol Violation|1|||
48359042|NCT00681668|155509660|FG000|Overall Study|Withdrawal by Subject|1|||
48359043|NCT01200290|155509661|FG000|Treatment Period|Adverse Event|1|||
48359044|NCT01200290|155509661|FG000|Post-Treatment Follow-Up Period|Death|2|||
48359045|NCT01217437|155509662|FG000|Overall Study|Adverse Event|0|||
48359046|NCT01217437|155509663|FG001|Overall Study|Adverse Event|8|||
48359047|NCT01217437|155509662|FG000|Overall Study|Death|5|||
48359048|NCT01217437|155509663|FG001|Overall Study|Death|0|||
48359049|NCT01217437|155509662|FG000|Overall Study|Lack of Efficacy|29|||
48359050|NCT01217437|155509663|FG001|Overall Study|Lack of Efficacy|25|||
48359051|NCT01217437|155509662|FG000|Overall Study|Physician Decision|8|||
48359052|NCT01217437|155509663|FG001|Overall Study|Physician Decision|5|||
48359053|NCT01217437|155509662|FG000|Overall Study|Withdrawal by Subject|0|||
48411958|NCT02076165|155696854|FG000|Overall Study|Lost to Follow-up|7|||
48411959|NCT02076165|155696855|FG001|Overall Study|Lost to Follow-up|5|||
48411960|NCT02076165|155696854|FG000|Overall Study|Refused follow-up assessment|1|||
48411961|NCT02076165|155696855|FG001|Overall Study|Refused follow-up assessment|1|||
48411962|NCT02429856|155696856|FG000|Overall Study|Death|12|||
48411963|NCT02429856|155696857|FG001|Overall Study|Death|13|||
48411964|NCT02429856|155696856|FG000|Overall Study|Lost to Follow-up|6|||
48411965|NCT02429856|155696857|FG001|Overall Study|Lost to Follow-up|5|||
48411966|NCT02429856|155696856|FG000|Overall Study|Withdrawal by Subject|1|||
48411967|NCT02429856|155696857|FG001|Overall Study|Withdrawal by Subject|1|||
48411968|NCT01111604|155696858|FG000|Overall Study|Lost to Follow-up|0|||
48411969|NCT01111604|155696859|FG001|Overall Study|Lost to Follow-up|0|||
48411970|NCT01111604|155696860|FG002|Overall Study|Lost to Follow-up|1|||
48411971|NCT01111604|155696858|FG000|Overall Study|Withdrew Consent|3|||
48411972|NCT01111604|155696859|FG001|Overall Study|Withdrew Consent|0|||
48411973|NCT01111604|155696860|FG002|Overall Study|Withdrew Consent|2|||
48411974|NCT01111604|155696858|FG000|Overall Study|Withdrawal by Subject|2|||
48411975|NCT01111604|155696859|FG001|Overall Study|Withdrawal by Subject|0|||
48411976|NCT01111604|155696860|FG002|Overall Study|Withdrawal by Subject|0|||
48411977|NCT01111604|155696858|FG000|Overall Study|Death|1|||
48411978|NCT01111604|155696859|FG001|Overall Study|Death|0|||
48359054|NCT01217437|155509663|FG001|Overall Study|Withdrawal by Subject|2|||
48359055|NCT01217437|155509662|FG000|Overall Study|Ineligible|1|||
48359056|NCT01217437|155509663|FG001|Overall Study|Ineligible|1|||
48359057|NCT00862836|155509664|FG000|Overall Study|Withdrawal by Subject|1|||
48359058|NCT01144377|155509665|FG000|52 Week Treatment Period|Adverse Event|0|||
48359059|NCT01144377|155509666|FG001|52 Week Treatment Period|Adverse Event|0|||
48411979|NCT01111604|155696860|FG002|Overall Study|Death|0|||
48411980|NCT01111604|155696858|FG000|Overall Study|Met Exclusion Criteria|2|||
48411981|NCT01111604|155696859|FG001|Overall Study|Met Exclusion Criteria|0|||
48411982|NCT01111604|155696860|FG002|Overall Study|Met Exclusion Criteria|0|||
48411983|NCT00355264|155696861|FG000|Extension (Variable Duration)|Adverse Event|1|||
48411984|NCT00355264|155696861|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
48411985|NCT00238264|155696862|FG000|Overall Study|Death|7|||
48411986|NCT00238264|155696862|FG000|Overall Study|Lost to Follow-up|18|||
48411987|NCT00238264|155696862|FG000|Overall Study|Withdrawal by Subject|4|||
48411988|NCT00238264|155696862|FG000|Overall Study|Ineligible|7|||
48411989|NCT01157117|155696863|FG000|Overall Study|Dosing Symptoms|0|||
48411990|NCT01157117|155696864|FG001|Overall Study|Dosing Symptoms|4|||
48411991|NCT01157117|155696865|FG002|Overall Study|Dosing Symptoms|0|||
48692536|NCT02322281|156724524|FG001|Overall Study|Progressive Disease|14|||
48692537|NCT02322281|156724525|FG002|Overall Study|Progressive Disease|49|||
48692538|NCT02322281|156724523|FG000|Overall Study|Adverse Event|3|||
48692539|NCT02322281|156724524|FG001|Overall Study|Adverse Event|4|||
48692540|NCT02322281|156724525|FG002|Overall Study|Adverse Event|6|||
48692541|NCT02322281|156724523|FG000|Overall Study|Death|3|||
48692542|NCT02322281|156724524|FG001|Overall Study|Death|3|||
48692543|NCT02322281|156724525|FG002|Overall Study|Death|3|||
48692544|NCT02322281|156724523|FG000|Overall Study|Withdrawal by Subject|1|||
48692545|NCT02322281|156724524|FG001|Overall Study|Withdrawal by Subject|1|||
48692546|NCT02322281|156724525|FG002|Overall Study|Withdrawal by Subject|6|||
48692547|NCT02322281|156724523|FG000|Overall Study|Physician Decision|2|||
48692548|NCT02322281|156724524|FG001|Overall Study|Physician Decision|0|||
48692549|NCT02322281|156724525|FG002|Overall Study|Physician Decision|5|||
48692550|NCT02322281|156724523|FG000|Overall Study|Study Terminated by Sponsor|2|||
48411992|NCT01157117|155696863|FG000|Overall Study|Withdrawal by Subject|4|||
48359060|NCT01144377|155509667|FG002|52 Week Treatment Period|Adverse Event|3|||
48359061|NCT01144377|155509668|FG003|52 Week Treatment Period|Adverse Event|2|||
48359062|NCT01144377|155509669|FG004|52 Week Treatment Period|Adverse Event|1|||
48359063|NCT01144377|155509665|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
48359064|NCT01144377|155509666|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
48359065|NCT01144377|155509667|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
48359066|NCT01144377|155509668|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
48359067|NCT01144377|155509669|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
48359068|NCT01144377|155509665|FG000|52 Week Treatment Period|Protocol Violation|0|||
48359069|NCT01144377|155509666|FG001|52 Week Treatment Period|Protocol Violation|0|||
48359070|NCT01144377|155509667|FG002|52 Week Treatment Period|Protocol Violation|0|||
48359071|NCT01144377|155509668|FG003|52 Week Treatment Period|Protocol Violation|0|||
48359072|NCT01144377|155509669|FG004|52 Week Treatment Period|Protocol Violation|1|||
48411993|NCT01157117|155696864|FG001|Overall Study|Withdrawal by Subject|1|||
48411994|NCT01157117|155696865|FG002|Overall Study|Withdrawal by Subject|1|||
48411995|NCT01157117|155696863|FG000|Overall Study|Lack of Efficacy|1|||
48359073|NCT01144377|155509665|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
48359074|NCT01144377|155509666|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
48692551|NCT02322281|156724524|FG001|Overall Study|Study Terminated by Sponsor|0|||
48411996|NCT01157117|155696864|FG001|Overall Study|Lack of Efficacy|1|||
48411997|NCT01157117|155696865|FG002|Overall Study|Lack of Efficacy|0|||
48411998|NCT01157117|155696863|FG000|Overall Study|Lost to Follow-up|0|||
48692552|NCT02322281|156724525|FG002|Overall Study|Study Terminated by Sponsor|0|||
48692553|NCT02322281|156724523|FG000|Overall Study|Missing|0|||
48692554|NCT02322281|156724524|FG001|Overall Study|Missing|0|||
48411999|NCT01157117|155696864|FG001|Overall Study|Lost to Follow-up|0|||
48412000|NCT01157117|155696865|FG002|Overall Study|Lost to Follow-up|1|||
48412001|NCT01157117|155696863|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
48412002|NCT01157117|155696864|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
48412003|NCT01157117|155696865|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
48412004|NCT00885365|155696869|FG000|4 Weeks ON Treatment|Adverse Event|2|||
48412005|NCT00885365|155696870|FG001|4 Weeks ON Treatment|Adverse Event|4|||
48412006|NCT00885365|155696869|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
48412007|NCT00885365|155696870|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
48412008|NCT00885365|155696869|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
48412009|NCT00885365|155696870|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
48412010|NCT04897867|155696873|FG000|Overall Study|Withdrawal of Consent|1|||
48412011|NCT04897867|155696873|FG000|Overall Study|Pregnancy|1|||
48412012|NCT04897867|155696873|FG000|Overall Study|Lost to Follow-up|7|||
48412013|NCT04897867|155696873|FG000|Overall Study|Reason not Specified|2|||
48412014|NCT03838484|155696874|FG000|Overall Study|Lost to Follow-up|0|||
48412015|NCT03838484|155696875|FG001|Overall Study|Lost to Follow-up|1|||
48412016|NCT03838484|155696876|FG002|Overall Study|Lost to Follow-up|0|||
48412017|NCT03838484|155696877|FG003|Overall Study|Lost to Follow-up|0|||
48359075|NCT01144377|155509667|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
48359076|NCT01144377|155509668|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
48359077|NCT01144377|155509669|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
48359078|NCT01144377|155509665|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
48359079|NCT01144377|155509666|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
48412018|NCT05172544|155696891|FG000|Overall Study|Withdrawal by Subject|1|||
48359080|NCT01144377|155509667|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
48359081|NCT01144377|155509668|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
48359082|NCT01144377|155509669|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
48359083|NCT01144377|155509665|FG000|52 Week Treatment Period|Sponsor Decision|0|||
48359084|NCT01144377|155509666|FG001|52 Week Treatment Period|Sponsor Decision|0|||
48359085|NCT01144377|155509667|FG002|52 Week Treatment Period|Sponsor Decision|0|||
48359086|NCT01144377|155509668|FG003|52 Week Treatment Period|Sponsor Decision|0|||
48359087|NCT01144377|155509669|FG004|52 Week Treatment Period|Sponsor Decision|1|||
48359088|NCT01144377|155509665|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
48359089|NCT01144377|155509666|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
48359090|NCT01144377|155509667|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
48359091|NCT01144377|155509668|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
48359092|NCT01144377|155509669|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
48359093|NCT01144377|155509665|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
48359094|NCT01144377|155509666|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
48359095|NCT01144377|155509667|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
48359096|NCT01144377|155509668|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
48359097|NCT01144377|155509669|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
48359098|NCT01144377|155509665|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
48359099|NCT01144377|155509666|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
48359100|NCT01144377|155509667|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
48359101|NCT01144377|155509668|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
48359102|NCT01144377|155509669|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
48359103|NCT02951052|155510775|FG000|Overall Study|Adverse Event|13|||
48359104|NCT02951052|155510776|FG001|Overall Study|Adverse Event|5|||
48359105|NCT02951052|155510775|FG000|Overall Study|Withdrawal by Subject|1|||
48359106|NCT02951052|155510776|FG001|Overall Study|Withdrawal by Subject|5|||
48359107|NCT02951052|155510775|FG000|Overall Study|Physician Decision|2|||
48359108|NCT02951052|155510776|FG001|Overall Study|Physician Decision|0|||
48359109|NCT02951052|155510775|FG000|Overall Study|Lost to Follow-up|1|||
48359110|NCT02951052|155510776|FG001|Overall Study|Lost to Follow-up|1|||
48359111|NCT02951052|155510775|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
48359112|NCT02951052|155510776|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
48359113|NCT02951052|155510775|FG000|Overall Study|Protocol Violation|5|||
48359114|NCT02951052|155510776|FG001|Overall Study|Protocol Violation|3|||
48359115|NCT02951052|155510775|FG000|Overall Study|Lack of Efficacy|3|||
48359116|NCT02951052|155510776|FG001|Overall Study|Lack of Efficacy|4|||
48359117|NCT02951052|155510775|FG000|Overall Study|Ongoing|1|||
48359118|NCT02951052|155510776|FG001|Overall Study|Ongoing|0|||
48359119|NCT04710576|155510777|FG000|Overall Study|Participants still in the study|73|||
48359120|NCT04710576|155510778|FG001|Overall Study|Participants still in the study|70|||
48412019|NCT05172544|155696892|FG001|Overall Study|Withdrawal by Subject|0|||
48412020|NCT05172544|155696893|FG002|Overall Study|Withdrawal by Subject|0|||
48359121|NCT04710576|155510779|FG002|Overall Study|Participants still in the study|60|||
48359122|NCT04710576|155510777|FG000|Overall Study|Death|2|||
48359123|NCT04710576|155510778|FG001|Overall Study|Death|7|||
48412021|NCT05172544|155696891|FG000|Overall Study|Physician Decision|0|||
48412022|NCT05172544|155696892|FG001|Overall Study|Physician Decision|0|||
48359124|NCT04710576|155510779|FG002|Overall Study|Death|12|||
48359125|NCT04710576|155510777|FG000|Overall Study|Withdrawal by Subject|4|||
48359126|NCT04710576|155510778|FG001|Overall Study|Withdrawal by Subject|3|||
48359127|NCT04710576|155510779|FG002|Overall Study|Withdrawal by Subject|7|||
48359128|NCT04710576|155510777|FG000|Overall Study|Sponsor decision|1|||
48359129|NCT04710576|155510778|FG001|Overall Study|Sponsor decision|0|||
48359130|NCT04710576|155510779|FG002|Overall Study|Sponsor decision|0|||
48359131|NCT01850589|155510782|FG000|Overall Study|Withdrawal by Subject|8|||
48359132|NCT01850589|155510783|FG001|Overall Study|Withdrawal by Subject|0|||
48359133|NCT01250925|155510793|FG000|Overall Study|Lost to Follow-up|1|||
48359134|NCT01250925|155510794|FG001|Overall Study|Lost to Follow-up|1|||
48359135|NCT01250925|155510795|FG002|Overall Study|Lost to Follow-up|0|||
48359136|NCT01250925|155510793|FG000|Overall Study|Withdrawal by Subject|2|||
48359137|NCT01250925|155510794|FG001|Overall Study|Withdrawal by Subject|0|||
48359138|NCT01250925|155510795|FG002|Overall Study|Withdrawal by Subject|0|||
48359139|NCT01250925|155510793|FG000|Overall Study|Protocol Violation|2|||
48359140|NCT01250925|155510794|FG001|Overall Study|Protocol Violation|0|||
48359141|NCT01250925|155510795|FG002|Overall Study|Protocol Violation|0|||
48359142|NCT01250925|155510793|FG000|Overall Study|Physician Decision|0|||
48359143|NCT01250925|155510794|FG001|Overall Study|Physician Decision|2|||
48359144|NCT01250925|155510795|FG002|Overall Study|Physician Decision|1|||
48359145|NCT01250925|155510793|FG000|Overall Study|Adverse Event|0|||
48359146|NCT01250925|155510794|FG001|Overall Study|Adverse Event|0|||
48359147|NCT01250925|155510795|FG002|Overall Study|Adverse Event|1|||
48359148|NCT03895203|155510796|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
48359149|NCT03895203|155510797|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
48359150|NCT03895203|155510798|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
48359151|NCT03895203|155510799|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
48359152|NCT03895203|155510800|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
48359153|NCT03895203|155510801|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
48359154|NCT03895203|155510796|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
48359155|NCT03895203|155510797|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48359156|NCT03895203|155510798|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48359157|NCT03895203|155510799|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48359158|NCT03895203|155510800|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48359159|NCT03895203|155510801|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
48359160|NCT03895203|155510796|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
48359161|NCT03895203|155510797|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48359162|NCT03895203|155510798|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48359163|NCT03895203|155510799|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48359164|NCT03895203|155510800|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48359165|NCT03895203|155510801|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
48359166|NCT03895203|155510796|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
48359167|NCT03895203|155510797|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
48359168|NCT03895203|155510798|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
48359169|NCT03895203|155510799|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
48359170|NCT03895203|155510800|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
48359171|NCT03895203|155510801|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
48359172|NCT03895203|155510796|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48359173|NCT03895203|155510797|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
48359174|NCT03895203|155510798|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48359175|NCT03895203|155510799|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48359176|NCT03895203|155510800|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48359177|NCT03895203|155510801|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
48359178|NCT03895203|155510796|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48359179|NCT03895203|155510797|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
48359180|NCT03895203|155510798|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48359181|NCT03895203|155510799|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48359182|NCT03895203|155510800|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48359183|NCT03895203|155510801|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
48359184|NCT03895203|155510796|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48359185|NCT03895203|155510797|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48359186|NCT03895203|155510798|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48359187|NCT03895203|155510799|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
48359188|NCT03895203|155510800|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48359189|NCT03895203|155510801|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
48359190|NCT03895203|155510796|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
48359191|NCT03895203|155510797|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
48359192|NCT03895203|155510798|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
48359193|NCT03895203|155510799|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
48359194|NCT03895203|155510800|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
48359195|NCT03895203|155510801|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
48359196|NCT03895203|155510796|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
48359197|NCT03895203|155510797|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
48359198|NCT03895203|155510798|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
48359199|NCT03895203|155510799|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
48359200|NCT03895203|155510800|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
48359201|NCT03895203|155510801|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
48359202|NCT03895203|155510796|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
48359203|NCT03895203|155510797|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
48359204|NCT03895203|155510798|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
48359205|NCT03895203|155510799|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
48359206|NCT03895203|155510800|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
48359207|NCT03895203|155510801|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
48359208|NCT03895203|155510796|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
48359209|NCT03895203|155510797|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
48359210|NCT03895203|155510798|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
48359211|NCT03895203|155510799|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
48359212|NCT03895203|155510800|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
48359213|NCT03895203|155510801|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
48359214|NCT03895203|155510796|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48359215|NCT03895203|155510797|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48359216|NCT03895203|155510798|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48359217|NCT03895203|155510799|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
48359218|NCT03895203|155510800|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48359219|NCT03895203|155510801|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
48359220|NCT03895203|155510796|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48359221|NCT03895203|155510797|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48359222|NCT03895203|155510798|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48359223|NCT03895203|155510799|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
48359224|NCT03895203|155510800|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48359225|NCT03895203|155510801|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
48359226|NCT03895203|155510796|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48359227|NCT03895203|155510797|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48359228|NCT03895203|155510798|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48359229|NCT03895203|155510799|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48359230|NCT03895203|155510800|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
48359231|NCT03895203|155510801|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
48359232|NCT03738475|155510803|FG000|Overall Study|Participant Non-Compliance|1|||
48359233|NCT03738475|155510804|FG001|Overall Study|Participant Non-Compliance|0|||
48359234|NCT00332462|155510807|FG000|Overall Study|Adverse Event|5|||
48359235|NCT00332462|155510807|FG000|Overall Study|Abnormal Lab Value|1|||
48359236|NCT00332462|155510807|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48359237|NCT00332462|155510807|FG000|Overall Study|no longer requires study drug|1|||
48359238|NCT00332462|155510807|FG000|Overall Study|Death|3|||
48359239|NCT00332462|155510807|FG000|Overall Study|Graft Loss|2|||
48359240|NCT03046121|155510808|FG000|Overall Study|Death|32|||
48359241|NCT03046121|155510809|FG001|Overall Study|Death|60|||
48359242|NCT03046121|155510808|FG000|Overall Study|Withdrawal by Subject|14|||
48359243|NCT03046121|155510809|FG001|Overall Study|Withdrawal by Subject|12|||
48359244|NCT02159040|155510812|FG000|Overall Study|Death|1|||
48359245|NCT01886287|155510813|FG000|Overall Study|Radiographic disease progression|1|||
48359246|NCT01886287|155510813|FG000|Overall Study|Clinical progression due to disease|1|||
48359247|NCT04019873|155510814|FG000|Overall Study|Discontinued from the treatment|1|||
48359248|NCT04019873|155510815|FG001|Overall Study|Discontinued from the treatment|39|||
48359249|NCT04019873|155510816|FG002|Overall Study|Discontinued from the treatment|2|||
48359250|NCT03392168|155510817|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
48359251|NCT03392168|155510818|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
48359252|NCT03392168|155510819|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
48359253|NCT03392168|155510820|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
48359254|NCT03392168|155510817|FG000|Period 2: Cohort 2|Other|0|||
48359255|NCT03392168|155510818|FG001|Period 2: Cohort 2|Other|1|||
48359256|NCT03392168|155510819|FG002|Period 2: Cohort 2|Other|0|||
48359257|NCT03392168|155510820|FG003|Period 2: Cohort 2|Other|0|||
48359258|NCT04350463|155510821|FG000|Overall Study|Other reason|0|||
48359259|NCT04350463|155510822|FG001|Overall Study|Other reason|0|||
48359260|NCT04350463|155510823|FG002|Overall Study|Other reason|0|||
48359261|NCT04350463|155510824|FG003|Overall Study|Other reason|1|||
48359262|NCT04350463|155510821|FG000|Overall Study|Lost to Follow-up|0|||
48359263|NCT04350463|155510822|FG001|Overall Study|Lost to Follow-up|0|||
48359264|NCT04350463|155510823|FG002|Overall Study|Lost to Follow-up|0|||
48359265|NCT04350463|155510824|FG003|Overall Study|Lost to Follow-up|2|||
48359266|NCT04350463|155510821|FG000|Overall Study|Withdrawal by Subject|4|||
48359267|NCT04350463|155510822|FG001|Overall Study|Withdrawal by Subject|0|||
48359268|NCT04350463|155510823|FG002|Overall Study|Withdrawal by Subject|1|||
48359269|NCT04350463|155510824|FG003|Overall Study|Withdrawal by Subject|4|||
48359270|NCT04350463|155510821|FG000|Overall Study|Adverse Event|0|||
48359271|NCT04350463|155510822|FG001|Overall Study|Adverse Event|0|||
48359272|NCT04350463|155510823|FG002|Overall Study|Adverse Event|0|||
48359273|NCT04350463|155510824|FG003|Overall Study|Adverse Event|2|||
48359274|NCT04350463|155510821|FG000|Overall Study|Death|27|||
48359275|NCT04350463|155510822|FG001|Overall Study|Death|2|||
48359276|NCT04350463|155510823|FG002|Overall Study|Death|13|||
48359277|NCT04350463|155510824|FG003|Overall Study|Death|26|||
48359278|NCT02683447|155510826|FG000|Overall Study|Lost to Follow-up|2|||
48359279|NCT01399918|155510827|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
48359280|NCT03026075|155510829|FG000|Overall Study|Physician Decision|1|||
48359281|NCT01436253|155510830|FG000|Overall Study|Lost to Follow-up|182|||
48359282|NCT01436253|155510830|FG000|Overall Study|Not meeting all eligibility criteria|117|||
48359283|NCT05269667|155510831|FG000|Overall Study|Study Terminated by Sponsor|4|||
48359284|NCT00623805|155510832|FG000|Overall Study|Adverse Event|9|||
48359285|NCT00623805|155510833|FG001|Overall Study|Adverse Event|6|||
48359286|NCT00623805|155510832|FG000|Overall Study|Death|2|||
48359287|NCT00623805|155510833|FG001|Overall Study|Death|0|||
48359288|NCT00623805|155510832|FG000|Overall Study|Lack of Efficacy|3|||
48359289|NCT00623805|155510833|FG001|Overall Study|Lack of Efficacy|7|||
48359290|NCT00623805|155510832|FG000|Overall Study|Lost to Follow-up|2|||
48359291|NCT00623805|155510833|FG001|Overall Study|Lost to Follow-up|2|||
48359292|NCT00623805|155510832|FG000|Overall Study|Protocol Violation|1|||
48359293|NCT00623805|155510833|FG001|Overall Study|Protocol Violation|1|||
48359294|NCT00623805|155510832|FG000|Overall Study|Reason not Specified|3|||
48359295|NCT00623805|155510833|FG001|Overall Study|Reason not Specified|6|||
48359296|NCT04524364|155510834|FG000|Overall Study|Physician Decision|3|||
48359297|NCT04524364|155510835|FG001|Overall Study|Physician Decision|6|||
48359298|NCT04524364|155510834|FG000|Overall Study|Adverse Event|0|||
48359299|NCT04524364|155510835|FG001|Overall Study|Adverse Event|1|||
48359300|NCT04524364|155510834|FG000|Overall Study|Investigational device deficiency|0|||
48359301|NCT04524364|155510835|FG001|Overall Study|Investigational device deficiency|1|||
48359302|NCT04524364|155510834|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
48359303|NCT04524364|155510835|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
48359304|NCT04524364|155510834|FG000|Overall Study|Device unavailability|0|||
48359305|NCT04524364|155510835|FG001|Overall Study|Device unavailability|2|||
48359306|NCT04524364|155510834|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
48359307|NCT04524364|155510835|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
48359308|NCT04524364|155510834|FG000|Overall Study|Low International normalized ratio (INR)|1|||
48359309|NCT04524364|155510835|FG001|Overall Study|Low International normalized ratio (INR)|0|||
48359310|NCT01946789|155510837|FG000|Overall Study|Death|0|||
48359311|NCT01946789|155510838|FG001|Overall Study|Death|2|||
48359312|NCT01946789|155510839|FG002|Overall Study|Death|1|||
48359313|NCT01946789|155510840|FG003|Overall Study|Death|1|||
48359314|NCT01946789|155510841|FG004|Overall Study|Death|1|||
48359315|NCT01946789|155510842|FG005|Overall Study|Death|1|||
48359316|NCT01946789|155510843|FG006|Overall Study|Death|3|||
48359317|NCT01946789|155510844|FG007|Overall Study|Death|1|||
48359318|NCT01946789|155510845|FG008|Overall Study|Death|2|||
48359319|NCT01946789|155510837|FG000|Overall Study|Progressive Disease|0|||
48359320|NCT01946789|155510838|FG001|Overall Study|Progressive Disease|0|||
48359321|NCT01946789|155510839|FG002|Overall Study|Progressive Disease|1|||
48359322|NCT01946789|155510840|FG003|Overall Study|Progressive Disease|0|||
48359323|NCT01946789|155510841|FG004|Overall Study|Progressive Disease|0|||
48359324|NCT01946789|155510842|FG005|Overall Study|Progressive Disease|2|||
48359325|NCT01946789|155510843|FG006|Overall Study|Progressive Disease|0|||
48359326|NCT01946789|155510844|FG007|Overall Study|Progressive Disease|0|||
48359327|NCT01946789|155510845|FG008|Overall Study|Progressive Disease|0|||
48359328|NCT01946789|155510837|FG000|Overall Study|Withdrawal by Subject|0|||
48359329|NCT01946789|155510838|FG001|Overall Study|Withdrawal by Subject|0|||
48359330|NCT01946789|155510839|FG002|Overall Study|Withdrawal by Subject|0|||
48359331|NCT01946789|155510840|FG003|Overall Study|Withdrawal by Subject|2|||
48359332|NCT01946789|155510841|FG004|Overall Study|Withdrawal by Subject|1|||
48359333|NCT01946789|155510842|FG005|Overall Study|Withdrawal by Subject|0|||
48359334|NCT01946789|155510843|FG006|Overall Study|Withdrawal by Subject|1|||
48359335|NCT01946789|155510844|FG007|Overall Study|Withdrawal by Subject|0|||
48359336|NCT01946789|155510845|FG008|Overall Study|Withdrawal by Subject|0|||
48359337|NCT03517449|155510846|FG000|Overall Study|Death|184|||
48359338|NCT03517449|155510847|FG001|Overall Study|Death|236|||
48359339|NCT03517449|155510846|FG000|Overall Study|Lost to Follow-up|0|||
48359340|NCT03517449|155510847|FG001|Overall Study|Lost to Follow-up|2|||
48359341|NCT03517449|155510846|FG000|Overall Study|Withdrawal by Subject|7|||
48359342|NCT03517449|155510847|FG001|Overall Study|Withdrawal by Subject|26|||
48359343|NCT03517449|155510846|FG000|Overall Study|Participants Ongoing|220|||
48359344|NCT03517449|155510847|FG001|Overall Study|Participants Ongoing|152|||
48359345|NCT01147536|155510852|FG000|Overall Study|Administrative study close|2|||
48359346|NCT01147536|155510852|FG000|Overall Study|Death|1|||
48359347|NCT03762200|155510853|FG000|Overall Study|Death|2|||
48359348|NCT04577001|155510854|FG000|Overall Study|Subject became ineligible|0|||
48359349|NCT04577001|155510855|FG001|Overall Study|Subject became ineligible|1|||
48359350|NCT01214642|155510856|FG000|Overall Study|Progressive Disease|3|||
48359351|NCT01214642|155510857|FG001|Overall Study|Progressive Disease|2|||
48359352|NCT01214642|155510858|FG002|Overall Study|Progressive Disease|3|||
48359353|NCT01214642|155510859|FG003|Overall Study|Progressive Disease|5|||
48359354|NCT01214642|155510860|FG004|Overall Study|Progressive Disease|5|||
48359355|NCT01214642|155510861|FG005|Overall Study|Progressive Disease|3|||
48359356|NCT01214642|155510862|FG006|Overall Study|Progressive Disease|5|||
48359357|NCT01214642|155510863|FG007|Overall Study|Progressive Disease|3|||
48359358|NCT01214642|155510864|FG008|Overall Study|Progressive Disease|10|||
48359359|NCT01214642|155510865|FG009|Overall Study|Progressive Disease|2|||
48359360|NCT01214642|155510866|FG010|Overall Study|Progressive Disease|1|||
48359361|NCT01214642|155510867|FG011|Overall Study|Progressive Disease|4|||
48359362|NCT01214642|155510856|FG000|Overall Study|Adverse Event|0|||
48359363|NCT01214642|155510857|FG001|Overall Study|Adverse Event|1|||
48359364|NCT01214642|155510858|FG002|Overall Study|Adverse Event|0|||
48359365|NCT01214642|155510859|FG003|Overall Study|Adverse Event|0|||
48359366|NCT01214642|155510860|FG004|Overall Study|Adverse Event|0|||
48359367|NCT01214642|155510861|FG005|Overall Study|Adverse Event|0|||
48359368|NCT01214642|155510862|FG006|Overall Study|Adverse Event|1|||
48359369|NCT01214642|155510863|FG007|Overall Study|Adverse Event|0|||
48359370|NCT01214642|155510864|FG008|Overall Study|Adverse Event|0|||
48359371|NCT01214642|155510865|FG009|Overall Study|Adverse Event|1|||
48359372|NCT01214642|155510866|FG010|Overall Study|Adverse Event|1|||
48359373|NCT01214642|155510867|FG011|Overall Study|Adverse Event|0|||
48359374|NCT01214642|155510856|FG000|Overall Study|Death|0|||
48359375|NCT01214642|155510857|FG001|Overall Study|Death|0|||
48359376|NCT01214642|155510858|FG002|Overall Study|Death|1|||
48359377|NCT01214642|155510859|FG003|Overall Study|Death|0|||
48359378|NCT01214642|155510860|FG004|Overall Study|Death|0|||
48359379|NCT01214642|155510861|FG005|Overall Study|Death|0|||
48359380|NCT01214642|155510862|FG006|Overall Study|Death|0|||
48359381|NCT01214642|155510863|FG007|Overall Study|Death|0|||
48359382|NCT01214642|155510864|FG008|Overall Study|Death|0|||
48359383|NCT01214642|155510865|FG009|Overall Study|Death|0|||
48359384|NCT01214642|155510866|FG010|Overall Study|Death|1|||
48359385|NCT01214642|155510867|FG011|Overall Study|Death|0|||
48359386|NCT01214642|155510856|FG000|Overall Study|Withdrawal by Subject|0|||
48359387|NCT01214642|155510857|FG001|Overall Study|Withdrawal by Subject|0|||
48359388|NCT01214642|155510858|FG002|Overall Study|Withdrawal by Subject|1|||
48359389|NCT01214642|155510859|FG003|Overall Study|Withdrawal by Subject|0|||
48359390|NCT01214642|155510860|FG004|Overall Study|Withdrawal by Subject|0|||
48359391|NCT01214642|155510861|FG005|Overall Study|Withdrawal by Subject|0|||
48359392|NCT01214642|155510862|FG006|Overall Study|Withdrawal by Subject|0|||
48359393|NCT01214642|155510863|FG007|Overall Study|Withdrawal by Subject|0|||
48359394|NCT01214642|155510864|FG008|Overall Study|Withdrawal by Subject|3|||
48359395|NCT01214642|155510865|FG009|Overall Study|Withdrawal by Subject|1|||
48359396|NCT01214642|155510866|FG010|Overall Study|Withdrawal by Subject|1|||
48359397|NCT01214642|155510867|FG011|Overall Study|Withdrawal by Subject|0|||
48359398|NCT01214642|155510856|FG000|Overall Study|Physician Decision|0|||
48359399|NCT01214642|155510857|FG001|Overall Study|Physician Decision|0|||
48359400|NCT01214642|155510858|FG002|Overall Study|Physician Decision|1|||
48359401|NCT01214642|155510859|FG003|Overall Study|Physician Decision|1|||
48359402|NCT01214642|155510860|FG004|Overall Study|Physician Decision|1|||
48359403|NCT01214642|155510861|FG005|Overall Study|Physician Decision|0|||
48359404|NCT01214642|155510862|FG006|Overall Study|Physician Decision|0|||
48359405|NCT01214642|155510863|FG007|Overall Study|Physician Decision|0|||
48359406|NCT01214642|155510864|FG008|Overall Study|Physician Decision|0|||
48359407|NCT01214642|155510865|FG009|Overall Study|Physician Decision|0|||
48359408|NCT01214642|155510866|FG010|Overall Study|Physician Decision|0|||
48359409|NCT01214642|155510867|FG011|Overall Study|Physician Decision|2|||
48359410|NCT01064648|155510879|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
48359411|NCT01064648|155510880|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
48359412|NCT01064648|155510881|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
48359413|NCT01064648|155510882|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
48359414|NCT01064648|155510879|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
48359415|NCT01064648|155510880|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
48359416|NCT01064648|155510881|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
48359417|NCT01064648|155510882|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
48359418|NCT01064648|155510879|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
48359419|NCT01064648|155510880|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
48359420|NCT01064648|155510881|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
48359421|NCT01064648|155510882|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
48359422|NCT01064648|155510879|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
48359423|NCT01064648|155510880|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
48359424|NCT01064648|155510881|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
48359425|NCT01064648|155510882|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
48359426|NCT01064648|155510879|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
48359427|NCT01064648|155510880|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
48359428|NCT01064648|155510881|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
48359429|NCT01064648|155510882|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
48359430|NCT01064648|155510879|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
48359431|NCT01064648|155510880|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
48359432|NCT01064648|155510881|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
48359433|NCT01064648|155510882|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
48359434|NCT01064648|155510879|FG000|Phase II|Adverse Event|0|||
48359435|NCT01064648|155510880|FG001|Phase II|Adverse Event|0|||
48359436|NCT01064648|155510881|FG002|Phase II|Adverse Event|15|||
48359437|NCT01064648|155510882|FG003|Phase II|Adverse Event|8|||
48359438|NCT01064648|155510879|FG000|Phase II|Death|0|||
48359439|NCT01064648|155510880|FG001|Phase II|Death|0|||
48359440|NCT01064648|155510881|FG002|Phase II|Death|4|||
48359441|NCT01064648|155510882|FG003|Phase II|Death|5|||
48359442|NCT01064648|155510879|FG000|Phase II|Withdrawal by Subject|0|||
48359443|NCT01064648|155510880|FG001|Phase II|Withdrawal by Subject|0|||
48359444|NCT01064648|155510881|FG002|Phase II|Withdrawal by Subject|2|||
48359445|NCT01064648|155510882|FG003|Phase II|Withdrawal by Subject|5|||
48359446|NCT01064648|155510879|FG000|Phase II|Progression|0|||
48359447|NCT01064648|155510880|FG001|Phase II|Progression|0|||
48359448|NCT01064648|155510881|FG002|Phase II|Progression|21|||
48359449|NCT01064648|155510882|FG003|Phase II|Progression|27|||
48359450|NCT01064648|155510879|FG000|Phase II|Non-protocol specified|0|||
48359451|NCT01064648|155510880|FG001|Phase II|Non-protocol specified|0|||
48359452|NCT01064648|155510881|FG002|Phase II|Non-protocol specified|5|||
48359453|NCT01064648|155510882|FG003|Phase II|Non-protocol specified|3|||
48359454|NCT01064648|155510879|FG000|Phase II|Under Review|0|||
48359455|NCT01064648|155510880|FG001|Phase II|Under Review|0|||
48359456|NCT01064648|155510881|FG002|Phase II|Under Review|2|||
48359457|NCT01064648|155510882|FG003|Phase II|Under Review|0|||
48587191|NCT01492101|156343152|FG001|Overall Study|Lost to Follow-up|2|||
48587192|NCT02045732|156343153|FG000|Overall Study|At the discretion of the investigator|1|||
48587193|NCT02045732|156343154|FG001|Overall Study|At the discretion of the investigator|1|||
48359461|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
48359462|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
48359463|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
48359464|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Death|4|||
48359465|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Death|2|||
48359466|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Death|3|||
48359467|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
48359468|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
48359469|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
48359470|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
48359471|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
48359472|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
48359473|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
48359474|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
48359475|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
48359476|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
48359477|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
48359478|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
48359479|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
48359480|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
48359481|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
48359482|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
48359483|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
48359484|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
48359485|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
48359486|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
48359487|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
48359488|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
48359489|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
48359490|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
48359491|NCT02783573|155512160|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
48359492|NCT02783573|155512161|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
48359493|NCT02783573|155512162|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
48359494|NCT02783573|155512160|FG000|Delayed-Start Period|Sponsor Decision|0|||
48359495|NCT02783573|155512161|FG001|Delayed-Start Period|Sponsor Decision|17|||
48359496|NCT02783573|155512162|FG002|Delayed-Start Period|Sponsor Decision|12|||
48359497|NCT01200342|155512163|FG000|Overall Study|Disease Progression|1|||
48359498|NCT01251770|155512164|FG000|Overall Study|Protocol Violation|13|||
48359499|NCT01251770|155512165|FG001|Overall Study|Protocol Violation|7|||
48359500|NCT02412735|155512166|FG000|Overall Study|Adverse Event|0|||
48359501|NCT02412735|155512167|FG001|Overall Study|Adverse Event|1|||
48359502|NCT02412735|155512168|FG002|Overall Study|Adverse Event|2|||
48359503|NCT02412735|155512166|FG000|Overall Study|Withdrawal by Subject|23|||
48359504|NCT02412735|155512167|FG001|Overall Study|Withdrawal by Subject|27|||
48359505|NCT02412735|155512168|FG002|Overall Study|Withdrawal by Subject|22|||
48359506|NCT02412735|155512166|FG000|Overall Study|Investigator Decision|3|||
48359507|NCT02412735|155512167|FG001|Overall Study|Investigator Decision|3|||
48359508|NCT02412735|155512168|FG002|Overall Study|Investigator Decision|2|||
48359509|NCT02412735|155512166|FG000|Overall Study|Lost to Follow-up|17|||
48359510|NCT02412735|155512167|FG001|Overall Study|Lost to Follow-up|11|||
48359511|NCT02412735|155512168|FG002|Overall Study|Lost to Follow-up|18|||
48359512|NCT02412735|155512166|FG000|Overall Study|Reason not Specified|3|||
48359513|NCT02412735|155512167|FG001|Overall Study|Reason not Specified|2|||
48359514|NCT02412735|155512168|FG002|Overall Study|Reason not Specified|2|||
48359515|NCT03175029|155512169|FG000|Overall Study|Withdrawal by Subject|2|||
48359516|NCT03175029|155512170|FG001|Overall Study|Withdrawal by Subject|1|||
48359517|NCT03175029|155512169|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
48359518|NCT03175029|155512170|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
48359519|NCT02179177|155512171|FG000|Overall Study|Lost to Follow-up|1|||
48359520|NCT02179177|155512172|FG001|Overall Study|Lost to Follow-up|1|||
48359521|NCT02179177|155512171|FG000|Overall Study|Withdrawal by Subject|1|||
48359522|NCT02179177|155512172|FG001|Overall Study|Withdrawal by Subject|1|||
48359523|NCT00678301|155512176|FG000|Overall Study|Non-compliance with study procedures|0|||
48359524|NCT00678301|155512177|FG001|Overall Study|Non-compliance with study procedures|1|||
48359525|NCT00678301|155512176|FG000|Overall Study|Adverse Event|1|||
48359526|NCT00678301|155512177|FG001|Overall Study|Adverse Event|0|||
48359527|NCT00678301|155512176|FG000|Overall Study|Withdrawal by Subject|4|||
48359528|NCT00678301|155512177|FG001|Overall Study|Withdrawal by Subject|0|||
48359529|NCT00678301|155512176|FG000|Overall Study|Lost to Follow-up|3|||
48359530|NCT00678301|155512177|FG001|Overall Study|Lost to Follow-up|1|||
48359531|NCT00702962|155512178|FG000|Overall Study|Progressive disease|0|||
48359532|NCT00702962|155512179|FG001|Overall Study|Progressive disease|1|||
48359533|NCT00702962|155512178|FG000|Overall Study|Hospitalized for other health disorder|1|||
48359534|NCT00702962|155512179|FG001|Overall Study|Hospitalized for other health disorder|0|||
48359535|NCT00335140|155512182|FG000|Overall Study|Ineligible|1|||
48359536|NCT01132820|155512184|FG000|Overall Study|Ineligible: wrong cell type|1|||
48359537|NCT01132820|155512184|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
48359538|NCT01132820|155512184|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
48359539|NCT01132820|155512184|FG000|Overall Study|Never treated|1|||
48359540|NCT01132820|155512184|FG000|Overall Study|Inadequate data|1|||
48359541|NCT00677534|155512185|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
48359542|NCT00677534|155512185|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
48359543|NCT00677534|155512185|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
48359544|NCT01923467|155512186|FG000|Overall Study|Lost to Follow-up|62|||
48359545|NCT01923467|155512186|FG000|Overall Study|Subject non-interest|479|||
48359546|NCT02687035|155512187|FG000|Overall Study|Withdrawal by Subject|1|||
48359547|NCT02687035|155512187|FG000|Overall Study|Death|87|||
48359548|NCT02687035|155512187|FG000|Overall Study|Lost to Follow-up|1|||
48359549|NCT02687035|155512187|FG000|Overall Study|Missed Visit|87|||
48359550|NCT02687035|155512187|FG000|Overall Study|Did not receive Study Device|8|||
48587194|NCT01004432|156343155|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
48587195|NCT01004432|156343156|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
48587196|NCT01004432|156343157|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
48359555|NCT03898960|155512190|FG000|Overall Study|Death|10|||
48359556|NCT03149042|155512191|FG000|Overall Study|Invasive FFR not performed|21|||
48359557|NCT03149042|155512191|FG000|Overall Study|Poor CT Image Quality|1|||
48359558|NCT03149042|155512191|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
48359559|NCT01023958|155512192|FG000|Overall Study|Progressive disease|48|||
48359560|NCT01023958|155512192|FG000|Overall Study|Other adverse event|1|||
48359561|NCT01023958|155512192|FG000|Overall Study|Refused to continue medication|1|||
48359562|NCT01195623|155512193|FG000|Overall Study|Lost to Follow-up|35|||
48359563|NCT01195623|155512194|FG001|Overall Study|Lost to Follow-up|37|||
48359564|NCT00842244|155512198|FG000|Overall Study|Death|3|||
48359565|NCT00842244|155512198|FG000|Overall Study|Withdrawal by Subject|1|||
48359566|NCT00842244|155512198|FG000|Overall Study|Other|17|||
48359567|NCT03846453|155512199|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
48359568|NCT03846453|155512200|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
48359569|NCT03846453|155512201|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
48359570|NCT03846453|155512199|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
48359571|NCT03846453|155512200|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
48359572|NCT03846453|155512201|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
48359573|NCT03846453|155512199|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
48359574|NCT03846453|155512200|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
48359575|NCT03846453|155512201|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
48359576|NCT03846453|155512199|FG000|Placebo Run-in (14 Days)|Other|2|||
48359577|NCT03846453|155512200|FG001|Placebo Run-in (14 Days)|Other|0|||
48359578|NCT03846453|155512201|FG002|Placebo Run-in (14 Days)|Other|0|||
48359579|NCT03846453|155512199|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
48359580|NCT03846453|155512200|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
48359581|NCT03846453|155512201|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
48359582|NCT03846453|155512199|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
48359583|NCT03846453|155512200|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
48359584|NCT03846453|155512201|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
48359585|NCT03846453|155512199|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
48359586|NCT03846453|155512200|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
48359587|NCT03846453|155512201|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
48359588|NCT03846453|155512199|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
48359589|NCT03846453|155512200|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
48359590|NCT03846453|155512201|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
48359591|NCT03846453|155512199|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
48359592|NCT03846453|155512200|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
48359593|NCT03846453|155512201|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
48359594|NCT01711853|155512203|FG000|Overall Study|Not treated|3|||
48359595|NCT01606670|155512204|FG000|Overall Study|Adverse Event|6|||
48359596|NCT01606670|155512204|FG000|Overall Study|Lack of Efficacy|2|||
48359597|NCT01606670|155512204|FG000|Overall Study|Lost to Follow-up|3|||
48359598|NCT01606670|155512204|FG000|Overall Study|Withdrawal by Subject|3|||
48359599|NCT01606670|155512204|FG000|Overall Study|Other Reason|2|||
48359600|NCT01886872|155512207|FG000|Overall Study|Ineligible|7|||
48359601|NCT01886872|155512208|FG001|Overall Study|Ineligible|4|||
48359602|NCT01886872|155512209|FG002|Overall Study|Ineligible|12|||
48359603|NCT04499924|155512210|FG000|Overall Study|Study termination by sponsor|4|||
48359604|NCT04499924|155512211|FG001|Overall Study|Study termination by sponsor|6|||
48359605|NCT04499924|155512210|FG000|Overall Study|Withdrawal by Subject|1|||
48359606|NCT04499924|155512211|FG001|Overall Study|Withdrawal by Subject|3|||
48359607|NCT01011868|155512215|FG000|After Week 18 Follow-up|Adverse Event|8|||
48359608|NCT01011868|155512216|FG001|After Week 18 Follow-up|Adverse Event|6|||
48359609|NCT01011868|155512217|FG002|After Week 18 Follow-up|Adverse Event|13|||
48359610|NCT01011868|155512215|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
48359611|NCT01011868|155512216|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
48359612|NCT01011868|155512217|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
48359613|NCT01011868|155512215|FG000|After Week 18 Follow-up|Protocol Violation|1|||
48359614|NCT01011868|155512216|FG001|After Week 18 Follow-up|Protocol Violation|1|||
48359615|NCT01011868|155512217|FG002|After Week 18 Follow-up|Protocol Violation|1|||
48359616|NCT01011868|155512215|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
48359617|NCT01011868|155512216|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
48359618|NCT01011868|155512217|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
48359619|NCT01011868|155512215|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
48359620|NCT01011868|155512216|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
48359621|NCT01011868|155512217|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
48359622|NCT01011868|155512215|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
48359623|NCT01011868|155512216|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
48359624|NCT01011868|155512217|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
48359625|NCT01011868|155512215|FG000|After Week 78 Follow-up|Adverse Event|14|||
48359626|NCT01011868|155512216|FG001|After Week 78 Follow-up|Adverse Event|18|||
48359627|NCT01011868|155512217|FG002|After Week 78 Follow-up|Adverse Event|21|||
48359628|NCT01011868|155512215|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
48359629|NCT01011868|155512216|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
48359630|NCT01011868|155512217|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
48359631|NCT01011868|155512215|FG000|After Week 78 Follow-up|Protocol Violation|9|||
48359632|NCT01011868|155512216|FG001|After Week 78 Follow-up|Protocol Violation|1|||
48359633|NCT01011868|155512217|FG002|After Week 78 Follow-up|Protocol Violation|2|||
48359634|NCT01011868|155512215|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
48359635|NCT01011868|155512216|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
48359636|NCT01011868|155512217|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
48359637|NCT01011868|155512215|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
48359638|NCT01011868|155512216|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
48359639|NCT01011868|155512217|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
48359640|NCT01011868|155512215|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
48359641|NCT01011868|155512216|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
48359642|NCT01011868|155512217|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
48359643|NCT01509547|155512225|FG000|Overall Study|Lost to Follow-up|24|||
48359644|NCT01509547|155512226|FG001|Overall Study|Lost to Follow-up|14|||
48359645|NCT01509547|155512225|FG000|Overall Study|Withdrawal by Subject|11|||
48359646|NCT01509547|155512226|FG001|Overall Study|Withdrawal by Subject|24|||
48359647|NCT01509547|155512225|FG000|Overall Study|Physician Decision|0|||
48359648|NCT01509547|155512226|FG001|Overall Study|Physician Decision|1|||
48359649|NCT00594880|155512227|FG000|Overall Study|Withdrawal by Subject|1|||
48359650|NCT00594880|155512228|FG001|Overall Study|Withdrawal by Subject|1|||
48359651|NCT00594880|155512227|FG000|Overall Study|Lost to Follow-up|1|||
48359652|NCT00594880|155512228|FG001|Overall Study|Lost to Follow-up|0|||
48359653|NCT02206061|155512229|FG000|Overall Study|Withdrawal by Subject|4|||
48359654|NCT02206061|155512230|FG001|Overall Study|Withdrawal by Subject|7|||
48359655|NCT02206061|155512231|FG002|Overall Study|Withdrawal by Subject|1|||
48359656|NCT02206061|155512229|FG000|Overall Study|Lost to Follow-up|14|||
48359657|NCT02206061|155512230|FG001|Overall Study|Lost to Follow-up|7|||
48359658|NCT02206061|155512231|FG002|Overall Study|Lost to Follow-up|20|||
48359659|NCT01254747|155512232|FG000|Overall Study|Unacceptable subjective vision|0|||
48359660|NCT01254747|155512233|FG001|Overall Study|Unacceptable subjective vision|0|||
48359661|NCT01254747|155512234|FG002|Overall Study|Unacceptable subjective vision|0|||
48359662|NCT01254747|155512235|FG003|Overall Study|Unacceptable subjective vision|2|||
48359663|NCT01254747|155512232|FG000|Overall Study|Difficult removal handling|0|||
48359664|NCT01254747|155512233|FG001|Overall Study|Difficult removal handling|0|||
48359665|NCT01254747|155512234|FG002|Overall Study|Difficult removal handling|1|||
48359666|NCT01254747|155512235|FG003|Overall Study|Difficult removal handling|0|||
48359667|NCT01254747|155512232|FG000|Overall Study|Symptoms and problems|0|||
48359668|NCT01254747|155512233|FG001|Overall Study|Symptoms and problems|2|||
48359669|NCT01254747|155512234|FG002|Overall Study|Symptoms and problems|1|||
48359670|NCT01254747|155512235|FG003|Overall Study|Symptoms and problems|0|||
48359671|NCT01254747|155512232|FG000|Overall Study|Lost to Follow-up|0|||
48359672|NCT01254747|155512233|FG001|Overall Study|Lost to Follow-up|0|||
48359673|NCT01254747|155512234|FG002|Overall Study|Lost to Follow-up|1|||
48359674|NCT01254747|155512235|FG003|Overall Study|Lost to Follow-up|0|||
48359675|NCT01254747|155512232|FG000|Overall Study|Biomicroscopy|0|||
48359676|NCT01254747|155512233|FG001|Overall Study|Biomicroscopy|0|||
48359677|NCT01254747|155512234|FG002|Overall Study|Biomicroscopy|1|||
48359678|NCT01254747|155512235|FG003|Overall Study|Biomicroscopy|0|||
48359679|NCT01254747|155512232|FG000|Overall Study|Discomfort|0|||
48359680|NCT01254747|155512233|FG001|Overall Study|Discomfort|4|||
48359681|NCT01254747|155512234|FG002|Overall Study|Discomfort|0|||
48359682|NCT01254747|155512235|FG003|Overall Study|Discomfort|0|||
48359683|NCT02817906|155512236|FG000|Overall Study|Adverse Event|3|||
48359684|NCT02817906|155512237|FG001|Overall Study|Adverse Event|0|||
48359685|NCT02817906|155512236|FG000|Overall Study|Lack of Efficacy|1|||
48359686|NCT02817906|155512237|FG001|Overall Study|Lack of Efficacy|0|||
48359687|NCT02817906|155512236|FG000|Overall Study|Protocol Violation|1|||
48359688|NCT02817906|155512237|FG001|Overall Study|Protocol Violation|1|||
48359689|NCT02817906|155512236|FG000|Overall Study|Study Terminated by Sponsor|2|||
48359690|NCT02817906|155512237|FG001|Overall Study|Study Terminated by Sponsor|2|||
48359691|NCT02817906|155512236|FG000|Overall Study|Withdrawal by Subject|7|||
48359692|NCT02817906|155512237|FG001|Overall Study|Withdrawal by Subject|0|||
48359693|NCT02817906|155512236|FG000|Overall Study|Other|2|||
48359694|NCT02817906|155512237|FG001|Overall Study|Other|2|||
48359695|NCT03381339|155512240|FG000|Overall Study|Protocol Violation|4|||
48359696|NCT03381339|155512241|FG001|Overall Study|Protocol Violation|3|||
48359697|NCT03381339|155512240|FG000|Overall Study|Lost to Follow-up|0|||
48359698|NCT03381339|155512241|FG001|Overall Study|Lost to Follow-up|1|||
48412023|NCT05172544|155696893|FG002|Overall Study|Physician Decision|1|||
48412024|NCT03371355|155696894|FG000|Overall Study|Investigator judgment|0|||
48412025|NCT03371355|155696895|FG001|Overall Study|Investigator judgment|0|||
48359699|NCT02108964|155512242|FG000|Overall Study|Progressive disease|15|||
48359700|NCT02108964|155512243|FG001|Overall Study|Progressive disease|31|||
48359701|NCT02108964|155512244|FG002|Overall Study|Progressive disease|54|||
48359702|NCT02108964|155512245|FG003|Overall Study|Progressive disease|7|||
48359703|NCT02108964|155512246|FG004|Overall Study|Progressive disease|20|||
48359704|NCT02108964|155512247|FG005|Overall Study|Progressive disease|4|||
48359705|NCT02108964|155512248|FG006|Overall Study|Progressive disease|6|||
48359706|NCT02108964|155512249|FG007|Overall Study|Progressive disease|33|||
48359707|NCT02108964|155512242|FG000|Overall Study|Physician Decision|1|||
48359708|NCT02108964|155512243|FG001|Overall Study|Physician Decision|5|||
48359709|NCT02108964|155512244|FG002|Overall Study|Physician Decision|7|||
48359710|NCT02108964|155512245|FG003|Overall Study|Physician Decision|1|||
48359711|NCT02108964|155512246|FG004|Overall Study|Physician Decision|2|||
48359712|NCT02108964|155512247|FG005|Overall Study|Physician Decision|1|||
48359713|NCT02108964|155512248|FG006|Overall Study|Physician Decision|1|||
48359714|NCT02108964|155512249|FG007|Overall Study|Physician Decision|3|||
48359715|NCT02108964|155512242|FG000|Overall Study|Adverse Event|0|||
48359716|NCT02108964|155512243|FG001|Overall Study|Adverse Event|0|||
48359717|NCT02108964|155512244|FG002|Overall Study|Adverse Event|4|||
48359718|NCT02108964|155512245|FG003|Overall Study|Adverse Event|0|||
48359719|NCT02108964|155512246|FG004|Overall Study|Adverse Event|1|||
48359720|NCT02108964|155512247|FG005|Overall Study|Adverse Event|0|||
48359721|NCT02108964|155512248|FG006|Overall Study|Adverse Event|3|||
48359722|NCT02108964|155512249|FG007|Overall Study|Adverse Event|2|||
48359723|NCT02108964|155512242|FG000|Overall Study|Death|1|||
48359724|NCT02108964|155512243|FG001|Overall Study|Death|1|||
48359725|NCT02108964|155512244|FG002|Overall Study|Death|4|||
48359726|NCT02108964|155512245|FG003|Overall Study|Death|0|||
48359727|NCT02108964|155512246|FG004|Overall Study|Death|3|||
48359728|NCT02108964|155512247|FG005|Overall Study|Death|0|||
48359729|NCT02108964|155512248|FG006|Overall Study|Death|0|||
48359730|NCT02108964|155512249|FG007|Overall Study|Death|2|||
48359731|NCT02108964|155512242|FG000|Overall Study|Subject/Guardian decision|0|||
48359732|NCT02108964|155512243|FG001|Overall Study|Subject/Guardian decision|1|||
48359733|NCT02108964|155512244|FG002|Overall Study|Subject/Guardian decision|4|||
48359734|NCT02108964|155512245|FG003|Overall Study|Subject/Guardian decision|0|||
48359735|NCT02108964|155512246|FG004|Overall Study|Subject/Guardian decision|2|||
48359736|NCT02108964|155512247|FG005|Overall Study|Subject/Guardian decision|0|||
48359737|NCT02108964|155512248|FG006|Overall Study|Subject/Guardian decision|1|||
48359738|NCT02108964|155512249|FG007|Overall Study|Subject/Guardian decision|2|||
48359739|NCT02108964|155512242|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48359740|NCT02108964|155512243|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48359741|NCT02108964|155512244|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48359742|NCT02108964|155512245|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48359743|NCT02108964|155512246|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48359744|NCT02108964|155512247|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48359745|NCT02108964|155512248|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
48359746|NCT02108964|155512249|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
48359747|NCT03462719|155512250|FG000|Overall Study|Withdrawal by Subject|4|||
48359748|NCT03462719|155512251|FG001|Overall Study|Withdrawal by Subject|3|||
48359749|NCT03462719|155512250|FG000|Overall Study|Ongoing|87|||
48359750|NCT03462719|155512251|FG001|Overall Study|Ongoing|72|||
48359751|NCT04850898|155512252|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
48359752|NCT04850898|155512253|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
48359753|NCT04949841|155512255|FG000|Overall Study|Adverse Event|7|||
48359754|NCT04949841|155512255|FG000|Overall Study|Death|1|||
48359755|NCT04949841|155512255|FG000|Overall Study|Withdrawal by Subject|52|||
48359756|NCT04949841|155512255|FG000|Overall Study|Pregnancy|4|||
48359757|NCT04949841|155512255|FG000|Overall Study|Lost to Follow-up|9|||
48359758|NCT04949841|155512255|FG000|Overall Study|Lack of Efficacy|55|||
48359759|NCT04949841|155512255|FG000|Overall Study|Various reasons|9|||
48359760|NCT00552929|155512258|FG000|Overall Study|Lost to Follow-up|0|||
48359761|NCT00552929|155512259|FG001|Overall Study|Lost to Follow-up|0|||
48359762|NCT00552929|155512260|FG002|Overall Study|Lost to Follow-up|0|||
48359763|NCT00552929|155512261|FG003|Overall Study|Lost to Follow-up|0|||
48359764|NCT00552929|155512262|FG004|Overall Study|Lost to Follow-up|0|||
48359765|NCT00552929|155512263|FG005|Overall Study|Lost to Follow-up|0|||
48359766|NCT00552929|155512264|FG006|Overall Study|Lost to Follow-up|0|||
48359767|NCT00552929|155512265|FG007|Overall Study|Lost to Follow-up|0|||
48359768|NCT00552929|155512266|FG008|Overall Study|Lost to Follow-up|1|||
48359769|NCT00552929|155512267|FG009|Overall Study|Lost to Follow-up|0|||
48359770|NCT00552929|155512258|FG000|Overall Study|Not Eligible|0|||
48359771|NCT00552929|155512259|FG001|Overall Study|Not Eligible|0|||
48359772|NCT00552929|155512260|FG002|Overall Study|Not Eligible|0|||
48359773|NCT00552929|155512261|FG003|Overall Study|Not Eligible|0|||
48359774|NCT00552929|155512262|FG004|Overall Study|Not Eligible|0|||
48359775|NCT00552929|155512263|FG005|Overall Study|Not Eligible|1|||
48359776|NCT00552929|155512264|FG006|Overall Study|Not Eligible|0|||
48359777|NCT00552929|155512265|FG007|Overall Study|Not Eligible|0|||
48359778|NCT00552929|155512266|FG008|Overall Study|Not Eligible|0|||
48359779|NCT00552929|155512267|FG009|Overall Study|Not Eligible|0|||
48359780|NCT01865747|155512270|FG000|Overall Study (ITT)|Adverse Event|32|||
48359781|NCT01865747|155512271|FG001|Overall Study (ITT)|Adverse Event|31|||
48359782|NCT01865747|155512270|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
48359783|NCT01865747|155512271|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
48359784|NCT01865747|155512270|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
48431451|NCT00002663|155767266|FG002|Overall Study|Adverse Event|0|||
48359785|NCT01865747|155512271|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
48359786|NCT01865747|155512270|FG000|Overall Study (ITT)|Protocol Violation|1|||
48359787|NCT01865747|155512271|FG001|Overall Study (ITT)|Protocol Violation|1|||
48359788|NCT01865747|155512270|FG000|Overall Study (ITT)|Physician Decision|5|||
48359789|NCT01865747|155512271|FG001|Overall Study (ITT)|Physician Decision|2|||
48359790|NCT01865747|155512270|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
48359791|NCT01865747|155512271|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
48359792|NCT01865747|155512270|FG000|Overall Study (ITT)|Sponsor Decision|0|||
48359793|NCT01865747|155512271|FG001|Overall Study (ITT)|Sponsor Decision|1|||
48359794|NCT01865747|155512270|FG000|Overall Study (ITT)|Progressive Disease|122|||
48359795|NCT01865747|155512271|FG001|Overall Study (ITT)|Progressive Disease|158|||
48359796|NCT01865747|155512270|FG000|Overall Study (ITT)|Reason Not Provided|0|||
48359797|NCT01865747|155512271|FG001|Overall Study (ITT)|Reason Not Provided|1|||
48359798|NCT01865747|155512270|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
48359799|NCT01865747|155512271|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
48359800|NCT01865747|155512270|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
48359801|NCT01865747|155512271|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
48359802|NCT01865747|155512270|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
48359803|NCT01865747|155512271|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
48359804|NCT01865747|155512270|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
48359805|NCT01865747|155512271|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
48359806|NCT01865747|155512270|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
48359807|NCT01865747|155512271|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
48359808|NCT01865747|155512270|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
48359809|NCT01865747|155512271|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
48359810|NCT01865747|155512270|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
48359811|NCT01865747|155512271|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
48359812|NCT01865747|155512270|FG000|Primary Intent to Treat (PITT)|Other|0|||
48359813|NCT01865747|155512271|FG001|Primary Intent to Treat (PITT)|Other|1|||
48359814|NCT01133418|155512272|FG000|Overall Study|Lost to Follow-up|5|||
48359815|NCT01133418|155512273|FG001|Overall Study|Lost to Follow-up|6|||
48359816|NCT04469270|155512274|FG000|Overall Study|Adverse Event|2|||
48359817|NCT04469270|155512275|FG001|Overall Study|Adverse Event|0|||
48359818|NCT04469270|155512274|FG000|Overall Study|Lost to Follow-up|4|||
48359819|NCT04469270|155512275|FG001|Overall Study|Lost to Follow-up|3|||
48359820|NCT04469270|155512274|FG000|Overall Study|Withdrawal by Subject|7|||
48359821|NCT04469270|155512275|FG001|Overall Study|Withdrawal by Subject|3|||
48359822|NCT04469270|155512274|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
48359823|NCT04469270|155512275|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
48359824|NCT04469270|155512274|FG000|Overall Study|missing|1|||
48359825|NCT04469270|155512275|FG001|Overall Study|missing|0|||
48359826|NCT04820322|155512276|FG000|Overall Study|Adverse Event|1|||
48359827|NCT04820322|155512277|FG001|Overall Study|Adverse Event|0|||
48359828|NCT01820611|155512280|FG000|Overall Study|Death|8|||
48359829|NCT01820611|155512280|FG000|Overall Study|Adverse Event|1|||
48359830|NCT01820611|155512280|FG000|Overall Study|Withdrawal by Subject|9|||
48359831|NCT03043872|155512283|FG000|Overall Study|Withdrawal by Subject|6|||
48359832|NCT03043872|155512284|FG001|Overall Study|Withdrawal by Subject|6|||
48359833|NCT03043872|155512285|FG002|Overall Study|Withdrawal by Subject|15|||
48359834|NCT03043872|155512283|FG000|Overall Study|Lost to Follow-up|2|||
48359835|NCT03043872|155512284|FG001|Overall Study|Lost to Follow-up|1|||
48359836|NCT03043872|155512285|FG002|Overall Study|Lost to Follow-up|1|||
48359837|NCT03043872|155512283|FG000|Overall Study|Death|270|||
48359838|NCT03043872|155512284|FG001|Overall Study|Death|269|||
48359839|NCT03043872|155512285|FG002|Overall Study|Death|296|||
48359840|NCT02963090|155513945|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
48359841|NCT02963090|155513946|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
48359842|NCT04089371|155513949|FG000|Overall Study|Withdrawal by Subject|0|||
48359843|NCT04089371|155513950|FG001|Overall Study|Withdrawal by Subject|1|||
48359844|NCT04089371|155513949|FG000|Overall Study|Study terminated early|0|||
48359845|NCT04089371|155513950|FG001|Overall Study|Study terminated early|9|||
48359846|NCT01706705|155513951|FG000|Overall Study|Death|1|||
48359847|NCT01706705|155513951|FG000|Overall Study|Lack of Efficacy|13|||
48359848|NCT01706705|155513951|FG000|Overall Study|Non-clinical|6|||
48359849|NCT00863681|155513952|FG000|Overall Study|Other|2|||
48359850|NCT00863681|155513953|FG001|Overall Study|Other|0|||
48359851|NCT00863681|155513954|FG002|Overall Study|Other|0|||
48359852|NCT00863681|155513952|FG000|Overall Study|Missing|1|||
48359853|NCT00863681|155513953|FG001|Overall Study|Missing|0|||
48359854|NCT00863681|155513954|FG002|Overall Study|Missing|0|||
48359855|NCT00863681|155513952|FG000|Overall Study|Death|40|||
48359856|NCT00863681|155513953|FG001|Overall Study|Death|23|||
48359857|NCT00863681|155513954|FG002|Overall Study|Death|6|||
48359858|NCT00863681|155513952|FG000|Overall Study|Withdrawal by Subject|12|||
48359859|NCT00863681|155513953|FG001|Overall Study|Withdrawal by Subject|5|||
48359860|NCT00863681|155513954|FG002|Overall Study|Withdrawal by Subject|2|||
48359861|NCT00863681|155513952|FG000|Overall Study|Protocol Violation|2|||
48359862|NCT00863681|155513953|FG001|Overall Study|Protocol Violation|0|||
48359863|NCT00863681|155513954|FG002|Overall Study|Protocol Violation|0|||
48359864|NCT00863681|155513952|FG000|Overall Study|Lost to Follow-up|3|||
48359865|NCT00863681|155513953|FG001|Overall Study|Lost to Follow-up|0|||
48359866|NCT00863681|155513954|FG002|Overall Study|Lost to Follow-up|3|||
48359867|NCT00863681|155513952|FG000|Overall Study|Adverse Event|28|||
48359868|NCT00863681|155513953|FG001|Overall Study|Adverse Event|10|||
48359869|NCT00863681|155513954|FG002|Overall Study|Adverse Event|6|||
48359870|NCT00863681|155513952|FG000|Overall Study|Lack of Efficacy|2|||
48359871|NCT00863681|155513953|FG001|Overall Study|Lack of Efficacy|2|||
48359872|NCT00863681|155513954|FG002|Overall Study|Lack of Efficacy|1|||
48359873|NCT00863681|155513952|FG000|Overall Study|Non-compliance with study drug|1|||
48359874|NCT00863681|155513953|FG001|Overall Study|Non-compliance with study drug|3|||
48359875|NCT00863681|155513954|FG002|Overall Study|Non-compliance with study drug|0|||
48359876|NCT00338962|155513955|FG000|Overall Study|Lost to Follow-up|3|||
48359877|NCT00338962|155513956|FG001|Overall Study|Lost to Follow-up|3|||
48412026|NCT03371355|155696896|FG002|Overall Study|Investigator judgment|1|||
48412027|NCT03371355|155696897|FG003|Overall Study|Investigator judgment|1|||
48412028|NCT03371355|155696894|FG000|Overall Study|Voluntary withdrawal|1|||
48412029|NCT03371355|155696895|FG001|Overall Study|Voluntary withdrawal|0|||
48412030|NCT03371355|155696896|FG002|Overall Study|Voluntary withdrawal|1|||
48412031|NCT03371355|155696897|FG003|Overall Study|Voluntary withdrawal|2|||
48412032|NCT03371355|155696894|FG000|Overall Study|Adverse Event|0|||
48412033|NCT03371355|155696895|FG001|Overall Study|Adverse Event|1|||
48412034|NCT03371355|155696896|FG002|Overall Study|Adverse Event|2|||
48412035|NCT03371355|155696897|FG003|Overall Study|Adverse Event|3|||
48412036|NCT03371355|155696894|FG000|Overall Study|Reason not Specified|0|||
48412037|NCT03371355|155696895|FG001|Overall Study|Reason not Specified|1|||
48412038|NCT03371355|155696896|FG002|Overall Study|Reason not Specified|0|||
48412039|NCT03371355|155696897|FG003|Overall Study|Reason not Specified|1|||
48412040|NCT00727402|155696898|FG000|Overall Study|Physician Decision|116|||
48412041|NCT00723957|155696899|FG000|Overall Study|Adverse event unrelated to study drug|1|||
48412042|NCT00723957|155696900|FG001|Overall Study|Adverse event unrelated to study drug|4|||
48412043|NCT00723957|155696899|FG000|Overall Study|Death|3|||
48412044|NCT00723957|155696900|FG001|Overall Study|Death|4|||
48412045|NCT00723957|155696899|FG000|Overall Study|Disease progression|27|||
48412046|NCT00723957|155696900|FG001|Overall Study|Disease progression|25|||
48412047|NCT00723957|155696899|FG000|Overall Study|Maximum clinical benefit|4|||
48412048|NCT00723957|155696900|FG001|Overall Study|Maximum clinical benefit|5|||
48412049|NCT00723957|155696899|FG000|Overall Study|Investigator decision|1|||
48412050|NCT00723957|155696900|FG001|Overall Study|Investigator decision|1|||
48412051|NCT00723957|155696899|FG000|Overall Study|Study drug toxicity|4|||
48412052|NCT00723957|155696900|FG001|Overall Study|Study drug toxicity|6|||
48412053|NCT00723957|155696899|FG000|Overall Study|Withdrawal by Subject|7|||
48412054|NCT00723957|155696900|FG001|Overall Study|Withdrawal by Subject|5|||
48412055|NCT00723957|155696899|FG000|Overall Study|Reason not analyzed|1|||
48412056|NCT00723957|155696900|FG001|Overall Study|Reason not analyzed|0|||
48412057|NCT00723957|155696899|FG000|Overall Study|Never received treatment|3|||
48412058|NCT00723957|155696900|FG001|Overall Study|Never received treatment|3|||
48412059|NCT00755079|155696901|FG000|Overall Study|Lost to Follow-up|1|||
48412060|NCT00755079|155696902|FG001|Overall Study|Lost to Follow-up|3|||
48412061|NCT00755079|155696901|FG000|Overall Study|Adverse Event|0|||
48412062|NCT00755079|155696902|FG001|Overall Study|Adverse Event|1|||
48412063|NCT00755079|155696901|FG000|Overall Study|Withdrawal by Subject|0|||
48412064|NCT00755079|155696902|FG001|Overall Study|Withdrawal by Subject|2|||
48412065|NCT00868790|155696903|FG000|Period 1|Adverse Event|1|||
48412066|NCT00868790|155696904|FG001|Period 1|Adverse Event|0|||
48412067|NCT00868790|155696905|FG002|Period 1|Adverse Event|0|||
48412068|NCT00868790|155696906|FG003|Period 1|Adverse Event|0|||
48412069|NCT00868790|155696907|FG004|Period 1|Adverse Event|0|||
48412070|NCT00868790|155696908|FG005|Period 1|Adverse Event|0|||
48412071|NCT00868790|155696909|FG006|Period 1|Adverse Event|0|||
48412072|NCT00868790|155696910|FG007|Period 1|Adverse Event|3|||
48359878|NCT00338962|155513957|FG002|Overall Study|Lost to Follow-up|2|||
48359879|NCT00338962|155513958|FG003|Overall Study|Lost to Follow-up|3|||
48359880|NCT00338962|155513955|FG000|Overall Study|Withdrawal by Subject|1|||
48359881|NCT00338962|155513956|FG001|Overall Study|Withdrawal by Subject|0|||
48412073|NCT00868790|155696911|FG008|Period 1|Adverse Event|1|||
48412074|NCT00868790|155696912|FG009|Period 1|Adverse Event|0|||
48412075|NCT00868790|155696913|FG010|Period 1|Adverse Event|0|||
48412076|NCT00868790|155696914|FG011|Period 1|Adverse Event|0|||
48412077|NCT00868790|155696915|FG012|Period 1|Adverse Event|0|||
48412078|NCT00868790|155696916|FG013|Period 1|Adverse Event|1|||
48412079|NCT00868790|155696903|FG000|Period 1|Protocol Violation|1|||
48412080|NCT00868790|155696904|FG001|Period 1|Protocol Violation|0|||
48412081|NCT00868790|155696905|FG002|Period 1|Protocol Violation|0|||
48412082|NCT00868790|155696906|FG003|Period 1|Protocol Violation|0|||
48412083|NCT00868790|155696907|FG004|Period 1|Protocol Violation|0|||
48359882|NCT00338962|155513957|FG002|Overall Study|Withdrawal by Subject|0|||
48359883|NCT00338962|155513958|FG003|Overall Study|Withdrawal by Subject|0|||
48359884|NCT00338962|155513955|FG000|Overall Study|No Transportation|2|||
48359885|NCT00338962|155513956|FG001|Overall Study|No Transportation|0|||
48359886|NCT00338962|155513957|FG002|Overall Study|No Transportation|0|||
48359887|NCT00338962|155513958|FG003|Overall Study|No Transportation|0|||
48359888|NCT00338962|155513955|FG000|Overall Study|Time Constraint|2|||
48359889|NCT00338962|155513956|FG001|Overall Study|Time Constraint|0|||
48359890|NCT00338962|155513957|FG002|Overall Study|Time Constraint|0|||
48359891|NCT00338962|155513958|FG003|Overall Study|Time Constraint|0|||
48359892|NCT00338962|155513955|FG000|Overall Study|Moved|0|||
48359893|NCT00338962|155513956|FG001|Overall Study|Moved|1|||
48359894|NCT00338962|155513957|FG002|Overall Study|Moved|0|||
48359895|NCT00338962|155513958|FG003|Overall Study|Moved|0|||
48359896|NCT00338962|155513955|FG000|Overall Study|Adverse Event|0|||
48359897|NCT00338962|155513956|FG001|Overall Study|Adverse Event|0|||
48359898|NCT00338962|155513957|FG002|Overall Study|Adverse Event|2|||
48359899|NCT00338962|155513958|FG003|Overall Study|Adverse Event|0|||
48359900|NCT00338962|155513955|FG000|Overall Study|Poor Compliance|0|||
48359901|NCT00338962|155513956|FG001|Overall Study|Poor Compliance|0|||
48359902|NCT00338962|155513957|FG002|Overall Study|Poor Compliance|2|||
48359903|NCT00338962|155513958|FG003|Overall Study|Poor Compliance|0|||
48359904|NCT00742326|155513959|FG000|Overall Study|Physician Decision|0|||
48359905|NCT00742326|155513960|FG001|Overall Study|Physician Decision|1|||
48359906|NCT01441635|155513961|FG000|Overall Study|Adverse Event|4|||
48359907|NCT01441635|155513962|FG001|Overall Study|Adverse Event|3|||
48359908|NCT01441635|155513963|FG002|Overall Study|Adverse Event|1|||
48359909|NCT01441635|155513964|FG003|Overall Study|Adverse Event|5|||
48359910|NCT01441635|155513965|FG004|Overall Study|Adverse Event|1|||
48359911|NCT01441635|155513966|FG005|Overall Study|Adverse Event|2|||
48359912|NCT01441635|155513967|FG006|Overall Study|Adverse Event|2|||
48359913|NCT01441635|155513968|FG007|Overall Study|Adverse Event|2|||
48359914|NCT01441635|155513969|FG008|Overall Study|Adverse Event|1|||
48359915|NCT01441635|155513970|FG009|Overall Study|Adverse Event|0|||
48359916|NCT01441635|155513961|FG000|Overall Study|Withdrawal by Subject|1|||
48359917|NCT01441635|155513962|FG001|Overall Study|Withdrawal by Subject|1|||
48359918|NCT01441635|155513963|FG002|Overall Study|Withdrawal by Subject|0|||
48359919|NCT01441635|155513964|FG003|Overall Study|Withdrawal by Subject|1|||
48359920|NCT01441635|155513965|FG004|Overall Study|Withdrawal by Subject|0|||
48359921|NCT01441635|155513966|FG005|Overall Study|Withdrawal by Subject|0|||
48359922|NCT01441635|155513967|FG006|Overall Study|Withdrawal by Subject|2|||
48359923|NCT01441635|155513968|FG007|Overall Study|Withdrawal by Subject|0|||
48359924|NCT01441635|155513969|FG008|Overall Study|Withdrawal by Subject|1|||
48359925|NCT01441635|155513970|FG009|Overall Study|Withdrawal by Subject|1|||
48359926|NCT01441635|155513961|FG000|Overall Study|Lost to Follow-up|0|||
48359927|NCT01441635|155513962|FG001|Overall Study|Lost to Follow-up|1|||
48359928|NCT01441635|155513963|FG002|Overall Study|Lost to Follow-up|1|||
48359929|NCT01441635|155513964|FG003|Overall Study|Lost to Follow-up|1|||
48359930|NCT01441635|155513965|FG004|Overall Study|Lost to Follow-up|1|||
48359931|NCT01441635|155513966|FG005|Overall Study|Lost to Follow-up|3|||
48359932|NCT01441635|155513967|FG006|Overall Study|Lost to Follow-up|1|||
48359933|NCT01441635|155513968|FG007|Overall Study|Lost to Follow-up|1|||
48359934|NCT01441635|155513969|FG008|Overall Study|Lost to Follow-up|0|||
48359935|NCT01441635|155513970|FG009|Overall Study|Lost to Follow-up|1|||
48359936|NCT01441635|155513961|FG000|Overall Study|Noncompliance|0|||
48359937|NCT01441635|155513962|FG001|Overall Study|Noncompliance|1|||
48359938|NCT01441635|155513963|FG002|Overall Study|Noncompliance|0|||
48359939|NCT01441635|155513964|FG003|Overall Study|Noncompliance|0|||
48359940|NCT01441635|155513965|FG004|Overall Study|Noncompliance|0|||
48359941|NCT01441635|155513966|FG005|Overall Study|Noncompliance|0|||
48359942|NCT01441635|155513967|FG006|Overall Study|Noncompliance|1|||
48359943|NCT01441635|155513968|FG007|Overall Study|Noncompliance|0|||
48359944|NCT01441635|155513969|FG008|Overall Study|Noncompliance|0|||
48359945|NCT01441635|155513970|FG009|Overall Study|Noncompliance|0|||
48359946|NCT01441635|155513961|FG000|Overall Study|Surgery or Invasive Intervention|0|||
48359947|NCT01441635|155513962|FG001|Overall Study|Surgery or Invasive Intervention|0|||
48359948|NCT01441635|155513963|FG002|Overall Study|Surgery or Invasive Intervention|1|||
48359949|NCT01441635|155513964|FG003|Overall Study|Surgery or Invasive Intervention|0|||
48359950|NCT01441635|155513965|FG004|Overall Study|Surgery or Invasive Intervention|0|||
48359951|NCT01441635|155513966|FG005|Overall Study|Surgery or Invasive Intervention|0|||
48359952|NCT01441635|155513967|FG006|Overall Study|Surgery or Invasive Intervention|0|||
48359953|NCT01441635|155513968|FG007|Overall Study|Surgery or Invasive Intervention|0|||
48359954|NCT01441635|155513969|FG008|Overall Study|Surgery or Invasive Intervention|0|||
48359955|NCT01441635|155513970|FG009|Overall Study|Surgery or Invasive Intervention|0|||
48359956|NCT01441635|155513961|FG000|Overall Study|Received Exclusionary Medication|1|||
48359957|NCT01441635|155513962|FG001|Overall Study|Received Exclusionary Medication|0|||
48359958|NCT01441635|155513963|FG002|Overall Study|Received Exclusionary Medication|0|||
48359959|NCT01441635|155513964|FG003|Overall Study|Received Exclusionary Medication|0|||
48359960|NCT01441635|155513965|FG004|Overall Study|Received Exclusionary Medication|0|||
48359961|NCT01441635|155513966|FG005|Overall Study|Received Exclusionary Medication|0|||
48359962|NCT01441635|155513967|FG006|Overall Study|Received Exclusionary Medication|0|||
48359963|NCT01441635|155513968|FG007|Overall Study|Received Exclusionary Medication|0|||
48359964|NCT01441635|155513969|FG008|Overall Study|Received Exclusionary Medication|0|||
48359965|NCT01441635|155513970|FG009|Overall Study|Received Exclusionary Medication|0|||
48359966|NCT01441635|155513961|FG000|Overall Study|Other|0|||
48359967|NCT01441635|155513962|FG001|Overall Study|Other|0|||
48359968|NCT01441635|155513963|FG002|Overall Study|Other|0|||
48359969|NCT01441635|155513964|FG003|Overall Study|Other|0|||
48359970|NCT01441635|155513965|FG004|Overall Study|Other|0|||
48359971|NCT01441635|155513966|FG005|Overall Study|Other|0|||
48359972|NCT01441635|155513967|FG006|Overall Study|Other|0|||
48359973|NCT01441635|155513968|FG007|Overall Study|Other|1|||
48359974|NCT01441635|155513969|FG008|Overall Study|Other|0|||
48359975|NCT01441635|155513970|FG009|Overall Study|Other|0|||
48359976|NCT00477490|155513973|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
48359977|NCT00477490|155513974|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
48359978|NCT00477490|155513975|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
48359979|NCT00477490|155513976|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
48359980|NCT00477490|155513977|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
48359981|NCT00477490|155513978|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
48359982|NCT00477490|155513979|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
48359983|NCT00477490|155513980|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
48359984|NCT00477490|155513981|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
48359985|NCT00477490|155513973|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
48359986|NCT00477490|155513974|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48359987|NCT00477490|155513975|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48359988|NCT00477490|155513976|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
48359989|NCT00477490|155513977|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
48359990|NCT00477490|155513978|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48359991|NCT00477490|155513979|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48359992|NCT00477490|155513980|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48359993|NCT00477490|155513981|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
48359994|NCT00477490|155513973|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
48359995|NCT00477490|155513974|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
48359996|NCT00477490|155513975|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
48359997|NCT00477490|155513976|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
48359998|NCT00477490|155513977|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
48359999|NCT00477490|155513978|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
48360000|NCT00477490|155513979|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
48360001|NCT00477490|155513980|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
48360002|NCT00477490|155513981|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
48360003|NCT00477490|155513973|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
48360004|NCT00477490|155513974|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
48360005|NCT00477490|155513975|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
48360006|NCT00477490|155513976|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
48360007|NCT00477490|155513977|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
48360008|NCT00477490|155513978|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
48360009|NCT00477490|155513979|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
48360010|NCT00477490|155513980|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
48360011|NCT00477490|155513981|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
48360012|NCT00477490|155513973|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
48360013|NCT00477490|155513974|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
48360014|NCT00477490|155513975|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
48360015|NCT00477490|155513976|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
48360016|NCT00477490|155513977|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
48360017|NCT00477490|155513978|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
48360018|NCT00477490|155513979|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
48360019|NCT00477490|155513980|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
48360020|NCT00477490|155513981|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
48360021|NCT00477490|155513973|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
48360022|NCT00477490|155513974|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
48360023|NCT00477490|155513975|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
48360024|NCT00477490|155513976|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
48360025|NCT00477490|155513977|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
48360026|NCT00477490|155513978|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
48360027|NCT00477490|155513979|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
48360028|NCT00477490|155513980|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
48360029|NCT00477490|155513981|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
48360030|NCT00477490|155513973|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
48360031|NCT00477490|155513974|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
48360032|NCT00477490|155513975|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
48360033|NCT00477490|155513976|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
48360034|NCT00477490|155513977|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
48360035|NCT00477490|155513978|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
48360036|NCT00477490|155513979|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
48360037|NCT00477490|155513980|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
48360038|NCT00477490|155513981|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
48360039|NCT00477490|155513973|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
48360040|NCT00477490|155513974|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
48360041|NCT00477490|155513975|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
48360042|NCT00477490|155513976|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
48360043|NCT00477490|155513977|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
48360044|NCT00477490|155513978|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
48360045|NCT00477490|155513979|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
48360046|NCT00477490|155513980|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
48360047|NCT00477490|155513981|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
48360048|NCT00477490|155513973|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
48360049|NCT00477490|155513974|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
48360050|NCT00477490|155513975|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
48360051|NCT00477490|155513976|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48360052|NCT00477490|155513977|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48360053|NCT00477490|155513978|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48412084|NCT00868790|155696908|FG005|Period 1|Protocol Violation|0|||
48412085|NCT00868790|155696909|FG006|Period 1|Protocol Violation|0|||
48412086|NCT00868790|155696910|FG007|Period 1|Protocol Violation|0|||
48412087|NCT00868790|155696911|FG008|Period 1|Protocol Violation|0|||
48412088|NCT00868790|155696912|FG009|Period 1|Protocol Violation|0|||
48412089|NCT00868790|155696913|FG010|Period 1|Protocol Violation|0|||
48412090|NCT00868790|155696914|FG011|Period 1|Protocol Violation|0|||
48412091|NCT00868790|155696915|FG012|Period 1|Protocol Violation|0|||
48412092|NCT00868790|155696916|FG013|Period 1|Protocol Violation|0|||
48412093|NCT00868790|155696903|FG000|Period 1|Withdrawal by Subject|0|||
48412094|NCT00868790|155696904|FG001|Period 1|Withdrawal by Subject|1|||
48412095|NCT00868790|155696905|FG002|Period 1|Withdrawal by Subject|0|||
48412096|NCT00868790|155696906|FG003|Period 1|Withdrawal by Subject|0|||
48412097|NCT00868790|155696907|FG004|Period 1|Withdrawal by Subject|0|||
48412098|NCT00868790|155696908|FG005|Period 1|Withdrawal by Subject|0|||
48412099|NCT00868790|155696909|FG006|Period 1|Withdrawal by Subject|0|||
48412100|NCT00868790|155696910|FG007|Period 1|Withdrawal by Subject|0|||
48412101|NCT00868790|155696911|FG008|Period 1|Withdrawal by Subject|0|||
48412102|NCT00868790|155696912|FG009|Period 1|Withdrawal by Subject|0|||
48412103|NCT00868790|155696913|FG010|Period 1|Withdrawal by Subject|0|||
48412104|NCT00868790|155696914|FG011|Period 1|Withdrawal by Subject|0|||
48412105|NCT00868790|155696915|FG012|Period 1|Withdrawal by Subject|0|||
48412106|NCT00868790|155696916|FG013|Period 1|Withdrawal by Subject|1|||
48412107|NCT00868790|155696903|FG000|Period 1|Abnormal Triglycerides|0|||
48412108|NCT00868790|155696904|FG001|Period 1|Abnormal Triglycerides|0|||
48412109|NCT00868790|155696905|FG002|Period 1|Abnormal Triglycerides|0|||
48412110|NCT00868790|155696906|FG003|Period 1|Abnormal Triglycerides|0|||
48412111|NCT00868790|155696907|FG004|Period 1|Abnormal Triglycerides|1|||
48412112|NCT00868790|155696908|FG005|Period 1|Abnormal Triglycerides|0|||
48412113|NCT00868790|155696909|FG006|Period 1|Abnormal Triglycerides|0|||
48412114|NCT00868790|155696910|FG007|Period 1|Abnormal Triglycerides|0|||
48412115|NCT00868790|155696911|FG008|Period 1|Abnormal Triglycerides|0|||
48412116|NCT00868790|155696912|FG009|Period 1|Abnormal Triglycerides|0|||
48412117|NCT00868790|155696913|FG010|Period 1|Abnormal Triglycerides|0|||
48412118|NCT00868790|155696914|FG011|Period 1|Abnormal Triglycerides|0|||
48412119|NCT00868790|155696915|FG012|Period 1|Abnormal Triglycerides|0|||
48412120|NCT00868790|155696916|FG013|Period 1|Abnormal Triglycerides|0|||
48412121|NCT00868790|155696903|FG000|Period 1|Lost to Follow-up|0|||
48412122|NCT00868790|155696904|FG001|Period 1|Lost to Follow-up|0|||
48412123|NCT00868790|155696905|FG002|Period 1|Lost to Follow-up|0|||
48412124|NCT00868790|155696906|FG003|Period 1|Lost to Follow-up|0|||
48412125|NCT00868790|155696907|FG004|Period 1|Lost to Follow-up|0|||
48412126|NCT00868790|155696908|FG005|Period 1|Lost to Follow-up|1|||
48412127|NCT00868790|155696909|FG006|Period 1|Lost to Follow-up|0|||
48412128|NCT00868790|155696910|FG007|Period 1|Lost to Follow-up|0|||
48412129|NCT00868790|155696911|FG008|Period 1|Lost to Follow-up|0|||
48360054|NCT00477490|155513979|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48412130|NCT00868790|155696912|FG009|Period 1|Lost to Follow-up|0|||
48412131|NCT00868790|155696913|FG010|Period 1|Lost to Follow-up|0|||
48412132|NCT00868790|155696914|FG011|Period 1|Lost to Follow-up|0|||
48412133|NCT00868790|155696915|FG012|Period 1|Lost to Follow-up|0|||
48412134|NCT00868790|155696916|FG013|Period 1|Lost to Follow-up|0|||
48412135|NCT00868790|155696903|FG000|Period 2|Adverse Event|0|||
48412136|NCT00868790|155696904|FG001|Period 2|Adverse Event|0|||
48412137|NCT00868790|155696905|FG002|Period 2|Adverse Event|0|||
48412138|NCT00868790|155696906|FG003|Period 2|Adverse Event|0|||
48412139|NCT00868790|155696907|FG004|Period 2|Adverse Event|0|||
48360055|NCT00477490|155513980|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
48360056|NCT00477490|155513981|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
48360057|NCT00477490|155513973|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48360058|NCT00477490|155513974|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
48360059|NCT00477490|155513975|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
48360060|NCT00477490|155513976|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48360061|NCT00477490|155513977|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
48360062|NCT00477490|155513978|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48360063|NCT00477490|155513979|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
48360064|NCT00477490|155513980|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48360065|NCT00477490|155513981|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
48360066|NCT00477490|155513973|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48360067|NCT00477490|155513974|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48360068|NCT00477490|155513975|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48360069|NCT00477490|155513976|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48360070|NCT00477490|155513977|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
48360071|NCT00477490|155513978|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48360072|NCT00477490|155513979|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
48360073|NCT00477490|155513980|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
48360074|NCT00477490|155513981|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
48360075|NCT00477490|155513973|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48360076|NCT00477490|155513974|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
48360077|NCT00477490|155513975|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48360078|NCT00477490|155513976|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48360079|NCT00477490|155513977|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48360080|NCT00477490|155513978|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48360081|NCT00477490|155513979|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48360082|NCT00477490|155513980|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48360083|NCT00477490|155513981|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
48360084|NCT00477490|155513973|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
48360085|NCT00477490|155513974|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
48360086|NCT00477490|155513975|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
48360087|NCT00477490|155513976|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
48360088|NCT00477490|155513977|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
48360089|NCT00477490|155513978|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
48360090|NCT00477490|155513979|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
48360091|NCT00477490|155513980|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
48360092|NCT00477490|155513981|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
48360093|NCT00477490|155513973|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48360094|NCT00477490|155513974|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
48360095|NCT00477490|155513975|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
48360096|NCT00477490|155513976|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48360097|NCT00477490|155513977|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
48360098|NCT00477490|155513978|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48360099|NCT00477490|155513979|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48360100|NCT00477490|155513980|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48360101|NCT00477490|155513981|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
48360102|NCT01646177|155513982|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
48360103|NCT01646177|155513983|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
48360104|NCT01646177|155513984|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
48360105|NCT01646177|155513985|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
48360106|NCT01646177|155513986|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48360107|NCT01646177|155513987|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48360108|NCT01646177|155513988|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48360109|NCT01646177|155513989|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48360110|NCT01646177|155513990|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48360111|NCT01646177|155513991|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48360112|NCT01646177|155513992|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48360113|NCT01646177|155513993|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
48360114|NCT01646177|155513982|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
48360115|NCT01646177|155513983|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
48360116|NCT01646177|155513984|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
48360117|NCT01646177|155513985|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
48360118|NCT01646177|155513986|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48360119|NCT01646177|155513987|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48360120|NCT01646177|155513988|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48360121|NCT01646177|155513989|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48360122|NCT01646177|155513990|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48360123|NCT01646177|155513991|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48360124|NCT01646177|155513992|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48360125|NCT01646177|155513993|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
48360126|NCT01646177|155513982|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
48360127|NCT01646177|155513983|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
48360128|NCT01646177|155513984|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
48360129|NCT01646177|155513985|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
48360130|NCT01646177|155513986|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48360131|NCT01646177|155513987|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48360132|NCT01646177|155513988|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48360133|NCT01646177|155513989|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48360134|NCT01646177|155513990|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48360135|NCT01646177|155513991|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48360136|NCT01646177|155513992|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48360137|NCT01646177|155513993|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
48360138|NCT01646177|155513982|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
48360139|NCT01646177|155513983|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
48360140|NCT01646177|155513984|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
48360141|NCT01646177|155513985|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
48360142|NCT01646177|155513986|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48360143|NCT01646177|155513987|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48360144|NCT01646177|155513988|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48360145|NCT01646177|155513989|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48360146|NCT01646177|155513990|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48360147|NCT01646177|155513991|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48360148|NCT01646177|155513992|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48360149|NCT01646177|155513993|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
48360150|NCT01646177|155513982|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48360151|NCT01646177|155513983|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48360152|NCT01646177|155513984|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
48360153|NCT01646177|155513985|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
48360154|NCT01646177|155513986|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48360155|NCT01646177|155513987|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48360156|NCT01646177|155513988|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48360157|NCT01646177|155513989|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48360158|NCT01646177|155513990|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48360159|NCT01646177|155513991|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48412140|NCT00868790|155696908|FG005|Period 2|Adverse Event|0|||
48412141|NCT00868790|155696909|FG006|Period 2|Adverse Event|0|||
48412142|NCT00868790|155696910|FG007|Period 2|Adverse Event|0|||
48412143|NCT00868790|155696911|FG008|Period 2|Adverse Event|1|||
48412144|NCT00868790|155696912|FG009|Period 2|Adverse Event|0|||
48412145|NCT00868790|155696913|FG010|Period 2|Adverse Event|0|||
48412146|NCT00868790|155696914|FG011|Period 2|Adverse Event|0|||
48412147|NCT00868790|155696915|FG012|Period 2|Adverse Event|0|||
48412148|NCT00868790|155696916|FG013|Period 2|Adverse Event|0|||
48412149|NCT00868790|155696903|FG000|Period 2|Lost to Follow-up|0|||
48412150|NCT00868790|155696904|FG001|Period 2|Lost to Follow-up|1|||
48412151|NCT00868790|155696905|FG002|Period 2|Lost to Follow-up|0|||
48412152|NCT00868790|155696906|FG003|Period 2|Lost to Follow-up|0|||
48412153|NCT00868790|155696907|FG004|Period 2|Lost to Follow-up|0|||
48412154|NCT00868790|155696908|FG005|Period 2|Lost to Follow-up|1|||
48412155|NCT00868790|155696909|FG006|Period 2|Lost to Follow-up|0|||
48412156|NCT00868790|155696910|FG007|Period 2|Lost to Follow-up|0|||
48412157|NCT00868790|155696911|FG008|Period 2|Lost to Follow-up|0|||
48412158|NCT00868790|155696912|FG009|Period 2|Lost to Follow-up|0|||
48412159|NCT00868790|155696913|FG010|Period 2|Lost to Follow-up|0|||
48360160|NCT01646177|155513992|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48360161|NCT01646177|155513993|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
48412160|NCT00868790|155696914|FG011|Period 2|Lost to Follow-up|0|||
48412161|NCT00868790|155696915|FG012|Period 2|Lost to Follow-up|0|||
48412162|NCT00868790|155696916|FG013|Period 2|Lost to Follow-up|0|||
48412163|NCT00868790|155696903|FG000|Period 2|Withdrawal by Subject|0|||
48412164|NCT00868790|155696904|FG001|Period 2|Withdrawal by Subject|0|||
48412165|NCT00868790|155696905|FG002|Period 2|Withdrawal by Subject|0|||
48412166|NCT00868790|155696906|FG003|Period 2|Withdrawal by Subject|0|||
48412167|NCT00868790|155696907|FG004|Period 2|Withdrawal by Subject|0|||
48360162|NCT01646177|155513982|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
48360163|NCT01646177|155513983|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
48360164|NCT01646177|155513984|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
48360165|NCT01646177|155513985|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360166|NCT01646177|155513986|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360167|NCT01646177|155513987|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360168|NCT01646177|155513988|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360169|NCT01646177|155513989|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360170|NCT01646177|155513990|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360171|NCT01646177|155513991|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360172|NCT01646177|155513992|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360173|NCT01646177|155513993|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
48360174|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48360175|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48360176|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48360177|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48360178|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
48360179|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
48360180|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
48360181|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
48360182|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48360183|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48360184|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48360185|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
48360186|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48360187|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48360188|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48360189|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48360190|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
48360191|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
48360192|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
48360193|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
48360194|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48360195|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48360196|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48360197|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
48360198|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48360199|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48360200|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48360201|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48360202|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
48360203|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
48360204|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
48360205|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
48360206|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48360207|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48360208|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48360209|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
48360210|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48360211|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48360212|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48360213|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48360214|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
48360215|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
48360216|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
48360217|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
48360218|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48360219|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48360220|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48360221|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
48360222|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48360223|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48360224|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48360225|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48360226|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
48360227|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
48360228|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
48360229|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
48360230|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48360231|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48360232|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48360233|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
48360234|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360235|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360236|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360237|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360238|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
48360239|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
48360240|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360241|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
48360242|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360243|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360244|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360245|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
48360246|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48360247|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48360248|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48360249|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48360250|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
48360251|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
48360252|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
48360253|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
48360254|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48360255|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48360256|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48360257|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
48360258|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
48360259|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
48360260|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
48360261|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
48360262|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
48360263|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
48360264|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
48360265|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
48360266|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
48360267|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
48360268|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
48360269|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
48360270|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48360271|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48360272|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48360273|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48360274|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
48360275|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
48360276|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
48360277|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
48360278|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48360279|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48360280|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48360281|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
48360282|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360283|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360284|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360285|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360286|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360287|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360288|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360289|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
48360290|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360291|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360292|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360293|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
48360294|NCT01646177|155513982|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360295|NCT01646177|155513983|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360296|NCT01646177|155513984|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360297|NCT01646177|155513985|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360298|NCT01646177|155513986|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360299|NCT01646177|155513987|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
48360300|NCT01646177|155513988|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
48360301|NCT01646177|155513989|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
48360302|NCT01646177|155513990|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360303|NCT01646177|155513991|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360304|NCT01646177|155513992|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360305|NCT01646177|155513993|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
48360306|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48360307|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48360308|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48360309|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48360310|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48360311|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48360312|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48360313|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
48360314|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
48360315|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
48360316|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
48360317|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
48360318|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48360319|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48360320|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48360321|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48360322|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48360323|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48360324|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48360325|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
48360326|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
48360327|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
48360328|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
48360329|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
48360330|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48360331|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48360332|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48360333|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48360334|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48360335|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48360336|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48360337|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
48360338|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
48360339|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
48360340|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
48360341|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
48360342|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48360343|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48360344|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48360345|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48360346|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48360347|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48360348|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48360349|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
48360350|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
48360351|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
48360352|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
48412168|NCT00868790|155696908|FG005|Period 2|Withdrawal by Subject|0|||
48412169|NCT00868790|155696909|FG006|Period 2|Withdrawal by Subject|0|||
48412170|NCT00868790|155696910|FG007|Period 2|Withdrawal by Subject|0|||
48412171|NCT00868790|155696911|FG008|Period 2|Withdrawal by Subject|1|||
48412172|NCT00868790|155696912|FG009|Period 2|Withdrawal by Subject|0|||
48412173|NCT00868790|155696913|FG010|Period 2|Withdrawal by Subject|0|||
48412174|NCT00868790|155696914|FG011|Period 2|Withdrawal by Subject|0|||
48412175|NCT00868790|155696915|FG012|Period 2|Withdrawal by Subject|0|||
48412176|NCT00868790|155696916|FG013|Period 2|Withdrawal by Subject|1|||
48412177|NCT00868790|155696903|FG000|Period 3|Adverse Event|0|||
48412178|NCT00868790|155696904|FG001|Period 3|Adverse Event|0|||
48412179|NCT00868790|155696905|FG002|Period 3|Adverse Event|0|||
48412180|NCT00868790|155696906|FG003|Period 3|Adverse Event|0|||
48412181|NCT00868790|155696907|FG004|Period 3|Adverse Event|0|||
48412182|NCT00868790|155696908|FG005|Period 3|Adverse Event|0|||
48412183|NCT00868790|155696909|FG006|Period 3|Adverse Event|0|||
48412184|NCT00868790|155696910|FG007|Period 3|Adverse Event|0|||
48412185|NCT00868790|155696911|FG008|Period 3|Adverse Event|0|||
48412186|NCT00868790|155696912|FG009|Period 3|Adverse Event|1|||
48412187|NCT00868790|155696913|FG010|Period 3|Adverse Event|0|||
48412188|NCT00868790|155696914|FG011|Period 3|Adverse Event|0|||
48412189|NCT00868790|155696915|FG012|Period 3|Adverse Event|0|||
48412190|NCT00868790|155696916|FG013|Period 3|Adverse Event|0|||
48412191|NCT00868790|155696903|FG000|Period 3|Protocol Violation|0|||
48412192|NCT00868790|155696904|FG001|Period 3|Protocol Violation|0|||
48412193|NCT00868790|155696905|FG002|Period 3|Protocol Violation|0|||
48412194|NCT00868790|155696906|FG003|Period 3|Protocol Violation|0|||
48412195|NCT00868790|155696907|FG004|Period 3|Protocol Violation|0|||
48412196|NCT00868790|155696908|FG005|Period 3|Protocol Violation|0|||
48412197|NCT00868790|155696909|FG006|Period 3|Protocol Violation|0|||
48412198|NCT00868790|155696910|FG007|Period 3|Protocol Violation|0|||
48412199|NCT00868790|155696911|FG008|Period 3|Protocol Violation|0|||
48412200|NCT00868790|155696912|FG009|Period 3|Protocol Violation|0|||
48412201|NCT00868790|155696913|FG010|Period 3|Protocol Violation|1|||
48412202|NCT00868790|155696914|FG011|Period 3|Protocol Violation|0|||
48412203|NCT00868790|155696915|FG012|Period 3|Protocol Violation|0|||
48412204|NCT00868790|155696916|FG013|Period 3|Protocol Violation|0|||
48412205|NCT00868790|155696903|FG000|Period 3|Study Terminated by Sponsor|0|||
48412206|NCT00868790|155696904|FG001|Period 3|Study Terminated by Sponsor|0|||
48412207|NCT00868790|155696905|FG002|Period 3|Study Terminated by Sponsor|0|||
48412208|NCT00868790|155696906|FG003|Period 3|Study Terminated by Sponsor|1|||
48412209|NCT00868790|155696907|FG004|Period 3|Study Terminated by Sponsor|0|||
48412210|NCT00868790|155696908|FG005|Period 3|Study Terminated by Sponsor|0|||
48412211|NCT00868790|155696909|FG006|Period 3|Study Terminated by Sponsor|0|||
48412212|NCT00868790|155696910|FG007|Period 3|Study Terminated by Sponsor|0|||
48412213|NCT00868790|155696911|FG008|Period 3|Study Terminated by Sponsor|0|||
48412214|NCT00868790|155696912|FG009|Period 3|Study Terminated by Sponsor|0|||
48412215|NCT00868790|155696913|FG010|Period 3|Study Terminated by Sponsor|0|||
48412216|NCT00868790|155696914|FG011|Period 3|Study Terminated by Sponsor|0|||
48412217|NCT00868790|155696915|FG012|Period 3|Study Terminated by Sponsor|0|||
48412218|NCT00868790|155696916|FG013|Period 3|Study Terminated by Sponsor|0|||
48412219|NCT00868790|155696903|FG000|Period 4|Adverse Event|0|||
48412220|NCT00868790|155696904|FG001|Period 4|Adverse Event|0|||
48412221|NCT00868790|155696905|FG002|Period 4|Adverse Event|0|||
48412222|NCT00868790|155696906|FG003|Period 4|Adverse Event|0|||
48412223|NCT00868790|155696907|FG004|Period 4|Adverse Event|0|||
48412224|NCT00868790|155696908|FG005|Period 4|Adverse Event|0|||
48412225|NCT00868790|155696909|FG006|Period 4|Adverse Event|0|||
48412226|NCT00868790|155696910|FG007|Period 4|Adverse Event|1|||
48412227|NCT00868790|155696911|FG008|Period 4|Adverse Event|0|||
48412228|NCT00868790|155696912|FG009|Period 4|Adverse Event|0|||
48412229|NCT00868790|155696913|FG010|Period 4|Adverse Event|1|||
48412230|NCT00868790|155696914|FG011|Period 4|Adverse Event|0|||
48412231|NCT00868790|155696915|FG012|Period 4|Adverse Event|1|||
48412232|NCT00868790|155696916|FG013|Period 4|Adverse Event|0|||
48412233|NCT00868790|155696903|FG000|Period 4|Lost to Follow-up|0|||
48412234|NCT00868790|155696904|FG001|Period 4|Lost to Follow-up|0|||
48412235|NCT00868790|155696905|FG002|Period 4|Lost to Follow-up|0|||
48412236|NCT00868790|155696906|FG003|Period 4|Lost to Follow-up|0|||
48412237|NCT00868790|155696907|FG004|Period 4|Lost to Follow-up|0|||
48412238|NCT00868790|155696908|FG005|Period 4|Lost to Follow-up|0|||
48412239|NCT00868790|155696909|FG006|Period 4|Lost to Follow-up|0|||
48412240|NCT00868790|155696910|FG007|Period 4|Lost to Follow-up|1|||
48412241|NCT00868790|155696911|FG008|Period 4|Lost to Follow-up|0|||
48412242|NCT00868790|155696912|FG009|Period 4|Lost to Follow-up|0|||
48412243|NCT00868790|155696913|FG010|Period 4|Lost to Follow-up|0|||
48412244|NCT00868790|155696914|FG011|Period 4|Lost to Follow-up|0|||
48412245|NCT00868790|155696915|FG012|Period 4|Lost to Follow-up|0|||
48412246|NCT00868790|155696916|FG013|Period 4|Lost to Follow-up|0|||
48412247|NCT00868790|155696903|FG000|Period 4|Study Terminated by Sponsor|2|||
48412248|NCT00868790|155696904|FG001|Period 4|Study Terminated by Sponsor|0|||
48412249|NCT00868790|155696905|FG002|Period 4|Study Terminated by Sponsor|0|||
48412250|NCT00868790|155696906|FG003|Period 4|Study Terminated by Sponsor|0|||
48412251|NCT00868790|155696907|FG004|Period 4|Study Terminated by Sponsor|0|||
48412252|NCT00868790|155696908|FG005|Period 4|Study Terminated by Sponsor|0|||
48412253|NCT00868790|155696909|FG006|Period 4|Study Terminated by Sponsor|0|||
48412254|NCT00868790|155696910|FG007|Period 4|Study Terminated by Sponsor|1|||
48412255|NCT00868790|155696911|FG008|Period 4|Study Terminated by Sponsor|2|||
48412256|NCT00868790|155696912|FG009|Period 4|Study Terminated by Sponsor|0|||
48412257|NCT00868790|155696913|FG010|Period 4|Study Terminated by Sponsor|2|||
48412258|NCT00868790|155696914|FG011|Period 4|Study Terminated by Sponsor|1|||
48412259|NCT00868790|155696915|FG012|Period 4|Study Terminated by Sponsor|0|||
48412260|NCT00868790|155696916|FG013|Period 4|Study Terminated by Sponsor|1|||
48412261|NCT00868790|155696903|FG000|Period 4|Abnormal ALT/AST|0|||
48412262|NCT00868790|155696904|FG001|Period 4|Abnormal ALT/AST|0|||
48412263|NCT00868790|155696905|FG002|Period 4|Abnormal ALT/AST|1|||
48412264|NCT00868790|155696906|FG003|Period 4|Abnormal ALT/AST|0|||
48412265|NCT00868790|155696907|FG004|Period 4|Abnormal ALT/AST|0|||
48412266|NCT00868790|155696908|FG005|Period 4|Abnormal ALT/AST|0|||
48412267|NCT00868790|155696909|FG006|Period 4|Abnormal ALT/AST|0|||
48412268|NCT00868790|155696910|FG007|Period 4|Abnormal ALT/AST|0|||
48412269|NCT00868790|155696911|FG008|Period 4|Abnormal ALT/AST|0|||
48412270|NCT00868790|155696912|FG009|Period 4|Abnormal ALT/AST|0|||
48412271|NCT00868790|155696913|FG010|Period 4|Abnormal ALT/AST|0|||
48412272|NCT00868790|155696914|FG011|Period 4|Abnormal ALT/AST|0|||
48412273|NCT00868790|155696915|FG012|Period 4|Abnormal ALT/AST|0|||
48412274|NCT00868790|155696916|FG013|Period 4|Abnormal ALT/AST|0|||
48412275|NCT00868790|155696903|FG000|Post-study|Withdrawal by Subject|0|||
48412276|NCT00868790|155696904|FG001|Post-study|Withdrawal by Subject|0|||
48412277|NCT00868790|155696905|FG002|Post-study|Withdrawal by Subject|0|||
48412278|NCT00868790|155696906|FG003|Post-study|Withdrawal by Subject|0|||
48412279|NCT00868790|155696907|FG004|Post-study|Withdrawal by Subject|1|||
48412280|NCT00868790|155696908|FG005|Post-study|Withdrawal by Subject|0|||
48412281|NCT00868790|155696909|FG006|Post-study|Withdrawal by Subject|0|||
48412282|NCT00868790|155696910|FG007|Post-study|Withdrawal by Subject|0|||
48412283|NCT00868790|155696911|FG008|Post-study|Withdrawal by Subject|0|||
48412284|NCT00868790|155696912|FG009|Post-study|Withdrawal by Subject|0|||
48412285|NCT00868790|155696913|FG010|Post-study|Withdrawal by Subject|0|||
48412286|NCT00868790|155696914|FG011|Post-study|Withdrawal by Subject|0|||
48412287|NCT00868790|155696915|FG012|Post-study|Withdrawal by Subject|0|||
48412288|NCT00868790|155696916|FG013|Post-study|Withdrawal by Subject|0|||
48412289|NCT00868790|155696903|FG000|Post-study|Excluded Medication|0|||
48412290|NCT00868790|155696904|FG001|Post-study|Excluded Medication|0|||
48412291|NCT00868790|155696905|FG002|Post-study|Excluded Medication|0|||
48412292|NCT00868790|155696906|FG003|Post-study|Excluded Medication|0|||
48412293|NCT00868790|155696907|FG004|Post-study|Excluded Medication|0|||
48412294|NCT00868790|155696908|FG005|Post-study|Excluded Medication|0|||
48412295|NCT00868790|155696909|FG006|Post-study|Excluded Medication|0|||
48412296|NCT00868790|155696910|FG007|Post-study|Excluded Medication|2|||
48412297|NCT00868790|155696911|FG008|Post-study|Excluded Medication|0|||
48412298|NCT00868790|155696912|FG009|Post-study|Excluded Medication|1|||
48412299|NCT00868790|155696913|FG010|Post-study|Excluded Medication|0|||
48412300|NCT00868790|155696914|FG011|Post-study|Excluded Medication|0|||
48412301|NCT00868790|155696915|FG012|Post-study|Excluded Medication|0|||
48412302|NCT00868790|155696916|FG013|Post-study|Excluded Medication|0|||
48412303|NCT03068715|155696917|FG000|Overall Study|No longer met inclusion criteria|1|||
48412304|NCT03068715|155696918|FG001|Overall Study|No longer met inclusion criteria|0|||
48412305|NCT03403400|155696919|FG000|Overall Study|Lost to Follow-up|1|||
48412306|NCT03403400|155696920|FG001|Overall Study|Lost to Follow-up|0|||
48412307|NCT03403400|155696921|FG002|Overall Study|Lost to Follow-up|1|||
48412308|NCT03403400|155696919|FG000|Overall Study|Hospitalization|1|||
48412309|NCT03403400|155696920|FG001|Overall Study|Hospitalization|0|||
48412310|NCT03403400|155696921|FG002|Overall Study|Hospitalization|0|||
48412311|NCT03403400|155696919|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
48412312|NCT03403400|155696920|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
48412313|NCT03403400|155696921|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
48412314|NCT00737529|155696928|FG000|Overall Study|Disease Progression|95|||
48412315|NCT00737529|155696928|FG000|Overall Study|Adverse Event|24|||
48412316|NCT00737529|155696928|FG000|Overall Study|Withdrawal by Subject|5|||
48412317|NCT00737529|155696928|FG000|Overall Study|Death|4|||
48412318|NCT00737529|155696928|FG000|Overall Study|Protocol Violation|1|||
48412319|NCT00737529|155696928|FG000|Overall Study|Other|4|||
48412320|NCT04433117|155696929|FG000|Overall Study|Withdrawal by Subject|1|||
48412321|NCT04433117|155696930|FG001|Overall Study|Withdrawal by Subject|0|||
48412322|NCT00552110|155696931|FG000|Overall Study|Serious or Life-Threatening AE|0|||
48412323|NCT00552110|155696932|FG001|Overall Study|Serious or Life-Threatening AE|0|||
48412324|NCT00552110|155696933|FG002|Overall Study|Serious or Life-Threatening AE|1|||
48412325|NCT00552110|155696934|FG003|Overall Study|Serious or Life-Threatening AE|0|||
48412326|NCT00552110|155696935|FG004|Overall Study|Serious or Life-Threatening AE|0|||
48412327|NCT00552110|155696931|FG000|Overall Study|Lack of Efficacy|1|||
48412328|NCT00552110|155696932|FG001|Overall Study|Lack of Efficacy|0|||
48412329|NCT00552110|155696933|FG002|Overall Study|Lack of Efficacy|0|||
48412330|NCT00552110|155696934|FG003|Overall Study|Lack of Efficacy|1|||
48412331|NCT00552110|155696935|FG004|Overall Study|Lack of Efficacy|4|||
48412332|NCT00552110|155696931|FG000|Overall Study|Withdrawal by Subject|0|||
48412333|NCT00552110|155696932|FG001|Overall Study|Withdrawal by Subject|2|||
48412334|NCT00552110|155696933|FG002|Overall Study|Withdrawal by Subject|0|||
48412335|NCT00552110|155696934|FG003|Overall Study|Withdrawal by Subject|3|||
48412336|NCT00552110|155696935|FG004|Overall Study|Withdrawal by Subject|2|||
48412337|NCT00552110|155696931|FG000|Overall Study|Lost to Follow-up|0|||
48412338|NCT00552110|155696932|FG001|Overall Study|Lost to Follow-up|0|||
48412339|NCT00552110|155696933|FG002|Overall Study|Lost to Follow-up|0|||
48412340|NCT00552110|155696934|FG003|Overall Study|Lost to Follow-up|1|||
48412341|NCT00552110|155696935|FG004|Overall Study|Lost to Follow-up|1|||
48412342|NCT00552110|155696931|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
48412343|NCT00552110|155696932|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
48412344|NCT00552110|155696933|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
48412345|NCT00552110|155696934|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
48412346|NCT00552110|155696935|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
48412347|NCT00552110|155696931|FG000|Overall Study|Withdrawn per Sponsor|0|||
48412348|NCT00552110|155696932|FG001|Overall Study|Withdrawn per Sponsor|1|||
48412349|NCT00552110|155696933|FG002|Overall Study|Withdrawn per Sponsor|0|||
48412350|NCT00552110|155696934|FG003|Overall Study|Withdrawn per Sponsor|0|||
48412351|NCT00552110|155696935|FG004|Overall Study|Withdrawn per Sponsor|1|||
48360353|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
48360354|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48360355|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48360356|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48360357|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48360358|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48360359|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48360360|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48360361|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
48360362|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
48360363|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
48360364|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
48360365|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
48360366|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48360367|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48360368|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48360369|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48412352|NCT00552110|155696931|FG000|Overall Study|Use of Prohibited Medication|1|||
48412353|NCT00552110|155696932|FG001|Overall Study|Use of Prohibited Medication|1|||
48412354|NCT00552110|155696933|FG002|Overall Study|Use of Prohibited Medication|0|||
48412355|NCT00552110|155696934|FG003|Overall Study|Use of Prohibited Medication|0|||
48412356|NCT00552110|155696935|FG004|Overall Study|Use of Prohibited Medication|0|||
48412357|NCT00552110|155696931|FG000|Overall Study|Delay of Study due to Relabeling|0|||
48412358|NCT00552110|155696932|FG001|Overall Study|Delay of Study due to Relabeling|0|||
48412359|NCT00552110|155696933|FG002|Overall Study|Delay of Study due to Relabeling|0|||
48412360|NCT00552110|155696934|FG003|Overall Study|Delay of Study due to Relabeling|1|||
48412361|NCT00552110|155696935|FG004|Overall Study|Delay of Study due to Relabeling|0|||
48412362|NCT00552110|155696931|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
48412363|NCT00552110|155696932|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
48412364|NCT00552110|155696933|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
48412365|NCT00552110|155696934|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
48412366|NCT00552110|155696935|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
48412367|NCT00552110|155696931|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
48412368|NCT00552110|155696932|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
48412369|NCT00552110|155696933|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
48360370|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48360371|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48360372|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48360373|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
48360374|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
48412370|NCT00552110|155696934|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
48412371|NCT00552110|155696935|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
48412372|NCT01628926|155696938|FG000|Overall Study|Adverse Event|13|||
48412373|NCT01628926|155696939|FG001|Overall Study|Adverse Event|11|||
48412374|NCT01628926|155696940|FG002|Overall Study|Adverse Event|9|||
48412375|NCT01628926|155696938|FG000|Overall Study|Lack of Efficacy|2|||
48412376|NCT01628926|155696939|FG001|Overall Study|Lack of Efficacy|1|||
48360375|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
48360376|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
48360377|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
48360378|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48360379|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48360380|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48360381|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48412377|NCT01628926|155696940|FG002|Overall Study|Lack of Efficacy|5|||
48412378|NCT01628926|155696938|FG000|Overall Study|Withdrawal by Subject|6|||
48412379|NCT01628926|155696939|FG001|Overall Study|Withdrawal by Subject|4|||
48360382|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48360383|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48360384|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48360385|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48360386|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
48360387|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
48360388|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
48692555|NCT02322281|156724525|FG002|Overall Study|Missing|1|||
48692556|NCT02322281|156724523|FG000|Overall Study|Miscellaneous|0|||
48692557|NCT02322281|156724524|FG001|Overall Study|Miscellaneous|0|||
48360389|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
48360390|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360391|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360392|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360393|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360394|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360395|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360396|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360397|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360398|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
48360399|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
48360400|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
48360401|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
48360402|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360403|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360404|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360405|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360406|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360407|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360408|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360409|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360410|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
48360411|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
48360412|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
48360413|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
48360414|NCT01646177|155513982|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360415|NCT01646177|155513983|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360416|NCT01646177|155513984|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360417|NCT01646177|155513985|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360418|NCT01646177|155513986|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360419|NCT01646177|155513987|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360420|NCT01646177|155513988|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360421|NCT01646177|155513989|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360422|NCT01646177|155513990|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360423|NCT01646177|155513991|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
48360424|NCT01646177|155513992|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
48360425|NCT01646177|155513993|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
48360426|NCT02807272|155513995|FG000|Overall Study|Death|9|||
48360427|NCT02807272|155513996|FG001|Overall Study|Death|5|||
48360428|NCT02807272|155513997|FG002|Overall Study|Death|2|||
48360429|NCT02807272|155513998|FG003|Overall Study|Death|0|||
48360430|NCT02807272|155513999|FG004|Overall Study|Death|1|||
48360431|NCT02807272|155513995|FG000|Overall Study|Lost to Follow-up|1|||
48360432|NCT02807272|155513996|FG001|Overall Study|Lost to Follow-up|0|||
48412380|NCT01628926|155696940|FG002|Overall Study|Withdrawal by Subject|2|||
48360433|NCT02807272|155513997|FG002|Overall Study|Lost to Follow-up|0|||
48360434|NCT02807272|155513998|FG003|Overall Study|Lost to Follow-up|0|||
48360435|NCT02807272|155513999|FG004|Overall Study|Lost to Follow-up|0|||
48360436|NCT02807272|155513995|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
48360437|NCT02807272|155513996|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
48360438|NCT02807272|155513997|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
48360439|NCT02807272|155513998|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
48360440|NCT02807272|155513999|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
48360441|NCT02807272|155513995|FG000|Overall Study|Protocol-defined Disease Progression|0|||
48360442|NCT02807272|155513996|FG001|Overall Study|Protocol-defined Disease Progression|1|||
48360443|NCT02807272|155513997|FG002|Overall Study|Protocol-defined Disease Progression|0|||
48360444|NCT02807272|155513998|FG003|Overall Study|Protocol-defined Disease Progression|0|||
48360445|NCT02807272|155513999|FG004|Overall Study|Protocol-defined Disease Progression|1|||
48360446|NCT02807272|155513995|FG000|Overall Study|Study Terminated by Sponsor|1|||
48360447|NCT02807272|155513996|FG001|Overall Study|Study Terminated by Sponsor|0|||
48360448|NCT02807272|155513997|FG002|Overall Study|Study Terminated by Sponsor|0|||
48360449|NCT02807272|155513998|FG003|Overall Study|Study Terminated by Sponsor|1|||
48360450|NCT02807272|155513999|FG004|Overall Study|Study Terminated by Sponsor|0|||
48360451|NCT02807272|155513995|FG000|Overall Study|Other|1|||
48360452|NCT02807272|155513996|FG001|Overall Study|Other|0|||
48360453|NCT02807272|155513997|FG002|Overall Study|Other|0|||
48360454|NCT02807272|155513998|FG003|Overall Study|Other|0|||
48360455|NCT02807272|155513999|FG004|Overall Study|Other|1|||
48360456|NCT00820170|155514008|FG000|Overall Study|Adverse Event|0|||
48360457|NCT00820170|155514009|FG001|Overall Study|Adverse Event|0|||
48360458|NCT00820170|155514010|FG002|Overall Study|Adverse Event|0|||
48360459|NCT00820170|155514011|FG003|Overall Study|Adverse Event|0|||
48360460|NCT00820170|155514012|FG004|Overall Study|Adverse Event|2|||
48360461|NCT00820170|155514008|FG000|Overall Study|Progressive Disease|0|||
48360462|NCT00820170|155514009|FG001|Overall Study|Progressive Disease|0|||
48360463|NCT00820170|155514010|FG002|Overall Study|Progressive Disease|0|||
48360464|NCT00820170|155514011|FG003|Overall Study|Progressive Disease|0|||
48360465|NCT00820170|155514012|FG004|Overall Study|Progressive Disease|2|||
48587197|NCT01004432|156343158|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
48587198|NCT01004432|156343159|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
48587199|NCT01004432|156343155|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
48587200|NCT01004432|156343156|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
48692558|NCT02322281|156724525|FG002|Overall Study|Miscellaneous|4|||
48360472|NCT00902746|155514022|FG000|Overall Study|Protocol Violation|7|||
48360473|NCT00902746|155514022|FG000|Overall Study|Withdrawal by Subject|16|||
48360474|NCT00902746|155514022|FG000|Overall Study|Adverse Event|8|||
48360475|NCT00902746|155514022|FG000|Overall Study|Lost to Follow-up|3|||
48360476|NCT00902746|155514022|FG000|Overall Study|Physician Decision|2|||
48360477|NCT00755105|155514025|FG000|Overall Study|Withdrawal by Subject|9|||
48360478|NCT00755105|155514026|FG001|Overall Study|Withdrawal by Subject|11|||
48360479|NCT00755105|155514027|FG002|Overall Study|Withdrawal by Subject|4|||
48360480|NCT01277887|155514029|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
48360481|NCT01277887|155514030|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
48360482|NCT01277887|155514029|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
48360483|NCT01277887|155514030|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
48360484|NCT01277887|155514029|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
48360485|NCT01277887|155514030|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
48360486|NCT02416453|155514031|FG000|Overall Study|Adverse Event|0|||
48360487|NCT02416453|155514032|FG001|Overall Study|Adverse Event|0|||
48360488|NCT02416453|155514033|FG002|Overall Study|Adverse Event|0|||
48360489|NCT02416453|155514034|FG003|Overall Study|Adverse Event|2|||
48360490|NCT02416453|155514035|FG004|Overall Study|Adverse Event|0|||
48360491|NCT02416453|155514036|FG005|Overall Study|Adverse Event|1|||
48360492|NCT02416453|155514037|FG006|Overall Study|Adverse Event|0|||
48360493|NCT02416453|155514038|FG007|Overall Study|Adverse Event|0|||
48360494|NCT02416453|155514039|FG008|Overall Study|Adverse Event|0|||
48360495|NCT02416453|155514040|FG009|Overall Study|Adverse Event|0|||
48360496|NCT02416453|155514041|FG010|Overall Study|Adverse Event|0|||
48360497|NCT02416453|155514031|FG000|Overall Study|Lost to Follow-up|1|||
48360498|NCT02416453|155514032|FG001|Overall Study|Lost to Follow-up|3|||
48360499|NCT02416453|155514033|FG002|Overall Study|Lost to Follow-up|0|||
48360500|NCT02416453|155514034|FG003|Overall Study|Lost to Follow-up|8|||
48360501|NCT02416453|155514035|FG004|Overall Study|Lost to Follow-up|0|||
48360502|NCT02416453|155514036|FG005|Overall Study|Lost to Follow-up|5|||
48360503|NCT02416453|155514037|FG006|Overall Study|Lost to Follow-up|1|||
48360504|NCT02416453|155514038|FG007|Overall Study|Lost to Follow-up|3|||
48360505|NCT02416453|155514039|FG008|Overall Study|Lost to Follow-up|1|||
48360506|NCT02416453|155514040|FG009|Overall Study|Lost to Follow-up|0|||
48360507|NCT02416453|155514041|FG010|Overall Study|Lost to Follow-up|0|||
48360508|NCT02416453|155514031|FG000|Overall Study|Physician Decision|0|||
48360509|NCT02416453|155514032|FG001|Overall Study|Physician Decision|0|||
48360510|NCT02416453|155514033|FG002|Overall Study|Physician Decision|0|||
48360511|NCT02416453|155514034|FG003|Overall Study|Physician Decision|0|||
48360512|NCT02416453|155514035|FG004|Overall Study|Physician Decision|0|||
48360513|NCT02416453|155514036|FG005|Overall Study|Physician Decision|1|||
48360514|NCT02416453|155514037|FG006|Overall Study|Physician Decision|1|||
48360515|NCT02416453|155514038|FG007|Overall Study|Physician Decision|1|||
48360516|NCT02416453|155514039|FG008|Overall Study|Physician Decision|0|||
48360517|NCT02416453|155514040|FG009|Overall Study|Physician Decision|0|||
48360518|NCT02416453|155514041|FG010|Overall Study|Physician Decision|0|||
48360519|NCT02416453|155514031|FG000|Overall Study|Withdrawal by Subject|2|||
48360520|NCT02416453|155514032|FG001|Overall Study|Withdrawal by Subject|0|||
48360521|NCT02416453|155514033|FG002|Overall Study|Withdrawal by Subject|0|||
48360522|NCT02416453|155514034|FG003|Overall Study|Withdrawal by Subject|5|||
48360523|NCT02416453|155514035|FG004|Overall Study|Withdrawal by Subject|1|||
48360524|NCT02416453|155514036|FG005|Overall Study|Withdrawal by Subject|8|||
48360525|NCT02416453|155514037|FG006|Overall Study|Withdrawal by Subject|0|||
48360526|NCT02416453|155514038|FG007|Overall Study|Withdrawal by Subject|8|||
48360527|NCT02416453|155514039|FG008|Overall Study|Withdrawal by Subject|4|||
48360528|NCT02416453|155514040|FG009|Overall Study|Withdrawal by Subject|0|||
48360529|NCT02416453|155514041|FG010|Overall Study|Withdrawal by Subject|0|||
48360530|NCT02416453|155514031|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360531|NCT02416453|155514032|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360532|NCT02416453|155514033|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
48360533|NCT02416453|155514034|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360534|NCT02416453|155514035|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360535|NCT02416453|155514036|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360536|NCT02416453|155514037|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360537|NCT02416453|155514038|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360538|NCT02416453|155514039|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360539|NCT02416453|155514040|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360540|NCT02416453|155514041|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
48360541|NCT02416453|155514031|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360542|NCT02416453|155514032|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360543|NCT02416453|155514033|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360544|NCT02416453|155514034|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360545|NCT02416453|155514035|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360546|NCT02416453|155514036|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
48360547|NCT02416453|155514037|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360548|NCT02416453|155514038|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360549|NCT02416453|155514039|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360550|NCT02416453|155514040|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360551|NCT02416453|155514041|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
48360552|NCT00368927|155514042|FG000|Overall Study|Lost to Follow-up|2|||
48360553|NCT00368927|155514043|FG001|Overall Study|Lost to Follow-up|0|||
48360554|NCT00368927|155514042|FG000|Overall Study|Adverse Event|1|||
48360555|NCT00368927|155514043|FG001|Overall Study|Adverse Event|1|||
48360556|NCT00368927|155514042|FG000|Overall Study|Withdrawal by Subject|1|||
48360557|NCT00368927|155514043|FG001|Overall Study|Withdrawal by Subject|2|||
48360558|NCT00368927|155514042|FG000|Overall Study|Physician Decision|1|||
48360559|NCT00368927|155514043|FG001|Overall Study|Physician Decision|0|||
48360560|NCT04145700|155514049|FG000|Overall Study|Withdrawal by Subject|8|||
48360561|NCT04145700|155514050|FG001|Overall Study|Withdrawal by Subject|3|||
48360562|NCT01259089|155514051|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48360563|NCT01259089|155514052|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48360564|NCT01259089|155514053|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48360565|NCT01259089|155514054|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48360566|NCT01259089|155514055|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
48360567|NCT01259089|155514056|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
48360568|NCT01259089|155514051|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
48360569|NCT01259089|155514052|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
48360570|NCT01259089|155514053|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
48360571|NCT01259089|155514054|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
48360572|NCT01259089|155514055|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
48360573|NCT01259089|155514056|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
48360574|NCT01259089|155514051|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48360575|NCT01259089|155514052|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48360576|NCT01259089|155514053|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48360577|NCT01259089|155514054|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48360578|NCT01259089|155514055|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
48360579|NCT01259089|155514056|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
48360580|NCT01259089|155514051|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
48360581|NCT01259089|155514052|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
48360582|NCT01259089|155514053|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
48360583|NCT01259089|155514054|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
48360584|NCT01259089|155514055|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
48360585|NCT01259089|155514056|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
48360586|NCT01259089|155514051|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
48412381|NCT01628926|155696938|FG000|Overall Study|Protocol Violation|0|||
48412382|NCT01628926|155696939|FG001|Overall Study|Protocol Violation|1|||
48412383|NCT01628926|155696940|FG002|Overall Study|Protocol Violation|0|||
48412384|NCT01628926|155696938|FG000|Overall Study|Discontinuation criteria|3|||
48412385|NCT01628926|155696939|FG001|Overall Study|Discontinuation criteria|4|||
48412386|NCT01628926|155696940|FG002|Overall Study|Discontinuation criteria|0|||
48412387|NCT01628926|155696938|FG000|Overall Study|Physician Decision|2|||
48412388|NCT01628926|155696939|FG001|Overall Study|Physician Decision|2|||
48412389|NCT01628926|155696940|FG002|Overall Study|Physician Decision|1|||
48412390|NCT02700451|155696941|FG000|Overall Study|Protocol Violation|2|||
48412391|NCT02700451|155696942|FG001|Overall Study|Protocol Violation|2|||
48412392|NCT02700451|155696943|FG002|Overall Study|Protocol Violation|3|||
48412393|NCT02700451|155696941|FG000|Overall Study|Discontinued intervention|14|||
48412394|NCT02700451|155696942|FG001|Overall Study|Discontinued intervention|15|||
48412395|NCT02700451|155696943|FG002|Overall Study|Discontinued intervention|14|||
48412396|NCT00454207|155696944|FG000|Overall Study|Adverse Event|3|||
48412397|NCT00454207|155696945|FG001|Overall Study|Adverse Event|1|||
48412398|NCT00454207|155696944|FG000|Overall Study|Lack of Efficacy|1|||
48412399|NCT00454207|155696945|FG001|Overall Study|Lack of Efficacy|0|||
48412400|NCT00454207|155696944|FG000|Overall Study|Protocol Violation|0|||
48412401|NCT00454207|155696945|FG001|Overall Study|Protocol Violation|1|||
48412402|NCT01672957|155696946|FG000|Overall Study|Protocol Violation|48|||
48412403|NCT01672957|155696946|FG000|Overall Study|Death|2|||
48412404|NCT01672957|155696946|FG000|Overall Study|ICF Signed After Transplantation|5|||
48412405|NCT02115308|155696948|FG000|Overall Study|Safety Screening|2|||
48412406|NCT02115308|155696949|FG001|Overall Study|Safety Screening|2|||
48360587|NCT01259089|155514052|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
48360588|NCT01259089|155514053|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
48360589|NCT01259089|155514054|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
48360590|NCT01259089|155514055|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
48360591|NCT01259089|155514056|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
48360592|NCT01259089|155514051|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
48360593|NCT01259089|155514052|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48360594|NCT01259089|155514053|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48360595|NCT01259089|155514054|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48360596|NCT01259089|155514055|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48360597|NCT01259089|155514056|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
48360598|NCT01259089|155514051|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
48360599|NCT01259089|155514052|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
48360600|NCT01259089|155514053|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
48360601|NCT01259089|155514054|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
48412407|NCT01889602|155696950|FG000|First Intervention|Adverse Event|1|||
48412408|NCT01889602|155696951|FG001|First Intervention|Adverse Event|1|||
48412409|NCT01889602|155696952|FG002|First Intervention|Adverse Event|1|||
48412410|NCT01889602|155696950|FG000|First Intervention|Protocol Violation|0|||
48412411|NCT01889602|155696951|FG001|First Intervention|Protocol Violation|1|||
48412412|NCT01889602|155696952|FG002|First Intervention|Protocol Violation|1|||
48412413|NCT01889602|155696950|FG000|First Intervention|Study ending|0|||
48412414|NCT01889602|155696951|FG001|First Intervention|Study ending|1|||
48412415|NCT01889602|155696952|FG002|First Intervention|Study ending|0|||
48412416|NCT01889602|155696950|FG000|Second Intervention|Adverse Event|0|||
48412417|NCT01889602|155696951|FG001|Second Intervention|Adverse Event|0|||
48412418|NCT01889602|155696952|FG002|Second Intervention|Adverse Event|1|||
48412419|NCT01889602|155696950|FG000|Second Intervention|Study ending|1|||
48412420|NCT01889602|155696951|FG001|Second Intervention|Study ending|0|||
48412421|NCT01889602|155696952|FG002|Second Intervention|Study ending|0|||
48412422|NCT01889602|155696950|FG000|Second Intervention|Withdrawal by Subject|0|||
48412423|NCT01889602|155696951|FG001|Second Intervention|Withdrawal by Subject|0|||
48412424|NCT01889602|155696952|FG002|Second Intervention|Withdrawal by Subject|1|||
48412425|NCT01889602|155696950|FG000|Third Intervention|Protocol Violation|1|||
48412426|NCT01889602|155696951|FG001|Third Intervention|Protocol Violation|0|||
48412427|NCT01889602|155696952|FG002|Third Intervention|Protocol Violation|0|||
48412428|NCT01889602|155696950|FG000|Third Intervention|Withdrawal by Subject|2|||
48360602|NCT01259089|155514055|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
48360603|NCT01259089|155514056|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
48412429|NCT01889602|155696951|FG001|Third Intervention|Withdrawal by Subject|2|||
48412430|NCT01889602|155696952|FG002|Third Intervention|Withdrawal by Subject|0|||
48412431|NCT00961961|155696953|FG000|Phase I|Withdrawal by Subject|7|||
48412432|NCT00961961|155696954|FG001|Phase I|Withdrawal by Subject|0|||
48412433|NCT00961961|155696955|FG002|Phase I|Withdrawal by Subject|0|||
48412434|NCT00961961|155696956|FG003|Phase I|Withdrawal by Subject|0|||
48412435|NCT00961961|155696953|FG000|Phase I|Lost to Follow-up|10|||
48360604|NCT01259089|155514051|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
48412436|NCT00961961|155696954|FG001|Phase I|Lost to Follow-up|0|||
48412437|NCT00961961|155696955|FG002|Phase I|Lost to Follow-up|0|||
48360605|NCT01259089|155514052|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
48412438|NCT00961961|155696956|FG003|Phase I|Lost to Follow-up|0|||
48412439|NCT00961961|155696953|FG000|Phase I|Lack of Efficacy|94|||
48412440|NCT00961961|155696954|FG001|Phase I|Lack of Efficacy|0|||
48412441|NCT00961961|155696955|FG002|Phase I|Lack of Efficacy|0|||
48412442|NCT00961961|155696956|FG003|Phase I|Lack of Efficacy|0|||
48412443|NCT00961961|155696953|FG000|Phase I|Adverse Event|7|||
48412444|NCT00961961|155696954|FG001|Phase I|Adverse Event|0|||
48412445|NCT00961961|155696955|FG002|Phase I|Adverse Event|0|||
48412446|NCT00961961|155696956|FG003|Phase I|Adverse Event|0|||
48412447|NCT00961961|155696953|FG000|Phase I|Physician Decision|8|||
48412448|NCT00961961|155696954|FG001|Phase I|Physician Decision|0|||
48412449|NCT00961961|155696955|FG002|Phase I|Physician Decision|0|||
48412450|NCT00961961|155696956|FG003|Phase I|Physician Decision|0|||
48360606|NCT01259089|155514053|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
48360607|NCT01259089|155514054|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
48360608|NCT01259089|155514055|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
48360609|NCT01259089|155514056|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
48360610|NCT01259089|155514051|FG000|Survival Follow up for Two Years|Death|3|||
48360611|NCT01259089|155514052|FG001|Survival Follow up for Two Years|Death|2|||
48360612|NCT01259089|155514053|FG002|Survival Follow up for Two Years|Death|2|||
48360613|NCT01259089|155514054|FG003|Survival Follow up for Two Years|Death|3|||
48360614|NCT01259089|155514055|FG004|Survival Follow up for Two Years|Death|6|||
48360615|NCT01259089|155514056|FG005|Survival Follow up for Two Years|Death|13|||
48360616|NCT01259089|155514051|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
48360617|NCT01259089|155514052|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
48360618|NCT01259089|155514053|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
48360619|NCT01259089|155514054|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
48360620|NCT01259089|155514055|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
48360621|NCT01259089|155514056|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
48360622|NCT01259089|155514051|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48360623|NCT01259089|155514052|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48360624|NCT01259089|155514053|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48360625|NCT01259089|155514054|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48360626|NCT01259089|155514055|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
48360627|NCT01259089|155514056|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
48360628|NCT01245374|155514061|FG000|Overall Study|Protocol Violation|1|||
48360629|NCT01245374|155514061|FG000|Overall Study|Withdrawal by Subject|3|||
48360630|NCT01840410|155514062|FG000|Overall Study|Physician Decision|1|||
48360631|NCT01840410|155514063|FG001|Overall Study|Physician Decision|2|||
48412451|NCT00961961|155696953|FG000|Phase II|Lost to Follow-up|0|||
48412452|NCT00961961|155696954|FG001|Phase II|Lost to Follow-up|0|||
48412453|NCT00961961|155696955|FG002|Phase II|Lost to Follow-up|10|||
48412454|NCT00961961|155696956|FG003|Phase II|Lost to Follow-up|7|||
48412455|NCT00961961|155696953|FG000|Phase II|Adverse Event|0|||
48360632|NCT01840410|155514062|FG000|Overall Study|Pregnancy|1|||
48360633|NCT01840410|155514063|FG001|Overall Study|Pregnancy|0|||
48360634|NCT01840410|155514062|FG000|Overall Study|Protocol deviation|1|||
48360635|NCT01840410|155514063|FG001|Overall Study|Protocol deviation|0|||
48360636|NCT01840410|155514062|FG000|Overall Study|Lost to Follow-up|1|||
48360637|NCT01840410|155514063|FG001|Overall Study|Lost to Follow-up|0|||
48360638|NCT01840410|155514062|FG000|Overall Study|Withdrawal by Subject|2|||
48412456|NCT00961961|155696954|FG001|Phase II|Adverse Event|0|||
48412457|NCT00961961|155696955|FG002|Phase II|Adverse Event|0|||
48412458|NCT00961961|155696956|FG003|Phase II|Adverse Event|1|||
48412459|NCT00961961|155696953|FG000|Phase II|Physician Decision|0|||
48412460|NCT00961961|155696954|FG001|Phase II|Physician Decision|0|||
48412461|NCT00961961|155696955|FG002|Phase II|Physician Decision|1|||
48412462|NCT00961961|155696956|FG003|Phase II|Physician Decision|0|||
48360639|NCT01840410|155514063|FG001|Overall Study|Withdrawal by Subject|1|||
48412463|NCT00961961|155696953|FG000|Phase II|Withdrawal by Subject|0|||
48412464|NCT00961961|155696954|FG001|Phase II|Withdrawal by Subject|0|||
48412465|NCT00961961|155696955|FG002|Phase II|Withdrawal by Subject|1|||
48412466|NCT00961961|155696956|FG003|Phase II|Withdrawal by Subject|0|||
48412467|NCT00404092|155696957|FG000|Overall Study|Death|1|||
48412468|NCT00404092|155696958|FG001|Overall Study|Death|0|||
48360640|NCT01840410|155514062|FG000|Overall Study|Adverse Event|1|||
48360641|NCT01840410|155514063|FG001|Overall Study|Adverse Event|1|||
48412469|NCT00404092|155696959|FG002|Overall Study|Death|0|||
48360642|NCT01747551|155514064|FG000|Overall Study|Progressive Disease|24|||
48360643|NCT01747551|155514065|FG001|Overall Study|Progressive Disease|17|||
48360644|NCT01747551|155514064|FG000|Overall Study|Death|3|||
48412470|NCT00404092|155696960|FG003|Overall Study|Death|0|||
48412471|NCT00404092|155696957|FG000|Overall Study|Adverse Event|0|||
48412472|NCT00404092|155696958|FG001|Overall Study|Adverse Event|0|||
48412473|NCT00404092|155696959|FG002|Overall Study|Adverse Event|1|||
48360645|NCT01747551|155514065|FG001|Overall Study|Death|1|||
48412474|NCT00404092|155696960|FG003|Overall Study|Adverse Event|0|||
48360646|NCT01747551|155514064|FG000|Overall Study|Adverse Event|7|||
48360647|NCT01747551|155514065|FG001|Overall Study|Adverse Event|1|||
48360648|NCT01747551|155514064|FG000|Overall Study|Prolonged Treatment Delay|2|||
48360649|NCT01747551|155514065|FG001|Overall Study|Prolonged Treatment Delay|0|||
48360650|NCT01747551|155514064|FG000|Overall Study|Withdrawal by Subject|3|||
48360651|NCT01747551|155514065|FG001|Overall Study|Withdrawal by Subject|1|||
48360652|NCT01747551|155514064|FG000|Overall Study|Physician Decision|2|||
48360653|NCT01747551|155514065|FG001|Overall Study|Physician Decision|1|||
48360654|NCT01747551|155514064|FG000|Overall Study|Other|2|||
48360655|NCT01747551|155514065|FG001|Overall Study|Other|0|||
48360656|NCT01413503|155514066|FG000|Overall Study|Lost to Follow-up|1|||
48360657|NCT02406677|155514067|FG000|Overall Study|Death|16|||
48360658|NCT02406677|155514068|FG001|Overall Study|Death|8|||
48360659|NCT02406677|155514067|FG000|Overall Study|Discharged without P2Y12|1|||
48360660|NCT02406677|155514068|FG001|Overall Study|Discharged without P2Y12|3|||
48360661|NCT02406677|155514067|FG000|Overall Study|Discharged on prasugrel|283|||
48360662|NCT02406677|155514068|FG001|Overall Study|Discharged on prasugrel|587|||
48360663|NCT02406677|155514067|FG000|Overall Study|Withdrawal by Subject|1|||
48360664|NCT02406677|155514068|FG001|Overall Study|Withdrawal by Subject|0|||
48360665|NCT01114880|155514069|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
48360666|NCT01114880|155514070|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
48360667|NCT01114880|155514069|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
48360668|NCT01114880|155514070|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
48360669|NCT01114880|155514069|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
48360670|NCT01114880|155514070|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
48360671|NCT01114880|155514069|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
48360672|NCT01114880|155514070|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
48360673|NCT01114880|155514069|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
48360674|NCT01114880|155514070|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
48360675|NCT01114880|155514069|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
48360676|NCT01114880|155514070|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
48360677|NCT00283244|155514076|FG000|Overall Study|Adverse Event|0|||
48360678|NCT00283244|155514077|FG001|Overall Study|Adverse Event|8|||
48360679|NCT00283244|155514078|FG002|Overall Study|Adverse Event|11|||
48360680|NCT00283244|155514076|FG000|Overall Study|Death|4|||
48360681|NCT00283244|155514077|FG001|Overall Study|Death|3|||
48360682|NCT00283244|155514078|FG002|Overall Study|Death|2|||
48412475|NCT01442181|155696961|FG000|Overall Study|patient refused surgery|1|||
48412476|NCT01442181|155696962|FG001|Overall Study|patient refused surgery|0|||
48412477|NCT01442181|155696961|FG000|Overall Study|no insurance for surgery|1|||
48412478|NCT01442181|155696962|FG001|Overall Study|no insurance for surgery|0|||
48412479|NCT01442181|155696961|FG000|Overall Study|low ejection factor|0|||
48412480|NCT01442181|155696962|FG001|Overall Study|low ejection factor|1|||
48412481|NCT01442181|155696961|FG000|Overall Study|Lost to Follow-up|1|||
48412482|NCT01442181|155696962|FG001|Overall Study|Lost to Follow-up|1|||
48360683|NCT00283244|155514076|FG000|Overall Study|Lack of Efficacy|8|||
48360684|NCT00283244|155514077|FG001|Overall Study|Lack of Efficacy|32|||
48360685|NCT00283244|155514078|FG002|Overall Study|Lack of Efficacy|26|||
48360686|NCT00283244|155514076|FG000|Overall Study|Withdrawal by Subject|1|||
48360687|NCT00283244|155514077|FG001|Overall Study|Withdrawal by Subject|2|||
48360688|NCT00283244|155514078|FG002|Overall Study|Withdrawal by Subject|2|||
48360689|NCT00283244|155514076|FG000|Overall Study|Physician Decision|0|||
48360690|NCT00283244|155514077|FG001|Overall Study|Physician Decision|0|||
48360691|NCT00283244|155514078|FG002|Overall Study|Physician Decision|1|||
48360692|NCT00283244|155514076|FG000|Overall Study|Medical illness (other complicating dz)|4|||
48360693|NCT00283244|155514077|FG001|Overall Study|Medical illness (other complicating dz)|3|||
48360694|NCT00283244|155514078|FG002|Overall Study|Medical illness (other complicating dz)|6|||
48360695|NCT00283244|155514076|FG000|Overall Study|Clinical deterioration|1|||
48360696|NCT00283244|155514077|FG001|Overall Study|Clinical deterioration|3|||
48360697|NCT00283244|155514078|FG002|Overall Study|Clinical deterioration|3|||
48360698|NCT02145468|155514079|FG000|Overall Study|Withdrawal by Subject|5|||
48360699|NCT02145468|155514080|FG001|Overall Study|Withdrawal by Subject|8|||
48360700|NCT01609062|155514082|FG000|Extension Phase|Terminated by Sponsor|14|||
48360701|NCT01609062|155514083|FG001|Extension Phase|Terminated by Sponsor|9|||
48360702|NCT01609062|155514082|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
48360703|NCT01609062|155514083|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
48412483|NCT01442181|155696961|FG000|Overall Study|patient in an additional study|1|||
48412484|NCT01442181|155696962|FG001|Overall Study|patient in an additional study|0|||
48360704|NCT01609062|155514082|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
48412485|NCT01442181|155696961|FG000|Overall Study|atrial fibrillation not noted|0|||
48360705|NCT01609062|155514083|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
48360706|NCT00680992|155514084|FG000|Overall Study|Complete Resection (as per protocol)|25|||
48360707|NCT00680992|155514085|FG001|Overall Study|Complete Resection (as per protocol)|121|||
48360708|NCT00680992|155514086|FG002|Overall Study|Complete Resection (as per protocol)|0|||
48360709|NCT00680992|155514084|FG000|Overall Study|Administrative Decision|83|||
48412486|NCT01442181|155696962|FG001|Overall Study|atrial fibrillation not noted|1|||
48412487|NCT00709202|155696963|FG000|Overall Study|Withdrawal by Subject|6|||
48412488|NCT00709202|155696964|FG001|Overall Study|Withdrawal by Subject|6|||
48412489|NCT01551745|155696965|FG000|Overall Study|Withdrawal by Subject|1|||
48412490|NCT01551745|155696965|FG000|Overall Study|Disease Progression|2|||
48412491|NCT02337387|155696983|FG000|Overall Study|Adverse Event|0|||
48412492|NCT02337387|155696984|FG001|Overall Study|Adverse Event|1|||
48412493|NCT02337387|155696985|FG002|Overall Study|Adverse Event|0|||
48412494|NCT02337387|155696986|FG003|Overall Study|Adverse Event|0|||
48412495|NCT02337387|155696983|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
48412496|NCT02337387|155696984|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
48412497|NCT02337387|155696985|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
48412498|NCT02337387|155696986|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
48412499|NCT01856114|155696987|FG000|Overall Study|Withdrawal by Subject|1|||
48412500|NCT01856114|155696988|FG001|Overall Study|Withdrawal by Subject|0|||
48412501|NCT01856114|155696987|FG000|Overall Study|Adverse Event|1|||
48412502|NCT01856114|155696988|FG001|Overall Study|Adverse Event|0|||
48360710|NCT00680992|155514085|FG001|Overall Study|Administrative Decision|42|||
48360711|NCT00680992|155514086|FG002|Overall Study|Administrative Decision|5|||
48360712|NCT00680992|155514084|FG000|Overall Study|End of Trial|32|||
48360713|NCT00680992|155514085|FG001|Overall Study|End of Trial|12|||
48360714|NCT00680992|155514086|FG002|Overall Study|End of Trial|3|||
48360715|NCT00680992|155514084|FG000|Overall Study|Withdrawal by Subject|33|||
48360716|NCT00680992|155514085|FG001|Overall Study|Withdrawal by Subject|11|||
48360717|NCT00680992|155514086|FG002|Overall Study|Withdrawal by Subject|1|||
48360718|NCT00680992|155514084|FG000|Overall Study|Adverse Event|21|||
48360719|NCT00680992|155514085|FG001|Overall Study|Adverse Event|19|||
48360720|NCT00680992|155514086|FG002|Overall Study|Adverse Event|1|||
48360721|NCT00680992|155514084|FG000|Overall Study|Other|19|||
48360722|NCT00680992|155514085|FG001|Overall Study|Other|14|||
48360723|NCT00680992|155514086|FG002|Overall Study|Other|1|||
48360724|NCT00680992|155514084|FG000|Overall Study|Disease Progression|21|||
48360725|NCT00680992|155514085|FG001|Overall Study|Disease Progression|9|||
48360726|NCT00680992|155514086|FG002|Overall Study|Disease Progression|0|||
48360727|NCT00680992|155514084|FG000|Overall Study|Lost to Follow-up|12|||
48360728|NCT00680992|155514085|FG001|Overall Study|Lost to Follow-up|14|||
48360729|NCT00680992|155514086|FG002|Overall Study|Lost to Follow-up|0|||
48360730|NCT00680992|155514084|FG000|Overall Study|Noncompliance|4|||
48360731|NCT00680992|155514085|FG001|Overall Study|Noncompliance|6|||
48360732|NCT00680992|155514086|FG002|Overall Study|Noncompliance|0|||
48360733|NCT00680992|155514084|FG000|Overall Study|Requirement for Alternative Therapy|8|||
48360734|NCT00680992|155514085|FG001|Overall Study|Requirement for Alternative Therapy|2|||
48412503|NCT01642212|155696989|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
48412504|NCT01642212|155696990|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
48412505|NCT01642212|155696991|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
48412506|NCT01642212|155696992|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
48412507|NCT01642212|155696993|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
48360735|NCT00680992|155514086|FG002|Overall Study|Requirement for Alternative Therapy|0|||
48360736|NCT00680992|155514084|FG000|Overall Study|Pregnancy|5|||
48360737|NCT00680992|155514085|FG001|Overall Study|Pregnancy|0|||
48360738|NCT00680992|155514086|FG002|Overall Study|Pregnancy|1|||
48360739|NCT00680992|155514084|FG000|Overall Study|Death|5|||
48360740|NCT00680992|155514085|FG001|Overall Study|Death|1|||
48360741|NCT00680992|155514086|FG002|Overall Study|Death|0|||
48360742|NCT00680992|155514084|FG000|Overall Study|Ineligibility Determined|0|||
48360743|NCT00680992|155514085|FG001|Overall Study|Ineligibility Determined|1|||
48360744|NCT00680992|155514086|FG002|Overall Study|Ineligibility Determined|0|||
48360745|NCT00513305|155514087|FG000|Overall Study|Adverse Event|6|||
48360746|NCT00513305|155514088|FG001|Overall Study|Adverse Event|2|||
48360747|NCT00513305|155514087|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
48360748|NCT00513305|155514088|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
48360749|NCT00513305|155514087|FG000|Overall Study|Lack of Efficacy|8|||
48360750|NCT00513305|155514088|FG001|Overall Study|Lack of Efficacy|13|||
48360751|NCT00513305|155514087|FG000|Overall Study|Withdrawal by Subject|1|||
48412508|NCT01642212|155696989|FG000|Double-blind Treatment|Other|0|||
48360752|NCT00513305|155514088|FG001|Overall Study|Withdrawal by Subject|2|||
48360753|NCT00513305|155514087|FG000|Overall Study|Disease progression|8|||
48360754|NCT00513305|155514088|FG001|Overall Study|Disease progression|5|||
48360755|NCT00513305|155514087|FG000|Overall Study|Eligible for stem cell transplant|1|||
48360756|NCT00513305|155514088|FG001|Overall Study|Eligible for stem cell transplant|0|||
48360757|NCT00513305|155514087|FG000|Overall Study|Hematologic counts did not recover|1|||
48412509|NCT01642212|155696990|FG001|Double-blind Treatment|Other|2|||
48412510|NCT01642212|155696991|FG002|Double-blind Treatment|Other|1|||
48360758|NCT00513305|155514088|FG001|Overall Study|Hematologic counts did not recover|0|||
48360759|NCT00513305|155514087|FG000|Overall Study|Physician Decision|1|||
48360760|NCT00513305|155514088|FG001|Overall Study|Physician Decision|0|||
48360761|NCT00513305|155514087|FG000|Overall Study|Persistent hypocellularity|0|||
48412511|NCT01642212|155696992|FG003|Double-blind Treatment|Other|0|||
48412512|NCT01642212|155696993|FG004|Double-blind Treatment|Other|0|||
48412513|NCT01642212|155696989|FG000|Double-blind Treatment|Non-compliance|0|||
48412514|NCT01642212|155696990|FG001|Double-blind Treatment|Non-compliance|1|||
48412515|NCT01642212|155696991|FG002|Double-blind Treatment|Non-compliance|0|||
48412516|NCT01642212|155696992|FG003|Double-blind Treatment|Non-compliance|0|||
48412517|NCT01642212|155696993|FG004|Double-blind Treatment|Non-compliance|0|||
48412518|NCT01642212|155696989|FG000|Double-blind Treatment|Adverse Event|0|||
48412519|NCT01642212|155696990|FG001|Double-blind Treatment|Adverse Event|0|||
48412520|NCT01642212|155696991|FG002|Double-blind Treatment|Adverse Event|1|||
48360762|NCT00513305|155514088|FG001|Overall Study|Persistent hypocellularity|1|||
48360763|NCT00513305|155514087|FG000|Overall Study|Sponsor Decision|0|||
48360764|NCT00513305|155514088|FG001|Overall Study|Sponsor Decision|2|||
48360765|NCT04177394|155514110|FG000|Overall Study|Death|16|||
48360766|NCT04177394|155514110|FG000|Overall Study|Withdrawal by Subject|19|||
48360767|NCT04177394|155514110|FG000|Overall Study|Missed visits|61|||
48360768|NCT04177394|155514110|FG000|Overall Study|Expected Visits|15|||
48360769|NCT05123586|155514111|FG000|Overall Study|Physician Decision|1|||
48360770|NCT05123586|155514112|FG001|Overall Study|Physician Decision|1|||
48360771|NCT05123586|155514111|FG000|Overall Study|Withdrawal by Subject|0|||
48360772|NCT05123586|155514112|FG001|Overall Study|Withdrawal by Subject|3|||
48360773|NCT01934790|155514113|FG000|Treatment|Adverse Event|3|||
48360774|NCT01934790|155514113|FG000|Treatment|Clinical progression|6|||
48412521|NCT01642212|155696992|FG003|Double-blind Treatment|Adverse Event|0|||
48412522|NCT01642212|155696993|FG004|Double-blind Treatment|Adverse Event|0|||
48412523|NCT01642212|155696989|FG000|Open-label Extension|Adverse Event|0|||
48412524|NCT01642212|155696990|FG001|Open-label Extension|Adverse Event|0|||
48412525|NCT01642212|155696991|FG002|Open-label Extension|Adverse Event|0|||
48412526|NCT01642212|155696992|FG003|Open-label Extension|Adverse Event|3|||
48412527|NCT01642212|155696993|FG004|Open-label Extension|Adverse Event|0|||
48412528|NCT01642212|155696989|FG000|Open-label Extension|Sponsor Decision|0|||
48412529|NCT01642212|155696990|FG001|Open-label Extension|Sponsor Decision|0|||
48412530|NCT01642212|155696991|FG002|Open-label Extension|Sponsor Decision|0|||
48412531|NCT01642212|155696992|FG003|Open-label Extension|Sponsor Decision|7|||
48412532|NCT01642212|155696993|FG004|Open-label Extension|Sponsor Decision|4|||
48412533|NCT01642212|155696989|FG000|Open-label Extension|Consent Withdrawn|0|||
48412534|NCT01642212|155696990|FG001|Open-label Extension|Consent Withdrawn|0|||
48412535|NCT01642212|155696991|FG002|Open-label Extension|Consent Withdrawn|0|||
48412536|NCT01642212|155696992|FG003|Open-label Extension|Consent Withdrawn|0|||
48412537|NCT01642212|155696993|FG004|Open-label Extension|Consent Withdrawn|2|||
48412538|NCT01642212|155696989|FG000|Open-label Extension|Lost to Follow-up|0|||
48412539|NCT01642212|155696990|FG001|Open-label Extension|Lost to Follow-up|0|||
48412540|NCT01642212|155696991|FG002|Open-label Extension|Lost to Follow-up|0|||
48412541|NCT01642212|155696992|FG003|Open-label Extension|Lost to Follow-up|0|||
48360775|NCT01934790|155514113|FG000|Treatment|Radiological progression|4|||
48360776|NCT01934790|155514113|FG000|Treatment|Withdrawal by Subject|2|||
48360777|NCT01934790|155514113|FG000|Treatment|Study drug never administered|1|||
48360778|NCT01934790|155514113|FG000|Active Follow up|Death|20|||
48360779|NCT01934790|155514113|FG000|Active Follow up|Physician Decision|2|||
48360780|NCT01934790|155514113|FG000|Active Follow up|Progressive disease|1|||
48360781|NCT01934790|155514113|FG000|Active Follow up|Other reason|1|||
48360782|NCT05167864|155514114|FG000|Overall Study|Lost to Follow-up|7|||
48360783|NCT05167864|155514115|FG001|Overall Study|Lost to Follow-up|6|||
48360784|NCT05167864|155514116|FG002|Overall Study|Lost to Follow-up|7|||
48360785|NCT05167864|155514117|FG003|Overall Study|Lost to Follow-up|9|||
48360786|NCT04862234|155514122|FG000|Overall Study|Surgery cancellation|1|||
48360787|NCT04862234|155514123|FG001|Overall Study|Surgery cancellation|2|||
48412542|NCT01642212|155696993|FG004|Open-label Extension|Lost to Follow-up|1|||
48412543|NCT01642212|155696989|FG000|Open-label Extension|Other|0|||
48412544|NCT01642212|155696990|FG001|Open-label Extension|Other|0|||
48412545|NCT01642212|155696991|FG002|Open-label Extension|Other|0|||
48412546|NCT01642212|155696992|FG003|Open-label Extension|Other|0|||
48360788|NCT04862234|155514122|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
48360789|NCT04862234|155514123|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
48360790|NCT04862234|155514122|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
48360791|NCT04862234|155514123|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
48360792|NCT02489968|155514124|FG000|Open-label Treatment Period|Adverse Event|14|||
48360793|NCT02489968|155514125|FG001|Open-label Treatment Period|Adverse Event|7|||
48360794|NCT02489968|155514126|FG002|Open-label Treatment Period|Adverse Event|0|||
48360795|NCT02489968|155514127|FG003|Open-label Treatment Period|Adverse Event|0|||
48360796|NCT02489968|155514128|FG004|Open-label Treatment Period|Adverse Event|0|||
48360797|NCT02489968|155514129|FG005|Open-label Treatment Period|Adverse Event|0|||
48360798|NCT02489968|155514124|FG000|Open-label Treatment Period|Protocol Violation|2|||
48360799|NCT02489968|155514125|FG001|Open-label Treatment Period|Protocol Violation|2|||
48412547|NCT01642212|155696993|FG004|Open-label Extension|Other|1|||
48412548|NCT01243268|155696994|FG000|Overall Study|Lost to Follow-up|4|||
48360800|NCT02489968|155514126|FG002|Open-label Treatment Period|Protocol Violation|0|||
48360801|NCT02489968|155514127|FG003|Open-label Treatment Period|Protocol Violation|0|||
48360802|NCT02489968|155514128|FG004|Open-label Treatment Period|Protocol Violation|0|||
48360803|NCT02489968|155514129|FG005|Open-label Treatment Period|Protocol Violation|0|||
48360804|NCT02489968|155514124|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
48360805|NCT02489968|155514125|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
48360806|NCT02489968|155514126|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
48360807|NCT02489968|155514127|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
48360808|NCT02489968|155514128|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
48360809|NCT02489968|155514129|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
48360810|NCT02489968|155514124|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
48360811|NCT02489968|155514125|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
48360812|NCT02489968|155514126|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
48360813|NCT02489968|155514127|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
48360814|NCT02489968|155514128|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
48360815|NCT02489968|155514129|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
48360816|NCT02489968|155514124|FG000|Open-label Treatment Period|Other than specified above|204|||
48360817|NCT02489968|155514125|FG001|Open-label Treatment Period|Other than specified above|189|||
48360818|NCT02489968|155514126|FG002|Open-label Treatment Period|Other than specified above|0|||
48360819|NCT02489968|155514127|FG003|Open-label Treatment Period|Other than specified above|0|||
48360820|NCT02489968|155514128|FG004|Open-label Treatment Period|Other than specified above|0|||
48360821|NCT02489968|155514129|FG005|Open-label Treatment Period|Other than specified above|0|||
48360822|NCT02489968|155514124|FG000|Double-blind Treatment Period|Adverse Event|0|||
48360823|NCT02489968|155514125|FG001|Double-blind Treatment Period|Adverse Event|0|||
48360824|NCT02489968|155514126|FG002|Double-blind Treatment Period|Adverse Event|2|||
48360825|NCT02489968|155514127|FG003|Double-blind Treatment Period|Adverse Event|6|||
48360826|NCT02489968|155514128|FG004|Double-blind Treatment Period|Adverse Event|4|||
48360827|NCT02489968|155514129|FG005|Double-blind Treatment Period|Adverse Event|5|||
48360828|NCT02489968|155514124|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48360829|NCT02489968|155514125|FG001|Double-blind Treatment Period|Protocol Violation|0|||
48360830|NCT02489968|155514126|FG002|Double-blind Treatment Period|Protocol Violation|0|||
48360831|NCT02489968|155514127|FG003|Double-blind Treatment Period|Protocol Violation|0|||
48360832|NCT02489968|155514128|FG004|Double-blind Treatment Period|Protocol Violation|1|||
48360833|NCT02489968|155514129|FG005|Double-blind Treatment Period|Protocol Violation|1|||
48360834|NCT02489968|155514124|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
48360835|NCT02489968|155514125|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
48360836|NCT02489968|155514126|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48360837|NCT02489968|155514127|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
48360838|NCT02489968|155514128|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
48360839|NCT02489968|155514129|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
48360840|NCT02489968|155514124|FG000|Double-blind Treatment Period|Other than specified above|0|||
48360841|NCT02489968|155514125|FG001|Double-blind Treatment Period|Other than specified above|0|||
48360842|NCT02489968|155514126|FG002|Double-blind Treatment Period|Other than specified above|0|||
48360843|NCT02489968|155514127|FG003|Double-blind Treatment Period|Other than specified above|0|||
48360844|NCT02489968|155514128|FG004|Double-blind Treatment Period|Other than specified above|1|||
48360845|NCT02489968|155514129|FG005|Double-blind Treatment Period|Other than specified above|0|||
48360846|NCT00384397|155514131|FG000|Overall Study|Adverse Event|0|||
48360847|NCT00384397|155514132|FG001|Overall Study|Adverse Event|1|||
48360848|NCT00384397|155514133|FG002|Overall Study|Adverse Event|2|||
48360849|NCT00384397|155514131|FG000|Overall Study|Protocol Violation|7|||
48360850|NCT00384397|155514132|FG001|Overall Study|Protocol Violation|15|||
48360851|NCT00384397|155514133|FG002|Overall Study|Protocol Violation|13|||
48360852|NCT00384397|155514131|FG000|Overall Study|Lost to Follow-up|11|||
48360853|NCT00384397|155514132|FG001|Overall Study|Lost to Follow-up|13|||
48360854|NCT00384397|155514133|FG002|Overall Study|Lost to Follow-up|3|||
48360855|NCT00384397|155514131|FG000|Overall Study|Withdrawal by Subject|14|||
48360856|NCT00384397|155514132|FG001|Overall Study|Withdrawal by Subject|17|||
48360857|NCT00384397|155514133|FG002|Overall Study|Withdrawal by Subject|15|||
48360858|NCT01593787|155514134|FG000|Overall Study|Adverse Event|1|||
48360859|NCT01593787|155514135|FG001|Overall Study|Adverse Event|0|||
48360860|NCT01593787|155514136|FG002|Overall Study|Adverse Event|0|||
48360861|NCT03192462|155515413|FG000|Overall Study|Death|13|||
48360862|NCT03192462|155515414|FG001|Overall Study|Death|11|||
48360863|NCT03192462|155515415|FG002|Overall Study|Death|9|||
48360864|NCT03192462|155515413|FG000|Overall Study|Lost to Follow-up|0|||
48360865|NCT03192462|155515414|FG001|Overall Study|Lost to Follow-up|1|||
48360866|NCT03192462|155515415|FG002|Overall Study|Lost to Follow-up|0|||
48360867|NCT03192462|155515413|FG000|Overall Study|On follow up|0|||
48360868|NCT03192462|155515414|FG001|Overall Study|On follow up|0|||
48360869|NCT03192462|155515415|FG002|Overall Study|On follow up|3|||
48360870|NCT01385748|155515417|FG000|Overall Study|Withdrawal by Subject|7|||
48360871|NCT01385748|155515418|FG001|Overall Study|Withdrawal by Subject|4|||
48360872|NCT01385748|155515419|FG002|Overall Study|Withdrawal by Subject|5|||
48360873|NCT01385748|155515417|FG000|Overall Study|Noncompliance|3|||
48360874|NCT01385748|155515418|FG001|Overall Study|Noncompliance|1|||
48360875|NCT01385748|155515419|FG002|Overall Study|Noncompliance|6|||
48360876|NCT01385748|155515417|FG000|Overall Study|Other|1|||
48360877|NCT01385748|155515418|FG001|Overall Study|Other|7|||
48360878|NCT01385748|155515419|FG002|Overall Study|Other|1|||
48360879|NCT01385748|155515417|FG000|Overall Study|Adverse Event|4|||
48360880|NCT01385748|155515418|FG001|Overall Study|Adverse Event|2|||
48360881|NCT01385748|155515419|FG002|Overall Study|Adverse Event|1|||
48360882|NCT03232931|155515420|FG000|Overall Study|Physician Decision|1|||
48360883|NCT03232931|155515421|FG001|Overall Study|Physician Decision|1|||
48360884|NCT03232931|155515420|FG000|Overall Study|Withdrawal by Subject|6|||
48360885|NCT03232931|155515421|FG001|Overall Study|Withdrawal by Subject|0|||
48360886|NCT03232931|155515420|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
48360887|NCT03232931|155515421|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
48360888|NCT03232931|155515420|FG000|Overall Study|Parent did not record voice|1|||
48360889|NCT03232931|155515421|FG001|Overall Study|Parent did not record voice|2|||
48360890|NCT03232931|155515420|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
48360891|NCT03232931|155515421|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
48360892|NCT01681277|155515424|FG000|Overall Study|Adverse Event|1|||
48360893|NCT01681277|155515425|FG001|Overall Study|Adverse Event|0|||
48360894|NCT01681277|155515426|FG002|Overall Study|Adverse Event|0|||
48360895|NCT01681277|155515427|FG003|Overall Study|Adverse Event|0|||
48360896|NCT01681277|155515428|FG004|Overall Study|Adverse Event|0|||
48360897|NCT04707664|155515437|FG000|Overall Study|Adverse Event|2|||
48360898|NCT04707664|155515438|FG001|Overall Study|Adverse Event|0|||
48360899|NCT04707664|155515437|FG000|Overall Study|Death|1|||
48360900|NCT04707664|155515438|FG001|Overall Study|Death|2|||
48360901|NCT04707664|155515437|FG000|Overall Study|Withdrawal by Subject|13|||
48412549|NCT01243268|155696994|FG000|Overall Study|Protocol Violation|51|||
48412550|NCT01243268|155696994|FG000|Overall Study|Deviation with contract date|7|||
48412551|NCT01243268|155696994|FG000|Overall Study|Duplicate subject|2|||
48412552|NCT00100048|155696997|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
48412553|NCT00100048|155696998|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
48412554|NCT00100048|155696999|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
48412555|NCT00100048|155697000|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
48412556|NCT00100048|155697001|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
48412557|NCT00100048|155697002|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
48412558|NCT00100048|155696997|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
48412559|NCT00100048|155696998|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
48412560|NCT00100048|155696999|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
48412561|NCT00100048|155697000|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
48412562|NCT00100048|155697001|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
48412563|NCT00100048|155697002|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
48412564|NCT00100048|155696997|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
48412565|NCT00100048|155696998|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
48412566|NCT00100048|155696999|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
48412567|NCT00100048|155697000|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
48412568|NCT00100048|155697001|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
48412569|NCT00100048|155697002|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
48412570|NCT00100048|155696997|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
48412571|NCT00100048|155696998|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
48412572|NCT00100048|155696999|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
48412573|NCT00100048|155697000|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
48412574|NCT00100048|155697001|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
48412575|NCT00100048|155697002|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
48412576|NCT00100048|155696997|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
48412577|NCT00100048|155696998|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
48412578|NCT00100048|155696999|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
48412579|NCT00100048|155697000|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
48412580|NCT00100048|155697001|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
48412581|NCT00100048|155697002|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
48412582|NCT00100048|155696997|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
48360902|NCT04707664|155515438|FG001|Overall Study|Withdrawal by Subject|21|||
48360903|NCT04707664|155515437|FG000|Overall Study|Lost to Follow-up|11|||
48360904|NCT04707664|155515438|FG001|Overall Study|Lost to Follow-up|13|||
48412583|NCT00100048|155696998|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
48412584|NCT00100048|155696999|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
48412585|NCT00100048|155697000|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
48412586|NCT00100048|155697001|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
48412587|NCT00100048|155697002|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
48412588|NCT00100048|155696997|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
48412589|NCT00100048|155696998|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
48412590|NCT00100048|155696999|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
48412591|NCT00100048|155697000|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
48412592|NCT00100048|155697001|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
48412593|NCT00100048|155697002|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
48412594|NCT00100048|155696997|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48412595|NCT00100048|155696998|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48412596|NCT00100048|155696999|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48412597|NCT00100048|155697000|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
48412598|NCT00100048|155697001|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48412599|NCT00100048|155697002|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
48360905|NCT04707664|155515437|FG000|Overall Study|Not treated|2|||
48412600|NCT00256295|155697005|FG000|Overall Study|Withdrawal by Subject|3|||
48360906|NCT04707664|155515438|FG001|Overall Study|Not treated|0|||
48360907|NCT02056626|155515439|FG000|Overall Study|patient did not follow directions|3|||
48412601|NCT00256295|155697005|FG000|Overall Study|Death|1|||
48412602|NCT01926626|155697006|FG000|Overall Study|Withdrawal by Subject|15|||
48412603|NCT01926626|155697006|FG000|Overall Study|Lost to Follow-up|7|||
48412604|NCT00741819|155697007|FG000|Overall Study|Adverse Event|3|||
48412605|NCT00741819|155697007|FG000|Overall Study|Withdrawal by Subject|3|||
48412606|NCT00741819|155697007|FG000|Overall Study|Death|1|||
48412607|NCT00741819|155697007|FG000|Overall Study|Disease progression|1|||
48412608|NCT01126580|155697008|FG000|Overall Study|Adverse Event|14|||
48412609|NCT01126580|155697009|FG001|Overall Study|Adverse Event|8|||
48412610|NCT01126580|155697010|FG002|Overall Study|Adverse Event|12|||
48412611|NCT01126580|155697008|FG000|Overall Study|Withdrawal by Subject|11|||
48412612|NCT01126580|155697009|FG001|Overall Study|Withdrawal by Subject|19|||
48412613|NCT01126580|155697010|FG002|Overall Study|Withdrawal by Subject|14|||
48412614|NCT01126580|155697008|FG000|Overall Study|Sponsor Decision|5|||
48412615|NCT01126580|155697009|FG001|Overall Study|Sponsor Decision|4|||
48412616|NCT01126580|155697010|FG002|Overall Study|Sponsor Decision|7|||
48412617|NCT01126580|155697008|FG000|Overall Study|Physician Decision|1|||
48412618|NCT01126580|155697009|FG001|Overall Study|Physician Decision|1|||
48412619|NCT01126580|155697010|FG002|Overall Study|Physician Decision|2|||
48412620|NCT01126580|155697008|FG000|Overall Study|Entry Criteria Not Met|1|||
48412621|NCT01126580|155697009|FG001|Overall Study|Entry Criteria Not Met|1|||
48412622|NCT01126580|155697010|FG002|Overall Study|Entry Criteria Not Met|2|||
48412623|NCT01126580|155697008|FG000|Overall Study|Lack of Efficacy|2|||
48360908|NCT02056626|155515440|FG001|Overall Study|patient did not follow directions|1|||
48360909|NCT02056626|155515441|FG002|Overall Study|patient did not follow directions|0|||
48360910|NCT02056626|155515442|FG003|Overall Study|patient did not follow directions|0|||
48360911|NCT02460575|155515443|FG000|Overall Study|Lost to Follow-up|1|||
48360912|NCT02460575|155515444|FG001|Overall Study|Lost to Follow-up|0|||
48360913|NCT04307940|155515445|FG000|Overall Study|Adverse Event|1|||
48360914|NCT04307940|155515446|FG001|Overall Study|Adverse Event|0|||
48360915|NCT04307940|155515447|FG002|Overall Study|Adverse Event|0|||
48360916|NCT04307940|155515445|FG000|Overall Study|Withdrawal by Subject|2|||
48360917|NCT04307940|155515446|FG001|Overall Study|Withdrawal by Subject|3|||
48360918|NCT04307940|155515447|FG002|Overall Study|Withdrawal by Subject|1|||
48360919|NCT04307940|155515445|FG000|Overall Study|Lost to Follow-up|2|||
48360920|NCT04307940|155515446|FG001|Overall Study|Lost to Follow-up|0|||
48360921|NCT04307940|155515447|FG002|Overall Study|Lost to Follow-up|1|||
48360922|NCT04400487|155515452|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
48412624|NCT01126580|155697009|FG001|Overall Study|Lack of Efficacy|3|||
48412625|NCT01126580|155697010|FG002|Overall Study|Lack of Efficacy|4|||
48412626|NCT01126580|155697008|FG000|Overall Study|Protocol Violation|0|||
48360923|NCT04400487|155515452|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
48360924|NCT04400487|155515452|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
48360925|NCT00127205|155515457|FG000|Overall Study|Adverse Event|228|||
48360926|NCT00127205|155515458|FG001|Overall Study|Adverse Event|387|||
48360927|NCT00127205|155515459|FG002|Overall Study|Adverse Event|273|||
48360928|NCT00127205|155515457|FG000|Overall Study|Death|8|||
48360929|NCT00127205|155515458|FG001|Overall Study|Death|6|||
48360930|NCT00127205|155515459|FG002|Overall Study|Death|5|||
48360931|NCT00127205|155515457|FG000|Overall Study|Withdrawal by Subject|318|||
48360932|NCT00127205|155515458|FG001|Overall Study|Withdrawal by Subject|310|||
48360933|NCT00127205|155515459|FG002|Overall Study|Withdrawal by Subject|172|||
48360934|NCT00127205|155515457|FG000|Overall Study|Other-non protocol specified|142|||
48412627|NCT01126580|155697009|FG001|Overall Study|Protocol Violation|1|||
48360935|NCT00127205|155515458|FG001|Overall Study|Other-non protocol specified|129|||
48360936|NCT00127205|155515459|FG002|Overall Study|Other-non protocol specified|77|||
48360937|NCT00127205|155515457|FG000|Overall Study|Data not reported|6|||
48360938|NCT00127205|155515458|FG001|Overall Study|Data not reported|10|||
48360939|NCT00127205|155515459|FG002|Overall Study|Data not reported|1|||
48360940|NCT00127205|155515457|FG000|Overall Study|Progression|127|||
48360941|NCT00127205|155515458|FG001|Overall Study|Progression|131|||
48360942|NCT00127205|155515459|FG002|Overall Study|Progression|84|||
48360943|NCT00734591|155515460|FG000|Screening for Prospective Period|Site did not participate|1604|||
48360944|NCT00734591|155515461|FG001|Screening for Prospective Period|Site did not participate|1488|||
48360945|NCT00734591|155515460|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
48360946|NCT00734591|155515461|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
48360947|NCT00734591|155515460|FG000|Prospective Period|Withdrawal by Subject|11|||
48360948|NCT00734591|155515461|FG001|Prospective Period|Withdrawal by Subject|9|||
48360949|NCT00734591|155515460|FG000|Prospective Period|Lost to Follow-up|37|||
48360950|NCT00734591|155515461|FG001|Prospective Period|Lost to Follow-up|33|||
48360951|NCT00734591|155515460|FG000|Prospective Period|Study Terminated|1|||
48360952|NCT00734591|155515461|FG001|Prospective Period|Study Terminated|0|||
48360953|NCT00734591|155515460|FG000|Prospective Period|Other|2|||
48360954|NCT00734591|155515461|FG001|Prospective Period|Other|2|||
48360955|NCT02138786|155515462|FG000|Overall Study|Adverse Event|0|||
48360956|NCT02138786|155515463|FG001|Overall Study|Adverse Event|2|||
48360957|NCT02138786|155515464|FG002|Overall Study|Adverse Event|1|||
48360958|NCT02138786|155515462|FG000|Overall Study|Death|1|||
48360959|NCT02138786|155515463|FG001|Overall Study|Death|7|||
48360960|NCT02138786|155515464|FG002|Overall Study|Death|2|||
48360961|NCT02138786|155515462|FG000|Overall Study|Disease Progression|1|||
48360962|NCT02138786|155515463|FG001|Overall Study|Disease Progression|1|||
48360963|NCT02138786|155515464|FG002|Overall Study|Disease Progression|3|||
48360964|NCT02138786|155515462|FG000|Overall Study|Withdrawal by Subject|1|||
48360965|NCT02138786|155515463|FG001|Overall Study|Withdrawal by Subject|2|||
48360966|NCT02138786|155515464|FG002|Overall Study|Withdrawal by Subject|0|||
48360967|NCT02138786|155515462|FG000|Overall Study|Patient's Wish|0|||
48360968|NCT02138786|155515463|FG001|Overall Study|Patient's Wish|2|||
48360969|NCT02138786|155515464|FG002|Overall Study|Patient's Wish|0|||
48360970|NCT02138786|155515462|FG000|Overall Study|Sponsor Terminated Study|0|||
48360971|NCT02138786|155515463|FG001|Overall Study|Sponsor Terminated Study|1|||
48360972|NCT02138786|155515464|FG002|Overall Study|Sponsor Terminated Study|1|||
48360973|NCT02138786|155515462|FG000|Overall Study|Non-Compliance|0|||
48360974|NCT02138786|155515463|FG001|Overall Study|Non-Compliance|0|||
48360975|NCT02138786|155515464|FG002|Overall Study|Non-Compliance|1|||
48360976|NCT01681992|155515465|FG000|Overall Study|Adverse Event|3|||
48360977|NCT01681992|155515466|FG001|Overall Study|Adverse Event|2|||
48360978|NCT01681992|155515467|FG002|Overall Study|Adverse Event|3|||
48360979|NCT01681992|155515465|FG000|Overall Study|Lost to Follow-up|36|||
48360980|NCT01681992|155515466|FG001|Overall Study|Lost to Follow-up|38|||
48360981|NCT01681992|155515467|FG002|Overall Study|Lost to Follow-up|53|||
48360982|NCT01681992|155515465|FG000|Overall Study|As Per Sponsor Decision|0|||
48360983|NCT01681992|155515466|FG001|Overall Study|As Per Sponsor Decision|0|||
48360984|NCT01681992|155515467|FG002|Overall Study|As Per Sponsor Decision|1|||
48360985|NCT01681992|155515465|FG000|Overall Study|Protocol Violation|0|||
48360986|NCT01681992|155515466|FG001|Overall Study|Protocol Violation|0|||
48360987|NCT01681992|155515467|FG002|Overall Study|Protocol Violation|1|||
48360988|NCT01681992|155515465|FG000|Overall Study|Withdrawal by Subject|27|||
48360989|NCT01681992|155515466|FG001|Overall Study|Withdrawal by Subject|30|||
48360990|NCT01681992|155515467|FG002|Overall Study|Withdrawal by Subject|25|||
48360991|NCT01294397|155515471|FG000|Overall Study|Withdrawal by Subject|1|||
48360992|NCT01294397|155515471|FG000|Overall Study|Administrative Decision|1|||
48360993|NCT00426127|155515472|FG000|Overall Study|Adverse Event|1|||
48360994|NCT00426127|155515472|FG000|Overall Study|Removed due to disease progression|1|||
48360995|NCT02476175|155515473|FG000|Overall Study|Adverse Event|2|||
48360996|NCT01162486|155515475|FG000|Overall Study|low ANC|1|||
48360997|NCT01162486|155515476|FG001|Overall Study|low ANC|0|||
48360998|NCT01162486|155515477|FG002|Overall Study|low ANC|0|||
48360999|NCT01162486|155515478|FG003|Overall Study|low ANC|0|||
48361000|NCT01162486|155515479|FG004|Overall Study|low ANC|0|||
48361001|NCT01162486|155515475|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
48361002|NCT01162486|155515476|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
48361003|NCT01162486|155515477|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
48361004|NCT01162486|155515478|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
48361005|NCT01162486|155515479|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
48361006|NCT01162486|155515475|FG000|Overall Study|elevated LFTs|0|||
48361007|NCT01162486|155515476|FG001|Overall Study|elevated LFTs|0|||
48361008|NCT01162486|155515477|FG002|Overall Study|elevated LFTs|1|||
48361009|NCT01162486|155515478|FG003|Overall Study|elevated LFTs|0|||
48361010|NCT01162486|155515479|FG004|Overall Study|elevated LFTs|0|||
48361011|NCT01162486|155515475|FG000|Overall Study|Pregnancy|0|||
48361012|NCT01162486|155515476|FG001|Overall Study|Pregnancy|0|||
48361013|NCT01162486|155515477|FG002|Overall Study|Pregnancy|0|||
48412628|NCT01126580|155697010|FG002|Overall Study|Protocol Violation|2|||
48412629|NCT01126580|155697008|FG000|Overall Study|Lost to Follow-up|15|||
48412630|NCT01126580|155697009|FG001|Overall Study|Lost to Follow-up|13|||
48361014|NCT01162486|155515478|FG003|Overall Study|Pregnancy|1|||
48361015|NCT01162486|155515479|FG004|Overall Study|Pregnancy|0|||
48412631|NCT01126580|155697010|FG002|Overall Study|Lost to Follow-up|9|||
48412632|NCT01126580|155697008|FG000|Overall Study|Treatment Non-compliance|0|||
48412633|NCT01126580|155697009|FG001|Overall Study|Treatment Non-compliance|2|||
48412634|NCT01126580|155697010|FG002|Overall Study|Treatment Non-compliance|3|||
48412635|NCT01731002|155697011|FG000|Overall Study|Adverse Event|0|||
48412636|NCT01731002|155697012|FG001|Overall Study|Adverse Event|2|||
48412637|NCT01731002|155697013|FG002|Overall Study|Adverse Event|2|||
48412638|NCT01731002|155697011|FG000|Overall Study|Non-Compliant|0|||
48412639|NCT01731002|155697012|FG001|Overall Study|Non-Compliant|1|||
48412640|NCT01731002|155697013|FG002|Overall Study|Non-Compliant|0|||
48412641|NCT01731002|155697011|FG000|Overall Study|Lost to Follow-up|1|||
48412642|NCT01731002|155697012|FG001|Overall Study|Lost to Follow-up|0|||
48412643|NCT01731002|155697013|FG002|Overall Study|Lost to Follow-up|0|||
48412644|NCT01731002|155697011|FG000|Overall Study|Test Agent Discontinuation|0|||
48412645|NCT01731002|155697012|FG001|Overall Study|Test Agent Discontinuation|1|||
48412646|NCT01731002|155697013|FG002|Overall Study|Test Agent Discontinuation|0|||
48412647|NCT01731002|155697011|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
48412648|NCT01731002|155697012|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
48412649|NCT01731002|155697013|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
48412650|NCT01731002|155697011|FG000|Overall Study|Elevated IOP|1|||
48412651|NCT01731002|155697012|FG001|Overall Study|Elevated IOP|0|||
48412652|NCT01731002|155697013|FG002|Overall Study|Elevated IOP|0|||
48412653|NCT01731002|155697011|FG000|Overall Study|Inappropriate use of study medications|0|||
48412654|NCT01731002|155697012|FG001|Overall Study|Inappropriate use of study medications|0|||
48412655|NCT01731002|155697013|FG002|Overall Study|Inappropriate use of study medications|1|||
48412656|NCT01053429|155697014|FG000|Overall Study|Adverse Event|64|||
48412657|NCT01053429|155697014|FG000|Overall Study|Other|309|||
48412658|NCT00924703|155697015|FG000|Overall Study|Withdrawal by Subject|11|||
48361016|NCT01305408|155515480|FG000|Overall Study|Adverse Event|10|||
48361017|NCT01305408|155515481|FG001|Overall Study|Adverse Event|7|||
48412659|NCT00924703|155697015|FG000|Overall Study|Physician Decision|5|||
48412660|NCT00924703|155697015|FG000|Overall Study|Lost to Follow-up|3|||
48412661|NCT00924703|155697015|FG000|Overall Study|Adverse Event|2|||
48412662|NCT00924703|155697015|FG000|Overall Study|Withdrawal by Sponsor|1|||
48412663|NCT02582658|155697023|FG000|Overall Study|Failure to Return|10|||
48361018|NCT01305408|155515480|FG000|Overall Study|Lack of Efficacy|3|||
48361019|NCT01305408|155515481|FG001|Overall Study|Lack of Efficacy|4|||
48361020|NCT01305408|155515480|FG000|Overall Study|Withdrawal by Subject|9|||
48361021|NCT01305408|155515481|FG001|Overall Study|Withdrawal by Subject|9|||
48361022|NCT01305408|155515480|FG000|Overall Study|Protocol Violation|4|||
48361023|NCT01305408|155515481|FG001|Overall Study|Protocol Violation|6|||
48361024|NCT01305408|155515480|FG000|Overall Study|Lost to Follow-up|5|||
48361025|NCT01305408|155515481|FG001|Overall Study|Lost to Follow-up|3|||
48361026|NCT01305408|155515480|FG000|Overall Study|Noncompliance with study medication|0|||
48361027|NCT01305408|155515481|FG001|Overall Study|Noncompliance with study medication|1|||
48361028|NCT01305408|155515480|FG000|Overall Study|Noncompliance with study procedures|0|||
48361029|NCT01305408|155515481|FG001|Overall Study|Noncompliance with study procedures|1|||
48361030|NCT01305408|155515480|FG000|Overall Study|Other|1|||
48361031|NCT01305408|155515481|FG001|Overall Study|Other|0|||
48361032|NCT01818531|155515482|FG000|Overall Study|Withdrawn for case delay after block|1|||
48361033|NCT01818531|155515483|FG001|Overall Study|Withdrawn for case delay after block|0|||
48361034|NCT01818531|155515482|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
48361035|NCT01818531|155515483|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
48361036|NCT01818531|155515482|FG000|Overall Study|Withdrawn for failure to place block|0|||
48361037|NCT01818531|155515483|FG001|Overall Study|Withdrawn for failure to place block|1|||
48361038|NCT03274895|155515488|FG000|Overall Study|Lack of Efficacy|1|||
48361039|NCT03274895|155515489|FG001|Overall Study|Lack of Efficacy|0|||
48361040|NCT03274895|155515488|FG000|Overall Study|Adverse Event|8|||
48361041|NCT03274895|155515489|FG001|Overall Study|Adverse Event|7|||
48361042|NCT03274895|155515488|FG000|Overall Study|Lost to Follow-up|1|||
48361043|NCT03274895|155515489|FG001|Overall Study|Lost to Follow-up|0|||
48361044|NCT03274895|155515488|FG000|Overall Study|Diagnosis not confirmed|3|||
48412664|NCT02582658|155697023|FG000|Overall Study|Insufficient Virological Response|2|||
48412665|NCT02582658|155697023|FG000|Overall Study|Withdrawn Consent|1|||
48412666|NCT02582658|155697023|FG000|Overall Study|Death|1|||
48412667|NCT02582658|155697023|FG000|Overall Study|Not further specified|11|||
48412668|NCT01769105|155697028|FG000|First Intervention|Protocol Violation|2|||
48412669|NCT01769105|155697029|FG001|First Intervention|Protocol Violation|2|||
48412670|NCT01769105|155697028|FG000|Cross-over|Lost to Follow-up|5|||
48412671|NCT01769105|155697029|FG001|Cross-over|Lost to Follow-up|0|||
48412672|NCT01392183|155697030|FG000|First Drug Administration|Adverse Event|3|||
48412673|NCT01392183|155697031|FG001|First Drug Administration|Adverse Event|2|||
48412674|NCT01392183|155697030|FG000|First Drug Administration|Death|1|||
48412675|NCT01392183|155697031|FG001|First Drug Administration|Death|0|||
48412676|NCT01392183|155697030|FG000|First Drug Administration|Withdrawal by Subject|10|||
48412677|NCT01392183|155697031|FG001|First Drug Administration|Withdrawal by Subject|17|||
48412678|NCT01475734|155698907|FG000|Overall Study|Withdrawal by Subject|1|||
48412679|NCT01475734|155698908|FG001|Overall Study|Withdrawal by Subject|0|||
48412680|NCT01475734|155698907|FG000|Overall Study|Protocol Violation|1|||
48412681|NCT01475734|155698908|FG001|Overall Study|Protocol Violation|0|||
48412682|NCT01475734|155698907|FG000|Overall Study|Physician Decision|0|||
48412683|NCT01475734|155698908|FG001|Overall Study|Physician Decision|1|||
48412684|NCT00127127|155698909|FG000|Overall Study|Adverse Event|0|||
48412685|NCT00127127|155698910|FG001|Overall Study|Adverse Event|2|||
48412686|NCT00127127|155698911|FG002|Overall Study|Adverse Event|0|||
48412687|NCT00127127|155698912|FG003|Overall Study|Adverse Event|1|||
48412688|NCT00127127|155698909|FG000|Overall Study|Lack of Efficacy|1|||
48412689|NCT00127127|155698910|FG001|Overall Study|Lack of Efficacy|3|||
48412690|NCT00127127|155698911|FG002|Overall Study|Lack of Efficacy|0|||
48412691|NCT00127127|155698912|FG003|Overall Study|Lack of Efficacy|2|||
48412692|NCT00398112|155698935|FG000|Overall Study|Adverse Event|4|||
48412693|NCT00398112|155698935|FG000|Overall Study|Disease progression|9|||
48412694|NCT00398112|155698935|FG000|Overall Study|Alternative treatment|1|||
48361045|NCT03274895|155515489|FG001|Overall Study|Diagnosis not confirmed|4|||
48361046|NCT00669877|155515492|FG000|Overall Study|Disease Progression/Death|4|||
48361047|NCT03635099|155515493|FG000|Period 1|Adverse Event|1|||
48412695|NCT00398112|155698935|FG000|Overall Study|Withdrawal by Subject|3|||
48412696|NCT00398112|155698935|FG000|Overall Study|Death|1|||
48412697|NCT05148884|155698936|FG000|Overall Study|Withdrawal by Subject|3|||
48412698|NCT05148884|155698937|FG001|Overall Study|Withdrawal by Subject|0|||
48412699|NCT05148884|155698936|FG000|Overall Study|Deep brain stimulation operation|0|||
48412700|NCT05148884|155698937|FG001|Overall Study|Deep brain stimulation operation|1|||
48412701|NCT03244059|155698938|FG000|Specific Aim 1|Physician Decision|1|||
48412702|NCT03244059|155698939|FG001|Specific Aim 1|Physician Decision|0|||
48412703|NCT03244059|155698938|FG000|Specific Aim 2|Physician Decision|1|||
48412704|NCT03244059|155698939|FG001|Specific Aim 2|Physician Decision|0|||
48412705|NCT01993888|155698942|FG000|Overall Study|Death|1|||
48412706|NCT01993888|155698943|FG001|Overall Study|Death|1|||
48412707|NCT01993888|155698942|FG000|Overall Study|Lost to Follow-up|1|||
48412708|NCT01993888|155698943|FG001|Overall Study|Lost to Follow-up|1|||
48412709|NCT01993888|155698942|FG000|Overall Study|Withdrawal by Subject|0|||
48412710|NCT01993888|155698943|FG001|Overall Study|Withdrawal by Subject|1|||
48412711|NCT01276821|155698949|FG000|Overall Study|Protocol Violation|0|||
48412712|NCT01276821|155698950|FG001|Overall Study|Protocol Violation|1|||
48412713|NCT00317044|155698951|FG000|Overall Study|Protocol Violation|28|||
48412714|NCT00317044|155698952|FG001|Overall Study|Protocol Violation|22|||
48412715|NCT00317044|155698953|FG002|Overall Study|Protocol Violation|20|||
48412716|NCT00317044|155698951|FG000|Overall Study|Adverse Event|4|||
48412717|NCT00317044|155698952|FG001|Overall Study|Adverse Event|7|||
48412718|NCT00317044|155698953|FG002|Overall Study|Adverse Event|4|||
48412719|NCT00317044|155698951|FG000|Overall Study|Withdrawal by Subject|10|||
48412720|NCT00317044|155698952|FG001|Overall Study|Withdrawal by Subject|7|||
48412721|NCT00317044|155698953|FG002|Overall Study|Withdrawal by Subject|12|||
48412722|NCT00317044|155698951|FG000|Overall Study|Lost to Follow-up|0|||
48412723|NCT00317044|155698952|FG001|Overall Study|Lost to Follow-up|2|||
48412724|NCT00317044|155698953|FG002|Overall Study|Lost to Follow-up|3|||
48412725|NCT00317044|155698951|FG000|Overall Study|Multiple Reasons|6|||
48412726|NCT00317044|155698952|FG001|Overall Study|Multiple Reasons|2|||
48412727|NCT00317044|155698953|FG002|Overall Study|Multiple Reasons|6|||
48412728|NCT00260208|155698954|FG000|Overall Study|Subject withdrew consent|11|||
48412729|NCT00260208|155698955|FG001|Overall Study|Subject withdrew consent|7|||
48361048|NCT03635099|155515494|FG001|Period 1|Adverse Event|0|||
48361049|NCT03635099|155515495|FG002|Period 1|Adverse Event|0|||
48361050|NCT03635099|155515496|FG003|Period 1|Adverse Event|1|||
48361051|NCT03635099|155515497|FG004|Period 1|Adverse Event|0|||
48361052|NCT03635099|155515498|FG005|Period 1|Adverse Event|0|||
48361053|NCT03635099|155515499|FG006|Period 1|Adverse Event|0|||
48361054|NCT03635099|155515500|FG007|Period 1|Adverse Event|0|||
48412730|NCT00260208|155698954|FG000|Overall Study|Lost to Follow-up|6|||
48412731|NCT00260208|155698955|FG001|Overall Study|Lost to Follow-up|1|||
48412732|NCT00260208|155698954|FG000|Overall Study|Death|12|||
48412733|NCT00260208|155698955|FG001|Overall Study|Death|10|||
48412734|NCT00260208|155698954|FG000|Overall Study|Missing|18|||
48412735|NCT00260208|155698955|FG001|Overall Study|Missing|16|||
48412736|NCT02612909|155698956|FG000|Phase 2|Withdrawal by Subject|2|||
48412737|NCT02612909|155698957|FG001|Phase 2|Withdrawal by Subject|5|||
48412738|NCT02612909|155698958|FG002|Phase 2|Withdrawal by Subject|0|||
48412739|NCT02612909|155698959|FG003|Phase 2|Withdrawal by Subject|0|||
48412740|NCT02612909|155698960|FG004|Phase 2|Withdrawal by Subject|0|||
48361055|NCT03635099|155515493|FG000|Period 1|Protocol Violation|0|||
48412741|NCT02612909|155698956|FG000|Phase 2|Pregnancy|0|||
48412742|NCT02612909|155698957|FG001|Phase 2|Pregnancy|0|||
48412743|NCT02612909|155698958|FG002|Phase 2|Pregnancy|1|||
48412744|NCT02612909|155698959|FG003|Phase 2|Pregnancy|0|||
48412745|NCT02612909|155698960|FG004|Phase 2|Pregnancy|0|||
48412746|NCT02612909|155698956|FG000|Phase 3|Withdrawal by Subject|0|||
48412747|NCT02612909|155698957|FG001|Phase 3|Withdrawal by Subject|0|||
48412748|NCT02612909|155698958|FG002|Phase 3|Withdrawal by Subject|0|||
48412749|NCT02612909|155698959|FG003|Phase 3|Withdrawal by Subject|1|||
48412750|NCT02612909|155698960|FG004|Phase 3|Withdrawal by Subject|0|||
48412751|NCT02162862|155698961|FG000|Overall Study|Lost to Follow-up|0|||
48412752|NCT02162862|155698962|FG001|Overall Study|Lost to Follow-up|11|||
48412753|NCT02162862|155698963|FG002|Overall Study|Lost to Follow-up|0|||
48412754|NCT02162862|155698961|FG000|Overall Study|Subject did not feel the med was needed|0|||
48412755|NCT02162862|155698962|FG001|Overall Study|Subject did not feel the med was needed|0|||
48412756|NCT02162862|155698963|FG002|Overall Study|Subject did not feel the med was needed|4|||
48412757|NCT01552057|155698969|FG000|Overall Study|Adverse Event|14|||
48412758|NCT01552057|155698970|FG001|Overall Study|Adverse Event|15|||
48412759|NCT01552057|155698969|FG000|Overall Study|Lack of Efficacy|8|||
48412760|NCT01552057|155698970|FG001|Overall Study|Lack of Efficacy|23|||
48412761|NCT01552057|155698969|FG000|Overall Study|Withdrawal by Subject|5|||
48412762|NCT01552057|155698970|FG001|Overall Study|Withdrawal by Subject|8|||
48412763|NCT01552057|155698969|FG000|Overall Study|Entry Criteria Not Met|2|||
48412764|NCT01552057|155698970|FG001|Overall Study|Entry Criteria Not Met|2|||
48412765|NCT01552057|155698969|FG000|Overall Study|Physician Decision|1|||
48412766|NCT01552057|155698970|FG001|Overall Study|Physician Decision|0|||
48412767|NCT00542191|155698971|FG000|Overall Study|Death|3|||
48412768|NCT02581995|155698981|FG000|Overall Study|Unspecified other|3|||
48412769|NCT02581995|155698981|FG000|Overall Study|Adverse Event|6|||
48412770|NCT02581995|155698981|FG000|Overall Study|Lost to Follow-up|5|||
48412771|NCT02581995|155698981|FG000|Overall Study|Withdrawal by participant|12|||
48412772|NCT02581995|155698981|FG000|Overall Study|Physician Decision|1|||
48412773|NCT02581995|155698981|FG000|Overall Study|Death|4|||
48412774|NCT03617705|155698982|FG000|Overall Study|Withdrawal by Subject|2|||
48412775|NCT03617705|155698982|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
48412776|NCT03617705|155698982|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
48412777|NCT00733902|155698983|FG000|Overall Study|Death|0|||
48412778|NCT00733902|155698984|FG001|Overall Study|Death|0|||
48412779|NCT00733902|155698985|FG002|Overall Study|Death|0|||
48412780|NCT00733902|155698986|FG003|Overall Study|Death|1|||
48412781|NCT00733902|155698983|FG000|Overall Study|Adverse Event|3|||
48412782|NCT00733902|155698984|FG001|Overall Study|Adverse Event|4|||
48412783|NCT00733902|155698985|FG002|Overall Study|Adverse Event|7|||
48361056|NCT03635099|155515494|FG001|Period 1|Protocol Violation|0|||
48361057|NCT03635099|155515495|FG002|Period 1|Protocol Violation|1|||
48361058|NCT03635099|155515496|FG003|Period 1|Protocol Violation|0|||
48361059|NCT03635099|155515497|FG004|Period 1|Protocol Violation|0|||
48361060|NCT03635099|155515498|FG005|Period 1|Protocol Violation|0|||
48361061|NCT03635099|155515499|FG006|Period 1|Protocol Violation|0|||
48361062|NCT03635099|155515500|FG007|Period 1|Protocol Violation|0|||
48361063|NCT03635099|155515493|FG000|Period 1|Lost to Follow-up|0|||
48361064|NCT03635099|155515494|FG001|Period 1|Lost to Follow-up|0|||
48361065|NCT03635099|155515495|FG002|Period 1|Lost to Follow-up|1|||
48361066|NCT03635099|155515496|FG003|Period 1|Lost to Follow-up|2|||
48361067|NCT03635099|155515497|FG004|Period 1|Lost to Follow-up|1|||
48361068|NCT03635099|155515498|FG005|Period 1|Lost to Follow-up|0|||
48361069|NCT03635099|155515499|FG006|Period 1|Lost to Follow-up|1|||
48361070|NCT03635099|155515500|FG007|Period 1|Lost to Follow-up|2|||
48361071|NCT03635099|155515493|FG000|Period 1|Withdrawal by Subject|3|||
48361072|NCT03635099|155515494|FG001|Period 1|Withdrawal by Subject|3|||
48361073|NCT03635099|155515495|FG002|Period 1|Withdrawal by Subject|5|||
48361074|NCT03635099|155515496|FG003|Period 1|Withdrawal by Subject|2|||
48361075|NCT03635099|155515497|FG004|Period 1|Withdrawal by Subject|2|||
48361076|NCT03635099|155515498|FG005|Period 1|Withdrawal by Subject|0|||
48361077|NCT03635099|155515499|FG006|Period 1|Withdrawal by Subject|3|||
48361078|NCT03635099|155515500|FG007|Period 1|Withdrawal by Subject|0|||
48361079|NCT03635099|155515493|FG000|Period 1|History of suicidal ideation|0|||
48361080|NCT03635099|155515494|FG001|Period 1|History of suicidal ideation|0|||
48412784|NCT00733902|155698986|FG003|Overall Study|Adverse Event|11|||
48412785|NCT00733902|155698983|FG000|Overall Study|Lack of Efficacy|56|||
48412786|NCT00733902|155698984|FG001|Overall Study|Lack of Efficacy|21|||
48412787|NCT00733902|155698985|FG002|Overall Study|Lack of Efficacy|34|||
48361081|NCT03635099|155515495|FG002|Period 1|History of suicidal ideation|1|||
48361082|NCT03635099|155515496|FG003|Period 1|History of suicidal ideation|0|||
48361083|NCT03635099|155515497|FG004|Period 1|History of suicidal ideation|0|||
48412788|NCT00733902|155698986|FG003|Overall Study|Lack of Efficacy|23|||
48361084|NCT03635099|155515498|FG005|Period 1|History of suicidal ideation|0|||
48412789|NCT00733902|155698983|FG000|Overall Study|Protocol Violation|4|||
48412790|NCT00733902|155698984|FG001|Overall Study|Protocol Violation|6|||
48412791|NCT00733902|155698985|FG002|Overall Study|Protocol Violation|3|||
48412792|NCT00733902|155698986|FG003|Overall Study|Protocol Violation|3|||
48412793|NCT00733902|155698983|FG000|Overall Study|Withdrawal by Subject|10|||
48412794|NCT00733902|155698984|FG001|Overall Study|Withdrawal by Subject|5|||
48361085|NCT03635099|155515499|FG006|Period 1|History of suicidal ideation|0|||
48361086|NCT03635099|155515500|FG007|Period 1|History of suicidal ideation|0|||
48361087|NCT03635099|155515493|FG000|Period 1|pursue other treatment options|0|||
48361088|NCT03635099|155515494|FG001|Period 1|pursue other treatment options|0|||
48361089|NCT03635099|155515495|FG002|Period 1|pursue other treatment options|0|||
48361090|NCT03635099|155515496|FG003|Period 1|pursue other treatment options|0|||
48361091|NCT03635099|155515497|FG004|Period 1|pursue other treatment options|0|||
48361092|NCT03635099|155515498|FG005|Period 1|pursue other treatment options|1|||
48361093|NCT03635099|155515499|FG006|Period 1|pursue other treatment options|0|||
48361094|NCT03635099|155515500|FG007|Period 1|pursue other treatment options|0|||
48361095|NCT03635099|155515493|FG000|Not Eligible for Period 2|Pregnancy|0|||
48361096|NCT03635099|155515494|FG001|Not Eligible for Period 2|Pregnancy|0|||
48361097|NCT03635099|155515495|FG002|Not Eligible for Period 2|Pregnancy|0|||
48361098|NCT03635099|155515496|FG003|Not Eligible for Period 2|Pregnancy|1|||
48361099|NCT03635099|155515497|FG004|Not Eligible for Period 2|Pregnancy|0|||
48361100|NCT03635099|155515498|FG005|Not Eligible for Period 2|Pregnancy|0|||
48361101|NCT03635099|155515499|FG006|Not Eligible for Period 2|Pregnancy|0|||
48361102|NCT03635099|155515500|FG007|Not Eligible for Period 2|Pregnancy|0|||
48361103|NCT03635099|155515493|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
48361104|NCT03635099|155515494|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
48361105|NCT03635099|155515495|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
48361106|NCT03635099|155515496|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
48361107|NCT03635099|155515497|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
48361108|NCT03635099|155515498|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
48361109|NCT03635099|155515499|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
48361110|NCT03635099|155515500|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
48361111|NCT03635099|155515493|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48361112|NCT03635099|155515494|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48361113|NCT03635099|155515495|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48361114|NCT03635099|155515496|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48361115|NCT03635099|155515497|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
48361116|NCT03635099|155515498|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
48361117|NCT03635099|155515499|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
48361118|NCT03635099|155515500|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
48361119|NCT03635099|155515493|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
48361120|NCT03635099|155515494|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
48361121|NCT03635099|155515495|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
48361122|NCT03635099|155515496|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
48361123|NCT03635099|155515497|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
48361124|NCT03635099|155515498|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
48361125|NCT03635099|155515499|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
48361126|NCT03635099|155515500|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
48361127|NCT03635099|155515493|FG000|Period 2|Adverse Event|0|||
48361128|NCT03635099|155515494|FG001|Period 2|Adverse Event|0|||
48361129|NCT03635099|155515495|FG002|Period 2|Adverse Event|1|||
48361130|NCT03635099|155515496|FG003|Period 2|Adverse Event|0|||
48361131|NCT03635099|155515497|FG004|Period 2|Adverse Event|1|||
48361132|NCT03635099|155515498|FG005|Period 2|Adverse Event|0|||
48361133|NCT03635099|155515499|FG006|Period 2|Adverse Event|0|||
48361134|NCT03635099|155515500|FG007|Period 2|Adverse Event|0|||
48361135|NCT03635099|155515493|FG000|Period 2|Lost to Follow-up|0|||
48361136|NCT03635099|155515494|FG001|Period 2|Lost to Follow-up|0|||
48361137|NCT03635099|155515495|FG002|Period 2|Lost to Follow-up|1|||
48361138|NCT03635099|155515496|FG003|Period 2|Lost to Follow-up|0|||
48361139|NCT03635099|155515497|FG004|Period 2|Lost to Follow-up|4|||
48361140|NCT03635099|155515498|FG005|Period 2|Lost to Follow-up|0|||
48361141|NCT03635099|155515499|FG006|Period 2|Lost to Follow-up|0|||
48361142|NCT03635099|155515500|FG007|Period 2|Lost to Follow-up|0|||
48361143|NCT03635099|155515493|FG000|Period 2|Withdrawal by Subject|0|||
48361144|NCT03635099|155515494|FG001|Period 2|Withdrawal by Subject|0|||
48361145|NCT03635099|155515495|FG002|Period 2|Withdrawal by Subject|7|||
48361146|NCT03635099|155515496|FG003|Period 2|Withdrawal by Subject|4|||
48361147|NCT03635099|155515497|FG004|Period 2|Withdrawal by Subject|7|||
48361148|NCT03635099|155515498|FG005|Period 2|Withdrawal by Subject|0|||
48361149|NCT03635099|155515499|FG006|Period 2|Withdrawal by Subject|0|||
48361150|NCT03635099|155515500|FG007|Period 2|Withdrawal by Subject|0|||
48361151|NCT01068665|155515501|FG000|Overall Study|Adverse Event|5|||
48361152|NCT01068665|155515502|FG001|Overall Study|Adverse Event|4|||
48361153|NCT01068665|155515501|FG000|Overall Study|Lack of Efficacy|0|||
48361154|NCT01068665|155515502|FG001|Overall Study|Lack of Efficacy|2|||
48361155|NCT01068665|155515501|FG000|Overall Study|Protocol Violation|5|||
48361156|NCT01068665|155515502|FG001|Overall Study|Protocol Violation|2|||
48361157|NCT01068665|155515501|FG000|Overall Study|Withdrawal Criteria|3|||
48361158|NCT01068665|155515502|FG001|Overall Study|Withdrawal Criteria|9|||
48361159|NCT01068665|155515501|FG000|Overall Study|Other|17|||
48361160|NCT01068665|155515502|FG001|Overall Study|Other|12|||
48361161|NCT01162863|155515510|FG000|Overall Study|Lack of Efficacy|1|||
48361162|NCT01162863|155515511|FG001|Overall Study|Lack of Efficacy|0|||
48361163|NCT01162863|155515512|FG002|Overall Study|Lack of Efficacy|0|||
48361164|NCT01162863|155515510|FG000|Overall Study|Adverse Event|0|||
48361165|NCT01162863|155515511|FG001|Overall Study|Adverse Event|1|||
48361166|NCT01162863|155515512|FG002|Overall Study|Adverse Event|0|||
48361167|NCT04230122|155515514|FG000|Overall Study|Lost to Follow-up|1|||
48361168|NCT04230122|155515515|FG001|Overall Study|Lost to Follow-up|0|||
48361169|NCT01696955|155515516|FG000|Main Study|Protocol Violation|1|||
48361170|NCT01696955|155515517|FG001|Main Study|Protocol Violation|0|||
48361171|NCT01696955|155515516|FG000|Main Study|Withdrawal by Subject|1|||
48361172|NCT01696955|155515517|FG001|Main Study|Withdrawal by Subject|1|||
48361173|NCT04531904|155515525|FG000|Overall Study|Lost to Follow-up|1|||
48361174|NCT04531904|155515525|FG000|Overall Study|Death|14|||
48361175|NCT02628028|155515526|FG000|Dosing Period|Withdrawal by Subject|0|||
48361176|NCT02628028|155515527|FG001|Dosing Period|Withdrawal by Subject|0|||
48361177|NCT02628028|155515528|FG002|Dosing Period|Withdrawal by Subject|1|||
48361178|NCT02628028|155515529|FG003|Dosing Period|Withdrawal by Subject|0|||
48361179|NCT02628028|155515530|FG004|Dosing Period|Withdrawal by Subject|2|||
48361180|NCT02628028|155515531|FG005|Dosing Period|Withdrawal by Subject|4|||
48361181|NCT02628028|155515532|FG006|Dosing Period|Withdrawal by Subject|1|||
48361182|NCT02628028|155515533|FG007|Dosing Period|Withdrawal by Subject|1|||
48361183|NCT02628028|155515526|FG000|Dosing Period|Adverse Event|0|||
48361184|NCT02628028|155515527|FG001|Dosing Period|Adverse Event|0|||
48361185|NCT02628028|155515528|FG002|Dosing Period|Adverse Event|0|||
48361186|NCT02628028|155515529|FG003|Dosing Period|Adverse Event|0|||
48361187|NCT02628028|155515530|FG004|Dosing Period|Adverse Event|2|||
48361188|NCT02628028|155515531|FG005|Dosing Period|Adverse Event|1|||
48361189|NCT02628028|155515532|FG006|Dosing Period|Adverse Event|3|||
48361190|NCT02628028|155515533|FG007|Dosing Period|Adverse Event|2|||
48361191|NCT02628028|155515526|FG000|Dosing Period|Death|0|||
48361192|NCT02628028|155515527|FG001|Dosing Period|Death|0|||
48361193|NCT02628028|155515528|FG002|Dosing Period|Death|0|||
48361194|NCT02628028|155515529|FG003|Dosing Period|Death|0|||
48361195|NCT02628028|155515530|FG004|Dosing Period|Death|0|||
48361196|NCT02628028|155515531|FG005|Dosing Period|Death|0|||
48361197|NCT02628028|155515532|FG006|Dosing Period|Death|0|||
48361198|NCT02628028|155515533|FG007|Dosing Period|Death|1|||
48361199|NCT02628028|155515526|FG000|Dosing Period|Lack of Efficacy|0|||
48361200|NCT02628028|155515527|FG001|Dosing Period|Lack of Efficacy|0|||
48361201|NCT02628028|155515528|FG002|Dosing Period|Lack of Efficacy|0|||
48361202|NCT02628028|155515529|FG003|Dosing Period|Lack of Efficacy|0|||
48412795|NCT00733902|155698985|FG002|Overall Study|Withdrawal by Subject|4|||
48412796|NCT00733902|155698986|FG003|Overall Study|Withdrawal by Subject|16|||
48412797|NCT00733902|155698983|FG000|Overall Study|Entered extension study|89|||
48412798|NCT00733902|155698984|FG001|Overall Study|Entered extension study|124|||
48412799|NCT00733902|155698985|FG002|Overall Study|Entered extension study|111|||
48412800|NCT00733902|155698986|FG003|Overall Study|Entered extension study|109|||
48361203|NCT02628028|155515530|FG004|Dosing Period|Lack of Efficacy|3|||
48412801|NCT00733902|155698983|FG000|Overall Study|Randomized but not treated|2|||
48412802|NCT00733902|155698984|FG001|Overall Study|Randomized but not treated|2|||
48412803|NCT00733902|155698985|FG002|Overall Study|Randomized but not treated|2|||
48412804|NCT00733902|155698986|FG003|Overall Study|Randomized but not treated|1|||
48412805|NCT03293654|155698987|FG000|Overall Study|Lost to Follow-up|0|||
48412806|NCT03293654|155698988|FG001|Overall Study|Lost to Follow-up|1|||
48412807|NCT03293654|155698989|FG002|Overall Study|Lost to Follow-up|0|||
48412808|NCT01491178|155698990|FG000|Overall Study|Adverse Event|1016|||
48361204|NCT02628028|155515531|FG005|Dosing Period|Lack of Efficacy|0|||
48361205|NCT02628028|155515532|FG006|Dosing Period|Lack of Efficacy|1|||
48361206|NCT02628028|155515533|FG007|Dosing Period|Lack of Efficacy|0|||
48412809|NCT01491178|155698990|FG000|Overall Study|Improvement of NVAF|210|||
48361207|NCT02628028|155515526|FG000|Dosing Period|Study Terminated by Sponsor|0|||
48361208|NCT02628028|155515527|FG001|Dosing Period|Study Terminated by Sponsor|0|||
48361209|NCT02628028|155515528|FG002|Dosing Period|Study Terminated by Sponsor|0|||
48361210|NCT02628028|155515529|FG003|Dosing Period|Study Terminated by Sponsor|0|||
48361211|NCT02628028|155515530|FG004|Dosing Period|Study Terminated by Sponsor|7|||
48361212|NCT02628028|155515531|FG005|Dosing Period|Study Terminated by Sponsor|6|||
48361213|NCT02628028|155515532|FG006|Dosing Period|Study Terminated by Sponsor|7|||
48361214|NCT02628028|155515533|FG007|Dosing Period|Study Terminated by Sponsor|7|||
48412810|NCT01491178|155698990|FG000|Overall Study|To conduct invasive treatment|59|||
48361215|NCT02628028|155515526|FG000|Dosing Period|Physician Decision|0|||
48361216|NCT02628028|155515527|FG001|Dosing Period|Physician Decision|0|||
48361217|NCT02628028|155515528|FG002|Dosing Period|Physician Decision|0|||
48412811|NCT01491178|155698990|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
48431452|NCT00002663|155767267|FG003|Overall Study|Adverse Event|1|||
48361218|NCT02628028|155515529|FG003|Dosing Period|Physician Decision|0|||
48361219|NCT02628028|155515530|FG004|Dosing Period|Physician Decision|0|||
48361220|NCT02628028|155515531|FG005|Dosing Period|Physician Decision|1|||
48361221|NCT02628028|155515532|FG006|Dosing Period|Physician Decision|0|||
48361222|NCT02628028|155515533|FG007|Dosing Period|Physician Decision|0|||
48361223|NCT02628028|155515526|FG000|Dosing Period|Site Terminated by Sponsor|0|||
48361224|NCT02628028|155515527|FG001|Dosing Period|Site Terminated by Sponsor|0|||
48361225|NCT02628028|155515528|FG002|Dosing Period|Site Terminated by Sponsor|0|||
48361226|NCT02628028|155515529|FG003|Dosing Period|Site Terminated by Sponsor|0|||
48361227|NCT02628028|155515530|FG004|Dosing Period|Site Terminated by Sponsor|0|||
48361228|NCT02628028|155515531|FG005|Dosing Period|Site Terminated by Sponsor|1|||
48361229|NCT02628028|155515532|FG006|Dosing Period|Site Terminated by Sponsor|1|||
48361230|NCT02628028|155515533|FG007|Dosing Period|Site Terminated by Sponsor|0|||
48361231|NCT02628028|155515526|FG000|Dosing Period|Lost to Follow-up|0|||
48361232|NCT02628028|155515527|FG001|Dosing Period|Lost to Follow-up|0|||
48361233|NCT02628028|155515528|FG002|Dosing Period|Lost to Follow-up|0|||
48361234|NCT02628028|155515529|FG003|Dosing Period|Lost to Follow-up|0|||
48361235|NCT02628028|155515530|FG004|Dosing Period|Lost to Follow-up|0|||
48361236|NCT02628028|155515531|FG005|Dosing Period|Lost to Follow-up|0|||
48361237|NCT02628028|155515532|FG006|Dosing Period|Lost to Follow-up|1|||
48361238|NCT02628028|155515533|FG007|Dosing Period|Lost to Follow-up|0|||
48361239|NCT02628028|155515526|FG000|Dosing Period|Other|0|||
48361240|NCT02628028|155515527|FG001|Dosing Period|Other|0|||
48361241|NCT02628028|155515528|FG002|Dosing Period|Other|0|||
48361242|NCT02628028|155515529|FG003|Dosing Period|Other|0|||
48361243|NCT02628028|155515530|FG004|Dosing Period|Other|2|||
48361244|NCT02628028|155515531|FG005|Dosing Period|Other|1|||
48361245|NCT02628028|155515532|FG006|Dosing Period|Other|2|||
48361246|NCT02628028|155515533|FG007|Dosing Period|Other|4|||
48361247|NCT02628028|155515526|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
48361248|NCT02628028|155515527|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
48361249|NCT02628028|155515528|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
48361250|NCT02628028|155515529|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
48361251|NCT02628028|155515530|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
48361252|NCT02628028|155515531|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
48361253|NCT02628028|155515532|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
48361254|NCT02628028|155515533|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
48361255|NCT02628028|155515526|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48361256|NCT02628028|155515527|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48361257|NCT02628028|155515528|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48361258|NCT02628028|155515529|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48361259|NCT02628028|155515530|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48361260|NCT02628028|155515531|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
48361261|NCT02628028|155515532|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
48361262|NCT02628028|155515533|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
48361263|NCT02628028|155515526|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48361264|NCT02628028|155515527|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48361265|NCT02628028|155515528|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48361266|NCT02628028|155515529|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48361267|NCT02628028|155515530|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
48361268|NCT02628028|155515531|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
48361269|NCT02628028|155515532|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
48361270|NCT02628028|155515533|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
48361271|NCT02628028|155515526|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48361272|NCT02628028|155515527|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48361273|NCT02628028|155515528|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48361274|NCT02628028|155515529|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48361275|NCT02628028|155515530|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
48361276|NCT02628028|155515531|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
48361277|NCT02628028|155515532|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
48361278|NCT02628028|155515533|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
48361279|NCT02628028|155515526|FG000|Long-term Extension (LTE) Period|Other|0|||
48361280|NCT02628028|155515527|FG001|Long-term Extension (LTE) Period|Other|0|||
48361281|NCT02628028|155515528|FG002|Long-term Extension (LTE) Period|Other|0|||
48361282|NCT02628028|155515529|FG003|Long-term Extension (LTE) Period|Other|0|||
48361283|NCT02628028|155515530|FG004|Long-term Extension (LTE) Period|Other|0|||
48361284|NCT02628028|155515531|FG005|Long-term Extension (LTE) Period|Other|3|||
48361285|NCT02628028|155515532|FG006|Long-term Extension (LTE) Period|Other|4|||
48361286|NCT02628028|155515533|FG007|Long-term Extension (LTE) Period|Other|3|||
48361287|NCT03835754|155515536|FG000|Overall Study|Death|4|||
48361288|NCT02737826|155517875|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
48361289|NCT02737826|155517876|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
48361290|NCT02737826|155517877|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
48361291|NCT02666664|155517878|FG000|Overall Study|Physician Decision|0|||
48361292|NCT02666664|155517879|FG001|Overall Study|Physician Decision|1|||
48361293|NCT02666664|155517878|FG000|Overall Study|Protocol Violation|0|||
48361294|NCT02666664|155517879|FG001|Overall Study|Protocol Violation|2|||
48361295|NCT02666664|155517878|FG000|Overall Study|Other|0|||
48361296|NCT02666664|155517879|FG001|Overall Study|Other|1|||
48361297|NCT02666664|155517878|FG000|Overall Study|Adverse Event|12|||
48361298|NCT02666664|155517879|FG001|Overall Study|Adverse Event|37|||
48361299|NCT02666664|155517878|FG000|Overall Study|Withdrawal by participant|23|||
48361300|NCT02666664|155517879|FG001|Overall Study|Withdrawal by participant|40|||
48361301|NCT02666664|155517878|FG000|Overall Study|Sponsor decision|0|||
48361302|NCT02666664|155517879|FG001|Overall Study|Sponsor decision|1|||
48412812|NCT01491178|155698990|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
48412813|NCT01491178|155698990|FG000|Overall Study|To take a contraindication|20|||
48412814|NCT01491178|155698990|FG000|Overall Study|Other than specified above|657|||
48412815|NCT00395967|155698991|FG000|Treatment Period|Failed Mobilization|1|||
48412816|NCT00395967|155698991|FG000|Follow-up Period|Death|1|||
48412817|NCT00395967|155698991|FG000|Follow-up Period|Lost to Follow-up|1|||
48412818|NCT02542267|155698992|FG000|Overall Study|Withdrawal by Subject|10|||
48412819|NCT02542267|155698992|FG000|Overall Study|Physician Decision|6|||
48412820|NCT02542267|155698992|FG000|Overall Study|Lost to Follow-up|4|||
48412821|NCT02542267|155698992|FG000|Overall Study|Death|13|||
48412822|NCT02542267|155698992|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
48412823|NCT02542267|155698992|FG000|Overall Study|Other|9|||
48361303|NCT02666664|155517878|FG000|Overall Study|Lost to Follow-up|1|||
48361304|NCT02666664|155517879|FG001|Overall Study|Lost to Follow-up|2|||
48361305|NCT02550938|155517880|FG000|Overall Study|Lost to Follow-up|8|||
48361306|NCT02550938|155517881|FG001|Overall Study|Lost to Follow-up|7|||
48361307|NCT02550938|155517882|FG002|Overall Study|Lost to Follow-up|12|||
48361308|NCT02550938|155517883|FG003|Overall Study|Lost to Follow-up|11|||
48361309|NCT00667225|155517889|FG000|Overall Study|Subject had no more lesions to treat.|1|||
48361310|NCT00667225|155517890|FG001|Overall Study|Subject had no more lesions to treat.|0|||
48361311|NCT00667225|155517889|FG000|Overall Study|Lost to Follow-up|0|||
48361312|NCT00667225|155517890|FG001|Overall Study|Lost to Follow-up|1|||
48361313|NCT05262517|155517891|FG000|Overall Study|Randomized but not treated|5|||
48361314|NCT05262517|155517892|FG001|Overall Study|Randomized but not treated|11|||
48361315|NCT01896557|155517897|FG000|Clopidogrel Alone|Adverse Event|1|||
48361316|NCT01896557|155517898|FG001|Clopidogrel Alone|Adverse Event|0|||
48361317|NCT01896557|155517897|FG000|Clopidogrel + GI Protector|low adherence|1|||
48412824|NCT03049449|155698996|FG000|Overall Study|Did not receive treatment.|0|||
48361318|NCT01896557|155517898|FG001|Clopidogrel + GI Protector|low adherence|1|||
48361319|NCT01896557|155517897|FG000|Clopidogrel + GI Protector|Reading error|1|||
48361320|NCT01896557|155517898|FG001|Clopidogrel + GI Protector|Reading error|3|||
48361321|NCT03301155|155517899|FG000|Overall Study|Сompliance with exclusion criteria|8|||
48361322|NCT03301155|155517900|FG001|Overall Study|Сompliance with exclusion criteria|7|||
48361323|NCT04939701|155517906|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
48361324|NCT04939701|155517907|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
48361325|NCT04939701|155517908|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
48361326|NCT04939701|155517906|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
48361327|NCT04939701|155517907|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
48361328|NCT04939701|155517908|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
48361329|NCT04939701|155517906|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
48361330|NCT04939701|155517907|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
48361331|NCT04939701|155517908|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
48361332|NCT04939701|155517906|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
48361333|NCT04939701|155517907|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
48361334|NCT04939701|155517908|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
48412825|NCT03049449|155698997|FG001|Overall Study|Did not receive treatment.|0|||
48412826|NCT03049449|155698998|FG002|Overall Study|Did not receive treatment.|0|||
48412827|NCT03049449|155698999|FG003|Overall Study|Did not receive treatment.|0|||
48412828|NCT03049449|155699000|FG004|Overall Study|Did not receive treatment.|0|||
48412829|NCT03049449|155699001|FG005|Overall Study|Did not receive treatment.|0|||
48412830|NCT03049449|155699002|FG006|Overall Study|Did not receive treatment.|0|||
48412831|NCT03049449|155699003|FG007|Overall Study|Did not receive treatment.|0|||
48361335|NCT04939701|155517906|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
48361336|NCT04939701|155517907|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
48361337|NCT04939701|155517908|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
48412832|NCT03049449|155699004|FG008|Overall Study|Did not receive treatment.|1|||
48361338|NCT04939701|155517906|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
48361339|NCT04939701|155517907|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
48361340|NCT04939701|155517908|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
48412833|NCT03049449|155699005|FG009|Overall Study|Did not receive treatment.|0|||
48412834|NCT03049449|155698996|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
48361341|NCT04939701|155517906|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
48361342|NCT04939701|155517907|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
48361343|NCT04939701|155517908|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
48412835|NCT03049449|155698997|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
48412836|NCT03049449|155698998|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
48412837|NCT03049449|155698999|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
48412838|NCT03049449|155699000|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
48412839|NCT03049449|155699001|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
48412840|NCT03049449|155699002|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
48412841|NCT03049449|155699003|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
48412842|NCT03049449|155699004|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
48412843|NCT03049449|155699005|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
48412844|NCT03049449|155698996|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48412845|NCT03049449|155698997|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48412846|NCT03049449|155698998|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48412847|NCT03049449|155698999|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48412848|NCT03049449|155699000|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48412849|NCT03049449|155699001|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48412850|NCT03049449|155699002|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48412851|NCT03049449|155699003|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
48412852|NCT03049449|155699004|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
48412853|NCT03049449|155699005|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
48412854|NCT04698525|155699006|FG000|Overall Study|Lost to Follow-up|1|||
48412855|NCT04698525|155699007|FG001|Overall Study|Lost to Follow-up|2|||
48412856|NCT04698525|155699006|FG000|Overall Study|Three suffered of Covid-19|2|||
48412857|NCT04698525|155699007|FG001|Overall Study|Three suffered of Covid-19|1|||
48412858|NCT00474240|155699012|FG000|Overall Study|Withdrawal by Subject|1|||
48412859|NCT00474240|155699013|FG001|Overall Study|Withdrawal by Subject|1|||
48412860|NCT00474240|155699014|FG002|Overall Study|Withdrawal by Subject|0|||
48412861|NCT00474240|155699015|FG003|Overall Study|Withdrawal by Subject|2|||
48412862|NCT00474240|155699016|FG004|Overall Study|Withdrawal by Subject|3|||
48412863|NCT00474240|155699017|FG005|Overall Study|Withdrawal by Subject|1|||
48361344|NCT01519089|155517909|FG000|Overall Study|Adverse Event|4|||
48361345|NCT01519089|155517910|FG001|Overall Study|Adverse Event|4|||
48361346|NCT01519089|155517909|FG000|Overall Study|Lack of Efficacy|0|||
48361347|NCT01519089|155517910|FG001|Overall Study|Lack of Efficacy|2|||
48361348|NCT01519089|155517909|FG000|Overall Study|Lost to Follow-up|1|||
48361349|NCT01519089|155517910|FG001|Overall Study|Lost to Follow-up|0|||
48361350|NCT01519089|155517909|FG000|Overall Study|Withdrawal by Subject|0|||
48361351|NCT01519089|155517910|FG001|Overall Study|Withdrawal by Subject|2|||
48412864|NCT00474240|155699012|FG000|Overall Study|Adverse Event|0|||
48412865|NCT00474240|155699013|FG001|Overall Study|Adverse Event|0|||
48412866|NCT00474240|155699014|FG002|Overall Study|Adverse Event|9|||
48412867|NCT00474240|155699015|FG003|Overall Study|Adverse Event|14|||
48412868|NCT00474240|155699016|FG004|Overall Study|Adverse Event|5|||
48412869|NCT00474240|155699017|FG005|Overall Study|Adverse Event|16|||
48412870|NCT00474240|155699012|FG000|Overall Study|Removed due to lab value|0|||
48412871|NCT00474240|155699013|FG001|Overall Study|Removed due to lab value|0|||
48412872|NCT00474240|155699014|FG002|Overall Study|Removed due to lab value|0|||
48412873|NCT00474240|155699015|FG003|Overall Study|Removed due to lab value|0|||
48412874|NCT00474240|155699016|FG004|Overall Study|Removed due to lab value|0|||
48412875|NCT00474240|155699017|FG005|Overall Study|Removed due to lab value|1|||
48412876|NCT02347631|155699018|FG000|First Intervention (2 Months)|Adverse Event|1|||
48412877|NCT02347631|155699019|FG001|First Intervention (2 Months)|Adverse Event|1|||
48361352|NCT01519089|155517909|FG000|Overall Study|Other|2|||
48361353|NCT01519089|155517910|FG001|Overall Study|Other|6|||
48361354|NCT01519089|155517909|FG000|Overall Study|Not received study drug|0|||
48361355|NCT01519089|155517910|FG001|Overall Study|Not received study drug|1|||
48361356|NCT02493062|155517911|FG000|Overall Study|Physician Decision|12|||
48361357|NCT01607879|155517912|FG000|Overall Study|Death|1|||
48361358|NCT01607879|155517913|FG001|Overall Study|Death|0|||
48361359|NCT00384189|155517914|FG000|Overall Study|Reason Not Specified|50|||
48361360|NCT00384189|155517915|FG001|Overall Study|Reason Not Specified|57|||
48361361|NCT00384189|155517916|FG002|Overall Study|Reason Not Specified|58|||
48361362|NCT00384189|155517917|FG003|Overall Study|Reason Not Specified|40|||
48361363|NCT03926195|155517920|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
48361364|NCT03926195|155517921|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
48361365|NCT03926195|155517920|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
48361366|NCT03926195|155517921|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
48361367|NCT03926195|155517920|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
48361368|NCT03926195|155517921|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
48361369|NCT03926195|155517920|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
48361370|NCT03926195|155517921|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
48361371|NCT03926195|155517920|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
48361372|NCT03926195|155517921|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
48361373|NCT03926195|155517920|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
48361374|NCT03926195|155517921|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
48361375|NCT02088957|155517922|FG000|Overall Study|Lack of Efficacy|1|||
48361376|NCT02088957|155517923|FG001|Overall Study|Lack of Efficacy|0|||
48361377|NCT02071290|155517924|FG000|Overall Study|Death|1|||
48361378|NCT02071290|155517925|FG001|Overall Study|Death|0|||
48361379|NCT02071290|155517924|FG000|Overall Study|Withdrawal by Subject|0|||
48361380|NCT02071290|155517925|FG001|Overall Study|Withdrawal by Subject|1|||
48361381|NCT02071290|155517924|FG000|Overall Study|Protocol Violation|3|||
48361382|NCT02071290|155517925|FG001|Overall Study|Protocol Violation|5|||
48361383|NCT02071290|155517924|FG000|Overall Study|Physician Decision|0|||
48361384|NCT02071290|155517925|FG001|Overall Study|Physician Decision|1|||
48361385|NCT03338296|155517926|FG000|Overall Study|Adverse Event|0|||
48361386|NCT03338296|155517927|FG001|Overall Study|Adverse Event|1|||
48361387|NCT03338296|155517926|FG000|Overall Study|Withdrawal by Subject|14|||
48361388|NCT03338296|155517927|FG001|Overall Study|Withdrawal by Subject|13|||
48361389|NCT03338296|155517926|FG000|Overall Study|Lost to Follow-up|10|||
48361390|NCT03338296|155517927|FG001|Overall Study|Lost to Follow-up|10|||
48361391|NCT03338296|155517926|FG000|Overall Study|Study Terminated by Sponsor|77|||
48361392|NCT03338296|155517927|FG001|Overall Study|Study Terminated by Sponsor|76|||
48361393|NCT03338296|155517926|FG000|Overall Study|Other|2|||
48361394|NCT03338296|155517927|FG001|Overall Study|Other|7|||
48361395|NCT03338296|155517926|FG000|Overall Study|Missing|0|||
48361396|NCT03338296|155517927|FG001|Overall Study|Missing|1|||
48361397|NCT02175641|155517930|FG000|Overall Study|Death|3|||
48361398|NCT02175641|155517931|FG001|Overall Study|Death|4|||
48361399|NCT02175641|155517930|FG000|Overall Study|Lost to Follow-up|4|||
48361400|NCT02175641|155517931|FG001|Overall Study|Lost to Follow-up|4|||
48361401|NCT02175641|155517930|FG000|Overall Study|Withdrawal by Subject|7|||
48361402|NCT02175641|155517931|FG001|Overall Study|Withdrawal by Subject|4|||
48361403|NCT02175641|155517930|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
48361404|NCT02175641|155517931|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
48361405|NCT02175641|155517930|FG000|Overall Study|Developed Contraindicated Condition|8|||
48361406|NCT02175641|155517931|FG001|Overall Study|Developed Contraindicated Condition|0|||
48361407|NCT01725126|155517932|FG000|Overall Study|Protocol Violation|0|||
48361408|NCT01725126|155517933|FG001|Overall Study|Protocol Violation|1|||
48361409|NCT01725126|155517934|FG002|Overall Study|Protocol Violation|0|||
48361410|NCT01725126|155517935|FG003|Overall Study|Protocol Violation|0|||
48361411|NCT01725126|155517936|FG004|Overall Study|Protocol Violation|0|||
48361412|NCT01725126|155517937|FG005|Overall Study|Protocol Violation|0|||
48361413|NCT01725126|155517932|FG000|Overall Study|Withdrawal by Subject|0|||
48361414|NCT01725126|155517933|FG001|Overall Study|Withdrawal by Subject|0|||
48361415|NCT01725126|155517934|FG002|Overall Study|Withdrawal by Subject|0|||
48361416|NCT01725126|155517935|FG003|Overall Study|Withdrawal by Subject|1|||
48361417|NCT01725126|155517936|FG004|Overall Study|Withdrawal by Subject|0|||
48361418|NCT01725126|155517937|FG005|Overall Study|Withdrawal by Subject|0|||
48361419|NCT00479882|155517942|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
48361420|NCT00479882|155517943|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
48361421|NCT00479882|155517944|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
48361422|NCT00479882|155517945|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
48361423|NCT00479882|155517942|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
48361424|NCT00479882|155517943|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
48361425|NCT00479882|155517944|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
48361426|NCT00479882|155517945|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
48361427|NCT00479882|155517942|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
48361428|NCT00479882|155517943|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
48361429|NCT00479882|155517944|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
48361430|NCT00479882|155517945|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
48361431|NCT00479882|155517942|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
48361432|NCT00479882|155517943|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
48361433|NCT00479882|155517944|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
48361434|NCT00479882|155517945|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
48361435|NCT00479882|155517942|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
48361436|NCT00479882|155517943|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
48361437|NCT00479882|155517944|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
48361438|NCT00479882|155517945|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
48361439|NCT00479882|155517942|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
48361440|NCT00479882|155517943|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
48361441|NCT00479882|155517944|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
48361442|NCT00479882|155517945|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
48361443|NCT00479882|155517942|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
48361444|NCT00479882|155517943|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
48361445|NCT00479882|155517944|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
48361446|NCT00479882|155517945|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
48361447|NCT00479882|155517942|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
48361448|NCT00479882|155517943|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
48361449|NCT00479882|155517944|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
48361450|NCT00479882|155517945|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
48361451|NCT00479882|155517942|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
48361452|NCT00479882|155517943|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
48361453|NCT00479882|155517944|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
48361454|NCT00479882|155517945|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
48361455|NCT00479882|155517942|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
48412878|NCT02347631|155699018|FG000|First Intervention (2 Months)|Pregnancy|1|||
48412879|NCT02347631|155699019|FG001|First Intervention (2 Months)|Pregnancy|0|||
48412880|NCT02347631|155699018|FG000|First Intervention (2 Months)|Moved out of area|0|||
48412881|NCT02347631|155699019|FG001|First Intervention (2 Months)|Moved out of area|2|||
48412882|NCT02347631|155699018|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
48412883|NCT02347631|155699019|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
48412884|NCT02347631|155699018|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
48412885|NCT02347631|155699019|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
48412886|NCT02347631|155699018|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
48412887|NCT02347631|155699019|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
48412888|NCT02347631|155699018|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
48412889|NCT02347631|155699019|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
48361456|NCT00479882|155517943|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
48361457|NCT00479882|155517944|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
48361458|NCT00479882|155517945|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
48361459|NCT00479882|155517942|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
48361460|NCT00479882|155517943|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
48361461|NCT00479882|155517944|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
48361462|NCT00479882|155517945|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
48361463|NCT00479882|155517942|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
48361464|NCT00479882|155517943|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
48361465|NCT00479882|155517944|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
48361466|NCT00479882|155517945|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
48361467|NCT00479882|155517942|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
48361468|NCT00479882|155517943|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
48361469|NCT00479882|155517944|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
48361470|NCT00479882|155517945|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
48361471|NCT00479882|155517942|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
48412890|NCT02347631|155699018|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
48412891|NCT02347631|155699019|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
48412892|NCT02388295|155699022|FG000|Dose Escalation Week 1|Adverse Event|1|||
48412893|NCT02388295|155699023|FG001|Dose Escalation Week 1|Adverse Event|2|||
48412894|NCT02388295|155699024|FG002|Dose Escalation Week 1|Adverse Event|1|||
48412895|NCT02388295|155699022|FG000|Dose Escalation Week 1|Determined not eligible|1|||
48412896|NCT02388295|155699023|FG001|Dose Escalation Week 1|Determined not eligible|1|||
48412897|NCT02388295|155699024|FG002|Dose Escalation Week 1|Determined not eligible|1|||
48412898|NCT02388295|155699022|FG000|Dose Escalation Week 2|Protocol Violation|0|||
48412899|NCT02388295|155699023|FG001|Dose Escalation Week 2|Protocol Violation|1|||
48361472|NCT00479882|155517943|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
48361473|NCT00479882|155517944|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
48361474|NCT00479882|155517945|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
48361475|NCT02242097|155517953|FG000|Ibrutinib Treatment|Adverse Event|16|||
48361476|NCT02242097|155517953|FG000|Ibrutinib Treatment|Physician Decision|1|||
48361477|NCT02242097|155517953|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
48361478|NCT02242097|155517953|FG000|Ibrutinib Treatment|Death|1|||
48361479|NCT02242097|155517953|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
48361480|NCT02242097|155517953|FG000|Post Therapy Follow Up|Death|3|||
48412900|NCT02388295|155699024|FG002|Dose Escalation Week 2|Protocol Violation|0|||
48412901|NCT02388295|155699022|FG000|Dose Escalation Week 2|Determined not eligible|1|||
48412902|NCT02388295|155699023|FG001|Dose Escalation Week 2|Determined not eligible|1|||
48412903|NCT02388295|155699024|FG002|Dose Escalation Week 2|Determined not eligible|1|||
48412904|NCT02388295|155699022|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
48412905|NCT02388295|155699023|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
48361481|NCT02242097|155517953|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
48361482|NCT02224703|155517954|FG000|Overall Study|Adverse Event|0|||
48361483|NCT02224703|155517955|FG001|Overall Study|Adverse Event|5|||
48361484|NCT02224703|155517956|FG002|Overall Study|Adverse Event|0|||
48361485|NCT02224703|155517954|FG000|Overall Study|Withdrawn by investigator|1|||
48361486|NCT02224703|155517955|FG001|Overall Study|Withdrawn by investigator|0|||
48361487|NCT02224703|155517956|FG002|Overall Study|Withdrawn by investigator|0|||
48361488|NCT02224703|155517954|FG000|Overall Study|Advised by medical monitor|1|||
48361489|NCT02224703|155517955|FG001|Overall Study|Advised by medical monitor|0|||
48361490|NCT02224703|155517956|FG002|Overall Study|Advised by medical monitor|0|||
48361491|NCT02224703|155517954|FG000|Overall Study|Withdrawn by parent/guardian|0|||
48361492|NCT02224703|155517955|FG001|Overall Study|Withdrawn by parent/guardian|1|||
48412906|NCT02388295|155699024|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
48412907|NCT04007159|155699025|FG000|Induction Phase|(missed study visits)|16|||
48412908|NCT04007159|155699025|FG000|Induction Phase|Withdrawal by Subject|4|||
48412909|NCT04007159|155699025|FG000|Induction Phase|Adverse Event|2|||
48361493|NCT02224703|155517956|FG002|Overall Study|Withdrawn by parent/guardian|0|||
48361494|NCT02224703|155517954|FG000|Overall Study|Lack of Efficacy|1|||
48361495|NCT02224703|155517955|FG001|Overall Study|Lack of Efficacy|0|||
48361496|NCT02224703|155517956|FG002|Overall Study|Lack of Efficacy|0|||
48412910|NCT04007159|155699025|FG000|Challenge Phase|missed study visits|3|||
48412911|NCT00331760|155699026|FG000|Overall Study|Ineligible / no protocol treatment|15|||
48412912|NCT00331760|155699027|FG001|Overall Study|Ineligible / no protocol treatment|8|||
48412913|NCT01950819|155699029|FG000|Overall Study|Graft Loss|35|||
48412914|NCT01950819|155699030|FG001|Overall Study|Graft Loss|30|||
48412915|NCT01950819|155699029|FG000|Overall Study|Death|29|||
48412916|NCT01950819|155699030|FG001|Overall Study|Death|34|||
48412917|NCT01950819|155699029|FG000|Overall Study|Subject / Gardian decision|54|||
48412918|NCT01950819|155699030|FG001|Overall Study|Subject / Gardian decision|51|||
48412919|NCT01950819|155699029|FG000|Overall Study|technical problems|2|||
48412920|NCT01950819|155699030|FG001|Overall Study|technical problems|0|||
48412921|NCT01950819|155699029|FG000|Overall Study|Pregnancy|0|||
48412922|NCT01950819|155699030|FG001|Overall Study|Pregnancy|2|||
48412923|NCT01950819|155699029|FG000|Overall Study|Lost to Follow-up|9|||
48412924|NCT01950819|155699030|FG001|Overall Study|Lost to Follow-up|17|||
48412925|NCT00486603|155699035|FG000|Overall Study|Withdrawal by Subject|1|||
48412926|NCT00486603|155699036|FG001|Overall Study|Withdrawal by Subject|0|||
48412927|NCT00486603|155699037|FG002|Overall Study|Withdrawal by Subject|0|||
48361497|NCT01643044|155517957|FG000|Overall Study|Lost to Follow-up|1|||
48361498|NCT01643044|155517958|FG001|Overall Study|Lost to Follow-up|1|||
48361499|NCT01643044|155517957|FG000|Overall Study|Miscarried baby|2|||
48361500|NCT01643044|155517958|FG001|Overall Study|Miscarried baby|2|||
48361501|NCT01643044|155517957|FG000|Overall Study|Delivered outside of hospital|1|||
48361502|NCT01643044|155517958|FG001|Overall Study|Delivered outside of hospital|2|||
48361503|NCT02922023|155517961|FG000|Overall Study|Lost to Follow-up|2|||
48361504|NCT02922023|155517962|FG001|Overall Study|Lost to Follow-up|0|||
48361505|NCT03031496|155517965|FG000|Period 1|Adverse Event|2|||
48361506|NCT03031496|155517966|FG001|Period 1|Adverse Event|0|||
48361507|NCT03031496|155517965|FG000|Period 1|Withdrawal by Subject|0|||
48361508|NCT03031496|155517966|FG001|Period 1|Withdrawal by Subject|2|||
48361509|NCT01685229|155517967|FG000|Overall Study|Subjects missing Study Exit form|3|||
48361510|NCT01685229|155517968|FG001|Overall Study|Subjects missing Study Exit form|1|||
48361511|NCT01685229|155517967|FG000|Overall Study|Lost to Follow-up|16|||
48361512|NCT01685229|155517968|FG001|Overall Study|Lost to Follow-up|10|||
48361513|NCT01685229|155517967|FG000|Overall Study|Withdrawal by Subject|6|||
48361514|NCT01685229|155517968|FG001|Overall Study|Withdrawal by Subject|5|||
48361515|NCT01685229|155517967|FG000|Overall Study|Death|1|||
48361516|NCT01685229|155517968|FG001|Overall Study|Death|0|||
48361517|NCT02574845|155517974|FG000|Overall Study|Consent withdrawn further participation|0|||
48361518|NCT02574845|155517975|FG001|Overall Study|Consent withdrawn further participation|0|||
48361519|NCT02574845|155517976|FG002|Overall Study|Consent withdrawn further participation|0|||
48361520|NCT02574845|155517977|FG003|Overall Study|Consent withdrawn further participation|0|||
48361521|NCT02574845|155517978|FG004|Overall Study|Consent withdrawn further participation|1|||
48361522|NCT02574845|155517979|FG005|Overall Study|Consent withdrawn further participation|0|||
48361523|NCT02574845|155517974|FG000|Overall Study|Adverse Event|0|||
48361524|NCT02574845|155517975|FG001|Overall Study|Adverse Event|1|||
48412928|NCT00486603|155699038|FG003|Overall Study|Withdrawal by Subject|0|||
48412929|NCT00486603|155699039|FG004|Overall Study|Withdrawal by Subject|0|||
48412930|NCT00486603|155699035|FG000|Overall Study|Physician Decision|0|||
48361525|NCT02574845|155517976|FG002|Overall Study|Adverse Event|0|||
48361526|NCT02574845|155517977|FG003|Overall Study|Adverse Event|0|||
48361527|NCT02574845|155517978|FG004|Overall Study|Adverse Event|0|||
48361528|NCT02574845|155517979|FG005|Overall Study|Adverse Event|1|||
48361529|NCT03174431|155517991|FG000|Overall Study|Withdrawal by Subject|14|||
48412931|NCT00486603|155699036|FG001|Overall Study|Physician Decision|1|||
48412932|NCT00486603|155699037|FG002|Overall Study|Physician Decision|0|||
48412933|NCT00486603|155699038|FG003|Overall Study|Physician Decision|0|||
48412934|NCT00486603|155699039|FG004|Overall Study|Physician Decision|0|||
48431453|NCT00002663|155767268|FG004|Overall Study|Adverse Event|0|||
48361530|NCT03174431|155517992|FG001|Overall Study|Withdrawal by Subject|11|||
48361531|NCT03174431|155517991|FG000|Overall Study|alternative treatment|2|||
48361532|NCT03174431|155517992|FG001|Overall Study|alternative treatment|0|||
48361533|NCT03174431|155517991|FG000|Overall Study|Lost to Follow-up|1|||
48361534|NCT03174431|155517992|FG001|Overall Study|Lost to Follow-up|5|||
48361535|NCT02797080|155517999|FG000|Overall Study|Lost to Follow-up|1|||
48361536|NCT02797080|155517999|FG000|Overall Study|Withdrawal by Subject|1|||
48361537|NCT04148651|155518003|FG000|Overall Study|Lost to Follow-up|2|||
48361538|NCT03519204|155518004|FG000|Overall Study|Lost to Follow-up|3|||
48361539|NCT03519204|155518005|FG001|Overall Study|Lost to Follow-up|8|||
48412935|NCT01075178|155699040|FG000|Subject Matching|eligible but not matched|130|||
48412936|NCT01075178|155699041|FG001|Subject Matching|eligible but not matched|403|||
48412937|NCT01075178|155699040|FG000|Subject Chart Review|died before chart review period|0|||
48412938|NCT01075178|155699041|FG001|Subject Chart Review|died before chart review period|2|||
48412939|NCT01075178|155699040|FG000|Subject Chart Review|no data collected due to site closure|3|||
48412940|NCT01075178|155699041|FG001|Subject Chart Review|no data collected due to site closure|4|||
48412941|NCT01075178|155699040|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
48412942|NCT01075178|155699041|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
48412943|NCT01686568|155699046|FG000|Main Study|Withdrawal by Subject|1|||
48412944|NCT01686568|155699047|FG001|Main Study|Withdrawal by Subject|3|||
48412945|NCT01686568|155699046|FG000|Main Study|Noncompliance with protocol|0|||
48412946|NCT01686568|155699047|FG001|Main Study|Noncompliance with protocol|1|||
48412947|NCT01686568|155699046|FG000|Main Study|Liver enzymes above range of exclusion|1|||
48412948|NCT01686568|155699047|FG001|Main Study|Liver enzymes above range of exclusion|0|||
48412949|NCT01686568|155699046|FG000|Sub-Study|Not consented for sub-study|2|||
48412950|NCT01686568|155699047|FG001|Sub-Study|Not consented for sub-study|2|||
48412951|NCT01147809|155699048|FG000|Phase I (168 Days)|Adverse Event|0|||
48412952|NCT01147809|155699049|FG001|Phase I (168 Days)|Adverse Event|0|||
48412953|NCT01147809|155699050|FG002|Phase I (168 Days)|Adverse Event|0|||
48412954|NCT01147809|155699051|FG003|Phase I (168 Days)|Adverse Event|1|||
48412955|NCT01147809|155699052|FG004|Phase I (168 Days)|Adverse Event|0|||
48412956|NCT01147809|155699053|FG005|Phase I (168 Days)|Adverse Event|0|||
48412957|NCT01147809|155699048|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
48412958|NCT01147809|155699049|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
48412959|NCT01147809|155699050|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
48412960|NCT01147809|155699051|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
48412961|NCT01147809|155699052|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
48412962|NCT01147809|155699053|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
48412963|NCT01147809|155699048|FG000|Phase I (168 Days)|Physician Decision|0|||
48412964|NCT01147809|155699049|FG001|Phase I (168 Days)|Physician Decision|1|||
48412965|NCT01147809|155699050|FG002|Phase I (168 Days)|Physician Decision|2|||
48412966|NCT01147809|155699051|FG003|Phase I (168 Days)|Physician Decision|0|||
48412967|NCT01147809|155699052|FG004|Phase I (168 Days)|Physician Decision|0|||
48412968|NCT01147809|155699053|FG005|Phase I (168 Days)|Physician Decision|0|||
48412969|NCT01147809|155699048|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
48412970|NCT01147809|155699049|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
48412971|NCT01147809|155699050|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
48412972|NCT01147809|155699051|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
48412973|NCT01147809|155699052|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
48412974|NCT01147809|155699053|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
48412975|NCT01147809|155699048|FG000|Phase II (168 Days)|Adverse Event|0|||
48412976|NCT01147809|155699049|FG001|Phase II (168 Days)|Adverse Event|0|||
48412977|NCT01147809|155699050|FG002|Phase II (168 Days)|Adverse Event|0|||
48412978|NCT01147809|155699051|FG003|Phase II (168 Days)|Adverse Event|0|||
48412979|NCT01147809|155699052|FG004|Phase II (168 Days)|Adverse Event|3|||
48412980|NCT01147809|155699053|FG005|Phase II (168 Days)|Adverse Event|6|||
48412981|NCT01147809|155699048|FG000|Phase II (168 Days)|Protocol Violation|0|||
48412982|NCT01147809|155699049|FG001|Phase II (168 Days)|Protocol Violation|0|||
48412983|NCT01147809|155699050|FG002|Phase II (168 Days)|Protocol Violation|0|||
48412984|NCT01147809|155699051|FG003|Phase II (168 Days)|Protocol Violation|0|||
48412985|NCT01147809|155699052|FG004|Phase II (168 Days)|Protocol Violation|0|||
48412986|NCT01147809|155699053|FG005|Phase II (168 Days)|Protocol Violation|1|||
48412987|NCT01147809|155699048|FG000|Phase II (168 Days)|Physician Decision|0|||
48412988|NCT01147809|155699049|FG001|Phase II (168 Days)|Physician Decision|0|||
48412989|NCT01147809|155699050|FG002|Phase II (168 Days)|Physician Decision|0|||
48412990|NCT01147809|155699051|FG003|Phase II (168 Days)|Physician Decision|0|||
48412991|NCT01147809|155699052|FG004|Phase II (168 Days)|Physician Decision|5|||
48412992|NCT01147809|155699053|FG005|Phase II (168 Days)|Physician Decision|11|||
48412993|NCT01147809|155699048|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
48412994|NCT01147809|155699049|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
48412995|NCT01147809|155699050|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
48412996|NCT01147809|155699051|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
48412997|NCT01147809|155699052|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
48412998|NCT01147809|155699053|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
48361540|NCT03519204|155518004|FG000|Overall Study|Withdrawal by Subject|9|||
48361541|NCT03519204|155518005|FG001|Overall Study|Withdrawal by Subject|7|||
48361542|NCT03519204|155518004|FG000|Overall Study|Other Miscellaneous Reasons|1|||
48361543|NCT03519204|155518005|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48361544|NCT02597712|155518006|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
48361545|NCT02597712|155518007|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
48361546|NCT02597712|155518006|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
48361547|NCT02597712|155518007|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
48361548|NCT02597712|155518006|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
48361549|NCT02597712|155518007|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
48361550|NCT02683785|155518008|FG000|Overall Study|Withdrawal by Subject|1|||
48361551|NCT02683785|155518009|FG001|Overall Study|Withdrawal by Subject|1|||
48361552|NCT02683785|155518008|FG000|Overall Study|Lost to Follow-up|0|||
48361553|NCT02683785|155518009|FG001|Overall Study|Lost to Follow-up|1|||
48361554|NCT02683785|155518008|FG000|Overall Study|Adverse Event|0|||
48361555|NCT02683785|155518009|FG001|Overall Study|Adverse Event|2|||
48361556|NCT00534495|155518015|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
48361557|NCT00534495|155518016|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
48361558|NCT00534495|155518017|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
48361559|NCT00534495|155518015|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
48361560|NCT00534495|155518016|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
48361561|NCT00534495|155518017|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
48361562|NCT00534495|155518015|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
48361563|NCT00534495|155518016|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
48361564|NCT00534495|155518017|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
48361565|NCT00534495|155518015|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
48361566|NCT00534495|155518016|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
48361567|NCT00534495|155518017|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
48361568|NCT00534495|155518015|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
48361569|NCT00534495|155518016|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
48361570|NCT00534495|155518017|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
48361571|NCT00534495|155518015|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
48361572|NCT00534495|155518016|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
48361573|NCT00534495|155518017|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
48361574|NCT00534495|155518015|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
48361575|NCT00534495|155518016|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
48361576|NCT00534495|155518017|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
48361577|NCT00534495|155518015|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
48361578|NCT00534495|155518016|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
48361579|NCT00534495|155518017|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
48361580|NCT00534495|155518015|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
48361581|NCT00534495|155518016|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
48361582|NCT00534495|155518017|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
48361583|NCT02440425|155518018|FG000|Overall Study|Death likely due to disease progression|1|||
48361584|NCT02440425|155518018|FG000|Overall Study|Withdrawal by Subject|2|||
48361585|NCT02440425|155518018|FG000|Overall Study|Adverse Event|1|||
48361586|NCT02440425|155518018|FG000|Overall Study|Adverse Event/Ineligible|1|||
48361587|NCT01430468|155518019|FG000|Overall Study|Physician Decision|2|||
48361588|NCT01430468|155518020|FG001|Overall Study|Physician Decision|1|||
48361589|NCT01430468|155518019|FG000|Overall Study|Withdrawal by Subject|5|||
48361590|NCT01430468|155518020|FG001|Overall Study|Withdrawal by Subject|5|||
48361591|NCT03538938|155518021|FG000|Overall Study|Death|0|||
48361592|NCT03538938|155518022|FG001|Overall Study|Death|0|||
48361593|NCT03538938|155518023|FG002|Overall Study|Death|2|||
48361594|NCT03538938|155518024|FG003|Overall Study|Death|0|||
48361595|NCT03538938|155518025|FG004|Overall Study|Death|0|||
48361596|NCT03538938|155518026|FG005|Overall Study|Death|1|||
48361597|NCT03538938|155518027|FG006|Overall Study|Death|0|||
48361598|NCT03538938|155518028|FG007|Overall Study|Death|1|||
48361599|NCT03538938|155518029|FG008|Overall Study|Death|1|||
48361600|NCT03538938|155518030|FG009|Overall Study|Death|1|||
48361601|NCT03538938|155518031|FG010|Overall Study|Death|0|||
48361602|NCT03538938|155518032|FG011|Overall Study|Death|0|||
48361603|NCT03538938|155518033|FG012|Overall Study|Death|1|||
48361604|NCT03538938|155518034|FG013|Overall Study|Death|1|||
48361605|NCT03538938|155518035|FG014|Overall Study|Death|0|||
48361606|NCT03538938|155518036|FG015|Overall Study|Death|1|||
48361607|NCT03538938|155518021|FG000|Overall Study|Withdrawal by Subject|4|||
48361608|NCT03538938|155518022|FG001|Overall Study|Withdrawal by Subject|6|||
48361609|NCT03538938|155518023|FG002|Overall Study|Withdrawal by Subject|5|||
48361610|NCT03538938|155518024|FG003|Overall Study|Withdrawal by Subject|3|||
48361611|NCT03538938|155518025|FG004|Overall Study|Withdrawal by Subject|0|||
48412999|NCT01147809|155699048|FG000|Phase II (168 Days)|Ongoing|0|||
48361612|NCT03538938|155518026|FG005|Overall Study|Withdrawal by Subject|0|||
48361613|NCT03538938|155518027|FG006|Overall Study|Withdrawal by Subject|3|||
48361614|NCT03538938|155518028|FG007|Overall Study|Withdrawal by Subject|1|||
48361615|NCT03538938|155518029|FG008|Overall Study|Withdrawal by Subject|5|||
48361616|NCT03538938|155518030|FG009|Overall Study|Withdrawal by Subject|1|||
48361617|NCT03538938|155518031|FG010|Overall Study|Withdrawal by Subject|2|||
48361618|NCT03538938|155518032|FG011|Overall Study|Withdrawal by Subject|1|||
48361619|NCT03538938|155518033|FG012|Overall Study|Withdrawal by Subject|3|||
48361620|NCT03538938|155518034|FG013|Overall Study|Withdrawal by Subject|0|||
48361621|NCT03538938|155518035|FG014|Overall Study|Withdrawal by Subject|2|||
48361622|NCT03538938|155518036|FG015|Overall Study|Withdrawal by Subject|4|||
48361623|NCT03538938|155518021|FG000|Overall Study|Incarcerated|0|||
48361624|NCT03538938|155518022|FG001|Overall Study|Incarcerated|0|||
48361625|NCT03538938|155518023|FG002|Overall Study|Incarcerated|0|||
48361626|NCT03538938|155518024|FG003|Overall Study|Incarcerated|0|||
48361627|NCT03538938|155518025|FG004|Overall Study|Incarcerated|0|||
48361628|NCT03538938|155518026|FG005|Overall Study|Incarcerated|0|||
48361629|NCT03538938|155518027|FG006|Overall Study|Incarcerated|0|||
48361630|NCT03538938|155518028|FG007|Overall Study|Incarcerated|0|||
48361631|NCT03538938|155518029|FG008|Overall Study|Incarcerated|0|||
48361632|NCT03538938|155518030|FG009|Overall Study|Incarcerated|0|||
48361633|NCT03538938|155518031|FG010|Overall Study|Incarcerated|0|||
48361634|NCT03538938|155518032|FG011|Overall Study|Incarcerated|1|||
48361635|NCT03538938|155518033|FG012|Overall Study|Incarcerated|0|||
48361636|NCT03538938|155518034|FG013|Overall Study|Incarcerated|0|||
48361637|NCT03538938|155518035|FG014|Overall Study|Incarcerated|0|||
48361638|NCT03538938|155518036|FG015|Overall Study|Incarcerated|0|||
48361639|NCT03653208|155518039|FG000|Overall Study|Withdrawal by Subject|0|||
48361640|NCT03653208|155518040|FG001|Overall Study|Withdrawal by Subject|0|||
48361641|NCT03653208|155518041|FG002|Overall Study|Withdrawal by Subject|0|||
48361642|NCT03653208|155518042|FG003|Overall Study|Withdrawal by Subject|0|||
48361643|NCT03653208|155518043|FG004|Overall Study|Withdrawal by Subject|1|||
48361644|NCT03653208|155518044|FG005|Overall Study|Withdrawal by Subject|0|||
48361645|NCT03653208|155518045|FG006|Overall Study|Withdrawal by Subject|0|||
48361646|NCT03653208|155518046|FG007|Overall Study|Withdrawal by Subject|1|||
48361647|NCT03653208|155518047|FG008|Overall Study|Withdrawal by Subject|1|||
48361648|NCT03752970|155518048|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
48413000|NCT01147809|155699049|FG001|Phase II (168 Days)|Ongoing|0|||
48413001|NCT01147809|155699050|FG002|Phase II (168 Days)|Ongoing|0|||
48413002|NCT01147809|155699051|FG003|Phase II (168 Days)|Ongoing|0|||
48413003|NCT01147809|155699052|FG004|Phase II (168 Days)|Ongoing|1|||
48361649|NCT03752970|155518049|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
48361650|NCT03752970|155518050|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
48361651|NCT03752970|155518048|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
48361652|NCT03752970|155518049|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
48361653|NCT03752970|155518050|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
48361654|NCT03752970|155518048|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
48413004|NCT01147809|155699053|FG005|Phase II (168 Days)|Ongoing|0|||
48413005|NCT02209766|155699056|FG000|Overall Study|Withdrawal by Subject|0|||
48413006|NCT02209766|155699057|FG001|Overall Study|Withdrawal by Subject|0|||
48413007|NCT02209766|155699058|FG002|Overall Study|Withdrawal by Subject|0|||
48361655|NCT03752970|155518049|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
48361656|NCT03752970|155518050|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
48361657|NCT03752970|155518048|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
48413008|NCT02209766|155699059|FG003|Overall Study|Withdrawal by Subject|1|||
48361658|NCT03752970|155518049|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
48361659|NCT03752970|155518050|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
48361660|NCT03752970|155518048|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
48361661|NCT03752970|155518049|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
48361662|NCT03752970|155518050|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
48361663|NCT01281839|155518051|FG000|Overall Study|Lost to Follow-up|6|||
48361664|NCT01281839|155518052|FG001|Overall Study|Lost to Follow-up|3|||
48361665|NCT01281839|155518051|FG000|Overall Study|Withdrawal by Subject|4|||
48361666|NCT01281839|155518052|FG001|Overall Study|Withdrawal by Subject|10|||
48361667|NCT01281839|155518051|FG000|Overall Study|Reason not specified|0|||
48361668|NCT01281839|155518052|FG001|Overall Study|Reason not specified|1|||
48361669|NCT03449901|155518053|FG000|Overall Study|Progression|57|||
48361670|NCT03449901|155518054|FG001|Overall Study|Progression|12|||
48413009|NCT02209766|155699060|FG004|Overall Study|Withdrawal by Subject|0|||
48413010|NCT03772327|155699064|FG000|Overall Study|Lost to Follow-up|3|||
48361671|NCT03449901|155518053|FG000|Overall Study|Adverse Event|3|||
48361672|NCT03449901|155518054|FG001|Overall Study|Adverse Event|0|||
48361673|NCT03449901|155518053|FG000|Overall Study|Death|6|||
48361674|NCT03449901|155518054|FG001|Overall Study|Death|2|||
48413011|NCT03772327|155699065|FG001|Overall Study|Lost to Follow-up|4|||
48413012|NCT03772327|155699064|FG000|Overall Study|Withdrawal by Subject|2|||
48413013|NCT03772327|155699065|FG001|Overall Study|Withdrawal by Subject|3|||
48413014|NCT01658514|155699066|FG000|Overall Study|Protocol Violation|1|||
48413015|NCT01658514|155699067|FG001|Overall Study|Protocol Violation|0|||
48413016|NCT01658514|155699068|FG002|Overall Study|Protocol Violation|2|||
48413017|NCT03437447|155699069|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48413018|NCT03437447|155699070|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48413019|NCT03437447|155699071|FG002|Treatment Period 1|Withdrawal by Subject|1|||
48413020|NCT01511445|155699072|FG000|Overall Study|Lost to Follow-up|3|||
48413021|NCT01511445|155699073|FG001|Overall Study|Lost to Follow-up|1|||
48413022|NCT01511445|155699072|FG000|Overall Study|Protocol Violation|1|||
48413023|NCT01511445|155699073|FG001|Overall Study|Protocol Violation|3|||
48413024|NCT01511445|155699072|FG000|Overall Study|Protocol Violation|1|||
48413025|NCT01511445|155699073|FG001|Overall Study|Protocol Violation|0|||
48413026|NCT00484315|155699074|FG000|12-Month Clinical Follow-up|Death|6|||
48413027|NCT00484315|155699075|FG001|12-Month Clinical Follow-up|Death|2|||
48413028|NCT00484315|155699074|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
48413029|NCT00484315|155699075|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
48413030|NCT00484315|155699074|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
48413031|NCT00484315|155699075|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
48413032|NCT00484315|155699074|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
48413033|NCT00484315|155699075|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
48413034|NCT00484315|155699074|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
48413035|NCT00484315|155699075|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
48413036|NCT00484315|155699074|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
48413037|NCT00484315|155699075|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
48413038|NCT00484315|155699074|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
48413039|NCT00484315|155699075|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
48413040|NCT02344576|155699076|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
48413041|NCT02344576|155699077|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
48413042|NCT02344576|155699078|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
48413043|NCT02344576|155699079|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
48413044|NCT02344576|155699076|FG000|1-Month Follow-Up|Death|13|||
48413045|NCT02344576|155699077|FG001|1-Month Follow-Up|Death|8|||
48413046|NCT02344576|155699078|FG002|1-Month Follow-Up|Death|0|||
48413047|NCT02344576|155699079|FG003|1-Month Follow-Up|Death|0|||
48413048|NCT02344576|155699076|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
48413049|NCT02344576|155699077|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
48413050|NCT02344576|155699078|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
48413051|NCT02344576|155699079|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
48413052|NCT02344576|155699076|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
48413053|NCT02344576|155699077|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
48413054|NCT02344576|155699078|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
48413055|NCT02344576|155699079|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
48413056|NCT02344576|155699076|FG000|6-Month Follow-Up|Death|14|||
48413057|NCT02344576|155699077|FG001|6-Month Follow-Up|Death|14|||
48413058|NCT02344576|155699078|FG002|6-Month Follow-Up|Death|0|||
48413059|NCT02344576|155699079|FG003|6-Month Follow-Up|Death|0|||
48413060|NCT02344576|155699076|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
48413061|NCT02344576|155699077|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
48413062|NCT02344576|155699078|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
48413063|NCT02344576|155699079|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
48413064|NCT02344576|155699076|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
48413065|NCT02344576|155699077|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
48413066|NCT02344576|155699078|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
48413067|NCT02344576|155699079|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
48413068|NCT02500537|155699080|FG000|Overall Study|Death|2|||
48413069|NCT02500537|155699081|FG001|Overall Study|Death|0|||
48413070|NCT02500537|155699080|FG000|Overall Study|Lost to Follow-up|0|||
48413071|NCT02500537|155699081|FG001|Overall Study|Lost to Follow-up|1|||
48413072|NCT02500537|155699080|FG000|Overall Study|Withdrawal by Subject|1|||
48413073|NCT02500537|155699081|FG001|Overall Study|Withdrawal by Subject|0|||
48413074|NCT02272790|155699084|FG000|Overall Study|Physician Decision|0|||
48413075|NCT02272790|155699085|FG001|Overall Study|Physician Decision|1|||
48413076|NCT02272790|155699086|FG002|Overall Study|Physician Decision|0|||
48413077|NCT02272790|155699087|FG003|Overall Study|Physician Decision|0|||
48413078|NCT02272790|155699088|FG004|Overall Study|Physician Decision|0|||
48413079|NCT02272790|155699089|FG005|Overall Study|Physician Decision|0|||
48413080|NCT02040142|155699090|FG000|Overall Study|Lost to Follow-up|5|||
48413081|NCT02040142|155699090|FG000|Overall Study|Death|17|||
48413082|NCT02040142|155699090|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
48413083|NCT03871491|155699091|FG000|Overall Study|Withdrawal by Subject|14|||
48413084|NCT03871491|155699092|FG001|Overall Study|Withdrawal by Subject|14|||
48413085|NCT03871491|155699093|FG002|Overall Study|Withdrawal by Subject|14|||
48413086|NCT03871491|155699094|FG003|Overall Study|Withdrawal by Subject|14|||
48361675|NCT03449901|155518053|FG000|Overall Study|Withdrawal by Subject|12|||
48361676|NCT03449901|155518054|FG001|Overall Study|Withdrawal by Subject|1|||
48361677|NCT03449901|155518053|FG000|Overall Study|Physician Decision|1|||
48361678|NCT03449901|155518054|FG001|Overall Study|Physician Decision|0|||
48361679|NCT03449901|155518053|FG000|Overall Study|Patient elected for surgical intervention|1|||
48361680|NCT03449901|155518054|FG001|Overall Study|Patient elected for surgical intervention|0|||
48361681|NCT03449901|155518053|FG000|Overall Study|Patient off for other complicating disease|1|||
48361682|NCT03449901|155518054|FG001|Overall Study|Patient off for other complicating disease|0|||
48361683|NCT00743431|155518056|FG000|Overall Study|Toxicity|6|||
48361684|NCT00743431|155518056|FG000|Overall Study|Tumor progression|56|||
48361685|NCT00743431|155518056|FG000|Overall Study|Withdrawal by Subject|13|||
48361686|NCT00743431|155518056|FG000|Overall Study|Death|9|||
48361687|NCT00743431|155518056|FG000|Overall Study|Reason for discontinuation not specified|29|||
48361688|NCT00743431|155518056|FG000|Overall Study|No documentation available|13|||
48361689|NCT04343976|155518057|FG000|Overall Study|Withdrawal by Subject|0|||
48361690|NCT04343976|155518058|FG001|Overall Study|Withdrawal by Subject|1|||
48361691|NCT00737698|155518059|FG000|Overall Study|Withdrawal by Subject|6|||
48361692|NCT00737698|155518060|FG001|Overall Study|Withdrawal by Subject|5|||
48361693|NCT00737698|155518061|FG002|Overall Study|Withdrawal by Subject|3|||
48361694|NCT00737698|155518059|FG000|Overall Study|Death|0|||
48361695|NCT00737698|155518060|FG001|Overall Study|Death|0|||
48361696|NCT00737698|155518061|FG002|Overall Study|Death|1|||
48361697|NCT03406078|155518062|FG000|Overall Study|Death|1|||
48361698|NCT03406078|155518063|FG001|Overall Study|Death|0|||
48413087|NCT03871491|155699091|FG000|Overall Study|Physician Decision|0|||
48413088|NCT03871491|155699092|FG001|Overall Study|Physician Decision|0|||
48413089|NCT03871491|155699093|FG002|Overall Study|Physician Decision|1|||
48413090|NCT03871491|155699094|FG003|Overall Study|Physician Decision|1|||
48413091|NCT03871491|155699091|FG000|Overall Study|Lost to Follow-up|50|||
48413092|NCT03871491|155699092|FG001|Overall Study|Lost to Follow-up|15|||
48413093|NCT03871491|155699093|FG002|Overall Study|Lost to Follow-up|36|||
48413094|NCT03871491|155699094|FG003|Overall Study|Lost to Follow-up|11|||
48413095|NCT05300087|155699095|FG000|Overall Study|Withdrawal by Subject|0|||
48413096|NCT05300087|155699096|FG001|Overall Study|Withdrawal by Subject|1|||
48413097|NCT01822561|155699097|FG000|Overall Study|Withdrawal by Subject|2|||
48413098|NCT04826900|155699098|FG000|Overall Study|Family factor|1|||
48413099|NCT04826900|155699099|FG001|Overall Study|Family factor|1|||
48413100|NCT03283085|155699100|FG000|Overall Study|Adverse Event|18|||
48413101|NCT03283085|155699101|FG001|Overall Study|Adverse Event|3|||
48413102|NCT03283085|155699102|FG002|Overall Study|Adverse Event|13|||
48413103|NCT03283085|155699103|FG003|Overall Study|Adverse Event|0|||
48413104|NCT03283085|155699104|FG004|Overall Study|Adverse Event|0|||
48413105|NCT03283085|155699105|FG005|Overall Study|Adverse Event|5|||
48413106|NCT03283085|155699100|FG000|Overall Study|Death|0|||
48413107|NCT03283085|155699101|FG001|Overall Study|Death|0|||
48413108|NCT03283085|155699102|FG002|Overall Study|Death|3|||
48361699|NCT03406078|155518062|FG000|Overall Study|Lost to Follow-up|0|||
48361700|NCT03406078|155518063|FG001|Overall Study|Lost to Follow-up|1|||
48361701|NCT03406078|155518062|FG000|Overall Study|Withdrawal by Subject|5|||
48361702|NCT03406078|155518063|FG001|Overall Study|Withdrawal by Subject|2|||
48361703|NCT03686423|155518064|FG000|Overall Study|Withdrawal by Subject|9|||
48361704|NCT03686423|155518064|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
48361705|NCT04531098|155518067|FG000|Stage I|Adverse Event|0|||
48361706|NCT04531098|155518068|FG001|Stage I|Adverse Event|0|||
48361707|NCT04531098|155518069|FG002|Stage I|Adverse Event|3|||
48413109|NCT03283085|155699103|FG003|Overall Study|Death|1|||
48413110|NCT03283085|155699104|FG004|Overall Study|Death|0|||
48413111|NCT03283085|155699105|FG005|Overall Study|Death|0|||
48413112|NCT03283085|155699100|FG000|Overall Study|Withdrawal by Subject|42|||
48413113|NCT03283085|155699101|FG001|Overall Study|Withdrawal by Subject|21|||
48413114|NCT03283085|155699102|FG002|Overall Study|Withdrawal by Subject|66|||
48413115|NCT03283085|155699103|FG003|Overall Study|Withdrawal by Subject|3|||
48413116|NCT03283085|155699104|FG004|Overall Study|Withdrawal by Subject|3|||
48413117|NCT03283085|155699105|FG005|Overall Study|Withdrawal by Subject|5|||
48413118|NCT03283085|155699100|FG000|Overall Study|Physician Decision|14|||
48413119|NCT03283085|155699101|FG001|Overall Study|Physician Decision|8|||
48413120|NCT03283085|155699102|FG002|Overall Study|Physician Decision|19|||
48413121|NCT03283085|155699103|FG003|Overall Study|Physician Decision|0|||
48413122|NCT03283085|155699104|FG004|Overall Study|Physician Decision|0|||
48413123|NCT03283085|155699105|FG005|Overall Study|Physician Decision|2|||
48361708|NCT04531098|155518067|FG000|Stage I|Protocol Violation|0|||
48361709|NCT04531098|155518068|FG001|Stage I|Protocol Violation|0|||
48361710|NCT04531098|155518069|FG002|Stage I|Protocol Violation|5|||
48361711|NCT04531098|155518067|FG000|Stage I|Withdrawal by Subject|0|||
48361712|NCT04531098|155518068|FG001|Stage I|Withdrawal by Subject|5|||
48361713|NCT04531098|155518069|FG002|Stage I|Withdrawal by Subject|10|||
48361714|NCT04531098|155518067|FG000|Stage II|Adverse Event|1|||
48361715|NCT04531098|155518068|FG001|Stage II|Adverse Event|2|||
48361716|NCT04531098|155518069|FG002|Stage II|Adverse Event|0|||
48431454|NCT00002663|155767269|FG005|Overall Study|Adverse Event|0|||
48361717|NCT04531098|155518067|FG000|Stage II|Protocol Violation|1|||
48361718|NCT04531098|155518068|FG001|Stage II|Protocol Violation|2|||
48361719|NCT04531098|155518069|FG002|Stage II|Protocol Violation|0|||
48361720|NCT04531098|155518067|FG000|Stage II|Withdrawal by Subject|3|||
48361721|NCT04531098|155518068|FG001|Stage II|Withdrawal by Subject|1|||
48361722|NCT04531098|155518069|FG002|Stage II|Withdrawal by Subject|0|||
48361723|NCT04531098|155518067|FG000|Stage II|Moved from study area|8|||
48361724|NCT04531098|155518068|FG001|Stage II|Moved from study area|5|||
48361725|NCT04531098|155518069|FG002|Stage II|Moved from study area|0|||
48361726|NCT02001064|155518070|FG000|Overall Study|Withdrawal by Subject|2|||
48361727|NCT02001064|155518071|FG001|Overall Study|Withdrawal by Subject|1|||
48361728|NCT00438672|155518072|FG000|Overall Study|Lost to Follow-up|7|||
48361729|NCT00438672|155518073|FG001|Overall Study|Lost to Follow-up|9|||
48361730|NCT00316017|155518075|FG000|Overall Study|Protocol Violation|11|||
48361731|NCT00316017|155518076|FG001|Overall Study|Protocol Violation|13|||
48361732|NCT00316017|155518077|FG002|Overall Study|Protocol Violation|19|||
48361733|NCT00320528|155518078|FG000|Study Period II|Adverse Event|3|||
48361734|NCT00320528|155518079|FG001|Study Period II|Adverse Event|4|||
48361735|NCT00320528|155518080|FG002|Study Period II|Adverse Event|8|||
48361736|NCT00320528|155518078|FG000|Study Period II|Parent/Caregiver Decision|8|||
48361737|NCT00320528|155518079|FG001|Study Period II|Parent/Caregiver Decision|3|||
48361738|NCT00320528|155518080|FG002|Study Period II|Parent/Caregiver Decision|11|||
48361739|NCT00320528|155518078|FG000|Study Period II|Withdrawal by Subject|0|||
48361740|NCT00320528|155518079|FG001|Study Period II|Withdrawal by Subject|1|||
48361741|NCT00320528|155518080|FG002|Study Period II|Withdrawal by Subject|1|||
48361742|NCT00320528|155518078|FG000|Study Period II|Entry Criteria Exclusion|0|||
48361743|NCT00320528|155518079|FG001|Study Period II|Entry Criteria Exclusion|2|||
48361744|NCT00320528|155518080|FG002|Study Period II|Entry Criteria Exclusion|2|||
48361745|NCT00320528|155518078|FG000|Study Period III|Adverse Event|1|||
48361746|NCT00320528|155518079|FG001|Study Period III|Adverse Event|0|||
48361747|NCT00320528|155518080|FG002|Study Period III|Adverse Event|0|||
48361748|NCT00320528|155518078|FG000|Study Period III|Lost to Follow-up|1|||
48361749|NCT00320528|155518079|FG001|Study Period III|Lost to Follow-up|0|||
48361750|NCT00320528|155518080|FG002|Study Period III|Lost to Follow-up|0|||
48361751|NCT00320528|155518078|FG000|Study Period III|Withdrawal by Subject|1|||
48361752|NCT00320528|155518079|FG001|Study Period III|Withdrawal by Subject|1|||
48361753|NCT00320528|155518080|FG002|Study Period III|Withdrawal by Subject|2|||
48361754|NCT00320528|155518078|FG000|Study Period III|Lack of Efficacy|2|||
48361755|NCT00320528|155518079|FG001|Study Period III|Lack of Efficacy|0|||
48361756|NCT00320528|155518080|FG002|Study Period III|Lack of Efficacy|0|||
48361757|NCT00320528|155518078|FG000|Study Period III|Parent/Caregiver Decision|14|||
48361758|NCT00320528|155518079|FG001|Study Period III|Parent/Caregiver Decision|3|||
48361759|NCT00320528|155518080|FG002|Study Period III|Parent/Caregiver Decision|11|||
48361760|NCT00320528|155518078|FG000|Study Period III|Protocol Violation|0|||
48361761|NCT00320528|155518079|FG001|Study Period III|Protocol Violation|1|||
48361762|NCT00320528|155518080|FG002|Study Period III|Protocol Violation|0|||
48361763|NCT00320528|155518078|FG000|Study Period III|Physician Decision|0|||
48361764|NCT00320528|155518079|FG001|Study Period III|Physician Decision|1|||
48361765|NCT00320528|155518080|FG002|Study Period III|Physician Decision|2|||
48361766|NCT00320528|155518078|FG000|Study Period III|Sponsor Decision|0|||
48361767|NCT00320528|155518079|FG001|Study Period III|Sponsor Decision|0|||
48361768|NCT00320528|155518080|FG002|Study Period III|Sponsor Decision|1|||
48361769|NCT00320528|155518078|FG000|Study Period III|Atomoxetine Commercially Available|68|||
48361770|NCT00320528|155518079|FG001|Study Period III|Atomoxetine Commercially Available|25|||
48361771|NCT00320528|155518080|FG002|Study Period III|Atomoxetine Commercially Available|90|||
48361772|NCT01468181|155518081|FG000|Overall Study|Adverse Event|8|||
48361773|NCT01468181|155518082|FG001|Overall Study|Adverse Event|1|||
48361774|NCT01468181|155518083|FG002|Overall Study|Adverse Event|6|||
48361775|NCT01468181|155518084|FG003|Overall Study|Adverse Event|2|||
48361776|NCT01468181|155518085|FG004|Overall Study|Adverse Event|2|||
48361777|NCT01468181|155518081|FG000|Overall Study|Protocol Violation|2|||
48361778|NCT01468181|155518082|FG001|Overall Study|Protocol Violation|0|||
48361779|NCT01468181|155518083|FG002|Overall Study|Protocol Violation|1|||
48361780|NCT01468181|155518084|FG003|Overall Study|Protocol Violation|0|||
48361781|NCT01468181|155518085|FG004|Overall Study|Protocol Violation|1|||
48361782|NCT01468181|155518081|FG000|Overall Study|Physician Decision|0|||
48361783|NCT01468181|155518082|FG001|Overall Study|Physician Decision|0|||
48361784|NCT01468181|155518083|FG002|Overall Study|Physician Decision|0|||
48361785|NCT01468181|155518084|FG003|Overall Study|Physician Decision|1|||
48361786|NCT01468181|155518085|FG004|Overall Study|Physician Decision|1|||
48361787|NCT01468181|155518081|FG000|Overall Study|Lost to Follow-up|0|||
48361788|NCT01468181|155518082|FG001|Overall Study|Lost to Follow-up|0|||
48361789|NCT01468181|155518083|FG002|Overall Study|Lost to Follow-up|1|||
48361790|NCT01468181|155518084|FG003|Overall Study|Lost to Follow-up|0|||
48361791|NCT01468181|155518085|FG004|Overall Study|Lost to Follow-up|1|||
48361792|NCT01468181|155518081|FG000|Overall Study|Withdrawal by Subject|0|||
48361793|NCT01468181|155518082|FG001|Overall Study|Withdrawal by Subject|1|||
48361794|NCT01468181|155518083|FG002|Overall Study|Withdrawal by Subject|0|||
48361795|NCT01468181|155518084|FG003|Overall Study|Withdrawal by Subject|0|||
48361796|NCT01468181|155518085|FG004|Overall Study|Withdrawal by Subject|0|||
48361797|NCT03816761|155520100|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48361798|NCT03816761|155520101|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48361799|NCT03816761|155520102|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48361800|NCT03816761|155520103|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48361801|NCT03816761|155520104|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
48361802|NCT03816761|155520105|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
48361803|NCT03816761|155520100|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
48361804|NCT03816761|155520101|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
48361805|NCT03816761|155520102|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
48361806|NCT03816761|155520103|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
48361807|NCT03816761|155520104|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
48361808|NCT03816761|155520105|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
48361809|NCT01730950|155520110|FG000|Overall Study|Protocol Violation|6|||
48361810|NCT01730950|155520111|FG001|Overall Study|Protocol Violation|6|||
48361811|NCT00581893|155520114|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
48361812|NCT00581893|155520115|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
48361813|NCT01484431|155520116|FG000|Period 1: High Dose|Physician Decision|0|||
48361814|NCT01484431|155520117|FG001|Period 1: High Dose|Physician Decision|1|||
48361815|NCT01484431|155520118|FG002|Period 1: High Dose|Physician Decision|0|||
48361816|NCT01484431|155520116|FG000|Period 2|Death|0|||
48361817|NCT01484431|155520117|FG001|Period 2|Death|1|||
48361818|NCT01484431|155520118|FG002|Period 2|Death|1|||
48361819|NCT01484431|155520116|FG000|Period 2|Physician Decision|0|||
48361820|NCT01484431|155520117|FG001|Period 2|Physician Decision|0|||
48361821|NCT01484431|155520118|FG002|Period 2|Physician Decision|1|||
48361822|NCT01484431|155520116|FG000|Period 2|Non-Compliance with Study Drug|1|||
48361823|NCT01484431|155520117|FG001|Period 2|Non-Compliance with Study Drug|0|||
48361824|NCT01484431|155520118|FG002|Period 2|Non-Compliance with Study Drug|0|||
48361825|NCT00918879|155520124|FG000|Overall Study|Withdrawal by Subject|4|||
48361826|NCT00918879|155520125|FG001|Overall Study|Withdrawal by Subject|4|||
48361827|NCT00918879|155520124|FG000|Overall Study|Lost to Follow-up|1|||
48361828|NCT00918879|155520125|FG001|Overall Study|Lost to Follow-up|1|||
48361829|NCT00918879|155520124|FG000|Overall Study|Severe non-compliance to protocol|1|||
48361830|NCT00918879|155520125|FG001|Overall Study|Severe non-compliance to protocol|1|||
48361831|NCT04491877|155520126|FG000|Overall Study|Protocol Deviation|1|||
48361832|NCT04491877|155520127|FG001|Overall Study|Protocol Deviation|0|||
48361833|NCT04491877|155520128|FG002|Overall Study|Protocol Deviation|2|||
48361834|NCT04491877|155520129|FG003|Overall Study|Protocol Deviation|0|||
48361835|NCT04491877|155520130|FG004|Overall Study|Protocol Deviation|0|||
48361836|NCT04491877|155520131|FG005|Overall Study|Protocol Deviation|0|||
48361837|NCT04491877|155520132|FG006|Overall Study|Protocol Deviation|1|||
48361838|NCT04491877|155520133|FG007|Overall Study|Protocol Deviation|1|||
48361839|NCT04491877|155520134|FG008|Overall Study|Protocol Deviation|0|||
48361840|NCT04491877|155520126|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48361841|NCT04491877|155520127|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48361842|NCT04491877|155520128|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48361843|NCT04491877|155520129|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
48361844|NCT04491877|155520130|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48361845|NCT04491877|155520131|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
48361846|NCT04491877|155520132|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
48361847|NCT04491877|155520133|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
48361848|NCT04491877|155520134|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
48361849|NCT04491877|155520126|FG000|Overall Study|Lost to Follow-up|0|||
48361850|NCT04491877|155520127|FG001|Overall Study|Lost to Follow-up|2|||
48361851|NCT04491877|155520128|FG002|Overall Study|Lost to Follow-up|0|||
48361852|NCT04491877|155520129|FG003|Overall Study|Lost to Follow-up|0|||
48361853|NCT04491877|155520130|FG004|Overall Study|Lost to Follow-up|0|||
48361854|NCT04491877|155520131|FG005|Overall Study|Lost to Follow-up|0|||
48361855|NCT04491877|155520132|FG006|Overall Study|Lost to Follow-up|2|||
48361856|NCT04491877|155520133|FG007|Overall Study|Lost to Follow-up|1|||
48361857|NCT04491877|155520134|FG008|Overall Study|Lost to Follow-up|1|||
48361858|NCT02993406|155520140|FG000|Overall Study|Withdrawal by Subject|170|||
48361859|NCT02993406|155520141|FG001|Overall Study|Withdrawal by Subject|196|||
48361860|NCT02993406|155520140|FG000|Overall Study|Physician Decision|3|||
48361861|NCT02993406|155520141|FG001|Overall Study|Physician Decision|5|||
48361862|NCT02993406|155520140|FG000|Overall Study|Lost to Follow-up|12|||
48361863|NCT02993406|155520141|FG001|Overall Study|Lost to Follow-up|13|||
48361864|NCT02993406|155520140|FG000|Overall Study|Unclassifiable Response|105|||
48361865|NCT02993406|155520141|FG001|Overall Study|Unclassifiable Response|139|||
48361866|NCT02993406|155520140|FG000|Overall Study|Administrative decision|1|||
48361867|NCT02993406|155520141|FG001|Overall Study|Administrative decision|0|||
48361868|NCT02993406|155520140|FG000|Overall Study|Sponsor decision|4|||
48361869|NCT02993406|155520141|FG001|Overall Study|Sponsor decision|5|||
48361870|NCT02706405|155520153|FG000|Overall Study|Death|3|||
48361871|NCT02706405|155520154|FG001|Overall Study|Death|2|||
48361872|NCT02706405|155520155|FG002|Overall Study|Death|0|||
48361873|NCT02706405|155520156|FG003|Overall Study|Death|1|||
48361874|NCT02706405|155520157|FG004|Overall Study|Death|0|||
48361875|NCT02706405|155520158|FG005|Overall Study|Death|0|||
48361876|NCT02706405|155520159|FG006|Overall Study|Death|3|||
48361877|NCT02706405|155520160|FG007|Overall Study|Death|4|||
48361878|NCT02706405|155520153|FG000|Overall Study|Disease progression|0|||
48361879|NCT02706405|155520154|FG001|Overall Study|Disease progression|0|||
48361880|NCT02706405|155520155|FG002|Overall Study|Disease progression|0|||
48361881|NCT02706405|155520156|FG003|Overall Study|Disease progression|0|||
48361882|NCT02706405|155520157|FG004|Overall Study|Disease progression|0|||
48361883|NCT02706405|155520158|FG005|Overall Study|Disease progression|0|||
48361884|NCT02706405|155520159|FG006|Overall Study|Disease progression|0|||
48361885|NCT02706405|155520160|FG007|Overall Study|Disease progression|1|||
48361886|NCT02706405|155520153|FG000|Overall Study|Pt moved to new therapy|0|||
48361887|NCT02706405|155520154|FG001|Overall Study|Pt moved to new therapy|0|||
48361888|NCT02706405|155520155|FG002|Overall Study|Pt moved to new therapy|0|||
48361889|NCT02706405|155520156|FG003|Overall Study|Pt moved to new therapy|0|||
48361890|NCT02706405|155520157|FG004|Overall Study|Pt moved to new therapy|0|||
48361891|NCT02706405|155520158|FG005|Overall Study|Pt moved to new therapy|1|||
48361892|NCT02706405|155520159|FG006|Overall Study|Pt moved to new therapy|0|||
48361893|NCT02706405|155520160|FG007|Overall Study|Pt moved to new therapy|1|||
48361894|NCT02706405|155520153|FG000|Overall Study|Physician Decision|1|||
48361895|NCT02706405|155520154|FG001|Overall Study|Physician Decision|0|||
48361896|NCT02706405|155520155|FG002|Overall Study|Physician Decision|0|||
48361897|NCT02706405|155520156|FG003|Overall Study|Physician Decision|0|||
48361898|NCT02706405|155520157|FG004|Overall Study|Physician Decision|0|||
48361899|NCT02706405|155520158|FG005|Overall Study|Physician Decision|0|||
48361900|NCT02706405|155520159|FG006|Overall Study|Physician Decision|0|||
48361901|NCT02706405|155520160|FG007|Overall Study|Physician Decision|0|||
48361902|NCT01228318|155520161|FG000|Overall Study|Clinic no show to receive intervention|1|||
48361903|NCT01228318|155520162|FG001|Overall Study|Clinic no show to receive intervention|0|||
48361904|NCT01228318|155520161|FG000|Overall Study|Unable to contact|2|||
48413124|NCT03283085|155699100|FG000|Overall Study|Site Terminated by Sponsor|1|||
48413125|NCT03283085|155699101|FG001|Overall Study|Site Terminated by Sponsor|0|||
48413126|NCT03283085|155699102|FG002|Overall Study|Site Terminated by Sponsor|3|||
48413127|NCT03283085|155699103|FG003|Overall Study|Site Terminated by Sponsor|0|||
48413128|NCT03283085|155699104|FG004|Overall Study|Site Terminated by Sponsor|0|||
48413129|NCT03283085|155699105|FG005|Overall Study|Site Terminated by Sponsor|0|||
48413130|NCT03283085|155699100|FG000|Overall Study|Lost to Follow-up|2|||
48413131|NCT03283085|155699101|FG001|Overall Study|Lost to Follow-up|0|||
48413132|NCT03283085|155699102|FG002|Overall Study|Lost to Follow-up|2|||
48413133|NCT03283085|155699103|FG003|Overall Study|Lost to Follow-up|0|||
48413134|NCT03283085|155699104|FG004|Overall Study|Lost to Follow-up|0|||
48413135|NCT03283085|155699105|FG005|Overall Study|Lost to Follow-up|1|||
48413136|NCT03283085|155699100|FG000|Overall Study|Pregnancy|0|||
48413137|NCT03283085|155699101|FG001|Overall Study|Pregnancy|0|||
48413138|NCT03283085|155699102|FG002|Overall Study|Pregnancy|1|||
48413139|NCT03283085|155699103|FG003|Overall Study|Pregnancy|0|||
48413140|NCT03283085|155699104|FG004|Overall Study|Pregnancy|0|||
48413141|NCT03283085|155699105|FG005|Overall Study|Pregnancy|0|||
48413142|NCT03283085|155699100|FG000|Overall Study|Lack of Efficacy|12|||
48413143|NCT03283085|155699101|FG001|Overall Study|Lack of Efficacy|6|||
48413144|NCT03283085|155699102|FG002|Overall Study|Lack of Efficacy|24|||
48413145|NCT03283085|155699103|FG003|Overall Study|Lack of Efficacy|1|||
48413146|NCT03283085|155699104|FG004|Overall Study|Lack of Efficacy|1|||
48413147|NCT03283085|155699105|FG005|Overall Study|Lack of Efficacy|0|||
48413148|NCT03283085|155699100|FG000|Overall Study|Reason not Specified|0|||
48413149|NCT03283085|155699101|FG001|Overall Study|Reason not Specified|4|||
48413150|NCT03283085|155699102|FG002|Overall Study|Reason not Specified|8|||
48413151|NCT03283085|155699103|FG003|Overall Study|Reason not Specified|0|||
48413152|NCT03283085|155699104|FG004|Overall Study|Reason not Specified|0|||
48413153|NCT03283085|155699105|FG005|Overall Study|Reason not Specified|1|||
48413154|NCT00686543|155699106|FG000|Overall Study|Adverse Event|9|||
48413155|NCT00686543|155699107|FG001|Overall Study|Adverse Event|1|||
48413156|NCT00686543|155699108|FG002|Overall Study|Adverse Event|3|||
48413157|NCT00686543|155699109|FG003|Overall Study|Adverse Event|2|||
48413158|NCT00686543|155699106|FG000|Overall Study|Withdrawal by Subject|2|||
48413159|NCT00686543|155699107|FG001|Overall Study|Withdrawal by Subject|0|||
48413160|NCT00686543|155699108|FG002|Overall Study|Withdrawal by Subject|0|||
48361905|NCT01228318|155520162|FG001|Overall Study|Unable to contact|5|||
48361906|NCT01228318|155520161|FG000|Overall Study|Moved|0|||
48361907|NCT01228318|155520162|FG001|Overall Study|Moved|2|||
48413161|NCT00686543|155699109|FG003|Overall Study|Withdrawal by Subject|0|||
48413162|NCT00686543|155699106|FG000|Overall Study|Protocol Violation|3|||
48413163|NCT00686543|155699107|FG001|Overall Study|Protocol Violation|0|||
48361908|NCT01228318|155520161|FG000|Overall Study|Incarcerated|1|||
48413164|NCT00686543|155699108|FG002|Overall Study|Protocol Violation|2|||
48413165|NCT00686543|155699109|FG003|Overall Study|Protocol Violation|1|||
48361909|NCT01228318|155520162|FG001|Overall Study|Incarcerated|0|||
48361910|NCT02037477|155520163|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
48361911|NCT02037477|155520164|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
48361912|NCT02037477|155520165|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
48361913|NCT02037477|155520166|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
48361914|NCT01182441|155520171|FG000|Overall Study|Patient Still in Follow-up|152|||
48361915|NCT01182441|155520172|FG001|Overall Study|Patient Still in Follow-up|72|||
48361916|NCT01182441|155520171|FG000|Overall Study|Death|37|||
48361917|NCT01182441|155520172|FG001|Overall Study|Death|25|||
48361918|NCT01182441|155520171|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
48361919|NCT01182441|155520172|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
48361920|NCT01182441|155520171|FG000|Overall Study|Lost to Follow-up|5|||
48361921|NCT01182441|155520172|FG001|Overall Study|Lost to Follow-up|8|||
48361922|NCT01182441|155520171|FG000|Overall Study|Withdrawal by Subject|6|||
48361923|NCT01182441|155520172|FG001|Overall Study|Withdrawal by Subject|13|||
48361924|NCT01182441|155520171|FG000|Overall Study|Implant Not Attempted|4|||
48361925|NCT01182441|155520172|FG001|Overall Study|Implant Not Attempted|0|||
48361926|NCT01182441|155520171|FG000|Overall Study|Adverse Event|2|||
48361927|NCT01182441|155520172|FG001|Overall Study|Adverse Event|0|||
48361928|NCT01182441|155520171|FG000|Overall Study|Physician Decision|1|||
48361929|NCT01182441|155520172|FG001|Overall Study|Physician Decision|1|||
48361930|NCT00603525|155520173|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
48361931|NCT00603525|155520174|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
48361932|NCT00603525|155520175|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48361933|NCT00603525|155520173|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
48361934|NCT00603525|155520174|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48361935|NCT00603525|155520175|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48361936|NCT00603525|155520173|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
48361937|NCT00603525|155520174|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
48361938|NCT00603525|155520175|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48361939|NCT00603525|155520173|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48361940|NCT00603525|155520174|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
48361941|NCT00603525|155520175|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48361942|NCT00603525|155520173|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
48361943|NCT00603525|155520174|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
48361944|NCT00603525|155520175|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48361945|NCT00603525|155520173|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
48361946|NCT00603525|155520174|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
48361947|NCT00603525|155520175|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
48361948|NCT00603525|155520173|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
48361949|NCT00603525|155520174|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
48361950|NCT00603525|155520175|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
48361951|NCT00603525|155520173|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
48361952|NCT00603525|155520174|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
48361953|NCT00603525|155520175|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
48361954|NCT00603525|155520173|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
48361955|NCT00603525|155520174|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
48361956|NCT00603525|155520175|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
48361957|NCT00603525|155520173|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
48361958|NCT00603525|155520174|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
48361959|NCT00603525|155520175|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
48361960|NCT00603525|155520173|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
48361961|NCT00603525|155520174|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
48361962|NCT00603525|155520175|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
48361963|NCT00603525|155520173|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
48361964|NCT00603525|155520174|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
48361965|NCT00603525|155520175|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
48361966|NCT00603525|155520173|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
48361967|NCT00603525|155520174|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
48361968|NCT00603525|155520175|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
48361969|NCT00603525|155520173|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
48361970|NCT00603525|155520174|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
48361971|NCT00603525|155520175|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
48361972|NCT00603525|155520173|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
48361973|NCT00603525|155520174|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
48361974|NCT00603525|155520175|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
48361975|NCT02815579|155520176|FG000|Overall Study|Non-payment of loan down-payment|16|||
48361976|NCT02815579|155520177|FG001|Overall Study|Non-payment of loan down-payment|0|||
48361977|NCT02815579|155520176|FG000|Overall Study|Withdrawal by Subject|7|||
48361978|NCT02815579|155520177|FG001|Overall Study|Withdrawal by Subject|1|||
48361979|NCT02815579|155520176|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
48361980|NCT02815579|155520177|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
48361981|NCT02815579|155520176|FG000|Overall Study|Lost to Follow-up|7|||
48361982|NCT02815579|155520177|FG001|Overall Study|Lost to Follow-up|4|||
48361983|NCT02815579|155520176|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
48361984|NCT02815579|155520177|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
48361985|NCT02815579|155520176|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
48361986|NCT02815579|155520177|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
48361987|NCT02815579|155520176|FG000|Overall Study|Death|5|||
48361988|NCT02815579|155520177|FG001|Overall Study|Death|4|||
48361989|NCT02815579|155520176|FG000|Overall Study|Imprisoned|0|||
48361990|NCT02815579|155520177|FG001|Overall Study|Imprisoned|2|||
48361991|NCT02815579|155520176|FG000|Overall Study|Did not meet enrollment criteria|0|||
48361992|NCT02815579|155520177|FG001|Overall Study|Did not meet enrollment criteria|1|||
48361993|NCT04043143|155520178|FG000|Overall Study|Lost to Follow-up|5|||
48361994|NCT04043143|155520179|FG001|Overall Study|Lost to Follow-up|5|||
48361995|NCT04043143|155520178|FG000|Overall Study|screen failure|1|||
48361996|NCT04043143|155520179|FG001|Overall Study|screen failure|0|||
48361997|NCT03480932|155520180|FG000|Overall Study|Death|1|||
48361998|NCT03480932|155520181|FG001|Overall Study|Death|1|||
48361999|NCT03480932|155520182|FG002|Overall Study|Death|0|||
48362000|NCT03480932|155520180|FG000|Overall Study|Lost to Follow-up|0|||
48362001|NCT03480932|155520181|FG001|Overall Study|Lost to Follow-up|2|||
48362002|NCT03480932|155520182|FG002|Overall Study|Lost to Follow-up|3|||
48362003|NCT03480932|155520180|FG000|Overall Study|Incarcerated|2|||
48362004|NCT03480932|155520181|FG001|Overall Study|Incarcerated|2|||
48362005|NCT03480932|155520182|FG002|Overall Study|Incarcerated|2|||
48362006|NCT02248818|155520183|FG000|Screening|Protocol Violation|0|||
48362007|NCT02248818|155520184|FG001|Screening|Protocol Violation|0|||
48362008|NCT02248818|155520185|FG002|Screening|Protocol Violation|0|||
48362009|NCT02248818|155520186|FG003|Screening|Protocol Violation|0|||
48362010|NCT02248818|155520187|FG004|Screening|Protocol Violation|0|||
48362011|NCT02248818|155520188|FG005|Screening|Protocol Violation|0|||
48362012|NCT02248818|155520189|FG006|Screening|Protocol Violation|0|||
48362013|NCT02248818|155520190|FG007|Screening|Protocol Violation|0|||
48362014|NCT02248818|155520191|FG008|Screening|Protocol Violation|7|||
48362015|NCT02248818|155520183|FG000|Screening|Study fully enrolled|0|||
48362016|NCT02248818|155520184|FG001|Screening|Study fully enrolled|0|||
48362017|NCT02248818|155520185|FG002|Screening|Study fully enrolled|0|||
48362018|NCT02248818|155520186|FG003|Screening|Study fully enrolled|0|||
48362019|NCT02248818|155520187|FG004|Screening|Study fully enrolled|0|||
48362020|NCT02248818|155520188|FG005|Screening|Study fully enrolled|0|||
48362021|NCT02248818|155520189|FG006|Screening|Study fully enrolled|0|||
48362022|NCT02248818|155520190|FG007|Screening|Study fully enrolled|0|||
48362023|NCT02248818|155520191|FG008|Screening|Study fully enrolled|14|||
48362024|NCT02248818|155520183|FG000|Screening|Physician Decision|0|||
48362025|NCT02248818|155520184|FG001|Screening|Physician Decision|0|||
48362026|NCT02248818|155520185|FG002|Screening|Physician Decision|0|||
48362027|NCT02248818|155520186|FG003|Screening|Physician Decision|0|||
48362028|NCT02248818|155520187|FG004|Screening|Physician Decision|0|||
48362029|NCT02248818|155520188|FG005|Screening|Physician Decision|0|||
48362030|NCT02248818|155520189|FG006|Screening|Physician Decision|0|||
48362031|NCT02248818|155520190|FG007|Screening|Physician Decision|0|||
48362032|NCT02248818|155520191|FG008|Screening|Physician Decision|73|||
48362033|NCT02248818|155520183|FG000|Screening|Withdrawal by Subject|0|||
48362034|NCT02248818|155520184|FG001|Screening|Withdrawal by Subject|0|||
48362035|NCT02248818|155520185|FG002|Screening|Withdrawal by Subject|0|||
48362036|NCT02248818|155520186|FG003|Screening|Withdrawal by Subject|0|||
48362037|NCT02248818|155520187|FG004|Screening|Withdrawal by Subject|0|||
48362038|NCT02248818|155520188|FG005|Screening|Withdrawal by Subject|0|||
48362039|NCT02248818|155520189|FG006|Screening|Withdrawal by Subject|0|||
48362040|NCT02248818|155520190|FG007|Screening|Withdrawal by Subject|0|||
48362041|NCT02248818|155520191|FG008|Screening|Withdrawal by Subject|6|||
48362042|NCT02248818|155520183|FG000|Screening|Lost to Follow-up|0|||
48362043|NCT02248818|155520184|FG001|Screening|Lost to Follow-up|0|||
48362044|NCT02248818|155520185|FG002|Screening|Lost to Follow-up|0|||
48362045|NCT02248818|155520186|FG003|Screening|Lost to Follow-up|0|||
48362046|NCT02248818|155520187|FG004|Screening|Lost to Follow-up|0|||
48362047|NCT02248818|155520188|FG005|Screening|Lost to Follow-up|0|||
48362048|NCT02248818|155520189|FG006|Screening|Lost to Follow-up|0|||
48362049|NCT02248818|155520190|FG007|Screening|Lost to Follow-up|0|||
48362050|NCT02248818|155520191|FG008|Screening|Lost to Follow-up|7|||
48362051|NCT02248818|155520183|FG000|Randomised Study|Administrative - randomization error|0|||
48362052|NCT02248818|155520184|FG001|Randomised Study|Administrative - randomization error|0|||
48362053|NCT02248818|155520185|FG002|Randomised Study|Administrative - randomization error|0|||
48362054|NCT02248818|155520186|FG003|Randomised Study|Administrative - randomization error|0|||
48362055|NCT02248818|155520187|FG004|Randomised Study|Administrative - randomization error|0|||
48362056|NCT02248818|155520188|FG005|Randomised Study|Administrative - randomization error|8|||
48362057|NCT02248818|155520189|FG006|Randomised Study|Administrative - randomization error|0|||
48362058|NCT02248818|155520190|FG007|Randomised Study|Administrative - randomization error|0|||
48362059|NCT02248818|155520191|FG008|Randomised Study|Administrative - randomization error|0|||
48362060|NCT00953771|155520192|FG000|Overall Study|Death|1|||
48362061|NCT00953771|155520193|FG001|Overall Study|Death|0|||
48362062|NCT00567567|155520194|FG000|Overall Study|Adverse Event|0|||
48362063|NCT00567567|155520195|FG001|Overall Study|Adverse Event|2|||
48362064|NCT00567567|155520196|FG002|Overall Study|Adverse Event|5|||
48362065|NCT00567567|155520194|FG000|Overall Study|Death|8|||
48362066|NCT00567567|155520195|FG001|Overall Study|Death|1|||
48362067|NCT00567567|155520196|FG002|Overall Study|Death|5|||
48362068|NCT00567567|155520194|FG000|Overall Study|Lack of Efficacy|16|||
48362069|NCT00567567|155520195|FG001|Overall Study|Lack of Efficacy|17|||
48362070|NCT00567567|155520196|FG002|Overall Study|Lack of Efficacy|48|||
48362071|NCT00567567|155520194|FG000|Overall Study|Lost to Follow-up|0|||
48362072|NCT00567567|155520195|FG001|Overall Study|Lost to Follow-up|0|||
48362073|NCT00567567|155520196|FG002|Overall Study|Lost to Follow-up|1|||
48362074|NCT00567567|155520194|FG000|Overall Study|Physician Decision|16|||
48362075|NCT00567567|155520195|FG001|Overall Study|Physician Decision|18|||
48362076|NCT00567567|155520196|FG002|Overall Study|Physician Decision|84|||
48362077|NCT00567567|155520194|FG000|Overall Study|Withdrawal by Subject|0|||
48362078|NCT00567567|155520195|FG001|Overall Study|Withdrawal by Subject|0|||
48362079|NCT00567567|155520196|FG002|Overall Study|Withdrawal by Subject|2|||
48362080|NCT00567567|155520194|FG000|Overall Study|Ineligible|4|||
48362081|NCT00567567|155520195|FG001|Overall Study|Ineligible|0|||
48362082|NCT00567567|155520196|FG002|Overall Study|Ineligible|9|||
48362083|NCT00567567|155520194|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
48362084|NCT00567567|155520195|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
48413166|NCT05369806|155699112|FG000|Overall Study|Lost to Follow-up|1|||
48413167|NCT00140855|155699113|FG000|Overall Study|Progressive disease|2|||
48413168|NCT02932267|155699115|FG000|Overall Study|Withdrawal by Subject|3|||
48413169|NCT02932267|155699115|FG000|Overall Study|Lost to Follow-up|4|||
48413170|NCT02932267|155699115|FG000|Overall Study|Pregnancy|1|||
48413171|NCT03430310|155699117|FG000|Overall Study|Protocol Violation|2|||
48413172|NCT03430310|155699118|FG001|Overall Study|Protocol Violation|0|||
48413173|NCT03430310|155699117|FG000|Overall Study|Withdrawal by Subject|3|||
48413174|NCT03430310|155699118|FG001|Overall Study|Withdrawal by Subject|2|||
48413175|NCT03430310|155699117|FG000|Overall Study|COVID shutdown March 2020|0|||
48413176|NCT03430310|155699118|FG001|Overall Study|COVID shutdown March 2020|1|||
48413177|NCT01070329|155701099|FG000|Overall Study|Adverse Event|13|||
48413178|NCT01070329|155701100|FG001|Overall Study|Adverse Event|10|||
48413179|NCT01070329|155701099|FG000|Overall Study|Lost to Follow-up|22|||
48413180|NCT01070329|155701100|FG001|Overall Study|Lost to Follow-up|12|||
48413181|NCT01070329|155701099|FG000|Overall Study|Withdrawal by Subject|9|||
48413182|NCT01070329|155701100|FG001|Overall Study|Withdrawal by Subject|11|||
48413183|NCT01070329|155701099|FG000|Overall Study|Protocol Violation|3|||
48413184|NCT01070329|155701100|FG001|Overall Study|Protocol Violation|8|||
48413185|NCT01070329|155701099|FG000|Overall Study|Lack of Efficacy|2|||
48413186|NCT01070329|155701100|FG001|Overall Study|Lack of Efficacy|6|||
48413187|NCT01070329|155701099|FG000|Overall Study|Physician Decision|2|||
48413188|NCT01070329|155701100|FG001|Overall Study|Physician Decision|1|||
48413189|NCT01070329|155701099|FG000|Overall Study|Entry Criteria Not Met|1|||
48413190|NCT01070329|155701100|FG001|Overall Study|Entry Criteria Not Met|0|||
48413191|NCT01070329|155701099|FG000|Overall Study|Sponsor Decision|0|||
48413192|NCT01070329|155701100|FG001|Overall Study|Sponsor Decision|1|||
48413193|NCT01748071|155701101|FG000|Overall Study|Adverse Event|2|||
48413194|NCT01748071|155701102|FG001|Overall Study|Adverse Event|2|||
48413195|NCT01748071|155701103|FG002|Overall Study|Adverse Event|0|||
48413196|NCT05195528|155701104|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
48413197|NCT05195528|155701105|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
48413198|NCT05195528|155701106|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
48413199|NCT05195528|155701107|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
48413200|NCT05195528|155701108|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
48413201|NCT05195528|155701104|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
48362085|NCT00567567|155520196|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
48362086|NCT00567567|155520194|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
48362087|NCT00567567|155520195|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
48362088|NCT00567567|155520196|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
48362089|NCT00567567|155520194|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
48362090|NCT00567567|155520195|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
48362091|NCT00567567|155520196|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
48413202|NCT05195528|155701105|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
48413203|NCT05195528|155701106|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
48413204|NCT05195528|155701107|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48413205|NCT05195528|155701108|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48413206|NCT05195528|155701104|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48413207|NCT05195528|155701105|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
48413208|NCT05195528|155701106|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
48413209|NCT05195528|155701107|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48413210|NCT05195528|155701108|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48413211|NCT05195528|155701104|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
48413212|NCT05195528|155701105|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
48413213|NCT05195528|155701106|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
48413214|NCT05195528|155701107|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
48413215|NCT05195528|155701108|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
48413216|NCT05195528|155701104|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
48362092|NCT03433677|155520197|FG000|Period 1|Protocol Violation|1|||
48362093|NCT03433677|155520198|FG001|Period 1|Protocol Violation|0|||
48362094|NCT03433677|155520197|FG000|Period 2|Withdrawal by Subject|1|||
48362095|NCT03433677|155520198|FG001|Period 2|Withdrawal by Subject|1|||
48362096|NCT00709228|155520199|FG000|Overall Study|Not treated|14|||
48362097|NCT00709228|155520199|FG000|Overall Study|Eligibility criteria not met|281|||
48413217|NCT05195528|155701105|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
48413218|NCT05195528|155701106|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
48413219|NCT05195528|155701107|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
48413220|NCT05195528|155701108|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
48413221|NCT05195528|155701104|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
48413222|NCT05195528|155701105|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
48413223|NCT05195528|155701106|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
48413224|NCT05195528|155701107|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
48413225|NCT05195528|155701108|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
48413226|NCT05195528|155701104|FG000|Placebo-controlled Treatment Period|Other|0|||
48413227|NCT05195528|155701105|FG001|Placebo-controlled Treatment Period|Other|0|||
48413228|NCT05195528|155701106|FG002|Placebo-controlled Treatment Period|Other|1|||
48413229|NCT05195528|155701107|FG003|Placebo-controlled Treatment Period|Other|0|||
48362098|NCT00709228|155520199|FG000|Overall Study|Adverse events|2|||
48362099|NCT00709228|155520199|FG000|Overall Study|Discontinued treatment|14|||
48362100|NCT00709228|155520199|FG000|Overall Study|Did not enter follow-up|4|||
48362101|NCT00709228|155520199|FG000|Overall Study|Discontinued follow-up|5|||
48362102|NCT00709228|155520199|FG000|Overall Study|Disease progression|1|||
48362103|NCT00709228|155520199|FG000|Overall Study|Lost to Follow-up|6|||
48362104|NCT00709228|155520199|FG000|Overall Study|Non-compliance|5|||
48362105|NCT04497389|155520200|FG000|Overall Study|Withdrawal by Subject|1|||
48362106|NCT04497389|155520201|FG001|Overall Study|Withdrawal by Subject|0|||
48362107|NCT00789360|155520202|FG000|Overall Study|Protocol Violation|3|||
48362108|NCT00789360|155520203|FG001|Overall Study|Protocol Violation|1|||
48362109|NCT03139604|155520204|FG000|Overall Study|Other|7|||
48362110|NCT03139604|155520205|FG001|Overall Study|Other|3|||
48362111|NCT03139604|155520204|FG000|Overall Study|Withdrawal by Subject|16|||
48362112|NCT03139604|155520205|FG001|Overall Study|Withdrawal by Subject|17|||
48362113|NCT03139604|155520204|FG000|Overall Study|Physician Decision|1|||
48362114|NCT03139604|155520205|FG001|Overall Study|Physician Decision|2|||
48362115|NCT03139604|155520204|FG000|Overall Study|Lost to Follow-up|3|||
48362116|NCT03139604|155520205|FG001|Overall Study|Lost to Follow-up|1|||
48362117|NCT03139604|155520204|FG000|Overall Study|Death|65|||
48362118|NCT03139604|155520205|FG001|Overall Study|Death|67|||
48362119|NCT03139604|155520204|FG000|Overall Study|Study Terminated by Sponsor|122|||
48362120|NCT03139604|155520205|FG001|Overall Study|Study Terminated by Sponsor|127|||
48362121|NCT03139604|155520204|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
48362122|NCT03139604|155520205|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
48362123|NCT03559062|155520206|FG000|Overall Study|Other|0|||
48362124|NCT03559062|155520207|FG001|Overall Study|Other|1|||
48362125|NCT03559062|155520208|FG002|Overall Study|Other|0|||
48362126|NCT01940939|155520209|FG000|Overall Study|Withdrawal by Subject|2|||
48362127|NCT01940939|155520210|FG001|Overall Study|Withdrawal by Subject|8|||
48362128|NCT01144052|155520211|FG000|Overall Study|Withdrawal by Subject|1|||
48362129|NCT01144052|155520212|FG001|Overall Study|Withdrawal by Subject|1|||
48362130|NCT02591953|155520213|FG000|Overall Study|Lost to Follow-up|6|||
48413230|NCT05195528|155701108|FG004|Placebo-controlled Treatment Period|Other|0|||
48362131|NCT02591953|155520214|FG001|Overall Study|Lost to Follow-up|6|||
48362132|NCT01499303|155520216|FG000|Overall Study|Ongoing|2|||
48362133|NCT01499303|155520217|FG001|Overall Study|Ongoing|1|||
48362134|NCT01499303|155520216|FG000|Overall Study|Withdrawal by Subject|0|||
48362135|NCT01499303|155520217|FG001|Overall Study|Withdrawal by Subject|1|||
48413231|NCT05195528|155701104|FG000|Extension Period|PTE or AE or SAE|0|||
48413232|NCT05195528|155701105|FG001|Extension Period|PTE or AE or SAE|4|||
48362136|NCT01499303|155520216|FG000|Overall Study|Adverse Event|1|||
48362137|NCT01499303|155520217|FG001|Overall Study|Adverse Event|4|||
48362138|NCT01499303|155520216|FG000|Overall Study|Other|0|||
48362139|NCT01499303|155520217|FG001|Overall Study|Other|1|||
48413233|NCT05195528|155701106|FG002|Extension Period|PTE or AE or SAE|5|||
48413234|NCT05195528|155701107|FG003|Extension Period|PTE or AE or SAE|4|||
48413235|NCT05195528|155701108|FG004|Extension Period|PTE or AE or SAE|4|||
48413236|NCT05195528|155701104|FG000|Extension Period|Protocol Violation|0|||
48413237|NCT05195528|155701105|FG001|Extension Period|Protocol Violation|2|||
48413238|NCT05195528|155701106|FG002|Extension Period|Protocol Violation|1|||
48413239|NCT05195528|155701107|FG003|Extension Period|Protocol Violation|0|||
48413240|NCT05195528|155701108|FG004|Extension Period|Protocol Violation|1|||
48413241|NCT05195528|155701104|FG000|Extension Period|Lost to Follow-up|0|||
48413242|NCT05195528|155701105|FG001|Extension Period|Lost to Follow-up|6|||
48413243|NCT05195528|155701106|FG002|Extension Period|Lost to Follow-up|13|||
48413244|NCT05195528|155701107|FG003|Extension Period|Lost to Follow-up|3|||
48413245|NCT05195528|155701108|FG004|Extension Period|Lost to Follow-up|7|||
48413246|NCT05195528|155701104|FG000|Extension Period|Withdrawal by Subject|0|||
48413247|NCT05195528|155701105|FG001|Extension Period|Withdrawal by Subject|12|||
48413248|NCT05195528|155701106|FG002|Extension Period|Withdrawal by Subject|9|||
48413249|NCT05195528|155701107|FG003|Extension Period|Withdrawal by Subject|6|||
48413250|NCT05195528|155701108|FG004|Extension Period|Withdrawal by Subject|5|||
48413251|NCT05195528|155701104|FG000|Extension Period|Lack of Efficacy|0|||
48413252|NCT05195528|155701105|FG001|Extension Period|Lack of Efficacy|3|||
48413253|NCT05195528|155701106|FG002|Extension Period|Lack of Efficacy|0|||
48413254|NCT05195528|155701107|FG003|Extension Period|Lack of Efficacy|0|||
48413255|NCT05195528|155701108|FG004|Extension Period|Lack of Efficacy|2|||
48413256|NCT05195528|155701104|FG000|Extension Period|Not Treated|0|||
48413257|NCT05195528|155701105|FG001|Extension Period|Not Treated|0|||
48413258|NCT05195528|155701106|FG002|Extension Period|Not Treated|2|||
48413259|NCT05195528|155701107|FG003|Extension Period|Not Treated|3|||
48413260|NCT05195528|155701108|FG004|Extension Period|Not Treated|0|||
48413261|NCT05195528|155701104|FG000|Extension Period|Other|0|||
48413262|NCT05195528|155701105|FG001|Extension Period|Other|1|||
48413263|NCT05195528|155701106|FG002|Extension Period|Other|1|||
48413264|NCT05195528|155701107|FG003|Extension Period|Other|0|||
48413265|NCT05195528|155701108|FG004|Extension Period|Other|0|||
48413266|NCT00393718|155701113|FG000|Overall Study|Adverse Event|20|||
48413267|NCT00393718|155701114|FG001|Overall Study|Adverse Event|8|||
48413268|NCT00393718|155701113|FG000|Overall Study|Protocol Violation|1|||
48413269|NCT00393718|155701114|FG001|Overall Study|Protocol Violation|2|||
48413270|NCT00393718|155701113|FG000|Overall Study|Lack of Efficacy|10|||
48413271|NCT00393718|155701114|FG001|Overall Study|Lack of Efficacy|9|||
48413272|NCT00393718|155701113|FG000|Overall Study|Hypoglycaemia|3|||
48362140|NCT00461981|155520218|FG000|Overall Study|Lost to Follow-up|9|||
48362141|NCT00461981|155520219|FG001|Overall Study|Lost to Follow-up|6|||
48362142|NCT00461981|155520218|FG000|Overall Study|Withdrawal by Subject|2|||
48362143|NCT00461981|155520219|FG001|Overall Study|Withdrawal by Subject|3|||
48362144|NCT00874731|155520227|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
48362145|NCT00874731|155520228|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
48362146|NCT00874731|155520229|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
48362147|NCT00874731|155520227|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
48362148|NCT00874731|155520228|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
48362149|NCT00874731|155520229|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
48362150|NCT00874731|155520227|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
48362151|NCT00874731|155520228|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
48362152|NCT00874731|155520229|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
48362153|NCT03015129|155520230|FG000|Overall Study|Death|2|||
48362154|NCT03015129|155520231|FG001|Overall Study|Death|2|||
48362155|NCT03015129|155520230|FG000|Overall Study|Lost to Follow-up|0|||
48362156|NCT03015129|155520231|FG001|Overall Study|Lost to Follow-up|1|||
48362157|NCT03015129|155520230|FG000|Overall Study|Progression of disease|38|||
48362158|NCT03015129|155520231|FG001|Overall Study|Progression of disease|33|||
48362159|NCT03015129|155520230|FG000|Overall Study|Adverse Event|0|||
48413273|NCT00393718|155701114|FG001|Overall Study|Hypoglycaemia|2|||
48362160|NCT03015129|155520231|FG001|Overall Study|Adverse Event|4|||
48362161|NCT01022112|155520234|FG000|Overall Study|Adverse Event|1|||
48362162|NCT01022112|155520235|FG001|Overall Study|Adverse Event|2|||
48362163|NCT01022112|155520236|FG002|Overall Study|Adverse Event|0|||
48362164|NCT01022112|155520237|FG003|Overall Study|Adverse Event|1|||
48413274|NCT00393718|155701113|FG000|Overall Study|Subject decision|5|||
48413275|NCT00393718|155701114|FG001|Overall Study|Subject decision|0|||
48413276|NCT00393718|155701113|FG000|Overall Study|Withdrawal of consent|2|||
48413277|NCT00393718|155701114|FG001|Overall Study|Withdrawal of consent|1|||
48413278|NCT00393718|155701113|FG000|Overall Study|Missed measurement|1|||
48413279|NCT00393718|155701114|FG001|Overall Study|Missed measurement|0|||
48413280|NCT00393718|155701113|FG000|Overall Study|Move|1|||
48413281|NCT00393718|155701114|FG001|Overall Study|Move|0|||
48413282|NCT00883493|155701116|FG000|Overall Study|Adverse Event|11|||
48362165|NCT01022112|155520238|FG004|Overall Study|Adverse Event|0|||
48362166|NCT01022112|155520234|FG000|Overall Study|Lack of Efficacy|1|||
48362167|NCT01022112|155520235|FG001|Overall Study|Lack of Efficacy|0|||
48362168|NCT01022112|155520236|FG002|Overall Study|Lack of Efficacy|0|||
48362169|NCT01022112|155520237|FG003|Overall Study|Lack of Efficacy|0|||
48362170|NCT01022112|155520238|FG004|Overall Study|Lack of Efficacy|1|||
48362171|NCT01022112|155520234|FG000|Overall Study|Physician Decision|0|||
48362172|NCT01022112|155520235|FG001|Overall Study|Physician Decision|0|||
48362173|NCT01022112|155520236|FG002|Overall Study|Physician Decision|1|||
48362174|NCT01022112|155520237|FG003|Overall Study|Physician Decision|0|||
48362175|NCT01022112|155520238|FG004|Overall Study|Physician Decision|1|||
48362176|NCT01022112|155520234|FG000|Overall Study|Withdrawal by Subject|0|||
48362177|NCT01022112|155520235|FG001|Overall Study|Withdrawal by Subject|1|||
48362178|NCT01022112|155520236|FG002|Overall Study|Withdrawal by Subject|2|||
48362179|NCT01022112|155520237|FG003|Overall Study|Withdrawal by Subject|2|||
48362180|NCT01022112|155520238|FG004|Overall Study|Withdrawal by Subject|1|||
48362181|NCT01022112|155520234|FG000|Overall Study|Fasting plasma glucose level increased|1|||
48362182|NCT01022112|155520235|FG001|Overall Study|Fasting plasma glucose level increased|0|||
48362183|NCT01022112|155520236|FG002|Overall Study|Fasting plasma glucose level increased|0|||
48362184|NCT01022112|155520237|FG003|Overall Study|Fasting plasma glucose level increased|0|||
48362185|NCT01022112|155520238|FG004|Overall Study|Fasting plasma glucose level increased|7|||
48362186|NCT01803282|155520241|FG000|Overall Study|Progressive Disease|4|||
48362187|NCT01803282|155520242|FG001|Overall Study|Progressive Disease|3|||
48362188|NCT01803282|155520243|FG002|Overall Study|Progressive Disease|6|||
48362189|NCT01803282|155520244|FG003|Overall Study|Progressive Disease|22|||
48362190|NCT01803282|155520245|FG004|Overall Study|Progressive Disease|5|||
48362191|NCT01803282|155520246|FG005|Overall Study|Progressive Disease|8|||
48362192|NCT01803282|155520247|FG006|Overall Study|Progressive Disease|23|||
48362193|NCT01803282|155520248|FG007|Overall Study|Progressive Disease|24|||
48362194|NCT01803282|155520249|FG008|Overall Study|Progressive Disease|3|||
48362195|NCT01803282|155520250|FG009|Overall Study|Progressive Disease|29|||
48362196|NCT01803282|155520251|FG010|Overall Study|Progressive Disease|6|||
48362197|NCT01803282|155520252|FG011|Overall Study|Progressive Disease|11|||
48362198|NCT01803282|155520241|FG000|Overall Study|Death|0|||
48362199|NCT01803282|155520242|FG001|Overall Study|Death|0|||
48362200|NCT01803282|155520243|FG002|Overall Study|Death|0|||
48362201|NCT01803282|155520244|FG003|Overall Study|Death|0|||
48362202|NCT01803282|155520245|FG004|Overall Study|Death|2|||
48362203|NCT01803282|155520246|FG005|Overall Study|Death|1|||
48362204|NCT01803282|155520247|FG006|Overall Study|Death|1|||
48362205|NCT01803282|155520248|FG007|Overall Study|Death|5|||
48362206|NCT01803282|155520249|FG008|Overall Study|Death|1|||
48362207|NCT01803282|155520250|FG009|Overall Study|Death|1|||
48362208|NCT01803282|155520251|FG010|Overall Study|Death|0|||
48362209|NCT01803282|155520252|FG011|Overall Study|Death|0|||
48362210|NCT01803282|155520241|FG000|Overall Study|Withdrew Consent|0|||
48362211|NCT01803282|155520242|FG001|Overall Study|Withdrew Consent|0|||
48362212|NCT01803282|155520243|FG002|Overall Study|Withdrew Consent|0|||
48362213|NCT01803282|155520244|FG003|Overall Study|Withdrew Consent|6|||
48362214|NCT01803282|155520245|FG004|Overall Study|Withdrew Consent|1|||
48362215|NCT01803282|155520246|FG005|Overall Study|Withdrew Consent|0|||
48362216|NCT01803282|155520247|FG006|Overall Study|Withdrew Consent|8|||
48362217|NCT01803282|155520248|FG007|Overall Study|Withdrew Consent|3|||
48362218|NCT01803282|155520249|FG008|Overall Study|Withdrew Consent|1|||
48362219|NCT01803282|155520250|FG009|Overall Study|Withdrew Consent|5|||
48362220|NCT01803282|155520251|FG010|Overall Study|Withdrew Consent|0|||
48362221|NCT01803282|155520252|FG011|Overall Study|Withdrew Consent|1|||
48362222|NCT01803282|155520241|FG000|Overall Study|Investigator's Discretion|0|||
48362223|NCT01803282|155520242|FG001|Overall Study|Investigator's Discretion|0|||
48362224|NCT01803282|155520243|FG002|Overall Study|Investigator's Discretion|0|||
48362225|NCT01803282|155520244|FG003|Overall Study|Investigator's Discretion|7|||
48362226|NCT01803282|155520245|FG004|Overall Study|Investigator's Discretion|2|||
48362227|NCT01803282|155520246|FG005|Overall Study|Investigator's Discretion|1|||
48362228|NCT01803282|155520247|FG006|Overall Study|Investigator's Discretion|7|||
48362229|NCT01803282|155520248|FG007|Overall Study|Investigator's Discretion|10|||
48362230|NCT01803282|155520249|FG008|Overall Study|Investigator's Discretion|6|||
48362231|NCT01803282|155520250|FG009|Overall Study|Investigator's Discretion|7|||
48362232|NCT01803282|155520251|FG010|Overall Study|Investigator's Discretion|1|||
48362233|NCT01803282|155520252|FG011|Overall Study|Investigator's Discretion|0|||
48362234|NCT01803282|155520241|FG000|Overall Study|Adverse Event|0|||
48362235|NCT01803282|155520242|FG001|Overall Study|Adverse Event|0|||
48362236|NCT01803282|155520243|FG002|Overall Study|Adverse Event|0|||
48362237|NCT01803282|155520244|FG003|Overall Study|Adverse Event|0|||
48362238|NCT01803282|155520245|FG004|Overall Study|Adverse Event|0|||
48362239|NCT01803282|155520246|FG005|Overall Study|Adverse Event|0|||
48362240|NCT01803282|155520247|FG006|Overall Study|Adverse Event|1|||
48362241|NCT01803282|155520248|FG007|Overall Study|Adverse Event|2|||
48362242|NCT01803282|155520249|FG008|Overall Study|Adverse Event|0|||
48362243|NCT01803282|155520250|FG009|Overall Study|Adverse Event|1|||
48362244|NCT01803282|155520251|FG010|Overall Study|Adverse Event|0|||
48362245|NCT01803282|155520252|FG011|Overall Study|Adverse Event|3|||
48362246|NCT01803282|155520241|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48362247|NCT01803282|155520242|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48362248|NCT01803282|155520243|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48362249|NCT01803282|155520244|FG003|Overall Study|Non-Compliance with Study Drug|1|||
48362250|NCT01803282|155520245|FG004|Overall Study|Non-Compliance with Study Drug|0|||
48362251|NCT01803282|155520246|FG005|Overall Study|Non-Compliance with Study Drug|0|||
48362252|NCT01803282|155520247|FG006|Overall Study|Non-Compliance with Study Drug|0|||
48362253|NCT01803282|155520248|FG007|Overall Study|Non-Compliance with Study Drug|0|||
48362254|NCT01803282|155520249|FG008|Overall Study|Non-Compliance with Study Drug|0|||
48362255|NCT01803282|155520250|FG009|Overall Study|Non-Compliance with Study Drug|0|||
48362256|NCT01803282|155520251|FG010|Overall Study|Non-Compliance with Study Drug|0|||
48362257|NCT01803282|155520252|FG011|Overall Study|Non-Compliance with Study Drug|0|||
48362258|NCT01803282|155520241|FG000|Overall Study|Unknown Reason|0|||
48362259|NCT01803282|155520242|FG001|Overall Study|Unknown Reason|0|||
48362260|NCT01803282|155520243|FG002|Overall Study|Unknown Reason|0|||
48362261|NCT01803282|155520244|FG003|Overall Study|Unknown Reason|0|||
48362262|NCT01803282|155520245|FG004|Overall Study|Unknown Reason|0|||
48362263|NCT01803282|155520246|FG005|Overall Study|Unknown Reason|0|||
48362264|NCT01803282|155520247|FG006|Overall Study|Unknown Reason|0|||
48362265|NCT01803282|155520248|FG007|Overall Study|Unknown Reason|1|||
48362266|NCT01803282|155520249|FG008|Overall Study|Unknown Reason|0|||
48362267|NCT01803282|155520250|FG009|Overall Study|Unknown Reason|0|||
48362268|NCT01803282|155520251|FG010|Overall Study|Unknown Reason|0|||
48362269|NCT01803282|155520252|FG011|Overall Study|Unknown Reason|0|||
48362270|NCT01803282|155520241|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
48362271|NCT01803282|155520242|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
48362272|NCT01803282|155520243|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
48362273|NCT01803282|155520244|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
48362274|NCT01803282|155520245|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
48362275|NCT01803282|155520246|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
48362276|NCT01803282|155520247|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
48362277|NCT01803282|155520248|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
48362278|NCT01803282|155520249|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
48362279|NCT01803282|155520250|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
48362280|NCT01803282|155520251|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
48362281|NCT01803282|155520252|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
48362282|NCT01803282|155520241|FG000|Overall Study|Enrolled but Never Treated|0|||
48362283|NCT01803282|155520242|FG001|Overall Study|Enrolled but Never Treated|0|||
48362284|NCT01803282|155520243|FG002|Overall Study|Enrolled but Never Treated|0|||
48362285|NCT01803282|155520244|FG003|Overall Study|Enrolled but Never Treated|0|||
48362286|NCT01803282|155520245|FG004|Overall Study|Enrolled but Never Treated|1|||
48362287|NCT01803282|155520246|FG005|Overall Study|Enrolled but Never Treated|0|||
48362288|NCT01803282|155520247|FG006|Overall Study|Enrolled but Never Treated|1|||
48362289|NCT01803282|155520248|FG007|Overall Study|Enrolled but Never Treated|1|||
48362290|NCT01803282|155520249|FG008|Overall Study|Enrolled but Never Treated|0|||
48362291|NCT01803282|155520250|FG009|Overall Study|Enrolled but Never Treated|1|||
48362292|NCT01803282|155520251|FG010|Overall Study|Enrolled but Never Treated|0|||
48362293|NCT01803282|155520252|FG011|Overall Study|Enrolled but Never Treated|0|||
48362294|NCT01743989|155520255|FG000|Treatment Phase|Unstable MR4.0|0|||
48362295|NCT01743989|155520256|FG001|Treatment Phase|Unstable MR4.0|6|||
48362296|NCT01743989|155520257|FG002|Treatment Phase|Unstable MR4.0|263|||
48362297|NCT01743989|155520255|FG000|Treatment Phase|Adverse Event|0|||
48362298|NCT01743989|155520256|FG001|Treatment Phase|Adverse Event|4|||
48362299|NCT01743989|155520257|FG002|Treatment Phase|Adverse Event|67|||
48362300|NCT01743989|155520255|FG000|Treatment Phase|Withdrawal by Subject|1|||
48362301|NCT01743989|155520256|FG001|Treatment Phase|Withdrawal by Subject|3|||
48362302|NCT01743989|155520257|FG002|Treatment Phase|Withdrawal by Subject|28|||
48362303|NCT01743989|155520255|FG000|Treatment Phase|Death|0|||
48362304|NCT01743989|155520256|FG001|Treatment Phase|Death|1|||
48362305|NCT01743989|155520257|FG002|Treatment Phase|Death|3|||
48362306|NCT01743989|155520255|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
48362307|NCT01743989|155520256|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
48362308|NCT01743989|155520257|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
48362309|NCT01743989|155520255|FG000|Treatment Phase|Protocol deviation|0|||
48362310|NCT01743989|155520256|FG001|Treatment Phase|Protocol deviation|0|||
48362311|NCT01743989|155520257|FG002|Treatment Phase|Protocol deviation|3|||
48362312|NCT01743989|155520255|FG000|Treatment Phase|Pregnancy|0|||
48362313|NCT01743989|155520256|FG001|Treatment Phase|Pregnancy|0|||
48362314|NCT01743989|155520257|FG002|Treatment Phase|Pregnancy|2|||
48362315|NCT01743989|155520255|FG000|Treatment Phase|Lost to Follow-up|0|||
48362316|NCT01743989|155520256|FG001|Treatment Phase|Lost to Follow-up|0|||
48362317|NCT01743989|155520257|FG002|Treatment Phase|Lost to Follow-up|2|||
48362318|NCT01743989|155520255|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
48362319|NCT01743989|155520256|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
48413283|NCT00883493|155701117|FG001|Overall Study|Adverse Event|12|||
48413284|NCT00883493|155701116|FG000|Overall Study|Lack of Efficacy|4|||
48413285|NCT00883493|155701117|FG001|Overall Study|Lack of Efficacy|3|||
48413286|NCT00883493|155701116|FG000|Overall Study|Lost to Follow-up|7|||
48362320|NCT01743989|155520257|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
48362321|NCT01743989|155520255|FG000|Treatment Phase|Administrative problems|0|||
48362322|NCT01743989|155520256|FG001|Treatment Phase|Administrative problems|0|||
48362323|NCT01743989|155520257|FG002|Treatment Phase|Administrative problems|1|||
48362324|NCT01743989|155520255|FG000|Treatment Phase|New cancer (CML) therapy|0|||
48362325|NCT01743989|155520256|FG001|Treatment Phase|New cancer (CML) therapy|1|||
48362326|NCT01743989|155520257|FG002|Treatment Phase|New cancer (CML) therapy|0|||
48362327|NCT01743989|155520255|FG000|Treatment Phase|Physician Decision|0|||
48413287|NCT00883493|155701117|FG001|Overall Study|Lost to Follow-up|6|||
48413288|NCT00883493|155701116|FG000|Overall Study|Withdrawal by Subject|11|||
48413289|NCT00883493|155701117|FG001|Overall Study|Withdrawal by Subject|20|||
48362328|NCT01743989|155520256|FG001|Treatment Phase|Physician Decision|0|||
48362329|NCT01743989|155520257|FG002|Treatment Phase|Physician Decision|3|||
48362330|NCT01743989|155520255|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
48362331|NCT01743989|155520256|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
48413290|NCT00883493|155701116|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
48413291|NCT00883493|155701117|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
48413292|NCT00883493|155701116|FG000|Overall Study|Study specific disc. criteria|2|||
48413293|NCT00883493|155701117|FG001|Overall Study|Study specific disc. criteria|0|||
48413294|NCT00883493|155701116|FG000|Overall Study|Other|5|||
48413295|NCT00883493|155701117|FG001|Overall Study|Other|3|||
48413296|NCT01427309|155701119|FG000|Overall Study|Lost to Follow-up|130|||
48413297|NCT01427309|155701120|FG001|Overall Study|Lost to Follow-up|145|||
48413298|NCT01427309|155701121|FG002|Overall Study|Lost to Follow-up|122|||
48413299|NCT01427309|155701122|FG003|Overall Study|Lost to Follow-up|135|||
48413300|NCT01427309|155701119|FG000|Overall Study|Protocol Violation|42|||
48413301|NCT01427309|155701120|FG001|Overall Study|Protocol Violation|69|||
48413302|NCT01427309|155701121|FG002|Overall Study|Protocol Violation|125|||
48413303|NCT01427309|155701122|FG003|Overall Study|Protocol Violation|124|||
48413304|NCT01427309|155701119|FG000|Overall Study|Adverse Event|0|||
48413305|NCT01427309|155701120|FG001|Overall Study|Adverse Event|0|||
48413306|NCT01427309|155701121|FG002|Overall Study|Adverse Event|3|||
48413307|NCT01427309|155701122|FG003|Overall Study|Adverse Event|1|||
48413308|NCT01427309|155701119|FG000|Overall Study|Serious adverse event|52|||
48413309|NCT01427309|155701120|FG001|Overall Study|Serious adverse event|45|||
48413310|NCT01427309|155701121|FG002|Overall Study|Serious adverse event|50|||
48413311|NCT01427309|155701122|FG003|Overall Study|Serious adverse event|61|||
48413312|NCT01427309|155701119|FG000|Overall Study|Withdrawal by Subject|148|||
48413313|NCT01427309|155701120|FG001|Overall Study|Withdrawal by Subject|148|||
48413314|NCT01427309|155701121|FG002|Overall Study|Withdrawal by Subject|61|||
48413315|NCT01427309|155701122|FG003|Overall Study|Withdrawal by Subject|55|||
48413316|NCT00928070|155701126|FG000|Overall Study|Lost to Follow-up|1|||
48413317|NCT00928070|155701127|FG001|Overall Study|Lost to Follow-up|2|||
48413318|NCT00928070|155701126|FG000|Overall Study|Withdrawal by Subject|10|||
48413319|NCT00928070|155701127|FG001|Overall Study|Withdrawal by Subject|3|||
48413320|NCT00928070|155701126|FG000|Overall Study|Adverse Event|14|||
48413321|NCT00928070|155701127|FG001|Overall Study|Adverse Event|26|||
48413322|NCT00928070|155701126|FG000|Overall Study|Lack of Efficacy|9|||
48413323|NCT00928070|155701127|FG001|Overall Study|Lack of Efficacy|5|||
48413324|NCT00928070|155701126|FG000|Overall Study|Did not meet entrance criteria|16|||
48413325|NCT00928070|155701127|FG001|Overall Study|Did not meet entrance criteria|9|||
48413326|NCT00928070|155701126|FG000|Overall Study|Protocol Violation|6|||
48413327|NCT00928070|155701127|FG001|Overall Study|Protocol Violation|5|||
48413328|NCT00928070|155701126|FG000|Overall Study|Randomized but not treated|2|||
48413329|NCT00928070|155701127|FG001|Overall Study|Randomized but not treated|2|||
48413330|NCT00928070|155701126|FG000|Overall Study|Other|5|||
48413331|NCT00928070|155701127|FG001|Overall Study|Other|5|||
48413332|NCT01061008|155701128|FG000|Overall Study|Badiocephalic fistula failed|3|||
48413333|NCT01061008|155701129|FG001|Overall Study|Badiocephalic fistula failed|2|||
48413334|NCT01061008|155701128|FG000|Overall Study|Death|1|||
48413335|NCT01061008|155701129|FG001|Overall Study|Death|0|||
48413336|NCT01061008|155701128|FG000|Overall Study|Withdrawal by Subject|1|||
48413337|NCT01061008|155701129|FG001|Overall Study|Withdrawal by Subject|3|||
48413338|NCT01061008|155701128|FG000|Overall Study|Unable to exercise following surgery|1|||
48362332|NCT01743989|155520257|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
48413339|NCT01061008|155701129|FG001|Overall Study|Unable to exercise following surgery|0|||
48413340|NCT01061008|155701128|FG000|Overall Study|Adverse Event|0|||
48413341|NCT01061008|155701129|FG001|Overall Study|Adverse Event|1|||
48413342|NCT03041311|155701133|FG000|Overall Study|Death|39|||
48413343|NCT03041311|155701134|FG001|Overall Study|Death|42|||
48413344|NCT03041311|155701133|FG000|Overall Study|Lost to Follow-up|0|||
48413345|NCT03041311|155701134|FG001|Overall Study|Lost to Follow-up|1|||
48413346|NCT03041311|155701133|FG000|Overall Study|Withdrawal by Subject|8|||
48413347|NCT03041311|155701134|FG001|Overall Study|Withdrawal by Subject|5|||
48362333|NCT01743989|155520255|FG000|Treatment Phase|Not randomized by mistake|0|||
48362334|NCT01743989|155520256|FG001|Treatment Phase|Not randomized by mistake|0|||
48362335|NCT01743989|155520257|FG002|Treatment Phase|Not randomized by mistake|1|||
48362336|NCT01743989|155520255|FG000|Treatment Phase|Included by mistake|0|||
48362337|NCT01743989|155520256|FG001|Treatment Phase|Included by mistake|0|||
48362338|NCT01743989|155520257|FG002|Treatment Phase|Included by mistake|1|||
48362339|NCT01743989|155520255|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
48362340|NCT01743989|155520256|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
48362341|NCT01743989|155520257|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
48362342|NCT01743989|155520255|FG000|TFR Phase|Adverse Event|0|||
48362343|NCT01743989|155520256|FG001|TFR Phase|Adverse Event|1|||
48362344|NCT01743989|155520257|FG002|TFR Phase|Adverse Event|0|||
48362345|NCT01743989|155520255|FG000|TFR Phase|Lost to Follow-up|0|||
48362346|NCT01743989|155520256|FG001|TFR Phase|Lost to Follow-up|2|||
48362347|NCT01743989|155520257|FG002|TFR Phase|Lost to Follow-up|0|||
48413348|NCT03041311|155701133|FG000|Overall Study|Sponsor Terminated Study|2|||
48362348|NCT01743989|155520255|FG000|TFR Phase|Physician Decision|0|||
48362349|NCT01743989|155520256|FG001|TFR Phase|Physician Decision|1|||
48362350|NCT01743989|155520257|FG002|TFR Phase|Physician Decision|0|||
48362351|NCT01743989|155520255|FG000|TFR Phase|Logistical problems|0|||
48362352|NCT01743989|155520256|FG001|TFR Phase|Logistical problems|2|||
48362353|NCT01743989|155520257|FG002|TFR Phase|Logistical problems|0|||
48362354|NCT01743989|155520255|FG000|TFR Phase|Protocol deviation|0|||
48362355|NCT01743989|155520256|FG001|TFR Phase|Protocol deviation|1|||
48362356|NCT01743989|155520257|FG002|TFR Phase|Protocol deviation|0|||
48362357|NCT01743989|155520255|FG000|TFR Phase|Withdrawal by Subject|0|||
48362358|NCT01743989|155520256|FG001|TFR Phase|Withdrawal by Subject|2|||
48362359|NCT01743989|155520257|FG002|TFR Phase|Withdrawal by Subject|0|||
48362360|NCT01743989|155520255|FG000|Re-treatment Phase|Adverse Event|8|||
48362361|NCT01743989|155520256|FG001|Re-treatment Phase|Adverse Event|4|||
48362362|NCT01743989|155520257|FG002|Re-treatment Phase|Adverse Event|0|||
48362363|NCT01743989|155520255|FG000|Re-treatment Phase|Death|1|||
48362364|NCT01743989|155520256|FG001|Re-treatment Phase|Death|1|||
48362365|NCT01743989|155520257|FG002|Re-treatment Phase|Death|0|||
48362366|NCT01743989|155520255|FG000|Re-treatment Phase|Administrative problems|1|||
48362367|NCT01743989|155520256|FG001|Re-treatment Phase|Administrative problems|1|||
48362368|NCT01743989|155520257|FG002|Re-treatment Phase|Administrative problems|0|||
48362369|NCT01743989|155520255|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
48362370|NCT01743989|155520256|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
48362371|NCT01743989|155520257|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
48362372|NCT01743989|155520255|FG000|Re-treatment Phase|Unstable MR|1|||
48362373|NCT01743989|155520256|FG001|Re-treatment Phase|Unstable MR|0|||
48362374|NCT01743989|155520257|FG002|Re-treatment Phase|Unstable MR|0|||
48362375|NCT01743989|155520255|FG000|Re-treatment Phase|Physician Decision|0|||
48362376|NCT01743989|155520256|FG001|Re-treatment Phase|Physician Decision|1|||
48362377|NCT01743989|155520257|FG002|Re-treatment Phase|Physician Decision|0|||
48362378|NCT01743989|155520255|FG000|Re-treatment Phase|Lost to Follow-up|0|||
48362379|NCT01743989|155520256|FG001|Re-treatment Phase|Lost to Follow-up|1|||
48362380|NCT01743989|155520257|FG002|Re-treatment Phase|Lost to Follow-up|0|||
48362381|NCT02235311|155520261|FG000|Overall Study|Lost to Follow-up|0|||
48362382|NCT02235311|155520262|FG001|Overall Study|Lost to Follow-up|1|||
48362383|NCT02235311|155520261|FG000|Overall Study|Protocol Violation|0|||
48362384|NCT02235311|155520262|FG001|Overall Study|Protocol Violation|1|||
48362385|NCT04655027|155520264|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
48362386|NCT04655027|155520265|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
48362387|NCT03014479|155520270|FG000|Overall Study|Adverse Event|0|||
48362388|NCT03014479|155520271|FG001|Overall Study|Adverse Event|1|||
48362389|NCT03014479|155520270|FG000|Overall Study|Voluntary Withdrawal|0|||
48362390|NCT03014479|155520271|FG001|Overall Study|Voluntary Withdrawal|2|||
48362391|NCT03014479|155520270|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
48413349|NCT03041311|155701134|FG001|Overall Study|Sponsor Terminated Study|4|||
48413350|NCT03041311|155701133|FG000|Overall Study|Disease Progression|3|||
48413351|NCT03041311|155701134|FG001|Overall Study|Disease Progression|1|||
48413352|NCT03041311|155701133|FG000|Overall Study|Randomized in error, did not receive drug|2|||
48413353|NCT03041311|155701134|FG001|Overall Study|Randomized in error, did not receive drug|0|||
48413354|NCT04398732|155701135|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
48362392|NCT03014479|155520271|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
48362393|NCT05597787|155520272|FG000|Overall Study|Withdrawal by Subject|0|||
48362394|NCT05597787|155520273|FG001|Overall Study|Withdrawal by Subject|0|||
48413355|NCT01299727|155701136|FG000|Overall Study|Withdrawal by Subject|1|||
48413356|NCT01299727|155701137|FG001|Overall Study|Withdrawal by Subject|0|||
48413357|NCT01299727|155701138|FG002|Overall Study|Withdrawal by Subject|0|||
48362395|NCT05597787|155520274|FG002|Overall Study|Withdrawal by Subject|1|||
48362396|NCT05215054|155520275|FG000|Overall Study|Lost to Follow-up|1|||
48362397|NCT05215054|155520276|FG001|Overall Study|Lost to Follow-up|1|||
48413358|NCT01299727|155701136|FG000|Overall Study|Adverse Event|0|||
48413359|NCT01299727|155701137|FG001|Overall Study|Adverse Event|0|||
48413360|NCT01299727|155701138|FG002|Overall Study|Adverse Event|1|||
48413361|NCT01299727|155701136|FG000|Overall Study|Completed the Treatment Period|3|||
48362398|NCT05215054|155520275|FG000|Overall Study|Protocol Violation|1|||
48362399|NCT05215054|155520276|FG001|Overall Study|Protocol Violation|1|||
48362400|NCT05215054|155520275|FG000|Overall Study|Withdrawal by Subject|4|||
48362401|NCT05215054|155520276|FG001|Overall Study|Withdrawal by Subject|4|||
48362402|NCT00233480|155522468|FG000|Overall Study|Underwent status II heart transplant|0|||
48362403|NCT00233480|155522469|FG001|Overall Study|Underwent status II heart transplant|1|||
48413362|NCT01299727|155701137|FG001|Overall Study|Completed the Treatment Period|4|||
48413363|NCT01299727|155701138|FG002|Overall Study|Completed the Treatment Period|3|||
48413364|NCT03093402|155701139|FG000|Overall Study|Lost to Follow-up|1|||
48413365|NCT03093402|155701140|FG001|Overall Study|Lost to Follow-up|0|||
48413366|NCT03093402|155701141|FG002|Overall Study|Lost to Follow-up|0|||
48413367|NCT03093402|155701142|FG003|Overall Study|Lost to Follow-up|0|||
48413368|NCT03093402|155701139|FG000|Overall Study|Withdrawal by Subject|3|||
48413369|NCT03093402|155701140|FG001|Overall Study|Withdrawal by Subject|3|||
48413370|NCT03093402|155701141|FG002|Overall Study|Withdrawal by Subject|0|||
48413371|NCT03093402|155701142|FG003|Overall Study|Withdrawal by Subject|1|||
48413372|NCT03093402|155701139|FG000|Overall Study|Withdrew prior to dosing|2|||
48413373|NCT03093402|155701140|FG001|Overall Study|Withdrew prior to dosing|1|||
48413374|NCT03093402|155701141|FG002|Overall Study|Withdrew prior to dosing|2|||
48413375|NCT03093402|155701142|FG003|Overall Study|Withdrew prior to dosing|3|||
48413376|NCT03093402|155701139|FG000|Overall Study|Ineligible for study|1|||
48413377|NCT03093402|155701140|FG001|Overall Study|Ineligible for study|0|||
48413378|NCT03093402|155701141|FG002|Overall Study|Ineligible for study|0|||
48413379|NCT03093402|155701142|FG003|Overall Study|Ineligible for study|0|||
48413380|NCT03093402|155701139|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
48413381|NCT03093402|155701140|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
48413382|NCT03093402|155701141|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
48413383|NCT03093402|155701142|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
48413384|NCT02886702|155701143|FG000|Overall Study|Other|4|||
48413385|NCT02886702|155701144|FG001|Overall Study|Other|3|||
48413386|NCT02886702|155701145|FG002|Overall Study|Other|9|||
48413387|NCT02886702|155701143|FG000|Overall Study|Withdrawal by Subject|24|||
48362404|NCT04942366|155522476|FG000|Overall Study|Withdrawal by Subject|5|||
48362405|NCT04942366|155522477|FG001|Overall Study|Withdrawal by Subject|5|||
48362406|NCT02311673|155522478|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
48362407|NCT02311673|155522479|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
48362408|NCT02311673|155522480|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
48362409|NCT02311673|155522481|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
48362410|NCT01977677|155522482|FG000|Overall Study|Unrelated Adverse Event|0|||
48362411|NCT01977677|155522483|FG001|Overall Study|Unrelated Adverse Event|0|||
48362412|NCT01977677|155522484|FG002|Overall Study|Unrelated Adverse Event|1|||
48362413|NCT00974259|155522487|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
48362414|NCT00974259|155522488|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
48362415|NCT02787044|155522489|FG000|Overall Study|Lost to Follow-up|15|||
48362416|NCT02787044|155522490|FG001|Overall Study|Lost to Follow-up|19|||
48362417|NCT00943852|155522493|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362418|NCT00943852|155522494|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362419|NCT00943852|155522495|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362420|NCT00943852|155522496|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
48362421|NCT00943852|155522497|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362422|NCT00943852|155522498|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362423|NCT00943852|155522499|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362424|NCT00943852|155522500|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362425|NCT00943852|155522501|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362426|NCT00943852|155522502|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
48362427|NCT00943852|155522493|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48362428|NCT00943852|155522494|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48362429|NCT00943852|155522495|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48413388|NCT02886702|155701144|FG001|Overall Study|Withdrawal by Subject|18|||
48413389|NCT02886702|155701145|FG002|Overall Study|Withdrawal by Subject|22|||
48413390|NCT02886702|155701143|FG000|Overall Study|Significant Worsening of Condition|0|||
48413391|NCT02886702|155701144|FG001|Overall Study|Significant Worsening of Condition|1|||
48413392|NCT02886702|155701145|FG002|Overall Study|Significant Worsening of Condition|0|||
48413393|NCT02886702|155701143|FG000|Overall Study|Protocol Violation|2|||
48413394|NCT02886702|155701144|FG001|Overall Study|Protocol Violation|2|||
48413395|NCT02886702|155701145|FG002|Overall Study|Protocol Violation|1|||
48413396|NCT02886702|155701143|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48413397|NCT02886702|155701144|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48413398|NCT02886702|155701145|FG002|Overall Study|Non-Compliance With Study Drug|4|||
48413399|NCT02886702|155701143|FG000|Overall Study|Lost to Follow-up|11|||
48413400|NCT02886702|155701144|FG001|Overall Study|Lost to Follow-up|13|||
48413401|NCT02886702|155701145|FG002|Overall Study|Lost to Follow-up|8|||
48413402|NCT02886702|155701143|FG000|Overall Study|Lack of Efficacy|3|||
48413403|NCT02886702|155701144|FG001|Overall Study|Lack of Efficacy|4|||
48362430|NCT00943852|155522496|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48362431|NCT00943852|155522497|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48362432|NCT00943852|155522498|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
48413404|NCT02886702|155701145|FG002|Overall Study|Lack of Efficacy|5|||
48413405|NCT02886702|155701143|FG000|Overall Study|Adverse Event|4|||
48413406|NCT02886702|155701144|FG001|Overall Study|Adverse Event|9|||
48413407|NCT02886702|155701145|FG002|Overall Study|Adverse Event|3|||
48413408|NCT02886702|155701143|FG000|Overall Study|Administrative Reasons|0|||
48413409|NCT02886702|155701144|FG001|Overall Study|Administrative Reasons|0|||
48413410|NCT02886702|155701145|FG002|Overall Study|Administrative Reasons|1|||
48413411|NCT01147497|155701150|FG000|Overall Study|failed insertion|2|||
48413412|NCT01147497|155701151|FG001|Overall Study|failed insertion|0|||
48413413|NCT01700829|155701154|FG000|Overall Study|Withdrawal by Subject|1|||
48413414|NCT01700829|155701155|FG001|Overall Study|Withdrawal by Subject|1|||
48413415|NCT02786901|155701158|FG000|Overall Study|Adverse Event|1|||
48413416|NCT02786901|155701159|FG001|Overall Study|Adverse Event|1|||
48362433|NCT00943852|155522499|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48362434|NCT00943852|155522500|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48362435|NCT00943852|155522501|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48362436|NCT00943852|155522502|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
48362437|NCT00943852|155522493|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48362438|NCT00943852|155522494|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48413417|NCT02786901|155701160|FG002|Overall Study|Adverse Event|2|||
48413418|NCT02786901|155701158|FG000|Overall Study|Physician Decision|1|||
48413419|NCT02786901|155701159|FG001|Overall Study|Physician Decision|0|||
48413420|NCT02786901|155701160|FG002|Overall Study|Physician Decision|0|||
48413421|NCT02786901|155701158|FG000|Overall Study|Rescue Therapy Use|71|||
48413422|NCT02786901|155701159|FG001|Overall Study|Rescue Therapy Use|49|||
48413423|NCT02786901|155701160|FG002|Overall Study|Rescue Therapy Use|33|||
48413424|NCT02786901|155701158|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
48413425|NCT02786901|155701159|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
48413426|NCT02786901|155701160|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
48413427|NCT02786901|155701158|FG000|Overall Study|Disallowed medication|1|||
48413428|NCT02786901|155701159|FG001|Overall Study|Disallowed medication|1|||
48413429|NCT02786901|155701160|FG002|Overall Study|Disallowed medication|0|||
48413430|NCT02786901|155701158|FG000|Overall Study|Randomized in error|2|||
48362439|NCT00943852|155522495|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48362440|NCT00943852|155522496|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48362441|NCT00943852|155522497|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48362442|NCT00943852|155522498|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48362443|NCT00943852|155522499|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
48362444|NCT00943852|155522500|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48362445|NCT00943852|155522501|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48362446|NCT00943852|155522502|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
48362447|NCT00943852|155522493|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48362448|NCT00943852|155522494|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48362449|NCT00943852|155522495|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48362450|NCT00943852|155522496|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48362451|NCT00943852|155522497|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48362452|NCT00943852|155522498|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48362453|NCT00943852|155522499|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48413431|NCT02786901|155701159|FG001|Overall Study|Randomized in error|0|||
48413432|NCT02786901|155701160|FG002|Overall Study|Randomized in error|1|||
48413433|NCT03514914|155701161|FG000|Overall Study|Death|3|||
48413434|NCT03514914|155701162|FG001|Overall Study|Death|3|||
48413435|NCT03514914|155701161|FG000|Overall Study|Lost to Follow-up|117|||
48413436|NCT03514914|155701162|FG001|Overall Study|Lost to Follow-up|89|||
48413437|NCT02706938|155701163|FG000|First Period, 6 Weeks|Adverse Event|8|||
48413438|NCT02706938|155701164|FG001|First Period, 6 Weeks|Adverse Event|0|||
48413439|NCT02706938|155701163|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
48362454|NCT00943852|155522500|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
48362455|NCT00943852|155522501|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48362456|NCT00943852|155522502|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
48362457|NCT00943852|155522493|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
48362458|NCT00943852|155522494|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48362459|NCT00943852|155522495|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
48362460|NCT00943852|155522496|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
48362461|NCT00943852|155522497|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48362462|NCT00943852|155522498|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48362463|NCT00943852|155522499|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
48362464|NCT00943852|155522500|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48362465|NCT00943852|155522501|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48362466|NCT00943852|155522502|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
48362467|NCT02383940|155522507|FG000|Overall Study|Adverse Event|1|||
48362468|NCT02383940|155522508|FG001|Overall Study|Adverse Event|0|||
48362469|NCT02383940|155522507|FG000|Overall Study|Lost to Follow-up|2|||
48362470|NCT02383940|155522508|FG001|Overall Study|Lost to Follow-up|2|||
48362471|NCT02383940|155522507|FG000|Overall Study|Physician Decision|2|||
48362472|NCT02383940|155522508|FG001|Overall Study|Physician Decision|0|||
48362473|NCT02383940|155522507|FG000|Overall Study|Withdrawal by Subject|1|||
48362474|NCT02383940|155522508|FG001|Overall Study|Withdrawal by Subject|1|||
48362475|NCT02383940|155522507|FG000|Overall Study|Randomized but not treated|2|||
48413440|NCT02706938|155701164|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
48413441|NCT02706938|155701163|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
48413442|NCT02706938|155701164|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
48413443|NCT02706938|155701163|FG000|Second Period, 6 Weeks|Adverse Event|0|||
48413444|NCT02706938|155701164|FG001|Second Period, 6 Weeks|Adverse Event|7|||
48413445|NCT02706938|155701163|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
48413446|NCT02706938|155701164|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
48413447|NCT01838044|155701166|FG000|Overall Study|Adverse Event|4|||
48413448|NCT01838044|155701167|FG001|Overall Study|Adverse Event|6|||
48413449|NCT01838044|155701166|FG000|Overall Study|Protocol Violation|3|||
48413450|NCT01838044|155701167|FG001|Overall Study|Protocol Violation|3|||
48413451|NCT01838044|155701166|FG000|Overall Study|Withdrawal by Subject|0|||
48413452|NCT01838044|155701167|FG001|Overall Study|Withdrawal by Subject|2|||
48413453|NCT01838044|155701166|FG000|Overall Study|Insufficient clinical response|1|||
48413454|NCT01838044|155701167|FG001|Overall Study|Insufficient clinical response|2|||
48413455|NCT01838044|155701166|FG000|Overall Study|Medication error without associated AE|0|||
48413456|NCT01838044|155701167|FG001|Overall Study|Medication error without associated AE|1|||
48413457|NCT01838044|155701166|FG000|Overall Study|Lost to Follow-up|0|||
48413458|NCT01838044|155701167|FG001|Overall Study|Lost to Follow-up|2|||
48413459|NCT02507349|155701169|FG000|Overall Study|Death|12|||
48413460|NCT02507349|155701170|FG001|Overall Study|Death|16|||
48413461|NCT02507349|155701169|FG000|Overall Study|Withdrawal by Subject|1|||
48413462|NCT02507349|155701170|FG001|Overall Study|Withdrawal by Subject|1|||
48413463|NCT02507349|155701169|FG000|Overall Study|Lost to Follow-up|174|||
48413464|NCT02507349|155701170|FG001|Overall Study|Lost to Follow-up|144|||
48413465|NCT01032629|155701173|FG000|Overall Study|Closed Site|21|||
48413466|NCT01032629|155701174|FG001|Overall Study|Closed Site|18|||
48413467|NCT01032629|155701175|FG002|Overall Study|Closed Site|16|||
48413468|NCT01032629|155701173|FG000|Overall Study|Withdrawal by Subject|50|||
48413469|NCT01032629|155701174|FG001|Overall Study|Withdrawal by Subject|36|||
48413470|NCT01032629|155701175|FG002|Overall Study|Withdrawal by Subject|35|||
48413471|NCT01032629|155701173|FG000|Overall Study|Lost to Follow-up|74|||
48413472|NCT01032629|155701174|FG001|Overall Study|Lost to Follow-up|47|||
48413473|NCT01032629|155701175|FG002|Overall Study|Lost to Follow-up|37|||
48413474|NCT00348140|155701176|FG000|Overall Study|Adverse Event|46|||
48413475|NCT00348140|155701177|FG001|Overall Study|Adverse Event|49|||
48413476|NCT00348140|155701178|FG002|Overall Study|Adverse Event|78|||
48413477|NCT00348140|155701176|FG000|Overall Study|Lost to Follow-up|4|||
48362476|NCT02383940|155522508|FG001|Overall Study|Randomized but not treated|0|||
48362477|NCT02383940|155522507|FG000|Overall Study|Other than specified above|1|||
48413478|NCT00348140|155701177|FG001|Overall Study|Lost to Follow-up|4|||
48413479|NCT00348140|155701178|FG002|Overall Study|Lost to Follow-up|4|||
48413480|NCT00348140|155701176|FG000|Overall Study|Protocol Violation|12|||
48413481|NCT00348140|155701177|FG001|Overall Study|Protocol Violation|13|||
48413482|NCT00348140|155701178|FG002|Overall Study|Protocol Violation|14|||
48413483|NCT00348140|155701176|FG000|Overall Study|Withdrawal by Subject|32|||
48413484|NCT00348140|155701177|FG001|Overall Study|Withdrawal by Subject|40|||
48413485|NCT00348140|155701178|FG002|Overall Study|Withdrawal by Subject|40|||
48413486|NCT00348140|155701176|FG000|Overall Study|Non-compliance|8|||
48413487|NCT00348140|155701177|FG001|Overall Study|Non-compliance|13|||
48413488|NCT00348140|155701178|FG002|Overall Study|Non-compliance|5|||
48413489|NCT00348140|155701176|FG000|Overall Study|Participant at risk due to study drug|2|||
48362478|NCT02383940|155522508|FG001|Overall Study|Other than specified above|0|||
48362479|NCT00685698|155522509|FG000|Overall Study|Withdrawal by Subject|1|||
48362480|NCT00685698|155522509|FG000|Overall Study|Protocol Violation|6|||
48362481|NCT00685698|155522509|FG000|Overall Study|Adverse Event|3|||
48362482|NCT00685698|155522509|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
48362483|NCT00685698|155522509|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
48362484|NCT00685698|155522509|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
48362485|NCT05383508|155522513|FG000|Overall Study|Withdrawal by Subject|1|||
48362486|NCT05383508|155522514|FG001|Overall Study|Withdrawal by Subject|0|||
48362487|NCT05383508|155522515|FG002|Overall Study|Withdrawal by Subject|1|||
48362488|NCT05383508|155522516|FG003|Overall Study|Withdrawal by Subject|1|||
48362489|NCT05383508|155522517|FG004|Overall Study|Withdrawal by Subject|2|||
48362490|NCT05383508|155522518|FG005|Overall Study|Withdrawal by Subject|0|||
48362491|NCT02949362|155522528|FG000|Retrospective Period|Inform consent not signed by participant|4|||
48362492|NCT02949362|155522529|FG001|Retrospective Period|Inform consent not signed by participant|1|||
48362493|NCT02949362|155522530|FG002|Retrospective Period|Inform consent not signed by participant|0|||
48362494|NCT02949362|155522531|FG003|Retrospective Period|Inform consent not signed by participant|0|||
48362495|NCT02949362|155522528|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
48362496|NCT02949362|155522529|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
48362497|NCT02949362|155522530|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
48362498|NCT02949362|155522531|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
48362499|NCT02949362|155522528|FG000|Prospective Period|Other|0|||
48362500|NCT02949362|155522529|FG001|Prospective Period|Other|0|||
48362501|NCT02949362|155522530|FG002|Prospective Period|Other|0|||
48362502|NCT02949362|155522531|FG003|Prospective Period|Other|4|||
48362503|NCT01853475|155522532|FG000|Overall Study|Withdrawal by Subject|0|||
48362504|NCT01853475|155522533|FG001|Overall Study|Withdrawal by Subject|1|||
48362505|NCT01853475|155522534|FG002|Overall Study|Withdrawal by Subject|0|||
48362506|NCT02766777|155522535|FG000|Overall Study|Adverse Event|12|||
48362507|NCT02766777|155522535|FG000|Overall Study|Lost to Follow-up|16|||
48362508|NCT02766777|155522535|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48362509|NCT02766777|155522535|FG000|Overall Study|Protocol Violation|1|||
48413490|NCT00348140|155701177|FG001|Overall Study|Participant at risk due to study drug|0|||
48413491|NCT00348140|155701178|FG002|Overall Study|Participant at risk due to study drug|0|||
48413492|NCT00348140|155701176|FG000|Overall Study|Conditional medication increased dose|1|||
48413493|NCT00348140|155701177|FG001|Overall Study|Conditional medication increased dose|0|||
48413494|NCT00348140|155701178|FG002|Overall Study|Conditional medication increased dose|0|||
48413495|NCT00348140|155701176|FG000|Overall Study|Caregiver related|4|||
48413496|NCT00348140|155701177|FG001|Overall Study|Caregiver related|7|||
48413497|NCT00348140|155701178|FG002|Overall Study|Caregiver related|3|||
48413498|NCT00348140|155701176|FG000|Overall Study|Participant hospitalised|3|||
48413499|NCT00348140|155701177|FG001|Overall Study|Participant hospitalised|0|||
48413500|NCT00348140|155701178|FG002|Overall Study|Participant hospitalised|0|||
48413501|NCT00348140|155701176|FG000|Overall Study|Efficacy related|1|||
48413502|NCT00348140|155701177|FG001|Overall Study|Efficacy related|1|||
48413503|NCT00348140|155701178|FG002|Overall Study|Efficacy related|0|||
48413504|NCT00348140|155701176|FG000|Overall Study|Administration related|3|||
48413505|NCT00348140|155701177|FG001|Overall Study|Administration related|1|||
48413506|NCT00348140|155701178|FG002|Overall Study|Administration related|1|||
48413507|NCT00348140|155701176|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
48413508|NCT00348140|155701177|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
48413509|NCT00348140|155701178|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
48413510|NCT00348140|155701176|FG000|Overall Study|Participant unwell|1|||
48413511|NCT00348140|155701177|FG001|Overall Study|Participant unwell|0|||
48413512|NCT00348140|155701178|FG002|Overall Study|Participant unwell|0|||
48413513|NCT00348140|155701176|FG000|Overall Study|Screen failure|1|||
48362510|NCT02766777|155522535|FG000|Overall Study|Withdrawal by Subject|4|||
48362511|NCT00406692|155522536|FG000|Overall Study|Withdrawal by Subject|4|||
48362512|NCT00406692|155522536|FG000|Overall Study|Physician Decision|1|||
48362513|NCT00406692|155522536|FG000|Overall Study|Adverse Event|1|||
48362514|NCT00406692|155522536|FG000|Overall Study|Lack of Efficacy|1|||
48362515|NCT02510040|155522537|FG000|Overall Study|Deemed no longer eligible|18|||
48362516|NCT02510040|155522538|FG001|Overall Study|Deemed no longer eligible|3|||
48362517|NCT02510040|155522539|FG002|Overall Study|Deemed no longer eligible|1|||
48362518|NCT03596762|155522540|FG000|Overall Study|Protocol Violation|0|||
48362519|NCT03596762|155522541|FG001|Overall Study|Protocol Violation|0|||
48362520|NCT03596762|155522542|FG002|Overall Study|Protocol Violation|0|||
48362521|NCT03596762|155522543|FG003|Overall Study|Protocol Violation|0|||
48362522|NCT03596762|155522544|FG004|Overall Study|Protocol Violation|1|||
48362523|NCT03596762|155522540|FG000|Overall Study|Adverse Event|2|||
48413514|NCT00348140|155701177|FG001|Overall Study|Screen failure|0|||
48362524|NCT03596762|155522541|FG001|Overall Study|Adverse Event|0|||
48413515|NCT00348140|155701178|FG002|Overall Study|Screen failure|0|||
48413516|NCT00348140|155701176|FG000|Overall Study|Investigator decided to discontinue|4|||
48362525|NCT03596762|155522542|FG002|Overall Study|Adverse Event|1|||
48362526|NCT03596762|155522543|FG003|Overall Study|Adverse Event|0|||
48362527|NCT03596762|155522544|FG004|Overall Study|Adverse Event|5|||
48362528|NCT03596762|155522540|FG000|Overall Study|Withdrawal by Subject|2|||
48362529|NCT03596762|155522541|FG001|Overall Study|Withdrawal by Subject|1|||
48362530|NCT03596762|155522542|FG002|Overall Study|Withdrawal by Subject|0|||
48362531|NCT03596762|155522543|FG003|Overall Study|Withdrawal by Subject|1|||
48362532|NCT03596762|155522544|FG004|Overall Study|Withdrawal by Subject|1|||
48362533|NCT01129102|155522545|FG000|Overall Study|No study drug treatment|2|||
48362534|NCT01129102|155522546|FG001|Overall Study|No study drug treatment|3|||
48362535|NCT01129102|155522547|FG002|Overall Study|No study drug treatment|1|||
48362536|NCT01129102|155522545|FG000|Overall Study|Withdrawal by Subject|2|||
48362537|NCT01129102|155522546|FG001|Overall Study|Withdrawal by Subject|0|||
48362538|NCT01129102|155522547|FG002|Overall Study|Withdrawal by Subject|3|||
48362539|NCT01129102|155522545|FG000|Overall Study|Protocol Violation|0|||
48362540|NCT01129102|155522546|FG001|Overall Study|Protocol Violation|1|||
48362541|NCT01129102|155522547|FG002|Overall Study|Protocol Violation|1|||
48362542|NCT01129102|155522545|FG000|Overall Study|Pregnancy|0|||
48362543|NCT01129102|155522546|FG001|Overall Study|Pregnancy|0|||
48362544|NCT01129102|155522547|FG002|Overall Study|Pregnancy|1|||
48362545|NCT01129102|155522545|FG000|Overall Study|Adverse Event|2|||
48362546|NCT01129102|155522546|FG001|Overall Study|Adverse Event|2|||
48362547|NCT01129102|155522547|FG002|Overall Study|Adverse Event|1|||
48362548|NCT01129102|155522545|FG000|Overall Study|Lost to Follow-up|2|||
48362549|NCT01129102|155522546|FG001|Overall Study|Lost to Follow-up|0|||
48413517|NCT00348140|155701177|FG001|Overall Study|Investigator decided to discontinue|1|||
48413518|NCT00348140|155701178|FG002|Overall Study|Investigator decided to discontinue|4|||
48413519|NCT00348140|155701176|FG000|Overall Study|Decided to discontinue on their own|1|||
48413520|NCT00348140|155701177|FG001|Overall Study|Decided to discontinue on their own|4|||
48413521|NCT00348140|155701178|FG002|Overall Study|Decided to discontinue on their own|1|||
48413522|NCT00348140|155701176|FG000|Overall Study|Use of prohibited drug|1|||
48413523|NCT00348140|155701177|FG001|Overall Study|Use of prohibited drug|0|||
48413524|NCT00348140|155701178|FG002|Overall Study|Use of prohibited drug|2|||
48413525|NCT00348140|155701176|FG000|Overall Study|Disease progression|1|||
48413526|NCT00348140|155701177|FG001|Overall Study|Disease progression|2|||
48413527|NCT00348140|155701178|FG002|Overall Study|Disease progression|5|||
48413528|NCT00348140|155701176|FG000|Overall Study|Increased risk of cardiac infarction|0|||
48413529|NCT00348140|155701177|FG001|Overall Study|Increased risk of cardiac infarction|1|||
48413530|NCT00348140|155701178|FG002|Overall Study|Increased risk of cardiac infarction|0|||
48413531|NCT00348140|155701176|FG000|Overall Study|Serious adverse event|0|||
48413532|NCT00348140|155701177|FG001|Overall Study|Serious adverse event|1|||
48413533|NCT00348140|155701178|FG002|Overall Study|Serious adverse event|0|||
48413534|NCT00348140|155701176|FG000|Overall Study|Abnormal ECG|0|||
48413535|NCT00348140|155701177|FG001|Overall Study|Abnormal ECG|1|||
48413536|NCT00348140|155701178|FG002|Overall Study|Abnormal ECG|3|||
48413537|NCT00348140|155701176|FG000|Overall Study|Participant died|0|||
48413538|NCT00348140|155701177|FG001|Overall Study|Participant died|1|||
48413539|NCT00348140|155701178|FG002|Overall Study|Participant died|0|||
48413540|NCT00348140|155701176|FG000|Overall Study|Exclusion criteria met|0|||
48413541|NCT00348140|155701177|FG001|Overall Study|Exclusion criteria met|0|||
48413542|NCT00348140|155701178|FG002|Overall Study|Exclusion criteria met|1|||
48413543|NCT00348140|155701176|FG000|Overall Study|Memory declined|0|||
48413544|NCT00348140|155701177|FG001|Overall Study|Memory declined|0|||
48413545|NCT00348140|155701178|FG002|Overall Study|Memory declined|1|||
48413546|NCT01662648|155701184|FG000|Overall Study|Death|1|||
48413547|NCT01662648|155701185|FG001|Overall Study|Death|3|||
48413548|NCT01662648|155701184|FG000|Overall Study|Adverse Event|40|||
48413549|NCT01662648|155701185|FG001|Overall Study|Adverse Event|37|||
48413550|NCT01662648|155701184|FG000|Overall Study|Lack of Efficacy|17|||
48413551|NCT01662648|155701185|FG001|Overall Study|Lack of Efficacy|16|||
48413552|NCT01662648|155701184|FG000|Overall Study|Participant ineligible to continue trial|1|||
48413553|NCT01662648|155701185|FG001|Overall Study|Participant ineligible to continue trial|1|||
48413554|NCT01662648|155701184|FG000|Overall Study|Lost to Follow-up|24|||
48413555|NCT01662648|155701185|FG001|Overall Study|Lost to Follow-up|36|||
48413556|NCT01662648|155701184|FG000|Overall Study|Withdrawal by Subject|36|||
48362550|NCT01129102|155522547|FG002|Overall Study|Lost to Follow-up|0|||
48362551|NCT00951015|155522548|FG000|Randomization Phase 96 Week|Adverse Event|1|||
48362552|NCT00951015|155522549|FG001|Randomization Phase 96 Week|Adverse Event|1|||
48362553|NCT00951015|155522550|FG002|Randomization Phase 96 Week|Adverse Event|2|||
48362554|NCT00951015|155522551|FG003|Randomization Phase 96 Week|Adverse Event|5|||
48362555|NCT00951015|155522552|FG004|Randomization Phase 96 Week|Adverse Event|0|||
48362556|NCT00951015|155522548|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
48362557|NCT00951015|155522549|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
48413557|NCT01662648|155701185|FG001|Overall Study|Withdrawal by Subject|53|||
48413558|NCT01662648|155701184|FG000|Overall Study|Participant non-compliant|16|||
48413559|NCT01662648|155701185|FG001|Overall Study|Participant non-compliant|20|||
48413560|NCT01662648|155701184|FG000|Overall Study|Other|8|||
48413561|NCT01662648|155701185|FG001|Overall Study|Other|11|||
48413562|NCT01662648|155701184|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
48413563|NCT01662648|155701185|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
48413564|NCT01662648|155701184|FG000|Overall Study|LOE and other reason unspecified|1|||
48413565|NCT01662648|155701185|FG001|Overall Study|LOE and other reason unspecified|0|||
48413566|NCT01662648|155701184|FG000|Overall Study|LOE and Participant non-compliant|0|||
48413567|NCT01662648|155701185|FG001|Overall Study|LOE and Participant non-compliant|1|||
48413568|NCT00619957|155701189|FG000|Month 24 Double-Blind|Adverse Event|9|||
48413569|NCT00619957|155701190|FG001|Month 24 Double-Blind|Adverse Event|7|||
48413570|NCT00619957|155701189|FG000|Month 24 Double-Blind|Protocol Violation|1|||
48413571|NCT00619957|155701190|FG001|Month 24 Double-Blind|Protocol Violation|0|||
48413572|NCT00619957|155701189|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
48413573|NCT00619957|155701190|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
48413574|NCT00619957|155701189|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
48413575|NCT00619957|155701190|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
48413576|NCT00619957|155701189|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
48362558|NCT00951015|155522550|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
48362559|NCT00951015|155522551|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
48362560|NCT00951015|155522552|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
48413577|NCT00619957|155701190|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
48413578|NCT00619957|155701189|FG000|Month 48 Open-Label|Adverse Event|4|||
48413579|NCT00619957|155701190|FG001|Month 48 Open-Label|Adverse Event|4|||
48362561|NCT00951015|155522548|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
48362562|NCT00951015|155522549|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
48362563|NCT00951015|155522550|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
48362564|NCT00951015|155522551|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
48362565|NCT00951015|155522552|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
48362566|NCT00951015|155522548|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
48362567|NCT00951015|155522549|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
48362568|NCT00951015|155522550|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
48362569|NCT00951015|155522551|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
48362570|NCT00951015|155522552|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
48362571|NCT00951015|155522548|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
48362572|NCT00951015|155522549|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
48362573|NCT00951015|155522550|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
48362574|NCT00951015|155522551|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
48362575|NCT00951015|155522552|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
48362576|NCT00951015|155522548|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
48362577|NCT00951015|155522549|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
48362578|NCT00951015|155522550|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
48362579|NCT00951015|155522551|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
48362580|NCT00951015|155522552|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
48362581|NCT00951015|155522548|FG000|Open-label Phase|Adverse Event|0|||
48362582|NCT00951015|155522549|FG001|Open-label Phase|Adverse Event|0|||
48362583|NCT00951015|155522550|FG002|Open-label Phase|Adverse Event|0|||
48362584|NCT00951015|155522551|FG003|Open-label Phase|Adverse Event|0|||
48362585|NCT00951015|155522552|FG004|Open-label Phase|Adverse Event|3|||
48362586|NCT00951015|155522548|FG000|Open-label Phase|Lack of Efficacy|0|||
48362587|NCT00951015|155522549|FG001|Open-label Phase|Lack of Efficacy|0|||
48362588|NCT00951015|155522550|FG002|Open-label Phase|Lack of Efficacy|0|||
48362589|NCT00951015|155522551|FG003|Open-label Phase|Lack of Efficacy|0|||
48362590|NCT00951015|155522552|FG004|Open-label Phase|Lack of Efficacy|1|||
48362591|NCT00951015|155522548|FG000|Open-label Phase|Protocol Violation|0|||
48362592|NCT00951015|155522549|FG001|Open-label Phase|Protocol Violation|0|||
48362593|NCT00951015|155522550|FG002|Open-label Phase|Protocol Violation|0|||
48362594|NCT00951015|155522551|FG003|Open-label Phase|Protocol Violation|0|||
48362595|NCT00951015|155522552|FG004|Open-label Phase|Protocol Violation|12|||
48362596|NCT00951015|155522548|FG000|Open-label Phase|Lost to Follow-up|0|||
48362597|NCT00951015|155522549|FG001|Open-label Phase|Lost to Follow-up|0|||
48362598|NCT00951015|155522550|FG002|Open-label Phase|Lost to Follow-up|0|||
48362599|NCT00951015|155522551|FG003|Open-label Phase|Lost to Follow-up|0|||
48362600|NCT00951015|155522552|FG004|Open-label Phase|Lost to Follow-up|12|||
48362601|NCT00951015|155522548|FG000|Open-label Phase|Withdrawal by Subject|0|||
48362602|NCT00951015|155522549|FG001|Open-label Phase|Withdrawal by Subject|0|||
48362603|NCT00951015|155522550|FG002|Open-label Phase|Withdrawal by Subject|0|||
48362604|NCT00951015|155522551|FG003|Open-label Phase|Withdrawal by Subject|0|||
48362605|NCT00951015|155522552|FG004|Open-label Phase|Withdrawal by Subject|14|||
48362606|NCT00951015|155522548|FG000|Open-label Phase|Physician Decision|0|||
48362607|NCT00951015|155522549|FG001|Open-label Phase|Physician Decision|0|||
48362608|NCT00951015|155522550|FG002|Open-label Phase|Physician Decision|0|||
48362609|NCT00951015|155522551|FG003|Open-label Phase|Physician Decision|0|||
48413580|NCT00619957|155701189|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
48362610|NCT00951015|155522552|FG004|Open-label Phase|Physician Decision|8|||
48413581|NCT00619957|155701190|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
48413582|NCT00619957|155701189|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
48413583|NCT00619957|155701190|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
48413584|NCT03545282|155701191|FG000|Overall Study|Lost to Follow-up|15|||
48413585|NCT03545282|155701192|FG001|Overall Study|Lost to Follow-up|10|||
48413586|NCT03545282|155701191|FG000|Overall Study|Withdrawal by Subject|2|||
48413587|NCT03545282|155701192|FG001|Overall Study|Withdrawal by Subject|2|||
48413588|NCT01264939|155701194|FG000|Overall Study|Adverse Event|1|||
48413589|NCT01264939|155701195|FG001|Overall Study|Adverse Event|3|||
48413590|NCT01264939|155701194|FG000|Overall Study|Lost to Follow-up|0|||
48413591|NCT01264939|155701195|FG001|Overall Study|Lost to Follow-up|3|||
48413592|NCT01264939|155701194|FG000|Overall Study|Physician Decision|1|||
48413593|NCT01264939|155701195|FG001|Overall Study|Physician Decision|1|||
48413594|NCT01264939|155701194|FG000|Overall Study|Patient/Guardian Decision|8|||
48413595|NCT01264939|155701195|FG001|Overall Study|Patient/Guardian Decision|10|||
48413596|NCT01264939|155701194|FG000|Overall Study|Disease Progression|8|||
48413597|NCT01264939|155701195|FG001|Overall Study|Disease Progression|11|||
48413598|NCT01454076|155701196|FG000|Overall Study|Other|2|||
48413599|NCT01454076|155701197|FG001|Overall Study|Other|0|||
48413600|NCT01454076|155701198|FG002|Overall Study|Other|0|||
48413601|NCT01454076|155701199|FG003|Overall Study|Other|1|||
48413602|NCT01454076|155701200|FG004|Overall Study|Other|2|||
48413603|NCT01454076|155701196|FG000|Overall Study|Withdrawal by Subject|3|||
48413604|NCT01454076|155701197|FG001|Overall Study|Withdrawal by Subject|4|||
48413605|NCT01454076|155701198|FG002|Overall Study|Withdrawal by Subject|2|||
48413606|NCT01454076|155701199|FG003|Overall Study|Withdrawal by Subject|1|||
48413607|NCT01454076|155701200|FG004|Overall Study|Withdrawal by Subject|2|||
48413608|NCT01454076|155701196|FG000|Overall Study|Adverse Event|8|||
48413609|NCT01454076|155701197|FG001|Overall Study|Adverse Event|2|||
48413610|NCT01454076|155701198|FG002|Overall Study|Adverse Event|7|||
48413611|NCT01454076|155701199|FG003|Overall Study|Adverse Event|0|||
48413612|NCT01454076|155701200|FG004|Overall Study|Adverse Event|2|||
48413613|NCT04348851|155701201|FG000|Post-Test 1|Withdrawal by Subject|0|||
48413614|NCT04348851|155701202|FG001|Post-Test 1|Withdrawal by Subject|1|||
48413615|NCT04348851|155701203|FG002|Post-Test 1|Withdrawal by Subject|0|||
48413616|NCT04348851|155701204|FG003|Post-Test 1|Withdrawal by Subject|0|||
48413617|NCT04348851|155701201|FG000|Post-Test 1|Lost to Follow-up|0|||
48413618|NCT04348851|155701202|FG001|Post-Test 1|Lost to Follow-up|1|||
48413619|NCT04348851|155701203|FG002|Post-Test 1|Lost to Follow-up|0|||
48413620|NCT04348851|155701204|FG003|Post-Test 1|Lost to Follow-up|0|||
48413621|NCT04348851|155701201|FG000|Post-Test 2|Stroke survivor death|0|||
48413622|NCT04348851|155701202|FG001|Post-Test 2|Stroke survivor death|1|||
48413623|NCT04348851|155701203|FG002|Post-Test 2|Stroke survivor death|0|||
48413624|NCT04348851|155701204|FG003|Post-Test 2|Stroke survivor death|1|||
48413625|NCT02965378|155701205|FG000|Overall Study|Progression|16|||
48413626|NCT02965378|155701206|FG001|Overall Study|Progression|4|||
48413627|NCT02965378|155701205|FG000|Overall Study|Adverse Event|5|||
48413628|NCT02965378|155701206|FG001|Overall Study|Adverse Event|2|||
48413629|NCT02965378|155701205|FG000|Overall Study|Death|2|||
48413630|NCT02965378|155701206|FG001|Overall Study|Death|0|||
48413631|NCT02965378|155701205|FG000|Overall Study|Refusal|2|||
48413632|NCT02965378|155701206|FG001|Overall Study|Refusal|1|||
48413633|NCT02965378|155701205|FG000|Overall Study|Not protocol specified|0|||
48413634|NCT02965378|155701206|FG001|Overall Study|Not protocol specified|2|||
48413635|NCT00195650|155701207|FG000|Overall Study|Adverse Event|194|||
48413636|NCT00195650|155701207|FG000|Overall Study|Lack of Efficacy|99|||
48413637|NCT00195650|155701207|FG000|Overall Study|Withdrawal by Subject|67|||
48413638|NCT00195650|155701207|FG000|Overall Study|Lost to Follow-up|44|||
48413639|NCT00195650|155701207|FG000|Overall Study|Death|23|||
48413640|NCT00195650|155701207|FG000|Overall Study|Protocol Violation|15|||
48413641|NCT00195650|155701207|FG000|Overall Study|Administrative reasons|83|||
48413642|NCT01535235|155701212|FG000|Overall Study|Adverse Event|1|||
48413643|NCT01535235|155701213|FG001|Overall Study|Adverse Event|0|||
48413644|NCT01171612|155701214|FG000|Overall Study|Lost to Follow-up|51|||
48413645|NCT05292755|155701215|FG000|Overall Study|Lost to Follow-up|5|||
48413646|NCT05292755|155701216|FG001|Overall Study|Lost to Follow-up|9|||
48413647|NCT01193686|155701220|FG000|Overall Study|Withdrawal by Subject|4|||
48413648|NCT01193686|155701221|FG001|Overall Study|Withdrawal by Subject|1|||
48413649|NCT01193686|155701220|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
48413650|NCT01193686|155701221|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
48413651|NCT00432809|155701224|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
48413652|NCT00432809|155701225|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
48413653|NCT00432809|155701226|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
48413654|NCT00432809|155701224|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
48413655|NCT00432809|155701225|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
48413656|NCT00432809|155701226|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
48413657|NCT03029832|155701228|FG000|Overall Study|Safety Follow-Up Completed|2|||
48413658|NCT03029832|155701229|FG001|Overall Study|Safety Follow-Up Completed|0|||
48413659|NCT03029832|155701228|FG000|Overall Study|Death due to Disease Progression|1|||
48362611|NCT00299494|155522555|FG000|Overall Study|Withdrawal by Subject|0|||
48362612|NCT00299494|155522556|FG001|Overall Study|Withdrawal by Subject|0|||
48362613|NCT00299494|155522557|FG002|Overall Study|Withdrawal by Subject|0|||
48362614|NCT00299494|155522558|FG003|Overall Study|Withdrawal by Subject|3|||
48362615|NCT00299494|155522559|FG004|Overall Study|Withdrawal by Subject|1|||
48362616|NCT00299494|155522560|FG005|Overall Study|Withdrawal by Subject|4|||
48362617|NCT00299494|155522555|FG000|Overall Study|Physician Decision|0|||
48362618|NCT00299494|155522556|FG001|Overall Study|Physician Decision|0|||
48362619|NCT00299494|155522557|FG002|Overall Study|Physician Decision|0|||
48362620|NCT00299494|155522558|FG003|Overall Study|Physician Decision|0|||
48362621|NCT00299494|155522559|FG004|Overall Study|Physician Decision|1|||
48362622|NCT00299494|155522560|FG005|Overall Study|Physician Decision|0|||
48362623|NCT00299494|155522555|FG000|Overall Study|Death|3|||
48362624|NCT00299494|155522556|FG001|Overall Study|Death|1|||
48362625|NCT00299494|155522557|FG002|Overall Study|Death|4|||
48362626|NCT00299494|155522558|FG003|Overall Study|Death|6|||
48362627|NCT00299494|155522559|FG004|Overall Study|Death|18|||
48362628|NCT00299494|155522560|FG005|Overall Study|Death|19|||
48362629|NCT00299494|155522555|FG000|Overall Study|Lost to Follow-up|0|||
48362630|NCT00299494|155522556|FG001|Overall Study|Lost to Follow-up|0|||
48362631|NCT00299494|155522557|FG002|Overall Study|Lost to Follow-up|0|||
48362632|NCT00299494|155522558|FG003|Overall Study|Lost to Follow-up|0|||
48362633|NCT00299494|155522559|FG004|Overall Study|Lost to Follow-up|3|||
48362634|NCT00299494|155522560|FG005|Overall Study|Lost to Follow-up|1|||
48362635|NCT00299494|155522555|FG000|Overall Study|Other - Unspecified|0|||
48362636|NCT00299494|155522556|FG001|Overall Study|Other - Unspecified|0|||
48362637|NCT00299494|155522557|FG002|Overall Study|Other - Unspecified|0|||
48362638|NCT00299494|155522558|FG003|Overall Study|Other - Unspecified|0|||
48362639|NCT00299494|155522559|FG004|Overall Study|Other - Unspecified|3|||
48362640|NCT00299494|155522560|FG005|Overall Study|Other - Unspecified|1|||
48362641|NCT00299494|155522555|FG000|Overall Study|Other - site closure|0|||
48362642|NCT00299494|155522556|FG001|Overall Study|Other - site closure|0|||
48362643|NCT00299494|155522557|FG002|Overall Study|Other - site closure|0|||
48362644|NCT00299494|155522558|FG003|Overall Study|Other - site closure|1|||
48362645|NCT00299494|155522559|FG004|Overall Study|Other - site closure|1|||
48362646|NCT00299494|155522560|FG005|Overall Study|Other - site closure|1|||
48362647|NCT00214019|155522561|FG000|Overall Study|Lost to Follow-up|11|||
48362648|NCT00214019|155522561|FG000|Overall Study|Withdrawal by Subject|2|||
48362649|NCT00214019|155522561|FG000|Overall Study|Screen Failed prior to randomization|17|||
48362650|NCT01677767|155522562|FG000|Overall Study|Adverse Event|1|||
48413660|NCT03029832|155701229|FG001|Overall Study|Death due to Disease Progression|0|||
48413661|NCT03029832|155701228|FG000|Overall Study|Study Terminated By Sponsor|1|||
48413662|NCT03029832|155701229|FG001|Overall Study|Study Terminated By Sponsor|1|||
48413663|NCT01023789|155701230|FG000|3 - Year Visit|Death|29|||
48413664|NCT01023789|155701230|FG000|3 - Year Visit|Withdrawal of consent|1|||
48362651|NCT01677767|155522562|FG000|Overall Study|Death|4|||
48362652|NCT01677767|155522562|FG000|Overall Study|Protocol Violation|4|||
48362653|NCT01677767|155522562|FG000|Overall Study|Withdrawal by Subject|10|||
48362654|NCT01677767|155522562|FG000|Overall Study|Non-compliance by the participants|3|||
48362655|NCT00468143|155522564|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
48362656|NCT00468143|155522565|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
48362657|NCT00468143|155522564|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
48362658|NCT00468143|155522565|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
48362659|NCT02992691|155522568|FG000|Overall Study|Adverse Event|2|||
48362660|NCT02992691|155522568|FG000|Overall Study|Withdrawal by Subject|1|||
48362661|NCT00588692|155522569|FG000|Overall Study|Withdrawal by Subject|4|||
48362662|NCT00588692|155522570|FG001|Overall Study|Withdrawal by Subject|2|||
48362663|NCT00588692|155522569|FG000|Overall Study|Hip Surgery|0|||
48362664|NCT00588692|155522570|FG001|Overall Study|Hip Surgery|1|||
48362665|NCT00588692|155522569|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
48362666|NCT00588692|155522570|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
48362667|NCT00588692|155522569|FG000|Overall Study|Cancer|1|||
48362668|NCT00588692|155522570|FG001|Overall Study|Cancer|0|||
48362669|NCT00588692|155522569|FG000|Overall Study|Death|1|||
48362670|NCT00588692|155522570|FG001|Overall Study|Death|0|||
48362671|NCT01374568|155522571|FG000|Overall Study|Lab unable to analyze BTM|0|||
48362672|NCT01374568|155522572|FG001|Overall Study|Lab unable to analyze BTM|2|||
48362673|NCT00392925|155522575|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
48362674|NCT00392925|155522576|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
48362675|NCT00392925|155522577|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
48362676|NCT00392925|155522578|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
48362677|NCT00392925|155522575|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
48362678|NCT00392925|155522576|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
48362679|NCT00392925|155522577|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
48362680|NCT00392925|155522578|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
48362681|NCT00392925|155522575|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
48362682|NCT00392925|155522576|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
48362683|NCT00392925|155522577|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
48362684|NCT00392925|155522578|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
48362685|NCT00392925|155522575|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
48362686|NCT00392925|155522576|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
48362687|NCT00392925|155522577|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
48362688|NCT00392925|155522578|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
48362689|NCT00392925|155522575|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
48362690|NCT00392925|155522576|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
48362691|NCT00392925|155522577|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
48362692|NCT00392925|155522578|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
48362693|NCT00392925|155522575|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
48362694|NCT00392925|155522576|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
48362695|NCT00392925|155522577|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
48362696|NCT00392925|155522578|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
48362697|NCT00392925|155522575|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
48362698|NCT00392925|155522576|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
48362699|NCT00392925|155522577|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
48362700|NCT00392925|155522578|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
48362701|NCT00392925|155522575|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
48362702|NCT00392925|155522576|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
48362703|NCT00392925|155522577|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
48362704|NCT00392925|155522578|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
48362705|NCT00392925|155522575|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
48362706|NCT00392925|155522576|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
48362707|NCT00392925|155522577|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
48362708|NCT00392925|155522578|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
48362709|NCT00403767|155522581|FG000|Overall Study|Adverse Event|993|||
48413665|NCT01023789|155701230|FG000|3 - Year Visit|Lost to Follow-up|13|||
48362710|NCT00403767|155522582|FG001|Overall Study|Adverse Event|919|||
48362711|NCT00403767|155522581|FG000|Overall Study|Non-compliant with study medication|134|||
48362712|NCT00403767|155522582|FG001|Overall Study|Non-compliant with study medication|164|||
48413666|NCT00749203|155701236|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
48413667|NCT00749203|155701237|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
48413668|NCT00749203|155701236|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
48413669|NCT00749203|155701237|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
48413670|NCT00749203|155701236|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
48413671|NCT00749203|155701237|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
48413672|NCT00749203|155701236|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
48413673|NCT00749203|155701237|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
48413674|NCT00749203|155701236|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
48413675|NCT00749203|155701237|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
48362713|NCT00403767|155522581|FG000|Overall Study|Consent withdrawn|671|||
48362714|NCT00403767|155522582|FG001|Overall Study|Consent withdrawn|673|||
48362715|NCT00403767|155522581|FG000|Overall Study|Investigator dec./not protocol-related|191|||
48362716|NCT00403767|155522582|FG001|Overall Study|Investigator dec./not protocol-related|178|||
48413676|NCT00749203|155701236|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
48413677|NCT00749203|155701237|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
48413678|NCT03440944|155701238|FG000|Overall Study|Physician Decision|1|||
48413679|NCT03440944|155701239|FG001|Overall Study|Physician Decision|0|||
48413680|NCT03440944|155701238|FG000|Overall Study|No Acceptable Vasculature|0|||
48413681|NCT03440944|155701239|FG001|Overall Study|No Acceptable Vasculature|1|||
48413682|NCT00591734|155701240|FG000|Overall Study|Lack of Efficacy|35|||
48413683|NCT00591734|155701240|FG000|Overall Study|Adverse Event|5|||
48413684|NCT00591734|155701240|FG000|Overall Study|Physician Decision|5|||
48362717|NCT00403767|155522581|FG000|Overall Study|Lost to Follow-up|6|||
48362718|NCT00403767|155522582|FG001|Overall Study|Lost to Follow-up|8|||
48362719|NCT00403767|155522581|FG000|Overall Study|Protocol Violation|142|||
48362720|NCT00403767|155522582|FG001|Overall Study|Protocol Violation|124|||
48362721|NCT00403767|155522581|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
48362722|NCT00403767|155522582|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
48362723|NCT00403767|155522581|FG000|Overall Study|Study terminated by sponsor|82|||
48413685|NCT00591734|155701240|FG000|Overall Study|Intercurrent Illness|8|||
48413686|NCT00943683|155701241|FG000|Overall Study|Adverse Event|3|||
48413687|NCT00943683|155701242|FG001|Overall Study|Adverse Event|3|||
48413688|NCT00943683|155701241|FG000|Overall Study|Lost to Follow-up|1|||
48413689|NCT00943683|155701242|FG001|Overall Study|Lost to Follow-up|1|||
48413690|NCT00943683|155701241|FG000|Overall Study|Protocol Violation|1|||
48413691|NCT00943683|155701242|FG001|Overall Study|Protocol Violation|2|||
48413692|NCT00943683|155701241|FG000|Overall Study|Withdrawal by Subject|1|||
48413693|NCT00943683|155701242|FG001|Overall Study|Withdrawal by Subject|0|||
48413694|NCT00943683|155701241|FG000|Overall Study|Patient Moved|1|||
48413695|NCT00943683|155701242|FG001|Overall Study|Patient Moved|0|||
48413696|NCT02698189|155701243|FG000|Overall Study|Physician Decision|3|||
48413697|NCT02698189|155701244|FG001|Overall Study|Physician Decision|0|||
48413698|NCT02698189|155701243|FG000|Overall Study|Progressive disease|0|||
48413699|NCT02698189|155701244|FG001|Overall Study|Progressive disease|5|||
48362724|NCT00403767|155522582|FG001|Overall Study|Study terminated by sponsor|69|||
48362725|NCT00403767|155522581|FG000|Overall Study|Missing/incomplete data|1|||
48413700|NCT02698189|155701243|FG000|Overall Study|Study terminated by sponsor|0|||
48413701|NCT02698189|155701244|FG001|Overall Study|Study terminated by sponsor|1|||
48413702|NCT01523873|155701258|FG000|Overall Study|Protocol Violation|422|||
48362726|NCT00403767|155522582|FG001|Overall Study|Missing/incomplete data|1|||
48362727|NCT01137578|155522590|FG000|Overall Study|Participant requested to Discontinue|3|||
48362728|NCT01137578|155522591|FG001|Overall Study|Participant requested to Discontinue|0|||
48362729|NCT01137578|155522592|FG002|Overall Study|Participant requested to Discontinue|0|||
48362730|NCT01137578|155522590|FG000|Overall Study|Withdrawal by Subject|1|||
48362731|NCT01137578|155522591|FG001|Overall Study|Withdrawal by Subject|0|||
48362732|NCT01137578|155522592|FG002|Overall Study|Withdrawal by Subject|0|||
48362733|NCT01137578|155522590|FG000|Overall Study|Other|12|||
48362734|NCT01137578|155522591|FG001|Overall Study|Other|2|||
48362735|NCT01137578|155522592|FG002|Overall Study|Other|6|||
48362736|NCT01152814|155522597|FG000|Overall Study|Lost to Follow-up|2|||
48362737|NCT03284203|155522598|FG000|Overall Study|Lost to Follow-up|3|||
48362738|NCT02229851|155522599|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
48362739|NCT02229851|155522600|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
48362740|NCT02229851|155522601|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
48362741|NCT02229851|155522602|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
48362742|NCT02229851|155522603|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
48362743|NCT02229851|155522604|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
48362744|NCT02229851|155522605|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
48362745|NCT02229851|155522599|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48362746|NCT02229851|155522600|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
48362747|NCT02229851|155522601|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48362748|NCT02229851|155522602|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48362749|NCT02229851|155522603|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48362750|NCT02229851|155522604|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48362751|NCT02229851|155522605|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
48362752|NCT02229851|155522599|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
48362753|NCT02229851|155522600|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
48362754|NCT02229851|155522601|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
48362755|NCT02229851|155522602|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
48362756|NCT02229851|155522603|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
48362757|NCT02229851|155522604|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
48362758|NCT02229851|155522605|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
48362759|NCT02229851|155522599|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48362760|NCT02229851|155522600|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48362761|NCT02229851|155522601|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
48362762|NCT02229851|155522602|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48362763|NCT02229851|155522603|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48362764|NCT02229851|155522604|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48362765|NCT02229851|155522605|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
48362766|NCT02229851|155522599|FG000|Main Phase (Double-blind Phase)|Death|1|||
48362767|NCT02229851|155522600|FG001|Main Phase (Double-blind Phase)|Death|1|||
48362768|NCT02229851|155522601|FG002|Main Phase (Double-blind Phase)|Death|0|||
48362769|NCT02229851|155522602|FG003|Main Phase (Double-blind Phase)|Death|0|||
48362770|NCT02229851|155522603|FG004|Main Phase (Double-blind Phase)|Death|0|||
48362771|NCT02229851|155522604|FG005|Main Phase (Double-blind Phase)|Death|0|||
48362772|NCT02229851|155522605|FG006|Main Phase (Double-blind Phase)|Death|0|||
48362773|NCT02229851|155522599|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
48362774|NCT02229851|155522600|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
48362775|NCT02229851|155522601|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
48362776|NCT02229851|155522602|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
48362777|NCT02229851|155522603|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
48362778|NCT02229851|155522604|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
48362779|NCT02229851|155522605|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
48362780|NCT02229851|155522599|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
48362781|NCT02229851|155522600|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
48362782|NCT02229851|155522601|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
48413703|NCT02006576|155701264|FG000|Overall Study|Withdrawal by Subject|4|||
48413704|NCT02006576|155701265|FG001|Overall Study|Withdrawal by Subject|6|||
48362783|NCT02229851|155522602|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
48362784|NCT02229851|155522603|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
48362785|NCT02229851|155522604|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
48362786|NCT02229851|155522605|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
48362787|NCT02229851|155522599|FG000|Extension Phase (Open-label Phase)|Death|0|||
48362788|NCT02229851|155522600|FG001|Extension Phase (Open-label Phase)|Death|0|||
48362789|NCT02229851|155522601|FG002|Extension Phase (Open-label Phase)|Death|0|||
48362790|NCT02229851|155522602|FG003|Extension Phase (Open-label Phase)|Death|1|||
48362791|NCT02229851|155522603|FG004|Extension Phase (Open-label Phase)|Death|0|||
48362792|NCT02229851|155522604|FG005|Extension Phase (Open-label Phase)|Death|1|||
48362793|NCT02229851|155522605|FG006|Extension Phase (Open-label Phase)|Death|1|||
48362794|NCT02310100|155522606|FG000|Overall Study|Physician Decision|3|||
48362795|NCT02310100|155522606|FG000|Overall Study|Withdrawal by Subject|10|||
48362796|NCT02310100|155522606|FG000|Overall Study|Enrollment closure|1|||
48362797|NCT02310100|155522606|FG000|Overall Study|Unapproved ablation operator|1|||
48362798|NCT02310100|155522606|FG000|Overall Study|Visit compliance|1|||
48362799|NCT02310100|155522606|FG000|Overall Study|Lost to Follow-up|2|||
48362800|NCT01518153|155522607|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
48362801|NCT01518153|155522608|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
48362802|NCT01518153|155522609|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
48362803|NCT01518153|155522607|FG000|Stem Cell Transplant|Death|2|||
48362804|NCT01518153|155522608|FG001|Stem Cell Transplant|Death|0|||
48362805|NCT01518153|155522609|FG002|Stem Cell Transplant|Death|0|||
48362806|NCT01518153|155522607|FG000|Stem Cell Transplant|Secondary graft failure|1|||
48362807|NCT01518153|155522608|FG001|Stem Cell Transplant|Secondary graft failure|0|||
48362808|NCT01518153|155522609|FG002|Stem Cell Transplant|Secondary graft failure|0|||
48362809|NCT01518153|155522607|FG000|Stem Cell Transplant|Adverse Event|1|||
48362810|NCT01518153|155522608|FG001|Stem Cell Transplant|Adverse Event|0|||
48362811|NCT01518153|155522609|FG002|Stem Cell Transplant|Adverse Event|0|||
48362812|NCT01518153|155522607|FG000|Donor Lymphocyte Infusion|Death|0|||
48362813|NCT01518153|155522608|FG001|Donor Lymphocyte Infusion|Death|2|||
48362814|NCT01518153|155522609|FG002|Donor Lymphocyte Infusion|Death|1|||
48362815|NCT00911768|155522610|FG000|Overall Study|Protocol Violation|5|||
48362816|NCT00911768|155522611|FG001|Overall Study|Protocol Violation|4|||
48362817|NCT00911768|155522610|FG000|Overall Study|Withdrawal by Subject|1|||
48362818|NCT00911768|155522611|FG001|Overall Study|Withdrawal by Subject|0|||
48362819|NCT04157400|155522616|FG000|Overall Study|Withdrawal by Subject|1|||
48362820|NCT04157400|155522616|FG000|Overall Study|Lost to Follow-up|3|||
48362821|NCT01397422|155522622|FG000|Overall Study|Adverse Event|0|||
48362822|NCT01397422|155522623|FG001|Overall Study|Adverse Event|3|||
48362823|NCT01397422|155522624|FG002|Overall Study|Adverse Event|3|||
48362824|NCT01397422|155522625|FG003|Overall Study|Adverse Event|8|||
48362825|NCT01397422|155522622|FG000|Overall Study|Withdrawal by Subject|1|||
48362826|NCT01397422|155522623|FG001|Overall Study|Withdrawal by Subject|0|||
48362827|NCT01397422|155522624|FG002|Overall Study|Withdrawal by Subject|0|||
48362828|NCT01397422|155522625|FG003|Overall Study|Withdrawal by Subject|0|||
48362829|NCT01397422|155522622|FG000|Overall Study|Increased bradykinesia related to PD|1|||
48362830|NCT01397422|155522623|FG001|Overall Study|Increased bradykinesia related to PD|0|||
48362831|NCT01397422|155522624|FG002|Overall Study|Increased bradykinesia related to PD|0|||
48362832|NCT01397422|155522625|FG003|Overall Study|Increased bradykinesia related to PD|0|||
48362833|NCT00925353|155522626|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
48362834|NCT05543707|155522632|FG000|Overall Study|Study drug non-compliance/|5|||
48362835|NCT05543707|155522633|FG001|Overall Study|Study drug non-compliance/|0|||
48362836|NCT05543707|155522632|FG000|Overall Study|Withdrawal by Subject|1|||
48362837|NCT05543707|155522633|FG001|Overall Study|Withdrawal by Subject|1|||
48362838|NCT05543707|155522632|FG000|Overall Study|Adverse Event|1|||
48362839|NCT05543707|155522633|FG001|Overall Study|Adverse Event|0|||
48362840|NCT05543707|155522632|FG000|Overall Study|concurrent illness|0|||
48362841|NCT05543707|155522633|FG001|Overall Study|concurrent illness|1|||
48362842|NCT05543707|155522632|FG000|Overall Study|Pregnancy|1|||
48362843|NCT05543707|155522633|FG001|Overall Study|Pregnancy|1|||
48362844|NCT05384938|155522634|FG000|Overall Study|Withdrawal by Subject|8|||
48362845|NCT05384938|155522634|FG000|Overall Study|Lost to Follow-up|6|||
48362846|NCT05384938|155522634|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
48362847|NCT01905150|155522635|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
48362848|NCT01905150|155522636|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
48362849|NCT01920477|155524235|FG000|Overall Study|Adverse Event|0|||
48362850|NCT01920477|155524236|FG001|Overall Study|Adverse Event|1|||
48362851|NCT01920477|155524235|FG000|Overall Study|Lack of Efficacy|1|||
48362852|NCT01920477|155524236|FG001|Overall Study|Lack of Efficacy|0|||
48362853|NCT01920477|155524235|FG000|Overall Study|Study closed/terminated|14|||
48362854|NCT01920477|155524236|FG001|Overall Study|Study closed/terminated|15|||
48362855|NCT01920477|155524235|FG000|Overall Study|Withdrawal by Subject|0|||
48362856|NCT01920477|155524236|FG001|Overall Study|Withdrawal by Subject|1|||
48362857|NCT00387426|155524239|FG000|Overall Study|Lack of Response|7|||
48362858|NCT00387426|155524239|FG000|Overall Study|Toxicities|4|||
48362859|NCT00387426|155524239|FG000|Overall Study|Disease Progression|3|||
48362860|NCT00747227|155524240|FG000|Overall Study|Death|3|||
48362861|NCT00747227|155524241|FG001|Overall Study|Death|1|||
48362862|NCT00747227|155524240|FG000|Overall Study|Withdrawal by Subject|1|||
48362863|NCT00747227|155524241|FG001|Overall Study|Withdrawal by Subject|0|||
48362864|NCT00747227|155524240|FG000|Overall Study|Lost to Follow-up|1|||
48362865|NCT00747227|155524241|FG001|Overall Study|Lost to Follow-up|2|||
48362866|NCT00747227|155524240|FG000|Overall Study|Illness|1|||
48362867|NCT00747227|155524241|FG001|Overall Study|Illness|1|||
48362868|NCT01253135|155524242|FG000|Original Protocol|Protocol Amendment|15|||
48362869|NCT01253135|155524242|FG000|Amended Protocol|Non-compliance|1|||
48362870|NCT01020877|155524243|FG000|Second Intervention|Withdrawal by Subject|1|||
48362871|NCT01020877|155524244|FG001|Second Intervention|Withdrawal by Subject|0|||
48362872|NCT01088984|155524245|FG000|Phase 1|Death|2|||
48362873|NCT01088984|155524246|FG001|Phase 1|Death|1|||
48362874|NCT01088984|155524245|FG000|Phase 1|Disease Progression|2|||
48362875|NCT01088984|155524246|FG001|Phase 1|Disease Progression|4|||
48362876|NCT01088984|155524245|FG000|Phase 1|Other|1|||
48362877|NCT01088984|155524246|FG001|Phase 1|Other|1|||
48362878|NCT01088984|155524245|FG000|Phase 2|Death|0|||
48362879|NCT01088984|155524246|FG001|Phase 2|Death|5|||
48362880|NCT01088984|155524245|FG000|Phase 2|Withdrawal by Subject|0|||
48362881|NCT01088984|155524246|FG001|Phase 2|Withdrawal by Subject|1|||
48362882|NCT01088984|155524245|FG000|Phase 2|DIsease Progression|0|||
48362883|NCT01088984|155524246|FG001|Phase 2|DIsease Progression|25|||
48362884|NCT01088984|155524245|FG000|Phase 2|Other|0|||
48362885|NCT01088984|155524246|FG001|Phase 2|Other|1|||
48362886|NCT00699153|155524248|FG000|Overall Study|Lost to Follow-up|1|||
48362887|NCT00699153|155524249|FG001|Overall Study|Lost to Follow-up|0|||
48362888|NCT00699153|155524248|FG000|Overall Study|Adverse Event|0|||
48362889|NCT00699153|155524249|FG001|Overall Study|Adverse Event|2|||
48362890|NCT00699153|155524248|FG000|Overall Study|Protocol Violation|1|||
48362891|NCT00699153|155524249|FG001|Overall Study|Protocol Violation|0|||
48362892|NCT00699153|155524248|FG000|Overall Study|Travel Problem|1|||
48362893|NCT00699153|155524249|FG001|Overall Study|Travel Problem|0|||
48362894|NCT00357110|155524252|FG000|Overall Study|Early study termination|5|||
48362895|NCT00357110|155524253|FG001|Overall Study|Early study termination|5|||
48362896|NCT00545753|155524259|FG000|Overall Study|Withdrawal by Subject|0|||
48362897|NCT00545753|155524260|FG001|Overall Study|Withdrawal by Subject|1|||
48362898|NCT00545753|155524261|FG002|Overall Study|Withdrawal by Subject|10|||
48362899|NCT00545753|155524259|FG000|Overall Study|Lost to Follow-up|13|||
48362900|NCT00545753|155524260|FG001|Overall Study|Lost to Follow-up|3|||
48362901|NCT00545753|155524261|FG002|Overall Study|Lost to Follow-up|12|||
48362902|NCT00545753|155524259|FG000|Overall Study|Protocol Violation|3|||
48362903|NCT00545753|155524260|FG001|Overall Study|Protocol Violation|1|||
48362904|NCT00545753|155524261|FG002|Overall Study|Protocol Violation|4|||
48362905|NCT01531673|155524264|FG000|Overall Study|Non-Compliance|0|||
48362906|NCT01531673|155524265|FG001|Overall Study|Non-Compliance|0|||
48362907|NCT01531673|155524266|FG002|Overall Study|Non-Compliance|0|||
48362908|NCT01531673|155524267|FG003|Overall Study|Non-Compliance|0|||
48362909|NCT01531673|155524268|FG004|Overall Study|Non-Compliance|0|||
48362910|NCT01531673|155524269|FG005|Overall Study|Non-Compliance|1|||
48362911|NCT01531673|155524270|FG006|Overall Study|Non-Compliance|0|||
48362912|NCT01531673|155524271|FG007|Overall Study|Non-Compliance|0|||
48362913|NCT01531673|155524272|FG008|Overall Study|Non-Compliance|0|||
48362914|NCT01531673|155524273|FG009|Overall Study|Non-Compliance|0|||
48362915|NCT01531673|155524274|FG010|Overall Study|Non-Compliance|0|||
48362916|NCT01531673|155524275|FG011|Overall Study|Non-Compliance|0|||
48362917|NCT01531673|155524276|FG012|Overall Study|Non-Compliance|0|||
48362918|NCT01531673|155524264|FG000|Overall Study|Adverse Event|0|||
48362919|NCT01531673|155524265|FG001|Overall Study|Adverse Event|1|||
48362920|NCT01531673|155524266|FG002|Overall Study|Adverse Event|0|||
48362921|NCT01531673|155524267|FG003|Overall Study|Adverse Event|0|||
48362922|NCT01531673|155524268|FG004|Overall Study|Adverse Event|0|||
48362923|NCT01531673|155524269|FG005|Overall Study|Adverse Event|0|||
48362924|NCT01531673|155524270|FG006|Overall Study|Adverse Event|0|||
48362925|NCT01531673|155524271|FG007|Overall Study|Adverse Event|0|||
48362926|NCT01531673|155524272|FG008|Overall Study|Adverse Event|0|||
48362927|NCT01531673|155524273|FG009|Overall Study|Adverse Event|0|||
48362928|NCT01531673|155524274|FG010|Overall Study|Adverse Event|0|||
48362929|NCT01531673|155524275|FG011|Overall Study|Adverse Event|0|||
48362930|NCT01531673|155524276|FG012|Overall Study|Adverse Event|0|||
48362931|NCT01531673|155524264|FG000|Overall Study|Lost to Follow-up|0|||
48362932|NCT01531673|155524265|FG001|Overall Study|Lost to Follow-up|0|||
48362933|NCT01531673|155524266|FG002|Overall Study|Lost to Follow-up|0|||
48362934|NCT01531673|155524267|FG003|Overall Study|Lost to Follow-up|0|||
48362935|NCT01531673|155524268|FG004|Overall Study|Lost to Follow-up|1|||
48362936|NCT01531673|155524269|FG005|Overall Study|Lost to Follow-up|0|||
48362937|NCT01531673|155524270|FG006|Overall Study|Lost to Follow-up|0|||
48413705|NCT02006576|155701266|FG002|Overall Study|Withdrawal by Subject|2|||
48413706|NCT02006576|155701264|FG000|Overall Study|Death|0|||
48413707|NCT02006576|155701265|FG001|Overall Study|Death|0|||
48413708|NCT02006576|155701266|FG002|Overall Study|Death|1|||
48413709|NCT02006576|155701264|FG000|Overall Study|Lost to Follow-up|1|||
48413710|NCT02006576|155701265|FG001|Overall Study|Lost to Follow-up|0|||
48413711|NCT02006576|155701266|FG002|Overall Study|Lost to Follow-up|1|||
48413712|NCT02006576|155701264|FG000|Overall Study|Screen Failure, too sick, other|13|||
48413713|NCT02006576|155701265|FG001|Overall Study|Screen Failure, too sick, other|1|||
48413714|NCT02006576|155701266|FG002|Overall Study|Screen Failure, too sick, other|13|||
48413715|NCT03219164|155703186|FG000|Overall Study|Study Terminated by Sponsor|16|||
48413716|NCT03219164|155703187|FG001|Overall Study|Study Terminated by Sponsor|12|||
48413717|NCT03219164|155703186|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
48413718|NCT03219164|155703187|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
48413719|NCT03219164|155703186|FG000|Overall Study|Lost to Follow-up|1|||
48413720|NCT03219164|155703187|FG001|Overall Study|Lost to Follow-up|1|||
48362938|NCT01531673|155524271|FG007|Overall Study|Lost to Follow-up|0|||
48362939|NCT01531673|155524272|FG008|Overall Study|Lost to Follow-up|0|||
48362940|NCT01531673|155524273|FG009|Overall Study|Lost to Follow-up|0|||
48362941|NCT01531673|155524274|FG010|Overall Study|Lost to Follow-up|0|||
48362942|NCT01531673|155524275|FG011|Overall Study|Lost to Follow-up|0|||
48413721|NCT03219164|155703186|FG000|Overall Study|Adverse Event|1|||
48413722|NCT03219164|155703187|FG001|Overall Study|Adverse Event|0|||
48413723|NCT03219164|155703186|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48413724|NCT03219164|155703187|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48413725|NCT03219164|155703186|FG000|Overall Study|Protocol Violation|0|||
48362943|NCT01531673|155524276|FG012|Overall Study|Lost to Follow-up|0|||
48362944|NCT01531673|155524264|FG000|Overall Study|Other|0|||
48362945|NCT01531673|155524265|FG001|Overall Study|Other|0|||
48362946|NCT01531673|155524266|FG002|Overall Study|Other|0|||
48362947|NCT01531673|155524267|FG003|Overall Study|Other|1|||
48362948|NCT01531673|155524268|FG004|Overall Study|Other|0|||
48362949|NCT01531673|155524269|FG005|Overall Study|Other|0|||
48362950|NCT01531673|155524270|FG006|Overall Study|Other|0|||
48362951|NCT01531673|155524271|FG007|Overall Study|Other|0|||
48362952|NCT01531673|155524272|FG008|Overall Study|Other|0|||
48362953|NCT01531673|155524273|FG009|Overall Study|Other|1|||
48362954|NCT01531673|155524274|FG010|Overall Study|Other|0|||
48362955|NCT01531673|155524275|FG011|Overall Study|Other|0|||
48362956|NCT01531673|155524276|FG012|Overall Study|Other|0|||
48362957|NCT00288639|155524277|FG000|Overall Study|Adverse Event|5|||
48362958|NCT00288639|155524277|FG000|Overall Study|Lack of Efficacy|4|||
48362959|NCT00288639|155524277|FG000|Overall Study|Withdrawal by Subject|2|||
48362960|NCT00288639|155524277|FG000|Overall Study|Other|1|||
48362961|NCT00264303|155524278|FG000|Overall Study|Adverse Event|4|||
48362962|NCT00264303|155524279|FG001|Overall Study|Adverse Event|3|||
48362963|NCT00264303|155524278|FG000|Overall Study|Lack of Efficacy|10|||
48362964|NCT00264303|155524279|FG001|Overall Study|Lack of Efficacy|13|||
48362965|NCT00264303|155524278|FG000|Overall Study|Lost to Follow-up|3|||
48362966|NCT00264303|155524279|FG001|Overall Study|Lost to Follow-up|3|||
48362967|NCT00264303|155524278|FG000|Overall Study|Withdrawal by Subject|2|||
48362968|NCT00264303|155524279|FG001|Overall Study|Withdrawal by Subject|3|||
48362969|NCT00264303|155524278|FG000|Overall Study|Various reasons listed in study report|6|||
48362970|NCT00264303|155524279|FG001|Overall Study|Various reasons listed in study report|7|||
48362971|NCT02304705|155524285|FG000|Overall Study|Withdrawal by Subject|2|||
48362972|NCT02304705|155524286|FG001|Overall Study|Withdrawal by Subject|0|||
48362973|NCT02304705|155524285|FG000|Overall Study|Physician Decision|2|||
48362974|NCT02304705|155524286|FG001|Overall Study|Physician Decision|4|||
48362975|NCT02304705|155524285|FG000|Overall Study|Death|0|||
48413726|NCT03219164|155703187|FG001|Overall Study|Protocol Violation|1|||
48413727|NCT03219164|155703186|FG000|Overall Study|Withdrew Assent|1|||
48413728|NCT03219164|155703187|FG001|Overall Study|Withdrew Assent|0|||
48413729|NCT00880750|155703188|FG000|First Intervention|Adverse Event|1|||
48413730|NCT00880750|155703189|FG001|First Intervention|Adverse Event|0|||
48413731|NCT00880750|155703188|FG000|First Intervention|Unable to collect urine|4|||
48362976|NCT02304705|155524286|FG001|Overall Study|Death|1|||
48362977|NCT02304705|155524285|FG000|Overall Study|Lost to Follow-up|0|||
48362978|NCT02304705|155524286|FG001|Overall Study|Lost to Follow-up|2|||
48362979|NCT00979576|155524287|FG000|Combination Treatment Phase|Progressive disease|3|||
48362980|NCT00979576|155524288|FG001|Combination Treatment Phase|Progressive disease|1|||
48362981|NCT00979576|155524289|FG002|Combination Treatment Phase|Progressive disease|5|||
48362982|NCT00979576|155524287|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
48362983|NCT00979576|155524288|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
48362984|NCT00979576|155524289|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
48362985|NCT00979576|155524287|FG000|Combination Treatment Phase|Adverse Event|0|||
48362986|NCT00979576|155524288|FG001|Combination Treatment Phase|Adverse Event|2|||
48413732|NCT00880750|155703189|FG001|First Intervention|Unable to collect urine|0|||
48413733|NCT00880750|155703188|FG000|First Intervention|Non-compliance with meals|0|||
48431455|NCT00002663|155767270|FG006|Overall Study|Adverse Event|0|||
48413734|NCT00880750|155703189|FG001|First Intervention|Non-compliance with meals|1|||
48413735|NCT00880750|155703188|FG000|First Intervention|Withdrawal by Subject|2|||
48413736|NCT00880750|155703189|FG001|First Intervention|Withdrawal by Subject|0|||
48413737|NCT00880750|155703188|FG000|First Intervention|Lost to Follow-up|2|||
48413738|NCT00880750|155703189|FG001|First Intervention|Lost to Follow-up|0|||
48413739|NCT00880750|155703188|FG000|Second Intervention|Withdrawal by Subject|2|||
48362987|NCT00979576|155524289|FG002|Combination Treatment Phase|Adverse Event|2|||
48362988|NCT00979576|155524287|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
48362989|NCT00979576|155524288|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
48362990|NCT00979576|155524289|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
48362991|NCT02530970|155524292|FG000|Overall Study|Adverse Event|8|||
48362992|NCT02530970|155524292|FG000|Overall Study|Lost to Follow-up|88|||
48362993|NCT02530970|155524292|FG000|Overall Study|Physician Decision|5|||
48362994|NCT02530970|155524292|FG000|Overall Study|Withdrawal by Subject|14|||
48362995|NCT02530970|155524292|FG000|Overall Study|Death|6|||
48362996|NCT02530970|155524292|FG000|Overall Study|Hospitalization|1|||
48362997|NCT02530970|155524292|FG000|Overall Study|Insurance|2|||
48362998|NCT02530970|155524292|FG000|Overall Study|Explant|2|||
48362999|NCT02530970|155524292|FG000|Overall Study|Change in Provider|5|||
48363000|NCT02530970|155524292|FG000|Overall Study|Relocation|3|||
48363001|NCT02233803|155524295|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
48363002|NCT02233803|155524296|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
48363003|NCT02233803|155524295|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
48363004|NCT02233803|155524296|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
48363005|NCT02233803|155524295|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
48363006|NCT02233803|155524296|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
48363007|NCT02233803|155524295|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
48363008|NCT02233803|155524296|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
48363009|NCT02233803|155524295|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
48363010|NCT02233803|155524296|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
48363011|NCT02233803|155524295|FG000|Washout Period (4-Wks)|Physician Decision|1|||
48363012|NCT02233803|155524296|FG001|Washout Period (4-Wks)|Physician Decision|0|||
48363013|NCT02233803|155524295|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
48363014|NCT02233803|155524296|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
48363015|NCT02233803|155524295|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
48363016|NCT02233803|155524296|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
48363017|NCT02233803|155524295|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
48363018|NCT02233803|155524296|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
48363019|NCT01365481|155524299|FG000|Overall Study|Adverse Event|6|||
48363020|NCT01365481|155524300|FG001|Overall Study|Adverse Event|9|||
48363021|NCT01365481|155524301|FG002|Overall Study|Adverse Event|0|||
48363022|NCT01365481|155524302|FG003|Overall Study|Adverse Event|2|||
48363023|NCT01365481|155524299|FG000|Overall Study|Withdrawal by Subject|0|||
48363024|NCT01365481|155524300|FG001|Overall Study|Withdrawal by Subject|2|||
48363025|NCT01365481|155524301|FG002|Overall Study|Withdrawal by Subject|1|||
48363026|NCT01365481|155524302|FG003|Overall Study|Withdrawal by Subject|1|||
48363027|NCT01365481|155524299|FG000|Overall Study|Lost to Follow-up|1|||
48363028|NCT01365481|155524300|FG001|Overall Study|Lost to Follow-up|1|||
48363029|NCT01365481|155524301|FG002|Overall Study|Lost to Follow-up|2|||
48363030|NCT01365481|155524302|FG003|Overall Study|Lost to Follow-up|3|||
48363031|NCT01365481|155524299|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48363032|NCT01365481|155524300|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48363033|NCT01365481|155524301|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48363034|NCT01365481|155524302|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48363035|NCT01365481|155524299|FG000|Overall Study|Administrative problems|0|||
48363036|NCT01365481|155524300|FG001|Overall Study|Administrative problems|1|||
48363037|NCT01365481|155524301|FG002|Overall Study|Administrative problems|0|||
48363038|NCT01365481|155524302|FG003|Overall Study|Administrative problems|0|||
48413740|NCT00880750|155703189|FG001|Second Intervention|Withdrawal by Subject|2|||
48413741|NCT00880750|155703188|FG000|Second Intervention|Protocol Violation|1|||
48413742|NCT00880750|155703189|FG001|Second Intervention|Protocol Violation|0|||
48413743|NCT00880750|155703188|FG000|Second Intervention|Unable to collect urine|1|||
48413744|NCT00880750|155703189|FG001|Second Intervention|Unable to collect urine|0|||
48413745|NCT03195894|155703195|FG000|Overall Study|"An example is Started other treatment."|4|||
48413746|NCT03195894|155703196|FG001|Overall Study|"An example is Started other treatment."|5|||
48363039|NCT01365481|155524299|FG000|Overall Study|Protocol deviation|0|||
48363040|NCT01365481|155524300|FG001|Overall Study|Protocol deviation|1|||
48363041|NCT01365481|155524301|FG002|Overall Study|Protocol deviation|0|||
48363042|NCT01365481|155524302|FG003|Overall Study|Protocol deviation|1|||
48363043|NCT01365481|155524299|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48363044|NCT01365481|155524300|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48363045|NCT01365481|155524301|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
48363046|NCT01365481|155524302|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
48363047|NCT00635661|155524303|FG000|Overall Study|Withdrawal by Subject|4|||
48363048|NCT01427725|155524312|FG000|Overall Study|Lost to Follow-up|17|||
48363049|NCT01427725|155524312|FG000|Overall Study|Protocol Violation|1|||
48363050|NCT01427725|155524312|FG000|Overall Study|Drug not administered|1|||
48363051|NCT01427725|155524312|FG000|Overall Study|Failure to visit|7|||
48363052|NCT01427725|155524312|FG000|Overall Study|Adverse Event|46|||
48363053|NCT01427725|155524312|FG000|Overall Study|Failure to visit after administration|40|||
48363054|NCT01427725|155524312|FG000|Overall Study|Patient's rejection|27|||
48363055|NCT01427725|155524312|FG000|Overall Study|Transfer to a different hospital|17|||
48363056|NCT01427725|155524312|FG000|Overall Study|Lack of Efficacy|8|||
48363057|NCT01427725|155524312|FG000|Overall Study|Death|7|||
48363058|NCT01427725|155524312|FG000|Overall Study|Symptom improvement|6|||
48363059|NCT01427725|155524312|FG000|Overall Study|AE and Patient's rejection|5|||
48363060|NCT01427725|155524312|FG000|Overall Study|Physician Decision|5|||
48363061|NCT01427725|155524312|FG000|Overall Study|Exacerbation of underlying disease|5|||
48363062|NCT01427725|155524312|FG000|Overall Study|Oral feeding difficulty|5|||
48363063|NCT01427725|155524312|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
48363064|NCT01427725|155524312|FG000|Overall Study|Forgetting prescription|1|||
48363065|NCT01427725|155524312|FG000|Overall Study|Other|2|||
48363066|NCT00468559|155524313|FG000|Open-label Treatment Phase|Adverse Event|5|||
48363067|NCT00468559|155524314|FG001|Open-label Treatment Phase|Adverse Event|0|||
48363068|NCT00468559|155524315|FG002|Open-label Treatment Phase|Adverse Event|0|||
48363069|NCT00468559|155524313|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
48363070|NCT00468559|155524314|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
48363071|NCT00468559|155524315|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
48363072|NCT00468559|155524313|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
48363073|NCT00468559|155524314|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
48363074|NCT00468559|155524315|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
48363075|NCT00468559|155524313|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
48363076|NCT00468559|155524314|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
48363077|NCT00468559|155524315|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
48363078|NCT00468559|155524313|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
48363079|NCT00468559|155524314|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
48363080|NCT00468559|155524315|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
48363081|NCT01641159|155524316|FG000|Overall Study|Lost to Follow-up|2|||
48363082|NCT01641159|155524317|FG001|Overall Study|Lost to Follow-up|1|||
48363083|NCT01641159|155524316|FG000|Overall Study|Withdrawal by Subject|0|||
48363084|NCT01641159|155524317|FG001|Overall Study|Withdrawal by Subject|1|||
48363085|NCT00436605|155524318|FG000|Overall Study|Protocol Violation|3|||
48363086|NCT01696045|155524321|FG000|Overall Study|Study drug toxicity|1|||
48363087|NCT01696045|155524322|FG001|Overall Study|Study drug toxicity|5|||
48363088|NCT01696045|155524321|FG000|Overall Study|Disease progression|2|||
48363089|NCT01696045|155524322|FG001|Overall Study|Disease progression|2|||
48363090|NCT00573859|155524323|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
48413747|NCT03195894|155703195|FG000|Overall Study|Withdrawal by Subject|15|||
48413748|NCT03195894|155703196|FG001|Overall Study|Withdrawal by Subject|4|||
48363091|NCT00573859|155524323|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
48363092|NCT00415051|155524324|FG000|Overall Study|Protocol Violation|1|||
48363093|NCT01163292|155524326|FG000|Overall Study|Lack of Efficacy|9|||
48413749|NCT03195894|155703195|FG000|Overall Study|Lost to Follow-up|14|||
48413750|NCT03195894|155703196|FG001|Overall Study|Lost to Follow-up|19|||
48413751|NCT02338843|155703197|FG000|Overall Study|Adverse Event|2|||
48413752|NCT02338843|155703198|FG001|Overall Study|Adverse Event|1|||
48413753|NCT02338843|155703197|FG000|Overall Study|Death|40|||
48413754|NCT02338843|155703198|FG001|Overall Study|Death|53|||
48413755|NCT02338843|155703197|FG000|Overall Study|Physician Decision|1|||
48413756|NCT02338843|155703198|FG001|Overall Study|Physician Decision|0|||
48413757|NCT02338843|155703197|FG000|Overall Study|Withdrawal by Subject|0|||
48413758|NCT02338843|155703198|FG001|Overall Study|Withdrawal by Subject|2|||
48413759|NCT02338843|155703197|FG000|Overall Study|Subject Recovered|0|||
48413760|NCT02338843|155703198|FG001|Overall Study|Subject Recovered|2|||
48413761|NCT02338843|155703197|FG000|Overall Study|Discontinued prior to randomizat|1|||
48413762|NCT02338843|155703198|FG001|Overall Study|Discontinued prior to randomizat|0|||
48413763|NCT00623831|155703200|FG000|Overall Study|Withdrawal by Subject|1|||
48413764|NCT00623831|155703201|FG001|Overall Study|Withdrawal by Subject|0|||
48413765|NCT00623831|155703200|FG000|Overall Study|Progressive Disease|0|||
48413766|NCT00623831|155703201|FG001|Overall Study|Progressive Disease|1|||
48413767|NCT03124459|155703202|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48413768|NCT03124459|155703203|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48363094|NCT01163292|155524327|FG001|Overall Study|Lack of Efficacy|0|||
48363095|NCT01163292|155524326|FG000|Overall Study|Adverse Event|6|||
48363096|NCT01163292|155524327|FG001|Overall Study|Adverse Event|0|||
48363097|NCT01163292|155524326|FG000|Overall Study|Initiation of biological therapy|0|||
48363098|NCT01163292|155524327|FG001|Overall Study|Initiation of biological therapy|15|||
48413769|NCT03124459|155703204|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48413770|NCT03124459|155703205|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48431456|NCT00002663|155767271|FG007|Overall Study|Adverse Event|1|||
48363099|NCT01163292|155524326|FG000|Overall Study|Sufficient response to adalimumab|8|||
48363100|NCT01163292|155524327|FG001|Overall Study|Sufficient response to adalimumab|0|||
48363101|NCT01163292|155524326|FG000|Overall Study|Refusal to receive adalimumab|7|||
48363102|NCT01163292|155524327|FG001|Overall Study|Refusal to receive adalimumab|0|||
48363103|NCT01163292|155524326|FG000|Overall Study|Economic reasons|6|||
48363104|NCT01163292|155524327|FG001|Overall Study|Economic reasons|0|||
48363105|NCT01163292|155524326|FG000|Overall Study|No further visits|5|||
48363106|NCT01163292|155524327|FG001|Overall Study|No further visits|7|||
48363107|NCT00886795|155524331|FG000|Overall Study|Lack of Efficacy|1|||
48363108|NCT05132127|155524334|FG000|Overall Study|Adverse Event|1|||
48363109|NCT04276415|155524335|FG000|Overall Study|Adverse Event|0|||
48363110|NCT04276415|155524336|FG001|Overall Study|Adverse Event|0|||
48363111|NCT04276415|155524337|FG002|Overall Study|Adverse Event|0|||
48363112|NCT04276415|155524338|FG003|Overall Study|Adverse Event|3|||
48363113|NCT04276415|155524339|FG004|Overall Study|Adverse Event|0|||
48363114|NCT04276415|155524340|FG005|Overall Study|Adverse Event|0|||
48363115|NCT04276415|155524335|FG000|Overall Study|Clinical progression|1|||
48363116|NCT04276415|155524336|FG001|Overall Study|Clinical progression|1|||
48363117|NCT04276415|155524337|FG002|Overall Study|Clinical progression|0|||
48363118|NCT04276415|155524338|FG003|Overall Study|Clinical progression|0|||
48363119|NCT04276415|155524339|FG004|Overall Study|Clinical progression|1|||
48363120|NCT04276415|155524340|FG005|Overall Study|Clinical progression|0|||
48363121|NCT04276415|155524335|FG000|Overall Study|Other|0|||
48363122|NCT04276415|155524336|FG001|Overall Study|Other|0|||
48363123|NCT04276415|155524337|FG002|Overall Study|Other|0|||
48363124|NCT04276415|155524338|FG003|Overall Study|Other|1|||
48363125|NCT04276415|155524339|FG004|Overall Study|Other|0|||
48363126|NCT04276415|155524340|FG005|Overall Study|Other|0|||
48363127|NCT04276415|155524335|FG000|Overall Study|Physician Decision|0|||
48363128|NCT04276415|155524336|FG001|Overall Study|Physician Decision|0|||
48413771|NCT03124459|155703206|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
48363129|NCT04276415|155524337|FG002|Overall Study|Physician Decision|1|||
48363130|NCT04276415|155524338|FG003|Overall Study|Physician Decision|3|||
48363131|NCT04276415|155524339|FG004|Overall Study|Physician Decision|2|||
48413772|NCT03124459|155703207|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
48413773|NCT03124459|155703202|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48413774|NCT03124459|155703203|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48413775|NCT03124459|155703204|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48413776|NCT03124459|155703205|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48413777|NCT03124459|155703206|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
48413778|NCT03124459|155703207|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
48413779|NCT03124459|155703202|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
48363132|NCT04276415|155524340|FG005|Overall Study|Physician Decision|0|||
48413780|NCT03124459|155703203|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
48413781|NCT03124459|155703204|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
48413782|NCT03124459|155703205|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
48413783|NCT03124459|155703206|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
48413784|NCT03124459|155703207|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
48413785|NCT03124459|155703202|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
48363133|NCT04276415|155524335|FG000|Overall Study|Progressive disease|3|||
48363134|NCT04276415|155524336|FG001|Overall Study|Progressive disease|3|||
48363135|NCT04276415|155524337|FG002|Overall Study|Progressive disease|4|||
48363136|NCT04276415|155524338|FG003|Overall Study|Progressive disease|5|||
48363137|NCT04276415|155524339|FG004|Overall Study|Progressive disease|1|||
48363138|NCT04276415|155524340|FG005|Overall Study|Progressive disease|2|||
48363139|NCT04276415|155524335|FG000|Overall Study|Withdrawal by patient|0|||
48363140|NCT04276415|155524336|FG001|Overall Study|Withdrawal by patient|0|||
48363141|NCT04276415|155524337|FG002|Overall Study|Withdrawal by patient|0|||
48413786|NCT03124459|155703203|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
48413787|NCT03124459|155703204|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
48413788|NCT03124459|155703205|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
48413789|NCT03124459|155703206|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
48413790|NCT03124459|155703207|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
48413791|NCT03124459|155703202|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48413792|NCT03124459|155703203|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48363142|NCT04276415|155524338|FG003|Overall Study|Withdrawal by patient|1|||
48363143|NCT04276415|155524339|FG004|Overall Study|Withdrawal by patient|2|||
48363144|NCT04276415|155524340|FG005|Overall Study|Withdrawal by patient|0|||
48363145|NCT01373151|155524341|FG000|Period 1|Lack of Efficacy|3|||
48363146|NCT01373151|155524342|FG001|Period 1|Lack of Efficacy|0|||
48363147|NCT01373151|155524343|FG002|Period 1|Lack of Efficacy|0|||
48363148|NCT01373151|155524344|FG003|Period 1|Lack of Efficacy|0|||
48363149|NCT01373151|155524345|FG004|Period 1|Lack of Efficacy|1|||
48363150|NCT01373151|155524346|FG005|Period 1|Lack of Efficacy|0|||
48363151|NCT01373151|155524347|FG006|Period 1|Lack of Efficacy|0|||
48413793|NCT03124459|155703204|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48413794|NCT03124459|155703205|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48413795|NCT03124459|155703206|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
48413796|NCT03124459|155703207|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
48413797|NCT03124459|155703202|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48413798|NCT03124459|155703203|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48413799|NCT03124459|155703204|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48413800|NCT03124459|155703205|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48413801|NCT03124459|155703206|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
48413802|NCT03124459|155703207|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
48413803|NCT00282243|155703208|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
48413804|NCT00282243|155703208|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
48413805|NCT00282243|155703208|FG000|Extension Treatment Period|Adverse Event|15|||
48413806|NCT00282243|155703208|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
48413807|NCT00282243|155703208|FG000|Extension Treatment Period|Non-compliance|2|||
48413808|NCT00282243|155703208|FG000|Extension Treatment Period|Physician Decision|1|||
48413809|NCT00851903|155703209|FG000|Overall Study|Withdrawal by Subject|2|||
48413810|NCT00270894|155703210|FG000|Overall Study|Adverse Event|1|||
48413811|NCT00270894|155703210|FG000|Overall Study|Withdrawal by Subject|1|||
48413812|NCT00686127|155703215|FG000|Overall Study|Withdrawal by Subject|14|||
48363152|NCT01373151|155524341|FG000|Period 1|Adverse Event|0|||
48363153|NCT01373151|155524342|FG001|Period 1|Adverse Event|0|||
48363154|NCT01373151|155524343|FG002|Period 1|Adverse Event|1|||
48363155|NCT01373151|155524344|FG003|Period 1|Adverse Event|0|||
48363156|NCT01373151|155524345|FG004|Period 1|Adverse Event|4|||
48363157|NCT01373151|155524346|FG005|Period 1|Adverse Event|3|||
48363158|NCT01373151|155524347|FG006|Period 1|Adverse Event|0|||
48363159|NCT01373151|155524341|FG000|Period 1|Withdrawal by Subject|2|||
48363160|NCT01373151|155524342|FG001|Period 1|Withdrawal by Subject|0|||
48363161|NCT01373151|155524343|FG002|Period 1|Withdrawal by Subject|3|||
48363162|NCT01373151|155524344|FG003|Period 1|Withdrawal by Subject|1|||
48363163|NCT01373151|155524345|FG004|Period 1|Withdrawal by Subject|0|||
48363164|NCT01373151|155524346|FG005|Period 1|Withdrawal by Subject|1|||
48363165|NCT01373151|155524347|FG006|Period 1|Withdrawal by Subject|0|||
48363166|NCT01373151|155524341|FG000|Period 2|Lack of Efficacy|9|||
48363167|NCT01373151|155524342|FG001|Period 2|Lack of Efficacy|0|||
48363168|NCT01373151|155524343|FG002|Period 2|Lack of Efficacy|0|||
48363169|NCT01373151|155524344|FG003|Period 2|Lack of Efficacy|1|||
48363170|NCT01373151|155524345|FG004|Period 2|Lack of Efficacy|2|||
48363171|NCT01373151|155524346|FG005|Period 2|Lack of Efficacy|0|||
48363172|NCT01373151|155524347|FG006|Period 2|Lack of Efficacy|3|||
48363173|NCT01373151|155524341|FG000|Period 2|Adverse Event|0|||
48363174|NCT01373151|155524342|FG001|Period 2|Adverse Event|0|||
48363175|NCT01373151|155524343|FG002|Period 2|Adverse Event|3|||
48363176|NCT01373151|155524344|FG003|Period 2|Adverse Event|3|||
48363177|NCT01373151|155524345|FG004|Period 2|Adverse Event|0|||
48363178|NCT01373151|155524346|FG005|Period 2|Adverse Event|0|||
48363179|NCT01373151|155524347|FG006|Period 2|Adverse Event|1|||
48363180|NCT01373151|155524341|FG000|Period 2|subject request to discontinue|0|||
48363181|NCT01373151|155524342|FG001|Period 2|subject request to discontinue|1|||
48363182|NCT01373151|155524343|FG002|Period 2|subject request to discontinue|0|||
48363183|NCT01373151|155524344|FG003|Period 2|subject request to discontinue|0|||
48363184|NCT01373151|155524345|FG004|Period 2|subject request to discontinue|0|||
48363185|NCT01373151|155524346|FG005|Period 2|subject request to discontinue|0|||
48413813|NCT00686127|155703216|FG001|Overall Study|Withdrawal by Subject|6|||
48413814|NCT00450580|155703222|FG000|Overall Study|Adverse Event|5|||
48413815|NCT00450580|155703223|FG001|Overall Study|Adverse Event|7|||
48413816|NCT00450580|155703222|FG000|Overall Study|Lost to Follow-up|4|||
48413817|NCT00450580|155703223|FG001|Overall Study|Lost to Follow-up|5|||
48413818|NCT00450580|155703222|FG000|Overall Study|Withdrawal by Subject|2|||
48413819|NCT00450580|155703223|FG001|Overall Study|Withdrawal by Subject|2|||
48413820|NCT00450580|155703222|FG000|Overall Study|Protocol Violation|1|||
48413821|NCT00450580|155703223|FG001|Overall Study|Protocol Violation|1|||
48413822|NCT00450580|155703222|FG000|Overall Study|Protocol-defined virologic failure|1|||
48363186|NCT01373151|155524347|FG006|Period 2|subject request to discontinue|0|||
48363187|NCT01373151|155524341|FG000|Period 2|Withdrawal by Subject|0|||
48363188|NCT01373151|155524342|FG001|Period 2|Withdrawal by Subject|0|||
48363189|NCT01373151|155524343|FG002|Period 2|Withdrawal by Subject|0|||
48363190|NCT01373151|155524344|FG003|Period 2|Withdrawal by Subject|1|||
48363191|NCT01373151|155524345|FG004|Period 2|Withdrawal by Subject|0|||
48363192|NCT01373151|155524346|FG005|Period 2|Withdrawal by Subject|0|||
48363193|NCT01373151|155524347|FG006|Period 2|Withdrawal by Subject|0|||
48363194|NCT01373151|155524341|FG000|Period 2|Other|0|||
48363195|NCT01373151|155524342|FG001|Period 2|Other|0|||
48363196|NCT01373151|155524343|FG002|Period 2|Other|1|||
48413823|NCT00450580|155703223|FG001|Overall Study|Protocol-defined virologic failure|0|||
48413824|NCT00450580|155703222|FG000|Overall Study|Could not comply with scheduled visits|1|||
48413825|NCT00450580|155703223|FG001|Overall Study|Could not comply with scheduled visits|0|||
48413826|NCT00450580|155703222|FG000|Overall Study|Patient went to Brazil|1|||
48363197|NCT01373151|155524344|FG003|Period 2|Other|0|||
48363198|NCT01373151|155524345|FG004|Period 2|Other|0|||
48363199|NCT01373151|155524346|FG005|Period 2|Other|0|||
48363200|NCT01373151|155524347|FG006|Period 2|Other|1|||
48363201|NCT04958200|155524351|FG000|Overall Study|Withdrawal by Subject|0|||
48363202|NCT04958200|155524352|FG001|Overall Study|Withdrawal by Subject|2|||
48363203|NCT04958200|155524351|FG000|Overall Study|Lost to Follow-up|3|||
48363204|NCT04958200|155524352|FG001|Overall Study|Lost to Follow-up|2|||
48363205|NCT02387970|155524353|FG000|Overall Study|Did not complete 1-year follow up|1|||
48363206|NCT02387970|155524354|FG001|Overall Study|Did not complete 1-year follow up|2|||
48363207|NCT03117998|155524355|FG000|Overall Study|Adverse Event|1|||
48363208|NCT03117998|155524356|FG001|Overall Study|Adverse Event|0|||
48363209|NCT03117998|155524357|FG002|Overall Study|Adverse Event|0|||
48363210|NCT03117998|155524358|FG003|Overall Study|Adverse Event|0|||
48363211|NCT03117998|155524359|FG004|Overall Study|Adverse Event|0|||
48363212|NCT03117998|155524360|FG005|Overall Study|Adverse Event|0|||
48363213|NCT03117998|155524355|FG000|Overall Study|Withdrawal by Subject|0|||
48363214|NCT03117998|155524356|FG001|Overall Study|Withdrawal by Subject|0|||
48363215|NCT03117998|155524357|FG002|Overall Study|Withdrawal by Subject|2|||
48363216|NCT03117998|155524358|FG003|Overall Study|Withdrawal by Subject|3|||
48363217|NCT03117998|155524359|FG004|Overall Study|Withdrawal by Subject|3|||
48363218|NCT03117998|155524360|FG005|Overall Study|Withdrawal by Subject|0|||
48363219|NCT03117998|155524355|FG000|Overall Study|Physician Decision|0|||
48363220|NCT03117998|155524356|FG001|Overall Study|Physician Decision|1|||
48363221|NCT03117998|155524357|FG002|Overall Study|Physician Decision|1|||
48363222|NCT03117998|155524358|FG003|Overall Study|Physician Decision|0|||
48363223|NCT03117998|155524359|FG004|Overall Study|Physician Decision|0|||
48363224|NCT03117998|155524360|FG005|Overall Study|Physician Decision|0|||
48363225|NCT03117998|155524355|FG000|Overall Study|Lost to Follow-up|0|||
48363226|NCT03117998|155524356|FG001|Overall Study|Lost to Follow-up|0|||
48363227|NCT03117998|155524357|FG002|Overall Study|Lost to Follow-up|0|||
48363228|NCT03117998|155524358|FG003|Overall Study|Lost to Follow-up|1|||
48363229|NCT03117998|155524359|FG004|Overall Study|Lost to Follow-up|4|||
48363230|NCT03117998|155524360|FG005|Overall Study|Lost to Follow-up|0|||
48363231|NCT03117998|155524355|FG000|Overall Study|Subject noncompliance|0|||
48363232|NCT03117998|155524356|FG001|Overall Study|Subject noncompliance|0|||
48363233|NCT03117998|155524357|FG002|Overall Study|Subject noncompliance|1|||
48363234|NCT03117998|155524358|FG003|Overall Study|Subject noncompliance|0|||
48363235|NCT03117998|155524359|FG004|Overall Study|Subject noncompliance|0|||
48363236|NCT03117998|155524360|FG005|Overall Study|Subject noncompliance|2|||
48363237|NCT03117998|155524355|FG000|Overall Study|Protocol Violation|0|||
48363238|NCT03117998|155524356|FG001|Overall Study|Protocol Violation|0|||
48363239|NCT03117998|155524357|FG002|Overall Study|Protocol Violation|0|||
48363240|NCT03117998|155524358|FG003|Overall Study|Protocol Violation|0|||
48363241|NCT03117998|155524359|FG004|Overall Study|Protocol Violation|0|||
48363242|NCT03117998|155524360|FG005|Overall Study|Protocol Violation|1|||
48363243|NCT00293059|155524361|FG000|Overall Study|Adverse Event|12|||
48363244|NCT00293059|155524362|FG001|Overall Study|Adverse Event|4|||
48363245|NCT00293059|155524361|FG000|Overall Study|Lack of Efficacy|2|||
48363246|NCT00293059|155524362|FG001|Overall Study|Lack of Efficacy|0|||
48363247|NCT00293059|155524361|FG000|Overall Study|Lost to Follow-up|2|||
48363248|NCT00293059|155524362|FG001|Overall Study|Lost to Follow-up|3|||
48363249|NCT00293059|155524361|FG000|Overall Study|Pregnancy|1|||
48363250|NCT00293059|155524362|FG001|Overall Study|Pregnancy|1|||
48363251|NCT00293059|155524361|FG000|Overall Study|Protocol Violation|2|||
48363252|NCT00293059|155524362|FG001|Overall Study|Protocol Violation|0|||
48363253|NCT00293059|155524361|FG000|Overall Study|Withdrawal by Subject|11|||
48363254|NCT00293059|155524362|FG001|Overall Study|Withdrawal by Subject|5|||
48363255|NCT00293059|155524361|FG000|Overall Study|Participant moved out of state|1|||
48363256|NCT00293059|155524362|FG001|Overall Study|Participant moved out of state|0|||
48363257|NCT00293059|155524361|FG000|Overall Study|Participant stopped study drug|1|||
48363258|NCT00293059|155524362|FG001|Overall Study|Participant stopped study drug|0|||
48363259|NCT00293059|155524361|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
48363260|NCT00293059|155524362|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
48363261|NCT00293059|155524361|FG000|Overall Study|missing|3|||
48363262|NCT00293059|155524362|FG001|Overall Study|missing|5|||
48363263|NCT00586612|155524363|FG000|Primary Phase|Protocol Violation|1|||
48363264|NCT00586612|155524364|FG001|Primary Phase|Protocol Violation|0|||
48363265|NCT00586612|155524363|FG000|Primary Phase|Lost to Follow-up|0|||
48363266|NCT00586612|155524364|FG001|Primary Phase|Lost to Follow-up|1|||
48363267|NCT00586612|155524363|FG000|Primary Phase|Withdrawal by Subject|0|||
48363268|NCT00586612|155524364|FG001|Primary Phase|Withdrawal by Subject|2|||
48363269|NCT00586612|155524363|FG000|Booster Phase|Lost to Follow-up|3|||
48363270|NCT00586612|155524364|FG001|Booster Phase|Lost to Follow-up|1|||
48363271|NCT01879553|155524365|FG000|Overall Study|Withdrawal by Subject|1|||
48363272|NCT01879553|155524366|FG001|Overall Study|Withdrawal by Subject|0|||
48363273|NCT02738853|155524367|FG000|Enrollment|Inclusion/Exclusion not met|21|||
48363274|NCT02738853|155524367|FG000|Enrollment|Withdrawal by Subject|3|||
48363275|NCT02738853|155524367|FG000|Enrollment|Subject treated with commercially available device|6|||
48363276|NCT02738853|155524367|FG000|Enrollment|Study Enrollment Closed|3|||
48363277|NCT02738853|155524367|FG000|Procedure|Death|1|||
48363278|NCT02738853|155524367|FG000|1 Month|Death|2|||
48363279|NCT02738853|155524367|FG000|6 Month|Death|4|||
48363280|NCT02738853|155524367|FG000|6 Month|Withdrawal by Subject|2|||
48363281|NCT02738853|155524367|FG000|1 Year|Death|6|||
48363282|NCT02738853|155524367|FG000|1 Year|Withdrawal by Subject|1|||
48363283|NCT02738853|155524367|FG000|2 Year|Death|2|||
48363284|NCT02738853|155524367|FG000|2 Year|Lost to Follow-up|1|||
48363285|NCT02738853|155524367|FG000|3 Year|Death|2|||
48363286|NCT02738853|155524367|FG000|3 Year|Withdrawal by Subject|1|||
48363287|NCT02738853|155524367|FG000|4 Year|Death|9|||
48363288|NCT02738853|155524367|FG000|5 Year|Lost to Follow-up|4|||
48363289|NCT01585155|155524368|FG000|Overall Study|Adverse Event|1|||
48363290|NCT01585155|155524368|FG000|Overall Study|Lack of Efficacy|2|||
48363291|NCT01585155|155524368|FG000|Overall Study|Worsening ulcerative colitis|2|||
48363292|NCT03772587|155524371|FG000|Overall Study|COVID-19|0|||
48363293|NCT03772587|155524372|FG001|Overall Study|COVID-19|0|||
48363294|NCT03772587|155524373|FG002|Overall Study|COVID-19|1|||
48363295|NCT03772587|155524374|FG003|Overall Study|COVID-19|1|||
48363296|NCT03772587|155524375|FG004|Overall Study|COVID-19|0|||
48363297|NCT03772587|155524371|FG000|Overall Study|Withdrawal by Subject|1|||
48363298|NCT03772587|155524372|FG001|Overall Study|Withdrawal by Subject|0|||
48363299|NCT03772587|155524373|FG002|Overall Study|Withdrawal by Subject|0|||
48363300|NCT03772587|155524374|FG003|Overall Study|Withdrawal by Subject|0|||
48363301|NCT03772587|155524375|FG004|Overall Study|Withdrawal by Subject|0|||
48363302|NCT00126503|155524376|FG000|Overall Study|disease progression|23|||
48363303|NCT00126503|155524377|FG001|Overall Study|disease progression|14|||
48363304|NCT00126503|155524376|FG000|Overall Study|Withdrawal by Subject|0|||
48413827|NCT00450580|155703223|FG001|Overall Study|Patient went to Brazil|0|||
48413828|NCT00450580|155703222|FG000|Overall Study|Patient could not swallow Norvir|1|||
48413829|NCT00450580|155703223|FG001|Overall Study|Patient could not swallow Norvir|0|||
48413830|NCT00450580|155703222|FG000|Overall Study|Withdrawal due to pregnancy|0|||
48413831|NCT00450580|155703223|FG001|Overall Study|Withdrawal due to pregnancy|1|||
48413832|NCT02207907|155703231|FG000|Overall Study|Lost to Follow-up|3|||
48413833|NCT02207907|155703232|FG001|Overall Study|Lost to Follow-up|1|||
48413834|NCT02207907|155703231|FG000|Overall Study|Withdrawal by Subject|5|||
48413835|NCT02207907|155703232|FG001|Overall Study|Withdrawal by Subject|6|||
48413836|NCT02207907|155703231|FG000|Overall Study|Did not meet study criteria|3|||
48413837|NCT02207907|155703232|FG001|Overall Study|Did not meet study criteria|0|||
48413838|NCT02207907|155703231|FG000|Overall Study|Pregnancy|0|||
48413839|NCT02207907|155703232|FG001|Overall Study|Pregnancy|1|||
48413840|NCT00158184|155703233|FG000|Overall Study|personal issues|3|||
48363305|NCT00126503|155524377|FG001|Overall Study|Withdrawal by Subject|1|||
48363306|NCT00126503|155524376|FG000|Overall Study|alternative therapy|1|||
48363307|NCT00126503|155524377|FG001|Overall Study|alternative therapy|1|||
48363308|NCT00126503|155524376|FG000|Overall Study|other complicating disease|4|||
48363309|NCT00126503|155524377|FG001|Overall Study|other complicating disease|1|||
48363310|NCT00126503|155524376|FG000|Overall Study|Death|3|||
48363311|NCT00126503|155524377|FG001|Overall Study|Death|0|||
48363312|NCT00126503|155524376|FG000|Overall Study|Adverse Event|13|||
48363313|NCT00126503|155524377|FG001|Overall Study|Adverse Event|3|||
48363314|NCT00126503|155524376|FG000|Overall Study|non-compliant|1|||
48363315|NCT00126503|155524377|FG001|Overall Study|non-compliant|0|||
48363316|NCT00126503|155524376|FG000|Overall Study|Physician Decision|2|||
48363317|NCT00126503|155524377|FG001|Overall Study|Physician Decision|1|||
48363318|NCT05000931|155524378|FG000|Overall Study|Lost to Follow-up|1|||
48363319|NCT03345576|155524379|FG000|Overall Study|Withdrawal by Subject|2|||
48363320|NCT03345576|155524380|FG001|Overall Study|Withdrawal by Subject|2|||
48363321|NCT03345576|155524379|FG000|Overall Study|Adverse Event|1|||
48363322|NCT03345576|155524380|FG001|Overall Study|Adverse Event|0|||
48363323|NCT01123070|155526836|FG000|Part B Double Blind Period|Protocol Violation|0|||
48363324|NCT01123070|155526837|FG001|Part B Double Blind Period|Protocol Violation|0|||
48363325|NCT01123070|155526838|FG002|Part B Double Blind Period|Protocol Violation|0|||
48363326|NCT01123070|155526839|FG003|Part B Double Blind Period|Protocol Violation|1|||
48363327|NCT01123070|155526836|FG000|Part B Double Blind Period|Adverse Event|0|||
48363328|NCT01123070|155526837|FG001|Part B Double Blind Period|Adverse Event|0|||
48363329|NCT01123070|155526838|FG002|Part B Double Blind Period|Adverse Event|2|||
48363330|NCT01123070|155526839|FG003|Part B Double Blind Period|Adverse Event|0|||
48363331|NCT01123070|155526836|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
48363332|NCT01123070|155526837|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
48363333|NCT01123070|155526838|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
48363334|NCT01123070|155526839|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
48363335|NCT02218606|155526840|FG000|Overall Study|Adverse Event|1|||
48363336|NCT02218606|155526841|FG001|Overall Study|Adverse Event|1|||
48363337|NCT02218606|155526840|FG000|Overall Study|Death|15|||
48363338|NCT02218606|155526841|FG001|Overall Study|Death|28|||
48413841|NCT00158184|155703234|FG001|Overall Study|personal issues|1|||
48413842|NCT00158184|155703233|FG000|Overall Study|failed for follow unit/study rules|2|||
48431457|NCT00002663|155767272|FG008|Overall Study|Adverse Event|0|||
48363339|NCT02218606|155526840|FG000|Overall Study|Physician Decision|0|||
48363340|NCT02218606|155526841|FG001|Overall Study|Physician Decision|1|||
48363341|NCT02218606|155526840|FG000|Overall Study|Withdrawal by Subject|4|||
48363342|NCT02218606|155526841|FG001|Overall Study|Withdrawal by Subject|0|||
48363343|NCT02218606|155526840|FG000|Overall Study|Noncompliance|1|||
48363344|NCT02218606|155526841|FG001|Overall Study|Noncompliance|0|||
48363345|NCT02218606|155526840|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
48363346|NCT02218606|155526841|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
48363347|NCT02218606|155526840|FG000|Overall Study|Other|2|||
48363348|NCT02218606|155526841|FG001|Overall Study|Other|1|||
48363349|NCT02218606|155526840|FG000|Overall Study|Never started treatment|0|||
48363350|NCT02218606|155526841|FG001|Overall Study|Never started treatment|1|||
48363351|NCT00515671|155526842|FG000|Overall Study|Lost to Follow-up|13|||
48363352|NCT00515671|155526843|FG001|Overall Study|Lost to Follow-up|10|||
48363353|NCT00515671|155526842|FG000|Overall Study|Withdrawal by Subject|3|||
48363354|NCT00515671|155526843|FG001|Overall Study|Withdrawal by Subject|5|||
48363355|NCT00515671|155526842|FG000|Overall Study|incarcerated|1|||
48363356|NCT00515671|155526843|FG001|Overall Study|incarcerated|2|||
48363357|NCT00568178|155526844|FG000|Double Blind Base Study|Adverse Event|0|||
48363358|NCT00568178|155526845|FG001|Double Blind Base Study|Adverse Event|2|||
48363359|NCT00568178|155526846|FG002|Double Blind Base Study|Adverse Event|1|||
48363360|NCT00568178|155526847|FG003|Double Blind Base Study|Adverse Event|2|||
48363361|NCT00568178|155526848|FG004|Double Blind Base Study|Adverse Event|0|||
48363362|NCT00568178|155526849|FG005|Double Blind Base Study|Adverse Event|0|||
48363363|NCT00568178|155526844|FG000|Double Blind Base Study|Lost to Follow-up|1|||
48363364|NCT00568178|155526845|FG001|Double Blind Base Study|Lost to Follow-up|0|||
48363365|NCT00568178|155526846|FG002|Double Blind Base Study|Lost to Follow-up|0|||
48363366|NCT00568178|155526847|FG003|Double Blind Base Study|Lost to Follow-up|1|||
48363367|NCT00568178|155526848|FG004|Double Blind Base Study|Lost to Follow-up|0|||
48363368|NCT00568178|155526849|FG005|Double Blind Base Study|Lost to Follow-up|0|||
48363369|NCT00568178|155526844|FG000|Double Blind Base Study|Physician Decision|1|||
48363370|NCT00568178|155526845|FG001|Double Blind Base Study|Physician Decision|1|||
48363371|NCT00568178|155526846|FG002|Double Blind Base Study|Physician Decision|0|||
48363372|NCT00568178|155526847|FG003|Double Blind Base Study|Physician Decision|1|||
48363373|NCT00568178|155526848|FG004|Double Blind Base Study|Physician Decision|0|||
48363374|NCT00568178|155526849|FG005|Double Blind Base Study|Physician Decision|0|||
48363375|NCT00568178|155526844|FG000|Double Blind Base Study|Protocol Violation|3|||
48363376|NCT00568178|155526845|FG001|Double Blind Base Study|Protocol Violation|2|||
48363377|NCT00568178|155526846|FG002|Double Blind Base Study|Protocol Violation|0|||
48363378|NCT00568178|155526847|FG003|Double Blind Base Study|Protocol Violation|0|||
48363379|NCT00568178|155526848|FG004|Double Blind Base Study|Protocol Violation|0|||
48363380|NCT00568178|155526849|FG005|Double Blind Base Study|Protocol Violation|0|||
48363381|NCT00568178|155526844|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
48363382|NCT00568178|155526845|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
48363383|NCT00568178|155526846|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
48363384|NCT00568178|155526847|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
48363385|NCT00568178|155526848|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
48363386|NCT00568178|155526849|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
48363387|NCT00568178|155526844|FG000|Double Blind Base Study|Progressive Disease|0|||
48363388|NCT00568178|155526845|FG001|Double Blind Base Study|Progressive Disease|0|||
48363389|NCT00568178|155526846|FG002|Double Blind Base Study|Progressive Disease|0|||
48363390|NCT00568178|155526847|FG003|Double Blind Base Study|Progressive Disease|1|||
48363391|NCT00568178|155526848|FG004|Double Blind Base Study|Progressive Disease|0|||
48363392|NCT00568178|155526849|FG005|Double Blind Base Study|Progressive Disease|0|||
48363393|NCT00568178|155526844|FG000|Open Label Extension|Adverse Event|0|||
48363394|NCT00568178|155526845|FG001|Open Label Extension|Adverse Event|0|||
48363395|NCT00568178|155526846|FG002|Open Label Extension|Adverse Event|0|||
48363396|NCT00568178|155526847|FG003|Open Label Extension|Adverse Event|0|||
48363397|NCT00568178|155526848|FG004|Open Label Extension|Adverse Event|11|||
48363398|NCT00568178|155526849|FG005|Open Label Extension|Adverse Event|8|||
48363399|NCT00568178|155526844|FG000|Open Label Extension|Protocol Violation|0|||
48363400|NCT00568178|155526845|FG001|Open Label Extension|Protocol Violation|0|||
48363401|NCT00568178|155526846|FG002|Open Label Extension|Protocol Violation|0|||
48363402|NCT00568178|155526847|FG003|Open Label Extension|Protocol Violation|0|||
48363403|NCT00568178|155526848|FG004|Open Label Extension|Protocol Violation|1|||
48363404|NCT00568178|155526849|FG005|Open Label Extension|Protocol Violation|0|||
48363405|NCT00568178|155526844|FG000|Open Label Extension|Lost to Follow-up|0|||
48363406|NCT00568178|155526845|FG001|Open Label Extension|Lost to Follow-up|0|||
48363407|NCT00568178|155526846|FG002|Open Label Extension|Lost to Follow-up|0|||
48363408|NCT00568178|155526847|FG003|Open Label Extension|Lost to Follow-up|0|||
48363409|NCT00568178|155526848|FG004|Open Label Extension|Lost to Follow-up|6|||
48363410|NCT00568178|155526849|FG005|Open Label Extension|Lost to Follow-up|11|||
48363411|NCT00568178|155526844|FG000|Open Label Extension|Physician Decision|0|||
48363412|NCT00568178|155526845|FG001|Open Label Extension|Physician Decision|0|||
48363413|NCT00568178|155526846|FG002|Open Label Extension|Physician Decision|0|||
48363414|NCT00568178|155526847|FG003|Open Label Extension|Physician Decision|0|||
48363415|NCT00568178|155526848|FG004|Open Label Extension|Physician Decision|9|||
48363416|NCT00568178|155526849|FG005|Open Label Extension|Physician Decision|8|||
48363417|NCT00568178|155526844|FG000|Open Label Extension|Pregnancy|0|||
48363418|NCT00568178|155526845|FG001|Open Label Extension|Pregnancy|0|||
48363419|NCT00568178|155526846|FG002|Open Label Extension|Pregnancy|0|||
48363420|NCT00568178|155526847|FG003|Open Label Extension|Pregnancy|0|||
48363421|NCT00568178|155526848|FG004|Open Label Extension|Pregnancy|0|||
48363422|NCT00568178|155526849|FG005|Open Label Extension|Pregnancy|1|||
48363423|NCT00568178|155526844|FG000|Open Label Extension|Progressive Disease|0|||
48363424|NCT00568178|155526845|FG001|Open Label Extension|Progressive Disease|0|||
48363425|NCT00568178|155526846|FG002|Open Label Extension|Progressive Disease|0|||
48363426|NCT00568178|155526847|FG003|Open Label Extension|Progressive Disease|0|||
48363427|NCT00568178|155526848|FG004|Open Label Extension|Progressive Disease|3|||
48363428|NCT00568178|155526849|FG005|Open Label Extension|Progressive Disease|1|||
48363429|NCT00568178|155526844|FG000|Open Label Extension|Termination of Trial|0|||
48363430|NCT00568178|155526845|FG001|Open Label Extension|Termination of Trial|0|||
48363431|NCT00568178|155526846|FG002|Open Label Extension|Termination of Trial|0|||
48363432|NCT00568178|155526847|FG003|Open Label Extension|Termination of Trial|0|||
48363433|NCT00568178|155526848|FG004|Open Label Extension|Termination of Trial|45|||
48363434|NCT00568178|155526849|FG005|Open Label Extension|Termination of Trial|47|||
48363435|NCT00568178|155526844|FG000|Open Label Extension|Withdrawal by Subject|0|||
48363436|NCT00568178|155526845|FG001|Open Label Extension|Withdrawal by Subject|0|||
48363437|NCT00568178|155526846|FG002|Open Label Extension|Withdrawal by Subject|0|||
48363438|NCT00568178|155526847|FG003|Open Label Extension|Withdrawal by Subject|0|||
48363439|NCT00568178|155526848|FG004|Open Label Extension|Withdrawal by Subject|4|||
48363440|NCT00568178|155526849|FG005|Open Label Extension|Withdrawal by Subject|4|||
48363441|NCT00095056|155526850|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
48363442|NCT00095056|155526851|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
48363443|NCT00095056|155526850|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
48363444|NCT00095056|155526851|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
48363445|NCT00095056|155526850|FG000|Phase A (Weeks 0-12)|Death|1|||
48363446|NCT00095056|155526851|FG001|Phase A (Weeks 0-12)|Death|0|||
48363447|NCT00095056|155526850|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
48363448|NCT00095056|155526851|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
48363449|NCT00095056|155526850|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
48363450|NCT00095056|155526851|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
48363451|NCT00095056|155526850|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
48363452|NCT00095056|155526851|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
48363453|NCT00095056|155526850|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
48363454|NCT00095056|155526851|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
48363455|NCT00095056|155526850|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
48363456|NCT00095056|155526851|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
48363457|NCT00095056|155526850|FG000|Phase B (Weeks 12-54)|Death|3|||
48363458|NCT00095056|155526851|FG001|Phase B (Weeks 12-54)|Death|1|||
48363459|NCT00095056|155526850|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
48363460|NCT00095056|155526851|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
48363461|NCT00095056|155526850|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
48363462|NCT00095056|155526851|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
48363463|NCT00616902|155526854|FG000|Overall Study|Termination of study|6|||
48363464|NCT00616902|155526855|FG001|Overall Study|Termination of study|6|||
48363465|NCT05602727|155526856|FG000|Overall Study|Physician Decision|0|||
48363466|NCT05602727|155526857|FG001|Overall Study|Physician Decision|1|||
48363467|NCT05602727|155526858|FG002|Overall Study|Physician Decision|0|||
48363468|NCT05602727|155526856|FG000|Overall Study|Randomized by mistake without study medication|1|||
48363469|NCT05602727|155526857|FG001|Overall Study|Randomized by mistake without study medication|0|||
48363470|NCT05602727|155526858|FG002|Overall Study|Randomized by mistake without study medication|0|||
48363471|NCT05602727|155526856|FG000|Overall Study|Study termination by Sponsor|18|||
48363472|NCT05602727|155526857|FG001|Overall Study|Study termination by Sponsor|15|||
48363473|NCT05602727|155526858|FG002|Overall Study|Study termination by Sponsor|19|||
48363474|NCT05602727|155526856|FG000|Overall Study|Withdrawal by Subject|2|||
48363475|NCT05602727|155526857|FG001|Overall Study|Withdrawal by Subject|1|||
48363476|NCT05602727|155526858|FG002|Overall Study|Withdrawal by Subject|1|||
48363477|NCT05602727|155526856|FG000|Overall Study|Various reasons|1|||
48363478|NCT05602727|155526857|FG001|Overall Study|Various reasons|6|||
48363479|NCT05602727|155526858|FG002|Overall Study|Various reasons|1|||
48363480|NCT01283152|155526859|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
48363481|NCT01283152|155526860|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
48363482|NCT01283152|155526859|FG000|Overall Study|Refused HESA|1|||
48363483|NCT01283152|155526860|FG001|Overall Study|Refused HESA|0|||
48363484|NCT04833127|155526861|FG000|Overall Study|Lost to Follow-up|1|||
48363485|NCT04833127|155526862|FG001|Overall Study|Lost to Follow-up|1|||
48363486|NCT00772330|155526865|FG000|Overall Study|Lost to Follow-up|3|||
48363487|NCT00224887|155526867|FG000|Overall Study|Pregnancy|6|||
48363488|NCT00224887|155526868|FG001|Overall Study|Pregnancy|6|||
48363489|NCT02672852|155526869|FG000|Part A1|Disease Worsening|1|||
48363490|NCT02672852|155526870|FG001|Part A1|Disease Worsening|0|||
48363491|NCT02672852|155526871|FG002|Part A1|Disease Worsening|0|||
48363492|NCT02672852|155526872|FG003|Part A1|Disease Worsening|0|||
48363493|NCT02672852|155526873|FG004|Part A1|Disease Worsening|0|||
48363494|NCT02672852|155526874|FG005|Part A1|Disease Worsening|0|||
48363495|NCT02672852|155526875|FG006|Part A1|Disease Worsening|0|||
48363496|NCT02672852|155526869|FG000|Part A1|Adverse Event|0|||
48363497|NCT02672852|155526870|FG001|Part A1|Adverse Event|1|||
48363498|NCT02672852|155526871|FG002|Part A1|Adverse Event|0|||
48363499|NCT02672852|155526872|FG003|Part A1|Adverse Event|0|||
48363500|NCT02672852|155526873|FG004|Part A1|Adverse Event|0|||
48363501|NCT02672852|155526874|FG005|Part A1|Adverse Event|0|||
48363502|NCT02672852|155526875|FG006|Part A1|Adverse Event|0|||
48363503|NCT02672852|155526869|FG000|Part A1|Lost to Follow-up|1|||
48363504|NCT02672852|155526870|FG001|Part A1|Lost to Follow-up|2|||
48363505|NCT02672852|155526871|FG002|Part A1|Lost to Follow-up|0|||
48363506|NCT02672852|155526872|FG003|Part A1|Lost to Follow-up|0|||
48363507|NCT02672852|155526873|FG004|Part A1|Lost to Follow-up|0|||
48363508|NCT02672852|155526874|FG005|Part A1|Lost to Follow-up|0|||
48363509|NCT02672852|155526875|FG006|Part A1|Lost to Follow-up|0|||
48363510|NCT02672852|155526869|FG000|Part A1|Withdrawal by Subject|1|||
48363511|NCT02672852|155526870|FG001|Part A1|Withdrawal by Subject|1|||
48363512|NCT02672852|155526871|FG002|Part A1|Withdrawal by Subject|0|||
48363513|NCT02672852|155526872|FG003|Part A1|Withdrawal by Subject|0|||
48363514|NCT02672852|155526873|FG004|Part A1|Withdrawal by Subject|0|||
48363515|NCT02672852|155526874|FG005|Part A1|Withdrawal by Subject|0|||
48363516|NCT02672852|155526875|FG006|Part A1|Withdrawal by Subject|0|||
48363517|NCT02672852|155526869|FG000|Part A2|Disease worsening|0|||
48363518|NCT02672852|155526870|FG001|Part A2|Disease worsening|0|||
48363519|NCT02672852|155526871|FG002|Part A2|Disease worsening|1|||
48363520|NCT02672852|155526872|FG003|Part A2|Disease worsening|0|||
48363521|NCT02672852|155526873|FG004|Part A2|Disease worsening|0|||
48363522|NCT02672852|155526874|FG005|Part A2|Disease worsening|0|||
48363523|NCT02672852|155526875|FG006|Part A2|Disease worsening|0|||
48363524|NCT02672852|155526869|FG000|Part A2|Adverse Event|0|||
48363525|NCT02672852|155526870|FG001|Part A2|Adverse Event|0|||
48363526|NCT02672852|155526871|FG002|Part A2|Adverse Event|3|||
48363527|NCT02672852|155526872|FG003|Part A2|Adverse Event|0|||
48363528|NCT02672852|155526873|FG004|Part A2|Adverse Event|0|||
48363529|NCT02672852|155526874|FG005|Part A2|Adverse Event|0|||
48363530|NCT02672852|155526875|FG006|Part A2|Adverse Event|0|||
48363531|NCT02672852|155526869|FG000|Part A2|Lost to Follow-up|0|||
48363532|NCT02672852|155526870|FG001|Part A2|Lost to Follow-up|0|||
48363533|NCT02672852|155526871|FG002|Part A2|Lost to Follow-up|2|||
48363534|NCT02672852|155526872|FG003|Part A2|Lost to Follow-up|0|||
48363535|NCT02672852|155526873|FG004|Part A2|Lost to Follow-up|0|||
48363536|NCT02672852|155526874|FG005|Part A2|Lost to Follow-up|0|||
48363537|NCT02672852|155526875|FG006|Part A2|Lost to Follow-up|0|||
48363538|NCT02672852|155526869|FG000|Part A2|Withdrawal by Subject|0|||
48363539|NCT02672852|155526870|FG001|Part A2|Withdrawal by Subject|0|||
48363540|NCT02672852|155526871|FG002|Part A2|Withdrawal by Subject|1|||
48363541|NCT02672852|155526872|FG003|Part A2|Withdrawal by Subject|0|||
48363542|NCT02672852|155526873|FG004|Part A2|Withdrawal by Subject|0|||
48363543|NCT02672852|155526874|FG005|Part A2|Withdrawal by Subject|0|||
48363544|NCT02672852|155526875|FG006|Part A2|Withdrawal by Subject|0|||
48363545|NCT02672852|155526869|FG000|Part A2|Other|0|||
48363546|NCT02672852|155526870|FG001|Part A2|Other|0|||
48363547|NCT02672852|155526871|FG002|Part A2|Other|3|||
48363548|NCT02672852|155526872|FG003|Part A2|Other|0|||
48363549|NCT02672852|155526873|FG004|Part A2|Other|0|||
48363550|NCT02672852|155526874|FG005|Part A2|Other|0|||
48363551|NCT02672852|155526875|FG006|Part A2|Other|0|||
48363552|NCT02672852|155526869|FG000|Part A2|Not entered in Part B|0|||
48363553|NCT02672852|155526870|FG001|Part A2|Not entered in Part B|0|||
48363554|NCT02672852|155526871|FG002|Part A2|Not entered in Part B|0|||
48363555|NCT02672852|155526872|FG003|Part A2|Not entered in Part B|4|||
48363556|NCT02672852|155526873|FG004|Part A2|Not entered in Part B|0|||
48363557|NCT02672852|155526874|FG005|Part A2|Not entered in Part B|0|||
48363558|NCT02672852|155526875|FG006|Part A2|Not entered in Part B|0|||
48363559|NCT02672852|155526869|FG000|Part B|Disease worsening|0|||
48363560|NCT02672852|155526870|FG001|Part B|Disease worsening|0|||
48363561|NCT02672852|155526871|FG002|Part B|Disease worsening|0|||
48363562|NCT02672852|155526872|FG003|Part B|Disease worsening|0|||
48363563|NCT02672852|155526873|FG004|Part B|Disease worsening|1|||
48363564|NCT02672852|155526874|FG005|Part B|Disease worsening|0|||
48363565|NCT02672852|155526875|FG006|Part B|Disease worsening|1|||
48363566|NCT02672852|155526869|FG000|Part B|Worsening pre-existing condition|0|||
48363567|NCT02672852|155526870|FG001|Part B|Worsening pre-existing condition|0|||
48363568|NCT02672852|155526871|FG002|Part B|Worsening pre-existing condition|0|||
48363569|NCT02672852|155526872|FG003|Part B|Worsening pre-existing condition|0|||
48363570|NCT02672852|155526873|FG004|Part B|Worsening pre-existing condition|0|||
48363571|NCT02672852|155526874|FG005|Part B|Worsening pre-existing condition|1|||
48363572|NCT02672852|155526875|FG006|Part B|Worsening pre-existing condition|0|||
48363573|NCT02672852|155526869|FG000|Part B|Other adverse event|0|||
48363574|NCT02672852|155526870|FG001|Part B|Other adverse event|0|||
48363575|NCT02672852|155526871|FG002|Part B|Other adverse event|0|||
48363576|NCT02672852|155526872|FG003|Part B|Other adverse event|0|||
48363577|NCT02672852|155526873|FG004|Part B|Other adverse event|3|||
48363578|NCT02672852|155526874|FG005|Part B|Other adverse event|5|||
48363579|NCT02672852|155526875|FG006|Part B|Other adverse event|1|||
48363580|NCT02672852|155526869|FG000|Part B|Lost to Follow-up|0|||
48363581|NCT02672852|155526870|FG001|Part B|Lost to Follow-up|0|||
48363582|NCT02672852|155526871|FG002|Part B|Lost to Follow-up|0|||
48363583|NCT02672852|155526872|FG003|Part B|Lost to Follow-up|0|||
48363584|NCT02672852|155526873|FG004|Part B|Lost to Follow-up|3|||
48363585|NCT02672852|155526874|FG005|Part B|Lost to Follow-up|4|||
48363586|NCT02672852|155526875|FG006|Part B|Lost to Follow-up|1|||
48363587|NCT02672852|155526869|FG000|Part B|Withdrawal by Subject|0|||
48363588|NCT02672852|155526870|FG001|Part B|Withdrawal by Subject|0|||
48363589|NCT02672852|155526871|FG002|Part B|Withdrawal by Subject|0|||
48363590|NCT02672852|155526872|FG003|Part B|Withdrawal by Subject|0|||
48363591|NCT02672852|155526873|FG004|Part B|Withdrawal by Subject|5|||
48363592|NCT02672852|155526874|FG005|Part B|Withdrawal by Subject|0|||
48363593|NCT02672852|155526875|FG006|Part B|Withdrawal by Subject|7|||
48363594|NCT02672852|155526869|FG000|Part B|Other|0|||
48363595|NCT02672852|155526870|FG001|Part B|Other|0|||
48363596|NCT02672852|155526871|FG002|Part B|Other|0|||
48363597|NCT02672852|155526872|FG003|Part B|Other|0|||
48363598|NCT02672852|155526873|FG004|Part B|Other|4|||
48363599|NCT02672852|155526874|FG005|Part B|Other|1|||
48363600|NCT02672852|155526875|FG006|Part B|Other|2|||
48363601|NCT03845140|155526876|FG000|Overall Study|Participant travelled outside study area|0|||
48363602|NCT03845140|155526877|FG001|Overall Study|Participant travelled outside study area|1|||
48363603|NCT03845140|155526878|FG002|Overall Study|Participant travelled outside study area|0|||
48363604|NCT03845140|155526879|FG003|Overall Study|Participant travelled outside study area|0|||
48363605|NCT03845140|155526880|FG004|Overall Study|Participant travelled outside study area|0|||
48363606|NCT03845140|155526881|FG005|Overall Study|Participant travelled outside study area|0|||
48363607|NCT04958642|155526882|FG000|Overall Study|Transferred to OLEX program|3|||
48363608|NCT04958642|155526883|FG001|Overall Study|Transferred to OLEX program|0|||
48363609|NCT04958642|155526884|FG002|Overall Study|Transferred to OLEX program|5|||
48363610|NCT04958642|155526882|FG000|Overall Study|Death|0|||
48363611|NCT04958642|155526883|FG001|Overall Study|Death|0|||
48363612|NCT04958642|155526884|FG002|Overall Study|Death|1|||
48363613|NCT04958642|155526882|FG000|Overall Study|Withdrawal by Subject|4|||
48363614|NCT04958642|155526883|FG001|Overall Study|Withdrawal by Subject|9|||
48363615|NCT04958642|155526884|FG002|Overall Study|Withdrawal by Subject|13|||
48413843|NCT00158184|155703234|FG001|Overall Study|failed for follow unit/study rules|0|||
48413844|NCT00158184|155703233|FG000|Overall Study|Adverse Event|1|||
48413845|NCT00158184|155703234|FG001|Overall Study|Adverse Event|1|||
48413846|NCT05340504|155703235|FG000|Overall Study|Withdrawal by Subject|1|||
48413847|NCT05340504|155703236|FG001|Overall Study|Withdrawal by Subject|0|||
48413848|NCT03182738|155703238|FG000|Overall Study|Lost to Follow-up|9|||
48413849|NCT03182738|155703239|FG001|Overall Study|Lost to Follow-up|3|||
48413850|NCT03182738|155703238|FG000|Overall Study|Pregnancy|0|||
48413851|NCT03182738|155703239|FG001|Overall Study|Pregnancy|1|||
48413852|NCT03182738|155703238|FG000|Overall Study|Withdrawal by Subject|0|||
48413853|NCT03182738|155703239|FG001|Overall Study|Withdrawal by Subject|1|||
48413854|NCT02582671|155703240|FG000|Overall Study|Failure to return|1|||
48413855|NCT02582671|155703240|FG000|Overall Study|Other, not specified|1|||
48413856|NCT02537678|155703241|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
48413857|NCT02537678|155703242|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
48413858|NCT02537678|155703241|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
48413859|NCT02537678|155703242|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
48413860|NCT02537678|155703241|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
48413861|NCT02537678|155703242|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
48413862|NCT02537678|155703241|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
48413863|NCT02537678|155703242|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
48413864|NCT02537678|155703241|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
48413865|NCT02537678|155703242|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
48413866|NCT02537678|155703241|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
48363616|NCT04958642|155526882|FG000|Overall Study|Investigator's Decision|0|||
48363617|NCT04958642|155526883|FG001|Overall Study|Investigator's Decision|0|||
48363618|NCT04958642|155526884|FG002|Overall Study|Investigator's Decision|1|||
48363619|NCT04958642|155526882|FG000|Overall Study|Adverse Event|1|||
48363620|NCT04958642|155526883|FG001|Overall Study|Adverse Event|0|||
48363621|NCT04958642|155526884|FG002|Overall Study|Adverse Event|1|||
48363622|NCT04958642|155526882|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
48363623|NCT04958642|155526883|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
48413867|NCT02537678|155703242|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
48363624|NCT04958642|155526884|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
48363625|NCT04958642|155526882|FG000|Overall Study|Lost to Follow-up|1|||
48363626|NCT04958642|155526883|FG001|Overall Study|Lost to Follow-up|0|||
48363627|NCT04958642|155526884|FG002|Overall Study|Lost to Follow-up|0|||
48363628|NCT04958642|155526882|FG000|Overall Study|Transferred to EAP following study termination|0|||
48363629|NCT04958642|155526883|FG001|Overall Study|Transferred to EAP following study termination|0|||
48363630|NCT04958642|155526884|FG002|Overall Study|Transferred to EAP following study termination|1|||
48363631|NCT04958642|155526882|FG000|Overall Study|Transferred to Expanded Access Program|1|||
48363632|NCT04958642|155526883|FG001|Overall Study|Transferred to Expanded Access Program|0|||
48363633|NCT04958642|155526884|FG002|Overall Study|Transferred to Expanded Access Program|0|||
48363634|NCT01656200|155526885|FG000|Overall Study|Withdrawal by Subject|1|||
48363635|NCT01156376|155526886|FG000|Overall Study|Adverse Event|1|||
48363636|NCT01156376|155526887|FG001|Overall Study|Adverse Event|0|||
48363637|NCT01156376|155526888|FG002|Overall Study|Adverse Event|1|||
48363638|NCT01156376|155526886|FG000|Overall Study|Withdrawal by Subject|0|||
48363639|NCT01156376|155526887|FG001|Overall Study|Withdrawal by Subject|0|||
48363640|NCT01156376|155526888|FG002|Overall Study|Withdrawal by Subject|3|||
48363641|NCT00565773|155526891|FG000|Overall Study|Withdrawal by Subject|1|||
48363642|NCT00565773|155526891|FG000|Overall Study|Physician Decision|1|||
48363643|NCT04546425|155526892|FG000|Overall Study|Protocol Violation|1|||
48363644|NCT04546425|155526893|FG001|Overall Study|Protocol Violation|1|||
48363645|NCT04546425|155526894|FG002|Overall Study|Protocol Violation|0|||
48363646|NCT04546425|155526895|FG003|Overall Study|Protocol Violation|0|||
48363647|NCT04546425|155526892|FG000|Overall Study|Adverse Event|3|||
48363648|NCT04546425|155526893|FG001|Overall Study|Adverse Event|0|||
48363649|NCT04546425|155526894|FG002|Overall Study|Adverse Event|0|||
48363650|NCT04546425|155526895|FG003|Overall Study|Adverse Event|0|||
48363651|NCT04546425|155526892|FG000|Overall Study|Lost to Follow-up|5|||
48363652|NCT04546425|155526893|FG001|Overall Study|Lost to Follow-up|4|||
48363653|NCT04546425|155526894|FG002|Overall Study|Lost to Follow-up|0|||
48363654|NCT04546425|155526895|FG003|Overall Study|Lost to Follow-up|0|||
48363655|NCT04546425|155526892|FG000|Overall Study|No Longer met eligibility criteria|3|||
48363656|NCT04546425|155526893|FG001|Overall Study|No Longer met eligibility criteria|3|||
48363657|NCT04546425|155526894|FG002|Overall Study|No Longer met eligibility criteria|1|||
48363658|NCT04546425|155526895|FG003|Overall Study|No Longer met eligibility criteria|1|||
48363659|NCT04546425|155526892|FG000|Overall Study|Withdrawal by parent/guardian|6|||
48363660|NCT04546425|155526893|FG001|Overall Study|Withdrawal by parent/guardian|5|||
48363661|NCT04546425|155526894|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48363662|NCT04546425|155526895|FG003|Overall Study|Withdrawal by parent/guardian|1|||
48363663|NCT03921723|155526898|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
48363664|NCT03921723|155526898|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
48363665|NCT01461811|155526899|FG000|Overall Study|Adverse Event|2|||
48363666|NCT01461811|155526900|FG001|Overall Study|Adverse Event|1|||
48363667|NCT01461811|155526899|FG000|Overall Study|Subject decision unrelated to an AE|1|||
48363668|NCT01461811|155526900|FG001|Overall Study|Subject decision unrelated to an AE|1|||
48363669|NCT01461811|155526899|FG000|Overall Study|Noncompliance|1|||
48363670|NCT01461811|155526900|FG001|Overall Study|Noncompliance|1|||
48363671|NCT04076943|155526903|FG000|Overall Study|Withdrawal by Subject|12|||
48363672|NCT04076943|155526903|FG000|Overall Study|Adverse Event|1|||
48363673|NCT04076943|155526903|FG000|Overall Study|Progressive Disease|2|||
48363674|NCT04076943|155526903|FG000|Overall Study|Death|13|||
48363675|NCT04076943|155526903|FG000|Overall Study|Other than specified|6|||
48363676|NCT03047395|155526904|FG000|Overall Study|Adverse Event|142|||
48363677|NCT03047395|155526904|FG000|Overall Study|Withdrawal by Subject|155|||
48363678|NCT03047395|155526904|FG000|Overall Study|Lost to Follow-up|144|||
48363679|NCT03047395|155526904|FG000|Overall Study|COVID-19 Infection|2|||
48363680|NCT03047395|155526904|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
48363681|NCT03047395|155526904|FG000|Overall Study|Other, Not Specified|117|||
48363682|NCT01075958|155526907|FG000|Overall Study|Blood sample could not be obtained|44|||
48363683|NCT01232738|155526912|FG000|Overall Study|Death|3|||
48363684|NCT01232738|155526912|FG000|Overall Study|Physician Decision|2|||
48363685|NCT01232738|155526912|FG000|Overall Study|Lost to Follow-up|1|||
48363686|NCT01232738|155526912|FG000|Overall Study|Withdrawal by Subject|2|||
48363687|NCT01232738|155526912|FG000|Overall Study|Adverse Event|5|||
48363688|NCT01125046|155526913|FG000|First 6 Months of Treatment|Death|1|||
48363689|NCT01125046|155526913|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
48363690|NCT01125046|155526913|FG000|First 6 Months of Treatment|Non-compliance|1|||
48363691|NCT01125046|155526913|FG000|First 6 Months of Treatment|Surgery|1|||
48363692|NCT01125046|155526913|FG000|First 6 Months of Treatment|Progressive Disease|7|||
48363693|NCT01125046|155526913|FG000|First 6 Months of Treatment|Adverse Event|2|||
48363694|NCT01125046|155526913|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
48363695|NCT01125046|155526913|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
48363696|NCT01125046|155526913|FG000|Follow-up/Data Cut Off Point|Death|29|||
48363697|NCT01125046|155526913|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
48363698|NCT03868787|155526914|FG000|Overall Study|Withdrawal by Subject|2|||
48363699|NCT03868787|155526915|FG001|Overall Study|Withdrawal by Subject|1|||
48363700|NCT00659880|155526916|FG000|Overall Study|Lost to Follow-up|5|||
48363701|NCT00941070|155526917|FG000|Overall Study|Patient non-compliant|1|||
48363702|NCT04488770|155526918|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48413868|NCT02537678|155703241|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
48413869|NCT02537678|155703242|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
48413870|NCT01360996|155703243|FG000|Overall Study|Withdrawal by Subject|4|||
48413871|NCT01360996|155703244|FG001|Overall Study|Withdrawal by Subject|3|||
48413872|NCT01360996|155703245|FG002|Overall Study|Withdrawal by Subject|2|||
48413873|NCT01360996|155703243|FG000|Overall Study|Noncompliant|2|||
48363703|NCT04488770|155526919|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363704|NCT04488770|155526920|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363705|NCT04488770|155526921|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
48363706|NCT04488770|155526922|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363707|NCT04488770|155526923|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363708|NCT04488770|155526924|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363709|NCT04488770|155526925|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363710|NCT04488770|155526926|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363711|NCT04488770|155526927|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363712|NCT04488770|155526928|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363713|NCT04488770|155526929|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363714|NCT04488770|155526930|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
48363715|NCT04488770|155526918|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
48363716|NCT04488770|155526919|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363717|NCT04488770|155526920|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363718|NCT04488770|155526921|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363719|NCT04488770|155526922|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363720|NCT04488770|155526923|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363721|NCT04488770|155526924|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363722|NCT04488770|155526925|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363723|NCT04488770|155526926|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363724|NCT04488770|155526927|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363725|NCT04488770|155526928|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363726|NCT04488770|155526929|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363727|NCT04488770|155526930|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
48363728|NCT04488770|155526918|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363729|NCT04488770|155526919|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363730|NCT04488770|155526920|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363731|NCT04488770|155526921|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363732|NCT04488770|155526922|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363733|NCT04488770|155526923|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
48363734|NCT04488770|155526924|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
48363735|NCT04488770|155526925|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363736|NCT04488770|155526926|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363737|NCT04488770|155526927|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363738|NCT04488770|155526928|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363739|NCT04488770|155526929|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363740|NCT04488770|155526930|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
48363741|NCT04488770|155526918|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363742|NCT04488770|155526919|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363743|NCT04488770|155526920|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363744|NCT04488770|155526921|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363745|NCT04488770|155526922|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
48363746|NCT04488770|155526923|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363747|NCT04488770|155526924|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363748|NCT04488770|155526925|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363749|NCT04488770|155526926|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363750|NCT04488770|155526927|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363751|NCT04488770|155526928|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363752|NCT04488770|155526929|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48363753|NCT04488770|155526930|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
48413874|NCT01360996|155703244|FG001|Overall Study|Noncompliant|0|||
48413875|NCT01360996|155703245|FG002|Overall Study|Noncompliant|0|||
48413876|NCT03377634|155703247|FG000|Study Period|Adverse Event|1|||
48413877|NCT03377634|155703248|FG001|Study Period|Adverse Event|0|||
48413878|NCT03377634|155703247|FG000|Study Period|Withdrawal by Subject|1|||
48363754|NCT03361605|155526934|FG000|Overall Study|Analyzable data not available|3|||
48363755|NCT01559129|155526938|FG000|Treatment Phase|Adverse Event|0|||
48363756|NCT01559129|155526939|FG001|Treatment Phase|Adverse Event|2|||
48363757|NCT01559129|155526938|FG000|Treatment Phase|Progressive Disease|1|||
48363758|NCT01559129|155526939|FG001|Treatment Phase|Progressive Disease|1|||
48363759|NCT01559129|155526938|FG000|Treatment Phase|Lack of Efficacy|0|||
48363760|NCT01559129|155526939|FG001|Treatment Phase|Lack of Efficacy|1|||
48363761|NCT01559129|155526938|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
48363762|NCT01559129|155526939|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
48363763|NCT01559129|155526938|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
48363764|NCT01559129|155526939|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
48363765|NCT01559129|155526938|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
48363766|NCT01559129|155526939|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
48363767|NCT01559129|155526938|FG000|Open-label Extension Period|Adverse Event|1|||
48363768|NCT01559129|155526939|FG001|Open-label Extension Period|Adverse Event|0|||
48363769|NCT01559129|155526938|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
48363770|NCT01559129|155526939|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
48363771|NCT04806373|155526940|FG000|Overall Study|Withdrawal by Subject|1|||
48363772|NCT04806373|155526941|FG001|Overall Study|Withdrawal by Subject|1|||
48363773|NCT05269966|155526942|FG000|Overall Study|Adverse Event|4|||
48363774|NCT05269966|155526942|FG000|Overall Study|Withdrawal by Subject|1|||
48363775|NCT05269966|155526942|FG000|Overall Study|Lost to Follow-up|4|||
48363776|NCT05269966|155526942|FG000|Overall Study|Physician Decision|1|||
48363777|NCT01525238|155526947|FG000|Overall Study|Withdrawal by Subject|1|||
48363778|NCT01525238|155526948|FG001|Overall Study|Withdrawal by Subject|0|||
48363779|NCT01525238|155526949|FG002|Overall Study|Withdrawal by Subject|0|||
48363780|NCT03738423|155526950|FG000|Overall Study|Withdrawal by Subject|9|||
48363781|NCT03738423|155526951|FG001|Overall Study|Withdrawal by Subject|12|||
48413879|NCT03377634|155703248|FG001|Study Period|Withdrawal by Subject|0|||
48413880|NCT00977470|155703251|FG000|Overall Study|Lack of Efficacy|32|||
48413881|NCT00977470|155703252|FG001|Overall Study|Lack of Efficacy|30|||
48413882|NCT00977470|155703251|FG000|Overall Study|Physician Decision|2|||
48413883|NCT00977470|155703252|FG001|Overall Study|Physician Decision|0|||
48413884|NCT00977470|155703251|FG000|Overall Study|Adverse Event|1|||
48413885|NCT00977470|155703252|FG001|Overall Study|Adverse Event|2|||
48413886|NCT00977470|155703251|FG000|Overall Study|Protocol Violation|1|||
48413887|NCT00977470|155703252|FG001|Overall Study|Protocol Violation|0|||
48413888|NCT00977470|155703251|FG000|Overall Study|Withdrawal by Subject|0|||
48413889|NCT00977470|155703252|FG001|Overall Study|Withdrawal by Subject|2|||
48413890|NCT00977470|155703251|FG000|Overall Study|Death|0|||
48413891|NCT00977470|155703252|FG001|Overall Study|Death|2|||
48413892|NCT00977470|155703251|FG000|Overall Study|clinical decline|0|||
48363782|NCT03738423|155526952|FG002|Overall Study|Withdrawal by Subject|9|||
48363783|NCT03738423|155526953|FG003|Overall Study|Withdrawal by Subject|12|||
48363784|NCT03738423|155526954|FG004|Overall Study|Withdrawal by Subject|10|||
48363785|NCT03738423|155526950|FG000|Overall Study|Lack of Efficacy|3|||
48363786|NCT03738423|155526951|FG001|Overall Study|Lack of Efficacy|1|||
48363787|NCT03738423|155526952|FG002|Overall Study|Lack of Efficacy|1|||
48363788|NCT03738423|155526953|FG003|Overall Study|Lack of Efficacy|1|||
48363789|NCT03738423|155526954|FG004|Overall Study|Lack of Efficacy|2|||
48363790|NCT03738423|155526950|FG000|Overall Study|Lost to Follow-up|1|||
48363791|NCT03738423|155526951|FG001|Overall Study|Lost to Follow-up|0|||
48363792|NCT03738423|155526952|FG002|Overall Study|Lost to Follow-up|1|||
48363793|NCT03738423|155526953|FG003|Overall Study|Lost to Follow-up|1|||
48363794|NCT03738423|155526954|FG004|Overall Study|Lost to Follow-up|0|||
48363795|NCT03738423|155526950|FG000|Overall Study|Protocol Violation|1|||
48363796|NCT03738423|155526951|FG001|Overall Study|Protocol Violation|0|||
48363797|NCT03738423|155526952|FG002|Overall Study|Protocol Violation|0|||
48363798|NCT03738423|155526953|FG003|Overall Study|Protocol Violation|0|||
48363799|NCT03738423|155526954|FG004|Overall Study|Protocol Violation|1|||
48363800|NCT03738423|155526950|FG000|Overall Study|Physician Decision|0|||
48363801|NCT03738423|155526951|FG001|Overall Study|Physician Decision|0|||
48413893|NCT00977470|155703252|FG001|Overall Study|clinical decline|1|||
48413894|NCT00977470|155703251|FG000|Overall Study|prolonged recovery post-surgery|0|||
48413895|NCT00977470|155703252|FG001|Overall Study|prolonged recovery post-surgery|1|||
48413896|NCT00977470|155703251|FG000|Overall Study|Still on-study|2|||
48413897|NCT00977470|155703252|FG001|Overall Study|Still on-study|0|||
48363802|NCT03738423|155526952|FG002|Overall Study|Physician Decision|1|||
48363803|NCT03738423|155526953|FG003|Overall Study|Physician Decision|0|||
48363804|NCT03738423|155526954|FG004|Overall Study|Physician Decision|1|||
48363805|NCT03738423|155526950|FG000|Overall Study|Death|0|||
48363806|NCT03738423|155526951|FG001|Overall Study|Death|0|||
48363807|NCT03738423|155526952|FG002|Overall Study|Death|0|||
48363808|NCT03738423|155526953|FG003|Overall Study|Death|0|||
48413898|NCT02635204|155703253|FG000|Overall Study|Adverse Event|1|||
48413899|NCT02635204|155703254|FG001|Overall Study|Adverse Event|0|||
48413900|NCT02635204|155703253|FG000|Overall Study|Lost to Follow-up|1|||
48413901|NCT02635204|155703254|FG001|Overall Study|Lost to Follow-up|1|||
48413902|NCT01145560|155703256|FG000|Overall Study|Withdrawal by Subject|2|||
48413903|NCT01145560|155703257|FG001|Overall Study|Withdrawal by Subject|1|||
48413904|NCT01145560|155703258|FG002|Overall Study|Withdrawal by Subject|0|||
48413905|NCT01145560|155703256|FG000|Overall Study|Lost to Follow-up|1|||
48413906|NCT01145560|155703257|FG001|Overall Study|Lost to Follow-up|1|||
48413907|NCT01145560|155703258|FG002|Overall Study|Lost to Follow-up|1|||
48413908|NCT01145560|155703256|FG000|Overall Study|No study drug by 24h after organ failure|1|||
48413909|NCT01145560|155703257|FG001|Overall Study|No study drug by 24h after organ failure|0|||
48363809|NCT03738423|155526954|FG004|Overall Study|Death|1|||
48363810|NCT03738423|155526950|FG000|Overall Study|Randomized but never treated|0|||
48363811|NCT03738423|155526951|FG001|Overall Study|Randomized but never treated|0|||
48363812|NCT03738423|155526952|FG002|Overall Study|Randomized but never treated|1|||
48363813|NCT03738423|155526953|FG003|Overall Study|Randomized but never treated|1|||
48363814|NCT03738423|155526954|FG004|Overall Study|Randomized but never treated|0|||
48363815|NCT01370590|155526955|FG000|Period 1|Adverse Event|8|||
48413910|NCT01145560|155703258|FG002|Overall Study|No study drug by 24h after organ failure|0|||
48413911|NCT01145560|155703256|FG000|Overall Study|Accidental unblinding of study treatment|0|||
48413912|NCT01145560|155703257|FG001|Overall Study|Accidental unblinding of study treatment|1|||
48413913|NCT01145560|155703258|FG002|Overall Study|Accidental unblinding of study treatment|0|||
48413914|NCT01145560|155703256|FG000|Overall Study|False insurance information|0|||
48413915|NCT01145560|155703257|FG001|Overall Study|False insurance information|1|||
48413916|NCT01145560|155703258|FG002|Overall Study|False insurance information|0|||
48413917|NCT01145560|155703256|FG000|Overall Study|Withdrawal of therapy|0|||
48413918|NCT01145560|155703257|FG001|Overall Study|Withdrawal of therapy|0|||
48413919|NCT01145560|155703258|FG002|Overall Study|Withdrawal of therapy|1|||
48413920|NCT00424398|155703267|FG000|Overall Study|Withdrawal by Subject|2|||
48413921|NCT00424398|155703268|FG001|Overall Study|Withdrawal by Subject|1|||
48413922|NCT00424398|155703269|FG002|Overall Study|Withdrawal by Subject|0|||
48413923|NCT00424398|155703267|FG000|Overall Study|Subject met exclusion criteria|1|||
48413924|NCT00424398|155703268|FG001|Overall Study|Subject met exclusion criteria|0|||
48413925|NCT00424398|155703269|FG002|Overall Study|Subject met exclusion criteria|0|||
48413926|NCT04672083|155703270|FG000|Overall Study|Lost to Follow-up|1|||
48413927|NCT04672083|155703271|FG001|Overall Study|Lost to Follow-up|0|||
48413928|NCT04672083|155703272|FG002|Overall Study|Lost to Follow-up|0|||
48413929|NCT04672083|155703273|FG003|Overall Study|Lost to Follow-up|0|||
48413930|NCT04672083|155703274|FG004|Overall Study|Lost to Follow-up|0|||
48413931|NCT00855439|155703277|FG000|Overall Study|Withdrawal by Subject|2|||
48413932|NCT00855439|155703278|FG001|Overall Study|Withdrawal by Subject|0|||
48413933|NCT00855439|155703277|FG000|Overall Study|Pregnancy|1|||
48413934|NCT00855439|155703278|FG001|Overall Study|Pregnancy|0|||
48413935|NCT00144170|155703281|FG000|Overall Study|Adverse Event|84|||
48413936|NCT00144170|155703282|FG001|Overall Study|Adverse Event|41|||
48413937|NCT00144170|155703281|FG000|Overall Study|Protocol Violation|23|||
48413938|NCT00144170|155703282|FG001|Overall Study|Protocol Violation|16|||
48413939|NCT00144170|155703281|FG000|Overall Study|Lost to Follow-up|5|||
48413940|NCT00144170|155703282|FG001|Overall Study|Lost to Follow-up|10|||
48413941|NCT00144170|155703281|FG000|Overall Study|Withdrawal by Subject|29|||
48413942|NCT00144170|155703282|FG001|Overall Study|Withdrawal by Subject|13|||
48413943|NCT00144170|155703281|FG000|Overall Study|Other reason not defined above|211|||
48413944|NCT00144170|155703282|FG001|Overall Study|Other reason not defined above|316|||
48413945|NCT00332202|155703283|FG000|Overall Study|Adverse Event|72|||
48413946|NCT00332202|155703284|FG001|Overall Study|Adverse Event|28|||
48413947|NCT00332202|155703283|FG000|Overall Study|Lost to Follow-up|2|||
48413948|NCT00332202|155703284|FG001|Overall Study|Lost to Follow-up|1|||
48413949|NCT00332202|155703283|FG000|Overall Study|Physician Decision|6|||
48413950|NCT00332202|155703284|FG001|Overall Study|Physician Decision|8|||
48413951|NCT00332202|155703283|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
48413952|NCT00332202|155703284|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
48413953|NCT00332202|155703283|FG000|Overall Study|Protocol Violation|7|||
48413954|NCT00332202|155703284|FG001|Overall Study|Protocol Violation|2|||
48413955|NCT00332202|155703283|FG000|Overall Study|Sponsor Decision|1|||
48363816|NCT01370590|155526956|FG001|Period 1|Adverse Event|4|||
48363817|NCT01370590|155526955|FG000|Period 1|Lost to Follow-up|2|||
48363818|NCT01370590|155526956|FG001|Period 1|Lost to Follow-up|2|||
48363819|NCT01370590|155526955|FG000|Period 1|Protocol Violation|2|||
48363820|NCT01370590|155526956|FG001|Period 1|Protocol Violation|2|||
48413956|NCT00332202|155703284|FG001|Overall Study|Sponsor Decision|2|||
48363821|NCT01370590|155526955|FG000|Period 1|Withdrawal by Subject|4|||
48413957|NCT00332202|155703283|FG000|Overall Study|Withdrawal by Subject|36|||
48413958|NCT00332202|155703284|FG001|Overall Study|Withdrawal by Subject|17|||
48413959|NCT00332202|155703283|FG000|Overall Study|Progressive Disease|106|||
48413960|NCT00332202|155703284|FG001|Overall Study|Progressive Disease|60|||
48413961|NCT00332202|155703283|FG000|Overall Study|Death|5|||
48413962|NCT00332202|155703284|FG001|Overall Study|Death|2|||
48413963|NCT00702143|155703285|FG000|Overall Study|Lost to Follow-up|0|||
48413964|NCT00702143|155703286|FG001|Overall Study|Lost to Follow-up|0|||
48413965|NCT00702143|155703287|FG002|Overall Study|Lost to Follow-up|1|||
48413966|NCT01624142|155703290|FG000|Overall Study|Withdrawal by Subject|14|||
48413967|NCT01624142|155703291|FG001|Overall Study|Withdrawal by Subject|4|||
48413968|NCT01624142|155703290|FG000|Overall Study|Death|3|||
48413969|NCT01624142|155703291|FG001|Overall Study|Death|6|||
48413970|NCT01624142|155703290|FG000|Overall Study|Study Closure|12|||
48413971|NCT01624142|155703291|FG001|Overall Study|Study Closure|6|||
48413972|NCT01624142|155703290|FG000|Overall Study|Lost to Follow-up|2|||
48413973|NCT01624142|155703291|FG001|Overall Study|Lost to Follow-up|0|||
48413974|NCT01624142|155703290|FG000|Overall Study|Other|1|||
48413975|NCT01624142|155703291|FG001|Overall Study|Other|0|||
48413976|NCT01228747|155703292|FG000|Overall Study|Adverse Event|8|||
48413977|NCT01228747|155703293|FG001|Overall Study|Adverse Event|4|||
48413978|NCT01228747|155703292|FG000|Overall Study|Lack of Efficacy|40|||
48413979|NCT01228747|155703293|FG001|Overall Study|Lack of Efficacy|27|||
48413980|NCT01228747|155703292|FG000|Overall Study|Protocol Violation|6|||
48413981|NCT01228747|155703293|FG001|Overall Study|Protocol Violation|5|||
48413982|NCT01228747|155703292|FG000|Overall Study|Lost to Follow-up|4|||
48413983|NCT01228747|155703293|FG001|Overall Study|Lost to Follow-up|3|||
48413984|NCT01228747|155703292|FG000|Overall Study|Withdrawal by Subject|5|||
48363822|NCT01370590|155526956|FG001|Period 1|Withdrawal by Subject|2|||
48363823|NCT01370590|155526955|FG000|Period 1|Could not access randomization system|0|||
48363824|NCT01370590|155526956|FG001|Period 1|Could not access randomization system|1|||
48363825|NCT01370590|155526955|FG000|Crossover Washout Period|Adverse Event|1|||
48363826|NCT01370590|155526956|FG001|Crossover Washout Period|Adverse Event|4|||
48363827|NCT01370590|155526955|FG000|Crossover Washout Period|Lost to Follow-up|2|||
48363828|NCT01370590|155526956|FG001|Crossover Washout Period|Lost to Follow-up|0|||
48363829|NCT01370590|155526955|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
48363830|NCT01370590|155526956|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
48363831|NCT01370590|155526955|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
48363832|NCT01370590|155526956|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
48363833|NCT01370590|155526955|FG000|Period 2|Adverse Event|0|||
48363834|NCT01370590|155526956|FG001|Period 2|Adverse Event|1|||
48363835|NCT01370590|155526955|FG000|Period 2|Withdrawal by Subject|1|||
48363836|NCT01370590|155526956|FG001|Period 2|Withdrawal by Subject|1|||
48363837|NCT05172050|155526957|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
48363838|NCT05172050|155526958|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
48363839|NCT05172050|155526959|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
48363840|NCT05172050|155526957|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
48363841|NCT05172050|155526958|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
48363842|NCT05172050|155526959|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
48363843|NCT05172050|155526957|FG000|Overall Study|Other|2|||
48363844|NCT05172050|155526958|FG001|Overall Study|Other|2|||
48363845|NCT05172050|155526959|FG002|Overall Study|Other|1|||
48363846|NCT00867308|155526966|FG000|Overall Study|Death|1|||
48363847|NCT00867308|155526967|FG001|Overall Study|Death|0|||
48363848|NCT00867308|155526966|FG000|Overall Study|Adverse Event|1|||
48363849|NCT00867308|155526967|FG001|Overall Study|Adverse Event|4|||
48363850|NCT00867308|155526966|FG000|Overall Study|Lack of Efficacy|6|||
48363851|NCT00867308|155526967|FG001|Overall Study|Lack of Efficacy|12|||
48363852|NCT00867308|155526966|FG000|Overall Study|Withdrawal by Subject|1|||
48363853|NCT00867308|155526967|FG001|Overall Study|Withdrawal by Subject|2|||
48363854|NCT00604825|155526968|FG000|Overall Study|Adverse Event|2|||
48363855|NCT00604825|155526969|FG001|Overall Study|Adverse Event|6|||
48363856|NCT00604825|155526970|FG002|Overall Study|Adverse Event|7|||
48363857|NCT00604825|155526971|FG003|Overall Study|Adverse Event|4|||
48363858|NCT00604825|155526968|FG000|Overall Study|Lost to Follow-up|0|||
48363859|NCT00604825|155526969|FG001|Overall Study|Lost to Follow-up|3|||
48363860|NCT00604825|155526970|FG002|Overall Study|Lost to Follow-up|1|||
48363861|NCT00604825|155526971|FG003|Overall Study|Lost to Follow-up|0|||
48363862|NCT00604825|155526968|FG000|Overall Study|Protocol Violation|0|||
48363863|NCT00604825|155526969|FG001|Overall Study|Protocol Violation|1|||
48363864|NCT00604825|155526970|FG002|Overall Study|Protocol Violation|0|||
48363865|NCT00604825|155526971|FG003|Overall Study|Protocol Violation|0|||
48363866|NCT00604825|155526968|FG000|Overall Study|Withdrawal by Subject|4|||
48363867|NCT00604825|155526969|FG001|Overall Study|Withdrawal by Subject|3|||
48363868|NCT00604825|155526970|FG002|Overall Study|Withdrawal by Subject|5|||
48363869|NCT00604825|155526971|FG003|Overall Study|Withdrawal by Subject|5|||
48363870|NCT00604825|155526968|FG000|Overall Study|Lack of Efficacy|3|||
48363871|NCT00604825|155526969|FG001|Overall Study|Lack of Efficacy|2|||
48363872|NCT00604825|155526970|FG002|Overall Study|Lack of Efficacy|1|||
48363873|NCT00604825|155526971|FG003|Overall Study|Lack of Efficacy|0|||
48363874|NCT00604825|155526968|FG000|Overall Study|Did not meet eligibility criteria|0|||
48413985|NCT01228747|155703293|FG001|Overall Study|Withdrawal by Subject|1|||
48413986|NCT01228747|155703292|FG000|Overall Study|Other Reason|2|||
48413987|NCT01228747|155703293|FG001|Overall Study|Other Reason|5|||
48413988|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
48413989|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
48413990|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
48363875|NCT00604825|155526969|FG001|Overall Study|Did not meet eligibility criteria|0|||
48363876|NCT00604825|155526970|FG002|Overall Study|Did not meet eligibility criteria|2|||
48363877|NCT00604825|155526971|FG003|Overall Study|Did not meet eligibility criteria|0|||
48363878|NCT00604825|155526968|FG000|Overall Study|Physician Decision|0|||
48363879|NCT00604825|155526969|FG001|Overall Study|Physician Decision|0|||
48363880|NCT00604825|155526970|FG002|Overall Study|Physician Decision|0|||
48363881|NCT00604825|155526971|FG003|Overall Study|Physician Decision|1|||
48363882|NCT00604825|155526968|FG000|Overall Study|Exclusion criterion met|0|||
48363883|NCT00604825|155526969|FG001|Overall Study|Exclusion criterion met|0|||
48363884|NCT00604825|155526970|FG002|Overall Study|Exclusion criterion met|0|||
48363885|NCT00604825|155526971|FG003|Overall Study|Exclusion criterion met|1|||
48363886|NCT04617275|155526972|FG000|Treatment Period|Adverse Event|1|||
48363887|NCT04617275|155526973|FG001|Treatment Period|Adverse Event|6|||
48363888|NCT04617275|155526974|FG002|Treatment Period|Adverse Event|4|||
48363889|NCT04617275|155526975|FG003|Treatment Period|Adverse Event|6|||
48363890|NCT04617275|155526976|FG004|Treatment Period|Adverse Event|7|||
48363891|NCT04617275|155526977|FG005|Treatment Period|Adverse Event|8|||
48363892|NCT04617275|155526978|FG006|Treatment Period|Adverse Event|0|||
48363893|NCT04617275|155526979|FG007|Treatment Period|Adverse Event|12|||
48363894|NCT04617275|155526972|FG000|Treatment Period|Lost to Follow-up|0|||
48363895|NCT04617275|155526973|FG001|Treatment Period|Lost to Follow-up|0|||
48363896|NCT04617275|155526974|FG002|Treatment Period|Lost to Follow-up|2|||
48363897|NCT04617275|155526975|FG003|Treatment Period|Lost to Follow-up|0|||
48363898|NCT04617275|155526976|FG004|Treatment Period|Lost to Follow-up|0|||
48363899|NCT04617275|155526977|FG005|Treatment Period|Lost to Follow-up|3|||
48363900|NCT04617275|155526978|FG006|Treatment Period|Lost to Follow-up|0|||
48363901|NCT04617275|155526979|FG007|Treatment Period|Lost to Follow-up|2|||
48363902|NCT04617275|155526972|FG000|Treatment Period|No longer meets eligibility criteria|0|||
48363903|NCT04617275|155526973|FG001|Treatment Period|No longer meets eligibility criteria|0|||
48363904|NCT04617275|155526974|FG002|Treatment Period|No longer meets eligibility criteria|0|||
48363905|NCT04617275|155526975|FG003|Treatment Period|No longer meets eligibility criteria|1|||
48363906|NCT04617275|155526976|FG004|Treatment Period|No longer meets eligibility criteria|0|||
48363907|NCT04617275|155526977|FG005|Treatment Period|No longer meets eligibility criteria|0|||
48363908|NCT04617275|155526978|FG006|Treatment Period|No longer meets eligibility criteria|0|||
48363909|NCT04617275|155526979|FG007|Treatment Period|No longer meets eligibility criteria|0|||
48363910|NCT04617275|155526972|FG000|Treatment Period|Other|0|||
48363911|NCT04617275|155526973|FG001|Treatment Period|Other|1|||
48363912|NCT04617275|155526974|FG002|Treatment Period|Other|0|||
48363913|NCT04617275|155526975|FG003|Treatment Period|Other|0|||
48363914|NCT04617275|155526976|FG004|Treatment Period|Other|0|||
48363915|NCT04617275|155526977|FG005|Treatment Period|Other|0|||
48363916|NCT04617275|155526978|FG006|Treatment Period|Other|0|||
48363917|NCT04617275|155526979|FG007|Treatment Period|Other|0|||
48363918|NCT04617275|155526972|FG000|Treatment Period|Withdrawal by Subject|2|||
48363919|NCT04617275|155526973|FG001|Treatment Period|Withdrawal by Subject|0|||
48363920|NCT04617275|155526974|FG002|Treatment Period|Withdrawal by Subject|0|||
48363921|NCT04617275|155526975|FG003|Treatment Period|Withdrawal by Subject|2|||
48363922|NCT04617275|155526976|FG004|Treatment Period|Withdrawal by Subject|2|||
48363923|NCT04617275|155526977|FG005|Treatment Period|Withdrawal by Subject|0|||
48363924|NCT04617275|155526978|FG006|Treatment Period|Withdrawal by Subject|1|||
48363925|NCT04617275|155526979|FG007|Treatment Period|Withdrawal by Subject|2|||
48363926|NCT04617275|155526972|FG000|Follow-up Period|Adverse Event|1|||
48363927|NCT04617275|155526973|FG001|Follow-up Period|Adverse Event|1|||
48363928|NCT04617275|155526974|FG002|Follow-up Period|Adverse Event|2|||
48363929|NCT04617275|155526975|FG003|Follow-up Period|Adverse Event|3|||
48363930|NCT04617275|155526976|FG004|Follow-up Period|Adverse Event|4|||
48363931|NCT04617275|155526977|FG005|Follow-up Period|Adverse Event|3|||
48363932|NCT04617275|155526978|FG006|Follow-up Period|Adverse Event|0|||
48363933|NCT04617275|155526979|FG007|Follow-up Period|Adverse Event|3|||
48363934|NCT04617275|155526972|FG000|Follow-up Period|Lost to Follow-up|0|||
48363935|NCT04617275|155526973|FG001|Follow-up Period|Lost to Follow-up|1|||
48363936|NCT04617275|155526974|FG002|Follow-up Period|Lost to Follow-up|2|||
48363937|NCT04617275|155526975|FG003|Follow-up Period|Lost to Follow-up|0|||
48363938|NCT04617275|155526976|FG004|Follow-up Period|Lost to Follow-up|0|||
48363939|NCT04617275|155526977|FG005|Follow-up Period|Lost to Follow-up|4|||
48363940|NCT04617275|155526978|FG006|Follow-up Period|Lost to Follow-up|0|||
48363941|NCT04617275|155526979|FG007|Follow-up Period|Lost to Follow-up|3|||
48363942|NCT04617275|155526972|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
48363943|NCT04617275|155526973|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
48363944|NCT04617275|155526974|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
48363945|NCT04617275|155526975|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
48363946|NCT04617275|155526976|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
48363947|NCT04617275|155526977|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
48363948|NCT04617275|155526978|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
48363949|NCT04617275|155526979|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
48363950|NCT04617275|155526972|FG000|Follow-up Period|Other|0|||
48363951|NCT04617275|155526973|FG001|Follow-up Period|Other|1|||
48363952|NCT04617275|155526974|FG002|Follow-up Period|Other|0|||
48363953|NCT04617275|155526975|FG003|Follow-up Period|Other|0|||
48363954|NCT04617275|155526976|FG004|Follow-up Period|Other|0|||
48363955|NCT04617275|155526977|FG005|Follow-up Period|Other|0|||
48363956|NCT04617275|155526978|FG006|Follow-up Period|Other|0|||
48363957|NCT04617275|155526979|FG007|Follow-up Period|Other|0|||
48363958|NCT04617275|155526972|FG000|Follow-up Period|Withdrawal by Subject|2|||
48363959|NCT04617275|155526973|FG001|Follow-up Period|Withdrawal by Subject|0|||
48363960|NCT04617275|155526974|FG002|Follow-up Period|Withdrawal by Subject|0|||
48363961|NCT04617275|155526975|FG003|Follow-up Period|Withdrawal by Subject|2|||
48363962|NCT04617275|155526976|FG004|Follow-up Period|Withdrawal by Subject|2|||
48363963|NCT04617275|155526977|FG005|Follow-up Period|Withdrawal by Subject|0|||
48363964|NCT04617275|155526978|FG006|Follow-up Period|Withdrawal by Subject|1|||
48363965|NCT04617275|155526979|FG007|Follow-up Period|Withdrawal by Subject|2|||
48363966|NCT04927884|155526990|FG000|Overall Study|Progressive Disease|2|||
48363967|NCT05618912|155526991|FG000|Overall Study|Lost to Follow-up|14|||
48363968|NCT05618912|155526992|FG001|Overall Study|Lost to Follow-up|19|||
48363969|NCT05038800|155526993|FG000|Overall Study|Death|1|||
48363970|NCT05038800|155526994|FG001|Overall Study|Death|1|||
48363971|NCT05038800|155526995|FG002|Overall Study|Death|5|||
48363972|NCT05038800|155526996|FG003|Overall Study|Death|3|||
48363973|NCT05038800|155526997|FG004|Overall Study|Death|1|||
48363974|NCT05038800|155526993|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48363975|NCT05038800|155526994|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48363976|NCT05038800|155526995|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48363977|NCT05038800|155526996|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
48363978|NCT05038800|155526997|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
48363979|NCT05038800|155526993|FG000|Overall Study|Lack of Efficacy|0|||
48363980|NCT05038800|155526994|FG001|Overall Study|Lack of Efficacy|0|||
48363981|NCT05038800|155526995|FG002|Overall Study|Lack of Efficacy|0|||
48363982|NCT05038800|155526996|FG003|Overall Study|Lack of Efficacy|0|||
48363983|NCT05038800|155526997|FG004|Overall Study|Lack of Efficacy|1|||
48363984|NCT04500769|155528351|FG000|Overall Study|Withdrawal by Subject|5|||
48363985|NCT01006980|155528352|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
48363986|NCT01006980|155528353|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
48363987|NCT01006980|155528352|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
48363988|NCT01006980|155528353|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
48363989|NCT01006980|155528352|FG000|Vemurafenib and Dacarbazine|Death|13|||
48363990|NCT01006980|155528353|FG001|Vemurafenib and Dacarbazine|Death|12|||
48363991|NCT01006980|155528352|FG000|Vemurafenib and Dacarbazine|Progression|257|||
48363992|NCT01006980|155528353|FG001|Vemurafenib and Dacarbazine|Progression|218|||
48363993|NCT01006980|155528352|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
48363994|NCT01006980|155528353|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
48363995|NCT01006980|155528352|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
48363996|NCT01006980|155528353|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
48363997|NCT01006980|155528352|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
48363998|NCT01006980|155528353|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
48363999|NCT01006980|155528352|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
48364000|NCT01006980|155528353|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
48364001|NCT01006980|155528352|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
48364002|NCT01006980|155528353|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
48364003|NCT01006980|155528352|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
48364004|NCT01006980|155528353|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
48364005|NCT01006980|155528352|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
48364006|NCT01006980|155528353|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
48364007|NCT01006980|155528352|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
48364008|NCT01006980|155528353|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
48364009|NCT01006980|155528352|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
48364010|NCT01006980|155528353|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
48364011|NCT04828837|155528361|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
48364012|NCT04828837|155528362|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
48364013|NCT04828837|155528361|FG000|Overall Study|Lost to Follow-up|2|||
48364014|NCT04828837|155528362|FG001|Overall Study|Lost to Follow-up|6|||
48364015|NCT04828837|155528361|FG000|Overall Study|Lack of Efficacy|1|||
48364016|NCT04828837|155528362|FG001|Overall Study|Lack of Efficacy|0|||
48364017|NCT04828837|155528361|FG000|Overall Study|Admitted due to pneumothorax.|1|||
48364018|NCT04828837|155528362|FG001|Overall Study|Admitted due to pneumothorax.|0|||
48364019|NCT04828837|155528361|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
48364020|NCT04828837|155528362|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
48364021|NCT00837694|155528365|FG000|Overall Study|Lost to Follow-up|2|||
48364022|NCT00837694|155528366|FG001|Overall Study|Lost to Follow-up|0|||
48364023|NCT00837694|155528367|FG002|Overall Study|Lost to Follow-up|2|||
48413991|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
48413992|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
48413993|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
48413994|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
48413995|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
48413996|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
48413997|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
48413998|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
48413999|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48414000|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48414001|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48414002|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
48414003|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
48414004|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
48414005|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
48414006|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
48414007|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
48692559|NCT04630262|156724526|FG000|Overall Study|Intraoperative Screen Failure|5|||
48692560|NCT04630262|156724526|FG000|Overall Study|Study terminated prematurely|71|||
48364024|NCT00837694|155528368|FG003|Overall Study|Lost to Follow-up|1|||
48364025|NCT00837694|155528369|FG004|Overall Study|Lost to Follow-up|1|||
48364026|NCT00837694|155528370|FG005|Overall Study|Lost to Follow-up|1|||
48364027|NCT04996004|155528375|FG000|Phase I|Death|1|||
48364028|NCT04996004|155528376|FG001|Phase I|Death|2|||
48364029|NCT04996004|155528377|FG002|Phase I|Death|1|||
48692561|NCT04630262|156724526|FG000|Overall Study|Withdrawal by Subject|2|||
48692562|NCT04630262|156724526|FG000|Overall Study|Physician Decision|2|||
48692563|NCT05101486|156724527|FG000|Overall Study|Death|1|||
48364030|NCT04996004|155528378|FG003|Phase I|Death|0|||
48364031|NCT04996004|155528379|FG004|Phase I|Death|0|||
48364032|NCT04996004|155528380|FG005|Phase I|Death|0|||
48364033|NCT04996004|155528375|FG000|Phase I|Study terminated by sponsor|2|||
48364034|NCT04996004|155528376|FG001|Phase I|Study terminated by sponsor|1|||
48364035|NCT04996004|155528377|FG002|Phase I|Study terminated by sponsor|2|||
48364036|NCT04996004|155528378|FG003|Phase I|Study terminated by sponsor|0|||
48364037|NCT04996004|155528379|FG004|Phase I|Study terminated by sponsor|0|||
48364038|NCT04996004|155528380|FG005|Phase I|Study terminated by sponsor|0|||
48364039|NCT04996004|155528375|FG000|Phase II|Study terminated by sponsor|0|||
48364040|NCT04996004|155528376|FG001|Phase II|Study terminated by sponsor|0|||
48364041|NCT04996004|155528377|FG002|Phase II|Study terminated by sponsor|0|||
48364042|NCT04996004|155528378|FG003|Phase II|Study terminated by sponsor|20|||
48364043|NCT04996004|155528379|FG004|Phase II|Study terminated by sponsor|10|||
48364044|NCT04996004|155528380|FG005|Phase II|Study terminated by sponsor|10|||
48364045|NCT04996004|155528375|FG000|Phase II|Withdrawal by Subject|0|||
48364046|NCT04996004|155528376|FG001|Phase II|Withdrawal by Subject|0|||
48364047|NCT04996004|155528377|FG002|Phase II|Withdrawal by Subject|0|||
48364048|NCT04996004|155528378|FG003|Phase II|Withdrawal by Subject|0|||
48364049|NCT04996004|155528379|FG004|Phase II|Withdrawal by Subject|1|||
48364050|NCT04996004|155528380|FG005|Phase II|Withdrawal by Subject|2|||
48364051|NCT04996004|155528375|FG000|Phase II|Death|0|||
48364052|NCT04996004|155528376|FG001|Phase II|Death|0|||
48364053|NCT04996004|155528377|FG002|Phase II|Death|0|||
48364054|NCT04996004|155528378|FG003|Phase II|Death|12|||
48364055|NCT04996004|155528379|FG004|Phase II|Death|2|||
48364056|NCT04996004|155528380|FG005|Phase II|Death|9|||
48364057|NCT04996004|155528375|FG000|Phase II|Other|0|||
48364058|NCT04996004|155528376|FG001|Phase II|Other|0|||
48364059|NCT04996004|155528377|FG002|Phase II|Other|0|||
48364060|NCT04996004|155528378|FG003|Phase II|Other|0|||
48364061|NCT04996004|155528379|FG004|Phase II|Other|0|||
48364062|NCT04996004|155528380|FG005|Phase II|Other|1|||
48364063|NCT05110690|155528381|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
48364064|NCT05110690|155528381|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
48364065|NCT05110690|155528381|FG000|Completion of Intervention|Lost to Follow-up|1|||
48364066|NCT05110690|155528381|FG000|Completion of Intervention|Death|1|||
48364067|NCT05110690|155528381|FG000|Completion of Intervention|Withdrawal by Subject|2|||
48364068|NCT01638429|155528387|FG000|Overall Study|Withdrawal by Subject|1|||
48364069|NCT03889704|155528388|FG000|Overall Study|Study terminated due to pandemic|1|||
48692564|NCT05101486|156724528|FG001|Overall Study|Death|0|||
48364070|NCT02060370|155528389|FG000|Overall Study|Physician Decision|1|||
48364071|NCT03377699|155528392|FG000|Overall Study|Withdrawal by Subject|2|||
48364072|NCT03377699|155528393|FG001|Overall Study|Withdrawal by Subject|9|||
48364073|NCT03377699|155528392|FG000|Overall Study|Lost to Follow-up|1|||
48364074|NCT03377699|155528393|FG001|Overall Study|Lost to Follow-up|1|||
48364075|NCT03377699|155528392|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
48364076|NCT03377699|155528393|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
48692565|NCT05101486|156724529|FG002|Overall Study|Death|1|||
48692566|NCT05101486|156724527|FG000|Overall Study|Lost to Follow-up|12|||
48692567|NCT05101486|156724528|FG001|Overall Study|Lost to Follow-up|8|||
48692568|NCT05101486|156724529|FG002|Overall Study|Lost to Follow-up|17|||
48692569|NCT05101486|156724527|FG000|Overall Study|Physician Decision|1|||
48692570|NCT05101486|156724528|FG001|Overall Study|Physician Decision|0|||
48692571|NCT05101486|156724529|FG002|Overall Study|Physician Decision|0|||
48692572|NCT05101486|156724527|FG000|Overall Study|Protocol Violation|0|||
48692573|NCT05101486|156724528|FG001|Overall Study|Protocol Violation|0|||
48692574|NCT05101486|156724529|FG002|Overall Study|Protocol Violation|1|||
48692575|NCT05101486|156724527|FG000|Overall Study|Withdrawal by Subject|5|||
48692576|NCT05101486|156724528|FG001|Overall Study|Withdrawal by Subject|2|||
48692577|NCT05101486|156724529|FG002|Overall Study|Withdrawal by Subject|4|||
48692578|NCT05101486|156724527|FG000|Overall Study|Randomized but not vaccinated|1|||
48692579|NCT05101486|156724528|FG001|Overall Study|Randomized but not vaccinated|1|||
48692580|NCT05101486|156724529|FG002|Overall Study|Randomized but not vaccinated|1|||
48692581|NCT04349891|156724531|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
48692582|NCT04349891|156724532|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
48692583|NCT04349891|156724531|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
48692584|NCT04349891|156724532|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
48692585|NCT04349891|156724531|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
48692586|NCT04349891|156724532|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
48692587|NCT04349891|156724531|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
48692588|NCT04349891|156724532|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
48692589|NCT02727699|156724533|FG000|Overall Study|Adverse Event|2|||
48692590|NCT02727699|156724534|FG001|Overall Study|Adverse Event|0|||
48692591|NCT02727699|156724533|FG000|Overall Study|Withdrawal by Subject|5|||
48692592|NCT02727699|156724534|FG001|Overall Study|Withdrawal by Subject|3|||
48364077|NCT03377699|155528392|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
48364078|NCT03377699|155528393|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
48364079|NCT03377699|155528392|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
48364080|NCT03377699|155528393|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
48364081|NCT03377699|155528392|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
48414008|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Death|0|||
48414009|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Death|1|||
48414010|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Death|0|||
48414011|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Death|0|||
48414012|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Death|0|||
48414013|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
48414014|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
48414015|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
48414016|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
48414017|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
48414018|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
48364082|NCT03377699|155528393|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
48364083|NCT03248882|155528394|FG000|Overall Study|Adverse Event|3|||
48364084|NCT03248882|155528395|FG001|Overall Study|Adverse Event|3|||
48364085|NCT03248882|155528396|FG002|Overall Study|Adverse Event|2|||
48364086|NCT03248882|155528397|FG003|Overall Study|Adverse Event|6|||
48364087|NCT03248882|155528398|FG004|Overall Study|Adverse Event|9|||
48364088|NCT03248882|155528394|FG000|Overall Study|Lost to Follow-up|0|||
48364089|NCT03248882|155528395|FG001|Overall Study|Lost to Follow-up|0|||
48364090|NCT03248882|155528396|FG002|Overall Study|Lost to Follow-up|0|||
48364091|NCT03248882|155528397|FG003|Overall Study|Lost to Follow-up|0|||
48364092|NCT03248882|155528398|FG004|Overall Study|Lost to Follow-up|1|||
48364093|NCT03248882|155528394|FG000|Overall Study|Protocol Violation|2|||
48364094|NCT03248882|155528395|FG001|Overall Study|Protocol Violation|0|||
48364095|NCT03248882|155528396|FG002|Overall Study|Protocol Violation|2|||
48364096|NCT03248882|155528397|FG003|Overall Study|Protocol Violation|0|||
48414019|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
48414020|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
48414021|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
48414022|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
48414023|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
48414024|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
48414025|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
48414026|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
48431458|NCT00002663|155767273|FG009|Overall Study|Adverse Event|0|||
48692593|NCT02727699|156724533|FG000|Overall Study|Protocol Violation|0|||
48692594|NCT02727699|156724534|FG001|Overall Study|Protocol Violation|1|||
48692595|NCT02727699|156724533|FG000|Overall Study|Physician Decision|0|||
48414027|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
48414028|NCT05087030|155703294|FG000|Main Period (Week 0 to Week 52)|Other|1|||
48414029|NCT05087030|155703295|FG001|Main Period (Week 0 to Week 52)|Other|2|||
48414030|NCT05087030|155703296|FG002|Main Period (Week 0 to Week 52)|Other|0|||
48414031|NCT05087030|155703297|FG003|Main Period (Week 0 to Week 52)|Other|0|||
48414032|NCT05087030|155703298|FG004|Main Period (Week 0 to Week 52)|Other|0|||
48414033|NCT05087030|155703294|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48414034|NCT05087030|155703295|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48414035|NCT05087030|155703296|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48414036|NCT05087030|155703297|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
48414037|NCT05087030|155703298|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
48414038|NCT01914679|155703300|FG000|Overall Study|Lack of Efficacy|1|||
48414039|NCT01914679|155703300|FG000|Overall Study|Sponsor terminated study|4|||
48414040|NCT02722044|155703303|FG000|Overall Study|Adverse Event|2|||
48414041|NCT02722044|155703303|FG000|Overall Study|Physician Decision|1|||
48414042|NCT02722044|155703303|FG000|Overall Study|Withdrawal by Subject|1|||
48414043|NCT02722044|155703303|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
48414044|NCT01708057|155703306|FG000|Overall Study|Withdrawal due to study termination.|1|||
48414045|NCT01708057|155703307|FG001|Overall Study|Withdrawal due to study termination.|1|||
48414046|NCT01708057|155703308|FG002|Overall Study|Withdrawal due to study termination.|1|||
48414047|NCT00628355|155703310|FG000|Overall Study|Withdrawal by Subject|1|||
48414048|NCT00628355|155703311|FG001|Overall Study|Withdrawal by Subject|1|||
48414049|NCT02370121|155703314|FG000|Overall Study|Lost to Follow-up|1|||
48414050|NCT02370121|155703315|FG001|Overall Study|Lost to Follow-up|1|||
48414051|NCT05900115|155705431|FG000|Overall Study|Lost to Follow-up|129|||
48414052|NCT05900115|155705432|FG001|Overall Study|Lost to Follow-up|98|||
48414053|NCT02689492|155705433|FG000|Overall Study|Lost to Follow-up|61|||
48414054|NCT02689492|155705433|FG000|Overall Study|Withdrawal by Subject|11|||
48414055|NCT02689492|155705433|FG000|Overall Study|Death|9|||
48414056|NCT02689492|155705433|FG000|Overall Study|Physician Decision|2|||
48414057|NCT02689492|155705433|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
48414058|NCT02689492|155705433|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
48414059|NCT02689492|155705433|FG000|Overall Study|Other than listed|1|||
48414060|NCT01431287|155705434|FG000|Overall Study|not treated|0|||
48414061|NCT01431287|155705435|FG001|Overall Study|not treated|0|||
48414062|NCT01431287|155705436|FG002|Overall Study|not treated|1|||
48414063|NCT01431287|155705437|FG003|Overall Study|not treated|0|||
48414064|NCT01431287|155705438|FG004|Overall Study|not treated|0|||
48414065|NCT01431287|155705434|FG000|Overall Study|Adverse Event|59|||
48414066|NCT01431287|155705435|FG001|Overall Study|Adverse Event|57|||
48414067|NCT01431287|155705436|FG002|Overall Study|Adverse Event|53|||
48414068|NCT01431287|155705437|FG003|Overall Study|Adverse Event|33|||
48414069|NCT01431287|155705438|FG004|Overall Study|Adverse Event|41|||
48414070|NCT01431287|155705434|FG000|Overall Study|Non compliant with protocol|6|||
48414071|NCT01431287|155705435|FG001|Overall Study|Non compliant with protocol|6|||
48414072|NCT01431287|155705436|FG002|Overall Study|Non compliant with protocol|5|||
48414073|NCT01431287|155705437|FG003|Overall Study|Non compliant with protocol|6|||
48414074|NCT01431287|155705438|FG004|Overall Study|Non compliant with protocol|5|||
48414075|NCT01431287|155705434|FG000|Overall Study|Lost to Follow-up|0|||
48414076|NCT01431287|155705435|FG001|Overall Study|Lost to Follow-up|3|||
48414077|NCT01431287|155705436|FG002|Overall Study|Lost to Follow-up|2|||
48414078|NCT01431287|155705437|FG003|Overall Study|Lost to Follow-up|3|||
48414079|NCT01431287|155705438|FG004|Overall Study|Lost to Follow-up|1|||
48414080|NCT01431287|155705434|FG000|Overall Study|Consent withdrawn not due to AE|29|||
48414081|NCT01431287|155705435|FG001|Overall Study|Consent withdrawn not due to AE|30|||
48414082|NCT01431287|155705436|FG002|Overall Study|Consent withdrawn not due to AE|34|||
48414083|NCT01431287|155705437|FG003|Overall Study|Consent withdrawn not due to AE|19|||
48414084|NCT01431287|155705438|FG004|Overall Study|Consent withdrawn not due to AE|29|||
48414085|NCT01431287|155705434|FG000|Overall Study|not stated above|4|||
48414086|NCT01431287|155705435|FG001|Overall Study|not stated above|2|||
48414087|NCT01431287|155705436|FG002|Overall Study|not stated above|2|||
48414088|NCT01431287|155705437|FG003|Overall Study|not stated above|2|||
48414089|NCT01431287|155705438|FG004|Overall Study|not stated above|1|||
48414090|NCT02029976|155705439|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
48414091|NCT02029976|155705440|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
48692596|NCT02727699|156724534|FG001|Overall Study|Physician Decision|1|||
48692597|NCT02727699|156724533|FG000|Overall Study|Lost to Follow-up|1|||
48692598|NCT02727699|156724534|FG001|Overall Study|Lost to Follow-up|0|||
48692599|NCT02727699|156724533|FG000|Overall Study|Sponsor Decision|1|||
48692600|NCT02727699|156724534|FG001|Overall Study|Sponsor Decision|0|||
48692601|NCT04034251|156724535|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
48692602|NCT04034251|156724536|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
48692603|NCT04034251|156724537|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
48364097|NCT03248882|155528398|FG004|Overall Study|Protocol Violation|1|||
48364098|NCT03248882|155528394|FG000|Overall Study|Withdrawal by Subject|2|||
48364099|NCT03248882|155528395|FG001|Overall Study|Withdrawal by Subject|2|||
48364100|NCT03248882|155528396|FG002|Overall Study|Withdrawal by Subject|3|||
48364101|NCT03248882|155528397|FG003|Overall Study|Withdrawal by Subject|4|||
48364102|NCT03248882|155528398|FG004|Overall Study|Withdrawal by Subject|2|||
48364103|NCT02182947|155528399|FG000|Overall Study|Withdrawal by Subject|7|||
48364104|NCT02182947|155528399|FG000|Overall Study|Lost to Follow-up|3|||
48364105|NCT02182947|155528399|FG000|Overall Study|Failed screening activities|8|||
48364106|NCT02030002|155528400|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
48364107|NCT02030002|155528400|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
48364108|NCT02030002|155528400|FG000|Follow-up|Lost to Follow-up|2|||
48364109|NCT01598662|155528401|FG000|Overall Study|Lost to Follow-up|10|||
48364110|NCT01598662|155528402|FG001|Overall Study|Lost to Follow-up|17|||
48364111|NCT01598662|155528401|FG000|Overall Study|Physician Decision|1|||
48364112|NCT01598662|155528402|FG001|Overall Study|Physician Decision|2|||
48364113|NCT01598662|155528401|FG000|Overall Study|IUD expelled before month 6|0|||
48364114|NCT01598662|155528402|FG001|Overall Study|IUD expelled before month 6|2|||
48364115|NCT01399697|155528404|FG000|Overall Study|Adverse Event|13|||
48364116|NCT01399697|155528405|FG001|Overall Study|Adverse Event|3|||
48364117|NCT01399697|155528406|FG002|Overall Study|Adverse Event|1|||
48364118|NCT01399697|155528404|FG000|Overall Study|Lost to Follow-up|2|||
48364119|NCT01399697|155528405|FG001|Overall Study|Lost to Follow-up|0|||
48364120|NCT01399697|155528406|FG002|Overall Study|Lost to Follow-up|0|||
48364121|NCT01399697|155528404|FG000|Overall Study|Withdrawal by Subject|8|||
48364122|NCT01399697|155528405|FG001|Overall Study|Withdrawal by Subject|0|||
48364123|NCT01399697|155528406|FG002|Overall Study|Withdrawal by Subject|0|||
48364124|NCT01399697|155528404|FG000|Overall Study|Investigator Decisión|1|||
48364125|NCT01399697|155528405|FG001|Overall Study|Investigator Decisión|0|||
48364126|NCT01399697|155528406|FG002|Overall Study|Investigator Decisión|2|||
48364127|NCT01399697|155528404|FG000|Overall Study|Lack of Efficacy|9|||
48364128|NCT01399697|155528405|FG001|Overall Study|Lack of Efficacy|0|||
48364129|NCT01399697|155528406|FG002|Overall Study|Lack of Efficacy|1|||
48364130|NCT01399697|155528404|FG000|Overall Study|Protocol Violation|2|||
48364131|NCT01399697|155528405|FG001|Overall Study|Protocol Violation|0|||
48364132|NCT01399697|155528406|FG002|Overall Study|Protocol Violation|0|||
48364133|NCT01399697|155528404|FG000|Overall Study|Non-Compliant|1|||
48364134|NCT01399697|155528405|FG001|Overall Study|Non-Compliant|0|||
48364135|NCT01399697|155528406|FG002|Overall Study|Non-Compliant|0|||
48364136|NCT01399697|155528404|FG000|Overall Study|Inclusion Error|2|||
48364137|NCT01399697|155528405|FG001|Overall Study|Inclusion Error|0|||
48364138|NCT01399697|155528406|FG002|Overall Study|Inclusion Error|0|||
48364139|NCT01399697|155528404|FG000|Overall Study|Positive result for hepatitis B|1|||
48364140|NCT01399697|155528405|FG001|Overall Study|Positive result for hepatitis B|0|||
48364141|NCT01399697|155528406|FG002|Overall Study|Positive result for hepatitis B|0|||
48364142|NCT01399697|155528404|FG000|Overall Study|Clinical RA remission|1|||
48364143|NCT01399697|155528405|FG001|Overall Study|Clinical RA remission|0|||
48364144|NCT01399697|155528406|FG002|Overall Study|Clinical RA remission|0|||
48364145|NCT01399697|155528404|FG000|Overall Study|Sponsor Decision|1|||
48364146|NCT01399697|155528405|FG001|Overall Study|Sponsor Decision|0|||
48364147|NCT01399697|155528406|FG002|Overall Study|Sponsor Decision|0|||
48364148|NCT03435692|155528409|FG000|Overall Study|Lack of Efficacy|2|||
48364149|NCT03435692|155528410|FG001|Overall Study|Lack of Efficacy|2|||
48364150|NCT03435692|155528411|FG002|Overall Study|Lack of Efficacy|0|||
48364151|NCT03231800|155528412|FG000|Overall Study|Lost to Follow-up|0|||
48364152|NCT03231800|155528413|FG001|Overall Study|Lost to Follow-up|2|||
48364153|NCT03231800|155528412|FG000|Overall Study|Protocol Violation|1|||
48364154|NCT03231800|155528413|FG001|Overall Study|Protocol Violation|1|||
48364155|NCT03231800|155528412|FG000|Overall Study|reason not provided|2|||
48364156|NCT03231800|155528413|FG001|Overall Study|reason not provided|0|||
48364157|NCT00859222|155528414|FG000|Overall Study|Adverse Event|2|||
48364158|NCT00859222|155528415|FG001|Overall Study|Adverse Event|3|||
48364159|NCT00859222|155528416|FG002|Overall Study|Adverse Event|6|||
48364160|NCT00859222|155528417|FG003|Overall Study|Adverse Event|24|||
48364161|NCT00859222|155528418|FG004|Overall Study|Adverse Event|15|||
48364162|NCT00859222|155528414|FG000|Overall Study|DLT|1|||
48364163|NCT00859222|155528415|FG001|Overall Study|DLT|0|||
48364164|NCT00859222|155528416|FG002|Overall Study|DLT|0|||
48364165|NCT00859222|155528417|FG003|Overall Study|DLT|0|||
48364166|NCT00859222|155528418|FG004|Overall Study|DLT|0|||
48364167|NCT00821587|155528419|FG000|Overall Study|Physician Decision|0|||
48364168|NCT00821587|155528420|FG001|Overall Study|Physician Decision|1|||
48364169|NCT01208103|155528425|FG000|Overall Study|Adverse Event|1|||
48364170|NCT01208103|155528425|FG000|Overall Study|Withdrawal by Subject|1|||
48364171|NCT01401153|155528426|FG000|First Test Day|Learning disabilities; illness|1|||
48364172|NCT01401153|155528427|FG001|First Test Day|Learning disabilities; illness|10|||
48364173|NCT01401153|155528426|FG000|Second Test Day|illness|0|||
48364174|NCT01401153|155528427|FG001|Second Test Day|illness|5|||
48364175|NCT01605019|155528428|FG000|Overall Study|pt did not meet transplant endpoint|3|||
48364176|NCT01605019|155528429|FG001|Overall Study|pt did not meet transplant endpoint|0|||
48364177|NCT02636725|155528433|FG000|Overall Study|Adverse Event|1|||
48364178|NCT02180243|155528434|FG000|Overall Study|Withdrawal by Subject|12|||
48364179|NCT02180243|155528435|FG001|Overall Study|Withdrawal by Subject|12|||
48364180|NCT02180243|155528434|FG000|Overall Study|Lost to Follow-up|12|||
48364181|NCT02180243|155528435|FG001|Overall Study|Lost to Follow-up|2|||
48364182|NCT02535091|155528436|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
48364183|NCT02535091|155528437|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
48364184|NCT02535091|155528438|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
48364185|NCT02535091|155528436|FG000|Overall Study|Withdrawal by Subject|14|||
48364186|NCT02535091|155528437|FG001|Overall Study|Withdrawal by Subject|5|||
48364187|NCT02535091|155528438|FG002|Overall Study|Withdrawal by Subject|121|||
48364188|NCT02535091|155528436|FG000|Overall Study|Adverse Event|9|||
48364189|NCT02535091|155528437|FG001|Overall Study|Adverse Event|4|||
48364190|NCT02535091|155528438|FG002|Overall Study|Adverse Event|170|||
48364191|NCT02535091|155528436|FG000|Overall Study|Other|4|||
48364192|NCT02535091|155528437|FG001|Overall Study|Other|3|||
48364193|NCT02535091|155528438|FG002|Overall Study|Other|81|||
48364194|NCT02535091|155528436|FG000|Overall Study|Lost to Follow-up|0|||
48364195|NCT02535091|155528437|FG001|Overall Study|Lost to Follow-up|1|||
48364196|NCT02535091|155528438|FG002|Overall Study|Lost to Follow-up|19|||
48364197|NCT02535091|155528436|FG000|Overall Study|Protocol Violation|0|||
48364198|NCT02535091|155528437|FG001|Overall Study|Protocol Violation|1|||
48364199|NCT02535091|155528438|FG002|Overall Study|Protocol Violation|11|||
48364200|NCT02535091|155528436|FG000|Overall Study|Pregnancy|0|||
48364201|NCT02535091|155528437|FG001|Overall Study|Pregnancy|0|||
48364202|NCT02535091|155528438|FG002|Overall Study|Pregnancy|7|||
48364203|NCT02643472|155528439|FG000|Overall Study|Death|2|||
48364204|NCT02643472|155528440|FG001|Overall Study|Death|5|||
48364205|NCT02643472|155528439|FG000|Overall Study|Withdrawal by Subject|3|||
48364206|NCT02643472|155528440|FG001|Overall Study|Withdrawal by Subject|2|||
48364207|NCT02643472|155528439|FG000|Overall Study|Protocol Violation|0|||
48364208|NCT02643472|155528440|FG001|Overall Study|Protocol Violation|1|||
48364209|NCT02643472|155528439|FG000|Overall Study|Lost to Follow-up|22|||
48364210|NCT02643472|155528440|FG001|Overall Study|Lost to Follow-up|26|||
48364211|NCT01280357|155528441|FG000|Overall Study|Excluded no internal monitoring|14|||
48364212|NCT01280357|155528441|FG000|Overall Study|IInsufficient data/No data supplied|12|||
48364213|NCT01258595|155528444|FG000|Overall Study|Lost to Follow-up|1|||
48364214|NCT01258595|155528445|FG001|Overall Study|Lost to Follow-up|0|||
48692604|NCT04663321|156724538|FG000|Overall Study|Study terminated by Sponsor|2|||
48692605|NCT04663321|156724539|FG001|Overall Study|Study terminated by Sponsor|1|||
48692606|NCT04663321|156724540|FG002|Overall Study|Study terminated by Sponsor|2|||
48692607|NCT04663321|156724538|FG000|Overall Study|Withdrawal by Subject|10|||
48692608|NCT04663321|156724539|FG001|Overall Study|Withdrawal by Subject|3|||
48692609|NCT04663321|156724540|FG002|Overall Study|Withdrawal by Subject|2|||
48692610|NCT04663321|156724538|FG000|Overall Study|Not provided|0|||
48692611|NCT04663321|156724539|FG001|Overall Study|Not provided|0|||
48692612|NCT04663321|156724540|FG002|Overall Study|Not provided|1|||
48692613|NCT03001557|156724541|FG000|Core Phase|Randomized but not treated|0|||
48692614|NCT03001557|156724542|FG001|Core Phase|Randomized but not treated|0|||
48692615|NCT03001557|156724543|FG002|Core Phase|Randomized but not treated|1|||
48692616|NCT03001557|156724544|FG003|Core Phase|Randomized but not treated|0|||
48414092|NCT02029976|155705439|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
48414093|NCT02029976|155705440|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
48414094|NCT02029976|155705439|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
48414095|NCT02029976|155705440|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
48414096|NCT02029976|155705439|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
48364215|NCT01258595|155528444|FG000|Overall Study|Withdrawal by Subject|0|||
48364216|NCT01258595|155528445|FG001|Overall Study|Withdrawal by Subject|1|||
48364217|NCT03541200|155528446|FG000|Overall Study|Adverse Event|19|||
48414097|NCT02029976|155705440|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
48414098|NCT00618722|155705441|FG000|Overall Study|Refusal of Treatment|0|||
48414099|NCT00618722|155705442|FG001|Overall Study|Refusal of Treatment|0|||
48414100|NCT00618722|155705443|FG002|Overall Study|Refusal of Treatment|1|||
48414101|NCT00618722|155705444|FG003|Overall Study|Refusal of Treatment|0|||
48364218|NCT03541200|155528446|FG000|Overall Study|Death|1|||
48364219|NCT03541200|155528446|FG000|Overall Study|Lost to Follow-up|10|||
48364220|NCT03541200|155528446|FG000|Overall Study|Physician Decision|1|||
48364221|NCT03541200|155528446|FG000|Overall Study|Protocol Violation|51|||
48364222|NCT03541200|155528446|FG000|Overall Study|Withdrawal by Subject|23|||
48364223|NCT03541200|155528446|FG000|Overall Study|other|8|||
48414102|NCT00618722|155705441|FG000|Overall Study|Patient Request|1|||
48414103|NCT00618722|155705442|FG001|Overall Study|Patient Request|1|||
48364224|NCT00506441|155528447|FG000|Period 1; Open-label Period|Adverse Event|21|||
48414104|NCT00618722|155705443|FG002|Overall Study|Patient Request|1|||
48364225|NCT00506441|155528448|FG001|Period 1; Open-label Period|Adverse Event|0|||
48414105|NCT00618722|155705444|FG003|Overall Study|Patient Request|1|||
48364226|NCT00506441|155528447|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
48364227|NCT00506441|155528448|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
48364228|NCT00506441|155528447|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
48364229|NCT00506441|155528448|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
48364230|NCT00506441|155528447|FG000|Period 1; Open-label Period|Physician Decision|5|||
48364231|NCT00506441|155528448|FG001|Period 1; Open-label Period|Physician Decision|0|||
48364232|NCT00506441|155528447|FG000|Period 1; Open-label Period|Protocol Violation|9|||
48364233|NCT00506441|155528448|FG001|Period 1; Open-label Period|Protocol Violation|0|||
48364234|NCT00506441|155528447|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
48364235|NCT00506441|155528448|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
48364236|NCT00506441|155528447|FG000|Period 1; Open-label Period|Other Reasons|13|||
48364237|NCT00506441|155528448|FG001|Period 1; Open-label Period|Other Reasons|0|||
48364238|NCT00506441|155528447|FG000|Period 2; Double-blind Period|Adverse Event|0|||
48364239|NCT00506441|155528448|FG001|Period 2; Double-blind Period|Adverse Event|1|||
48364240|NCT00506441|155528447|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
48364241|NCT00506441|155528448|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
48364242|NCT00506441|155528447|FG000|Period 2; Double-blind Period|Physician Decision|1|||
48364243|NCT00506441|155528448|FG001|Period 2; Double-blind Period|Physician Decision|1|||
48364244|NCT00506441|155528447|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
48364245|NCT00506441|155528448|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
48364246|NCT00506441|155528447|FG000|Period 2; Double-blind Period|Other Reason|1|||
48364247|NCT00506441|155528448|FG001|Period 2; Double-blind Period|Other Reason|1|||
48364248|NCT00528931|155528453|FG000|Overall Study|Lost to Follow-up|1|||
48364249|NCT01253018|155528454|FG000|Overall Study|Lost to Follow-up|1|||
48364250|NCT01253018|155528455|FG001|Overall Study|Lost to Follow-up|1|||
48364251|NCT01253018|155528454|FG000|Overall Study|Robot Repair Issues|2|||
48364252|NCT01253018|155528455|FG001|Overall Study|Robot Repair Issues|0|||
48364253|NCT01253018|155528454|FG000|Overall Study|Withdrawal by Subject|1|||
48364254|NCT01253018|155528455|FG001|Overall Study|Withdrawal by Subject|1|||
48364255|NCT00818779|155528456|FG000|Overall Study|Protocol Violation|1|||
48364256|NCT00818779|155528457|FG001|Overall Study|Protocol Violation|0|||
48364257|NCT00818779|155528456|FG000|Overall Study|Lost to Follow-up|1|||
48364258|NCT00818779|155528457|FG001|Overall Study|Lost to Follow-up|0|||
48364259|NCT00818779|155528456|FG000|Overall Study|Adverse Event|4|||
48364260|NCT00818779|155528457|FG001|Overall Study|Adverse Event|1|||
48364261|NCT03682302|155528458|FG000|Overall Study|Lost to Follow-up|1|||
48364262|NCT03682302|155528459|FG001|Overall Study|Lost to Follow-up|2|||
48364263|NCT03682302|155528460|FG002|Overall Study|Lost to Follow-up|0|||
48364264|NCT03682302|155528461|FG003|Overall Study|Lost to Follow-up|1|||
48364265|NCT03682302|155528458|FG000|Overall Study|Study drug was not administered|0|||
48364266|NCT03682302|155528459|FG001|Overall Study|Study drug was not administered|0|||
48364267|NCT03682302|155528460|FG002|Overall Study|Study drug was not administered|1|||
48364268|NCT03682302|155528461|FG003|Overall Study|Study drug was not administered|1|||
48364269|NCT01204710|155528473|FG000|Randomization Treatment|Lost to Follow-up|1|||
48364270|NCT01204710|155528474|FG001|Randomization Treatment|Lost to Follow-up|0|||
48364271|NCT01204710|155528473|FG000|Randomization Treatment|Withdrawal by Subject|6|||
48364272|NCT01204710|155528474|FG001|Randomization Treatment|Withdrawal by Subject|5|||
48364273|NCT01204710|155528473|FG000|Randomization Treatment|Physician Decision|3|||
48364274|NCT01204710|155528474|FG001|Randomization Treatment|Physician Decision|2|||
48364275|NCT01204710|155528473|FG000|Randomization Treatment|Entry criteria not met|0|||
48364276|NCT01204710|155528474|FG001|Randomization Treatment|Entry criteria not met|1|||
48364277|NCT01204710|155528473|FG000|Randomization Treatment|Adverse Event|4|||
48364278|NCT01204710|155528474|FG001|Randomization Treatment|Adverse Event|2|||
48364279|NCT01204710|155528473|FG000|Randomization Treatment|Sponsor Decision|0|||
48364280|NCT01204710|155528474|FG001|Randomization Treatment|Sponsor Decision|1|||
48364281|NCT01204710|155528473|FG000|Randomization Treatment|Worsening of General condition|0|||
48364282|NCT01204710|155528474|FG001|Randomization Treatment|Worsening of General condition|1|||
48364283|NCT01204710|155528473|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
48364284|NCT01204710|155528474|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
48364285|NCT01204710|155528473|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
48364286|NCT01204710|155528474|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
48364287|NCT01204710|155528473|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
48364288|NCT01204710|155528474|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
48364289|NCT01204710|155528473|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
48364290|NCT01204710|155528474|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
48364291|NCT02996474|155528475|FG000|Overall Study|Physician Decision|5|||
48364292|NCT01142115|155528477|FG000|First Intervention|Lack of Efficacy|1|||
48364293|NCT01142115|155528478|FG001|First Intervention|Lack of Efficacy|1|||
48364294|NCT01142115|155528477|FG000|First Intervention|Adverse Event|1|||
48364295|NCT01142115|155528478|FG001|First Intervention|Adverse Event|0|||
48364296|NCT00633880|155528480|FG000|Open Label Titration|Lack of Efficacy|1|||
48364297|NCT00633880|155528481|FG001|Open Label Titration|Lack of Efficacy|0|||
48414106|NCT00618722|155705441|FG000|Overall Study|Inability to Complete Study Procedure|0|||
48414107|NCT00618722|155705442|FG001|Overall Study|Inability to Complete Study Procedure|1|||
48414108|NCT00618722|155705443|FG002|Overall Study|Inability to Complete Study Procedure|0|||
48414109|NCT00618722|155705444|FG003|Overall Study|Inability to Complete Study Procedure|0|||
48414110|NCT00618722|155705441|FG000|Overall Study|Lost to Follow-up|2|||
48414111|NCT00618722|155705442|FG001|Overall Study|Lost to Follow-up|0|||
48414112|NCT00618722|155705443|FG002|Overall Study|Lost to Follow-up|0|||
48414113|NCT00618722|155705444|FG003|Overall Study|Lost to Follow-up|2|||
48414114|NCT00618722|155705441|FG000|Overall Study|Miscellaneous Reasons|0|||
48414115|NCT00618722|155705442|FG001|Overall Study|Miscellaneous Reasons|0|||
48414116|NCT00618722|155705443|FG002|Overall Study|Miscellaneous Reasons|1|||
48414117|NCT00618722|155705444|FG003|Overall Study|Miscellaneous Reasons|1|||
48414118|NCT02031679|155705445|FG000|Overall Study|Protocol Violation|0|||
48414119|NCT02031679|155705446|FG001|Overall Study|Protocol Violation|1|||
48414120|NCT02031679|155705445|FG000|Overall Study|Lack of Efficacy|0|||
48414121|NCT02031679|155705446|FG001|Overall Study|Lack of Efficacy|1|||
48414122|NCT01059448|155705451|FG000|Overall Study|Adverse Event|1|||
48414123|NCT01059448|155705452|FG001|Overall Study|Adverse Event|3|||
48414124|NCT01059448|155705453|FG002|Overall Study|Adverse Event|0|||
48414125|NCT01059448|155705454|FG003|Overall Study|Adverse Event|1|||
48414126|NCT01059448|155705451|FG000|Overall Study|Withdrawal by Subject|2|||
48414127|NCT01059448|155705452|FG001|Overall Study|Withdrawal by Subject|0|||
48414128|NCT01059448|155705453|FG002|Overall Study|Withdrawal by Subject|2|||
48414129|NCT01059448|155705454|FG003|Overall Study|Withdrawal by Subject|4|||
48414130|NCT01059448|155705451|FG000|Overall Study|Disease Progression|2|||
48414131|NCT01059448|155705452|FG001|Overall Study|Disease Progression|1|||
48414132|NCT01059448|155705453|FG002|Overall Study|Disease Progression|4|||
48414133|NCT01059448|155705454|FG003|Overall Study|Disease Progression|2|||
48414134|NCT01059448|155705451|FG000|Overall Study|Administrative Decision|43|||
48414135|NCT01059448|155705452|FG001|Overall Study|Administrative Decision|49|||
48414136|NCT01059448|155705453|FG002|Overall Study|Administrative Decision|45|||
48364298|NCT00633880|155528482|FG002|Open Label Titration|Lack of Efficacy|0|||
48364299|NCT00633880|155528480|FG000|Open Label Titration|Adverse Event|13|||
48364300|NCT00633880|155528481|FG001|Open Label Titration|Adverse Event|0|||
48364301|NCT00633880|155528482|FG002|Open Label Titration|Adverse Event|0|||
48364302|NCT00633880|155528480|FG000|Open Label Titration|Treatment Failure|55|||
48364303|NCT00633880|155528481|FG001|Open Label Titration|Treatment Failure|0|||
48364304|NCT00633880|155528482|FG002|Open Label Titration|Treatment Failure|0|||
48364305|NCT00633880|155528480|FG000|Open Label Titration|Protocol Violation|6|||
48364306|NCT00633880|155528481|FG001|Open Label Titration|Protocol Violation|0|||
48364307|NCT00633880|155528482|FG002|Open Label Titration|Protocol Violation|0|||
48364308|NCT00633880|155528480|FG000|Open Label Titration|Physician Decision|1|||
48364309|NCT00633880|155528481|FG001|Open Label Titration|Physician Decision|0|||
48364310|NCT00633880|155528482|FG002|Open Label Titration|Physician Decision|0|||
48364311|NCT00633880|155528480|FG000|Open Label Titration|Withdrawal by Subject|4|||
48364312|NCT00633880|155528481|FG001|Open Label Titration|Withdrawal by Subject|0|||
48364313|NCT00633880|155528482|FG002|Open Label Titration|Withdrawal by Subject|0|||
48364314|NCT04445987|155528483|FG000|Overall Study|Adverse Event|0|||
48364315|NCT04445987|155528484|FG001|Overall Study|Adverse Event|0|||
48364316|NCT04445987|155528485|FG002|Overall Study|Adverse Event|1|||
48364317|NCT04445987|155528486|FG003|Overall Study|Adverse Event|0|||
48414137|NCT01059448|155705454|FG003|Overall Study|Administrative Decision|46|||
48414138|NCT01059448|155705451|FG000|Overall Study|Lost to Follow-up|0|||
48414139|NCT01059448|155705452|FG001|Overall Study|Lost to Follow-up|0|||
48414140|NCT01059448|155705453|FG002|Overall Study|Lost to Follow-up|2|||
48414141|NCT01059448|155705454|FG003|Overall Study|Lost to Follow-up|0|||
48414142|NCT01059448|155705451|FG000|Overall Study|Death|0|||
48414143|NCT01059448|155705452|FG001|Overall Study|Death|1|||
48364318|NCT04445987|155528487|FG004|Overall Study|Adverse Event|4|||
48364319|NCT04445987|155528488|FG005|Overall Study|Adverse Event|0|||
48364320|NCT04445987|155528483|FG000|Overall Study|Lost to Follow-up|4|||
48364321|NCT04445987|155528484|FG001|Overall Study|Lost to Follow-up|3|||
48364322|NCT04445987|155528485|FG002|Overall Study|Lost to Follow-up|1|||
48364323|NCT04445987|155528486|FG003|Overall Study|Lost to Follow-up|1|||
48364324|NCT04445987|155528487|FG004|Overall Study|Lost to Follow-up|29|||
48364325|NCT04445987|155528488|FG005|Overall Study|Lost to Follow-up|0|||
48364326|NCT04445987|155528483|FG000|Overall Study|Physician Decision|0|||
48364327|NCT04445987|155528484|FG001|Overall Study|Physician Decision|0|||
48364328|NCT04445987|155528485|FG002|Overall Study|Physician Decision|0|||
48364329|NCT04445987|155528486|FG003|Overall Study|Physician Decision|0|||
48364330|NCT04445987|155528487|FG004|Overall Study|Physician Decision|1|||
48364331|NCT04445987|155528488|FG005|Overall Study|Physician Decision|0|||
48364332|NCT04445987|155528483|FG000|Overall Study|Protocol Violation|1|||
48364333|NCT04445987|155528484|FG001|Overall Study|Protocol Violation|0|||
48364334|NCT04445987|155528485|FG002|Overall Study|Protocol Violation|0|||
48414144|NCT01059448|155705453|FG002|Overall Study|Death|0|||
48364335|NCT04445987|155528486|FG003|Overall Study|Protocol Violation|0|||
48364336|NCT04445987|155528487|FG004|Overall Study|Protocol Violation|2|||
48414145|NCT01059448|155705454|FG003|Overall Study|Death|0|||
48414146|NCT01059448|155705451|FG000|Overall Study|Other|1|||
48414147|NCT01059448|155705452|FG001|Overall Study|Other|1|||
48414148|NCT01059448|155705453|FG002|Overall Study|Other|0|||
48414149|NCT01059448|155705454|FG003|Overall Study|Other|1|||
48414150|NCT01390389|155705455|FG000|Overall Study|Withdrawal by Subject|2|||
48414151|NCT01390389|155705456|FG001|Overall Study|Withdrawal by Subject|0|||
48414152|NCT01390389|155705455|FG000|Overall Study|Screen Fail|2|||
48414153|NCT01390389|155705456|FG001|Overall Study|Screen Fail|1|||
48414154|NCT00778830|155705457|FG000|Overall Study|Ongoing at data cut-off|0|||
48414155|NCT00778830|155705458|FG001|Overall Study|Ongoing at data cut-off|1|||
48414156|NCT01891643|155705459|FG000|Overall Study|Adverse event unrelated to study drug|2|||
48414157|NCT01891643|155705460|FG001|Overall Study|Adverse event unrelated to study drug|5|||
48414158|NCT01891643|155705459|FG000|Overall Study|Disease Progression|4|||
48414159|NCT01891643|155705460|FG001|Overall Study|Disease Progression|3|||
48414160|NCT01891643|155705459|FG000|Overall Study|Study Drug Toxicity|3|||
48414161|NCT01891643|155705460|FG001|Overall Study|Study Drug Toxicity|0|||
48414162|NCT01891643|155705459|FG000|Overall Study|Maximum Clinical Benefit|0|||
48414163|NCT01891643|155705460|FG001|Overall Study|Maximum Clinical Benefit|1|||
48414164|NCT01891643|155705459|FG000|Overall Study|Poor/Non-compliance|0|||
48414165|NCT01891643|155705460|FG001|Overall Study|Poor/Non-compliance|1|||
48364337|NCT04445987|155528488|FG005|Overall Study|Protocol Violation|0|||
48414166|NCT01891643|155705459|FG000|Overall Study|Participant request to discontinue|1|||
48364338|NCT04445987|155528483|FG000|Overall Study|Withdrawal by Subject|4|||
48364339|NCT04445987|155528484|FG001|Overall Study|Withdrawal by Subject|0|||
48364340|NCT04445987|155528485|FG002|Overall Study|Withdrawal by Subject|1|||
48364341|NCT04445987|155528486|FG003|Overall Study|Withdrawal by Subject|0|||
48364342|NCT04445987|155528487|FG004|Overall Study|Withdrawal by Subject|18|||
48364343|NCT04445987|155528488|FG005|Overall Study|Withdrawal by Subject|1|||
48364344|NCT04445987|155528483|FG000|Overall Study|Other reason|0|||
48364345|NCT04445987|155528484|FG001|Overall Study|Other reason|0|||
48364346|NCT04445987|155528485|FG002|Overall Study|Other reason|1|||
48364347|NCT04445987|155528486|FG003|Overall Study|Other reason|0|||
48364348|NCT04445987|155528487|FG004|Overall Study|Other reason|2|||
48364349|NCT04445987|155528488|FG005|Overall Study|Other reason|0|||
48364350|NCT04608773|155528492|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
48364351|NCT04608773|155528493|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
48364352|NCT04608773|155528492|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
48364353|NCT04608773|155528493|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
48364354|NCT04608773|155528492|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
48364355|NCT04608773|155528493|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
48364356|NCT04608773|155528492|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
48364357|NCT04608773|155528493|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
48364358|NCT04608773|155528492|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
48364359|NCT04608773|155528493|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
48364360|NCT02412371|155528495|FG000|Overall Study|Withdrawal by Subject|0|||
48364361|NCT02412371|155528496|FG001|Overall Study|Withdrawal by Subject|2|||
48364362|NCT02412371|155528497|FG002|Overall Study|Withdrawal by Subject|0|||
48364363|NCT02412371|155528498|FG003|Overall Study|Withdrawal by Subject|1|||
48364364|NCT02412371|155528499|FG004|Overall Study|Withdrawal by Subject|1|||
48364365|NCT02412371|155528500|FG005|Overall Study|Withdrawal by Subject|0|||
48364366|NCT02412371|155528495|FG000|Overall Study|Sponsor Discontinued Study|1|||
48364367|NCT02412371|155528496|FG001|Overall Study|Sponsor Discontinued Study|4|||
48364368|NCT02412371|155528497|FG002|Overall Study|Sponsor Discontinued Study|6|||
48364369|NCT02412371|155528498|FG003|Overall Study|Sponsor Discontinued Study|4|||
48364370|NCT02412371|155528499|FG004|Overall Study|Sponsor Discontinued Study|5|||
48364371|NCT02412371|155528500|FG005|Overall Study|Sponsor Discontinued Study|0|||
48364372|NCT02412371|155528495|FG000|Overall Study|Death|4|||
48364373|NCT02412371|155528496|FG001|Overall Study|Death|2|||
48364374|NCT02412371|155528497|FG002|Overall Study|Death|1|||
48364375|NCT02412371|155528498|FG003|Overall Study|Death|3|||
48364376|NCT02412371|155528499|FG004|Overall Study|Death|5|||
48364377|NCT02412371|155528500|FG005|Overall Study|Death|2|||
48414167|NCT01891643|155705460|FG001|Overall Study|Participant request to discontinue|0|||
48364378|NCT02412371|155528495|FG000|Overall Study|Other|2|||
48364379|NCT02412371|155528496|FG001|Overall Study|Other|1|||
48364380|NCT02412371|155528497|FG002|Overall Study|Other|0|||
48414168|NCT05047523|155705462|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48364381|NCT02412371|155528498|FG003|Overall Study|Other|0|||
48364382|NCT02412371|155528499|FG004|Overall Study|Other|1|||
48364383|NCT02412371|155528500|FG005|Overall Study|Other|3|||
48364384|NCT02053792|155528501|FG000|Overall Study|Physician Decision|0|||
48364385|NCT02053792|155528502|FG001|Overall Study|Physician Decision|1|||
48364386|NCT02053792|155528501|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
48414169|NCT05047523|155705463|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48414170|NCT05047523|155705464|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
48414171|NCT05047523|155705465|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48364387|NCT02053792|155528502|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
48364388|NCT02053792|155528501|FG000|Overall Study|Lack of Efficacy|1|||
48364389|NCT02053792|155528502|FG001|Overall Study|Lack of Efficacy|0|||
48364390|NCT02053792|155528501|FG000|Overall Study|Adverse Event|1|||
48364391|NCT02053792|155528502|FG001|Overall Study|Adverse Event|0|||
48364392|NCT02053792|155528501|FG000|Overall Study|Withdrawal by Subject|2|||
48364393|NCT02053792|155528502|FG001|Overall Study|Withdrawal by Subject|2|||
48364394|NCT02053792|155528501|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
48364395|NCT02053792|155528502|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
48364396|NCT02053792|155528501|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
48364397|NCT02053792|155528502|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
48364398|NCT04869358|155528503|FG000|Overall Study|Wish to have children.|1|||
48364399|NCT04869358|155528504|FG001|Overall Study|Wish to have children.|0|||
48364400|NCT04869358|155528505|FG002|Overall Study|Wish to have children.|0|||
48364401|NCT04869358|155528506|FG003|Overall Study|Wish to have children.|0|||
48364402|NCT01012817|155530334|FG000|Overall Study|Withdrawal by Subject|0|||
48364403|NCT01012817|155530335|FG001|Overall Study|Withdrawal by Subject|0|||
48364404|NCT01012817|155530336|FG002|Overall Study|Withdrawal by Subject|0|||
48364405|NCT01012817|155530337|FG003|Overall Study|Withdrawal by Subject|1|||
48364406|NCT01012817|155530338|FG004|Overall Study|Withdrawal by Subject|0|||
48364407|NCT01012817|155530339|FG005|Overall Study|Withdrawal by Subject|0|||
48364408|NCT01012817|155530340|FG006|Overall Study|Withdrawal by Subject|0|||
48364409|NCT01012817|155530341|FG007|Overall Study|Withdrawal by Subject|1|||
48364410|NCT01012817|155530342|FG008|Overall Study|Withdrawal by Subject|0|||
48364411|NCT01012817|155530343|FG009|Overall Study|Withdrawal by Subject|0|||
48364412|NCT01012817|155530344|FG010|Overall Study|Withdrawal by Subject|1|||
48364413|NCT01012817|155530345|FG011|Overall Study|Withdrawal by Subject|1|||
48364414|NCT01012817|155530346|FG012|Overall Study|Withdrawal by Subject|0|||
48364415|NCT01012817|155530347|FG013|Overall Study|Withdrawal by Subject|1|||
48364416|NCT01012817|155530334|FG000|Overall Study|Adverse Event|0|||
48364417|NCT01012817|155530335|FG001|Overall Study|Adverse Event|0|||
48364418|NCT01012817|155530336|FG002|Overall Study|Adverse Event|0|||
48364419|NCT01012817|155530337|FG003|Overall Study|Adverse Event|0|||
48364420|NCT01012817|155530338|FG004|Overall Study|Adverse Event|0|||
48364421|NCT01012817|155530339|FG005|Overall Study|Adverse Event|1|||
48364422|NCT01012817|155530340|FG006|Overall Study|Adverse Event|0|||
48364423|NCT01012817|155530341|FG007|Overall Study|Adverse Event|0|||
48364424|NCT01012817|155530342|FG008|Overall Study|Adverse Event|0|||
48364425|NCT01012817|155530343|FG009|Overall Study|Adverse Event|0|||
48364426|NCT01012817|155530344|FG010|Overall Study|Adverse Event|1|||
48364427|NCT01012817|155530345|FG011|Overall Study|Adverse Event|0|||
48364428|NCT01012817|155530346|FG012|Overall Study|Adverse Event|0|||
48364429|NCT01012817|155530347|FG013|Overall Study|Adverse Event|1|||
48364430|NCT00474526|155530348|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
48364431|NCT00474526|155530349|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
48364432|NCT00474526|155530350|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
48364433|NCT00474526|155530351|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
48364434|NCT00474526|155530352|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
48364435|NCT00474526|155530353|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
48364436|NCT00474526|155530354|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
48364437|NCT00474526|155530355|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
48364438|NCT00474526|155530356|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
48364439|NCT00474526|155530357|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
48364440|NCT00474526|155530358|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
48364441|NCT00474526|155530359|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
48364442|NCT00474526|155530360|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
48364443|NCT00474526|155530361|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
48364444|NCT00474526|155530362|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
48364445|NCT00474526|155530363|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
48364446|NCT00474526|155530364|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
48364447|NCT00474526|155530348|FG000|Overall Study|Adverse Event|2|||
48364448|NCT00474526|155530349|FG001|Overall Study|Adverse Event|0|||
48364449|NCT00474526|155530350|FG002|Overall Study|Adverse Event|2|||
48364450|NCT00474526|155530351|FG003|Overall Study|Adverse Event|4|||
48364451|NCT00474526|155530352|FG004|Overall Study|Adverse Event|2|||
48364452|NCT00474526|155530353|FG005|Overall Study|Adverse Event|1|||
48364453|NCT00474526|155530354|FG006|Overall Study|Adverse Event|1|||
48364454|NCT00474526|155530355|FG007|Overall Study|Adverse Event|0|||
48364455|NCT00474526|155530356|FG008|Overall Study|Adverse Event|0|||
48364456|NCT00474526|155530357|FG009|Overall Study|Adverse Event|0|||
48364457|NCT00474526|155530358|FG010|Overall Study|Adverse Event|0|||
48364458|NCT00474526|155530359|FG011|Overall Study|Adverse Event|0|||
48364459|NCT00474526|155530360|FG012|Overall Study|Adverse Event|0|||
48364460|NCT00474526|155530361|FG013|Overall Study|Adverse Event|0|||
48414172|NCT05047523|155705466|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48414173|NCT05047523|155705467|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
48414174|NCT05047523|155705462|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48414175|NCT05047523|155705463|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
48364461|NCT00474526|155530362|FG014|Overall Study|Adverse Event|1|||
48364462|NCT00474526|155530363|FG015|Overall Study|Adverse Event|1|||
48364463|NCT00474526|155530364|FG016|Overall Study|Adverse Event|0|||
48364464|NCT00474526|155530348|FG000|Overall Study|Death|0|||
48364465|NCT00474526|155530349|FG001|Overall Study|Death|0|||
48364466|NCT00474526|155530350|FG002|Overall Study|Death|0|||
48364467|NCT00474526|155530351|FG003|Overall Study|Death|0|||
48364468|NCT00474526|155530352|FG004|Overall Study|Death|0|||
48364469|NCT00474526|155530353|FG005|Overall Study|Death|0|||
48364470|NCT00474526|155530354|FG006|Overall Study|Death|0|||
48364471|NCT00474526|155530355|FG007|Overall Study|Death|0|||
48364472|NCT00474526|155530356|FG008|Overall Study|Death|0|||
48364473|NCT00474526|155530357|FG009|Overall Study|Death|0|||
48364474|NCT00474526|155530358|FG010|Overall Study|Death|0|||
48364475|NCT00474526|155530359|FG011|Overall Study|Death|0|||
48364476|NCT00474526|155530360|FG012|Overall Study|Death|0|||
48364477|NCT00474526|155530361|FG013|Overall Study|Death|3|||
48364478|NCT00474526|155530362|FG014|Overall Study|Death|0|||
48364479|NCT00474526|155530363|FG015|Overall Study|Death|0|||
48364480|NCT00474526|155530364|FG016|Overall Study|Death|0|||
48364481|NCT00474526|155530348|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48414176|NCT05047523|155705464|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48414177|NCT05047523|155705465|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48414178|NCT05047523|155705466|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48414179|NCT05047523|155705467|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
48414180|NCT05047523|155705462|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
48414181|NCT05047523|155705463|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
48414182|NCT05047523|155705464|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
48414183|NCT05047523|155705465|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
48414184|NCT05047523|155705466|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
48414185|NCT05047523|155705467|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
48414186|NCT05047523|155705462|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
48414187|NCT05047523|155705463|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48414188|NCT05047523|155705464|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48414189|NCT05047523|155705465|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48414190|NCT05047523|155705466|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48364482|NCT00474526|155530349|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
48364483|NCT00474526|155530350|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364484|NCT00474526|155530351|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
48364485|NCT00474526|155530352|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
48364486|NCT00474526|155530353|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364487|NCT00474526|155530354|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364488|NCT00474526|155530355|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364489|NCT00474526|155530356|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364490|NCT00474526|155530357|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364491|NCT00474526|155530358|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364492|NCT00474526|155530359|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364493|NCT00474526|155530360|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364494|NCT00474526|155530361|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
48364495|NCT00474526|155530362|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
48364496|NCT00474526|155530363|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364497|NCT00474526|155530364|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
48364498|NCT00474526|155530348|FG000|Overall Study|Lost to Follow-up|8|||
48364499|NCT00474526|155530349|FG001|Overall Study|Lost to Follow-up|6|||
48364500|NCT00474526|155530350|FG002|Overall Study|Lost to Follow-up|13|||
48364501|NCT00474526|155530351|FG003|Overall Study|Lost to Follow-up|29|||
48364502|NCT00474526|155530352|FG004|Overall Study|Lost to Follow-up|11|||
48414191|NCT05047523|155705467|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
48414192|NCT05047523|155705462|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
48364503|NCT00474526|155530353|FG005|Overall Study|Lost to Follow-up|5|||
48364504|NCT00474526|155530354|FG006|Overall Study|Lost to Follow-up|8|||
48364505|NCT00474526|155530355|FG007|Overall Study|Lost to Follow-up|1|||
48414193|NCT05047523|155705463|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
48364506|NCT00474526|155530356|FG008|Overall Study|Lost to Follow-up|0|||
48364507|NCT00474526|155530357|FG009|Overall Study|Lost to Follow-up|6|||
48364508|NCT00474526|155530358|FG010|Overall Study|Lost to Follow-up|2|||
48364509|NCT00474526|155530359|FG011|Overall Study|Lost to Follow-up|4|||
48364510|NCT00474526|155530360|FG012|Overall Study|Lost to Follow-up|6|||
48364511|NCT00474526|155530361|FG013|Overall Study|Lost to Follow-up|74|||
48364512|NCT00474526|155530362|FG014|Overall Study|Lost to Follow-up|29|||
48364513|NCT00474526|155530363|FG015|Overall Study|Lost to Follow-up|4|||
48364514|NCT00474526|155530364|FG016|Overall Study|Lost to Follow-up|5|||
48364515|NCT00474526|155530348|FG000|Overall Study|Protocol Violation|2|||
48364516|NCT00474526|155530349|FG001|Overall Study|Protocol Violation|6|||
48364517|NCT00474526|155530350|FG002|Overall Study|Protocol Violation|4|||
48364518|NCT00474526|155530351|FG003|Overall Study|Protocol Violation|12|||
48364519|NCT00474526|155530352|FG004|Overall Study|Protocol Violation|3|||
48364520|NCT00474526|155530353|FG005|Overall Study|Protocol Violation|1|||
48364521|NCT00474526|155530354|FG006|Overall Study|Protocol Violation|3|||
48364522|NCT00474526|155530355|FG007|Overall Study|Protocol Violation|0|||
48364523|NCT00474526|155530356|FG008|Overall Study|Protocol Violation|0|||
48364524|NCT00474526|155530357|FG009|Overall Study|Protocol Violation|4|||
48414194|NCT05047523|155705464|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
48414195|NCT05047523|155705465|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
48414196|NCT05047523|155705466|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
48414197|NCT05047523|155705467|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
48414198|NCT05047523|155705462|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
48414199|NCT05047523|155705463|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
48414200|NCT05047523|155705464|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
48414201|NCT05047523|155705465|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
48414202|NCT05047523|155705466|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
48414203|NCT05047523|155705467|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
48414204|NCT01220414|155705472|FG000|Overall Study|Withdrawal by Subject|1|||
48414205|NCT01220414|155705473|FG001|Overall Study|Withdrawal by Subject|0|||
48414206|NCT01220414|155705474|FG002|Overall Study|Withdrawal by Subject|0|||
48414207|NCT01220414|155705475|FG003|Overall Study|Withdrawal by Subject|1|||
48414208|NCT02863848|155705478|FG000|Overall Study|Lost to Follow-up|1|||
48414209|NCT02863848|155705479|FG001|Overall Study|Lost to Follow-up|1|||
48414210|NCT02863848|155705478|FG000|Overall Study|Protocol Violation|1|||
48414211|NCT02863848|155705479|FG001|Overall Study|Protocol Violation|2|||
48414212|NCT02318095|155705486|FG000|Overall Study|Adverse Event|1|||
48414213|NCT03323749|155705487|FG000|Double-blind Period|Lost to Follow-up|4|||
48414214|NCT03323749|155705488|FG001|Double-blind Period|Lost to Follow-up|5|||
48364525|NCT00474526|155530358|FG010|Overall Study|Protocol Violation|2|||
48364526|NCT00474526|155530359|FG011|Overall Study|Protocol Violation|2|||
48364527|NCT00474526|155530360|FG012|Overall Study|Protocol Violation|4|||
48364528|NCT00474526|155530361|FG013|Overall Study|Protocol Violation|19|||
48364529|NCT00474526|155530362|FG014|Overall Study|Protocol Violation|9|||
48364530|NCT00474526|155530363|FG015|Overall Study|Protocol Violation|6|||
48364531|NCT00474526|155530364|FG016|Overall Study|Protocol Violation|2|||
48414215|NCT03323749|155705487|FG000|Double-blind Period|Adverse Event|3|||
48414216|NCT03323749|155705488|FG001|Double-blind Period|Adverse Event|1|||
48414217|NCT03323749|155705487|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
48414218|NCT03323749|155705488|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
48414219|NCT03323749|155705487|FG000|Open-Label Period|Adverse Event|3|||
48414220|NCT03323749|155705488|FG001|Open-Label Period|Adverse Event|10|||
48414221|NCT03323749|155705487|FG000|Open-Label Period|Withdrawal by Subject|7|||
48414222|NCT03323749|155705488|FG001|Open-Label Period|Withdrawal by Subject|5|||
48364532|NCT00474526|155530348|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
48364533|NCT00474526|155530349|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
48364534|NCT00474526|155530350|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
48364535|NCT00474526|155530351|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
48364536|NCT00474526|155530352|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
48364537|NCT00474526|155530353|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
48364538|NCT00474526|155530354|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
48364539|NCT00474526|155530355|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
48364540|NCT00474526|155530356|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
48364541|NCT00474526|155530357|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
48364542|NCT00474526|155530358|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
48364543|NCT00474526|155530359|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
48364544|NCT00474526|155530360|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
48364545|NCT00474526|155530361|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
48364546|NCT00474526|155530362|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
48364547|NCT00474526|155530363|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
48414223|NCT03539432|155705489|FG000|Overall Study|Lost to Follow-up|0|||
48414224|NCT03539432|155705490|FG001|Overall Study|Lost to Follow-up|1|||
48414225|NCT01381094|155705491|FG000|Overall Study|Adverse Event|1|||
48414226|NCT01381094|155705492|FG001|Overall Study|Adverse Event|2|||
48414227|NCT01381094|155705493|FG002|Overall Study|Adverse Event|0|||
48364548|NCT00474526|155530364|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
48364549|NCT00474526|155530348|FG000|Overall Study|Withdrawal by Subject|9|||
48364550|NCT00474526|155530349|FG001|Overall Study|Withdrawal by Subject|24|||
48364551|NCT00474526|155530350|FG002|Overall Study|Withdrawal by Subject|21|||
48364552|NCT00474526|155530351|FG003|Overall Study|Withdrawal by Subject|52|||
48364553|NCT00474526|155530352|FG004|Overall Study|Withdrawal by Subject|38|||
48364554|NCT00474526|155530353|FG005|Overall Study|Withdrawal by Subject|6|||
48364555|NCT00474526|155530354|FG006|Overall Study|Withdrawal by Subject|12|||
48364556|NCT00474526|155530355|FG007|Overall Study|Withdrawal by Subject|4|||
48414228|NCT01381094|155705494|FG003|Overall Study|Adverse Event|1|||
48414229|NCT01381094|155705495|FG004|Overall Study|Adverse Event|0|||
48414230|NCT01381094|155705491|FG000|Overall Study|Lost to Follow-up|0|||
48414231|NCT01381094|155705492|FG001|Overall Study|Lost to Follow-up|0|||
48414232|NCT01381094|155705493|FG002|Overall Study|Lost to Follow-up|0|||
48414233|NCT01381094|155705494|FG003|Overall Study|Lost to Follow-up|0|||
48414234|NCT01381094|155705495|FG004|Overall Study|Lost to Follow-up|1|||
48414235|NCT01381094|155705491|FG000|Overall Study|Withdrawal of informed consent|0|||
48414236|NCT01381094|155705492|FG001|Overall Study|Withdrawal of informed consent|1|||
48414237|NCT01381094|155705493|FG002|Overall Study|Withdrawal of informed consent|0|||
48364557|NCT00474526|155530356|FG008|Overall Study|Withdrawal by Subject|4|||
48364558|NCT00474526|155530357|FG009|Overall Study|Withdrawal by Subject|13|||
48364559|NCT00474526|155530358|FG010|Overall Study|Withdrawal by Subject|5|||
48364560|NCT00474526|155530359|FG011|Overall Study|Withdrawal by Subject|4|||
48364561|NCT00474526|155530360|FG012|Overall Study|Withdrawal by Subject|4|||
48364562|NCT00474526|155530361|FG013|Overall Study|Withdrawal by Subject|37|||
48364563|NCT00474526|155530362|FG014|Overall Study|Withdrawal by Subject|22|||
48364564|NCT00474526|155530363|FG015|Overall Study|Withdrawal by Subject|1|||
48364565|NCT00474526|155530364|FG016|Overall Study|Withdrawal by Subject|1|||
48364566|NCT04546217|155530366|FG000|Overall Study|Withdrawal by Subject|2|||
48364567|NCT04546217|155530367|FG001|Overall Study|Withdrawal by Subject|0|||
48364568|NCT04546217|155530366|FG000|Overall Study|Uncontrolled hypertension|1|||
48364569|NCT04546217|155530367|FG001|Overall Study|Uncontrolled hypertension|0|||
48364570|NCT00890695|155530374|FG000|Overall Study|Protocol Violation|1|||
48364571|NCT00890695|155530375|FG001|Overall Study|Protocol Violation|0|||
48364572|NCT02113124|155530376|FG000|Overall Study|Unable to retrieve blood sample|1|||
48364573|NCT02113124|155530377|FG001|Overall Study|Unable to retrieve blood sample|1|||
48364574|NCT01732822|155530380|FG000|Overall Study|Withdrawal by Subject|123|||
48364575|NCT01732822|155530381|FG001|Overall Study|Withdrawal by Subject|113|||
48364576|NCT03002220|155530388|FG000|Overall Study|Lack of Efficacy|2|||
48364577|NCT03002220|155530388|FG000|Overall Study|Withdrawal by Subject|3|||
48364578|NCT03002220|155530388|FG000|Overall Study|Adverse Event|2|||
48364579|NCT03002220|155530388|FG000|Overall Study|Disease progression|13|||
48364580|NCT03002220|155530388|FG000|Overall Study|Physician Decision|1|||
48364581|NCT00128102|155530389|FG000|Overall Study|Site Discontinued|3|||
48364582|NCT00128102|155530390|FG001|Overall Study|Site Discontinued|6|||
48364583|NCT00128102|155530389|FG000|Overall Study|Other|0|||
48364584|NCT00128102|155530390|FG001|Overall Study|Other|1|||
48364585|NCT00128102|155530389|FG000|Overall Study|Progressive Disease|255|||
48364586|NCT00128102|155530390|FG001|Overall Study|Progressive Disease|285|||
48364587|NCT00128102|155530389|FG000|Overall Study|Adverse Event|34|||
48364588|NCT00128102|155530390|FG001|Overall Study|Adverse Event|11|||
48364589|NCT00128102|155530389|FG000|Overall Study|Death|12|||
48364590|NCT00128102|155530390|FG001|Overall Study|Death|13|||
48364591|NCT00128102|155530389|FG000|Overall Study|Physician Decision|3|||
48364592|NCT00128102|155530390|FG001|Overall Study|Physician Decision|3|||
48364593|NCT00128102|155530389|FG000|Overall Study|Withdrawal by Subject|19|||
48364594|NCT00128102|155530390|FG001|Overall Study|Withdrawal by Subject|11|||
48364595|NCT00128102|155530389|FG000|Overall Study|Protocol Violation|2|||
48364596|NCT00128102|155530390|FG001|Overall Study|Protocol Violation|2|||
48364597|NCT01202903|155530393|FG000|Overall Study|Administrative Probelms|1|||
48364598|NCT01202903|155530394|FG001|Overall Study|Administrative Probelms|4|||
48364599|NCT01202903|155530393|FG000|Overall Study|Protocol Violation|0|||
48364600|NCT01202903|155530394|FG001|Overall Study|Protocol Violation|1|||
48364601|NCT01202903|155530393|FG000|Overall Study|Death|1|||
48364602|NCT01202903|155530394|FG001|Overall Study|Death|0|||
48364603|NCT01202903|155530393|FG000|Overall Study|Lost to Follow-up|1|||
48364604|NCT01202903|155530394|FG001|Overall Study|Lost to Follow-up|1|||
48364605|NCT01202903|155530393|FG000|Overall Study|Lack of Efficacy|1|||
48364606|NCT01202903|155530394|FG001|Overall Study|Lack of Efficacy|3|||
48364607|NCT01202903|155530393|FG000|Overall Study|Adverse Event|3|||
48364608|NCT01202903|155530394|FG001|Overall Study|Adverse Event|3|||
48364609|NCT01202903|155530393|FG000|Overall Study|Withdrawal by Subject|4|||
48364610|NCT01202903|155530394|FG001|Overall Study|Withdrawal by Subject|4|||
48364611|NCT01302080|155530395|FG000|Overall Study|Withdrew Consent|92|||
48364612|NCT01302080|155530396|FG001|Overall Study|Withdrew Consent|39|||
48364613|NCT01302080|155530395|FG000|Overall Study|Patient/Family Moved|28|||
48364614|NCT01302080|155530396|FG001|Overall Study|Patient/Family Moved|3|||
48414238|NCT01381094|155705494|FG003|Overall Study|Withdrawal of informed consent|0|||
48414239|NCT01381094|155705495|FG004|Overall Study|Withdrawal of informed consent|0|||
48414240|NCT01381094|155705491|FG000|Overall Study|Participant given Aranesp injection|1|||
48364615|NCT01302080|155530395|FG000|Overall Study|Lost to Follow-up|192|||
48364616|NCT01302080|155530396|FG001|Overall Study|Lost to Follow-up|93|||
48364617|NCT01302080|155530395|FG000|Overall Study|Death|1|||
48364618|NCT01302080|155530396|FG001|Overall Study|Death|0|||
48364619|NCT01302080|155530395|FG000|Overall Study|Other|52|||
48364620|NCT01302080|155530396|FG001|Overall Study|Other|8|||
48364621|NCT01302080|155530395|FG000|Overall Study|Reason Missing For Discontinuation|1|||
48431605|NCT03599141|155767328|FG000|Overall Study|Lost to Follow-up|3|||
48364622|NCT01302080|155530396|FG001|Overall Study|Reason Missing For Discontinuation|0|||
48364623|NCT02731690|155530404|FG000|Overall Study|Adverse Event|1|||
48364624|NCT02731690|155530404|FG000|Overall Study|Withdrawal by Subject|3|||
48364625|NCT02731690|155530404|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
48364626|NCT02735577|155530405|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
48364627|NCT02735577|155530405|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
48364628|NCT01552603|155530409|FG000|Overall Study|Physician Decision|1|||
48364629|NCT04020185|155530410|FG000|Overall Study|Death|0|||
48364630|NCT04020185|155530411|FG001|Overall Study|Death|0|||
48364631|NCT04020185|155530412|FG002|Overall Study|Death|1|||
48364632|NCT04020185|155530413|FG003|Overall Study|Death|2|||
48364633|NCT04020185|155530414|FG004|Overall Study|Death|1|||
48364634|NCT04020185|155530415|FG005|Overall Study|Death|0|||
48364635|NCT04020185|155530416|FG006|Overall Study|Death|1|||
48364636|NCT04020185|155530417|FG007|Overall Study|Death|0|||
48364637|NCT04020185|155530410|FG000|Overall Study|Consent withdrawn|1|||
48364638|NCT04020185|155530411|FG001|Overall Study|Consent withdrawn|0|||
48364639|NCT04020185|155530412|FG002|Overall Study|Consent withdrawn|0|||
48364640|NCT04020185|155530413|FG003|Overall Study|Consent withdrawn|0|||
48364641|NCT04020185|155530414|FG004|Overall Study|Consent withdrawn|2|||
48364642|NCT04020185|155530415|FG005|Overall Study|Consent withdrawn|0|||
48364643|NCT04020185|155530416|FG006|Overall Study|Consent withdrawn|1|||
48364644|NCT04020185|155530417|FG007|Overall Study|Consent withdrawn|1|||
48364645|NCT04020185|155530410|FG000|Overall Study|Patient in hospice|0|||
48364646|NCT04020185|155530411|FG001|Overall Study|Patient in hospice|1|||
48364647|NCT04020185|155530412|FG002|Overall Study|Patient in hospice|0|||
48364648|NCT04020185|155530413|FG003|Overall Study|Patient in hospice|0|||
48364649|NCT04020185|155530414|FG004|Overall Study|Patient in hospice|0|||
48364650|NCT04020185|155530415|FG005|Overall Study|Patient in hospice|0|||
48364651|NCT04020185|155530416|FG006|Overall Study|Patient in hospice|0|||
48364652|NCT04020185|155530417|FG007|Overall Study|Patient in hospice|0|||
48364653|NCT04020185|155530410|FG000|Overall Study|Continuing on expanded access|0|||
48364654|NCT04020185|155530411|FG001|Overall Study|Continuing on expanded access|0|||
48364655|NCT04020185|155530412|FG002|Overall Study|Continuing on expanded access|0|||
48364656|NCT04020185|155530413|FG003|Overall Study|Continuing on expanded access|0|||
48364657|NCT04020185|155530414|FG004|Overall Study|Continuing on expanded access|0|||
48364658|NCT04020185|155530415|FG005|Overall Study|Continuing on expanded access|0|||
48364659|NCT04020185|155530416|FG006|Overall Study|Continuing on expanded access|1|||
48364660|NCT04020185|155530417|FG007|Overall Study|Continuing on expanded access|1|||
48364661|NCT02898077|155530418|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
48364662|NCT02898077|155530419|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
48364663|NCT02898077|155530418|FG000|Overall Study|Lost to Follow-up|4|||
48364664|NCT02898077|155530419|FG001|Overall Study|Lost to Follow-up|3|||
48364665|NCT02898077|155530418|FG000|Overall Study|Physician Decision|0|||
48364666|NCT02898077|155530419|FG001|Overall Study|Physician Decision|2|||
48364667|NCT02898077|155530418|FG000|Overall Study|Sponsor Decision|32|||
48364668|NCT02898077|155530419|FG001|Overall Study|Sponsor Decision|13|||
48364669|NCT02898077|155530418|FG000|Overall Study|Withdrawal by Subject|6|||
48364670|NCT02898077|155530419|FG001|Overall Study|Withdrawal by Subject|3|||
48364671|NCT02898077|155530418|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
48364672|NCT02898077|155530419|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
48364673|NCT02898077|155530418|FG000|Overall Study|Ended extension period|3|||
48364674|NCT02898077|155530419|FG001|Overall Study|Ended extension period|0|||
48364675|NCT03330405|155530420|FG000|Overall Study|Other|1|||
48364676|NCT03330405|155530421|FG001|Overall Study|Other|3|||
48364677|NCT03330405|155530422|FG002|Overall Study|Other|1|||
48364678|NCT03330405|155530423|FG003|Overall Study|Other|0|||
48364679|NCT03330405|155530424|FG004|Overall Study|Other|2|||
48364680|NCT03330405|155530425|FG005|Overall Study|Other|0|||
48364681|NCT03330405|155530426|FG006|Overall Study|Other|1|||
48364682|NCT03330405|155530427|FG007|Overall Study|Other|0|||
48364683|NCT03330405|155530428|FG008|Overall Study|Other|0|||
48364684|NCT03330405|155530429|FG009|Overall Study|Other|0|||
48364685|NCT03330405|155530430|FG010|Overall Study|Other|0|||
48364686|NCT03330405|155530420|FG000|Overall Study|Progressive disease|8|||
48364687|NCT03330405|155530421|FG001|Overall Study|Progressive disease|27|||
48364688|NCT03330405|155530422|FG002|Overall Study|Progressive disease|4|||
48364689|NCT03330405|155530423|FG003|Overall Study|Progressive disease|18|||
48414241|NCT01381094|155705492|FG001|Overall Study|Participant given Aranesp injection|0|||
48364690|NCT03330405|155530424|FG004|Overall Study|Progressive disease|16|||
48364691|NCT03330405|155530425|FG005|Overall Study|Progressive disease|14|||
48364692|NCT03330405|155530426|FG006|Overall Study|Progressive disease|7|||
48364693|NCT03330405|155530427|FG007|Overall Study|Progressive disease|29|||
48364694|NCT03330405|155530428|FG008|Overall Study|Progressive disease|9|||
48364695|NCT03330405|155530429|FG009|Overall Study|Progressive disease|11|||
48364696|NCT03330405|155530430|FG010|Overall Study|Progressive disease|5|||
48364697|NCT03330405|155530420|FG000|Overall Study|Withdrawal by Subject|1|||
48364698|NCT03330405|155530421|FG001|Overall Study|Withdrawal by Subject|4|||
48364699|NCT03330405|155530422|FG002|Overall Study|Withdrawal by Subject|0|||
48364700|NCT03330405|155530423|FG003|Overall Study|Withdrawal by Subject|1|||
48364701|NCT03330405|155530424|FG004|Overall Study|Withdrawal by Subject|1|||
48364702|NCT03330405|155530425|FG005|Overall Study|Withdrawal by Subject|1|||
48364703|NCT03330405|155530426|FG006|Overall Study|Withdrawal by Subject|0|||
48364704|NCT03330405|155530427|FG007|Overall Study|Withdrawal by Subject|2|||
48364705|NCT03330405|155530428|FG008|Overall Study|Withdrawal by Subject|2|||
48364706|NCT03330405|155530429|FG009|Overall Study|Withdrawal by Subject|1|||
48364707|NCT03330405|155530430|FG010|Overall Study|Withdrawal by Subject|1|||
48364708|NCT03330405|155530420|FG000|Overall Study|Global deterioration of health status|2|||
48364709|NCT03330405|155530421|FG001|Overall Study|Global deterioration of health status|3|||
48364710|NCT03330405|155530422|FG002|Overall Study|Global deterioration of health status|0|||
48364711|NCT03330405|155530423|FG003|Overall Study|Global deterioration of health status|2|||
48364712|NCT03330405|155530424|FG004|Overall Study|Global deterioration of health status|3|||
48364713|NCT03330405|155530425|FG005|Overall Study|Global deterioration of health status|3|||
48364714|NCT03330405|155530426|FG006|Overall Study|Global deterioration of health status|0|||
48364715|NCT03330405|155530427|FG007|Overall Study|Global deterioration of health status|2|||
48364716|NCT03330405|155530428|FG008|Overall Study|Global deterioration of health status|8|||
48364717|NCT03330405|155530429|FG009|Overall Study|Global deterioration of health status|4|||
48364718|NCT03330405|155530430|FG010|Overall Study|Global deterioration of health status|1|||
48364719|NCT03330405|155530420|FG000|Overall Study|Adverse Event|0|||
48364720|NCT03330405|155530421|FG001|Overall Study|Adverse Event|1|||
48364721|NCT03330405|155530422|FG002|Overall Study|Adverse Event|0|||
48364722|NCT03330405|155530423|FG003|Overall Study|Adverse Event|1|||
48414242|NCT01381094|155705493|FG002|Overall Study|Participant given Aranesp injection|0|||
48414243|NCT01381094|155705494|FG003|Overall Study|Participant given Aranesp injection|0|||
48414244|NCT01381094|155705495|FG004|Overall Study|Participant given Aranesp injection|0|||
48414245|NCT00522392|155705498|FG000|Overall Study|Disease progression|0|||
48414246|NCT00522392|155705499|FG001|Overall Study|Disease progression|3|||
48414247|NCT00522392|155705498|FG000|Overall Study|Adverse Event|7|||
48414248|NCT00522392|155705499|FG001|Overall Study|Adverse Event|7|||
48414249|NCT00522392|155705498|FG000|Overall Study|Withdrawal by Subject|1|||
48414250|NCT00522392|155705499|FG001|Overall Study|Withdrawal by Subject|1|||
48414251|NCT00522392|155705498|FG000|Overall Study|Physician Decision|0|||
48414252|NCT00522392|155705499|FG001|Overall Study|Physician Decision|1|||
48414253|NCT00522392|155705498|FG000|Overall Study|Non-compliance|0|||
48414254|NCT00522392|155705499|FG001|Overall Study|Non-compliance|1|||
48414255|NCT00486902|155705500|FG000|Overall Study|Withdrawal by Subject|1|||
48414256|NCT00486902|155705501|FG001|Overall Study|Withdrawal by Subject|2|||
48364723|NCT03330405|155530424|FG004|Overall Study|Adverse Event|1|||
48364724|NCT03330405|155530425|FG005|Overall Study|Adverse Event|1|||
48364725|NCT03330405|155530426|FG006|Overall Study|Adverse Event|3|||
48364726|NCT03330405|155530427|FG007|Overall Study|Adverse Event|4|||
48364727|NCT03330405|155530428|FG008|Overall Study|Adverse Event|2|||
48364728|NCT03330405|155530429|FG009|Overall Study|Adverse Event|2|||
48364729|NCT03330405|155530430|FG010|Overall Study|Adverse Event|2|||
48364730|NCT03330405|155530420|FG000|Overall Study|Death|0|||
48364731|NCT03330405|155530421|FG001|Overall Study|Death|4|||
48364732|NCT03330405|155530422|FG002|Overall Study|Death|0|||
48364733|NCT03330405|155530423|FG003|Overall Study|Death|0|||
48364734|NCT03330405|155530424|FG004|Overall Study|Death|0|||
48364735|NCT03330405|155530425|FG005|Overall Study|Death|1|||
48364736|NCT03330405|155530426|FG006|Overall Study|Death|0|||
48364737|NCT03330405|155530427|FG007|Overall Study|Death|2|||
48364738|NCT03330405|155530428|FG008|Overall Study|Death|0|||
48364739|NCT03330405|155530429|FG009|Overall Study|Death|0|||
48364740|NCT03330405|155530430|FG010|Overall Study|Death|0|||
48364741|NCT03330405|155530420|FG000|Overall Study|Physician Decision|0|||
48364742|NCT03330405|155530421|FG001|Overall Study|Physician Decision|0|||
48364743|NCT03330405|155530422|FG002|Overall Study|Physician Decision|0|||
48364744|NCT03330405|155530423|FG003|Overall Study|Physician Decision|0|||
48364745|NCT03330405|155530424|FG004|Overall Study|Physician Decision|0|||
48364746|NCT03330405|155530425|FG005|Overall Study|Physician Decision|0|||
48364747|NCT03330405|155530426|FG006|Overall Study|Physician Decision|0|||
48364748|NCT03330405|155530427|FG007|Overall Study|Physician Decision|1|||
48364749|NCT03330405|155530428|FG008|Overall Study|Physician Decision|0|||
48364750|NCT03330405|155530429|FG009|Overall Study|Physician Decision|0|||
48364751|NCT03330405|155530430|FG010|Overall Study|Physician Decision|0|||
48364752|NCT00626197|155530431|FG000|Overall Study|Did not cooperate|2|||
48364753|NCT00626197|155530432|FG001|Overall Study|Did not cooperate|6|||
48364754|NCT00626197|155530433|FG002|Overall Study|Did not cooperate|1|||
48364755|NCT00626197|155530431|FG000|Overall Study|Failure to return|6|||
48364756|NCT00626197|155530432|FG001|Overall Study|Failure to return|5|||
48364757|NCT00626197|155530433|FG002|Overall Study|Failure to return|6|||
48364758|NCT00626197|155530431|FG000|Overall Study|Adverse event, serious fatal|3|||
48364759|NCT00626197|155530432|FG001|Overall Study|Adverse event, serious fatal|6|||
48364760|NCT00626197|155530433|FG002|Overall Study|Adverse event, serious fatal|6|||
48414257|NCT00486902|155705500|FG000|Overall Study|decision for postpartum tubal ligation|3|||
48364761|NCT00626197|155530431|FG000|Overall Study|Adverse Event|1|||
48364762|NCT00626197|155530432|FG001|Overall Study|Adverse Event|1|||
48364763|NCT00626197|155530433|FG002|Overall Study|Adverse Event|2|||
48364764|NCT00626197|155530431|FG000|Overall Study|Withdrawal by Subject|17|||
48364765|NCT00626197|155530432|FG001|Overall Study|Withdrawal by Subject|17|||
48364766|NCT00626197|155530433|FG002|Overall Study|Withdrawal by Subject|7|||
48364767|NCT00626197|155530431|FG000|Overall Study|Administrative reasons|15|||
48364768|NCT00626197|155530432|FG001|Overall Study|Administrative reasons|19|||
48364769|NCT00626197|155530433|FG002|Overall Study|Administrative reasons|55|||
48364770|NCT00022659|155530434|FG000|Overall Study|Ineligible: wrong primary|1|||
48364771|NCT00022659|155530434|FG000|Overall Study|Never treated|1|||
48364772|NCT01757197|155530435|FG000|Overall Study|Death|2|||
48364773|NCT02236988|155530436|FG000|Overall Study|Lost to Follow-up|0|||
48364774|NCT02236988|155530437|FG001|Overall Study|Lost to Follow-up|0|||
48364775|NCT02236988|155530438|FG002|Overall Study|Lost to Follow-up|0|||
48364776|NCT02236988|155530439|FG003|Overall Study|Lost to Follow-up|1|||
48364777|NCT02236988|155530436|FG000|Overall Study|Unable to Comply with Study Visits|0|||
48364778|NCT02236988|155530437|FG001|Overall Study|Unable to Comply with Study Visits|0|||
48364779|NCT02236988|155530438|FG002|Overall Study|Unable to Comply with Study Visits|0|||
48364780|NCT02236988|155530439|FG003|Overall Study|Unable to Comply with Study Visits|2|||
48364781|NCT00608868|155530440|FG000|Overall Study|Withdrawal by Subject|7|||
48364782|NCT00608868|155530440|FG000|Overall Study|Protocol Violation|3|||
48364783|NCT00608868|155530440|FG000|Overall Study|Lost to Follow-up|2|||
48364784|NCT00608868|155530440|FG000|Overall Study|Adverse Event|1|||
48364785|NCT00608868|155530440|FG000|Overall Study|Physician Decision|2|||
48364786|NCT04032613|155530441|FG000|Overall Study|Did not complete post-program assessment|5|||
48364787|NCT04032613|155530442|FG001|Overall Study|Did not complete post-program assessment|2|||
48364788|NCT00523640|155530444|FG000|Overall Study|Death|1|||
48364789|NCT05032872|155530446|FG000|Overall Study|Adverse Event|1|||
48364790|NCT05032872|155530447|FG001|Overall Study|Adverse Event|0|||
48364791|NCT05032872|155530446|FG000|Overall Study|Lost to Follow-up|2|||
48364792|NCT05032872|155530447|FG001|Overall Study|Lost to Follow-up|4|||
48364793|NCT05032872|155530446|FG000|Overall Study|Withdrawal by Subject|4|||
48364794|NCT05032872|155530447|FG001|Overall Study|Withdrawal by Subject|3|||
48364795|NCT04514510|155530450|FG000|Overall Study|Lost to Follow-up|0|||
48364796|NCT04514510|155530451|FG001|Overall Study|Lost to Follow-up|1|||
48364797|NCT04514510|155530450|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
48364798|NCT04514510|155530451|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
48364799|NCT00488475|155530458|FG000|Overall Study|Other|1754|||
48364800|NCT02964325|155530463|FG000|Overall Study|Lost to Follow-up|3|||
48364801|NCT02964325|155530464|FG001|Overall Study|Lost to Follow-up|3|||
48364802|NCT02964325|155530463|FG000|Overall Study|Physician Decision|5|||
48364803|NCT02964325|155530464|FG001|Overall Study|Physician Decision|4|||
48364804|NCT02964325|155530463|FG000|Overall Study|Death|1|||
48364805|NCT02964325|155530464|FG001|Overall Study|Death|3|||
48364806|NCT02964325|155530463|FG000|Overall Study|Withdrawal by Subject|2|||
48364807|NCT02964325|155530464|FG001|Overall Study|Withdrawal by Subject|1|||
48364808|NCT02964325|155530463|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
48364809|NCT02964325|155530464|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
48364810|NCT02781090|155530465|FG000|3-Month Follow-Up|Missed Visit|20|||
48364811|NCT02781090|155530466|FG001|3-Month Follow-Up|Missed Visit|20|||
48364812|NCT02781090|155530465|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
48364813|NCT02781090|155530466|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
48364814|NCT02781090|155530465|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
48364815|NCT02781090|155530466|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
48364816|NCT02781090|155530465|FG000|3-Month Follow-Up|Death|1|||
48364817|NCT02781090|155530466|FG001|3-Month Follow-Up|Death|0|||
48364818|NCT02781090|155530465|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
48364819|NCT02781090|155530466|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
48364820|NCT02781090|155530465|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
48364821|NCT02781090|155530466|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
48364822|NCT02781090|155530465|FG000|6-Month Follow-Up|Death|0|||
48364823|NCT02781090|155530466|FG001|6-Month Follow-Up|Death|1|||
48364824|NCT01867333|155530467|FG000|Overall Study|Withdrawal by Subject|1|||
48364825|NCT01867333|155530468|FG001|Overall Study|Withdrawal by Subject|0|||
48364826|NCT01867333|155530467|FG000|Overall Study|Adverse Event|1|||
48364827|NCT01867333|155530468|FG001|Overall Study|Adverse Event|0|||
48364828|NCT01867333|155530467|FG000|Overall Study|Participant choice|1|||
48364829|NCT01867333|155530468|FG001|Overall Study|Participant choice|2|||
48364830|NCT01867333|155530467|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
48414258|NCT00486902|155705501|FG001|Overall Study|decision for postpartum tubal ligation|1|||
48364831|NCT01867333|155530468|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
48364832|NCT01867333|155530467|FG000|Overall Study|Death|0|||
48364833|NCT01867333|155530468|FG001|Overall Study|Death|1|||
48364834|NCT01867333|155530467|FG000|Overall Study|Physician Decision|3|||
48364835|NCT01867333|155530468|FG001|Overall Study|Physician Decision|2|||
48364836|NCT01867333|155530467|FG000|Overall Study|Switched to alternative treatment|1|||
48414259|NCT00486902|155705500|FG000|Overall Study|spinal anesthetic protocal violation|1|||
48414260|NCT00486902|155705501|FG001|Overall Study|spinal anesthetic protocal violation|1|||
48414261|NCT00486902|155705500|FG000|Overall Study|Did not meet inclusion criteria|1|||
48414262|NCT00486902|155705501|FG001|Overall Study|Did not meet inclusion criteria|0|||
48414263|NCT00486902|155705500|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
48414264|NCT00486902|155705501|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
48414265|NCT01409928|155705503|FG000|Overall Study|Physician Decision|12|||
48414266|NCT00432237|155705504|FG000|Overall Study|Adverse Event|0|||
48414267|NCT00432237|155705505|FG001|Overall Study|Adverse Event|0|||
48414268|NCT00432237|155705506|FG002|Overall Study|Adverse Event|0|||
48414269|NCT00432237|155705507|FG003|Overall Study|Adverse Event|1|||
48364837|NCT01867333|155530468|FG001|Overall Study|Switched to alternative treatment|0|||
48364838|NCT04075994|155530469|FG000|Overall Study|Withdrawal by Subject|8|||
48364839|NCT04075994|155530470|FG001|Overall Study|Withdrawal by Subject|9|||
48364840|NCT04075994|155530469|FG000|Overall Study|Adverse Event|2|||
48364841|NCT04075994|155530470|FG001|Overall Study|Adverse Event|2|||
48364842|NCT04075994|155530469|FG000|Overall Study|Investigator withdrew|3|||
48364843|NCT04075994|155530470|FG001|Overall Study|Investigator withdrew|1|||
48364844|NCT02770612|155530472|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
48364845|NCT05330676|155530473|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
48364846|NCT05330676|155530474|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
48364847|NCT01305239|155530476|FG000|Overall Study|Adverse Event|22|||
48364848|NCT01305239|155530476|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
48364849|NCT01361594|155530479|FG000|Overall Study|Withdrawal by Subject|1|||
48364850|NCT01361594|155530480|FG001|Overall Study|Withdrawal by Subject|2|||
48364851|NCT03525392|155530491|FG000|Overall Study|Adverse Event|1|||
48364852|NCT03525392|155530492|FG001|Overall Study|Adverse Event|0|||
48364853|NCT03525392|155530493|FG002|Overall Study|Adverse Event|2|||
48364854|NCT03525392|155530494|FG003|Overall Study|Adverse Event|0|||
48364855|NCT03525392|155530495|FG004|Overall Study|Adverse Event|0|||
48364856|NCT03525392|155530491|FG000|Overall Study|Progressive disease|0|||
48364857|NCT03525392|155530492|FG001|Overall Study|Progressive disease|1|||
48364858|NCT03525392|155530493|FG002|Overall Study|Progressive disease|1|||
48364859|NCT03525392|155530494|FG003|Overall Study|Progressive disease|3|||
48364860|NCT03525392|155530495|FG004|Overall Study|Progressive disease|1|||
48364861|NCT02703259|155530500|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
48364862|NCT02703259|155530501|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
48364863|NCT02703259|155530500|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
48364864|NCT02703259|155530501|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
48364865|NCT02703259|155530500|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
48364866|NCT02703259|155530501|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
48364867|NCT01012414|155530502|FG000|Overall Study|Withdrawal by Subject|2|||
48364868|NCT01012414|155530502|FG000|Overall Study|Lost to Follow-up|1|||
48364869|NCT01012414|155530502|FG000|Overall Study|Trial was stopped before completed|7|||
48364870|NCT05917470|155530503|FG000|Overall Study|Progressive Disease|1|||
48414270|NCT00432237|155705504|FG000|Overall Study|Lack of Efficacy|0|||
48414271|NCT00432237|155705505|FG001|Overall Study|Lack of Efficacy|0|||
48414272|NCT00432237|155705506|FG002|Overall Study|Lack of Efficacy|0|||
48414273|NCT00432237|155705507|FG003|Overall Study|Lack of Efficacy|1|||
48364871|NCT05917470|155530504|FG001|Overall Study|Progressive Disease|1|||
48364872|NCT05917470|155530505|FG002|Overall Study|Progressive Disease|2|||
48364873|NCT05917470|155530506|FG003|Overall Study|Progressive Disease|3|||
48364874|NCT05917470|155530507|FG004|Overall Study|Progressive Disease|1|||
48364875|NCT05917470|155530508|FG005|Overall Study|Progressive Disease|1|||
48364876|NCT05917470|155530509|FG006|Overall Study|Progressive Disease|0|||
48364877|NCT05917470|155530510|FG007|Overall Study|Progressive Disease|0|||
48364878|NCT05917470|155530503|FG000|Overall Study|Withdrawal by Subject|0|||
48364879|NCT05917470|155530504|FG001|Overall Study|Withdrawal by Subject|0|||
48364880|NCT05917470|155530505|FG002|Overall Study|Withdrawal by Subject|1|||
48364881|NCT05917470|155530506|FG003|Overall Study|Withdrawal by Subject|0|||
48364882|NCT05917470|155530507|FG004|Overall Study|Withdrawal by Subject|0|||
48364883|NCT05917470|155530508|FG005|Overall Study|Withdrawal by Subject|0|||
48364884|NCT05917470|155530509|FG006|Overall Study|Withdrawal by Subject|0|||
48364885|NCT05917470|155530510|FG007|Overall Study|Withdrawal by Subject|0|||
48364886|NCT05917470|155530503|FG000|Overall Study|Sponsor Decision|0|||
48364887|NCT05917470|155530504|FG001|Overall Study|Sponsor Decision|0|||
48364888|NCT05917470|155530505|FG002|Overall Study|Sponsor Decision|1|||
48364889|NCT05917470|155530506|FG003|Overall Study|Sponsor Decision|0|||
48364890|NCT05917470|155530507|FG004|Overall Study|Sponsor Decision|2|||
48364891|NCT05917470|155530508|FG005|Overall Study|Sponsor Decision|1|||
48364892|NCT05917470|155530509|FG006|Overall Study|Sponsor Decision|3|||
48364893|NCT05917470|155530510|FG007|Overall Study|Sponsor Decision|3|||
48364894|NCT05917470|155530503|FG000|Overall Study|Adverse Event|0|||
48364895|NCT05917470|155530504|FG001|Overall Study|Adverse Event|0|||
48364896|NCT05917470|155530505|FG002|Overall Study|Adverse Event|0|||
48414274|NCT00432237|155705504|FG000|Overall Study|Lost to Follow-up|10|||
48414275|NCT00432237|155705505|FG001|Overall Study|Lost to Follow-up|10|||
48414276|NCT00432237|155705506|FG002|Overall Study|Lost to Follow-up|18|||
48414277|NCT00432237|155705507|FG003|Overall Study|Lost to Follow-up|18|||
48414278|NCT00432237|155705504|FG000|Overall Study|Physician Decision|1|||
48414279|NCT00432237|155705505|FG001|Overall Study|Physician Decision|3|||
48414280|NCT00432237|155705506|FG002|Overall Study|Physician Decision|2|||
48414281|NCT00432237|155705507|FG003|Overall Study|Physician Decision|1|||
48414282|NCT00432237|155705504|FG000|Overall Study|Pregnancy|0|||
48414283|NCT00432237|155705505|FG001|Overall Study|Pregnancy|1|||
48414284|NCT00432237|155705506|FG002|Overall Study|Pregnancy|0|||
48414285|NCT00432237|155705507|FG003|Overall Study|Pregnancy|0|||
48414286|NCT00432237|155705504|FG000|Overall Study|Protocol Violation|13|||
48414287|NCT00432237|155705505|FG001|Overall Study|Protocol Violation|10|||
48414288|NCT00432237|155705506|FG002|Overall Study|Protocol Violation|11|||
48414289|NCT00432237|155705507|FG003|Overall Study|Protocol Violation|8|||
48414290|NCT00432237|155705504|FG000|Overall Study|Withdrawal by Subject|5|||
48414291|NCT00432237|155705505|FG001|Overall Study|Withdrawal by Subject|6|||
48414292|NCT00432237|155705506|FG002|Overall Study|Withdrawal by Subject|9|||
48414293|NCT00432237|155705507|FG003|Overall Study|Withdrawal by Subject|11|||
48414294|NCT00432237|155705504|FG000|Overall Study|Lack of Qualifying Event|38|||
48364897|NCT05917470|155530506|FG003|Overall Study|Adverse Event|0|||
48364898|NCT05917470|155530507|FG004|Overall Study|Adverse Event|0|||
48414295|NCT00432237|155705505|FG001|Overall Study|Lack of Qualifying Event|71|||
48414296|NCT00432237|155705506|FG002|Overall Study|Lack of Qualifying Event|69|||
48364899|NCT05917470|155530508|FG005|Overall Study|Adverse Event|1|||
48364900|NCT05917470|155530509|FG006|Overall Study|Adverse Event|0|||
48364901|NCT05917470|155530510|FG007|Overall Study|Adverse Event|0|||
48364902|NCT01255631|155532423|FG000|Overall Study|poor enrollment, no data analyzed|9|||
48364903|NCT01255631|155532424|FG001|Overall Study|poor enrollment, no data analyzed|6|||
48364904|NCT03339245|155532425|FG000|Overall Study|Adverse Event|1|||
48364905|NCT03339245|155532426|FG001|Overall Study|Adverse Event|1|||
48364906|NCT03339245|155532425|FG000|Overall Study|Withdrawal by Subject|1|||
48364907|NCT03339245|155532426|FG001|Overall Study|Withdrawal by Subject|0|||
48364908|NCT02124811|155532439|FG000|Overall Study|Early termination|2|||
48364909|NCT02124811|155532440|FG001|Overall Study|Early termination|2|||
48364910|NCT02124811|155532439|FG000|Overall Study|Withdrawal by Subject|1|||
48364911|NCT02124811|155532440|FG001|Overall Study|Withdrawal by Subject|0|||
48364912|NCT01332630|155532443|FG000|Overall Study|Withdrawal by Subject|3|||
48364913|NCT00316602|155532444|FG000|Overall Study|Withdrawal by Subject|3|||
48364914|NCT00316602|155532445|FG001|Overall Study|Withdrawal by Subject|2|||
48364915|NCT00316602|155532444|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
48364916|NCT00316602|155532445|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
48364917|NCT00316602|155532444|FG000|Overall Study|Adverse Event|1|||
48414297|NCT00432237|155705507|FG003|Overall Study|Lack of Qualifying Event|84|||
48414298|NCT02357420|155705508|FG000|Overall Study|Adverse Event|3|||
48414299|NCT02357420|155705509|FG001|Overall Study|Adverse Event|3|||
48414300|NCT02357420|155705510|FG002|Overall Study|Adverse Event|8|||
48414301|NCT02357420|155705511|FG003|Overall Study|Adverse Event|9|||
48414302|NCT02357420|155705508|FG000|Overall Study|Investigator Decision|1|||
48414303|NCT02357420|155705509|FG001|Overall Study|Investigator Decision|0|||
48414304|NCT02357420|155705510|FG002|Overall Study|Investigator Decision|0|||
48414305|NCT02357420|155705511|FG003|Overall Study|Investigator Decision|0|||
48414306|NCT02357420|155705508|FG000|Overall Study|Prohibited Medication|1|||
48364918|NCT00316602|155532445|FG001|Overall Study|Adverse Event|0|||
48364919|NCT00316602|155532444|FG000|Overall Study|Other|3|||
48364920|NCT00316602|155532445|FG001|Overall Study|Other|6|||
48364921|NCT01008410|155532446|FG000|Overall Study|Adverse Event|13|||
48364922|NCT01008410|155532447|FG001|Overall Study|Adverse Event|7|||
48364923|NCT01008410|155532446|FG000|Overall Study|Withdrawal by Subject|6|||
48364924|NCT01008410|155532447|FG001|Overall Study|Withdrawal by Subject|2|||
48364925|NCT01008410|155532446|FG000|Overall Study|Lost to Follow-up|1|||
48364926|NCT01008410|155532447|FG001|Overall Study|Lost to Follow-up|0|||
48364927|NCT01008410|155532446|FG000|Overall Study|Noncompliance|1|||
48364928|NCT01008410|155532447|FG001|Overall Study|Noncompliance|0|||
48364929|NCT01008410|155532446|FG000|Overall Study|Low Cortisol|2|||
48364930|NCT01008410|155532447|FG001|Overall Study|Low Cortisol|0|||
48364931|NCT01008410|155532446|FG000|Overall Study|Lack of Efficacy|2|||
48364932|NCT01008410|155532447|FG001|Overall Study|Lack of Efficacy|6|||
48364933|NCT01008410|155532446|FG000|Overall Study|Met Exclusion Criterion|0|||
48364934|NCT01008410|155532447|FG001|Overall Study|Met Exclusion Criterion|1|||
48414307|NCT02357420|155705509|FG001|Overall Study|Prohibited Medication|1|||
48414308|NCT02357420|155705510|FG002|Overall Study|Prohibited Medication|0|||
48414309|NCT02357420|155705511|FG003|Overall Study|Prohibited Medication|0|||
48414310|NCT02357420|155705508|FG000|Overall Study|Protocol Non-compliance|0|||
48414311|NCT02357420|155705509|FG001|Overall Study|Protocol Non-compliance|0|||
48364935|NCT01302067|155532448|FG000|Overall Study|Death|0|||
48414312|NCT02357420|155705510|FG002|Overall Study|Protocol Non-compliance|0|||
48431606|NCT03599141|155767329|FG001|Overall Study|Lost to Follow-up|1|||
48414313|NCT02357420|155705511|FG003|Overall Study|Protocol Non-compliance|1|||
48414314|NCT02357420|155705508|FG000|Overall Study|Withdrawn Consent|4|||
48414315|NCT02357420|155705509|FG001|Overall Study|Withdrawn Consent|8|||
48414316|NCT02357420|155705510|FG002|Overall Study|Withdrawn Consent|6|||
48364936|NCT01302067|155532449|FG001|Overall Study|Death|0|||
48364937|NCT01302067|155532450|FG002|Overall Study|Death|1|||
48364938|NCT01302067|155532448|FG000|Overall Study|Physician Decision|9|||
48364939|NCT01302067|155532449|FG001|Overall Study|Physician Decision|5|||
48364940|NCT01302067|155532450|FG002|Overall Study|Physician Decision|14|||
48364941|NCT01302067|155532448|FG000|Overall Study|Lack of Efficacy|8|||
48364942|NCT01302067|155532449|FG001|Overall Study|Lack of Efficacy|4|||
48364943|NCT01302067|155532450|FG002|Overall Study|Lack of Efficacy|2|||
48364944|NCT01302067|155532448|FG000|Overall Study|Lost to Follow-up|9|||
48364945|NCT01302067|155532449|FG001|Overall Study|Lost to Follow-up|4|||
48364946|NCT01302067|155532450|FG002|Overall Study|Lost to Follow-up|15|||
48364947|NCT01302067|155532448|FG000|Overall Study|Withdrawal by Subject|13|||
48364948|NCT01302067|155532449|FG001|Overall Study|Withdrawal by Subject|6|||
48364949|NCT01302067|155532450|FG002|Overall Study|Withdrawal by Subject|10|||
48364950|NCT01302067|155532448|FG000|Overall Study|Other|1|||
48364951|NCT01302067|155532449|FG001|Overall Study|Other|1|||
48364952|NCT01302067|155532450|FG002|Overall Study|Other|3|||
48364953|NCT01302067|155532448|FG000|Overall Study|Protocol Violation|11|||
48364954|NCT01302067|155532449|FG001|Overall Study|Protocol Violation|0|||
48364955|NCT01302067|155532450|FG002|Overall Study|Protocol Violation|8|||
48364956|NCT01302067|155532448|FG000|Overall Study|Adverse Event|27|||
48364957|NCT01302067|155532449|FG001|Overall Study|Adverse Event|14|||
48364958|NCT01302067|155532450|FG002|Overall Study|Adverse Event|45|||
48364959|NCT02349425|155532451|FG000|Period 1|Adverse Event|1|||
48364960|NCT02349425|155532452|FG001|Period 1|Adverse Event|1|||
48364961|NCT02349425|155532453|FG002|Period 1|Adverse Event|0|||
48364962|NCT02349425|155532454|FG003|Period 1|Adverse Event|0|||
48364963|NCT02349425|155532451|FG000|Period 2|Adverse Event|0|||
48364964|NCT02349425|155532452|FG001|Period 2|Adverse Event|1|||
48364965|NCT02349425|155532453|FG002|Period 2|Adverse Event|1|||
48364966|NCT02349425|155532454|FG003|Period 2|Adverse Event|0|||
48364967|NCT01498887|155532455|FG000|Overall Study|Administrative problems|1|||
48364968|NCT01498887|155532456|FG001|Overall Study|Administrative problems|0|||
48364969|NCT01498887|155532455|FG000|Overall Study|Lost to Follow-up|1|||
48364970|NCT01498887|155532456|FG001|Overall Study|Lost to Follow-up|1|||
48364971|NCT01498887|155532455|FG000|Overall Study|Withdrawal by Subject|1|||
48364972|NCT01498887|155532456|FG001|Overall Study|Withdrawal by Subject|0|||
48364973|NCT01498887|155532455|FG000|Overall Study|Protocol Violation|1|||
48364974|NCT01498887|155532456|FG001|Overall Study|Protocol Violation|3|||
48364975|NCT01498887|155532455|FG000|Overall Study|Lack of Efficacy|5|||
48364976|NCT01498887|155532456|FG001|Overall Study|Lack of Efficacy|3|||
48364977|NCT01498887|155532455|FG000|Overall Study|Abnormal result from test procedure|1|||
48364978|NCT01498887|155532456|FG001|Overall Study|Abnormal result from test procedure|1|||
48364979|NCT01498887|155532455|FG000|Overall Study|Abnormal laboratory value|2|||
48364980|NCT01498887|155532456|FG001|Overall Study|Abnormal laboratory value|2|||
48364981|NCT01498887|155532455|FG000|Overall Study|Adverse Event|4|||
48364982|NCT01498887|155532456|FG001|Overall Study|Adverse Event|1|||
48364983|NCT02738203|155532457|FG000|Overall Study|Failed IUD Insertion|2|||
48364984|NCT02738203|155532458|FG001|Overall Study|Failed IUD Insertion|2|||
48364985|NCT02738203|155532457|FG000|Overall Study|Protocol Violation|0|||
48364986|NCT02738203|155532458|FG001|Overall Study|Protocol Violation|1|||
48364987|NCT00297427|155532459|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
48364988|NCT00297427|155532460|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
48364989|NCT00297427|155532459|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
48364990|NCT00297427|155532460|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
48364991|NCT00297427|155532459|FG000|Phase 1: Initial Intervention|Death|0|||
48364992|NCT00297427|155532460|FG001|Phase 1: Initial Intervention|Death|1|||
48364993|NCT00297427|155532459|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
48364994|NCT00297427|155532460|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
48364995|NCT00297427|155532459|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
48364996|NCT00297427|155532460|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
48364997|NCT00297427|155532459|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
48364998|NCT00297427|155532460|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
48364999|NCT00297427|155532459|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
48365000|NCT00297427|155532460|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
48365001|NCT00297427|155532459|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
48365002|NCT00297427|155532460|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
48365003|NCT03241927|155532462|FG000|Overall Study|study terminated|1|||
48365004|NCT03241927|155532463|FG001|Overall Study|study terminated|0|||
48365005|NCT03056300|155532464|FG000|Overall Study|Surgical reason per study protocol|3|||
48365006|NCT03563157|155532467|FG000|Overall Study|Progressive Disease|2|||
48414317|NCT02357420|155705511|FG003|Overall Study|Withdrawn Consent|6|||
48365007|NCT03245151|155532468|FG000|Overall Study|Withdrawal by Subject|2|||
48365008|NCT03245151|155532469|FG001|Overall Study|Withdrawal by Subject|0|||
48365009|NCT03245151|155532470|FG002|Overall Study|Withdrawal by Subject|0|||
48365010|NCT03245151|155532471|FG003|Overall Study|Withdrawal by Subject|2|||
48365011|NCT03245151|155532472|FG004|Overall Study|Withdrawal by Subject|1|||
48365012|NCT03245151|155532468|FG000|Overall Study|Death|3|||
48365013|NCT03245151|155532469|FG001|Overall Study|Death|14|||
48365014|NCT03245151|155532470|FG002|Overall Study|Death|9|||
48365015|NCT03245151|155532471|FG003|Overall Study|Death|16|||
48365016|NCT03245151|155532472|FG004|Overall Study|Death|7|||
48365017|NCT03245151|155532468|FG000|Overall Study|Sponsor's decision|0|||
48365018|NCT03245151|155532469|FG001|Overall Study|Sponsor's decision|1|||
48365019|NCT03245151|155532470|FG002|Overall Study|Sponsor's decision|0|||
48365020|NCT03245151|155532471|FG003|Overall Study|Sponsor's decision|0|||
48365021|NCT03245151|155532472|FG004|Overall Study|Sponsor's decision|0|||
48365022|NCT02942277|155532475|FG000|Year 1|Withdrawal by Subject|0|||
48365023|NCT02942277|155532476|FG001|Year 1|Withdrawal by Subject|0|||
48365024|NCT02942277|155532477|FG002|Year 1|Withdrawal by Subject|0|||
48365025|NCT02942277|155532478|FG003|Year 1|Withdrawal by Subject|0|||
48365026|NCT02942277|155532479|FG004|Year 1|Withdrawal by Subject|1|||
48365027|NCT02942277|155532480|FG005|Year 1|Withdrawal by Subject|3|||
48365028|NCT02942277|155532481|FG006|Year 1|Withdrawal by Subject|0|||
48365029|NCT02942277|155532482|FG007|Year 1|Withdrawal by Subject|1|||
48365030|NCT02942277|155532483|FG008|Year 1|Withdrawal by Subject|0|||
48365031|NCT02942277|155532484|FG009|Year 1|Withdrawal by Subject|0|||
48365032|NCT02942277|155532485|FG010|Year 1|Withdrawal by Subject|3|||
48365033|NCT02942277|155532475|FG000|Year 1|Travel|0|||
48365034|NCT02942277|155532476|FG001|Year 1|Travel|1|||
48365035|NCT02942277|155532477|FG002|Year 1|Travel|0|||
48365036|NCT02942277|155532478|FG003|Year 1|Travel|0|||
48365037|NCT02942277|155532479|FG004|Year 1|Travel|4|||
48365038|NCT02942277|155532480|FG005|Year 1|Travel|5|||
48365039|NCT02942277|155532481|FG006|Year 1|Travel|0|||
48365040|NCT02942277|155532482|FG007|Year 1|Travel|0|||
48365041|NCT02942277|155532483|FG008|Year 1|Travel|0|||
48365042|NCT02942277|155532484|FG009|Year 1|Travel|0|||
48365043|NCT02942277|155532485|FG010|Year 1|Travel|8|||
48365044|NCT02942277|155532475|FG000|Year 1|Joined Army|0|||
48365045|NCT02942277|155532476|FG001|Year 1|Joined Army|1|||
48365046|NCT02942277|155532477|FG002|Year 1|Joined Army|0|||
48365047|NCT02942277|155532478|FG003|Year 1|Joined Army|0|||
48365048|NCT02942277|155532479|FG004|Year 1|Joined Army|0|||
48365049|NCT02942277|155532480|FG005|Year 1|Joined Army|0|||
48365050|NCT02942277|155532481|FG006|Year 1|Joined Army|0|||
48365051|NCT02942277|155532482|FG007|Year 1|Joined Army|0|||
48365052|NCT02942277|155532483|FG008|Year 1|Joined Army|0|||
48365053|NCT02942277|155532484|FG009|Year 1|Joined Army|0|||
48365054|NCT02942277|155532485|FG010|Year 1|Joined Army|0|||
48365055|NCT02942277|155532475|FG000|Year 1|Subject met withdrawal criteria|0|||
48365056|NCT02942277|155532476|FG001|Year 1|Subject met withdrawal criteria|0|||
48365057|NCT02942277|155532477|FG002|Year 1|Subject met withdrawal criteria|0|||
48365058|NCT02942277|155532478|FG003|Year 1|Subject met withdrawal criteria|1|||
48365059|NCT02942277|155532479|FG004|Year 1|Subject met withdrawal criteria|0|||
48365060|NCT02942277|155532480|FG005|Year 1|Subject met withdrawal criteria|0|||
48365061|NCT02942277|155532481|FG006|Year 1|Subject met withdrawal criteria|0|||
48365062|NCT02942277|155532482|FG007|Year 1|Subject met withdrawal criteria|0|||
48365063|NCT02942277|155532483|FG008|Year 1|Subject met withdrawal criteria|0|||
48365064|NCT02942277|155532484|FG009|Year 1|Subject met withdrawal criteria|0|||
48365065|NCT02942277|155532485|FG010|Year 1|Subject met withdrawal criteria|0|||
48365066|NCT02942277|155532475|FG000|Year 1|Lost to Follow-up|0|||
48365067|NCT02942277|155532476|FG001|Year 1|Lost to Follow-up|0|||
48365068|NCT02942277|155532477|FG002|Year 1|Lost to Follow-up|0|||
48365069|NCT02942277|155532478|FG003|Year 1|Lost to Follow-up|0|||
48365070|NCT02942277|155532479|FG004|Year 1|Lost to Follow-up|1|||
48365071|NCT02942277|155532480|FG005|Year 1|Lost to Follow-up|0|||
48365072|NCT02942277|155532481|FG006|Year 1|Lost to Follow-up|0|||
48365073|NCT02942277|155532482|FG007|Year 1|Lost to Follow-up|0|||
48365074|NCT02942277|155532483|FG008|Year 1|Lost to Follow-up|0|||
48365075|NCT02942277|155532484|FG009|Year 1|Lost to Follow-up|0|||
48365076|NCT02942277|155532485|FG010|Year 1|Lost to Follow-up|2|||
48365077|NCT02942277|155532475|FG000|Year 1|Protocol Violation|0|||
48365078|NCT02942277|155532476|FG001|Year 1|Protocol Violation|0|||
48365079|NCT02942277|155532477|FG002|Year 1|Protocol Violation|0|||
48365080|NCT02942277|155532478|FG003|Year 1|Protocol Violation|0|||
48365081|NCT02942277|155532479|FG004|Year 1|Protocol Violation|1|||
48365082|NCT02942277|155532480|FG005|Year 1|Protocol Violation|1|||
48365083|NCT02942277|155532481|FG006|Year 1|Protocol Violation|0|||
48365084|NCT02942277|155532482|FG007|Year 1|Protocol Violation|0|||
48365085|NCT02942277|155532483|FG008|Year 1|Protocol Violation|0|||
48365086|NCT02942277|155532484|FG009|Year 1|Protocol Violation|0|||
48365087|NCT02942277|155532485|FG010|Year 1|Protocol Violation|2|||
48365088|NCT02942277|155532475|FG000|Year 1|Pregnancy|0|||
48365089|NCT02942277|155532476|FG001|Year 1|Pregnancy|0|||
48365090|NCT02942277|155532477|FG002|Year 1|Pregnancy|0|||
48365091|NCT02942277|155532478|FG003|Year 1|Pregnancy|0|||
48365092|NCT02942277|155532479|FG004|Year 1|Pregnancy|0|||
48365093|NCT02942277|155532480|FG005|Year 1|Pregnancy|1|||
48365094|NCT02942277|155532481|FG006|Year 1|Pregnancy|0|||
48365095|NCT02942277|155532482|FG007|Year 1|Pregnancy|0|||
48365096|NCT02942277|155532483|FG008|Year 1|Pregnancy|0|||
48365097|NCT02942277|155532484|FG009|Year 1|Pregnancy|0|||
48365098|NCT02942277|155532485|FG010|Year 1|Pregnancy|0|||
48365099|NCT02942277|155532475|FG000|Year 2|Lost to Follow-up|0|||
48365100|NCT02942277|155532476|FG001|Year 2|Lost to Follow-up|0|||
48365101|NCT02942277|155532477|FG002|Year 2|Lost to Follow-up|0|||
48365102|NCT02942277|155532478|FG003|Year 2|Lost to Follow-up|0|||
48365103|NCT02942277|155532479|FG004|Year 2|Lost to Follow-up|2|||
48365104|NCT02942277|155532480|FG005|Year 2|Lost to Follow-up|1|||
48365105|NCT02942277|155532481|FG006|Year 2|Lost to Follow-up|0|||
48365106|NCT02942277|155532482|FG007|Year 2|Lost to Follow-up|0|||
48365107|NCT02942277|155532483|FG008|Year 2|Lost to Follow-up|0|||
48365108|NCT02942277|155532484|FG009|Year 2|Lost to Follow-up|0|||
48365109|NCT02942277|155532485|FG010|Year 2|Lost to Follow-up|0|||
48365110|NCT02942277|155532475|FG000|Year 2|Did not rescreen|0|||
48365111|NCT02942277|155532476|FG001|Year 2|Did not rescreen|0|||
48365112|NCT02942277|155532477|FG002|Year 2|Did not rescreen|1|||
48365113|NCT02942277|155532478|FG003|Year 2|Did not rescreen|1|||
48365114|NCT02942277|155532479|FG004|Year 2|Did not rescreen|9|||
48365115|NCT02942277|155532480|FG005|Year 2|Did not rescreen|6|||
48365116|NCT02942277|155532481|FG006|Year 2|Did not rescreen|0|||
48365117|NCT02942277|155532482|FG007|Year 2|Did not rescreen|1|||
48365118|NCT02942277|155532483|FG008|Year 2|Did not rescreen|0|||
48365119|NCT02942277|155532484|FG009|Year 2|Did not rescreen|0|||
48365120|NCT02942277|155532485|FG010|Year 2|Did not rescreen|21|||
48365121|NCT02942277|155532475|FG000|Year 2|Met withdrawal criteria|0|||
48365122|NCT02942277|155532476|FG001|Year 2|Met withdrawal criteria|0|||
48365123|NCT02942277|155532477|FG002|Year 2|Met withdrawal criteria|0|||
48365124|NCT02942277|155532478|FG003|Year 2|Met withdrawal criteria|0|||
48365125|NCT02942277|155532479|FG004|Year 2|Met withdrawal criteria|1|||
48365126|NCT02942277|155532480|FG005|Year 2|Met withdrawal criteria|2|||
48365127|NCT02942277|155532481|FG006|Year 2|Met withdrawal criteria|0|||
48365128|NCT02942277|155532482|FG007|Year 2|Met withdrawal criteria|0|||
48365129|NCT02942277|155532483|FG008|Year 2|Met withdrawal criteria|0|||
48365130|NCT02942277|155532484|FG009|Year 2|Met withdrawal criteria|0|||
48365131|NCT02942277|155532485|FG010|Year 2|Met withdrawal criteria|1|||
48365132|NCT02942277|155532475|FG000|Year 2|Travel|0|||
48365133|NCT02942277|155532476|FG001|Year 2|Travel|1|||
48365134|NCT02942277|155532477|FG002|Year 2|Travel|0|||
48365135|NCT02942277|155532478|FG003|Year 2|Travel|0|||
48365136|NCT02942277|155532479|FG004|Year 2|Travel|0|||
48365137|NCT02942277|155532480|FG005|Year 2|Travel|1|||
48365138|NCT02942277|155532481|FG006|Year 2|Travel|0|||
48365139|NCT02942277|155532482|FG007|Year 2|Travel|0|||
48365140|NCT02942277|155532483|FG008|Year 2|Travel|0|||
48365141|NCT02942277|155532484|FG009|Year 2|Travel|1|||
48365142|NCT02942277|155532485|FG010|Year 2|Travel|3|||
48365143|NCT02942277|155532475|FG000|Year 2|Non-compliant|0|||
48365144|NCT02942277|155532476|FG001|Year 2|Non-compliant|0|||
48365145|NCT02942277|155532477|FG002|Year 2|Non-compliant|0|||
48414318|NCT02357420|155705508|FG000|Overall Study|Lost to Follow-up|3|||
48414319|NCT02357420|155705509|FG001|Overall Study|Lost to Follow-up|0|||
48414320|NCT02357420|155705510|FG002|Overall Study|Lost to Follow-up|2|||
48414321|NCT02357420|155705511|FG003|Overall Study|Lost to Follow-up|3|||
48414322|NCT02292849|155705512|FG000|Overall Study|Lost to Follow-up|0|||
48414323|NCT02292849|155705513|FG001|Overall Study|Lost to Follow-up|2|||
48414324|NCT02292849|155705514|FG002|Overall Study|Lost to Follow-up|2|||
48365146|NCT02942277|155532478|FG003|Year 2|Non-compliant|0|||
48365147|NCT02942277|155532479|FG004|Year 2|Non-compliant|1|||
48414325|NCT02292849|155705512|FG000|Overall Study|Physician Decision|4|||
48414326|NCT02292849|155705513|FG001|Overall Study|Physician Decision|0|||
48365148|NCT02942277|155532480|FG005|Year 2|Non-compliant|1|||
48365149|NCT02942277|155532481|FG006|Year 2|Non-compliant|0|||
48365150|NCT02942277|155532482|FG007|Year 2|Non-compliant|0|||
48414327|NCT02292849|155705514|FG002|Overall Study|Physician Decision|0|||
48414328|NCT04125680|155705515|FG000|Overall Study|Lost to Follow-up|15|||
48365151|NCT02942277|155532483|FG008|Year 2|Non-compliant|0|||
48365152|NCT02942277|155532484|FG009|Year 2|Non-compliant|0|||
48365153|NCT02942277|155532485|FG010|Year 2|Non-compliant|0|||
48365154|NCT02942277|155532475|FG000|Year 2|Withdrawal by Subject|0|||
48365155|NCT02942277|155532476|FG001|Year 2|Withdrawal by Subject|0|||
48365156|NCT02942277|155532477|FG002|Year 2|Withdrawal by Subject|0|||
48365157|NCT02942277|155532478|FG003|Year 2|Withdrawal by Subject|0|||
48365158|NCT02942277|155532479|FG004|Year 2|Withdrawal by Subject|0|||
48365159|NCT02942277|155532480|FG005|Year 2|Withdrawal by Subject|0|||
48365160|NCT02942277|155532481|FG006|Year 2|Withdrawal by Subject|1|||
48414329|NCT01562028|155705516|FG000|Overall Study|Withdrawal by Subject|1|||
48414330|NCT01562028|155705517|FG001|Overall Study|Withdrawal by Subject|1|||
48414331|NCT01562028|155705516|FG000|Overall Study|Lost to Follow-up|2|||
48365161|NCT02942277|155532482|FG007|Year 2|Withdrawal by Subject|0|||
48365162|NCT02942277|155532483|FG008|Year 2|Withdrawal by Subject|0|||
48365163|NCT02942277|155532484|FG009|Year 2|Withdrawal by Subject|0|||
48365164|NCT02942277|155532485|FG010|Year 2|Withdrawal by Subject|0|||
48365165|NCT00836745|155532488|FG000|Overall Study|Death|2|||
48365166|NCT00836745|155532488|FG000|Overall Study|Lost to Follow-up|10|||
48365167|NCT00836745|155532488|FG000|Overall Study|Adverse Event|3|||
48365168|NCT00836745|155532488|FG000|Overall Study|Objective progression or relapse|4|||
48365169|NCT00836745|155532488|FG000|Overall Study|Other|2|||
48365170|NCT05096221|155532494|FG000|Part 2|Ongoing in Part 2 of the Study|63|||
48365171|NCT05096221|155532495|FG001|Part 2|Ongoing in Part 2 of the Study|62|||
48365172|NCT01669577|155532496|FG000|Overall Study|Death|22|||
48365173|NCT01669577|155532496|FG000|Overall Study|Lost to Follow-up|78|||
48365174|NCT01669577|155532496|FG000|Overall Study|Physician Decision|34|||
48365175|NCT01769326|155532497|FG000|Overall Study|Lost to Follow-up|1|||
48365176|NCT01769326|155532498|FG001|Overall Study|Lost to Follow-up|2|||
48365177|NCT01769326|155532499|FG002|Overall Study|Lost to Follow-up|0|||
48365178|NCT01769326|155532500|FG003|Overall Study|Lost to Follow-up|0|||
48365179|NCT01769326|155532497|FG000|Overall Study|unrelated injry|1|||
48365180|NCT01769326|155532498|FG001|Overall Study|unrelated injry|1|||
48365181|NCT01769326|155532499|FG002|Overall Study|unrelated injry|0|||
48365182|NCT01769326|155532500|FG003|Overall Study|unrelated injry|0|||
48365183|NCT01769326|155532497|FG000|Overall Study|got a job|0|||
48365184|NCT01769326|155532498|FG001|Overall Study|got a job|1|||
48365185|NCT01769326|155532499|FG002|Overall Study|got a job|0|||
48365186|NCT01769326|155532500|FG003|Overall Study|got a job|0|||
48365187|NCT01769326|155532497|FG000|Overall Study|Got sick and could not complete study|0|||
48365188|NCT01769326|155532498|FG001|Overall Study|Got sick and could not complete study|0|||
48365189|NCT01769326|155532499|FG002|Overall Study|Got sick and could not complete study|1|||
48365190|NCT01769326|155532500|FG003|Overall Study|Got sick and could not complete study|0|||
48365191|NCT02546921|155532503|FG000|Overall Study|Adverse Event|0|||
48365192|NCT02546921|155532504|FG001|Overall Study|Adverse Event|5|||
48365193|NCT02546921|155532505|FG002|Overall Study|Adverse Event|2|||
48365194|NCT02546921|155532506|FG003|Overall Study|Adverse Event|0|||
48414332|NCT01562028|155705517|FG001|Overall Study|Lost to Follow-up|1|||
48365195|NCT02546921|155532507|FG004|Overall Study|Adverse Event|0|||
48365196|NCT02546921|155532508|FG005|Overall Study|Adverse Event|0|||
48365197|NCT02546921|155532509|FG006|Overall Study|Adverse Event|0|||
48365198|NCT02546921|155532503|FG000|Overall Study|Evidence of Disease Progression|1|||
48365199|NCT02546921|155532504|FG001|Overall Study|Evidence of Disease Progression|0|||
48365200|NCT02546921|155532505|FG002|Overall Study|Evidence of Disease Progression|0|||
48414333|NCT00828464|155705522|FG000|Overall Study|Withdrawal by Subject|1|||
48414334|NCT04026568|155705527|FG000|Overall Study|study terminated|0|||
48414335|NCT04026568|155705528|FG001|Overall Study|study terminated|1|||
48414336|NCT02197377|155705531|FG000|Overall Study|Insertion Failure|0|||
48414337|NCT02197377|155705532|FG001|Overall Study|Insertion Failure|3|||
48414338|NCT00461175|155705533|FG000|Overall Study|Protocol Violation|522|||
48414339|NCT00461175|155705534|FG001|Overall Study|Protocol Violation|365|||
48414340|NCT00809133|155705535|FG000|Overall Study|Progressive disease|2|||
48414341|NCT00809133|155705536|FG001|Overall Study|Progressive disease|5|||
48365201|NCT02546921|155532506|FG003|Overall Study|Evidence of Disease Progression|0|||
48365202|NCT02546921|155532507|FG004|Overall Study|Evidence of Disease Progression|1|||
48365203|NCT02546921|155532508|FG005|Overall Study|Evidence of Disease Progression|0|||
48365204|NCT02546921|155532509|FG006|Overall Study|Evidence of Disease Progression|0|||
48365205|NCT02546921|155532503|FG000|Overall Study|Patient Choice|0|||
48365206|NCT02546921|155532504|FG001|Overall Study|Patient Choice|1|||
48365207|NCT02546921|155532505|FG002|Overall Study|Patient Choice|0|||
48365208|NCT02546921|155532506|FG003|Overall Study|Patient Choice|0|||
48365209|NCT02546921|155532507|FG004|Overall Study|Patient Choice|0|||
48365210|NCT02546921|155532508|FG005|Overall Study|Patient Choice|1|||
48365211|NCT02546921|155532509|FG006|Overall Study|Patient Choice|0|||
48365212|NCT02091206|155532510|FG000|Treatment Period|Adverse Event|0|||
48365213|NCT02091206|155532511|FG001|Treatment Period|Adverse Event|1|||
48365214|NCT02091206|155532512|FG002|Treatment Period|Adverse Event|0|||
48365215|NCT02091206|155532513|FG003|Treatment Period|Adverse Event|0|||
48365216|NCT02091206|155532510|FG000|Treatment Period|Met withdrawal criteria|0|||
48365217|NCT02091206|155532511|FG001|Treatment Period|Met withdrawal criteria|0|||
48365218|NCT02091206|155532512|FG002|Treatment Period|Met withdrawal criteria|1|||
48414342|NCT00809133|155705537|FG002|Overall Study|Progressive disease|5|||
48414343|NCT00809133|155705538|FG003|Overall Study|Progressive disease|3|||
48414344|NCT00809133|155705539|FG004|Overall Study|Progressive disease|4|||
48414345|NCT00809133|155705540|FG005|Overall Study|Progressive disease|1|||
48414346|NCT00809133|155705541|FG006|Overall Study|Progressive disease|3|||
48365219|NCT02091206|155532513|FG003|Treatment Period|Met withdrawal criteria|0|||
48365220|NCT02091206|155532510|FG000|Taper Period|Participant refused study drug|1|||
48365221|NCT02091206|155532511|FG001|Taper Period|Participant refused study drug|0|||
48365222|NCT02091206|155532512|FG002|Taper Period|Participant refused study drug|0|||
48365223|NCT02091206|155532513|FG003|Taper Period|Participant refused study drug|1|||
48365224|NCT02091206|155532510|FG000|Taper Period|Lost to Follow-up|0|||
48365225|NCT02091206|155532511|FG001|Taper Period|Lost to Follow-up|0|||
48365226|NCT02091206|155532512|FG002|Taper Period|Lost to Follow-up|0|||
48414347|NCT00809133|155705542|FG007|Overall Study|Progressive disease|3|||
48414348|NCT00809133|155705543|FG008|Overall Study|Progressive disease|3|||
48365227|NCT02091206|155532513|FG003|Taper Period|Lost to Follow-up|1|||
48365228|NCT03538301|155532514|FG000|Overall Study|Adverse Event|1|||
48365229|NCT03538301|155532515|FG001|Overall Study|Adverse Event|4|||
48365230|NCT03538301|155532516|FG002|Overall Study|Adverse Event|4|||
48365231|NCT03538301|155532514|FG000|Overall Study|Death|1|||
48365232|NCT03538301|155532515|FG001|Overall Study|Death|1|||
48365233|NCT03538301|155532516|FG002|Overall Study|Death|0|||
48365234|NCT03538301|155532514|FG000|Overall Study|Physician Decision|0|||
48365235|NCT03538301|155532515|FG001|Overall Study|Physician Decision|1|||
48365236|NCT03538301|155532516|FG002|Overall Study|Physician Decision|0|||
48365237|NCT03538301|155532514|FG000|Overall Study|Protocol Violation|0|||
48365238|NCT03538301|155532515|FG001|Overall Study|Protocol Violation|0|||
48365239|NCT03538301|155532516|FG002|Overall Study|Protocol Violation|1|||
48365240|NCT03538301|155532514|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
48365241|NCT03538301|155532515|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
48365242|NCT03538301|155532516|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
48365243|NCT00350103|155532521|FG000|Overall Study|Adverse Event|12|||
48365244|NCT00350103|155532522|FG001|Overall Study|Adverse Event|29|||
48365245|NCT00350103|155532523|FG002|Overall Study|Adverse Event|17|||
48365246|NCT00350103|155532521|FG000|Overall Study|Lack of Efficacy|5|||
48365247|NCT00350103|155532522|FG001|Overall Study|Lack of Efficacy|1|||
48365248|NCT00350103|155532523|FG002|Overall Study|Lack of Efficacy|3|||
48365249|NCT00350103|155532521|FG000|Overall Study|Withdrawal by Subject|6|||
48365250|NCT00350103|155532522|FG001|Overall Study|Withdrawal by Subject|6|||
48365251|NCT00350103|155532523|FG002|Overall Study|Withdrawal by Subject|8|||
48365252|NCT00350103|155532521|FG000|Overall Study|Protocol Violation|0|||
48365253|NCT00350103|155532522|FG001|Overall Study|Protocol Violation|0|||
48365254|NCT00350103|155532523|FG002|Overall Study|Protocol Violation|1|||
48365255|NCT00350103|155532521|FG000|Overall Study|Unsatisfactory Compliance|2|||
48365256|NCT00350103|155532522|FG001|Overall Study|Unsatisfactory Compliance|2|||
48365257|NCT00350103|155532523|FG002|Overall Study|Unsatisfactory Compliance|1|||
48365258|NCT00350103|155532521|FG000|Overall Study|Investigator´s decision|1|||
48365259|NCT00350103|155532522|FG001|Overall Study|Investigator´s decision|1|||
48365260|NCT00350103|155532523|FG002|Overall Study|Investigator´s decision|0|||
48365261|NCT00350103|155532521|FG000|Overall Study|Exclusion criteria met|0|||
48365262|NCT00350103|155532522|FG001|Overall Study|Exclusion criteria met|0|||
48365263|NCT00350103|155532523|FG002|Overall Study|Exclusion criteria met|1|||
48365264|NCT00350103|155532521|FG000|Overall Study|Patient relocated|0|||
48365265|NCT00350103|155532522|FG001|Overall Study|Patient relocated|0|||
48365266|NCT00350103|155532523|FG002|Overall Study|Patient relocated|1|||
48365267|NCT00350103|155532521|FG000|Overall Study|Need for prohibited medication|1|||
48365268|NCT00350103|155532522|FG001|Overall Study|Need for prohibited medication|0|||
48365269|NCT00350103|155532523|FG002|Overall Study|Need for prohibited medication|0|||
48365270|NCT00350103|155532521|FG000|Overall Study|Personal reasons|0|||
48365271|NCT00350103|155532522|FG001|Overall Study|Personal reasons|0|||
48365272|NCT00350103|155532523|FG002|Overall Study|Personal reasons|1|||
48365273|NCT00350103|155532521|FG000|Overall Study|Patient stopped feeling pain|1|||
48365274|NCT00350103|155532522|FG001|Overall Study|Patient stopped feeling pain|0|||
48365275|NCT00350103|155532523|FG002|Overall Study|Patient stopped feeling pain|0|||
48365276|NCT00350103|155532521|FG000|Overall Study|PR greater than 250ms|0|||
48365277|NCT00350103|155532522|FG001|Overall Study|PR greater than 250ms|0|||
48365278|NCT00350103|155532523|FG002|Overall Study|PR greater than 250ms|1|||
48365279|NCT00350103|155532521|FG000|Overall Study|Wrong calculation of QT interval|0|||
48365280|NCT00350103|155532522|FG001|Overall Study|Wrong calculation of QT interval|0|||
48365281|NCT00350103|155532523|FG002|Overall Study|Wrong calculation of QT interval|1|||
48365282|NCT00350103|155532521|FG000|Overall Study|Sponsor mistake|1|||
48365283|NCT00350103|155532522|FG001|Overall Study|Sponsor mistake|0|||
48365284|NCT00350103|155532523|FG002|Overall Study|Sponsor mistake|0|||
48365285|NCT00350103|155532521|FG000|Overall Study|Randomization mistake|0|||
48365286|NCT00350103|155532522|FG001|Overall Study|Randomization mistake|1|||
48365287|NCT00350103|155532523|FG002|Overall Study|Randomization mistake|1|||
48365288|NCT00350103|155532521|FG000|Overall Study|Sponsor´s decision|0|||
48365289|NCT00350103|155532522|FG001|Overall Study|Sponsor´s decision|1|||
48365290|NCT00350103|155532523|FG002|Overall Study|Sponsor´s decision|0|||
48365291|NCT00350103|155532521|FG000|Overall Study|Lost, Reason unknown|1|||
48365292|NCT00350103|155532522|FG001|Overall Study|Lost, Reason unknown|1|||
48365293|NCT00350103|155532523|FG002|Overall Study|Lost, Reason unknown|0|||
48365294|NCT02842151|155532524|FG000|Overall Study|Adverse Event|1|||
48365295|NCT02842151|155532524|FG000|Overall Study|Subject moved too far away|1|||
48365296|NCT02559895|155532525|FG000|Overall Study|Adverse Event|3|||
48365297|NCT02559895|155532526|FG001|Overall Study|Adverse Event|3|||
48365298|NCT02559895|155532527|FG002|Overall Study|Adverse Event|2|||
48365299|NCT02559895|155532528|FG003|Overall Study|Adverse Event|1|||
48365300|NCT02559895|155532525|FG000|Overall Study|Lack of Efficacy|2|||
48365301|NCT02559895|155532526|FG001|Overall Study|Lack of Efficacy|3|||
48365302|NCT02559895|155532527|FG002|Overall Study|Lack of Efficacy|2|||
48365303|NCT02559895|155532528|FG003|Overall Study|Lack of Efficacy|8|||
48365304|NCT02559895|155532525|FG000|Overall Study|Lost to Follow-up|22|||
48365305|NCT02559895|155532526|FG001|Overall Study|Lost to Follow-up|16|||
48365306|NCT02559895|155532527|FG002|Overall Study|Lost to Follow-up|12|||
48365307|NCT02559895|155532528|FG003|Overall Study|Lost to Follow-up|17|||
48365308|NCT02559895|155532525|FG000|Overall Study|Physician Decision|1|||
48365309|NCT02559895|155532526|FG001|Overall Study|Physician Decision|1|||
48365310|NCT02559895|155532527|FG002|Overall Study|Physician Decision|3|||
48365311|NCT02559895|155532528|FG003|Overall Study|Physician Decision|0|||
48365312|NCT02559895|155532525|FG000|Overall Study|Withdrawal by Subject|16|||
48365313|NCT02559895|155532526|FG001|Overall Study|Withdrawal by Subject|9|||
48365314|NCT02559895|155532527|FG002|Overall Study|Withdrawal by Subject|20|||
48365315|NCT02559895|155532528|FG003|Overall Study|Withdrawal by Subject|9|||
48365316|NCT02559895|155532525|FG000|Overall Study|Study Burden|10|||
48365317|NCT02559895|155532526|FG001|Overall Study|Study Burden|16|||
48365318|NCT02559895|155532527|FG002|Overall Study|Study Burden|12|||
48365319|NCT02559895|155532528|FG003|Overall Study|Study Burden|22|||
48365320|NCT02559895|155532525|FG000|Overall Study|Other|1|||
48365321|NCT02559895|155532526|FG001|Overall Study|Other|5|||
48365322|NCT02559895|155532527|FG002|Overall Study|Other|3|||
48365323|NCT02559895|155532528|FG003|Overall Study|Other|3|||
48365324|NCT02712905|155532529|FG000|Monotherapy|Death|2|||
48365325|NCT02712905|155532530|FG001|Monotherapy|Death|5|||
48365326|NCT02712905|155532531|FG002|Monotherapy|Death|0|||
48365327|NCT02712905|155532532|FG003|Monotherapy|Death|3|||
48365328|NCT02712905|155532533|FG004|Monotherapy|Death|15|||
48365329|NCT02712905|155532534|FG005|Monotherapy|Death|1|||
48365330|NCT02712905|155532535|FG006|Monotherapy|Death|3|||
48365331|NCT02712905|155532536|FG007|Monotherapy|Death|3|||
48365332|NCT02712905|155532537|FG008|Monotherapy|Death|0|||
48365333|NCT02712905|155532538|FG009|Monotherapy|Death|27|||
48365334|NCT02712905|155532539|FG010|Monotherapy|Death|2|||
48365335|NCT02712905|155532540|FG011|Monotherapy|Death|5|||
48365336|NCT02712905|155532541|FG012|Monotherapy|Death|0|||
48365337|NCT02712905|155532542|FG013|Monotherapy|Death|0|||
48365338|NCT02712905|155532543|FG014|Monotherapy|Death|0|||
48365339|NCT02712905|155532544|FG015|Monotherapy|Death|0|||
48365340|NCT02712905|155532545|FG016|Monotherapy|Death|0|||
48365341|NCT02712905|155532546|FG017|Monotherapy|Death|0|||
48365342|NCT02712905|155532529|FG000|Monotherapy|Lost to Follow-up|0|||
48365343|NCT02712905|155532530|FG001|Monotherapy|Lost to Follow-up|1|||
48365344|NCT02712905|155532531|FG002|Monotherapy|Lost to Follow-up|0|||
48365345|NCT02712905|155532532|FG003|Monotherapy|Lost to Follow-up|1|||
48365346|NCT02712905|155532533|FG004|Monotherapy|Lost to Follow-up|0|||
48365347|NCT02712905|155532534|FG005|Monotherapy|Lost to Follow-up|0|||
48365348|NCT02712905|155532535|FG006|Monotherapy|Lost to Follow-up|0|||
48365349|NCT02712905|155532536|FG007|Monotherapy|Lost to Follow-up|0|||
48365350|NCT02712905|155532537|FG008|Monotherapy|Lost to Follow-up|0|||
48365351|NCT02712905|155532538|FG009|Monotherapy|Lost to Follow-up|2|||
48365352|NCT02712905|155532539|FG010|Monotherapy|Lost to Follow-up|0|||
48365353|NCT02712905|155532540|FG011|Monotherapy|Lost to Follow-up|0|||
48365354|NCT02712905|155532541|FG012|Monotherapy|Lost to Follow-up|0|||
48365355|NCT02712905|155532542|FG013|Monotherapy|Lost to Follow-up|0|||
48365356|NCT02712905|155532543|FG014|Monotherapy|Lost to Follow-up|0|||
48365357|NCT02712905|155532544|FG015|Monotherapy|Lost to Follow-up|0|||
48365358|NCT02712905|155532545|FG016|Monotherapy|Lost to Follow-up|0|||
48365359|NCT02712905|155532546|FG017|Monotherapy|Lost to Follow-up|0|||
48365360|NCT02712905|155532529|FG000|Monotherapy|Physician Decision|1|||
48365361|NCT02712905|155532530|FG001|Monotherapy|Physician Decision|0|||
48365362|NCT02712905|155532531|FG002|Monotherapy|Physician Decision|0|||
48365363|NCT02712905|155532532|FG003|Monotherapy|Physician Decision|1|||
48365364|NCT02712905|155532533|FG004|Monotherapy|Physician Decision|0|||
48365365|NCT02712905|155532534|FG005|Monotherapy|Physician Decision|0|||
48365366|NCT02712905|155532535|FG006|Monotherapy|Physician Decision|0|||
48365367|NCT02712905|155532536|FG007|Monotherapy|Physician Decision|0|||
48365368|NCT02712905|155532537|FG008|Monotherapy|Physician Decision|0|||
48365369|NCT02712905|155532538|FG009|Monotherapy|Physician Decision|1|||
48365370|NCT02712905|155532539|FG010|Monotherapy|Physician Decision|0|||
48365371|NCT02712905|155532540|FG011|Monotherapy|Physician Decision|0|||
48365372|NCT02712905|155532541|FG012|Monotherapy|Physician Decision|0|||
48365373|NCT02712905|155532542|FG013|Monotherapy|Physician Decision|0|||
48365374|NCT02712905|155532543|FG014|Monotherapy|Physician Decision|0|||
48365375|NCT02712905|155532544|FG015|Monotherapy|Physician Decision|0|||
48365376|NCT02712905|155532545|FG016|Monotherapy|Physician Decision|0|||
48365377|NCT02712905|155532546|FG017|Monotherapy|Physician Decision|0|||
48365378|NCT02712905|155532529|FG000|Monotherapy|Study Terminated by Sponsor|0|||
48365379|NCT02712905|155532530|FG001|Monotherapy|Study Terminated by Sponsor|0|||
48365380|NCT02712905|155532531|FG002|Monotherapy|Study Terminated by Sponsor|0|||
48365381|NCT02712905|155532532|FG003|Monotherapy|Study Terminated by Sponsor|0|||
48365382|NCT02712905|155532533|FG004|Monotherapy|Study Terminated by Sponsor|1|||
48365383|NCT02712905|155532534|FG005|Monotherapy|Study Terminated by Sponsor|0|||
48365384|NCT02712905|155532535|FG006|Monotherapy|Study Terminated by Sponsor|0|||
48365385|NCT02712905|155532536|FG007|Monotherapy|Study Terminated by Sponsor|0|||
48365386|NCT02712905|155532537|FG008|Monotherapy|Study Terminated by Sponsor|0|||
48414349|NCT00809133|155705544|FG009|Overall Study|Progressive disease|9|||
48365387|NCT02712905|155532538|FG009|Monotherapy|Study Terminated by Sponsor|2|||
48414350|NCT00809133|155705545|FG010|Overall Study|Progressive disease|5|||
48414351|NCT00809133|155705546|FG011|Overall Study|Progressive disease|7|||
48414352|NCT00809133|155705547|FG012|Overall Study|Progressive disease|5|||
48414353|NCT00809133|155705548|FG013|Overall Study|Progressive disease|4|||
48414354|NCT00809133|155705535|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414355|NCT00809133|155705536|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414356|NCT00809133|155705537|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414357|NCT00809133|155705538|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414358|NCT00809133|155705539|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414359|NCT00809133|155705540|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48414360|NCT00809133|155705541|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48414361|NCT00809133|155705542|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
48414362|NCT00809133|155705543|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414363|NCT00809133|155705544|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414364|NCT00809133|155705545|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414365|NCT00809133|155705546|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414366|NCT00809133|155705547|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
48414367|NCT00809133|155705548|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
48365388|NCT02712905|155532539|FG010|Monotherapy|Study Terminated by Sponsor|0|||
48365389|NCT02712905|155532540|FG011|Monotherapy|Study Terminated by Sponsor|0|||
48365390|NCT02712905|155532541|FG012|Monotherapy|Study Terminated by Sponsor|0|||
48365391|NCT02712905|155532542|FG013|Monotherapy|Study Terminated by Sponsor|0|||
48365392|NCT02712905|155532543|FG014|Monotherapy|Study Terminated by Sponsor|0|||
48365393|NCT02712905|155532544|FG015|Monotherapy|Study Terminated by Sponsor|0|||
48365394|NCT02712905|155532545|FG016|Monotherapy|Study Terminated by Sponsor|0|||
48365395|NCT02712905|155532546|FG017|Monotherapy|Study Terminated by Sponsor|0|||
48365396|NCT02712905|155532529|FG000|Monotherapy|Withdrawal by Subject|0|||
48365397|NCT02712905|155532530|FG001|Monotherapy|Withdrawal by Subject|0|||
48365398|NCT02712905|155532531|FG002|Monotherapy|Withdrawal by Subject|1|||
48365399|NCT02712905|155532532|FG003|Monotherapy|Withdrawal by Subject|0|||
48365400|NCT02712905|155532533|FG004|Monotherapy|Withdrawal by Subject|2|||
48365401|NCT02712905|155532534|FG005|Monotherapy|Withdrawal by Subject|0|||
48365402|NCT02712905|155532535|FG006|Monotherapy|Withdrawal by Subject|0|||
48365403|NCT02712905|155532536|FG007|Monotherapy|Withdrawal by Subject|0|||
48365404|NCT02712905|155532537|FG008|Monotherapy|Withdrawal by Subject|0|||
48365405|NCT02712905|155532538|FG009|Monotherapy|Withdrawal by Subject|4|||
48365406|NCT02712905|155532539|FG010|Monotherapy|Withdrawal by Subject|1|||
48365407|NCT02712905|155532540|FG011|Monotherapy|Withdrawal by Subject|2|||
48365408|NCT02712905|155532541|FG012|Monotherapy|Withdrawal by Subject|0|||
48365409|NCT02712905|155532542|FG013|Monotherapy|Withdrawal by Subject|0|||
48365410|NCT02712905|155532543|FG014|Monotherapy|Withdrawal by Subject|0|||
48365411|NCT02712905|155532544|FG015|Monotherapy|Withdrawal by Subject|0|||
48365412|NCT02712905|155532545|FG016|Monotherapy|Withdrawal by Subject|0|||
48365413|NCT02712905|155532546|FG017|Monotherapy|Withdrawal by Subject|0|||
48365414|NCT02712905|155532529|FG000|Monotherapy|Started New Cancer Drug|0|||
48365415|NCT02712905|155532530|FG001|Monotherapy|Started New Cancer Drug|0|||
48365416|NCT02712905|155532531|FG002|Monotherapy|Started New Cancer Drug|0|||
48365417|NCT02712905|155532532|FG003|Monotherapy|Started New Cancer Drug|0|||
48365418|NCT02712905|155532533|FG004|Monotherapy|Started New Cancer Drug|0|||
48365419|NCT02712905|155532534|FG005|Monotherapy|Started New Cancer Drug|1|||
48365420|NCT02712905|155532535|FG006|Monotherapy|Started New Cancer Drug|0|||
48365421|NCT02712905|155532536|FG007|Monotherapy|Started New Cancer Drug|0|||
48365422|NCT02712905|155532537|FG008|Monotherapy|Started New Cancer Drug|0|||
48365423|NCT02712905|155532538|FG009|Monotherapy|Started New Cancer Drug|0|||
48365424|NCT02712905|155532539|FG010|Monotherapy|Started New Cancer Drug|0|||
48365425|NCT02712905|155532540|FG011|Monotherapy|Started New Cancer Drug|0|||
48365426|NCT02712905|155532541|FG012|Monotherapy|Started New Cancer Drug|0|||
48365427|NCT02712905|155532542|FG013|Monotherapy|Started New Cancer Drug|0|||
48365428|NCT02712905|155532543|FG014|Monotherapy|Started New Cancer Drug|0|||
48365429|NCT02712905|155532544|FG015|Monotherapy|Started New Cancer Drug|0|||
48365430|NCT02712905|155532545|FG016|Monotherapy|Started New Cancer Drug|0|||
48365431|NCT02712905|155532546|FG017|Monotherapy|Started New Cancer Drug|0|||
48365432|NCT02712905|155532529|FG000|Monotherapy|Adverse Event|0|||
48365433|NCT02712905|155532530|FG001|Monotherapy|Adverse Event|0|||
48414368|NCT00809133|155705535|FG000|Overall Study|Other adverse event|1|||
48414369|NCT00809133|155705536|FG001|Overall Study|Other adverse event|1|||
48414370|NCT00809133|155705537|FG002|Overall Study|Other adverse event|1|||
48414371|NCT00809133|155705538|FG003|Overall Study|Other adverse event|0|||
48414372|NCT00809133|155705539|FG004|Overall Study|Other adverse event|0|||
48365434|NCT02712905|155532531|FG002|Monotherapy|Adverse Event|0|||
48365435|NCT02712905|155532532|FG003|Monotherapy|Adverse Event|0|||
48365436|NCT02712905|155532533|FG004|Monotherapy|Adverse Event|0|||
48365437|NCT02712905|155532534|FG005|Monotherapy|Adverse Event|0|||
48365438|NCT02712905|155532535|FG006|Monotherapy|Adverse Event|0|||
48365439|NCT02712905|155532536|FG007|Monotherapy|Adverse Event|0|||
48365440|NCT02712905|155532537|FG008|Monotherapy|Adverse Event|1|||
48365441|NCT02712905|155532538|FG009|Monotherapy|Adverse Event|0|||
48365442|NCT02712905|155532539|FG010|Monotherapy|Adverse Event|0|||
48365443|NCT02712905|155532540|FG011|Monotherapy|Adverse Event|0|||
48365444|NCT02712905|155532541|FG012|Monotherapy|Adverse Event|0|||
48365445|NCT02712905|155532542|FG013|Monotherapy|Adverse Event|0|||
48365446|NCT02712905|155532543|FG014|Monotherapy|Adverse Event|0|||
48365447|NCT02712905|155532544|FG015|Monotherapy|Adverse Event|0|||
48365448|NCT02712905|155532545|FG016|Monotherapy|Adverse Event|0|||
48365449|NCT02712905|155532546|FG017|Monotherapy|Adverse Event|0|||
48365450|NCT02712905|155532529|FG000|Combination Therapy|Death|0|||
48365451|NCT02712905|155532530|FG001|Combination Therapy|Death|0|||
48365452|NCT02712905|155532531|FG002|Combination Therapy|Death|0|||
48365453|NCT02712905|155532532|FG003|Combination Therapy|Death|0|||
48365454|NCT02712905|155532533|FG004|Combination Therapy|Death|0|||
48365455|NCT02712905|155532534|FG005|Combination Therapy|Death|0|||
48365456|NCT02712905|155532535|FG006|Combination Therapy|Death|0|||
48365457|NCT02712905|155532536|FG007|Combination Therapy|Death|0|||
48365458|NCT02712905|155532537|FG008|Combination Therapy|Death|0|||
48365459|NCT02712905|155532538|FG009|Combination Therapy|Death|0|||
48365460|NCT02712905|155532539|FG010|Combination Therapy|Death|0|||
48365461|NCT02712905|155532540|FG011|Combination Therapy|Death|0|||
48365462|NCT02712905|155532541|FG012|Combination Therapy|Death|5|||
48365463|NCT02712905|155532542|FG013|Combination Therapy|Death|6|||
48365464|NCT02712905|155532543|FG014|Combination Therapy|Death|1|||
48365465|NCT02712905|155532544|FG015|Combination Therapy|Death|3|||
48365466|NCT02712905|155532545|FG016|Combination Therapy|Death|1|||
48365467|NCT02712905|155532546|FG017|Combination Therapy|Death|3|||
48365468|NCT02712905|155532529|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
48365469|NCT02712905|155532530|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
48365470|NCT02712905|155532531|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
48365471|NCT02712905|155532532|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
48365472|NCT02712905|155532533|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
48365473|NCT02712905|155532534|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
48365474|NCT02712905|155532535|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
48365475|NCT02712905|155532536|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
48365476|NCT02712905|155532537|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
48365477|NCT02712905|155532538|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
48365478|NCT02712905|155532539|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
48365479|NCT02712905|155532540|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
48365480|NCT02712905|155532541|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
48365481|NCT02712905|155532542|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
48365482|NCT02712905|155532543|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
48365483|NCT02712905|155532544|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
48365484|NCT02712905|155532545|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
48365485|NCT02712905|155532546|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
48365486|NCT02712905|155532529|FG000|Combination Therapy|Withdrawal by Subject|0|||
48365487|NCT02712905|155532530|FG001|Combination Therapy|Withdrawal by Subject|0|||
48365488|NCT02712905|155532531|FG002|Combination Therapy|Withdrawal by Subject|0|||
48365489|NCT02712905|155532532|FG003|Combination Therapy|Withdrawal by Subject|0|||
48365490|NCT02712905|155532533|FG004|Combination Therapy|Withdrawal by Subject|0|||
48365491|NCT02712905|155532534|FG005|Combination Therapy|Withdrawal by Subject|0|||
48365492|NCT02712905|155532535|FG006|Combination Therapy|Withdrawal by Subject|0|||
48365493|NCT02712905|155532536|FG007|Combination Therapy|Withdrawal by Subject|0|||
48365494|NCT02712905|155532537|FG008|Combination Therapy|Withdrawal by Subject|0|||
48365495|NCT02712905|155532538|FG009|Combination Therapy|Withdrawal by Subject|0|||
48365496|NCT02712905|155532539|FG010|Combination Therapy|Withdrawal by Subject|0|||
48365497|NCT02712905|155532540|FG011|Combination Therapy|Withdrawal by Subject|0|||
48365498|NCT02712905|155532541|FG012|Combination Therapy|Withdrawal by Subject|0|||
48365499|NCT02712905|155532542|FG013|Combination Therapy|Withdrawal by Subject|0|||
48365500|NCT02712905|155532543|FG014|Combination Therapy|Withdrawal by Subject|0|||
48365501|NCT02712905|155532544|FG015|Combination Therapy|Withdrawal by Subject|1|||
48365502|NCT02712905|155532545|FG016|Combination Therapy|Withdrawal by Subject|0|||
48365503|NCT02712905|155532546|FG017|Combination Therapy|Withdrawal by Subject|2|||
48365504|NCT02712905|155532529|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365505|NCT02712905|155532530|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365506|NCT02712905|155532531|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365507|NCT02712905|155532532|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365508|NCT02712905|155532533|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365509|NCT02712905|155532534|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365510|NCT02712905|155532535|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365511|NCT02712905|155532536|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365512|NCT02712905|155532537|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365513|NCT02712905|155532538|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365514|NCT02712905|155532539|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365515|NCT02712905|155532540|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365516|NCT02712905|155532541|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365517|NCT02712905|155532542|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365518|NCT02712905|155532543|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365519|NCT02712905|155532544|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
48365520|NCT02712905|155532545|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365521|NCT02712905|155532546|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
48365522|NCT04664400|155532547|FG000|Overall Study|Withdrawal by Subject|2|||
48365523|NCT00515853|155532548|FG000|Overall Study|Lost to Follow-up|9|||
48365524|NCT00515853|155532549|FG001|Overall Study|Lost to Follow-up|13|||
48365525|NCT00515853|155532548|FG000|Overall Study|Withdrawal by Subject|6|||
48365526|NCT00515853|155532549|FG001|Overall Study|Withdrawal by Subject|4|||
48365527|NCT00490724|155532554|FG000|Period I|Physician Decision|0|||
48365528|NCT00490724|155532555|FG001|Period I|Physician Decision|0|||
48365529|NCT00490724|155532556|FG002|Period I|Physician Decision|1|||
48365530|NCT00490724|155532554|FG000|Period II|Treatment Discontinuation|3|||
48365531|NCT00490724|155532555|FG001|Period II|Treatment Discontinuation|1|||
48365532|NCT00490724|155532556|FG002|Period II|Treatment Discontinuation|3|||
48365533|NCT01011153|155532557|FG000|Overall Study|Less than 78 cases completed|8|||
48365534|NCT01011153|155532558|FG001|Overall Study|Less than 78 cases completed|11|||
48365535|NCT01011153|155532559|FG002|Overall Study|Less than 78 cases completed|9|||
48365536|NCT05038163|155532561|FG000|Stage 1|Did not complete survey|374|||
48365537|NCT05038163|155532562|FG001|Stage 1|Did not complete survey|0|||
48365538|NCT05038163|155532563|FG002|Stage 1|Did not complete survey|0|||
48365539|NCT05038163|155532564|FG003|Stage 1|Did not complete survey|0|||
48365540|NCT05038163|155532565|FG004|Stage 1|Did not complete survey|0|||
48365541|NCT05038163|155532566|FG005|Stage 1|Did not complete survey|0|||
48365542|NCT05038163|155532561|FG000|Stage 2|Did not complete Stage 2 survey|0|||
48365543|NCT05038163|155532562|FG001|Stage 2|Did not complete Stage 2 survey|29|||
48365544|NCT05038163|155532563|FG002|Stage 2|Did not complete Stage 2 survey|30|||
48365545|NCT05038163|155532564|FG003|Stage 2|Did not complete Stage 2 survey|24|||
48365546|NCT05038163|155532565|FG004|Stage 2|Did not complete Stage 2 survey|21|||
48365547|NCT05038163|155532566|FG005|Stage 2|Did not complete Stage 2 survey|100|||
48365548|NCT02656706|155532569|FG000|Overall Study|Insurance Denial|1|||
48365549|NCT03149549|155532572|FG000|Study Discontinuation--Treatment Period|Death|0|||
48365550|NCT03149549|155532573|FG001|Study Discontinuation--Treatment Period|Death|0|||
48365551|NCT03149549|155532574|FG002|Study Discontinuation--Treatment Period|Death|0|||
48365552|NCT03149549|155532575|FG003|Study Discontinuation--Treatment Period|Death|1|||
48365553|NCT03149549|155532576|FG004|Study Discontinuation--Treatment Period|Death|2|||
48365554|NCT03149549|155532577|FG005|Study Discontinuation--Treatment Period|Death|1|||
48365555|NCT03149549|155532578|FG006|Study Discontinuation--Treatment Period|Death|1|||
48365556|NCT03149549|155532579|FG007|Study Discontinuation--Treatment Period|Death|2|||
48365557|NCT03149549|155532580|FG008|Study Discontinuation--Treatment Period|Death|4|||
48365558|NCT03149549|155532581|FG009|Study Discontinuation--Treatment Period|Death|1|||
48365559|NCT03149549|155532582|FG010|Study Discontinuation--Treatment Period|Death|0|||
48365560|NCT03149549|155532583|FG011|Study Discontinuation--Treatment Period|Death|0|||
48365561|NCT03149549|155532584|FG012|Study Discontinuation--Treatment Period|Death|1|||
48365562|NCT03149549|155532572|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365563|NCT03149549|155532573|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365564|NCT03149549|155532574|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365565|NCT03149549|155532575|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365566|NCT03149549|155532576|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365567|NCT03149549|155532577|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365568|NCT03149549|155532578|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365569|NCT03149549|155532579|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
48365570|NCT03149549|155532580|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365571|NCT03149549|155532581|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365572|NCT03149549|155532582|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365573|NCT03149549|155532583|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
48365574|NCT03149549|155532584|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
48365575|NCT03149549|155532572|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48365576|NCT03149549|155532573|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48365577|NCT03149549|155532574|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48365578|NCT03149549|155532575|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
48365579|NCT03149549|155532576|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
48365580|NCT03149549|155532577|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
48365581|NCT03149549|155532578|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
48365582|NCT03149549|155532579|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48365583|NCT03149549|155532580|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
48365584|NCT03149549|155532581|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48365585|NCT03149549|155532582|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48365586|NCT03149549|155532583|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48365587|NCT03149549|155532584|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
48365588|NCT03149549|155532572|FG000|Study Discontinuation--Treatment Period|Other|0|||
48365589|NCT03149549|155532573|FG001|Study Discontinuation--Treatment Period|Other|0|||
48365590|NCT03149549|155532574|FG002|Study Discontinuation--Treatment Period|Other|0|||
48365591|NCT03149549|155532575|FG003|Study Discontinuation--Treatment Period|Other|0|||
48365592|NCT03149549|155532576|FG004|Study Discontinuation--Treatment Period|Other|0|||
48365593|NCT03149549|155532577|FG005|Study Discontinuation--Treatment Period|Other|0|||
48365594|NCT03149549|155532578|FG006|Study Discontinuation--Treatment Period|Other|0|||
48365595|NCT03149549|155532579|FG007|Study Discontinuation--Treatment Period|Other|1|||
48365596|NCT03149549|155532580|FG008|Study Discontinuation--Treatment Period|Other|0|||
48365597|NCT03149549|155532581|FG009|Study Discontinuation--Treatment Period|Other|1|||
48365598|NCT03149549|155532582|FG010|Study Discontinuation--Treatment Period|Other|0|||
48365599|NCT03149549|155532583|FG011|Study Discontinuation--Treatment Period|Other|0|||
48365600|NCT03149549|155532584|FG012|Study Discontinuation--Treatment Period|Other|0|||
48365601|NCT03149549|155532572|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365602|NCT03149549|155532573|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365603|NCT03149549|155532574|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365604|NCT03149549|155532575|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365605|NCT03149549|155532576|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365606|NCT03149549|155532577|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
48365607|NCT03149549|155532578|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
48365608|NCT03149549|155532579|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365609|NCT03149549|155532580|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
48365610|NCT03149549|155532581|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365611|NCT03149549|155532582|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365612|NCT03149549|155532583|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365613|NCT03149549|155532584|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
48365614|NCT03149549|155532572|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48365615|NCT03149549|155532573|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48365616|NCT03149549|155532574|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48365617|NCT03149549|155532575|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48365618|NCT03149549|155532576|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
48365619|NCT03149549|155532577|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48365620|NCT03149549|155532578|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48365621|NCT03149549|155532579|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
48365622|NCT03149549|155532580|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
48365623|NCT03149549|155532581|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48365624|NCT03149549|155532582|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
48365625|NCT03149549|155532583|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
48365626|NCT03149549|155532584|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
48365627|NCT03149549|155532572|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48365628|NCT03149549|155532573|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48365629|NCT03149549|155532574|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48365630|NCT03149549|155532575|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48365631|NCT03149549|155532576|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
48365632|NCT03149549|155532577|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48365633|NCT03149549|155532578|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48365634|NCT03149549|155532579|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
48365635|NCT03149549|155532580|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
48365636|NCT03149549|155532581|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
48365637|NCT03149549|155532582|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
48365638|NCT03149549|155532583|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
48365639|NCT03149549|155532584|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
48365640|NCT03149549|155532572|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
48365641|NCT03149549|155532573|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
48365642|NCT03149549|155532574|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
48365643|NCT03149549|155532575|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
48365644|NCT03149549|155532576|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
48365645|NCT03149549|155532577|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
48365646|NCT03149549|155532578|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
48365647|NCT03149549|155532579|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
48365648|NCT03149549|155532580|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
48365649|NCT03149549|155532581|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
48365650|NCT03149549|155532582|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
48365651|NCT03149549|155532583|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
48365652|NCT03149549|155532584|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
48365653|NCT03149549|155532572|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
48365654|NCT03149549|155532573|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
48365655|NCT03149549|155532574|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
48365656|NCT03149549|155532575|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
48365657|NCT03149549|155532576|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
48365658|NCT03149549|155532577|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
48365659|NCT03149549|155532578|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
48365660|NCT03149549|155532579|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
48365661|NCT03149549|155532580|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
48365662|NCT03149549|155532581|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
48365663|NCT03149549|155532582|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
48365664|NCT03149549|155532583|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
48365665|NCT03149549|155532584|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
48365666|NCT02631577|155532587|FG000|Overall Study|Death|1|||
48365667|NCT02631577|155532588|FG001|Overall Study|Death|7|||
48365668|NCT02631577|155532587|FG000|Overall Study|Withdrawal by Subject|0|||
48365669|NCT02631577|155532588|FG001|Overall Study|Withdrawal by Subject|3|||
48365670|NCT01892540|155532589|FG000|Overall Study|Did not complete PET/MRI|0|||
48365671|NCT01892540|155532590|FG001|Overall Study|Did not complete PET/MRI|0|||
48365672|NCT01892540|155532591|FG002|Overall Study|Did not complete PET/MRI|2|||
48365673|NCT01892540|155532589|FG000|Overall Study|Did not fit in scanner|0|||
48365674|NCT01892540|155532590|FG001|Overall Study|Did not fit in scanner|0|||
48365675|NCT01892540|155532591|FG002|Overall Study|Did not fit in scanner|1|||
48365676|NCT01342341|155534215|FG000|Overall Study|Lost to Follow-up|4|||
48365677|NCT01342341|155534216|FG001|Overall Study|Lost to Follow-up|4|||
48365678|NCT02075476|155534222|FG000|Overall Study|Death|2|||
48365679|NCT02075476|155534223|FG001|Overall Study|Death|2|||
48365680|NCT02075476|155534222|FG000|Overall Study|Lost to Follow-up|1|||
48365681|NCT02075476|155534223|FG001|Overall Study|Lost to Follow-up|3|||
48365682|NCT02389452|155534224|FG000|Overall Study|Lost to Follow-up|13|||
48365683|NCT02389452|155534224|FG000|Overall Study|Adverse Event|1|||
48365684|NCT02389452|155534224|FG000|Overall Study|Withdrawal by Subject|5|||
48365685|NCT02389452|155534224|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
48365686|NCT01195948|155534225|FG000|Overall Study|Lost to Follow-up|0|||
48365687|NCT01195948|155534226|FG001|Overall Study|Lost to Follow-up|1|||
48365688|NCT01195948|155534227|FG002|Overall Study|Lost to Follow-up|2|||
48365689|NCT00414908|155534228|FG000|Overall Study|Protocol Violation|1|||
48365690|NCT00414908|155534229|FG001|Overall Study|Protocol Violation|1|||
48365691|NCT04165031|155534230|FG000|Overall Study|Adverse Event|1|||
48365692|NCT04165031|155534231|FG001|Overall Study|Adverse Event|1|||
48365693|NCT04165031|155534232|FG002|Overall Study|Adverse Event|0|||
48365694|NCT04165031|155534233|FG003|Overall Study|Adverse Event|0|||
48365695|NCT04165031|155534234|FG004|Overall Study|Adverse Event|0|||
48365696|NCT04165031|155534235|FG005|Overall Study|Adverse Event|0|||
48365697|NCT04165031|155534230|FG000|Overall Study|Withdrawal by Subject|0|||
48365698|NCT04165031|155534231|FG001|Overall Study|Withdrawal by Subject|0|||
48365699|NCT04165031|155534232|FG002|Overall Study|Withdrawal by Subject|1|||
48365700|NCT04165031|155534233|FG003|Overall Study|Withdrawal by Subject|0|||
48365701|NCT04165031|155534234|FG004|Overall Study|Withdrawal by Subject|0|||
48365702|NCT04165031|155534235|FG005|Overall Study|Withdrawal by Subject|0|||
48365703|NCT03140280|155534236|FG000|Overall Study|Physician Decision|5|||
48365704|NCT04476251|155534239|FG000|Overall Study|Not treated|1|||
48365705|NCT00663702|155534245|FG000|Overall Study|Adverse Event|8|||
48365706|NCT00663702|155534246|FG001|Overall Study|Adverse Event|4|||
48365707|NCT00663702|155534245|FG000|Overall Study|Withdrawal by Subject|3|||
48365708|NCT00663702|155534246|FG001|Overall Study|Withdrawal by Subject|1|||
48365709|NCT00663702|155534245|FG000|Overall Study|Pregnancy|0|||
48365710|NCT00663702|155534246|FG001|Overall Study|Pregnancy|1|||
48365711|NCT00663702|155534245|FG000|Overall Study|Lost to Follow-up|3|||
48365712|NCT00663702|155534246|FG001|Overall Study|Lost to Follow-up|0|||
48365713|NCT00663702|155534245|FG000|Overall Study|Death|1|||
48365714|NCT00663702|155534246|FG001|Overall Study|Death|1|||
48365715|NCT00663702|155534245|FG000|Overall Study|Lack of Efficacy|3|||
48365716|NCT00663702|155534246|FG001|Overall Study|Lack of Efficacy|3|||
48365717|NCT00626990|155534247|FG000|Overall Study|Lack of Efficacy|6|||
48365718|NCT00626990|155534248|FG001|Overall Study|Lack of Efficacy|7|||
48365719|NCT00626990|155534249|FG002|Overall Study|Lack of Efficacy|49|||
48365720|NCT00626990|155534250|FG003|Overall Study|Lack of Efficacy|40|||
48365721|NCT00626990|155534247|FG000|Overall Study|Adverse Event|1|||
48365722|NCT00626990|155534248|FG001|Overall Study|Adverse Event|7|||
48365723|NCT00626990|155534249|FG002|Overall Study|Adverse Event|14|||
48365724|NCT00626990|155534250|FG003|Overall Study|Adverse Event|28|||
48365725|NCT00626990|155534247|FG000|Overall Study|Death|0|||
48365726|NCT00626990|155534248|FG001|Overall Study|Death|1|||
48365727|NCT00626990|155534249|FG002|Overall Study|Death|0|||
48365728|NCT00626990|155534250|FG003|Overall Study|Death|0|||
48365729|NCT00626990|155534247|FG000|Overall Study|Withdrawal by Subject|3|||
48365730|NCT00626990|155534248|FG001|Overall Study|Withdrawal by Subject|1|||
48365731|NCT00626990|155534249|FG002|Overall Study|Withdrawal by Subject|5|||
48365732|NCT00626990|155534250|FG003|Overall Study|Withdrawal by Subject|11|||
48365733|NCT00626990|155534247|FG000|Overall Study|Protocol Violation|0|||
48365734|NCT00626990|155534248|FG001|Overall Study|Protocol Violation|1|||
48365735|NCT00626990|155534249|FG002|Overall Study|Protocol Violation|1|||
48365736|NCT00626990|155534250|FG003|Overall Study|Protocol Violation|0|||
48365737|NCT00626990|155534247|FG000|Overall Study|Various different reasons/missing|4|||
48365738|NCT00626990|155534248|FG001|Overall Study|Various different reasons/missing|8|||
48365739|NCT00626990|155534249|FG002|Overall Study|Various different reasons/missing|8|||
48365740|NCT00626990|155534250|FG003|Overall Study|Various different reasons/missing|16|||
48365741|NCT02187159|155534251|FG000|Overall Study|Protocol Violation|4|||
48365742|NCT02187159|155534252|FG001|Overall Study|Protocol Violation|6|||
48365743|NCT02187159|155534253|FG002|Overall Study|Protocol Violation|3|||
48365744|NCT02187159|155534254|FG003|Overall Study|Protocol Violation|4|||
48365745|NCT02187159|155534251|FG000|Overall Study|Lack of Efficacy|10|||
48365746|NCT02187159|155534252|FG001|Overall Study|Lack of Efficacy|5|||
48365747|NCT02187159|155534253|FG002|Overall Study|Lack of Efficacy|4|||
48365748|NCT02187159|155534254|FG003|Overall Study|Lack of Efficacy|7|||
48365749|NCT02187159|155534251|FG000|Overall Study|Adverse Event|28|||
48365750|NCT02187159|155534252|FG001|Overall Study|Adverse Event|33|||
48365751|NCT02187159|155534253|FG002|Overall Study|Adverse Event|42|||
48365752|NCT02187159|155534254|FG003|Overall Study|Adverse Event|50|||
48365753|NCT02187159|155534251|FG000|Overall Study|Withdrawal by Subject|24|||
48365754|NCT02187159|155534252|FG001|Overall Study|Withdrawal by Subject|28|||
48365755|NCT02187159|155534253|FG002|Overall Study|Withdrawal by Subject|25|||
48365756|NCT02187159|155534254|FG003|Overall Study|Withdrawal by Subject|26|||
48365757|NCT02187159|155534251|FG000|Overall Study|Other|3|||
48365758|NCT02187159|155534252|FG001|Overall Study|Other|7|||
48365759|NCT02187159|155534253|FG002|Overall Study|Other|3|||
48365760|NCT02187159|155534254|FG003|Overall Study|Other|9|||
48365761|NCT03482466|155534257|FG000|Overall Study|Protocol Violation|2|||
48365762|NCT03896152|155534262|FG000|Overall Study|Patient/guardian decision|1|||
48365763|NCT03896152|155534263|FG001|Overall Study|Patient/guardian decision|1|||
48365764|NCT03896152|155534262|FG000|Overall Study|Adverse Event|0|||
48365765|NCT03896152|155534263|FG001|Overall Study|Adverse Event|1|||
48365766|NCT03896152|155534262|FG000|Overall Study|Physician Decision|1|||
48365767|NCT03896152|155534263|FG001|Overall Study|Physician Decision|0|||
48365768|NCT03896152|155534262|FG000|Overall Study|Technical problems|1|||
48365769|NCT03896152|155534263|FG001|Overall Study|Technical problems|0|||
48365770|NCT00436852|155534264|FG000|Overall Study|Death|23|||
48365771|NCT00436852|155534265|FG001|Overall Study|Death|34|||
48365772|NCT00436852|155534264|FG000|Overall Study|Lack of Efficacy|9|||
48365773|NCT00436852|155534265|FG001|Overall Study|Lack of Efficacy|7|||
48365774|NCT00436852|155534264|FG000|Overall Study|Withdrawal by Subject|2|||
48365775|NCT00436852|155534265|FG001|Overall Study|Withdrawal by Subject|4|||
48365776|NCT00436852|155534264|FG000|Overall Study|Ineligible|1|||
48365777|NCT00436852|155534265|FG001|Overall Study|Ineligible|0|||
48365778|NCT03167359|155534266|FG000|Overall Study|Physician Decision|1|||
48365779|NCT03167359|155534266|FG000|Overall Study|Lost to Follow-up|1|||
48365780|NCT03339583|155534267|FG000|First Intervention (14 Days)|Adverse Event|1|||
48365781|NCT03339583|155534268|FG001|First Intervention (14 Days)|Adverse Event|0|||
48365782|NCT03339583|155534267|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
48365783|NCT03339583|155534268|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
48365784|NCT03339583|155534267|FG000|Second Intervention (14 Days)|Adverse Event|0|||
48365785|NCT03339583|155534268|FG001|Second Intervention (14 Days)|Adverse Event|1|||
48365786|NCT03339583|155534267|FG000|Follow-up (14 Days)|Physician Decision|6|||
48365787|NCT03339583|155534268|FG001|Follow-up (14 Days)|Physician Decision|3|||
48365788|NCT02141620|155534269|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
48365789|NCT02141620|155534270|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
48365790|NCT01004848|155534275|FG000|Overall Study|Lost to Follow-up|55|||
48365791|NCT01004848|155534276|FG001|Overall Study|Lost to Follow-up|45|||
48365792|NCT03582943|155534277|FG000|Allocated to Groups|Withdrawal by Subject|1|||
48365793|NCT03582943|155534278|FG001|Allocated to Groups|Withdrawal by Subject|1|||
48365794|NCT03582943|155534277|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
48365795|NCT03582943|155534278|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
48365796|NCT03582943|155534277|FG000|Analyzed|Protocol Violation|4|||
48365797|NCT03582943|155534278|FG001|Analyzed|Protocol Violation|1|||
48365798|NCT01416389|155534281|FG000|Overall Study|Lost to Follow-up|1|||
48365799|NCT01416389|155534282|FG001|Overall Study|Lost to Follow-up|0|||
48365800|NCT01416389|155534281|FG000|Overall Study|Started New Therapy|2|||
48365801|NCT01416389|155534282|FG001|Overall Study|Started New Therapy|0|||
48365802|NCT01528345|155534286|FG000|Overall Study|Adverse Event|10|||
48365803|NCT01528345|155534287|FG001|Overall Study|Adverse Event|1|||
48365804|NCT01528345|155534286|FG000|Overall Study|Death|1|||
48365805|NCT01528345|155534287|FG001|Overall Study|Death|1|||
48365806|NCT01528345|155534286|FG000|Overall Study|Non-compliance with study treatment|1|||
48365807|NCT01528345|155534287|FG001|Overall Study|Non-compliance with study treatment|0|||
48365808|NCT01528345|155534286|FG000|Overall Study|Progressive Disease|26|||
48365809|NCT01528345|155534287|FG001|Overall Study|Progressive Disease|40|||
48365810|NCT01528345|155534286|FG000|Overall Study|Study Terminated by Sponsor|4|||
48365811|NCT01528345|155534287|FG001|Overall Study|Study Terminated by Sponsor|8|||
48365812|NCT01528345|155534286|FG000|Overall Study|Subject/Guardian Decision|5|||
48365813|NCT01528345|155534287|FG001|Overall Study|Subject/Guardian Decision|0|||
48365814|NCT02971761|155534290|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
48365815|NCT00735475|155534291|FG000|Overall Study|Adverse Event|0|||
48365816|NCT00735475|155534292|FG001|Overall Study|Adverse Event|1|||
48365817|NCT00735475|155534291|FG000|Overall Study|Death|1|||
48365818|NCT00735475|155534292|FG001|Overall Study|Death|1|||
48365819|NCT00735475|155534291|FG000|Overall Study|Lost to Follow-up|3|||
48365820|NCT00735475|155534292|FG001|Overall Study|Lost to Follow-up|3|||
48365821|NCT00735475|155534291|FG000|Overall Study|Physician Decision|0|||
48365822|NCT00735475|155534292|FG001|Overall Study|Physician Decision|1|||
48365823|NCT00735475|155534291|FG000|Overall Study|Withdrawal by Subject|4|||
48365824|NCT00735475|155534292|FG001|Overall Study|Withdrawal by Subject|5|||
48365825|NCT00548262|155534293|FG000|Overall Study|Death|21|||
48365826|NCT00548262|155534293|FG000|Overall Study|Adverse Event|2|||
48365827|NCT00548262|155534293|FG000|Overall Study|Lack of Efficacy|4|||
48365828|NCT00548262|155534293|FG000|Overall Study|Lost to Follow-up|1|||
48365829|NCT00548262|155534293|FG000|Overall Study|Other|3|||
48365830|NCT00548262|155534293|FG000|Overall Study|Withdrawal by Subject|1|||
48365831|NCT02285153|155534294|FG000|Overall Study|Adverse Event|1|||
48365832|NCT02285153|155534295|FG001|Overall Study|Adverse Event|0|||
48365833|NCT01283516|155534301|FG000|Overall Study|Adverse Event|0|||
48365834|NCT01283516|155534302|FG001|Overall Study|Adverse Event|0|||
48365835|NCT01283516|155534303|FG002|Overall Study|Adverse Event|0|||
48365836|NCT01283516|155534304|FG003|Overall Study|Adverse Event|0|||
48365837|NCT01283516|155534305|FG004|Overall Study|Adverse Event|0|||
48365838|NCT01283516|155534306|FG005|Overall Study|Adverse Event|0|||
48365839|NCT01283516|155534307|FG006|Overall Study|Adverse Event|2|||
48365840|NCT01283516|155534308|FG007|Overall Study|Adverse Event|0|||
48365841|NCT01283516|155534309|FG008|Overall Study|Adverse Event|28|||
48365842|NCT01283516|155534301|FG000|Overall Study|Death|0|||
48365843|NCT01283516|155534302|FG001|Overall Study|Death|0|||
48365844|NCT01283516|155534303|FG002|Overall Study|Death|0|||
48365845|NCT01283516|155534304|FG003|Overall Study|Death|0|||
48365846|NCT01283516|155534305|FG004|Overall Study|Death|0|||
48365847|NCT01283516|155534306|FG005|Overall Study|Death|1|||
48365848|NCT01283516|155534307|FG006|Overall Study|Death|0|||
48365849|NCT01283516|155534308|FG007|Overall Study|Death|1|||
48365850|NCT01283516|155534309|FG008|Overall Study|Death|12|||
48365851|NCT01283516|155534301|FG000|Overall Study|Disease Progression|2|||
48365852|NCT01283516|155534302|FG001|Overall Study|Disease Progression|2|||
48365853|NCT01283516|155534303|FG002|Overall Study|Disease Progression|3|||
48365854|NCT01283516|155534304|FG003|Overall Study|Disease Progression|3|||
48365855|NCT01283516|155534305|FG004|Overall Study|Disease Progression|13|||
48365856|NCT01283516|155534306|FG005|Overall Study|Disease Progression|8|||
48365857|NCT01283516|155534307|FG006|Overall Study|Disease Progression|6|||
48365858|NCT01283516|155534308|FG007|Overall Study|Disease Progression|3|||
48365859|NCT01283516|155534309|FG008|Overall Study|Disease Progression|139|||
48365860|NCT01283516|155534301|FG000|Overall Study|Withdrawal by Subject|0|||
48365861|NCT01283516|155534302|FG001|Overall Study|Withdrawal by Subject|0|||
48365862|NCT01283516|155534303|FG002|Overall Study|Withdrawal by Subject|0|||
48365863|NCT01283516|155534304|FG003|Overall Study|Withdrawal by Subject|0|||
48365864|NCT01283516|155534305|FG004|Overall Study|Withdrawal by Subject|1|||
48365865|NCT01283516|155534306|FG005|Overall Study|Withdrawal by Subject|0|||
48365866|NCT01283516|155534307|FG006|Overall Study|Withdrawal by Subject|1|||
48365867|NCT01283516|155534308|FG007|Overall Study|Withdrawal by Subject|0|||
48365868|NCT01283516|155534309|FG008|Overall Study|Withdrawal by Subject|36|||
48365869|NCT01283516|155534301|FG000|Overall Study|Administrative problems|0|||
48365870|NCT01283516|155534302|FG001|Overall Study|Administrative problems|0|||
48365871|NCT01283516|155534303|FG002|Overall Study|Administrative problems|0|||
48365872|NCT01283516|155534304|FG003|Overall Study|Administrative problems|0|||
48365873|NCT01283516|155534305|FG004|Overall Study|Administrative problems|0|||
48365874|NCT01283516|155534306|FG005|Overall Study|Administrative problems|1|||
48365875|NCT01283516|155534307|FG006|Overall Study|Administrative problems|1|||
48365876|NCT01283516|155534308|FG007|Overall Study|Administrative problems|1|||
48365877|NCT01283516|155534309|FG008|Overall Study|Administrative problems|39|||
48365878|NCT01283516|155534301|FG000|Overall Study|Lost to Follow-up|0|||
48365879|NCT01283516|155534302|FG001|Overall Study|Lost to Follow-up|0|||
48365880|NCT01283516|155534303|FG002|Overall Study|Lost to Follow-up|0|||
48365881|NCT01283516|155534304|FG003|Overall Study|Lost to Follow-up|0|||
48365882|NCT01283516|155534305|FG004|Overall Study|Lost to Follow-up|0|||
48365883|NCT01283516|155534306|FG005|Overall Study|Lost to Follow-up|0|||
48365884|NCT01283516|155534307|FG006|Overall Study|Lost to Follow-up|0|||
48365885|NCT01283516|155534308|FG007|Overall Study|Lost to Follow-up|0|||
48365886|NCT01283516|155534309|FG008|Overall Study|Lost to Follow-up|1|||
48365887|NCT00998790|155534312|FG000|Overall Study|Withdrawal by Subject|21|||
48365888|NCT02576587|155534313|FG000|Baseline|Equipment failure|0|||
48365889|NCT02576587|155534314|FG001|Baseline|Equipment failure|1|||
48365890|NCT02576587|155534313|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
48365891|NCT02576587|155534314|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
48365892|NCT02576587|155534313|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
48365893|NCT02576587|155534314|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
48414373|NCT00809133|155705540|FG005|Overall Study|Other adverse event|3|||
48414374|NCT00809133|155705541|FG006|Overall Study|Other adverse event|2|||
48365894|NCT02576587|155534313|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
48365895|NCT02576587|155534314|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
48365896|NCT00532493|155534317|FG000|Overall Study|Death|1|||
48365897|NCT00532493|155534318|FG001|Overall Study|Death|1|||
48365898|NCT00532493|155534317|FG000|Overall Study|Lost to Follow-up|10|||
48365899|NCT00532493|155534318|FG001|Overall Study|Lost to Follow-up|7|||
48365900|NCT00532493|155534317|FG000|Overall Study|Withdrawal by Subject|7|||
48365901|NCT00532493|155534318|FG001|Overall Study|Withdrawal by Subject|9|||
48365902|NCT00532493|155534317|FG000|Overall Study|Physician Decision|1|||
48365903|NCT00532493|155534318|FG001|Overall Study|Physician Decision|6|||
48365904|NCT00532493|155534317|FG000|Overall Study|Adverse Event|6|||
48365905|NCT00532493|155534318|FG001|Overall Study|Adverse Event|5|||
48365906|NCT00532493|155534317|FG000|Overall Study|Protocol Deviation|1|||
48365907|NCT00532493|155534318|FG001|Overall Study|Protocol Deviation|0|||
48365908|NCT00532493|155534317|FG000|Overall Study|Subject Moved Away|3|||
48365909|NCT00532493|155534318|FG001|Overall Study|Subject Moved Away|1|||
48365910|NCT00532493|155534317|FG000|Overall Study|Contraindicative Medication|1|||
48365911|NCT00532493|155534318|FG001|Overall Study|Contraindicative Medication|0|||
48365912|NCT00444275|155534319|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
48365913|NCT00444275|155534320|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
48365914|NCT00444275|155534321|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
48365915|NCT00444275|155534322|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
48365916|NCT00444275|155534323|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
48365917|NCT00444275|155534319|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
48365918|NCT00444275|155534320|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
48365919|NCT00444275|155534321|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
48414375|NCT00809133|155705542|FG007|Overall Study|Other adverse event|4|||
48414376|NCT00809133|155705543|FG008|Overall Study|Other adverse event|0|||
48414377|NCT00809133|155705544|FG009|Overall Study|Other adverse event|0|||
48414378|NCT00809133|155705545|FG010|Overall Study|Other adverse event|1|||
48414379|NCT00809133|155705546|FG011|Overall Study|Other adverse event|1|||
48414380|NCT00809133|155705547|FG012|Overall Study|Other adverse event|0|||
48414381|NCT00809133|155705548|FG013|Overall Study|Other adverse event|1|||
48414382|NCT00809133|155705535|FG000|Overall Study|Lost to Follow-up|0|||
48365920|NCT00444275|155534322|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
48365921|NCT00444275|155534323|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
48365922|NCT00444275|155534319|FG000|Maintenance Treatment Phase|Adverse Event|0|||
48365923|NCT00444275|155534320|FG001|Maintenance Treatment Phase|Adverse Event|0|||
48365924|NCT00444275|155534321|FG002|Maintenance Treatment Phase|Adverse Event|3|||
48365925|NCT00444275|155534322|FG003|Maintenance Treatment Phase|Adverse Event|2|||
48365926|NCT00444275|155534323|FG004|Maintenance Treatment Phase|Adverse Event|13|||
48365927|NCT00444275|155534319|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
48365928|NCT00444275|155534320|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
48365929|NCT00444275|155534321|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
48414383|NCT00809133|155705536|FG001|Overall Study|Lost to Follow-up|0|||
48414384|NCT00809133|155705537|FG002|Overall Study|Lost to Follow-up|0|||
48414385|NCT00809133|155705538|FG003|Overall Study|Lost to Follow-up|0|||
48365930|NCT00444275|155534322|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
48365931|NCT00444275|155534323|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
48365932|NCT00444275|155534319|FG000|Maintenance Treatment Phase|Patient's wish|0|||
48414386|NCT00809133|155705539|FG004|Overall Study|Lost to Follow-up|0|||
48414387|NCT00809133|155705540|FG005|Overall Study|Lost to Follow-up|1|||
48365933|NCT00444275|155534320|FG001|Maintenance Treatment Phase|Patient's wish|0|||
48414388|NCT00809133|155705541|FG006|Overall Study|Lost to Follow-up|0|||
48414389|NCT00809133|155705542|FG007|Overall Study|Lost to Follow-up|0|||
48414390|NCT00809133|155705543|FG008|Overall Study|Lost to Follow-up|0|||
48414391|NCT00809133|155705544|FG009|Overall Study|Lost to Follow-up|0|||
48414392|NCT00809133|155705545|FG010|Overall Study|Lost to Follow-up|0|||
48414393|NCT00809133|155705546|FG011|Overall Study|Lost to Follow-up|0|||
48414394|NCT00809133|155705547|FG012|Overall Study|Lost to Follow-up|0|||
48414395|NCT00809133|155705548|FG013|Overall Study|Lost to Follow-up|0|||
48414396|NCT00809133|155705535|FG000|Overall Study|Consent withdrawn|0|||
48414397|NCT00809133|155705536|FG001|Overall Study|Consent withdrawn|0|||
48414398|NCT00809133|155705537|FG002|Overall Study|Consent withdrawn|0|||
48414399|NCT00809133|155705538|FG003|Overall Study|Consent withdrawn|0|||
48414400|NCT00809133|155705539|FG004|Overall Study|Consent withdrawn|1|||
48414401|NCT00809133|155705540|FG005|Overall Study|Consent withdrawn|0|||
48414402|NCT00809133|155705541|FG006|Overall Study|Consent withdrawn|0|||
48414403|NCT00809133|155705542|FG007|Overall Study|Consent withdrawn|0|||
48414404|NCT00809133|155705543|FG008|Overall Study|Consent withdrawn|0|||
48414405|NCT00809133|155705544|FG009|Overall Study|Consent withdrawn|0|||
48414406|NCT00809133|155705545|FG010|Overall Study|Consent withdrawn|0|||
48414407|NCT00809133|155705546|FG011|Overall Study|Consent withdrawn|0|||
48414408|NCT00809133|155705547|FG012|Overall Study|Consent withdrawn|0|||
48414409|NCT00809133|155705548|FG013|Overall Study|Consent withdrawn|0|||
48414410|NCT00809133|155705535|FG000|Overall Study|Other not mentioned above|0|||
48414411|NCT00809133|155705536|FG001|Overall Study|Other not mentioned above|1|||
48414412|NCT00809133|155705537|FG002|Overall Study|Other not mentioned above|0|||
48414413|NCT00809133|155705538|FG003|Overall Study|Other not mentioned above|0|||
48414414|NCT00809133|155705539|FG004|Overall Study|Other not mentioned above|0|||
48414415|NCT00809133|155705540|FG005|Overall Study|Other not mentioned above|1|||
48414416|NCT00809133|155705541|FG006|Overall Study|Other not mentioned above|0|||
48414417|NCT00809133|155705542|FG007|Overall Study|Other not mentioned above|0|||
48365934|NCT00444275|155534321|FG002|Maintenance Treatment Phase|Patient's wish|19|||
48365935|NCT00444275|155534322|FG003|Maintenance Treatment Phase|Patient's wish|9|||
48365936|NCT00444275|155534323|FG004|Maintenance Treatment Phase|Patient's wish|20|||
48365937|NCT00444275|155534319|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
48414418|NCT00809133|155705543|FG008|Overall Study|Other not mentioned above|0|||
48414419|NCT00809133|155705544|FG009|Overall Study|Other not mentioned above|0|||
48414420|NCT00809133|155705545|FG010|Overall Study|Other not mentioned above|0|||
48414421|NCT00809133|155705546|FG011|Overall Study|Other not mentioned above|0|||
48414422|NCT00809133|155705547|FG012|Overall Study|Other not mentioned above|0|||
48414423|NCT00809133|155705548|FG013|Overall Study|Other not mentioned above|0|||
48414424|NCT02586805|155705552|FG000|Overall Study|Withdrawal by Subject|3|||
48414425|NCT02586805|155705553|FG001|Overall Study|Withdrawal by Subject|1|||
48414426|NCT02586805|155705554|FG002|Overall Study|Withdrawal by Subject|1|||
48414427|NCT02586805|155705555|FG003|Overall Study|Withdrawal by Subject|2|||
48414428|NCT02586805|155705552|FG000|Overall Study|Adverse Event|2|||
48414429|NCT02586805|155705553|FG001|Overall Study|Adverse Event|0|||
48414430|NCT02586805|155705554|FG002|Overall Study|Adverse Event|1|||
48414431|NCT02586805|155705555|FG003|Overall Study|Adverse Event|0|||
48365938|NCT00444275|155534320|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
48365939|NCT00444275|155534321|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
48365940|NCT00444275|155534322|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
48365941|NCT00444275|155534323|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
48365942|NCT00444275|155534319|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
48365943|NCT00444275|155534320|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
48365944|NCT00444275|155534321|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
48365945|NCT00444275|155534322|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
48365946|NCT00444275|155534323|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
48414432|NCT02586805|155705552|FG000|Overall Study|Lost to Follow-up|0|||
48414433|NCT02586805|155705553|FG001|Overall Study|Lost to Follow-up|0|||
48414434|NCT02586805|155705554|FG002|Overall Study|Lost to Follow-up|1|||
48414435|NCT02586805|155705555|FG003|Overall Study|Lost to Follow-up|0|||
48414436|NCT02586805|155705552|FG000|Overall Study|Physician Decision|1|||
48414437|NCT02586805|155705553|FG001|Overall Study|Physician Decision|0|||
48414438|NCT02586805|155705554|FG002|Overall Study|Physician Decision|0|||
48414439|NCT02586805|155705555|FG003|Overall Study|Physician Decision|0|||
48414440|NCT00087438|155705556|FG000|Overall Study|Ineligible / No protocol treatment|4|||
48365947|NCT02045875|155534324|FG000|Overall Study|Lost to Follow-up|3|||
48365948|NCT02045875|155534325|FG001|Overall Study|Lost to Follow-up|0|||
48365949|NCT02045875|155534324|FG000|Overall Study|Withdrawal by Subject|4|||
48365950|NCT02045875|155534325|FG001|Overall Study|Withdrawal by Subject|3|||
48414441|NCT00699192|155705558|FG000|Overall Study|Missing|1|||
48414442|NCT00699192|155705559|FG001|Overall Study|Missing|1|||
48414443|NCT00699192|155705560|FG002|Overall Study|Missing|1|||
48414444|NCT00699192|155705558|FG000|Overall Study|Adverse Event|9|||
48365951|NCT02153073|155534326|FG000|Overall Study|Case Report Forms Uncollected|230|||
48414445|NCT00699192|155705559|FG001|Overall Study|Adverse Event|4|||
48414446|NCT00699192|155705560|FG002|Overall Study|Adverse Event|3|||
48414447|NCT00699192|155705558|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48414448|NCT00699192|155705559|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48414449|NCT00699192|155705560|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48365952|NCT02153073|155534326|FG000|Overall Study|Protocol Deviation|68|||
48365953|NCT03291288|155534327|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
48365954|NCT03291288|155534328|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
48365955|NCT03291288|155534327|FG000|Drug-drug Interaction Phase|Disease progression|1|||
48365956|NCT03291288|155534328|FG001|Drug-drug Interaction Phase|Disease progression|0|||
48365957|NCT03291288|155534327|FG000|Drug-drug Interaction Phase|Other|3|||
48365958|NCT03291288|155534328|FG001|Drug-drug Interaction Phase|Other|0|||
48365959|NCT03291288|155534327|FG000|Pexidartinib Only|Ongoing|0|||
48365960|NCT03291288|155534328|FG001|Pexidartinib Only|Ongoing|2|||
48365961|NCT01080716|155534329|FG000|Part 1|Physician Decision|1|||
48365962|NCT01080716|155534330|FG001|Part 1|Physician Decision|0|||
48365963|NCT01080716|155534331|FG002|Part 1|Physician Decision|0|||
48414450|NCT00699192|155705558|FG000|Overall Study|Lack of Efficacy|0|||
48414451|NCT00699192|155705559|FG001|Overall Study|Lack of Efficacy|0|||
48414452|NCT00699192|155705560|FG002|Overall Study|Lack of Efficacy|1|||
48414453|NCT00699192|155705558|FG000|Overall Study|Withdrawal by Subject|3|||
48414454|NCT00699192|155705559|FG001|Overall Study|Withdrawal by Subject|2|||
48414455|NCT00699192|155705560|FG002|Overall Study|Withdrawal by Subject|4|||
48414456|NCT00699192|155705558|FG000|Overall Study|Administrative problems|1|||
48414457|NCT00699192|155705559|FG001|Overall Study|Administrative problems|3|||
48414458|NCT00699192|155705560|FG002|Overall Study|Administrative problems|1|||
48414459|NCT00699192|155705558|FG000|Overall Study|Protocol Violation|2|||
48414460|NCT00699192|155705559|FG001|Overall Study|Protocol Violation|2|||
48414461|NCT00699192|155705560|FG002|Overall Study|Protocol Violation|0|||
48414462|NCT00891735|155705563|FG000|Overall Study|Adverse Event|2|||
48414463|NCT00891735|155705564|FG001|Overall Study|Adverse Event|0|||
48414464|NCT00891735|155705565|FG002|Overall Study|Adverse Event|2|||
48414465|NCT00891735|155705566|FG003|Overall Study|Adverse Event|0|||
48414466|NCT00891735|155705563|FG000|Overall Study|Death|8|||
48414467|NCT00891735|155705564|FG001|Overall Study|Death|5|||
48414468|NCT00891735|155705565|FG002|Overall Study|Death|4|||
48414469|NCT00891735|155705566|FG003|Overall Study|Death|5|||
48414470|NCT00891735|155705563|FG000|Overall Study|Lost to Follow-up|2|||
48414471|NCT00891735|155705564|FG001|Overall Study|Lost to Follow-up|2|||
48414472|NCT00891735|155705565|FG002|Overall Study|Lost to Follow-up|2|||
48414473|NCT00891735|155705566|FG003|Overall Study|Lost to Follow-up|2|||
48414474|NCT00891735|155705563|FG000|Overall Study|Physician's decision to withdraw patient|1|||
48414475|NCT00891735|155705564|FG001|Overall Study|Physician's decision to withdraw patient|0|||
48414476|NCT00891735|155705565|FG002|Overall Study|Physician's decision to withdraw patient|0|||
48414477|NCT00891735|155705566|FG003|Overall Study|Physician's decision to withdraw patient|0|||
48414478|NCT00891735|155705563|FG000|Overall Study|Patient's decision to withdraw|4|||
48414479|NCT00891735|155705564|FG001|Overall Study|Patient's decision to withdraw|9|||
48414480|NCT00891735|155705565|FG002|Overall Study|Patient's decision to withdraw|4|||
48414481|NCT00891735|155705566|FG003|Overall Study|Patient's decision to withdraw|8|||
48414482|NCT01085682|155705567|FG000|Overall Study|Withdrawal by Subject|25|||
48414483|NCT01085682|155705568|FG001|Overall Study|Withdrawal by Subject|25|||
48414484|NCT03926143|155705571|FG000|Overall Study|Physician Decision|3|||
48414485|NCT03926143|155705571|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
48414486|NCT03926143|155705571|FG000|Overall Study|Adverse Event|2|||
48414487|NCT03926143|155705571|FG000|Overall Study|Progressive disease|3|||
48414488|NCT02978222|155705572|FG000|Overall Study|Withdrawal by Subject|2|||
48414489|NCT02978222|155705573|FG001|Overall Study|Withdrawal by Subject|2|||
48414490|NCT02978222|155705572|FG000|Overall Study|Physician Decision|2|||
48414491|NCT02978222|155705573|FG001|Overall Study|Physician Decision|0|||
48414492|NCT02978222|155705572|FG000|Overall Study|Adverse Event|0|||
48365964|NCT01080716|155534332|FG003|Part 1|Physician Decision|0|||
48365965|NCT01056718|155534333|FG000|Overall Study|Withdrawal by Subject|2|||
48365966|NCT01056718|155534333|FG000|Overall Study|Ischemia on baseline stress test|1|||
48365967|NCT01276379|155534334|FG000|Overall Study|Screening failure|40|||
48414493|NCT02978222|155705573|FG001|Overall Study|Adverse Event|1|||
48365968|NCT00287690|155534335|FG000|Overall Study|Protocol Violation|20|||
48365969|NCT00287690|155534336|FG001|Overall Study|Protocol Violation|26|||
48365970|NCT03592745|155534337|FG000|Overall Study|Adverse Event|0|||
48365971|NCT03592745|155534338|FG001|Overall Study|Adverse Event|2|||
48365972|NCT03592745|155534337|FG000|Overall Study|Lost to Follow-up|2|||
48365973|NCT03592745|155534338|FG001|Overall Study|Lost to Follow-up|0|||
48365974|NCT03592745|155534337|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
48365975|NCT03592745|155534338|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
48365976|NCT00864253|155534339|FG000|Overall Study|Adverse Event|56|||
48365977|NCT00864253|155534340|FG001|Overall Study|Adverse Event|11|||
48414494|NCT02978222|155705572|FG000|Overall Study|Death|1|||
48414495|NCT02978222|155705573|FG001|Overall Study|Death|0|||
48414496|NCT02978222|155705572|FG000|Overall Study|Disease Progression|32|||
48414497|NCT02978222|155705573|FG001|Overall Study|Disease Progression|32|||
48414498|NCT02978222|155705572|FG000|Overall Study|Early Study Termination|24|||
48414499|NCT02978222|155705573|FG001|Overall Study|Early Study Termination|21|||
48414500|NCT03258814|155705576|FG000|Overall Study|Early Termination|4|||
48414501|NCT03258814|155705577|FG001|Overall Study|Early Termination|3|||
48414502|NCT03258814|155705578|FG002|Overall Study|Early Termination|10|||
48414503|NCT00813995|155705579|FG000|Overall Study|Clinical adverse event|9|||
48414504|NCT00813995|155705580|FG001|Overall Study|Clinical adverse event|3|||
48414505|NCT00813995|155705579|FG000|Overall Study|Laboratory adverse event|0|||
48414506|NCT00813995|155705580|FG001|Overall Study|Laboratory adverse event|2|||
48414507|NCT00813995|155705579|FG000|Overall Study|Lack of Efficacy|1|||
48414508|NCT00813995|155705580|FG001|Overall Study|Lack of Efficacy|0|||
48414509|NCT00813995|155705579|FG000|Overall Study|Lost to Follow-up|4|||
48414510|NCT00813995|155705580|FG001|Overall Study|Lost to Follow-up|2|||
48414511|NCT00813995|155705579|FG000|Overall Study|Other reason|2|||
48414512|NCT00813995|155705580|FG001|Overall Study|Other reason|2|||
48414513|NCT00813995|155705579|FG000|Overall Study|Protocol Violation|3|||
48414514|NCT00813995|155705580|FG001|Overall Study|Protocol Violation|2|||
48414515|NCT00813995|155705579|FG000|Overall Study|Subject moved|4|||
48414516|NCT00813995|155705580|FG001|Overall Study|Subject moved|0|||
48414517|NCT00813995|155705579|FG000|Overall Study|Withdrawal by Subject|0|||
48414518|NCT00813995|155705580|FG001|Overall Study|Withdrawal by Subject|5|||
48414519|NCT01966731|155705581|FG000|Overall Study|Death|2|||
48414520|NCT01966731|155705581|FG000|Overall Study|Lost to Follow-up|1|||
48414521|NCT01966731|155705581|FG000|Overall Study|Physician Decision|2|||
48414522|NCT01966731|155705581|FG000|Overall Study|Follow up is not complete|600|||
48414523|NCT01966731|155705581|FG000|Overall Study|Screening Failure|29|||
48414524|NCT01966731|155705581|FG000|Overall Study|Found to be ineligible|1|||
48414525|NCT02620020|155705584|FG000|Overall Study|Adverse Event|8|||
48414526|NCT02620020|155705585|FG001|Overall Study|Adverse Event|4|||
48414527|NCT02620020|155705586|FG002|Overall Study|Adverse Event|3|||
48414528|NCT02620020|155705587|FG003|Overall Study|Adverse Event|5|||
48414529|NCT02620020|155705584|FG000|Overall Study|Lost to Follow-up|4|||
48414530|NCT02620020|155705585|FG001|Overall Study|Lost to Follow-up|8|||
48414531|NCT02620020|155705586|FG002|Overall Study|Lost to Follow-up|1|||
48414532|NCT02620020|155705587|FG003|Overall Study|Lost to Follow-up|4|||
48414533|NCT02620020|155705584|FG000|Overall Study|Physician Decision|7|||
48414534|NCT02620020|155705585|FG001|Overall Study|Physician Decision|4|||
48414535|NCT02620020|155705586|FG002|Overall Study|Physician Decision|3|||
48414536|NCT02620020|155705587|FG003|Overall Study|Physician Decision|4|||
48414537|NCT02620020|155705584|FG000|Overall Study|Protocol Violation|5|||
48414538|NCT02620020|155705585|FG001|Overall Study|Protocol Violation|2|||
48414539|NCT02620020|155705586|FG002|Overall Study|Protocol Violation|1|||
48414540|NCT02620020|155705587|FG003|Overall Study|Protocol Violation|1|||
48414541|NCT02620020|155705584|FG000|Overall Study|Withdrawal by Subject|20|||
48414542|NCT02620020|155705585|FG001|Overall Study|Withdrawal by Subject|16|||
48414543|NCT02620020|155705586|FG002|Overall Study|Withdrawal by Subject|17|||
48414544|NCT02620020|155705587|FG003|Overall Study|Withdrawal by Subject|12|||
48414545|NCT02620020|155705584|FG000|Overall Study|Death|0|||
48414546|NCT02620020|155705585|FG001|Overall Study|Death|1|||
48414547|NCT02620020|155705586|FG002|Overall Study|Death|0|||
48414548|NCT02620020|155705587|FG003|Overall Study|Death|0|||
48414549|NCT01025635|155705588|FG000|Overall Study|Withdrawal by Subject|6|||
48414550|NCT01025635|155705589|FG001|Overall Study|Withdrawal by Subject|7|||
48414551|NCT01025635|155705588|FG000|Overall Study|Protocol Violation|4|||
48414552|NCT01025635|155705589|FG001|Overall Study|Protocol Violation|2|||
48414553|NCT01025635|155705588|FG000|Overall Study|Lack of Efficacy|0|||
48414554|NCT01025635|155705589|FG001|Overall Study|Lack of Efficacy|1|||
48414555|NCT01025635|155705588|FG000|Overall Study|Lost to Follow-up|9|||
48414556|NCT01025635|155705589|FG001|Overall Study|Lost to Follow-up|13|||
48414557|NCT01025635|155705588|FG000|Overall Study|Reason not known|4|||
48414558|NCT01025635|155705589|FG001|Overall Study|Reason not known|2|||
48414559|NCT02928952|155705591|FG000|Overall Study|Lost to Follow-up|5|||
48414560|NCT02928952|155705592|FG001|Overall Study|Lost to Follow-up|5|||
48414561|NCT02928952|155705591|FG000|Overall Study|Withdrawal by Subject|5|||
48414562|NCT02928952|155705592|FG001|Overall Study|Withdrawal by Subject|1|||
48414563|NCT02928952|155705591|FG000|Overall Study|Physician Decision|0|||
48414564|NCT02928952|155705592|FG001|Overall Study|Physician Decision|1|||
48414565|NCT00706628|155705593|FG000|Overall Study|Other Adverse Event|16|||
48414566|NCT00706628|155705594|FG001|Overall Study|Other Adverse Event|5|||
48414567|NCT00706628|155705595|FG002|Overall Study|Other Adverse Event|5|||
48414568|NCT00706628|155705596|FG003|Overall Study|Other Adverse Event|2|||
48414569|NCT00706628|155705593|FG000|Overall Study|Non compliant with protocol|0|||
48414570|NCT00706628|155705594|FG001|Overall Study|Non compliant with protocol|1|||
48414571|NCT00706628|155705595|FG002|Overall Study|Non compliant with protocol|0|||
48414572|NCT00706628|155705596|FG003|Overall Study|Non compliant with protocol|0|||
48414573|NCT00706628|155705593|FG000|Overall Study|Consent withdrawn|6|||
48414574|NCT00706628|155705594|FG001|Overall Study|Consent withdrawn|1|||
48414575|NCT00706628|155705595|FG002|Overall Study|Consent withdrawn|3|||
48414576|NCT00706628|155705596|FG003|Overall Study|Consent withdrawn|0|||
48414577|NCT00706628|155705593|FG000|Overall Study|Progressive disease|20|||
48414578|NCT00706628|155705594|FG001|Overall Study|Progressive disease|13|||
48414579|NCT00706628|155705595|FG002|Overall Study|Progressive disease|8|||
48414580|NCT00706628|155705596|FG003|Overall Study|Progressive disease|1|||
48414581|NCT00706628|155705593|FG000|Overall Study|Other than those stated above|4|||
48414582|NCT00706628|155705594|FG001|Overall Study|Other than those stated above|0|||
48414583|NCT00706628|155705595|FG002|Overall Study|Other than those stated above|0|||
48414584|NCT00706628|155705596|FG003|Overall Study|Other than those stated above|0|||
48414585|NCT00706628|155705593|FG000|Overall Study|Not treated|1|||
48414586|NCT00706628|155705594|FG001|Overall Study|Not treated|1|||
48414587|NCT00706628|155705595|FG002|Overall Study|Not treated|0|||
48414588|NCT00706628|155705596|FG003|Overall Study|Not treated|0|||
48414589|NCT01499290|155705597|FG000|Overall Study|Withdrawal by Subject|22|||
48414590|NCT01499290|155705598|FG001|Overall Study|Withdrawal by Subject|15|||
48414591|NCT01499290|155705597|FG000|Overall Study|Not specified in study report|11|||
48414592|NCT01499290|155705598|FG001|Overall Study|Not specified in study report|5|||
48414593|NCT01499290|155705597|FG000|Overall Study|Condition improved/subject recovered|1|||
48414594|NCT01499290|155705598|FG001|Overall Study|Condition improved/subject recovered|0|||
48414595|NCT01499290|155705597|FG000|Overall Study|Lack of Efficacy|7|||
48414596|NCT01499290|155705598|FG001|Overall Study|Lack of Efficacy|8|||
48365978|NCT00864253|155534339|FG000|Overall Study|Unrelated Adverse Event|3|||
48365979|NCT00864253|155534340|FG001|Overall Study|Unrelated Adverse Event|1|||
48365980|NCT00864253|155534339|FG000|Overall Study|Physician Decision|11|||
48365981|NCT00864253|155534340|FG001|Overall Study|Physician Decision|15|||
48365982|NCT00864253|155534339|FG000|Overall Study|Protocol Violation|0|||
48365983|NCT00864253|155534340|FG001|Overall Study|Protocol Violation|2|||
48365984|NCT00864253|155534339|FG000|Overall Study|Lost to Follow-up|1|||
48365985|NCT00864253|155534340|FG001|Overall Study|Lost to Follow-up|1|||
48365986|NCT00864253|155534339|FG000|Overall Study|Withdrawal by Subject|18|||
48365987|NCT00864253|155534340|FG001|Overall Study|Withdrawal by Subject|18|||
48365988|NCT00864253|155534339|FG000|Overall Study|Death|1|||
48365989|NCT00864253|155534340|FG001|Overall Study|Death|0|||
48365990|NCT00864253|155534339|FG000|Overall Study|Ongoing|2|||
48365991|NCT00864253|155534340|FG001|Overall Study|Ongoing|3|||
48365992|NCT00864253|155534339|FG000|Overall Study|Untreated|7|||
48414597|NCT01499290|155705597|FG000|Overall Study|Adverse Event|14|||
48414598|NCT01499290|155705598|FG001|Overall Study|Adverse Event|7|||
48414599|NCT04052139|155705599|FG000|Overall Study|Lost to Follow-up|2|||
48414600|NCT04052139|155705600|FG001|Overall Study|Lost to Follow-up|0|||
48414601|NCT04052139|155705601|FG002|Overall Study|Lost to Follow-up|0|||
48365993|NCT00864253|155534340|FG001|Overall Study|Untreated|7|||
48365994|NCT03590366|155534341|FG000|Overall Study|Adverse Event|0|||
48365995|NCT03590366|155534342|FG001|Overall Study|Adverse Event|3|||
48365996|NCT03590366|155534341|FG000|Overall Study|Lost to Follow-up|3|||
48365997|NCT03590366|155534342|FG001|Overall Study|Lost to Follow-up|3|||
48365998|NCT03590366|155534341|FG000|Overall Study|Withdrawal by Subject|0|||
48365999|NCT03590366|155534342|FG001|Overall Study|Withdrawal by Subject|2|||
48366000|NCT03309813|155534343|FG000|Main Randomized Study|Withdrawal by Subject|1|||
48366001|NCT03309813|155534344|FG001|Main Randomized Study|Withdrawal by Subject|0|||
48366002|NCT00738894|155534345|FG000|Overall Study|Lost to Follow-up|23|||
48366003|NCT00738894|155534346|FG001|Overall Study|Lost to Follow-up|13|||
48366004|NCT00738894|155534345|FG000|Overall Study|Withdrawal by Subject|10|||
48414602|NCT04052139|155705599|FG000|Overall Study|Withdrawal by Subject|1|||
48414603|NCT04052139|155705600|FG001|Overall Study|Withdrawal by Subject|0|||
48414604|NCT04052139|155705601|FG002|Overall Study|Withdrawal by Subject|0|||
48366005|NCT00738894|155534346|FG001|Overall Study|Withdrawal by Subject|15|||
48366006|NCT00738894|155534345|FG000|Overall Study|Physician Decision|4|||
48366007|NCT00738894|155534346|FG001|Overall Study|Physician Decision|5|||
48366008|NCT00738894|155534345|FG000|Overall Study|Death|2|||
48366009|NCT00738894|155534346|FG001|Overall Study|Death|0|||
48366010|NCT02656329|155534350|FG000|Overall Study|Lost to Follow-up|2|||
48366011|NCT02656329|155534351|FG001|Overall Study|Lost to Follow-up|3|||
48366012|NCT02656329|155534350|FG000|Overall Study|Withdrawal by Subject|7|||
48366013|NCT02656329|155534351|FG001|Overall Study|Withdrawal by Subject|6|||
48366014|NCT02656329|155534350|FG000|Overall Study|Study termination by Sponsor|150|||
48414605|NCT00190775|155705603|FG000|Overall Study|Adverse Event|57|||
48414606|NCT00190775|155705604|FG001|Overall Study|Adverse Event|22|||
48414607|NCT00190775|155705603|FG000|Overall Study|Satisfactory Response|1|||
48414608|NCT00190775|155705604|FG001|Overall Study|Satisfactory Response|0|||
48366015|NCT02656329|155534351|FG001|Overall Study|Study termination by Sponsor|142|||
48414609|NCT00190775|155705603|FG000|Overall Study|Lack of Efficacy|28|||
48414610|NCT00190775|155705604|FG001|Overall Study|Lack of Efficacy|32|||
48366016|NCT02656329|155534350|FG000|Overall Study|Other than specified above|5|||
48366017|NCT02656329|155534351|FG001|Overall Study|Other than specified above|6|||
48414611|NCT00190775|155705603|FG000|Overall Study|Lost to Follow-up|31|||
48414612|NCT00190775|155705604|FG001|Overall Study|Lost to Follow-up|23|||
48414613|NCT00190775|155705603|FG000|Overall Study|Participant Moved|0|||
48414614|NCT00190775|155705604|FG001|Overall Study|Participant Moved|1|||
48366018|NCT03208036|155534352|FG000|Baseline Assessment|Withdrawal by Subject|1|||
48366019|NCT03208036|155534353|FG001|Baseline Assessment|Withdrawal by Subject|1|||
48366020|NCT03208036|155534352|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
48366021|NCT03208036|155534353|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
48366022|NCT03208036|155534352|FG000|Intervention|Withdrawal by Subject|3|||
48414615|NCT00190775|155705603|FG000|Overall Study|Withdrawal by Subject|24|||
48414616|NCT00190775|155705604|FG001|Overall Study|Withdrawal by Subject|13|||
48414617|NCT00190775|155705603|FG000|Overall Study|Sponsor Decision|1|||
48414618|NCT00190775|155705604|FG001|Overall Study|Sponsor Decision|0|||
48414619|NCT00190775|155705603|FG000|Overall Study|Physician Decision|3|||
48414620|NCT00190775|155705604|FG001|Overall Study|Physician Decision|0|||
48414621|NCT00190775|155705603|FG000|Overall Study|Noncompliance|3|||
48414622|NCT00190775|155705604|FG001|Overall Study|Noncompliance|5|||
48414623|NCT00190775|155705603|FG000|Overall Study|Protocol Violation|0|||
48414624|NCT00190775|155705604|FG001|Overall Study|Protocol Violation|1|||
48414625|NCT00190775|155705603|FG000|Overall Study|Exclusion Criteria Met|1|||
48414626|NCT00190775|155705604|FG001|Overall Study|Exclusion Criteria Met|3|||
48414627|NCT04003610|155705605|FG000|Overall Study|Lost to Follow-up|0|||
48414628|NCT04003610|155705606|FG001|Overall Study|Lost to Follow-up|1|||
48414629|NCT04003610|155705607|FG002|Overall Study|Lost to Follow-up|0|||
48414630|NCT04003610|155705605|FG000|Overall Study|Death|0|||
48414631|NCT04003610|155705606|FG001|Overall Study|Death|0|||
48414632|NCT04003610|155705607|FG002|Overall Study|Death|3|||
48414633|NCT04003610|155705605|FG000|Overall Study|Study Terminated by Sponsor|0|||
48414634|NCT04003610|155705606|FG001|Overall Study|Study Terminated by Sponsor|0|||
48414635|NCT04003610|155705607|FG002|Overall Study|Study Terminated by Sponsor|3|||
48414636|NCT00666562|155705611|FG000|Overall Study|Withdrawal by Subject|0|||
48414637|NCT00666562|155705612|FG001|Overall Study|Withdrawal by Subject|1|||
48414638|NCT00666562|155705613|FG002|Overall Study|Withdrawal by Subject|0|||
48414639|NCT00666562|155705611|FG000|Overall Study|Concomitant Medication|0|||
48414640|NCT00666562|155705612|FG001|Overall Study|Concomitant Medication|1|||
48414641|NCT00666562|155705613|FG002|Overall Study|Concomitant Medication|0|||
48414642|NCT01662999|155705615|FG000|Period 3|Withdrawal by Subject|0|||
48414643|NCT01662999|155705616|FG001|Period 3|Withdrawal by Subject|1|||
48414644|NCT01662999|155705617|FG002|Period 3|Withdrawal by Subject|0|||
48414645|NCT01662999|155705618|FG003|Period 3|Withdrawal by Subject|0|||
48414646|NCT01662999|155705619|FG004|Period 3|Withdrawal by Subject|0|||
48414647|NCT01662999|155705620|FG005|Period 3|Withdrawal by Subject|0|||
48414648|NCT01587989|155705623|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
48414649|NCT01587989|155705624|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
48414650|NCT01587989|155705625|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
48414651|NCT01587989|155705623|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
48414652|NCT01587989|155705624|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
48414653|NCT01587989|155705625|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
48414654|NCT01587989|155705623|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
48414655|NCT01587989|155705624|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
48414656|NCT01587989|155705625|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
48414657|NCT01587989|155705623|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
48414658|NCT01587989|155705624|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
48414659|NCT01587989|155705625|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
48414660|NCT01587989|155705623|FG000|Randomized Study Treatment|Screening failure|0|||
48414661|NCT01587989|155705624|FG001|Randomized Study Treatment|Screening failure|1|||
48414662|NCT01587989|155705625|FG002|Randomized Study Treatment|Screening failure|0|||
48414663|NCT01587989|155705623|FG000|Randomized Study Treatment|Physician Decision|0|||
48414664|NCT01587989|155705624|FG001|Randomized Study Treatment|Physician Decision|0|||
48414665|NCT01587989|155705625|FG002|Randomized Study Treatment|Physician Decision|1|||
48414666|NCT03542682|155705628|FG000|Overall Study|COVID-19 Protocol|0|||
48414667|NCT03542682|155705629|FG001|Overall Study|COVID-19 Protocol|1|||
48414668|NCT04725682|155705632|FG000|Overall Study|Withdrawal by Subject|7|||
48414669|NCT04725682|155705633|FG001|Overall Study|Withdrawal by Subject|5|||
48414670|NCT04725682|155705632|FG000|Overall Study|Failed to comply with the requirements|2|||
48414671|NCT04725682|155705633|FG001|Overall Study|Failed to comply with the requirements|1|||
48414672|NCT04725682|155705632|FG000|Overall Study|Adverse Event|1|||
48414673|NCT04725682|155705633|FG001|Overall Study|Adverse Event|1|||
48414674|NCT04725682|155705632|FG000|Overall Study|Death|0|||
48414675|NCT04725682|155705633|FG001|Overall Study|Death|1|||
48414676|NCT04321343|155705636|FG000|Overall Study|Adverse Event|0|||
48414677|NCT04321343|155705637|FG001|Overall Study|Adverse Event|0|||
48414678|NCT04321343|155705638|FG002|Overall Study|Adverse Event|1|||
48414679|NCT04321343|155705639|FG003|Overall Study|Adverse Event|0|||
48414680|NCT04321343|155705636|FG000|Overall Study|Death|0|||
48414681|NCT04321343|155705637|FG001|Overall Study|Death|0|||
48414682|NCT04321343|155705638|FG002|Overall Study|Death|0|||
48414683|NCT04321343|155705639|FG003|Overall Study|Death|1|||
48414684|NCT04321343|155705636|FG000|Overall Study|Pregnancy|1|||
48414685|NCT04321343|155705637|FG001|Overall Study|Pregnancy|0|||
48414686|NCT04321343|155705638|FG002|Overall Study|Pregnancy|0|||
48414687|NCT04321343|155705639|FG003|Overall Study|Pregnancy|0|||
48414688|NCT04321343|155705636|FG000|Overall Study|Protocol Violation|1|||
48414689|NCT04321343|155705637|FG001|Overall Study|Protocol Violation|1|||
48414690|NCT04321343|155705638|FG002|Overall Study|Protocol Violation|1|||
48414691|NCT04321343|155705639|FG003|Overall Study|Protocol Violation|1|||
48366023|NCT03208036|155534353|FG001|Intervention|Withdrawal by Subject|2|||
48366024|NCT03208036|155534352|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
48366025|NCT03208036|155534353|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
48366026|NCT00700778|155534354|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
48366027|NCT04927247|155534355|FG000|Overall Study|Other|2|||
48366028|NCT04927247|155534356|FG001|Overall Study|Other|1|||
48366029|NCT04927247|155534355|FG000|Overall Study|Physician Decision|0|||
48366030|NCT04927247|155534356|FG001|Overall Study|Physician Decision|1|||
48366031|NCT04927247|155534355|FG000|Overall Study|Adverse Event|1|||
48366032|NCT04927247|155534356|FG001|Overall Study|Adverse Event|0|||
48366033|NCT00591851|155534357|FG000|Overall Study|Withdrawal by Subject|3|||
48366034|NCT00591851|155534357|FG000|Overall Study|Adverse Event|2|||
48366035|NCT00591851|155534357|FG000|Overall Study|Progressive Disease|1|||
48366036|NCT00704405|155534358|FG000|Overall Study (NC Population)|Adverse Event|1|||
48366037|NCT00704405|155534359|FG001|Overall Study (NC Population)|Adverse Event|0|||
48366038|NCT00704405|155534360|FG002|Overall Study (NC Population)|Adverse Event|0|||
48366039|NCT00704405|155534361|FG003|Overall Study (NC Population)|Adverse Event|0|||
48366040|NCT00704405|155534362|FG004|Overall Study (NC Population)|Adverse Event|0|||
48366041|NCT00704405|155534358|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
48366042|NCT00704405|155534359|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
48366043|NCT00704405|155534360|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
48366044|NCT00704405|155534361|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
48366045|NCT00704405|155534362|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
48366046|NCT00704405|155534358|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
48366047|NCT00704405|155534359|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
48366048|NCT00704405|155534360|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
48366049|NCT00704405|155534361|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
48366050|NCT00704405|155534362|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
48366051|NCT00704405|155534358|FG000|Overall Study (NC Population)|Other|0|||
48366052|NCT00704405|155534359|FG001|Overall Study (NC Population)|Other|0|||
48366053|NCT00704405|155534360|FG002|Overall Study (NC Population)|Other|0|||
48366054|NCT00704405|155534361|FG003|Overall Study (NC Population)|Other|0|||
48366055|NCT00704405|155534362|FG004|Overall Study (NC Population)|Other|1|||
48366056|NCT00704405|155534358|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
48366057|NCT00704405|155534359|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
48366058|NCT00704405|155534360|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
48366059|NCT00704405|155534361|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
48366060|NCT00704405|155534362|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
48366061|NCT00704405|155534358|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
48366062|NCT00704405|155534359|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
48366063|NCT00704405|155534360|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
48366064|NCT00704405|155534361|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
48366065|NCT00704405|155534362|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
48366066|NCT02760498|155534366|FG000|Overall Study|Adverse Event|3|||
48366067|NCT02760498|155534367|FG001|Overall Study|Adverse Event|3|||
48366068|NCT02760498|155534368|FG002|Overall Study|Adverse Event|1|||
48366069|NCT02760498|155534369|FG003|Overall Study|Adverse Event|1|||
48366070|NCT02760498|155534370|FG004|Overall Study|Adverse Event|0|||
48366071|NCT02760498|155534371|FG005|Overall Study|Adverse Event|6|||
48366072|NCT02760498|155534366|FG000|Overall Study|Death|7|||
48366073|NCT02760498|155534367|FG001|Overall Study|Death|5|||
48366074|NCT02760498|155534368|FG002|Overall Study|Death|5|||
48366075|NCT02760498|155534369|FG003|Overall Study|Death|7|||
48366076|NCT02760498|155534370|FG004|Overall Study|Death|0|||
48366077|NCT02760498|155534371|FG005|Overall Study|Death|23|||
48366078|NCT02760498|155534366|FG000|Overall Study|Lost to Follow-up|0|||
48366079|NCT02760498|155534367|FG001|Overall Study|Lost to Follow-up|0|||
48366080|NCT02760498|155534368|FG002|Overall Study|Lost to Follow-up|0|||
48366081|NCT02760498|155534369|FG003|Overall Study|Lost to Follow-up|0|||
48366082|NCT02760498|155534370|FG004|Overall Study|Lost to Follow-up|0|||
48366083|NCT02760498|155534371|FG005|Overall Study|Lost to Follow-up|3|||
48366084|NCT02760498|155534366|FG000|Overall Study|Non-compliance with study drug|0|||
48366085|NCT02760498|155534367|FG001|Overall Study|Non-compliance with study drug|2|||
48366086|NCT02760498|155534368|FG002|Overall Study|Non-compliance with study drug|0|||
48366087|NCT02760498|155534369|FG003|Overall Study|Non-compliance with study drug|0|||
48366088|NCT02760498|155534370|FG004|Overall Study|Non-compliance with study drug|0|||
48366089|NCT02760498|155534371|FG005|Overall Study|Non-compliance with study drug|0|||
48366090|NCT02760498|155534366|FG000|Overall Study|Participant decision|1|||
48366091|NCT02760498|155534367|FG001|Overall Study|Participant decision|4|||
48366092|NCT02760498|155534368|FG002|Overall Study|Participant decision|2|||
48366093|NCT02760498|155534369|FG003|Overall Study|Participant decision|2|||
48366094|NCT02760498|155534370|FG004|Overall Study|Participant decision|1|||
48366095|NCT02760498|155534371|FG005|Overall Study|Participant decision|6|||
48366096|NCT02760498|155534366|FG000|Overall Study|Sponsor decision|0|||
48366097|NCT02760498|155534367|FG001|Overall Study|Sponsor decision|0|||
48366098|NCT02760498|155534368|FG002|Overall Study|Sponsor decision|0|||
48366099|NCT02760498|155534369|FG003|Overall Study|Sponsor decision|3|||
48366100|NCT02760498|155534370|FG004|Overall Study|Sponsor decision|0|||
48366101|NCT02760498|155534371|FG005|Overall Study|Sponsor decision|0|||
48366102|NCT02760498|155534366|FG000|Overall Study|Physician Decision|3|||
48366103|NCT02760498|155534367|FG001|Overall Study|Physician Decision|4|||
48366104|NCT02760498|155534368|FG002|Overall Study|Physician Decision|1|||
48366105|NCT02760498|155534369|FG003|Overall Study|Physician Decision|4|||
48366106|NCT02760498|155534370|FG004|Overall Study|Physician Decision|0|||
48366107|NCT02760498|155534371|FG005|Overall Study|Physician Decision|2|||
48366108|NCT02760498|155534366|FG000|Overall Study|Disease progression|21|||
48366109|NCT02760498|155534367|FG001|Overall Study|Disease progression|19|||
48366110|NCT02760498|155534368|FG002|Overall Study|Disease progression|20|||
48366111|NCT02760498|155534369|FG003|Overall Study|Disease progression|18|||
48366112|NCT02760498|155534370|FG004|Overall Study|Disease progression|4|||
48366113|NCT02760498|155534371|FG005|Overall Study|Disease progression|55|||
48366114|NCT02760498|155534366|FG000|Overall Study|Withdrawal by Subject|4|||
48366115|NCT02760498|155534367|FG001|Overall Study|Withdrawal by Subject|7|||
48366116|NCT02760498|155534368|FG002|Overall Study|Withdrawal by Subject|5|||
48366117|NCT02760498|155534369|FG003|Overall Study|Withdrawal by Subject|1|||
48366118|NCT02760498|155534370|FG004|Overall Study|Withdrawal by Subject|0|||
48366119|NCT02760498|155534371|FG005|Overall Study|Withdrawal by Subject|6|||
48366120|NCT02760498|155534366|FG000|Overall Study|Other than specified|1|||
48366121|NCT02760498|155534367|FG001|Overall Study|Other than specified|6|||
48366122|NCT02760498|155534368|FG002|Overall Study|Other than specified|0|||
48366123|NCT02760498|155534369|FG003|Overall Study|Other than specified|3|||
48366124|NCT02760498|155534370|FG004|Overall Study|Other than specified|1|||
48366125|NCT02760498|155534371|FG005|Overall Study|Other than specified|0|||
48366126|NCT02760498|155534366|FG000|Overall Study|Not treated|0|||
48366127|NCT02760498|155534367|FG001|Overall Study|Not treated|0|||
48366128|NCT02760498|155534368|FG002|Overall Study|Not treated|0|||
48366129|NCT02760498|155534369|FG003|Overall Study|Not treated|0|||
48366130|NCT02760498|155534370|FG004|Overall Study|Not treated|0|||
48366131|NCT02760498|155534371|FG005|Overall Study|Not treated|2|||
48366132|NCT01305200|155534372|FG000|Overall Study|Physician Decision|4|||
48366133|NCT01305200|155534373|FG001|Overall Study|Physician Decision|6|||
48366134|NCT01305200|155534374|FG002|Overall Study|Physician Decision|1|||
48366135|NCT01305200|155534372|FG000|Overall Study|Withdrawal by Subject|24|||
48366136|NCT01305200|155534373|FG001|Overall Study|Withdrawal by Subject|21|||
48366137|NCT01305200|155534374|FG002|Overall Study|Withdrawal by Subject|1|||
48366138|NCT01305200|155534372|FG000|Overall Study|Ineligible|1|||
48366139|NCT01305200|155534373|FG001|Overall Study|Ineligible|2|||
48366140|NCT01305200|155534374|FG002|Overall Study|Ineligible|1|||
48366141|NCT01305200|155534372|FG000|Overall Study|Death|0|||
48366142|NCT01305200|155534373|FG001|Overall Study|Death|2|||
48414692|NCT04321343|155705636|FG000|Overall Study|Withdrawal by Subject|0|||
48414693|NCT04321343|155705637|FG001|Overall Study|Withdrawal by Subject|6|||
48414694|NCT04321343|155705638|FG002|Overall Study|Withdrawal by Subject|0|||
48414695|NCT04321343|155705639|FG003|Overall Study|Withdrawal by Subject|2|||
48414696|NCT04321343|155705636|FG000|Overall Study|Lost to Follow-up|2|||
48414697|NCT04321343|155705637|FG001|Overall Study|Lost to Follow-up|2|||
48366143|NCT01305200|155534374|FG002|Overall Study|Death|0|||
48366144|NCT01967147|155536384|FG000|Overall Study|Adverse Event|5|||
48366145|NCT01967147|155536385|FG001|Overall Study|Adverse Event|2|||
48366146|NCT01967147|155536384|FG000|Overall Study|Lack of Efficacy|1|||
48366147|NCT01967147|155536385|FG001|Overall Study|Lack of Efficacy|4|||
48366148|NCT01967147|155536384|FG000|Overall Study|Lost to Follow-up|1|||
48414698|NCT04321343|155705638|FG002|Overall Study|Lost to Follow-up|1|||
48414699|NCT04321343|155705639|FG003|Overall Study|Lost to Follow-up|3|||
48414700|NCT00998738|155705640|FG000|Overall Study|Uknown|1|||
48414701|NCT01682044|155705641|FG000|Overall Study|Death|1|||
48366149|NCT01967147|155536385|FG001|Overall Study|Lost to Follow-up|2|||
48366150|NCT01967147|155536384|FG000|Overall Study|Withdrawal by Subject|2|||
48366151|NCT01967147|155536385|FG001|Overall Study|Withdrawal by Subject|4|||
48414702|NCT01682044|155705641|FG000|Overall Study|Progression|3|||
48414703|NCT03277196|155705642|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
48366152|NCT01967147|155536384|FG000|Overall Study|Non-compliance with Study Drug|0|||
48366153|NCT01967147|155536385|FG001|Overall Study|Non-compliance with Study Drug|3|||
48414704|NCT03277196|155705642|FG000|Overall Study|Lost to Follow-up|3|||
48414705|NCT03277196|155705642|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
48414706|NCT03277196|155705642|FG000|Overall Study|Other|2|||
48366154|NCT01967147|155536384|FG000|Overall Study|Other|4|||
48366155|NCT01967147|155536385|FG001|Overall Study|Other|5|||
48366156|NCT01099215|155536386|FG000|Overall Study|Withdrawal by Subject|1|||
48366157|NCT01099215|155536387|FG001|Overall Study|Withdrawal by Subject|0|||
48366158|NCT01099215|155536386|FG000|Overall Study|Adverse Event|0|||
48366159|NCT01099215|155536387|FG001|Overall Study|Adverse Event|1|||
48366160|NCT01901432|155536396|FG000|Overall Study|Adverse Event|0|||
48414707|NCT00960076|155707471|FG000|Overall Study|Adverse Event|1|||
48414708|NCT00960076|155707472|FG001|Overall Study|Adverse Event|7|||
48414709|NCT00960076|155707471|FG000|Overall Study|No longer met study criteria|1|||
48414710|NCT00960076|155707472|FG001|Overall Study|No longer met study criteria|5|||
48414711|NCT00960076|155707471|FG000|Overall Study|Withdrawal by Subject|1|||
48414712|NCT00960076|155707472|FG001|Overall Study|Withdrawal by Subject|2|||
48414713|NCT00960076|155707471|FG000|Overall Study|Lost to Follow-up|3|||
48414714|NCT00960076|155707472|FG001|Overall Study|Lost to Follow-up|3|||
48414715|NCT00960076|155707471|FG000|Overall Study|Severe non-compliance to protocol|1|||
48414716|NCT00960076|155707472|FG001|Overall Study|Severe non-compliance to protocol|2|||
48414717|NCT00960076|155707471|FG000|Overall Study|Hyperglycemia|1|||
48414718|NCT00960076|155707472|FG001|Overall Study|Hyperglycemia|5|||
48414719|NCT00960076|155707471|FG000|Overall Study|Did not attend the termination visit|0|||
48414720|NCT00960076|155707472|FG001|Overall Study|Did not attend the termination visit|1|||
48414721|NCT00500266|155707473|FG000|Overall Study|Death|3|||
48414722|NCT00500266|155707473|FG000|Overall Study|Lost to Follow-up|3|||
48414723|NCT00500266|155707473|FG000|Overall Study|Withdrawal by Subject|3|||
48414724|NCT00500266|155707473|FG000|Overall Study|Assigned, not treated|4|||
48414725|NCT04025632|155707474|FG000|Overall Study|Adverse Event|1|||
48414726|NCT04025632|155707475|FG001|Overall Study|Adverse Event|1|||
48366161|NCT01901432|155536397|FG001|Overall Study|Adverse Event|1|||
48366162|NCT01901432|155536398|FG002|Overall Study|Adverse Event|1|||
48366163|NCT01901432|155536399|FG003|Overall Study|Adverse Event|0|||
48366164|NCT01901432|155536400|FG004|Overall Study|Adverse Event|1|||
48366165|NCT01901432|155536396|FG000|Overall Study|Withdrawal by Subject|0|||
48414727|NCT04025632|155707474|FG000|Overall Study|Withdrawal by Subject|1|||
48414728|NCT04025632|155707475|FG001|Overall Study|Withdrawal by Subject|1|||
48366166|NCT01901432|155536397|FG001|Overall Study|Withdrawal by Subject|0|||
48366167|NCT01901432|155536398|FG002|Overall Study|Withdrawal by Subject|1|||
48366168|NCT01901432|155536399|FG003|Overall Study|Withdrawal by Subject|0|||
48366169|NCT01901432|155536400|FG004|Overall Study|Withdrawal by Subject|5|||
48366170|NCT01901432|155536396|FG000|Overall Study|Physician Decision|0|||
48366171|NCT01901432|155536397|FG001|Overall Study|Physician Decision|0|||
48366172|NCT01901432|155536398|FG002|Overall Study|Physician Decision|0|||
48366173|NCT01901432|155536399|FG003|Overall Study|Physician Decision|0|||
48366174|NCT01901432|155536400|FG004|Overall Study|Physician Decision|2|||
48366175|NCT01901432|155536396|FG000|Overall Study|Patient decision to stop study drug|0|||
48366176|NCT01901432|155536397|FG001|Overall Study|Patient decision to stop study drug|0|||
48366177|NCT01901432|155536398|FG002|Overall Study|Patient decision to stop study drug|0|||
48366178|NCT01901432|155536399|FG003|Overall Study|Patient decision to stop study drug|0|||
48366179|NCT01901432|155536400|FG004|Overall Study|Patient decision to stop study drug|1|||
48366180|NCT01901419|155536401|FG000|Overall Study|Protocol Violation|2|||
48366181|NCT01901419|155536402|FG001|Overall Study|Protocol Violation|6|||
48366182|NCT01901419|155536401|FG000|Overall Study|unavailable researchers|6|||
48366183|NCT01901419|155536402|FG001|Overall Study|unavailable researchers|3|||
48366184|NCT00379288|155536403|FG000|Overall Study|Adverse Event|5|||
48366185|NCT00379288|155536404|FG001|Overall Study|Adverse Event|6|||
48366186|NCT00379288|155536405|FG002|Overall Study|Adverse Event|2|||
48366187|NCT00379288|155536406|FG003|Overall Study|Adverse Event|0|||
48366188|NCT00379288|155536403|FG000|Overall Study|Treatment Failure|0|||
48366189|NCT00379288|155536404|FG001|Overall Study|Treatment Failure|1|||
48366190|NCT00379288|155536405|FG002|Overall Study|Treatment Failure|0|||
48366191|NCT00379288|155536406|FG003|Overall Study|Treatment Failure|1|||
48366192|NCT00379288|155536403|FG000|Overall Study|Lost to Follow-up|3|||
48366193|NCT00379288|155536404|FG001|Overall Study|Lost to Follow-up|3|||
48366194|NCT00379288|155536405|FG002|Overall Study|Lost to Follow-up|2|||
48366195|NCT00379288|155536406|FG003|Overall Study|Lost to Follow-up|0|||
48366196|NCT00379288|155536403|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
48366197|NCT00379288|155536404|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
48366198|NCT00379288|155536405|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
48366199|NCT00379288|155536406|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
48366200|NCT00379288|155536403|FG000|Overall Study|Subject withdrew-related to study drug|1|||
48366201|NCT00379288|155536404|FG001|Overall Study|Subject withdrew-related to study drug|0|||
48366202|NCT00379288|155536405|FG002|Overall Study|Subject withdrew-related to study drug|0|||
48366203|NCT00379288|155536406|FG003|Overall Study|Subject withdrew-related to study drug|1|||
48366204|NCT00379288|155536403|FG000|Overall Study|Noncompliance with protocol|8|||
48366205|NCT00379288|155536404|FG001|Overall Study|Noncompliance with protocol|6|||
48366206|NCT00379288|155536405|FG002|Overall Study|Noncompliance with protocol|2|||
48366207|NCT00379288|155536406|FG003|Overall Study|Noncompliance with protocol|1|||
48366208|NCT00379288|155536403|FG000|Overall Study|Did not meet protocol eligibility|0|||
48366209|NCT00379288|155536404|FG001|Overall Study|Did not meet protocol eligibility|1|||
48414729|NCT04025632|155707474|FG000|Overall Study|Study Terminated by Sponsor|10|||
48366210|NCT00379288|155536405|FG002|Overall Study|Did not meet protocol eligibility|0|||
48366211|NCT00379288|155536406|FG003|Overall Study|Did not meet protocol eligibility|2|||
48366212|NCT00379288|155536403|FG000|Overall Study|Administrative|2|||
48366213|NCT00379288|155536404|FG001|Overall Study|Administrative|2|||
48366214|NCT00379288|155536405|FG002|Overall Study|Administrative|0|||
48366215|NCT00379288|155536406|FG003|Overall Study|Administrative|1|||
48366216|NCT03333876|155536407|FG000|Screening Period|Screen Failure|4|||
48366217|NCT03333876|155536407|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
48366218|NCT03333876|155536407|FG000|Mandibular Advancement|Adverse Event|2|||
48366219|NCT03333876|155536407|FG000|Mandibular Advancement|Product Damage|2|||
48366220|NCT00818168|155536410|FG000|Overall Study|Lack of Efficacy|18|||
48366221|NCT00818168|155536410|FG000|Overall Study|Pregnancy|2|||
48366222|NCT00818168|155536410|FG000|Overall Study|Withdrawal by Subject|16|||
48366223|NCT00818168|155536410|FG000|Overall Study|Lost to Follow-up|7|||
48366224|NCT00818168|155536410|FG000|Overall Study|Adverse Event|19|||
48366225|NCT00818168|155536410|FG000|Overall Study|Reason for Non-completion Not reported|6|||
48366226|NCT00818168|155536410|FG000|Overall Study|Participant Moved|2|||
48366227|NCT04138576|155536411|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
48366228|NCT03900416|155536414|FG000|Six Week Follow-up|Lost to Follow-up|1|||
48414730|NCT04025632|155707475|FG001|Overall Study|Study Terminated by Sponsor|9|||
48414731|NCT04025632|155707474|FG000|Overall Study|Physician Decision|3|||
48414732|NCT04025632|155707475|FG001|Overall Study|Physician Decision|1|||
48414733|NCT00376961|155707476|FG000|Initial Registration|Adverse Event|1|||
48414734|NCT00376961|155707477|FG001|Initial Registration|Adverse Event|0|||
48414735|NCT00376961|155707476|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
48414736|NCT00376961|155707477|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
48414737|NCT00376961|155707476|FG000|Initial Registration|Progression/relapse|1|||
48414738|NCT00376961|155707477|FG001|Initial Registration|Progression/relapse|0|||
48414739|NCT00376961|155707476|FG000|Initial Registration|Ineligible|3|||
48366229|NCT03900416|155536415|FG001|Six Week Follow-up|Lost to Follow-up|0|||
48366230|NCT03900416|155536414|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
48366231|NCT03900416|155536415|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
48366232|NCT03900416|155536414|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
48366233|NCT03900416|155536415|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
48366234|NCT03900416|155536414|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
48414740|NCT00376961|155707477|FG001|Initial Registration|Ineligible|0|||
48414741|NCT00376961|155707476|FG000|Maintenance|Adverse Event|0|||
48414742|NCT00376961|155707477|FG001|Maintenance|Adverse Event|1|||
48414743|NCT00376961|155707476|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
48414744|NCT00376961|155707477|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
48414745|NCT00376961|155707476|FG000|Maintenance|Progression/relapse|0|||
48414746|NCT00376961|155707477|FG001|Maintenance|Progression/relapse|18|||
48414747|NCT00376961|155707476|FG000|Maintenance|Ineligible|0|||
48414748|NCT00376961|155707477|FG001|Maintenance|Ineligible|3|||
48414749|NCT00200057|155707478|FG000|Overall Study|Lack of Efficacy|3|||
48414750|NCT00200057|155707478|FG000|Overall Study|Exited due to terminal illness of PI|2|||
48414751|NCT00200057|155707478|FG000|Overall Study|Withdrawal by Subject|1|||
48366235|NCT03900416|155536415|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
48366236|NCT03900416|155536414|FG000|Twelve Week Follow-up|Adverse Event|1|||
48366237|NCT03900416|155536415|FG001|Twelve Week Follow-up|Adverse Event|1|||
48366238|NCT03900416|155536414|FG000|Six Month Follow-up|Lost to Follow-up|4|||
48366239|NCT03900416|155536415|FG001|Six Month Follow-up|Lost to Follow-up|3|||
48366240|NCT03900416|155536414|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
48366241|NCT03900416|155536415|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
48366242|NCT00201643|155536416|FG000|Overall Study|Withdrawal by Subject|5|||
48366243|NCT00201643|155536417|FG001|Overall Study|Withdrawal by Subject|4|||
48366244|NCT00727311|155536418|FG000|Overall Study|Did not receive drug|316|||
48366245|NCT00727311|155536418|FG000|Overall Study|Missing end of therapy data|205|||
48366246|NCT00727311|155536418|FG000|Overall Study|Adverse Event|58|||
48366247|NCT00727311|155536418|FG000|Overall Study|Lack of Efficacy|242|||
48366248|NCT00727311|155536418|FG000|Overall Study|Lost to Follow-up|73|||
48366249|NCT00727311|155536418|FG000|Overall Study|Withdrawal by Subject|77|||
48366250|NCT00727311|155536418|FG000|Overall Study|Other|97|||
48366251|NCT00727311|155536418|FG000|Overall Study|Multiple reasons|39|||
48366252|NCT02643303|155536422|FG000|Overall Study|Progressive Disease|4|||
48414752|NCT00200057|155707478|FG000|Overall Study|Change in medical condition|1|||
48414753|NCT00200057|155707478|FG000|Overall Study|Infection|1|||
48366253|NCT02643303|155536423|FG001|Overall Study|Progressive Disease|4|||
48366254|NCT02643303|155536424|FG002|Overall Study|Progressive Disease|1|||
48366255|NCT02643303|155536425|FG003|Overall Study|Progressive Disease|12|||
48366256|NCT02643303|155536426|FG004|Overall Study|Progressive Disease|6|||
48366257|NCT02643303|155536427|FG005|Overall Study|Progressive Disease|4|||
48366258|NCT02643303|155536428|FG006|Overall Study|Progressive Disease|8|||
48414754|NCT00200057|155707478|FG000|Overall Study|Death|1|||
48414755|NCT00162773|155707480|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
48414756|NCT00110305|155707481|FG000|Overall Study|Adverse Event|46|||
48366259|NCT02643303|155536429|FG007|Overall Study|Progressive Disease|2|||
48366260|NCT02643303|155536430|FG008|Overall Study|Progressive Disease|6|||
48366261|NCT02643303|155536422|FG000|Overall Study|Adverse Event|0|||
48366262|NCT02643303|155536423|FG001|Overall Study|Adverse Event|1|||
48366263|NCT02643303|155536424|FG002|Overall Study|Adverse Event|0|||
48414757|NCT00110305|155707482|FG001|Overall Study|Adverse Event|13|||
48414758|NCT00110305|155707481|FG000|Overall Study|Sponsors Decision|1|||
48414759|NCT00110305|155707482|FG001|Overall Study|Sponsors Decision|0|||
48414760|NCT00110305|155707481|FG000|Overall Study|Subject Non-Compliant|9|||
48414761|NCT00110305|155707482|FG001|Overall Study|Subject Non-Compliant|2|||
48414762|NCT00110305|155707481|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
48414763|NCT00110305|155707482|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
48414764|NCT00110305|155707481|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
48414765|NCT00110305|155707482|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
48414766|NCT00110305|155707481|FG000|Overall Study|Protocol Violation|0|||
48414767|NCT00110305|155707482|FG001|Overall Study|Protocol Violation|1|||
48414768|NCT00110305|155707481|FG000|Overall Study|Withdrawal by Subject|7|||
48414769|NCT00110305|155707482|FG001|Overall Study|Withdrawal by Subject|7|||
48414770|NCT00110305|155707481|FG000|Overall Study|Lost to Follow-up|20|||
48414771|NCT00110305|155707482|FG001|Overall Study|Lost to Follow-up|3|||
48414772|NCT00110305|155707481|FG000|Overall Study|Other|8|||
48414773|NCT00110305|155707482|FG001|Overall Study|Other|2|||
48414774|NCT00206726|155707486|FG000|Overall Study|Delayed recovery of blood counts|1|||
48414775|NCT00206726|155707486|FG000|Overall Study|Progressive disease or relapsed disease|18|||
48414776|NCT00206726|155707486|FG000|Overall Study|Placed on new protocol|1|||
48414777|NCT00206726|155707486|FG000|Overall Study|Bone marrow transplant|1|||
48414778|NCT00206726|155707486|FG000|Overall Study|Adverse Event|17|||
48414779|NCT00206726|155707486|FG000|Overall Study|Death|4|||
48414780|NCT00206726|155707486|FG000|Overall Study|Protocol Violation|1|||
48414781|NCT00206726|155707486|FG000|Overall Study|Withdrawal by Subject|8|||
48414782|NCT00496366|155707487|FG000|Overall Study|Death|1|||
48414783|NCT02468193|155707488|FG000|Overall Study|Adverse Event|4|||
48414784|NCT02468193|155707488|FG000|Overall Study|Subject/ Guardian decision|2|||
48414785|NCT00742781|155707489|FG000|Overall Study|Withdrawal by Subject|3|||
48414786|NCT01934504|155707491|FG000|Overall Study|Protocol Deviation|0|||
48414787|NCT01934504|155707492|FG001|Overall Study|Protocol Deviation|0|||
48414788|NCT01934504|155707493|FG002|Overall Study|Protocol Deviation|0|||
48414789|NCT01934504|155707494|FG003|Overall Study|Protocol Deviation|2|||
48414790|NCT01934504|155707491|FG000|Overall Study|Study Terminated by Sponsor|1|||
48414791|NCT01934504|155707492|FG001|Overall Study|Study Terminated by Sponsor|0|||
48414792|NCT01934504|155707493|FG002|Overall Study|Study Terminated by Sponsor|5|||
48414793|NCT01934504|155707494|FG003|Overall Study|Study Terminated by Sponsor|5|||
48414794|NCT00824564|155707495|FG000|Overall Study|Lost to Follow-up|5|||
48414795|NCT00824564|155707496|FG001|Overall Study|Lost to Follow-up|7|||
48414796|NCT00824564|155707495|FG000|Overall Study|Withdrawal by Subject|1|||
48414797|NCT00824564|155707496|FG001|Overall Study|Withdrawal by Subject|1|||
48414798|NCT00824564|155707495|FG000|Overall Study|Other|1|||
48414799|NCT00824564|155707496|FG001|Overall Study|Other|2|||
48414800|NCT00824564|155707495|FG000|Overall Study|Randomized, but not treated|1|||
48414801|NCT00824564|155707496|FG001|Overall Study|Randomized, but not treated|0|||
48366264|NCT02643303|155536425|FG003|Overall Study|Adverse Event|0|||
48366265|NCT02643303|155536426|FG004|Overall Study|Adverse Event|1|||
48414802|NCT00541307|155707501|FG000|Overall Study|Death|5|||
48414803|NCT00541307|155707501|FG000|Overall Study|Physician Decision|3|||
48414804|NCT00541307|155707501|FG000|Overall Study|Withdrawal by Subject|6|||
48414805|NCT00541307|155707501|FG000|Overall Study|Lost to Follow-up|4|||
48414806|NCT00541307|155707501|FG000|Overall Study|Subject returned early (outside window)|1|||
48414807|NCT00541307|155707501|FG000|Overall Study|Surgical Bypass|5|||
48414808|NCT01324830|155707502|FG000|Overall Study|Progressive Disease|3|||
48414809|NCT01324830|155707503|FG001|Overall Study|Progressive Disease|2|||
48414810|NCT01324830|155707504|FG002|Overall Study|Progressive Disease|3|||
48414811|NCT01324830|155707505|FG003|Overall Study|Progressive Disease|3|||
48414812|NCT01324830|155707506|FG004|Overall Study|Progressive Disease|6|||
48414813|NCT01324830|155707507|FG005|Overall Study|Progressive Disease|6|||
48414814|NCT01324830|155707508|FG006|Overall Study|Progressive Disease|3|||
48414815|NCT01324830|155707509|FG007|Overall Study|Progressive Disease|3|||
48414816|NCT01324830|155707510|FG008|Overall Study|Progressive Disease|3|||
48414817|NCT01324830|155707511|FG009|Overall Study|Progressive Disease|6|||
48366266|NCT02643303|155536427|FG005|Overall Study|Adverse Event|0|||
48414818|NCT01324830|155707512|FG010|Overall Study|Progressive Disease|2|||
48366267|NCT02643303|155536428|FG006|Overall Study|Adverse Event|0|||
48366268|NCT02643303|155536429|FG007|Overall Study|Adverse Event|0|||
48414819|NCT01324830|155707513|FG011|Overall Study|Progressive Disease|1|||
48366269|NCT02643303|155536430|FG008|Overall Study|Adverse Event|0|||
48366270|NCT02643303|155536422|FG000|Overall Study|Withdrawal by Subject|0|||
48414820|NCT01324830|155707514|FG012|Overall Study|Progressive Disease|1|||
48414821|NCT01324830|155707515|FG013|Overall Study|Progressive Disease|1|||
48414822|NCT01324830|155707516|FG014|Overall Study|Progressive Disease|1|||
48414823|NCT01324830|155707517|FG015|Overall Study|Progressive Disease|3|||
48414824|NCT01324830|155707518|FG016|Overall Study|Progressive Disease|2|||
48414825|NCT01324830|155707519|FG017|Overall Study|Progressive Disease|3|||
48414826|NCT01324830|155707520|FG018|Overall Study|Progressive Disease|4|||
48414827|NCT01324830|155707502|FG000|Overall Study|Dose limiting toxicity|0|||
48366271|NCT02643303|155536423|FG001|Overall Study|Withdrawal by Subject|0|||
48366272|NCT02643303|155536424|FG002|Overall Study|Withdrawal by Subject|0|||
48366273|NCT02643303|155536425|FG003|Overall Study|Withdrawal by Subject|1|||
48366274|NCT02643303|155536426|FG004|Overall Study|Withdrawal by Subject|0|||
48366275|NCT02643303|155536427|FG005|Overall Study|Withdrawal by Subject|0|||
48366276|NCT02643303|155536428|FG006|Overall Study|Withdrawal by Subject|1|||
48366277|NCT02643303|155536429|FG007|Overall Study|Withdrawal by Subject|1|||
48366278|NCT02643303|155536430|FG008|Overall Study|Withdrawal by Subject|1|||
48366279|NCT00490490|155536431|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
48366280|NCT00490490|155536431|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
48366281|NCT01097707|155536440|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48366282|NCT01097707|155536441|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
48366283|NCT01097707|155536442|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48366284|NCT01097707|155536443|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48366285|NCT01097707|155536444|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
48366286|NCT01097707|155536440|FG000|Overall Study|Adverse Event|4|||
48366287|NCT01097707|155536441|FG001|Overall Study|Adverse Event|2|||
48366288|NCT01097707|155536442|FG002|Overall Study|Adverse Event|3|||
48366289|NCT01097707|155536443|FG003|Overall Study|Adverse Event|1|||
48366290|NCT01097707|155536444|FG004|Overall Study|Adverse Event|3|||
48366291|NCT01097707|155536440|FG000|Overall Study|Entry Criteria Not Met|2|||
48366292|NCT01097707|155536441|FG001|Overall Study|Entry Criteria Not Met|1|||
48366293|NCT01097707|155536442|FG002|Overall Study|Entry Criteria Not Met|1|||
48366294|NCT01097707|155536443|FG003|Overall Study|Entry Criteria Not Met|0|||
48366295|NCT01097707|155536444|FG004|Overall Study|Entry Criteria Not Met|1|||
48414828|NCT01324830|155707503|FG001|Overall Study|Dose limiting toxicity|0|||
48414829|NCT01324830|155707504|FG002|Overall Study|Dose limiting toxicity|0|||
48414830|NCT01324830|155707505|FG003|Overall Study|Dose limiting toxicity|0|||
48414831|NCT01324830|155707506|FG004|Overall Study|Dose limiting toxicity|1|||
48414832|NCT01324830|155707507|FG005|Overall Study|Dose limiting toxicity|0|||
48414833|NCT01324830|155707508|FG006|Overall Study|Dose limiting toxicity|0|||
48366296|NCT01097707|155536440|FG000|Overall Study|Lack of Efficacy|1|||
48366297|NCT01097707|155536441|FG001|Overall Study|Lack of Efficacy|0|||
48366298|NCT01097707|155536442|FG002|Overall Study|Lack of Efficacy|0|||
48366299|NCT01097707|155536443|FG003|Overall Study|Lack of Efficacy|1|||
48366300|NCT01097707|155536444|FG004|Overall Study|Lack of Efficacy|0|||
48366301|NCT01097707|155536440|FG000|Overall Study|Lost to Follow-up|1|||
48366302|NCT01097707|155536441|FG001|Overall Study|Lost to Follow-up|1|||
48366303|NCT01097707|155536442|FG002|Overall Study|Lost to Follow-up|2|||
48366304|NCT01097707|155536443|FG003|Overall Study|Lost to Follow-up|0|||
48366305|NCT01097707|155536444|FG004|Overall Study|Lost to Follow-up|3|||
48366306|NCT01097707|155536440|FG000|Overall Study|Protocol Violation|2|||
48366307|NCT01097707|155536441|FG001|Overall Study|Protocol Violation|2|||
48366308|NCT01097707|155536442|FG002|Overall Study|Protocol Violation|3|||
48366309|NCT01097707|155536443|FG003|Overall Study|Protocol Violation|2|||
48366310|NCT01097707|155536444|FG004|Overall Study|Protocol Violation|2|||
48366311|NCT01097707|155536440|FG000|Overall Study|Sponsor Decision|31|||
48366312|NCT01097707|155536441|FG001|Overall Study|Sponsor Decision|31|||
48366313|NCT01097707|155536442|FG002|Overall Study|Sponsor Decision|34|||
48366314|NCT01097707|155536443|FG003|Overall Study|Sponsor Decision|35|||
48366315|NCT01097707|155536444|FG004|Overall Study|Sponsor Decision|36|||
48366316|NCT01097707|155536440|FG000|Overall Study|Withdrawal by Subject|3|||
48366317|NCT01097707|155536441|FG001|Overall Study|Withdrawal by Subject|6|||
48366318|NCT01097707|155536442|FG002|Overall Study|Withdrawal by Subject|1|||
48366319|NCT01097707|155536443|FG003|Overall Study|Withdrawal by Subject|4|||
48366320|NCT01097707|155536444|FG004|Overall Study|Withdrawal by Subject|3|||
48366321|NCT01097707|155536440|FG000|Overall Study|Reason unknown|0|||
48366322|NCT01097707|155536441|FG001|Overall Study|Reason unknown|0|||
48366323|NCT01097707|155536442|FG002|Overall Study|Reason unknown|0|||
48366324|NCT01097707|155536443|FG003|Overall Study|Reason unknown|0|||
48366325|NCT01097707|155536444|FG004|Overall Study|Reason unknown|1|||
48366326|NCT05775991|155536448|FG000|Overall Study|Withdrawal by Subject|0|||
48366327|NCT05775991|155536449|FG001|Overall Study|Withdrawal by Subject|0|||
48366328|NCT05775991|155536450|FG002|Overall Study|Withdrawal by Subject|2|||
48366329|NCT00964886|155536451|FG000|Overall Study|Lost to Follow-up|2|||
48366330|NCT00964886|155536452|FG001|Overall Study|Lost to Follow-up|2|||
48366331|NCT00964886|155536453|FG002|Overall Study|Lost to Follow-up|6|||
48366332|NCT00964886|155536454|FG003|Overall Study|Lost to Follow-up|4|||
48366333|NCT00964886|155536451|FG000|Overall Study|Withdrawal by Subject|6|||
48366334|NCT00964886|155536452|FG001|Overall Study|Withdrawal by Subject|2|||
48366335|NCT00964886|155536453|FG002|Overall Study|Withdrawal by Subject|5|||
48366336|NCT00964886|155536454|FG003|Overall Study|Withdrawal by Subject|3|||
48414834|NCT01324830|155707509|FG007|Overall Study|Dose limiting toxicity|0|||
48414835|NCT01324830|155707510|FG008|Overall Study|Dose limiting toxicity|0|||
48366337|NCT00964886|155536451|FG000|Overall Study|Adverse Event|3|||
48366338|NCT00964886|155536452|FG001|Overall Study|Adverse Event|1|||
48366339|NCT00964886|155536453|FG002|Overall Study|Adverse Event|5|||
48366340|NCT00964886|155536454|FG003|Overall Study|Adverse Event|2|||
48366341|NCT00964886|155536451|FG000|Overall Study|Protocol Violation|0|||
48366342|NCT00964886|155536452|FG001|Overall Study|Protocol Violation|2|||
48366343|NCT00964886|155536453|FG002|Overall Study|Protocol Violation|0|||
48366344|NCT00964886|155536454|FG003|Overall Study|Protocol Violation|0|||
48366345|NCT00652327|155536457|FG000|Overall Study|Adverse Event|0|||
48366346|NCT00652327|155536458|FG001|Overall Study|Adverse Event|2|||
48366347|NCT00652327|155536457|FG000|Overall Study|Lost to Follow-up|0|||
48366348|NCT00652327|155536458|FG001|Overall Study|Lost to Follow-up|3|||
48366349|NCT00910039|155536459|FG000|Overall Study|Physician Decision|1|||
48366350|NCT00400725|155536474|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
48366351|NCT00400725|155536475|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
48366352|NCT00400725|155536476|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
48366353|NCT00400725|155536474|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
48366354|NCT00400725|155536475|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
48366355|NCT00400725|155536476|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
48366356|NCT00400725|155536474|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
48366357|NCT00400725|155536475|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
48366358|NCT00400725|155536476|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
48366359|NCT00400725|155536474|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
48366360|NCT00400725|155536475|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
48366361|NCT00400725|155536476|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
48366362|NCT00400725|155536474|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
48366363|NCT00400725|155536475|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
48366364|NCT00400725|155536476|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
48366365|NCT00400725|155536474|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
48366366|NCT00400725|155536475|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
48366367|NCT00400725|155536476|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
48366368|NCT00400725|155536474|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
48366369|NCT00400725|155536475|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
48366370|NCT00400725|155536476|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
48366371|NCT00400725|155536474|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
48366372|NCT00400725|155536475|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
48366373|NCT00400725|155536476|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
48366374|NCT00400725|155536474|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
48366375|NCT00400725|155536475|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
48366376|NCT00400725|155536476|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
48366377|NCT02884908|155536477|FG000|Overall Study|Lost to Follow-up|13|||
48366378|NCT02884908|155536478|FG001|Overall Study|Lost to Follow-up|18|||
48366379|NCT04860297|155536479|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
48414836|NCT01324830|155707511|FG009|Overall Study|Dose limiting toxicity|0|||
48414837|NCT01324830|155707512|FG010|Overall Study|Dose limiting toxicity|0|||
48414838|NCT01324830|155707513|FG011|Overall Study|Dose limiting toxicity|0|||
48414839|NCT01324830|155707514|FG012|Overall Study|Dose limiting toxicity|0|||
48414840|NCT01324830|155707515|FG013|Overall Study|Dose limiting toxicity|0|||
48414841|NCT01324830|155707516|FG014|Overall Study|Dose limiting toxicity|0|||
48366380|NCT04860297|155536480|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
48366381|NCT04860297|155536481|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
48366382|NCT04860297|155536482|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
48366383|NCT04860297|155536483|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
48366384|NCT04860297|155536484|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
48366385|NCT04860297|155536485|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
48366386|NCT04860297|155536486|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
48366387|NCT04860297|155536479|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
48366388|NCT04860297|155536480|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
48366389|NCT04860297|155536481|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
48366390|NCT04860297|155536482|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
48366391|NCT04860297|155536483|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
48366392|NCT04860297|155536484|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
48366393|NCT04860297|155536485|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
48366394|NCT04860297|155536486|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
48366395|NCT04860297|155536479|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
48366396|NCT04860297|155536480|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
48366397|NCT04860297|155536481|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
48414842|NCT01324830|155707517|FG015|Overall Study|Dose limiting toxicity|0|||
48414843|NCT01324830|155707518|FG016|Overall Study|Dose limiting toxicity|1|||
48414844|NCT01324830|155707519|FG017|Overall Study|Dose limiting toxicity|1|||
48414845|NCT01324830|155707520|FG018|Overall Study|Dose limiting toxicity|1|||
48366398|NCT04860297|155536482|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
48366399|NCT04860297|155536483|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
48366400|NCT04860297|155536484|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
48366401|NCT04860297|155536485|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
48366402|NCT04860297|155536486|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
48366403|NCT04860297|155536479|FG000|Part B (Booster Dose)|Other Than Specified|0|||
48366404|NCT04860297|155536480|FG001|Part B (Booster Dose)|Other Than Specified|0|||
48366405|NCT04860297|155536481|FG002|Part B (Booster Dose)|Other Than Specified|0|||
48366406|NCT04860297|155536482|FG003|Part B (Booster Dose)|Other Than Specified|0|||
48366407|NCT04860297|155536483|FG004|Part B (Booster Dose)|Other Than Specified|0|||
48366408|NCT04860297|155536484|FG005|Part B (Booster Dose)|Other Than Specified|1|||
48366409|NCT04860297|155536485|FG006|Part B (Booster Dose)|Other Than Specified|1|||
48366410|NCT04860297|155536486|FG007|Part B (Booster Dose)|Other Than Specified|0|||
48366411|NCT04860297|155536479|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
48366412|NCT04860297|155536480|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
48366413|NCT04860297|155536481|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
48366414|NCT04860297|155536482|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
48414846|NCT01324830|155707502|FG000|Overall Study|Reason not mentioned above|0|||
48414847|NCT01324830|155707503|FG001|Overall Study|Reason not mentioned above|0|||
48414848|NCT01324830|155707504|FG002|Overall Study|Reason not mentioned above|0|||
48414849|NCT01324830|155707505|FG003|Overall Study|Reason not mentioned above|0|||
48414850|NCT01324830|155707506|FG004|Overall Study|Reason not mentioned above|0|||
48414851|NCT01324830|155707507|FG005|Overall Study|Reason not mentioned above|0|||
48414852|NCT01324830|155707508|FG006|Overall Study|Reason not mentioned above|0|||
48414853|NCT01324830|155707509|FG007|Overall Study|Reason not mentioned above|0|||
48414854|NCT01324830|155707510|FG008|Overall Study|Reason not mentioned above|0|||
48414855|NCT01324830|155707511|FG009|Overall Study|Reason not mentioned above|0|||
48366415|NCT04860297|155536483|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
48366416|NCT04860297|155536484|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
48366417|NCT04860297|155536485|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
48366418|NCT04860297|155536486|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
48366419|NCT04860297|155536479|FG000|Part B (Booster Dose)|Death|0|||
48366420|NCT04860297|155536480|FG001|Part B (Booster Dose)|Death|0|||
48366421|NCT04860297|155536481|FG002|Part B (Booster Dose)|Death|0|||
48366422|NCT04860297|155536482|FG003|Part B (Booster Dose)|Death|0|||
48366423|NCT04860297|155536483|FG004|Part B (Booster Dose)|Death|1|||
48366424|NCT04860297|155536484|FG005|Part B (Booster Dose)|Death|2|||
48366425|NCT04860297|155536485|FG006|Part B (Booster Dose)|Death|1|||
48366426|NCT04860297|155536486|FG007|Part B (Booster Dose)|Death|0|||
48366427|NCT04860297|155536479|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
48366428|NCT04860297|155536480|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
48366429|NCT04860297|155536481|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
48366430|NCT04860297|155536482|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
48366431|NCT04860297|155536483|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
48366432|NCT04860297|155536484|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
48366433|NCT04860297|155536485|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
48366434|NCT04860297|155536486|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
48366435|NCT00862719|155536487|FG000|Overall Study|Disease Progression|5|||
48366436|NCT00862719|155536488|FG001|Overall Study|Disease Progression|0|||
48366437|NCT00862719|155536489|FG002|Overall Study|Disease Progression|1|||
48366438|NCT00862719|155536490|FG003|Overall Study|Disease Progression|0|||
48366439|NCT00862719|155536487|FG000|Overall Study|Death|5|||
48366440|NCT00862719|155536488|FG001|Overall Study|Death|6|||
48366441|NCT00862719|155536489|FG002|Overall Study|Death|1|||
48366442|NCT00862719|155536490|FG003|Overall Study|Death|1|||
48366443|NCT00862719|155536487|FG000|Overall Study|Engraftment failure|0|||
48366444|NCT00862719|155536488|FG001|Overall Study|Engraftment failure|0|||
48366445|NCT00862719|155536489|FG002|Overall Study|Engraftment failure|1|||
48366446|NCT00862719|155536490|FG003|Overall Study|Engraftment failure|0|||
48366447|NCT00862719|155536487|FG000|Overall Study|Veno-Occlusive Disease|0|||
48366448|NCT00862719|155536488|FG001|Overall Study|Veno-Occlusive Disease|0|||
48366449|NCT00862719|155536489|FG002|Overall Study|Veno-Occlusive Disease|1|||
48366450|NCT00862719|155536490|FG003|Overall Study|Veno-Occlusive Disease|0|||
48366451|NCT00798590|155536491|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
48366452|NCT00798590|155536492|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
48366453|NCT00324116|155536493|FG000|Overall Study|Adverse Event|5|||
48366454|NCT00324116|155536493|FG000|Overall Study|Lack of Efficacy|17|||
48366455|NCT00324116|155536493|FG000|Overall Study|Withdrawal by Subject|5|||
48366456|NCT00324116|155536493|FG000|Overall Study|Other|5|||
48366457|NCT00929110|155536496|FG000|Overall Study|Adverse Event|40|||
48366458|NCT00929110|155536497|FG001|Overall Study|Adverse Event|29|||
48366459|NCT00929110|155536498|FG002|Overall Study|Adverse Event|18|||
48366460|NCT00929110|155536496|FG000|Overall Study|Subject withdrew consent|40|||
48366461|NCT00929110|155536497|FG001|Overall Study|Subject withdrew consent|23|||
48366462|NCT00929110|155536498|FG002|Overall Study|Subject withdrew consent|26|||
48366463|NCT00929110|155536496|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
48414856|NCT01324830|155707512|FG010|Overall Study|Reason not mentioned above|0|||
48366464|NCT00929110|155536497|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
48366465|NCT00929110|155536498|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
48366466|NCT00929110|155536496|FG000|Overall Study|Lost to Follow-up|7|||
48366467|NCT00929110|155536497|FG001|Overall Study|Lost to Follow-up|7|||
48414857|NCT01324830|155707513|FG011|Overall Study|Reason not mentioned above|0|||
48414858|NCT01324830|155707514|FG012|Overall Study|Reason not mentioned above|0|||
48414859|NCT01324830|155707515|FG013|Overall Study|Reason not mentioned above|0|||
48414860|NCT01324830|155707516|FG014|Overall Study|Reason not mentioned above|0|||
48414861|NCT01324830|155707517|FG015|Overall Study|Reason not mentioned above|0|||
48366468|NCT00929110|155536498|FG002|Overall Study|Lost to Follow-up|3|||
48366469|NCT00929110|155536496|FG000|Overall Study|Protocol deviation|5|||
48366470|NCT00929110|155536497|FG001|Overall Study|Protocol deviation|2|||
48366471|NCT00929110|155536498|FG002|Overall Study|Protocol deviation|4|||
48366472|NCT00929110|155536496|FG000|Overall Study|Administrative problems|4|||
48366473|NCT00929110|155536497|FG001|Overall Study|Administrative problems|1|||
48366474|NCT00929110|155536498|FG002|Overall Study|Administrative problems|2|||
48366475|NCT00929110|155536496|FG000|Overall Study|Death|2|||
48366476|NCT00929110|155536497|FG001|Overall Study|Death|2|||
48366477|NCT00929110|155536498|FG002|Overall Study|Death|2|||
48366478|NCT00929110|155536496|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48366479|NCT00929110|155536497|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48366480|NCT00929110|155536498|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48366481|NCT00929110|155536496|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48366482|NCT00929110|155536497|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48366483|NCT00929110|155536498|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48366484|NCT00929110|155536496|FG000|Overall Study|Patient inability to use the device|0|||
48366485|NCT00929110|155536497|FG001|Overall Study|Patient inability to use the device|1|||
48366486|NCT00929110|155536498|FG002|Overall Study|Patient inability to use the device|0|||
48366487|NCT02217475|155536499|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
48366488|NCT02217475|155536500|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
48366489|NCT02217475|155536501|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
48366490|NCT02217475|155536499|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
48366491|NCT02217475|155536500|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
48366492|NCT02217475|155536501|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
48366493|NCT02217475|155536499|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
48366494|NCT02217475|155536500|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
48366495|NCT02217475|155536501|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
48366496|NCT02217475|155536499|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
48366497|NCT02217475|155536500|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
48366498|NCT02217475|155536501|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
48366499|NCT02217475|155536499|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
48366500|NCT02217475|155536500|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
48366501|NCT02217475|155536501|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
48366502|NCT02217475|155536499|FG000|Discontinued After Period 1|Adverse Event|1|||
48366503|NCT02217475|155536500|FG001|Discontinued After Period 1|Adverse Event|2|||
48366504|NCT02217475|155536501|FG002|Discontinued After Period 1|Adverse Event|0|||
48366505|NCT02217475|155536499|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
48366506|NCT02217475|155536500|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
48366507|NCT02217475|155536501|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
48366508|NCT02217475|155536499|FG000|Discontinued After Period 1|Physician Decision|0|||
48366509|NCT02217475|155536500|FG001|Discontinued After Period 1|Physician Decision|0|||
48366510|NCT02217475|155536501|FG002|Discontinued After Period 1|Physician Decision|1|||
48366511|NCT02217475|155536499|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
48366512|NCT02217475|155536500|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
48366513|NCT02217475|155536501|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
48366514|NCT02217475|155536499|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
48366515|NCT02217475|155536500|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
48366516|NCT02217475|155536501|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
48366517|NCT02217475|155536499|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
48366518|NCT02217475|155536500|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
48366519|NCT02217475|155536501|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
48366520|NCT02217475|155536499|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
48366521|NCT02217475|155536500|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
48366522|NCT02217475|155536501|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
48366523|NCT02217475|155536499|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
48366524|NCT02217475|155536500|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
48366525|NCT02217475|155536501|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
48366526|NCT01215188|155536502|FG000|Overall Study|Lost to Follow-up|22|||
48366527|NCT01215188|155536503|FG001|Overall Study|Lost to Follow-up|22|||
48366528|NCT01215188|155536504|FG002|Overall Study|Lost to Follow-up|16|||
48366529|NCT01215188|155536502|FG000|Overall Study|Adverse Event|1|||
48366530|NCT01215188|155536503|FG001|Overall Study|Adverse Event|1|||
48366531|NCT01215188|155536504|FG002|Overall Study|Adverse Event|3|||
48366532|NCT01215188|155536502|FG000|Overall Study|Physician Decision|2|||
48366533|NCT01215188|155536503|FG001|Overall Study|Physician Decision|1|||
48366534|NCT01215188|155536504|FG002|Overall Study|Physician Decision|0|||
48366535|NCT01215188|155536502|FG000|Overall Study|Lack of Efficacy|0|||
48366536|NCT01215188|155536503|FG001|Overall Study|Lack of Efficacy|0|||
48366537|NCT01215188|155536504|FG002|Overall Study|Lack of Efficacy|1|||
48366538|NCT01215188|155536502|FG000|Overall Study|Protocol Violation|1|||
48366539|NCT01215188|155536503|FG001|Overall Study|Protocol Violation|1|||
48366540|NCT01215188|155536504|FG002|Overall Study|Protocol Violation|1|||
48366541|NCT01215188|155536502|FG000|Overall Study|Withdrawal by Subject|32|||
48366542|NCT01215188|155536503|FG001|Overall Study|Withdrawal by Subject|34|||
48366543|NCT01215188|155536504|FG002|Overall Study|Withdrawal by Subject|31|||
48366544|NCT01127763|155536505|FG000|Overall Study|Adverse Event|2|||
48366545|NCT01127763|155536505|FG000|Overall Study|Withdrawal by Subject|1|||
48366546|NCT01127763|155536505|FG000|Overall Study|Physician Decision|2|||
48366547|NCT00992225|155536512|FG000|Overall Study|Entry Criteria Not Met|8|||
48366548|NCT00992225|155536512|FG000|Overall Study|Adverse Event|2|||
48366549|NCT03122223|155536513|FG000|Overall Study|Withdrawal by Subject|2|||
48366550|NCT03122223|155536514|FG001|Overall Study|Withdrawal by Subject|2|||
48366551|NCT03122223|155536515|FG002|Overall Study|Withdrawal by Subject|1|||
48366552|NCT03122223|155536516|FG003|Overall Study|Withdrawal by Subject|0|||
48366553|NCT03122223|155536513|FG000|Overall Study|Lost to Follow-up|0|||
48366554|NCT03122223|155536514|FG001|Overall Study|Lost to Follow-up|2|||
48366555|NCT03122223|155536515|FG002|Overall Study|Lost to Follow-up|2|||
48366556|NCT03122223|155536516|FG003|Overall Study|Lost to Follow-up|0|||
48366557|NCT03122223|155536513|FG000|Overall Study|Participant unable to adhere|1|||
48366558|NCT03122223|155536514|FG001|Overall Study|Participant unable to adhere|1|||
48366559|NCT03122223|155536515|FG002|Overall Study|Participant unable to adhere|1|||
48366560|NCT03122223|155536516|FG003|Overall Study|Participant unable to adhere|0|||
48366561|NCT03181789|155536518|FG000|Overall Study|Withdrawal by Subject|0|||
48366562|NCT03181789|155536519|FG001|Overall Study|Withdrawal by Subject|1|||
48366563|NCT03181789|155536520|FG002|Overall Study|Withdrawal by Subject|1|||
48366564|NCT03181789|155536521|FG003|Overall Study|Withdrawal by Subject|0|||
48366565|NCT03181789|155536518|FG000|Overall Study|Lost to Follow-up|7|||
48366566|NCT03181789|155536519|FG001|Overall Study|Lost to Follow-up|1|||
48366567|NCT03181789|155536520|FG002|Overall Study|Lost to Follow-up|0|||
48366568|NCT03181789|155536521|FG003|Overall Study|Lost to Follow-up|0|||
48366569|NCT03181789|155536518|FG000|Overall Study|Participant unable to adhere to visit|0|||
48366570|NCT03181789|155536519|FG001|Overall Study|Participant unable to adhere to visit|1|||
48366571|NCT03181789|155536520|FG002|Overall Study|Participant unable to adhere to visit|0|||
48366572|NCT03181789|155536521|FG003|Overall Study|Participant unable to adhere to visit|0|||
48366573|NCT02624791|155536522|FG000|Overall Study|Withdrawal by Subject|2|||
48366574|NCT02624791|155536523|FG001|Overall Study|Withdrawal by Subject|0|||
48366575|NCT02624791|155536524|FG002|Overall Study|Withdrawal by Subject|0|||
48366576|NCT02624791|155536525|FG003|Overall Study|Withdrawal by Subject|0|||
48366577|NCT02624791|155536526|FG004|Overall Study|Withdrawal by Subject|0|||
48366578|NCT02624791|155536527|FG005|Overall Study|Withdrawal by Subject|0|||
48366579|NCT04189952|155536528|FG000|Follow-up Period|Death|1|||
48366580|NCT04189952|155536528|FG000|Follow-up Period|Withdrawal by Subject|1|||
48366581|NCT03466073|155536529|FG000|Overall Study|Death|1|||
48366582|NCT03466073|155536530|FG001|Overall Study|Death|0|||
48366583|NCT03466073|155536531|FG002|Overall Study|Death|0|||
48366584|NCT03466073|155536532|FG003|Overall Study|Death|0|||
48366585|NCT03466073|155536533|FG004|Overall Study|Death|0|||
48366586|NCT03466073|155536534|FG005|Overall Study|Death|1|||
48366587|NCT01081665|155536535|FG000|Overall Study|Death|41|||
48366588|NCT01081665|155536535|FG000|Overall Study|Lost to Follow-up|18|||
48366589|NCT01081665|155536535|FG000|Overall Study|Withdrawal by Subject|17|||
48366590|NCT01081665|155536535|FG000|Overall Study|Change of dialysis unit|10|||
48366591|NCT01081665|155536535|FG000|Overall Study|Regulation of iPTH|5|||
48366592|NCT01081665|155536535|FG000|Overall Study|Change in renal replacement therapy|2|||
48366593|NCT01081665|155536535|FG000|Overall Study|Adverse Event|1|||
48366594|NCT01081665|155536535|FG000|Overall Study|Lack of Efficacy|1|||
48366595|NCT01395888|155536540|FG000|2-week Run-in Period|Adverse Event|2|||
48366596|NCT01395888|155536541|FG001|2-week Run-in Period|Adverse Event|0|||
48366597|NCT01395888|155536542|FG002|2-week Run-in Period|Adverse Event|0|||
48366598|NCT01395888|155536540|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
48414862|NCT01324830|155707518|FG016|Overall Study|Reason not mentioned above|0|||
48414863|NCT01324830|155707519|FG017|Overall Study|Reason not mentioned above|1|||
48366599|NCT01395888|155536541|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
48366600|NCT01395888|155536542|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
48366601|NCT01395888|155536540|FG000|2-week Run-in Period|Lost to Follow-up|1|||
48366602|NCT01395888|155536541|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48366603|NCT01395888|155536542|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48366604|NCT01395888|155536540|FG000|2-week Run-in Period|Protocol Violation|2|||
48366605|NCT01395888|155536541|FG001|2-week Run-in Period|Protocol Violation|0|||
48366606|NCT01395888|155536542|FG002|2-week Run-in Period|Protocol Violation|0|||
48366607|NCT01395888|155536540|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
48366608|NCT01395888|155536541|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48366609|NCT01395888|155536542|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48366610|NCT01395888|155536540|FG000|Treatment Period (TP)|Adverse Event|0|||
48366611|NCT01395888|155536541|FG001|Treatment Period (TP)|Adverse Event|7|||
48366612|NCT01395888|155536542|FG002|Treatment Period (TP)|Adverse Event|6|||
48366613|NCT01395888|155536540|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
48366614|NCT01395888|155536541|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
48366615|NCT01395888|155536542|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
48366616|NCT01395888|155536540|FG000|Treatment Period (TP)|Protocol Violation|0|||
48366617|NCT01395888|155536541|FG001|Treatment Period (TP)|Protocol Violation|1|||
48366618|NCT01395888|155536542|FG002|Treatment Period (TP)|Protocol Violation|5|||
48366619|NCT01395888|155536540|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
48366620|NCT01395888|155536541|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
48366621|NCT01395888|155536542|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
48366622|NCT01395888|155536540|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
48366623|NCT01395888|155536541|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
48366624|NCT01395888|155536542|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
48366625|NCT02217501|155536549|FG000|Overall Study|Death|3|||
48366626|NCT02217501|155536550|FG001|Overall Study|Death|4|||
48366627|NCT02019667|155536553|FG000|First Intervention (6 Months)|Adverse Event|0|||
48366628|NCT02019667|155536554|FG001|First Intervention (6 Months)|Adverse Event|1|||
48366629|NCT02019667|155536553|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
48366630|NCT02019667|155536554|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
48366631|NCT02019667|155536553|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
48366632|NCT02019667|155536554|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
48366633|NCT05114473|155536555|FG000|Overall Study|Lost to Follow-up|2|||
48366634|NCT05114473|155536556|FG001|Overall Study|Lost to Follow-up|2|||
48366635|NCT05114473|155536557|FG002|Overall Study|Lost to Follow-up|0|||
48366636|NCT02495792|155536558|FG000|Overall Study|Lost to Follow-up|5|||
48366637|NCT02495792|155536559|FG001|Overall Study|Lost to Follow-up|9|||
48366638|NCT02495792|155536558|FG000|Overall Study|Protocol Violation|32|||
48366639|NCT02495792|155536559|FG001|Overall Study|Protocol Violation|31|||
48366640|NCT02101385|155536560|FG000|Study Treatment|Disease Progression|9|||
48366641|NCT02101385|155536561|FG001|Study Treatment|Disease Progression|3|||
48366642|NCT02101385|155536560|FG000|Study Treatment|Alternative therapy|0|||
48366643|NCT02101385|155536561|FG001|Study Treatment|Alternative therapy|1|||
48366644|NCT02101385|155536560|FG000|Study Treatment|No treatment, per protocol criteria|0|||
48366645|NCT02101385|155536561|FG001|Study Treatment|No treatment, per protocol criteria|4|||
48366646|NCT02101385|155536560|FG000|Study Treatment|Patient Non compliance|0|||
48366647|NCT02101385|155536561|FG001|Study Treatment|Patient Non compliance|2|||
48366648|NCT02101385|155536560|FG000|Study Treatment|Withdrawal by Subject|5|||
48366649|NCT02101385|155536561|FG001|Study Treatment|Withdrawal by Subject|2|||
48366650|NCT02101385|155536560|FG000|Study Treatment|screen failure|1|||
48366651|NCT02101385|155536561|FG001|Study Treatment|screen failure|0|||
48366652|NCT02101385|155536560|FG000|Study Treatment|AE/Side Effects/Complications|8|||
48366653|NCT02101385|155536561|FG001|Study Treatment|AE/Side Effects/Complications|0|||
48366654|NCT02101385|155536560|FG000|Study Treatment|Lost to Follow-up|1|||
48366655|NCT02101385|155536561|FG001|Study Treatment|Lost to Follow-up|0|||
48366656|NCT02101385|155536560|FG000|Study Treatment|Disease Progression before treatment|1|||
48366657|NCT02101385|155536561|FG001|Study Treatment|Disease Progression before treatment|0|||
48366658|NCT02101385|155536560|FG000|Study Treatment|Death|1|||
48366659|NCT02101385|155536561|FG001|Study Treatment|Death|0|||
48366660|NCT02101385|155536560|FG000|Follow up|Lost to Follow-up|4|||
48366661|NCT02101385|155536561|FG001|Follow up|Lost to Follow-up|9|||
48366662|NCT02101385|155536560|FG000|Follow up|Refused to follow up|5|||
48366663|NCT02101385|155536561|FG001|Follow up|Refused to follow up|4|||
48366664|NCT02101385|155536560|FG000|Follow up|Death|21|||
48366665|NCT02101385|155536561|FG001|Follow up|Death|39|||
48366666|NCT02101385|155536560|FG000|Follow up|study completed|33|||
48366667|NCT02101385|155536561|FG001|Follow up|study completed|52|||
48366668|NCT02101385|155536560|FG000|Follow up|screen failure|2|||
48366669|NCT02101385|155536561|FG001|Follow up|screen failure|0|||
48366670|NCT02101385|155536560|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
48366671|NCT02101385|155536561|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
48366672|NCT02101385|155536560|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
48366673|NCT02101385|155536561|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
48366674|NCT02101385|155536560|FG000|Follow up|Withdrawal by Subject|2|||
48366675|NCT02101385|155536561|FG001|Follow up|Withdrawal by Subject|2|||
48366676|NCT02101385|155536560|FG000|Follow up|PI requested closure of site|0|||
48366677|NCT02101385|155536561|FG001|Follow up|PI requested closure of site|5|||
48366678|NCT00847808|155536562|FG000|Overall Study|Adverse Event|7|||
48366679|NCT00847808|155536562|FG000|Overall Study|Protocol Violation|1|||
48366680|NCT00847808|155536562|FG000|Overall Study|Lost to Follow-up|1|||
48366681|NCT00847808|155536562|FG000|Overall Study|Withdrawal by Subject|4|||
48366682|NCT00847808|155536562|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
48366683|NCT00847808|155536562|FG000|Overall Study|Participant Took Excluded Medication|1|||
48366684|NCT02432196|155536563|FG000|Overall Study|Exit - did not receive study device|1|||
48366685|NCT02432196|155536563|FG000|Overall Study|Death|2|||
48366686|NCT02432196|155536563|FG000|Overall Study|Reoperation|3|||
48366687|NCT03248492|155536568|FG000|Overall Study|Ongoing|23|||
48366688|NCT03248492|155536569|FG001|Overall Study|Ongoing|26|||
48366689|NCT03248492|155536570|FG002|Overall Study|Ongoing|3|||
48366690|NCT03248492|155536571|FG003|Overall Study|Ongoing|85|||
48366691|NCT03248492|155536572|FG004|Overall Study|Ongoing|2|||
48366692|NCT03248492|155536568|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
48366693|NCT03248492|155536569|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
48366694|NCT03248492|155536570|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
48366695|NCT03248492|155536571|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
48366696|NCT03248492|155536572|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
48366697|NCT03248492|155536568|FG000|Overall Study|Adverse Event|6|||
48366698|NCT03248492|155536569|FG001|Overall Study|Adverse Event|6|||
48366699|NCT03248492|155536570|FG002|Overall Study|Adverse Event|8|||
48366700|NCT03248492|155536571|FG003|Overall Study|Adverse Event|8|||
48366701|NCT03248492|155536572|FG004|Overall Study|Adverse Event|1|||
48366702|NCT03248492|155536568|FG000|Overall Study|Withdrawal by Subject|3|||
48366703|NCT03248492|155536569|FG001|Overall Study|Withdrawal by Subject|3|||
48366704|NCT03248492|155536570|FG002|Overall Study|Withdrawal by Subject|0|||
48366705|NCT03248492|155536571|FG003|Overall Study|Withdrawal by Subject|3|||
48366706|NCT03248492|155536572|FG004|Overall Study|Withdrawal by Subject|1|||
48366707|NCT03248492|155536568|FG000|Overall Study|Physician Decision|1|||
48366708|NCT03248492|155536569|FG001|Overall Study|Physician Decision|0|||
48366709|NCT03248492|155536570|FG002|Overall Study|Physician Decision|1|||
48366710|NCT03248492|155536571|FG003|Overall Study|Physician Decision|2|||
48366711|NCT03248492|155536572|FG004|Overall Study|Physician Decision|0|||
48366712|NCT03248492|155536568|FG000|Overall Study|Death|1|||
48366713|NCT03248492|155536569|FG001|Overall Study|Death|0|||
48366714|NCT03248492|155536570|FG002|Overall Study|Death|0|||
48414864|NCT01324830|155707520|FG018|Overall Study|Reason not mentioned above|0|||
48414865|NCT01324830|155707502|FG000|Overall Study|Adverse Event, serious fatal|0|||
48414866|NCT01324830|155707503|FG001|Overall Study|Adverse Event, serious fatal|1|||
48414867|NCT01324830|155707504|FG002|Overall Study|Adverse Event, serious fatal|0|||
48414868|NCT01324830|155707505|FG003|Overall Study|Adverse Event, serious fatal|0|||
48414869|NCT01324830|155707506|FG004|Overall Study|Adverse Event, serious fatal|0|||
48414870|NCT01324830|155707507|FG005|Overall Study|Adverse Event, serious fatal|0|||
48414871|NCT01324830|155707508|FG006|Overall Study|Adverse Event, serious fatal|0|||
48414872|NCT01324830|155707509|FG007|Overall Study|Adverse Event, serious fatal|0|||
48414873|NCT01324830|155707510|FG008|Overall Study|Adverse Event, serious fatal|0|||
48414874|NCT01324830|155707511|FG009|Overall Study|Adverse Event, serious fatal|0|||
48414875|NCT01324830|155707512|FG010|Overall Study|Adverse Event, serious fatal|0|||
48414876|NCT01324830|155707513|FG011|Overall Study|Adverse Event, serious fatal|0|||
48414877|NCT01324830|155707514|FG012|Overall Study|Adverse Event, serious fatal|0|||
48414878|NCT01324830|155707515|FG013|Overall Study|Adverse Event, serious fatal|0|||
48414879|NCT01324830|155707516|FG014|Overall Study|Adverse Event, serious fatal|0|||
48414880|NCT01324830|155707517|FG015|Overall Study|Adverse Event, serious fatal|0|||
48414881|NCT01324830|155707518|FG016|Overall Study|Adverse Event, serious fatal|0|||
48414882|NCT01324830|155707519|FG017|Overall Study|Adverse Event, serious fatal|0|||
48414883|NCT01324830|155707520|FG018|Overall Study|Adverse Event, serious fatal|0|||
48366715|NCT03248492|155536571|FG003|Overall Study|Death|6|||
48366716|NCT03248492|155536572|FG004|Overall Study|Death|0|||
48366717|NCT03248492|155536568|FG000|Overall Study|Other|0|||
48366718|NCT03248492|155536569|FG001|Overall Study|Other|1|||
48366719|NCT03248492|155536570|FG002|Overall Study|Other|0|||
48366720|NCT03248492|155536571|FG003|Overall Study|Other|4|||
48366721|NCT03248492|155536572|FG004|Overall Study|Other|0|||
48414884|NCT01324830|155707502|FG000|Overall Study|Adverse Event, non-fatal|0|||
48414885|NCT01324830|155707503|FG001|Overall Study|Adverse Event, non-fatal|0|||
48414886|NCT01324830|155707504|FG002|Overall Study|Adverse Event, non-fatal|0|||
48414887|NCT01324830|155707505|FG003|Overall Study|Adverse Event, non-fatal|0|||
48414888|NCT01324830|155707506|FG004|Overall Study|Adverse Event, non-fatal|0|||
48366722|NCT02766465|155536574|FG000|Overall Study|Withdrawal by Subject|0|||
48366723|NCT02766465|155536575|FG001|Overall Study|Withdrawal by Subject|10|||
48366724|NCT03775486|155536576|FG000|Initial Therapy Phase|Other reason provided|0|||
48366725|NCT03775486|155536577|FG001|Initial Therapy Phase|Other reason provided|15|||
48366726|NCT03775486|155536576|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
48366727|NCT03775486|155536577|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
48366728|NCT03775486|155536576|FG000|Initial Therapy Phase|Protocol Violation|0|||
48366729|NCT03775486|155536577|FG001|Initial Therapy Phase|Protocol Violation|2|||
48366730|NCT03775486|155536576|FG000|Initial Therapy Phase|Adverse Event|0|||
48366731|NCT03775486|155536577|FG001|Initial Therapy Phase|Adverse Event|34|||
48366732|NCT03775486|155536576|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
48414889|NCT01324830|155707507|FG005|Overall Study|Adverse Event, non-fatal|0|||
48366733|NCT03775486|155536577|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
48366734|NCT03775486|155536576|FG000|Maintenance Phase|Withdrawal by Subject|13|||
48366735|NCT03775486|155536577|FG001|Maintenance Phase|Withdrawal by Subject|12|||
48366736|NCT03775486|155536576|FG000|Maintenance Phase|Death|44|||
48366737|NCT03775486|155536577|FG001|Maintenance Phase|Death|45|||
48366738|NCT01758900|155536580|FG000|Overall Study|difficulty for further intubation|7|||
48366739|NCT01758900|155536581|FG001|Overall Study|difficulty for further intubation|8|||
48366740|NCT00935818|155536582|FG000|Overall Study|Withdrawal by Subject|45|||
48366741|NCT00935818|155536583|FG001|Overall Study|Withdrawal by Subject|50|||
48366742|NCT00935818|155536582|FG000|Overall Study|Lost to Follow-up|40|||
48366743|NCT00935818|155536583|FG001|Overall Study|Lost to Follow-up|42|||
48366744|NCT00935818|155536582|FG000|Overall Study|Adverse Event|6|||
48366745|NCT00935818|155536583|FG001|Overall Study|Adverse Event|7|||
48366746|NCT00935818|155536582|FG000|Overall Study|Physician Decision|0|||
48366747|NCT00935818|155536583|FG001|Overall Study|Physician Decision|1|||
48366748|NCT03284229|155537705|FG000|Overall Study|Lost to Follow-up|3|||
48366749|NCT01014208|155537706|FG000|Overall Study|Lost to Follow-up|2|||
48366750|NCT01014208|155537707|FG001|Overall Study|Lost to Follow-up|5|||
48366751|NCT01014208|155537706|FG000|Overall Study|Participant Withdrew Consent|12|||
48366752|NCT01014208|155537707|FG001|Overall Study|Participant Withdrew Consent|12|||
48366753|NCT01014208|155537706|FG000|Overall Study|Did Not Receive Study Drug|2|||
48366754|NCT01014208|155537707|FG001|Overall Study|Did Not Receive Study Drug|0|||
48366755|NCT01014208|155537706|FG000|Overall Study|Study Closed/terminated|78|||
48366756|NCT01014208|155537707|FG001|Overall Study|Study Closed/terminated|83|||
48366757|NCT02040259|155537708|FG000|Overall Study|Death|280|||
48366758|NCT02040259|155537708|FG000|Overall Study|Lost to Follow-up|76|||
48366759|NCT02040259|155537708|FG000|Overall Study|Assessment not completed|3|||
48366760|NCT02040259|155537708|FG000|Overall Study|Withdrawal by Subject|4|||
48366761|NCT01142232|155537709|FG000|Overall Study|Adverse Event|1|||
48366762|NCT01142232|155537710|FG001|Overall Study|Adverse Event|2|||
48366763|NCT01142232|155537711|FG002|Overall Study|Adverse Event|1|||
48366764|NCT01142232|155537712|FG003|Overall Study|Adverse Event|0|||
48366765|NCT01142232|155537713|FG004|Overall Study|Adverse Event|4|||
48366766|NCT01142232|155537709|FG000|Overall Study|Death|0|||
48366767|NCT01142232|155537710|FG001|Overall Study|Death|0|||
48366768|NCT01142232|155537711|FG002|Overall Study|Death|0|||
48366769|NCT01142232|155537712|FG003|Overall Study|Death|0|||
48366770|NCT01142232|155537713|FG004|Overall Study|Death|1|||
48366771|NCT01142232|155537709|FG000|Overall Study|Disease Progression|2|||
48366772|NCT01142232|155537710|FG001|Overall Study|Disease Progression|0|||
48366773|NCT01142232|155537711|FG002|Overall Study|Disease Progression|1|||
48366774|NCT01142232|155537712|FG003|Overall Study|Disease Progression|2|||
48366775|NCT01142232|155537713|FG004|Overall Study|Disease Progression|12|||
48366776|NCT01142232|155537709|FG000|Overall Study|Withdrawal by Subject|0|||
48366777|NCT01142232|155537710|FG001|Overall Study|Withdrawal by Subject|0|||
48366778|NCT01142232|155537711|FG002|Overall Study|Withdrawal by Subject|0|||
48366779|NCT01142232|155537712|FG003|Overall Study|Withdrawal by Subject|1|||
48366780|NCT01142232|155537713|FG004|Overall Study|Withdrawal by Subject|3|||
48366781|NCT01142232|155537709|FG000|Overall Study|Physician Decision|0|||
48366782|NCT01142232|155537710|FG001|Overall Study|Physician Decision|1|||
48366783|NCT01142232|155537711|FG002|Overall Study|Physician Decision|0|||
48366784|NCT01142232|155537712|FG003|Overall Study|Physician Decision|2|||
48366785|NCT01142232|155537713|FG004|Overall Study|Physician Decision|10|||
48366786|NCT01142232|155537709|FG000|Overall Study|Alternative Therapy|0|||
48366787|NCT01142232|155537710|FG001|Overall Study|Alternative Therapy|1|||
48366788|NCT01142232|155537711|FG002|Overall Study|Alternative Therapy|1|||
48366789|NCT01142232|155537712|FG003|Overall Study|Alternative Therapy|0|||
48366790|NCT01142232|155537713|FG004|Overall Study|Alternative Therapy|1|||
48366791|NCT01142232|155537709|FG000|Overall Study|Off Trt for other complicating disease|0|||
48366792|NCT01142232|155537710|FG001|Overall Study|Off Trt for other complicating disease|0|||
48366793|NCT01142232|155537711|FG002|Overall Study|Off Trt for other complicating disease|0|||
48366794|NCT01142232|155537712|FG003|Overall Study|Off Trt for other complicating disease|0|||
48366795|NCT01142232|155537713|FG004|Overall Study|Off Trt for other complicating disease|1|||
48366796|NCT01142232|155537709|FG000|Overall Study|Noncompliance|0|||
48366797|NCT01142232|155537710|FG001|Overall Study|Noncompliance|0|||
48366798|NCT01142232|155537711|FG002|Overall Study|Noncompliance|0|||
48366799|NCT01142232|155537712|FG003|Overall Study|Noncompliance|0|||
48366800|NCT01142232|155537713|FG004|Overall Study|Noncompliance|2|||
48366801|NCT00266227|155537714|FG000|Initial Treatment|Adverse Event|0|||
48366802|NCT00266227|155537715|FG001|Initial Treatment|Adverse Event|0|||
48366803|NCT00266227|155537716|FG002|Initial Treatment|Adverse Event|13|||
48366804|NCT00266227|155537714|FG000|Initial Treatment|Lost to Follow-up|0|||
48366805|NCT00266227|155537715|FG001|Initial Treatment|Lost to Follow-up|0|||
48366806|NCT00266227|155537716|FG002|Initial Treatment|Lost to Follow-up|6|||
48366807|NCT00266227|155537714|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
48366808|NCT00266227|155537715|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
48366809|NCT00266227|155537716|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
48366810|NCT00266227|155537714|FG000|Initial Treatment|Physician decision to withdraw|0|||
48366811|NCT00266227|155537715|FG001|Initial Treatment|Physician decision to withdraw|0|||
48366812|NCT00266227|155537716|FG002|Initial Treatment|Physician decision to withdraw|12|||
48366813|NCT00266227|155537714|FG000|Initial Treatment|Pregnancy|0|||
48366814|NCT00266227|155537715|FG001|Initial Treatment|Pregnancy|0|||
48366815|NCT00266227|155537716|FG002|Initial Treatment|Pregnancy|1|||
48366816|NCT00266227|155537714|FG000|Retreatment: Up to Week 48|Death|1|||
48366817|NCT00266227|155537715|FG001|Retreatment: Up to Week 48|Death|0|||
48366818|NCT00266227|155537716|FG002|Retreatment: Up to Week 48|Death|0|||
48366819|NCT00266227|155537714|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
48366820|NCT00266227|155537715|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
48366821|NCT00266227|155537716|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
48366822|NCT00266227|155537714|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
48366823|NCT00266227|155537715|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
48366824|NCT00266227|155537716|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
48366825|NCT00266227|155537714|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
48366826|NCT00266227|155537715|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
48366827|NCT00266227|155537716|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
48366828|NCT00266227|155537714|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
48366829|NCT00266227|155537715|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
48366830|NCT00266227|155537716|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
48366831|NCT00266227|155537714|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
48366832|NCT00266227|155537715|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
48366833|NCT00266227|155537716|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
48366834|NCT00266227|155537714|FG000|Retreatment: Week 48 to Week 72|Death|1|||
48366835|NCT00266227|155537715|FG001|Retreatment: Week 48 to Week 72|Death|1|||
48366836|NCT00266227|155537716|FG002|Retreatment: Week 48 to Week 72|Death|0|||
48366837|NCT00266227|155537714|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
48366838|NCT00266227|155537715|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
48366839|NCT00266227|155537716|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
48366840|NCT00266227|155537714|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
48366841|NCT00266227|155537715|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
48366842|NCT00266227|155537716|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
48414890|NCT01324830|155707508|FG006|Overall Study|Adverse Event, non-fatal|0|||
48414891|NCT01324830|155707509|FG007|Overall Study|Adverse Event, non-fatal|0|||
48414892|NCT01324830|155707510|FG008|Overall Study|Adverse Event, non-fatal|2|||
48366843|NCT00266227|155537714|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
48366844|NCT00266227|155537715|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
48366845|NCT00266227|155537716|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
48366846|NCT00266227|155537714|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
48366847|NCT00266227|155537715|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
48366848|NCT00266227|155537716|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
48366849|NCT03507777|155537717|FG000|Overall Study|Lost to Follow-up|5|||
48366850|NCT03507777|155537718|FG001|Overall Study|Lost to Follow-up|7|||
48366851|NCT03507777|155537717|FG000|Overall Study|Withdrawal by Subject|6|||
48366852|NCT03507777|155537718|FG001|Overall Study|Withdrawal by Subject|11|||
48366853|NCT03507777|155537717|FG000|Overall Study|Death|30|||
48366854|NCT03507777|155537718|FG001|Overall Study|Death|44|||
48366855|NCT03507777|155537717|FG000|Overall Study|Other Reasons|3|||
48414893|NCT01324830|155707511|FG009|Overall Study|Adverse Event, non-fatal|0|||
48414894|NCT01324830|155707512|FG010|Overall Study|Adverse Event, non-fatal|1|||
48414895|NCT01324830|155707513|FG011|Overall Study|Adverse Event, non-fatal|0|||
48414896|NCT01324830|155707514|FG012|Overall Study|Adverse Event, non-fatal|0|||
48414897|NCT01324830|155707515|FG013|Overall Study|Adverse Event, non-fatal|0|||
48414898|NCT01324830|155707516|FG014|Overall Study|Adverse Event, non-fatal|0|||
48414899|NCT01324830|155707517|FG015|Overall Study|Adverse Event, non-fatal|0|||
48414900|NCT01324830|155707518|FG016|Overall Study|Adverse Event, non-fatal|0|||
48414901|NCT01324830|155707519|FG017|Overall Study|Adverse Event, non-fatal|1|||
48414902|NCT01324830|155707520|FG018|Overall Study|Adverse Event, non-fatal|0|||
48414903|NCT01324830|155707502|FG000|Overall Study|Withdrawal by Subject|0|||
48414904|NCT01324830|155707503|FG001|Overall Study|Withdrawal by Subject|0|||
48414905|NCT01324830|155707504|FG002|Overall Study|Withdrawal by Subject|0|||
48414906|NCT01324830|155707505|FG003|Overall Study|Withdrawal by Subject|0|||
48366856|NCT03507777|155537718|FG001|Overall Study|Other Reasons|8|||
48366857|NCT04101318|155537719|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
48366858|NCT04101318|155537720|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
48366859|NCT04101318|155537719|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
48366860|NCT04101318|155537720|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
48366861|NCT04101318|155537719|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
48366862|NCT04101318|155537720|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
48414907|NCT01324830|155707506|FG004|Overall Study|Withdrawal by Subject|0|||
48414908|NCT01324830|155707507|FG005|Overall Study|Withdrawal by Subject|1|||
48366863|NCT03207451|155537721|FG000|Overall Study|scheduling conflict|1|||
48366864|NCT03207451|155537722|FG001|Overall Study|scheduling conflict|0|||
48366865|NCT03207451|155537723|FG002|Overall Study|scheduling conflict|2|||
48366866|NCT03207451|155537724|FG003|Overall Study|scheduling conflict|2|||
48366867|NCT03207451|155537721|FG000|Overall Study|Adverse Event|0|||
48366868|NCT03207451|155537722|FG001|Overall Study|Adverse Event|0|||
48366869|NCT03207451|155537723|FG002|Overall Study|Adverse Event|0|||
48414909|NCT01324830|155707508|FG006|Overall Study|Withdrawal by Subject|0|||
48414910|NCT01324830|155707509|FG007|Overall Study|Withdrawal by Subject|0|||
48414911|NCT01324830|155707510|FG008|Overall Study|Withdrawal by Subject|0|||
48414912|NCT01324830|155707511|FG009|Overall Study|Withdrawal by Subject|0|||
48414913|NCT01324830|155707512|FG010|Overall Study|Withdrawal by Subject|1|||
48414914|NCT01324830|155707513|FG011|Overall Study|Withdrawal by Subject|0|||
48414915|NCT01324830|155707514|FG012|Overall Study|Withdrawal by Subject|0|||
48414916|NCT01324830|155707515|FG013|Overall Study|Withdrawal by Subject|0|||
48414917|NCT01324830|155707516|FG014|Overall Study|Withdrawal by Subject|0|||
48414918|NCT01324830|155707517|FG015|Overall Study|Withdrawal by Subject|0|||
48414919|NCT01324830|155707518|FG016|Overall Study|Withdrawal by Subject|0|||
48414920|NCT01324830|155707519|FG017|Overall Study|Withdrawal by Subject|0|||
48414921|NCT01324830|155707520|FG018|Overall Study|Withdrawal by Subject|1|||
48414922|NCT00049127|155707523|FG000|Overall Study|Withdrawal by Subject|0|||
48414923|NCT00049127|155707524|FG001|Overall Study|Withdrawal by Subject|0|||
48366870|NCT03207451|155537724|FG003|Overall Study|Adverse Event|1|||
48366871|NCT04552899|155537725|FG000|Overall Study|Adverse Event|4|||
48366872|NCT04552899|155537726|FG001|Overall Study|Adverse Event|3|||
48366873|NCT04552899|155537725|FG000|Overall Study|Death|4|||
48366874|NCT04552899|155537726|FG001|Overall Study|Death|4|||
48366875|NCT04552899|155537725|FG000|Overall Study|Lost to Follow-up|8|||
48366876|NCT04552899|155537726|FG001|Overall Study|Lost to Follow-up|13|||
48366877|NCT04552899|155537725|FG000|Overall Study|Lung Transplant|4|||
48366878|NCT04552899|155537726|FG001|Overall Study|Lung Transplant|3|||
48366879|NCT04552899|155537725|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
48414924|NCT00049127|155707525|FG002|Overall Study|Withdrawal by Subject|1|||
48414925|NCT00049127|155707526|FG003|Overall Study|Withdrawal by Subject|0|||
48414926|NCT00049127|155707527|FG004|Overall Study|Withdrawal by Subject|0|||
48414927|NCT01929083|155707529|FG000|Intervention 1|Lost to Follow-up|2|||
48414928|NCT01929083|155707530|FG001|Intervention 1|Lost to Follow-up|0|||
48414929|NCT01929083|155707529|FG000|Intervention 1|Nonadherent to study medications|1|||
48414930|NCT01929083|155707530|FG001|Intervention 1|Nonadherent to study medications|0|||
48414931|NCT01929083|155707529|FG000|Intervention 2|Adverse Event|0|||
48414932|NCT01929083|155707530|FG001|Intervention 2|Adverse Event|1|||
48414933|NCT00502840|155707531|FG000|Overall Study|Adverse Event|5|||
48414934|NCT00502840|155707531|FG000|Overall Study|Additional or changed therapy|48|||
48414935|NCT00502840|155707531|FG000|Overall Study|Lack of Efficacy|11|||
48414936|NCT00502840|155707531|FG000|Overall Study|Protocol Violation|4|||
48366880|NCT04552899|155537726|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
48366881|NCT04552899|155537725|FG000|Overall Study|Physician Decision|3|||
48366882|NCT04552899|155537726|FG001|Overall Study|Physician Decision|4|||
48366883|NCT04552899|155537725|FG000|Overall Study|Study Terminated By Sponsor|237|||
48366884|NCT04552899|155537726|FG001|Overall Study|Study Terminated By Sponsor|239|||
48366885|NCT04552899|155537725|FG000|Overall Study|Withdrawal by Subject|15|||
48366886|NCT04552899|155537726|FG001|Overall Study|Withdrawal by Subject|17|||
48366887|NCT02929329|155537727|FG000|Overall Study|Withdrawal by Subject|24|||
48366888|NCT02929329|155537728|FG001|Overall Study|Withdrawal by Subject|21|||
48366889|NCT02929329|155537727|FG000|Overall Study|Lost to Follow-up|26|||
48366890|NCT02929329|155537728|FG001|Overall Study|Lost to Follow-up|20|||
48366891|NCT02929329|155537727|FG000|Overall Study|Death|1054|||
48366892|NCT02929329|155537728|FG001|Overall Study|Death|1051|||
48366893|NCT04772898|155537730|FG000|Overall Study|Withdrawal by Subject|0|||
48366894|NCT04772898|155537731|FG001|Overall Study|Withdrawal by Subject|1|||
48366895|NCT00473265|155537732|FG000|Overall Study|Unrelated adverse event|5|||
48366896|NCT00473265|155537732|FG000|Overall Study|Off treatment early|15|||
48366897|NCT01470001|155537733|FG000|Overall Study|Lost to Follow-up|1|||
48366898|NCT01470001|155537734|FG001|Overall Study|Lost to Follow-up|1|||
48366899|NCT01470001|155537733|FG000|Overall Study|Physician Decision|2|||
48366900|NCT01470001|155537734|FG001|Overall Study|Physician Decision|0|||
48366901|NCT01470001|155537733|FG000|Overall Study|Withdrawal by Subject|2|||
48366902|NCT01470001|155537734|FG001|Overall Study|Withdrawal by Subject|1|||
48366903|NCT03836716|155537735|FG000|Overall Study|Adverse Event|3|||
48414937|NCT00502840|155707531|FG000|Overall Study|Withdrawal by Subject|5|||
48414938|NCT00502840|155707531|FG000|Overall Study|Lost to Follow-up|6|||
48366904|NCT03836716|155537735|FG000|Overall Study|Death|22|||
48366905|NCT03836716|155537735|FG000|Overall Study|Withdrawal by Subject|8|||
48366906|NCT03836716|155537735|FG000|Overall Study|Study terminated by sponsor|87|||
48366907|NCT00037830|155537736|FG000|Overall Study|Adverse Event|2|||
48366908|NCT00037830|155537737|FG001|Overall Study|Adverse Event|0|||
48366909|NCT00037830|155537738|FG002|Overall Study|Adverse Event|0|||
48414939|NCT00502840|155707531|FG000|Overall Study|Administrative problems|1|||
48366910|NCT00037830|155537736|FG000|Overall Study|Withdrawal by Subject|4|||
48366911|NCT00037830|155537737|FG001|Overall Study|Withdrawal by Subject|5|||
48366912|NCT00037830|155537738|FG002|Overall Study|Withdrawal by Subject|1|||
48366913|NCT00037830|155537736|FG000|Overall Study|Protocol Violation|2|||
48366914|NCT00037830|155537737|FG001|Overall Study|Protocol Violation|2|||
48366915|NCT00037830|155537738|FG002|Overall Study|Protocol Violation|0|||
48366916|NCT00037830|155537736|FG000|Overall Study|Unrelated Medical Problem|2|||
48366917|NCT00037830|155537737|FG001|Overall Study|Unrelated Medical Problem|0|||
48366918|NCT00037830|155537738|FG002|Overall Study|Unrelated Medical Problem|0|||
48366919|NCT01517295|155537739|FG000|Overall Study|Physician Decision|1|||
48366920|NCT01517295|155537740|FG001|Overall Study|Physician Decision|0|||
48366921|NCT01353859|155537741|FG000|Overall Study|Adverse Event|3|||
48366922|NCT01353859|155537741|FG000|Overall Study|Lack of Efficacy|1|||
48366923|NCT01631227|155537742|FG000|Overall Study|withdrawn consent|27|||
48366924|NCT01631227|155537743|FG001|Overall Study|withdrawn consent|21|||
48366925|NCT01631227|155537742|FG000|Overall Study|Adverse Event|1|||
48366926|NCT01631227|155537743|FG001|Overall Study|Adverse Event|0|||
48366927|NCT01631227|155537742|FG000|Overall Study|administrative|2|||
48366928|NCT01631227|155537743|FG001|Overall Study|administrative|1|||
48366929|NCT03053518|155537747|FG000|Overall Study|Withdrawal by Subject|3|||
48366930|NCT03053518|155537747|FG000|Overall Study|Lost to Follow-up|2|||
48366931|NCT03053518|155537747|FG000|Overall Study|Ineligible|5|||
48366932|NCT03775434|155537748|FG000|Overall Study|Adverse Event|2|||
48414940|NCT00502840|155707531|FG000|Overall Study|Other|20|||
48414941|NCT03417440|155707532|FG000|Overall Study|Lost to Follow-up|0|||
48414942|NCT03417440|155707533|FG001|Overall Study|Lost to Follow-up|1|||
48414943|NCT03417440|155707534|FG002|Overall Study|Lost to Follow-up|0|||
48414944|NCT03417440|155707535|FG003|Overall Study|Lost to Follow-up|0|||
48414945|NCT03417440|155707536|FG004|Overall Study|Lost to Follow-up|1|||
48366933|NCT03775434|155537748|FG000|Overall Study|Withdrawal by Subject|1|||
48366934|NCT05560243|155537750|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
48366935|NCT00939822|155537755|FG000|Overall Study|Lost to Follow-up|1|||
48366936|NCT00939822|155537756|FG001|Overall Study|Lost to Follow-up|0|||
48366937|NCT00939822|155537755|FG000|Overall Study|withdrew from study due to busy schedule|1|||
48366938|NCT00939822|155537756|FG001|Overall Study|withdrew from study due to busy schedule|1|||
48366939|NCT00939822|155537755|FG000|Overall Study|Mental health issues|0|||
48366940|NCT00939822|155537756|FG001|Overall Study|Mental health issues|2|||
48366941|NCT01072630|155537757|FG000|Overall Study|Adverse Event|11|||
48366942|NCT01072630|155537758|FG001|Overall Study|Adverse Event|19|||
48366943|NCT01072630|155537759|FG002|Overall Study|Adverse Event|2|||
48366944|NCT01072630|155537757|FG000|Overall Study|Lack of Efficacy|10|||
48366945|NCT01072630|155537758|FG001|Overall Study|Lack of Efficacy|10|||
48366946|NCT01072630|155537759|FG002|Overall Study|Lack of Efficacy|1|||
48366947|NCT01072630|155537757|FG000|Overall Study|Withdrawal by Subject|8|||
48366948|NCT01072630|155537758|FG001|Overall Study|Withdrawal by Subject|7|||
48366949|NCT01072630|155537759|FG002|Overall Study|Withdrawal by Subject|2|||
48366950|NCT01072630|155537757|FG000|Overall Study|Protocol Violation|10|||
48366951|NCT01072630|155537758|FG001|Overall Study|Protocol Violation|8|||
48366952|NCT01072630|155537759|FG002|Overall Study|Protocol Violation|4|||
48366953|NCT01072630|155537757|FG000|Overall Study|Lost to Follow-up|11|||
48366954|NCT01072630|155537758|FG001|Overall Study|Lost to Follow-up|11|||
48366955|NCT01072630|155537759|FG002|Overall Study|Lost to Follow-up|1|||
48366956|NCT01072630|155537757|FG000|Overall Study|Noncompliance with study medication|1|||
48366957|NCT01072630|155537758|FG001|Overall Study|Noncompliance with study medication|1|||
48366958|NCT01072630|155537759|FG002|Overall Study|Noncompliance with study medication|1|||
48366959|NCT01072630|155537757|FG000|Overall Study|Noncompliance with study procedures|1|||
48366960|NCT01072630|155537758|FG001|Overall Study|Noncompliance with study procedures|2|||
48366961|NCT01072630|155537759|FG002|Overall Study|Noncompliance with study procedures|1|||
48366962|NCT01072630|155537757|FG000|Overall Study|Other|3|||
48366963|NCT01072630|155537758|FG001|Overall Study|Other|2|||
48366964|NCT01072630|155537759|FG002|Overall Study|Other|1|||
48366965|NCT03214640|155537760|FG000|Overall Study|Protocol Violation|1|||
48366966|NCT03214640|155537761|FG001|Overall Study|Protocol Violation|2|||
48366967|NCT03214640|155537762|FG002|Overall Study|Protocol Violation|1|||
48366968|NCT03214640|155537763|FG003|Overall Study|Protocol Violation|4|||
48366969|NCT04155047|155537764|FG000|Overall Study|Adverse Event|1|||
48366970|NCT04155047|155537765|FG001|Overall Study|Adverse Event|0|||
48366971|NCT04155047|155537764|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
48366972|NCT04155047|155537765|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
48366973|NCT00635427|155537774|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
48366974|NCT00635427|155537775|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
48366975|NCT00635427|155537776|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
48366976|NCT00635427|155537777|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
48366977|NCT00635427|155537778|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
48366978|NCT00635427|155537774|FG000|Overall Study|Death|0|||
48414946|NCT03417440|155707537|FG005|Overall Study|Lost to Follow-up|0|||
48414947|NCT03417440|155707538|FG006|Overall Study|Lost to Follow-up|0|||
48366979|NCT00635427|155537775|FG001|Overall Study|Death|0|||
48366980|NCT00635427|155537776|FG002|Overall Study|Death|0|||
48366981|NCT00635427|155537777|FG003|Overall Study|Death|1|||
48366982|NCT00635427|155537778|FG004|Overall Study|Death|0|||
48366983|NCT00635427|155537774|FG000|Overall Study|Termination Of Study By Sponsor|12|||
48366984|NCT00635427|155537775|FG001|Overall Study|Termination Of Study By Sponsor|6|||
48366985|NCT00635427|155537776|FG002|Overall Study|Termination Of Study By Sponsor|10|||
48366986|NCT00635427|155537777|FG003|Overall Study|Termination Of Study By Sponsor|6|||
48366987|NCT00635427|155537778|FG004|Overall Study|Termination Of Study By Sponsor|6|||
48366988|NCT00635427|155537774|FG000|Overall Study|Withdrawal Of Consent|0|||
48366989|NCT00635427|155537775|FG001|Overall Study|Withdrawal Of Consent|0|||
48366990|NCT00635427|155537776|FG002|Overall Study|Withdrawal Of Consent|0|||
48366991|NCT00635427|155537777|FG003|Overall Study|Withdrawal Of Consent|2|||
48366992|NCT00635427|155537778|FG004|Overall Study|Withdrawal Of Consent|2|||
48366993|NCT02081417|155537779|FG000|Overall Study|Lost to Follow-up|26|||
48366994|NCT02081417|155537780|FG001|Overall Study|Lost to Follow-up|23|||
48366995|NCT02081417|155537779|FG000|Overall Study|Moved Away|1|||
48366996|NCT02081417|155537780|FG001|Overall Study|Moved Away|2|||
48366997|NCT02081417|155537779|FG000|Overall Study|Incarcerated|2|||
48366998|NCT02081417|155537780|FG001|Overall Study|Incarcerated|2|||
48366999|NCT02081417|155537779|FG000|Overall Study|Death|4|||
48367000|NCT02081417|155537780|FG001|Overall Study|Death|3|||
48367001|NCT02081417|155537779|FG000|Overall Study|Withdrawal by Subject|4|||
48367002|NCT02081417|155537780|FG001|Overall Study|Withdrawal by Subject|0|||
48367003|NCT02081417|155537779|FG000|Overall Study|Admitted to Residential Treatment|2|||
48367004|NCT02081417|155537780|FG001|Overall Study|Admitted to Residential Treatment|0|||
48367005|NCT02081417|155537779|FG000|Overall Study|Did not start treatment|17|||
48367006|NCT02081417|155537780|FG001|Overall Study|Did not start treatment|21|||
48367007|NCT01145898|155537788|FG000|3-year Treatment|medication change by treating physician|3|||
48367008|NCT01145898|155537789|FG001|3-year Treatment|medication change by treating physician|16|||
48367009|NCT04811131|155537790|FG000|Overall Study|Adverse Event|0|||
48367010|NCT04811131|155537791|FG001|Overall Study|Adverse Event|0|||
48367011|NCT04811131|155537792|FG002|Overall Study|Adverse Event|1|||
48367012|NCT04811131|155537793|FG003|Overall Study|Adverse Event|0|||
48367013|NCT04811131|155537790|FG000|Overall Study|Lack of Efficacy|0|||
48367014|NCT04811131|155537791|FG001|Overall Study|Lack of Efficacy|0|||
48367015|NCT04811131|155537792|FG002|Overall Study|Lack of Efficacy|0|||
48367016|NCT04811131|155537793|FG003|Overall Study|Lack of Efficacy|1|||
48367017|NCT04811131|155537790|FG000|Overall Study|Lost to Follow-up|0|||
48367018|NCT04811131|155537791|FG001|Overall Study|Lost to Follow-up|1|||
48367019|NCT04811131|155537792|FG002|Overall Study|Lost to Follow-up|0|||
48367020|NCT04811131|155537793|FG003|Overall Study|Lost to Follow-up|0|||
48367021|NCT04811131|155537790|FG000|Overall Study|Sponsor request|31|||
48367022|NCT04811131|155537791|FG001|Overall Study|Sponsor request|35|||
48367023|NCT04811131|155537792|FG002|Overall Study|Sponsor request|27|||
48367024|NCT04811131|155537793|FG003|Overall Study|Sponsor request|10|||
48367025|NCT04811131|155537790|FG000|Overall Study|Withdrawal by Subject|3|||
48367026|NCT04811131|155537791|FG001|Overall Study|Withdrawal by Subject|1|||
48367027|NCT04811131|155537792|FG002|Overall Study|Withdrawal by Subject|3|||
48367028|NCT04811131|155537793|FG003|Overall Study|Withdrawal by Subject|1|||
48367029|NCT02755818|155537794|FG000|Overall Study|Withdrawal by Subject|0|||
48367030|NCT02755818|155537795|FG001|Overall Study|Withdrawal by Subject|0|||
48367031|NCT02755818|155537796|FG002|Overall Study|Withdrawal by Subject|0|||
48367032|NCT02755818|155537797|FG003|Overall Study|Withdrawal by Subject|2|||
48367033|NCT02755818|155537794|FG000|Overall Study|withdrawal by PI|0|||
48367034|NCT02755818|155537795|FG001|Overall Study|withdrawal by PI|0|||
48367035|NCT02755818|155537796|FG002|Overall Study|withdrawal by PI|1|||
48367036|NCT02755818|155537797|FG003|Overall Study|withdrawal by PI|1|||
48367037|NCT01877239|155537798|FG000|Overall Study|Adverse Event|4|||
48367038|NCT01877239|155537798|FG000|Overall Study|Disease Remission|1|||
48367039|NCT01877239|155537798|FG000|Overall Study|Withdrawal by Subject|4|||
48367040|NCT01877239|155537798|FG000|Overall Study|Other|2|||
48367041|NCT01877239|155537798|FG000|Overall Study|Lack of Efficacy|4|||
48367042|NCT01877239|155537798|FG000|Overall Study|Data not available|35|||
48367043|NCT00291642|155537807|FG000|Overall Study|Adverse Event|1|||
48367044|NCT00291642|155537808|FG001|Overall Study|Adverse Event|0|||
48367045|NCT00291642|155537809|FG002|Overall Study|Adverse Event|1|||
48367046|NCT00291642|155537810|FG003|Overall Study|Adverse Event|0|||
48367047|NCT00291642|155537811|FG004|Overall Study|Adverse Event|1|||
48367048|NCT00291642|155537807|FG000|Overall Study|Patient missed visit|0|||
48367049|NCT00291642|155537808|FG001|Overall Study|Patient missed visit|0|||
48367050|NCT00291642|155537809|FG002|Overall Study|Patient missed visit|1|||
48367051|NCT00291642|155537810|FG003|Overall Study|Patient missed visit|0|||
48367052|NCT00291642|155537811|FG004|Overall Study|Patient missed visit|0|||
48367053|NCT00291642|155537807|FG000|Overall Study|Intake of prohibited medication|1|||
48367054|NCT00291642|155537808|FG001|Overall Study|Intake of prohibited medication|0|||
48367055|NCT00291642|155537809|FG002|Overall Study|Intake of prohibited medication|0|||
48367056|NCT00291642|155537810|FG003|Overall Study|Intake of prohibited medication|0|||
48414948|NCT03417440|155707539|FG007|Overall Study|Lost to Follow-up|0|||
48414949|NCT03417440|155707532|FG000|Overall Study|Withdrawal by Subject|2|||
48414950|NCT03417440|155707533|FG001|Overall Study|Withdrawal by Subject|0|||
48414951|NCT03417440|155707534|FG002|Overall Study|Withdrawal by Subject|2|||
48414952|NCT03417440|155707535|FG003|Overall Study|Withdrawal by Subject|1|||
48414953|NCT03417440|155707536|FG004|Overall Study|Withdrawal by Subject|1|||
48414954|NCT03417440|155707537|FG005|Overall Study|Withdrawal by Subject|0|||
48414955|NCT03417440|155707538|FG006|Overall Study|Withdrawal by Subject|0|||
48367057|NCT00291642|155537811|FG004|Overall Study|Intake of prohibited medication|0|||
48367058|NCT00777088|155537812|FG000|Overall Study|PED Treatment not attempted|1|||
48367059|NCT03432260|155537815|FG000|Overall Study|Lost to Follow-up|1|||
48367060|NCT03432260|155537816|FG001|Overall Study|Lost to Follow-up|1|||
48367061|NCT03432260|155537817|FG002|Overall Study|Lost to Follow-up|0|||
48367062|NCT03432260|155537818|FG003|Overall Study|Lost to Follow-up|0|||
48367063|NCT03432260|155537819|FG004|Overall Study|Lost to Follow-up|1|||
48367064|NCT02317432|155537820|FG000|Overall Study|Death|4|||
48367065|NCT02317432|155537821|FG001|Overall Study|Death|1|||
48367066|NCT02317432|155537820|FG000|Overall Study|Lost to Follow-up|0|||
48367067|NCT02317432|155537821|FG001|Overall Study|Lost to Follow-up|5|||
48367068|NCT02317432|155537820|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
48367069|NCT02317432|155537821|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
48367070|NCT05593445|155537822|FG000|12-Week DBVC Period|Adverse Event|1|||
48367071|NCT05593445|155537823|FG001|12-Week DBVC Period|Adverse Event|0|||
48367072|NCT05593445|155537824|FG002|12-Week DBVC Period|Adverse Event|0|||
48367073|NCT05593445|155537825|FG003|12-Week DBVC Period|Adverse Event|0|||
48367074|NCT05593445|155537822|FG000|12-Week DBVC Period|Physician Decision|0|||
48367075|NCT05593445|155537823|FG001|12-Week DBVC Period|Physician Decision|1|||
48367076|NCT05593445|155537824|FG002|12-Week DBVC Period|Physician Decision|0|||
48367077|NCT05593445|155537825|FG003|12-Week DBVC Period|Physician Decision|0|||
48367078|NCT05593445|155537822|FG000|12-Week DBVC Period|Protocol Violation|0|||
48367079|NCT05593445|155537823|FG001|12-Week DBVC Period|Protocol Violation|1|||
48367080|NCT05593445|155537824|FG002|12-Week DBVC Period|Protocol Violation|0|||
48367081|NCT05593445|155537825|FG003|12-Week DBVC Period|Protocol Violation|0|||
48367082|NCT05593445|155537822|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
48367083|NCT05593445|155537823|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
48367084|NCT05593445|155537824|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
48367085|NCT05593445|155537825|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
48367086|NCT05593445|155537822|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
48367087|NCT05593445|155537823|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
48367088|NCT05593445|155537824|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
48367089|NCT05593445|155537825|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
48367090|NCT05593445|155537822|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
48367091|NCT05593445|155537823|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
48367092|NCT05593445|155537824|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
48367093|NCT05593445|155537825|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
48367094|NCT05593445|155537822|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
48367095|NCT05593445|155537823|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
48367096|NCT05593445|155537824|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
48367097|NCT05593445|155537825|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
48367098|NCT05593445|155537822|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48367099|NCT05593445|155537823|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48367100|NCT05593445|155537824|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
48367101|NCT05593445|155537825|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
48367102|NCT03981861|155537826|FG000|Overall Study|Withdrawal by Subject|3|||
48367103|NCT00774930|155539650|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
48367104|NCT00774930|155539651|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
48367105|NCT00774930|155539650|FG000|DB Phase|Adverse Event|1|||
48367106|NCT00774930|155539651|FG001|DB Phase|Adverse Event|2|||
48367107|NCT00774930|155539650|FG000|DB Phase|Subject Decision|1|||
48367108|NCT00774930|155539651|FG001|DB Phase|Subject Decision|5|||
48367109|NCT00774930|155539650|FG000|DB Phase|Sponsor Decision|0|||
48367110|NCT00774930|155539651|FG001|DB Phase|Sponsor Decision|1|||
48367111|NCT00774930|155539650|FG000|DB Phase|Disease Progression|1|||
48367112|NCT00774930|155539651|FG001|DB Phase|Disease Progression|1|||
48367113|NCT00774930|155539650|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
48367114|NCT00774930|155539651|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
48367115|NCT00774930|155539650|FG000|IOL Phase|Adverse Event|1|||
48367116|NCT00774930|155539651|FG001|IOL Phase|Adverse Event|1|||
48367117|NCT00774930|155539650|FG000|IOL Phase|Subject Decision|4|||
48367118|NCT00774930|155539651|FG001|IOL Phase|Subject Decision|3|||
48367119|NCT00774930|155539650|FG000|IOL Phase|Physician Decision|3|||
48367120|NCT00774930|155539651|FG001|IOL Phase|Physician Decision|2|||
48367121|NCT00774930|155539650|FG000|IOL Phase|Sponsor Decision|1|||
48414956|NCT03417440|155707539|FG007|Overall Study|Withdrawal by Subject|1|||
48431607|NCT01721408|155767330|FG000|Overall Study|Adverse Event|6|||
48414957|NCT02868892|155707540|FG000|Overall Study|Investigator left site and no follow-up|6|||
48414958|NCT00222105|155707541|FG000|Overall Study|Removed due to wrong diagnosis|1|||
48414959|NCT00222105|155707541|FG000|Overall Study|Withdrawal by Subject|1|||
48414960|NCT00222105|155707541|FG000|Overall Study|Adverse Event|8|||
48414961|NCT00222105|155707541|FG000|Overall Study|Treatment delays|2|||
48414962|NCT00222105|155707541|FG000|Overall Study|Death|2|||
48414963|NCT01128387|155707542|FG000|Overall Study|Physician Decision|0|||
48414964|NCT01128387|155707543|FG001|Overall Study|Physician Decision|1|||
48414965|NCT04525703|155707544|FG000|Overall Study|Lost to Follow-up|6|||
48414966|NCT04525703|155707545|FG001|Overall Study|Lost to Follow-up|15|||
48414967|NCT04525703|155707546|FG002|Overall Study|Lost to Follow-up|8|||
48414968|NCT02909153|155707547|FG000|Overall Study|Withdrawal by Subject|0|||
48414969|NCT02909153|155707548|FG001|Overall Study|Withdrawal by Subject|1|||
48414970|NCT02909153|155707549|FG002|Overall Study|Withdrawal by Subject|0|||
48414971|NCT02909153|155707550|FG003|Overall Study|Withdrawal by Subject|0|||
48414972|NCT02909153|155707551|FG004|Overall Study|Withdrawal by Subject|0|||
48414973|NCT01526148|155707552|FG000|Overall Study|Adverse Event|6|||
48414974|NCT01526148|155707553|FG001|Overall Study|Adverse Event|5|||
48414975|NCT01526148|155707552|FG000|Overall Study|Lost to Follow-up|3|||
48414976|NCT01526148|155707553|FG001|Overall Study|Lost to Follow-up|6|||
48414977|NCT01526148|155707552|FG000|Overall Study|Withdrawal by Subject|2|||
48414978|NCT01526148|155707553|FG001|Overall Study|Withdrawal by Subject|0|||
48414979|NCT01526148|155707552|FG000|Overall Study|Unstable Medical Condition|1|||
48414980|NCT01526148|155707553|FG001|Overall Study|Unstable Medical Condition|0|||
48414981|NCT01526148|155707552|FG000|Overall Study|Unable to discontinue concomitant med|1|||
48414982|NCT01526148|155707553|FG001|Overall Study|Unable to discontinue concomitant med|0|||
48414983|NCT01526148|155707552|FG000|Overall Study|Moved out of state|1|||
48414984|NCT01526148|155707553|FG001|Overall Study|Moved out of state|0|||
48414985|NCT01526148|155707552|FG000|Overall Study|Incarcerated|0|||
48414986|NCT01526148|155707553|FG001|Overall Study|Incarcerated|2|||
48414987|NCT00927485|155707554|FG000|Overall Study|Adverse Event|4|||
48414988|NCT00927485|155707555|FG001|Overall Study|Adverse Event|2|||
48414989|NCT00927485|155707554|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
48414990|NCT00927485|155707555|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
48414991|NCT03770403|155707557|FG000|Overall Study|Adverse Event|8|||
48414992|NCT03770403|155707557|FG000|Overall Study|Death|5|||
48414993|NCT03770403|155707557|FG000|Overall Study|Physician Decision|1|||
48414994|NCT03770403|155707557|FG000|Overall Study|Sponsor decision|1|||
48414995|NCT03770403|155707557|FG000|Overall Study|Study terminated by Sponsor|1|||
48414996|NCT03770403|155707557|FG000|Overall Study|Withdrawal by Subject|13|||
48414997|NCT03770403|155707557|FG000|Overall Study|Other|88|||
48414998|NCT03192904|155707558|FG000|Overall Study|Physician Decision|3|||
48414999|NCT03192904|155707559|FG001|Overall Study|Physician Decision|1|||
48415000|NCT03192904|155707558|FG000|Overall Study|Lost to Follow-up|0|||
48415001|NCT03192904|155707559|FG001|Overall Study|Lost to Follow-up|1|||
48415002|NCT02690701|155707562|FG000|Treatment Period 1|Adverse Event|2|||
48415003|NCT02690701|155707563|FG001|Treatment Period 1|Adverse Event|2|||
48415004|NCT02690701|155707562|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48415005|NCT02690701|155707563|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48415006|NCT02690701|155707562|FG000|Treatment Period 2|Adverse Event|2|||
48415007|NCT02690701|155707563|FG001|Treatment Period 2|Adverse Event|0|||
48415008|NCT02690701|155707562|FG000|Treatment Period 2|Lack of Efficacy|1|||
48415009|NCT02690701|155707563|FG001|Treatment Period 2|Lack of Efficacy|0|||
48415010|NCT02690701|155707562|FG000|Treatment Period 2|Lost to Follow-up|0|||
48415011|NCT02690701|155707563|FG001|Treatment Period 2|Lost to Follow-up|2|||
48415012|NCT02690701|155707562|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48415013|NCT02690701|155707563|FG001|Treatment Period 2|Withdrawal by Subject|2|||
48415014|NCT02690701|155707562|FG000|Treatment Period 2|Protocol Violation|0|||
48367122|NCT00774930|155539651|FG001|IOL Phase|Sponsor Decision|0|||
48367123|NCT00774930|155539650|FG000|IOL Phase|Disease Progression|2|||
48367124|NCT00774930|155539651|FG001|IOL Phase|Disease Progression|1|||
48367125|NCT00774930|155539650|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
48367126|NCT00774930|155539651|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
48367127|NCT00774930|155539650|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
48367128|NCT00774930|155539651|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
48367129|NCT00774930|155539650|FG000|IOL Phase|Other|1|||
48367130|NCT00774930|155539651|FG001|IOL Phase|Other|0|||
48367131|NCT00774930|155539650|FG000|IOL Phase|Brain radiation|0|||
48367132|NCT00774930|155539651|FG001|IOL Phase|Brain radiation|1|||
48415015|NCT02690701|155707563|FG001|Treatment Period 2|Protocol Violation|1|||
48415016|NCT01309737|155707564|FG000|Week 0 to 16|Death|1|||
48367133|NCT00774930|155539650|FG000|LTOLE Phase|Adverse Event|7|||
48367134|NCT00774930|155539651|FG001|LTOLE Phase|Adverse Event|3|||
48367135|NCT00774930|155539650|FG000|LTOLE Phase|Subject decision|0|||
48415017|NCT01309737|155707565|FG001|Week 0 to 16|Death|0|||
48415018|NCT01309737|155707566|FG002|Week 0 to 16|Death|1|||
48367136|NCT00774930|155539651|FG001|LTOLE Phase|Subject decision|5|||
48367137|NCT00774930|155539650|FG000|LTOLE Phase|Physician Decision|4|||
48415019|NCT01309737|155707567|FG003|Week 0 to 16|Death|0|||
48415020|NCT01309737|155707568|FG004|Week 0 to 16|Death|0|||
48415021|NCT01309737|155707564|FG000|Week 0 to 16|Adverse Event|11|||
48415022|NCT01309737|155707565|FG001|Week 0 to 16|Adverse Event|10|||
48415023|NCT01309737|155707566|FG002|Week 0 to 16|Adverse Event|5|||
48415024|NCT01309737|155707567|FG003|Week 0 to 16|Adverse Event|0|||
48415025|NCT01309737|155707568|FG004|Week 0 to 16|Adverse Event|0|||
48415026|NCT01309737|155707564|FG000|Week 0 to 16|Lack of Efficacy|15|||
48415027|NCT01309737|155707565|FG001|Week 0 to 16|Lack of Efficacy|2|||
48415028|NCT01309737|155707566|FG002|Week 0 to 16|Lack of Efficacy|24|||
48415029|NCT01309737|155707567|FG003|Week 0 to 16|Lack of Efficacy|0|||
48415030|NCT01309737|155707568|FG004|Week 0 to 16|Lack of Efficacy|0|||
48415031|NCT01309737|155707564|FG000|Week 0 to 16|Lost to Follow-up|7|||
48415032|NCT01309737|155707565|FG001|Week 0 to 16|Lost to Follow-up|8|||
48415033|NCT01309737|155707566|FG002|Week 0 to 16|Lost to Follow-up|3|||
48415034|NCT01309737|155707567|FG003|Week 0 to 16|Lost to Follow-up|0|||
48415035|NCT01309737|155707568|FG004|Week 0 to 16|Lost to Follow-up|0|||
48415036|NCT01309737|155707564|FG000|Week 0 to 16|Withdrawal by Subject|7|||
48367138|NCT00774930|155539651|FG001|LTOLE Phase|Physician Decision|1|||
48367139|NCT00774930|155539650|FG000|LTOLE Phase|Sponsor decision|2|||
48367140|NCT00774930|155539651|FG001|LTOLE Phase|Sponsor decision|1|||
48367141|NCT00774930|155539650|FG000|LTOLE Phase|Disease Progression|2|||
48367142|NCT00774930|155539651|FG001|LTOLE Phase|Disease Progression|5|||
48367143|NCT00774930|155539650|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
48367144|NCT00774930|155539651|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
48367145|NCT00774930|155539650|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
48367146|NCT00774930|155539651|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
48367147|NCT00730275|155539652|FG000|Overall Study|Withdrawal by Subject|0|||
48367148|NCT00730275|155539653|FG001|Overall Study|Withdrawal by Subject|0|||
48367149|NCT00730275|155539654|FG002|Overall Study|Withdrawal by Subject|0|||
48367150|NCT00730275|155539655|FG003|Overall Study|Withdrawal by Subject|1|||
48367151|NCT03020576|155539656|FG000|Overall Study|Withdrawal by Subject|1|||
48367152|NCT03020576|155539657|FG001|Overall Study|Withdrawal by Subject|2|||
48367153|NCT01153321|155539658|FG000|Overall Study|Development of study withdrawal criteria|0|||
48367154|NCT01153321|155539659|FG001|Overall Study|Development of study withdrawal criteria|1|||
48367155|NCT01153321|155539658|FG000|Overall Study|Withdrawal by Subject|0|||
48367156|NCT01153321|155539659|FG001|Overall Study|Withdrawal by Subject|1|||
48367157|NCT01153321|155539658|FG000|Overall Study|Adverse Event|1|||
48367158|NCT01153321|155539659|FG001|Overall Study|Adverse Event|1|||
48367159|NCT01177800|155539660|FG000|Overall Study|Adverse Event|9|||
48367160|NCT01177800|155539661|FG001|Overall Study|Adverse Event|3|||
48367161|NCT01177800|155539660|FG000|Overall Study|Protocol Violation|0|||
48367162|NCT01177800|155539661|FG001|Overall Study|Protocol Violation|1|||
48367163|NCT01177800|155539660|FG000|Overall Study|Physician Decision|1|||
48367164|NCT01177800|155539661|FG001|Overall Study|Physician Decision|0|||
48367165|NCT01177800|155539660|FG000|Overall Study|Withdrawal of informed consent|0|||
48367166|NCT01177800|155539661|FG001|Overall Study|Withdrawal of informed consent|1|||
48367167|NCT00356408|155539662|FG000|Overall Study|Adverse Event|9|||
48367168|NCT00356408|155539662|FG000|Overall Study|Lack of Efficacy|36|||
48367169|NCT00356408|155539662|FG000|Overall Study|Lost to Follow-up|2|||
48367170|NCT00356408|155539662|FG000|Overall Study|Withdrawal by Subject|6|||
48367171|NCT00356408|155539662|FG000|Overall Study|Other: Principal investigator discretion|3|||
48367172|NCT00356408|155539662|FG000|Overall Study|Other: Sponsor request|1|||
48367173|NCT00356408|155539662|FG000|Overall Study|Other: Azathioprine stopped|1|||
48367174|NCT00356408|155539662|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
48367175|NCT00356408|155539662|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
48367176|NCT03527550|155539663|FG000|Overall Study|Lost to Follow-up|4|||
48367177|NCT03527550|155539664|FG001|Overall Study|Lost to Follow-up|2|||
48367178|NCT03527550|155539663|FG000|Overall Study|Withdrawal by Subject|4|||
48367179|NCT03527550|155539664|FG001|Overall Study|Withdrawal by Subject|1|||
48367180|NCT03527550|155539663|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
48367181|NCT03527550|155539664|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
48367182|NCT00911937|155539665|FG000|Overall Study|Death|1|||
48367183|NCT00911937|155539666|FG001|Overall Study|Death|0|||
48367184|NCT00911937|155539665|FG000|Overall Study|Lost to Follow-up|8|||
48367185|NCT00911937|155539666|FG001|Overall Study|Lost to Follow-up|5|||
48367186|NCT00911937|155539665|FG000|Overall Study|Withdrawal by Subject|10|||
48367187|NCT00911937|155539666|FG001|Overall Study|Withdrawal by Subject|7|||
48415037|NCT01309737|155707565|FG001|Week 0 to 16|Withdrawal by Subject|6|||
48415038|NCT01309737|155707566|FG002|Week 0 to 16|Withdrawal by Subject|7|||
48415039|NCT01309737|155707567|FG003|Week 0 to 16|Withdrawal by Subject|0|||
48415040|NCT01309737|155707568|FG004|Week 0 to 16|Withdrawal by Subject|0|||
48415041|NCT01309737|155707564|FG000|Week 0 to 16|Other|10|||
48367188|NCT00911937|155539665|FG000|Overall Study|Withdrawn due to pregnancy|1|||
48367189|NCT00911937|155539666|FG001|Overall Study|Withdrawn due to pregnancy|0|||
48367190|NCT00911937|155539665|FG000|Overall Study|Adverse Event|11|||
48367191|NCT00911937|155539666|FG001|Overall Study|Adverse Event|25|||
48415042|NCT01309737|155707565|FG001|Week 0 to 16|Other|14|||
48415043|NCT01309737|155707566|FG002|Week 0 to 16|Other|4|||
48415044|NCT01309737|155707567|FG003|Week 0 to 16|Other|0|||
48415045|NCT01309737|155707568|FG004|Week 0 to 16|Other|0|||
48415046|NCT01309737|155707564|FG000|Week 0 to 16|Randomized, but not treated|1|||
48415047|NCT01309737|155707565|FG001|Week 0 to 16|Randomized, but not treated|0|||
48415048|NCT01309737|155707566|FG002|Week 0 to 16|Randomized, but not treated|0|||
48415049|NCT01309737|155707567|FG003|Week 0 to 16|Randomized, but not treated|0|||
48415050|NCT01309737|155707568|FG004|Week 0 to 16|Randomized, but not treated|0|||
48415051|NCT01309737|155707564|FG000|Week 16 to 52|Death|0|||
48415052|NCT01309737|155707565|FG001|Week 16 to 52|Death|0|||
48415053|NCT01309737|155707566|FG002|Week 16 to 52|Death|0|||
48415054|NCT01309737|155707567|FG003|Week 16 to 52|Death|0|||
48415055|NCT01309737|155707568|FG004|Week 16 to 52|Death|1|||
48415056|NCT01309737|155707564|FG000|Week 16 to 52|Adverse Event|7|||
48415057|NCT01309737|155707565|FG001|Week 16 to 52|Adverse Event|7|||
48415058|NCT01309737|155707566|FG002|Week 16 to 52|Adverse Event|0|||
48415059|NCT01309737|155707567|FG003|Week 16 to 52|Adverse Event|6|||
48367192|NCT00911937|155539665|FG000|Overall Study|Lack of Efficacy|11|||
48367193|NCT00911937|155539666|FG001|Overall Study|Lack of Efficacy|6|||
48367194|NCT00911937|155539665|FG000|Overall Study|Did not meet inclusion criteria|9|||
48367195|NCT00911937|155539666|FG001|Overall Study|Did not meet inclusion criteria|11|||
48367196|NCT00911937|155539665|FG000|Overall Study|Protocol Violation|14|||
48367197|NCT00911937|155539666|FG001|Overall Study|Protocol Violation|23|||
48367198|NCT00911937|155539665|FG000|Overall Study|Randomized but not treated|13|||
48367199|NCT00911937|155539666|FG001|Overall Study|Randomized but not treated|13|||
48367200|NCT00911937|155539665|FG000|Overall Study|Other|9|||
48367201|NCT00911937|155539666|FG001|Overall Study|Other|5|||
48367202|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
48367203|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
48367204|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
48367205|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
48367206|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
48367207|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
48367208|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
48367209|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
48367210|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
48367211|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
48367212|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
48367213|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
48367214|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
48367215|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
48367216|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
48367217|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
48367218|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
48367219|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
48367220|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
48367221|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
48367222|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
48367223|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
48367224|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
48367225|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
48367226|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
48367227|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
48367228|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
48367229|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
48367230|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
48367231|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
48367232|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
48367233|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
48367234|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
48367235|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
48367236|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
48367237|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
48367238|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
48367239|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
48367240|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
48367241|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
48415060|NCT01309737|155707568|FG004|Week 16 to 52|Adverse Event|5|||
48415061|NCT01309737|155707564|FG000|Week 16 to 52|Lack of Efficacy|107|||
48415062|NCT01309737|155707565|FG001|Week 16 to 52|Lack of Efficacy|76|||
48367242|NCT00700427|155539667|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
48367243|NCT00700427|155539668|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
48367244|NCT00700427|155539669|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
48367245|NCT00700427|155539670|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
48367246|NCT00700427|155539671|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
48367247|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
48367248|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
48367249|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
48367250|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
48367251|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
48367252|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
48367253|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
48367254|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
48367255|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
48367256|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
48367257|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
48367258|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
48367259|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
48367260|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
48367261|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
48367262|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
48367263|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
48367264|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
48367265|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
48367266|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
48367267|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
48367268|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
48367269|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
48367270|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
48367271|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
48367272|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
48367273|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
48367274|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
48367275|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
48367276|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
48367277|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
48367278|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
48367279|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
48367280|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
48367281|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
48367282|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
48367283|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
48367284|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
48367285|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
48367286|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
48367287|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
48367288|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
48367289|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
48367290|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
48367291|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
48367292|NCT00700427|155539667|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
48367293|NCT00700427|155539668|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
48367294|NCT00700427|155539669|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
48367295|NCT00700427|155539670|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
48367296|NCT00700427|155539671|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
48367297|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
48367298|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
48367299|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
48367300|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
48367301|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
48367302|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
48367303|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
48367304|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
48367305|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
48367306|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
48367307|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
48367308|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
48367309|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
48367310|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
48367311|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
48367312|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
48367313|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
48367314|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
48367315|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
48367316|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
48367317|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
48367318|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
48367319|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
48367320|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
48367321|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
48367322|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
48367323|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
48367324|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
48367325|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
48367326|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
48367327|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
48367328|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
48367329|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
48367330|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
48367331|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
48367332|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
48367333|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
48367334|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
48367335|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
48367336|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
48367337|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
48367338|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
48367339|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
48367340|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
48367341|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
48367342|NCT00700427|155539667|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
48367343|NCT00700427|155539668|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
48367344|NCT00700427|155539669|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
48367345|NCT00700427|155539670|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
48367346|NCT00700427|155539671|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
48367347|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
48367348|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
48367349|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
48367350|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
48367351|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
48367352|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
48367353|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
48367354|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
48367355|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
48367356|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
48367357|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
48367358|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
48367359|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
48367360|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
48367361|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
48367362|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
48367363|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
48367364|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
48367365|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
48367366|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
48367367|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
48367368|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
48367369|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
48367370|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
48367371|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
48367372|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
48367373|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
48367374|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
48367375|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
48367376|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
48367377|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
48367378|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
48367379|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
48367380|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
48367381|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
48367382|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
48367383|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
48367384|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
48367385|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
48367386|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
48367387|NCT00700427|155539667|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
48367388|NCT00700427|155539668|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
48367389|NCT00700427|155539669|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
48367390|NCT00700427|155539670|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
48367391|NCT00700427|155539671|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
48367392|NCT02207569|155539676|FG000|1-Month|Death|6|||
48367393|NCT02207569|155539676|FG000|1-Month|Withdrawal by Subject|2|||
48367394|NCT02207569|155539676|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
48367395|NCT02207569|155539676|FG000|6-Month|Death|8|||
48367396|NCT02207569|155539676|FG000|6-Month|Withdrawal by Subject|2|||
48367397|NCT02207569|155539676|FG000|12-Month|Death|14|||
48367398|NCT02207569|155539676|FG000|12-Month|Withdrawal by Subject|2|||
48367399|NCT02207569|155539676|FG000|24-Month|Death|23|||
48367400|NCT02207569|155539676|FG000|24-Month|Withdrawal by Subject|3|||
48367401|NCT02207569|155539676|FG000|36-Month|Death|23|||
48367402|NCT02207569|155539676|FG000|36-Month|Withdrawal by Subject|4|||
48367403|NCT02207569|155539676|FG000|48-Month|Death|25|||
48367404|NCT02207569|155539676|FG000|48-Month|Withdrawal by Subject|2|||
48367405|NCT02207569|155539676|FG000|48-Month|Lost to Follow-up|4|||
48367406|NCT02207569|155539676|FG000|60-Month|Death|1|||
48367407|NCT02207569|155539676|FG000|60-Month|Lost to Follow-up|1|||
48367408|NCT02207569|155539676|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
48367409|NCT02207569|155539676|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
48367410|NCT01014143|155539677|FG000|Second Intervention|Lost to Follow-up|2|||
48367411|NCT01014143|155539678|FG001|Second Intervention|Lost to Follow-up|0|||
48367412|NCT01014143|155539679|FG002|Second Intervention|Lost to Follow-up|0|||
48367413|NCT01493427|155539682|FG000|Overall Study|Adverse Event|10|||
48367414|NCT01493427|155539682|FG000|Overall Study|Personal Reasons|4|||
48367415|NCT01493427|155539682|FG000|Overall Study|Lost to Follow-up|2|||
48367416|NCT01493427|155539682|FG000|Overall Study|Inability to Follow Instructions|2|||
48367417|NCT01493427|155539682|FG000|Overall Study|Other|2|||
48367418|NCT02334423|155539685|FG000|Overall Study|Protocol Violation|10|||
48367419|NCT02334423|155539686|FG001|Overall Study|Protocol Violation|3|||
48367420|NCT01076647|155539689|FG000|Overall Study|Adverse Event|4|||
48367421|NCT01076647|155539690|FG001|Overall Study|Adverse Event|1|||
48367422|NCT01076647|155539689|FG000|Overall Study|Lack of Efficacy|0|||
48367423|NCT01076647|155539690|FG001|Overall Study|Lack of Efficacy|1|||
48367424|NCT01076647|155539689|FG000|Overall Study|Protocol Violation|7|||
48367425|NCT01076647|155539690|FG001|Overall Study|Protocol Violation|9|||
48367426|NCT01076647|155539689|FG000|Overall Study|Withdrawal criteria|2|||
48367427|NCT01076647|155539690|FG001|Overall Study|Withdrawal criteria|2|||
48367428|NCT01076647|155539689|FG000|Overall Study|Unclassified|12|||
48367429|NCT01076647|155539690|FG001|Overall Study|Unclassified|12|||
48367430|NCT04313608|155539691|FG000|Overall Study|Death|12|||
48367431|NCT04313608|155539692|FG001|Overall Study|Death|3|||
48367432|NCT03223662|155539693|FG000|Overall Study|Physician Decision|1|||
48367433|NCT03223662|155539693|FG000|Overall Study|Study closure|1|||
48367434|NCT00831129|155539696|FG000|Overall Study|Adverse Event|0|||
48367435|NCT00831129|155539697|FG001|Overall Study|Adverse Event|1|||
48367436|NCT00831129|155539696|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
48367437|NCT00831129|155539697|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
48367438|NCT01712659|155539698|FG000|Dose Escalation|Physician Decision|0|||
48367439|NCT01712659|155539699|FG001|Dose Escalation|Physician Decision|1|||
48367440|NCT01712659|155539700|FG002|Dose Escalation|Physician Decision|0|||
48367441|NCT01712659|155539701|FG003|Dose Escalation|Physician Decision|0|||
48367442|NCT01712659|155539702|FG004|Dose Escalation|Physician Decision|0|||
48367443|NCT01712659|155539698|FG000|Dose Escalation|Unable to take study drug|0|||
48415063|NCT01309737|155707566|FG002|Week 16 to 52|Lack of Efficacy|0|||
48367444|NCT01712659|155539699|FG001|Dose Escalation|Unable to take study drug|1|||
48367445|NCT01712659|155539700|FG002|Dose Escalation|Unable to take study drug|0|||
48367446|NCT01712659|155539701|FG003|Dose Escalation|Unable to take study drug|0|||
48367447|NCT01712659|155539702|FG004|Dose Escalation|Unable to take study drug|0|||
48367448|NCT01712659|155539698|FG000|Dose Expansion|Early disease progression|1|||
48367449|NCT01712659|155539699|FG001|Dose Expansion|Early disease progression|0|||
48367450|NCT01712659|155539700|FG002|Dose Expansion|Early disease progression|0|||
48367451|NCT01712659|155539701|FG003|Dose Expansion|Early disease progression|0|||
48367452|NCT01712659|155539702|FG004|Dose Expansion|Early disease progression|0|||
48367453|NCT01712659|155539698|FG000|Dose Expansion|Physician Decision|1|||
48367454|NCT01712659|155539699|FG001|Dose Expansion|Physician Decision|0|||
48367455|NCT01712659|155539700|FG002|Dose Expansion|Physician Decision|0|||
48367456|NCT01712659|155539701|FG003|Dose Expansion|Physician Decision|0|||
48367457|NCT01712659|155539702|FG004|Dose Expansion|Physician Decision|0|||
48367458|NCT02544451|155539704|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
48367459|NCT02544451|155539705|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
48367460|NCT02544451|155539706|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
48367461|NCT02544451|155539707|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
48367462|NCT02544451|155539704|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
48367463|NCT02544451|155539705|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
48367464|NCT02544451|155539706|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
48367465|NCT02544451|155539707|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
48367466|NCT02544451|155539704|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
48367467|NCT02544451|155539705|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
48367468|NCT02544451|155539706|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
48367469|NCT02544451|155539707|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
48367470|NCT02544451|155539704|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
48367471|NCT02544451|155539705|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
48367472|NCT02544451|155539706|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
48367473|NCT02544451|155539707|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
48367474|NCT02544451|155539704|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
48367475|NCT02544451|155539705|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
48367476|NCT02544451|155539706|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
48367477|NCT02544451|155539707|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
48367478|NCT02544451|155539704|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
48367479|NCT02544451|155539705|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
48367480|NCT02544451|155539706|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
48367481|NCT02544451|155539707|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
48367482|NCT02581631|155539709|FG000|Overall Study|Disease progression|29|||
48367483|NCT02581631|155539710|FG001|Overall Study|Disease progression|19|||
48367484|NCT02581631|155539711|FG002|Overall Study|Disease progression|13|||
48367485|NCT02581631|155539712|FG003|Overall Study|Disease progression|5|||
48367486|NCT02581631|155539713|FG004|Overall Study|Disease progression|8|||
48367487|NCT02581631|155539709|FG000|Overall Study|Study drug toxicity|4|||
48367488|NCT02581631|155539710|FG001|Overall Study|Study drug toxicity|6|||
48367489|NCT02581631|155539711|FG002|Overall Study|Study drug toxicity|7|||
48367490|NCT02581631|155539712|FG003|Overall Study|Study drug toxicity|0|||
48367491|NCT02581631|155539713|FG004|Overall Study|Study drug toxicity|3|||
48367492|NCT02581631|155539709|FG000|Overall Study|AE unrelated to study drug|3|||
48367493|NCT02581631|155539710|FG001|Overall Study|AE unrelated to study drug|1|||
48367494|NCT02581631|155539711|FG002|Overall Study|AE unrelated to study drug|1|||
48367495|NCT02581631|155539712|FG003|Overall Study|AE unrelated to study drug|0|||
48367496|NCT02581631|155539713|FG004|Overall Study|AE unrelated to study drug|2|||
48367497|NCT02581631|155539709|FG000|Overall Study|Request to discontinue|1|||
48367498|NCT02581631|155539710|FG001|Overall Study|Request to discontinue|0|||
48367499|NCT02581631|155539711|FG002|Overall Study|Request to discontinue|3|||
48367500|NCT02581631|155539712|FG003|Overall Study|Request to discontinue|0|||
48367501|NCT02581631|155539713|FG004|Overall Study|Request to discontinue|1|||
48367502|NCT02581631|155539709|FG000|Overall Study|participant withdrew consent|3|||
48367503|NCT02581631|155539710|FG001|Overall Study|participant withdrew consent|0|||
48367504|NCT02581631|155539711|FG002|Overall Study|participant withdrew consent|1|||
48367505|NCT02581631|155539712|FG003|Overall Study|participant withdrew consent|0|||
48367506|NCT02581631|155539713|FG004|Overall Study|participant withdrew consent|0|||
48367507|NCT02581631|155539709|FG000|Overall Study|Maximum clinical benefit|1|||
48367508|NCT02581631|155539710|FG001|Overall Study|Maximum clinical benefit|7|||
48367509|NCT02581631|155539711|FG002|Overall Study|Maximum clinical benefit|1|||
48367510|NCT02581631|155539712|FG003|Overall Study|Maximum clinical benefit|3|||
48367511|NCT02581631|155539713|FG004|Overall Study|Maximum clinical benefit|13|||
48367512|NCT02581631|155539709|FG000|Overall Study|Other Reasons|1|||
48367513|NCT02581631|155539710|FG001|Overall Study|Other Reasons|0|||
48367514|NCT02581631|155539711|FG002|Overall Study|Other Reasons|2|||
48367515|NCT02581631|155539712|FG003|Overall Study|Other Reasons|2|||
48367516|NCT02581631|155539713|FG004|Overall Study|Other Reasons|3|||
48367517|NCT02581631|155539709|FG000|Overall Study|Poor/Non-Compliance|0|||
48367518|NCT02581631|155539710|FG001|Overall Study|Poor/Non-Compliance|0|||
48367519|NCT02581631|155539711|FG002|Overall Study|Poor/Non-Compliance|1|||
48367520|NCT02581631|155539712|FG003|Overall Study|Poor/Non-Compliance|0|||
48367521|NCT02581631|155539713|FG004|Overall Study|Poor/Non-Compliance|0|||
48367522|NCT03001076|155539714|FG000|Overall Study|Withdrawal by patient|2|||
48367523|NCT03001076|155539715|FG001|Overall Study|Withdrawal by patient|0|||
48367524|NCT03001076|155539714|FG000|Overall Study|Other|1|||
48367525|NCT03001076|155539715|FG001|Overall Study|Other|0|||
48367526|NCT03001076|155539714|FG000|Overall Study|Adverse Event|3|||
48367527|NCT03001076|155539715|FG001|Overall Study|Adverse Event|3|||
48367528|NCT03001076|155539714|FG000|Overall Study|Sponsor decision|1|||
48367529|NCT03001076|155539715|FG001|Overall Study|Sponsor decision|0|||
48367530|NCT03001076|155539714|FG000|Overall Study|Lost to Follow-up|0|||
48367531|NCT03001076|155539715|FG001|Overall Study|Lost to Follow-up|2|||
48367532|NCT00844532|155539717|FG000|Overall Study|Death|16|||
48367533|NCT00844532|155539717|FG000|Overall Study|Withdrawal by Subject|16|||
48367534|NCT00844532|155539717|FG000|Overall Study|Lost to Follow-up|7|||
48367535|NCT00132873|155539718|FG000|Overall Study|Adverse Event|3|||
48367536|NCT00132873|155539718|FG000|Overall Study|Lost to Follow-up|1|||
48367537|NCT00132873|155539718|FG000|Overall Study|Lack of Efficacy|1|||
48367538|NCT00132873|155539718|FG000|Overall Study|Withdrawal by Subject|3|||
48367539|NCT00132873|155539718|FG000|Overall Study|Planned Pregnancy|1|||
48367540|NCT01775124|155539721|FG000|Core Period|Disease Progression|0|||
48367541|NCT01775124|155539722|FG001|Core Period|Disease Progression|1|||
48367542|NCT01775124|155539721|FG000|Core Period|Physician Decision|1|||
48367543|NCT01775124|155539722|FG001|Core Period|Physician Decision|1|||
48367544|NCT01775124|155539721|FG000|Core Period|Death|0|||
48367545|NCT01775124|155539722|FG001|Core Period|Death|1|||
48367546|NCT01775124|155539721|FG000|Core Period|Administrative problems|1|||
48367547|NCT01775124|155539722|FG001|Core Period|Administrative problems|0|||
48367548|NCT01775124|155539721|FG000|Core Period|Withdrawal by Subject|4|||
48367549|NCT01775124|155539722|FG001|Core Period|Withdrawal by Subject|2|||
48367550|NCT01775124|155539721|FG000|Core Period|Adverse Event|5|||
48367551|NCT01775124|155539722|FG001|Core Period|Adverse Event|5|||
48367552|NCT01775124|155539721|FG000|Extension Period|Adverse Event|3|||
48367553|NCT01775124|155539722|FG001|Extension Period|Adverse Event|2|||
48367554|NCT01775124|155539721|FG000|Extension Period|Physician Decision|0|||
48367555|NCT01775124|155539722|FG001|Extension Period|Physician Decision|2|||
48367556|NCT01775124|155539721|FG000|Extension Period|Administrative problems|0|||
48367557|NCT01775124|155539722|FG001|Extension Period|Administrative problems|1|||
48367558|NCT01775124|155539721|FG000|Extension Period|Lost to Follow-up|0|||
48367559|NCT01775124|155539722|FG001|Extension Period|Lost to Follow-up|1|||
48367560|NCT01775124|155539721|FG000|Extension Period|Withdrawal by Subject|9|||
48367561|NCT01775124|155539722|FG001|Extension Period|Withdrawal by Subject|12|||
48367562|NCT01036438|155539723|FG000|Overall Study|Adverse Event|7|||
48367563|NCT01036438|155539724|FG001|Overall Study|Adverse Event|8|||
48367564|NCT01036438|155539723|FG000|Overall Study|Death|0|||
48367565|NCT01036438|155539724|FG001|Overall Study|Death|1|||
48367566|NCT01036438|155539723|FG000|Overall Study|No effect of study treatment|3|||
48367567|NCT01036438|155539724|FG001|Overall Study|No effect of study treatment|1|||
48367568|NCT00888927|155539725|FG000|Overall Study|Adverse Event|0|||
48367569|NCT00888927|155539726|FG001|Overall Study|Adverse Event|0|||
48367570|NCT00888927|155539727|FG002|Overall Study|Adverse Event|0|||
48367571|NCT00888927|155539728|FG003|Overall Study|Adverse Event|1|||
48367572|NCT00888927|155539725|FG000|Overall Study|Withdrawal of consent|0|||
48367573|NCT00888927|155539726|FG001|Overall Study|Withdrawal of consent|0|||
48367574|NCT00888927|155539727|FG002|Overall Study|Withdrawal of consent|0|||
48367575|NCT00888927|155539728|FG003|Overall Study|Withdrawal of consent|1|||
48367576|NCT01993927|155539729|FG000|Overall Study|Case Report Forms Uncollected|18|||
48367577|NCT01993927|155539729|FG000|Overall Study|Protocol Violation|11|||
48367578|NCT05086276|155539730|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
48367579|NCT05086276|155539731|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
48367580|NCT00895154|155539732|FG000|Overall Study|Lost to Follow-up|1|||
48367581|NCT00895154|155539733|FG001|Overall Study|Lost to Follow-up|1|||
48367582|NCT00895154|155539732|FG000|Overall Study|Withdrawal by Subject|0|||
48367583|NCT00895154|155539733|FG001|Overall Study|Withdrawal by Subject|1|||
48367584|NCT01278173|155539734|FG000|Overall Study|Lack of Efficacy|13|||
48367585|NCT01278173|155539734|FG000|Overall Study|Adverse Event|8|||
48367586|NCT01278173|155539734|FG000|Overall Study|Administrative or other reason|4|||
48367587|NCT01278173|155539734|FG000|Overall Study|Protocol Violation|1|||
48367588|NCT01278173|155539734|FG000|Overall Study|Withdrawal by Subject|1|||
48367589|NCT02751320|155539742|FG000|Overall Study|Adverse Event|2|||
48367590|NCT02751320|155539742|FG000|Overall Study|Withdrawal by Subject|1|||
48367591|NCT05017103|155539743|FG000|Overall Study|Death|2|||
48367592|NCT00296400|155539744|FG000|Overall Study|Adverse Event|7|||
48367593|NCT00296400|155539745|FG001|Overall Study|Adverse Event|7|||
48367594|NCT00296400|155539746|FG002|Overall Study|Adverse Event|7|||
48367595|NCT00296400|155539744|FG000|Overall Study|Withdrawal by Subject|5|||
48415064|NCT01309737|155707567|FG003|Week 16 to 52|Lack of Efficacy|25|||
48367596|NCT00296400|155539745|FG001|Overall Study|Withdrawal by Subject|6|||
48367597|NCT00296400|155539746|FG002|Overall Study|Withdrawal by Subject|2|||
48367598|NCT00296400|155539744|FG000|Overall Study|Incorrect enrollment|2|||
48367599|NCT00296400|155539745|FG001|Overall Study|Incorrect enrollment|0|||
48367600|NCT00296400|155539746|FG002|Overall Study|Incorrect enrollment|0|||
48367601|NCT00296400|155539744|FG000|Overall Study|Protocol Violation|1|||
48367602|NCT00296400|155539745|FG001|Overall Study|Protocol Violation|1|||
48367603|NCT00296400|155539746|FG002|Overall Study|Protocol Violation|1|||
48367604|NCT00296400|155539744|FG000|Overall Study|Lost to Follow-up|1|||
48367605|NCT00296400|155539745|FG001|Overall Study|Lost to Follow-up|1|||
48367606|NCT00296400|155539746|FG002|Overall Study|Lost to Follow-up|2|||
48367607|NCT00296400|155539744|FG000|Overall Study|Study specific discontinuation criteria|0|||
48367608|NCT00296400|155539745|FG001|Overall Study|Study specific discontinuation criteria|0|||
48367609|NCT00296400|155539746|FG002|Overall Study|Study specific discontinuation criteria|1|||
48367610|NCT00296400|155539744|FG000|Overall Study|Visit 10 was performed earlier|0|||
48367611|NCT00296400|155539745|FG001|Overall Study|Visit 10 was performed earlier|1|||
48367612|NCT00296400|155539746|FG002|Overall Study|Visit 10 was performed earlier|0|||
48367613|NCT00296400|155539744|FG000|Overall Study|Pregnancy|1|||
48367614|NCT00296400|155539745|FG001|Overall Study|Pregnancy|2|||
48367615|NCT00296400|155539746|FG002|Overall Study|Pregnancy|0|||
48367616|NCT01242800|155539753|FG000|Overall Study|Patient refusal|0|||
48367617|NCT01242800|155539754|FG001|Overall Study|Patient refusal|10|||
48367618|NCT01242800|155539753|FG000|Overall Study|Physician Decision|0|||
48367619|NCT01242800|155539754|FG001|Overall Study|Physician Decision|1|||
48367620|NCT01242800|155539753|FG000|Overall Study|Disease progression|0|||
48367621|NCT01242800|155539754|FG001|Overall Study|Disease progression|3|||
48367622|NCT01242800|155539753|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
48367623|NCT01242800|155539754|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
48367624|NCT01242800|155539753|FG000|Overall Study|Reasons not reported|0|||
48367625|NCT01242800|155539754|FG001|Overall Study|Reasons not reported|4|||
48367626|NCT03683823|155539755|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
48367627|NCT03683823|155539756|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
48367628|NCT03683823|155539755|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
48367629|NCT03683823|155539756|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
48367630|NCT03683823|155539755|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
48367631|NCT03683823|155539756|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
48367632|NCT01262027|155539757|FG000|Overall Study|Adverse Event|1|||
48367633|NCT01262027|155539757|FG000|Overall Study|Withdrawal by Subject|3|||
48367634|NCT01262027|155539757|FG000|Overall Study|Protocol Violation|1|||
48367635|NCT01394978|155539758|FG000|Overall Study|Withdrawal by Subject|2|||
48367636|NCT01394978|155539759|FG001|Overall Study|Withdrawal by Subject|4|||
48367637|NCT01394978|155539758|FG000|Overall Study|Lost to Follow-up|13|||
48367638|NCT01394978|155539759|FG001|Overall Study|Lost to Follow-up|20|||
48367639|NCT01394978|155539758|FG000|Overall Study|Death|6|||
48367640|NCT01394978|155539759|FG001|Overall Study|Death|7|||
48367641|NCT00589121|155539760|FG000|Overall Study|Protocol Violation|2|||
48367642|NCT00589121|155539761|FG001|Overall Study|Protocol Violation|6|||
48367643|NCT00589121|155539760|FG000|Overall Study|No protocol treatment received|0|||
48367644|NCT00589121|155539761|FG001|Overall Study|No protocol treatment received|1|||
48367645|NCT01081132|155539762|FG000|Overall Study|Lack of Efficacy|25|||
48367646|NCT01081132|155539763|FG001|Overall Study|Lack of Efficacy|9|||
48367647|NCT01081132|155539762|FG000|Overall Study|Withdrawal by Subject|13|||
48367648|NCT01081132|155539763|FG001|Overall Study|Withdrawal by Subject|16|||
48367649|NCT01081132|155539762|FG000|Overall Study|Lost to Follow-up|4|||
48367650|NCT01081132|155539763|FG001|Overall Study|Lost to Follow-up|11|||
48367651|NCT01081132|155539762|FG000|Overall Study|Adverse Event|3|||
48367652|NCT01081132|155539763|FG001|Overall Study|Adverse Event|9|||
48367653|NCT01081132|155539762|FG000|Overall Study|Non Compliance|4|||
48367654|NCT01081132|155539763|FG001|Overall Study|Non Compliance|2|||
48367655|NCT01081132|155539762|FG000|Overall Study|Lack Of Compliance|0|||
48367656|NCT01081132|155539763|FG001|Overall Study|Lack Of Compliance|1|||
48367657|NCT01081132|155539762|FG000|Overall Study|Missed Visits|1|||
48367658|NCT01081132|155539763|FG001|Overall Study|Missed Visits|1|||
48367659|NCT01081132|155539762|FG000|Overall Study|Stopped Taking Meds|2|||
48415065|NCT01309737|155707568|FG004|Week 16 to 52|Lack of Efficacy|21|||
48415066|NCT01309737|155707564|FG000|Week 16 to 52|Lost to Follow-up|4|||
48415067|NCT01309737|155707565|FG001|Week 16 to 52|Lost to Follow-up|2|||
48367660|NCT01081132|155539763|FG001|Overall Study|Stopped Taking Meds|0|||
48367661|NCT01081132|155539762|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
48367662|NCT01081132|155539763|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
48367663|NCT01081132|155539762|FG000|Overall Study|Declined Taper Phase|0|||
48367664|NCT01081132|155539763|FG001|Overall Study|Declined Taper Phase|1|||
48367665|NCT01081132|155539762|FG000|Overall Study|Protocol Violation|3|||
48367666|NCT01081132|155539763|FG001|Overall Study|Protocol Violation|1|||
48367667|NCT02297139|155539764|FG000|Overall Study|Disease progression|0|||
48367668|NCT02297139|155539765|FG001|Overall Study|Disease progression|1|||
48367669|NCT02297139|155539764|FG000|Overall Study|Study drug toxicity|0|||
48367670|NCT02297139|155539765|FG001|Overall Study|Study drug toxicity|4|||
48367671|NCT02297139|155539764|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48367672|NCT02297139|155539765|FG001|Overall Study|Participant request to discontinue study treatment|1|||
48367673|NCT02297139|155539764|FG000|Overall Study|Maximum clinical benefit|1|||
48367674|NCT02297139|155539765|FG001|Overall Study|Maximum clinical benefit|0|||
48367675|NCT02297139|155539764|FG000|Overall Study|Administrative reason by sponsor|0|||
48367676|NCT02297139|155539765|FG001|Overall Study|Administrative reason by sponsor|2|||
48367677|NCT02297139|155539764|FG000|Overall Study|Other reasons|0|||
48367678|NCT02297139|155539765|FG001|Overall Study|Other reasons|8|||
48367679|NCT03562975|155539768|FG000|Overall Study|Death|1|||
48367680|NCT03562975|155539768|FG000|Overall Study|Lost to Follow-up|1|||
48367681|NCT03562975|155539768|FG000|Overall Study|Withdrawal by Subject|1|||
48367682|NCT05148962|155539769|FG000|Overall Study|Withdrawal by Subject|1|||
48367683|NCT05148962|155539770|FG001|Overall Study|Withdrawal by Subject|1|||
48367684|NCT05148962|155539771|FG002|Overall Study|Withdrawal by Subject|0|||
48367685|NCT05148962|155539772|FG003|Overall Study|Withdrawal by Subject|1|||
48367686|NCT05148962|155539773|FG004|Overall Study|Withdrawal by Subject|0|||
48367687|NCT05148962|155539769|FG000|Overall Study|Participant was early terminated per protocol|0|||
48367688|NCT05148962|155539770|FG001|Overall Study|Participant was early terminated per protocol|0|||
48367689|NCT05148962|155539771|FG002|Overall Study|Participant was early terminated per protocol|3|||
48367690|NCT05148962|155539772|FG003|Overall Study|Participant was early terminated per protocol|5|||
48367691|NCT05148962|155539773|FG004|Overall Study|Participant was early terminated per protocol|2|||
48367692|NCT05148962|155539769|FG000|Overall Study|Miscellaneous|0|||
48367693|NCT05148962|155539770|FG001|Overall Study|Miscellaneous|0|||
48367694|NCT05148962|155539771|FG002|Overall Study|Miscellaneous|0|||
48367695|NCT05148962|155539772|FG003|Overall Study|Miscellaneous|1|||
48367696|NCT05148962|155539773|FG004|Overall Study|Miscellaneous|0|||
48367697|NCT03141905|155539774|FG000|Overall Study|Death|3|||
48367698|NCT03141905|155539775|FG001|Overall Study|Death|2|||
48367699|NCT03141905|155539774|FG000|Overall Study|Withdrawal by Subject|1|||
48367700|NCT03141905|155539775|FG001|Overall Study|Withdrawal by Subject|0|||
48367701|NCT03141905|155539774|FG000|Overall Study|Lost to Follow-up|3|||
48367702|NCT03141905|155539775|FG001|Overall Study|Lost to Follow-up|7|||
48367703|NCT03141905|155539774|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
48367704|NCT03141905|155539775|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
48367705|NCT00151281|155539776|FG000|Overall Study|Not evaluable|3|||
48367706|NCT05180500|155539777|FG000|Overall Study|Adverse Event|1|||
48367707|NCT05180500|155539778|FG001|Overall Study|Adverse Event|0|||
48367708|NCT05180500|155539777|FG000|Overall Study|Withdrawal by Subject|2|||
48367709|NCT05180500|155539778|FG001|Overall Study|Withdrawal by Subject|0|||
48367710|NCT03668223|155539780|FG000|Overall Study|Death|10|||
48367711|NCT03668223|155539781|FG001|Overall Study|Death|5|||
48367712|NCT03668223|155539780|FG000|Overall Study|Lost to Follow-up|12|||
48367713|NCT03668223|155539781|FG001|Overall Study|Lost to Follow-up|12|||
48367714|NCT03668223|155539780|FG000|Overall Study|Withdrawal by Subject|8|||
48367715|NCT03668223|155539781|FG001|Overall Study|Withdrawal by Subject|3|||
48367716|NCT03465904|155539786|FG000|Overall Study|Withdrawal by Subject|9|||
48367717|NCT03465904|155539787|FG001|Overall Study|Withdrawal by Subject|5|||
48367718|NCT03465904|155539786|FG000|Overall Study|Lost to Follow-up|11|||
48367719|NCT03465904|155539787|FG001|Overall Study|Lost to Follow-up|9|||
48367720|NCT03465904|155539786|FG000|Overall Study|Protocol Violation|20|||
48367721|NCT03465904|155539787|FG001|Overall Study|Protocol Violation|15|||
48367722|NCT03554629|155541772|FG000|Overall Study|Inadequate data|6|||
48367723|NCT02514239|155541773|FG000|Overall Study|Refused to continue trial medication|0|||
48367724|NCT02514239|155541774|FG001|Overall Study|Refused to continue trial medication|0|||
48367725|NCT02514239|155541775|FG002|Overall Study|Refused to continue trial medication|0|||
48367726|NCT02514239|155541776|FG003|Overall Study|Refused to continue trial medication|0|||
48367727|NCT02514239|155541777|FG004|Overall Study|Refused to continue trial medication|0|||
48415068|NCT01309737|155707566|FG002|Week 16 to 52|Lost to Follow-up|0|||
48367728|NCT02514239|155541778|FG005|Overall Study|Refused to continue trial medication|0|||
48367729|NCT02514239|155541779|FG006|Overall Study|Refused to continue trial medication|0|||
48367730|NCT02514239|155541780|FG007|Overall Study|Refused to continue trial medication|0|||
48367731|NCT02514239|155541781|FG008|Overall Study|Refused to continue trial medication|0|||
48367732|NCT02514239|155541782|FG009|Overall Study|Refused to continue trial medication|1|||
48367733|NCT02514239|155541773|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
48367734|NCT02514239|155541774|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
48367735|NCT02514239|155541775|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
48367736|NCT02514239|155541776|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
48367737|NCT02514239|155541777|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
48367738|NCT02514239|155541778|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
48367739|NCT02514239|155541779|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
48367740|NCT02514239|155541780|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
48367741|NCT02514239|155541781|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
48367742|NCT02514239|155541782|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
48367743|NCT02514239|155541773|FG000|Overall Study|Not treated|0|||
48367744|NCT02514239|155541774|FG001|Overall Study|Not treated|1|||
48367745|NCT02514239|155541775|FG002|Overall Study|Not treated|0|||
48367746|NCT02514239|155541776|FG003|Overall Study|Not treated|0|||
48367747|NCT02514239|155541777|FG004|Overall Study|Not treated|0|||
48367748|NCT02514239|155541778|FG005|Overall Study|Not treated|0|||
48367749|NCT02514239|155541779|FG006|Overall Study|Not treated|0|||
48367750|NCT02514239|155541780|FG007|Overall Study|Not treated|0|||
48367751|NCT02514239|155541781|FG008|Overall Study|Not treated|0|||
48367752|NCT02514239|155541782|FG009|Overall Study|Not treated|0|||
48367753|NCT02514239|155541773|FG000|Overall Study|Other Adverse Events|2|||
48367754|NCT02514239|155541774|FG001|Overall Study|Other Adverse Events|0|||
48367755|NCT02514239|155541775|FG002|Overall Study|Other Adverse Events|0|||
48367756|NCT02514239|155541776|FG003|Overall Study|Other Adverse Events|1|||
48367757|NCT02514239|155541777|FG004|Overall Study|Other Adverse Events|0|||
48367758|NCT02514239|155541778|FG005|Overall Study|Other Adverse Events|1|||
48367759|NCT02514239|155541779|FG006|Overall Study|Other Adverse Events|0|||
48367760|NCT02514239|155541780|FG007|Overall Study|Other Adverse Events|1|||
48367761|NCT02514239|155541781|FG008|Overall Study|Other Adverse Events|2|||
48367762|NCT02514239|155541782|FG009|Overall Study|Other Adverse Events|0|||
48367763|NCT02514239|155541773|FG000|Overall Study|Progressive disease|3|||
48367764|NCT02514239|155541774|FG001|Overall Study|Progressive disease|3|||
48367765|NCT02514239|155541775|FG002|Overall Study|Progressive disease|2|||
48367766|NCT02514239|155541776|FG003|Overall Study|Progressive disease|2|||
48367767|NCT02514239|155541777|FG004|Overall Study|Progressive disease|3|||
48367768|NCT02514239|155541778|FG005|Overall Study|Progressive disease|3|||
48367769|NCT02514239|155541779|FG006|Overall Study|Progressive disease|4|||
48367770|NCT02514239|155541780|FG007|Overall Study|Progressive disease|2|||
48367771|NCT02514239|155541781|FG008|Overall Study|Progressive disease|5|||
48367772|NCT02514239|155541782|FG009|Overall Study|Progressive disease|0|||
48367773|NCT02314780|155541783|FG000|Overall Study|organizational reasons|0|||
48367774|NCT02314780|155541784|FG001|Overall Study|organizational reasons|2|||
48367775|NCT02314780|155541785|FG002|Overall Study|organizational reasons|0|||
48367776|NCT02314780|155541783|FG000|Overall Study|Adverse Event|0|||
48367777|NCT02314780|155541784|FG001|Overall Study|Adverse Event|1|||
48367778|NCT02314780|155541785|FG002|Overall Study|Adverse Event|0|||
48367779|NCT00215137|155541786|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
48367780|NCT00215137|155541787|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
48367781|NCT00215137|155541788|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
48367782|NCT00215137|155541786|FG000|Randomization Period|Lost to Follow-up|0|||
48367783|NCT00215137|155541787|FG001|Randomization Period|Lost to Follow-up|1|||
48367784|NCT00215137|155541788|FG002|Randomization Period|Lost to Follow-up|0|||
48367785|NCT00215137|155541786|FG000|Randomization Period|Withdrawal by Subject|0|||
48367786|NCT00215137|155541787|FG001|Randomization Period|Withdrawal by Subject|1|||
48367787|NCT00215137|155541788|FG002|Randomization Period|Withdrawal by Subject|0|||
48367788|NCT00166712|155541791|FG000|Overall Study|Death|0|||
48367789|NCT00166712|155541792|FG001|Overall Study|Death|1|||
48367790|NCT00166712|155541791|FG000|Overall Study|Adverse Event|1|||
48367791|NCT00166712|155541792|FG001|Overall Study|Adverse Event|0|||
48367792|NCT00166712|155541791|FG000|Overall Study|Withdrawal by Subject|1|||
48367793|NCT00166712|155541792|FG001|Overall Study|Withdrawal by Subject|2|||
48367794|NCT00166712|155541791|FG000|Overall Study|Physician Decision|0|||
48367795|NCT00166712|155541792|FG001|Overall Study|Physician Decision|2|||
48367796|NCT04684394|155541793|FG000|Overall Study|Death|1|||
48367797|NCT04684394|155541794|FG001|Overall Study|Death|2|||
48367798|NCT04684394|155541793|FG000|Overall Study|Lost to Follow-up|1|||
48367799|NCT04684394|155541794|FG001|Overall Study|Lost to Follow-up|0|||
48367800|NCT04684394|155541793|FG000|Overall Study|Withdrawal by Subject|2|||
48367801|NCT04684394|155541794|FG001|Overall Study|Withdrawal by Subject|0|||
48367802|NCT04684394|155541793|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
48367803|NCT04684394|155541794|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
48367804|NCT00969709|155541795|FG000|Overall Study|Adverse Event|3|||
48367805|NCT00969709|155541796|FG001|Overall Study|Adverse Event|13|||
48367806|NCT00969709|155541797|FG002|Overall Study|Adverse Event|26|||
48367807|NCT00969709|155541798|FG003|Overall Study|Adverse Event|12|||
48367808|NCT00969709|155541795|FG000|Overall Study|Lack of Efficacy|7|||
48367809|NCT00969709|155541796|FG001|Overall Study|Lack of Efficacy|4|||
48367810|NCT00969709|155541797|FG002|Overall Study|Lack of Efficacy|1|||
48367811|NCT00969709|155541798|FG003|Overall Study|Lack of Efficacy|3|||
48367812|NCT00969709|155541795|FG000|Overall Study|Protocol Violation|9|||
48367813|NCT00969709|155541796|FG001|Overall Study|Protocol Violation|5|||
48367814|NCT00969709|155541797|FG002|Overall Study|Protocol Violation|9|||
48367815|NCT00969709|155541798|FG003|Overall Study|Protocol Violation|10|||
48367816|NCT00969709|155541795|FG000|Overall Study|Withdrawal by Subject|9|||
48367817|NCT00969709|155541796|FG001|Overall Study|Withdrawal by Subject|12|||
48367818|NCT00969709|155541797|FG002|Overall Study|Withdrawal by Subject|11|||
48367819|NCT00969709|155541798|FG003|Overall Study|Withdrawal by Subject|23|||
48367820|NCT00969709|155541795|FG000|Overall Study|Lost to Follow-up|10|||
48367821|NCT00969709|155541796|FG001|Overall Study|Lost to Follow-up|14|||
48367822|NCT00969709|155541797|FG002|Overall Study|Lost to Follow-up|8|||
48367823|NCT00969709|155541798|FG003|Overall Study|Lost to Follow-up|15|||
48367824|NCT00969709|155541795|FG000|Overall Study|Other reasons|0|||
48367825|NCT00969709|155541796|FG001|Overall Study|Other reasons|0|||
48367826|NCT00969709|155541797|FG002|Overall Study|Other reasons|3|||
48367827|NCT00969709|155541798|FG003|Overall Study|Other reasons|0|||
48367828|NCT02980731|155541799|FG000|Overall Study|Death|63|||
48367829|NCT02980731|155541799|FG000|Overall Study|Withdrawal by Subject|6|||
48367830|NCT02980731|155541799|FG000|Overall Study|Lost to Follow-up|5|||
48367831|NCT02980731|155541799|FG000|Overall Study|Study terminated by Sponsor|4|||
48367832|NCT02980731|155541799|FG000|Overall Study|Completed survival follow-up period|65|||
48367833|NCT02980731|155541799|FG000|Overall Study|COVID-19 infection|1|||
48367834|NCT02980731|155541799|FG000|Overall Study|Other, not specified|66|||
48367835|NCT02516332|155541800|FG000|Overall Study|Withdrawal by Subject|2|||
48367836|NCT02516332|155541801|FG001|Overall Study|Withdrawal by Subject|1|||
48367837|NCT02516332|155541802|FG002|Overall Study|Withdrawal by Subject|2|||
48367838|NCT01015560|155541803|FG000|Overall Study|Adverse Event|1|||
48367839|NCT01015560|155541803|FG000|Overall Study|Not protocol specified|1|||
48367840|NCT01015560|155541803|FG000|Overall Study|Withdrawal by Subject|1|||
48367841|NCT00770029|155541806|FG000|Overall Study|Lost to Follow-up|2|||
48367842|NCT00770029|155541807|FG001|Overall Study|Lost to Follow-up|0|||
48367843|NCT00770029|155541806|FG000|Overall Study|Withdrawal by Subject|3|||
48367844|NCT00770029|155541807|FG001|Overall Study|Withdrawal by Subject|3|||
48367845|NCT00770029|155541806|FG000|Overall Study|Adverse Event|1|||
48367846|NCT00770029|155541807|FG001|Overall Study|Adverse Event|0|||
48367847|NCT01789567|155541808|FG000|Overall Study|Death|6|||
48367848|NCT01775475|155541809|FG000|Overall Study|Death|3|||
48367849|NCT01775475|155541810|FG001|Overall Study|Death|3|||
48367850|NCT01994837|155541811|FG000|Overall Study|Progressive disease per protocol|23|||
48367851|NCT01994837|155541811|FG000|Overall Study|Adv event related to progressive disease|3|||
48367852|NCT01994837|155541811|FG000|Overall Study|Fatal progressive disease|2|||
48367853|NCT01994837|155541811|FG000|Overall Study|Adverse event not related to progression|1|||
48367854|NCT01994837|155541811|FG000|Overall Study|Chose palliative care|1|||
48367855|NCT01994837|155541811|FG000|Overall Study|Proceeded to transplant|1|||
48367856|NCT01994837|155541811|FG000|Overall Study|Removed from study due to no response|1|||
48367857|NCT03446781|155541812|FG000|Overall Study|Lost to Follow-up|11|||
48367858|NCT03446781|155541813|FG001|Overall Study|Lost to Follow-up|5|||
48367859|NCT03446781|155541812|FG000|Overall Study|Withdrawal by Subject|9|||
48367860|NCT03446781|155541813|FG001|Overall Study|Withdrawal by Subject|7|||
48367861|NCT03446781|155541812|FG000|Overall Study|Adverse Event|8|||
48367862|NCT03446781|155541813|FG001|Overall Study|Adverse Event|2|||
48367863|NCT03446781|155541812|FG000|Overall Study|Protocol Violation|0|||
48367864|NCT03446781|155541813|FG001|Overall Study|Protocol Violation|3|||
48367865|NCT03651622|155541823|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
48367866|NCT03651622|155541824|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
48367867|NCT03651622|155541825|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
48367868|NCT03651622|155541823|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
48367869|NCT03651622|155541824|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
48367870|NCT03651622|155541825|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
48367871|NCT03651622|155541823|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
48367872|NCT03651622|155541824|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
48367873|NCT03651622|155541825|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
48367874|NCT03651622|155541823|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
48367875|NCT03651622|155541824|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
48367876|NCT03651622|155541825|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
48367877|NCT03651622|155541823|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
48367878|NCT03651622|155541824|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
48367879|NCT03651622|155541825|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
48367880|NCT01253304|155541826|FG000|Overall Study|Adverse Event|0|||
48367881|NCT01253304|155541827|FG001|Overall Study|Adverse Event|0|||
48367882|NCT01253304|155541828|FG002|Overall Study|Adverse Event|0|||
48367883|NCT01253304|155541829|FG003|Overall Study|Adverse Event|1|||
48367884|NCT01327495|155541830|FG000|Overall Study|Adverse Event|2|||
48367885|NCT01327495|155541831|FG001|Overall Study|Adverse Event|1|||
48367886|NCT01327495|155541832|FG002|Overall Study|Adverse Event|1|||
48367887|NCT01327495|155541833|FG003|Overall Study|Adverse Event|0|||
48367888|NCT01327495|155541834|FG004|Overall Study|Adverse Event|0|||
48367889|NCT01327495|155541835|FG005|Overall Study|Adverse Event|2|||
48367890|NCT01327495|155541830|FG000|Overall Study|Withdrawal by Subject|0|||
48367891|NCT01327495|155541831|FG001|Overall Study|Withdrawal by Subject|1|||
48367892|NCT01327495|155541832|FG002|Overall Study|Withdrawal by Subject|1|||
48367893|NCT01327495|155541833|FG003|Overall Study|Withdrawal by Subject|0|||
48367894|NCT01327495|155541834|FG004|Overall Study|Withdrawal by Subject|1|||
48367895|NCT01327495|155541835|FG005|Overall Study|Withdrawal by Subject|0|||
48367896|NCT01327495|155541830|FG000|Overall Study|Physician Decision|0|||
48367897|NCT01327495|155541831|FG001|Overall Study|Physician Decision|0|||
48367898|NCT01327495|155541832|FG002|Overall Study|Physician Decision|0|||
48367899|NCT01327495|155541833|FG003|Overall Study|Physician Decision|0|||
48367900|NCT01327495|155541834|FG004|Overall Study|Physician Decision|2|||
48367901|NCT01327495|155541835|FG005|Overall Study|Physician Decision|0|||
48367902|NCT00307684|155541839|FG000|Open Label Phase|Lack of Efficacy|0|||
48367903|NCT00307684|155541840|FG001|Open Label Phase|Lack of Efficacy|0|||
48367904|NCT00307684|155541841|FG002|Open Label Phase|Lack of Efficacy|3|||
48367905|NCT00307684|155541839|FG000|Open Label Phase|Adverse Event|0|||
48367906|NCT00307684|155541840|FG001|Open Label Phase|Adverse Event|0|||
48367907|NCT00307684|155541841|FG002|Open Label Phase|Adverse Event|16|||
48367908|NCT00307684|155541839|FG000|Open Label Phase|Withdrawal by Subject|0|||
48367909|NCT00307684|155541840|FG001|Open Label Phase|Withdrawal by Subject|0|||
48367910|NCT00307684|155541841|FG002|Open Label Phase|Withdrawal by Subject|15|||
48367911|NCT00307684|155541839|FG000|Open Label Phase|Lost to Follow-up|0|||
48367912|NCT00307684|155541840|FG001|Open Label Phase|Lost to Follow-up|0|||
48367913|NCT00307684|155541841|FG002|Open Label Phase|Lost to Follow-up|11|||
48367914|NCT00307684|155541839|FG000|Open Label Phase|non compliance|0|||
48367915|NCT00307684|155541840|FG001|Open Label Phase|non compliance|0|||
48367916|NCT00307684|155541841|FG002|Open Label Phase|non compliance|5|||
48367917|NCT00307684|155541839|FG000|Open Label Phase|other|0|||
48367918|NCT00307684|155541840|FG001|Open Label Phase|other|0|||
48367919|NCT00307684|155541841|FG002|Open Label Phase|other|6|||
48367920|NCT00307684|155541839|FG000|Double Blind Phase|Lack of Efficacy|2|||
48367921|NCT00307684|155541840|FG001|Double Blind Phase|Lack of Efficacy|5|||
48367922|NCT00307684|155541841|FG002|Double Blind Phase|Lack of Efficacy|0|||
48367923|NCT01699503|155541842|FG000|Overall Study|Death|31|||
48367924|NCT01699503|155541843|FG001|Overall Study|Death|40|||
48367925|NCT01699503|155541842|FG000|Overall Study|Withdrawal by Subject|65|||
48367926|NCT01699503|155541843|FG001|Overall Study|Withdrawal by Subject|57|||
48367927|NCT01699503|155541842|FG000|Overall Study|Lost to Follow-up|121|||
48367928|NCT01699503|155541843|FG001|Overall Study|Lost to Follow-up|117|||
48367929|NCT01699503|155541842|FG000|Overall Study|Excluded due to quality|783|||
48367930|NCT01699503|155541843|FG001|Overall Study|Excluded due to quality|791|||
48367931|NCT02580305|155541844|FG000|Overall Study|Adverse Event|15|||
48367932|NCT02580305|155541845|FG001|Overall Study|Adverse Event|19|||
48367933|NCT02580305|155541846|FG002|Overall Study|Adverse Event|10|||
48367934|NCT02580305|155541844|FG000|Overall Study|Lack of Efficacy|5|||
48367935|NCT02580305|155541845|FG001|Overall Study|Lack of Efficacy|0|||
48367936|NCT02580305|155541846|FG002|Overall Study|Lack of Efficacy|2|||
48367937|NCT02580305|155541844|FG000|Overall Study|Protocol Violation|4|||
48367938|NCT02580305|155541845|FG001|Overall Study|Protocol Violation|9|||
48367939|NCT02580305|155541846|FG002|Overall Study|Protocol Violation|6|||
48367940|NCT02580305|155541844|FG000|Overall Study|Lost to Follow-up|4|||
48367941|NCT02580305|155541845|FG001|Overall Study|Lost to Follow-up|4|||
48367942|NCT02580305|155541846|FG002|Overall Study|Lost to Follow-up|2|||
48367943|NCT02580305|155541844|FG000|Overall Study|Withdrawal by Subject|11|||
48367944|NCT02580305|155541845|FG001|Overall Study|Withdrawal by Subject|9|||
48367945|NCT02580305|155541846|FG002|Overall Study|Withdrawal by Subject|7|||
48367946|NCT02580305|155541844|FG000|Overall Study|Randomized in error and never treated|4|||
48367947|NCT02580305|155541845|FG001|Overall Study|Randomized in error and never treated|8|||
48367948|NCT02580305|155541846|FG002|Overall Study|Randomized in error and never treated|5|||
48367949|NCT00006011|155541849|FG000|Overall Study|Disease progression|13|||
48367950|NCT00006011|155541850|FG001|Overall Study|Disease progression|6|||
48367951|NCT00006011|155541851|FG002|Overall Study|Disease progression|26|||
48367952|NCT00006011|155541849|FG000|Overall Study|Refused further treatment|15|||
48367953|NCT00006011|155541850|FG001|Overall Study|Refused further treatment|13|||
48367954|NCT00006011|155541851|FG002|Overall Study|Refused further treatment|26|||
48367955|NCT00006011|155541849|FG000|Overall Study|Adverse Event|15|||
48367956|NCT00006011|155541850|FG001|Overall Study|Adverse Event|39|||
48367957|NCT00006011|155541851|FG002|Overall Study|Adverse Event|5|||
48367958|NCT00006011|155541849|FG000|Overall Study|Death|0|||
48367959|NCT00006011|155541850|FG001|Overall Study|Death|1|||
48367960|NCT00006011|155541851|FG002|Overall Study|Death|2|||
48367961|NCT00006011|155541849|FG000|Overall Study|Other|4|||
48367962|NCT00006011|155541850|FG001|Overall Study|Other|2|||
48367963|NCT00006011|155541851|FG002|Overall Study|Other|5|||
48367964|NCT00006011|155541849|FG000|Overall Study|Ineligible|18|||
48367965|NCT00006011|155541850|FG001|Overall Study|Ineligible|16|||
48367966|NCT00006011|155541851|FG002|Overall Study|Ineligible|9|||
48367967|NCT01888900|155541854|FG000|Overall Study|failed treatment|0|||
48367968|NCT01888900|155541855|FG001|Overall Study|failed treatment|2|||
48367969|NCT01639560|155541856|FG000|Overall Study|Withdrawal by Subject|9|||
48367970|NCT01639560|155541857|FG001|Overall Study|Withdrawal by Subject|14|||
48367971|NCT01639560|155541856|FG000|Overall Study|Lack of Efficacy|1|||
48367972|NCT01639560|155541857|FG001|Overall Study|Lack of Efficacy|2|||
48367973|NCT01639560|155541856|FG000|Overall Study|Lost to Follow-up|9|||
48367974|NCT01639560|155541857|FG001|Overall Study|Lost to Follow-up|11|||
48367975|NCT01639560|155541856|FG000|Overall Study|Adverse Event|0|||
48367976|NCT01639560|155541857|FG001|Overall Study|Adverse Event|2|||
48367977|NCT03932812|155541861|FG000|Overall Study|Lost to Follow-up|12|||
48367978|NCT03932812|155541862|FG001|Overall Study|Lost to Follow-up|14|||
48367979|NCT03932812|155541861|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
48367980|NCT03932812|155541862|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
48367981|NCT01859988|155541865|FG000|Overall Study|Withdrawal by Subject|6|||
48367982|NCT01859988|155541866|FG001|Overall Study|Withdrawal by Subject|3|||
48367983|NCT01859988|155541867|FG002|Overall Study|Withdrawal by Subject|4|||
48367984|NCT01859988|155541868|FG003|Overall Study|Withdrawal by Subject|3|||
48367985|NCT01859988|155541869|FG004|Overall Study|Withdrawal by Subject|2|||
48367986|NCT01859988|155541870|FG005|Overall Study|Withdrawal by Subject|2|||
48367987|NCT01859988|155541865|FG000|Overall Study|Lack of Efficacy|1|||
48367988|NCT01859988|155541866|FG001|Overall Study|Lack of Efficacy|1|||
48367989|NCT01859988|155541867|FG002|Overall Study|Lack of Efficacy|5|||
48367990|NCT01859988|155541868|FG003|Overall Study|Lack of Efficacy|0|||
48367991|NCT01859988|155541869|FG004|Overall Study|Lack of Efficacy|7|||
48367992|NCT01859988|155541870|FG005|Overall Study|Lack of Efficacy|9|||
48367993|NCT01859988|155541865|FG000|Overall Study|Physician Decision|1|||
48367994|NCT01859988|155541866|FG001|Overall Study|Physician Decision|3|||
48367995|NCT01859988|155541867|FG002|Overall Study|Physician Decision|1|||
48367996|NCT01859988|155541868|FG003|Overall Study|Physician Decision|3|||
48367997|NCT01859988|155541869|FG004|Overall Study|Physician Decision|4|||
48367998|NCT01859988|155541870|FG005|Overall Study|Physician Decision|1|||
48367999|NCT01859988|155541865|FG000|Overall Study|Adverse Event|2|||
48368000|NCT01859988|155541866|FG001|Overall Study|Adverse Event|1|||
48368001|NCT01859988|155541867|FG002|Overall Study|Adverse Event|3|||
48368002|NCT01859988|155541868|FG003|Overall Study|Adverse Event|1|||
48368003|NCT01859988|155541869|FG004|Overall Study|Adverse Event|2|||
48368004|NCT01859988|155541870|FG005|Overall Study|Adverse Event|2|||
48368005|NCT01859988|155541865|FG000|Overall Study|Lost to Follow-up|1|||
48368006|NCT01859988|155541866|FG001|Overall Study|Lost to Follow-up|2|||
48368007|NCT01859988|155541867|FG002|Overall Study|Lost to Follow-up|3|||
48368008|NCT01859988|155541868|FG003|Overall Study|Lost to Follow-up|0|||
48368009|NCT01859988|155541869|FG004|Overall Study|Lost to Follow-up|3|||
48368010|NCT01859988|155541870|FG005|Overall Study|Lost to Follow-up|2|||
48368011|NCT01859988|155541865|FG000|Overall Study|Protocol Violation|0|||
48368012|NCT01859988|155541866|FG001|Overall Study|Protocol Violation|0|||
48368013|NCT01859988|155541867|FG002|Overall Study|Protocol Violation|1|||
48368014|NCT01859988|155541868|FG003|Overall Study|Protocol Violation|0|||
48368015|NCT01859988|155541869|FG004|Overall Study|Protocol Violation|0|||
48368016|NCT01859988|155541870|FG005|Overall Study|Protocol Violation|0|||
48368017|NCT01859988|155541865|FG000|Overall Study|Other than specified above|0|||
48368018|NCT01859988|155541866|FG001|Overall Study|Other than specified above|2|||
48368019|NCT01859988|155541867|FG002|Overall Study|Other than specified above|11|||
48368020|NCT01859988|155541868|FG003|Overall Study|Other than specified above|3|||
48368021|NCT01859988|155541869|FG004|Overall Study|Other than specified above|5|||
48368022|NCT01859988|155541870|FG005|Overall Study|Other than specified above|3|||
48368023|NCT03292432|155541872|FG000|Overall Study|Lost to Follow-up|11|||
48368024|NCT03292432|155541873|FG001|Overall Study|Lost to Follow-up|8|||
48368025|NCT03292432|155541872|FG000|Overall Study|Death|2|||
48368026|NCT03292432|155541873|FG001|Overall Study|Death|1|||
48368027|NCT03292432|155541872|FG000|Overall Study|Withdrawal by Subject|1|||
48368028|NCT03292432|155541873|FG001|Overall Study|Withdrawal by Subject|2|||
48368029|NCT03292432|155541872|FG000|Overall Study|Site closed before any data collected|1|||
48368030|NCT03292432|155541873|FG001|Overall Study|Site closed before any data collected|0|||
48368031|NCT01844687|155541874|FG000|Visit 1|Protocol Violation|3|||
48368032|NCT01844687|155541874|FG000|Visit 1|Lost to Follow-up|5|||
48368033|NCT01844687|155541874|FG000|Visit 2|Withdrawal by Subject|1|||
48368034|NCT01844687|155541874|FG000|Visit 2|Protocol Violation|1|||
48368035|NCT01844687|155541874|FG000|Visit 3|Lost to Follow-up|1|||
48368036|NCT01844687|155541874|FG000|Visit 3|Withdrawal by Subject|3|||
48368037|NCT01844687|155541874|FG000|Visit 3|child care problems|1|||
48368038|NCT01844687|155541874|FG000|Visit 4|Pregnancy|1|||
48368039|NCT01844687|155541874|FG000|Visit 4|Lost to Follow-up|1|||
48368040|NCT01844687|155541874|FG000|Visit 4|Withdrawal by Subject|2|||
48368041|NCT01871805|155541878|FG000|Phase I|Death|7|||
48368042|NCT01871805|155541879|FG001|Phase I|Death|4|||
48368043|NCT01871805|155541880|FG002|Phase I|Death|6|||
48368044|NCT01871805|155541881|FG003|Phase I|Death|2|||
48368045|NCT01871805|155541882|FG004|Phase I|Death|9|||
48368046|NCT01871805|155541883|FG005|Phase I|Death|0|||
48368047|NCT01871805|155541878|FG000|Phase I|Alive in Survival Follow-up|0|||
48368048|NCT01871805|155541879|FG001|Phase I|Alive in Survival Follow-up|2|||
48368049|NCT01871805|155541880|FG002|Phase I|Alive in Survival Follow-up|4|||
48368050|NCT01871805|155541881|FG003|Phase I|Alive in Survival Follow-up|5|||
48368051|NCT01871805|155541882|FG004|Phase I|Alive in Survival Follow-up|4|||
48368052|NCT01871805|155541883|FG005|Phase I|Alive in Survival Follow-up|0|||
48368053|NCT01871805|155541878|FG000|Phase I|Lost to Follow-up|0|||
48368054|NCT01871805|155541879|FG001|Phase I|Lost to Follow-up|1|||
48368055|NCT01871805|155541880|FG002|Phase I|Lost to Follow-up|3|||
48368056|NCT01871805|155541881|FG003|Phase I|Lost to Follow-up|0|||
48368057|NCT01871805|155541882|FG004|Phase I|Lost to Follow-up|0|||
48368058|NCT01871805|155541883|FG005|Phase I|Lost to Follow-up|0|||
48368059|NCT01871805|155541878|FG000|Phase II|Death|0|||
48368060|NCT01871805|155541879|FG001|Phase II|Death|0|||
48368061|NCT01871805|155541880|FG002|Phase II|Death|0|||
48368062|NCT01871805|155541881|FG003|Phase II|Death|0|||
48368063|NCT01871805|155541882|FG004|Phase II|Death|0|||
48368064|NCT01871805|155541883|FG005|Phase II|Death|45|||
48368065|NCT01871805|155541878|FG000|Phase II|Alive in Survival Follow-up|0|||
48368066|NCT01871805|155541879|FG001|Phase II|Alive in Survival Follow-up|0|||
48368067|NCT01871805|155541880|FG002|Phase II|Alive in Survival Follow-up|0|||
48368068|NCT01871805|155541881|FG003|Phase II|Alive in Survival Follow-up|0|||
48368069|NCT01871805|155541882|FG004|Phase II|Alive in Survival Follow-up|0|||
48368070|NCT01871805|155541883|FG005|Phase II|Alive in Survival Follow-up|29|||
48368071|NCT01871805|155541878|FG000|Phase II|Lost to Follow-up|0|||
48368072|NCT01871805|155541879|FG001|Phase II|Lost to Follow-up|0|||
48368073|NCT01871805|155541880|FG002|Phase II|Lost to Follow-up|0|||
48368074|NCT01871805|155541881|FG003|Phase II|Lost to Follow-up|0|||
48368075|NCT01871805|155541882|FG004|Phase II|Lost to Follow-up|0|||
48368076|NCT01871805|155541883|FG005|Phase II|Lost to Follow-up|13|||
48368077|NCT00564889|155541884|FG000|Overall Study|Death|7|||
48368078|NCT00564889|155541884|FG000|Overall Study|Adverse Event|12|||
48368079|NCT00564889|155541884|FG000|Overall Study|Alternative treatment|3|||
48368080|NCT00564889|155541884|FG000|Overall Study|Disease progression|3|||
48368081|NCT00564889|155541884|FG000|Overall Study|Other, not specified|4|||
48368082|NCT04510090|155541885|FG000|FE-HS|Withdrawal by Subject|0|||
48368083|NCT04510090|155541886|FG001|FE-HS|Withdrawal by Subject|0|||
48368084|NCT04510090|155541887|FG002|FE-HS|Withdrawal by Subject|0|||
48368085|NCT04510090|155541888|FG003|FE-HS|Withdrawal by Subject|0|||
48368086|NCT04510090|155541889|FG004|FE-HS|Withdrawal by Subject|1|||
48368087|NCT04510090|155541890|FG005|FE-HS|Withdrawal by Subject|0|||
48368088|NCT04510090|155541891|FG006|FE-HS|Withdrawal by Subject|0|||
48368089|NCT04510090|155541892|FG007|FE-HS|Withdrawal by Subject|0|||
48368090|NCT03412747|155541893|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
48368091|NCT03412747|155541894|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
48368092|NCT03412747|155541895|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
48368093|NCT03412747|155541893|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
48368094|NCT03412747|155541894|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
48368095|NCT03412747|155541895|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
48368096|NCT03412747|155541893|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
48368097|NCT03412747|155541894|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
48368098|NCT03412747|155541895|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
48368099|NCT03412747|155541893|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
48368100|NCT03412747|155541894|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
48368101|NCT03412747|155541895|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
48368102|NCT03412747|155541893|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
48368103|NCT03412747|155541894|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
48368104|NCT03412747|155541895|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
48368105|NCT03412747|155541893|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
48368106|NCT03412747|155541894|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
48368107|NCT03412747|155541895|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
48368108|NCT03412747|155541893|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
48368109|NCT03412747|155541894|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
48368110|NCT03412747|155541895|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
48368111|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
48368112|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
48368113|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
48368114|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
48368115|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
48368116|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
48368117|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
48368118|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
48368119|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
48368120|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
48368121|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
48368122|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
48368123|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
48368124|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
48368125|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
48368126|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
48368127|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
48368128|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
48415069|NCT01309737|155707567|FG003|Week 16 to 52|Lost to Follow-up|1|||
48368129|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
48368130|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
48368131|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
48368132|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
48368133|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
48368134|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
48368135|NCT03412747|155541893|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
48368136|NCT03412747|155541894|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
48368137|NCT03412747|155541895|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
48368138|NCT02075073|155541896|FG000|Overall Study|Withdrawal by Subject|0|||
48368139|NCT02075073|155541897|FG001|Overall Study|Withdrawal by Subject|1|||
48368140|NCT02075073|155541898|FG002|Overall Study|Withdrawal by Subject|0|||
48368141|NCT00958841|155541899|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48368142|NCT00958841|155541899|FG000|Overall Study|Abnormal test procedure result(s)|3|||
48368143|NCT00958841|155541899|FG000|Overall Study|Administrative problems|1|||
48368144|NCT00958841|155541899|FG000|Overall Study|Adverse Event|8|||
48368145|NCT00958841|155541899|FG000|Overall Study|New cancer therapy|5|||
48368146|NCT00958841|155541899|FG000|Overall Study|Withdrawal by Subject|1|||
48368147|NCT00958841|155541899|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
48368148|NCT00958841|155541899|FG000|Overall Study|Completed M6/did not enter extension|27|||
48368149|NCT00958841|155541899|FG000|Overall Study|Discontinued prior to M*|28|||
48368150|NCT01125514|155541903|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
48368151|NCT01125514|155541903|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
48368152|NCT01125514|155541903|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
48368153|NCT01125514|155541903|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
48368154|NCT01125514|155541903|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
48368155|NCT01125514|155541903|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
48368156|NCT00858364|155541904|FG000|Overall Study|Administrative Decision|3|||
48368157|NCT00858364|155541905|FG001|Overall Study|Administrative Decision|2|||
48368158|NCT00858364|155541904|FG000|Overall Study|Adverse Event|5|||
48368159|NCT00858364|155541905|FG001|Overall Study|Adverse Event|2|||
48368160|NCT00858364|155541904|FG000|Overall Study|Withdrawal by Subject|44|||
48368161|NCT00858364|155541905|FG001|Overall Study|Withdrawal by Subject|118|||
48368162|NCT00858364|155541904|FG000|Overall Study|Ineligibility Determined|1|||
48368163|NCT00858364|155541905|FG001|Overall Study|Ineligibility Determined|10|||
48368164|NCT00858364|155541904|FG000|Overall Study|Lost to Follow-up|24|||
48368165|NCT00858364|155541905|FG001|Overall Study|Lost to Follow-up|54|||
48368166|NCT00858364|155541904|FG000|Overall Study|Noncompliance|3|||
48368167|NCT00858364|155541905|FG001|Overall Study|Noncompliance|4|||
48368168|NCT00858364|155541904|FG000|Overall Study|Protocol Deviation|0|||
48368169|NCT00858364|155541905|FG001|Overall Study|Protocol Deviation|2|||
48368170|NCT00858364|155541904|FG000|Overall Study|Other|9|||
48368171|NCT00858364|155541905|FG001|Overall Study|Other|17|||
48368172|NCT00858364|155541904|FG000|Overall Study|Missing|1|||
48368173|NCT00858364|155541905|FG001|Overall Study|Missing|1|||
48368174|NCT00858364|155541904|FG000|Overall Study|Still on-study|114|||
48368175|NCT00858364|155541905|FG001|Overall Study|Still on-study|247|||
48368176|NCT03980808|155541906|FG000|Overall Study|Lost to Follow-up|2|||
48368177|NCT03980808|155541907|FG001|Overall Study|Lost to Follow-up|2|||
48368178|NCT01806623|155541909|FG000|Overall Study|Withdrawal by Subject|1|||
48368179|NCT01806623|155541909|FG000|Overall Study|Adverse Event|1|||
48368180|NCT01806623|155541909|FG000|Overall Study|Did not meet the inclusion criteria|56|||
48368181|NCT01451827|155541911|FG000|Overall Study|Adverse Event|2|||
48368182|NCT01451827|155541912|FG001|Overall Study|Adverse Event|0|||
48368183|NCT01451827|155541913|FG002|Overall Study|Adverse Event|1|||
48368184|NCT01451827|155541914|FG003|Overall Study|Adverse Event|1|||
48368185|NCT01451827|155541911|FG000|Overall Study|Protocol deviation|1|||
48368186|NCT01451827|155541912|FG001|Overall Study|Protocol deviation|0|||
48368187|NCT01451827|155541913|FG002|Overall Study|Protocol deviation|0|||
48368188|NCT01451827|155541914|FG003|Overall Study|Protocol deviation|0|||
48368189|NCT01451827|155541911|FG000|Overall Study|Lost to Follow-up|0|||
48368190|NCT01451827|155541912|FG001|Overall Study|Lost to Follow-up|3|||
48368191|NCT01451827|155541913|FG002|Overall Study|Lost to Follow-up|0|||
48368192|NCT01451827|155541914|FG003|Overall Study|Lost to Follow-up|2|||
48368193|NCT01451827|155541911|FG000|Overall Study|Participant met withdrawal criteria|0|||
48368194|NCT01451827|155541912|FG001|Overall Study|Participant met withdrawal criteria|2|||
48368195|NCT01451827|155541913|FG002|Overall Study|Participant met withdrawal criteria|0|||
48368196|NCT01451827|155541914|FG003|Overall Study|Participant met withdrawal criteria|0|||
48368197|NCT01451827|155541911|FG000|Overall Study|Withdrawal by Subject|0|||
48368198|NCT01451827|155541912|FG001|Overall Study|Withdrawal by Subject|0|||
48368199|NCT01451827|155541913|FG002|Overall Study|Withdrawal by Subject|1|||
48368200|NCT01451827|155541914|FG003|Overall Study|Withdrawal by Subject|1|||
48368201|NCT01964924|155541915|FG000|Trametinib Monotherapy|Progression|19|||
48368202|NCT01964924|155541916|FG001|Trametinib Monotherapy|Progression|0|||
48368203|NCT02601300|155541918|FG000|Induction Phase|Lack of Efficacy|2|||
48368204|NCT02601300|155541918|FG000|Induction Phase|Protocol Violation|1|||
48368205|NCT02601300|155541918|FG000|Extension Phase|Withdrawal by Subject|3|||
48368206|NCT02601300|155541918|FG000|Extension Phase|Adverse Event|4|||
48368207|NCT02601300|155541918|FG000|Extension Phase|Lack of Efficacy|10|||
48368208|NCT02232243|155541920|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
48368209|NCT02232243|155541921|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
48368210|NCT02232243|155541922|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
48368211|NCT01679405|155541928|FG000|Overall Study|Death|2|||
48368212|NCT01679405|155541929|FG001|Overall Study|Death|5|||
48368213|NCT00658788|155541930|FG000|Overall Study|Adverse Event|11|||
48368214|NCT00658788|155541930|FG000|Overall Study|Withdrawal by Subject|13|||
48368215|NCT00658788|155541930|FG000|Overall Study|Lost to Follow-up|18|||
48368216|NCT00658788|155541930|FG000|Overall Study|Treatment Discontinuation|32|||
48368217|NCT00653523|155541931|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
48368218|NCT00653523|155541931|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
48368219|NCT00653523|155541931|FG000|Overall Study|Adverse Event|7|||
48368220|NCT00653523|155541931|FG000|Overall Study|Withdrawal by Subject|6|||
48368221|NCT00653523|155541931|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
48368222|NCT00653523|155541931|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
48368223|NCT00529958|155541932|FG000|2-Year Follow-up|Lost to Follow-up|1|||
48368224|NCT00529958|155541933|FG001|2-Year Follow-up|Lost to Follow-up|2|||
48368225|NCT00529958|155541934|FG002|2-Year Follow-up|Lost to Follow-up|2|||
48368226|NCT00529958|155541932|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
48368227|NCT00529958|155541933|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
48368228|NCT00529958|155541934|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
48368229|NCT00529958|155541932|FG000|5-Year Follow-up|Lost to Follow-up|2|||
48368230|NCT00529958|155541933|FG001|5-Year Follow-up|Lost to Follow-up|3|||
48368231|NCT00529958|155541934|FG002|5-Year Follow-up|Lost to Follow-up|1|||
48368232|NCT00529958|155541932|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
48368233|NCT00529958|155541933|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
48368234|NCT00529958|155541934|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
48368235|NCT04227704|155541935|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
48368236|NCT04227704|155541936|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
48368237|NCT04227704|155541937|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
48368238|NCT04227704|155541935|FG000|Overall Study|due to C/S being cancelled|1|||
48368239|NCT04227704|155541936|FG001|Overall Study|due to C/S being cancelled|0|||
48368240|NCT04227704|155541937|FG002|Overall Study|due to C/S being cancelled|0|||
48368241|NCT03319849|155541944|FG000|Overall Study|Adverse Event|1|||
48368242|NCT03319849|155541945|FG001|Overall Study|Adverse Event|0|||
48368243|NCT03319849|155541944|FG000|Overall Study|Physician Decision|0|||
48368244|NCT03319849|155541945|FG001|Overall Study|Physician Decision|1|||
48368245|NCT03319849|155541944|FG000|Overall Study|Withdrawal by Subject|0|||
48368246|NCT03319849|155541945|FG001|Overall Study|Withdrawal by Subject|1|||
48368247|NCT03319849|155541944|FG000|Overall Study|COVID-19|0|||
48368248|NCT03319849|155541945|FG001|Overall Study|COVID-19|1|||
48368249|NCT03319849|155541944|FG000|Overall Study|Other|1|||
48368250|NCT03319849|155541945|FG001|Overall Study|Other|2|||
48368251|NCT03319849|155541944|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
48368252|NCT03319849|155541945|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
48368253|NCT03319849|155541944|FG000|Overall Study|Lost to Follow-up|0|||
48368254|NCT03319849|155541945|FG001|Overall Study|Lost to Follow-up|2|||
48368255|NCT05559476|155541948|FG000|Overall Study|Adverse Event|2|||
48368256|NCT05559476|155541949|FG001|Overall Study|Adverse Event|0|||
48368257|NCT05559476|155541948|FG000|Overall Study|Lost to Follow-up|13|||
48368258|NCT05559476|155541949|FG001|Overall Study|Lost to Follow-up|12|||
48368259|NCT05559476|155541948|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
48368260|NCT05559476|155541949|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
48368261|NCT05559476|155541948|FG000|Overall Study|Other|0|||
48368262|NCT05559476|155541949|FG001|Overall Study|Other|2|||
48368263|NCT01307579|155541950|FG000|Overall Study|Death|3|||
48368264|NCT01307579|155541951|FG001|Overall Study|Death|6|||
48368265|NCT01307579|155541950|FG000|Overall Study|Physician Decision|26|||
48368266|NCT01307579|155541951|FG001|Overall Study|Physician Decision|29|||
48368267|NCT01307579|155541950|FG000|Overall Study|Withdrawal by Subject|7|||
48368268|NCT01307579|155541951|FG001|Overall Study|Withdrawal by Subject|3|||
48368269|NCT01307579|155541950|FG000|Overall Study|Institutional diagnosis of IFD|21|||
48368270|NCT01307579|155541951|FG001|Overall Study|Institutional diagnosis of IFD|36|||
48368271|NCT01307579|155541950|FG000|Overall Study|Begin conditioning for HSCT|42|||
48368272|NCT01307579|155541951|FG001|Overall Study|Begin conditioning for HSCT|44|||
48368273|NCT01307579|155541950|FG000|Overall Study|Refractory or relapsed AML|38|||
48368274|NCT01307579|155541951|FG001|Overall Study|Refractory or relapsed AML|23|||
48368275|NCT01307579|155541950|FG000|Overall Study|Ineligible|3|||
48368276|NCT01307579|155541951|FG001|Overall Study|Ineligible|4|||
48368277|NCT00565851|155543250|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
48415070|NCT01309737|155707568|FG004|Week 16 to 52|Lost to Follow-up|4|||
48368278|NCT00565851|155543251|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
48368279|NCT00565851|155543252|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
48368280|NCT00565851|155543253|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
48368281|NCT00565851|155543254|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
48368282|NCT00565851|155543255|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
48368283|NCT00565851|155543256|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
48368284|NCT00565851|155543257|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
48368285|NCT00565851|155543250|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
48368286|NCT00565851|155543251|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
48368287|NCT00565851|155543252|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
48368288|NCT00565851|155543253|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
48368289|NCT00565851|155543254|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
48368290|NCT00565851|155543255|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
48368291|NCT00565851|155543256|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
48368292|NCT00565851|155543257|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
48368293|NCT01076153|155543261|FG000|Overall Study|Symptoms improved/resolved|10|||
48368294|NCT01076153|155543261|FG000|Overall Study|Adverse Event|1|||
48368295|NCT00503139|155543262|FG000|Overall Study|Case Report Forms were not collected|4|||
48368296|NCT00503139|155543262|FG000|Overall Study|Protocol Violation|4|||
48368297|NCT02914275|155543263|FG000|Overall Study|Lost to Follow-up|84|||
48368298|NCT02914275|155543264|FG001|Overall Study|Lost to Follow-up|29|||
48368299|NCT02914275|155543263|FG000|Overall Study|Withdrawal by Subject|26|||
48368300|NCT02914275|155543264|FG001|Overall Study|Withdrawal by Subject|10|||
48368301|NCT02914275|155543263|FG000|Overall Study|Protocol Violation|1|||
48368302|NCT02914275|155543264|FG001|Overall Study|Protocol Violation|1|||
48368303|NCT02914275|155543263|FG000|Overall Study|Physician Decision|3|||
48368304|NCT02914275|155543264|FG001|Overall Study|Physician Decision|1|||
48368305|NCT02914275|155543263|FG000|Overall Study|Other|4|||
48368306|NCT02914275|155543264|FG001|Overall Study|Other|1|||
48368307|NCT02914275|155543263|FG000|Overall Study|Excluded due to invalid informed consent|3|||
48368308|NCT02914275|155543264|FG001|Overall Study|Excluded due to invalid informed consent|0|||
48368309|NCT01238900|155543272|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
48368310|NCT01238900|155543272|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
48368311|NCT02233543|155543273|FG000|Period 1|Withdrawal by Subject|1|||
48368312|NCT02233543|155543274|FG001|Period 1|Withdrawal by Subject|0|||
48368313|NCT02233543|155543273|FG000|Period 1|Participants required other treatment.|2|||
48368314|NCT02233543|155543274|FG001|Period 1|Participants required other treatment.|3|||
48368315|NCT02233543|155543273|FG000|Period 2|Adverse Event|1|||
48368316|NCT02233543|155543274|FG001|Period 2|Adverse Event|0|||
48368317|NCT02233543|155543273|FG000|Period 2|Participant required other treatment.|0|||
48368318|NCT02233543|155543274|FG001|Period 2|Participant required other treatment.|1|||
48368319|NCT02233543|155543273|FG000|Period 2|COPD exacerbation|1|||
48368320|NCT02233543|155543274|FG001|Period 2|COPD exacerbation|0|||
48368321|NCT03573583|155543275|FG000|Overall Study|Lost to Follow-up|1|||
48368322|NCT03573583|155543276|FG001|Overall Study|Lost to Follow-up|0|||
48368323|NCT03573583|155543275|FG000|Overall Study|Withdrawal by Subject|1|||
48368324|NCT03573583|155543276|FG001|Overall Study|Withdrawal by Subject|1|||
48368325|NCT00574873|155543278|FG000|Overall Study|Withdrawal by Subject|18|||
48368326|NCT00574873|155543279|FG001|Overall Study|Withdrawal by Subject|19|||
48368327|NCT00574873|155543278|FG000|Overall Study|Investigator request|18|||
48368328|NCT00574873|155543279|FG001|Overall Study|Investigator request|8|||
48368329|NCT00574873|155543278|FG000|Overall Study|Death|15|||
48368330|NCT00574873|155543279|FG001|Overall Study|Death|14|||
48368331|NCT00574873|155543278|FG000|Overall Study|Lost to Follow-up|14|||
48368332|NCT00574873|155543279|FG001|Overall Study|Lost to Follow-up|5|||
48368333|NCT00574873|155543278|FG000|Overall Study|Other|40|||
48368334|NCT00574873|155543279|FG001|Overall Study|Other|4|||
48368335|NCT00574873|155543278|FG000|Overall Study|Discontinuation of study by sponsor|5|||
48368336|NCT00574873|155543279|FG001|Overall Study|Discontinuation of study by sponsor|199|||
48368337|NCT00574873|155543278|FG000|Overall Study|Blank, site closed per local regulations|2|||
48368338|NCT00574873|155543279|FG001|Overall Study|Blank, site closed per local regulations|2|||
48368339|NCT00574873|155543278|FG000|Overall Study|Extension Study|126|||
48368340|NCT00574873|155543279|FG001|Overall Study|Extension Study|0|||
48368341|NCT01850446|155543282|FG000|Overall Study|Lack of Efficacy|1|||
48368342|NCT01850446|155543283|FG001|Overall Study|Lack of Efficacy|0|||
48368343|NCT01850446|155543282|FG000|Overall Study|Withdrawal by Subject|4|||
48368344|NCT01850446|155543283|FG001|Overall Study|Withdrawal by Subject|0|||
48368345|NCT01850446|155543282|FG000|Overall Study|Protocol Violation|0|||
48368346|NCT01850446|155543283|FG001|Overall Study|Protocol Violation|2|||
48368347|NCT00591721|155543284|FG000|Overall Study|Withdrawal by Subject|10|||
48368348|NCT00591721|155543285|FG001|Overall Study|Withdrawal by Subject|10|||
48368349|NCT00591721|155543284|FG000|Overall Study|Lost to Follow-up|1|||
48368350|NCT00591721|155543285|FG001|Overall Study|Lost to Follow-up|4|||
48368351|NCT00591721|155543284|FG000|Overall Study|Intervention not received|10|||
48368352|NCT00591721|155543285|FG001|Overall Study|Intervention not received|8|||
48368353|NCT02704754|155543286|FG000|Overall Study|Lost to Follow-up|1|||
48368354|NCT02704754|155543287|FG001|Overall Study|Lost to Follow-up|1|||
48368355|NCT02704754|155543286|FG000|Overall Study|Lack of Efficacy|1|||
48368356|NCT02704754|155543287|FG001|Overall Study|Lack of Efficacy|0|||
48368357|NCT02704754|155543286|FG000|Overall Study|Withdrawal by Subject|1|||
48368358|NCT02704754|155543287|FG001|Overall Study|Withdrawal by Subject|0|||
48368359|NCT03828747|155543289|FG000|Double-Blind Treatment Period|Adverse Event|6|||
48368360|NCT03828747|155543290|FG001|Double-Blind Treatment Period|Adverse Event|6|||
48368361|NCT03828747|155543289|FG000|Double-Blind Treatment Period|Death|1|||
48368362|NCT03828747|155543290|FG001|Double-Blind Treatment Period|Death|1|||
48368363|NCT03828747|155543289|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48368364|NCT03828747|155543290|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48368365|NCT03828747|155543289|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
48368366|NCT03828747|155543290|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
48368367|NCT03828747|155543289|FG000|Double-Blind Treatment Period|Physician Decision|1|||
48368368|NCT03828747|155543290|FG001|Double-Blind Treatment Period|Physician Decision|4|||
48368369|NCT03828747|155543289|FG000|Double-Blind Treatment Period|Various reasons|5|||
48368370|NCT03828747|155543290|FG001|Double-Blind Treatment Period|Various reasons|3|||
48368371|NCT03828747|155543289|FG000|Open-Label Extension|Adverse Event|9|||
48368372|NCT03828747|155543290|FG001|Open-Label Extension|Adverse Event|7|||
48368373|NCT03828747|155543289|FG000|Open-Label Extension|Death|0|||
48368374|NCT03828747|155543290|FG001|Open-Label Extension|Death|2|||
48368375|NCT03828747|155543289|FG000|Open-Label Extension|Lost to Follow-up|4|||
48368376|NCT03828747|155543290|FG001|Open-Label Extension|Lost to Follow-up|0|||
48368377|NCT03828747|155543289|FG000|Open-Label Extension|Withdrawal by Subject|31|||
48368378|NCT03828747|155543290|FG001|Open-Label Extension|Withdrawal by Subject|30|||
48368379|NCT03828747|155543289|FG000|Open-Label Extension|Various reasons|4|||
48368380|NCT03828747|155543290|FG001|Open-Label Extension|Various reasons|4|||
48368381|NCT03828747|155543289|FG000|Open-Label Extension|Physician Decision|6|||
48368382|NCT03828747|155543290|FG001|Open-Label Extension|Physician Decision|2|||
48368383|NCT01346475|155543291|FG000|First Intervention|Lost to Follow-up|4|||
48368384|NCT01346475|155543292|FG001|First Intervention|Lost to Follow-up|3|||
48368385|NCT01171807|155543293|FG000|Overall Study|Treatment failure|2|||
48368386|NCT01171807|155543294|FG001|Overall Study|Treatment failure|4|||
48368387|NCT01171807|155543293|FG000|Overall Study|Non compliance|1|||
48368388|NCT01171807|155543294|FG001|Overall Study|Non compliance|0|||
48368389|NCT01171807|155543293|FG000|Overall Study|Lost to Follow-up|3|||
48368390|NCT01171807|155543294|FG001|Overall Study|Lost to Follow-up|0|||
48368391|NCT00621777|155543295|FG000|Open Phase|Adverse Event|20|||
48368392|NCT00621777|155543296|FG001|Open Phase|Adverse Event|0|||
48368393|NCT00621777|155543295|FG000|Open Phase|Did not abstain during open phase|56|||
48368394|NCT00621777|155543296|FG001|Open Phase|Did not abstain during open phase|0|||
48368395|NCT00621777|155543295|FG000|Open Phase|Withdrawal by Subject|17|||
48368396|NCT00621777|155543296|FG001|Open Phase|Withdrawal by Subject|0|||
48368397|NCT00621777|155543295|FG000|Open Phase|administrative|13|||
48368398|NCT00621777|155543296|FG001|Open Phase|administrative|0|||
48368399|NCT00621777|155543295|FG000|Open Phase|Lost to Follow-up|10|||
48368400|NCT00621777|155543296|FG001|Open Phase|Lost to Follow-up|0|||
48368401|NCT00621777|155543295|FG000|Randomized Phase|Adverse Event|3|||
48368402|NCT00621777|155543296|FG001|Randomized Phase|Adverse Event|3|||
48368403|NCT00621777|155543295|FG000|Randomized Phase|Lost to Follow-up|3|||
48368404|NCT00621777|155543296|FG001|Randomized Phase|Lost to Follow-up|3|||
48368405|NCT00621777|155543295|FG000|Randomized Phase|Withdrawal by Subject|1|||
48368406|NCT00621777|155543296|FG001|Randomized Phase|Withdrawal by Subject|9|||
48368407|NCT00621777|155543295|FG000|Randomized Phase|administrative|0|||
48368408|NCT00621777|155543296|FG001|Randomized Phase|administrative|3|||
48368409|NCT00621777|155543295|FG000|Randomized Phase|Death|0|||
48368410|NCT00621777|155543296|FG001|Randomized Phase|Death|1|||
48368411|NCT00446043|155543298|FG000|Overall Study|Adverse Event|9|||
48368412|NCT00446043|155543298|FG000|Overall Study|Withdrawal by Subject|70|||
48368413|NCT00446043|155543298|FG000|Overall Study|Protocol Violation|2|||
48368414|NCT00446043|155543298|FG000|Overall Study|Lost to Follow-up|42|||
48368415|NCT00446043|155543298|FG000|Overall Study|Pregnancy|2|||
48368416|NCT01239043|155543299|FG000|Overall Study|Protocol Violation|2|||
48368417|NCT01239043|155543300|FG001|Overall Study|Protocol Violation|1|||
48368418|NCT00309959|155543305|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
48368419|NCT01895101|155543306|FG000|Overall Study|OPCAB procedure|1|||
48368420|NCT01895101|155543307|FG001|Overall Study|OPCAB procedure|1|||
48368421|NCT01895101|155543308|FG002|Overall Study|OPCAB procedure|3|||
48368422|NCT01895101|155543306|FG000|Overall Study|Withdrawal by Subject|0|||
48368423|NCT01895101|155543307|FG001|Overall Study|Withdrawal by Subject|1|||
48368424|NCT01895101|155543308|FG002|Overall Study|Withdrawal by Subject|2|||
48368425|NCT01895101|155543306|FG000|Overall Study|another study, enrolled in other study|0|||
48368426|NCT01895101|155543307|FG001|Overall Study|another study, enrolled in other study|1|||
48368427|NCT01895101|155543308|FG002|Overall Study|another study, enrolled in other study|0|||
48368428|NCT01895101|155543306|FG000|Overall Study|Death|0|||
48368429|NCT01895101|155543307|FG001|Overall Study|Death|1|||
48368430|NCT01895101|155543308|FG002|Overall Study|Death|0|||
48368431|NCT01895101|155543306|FG000|Overall Study|coagulation disorder|0|||
48368432|NCT01895101|155543307|FG001|Overall Study|coagulation disorder|1|||
48368433|NCT01895101|155543308|FG002|Overall Study|coagulation disorder|0|||
48368434|NCT02663518|155543309|FG000|Part 1: Phase 1a Escalation|Death|0|||
48368435|NCT02663518|155543310|FG001|Part 1: Phase 1a Escalation|Death|0|||
48368436|NCT02663518|155543311|FG002|Part 1: Phase 1a Escalation|Death|1|||
48368437|NCT02663518|155543312|FG003|Part 1: Phase 1a Escalation|Death|0|||
48368438|NCT02663518|155543313|FG004|Part 1: Phase 1a Escalation|Death|0|||
48368439|NCT02663518|155543314|FG005|Part 1: Phase 1a Escalation|Death|0|||
48368440|NCT02663518|155543315|FG006|Part 1: Phase 1a Escalation|Death|0|||
48368441|NCT02663518|155543316|FG007|Part 1: Phase 1a Escalation|Death|0|||
48368442|NCT02663518|155543317|FG008|Part 1: Phase 1a Escalation|Death|0|||
48368443|NCT02663518|155543318|FG009|Part 1: Phase 1a Escalation|Death|0|||
48368444|NCT02663518|155543319|FG010|Part 1: Phase 1a Escalation|Death|0|||
48368445|NCT02663518|155543320|FG011|Part 1: Phase 1a Escalation|Death|0|||
48368446|NCT02663518|155543321|FG012|Part 1: Phase 1a Escalation|Death|0|||
48368447|NCT02663518|155543322|FG013|Part 1: Phase 1a Escalation|Death|0|||
48368448|NCT02663518|155543309|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368449|NCT02663518|155543310|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368450|NCT02663518|155543311|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
48368451|NCT02663518|155543312|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368452|NCT02663518|155543313|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368453|NCT02663518|155543314|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368454|NCT02663518|155543315|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368455|NCT02663518|155543316|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368456|NCT02663518|155543317|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368457|NCT02663518|155543318|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368458|NCT02663518|155543319|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368459|NCT02663518|155543320|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368460|NCT02663518|155543321|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368461|NCT02663518|155543322|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
48368462|NCT02663518|155543309|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
48368463|NCT02663518|155543310|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
48368464|NCT02663518|155543311|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
48368465|NCT02663518|155543312|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
48368466|NCT02663518|155543313|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368467|NCT02663518|155543314|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368468|NCT02663518|155543315|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368469|NCT02663518|155543316|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368470|NCT02663518|155543317|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368471|NCT02663518|155543318|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368472|NCT02663518|155543319|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368473|NCT02663518|155543320|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368474|NCT02663518|155543321|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368475|NCT02663518|155543322|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
48368476|NCT02663518|155543309|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
48368477|NCT02663518|155543310|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368478|NCT02663518|155543311|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
48368479|NCT02663518|155543312|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
48368480|NCT02663518|155543313|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368481|NCT02663518|155543314|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368482|NCT02663518|155543315|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368483|NCT02663518|155543316|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368484|NCT02663518|155543317|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368485|NCT02663518|155543318|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368486|NCT02663518|155543319|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368487|NCT02663518|155543320|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368488|NCT02663518|155543321|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368489|NCT02663518|155543322|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
48368490|NCT02663518|155543309|FG000|Part 1: Phase 1a Escalation|Other|0|||
48368491|NCT02663518|155543310|FG001|Part 1: Phase 1a Escalation|Other|0|||
48368492|NCT02663518|155543311|FG002|Part 1: Phase 1a Escalation|Other|2|||
48368493|NCT02663518|155543312|FG003|Part 1: Phase 1a Escalation|Other|0|||
48368494|NCT02663518|155543313|FG004|Part 1: Phase 1a Escalation|Other|0|||
48368495|NCT02663518|155543314|FG005|Part 1: Phase 1a Escalation|Other|0|||
48368496|NCT02663518|155543315|FG006|Part 1: Phase 1a Escalation|Other|0|||
48368497|NCT02663518|155543316|FG007|Part 1: Phase 1a Escalation|Other|0|||
48368498|NCT02663518|155543317|FG008|Part 1: Phase 1a Escalation|Other|0|||
48368499|NCT02663518|155543318|FG009|Part 1: Phase 1a Escalation|Other|0|||
48368500|NCT02663518|155543319|FG010|Part 1: Phase 1a Escalation|Other|0|||
48368501|NCT02663518|155543320|FG011|Part 1: Phase 1a Escalation|Other|0|||
48368502|NCT02663518|155543321|FG012|Part 1: Phase 1a Escalation|Other|0|||
48368503|NCT02663518|155543322|FG013|Part 1: Phase 1a Escalation|Other|0|||
48368504|NCT02663518|155543309|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368505|NCT02663518|155543310|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368506|NCT02663518|155543311|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368507|NCT02663518|155543312|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368508|NCT02663518|155543313|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
48368509|NCT02663518|155543314|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368510|NCT02663518|155543315|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
48368511|NCT02663518|155543316|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
48368512|NCT02663518|155543317|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368513|NCT02663518|155543318|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368514|NCT02663518|155543319|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368515|NCT02663518|155543320|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368516|NCT02663518|155543321|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368517|NCT02663518|155543322|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
48368518|NCT02663518|155543309|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368519|NCT02663518|155543310|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368520|NCT02663518|155543311|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368521|NCT02663518|155543312|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368522|NCT02663518|155543313|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
48368523|NCT02663518|155543314|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368524|NCT02663518|155543315|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
48368525|NCT02663518|155543316|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
48368526|NCT02663518|155543317|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368527|NCT02663518|155543318|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368528|NCT02663518|155543319|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368529|NCT02663518|155543320|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368530|NCT02663518|155543321|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368531|NCT02663518|155543322|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
48368532|NCT02663518|155543309|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368533|NCT02663518|155543310|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368534|NCT02663518|155543311|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368535|NCT02663518|155543312|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368536|NCT02663518|155543313|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
48368537|NCT02663518|155543314|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368538|NCT02663518|155543315|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368539|NCT02663518|155543316|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368540|NCT02663518|155543317|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368541|NCT02663518|155543318|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368542|NCT02663518|155543319|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368543|NCT02663518|155543320|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368544|NCT02663518|155543321|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368545|NCT02663518|155543322|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
48368546|NCT02663518|155543309|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368547|NCT02663518|155543310|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368548|NCT02663518|155543311|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368549|NCT02663518|155543312|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368550|NCT02663518|155543313|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
48368551|NCT02663518|155543314|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
48368552|NCT02663518|155543315|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
48368553|NCT02663518|155543316|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
48368554|NCT02663518|155543317|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368555|NCT02663518|155543318|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368556|NCT02663518|155543319|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368557|NCT02663518|155543320|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368558|NCT02663518|155543321|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368559|NCT02663518|155543322|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
48368560|NCT02663518|155543309|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368561|NCT02663518|155543310|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368562|NCT02663518|155543311|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368563|NCT02663518|155543312|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368564|NCT02663518|155543313|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
48368565|NCT02663518|155543314|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368566|NCT02663518|155543315|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
48368567|NCT02663518|155543316|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368568|NCT02663518|155543317|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368569|NCT02663518|155543318|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368570|NCT02663518|155543319|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368571|NCT02663518|155543320|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368572|NCT02663518|155543321|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368573|NCT02663518|155543322|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
48368574|NCT02663518|155543309|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368575|NCT02663518|155543310|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368576|NCT02663518|155543311|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368577|NCT02663518|155543312|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368578|NCT02663518|155543313|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368579|NCT02663518|155543314|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368580|NCT02663518|155543315|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
48368581|NCT02663518|155543316|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368582|NCT02663518|155543317|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368583|NCT02663518|155543318|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368584|NCT02663518|155543319|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368585|NCT02663518|155543320|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368586|NCT02663518|155543321|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368587|NCT02663518|155543322|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
48368588|NCT02663518|155543309|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
48368589|NCT02663518|155543310|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
48368590|NCT02663518|155543311|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
48368591|NCT02663518|155543312|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
48368592|NCT02663518|155543313|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
48368593|NCT02663518|155543314|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
48368594|NCT02663518|155543315|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
48368595|NCT02663518|155543316|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
48368596|NCT02663518|155543317|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
48368597|NCT02663518|155543318|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
48368598|NCT02663518|155543319|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
48368599|NCT02663518|155543320|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
48368600|NCT02663518|155543321|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
48368601|NCT02663518|155543322|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
48368602|NCT02663518|155543309|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368603|NCT02663518|155543310|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368604|NCT02663518|155543311|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368605|NCT02663518|155543312|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368606|NCT02663518|155543313|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368607|NCT02663518|155543314|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368608|NCT02663518|155543315|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368609|NCT02663518|155543316|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368610|NCT02663518|155543317|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368611|NCT02663518|155543318|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368612|NCT02663518|155543319|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368613|NCT02663518|155543320|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368614|NCT02663518|155543321|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
48368615|NCT02663518|155543322|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
48368616|NCT02663518|155543309|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368617|NCT02663518|155543310|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368618|NCT02663518|155543311|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368619|NCT02663518|155543312|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368620|NCT02663518|155543313|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368621|NCT02663518|155543314|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368622|NCT02663518|155543315|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368623|NCT02663518|155543316|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368624|NCT02663518|155543317|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368625|NCT02663518|155543318|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368626|NCT02663518|155543319|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368627|NCT02663518|155543320|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
48368628|NCT02663518|155543321|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368629|NCT02663518|155543322|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
48368630|NCT02663518|155543309|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368631|NCT02663518|155543310|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368632|NCT02663518|155543311|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368633|NCT02663518|155543312|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368634|NCT02663518|155543313|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368635|NCT02663518|155543314|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368636|NCT02663518|155543315|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368637|NCT02663518|155543316|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368638|NCT02663518|155543317|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368639|NCT02663518|155543318|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
48368640|NCT02663518|155543319|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
48368641|NCT02663518|155543320|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
48368642|NCT02663518|155543321|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
48368643|NCT02663518|155543322|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
48368644|NCT02663518|155543309|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
48368645|NCT02663518|155543310|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
48368646|NCT02663518|155543311|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
48368647|NCT02663518|155543312|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
48368648|NCT02663518|155543313|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
48368649|NCT02663518|155543314|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
48368650|NCT02663518|155543315|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
48368651|NCT02663518|155543316|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
48368652|NCT02663518|155543317|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
48368653|NCT02663518|155543318|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
48368654|NCT02663518|155543319|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
48368655|NCT02663518|155543320|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
48368656|NCT02663518|155543321|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
48368657|NCT02663518|155543322|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
48368658|NCT02663518|155543309|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368659|NCT02663518|155543310|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368660|NCT02663518|155543311|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368661|NCT02663518|155543312|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368662|NCT02663518|155543313|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368663|NCT02663518|155543314|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368664|NCT02663518|155543315|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368665|NCT02663518|155543316|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368666|NCT02663518|155543317|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368667|NCT02663518|155543318|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368668|NCT02663518|155543319|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368669|NCT02663518|155543320|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368670|NCT02663518|155543321|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
48368671|NCT02663518|155543322|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
48368672|NCT02947087|155543325|FG000|Overall Study|Withdrawal by Subject|3|||
48368673|NCT02947087|155543326|FG001|Overall Study|Withdrawal by Subject|2|||
48368674|NCT01052103|155543330|FG000|Overall Study|Adverse Event|10|||
48368675|NCT01052103|155543331|FG001|Overall Study|Adverse Event|6|||
48368676|NCT01052103|155543330|FG000|Overall Study|Entry Criteria Not Met|3|||
48368677|NCT01052103|155543331|FG001|Overall Study|Entry Criteria Not Met|1|||
48368678|NCT01052103|155543330|FG000|Overall Study|Lost to Follow-up|3|||
48368679|NCT01052103|155543331|FG001|Overall Study|Lost to Follow-up|5|||
48368680|NCT01052103|155543330|FG000|Overall Study|Protocol Violation|10|||
48368681|NCT01052103|155543331|FG001|Overall Study|Protocol Violation|4|||
48368682|NCT01052103|155543330|FG000|Overall Study|Scheduling conflict|2|||
48368683|NCT01052103|155543331|FG001|Overall Study|Scheduling conflict|1|||
48368684|NCT01052103|155543330|FG000|Overall Study|Sponsor Decision|2|||
48368685|NCT01052103|155543331|FG001|Overall Study|Sponsor Decision|0|||
48368686|NCT01052103|155543330|FG000|Overall Study|Withdrawal by Subject|3|||
48368687|NCT01052103|155543331|FG001|Overall Study|Withdrawal by Subject|6|||
48368688|NCT01052103|155543330|FG000|Overall Study|Perceived Lack of Efficacy|1|||
48368689|NCT01052103|155543331|FG001|Overall Study|Perceived Lack of Efficacy|0|||
48368690|NCT00370682|155543332|FG000|Overall Study|Moved from area|0|||
48368691|NCT00370682|155543333|FG001|Overall Study|Moved from area|2|||
48368692|NCT00370682|155543334|FG002|Overall Study|Moved from area|0|||
48368693|NCT00370682|155543332|FG000|Overall Study|Lost to Follow-up|0|||
48368694|NCT00370682|155543333|FG001|Overall Study|Lost to Follow-up|1|||
48368695|NCT00370682|155543334|FG002|Overall Study|Lost to Follow-up|1|||
48368696|NCT01983254|155543335|FG000|Overall Study|Death|6|||
48368697|NCT01983254|155543336|FG001|Overall Study|Death|6|||
48368698|NCT01983254|155543335|FG000|Overall Study|Lost to Follow-up|17|||
48368699|NCT01983254|155543336|FG001|Overall Study|Lost to Follow-up|16|||
48368700|NCT01983254|155543335|FG000|Overall Study|too ill|11|||
48368701|NCT01983254|155543336|FG001|Overall Study|too ill|8|||
48368702|NCT01160289|155543337|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
48368703|NCT01160289|155543338|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48368704|NCT01160289|155543339|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48368705|NCT01160289|155543340|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48368706|NCT01160289|155543341|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48368707|NCT01160289|155543342|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
48431608|NCT01721408|155767331|FG001|Overall Study|Adverse Event|1|||
48368708|NCT01160289|155543337|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
48368709|NCT01160289|155543338|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48368710|NCT01160289|155543339|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48368711|NCT01160289|155543340|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48368712|NCT01160289|155543341|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48368713|NCT01160289|155543342|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
48368714|NCT01160289|155543337|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
48368715|NCT01160289|155543338|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48368716|NCT01160289|155543339|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48368717|NCT01160289|155543340|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48368718|NCT01160289|155543341|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48368719|NCT01160289|155543342|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
48368720|NCT01160289|155543337|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
48368721|NCT01160289|155543338|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48368722|NCT01160289|155543339|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48368723|NCT01160289|155543340|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48368724|NCT01160289|155543341|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48368725|NCT01160289|155543342|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
48368726|NCT01160289|155543337|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
48368727|NCT01160289|155543338|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48368728|NCT01160289|155543339|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48368729|NCT01160289|155543340|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48368730|NCT01160289|155543341|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48368731|NCT01160289|155543342|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
48368732|NCT01160289|155543337|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
48368733|NCT01160289|155543338|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48368734|NCT01160289|155543339|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48368735|NCT01160289|155543340|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48368736|NCT01160289|155543341|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48368737|NCT01160289|155543342|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
48368738|NCT01160289|155543337|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
48368739|NCT01160289|155543338|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48368740|NCT01160289|155543339|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48368741|NCT01160289|155543340|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48368742|NCT01160289|155543341|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48368743|NCT01160289|155543342|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
48368744|NCT01160289|155543337|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
48368745|NCT01160289|155543338|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48368746|NCT01160289|155543339|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48368747|NCT01160289|155543340|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48368748|NCT01160289|155543341|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48368749|NCT01160289|155543342|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
48368750|NCT01160289|155543337|FG000|Post-Randomization Period|Adverse Event|0|||
48368751|NCT01160289|155543338|FG001|Post-Randomization Period|Adverse Event|4|||
48368752|NCT01160289|155543339|FG002|Post-Randomization Period|Adverse Event|4|||
48368753|NCT01160289|155543340|FG003|Post-Randomization Period|Adverse Event|2|||
48368754|NCT01160289|155543341|FG004|Post-Randomization Period|Adverse Event|0|||
48368755|NCT01160289|155543342|FG005|Post-Randomization Period|Adverse Event|0|||
48368756|NCT01160289|155543337|FG000|Post-Randomization Period|Death|0|||
48368757|NCT01160289|155543338|FG001|Post-Randomization Period|Death|0|||
48368758|NCT01160289|155543339|FG002|Post-Randomization Period|Death|0|||
48368759|NCT01160289|155543340|FG003|Post-Randomization Period|Death|1|||
48368760|NCT01160289|155543341|FG004|Post-Randomization Period|Death|0|||
48368761|NCT01160289|155543342|FG005|Post-Randomization Period|Death|0|||
48368762|NCT01160289|155543337|FG000|Post-Randomization Period|Lack of Efficacy|0|||
48368763|NCT01160289|155543338|FG001|Post-Randomization Period|Lack of Efficacy|1|||
48368764|NCT01160289|155543339|FG002|Post-Randomization Period|Lack of Efficacy|0|||
48368765|NCT01160289|155543340|FG003|Post-Randomization Period|Lack of Efficacy|3|||
48368766|NCT01160289|155543341|FG004|Post-Randomization Period|Lack of Efficacy|0|||
48368767|NCT01160289|155543342|FG005|Post-Randomization Period|Lack of Efficacy|0|||
48368768|NCT01160289|155543337|FG000|Post-Randomization Period|Lost to Follow-up|0|||
48368769|NCT01160289|155543338|FG001|Post-Randomization Period|Lost to Follow-up|3|||
48368770|NCT01160289|155543339|FG002|Post-Randomization Period|Lost to Follow-up|2|||
48368771|NCT01160289|155543340|FG003|Post-Randomization Period|Lost to Follow-up|5|||
48368772|NCT01160289|155543341|FG004|Post-Randomization Period|Lost to Follow-up|3|||
48368773|NCT01160289|155543342|FG005|Post-Randomization Period|Lost to Follow-up|4|||
48368774|NCT01160289|155543337|FG000|Post-Randomization Period|Physician Decision|0|||
48368775|NCT01160289|155543338|FG001|Post-Randomization Period|Physician Decision|0|||
48368776|NCT01160289|155543339|FG002|Post-Randomization Period|Physician Decision|1|||
48368777|NCT01160289|155543340|FG003|Post-Randomization Period|Physician Decision|0|||
48692617|NCT03001557|156724545|FG004|Core Phase|Randomized but not treated|0|||
48692618|NCT03001557|156724546|FG005|Core Phase|Randomized but not treated|0|||
48692619|NCT03001557|156724547|FG006|Core Phase|Randomized but not treated|0|||
48692620|NCT03001557|156724548|FG007|Core Phase|Randomized but not treated|0|||
48692621|NCT03001557|156724541|FG000|Extension Phase|Adverse Event|0|||
48692622|NCT03001557|156724542|FG001|Extension Phase|Adverse Event|0|||
48692623|NCT03001557|156724543|FG002|Extension Phase|Adverse Event|0|||
48692624|NCT03001557|156724544|FG003|Extension Phase|Adverse Event|0|||
48692625|NCT03001557|156724545|FG004|Extension Phase|Adverse Event|0|||
48692626|NCT03001557|156724546|FG005|Extension Phase|Adverse Event|2|||
48692627|NCT03001557|156724547|FG006|Extension Phase|Adverse Event|0|||
48692628|NCT03001557|156724548|FG007|Extension Phase|Adverse Event|0|||
48692629|NCT03001557|156724541|FG000|Extension Phase|Withdrawal by Subject|0|||
48692630|NCT03001557|156724542|FG001|Extension Phase|Withdrawal by Subject|0|||
48692631|NCT03001557|156724543|FG002|Extension Phase|Withdrawal by Subject|0|||
48692632|NCT03001557|156724544|FG003|Extension Phase|Withdrawal by Subject|0|||
48692633|NCT03001557|156724545|FG004|Extension Phase|Withdrawal by Subject|0|||
48692634|NCT03001557|156724546|FG005|Extension Phase|Withdrawal by Subject|1|||
48692635|NCT03001557|156724547|FG006|Extension Phase|Withdrawal by Subject|5|||
48692636|NCT03001557|156724548|FG007|Extension Phase|Withdrawal by Subject|2|||
48692637|NCT03001557|156724541|FG000|Extension Phase|Lost to Follow-up|0|||
48368778|NCT01160289|155543341|FG004|Post-Randomization Period|Physician Decision|0|||
48368779|NCT01160289|155543342|FG005|Post-Randomization Period|Physician Decision|0|||
48368780|NCT01160289|155543337|FG000|Post-Randomization Period|Protocol Violation|0|||
48368781|NCT01160289|155543338|FG001|Post-Randomization Period|Protocol Violation|4|||
48368782|NCT01160289|155543339|FG002|Post-Randomization Period|Protocol Violation|2|||
48368783|NCT01160289|155543340|FG003|Post-Randomization Period|Protocol Violation|0|||
48368784|NCT01160289|155543341|FG004|Post-Randomization Period|Protocol Violation|1|||
48368785|NCT01160289|155543342|FG005|Post-Randomization Period|Protocol Violation|3|||
48368786|NCT01160289|155543337|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
48368787|NCT01160289|155543338|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
48368788|NCT01160289|155543339|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
48368789|NCT01160289|155543340|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
48368790|NCT01160289|155543341|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
48368791|NCT01160289|155543342|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
48368792|NCT01160289|155543337|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
48368793|NCT01160289|155543338|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
48368794|NCT01160289|155543339|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
48368795|NCT01160289|155543340|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
48368796|NCT01160289|155543341|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
48368797|NCT01160289|155543342|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
48368798|NCT01160289|155543337|FG000|Post-Randomization Period|Sponsor Decision|0|||
48368799|NCT01160289|155543338|FG001|Post-Randomization Period|Sponsor Decision|1|||
48368800|NCT01160289|155543339|FG002|Post-Randomization Period|Sponsor Decision|0|||
48368801|NCT01160289|155543340|FG003|Post-Randomization Period|Sponsor Decision|0|||
48368802|NCT01160289|155543341|FG004|Post-Randomization Period|Sponsor Decision|0|||
48368803|NCT01160289|155543342|FG005|Post-Randomization Period|Sponsor Decision|0|||
48368804|NCT00381615|155543344|FG000|Overall Study|Withdrawal by Subject|1|||
48368805|NCT00381615|155543345|FG001|Overall Study|Withdrawal by Subject|3|||
48368806|NCT00381615|155543346|FG002|Overall Study|Withdrawal by Subject|0|||
48368807|NCT00381615|155543347|FG003|Overall Study|Withdrawal by Subject|1|||
48368808|NCT00381615|155543344|FG000|Overall Study|Lost to Follow-up|3|||
48368809|NCT00381615|155543345|FG001|Overall Study|Lost to Follow-up|2|||
48368810|NCT00381615|155543346|FG002|Overall Study|Lost to Follow-up|0|||
48368811|NCT00381615|155543347|FG003|Overall Study|Lost to Follow-up|1|||
48368812|NCT00381615|155543344|FG000|Overall Study|Protocol Violation|0|||
48368813|NCT00381615|155543345|FG001|Overall Study|Protocol Violation|0|||
48368814|NCT00381615|155543346|FG002|Overall Study|Protocol Violation|1|||
48368815|NCT00381615|155543347|FG003|Overall Study|Protocol Violation|0|||
48368816|NCT03014011|155543348|FG000|First Intervention|Withdrawal by Subject|1|||
48368817|NCT03014011|155543349|FG001|First Intervention|Withdrawal by Subject|0|||
48368818|NCT03014011|155543348|FG000|Washout|Withdrawal by Subject|1|||
48368819|NCT03014011|155543349|FG001|Washout|Withdrawal by Subject|0|||
48368820|NCT00620282|155543352|FG000|Overall Study|Adverse Event|0|||
48368821|NCT00620282|155543353|FG001|Overall Study|Adverse Event|1|||
48368822|NCT00620282|155543354|FG002|Overall Study|Adverse Event|0|||
48368823|NCT00620282|155543352|FG000|Overall Study|Arterial line unable to be placed|0|||
48368824|NCT00620282|155543353|FG001|Overall Study|Arterial line unable to be placed|0|||
48368825|NCT00620282|155543354|FG002|Overall Study|Arterial line unable to be placed|1|||
48431609|NCT01721408|155767330|FG000|Overall Study|Death|1|||
48692638|NCT03001557|156724542|FG001|Extension Phase|Lost to Follow-up|0|||
48692639|NCT03001557|156724543|FG002|Extension Phase|Lost to Follow-up|0|||
48368826|NCT00620282|155543352|FG000|Overall Study|Withdrawal by Subject|0|||
48368827|NCT00620282|155543353|FG001|Overall Study|Withdrawal by Subject|1|||
48368828|NCT00620282|155543354|FG002|Overall Study|Withdrawal by Subject|0|||
48368829|NCT04738292|155543355|FG000|Overall Study|Death|1|||
48368830|NCT01151410|155543356|FG000|Overall Study|Withdrawal by Subject|3|||
48368831|NCT01151410|155543357|FG001|Overall Study|Withdrawal by Subject|5|||
48368832|NCT01151410|155543356|FG000|Overall Study|Lost to Follow-up|3|||
48368833|NCT01151410|155543357|FG001|Overall Study|Lost to Follow-up|4|||
48368834|NCT01151410|155543356|FG000|Overall Study|Adverse Event|1|||
48368835|NCT01151410|155543357|FG001|Overall Study|Adverse Event|2|||
48368836|NCT01151410|155543356|FG000|Overall Study|Protocol deviation|2|||
48368837|NCT01151410|155543357|FG001|Overall Study|Protocol deviation|1|||
48368838|NCT01151410|155543356|FG000|Overall Study|Administrative problems|1|||
48368839|NCT01151410|155543357|FG001|Overall Study|Administrative problems|1|||
48368840|NCT01151410|155543356|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48368841|NCT01151410|155543357|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48368842|NCT01151410|155543356|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48368843|NCT01151410|155543357|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48368844|NCT01131182|155543358|FG000|Overall Study|Withdrawal by Subject|1|||
48368845|NCT01131182|155543359|FG001|Overall Study|Withdrawal by Subject|1|||
48368846|NCT01131182|155543358|FG000|Overall Study|Lost to Follow-up|14|||
48368847|NCT01131182|155543359|FG001|Overall Study|Lost to Follow-up|15|||
48368848|NCT01131182|155543358|FG000|Overall Study|Other Reason|1|||
48368849|NCT01131182|155543359|FG001|Overall Study|Other Reason|0|||
48368850|NCT01034163|155543360|FG000|Overall Study|Treatment completed as per protocol|8|||
48368851|NCT01034163|155543361|FG001|Overall Study|Treatment completed as per protocol|7|||
48368852|NCT01034163|155543360|FG000|Overall Study|Withdrawal by Subject|8|||
48368853|NCT01034163|155543361|FG001|Overall Study|Withdrawal by Subject|2|||
48368854|NCT01034163|155543360|FG000|Overall Study|Protocol deviation|1|||
48368855|NCT01034163|155543361|FG001|Overall Study|Protocol deviation|0|||
48368856|NCT01034163|155543360|FG000|Overall Study|Disease progression|3|||
48368857|NCT01034163|155543361|FG001|Overall Study|Disease progression|4|||
48368858|NCT01034163|155543360|FG000|Overall Study|Adverse Event|6|||
48368859|NCT01034163|155543361|FG001|Overall Study|Adverse Event|0|||
48368860|NCT01034163|155543360|FG000|Overall Study|Administrative problems|0|||
48368861|NCT01034163|155543361|FG001|Overall Study|Administrative problems|1|||
48368862|NCT01034163|155543360|FG000|Overall Study|Abnormal laboratory value|1|||
48368863|NCT01034163|155543361|FG001|Overall Study|Abnormal laboratory value|0|||
48368864|NCT00744757|155543362|FG000|Overall Study|Objective disease progression|7|||
48368865|NCT00744757|155543362|FG000|Overall Study|Physician Decision|5|||
48368866|NCT00744757|155543362|FG000|Overall Study|Withdrawal by Subject|1|||
48368867|NCT00744757|155543362|FG000|Overall Study|Death|6|||
48368868|NCT00744757|155543362|FG000|Overall Study|Adverse Event|2|||
48368869|NCT02442336|155543363|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
48368870|NCT02442336|155543363|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
48368871|NCT02442336|155543363|FG000|Overall Study|Lost to Follow-up|11|||
48368872|NCT03189745|155543364|FG000|Overall Study|Conflict in work schedule of participant|1|||
48368873|NCT03189745|155543365|FG001|Overall Study|Conflict in work schedule of participant|1|||
48368874|NCT00760474|155543366|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
48368875|NCT00760474|155543367|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
48368876|NCT00760474|155543366|FG000|Placebo Washout Period|Other|0|||
48368877|NCT00760474|155543367|FG001|Placebo Washout Period|Other|1|||
48368878|NCT00760474|155543366|FG000|Period 2 (P2)|Lost to Follow-up|1|||
48368879|NCT00760474|155543367|FG001|Period 2 (P2)|Lost to Follow-up|0|||
48368880|NCT00760474|155543366|FG000|Period 2 (P2)|Adverse Event|0|||
48368881|NCT00760474|155543367|FG001|Period 2 (P2)|Adverse Event|1|||
48368882|NCT04677179|155543368|FG000|Induction Treatment Period|Adverse Event|1|||
48368883|NCT04677179|155543369|FG001|Induction Treatment Period|Adverse Event|0|||
48368884|NCT04677179|155543370|FG002|Induction Treatment Period|Adverse Event|0|||
48368885|NCT04677179|155543371|FG003|Induction Treatment Period|Adverse Event|0|||
48368886|NCT04677179|155543372|FG004|Induction Treatment Period|Adverse Event|0|||
48368887|NCT04677179|155543373|FG005|Induction Treatment Period|Adverse Event|0|||
48368888|NCT04677179|155543374|FG006|Induction Treatment Period|Adverse Event|0|||
48368889|NCT04677179|155543375|FG007|Induction Treatment Period|Adverse Event|0|||
48368890|NCT04677179|155543376|FG008|Induction Treatment Period|Adverse Event|0|||
48368891|NCT04677179|155543377|FG009|Induction Treatment Period|Adverse Event|0|||
48368892|NCT04677179|155543368|FG000|Induction Treatment Period|Physician Decision|1|||
48368893|NCT04677179|155543369|FG001|Induction Treatment Period|Physician Decision|0|||
48368894|NCT04677179|155543370|FG002|Induction Treatment Period|Physician Decision|1|||
48368895|NCT04677179|155543371|FG003|Induction Treatment Period|Physician Decision|0|||
48368896|NCT04677179|155543372|FG004|Induction Treatment Period|Physician Decision|0|||
48368897|NCT04677179|155543373|FG005|Induction Treatment Period|Physician Decision|0|||
48368898|NCT04677179|155543374|FG006|Induction Treatment Period|Physician Decision|0|||
48368899|NCT04677179|155543375|FG007|Induction Treatment Period|Physician Decision|0|||
48415071|NCT01309737|155707564|FG000|Week 16 to 52|Withdrawal by Subject|5|||
48368900|NCT04677179|155543376|FG008|Induction Treatment Period|Physician Decision|0|||
48368901|NCT04677179|155543377|FG009|Induction Treatment Period|Physician Decision|0|||
48368902|NCT04677179|155543368|FG000|Induction Treatment Period|Protocol Violation|0|||
48368903|NCT04677179|155543369|FG001|Induction Treatment Period|Protocol Violation|1|||
48368904|NCT04677179|155543370|FG002|Induction Treatment Period|Protocol Violation|0|||
48368905|NCT04677179|155543371|FG003|Induction Treatment Period|Protocol Violation|0|||
48368906|NCT04677179|155543372|FG004|Induction Treatment Period|Protocol Violation|0|||
48368907|NCT04677179|155543373|FG005|Induction Treatment Period|Protocol Violation|0|||
48368908|NCT04677179|155543374|FG006|Induction Treatment Period|Protocol Violation|0|||
48368909|NCT04677179|155543375|FG007|Induction Treatment Period|Protocol Violation|0|||
48368910|NCT04677179|155543376|FG008|Induction Treatment Period|Protocol Violation|0|||
48368911|NCT04677179|155543377|FG009|Induction Treatment Period|Protocol Violation|0|||
48368912|NCT04677179|155543368|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
48368913|NCT04677179|155543369|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
48368914|NCT04677179|155543370|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
48368915|NCT04677179|155543371|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
48368916|NCT04677179|155543372|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
48368917|NCT04677179|155543373|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
48368918|NCT04677179|155543374|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
48368919|NCT04677179|155543375|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
48368920|NCT04677179|155543376|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
48368921|NCT04677179|155543377|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
48368922|NCT04677179|155543368|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
48368923|NCT04677179|155543369|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
48368924|NCT04677179|155543370|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
48368925|NCT04677179|155543371|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
48368926|NCT04677179|155543372|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
48368927|NCT04677179|155543373|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
48368928|NCT04677179|155543374|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
48368929|NCT04677179|155543375|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
48368930|NCT04677179|155543376|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
48368931|NCT04677179|155543377|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
48368932|NCT04677179|155543368|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
48368933|NCT04677179|155543369|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
48368934|NCT04677179|155543370|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
48368935|NCT04677179|155543371|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
48368936|NCT04677179|155543372|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
48368937|NCT04677179|155543373|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
48368938|NCT04677179|155543374|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
48368939|NCT04677179|155543375|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
48368940|NCT04677179|155543376|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
48368941|NCT04677179|155543377|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
48368942|NCT04677179|155543368|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368943|NCT04677179|155543369|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368944|NCT04677179|155543370|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368945|NCT04677179|155543371|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
48368946|NCT04677179|155543372|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368947|NCT04677179|155543373|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368948|NCT04677179|155543374|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368949|NCT04677179|155543375|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368950|NCT04677179|155543376|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368951|NCT04677179|155543377|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
48368952|NCT04677179|155543368|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
48368953|NCT04677179|155543369|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
48368954|NCT04677179|155543370|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
48368955|NCT04677179|155543371|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
48368956|NCT04677179|155543372|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
48368957|NCT04677179|155543373|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
48368958|NCT04677179|155543374|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
48368959|NCT04677179|155543375|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
48368960|NCT04677179|155543376|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
48368961|NCT04677179|155543377|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
48368962|NCT04677179|155543368|FG000|Extension Treatment Period|Lack of Efficacy|0|||
48368963|NCT04677179|155543369|FG001|Extension Treatment Period|Lack of Efficacy|0|||
48692640|NCT03001557|156724544|FG003|Extension Phase|Lost to Follow-up|0|||
48368964|NCT04677179|155543370|FG002|Extension Treatment Period|Lack of Efficacy|0|||
48368965|NCT04677179|155543371|FG003|Extension Treatment Period|Lack of Efficacy|0|||
48368966|NCT04677179|155543372|FG004|Extension Treatment Period|Lack of Efficacy|0|||
48368967|NCT04677179|155543373|FG005|Extension Treatment Period|Lack of Efficacy|0|||
48368968|NCT04677179|155543374|FG006|Extension Treatment Period|Lack of Efficacy|6|||
48368969|NCT04677179|155543375|FG007|Extension Treatment Period|Lack of Efficacy|0|||
48368970|NCT04677179|155543376|FG008|Extension Treatment Period|Lack of Efficacy|0|||
48368971|NCT04677179|155543377|FG009|Extension Treatment Period|Lack of Efficacy|0|||
48368972|NCT04677179|155543368|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
48368973|NCT04677179|155543369|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
48368974|NCT04677179|155543370|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
48368975|NCT04677179|155543371|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
48368976|NCT04677179|155543372|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
48368977|NCT04677179|155543373|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
48368978|NCT04677179|155543374|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
48368979|NCT04677179|155543375|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
48368980|NCT04677179|155543376|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
48368981|NCT04677179|155543377|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
48368982|NCT04677179|155543368|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
48368983|NCT04677179|155543369|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
48368984|NCT04677179|155543370|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
48368985|NCT04677179|155543371|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
48368986|NCT04677179|155543372|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
48368987|NCT04677179|155543373|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
48368988|NCT04677179|155543374|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
48368989|NCT04677179|155543375|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
48368990|NCT04677179|155543376|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
48368991|NCT04677179|155543377|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
48368992|NCT04677179|155543368|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
48368993|NCT04677179|155543369|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
48368994|NCT04677179|155543370|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
48368995|NCT04677179|155543371|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
48368996|NCT04677179|155543372|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
48368997|NCT04677179|155543373|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
48368998|NCT04677179|155543374|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
48368999|NCT04677179|155543375|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
48369000|NCT04677179|155543376|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
48369001|NCT04677179|155543377|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
48369002|NCT04677179|155543368|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48369003|NCT04677179|155543369|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48369004|NCT04677179|155543370|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48369005|NCT04677179|155543371|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48369006|NCT04677179|155543372|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48369007|NCT04677179|155543373|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48369008|NCT04677179|155543374|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48369009|NCT04677179|155543375|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
48369010|NCT04677179|155543376|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
48369011|NCT04677179|155543377|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
48369012|NCT04677179|155543368|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369013|NCT04677179|155543369|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369014|NCT04677179|155543370|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369015|NCT04677179|155543371|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369016|NCT04677179|155543372|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369017|NCT04677179|155543373|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369018|NCT04677179|155543374|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369019|NCT04677179|155543375|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
48369020|NCT04677179|155543376|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369021|NCT04677179|155543377|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
48369022|NCT04677179|155543368|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48369023|NCT04677179|155543369|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48369024|NCT04677179|155543370|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48369025|NCT04677179|155543371|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48369026|NCT04677179|155543372|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48369027|NCT04677179|155543373|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48369028|NCT04677179|155543374|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48369029|NCT04677179|155543375|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
48369030|NCT04677179|155543376|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
48369031|NCT04677179|155543377|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
48369032|NCT04677179|155543368|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48369033|NCT04677179|155543369|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48369034|NCT04677179|155543370|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48369035|NCT04677179|155543371|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48369036|NCT04677179|155543372|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48369037|NCT04677179|155543373|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48369038|NCT04677179|155543374|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
48369039|NCT04677179|155543375|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
48369040|NCT04677179|155543376|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
48369041|NCT04677179|155543377|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
48369042|NCT00467285|155543379|FG000|Overall Study|Lost to Follow-up|4|||
48369043|NCT00467285|155543380|FG001|Overall Study|Lost to Follow-up|4|||
48369044|NCT05020327|155544632|FG000|Overall Study|Physician Decision|3|||
48369045|NCT05020327|155544633|FG001|Overall Study|Physician Decision|0|||
48369046|NCT05020327|155544634|FG002|Overall Study|Physician Decision|0|||
48369047|NCT05020327|155544632|FG000|Overall Study|Withdrawal by Subject|1|||
48369048|NCT05020327|155544633|FG001|Overall Study|Withdrawal by Subject|1|||
48369049|NCT05020327|155544634|FG002|Overall Study|Withdrawal by Subject|0|||
48369050|NCT05020327|155544632|FG000|Overall Study|personal/cultural, ineligible|12|||
48369051|NCT05020327|155544633|FG001|Overall Study|personal/cultural, ineligible|0|||
48369052|NCT05020327|155544634|FG002|Overall Study|personal/cultural, ineligible|0|||
48369053|NCT00833261|155544637|FG000|Overall Study|Withdrawal by Subject|4|||
48369054|NCT00605215|155544638|FG000|Overall Study|Death|0|||
48369055|NCT00605215|155544639|FG001|Overall Study|Death|0|||
48369056|NCT00605215|155544640|FG002|Overall Study|Death|1|||
48369057|NCT00605215|155544638|FG000|Overall Study|Adverse Event|19|||
48369058|NCT00605215|155544639|FG001|Overall Study|Adverse Event|21|||
48369059|NCT00605215|155544640|FG002|Overall Study|Adverse Event|26|||
48369060|NCT00605215|155544638|FG000|Overall Study|Refusal to sign the re-consent form|8|||
48369061|NCT00605215|155544639|FG001|Overall Study|Refusal to sign the re-consent form|3|||
48369062|NCT00605215|155544640|FG002|Overall Study|Refusal to sign the re-consent form|3|||
48369063|NCT00605215|155544638|FG000|Overall Study|Withdrawal by Subject|39|||
48369064|NCT00605215|155544639|FG001|Overall Study|Withdrawal by Subject|37|||
48369065|NCT00605215|155544640|FG002|Overall Study|Withdrawal by Subject|27|||
48369066|NCT00605215|155544638|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
48369067|NCT00605215|155544639|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
48369068|NCT00605215|155544640|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
48369069|NCT00605215|155544638|FG000|Overall Study|Protocol Violation|3|||
48369070|NCT00605215|155544639|FG001|Overall Study|Protocol Violation|4|||
48369071|NCT00605215|155544640|FG002|Overall Study|Protocol Violation|1|||
48369072|NCT00605215|155544638|FG000|Overall Study|Pregnancy|8|||
48369073|NCT00605215|155544639|FG001|Overall Study|Pregnancy|5|||
48369074|NCT00605215|155544640|FG002|Overall Study|Pregnancy|4|||
48369075|NCT00605215|155544638|FG000|Overall Study|Lost to Follow-up|8|||
48369076|NCT00605215|155544639|FG001|Overall Study|Lost to Follow-up|5|||
48369077|NCT00605215|155544640|FG002|Overall Study|Lost to Follow-up|2|||
48369078|NCT00605215|155544638|FG000|Overall Study|Other than specified|0|||
48369079|NCT00605215|155544639|FG001|Overall Study|Other than specified|2|||
48369080|NCT00605215|155544640|FG002|Overall Study|Other than specified|1|||
48369081|NCT00603304|155544642|FG000|Overall Study|Lost to Follow-up|5|||
48369082|NCT00603304|155544643|FG001|Overall Study|Lost to Follow-up|7|||
48369083|NCT00603304|155544642|FG000|Overall Study|Withdrawal by Subject|8|||
48369084|NCT00603304|155544643|FG001|Overall Study|Withdrawal by Subject|5|||
48369085|NCT00603304|155544642|FG000|Overall Study|Protocol Violation|1|||
48369086|NCT00603304|155544643|FG001|Overall Study|Protocol Violation|0|||
48369087|NCT00603304|155544642|FG000|Overall Study|Adverse Event|4|||
48369088|NCT00603304|155544643|FG001|Overall Study|Adverse Event|2|||
48369089|NCT00603304|155544642|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
48369090|NCT00603304|155544643|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
48369091|NCT00603304|155544642|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
48369092|NCT00603304|155544643|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
48369093|NCT00603304|155544642|FG000|Overall Study|Exclusionary Medication|2|||
48369094|NCT00603304|155544643|FG001|Overall Study|Exclusionary Medication|3|||
48369095|NCT00603304|155544642|FG000|Overall Study|Non-Compliant|0|||
48369096|NCT00603304|155544643|FG001|Overall Study|Non-Compliant|1|||
48369097|NCT00603304|155544642|FG000|Overall Study|Moved Away|0|||
48369098|NCT00603304|155544643|FG001|Overall Study|Moved Away|2|||
48369099|NCT00603304|155544642|FG000|Overall Study|Other|2|||
48369100|NCT00603304|155544643|FG001|Overall Study|Other|0|||
48369101|NCT00603304|155544642|FG000|Overall Study|Patient Decision|2|||
48369102|NCT00603304|155544643|FG001|Overall Study|Patient Decision|0|||
48369103|NCT01034176|155544644|FG000|Overall Study|Physician Decision|2|||
48369104|NCT01034176|155544645|FG001|Overall Study|Physician Decision|0|||
48369105|NCT01034176|155544644|FG000|Overall Study|Withdrawal by Subject|0|||
48369106|NCT01034176|155544645|FG001|Overall Study|Withdrawal by Subject|1|||
48369107|NCT01034176|155544644|FG000|Overall Study|Lost to Follow-up|0|||
48369108|NCT01034176|155544645|FG001|Overall Study|Lost to Follow-up|1|||
48369109|NCT04343872|155544646|FG000|Overall Study|Lost to Follow-up|6|||
48369110|NCT04343872|155544647|FG001|Overall Study|Lost to Follow-up|3|||
48369111|NCT00423943|155544652|FG000|Overall Study|Withdrawal by Subject|3|||
48369112|NCT00423943|155544653|FG001|Overall Study|Withdrawal by Subject|1|||
48369113|NCT00581555|155544654|FG000|Overall Study|Adverse Event|4|||
48369114|NCT00581555|155544655|FG001|Overall Study|Adverse Event|3|||
48369115|NCT00581555|155544654|FG000|Overall Study|Physician Decision|3|||
48369116|NCT00581555|155544655|FG001|Overall Study|Physician Decision|2|||
48369117|NCT00581555|155544654|FG000|Overall Study|Withdrawal by Subject|18|||
48369118|NCT00581555|155544655|FG001|Overall Study|Withdrawal by Subject|9|||
48369119|NCT00581555|155544654|FG000|Overall Study|Lost to Follow-up|2|||
48369120|NCT00581555|155544655|FG001|Overall Study|Lost to Follow-up|2|||
48369121|NCT00581555|155544654|FG000|Overall Study|Other reasons|16|||
48369122|NCT00581555|155544655|FG001|Overall Study|Other reasons|4|||
48369123|NCT00194987|155544656|FG000|Overall Study|Withdrawal by Subject|0|||
48369124|NCT00194987|155544657|FG001|Overall Study|Withdrawal by Subject|3|||
48369125|NCT01901341|155544663|FG000|Overall Study|Adverse Event|4|||
48369126|NCT01901341|155544664|FG001|Overall Study|Adverse Event|2|||
48369127|NCT01901341|155544663|FG000|Overall Study|Lack of Efficacy|0|||
48369128|NCT01901341|155544664|FG001|Overall Study|Lack of Efficacy|2|||
48369129|NCT01901341|155544663|FG000|Overall Study|Lost to Follow-up|0|||
48369130|NCT01901341|155544664|FG001|Overall Study|Lost to Follow-up|1|||
48369131|NCT01901341|155544663|FG000|Overall Study|Protocol Violation|2|||
48369132|NCT01901341|155544664|FG001|Overall Study|Protocol Violation|0|||
48369133|NCT01901341|155544663|FG000|Overall Study|Study Terminated by Sponsor|13|||
48369134|NCT01901341|155544664|FG001|Overall Study|Study Terminated by Sponsor|15|||
48369135|NCT01901341|155544663|FG000|Overall Study|Withdrawal by Subject|1|||
48369136|NCT01901341|155544664|FG001|Overall Study|Withdrawal by Subject|1|||
48369137|NCT01737827|155544665|FG000|Overall Study|Adverse Event|3|||
48369138|NCT01737827|155544666|FG001|Overall Study|Adverse Event|6|||
48369139|NCT01737827|155544667|FG002|Overall Study|Adverse Event|0|||
48369140|NCT01737827|155544665|FG000|Overall Study|Lost to Follow-up|0|||
48369141|NCT01737827|155544666|FG001|Overall Study|Lost to Follow-up|1|||
48369142|NCT01737827|155544667|FG002|Overall Study|Lost to Follow-up|0|||
48369143|NCT01737827|155544665|FG000|Overall Study|Physician Decision|0|||
48369144|NCT01737827|155544666|FG001|Overall Study|Physician Decision|2|||
48369145|NCT01737827|155544667|FG002|Overall Study|Physician Decision|0|||
48369146|NCT01737827|155544665|FG000|Overall Study|Progressive Disease|5|||
48369147|NCT01737827|155544666|FG001|Overall Study|Progressive Disease|16|||
48369148|NCT01737827|155544667|FG002|Overall Study|Progressive Disease|2|||
48369149|NCT01737827|155544665|FG000|Overall Study|Study Terminated by Sponsor|0|||
48369150|NCT01737827|155544666|FG001|Overall Study|Study Terminated by Sponsor|1|||
48369151|NCT01737827|155544667|FG002|Overall Study|Study Terminated by Sponsor|0|||
48369152|NCT01737827|155544665|FG000|Overall Study|Subject/Guardian Decision|0|||
48369153|NCT01737827|155544666|FG001|Overall Study|Subject/Guardian Decision|2|||
48369154|NCT01737827|155544667|FG002|Overall Study|Subject/Guardian Decision|0|||
48369155|NCT00439231|155544668|FG000|Overall Study|Lack of Efficacy|28|||
48369156|NCT03702231|155544669|FG000|Overall Study|Withdrawal by Subject|1|||
48369157|NCT03702231|155544670|FG001|Overall Study|Withdrawal by Subject|0|||
48369158|NCT03702231|155544671|FG002|Overall Study|Withdrawal by Subject|0|||
48369159|NCT03702231|155544669|FG000|Overall Study|Protocol Violation|0|||
48369160|NCT03702231|155544670|FG001|Overall Study|Protocol Violation|0|||
48369161|NCT03702231|155544671|FG002|Overall Study|Protocol Violation|1|||
48369162|NCT03702231|155544669|FG000|Overall Study|Change in CLL Treatment|0|||
48369163|NCT03702231|155544670|FG001|Overall Study|Change in CLL Treatment|0|||
48369164|NCT03702231|155544671|FG002|Overall Study|Change in CLL Treatment|1|||
48369165|NCT03702231|155544669|FG000|Overall Study|COVID Pandemic|1|||
48369166|NCT03702231|155544670|FG001|Overall Study|COVID Pandemic|4|||
48369167|NCT03702231|155544671|FG002|Overall Study|COVID Pandemic|1|||
48369168|NCT03702231|155544669|FG000|Overall Study|Non-compliance|0|||
48369169|NCT03702231|155544670|FG001|Overall Study|Non-compliance|0|||
48369170|NCT03702231|155544671|FG002|Overall Study|Non-compliance|1|||
48369171|NCT02549196|155544675|FG000|Overall Study|Protocol Violation|0|||
48369172|NCT02549196|155544676|FG001|Overall Study|Protocol Violation|0|||
48369173|NCT02549196|155544677|FG002|Overall Study|Protocol Violation|0|||
48369174|NCT02549196|155544678|FG003|Overall Study|Protocol Violation|1|||
48369175|NCT02549196|155544675|FG000|Overall Study|Withdrawal by Subject|1|||
48369176|NCT02549196|155544676|FG001|Overall Study|Withdrawal by Subject|0|||
48369177|NCT02549196|155544677|FG002|Overall Study|Withdrawal by Subject|1|||
48369178|NCT02549196|155544678|FG003|Overall Study|Withdrawal by Subject|0|||
48369179|NCT03426605|155544679|FG000|Overall Study|AML relapse or progression|2|||
48369180|NCT03426605|155544680|FG001|Overall Study|AML relapse or progression|1|||
48369181|NCT03426605|155544681|FG002|Overall Study|AML relapse or progression|2|||
48369182|NCT03426605|155544682|FG003|Overall Study|AML relapse or progression|2|||
48369183|NCT03426605|155544679|FG000|Overall Study|Treatment failure|3|||
48369184|NCT03426605|155544680|FG001|Overall Study|Treatment failure|2|||
48369185|NCT03426605|155544681|FG002|Overall Study|Treatment failure|0|||
48369186|NCT03426605|155544682|FG003|Overall Study|Treatment failure|0|||
48369187|NCT03426605|155544679|FG000|Overall Study|Adverse Event|1|||
48369188|NCT03426605|155544680|FG001|Overall Study|Adverse Event|0|||
48369189|NCT03426605|155544681|FG002|Overall Study|Adverse Event|1|||
48369190|NCT03426605|155544682|FG003|Overall Study|Adverse Event|1|||
48369191|NCT03426605|155544679|FG000|Overall Study|Withdrawal by Subject|0|||
48369192|NCT03426605|155544680|FG001|Overall Study|Withdrawal by Subject|0|||
48369193|NCT03426605|155544681|FG002|Overall Study|Withdrawal by Subject|1|||
48369194|NCT03426605|155544682|FG003|Overall Study|Withdrawal by Subject|1|||
48369195|NCT00185965|155544683|FG000|Overall Study|Adverse Event|0|||
48369196|NCT00185965|155544684|FG001|Overall Study|Adverse Event|1|||
48369197|NCT02047903|155544687|FG000|Overall Study|Adverse Event|14|||
48369198|NCT02047903|155544687|FG000|Overall Study|Serious adverse event|10|||
48369199|NCT02047903|155544687|FG000|Overall Study|Withdrawal by Subject|16|||
48369200|NCT02047903|155544687|FG000|Overall Study|Lost to Follow-up|4|||
48369201|NCT02047903|155544687|FG000|Overall Study|Reason not listed|6|||
48369202|NCT02047903|155544687|FG000|Overall Study|Not Treated|9|||
48369203|NCT00196976|155544688|FG000|Primary Study|Migrated from study area|0|||
48369204|NCT00196976|155544689|FG001|Primary Study|Migrated from study area|0|||
48369205|NCT00196976|155544690|FG002|Primary Study|Migrated from study area|0|||
48369206|NCT00196976|155544691|FG003|Primary Study|Migrated from study area|0|||
48369207|NCT00196976|155544692|FG004|Primary Study|Migrated from study area|0|||
48369208|NCT00196976|155544693|FG005|Primary Study|Migrated from study area|0|||
48369209|NCT00196976|155544694|FG006|Primary Study|Migrated from study area|0|||
48369210|NCT00196976|155544695|FG007|Primary Study|Migrated from study area|1|||
48369211|NCT00196976|155544696|FG008|Primary Study|Migrated from study area|0|||
48369212|NCT00196976|155544697|FG009|Primary Study|Migrated from study area|0|||
48369213|NCT00196976|155544698|FG010|Primary Study|Migrated from study area|0|||
48369214|NCT00196976|155544699|FG011|Primary Study|Migrated from study area|0|||
48369215|NCT00196976|155544700|FG012|Primary Study|Migrated from study area|0|||
48369216|NCT00196976|155544701|FG013|Primary Study|Migrated from study area|0|||
48369217|NCT00196976|155544688|FG000|Primary Study|Protocol Violation|0|||
48369218|NCT00196976|155544689|FG001|Primary Study|Protocol Violation|1|||
48369219|NCT00196976|155544690|FG002|Primary Study|Protocol Violation|1|||
48369220|NCT00196976|155544691|FG003|Primary Study|Protocol Violation|0|||
48369221|NCT00196976|155544692|FG004|Primary Study|Protocol Violation|0|||
48369222|NCT00196976|155544693|FG005|Primary Study|Protocol Violation|0|||
48369223|NCT00196976|155544694|FG006|Primary Study|Protocol Violation|0|||
48369224|NCT00196976|155544695|FG007|Primary Study|Protocol Violation|0|||
48369225|NCT00196976|155544696|FG008|Primary Study|Protocol Violation|0|||
48369226|NCT00196976|155544697|FG009|Primary Study|Protocol Violation|0|||
48369227|NCT00196976|155544698|FG010|Primary Study|Protocol Violation|0|||
48369228|NCT00196976|155544699|FG011|Primary Study|Protocol Violation|0|||
48369229|NCT00196976|155544700|FG012|Primary Study|Protocol Violation|0|||
48369230|NCT00196976|155544701|FG013|Primary Study|Protocol Violation|0|||
48369231|NCT00196976|155544688|FG000|Primary Study|Withdrawal by Subject|1|||
48369232|NCT00196976|155544689|FG001|Primary Study|Withdrawal by Subject|0|||
48369233|NCT00196976|155544690|FG002|Primary Study|Withdrawal by Subject|1|||
48369234|NCT00196976|155544691|FG003|Primary Study|Withdrawal by Subject|1|||
48369235|NCT00196976|155544692|FG004|Primary Study|Withdrawal by Subject|2|||
48369236|NCT00196976|155544693|FG005|Primary Study|Withdrawal by Subject|1|||
48369237|NCT00196976|155544694|FG006|Primary Study|Withdrawal by Subject|0|||
48369238|NCT00196976|155544695|FG007|Primary Study|Withdrawal by Subject|0|||
48369239|NCT00196976|155544696|FG008|Primary Study|Withdrawal by Subject|0|||
48369240|NCT00196976|155544697|FG009|Primary Study|Withdrawal by Subject|1|||
48369241|NCT00196976|155544698|FG010|Primary Study|Withdrawal by Subject|0|||
48369242|NCT00196976|155544699|FG011|Primary Study|Withdrawal by Subject|0|||
48369243|NCT00196976|155544700|FG012|Primary Study|Withdrawal by Subject|0|||
48369244|NCT00196976|155544701|FG013|Primary Study|Withdrawal by Subject|0|||
48369245|NCT00196976|155544688|FG000|Primary Study|Lost to Follow-up|0|||
48369246|NCT00196976|155544689|FG001|Primary Study|Lost to Follow-up|0|||
48369247|NCT00196976|155544690|FG002|Primary Study|Lost to Follow-up|0|||
48369248|NCT00196976|155544691|FG003|Primary Study|Lost to Follow-up|0|||
48369249|NCT00196976|155544692|FG004|Primary Study|Lost to Follow-up|1|||
48369250|NCT00196976|155544693|FG005|Primary Study|Lost to Follow-up|1|||
48369251|NCT00196976|155544694|FG006|Primary Study|Lost to Follow-up|0|||
48369252|NCT00196976|155544695|FG007|Primary Study|Lost to Follow-up|2|||
48369253|NCT00196976|155544696|FG008|Primary Study|Lost to Follow-up|0|||
48369254|NCT00196976|155544697|FG009|Primary Study|Lost to Follow-up|0|||
48369255|NCT00196976|155544698|FG010|Primary Study|Lost to Follow-up|0|||
48369256|NCT00196976|155544699|FG011|Primary Study|Lost to Follow-up|0|||
48369257|NCT00196976|155544700|FG012|Primary Study|Lost to Follow-up|0|||
48369258|NCT00196976|155544701|FG013|Primary Study|Lost to Follow-up|0|||
48369259|NCT00196976|155544688|FG000|Primary Study|Other|0|||
48369260|NCT00196976|155544689|FG001|Primary Study|Other|0|||
48369261|NCT00196976|155544690|FG002|Primary Study|Other|2|||
48369262|NCT00196976|155544691|FG003|Primary Study|Other|0|||
48369263|NCT00196976|155544692|FG004|Primary Study|Other|0|||
48369264|NCT00196976|155544693|FG005|Primary Study|Other|0|||
48369265|NCT00196976|155544694|FG006|Primary Study|Other|0|||
48369266|NCT00196976|155544695|FG007|Primary Study|Other|0|||
48369267|NCT00196976|155544696|FG008|Primary Study|Other|0|||
48369268|NCT00196976|155544697|FG009|Primary Study|Other|0|||
48369269|NCT00196976|155544698|FG010|Primary Study|Other|0|||
48369270|NCT00196976|155544699|FG011|Primary Study|Other|0|||
48369271|NCT00196976|155544700|FG012|Primary Study|Other|0|||
48369272|NCT00196976|155544701|FG013|Primary Study|Other|0|||
48369273|NCT00196976|155544688|FG000|Booster Study|Withdrawal by Subject|0|||
48369274|NCT00196976|155544689|FG001|Booster Study|Withdrawal by Subject|0|||
48369275|NCT00196976|155544690|FG002|Booster Study|Withdrawal by Subject|0|||
48369276|NCT00196976|155544691|FG003|Booster Study|Withdrawal by Subject|0|||
48369277|NCT00196976|155544692|FG004|Booster Study|Withdrawal by Subject|0|||
48369278|NCT00196976|155544693|FG005|Booster Study|Withdrawal by Subject|0|||
48369279|NCT00196976|155544694|FG006|Booster Study|Withdrawal by Subject|0|||
48369280|NCT00196976|155544695|FG007|Booster Study|Withdrawal by Subject|0|||
48369281|NCT00196976|155544696|FG008|Booster Study|Withdrawal by Subject|0|||
48369282|NCT00196976|155544697|FG009|Booster Study|Withdrawal by Subject|0|||
48369283|NCT00196976|155544698|FG010|Booster Study|Withdrawal by Subject|1|||
48369284|NCT00196976|155544699|FG011|Booster Study|Withdrawal by Subject|0|||
48369285|NCT00196976|155544700|FG012|Booster Study|Withdrawal by Subject|0|||
48369286|NCT00196976|155544701|FG013|Booster Study|Withdrawal by Subject|0|||
48369287|NCT00196976|155544688|FG000|Booster Study|Lost to Follow-up|0|||
48369288|NCT00196976|155544689|FG001|Booster Study|Lost to Follow-up|0|||
48369289|NCT00196976|155544690|FG002|Booster Study|Lost to Follow-up|0|||
48369290|NCT00196976|155544691|FG003|Booster Study|Lost to Follow-up|0|||
48369291|NCT00196976|155544692|FG004|Booster Study|Lost to Follow-up|0|||
48369292|NCT00196976|155544693|FG005|Booster Study|Lost to Follow-up|0|||
48369293|NCT00196976|155544694|FG006|Booster Study|Lost to Follow-up|0|||
48369294|NCT00196976|155544695|FG007|Booster Study|Lost to Follow-up|0|||
48369295|NCT00196976|155544696|FG008|Booster Study|Lost to Follow-up|0|||
48369296|NCT00196976|155544697|FG009|Booster Study|Lost to Follow-up|0|||
48369297|NCT00196976|155544698|FG010|Booster Study|Lost to Follow-up|1|||
48369298|NCT00196976|155544699|FG011|Booster Study|Lost to Follow-up|2|||
48369299|NCT00196976|155544700|FG012|Booster Study|Lost to Follow-up|0|||
48369300|NCT00196976|155544701|FG013|Booster Study|Lost to Follow-up|0|||
48369301|NCT01942590|155544703|FG000|Overall Study|Withdrawal by Subject|0|||
48369302|NCT01942590|155544704|FG001|Overall Study|Withdrawal by Subject|1|||
48369303|NCT01942590|155544703|FG000|Overall Study|Adverse Event|1|||
48369304|NCT01942590|155544704|FG001|Overall Study|Adverse Event|0|||
48369305|NCT01139580|155544706|FG000|Overall Study|Adverse Event|5|||
48369306|NCT01139580|155544707|FG001|Overall Study|Adverse Event|4|||
48369307|NCT01139580|155544706|FG000|Overall Study|Lost to Follow-up|9|||
48369308|NCT01139580|155544707|FG001|Overall Study|Lost to Follow-up|1|||
48369309|NCT01139580|155544706|FG000|Overall Study|Lack of Efficacy|0|||
48369310|NCT01139580|155544707|FG001|Overall Study|Lack of Efficacy|2|||
48369311|NCT01139580|155544706|FG000|Overall Study|Withdrawal by Subject|6|||
48369312|NCT01139580|155544707|FG001|Overall Study|Withdrawal by Subject|9|||
48369313|NCT01139580|155544706|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
48369314|NCT01139580|155544707|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
48369315|NCT01139580|155544706|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
48369316|NCT01139580|155544707|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
48369317|NCT01139580|155544706|FG000|Overall Study|Misrandomized|1|||
48369318|NCT01139580|155544707|FG001|Overall Study|Misrandomized|0|||
48369319|NCT01139580|155544706|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
48369320|NCT01139580|155544707|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
48369321|NCT01139580|155544706|FG000|Overall Study|Participant Randomization in Error|0|||
48369322|NCT01139580|155544707|FG001|Overall Study|Participant Randomization in Error|1|||
48369323|NCT02679508|155544709|FG000|Healing Phase|Protocol Violation|1|||
48369324|NCT02679508|155544710|FG001|Healing Phase|Protocol Violation|1|||
48369325|NCT02679508|155544709|FG000|Healing Phase|Lost to Follow-up|1|||
48369326|NCT02679508|155544710|FG001|Healing Phase|Lost to Follow-up|0|||
48369327|NCT02679508|155544709|FG000|Maintenance Phase|Adverse Event|12|||
48369328|NCT02679508|155544710|FG001|Maintenance Phase|Adverse Event|2|||
48369329|NCT02679508|155544709|FG000|Maintenance Phase|Lost to Follow-up|0|||
48369330|NCT02679508|155544710|FG001|Maintenance Phase|Lost to Follow-up|1|||
48369331|NCT02679508|155544709|FG000|Maintenance Phase|Withdrawal by Subject|15|||
48369332|NCT02679508|155544710|FG001|Maintenance Phase|Withdrawal by Subject|8|||
48369333|NCT02679508|155544709|FG000|Maintenance Phase|Other|5|||
48369334|NCT02679508|155544710|FG001|Maintenance Phase|Other|4|||
48369335|NCT00572039|155544730|FG000|Overall Study|Withdrawal by Subject|9|||
48369336|NCT00572039|155544731|FG001|Overall Study|Withdrawal by Subject|6|||
48369337|NCT00572039|155544730|FG000|Overall Study|Death|2|||
48369338|NCT00572039|155544731|FG001|Overall Study|Death|3|||
48369339|NCT00572039|155544730|FG000|Overall Study|Ill|5|||
48369340|NCT00572039|155544731|FG001|Overall Study|Ill|1|||
48369341|NCT02112708|155544736|FG000|Baseline|Physician Decision|16|||
48369342|NCT02112708|155544737|FG001|Baseline|Physician Decision|11|||
48369343|NCT02112708|155544736|FG000|Baseline|Lost to Follow-up|12|||
48369344|NCT02112708|155544737|FG001|Baseline|Lost to Follow-up|0|||
48369345|NCT02112708|155544736|FG000|4 Month|Death|0|||
48369346|NCT02112708|155544737|FG001|4 Month|Death|1|||
48369347|NCT02112708|155544736|FG000|4 Month|Withdrawal by Subject|12|||
48369348|NCT02112708|155544737|FG001|4 Month|Withdrawal by Subject|0|||
48369349|NCT04540887|155544739|FG000|Overall Study|Withdrawal by Subject|2|||
48369350|NCT03965351|155544740|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
48369351|NCT03965351|155544741|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
48369352|NCT03965351|155544740|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
48369353|NCT03965351|155544741|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
48369354|NCT00953745|155544743|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
48369355|NCT00953745|155544744|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
48369356|NCT00953745|155544743|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
48369357|NCT00953745|155544744|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
48369358|NCT00953745|155544743|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
48369359|NCT00953745|155544744|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
48369360|NCT00953745|155544743|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
48369361|NCT00953745|155544744|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
48369362|NCT00953745|155544743|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
48369363|NCT00953745|155544744|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
48369364|NCT00953745|155544743|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
48369365|NCT00953745|155544744|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
48369366|NCT01323972|155544745|FG000|Overall Study|Withdrawal by Subject|1|||
48369367|NCT01323972|155544746|FG001|Overall Study|Withdrawal by Subject|0|||
48369368|NCT01323972|155544747|FG002|Overall Study|Withdrawal by Subject|1|||
48369369|NCT01323972|155544748|FG003|Overall Study|Withdrawal by Subject|0|||
48369370|NCT01323972|155544745|FG000|Overall Study|Migrated/moved from study area|1|||
48369371|NCT01323972|155544746|FG001|Overall Study|Migrated/moved from study area|2|||
48369372|NCT01323972|155544747|FG002|Overall Study|Migrated/moved from study area|0|||
48369373|NCT01323972|155544748|FG003|Overall Study|Migrated/moved from study area|0|||
48369374|NCT01323972|155544745|FG000|Overall Study|Lost to Follow-up|0|||
48369375|NCT01323972|155544746|FG001|Overall Study|Lost to Follow-up|1|||
48369376|NCT01323972|155544747|FG002|Overall Study|Lost to Follow-up|1|||
48369377|NCT01323972|155544748|FG003|Overall Study|Lost to Follow-up|1|||
48369378|NCT02399254|155544749|FG000|Overall Study|Physician Decision|2|||
48369379|NCT02008877|155544750|FG000|Overall Study|Inevaluable|0|||
48369380|NCT02008877|155544751|FG001|Overall Study|Inevaluable|1|||
48369381|NCT02008877|155544752|FG002|Overall Study|Inevaluable|0|||
48369382|NCT00903682|155544754|FG000|Overall Study|Adverse Event|6|||
48369383|NCT00903682|155544755|FG001|Overall Study|Adverse Event|13|||
48369384|NCT00903682|155544754|FG000|Overall Study|Lost to Follow-up|1|||
48369385|NCT00903682|155544755|FG001|Overall Study|Lost to Follow-up|0|||
48369386|NCT00903682|155544754|FG000|Overall Study|Withdrawal by Subject|5|||
48369387|NCT00903682|155544755|FG001|Overall Study|Withdrawal by Subject|0|||
48369388|NCT00903682|155544754|FG000|Overall Study|Pregnancy|0|||
48369389|NCT00903682|155544755|FG001|Overall Study|Pregnancy|1|||
48369390|NCT00903682|155544754|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
48369391|NCT00903682|155544755|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
48369392|NCT00903682|155544754|FG000|Overall Study|Subject Non-Compliant|1|||
48369393|NCT00903682|155544755|FG001|Overall Study|Subject Non-Compliant|0|||
48369394|NCT00903682|155544754|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
48369395|NCT00903682|155544755|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
48369396|NCT00903682|155544754|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
48369397|NCT00903682|155544755|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
48369398|NCT03965689|155544756|FG000|Overall Study|Too sick to get study intervention|2|||
48369399|NCT01942785|155544757|FG000|Overall Study|Adverse Event|2|||
48369400|NCT01942785|155544757|FG000|Overall Study|Withdrawal by Subject|1|||
48369401|NCT01942785|155544757|FG000|Overall Study|Protocol Violation|1|||
48369402|NCT03534284|155544758|FG000|Overall Study|Death|2|||
48369403|NCT03534284|155544759|FG001|Overall Study|Death|3|||
48369404|NCT03534284|155544760|FG002|Overall Study|Death|3|||
48369405|NCT03534284|155544758|FG000|Overall Study|Withdrawal by Subject|5|||
48369406|NCT03534284|155544759|FG001|Overall Study|Withdrawal by Subject|0|||
48369407|NCT03534284|155544760|FG002|Overall Study|Withdrawal by Subject|0|||
48369408|NCT05326815|155544761|FG000|Overall Study|Withdrawal by Subject|3|||
48369409|NCT05326815|155544761|FG000|Overall Study|Did not complete required labs|6|||
48369410|NCT05326815|155544761|FG000|Overall Study|Screen fail- abnormal labs|5|||
48369411|NCT04737187|155544763|FG000|Overall Study|Switched to marketed drug|32|||
48369412|NCT04737187|155544764|FG001|Overall Study|Switched to marketed drug|4|||
48369413|NCT04737187|155544763|FG000|Overall Study|Radiological Progressive Disease|145|||
48369414|NCT04737187|155544764|FG001|Overall Study|Radiological Progressive Disease|146|||
48369415|NCT04737187|155544763|FG000|Overall Study|Clinical Progressive Disease|20|||
48369416|NCT04737187|155544764|FG001|Overall Study|Clinical Progressive Disease|20|||
48369417|NCT04737187|155544763|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
48369418|NCT04737187|155544764|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
48369419|NCT04737187|155544763|FG000|Overall Study|Adverse Event|16|||
48369420|NCT04737187|155544764|FG001|Overall Study|Adverse Event|16|||
48369421|NCT04737187|155544763|FG000|Overall Study|Physician Decision|2|||
48369422|NCT04737187|155544764|FG001|Overall Study|Physician Decision|0|||
48369423|NCT04737187|155544763|FG000|Overall Study|Withdrawal by Subject|5|||
48369424|NCT04737187|155544764|FG001|Overall Study|Withdrawal by Subject|8|||
48369425|NCT02730598|155544766|FG000|Overall Study|Withdrawal by Subject|3|||
48369426|NCT02730598|155544767|FG001|Overall Study|Withdrawal by Subject|3|||
48369427|NCT02730598|155544766|FG000|Overall Study|Protocol Violation|0|||
48369428|NCT02730598|155544767|FG001|Overall Study|Protocol Violation|1|||
48369429|NCT02730598|155544766|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
48369430|NCT02730598|155544767|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
48369431|NCT03282240|155544768|FG000|Overall Study|Adverse Event|2|||
48369432|NCT03282240|155544769|FG001|Overall Study|Adverse Event|2|||
48369433|NCT03282240|155544770|FG002|Overall Study|Adverse Event|0|||
48369434|NCT03282240|155544768|FG000|Overall Study|Lost to Follow-up|3|||
48369435|NCT03282240|155544769|FG001|Overall Study|Lost to Follow-up|0|||
48369436|NCT03282240|155544770|FG002|Overall Study|Lost to Follow-up|0|||
48369437|NCT03282240|155544768|FG000|Overall Study|Protocol Deviation|4|||
48369438|NCT03282240|155544769|FG001|Overall Study|Protocol Deviation|1|||
48369439|NCT03282240|155544770|FG002|Overall Study|Protocol Deviation|2|||
48369440|NCT03282240|155544768|FG000|Overall Study|Withdrawal by Subject|1|||
48369441|NCT03282240|155544769|FG001|Overall Study|Withdrawal by Subject|0|||
48369442|NCT03282240|155544770|FG002|Overall Study|Withdrawal by Subject|1|||
48369443|NCT00923260|155546291|FG000|Overall Study|Lost to Follow-up|1|||
48369444|NCT00923260|155546292|FG001|Overall Study|Lost to Follow-up|1|||
48369445|NCT00910689|155546294|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
48369446|NCT00910689|155546295|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
48369447|NCT00910689|155546296|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
48369448|NCT00910689|155546297|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
48369449|NCT00910689|155546294|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
48369450|NCT00910689|155546295|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
48369451|NCT00910689|155546296|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
48369452|NCT00910689|155546297|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
48369453|NCT00910689|155546294|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
48369454|NCT00910689|155546295|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
48369455|NCT00910689|155546296|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
48369456|NCT00910689|155546297|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
48369457|NCT00910689|155546294|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
48369458|NCT00910689|155546295|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
48369459|NCT00910689|155546296|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
48369460|NCT00910689|155546297|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
48369461|NCT00910689|155546294|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
48369462|NCT00910689|155546295|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
48369463|NCT00910689|155546296|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
48369464|NCT00910689|155546297|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
48369465|NCT00910689|155546294|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
48369466|NCT00910689|155546295|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
48369467|NCT00910689|155546296|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
48369468|NCT00910689|155546297|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
48369469|NCT00910689|155546294|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
48369470|NCT00910689|155546295|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
48369471|NCT00910689|155546296|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
48369472|NCT00910689|155546297|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
48369473|NCT00910689|155546294|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
48369474|NCT00910689|155546295|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
48369475|NCT00910689|155546296|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
48369476|NCT00910689|155546297|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
48369477|NCT00910689|155546294|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
48369478|NCT00910689|155546295|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
48369479|NCT00910689|155546296|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
48369480|NCT00910689|155546297|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
48369481|NCT00910689|155546294|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
48369482|NCT00910689|155546295|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
48369483|NCT00910689|155546296|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
48369484|NCT00910689|155546297|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
48369485|NCT00910689|155546294|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
48369486|NCT00910689|155546295|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
48369487|NCT00910689|155546296|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
48369488|NCT00910689|155546297|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
48369489|NCT00910689|155546294|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
48369490|NCT00910689|155546295|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
48369491|NCT00910689|155546296|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
48369492|NCT00910689|155546297|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
48369493|NCT00910689|155546294|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
48369494|NCT00910689|155546295|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
48369495|NCT00910689|155546296|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
48369496|NCT00910689|155546297|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
48369497|NCT00910689|155546294|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
48369498|NCT00910689|155546295|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
48369499|NCT00910689|155546296|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
48369500|NCT00910689|155546297|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
48369501|NCT00910689|155546294|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
48369502|NCT00910689|155546295|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
48369503|NCT00910689|155546296|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
48369504|NCT00910689|155546297|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
48369505|NCT00910689|155546294|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
48369506|NCT00910689|155546295|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
48369507|NCT00910689|155546296|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
48369508|NCT00910689|155546297|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
48369509|NCT00910689|155546294|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
48369510|NCT00910689|155546295|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
48369511|NCT00910689|155546296|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
48369512|NCT00910689|155546297|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
48369513|NCT00910689|155546294|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
48369514|NCT00910689|155546295|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
48369515|NCT00910689|155546296|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
48369516|NCT00910689|155546297|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
48369517|NCT00910689|155546294|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
48369518|NCT00910689|155546295|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
48369519|NCT00910689|155546296|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
48369520|NCT00910689|155546297|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
48369521|NCT00910689|155546294|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
48369522|NCT00910689|155546295|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
48369523|NCT00910689|155546296|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
48369524|NCT00910689|155546297|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
48369525|NCT00910689|155546294|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
48369526|NCT00910689|155546295|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
48369527|NCT00910689|155546296|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
48369528|NCT00910689|155546297|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
48369529|NCT01290029|155546298|FG000|Overall Study|Other|2|||
48369530|NCT00189488|155546299|FG000|Overall Study|Ineligibility determined|1|||
48369531|NCT00189488|155546300|FG001|Overall Study|Ineligibility determined|0|||
48369532|NCT00189488|155546299|FG000|Overall Study|Protocol deviation|2|||
48369533|NCT00189488|155546300|FG001|Overall Study|Protocol deviation|1|||
48369534|NCT00189488|155546299|FG000|Overall Study|Adverse Event|2|||
48369535|NCT00189488|155546300|FG001|Overall Study|Adverse Event|1|||
48369536|NCT00189488|155546299|FG000|Overall Study|Withdrawal by Subject|2|||
48369537|NCT00189488|155546300|FG001|Overall Study|Withdrawal by Subject|6|||
48369538|NCT00189488|155546299|FG000|Overall Study|Disease progression|2|||
48369539|NCT00189488|155546300|FG001|Overall Study|Disease progression|4|||
48369540|NCT00189488|155546299|FG000|Overall Study|Administrative Decision|0|||
48369541|NCT00189488|155546300|FG001|Overall Study|Administrative Decision|2|||
48369542|NCT00189488|155546299|FG000|Overall Study|Death|5|||
48369543|NCT00189488|155546300|FG001|Overall Study|Death|8|||
48369544|NCT00189488|155546299|FG000|Overall Study|Other|1|||
48369545|NCT00189488|155546300|FG001|Overall Study|Other|0|||
48369546|NCT02366468|155546305|FG000|Overall Study|Adverse Event|2|||
48369547|NCT02366468|155546306|FG001|Overall Study|Adverse Event|0|||
48369548|NCT02366468|155546305|FG000|Overall Study|Withdrawal by Subject|1|||
48369549|NCT02366468|155546306|FG001|Overall Study|Withdrawal by Subject|5|||
48369550|NCT02366468|155546305|FG000|Overall Study|Lost to Follow-up|2|||
48369551|NCT02366468|155546306|FG001|Overall Study|Lost to Follow-up|0|||
48369552|NCT02366468|155546305|FG000|Overall Study|Death|1|||
48369553|NCT02366468|155546306|FG001|Overall Study|Death|2|||
48369554|NCT02366468|155546305|FG000|Overall Study|Other|0|||
48369555|NCT02366468|155546306|FG001|Overall Study|Other|2|||
48369556|NCT04289051|155546309|FG000|Overall Study|Lost to Follow-up|0|||
48369557|NCT04289051|155546310|FG001|Overall Study|Lost to Follow-up|0|||
48369558|NCT04289051|155546311|FG002|Overall Study|Lost to Follow-up|2|||
48369559|NCT02874924|155546312|FG000|Overall Study|Adverse Event|2|||
48369560|NCT02874924|155546313|FG001|Overall Study|Adverse Event|0|||
48369561|NCT02874924|155546314|FG002|Overall Study|Adverse Event|0|||
48369562|NCT02874924|155546312|FG000|Overall Study|Withdrawal by Subject|1|||
48369563|NCT02874924|155546313|FG001|Overall Study|Withdrawal by Subject|0|||
48369564|NCT02874924|155546314|FG002|Overall Study|Withdrawal by Subject|0|||
48692641|NCT03001557|156724545|FG004|Extension Phase|Lost to Follow-up|0|||
48369565|NCT00657020|155546317|FG000|PERIOD 1|Adverse Event|0|||
48369566|NCT00657020|155546318|FG001|PERIOD 1|Adverse Event|1|||
48369567|NCT01183234|155546321|FG000|First Intervention|Adverse Event|1|||
48369568|NCT01183234|155546322|FG001|First Intervention|Adverse Event|0|||
48369569|NCT01981473|155546328|FG000|Overall Study|Incorrect diagnosis of RA|0|||
48369570|NCT01981473|155546329|FG001|Overall Study|Incorrect diagnosis of RA|0|||
48369571|NCT01981473|155546330|FG002|Overall Study|Incorrect diagnosis of RA|1|||
48369572|NCT01981473|155546328|FG000|Overall Study|Received treatment for < 6 months|0|||
48369573|NCT01981473|155546329|FG001|Overall Study|Received treatment for < 6 months|0|||
48369574|NCT01981473|155546330|FG002|Overall Study|Received treatment for < 6 months|1|||
48369575|NCT01981473|155546328|FG000|Overall Study|Received treatment for >24 months|2|||
48369576|NCT01981473|155546329|FG001|Overall Study|Received treatment for >24 months|0|||
48369577|NCT01981473|155546330|FG002|Overall Study|Received treatment for >24 months|6|||
48369578|NCT00434213|155546333|FG000|Overall Study|Adverse Event|12|||
48369579|NCT00434213|155546333|FG000|Overall Study|Lack of Efficacy|9|||
48369580|NCT00434213|155546333|FG000|Overall Study|Lost to Follow-up|14|||
48369581|NCT00434213|155546333|FG000|Overall Study|Withdrawal by Subject|7|||
48369582|NCT00434213|155546333|FG000|Overall Study|Protocol Violation|3|||
48369583|NCT00434213|155546333|FG000|Overall Study|Unable to comply with study visit window|2|||
48369584|NCT00434213|155546333|FG000|Overall Study|Application site reaction|1|||
48369585|NCT00434213|155546333|FG000|Overall Study|Non-compliant to study schedule|1|||
48369586|NCT05062759|155546334|FG000|Overall Study|Death|0|||
48369587|NCT05062759|155546335|FG001|Overall Study|Death|1|||
48369588|NCT05062759|155546334|FG000|Overall Study|Lost to Follow-up|1|||
48369589|NCT05062759|155546335|FG001|Overall Study|Lost to Follow-up|0|||
48369590|NCT00766363|155546338|FG000|Overall Study|Withdrawal by Subject|1|||
48369591|NCT00766363|155546339|FG001|Overall Study|Withdrawal by Subject|0|||
48369592|NCT00766363|155546340|FG002|Overall Study|Withdrawal by Subject|0|||
48369593|NCT00766363|155546341|FG003|Overall Study|Withdrawal by Subject|0|||
48369594|NCT00766363|155546338|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
48369595|NCT00766363|155546339|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
48369596|NCT00766363|155546340|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
48369597|NCT00766363|155546341|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
48369598|NCT00768079|155546346|FG000|Overall Study|Lost to Follow-up|2|||
48369599|NCT00768079|155546347|FG001|Overall Study|Lost to Follow-up|0|||
48369600|NCT00768079|155546348|FG002|Overall Study|Lost to Follow-up|4|||
48369601|NCT00768079|155546346|FG000|Overall Study|Participant incarcerated|0|||
48369602|NCT00768079|155546347|FG001|Overall Study|Participant incarcerated|1|||
48369603|NCT00768079|155546348|FG002|Overall Study|Participant incarcerated|0|||
48369604|NCT00993668|155546352|FG000|Single-Blind Period|Adverse Event|1|||
48369605|NCT00993668|155546353|FG001|Single-Blind Period|Adverse Event|1|||
48369606|NCT00993668|155546352|FG000|Single-Blind Period|Lack of Efficacy|0|||
48369607|NCT00993668|155546353|FG001|Single-Blind Period|Lack of Efficacy|1|||
48369608|NCT00993668|155546352|FG000|Single-Blind Period|Lost to Follow-up|3|||
48369609|NCT00993668|155546353|FG001|Single-Blind Period|Lost to Follow-up|1|||
48369610|NCT00993668|155546352|FG000|Open-Label Period|Adverse Event|9|||
48369611|NCT00993668|155546353|FG001|Open-Label Period|Adverse Event|8|||
48369612|NCT00993668|155546352|FG000|Open-Label Period|Lack of Efficacy|4|||
48369613|NCT00993668|155546353|FG001|Open-Label Period|Lack of Efficacy|3|||
48369614|NCT00993668|155546352|FG000|Open-Label Period|Withdrawal by Subject|4|||
48369615|NCT00993668|155546353|FG001|Open-Label Period|Withdrawal by Subject|3|||
48369616|NCT00993668|155546352|FG000|Open-Label Period|Lost to Follow-up|6|||
48369617|NCT00993668|155546353|FG001|Open-Label Period|Lost to Follow-up|1|||
48369618|NCT01236534|155546355|FG000|Overall Study|Adverse Event|3|||
48369619|NCT01236534|155546356|FG001|Overall Study|Adverse Event|0|||
48369620|NCT01659853|155546357|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
48369621|NCT01659853|155546358|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
48369622|NCT01659853|155546357|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
48369623|NCT01659853|155546358|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
48369624|NCT01079663|155546361|FG000|Overall Study|Adverse Event|0|||
48369625|NCT01079663|155546362|FG001|Overall Study|Adverse Event|2|||
48369626|NCT01079663|155546361|FG000|Overall Study|Protocol Violation|0|||
48369627|NCT01079663|155546362|FG001|Overall Study|Protocol Violation|2|||
48369628|NCT00424385|155546374|FG000|Cohort 0|Withdrawal by Subject|5|||
48369629|NCT00424385|155546374|FG000|Cohort 0|Physician Decision|1|||
48369630|NCT00424385|155546374|FG000|Cohort 1|Withdrawal by Subject|1|||
48369631|NCT05653427|155546379|FG000|Overall Study|Study Terminated by Sponsor|13|||
48369632|NCT01621568|155546381|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
48369633|NCT01621568|155546382|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
48369634|NCT01621568|155546381|FG000|Week 5-6 No Treatment|Death|1|||
48369635|NCT01621568|155546382|FG001|Week 5-6 No Treatment|Death|0|||
48369636|NCT02930226|155546383|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
48369637|NCT02930226|155546384|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
48369638|NCT02930226|155546385|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
48369639|NCT02930226|155546386|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
48369640|NCT02930226|155546387|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
48369641|NCT02930226|155546388|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
48369642|NCT01205152|155546391|FG000|Overall Study|Death|1|||
48369643|NCT00141219|155546400|FG000|Overall Study|Protocol violations|5|||
48369644|NCT00141219|155546401|FG001|Overall Study|Protocol violations|4|||
48369645|NCT00141219|155546400|FG000|Overall Study|Adverse Event|8|||
48369646|NCT00141219|155546401|FG001|Overall Study|Adverse Event|6|||
48369647|NCT00141219|155546400|FG000|Overall Study|Lack of Efficacy|5|||
48369648|NCT00141219|155546401|FG001|Overall Study|Lack of Efficacy|4|||
48369649|NCT00141219|155546400|FG000|Overall Study|Withdrawal by Subject|6|||
48369650|NCT00141219|155546401|FG001|Overall Study|Withdrawal by Subject|2|||
48369651|NCT02595073|155546404|FG000|Overall Study|Progressive Disease|0|||
48369652|NCT02595073|155546405|FG001|Overall Study|Progressive Disease|1|||
48369653|NCT02595073|155546404|FG000|Overall Study|Protocol Violation|2|||
48369654|NCT02595073|155546405|FG001|Overall Study|Protocol Violation|0|||
48369655|NCT01655693|155546406|FG000|Overall Study|Progression of Disease|92|||
48369656|NCT01655693|155546407|FG001|Overall Study|Progression of Disease|76|||
48369657|NCT01655693|155546408|FG002|Overall Study|Progression of Disease|58|||
48369658|NCT01655693|155546406|FG000|Overall Study|Death|8|||
48369659|NCT01655693|155546407|FG001|Overall Study|Death|9|||
48369660|NCT01655693|155546408|FG002|Overall Study|Death|12|||
48369661|NCT01655693|155546406|FG000|Overall Study|Serious Adverse Event|3|||
48369662|NCT01655693|155546407|FG001|Overall Study|Serious Adverse Event|15|||
48369663|NCT01655693|155546408|FG002|Overall Study|Serious Adverse Event|11|||
48369664|NCT01655693|155546406|FG000|Overall Study|Withdrawal by Subject|3|||
48369665|NCT01655693|155546407|FG001|Overall Study|Withdrawal by Subject|2|||
48369666|NCT01655693|155546408|FG002|Overall Study|Withdrawal by Subject|20|||
48369667|NCT01655693|155546406|FG000|Overall Study|Adverse Event|3|||
48369668|NCT01655693|155546407|FG001|Overall Study|Adverse Event|11|||
48369669|NCT01655693|155546408|FG002|Overall Study|Adverse Event|3|||
48369670|NCT01655693|155546406|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
48369671|NCT01655693|155546407|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
48369672|NCT01655693|155546408|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
48369673|NCT01655693|155546406|FG000|Overall Study|Non-Compliance|0|||
48369674|NCT01655693|155546407|FG001|Overall Study|Non-Compliance|0|||
48369675|NCT01655693|155546408|FG002|Overall Study|Non-Compliance|7|||
48369676|NCT01655693|155546406|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
48369677|NCT01655693|155546407|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
48369678|NCT01655693|155546408|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
48369679|NCT01655693|155546406|FG000|Overall Study|Protocol Violation|1|||
48369680|NCT01655693|155546407|FG001|Overall Study|Protocol Violation|0|||
48369681|NCT01655693|155546408|FG002|Overall Study|Protocol Violation|3|||
48369682|NCT01655693|155546406|FG000|Overall Study|Lost to Follow-up|1|||
48369683|NCT01655693|155546407|FG001|Overall Study|Lost to Follow-up|0|||
48369684|NCT01655693|155546408|FG002|Overall Study|Lost to Follow-up|1|||
48369685|NCT01655693|155546406|FG000|Overall Study|Screening Failure|1|||
48369686|NCT01655693|155546407|FG001|Overall Study|Screening Failure|0|||
48369687|NCT01655693|155546408|FG002|Overall Study|Screening Failure|0|||
48369688|NCT01655693|155546406|FG000|Overall Study|Other|8|||
48369689|NCT01655693|155546407|FG001|Overall Study|Other|6|||
48369690|NCT01655693|155546408|FG002|Overall Study|Other|15|||
48369691|NCT03218397|155546411|FG000|Overall Study|Prior positive blood culture|8|||
48369692|NCT03218397|155546412|FG001|Overall Study|Prior positive blood culture|13|||
48369693|NCT03218397|155546411|FG000|Overall Study|Comfort care|8|||
48369694|NCT03218397|155546412|FG001|Overall Study|Comfort care|5|||
48369695|NCT03218397|155546411|FG000|Overall Study|Comfort care and positive blood culture|1|||
48369696|NCT03218397|155546412|FG001|Overall Study|Comfort care and positive blood culture|0|||
48369697|NCT03218397|155546411|FG000|Overall Study|Comfort care and mixed culture|0|||
48369698|NCT03218397|155546412|FG001|Overall Study|Comfort care and mixed culture|1|||
48369699|NCT03218397|155546411|FG000|Overall Study|Mixed culture|2|||
48369700|NCT03218397|155546412|FG001|Overall Study|Mixed culture|2|||
48369701|NCT03218397|155546411|FG000|Overall Study|Inaccessible hospital records|2|||
48369702|NCT03218397|155546412|FG001|Overall Study|Inaccessible hospital records|5|||
48369703|NCT03218397|155546411|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
48369704|NCT03218397|155546412|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
48369705|NCT03218397|155546411|FG000|Overall Study|Randomized during laboratory off hours|2|||
48369706|NCT03218397|155546412|FG001|Overall Study|Randomized during laboratory off hours|1|||
48369707|NCT01796548|155546413|FG000|Overall Study|Lost to Follow-up|1|||
48369708|NCT01796548|155546413|FG000|Overall Study|Other|2|||
48369709|NCT02665338|155546415|FG000|Overall Study|Withdrawal by Subject|0|||
48369710|NCT02665338|155546416|FG001|Overall Study|Withdrawal by Subject|1|||
48369711|NCT00998335|155546419|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
48369712|NCT00998335|155546420|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
48369713|NCT02641496|155546422|FG000|Overall Study|Lost to Follow-up|13|||
48369714|NCT02641496|155546423|FG001|Overall Study|Lost to Follow-up|12|||
48369715|NCT02641496|155546422|FG000|Overall Study|Withdrawal by Subject|1|||
48369716|NCT02641496|155546423|FG001|Overall Study|Withdrawal by Subject|0|||
48369717|NCT01204398|155546424|FG000|Overall Study|Adverse Event|1|||
48369718|NCT02523599|155546425|FG000|Overall Study|Adverse Event|1|||
48369719|NCT02523599|155546426|FG001|Overall Study|Adverse Event|0|||
48369720|NCT02523599|155546425|FG000|Overall Study|Physician Decision|1|||
48369721|NCT02523599|155546426|FG001|Overall Study|Physician Decision|0|||
48369722|NCT02523599|155546425|FG000|Overall Study|Lost to Follow-up|4|||
48369723|NCT02523599|155546426|FG001|Overall Study|Lost to Follow-up|1|||
48369724|NCT02523599|155546425|FG000|Overall Study|Did not return for Day 30 visit|2|||
48369725|NCT02523599|155546426|FG001|Overall Study|Did not return for Day 30 visit|0|||
48369726|NCT01427751|155546427|FG000|Overall Study|Adverse Event|18|||
48369727|NCT01427751|155546428|FG001|Overall Study|Adverse Event|2|||
48369728|NCT01427751|155546427|FG000|Overall Study|No further treatment benefit expected|5|||
48369729|NCT01427751|155546428|FG001|Overall Study|No further treatment benefit expected|1|||
48369730|NCT01427751|155546427|FG000|Overall Study|Lost to Follow-up|3|||
48369731|NCT01427751|155546428|FG001|Overall Study|Lost to Follow-up|1|||
48369732|NCT01427751|155546427|FG000|Overall Study|Withdrawal of consent|2|||
48369733|NCT01427751|155546428|FG001|Overall Study|Withdrawal of consent|2|||
48369734|NCT01427751|155546427|FG000|Overall Study|Protocol Violation|6|||
48369735|NCT01427751|155546428|FG001|Overall Study|Protocol Violation|4|||
48369736|NCT01427751|155546427|FG000|Overall Study|Death|2|||
48369737|NCT01427751|155546428|FG001|Overall Study|Death|0|||
48369738|NCT01427751|155546427|FG000|Overall Study|Other miscellaneous reasons|6|||
48369739|NCT01427751|155546428|FG001|Overall Study|Other miscellaneous reasons|4|||
48369740|NCT01028027|155546429|FG000|Overall Study|Lost to Follow-up|4|||
48369741|NCT01028027|155546430|FG001|Overall Study|Lost to Follow-up|1|||
48369742|NCT01028027|155546429|FG000|Overall Study|Withdrawal by Subject|5|||
48369743|NCT01028027|155546430|FG001|Overall Study|Withdrawal by Subject|3|||
48369744|NCT01028027|155546429|FG000|Overall Study|Adverse Event|4|||
48369745|NCT01028027|155546430|FG001|Overall Study|Adverse Event|7|||
48369746|NCT01028027|155546429|FG000|Overall Study|Protocol Violation|3|||
48369747|NCT01028027|155546430|FG001|Overall Study|Protocol Violation|1|||
48369748|NCT01028027|155546429|FG000|Overall Study|Lack of Efficacy|0|||
48369749|NCT01028027|155546430|FG001|Overall Study|Lack of Efficacy|1|||
48369750|NCT05330312|155546434|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
48369751|NCT05330312|155546435|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
48369752|NCT05330312|155546436|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
48369753|NCT05330312|155546434|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
48369754|NCT05330312|155546435|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
48369755|NCT05330312|155546436|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
48369756|NCT05330312|155546434|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
48369757|NCT05330312|155546435|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
48369758|NCT05330312|155546436|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
48369759|NCT05330312|155546434|FG000|Pivotal Investigation - Part 2|Death|1|||
48369760|NCT05330312|155546435|FG001|Pivotal Investigation - Part 2|Death|4|||
48369761|NCT05330312|155546436|FG002|Pivotal Investigation - Part 2|Death|0|||
48369762|NCT00925132|155546437|FG000|Overall Study|Withdrawal by Subject|2|||
48369763|NCT00925132|155546438|FG001|Overall Study|Withdrawal by Subject|0|||
48369764|NCT00925132|155546439|FG002|Overall Study|Withdrawal by Subject|0|||
48369765|NCT00925132|155546440|FG003|Overall Study|Withdrawal by Subject|0|||
48369766|NCT00925132|155546441|FG004|Overall Study|Withdrawal by Subject|1|||
48369767|NCT00925132|155546437|FG000|Overall Study|Removed due to disease progression|0|||
48369768|NCT00925132|155546438|FG001|Overall Study|Removed due to disease progression|0|||
48369769|NCT00925132|155546439|FG002|Overall Study|Removed due to disease progression|0|||
48369770|NCT00925132|155546440|FG003|Overall Study|Removed due to disease progression|0|||
48369771|NCT00925132|155546441|FG004|Overall Study|Removed due to disease progression|4|||
48369772|NCT01910181|155546442|FG000|Overall Study|Death|37|||
48369773|NCT01910181|155546442|FG000|Overall Study|Lost to Follow-up|3|||
48369774|NCT01910181|155546442|FG000|Overall Study|Study Terminated by Sponsor|6|||
48369775|NCT00872989|155548154|FG000|Overall Study|Adverse Event|7|||
48369776|NCT00872989|155548155|FG001|Overall Study|Adverse Event|15|||
48369777|NCT00872989|155548154|FG000|Overall Study|Withdrawal by Subject|8|||
48369778|NCT00872989|155548155|FG001|Overall Study|Withdrawal by Subject|5|||
48369779|NCT00872989|155548154|FG000|Overall Study|Progression/relapse|47|||
48369780|NCT00872989|155548155|FG001|Overall Study|Progression/relapse|35|||
48369781|NCT00872989|155548154|FG000|Overall Study|Not protocol specified|3|||
48369782|NCT00872989|155548155|FG001|Overall Study|Not protocol specified|8|||
48369783|NCT01198756|155548156|FG000|Overall Study|Adverse Event|0|||
48369784|NCT01198756|155548157|FG001|Overall Study|Adverse Event|0|||
48369785|NCT01198756|155548158|FG002|Overall Study|Adverse Event|0|||
48369786|NCT01198756|155548159|FG003|Overall Study|Adverse Event|1|||
48369787|NCT01198756|155548156|FG000|Overall Study|Protocol Violation|0|||
48369788|NCT01198756|155548157|FG001|Overall Study|Protocol Violation|0|||
48369789|NCT01198756|155548158|FG002|Overall Study|Protocol Violation|0|||
48369790|NCT01198756|155548159|FG003|Overall Study|Protocol Violation|2|||
48369791|NCT01198756|155548156|FG000|Overall Study|Withdrawal by Subject|9|||
48369792|NCT01198756|155548157|FG001|Overall Study|Withdrawal by Subject|4|||
48369793|NCT01198756|155548158|FG002|Overall Study|Withdrawal by Subject|7|||
48369794|NCT01198756|155548159|FG003|Overall Study|Withdrawal by Subject|5|||
48369795|NCT01198756|155548156|FG000|Overall Study|Lost to Follow-up|29|||
48369796|NCT01198756|155548157|FG001|Overall Study|Lost to Follow-up|36|||
48369797|NCT01198756|155548158|FG002|Overall Study|Lost to Follow-up|23|||
48369798|NCT01198756|155548159|FG003|Overall Study|Lost to Follow-up|18|||
48369799|NCT01127893|155548160|FG000|Overall Study|Study Termination by the Sponsor|1|||
48369800|NCT04797650|155548167|FG000|Overall Study|Reason Not Specified|5|||
48369801|NCT04797650|155548168|FG001|Overall Study|Reason Not Specified|12|||
48369802|NCT04797650|155548169|FG002|Overall Study|Reason Not Specified|5|||
48369803|NCT04797650|155548167|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
48369804|NCT04797650|155548168|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
48369805|NCT04797650|155548169|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
48369806|NCT04797650|155548167|FG000|Overall Study|Lack of Efficacy|1|||
48369807|NCT04797650|155548168|FG001|Overall Study|Lack of Efficacy|0|||
48369808|NCT04797650|155548169|FG002|Overall Study|Lack of Efficacy|1|||
48369809|NCT04797650|155548167|FG000|Overall Study|Non-compliance with Study Drug|0|||
48369810|NCT04797650|155548168|FG001|Overall Study|Non-compliance with Study Drug|0|||
48369811|NCT04797650|155548169|FG002|Overall Study|Non-compliance with Study Drug|2|||
48369812|NCT04797650|155548167|FG000|Overall Study|Lost to Follow-up|4|||
48369813|NCT04797650|155548168|FG001|Overall Study|Lost to Follow-up|6|||
48369814|NCT04797650|155548169|FG002|Overall Study|Lost to Follow-up|1|||
48369815|NCT02040584|155548170|FG000|Overall Study|Adverse Event|13|||
48369816|NCT02040584|155548171|FG001|Overall Study|Adverse Event|6|||
48369817|NCT02040584|155548170|FG000|Overall Study|Protocol Violation|9|||
48369818|NCT02040584|155548171|FG001|Overall Study|Protocol Violation|11|||
48369819|NCT02040584|155548170|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48369820|NCT02040584|155548171|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48369821|NCT02040584|155548170|FG000|Overall Study|Death|6|||
48369822|NCT02040584|155548171|FG001|Overall Study|Death|3|||
48369823|NCT02040584|155548170|FG000|Overall Study|Transplant rejection/retransplant|0|||
48369824|NCT02040584|155548171|FG001|Overall Study|Transplant rejection/retransplant|1|||
48369825|NCT02040584|155548170|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
48369826|NCT02040584|155548171|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
48369827|NCT00996476|155548172|FG000|Overall Study|Withdrawal by Subject|1|||
48369828|NCT00996476|155548173|FG001|Overall Study|Withdrawal by Subject|2|||
48369829|NCT00996476|155548174|FG002|Overall Study|Withdrawal by Subject|1|||
48369830|NCT00996476|155548175|FG003|Overall Study|Withdrawal by Subject|0|||
48369831|NCT00996476|155548176|FG004|Overall Study|Withdrawal by Subject|1|||
48369832|NCT00996476|155548172|FG000|Overall Study|Adverse Event|0|||
48369833|NCT00996476|155548173|FG001|Overall Study|Adverse Event|1|||
48369834|NCT00996476|155548174|FG002|Overall Study|Adverse Event|0|||
48369835|NCT00996476|155548175|FG003|Overall Study|Adverse Event|0|||
48369836|NCT00996476|155548176|FG004|Overall Study|Adverse Event|1|||
48369837|NCT00757588|155548179|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
48369838|NCT00757588|155548180|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
48369839|NCT00757588|155548179|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
48369840|NCT00757588|155548180|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
48369841|NCT00757588|155548179|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
48369842|NCT00757588|155548180|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
48369843|NCT00757588|155548179|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
48369844|NCT00757588|155548180|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
48369845|NCT00757588|155548179|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
48369846|NCT00757588|155548180|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
48369847|NCT00757588|155548179|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
48369848|NCT00757588|155548180|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
48369849|NCT00757588|155548179|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
48369850|NCT00757588|155548180|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
48369851|NCT00757588|155548179|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
48369852|NCT00757588|155548180|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
48369853|NCT00757588|155548179|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
48369854|NCT00757588|155548180|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
48369855|NCT00757588|155548179|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
48369856|NCT00757588|155548180|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
48369857|NCT00757588|155548179|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
48369858|NCT00757588|155548180|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
48369859|NCT00757588|155548179|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
48369860|NCT00757588|155548180|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
48369861|NCT00757588|155548179|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
48369862|NCT00757588|155548180|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
48369863|NCT00757588|155548179|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
48369864|NCT00757588|155548180|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
48369865|NCT00757588|155548179|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
48369866|NCT00757588|155548180|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
48369867|NCT00757588|155548179|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
48369868|NCT00757588|155548180|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
48369869|NCT03212989|155548183|FG000|Overall Study|Physician Decision|8|||
48369870|NCT02224690|155548184|FG000|Overall Study|Adverse Event|8|||
48369871|NCT02224690|155548185|FG001|Overall Study|Adverse Event|1|||
48369872|NCT02224690|155548184|FG000|Overall Study|Met Withdrawal Criteria|4|||
48369873|NCT02224690|155548185|FG001|Overall Study|Met Withdrawal Criteria|0|||
48369874|NCT02224690|155548184|FG000|Overall Study|Use of G-tube|1|||
48369875|NCT02224690|155548185|FG001|Overall Study|Use of G-tube|0|||
48369876|NCT02224690|155548184|FG000|Overall Study|Did not meet eligibility criteria|1|||
48369877|NCT02224690|155548185|FG001|Overall Study|Did not meet eligibility criteria|0|||
48369878|NCT01744392|155548186|FG000|Overall Study|Physician Decision|1|||
48369879|NCT04971681|155548187|FG000|Followup|Lost to Follow-up|1|||
48369880|NCT04971681|155548188|FG001|Followup|Lost to Follow-up|0|||
48369881|NCT00577577|155548194|FG000|Overall Study|Adverse Event|3|||
48369882|NCT00577577|155548195|FG001|Overall Study|Adverse Event|2|||
48369883|NCT00577577|155548194|FG000|Overall Study|Lost to Follow-up|1|||
48369884|NCT00577577|155548195|FG001|Overall Study|Lost to Follow-up|0|||
48369885|NCT00577577|155548194|FG000|Overall Study|Protocol Violation|0|||
48369886|NCT00577577|155548195|FG001|Overall Study|Protocol Violation|3|||
48369887|NCT00577577|155548194|FG000|Overall Study|Transportation|1|||
48369888|NCT00577577|155548195|FG001|Overall Study|Transportation|0|||
48369889|NCT00688870|155548196|FG000|Infant Series|Parent or legal guardian request|4|||
48369890|NCT00688870|155548197|FG001|Infant Series|Parent or legal guardian request|0|||
48369891|NCT00371683|155548201|FG000|DB Treatment Period-Randomized Patients|Death|1|||
48369892|NCT00371683|155548202|FG001|DB Treatment Period-Randomized Patients|Death|1|||
48369893|NCT00371683|155548201|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
48369894|NCT00371683|155548202|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
48369895|NCT00371683|155548201|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
48369896|NCT00371683|155548202|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
48369897|NCT00371683|155548201|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
48369898|NCT00371683|155548202|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
48369899|NCT00371683|155548201|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
48369900|NCT00371683|155548202|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
48369901|NCT00371683|155548201|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
48369902|NCT00371683|155548202|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
48369903|NCT00371683|155548201|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
48369904|NCT00371683|155548202|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
48369905|NCT00371683|155548201|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
48369906|NCT00371683|155548202|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
48369907|NCT00371683|155548201|FG000|Follow-Up Period - Randomized Patients|Death|0|||
48369908|NCT00371683|155548202|FG001|Follow-Up Period - Randomized Patients|Death|2|||
48369909|NCT00371683|155548201|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
48369910|NCT00371683|155548202|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
48369911|NCT00371683|155548201|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
48369912|NCT00371683|155548202|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
48369913|NCT00232544|155548203|FG000|Overall Study|Lost to Follow-up|20|||
48369914|NCT00232544|155548204|FG001|Overall Study|Lost to Follow-up|15|||
48369915|NCT01820585|155548205|FG000|Overall Study|Adverse Event|9|||
48369916|NCT01820585|155548206|FG001|Overall Study|Adverse Event|13|||
48369917|NCT01820585|155548207|FG002|Overall Study|Adverse Event|23|||
48369918|NCT01820585|155548208|FG003|Overall Study|Adverse Event|34|||
48369919|NCT01820585|155548205|FG000|Overall Study|Lack of Efficacy|9|||
48369920|NCT01820585|155548206|FG001|Overall Study|Lack of Efficacy|7|||
48369921|NCT01820585|155548207|FG002|Overall Study|Lack of Efficacy|5|||
48369922|NCT01820585|155548208|FG003|Overall Study|Lack of Efficacy|1|||
48369923|NCT01820585|155548205|FG000|Overall Study|Withdrawal by Subject|3|||
48369924|NCT01820585|155548206|FG001|Overall Study|Withdrawal by Subject|7|||
48369925|NCT01820585|155548207|FG002|Overall Study|Withdrawal by Subject|3|||
48369926|NCT01820585|155548208|FG003|Overall Study|Withdrawal by Subject|8|||
48369927|NCT01820585|155548205|FG000|Overall Study|Lost to Follow-up|3|||
48369928|NCT01820585|155548206|FG001|Overall Study|Lost to Follow-up|3|||
48369929|NCT01820585|155548207|FG002|Overall Study|Lost to Follow-up|0|||
48369930|NCT01820585|155548208|FG003|Overall Study|Lost to Follow-up|3|||
48369931|NCT01820585|155548205|FG000|Overall Study|Protocol Violation|3|||
48369932|NCT01820585|155548206|FG001|Overall Study|Protocol Violation|1|||
48369933|NCT01820585|155548207|FG002|Overall Study|Protocol Violation|1|||
48369934|NCT01820585|155548208|FG003|Overall Study|Protocol Violation|1|||
48369935|NCT01820585|155548205|FG000|Overall Study|Subject non-compliance|0|||
48369936|NCT01820585|155548206|FG001|Overall Study|Subject non-compliance|0|||
48369937|NCT01820585|155548207|FG002|Overall Study|Subject non-compliance|1|||
48369938|NCT01820585|155548208|FG003|Overall Study|Subject non-compliance|2|||
48369939|NCT01820585|155548205|FG000|Overall Study|at sponsor request|0|||
48369940|NCT01820585|155548206|FG001|Overall Study|at sponsor request|0|||
48369941|NCT01820585|155548207|FG002|Overall Study|at sponsor request|1|||
48369942|NCT01820585|155548208|FG003|Overall Study|at sponsor request|0|||
48369943|NCT01820585|155548205|FG000|Overall Study|Pregnancy|0|||
48369944|NCT01820585|155548206|FG001|Overall Study|Pregnancy|1|||
48369945|NCT01820585|155548207|FG002|Overall Study|Pregnancy|0|||
48369946|NCT01820585|155548208|FG003|Overall Study|Pregnancy|0|||
48369947|NCT00948766|155548213|FG000|Core Study|Adverse Event|73|||
48369948|NCT00948766|155548214|FG001|Core Study|Adverse Event|51|||
48369949|NCT00948766|155548213|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
48369950|NCT00948766|155548214|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
48369951|NCT00948766|155548213|FG000|Core Study|Patient Withdrew Consent|27|||
48369952|NCT00948766|155548214|FG001|Core Study|Patient Withdrew Consent|46|||
48369953|NCT00948766|155548213|FG000|Core Study|Lost to Follow-up|3|||
48369954|NCT00948766|155548214|FG001|Core Study|Lost to Follow-up|2|||
48369955|NCT00948766|155548213|FG000|Core Study|Administrative Problems|2|||
48369956|NCT00948766|155548214|FG001|Core Study|Administrative Problems|2|||
48369957|NCT00948766|155548213|FG000|Core Study|Death|1|||
48369958|NCT00948766|155548214|FG001|Core Study|Death|1|||
48369959|NCT00948766|155548213|FG000|Core Study|Protocol Deviation|8|||
48369960|NCT00948766|155548214|FG001|Core Study|Protocol Deviation|10|||
48369961|NCT00948766|155548213|FG000|Extension Study|Adverse Event|43|||
48369962|NCT00948766|155548214|FG001|Extension Study|Adverse Event|0|||
48369963|NCT00948766|155548213|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
48369964|NCT00948766|155548214|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
48369965|NCT00948766|155548213|FG000|Extension Study|Study Drug No Longer Required|1|||
48369966|NCT00948766|155548214|FG001|Extension Study|Study Drug No Longer Required|0|||
48369967|NCT00948766|155548213|FG000|Extension Study|Patient Withdrew Consent|32|||
48369968|NCT00948766|155548214|FG001|Extension Study|Patient Withdrew Consent|0|||
48369969|NCT00948766|155548213|FG000|Extension Study|Lost to Follow-up|8|||
48369970|NCT00948766|155548214|FG001|Extension Study|Lost to Follow-up|0|||
48369971|NCT00948766|155548213|FG000|Extension Study|Administrative Problems|1|||
48369972|NCT00948766|155548214|FG001|Extension Study|Administrative Problems|0|||
48369973|NCT00948766|155548213|FG000|Extension Study|Death|4|||
48369974|NCT00948766|155548214|FG001|Extension Study|Death|0|||
48369975|NCT00345293|155548218|FG000|Overall Study|Unable to access line for sample|1|||
48369976|NCT00345293|155548219|FG001|Overall Study|Unable to access line for sample|0|||
48369977|NCT00345293|155548218|FG000|Overall Study|Withdrawal by Subject|1|||
48369978|NCT00345293|155548219|FG001|Overall Study|Withdrawal by Subject|0|||
48369979|NCT02150343|155548220|FG000|Overall Study|Adverse Event|2|||
48369980|NCT02150343|155548221|FG001|Overall Study|Adverse Event|0|||
48369981|NCT02150343|155548222|FG002|Overall Study|Adverse Event|1|||
48369982|NCT02150343|155548223|FG003|Overall Study|Adverse Event|1|||
48369983|NCT02150343|155548220|FG000|Overall Study|Withdrawal by Subject|13|||
48369984|NCT02150343|155548221|FG001|Overall Study|Withdrawal by Subject|10|||
48369985|NCT02150343|155548222|FG002|Overall Study|Withdrawal by Subject|9|||
48369986|NCT02150343|155548223|FG003|Overall Study|Withdrawal by Subject|4|||
48369987|NCT02150343|155548220|FG000|Overall Study|Lost to Follow-up|4|||
48369988|NCT02150343|155548221|FG001|Overall Study|Lost to Follow-up|4|||
48369989|NCT02150343|155548222|FG002|Overall Study|Lost to Follow-up|2|||
48369990|NCT02150343|155548223|FG003|Overall Study|Lost to Follow-up|3|||
48369991|NCT02150343|155548220|FG000|Overall Study|Other|2|||
48369992|NCT02150343|155548221|FG001|Overall Study|Other|6|||
48369993|NCT02150343|155548222|FG002|Overall Study|Other|0|||
48369994|NCT02150343|155548223|FG003|Overall Study|Other|2|||
48369995|NCT03459443|155548224|FG000|Overall Study|Lack of Efficacy|3|||
48369996|NCT03459443|155548224|FG000|Overall Study|Adverse Event|1|||
48369997|NCT03459443|155548224|FG000|Overall Study|Sponsor's decision to close the study|18|||
48369998|NCT01200589|155548225|FG000|Overall Study|Withdrawal by Subject|13|||
48369999|NCT01200589|155548226|FG001|Overall Study|Withdrawal by Subject|11|||
48370000|NCT01200589|155548225|FG000|Overall Study|Physician Decision|2|||
48370001|NCT01200589|155548226|FG001|Overall Study|Physician Decision|2|||
48370002|NCT01200589|155548225|FG000|Overall Study|Lost to Follow-up|5|||
48370003|NCT01200589|155548226|FG001|Overall Study|Lost to Follow-up|4|||
48370004|NCT01200589|155548225|FG000|Overall Study|Study terminated|170|||
48431610|NCT01721408|155767331|FG001|Overall Study|Death|0|||
48370005|NCT01200589|155548226|FG001|Overall Study|Study terminated|172|||
48370006|NCT00598273|155548230|FG000|Overall Study|Adverse Event|4|||
48370007|NCT00598273|155548231|FG001|Overall Study|Adverse Event|5|||
48370008|NCT00598273|155548232|FG002|Overall Study|Adverse Event|2|||
48370009|NCT00598273|155548230|FG000|Overall Study|Death|6|||
48370010|NCT00598273|155548231|FG001|Overall Study|Death|12|||
48370011|NCT00598273|155548232|FG002|Overall Study|Death|8|||
48370012|NCT00598273|155548230|FG000|Overall Study|Lost to Follow-up|8|||
48370013|NCT00598273|155548231|FG001|Overall Study|Lost to Follow-up|3|||
48370014|NCT00598273|155548232|FG002|Overall Study|Lost to Follow-up|5|||
48370015|NCT00598273|155548230|FG000|Overall Study|Physician Decision|0|||
48370016|NCT00598273|155548231|FG001|Overall Study|Physician Decision|0|||
48370017|NCT00598273|155548232|FG002|Overall Study|Physician Decision|1|||
48370018|NCT00598273|155548230|FG000|Overall Study|Withdrawal by Subject|12|||
48370019|NCT00598273|155548231|FG001|Overall Study|Withdrawal by Subject|10|||
48370020|NCT00598273|155548232|FG002|Overall Study|Withdrawal by Subject|10|||
48370021|NCT00598273|155548230|FG000|Overall Study|Noncompliance|3|||
48370022|NCT00598273|155548231|FG001|Overall Study|Noncompliance|2|||
48370023|NCT00598273|155548232|FG002|Overall Study|Noncompliance|3|||
48370024|NCT00598273|155548230|FG000|Overall Study|Relocation|0|||
48370025|NCT00598273|155548231|FG001|Overall Study|Relocation|2|||
48370026|NCT00598273|155548232|FG002|Overall Study|Relocation|4|||
48370027|NCT00598273|155548230|FG000|Overall Study|Renal transplant|1|||
48370028|NCT00598273|155548231|FG001|Overall Study|Renal transplant|0|||
48370029|NCT00598273|155548232|FG002|Overall Study|Renal transplant|1|||
48370030|NCT00598273|155548230|FG000|Overall Study|Site elected to close|1|||
48370031|NCT00598273|155548231|FG001|Overall Study|Site elected to close|0|||
48370032|NCT00598273|155548232|FG002|Overall Study|Site elected to close|0|||
48370033|NCT00598273|155548230|FG000|Overall Study|Started dialysis|6|||
48370034|NCT00598273|155548231|FG001|Overall Study|Started dialysis|4|||
48370035|NCT00598273|155548232|FG002|Overall Study|Started dialysis|5|||
48370036|NCT01146782|155548233|FG000|Screening Cohort|Screen Failure|187|||
48370037|NCT01146782|155548233|FG000|Screening Cohort|Lost to Follow-up|4|||
48370038|NCT01146782|155548233|FG000|Screening Cohort|Physician Decision|1|||
48370039|NCT01146782|155548233|FG000|Screening Cohort|Withdrawal by Subject|29|||
48370040|NCT01146782|155548233|FG000|Safety Cohort|Screen Failure|61|||
48370041|NCT01146782|155548233|FG000|Safety Cohort|Withdrawal by Subject|4|||
48370042|NCT01146782|155548233|FG000|Safety Cohort|Control AHI <5|4|||
48370043|NCT01146782|155548233|FG000|Safety Cohort|TST <4 hrs|14|||
48370044|NCT01146782|155548233|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
48370045|NCT01146782|155548233|FG000|Primary Endpoint Cohort|Physician Decision|1|||
48370046|NCT01771107|155548235|FG000|Overall Study|Adverse Event|1|||
48370047|NCT01771107|155548236|FG001|Overall Study|Adverse Event|3|||
48370048|NCT01771107|155548235|FG000|Overall Study|Withdrawal by Subject|0|||
48370049|NCT01771107|155548236|FG001|Overall Study|Withdrawal by Subject|2|||
48370050|NCT01771107|155548235|FG000|Overall Study|Lost to Follow-up|0|||
48370051|NCT01771107|155548236|FG001|Overall Study|Lost to Follow-up|1|||
48370052|NCT01771107|155548235|FG000|Overall Study|participant moved|0|||
48370053|NCT01771107|155548236|FG001|Overall Study|participant moved|1|||
48370054|NCT01771107|155548235|FG000|Overall Study|Other|0|||
48370055|NCT01771107|155548236|FG001|Overall Study|Other|1|||
48370056|NCT02390245|155548237|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
48370057|NCT02390245|155548238|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
48370058|NCT02390245|155548239|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
48370059|NCT02390245|155548237|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
48370060|NCT02390245|155548238|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
48370061|NCT02390245|155548239|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
48370062|NCT02891408|155548240|FG000|Overall Study|Lost to Follow-up|0|||
48370063|NCT02891408|155548241|FG001|Overall Study|Lost to Follow-up|0|||
48370064|NCT02891408|155548242|FG002|Overall Study|Lost to Follow-up|1|||
48370065|NCT02891408|155548243|FG003|Overall Study|Lost to Follow-up|0|||
48370066|NCT02891408|155548244|FG004|Overall Study|Lost to Follow-up|0|||
48370067|NCT02891408|155548245|FG005|Overall Study|Lost to Follow-up|0|||
48370068|NCT02891408|155548246|FG006|Overall Study|Lost to Follow-up|0|||
48370069|NCT00540046|155548247|FG000|Overall Study|Lost to Follow-up|33|||
48370070|NCT00540046|155548248|FG001|Overall Study|Lost to Follow-up|23|||
48370071|NCT02891837|155548249|FG000|Overall Study|Lost to Follow-up|2|||
48370072|NCT02891837|155548250|FG001|Overall Study|Lost to Follow-up|0|||
48370073|NCT02891837|155548249|FG000|Overall Study|Withdrawal by Subject|1|||
48370074|NCT02891837|155548250|FG001|Overall Study|Withdrawal by Subject|0|||
48370075|NCT00709852|155548251|FG000|Period 1|Adverse Event|2|||
48370076|NCT00709852|155548252|FG001|Period 1|Adverse Event|0|||
48370077|NCT00709852|155548251|FG000|Period 1|Withdrawal by Subject|4|||
48370078|NCT00709852|155548252|FG001|Period 1|Withdrawal by Subject|2|||
48370079|NCT00709852|155548251|FG000|Period 1|Protocol Violation|1|||
48370080|NCT00709852|155548252|FG001|Period 1|Protocol Violation|0|||
48370081|NCT00709852|155548251|FG000|Period 1|Defective scanner|0|||
48370082|NCT00709852|155548252|FG001|Period 1|Defective scanner|1|||
48370083|NCT00709852|155548251|FG000|Period 1|Lost to Follow-up|1|||
48370084|NCT00709852|155548252|FG001|Period 1|Lost to Follow-up|0|||
48370085|NCT00709852|155548251|FG000|Period 2|Protocol Violation|4|||
48370086|NCT00709852|155548252|FG001|Period 2|Protocol Violation|1|||
48370087|NCT00709852|155548251|FG000|Period 2|Adverse Event|1|||
48370088|NCT00709852|155548252|FG001|Period 2|Adverse Event|1|||
48370089|NCT00709852|155548251|FG000|Period 2|Lost to Follow-up|1|||
48370090|NCT00709852|155548252|FG001|Period 2|Lost to Follow-up|0|||
48370091|NCT00709852|155548251|FG000|Period 2|No 72-hour follow-up|3|||
48370092|NCT00709852|155548252|FG001|Period 2|No 72-hour follow-up|0|||
48370093|NCT00112047|155548253|FG000|Randomized Phase|Lost to Follow-up|26|||
48370094|NCT00112047|155548254|FG001|Randomized Phase|Lost to Follow-up|33|||
48370095|NCT00112047|155548253|FG000|Randomized Phase|Adverse Event|10|||
48370096|NCT00112047|155548254|FG001|Randomized Phase|Adverse Event|10|||
48370097|NCT00112047|155548253|FG000|Randomized Phase|Withrawal of consent|10|||
48370098|NCT00112047|155548254|FG001|Randomized Phase|Withrawal of consent|18|||
48370099|NCT00112047|155548253|FG000|Randomized Phase|Sub-optimal virological response|3|||
48370100|NCT00112047|155548254|FG001|Randomized Phase|Sub-optimal virological response|13|||
48370101|NCT00112047|155548253|FG000|Randomized Phase|Noncompliance|8|||
48370102|NCT00112047|155548254|FG001|Randomized Phase|Noncompliance|4|||
48370103|NCT00112047|155548253|FG000|Randomized Phase|Protocol Violation|2|||
48370104|NCT00112047|155548254|FG001|Randomized Phase|Protocol Violation|0|||
48370105|NCT00112047|155548253|FG000|Randomized Phase|Pregnancy|3|||
48370106|NCT00112047|155548254|FG001|Randomized Phase|Pregnancy|1|||
48370107|NCT00112047|155548253|FG000|Randomized Phase|Death|1|||
48370108|NCT00112047|155548254|FG001|Randomized Phase|Death|3|||
48370109|NCT00112047|155548253|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
48370110|NCT00112047|155548254|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
48370111|NCT00112047|155548253|FG000|Randomized Phase|Inability to swallow pills|0|||
48370112|NCT00112047|155548254|FG001|Randomized Phase|Inability to swallow pills|1|||
48370113|NCT00112047|155548253|FG000|Randomized Phase|Incarceration|3|||
48370114|NCT00112047|155548254|FG001|Randomized Phase|Incarceration|2|||
48370115|NCT00112047|155548253|FG000|Randomized Phase|Moved out of State|0|||
48370116|NCT00112047|155548254|FG001|Randomized Phase|Moved out of State|1|||
48370117|NCT00112047|155548253|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
48370118|NCT00112047|155548254|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
48370119|NCT00112047|155548253|FG000|Randomized Phase|High Hepatitis B DNA|0|||
48370120|NCT00112047|155548254|FG001|Randomized Phase|High Hepatitis B DNA|1|||
48370121|NCT00112047|155548253|FG000|Atripla Phase|Adverse Event|2|||
48370122|NCT00112047|155548254|FG001|Atripla Phase|Adverse Event|1|||
48370123|NCT00112047|155548253|FG000|Atripla Phase|Lost to Follow-up|5|||
48370124|NCT00112047|155548254|FG001|Atripla Phase|Lost to Follow-up|7|||
48370125|NCT00112047|155548253|FG000|Atripla Phase|Pregnancy|0|||
48370126|NCT00112047|155548254|FG001|Atripla Phase|Pregnancy|1|||
48370127|NCT00112047|155548253|FG000|Atripla Phase|Death|0|||
48370128|NCT00112047|155548254|FG001|Atripla Phase|Death|2|||
48370129|NCT00112047|155548253|FG000|Atripla Phase|Withdrew consent|7|||
48370130|NCT00112047|155548254|FG001|Atripla Phase|Withdrew consent|7|||
48370131|NCT00112047|155548253|FG000|Atripla Phase|Sub-optimal virological response|0|||
48370132|NCT00112047|155548254|FG001|Atripla Phase|Sub-optimal virological response|1|||
48370133|NCT00112047|155548253|FG000|Atripla Phase|Non-compliance|1|||
48370134|NCT00112047|155548254|FG001|Atripla Phase|Non-compliance|0|||
48370135|NCT00112047|155548253|FG000|Atripla Phase|Other|3|||
48370136|NCT00112047|155548254|FG001|Atripla Phase|Other|1|||
48370137|NCT01021215|155548255|FG000|Overall Study|Lost to Follow-up|3|||
48370138|NCT01021215|155548256|FG001|Overall Study|Lost to Follow-up|0|||
48370139|NCT02533531|155548257|FG000|Overall Study|Device did not turn on|1|||
48370140|NCT03169101|155548258|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
48370141|NCT03169101|155548259|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
48370142|NCT03169101|155548260|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
48370143|NCT03169101|155548261|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
48370144|NCT00979134|155548274|FG000|Overall Study|Disease progression|18|||
48370145|NCT00979134|155548275|FG001|Overall Study|Disease progression|2|||
48370146|NCT00979134|155548276|FG002|Overall Study|Disease progression|5|||
48370147|NCT00979134|155548274|FG000|Overall Study|Adverse Event|0|||
48370148|NCT00979134|155548275|FG001|Overall Study|Adverse Event|0|||
48370149|NCT00979134|155548276|FG002|Overall Study|Adverse Event|2|||
48370150|NCT00979134|155548274|FG000|Overall Study|Withdrawal by Subject|1|||
48370151|NCT00979134|155548275|FG001|Overall Study|Withdrawal by Subject|1|||
48370152|NCT00979134|155548276|FG002|Overall Study|Withdrawal by Subject|2|||
48370153|NCT00979134|155548274|FG000|Overall Study|Lost to Follow-up|2|||
48370154|NCT00979134|155548275|FG001|Overall Study|Lost to Follow-up|2|||
48370155|NCT00979134|155548276|FG002|Overall Study|Lost to Follow-up|0|||
48370156|NCT00979134|155548274|FG000|Overall Study|Death|4|||
48370157|NCT00979134|155548275|FG001|Overall Study|Death|0|||
48370158|NCT00979134|155548276|FG002|Overall Study|Death|26|||
48370159|NCT00979134|155548274|FG000|Overall Study|Other|8|||
48370160|NCT00979134|155548275|FG001|Overall Study|Other|1|||
48370161|NCT00979134|155548276|FG002|Overall Study|Other|5|||
48370162|NCT00924027|155548283|FG000|Overall Study|Lost to Further Follow-Up|4|||
48370163|NCT00924027|155548284|FG001|Overall Study|Lost to Further Follow-Up|0|||
48370164|NCT00924027|155548285|FG002|Overall Study|Lost to Further Follow-Up|0|||
48370165|NCT00924027|155548286|FG003|Overall Study|Lost to Further Follow-Up|0|||
48370166|NCT00924027|155548283|FG000|Overall Study|Physician Decision|1|||
48370167|NCT00924027|155548284|FG001|Overall Study|Physician Decision|0|||
48370168|NCT00924027|155548285|FG002|Overall Study|Physician Decision|0|||
48370169|NCT00924027|155548286|FG003|Overall Study|Physician Decision|1|||
48370170|NCT00924027|155548283|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
48370171|NCT00924027|155548284|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
48370172|NCT00924027|155548285|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
48370173|NCT00924027|155548286|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
48370174|NCT00924027|155548283|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
48370175|NCT00924027|155548284|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
48370176|NCT00924027|155548285|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
48370177|NCT00924027|155548286|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
48370178|NCT00924027|155548283|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
48370179|NCT00924027|155548284|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
48370180|NCT00924027|155548285|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
48370181|NCT00924027|155548286|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
48370182|NCT05718466|155550878|FG000|Overall Study|Withdrawal by Subject|1|||
48370183|NCT05718466|155550879|FG001|Overall Study|Withdrawal by Subject|2|||
48370184|NCT05718466|155550878|FG000|Overall Study|Death|0|||
48370185|NCT05718466|155550879|FG001|Overall Study|Death|1|||
48370186|NCT03647488|155550883|FG000|Overall Study|Progressive disease|10|||
48370187|NCT03647488|155550884|FG001|Overall Study|Progressive disease|0|||
48370188|NCT03647488|155550885|FG002|Overall Study|Progressive disease|0|||
48370189|NCT03647488|155550883|FG000|Overall Study|Adverse Event|5|||
48370190|NCT03647488|155550884|FG001|Overall Study|Adverse Event|0|||
48370191|NCT03647488|155550885|FG002|Overall Study|Adverse Event|0|||
48370192|NCT03647488|155550883|FG000|Overall Study|Clinical progression|2|||
48370193|NCT03647488|155550884|FG001|Overall Study|Clinical progression|0|||
48370194|NCT03647488|155550885|FG002|Overall Study|Clinical progression|0|||
48370195|NCT03647488|155550883|FG000|Overall Study|Participant refused to take investigational product|1|||
48370196|NCT03647488|155550884|FG001|Overall Study|Participant refused to take investigational product|0|||
48370197|NCT03647488|155550885|FG002|Overall Study|Participant refused to take investigational product|0|||
48370198|NCT05087979|155550896|FG000|Overall Study|Converted to general anesthesia|1|||
48370199|NCT05087979|155550897|FG001|Overall Study|Converted to general anesthesia|0|||
48370200|NCT03207009|155550900|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
48370201|NCT01262677|155550901|FG000|Overall Study|Does not meet entrance criteria|0|||
48370202|NCT01262677|155550902|FG001|Overall Study|Does not meet entrance criteria|2|||
48370203|NCT01262677|155550903|FG002|Overall Study|Does not meet entrance criteria|0|||
48370204|NCT01262677|155550901|FG000|Overall Study|Insufficient clinical response|0|||
48370205|NCT01262677|155550902|FG001|Overall Study|Insufficient clinical response|0|||
48370206|NCT01262677|155550903|FG002|Overall Study|Insufficient clinical response|1|||
48370207|NCT01262677|155550901|FG000|Overall Study|Lost to Follow-up|1|||
48370208|NCT01262677|155550902|FG001|Overall Study|Lost to Follow-up|0|||
48370209|NCT01262677|155550903|FG002|Overall Study|Lost to Follow-up|2|||
48370210|NCT01262677|155550901|FG000|Overall Study|No longer willing to participate|3|||
48370211|NCT01262677|155550902|FG001|Overall Study|No longer willing to participate|3|||
48370212|NCT01262677|155550903|FG002|Overall Study|No longer willing to participate|2|||
48370213|NCT01262677|155550901|FG000|Overall Study|Reason not provided|2|||
48370214|NCT01262677|155550902|FG001|Overall Study|Reason not provided|1|||
48370215|NCT01262677|155550903|FG002|Overall Study|Reason not provided|3|||
48370216|NCT01262677|155550901|FG000|Overall Study|Protocol Violation|0|||
48370217|NCT01262677|155550902|FG001|Overall Study|Protocol Violation|1|||
48370218|NCT01262677|155550903|FG002|Overall Study|Protocol Violation|1|||
48370219|NCT01262677|155550901|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
48370220|NCT01262677|155550902|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
48370221|NCT01262677|155550903|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
48370222|NCT02924428|155550904|FG000|Overall Study|Adverse Event|1|||
48370223|NCT02924428|155550905|FG001|Overall Study|Adverse Event|0|||
48370224|NCT02924428|155550904|FG000|Overall Study|Physician Decision|1|||
48370225|NCT02924428|155550905|FG001|Overall Study|Physician Decision|0|||
48370226|NCT02924428|155550904|FG000|Overall Study|Lost to Follow-up|2|||
48370227|NCT02924428|155550905|FG001|Overall Study|Lost to Follow-up|4|||
48370228|NCT02924428|155550904|FG000|Overall Study|Pregnancy|0|||
48370229|NCT02924428|155550905|FG001|Overall Study|Pregnancy|1|||
48370230|NCT01877837|155550906|FG000|Overall Study|Lost to Follow-up|1|||
48370231|NCT01877837|155550906|FG000|Overall Study|Ineligible|4|||
48370232|NCT01970345|155550914|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
48370233|NCT01970345|155550915|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
48370234|NCT01970345|155550914|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
48370235|NCT01970345|155550915|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
48370236|NCT02245737|155550916|FG000|Overall Study|Adverse Event|23|||
48370237|NCT02245737|155550917|FG001|Overall Study|Adverse Event|26|||
48370238|NCT02245737|155550918|FG002|Overall Study|Adverse Event|33|||
48370239|NCT02245737|155550916|FG000|Overall Study|Condition Worsened|9|||
48370240|NCT02245737|155550917|FG001|Overall Study|Condition Worsened|10|||
48370241|NCT02245737|155550918|FG002|Overall Study|Condition Worsened|9|||
48370242|NCT02245737|155550916|FG000|Overall Study|Death|2|||
48370243|NCT02245737|155550917|FG001|Overall Study|Death|4|||
48370244|NCT02245737|155550918|FG002|Overall Study|Death|4|||
48370245|NCT02245737|155550916|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
48370246|NCT02245737|155550917|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
48370247|NCT02245737|155550918|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
48370248|NCT02245737|155550916|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
48370249|NCT02245737|155550917|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
48370250|NCT02245737|155550918|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
48370251|NCT02245737|155550916|FG000|Overall Study|Lost to Follow-up|2|||
48370252|NCT02245737|155550917|FG001|Overall Study|Lost to Follow-up|5|||
48370253|NCT02245737|155550918|FG002|Overall Study|Lost to Follow-up|4|||
48370254|NCT02245737|155550916|FG000|Overall Study|Other-determined by Investigator|9|||
48370255|NCT02245737|155550917|FG001|Overall Study|Other-determined by Investigator|10|||
48370256|NCT02245737|155550918|FG002|Overall Study|Other-determined by Investigator|10|||
48370257|NCT02245737|155550916|FG000|Overall Study|Physician Decision|6|||
48370258|NCT02245737|155550917|FG001|Overall Study|Physician Decision|3|||
48370259|NCT02245737|155550918|FG002|Overall Study|Physician Decision|6|||
48370260|NCT02245737|155550916|FG000|Overall Study|Protocol Violation|3|||
48370261|NCT02245737|155550917|FG001|Overall Study|Protocol Violation|2|||
48370262|NCT02245737|155550918|FG002|Overall Study|Protocol Violation|3|||
48370263|NCT02245737|155550916|FG000|Overall Study|Withdrawal by Subject|40|||
48370264|NCT02245737|155550917|FG001|Overall Study|Withdrawal by Subject|41|||
48370265|NCT02245737|155550918|FG002|Overall Study|Withdrawal by Subject|44|||
48370266|NCT02245737|155550916|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
48370267|NCT02245737|155550917|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
48370268|NCT02245737|155550918|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
48370269|NCT02245737|155550916|FG000|Overall Study|Sponsor Decision|445|||
48370270|NCT02245737|155550917|FG001|Overall Study|Sponsor Decision|430|||
48370271|NCT02245737|155550918|FG002|Overall Study|Sponsor Decision|432|||
48370272|NCT04279392|155550919|FG000|Overall Study|Physician Decision|1|||
48370273|NCT04279392|155550920|FG001|Overall Study|Physician Decision|0|||
48370274|NCT01879722|155550921|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48370275|NCT01879722|155550922|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48370276|NCT01879722|155550923|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48370277|NCT01879722|155550924|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
48370278|NCT01879722|155550925|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
48370279|NCT01879722|155550926|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
48370280|NCT01879722|155550927|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
48370281|NCT01879722|155550928|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
48370282|NCT01879722|155550929|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
48370283|NCT01879722|155550930|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
48370284|NCT01879722|155550921|FG000|Overall Study|Voluntary Withdrawal|0|||
48370285|NCT01879722|155550922|FG001|Overall Study|Voluntary Withdrawal|0|||
48370286|NCT01879722|155550923|FG002|Overall Study|Voluntary Withdrawal|0|||
48370287|NCT01879722|155550924|FG003|Overall Study|Voluntary Withdrawal|0|||
48370288|NCT01879722|155550925|FG004|Overall Study|Voluntary Withdrawal|0|||
48370289|NCT01879722|155550926|FG005|Overall Study|Voluntary Withdrawal|0|||
48370290|NCT01879722|155550927|FG006|Overall Study|Voluntary Withdrawal|0|||
48370291|NCT01879722|155550928|FG007|Overall Study|Voluntary Withdrawal|0|||
48370292|NCT01879722|155550929|FG008|Overall Study|Voluntary Withdrawal|1|||
48370293|NCT01879722|155550930|FG009|Overall Study|Voluntary Withdrawal|0|||
48370294|NCT05398237|155550932|FG000|Overall Study|Withdrawal by Subject|1|||
48370295|NCT04988867|155550933|FG000|Overall Study|Study terminated by Sponsor|12|||
48370296|NCT04988867|155550933|FG000|Overall Study|Adverse Event|2|||
48370297|NCT04988867|155550933|FG000|Overall Study|Study drug noncompliance|1|||
48370298|NCT00903006|155550934|FG000|Overall Study|Withdrawal by Subject|2|||
48370299|NCT00903006|155550935|FG001|Overall Study|Withdrawal by Subject|0|||
48370300|NCT00903006|155550936|FG002|Overall Study|Withdrawal by Subject|0|||
48370301|NCT00903006|155550937|FG003|Overall Study|Withdrawal by Subject|0|||
48370302|NCT00903006|155550934|FG000|Overall Study|Progressive Disease|0|||
48370303|NCT00903006|155550935|FG001|Overall Study|Progressive Disease|3|||
48370304|NCT00903006|155550936|FG002|Overall Study|Progressive Disease|1|||
48370305|NCT00903006|155550937|FG003|Overall Study|Progressive Disease|0|||
48370306|NCT01156792|155550938|FG000|Overall Study|Adverse Event|1|||
48370307|NCT01156792|155550938|FG000|Overall Study|Lack of Efficacy|36|||
48370308|NCT01156792|155550938|FG000|Overall Study|Protocol Violation|6|||
48370309|NCT01156792|155550938|FG000|Overall Study|Lost to Follow-up|3|||
48370310|NCT01156792|155550938|FG000|Overall Study|Physician Decision|3|||
48370311|NCT01156792|155550938|FG000|Overall Study|Withdrawal by Subject|9|||
48370312|NCT01156792|155550938|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
48370313|NCT01474434|155550942|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
48370314|NCT01474434|155550943|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
48370315|NCT01474434|155550944|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
48370316|NCT01474434|155550945|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
48370317|NCT01474434|155550942|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
48370318|NCT01474434|155550943|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
48370319|NCT01474434|155550944|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
48370320|NCT01474434|155550945|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
48370321|NCT01474434|155550942|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
48370322|NCT01474434|155550943|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
48370323|NCT01474434|155550944|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
48370324|NCT01474434|155550945|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
48370325|NCT00560066|155550952|FG000|Overall Study|Death|2|||
48370326|NCT00560066|155550953|FG001|Overall Study|Death|1|||
48370327|NCT00560066|155550952|FG000|Overall Study|Withdrawal by Subject|0|||
48370328|NCT00560066|155550953|FG001|Overall Study|Withdrawal by Subject|3|||
48370329|NCT00560066|155550952|FG000|Overall Study|Lost to Follow-up|4|||
48370330|NCT00560066|155550953|FG001|Overall Study|Lost to Follow-up|10|||
48370331|NCT00560066|155550952|FG000|Overall Study|Protocol Violation|0|||
48370332|NCT00560066|155550953|FG001|Overall Study|Protocol Violation|1|||
48370333|NCT00560066|155550952|FG000|Overall Study|Administrative reason|0|||
48370334|NCT00560066|155550953|FG001|Overall Study|Administrative reason|5|||
48370335|NCT00560066|155550952|FG000|Overall Study|Missing primary reason|0|||
48370336|NCT00560066|155550953|FG001|Overall Study|Missing primary reason|2|||
48370337|NCT01153958|155550954|FG000|Overall Study|Study Terminated|36|||
48370338|NCT01153958|155550955|FG001|Overall Study|Study Terminated|32|||
48370339|NCT02004353|155550957|FG000|Overall Study|Voluntary participation|1334|||
48370340|NCT01691768|155550958|FG000|Overall Study|Death|0|||
48370341|NCT01691768|155550959|FG001|Overall Study|Death|2|||
48370342|NCT01691768|155550958|FG000|Overall Study|Lost to Follow-up|4|||
48370343|NCT01691768|155550959|FG001|Overall Study|Lost to Follow-up|3|||
48370344|NCT01691768|155550958|FG000|Overall Study|Withdrawal by Subject|10|||
48370345|NCT01691768|155550959|FG001|Overall Study|Withdrawal by Subject|9|||
48370346|NCT01691768|155550958|FG000|Overall Study|Relocated|0|||
48370347|NCT01691768|155550959|FG001|Overall Study|Relocated|1|||
48370348|NCT01691768|155550958|FG000|Overall Study|Investigator decision|1|||
48370349|NCT01691768|155550959|FG001|Overall Study|Investigator decision|1|||
48370350|NCT02424734|155550960|FG000|Overall Study|Treatment stopped to be discharged home|2|||
48370351|NCT02424734|155550961|FG001|Overall Study|Treatment stopped to be discharged home|2|||
48370352|NCT02424734|155550962|FG002|Overall Study|Treatment stopped to be discharged home|0|||
48370353|NCT00528645|155550963|FG000|Overall Study|Adverse Event|3|||
48370354|NCT00116753|155550964|FG000|Overall Study|Adverse Event|16|||
48370355|NCT00116753|155550965|FG001|Overall Study|Adverse Event|10|||
48370356|NCT00116753|155550966|FG002|Overall Study|Adverse Event|7|||
48370357|NCT00116753|155550964|FG000|Overall Study|Withdrawal by Subject|11|||
48370358|NCT00116753|155550965|FG001|Overall Study|Withdrawal by Subject|12|||
48370359|NCT00116753|155550966|FG002|Overall Study|Withdrawal by Subject|8|||
48370360|NCT00116753|155550964|FG000|Overall Study|Lost to Follow-up|0|||
48370361|NCT00116753|155550965|FG001|Overall Study|Lost to Follow-up|2|||
48370362|NCT00116753|155550966|FG002|Overall Study|Lost to Follow-up|1|||
48370363|NCT00116753|155550964|FG000|Overall Study|Protocol Violation|0|||
48370364|NCT00116753|155550965|FG001|Overall Study|Protocol Violation|0|||
48370365|NCT00116753|155550966|FG002|Overall Study|Protocol Violation|1|||
48370366|NCT00116753|155550964|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
48370367|NCT00116753|155550965|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
48370368|NCT00116753|155550966|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
48370369|NCT00116753|155550964|FG000|Overall Study|Disease Progression|3|||
48370370|NCT00116753|155550965|FG001|Overall Study|Disease Progression|4|||
48370371|NCT00116753|155550966|FG002|Overall Study|Disease Progression|3|||
48370372|NCT00116753|155550964|FG000|Overall Study|Abnormal Echocardiogram|0|||
48370373|NCT00116753|155550965|FG001|Overall Study|Abnormal Echocardiogram|0|||
48370374|NCT00116753|155550966|FG002|Overall Study|Abnormal Echocardiogram|1|||
48370375|NCT00116753|155550964|FG000|Overall Study|Progressive Parkinson's Disease|1|||
48370376|NCT00116753|155550965|FG001|Overall Study|Progressive Parkinson's Disease|0|||
48370377|NCT00116753|155550966|FG002|Overall Study|Progressive Parkinson's Disease|0|||
48370378|NCT00116753|155550964|FG000|Overall Study|Dosing Error|0|||
48370379|NCT00116753|155550965|FG001|Overall Study|Dosing Error|1|||
48370380|NCT00116753|155550966|FG002|Overall Study|Dosing Error|0|||
48370381|NCT01489891|155550968|FG000|Overall Study|Endoscopy failure|1|||
48370382|NCT01489891|155550969|FG001|Overall Study|Endoscopy failure|0|||
48370383|NCT01445301|155550970|FG000|Overall Study|Adverse Event|15|||
48370384|NCT01445301|155550971|FG001|Overall Study|Adverse Event|25|||
48370385|NCT01445301|155550972|FG002|Overall Study|Adverse Event|4|||
48370386|NCT01445301|155550970|FG000|Overall Study|Lack of Efficacy|0|||
48370387|NCT01445301|155550971|FG001|Overall Study|Lack of Efficacy|1|||
48370388|NCT01445301|155550972|FG002|Overall Study|Lack of Efficacy|0|||
48370389|NCT01445301|155550970|FG000|Overall Study|Protocol Violation|1|||
48370390|NCT01445301|155550971|FG001|Overall Study|Protocol Violation|0|||
48370391|NCT01445301|155550972|FG002|Overall Study|Protocol Violation|0|||
48370392|NCT01445301|155550970|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
48370393|NCT01445301|155550971|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
48370394|NCT01445301|155550972|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
48370395|NCT01445301|155550970|FG000|Overall Study|Physician Decision|0|||
48370396|NCT01445301|155550971|FG001|Overall Study|Physician Decision|2|||
48370397|NCT01445301|155550972|FG002|Overall Study|Physician Decision|0|||
48370398|NCT01445301|155550970|FG000|Overall Study|Withdrawal by Subject|5|||
48370399|NCT01445301|155550971|FG001|Overall Study|Withdrawal by Subject|6|||
48370400|NCT01445301|155550972|FG002|Overall Study|Withdrawal by Subject|4|||
48370401|NCT00752557|155550973|FG000|Overall Study|Withdrawal by Subject|4|||
48370402|NCT00752557|155550974|FG001|Overall Study|Withdrawal by Subject|3|||
48370403|NCT00752557|155550975|FG002|Overall Study|Withdrawal by Subject|3|||
48370404|NCT00752557|155550973|FG000|Overall Study|Unspecified resaons|0|||
48370405|NCT00752557|155550974|FG001|Overall Study|Unspecified resaons|2|||
48370406|NCT00752557|155550975|FG002|Overall Study|Unspecified resaons|2|||
48370407|NCT00752557|155550973|FG000|Overall Study|Lost to Follow-up|1|||
48370408|NCT00752557|155550974|FG001|Overall Study|Lost to Follow-up|0|||
48370409|NCT00752557|155550975|FG002|Overall Study|Lost to Follow-up|1|||
48370410|NCT01014533|155550978|FG000|Overall Study|Protocol Violation|3|||
48370411|NCT01014533|155550979|FG001|Overall Study|Protocol Violation|2|||
48370412|NCT01014533|155550978|FG000|Overall Study|Withdrawal by Subject|2|||
48370413|NCT01014533|155550979|FG001|Overall Study|Withdrawal by Subject|0|||
48370414|NCT01014533|155550978|FG000|Overall Study|unable to come to appointment|0|||
48370415|NCT01014533|155550979|FG001|Overall Study|unable to come to appointment|3|||
48370416|NCT01535560|155550982|FG000|Overall Study|Adverse Event|12|||
48370417|NCT01535560|155550983|FG001|Overall Study|Adverse Event|7|||
48370418|NCT01535560|155550982|FG000|Overall Study|Lost to Follow-up|1|||
48370419|NCT01535560|155550983|FG001|Overall Study|Lost to Follow-up|3|||
48370420|NCT01535560|155550982|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
48370421|NCT01535560|155550983|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
48370422|NCT01535560|155550982|FG000|Overall Study|Treatment Failure|21|||
48370423|NCT01535560|155550983|FG001|Overall Study|Treatment Failure|83|||
48370424|NCT01535560|155550982|FG000|Overall Study|Other|0|||
48370425|NCT01535560|155550983|FG001|Overall Study|Other|1|||
48370426|NCT01535560|155550982|FG000|Overall Study|Randomized in Error|0|||
48370427|NCT01535560|155550983|FG001|Overall Study|Randomized in Error|1|||
48370428|NCT02689518|155550984|FG000|Overall Study|Withdrawal by Subject|3|||
48370429|NCT02009761|155550985|FG000|Overall Study|Adverse Event|4|||
48370430|NCT02842827|155550990|FG000|Overall Study|Adverse Event|0|||
48370431|NCT02842827|155550991|FG001|Overall Study|Adverse Event|1|||
48370432|NCT02842827|155550992|FG002|Overall Study|Adverse Event|0|||
48370433|NCT02842827|155550993|FG003|Overall Study|Adverse Event|1|||
48370434|NCT02842827|155550994|FG004|Overall Study|Adverse Event|0|||
48370435|NCT02842827|155550995|FG005|Overall Study|Adverse Event|1|||
48370436|NCT02842827|155550996|FG006|Overall Study|Adverse Event|0|||
48370437|NCT02842827|155550997|FG007|Overall Study|Adverse Event|0|||
48370438|NCT02842827|155550990|FG000|Overall Study|Death|1|||
48370439|NCT02842827|155550991|FG001|Overall Study|Death|0|||
48370440|NCT02842827|155550992|FG002|Overall Study|Death|2|||
48370441|NCT02842827|155550993|FG003|Overall Study|Death|3|||
48370442|NCT02842827|155550994|FG004|Overall Study|Death|2|||
48370443|NCT02842827|155550995|FG005|Overall Study|Death|1|||
48370444|NCT02842827|155550996|FG006|Overall Study|Death|0|||
48370445|NCT02842827|155550997|FG007|Overall Study|Death|4|||
48370446|NCT02842827|155550990|FG000|Overall Study|Physician Decision|1|||
48370447|NCT02842827|155550991|FG001|Overall Study|Physician Decision|3|||
48370448|NCT02842827|155550992|FG002|Overall Study|Physician Decision|0|||
48370449|NCT02842827|155550993|FG003|Overall Study|Physician Decision|0|||
48370450|NCT02842827|155550994|FG004|Overall Study|Physician Decision|1|||
48370451|NCT02842827|155550995|FG005|Overall Study|Physician Decision|4|||
48370452|NCT02842827|155550996|FG006|Overall Study|Physician Decision|2|||
48370453|NCT02842827|155550997|FG007|Overall Study|Physician Decision|1|||
48370454|NCT02842827|155550990|FG000|Overall Study|Protocol Defined Disease Progression|0|||
48370455|NCT02842827|155550991|FG001|Overall Study|Protocol Defined Disease Progression|0|||
48370456|NCT02842827|155550992|FG002|Overall Study|Protocol Defined Disease Progression|0|||
48370457|NCT02842827|155550993|FG003|Overall Study|Protocol Defined Disease Progression|0|||
48370458|NCT02842827|155550994|FG004|Overall Study|Protocol Defined Disease Progression|0|||
48370459|NCT02842827|155550995|FG005|Overall Study|Protocol Defined Disease Progression|1|||
48370460|NCT02842827|155550996|FG006|Overall Study|Protocol Defined Disease Progression|0|||
48370461|NCT02842827|155550997|FG007|Overall Study|Protocol Defined Disease Progression|0|||
48370462|NCT02842827|155550990|FG000|Overall Study|Participant Withdrawal of Consent|1|||
48370463|NCT02842827|155550991|FG001|Overall Study|Participant Withdrawal of Consent|2|||
48370464|NCT02842827|155550992|FG002|Overall Study|Participant Withdrawal of Consent|2|||
48370465|NCT02842827|155550993|FG003|Overall Study|Participant Withdrawal of Consent|2|||
48370466|NCT02842827|155550994|FG004|Overall Study|Participant Withdrawal of Consent|2|||
48370467|NCT02842827|155550995|FG005|Overall Study|Participant Withdrawal of Consent|1|||
48370468|NCT02842827|155550996|FG006|Overall Study|Participant Withdrawal of Consent|2|||
48370469|NCT02842827|155550997|FG007|Overall Study|Participant Withdrawal of Consent|1|||
48370470|NCT00825825|155550998|FG000|First Medication Period (14 Days)|Adverse Event|1|||
48370471|NCT00825825|155550999|FG001|First Medication Period (14 Days)|Adverse Event|0|||
48370472|NCT00825825|155551000|FG002|First Medication Period (14 Days)|Adverse Event|0|||
48370473|NCT00825825|155551001|FG003|First Medication Period (14 Days)|Adverse Event|0|||
48370474|NCT00825825|155551002|FG004|First Medication Period (14 Days)|Adverse Event|0|||
48370475|NCT00825825|155551003|FG005|First Medication Period (14 Days)|Adverse Event|1|||
48370476|NCT00825825|155550998|FG000|First Medication Period (14 Days)|Physician Decision|2|||
48370477|NCT00825825|155550999|FG001|First Medication Period (14 Days)|Physician Decision|0|||
48370478|NCT00825825|155551000|FG002|First Medication Period (14 Days)|Physician Decision|1|||
48370479|NCT00825825|155551001|FG003|First Medication Period (14 Days)|Physician Decision|0|||
48370480|NCT00825825|155551002|FG004|First Medication Period (14 Days)|Physician Decision|0|||
48370481|NCT00825825|155551003|FG005|First Medication Period (14 Days)|Physician Decision|1|||
48370482|NCT00825825|155550998|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
48370483|NCT00825825|155550999|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
48370484|NCT00825825|155551000|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
48370485|NCT00825825|155551001|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
48370486|NCT00825825|155551002|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
48370487|NCT00825825|155551003|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
48370488|NCT00825825|155550998|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
48370489|NCT00825825|155550999|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
48370490|NCT00825825|155551000|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
48370491|NCT00825825|155551001|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
48370492|NCT00825825|155551002|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
48370493|NCT00825825|155551003|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
48370494|NCT00825825|155550998|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
48370495|NCT00825825|155550999|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
48370496|NCT00825825|155551000|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
48370497|NCT00825825|155551001|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
48370498|NCT00825825|155551002|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
48370499|NCT00825825|155551003|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
48370500|NCT00825825|155550998|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
48370501|NCT00825825|155550999|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
48370502|NCT00825825|155551000|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
48370503|NCT00825825|155551001|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
48370504|NCT00825825|155551002|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
48370505|NCT00825825|155551003|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
48370506|NCT00825825|155550998|FG000|Third Medication Period (14 Days)|poor data quality|0|||
48370507|NCT00825825|155550999|FG001|Third Medication Period (14 Days)|poor data quality|1|||
48370508|NCT00825825|155551000|FG002|Third Medication Period (14 Days)|poor data quality|0|||
48370509|NCT00825825|155551001|FG003|Third Medication Period (14 Days)|poor data quality|0|||
48370510|NCT00825825|155551002|FG004|Third Medication Period (14 Days)|poor data quality|0|||
48370511|NCT00825825|155551003|FG005|Third Medication Period (14 Days)|poor data quality|0|||
48370512|NCT02433340|155551008|FG000|Overall Study|Adverse Event|0|||
48370513|NCT02433340|155551009|FG001|Overall Study|Adverse Event|0|||
48370514|NCT02433340|155551010|FG002|Overall Study|Adverse Event|1|||
48370515|NCT02433340|155551011|FG003|Overall Study|Adverse Event|0|||
48370516|NCT02433340|155551008|FG000|Overall Study|Withdrawal by Subject|1|||
48370517|NCT02433340|155551009|FG001|Overall Study|Withdrawal by Subject|0|||
48370518|NCT02433340|155551010|FG002|Overall Study|Withdrawal by Subject|1|||
48370519|NCT02433340|155551011|FG003|Overall Study|Withdrawal by Subject|2|||
48370520|NCT02433340|155551008|FG000|Overall Study|Lost to Follow-up|0|||
48370521|NCT02433340|155551009|FG001|Overall Study|Lost to Follow-up|1|||
48370522|NCT02433340|155551010|FG002|Overall Study|Lost to Follow-up|0|||
48370523|NCT02433340|155551011|FG003|Overall Study|Lost to Follow-up|0|||
48370524|NCT02433340|155551008|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
48370525|NCT02433340|155551009|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
48370526|NCT02433340|155551010|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
48370527|NCT02433340|155551011|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
48370528|NCT02433340|155551008|FG000|Overall Study|Other|0|||
48370529|NCT02433340|155551009|FG001|Overall Study|Other|1|||
48370530|NCT02433340|155551010|FG002|Overall Study|Other|0|||
48370531|NCT02433340|155551011|FG003|Overall Study|Other|0|||
48370532|NCT00943111|155551012|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
48370533|NCT00943111|155551013|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
48370534|NCT00943111|155551014|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
48370535|NCT00943111|155551012|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
48370536|NCT00943111|155551013|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
48370537|NCT00943111|155551014|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
48370538|NCT00943111|155551012|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
48370539|NCT00943111|155551013|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
48370540|NCT00943111|155551014|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
48370541|NCT00943111|155551012|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
48370542|NCT00943111|155551013|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
48370543|NCT00943111|155551014|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
48370544|NCT00943111|155551012|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
48370545|NCT00943111|155551013|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
48370546|NCT00943111|155551014|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
48370547|NCT00943111|155551012|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
48370548|NCT00943111|155551013|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
48370549|NCT00943111|155551014|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
48370550|NCT00943111|155551012|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
48370551|NCT00943111|155551013|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
48370552|NCT00943111|155551014|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
48370553|NCT00943111|155551012|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
48370554|NCT00943111|155551013|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
48370555|NCT00943111|155551014|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
48370556|NCT01575028|155551019|FG000|Overall Study|Physician Decision|0|||
48370557|NCT01575028|155551020|FG001|Overall Study|Physician Decision|1|||
48370558|NCT01182194|155551021|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
48370559|NCT01182194|155551022|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
48370560|NCT00790751|155551023|FG000|Overall Study|Protocol non-compliance|16|||
48370561|NCT00790751|155551024|FG001|Overall Study|Protocol non-compliance|16|||
48370562|NCT00790751|155551025|FG002|Overall Study|Protocol non-compliance|10|||
48370563|NCT00790751|155551026|FG003|Overall Study|Protocol non-compliance|11|||
48370564|NCT00790751|155551023|FG000|Overall Study|Lost to Follow-up|4|||
48370565|NCT00790751|155551024|FG001|Overall Study|Lost to Follow-up|9|||
48370566|NCT00790751|155551025|FG002|Overall Study|Lost to Follow-up|4|||
48370567|NCT00790751|155551026|FG003|Overall Study|Lost to Follow-up|5|||
48370568|NCT00790751|155551023|FG000|Overall Study|Adverse Event|5|||
48370569|NCT00790751|155551024|FG001|Overall Study|Adverse Event|3|||
48370570|NCT00790751|155551025|FG002|Overall Study|Adverse Event|5|||
48370571|NCT00790751|155551026|FG003|Overall Study|Adverse Event|4|||
48370572|NCT00790751|155551023|FG000|Overall Study|Requirement for restricted medication|0|||
48370573|NCT00790751|155551024|FG001|Overall Study|Requirement for restricted medication|2|||
48370574|NCT00790751|155551025|FG002|Overall Study|Requirement for restricted medication|0|||
48370575|NCT00790751|155551026|FG003|Overall Study|Requirement for restricted medication|0|||
48370576|NCT00790751|155551023|FG000|Overall Study|Death|0|||
48370577|NCT00790751|155551024|FG001|Overall Study|Death|0|||
48370578|NCT00790751|155551025|FG002|Overall Study|Death|1|||
48370579|NCT00790751|155551026|FG003|Overall Study|Death|0|||
48370580|NCT00790751|155551023|FG000|Overall Study|Physician Decision|0|||
48370581|NCT00790751|155551024|FG001|Overall Study|Physician Decision|0|||
48370582|NCT00790751|155551025|FG002|Overall Study|Physician Decision|0|||
48370583|NCT00790751|155551026|FG003|Overall Study|Physician Decision|1|||
48370584|NCT01078454|155551027|FG000|Overall Study|Adverse Event|1|||
48370585|NCT01078454|155551028|FG001|Overall Study|Adverse Event|1|||
48370586|NCT01078454|155551027|FG000|Overall Study|Death|0|||
48370587|NCT01078454|155551028|FG001|Overall Study|Death|1|||
48370588|NCT02545933|155551029|FG000|Overall Study|Adverse Event|3|||
48370589|NCT02545933|155551030|FG001|Overall Study|Adverse Event|0|||
48370590|NCT02545933|155551031|FG002|Overall Study|Adverse Event|0|||
48370591|NCT02545933|155551029|FG000|Overall Study|Withdrawal by Subject|2|||
48370592|NCT02545933|155551030|FG001|Overall Study|Withdrawal by Subject|3|||
48370593|NCT02545933|155551031|FG002|Overall Study|Withdrawal by Subject|3|||
48370594|NCT02545933|155551029|FG000|Overall Study|Protocol Violation|1|||
48370595|NCT02545933|155551030|FG001|Overall Study|Protocol Violation|0|||
48370596|NCT02545933|155551031|FG002|Overall Study|Protocol Violation|1|||
48370597|NCT00423930|155551032|FG000|Overall Study|Withdrawal by Subject|2|||
48370598|NCT01050790|155551037|FG000|Overall Study|Adverse Event|1|||
48370599|NCT03705832|155551038|FG000|Overall Study|Physician Decision|0|||
48370600|NCT03705832|155551039|FG001|Overall Study|Physician Decision|1|||
48370601|NCT03705832|155551038|FG000|Overall Study|Withdrawal by Subject|1|||
48370602|NCT03705832|155551039|FG001|Overall Study|Withdrawal by Subject|0|||
48370603|NCT01880528|155551040|FG000|Overall Study|Other|1|||
48370604|NCT01880528|155551041|FG001|Overall Study|Other|1|||
48370605|NCT00432666|155553388|FG000|Main Period|Adverse Event|1|||
48370606|NCT00432666|155553389|FG001|Main Period|Adverse Event|1|||
48370607|NCT00432666|155553388|FG000|Main Period|Consent Withdrawn|1|||
48370608|NCT00432666|155553389|FG001|Main Period|Consent Withdrawn|0|||
48370609|NCT00432666|155553388|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
48370610|NCT00432666|155553389|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
48370611|NCT00432666|155553388|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
48370612|NCT00432666|155553389|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
48370613|NCT00432666|155553388|FG000|Open-Label Extension Period|Adverse Event|5|||
48370614|NCT00432666|155553389|FG001|Open-Label Extension Period|Adverse Event|0|||
48370615|NCT00432666|155553388|FG000|Open-Label Extension Period|Consent withdrawn|10|||
48370616|NCT00432666|155553389|FG001|Open-Label Extension Period|Consent withdrawn|0|||
48370617|NCT00432666|155553388|FG000|Open-Label Extension Period|Physician Decision|3|||
48432062|NCT01683071|155769032|FG001|Part 1|Lack of Efficacy|0|||
48370618|NCT00432666|155553389|FG001|Open-Label Extension Period|Physician Decision|0|||
48370619|NCT00978627|155553390|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
48370620|NCT00978627|155553391|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
48370621|NCT00978627|155553390|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
48370622|NCT00978627|155553391|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
48370623|NCT00978627|155553390|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
48370624|NCT00978627|155553391|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
48370625|NCT00978627|155553390|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
48370626|NCT00978627|155553391|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
48370627|NCT00978627|155553390|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
48370628|NCT00978627|155553391|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
48370629|NCT00978627|155553390|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
48370630|NCT00978627|155553391|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
48370631|NCT00978627|155553390|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
48370632|NCT00978627|155553391|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
48370633|NCT00978627|155553390|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
48370634|NCT00978627|155553391|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
48370635|NCT00978627|155553390|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
48370636|NCT00978627|155553391|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
48370637|NCT00812331|155553392|FG000|Overall Study|Adverse Event|1|||
48370638|NCT00812331|155553393|FG001|Overall Study|Adverse Event|0|||
48370639|NCT00812331|155553394|FG002|Overall Study|Adverse Event|0|||
48370640|NCT00812331|155553395|FG003|Overall Study|Adverse Event|0|||
48370641|NCT00812331|155553396|FG004|Overall Study|Adverse Event|0|||
48370642|NCT01077271|155553397|FG000|Overall Study|Parental desire|8|||
48370643|NCT01077271|155553397|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
48370644|NCT01077271|155553397|FG000|Overall Study|Noncompliance|2|||
48370645|NCT01077271|155553397|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
48370646|NCT01077271|155553397|FG000|Overall Study|Changed doctors|2|||
48370647|NCT01077271|155553397|FG000|Overall Study|Parents thought too many injections|2|||
48370648|NCT01077271|155553397|FG000|Overall Study|End of RSV season nearly reached|1|||
48370649|NCT01077271|155553397|FG000|Overall Study|Mother unconvinced of the necessity|1|||
48370650|NCT03694275|155553398|FG000|Overall Study|Adverse Event|0|||
48370651|NCT03694275|155553399|FG001|Overall Study|Adverse Event|1|||
48370652|NCT03694275|155553398|FG000|Overall Study|Reason not Specified|0|||
48370653|NCT03694275|155553399|FG001|Overall Study|Reason not Specified|1|||
48370654|NCT00095498|155553402|FG000|Overall Study|Physician Decision|9|||
48370655|NCT00095498|155553403|FG001|Overall Study|Physician Decision|10|||
48370656|NCT00095498|155553404|FG002|Overall Study|Physician Decision|8|||
48370657|NCT00095498|155553402|FG000|Overall Study|Adverse Event|1|||
48370658|NCT00095498|155553403|FG001|Overall Study|Adverse Event|0|||
48370659|NCT00095498|155553404|FG002|Overall Study|Adverse Event|1|||
48370660|NCT00095498|155553402|FG000|Overall Study|Withdrawal by Subject|15|||
48370661|NCT00095498|155553403|FG001|Overall Study|Withdrawal by Subject|16|||
48370662|NCT00095498|155553404|FG002|Overall Study|Withdrawal by Subject|15|||
48370663|NCT00095498|155553402|FG000|Overall Study|Disease progression|0|||
48370664|NCT00095498|155553403|FG001|Overall Study|Disease progression|1|||
48370665|NCT00095498|155553404|FG002|Overall Study|Disease progression|1|||
48370666|NCT00095498|155553402|FG000|Overall Study|Ineligibility determined|3|||
48370667|NCT00095498|155553403|FG001|Overall Study|Ineligibility determined|0|||
48370668|NCT00095498|155553404|FG002|Overall Study|Ineligibility determined|2|||
48370669|NCT00095498|155553402|FG000|Overall Study|Lost to Follow-up|1|||
48370670|NCT00095498|155553403|FG001|Overall Study|Lost to Follow-up|1|||
48370671|NCT00095498|155553404|FG002|Overall Study|Lost to Follow-up|2|||
48370672|NCT00095498|155553402|FG000|Overall Study|Noncompliance|1|||
48370673|NCT00095498|155553403|FG001|Overall Study|Noncompliance|0|||
48370674|NCT00095498|155553404|FG002|Overall Study|Noncompliance|1|||
48370675|NCT00095498|155553402|FG000|Overall Study|Other|6|||
48370676|NCT00095498|155553403|FG001|Overall Study|Other|7|||
48370677|NCT00095498|155553404|FG002|Overall Study|Other|6|||
48370678|NCT00095498|155553402|FG000|Overall Study|Protocol Violation|0|||
48370679|NCT00095498|155553403|FG001|Overall Study|Protocol Violation|0|||
48370680|NCT00095498|155553404|FG002|Overall Study|Protocol Violation|1|||
48370681|NCT00095498|155553402|FG000|Overall Study|Requirement for alternative therapy|1|||
48370682|NCT00095498|155553403|FG001|Overall Study|Requirement for alternative therapy|0|||
48370683|NCT00095498|155553404|FG002|Overall Study|Requirement for alternative therapy|2|||
48370684|NCT03695237|155553405|FG000|Overall Study|Withdrawal by Subject|1|||
48370685|NCT03695237|155553406|FG001|Overall Study|Withdrawal by Subject|3|||
48370686|NCT03695237|155553405|FG000|Overall Study|Lost to Follow-up|1|||
48370687|NCT03695237|155553406|FG001|Overall Study|Lost to Follow-up|2|||
48370688|NCT03695237|155553405|FG000|Overall Study|Other, Not Specified|8|||
48370689|NCT03695237|155553406|FG001|Overall Study|Other, Not Specified|2|||
48370690|NCT04375761|155553407|FG000|Overall Study|Death|1|||
48370691|NCT04375761|155553408|FG001|Overall Study|Death|2|||
48370692|NCT04375761|155553407|FG000|Overall Study|Lost to Follow-up|203|||
48370693|NCT04375761|155553408|FG001|Overall Study|Lost to Follow-up|380|||
48370694|NCT04375761|155553407|FG000|Overall Study|Withdrawal by Subject|47|||
48370695|NCT04375761|155553408|FG001|Overall Study|Withdrawal by Subject|98|||
48370696|NCT04375761|155553407|FG000|Overall Study|Noncompliance with study procedure|121|||
48370697|NCT04375761|155553408|FG001|Overall Study|Noncompliance with study procedure|251|||
48370698|NCT04375761|155553407|FG000|Overall Study|Reimbursement not enough|1|||
48370699|NCT04375761|155553408|FG001|Overall Study|Reimbursement not enough|2|||
48370700|NCT04375761|155553407|FG000|Overall Study|Unforeseen family circumstances|1|||
48370701|NCT04375761|155553408|FG001|Overall Study|Unforeseen family circumstances|3|||
48370702|NCT04375761|155553407|FG000|Overall Study|Test too painful|1|||
48370703|NCT04375761|155553408|FG001|Overall Study|Test too painful|1|||
48370704|NCT04375761|155553407|FG000|Overall Study|Moved|0|||
48370705|NCT04375761|155553408|FG001|Overall Study|Moved|2|||
48370706|NCT04375761|155553407|FG000|Overall Study|Nonresponsive|0|||
48370707|NCT04375761|155553408|FG001|Overall Study|Nonresponsive|5|||
48370708|NCT03725085|155553409|FG000|Overall Study|Lost to Follow-up|2|||
48370709|NCT00705679|155553410|FG000|Overall Study|Adverse Event|1|||
48370710|NCT00705679|155553411|FG001|Overall Study|Adverse Event|1|||
48370711|NCT00705679|155553412|FG002|Overall Study|Adverse Event|0|||
48370712|NCT00705679|155553413|FG003|Overall Study|Adverse Event|0|||
48370713|NCT00705679|155553414|FG004|Overall Study|Adverse Event|0|||
48370714|NCT00705679|155553410|FG000|Overall Study|Death|0|||
48370715|NCT00705679|155553411|FG001|Overall Study|Death|0|||
48370716|NCT00705679|155553412|FG002|Overall Study|Death|3|||
48370717|NCT00705679|155553413|FG003|Overall Study|Death|2|||
48370718|NCT00705679|155553414|FG004|Overall Study|Death|1|||
48370719|NCT00705679|155553410|FG000|Overall Study|Lost to Follow-up|32|||
48370720|NCT00705679|155553411|FG001|Overall Study|Lost to Follow-up|60|||
48370721|NCT00705679|155553412|FG002|Overall Study|Lost to Follow-up|44|||
48370722|NCT00705679|155553413|FG003|Overall Study|Lost to Follow-up|30|||
48370723|NCT00705679|155553414|FG004|Overall Study|Lost to Follow-up|35|||
48370724|NCT00705679|155553410|FG000|Overall Study|Physician Decision|0|||
48370725|NCT00705679|155553411|FG001|Overall Study|Physician Decision|1|||
48370726|NCT00705679|155553412|FG002|Overall Study|Physician Decision|0|||
48370727|NCT00705679|155553413|FG003|Overall Study|Physician Decision|1|||
48370728|NCT00705679|155553414|FG004|Overall Study|Physician Decision|0|||
48370729|NCT00705679|155553410|FG000|Overall Study|Withdrawal by Subject|32|||
48370730|NCT00705679|155553411|FG001|Overall Study|Withdrawal by Subject|77|||
48370731|NCT00705679|155553412|FG002|Overall Study|Withdrawal by Subject|68|||
48370732|NCT00705679|155553413|FG003|Overall Study|Withdrawal by Subject|47|||
48370733|NCT00705679|155553414|FG004|Overall Study|Withdrawal by Subject|33|||
48370734|NCT03730480|155553415|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
48370735|NCT00959647|155553418|FG000|Overall Study|Adverse Event|2|||
48370736|NCT00959647|155553418|FG000|Overall Study|Progressive disease|6|||
48370737|NCT00959647|155553418|FG000|Overall Study|Study terminated by sponsor|4|||
48370738|NCT00959647|155553418|FG000|Overall Study|Withdrawal by Subject|7|||
48370739|NCT01119105|155553419|FG000|Overall Study|Withdrawal by Subject|1|||
48370740|NCT01119105|155553420|FG001|Overall Study|Withdrawal by Subject|1|||
48370741|NCT01119105|155553421|FG002|Overall Study|Withdrawal by Subject|1|||
48370742|NCT01119105|155553419|FG000|Overall Study|Lost to Follow-up|0|||
48370743|NCT01119105|155553420|FG001|Overall Study|Lost to Follow-up|2|||
48370744|NCT01119105|155553421|FG002|Overall Study|Lost to Follow-up|5|||
48370745|NCT01119105|155553419|FG000|Overall Study|Adverse Event|1|||
48370746|NCT01119105|155553420|FG001|Overall Study|Adverse Event|0|||
48370747|NCT01119105|155553421|FG002|Overall Study|Adverse Event|1|||
48370748|NCT01119105|155553419|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
48370749|NCT01119105|155553420|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
48370750|NCT01119105|155553421|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
48370751|NCT01119105|155553419|FG000|Overall Study|Other|1|||
48370752|NCT01119105|155553420|FG001|Overall Study|Other|1|||
48370753|NCT01119105|155553421|FG002|Overall Study|Other|0|||
48370754|NCT02383056|155553422|FG000|Overall Study|Adverse Event|1|||
48370755|NCT02383056|155553423|FG001|Overall Study|Adverse Event|0|||
48370756|NCT02383056|155553422|FG000|Overall Study|Lost to Follow-up|0|||
48370757|NCT02383056|155553423|FG001|Overall Study|Lost to Follow-up|2|||
48370758|NCT01813929|155553424|FG000|Overall Study|Withdrawal by Subject|0|||
48370759|NCT01813929|155553425|FG001|Overall Study|Withdrawal by Subject|1|||
48370760|NCT00007345|155553426|FG000|Overall Study|Refused further treatment|0|||
48370761|NCT00007345|155553427|FG001|Overall Study|Refused further treatment|7|||
48370762|NCT00007345|155553426|FG000|Overall Study|Switched to alternative treatment|0|||
48370763|NCT00007345|155553427|FG001|Overall Study|Switched to alternative treatment|3|||
48370764|NCT00007345|155553426|FG000|Overall Study|Intercurrent illness|1|||
48370765|NCT00007345|155553427|FG001|Overall Study|Intercurrent illness|0|||
48370766|NCT00007345|155553426|FG000|Overall Study|Death on study|1|||
48370767|NCT00007345|155553427|FG001|Overall Study|Death on study|1|||
48587201|NCT01004432|156343157|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
48587202|NCT01004432|156343158|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
48370770|NCT00522873|155553432|FG000|Overall Study|Adverse Event|41|||
48370771|NCT00522873|155553433|FG001|Overall Study|Adverse Event|26|||
48370772|NCT00522873|155553432|FG000|Overall Study|Withdrawal by Subject|20|||
48370773|NCT00522873|155553433|FG001|Overall Study|Withdrawal by Subject|9|||
48370774|NCT00522873|155553432|FG000|Overall Study|Protocol Violation|14|||
48370775|NCT00522873|155553433|FG001|Overall Study|Protocol Violation|4|||
48370776|NCT00522873|155553432|FG000|Overall Study|Lost to Follow-up|11|||
48370777|NCT00522873|155553433|FG001|Overall Study|Lost to Follow-up|3|||
48370778|NCT00522873|155553432|FG000|Overall Study|Personal Reasons|8|||
48370779|NCT00522873|155553433|FG001|Overall Study|Personal Reasons|1|||
48370780|NCT00522873|155553432|FG000|Overall Study|Medication Errors|1|||
48370781|NCT00522873|155553433|FG001|Overall Study|Medication Errors|1|||
48370782|NCT00522873|155553432|FG000|Overall Study|Never Received Medication|1|||
48370783|NCT00522873|155553433|FG001|Overall Study|Never Received Medication|0|||
48370784|NCT00700258|155553438|FG000|Overall Study|Premature discontinuation of documentation|136|||
48370785|NCT00700258|155553438|FG000|Overall Study|Type of study end not documented|1|||
48370786|NCT00700258|155553438|FG000|Overall Study|Lost to Follow-up|81|||
48370787|NCT00700258|155553438|FG000|Overall Study|Premature discontinuation of therapy|1013|||
48370788|NCT00370331|155553439|FG000|Overall Study|Adverse Event|4|||
48370789|NCT00370331|155553440|FG001|Overall Study|Adverse Event|13|||
48370790|NCT00370331|155553439|FG000|Overall Study|Withdrawal by Subject|2|||
48370791|NCT00370331|155553440|FG001|Overall Study|Withdrawal by Subject|4|||
48370792|NCT00370331|155553439|FG000|Overall Study|Lost to Follow-up|0|||
48370793|NCT00370331|155553440|FG001|Overall Study|Lost to Follow-up|3|||
48370794|NCT00370331|155553439|FG000|Overall Study|Lack of Efficacy|0|||
48370795|NCT00370331|155553440|FG001|Overall Study|Lack of Efficacy|1|||
48370796|NCT00370331|155553439|FG000|Overall Study|Non-compliance|0|||
48370797|NCT00370331|155553440|FG001|Overall Study|Non-compliance|1|||
48370798|NCT00370331|155553439|FG000|Overall Study|Protocol Violation|1|||
48370799|NCT00370331|155553440|FG001|Overall Study|Protocol Violation|1|||
48370800|NCT01802567|155553441|FG000|Overall Study|Withdrawal by Subject|2|||
48370801|NCT01802567|155553441|FG000|Overall Study|Physician Decision|1|||
48370802|NCT01802567|155553441|FG000|Overall Study|Lack of Efficacy|7|||
48370803|NCT01802567|155553441|FG000|Overall Study|Consented but did not start therapy|7|||
48370804|NCT01802567|155553441|FG000|Overall Study|Protocol Violation|1|||
48370805|NCT02585232|155553444|FG000|Overall Study|Lost to Follow-up|8|||
48370806|NCT02585232|155553445|FG001|Overall Study|Lost to Follow-up|8|||
48370807|NCT02585232|155553444|FG000|Overall Study|Withdrawal by Subject|4|||
48370808|NCT02585232|155553445|FG001|Overall Study|Withdrawal by Subject|8|||
48370809|NCT00297232|155553446|FG000|Overall Study|Lack of Efficacy|7|||
48370810|NCT00297232|155553446|FG000|Overall Study|Lost to Follow-up|10|||
48370811|NCT00297232|155553446|FG000|Overall Study|Adverse Event|63|||
48370812|NCT00297232|155553446|FG000|Overall Study|Voluntary Withdrawal|120|||
48370813|NCT00297232|155553446|FG000|Overall Study|Subject was Noncompliant|9|||
48370814|NCT00297232|155553446|FG000|Overall Study|Death|9|||
48370815|NCT00297232|155553446|FG000|Overall Study|Anti-natalizumab Positive|8|||
48370816|NCT00297232|155553446|FG000|Overall Study|Switched to Commercial Tysabri|22|||
48370817|NCT00297232|155553446|FG000|Overall Study|Disease Progression|8|||
48370818|NCT00297232|155553446|FG000|Overall Study|Fear of PML|10|||
48370819|NCT00297232|155553446|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
48370820|NCT00297232|155553446|FG000|Overall Study|Miscellaneous|5|||
48370821|NCT00297232|155553446|FG000|Overall Study|Sponsor Decision|34|||
48370822|NCT00297232|155553446|FG000|Overall Study|Subject Relocated|7|||
48370823|NCT00297232|155553446|FG000|Overall Study|Subject Withdrew Consent|37|||
48370824|NCT00297232|155553446|FG000|Overall Study|Persistently Positive Antibodies|11|||
48370825|NCT00297232|155553446|FG000|Overall Study|Investigator Withdrew From Program|19|||
48370826|NCT00297232|155553446|FG000|Overall Study|Did Not Enroll to Week 264|34|||
48370827|NCT00297232|155553446|FG000|Overall Study|Did Not Enroll to Week 480|17|||
48370828|NCT00297232|155553446|FG000|Overall Study|No data available after Week 264|161|||
48370829|NCT00297232|155553446|FG000|Overall Study|Other|1|||
48370830|NCT03235284|155553447|FG000|Overall Study|Adverse Event|1|||
48370831|NCT03235284|155553448|FG001|Overall Study|Adverse Event|2|||
48370832|NCT03235284|155553449|FG002|Overall Study|Adverse Event|1|||
48370833|NCT00440999|155553450|FG000|Overall Study|Adverse Event|0|||
48370834|NCT00440999|155553451|FG001|Overall Study|Adverse Event|2|||
48370835|NCT00440999|155553450|FG000|Overall Study|Lack of Efficacy|6|||
48370836|NCT00440999|155553451|FG001|Overall Study|Lack of Efficacy|7|||
48370837|NCT00440999|155553450|FG000|Overall Study|Lost to Follow-up|19|||
48370838|NCT00440999|155553451|FG001|Overall Study|Lost to Follow-up|12|||
48370839|NCT00440999|155553450|FG000|Overall Study|Protocol Violation|1|||
48370840|NCT00440999|155553451|FG001|Overall Study|Protocol Violation|0|||
48370841|NCT00440999|155553450|FG000|Overall Study|Withdrawal by Subject|2|||
48370842|NCT00440999|155553451|FG001|Overall Study|Withdrawal by Subject|5|||
48370843|NCT00440999|155553450|FG000|Overall Study|Subjets missed the visit|1|||
48370844|NCT00440999|155553451|FG001|Overall Study|Subjets missed the visit|0|||
48370845|NCT00440999|155553450|FG000|Overall Study|Mixed infection at entry|1|||
48370846|NCT00440999|155553451|FG001|Overall Study|Mixed infection at entry|0|||
48370847|NCT00440999|155553450|FG000|Overall Study|P. falciparum malaria|5|||
48370848|NCT00440999|155553451|FG001|Overall Study|P. falciparum malaria|14|||
48370849|NCT00440999|155553450|FG000|Overall Study|Subj left hosp without inform staff|0|||
48370850|NCT00440999|155553451|FG001|Overall Study|Subj left hosp without inform staff|1|||
48370851|NCT01656733|155553452|FG000|Overall Study|No permission to collect birth outcomes|0|||
48370852|NCT01656733|155553453|FG001|Overall Study|No permission to collect birth outcomes|1|||
48370853|NCT01656733|155553452|FG000|Overall Study|Delivery at another hospital|0|||
48370854|NCT01656733|155553453|FG001|Overall Study|Delivery at another hospital|2|||
48370855|NCT01656733|155553452|FG000|Overall Study|Spontaneous abortion|0|||
48370856|NCT01656733|155553453|FG001|Overall Study|Spontaneous abortion|1|||
48370857|NCT03484273|155553454|FG000|Overall Study|Equipment Malfunction|1|||
48370858|NCT03484273|155553454|FG000|Overall Study|Data excluded from analysis|1|||
48370859|NCT00249002|155553455|FG000|Overall Study|Adverse Event|2|||
48370860|NCT00249002|155553455|FG000|Overall Study|Study cancellation|3|||
48370861|NCT00249002|155553455|FG000|Overall Study|Other|2|||
48370862|NCT00195091|155553456|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
48370863|NCT01157676|155553460|FG000|Randomization|Death|1|||
48370864|NCT01157676|155553461|FG001|Randomization|Death|1|||
48370865|NCT01157676|155553460|FG000|Randomization|unresectable|2|||
48370866|NCT01157676|155553461|FG001|Randomization|unresectable|3|||
48370867|NCT01157676|155553460|FG000|Randomization|Withdrawal by Subject|17|||
48370868|NCT01157676|155553461|FG001|Randomization|Withdrawal by Subject|13|||
48370869|NCT01157676|155553460|FG000|Randomization|Physician Decision|1|||
48370870|NCT01157676|155553461|FG001|Randomization|Physician Decision|0|||
48370871|NCT01157676|155553460|FG000|Surgery|underwent open cystectomy|0|||
48370872|NCT01157676|155553461|FG001|Surgery|underwent open cystectomy|4|||
48370873|NCT01157676|155553460|FG000|Surgery|converted to open procedure|0|||
48370874|NCT01157676|155553461|FG001|Surgery|converted to open procedure|5|||
48370875|NCT01157676|155553460|FG000|Surgery|underwent robotic cystectomy|1|||
48370876|NCT01157676|155553461|FG001|Surgery|underwent robotic cystectomy|0|||
48370877|NCT02476279|155553462|FG000|Overall Study|Lost to Follow-up|1|||
48370878|NCT02476279|155553463|FG001|Overall Study|Lost to Follow-up|1|||
48370879|NCT03545503|155553464|FG000|Overall Study|Protocol Violation|14|||
48370880|NCT03545503|155553465|FG001|Overall Study|Protocol Violation|16|||
48370881|NCT00986973|155553468|FG000|Overall Study|Withdrawn by study team|1|||
48370882|NCT01605916|155553470|FG000|Overall Study|Adverse Event|1|||
48370883|NCT01605916|155553471|FG001|Overall Study|Adverse Event|0|||
48370884|NCT01605916|155553472|FG002|Overall Study|Adverse Event|0|||
48370885|NCT01605916|155553473|FG003|Overall Study|Adverse Event|1|||
48370886|NCT01605916|155553474|FG004|Overall Study|Adverse Event|0|||
48370887|NCT01605916|155553470|FG000|Overall Study|Lack of Efficacy|2|||
48370888|NCT01605916|155553471|FG001|Overall Study|Lack of Efficacy|3|||
48370889|NCT01605916|155553472|FG002|Overall Study|Lack of Efficacy|3|||
48370890|NCT01605916|155553473|FG003|Overall Study|Lack of Efficacy|5|||
48370891|NCT01605916|155553474|FG004|Overall Study|Lack of Efficacy|4|||
48370892|NCT01605916|155553470|FG000|Overall Study|Withdrawal by Subject|1|||
48370893|NCT01605916|155553471|FG001|Overall Study|Withdrawal by Subject|1|||
48370894|NCT01605916|155553472|FG002|Overall Study|Withdrawal by Subject|0|||
48370895|NCT01605916|155553473|FG003|Overall Study|Withdrawal by Subject|0|||
48370896|NCT01605916|155553474|FG004|Overall Study|Withdrawal by Subject|2|||
48370897|NCT01590082|155553475|FG000|Overall Study|Withdrawal by Subject|1|||
48370898|NCT01590082|155553476|FG001|Overall Study|Withdrawal by Subject|0|||
48370899|NCT01590082|155553475|FG000|Overall Study|Ineligible|1|||
48370900|NCT01590082|155553476|FG001|Overall Study|Ineligible|0|||
48370901|NCT00470366|155553477|FG000|Overall Study|Adverse Event|3|||
48370902|NCT00470366|155553477|FG000|Overall Study|Poor compliance|1|||
48370903|NCT01853644|155553479|FG000|Registration and Treatment Start|Did not start treatment|1|||
48370904|NCT01853644|155553479|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
48370905|NCT01853644|155553479|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
48370906|NCT01853644|155553479|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
48370907|NCT01853644|155553479|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
48370908|NCT01853644|155553479|FG000|Continued Treatment After First Response|Adverse Event|2|||
48370909|NCT01853644|155553479|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
48370910|NCT01920854|155553480|FG000|Overall Study|Withdrawal by Subject|1|||
48370911|NCT01920854|155553481|FG001|Overall Study|Withdrawal by Subject|0|||
48370912|NCT01920854|155553482|FG002|Overall Study|Withdrawal by Subject|0|||
48370913|NCT01920854|155553483|FG003|Overall Study|Withdrawal by Subject|0|||
48370914|NCT01920854|155553484|FG004|Overall Study|Withdrawal by Subject|1|||
48370915|NCT01920854|155553485|FG005|Overall Study|Withdrawal by Subject|0|||
48370916|NCT01920854|155553486|FG006|Overall Study|Withdrawal by Subject|1|||
48370917|NCT01178385|155553488|FG000|Overall Study|Withdrawal by Subject|2|||
48370918|NCT01178385|155553489|FG001|Overall Study|Withdrawal by Subject|0|||
48370919|NCT01226095|155553490|FG000|Overall Study|Poor compliance|1|||
48370920|NCT02372136|155553492|FG000|Overall Study|Death|3|||
48370921|NCT02372136|155553493|FG001|Overall Study|Death|1|||
48370922|NCT01688830|155553494|FG000|Overall Study|Lost to Follow-up|0|||
48370923|NCT01688830|155553495|FG001|Overall Study|Lost to Follow-up|0|||
48370924|NCT01688830|155553496|FG002|Overall Study|Lost to Follow-up|0|||
48370925|NCT01688830|155553497|FG003|Overall Study|Lost to Follow-up|0|||
48370926|NCT01688830|155553498|FG004|Overall Study|Lost to Follow-up|0|||
48370927|NCT01688830|155553499|FG005|Overall Study|Lost to Follow-up|0|||
48370928|NCT01688830|155553500|FG006|Overall Study|Lost to Follow-up|0|||
48370929|NCT01688830|155553501|FG007|Overall Study|Lost to Follow-up|0|||
48370930|NCT01688830|155553502|FG008|Overall Study|Lost to Follow-up|0|||
48370931|NCT01688830|155553503|FG009|Overall Study|Lost to Follow-up|0|||
48370932|NCT01688830|155553504|FG010|Overall Study|Lost to Follow-up|1|||
48370933|NCT01688830|155553505|FG011|Overall Study|Lost to Follow-up|0|||
48370934|NCT01688830|155553506|FG012|Overall Study|Lost to Follow-up|0|||
48370935|NCT01688830|155553507|FG013|Overall Study|Lost to Follow-up|0|||
48370936|NCT01688830|155553508|FG014|Overall Study|Lost to Follow-up|0|||
48370937|NCT01688830|155553509|FG015|Overall Study|Lost to Follow-up|0|||
48370938|NCT01688830|155553510|FG016|Overall Study|Lost to Follow-up|0|||
48370939|NCT01688830|155553511|FG017|Overall Study|Lost to Follow-up|0|||
48370940|NCT01688830|155553512|FG018|Overall Study|Lost to Follow-up|0|||
48370941|NCT01688830|155553513|FG019|Overall Study|Lost to Follow-up|0|||
48370942|NCT01688830|155553514|FG020|Overall Study|Lost to Follow-up|0|||
48370943|NCT03616977|155553519|FG000|Period 1|Physician Decision|0|||
48370944|NCT03616977|155553520|FG001|Period 1|Physician Decision|1|||
48370945|NCT03616977|155553519|FG000|Period 3|Adverse Event|1|||
48370946|NCT03616977|155553520|FG001|Period 3|Adverse Event|1|||
48370947|NCT01049217|155553522|FG000|Overall Study|Adverse Event|2|||
48370948|NCT01049217|155553523|FG001|Overall Study|Adverse Event|1|||
48370949|NCT01049217|155553522|FG000|Overall Study|Lack of Efficacy|1|||
48370950|NCT01049217|155553523|FG001|Overall Study|Lack of Efficacy|1|||
48370951|NCT01049217|155553522|FG000|Overall Study|Lost to Follow-up|3|||
48370952|NCT01049217|155553523|FG001|Overall Study|Lost to Follow-up|8|||
48370953|NCT01049217|155553522|FG000|Overall Study|Withdrawal by Subject|4|||
48370954|NCT01049217|155553523|FG001|Overall Study|Withdrawal by Subject|3|||
48370955|NCT01049217|155553522|FG000|Overall Study|Protocol Violation|1|||
48370956|NCT01049217|155553523|FG001|Overall Study|Protocol Violation|3|||
48370957|NCT01049217|155553522|FG000|Overall Study|Pregnancy|1|||
48370958|NCT01049217|155553523|FG001|Overall Study|Pregnancy|0|||
48370959|NCT01049217|155553522|FG000|Overall Study|Study Terminated by Sponsor|43|||
48370960|NCT01049217|155553523|FG001|Overall Study|Study Terminated by Sponsor|43|||
48370961|NCT01049217|155553522|FG000|Overall Study|Other|1|||
48370962|NCT01049217|155553523|FG001|Overall Study|Other|2|||
48370963|NCT01049217|155553522|FG000|Overall Study|Randomized but not Treated|0|||
48370964|NCT01049217|155553523|FG001|Overall Study|Randomized but not Treated|2|||
48370965|NCT01946438|155553524|FG000|Overall Study|Adverse Event|0|||
48370966|NCT01946438|155553525|FG001|Overall Study|Adverse Event|0|||
48370967|NCT01946438|155553526|FG002|Overall Study|Adverse Event|0|||
48370968|NCT01946438|155553527|FG003|Overall Study|Adverse Event|1|||
48370969|NCT01946438|155553524|FG000|Overall Study|Serious Adverse event|1|||
48370970|NCT01946438|155553525|FG001|Overall Study|Serious Adverse event|0|||
48370971|NCT01946438|155553526|FG002|Overall Study|Serious Adverse event|0|||
48370972|NCT01946438|155553527|FG003|Overall Study|Serious Adverse event|0|||
48370973|NCT01946438|155553524|FG000|Overall Study|Protocol Violation|0|||
48370974|NCT01946438|155553525|FG001|Overall Study|Protocol Violation|0|||
48370975|NCT01946438|155553526|FG002|Overall Study|Protocol Violation|1|||
48370976|NCT01946438|155553527|FG003|Overall Study|Protocol Violation|0|||
48370977|NCT01946438|155553524|FG000|Overall Study|Withdrawal by Subject|1|||
48370978|NCT01946438|155553525|FG001|Overall Study|Withdrawal by Subject|0|||
48370979|NCT01946438|155553526|FG002|Overall Study|Withdrawal by Subject|0|||
48370980|NCT01946438|155553527|FG003|Overall Study|Withdrawal by Subject|0|||
48370981|NCT02457559|155553528|FG000|Overall Study|Progressive Disease|1|||
48370982|NCT02457559|155553529|FG001|Overall Study|Progressive Disease|2|||
48370983|NCT02457559|155553530|FG002|Overall Study|Progressive Disease|3|||
48370984|NCT02457559|155553531|FG003|Overall Study|Progressive Disease|0|||
48370985|NCT02457559|155553532|FG004|Overall Study|Progressive Disease|0|||
48370986|NCT02457559|155553533|FG005|Overall Study|Progressive Disease|2|||
48370987|NCT02457559|155553534|FG006|Overall Study|Progressive Disease|1|||
48370988|NCT02457559|155553535|FG007|Overall Study|Progressive Disease|0|||
48370989|NCT02457559|155553536|FG008|Overall Study|Progressive Disease|1|||
48370990|NCT02457559|155553537|FG009|Overall Study|Progressive Disease|1|||
48370991|NCT02457559|155553538|FG010|Overall Study|Progressive Disease|1|||
48370992|NCT02457559|155553528|FG000|Overall Study|Investigator's Discretion|0|||
48370993|NCT02457559|155553529|FG001|Overall Study|Investigator's Discretion|0|||
48370994|NCT02457559|155553530|FG002|Overall Study|Investigator's Discretion|2|||
48370995|NCT02457559|155553531|FG003|Overall Study|Investigator's Discretion|0|||
48370996|NCT02457559|155553532|FG004|Overall Study|Investigator's Discretion|1|||
48370997|NCT02457559|155553533|FG005|Overall Study|Investigator's Discretion|0|||
48370998|NCT02457559|155553534|FG006|Overall Study|Investigator's Discretion|1|||
48370999|NCT02457559|155553535|FG007|Overall Study|Investigator's Discretion|0|||
48371000|NCT02457559|155553536|FG008|Overall Study|Investigator's Discretion|1|||
48371001|NCT02457559|155553537|FG009|Overall Study|Investigator's Discretion|0|||
48371002|NCT02457559|155553538|FG010|Overall Study|Investigator's Discretion|1|||
48371003|NCT02457559|155553528|FG000|Overall Study|Adverse Event|0|||
48371004|NCT02457559|155553529|FG001|Overall Study|Adverse Event|1|||
48371005|NCT02457559|155553530|FG002|Overall Study|Adverse Event|2|||
48371006|NCT02457559|155553531|FG003|Overall Study|Adverse Event|0|||
48371007|NCT02457559|155553532|FG004|Overall Study|Adverse Event|0|||
48371008|NCT02457559|155553533|FG005|Overall Study|Adverse Event|0|||
48371009|NCT02457559|155553534|FG006|Overall Study|Adverse Event|0|||
48371010|NCT02457559|155553535|FG007|Overall Study|Adverse Event|0|||
48371011|NCT02457559|155553536|FG008|Overall Study|Adverse Event|0|||
48371012|NCT02457559|155553537|FG009|Overall Study|Adverse Event|0|||
48371013|NCT02457559|155553538|FG010|Overall Study|Adverse Event|0|||
48371014|NCT02457559|155553528|FG000|Overall Study|Reason not Specified|1|||
48371015|NCT02457559|155553529|FG001|Overall Study|Reason not Specified|0|||
48371016|NCT02457559|155553530|FG002|Overall Study|Reason not Specified|0|||
48371017|NCT02457559|155553531|FG003|Overall Study|Reason not Specified|0|||
48371018|NCT02457559|155553532|FG004|Overall Study|Reason not Specified|0|||
48371019|NCT02457559|155553533|FG005|Overall Study|Reason not Specified|0|||
48371020|NCT02457559|155553534|FG006|Overall Study|Reason not Specified|0|||
48371021|NCT02457559|155553535|FG007|Overall Study|Reason not Specified|0|||
48371022|NCT02457559|155553536|FG008|Overall Study|Reason not Specified|0|||
48371023|NCT02457559|155553537|FG009|Overall Study|Reason not Specified|2|||
48371024|NCT02457559|155553538|FG010|Overall Study|Reason not Specified|0|||
48371025|NCT02457559|155553528|FG000|Overall Study|Death|0|||
48371026|NCT02457559|155553529|FG001|Overall Study|Death|0|||
48371027|NCT02457559|155553530|FG002|Overall Study|Death|0|||
48371028|NCT02457559|155553531|FG003|Overall Study|Death|0|||
48371029|NCT02457559|155553532|FG004|Overall Study|Death|0|||
48371030|NCT02457559|155553533|FG005|Overall Study|Death|0|||
48371031|NCT02457559|155553534|FG006|Overall Study|Death|0|||
48371032|NCT02457559|155553535|FG007|Overall Study|Death|0|||
48371033|NCT02457559|155553536|FG008|Overall Study|Death|1|||
48371034|NCT02457559|155553537|FG009|Overall Study|Death|1|||
48371035|NCT02457559|155553538|FG010|Overall Study|Death|0|||
48371036|NCT03581825|155553539|FG000|Period 1|Lens Discomfort|1|||
48371037|NCT03581825|155553540|FG001|Period 1|Lens Discomfort|0|||
48371038|NCT03581825|155553539|FG000|Period 2|Unsatisfactory Vision to Test|0|||
48371039|NCT03581825|155553540|FG001|Period 2|Unsatisfactory Vision to Test|1|||
48371040|NCT00178126|155553541|FG000|Overall Study|Lost to Follow-up|21|||
48371041|NCT00178126|155553542|FG001|Overall Study|Lost to Follow-up|21|||
48371042|NCT00178126|155553541|FG000|Overall Study|did not receive intervention|4|||
48371043|NCT00178126|155553542|FG001|Overall Study|did not receive intervention|6|||
48371044|NCT04002401|155553543|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
48371045|NCT04002401|155553543|FG000|Overall Study|Death|10|||
48371046|NCT04002401|155553543|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
48371047|NCT04002401|155553543|FG000|Overall Study|Enrolled but Never Treated|1|||
48371048|NCT04002401|155553543|FG000|Overall Study|Lost to Follow-up|1|||
48371049|NCT01675479|155553544|FG000|Overall Study|Lost to Follow-up|11|||
48371050|NCT03035201|155553545|FG000|Overall Study|Death|9|||
48371051|NCT03035201|155553546|FG001|Overall Study|Death|12|||
48371052|NCT03035201|155553547|FG002|Overall Study|Death|9|||
48371053|NCT03035201|155553548|FG003|Overall Study|Death|10|||
48371054|NCT03035201|155553545|FG000|Overall Study|Withdrawal by Subject|51|||
48371055|NCT03035201|155553546|FG001|Overall Study|Withdrawal by Subject|49|||
48371056|NCT03035201|155553547|FG002|Overall Study|Withdrawal by Subject|37|||
48371057|NCT03035201|155553548|FG003|Overall Study|Withdrawal by Subject|46|||
48371058|NCT03035201|155553545|FG000|Overall Study|Lost to Follow-up|67|||
48371059|NCT03035201|155553546|FG001|Overall Study|Lost to Follow-up|51|||
48371060|NCT03035201|155553547|FG002|Overall Study|Lost to Follow-up|64|||
48371061|NCT03035201|155553548|FG003|Overall Study|Lost to Follow-up|69|||
48371062|NCT00591370|155555083|FG000|Overall Study|Not Treated|2|||
48371063|NCT03607422|155555084|FG000|Overall Study|Adverse Event|7|||
48371064|NCT03607422|155555085|FG001|Overall Study|Adverse Event|3|||
48371065|NCT03607422|155555086|FG002|Overall Study|Adverse Event|2|||
48371066|NCT03607422|155555087|FG003|Overall Study|Adverse Event|0|||
48371067|NCT03607422|155555088|FG004|Overall Study|Adverse Event|2|||
48371068|NCT03607422|155555089|FG005|Overall Study|Adverse Event|0|||
48371069|NCT03607422|155555084|FG000|Overall Study|Withdrawal by Subject|11|||
48371070|NCT03607422|155555085|FG001|Overall Study|Withdrawal by Subject|3|||
48371071|NCT03607422|155555086|FG002|Overall Study|Withdrawal by Subject|6|||
48371072|NCT03607422|155555087|FG003|Overall Study|Withdrawal by Subject|2|||
48371073|NCT03607422|155555088|FG004|Overall Study|Withdrawal by Subject|0|||
48371074|NCT03607422|155555089|FG005|Overall Study|Withdrawal by Subject|0|||
48371075|NCT03607422|155555084|FG000|Overall Study|Lost to Follow-up|0|||
48371076|NCT03607422|155555085|FG001|Overall Study|Lost to Follow-up|0|||
48371077|NCT03607422|155555086|FG002|Overall Study|Lost to Follow-up|1|||
48371078|NCT03607422|155555087|FG003|Overall Study|Lost to Follow-up|0|||
48371079|NCT03607422|155555088|FG004|Overall Study|Lost to Follow-up|0|||
48371080|NCT03607422|155555089|FG005|Overall Study|Lost to Follow-up|0|||
48371081|NCT03607422|155555084|FG000|Overall Study|Other|12|||
48371082|NCT03607422|155555085|FG001|Overall Study|Other|4|||
48371083|NCT03607422|155555086|FG002|Overall Study|Other|1|||
48371084|NCT03607422|155555087|FG003|Overall Study|Other|2|||
48371085|NCT03607422|155555088|FG004|Overall Study|Other|0|||
48371086|NCT03607422|155555089|FG005|Overall Study|Other|2|||
48371087|NCT03607422|155555084|FG000|Overall Study|Ongoing at Time of Analysis|8|||
48371088|NCT03607422|155555085|FG001|Overall Study|Ongoing at Time of Analysis|0|||
48371089|NCT03607422|155555086|FG002|Overall Study|Ongoing at Time of Analysis|2|||
48371090|NCT03607422|155555087|FG003|Overall Study|Ongoing at Time of Analysis|1|||
48371091|NCT03607422|155555088|FG004|Overall Study|Ongoing at Time of Analysis|1|||
48371092|NCT03607422|155555089|FG005|Overall Study|Ongoing at Time of Analysis|1|||
48371093|NCT03037931|155555090|FG000|Overall Study|Death|354|||
48371094|NCT03037931|155555091|FG001|Overall Study|Death|367|||
48371095|NCT03037931|155555090|FG000|Overall Study|Lost to Follow-up|7|||
48371096|NCT03037931|155555091|FG001|Overall Study|Lost to Follow-up|4|||
48371097|NCT03037931|155555090|FG000|Overall Study|Withdrawal by Subject|48|||
48371098|NCT03037931|155555091|FG001|Overall Study|Withdrawal by Subject|41|||
48371099|NCT01183260|155555092|FG000|Overall Study|Intraop screen failure|2|||
48371100|NCT01183260|155555093|FG001|Overall Study|Intraop screen failure|0|||
48371101|NCT01183260|155555092|FG000|Overall Study|Withdrawal by Subject|1|||
48371102|NCT01183260|155555093|FG001|Overall Study|Withdrawal by Subject|1|||
48371103|NCT01183260|155555092|FG000|Overall Study|Revised within 30 days|0|||
48371104|NCT01183260|155555093|FG001|Overall Study|Revised within 30 days|1|||
48371105|NCT01183260|155555092|FG000|Overall Study|Death|1|||
48371106|NCT01183260|155555093|FG001|Overall Study|Death|0|||
48371107|NCT00306670|155555096|FG000|Overall Study|patients recruited; Genentech, the st|0|||
48371108|NCT00306670|155555097|FG001|Overall Study|patients recruited; Genentech, the st|2|||
48371109|NCT00091169|155555101|FG000|Overall Study|Disease progression|3|||
48371110|NCT00091169|155555102|FG001|Overall Study|Disease progression|1|||
48371111|NCT00091169|155555101|FG000|Overall Study|Adverse Event|11|||
48371112|NCT00091169|155555102|FG001|Overall Study|Adverse Event|17|||
48371113|NCT00091169|155555101|FG000|Overall Study|Death|4|||
48371114|NCT00091169|155555102|FG001|Overall Study|Death|1|||
48371115|NCT00091169|155555101|FG000|Overall Study|Withdrawal by Subject|10|||
48371116|NCT00091169|155555102|FG001|Overall Study|Withdrawal by Subject|13|||
48371117|NCT00091169|155555101|FG000|Overall Study|Other|3|||
48371118|NCT00091169|155555102|FG001|Overall Study|Other|4|||
48371119|NCT00091169|155555101|FG000|Overall Study|Not start protocol therapy|26|||
48371120|NCT00091169|155555102|FG001|Overall Study|Not start protocol therapy|17|||
48371121|NCT00833833|155555103|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
48371122|NCT00833833|155555104|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
48371123|NCT00833833|155555105|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
48371124|NCT00833833|155555106|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
48371125|NCT00833833|155555107|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
48371126|NCT00833833|155555108|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
48371127|NCT00833833|155555103|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
48371128|NCT00833833|155555104|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
48371129|NCT00833833|155555105|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
48371130|NCT00833833|155555106|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
48371131|NCT00833833|155555107|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
48371132|NCT00833833|155555108|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
48371133|NCT00833833|155555103|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
48371134|NCT00833833|155555104|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
48371135|NCT00833833|155555105|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
48371136|NCT00833833|155555106|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
48371137|NCT00833833|155555107|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
48371138|NCT00833833|155555108|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
48371139|NCT00833833|155555103|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
48371140|NCT00833833|155555104|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
48371141|NCT00833833|155555105|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
48371142|NCT00833833|155555106|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
48371143|NCT00833833|155555107|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
48371144|NCT00833833|155555108|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
48371145|NCT00833833|155555103|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
48371146|NCT00833833|155555104|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48371147|NCT00833833|155555105|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
48371148|NCT00833833|155555106|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48371149|NCT00833833|155555107|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48371150|NCT00833833|155555108|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48371151|NCT00833833|155555103|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
48371152|NCT00833833|155555104|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
48371153|NCT00833833|155555105|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
48371154|NCT00833833|155555106|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
48371155|NCT00833833|155555107|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
48371156|NCT00833833|155555108|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
48371157|NCT00833833|155555103|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
48371158|NCT00833833|155555104|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
48371159|NCT00833833|155555105|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
48371160|NCT00833833|155555106|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
48371161|NCT00833833|155555107|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
48371162|NCT00833833|155555108|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
48371163|NCT00833833|155555103|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
48371164|NCT00833833|155555104|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
48371165|NCT00833833|155555105|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
48371166|NCT00833833|155555106|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
48371167|NCT00833833|155555107|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
48371168|NCT00833833|155555108|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
48371169|NCT00833833|155555103|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
48371170|NCT00833833|155555104|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
48371171|NCT00833833|155555105|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
48371172|NCT00833833|155555106|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
48371173|NCT00833833|155555107|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
48371174|NCT00833833|155555108|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
48371175|NCT00833833|155555103|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48371176|NCT00833833|155555104|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48371177|NCT00833833|155555105|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48371178|NCT00833833|155555106|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
48371179|NCT00833833|155555107|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
48371180|NCT00833833|155555108|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
48371181|NCT00833833|155555103|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
48371182|NCT00833833|155555104|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
48371183|NCT00833833|155555105|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
48371184|NCT00833833|155555106|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
48371185|NCT00833833|155555107|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
48371186|NCT00833833|155555108|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
48371187|NCT00833833|155555103|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
48371188|NCT00833833|155555104|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
48371189|NCT00833833|155555105|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
48371190|NCT00833833|155555106|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
48371191|NCT00833833|155555107|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
48371192|NCT00833833|155555108|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
48371193|NCT00833833|155555103|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48371194|NCT00833833|155555104|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48371195|NCT00833833|155555105|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48371196|NCT00833833|155555106|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48371197|NCT00833833|155555107|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
48371198|NCT00833833|155555108|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
48371199|NCT02407990|155555109|FG000|Overall Study|Death|2|||
48371200|NCT02407990|155555110|FG001|Overall Study|Death|22|||
48371201|NCT02407990|155555111|FG002|Overall Study|Death|23|||
48371202|NCT02407990|155555112|FG003|Overall Study|Death|7|||
48371203|NCT02407990|155555113|FG004|Overall Study|Death|17|||
48371204|NCT02407990|155555114|FG005|Overall Study|Death|16|||
48371205|NCT02407990|155555115|FG006|Overall Study|Death|10|||
48371206|NCT02407990|155555116|FG007|Overall Study|Death|248|||
48371207|NCT02407990|155555109|FG000|Overall Study|Lost to Follow-up|0|||
48371208|NCT02407990|155555110|FG001|Overall Study|Lost to Follow-up|1|||
48371209|NCT02407990|155555111|FG002|Overall Study|Lost to Follow-up|0|||
48371210|NCT02407990|155555112|FG003|Overall Study|Lost to Follow-up|0|||
48371211|NCT02407990|155555113|FG004|Overall Study|Lost to Follow-up|0|||
48371212|NCT02407990|155555114|FG005|Overall Study|Lost to Follow-up|0|||
48371213|NCT02407990|155555115|FG006|Overall Study|Lost to Follow-up|0|||
48371214|NCT02407990|155555116|FG007|Overall Study|Lost to Follow-up|17|||
48371215|NCT02407990|155555109|FG000|Overall Study|Progressive Disease|0|||
48371216|NCT02407990|155555110|FG001|Overall Study|Progressive Disease|0|||
48371217|NCT02407990|155555111|FG002|Overall Study|Progressive Disease|0|||
48371218|NCT02407990|155555112|FG003|Overall Study|Progressive Disease|0|||
48371219|NCT02407990|155555113|FG004|Overall Study|Progressive Disease|0|||
48371220|NCT02407990|155555114|FG005|Overall Study|Progressive Disease|0|||
48371221|NCT02407990|155555115|FG006|Overall Study|Progressive Disease|0|||
48371222|NCT02407990|155555116|FG007|Overall Study|Progressive Disease|1|||
48371223|NCT02407990|155555109|FG000|Overall Study|Withdrawal by Subject|0|||
48371224|NCT02407990|155555110|FG001|Overall Study|Withdrawal by Subject|0|||
48371225|NCT02407990|155555111|FG002|Overall Study|Withdrawal by Subject|0|||
48371226|NCT02407990|155555112|FG003|Overall Study|Withdrawal by Subject|0|||
48371227|NCT02407990|155555113|FG004|Overall Study|Withdrawal by Subject|1|||
48371228|NCT02407990|155555114|FG005|Overall Study|Withdrawal by Subject|0|||
48371229|NCT02407990|155555115|FG006|Overall Study|Withdrawal by Subject|0|||
48371230|NCT02407990|155555116|FG007|Overall Study|Withdrawal by Subject|30|||
48371231|NCT02407990|155555109|FG000|Overall Study|Study Terminated by Sponsor|1|||
48371232|NCT02407990|155555110|FG001|Overall Study|Study Terminated by Sponsor|3|||
48371233|NCT02407990|155555111|FG002|Overall Study|Study Terminated by Sponsor|3|||
48371234|NCT02407990|155555112|FG003|Overall Study|Study Terminated by Sponsor|0|||
48371235|NCT02407990|155555113|FG004|Overall Study|Study Terminated by Sponsor|3|||
48371236|NCT02407990|155555114|FG005|Overall Study|Study Terminated by Sponsor|4|||
48371237|NCT02407990|155555115|FG006|Overall Study|Study Terminated by Sponsor|3|||
48371238|NCT02407990|155555116|FG007|Overall Study|Study Terminated by Sponsor|37|||
48371239|NCT02407990|155555109|FG000|Overall Study|Logistics|0|||
48371240|NCT02407990|155555110|FG001|Overall Study|Logistics|0|||
48371241|NCT02407990|155555111|FG002|Overall Study|Logistics|0|||
48371242|NCT02407990|155555112|FG003|Overall Study|Logistics|0|||
48371243|NCT02407990|155555113|FG004|Overall Study|Logistics|0|||
48371244|NCT02407990|155555114|FG005|Overall Study|Logistics|0|||
48371245|NCT02407990|155555115|FG006|Overall Study|Logistics|0|||
48371246|NCT02407990|155555116|FG007|Overall Study|Logistics|1|||
48371247|NCT02407990|155555109|FG000|Overall Study|Rolled into long-term extension study|0|||
48371248|NCT02407990|155555110|FG001|Overall Study|Rolled into long-term extension study|0|||
48371249|NCT02407990|155555111|FG002|Overall Study|Rolled into long-term extension study|0|||
48371250|NCT02407990|155555112|FG003|Overall Study|Rolled into long-term extension study|0|||
48371251|NCT02407990|155555113|FG004|Overall Study|Rolled into long-term extension study|0|||
48371252|NCT02407990|155555114|FG005|Overall Study|Rolled into long-term extension study|0|||
48371253|NCT02407990|155555115|FG006|Overall Study|Rolled into long-term extension study|0|||
48371254|NCT02407990|155555116|FG007|Overall Study|Rolled into long-term extension study|1|||
48371255|NCT00734097|155555118|FG000|Screening|Protocol Violation|12|||
48371256|NCT00734097|155555118|FG000|Screening|Withdrawal by Subject|5|||
48371257|NCT00734097|155555118|FG000|Screening|Lost to Follow-up|2|||
48371258|NCT00734097|155555118|FG000|Screening|Unconfirmed pregnancy|1|||
48371259|NCT00734097|155555118|FG000|Open Label|Lost to Follow-up|7|||
48371260|NCT00734097|155555118|FG000|Open Label|Withdrawal by Subject|5|||
48371261|NCT00734097|155555118|FG000|Open Label|Protocol Violation|4|||
48371262|NCT00484289|155555121|FG000|Long Term Phase|Adverse Event|1|||
48371263|NCT00484289|155555122|FG001|Long Term Phase|Adverse Event|17|||
48371264|NCT00484289|155555123|FG002|Long Term Phase|Adverse Event|5|||
48371265|NCT00484289|155555121|FG000|Long Term Phase|Withdrawal by Subject|0|||
48371266|NCT00484289|155555122|FG001|Long Term Phase|Withdrawal by Subject|7|||
48371267|NCT00484289|155555123|FG002|Long Term Phase|Withdrawal by Subject|6|||
48371268|NCT00484289|155555121|FG000|Long Term Phase|Inadequate response|2|||
48371269|NCT00484289|155555122|FG001|Long Term Phase|Inadequate response|7|||
48371270|NCT00484289|155555123|FG002|Long Term Phase|Inadequate response|4|||
48371271|NCT00484289|155555121|FG000|Long Term Phase|Other Reason|0|||
48371272|NCT00484289|155555122|FG001|Long Term Phase|Other Reason|5|||
48371273|NCT00484289|155555123|FG002|Long Term Phase|Other Reason|1|||
48371274|NCT00484289|155555121|FG000|Post Marketing Phase|Adverse Event|0|||
48371275|NCT00484289|155555122|FG001|Post Marketing Phase|Adverse Event|1|||
48371276|NCT00484289|155555123|FG002|Post Marketing Phase|Adverse Event|0|||
48371277|NCT02831387|155555126|FG000|Overall Study|Withdrawal by Subject|1|||
48371278|NCT02831387|155555127|FG001|Overall Study|Withdrawal by Subject|1|||
48371279|NCT02831387|155555126|FG000|Overall Study|Discontinued due to stock recovery|0|||
48371280|NCT02831387|155555127|FG001|Overall Study|Discontinued due to stock recovery|1|||
48371281|NCT00192647|155555128|FG000|Overall Study|Death|1|||
48371282|NCT00192647|155555129|FG001|Overall Study|Death|1|||
48371283|NCT00192647|155555128|FG000|Overall Study|Adverse Event|35|||
48371284|NCT00192647|155555129|FG001|Overall Study|Adverse Event|29|||
48371285|NCT00192647|155555128|FG000|Overall Study|Laboratory Test Abnormality|4|||
48371286|NCT00192647|155555129|FG001|Overall Study|Laboratory Test Abnormality|2|||
48371287|NCT00192647|155555128|FG000|Overall Study|Insufficient Therapeutic Response|53|||
48371288|NCT00192647|155555129|FG001|Overall Study|Insufficient Therapeutic Response|83|||
48371289|NCT00192647|155555128|FG000|Overall Study|Entry Criteria Violation|6|||
48371290|NCT00192647|155555129|FG001|Overall Study|Entry Criteria Violation|6|||
48371291|NCT00192647|155555128|FG000|Overall Study|Protocol Violation|3|||
48371292|NCT00192647|155555129|FG001|Overall Study|Protocol Violation|1|||
48371293|NCT00192647|155555128|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
48371294|NCT00192647|155555129|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
48371295|NCT00192647|155555128|FG000|Overall Study|Failure to Return|11|||
48371296|NCT00192647|155555129|FG001|Overall Study|Failure to Return|13|||
48371297|NCT00192647|155555128|FG000|Overall Study|Other/Administrative|5|||
48371298|NCT00192647|155555129|FG001|Overall Study|Other/Administrative|3|||
48371299|NCT01290315|155555130|FG000|Overall Study|Adverse Event|0|||
48371300|NCT01290315|155555131|FG001|Overall Study|Adverse Event|0|||
48371301|NCT01290315|155555132|FG002|Overall Study|Adverse Event|0|||
48371302|NCT01290315|155555133|FG003|Overall Study|Adverse Event|3|||
48371303|NCT01290315|155555130|FG000|Overall Study|Selection criteria/compliance|2|||
48371304|NCT01290315|155555131|FG001|Overall Study|Selection criteria/compliance|1|||
48371305|NCT01290315|155555132|FG002|Overall Study|Selection criteria/compliance|0|||
48371306|NCT01290315|155555133|FG003|Overall Study|Selection criteria/compliance|2|||
48371307|NCT01290315|155555130|FG000|Overall Study|Lost to Follow-up|0|||
48371308|NCT01290315|155555131|FG001|Overall Study|Lost to Follow-up|1|||
48371309|NCT01290315|155555132|FG002|Overall Study|Lost to Follow-up|0|||
48371310|NCT01290315|155555133|FG003|Overall Study|Lost to Follow-up|0|||
48371311|NCT01290315|155555130|FG000|Overall Study|Withdrawal by Subject|1|||
48371312|NCT01290315|155555131|FG001|Overall Study|Withdrawal by Subject|1|||
48371313|NCT01290315|155555132|FG002|Overall Study|Withdrawal by Subject|0|||
48371314|NCT01290315|155555133|FG003|Overall Study|Withdrawal by Subject|0|||
48371315|NCT01248780|155555134|FG000|Overall Study|Lack of Efficacy|2|||
48371316|NCT01248780|155555135|FG001|Overall Study|Lack of Efficacy|0|||
48371317|NCT01248780|155555134|FG000|Overall Study|Lost to Follow-up|0|||
48371318|NCT01248780|155555135|FG001|Overall Study|Lost to Follow-up|1|||
48371319|NCT01248780|155555134|FG000|Overall Study|Death|0|||
48371320|NCT01248780|155555135|FG001|Overall Study|Death|1|||
48371321|NCT01248780|155555134|FG000|Overall Study|Adverse Event|2|||
48371322|NCT01248780|155555135|FG001|Overall Study|Adverse Event|7|||
48371323|NCT01248780|155555134|FG000|Overall Study|Protocol Violation|1|||
48371324|NCT01248780|155555135|FG001|Overall Study|Protocol Violation|1|||
48371325|NCT01248780|155555134|FG000|Overall Study|Withdrawal by Subject|4|||
48371326|NCT01248780|155555135|FG001|Overall Study|Withdrawal by Subject|4|||
48371327|NCT01248780|155555134|FG000|Overall Study|Not treated|0|||
48371328|NCT01248780|155555135|FG001|Overall Study|Not treated|1|||
48371329|NCT03241225|155555136|FG000|Overall Study|Lost to Follow-up|2|||
48371330|NCT03241225|155555137|FG001|Overall Study|Lost to Follow-up|1|||
48371331|NCT03241225|155555136|FG000|Overall Study|Protocol Violation|4|||
48371332|NCT03241225|155555137|FG001|Overall Study|Protocol Violation|1|||
48371333|NCT03241225|155555136|FG000|Overall Study|Withdrawal by Subject|1|||
48371334|NCT03241225|155555137|FG001|Overall Study|Withdrawal by Subject|0|||
48371335|NCT01776541|155555141|FG000|Overall Study|Administrative Reason|6|||
48371336|NCT01776541|155555142|FG001|Overall Study|Administrative Reason|2|||
48371337|NCT01776541|155555141|FG000|Overall Study|Death|4|||
48371338|NCT01776541|155555142|FG001|Overall Study|Death|0|||
48371339|NCT01776541|155555141|FG000|Overall Study|Lost to Follow-up|27|||
48371340|NCT01776541|155555142|FG001|Overall Study|Lost to Follow-up|48|||
48371341|NCT01776541|155555141|FG000|Overall Study|Unclassified|5|||
48371342|NCT01776541|155555142|FG001|Overall Study|Unclassified|4|||
48371343|NCT01776541|155555141|FG000|Overall Study|Protocol Violation|2|||
48371344|NCT01776541|155555142|FG001|Overall Study|Protocol Violation|1|||
48371345|NCT01776541|155555141|FG000|Overall Study|Withdrawal by Subject|12|||
48371346|NCT01776541|155555142|FG001|Overall Study|Withdrawal by Subject|20|||
48371347|NCT00618618|155555143|FG000|Overall Study|Patient Request|0|||
48371348|NCT00618618|155555144|FG001|Overall Study|Patient Request|0|||
48371349|NCT00618618|155555145|FG002|Overall Study|Patient Request|2|||
48371350|NCT00618618|155555146|FG003|Overall Study|Patient Request|0|||
48371351|NCT00618618|155555143|FG000|Overall Study|Inability to Complete Study Procedures|0|||
48371352|NCT00618618|155555144|FG001|Overall Study|Inability to Complete Study Procedures|1|||
48371353|NCT00618618|155555145|FG002|Overall Study|Inability to Complete Study Procedures|0|||
48371354|NCT00618618|155555146|FG003|Overall Study|Inability to Complete Study Procedures|0|||
48371355|NCT00618618|155555143|FG000|Overall Study|Lost to Follow-up|3|||
48371356|NCT00618618|155555144|FG001|Overall Study|Lost to Follow-up|0|||
48371357|NCT00618618|155555145|FG002|Overall Study|Lost to Follow-up|0|||
48371358|NCT00618618|155555146|FG003|Overall Study|Lost to Follow-up|1|||
48371359|NCT00618618|155555143|FG000|Overall Study|Non-compliance|1|||
48371360|NCT00618618|155555144|FG001|Overall Study|Non-compliance|1|||
48371361|NCT00618618|155555145|FG002|Overall Study|Non-compliance|0|||
48371362|NCT00618618|155555146|FG003|Overall Study|Non-compliance|0|||
48371363|NCT00618618|155555143|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
48371364|NCT00618618|155555144|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
48371365|NCT00618618|155555145|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
48371366|NCT00618618|155555146|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
48371367|NCT00618618|155555143|FG000|Overall Study|Death|0|||
48371368|NCT00618618|155555144|FG001|Overall Study|Death|1|||
48371369|NCT00618618|155555145|FG002|Overall Study|Death|0|||
48371370|NCT00618618|155555146|FG003|Overall Study|Death|0|||
48371371|NCT01236365|155555147|FG000|Overall Study|Lost to Follow-up|0|||
48371372|NCT01236365|155555148|FG001|Overall Study|Lost to Follow-up|2|||
48371373|NCT01236365|155555147|FG000|Overall Study|Moved Out of State|1|||
48371374|NCT01236365|155555148|FG001|Overall Study|Moved Out of State|0|||
48371375|NCT01236365|155555147|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
48371376|NCT01236365|155555148|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
48371377|NCT04410523|155555149|FG000|Overall Study|Study terminated by sponsor|1|||
48371378|NCT04410523|155555150|FG001|Overall Study|Study terminated by sponsor|3|||
48371379|NCT04410523|155555151|FG002|Overall Study|Study terminated by sponsor|2|||
48371380|NCT04410523|155555152|FG003|Overall Study|Study terminated by sponsor|6|||
48371381|NCT04410523|155555153|FG004|Overall Study|Study terminated by sponsor|3|||
48371382|NCT04410523|155555154|FG005|Overall Study|Study terminated by sponsor|4|||
48371383|NCT04410523|155555149|FG000|Overall Study|Adverse Event|1|||
48371384|NCT04410523|155555150|FG001|Overall Study|Adverse Event|0|||
48371385|NCT04410523|155555151|FG002|Overall Study|Adverse Event|0|||
48371386|NCT04410523|155555152|FG003|Overall Study|Adverse Event|0|||
48371387|NCT04410523|155555153|FG004|Overall Study|Adverse Event|0|||
48371388|NCT04410523|155555154|FG005|Overall Study|Adverse Event|2|||
48371389|NCT04410523|155555149|FG000|Overall Study|Lost to Follow-up|0|||
48371390|NCT04410523|155555150|FG001|Overall Study|Lost to Follow-up|1|||
48371391|NCT04410523|155555151|FG002|Overall Study|Lost to Follow-up|0|||
48371392|NCT04410523|155555152|FG003|Overall Study|Lost to Follow-up|0|||
48371393|NCT04410523|155555153|FG004|Overall Study|Lost to Follow-up|0|||
48371394|NCT04410523|155555154|FG005|Overall Study|Lost to Follow-up|0|||
48371395|NCT04410523|155555149|FG000|Overall Study|Physician Decision|0|||
48371396|NCT04410523|155555150|FG001|Overall Study|Physician Decision|1|||
48371397|NCT04410523|155555151|FG002|Overall Study|Physician Decision|0|||
48371398|NCT04410523|155555152|FG003|Overall Study|Physician Decision|0|||
48371399|NCT04410523|155555153|FG004|Overall Study|Physician Decision|0|||
48371400|NCT04410523|155555154|FG005|Overall Study|Physician Decision|0|||
48371401|NCT04410523|155555149|FG000|Overall Study|Pregnancy|0|||
48371402|NCT04410523|155555150|FG001|Overall Study|Pregnancy|0|||
48371403|NCT04410523|155555151|FG002|Overall Study|Pregnancy|0|||
48371404|NCT04410523|155555152|FG003|Overall Study|Pregnancy|0|||
48371405|NCT04410523|155555153|FG004|Overall Study|Pregnancy|0|||
48371406|NCT04410523|155555154|FG005|Overall Study|Pregnancy|1|||
48371407|NCT04410523|155555149|FG000|Overall Study|Protocol deviation|0|||
48371408|NCT04410523|155555150|FG001|Overall Study|Protocol deviation|0|||
48371409|NCT04410523|155555151|FG002|Overall Study|Protocol deviation|0|||
48371410|NCT04410523|155555152|FG003|Overall Study|Protocol deviation|0|||
48371411|NCT04410523|155555153|FG004|Overall Study|Protocol deviation|0|||
48371412|NCT04410523|155555154|FG005|Overall Study|Protocol deviation|2|||
48371413|NCT04410523|155555149|FG000|Overall Study|Subject decision|2|||
48371414|NCT04410523|155555150|FG001|Overall Study|Subject decision|0|||
48371415|NCT04410523|155555151|FG002|Overall Study|Subject decision|0|||
48371416|NCT04410523|155555152|FG003|Overall Study|Subject decision|1|||
48371417|NCT04410523|155555153|FG004|Overall Study|Subject decision|0|||
48371418|NCT04410523|155555154|FG005|Overall Study|Subject decision|1|||
48371419|NCT03606668|155555163|FG000|Overall Study|Screen Failure|1|||
48371420|NCT03606668|155555163|FG000|Overall Study|Lost to Follow-up|1|||
48371421|NCT00461032|155555164|FG000|Overall Study|Adverse Event|5|||
48371422|NCT00461032|155555165|FG001|Overall Study|Adverse Event|6|||
48371423|NCT00461032|155555164|FG000|Overall Study|Lack of Efficacy|5|||
48371424|NCT00461032|155555165|FG001|Overall Study|Lack of Efficacy|1|||
48371425|NCT00461032|155555164|FG000|Overall Study|Lost to Follow-up|7|||
48371426|NCT00461032|155555165|FG001|Overall Study|Lost to Follow-up|12|||
48371427|NCT00461032|155555164|FG000|Overall Study|Protocol Violation|4|||
48371428|NCT00461032|155555165|FG001|Overall Study|Protocol Violation|4|||
48371429|NCT00461032|155555164|FG000|Overall Study|Withdrawal by Subject|7|||
48371430|NCT00461032|155555165|FG001|Overall Study|Withdrawal by Subject|15|||
48371431|NCT00461032|155555164|FG000|Overall Study|Patient Moved or Relocated|2|||
48371432|NCT00461032|155555165|FG001|Overall Study|Patient Moved or Relocated|1|||
48371433|NCT00461032|155555164|FG000|Overall Study|Other|7|||
48371434|NCT00461032|155555165|FG001|Overall Study|Other|5|||
48371435|NCT04371198|155555166|FG000|Overall Study|inadequate sample|4|||
48371436|NCT00158860|155555171|FG000|Overall Study|Adverse Event|3|||
48371437|NCT00158860|155555172|FG001|Overall Study|Adverse Event|6|||
48371438|NCT00158860|155555171|FG000|Overall Study|Lost to Follow-up|11|||
48371439|NCT00158860|155555172|FG001|Overall Study|Lost to Follow-up|17|||
48371440|NCT00158860|155555171|FG000|Overall Study|Protocol Violation|8|||
48371441|NCT00158860|155555172|FG001|Overall Study|Protocol Violation|23|||
48371442|NCT00158860|155555171|FG000|Overall Study|Withdrawal by Subject|7|||
48371443|NCT00158860|155555172|FG001|Overall Study|Withdrawal by Subject|17|||
48371444|NCT00158860|155555171|FG000|Overall Study|MOVING OUT OF STATE|1|||
48371445|NCT00158860|155555172|FG001|Overall Study|MOVING OUT OF STATE|0|||
48371446|NCT00158860|155555171|FG000|Overall Study|Pregnancy|3|||
48371447|NCT00158860|155555172|FG001|Overall Study|Pregnancy|3|||
48371448|NCT00158860|155555171|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
48371449|NCT00158860|155555172|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
48371450|NCT00158860|155555171|FG000|Overall Study|SPONSOR REQUEST|0|||
48371451|NCT00158860|155555172|FG001|Overall Study|SPONSOR REQUEST|1|||
48371452|NCT00158860|155555171|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
48371453|NCT00158860|155555172|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
48371454|NCT00158860|155555171|FG000|Overall Study|Closed per sponsor|0|||
48371455|NCT00158860|155555172|FG001|Overall Study|Closed per sponsor|1|||
48371456|NCT03500159|155555175|FG000|Overall Study|Study Terminated|2|||
48371457|NCT03500159|155555176|FG001|Overall Study|Study Terminated|1|||
48371458|NCT03256851|155555181|FG000|Overall Study|Withdrawal by Subject|1|||
48371459|NCT03256851|155555182|FG001|Overall Study|Withdrawal by Subject|0|||
48371460|NCT00324675|155555183|FG000|Overall Study|Adverse Event|1|||
48371461|NCT00324675|155555184|FG001|Overall Study|Adverse Event|0|||
48371462|NCT01945060|155555190|FG000|Overall Study|Lost to follow up|1|||
48371463|NCT01945060|155555191|FG001|Overall Study|Lost to follow up|0|||
48371464|NCT01945060|155555190|FG000|Overall Study|Distress related to IV access|0|||
48371465|NCT01945060|155555191|FG001|Overall Study|Distress related to IV access|1|||
48371466|NCT00819390|155555196|FG000|Overall Study|Lost to Follow-up|1|||
48371467|NCT00819390|155555197|FG001|Overall Study|Lost to Follow-up|1|||
48371468|NCT00819390|155555198|FG002|Overall Study|Lost to Follow-up|0|||
48371469|NCT00819390|155555199|FG003|Overall Study|Lost to Follow-up|0|||
48371470|NCT00819390|155555196|FG000|Overall Study|Withdrawal by Subject|2|||
48371471|NCT00819390|155555197|FG001|Overall Study|Withdrawal by Subject|0|||
48371472|NCT00819390|155555198|FG002|Overall Study|Withdrawal by Subject|0|||
48371473|NCT00819390|155555199|FG003|Overall Study|Withdrawal by Subject|0|||
48371474|NCT00819390|155555196|FG000|Overall Study|Adverse Event|0|||
48371475|NCT00819390|155555197|FG001|Overall Study|Adverse Event|0|||
48371476|NCT00819390|155555198|FG002|Overall Study|Adverse Event|1|||
48371477|NCT00819390|155555199|FG003|Overall Study|Adverse Event|0|||
48371478|NCT02729753|155555200|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
48371479|NCT02729753|155555201|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
48371480|NCT01191268|155555202|FG000|Overall Study|Withdrawal by Subject|19|||
48371481|NCT01191268|155555203|FG001|Overall Study|Withdrawal by Subject|25|||
48371482|NCT01191268|155555204|FG002|Overall Study|Withdrawal by Subject|21|||
48371483|NCT01191268|155555202|FG000|Overall Study|Adverse Event|21|||
48371484|NCT01191268|155555203|FG001|Overall Study|Adverse Event|13|||
48371485|NCT01191268|155555204|FG002|Overall Study|Adverse Event|8|||
48371486|NCT01191268|155555202|FG000|Overall Study|Physician Decision|6|||
48371487|NCT01191268|155555203|FG001|Overall Study|Physician Decision|8|||
48371488|NCT01191268|155555204|FG002|Overall Study|Physician Decision|9|||
48371489|NCT01191268|155555202|FG000|Overall Study|Lost to Follow-up|8|||
48371490|NCT01191268|155555203|FG001|Overall Study|Lost to Follow-up|5|||
48371491|NCT01191268|155555204|FG002|Overall Study|Lost to Follow-up|9|||
48371492|NCT01191268|155555202|FG000|Overall Study|Entry Criteria Not Met|3|||
48371493|NCT01191268|155555203|FG001|Overall Study|Entry Criteria Not Met|1|||
48371494|NCT01191268|155555204|FG002|Overall Study|Entry Criteria Not Met|1|||
48371495|NCT01191268|155555202|FG000|Overall Study|Death|0|||
48371496|NCT01191268|155555203|FG001|Overall Study|Death|1|||
48371497|NCT01191268|155555204|FG002|Overall Study|Death|3|||
48371498|NCT01191268|155555202|FG000|Overall Study|Protocol Violation|1|||
48371499|NCT01191268|155555203|FG001|Overall Study|Protocol Violation|0|||
48371500|NCT01191268|155555204|FG002|Overall Study|Protocol Violation|1|||
48371501|NCT01191268|155555202|FG000|Overall Study|Sponsor Decision|0|||
48371502|NCT01191268|155555203|FG001|Overall Study|Sponsor Decision|2|||
48371503|NCT01191268|155555204|FG002|Overall Study|Sponsor Decision|0|||
48371504|NCT02414932|155555205|FG000|Overall Study|Withdrawal by Subject|2|||
48371505|NCT02414932|155555206|FG001|Overall Study|Withdrawal by Subject|3|||
48371506|NCT02414932|155555205|FG000|Overall Study|Adverse Event|1|||
48371507|NCT02414932|155555206|FG001|Overall Study|Adverse Event|0|||
48371508|NCT04493502|155555207|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
48371509|NCT04493502|155555208|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
48371510|NCT04493502|155555207|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
48371511|NCT04493502|155555208|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
48371512|NCT04493502|155555207|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
48371513|NCT04493502|155555208|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
48371514|NCT04493502|155555207|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
48371515|NCT04493502|155555208|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
48371516|NCT04493502|155555207|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
48371517|NCT04493502|155555208|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
48371518|NCT04493502|155555207|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
48371519|NCT04493502|155555208|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
48371520|NCT04493502|155555207|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
48371521|NCT04493502|155555208|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
48371522|NCT04493502|155555207|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
48371523|NCT04493502|155555208|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
48371524|NCT04493502|155555207|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
48371525|NCT04493502|155555208|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
48371526|NCT04493502|155555207|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
48371527|NCT04493502|155555208|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
48371528|NCT04493502|155555207|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
48371529|NCT04493502|155555208|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
48371530|NCT04493502|155555207|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
48371531|NCT04493502|155555208|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
48371532|NCT04493502|155555207|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
48371533|NCT04493502|155555208|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
48371534|NCT01768637|155555209|FG000|Overall Study|Lost to Follow-up|2|||
48371535|NCT01768637|155555210|FG001|Overall Study|Lost to Follow-up|7|||
48371536|NCT01768637|155555209|FG000|Overall Study|Difficult blood draw|1|||
48371537|NCT01768637|155555210|FG001|Overall Study|Difficult blood draw|0|||
48371538|NCT00412061|155555211|FG000|Double Blind Phase|Disease Progression|101|||
48371539|NCT00412061|155555212|FG001|Double Blind Phase|Disease Progression|154|||
48371540|NCT00412061|155555211|FG000|Double Blind Phase|Adverse Event|61|||
48371541|NCT00412061|155555212|FG001|Double Blind Phase|Adverse Event|16|||
48371542|NCT00412061|155555211|FG000|Double Blind Phase|Final Primary Analysis|26|||
48371543|NCT00412061|155555212|FG001|Double Blind Phase|Final Primary Analysis|14|||
48371544|NCT00412061|155555211|FG000|Double Blind Phase|Withdrawal by Subject|18|||
48371545|NCT00412061|155555212|FG001|Double Blind Phase|Withdrawal by Subject|20|||
48371546|NCT00412061|155555211|FG000|Double Blind Phase|Death|6|||
48371547|NCT00412061|155555212|FG001|Double Blind Phase|Death|3|||
48371548|NCT00412061|155555211|FG000|Double Blind Phase|Protocol Violation|3|||
48371549|NCT00412061|155555212|FG001|Double Blind Phase|Protocol Violation|4|||
48371550|NCT00412061|155555211|FG000|Double Blind Phase|New Cander Therapy|1|||
48371551|NCT00412061|155555212|FG001|Double Blind Phase|New Cander Therapy|1|||
48371552|NCT00412061|155555211|FG000|Double Blind Phase|Lost to Follow-up|0|||
48371553|NCT00412061|155555212|FG001|Double Blind Phase|Lost to Follow-up|1|||
48371554|NCT00412061|155555211|FG000|Open Label Phase|Disease Progression|0|||
48371555|NCT00412061|155555212|FG001|Open Label Phase|Disease Progression|86|||
48371556|NCT00412061|155555211|FG000|Open Label Phase|Adverse Event|0|||
48371557|NCT00412061|155555212|FG001|Open Label Phase|Adverse Event|46|||
48371558|NCT00412061|155555211|FG000|Open Label Phase|Withdrawal by Subject|0|||
48371559|NCT00412061|155555212|FG001|Open Label Phase|Withdrawal by Subject|15|||
48371560|NCT00412061|155555211|FG000|Open Label Phase|Administrative Problems|0|||
48371561|NCT00412061|155555212|FG001|Open Label Phase|Administrative Problems|13|||
48371562|NCT00412061|155555211|FG000|Open Label Phase|Death|0|||
48371563|NCT00412061|155555212|FG001|Open Label Phase|Death|7|||
48371564|NCT00412061|155555211|FG000|Open Label Phase|Lost to Follow-up|0|||
48371565|NCT00412061|155555212|FG001|Open Label Phase|Lost to Follow-up|2|||
48371566|NCT00412061|155555211|FG000|Open Label Phase|New Cancer Therapy|0|||
48371567|NCT00412061|155555212|FG001|Open Label Phase|New Cancer Therapy|1|||
48371568|NCT00994682|155555216|FG000|Double Bilnd|Withdrawal by Subject|5|||
48371569|NCT00994682|155555217|FG001|Double Bilnd|Withdrawal by Subject|6|||
48371570|NCT00994682|155555216|FG000|Double Bilnd|Lost to Follow-up|3|||
48371571|NCT00994682|155555217|FG001|Double Bilnd|Lost to Follow-up|3|||
48371572|NCT00994682|155555216|FG000|Double Bilnd|Adverse Event|1|||
48371573|NCT00994682|155555217|FG001|Double Bilnd|Adverse Event|0|||
48371574|NCT00994682|155555216|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
48371575|NCT00994682|155555217|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
48371576|NCT00994682|155555216|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
48371577|NCT00994682|155555217|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
48371578|NCT00994682|155555216|FG000|Pioglitazone Open Label|Physician Decision|6|||
48371579|NCT00994682|155555217|FG001|Pioglitazone Open Label|Physician Decision|1|||
48371580|NCT02374671|155555223|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
48371581|NCT02374671|155555224|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
48371582|NCT02374671|155555225|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
48371583|NCT02374671|155555223|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
48371584|NCT02374671|155555224|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
48371585|NCT02374671|155555225|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
48371586|NCT02374671|155555223|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
48371587|NCT02374671|155555224|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
48371588|NCT02374671|155555225|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
48371589|NCT02374671|155555223|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
48371590|NCT02374671|155555224|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
48371591|NCT02374671|155555225|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
48371592|NCT02374671|155555223|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
48371593|NCT02374671|155555224|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
48371594|NCT02374671|155555225|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
48371595|NCT03866473|155555226|FG000|Phase 1|Death|1|||
48371596|NCT03866473|155555227|FG001|Phase 1|Death|0|||
48371597|NCT03866473|155555226|FG000|Phase 2|Death|0|||
48371598|NCT03866473|155555227|FG001|Phase 2|Death|2|||
48371599|NCT03866473|155555226|FG000|Phase 2|Dropped|1|||
48371600|NCT03866473|155555227|FG001|Phase 2|Dropped|1|||
48371601|NCT03866473|155555226|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
48371602|NCT03866473|155555227|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
48371603|NCT01227577|155556871|FG000|Overall Study|Protocol deviation|3|||
48371604|NCT01227577|155556871|FG000|Overall Study|Death|3|||
48371605|NCT01227577|155556871|FG000|Overall Study|Administrative problems|2|||
48371606|NCT01227577|155556871|FG000|Overall Study|Lost to Follow-up|1|||
48371607|NCT01227577|155556871|FG000|Overall Study|Withdrawal by Subject|4|||
48371608|NCT01227577|155556871|FG000|Overall Study|Lack of Efficacy|5|||
48371609|NCT01227577|155556871|FG000|Overall Study|Adverse Event|17|||
48371610|NCT02630693|155556875|FG000|Overall Study|No receive treatment|0|||
48371611|NCT02630693|155556876|FG001|Overall Study|No receive treatment|1|||
48371612|NCT01248065|155556880|FG000|Overall Study|Lost to Follow-up|3|||
48371613|NCT01248065|155556881|FG001|Overall Study|Lost to Follow-up|5|||
48371614|NCT01248065|155556880|FG000|Overall Study|Withdrawal by Subject|14|||
48432063|NCT01683071|155769033|FG002|Part 1|Lack of Efficacy|0|||
48371615|NCT01248065|155556881|FG001|Overall Study|Withdrawal by Subject|11|||
48371616|NCT01248065|155556880|FG000|Overall Study|Adverse Event|3|||
48371617|NCT01248065|155556881|FG001|Overall Study|Adverse Event|0|||
48371618|NCT01248065|155556880|FG000|Overall Study|Third treatment failure event|3|||
48371619|NCT01248065|155556881|FG001|Overall Study|Third treatment failure event|1|||
48371620|NCT01248065|155556880|FG000|Overall Study|Other|3|||
48371621|NCT01248065|155556881|FG001|Overall Study|Other|5|||
48371622|NCT02781844|155556884|FG000|Treatment Period 1|Adverse Event|0|||
48371623|NCT02781844|155556885|FG001|Treatment Period 1|Adverse Event|0|||
48371624|NCT02781844|155556886|FG002|Treatment Period 1|Adverse Event|0|||
48371625|NCT02781844|155556887|FG003|Treatment Period 1|Adverse Event|0|||
48371626|NCT02781844|155556888|FG004|Treatment Period 1|Adverse Event|0|||
48371627|NCT02781844|155556889|FG005|Treatment Period 1|Adverse Event|1|||
48371628|NCT02781844|155556890|FG006|Treatment Period 1|Adverse Event|0|||
48371629|NCT02781844|155556891|FG007|Treatment Period 1|Adverse Event|0|||
48371630|NCT03010176|155556892|FG000|Overall Study|Death|21|||
48371631|NCT03010176|155556893|FG001|Overall Study|Death|35|||
48371632|NCT03010176|155556894|FG002|Overall Study|Death|19|||
48371633|NCT03010176|155556895|FG003|Overall Study|Death|19|||
48371634|NCT03010176|155556896|FG004|Overall Study|Death|14|||
48371635|NCT03010176|155556897|FG005|Overall Study|Death|0|||
48371636|NCT03010176|155556892|FG000|Overall Study|Lost to Follow-up|0|||
48371637|NCT03010176|155556893|FG001|Overall Study|Lost to Follow-up|0|||
48371638|NCT03010176|155556894|FG002|Overall Study|Lost to Follow-up|0|||
48371639|NCT03010176|155556895|FG003|Overall Study|Lost to Follow-up|0|||
48371640|NCT03010176|155556896|FG004|Overall Study|Lost to Follow-up|1|||
48371641|NCT03010176|155556897|FG005|Overall Study|Lost to Follow-up|0|||
48371642|NCT03010176|155556892|FG000|Overall Study|Physician Decision|0|||
48371643|NCT03010176|155556893|FG001|Overall Study|Physician Decision|4|||
48371644|NCT03010176|155556894|FG002|Overall Study|Physician Decision|0|||
48371645|NCT03010176|155556895|FG003|Overall Study|Physician Decision|1|||
48371646|NCT03010176|155556896|FG004|Overall Study|Physician Decision|0|||
48371647|NCT03010176|155556897|FG005|Overall Study|Physician Decision|0|||
48371648|NCT03010176|155556892|FG000|Overall Study|Sponsor Decision|0|||
48371649|NCT03010176|155556893|FG001|Overall Study|Sponsor Decision|4|||
48371650|NCT03010176|155556894|FG002|Overall Study|Sponsor Decision|4|||
48371651|NCT03010176|155556895|FG003|Overall Study|Sponsor Decision|1|||
48371652|NCT03010176|155556896|FG004|Overall Study|Sponsor Decision|6|||
48371653|NCT03010176|155556897|FG005|Overall Study|Sponsor Decision|0|||
48371654|NCT03010176|155556892|FG000|Overall Study|Withdrawal by Subject|11|||
48371655|NCT03010176|155556893|FG001|Overall Study|Withdrawal by Subject|9|||
48371656|NCT03010176|155556894|FG002|Overall Study|Withdrawal by Subject|3|||
48371657|NCT03010176|155556895|FG003|Overall Study|Withdrawal by Subject|0|||
48371658|NCT03010176|155556896|FG004|Overall Study|Withdrawal by Subject|4|||
48371659|NCT03010176|155556897|FG005|Overall Study|Withdrawal by Subject|0|||
48371660|NCT04275089|155556898|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
48371661|NCT01878214|155556905|FG000|Overall Study|Withdrawal by Subject|18|||
48371662|NCT01878214|155556906|FG001|Overall Study|Withdrawal by Subject|7|||
48371663|NCT01878214|155556905|FG000|Overall Study|Death|0|||
48371664|NCT01878214|155556906|FG001|Overall Study|Death|1|||
48371665|NCT01878214|155556905|FG000|Overall Study|Lost to Follow-up|35|||
48371666|NCT01878214|155556906|FG001|Overall Study|Lost to Follow-up|36|||
48371667|NCT03038438|155556909|FG000|Overall Study|Death|3|||
48371668|NCT03038438|155556909|FG000|Overall Study|Lost to Follow-up|8|||
48371669|NCT03038438|155556909|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
48371670|NCT03038438|155556909|FG000|Overall Study|Withdrawal by Subject|5|||
48371671|NCT03038438|155556909|FG000|Overall Study|No 36-Month Follow-Up|18|||
48371672|NCT02313233|155556910|FG000|Overall Study|Withdrawal by Subject|1|||
48371673|NCT02313233|155556911|FG001|Overall Study|Withdrawal by Subject|2|||
48371674|NCT02313233|155556910|FG000|Overall Study|Administrative reason|1|||
48371675|NCT02313233|155556911|FG001|Overall Study|Administrative reason|1|||
48371676|NCT00069108|155556912|FG000|Overall Study|Withdrawal by Subject|5|||
48371677|NCT00069108|155556913|FG001|Overall Study|Withdrawal by Subject|9|||
48371678|NCT00069108|155556912|FG000|Overall Study|Adverse Event|64|||
48371679|NCT00069108|155556913|FG001|Overall Study|Adverse Event|42|||
48371680|NCT00069108|155556912|FG000|Overall Study|Death|6|||
48371681|NCT00069108|155556913|FG001|Overall Study|Death|6|||
48371682|NCT00069108|155556912|FG000|Overall Study|Administration|15|||
48371683|NCT00069108|155556913|FG001|Overall Study|Administration|4|||
48371684|NCT00069108|155556912|FG000|Overall Study|Insufficient therapy|117|||
48371685|NCT00069108|155556913|FG001|Overall Study|Insufficient therapy|144|||
48371686|NCT00069108|155556912|FG000|Overall Study|Violation criteria|1|||
48371687|NCT00069108|155556913|FG001|Overall Study|Violation criteria|4|||
48371688|NCT00069108|155556912|FG000|Overall Study|Refused treatment|5|||
48371689|NCT00069108|155556913|FG001|Overall Study|Refused treatment|10|||
48371690|NCT01065844|155556914|FG000|Overall Study|Adverse Event|5|||
48371691|NCT00468104|155556915|FG000|First Intervention|Protocol Violation|2|||
48371692|NCT00468104|155556916|FG001|First Intervention|Protocol Violation|1|||
48371693|NCT00468104|155556915|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
48432064|NCT01683071|155769034|FG003|Part 1|Lack of Efficacy|3|||
48371694|NCT00468104|155556916|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
48371695|NCT00468104|155556915|FG000|First Intervention|died within 3 weeks|1|||
48371696|NCT00468104|155556916|FG001|First Intervention|died within 3 weeks|0|||
48371697|NCT00468104|155556915|FG000|First Intervention|malposition/blocked chest tube tube|2|||
48371698|NCT00468104|155556916|FG001|First Intervention|malposition/blocked chest tube tube|0|||
48371699|NCT00468104|155556915|FG000|First Intervention|large lung mass with minimal effusion|1|||
48371700|NCT00468104|155556916|FG001|First Intervention|large lung mass with minimal effusion|0|||
48371701|NCT00468104|155556915|FG000|First Intervention|associated prolonged pneumothorax|1|||
48371702|NCT00468104|155556916|FG001|First Intervention|associated prolonged pneumothorax|0|||
48371703|NCT00468104|155556915|FG000|First Intervention|trapped lung|1|||
48371704|NCT00468104|155556916|FG001|First Intervention|trapped lung|0|||
48371705|NCT00468104|155556915|FG000|Second Intervention|Withdrawal by Subject|5|||
48371706|NCT00468104|155556916|FG001|Second Intervention|Withdrawal by Subject|2|||
48371707|NCT00468104|155556915|FG000|Second Intervention|discarded for malposition of chest tube|0|||
48371708|NCT00468104|155556916|FG001|Second Intervention|discarded for malposition of chest tube|2|||
48371709|NCT01263665|155556917|FG000|Overall Study|Withdrew Consent|1|||
48371710|NCT01263665|155556917|FG000|Overall Study|Lost to Follow-up|3|||
48371711|NCT01263665|155556917|FG000|Overall Study|Death|2|||
48371712|NCT01263665|155556917|FG000|Overall Study|Amputation above the ankle|1|||
48371713|NCT01263665|155556917|FG000|Overall Study|Surgical Bypass|2|||
48371714|NCT01415531|155556918|FG000|Overall Study|Adverse Event|7|||
48371715|NCT01415531|155556919|FG001|Overall Study|Adverse Event|10|||
48371716|NCT01415531|155556918|FG000|Overall Study|Lack of Efficacy|3|||
48371717|NCT01415531|155556919|FG001|Overall Study|Lack of Efficacy|2|||
48371718|NCT01415531|155556918|FG000|Overall Study|Protocol Violation|0|||
48371719|NCT01415531|155556919|FG001|Overall Study|Protocol Violation|1|||
48371720|NCT01415531|155556918|FG000|Overall Study|Withdrawal by Subject|5|||
48371721|NCT01415531|155556919|FG001|Overall Study|Withdrawal by Subject|4|||
48371722|NCT01415531|155556918|FG000|Overall Study|Lost to Follow-up|6|||
48371723|NCT01415531|155556919|FG001|Overall Study|Lost to Follow-up|14|||
48371724|NCT01415531|155556918|FG000|Overall Study|Lack of Compliance|1|||
48371725|NCT01415531|155556919|FG001|Overall Study|Lack of Compliance|4|||
48371726|NCT01415531|155556918|FG000|Overall Study|Other Reasons|3|||
48371727|NCT01415531|155556919|FG001|Overall Study|Other Reasons|2|||
48371728|NCT02128542|155556920|FG000|Overall Study|Lost to Follow-up|3|||
48371729|NCT02128542|155556921|FG001|Overall Study|Lost to Follow-up|0|||
48371730|NCT02128542|155556920|FG000|Overall Study|Withdrew Consent|1|||
48371731|NCT02128542|155556921|FG001|Overall Study|Withdrew Consent|0|||
48371732|NCT03452579|155556923|FG000|Overall Study|Death|0|||
48371733|NCT03452579|155556924|FG001|Overall Study|Death|1|||
48371734|NCT03452579|155556923|FG000|Overall Study|Withdrawal by Subject|2|||
48371735|NCT03452579|155556924|FG001|Overall Study|Withdrawal by Subject|0|||
48371736|NCT03452579|155556923|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
48371737|NCT03452579|155556924|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
48371738|NCT03452579|155556923|FG000|Overall Study|Physician Decision|1|||
48371739|NCT03452579|155556924|FG001|Overall Study|Physician Decision|1|||
48371740|NCT03452579|155556923|FG000|Overall Study|Adverse Event|1|||
48371741|NCT03452579|155556924|FG001|Overall Study|Adverse Event|4|||
48371742|NCT01941719|155556925|FG000|Overall Study|Lost to Follow-up|20|||
48371743|NCT01941719|155556926|FG001|Overall Study|Lost to Follow-up|19|||
48371744|NCT01506609|155556927|FG000|Overall Study|Adverse Event Related to Progression|0|||
48371745|NCT01506609|155556928|FG001|Overall Study|Adverse Event Related to Progression|0|||
48371746|NCT01506609|155556929|FG002|Overall Study|Adverse Event Related to Progression|0|||
48371747|NCT01506609|155556930|FG003|Overall Study|Adverse Event Related to Progression|3|||
48371748|NCT01506609|155556931|FG004|Overall Study|Adverse Event Related to Progression|7|||
48371749|NCT01506609|155556932|FG005|Overall Study|Adverse Event Related to Progression|3|||
48371750|NCT01506609|155556927|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
48371751|NCT01506609|155556928|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
48371752|NCT01506609|155556929|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
48371753|NCT01506609|155556930|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
48371754|NCT01506609|155556931|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
48371755|NCT01506609|155556932|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
48371756|NCT01506609|155556927|FG000|Overall Study|Withdrawal by Subject|0|||
48371757|NCT01506609|155556928|FG001|Overall Study|Withdrawal by Subject|0|||
48371758|NCT01506609|155556929|FG002|Overall Study|Withdrawal by Subject|0|||
48371759|NCT01506609|155556930|FG003|Overall Study|Withdrawal by Subject|9|||
48371760|NCT01506609|155556931|FG004|Overall Study|Withdrawal by Subject|7|||
48371761|NCT01506609|155556932|FG005|Overall Study|Withdrawal by Subject|7|||
48371762|NCT01506609|155556927|FG000|Overall Study|Lost to Follow-up|0|||
48371763|NCT01506609|155556928|FG001|Overall Study|Lost to Follow-up|0|||
48371764|NCT01506609|155556929|FG002|Overall Study|Lost to Follow-up|0|||
48371765|NCT01506609|155556930|FG003|Overall Study|Lost to Follow-up|1|||
48371766|NCT01506609|155556931|FG004|Overall Study|Lost to Follow-up|2|||
48371767|NCT01506609|155556932|FG005|Overall Study|Lost to Follow-up|0|||
48371768|NCT01506609|155556927|FG000|Overall Study|Sponsor Discontinued Study|0|||
48371769|NCT01506609|155556928|FG001|Overall Study|Sponsor Discontinued Study|0|||
48371770|NCT01506609|155556929|FG002|Overall Study|Sponsor Discontinued Study|0|||
48371771|NCT01506609|155556930|FG003|Overall Study|Sponsor Discontinued Study|2|||
48371772|NCT01506609|155556931|FG004|Overall Study|Sponsor Discontinued Study|2|||
48371773|NCT01506609|155556932|FG005|Overall Study|Sponsor Discontinued Study|0|||
48371774|NCT01506609|155556927|FG000|Overall Study|Progressive Disease per Protocol|1|||
48371775|NCT01506609|155556928|FG001|Overall Study|Progressive Disease per Protocol|0|||
48371776|NCT01506609|155556929|FG002|Overall Study|Progressive Disease per Protocol|0|||
48371777|NCT01506609|155556930|FG003|Overall Study|Progressive Disease per Protocol|64|||
48371778|NCT01506609|155556931|FG004|Overall Study|Progressive Disease per Protocol|57|||
48371779|NCT01506609|155556932|FG005|Overall Study|Progressive Disease per Protocol|74|||
48371780|NCT01506609|155556927|FG000|Overall Study|Other, Not Specified|0|||
48371781|NCT01506609|155556928|FG001|Overall Study|Other, Not Specified|0|||
48371782|NCT01506609|155556929|FG002|Overall Study|Other, Not Specified|0|||
48371783|NCT01506609|155556930|FG003|Overall Study|Other, Not Specified|10|||
48371784|NCT01506609|155556931|FG004|Overall Study|Other, Not Specified|7|||
48371785|NCT01506609|155556932|FG005|Overall Study|Other, Not Specified|3|||
48371786|NCT01506609|155556927|FG000|Overall Study|Missing / Unknown Reason|1|||
48371787|NCT01506609|155556928|FG001|Overall Study|Missing / Unknown Reason|0|||
48371788|NCT01506609|155556929|FG002|Overall Study|Missing / Unknown Reason|1|||
48371789|NCT01506609|155556930|FG003|Overall Study|Missing / Unknown Reason|4|||
48371790|NCT01506609|155556931|FG004|Overall Study|Missing / Unknown Reason|4|||
48371791|NCT01506609|155556932|FG005|Overall Study|Missing / Unknown Reason|2|||
48371792|NCT00252577|155556933|FG000|Overall Study|Lost to Follow-up|20|||
48371793|NCT00577473|155556934|FG000|Overall Study|Protocol Violation|1|||
48371794|NCT00577473|155556935|FG001|Overall Study|Protocol Violation|4|||
48371795|NCT00577473|155556934|FG000|Overall Study|Adverse Event|8|||
48371796|NCT00577473|155556935|FG001|Overall Study|Adverse Event|5|||
48371797|NCT00577473|155556934|FG000|Overall Study|Withdrawal by Subject|2|||
48371798|NCT00577473|155556935|FG001|Overall Study|Withdrawal by Subject|6|||
48371799|NCT00577473|155556934|FG000|Overall Study|Physician Decision|2|||
48371800|NCT00577473|155556935|FG001|Overall Study|Physician Decision|2|||
48371801|NCT00577473|155556934|FG000|Overall Study|Lack of Efficacy|8|||
48371802|NCT00577473|155556935|FG001|Overall Study|Lack of Efficacy|7|||
48371803|NCT02962960|155556940|FG000|Overall Study|Withdrawal by Subject|1|||
48371804|NCT02962960|155556941|FG001|Overall Study|Withdrawal by Subject|1|||
48371805|NCT02962960|155556942|FG002|Overall Study|Withdrawal by Subject|0|||
48371806|NCT02962960|155556940|FG000|Overall Study|Adverse Event|1|||
48371807|NCT02962960|155556941|FG001|Overall Study|Adverse Event|1|||
48371808|NCT02962960|155556942|FG002|Overall Study|Adverse Event|0|||
48371809|NCT02962960|155556940|FG000|Overall Study|Protocol Violation|1|||
48371810|NCT02962960|155556941|FG001|Overall Study|Protocol Violation|0|||
48371811|NCT02962960|155556942|FG002|Overall Study|Protocol Violation|0|||
48371812|NCT00842985|155556943|FG000|Screening|Did not meet entrance requirements|27|||
48371813|NCT00842985|155556943|FG000|First Intervention|Withdrawal by Subject|3|||
48371814|NCT00842985|155556943|FG000|First Intervention|Protocol Violation|3|||
48371815|NCT00842985|155556943|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
48371816|NCT00842985|155556943|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
48371817|NCT02413333|155556944|FG000|Period 1|Adverse Event|1|||
48371818|NCT02413333|155556945|FG001|Period 1|Adverse Event|0|||
48371819|NCT02413333|155556944|FG000|Period 1|Reason Not Specified|0|||
48371820|NCT02413333|155556945|FG001|Period 1|Reason Not Specified|1|||
48371821|NCT02413333|155556944|FG000|Period 2|Protocol Deviation|1|||
48371822|NCT02413333|155556945|FG001|Period 2|Protocol Deviation|0|||
48371823|NCT01815138|155556946|FG000|Overall Study|Withdrawal by Subject|0|||
48371824|NCT01815138|155556947|FG001|Overall Study|Withdrawal by Subject|1|||
48371825|NCT01815138|155556946|FG000|Overall Study|Physician Decision|8|||
48371826|NCT01815138|155556947|FG001|Overall Study|Physician Decision|5|||
48371827|NCT01011387|155556949|FG000|Overall Study|Withdrawal by Subject|3|||
48371828|NCT01011387|155556949|FG000|Overall Study|Adverse Event|2|||
48371829|NCT01011387|155556949|FG000|Overall Study|Protocol Violation|1|||
48371830|NCT00757783|155556950|FG000|Overall Study|Adverse Event|0|||
48371831|NCT00757783|155556951|FG001|Overall Study|Adverse Event|2|||
48371832|NCT00757783|155556950|FG000|Overall Study|Lost to Follow-up|1|||
48371833|NCT00757783|155556951|FG001|Overall Study|Lost to Follow-up|1|||
48371834|NCT00757783|155556950|FG000|Overall Study|Protocol Violation|1|||
48371835|NCT00757783|155556951|FG001|Overall Study|Protocol Violation|0|||
48371836|NCT00757783|155556950|FG000|Overall Study|Withdrawal by Subject|2|||
48371837|NCT00757783|155556951|FG001|Overall Study|Withdrawal by Subject|1|||
48371838|NCT00757783|155556950|FG000|Overall Study|Other|1|||
48371839|NCT00757783|155556951|FG001|Overall Study|Other|2|||
48371840|NCT02054520|155556952|FG000|Overall Study|Adverse Event|1|||
48371841|NCT02054520|155556953|FG001|Overall Study|Adverse Event|4|||
48371842|NCT02054520|155556954|FG002|Overall Study|Adverse Event|2|||
48371843|NCT02054520|155556955|FG003|Overall Study|Adverse Event|1|||
48371844|NCT02054520|155556956|FG004|Overall Study|Adverse Event|1|||
48371845|NCT02054520|155556957|FG005|Overall Study|Adverse Event|0|||
48371846|NCT02054520|155556952|FG000|Overall Study|Lack of Efficacy|7|||
48371847|NCT02054520|155556953|FG001|Overall Study|Lack of Efficacy|0|||
48371848|NCT02054520|155556954|FG002|Overall Study|Lack of Efficacy|2|||
48371849|NCT02054520|155556955|FG003|Overall Study|Lack of Efficacy|1|||
48371850|NCT02054520|155556956|FG004|Overall Study|Lack of Efficacy|3|||
48371851|NCT02054520|155556957|FG005|Overall Study|Lack of Efficacy|2|||
48371852|NCT02054520|155556952|FG000|Overall Study|Withdrawal by Subject|1|||
48371853|NCT02054520|155556953|FG001|Overall Study|Withdrawal by Subject|0|||
48371854|NCT02054520|155556954|FG002|Overall Study|Withdrawal by Subject|0|||
48371855|NCT02054520|155556955|FG003|Overall Study|Withdrawal by Subject|2|||
48371856|NCT02054520|155556956|FG004|Overall Study|Withdrawal by Subject|1|||
48371857|NCT02054520|155556957|FG005|Overall Study|Withdrawal by Subject|0|||
48371858|NCT02054520|155556952|FG000|Overall Study|Physician Decision|0|||
48371859|NCT02054520|155556953|FG001|Overall Study|Physician Decision|1|||
48371860|NCT02054520|155556954|FG002|Overall Study|Physician Decision|0|||
48371861|NCT02054520|155556955|FG003|Overall Study|Physician Decision|1|||
48371862|NCT02054520|155556956|FG004|Overall Study|Physician Decision|0|||
48371863|NCT02054520|155556957|FG005|Overall Study|Physician Decision|1|||
48371864|NCT02054520|155556952|FG000|Overall Study|Study terminated by Sponsor|0|||
48371865|NCT02054520|155556953|FG001|Overall Study|Study terminated by Sponsor|0|||
48371866|NCT02054520|155556954|FG002|Overall Study|Study terminated by Sponsor|2|||
48371867|NCT02054520|155556955|FG003|Overall Study|Study terminated by Sponsor|1|||
48371868|NCT02054520|155556956|FG004|Overall Study|Study terminated by Sponsor|0|||
48371869|NCT02054520|155556957|FG005|Overall Study|Study terminated by Sponsor|0|||
48371870|NCT00985946|155556962|FG000|Overall Study|Lost to Follow-up|6|||
48371871|NCT00985946|155556962|FG000|Overall Study|Withdrawal by Subject|1|||
48371872|NCT03801915|155556963|FG000|Overall Study|Screen failure|0|||
48371873|NCT03801915|155556964|FG001|Overall Study|Screen failure|0|||
48371874|NCT03801915|155556965|FG002|Overall Study|Screen failure|1|||
48371875|NCT03801915|155556963|FG000|Overall Study|Ineligible|1|||
48371876|NCT03801915|155556964|FG001|Overall Study|Ineligible|0|||
48371877|NCT03801915|155556965|FG002|Overall Study|Ineligible|0|||
48371878|NCT03801915|155556963|FG000|Overall Study|Physician Decision|2|||
48371879|NCT03801915|155556964|FG001|Overall Study|Physician Decision|1|||
48371880|NCT03801915|155556965|FG002|Overall Study|Physician Decision|0|||
48371881|NCT00446992|155556968|FG000|Overall Study|Adverse Event|11|||
48371882|NCT00446992|155556968|FG000|Overall Study|Lost to Follow-up|5|||
48371883|NCT00505284|155556973|FG000|Overall Study|Adverse Event|3|||
48371884|NCT00505284|155556974|FG001|Overall Study|Adverse Event|7|||
48371885|NCT00505284|155556975|FG002|Overall Study|Adverse Event|9|||
48371886|NCT00505284|155556976|FG003|Overall Study|Adverse Event|14|||
48371887|NCT00505284|155556977|FG004|Overall Study|Adverse Event|22|||
48371888|NCT00505284|155556973|FG000|Overall Study|Protocol Violation|0|||
48371889|NCT00505284|155556974|FG001|Overall Study|Protocol Violation|1|||
48371890|NCT00505284|155556975|FG002|Overall Study|Protocol Violation|1|||
48371891|NCT00505284|155556976|FG003|Overall Study|Protocol Violation|0|||
48371892|NCT00505284|155556977|FG004|Overall Study|Protocol Violation|0|||
48371893|NCT00505284|155556973|FG000|Overall Study|Withdrawal by Subject|2|||
48371894|NCT00505284|155556974|FG001|Overall Study|Withdrawal by Subject|6|||
48371895|NCT00505284|155556975|FG002|Overall Study|Withdrawal by Subject|1|||
48371896|NCT00505284|155556976|FG003|Overall Study|Withdrawal by Subject|0|||
48371897|NCT00505284|155556977|FG004|Overall Study|Withdrawal by Subject|6|||
48371898|NCT00505284|155556973|FG000|Overall Study|Lack of Efficacy|0|||
48371899|NCT00505284|155556974|FG001|Overall Study|Lack of Efficacy|1|||
48371900|NCT00505284|155556975|FG002|Overall Study|Lack of Efficacy|1|||
48371901|NCT00505284|155556976|FG003|Overall Study|Lack of Efficacy|1|||
48371902|NCT00505284|155556977|FG004|Overall Study|Lack of Efficacy|1|||
48371903|NCT00505284|155556973|FG000|Overall Study|Physician Decision|0|||
48371904|NCT00505284|155556974|FG001|Overall Study|Physician Decision|1|||
48371905|NCT00505284|155556975|FG002|Overall Study|Physician Decision|0|||
48371906|NCT00505284|155556976|FG003|Overall Study|Physician Decision|0|||
48371907|NCT00505284|155556977|FG004|Overall Study|Physician Decision|0|||
48371908|NCT00505284|155556973|FG000|Overall Study|Other|5|||
48371909|NCT00505284|155556974|FG001|Overall Study|Other|0|||
48371910|NCT00505284|155556975|FG002|Overall Study|Other|0|||
48371911|NCT00505284|155556976|FG003|Overall Study|Other|4|||
48371912|NCT00505284|155556977|FG004|Overall Study|Other|4|||
48371913|NCT02075541|155556978|FG000|Overall Study|Serious Adverse Event|1|||
48371914|NCT02075541|155556979|FG001|Overall Study|Serious Adverse Event|4|||
48371915|NCT02075541|155556978|FG000|Overall Study|Protocol Violation|1|||
48371916|NCT02075541|155556979|FG001|Overall Study|Protocol Violation|0|||
48371917|NCT02075541|155556978|FG000|Overall Study|Withdrawal by Subject|1|||
48371918|NCT02075541|155556979|FG001|Overall Study|Withdrawal by Subject|3|||
48371919|NCT02075541|155556978|FG000|Overall Study|Sponsor study termination|0|||
48371920|NCT02075541|155556979|FG001|Overall Study|Sponsor study termination|1|||
48371921|NCT02075541|155556978|FG000|Overall Study|Other- unable to perform study procedure|1|||
48371922|NCT02075541|155556979|FG001|Overall Study|Other- unable to perform study procedure|0|||
48371923|NCT03143166|155556980|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
48371924|NCT02673515|155556983|FG000|Overall Study|Lack of motivation|2|||
48371925|NCT02673515|155556984|FG001|Overall Study|Lack of motivation|1|||
48371926|NCT00928018|155556985|FG000|Overall Study|Withdrawal by Subject|1|||
48371927|NCT00928018|155556986|FG001|Overall Study|Withdrawal by Subject|0|||
48371928|NCT02859324|155556987|FG000|Overall Study|Death|4|||
48371929|NCT02859324|155556988|FG001|Overall Study|Death|6|||
48371930|NCT02859324|155556989|FG002|Overall Study|Death|5|||
48371931|NCT02859324|155556987|FG000|Overall Study|Other reasons|3|||
48371932|NCT02859324|155556988|FG001|Overall Study|Other reasons|3|||
48371933|NCT02859324|155556989|FG002|Overall Study|Other reasons|0|||
48371934|NCT00710021|155556990|FG000|Overall Study|Lost to Follow-up|1|||
48371935|NCT00710021|155556991|FG001|Overall Study|Lost to Follow-up|0|||
48371936|NCT00710021|155556992|FG002|Overall Study|Lost to Follow-up|0|||
48371937|NCT00710021|155556990|FG000|Overall Study|Subject's Decision|0|||
48371938|NCT00710021|155556991|FG001|Overall Study|Subject's Decision|1|||
48371939|NCT00710021|155556992|FG002|Overall Study|Subject's Decision|0|||
48371940|NCT00710021|155556990|FG000|Overall Study|Subject misrandomized|0|||
48371941|NCT00710021|155556991|FG001|Overall Study|Subject misrandomized|1|||
48371942|NCT00710021|155556992|FG002|Overall Study|Subject misrandomized|1|||
48371943|NCT00710021|155556990|FG000|Overall Study|Physician Decision|0|||
48371944|NCT00710021|155556991|FG001|Overall Study|Physician Decision|1|||
48371945|NCT00710021|155556992|FG002|Overall Study|Physician Decision|0|||
48371946|NCT03261700|155556993|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
48371947|NCT03261700|155556994|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
48371948|NCT00600886|155556995|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
48371949|NCT00600886|155556996|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
48371950|NCT00600886|155556995|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
48371951|NCT00600886|155556996|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
48371952|NCT00600886|155556995|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
48371953|NCT00600886|155556996|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
48371954|NCT00600886|155556995|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
48371955|NCT00600886|155556996|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
48371956|NCT00600886|155556995|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
48371957|NCT00600886|155556996|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
48371958|NCT00600886|155556995|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
48371959|NCT00600886|155556996|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
48371960|NCT00600886|155556995|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
48371961|NCT00600886|155556996|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
48371962|NCT00600886|155556995|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
48371963|NCT00600886|155556996|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
48371964|NCT00600886|155556995|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
48371965|NCT00600886|155556996|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
48371966|NCT00600886|155556995|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
48371967|NCT00600886|155556996|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
48371968|NCT00600886|155556995|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
48371969|NCT00600886|155556996|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
48371970|NCT00600886|155556995|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
48371971|NCT00600886|155556996|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
48371972|NCT00600886|155556995|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
48371973|NCT00600886|155556996|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
48371974|NCT00600886|155556995|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
48371975|NCT00600886|155556996|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
48371976|NCT00600886|155556995|FG000|Extension - Same Treatment (FAS)|Death|1|||
48371977|NCT00600886|155556996|FG001|Extension - Same Treatment (FAS)|Death|1|||
48371978|NCT00600886|155556995|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
48371979|NCT00600886|155556996|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
48371980|NCT00600886|155556995|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
48371981|NCT00600886|155556996|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
48371982|NCT00600886|155556995|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
48371983|NCT00600886|155556996|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
48371984|NCT00600886|155556995|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
48371985|NCT00600886|155556996|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
48371986|NCT00600886|155556995|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
48371987|NCT00600886|155556996|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
48371988|NCT00600886|155556995|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
48371989|NCT00600886|155556996|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
48371990|NCT00600886|155556995|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
48371991|NCT00600886|155556996|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
48371992|NCT00600886|155556995|FG000|Extension - After Crossover (CAS)|Death|1|||
48371993|NCT00600886|155556996|FG001|Extension - After Crossover (CAS)|Death|0|||
48371994|NCT02533570|155557007|FG000|Overall Study|Adverse Event|0|||
48371995|NCT02533570|155557008|FG001|Overall Study|Adverse Event|1|||
48371996|NCT02533570|155557009|FG002|Overall Study|Adverse Event|1|||
48371997|NCT03756129|155557010|FG000|Overall Study|Adverse Event|1|||
48371998|NCT03756129|155557011|FG001|Overall Study|Adverse Event|1|||
48371999|NCT03756129|155557012|FG002|Overall Study|Adverse Event|0|||
48372000|NCT03756129|155557013|FG003|Overall Study|Adverse Event|2|||
48372001|NCT03756129|155557014|FG004|Overall Study|Adverse Event|0|||
48372002|NCT03756129|155557015|FG005|Overall Study|Adverse Event|0|||
48372003|NCT03756129|155557010|FG000|Overall Study|Withdrawal by Subject|2|||
48372004|NCT03756129|155557011|FG001|Overall Study|Withdrawal by Subject|1|||
48372005|NCT03756129|155557012|FG002|Overall Study|Withdrawal by Subject|3|||
48372006|NCT03756129|155557013|FG003|Overall Study|Withdrawal by Subject|1|||
48372007|NCT03756129|155557014|FG004|Overall Study|Withdrawal by Subject|1|||
48372008|NCT03756129|155557015|FG005|Overall Study|Withdrawal by Subject|3|||
48372009|NCT03756129|155557010|FG000|Overall Study|Lost to Follow-up|0|||
48372010|NCT03756129|155557011|FG001|Overall Study|Lost to Follow-up|0|||
48372011|NCT03756129|155557012|FG002|Overall Study|Lost to Follow-up|0|||
48372012|NCT03756129|155557013|FG003|Overall Study|Lost to Follow-up|0|||
48372013|NCT03756129|155557014|FG004|Overall Study|Lost to Follow-up|0|||
48372014|NCT03756129|155557015|FG005|Overall Study|Lost to Follow-up|1|||
48372015|NCT03756129|155557010|FG000|Overall Study|Physician Decision|0|||
48372016|NCT03756129|155557011|FG001|Overall Study|Physician Decision|0|||
48372017|NCT03756129|155557012|FG002|Overall Study|Physician Decision|0|||
48372018|NCT03756129|155557013|FG003|Overall Study|Physician Decision|0|||
48372019|NCT03756129|155557014|FG004|Overall Study|Physician Decision|0|||
48372020|NCT03756129|155557015|FG005|Overall Study|Physician Decision|1|||
48372021|NCT03254485|155557016|FG000|Overall Study|Adverse Event|3|||
48372022|NCT03254485|155557017|FG001|Overall Study|Adverse Event|0|||
48372023|NCT03254485|155557018|FG002|Overall Study|Adverse Event|0|||
48372024|NCT03254485|155557019|FG003|Overall Study|Adverse Event|6|||
48372025|NCT03254485|155557016|FG000|Overall Study|Protocol Violation|6|||
48372026|NCT03254485|155557017|FG001|Overall Study|Protocol Violation|0|||
48372027|NCT03254485|155557018|FG002|Overall Study|Protocol Violation|0|||
48372028|NCT03254485|155557019|FG003|Overall Study|Protocol Violation|2|||
48372029|NCT03254485|155557016|FG000|Overall Study|Withdrawal by Subject|1|||
48372030|NCT03254485|155557017|FG001|Overall Study|Withdrawal by Subject|0|||
48372031|NCT03254485|155557018|FG002|Overall Study|Withdrawal by Subject|0|||
48372032|NCT03254485|155557019|FG003|Overall Study|Withdrawal by Subject|4|||
48372033|NCT03254485|155557016|FG000|Overall Study|Death|0|||
48372034|NCT03254485|155557017|FG001|Overall Study|Death|0|||
48372035|NCT03254485|155557018|FG002|Overall Study|Death|0|||
48372036|NCT03254485|155557019|FG003|Overall Study|Death|1|||
48372037|NCT03254485|155557016|FG000|Overall Study|Lost to Follow-up|1|||
48372038|NCT03254485|155557017|FG001|Overall Study|Lost to Follow-up|0|||
48372039|NCT03254485|155557018|FG002|Overall Study|Lost to Follow-up|0|||
48372040|NCT03254485|155557019|FG003|Overall Study|Lost to Follow-up|0|||
48372041|NCT03254485|155557016|FG000|Overall Study|Other|1|||
48372042|NCT03254485|155557017|FG001|Overall Study|Other|0|||
48372043|NCT03254485|155557018|FG002|Overall Study|Other|0|||
48372044|NCT03254485|155557019|FG003|Overall Study|Other|2|||
48372045|NCT03567434|155557023|FG000|Overall Study|Lost to Follow-up|1|||
48372046|NCT03567434|155557024|FG001|Overall Study|Lost to Follow-up|3|||
48372047|NCT00640133|155558817|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
48372048|NCT00640133|155558818|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
48372049|NCT00640133|155558817|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
48372050|NCT00640133|155558818|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
48372051|NCT00640133|155558817|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
48372052|NCT00640133|155558818|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
48372053|NCT03541174|155558821|FG000|Part 1 Double-Blind|Adverse Event|6|||
48372054|NCT03541174|155558822|FG001|Part 1 Double-Blind|Adverse Event|5|||
48372055|NCT03541174|155558823|FG002|Part 1 Double-Blind|Adverse Event|2|||
48372056|NCT03541174|155558824|FG003|Part 1 Double-Blind|Adverse Event|0|||
48372057|NCT03541174|155558825|FG004|Part 1 Double-Blind|Adverse Event|0|||
48372058|NCT03541174|155558826|FG005|Part 1 Double-Blind|Adverse Event|0|||
48372059|NCT03541174|155558821|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
48372060|NCT03541174|155558822|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
48372061|NCT03541174|155558823|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
48372062|NCT03541174|155558824|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
48372063|NCT03541174|155558825|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
48372064|NCT03541174|155558826|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
48372065|NCT03541174|155558821|FG000|Part 1 Double-Blind|Other reasons|3|||
48372066|NCT03541174|155558822|FG001|Part 1 Double-Blind|Other reasons|2|||
48372067|NCT03541174|155558823|FG002|Part 1 Double-Blind|Other reasons|3|||
48372068|NCT03541174|155558824|FG003|Part 1 Double-Blind|Other reasons|0|||
48372069|NCT03541174|155558825|FG004|Part 1 Double-Blind|Other reasons|0|||
48372070|NCT03541174|155558826|FG005|Part 1 Double-Blind|Other reasons|0|||
48372071|NCT03541174|155558821|FG000|Part 2 Single-Blind|Adverse Event|0|||
48372072|NCT03541174|155558822|FG001|Part 2 Single-Blind|Adverse Event|0|||
48372073|NCT03541174|155558823|FG002|Part 2 Single-Blind|Adverse Event|0|||
48372074|NCT03541174|155558824|FG003|Part 2 Single-Blind|Adverse Event|25|||
48372075|NCT03541174|155558825|FG004|Part 2 Single-Blind|Adverse Event|0|||
48372076|NCT03541174|155558826|FG005|Part 2 Single-Blind|Adverse Event|0|||
48372077|NCT03541174|155558821|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
48372078|NCT03541174|155558822|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
48372079|NCT03541174|155558823|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
48372080|NCT03541174|155558824|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
48372081|NCT03541174|155558825|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
48372082|NCT03541174|155558826|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
48372083|NCT03541174|155558821|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
48372084|NCT03541174|155558822|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
48372085|NCT03541174|155558823|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
48372086|NCT03541174|155558824|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
48372087|NCT03541174|155558825|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
48372088|NCT03541174|155558826|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
48372089|NCT03541174|155558821|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
48372090|NCT03541174|155558822|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
48372091|NCT03541174|155558823|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
48372092|NCT03541174|155558824|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
48372093|NCT03541174|155558825|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
48372094|NCT03541174|155558826|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
48372095|NCT03541174|155558821|FG000|Part 2 Single-Blind|Death|0|||
48372096|NCT03541174|155558822|FG001|Part 2 Single-Blind|Death|0|||
48372097|NCT03541174|155558823|FG002|Part 2 Single-Blind|Death|0|||
48372098|NCT03541174|155558824|FG003|Part 2 Single-Blind|Death|5|||
48372099|NCT03541174|155558825|FG004|Part 2 Single-Blind|Death|0|||
48372100|NCT03541174|155558826|FG005|Part 2 Single-Blind|Death|0|||
48372101|NCT03541174|155558821|FG000|Part 2 Single-Blind|Pregnancy|0|||
48372102|NCT03541174|155558822|FG001|Part 2 Single-Blind|Pregnancy|0|||
48372103|NCT03541174|155558823|FG002|Part 2 Single-Blind|Pregnancy|0|||
48372104|NCT03541174|155558824|FG003|Part 2 Single-Blind|Pregnancy|1|||
48372105|NCT03541174|155558825|FG004|Part 2 Single-Blind|Pregnancy|0|||
48372106|NCT03541174|155558826|FG005|Part 2 Single-Blind|Pregnancy|0|||
48372107|NCT03541174|155558821|FG000|Part 2 Single-Blind|Other reasons|0|||
48372108|NCT03541174|155558822|FG001|Part 2 Single-Blind|Other reasons|0|||
48372109|NCT03541174|155558823|FG002|Part 2 Single-Blind|Other reasons|0|||
48372110|NCT03541174|155558824|FG003|Part 2 Single-Blind|Other reasons|32|||
48372111|NCT03541174|155558825|FG004|Part 2 Single-Blind|Other reasons|0|||
48372112|NCT03541174|155558826|FG005|Part 2 Single-Blind|Other reasons|0|||
48372113|NCT03541174|155558821|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
48372114|NCT03541174|155558822|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
48372115|NCT03541174|155558823|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
48372116|NCT03541174|155558824|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
48372117|NCT03541174|155558825|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
48372118|NCT03541174|155558826|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
48372119|NCT03541174|155558821|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
48372120|NCT03541174|155558822|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
48372121|NCT03541174|155558823|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
48372122|NCT03541174|155558824|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
48372123|NCT03541174|155558825|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
48372124|NCT03541174|155558826|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
48372125|NCT03541174|155558821|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48372126|NCT03541174|155558822|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48372127|NCT03541174|155558823|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48372128|NCT03541174|155558824|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48372129|NCT03541174|155558825|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
48372130|NCT03541174|155558826|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
48372131|NCT03541174|155558821|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
48372132|NCT03541174|155558822|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
48372133|NCT03541174|155558823|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
48372134|NCT03541174|155558824|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
48372135|NCT03541174|155558825|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
48372136|NCT03541174|155558826|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
48372137|NCT03541174|155558821|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48372138|NCT03541174|155558822|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48372139|NCT03541174|155558823|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48372140|NCT03541174|155558824|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48372141|NCT03541174|155558825|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
48372142|NCT03541174|155558826|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
48372143|NCT01664598|155558832|FG000|Overall Study|Sponsor Decision|1|||
48372144|NCT01664598|155558832|FG000|Overall Study|Withdrawal of Informed Consent|4|||
48372145|NCT01664598|155558832|FG000|Overall Study|Adverse Event|1|||
48372146|NCT00618982|155558833|FG000|Overall Study|Adverse Event|23|||
48372147|NCT00618982|155558833|FG000|Overall Study|Withdrawal by Subject|1|||
48372148|NCT00618982|155558833|FG000|Overall Study|Protocol Violation|1|||
48372149|NCT00618982|155558833|FG000|Overall Study|ongoing, still treated with study med.|25|||
48372150|NCT00558259|155558834|FG000|Overall Study|Adverse Event|50|||
48372151|NCT00558259|155558835|FG001|Overall Study|Adverse Event|81|||
48372152|NCT00558259|155558834|FG000|Overall Study|Protocol Violation|9|||
48372153|NCT00558259|155558835|FG001|Overall Study|Protocol Violation|5|||
48372154|NCT00558259|155558834|FG000|Overall Study|Withdrawal by Subject|12|||
48372155|NCT00558259|155558835|FG001|Overall Study|Withdrawal by Subject|13|||
48372156|NCT02121301|155558838|FG000|Overall Study|Protocol Violation|1|||
48372157|NCT02121301|155558839|FG001|Overall Study|Protocol Violation|4|||
48372158|NCT02121301|155558840|FG002|Overall Study|Protocol Violation|1|||
48372159|NCT01874431|155558844|FG000|Overall Study|Physician Decision|0|||
48372160|NCT01874431|155558845|FG001|Overall Study|Physician Decision|0|||
48372161|NCT01874431|155558846|FG002|Overall Study|Physician Decision|1|||
48372162|NCT01874431|155558847|FG003|Overall Study|Physician Decision|0|||
48372163|NCT01874431|155558848|FG004|Overall Study|Physician Decision|0|||
48372164|NCT01874431|155558849|FG005|Overall Study|Physician Decision|0|||
48372165|NCT01874431|155558850|FG006|Overall Study|Physician Decision|0|||
48372166|NCT01874431|155558851|FG007|Overall Study|Physician Decision|0|||
48372167|NCT01874431|155558844|FG000|Overall Study|Adverse Event|5|||
48372168|NCT01874431|155558845|FG001|Overall Study|Adverse Event|4|||
48372169|NCT01874431|155558846|FG002|Overall Study|Adverse Event|6|||
48372170|NCT01874431|155558847|FG003|Overall Study|Adverse Event|5|||
48372171|NCT01874431|155558848|FG004|Overall Study|Adverse Event|2|||
48372172|NCT01874431|155558849|FG005|Overall Study|Adverse Event|8|||
48372173|NCT01874431|155558850|FG006|Overall Study|Adverse Event|2|||
48372174|NCT01874431|155558851|FG007|Overall Study|Adverse Event|3|||
48372175|NCT01874431|155558844|FG000|Overall Study|Protocol Violation|1|||
48372176|NCT01874431|155558845|FG001|Overall Study|Protocol Violation|1|||
48372177|NCT01874431|155558846|FG002|Overall Study|Protocol Violation|1|||
48372178|NCT01874431|155558847|FG003|Overall Study|Protocol Violation|0|||
48372179|NCT01874431|155558848|FG004|Overall Study|Protocol Violation|3|||
48372180|NCT01874431|155558849|FG005|Overall Study|Protocol Violation|2|||
48372181|NCT01874431|155558850|FG006|Overall Study|Protocol Violation|1|||
48372182|NCT01874431|155558851|FG007|Overall Study|Protocol Violation|1|||
48372183|NCT01874431|155558844|FG000|Overall Study|Non-compliance|0|||
48372184|NCT01874431|155558845|FG001|Overall Study|Non-compliance|0|||
48372185|NCT01874431|155558846|FG002|Overall Study|Non-compliance|0|||
48372186|NCT01874431|155558847|FG003|Overall Study|Non-compliance|0|||
48372187|NCT01874431|155558848|FG004|Overall Study|Non-compliance|1|||
48372188|NCT01874431|155558849|FG005|Overall Study|Non-compliance|0|||
48372189|NCT01874431|155558850|FG006|Overall Study|Non-compliance|1|||
48372190|NCT01874431|155558851|FG007|Overall Study|Non-compliance|0|||
48372191|NCT01874431|155558844|FG000|Overall Study|Logistical difficulties|0|||
48372192|NCT01874431|155558845|FG001|Overall Study|Logistical difficulties|0|||
48372193|NCT01874431|155558846|FG002|Overall Study|Logistical difficulties|0|||
48372194|NCT01874431|155558847|FG003|Overall Study|Logistical difficulties|0|||
48372195|NCT01874431|155558848|FG004|Overall Study|Logistical difficulties|0|||
48372196|NCT01874431|155558849|FG005|Overall Study|Logistical difficulties|0|||
48372197|NCT01874431|155558850|FG006|Overall Study|Logistical difficulties|1|||
48372198|NCT01874431|155558851|FG007|Overall Study|Logistical difficulties|0|||
48372199|NCT01874431|155558844|FG000|Overall Study|Withdrawal by Subject|0|||
48372200|NCT01874431|155558845|FG001|Overall Study|Withdrawal by Subject|0|||
48372201|NCT01874431|155558846|FG002|Overall Study|Withdrawal by Subject|1|||
48372202|NCT01874431|155558847|FG003|Overall Study|Withdrawal by Subject|2|||
48372203|NCT01874431|155558848|FG004|Overall Study|Withdrawal by Subject|1|||
48372204|NCT01874431|155558849|FG005|Overall Study|Withdrawal by Subject|1|||
48372205|NCT01874431|155558850|FG006|Overall Study|Withdrawal by Subject|3|||
48372206|NCT01874431|155558851|FG007|Overall Study|Withdrawal by Subject|0|||
48372207|NCT01874431|155558844|FG000|Overall Study|Sponsor decision|0|||
48372208|NCT01874431|155558845|FG001|Overall Study|Sponsor decision|0|||
48372209|NCT01874431|155558846|FG002|Overall Study|Sponsor decision|0|||
48372210|NCT01874431|155558847|FG003|Overall Study|Sponsor decision|0|||
48372211|NCT01874431|155558848|FG004|Overall Study|Sponsor decision|1|||
48372212|NCT01874431|155558849|FG005|Overall Study|Sponsor decision|0|||
48372213|NCT01874431|155558850|FG006|Overall Study|Sponsor decision|0|||
48372214|NCT01874431|155558851|FG007|Overall Study|Sponsor decision|0|||
48372215|NCT01874431|155558844|FG000|Overall Study|Lost to Follow-up|0|||
48372216|NCT01874431|155558845|FG001|Overall Study|Lost to Follow-up|0|||
48372217|NCT01874431|155558846|FG002|Overall Study|Lost to Follow-up|1|||
48372218|NCT01874431|155558847|FG003|Overall Study|Lost to Follow-up|0|||
48372219|NCT01874431|155558848|FG004|Overall Study|Lost to Follow-up|0|||
48372220|NCT01874431|155558849|FG005|Overall Study|Lost to Follow-up|0|||
48372221|NCT01874431|155558850|FG006|Overall Study|Lost to Follow-up|0|||
48372222|NCT01874431|155558851|FG007|Overall Study|Lost to Follow-up|0|||
48372223|NCT01383499|155558859|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
48372224|NCT01383499|155558860|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48372225|NCT01383499|155558861|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48372226|NCT01383499|155558862|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48372227|NCT00946101|155558863|FG000|Overall Study|Lost to Follow-up|2|||
48372228|NCT00946101|155558864|FG001|Overall Study|Lost to Follow-up|1|||
48372229|NCT00946101|155558863|FG000|Overall Study|Withdrawal of consent|2|||
48372230|NCT00946101|155558864|FG001|Overall Study|Withdrawal of consent|0|||
48372231|NCT00946101|155558863|FG000|Overall Study|Physician Decision|0|||
48372232|NCT00946101|155558864|FG001|Overall Study|Physician Decision|1|||
48372233|NCT00262951|155558868|FG000|Overall Study|Progressive disease/relapse|3|||
48372234|NCT00262951|155558868|FG000|Overall Study|Adverse Event|7|||
48372235|NCT00262951|155558868|FG000|Overall Study|Death|1|||
48372236|NCT00262951|155558868|FG000|Overall Study|Withdrawal by Subject|1|||
48372237|NCT00262951|155558868|FG000|Overall Study|Alternative treatment|3|||
48372238|NCT00262951|155558868|FG000|Overall Study|Off treatment for other disease|1|||
48372239|NCT02706899|155558869|FG000|Overall Study|Withdrawal by Subject|1|||
48372240|NCT02706899|155558870|FG001|Overall Study|Withdrawal by Subject|0|||
48372241|NCT02706899|155558869|FG000|Overall Study|Death|8|||
48372242|NCT02706899|155558870|FG001|Overall Study|Death|0|||
48372243|NCT02706899|155558869|FG000|Overall Study|Study Termination by Sponsor|4|||
48372244|NCT02706899|155558870|FG001|Overall Study|Study Termination by Sponsor|6|||
48372245|NCT00848926|155558875|FG000|Treatment Period|Progressive disease|45|||
48372246|NCT00848926|155558875|FG000|Treatment Period|Adverse Event|20|||
48372247|NCT00848926|155558875|FG000|Treatment Period|Physician Decision|12|||
48372248|NCT00848926|155558875|FG000|Treatment Period|Withdrawal by Subject|7|||
48372249|NCT00848926|155558875|FG000|Follow-up Period|Lost to Follow-up|7|||
48372250|NCT00848926|155558875|FG000|Follow-up Period|Withdrawal by Subject|3|||
48372251|NCT00848926|155558875|FG000|Follow-up Period|Other|2|||
48372252|NCT02325557|155558877|FG000|Overall Study|Progressive disease|1|||
48372253|NCT02325557|155558878|FG001|Overall Study|Progressive disease|0|||
48372254|NCT02325557|155558879|FG002|Overall Study|Progressive disease|0|||
48372255|NCT02325557|155558880|FG003|Overall Study|Progressive disease|0|||
48372256|NCT02325557|155558877|FG000|Overall Study|Withdrawal by Subject|4|||
48372257|NCT02325557|155558878|FG001|Overall Study|Withdrawal by Subject|0|||
48372258|NCT02325557|155558879|FG002|Overall Study|Withdrawal by Subject|0|||
48372259|NCT02325557|155558880|FG003|Overall Study|Withdrawal by Subject|15|||
48372260|NCT02325557|155558877|FG000|Overall Study|Death|5|||
48372261|NCT02325557|155558878|FG001|Overall Study|Death|1|||
48372262|NCT02325557|155558879|FG002|Overall Study|Death|1|||
48372263|NCT02325557|155558880|FG003|Overall Study|Death|16|||
48372264|NCT02325557|155558877|FG000|Overall Study|Lost to Follow-up|0|||
48372265|NCT02325557|155558878|FG001|Overall Study|Lost to Follow-up|0|||
48372266|NCT02325557|155558879|FG002|Overall Study|Lost to Follow-up|1|||
48372267|NCT02325557|155558880|FG003|Overall Study|Lost to Follow-up|1|||
48372268|NCT02325557|155558877|FG000|Overall Study|Other|0|||
48372269|NCT02325557|155558878|FG001|Overall Study|Other|0|||
48372270|NCT02325557|155558879|FG002|Overall Study|Other|0|||
48372271|NCT02325557|155558880|FG003|Overall Study|Other|5|||
48372272|NCT01435616|155558881|FG000|Overall Study|Adverse Event|39|||
48372273|NCT01435616|155558882|FG001|Overall Study|Adverse Event|21|||
48372274|NCT01435616|155558881|FG000|Overall Study|Death|7|||
48372275|NCT01435616|155558882|FG001|Overall Study|Death|2|||
48372276|NCT01435616|155558881|FG000|Overall Study|Lost to Follow-up|22|||
48372277|NCT01435616|155558882|FG001|Overall Study|Lost to Follow-up|13|||
48372278|NCT01435616|155558881|FG000|Overall Study|Protocol Violation|16|||
48372279|NCT01435616|155558882|FG001|Overall Study|Protocol Violation|13|||
48372280|NCT01435616|155558881|FG000|Overall Study|Withdrawal by Subject|66|||
48372281|NCT01435616|155558882|FG001|Overall Study|Withdrawal by Subject|24|||
48372282|NCT01435616|155558881|FG000|Overall Study|Physician Decision|20|||
48372283|NCT01435616|155558882|FG001|Overall Study|Physician Decision|7|||
48372284|NCT01435616|155558881|FG000|Overall Study|Sponsor Decision|1|||
48372285|NCT01435616|155558882|FG001|Overall Study|Sponsor Decision|0|||
48372286|NCT01293487|155558883|FG000|Overall Study|Lost to Follow-up|0|||
48372287|NCT01293487|155558884|FG001|Overall Study|Lost to Follow-up|0|||
48372288|NCT01293487|155558885|FG002|Overall Study|Lost to Follow-up|0|||
48372289|NCT01293487|155558886|FG003|Overall Study|Lost to Follow-up|1|||
48372290|NCT01293487|155558887|FG004|Overall Study|Lost to Follow-up|0|||
48372291|NCT01293487|155558888|FG005|Overall Study|Lost to Follow-up|0|||
48372292|NCT01293487|155558889|FG006|Overall Study|Lost to Follow-up|0|||
48372293|NCT01293487|155558890|FG007|Overall Study|Lost to Follow-up|0|||
48372294|NCT01293487|155558883|FG000|Overall Study|Withdrawal by Subject|0|||
48372295|NCT01293487|155558884|FG001|Overall Study|Withdrawal by Subject|0|||
48372296|NCT01293487|155558885|FG002|Overall Study|Withdrawal by Subject|0|||
48372297|NCT01293487|155558886|FG003|Overall Study|Withdrawal by Subject|0|||
48372298|NCT01293487|155558887|FG004|Overall Study|Withdrawal by Subject|0|||
48372299|NCT01293487|155558888|FG005|Overall Study|Withdrawal by Subject|0|||
48372300|NCT01293487|155558889|FG006|Overall Study|Withdrawal by Subject|0|||
48372301|NCT01293487|155558890|FG007|Overall Study|Withdrawal by Subject|2|||
48372302|NCT01642251|155558893|FG000|Overall Study|Progressive disease|0|||
48372303|NCT01642251|155558894|FG001|Overall Study|Progressive disease|0|||
48372304|NCT01642251|155558895|FG002|Overall Study|Progressive disease|3|||
48372305|NCT01642251|155558896|FG003|Overall Study|Progressive disease|3|||
48372306|NCT01642251|155558893|FG000|Overall Study|Adverse Event|0|||
48372307|NCT01642251|155558894|FG001|Overall Study|Adverse Event|0|||
48372308|NCT01642251|155558895|FG002|Overall Study|Adverse Event|5|||
48372309|NCT01642251|155558896|FG003|Overall Study|Adverse Event|4|||
48372310|NCT01642251|155558893|FG000|Overall Study|Death|0|||
48372311|NCT01642251|155558894|FG001|Overall Study|Death|0|||
48372312|NCT01642251|155558895|FG002|Overall Study|Death|1|||
48372313|NCT01642251|155558896|FG003|Overall Study|Death|3|||
48372314|NCT01642251|155558893|FG000|Overall Study|Withdrawal by Subject|0|||
48372315|NCT01642251|155558894|FG001|Overall Study|Withdrawal by Subject|0|||
48372316|NCT01642251|155558895|FG002|Overall Study|Withdrawal by Subject|1|||
48372317|NCT01642251|155558896|FG003|Overall Study|Withdrawal by Subject|3|||
48372318|NCT01642251|155558893|FG000|Overall Study|Alternative therapy|0|||
48372319|NCT01642251|155558894|FG001|Overall Study|Alternative therapy|0|||
48372320|NCT01642251|155558895|FG002|Overall Study|Alternative therapy|0|||
48372321|NCT01642251|155558896|FG003|Overall Study|Alternative therapy|2|||
48372322|NCT01642251|155558893|FG000|Overall Study|Other complicating disease|0|||
48372323|NCT01642251|155558894|FG001|Overall Study|Other complicating disease|0|||
48372324|NCT01642251|155558895|FG002|Overall Study|Other complicating disease|1|||
48372325|NCT01642251|155558896|FG003|Overall Study|Other complicating disease|0|||
48372326|NCT01642251|155558893|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
48372327|NCT01642251|155558894|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
48372328|NCT01642251|155558895|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
48372329|NCT01642251|155558896|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
48372330|NCT04602221|155558897|FG000|Overall Study|Discontinuation of trial treatment|0|||
48372331|NCT04602221|155558898|FG001|Overall Study|Discontinuation of trial treatment|0|||
48372332|NCT04602221|155558899|FG002|Overall Study|Discontinuation of trial treatment|1|||
48372333|NCT04602221|155558900|FG003|Overall Study|Discontinuation of trial treatment|0|||
48372334|NCT04602221|155558901|FG004|Overall Study|Discontinuation of trial treatment|0|||
48372335|NCT04602221|155558902|FG005|Overall Study|Discontinuation of trial treatment|0|||
48372336|NCT04602221|155558903|FG006|Overall Study|Discontinuation of trial treatment|0|||
48372337|NCT04602221|155558904|FG007|Overall Study|Discontinuation of trial treatment|0|||
48372338|NCT04602221|155558905|FG008|Overall Study|Discontinuation of trial treatment|0|||
48372339|NCT04602221|155558906|FG009|Overall Study|Discontinuation of trial treatment|0|||
48372340|NCT04602221|155558907|FG010|Overall Study|Discontinuation of trial treatment|0|||
48372341|NCT04602221|155558908|FG011|Overall Study|Discontinuation of trial treatment|0|||
48372342|NCT04602221|155558909|FG012|Overall Study|Discontinuation of trial treatment|0|||
48372343|NCT04602221|155558910|FG013|Overall Study|Discontinuation of trial treatment|0|||
48372344|NCT04602221|155558911|FG014|Overall Study|Discontinuation of trial treatment|0|||
48372345|NCT04602221|155558912|FG015|Overall Study|Discontinuation of trial treatment|0|||
48372346|NCT04602221|155558913|FG016|Overall Study|Discontinuation of trial treatment|0|||
48372347|NCT04602221|155558914|FG017|Overall Study|Discontinuation of trial treatment|0|||
48372348|NCT04602221|155558897|FG000|Overall Study|Other than listed|0|||
48372349|NCT04602221|155558898|FG001|Overall Study|Other than listed|0|||
48372350|NCT04602221|155558899|FG002|Overall Study|Other than listed|0|||
48372351|NCT04602221|155558900|FG003|Overall Study|Other than listed|0|||
48372352|NCT04602221|155558901|FG004|Overall Study|Other than listed|0|||
48372353|NCT04602221|155558902|FG005|Overall Study|Other than listed|0|||
48372354|NCT04602221|155558903|FG006|Overall Study|Other than listed|0|||
48372355|NCT04602221|155558904|FG007|Overall Study|Other than listed|0|||
48372356|NCT04602221|155558905|FG008|Overall Study|Other than listed|0|||
48372357|NCT04602221|155558906|FG009|Overall Study|Other than listed|0|||
48372358|NCT04602221|155558907|FG010|Overall Study|Other than listed|0|||
48372359|NCT04602221|155558908|FG011|Overall Study|Other than listed|0|||
48372360|NCT04602221|155558909|FG012|Overall Study|Other than listed|0|||
48372361|NCT04602221|155558910|FG013|Overall Study|Other than listed|0|||
48372362|NCT04602221|155558911|FG014|Overall Study|Other than listed|0|||
48372363|NCT04602221|155558912|FG015|Overall Study|Other than listed|1|||
48372364|NCT04602221|155558913|FG016|Overall Study|Other than listed|0|||
48372365|NCT04602221|155558914|FG017|Overall Study|Other than listed|1|||
48372366|NCT04602221|155558897|FG000|Overall Study|Withdrawal by Subject|0|||
48372367|NCT04602221|155558898|FG001|Overall Study|Withdrawal by Subject|0|||
48372368|NCT04602221|155558899|FG002|Overall Study|Withdrawal by Subject|0|||
48372369|NCT04602221|155558900|FG003|Overall Study|Withdrawal by Subject|0|||
48372370|NCT04602221|155558901|FG004|Overall Study|Withdrawal by Subject|0|||
48372371|NCT04602221|155558902|FG005|Overall Study|Withdrawal by Subject|0|||
48372372|NCT04602221|155558903|FG006|Overall Study|Withdrawal by Subject|0|||
48415072|NCT01309737|155707565|FG001|Week 16 to 52|Withdrawal by Subject|6|||
48372373|NCT04602221|155558904|FG007|Overall Study|Withdrawal by Subject|0|||
48372374|NCT04602221|155558905|FG008|Overall Study|Withdrawal by Subject|0|||
48372375|NCT04602221|155558906|FG009|Overall Study|Withdrawal by Subject|0|||
48372376|NCT04602221|155558907|FG010|Overall Study|Withdrawal by Subject|0|||
48372377|NCT04602221|155558908|FG011|Overall Study|Withdrawal by Subject|0|||
48372378|NCT04602221|155558909|FG012|Overall Study|Withdrawal by Subject|1|||
48372379|NCT04602221|155558910|FG013|Overall Study|Withdrawal by Subject|0|||
48372380|NCT04602221|155558911|FG014|Overall Study|Withdrawal by Subject|0|||
48372381|NCT04602221|155558912|FG015|Overall Study|Withdrawal by Subject|0|||
48372382|NCT04602221|155558913|FG016|Overall Study|Withdrawal by Subject|0|||
48372383|NCT04602221|155558914|FG017|Overall Study|Withdrawal by Subject|0|||
48372384|NCT04602221|155558897|FG000|Overall Study|Lost to Follow-up|0|||
48372385|NCT04602221|155558898|FG001|Overall Study|Lost to Follow-up|0|||
48372386|NCT04602221|155558899|FG002|Overall Study|Lost to Follow-up|0|||
48372387|NCT04602221|155558900|FG003|Overall Study|Lost to Follow-up|0|||
48372388|NCT04602221|155558901|FG004|Overall Study|Lost to Follow-up|0|||
48372389|NCT04602221|155558902|FG005|Overall Study|Lost to Follow-up|1|||
48372390|NCT04602221|155558903|FG006|Overall Study|Lost to Follow-up|0|||
48372391|NCT04602221|155558904|FG007|Overall Study|Lost to Follow-up|0|||
48372392|NCT04602221|155558905|FG008|Overall Study|Lost to Follow-up|0|||
48372393|NCT04602221|155558906|FG009|Overall Study|Lost to Follow-up|0|||
48372394|NCT04602221|155558907|FG010|Overall Study|Lost to Follow-up|0|||
48372395|NCT04602221|155558908|FG011|Overall Study|Lost to Follow-up|0|||
48372396|NCT04602221|155558909|FG012|Overall Study|Lost to Follow-up|0|||
48372397|NCT04602221|155558910|FG013|Overall Study|Lost to Follow-up|0|||
48372398|NCT04602221|155558911|FG014|Overall Study|Lost to Follow-up|0|||
48372399|NCT04602221|155558912|FG015|Overall Study|Lost to Follow-up|0|||
48372400|NCT04602221|155558913|FG016|Overall Study|Lost to Follow-up|0|||
48372401|NCT04602221|155558914|FG017|Overall Study|Lost to Follow-up|0|||
48372402|NCT02270515|155558915|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
48372403|NCT02270515|155558915|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
48372404|NCT02270515|155558915|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
48372405|NCT02270515|155558915|FG000|Intervention Period 1: 0-6 Months|Death|7|||
48372406|NCT02270515|155558915|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
48372407|NCT02270515|155558915|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
48372408|NCT02270515|155558915|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
48372409|NCT02270515|155558915|FG000|Intervention Period 2: 6-12 Months|Death|5|||
48372410|NCT02270515|155558915|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
48372411|NCT02270515|155558915|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
48372412|NCT02270515|155558915|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
48372413|NCT02270515|155558915|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
48372414|NCT02270515|155558915|FG000|Intervention Period 3: 12-18 Months|Death|3|||
48372415|NCT02270515|155558915|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
48372416|NCT02729831|155558916|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
48372417|NCT02729831|155558917|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
48372418|NCT02729831|155558918|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
48372419|NCT02729831|155558919|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
48372420|NCT02729831|155558916|FG000|1 Week Post-visit|Lost to Follow-up|43|||
48372421|NCT02729831|155558917|FG001|1 Week Post-visit|Lost to Follow-up|40|||
48372422|NCT02729831|155558918|FG002|1 Week Post-visit|Lost to Follow-up|38|||
48372423|NCT02729831|155558919|FG003|1 Week Post-visit|Lost to Follow-up|36|||
48372424|NCT02729831|155558916|FG000|6 Month Follow-up|Lost to Follow-up|54|||
48372425|NCT02729831|155558917|FG001|6 Month Follow-up|Lost to Follow-up|51|||
48372426|NCT02729831|155558918|FG002|6 Month Follow-up|Lost to Follow-up|48|||
48372427|NCT02729831|155558919|FG003|6 Month Follow-up|Lost to Follow-up|42|||
48372428|NCT02729831|155558916|FG000|6 Month Follow-up|Death|1|||
48372429|NCT02729831|155558917|FG001|6 Month Follow-up|Death|3|||
48372430|NCT02729831|155558918|FG002|6 Month Follow-up|Death|0|||
48372431|NCT02729831|155558919|FG003|6 Month Follow-up|Death|1|||
48372432|NCT02481947|155558920|FG000|Overall Study|Withdrawal by Subject|24|||
48372433|NCT02481947|155558921|FG001|Overall Study|Withdrawal by Subject|10|||
48372434|NCT02481947|155558920|FG000|Overall Study|Lost to Follow-up|11|||
48372435|NCT02481947|155558921|FG001|Overall Study|Lost to Follow-up|5|||
48372436|NCT02481947|155558920|FG000|Overall Study|Adverse Event|6|||
48372437|NCT02481947|155558921|FG001|Overall Study|Adverse Event|11|||
48372438|NCT02481947|155558920|FG000|Overall Study|Physician Decision|4|||
48372439|NCT02481947|155558921|FG001|Overall Study|Physician Decision|5|||
48372440|NCT02481947|155558920|FG000|Overall Study|Protocol Violation|1|||
48372441|NCT02481947|155558921|FG001|Overall Study|Protocol Violation|5|||
48372442|NCT03265938|155558922|FG000|Overall Study|Withdrawal by Subject|1|||
48372443|NCT03265938|155558922|FG000|Overall Study|Physician Decision|1|||
48372444|NCT03265938|155558922|FG000|Overall Study|friable mass|6|||
48372445|NCT01211288|155558923|FG000|Overall Study|Lost to Follow-up|1|||
48372446|NCT01211288|155558924|FG001|Overall Study|Lost to Follow-up|1|||
48372447|NCT02447172|155558932|FG000|Overall Study|Adverse Event|11|||
48372448|NCT02447172|155558933|FG001|Overall Study|Adverse Event|8|||
48372449|NCT02447172|155558934|FG002|Overall Study|Adverse Event|7|||
48372450|NCT02447172|155558932|FG000|Overall Study|Death|3|||
48372451|NCT02447172|155558933|FG001|Overall Study|Death|1|||
48372452|NCT02447172|155558934|FG002|Overall Study|Death|0|||
48372453|NCT02447172|155558932|FG000|Overall Study|Protocol Violation|2|||
48372454|NCT02447172|155558933|FG001|Overall Study|Protocol Violation|1|||
48372455|NCT02447172|155558934|FG002|Overall Study|Protocol Violation|2|||
48372456|NCT02447172|155558932|FG000|Overall Study|Lost to Follow-up|7|||
48372457|NCT02447172|155558933|FG001|Overall Study|Lost to Follow-up|4|||
48372458|NCT02447172|155558934|FG002|Overall Study|Lost to Follow-up|4|||
48372459|NCT02447172|155558932|FG000|Overall Study|Withdrawal by Subject|5|||
48372460|NCT02447172|155558933|FG001|Overall Study|Withdrawal by Subject|1|||
48372461|NCT02447172|155558934|FG002|Overall Study|Withdrawal by Subject|3|||
48372462|NCT02447172|155558932|FG000|Overall Study|protocol specific treatment unrelated|3|||
48372463|NCT02447172|155558933|FG001|Overall Study|protocol specific treatment unrelated|0|||
48372464|NCT02447172|155558934|FG002|Overall Study|protocol specific treatment unrelated|2|||
48372465|NCT01281969|155558935|FG000|Overall Study|not randomized didn't meet criteria|0|||
48372466|NCT01281969|155558936|FG001|Overall Study|not randomized didn't meet criteria|0|||
48372467|NCT01281969|155558937|FG002|Overall Study|not randomized didn't meet criteria|7|||
48372468|NCT01281969|155558935|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
48372469|NCT01281969|155558936|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
48372470|NCT01281969|155558937|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
48372471|NCT01281969|155558935|FG000|Overall Study|not randomized, child consent not given|0|||
48372472|NCT01281969|155558936|FG001|Overall Study|not randomized, child consent not given|0|||
48372473|NCT01281969|155558937|FG002|Overall Study|not randomized, child consent not given|2|||
48372474|NCT01723254|155558938|FG000|Overall Study|Conflict with work schedule|0|||
48372475|NCT01723254|155558939|FG001|Overall Study|Conflict with work schedule|0|||
48372476|NCT01723254|155558940|FG002|Overall Study|Conflict with work schedule|0|||
48372477|NCT01723254|155558941|FG003|Overall Study|Conflict with work schedule|0|||
48372478|NCT01723254|155558942|FG004|Overall Study|Conflict with work schedule|0|||
48372479|NCT01723254|155558943|FG005|Overall Study|Conflict with work schedule|0|||
48372480|NCT01723254|155558944|FG006|Overall Study|Conflict with work schedule|0|||
48372481|NCT01723254|155558945|FG007|Overall Study|Conflict with work schedule|1|||
48372482|NCT01723254|155558938|FG000|Overall Study|Personal issues|0|||
48372483|NCT01723254|155558939|FG001|Overall Study|Personal issues|0|||
48372484|NCT01723254|155558940|FG002|Overall Study|Personal issues|0|||
48372485|NCT01723254|155558941|FG003|Overall Study|Personal issues|0|||
48372486|NCT01723254|155558942|FG004|Overall Study|Personal issues|0|||
48372487|NCT01723254|155558943|FG005|Overall Study|Personal issues|1|||
48372488|NCT01723254|155558944|FG006|Overall Study|Personal issues|0|||
48372489|NCT01723254|155558945|FG007|Overall Study|Personal issues|0|||
48372490|NCT01723254|155558938|FG000|Overall Study|No longer have time to participate|0|||
48372491|NCT01723254|155558939|FG001|Overall Study|No longer have time to participate|0|||
48372492|NCT01723254|155558940|FG002|Overall Study|No longer have time to participate|0|||
48372493|NCT01723254|155558941|FG003|Overall Study|No longer have time to participate|1|||
48372494|NCT01723254|155558942|FG004|Overall Study|No longer have time to participate|0|||
48372495|NCT01723254|155558943|FG005|Overall Study|No longer have time to participate|0|||
48372496|NCT01723254|155558944|FG006|Overall Study|No longer have time to participate|0|||
48372497|NCT01723254|155558945|FG007|Overall Study|No longer have time to participate|0|||
48372498|NCT01723254|155558938|FG000|Overall Study|Move/Left to another country/city|0|||
48372499|NCT01723254|155558939|FG001|Overall Study|Move/Left to another country/city|0|||
48372500|NCT01723254|155558940|FG002|Overall Study|Move/Left to another country/city|2|||
48372501|NCT01723254|155558941|FG003|Overall Study|Move/Left to another country/city|1|||
48372502|NCT01723254|155558942|FG004|Overall Study|Move/Left to another country/city|1|||
48372503|NCT01723254|155558943|FG005|Overall Study|Move/Left to another country/city|0|||
48372504|NCT01723254|155558944|FG006|Overall Study|Move/Left to another country/city|0|||
48372505|NCT01723254|155558945|FG007|Overall Study|Move/Left to another country/city|0|||
48372506|NCT01723254|155558938|FG000|Overall Study|Protocol Violation|0|||
48372507|NCT01723254|155558939|FG001|Overall Study|Protocol Violation|1|||
48372508|NCT01723254|155558940|FG002|Overall Study|Protocol Violation|0|||
48372509|NCT01723254|155558941|FG003|Overall Study|Protocol Violation|0|||
48372510|NCT01723254|155558942|FG004|Overall Study|Protocol Violation|0|||
48372511|NCT01723254|155558943|FG005|Overall Study|Protocol Violation|0|||
48372512|NCT01723254|155558944|FG006|Overall Study|Protocol Violation|0|||
48372513|NCT01723254|155558945|FG007|Overall Study|Protocol Violation|0|||
48372514|NCT01723254|155558938|FG000|Overall Study|Withdrawal by Subject|1|||
48372515|NCT01723254|155558939|FG001|Overall Study|Withdrawal by Subject|2|||
48372516|NCT01723254|155558940|FG002|Overall Study|Withdrawal by Subject|1|||
48372517|NCT01723254|155558941|FG003|Overall Study|Withdrawal by Subject|0|||
48372518|NCT01723254|155558942|FG004|Overall Study|Withdrawal by Subject|1|||
48372519|NCT01723254|155558943|FG005|Overall Study|Withdrawal by Subject|1|||
48372520|NCT01723254|155558944|FG006|Overall Study|Withdrawal by Subject|1|||
48372521|NCT01723254|155558945|FG007|Overall Study|Withdrawal by Subject|2|||
48372522|NCT01257425|155558950|FG000|Overall Study|Lack of Efficacy|3|||
48372523|NCT01257425|155558951|FG001|Overall Study|Lack of Efficacy|3|||
48372524|NCT01257425|155558950|FG000|Overall Study|Adverse Event|1|||
48372525|NCT01257425|155558951|FG001|Overall Study|Adverse Event|1|||
48372526|NCT01257425|155558950|FG000|Overall Study|Protocol Violation|1|||
48372527|NCT01257425|155558951|FG001|Overall Study|Protocol Violation|1|||
48372528|NCT01257425|155558950|FG000|Overall Study|Withdrawal by Subject|0|||
48372529|NCT01257425|155558951|FG001|Overall Study|Withdrawal by Subject|1|||
48372530|NCT01257425|155558950|FG000|Overall Study|Death|1|||
48372531|NCT01257425|155558951|FG001|Overall Study|Death|0|||
48372532|NCT02678247|155558961|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
48372533|NCT02678247|155558962|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
48372534|NCT02678247|155558961|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
48372535|NCT02678247|155558962|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
48372536|NCT02678247|155558961|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
48372537|NCT02678247|155558962|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
48372538|NCT02678247|155558961|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
48372539|NCT02678247|155558962|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
48372540|NCT02678247|155558961|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
48372541|NCT02678247|155558962|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
48372542|NCT02678247|155558961|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
48372543|NCT02678247|155558962|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
48372544|NCT00971243|155558969|FG000|Double Blind Period|Adverse Event|2|||
48372545|NCT00971243|155558970|FG001|Double Blind Period|Adverse Event|3|||
48372546|NCT00971243|155558971|FG002|Double Blind Period|Adverse Event|2|||
48372547|NCT00971243|155558972|FG003|Double Blind Period|Adverse Event|2|||
48372548|NCT00971243|155558973|FG004|Double Blind Period|Adverse Event|3|||
48372549|NCT00971243|155558969|FG000|Double Blind Period|Lost to Follow-up|0|||
48372550|NCT00971243|155558970|FG001|Double Blind Period|Lost to Follow-up|1|||
48372551|NCT00971243|155558971|FG002|Double Blind Period|Lost to Follow-up|1|||
48372552|NCT00971243|155558972|FG003|Double Blind Period|Lost to Follow-up|0|||
48372553|NCT00971243|155558973|FG004|Double Blind Period|Lost to Follow-up|1|||
48372554|NCT00971243|155558969|FG000|Double Blind Period|Physician Decision|10|||
48372555|NCT00971243|155558970|FG001|Double Blind Period|Physician Decision|6|||
48372556|NCT00971243|155558971|FG002|Double Blind Period|Physician Decision|7|||
48372557|NCT00971243|155558972|FG003|Double Blind Period|Physician Decision|6|||
48372558|NCT00971243|155558973|FG004|Double Blind Period|Physician Decision|7|||
48372559|NCT00971243|155558969|FG000|Double Blind Period|Protocol Violation|2|||
48372560|NCT00971243|155558970|FG001|Double Blind Period|Protocol Violation|0|||
48372561|NCT00971243|155558971|FG002|Double Blind Period|Protocol Violation|3|||
48372562|NCT00971243|155558972|FG003|Double Blind Period|Protocol Violation|2|||
48372563|NCT00971243|155558973|FG004|Double Blind Period|Protocol Violation|2|||
48372564|NCT00971243|155558969|FG000|Double Blind Period|Withdrawal by Subject|4|||
48372565|NCT00971243|155558970|FG001|Double Blind Period|Withdrawal by Subject|1|||
48372566|NCT00971243|155558971|FG002|Double Blind Period|Withdrawal by Subject|4|||
48372567|NCT00971243|155558972|FG003|Double Blind Period|Withdrawal by Subject|4|||
48372568|NCT00971243|155558973|FG004|Double Blind Period|Withdrawal by Subject|4|||
48372569|NCT00971243|155558969|FG000|Double Blind Period|Other reasons|1|||
48372570|NCT00971243|155558970|FG001|Double Blind Period|Other reasons|0|||
48372571|NCT00971243|155558971|FG002|Double Blind Period|Other reasons|2|||
48372572|NCT00971243|155558972|FG003|Double Blind Period|Other reasons|0|||
48372573|NCT00971243|155558973|FG004|Double Blind Period|Other reasons|1|||
48372574|NCT00971243|155558969|FG000|Open-label Period|Adverse Event|1|||
48372575|NCT00971243|155558970|FG001|Open-label Period|Adverse Event|0|||
48372576|NCT00971243|155558971|FG002|Open-label Period|Adverse Event|1|||
48372577|NCT00971243|155558972|FG003|Open-label Period|Adverse Event|1|||
48372578|NCT00971243|155558973|FG004|Open-label Period|Adverse Event|0|||
48372579|NCT00971243|155558969|FG000|Open-label Period|Physician Decision|5|||
48372580|NCT00971243|155558970|FG001|Open-label Period|Physician Decision|9|||
48372581|NCT00971243|155558971|FG002|Open-label Period|Physician Decision|3|||
48372582|NCT00971243|155558972|FG003|Open-label Period|Physician Decision|7|||
48372583|NCT00971243|155558973|FG004|Open-label Period|Physician Decision|2|||
48372584|NCT00971243|155558969|FG000|Open-label Period|Protocol Violation|1|||
48372585|NCT00971243|155558970|FG001|Open-label Period|Protocol Violation|1|||
48372586|NCT00971243|155558971|FG002|Open-label Period|Protocol Violation|1|||
48372587|NCT00971243|155558972|FG003|Open-label Period|Protocol Violation|0|||
48372588|NCT00971243|155558973|FG004|Open-label Period|Protocol Violation|1|||
48372589|NCT00971243|155558969|FG000|Open-label Period|Withdrawal by Subject|1|||
48372590|NCT00971243|155558970|FG001|Open-label Period|Withdrawal by Subject|0|||
48372591|NCT00971243|155558971|FG002|Open-label Period|Withdrawal by Subject|0|||
48372592|NCT00971243|155558972|FG003|Open-label Period|Withdrawal by Subject|2|||
48372593|NCT00971243|155558973|FG004|Open-label Period|Withdrawal by Subject|1|||
48372594|NCT00971243|155558969|FG000|Open-label Period|Other reason|0|||
48372595|NCT00971243|155558970|FG001|Open-label Period|Other reason|0|||
48372596|NCT00971243|155558971|FG002|Open-label Period|Other reason|0|||
48372597|NCT00971243|155558972|FG003|Open-label Period|Other reason|0|||
48372598|NCT00971243|155558973|FG004|Open-label Period|Other reason|2|||
48372599|NCT00585195|155558975|FG000|Overall Study|Adverse Event|0|||
48372600|NCT00585195|155558976|FG001|Overall Study|Adverse Event|0|||
48372601|NCT00585195|155558977|FG002|Overall Study|Adverse Event|0|||
48372602|NCT00585195|155558978|FG003|Overall Study|Adverse Event|0|||
48372603|NCT00585195|155558979|FG004|Overall Study|Adverse Event|2|||
48372604|NCT00585195|155558980|FG005|Overall Study|Adverse Event|1|||
48372605|NCT00585195|155558981|FG006|Overall Study|Adverse Event|0|||
48372606|NCT00585195|155558982|FG007|Overall Study|Adverse Event|1|||
48372607|NCT00585195|155558983|FG008|Overall Study|Adverse Event|0|||
48372608|NCT00585195|155558984|FG009|Overall Study|Adverse Event|0|||
48372609|NCT00585195|155558985|FG010|Overall Study|Adverse Event|3|||
48372610|NCT00585195|155558986|FG011|Overall Study|Adverse Event|0|||
48372611|NCT00585195|155558987|FG012|Overall Study|Adverse Event|8|||
48372612|NCT00585195|155558988|FG013|Overall Study|Adverse Event|6|||
48372613|NCT00585195|155558989|FG014|Overall Study|Adverse Event|4|||
48372614|NCT00585195|155558990|FG015|Overall Study|Adverse Event|1|||
48372615|NCT00585195|155558991|FG016|Overall Study|Adverse Event|14|||
48372616|NCT00585195|155558992|FG017|Overall Study|Adverse Event|9|||
48372617|NCT00585195|155558993|FG018|Overall Study|Adverse Event|2|||
48372618|NCT00585195|155558994|FG019|Overall Study|Adverse Event|3|||
48372619|NCT00585195|155558995|FG020|Overall Study|Adverse Event|1|||
48372620|NCT00585195|155558975|FG000|Overall Study|Progressive Disease|2|||
48372621|NCT00585195|155558976|FG001|Overall Study|Progressive Disease|2|||
48372622|NCT00585195|155558977|FG002|Overall Study|Progressive Disease|5|||
48372623|NCT00585195|155558978|FG003|Overall Study|Progressive Disease|4|||
48372624|NCT00585195|155558979|FG004|Overall Study|Progressive Disease|6|||
48372625|NCT00585195|155558980|FG005|Overall Study|Progressive Disease|4|||
48372626|NCT00585195|155558981|FG006|Overall Study|Progressive Disease|6|||
48372627|NCT00585195|155558982|FG007|Overall Study|Progressive Disease|3|||
48372628|NCT00585195|155558983|FG008|Overall Study|Progressive Disease|0|||
48372629|NCT00585195|155558984|FG009|Overall Study|Progressive Disease|5|||
48372630|NCT00585195|155558985|FG010|Overall Study|Progressive Disease|2|||
48372631|NCT00585195|155558986|FG011|Overall Study|Progressive Disease|25|||
48372632|NCT00585195|155558987|FG012|Overall Study|Progressive Disease|29|||
48372633|NCT00585195|155558988|FG013|Overall Study|Progressive Disease|26|||
48372634|NCT00585195|155558989|FG014|Overall Study|Progressive Disease|21|||
48372635|NCT00585195|155558990|FG015|Overall Study|Progressive Disease|12|||
48372636|NCT00585195|155558991|FG016|Overall Study|Progressive Disease|94|||
48372637|NCT00585195|155558992|FG017|Overall Study|Progressive Disease|42|||
48372638|NCT00585195|155558993|FG018|Overall Study|Progressive Disease|4|||
48372639|NCT00585195|155558994|FG019|Overall Study|Progressive Disease|9|||
48372640|NCT00585195|155558995|FG020|Overall Study|Progressive Disease|8|||
48372641|NCT00585195|155558975|FG000|Overall Study|Withdrawal by Subject|1|||
48372642|NCT00585195|155558976|FG001|Overall Study|Withdrawal by Subject|1|||
48372643|NCT00585195|155558977|FG002|Overall Study|Withdrawal by Subject|2|||
48372644|NCT00585195|155558978|FG003|Overall Study|Withdrawal by Subject|2|||
48372645|NCT00585195|155558979|FG004|Overall Study|Withdrawal by Subject|0|||
48372646|NCT00585195|155558980|FG005|Overall Study|Withdrawal by Subject|0|||
48372647|NCT00585195|155558981|FG006|Overall Study|Withdrawal by Subject|0|||
48372648|NCT00585195|155558982|FG007|Overall Study|Withdrawal by Subject|1|||
48372649|NCT00585195|155558983|FG008|Overall Study|Withdrawal by Subject|0|||
48372650|NCT00585195|155558984|FG009|Overall Study|Withdrawal by Subject|0|||
48372651|NCT00585195|155558985|FG010|Overall Study|Withdrawal by Subject|3|||
48372652|NCT00585195|155558986|FG011|Overall Study|Withdrawal by Subject|8|||
48372653|NCT00585195|155558987|FG012|Overall Study|Withdrawal by Subject|15|||
48372654|NCT00585195|155558988|FG013|Overall Study|Withdrawal by Subject|0|||
48372655|NCT00585195|155558989|FG014|Overall Study|Withdrawal by Subject|3|||
48372656|NCT00585195|155558990|FG015|Overall Study|Withdrawal by Subject|0|||
48372657|NCT00585195|155558991|FG016|Overall Study|Withdrawal by Subject|7|||
48372658|NCT00585195|155558992|FG017|Overall Study|Withdrawal by Subject|1|||
48372659|NCT00585195|155558993|FG018|Overall Study|Withdrawal by Subject|2|||
48372660|NCT00585195|155558994|FG019|Overall Study|Withdrawal by Subject|2|||
48372661|NCT00585195|155558995|FG020|Overall Study|Withdrawal by Subject|0|||
48372662|NCT00585195|155558975|FG000|Overall Study|Other|0|||
48372663|NCT00585195|155558976|FG001|Overall Study|Other|1|||
48372664|NCT00585195|155558977|FG002|Overall Study|Other|1|||
48372665|NCT00585195|155558978|FG003|Overall Study|Other|1|||
48372666|NCT00585195|155558979|FG004|Overall Study|Other|0|||
48372667|NCT00585195|155558980|FG005|Overall Study|Other|1|||
48372668|NCT00585195|155558981|FG006|Overall Study|Other|0|||
48372669|NCT00585195|155558982|FG007|Overall Study|Other|0|||
48372670|NCT00585195|155558983|FG008|Overall Study|Other|2|||
48372671|NCT00585195|155558984|FG009|Overall Study|Other|1|||
48372672|NCT00585195|155558985|FG010|Overall Study|Other|0|||
48372673|NCT00585195|155558986|FG011|Overall Study|Other|19|||
48372674|NCT00585195|155558987|FG012|Overall Study|Other|24|||
48372675|NCT00585195|155558988|FG013|Overall Study|Other|7|||
48372676|NCT00585195|155558989|FG014|Overall Study|Other|11|||
48372677|NCT00585195|155558990|FG015|Overall Study|Other|3|||
48372678|NCT00585195|155558991|FG016|Overall Study|Other|28|||
48372679|NCT00585195|155558992|FG017|Overall Study|Other|12|||
48372680|NCT00585195|155558993|FG018|Overall Study|Other|10|||
48372681|NCT00585195|155558994|FG019|Overall Study|Other|4|||
48372682|NCT00585195|155558995|FG020|Overall Study|Other|2|||
48372683|NCT00585195|155558975|FG000|Overall Study|Randomized not treated|0|||
48372684|NCT00585195|155558976|FG001|Overall Study|Randomized not treated|0|||
48372685|NCT00585195|155558977|FG002|Overall Study|Randomized not treated|1|||
48372686|NCT00585195|155558978|FG003|Overall Study|Randomized not treated|0|||
48372687|NCT00585195|155558979|FG004|Overall Study|Randomized not treated|1|||
48372688|NCT00585195|155558980|FG005|Overall Study|Randomized not treated|0|||
48372689|NCT00585195|155558981|FG006|Overall Study|Randomized not treated|1|||
48372690|NCT00585195|155558982|FG007|Overall Study|Randomized not treated|0|||
48372691|NCT00585195|155558983|FG008|Overall Study|Randomized not treated|0|||
48372692|NCT00585195|155558984|FG009|Overall Study|Randomized not treated|0|||
48372693|NCT00585195|155558985|FG010|Overall Study|Randomized not treated|2|||
48372694|NCT00585195|155558986|FG011|Overall Study|Randomized not treated|0|||
48372695|NCT00585195|155558987|FG012|Overall Study|Randomized not treated|0|||
48372696|NCT00585195|155558988|FG013|Overall Study|Randomized not treated|0|||
48372697|NCT00585195|155558989|FG014|Overall Study|Randomized not treated|0|||
48372698|NCT00585195|155558990|FG015|Overall Study|Randomized not treated|1|||
48372699|NCT00585195|155558991|FG016|Overall Study|Randomized not treated|0|||
48372700|NCT00585195|155558992|FG017|Overall Study|Randomized not treated|1|||
48372701|NCT00585195|155558993|FG018|Overall Study|Randomized not treated|3|||
48372702|NCT00585195|155558994|FG019|Overall Study|Randomized not treated|0|||
48372703|NCT00585195|155558995|FG020|Overall Study|Randomized not treated|2|||
48372704|NCT00585195|155558975|FG000|Overall Study|Death|0|||
48372705|NCT00585195|155558976|FG001|Overall Study|Death|0|||
48372706|NCT00585195|155558977|FG002|Overall Study|Death|0|||
48372707|NCT00585195|155558978|FG003|Overall Study|Death|0|||
48372708|NCT00585195|155558979|FG004|Overall Study|Death|0|||
48372709|NCT00585195|155558980|FG005|Overall Study|Death|0|||
48372710|NCT00585195|155558981|FG006|Overall Study|Death|0|||
48372711|NCT00585195|155558982|FG007|Overall Study|Death|0|||
48372712|NCT00585195|155558983|FG008|Overall Study|Death|1|||
48372713|NCT00585195|155558984|FG009|Overall Study|Death|0|||
48372714|NCT00585195|155558985|FG010|Overall Study|Death|1|||
48372715|NCT00585195|155558986|FG011|Overall Study|Death|1|||
48372716|NCT00585195|155558987|FG012|Overall Study|Death|7|||
48372717|NCT00585195|155558988|FG013|Overall Study|Death|2|||
48372718|NCT00585195|155558989|FG014|Overall Study|Death|8|||
48372719|NCT00585195|155558990|FG015|Overall Study|Death|2|||
48372720|NCT00585195|155558991|FG016|Overall Study|Death|11|||
48372721|NCT00585195|155558992|FG017|Overall Study|Death|0|||
48372722|NCT00585195|155558993|FG018|Overall Study|Death|0|||
48372723|NCT00585195|155558994|FG019|Overall Study|Death|0|||
48372724|NCT00585195|155558995|FG020|Overall Study|Death|1|||
48372725|NCT00585195|155558975|FG000|Overall Study|Lost to Follow-up|0|||
48372726|NCT00585195|155558976|FG001|Overall Study|Lost to Follow-up|0|||
48372727|NCT00585195|155558977|FG002|Overall Study|Lost to Follow-up|0|||
48372728|NCT00585195|155558978|FG003|Overall Study|Lost to Follow-up|0|||
48372729|NCT00585195|155558979|FG004|Overall Study|Lost to Follow-up|0|||
48372730|NCT00585195|155558980|FG005|Overall Study|Lost to Follow-up|0|||
48372731|NCT00585195|155558981|FG006|Overall Study|Lost to Follow-up|0|||
48372732|NCT00585195|155558982|FG007|Overall Study|Lost to Follow-up|0|||
48372733|NCT00585195|155558983|FG008|Overall Study|Lost to Follow-up|0|||
48372734|NCT00585195|155558984|FG009|Overall Study|Lost to Follow-up|0|||
48372735|NCT00585195|155558985|FG010|Overall Study|Lost to Follow-up|0|||
48372736|NCT00585195|155558986|FG011|Overall Study|Lost to Follow-up|0|||
48372737|NCT00585195|155558987|FG012|Overall Study|Lost to Follow-up|1|||
48372738|NCT00585195|155558988|FG013|Overall Study|Lost to Follow-up|0|||
48372739|NCT00585195|155558989|FG014|Overall Study|Lost to Follow-up|0|||
48372740|NCT00585195|155558990|FG015|Overall Study|Lost to Follow-up|0|||
48372741|NCT00585195|155558991|FG016|Overall Study|Lost to Follow-up|0|||
48372742|NCT00585195|155558992|FG017|Overall Study|Lost to Follow-up|2|||
48372743|NCT00585195|155558993|FG018|Overall Study|Lost to Follow-up|0|||
48372744|NCT00585195|155558994|FG019|Overall Study|Lost to Follow-up|0|||
48372745|NCT00585195|155558995|FG020|Overall Study|Lost to Follow-up|0|||
48372746|NCT00585195|155558975|FG000|Overall Study|Site Terminated by Sponsor|0|||
48372747|NCT00585195|155558976|FG001|Overall Study|Site Terminated by Sponsor|0|||
48372748|NCT00585195|155558977|FG002|Overall Study|Site Terminated by Sponsor|0|||
48372749|NCT00585195|155558978|FG003|Overall Study|Site Terminated by Sponsor|0|||
48372750|NCT00585195|155558979|FG004|Overall Study|Site Terminated by Sponsor|0|||
48372751|NCT00585195|155558980|FG005|Overall Study|Site Terminated by Sponsor|0|||
48372752|NCT00585195|155558981|FG006|Overall Study|Site Terminated by Sponsor|0|||
48372753|NCT00585195|155558982|FG007|Overall Study|Site Terminated by Sponsor|0|||
48372754|NCT00585195|155558983|FG008|Overall Study|Site Terminated by Sponsor|0|||
48372755|NCT00585195|155558984|FG009|Overall Study|Site Terminated by Sponsor|0|||
48372756|NCT00585195|155558985|FG010|Overall Study|Site Terminated by Sponsor|0|||
48372757|NCT00585195|155558986|FG011|Overall Study|Site Terminated by Sponsor|0|||
48372758|NCT00585195|155558987|FG012|Overall Study|Site Terminated by Sponsor|1|||
48372759|NCT00585195|155558988|FG013|Overall Study|Site Terminated by Sponsor|0|||
48372760|NCT00585195|155558989|FG014|Overall Study|Site Terminated by Sponsor|0|||
48372761|NCT00585195|155558990|FG015|Overall Study|Site Terminated by Sponsor|0|||
48372762|NCT00585195|155558991|FG016|Overall Study|Site Terminated by Sponsor|0|||
48372763|NCT00585195|155558992|FG017|Overall Study|Site Terminated by Sponsor|0|||
48372764|NCT00585195|155558993|FG018|Overall Study|Site Terminated by Sponsor|0|||
48372765|NCT00585195|155558994|FG019|Overall Study|Site Terminated by Sponsor|0|||
48372766|NCT00585195|155558995|FG020|Overall Study|Site Terminated by Sponsor|0|||
48372767|NCT00585195|155558975|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
48372768|NCT00585195|155558976|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
48372769|NCT00585195|155558977|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
48372770|NCT00585195|155558978|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
48372771|NCT00585195|155558979|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
48372772|NCT00585195|155558980|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
48372773|NCT00585195|155558981|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
48372774|NCT00585195|155558982|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
48372775|NCT00585195|155558983|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
48372776|NCT00585195|155558984|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
48372777|NCT00585195|155558985|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
48372778|NCT00585195|155558986|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
48372779|NCT00585195|155558987|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
48372780|NCT00585195|155558988|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
48372781|NCT00585195|155558989|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
48372782|NCT00585195|155558990|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
48372783|NCT00585195|155558991|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
48372784|NCT00585195|155558992|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
48372785|NCT00585195|155558993|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
48372786|NCT00585195|155558994|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
48372787|NCT00585195|155558995|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
48372788|NCT02337751|155558996|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
48372789|NCT02337751|155558997|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
48372790|NCT02337751|155558996|FG000|Overall Study|Voluntary Withdrawal|6|||
48372791|NCT02337751|155558997|FG001|Overall Study|Voluntary Withdrawal|8|||
48372792|NCT02337751|155558996|FG000|Overall Study|Lack of Efficacy|2|||
48372793|NCT02337751|155558997|FG001|Overall Study|Lack of Efficacy|5|||
48372794|NCT02337751|155558996|FG000|Overall Study|Investigator's Judgement|1|||
48372795|NCT02337751|155558997|FG001|Overall Study|Investigator's Judgement|0|||
48372796|NCT01315353|155558998|FG000|Overall Study|Death|2|||
48372797|NCT01315353|155558999|FG001|Overall Study|Death|1|||
48372798|NCT01315353|155559000|FG002|Overall Study|Death|0|||
48372799|NCT01315353|155558998|FG000|Overall Study|Withdrawal by Subject|2|||
48372800|NCT01315353|155558999|FG001|Overall Study|Withdrawal by Subject|6|||
48372801|NCT01315353|155559000|FG002|Overall Study|Withdrawal by Subject|1|||
48372802|NCT01315353|155558998|FG000|Overall Study|Lost to Follow-up|13|||
48372803|NCT01315353|155558999|FG001|Overall Study|Lost to Follow-up|6|||
48372804|NCT01315353|155559000|FG002|Overall Study|Lost to Follow-up|6|||
48372805|NCT01315353|155558998|FG000|Overall Study|Unwilling to adhere to requirements|5|||
48372806|NCT01315353|155558999|FG001|Overall Study|Unwilling to adhere to requirements|5|||
48372807|NCT01315353|155559000|FG002|Overall Study|Unwilling to adhere to requirements|4|||
48372808|NCT01315353|155558998|FG000|Overall Study|Site closing|7|||
48372809|NCT01315353|155558999|FG001|Overall Study|Site closing|4|||
48372810|NCT01315353|155559000|FG002|Overall Study|Site closing|0|||
48372811|NCT01315353|155558998|FG000|Overall Study|Taken off study by site in error|0|||
48372812|NCT01315353|155558999|FG001|Overall Study|Taken off study by site in error|1|||
48372813|NCT01315353|155559000|FG002|Overall Study|Taken off study by site in error|0|||
48372814|NCT01315353|155558998|FG000|Overall Study|Inadvertent randomization/assignment|0|||
48372815|NCT01315353|155558999|FG001|Overall Study|Inadvertent randomization/assignment|0|||
48372816|NCT01315353|155559000|FG002|Overall Study|Inadvertent randomization/assignment|2|||
48372817|NCT00153062|155560889|FG000|Overall Study|Death|360|||
48372818|NCT00153062|155560890|FG001|Overall Study|Death|352|||
48372819|NCT00153062|155560891|FG002|Overall Study|Death|369|||
48372820|NCT00153062|155560892|FG003|Overall Study|Death|365|||
48372821|NCT00153062|155560889|FG000|Overall Study|Withdrawal by Subject|14|||
48372822|NCT00153062|155560890|FG001|Overall Study|Withdrawal by Subject|30|||
48372823|NCT00153062|155560891|FG002|Overall Study|Withdrawal by Subject|27|||
48372824|NCT00153062|155560892|FG003|Overall Study|Withdrawal by Subject|28|||
48372825|NCT00153062|155560889|FG000|Overall Study|Lost to Follow-up|12|||
48372826|NCT00153062|155560890|FG001|Overall Study|Lost to Follow-up|20|||
48372827|NCT00153062|155560891|FG002|Overall Study|Lost to Follow-up|15|||
48372828|NCT00153062|155560892|FG003|Overall Study|Lost to Follow-up|16|||
48372829|NCT00153062|155560889|FG000|Overall Study|Adverse Event|0|||
48372830|NCT00153062|155560890|FG001|Overall Study|Adverse Event|1|||
48372831|NCT00153062|155560891|FG002|Overall Study|Adverse Event|1|||
48372832|NCT00153062|155560892|FG003|Overall Study|Adverse Event|0|||
48372833|NCT00153062|155560889|FG000|Overall Study|Protocol Violation|0|||
48372834|NCT00153062|155560890|FG001|Overall Study|Protocol Violation|2|||
48372835|NCT00153062|155560891|FG002|Overall Study|Protocol Violation|1|||
48372836|NCT00153062|155560892|FG003|Overall Study|Protocol Violation|1|||
48372837|NCT00153062|155560889|FG000|Overall Study|No disposition data available|1|||
48372838|NCT00153062|155560890|FG001|Overall Study|No disposition data available|1|||
48372839|NCT00153062|155560891|FG002|Overall Study|No disposition data available|1|||
48372840|NCT00153062|155560892|FG003|Overall Study|No disposition data available|1|||
48372841|NCT00153062|155560889|FG000|Overall Study|Other|0|||
48432065|NCT01683071|155769035|FG004|Part 1|Lack of Efficacy|0|||
48372842|NCT00153062|155560890|FG001|Overall Study|Other|0|||
48372843|NCT00153062|155560891|FG002|Overall Study|Other|1|||
48372844|NCT00153062|155560892|FG003|Overall Study|Other|0|||
48372845|NCT00596427|155560903|FG000|Overall Study|Withdrawal by Subject|2|||
48372846|NCT00596427|155560904|FG001|Overall Study|Withdrawal by Subject|2|||
48372847|NCT00596427|155560903|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
48372848|NCT00596427|155560904|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
48372849|NCT00596427|155560903|FG000|Overall Study|Protocol Violation|1|||
48372850|NCT00596427|155560904|FG001|Overall Study|Protocol Violation|0|||
48372851|NCT04097301|155560905|FG000|Overall Study|Death|1|||
48372852|NCT04097301|155560905|FG000|Overall Study|Withdrawal by Subject|1|||
48372853|NCT04097301|155560905|FG000|Overall Study|Screening Failure|5|||
48372854|NCT01635920|155560906|FG000|Overall Study|Adverse Event|1|||
48372855|NCT01635920|155560907|FG001|Overall Study|Adverse Event|0|||
48372856|NCT01635920|155560906|FG000|Overall Study|Lost to Follow-up|0|||
48372857|NCT01635920|155560907|FG001|Overall Study|Lost to Follow-up|1|||
48372858|NCT01635920|155560906|FG000|Overall Study|Subject decision|2|||
48372859|NCT01635920|155560907|FG001|Overall Study|Subject decision|0|||
48372860|NCT01614197|155560908|FG000|Overall Study|Withdrawal by Subject|0|||
48372861|NCT01614197|155560909|FG001|Overall Study|Withdrawal by Subject|1|||
48372862|NCT01614197|155560910|FG002|Overall Study|Withdrawal by Subject|0|||
48372863|NCT01614197|155560911|FG003|Overall Study|Withdrawal by Subject|0|||
48372864|NCT00971932|155560912|FG000|Overall Study|Withdrawal by Subject|1|||
48372865|NCT00971932|155560912|FG000|Overall Study|Investigator's decision|2|||
48372866|NCT00971932|155560912|FG000|Overall Study|Ongoing|4|||
48372867|NCT00545051|155560913|FG000|Overall Study|Adverse Event|7|||
48372868|NCT00545051|155560914|FG001|Overall Study|Adverse Event|3|||
48372869|NCT00545051|155560913|FG000|Overall Study|Death|1|||
48372870|NCT00545051|155560914|FG001|Overall Study|Death|0|||
48372871|NCT00545051|155560913|FG000|Overall Study|Violation of inclusion/exclusion|0|||
48372872|NCT00545051|155560914|FG001|Overall Study|Violation of inclusion/exclusion|2|||
48372873|NCT00545051|155560913|FG000|Overall Study|Protocol Violation|1|||
48372874|NCT00545051|155560914|FG001|Overall Study|Protocol Violation|0|||
48372875|NCT00545051|155560913|FG000|Overall Study|Withdrawal by Subject|0|||
48372876|NCT00545051|155560914|FG001|Overall Study|Withdrawal by Subject|1|||
48372877|NCT00545051|155560913|FG000|Overall Study|Administrative reasons|0|||
48372878|NCT00545051|155560914|FG001|Overall Study|Administrative reasons|1|||
48372879|NCT00799513|155560915|FG000|Overall Study|Physician Decision|1|||
48372880|NCT00799513|155560915|FG000|Overall Study|Adverse Event|1|||
48372881|NCT02257567|155560916|FG000|Overall Study|Adverse Event|0|||
48372882|NCT02257567|155560917|FG001|Overall Study|Adverse Event|0|||
48372883|NCT02257567|155560918|FG002|Overall Study|Adverse Event|0|||
48372884|NCT02257567|155560919|FG003|Overall Study|Adverse Event|1|||
48372885|NCT02257567|155560920|FG004|Overall Study|Adverse Event|1|||
48372886|NCT02257567|155560921|FG005|Overall Study|Adverse Event|0|||
48372887|NCT02257567|155560922|FG006|Overall Study|Adverse Event|0|||
48372888|NCT02257567|155560923|FG007|Overall Study|Adverse Event|0|||
48372889|NCT02257567|155560924|FG008|Overall Study|Adverse Event|1|||
48372890|NCT02257567|155560925|FG009|Overall Study|Adverse Event|0|||
48372891|NCT02257567|155560926|FG010|Overall Study|Adverse Event|0|||
48372892|NCT02257567|155560916|FG000|Overall Study|Death|2|||
48372893|NCT02257567|155560917|FG001|Overall Study|Death|2|||
48372894|NCT02257567|155560918|FG002|Overall Study|Death|2|||
48372895|NCT02257567|155560919|FG003|Overall Study|Death|4|||
48372896|NCT02257567|155560920|FG004|Overall Study|Death|15|||
48372897|NCT02257567|155560921|FG005|Overall Study|Death|11|||
48372898|NCT02257567|155560922|FG006|Overall Study|Death|26|||
48372899|NCT02257567|155560923|FG007|Overall Study|Death|30|||
48372900|NCT02257567|155560924|FG008|Overall Study|Death|2|||
48372901|NCT02257567|155560925|FG009|Overall Study|Death|18|||
48372902|NCT02257567|155560926|FG010|Overall Study|Death|65|||
48372903|NCT02257567|155560916|FG000|Overall Study|Lost to Follow-up|0|||
48372904|NCT02257567|155560917|FG001|Overall Study|Lost to Follow-up|0|||
48372905|NCT02257567|155560918|FG002|Overall Study|Lost to Follow-up|0|||
48372906|NCT02257567|155560919|FG003|Overall Study|Lost to Follow-up|0|||
48372907|NCT02257567|155560920|FG004|Overall Study|Lost to Follow-up|2|||
48372908|NCT02257567|155560921|FG005|Overall Study|Lost to Follow-up|2|||
48372909|NCT02257567|155560922|FG006|Overall Study|Lost to Follow-up|0|||
48372910|NCT02257567|155560923|FG007|Overall Study|Lost to Follow-up|0|||
48372911|NCT02257567|155560924|FG008|Overall Study|Lost to Follow-up|0|||
48372912|NCT02257567|155560925|FG009|Overall Study|Lost to Follow-up|1|||
48415073|NCT01309737|155707566|FG002|Week 16 to 52|Withdrawal by Subject|0|||
48415074|NCT01309737|155707567|FG003|Week 16 to 52|Withdrawal by Subject|0|||
48372913|NCT02257567|155560926|FG010|Overall Study|Lost to Follow-up|1|||
48372914|NCT02257567|155560916|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372915|NCT02257567|155560917|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372916|NCT02257567|155560918|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372917|NCT02257567|155560919|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372918|NCT02257567|155560920|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
48372919|NCT02257567|155560921|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372920|NCT02257567|155560922|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
48372921|NCT02257567|155560923|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372922|NCT02257567|155560924|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372923|NCT02257567|155560925|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372924|NCT02257567|155560926|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
48372925|NCT02257567|155560916|FG000|Overall Study|Physician Decision|0|||
48372926|NCT02257567|155560917|FG001|Overall Study|Physician Decision|0|||
48372927|NCT02257567|155560918|FG002|Overall Study|Physician Decision|0|||
48372928|NCT02257567|155560919|FG003|Overall Study|Physician Decision|0|||
48372929|NCT02257567|155560920|FG004|Overall Study|Physician Decision|0|||
48372930|NCT02257567|155560921|FG005|Overall Study|Physician Decision|0|||
48372931|NCT02257567|155560922|FG006|Overall Study|Physician Decision|0|||
48372932|NCT02257567|155560923|FG007|Overall Study|Physician Decision|2|||
48372933|NCT02257567|155560924|FG008|Overall Study|Physician Decision|0|||
48372934|NCT02257567|155560925|FG009|Overall Study|Physician Decision|1|||
48372935|NCT02257567|155560926|FG010|Overall Study|Physician Decision|0|||
48372936|NCT02257567|155560916|FG000|Overall Study|Withdrawal by Subject|0|||
48372937|NCT02257567|155560917|FG001|Overall Study|Withdrawal by Subject|0|||
48372938|NCT02257567|155560918|FG002|Overall Study|Withdrawal by Subject|2|||
48372939|NCT02257567|155560919|FG003|Overall Study|Withdrawal by Subject|0|||
48372940|NCT02257567|155560920|FG004|Overall Study|Withdrawal by Subject|0|||
48372941|NCT02257567|155560921|FG005|Overall Study|Withdrawal by Subject|6|||
48372942|NCT02257567|155560922|FG006|Overall Study|Withdrawal by Subject|6|||
48372943|NCT02257567|155560923|FG007|Overall Study|Withdrawal by Subject|6|||
48372944|NCT02257567|155560924|FG008|Overall Study|Withdrawal by Subject|1|||
48372945|NCT02257567|155560925|FG009|Overall Study|Withdrawal by Subject|1|||
48372946|NCT02257567|155560926|FG010|Overall Study|Withdrawal by Subject|10|||
48372947|NCT02683876|155560927|FG000|Overall Study|samples damaged during shipping|2|||
48372948|NCT02683876|155560928|FG001|Overall Study|samples damaged during shipping|0|||
48372949|NCT03536143|155560929|FG000|Overall Study|Early termination, Sponsor decision|1|||
48372950|NCT01347762|155560930|FG000|Overall Study|Lost to Follow-up|0|||
48372951|NCT01347762|155560931|FG001|Overall Study|Lost to Follow-up|1|||
48372952|NCT01347762|155560932|FG002|Overall Study|Lost to Follow-up|6|||
48372953|NCT01347762|155560933|FG003|Overall Study|Lost to Follow-up|5|||
48372954|NCT01347762|155560930|FG000|Overall Study|Withdrawal by Subject|4|||
48372955|NCT01347762|155560931|FG001|Overall Study|Withdrawal by Subject|1|||
48372956|NCT01347762|155560932|FG002|Overall Study|Withdrawal by Subject|3|||
48372957|NCT01347762|155560933|FG003|Overall Study|Withdrawal by Subject|3|||
48372958|NCT02057523|155560934|FG000|Overall Study|Withdrawal by Subject|1|||
48372959|NCT02057523|155560934|FG000|Overall Study|Lack of Efficacy|1|||
48372960|NCT02527343|155560935|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
48372961|NCT02527343|155560936|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48372962|NCT02527343|155560937|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48372963|NCT02527343|155560938|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48372964|NCT02527343|155560939|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48372965|NCT02527343|155560940|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
48372966|NCT02527343|155560935|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
48372967|NCT02527343|155560936|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48372968|NCT02527343|155560937|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48372969|NCT02527343|155560938|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48372970|NCT02527343|155560939|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48372971|NCT02527343|155560940|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
48372972|NCT02527343|155560935|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48372973|NCT02527343|155560936|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
48372974|NCT02527343|155560937|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48372975|NCT02527343|155560938|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48372976|NCT02527343|155560939|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48372977|NCT02527343|155560940|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
48372978|NCT02527343|155560935|FG000|RT Period: Weeks 1 to 52|Other|4|||
48372979|NCT02527343|155560936|FG001|RT Period: Weeks 1 to 52|Other|3|||
48372980|NCT02527343|155560937|FG002|RT Period: Weeks 1 to 52|Other|0|||
48372981|NCT02527343|155560938|FG003|RT Period: Weeks 1 to 52|Other|0|||
48372982|NCT02527343|155560939|FG004|RT Period: Weeks 1 to 52|Other|0|||
48372983|NCT02527343|155560940|FG005|RT Period: Weeks 1 to 52|Other|0|||
48372984|NCT02527343|155560935|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48372985|NCT02527343|155560936|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48372986|NCT02527343|155560937|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
48372987|NCT02527343|155560938|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48372988|NCT02527343|155560939|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48372989|NCT02527343|155560940|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
48372990|NCT02527343|155560935|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48372991|NCT02527343|155560936|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48372992|NCT02527343|155560937|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48372993|NCT02527343|155560938|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
48372994|NCT02527343|155560939|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48372995|NCT02527343|155560940|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
48372996|NCT02527343|155560935|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48372997|NCT02527343|155560936|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48372998|NCT02527343|155560937|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48372999|NCT02527343|155560938|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48373000|NCT02527343|155560939|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
48373001|NCT02527343|155560940|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
48373002|NCT02527343|155560935|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
48373003|NCT02527343|155560936|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
48373004|NCT02527343|155560937|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
48373005|NCT02527343|155560938|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
48373006|NCT02527343|155560939|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
48373007|NCT02527343|155560940|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
48373008|NCT02527343|155560935|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
48373009|NCT02527343|155560936|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
48373010|NCT02527343|155560937|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
48373011|NCT02527343|155560938|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
48373012|NCT02527343|155560939|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
48373013|NCT02527343|155560940|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
48373014|NCT02527343|155560935|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
48373015|NCT02527343|155560936|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
48373016|NCT02527343|155560937|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
48373017|NCT02527343|155560938|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
48373018|NCT02527343|155560939|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
48373019|NCT02527343|155560940|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
48373020|NCT02527343|155560935|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
48373021|NCT02527343|155560936|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
48373022|NCT02527343|155560937|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
48373023|NCT02527343|155560938|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
48373024|NCT02527343|155560939|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
48373025|NCT02527343|155560940|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
48373026|NCT02527343|155560935|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48373027|NCT02527343|155560936|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48373028|NCT02527343|155560937|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48373029|NCT02527343|155560938|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48373030|NCT02527343|155560939|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
48373031|NCT02527343|155560940|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
48373032|NCT02527343|155560935|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
48373033|NCT02527343|155560936|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
48373034|NCT02527343|155560937|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
48373035|NCT02527343|155560938|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
48373036|NCT02527343|155560939|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
48373037|NCT02527343|155560940|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
48373038|NCT02783768|155560944|FG000|Overall Study|Lost to Follow-up|1|||
48373039|NCT02783768|155560945|FG001|Overall Study|Lost to Follow-up|0|||
48373040|NCT00712673|155560947|FG000|Overall Study|Adverse Event|3|||
48373041|NCT00712673|155560948|FG001|Overall Study|Adverse Event|3|||
48373042|NCT00712673|155560949|FG002|Overall Study|Adverse Event|21|||
48373043|NCT00712673|155560950|FG003|Overall Study|Adverse Event|26|||
48373044|NCT00712673|155560947|FG000|Overall Study|Lack of Efficacy|2|||
48373045|NCT00712673|155560948|FG001|Overall Study|Lack of Efficacy|8|||
48373046|NCT00712673|155560949|FG002|Overall Study|Lack of Efficacy|8|||
48373047|NCT00712673|155560950|FG003|Overall Study|Lack of Efficacy|6|||
48373048|NCT00712673|155560947|FG000|Overall Study|Poor Compliance to Protocol|3|||
48373049|NCT00712673|155560948|FG001|Overall Study|Poor Compliance to Protocol|3|||
48373050|NCT00712673|155560949|FG002|Overall Study|Poor Compliance to Protocol|4|||
48373051|NCT00712673|155560950|FG003|Overall Study|Poor Compliance to Protocol|16|||
48373052|NCT00712673|155560947|FG000|Overall Study|Lost to Follow-up|1|||
48373053|NCT00712673|155560948|FG001|Overall Study|Lost to Follow-up|0|||
48373054|NCT00712673|155560949|FG002|Overall Study|Lost to Follow-up|2|||
48373055|NCT00712673|155560950|FG003|Overall Study|Lost to Follow-up|0|||
48373056|NCT00712673|155560947|FG000|Overall Study|Withdrawal by Subject|6|||
48373057|NCT00712673|155560948|FG001|Overall Study|Withdrawal by Subject|7|||
48373058|NCT00712673|155560949|FG002|Overall Study|Withdrawal by Subject|15|||
48373059|NCT00712673|155560950|FG003|Overall Study|Withdrawal by Subject|20|||
48373060|NCT00712673|155560947|FG000|Overall Study|Familial and Personal Reasons|5|||
48373061|NCT00712673|155560948|FG001|Overall Study|Familial and Personal Reasons|0|||
48373062|NCT00712673|155560949|FG002|Overall Study|Familial and Personal Reasons|5|||
48373063|NCT00712673|155560950|FG003|Overall Study|Familial and Personal Reasons|2|||
48373064|NCT00712673|155560947|FG000|Overall Study|Investigator's Decision|1|||
48373065|NCT00712673|155560948|FG001|Overall Study|Investigator's Decision|0|||
48373066|NCT00712673|155560949|FG002|Overall Study|Investigator's Decision|0|||
48373067|NCT00712673|155560950|FG003|Overall Study|Investigator's Decision|0|||
48373068|NCT00712673|155560947|FG000|Overall Study|Protocol Violation|0|||
48373069|NCT00712673|155560948|FG001|Overall Study|Protocol Violation|0|||
48373070|NCT00712673|155560949|FG002|Overall Study|Protocol Violation|2|||
48373071|NCT00712673|155560950|FG003|Overall Study|Protocol Violation|0|||
48373072|NCT00682890|155560951|FG000|Overall Study|Lost to Follow-up|1|||
48373073|NCT00682890|155560952|FG001|Overall Study|Lost to Follow-up|1|||
48373074|NCT00682890|155560951|FG000|Overall Study|subject moved away|0|||
48373075|NCT00682890|155560952|FG001|Overall Study|subject moved away|1|||
48373076|NCT00682890|155560951|FG000|Overall Study|heavy menstrual bleeding|1|||
48373077|NCT00682890|155560952|FG001|Overall Study|heavy menstrual bleeding|0|||
48373078|NCT01323647|155560953|FG000|Overall Study|Migrated/moved from study area|2|||
48373079|NCT01323647|155560954|FG001|Overall Study|Migrated/moved from study area|0|||
48373080|NCT01323647|155560953|FG000|Overall Study|Withdrawal by Subject|5|||
48373081|NCT01323647|155560954|FG001|Overall Study|Withdrawal by Subject|0|||
48373082|NCT01323647|155560953|FG000|Overall Study|Lost to Follow-up|2|||
48373083|NCT01323647|155560954|FG001|Overall Study|Lost to Follow-up|0|||
48373084|NCT03536754|155560960|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
48373085|NCT03536754|155560961|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
48373086|NCT03536754|155560962|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
48373087|NCT03536754|155560963|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
48373088|NCT03536754|155560964|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
48373089|NCT03536754|155560960|FG000|Open Label Extension|Other|0|||
48373090|NCT03536754|155560961|FG001|Open Label Extension|Other|0|||
48373091|NCT03536754|155560962|FG002|Open Label Extension|Other|0|||
48373092|NCT03536754|155560963|FG003|Open Label Extension|Other|0|||
48373093|NCT03536754|155560964|FG004|Open Label Extension|Other|1|||
48373094|NCT00122460|155560965|FG000|Overall Study|investigational study phase ongoing|7|||
48373095|NCT00122460|155560966|FG001|Overall Study|investigational study phase ongoing|1|||
48373096|NCT01853137|155560967|FG000|Overall Study|Lost to Follow-up|4|||
48373097|NCT01853137|155560968|FG001|Overall Study|Lost to Follow-up|1|||
48373098|NCT01054170|155560969|FG000|Overall Study|Protocol Violation|1|||
48373099|NCT01054170|155560970|FG001|Overall Study|Protocol Violation|0|||
48373100|NCT01054170|155560969|FG000|Overall Study|Withdrawal by Subject|3|||
48373101|NCT01054170|155560970|FG001|Overall Study|Withdrawal by Subject|2|||
48373102|NCT01054170|155560969|FG000|Overall Study|Adverse Event|0|||
48373103|NCT01054170|155560970|FG001|Overall Study|Adverse Event|4|||
48373104|NCT02951767|155560971|FG000|Overall Study|Study Terminated By Sponsor|9|||
48373105|NCT02951767|155560971|FG000|Overall Study|Withdrawal by Subject|11|||
48373106|NCT02951767|155560971|FG000|Overall Study|Death|96|||
48373107|NCT02951767|155560971|FG000|Overall Study|Lost to Follow-up|2|||
48373108|NCT02951767|155560971|FG000|Overall Study|Physician Decision|1|||
48373109|NCT01237587|155560972|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
48373110|NCT01237587|155560973|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
48373111|NCT01237587|155560972|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
48373112|NCT01237587|155560973|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
48373113|NCT01237587|155560972|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
48373114|NCT01237587|155560973|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
48373115|NCT01237587|155560972|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
48373116|NCT01237587|155560973|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
48373117|NCT01237587|155560972|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
48373118|NCT01237587|155560973|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
48373119|NCT01237587|155560972|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
48373120|NCT01237587|155560973|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
48373121|NCT01237587|155560972|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
48373122|NCT01237587|155560973|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
48373123|NCT01237587|155560972|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
48373124|NCT01237587|155560973|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
48373125|NCT01237587|155560972|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
48373126|NCT01237587|155560973|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
48373127|NCT01237587|155560972|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
48373128|NCT01237587|155560973|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
48415075|NCT01309737|155707568|FG004|Week 16 to 52|Withdrawal by Subject|2|||
48415076|NCT01309737|155707564|FG000|Week 16 to 52|Other|10|||
48373129|NCT01237587|155560972|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
48373130|NCT01237587|155560973|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
48373131|NCT01237587|155560972|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
48373132|NCT01237587|155560973|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
48373133|NCT01237587|155560972|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
48373134|NCT01237587|155560973|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
48373135|NCT01237587|155560972|FG000|Taper Phase|Adverse Event|0|||
48373136|NCT01237587|155560973|FG001|Taper Phase|Adverse Event|2|||
48373137|NCT01237587|155560972|FG000|Taper Phase|Protocol Violation|2|||
48373138|NCT01237587|155560973|FG001|Taper Phase|Protocol Violation|0|||
48373139|NCT01237587|155560972|FG000|Taper Phase|Lack of Efficacy|2|||
48373140|NCT01237587|155560973|FG001|Taper Phase|Lack of Efficacy|5|||
48373141|NCT01237587|155560972|FG000|Taper Phase|Parent/Guardian Decision|0|||
48373142|NCT01237587|155560973|FG001|Taper Phase|Parent/Guardian Decision|2|||
48373143|NCT01237587|155560972|FG000|Taper Phase|Sponsor Decision|1|||
48373144|NCT01237587|155560973|FG001|Taper Phase|Sponsor Decision|0|||
48373145|NCT01237587|155560972|FG000|Taper Phase|Withdrawal by Subject|0|||
48373146|NCT01237587|155560973|FG001|Taper Phase|Withdrawal by Subject|1|||
48373147|NCT01103362|155560974|FG000|Overall Study|study terminated|596|||
48373148|NCT00513604|155560975|FG000|Overall Study|Not treated|2|||
48373149|NCT00513604|155560976|FG001|Overall Study|Not treated|0|||
48373150|NCT00513604|155560977|FG002|Overall Study|Not treated|1|||
48373151|NCT00513604|155560978|FG003|Overall Study|Not treated|0|||
48373152|NCT00513604|155560979|FG004|Overall Study|Not treated|0|||
48373153|NCT00513604|155560975|FG000|Overall Study|Death during treatment|0|||
48373154|NCT00513604|155560976|FG001|Overall Study|Death during treatment|3|||
48373155|NCT00513604|155560977|FG002|Overall Study|Death during treatment|2|||
48373156|NCT00513604|155560978|FG003|Overall Study|Death during treatment|0|||
48373157|NCT00513604|155560979|FG004|Overall Study|Death during treatment|0|||
48373158|NCT01270971|155560988|FG000|Overall Study|Withdrawal by Subject|24|||
48373159|NCT01270971|155560989|FG001|Overall Study|Withdrawal by Subject|11|||
48373160|NCT01270971|155560988|FG000|Overall Study|Lost to Follow-up|18|||
48373161|NCT01270971|155560989|FG001|Overall Study|Lost to Follow-up|5|||
48373162|NCT01270971|155560988|FG000|Overall Study|Adverse Event|1|||
48373163|NCT01270971|155560989|FG001|Overall Study|Adverse Event|2|||
48373164|NCT01270971|155560988|FG000|Overall Study|Non compliance|2|||
48373165|NCT01270971|155560989|FG001|Overall Study|Non compliance|2|||
48373166|NCT01270971|155560988|FG000|Overall Study|Non-specific|7|||
48373167|NCT01270971|155560989|FG001|Overall Study|Non-specific|3|||
48373168|NCT00413972|155560990|FG000|Overall Study|Adverse Event|2|||
48373169|NCT00413972|155560991|FG001|Overall Study|Adverse Event|1|||
48373170|NCT00413972|155560992|FG002|Overall Study|Adverse Event|0|||
48373171|NCT00413972|155560993|FG003|Overall Study|Adverse Event|0|||
48373172|NCT00413972|155560990|FG000|Overall Study|Lost to Follow-up|1|||
48373173|NCT00413972|155560991|FG001|Overall Study|Lost to Follow-up|2|||
48373174|NCT00413972|155560992|FG002|Overall Study|Lost to Follow-up|1|||
48373175|NCT00413972|155560993|FG003|Overall Study|Lost to Follow-up|0|||
48373176|NCT00413972|155560990|FG000|Overall Study|Withdrawal by Subject|4|||
48373177|NCT00413972|155560991|FG001|Overall Study|Withdrawal by Subject|5|||
48373178|NCT00413972|155560992|FG002|Overall Study|Withdrawal by Subject|7|||
48373179|NCT00413972|155560993|FG003|Overall Study|Withdrawal by Subject|2|||
48373180|NCT00413972|155560990|FG000|Overall Study|Protocol Violation|0|||
48373181|NCT00413972|155560991|FG001|Overall Study|Protocol Violation|0|||
48373182|NCT00413972|155560992|FG002|Overall Study|Protocol Violation|2|||
48415077|NCT01309737|155707565|FG001|Week 16 to 52|Other|12|||
48373183|NCT00413972|155560993|FG003|Overall Study|Protocol Violation|0|||
48373184|NCT00413972|155560990|FG000|Overall Study|Other|0|||
48373185|NCT00413972|155560991|FG001|Overall Study|Other|0|||
48373186|NCT00413972|155560992|FG002|Overall Study|Other|0|||
48373187|NCT00413972|155560993|FG003|Overall Study|Other|1|||
48373188|NCT03170154|155560996|FG000|Overall Study|Lost to Follow-up|4|||
48373189|NCT03170154|155560996|FG000|Overall Study|Death|2|||
48373190|NCT03170154|155560996|FG000|Overall Study|Withdrawal by Subject|2|||
48373191|NCT05543187|155560997|FG000|Overall Study|Ongoing|3|||
48373192|NCT05543187|155560998|FG001|Overall Study|Ongoing|2|||
48373193|NCT03316300|155560999|FG000|Overall Study|Withdrawal by Subject|3|||
48373194|NCT03316300|155561000|FG001|Overall Study|Withdrawal by Subject|2|||
48373195|NCT03316300|155560999|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
48373196|NCT03316300|155561000|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
48373197|NCT03316300|155560999|FG000|Overall Study|Adverse Event|1|||
48373198|NCT03316300|155561000|FG001|Overall Study|Adverse Event|0|||
48373199|NCT03316300|155560999|FG000|Overall Study|COVID-19|0|||
48373200|NCT03316300|155561000|FG001|Overall Study|COVID-19|1|||
48415078|NCT01309737|155707566|FG002|Week 16 to 52|Other|0|||
48373201|NCT01411839|155561001|FG000|Overall Study|Lost to Follow-up|4|||
48373202|NCT01411839|155561002|FG001|Overall Study|Lost to Follow-up|3|||
48373203|NCT02146326|155561005|FG000|Overall Study|Lost to Follow-up|3|||
48373204|NCT02146326|155561006|FG001|Overall Study|Lost to Follow-up|3|||
48373205|NCT02146326|155561007|FG002|Overall Study|Lost to Follow-up|11|||
48373206|NCT02146326|155561008|FG003|Overall Study|Lost to Follow-up|19|||
48373207|NCT02146326|155561005|FG000|Overall Study|Withdrawal by Subject|2|||
48373208|NCT02146326|155561006|FG001|Overall Study|Withdrawal by Subject|1|||
48373209|NCT02146326|155561007|FG002|Overall Study|Withdrawal by Subject|15|||
48373210|NCT02146326|155561008|FG003|Overall Study|Withdrawal by Subject|11|||
48373211|NCT02146326|155561005|FG000|Overall Study|Separated from mental health center|23|||
48373212|NCT02146326|155561006|FG001|Overall Study|Separated from mental health center|33|||
48373213|NCT02146326|155561007|FG002|Overall Study|Separated from mental health center|0|||
48373214|NCT02146326|155561008|FG003|Overall Study|Separated from mental health center|0|||
48373215|NCT02146326|155561005|FG000|Overall Study|Incarcerated|0|||
48373216|NCT02146326|155561006|FG001|Overall Study|Incarcerated|0|||
48373217|NCT02146326|155561007|FG002|Overall Study|Incarcerated|3|||
48373218|NCT02146326|155561008|FG003|Overall Study|Incarcerated|8|||
48373219|NCT02146326|155561005|FG000|Overall Study|Death|0|||
48373220|NCT02146326|155561006|FG001|Overall Study|Death|0|||
48373221|NCT02146326|155561007|FG002|Overall Study|Death|4|||
48373222|NCT02146326|155561008|FG003|Overall Study|Death|4|||
48373223|NCT02146326|155561005|FG000|Overall Study|Unable to complete interview|0|||
48373224|NCT02146326|155561006|FG001|Overall Study|Unable to complete interview|0|||
48373225|NCT02146326|155561007|FG002|Overall Study|Unable to complete interview|10|||
48373226|NCT02146326|155561008|FG003|Overall Study|Unable to complete interview|6|||
48373227|NCT00081497|155561011|FG000|Overall Study|Adverse Event|2|||
48373228|NCT00081497|155561012|FG001|Overall Study|Adverse Event|0|||
48373229|NCT00081497|155561011|FG000|Overall Study|Death|0|||
48373230|NCT00081497|155561012|FG001|Overall Study|Death|1|||
48373231|NCT00081497|155561011|FG000|Overall Study|Withdrawal by Subject|1|||
48373232|NCT00081497|155561012|FG001|Overall Study|Withdrawal by Subject|0|||
48373233|NCT00081497|155561011|FG000|Overall Study|Non-compliance|0|||
48373234|NCT00081497|155561012|FG001|Overall Study|Non-compliance|1|||
48373235|NCT01439360|155561013|FG000|Overall Study|Adverse Event|4|||
48373236|NCT01439360|155561014|FG001|Overall Study|Adverse Event|16|||
48373237|NCT01439360|155561013|FG000|Overall Study|Lost to Follow-up|43|||
48373238|NCT01439360|155561014|FG001|Overall Study|Lost to Follow-up|58|||
48373239|NCT01439360|155561013|FG000|Overall Study|Others|10|||
48373240|NCT01439360|155561014|FG001|Overall Study|Others|5|||
48373241|NCT01439360|155561013|FG000|Overall Study|Protocol Violation|1|||
48373242|NCT01439360|155561014|FG001|Overall Study|Protocol Violation|0|||
48373243|NCT01439360|155561013|FG000|Overall Study|Withdrawal by Subject|140|||
48373244|NCT01439360|155561014|FG001|Overall Study|Withdrawal by Subject|129|||
48373245|NCT01598311|155561015|FG000|Overall Study|Physician Decision|4|||
48373246|NCT01598311|155561016|FG001|Overall Study|Physician Decision|5|||
48373247|NCT01598311|155561015|FG000|Overall Study|Adverse Event|9|||
48373248|NCT01598311|155561016|FG001|Overall Study|Adverse Event|13|||
48373249|NCT01598311|155561015|FG000|Overall Study|Lost to Follow-up|7|||
48373250|NCT01598311|155561016|FG001|Overall Study|Lost to Follow-up|12|||
48373251|NCT01598311|155561015|FG000|Overall Study|Withdrawal by Subject|9|||
48373252|NCT01598311|155561016|FG001|Overall Study|Withdrawal by Subject|13|||
48373253|NCT01598311|155561015|FG000|Overall Study|No reason provided.|0|||
48373254|NCT01598311|155561016|FG001|Overall Study|No reason provided.|5|||
48373255|NCT01598311|155561015|FG000|Overall Study|Randomized but never treated|8|||
48373256|NCT01598311|155561016|FG001|Overall Study|Randomized but never treated|5|||
48373257|NCT01598311|155561015|FG000|Overall Study|Treated but no confirmed CDAD|9|||
48373258|NCT01598311|155561016|FG001|Overall Study|Treated but no confirmed CDAD|8|||
48373259|NCT01598311|155561015|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
48373260|NCT01598311|155561016|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
48373261|NCT00658684|155561018|FG000|Overall Study|Adverse Event|10|||
48373262|NCT00658684|155561019|FG001|Overall Study|Adverse Event|8|||
48373263|NCT00658684|155561020|FG002|Overall Study|Adverse Event|2|||
48373264|NCT00658684|155561021|FG003|Overall Study|Adverse Event|0|||
48373265|NCT00658684|155561018|FG000|Overall Study|Withdrawal by Subject|6|||
48373266|NCT00658684|155561019|FG001|Overall Study|Withdrawal by Subject|4|||
48373267|NCT00658684|155561020|FG002|Overall Study|Withdrawal by Subject|1|||
48373268|NCT00658684|155561021|FG003|Overall Study|Withdrawal by Subject|1|||
48373269|NCT00658684|155561018|FG000|Overall Study|Lack of Efficacy|1|||
48373270|NCT00658684|155561019|FG001|Overall Study|Lack of Efficacy|1|||
48373271|NCT00658684|155561020|FG002|Overall Study|Lack of Efficacy|0|||
48373272|NCT00658684|155561021|FG003|Overall Study|Lack of Efficacy|0|||
48373273|NCT00658684|155561018|FG000|Overall Study|Protocol Violation|1|||
48373274|NCT00658684|155561019|FG001|Overall Study|Protocol Violation|1|||
48373275|NCT00658684|155561020|FG002|Overall Study|Protocol Violation|0|||
48373276|NCT00658684|155561021|FG003|Overall Study|Protocol Violation|0|||
48373277|NCT00658684|155561018|FG000|Overall Study|Pregnancy|1|||
48373278|NCT00658684|155561019|FG001|Overall Study|Pregnancy|1|||
48373279|NCT00658684|155561020|FG002|Overall Study|Pregnancy|0|||
48373280|NCT00658684|155561021|FG003|Overall Study|Pregnancy|0|||
48373281|NCT00688103|155561022|FG000|Overall Study|Adverse Event|4|||
48373282|NCT00688103|155561023|FG001|Overall Study|Adverse Event|1|||
48373283|NCT00688103|155561022|FG000|Overall Study|Lack of Efficacy|11|||
48373284|NCT00688103|155561023|FG001|Overall Study|Lack of Efficacy|1|||
48373285|NCT00688103|155561022|FG000|Overall Study|Withdrawal by Subject|4|||
48373286|NCT00688103|155561023|FG001|Overall Study|Withdrawal by Subject|2|||
48373287|NCT00688103|155561022|FG000|Overall Study|complex reasons|11|||
48373288|NCT00688103|155561023|FG001|Overall Study|complex reasons|9|||
48373289|NCT03727438|155561027|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
48373290|NCT03727438|155561028|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
48373291|NCT03727438|155561027|FG000|Intervention Period|Excluded (health)|1|||
48373292|NCT03727438|155561028|FG001|Intervention Period|Excluded (health)|0|||
48373293|NCT03727438|155561027|FG000|Intervention Period|Withdrawal by Subject|3|||
48373294|NCT03727438|155561028|FG001|Intervention Period|Withdrawal by Subject|1|||
48373295|NCT03727438|155561027|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
48373296|NCT03727438|155561028|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
48373297|NCT03727438|155561027|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
48373298|NCT03727438|155561028|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
48373299|NCT03727438|155561027|FG000|8 Week Assessment|Withdrawal by Subject|6|||
48373300|NCT03727438|155561028|FG001|8 Week Assessment|Withdrawal by Subject|1|||
48373301|NCT03727438|155561027|FG000|6 mo Assessment|did not complete assessment|10|||
48373302|NCT03727438|155561028|FG001|6 mo Assessment|did not complete assessment|11|||
48373303|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
48373304|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
48373305|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
48373306|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
48373307|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
48373308|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
48373309|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
48373310|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48373311|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48373312|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48373313|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48373314|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
48373315|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Death|1|||
48373316|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Death|2|||
48373317|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Death|2|||
48373318|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Death|0|||
48373319|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Death|0|||
48373320|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Death|0|||
48373321|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
48373322|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
48373323|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
48373324|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
48373325|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
48373326|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
48373327|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
48373328|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48373329|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48373330|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48373331|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48373332|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
48373333|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
48373334|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48373335|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48373336|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48373337|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48373338|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
48373339|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
48373340|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48373341|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48373342|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48373343|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48373344|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
48373345|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48373346|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
48373347|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48373348|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48373349|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48373350|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
48373351|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
48373352|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
48373353|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
48373354|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
48373355|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
48373356|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
48373357|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48373358|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48373359|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
48373360|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48373361|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48373362|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
48373363|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Site closure|0|||
48373364|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Site closure|0|||
48373365|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Site closure|1|||
48373366|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Site closure|0|||
48373367|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Site closure|0|||
48373368|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Site closure|0|||
48373369|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
48373370|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
48373371|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
48373372|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
48373373|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
48373374|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
48373375|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
48373376|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
48373377|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
48373378|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
48373379|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
48373380|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
48373381|NCT03439254|155562679|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
48373382|NCT03439254|155562680|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
48373383|NCT03439254|155562681|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
48373384|NCT03439254|155562682|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
48373385|NCT03439254|155562683|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
48373386|NCT03439254|155562684|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
48373387|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
48373388|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
48373389|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
48373390|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
48373391|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
48373392|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
48373393|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
48373394|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
48373395|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
48373396|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
48373397|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
48373398|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
48373399|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48373400|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48373401|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48373402|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48373403|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
48373404|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
48373405|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48373406|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48373407|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48373408|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48373409|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
48415079|NCT01309737|155707567|FG003|Week 16 to 52|Other|2|||
48373410|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
48373411|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48373412|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48373413|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48373414|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48373415|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
48373416|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
48373417|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48373418|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48373419|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48373420|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48373421|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
48373422|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
48373423|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48373424|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48373425|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48373426|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
48373427|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48373428|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
48373429|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
48373430|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
48373431|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
48373432|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
48373433|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
48373434|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
48373435|NCT03439254|155562679|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
48373436|NCT03439254|155562680|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
48373437|NCT03439254|155562681|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
48373438|NCT03439254|155562682|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
48373439|NCT03439254|155562683|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
48373440|NCT03439254|155562684|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
48373441|NCT02217332|155562687|FG000|Overall Study|Adverse Event|3|||
48373442|NCT02217332|155562687|FG000|Overall Study|Dose interruption >1 month|1|||
48373443|NCT02217332|155562687|FG000|Overall Study|Protocol Violation (eligibility)|1|||
48373444|NCT02217332|155562687|FG000|Overall Study|Withdrawal by Subject|1|||
48373445|NCT02217332|155562687|FG000|Overall Study|Lost to Follow-up|1|||
48373446|NCT01022268|155562688|FG000|Overall Study|Withdrawal by Subject|1|||
48373447|NCT01022268|155562689|FG001|Overall Study|Withdrawal by Subject|0|||
48373448|NCT01022268|155562688|FG000|Overall Study|Withdrawal by Subject|1|||
48373449|NCT01022268|155562689|FG001|Overall Study|Withdrawal by Subject|0|||
48373450|NCT03938545|155562690|FG000|Overall Study|Lost to Follow-up|0|||
48373451|NCT03938545|155562691|FG001|Overall Study|Lost to Follow-up|0|||
48373452|NCT03938545|155562692|FG002|Overall Study|Lost to Follow-up|0|||
48373453|NCT03938545|155562693|FG003|Overall Study|Lost to Follow-up|1|||
48373454|NCT03938545|155562690|FG000|Overall Study|Non-compliance with study drug|0|||
48373455|NCT03938545|155562691|FG001|Overall Study|Non-compliance with study drug|0|||
48373456|NCT03938545|155562692|FG002|Overall Study|Non-compliance with study drug|1|||
48373457|NCT03938545|155562693|FG003|Overall Study|Non-compliance with study drug|0|||
48373458|NCT03938545|155562690|FG000|Overall Study|Pregnancy|1|||
48373459|NCT03938545|155562691|FG001|Overall Study|Pregnancy|0|||
48373460|NCT03938545|155562692|FG002|Overall Study|Pregnancy|0|||
48373461|NCT03938545|155562693|FG003|Overall Study|Pregnancy|0|||
48373462|NCT03938545|155562690|FG000|Overall Study|Study terminated by sponsor|6|||
48373463|NCT03938545|155562691|FG001|Overall Study|Study terminated by sponsor|4|||
48373464|NCT03938545|155562692|FG002|Overall Study|Study terminated by sponsor|2|||
48373465|NCT03938545|155562693|FG003|Overall Study|Study terminated by sponsor|4|||
48373466|NCT03938545|155562690|FG000|Overall Study|Withdrawal by Subject|0|||
48373467|NCT03938545|155562691|FG001|Overall Study|Withdrawal by Subject|1|||
48373468|NCT03938545|155562692|FG002|Overall Study|Withdrawal by Subject|0|||
48373469|NCT03938545|155562693|FG003|Overall Study|Withdrawal by Subject|0|||
48373470|NCT03938545|155562690|FG000|Overall Study|Adverse Event|1|||
48373471|NCT03938545|155562691|FG001|Overall Study|Adverse Event|0|||
48373472|NCT03938545|155562692|FG002|Overall Study|Adverse Event|0|||
48373473|NCT03938545|155562693|FG003|Overall Study|Adverse Event|0|||
48373474|NCT00816400|155562694|FG000|Overall Study|Death|2|||
48373475|NCT00816400|155562695|FG001|Overall Study|Death|3|||
48373476|NCT00816400|155562696|FG002|Overall Study|Death|3|||
48373477|NCT00816400|155562697|FG003|Overall Study|Death|3|||
48373478|NCT00816400|155562698|FG004|Overall Study|Death|2|||
48373479|NCT00816400|155562699|FG005|Overall Study|Death|3|||
48373480|NCT00816400|155562700|FG006|Overall Study|Death|2|||
48373481|NCT00816400|155562701|FG007|Overall Study|Death|5|||
48373482|NCT00816400|155562702|FG008|Overall Study|Death|6|||
48373483|NCT00816400|155562694|FG000|Overall Study|In hospice care at the end of the study|0|||
48373484|NCT00816400|155562695|FG001|Overall Study|In hospice care at the end of the study|0|||
48373485|NCT00816400|155562696|FG002|Overall Study|In hospice care at the end of the study|2|||
48373486|NCT00816400|155562697|FG003|Overall Study|In hospice care at the end of the study|0|||
48373487|NCT00816400|155562698|FG004|Overall Study|In hospice care at the end of the study|0|||
48373488|NCT00816400|155562699|FG005|Overall Study|In hospice care at the end of the study|0|||
48373489|NCT00816400|155562700|FG006|Overall Study|In hospice care at the end of the study|0|||
48373490|NCT00816400|155562701|FG007|Overall Study|In hospice care at the end of the study|0|||
48373491|NCT00816400|155562702|FG008|Overall Study|In hospice care at the end of the study|0|||
48373492|NCT02401867|155562703|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
48373493|NCT02401867|155562703|FG000|Analysis|Cervical assay could not be conducted|9|||
48373494|NCT01386788|155562704|FG000|Overall Study|Lost to Follow-up|2|||
48373495|NCT00156819|155562705|FG000|Overall Study|Lost to Follow-up|1|||
48373496|NCT00156819|155562706|FG001|Overall Study|Lost to Follow-up|1|||
48373497|NCT00156819|155562707|FG002|Overall Study|Lost to Follow-up|3|||
48373498|NCT01689337|155562708|FG000|Overall Study|Study Discontinuation|1|||
48373499|NCT00642772|155562709|FG000|Overall Study|Lost to Follow-up|3|||
48373500|NCT00642772|155562709|FG000|Overall Study|Withdrawal by Subject|7|||
48373501|NCT00321373|155562711|FG000|Overall Study|Adverse Event|0|||
48373502|NCT00321373|155562712|FG001|Overall Study|Adverse Event|0|||
48373503|NCT00321373|155562713|FG002|Overall Study|Adverse Event|1|||
48373504|NCT00321373|155562711|FG000|Overall Study|Lost to Follow-up|1|||
48373505|NCT00321373|155562712|FG001|Overall Study|Lost to Follow-up|0|||
48373506|NCT00321373|155562713|FG002|Overall Study|Lost to Follow-up|1|||
48373507|NCT00321373|155562711|FG000|Overall Study|Withdrawal by Subject|1|||
48373508|NCT00321373|155562712|FG001|Overall Study|Withdrawal by Subject|0|||
48373509|NCT00321373|155562713|FG002|Overall Study|Withdrawal by Subject|0|||
48373510|NCT00321373|155562711|FG000|Overall Study|Other|0|||
48373511|NCT00321373|155562712|FG001|Overall Study|Other|0|||
48373512|NCT00321373|155562713|FG002|Overall Study|Other|1|||
48373513|NCT00918580|155562714|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
48373514|NCT00918580|155562714|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
48373515|NCT00918580|155562714|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
48373516|NCT00918580|155562714|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
48373517|NCT00918580|155562714|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
48373518|NCT00918580|155562714|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
48373519|NCT00918580|155562714|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
48373520|NCT04447846|155562715|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
48373521|NCT02292927|155562718|FG000|Overall Study|Protocol Violation|13|||
48373522|NCT02292927|155562719|FG001|Overall Study|Protocol Violation|7|||
48373523|NCT00211185|155562720|FG000|Overall Study|Death|2|||
48373524|NCT00211185|155562720|FG000|Overall Study|Disease progression|7|||
48373525|NCT00211185|155562720|FG000|Overall Study|Withdrawal by Subject|6|||
48373526|NCT00211185|155562720|FG000|Overall Study|Physician Decision|5|||
48373527|NCT03625895|155562721|FG000|Overall Study|Protocol Violation|585|||
48373528|NCT00552240|155562722|FG000|Overall Study|Adverse Event|9|||
48373529|NCT00552240|155562723|FG001|Overall Study|Adverse Event|9|||
48373530|NCT00552240|155562722|FG000|Overall Study|Protocol Violation|1|||
48373531|NCT00552240|155562723|FG001|Overall Study|Protocol Violation|1|||
48373532|NCT00552240|155562722|FG000|Overall Study|Lost to Follow-up|5|||
48373533|NCT00552240|155562723|FG001|Overall Study|Lost to Follow-up|6|||
48373534|NCT00552240|155562722|FG000|Overall Study|Withdrawal by Subject|2|||
48373535|NCT00552240|155562723|FG001|Overall Study|Withdrawal by Subject|2|||
48373536|NCT00552240|155562722|FG000|Overall Study|Lack of Efficacy|6|||
48373537|NCT00552240|155562723|FG001|Overall Study|Lack of Efficacy|0|||
48373538|NCT00552240|155562722|FG000|Overall Study|Other|1|||
48373539|NCT00552240|155562723|FG001|Overall Study|Other|0|||
48373540|NCT02679573|155562727|FG000|Overall Study|Adverse Event|13|||
48373541|NCT02679573|155562728|FG001|Overall Study|Adverse Event|6|||
48373542|NCT02679573|155562727|FG000|Overall Study|Lack of Efficacy|12|||
48373543|NCT02679573|155562728|FG001|Overall Study|Lack of Efficacy|15|||
48373544|NCT02679573|155562727|FG000|Overall Study|Could not complete required study visits|6|||
48373545|NCT02679573|155562728|FG001|Overall Study|Could not complete required study visits|2|||
48373546|NCT02679573|155562727|FG000|Overall Study|Withdrawal by Subject|2|||
48373547|NCT02679573|155562728|FG001|Overall Study|Withdrawal by Subject|9|||
48373548|NCT02679573|155562727|FG000|Overall Study|Death|2|||
48373549|NCT02679573|155562728|FG001|Overall Study|Death|0|||
48373550|NCT02679573|155562727|FG000|Overall Study|Physician Decision|2|||
48373551|NCT02679573|155562728|FG001|Overall Study|Physician Decision|4|||
48373552|NCT02679573|155562727|FG000|Overall Study|Lost to Follow-up|0|||
48373553|NCT02679573|155562728|FG001|Overall Study|Lost to Follow-up|3|||
48373554|NCT00986674|155562729|FG000|Overall Study|Lack of Efficacy|28|||
48373555|NCT00986674|155562730|FG001|Overall Study|Lack of Efficacy|25|||
48373556|NCT00986674|155562731|FG002|Overall Study|Lack of Efficacy|23|||
48373557|NCT00986674|155562729|FG000|Overall Study|Adverse Event|4|||
48373558|NCT00986674|155562730|FG001|Overall Study|Adverse Event|8|||
48373559|NCT00986674|155562731|FG002|Overall Study|Adverse Event|9|||
48373560|NCT00986674|155562729|FG000|Overall Study|Death|5|||
48373561|NCT00986674|155562730|FG001|Overall Study|Death|0|||
48373562|NCT00986674|155562731|FG002|Overall Study|Death|4|||
48373563|NCT00986674|155562729|FG000|Overall Study|Withdrawal by Subject|6|||
48373564|NCT00986674|155562730|FG001|Overall Study|Withdrawal by Subject|2|||
48373565|NCT00986674|155562731|FG002|Overall Study|Withdrawal by Subject|1|||
48373566|NCT00986674|155562729|FG000|Overall Study|alternative therapy|0|||
48373567|NCT00986674|155562730|FG001|Overall Study|alternative therapy|0|||
48373568|NCT00986674|155562731|FG002|Overall Study|alternative therapy|1|||
48373569|NCT00986674|155562729|FG000|Overall Study|not start protocol therapy|4|||
48373570|NCT00986674|155562730|FG001|Overall Study|not start protocol therapy|3|||
48373571|NCT00986674|155562731|FG002|Overall Study|not start protocol therapy|1|||
48373572|NCT00986674|155562729|FG000|Overall Study|unknown/not specify|0|||
48373573|NCT00986674|155562730|FG001|Overall Study|unknown/not specify|7|||
48373574|NCT00986674|155562731|FG002|Overall Study|unknown/not specify|9|||
48373575|NCT00394082|155562732|FG000|Overall Study|Unacceptable toxicity|15|||
48373576|NCT00394082|155562732|FG000|Overall Study|Adverse Event|4|||
48373577|NCT00394082|155562732|FG000|Overall Study|Physician Decision|4|||
48373578|NCT00394082|155562732|FG000|Overall Study|Withdrawal by Subject|2|||
48373579|NCT00394082|155562732|FG000|Overall Study|Other|1|||
48373580|NCT01801735|155562733|FG000|Overall Study|Adverse Event|79|||
48373581|NCT01801735|155562733|FG000|Overall Study|Lack of Efficacy|28|||
48373582|NCT01801735|155562733|FG000|Overall Study|Withdrawal by Subject|27|||
48373583|NCT01801735|155562733|FG000|Overall Study|Protocol Violation|25|||
48373584|NCT01801735|155562733|FG000|Overall Study|Lost to Follow-up|15|||
48373585|NCT01801735|155562733|FG000|Overall Study|Non-compliance with Trial Drug|13|||
48373586|NCT01801735|155562733|FG000|Overall Study|Physician Decision|3|||
48373587|NCT01801735|155562733|FG000|Overall Study|Death|1|||
48373588|NCT01801735|155562733|FG000|Overall Study|Other, including site closure|19|||
48373589|NCT02344004|155562734|FG000|Overall Study|Adverse Event|11|||
48373590|NCT02344004|155562735|FG001|Overall Study|Adverse Event|1|||
48373591|NCT02344004|155562734|FG000|Overall Study|Death|9|||
48373592|NCT02344004|155562735|FG001|Overall Study|Death|7|||
48373593|NCT02344004|155562734|FG000|Overall Study|Physician Decision|4|||
48373594|NCT02344004|155562735|FG001|Overall Study|Physician Decision|1|||
48373595|NCT02344004|155562734|FG000|Overall Study|Withdrawal by Subject|22|||
48373596|NCT02344004|155562735|FG001|Overall Study|Withdrawal by Subject|5|||
48373597|NCT02344004|155562734|FG000|Overall Study|Rescue Medication|2|||
48373598|NCT02344004|155562735|FG001|Overall Study|Rescue Medication|0|||
48373599|NCT02344004|155562734|FG000|Overall Study|Other Not Specified|12|||
48373600|NCT02344004|155562735|FG001|Overall Study|Other Not Specified|0|||
48373601|NCT02344004|155562734|FG000|Overall Study|Protocol Violation|1|||
48373602|NCT02344004|155562735|FG001|Overall Study|Protocol Violation|0|||
48373603|NCT01768117|155562736|FG000|Overall Study|Lost to Follow-up|1|||
48373604|NCT01768117|155562736|FG000|Overall Study|Withdrawal by Subject|2|||
48373605|NCT01768117|155562736|FG000|Overall Study|Protocol Violation|3|||
48373606|NCT02070588|155562737|FG000|Overall Study|Withdrawal by Subject|29|||
48373607|NCT02070588|155562738|FG001|Overall Study|Withdrawal by Subject|1|||
48373608|NCT02070588|155562739|FG002|Overall Study|Withdrawal by Subject|0|||
48373609|NCT02070588|155562737|FG000|Overall Study|Writhdrawal due to early termination|9|||
48373610|NCT02070588|155562738|FG001|Overall Study|Writhdrawal due to early termination|0|||
48373611|NCT02070588|155562739|FG002|Overall Study|Writhdrawal due to early termination|0|||
48373612|NCT02070588|155562737|FG000|Overall Study|Adverse Event|1|||
48373613|NCT02070588|155562738|FG001|Overall Study|Adverse Event|0|||
48373614|NCT02070588|155562739|FG002|Overall Study|Adverse Event|0|||
48373615|NCT00836095|155562740|FG000|Overall Study|Physician Decision|0|||
48373616|NCT00836095|155562741|FG001|Overall Study|Physician Decision|3|||
48373617|NCT01602562|155562742|FG000|Overall Study|Adverse Event|3|||
48373618|NCT01602562|155562743|FG001|Overall Study|Adverse Event|1|||
48373619|NCT01602562|155562742|FG000|Overall Study|Physician Decision|1|||
48373620|NCT01602562|155562743|FG001|Overall Study|Physician Decision|1|||
48373621|NCT01602562|155562742|FG000|Overall Study|Withdrawal by Subject|1|||
48373622|NCT01602562|155562743|FG001|Overall Study|Withdrawal by Subject|1|||
48373623|NCT01718353|155562744|FG000|Overall Study|Lost to Follow-up|0|||
48373624|NCT01718353|155562745|FG001|Overall Study|Lost to Follow-up|1|||
48373625|NCT01718353|155562744|FG000|Overall Study|Principal Investigator's Decision|10|||
48373626|NCT01718353|155562745|FG001|Overall Study|Principal Investigator's Decision|4|||
48373627|NCT01718353|155562744|FG000|Overall Study|Randomized but not treated|2|||
48373628|NCT01718353|155562745|FG001|Overall Study|Randomized but not treated|0|||
48373629|NCT00190749|155562754|FG000|Overall Study|Lost to Follow-up|8|||
48373630|NCT00190749|155562755|FG001|Overall Study|Lost to Follow-up|11|||
48373631|NCT00190749|155562754|FG000|Overall Study|Withdrawal by Subject|10|||
48373632|NCT00190749|155562755|FG001|Overall Study|Withdrawal by Subject|6|||
48373633|NCT00190749|155562754|FG000|Overall Study|Protocol Violation|5|||
48373634|NCT00190749|155562755|FG001|Overall Study|Protocol Violation|4|||
48373635|NCT00190749|155562754|FG000|Overall Study|Adverse Event|0|||
48373636|NCT00190749|155562755|FG001|Overall Study|Adverse Event|5|||
48373637|NCT00190749|155562754|FG000|Overall Study|Lack of Efficacy|2|||
48373638|NCT00190749|155562755|FG001|Overall Study|Lack of Efficacy|3|||
48373639|NCT00190749|155562754|FG000|Overall Study|Reason Not Specified|0|||
48373640|NCT00190749|155562755|FG001|Overall Study|Reason Not Specified|2|||
48373641|NCT00190749|155562754|FG000|Overall Study|Sponsor Decision|1|||
48373642|NCT00190749|155562755|FG001|Overall Study|Sponsor Decision|0|||
48373643|NCT01090427|155562756|FG000|After Controlled Period|Death|0|||
48373644|NCT01090427|155562757|FG001|After Controlled Period|Death|0|||
48373645|NCT01090427|155562758|FG002|After Controlled Period|Death|0|||
48373646|NCT01090427|155562759|FG003|After Controlled Period|Death|0|||
48373647|NCT01090427|155562760|FG004|After Controlled Period|Death|0|||
48373648|NCT01090427|155562761|FG005|After Controlled Period|Death|1|||
48373649|NCT01090427|155562762|FG006|After Controlled Period|Death|0|||
48373650|NCT01090427|155562756|FG000|After Controlled Period|Lack of Efficacy|0|||
48373651|NCT01090427|155562757|FG001|After Controlled Period|Lack of Efficacy|0|||
48373652|NCT01090427|155562758|FG002|After Controlled Period|Lack of Efficacy|0|||
48373653|NCT01090427|155562759|FG003|After Controlled Period|Lack of Efficacy|0|||
48373654|NCT01090427|155562760|FG004|After Controlled Period|Lack of Efficacy|0|||
48373655|NCT01090427|155562761|FG005|After Controlled Period|Lack of Efficacy|3|||
48373656|NCT01090427|155562762|FG006|After Controlled Period|Lack of Efficacy|2|||
48373657|NCT01090427|155562756|FG000|After Controlled Period|Adverse Event|0|||
48373658|NCT01090427|155562757|FG001|After Controlled Period|Adverse Event|0|||
48373659|NCT01090427|155562758|FG002|After Controlled Period|Adverse Event|0|||
48373660|NCT01090427|155562759|FG003|After Controlled Period|Adverse Event|2|||
48373661|NCT01090427|155562760|FG004|After Controlled Period|Adverse Event|0|||
48373662|NCT01090427|155562761|FG005|After Controlled Period|Adverse Event|1|||
48373663|NCT01090427|155562762|FG006|After Controlled Period|Adverse Event|0|||
48373664|NCT01154010|155562763|FG000|Overall Study|Lost to Follow-up|0|||
48373665|NCT01154010|155562764|FG001|Overall Study|Lost to Follow-up|1|||
48373666|NCT01959334|155562767|FG000|Second Dose|Adverse Event|1|||
48373667|NCT01959334|155562768|FG001|Second Dose|Adverse Event|0|||
48373668|NCT01959334|155562767|FG000|Third Dose|Adverse Event|0|||
48373669|NCT01959334|155562768|FG001|Third Dose|Adverse Event|1|||
48373670|NCT01465347|155562771|FG000|Overall Study|Withdrawal by Subject|1|||
48373671|NCT01465347|155562772|FG001|Overall Study|Withdrawal by Subject|1|||
48373672|NCT01465347|155562771|FG000|Overall Study|Physician Decision|0|||
48373673|NCT01465347|155562772|FG001|Overall Study|Physician Decision|1|||
48373674|NCT01465347|155562771|FG000|Overall Study|Admitted to hospice|0|||
48373675|NCT01465347|155562772|FG001|Overall Study|Admitted to hospice|1|||
48373676|NCT01048671|155562773|FG000|Overall Study|Protocol Violation|0|||
48373677|NCT01048671|155562774|FG001|Overall Study|Protocol Violation|1|||
48373678|NCT01048671|155562775|FG002|Overall Study|Protocol Violation|1|||
48373679|NCT05249829|155562776|FG000|Overall Study|Participant Relocation|0|||
48373680|NCT05249829|155562777|FG001|Overall Study|Participant Relocation|1|||
48373681|NCT05249829|155562778|FG002|Overall Study|Participant Relocation|2|||
48373682|NCT05249829|155562779|FG003|Overall Study|Participant Relocation|2|||
48373683|NCT05249829|155562776|FG000|Overall Study|Withdrawal by Subject|9|||
48373684|NCT05249829|155562777|FG001|Overall Study|Withdrawal by Subject|17|||
48373685|NCT05249829|155562778|FG002|Overall Study|Withdrawal by Subject|40|||
48373686|NCT05249829|155562779|FG003|Overall Study|Withdrawal by Subject|35|||
48373687|NCT05249829|155562776|FG000|Overall Study|Physician Decision|1|||
48373688|NCT05249829|155562777|FG001|Overall Study|Physician Decision|0|||
48373689|NCT05249829|155562778|FG002|Overall Study|Physician Decision|0|||
48373690|NCT05249829|155562779|FG003|Overall Study|Physician Decision|0|||
48373691|NCT05249829|155562776|FG000|Overall Study|Lost to Follow-up|16|||
48373692|NCT05249829|155562777|FG001|Overall Study|Lost to Follow-up|16|||
48373693|NCT05249829|155562778|FG002|Overall Study|Lost to Follow-up|57|||
48373694|NCT05249829|155562779|FG003|Overall Study|Lost to Follow-up|60|||
48373695|NCT05249829|155562776|FG000|Overall Study|Adverse Event|2|||
48373696|NCT05249829|155562777|FG001|Overall Study|Adverse Event|2|||
48373697|NCT05249829|155562778|FG002|Overall Study|Adverse Event|2|||
48373698|NCT05249829|155562779|FG003|Overall Study|Adverse Event|2|||
48373699|NCT05249829|155562776|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
48373700|NCT05249829|155562777|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
48373701|NCT05249829|155562778|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
48373702|NCT05249829|155562779|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
48373703|NCT05249829|155562776|FG000|Overall Study|Protocol Violation|2|||
48373704|NCT05249829|155562777|FG001|Overall Study|Protocol Violation|0|||
48373705|NCT05249829|155562778|FG002|Overall Study|Protocol Violation|5|||
48373706|NCT05249829|155562779|FG003|Overall Study|Protocol Violation|3|||
48373707|NCT05249829|155562776|FG000|Overall Study|Death|0|||
48373708|NCT05249829|155562777|FG001|Overall Study|Death|1|||
48373709|NCT05249829|155562778|FG002|Overall Study|Death|2|||
48373710|NCT05249829|155562779|FG003|Overall Study|Death|4|||
48373711|NCT02649946|155562780|FG000|Overall Study|Withdrawal by Subject|1|||
48373712|NCT02649946|155562781|FG001|Overall Study|Withdrawal by Subject|1|||
48373713|NCT02649946|155562780|FG000|Overall Study|Death|7|||
48373714|NCT02649946|155562781|FG001|Overall Study|Death|9|||
48373715|NCT02649946|155562780|FG000|Overall Study|Physician Decision|1|||
48373716|NCT02649946|155562781|FG001|Overall Study|Physician Decision|0|||
48373717|NCT02649946|155562780|FG000|Overall Study|Lost to Follow-up|2|||
48373718|NCT02649946|155562781|FG001|Overall Study|Lost to Follow-up|1|||
48373719|NCT02649946|155562780|FG000|Overall Study|Erroneously enrolled|1|||
48373720|NCT02649946|155562781|FG001|Overall Study|Erroneously enrolled|0|||
48373721|NCT02649946|155562780|FG000|Overall Study|Missed 6-month follow-up visit|0|||
48373722|NCT02649946|155562781|FG001|Overall Study|Missed 6-month follow-up visit|4|||
48373723|NCT02571049|155562782|FG000|Screening|Did not meet entry criteria|2|||
48373724|NCT02571049|155562783|FG001|Screening|Did not meet entry criteria|2|||
48373725|NCT02571049|155562782|FG000|Randomization|No migraine attack|0|||
48373726|NCT02571049|155562783|FG001|Randomization|No migraine attack|1|||
48373727|NCT02571049|155562782|FG000|Randomization|Adverse Event|0|||
48373728|NCT02571049|155562783|FG001|Randomization|Adverse Event|1|||
48373729|NCT04161495|155562784|FG000|Overall Study|Withdrawal by Subject|3|||
48373730|NCT04161495|155562785|FG001|Overall Study|Withdrawal by Subject|0|||
48373731|NCT04161495|155562784|FG000|Overall Study|Protocol Violation|1|||
48373732|NCT04161495|155562785|FG001|Overall Study|Protocol Violation|0|||
48373733|NCT04161495|155562784|FG000|Overall Study|Prohibited concomitant medication|3|||
48373734|NCT04161495|155562785|FG001|Overall Study|Prohibited concomitant medication|0|||
48373735|NCT04161495|155562784|FG000|Overall Study|Adverse Event|1|||
48373736|NCT04161495|155562785|FG001|Overall Study|Adverse Event|0|||
48373737|NCT04161495|155562784|FG000|Overall Study|Other - Unspecified|1|||
48373738|NCT04161495|155562785|FG001|Overall Study|Other - Unspecified|0|||
48373739|NCT04161495|155562784|FG000|Overall Study|Death|0|||
48373740|NCT04161495|155562785|FG001|Overall Study|Death|1|||
48373741|NCT01536015|155562786|FG000|Overall Study|Adverse Event|1|||
48373742|NCT01536015|155562787|FG001|Overall Study|Adverse Event|4|||
48373743|NCT01536015|155562786|FG000|Overall Study|Lost to Follow-up|0|||
48373744|NCT01536015|155562787|FG001|Overall Study|Lost to Follow-up|1|||
48373745|NCT01536015|155562786|FG000|Overall Study|Inclusion Criterion not met|2|||
48373746|NCT01536015|155562787|FG001|Overall Study|Inclusion Criterion not met|0|||
48373747|NCT01536015|155562786|FG000|Overall Study|Study closure|5|||
48373748|NCT01536015|155562787|FG001|Overall Study|Study closure|5|||
48373749|NCT02988622|155562788|FG000|Overall Study|Lost to Follow-up|17|||
48373750|NCT03562247|155562789|FG000|Overall Study|Lost to Follow-up|3|||
48373751|NCT03562247|155562790|FG001|Overall Study|Lost to Follow-up|1|||
48373752|NCT03562247|155562791|FG002|Overall Study|Lost to Follow-up|1|||
48373753|NCT00983931|155562792|FG000|14 Day Washout Period|Physician Decision|1|||
48373754|NCT03075410|155562793|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
48373755|NCT03075410|155562794|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
48373756|NCT03075410|155562795|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
48373757|NCT03075410|155562796|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
48373758|NCT03075410|155562797|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
48373759|NCT03075410|155562798|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
48373760|NCT03075410|155562799|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
48373761|NCT03075410|155562800|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
48373762|NCT03075410|155562801|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
48373763|NCT03075410|155562793|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
48373764|NCT03075410|155562794|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48373765|NCT03075410|155562795|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48373766|NCT03075410|155562796|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48373767|NCT03075410|155562797|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48373768|NCT03075410|155562798|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48373769|NCT03075410|155562799|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48373770|NCT03075410|155562800|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48373771|NCT03075410|155562801|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
48373772|NCT01759407|155562802|FG000|Overall Study|Protocol Violation|0|||
48373773|NCT01759407|155562803|FG001|Overall Study|Protocol Violation|2|||
48373774|NCT00427895|155562804|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48373775|NCT00427895|155562805|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48373776|NCT00427895|155562806|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48373777|NCT00427895|155562807|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
48373778|NCT00427895|155562808|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48373779|NCT00427895|155562809|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48373780|NCT00427895|155562810|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48373781|NCT00427895|155562811|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
48373782|NCT00427895|155562804|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48373783|NCT00427895|155562805|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48373784|NCT00427895|155562806|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48373785|NCT00427895|155562807|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48373786|NCT00427895|155562808|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48373787|NCT00427895|155562809|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48373788|NCT00427895|155562810|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
48373789|NCT00427895|155562811|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
48373790|NCT00427895|155562804|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
48373791|NCT00427895|155562805|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
48373792|NCT00427895|155562806|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
48373793|NCT00427895|155562807|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
48373794|NCT00427895|155562808|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
48373795|NCT00427895|155562809|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
48373796|NCT00427895|155562810|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
48373797|NCT00427895|155562811|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
48373798|NCT00427895|155562804|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
48373799|NCT00427895|155562805|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
48373800|NCT00427895|155562806|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
48373801|NCT00427895|155562807|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
48373802|NCT00427895|155562808|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
48373803|NCT00427895|155562809|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
48373804|NCT00427895|155562810|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
48373805|NCT00427895|155562811|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
48373806|NCT00427895|155562804|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48373807|NCT00427895|155562805|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
48373808|NCT00427895|155562806|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
48373809|NCT00427895|155562807|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
48373810|NCT00427895|155562808|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48373811|NCT00427895|155562809|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48373812|NCT00427895|155562810|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48373813|NCT00427895|155562811|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
48373814|NCT00427895|155562804|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
48373815|NCT00427895|155562805|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48373816|NCT00427895|155562806|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
48373817|NCT00427895|155562807|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
48373818|NCT00427895|155562808|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48373819|NCT00427895|155562809|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48373820|NCT00427895|155562810|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48373821|NCT00427895|155562811|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
48373822|NCT00427895|155562804|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
48373823|NCT00427895|155562805|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
48373824|NCT00427895|155562806|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48373825|NCT00427895|155562807|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48373826|NCT00427895|155562808|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48373827|NCT00427895|155562809|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48373828|NCT00427895|155562810|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48373829|NCT00427895|155562811|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
48373830|NCT00427895|155562804|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
48373831|NCT00427895|155562805|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
48373832|NCT00427895|155562806|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
48373833|NCT00427895|155562807|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
48373834|NCT00427895|155562808|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
48373835|NCT00427895|155562809|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
48373836|NCT00427895|155562810|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
48373837|NCT00427895|155562811|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
48373838|NCT00427895|155562804|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48373839|NCT00427895|155562805|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48373840|NCT00427895|155562806|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48373841|NCT00427895|155562807|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
48373842|NCT00427895|155562808|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48373843|NCT00427895|155562809|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48373844|NCT00427895|155562810|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48373845|NCT00427895|155562811|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
48373846|NCT00427895|155562804|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
48373847|NCT00427895|155562805|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
48373848|NCT00427895|155562806|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
48373849|NCT00427895|155562807|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
48373850|NCT00427895|155562808|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
48373851|NCT00427895|155562809|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
48373852|NCT00427895|155562810|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
48373853|NCT00427895|155562811|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
48373854|NCT00427895|155562804|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48373855|NCT00427895|155562805|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48373856|NCT00427895|155562806|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
48373857|NCT00427895|155562807|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
48373858|NCT00427895|155562808|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48373859|NCT00427895|155562809|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48373860|NCT00427895|155562810|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48373861|NCT00427895|155562811|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
48373862|NCT00427895|155562804|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48373863|NCT00427895|155562805|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
48373864|NCT00427895|155562806|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
48373865|NCT00427895|155562807|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
48373866|NCT00427895|155562808|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48373867|NCT00427895|155562809|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48373868|NCT00427895|155562810|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48373869|NCT00427895|155562811|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
48373870|NCT00427895|155562804|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
48373871|NCT00427895|155562805|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
48373872|NCT00427895|155562806|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48373873|NCT00427895|155562807|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
48373874|NCT00427895|155562808|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48373875|NCT00427895|155562809|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48373876|NCT00427895|155562810|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48373877|NCT00427895|155562811|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
48373878|NCT00427895|155562804|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
48373879|NCT00427895|155562805|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
48373880|NCT00427895|155562806|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
48373881|NCT00427895|155562807|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
48373882|NCT00427895|155562808|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
48373883|NCT00427895|155562809|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
48373884|NCT00427895|155562810|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
48373885|NCT00427895|155562811|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
48373886|NCT00427895|155562804|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48373887|NCT00427895|155562805|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
48373888|NCT00427895|155562806|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48373889|NCT00427895|155562807|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48373890|NCT00427895|155562808|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48373891|NCT00427895|155562809|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48373892|NCT00427895|155562810|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48373893|NCT00427895|155562811|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
48373894|NCT00427895|155562804|FG000|Vax 1/Year 1 Follow-up|Death|1|||
48373895|NCT00427895|155562805|FG001|Vax 1/Year 1 Follow-up|Death|0|||
48373896|NCT00427895|155562806|FG002|Vax 1/Year 1 Follow-up|Death|0|||
48373897|NCT00427895|155562807|FG003|Vax 1/Year 1 Follow-up|Death|0|||
48373898|NCT00427895|155562808|FG004|Vax 1/Year 1 Follow-up|Death|0|||
48373899|NCT00427895|155562809|FG005|Vax 1/Year 1 Follow-up|Death|0|||
48373900|NCT00427895|155562810|FG006|Vax 1/Year 1 Follow-up|Death|0|||
48373901|NCT00427895|155562811|FG007|Vax 1/Year 1 Follow-up|Death|0|||
48373902|NCT00427895|155562804|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48373903|NCT00427895|155562805|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48373904|NCT00427895|155562806|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
48373905|NCT00427895|155562807|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
48373906|NCT00427895|155562808|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48373907|NCT00427895|155562809|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48373908|NCT00427895|155562810|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48373909|NCT00427895|155562811|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
48373910|NCT00427895|155562804|FG000|Vax 1/Year 1 Follow-up|Other|0|||
48373911|NCT00427895|155562805|FG001|Vax 1/Year 1 Follow-up|Other|0|||
48373912|NCT00427895|155562806|FG002|Vax 1/Year 1 Follow-up|Other|0|||
48373913|NCT00427895|155562807|FG003|Vax 1/Year 1 Follow-up|Other|2|||
48373914|NCT00427895|155562808|FG004|Vax 1/Year 1 Follow-up|Other|0|||
48373915|NCT00427895|155562809|FG005|Vax 1/Year 1 Follow-up|Other|0|||
48373916|NCT00427895|155562810|FG006|Vax 1/Year 1 Follow-up|Other|0|||
48373917|NCT00427895|155562811|FG007|Vax 1/Year 1 Follow-up|Other|0|||
48373918|NCT00427895|155562804|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
48373919|NCT00427895|155562805|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
48373920|NCT00427895|155562806|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
48373921|NCT00427895|155562807|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
48373922|NCT00427895|155562808|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
48373923|NCT00427895|155562809|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
48373924|NCT00427895|155562810|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
48373925|NCT00427895|155562811|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
48373926|NCT00883051|155562812|FG000|Overall Study|Lost to Follow-up|0|||
48373927|NCT00883051|155562813|FG001|Overall Study|Lost to Follow-up|0|||
48373928|NCT00883051|155562814|FG002|Overall Study|Lost to Follow-up|0|||
48373929|NCT00883051|155562815|FG003|Overall Study|Lost to Follow-up|0|||
48373930|NCT00883051|155562816|FG004|Overall Study|Lost to Follow-up|1|||
48373931|NCT00883051|155562812|FG000|Overall Study|Did not use study medication|24|||
48373932|NCT00883051|155562813|FG001|Overall Study|Did not use study medication|22|||
48373933|NCT00883051|155562814|FG002|Overall Study|Did not use study medication|29|||
48373934|NCT00883051|155562815|FG003|Overall Study|Did not use study medication|29|||
48373935|NCT00883051|155562816|FG004|Overall Study|Did not use study medication|17|||
48373936|NCT00810394|155562819|FG000|Overall Study|Withdrawal by Subject|3|||
48373937|NCT02910739|155562820|FG000|Overall Study|Adverse Event|1|||
48373938|NCT02910739|155562821|FG001|Overall Study|Adverse Event|0|||
48373939|NCT02910739|155562822|FG002|Overall Study|Adverse Event|0|||
48373940|NCT02910739|155562823|FG003|Overall Study|Adverse Event|0|||
48373941|NCT05323396|155562824|FG000|Overall Study|Lost to Follow-up|1|||
48373942|NCT05323396|155562825|FG001|Overall Study|Lost to Follow-up|31|||
48373943|NCT05323396|155562824|FG000|Overall Study|Pregnancy|1|||
48373944|NCT05323396|155562825|FG001|Overall Study|Pregnancy|0|||
48373945|NCT02656823|155562826|FG000|Overall Study|Adverse Event|3|||
48373946|NCT02656823|155562826|FG000|Overall Study|Lost to Follow-up|2|||
48373947|NCT04675151|155562828|FG000|Overall Study|Protocol Violation|1|||
48373948|NCT04675151|155562829|FG001|Overall Study|Protocol Violation|0|||
48373949|NCT04675151|155562830|FG002|Overall Study|Protocol Violation|0|||
48373950|NCT04675151|155562831|FG003|Overall Study|Protocol Violation|1|||
48373951|NCT01340651|155562832|FG000|Overall Study|Adverse Event|3|||
48373952|NCT01340651|155562832|FG000|Overall Study|Consent Withdrawn|2|||
48373953|NCT01340651|155562832|FG000|Overall Study|Commercial Supply per Sponsor|12|||
48373954|NCT01009580|155562833|FG000|Overall Study|Adverse Event|4|||
48373955|NCT01009580|155562834|FG001|Overall Study|Adverse Event|4|||
48373956|NCT01009580|155562833|FG000|Overall Study|Lack of Efficacy|0|||
48373957|NCT01009580|155562834|FG001|Overall Study|Lack of Efficacy|1|||
48373958|NCT01009580|155562833|FG000|Overall Study|Protocol Violation|2|||
48373959|NCT01009580|155562834|FG001|Overall Study|Protocol Violation|3|||
48373960|NCT01009580|155562833|FG000|Overall Study|Withdrawal Criteria|4|||
48373961|NCT01009580|155562834|FG001|Overall Study|Withdrawal Criteria|6|||
48373962|NCT01009580|155562833|FG000|Overall Study|Unclassified|17|||
48373963|NCT01009580|155562834|FG001|Overall Study|Unclassified|21|||
48373964|NCT01696942|155562837|FG000|Overall Study|Withdrawal by Subject|1|||
48373965|NCT01696942|155562838|FG001|Overall Study|Withdrawal by Subject|0|||
48373966|NCT01696942|155562837|FG000|Overall Study|Protocol Violation|1|||
48373967|NCT01696942|155562838|FG001|Overall Study|Protocol Violation|2|||
48373968|NCT01696942|155562837|FG000|Overall Study|screen failure|0|||
48373969|NCT01696942|155562838|FG001|Overall Study|screen failure|1|||
48373970|NCT01313117|155562839|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
48373971|NCT01313117|155562839|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
48373972|NCT00055601|155564692|FG000|Overall Study|Protocol Violation|1|||
48373973|NCT00055601|155564693|FG001|Overall Study|Protocol Violation|1|||
48373974|NCT00055601|155564692|FG000|Overall Study|No protocol treatment received|1|||
48373975|NCT00055601|155564693|FG001|Overall Study|No protocol treatment received|1|||
48373976|NCT04058366|155564694|FG000|Overall Study|Adverse Event|14|||
48373977|NCT04058366|155564694|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
48373978|NCT04058366|155564694|FG000|Overall Study|Commercial drug is available for participants|6|||
48373979|NCT04058366|155564694|FG000|Overall Study|Death|1|||
48373980|NCT04058366|155564694|FG000|Overall Study|Other non-compliance|2|||
48373981|NCT04058366|155564694|FG000|Overall Study|Other|6|||
48373982|NCT01589237|155564695|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
48373983|NCT01589237|155564696|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
48373984|NCT01589237|155564697|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
48373985|NCT01589237|155564698|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
48373986|NCT01589237|155564695|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
48373987|NCT01589237|155564696|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
48373988|NCT01589237|155564697|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
48373989|NCT01589237|155564698|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
48373990|NCT01589237|155564695|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
48373991|NCT01589237|155564696|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
48373992|NCT01589237|155564697|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
48373993|NCT01589237|155564698|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
48373994|NCT01589237|155564695|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
48373995|NCT01589237|155564696|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
48373996|NCT01589237|155564697|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
48373997|NCT01589237|155564698|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
48373998|NCT01036763|155564699|FG000|Overall Study|Adverse Event|25|||
48373999|NCT01036763|155564699|FG000|Overall Study|Lost to Follow-up|28|||
48374000|NCT01036763|155564699|FG000|Overall Study|Other reason (not specified)|40|||
48374001|NCT01773291|155564714|FG000|Overall Study|Protocol Violation|1|||
48374002|NCT01773291|155564715|FG001|Overall Study|Protocol Violation|0|||
48374003|NCT01773291|155564716|FG002|Overall Study|Protocol Violation|0|||
48374004|NCT01773291|155564714|FG000|Overall Study|Withdrawal by Subject|0|||
48374005|NCT01773291|155564715|FG001|Overall Study|Withdrawal by Subject|0|||
48374006|NCT01773291|155564716|FG002|Overall Study|Withdrawal by Subject|1|||
48374007|NCT00901186|155564717|FG000|Overall Study|Lack of Efficacy|0|||
48374008|NCT00901186|155564718|FG001|Overall Study|Lack of Efficacy|1|||
48374009|NCT00901186|155564717|FG000|Overall Study|Abnormal laboratory values|0|||
48374010|NCT00901186|155564718|FG001|Overall Study|Abnormal laboratory values|1|||
48374011|NCT00901186|155564717|FG000|Overall Study|Lost to Follow-up|2|||
48374012|NCT00901186|155564718|FG001|Overall Study|Lost to Follow-up|0|||
48374013|NCT00901186|155564717|FG000|Overall Study|Adverse Event|2|||
48374014|NCT00901186|155564718|FG001|Overall Study|Adverse Event|4|||
48374015|NCT00901186|155564717|FG000|Overall Study|Administration problems|0|||
48374016|NCT00901186|155564718|FG001|Overall Study|Administration problems|1|||
48374017|NCT00901186|155564717|FG000|Overall Study|Protocol deviations|5|||
48374018|NCT00901186|155564718|FG001|Overall Study|Protocol deviations|4|||
48374019|NCT00203476|155564719|FG000|Overall Study|Lost to Follow-up|1|||
48374020|NCT00203476|155564720|FG001|Overall Study|Lost to Follow-up|0|||
48374021|NCT00203476|155564721|FG002|Overall Study|Lost to Follow-up|0|||
48374022|NCT00203476|155564719|FG000|Overall Study|Withdrawal by Subject|0|||
48374023|NCT00203476|155564720|FG001|Overall Study|Withdrawal by Subject|1|||
48374024|NCT00203476|155564721|FG002|Overall Study|Withdrawal by Subject|0|||
48374025|NCT01201317|155564722|FG000|Overall Study|Withdrawal by Subject|5|||
48374026|NCT01201317|155564723|FG001|Overall Study|Withdrawal by Subject|0|||
48374027|NCT01201317|155564724|FG002|Overall Study|Withdrawal by Subject|3|||
48374028|NCT01201317|155564722|FG000|Overall Study|Adverse Event|2|||
48374029|NCT01201317|155564723|FG001|Overall Study|Adverse Event|2|||
48374030|NCT01201317|155564724|FG002|Overall Study|Adverse Event|2|||
48374031|NCT01201317|155564722|FG000|Overall Study|Screen failure|1|||
48374032|NCT01201317|155564723|FG001|Overall Study|Screen failure|1|||
48374033|NCT01201317|155564724|FG002|Overall Study|Screen failure|0|||
48374034|NCT01201317|155564722|FG000|Overall Study|Protocol Violation|0|||
48374035|NCT01201317|155564723|FG001|Overall Study|Protocol Violation|1|||
48374036|NCT01201317|155564724|FG002|Overall Study|Protocol Violation|1|||
48374037|NCT01201317|155564722|FG000|Overall Study|Death|0|||
48374038|NCT01201317|155564723|FG001|Overall Study|Death|1|||
48374039|NCT01201317|155564724|FG002|Overall Study|Death|0|||
48374040|NCT01201317|155564722|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48374041|NCT01201317|155564723|FG001|Overall Study|Study-specific withdrawal criteria|0|||
48374042|NCT01201317|155564724|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48374043|NCT01201317|155564722|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
48374044|NCT01201317|155564723|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
48374045|NCT01201317|155564724|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
48374046|NCT01201317|155564722|FG000|Overall Study|Decrease in renal function|0|||
48374047|NCT01201317|155564723|FG001|Overall Study|Decrease in renal function|1|||
48374048|NCT01201317|155564724|FG002|Overall Study|Decrease in renal function|0|||
48374049|NCT01201317|155564722|FG000|Overall Study|Lack of Efficacy|1|||
48374050|NCT01201317|155564723|FG001|Overall Study|Lack of Efficacy|0|||
48374051|NCT01201317|155564724|FG002|Overall Study|Lack of Efficacy|0|||
48374052|NCT01201317|155564722|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
48374053|NCT01201317|155564723|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
48374054|NCT01201317|155564724|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
48374055|NCT01190514|155564725|FG000|First Intervention (Period 1)|Adverse Event|1|||
48374056|NCT01190514|155564726|FG001|First Intervention (Period 1)|Adverse Event|0|||
48374057|NCT01190514|155564727|FG002|First Intervention (Period 1)|Adverse Event|0|||
48374058|NCT01190514|155564728|FG003|First Intervention (Period 1)|Adverse Event|0|||
48374059|NCT01190514|155564725|FG000|Third Intervention (Period 3)|Adverse Event|1|||
48374060|NCT01190514|155564726|FG001|Third Intervention (Period 3)|Adverse Event|0|||
48374061|NCT01190514|155564727|FG002|Third Intervention (Period 3)|Adverse Event|0|||
48374062|NCT01190514|155564728|FG003|Third Intervention (Period 3)|Adverse Event|0|||
48374063|NCT00512317|155564729|FG000|Overall Study|Insufficient clinical response|36|||
48374064|NCT00512317|155564729|FG000|Overall Study|Withdrawal by Subject|23|||
48374065|NCT00512317|155564729|FG000|Overall Study|Sponsor closure of study|21|||
48374066|NCT00512317|155564729|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
48374067|NCT00512317|155564729|FG000|Overall Study|Adverse Event|13|||
48374068|NCT00512317|155564729|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
48374069|NCT00512317|155564729|FG000|Overall Study|Lost to Follow-up|2|||
48374070|NCT00512317|155564729|FG000|Overall Study|Other|2|||
48374071|NCT00852540|155564730|FG000|Overall Study|Adverse Event|10|||
48374072|NCT00852540|155564731|FG001|Overall Study|Adverse Event|3|||
48374073|NCT00852540|155564730|FG000|Overall Study|Lack of Efficacy|15|||
48374074|NCT00852540|155564731|FG001|Overall Study|Lack of Efficacy|3|||
48374075|NCT00852540|155564730|FG000|Overall Study|Protocol Violation|1|||
48374076|NCT00852540|155564731|FG001|Overall Study|Protocol Violation|2|||
48374077|NCT00852540|155564730|FG000|Overall Study|Lost to Follow-up|2|||
48374078|NCT00852540|155564731|FG001|Overall Study|Lost to Follow-up|3|||
48374079|NCT00852540|155564730|FG000|Overall Study|Investigator Discretion|2|||
48374080|NCT00852540|155564731|FG001|Overall Study|Investigator Discretion|3|||
48374081|NCT00852540|155564730|FG000|Overall Study|Withdrawal by Subject|3|||
48374082|NCT00852540|155564731|FG001|Overall Study|Withdrawal by Subject|1|||
48374083|NCT00852540|155564730|FG000|Overall Study|Did Not Receive Study Drug|3|||
48374084|NCT00852540|155564731|FG001|Overall Study|Did Not Receive Study Drug|3|||
48374085|NCT00601419|155564732|FG000|Overall Study|Lost to Follow-up|3|||
48374086|NCT00601419|155564732|FG000|Overall Study|Missed Visits|1|||
48374087|NCT00686725|155564742|FG000|Overall Study|Adverse Event|1|||
48374088|NCT00686725|155564743|FG001|Overall Study|Adverse Event|1|||
48374089|NCT00686725|155564742|FG000|Overall Study|Progressive Disease|17|||
48374090|NCT00686725|155564743|FG001|Overall Study|Progressive Disease|23|||
48374091|NCT00686725|155564742|FG000|Overall Study|Lost to Follow-up|7|||
48374092|NCT00686725|155564743|FG001|Overall Study|Lost to Follow-up|5|||
48374093|NCT00686725|155564742|FG000|Overall Study|Death|6|||
48374094|NCT00686725|155564743|FG001|Overall Study|Death|3|||
48374095|NCT00686725|155564742|FG000|Overall Study|Withdrawal by Subject|13|||
48374096|NCT00686725|155564743|FG001|Overall Study|Withdrawal by Subject|4|||
48374097|NCT00686725|155564742|FG000|Overall Study|Protocol Violation|1|||
48374098|NCT00686725|155564743|FG001|Overall Study|Protocol Violation|3|||
48374099|NCT00686725|155564742|FG000|Overall Study|Other|1|||
48374100|NCT00686725|155564743|FG001|Overall Study|Other|3|||
48374101|NCT00938470|155564744|FG000|Overall Study|Disease Progression|3|||
48374102|NCT00938470|155564745|FG001|Overall Study|Disease Progression|0|||
48374103|NCT00938470|155564744|FG000|Overall Study|Alternate Treatment|1|||
48374104|NCT00938470|155564745|FG001|Overall Study|Alternate Treatment|0|||
48374105|NCT00938470|155564744|FG000|Overall Study|Death|3|||
48374106|NCT00938470|155564745|FG001|Overall Study|Death|2|||
48374107|NCT00938470|155564744|FG000|Overall Study|Other Reason|0|||
48374108|NCT00938470|155564745|FG001|Overall Study|Other Reason|1|||
48374109|NCT02966301|155564752|FG000|Overall Study|Death|2|||
48374110|NCT02966301|155564752|FG000|Overall Study|Withdrawal by Subject|1|||
48374111|NCT00448279|155564754|FG000|Overall Study|Lost to Follow-up|2|||
48374112|NCT00448279|155564755|FG001|Overall Study|Lost to Follow-up|2|||
48374113|NCT00448279|155564754|FG000|Overall Study|Adverse Event|1|||
48374114|NCT00448279|155564755|FG001|Overall Study|Adverse Event|1|||
48374115|NCT00448279|155564754|FG000|Overall Study|Disease progression|16|||
48374116|NCT00448279|155564755|FG001|Overall Study|Disease progression|18|||
48374117|NCT00448279|155564754|FG000|Overall Study|Withdrawal by Subject|4|||
48374118|NCT00448279|155564755|FG001|Overall Study|Withdrawal by Subject|3|||
48374119|NCT00448279|155564754|FG000|Overall Study|Other|6|||
48374120|NCT00448279|155564755|FG001|Overall Study|Other|4|||
48374121|NCT00448279|155564754|FG000|Overall Study|Protocol Violation|0|||
48374122|NCT00448279|155564755|FG001|Overall Study|Protocol Violation|1|||
48374123|NCT02937454|155564756|FG000|Overall Study|Adverse Event|0|||
48374124|NCT02937454|155564757|FG001|Overall Study|Adverse Event|1|||
48374125|NCT02937454|155564756|FG000|Overall Study|Death|98|||
48374126|NCT02937454|155564757|FG001|Overall Study|Death|95|||
48374127|NCT02937454|155564756|FG000|Overall Study|Lost to Follow-up|1|||
48374128|NCT02937454|155564757|FG001|Overall Study|Lost to Follow-up|1|||
48374129|NCT02937454|155564756|FG000|Overall Study|Physician Decision|0|||
48374130|NCT02937454|155564757|FG001|Overall Study|Physician Decision|1|||
48374131|NCT02937454|155564756|FG000|Overall Study|Protocol Violation|6|||
48374132|NCT02937454|155564757|FG001|Overall Study|Protocol Violation|10|||
48374133|NCT02937454|155564756|FG000|Overall Study|Withdrawal by Subject|27|||
48374134|NCT02937454|155564757|FG001|Overall Study|Withdrawal by Subject|15|||
48374135|NCT02937454|155564756|FG000|Overall Study|Other|8|||
48374136|NCT02937454|155564757|FG001|Overall Study|Other|5|||
48374137|NCT04882995|155564760|FG000|Overall Study|Withdrawal by Subject|1|||
48374138|NCT04882995|155564761|FG001|Overall Study|Withdrawal by Subject|2|||
48374139|NCT04882995|155564760|FG000|Overall Study|Protocol Violation|4|||
48374140|NCT04882995|155564761|FG001|Overall Study|Protocol Violation|4|||
48374141|NCT04882995|155564760|FG000|Overall Study|Surgery postponed due to COVID|1|||
48374142|NCT04882995|155564761|FG001|Overall Study|Surgery postponed due to COVID|1|||
48374143|NCT00319839|155564764|FG000|Overall Study|Adverse Event|5|||
48374144|NCT00319839|155564764|FG000|Overall Study|Withdrawal by Subject|1|||
48374145|NCT00825916|155564765|FG000|Overall Study|Lost to Follow-up|4|||
48374146|NCT00825916|155564766|FG001|Overall Study|Lost to Follow-up|2|||
48374147|NCT00825916|155564767|FG002|Overall Study|Lost to Follow-up|1|||
48374148|NCT00903630|155564768|FG000|Phase 2|Adverse Event|0|||
48374149|NCT00903630|155564769|FG001|Phase 2|Adverse Event|0|||
48374150|NCT00903630|155564770|FG002|Phase 2|Adverse Event|1|||
48374151|NCT04025580|155564771|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
48374152|NCT04025580|155564772|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
48374153|NCT04025580|155564773|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
48374154|NCT00966277|155564776|FG000|Overall Study|Withdrawal by Subject|3|||
48374155|NCT00966277|155564777|FG001|Overall Study|Withdrawal by Subject|0|||
48374156|NCT00966277|155564776|FG000|Overall Study|Ineligible|1|||
48374157|NCT00966277|155564777|FG001|Overall Study|Ineligible|3|||
48374158|NCT00966277|155564776|FG000|Overall Study|Treatment Plan Changed|0|||
48374159|NCT00966277|155564777|FG001|Overall Study|Treatment Plan Changed|1|||
48374160|NCT02084056|155564780|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
48374161|NCT02084056|155564781|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48374162|NCT02084056|155564782|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48374163|NCT02084056|155564783|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48374164|NCT02084056|155564780|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
48374165|NCT02084056|155564781|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48374166|NCT02084056|155564782|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48374167|NCT02084056|155564783|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
48374168|NCT03305731|155564784|FG000|Overall Study|Protocol Violation|1|||
48374169|NCT01952054|155564785|FG000|Overall Study|Physician Decision|1|||
48374170|NCT01498653|155564787|FG000|Overall Study|Adverse Event|2|||
48374171|NCT01498653|155564788|FG001|Overall Study|Adverse Event|2|||
48374172|NCT01498653|155564787|FG000|Overall Study|Lack of Efficacy|12|||
48374173|NCT01498653|155564788|FG001|Overall Study|Lack of Efficacy|26|||
48374174|NCT01498653|155564787|FG000|Overall Study|Protocol Violation|0|||
48374175|NCT01498653|155564788|FG001|Overall Study|Protocol Violation|4|||
48374176|NCT01498653|155564787|FG000|Overall Study|Lost to Follow-up|1|||
48374177|NCT01498653|155564788|FG001|Overall Study|Lost to Follow-up|0|||
48374178|NCT01498653|155564787|FG000|Overall Study|Physician Decision|2|||
48374179|NCT01498653|155564788|FG001|Overall Study|Physician Decision|0|||
48374180|NCT01498653|155564787|FG000|Overall Study|Withdrawal by Subject|2|||
48374181|NCT01498653|155564788|FG001|Overall Study|Withdrawal by Subject|3|||
48374182|NCT01210664|155564789|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
48374183|NCT01210664|155564790|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
48374184|NCT01210664|155564791|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
48374185|NCT01210664|155564792|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
48374186|NCT01210664|155564789|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
48374187|NCT01210664|155564790|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
48374188|NCT01210664|155564791|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
48374189|NCT01210664|155564792|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
48374190|NCT01210664|155564789|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
48374191|NCT01210664|155564790|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
48374192|NCT01210664|155564791|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
48374193|NCT01210664|155564792|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
48374194|NCT01209780|155564793|FG000|Overall Study|Adverse Event|0|||
48374195|NCT01209780|155564794|FG001|Overall Study|Adverse Event|1|||
48374196|NCT01209780|155564795|FG002|Overall Study|Adverse Event|0|||
48374197|NCT01209780|155564796|FG003|Overall Study|Adverse Event|0|||
48374198|NCT01209780|155564797|FG004|Overall Study|Adverse Event|0|||
48374199|NCT01209780|155564793|FG000|Overall Study|Withdrawal by Subject|9|||
48374200|NCT01209780|155564794|FG001|Overall Study|Withdrawal by Subject|2|||
48374201|NCT01209780|155564795|FG002|Overall Study|Withdrawal by Subject|1|||
48374202|NCT01209780|155564796|FG003|Overall Study|Withdrawal by Subject|1|||
48374203|NCT01209780|155564797|FG004|Overall Study|Withdrawal by Subject|0|||
48374204|NCT01209780|155564793|FG000|Overall Study|Lost to Follow-up|17|||
48374205|NCT01209780|155564794|FG001|Overall Study|Lost to Follow-up|12|||
48374206|NCT01209780|155564795|FG002|Overall Study|Lost to Follow-up|3|||
48374207|NCT01209780|155564796|FG003|Overall Study|Lost to Follow-up|9|||
48374208|NCT01209780|155564797|FG004|Overall Study|Lost to Follow-up|4|||
48374209|NCT01209780|155564793|FG000|Overall Study|Protocol Violation|0|||
48374210|NCT01209780|155564794|FG001|Overall Study|Protocol Violation|1|||
48374211|NCT01209780|155564795|FG002|Overall Study|Protocol Violation|0|||
48374212|NCT01209780|155564796|FG003|Overall Study|Protocol Violation|0|||
48374213|NCT01209780|155564797|FG004|Overall Study|Protocol Violation|0|||
48374214|NCT01209780|155564793|FG000|Overall Study|Inappropriate enrollment|0|||
48374215|NCT01209780|155564794|FG001|Overall Study|Inappropriate enrollment|2|||
48374216|NCT01209780|155564795|FG002|Overall Study|Inappropriate enrollment|0|||
48374217|NCT01209780|155564796|FG003|Overall Study|Inappropriate enrollment|0|||
48374218|NCT01209780|155564797|FG004|Overall Study|Inappropriate enrollment|1|||
48374219|NCT00679627|155564798|FG000|Overall Study|Death|41|||
48374220|NCT00679627|155564799|FG001|Overall Study|Death|29|||
48374221|NCT00679627|155564798|FG000|Overall Study|Adverse Event|43|||
48374222|NCT00679627|155564799|FG001|Overall Study|Adverse Event|53|||
48374223|NCT00679627|155564798|FG000|Overall Study|Withdrawal by Subject|168|||
48374224|NCT00679627|155564799|FG001|Overall Study|Withdrawal by Subject|172|||
48374225|NCT00679627|155564798|FG000|Overall Study|Lost to Follow-up|22|||
48374226|NCT00679627|155564799|FG001|Overall Study|Lost to Follow-up|26|||
48374227|NCT00679627|155564798|FG000|Overall Study|Early Study Closure|425|||
48374228|NCT00679627|155564799|FG001|Overall Study|Early Study Closure|405|||
48374229|NCT01886378|155564802|FG000|Overall Study|Adverse Event|1|||
48374230|NCT01886378|155564802|FG000|Overall Study|Withdrawal by Subject|4|||
48374231|NCT01285609|155564803|FG000|Randomized|Progressive Disease|41|||
48374232|NCT01285609|155564804|FG001|Randomized|Progressive Disease|61|||
48374233|NCT01285609|155564803|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
48374234|NCT01285609|155564804|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
48374235|NCT01285609|155564803|FG000|Randomized|Study Drug Toxicity|13|||
48374236|NCT01285609|155564804|FG001|Randomized|Study Drug Toxicity|14|||
48374237|NCT01285609|155564803|FG000|Randomized|Death|5|||
48374238|NCT01285609|155564804|FG001|Randomized|Death|7|||
48374239|NCT01285609|155564803|FG000|Randomized|Withdrawal by Subject|8|||
48374240|NCT01285609|155564804|FG001|Randomized|Withdrawal by Subject|11|||
48374241|NCT01285609|155564803|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
48374242|NCT01285609|155564804|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
48374243|NCT01285609|155564803|FG000|Randomized|Undisclosed Reasons|1|||
48374244|NCT01285609|155564804|FG001|Randomized|Undisclosed Reasons|0|||
48374245|NCT01285609|155564803|FG000|Randomized|Randomized but not Treated|4|||
48374246|NCT01285609|155564804|FG001|Randomized|Randomized but not Treated|4|||
48374247|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
48374248|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
48374249|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
48374250|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
48374251|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
48374252|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
48374253|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
48374254|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
48374255|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Death|11|||
48374256|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Death|3|||
48374257|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
48374258|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
48374259|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Not Reported|0|||
48374260|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Not Reported|2|||
48374261|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
48374262|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
48374263|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
48374264|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
48374265|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
48374266|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
48374267|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
48374268|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
48374269|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
48374270|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
48374271|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
48374272|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
48374273|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
48374274|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
48374275|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
48374276|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
48374277|NCT01285609|155564803|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
48374278|NCT01285609|155564804|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
48374279|NCT01285609|155564803|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
48374280|NCT01285609|155564804|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
48374281|NCT04822597|155564805|FG000|Overall Study|Withdrawal by Subject|0|||
48374282|NCT04822597|155564806|FG001|Overall Study|Withdrawal by Subject|1|||
48374283|NCT04822597|155564807|FG002|Overall Study|Withdrawal by Subject|1|||
48374284|NCT04822597|155564808|FG003|Overall Study|Withdrawal by Subject|0|||
48374285|NCT04822597|155564805|FG000|Overall Study|Physician Decision|0|||
48374286|NCT04822597|155564806|FG001|Overall Study|Physician Decision|0|||
48374287|NCT04822597|155564807|FG002|Overall Study|Physician Decision|1|||
48374288|NCT04822597|155564808|FG003|Overall Study|Physician Decision|1|||
48374289|NCT04822597|155564805|FG000|Overall Study|Subject withdrawn after enrollment|0|||
48374290|NCT04822597|155564806|FG001|Overall Study|Subject withdrawn after enrollment|1|||
48374291|NCT04822597|155564807|FG002|Overall Study|Subject withdrawn after enrollment|0|||
48374292|NCT04822597|155564808|FG003|Overall Study|Subject withdrawn after enrollment|1|||
48374293|NCT04822597|155564805|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
48374294|NCT04822597|155564806|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
48374295|NCT04822597|155564807|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
48374296|NCT04822597|155564808|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
48374297|NCT02709096|155564813|FG000|Overall Study|non-compliance|1|||
48374298|NCT02709096|155564814|FG001|Overall Study|non-compliance|1|||
48374299|NCT01275131|155564816|FG000|Period 1|Withdrawal by Subject|1|||
48374300|NCT01275131|155564817|FG001|Period 1|Withdrawal by Subject|0|||
48374301|NCT01275131|155564818|FG002|Period 1|Withdrawal by Subject|3|||
48374302|NCT01275131|155564819|FG003|Period 1|Withdrawal by Subject|2|||
48374303|NCT01275131|155564816|FG000|Period 1|Physician Decision|1|||
48415080|NCT01309737|155707568|FG004|Week 16 to 52|Other|0|||
48415081|NCT00104871|155707580|FG000|Overall Study|Not evaluable|1|||
48374304|NCT01275131|155564817|FG001|Period 1|Physician Decision|0|||
48374305|NCT01275131|155564818|FG002|Period 1|Physician Decision|0|||
48374306|NCT01275131|155564819|FG003|Period 1|Physician Decision|0|||
48374307|NCT01275131|155564816|FG000|Period 2 (Crossover)|Adverse Event|0|||
48374308|NCT01275131|155564817|FG001|Period 2 (Crossover)|Adverse Event|1|||
48374309|NCT01275131|155564818|FG002|Period 2 (Crossover)|Adverse Event|0|||
48374310|NCT01275131|155564819|FG003|Period 2 (Crossover)|Adverse Event|0|||
48374311|NCT01275131|155564816|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
48374312|NCT01275131|155564817|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
48374313|NCT01275131|155564818|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
48374314|NCT01275131|155564819|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
48374315|NCT01142596|155564823|FG000|Overall Study|Withdrawal by Subject|9|||
48374316|NCT01142596|155564824|FG001|Overall Study|Withdrawal by Subject|35|||
48374317|NCT01142596|155564823|FG000|Overall Study|Adverse Event|8|||
48374318|NCT01142596|155564824|FG001|Overall Study|Adverse Event|35|||
48374319|NCT01142596|155564823|FG000|Overall Study|Lack of Efficacy|5|||
48374320|NCT01142596|155564824|FG001|Overall Study|Lack of Efficacy|9|||
48374321|NCT01142596|155564823|FG000|Overall Study|Lost to Follow-up|2|||
48374322|NCT01142596|155564824|FG001|Overall Study|Lost to Follow-up|3|||
48374323|NCT01142596|155564823|FG000|Overall Study|Other reason (not specified)|5|||
48374324|NCT01142596|155564824|FG001|Overall Study|Other reason (not specified)|4|||
48374325|NCT03945825|155564825|FG000|Overall Study|Enrolled but treatment not administered|0|||
48374326|NCT03945825|155564826|FG001|Overall Study|Enrolled but treatment not administered|0|||
48374327|NCT03945825|155564827|FG002|Overall Study|Enrolled but treatment not administered|0|||
48374328|NCT03945825|155564828|FG003|Overall Study|Enrolled but treatment not administered|0|||
48374329|NCT03945825|155564829|FG004|Overall Study|Enrolled but treatment not administered|1|||
48374330|NCT03945825|155564830|FG005|Overall Study|Enrolled but treatment not administered|0|||
48374331|NCT03945825|155564825|FG000|Overall Study|Lost to Follow-up|1|||
48374332|NCT03945825|155564826|FG001|Overall Study|Lost to Follow-up|5|||
48374333|NCT03945825|155564827|FG002|Overall Study|Lost to Follow-up|0|||
48374334|NCT03945825|155564828|FG003|Overall Study|Lost to Follow-up|1|||
48374335|NCT03945825|155564829|FG004|Overall Study|Lost to Follow-up|2|||
48374336|NCT03945825|155564830|FG005|Overall Study|Lost to Follow-up|2|||
48374337|NCT03945825|155564825|FG000|Overall Study|Withdrawal by Subject|1|||
48374338|NCT03945825|155564826|FG001|Overall Study|Withdrawal by Subject|0|||
48374339|NCT03945825|155564827|FG002|Overall Study|Withdrawal by Subject|1|||
48374340|NCT03945825|155564828|FG003|Overall Study|Withdrawal by Subject|1|||
48374341|NCT03945825|155564829|FG004|Overall Study|Withdrawal by Subject|0|||
48374342|NCT03945825|155564830|FG005|Overall Study|Withdrawal by Subject|1|||
48374343|NCT01588496|155564831|FG000|Overall Study|Withdrawal by Subject|0|||
48374344|NCT01588496|155564832|FG001|Overall Study|Withdrawal by Subject|1|||
48374345|NCT01588496|155564833|FG002|Overall Study|Withdrawal by Subject|0|||
48374346|NCT00511901|155564838|FG000|Overall Study|Withdrawal by Subject|1|||
48374347|NCT00511901|155564839|FG001|Overall Study|Withdrawal by Subject|3|||
48374348|NCT03110185|155564840|FG000|Overall Study|Death|0|||
48374349|NCT03110185|155564841|FG001|Overall Study|Death|1|||
48374350|NCT03110185|155564840|FG000|Overall Study|Withdrawal by Subject|2|||
48374351|NCT03110185|155564841|FG001|Overall Study|Withdrawal by Subject|7|||
48374352|NCT03110185|155564840|FG000|Overall Study|Time Constraints|0|||
48374353|NCT03110185|155564841|FG001|Overall Study|Time Constraints|6|||
48374354|NCT03110185|155564840|FG000|Overall Study|Conflict with care|5|||
48374355|NCT03110185|155564841|FG001|Overall Study|Conflict with care|12|||
48374356|NCT03110185|155564840|FG000|Overall Study|Protocol Violation|1|||
48374357|NCT03110185|155564841|FG001|Overall Study|Protocol Violation|4|||
48374358|NCT03110185|155564840|FG000|Overall Study|MRI Incompatible|2|||
48374359|NCT03110185|155564841|FG001|Overall Study|MRI Incompatible|0|||
48374360|NCT03110185|155564840|FG000|Overall Study|Patient Refusal|0|||
48374361|NCT03110185|155564841|FG001|Overall Study|Patient Refusal|1|||
48374362|NCT00421707|155564842|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
48374363|NCT00421707|155564843|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
48374364|NCT00421707|155564842|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
48374365|NCT00421707|155564843|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
48374366|NCT00421707|155564842|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
48374367|NCT00421707|155564843|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
48374368|NCT00421707|155564842|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
48374369|NCT00421707|155564843|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
48374370|NCT00421707|155564842|FG000|Period 2: Washout|Adverse Event|1|||
48374371|NCT00421707|155564843|FG001|Period 2: Washout|Adverse Event|1|||
48374372|NCT00421707|155564842|FG000|Period 2: Washout|Withdrawal by Subject|0|||
48374373|NCT00421707|155564843|FG001|Period 2: Washout|Withdrawal by Subject|1|||
48374374|NCT00421707|155564842|FG000|Period 2: Washout|Lost to Follow-up|0|||
48374375|NCT00421707|155564843|FG001|Period 2: Washout|Lost to Follow-up|1|||
48374376|NCT00421707|155564842|FG000|Period 2: Washout|Other: Pregnancy|0|||
48374377|NCT00421707|155564843|FG001|Period 2: Washout|Other: Pregnancy|1|||
48374378|NCT00421707|155564842|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
48374379|NCT00421707|155564843|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
48374380|NCT00421707|155564842|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
48374381|NCT00421707|155564843|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
48374382|NCT00421707|155564842|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
48374383|NCT00421707|155564843|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
48374384|NCT01201265|155564844|FG000|Overall Study|Death|14|||
48374385|NCT01201265|155564844|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48374386|NCT01201265|155564844|FG000|Overall Study|Lost to Follow-up|10|||
48374387|NCT01201265|155564844|FG000|Overall Study|Withdrawal by Subject|7|||
48374388|NCT01201265|155564844|FG000|Overall Study|Disease Progression|4|||
48374389|NCT02667587|155564845|FG000|Pre-Treatment|Not reported|1|||
48374390|NCT02667587|155564846|FG001|Pre-Treatment|Not reported|0|||
48374391|NCT02667587|155564845|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
48374392|NCT02667587|155564846|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
48374393|NCT02667587|155564845|FG000|Pre-Treatment|Participant withdrew consent|0|||
48374394|NCT02667587|155564846|FG001|Pre-Treatment|Participant withdrew consent|1|||
48374395|NCT02667587|155564845|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
48374396|NCT02667587|155564846|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
48374397|NCT02667587|155564845|FG000|End of Treatment|Other reasons|11|||
48374398|NCT02667587|155564846|FG001|End of Treatment|Other reasons|8|||
48374399|NCT02667587|155564845|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
48374400|NCT02667587|155564846|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
48374401|NCT02667587|155564845|FG000|End of Treatment|Poor/Non-Compliance|0|||
48374402|NCT02667587|155564846|FG001|End of Treatment|Poor/Non-Compliance|1|||
48374403|NCT02667587|155564845|FG000|End of Treatment|Maximum Clinical Benefit|3|||
48374404|NCT02667587|155564846|FG001|End of Treatment|Maximum Clinical Benefit|3|||
48374405|NCT02667587|155564845|FG000|End of Treatment|Participant Withdrew Consent|5|||
48374406|NCT02667587|155564846|FG001|End of Treatment|Participant Withdrew Consent|6|||
48374407|NCT02667587|155564845|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
48374408|NCT02667587|155564846|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
48374409|NCT02667587|155564845|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
48374410|NCT02667587|155564846|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
48374411|NCT02667587|155564845|FG000|End of Treatment|Death|2|||
48374412|NCT02667587|155564846|FG001|End of Treatment|Death|1|||
48374413|NCT02667587|155564845|FG000|End of Treatment|Study Drug Toxicity|74|||
48374414|NCT02667587|155564846|FG001|End of Treatment|Study Drug Toxicity|18|||
48374415|NCT02667587|155564845|FG000|End of Treatment|Disease progression|177|||
48374416|NCT02667587|155564846|FG001|End of Treatment|Disease progression|222|||
48374417|NCT02667587|155564845|FG000|End of Treatment|Lost to Follow-up|1|||
48374418|NCT02667587|155564846|FG001|End of Treatment|Lost to Follow-up|3|||
48374419|NCT03737474|155564849|FG000|Overall Study|Adverse Event|18|||
48374420|NCT03737474|155564850|FG001|Overall Study|Adverse Event|48|||
48374421|NCT03737474|155564849|FG000|Overall Study|Lack of Efficacy|1|||
48374422|NCT03737474|155564850|FG001|Overall Study|Lack of Efficacy|3|||
48374423|NCT03737474|155564849|FG000|Overall Study|Protocol Violation|0|||
48374424|NCT03737474|155564850|FG001|Overall Study|Protocol Violation|8|||
48374425|NCT03737474|155564849|FG000|Overall Study|Withdrawal by Subject|5|||
48374426|NCT03737474|155564850|FG001|Overall Study|Withdrawal by Subject|20|||
48374427|NCT03737474|155564849|FG000|Overall Study|Non-compliance With Study Drug|0|||
48374428|NCT03737474|155564850|FG001|Overall Study|Non-compliance With Study Drug|1|||
48374429|NCT03737474|155564849|FG000|Overall Study|Physician Decision|1|||
48374430|NCT03737474|155564850|FG001|Overall Study|Physician Decision|4|||
48374431|NCT01209143|155564851|FG000|Overall Study|Adverse Event|2|||
48374432|NCT01209143|155564852|FG001|Overall Study|Adverse Event|1|||
48374433|NCT01209143|155564851|FG000|Overall Study|Death|0|||
48374434|NCT01209143|155564852|FG001|Overall Study|Death|1|||
48374435|NCT01209143|155564851|FG000|Overall Study|Physician Decision|3|||
48374436|NCT01209143|155564852|FG001|Overall Study|Physician Decision|1|||
48374437|NCT01209143|155564851|FG000|Overall Study|Lost to Follow-up|1|||
48374438|NCT01209143|155564852|FG001|Overall Study|Lost to Follow-up|0|||
48374439|NCT01209143|155564851|FG000|Overall Study|Withdrawal by Subject|2|||
48374440|NCT01209143|155564852|FG001|Overall Study|Withdrawal by Subject|1|||
48374441|NCT01209143|155564851|FG000|Overall Study|Disease progression|11|||
48374442|NCT01209143|155564852|FG001|Overall Study|Disease progression|16|||
48374443|NCT00723021|155564853|FG000|Intervention Period 4|Adverse Event|0|||
48374444|NCT00723021|155564854|FG001|Intervention Period 4|Adverse Event|0|||
48374445|NCT00723021|155564855|FG002|Intervention Period 4|Adverse Event|0|||
48374446|NCT00723021|155564856|FG003|Intervention Period 4|Adverse Event|0|||
48374447|NCT00723021|155564857|FG004|Intervention Period 4|Adverse Event|1|||
48374448|NCT00770341|155564858|FG000|Overall Study|Did not meet eligibility criteria|1|||
48374449|NCT00770341|155564859|FG001|Overall Study|Did not meet eligibility criteria|0|||
48374450|NCT00770341|155564860|FG002|Overall Study|Did not meet eligibility criteria|0|||
48374451|NCT00770341|155564858|FG000|Overall Study|Withdrawal by Subject|0|||
48374452|NCT00770341|155564859|FG001|Overall Study|Withdrawal by Subject|1|||
48374453|NCT00770341|155564860|FG002|Overall Study|Withdrawal by Subject|0|||
48374454|NCT00770341|155564858|FG000|Overall Study|Clinical Adverse Event|3|||
48374455|NCT00770341|155564859|FG001|Overall Study|Clinical Adverse Event|1|||
48374456|NCT00770341|155564860|FG002|Overall Study|Clinical Adverse Event|2|||
48374457|NCT00770341|155564858|FG000|Overall Study|Laboratory adverse event|3|||
48374458|NCT00770341|155564859|FG001|Overall Study|Laboratory adverse event|3|||
48374459|NCT00770341|155564860|FG002|Overall Study|Laboratory adverse event|0|||
48374460|NCT00770341|155564858|FG000|Overall Study|Lack of Efficacy|3|||
48374461|NCT00770341|155564859|FG001|Overall Study|Lack of Efficacy|0|||
48374462|NCT00770341|155564860|FG002|Overall Study|Lack of Efficacy|1|||
48374463|NCT00770341|155564858|FG000|Overall Study|Other|1|||
48374464|NCT00770341|155564859|FG001|Overall Study|Other|0|||
48374465|NCT00770341|155564860|FG002|Overall Study|Other|0|||
48374466|NCT00770341|155564858|FG000|Overall Study|Not treated|1|||
48374467|NCT00770341|155564859|FG001|Overall Study|Not treated|0|||
48374468|NCT00770341|155564860|FG002|Overall Study|Not treated|0|||
48374469|NCT02796560|155564866|FG000|Overall Study|Adverse Event|2|||
48374470|NCT02796560|155564867|FG001|Overall Study|Adverse Event|0|||
48374471|NCT02796560|155564866|FG000|Overall Study|Withdrawal by Subject|2|||
48374472|NCT02796560|155564867|FG001|Overall Study|Withdrawal by Subject|2|||
48374473|NCT00777946|155564868|FG000|Overall Study|Adverse Event|11|||
48374474|NCT00777946|155564869|FG001|Overall Study|Adverse Event|1|||
48374475|NCT00777946|155564870|FG002|Overall Study|Adverse Event|3|||
48374476|NCT00777946|155564868|FG000|Overall Study|Lack of Efficacy|0|||
48374477|NCT00777946|155564869|FG001|Overall Study|Lack of Efficacy|0|||
48374478|NCT00777946|155564870|FG002|Overall Study|Lack of Efficacy|9|||
48374479|NCT00777946|155564868|FG000|Overall Study|Condition no longer required study drug|1|||
48374480|NCT00777946|155564869|FG001|Overall Study|Condition no longer required study drug|0|||
48374481|NCT00777946|155564870|FG002|Overall Study|Condition no longer required study drug|0|||
48374482|NCT00777946|155564868|FG000|Overall Study|Patient withdrew consent|3|||
48374483|NCT00777946|155564869|FG001|Overall Study|Patient withdrew consent|2|||
48374484|NCT00777946|155564870|FG002|Overall Study|Patient withdrew consent|3|||
48374485|NCT00777946|155564868|FG000|Overall Study|Lost to Follow-up|3|||
48374486|NCT00777946|155564869|FG001|Overall Study|Lost to Follow-up|1|||
48374487|NCT00777946|155564870|FG002|Overall Study|Lost to Follow-up|0|||
48374488|NCT00777946|155564868|FG000|Overall Study|Protocol deviation|2|||
48374489|NCT00777946|155564869|FG001|Overall Study|Protocol deviation|1|||
48374490|NCT00777946|155564870|FG002|Overall Study|Protocol deviation|1|||
48374491|NCT00777946|155564868|FG000|Overall Study|Randomized in error|1|||
48374492|NCT00777946|155564869|FG001|Overall Study|Randomized in error|1|||
48374493|NCT00777946|155564870|FG002|Overall Study|Randomized in error|0|||
48374494|NCT00475033|155564874|FG000|Infant Series|Failed to return|3|||
48374495|NCT00475033|155564875|FG001|Infant Series|Failed to return|4|||
48374496|NCT00475033|155564874|FG000|Infant Series|Parent or legal guardian request|1|||
48374497|NCT00475033|155564875|FG001|Infant Series|Parent or legal guardian request|5|||
48374498|NCT00475033|155564874|FG000|Infant Series|Protocol Violation|1|||
48374499|NCT00475033|155564875|FG001|Infant Series|Protocol Violation|2|||
48374500|NCT00475033|155564874|FG000|Infant Series|Lost to Follow-up|2|||
48374501|NCT00475033|155564875|FG001|Infant Series|Lost to Follow-up|0|||
48374502|NCT00475033|155564874|FG000|Infant Series|Adverse Event|0|||
48374503|NCT00475033|155564875|FG001|Infant Series|Adverse Event|2|||
48374504|NCT00475033|155564874|FG000|After the Infant Series|Adverse Event|0|||
48374505|NCT00475033|155564875|FG001|After the Infant Series|Adverse Event|4|||
48374506|NCT00475033|155564874|FG000|After the Infant Series|Parent or legal guardian request|2|||
48374507|NCT00475033|155564875|FG001|After the Infant Series|Parent or legal guardian request|2|||
48374508|NCT00475033|155564874|FG000|After the Infant Series|Failed to return|2|||
48374509|NCT00475033|155564875|FG001|After the Infant Series|Failed to return|1|||
48374510|NCT00475033|155564874|FG000|After the Infant Series|Protocol Violation|1|||
48374511|NCT00475033|155564875|FG001|After the Infant Series|Protocol Violation|0|||
48374512|NCT00475033|155564874|FG000|After the Infant Series|Lost to Follow-up|1|||
48374513|NCT00475033|155564875|FG001|After the Infant Series|Lost to Follow-up|0|||
48374514|NCT00475033|155564874|FG000|After the Infant Series|Other|0|||
48374515|NCT00475033|155564875|FG001|After the Infant Series|Other|1|||
48374516|NCT00475033|155564874|FG000|Toddler Dose|Parent or legal guardian request|2|||
48374517|NCT00475033|155564875|FG001|Toddler Dose|Parent or legal guardian request|0|||
48374518|NCT00475033|155564874|FG000|Toddler Dose|Failed to return|1|||
48374519|NCT00475033|155564875|FG001|Toddler Dose|Failed to return|0|||
48374520|NCT00475033|155564874|FG000|Toddler Dose|Lost to Follow-up|1|||
48374521|NCT00475033|155564875|FG001|Toddler Dose|Lost to Follow-up|0|||
48374522|NCT02502799|155566573|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
48374523|NCT02502799|155566574|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
48374524|NCT02502799|155566575|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
48374525|NCT02502799|155566576|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
48426311|NCT00933335|155749546|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
48374526|NCT02502799|155566573|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
48374527|NCT02502799|155566574|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
48374528|NCT02502799|155566575|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
48374529|NCT02502799|155566576|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
48374530|NCT02502799|155566573|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
48374531|NCT02502799|155566574|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
48374532|NCT02502799|155566575|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
48374533|NCT02502799|155566576|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
48374534|NCT02502799|155566573|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
48374535|NCT02502799|155566574|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
48374536|NCT02502799|155566575|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
48374537|NCT02502799|155566576|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
48374538|NCT02502799|155566573|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
48374539|NCT02502799|155566574|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
48374540|NCT02502799|155566575|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
48374541|NCT02502799|155566576|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
48374542|NCT01672723|155566577|FG000|First Intervention|Adverse Event|3|||
48374543|NCT01672723|155566578|FG001|First Intervention|Adverse Event|0|||
48374544|NCT01076192|155566585|FG000|Overall Study|Other|197|||
48374545|NCT02915302|155566586|FG000|Overall Study|Adverse Event|3|||
48374546|NCT02915302|155566587|FG001|Overall Study|Adverse Event|0|||
48374547|NCT02915302|155566586|FG000|Overall Study|Protocol Violation|20|||
48374548|NCT02915302|155566587|FG001|Overall Study|Protocol Violation|27|||
48374549|NCT02915302|155566586|FG000|Overall Study|Lost to Follow-up|19|||
48374550|NCT02915302|155566587|FG001|Overall Study|Lost to Follow-up|22|||
48374551|NCT02915302|155566586|FG000|Overall Study|Withdrawal by Subject|22|||
48374552|NCT02915302|155566587|FG001|Overall Study|Withdrawal by Subject|29|||
48374553|NCT02915302|155566586|FG000|Overall Study|Other|1|||
48374554|NCT02915302|155566587|FG001|Overall Study|Other|0|||
48374555|NCT03527173|155566588|FG000|Overall Study|Lost to Follow-up|4|||
48374556|NCT03527173|155566589|FG001|Overall Study|Lost to Follow-up|2|||
48374557|NCT03527173|155566588|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
48374558|NCT03527173|155566589|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
48374559|NCT03527173|155566588|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
48374560|NCT03527173|155566589|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
48374561|NCT03527173|155566588|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
48374562|NCT03527173|155566589|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48374563|NCT00932113|155566590|FG000|Overall Study|Lost to Follow-up|1|||
48374564|NCT00932113|155566591|FG001|Overall Study|Lost to Follow-up|0|||
48374565|NCT03809429|155566594|FG000|Overall Study|Withdrawal by Subject|7|||
48374566|NCT03809429|155566595|FG001|Overall Study|Withdrawal by Subject|3|||
48374567|NCT03809429|155566594|FG000|Overall Study|Adverse Event|6|||
48374568|NCT03809429|155566595|FG001|Overall Study|Adverse Event|9|||
48374569|NCT03809429|155566594|FG000|Overall Study|COVID-19|3|||
48374570|NCT03809429|155566595|FG001|Overall Study|COVID-19|1|||
48374571|NCT03809429|155566594|FG000|Overall Study|Participant was discontinued by investigator|12|||
48374572|NCT03809429|155566595|FG001|Overall Study|Participant was discontinued by investigator|7|||
48374573|NCT02502097|155566596|FG000|Period 1|Adverse Event|0|||
48374574|NCT02502097|155566597|FG001|Period 1|Adverse Event|0|||
48374575|NCT02502097|155566598|FG002|Period 1|Adverse Event|1|||
48374576|NCT02502097|155566599|FG003|Period 1|Adverse Event|0|||
48374577|NCT02502097|155566596|FG000|Wash Out Period|Adverse Event|0|||
48374578|NCT02502097|155566597|FG001|Wash Out Period|Adverse Event|1|||
48374579|NCT02502097|155566598|FG002|Wash Out Period|Adverse Event|1|||
48374580|NCT02502097|155566599|FG003|Wash Out Period|Adverse Event|1|||
48374581|NCT02502097|155566596|FG000|Period 2|Adverse Event|0|||
48374582|NCT02502097|155566597|FG001|Period 2|Adverse Event|0|||
48374583|NCT02502097|155566598|FG002|Period 2|Adverse Event|1|||
48374584|NCT02502097|155566599|FG003|Period 2|Adverse Event|0|||
48374585|NCT04875676|155566602|FG000|Overall Study|Lost to Follow-up|1|||
48374586|NCT04875676|155566603|FG001|Overall Study|Lost to Follow-up|0|||
48374587|NCT04875676|155566604|FG002|Overall Study|Lost to Follow-up|0|||
48374588|NCT04187989|155566607|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
48374589|NCT04187989|155566608|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
48374590|NCT04187989|155566607|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
48374591|NCT04187989|155566608|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
48374592|NCT03064035|155566609|FG000|Overall Study|Did not receive allocated intervention|4|||
48374593|NCT03064035|155566610|FG001|Overall Study|Did not receive allocated intervention|2|||
48374594|NCT03064035|155566609|FG000|Overall Study|Lost to Follow-up|1|||
48374595|NCT03064035|155566610|FG001|Overall Study|Lost to Follow-up|1|||
48374596|NCT02029846|155566611|FG000|Overall Study|n=1 each arm|1|||
48374597|NCT02029846|155566612|FG001|Overall Study|n=1 each arm|1|||
48374598|NCT00762970|155566613|FG000|Overall Study|Withdrawal by Subject|7|||
48374599|NCT00762970|155566614|FG001|Overall Study|Withdrawal by Subject|4|||
48374600|NCT00762970|155566615|FG002|Overall Study|Withdrawal by Subject|0|||
48374601|NCT00762970|155566613|FG000|Overall Study|Protocol Violation|3|||
48374602|NCT00762970|155566614|FG001|Overall Study|Protocol Violation|1|||
48374603|NCT00762970|155566615|FG002|Overall Study|Protocol Violation|1|||
48374604|NCT00762970|155566613|FG000|Overall Study|Lost to Follow-up|1|||
48374605|NCT00762970|155566614|FG001|Overall Study|Lost to Follow-up|2|||
48374606|NCT00762970|155566615|FG002|Overall Study|Lost to Follow-up|0|||
48374607|NCT00762970|155566613|FG000|Overall Study|Difficulty of handling lens|1|||
48374608|NCT00762970|155566614|FG001|Overall Study|Difficulty of handling lens|2|||
48374609|NCT00762970|155566615|FG002|Overall Study|Difficulty of handling lens|0|||
48374610|NCT03718533|155566616|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
48374611|NCT03718533|155566616|FG000|Overall Study|Protocol deviation|1|||
48374612|NCT03718533|155566616|FG000|Overall Study|Disease progression|1|||
48374613|NCT03718533|155566616|FG000|Overall Study|Relapse|1|||
48374614|NCT03718533|155566616|FG000|Overall Study|Physician Decision|2|||
48374615|NCT03718533|155566616|FG000|Overall Study|Physician Decision and Adverse Event|1|||
48374616|NCT04256629|155566617|FG000|Overall Study|Adverse Event|0|||
48374617|NCT04256629|155566618|FG001|Overall Study|Adverse Event|0|||
48374618|NCT04256629|155566619|FG002|Overall Study|Adverse Event|0|||
48374619|NCT04256629|155566620|FG003|Overall Study|Adverse Event|0|||
48374620|NCT04256629|155566621|FG004|Overall Study|Adverse Event|0|||
48374621|NCT04256629|155566622|FG005|Overall Study|Adverse Event|1|||
48374622|NCT04256629|155566617|FG000|Overall Study|Protocol Violation|0|||
48374623|NCT04256629|155566618|FG001|Overall Study|Protocol Violation|1|||
48374624|NCT04256629|155566619|FG002|Overall Study|Protocol Violation|0|||
48374625|NCT04256629|155566620|FG003|Overall Study|Protocol Violation|0|||
48374626|NCT04256629|155566621|FG004|Overall Study|Protocol Violation|0|||
48374627|NCT04256629|155566622|FG005|Overall Study|Protocol Violation|0|||
48374628|NCT01774487|155566623|FG000|Overall Study|Did not tolerate taste|4|||
48374629|NCT01774487|155566624|FG001|Overall Study|Did not tolerate taste|4|||
48374630|NCT00346632|155566625|FG000|Overall Study|Progressive Disease|2|||
48374631|NCT00346632|155566626|FG001|Overall Study|Progressive Disease|2|||
48374632|NCT00346632|155566627|FG002|Overall Study|Progressive Disease|4|||
48374633|NCT00346632|155566628|FG003|Overall Study|Progressive Disease|3|||
48374634|NCT00346632|155566629|FG004|Overall Study|Progressive Disease|3|||
48374635|NCT00346632|155566630|FG005|Overall Study|Progressive Disease|1|||
48374636|NCT00346632|155566631|FG006|Overall Study|Progressive Disease|2|||
48374637|NCT00346632|155566632|FG007|Overall Study|Progressive Disease|2|||
48374638|NCT00346632|155566633|FG008|Overall Study|Progressive Disease|2|||
48374639|NCT00346632|155566634|FG009|Overall Study|Progressive Disease|2|||
48374640|NCT00346632|155566625|FG000|Overall Study|Adverse Event|0|||
48374641|NCT00346632|155566626|FG001|Overall Study|Adverse Event|0|||
48374642|NCT00346632|155566627|FG002|Overall Study|Adverse Event|0|||
48374643|NCT00346632|155566628|FG003|Overall Study|Adverse Event|0|||
48374644|NCT00346632|155566629|FG004|Overall Study|Adverse Event|1|||
48374645|NCT00346632|155566630|FG005|Overall Study|Adverse Event|1|||
48374646|NCT00346632|155566631|FG006|Overall Study|Adverse Event|1|||
48374647|NCT00346632|155566632|FG007|Overall Study|Adverse Event|0|||
48374648|NCT00346632|155566633|FG008|Overall Study|Adverse Event|0|||
48374649|NCT00346632|155566634|FG009|Overall Study|Adverse Event|0|||
48374650|NCT00346632|155566625|FG000|Overall Study|Death|0|||
48374651|NCT00346632|155566626|FG001|Overall Study|Death|0|||
48374652|NCT00346632|155566627|FG002|Overall Study|Death|1|||
48374653|NCT00346632|155566628|FG003|Overall Study|Death|0|||
48374654|NCT00346632|155566629|FG004|Overall Study|Death|0|||
48374655|NCT00346632|155566630|FG005|Overall Study|Death|0|||
48374656|NCT00346632|155566631|FG006|Overall Study|Death|0|||
48374657|NCT00346632|155566632|FG007|Overall Study|Death|0|||
48374658|NCT00346632|155566633|FG008|Overall Study|Death|0|||
48374659|NCT00346632|155566634|FG009|Overall Study|Death|0|||
48374660|NCT00346632|155566625|FG000|Overall Study|Protocol Violation|0|||
48374661|NCT00346632|155566626|FG001|Overall Study|Protocol Violation|0|||
48374662|NCT00346632|155566627|FG002|Overall Study|Protocol Violation|0|||
48374663|NCT00346632|155566628|FG003|Overall Study|Protocol Violation|0|||
48374664|NCT00346632|155566629|FG004|Overall Study|Protocol Violation|0|||
48374665|NCT00346632|155566630|FG005|Overall Study|Protocol Violation|0|||
48374666|NCT00346632|155566631|FG006|Overall Study|Protocol Violation|1|||
48374667|NCT00346632|155566632|FG007|Overall Study|Protocol Violation|0|||
48374668|NCT00346632|155566633|FG008|Overall Study|Protocol Violation|0|||
48374669|NCT00346632|155566634|FG009|Overall Study|Protocol Violation|0|||
48374670|NCT00346632|155566625|FG000|Overall Study|Withdrawal by Subject|0|||
48374671|NCT00346632|155566626|FG001|Overall Study|Withdrawal by Subject|0|||
48374672|NCT00346632|155566627|FG002|Overall Study|Withdrawal by Subject|0|||
48374673|NCT00346632|155566628|FG003|Overall Study|Withdrawal by Subject|0|||
48374674|NCT00346632|155566629|FG004|Overall Study|Withdrawal by Subject|0|||
48374675|NCT00346632|155566630|FG005|Overall Study|Withdrawal by Subject|0|||
48374676|NCT00346632|155566631|FG006|Overall Study|Withdrawal by Subject|1|||
48374677|NCT00346632|155566632|FG007|Overall Study|Withdrawal by Subject|0|||
48374678|NCT00346632|155566633|FG008|Overall Study|Withdrawal by Subject|0|||
48374679|NCT00346632|155566634|FG009|Overall Study|Withdrawal by Subject|0|||
48374680|NCT00346632|155566625|FG000|Overall Study|Switched to alternative treatment|0|||
48374681|NCT00346632|155566626|FG001|Overall Study|Switched to alternative treatment|0|||
48374682|NCT00346632|155566627|FG002|Overall Study|Switched to alternative treatment|1|||
48374683|NCT00346632|155566628|FG003|Overall Study|Switched to alternative treatment|0|||
48374684|NCT00346632|155566629|FG004|Overall Study|Switched to alternative treatment|0|||
48374685|NCT00346632|155566630|FG005|Overall Study|Switched to alternative treatment|0|||
48374686|NCT00346632|155566631|FG006|Overall Study|Switched to alternative treatment|0|||
48374687|NCT00346632|155566632|FG007|Overall Study|Switched to alternative treatment|0|||
48374688|NCT00346632|155566633|FG008|Overall Study|Switched to alternative treatment|0|||
48374689|NCT00346632|155566634|FG009|Overall Study|Switched to alternative treatment|0|||
48374690|NCT00346632|155566625|FG000|Overall Study|Not Stated|1|||
48374691|NCT00346632|155566626|FG001|Overall Study|Not Stated|1|||
48374692|NCT00346632|155566627|FG002|Overall Study|Not Stated|0|||
48374693|NCT00346632|155566628|FG003|Overall Study|Not Stated|0|||
48374694|NCT00346632|155566629|FG004|Overall Study|Not Stated|0|||
48374695|NCT00346632|155566630|FG005|Overall Study|Not Stated|0|||
48374696|NCT00346632|155566631|FG006|Overall Study|Not Stated|0|||
48374697|NCT00346632|155566632|FG007|Overall Study|Not Stated|2|||
48374698|NCT00346632|155566633|FG008|Overall Study|Not Stated|2|||
48374699|NCT00346632|155566634|FG009|Overall Study|Not Stated|1|||
48374700|NCT02038543|155566642|FG000|Overall Study|Screen Failure|0|||
48374701|NCT02038543|155566643|FG001|Overall Study|Screen Failure|0|||
48374702|NCT02038543|155566644|FG002|Overall Study|Screen Failure|0|||
48374703|NCT02038543|155566645|FG003|Overall Study|Screen Failure|1|||
48374704|NCT02038543|155566642|FG000|Overall Study|Withdrawal by Subject|0|||
48374705|NCT02038543|155566643|FG001|Overall Study|Withdrawal by Subject|0|||
48374706|NCT02038543|155566644|FG002|Overall Study|Withdrawal by Subject|0|||
48374707|NCT02038543|155566645|FG003|Overall Study|Withdrawal by Subject|1|||
48374708|NCT03214094|155566646|FG000|Overall Study|Case Report Forms Uncollected|14|||
48374709|NCT03214094|155566646|FG000|Overall Study|Protocol Deviation|46|||
48374710|NCT01029652|155566647|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
48374711|NCT01029652|155566648|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
48374712|NCT01029652|155566647|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
48374713|NCT01029652|155566648|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
48374714|NCT01029652|155566647|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
48374715|NCT01029652|155566648|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
48374716|NCT01029652|155566647|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
48374717|NCT01029652|155566648|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
48374718|NCT01029652|155566647|FG000|Core Study (0-12 Weeks)|Death|0|||
48374719|NCT01029652|155566648|FG001|Core Study (0-12 Weeks)|Death|1|||
48374720|NCT01029652|155566647|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
48374721|NCT01029652|155566648|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
48374722|NCT01029652|155566647|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
48374723|NCT01029652|155566648|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
48374724|NCT01029652|155566647|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
48374725|NCT01029652|155566648|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
48374726|NCT01029652|155566647|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
48374727|NCT01029652|155566648|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
48374728|NCT01029652|155566647|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
48374729|NCT01029652|155566648|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
48374730|NCT01029652|155566647|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
48374731|NCT01029652|155566648|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
48374732|NCT01029652|155566647|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
48374733|NCT01029652|155566648|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
48374734|NCT01577745|155566649|FG000|Overall Study|Withdrawal by Subject|0|||
48374735|NCT01577745|155566650|FG001|Overall Study|Withdrawal by Subject|1|||
48374736|NCT01577745|155566651|FG002|Overall Study|Withdrawal by Subject|0|||
48374737|NCT01577745|155566652|FG003|Overall Study|Withdrawal by Subject|3|||
48374738|NCT01577745|155566653|FG004|Overall Study|Withdrawal by Subject|2|||
48374739|NCT01577745|155566654|FG005|Overall Study|Withdrawal by Subject|0|||
48374740|NCT01577745|155566649|FG000|Overall Study|Death|3|||
48374741|NCT01577745|155566650|FG001|Overall Study|Death|2|||
48374742|NCT01577745|155566651|FG002|Overall Study|Death|2|||
48374743|NCT01577745|155566652|FG003|Overall Study|Death|1|||
48374744|NCT01577745|155566653|FG004|Overall Study|Death|1|||
48374745|NCT01577745|155566654|FG005|Overall Study|Death|3|||
48374746|NCT01577745|155566649|FG000|Overall Study|Physician Decision|0|||
48374747|NCT01577745|155566650|FG001|Overall Study|Physician Decision|0|||
48374748|NCT01577745|155566651|FG002|Overall Study|Physician Decision|0|||
48374749|NCT01577745|155566652|FG003|Overall Study|Physician Decision|1|||
48374750|NCT01577745|155566653|FG004|Overall Study|Physician Decision|1|||
48374751|NCT01577745|155566654|FG005|Overall Study|Physician Decision|0|||
48374752|NCT01577745|155566649|FG000|Overall Study|Lost to Follow-up|0|||
48374753|NCT01577745|155566650|FG001|Overall Study|Lost to Follow-up|0|||
48374754|NCT01577745|155566651|FG002|Overall Study|Lost to Follow-up|0|||
48374755|NCT01577745|155566652|FG003|Overall Study|Lost to Follow-up|0|||
48374756|NCT01577745|155566653|FG004|Overall Study|Lost to Follow-up|0|||
48374757|NCT01577745|155566654|FG005|Overall Study|Lost to Follow-up|1|||
48374758|NCT01577745|155566649|FG000|Overall Study|Alternative Therapy|0|||
48374759|NCT01577745|155566650|FG001|Overall Study|Alternative Therapy|0|||
48374760|NCT01577745|155566651|FG002|Overall Study|Alternative Therapy|0|||
48374761|NCT01577745|155566652|FG003|Overall Study|Alternative Therapy|1|||
48374762|NCT01577745|155566653|FG004|Overall Study|Alternative Therapy|1|||
48374763|NCT01577745|155566654|FG005|Overall Study|Alternative Therapy|0|||
48374764|NCT02483585|155566657|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
48374765|NCT02483585|155566658|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
48374766|NCT02483585|155566657|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
48374767|NCT02483585|155566658|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
48374768|NCT02483585|155566657|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
48374769|NCT02483585|155566658|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
48374770|NCT02483585|155566657|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
48374771|NCT02483585|155566658|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
48374772|NCT02483585|155566657|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
48374773|NCT02483585|155566658|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
48374774|NCT02483585|155566657|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
48374775|NCT02483585|155566658|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
48374776|NCT02483585|155566657|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
48374777|NCT02483585|155566658|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
48374778|NCT01990560|155566660|FG000|Overall Study|Withdrawal by Subject|1|||
48374779|NCT01236339|155566661|FG000|Overall Study|Termination of study by sponsor|11|||
48374780|NCT01236339|155566662|FG001|Overall Study|Termination of study by sponsor|13|||
48374781|NCT01411215|155566663|FG000|Overall Study|Adverse Event|1|||
48374782|NCT01411215|155566664|FG001|Overall Study|Adverse Event|2|||
48374783|NCT01411215|155566663|FG000|Overall Study|Lack of Efficacy|2|||
48374784|NCT01411215|155566664|FG001|Overall Study|Lack of Efficacy|4|||
48374785|NCT01411215|155566663|FG000|Overall Study|Lost to Follow-up|12|||
48374786|NCT01411215|155566664|FG001|Overall Study|Lost to Follow-up|18|||
48374787|NCT01411215|155566663|FG000|Overall Study|Did not meet entrance criteria|0|||
48374788|NCT01411215|155566664|FG001|Overall Study|Did not meet entrance criteria|1|||
48374789|NCT01411215|155566663|FG000|Overall Study|Study terminated by sponsor|2|||
48374790|NCT01411215|155566664|FG001|Overall Study|Study terminated by sponsor|15|||
48374791|NCT01411215|155566663|FG000|Overall Study|Protocol Violation|3|||
48374792|NCT01411215|155566664|FG001|Overall Study|Protocol Violation|5|||
48374793|NCT01411215|155566663|FG000|Overall Study|Withdrawal by Subject|34|||
48374794|NCT01411215|155566664|FG001|Overall Study|Withdrawal by Subject|21|||
48374795|NCT01411215|155566663|FG000|Overall Study|Other|12|||
48374796|NCT01411215|155566664|FG001|Overall Study|Other|17|||
48374797|NCT01411215|155566663|FG000|Overall Study|Screen failure|0|||
48374798|NCT01411215|155566664|FG001|Overall Study|Screen failure|1|||
48374799|NCT02924064|155566665|FG000|Overall Study|Adverse Event|2|||
48374800|NCT02924064|155566666|FG001|Overall Study|Adverse Event|2|||
48374801|NCT02924064|155566665|FG000|Overall Study|Lost to Follow-up|0|||
48374802|NCT02924064|155566666|FG001|Overall Study|Lost to Follow-up|2|||
48374803|NCT02924064|155566665|FG000|Overall Study|Physician Decision|0|||
48374804|NCT02924064|155566666|FG001|Overall Study|Physician Decision|2|||
48374805|NCT02924064|155566665|FG000|Overall Study|Protocol Violation|1|||
48374806|NCT02924064|155566666|FG001|Overall Study|Protocol Violation|3|||
48374807|NCT02924064|155566665|FG000|Overall Study|Withdrawal by Subject|4|||
48374808|NCT02924064|155566666|FG001|Overall Study|Withdrawal by Subject|5|||
48374809|NCT02924064|155566665|FG000|Overall Study|Other|17|||
48374810|NCT02924064|155566666|FG001|Overall Study|Other|29|||
48374811|NCT00336895|155566669|FG000|Overall Study|diarrhea|1|||
48374812|NCT00336895|155566669|FG000|Overall Study|nausea and upset stomach|1|||
48374813|NCT00336895|155566669|FG000|Overall Study|Physician Decision|1|||
48374814|NCT00336895|155566669|FG000|Overall Study|screen failed|1|||
48374815|NCT00906945|155566670|FG000|Overall Study|Found to be not eligible|0|||
48374816|NCT00906945|155566671|FG001|Overall Study|Found to be not eligible|0|||
48374817|NCT00906945|155566672|FG002|Overall Study|Found to be not eligible|0|||
48374818|NCT00906945|155566673|FG003|Overall Study|Found to be not eligible|1|||
48374819|NCT00906945|155566674|FG004|Overall Study|Found to be not eligible|1|||
48374820|NCT00906945|155566675|FG005|Overall Study|Found to be not eligible|1|||
48374821|NCT00906945|155566670|FG000|Overall Study|Physician Decision|0|||
48374822|NCT00906945|155566671|FG001|Overall Study|Physician Decision|0|||
48374823|NCT00906945|155566672|FG002|Overall Study|Physician Decision|0|||
48374824|NCT00906945|155566673|FG003|Overall Study|Physician Decision|0|||
48374825|NCT00906945|155566674|FG004|Overall Study|Physician Decision|0|||
48374826|NCT00906945|155566675|FG005|Overall Study|Physician Decision|1|||
48374827|NCT01007448|155566676|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
48374828|NCT01007448|155566677|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
48374829|NCT01007448|155566676|FG000|Overall Study|Staph Skin Infection Flare|1|||
48374830|NCT01007448|155566677|FG001|Overall Study|Staph Skin Infection Flare|0|||
48374831|NCT01007448|155566676|FG000|Overall Study|Participant Leaving the Country|1|||
48374832|NCT01007448|155566677|FG001|Overall Study|Participant Leaving the Country|0|||
48374833|NCT01007448|155566676|FG000|Overall Study|Participant Given Prohibited Medication|1|||
48374834|NCT01007448|155566677|FG001|Overall Study|Participant Given Prohibited Medication|0|||
48374835|NCT01007448|155566676|FG000|Overall Study|Progressive Disease|1|||
48374836|NCT01007448|155566677|FG001|Overall Study|Progressive Disease|2|||
48374837|NCT01007448|155566676|FG000|Overall Study|Lack of Efficacy|2|||
48374838|NCT01007448|155566677|FG001|Overall Study|Lack of Efficacy|0|||
48374839|NCT01007448|155566676|FG000|Overall Study|Withdrawal by Subject|2|||
48374840|NCT01007448|155566677|FG001|Overall Study|Withdrawal by Subject|3|||
48374841|NCT01007448|155566676|FG000|Overall Study|Adverse Event|1|||
48374842|NCT01007448|155566677|FG001|Overall Study|Adverse Event|4|||
48374843|NCT02121834|155566678|FG000|Overall Study|Protocol Violation|0|||
48374844|NCT02121834|155566679|FG001|Overall Study|Protocol Violation|1|||
48374845|NCT02121834|155566680|FG002|Overall Study|Protocol Violation|0|||
48374846|NCT02121834|155566681|FG003|Overall Study|Protocol Violation|0|||
48374847|NCT02121834|155566682|FG004|Overall Study|Protocol Violation|0|||
48374848|NCT02121834|155566683|FG005|Overall Study|Protocol Violation|0|||
48374849|NCT02121834|155566684|FG006|Overall Study|Protocol Violation|0|||
48374850|NCT02121834|155566678|FG000|Overall Study|Withdrawal by Subject|0|||
48374851|NCT02121834|155566679|FG001|Overall Study|Withdrawal by Subject|1|||
48374852|NCT02121834|155566680|FG002|Overall Study|Withdrawal by Subject|1|||
48374853|NCT02121834|155566681|FG003|Overall Study|Withdrawal by Subject|0|||
48374854|NCT02121834|155566682|FG004|Overall Study|Withdrawal by Subject|0|||
48374855|NCT02121834|155566683|FG005|Overall Study|Withdrawal by Subject|0|||
48374856|NCT02121834|155566684|FG006|Overall Study|Withdrawal by Subject|0|||
48374857|NCT02121834|155566678|FG000|Overall Study|Lost to Follow-up|0|||
48374858|NCT02121834|155566679|FG001|Overall Study|Lost to Follow-up|0|||
48374859|NCT02121834|155566680|FG002|Overall Study|Lost to Follow-up|1|||
48374860|NCT02121834|155566681|FG003|Overall Study|Lost to Follow-up|0|||
48374861|NCT02121834|155566682|FG004|Overall Study|Lost to Follow-up|0|||
48374862|NCT02121834|155566683|FG005|Overall Study|Lost to Follow-up|0|||
48374863|NCT02121834|155566684|FG006|Overall Study|Lost to Follow-up|0|||
48374864|NCT03814187|155566685|FG000|Overall Study|Sponsor's Administrative Decision|0|||
48374865|NCT03814187|155566686|FG001|Overall Study|Sponsor's Administrative Decision|0|||
48374866|NCT03814187|155566687|FG002|Overall Study|Sponsor's Administrative Decision|272|||
48374867|NCT03814187|155566685|FG000|Overall Study|Death|80|||
48374868|NCT03814187|155566686|FG001|Overall Study|Death|81|||
48374869|NCT03814187|155566687|FG002|Overall Study|Death|4|||
48374870|NCT03814187|155566685|FG000|Overall Study|Withdrew Consent|77|||
48374871|NCT03814187|155566686|FG001|Overall Study|Withdrew Consent|78|||
48374872|NCT03814187|155566687|FG002|Overall Study|Withdrew Consent|2|||
48374873|NCT03814187|155566685|FG000|Overall Study|Lost to Follow-up|47|||
48374874|NCT03814187|155566686|FG001|Overall Study|Lost to Follow-up|52|||
48374875|NCT03814187|155566687|FG002|Overall Study|Lost to Follow-up|1|||
48374876|NCT03814187|155566685|FG000|Overall Study|Adverse Event|22|||
48374877|NCT03814187|155566686|FG001|Overall Study|Adverse Event|23|||
48374878|NCT03814187|155566687|FG002|Overall Study|Adverse Event|0|||
48374879|NCT03814187|155566685|FG000|Overall Study|Physician Decision|7|||
48374880|NCT03814187|155566686|FG001|Overall Study|Physician Decision|4|||
48374881|NCT03814187|155566687|FG002|Overall Study|Physician Decision|2|||
48374882|NCT03814187|155566685|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
48374883|NCT03814187|155566686|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
48374884|NCT03814187|155566687|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
48374885|NCT03814187|155566685|FG000|Overall Study|Other reasons|34|||
48374886|NCT03814187|155566686|FG001|Overall Study|Other reasons|40|||
48374887|NCT03814187|155566687|FG002|Overall Study|Other reasons|2|||
48374888|NCT00950950|155566688|FG000|Overall Study|Adverse Event|1|||
48374889|NCT00950950|155566689|FG001|Overall Study|Adverse Event|0|||
48374890|NCT00950950|155566688|FG000|Overall Study|Withdrawal by Subject|0|||
48374891|NCT00950950|155566689|FG001|Overall Study|Withdrawal by Subject|1|||
48374892|NCT01047293|155566690|FG000|Overall Study|DLT criteria not fulfilled|1|||
48374893|NCT01047293|155566691|FG001|Overall Study|DLT criteria not fulfilled|1|||
48374894|NCT01047293|155566692|FG002|Overall Study|DLT criteria not fulfilled|0|||
48374895|NCT01047293|155566693|FG003|Overall Study|DLT criteria not fulfilled|0|||
48374896|NCT02318797|155566694|FG000|Overall Study|Death|3|||
48374897|NCT02318797|155566695|FG001|Overall Study|Death|6|||
48374898|NCT02318797|155566694|FG000|Overall Study|Lost to Follow-up|85|||
48374899|NCT02318797|155566695|FG001|Overall Study|Lost to Follow-up|96|||
48374900|NCT00928447|155566696|FG000|Overall Study|Withdrawal by Subject|1|||
48374901|NCT00928447|155566696|FG000|Overall Study|Investigator's decision|1|||
48374902|NCT01012713|155566697|FG000|Overall Study|Lack of Efficacy|3|||
48374903|NCT01668667|155566698|FG000|Overall Study|Adverse Event|3|||
48374904|NCT01668667|155566699|FG001|Overall Study|Adverse Event|6|||
48374905|NCT01668667|155566700|FG002|Overall Study|Adverse Event|4|||
48374906|NCT01668667|155566701|FG003|Overall Study|Adverse Event|4|||
48374907|NCT01668667|155566698|FG000|Overall Study|Lack of Efficacy|3|||
48374908|NCT01668667|155566699|FG001|Overall Study|Lack of Efficacy|2|||
48374909|NCT01668667|155566700|FG002|Overall Study|Lack of Efficacy|2|||
48374910|NCT01668667|155566701|FG003|Overall Study|Lack of Efficacy|3|||
48374911|NCT01668667|155566698|FG000|Overall Study|Protocol Violation|6|||
48374912|NCT01668667|155566699|FG001|Overall Study|Protocol Violation|10|||
48374913|NCT01668667|155566700|FG002|Overall Study|Protocol Violation|12|||
48374914|NCT01668667|155566701|FG003|Overall Study|Protocol Violation|5|||
48374915|NCT01668667|155566698|FG000|Overall Study|Lost to Follow-up|9|||
48374916|NCT01668667|155566699|FG001|Overall Study|Lost to Follow-up|4|||
48374917|NCT01668667|155566700|FG002|Overall Study|Lost to Follow-up|7|||
48374918|NCT01668667|155566701|FG003|Overall Study|Lost to Follow-up|6|||
48374919|NCT01668667|155566698|FG000|Overall Study|Physician Decision|3|||
48374920|NCT01668667|155566699|FG001|Overall Study|Physician Decision|0|||
48374921|NCT01668667|155566700|FG002|Overall Study|Physician Decision|1|||
48374922|NCT01668667|155566701|FG003|Overall Study|Physician Decision|0|||
48374923|NCT01668667|155566698|FG000|Overall Study|Withdrawal by Subject|7|||
48374924|NCT01668667|155566699|FG001|Overall Study|Withdrawal by Subject|4|||
48374925|NCT01668667|155566700|FG002|Overall Study|Withdrawal by Subject|5|||
48374926|NCT01668667|155566701|FG003|Overall Study|Withdrawal by Subject|5|||
48374927|NCT05056987|155566705|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
48374928|NCT05056987|155566706|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
48374929|NCT05056987|155566705|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
48374930|NCT05056987|155566706|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
48374931|NCT01296347|155566707|FG000|Allocation|Withdrawal by Subject|1|||
48374932|NCT01296347|155566708|FG001|Allocation|Withdrawal by Subject|2|||
48374933|NCT01296347|155566707|FG000|Allocation|Lack of Efficacy|1|||
48374934|NCT01296347|155566708|FG001|Allocation|Lack of Efficacy|2|||
48374935|NCT01296347|155566707|FG000|Allocation|not received infusion|1|||
48374936|NCT01296347|155566708|FG001|Allocation|not received infusion|0|||
48374937|NCT01296347|155566707|FG000|6 Week Follow up|Death|0|||
48374938|NCT01296347|155566708|FG001|6 Week Follow up|Death|1|||
48374939|NCT01296347|155566707|FG000|3 Month Follow up|Death|1|||
48374940|NCT01296347|155566708|FG001|3 Month Follow up|Death|0|||
48374941|NCT01296347|155566707|FG000|3 Month Follow up|Lost to Follow-up|0|||
48374942|NCT01296347|155566708|FG001|3 Month Follow up|Lost to Follow-up|1|||
48374943|NCT01296347|155566707|FG000|6 Month Follow up|Death|2|||
48374944|NCT01296347|155566708|FG001|6 Month Follow up|Death|1|||
48374945|NCT01296347|155566707|FG000|6 Month Follow up|Lost to Follow-up|0|||
48374946|NCT01296347|155566708|FG001|6 Month Follow up|Lost to Follow-up|1|||
48374947|NCT01296347|155566707|FG000|12 Month Follow up|Lost to Follow-up|3|||
48374948|NCT01296347|155566708|FG001|12 Month Follow up|Lost to Follow-up|1|||
48374949|NCT01296347|155566707|FG000|12 Month Follow up|Death|1|||
48374950|NCT01296347|155566708|FG001|12 Month Follow up|Death|1|||
48374951|NCT01296347|155566707|FG000|12 Month Follow up|Withdrawal by Subject|0|||
48374952|NCT01296347|155566708|FG001|12 Month Follow up|Withdrawal by Subject|1|||
48374953|NCT01585987|155566709|FG000|Randomized|Withdrawal by Subject|0|||
48374954|NCT01585987|155566710|FG001|Randomized|Withdrawal by Subject|4|||
48374955|NCT01585987|155566709|FG000|Randomized|No longer met criteria|0|||
48374956|NCT01585987|155566710|FG001|Randomized|No longer met criteria|2|||
48374957|NCT01585987|155566709|FG000|Treated|Disease Progression|39|||
48374958|NCT01585987|155566710|FG001|Treated|Disease Progression|36|||
48374959|NCT01585987|155566709|FG000|Treated|Study Drug Toxicity|9|||
48374960|NCT01585987|155566710|FG001|Treated|Study Drug Toxicity|5|||
48374961|NCT01585987|155566709|FG000|Treated|Adverse Event|3|||
48374962|NCT01585987|155566710|FG001|Treated|Adverse Event|0|||
48374963|NCT01585987|155566709|FG000|Treated|Withdrawal by Subject|1|||
48374964|NCT01585987|155566710|FG001|Treated|Withdrawal by Subject|2|||
48374965|NCT01585987|155566709|FG000|Treated|Death|1|||
48374966|NCT01585987|155566710|FG001|Treated|Death|0|||
48374967|NCT01585987|155566709|FG000|Treated|Lost to Follow-up|0|||
48374968|NCT01585987|155566710|FG001|Treated|Lost to Follow-up|1|||
48374969|NCT01585987|155566709|FG000|Treated|Maximum Clinical Benefit|0|||
48374970|NCT01585987|155566710|FG001|Treated|Maximum Clinical Benefit|1|||
48374971|NCT01585987|155566709|FG000|Treated|Non-Specified|1|||
48374972|NCT01585987|155566710|FG001|Treated|Non-Specified|2|||
48374973|NCT01585987|155566709|FG000|Treated|Subject Request|0|||
48374974|NCT01585987|155566710|FG001|Treated|Subject Request|1|||
48374975|NCT01585987|155566709|FG000|Treated|Poor/Non-Compliance|0|||
48374976|NCT01585987|155566710|FG001|Treated|Poor/Non-Compliance|1|||
48374977|NCT02739360|155566711|FG000|Overall Study|Adverse Event|1|||
48374978|NCT02739360|155566711|FG000|Overall Study|Study terminated by Sponsor|2|||
48374979|NCT00960531|155566712|FG000|Overall Study|Lack of Efficacy|1|||
48374980|NCT00960531|155566713|FG001|Overall Study|Lack of Efficacy|0|||
48374981|NCT00960531|155566714|FG002|Overall Study|Lack of Efficacy|0|||
48374982|NCT00960531|155566715|FG003|Overall Study|Lack of Efficacy|0|||
48374983|NCT00960531|155566716|FG004|Overall Study|Lack of Efficacy|0|||
48374984|NCT00960531|155566717|FG005|Overall Study|Lack of Efficacy|0|||
48374985|NCT00960531|155566718|FG006|Overall Study|Lack of Efficacy|0|||
48374986|NCT00960531|155566719|FG007|Overall Study|Lack of Efficacy|0|||
48374987|NCT00960531|155566720|FG008|Overall Study|Lack of Efficacy|0|||
48374988|NCT00960531|155566721|FG009|Overall Study|Lack of Efficacy|0|||
48374989|NCT00960531|155566712|FG000|Overall Study|Withdrawal by Subject|1|||
48374990|NCT00960531|155566713|FG001|Overall Study|Withdrawal by Subject|0|||
48374991|NCT00960531|155566714|FG002|Overall Study|Withdrawal by Subject|5|||
48374992|NCT00960531|155566715|FG003|Overall Study|Withdrawal by Subject|2|||
48374993|NCT00960531|155566716|FG004|Overall Study|Withdrawal by Subject|0|||
48374994|NCT00960531|155566717|FG005|Overall Study|Withdrawal by Subject|0|||
48374995|NCT00960531|155566718|FG006|Overall Study|Withdrawal by Subject|2|||
48374996|NCT00960531|155566719|FG007|Overall Study|Withdrawal by Subject|0|||
48374997|NCT00960531|155566720|FG008|Overall Study|Withdrawal by Subject|1|||
48374998|NCT00960531|155566721|FG009|Overall Study|Withdrawal by Subject|0|||
48374999|NCT00960531|155566712|FG000|Overall Study|Caregiver Request|2|||
48375000|NCT00960531|155566713|FG001|Overall Study|Caregiver Request|0|||
48375001|NCT00960531|155566714|FG002|Overall Study|Caregiver Request|6|||
48375002|NCT00960531|155566715|FG003|Overall Study|Caregiver Request|5|||
48375003|NCT00960531|155566716|FG004|Overall Study|Caregiver Request|0|||
48375004|NCT00960531|155566717|FG005|Overall Study|Caregiver Request|2|||
48375005|NCT00960531|155566718|FG006|Overall Study|Caregiver Request|3|||
48375006|NCT00960531|155566719|FG007|Overall Study|Caregiver Request|1|||
48375007|NCT00960531|155566720|FG008|Overall Study|Caregiver Request|3|||
48375008|NCT00960531|155566721|FG009|Overall Study|Caregiver Request|0|||
48375009|NCT00960531|155566712|FG000|Overall Study|Investigator Request|0|||
48375010|NCT00960531|155566713|FG001|Overall Study|Investigator Request|0|||
48375011|NCT00960531|155566714|FG002|Overall Study|Investigator Request|1|||
48375012|NCT00960531|155566715|FG003|Overall Study|Investigator Request|0|||
48375013|NCT00960531|155566716|FG004|Overall Study|Investigator Request|0|||
48375014|NCT00960531|155566717|FG005|Overall Study|Investigator Request|0|||
48375015|NCT00960531|155566718|FG006|Overall Study|Investigator Request|0|||
48375016|NCT00960531|155566719|FG007|Overall Study|Investigator Request|0|||
48375017|NCT00960531|155566720|FG008|Overall Study|Investigator Request|0|||
48375018|NCT00960531|155566721|FG009|Overall Study|Investigator Request|0|||
48375019|NCT00960531|155566712|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
48375020|NCT00960531|155566713|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
48375021|NCT00960531|155566714|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
48375022|NCT00960531|155566715|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
48375023|NCT00960531|155566716|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
48375024|NCT00960531|155566717|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
48375025|NCT00960531|155566718|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
48375026|NCT00960531|155566719|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
48375027|NCT00960531|155566720|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
48375028|NCT00960531|155566721|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
48375029|NCT00960531|155566712|FG000|Overall Study|Lost to Follow-up|0|||
48375030|NCT00960531|155566713|FG001|Overall Study|Lost to Follow-up|0|||
48375031|NCT00960531|155566714|FG002|Overall Study|Lost to Follow-up|1|||
48375032|NCT00960531|155566715|FG003|Overall Study|Lost to Follow-up|0|||
48375033|NCT00960531|155566716|FG004|Overall Study|Lost to Follow-up|0|||
48375034|NCT00960531|155566717|FG005|Overall Study|Lost to Follow-up|0|||
48375035|NCT00960531|155566718|FG006|Overall Study|Lost to Follow-up|1|||
48375036|NCT00960531|155566719|FG007|Overall Study|Lost to Follow-up|0|||
48375037|NCT00960531|155566720|FG008|Overall Study|Lost to Follow-up|0|||
48375038|NCT00960531|155566721|FG009|Overall Study|Lost to Follow-up|0|||
48375039|NCT00960531|155566712|FG000|Overall Study|Failed to Return|2|||
48375040|NCT00960531|155566713|FG001|Overall Study|Failed to Return|0|||
48375041|NCT00960531|155566714|FG002|Overall Study|Failed to Return|0|||
48375042|NCT00960531|155566715|FG003|Overall Study|Failed to Return|0|||
48375043|NCT00960531|155566716|FG004|Overall Study|Failed to Return|0|||
48375044|NCT00960531|155566717|FG005|Overall Study|Failed to Return|0|||
48375045|NCT00960531|155566718|FG006|Overall Study|Failed to Return|0|||
48375046|NCT00960531|155566719|FG007|Overall Study|Failed to Return|2|||
48375047|NCT00960531|155566720|FG008|Overall Study|Failed to Return|0|||
48375048|NCT00960531|155566721|FG009|Overall Study|Failed to Return|0|||
48375049|NCT00960531|155566712|FG000|Overall Study|Adverse Event (AE)|2|||
48375050|NCT00960531|155566713|FG001|Overall Study|Adverse Event (AE)|0|||
48375051|NCT00960531|155566714|FG002|Overall Study|Adverse Event (AE)|0|||
48375052|NCT00960531|155566715|FG003|Overall Study|Adverse Event (AE)|0|||
48375053|NCT00960531|155566716|FG004|Overall Study|Adverse Event (AE)|0|||
48375054|NCT00960531|155566717|FG005|Overall Study|Adverse Event (AE)|1|||
48375055|NCT00960531|155566718|FG006|Overall Study|Adverse Event (AE)|2|||
48375056|NCT00960531|155566719|FG007|Overall Study|Adverse Event (AE)|0|||
48426312|NCT00933335|155749547|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
48375057|NCT00960531|155566720|FG008|Overall Study|Adverse Event (AE)|2|||
48375058|NCT00960531|155566721|FG009|Overall Study|Adverse Event (AE)|0|||
48375059|NCT00960531|155566712|FG000|Overall Study|Reason not Specified|2|||
48375060|NCT00960531|155566713|FG001|Overall Study|Reason not Specified|1|||
48375061|NCT00960531|155566714|FG002|Overall Study|Reason not Specified|13|||
48375062|NCT00960531|155566715|FG003|Overall Study|Reason not Specified|1|||
48375063|NCT00960531|155566716|FG004|Overall Study|Reason not Specified|2|||
48375064|NCT00960531|155566717|FG005|Overall Study|Reason not Specified|0|||
48375065|NCT00960531|155566718|FG006|Overall Study|Reason not Specified|16|||
48375066|NCT00960531|155566719|FG007|Overall Study|Reason not Specified|0|||
48375067|NCT00960531|155566720|FG008|Overall Study|Reason not Specified|8|||
48375068|NCT00960531|155566721|FG009|Overall Study|Reason not Specified|1|||
48375069|NCT00607022|155566724|FG000|Overall Study|Withdrawal by Subject|1|||
48375070|NCT00607022|155566725|FG001|Overall Study|Withdrawal by Subject|0|||
48375071|NCT00607022|155566726|FG002|Overall Study|Withdrawal by Subject|0|||
48375072|NCT02684357|155566727|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
48375073|NCT02684357|155566728|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
48375074|NCT02684357|155566729|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
48375075|NCT02684357|155566730|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
48375076|NCT02684357|155566731|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
48375077|NCT02684357|155566732|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
48375078|NCT02684357|155566727|FG000|Part A|Lost to Follow-up|0|||
48375079|NCT02684357|155566728|FG001|Part A|Lost to Follow-up|2|||
48375080|NCT02684357|155566729|FG002|Part A|Lost to Follow-up|2|||
48375081|NCT02684357|155566730|FG003|Part A|Lost to Follow-up|0|||
48375082|NCT02684357|155566731|FG004|Part A|Lost to Follow-up|0|||
48375083|NCT02684357|155566732|FG005|Part A|Lost to Follow-up|0|||
48375084|NCT02684357|155566727|FG000|Part A|Withdrawal by Subject|3|||
48375085|NCT02684357|155566728|FG001|Part A|Withdrawal by Subject|0|||
48375086|NCT02684357|155566729|FG002|Part A|Withdrawal by Subject|0|||
48375087|NCT02684357|155566730|FG003|Part A|Withdrawal by Subject|0|||
48375088|NCT02684357|155566731|FG004|Part A|Withdrawal by Subject|0|||
48375089|NCT02684357|155566732|FG005|Part A|Withdrawal by Subject|0|||
48375090|NCT02684357|155566727|FG000|Part A|Other|0|||
48375091|NCT02684357|155566728|FG001|Part A|Other|1|||
48375092|NCT02684357|155566729|FG002|Part A|Other|0|||
48375093|NCT02684357|155566730|FG003|Part A|Other|0|||
48375094|NCT02684357|155566731|FG004|Part A|Other|0|||
48375095|NCT02684357|155566732|FG005|Part A|Other|0|||
48375096|NCT02684357|155566727|FG000|Part B|Adverse Event (Other)|0|||
48375097|NCT02684357|155566728|FG001|Part B|Adverse Event (Other)|0|||
48375098|NCT02684357|155566729|FG002|Part B|Adverse Event (Other)|0|||
48375099|NCT02684357|155566730|FG003|Part B|Adverse Event (Other)|1|||
48375100|NCT02684357|155566731|FG004|Part B|Adverse Event (Other)|1|||
48375101|NCT02684357|155566732|FG005|Part B|Adverse Event (Other)|1|||
48375102|NCT02684357|155566727|FG000|Part B|Lost to Follow-up|0|||
48375103|NCT02684357|155566728|FG001|Part B|Lost to Follow-up|0|||
48375104|NCT02684357|155566729|FG002|Part B|Lost to Follow-up|0|||
48375105|NCT02684357|155566730|FG003|Part B|Lost to Follow-up|1|||
48375106|NCT02684357|155566731|FG004|Part B|Lost to Follow-up|1|||
48375107|NCT02684357|155566732|FG005|Part B|Lost to Follow-up|7|||
48375108|NCT02684357|155566727|FG000|Part B|Withdrawal by Subject|0|||
48375109|NCT02684357|155566728|FG001|Part B|Withdrawal by Subject|0|||
48375110|NCT02684357|155566729|FG002|Part B|Withdrawal by Subject|0|||
48375111|NCT02684357|155566730|FG003|Part B|Withdrawal by Subject|0|||
48375112|NCT02684357|155566731|FG004|Part B|Withdrawal by Subject|2|||
48375113|NCT02684357|155566732|FG005|Part B|Withdrawal by Subject|4|||
48375114|NCT02684357|155566727|FG000|Part B|Other|0|||
48375115|NCT02684357|155566728|FG001|Part B|Other|0|||
48375116|NCT02684357|155566729|FG002|Part B|Other|0|||
48375117|NCT02684357|155566730|FG003|Part B|Other|1|||
48375118|NCT02684357|155566731|FG004|Part B|Other|0|||
48375119|NCT02684357|155566732|FG005|Part B|Other|1|||
48375120|NCT01853982|155566733|FG000|Overall Study|Withdrawal by Subject|1|||
48375121|NCT01853982|155566734|FG001|Overall Study|Withdrawal by Subject|0|||
48375122|NCT01853982|155566733|FG000|Overall Study|Death|1|||
48375123|NCT01853982|155566734|FG001|Overall Study|Death|0|||
48375124|NCT01853982|155566733|FG000|Overall Study|Lost to Follow-up|0|||
48375125|NCT01853982|155566734|FG001|Overall Study|Lost to Follow-up|1|||
48375126|NCT01658826|155566735|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
48375127|NCT01658826|155566736|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
48375128|NCT01658826|155566735|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
48375129|NCT01658826|155566736|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
48375130|NCT01658826|155566735|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
48375131|NCT01658826|155566736|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
48375132|NCT01658826|155566735|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
48375133|NCT01658826|155566736|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
48375134|NCT01658826|155566735|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
48375135|NCT01658826|155566736|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
48375136|NCT01658826|155566735|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
48375137|NCT01658826|155566736|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
48375138|NCT01658826|155566735|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
48375139|NCT01658826|155566736|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
48375140|NCT01658826|155566735|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
48375141|NCT01658826|155566736|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
48375142|NCT01658826|155566735|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
48375143|NCT01658826|155566736|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
48375144|NCT02134977|155568271|FG000|Overall Study|Protocol Deviation|102|||
48375145|NCT02935452|155568275|FG000|Overall Study|work and life commintment|3|||
48375146|NCT02935452|155568276|FG001|Overall Study|work and life commintment|1|||
48375147|NCT04433585|155568284|FG000|Overall Study|Withdrawal by Subject|15|||
48375148|NCT04433585|155568285|FG001|Overall Study|Withdrawal by Subject|3|||
48375149|NCT04433585|155568286|FG002|Overall Study|Withdrawal by Subject|15|||
48375150|NCT04433585|155568287|FG003|Overall Study|Withdrawal by Subject|6|||
48375151|NCT04433585|155568284|FG000|Overall Study|Adverse Event|10|||
48375152|NCT04433585|155568285|FG001|Overall Study|Adverse Event|4|||
48375153|NCT04433585|155568286|FG002|Overall Study|Adverse Event|1|||
48375154|NCT04433585|155568287|FG003|Overall Study|Adverse Event|0|||
48375155|NCT04433585|155568284|FG000|Overall Study|Due to the conflict in Ukraine|2|||
48375156|NCT04433585|155568285|FG001|Overall Study|Due to the conflict in Ukraine|1|||
48375157|NCT04433585|155568286|FG002|Overall Study|Due to the conflict in Ukraine|1|||
48375158|NCT04433585|155568287|FG003|Overall Study|Due to the conflict in Ukraine|2|||
48375159|NCT04433585|155568284|FG000|Overall Study|Physician Decision|1|||
48375160|NCT04433585|155568285|FG001|Overall Study|Physician Decision|2|||
48375161|NCT04433585|155568286|FG002|Overall Study|Physician Decision|0|||
48375162|NCT04433585|155568287|FG003|Overall Study|Physician Decision|0|||
48375163|NCT04433585|155568284|FG000|Overall Study|Lost to Follow-up|1|||
48375164|NCT04433585|155568285|FG001|Overall Study|Lost to Follow-up|1|||
48375165|NCT04433585|155568286|FG002|Overall Study|Lost to Follow-up|1|||
48375166|NCT04433585|155568287|FG003|Overall Study|Lost to Follow-up|0|||
48375167|NCT04433585|155568284|FG000|Overall Study|Lack of Efficacy|0|||
48375168|NCT04433585|155568285|FG001|Overall Study|Lack of Efficacy|1|||
48375169|NCT04433585|155568286|FG002|Overall Study|Lack of Efficacy|1|||
48375170|NCT04433585|155568287|FG003|Overall Study|Lack of Efficacy|1|||
48375171|NCT04433585|155568284|FG000|Overall Study|Death|0|||
48375172|NCT04433585|155568285|FG001|Overall Study|Death|1|||
48375173|NCT04433585|155568286|FG002|Overall Study|Death|0|||
48375174|NCT04433585|155568287|FG003|Overall Study|Death|0|||
48375175|NCT02074553|155568288|FG000|Intervention Period 1|Family Emergency|0|||
48375176|NCT02074553|155568289|FG001|Intervention Period 1|Family Emergency|0|||
48375177|NCT02074553|155568290|FG002|Intervention Period 1|Family Emergency|0|||
48375178|NCT02074553|155568291|FG003|Intervention Period 1|Family Emergency|1|||
48375179|NCT02074553|155568292|FG004|Intervention Period 1|Family Emergency|0|||
48375180|NCT02074553|155568293|FG005|Intervention Period 1|Family Emergency|0|||
48375181|NCT02074553|155568294|FG006|Intervention Period 1|Family Emergency|0|||
48375182|NCT02074553|155568295|FG007|Intervention Period 1|Family Emergency|0|||
48375183|NCT02074553|155568288|FG000|Washout Period 1|Adverse Event|1|||
48375184|NCT02074553|155568289|FG001|Washout Period 1|Adverse Event|0|||
48375185|NCT02074553|155568290|FG002|Washout Period 1|Adverse Event|0|||
48375186|NCT02074553|155568291|FG003|Washout Period 1|Adverse Event|0|||
48375187|NCT02074553|155568292|FG004|Washout Period 1|Adverse Event|0|||
48375188|NCT02074553|155568293|FG005|Washout Period 1|Adverse Event|0|||
48375189|NCT02074553|155568294|FG006|Washout Period 1|Adverse Event|0|||
48375190|NCT02074553|155568295|FG007|Washout Period 1|Adverse Event|0|||
48375191|NCT02074553|155568288|FG000|Washout Period 1|Physician Decision|0|||
48375192|NCT02074553|155568289|FG001|Washout Period 1|Physician Decision|0|||
48375193|NCT02074553|155568290|FG002|Washout Period 1|Physician Decision|0|||
48375194|NCT02074553|155568291|FG003|Washout Period 1|Physician Decision|1|||
48375195|NCT02074553|155568292|FG004|Washout Period 1|Physician Decision|0|||
48375196|NCT02074553|155568293|FG005|Washout Period 1|Physician Decision|0|||
48375197|NCT02074553|155568294|FG006|Washout Period 1|Physician Decision|0|||
48375198|NCT02074553|155568295|FG007|Washout Period 1|Physician Decision|0|||
48375199|NCT02074553|155568288|FG000|Washout Period 1|Other|0|||
48375200|NCT02074553|155568289|FG001|Washout Period 1|Other|0|||
48375201|NCT02074553|155568290|FG002|Washout Period 1|Other|0|||
48375202|NCT02074553|155568291|FG003|Washout Period 1|Other|0|||
48375203|NCT02074553|155568292|FG004|Washout Period 1|Other|0|||
48375204|NCT02074553|155568293|FG005|Washout Period 1|Other|1|||
48375205|NCT02074553|155568294|FG006|Washout Period 1|Other|0|||
48375206|NCT02074553|155568295|FG007|Washout Period 1|Other|0|||
48375207|NCT02074553|155568288|FG000|Washout Period 2|Adverse Event|0|||
48375208|NCT02074553|155568289|FG001|Washout Period 2|Adverse Event|0|||
48375209|NCT02074553|155568290|FG002|Washout Period 2|Adverse Event|0|||
48375210|NCT02074553|155568291|FG003|Washout Period 2|Adverse Event|0|||
48375211|NCT02074553|155568292|FG004|Washout Period 2|Adverse Event|0|||
48375212|NCT02074553|155568293|FG005|Washout Period 2|Adverse Event|0|||
48375213|NCT02074553|155568294|FG006|Washout Period 2|Adverse Event|1|||
48375214|NCT02074553|155568295|FG007|Washout Period 2|Adverse Event|0|||
48375215|NCT02074553|155568288|FG000|Washout Period 2|Physician Decision|0|||
48375216|NCT02074553|155568289|FG001|Washout Period 2|Physician Decision|0|||
48375217|NCT02074553|155568290|FG002|Washout Period 2|Physician Decision|0|||
48375218|NCT02074553|155568291|FG003|Washout Period 2|Physician Decision|0|||
48426313|NCT00933335|155749546|FG000|Overall Study|Co-morbid Illness|1|||
48375219|NCT02074553|155568292|FG004|Washout Period 2|Physician Decision|0|||
48375220|NCT02074553|155568293|FG005|Washout Period 2|Physician Decision|1|||
48375221|NCT02074553|155568294|FG006|Washout Period 2|Physician Decision|0|||
48375222|NCT02074553|155568295|FG007|Washout Period 2|Physician Decision|0|||
48375223|NCT02074553|155568288|FG000|Washout Period 2|Lost to Follow-up|0|||
48375224|NCT02074553|155568289|FG001|Washout Period 2|Lost to Follow-up|0|||
48375225|NCT02074553|155568290|FG002|Washout Period 2|Lost to Follow-up|1|||
48375226|NCT02074553|155568291|FG003|Washout Period 2|Lost to Follow-up|0|||
48375227|NCT02074553|155568292|FG004|Washout Period 2|Lost to Follow-up|0|||
48375228|NCT02074553|155568293|FG005|Washout Period 2|Lost to Follow-up|0|||
48375229|NCT02074553|155568294|FG006|Washout Period 2|Lost to Follow-up|0|||
48375230|NCT02074553|155568295|FG007|Washout Period 2|Lost to Follow-up|0|||
48375231|NCT02074553|155568288|FG000|Washout Period 3|Physician Decision|0|||
48375232|NCT02074553|155568289|FG001|Washout Period 3|Physician Decision|0|||
48375233|NCT02074553|155568290|FG002|Washout Period 3|Physician Decision|0|||
48375234|NCT02074553|155568291|FG003|Washout Period 3|Physician Decision|0|||
48375235|NCT02074553|155568292|FG004|Washout Period 3|Physician Decision|0|||
48375236|NCT02074553|155568293|FG005|Washout Period 3|Physician Decision|0|||
48375237|NCT02074553|155568294|FG006|Washout Period 3|Physician Decision|0|||
48375238|NCT02074553|155568295|FG007|Washout Period 3|Physician Decision|1|||
48375239|NCT01640054|155568296|FG000|Overall Study|Study-specific disc criteria|1|||
48375240|NCT01640054|155568296|FG000|Overall Study|Lack of Efficacy|3|||
48375241|NCT01640054|155568296|FG000|Overall Study|Adverse Event|2|||
48375242|NCT05220254|155568297|FG000|Overall Study|Withdrawal by Subject|4|||
48375243|NCT05220254|155568297|FG000|Overall Study|Removed due to ineligibility|1|||
48375244|NCT05220254|155568297|FG000|Overall Study|Lost to Follow-up|7|||
48375245|NCT02080221|155568300|FG000|Overall Study|Withdrawal by Subject|1|||
48375246|NCT02080221|155568300|FG000|Overall Study|Clinical Progression of Disease|1|||
48375247|NCT02090959|155568301|FG000|Overall Study|Withdrawal by Subject|10|||
48375248|NCT02090959|155568301|FG000|Overall Study|Adverse Event|1|||
48375249|NCT02090959|155568301|FG000|Overall Study|Investigator decision|2|||
48375250|NCT02090959|155568301|FG000|Overall Study|Study termination|6|||
48375251|NCT02090959|155568301|FG000|Overall Study|Enrolled but not treated|1|||
48375252|NCT02090959|155568301|FG000|Overall Study|Transfer for compassionate use medicine|4|||
48375253|NCT02090959|155568301|FG000|Overall Study|Move to medical need program|3|||
48375254|NCT02090959|155568301|FG000|Overall Study|Entered in to other study|34|||
48375255|NCT02090959|155568301|FG000|Overall Study|Switched to commercial supply|88|||
48375256|NCT02090959|155568301|FG000|Overall Study|Other than specified|2|||
48375257|NCT00738582|155568302|FG000|Combination Therapy|Completed Combination Therapy|1|||
48375258|NCT00738582|155568303|FG001|Combination Therapy|Completed Combination Therapy|0|||
48375259|NCT00738582|155568302|FG000|Combination Therapy|Physician Decision|1|||
48375260|NCT00738582|155568303|FG001|Combination Therapy|Physician Decision|0|||
48375261|NCT00738582|155568302|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
48375262|NCT00738582|155568303|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
48375263|NCT00738582|155568302|FG000|Combination Therapy|Other|5|||
48375264|NCT00738582|155568303|FG001|Combination Therapy|Other|0|||
48375265|NCT00738582|155568302|FG000|Combination Therapy|Adverse Event|16|||
48375266|NCT00738582|155568303|FG001|Combination Therapy|Adverse Event|0|||
48375267|NCT00738582|155568302|FG000|Combination Therapy|Progressive Disease|9|||
48375268|NCT00738582|155568303|FG001|Combination Therapy|Progressive Disease|0|||
48375269|NCT00738582|155568302|FG000|Maintenance Therapy|Other|0|||
48375270|NCT00738582|155568303|FG001|Maintenance Therapy|Other|2|||
48375271|NCT00738582|155568302|FG000|Maintenance Therapy|Adverse Event|0|||
48375272|NCT00738582|155568303|FG001|Maintenance Therapy|Adverse Event|6|||
48375273|NCT00738582|155568302|FG000|Maintenance Therapy|Progressive Disease|0|||
48375274|NCT00738582|155568303|FG001|Maintenance Therapy|Progressive Disease|47|||
48375275|NCT00738582|155568302|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
48375276|NCT00738582|155568303|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
48375277|NCT00666679|155568306|FG000|First Intervention|Lost to Follow-up|1|||
48375278|NCT00666679|155568307|FG001|First Intervention|Lost to Follow-up|0|||
48375279|NCT00666679|155568306|FG000|First Intervention|Protocol Violation|1|||
48375280|NCT00666679|155568307|FG001|First Intervention|Protocol Violation|0|||
48375281|NCT00666679|155568306|FG000|First Intervention|Withdrawal by Subject|1|||
48375282|NCT00666679|155568307|FG001|First Intervention|Withdrawal by Subject|0|||
48375283|NCT00666679|155568306|FG000|First Intervention|Randomized did not start treatment|1|||
48375284|NCT00666679|155568307|FG001|First Intervention|Randomized did not start treatment|1|||
48375285|NCT00666679|155568306|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
48375286|NCT00666679|155568307|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
48375287|NCT00666679|155568306|FG000|Washout Period of 1 Week|Protocol Violation|0|||
48375288|NCT00666679|155568307|FG001|Washout Period of 1 Week|Protocol Violation|1|||
48375289|NCT00666679|155568306|FG000|Second Intervention|Adverse Event|1|||
48375290|NCT00666679|155568307|FG001|Second Intervention|Adverse Event|0|||
48375291|NCT00666679|155568306|FG000|Second Intervention|Death|0|||
48375292|NCT00666679|155568307|FG001|Second Intervention|Death|1|||
48375293|NCT02354508|155568308|FG000|Period 1: Core Phase|Adverse Event|1|||
48375294|NCT02354508|155568309|FG001|Period 1: Core Phase|Adverse Event|1|||
48375295|NCT02354508|155568310|FG002|Period 1: Core Phase|Adverse Event|2|||
48375296|NCT02354508|155568308|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
48375297|NCT02354508|155568309|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
48375298|NCT02354508|155568310|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
48375299|NCT02354508|155568308|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
48375300|NCT02354508|155568309|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
48375301|NCT02354508|155568310|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
48375302|NCT02354508|155568308|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
48375303|NCT02354508|155568309|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
48375304|NCT02354508|155568310|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
48375305|NCT02354508|155568308|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
48375306|NCT02354508|155568309|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
48375307|NCT02354508|155568310|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
48375308|NCT02354508|155568308|FG000|Period 2: Extension Phase|Physician Decision|5|||
48375309|NCT02354508|155568309|FG001|Period 2: Extension Phase|Physician Decision|0|||
48375310|NCT02354508|155568310|FG002|Period 2: Extension Phase|Physician Decision|1|||
48375311|NCT02354508|155568308|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
48375312|NCT02354508|155568309|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
48375313|NCT02354508|155568310|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
48375314|NCT02354508|155568308|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
48375315|NCT02354508|155568309|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
48375316|NCT02354508|155568310|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
48375317|NCT02354508|155568308|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
48375318|NCT02354508|155568309|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
48375319|NCT02354508|155568310|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
48375320|NCT00372229|155568315|FG000|Study Phase|Graft loss|0|||
48375321|NCT00372229|155568316|FG001|Study Phase|Graft loss|3|||
48375322|NCT00372229|155568315|FG000|Study Phase|Protocol Violation|3|||
48375323|NCT00372229|155568316|FG001|Study Phase|Protocol Violation|4|||
48375324|NCT00372229|155568315|FG000|Study Phase|Consent withdrawn|16|||
48375325|NCT00372229|155568316|FG001|Study Phase|Consent withdrawn|14|||
48375326|NCT00372229|155568315|FG000|Study Phase|Refused treatment/did not cooperate|3|||
48375327|NCT00372229|155568316|FG001|Study Phase|Refused treatment/did not cooperate|1|||
48375328|NCT00372229|155568315|FG000|Study Phase|Death|3|||
48375329|NCT00372229|155568316|FG001|Study Phase|Death|2|||
48375330|NCT00372229|155568315|FG000|Study Phase|Reason not specified|3|||
48375331|NCT00372229|155568316|FG001|Study Phase|Reason not specified|2|||
48375332|NCT00372229|155568315|FG000|Study Phase|Lost to Follow-up|3|||
48375333|NCT00372229|155568316|FG001|Study Phase|Lost to Follow-up|3|||
48375334|NCT00372229|155568315|FG000|Follow-Up Phase|Graft loss|8|||
48375335|NCT00372229|155568316|FG001|Follow-Up Phase|Graft loss|7|||
48375336|NCT00372229|155568315|FG000|Follow-Up Phase|Consent withdrawn|13|||
48375337|NCT00372229|155568316|FG001|Follow-Up Phase|Consent withdrawn|19|||
48375338|NCT00372229|155568315|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
48375339|NCT00372229|155568316|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
48375340|NCT00372229|155568315|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
48375341|NCT00372229|155568316|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
48375342|NCT00372229|155568315|FG000|Follow-Up Phase|Death|9|||
48375343|NCT00372229|155568316|FG001|Follow-Up Phase|Death|12|||
48375344|NCT00372229|155568315|FG000|Follow-Up Phase|Administrative|1|||
48375345|NCT00372229|155568316|FG001|Follow-Up Phase|Administrative|0|||
48375346|NCT00372229|155568315|FG000|Follow-Up Phase|Reason not specified|2|||
48375347|NCT00372229|155568316|FG001|Follow-Up Phase|Reason not specified|3|||
48375348|NCT00372229|155568315|FG000|Follow-Up Phase|Lost to Follow-up|12|||
48375349|NCT00372229|155568316|FG001|Follow-Up Phase|Lost to Follow-up|10|||
48375350|NCT00495586|155568317|FG000|Overall Study|Withdrawal by Subject|4|||
48375351|NCT00495586|155568318|FG001|Overall Study|Withdrawal by Subject|4|||
48375352|NCT01590017|155568319|FG000|Overall Study|Adverse Event|1|||
48375353|NCT01590017|155568319|FG000|Overall Study|Withdrawal by Subject|1|||
48375354|NCT01590017|155568319|FG000|Overall Study|Lack of Efficacy|1|||
48375355|NCT01590017|155568319|FG000|Overall Study|Physician Decision|1|||
48375356|NCT02095951|155568320|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
48375357|NCT02095951|155568321|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
48375358|NCT03618823|155568322|FG000|Overall Study|Lost to Follow-up|63|||
48375359|NCT03618823|155568323|FG001|Overall Study|Lost to Follow-up|61|||
48375360|NCT02208999|155568324|FG000|Overall Study|Lost to Follow-up|1|||
48375361|NCT01778023|155568325|FG000|Overall Study|Withdrawal by Subject|0|||
48375362|NCT01778023|155568326|FG001|Overall Study|Withdrawal by Subject|3|||
48375363|NCT01098097|155568327|FG000|Overall Study|Adverse Event|17|||
48375364|NCT01098097|155568327|FG000|Overall Study|Lost to Follow-up|18|||
48375365|NCT01098097|155568327|FG000|Overall Study|Status unknown|16|||
48375366|NCT01098097|155568327|FG000|Overall Study|No reason reported|31|||
48587203|NCT01004432|156343159|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
48587204|NCT01004432|156343155|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
48587205|NCT01004432|156343156|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
48587206|NCT01004432|156343157|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
48587207|NCT01004432|156343158|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
48375373|NCT02875977|155568332|FG000|Overall Study|Lost to Follow-up|42|||
48375374|NCT02875977|155568333|FG001|Overall Study|Lost to Follow-up|29|||
48375375|NCT01127139|155568334|FG000|Overall Study|Adverse Event|40|||
48375376|NCT01127139|155568334|FG000|Overall Study|Incompliance|12|||
48375377|NCT01127139|155568334|FG000|Overall Study|Lack of Efficacy|4|||
48375378|NCT01127139|155568334|FG000|Overall Study|Reason not specified|1|||
48375379|NCT01831856|155568337|FG000|Overall Study|Adverse Event|5|||
48375380|NCT01831856|155568338|FG001|Overall Study|Adverse Event|8|||
48375381|NCT01831856|155568337|FG000|Overall Study|Lack of Efficacy|13|||
48375382|NCT01831856|155568338|FG001|Overall Study|Lack of Efficacy|11|||
48375383|NCT01831856|155568337|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
48375384|NCT01831856|155568338|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
48375385|NCT02216357|155568340|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
48375386|NCT02216357|155568341|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
48375387|NCT00818649|155568349|FG000|Overall Study|Declining performance status|2|||
48375388|NCT00818649|155568349|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
48375389|NCT00818649|155568349|FG000|Overall Study|Adverse Event|1|||
48375390|NCT03513588|155568350|FG000|Overall Study|Lost to Follow-up|0|||
48375391|NCT03513588|155568351|FG001|Overall Study|Lost to Follow-up|1|||
48375392|NCT03513588|155568352|FG002|Overall Study|Lost to Follow-up|1|||
48375393|NCT03513588|155568350|FG000|Overall Study|Study dosing paused by sponsor|1|||
48375394|NCT03513588|155568351|FG001|Overall Study|Study dosing paused by sponsor|1|||
48375395|NCT03513588|155568352|FG002|Overall Study|Study dosing paused by sponsor|0|||
48375396|NCT03513588|155568350|FG000|Overall Study|Death|0|||
48375397|NCT03513588|155568351|FG001|Overall Study|Death|0|||
48375398|NCT03513588|155568352|FG002|Overall Study|Death|1|||
48375399|NCT00940108|155568353|FG000|Overall Study|Adverse Event|2|||
48375400|NCT00940108|155568354|FG001|Overall Study|Adverse Event|4|||
48375401|NCT00940108|155568355|FG002|Overall Study|Adverse Event|0|||
48375402|NCT00940108|155568356|FG003|Overall Study|Adverse Event|2|||
48375403|NCT00940108|155568353|FG000|Overall Study|Withdrew Consent|2|||
48375404|NCT00940108|155568354|FG001|Overall Study|Withdrew Consent|1|||
48375405|NCT00940108|155568355|FG002|Overall Study|Withdrew Consent|0|||
48375406|NCT00940108|155568356|FG003|Overall Study|Withdrew Consent|1|||
48375407|NCT00940108|155568353|FG000|Overall Study|Dose 2 contraindicated|1|||
48375408|NCT00940108|155568354|FG001|Overall Study|Dose 2 contraindicated|1|||
48375409|NCT00940108|155568355|FG002|Overall Study|Dose 2 contraindicated|0|||
48375410|NCT00940108|155568356|FG003|Overall Study|Dose 2 contraindicated|1|||
48375411|NCT00940108|155568353|FG000|Overall Study|Declined further vaccination|0|||
48375412|NCT00940108|155568354|FG001|Overall Study|Declined further vaccination|1|||
48375413|NCT00940108|155568355|FG002|Overall Study|Declined further vaccination|3|||
48375414|NCT00940108|155568356|FG003|Overall Study|Declined further vaccination|0|||
48375415|NCT00940108|155568353|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
48375416|NCT00940108|155568354|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
48375417|NCT00940108|155568355|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
48375418|NCT00940108|155568356|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
48375419|NCT00940108|155568353|FG000|Overall Study|Viral illness after Dose 1|0|||
48375420|NCT00940108|155568354|FG001|Overall Study|Viral illness after Dose 1|1|||
48375421|NCT00940108|155568355|FG002|Overall Study|Viral illness after Dose 1|0|||
48375422|NCT00940108|155568356|FG003|Overall Study|Viral illness after Dose 1|0|||
48375423|NCT00940108|155568353|FG000|Overall Study|Diagnosed with H1N1|0|||
48375424|NCT00940108|155568354|FG001|Overall Study|Diagnosed with H1N1|0|||
48375425|NCT00940108|155568355|FG002|Overall Study|Diagnosed with H1N1|0|||
48375426|NCT00940108|155568356|FG003|Overall Study|Diagnosed with H1N1|1|||
48375427|NCT02076178|155568358|FG000|Oral Phase|Adverse Event|0|||
48375428|NCT02076178|155568359|FG001|Oral Phase|Adverse Event|7|||
48375429|NCT02076178|155568358|FG000|Oral Phase|Withdrawal by Subject|0|||
48375430|NCT02076178|155568359|FG001|Oral Phase|Withdrawal by Subject|4|||
48375431|NCT02076178|155568358|FG000|Oral Phase|Physician Decision|0|||
48375432|NCT02076178|155568359|FG001|Oral Phase|Physician Decision|1|||
48375433|NCT02076178|155568358|FG000|Injection Phase|Protocol defined stopping criteria|1|||
48375434|NCT02076178|155568359|FG001|Injection Phase|Protocol defined stopping criteria|0|||
48375435|NCT02076178|155568358|FG000|Injection Phase|Withdrawal by Subject|0|||
48375436|NCT02076178|155568359|FG001|Injection Phase|Withdrawal by Subject|3|||
48375437|NCT02076178|155568358|FG000|Injection Phase|Physician Decision|0|||
48375438|NCT02076178|155568359|FG001|Injection Phase|Physician Decision|3|||
48375439|NCT02076178|155568358|FG000|Injection Phase|Lost to Follow-up|0|||
48375440|NCT02076178|155568359|FG001|Injection Phase|Lost to Follow-up|1|||
48375441|NCT00731120|155568360|FG000|Overall Study|Adverse Event|7|||
48375442|NCT00731120|155568361|FG001|Overall Study|Adverse Event|6|||
48375443|NCT00731120|155568362|FG002|Overall Study|Adverse Event|8|||
48375444|NCT00731120|155568360|FG000|Overall Study|Lack of Efficacy|4|||
48375445|NCT00731120|155568361|FG001|Overall Study|Lack of Efficacy|5|||
48375446|NCT00731120|155568362|FG002|Overall Study|Lack of Efficacy|4|||
48375447|NCT00731120|155568360|FG000|Overall Study|Noncompliance with Study Drug|3|||
48375448|NCT00731120|155568361|FG001|Overall Study|Noncompliance with Study Drug|3|||
48426314|NCT00933335|155749547|FG001|Overall Study|Co-morbid Illness|0|||
48375449|NCT00731120|155568362|FG002|Overall Study|Noncompliance with Study Drug|1|||
48375450|NCT00731120|155568360|FG000|Overall Study|Protocol Deviations|1|||
48375451|NCT00731120|155568361|FG001|Overall Study|Protocol Deviations|6|||
48375452|NCT00731120|155568362|FG002|Overall Study|Protocol Deviations|1|||
48375453|NCT00731120|155568360|FG000|Overall Study|Withdrawal of Consent|13|||
48375454|NCT00731120|155568361|FG001|Overall Study|Withdrawal of Consent|8|||
48375455|NCT00731120|155568362|FG002|Overall Study|Withdrawal of Consent|4|||
48375456|NCT00731120|155568360|FG000|Overall Study|Lost to Follow-up|10|||
48375457|NCT00731120|155568361|FG001|Overall Study|Lost to Follow-up|15|||
48375458|NCT00731120|155568362|FG002|Overall Study|Lost to Follow-up|17|||
48375459|NCT00731120|155568360|FG000|Overall Study|Other|4|||
48375460|NCT00731120|155568361|FG001|Overall Study|Other|0|||
48375461|NCT00731120|155568362|FG002|Overall Study|Other|1|||
48375462|NCT02434939|155568367|FG000|Overall Study|Lack of Efficacy|34|||
48375463|NCT02434939|155568368|FG001|Overall Study|Lack of Efficacy|48|||
48375464|NCT02434939|155568367|FG000|Overall Study|Withdrawal by Subject|3|||
48375465|NCT02434939|155568368|FG001|Overall Study|Withdrawal by Subject|0|||
48375466|NCT02434939|155568367|FG000|Overall Study|Adverse Event|0|||
48375467|NCT02434939|155568368|FG001|Overall Study|Adverse Event|1|||
48375468|NCT02471833|155568375|FG000|Overall Study|Lost to Follow-up|1|||
48375469|NCT02471833|155568376|FG001|Overall Study|Lost to Follow-up|0|||
48375470|NCT02471833|155568377|FG002|Overall Study|Lost to Follow-up|0|||
48375471|NCT02471833|155568375|FG000|Overall Study|Withdrawal by Subject|2|||
48375472|NCT02471833|155568376|FG001|Overall Study|Withdrawal by Subject|1|||
48375473|NCT02471833|155568377|FG002|Overall Study|Withdrawal by Subject|5|||
48375474|NCT04079803|155568378|FG000|Overall Study|Withdrawal by Subject|0|||
48375475|NCT04079803|155568379|FG001|Overall Study|Withdrawal by Subject|0|||
48375476|NCT04079803|155568380|FG002|Overall Study|Withdrawal by Subject|1|||
48375477|NCT02640157|155568381|FG000|Overall Study|Adverse Event|2|||
48375478|NCT02640157|155568382|FG001|Overall Study|Adverse Event|2|||
48375479|NCT02640157|155568383|FG002|Overall Study|Adverse Event|1|||
48375480|NCT02640157|155568381|FG000|Overall Study|Withdrew consent|2|||
48375481|NCT02640157|155568382|FG001|Overall Study|Withdrew consent|0|||
48375482|NCT02640157|155568383|FG002|Overall Study|Withdrew consent|2|||
48375483|NCT02640157|155568381|FG000|Overall Study|Lost to Follow-up|9|||
48375484|NCT02640157|155568382|FG001|Overall Study|Lost to Follow-up|2|||
48375485|NCT02640157|155568383|FG002|Overall Study|Lost to Follow-up|7|||
48375486|NCT02640157|155568381|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
48375487|NCT02640157|155568382|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
48375488|NCT02640157|155568383|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
48375489|NCT01596621|155568384|FG000|Overall Study|Death|4|||
48375490|NCT01596621|155568384|FG000|Overall Study|Withdrawal by Subject|9|||
48375491|NCT01596621|155568384|FG000|Overall Study|Disease Progression|49|||
48375492|NCT01596621|155568384|FG000|Overall Study|Lost to Follow-up|3|||
48375493|NCT01596621|155568384|FG000|Overall Study|Other than specified|13|||
48375494|NCT01074216|155568385|FG000|Overall Study|Physician Decision|1|||
48375495|NCT01074216|155568385|FG000|Overall Study|Not Treated|12|||
48375496|NCT01948908|155568387|FG000|Overall Study|Protocol Violation|1|||
48375497|NCT01948908|155568388|FG001|Overall Study|Protocol Violation|0|||
48375498|NCT01948908|155568389|FG002|Overall Study|Protocol Violation|2|||
48375499|NCT03343301|155568390|FG000|Overall Study|Withdrawal by Subject|1|||
48375500|NCT03343301|155568391|FG001|Overall Study|Withdrawal by Subject|1|||
48375501|NCT03343301|155568390|FG000|Overall Study|Death|0|||
48375502|NCT03343301|155568391|FG001|Overall Study|Death|2|||
48375503|NCT03343301|155568390|FG000|Overall Study|Other|0|||
48375504|NCT03343301|155568391|FG001|Overall Study|Other|6|||
48375505|NCT03343301|155568390|FG000|Overall Study|Missing|2|||
48375506|NCT03343301|155568391|FG001|Overall Study|Missing|0|||
48375507|NCT03291587|155568392|FG000|Overall Study|Lost to Follow-up|62|||
48375508|NCT03291587|155568393|FG001|Overall Study|Lost to Follow-up|43|||
48375509|NCT03291587|155568392|FG000|Overall Study|Refused to Answer|5|||
48375510|NCT03291587|155568393|FG001|Overall Study|Refused to Answer|2|||
48375511|NCT03291587|155568392|FG000|Overall Study|Death|2|||
48375512|NCT03291587|155568393|FG001|Overall Study|Death|4|||
48375513|NCT03291587|155568392|FG000|Overall Study|Not interested in participating|8|||
48375514|NCT03291587|155568393|FG001|Overall Study|Not interested in participating|6|||
48375515|NCT03291587|155568392|FG000|Overall Study|Too busy to participate|4|||
48375516|NCT03291587|155568393|FG001|Overall Study|Too busy to participate|2|||
48375517|NCT02041520|155568395|FG000|Overall Study|Adverse Event|2|||
48375518|NCT02041520|155568396|FG001|Overall Study|Adverse Event|1|||
48375519|NCT02041520|155568395|FG000|Overall Study|Withdrawal by Subject|3|||
48375520|NCT02041520|155568396|FG001|Overall Study|Withdrawal by Subject|4|||
48375521|NCT02041520|155568395|FG000|Overall Study|Protocol Violation|1|||
48375522|NCT02041520|155568396|FG001|Overall Study|Protocol Violation|0|||
48375523|NCT02041520|155568395|FG000|Overall Study|Lost to Follow-up|0|||
48375524|NCT02041520|155568396|FG001|Overall Study|Lost to Follow-up|1|||
48375525|NCT02041520|155568395|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
48375526|NCT02041520|155568396|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
48375527|NCT00494481|155568399|FG000|Overall Study|Condition under investigation worsened|11|||
48375528|NCT00494481|155568400|FG001|Overall Study|Condition under investigation worsened|13|||
48375529|NCT00494481|155568399|FG000|Overall Study|Adverse Event|15|||
48375530|NCT00494481|155568400|FG001|Overall Study|Adverse Event|11|||
48375531|NCT00494481|155568399|FG000|Overall Study|Other|1|||
48375532|NCT00494481|155568400|FG001|Overall Study|Other|0|||
48375533|NCT00494481|155568399|FG000|Overall Study|Never received IP|2|||
48375534|NCT00494481|155568400|FG001|Overall Study|Never received IP|0|||
48375535|NCT01030198|155568401|FG000|Overall Study|Could not measure efficacy accurately|0|||
48375536|NCT01030198|155568402|FG001|Overall Study|Could not measure efficacy accurately|7|||
48375537|NCT01163916|155568403|FG000|Overall Study|Withdrawal by Subject|2|||
48375538|NCT01163916|155568404|FG001|Overall Study|Withdrawal by Subject|0|||
48375539|NCT01163916|155568405|FG002|Overall Study|Withdrawal by Subject|2|||
48375540|NCT01163916|155568403|FG000|Overall Study|Adverse Event|2|||
48375541|NCT01163916|155568404|FG001|Overall Study|Adverse Event|0|||
48375542|NCT01163916|155568405|FG002|Overall Study|Adverse Event|1|||
48375543|NCT01163916|155568403|FG000|Overall Study|Lack of Efficacy|2|||
48375544|NCT01163916|155568404|FG001|Overall Study|Lack of Efficacy|0|||
48375545|NCT01163916|155568405|FG002|Overall Study|Lack of Efficacy|1|||
48375546|NCT01163916|155568403|FG000|Overall Study|Other|24|||
48375547|NCT01163916|155568404|FG001|Overall Study|Other|4|||
48375548|NCT01163916|155568405|FG002|Overall Study|Other|16|||
48375549|NCT01506453|155570198|FG000|Overall Study|Withdrawal prior to treatment|0|||
48375550|NCT01506453|155570199|FG001|Overall Study|Withdrawal prior to treatment|2|||
48375551|NCT00775463|155570200|FG000|Overall Study|Withdrawal by Subject|0|||
48375552|NCT00775463|155570201|FG001|Overall Study|Withdrawal by Subject|1|||
48375553|NCT00775463|155570200|FG000|Overall Study|Adverse Event|7|||
48375554|NCT00775463|155570201|FG001|Overall Study|Adverse Event|9|||
48375555|NCT00775463|155570200|FG000|Overall Study|Protocol Violation|2|||
48375556|NCT00775463|155570201|FG001|Overall Study|Protocol Violation|2|||
48375557|NCT00775463|155570200|FG000|Overall Study|Lost to Follow-up|1|||
48375558|NCT00775463|155570201|FG001|Overall Study|Lost to Follow-up|0|||
48375559|NCT00775463|155570200|FG000|Overall Study|Lack of Efficacy|1|||
48375560|NCT00775463|155570201|FG001|Overall Study|Lack of Efficacy|1|||
48375561|NCT00346268|155570204|FG000|Overall Study|Adverse Event|1|||
48375562|NCT00346268|155570205|FG001|Overall Study|Adverse Event|0|||
48375563|NCT00346268|155570204|FG000|Overall Study|Protocol Violation|1|||
48375564|NCT00346268|155570205|FG001|Overall Study|Protocol Violation|0|||
48375565|NCT00346268|155570204|FG000|Overall Study|Participant refused|0|||
48375566|NCT00346268|155570205|FG001|Overall Study|Participant refused|3|||
48375567|NCT00275262|155570206|FG000|Overall Study|Adverse Event|2|||
48375568|NCT00275262|155570207|FG001|Overall Study|Adverse Event|0|||
48375569|NCT00275262|155570206|FG000|Overall Study|Disease progression|2|||
48375570|NCT00275262|155570207|FG001|Overall Study|Disease progression|5|||
48375571|NCT00275262|155570206|FG000|Overall Study|Lost to Follow-up|0|||
48375572|NCT00275262|155570207|FG001|Overall Study|Lost to Follow-up|2|||
48375573|NCT00275262|155570206|FG000|Overall Study|Protocol Violation|0|||
48375574|NCT00275262|155570207|FG001|Overall Study|Protocol Violation|2|||
48375575|NCT00275262|155570206|FG000|Overall Study|Death|1|||
48375576|NCT00275262|155570207|FG001|Overall Study|Death|0|||
48375577|NCT00275262|155570206|FG000|Overall Study|Started Chemotherapy|1|||
48375578|NCT00275262|155570207|FG001|Overall Study|Started Chemotherapy|0|||
48375579|NCT00759915|155570212|FG000|Overall Study|Withdrawal by Subject|1|||
48375580|NCT00759915|155570213|FG001|Overall Study|Withdrawal by Subject|0|||
48375581|NCT00759915|155570212|FG000|Overall Study|Adverse Event|0|||
48375582|NCT00759915|155570213|FG001|Overall Study|Adverse Event|1|||
48375583|NCT00320541|155570215|FG000|Overall Study|Adverse Event|21|||
48375584|NCT00320541|155570216|FG001|Overall Study|Adverse Event|19|||
48375585|NCT00320541|155570215|FG000|Overall Study|Protocol Violation|0|||
48375586|NCT00320541|155570216|FG001|Overall Study|Protocol Violation|1|||
48375587|NCT00320541|155570215|FG000|Overall Study|Withdrawal by Subject|12|||
48375588|NCT00320541|155570216|FG001|Overall Study|Withdrawal by Subject|16|||
48375589|NCT00320541|155570215|FG000|Overall Study|Physician Decision|9|||
48375590|NCT00320541|155570216|FG001|Overall Study|Physician Decision|13|||
48375591|NCT00320541|155570215|FG000|Overall Study|Other|3|||
48375592|NCT00320541|155570216|FG001|Overall Study|Other|4|||
48375593|NCT00320541|155570215|FG000|Overall Study|Sponsor Decision|2|||
48375594|NCT00320541|155570216|FG001|Overall Study|Sponsor Decision|1|||
48375595|NCT00320541|155570215|FG000|Overall Study|Death due to Study Disease|1|||
48375596|NCT00320541|155570216|FG001|Overall Study|Death due to Study Disease|3|||
48375597|NCT00320541|155570215|FG000|Overall Study|Death due to Adverse Event(s)|1|||
48375598|NCT00320541|155570216|FG001|Overall Study|Death due to Adverse Event(s)|0|||
48375599|NCT00320541|155570215|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
48375600|NCT00320541|155570216|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
48375601|NCT01650246|155570217|FG000|Overall Study|Adverse Event|23|||
48375602|NCT01650246|155570217|FG000|Overall Study|Protocol Violation|5|||
48375603|NCT01650246|155570217|FG000|Overall Study|Sponsor terminated study|53|||
48375604|NCT01650246|155570217|FG000|Overall Study|Lost to Follow-up|5|||
48375605|NCT01650246|155570217|FG000|Overall Study|Withdrawal by Subject|26|||
48375606|NCT01650246|155570217|FG000|Overall Study|Death|1|||
48375607|NCT01650246|155570217|FG000|Overall Study|Lack of Efficacy|30|||
48375608|NCT02480153|155570218|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
48375609|NCT02480153|155570219|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
48375610|NCT02480153|155570220|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
48375611|NCT02480153|155570218|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
48375612|NCT02480153|155570219|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
48375613|NCT02480153|155570220|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
48375614|NCT02480153|155570218|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
48375615|NCT02480153|155570219|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
48375616|NCT02480153|155570220|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
48375617|NCT02480153|155570218|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
48375618|NCT02480153|155570219|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
48375619|NCT02480153|155570220|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
48375620|NCT02480153|155570218|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
48375621|NCT02480153|155570219|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
48375622|NCT02480153|155570220|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
48375623|NCT02480153|155570218|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
48375624|NCT02480153|155570219|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
48375625|NCT02480153|155570220|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
48375626|NCT02480153|155570218|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
48375627|NCT02480153|155570219|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
48375628|NCT02480153|155570220|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
48375629|NCT02480153|155570218|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
48375630|NCT02480153|155570219|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
48375631|NCT02480153|155570220|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
48375632|NCT02480153|155570218|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
48375633|NCT02480153|155570219|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
48375634|NCT02480153|155570220|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
48375635|NCT02480153|155570218|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
48375636|NCT02480153|155570219|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
48375637|NCT02480153|155570220|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
48375638|NCT02480153|155570218|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
48375639|NCT02480153|155570219|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
48375640|NCT02480153|155570220|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
48375641|NCT02480153|155570218|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
48375642|NCT02480153|155570219|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
48375643|NCT02480153|155570220|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
48375644|NCT02480153|155570218|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
48375645|NCT02480153|155570219|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
48375646|NCT02480153|155570220|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
48375647|NCT02480153|155570218|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
48375648|NCT02480153|155570219|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
48375649|NCT02480153|155570220|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
48375650|NCT02480153|155570218|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
48375651|NCT02480153|155570219|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
48375652|NCT02480153|155570220|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
48375653|NCT02480153|155570218|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
48375654|NCT02480153|155570219|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
48375655|NCT02480153|155570220|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
48375656|NCT02480153|155570218|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
48375657|NCT02480153|155570219|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
48375658|NCT02480153|155570220|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
48375659|NCT02480153|155570218|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
48375660|NCT02480153|155570219|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
48375661|NCT02480153|155570220|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
48375662|NCT00953407|155570221|FG000|Overall Study|Failed inclusion criteria|1|||
48375663|NCT00953407|155570222|FG001|Overall Study|Failed inclusion criteria|1|||
48375664|NCT00953407|155570223|FG002|Overall Study|Failed inclusion criteria|1|||
48375665|NCT00953407|155570224|FG003|Overall Study|Failed inclusion criteria|1|||
48375666|NCT00953407|155570225|FG004|Overall Study|Failed inclusion criteria|1|||
48375667|NCT00953407|155570221|FG000|Overall Study|Lost to Follow-up|0|||
48375668|NCT00953407|155570222|FG001|Overall Study|Lost to Follow-up|0|||
48375669|NCT00953407|155570223|FG002|Overall Study|Lost to Follow-up|0|||
48375670|NCT00953407|155570224|FG003|Overall Study|Lost to Follow-up|1|||
48375671|NCT00953407|155570225|FG004|Overall Study|Lost to Follow-up|0|||
48375672|NCT01639495|155570229|FG000|Overall Study|Lost to Follow-up|6|||
48375673|NCT01639495|155570229|FG000|Overall Study|Consented but didn't have study catheter|4|||
48375674|NCT01639495|155570229|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
48375675|NCT01639495|155570229|FG000|Overall Study|No radiofrequency energy applied|2|||
48375676|NCT04214600|155570232|FG000|Overall Study|Lost to Follow-up|9|||
48375677|NCT04214600|155570233|FG001|Overall Study|Lost to Follow-up|14|||
48375678|NCT00896051|155570237|FG000|Overall Study|Adverse Event|2|||
48375679|NCT00896051|155570238|FG001|Overall Study|Adverse Event|1|||
48375680|NCT00896051|155570237|FG000|Overall Study|Lost to Follow-up|3|||
48375681|NCT00896051|155570238|FG001|Overall Study|Lost to Follow-up|2|||
48375682|NCT00896051|155570237|FG000|Overall Study|Withdrawal by Subject|3|||
48375683|NCT00896051|155570238|FG001|Overall Study|Withdrawal by Subject|2|||
48375684|NCT00896051|155570237|FG000|Overall Study|Subject noncompliant|1|||
48375685|NCT00896051|155570238|FG001|Overall Study|Subject noncompliant|3|||
48375686|NCT00896051|155570237|FG000|Overall Study|Other|1|||
48375687|NCT00896051|155570238|FG001|Overall Study|Other|1|||
48375688|NCT01217957|155570247|FG000|Phase 1|Withdrawal by Patient|1|||
48375689|NCT01217957|155570248|FG001|Phase 1|Withdrawal by Patient|0|||
48375690|NCT01217957|155570249|FG002|Phase 1|Withdrawal by Patient|1|||
48375691|NCT01217957|155570250|FG003|Phase 1|Withdrawal by Patient|1|||
48375692|NCT01217957|155570251|FG004|Phase 1|Withdrawal by Patient|0|||
48375693|NCT01217957|155570247|FG000|Phase 2|Withdrawal by Patient|0|||
48375694|NCT01217957|155570248|FG001|Phase 2|Withdrawal by Patient|0|||
48375695|NCT01217957|155570249|FG002|Phase 2|Withdrawal by Patient|0|||
48375696|NCT01217957|155570250|FG003|Phase 2|Withdrawal by Patient|0|||
48375697|NCT01217957|155570251|FG004|Phase 2|Withdrawal by Patient|1|||
48375698|NCT01295034|155570252|FG000|Overall Study|Lost to Follow-up|5|||
48375699|NCT01295034|155570253|FG001|Overall Study|Lost to Follow-up|5|||
48375700|NCT03271021|155570257|FG000|Overall Study|Adverse Event|3|||
48375701|NCT03271021|155570258|FG001|Overall Study|Adverse Event|2|||
48375702|NCT03271021|155570257|FG000|Overall Study|Withdrawal by Subject|36|||
48375703|NCT03271021|155570258|FG001|Overall Study|Withdrawal by Subject|53|||
48375704|NCT03271021|155570257|FG000|Overall Study|Lost to Follow-up|34|||
48375705|NCT03271021|155570258|FG001|Overall Study|Lost to Follow-up|39|||
48375706|NCT03271021|155570257|FG000|Overall Study|Protocol Violation|6|||
48375707|NCT03271021|155570258|FG001|Overall Study|Protocol Violation|4|||
48375708|NCT03271021|155570257|FG000|Overall Study|Abnormal Lab Results|1|||
48375709|NCT03271021|155570258|FG001|Overall Study|Abnormal Lab Results|0|||
48375710|NCT03271021|155570257|FG000|Overall Study|Miscellaneous|9|||
48375711|NCT03271021|155570258|FG001|Overall Study|Miscellaneous|8|||
48375712|NCT02518490|155570259|FG000|Overall Study|Withdrawal by Subject|1|||
48375713|NCT02518490|155570260|FG001|Overall Study|Withdrawal by Subject|1|||
48375714|NCT01498679|155570263|FG000|Overall Study|Adverse Event|1|||
48375715|NCT01498679|155570264|FG001|Overall Study|Adverse Event|4|||
48375716|NCT01498679|155570263|FG000|Overall Study|Lack of Efficacy|72|||
48375717|NCT01498679|155570264|FG001|Overall Study|Lack of Efficacy|12|||
48375718|NCT01498679|155570263|FG000|Overall Study|Protocol Violation|4|||
48375719|NCT01498679|155570264|FG001|Overall Study|Protocol Violation|0|||
48375720|NCT01498679|155570263|FG000|Overall Study|Physician Decision|0|||
48375721|NCT01498679|155570264|FG001|Overall Study|Physician Decision|2|||
48375722|NCT01498679|155570263|FG000|Overall Study|Withdrawal by Subject|12|||
48375723|NCT01498679|155570264|FG001|Overall Study|Withdrawal by Subject|4|||
48375724|NCT00477334|155570265|FG000|Overall Study|Discontinued prior to taking study drug|106|||
48375725|NCT00477334|155570266|FG001|Overall Study|Discontinued prior to taking study drug|53|||
48375726|NCT00477334|155570265|FG000|Overall Study|Adverse Event|1|||
48375727|NCT00477334|155570266|FG001|Overall Study|Adverse Event|2|||
48375728|NCT00477334|155570265|FG000|Overall Study|Withdrawal by Subject|2|||
48375729|NCT00477334|155570266|FG001|Overall Study|Withdrawal by Subject|1|||
48375730|NCT00477334|155570265|FG000|Overall Study|Lost to Follow-up|15|||
48375731|NCT00477334|155570266|FG001|Overall Study|Lost to Follow-up|4|||
48375732|NCT00477334|155570265|FG000|Overall Study|Administrative Problems|39|||
48375733|NCT00477334|155570266|FG001|Overall Study|Administrative Problems|15|||
48375734|NCT00477334|155570265|FG000|Overall Study|Protocol Violation|7|||
48375735|NCT00477334|155570266|FG001|Overall Study|Protocol Violation|1|||
48375736|NCT02572882|155570267|FG000|Overall Study|Withdrawal by Subject|1|||
48375737|NCT02572882|155570267|FG000|Overall Study|Participant received kidney transplant|1|||
48375738|NCT01607554|155570268|FG000|Overall Study|Disease progression|2|||
48375739|NCT02054741|155570269|FG000|Overall Study|Protocol Violation|13|||
48375740|NCT02054741|155570270|FG001|Overall Study|Protocol Violation|2|||
48375741|NCT02054741|155570269|FG000|Overall Study|Withdrawal by Subject|10|||
48375742|NCT02054741|155570270|FG001|Overall Study|Withdrawal by Subject|5|||
48375743|NCT02054741|155570269|FG000|Overall Study|Death|94|||
48375744|NCT02054741|155570270|FG001|Overall Study|Death|90|||
48375745|NCT02054741|155570269|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
48375746|NCT02054741|155570270|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
48375747|NCT00784693|155570273|FG000|Overall Study|Lost to Follow-up|0|||
48375748|NCT00784693|155570274|FG001|Overall Study|Lost to Follow-up|1|||
48375749|NCT00784693|155570273|FG000|Overall Study|Lack of Efficacy|1|||
48375750|NCT00784693|155570274|FG001|Overall Study|Lack of Efficacy|1|||
48375751|NCT00784693|155570273|FG000|Overall Study|Withdrawal by Subject|0|||
48375752|NCT00784693|155570274|FG001|Overall Study|Withdrawal by Subject|4|||
48375753|NCT00784693|155570273|FG000|Overall Study|Randomized but not Treated|1|||
48375754|NCT00784693|155570274|FG001|Overall Study|Randomized but not Treated|0|||
48375755|NCT00784693|155570273|FG000|Overall Study|Other|1|||
48375756|NCT00784693|155570274|FG001|Overall Study|Other|0|||
48375757|NCT04507126|155570275|FG000|Overall Study|Withdrawal by Subject|1|||
48375758|NCT04507126|155570275|FG000|Overall Study|Protocol Violation|2|||
48375759|NCT04507126|155570275|FG000|Overall Study|Physician Decision|1|||
48375760|NCT01502631|155570276|FG000|Overall Study|Adverse Event|5|||
48375761|NCT01502631|155570277|FG001|Overall Study|Adverse Event|8|||
48375762|NCT01502631|155570276|FG000|Overall Study|Lost to Follow-up|2|||
48375763|NCT01502631|155570277|FG001|Overall Study|Lost to Follow-up|2|||
48375764|NCT01502631|155570276|FG000|Overall Study|Participant withdrew consent|2|||
48375765|NCT01502631|155570277|FG001|Overall Study|Participant withdrew consent|4|||
48375766|NCT01502631|155570276|FG000|Overall Study|Participant non-compliant|1|||
48375767|NCT01502631|155570277|FG001|Overall Study|Participant non-compliant|0|||
48375768|NCT01502631|155570276|FG000|Overall Study|Investigator's decision|0|||
48375769|NCT01502631|155570277|FG001|Overall Study|Investigator's decision|1|||
48375770|NCT01502631|155570276|FG000|Overall Study|Other|10|||
48375771|NCT01502631|155570277|FG001|Overall Study|Other|5|||
48375772|NCT00138671|155570281|FG000|Overall Study|Death|0|||
48375773|NCT00138671|155570282|FG001|Overall Study|Death|3|||
48375774|NCT00138671|155570281|FG000|Overall Study|Adverse Event|6|||
48375775|NCT00138671|155570282|FG001|Overall Study|Adverse Event|3|||
48375776|NCT00138671|155570281|FG000|Overall Study|Lost to Follow-up|1|||
48375777|NCT00138671|155570282|FG001|Overall Study|Lost to Follow-up|2|||
48375778|NCT00138671|155570281|FG000|Overall Study|Withdrawal by Subject|3|||
48375779|NCT00138671|155570282|FG001|Overall Study|Withdrawal by Subject|5|||
48375780|NCT00138671|155570281|FG000|Overall Study|Other|3|||
48375781|NCT00138671|155570282|FG001|Overall Study|Other|3|||
48375782|NCT00402597|155570285|FG000|Overall Study|Death|15|||
48375783|NCT00402597|155570286|FG001|Overall Study|Death|7|||
48375784|NCT00402597|155570287|FG002|Overall Study|Death|6|||
48375785|NCT00402597|155570288|FG003|Overall Study|Death|4|||
48375786|NCT00402597|155570289|FG004|Overall Study|Death|6|||
48375787|NCT00402597|155570285|FG000|Overall Study|Adverse Event|81|||
48375788|NCT00402597|155570286|FG001|Overall Study|Adverse Event|18|||
48375789|NCT00402597|155570287|FG002|Overall Study|Adverse Event|106|||
48375790|NCT00402597|155570288|FG003|Overall Study|Adverse Event|39|||
48375791|NCT00402597|155570289|FG004|Overall Study|Adverse Event|71|||
48375792|NCT00402597|155570285|FG000|Overall Study|Lost to Follow-up|8|||
48375793|NCT00402597|155570286|FG001|Overall Study|Lost to Follow-up|1|||
48375794|NCT00402597|155570287|FG002|Overall Study|Lost to Follow-up|8|||
48375795|NCT00402597|155570288|FG003|Overall Study|Lost to Follow-up|2|||
48375796|NCT00402597|155570289|FG004|Overall Study|Lost to Follow-up|3|||
48375797|NCT00402597|155570285|FG000|Overall Study|Withdrawal by Subject|57|||
48375798|NCT00402597|155570286|FG001|Overall Study|Withdrawal by Subject|16|||
48375799|NCT00402597|155570287|FG002|Overall Study|Withdrawal by Subject|65|||
48375800|NCT00402597|155570288|FG003|Overall Study|Withdrawal by Subject|15|||
48375801|NCT00402597|155570289|FG004|Overall Study|Withdrawal by Subject|24|||
48375802|NCT00402597|155570285|FG000|Overall Study|reason not specified|30|||
48375803|NCT00402597|155570286|FG001|Overall Study|reason not specified|4|||
48375804|NCT00402597|155570287|FG002|Overall Study|reason not specified|27|||
48375805|NCT00402597|155570288|FG003|Overall Study|reason not specified|14|||
48375806|NCT00402597|155570289|FG004|Overall Study|reason not specified|20|||
48375807|NCT05208866|155570290|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
48375808|NCT00938860|155570292|FG000|Overall Study|Adverse Event|2|||
48375809|NCT00938860|155570293|FG001|Overall Study|Adverse Event|1|||
48375810|NCT00938860|155570292|FG000|Overall Study|Abnormal laboratory values|2|||
48375811|NCT00938860|155570293|FG001|Overall Study|Abnormal laboratory values|2|||
48375812|NCT00938860|155570292|FG000|Overall Study|Withdrawal by Subject|11|||
48375813|NCT00938860|155570293|FG001|Overall Study|Withdrawal by Subject|8|||
48375814|NCT00938860|155570292|FG000|Overall Study|Lost to Follow-up|4|||
48375815|NCT00938860|155570293|FG001|Overall Study|Lost to Follow-up|4|||
48375816|NCT00938860|155570292|FG000|Overall Study|Administration problems|2|||
48375817|NCT00938860|155570293|FG001|Overall Study|Administration problems|0|||
48375818|NCT00938860|155570292|FG000|Overall Study|Death|1|||
48375819|NCT00938860|155570293|FG001|Overall Study|Death|1|||
48375820|NCT00938860|155570292|FG000|Overall Study|Protocol Violation|3|||
48375821|NCT00938860|155570293|FG001|Overall Study|Protocol Violation|1|||
48375822|NCT00899548|155570294|FG000|Overall Study|Physician Decision|3|||
48375823|NCT01636960|155570306|FG000|Induction Phase|Adverse Event|2|||
48375824|NCT01636960|155570306|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
48375825|NCT01636960|155570306|FG000|Maintenance Phase|Adverse Event|3|||
48375826|NCT01636960|155570306|FG000|Maintenance Phase|Progressive disease|1|||
48375827|NCT01745848|155570307|FG000|Overall Study|Adverse Event|6|||
48375828|NCT03226275|155570308|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
48426315|NCT02203838|155749550|FG000|Overall Study|Lack of Efficacy|7|||
48375829|NCT03226275|155570309|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
48375830|NCT03226275|155570310|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
48375831|NCT03226275|155570311|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
48375832|NCT03226275|155570308|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
48375833|NCT03226275|155570309|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
48375834|NCT03226275|155570310|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
48375835|NCT03226275|155570311|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
48375836|NCT00511472|155570314|FG000|Overall Study|Clinical Adverse Event|1|||
48375837|NCT00511472|155570315|FG001|Overall Study|Clinical Adverse Event|2|||
48375838|NCT00511472|155570314|FG000|Overall Study|Laboratory Adverse Event|0|||
48375839|NCT00511472|155570315|FG001|Overall Study|Laboratory Adverse Event|2|||
48375840|NCT00511472|155570314|FG000|Overall Study|Not reported|2|||
48375841|NCT00511472|155570315|FG001|Overall Study|Not reported|2|||
48375842|NCT01079741|155570316|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
48375843|NCT01079741|155570317|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
48375844|NCT01079741|155570318|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
48375845|NCT01079741|155570319|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
48375846|NCT01079741|155570320|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
48375847|NCT01079741|155570316|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
48375848|NCT01079741|155570317|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
48375849|NCT01079741|155570318|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
48375850|NCT01079741|155570319|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
48375851|NCT01079741|155570320|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
48375852|NCT00069238|155570322|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
48375853|NCT00069238|155570323|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
48375854|NCT00069238|155570324|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
48375855|NCT00069238|155570322|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
48375856|NCT00069238|155570323|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
48375857|NCT00069238|155570324|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
48375858|NCT00069238|155570322|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
48375859|NCT00069238|155570323|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
48375860|NCT00069238|155570324|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
48375861|NCT03333837|155570325|FG000|Overall Study|Adverse Event|2|||
48375862|NCT03333837|155570326|FG001|Overall Study|Adverse Event|1|||
48375863|NCT03333837|155570327|FG002|Overall Study|Adverse Event|1|||
48375864|NCT03333837|155570328|FG003|Overall Study|Adverse Event|1|||
48375865|NCT03333837|155570329|FG004|Overall Study|Adverse Event|0|||
48375866|NCT03333837|155570325|FG000|Overall Study|Caregiver withdrew|0|||
48375867|NCT03333837|155570326|FG001|Overall Study|Caregiver withdrew|2|||
48375868|NCT03333837|155570327|FG002|Overall Study|Caregiver withdrew|1|||
48375869|NCT03333837|155570328|FG003|Overall Study|Caregiver withdrew|0|||
48375870|NCT03333837|155570329|FG004|Overall Study|Caregiver withdrew|0|||
48375871|NCT03333837|155570325|FG000|Overall Study|Withdrawal by Subject|0|||
48375872|NCT03333837|155570326|FG001|Overall Study|Withdrawal by Subject|0|||
48375873|NCT03333837|155570327|FG002|Overall Study|Withdrawal by Subject|1|||
48375874|NCT03333837|155570328|FG003|Overall Study|Withdrawal by Subject|1|||
48375875|NCT03333837|155570329|FG004|Overall Study|Withdrawal by Subject|3|||
48375876|NCT03333837|155570325|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
48375877|NCT03333837|155570326|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
48375878|NCT03333837|155570327|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
48375879|NCT03333837|155570328|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
48375880|NCT03333837|155570329|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
48375881|NCT01551212|155570330|FG000|Overall Study|Graft loss/Retransplantation|0|||
48375882|NCT01551212|155570331|FG001|Overall Study|Graft loss/Retransplantation|1|||
48375883|NCT01551212|155570330|FG000|Overall Study|Administrative problems|1|||
48375884|NCT01551212|155570331|FG001|Overall Study|Administrative problems|2|||
48375885|NCT01551212|155570330|FG000|Overall Study|Lost to Follow-up|0|||
48375886|NCT01551212|155570331|FG001|Overall Study|Lost to Follow-up|1|||
48375887|NCT01551212|155570330|FG000|Overall Study|Protocol Violation|0|||
48375888|NCT01551212|155570331|FG001|Overall Study|Protocol Violation|1|||
48375889|NCT01551212|155570330|FG000|Overall Study|Withdrawal by Subject|0|||
48375890|NCT01551212|155570331|FG001|Overall Study|Withdrawal by Subject|7|||
48375891|NCT01551212|155570330|FG000|Overall Study|Death|2|||
48375892|NCT01551212|155570331|FG001|Overall Study|Death|4|||
48375893|NCT01551212|155570330|FG000|Overall Study|Never Received Study Treatment|2|||
48375894|NCT01551212|155570331|FG001|Overall Study|Never Received Study Treatment|4|||
48375895|NCT01001832|155570332|FG000|Short-term Period|Adverse Event|2|||
48375896|NCT01001832|155570333|FG001|Short-term Period|Adverse Event|3|||
48375897|NCT01001832|155570332|FG000|Long-term Period|Adverse Event|2|||
48375898|NCT01001832|155570333|FG001|Long-term Period|Adverse Event|1|||
48587208|NCT01004432|156343159|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
48375899|NCT01001832|155570332|FG000|Long-term Period|Withdrawal by Subject|1|||
48375900|NCT01001832|155570333|FG001|Long-term Period|Withdrawal by Subject|0|||
48375901|NCT01001832|155570332|FG000|Long-term Period|Lack of Efficacy|0|||
48375902|NCT01001832|155570333|FG001|Long-term Period|Lack of Efficacy|2|||
48375903|NCT01001832|155570332|FG000|Long-term Period|Other|1|||
48375904|NCT01001832|155570333|FG001|Long-term Period|Other|2|||
48375905|NCT01001832|155570332|FG000|Follow-up Period|Withdrawal by Subject|1|||
48375906|NCT01001832|155570333|FG001|Follow-up Period|Withdrawal by Subject|0|||
48375907|NCT01001832|155570332|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
48375908|NCT01001832|155570333|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
48375909|NCT01001832|155570332|FG000|Follow-up Period|Other|2|||
48375910|NCT01001832|155570333|FG001|Follow-up Period|Other|1|||
48375911|NCT03353350|155570339|FG000|30-week Core Treatment Period|Protocol Violation|1|||
48375912|NCT03353350|155570340|FG001|30-week Core Treatment Period|Protocol Violation|1|||
48375913|NCT03353350|155570341|FG002|30-week Core Treatment Period|Protocol Violation|1|||
48375914|NCT03353350|155570342|FG003|30-week Core Treatment Period|Protocol Violation|0|||
48375915|NCT03353350|155570339|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
48375916|NCT03353350|155570340|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
48375917|NCT03353350|155570341|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
48375918|NCT03353350|155570342|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
48375919|NCT03353350|155570339|FG000|30-week Core Treatment Period|Adverse Event|0|||
48375920|NCT03353350|155570340|FG001|30-week Core Treatment Period|Adverse Event|4|||
48375921|NCT03353350|155570341|FG002|30-week Core Treatment Period|Adverse Event|2|||
48375922|NCT03353350|155570342|FG003|30-week Core Treatment Period|Adverse Event|3|||
48375923|NCT03353350|155570339|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
48375924|NCT03353350|155570340|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
48375925|NCT03353350|155570341|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
48375926|NCT03353350|155570342|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
48375927|NCT03353350|155570339|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
48375928|NCT03353350|155570340|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
48375929|NCT03353350|155570341|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
48375930|NCT03353350|155570342|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
48375931|NCT03353350|155570339|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
48375932|NCT03353350|155570340|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
48375933|NCT03353350|155570341|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
48375934|NCT03353350|155570342|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
48375935|NCT03353350|155570339|FG000|26-week Treatment Extension Period|Adverse Event|1|||
48375936|NCT03353350|155570340|FG001|26-week Treatment Extension Period|Adverse Event|0|||
48375937|NCT03353350|155570341|FG002|26-week Treatment Extension Period|Adverse Event|0|||
48375938|NCT03353350|155570342|FG003|26-week Treatment Extension Period|Adverse Event|1|||
48375939|NCT03353350|155570339|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
48375940|NCT03353350|155570340|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
48375941|NCT03353350|155570341|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
48375942|NCT03353350|155570342|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
48375943|NCT02003573|155570344|FG000|Overall Study|Progressive disease|2|||
48375944|NCT02003573|155570345|FG001|Overall Study|Progressive disease|0|||
48375945|NCT02003573|155570346|FG002|Overall Study|Progressive disease|1|||
48375946|NCT02003573|155570344|FG000|Overall Study|Other Adverse event|0|||
48375947|NCT02003573|155570345|FG001|Overall Study|Other Adverse event|1|||
48375948|NCT02003573|155570346|FG002|Overall Study|Other Adverse event|1|||
48375949|NCT02003573|155570344|FG000|Overall Study|Refuse to take trial medication|0|||
48375950|NCT02003573|155570345|FG001|Overall Study|Refuse to take trial medication|1|||
48375951|NCT02003573|155570346|FG002|Overall Study|Refuse to take trial medication|1|||
48375952|NCT02003573|155570344|FG000|Overall Study|Other than specified|1|||
48375953|NCT02003573|155570345|FG001|Overall Study|Other than specified|2|||
48375954|NCT02003573|155570346|FG002|Overall Study|Other than specified|3|||
48375955|NCT00985153|155570347|FG000|Overall Study|Lost to Follow-up|16|||
48375956|NCT00985153|155570348|FG001|Overall Study|Lost to Follow-up|19|||
48375957|NCT00985153|155570349|FG002|Overall Study|Lost to Follow-up|17|||
48375958|NCT00985153|155570350|FG003|Overall Study|Lost to Follow-up|20|||
48375959|NCT00985153|155570347|FG000|Overall Study|Protocol Violation|3|||
48375960|NCT00985153|155570348|FG001|Overall Study|Protocol Violation|2|||
48375961|NCT00985153|155570349|FG002|Overall Study|Protocol Violation|4|||
48375962|NCT00985153|155570350|FG003|Overall Study|Protocol Violation|3|||
48375963|NCT00985153|155570347|FG000|Overall Study|Withdrawal by Subject|6|||
48375964|NCT00985153|155570348|FG001|Overall Study|Withdrawal by Subject|11|||
48375965|NCT00985153|155570349|FG002|Overall Study|Withdrawal by Subject|11|||
48375966|NCT00985153|155570350|FG003|Overall Study|Withdrawal by Subject|10|||
48375967|NCT00985153|155570347|FG000|Overall Study|Missed One or More Bleeds|7|||
48375968|NCT00985153|155570348|FG001|Overall Study|Missed One or More Bleeds|7|||
48375969|NCT00985153|155570349|FG002|Overall Study|Missed One or More Bleeds|8|||
48375970|NCT00985153|155570350|FG003|Overall Study|Missed One or More Bleeds|10|||
48375971|NCT00985153|155570347|FG000|Overall Study|Incomplete Safety Follow-up|3|||
48375972|NCT00985153|155570348|FG001|Overall Study|Incomplete Safety Follow-up|5|||
48375973|NCT00985153|155570349|FG002|Overall Study|Incomplete Safety Follow-up|4|||
48375974|NCT00985153|155570350|FG003|Overall Study|Incomplete Safety Follow-up|4|||
48375975|NCT01323634|155570351|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
48375976|NCT01323634|155570352|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
48375977|NCT01323634|155570353|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
48375978|NCT01323634|155570351|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
48375979|NCT01323634|155570352|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
48375980|NCT01323634|155570353|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
48375981|NCT01323634|155570351|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
48375982|NCT01323634|155570352|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48375983|NCT01323634|155570353|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48375984|NCT01323634|155570351|FG000|2-week Run-in Period|Physician Decision|5|||
48375985|NCT01323634|155570352|FG001|2-week Run-in Period|Physician Decision|0|||
48375986|NCT01323634|155570353|FG002|2-week Run-in Period|Physician Decision|0|||
48375987|NCT01323634|155570351|FG000|2-week Run-in Period|Protocol Violation|1|||
48375988|NCT01323634|155570352|FG001|2-week Run-in Period|Protocol Violation|0|||
48375989|NCT01323634|155570353|FG002|2-week Run-in Period|Protocol Violation|0|||
48375990|NCT01323634|155570351|FG000|2-week Run-in Period|Adverse Event|1|||
48375991|NCT01323634|155570352|FG001|2-week Run-in Period|Adverse Event|0|||
48375992|NCT01323634|155570353|FG002|2-week Run-in Period|Adverse Event|0|||
48375993|NCT01323634|155570351|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
48375994|NCT01323634|155570352|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
48375995|NCT01323634|155570353|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
48375996|NCT01323634|155570351|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48375997|NCT01323634|155570352|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
48375998|NCT01323634|155570353|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
48375999|NCT01323634|155570351|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
48376000|NCT01323634|155570352|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
48376001|NCT01323634|155570353|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
48376002|NCT01323634|155570351|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
48376003|NCT01323634|155570352|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
48376004|NCT01323634|155570353|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
48376005|NCT01323634|155570351|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
48376006|NCT01323634|155570352|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
48376007|NCT01323634|155570353|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
48376008|NCT01323634|155570351|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
48376009|NCT01323634|155570352|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
48376010|NCT01323634|155570353|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
48376011|NCT01323634|155570351|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
48376012|NCT01323634|155570352|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
48376013|NCT01323634|155570353|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
48376014|NCT02409368|155570354|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
48376015|NCT02409368|155570355|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
48376016|NCT02409368|155570356|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
48376017|NCT02409368|155570357|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
48376018|NCT02409368|155570354|FG000|ECOG Reclassification|Death|1|||
48376019|NCT02409368|155570355|FG001|ECOG Reclassification|Death|5|||
48376020|NCT02409368|155570356|FG002|ECOG Reclassification|Death|0|||
48376021|NCT02409368|155570357|FG003|ECOG Reclassification|Death|0|||
48376022|NCT02409368|155570354|FG000|ECOG Reclassification|Disease Progression|113|||
48376023|NCT02409368|155570355|FG001|ECOG Reclassification|Disease Progression|382|||
48376024|NCT02409368|155570356|FG002|ECOG Reclassification|Disease Progression|70|||
48376025|NCT02409368|155570357|FG003|ECOG Reclassification|Disease Progression|1|||
48376026|NCT02409368|155570354|FG000|ECOG Reclassification|Lost to Follow-up|1|||
48376027|NCT02409368|155570355|FG001|ECOG Reclassification|Lost to Follow-up|5|||
48376028|NCT02409368|155570356|FG002|ECOG Reclassification|Lost to Follow-up|0|||
48376029|NCT02409368|155570357|FG003|ECOG Reclassification|Lost to Follow-up|0|||
48376030|NCT02409368|155570354|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
48376031|NCT02409368|155570355|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
48376032|NCT02409368|155570356|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
48376033|NCT02409368|155570357|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
48376034|NCT02409368|155570354|FG000|ECOG Reclassification|Poor/non-compliance|0|||
48376035|NCT02409368|155570355|FG001|ECOG Reclassification|Poor/non-compliance|3|||
48376036|NCT02409368|155570356|FG002|ECOG Reclassification|Poor/non-compliance|2|||
48376037|NCT02409368|155570357|FG003|ECOG Reclassification|Poor/non-compliance|0|||
48376038|NCT02409368|155570354|FG000|ECOG Reclassification|Study drug toxicity|17|||
48376039|NCT02409368|155570355|FG001|ECOG Reclassification|Study drug toxicity|42|||
48376040|NCT02409368|155570356|FG002|ECOG Reclassification|Study drug toxicity|7|||
48376041|NCT02409368|155570357|FG003|ECOG Reclassification|Study drug toxicity|0|||
48376042|NCT02409368|155570354|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
48376043|NCT02409368|155570355|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
48376044|NCT02409368|155570356|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
48376045|NCT02409368|155570357|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
48587209|NCT01004432|156343155|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
48587210|NCT01004432|156343156|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
48587211|NCT01004432|156343157|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
48587212|NCT01004432|156343158|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
48587213|NCT01004432|156343159|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
48587214|NCT01004432|156343155|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
48587215|NCT01004432|156343156|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
48415090|NCT02333227|155707584|FG000|Overall Study|Lost to Follow-up|137|||
48415091|NCT02333227|155707585|FG001|Overall Study|Lost to Follow-up|106|||
48415092|NCT02333227|155707584|FG000|Overall Study|Pregnancy Interrupted|42|||
48415093|NCT02333227|155707585|FG001|Overall Study|Pregnancy Interrupted|89|||
48415094|NCT02333227|155707584|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
48415095|NCT02333227|155707585|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
48415096|NCT00981526|155707586|FG000|Overall Study|Withdrawal by Subject|0|||
48415097|NCT00981526|155707587|FG001|Overall Study|Withdrawal by Subject|2|||
48415098|NCT00981526|155707586|FG000|Overall Study|Physician Decision|4|||
48415099|NCT00981526|155707587|FG001|Overall Study|Physician Decision|4|||
48415100|NCT00947349|155707599|FG000|Triple Treatment Combination Period|Adverse Event|0|||
48415101|NCT00947349|155707600|FG001|Triple Treatment Combination Period|Adverse Event|1|||
48376046|NCT02409368|155570354|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
48376047|NCT02409368|155570355|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
48376048|NCT02409368|155570356|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
48376049|NCT02409368|155570357|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
48376050|NCT02409368|155570354|FG000|ECOG Reclassification|Participant withdrew consent|2|||
48376051|NCT02409368|155570355|FG001|ECOG Reclassification|Participant withdrew consent|3|||
48376052|NCT02409368|155570356|FG002|ECOG Reclassification|Participant withdrew consent|4|||
48376053|NCT02409368|155570357|FG003|ECOG Reclassification|Participant withdrew consent|0|||
48376054|NCT02409368|155570354|FG000|ECOG Reclassification|Other Reasons|5|||
48376055|NCT02409368|155570355|FG001|ECOG Reclassification|Other Reasons|26|||
48376056|NCT02409368|155570356|FG002|ECOG Reclassification|Other Reasons|2|||
48376057|NCT02409368|155570357|FG003|ECOG Reclassification|Other Reasons|0|||
48376058|NCT02409368|155570354|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
48376059|NCT02409368|155570355|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
48376060|NCT02409368|155570356|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
48376061|NCT02409368|155570357|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
48376062|NCT00753272|155570361|FG000|Overall Study|Adverse Event|878|||
48376063|NCT00753272|155570362|FG001|Overall Study|Adverse Event|869|||
48376064|NCT00753272|155570361|FG000|Overall Study|Protocol Violation|28|||
48376065|NCT00753272|155570362|FG001|Overall Study|Protocol Violation|46|||
48376066|NCT00753272|155570361|FG000|Overall Study|Withdrawal by Subject|2481|||
48376067|NCT00753272|155570362|FG001|Overall Study|Withdrawal by Subject|2407|||
48376068|NCT00753272|155570361|FG000|Overall Study|Lost to Follow-up|491|||
48376069|NCT00753272|155570362|FG001|Overall Study|Lost to Follow-up|497|||
48376070|NCT00753272|155570361|FG000|Overall Study|Other|1104|||
48376071|NCT00753272|155570362|FG001|Overall Study|Other|1088|||
48376072|NCT01328717|155572338|FG000|Overall Study|Adverse Event|1|||
48376073|NCT00031551|155572342|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
48376074|NCT00031551|155572343|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
48376075|NCT02359877|155572344|FG000|Overall Study|Withdrawal by Subject|1|||
48376076|NCT02359877|155572345|FG001|Overall Study|Withdrawal by Subject|0|||
48376077|NCT02359877|155572346|FG002|Overall Study|Withdrawal by Subject|0|||
48376078|NCT02359877|155572347|FG003|Overall Study|Withdrawal by Subject|2|||
48376079|NCT02359877|155572344|FG000|Overall Study|Adverse Event|0|||
48376080|NCT02359877|155572345|FG001|Overall Study|Adverse Event|0|||
48376081|NCT02359877|155572346|FG002|Overall Study|Adverse Event|0|||
48376082|NCT02359877|155572347|FG003|Overall Study|Adverse Event|1|||
48376083|NCT01919814|155572354|FG000|Overall Study|Adverse Event|1|||
48376084|NCT01919814|155572355|FG001|Overall Study|Adverse Event|0|||
48376085|NCT01919814|155572354|FG000|Overall Study|Protocol Violation|1|||
48376086|NCT01919814|155572355|FG001|Overall Study|Protocol Violation|0|||
48376087|NCT01919814|155572354|FG000|Overall Study|Withdrawal by Subject|1|||
48376088|NCT01919814|155572355|FG001|Overall Study|Withdrawal by Subject|0|||
48376089|NCT00690443|155572367|FG000|Overall Study|Adverse Event|1|||
48376090|NCT00690443|155572368|FG001|Overall Study|Adverse Event|2|||
48376091|NCT02680002|155572369|FG000|Overall Study|Lost to Follow-up|5|||
48376092|NCT02680002|155572370|FG001|Overall Study|Lost to Follow-up|1|||
48376093|NCT02680002|155572371|FG002|Overall Study|Lost to Follow-up|4|||
48415102|NCT00947349|155707601|FG002|Triple Treatment Combination Period|Adverse Event|0|||
48415103|NCT00947349|155707602|FG003|Triple Treatment Combination Period|Adverse Event|0|||
48415104|NCT00947349|155707599|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
48415105|NCT00947349|155707600|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
48415106|NCT00947349|155707601|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
48415107|NCT00947349|155707602|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
48415108|NCT00947349|155707599|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
48415109|NCT00947349|155707600|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
48415110|NCT00947349|155707601|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
48415111|NCT00947349|155707602|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
48415112|NCT00947349|155707599|FG000|Overall Study Standard of Care|Other|0|||
48415113|NCT00947349|155707600|FG001|Overall Study Standard of Care|Other|0|||
48415114|NCT00947349|155707601|FG002|Overall Study Standard of Care|Other|0|||
48415115|NCT00947349|155707602|FG003|Overall Study Standard of Care|Other|1|||
48415116|NCT00963807|155707603|FG000|Overall Study|Physician Decision|2|||
48415117|NCT00963807|155707603|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
48415118|NCT00963807|155707603|FG000|Overall Study|Disease progression|15|||
48415119|NCT03851510|155707605|FG000|Overall Study|Screen Fail|1|||
48415120|NCT03851510|155707605|FG000|Overall Study|Adverse Event|1|||
48415121|NCT03851510|155707605|FG000|Overall Study|Withdrawal by Subject|1|||
48415122|NCT01151137|155707606|FG000|Overall Study|Death|15|||
48415123|NCT01151137|155707607|FG001|Overall Study|Death|27|||
48415124|NCT01151137|155707606|FG000|Overall Study|Lost to Follow-up|1|||
48415125|NCT01151137|155707607|FG001|Overall Study|Lost to Follow-up|1|||
48415126|NCT01097044|155707608|FG000|Overall Study|Withdrawal by Subject|4|||
48415127|NCT01097044|155707609|FG001|Overall Study|Withdrawal by Subject|4|||
48415128|NCT01097044|155707608|FG000|Overall Study|Lost to Follow-up|1|||
48415129|NCT01097044|155707609|FG001|Overall Study|Lost to Follow-up|0|||
48415130|NCT01097044|155707608|FG000|Overall Study|Withdrawal by Sponsor|0|||
48415131|NCT01097044|155707609|FG001|Overall Study|Withdrawal by Sponsor|1|||
48415132|NCT01331161|155707610|FG000|Overall Study|Physician Decision|1|||
48415133|NCT01331161|155707611|FG001|Overall Study|Physician Decision|0|||
48415134|NCT01331161|155707610|FG000|Overall Study|Lost to Follow-up|0|||
48415135|NCT01331161|155707611|FG001|Overall Study|Lost to Follow-up|1|||
48415136|NCT01331161|155707610|FG000|Overall Study|Pregnancy|0|||
48415137|NCT01331161|155707611|FG001|Overall Study|Pregnancy|1|||
48415138|NCT00785577|155707612|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
48415139|NCT00785577|155707613|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
48415140|NCT00785577|155707614|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
48415141|NCT00785577|155707615|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
48415142|NCT00785577|155707616|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
48415143|NCT00785577|155707612|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48415144|NCT00785577|155707613|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48415145|NCT00785577|155707614|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48415146|NCT00785577|155707615|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
48415147|NCT00785577|155707616|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
48415148|NCT00785577|155707612|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
48415149|NCT00785577|155707613|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
48415150|NCT00785577|155707614|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
48415151|NCT00785577|155707615|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
48415152|NCT00785577|155707616|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
48415153|NCT00785577|155707612|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
48415154|NCT00785577|155707613|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
48415155|NCT00785577|155707614|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
48415156|NCT00785577|155707615|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
48415157|NCT00785577|155707616|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
48415158|NCT00785577|155707612|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
48415159|NCT00785577|155707613|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
48415160|NCT00785577|155707614|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
48415161|NCT00785577|155707615|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
48415162|NCT00785577|155707616|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
48415163|NCT00785577|155707612|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
48415164|NCT00785577|155707613|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
48415165|NCT00785577|155707614|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
48415166|NCT00785577|155707615|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
48415167|NCT00785577|155707616|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
48415168|NCT00785577|155707612|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
48415169|NCT00785577|155707613|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
48415170|NCT00785577|155707614|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
48415171|NCT00785577|155707615|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
48415172|NCT00785577|155707616|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
48415173|NCT00785577|155707612|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
48415174|NCT00785577|155707613|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
48415175|NCT00785577|155707614|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
48415176|NCT00785577|155707615|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
48415177|NCT00785577|155707616|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
48415178|NCT00785577|155707612|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
48415179|NCT00785577|155707613|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
48415180|NCT00785577|155707614|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
48415181|NCT00785577|155707615|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
48415182|NCT00785577|155707616|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
48415183|NCT00785577|155707612|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
48415184|NCT00785577|155707613|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
48415185|NCT00785577|155707614|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
48415186|NCT00785577|155707615|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
48415187|NCT00785577|155707616|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
48415188|NCT00023322|155709526|FG000|Overall Study|Lost to Follow-up|1|||
48415189|NCT02591615|155709535|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
48415190|NCT02591615|155709536|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
48415191|NCT02591615|155709537|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
48415192|NCT02591615|155709538|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
48415193|NCT02591615|155709535|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
48415194|NCT02591615|155709536|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
48415195|NCT02591615|155709537|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
48415196|NCT02591615|155709538|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
48415197|NCT02591615|155709535|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
48415198|NCT02591615|155709536|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
48415199|NCT02591615|155709537|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
48415200|NCT02591615|155709538|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
48415201|NCT02591615|155709535|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
48415202|NCT02591615|155709536|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
48415203|NCT02591615|155709537|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
48415204|NCT02591615|155709538|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
48415205|NCT02591615|155709535|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
48415206|NCT02591615|155709536|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
48415207|NCT02591615|155709537|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
48415208|NCT02591615|155709538|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
48415209|NCT02591615|155709535|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
48415210|NCT02591615|155709536|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
48415211|NCT02591615|155709537|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
48415212|NCT02591615|155709538|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
48415213|NCT02591615|155709535|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
48415214|NCT02591615|155709536|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
48415215|NCT02591615|155709537|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
48415216|NCT02591615|155709538|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
48415217|NCT02591615|155709535|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
48415218|NCT02591615|155709536|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
48415219|NCT02591615|155709537|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
48415220|NCT02591615|155709538|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
48415221|NCT02591615|155709535|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
48415222|NCT02591615|155709536|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
48415223|NCT02591615|155709537|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
48415224|NCT02591615|155709538|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
48415225|NCT02591615|155709535|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
48415226|NCT02591615|155709536|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
48415227|NCT02591615|155709537|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
48415228|NCT02591615|155709538|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
48415229|NCT02591615|155709535|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
48415230|NCT02591615|155709536|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
48415231|NCT02591615|155709537|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
48415232|NCT02591615|155709538|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
48415233|NCT02591615|155709535|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
48415234|NCT02591615|155709536|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
48415235|NCT02591615|155709537|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
48415236|NCT02591615|155709538|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
48415237|NCT02591615|155709535|FG000|Maintenance MK-3475|Adverse Event|0|||
48415238|NCT02591615|155709536|FG001|Maintenance MK-3475|Adverse Event|3|||
48415239|NCT02591615|155709537|FG002|Maintenance MK-3475|Adverse Event|1|||
48415240|NCT02591615|155709538|FG003|Maintenance MK-3475|Adverse Event|2|||
48415241|NCT02591615|155709535|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
48415242|NCT02591615|155709536|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
48415243|NCT02591615|155709537|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
48415244|NCT02591615|155709538|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
48415245|NCT02591615|155709535|FG000|Maintenance MK-3475|Death|0|||
48415246|NCT02591615|155709536|FG001|Maintenance MK-3475|Death|1|||
48415247|NCT02591615|155709537|FG002|Maintenance MK-3475|Death|1|||
48415248|NCT02591615|155709538|FG003|Maintenance MK-3475|Death|0|||
48415249|NCT02591615|155709535|FG000|Maintenance MK-3475|Physician discretion|0|||
48415250|NCT02591615|155709536|FG001|Maintenance MK-3475|Physician discretion|0|||
48415251|NCT02591615|155709537|FG002|Maintenance MK-3475|Physician discretion|1|||
48415252|NCT02591615|155709538|FG003|Maintenance MK-3475|Physician discretion|0|||
48415253|NCT02591615|155709535|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
48415254|NCT02591615|155709536|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
48415255|NCT02591615|155709537|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
48415256|NCT02591615|155709538|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
48415257|NCT02591615|155709535|FG000|Maintenance MK-3475|In active treatment|2|||
48415258|NCT02591615|155709536|FG001|Maintenance MK-3475|In active treatment|0|||
48415259|NCT02591615|155709537|FG002|Maintenance MK-3475|In active treatment|0|||
48415260|NCT02591615|155709538|FG003|Maintenance MK-3475|In active treatment|1|||
48415261|NCT04317690|155709545|FG000|Overall Study|did not have complete information for primary outcome|0|||
48415262|NCT04317690|155709546|FG001|Overall Study|did not have complete information for primary outcome|4|||
48415263|NCT04317690|155709547|FG002|Overall Study|did not have complete information for primary outcome|0|||
48415264|NCT04317690|155709548|FG003|Overall Study|did not have complete information for primary outcome|2|||
48415265|NCT04317690|155709549|FG004|Overall Study|did not have complete information for primary outcome|0|||
48415266|NCT02091440|155709550|FG000|Overall Study|Death|2|||
48415267|NCT00826748|155709551|FG000|Overall Study|Withdrawal by Subject|0|||
48415268|NCT00826748|155709552|FG001|Overall Study|Withdrawal by Subject|0|||
48415269|NCT00826748|155709553|FG002|Overall Study|Withdrawal by Subject|2|||
48415270|NCT00826748|155709551|FG000|Overall Study|Physician Decision|0|||
48415271|NCT00826748|155709552|FG001|Overall Study|Physician Decision|0|||
48415272|NCT00826748|155709553|FG002|Overall Study|Physician Decision|1|||
48415273|NCT00826748|155709551|FG000|Overall Study|Samples Did Not pass QC|0|||
48415274|NCT00826748|155709552|FG001|Overall Study|Samples Did Not pass QC|0|||
48415275|NCT00826748|155709553|FG002|Overall Study|Samples Did Not pass QC|1|||
48415276|NCT03312218|155709556|FG000|Overall Study|Never signed in to access the app|54|||
48415277|NCT03312218|155709557|FG001|Overall Study|Never signed in to access the app|58|||
48415278|NCT01887912|155709558|FG000|Overall Study|Serious adverse event|400|||
48415279|NCT01887912|155709559|FG001|Overall Study|Serious adverse event|198|||
48415280|NCT01887912|155709558|FG000|Overall Study|Other Adverse Event|34|||
48415281|NCT01887912|155709559|FG001|Overall Study|Other Adverse Event|15|||
48415282|NCT01887912|155709558|FG000|Overall Study|Protocol Violation|67|||
48415283|NCT01887912|155709559|FG001|Overall Study|Protocol Violation|37|||
48415284|NCT01887912|155709558|FG000|Overall Study|Lost to Follow-up|163|||
48415285|NCT01887912|155709559|FG001|Overall Study|Lost to Follow-up|74|||
48415286|NCT01887912|155709558|FG000|Overall Study|Withdrawal by Subject|606|||
48415287|NCT01887912|155709559|FG001|Overall Study|Withdrawal by Subject|349|||
48415288|NCT01887912|155709558|FG000|Overall Study|Other|122|||
48415289|NCT01887912|155709559|FG001|Overall Study|Other|58|||
48415290|NCT01389245|155709564|FG000|Overall Study|Protocol Violation|10|||
48415291|NCT01389245|155709564|FG000|Overall Study|Lost to Follow-up|3|||
48415292|NCT01389245|155709564|FG000|Overall Study|Withdrawal by Subject|2|||
48415293|NCT03822884|155709565|FG000|Overall Study|Withdrawal by Subject|0|||
48415294|NCT03822884|155709566|FG001|Overall Study|Withdrawal by Subject|0|||
48415295|NCT03822884|155709567|FG002|Overall Study|Withdrawal by Subject|0|||
48415296|NCT03822884|155709568|FG003|Overall Study|Withdrawal by Subject|0|||
48415297|NCT03822884|155709569|FG004|Overall Study|Withdrawal by Subject|1|||
48415298|NCT03822884|155709570|FG005|Overall Study|Withdrawal by Subject|0|||
48415299|NCT03304522|155709579|FG000|Overall Study|Adverse Event|0|||
48415300|NCT03304522|155709580|FG001|Overall Study|Adverse Event|4|||
48415301|NCT03304522|155709579|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
48415302|NCT03304522|155709580|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
48415303|NCT03304522|155709579|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
48415304|NCT03304522|155709580|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
48415305|NCT03304522|155709579|FG000|Overall Study|Other|0|||
48415306|NCT03304522|155709580|FG001|Overall Study|Other|1|||
48415307|NCT02983604|155709581|FG000|Overall Study|Enrolled but not Treated|0|||
48415308|NCT02983604|155709582|FG001|Overall Study|Enrolled but not Treated|0|||
48415309|NCT02983604|155709583|FG002|Overall Study|Enrolled but not Treated|1|||
48415310|NCT02983604|155709584|FG003|Overall Study|Enrolled but not Treated|0|||
48415311|NCT00316264|155709585|FG000|Overall Study|Lost to Follow-up|0|||
48415312|NCT00316264|155709586|FG001|Overall Study|Lost to Follow-up|1|||
48415313|NCT00316264|155709587|FG002|Overall Study|Lost to Follow-up|0|||
48415314|NCT00316264|155709585|FG000|Overall Study|Withdrawal of Consent|3|||
48415315|NCT00316264|155709586|FG001|Overall Study|Withdrawal of Consent|5|||
48415316|NCT00316264|155709587|FG002|Overall Study|Withdrawal of Consent|6|||
48415317|NCT00316264|155709585|FG000|Overall Study|Death|2|||
48415318|NCT00316264|155709586|FG001|Overall Study|Death|0|||
48415319|NCT00316264|155709587|FG002|Overall Study|Death|0|||
48415320|NCT00316264|155709585|FG000|Overall Study|Other|1|||
48415321|NCT00316264|155709586|FG001|Overall Study|Other|1|||
48415322|NCT00316264|155709587|FG002|Overall Study|Other|0|||
48415323|NCT01355289|155709588|FG000|Core Study|Adverse Event, Non-Fatal|1|||
48415324|NCT01355289|155709589|FG001|Core Study|Adverse Event, Non-Fatal|0|||
48415325|NCT01355289|155709590|FG002|Core Study|Adverse Event, Non-Fatal|0|||
48415326|NCT01355289|155709591|FG003|Core Study|Adverse Event, Non-Fatal|0|||
48415327|NCT01355289|155709592|FG004|Core Study|Adverse Event, Non-Fatal|0|||
48415328|NCT01355289|155709588|FG000|Core Study|Inadequate Therapeutic Effect|0|||
48415329|NCT01355289|155709589|FG001|Core Study|Inadequate Therapeutic Effect|0|||
48415330|NCT01355289|155709590|FG002|Core Study|Inadequate Therapeutic Effect|0|||
48415331|NCT01355289|155709591|FG003|Core Study|Inadequate Therapeutic Effect|1|||
48415332|NCT01355289|155709592|FG004|Core Study|Inadequate Therapeutic Effect|0|||
48415333|NCT01355289|155709588|FG000|Core Study|Other|0|||
48415334|NCT01355289|155709589|FG001|Core Study|Other|0|||
48415335|NCT01355289|155709590|FG002|Core Study|Other|0|||
48415336|NCT01355289|155709591|FG003|Core Study|Other|1|||
48415337|NCT01355289|155709592|FG004|Core Study|Other|0|||
48415338|NCT01355289|155709588|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
48415339|NCT01355289|155709589|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
48415340|NCT01355289|155709590|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
48415341|NCT01355289|155709591|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
48415342|NCT01355289|155709592|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
48415343|NCT01355289|155709588|FG000|Open Label Extension|Lost to Follow-up|0|||
48415344|NCT01355289|155709589|FG001|Open Label Extension|Lost to Follow-up|0|||
48415345|NCT01355289|155709590|FG002|Open Label Extension|Lost to Follow-up|0|||
48415346|NCT01355289|155709591|FG003|Open Label Extension|Lost to Follow-up|0|||
48415347|NCT01355289|155709592|FG004|Open Label Extension|Lost to Follow-up|1|||
48415348|NCT01355289|155709588|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
48415349|NCT01355289|155709589|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
48415350|NCT01355289|155709590|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
48415351|NCT01355289|155709591|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
48415352|NCT01355289|155709592|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
48415353|NCT01355289|155709588|FG000|Open Label Extension|Other|0|||
48415354|NCT01355289|155709589|FG001|Open Label Extension|Other|0|||
48415355|NCT01355289|155709590|FG002|Open Label Extension|Other|0|||
48415356|NCT01355289|155709591|FG003|Open Label Extension|Other|0|||
48415357|NCT01355289|155709592|FG004|Open Label Extension|Other|3|||
48415358|NCT02041962|155709593|FG000|Overall Study|Lost Aetna Coverage|43|||
48415359|NCT02041962|155709594|FG001|Overall Study|Lost Aetna Coverage|40|||
48415360|NCT02041962|155709593|FG000|Overall Study|Death|1|||
48415361|NCT02041962|155709594|FG001|Overall Study|Death|1|||
48415362|NCT02041962|155709593|FG000|Overall Study|Lost to Follow-up|37|||
48415363|NCT02041962|155709594|FG001|Overall Study|Lost to Follow-up|32|||
48415364|NCT02041962|155709593|FG000|Overall Study|Withdrawal by Subject|0|||
48415365|NCT02041962|155709594|FG001|Overall Study|Withdrawal by Subject|11|||
48415366|NCT00860470|155709597|FG000|Overall Study|Death|6|||
48415367|NCT00860470|155709598|FG001|Overall Study|Death|10|||
48415368|NCT00860470|155709597|FG000|Overall Study|Moved away|8|||
48415369|NCT00860470|155709598|FG001|Overall Study|Moved away|10|||
48415370|NCT00860470|155709597|FG000|Overall Study|Lost to Follow-up|34|||
48415371|NCT00860470|155709598|FG001|Overall Study|Lost to Follow-up|39|||
48415372|NCT02317510|155709608|FG000|Overall Study|Adverse Event|0|||
48415373|NCT02317510|155709609|FG001|Overall Study|Adverse Event|1|||
48415374|NCT01238120|155709610|FG000|Overall Study|Withdrawal by Subject|4|||
48415375|NCT01238120|155709611|FG001|Overall Study|Withdrawal by Subject|1|||
48415376|NCT01238120|155709612|FG002|Overall Study|Withdrawal by Subject|2|||
48415377|NCT01238120|155709613|FG003|Overall Study|Withdrawal by Subject|5|||
48415378|NCT01238120|155709610|FG000|Overall Study|Lost to Follow-up|2|||
48415379|NCT01238120|155709611|FG001|Overall Study|Lost to Follow-up|0|||
48415380|NCT01238120|155709612|FG002|Overall Study|Lost to Follow-up|1|||
48415381|NCT01238120|155709613|FG003|Overall Study|Lost to Follow-up|1|||
48415382|NCT01238120|155709610|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
48415383|NCT01238120|155709611|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
48415384|NCT01238120|155709612|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
48415385|NCT01238120|155709613|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
48415386|NCT01850615|155709614|FG000|Overall Study|Protocol Violation|4|||
48415387|NCT01850615|155709615|FG001|Overall Study|Protocol Violation|1|||
48415388|NCT01850615|155709614|FG000|Overall Study|Adverse Event|2|||
48415389|NCT01850615|155709615|FG001|Overall Study|Adverse Event|1|||
48415390|NCT01850615|155709614|FG000|Overall Study|Withdrawal by Subject|3|||
48415391|NCT01850615|155709615|FG001|Overall Study|Withdrawal by Subject|1|||
48415392|NCT01850615|155709614|FG000|Overall Study|Lost to Follow-up|0|||
48415393|NCT01850615|155709615|FG001|Overall Study|Lost to Follow-up|1|||
48415394|NCT01850615|155709614|FG000|Overall Study|Unclassified|0|||
48415395|NCT01850615|155709615|FG001|Overall Study|Unclassified|1|||
48415396|NCT02209506|155709616|FG000|Overall Study|Withdrawal by Subject|0|||
48415397|NCT02209506|155709617|FG001|Overall Study|Withdrawal by Subject|0|||
48415398|NCT02209506|155709618|FG002|Overall Study|Withdrawal by Subject|0|||
48415399|NCT02209506|155709619|FG003|Overall Study|Withdrawal by Subject|0|||
48415400|NCT02209506|155709620|FG004|Overall Study|Withdrawal by Subject|1|||
48415401|NCT00098787|155709625|FG000|Overall Study|Never started treatment|3|||
48415402|NCT00098787|155709626|FG001|Overall Study|Never started treatment|2|||
48415403|NCT00098787|155709627|FG002|Overall Study|Never started treatment|1|||
48415404|NCT00098787|155709625|FG000|Overall Study|Ineligible|9|||
48415405|NCT00098787|155709626|FG001|Overall Study|Ineligible|7|||
48415406|NCT00098787|155709627|FG002|Overall Study|Ineligible|3|||
48415407|NCT00098787|155709625|FG000|Overall Study|Disease progression|28|||
48415408|NCT00098787|155709626|FG001|Overall Study|Disease progression|17|||
48415409|NCT00098787|155709627|FG002|Overall Study|Disease progression|23|||
48415410|NCT00098787|155709625|FG000|Overall Study|Adverse Event|8|||
48415411|NCT00098787|155709626|FG001|Overall Study|Adverse Event|17|||
48415412|NCT00098787|155709627|FG002|Overall Study|Adverse Event|8|||
48415413|NCT00098787|155709625|FG000|Overall Study|Death|6|||
48415414|NCT00098787|155709626|FG001|Overall Study|Death|1|||
48415415|NCT00098787|155709627|FG002|Overall Study|Death|0|||
48415416|NCT00098787|155709625|FG000|Overall Study|Withdrawal by Subject|4|||
48415417|NCT00098787|155709626|FG001|Overall Study|Withdrawal by Subject|12|||
48415418|NCT00098787|155709627|FG002|Overall Study|Withdrawal by Subject|6|||
48415419|NCT00098787|155709625|FG000|Overall Study|Alternative therapy|8|||
48415420|NCT00098787|155709626|FG001|Overall Study|Alternative therapy|13|||
48415421|NCT00098787|155709627|FG002|Overall Study|Alternative therapy|13|||
48415422|NCT00098787|155709625|FG000|Overall Study|Other|7|||
48415423|NCT00098787|155709626|FG001|Overall Study|Other|6|||
48415424|NCT00098787|155709627|FG002|Overall Study|Other|9|||
48415425|NCT02203149|155709628|FG000|Part 1|Adverse Event|0|||
48415426|NCT02203149|155709629|FG001|Part 1|Adverse Event|1|||
48415427|NCT02203149|155709630|FG002|Part 1|Adverse Event|0|||
48415428|NCT02203149|155709631|FG003|Part 1|Adverse Event|0|||
48415429|NCT02203149|155709632|FG004|Part 1|Adverse Event|0|||
48415430|NCT02203149|155709628|FG000|Part 2|Death|0|||
48415431|NCT02203149|155709629|FG001|Part 2|Death|0|||
48415432|NCT02203149|155709630|FG002|Part 2|Death|1|||
48415433|NCT02203149|155709631|FG003|Part 2|Death|1|||
48415434|NCT02203149|155709632|FG004|Part 2|Death|0|||
48415435|NCT02203149|155709628|FG000|Part 2|Withdrawal by Subject|0|||
48415436|NCT02203149|155709629|FG001|Part 2|Withdrawal by Subject|0|||
48415437|NCT02203149|155709630|FG002|Part 2|Withdrawal by Subject|0|||
48415438|NCT02203149|155709631|FG003|Part 2|Withdrawal by Subject|1|||
48415439|NCT02203149|155709632|FG004|Part 2|Withdrawal by Subject|0|||
48415440|NCT02203149|155709628|FG000|Part 2|Adverse Event|0|||
48415441|NCT02203149|155709629|FG001|Part 2|Adverse Event|0|||
48415442|NCT02203149|155709630|FG002|Part 2|Adverse Event|0|||
48415443|NCT02203149|155709631|FG003|Part 2|Adverse Event|1|||
48415444|NCT02203149|155709632|FG004|Part 2|Adverse Event|1|||
48415445|NCT01276288|155709633|FG000|Overall Study|Adverse Event|1|||
48415446|NCT01276288|155709634|FG001|Overall Study|Adverse Event|1|||
48415447|NCT01276288|155709635|FG002|Overall Study|Adverse Event|0|||
48415448|NCT01276288|155709636|FG003|Overall Study|Adverse Event|0|||
48415449|NCT01276288|155709633|FG000|Overall Study|not treated|1|||
48415450|NCT01276288|155709634|FG001|Overall Study|not treated|0|||
48415451|NCT01276288|155709635|FG002|Overall Study|not treated|0|||
48415452|NCT01276288|155709636|FG003|Overall Study|not treated|0|||
48415453|NCT03812510|155709637|FG000|Overall Study|Lost to Follow-up|39|||
48415454|NCT03812510|155709637|FG000|Overall Study|Withdrawal by Subject|42|||
48415455|NCT03812510|155709637|FG000|Overall Study|Physician Decision|2|||
48415456|NCT03812510|155709637|FG000|Overall Study|Study Terminated by Sponsor|9|||
48415457|NCT03812510|155709637|FG000|Overall Study|Did Not Start Study Medication|55|||
48415458|NCT03812510|155709637|FG000|Overall Study|Adverse Event|5|||
48415459|NCT02469246|155709646|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
48415460|NCT02469246|155709647|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
48415461|NCT02469246|155709646|FG000|Double-Blind Phase|Adverse Event|12|||
48415462|NCT02469246|155709647|FG001|Double-Blind Phase|Adverse Event|9|||
48415463|NCT02469246|155709646|FG000|Double-Blind Phase|Death|2|||
48415464|NCT02469246|155709647|FG001|Double-Blind Phase|Death|0|||
48415465|NCT02469246|155709646|FG000|Double-Blind Phase|Lack of Efficacy|2|||
48415466|NCT02469246|155709647|FG001|Double-Blind Phase|Lack of Efficacy|1|||
48415467|NCT02469246|155709646|FG000|Double-Blind Phase|Investigator's Discretion|8|||
48415468|NCT02469246|155709647|FG001|Double-Blind Phase|Investigator's Discretion|8|||
48415469|NCT02469246|155709646|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
48415470|NCT02469246|155709647|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
48415471|NCT02469246|155709646|FG000|Double-Blind Phase|Protocol Violation|1|||
48415472|NCT02469246|155709647|FG001|Double-Blind Phase|Protocol Violation|1|||
48415473|NCT02469246|155709646|FG000|Double-Blind Phase|Withdrew Consent|25|||
48415474|NCT02469246|155709647|FG001|Double-Blind Phase|Withdrew Consent|25|||
48415475|NCT02469246|155709646|FG000|Double-Blind Phase|Lost to Follow-up|9|||
48415476|NCT02469246|155709647|FG001|Double-Blind Phase|Lost to Follow-up|5|||
48415477|NCT02034123|155709651|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415478|NCT02034123|155709652|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415479|NCT02034123|155709653|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415480|NCT02034123|155709654|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415481|NCT02034123|155709655|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
48415482|NCT02034123|155709656|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415483|NCT02034123|155709657|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415484|NCT02034123|155709658|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
48415485|NCT02034123|155709659|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
48415486|NCT02034123|155709660|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415487|NCT02034123|155709661|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415488|NCT02034123|155709662|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415489|NCT02034123|155709663|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415490|NCT02034123|155709664|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415491|NCT02034123|155709665|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415492|NCT02034123|155709666|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415493|NCT02034123|155709667|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415494|NCT02034123|155709668|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
48415495|NCT02034123|155709651|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415496|NCT02034123|155709652|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415497|NCT02034123|155709653|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415498|NCT02034123|155709654|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
48415499|NCT02034123|155709655|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415500|NCT02034123|155709656|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415501|NCT02034123|155709657|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415502|NCT02034123|155709658|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415503|NCT02034123|155709659|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415504|NCT02034123|155709660|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415505|NCT02034123|155709661|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415506|NCT02034123|155709662|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415507|NCT02034123|155709663|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415508|NCT02034123|155709664|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415509|NCT02034123|155709665|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415510|NCT02034123|155709666|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415511|NCT02034123|155709667|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415512|NCT02034123|155709668|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
48415513|NCT02034123|155709651|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415514|NCT02034123|155709652|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415515|NCT02034123|155709653|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415516|NCT02034123|155709654|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415517|NCT02034123|155709655|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415518|NCT02034123|155709656|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415519|NCT02034123|155709657|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415520|NCT02034123|155709658|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415521|NCT02034123|155709659|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
48415522|NCT02034123|155709660|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415523|NCT02034123|155709661|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415524|NCT02034123|155709662|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415525|NCT02034123|155709663|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415526|NCT02034123|155709664|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415527|NCT02034123|155709665|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415528|NCT02034123|155709666|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415529|NCT02034123|155709667|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415530|NCT02034123|155709668|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
48415531|NCT02034123|155709651|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415532|NCT02034123|155709652|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415533|NCT02034123|155709653|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415534|NCT02034123|155709654|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
48415535|NCT02034123|155709655|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
48415536|NCT02034123|155709656|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415537|NCT02034123|155709657|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415538|NCT02034123|155709658|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415539|NCT02034123|155709659|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415540|NCT02034123|155709660|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415541|NCT02034123|155709661|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415542|NCT02034123|155709662|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415543|NCT02034123|155709663|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415544|NCT02034123|155709664|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415545|NCT02034123|155709665|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415546|NCT02034123|155709666|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415547|NCT02034123|155709667|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415548|NCT02034123|155709668|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
48415549|NCT02048904|155709677|FG000|Overall Study|Withdrawal by Subject|7|||
48415550|NCT02048904|155709677|FG000|Overall Study|Physician Decision|70|||
48415551|NCT00749190|155709678|FG000|Overall Study|Adverse Event|0|||
48415552|NCT00749190|155709679|FG001|Overall Study|Adverse Event|2|||
48415553|NCT00749190|155709680|FG002|Overall Study|Adverse Event|0|||
48415554|NCT00749190|155709681|FG003|Overall Study|Adverse Event|4|||
48415555|NCT00749190|155709682|FG004|Overall Study|Adverse Event|0|||
48415556|NCT00749190|155709683|FG005|Overall Study|Adverse Event|3|||
48415557|NCT00749190|155709684|FG006|Overall Study|Adverse Event|0|||
48415558|NCT00749190|155709678|FG000|Overall Study|Lack of Efficacy|3|||
48415559|NCT00749190|155709679|FG001|Overall Study|Lack of Efficacy|1|||
48415560|NCT00749190|155709680|FG002|Overall Study|Lack of Efficacy|1|||
48415561|NCT00749190|155709681|FG003|Overall Study|Lack of Efficacy|0|||
48415562|NCT00749190|155709682|FG004|Overall Study|Lack of Efficacy|0|||
48415563|NCT00749190|155709683|FG005|Overall Study|Lack of Efficacy|1|||
48415564|NCT00749190|155709684|FG006|Overall Study|Lack of Efficacy|0|||
48415565|NCT00749190|155709678|FG000|Overall Study|Withdrawal by Subject|2|||
48415566|NCT00749190|155709679|FG001|Overall Study|Withdrawal by Subject|1|||
48415567|NCT00749190|155709680|FG002|Overall Study|Withdrawal by Subject|0|||
48415568|NCT00749190|155709681|FG003|Overall Study|Withdrawal by Subject|0|||
48415569|NCT00749190|155709682|FG004|Overall Study|Withdrawal by Subject|0|||
48415570|NCT00749190|155709683|FG005|Overall Study|Withdrawal by Subject|1|||
48415571|NCT00749190|155709684|FG006|Overall Study|Withdrawal by Subject|0|||
48415572|NCT00749190|155709678|FG000|Overall Study|Protocol Violation|0|||
48415573|NCT00749190|155709679|FG001|Overall Study|Protocol Violation|1|||
48415574|NCT00749190|155709680|FG002|Overall Study|Protocol Violation|0|||
48415575|NCT00749190|155709681|FG003|Overall Study|Protocol Violation|0|||
48415576|NCT00749190|155709682|FG004|Overall Study|Protocol Violation|0|||
48415577|NCT00749190|155709683|FG005|Overall Study|Protocol Violation|0|||
48415578|NCT00749190|155709684|FG006|Overall Study|Protocol Violation|1|||
48415579|NCT00749190|155709678|FG000|Overall Study|Other reason not defined above|0|||
48415580|NCT00749190|155709679|FG001|Overall Study|Other reason not defined above|0|||
48415581|NCT00749190|155709680|FG002|Overall Study|Other reason not defined above|0|||
48415582|NCT00749190|155709681|FG003|Overall Study|Other reason not defined above|1|||
48415583|NCT00749190|155709682|FG004|Overall Study|Other reason not defined above|0|||
48415584|NCT00749190|155709683|FG005|Overall Study|Other reason not defined above|0|||
48415585|NCT00749190|155709684|FG006|Overall Study|Other reason not defined above|0|||
48415586|NCT04325503|155709685|FG000|Overall Study|Withdrawal by Subject|1|||
48415587|NCT04325503|155709685|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
48415588|NCT01076179|155709686|FG000|Overall Study|Withdrawal by Subject|1|||
48415589|NCT04091217|155709687|FG000|Overall Study|Lost to Follow-up|2|||
48415590|NCT00538681|155709688|FG000|Overall Study|Progressive Disease|7|||
48415591|NCT00538681|155709689|FG001|Overall Study|Progressive Disease|0|||
48415592|NCT00538681|155709690|FG002|Overall Study|Progressive Disease|1|||
48415593|NCT00538681|155709691|FG003|Overall Study|Progressive Disease|0|||
48415594|NCT00538681|155709688|FG000|Overall Study|Sponsor Decision|1|||
48415595|NCT00538681|155709689|FG001|Overall Study|Sponsor Decision|3|||
48415596|NCT00538681|155709690|FG002|Overall Study|Sponsor Decision|8|||
48415597|NCT00538681|155709691|FG003|Overall Study|Sponsor Decision|9|||
48415598|NCT00538681|155709688|FG000|Overall Study|Adverse Event|1|||
48415599|NCT00538681|155709689|FG001|Overall Study|Adverse Event|1|||
48415600|NCT00538681|155709690|FG002|Overall Study|Adverse Event|1|||
48415601|NCT00538681|155709691|FG003|Overall Study|Adverse Event|0|||
48415602|NCT00538681|155709688|FG000|Overall Study|Death|0|||
48415603|NCT00538681|155709689|FG001|Overall Study|Death|0|||
48415604|NCT00538681|155709690|FG002|Overall Study|Death|1|||
48415605|NCT00538681|155709691|FG003|Overall Study|Death|1|||
48415606|NCT00538681|155709688|FG000|Overall Study|Investigator Decision|0|||
48415607|NCT00538681|155709689|FG001|Overall Study|Investigator Decision|0|||
48415608|NCT00538681|155709690|FG002|Overall Study|Investigator Decision|0|||
48415609|NCT00538681|155709691|FG003|Overall Study|Investigator Decision|1|||
48415610|NCT04574999|155711175|FG000|Overall Study|Adverse Event|1|||
48415611|NCT04574999|155711176|FG001|Overall Study|Adverse Event|0|||
48415612|NCT04574999|155711175|FG000|Overall Study|Lack of Efficacy|2|||
48415613|NCT04574999|155711176|FG001|Overall Study|Lack of Efficacy|3|||
48376094|NCT02680002|155572372|FG003|Overall Study|Lost to Follow-up|2|||
48376095|NCT02680002|155572373|FG004|Overall Study|Lost to Follow-up|0|||
48376096|NCT02680002|155572374|FG005|Overall Study|Lost to Follow-up|2|||
48376097|NCT02680002|155572369|FG000|Overall Study|Physician Decision|5|||
48376098|NCT02680002|155572370|FG001|Overall Study|Physician Decision|1|||
48376099|NCT02680002|155572371|FG002|Overall Study|Physician Decision|1|||
48376100|NCT02680002|155572372|FG003|Overall Study|Physician Decision|1|||
48376101|NCT02680002|155572373|FG004|Overall Study|Physician Decision|1|||
48376102|NCT02680002|155572374|FG005|Overall Study|Physician Decision|1|||
48376103|NCT02680002|155572369|FG000|Overall Study|Protocol Violation|1|||
48376104|NCT02680002|155572370|FG001|Overall Study|Protocol Violation|0|||
48376105|NCT02680002|155572371|FG002|Overall Study|Protocol Violation|1|||
48376106|NCT02680002|155572372|FG003|Overall Study|Protocol Violation|0|||
48376107|NCT02680002|155572373|FG004|Overall Study|Protocol Violation|1|||
48376108|NCT02680002|155572374|FG005|Overall Study|Protocol Violation|2|||
48376109|NCT02680002|155572369|FG000|Overall Study|Withdrawal by Subject|0|||
48376110|NCT02680002|155572370|FG001|Overall Study|Withdrawal by Subject|0|||
48376111|NCT02680002|155572371|FG002|Overall Study|Withdrawal by Subject|1|||
48376112|NCT02680002|155572372|FG003|Overall Study|Withdrawal by Subject|0|||
48376113|NCT02680002|155572373|FG004|Overall Study|Withdrawal by Subject|2|||
48376114|NCT02680002|155572374|FG005|Overall Study|Withdrawal by Subject|2|||
48376115|NCT02680002|155572369|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
48376116|NCT02680002|155572370|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
48376117|NCT02680002|155572371|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
48376118|NCT02680002|155572372|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
48376119|NCT02680002|155572373|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
48376120|NCT02680002|155572374|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
48376121|NCT02680002|155572369|FG000|Overall Study|Other|0|||
48376122|NCT02680002|155572370|FG001|Overall Study|Other|1|||
48376123|NCT02680002|155572371|FG002|Overall Study|Other|0|||
48376124|NCT02680002|155572372|FG003|Overall Study|Other|0|||
48376125|NCT02680002|155572373|FG004|Overall Study|Other|1|||
48376126|NCT02680002|155572374|FG005|Overall Study|Other|0|||
48376127|NCT02680002|155572369|FG000|Overall Study|Adverse Event|0|||
48376128|NCT02680002|155572370|FG001|Overall Study|Adverse Event|0|||
48376129|NCT02680002|155572371|FG002|Overall Study|Adverse Event|0|||
48376130|NCT02680002|155572372|FG003|Overall Study|Adverse Event|0|||
48376131|NCT02680002|155572373|FG004|Overall Study|Adverse Event|1|||
48376132|NCT02680002|155572374|FG005|Overall Study|Adverse Event|2|||
48376133|NCT00645801|155572375|FG000|Overall Study|unclear if patient took all the medication.|1|||
48376134|NCT00645801|155572376|FG001|Overall Study|unclear if patient took all the medication.|0|||
48376135|NCT00645801|155572375|FG000|Overall Study|Lost to Follow-up|19|||
48376136|NCT00645801|155572376|FG001|Overall Study|Lost to Follow-up|15|||
48376137|NCT01403610|155572377|FG000|Overall Study|Withdrawal by Subject|2|||
48376138|NCT01403610|155572378|FG001|Overall Study|Withdrawal by Subject|0|||
48376139|NCT01403610|155572379|FG002|Overall Study|Withdrawal by Subject|0|||
48376140|NCT01403610|155572380|FG003|Overall Study|Withdrawal by Subject|0|||
48376141|NCT01403610|155572377|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
48376142|NCT01403610|155572378|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
48376143|NCT01403610|155572379|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
48376144|NCT01403610|155572380|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
48376145|NCT03628898|155572385|FG000|Overall Study|Device deficiency|1|||
48376146|NCT01111474|155572388|FG000|Overall Study|Lost to Follow-up|12|||
48376147|NCT03103763|155572389|FG000|Overall Study|Death|15|||
48376148|NCT03103763|155572390|FG001|Overall Study|Death|5|||
48376149|NCT03103763|155572391|FG002|Overall Study|Death|5|||
48376150|NCT03103763|155572389|FG000|Overall Study|Withdrawal by Subject|0|||
48376151|NCT03103763|155572390|FG001|Overall Study|Withdrawal by Subject|3|||
48376152|NCT03103763|155572391|FG002|Overall Study|Withdrawal by Subject|2|||
48376153|NCT01143038|155572392|FG000|Overall Study|Withdrawal by Subject|4|||
48376154|NCT01143038|155572392|FG000|Overall Study|Requirement for alternative therapy|5|||
48376155|NCT01143038|155572392|FG000|Overall Study|Adverse Event|3|||
48376156|NCT01143038|155572392|FG000|Overall Study|Lost to Follow-up|2|||
48376157|NCT01143038|155572392|FG000|Overall Study|Protocol Deviation|1|||
48376158|NCT01143038|155572392|FG000|Overall Study|Death|1|||
48376159|NCT01280812|155572393|FG000|Overall Study|Withdrawal by Subject|2|||
48376160|NCT01280812|155572394|FG001|Overall Study|Withdrawal by Subject|1|||
48376161|NCT01280812|155572395|FG002|Overall Study|Withdrawal by Subject|0|||
48376162|NCT01280812|155572393|FG000|Overall Study|Lost to Follow-up|1|||
48376163|NCT01280812|155572394|FG001|Overall Study|Lost to Follow-up|1|||
48376164|NCT01280812|155572395|FG002|Overall Study|Lost to Follow-up|1|||
48376165|NCT00706433|155572396|FG000|Overall Study|Lost to Follow-up|3|||
48376166|NCT00706433|155572397|FG001|Overall Study|Lost to Follow-up|1|||
48376167|NCT00706433|155572398|FG002|Overall Study|Lost to Follow-up|6|||
48376168|NCT00706433|155572399|FG003|Overall Study|Lost to Follow-up|0|||
48376169|NCT00706433|155572396|FG000|Overall Study|Withdrawal by Subject|1|||
48376170|NCT00706433|155572397|FG001|Overall Study|Withdrawal by Subject|2|||
48376171|NCT00706433|155572398|FG002|Overall Study|Withdrawal by Subject|3|||
48376172|NCT00706433|155572399|FG003|Overall Study|Withdrawal by Subject|1|||
48376173|NCT00706433|155572396|FG000|Overall Study|Adverse Event|0|||
48376174|NCT00706433|155572397|FG001|Overall Study|Adverse Event|0|||
48376175|NCT00706433|155572398|FG002|Overall Study|Adverse Event|1|||
48376176|NCT00706433|155572399|FG003|Overall Study|Adverse Event|0|||
48376177|NCT00706433|155572396|FG000|Overall Study|Protocol Violation|1|||
48376178|NCT00706433|155572397|FG001|Overall Study|Protocol Violation|0|||
48376179|NCT00706433|155572398|FG002|Overall Study|Protocol Violation|0|||
48376180|NCT00706433|155572399|FG003|Overall Study|Protocol Violation|0|||
48376181|NCT00706433|155572396|FG000|Overall Study|new job|0|||
48376182|NCT00706433|155572397|FG001|Overall Study|new job|0|||
48376183|NCT00706433|155572398|FG002|Overall Study|new job|0|||
48376184|NCT00706433|155572399|FG003|Overall Study|new job|1|||
48376185|NCT00717067|155572400|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
48376186|NCT00717067|155572401|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
48376187|NCT00717067|155572402|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
48376188|NCT00717067|155572403|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
48376189|NCT00717067|155572404|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
48376190|NCT00250679|155572405|FG000|Overall Study|Adverse Event|12|||
48376191|NCT00250679|155572406|FG001|Overall Study|Adverse Event|15|||
48376192|NCT00250679|155572407|FG002|Overall Study|Adverse Event|16|||
48376193|NCT00250679|155572405|FG000|Overall Study|Protocol Violation|2|||
48376194|NCT00250679|155572406|FG001|Overall Study|Protocol Violation|4|||
48376195|NCT00250679|155572407|FG002|Overall Study|Protocol Violation|3|||
48376196|NCT00250679|155572405|FG000|Overall Study|Withdrawal by Subject|15|||
48376197|NCT00250679|155572406|FG001|Overall Study|Withdrawal by Subject|18|||
48376198|NCT00250679|155572407|FG002|Overall Study|Withdrawal by Subject|15|||
48376199|NCT00250679|155572405|FG000|Overall Study|Lost to Follow-up|3|||
48376200|NCT00250679|155572406|FG001|Overall Study|Lost to Follow-up|4|||
48376201|NCT00250679|155572407|FG002|Overall Study|Lost to Follow-up|2|||
48376202|NCT00250679|155572405|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
48376203|NCT00250679|155572406|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
48376204|NCT00250679|155572407|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
48376205|NCT00250679|155572405|FG000|Overall Study|Lack of Efficacy|0|||
48376206|NCT00250679|155572406|FG001|Overall Study|Lack of Efficacy|1|||
48376207|NCT00250679|155572407|FG002|Overall Study|Lack of Efficacy|3|||
48376208|NCT00250679|155572405|FG000|Overall Study|Technical Holter issues|1|||
48376209|NCT00250679|155572406|FG001|Overall Study|Technical Holter issues|0|||
48376210|NCT00250679|155572407|FG002|Overall Study|Technical Holter issues|2|||
48376211|NCT00250679|155572405|FG000|Overall Study|Moved|1|||
48376212|NCT00250679|155572406|FG001|Overall Study|Moved|1|||
48376213|NCT00250679|155572407|FG002|Overall Study|Moved|0|||
48376214|NCT00250679|155572405|FG000|Overall Study|Non-compliance|1|||
48376215|NCT00250679|155572406|FG001|Overall Study|Non-compliance|1|||
48376216|NCT00250679|155572407|FG002|Overall Study|Non-compliance|0|||
48376217|NCT00250679|155572405|FG000|Overall Study|various single events: hip surgery,diary|3|||
48376218|NCT00250679|155572406|FG001|Overall Study|various single events: hip surgery,diary|1|||
48376219|NCT00250679|155572407|FG002|Overall Study|various single events: hip surgery,diary|1|||
48376220|NCT00822172|155572408|FG000|Overall Study|Adverse Event|10|||
48376221|NCT00822172|155572409|FG001|Overall Study|Adverse Event|12|||
48376222|NCT00822172|155572408|FG000|Overall Study|Death|1|||
48376223|NCT00822172|155572409|FG001|Overall Study|Death|0|||
48376224|NCT00822172|155572408|FG000|Overall Study|Lost to Follow-up|3|||
48376225|NCT00822172|155572409|FG001|Overall Study|Lost to Follow-up|1|||
48376226|NCT00822172|155572408|FG000|Overall Study|Withdrawal by Subject|1|||
48376227|NCT00822172|155572409|FG001|Overall Study|Withdrawal by Subject|4|||
48376228|NCT00822172|155572408|FG000|Overall Study|site closed|0|||
48376229|NCT00822172|155572409|FG001|Overall Study|site closed|1|||
48376230|NCT00822172|155572408|FG000|Overall Study|Other|0|||
48376231|NCT00822172|155572409|FG001|Overall Study|Other|1|||
48376232|NCT00824161|155572410|FG000|Overall Study|Withdrawal by Subject|1|||
48376233|NCT00824161|155572410|FG000|Overall Study|Screen Failure|1|||
48376234|NCT01676909|155572411|FG000|Overall Study|Withdrawal by Subject|3|||
48376235|NCT01676909|155572412|FG001|Overall Study|Withdrawal by Subject|5|||
48376236|NCT01676909|155572411|FG000|Overall Study|Lost to Follow-up|15|||
48376237|NCT01676909|155572412|FG001|Overall Study|Lost to Follow-up|9|||
48376238|NCT02175004|155572415|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
48376239|NCT02175004|155572416|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
48376240|NCT02175004|155572415|FG000|Overall Study|Investigator Judgment|1|||
48376241|NCT02175004|155572416|FG001|Overall Study|Investigator Judgment|4|||
48376242|NCT02175004|155572415|FG000|Overall Study|Voluntary Withdrawal|6|||
48376243|NCT02175004|155572416|FG001|Overall Study|Voluntary Withdrawal|19|||
48376244|NCT02175004|155572415|FG000|Overall Study|Liver Transplant|1|||
48376245|NCT02175004|155572416|FG001|Overall Study|Liver Transplant|0|||
48376246|NCT02175004|155572415|FG000|Overall Study|Disease Progression|1|||
48376247|NCT02175004|155572416|FG001|Overall Study|Disease Progression|0|||
48376248|NCT02175004|155572415|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
48415614|NCT04574999|155711175|FG000|Overall Study|Protocol Violation|1|||
48376249|NCT02175004|155572416|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
48376250|NCT03215810|155572417|FG000|Overall Study|Still responding to nivolumab|1|||
48376251|NCT03215810|155572417|FG000|Overall Study|Insufficient TIL growth|1|||
48376252|NCT03215810|155572417|FG000|Overall Study|Decline in performance status|1|||
48376253|NCT03215810|155572417|FG000|Overall Study|Withdrawal by Subject|1|||
48376254|NCT00871780|155572418|FG000|Overall Study|Enrolled But Not Treated|6|||
48376255|NCT00871780|155572418|FG000|Overall Study|Withdrawal by Subject|9|||
48376256|NCT00871780|155572418|FG000|Overall Study|Adverse Event|6|||
48376257|NCT00871780|155572418|FG000|Overall Study|Voluntary Discontinuation|4|||
48376258|NCT00871780|155572418|FG000|Overall Study|Death|1|||
48376259|NCT00871780|155572418|FG000|Overall Study|Physician Decision|1|||
48376260|NCT03401229|155572425|FG000|Overall Study|Lost to Follow-up|2|||
48376261|NCT03401229|155572426|FG001|Overall Study|Lost to Follow-up|1|||
48376262|NCT03401229|155572425|FG000|Overall Study|Other|1|||
48376263|NCT03401229|155572426|FG001|Overall Study|Other|3|||
48376264|NCT03401229|155572425|FG000|Overall Study|Adverse Event|8|||
48376265|NCT03401229|155572426|FG001|Overall Study|Adverse Event|6|||
48376266|NCT03401229|155572425|FG000|Overall Study|Withdrawal by Subject|29|||
48376267|NCT03401229|155572426|FG001|Overall Study|Withdrawal by Subject|26|||
48376268|NCT03401229|155572425|FG000|Overall Study|COVID-19|0|||
48376269|NCT03401229|155572426|FG001|Overall Study|COVID-19|1|||
48376270|NCT02963610|155572427|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
48376271|NCT01324440|155572431|FG000|Overall Study|Subject moved|0|||
48376272|NCT01324440|155572432|FG001|Overall Study|Subject moved|1|||
48376273|NCT00063154|155572438|FG000|Overall Study|Disease progression|27|||
48376274|NCT00063154|155572438|FG000|Overall Study|Adverse Event|2|||
48376275|NCT00063154|155572438|FG000|Overall Study|Physician Decision|10|||
48376276|NCT00063154|155572438|FG000|Overall Study|Death|3|||
48376277|NCT00063154|155572438|FG000|Overall Study|Reason unspecified|1|||
48376278|NCT00063154|155572438|FG000|Overall Study|Did not receive treatment|8|||
48376279|NCT01122862|155572439|FG000|Period 1|Protocol Violation|0|||
48376280|NCT01122862|155572440|FG001|Period 1|Protocol Violation|1|||
48376281|NCT01122862|155572441|FG002|Period 1|Protocol Violation|0|||
48376282|NCT01122862|155572439|FG000|Period 2|Adverse Event|0|||
48376283|NCT01122862|155572440|FG001|Period 2|Adverse Event|0|||
48376284|NCT01122862|155572441|FG002|Period 2|Adverse Event|1|||
48376285|NCT02752074|155572442|FG000|Overall Study|Lost to Follow-up|1|||
48376286|NCT02752074|155572443|FG001|Overall Study|Lost to Follow-up|4|||
48376287|NCT02752074|155572442|FG000|Overall Study|Death|146|||
48376288|NCT02752074|155572443|FG001|Overall Study|Death|129|||
48376289|NCT02752074|155572442|FG000|Overall Study|Withdrawal by Subject|9|||
48376290|NCT02752074|155572443|FG001|Overall Study|Withdrawal by Subject|10|||
48376291|NCT01249274|155572444|FG000|Overall Study|Lost to Follow-up|3|||
48376292|NCT01249274|155572445|FG001|Overall Study|Lost to Follow-up|4|||
48376293|NCT01249274|155572444|FG000|Overall Study|Received inpatient substance treatment|1|||
48376294|NCT01249274|155572445|FG001|Overall Study|Received inpatient substance treatment|2|||
48376295|NCT03451162|155572446|FG000|Overall Study|Lost to Follow-up|1|||
48376296|NCT03451162|155572447|FG001|Overall Study|Lost to Follow-up|0|||
48376297|NCT03451162|155572448|FG002|Overall Study|Lost to Follow-up|0|||
48376298|NCT03451162|155572449|FG003|Overall Study|Lost to Follow-up|0|||
48376299|NCT03451162|155572450|FG004|Overall Study|Lost to Follow-up|0|||
48376300|NCT03451162|155572446|FG000|Overall Study|Physician Decision|0|||
48376301|NCT03451162|155572447|FG001|Overall Study|Physician Decision|1|||
48376302|NCT03451162|155572448|FG002|Overall Study|Physician Decision|0|||
48376303|NCT03451162|155572449|FG003|Overall Study|Physician Decision|0|||
48376304|NCT03451162|155572450|FG004|Overall Study|Physician Decision|0|||
48376305|NCT03451162|155572446|FG000|Overall Study|Withdrawal by Subject|1|||
48376306|NCT03451162|155572447|FG001|Overall Study|Withdrawal by Subject|1|||
48376307|NCT03451162|155572448|FG002|Overall Study|Withdrawal by Subject|0|||
48376308|NCT03451162|155572449|FG003|Overall Study|Withdrawal by Subject|0|||
48376309|NCT03451162|155572450|FG004|Overall Study|Withdrawal by Subject|0|||
48376310|NCT01488487|155572451|FG000|Overall Study|Adverse Event|6|||
48376311|NCT01488487|155572451|FG000|Overall Study|Death|1|||
48376312|NCT01488487|155572451|FG000|Overall Study|Withdrawal by Subject|2|||
48376313|NCT04634825|155572452|FG000|Overall Study|Death|10|||
48376314|NCT04634825|155572453|FG001|Overall Study|Death|3|||
48376315|NCT04634825|155572452|FG000|Overall Study|Lost to Follow-up|1|||
48376316|NCT04634825|155572453|FG001|Overall Study|Lost to Follow-up|0|||
48376317|NCT04634825|155572452|FG000|Overall Study|Study terminated by sponsor|35|||
48376318|NCT04634825|155572453|FG001|Overall Study|Study terminated by sponsor|11|||
48376319|NCT04634825|155572452|FG000|Overall Study|Withdrawal by Subject|2|||
48376320|NCT04634825|155572453|FG001|Overall Study|Withdrawal by Subject|0|||
48376321|NCT01959516|155572454|FG000|Epoch 1|Adverse Event|4|||
48376322|NCT01959516|155572455|FG001|Epoch 1|Adverse Event|1|||
48376323|NCT01959516|155572454|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
48376324|NCT01959516|155572455|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
48376325|NCT01959516|155572454|FG000|Epoch 1|Subject withdrew consent|3|||
48376326|NCT01959516|155572455|FG001|Epoch 1|Subject withdrew consent|2|||
48376327|NCT01959516|155572454|FG000|Epoch 1|Administrative problems|1|||
48376328|NCT01959516|155572455|FG001|Epoch 1|Administrative problems|0|||
48376329|NCT01959516|155572454|FG000|Epoch 1|Use of prohibited treatment|1|||
48376330|NCT01959516|155572455|FG001|Epoch 1|Use of prohibited treatment|0|||
48376331|NCT01959516|155572454|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
48376332|NCT01959516|155572455|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
48376333|NCT01959516|155572454|FG000|Epoch 1|Protocol deviation|0|||
48376334|NCT01959516|155572455|FG001|Epoch 1|Protocol deviation|1|||
48376335|NCT01959516|155572454|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
48376336|NCT01959516|155572455|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
48376337|NCT01959516|155572454|FG000|Epoch 2|Subject withdrew consent|1|||
48376338|NCT01959516|155572455|FG001|Epoch 2|Subject withdrew consent|0|||
48376339|NCT01959516|155572454|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
48376340|NCT01959516|155572455|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
48376341|NCT01477333|155572456|FG000|Overall Study|Adverse Event|1|||
48376342|NCT01477333|155572456|FG000|Overall Study|Withdrawal by Subject|1|||
48376343|NCT01477333|155572456|FG000|Overall Study|Clinical Deterioration|1|||
48376344|NCT03426267|155572459|FG000|Overall Study|Physician Decision|1|||
48376345|NCT03426267|155572460|FG001|Overall Study|Physician Decision|4|||
48376346|NCT03426267|155572459|FG000|Overall Study|Lost to Follow-up|1|||
48376347|NCT03426267|155572460|FG001|Overall Study|Lost to Follow-up|0|||
48376348|NCT03426267|155572459|FG000|Overall Study|Withdrawal by Subject|4|||
48376349|NCT03426267|155572460|FG001|Overall Study|Withdrawal by Subject|10|||
48376350|NCT03426267|155572459|FG000|Overall Study|Protocol Violation|1|||
48376351|NCT03426267|155572460|FG001|Overall Study|Protocol Violation|3|||
48376352|NCT03426267|155572459|FG000|Overall Study|Adverse Event|9|||
48376353|NCT03426267|155572460|FG001|Overall Study|Adverse Event|27|||
48376354|NCT03426267|155572459|FG000|Overall Study|Prohibited Treatment Intake|2|||
48376355|NCT03426267|155572460|FG001|Overall Study|Prohibited Treatment Intake|3|||
48376356|NCT03426267|155572459|FG000|Overall Study|Lack of Efficacy|0|||
48376357|NCT03426267|155572460|FG001|Overall Study|Lack of Efficacy|25|||
48376358|NCT03426267|155572459|FG000|Overall Study|other|3|||
48376359|NCT03426267|155572460|FG001|Overall Study|other|0|||
48376360|NCT01580969|155572461|FG000|Overall Study|Physician Decision|3|||
48376361|NCT01580969|155572462|FG001|Overall Study|Physician Decision|0|||
48376362|NCT01580969|155572463|FG002|Overall Study|Physician Decision|0|||
48376363|NCT02578862|155572464|FG000|Overall Study|Withdrawal by Subject|0|||
48376364|NCT02578862|155572465|FG001|Overall Study|Withdrawal by Subject|1|||
48376365|NCT02578862|155572464|FG000|Overall Study|Unplanned unilateral procedure|0|||
48376366|NCT02578862|155572465|FG001|Overall Study|Unplanned unilateral procedure|1|||
48376367|NCT00448123|155572466|FG000|Overall Study|Lost to Follow-up|9|||
48376368|NCT00448123|155572467|FG001|Overall Study|Lost to Follow-up|6|||
48376369|NCT00448123|155572466|FG000|Overall Study|Physician Decision|6|||
48376370|NCT00448123|155572467|FG001|Overall Study|Physician Decision|6|||
48376371|NCT02027623|155572468|FG000|Overall Study|Lost to Follow-up|3|||
48376372|NCT02027623|155572469|FG001|Overall Study|Lost to Follow-up|3|||
48376373|NCT02027623|155572468|FG000|Overall Study|Withdrawal by Subject|6|||
48376374|NCT02027623|155572469|FG001|Overall Study|Withdrawal by Subject|9|||
48376375|NCT04744285|155572471|FG000|Overall Study|Withdrawal by Subject|1|||
48376376|NCT04744285|155572472|FG001|Overall Study|Withdrawal by Subject|1|||
48376377|NCT04744285|155572473|FG002|Overall Study|Withdrawal by Subject|2|||
48376378|NCT04744285|155572474|FG003|Overall Study|Withdrawal by Subject|1|||
48376379|NCT01116882|155572475|FG000|30-day|Lost to Follow-up|50|||
48376380|NCT01116882|155572476|FG001|30-day|Lost to Follow-up|21|||
48376381|NCT01116882|155572475|FG000|30-day|Withdrawal by Subject|2|||
48376382|NCT01116882|155572476|FG001|30-day|Withdrawal by Subject|4|||
48376383|NCT01116882|155572475|FG000|30-day|Other Reasons|16|||
48376384|NCT01116882|155572476|FG001|30-day|Other Reasons|6|||
48376385|NCT01116882|155572475|FG000|12-month|Lost to Follow-up|111|||
48376386|NCT01116882|155572476|FG001|12-month|Lost to Follow-up|42|||
48376387|NCT01116882|155572475|FG000|12-month|Other Reasons|151|||
48376388|NCT01116882|155572476|FG001|12-month|Other Reasons|49|||
48376389|NCT01116882|155572475|FG000|12-month|Withdrawal by Subject|5|||
48376390|NCT01116882|155572476|FG001|12-month|Withdrawal by Subject|8|||
48376391|NCT01966471|155572477|FG000|Overall Study|Death|44|||
48376392|NCT01966471|155572478|FG001|Overall Study|Death|56|||
48376393|NCT01966471|155572477|FG000|Overall Study|Lost to Follow-up|46|||
48376394|NCT01966471|155572478|FG001|Overall Study|Lost to Follow-up|39|||
48376395|NCT01966471|155572477|FG000|Overall Study|Various reasons|4|||
48376396|NCT01966471|155572478|FG001|Overall Study|Various reasons|4|||
48376397|NCT01966471|155572477|FG000|Overall Study|Physician Decision|7|||
48376398|NCT01966471|155572478|FG001|Overall Study|Physician Decision|5|||
48376399|NCT01966471|155572477|FG000|Overall Study|Study Terminated By Sponsor|758|||
48376400|NCT01966471|155572478|FG001|Overall Study|Study Terminated By Sponsor|773|||
48376401|NCT01966471|155572477|FG000|Overall Study|Withdrawal by Subject|59|||
48376402|NCT01966471|155572478|FG001|Overall Study|Withdrawal by Subject|51|||
48376403|NCT00593957|155572479|FG000|Overall Study|Physician Decision|0|||
48376404|NCT00593957|155572480|FG001|Overall Study|Physician Decision|1|||
48376405|NCT00593957|155572481|FG002|Overall Study|Physician Decision|2|||
48376406|NCT01193920|155572482|FG000|Overall Study|Withdrawal by Subject|1|||
48376407|NCT01193920|155572483|FG001|Overall Study|Withdrawal by Subject|0|||
48376408|NCT01193920|155572484|FG002|Overall Study|Withdrawal by Subject|5|||
48376409|NCT01193920|155572485|FG003|Overall Study|Withdrawal by Subject|1|||
48376410|NCT01193920|155572486|FG004|Overall Study|Withdrawal by Subject|3|||
48376411|NCT01193920|155572487|FG005|Overall Study|Withdrawal by Subject|1|||
48376412|NCT01193920|155572488|FG006|Overall Study|Withdrawal by Subject|3|||
48376413|NCT01193920|155572489|FG007|Overall Study|Withdrawal by Subject|0|||
48376414|NCT01193920|155572490|FG008|Overall Study|Withdrawal by Subject|1|||
48376415|NCT01193920|155572491|FG009|Overall Study|Withdrawal by Subject|0|||
48376416|NCT01193920|155572482|FG000|Overall Study|Lost to Follow-up|1|||
48376417|NCT01193920|155572483|FG001|Overall Study|Lost to Follow-up|0|||
48376418|NCT01193920|155572484|FG002|Overall Study|Lost to Follow-up|1|||
48376419|NCT01193920|155572485|FG003|Overall Study|Lost to Follow-up|1|||
48376420|NCT01193920|155572486|FG004|Overall Study|Lost to Follow-up|3|||
48376421|NCT01193920|155572487|FG005|Overall Study|Lost to Follow-up|3|||
48376422|NCT01193920|155572488|FG006|Overall Study|Lost to Follow-up|1|||
48376423|NCT01193920|155572489|FG007|Overall Study|Lost to Follow-up|0|||
48376424|NCT01193920|155572490|FG008|Overall Study|Lost to Follow-up|2|||
48376425|NCT01193920|155572491|FG009|Overall Study|Lost to Follow-up|3|||
48376426|NCT01193920|155572482|FG000|Overall Study|Protocol Violation|1|||
48376427|NCT01193920|155572483|FG001|Overall Study|Protocol Violation|0|||
48376428|NCT01193920|155572484|FG002|Overall Study|Protocol Violation|0|||
48376429|NCT01193920|155572485|FG003|Overall Study|Protocol Violation|0|||
48376430|NCT01193920|155572486|FG004|Overall Study|Protocol Violation|0|||
48376431|NCT01193920|155572487|FG005|Overall Study|Protocol Violation|0|||
48376432|NCT01193920|155572488|FG006|Overall Study|Protocol Violation|0|||
48376433|NCT01193920|155572489|FG007|Overall Study|Protocol Violation|0|||
48376434|NCT01193920|155572490|FG008|Overall Study|Protocol Violation|0|||
48376435|NCT01193920|155572491|FG009|Overall Study|Protocol Violation|0|||
48376436|NCT01193920|155572482|FG000|Overall Study|Death|0|||
48376437|NCT01193920|155572483|FG001|Overall Study|Death|0|||
48376438|NCT01193920|155572484|FG002|Overall Study|Death|0|||
48376439|NCT01193920|155572485|FG003|Overall Study|Death|1|||
48376440|NCT01193920|155572486|FG004|Overall Study|Death|0|||
48376441|NCT01193920|155572487|FG005|Overall Study|Death|0|||
48376442|NCT01193920|155572488|FG006|Overall Study|Death|2|||
48376443|NCT01193920|155572489|FG007|Overall Study|Death|3|||
48376444|NCT01193920|155572490|FG008|Overall Study|Death|2|||
48376445|NCT01193920|155572491|FG009|Overall Study|Death|4|||
48376446|NCT01193920|155572482|FG000|Overall Study|Unable to classify|0|||
48376447|NCT01193920|155572483|FG001|Overall Study|Unable to classify|0|||
48376448|NCT01193920|155572484|FG002|Overall Study|Unable to classify|0|||
48376449|NCT01193920|155572485|FG003|Overall Study|Unable to classify|1|||
48376450|NCT01193920|155572486|FG004|Overall Study|Unable to classify|0|||
48376451|NCT01193920|155572487|FG005|Overall Study|Unable to classify|0|||
48376452|NCT01193920|155572488|FG006|Overall Study|Unable to classify|0|||
48376453|NCT01193920|155572489|FG007|Overall Study|Unable to classify|1|||
48376454|NCT01193920|155572490|FG008|Overall Study|Unable to classify|0|||
48376455|NCT01193920|155572491|FG009|Overall Study|Unable to classify|0|||
48376456|NCT01012739|155572492|FG000|Treatment Period 1|Adverse Event|0|||
48376457|NCT01012739|155572493|FG001|Treatment Period 1|Adverse Event|0|||
48376458|NCT01012739|155572494|FG002|Treatment Period 1|Adverse Event|0|||
48376459|NCT01012739|155572495|FG003|Treatment Period 1|Adverse Event|1|||
48376460|NCT01012739|155572492|FG000|Treatment Period 2|Abnormal test procedure results|0|||
48376461|NCT01012739|155572493|FG001|Treatment Period 2|Abnormal test procedure results|0|||
48376462|NCT01012739|155572494|FG002|Treatment Period 2|Abnormal test procedure results|0|||
48376463|NCT01012739|155572495|FG003|Treatment Period 2|Abnormal test procedure results|1|||
48376464|NCT00252733|155573906|FG000|Overall Study|Withdrawal by Subject|73|||
48376465|NCT00252733|155573907|FG001|Overall Study|Withdrawal by Subject|67|||
48376466|NCT00252733|155573906|FG000|Overall Study|Death|7|||
48376467|NCT00252733|155573907|FG001|Overall Study|Death|5|||
48376468|NCT00252733|155573906|FG000|Overall Study|Lost to Follow-up|12|||
48376469|NCT00252733|155573907|FG001|Overall Study|Lost to Follow-up|6|||
48376470|NCT00252733|155573906|FG000|Overall Study|Multiple Reasons|14|||
48376471|NCT00252733|155573907|FG001|Overall Study|Multiple Reasons|14|||
48376472|NCT00081770|155573908|FG000|Overall Study|Adverse Event|130|||
48376473|NCT00081770|155573909|FG001|Overall Study|Adverse Event|98|||
48376474|NCT00081770|155573910|FG002|Overall Study|Adverse Event|136|||
48376475|NCT00081770|155573908|FG000|Overall Study|Lack of Efficacy|262|||
48376476|NCT00081770|155573909|FG001|Overall Study|Lack of Efficacy|357|||
48376477|NCT00081770|155573910|FG002|Overall Study|Lack of Efficacy|211|||
48376478|NCT00081770|155573908|FG000|Overall Study|Lost to Follow-up|45|||
48376479|NCT00081770|155573909|FG001|Overall Study|Lost to Follow-up|34|||
48376480|NCT00081770|155573910|FG002|Overall Study|Lost to Follow-up|45|||
48376481|NCT00081770|155573908|FG000|Overall Study|Protocol Violation|15|||
48376482|NCT00081770|155573909|FG001|Overall Study|Protocol Violation|10|||
48376483|NCT00081770|155573910|FG002|Overall Study|Protocol Violation|10|||
48376484|NCT00081770|155573908|FG000|Overall Study|Withdrawal by Subject|45|||
48376485|NCT00081770|155573909|FG001|Overall Study|Withdrawal by Subject|40|||
48376486|NCT00081770|155573910|FG002|Overall Study|Withdrawal by Subject|42|||
48376487|NCT00081770|155573908|FG000|Overall Study|Did not meet protocol eligibility|2|||
48376488|NCT00081770|155573909|FG001|Overall Study|Did not meet protocol eligibility|0|||
48376489|NCT00081770|155573910|FG002|Overall Study|Did not meet protocol eligibility|3|||
48376490|NCT00081770|155573908|FG000|Overall Study|Administrative|1|||
48376491|NCT00081770|155573909|FG001|Overall Study|Administrative|0|||
48376492|NCT00081770|155573910|FG002|Overall Study|Administrative|1|||
48376493|NCT00081770|155573908|FG000|Overall Study|Other|2|||
48376494|NCT00081770|155573909|FG001|Overall Study|Other|7|||
48376495|NCT00081770|155573910|FG002|Overall Study|Other|8|||
48376496|NCT01350336|155573911|FG000|Overall Study|Lost to Follow-up|31|||
48376497|NCT01350336|155573911|FG000|Overall Study|Withdrawal by Subject|14|||
48376498|NCT01350336|155573911|FG000|Overall Study|Physician Decision|8|||
48376499|NCT01350336|155573911|FG000|Overall Study|Death|4|||
48376500|NCT01491672|155573914|FG000|Overall Study|Lost to Follow-up|0|||
48376501|NCT01491672|155573915|FG001|Overall Study|Lost to Follow-up|4|||
48376502|NCT01491672|155573916|FG002|Overall Study|Lost to Follow-up|1|||
48376503|NCT01491672|155573914|FG000|Overall Study|Withdrawal by Subject|6|||
48376504|NCT01491672|155573915|FG001|Overall Study|Withdrawal by Subject|7|||
48376505|NCT01491672|155573916|FG002|Overall Study|Withdrawal by Subject|0|||
48376506|NCT01491672|155573914|FG000|Overall Study|Adverse Event|8|||
48376507|NCT01491672|155573915|FG001|Overall Study|Adverse Event|10|||
48376508|NCT01491672|155573916|FG002|Overall Study|Adverse Event|4|||
48376509|NCT01491672|155573914|FG000|Overall Study|Disease progression|42|||
48376510|NCT01491672|155573915|FG001|Overall Study|Disease progression|34|||
48376511|NCT01491672|155573916|FG002|Overall Study|Disease progression|6|||
48376512|NCT01491672|155573914|FG000|Overall Study|Protocol deviation|0|||
48376513|NCT01491672|155573915|FG001|Overall Study|Protocol deviation|1|||
48376514|NCT01491672|155573916|FG002|Overall Study|Protocol deviation|0|||
48376515|NCT01491672|155573914|FG000|Overall Study|Death|0|||
48376516|NCT01491672|155573915|FG001|Overall Study|Death|4|||
48376517|NCT01491672|155573916|FG002|Overall Study|Death|0|||
48376518|NCT03435497|155573917|FG000|Overall Study|Lost to Follow-up|1|||
48376519|NCT03435497|155573918|FG001|Overall Study|Lost to Follow-up|0|||
48376520|NCT03435497|155573917|FG000|Overall Study|Death|1|||
48376521|NCT03435497|155573918|FG001|Overall Study|Death|0|||
48376522|NCT03435497|155573917|FG000|Overall Study|Withdrawal by Subject|0|||
48376523|NCT03435497|155573918|FG001|Overall Study|Withdrawal by Subject|4|||
48376524|NCT03435497|155573917|FG000|Overall Study|Wrong survey administered|0|||
48376525|NCT03435497|155573918|FG001|Overall Study|Wrong survey administered|2|||
48376526|NCT04281004|155573919|FG000|Overall Study|Physician Decision|1|||
48376527|NCT04281004|155573920|FG001|Overall Study|Physician Decision|0|||
48376528|NCT02079610|155573921|FG000|Overall Study|Withdrawal by Subject|1|||
48376529|NCT02079610|155573922|FG001|Overall Study|Withdrawal by Subject|1|||
48376530|NCT02342743|155573928|FG000|Baseline Period|Withdrawal by Subject|3|||
48376531|NCT02342743|155573928|FG000|Baseline Period|Lost to Follow-up|2|||
48376532|NCT02342743|155573928|FG000|Baseline Period|Change in prophylactic medication|3|||
48376533|NCT02342743|155573928|FG000|Baseline Period|Screening failure regarding baseline|7|||
48376534|NCT02342743|155573928|FG000|Treatment Period|Withdrawal by Subject|2|||
48376535|NCT02342743|155573928|FG000|Treatment Period|Lost to Follow-up|8|||
48376536|NCT02342743|155573928|FG000|Treatment Period|Change in prophylactic medication|1|||
48376537|NCT06023082|155573929|FG000|Overall Study|Withdrawal by Subject|2|||
48376538|NCT06023082|155573929|FG000|Overall Study|Lost to Follow-up|15|||
48376539|NCT06023082|155573929|FG000|Overall Study|Side effects|5|||
48376540|NCT00092495|155573930|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
48376541|NCT00092495|155573931|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
48376542|NCT00092495|155573932|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48376543|NCT00092495|155573933|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
48376544|NCT00092495|155573934|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48376545|NCT00092495|155573930|FG000|Base Study Vaccination Period|Extended|0|||
48376546|NCT00092495|155573931|FG001|Base Study Vaccination Period|Extended|0|||
48376547|NCT00092495|155573932|FG002|Base Study Vaccination Period|Extended|0|||
48376548|NCT00092495|155573933|FG003|Base Study Vaccination Period|Extended|1|||
48376549|NCT00092495|155573934|FG004|Base Study Vaccination Period|Extended|0|||
48376550|NCT00092495|155573930|FG000|Base Study Vaccination Period|*Clinical AE|1|||
48376551|NCT00092495|155573931|FG001|Base Study Vaccination Period|*Clinical AE|0|||
48376552|NCT00092495|155573932|FG002|Base Study Vaccination Period|*Clinical AE|1|||
48376553|NCT00092495|155573933|FG003|Base Study Vaccination Period|*Clinical AE|2|||
48376554|NCT00092495|155573934|FG004|Base Study Vaccination Period|*Clinical AE|0|||
48376555|NCT00092495|155573930|FG000|Base Study Vaccination Period|*Other reasons|1|||
48376556|NCT00092495|155573931|FG001|Base Study Vaccination Period|*Other reasons|0|||
48376557|NCT00092495|155573932|FG002|Base Study Vaccination Period|*Other reasons|0|||
48376558|NCT00092495|155573933|FG003|Base Study Vaccination Period|*Other reasons|1|||
48376559|NCT00092495|155573934|FG004|Base Study Vaccination Period|*Other reasons|0|||
48376560|NCT00092495|155573930|FG000|Base Study Vaccination Period|*Pregnancy|0|||
48376561|NCT00092495|155573931|FG001|Base Study Vaccination Period|*Pregnancy|2|||
48376562|NCT00092495|155573932|FG002|Base Study Vaccination Period|*Pregnancy|5|||
48376563|NCT00092495|155573933|FG003|Base Study Vaccination Period|*Pregnancy|7|||
48376564|NCT00092495|155573934|FG004|Base Study Vaccination Period|*Pregnancy|0|||
48376565|NCT00092495|155573930|FG000|Base Study Vaccination Period|Adverse Event|1|||
48376566|NCT00092495|155573931|FG001|Base Study Vaccination Period|Adverse Event|0|||
48376567|NCT00092495|155573932|FG002|Base Study Vaccination Period|Adverse Event|0|||
48376568|NCT00092495|155573933|FG003|Base Study Vaccination Period|Adverse Event|3|||
48376569|NCT00092495|155573934|FG004|Base Study Vaccination Period|Adverse Event|0|||
48376570|NCT00092495|155573930|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
48376571|NCT00092495|155573931|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
48376572|NCT00092495|155573932|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
48376573|NCT00092495|155573933|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
48376574|NCT00092495|155573934|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
48376575|NCT00092495|155573930|FG000|Base Study Vaccination Period|Moved|3|||
48376576|NCT00092495|155573931|FG001|Base Study Vaccination Period|Moved|1|||
48376577|NCT00092495|155573932|FG002|Base Study Vaccination Period|Moved|2|||
48376578|NCT00092495|155573933|FG003|Base Study Vaccination Period|Moved|2|||
48376579|NCT00092495|155573934|FG004|Base Study Vaccination Period|Moved|0|||
48376580|NCT00092495|155573930|FG000|Base Study Vaccination Period|Other|1|||
48376581|NCT00092495|155573931|FG001|Base Study Vaccination Period|Other|1|||
48376582|NCT00092495|155573932|FG002|Base Study Vaccination Period|Other|0|||
48376583|NCT00092495|155573933|FG003|Base Study Vaccination Period|Other|2|||
48376584|NCT00092495|155573934|FG004|Base Study Vaccination Period|Other|0|||
48376585|NCT00092495|155573930|FG000|Base Study Vaccination Period|Pregnancy|2|||
48376586|NCT00092495|155573931|FG001|Base Study Vaccination Period|Pregnancy|0|||
48376587|NCT00092495|155573932|FG002|Base Study Vaccination Period|Pregnancy|0|||
48376588|NCT00092495|155573933|FG003|Base Study Vaccination Period|Pregnancy|0|||
48376589|NCT00092495|155573934|FG004|Base Study Vaccination Period|Pregnancy|0|||
48376590|NCT00092495|155573930|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
48376591|NCT00092495|155573931|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
48376592|NCT00092495|155573932|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
48376593|NCT00092495|155573933|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
48376594|NCT00092495|155573934|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
48376595|NCT00092495|155573930|FG000|Base Study Vaccination Period|Protocol Violation|1|||
48376596|NCT00092495|155573931|FG001|Base Study Vaccination Period|Protocol Violation|0|||
48376597|NCT00092495|155573932|FG002|Base Study Vaccination Period|Protocol Violation|0|||
48376598|NCT00092495|155573933|FG003|Base Study Vaccination Period|Protocol Violation|0|||
48376599|NCT00092495|155573934|FG004|Base Study Vaccination Period|Protocol Violation|0|||
48376600|NCT00092495|155573930|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
48376601|NCT00092495|155573931|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
48376602|NCT00092495|155573932|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
48376603|NCT00092495|155573933|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
48376604|NCT00092495|155573934|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
48376605|NCT00092495|155573930|FG000|Base Study Follow-up Period|Extended|0|||
48376606|NCT00092495|155573931|FG001|Base Study Follow-up Period|Extended|0|||
48376607|NCT00092495|155573932|FG002|Base Study Follow-up Period|Extended|1|||
48376608|NCT00092495|155573933|FG003|Base Study Follow-up Period|Extended|2|||
48376609|NCT00092495|155573934|FG004|Base Study Follow-up Period|Extended|0|||
48376610|NCT00092495|155573930|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
48376611|NCT00092495|155573931|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
48376612|NCT00092495|155573932|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
48376613|NCT00092495|155573933|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
48376614|NCT00092495|155573934|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
48376615|NCT00092495|155573930|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
48376616|NCT00092495|155573931|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
48376617|NCT00092495|155573932|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
48376618|NCT00092495|155573933|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
48376619|NCT00092495|155573934|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
48376620|NCT03019185|155573945|FG000|Overall Study|Lost to Follow-up|3|||
48376621|NCT03019185|155573946|FG001|Overall Study|Lost to Follow-up|0|||
48376622|NCT03019185|155573947|FG002|Overall Study|Lost to Follow-up|2|||
48376623|NCT03019185|155573945|FG000|Overall Study|Withdrawal by Subject|1|||
48376624|NCT03019185|155573946|FG001|Overall Study|Withdrawal by Subject|1|||
48376625|NCT03019185|155573947|FG002|Overall Study|Withdrawal by Subject|0|||
48376626|NCT03019185|155573945|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
48376627|NCT03019185|155573946|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
48376628|NCT03019185|155573947|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
48376629|NCT03019185|155573945|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
48376630|NCT03019185|155573946|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
48376631|NCT03019185|155573947|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
48376632|NCT03907410|155573948|FG000|Overall Study|Lost to Follow-up|4|||
48376633|NCT03907410|155573949|FG001|Overall Study|Lost to Follow-up|1|||
48376634|NCT03907410|155573950|FG002|Overall Study|Lost to Follow-up|1|||
48376635|NCT03907410|155573948|FG000|Overall Study|Lost to follow-up and research burden|0|||
48376636|NCT03907410|155573949|FG001|Overall Study|Lost to follow-up and research burden|0|||
48376637|NCT03907410|155573950|FG002|Overall Study|Lost to follow-up and research burden|1|||
48376638|NCT02768870|155573951|FG000|Overall Study|Death|1|||
48376639|NCT02768870|155573951|FG000|Overall Study|Reoperation|6|||
48376640|NCT02768870|155573951|FG000|Overall Study|Lost to Follow-up|1|||
48376641|NCT02768870|155573951|FG000|Overall Study|Exit|4|||
48376642|NCT02699983|155573954|FG000|Overall Study|Withdrawal by Subject|1|||
48376643|NCT02699983|155573955|FG001|Overall Study|Withdrawal by Subject|0|||
48376644|NCT02349360|155573960|FG000|Overall Study|Withdrawal by Subject|0|||
48376645|NCT02349360|155573961|FG001|Overall Study|Withdrawal by Subject|1|||
48376646|NCT01003990|155573962|FG000|Overall Study|Adverse Event|8|||
48376647|NCT01003990|155573963|FG001|Overall Study|Adverse Event|5|||
48376648|NCT01003990|155573964|FG002|Overall Study|Adverse Event|11|||
48376649|NCT01003990|155573962|FG000|Overall Study|Death|0|||
48376650|NCT01003990|155573963|FG001|Overall Study|Death|8|||
48376651|NCT01003990|155573964|FG002|Overall Study|Death|1|||
48376652|NCT01003990|155573962|FG000|Overall Study|Lack of Efficacy|10|||
48376653|NCT01003990|155573963|FG001|Overall Study|Lack of Efficacy|2|||
48376654|NCT01003990|155573964|FG002|Overall Study|Lack of Efficacy|3|||
48376655|NCT01003990|155573962|FG000|Overall Study|Lost to Follow-up|30|||
48376656|NCT01003990|155573963|FG001|Overall Study|Lost to Follow-up|12|||
48376657|NCT01003990|155573964|FG002|Overall Study|Lost to Follow-up|7|||
48376658|NCT01003990|155573962|FG000|Overall Study|Reasons Not Identified|14|||
48376659|NCT01003990|155573963|FG001|Overall Study|Reasons Not Identified|13|||
48376660|NCT01003990|155573964|FG002|Overall Study|Reasons Not Identified|8|||
48376661|NCT01003990|155573962|FG000|Overall Study|Poor/Non-compliance|4|||
48376662|NCT01003990|155573963|FG001|Overall Study|Poor/Non-compliance|3|||
48376663|NCT01003990|155573964|FG002|Overall Study|Poor/Non-compliance|2|||
48376664|NCT01003990|155573962|FG000|Overall Study|Pregnancy|10|||
48376665|NCT01003990|155573963|FG001|Overall Study|Pregnancy|2|||
48376666|NCT01003990|155573964|FG002|Overall Study|Pregnancy|4|||
48376667|NCT01003990|155573962|FG000|Overall Study|No Longer Met Study Criteria|4|||
48376668|NCT01003990|155573963|FG001|Overall Study|No Longer Met Study Criteria|1|||
48376669|NCT01003990|155573964|FG002|Overall Study|No Longer Met Study Criteria|0|||
48376670|NCT01003990|155573962|FG000|Overall Study|Subject Withdrew Consent|12|||
48376671|NCT01003990|155573963|FG001|Overall Study|Subject Withdrew Consent|5|||
48376672|NCT01003990|155573964|FG002|Overall Study|Subject Withdrew Consent|7|||
48376673|NCT02019927|155573965|FG000|Overall Study|Lost to Follow-up|2|||
48376674|NCT02019927|155573966|FG001|Overall Study|Lost to Follow-up|4|||
48376675|NCT02019927|155573967|FG002|Overall Study|Lost to Follow-up|1|||
48376676|NCT02019927|155573968|FG003|Overall Study|Lost to Follow-up|2|||
48376677|NCT02019927|155573969|FG004|Overall Study|Lost to Follow-up|3|||
48376678|NCT02019927|155573970|FG005|Overall Study|Lost to Follow-up|1|||
48376679|NCT01054846|155573971|FG000|Overall Study|Lost to Follow-up|76|||
48376680|NCT01054846|155573972|FG001|Overall Study|Lost to Follow-up|17|||
48376681|NCT00394953|155573973|FG000|First Treatment Period|Adverse Event|1|||
48376682|NCT00394953|155573974|FG001|First Treatment Period|Adverse Event|2|||
48376683|NCT00394953|155573973|FG000|First Treatment Period|Death|6|||
48376684|NCT00394953|155573974|FG001|First Treatment Period|Death|7|||
48376685|NCT00394953|155573973|FG000|First Treatment Period|Lack of Efficacy|1|||
48376686|NCT00394953|155573974|FG001|First Treatment Period|Lack of Efficacy|1|||
48376687|NCT00394953|155573973|FG000|First Treatment Period|Withdrawal by Subject|6|||
48376688|NCT00394953|155573974|FG001|First Treatment Period|Withdrawal by Subject|3|||
48376689|NCT00394953|155573973|FG000|First Treatment Period|Lost to Follow-up|0|||
48376690|NCT00394953|155573974|FG001|First Treatment Period|Lost to Follow-up|1|||
48376691|NCT00394953|155573973|FG000|First Treatment Period|Renal transplant|11|||
48376692|NCT00394953|155573974|FG001|First Treatment Period|Renal transplant|7|||
48376693|NCT00394953|155573973|FG000|First Treatment Period|Not defined|4|||
48376694|NCT00394953|155573974|FG001|First Treatment Period|Not defined|1|||
48376695|NCT00394953|155573973|FG000|Second Treatment Period|Adverse Event|2|||
48376696|NCT00394953|155573974|FG001|Second Treatment Period|Adverse Event|5|||
48376697|NCT00394953|155573973|FG000|Second Treatment Period|Death|8|||
48376698|NCT00394953|155573974|FG001|Second Treatment Period|Death|4|||
48376699|NCT00394953|155573973|FG000|Second Treatment Period|Lack of Efficacy|9|||
48376700|NCT00394953|155573974|FG001|Second Treatment Period|Lack of Efficacy|47|||
48376701|NCT00394953|155573973|FG000|Second Treatment Period|Withdrawal by Subject|3|||
48376702|NCT00394953|155573974|FG001|Second Treatment Period|Withdrawal by Subject|3|||
48376703|NCT00394953|155573973|FG000|Second Treatment Period|Lost to Follow-up|0|||
48376704|NCT00394953|155573974|FG001|Second Treatment Period|Lost to Follow-up|1|||
48376705|NCT00394953|155573973|FG000|Second Treatment Period|Renal transplant|4|||
48376706|NCT00394953|155573974|FG001|Second Treatment Period|Renal transplant|6|||
48376707|NCT00394953|155573973|FG000|Second Treatment Period|Not defined|3|||
48376708|NCT00394953|155573974|FG001|Second Treatment Period|Not defined|8|||
48376709|NCT01259284|155573981|FG000|Overall Study|Study Termination|2|||
48376710|NCT01259284|155573982|FG001|Overall Study|Study Termination|0|||
48376711|NCT01259284|155573983|FG002|Overall Study|Study Termination|0|||
48376712|NCT03021954|155573984|FG000|Overall Study|Lost to Follow-up|10|||
48376713|NCT03021954|155573985|FG001|Overall Study|Lost to Follow-up|43|||
48376714|NCT03021954|155573984|FG000|Overall Study|Subjects had avulsion trauma|4|||
48376715|NCT03021954|155573985|FG001|Overall Study|Subjects had avulsion trauma|1|||
48376716|NCT01498289|155573991|FG000|Overall Study|Adverse Event|16|||
48376717|NCT01498289|155573992|FG001|Overall Study|Adverse Event|18|||
48376718|NCT01498289|155573991|FG000|Overall Study|Death|6|||
48376719|NCT01498289|155573992|FG001|Overall Study|Death|8|||
48376720|NCT01498289|155573991|FG000|Overall Study|Withdrawal unrelated to AE|16|||
48376721|NCT01498289|155573992|FG001|Overall Study|Withdrawal unrelated to AE|16|||
48376722|NCT01498289|155573991|FG000|Overall Study|Progression/relapse|53|||
48376723|NCT01498289|155573992|FG001|Overall Study|Progression/relapse|59|||
48376724|NCT01498289|155573991|FG000|Overall Study|Not protocol specified|7|||
48376725|NCT01498289|155573992|FG001|Overall Study|Not protocol specified|2|||
48376726|NCT01498289|155573991|FG000|Overall Study|Reason under review|0|||
48376727|NCT01498289|155573992|FG001|Overall Study|Reason under review|1|||
48376728|NCT00051363|155573993|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
48376729|NCT00051363|155573994|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
48376730|NCT00051363|155573993|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
48376731|NCT00051363|155573994|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
48376732|NCT00051363|155573993|FG000|Overall Study|Death|2|||
48376733|NCT00051363|155573994|FG001|Overall Study|Death|2|||
48376734|NCT00051363|155573993|FG000|Overall Study|Excluded Pre-Randomization|2|||
48376735|NCT00051363|155573994|FG001|Overall Study|Excluded Pre-Randomization|5|||
48376736|NCT00807235|155573995|FG000|Overall Study|Adverse Event|1|||
48376737|NCT00807235|155573996|FG001|Overall Study|Adverse Event|0|||
48376738|NCT00926211|155573997|FG000|Overall Study|Lost to Follow-up|1|||
48376739|NCT00412971|155573998|FG000|Overall Study|Lost to Follow-up|17|||
48376740|NCT00412971|155573999|FG001|Overall Study|Lost to Follow-up|9|||
48376741|NCT00412971|155573998|FG000|Overall Study|Protocol Violation|13|||
48376742|NCT00412971|155573999|FG001|Overall Study|Protocol Violation|1|||
48376743|NCT02513745|155574001|FG000|Overall Study|Criteria at time of surgery not met.|3|||
48376744|NCT02513745|155574002|FG001|Overall Study|Criteria at time of surgery not met.|3|||
48376745|NCT01145755|155574003|FG000|Overall Study|Adverse Event|2|||
48376746|NCT01145755|155574004|FG001|Overall Study|Adverse Event|4|||
48376747|NCT01145755|155574005|FG002|Overall Study|Adverse Event|2|||
48376748|NCT01145755|155574003|FG000|Overall Study|Withdrawal by Subject|2|||
48376749|NCT01145755|155574004|FG001|Overall Study|Withdrawal by Subject|2|||
48376750|NCT01145755|155574005|FG002|Overall Study|Withdrawal by Subject|2|||
48376751|NCT01145755|155574003|FG000|Overall Study|Lost to Follow-up|2|||
48376752|NCT01145755|155574004|FG001|Overall Study|Lost to Follow-up|3|||
48376753|NCT01145755|155574005|FG002|Overall Study|Lost to Follow-up|1|||
48376754|NCT01145755|155574003|FG000|Overall Study|Protocol Violation|0|||
48376755|NCT01145755|155574004|FG001|Overall Study|Protocol Violation|3|||
48376756|NCT01145755|155574005|FG002|Overall Study|Protocol Violation|1|||
48376757|NCT01145755|155574003|FG000|Overall Study|Study Closure|14|||
48376758|NCT01145755|155574004|FG001|Overall Study|Study Closure|14|||
48376759|NCT01145755|155574005|FG002|Overall Study|Study Closure|17|||
48376760|NCT01145755|155574003|FG000|Overall Study|Lack of Efficacy|0|||
48376761|NCT01145755|155574004|FG001|Overall Study|Lack of Efficacy|1|||
48376762|NCT01145755|155574005|FG002|Overall Study|Lack of Efficacy|0|||
48376763|NCT01145755|155574003|FG000|Overall Study|Patient could not swollow medication|0|||
48376764|NCT01145755|155574004|FG001|Overall Study|Patient could not swollow medication|0|||
48376765|NCT01145755|155574005|FG002|Overall Study|Patient could not swollow medication|1|||
48376766|NCT01145755|155574003|FG000|Overall Study|Withdrawal by Subject|0|||
48376767|NCT01145755|155574004|FG001|Overall Study|Withdrawal by Subject|0|||
48376768|NCT01145755|155574005|FG002|Overall Study|Withdrawal by Subject|1|||
48376769|NCT01145755|155574003|FG000|Overall Study|Positive urine ethanol|0|||
48376770|NCT01145755|155574004|FG001|Overall Study|Positive urine ethanol|1|||
48376771|NCT01145755|155574005|FG002|Overall Study|Positive urine ethanol|0|||
48376772|NCT00547365|155574006|FG000|Overall Study|Physician Decision|1|||
48376773|NCT00547365|155574006|FG000|Overall Study|Lost to Follow-up|1|||
48376774|NCT00547365|155574006|FG000|Overall Study|Protocol Violation|2|||
48376775|NCT00547365|155574006|FG000|Overall Study|death (not related to study)|4|||
48376776|NCT00504881|155574007|FG000|Overall Study|Lack of Efficacy|1|||
48376777|NCT00504881|155574008|FG001|Overall Study|Lack of Efficacy|5|||
48376778|NCT00504881|155574007|FG000|Overall Study|Lost to Follow-up|0|||
48376779|NCT00504881|155574008|FG001|Overall Study|Lost to Follow-up|2|||
48376780|NCT00504881|155574007|FG000|Overall Study|Withdrawal by Subject|1|||
48376781|NCT00504881|155574008|FG001|Overall Study|Withdrawal by Subject|4|||
48376782|NCT00504881|155574007|FG000|Overall Study|Non-Compliance|1|||
48376783|NCT00504881|155574008|FG001|Overall Study|Non-Compliance|0|||
48376784|NCT00504881|155574007|FG000|Overall Study|No Birth Control|0|||
48376785|NCT00504881|155574008|FG001|Overall Study|No Birth Control|1|||
48376786|NCT00504881|155574007|FG000|Overall Study|Safety Visit not performed|0|||
48376787|NCT00504881|155574008|FG001|Overall Study|Safety Visit not performed|1|||
48376788|NCT00504881|155574007|FG000|Overall Study|AE, serious fatal|0|||
48376789|NCT00504881|155574008|FG001|Overall Study|AE, serious fatal|1|||
48376790|NCT00504881|155574007|FG000|Overall Study|SAE, non-fatal|2|||
48376791|NCT00504881|155574008|FG001|Overall Study|SAE, non-fatal|6|||
48376792|NCT00504881|155574007|FG000|Overall Study|AE, non-serious non-fatal|4|||
48376793|NCT00504881|155574008|FG001|Overall Study|AE, non-serious non-fatal|14|||
48376794|NCT00504881|155574007|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
48376795|NCT00504881|155574008|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
48376796|NCT00504881|155574007|FG000|Overall Study|AE of unknown type|1|||
48376797|NCT00504881|155574008|FG001|Overall Study|AE of unknown type|0|||
48376798|NCT00688181|155574013|FG000|Overall Study|Lost to Follow-up|17|||
48376799|NCT00688181|155574013|FG000|Overall Study|Unknown Reason|4|||
48376800|NCT00688181|155574013|FG000|Overall Study|Non-clinical Reason|2|||
48376801|NCT03604523|155574014|FG000|Overall Study|Physician Decision|1|||
48376802|NCT03604523|155574015|FG001|Overall Study|Physician Decision|0|||
48376803|NCT02958267|155574018|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
48376804|NCT02958267|155574019|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
48376805|NCT02958267|155574018|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
48376806|NCT02958267|155574019|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
48376807|NCT02958267|155574018|FG000|Follow-up Visits|Additional treatment pursued|2|||
48376808|NCT02958267|155574019|FG001|Follow-up Visits|Additional treatment pursued|1|||
48376809|NCT01079130|155574020|FG000|Overall Study|Adverse Event|1|||
48376810|NCT01079130|155574021|FG001|Overall Study|Adverse Event|1|||
48376811|NCT01079130|155574022|FG002|Overall Study|Adverse Event|0|||
48376812|NCT01079130|155574023|FG003|Overall Study|Adverse Event|1|||
48376813|NCT01079130|155574024|FG004|Overall Study|Adverse Event|5|||
48376814|NCT01079130|155574025|FG005|Overall Study|Adverse Event|1|||
48376815|NCT01079130|155574020|FG000|Overall Study|Administrative problems|1|||
48376816|NCT01079130|155574021|FG001|Overall Study|Administrative problems|3|||
48376817|NCT01079130|155574022|FG002|Overall Study|Administrative problems|0|||
48376818|NCT01079130|155574023|FG003|Overall Study|Administrative problems|0|||
48376819|NCT01079130|155574024|FG004|Overall Study|Administrative problems|0|||
48376820|NCT01079130|155574025|FG005|Overall Study|Administrative problems|1|||
48376821|NCT01079130|155574020|FG000|Overall Study|Withdrawal by Subject|0|||
48376822|NCT01079130|155574021|FG001|Overall Study|Withdrawal by Subject|1|||
48376823|NCT01079130|155574022|FG002|Overall Study|Withdrawal by Subject|0|||
48376824|NCT01079130|155574023|FG003|Overall Study|Withdrawal by Subject|0|||
48376825|NCT01079130|155574024|FG004|Overall Study|Withdrawal by Subject|1|||
48376826|NCT01079130|155574025|FG005|Overall Study|Withdrawal by Subject|3|||
48376827|NCT01079130|155574020|FG000|Overall Study|Protocol deviation|0|||
48376828|NCT01079130|155574021|FG001|Overall Study|Protocol deviation|2|||
48376829|NCT01079130|155574022|FG002|Overall Study|Protocol deviation|1|||
48376830|NCT01079130|155574023|FG003|Overall Study|Protocol deviation|2|||
48376831|NCT01079130|155574024|FG004|Overall Study|Protocol deviation|0|||
48376832|NCT01079130|155574025|FG005|Overall Study|Protocol deviation|0|||
48376833|NCT01079130|155574020|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48376834|NCT01079130|155574021|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48376835|NCT01079130|155574022|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48376836|NCT01079130|155574023|FG003|Overall Study|Abnormal test procedure result(s)|0|||
48376837|NCT01079130|155574024|FG004|Overall Study|Abnormal test procedure result(s)|1|||
48376838|NCT01079130|155574025|FG005|Overall Study|Abnormal test procedure result(s)|0|||
48376839|NCT01079130|155574020|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48376840|NCT01079130|155574021|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48376841|NCT01079130|155574022|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48376842|NCT01079130|155574023|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
48376843|NCT01079130|155574024|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
48376844|NCT01079130|155574025|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
48376845|NCT01079130|155574020|FG000|Overall Study|Lost to Follow-up|0|||
48376846|NCT01079130|155574021|FG001|Overall Study|Lost to Follow-up|0|||
48376847|NCT01079130|155574022|FG002|Overall Study|Lost to Follow-up|0|||
48376848|NCT01079130|155574023|FG003|Overall Study|Lost to Follow-up|0|||
48376849|NCT01079130|155574024|FG004|Overall Study|Lost to Follow-up|1|||
48376850|NCT01079130|155574025|FG005|Overall Study|Lost to Follow-up|0|||
48376851|NCT00390910|155574026|FG000|Overall Study|Adverse Event|1|||
48376852|NCT00390910|155574027|FG001|Overall Study|Adverse Event|0|||
48376853|NCT00390910|155574028|FG002|Overall Study|Adverse Event|0|||
48376854|NCT00390910|155574026|FG000|Overall Study|Lost to Follow-up|0|||
48376855|NCT00390910|155574027|FG001|Overall Study|Lost to Follow-up|1|||
48376856|NCT00390910|155574028|FG002|Overall Study|Lost to Follow-up|5|||
48376857|NCT00390910|155574026|FG000|Overall Study|Withdrawal by Subject|1|||
48376858|NCT00390910|155574027|FG001|Overall Study|Withdrawal by Subject|3|||
48376859|NCT00390910|155574028|FG002|Overall Study|Withdrawal by Subject|2|||
48376860|NCT00390910|155574026|FG000|Overall Study|Migrated/moved from study area|0|||
48376861|NCT00390910|155574027|FG001|Overall Study|Migrated/moved from study area|0|||
48376862|NCT00390910|155574028|FG002|Overall Study|Migrated/moved from study area|3|||
48376863|NCT01839487|155574029|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
48376864|NCT01839487|155574030|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48376865|NCT01839487|155574031|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48376866|NCT01839487|155574032|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48376867|NCT01839487|155574033|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48376868|NCT01839487|155574034|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
48376869|NCT01839487|155574029|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
48376870|NCT01839487|155574030|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
48376871|NCT01839487|155574031|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
48376872|NCT01839487|155574032|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
48376873|NCT01839487|155574033|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
48376874|NCT01839487|155574034|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
48376875|NCT01839487|155574029|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48376876|NCT01839487|155574030|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
48376877|NCT01839487|155574031|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48376878|NCT01839487|155574032|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48376879|NCT01839487|155574033|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48376880|NCT01839487|155574034|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
48376881|NCT01839487|155574029|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
48376882|NCT01839487|155574030|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48376883|NCT01839487|155574031|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48376884|NCT01839487|155574032|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48376885|NCT01839487|155574033|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48376886|NCT01839487|155574034|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
48376887|NCT01839487|155574029|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
48376888|NCT01839487|155574030|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
48376889|NCT01839487|155574031|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
48376890|NCT01839487|155574032|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
48376891|NCT01839487|155574033|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
48376892|NCT01839487|155574034|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
48376893|NCT01839487|155574029|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
48376894|NCT01839487|155574030|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
48376895|NCT01839487|155574031|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
48376896|NCT01839487|155574032|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
48376897|NCT01839487|155574033|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
48376898|NCT01839487|155574034|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
48376899|NCT01839487|155574029|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
48376900|NCT01839487|155574030|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
48376901|NCT01839487|155574031|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
48376902|NCT01839487|155574032|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
48376903|NCT01839487|155574033|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
48376904|NCT01839487|155574034|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
48376905|NCT01839487|155574029|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
48376906|NCT01839487|155574030|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
48376907|NCT01839487|155574031|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
48376908|NCT01839487|155574032|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
48376909|NCT01839487|155574033|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
48376910|NCT01839487|155574034|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
48376911|NCT01839487|155574029|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
48376912|NCT01839487|155574030|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
48376913|NCT01839487|155574031|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
48376914|NCT01839487|155574032|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
48376915|NCT01839487|155574033|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
48376916|NCT01839487|155574034|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
48376917|NCT02499770|155574049|FG000|Overall Study|Death|17|||
48376918|NCT02499770|155574050|FG001|Overall Study|Death|56|||
48376919|NCT02499770|155574049|FG000|Overall Study|Study completion|1|||
48376920|NCT02499770|155574050|FG001|Overall Study|Study completion|10|||
48376921|NCT02499770|155574049|FG000|Overall Study|Withdrawal by Subject|0|||
48376922|NCT02499770|155574050|FG001|Overall Study|Withdrawal by Subject|7|||
48376923|NCT02499770|155574049|FG000|Overall Study|Lost to Follow-up|0|||
48376924|NCT02499770|155574050|FG001|Overall Study|Lost to Follow-up|2|||
48376925|NCT02499770|155574049|FG000|Overall Study|Subject declined further treatment|1|||
48376926|NCT02499770|155574050|FG001|Overall Study|Subject declined further treatment|0|||
48376927|NCT02499770|155574049|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
48376928|NCT02499770|155574050|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
48415615|NCT04574999|155711176|FG001|Overall Study|Protocol Violation|0|||
48415616|NCT04574999|155711175|FG000|Overall Study|Withdrawal by Subject|2|||
48376929|NCT02499770|155574049|FG000|Overall Study|Randomized but not enrolled|0|||
48376930|NCT02499770|155574050|FG001|Overall Study|Randomized but not enrolled|1|||
48376931|NCT02881957|155574056|FG000|Overall Study|Comfort care|0|||
48376932|NCT02881957|155574057|FG001|Overall Study|Comfort care|1|||
48376933|NCT02881957|155574056|FG000|Overall Study|Concurrent trial enrollment|0|||
48376934|NCT02881957|155574057|FG001|Overall Study|Concurrent trial enrollment|1|||
48376935|NCT02881957|155574056|FG000|Overall Study|Discharged within 48 hours|0|||
48376936|NCT02881957|155574057|FG001|Overall Study|Discharged within 48 hours|1|||
48376937|NCT02881957|155574056|FG000|Overall Study|Withdrawal by Subject|2|||
48376938|NCT02881957|155574057|FG001|Overall Study|Withdrawal by Subject|1|||
48376939|NCT02881957|155574056|FG000|Overall Study|Protocol Violation|1|||
48376940|NCT02881957|155574057|FG001|Overall Study|Protocol Violation|0|||
48376941|NCT02795429|155575761|FG000|Overall Study|Adverse Event|1|||
48376942|NCT02795429|155575762|FG001|Overall Study|Adverse Event|2|||
48376943|NCT02795429|155575763|FG002|Overall Study|Adverse Event|1|||
48376944|NCT02795429|155575764|FG003|Overall Study|Adverse Event|2|||
48376945|NCT02795429|155575765|FG004|Overall Study|Adverse Event|1|||
48376946|NCT02795429|155575761|FG000|Overall Study|Death|1|||
48376947|NCT02795429|155575762|FG001|Overall Study|Death|0|||
48376948|NCT02795429|155575763|FG002|Overall Study|Death|1|||
48376949|NCT02795429|155575764|FG003|Overall Study|Death|2|||
48376950|NCT02795429|155575765|FG004|Overall Study|Death|1|||
48376951|NCT02795429|155575761|FG000|Overall Study|Physician Decision|0|||
48376952|NCT02795429|155575762|FG001|Overall Study|Physician Decision|0|||
48376953|NCT02795429|155575763|FG002|Overall Study|Physician Decision|2|||
48376954|NCT02795429|155575764|FG003|Overall Study|Physician Decision|1|||
48376955|NCT02795429|155575765|FG004|Overall Study|Physician Decision|5|||
48376956|NCT02795429|155575761|FG000|Overall Study|Progressive disease|3|||
48376957|NCT02795429|155575762|FG001|Overall Study|Progressive disease|7|||
48376958|NCT02795429|155575763|FG002|Overall Study|Progressive disease|6|||
48376959|NCT02795429|155575764|FG003|Overall Study|Progressive disease|26|||
48376960|NCT02795429|155575765|FG004|Overall Study|Progressive disease|20|||
48376961|NCT02795429|155575761|FG000|Overall Study|Subject/guardian decision|1|||
48376962|NCT02795429|155575762|FG001|Overall Study|Subject/guardian decision|1|||
48376963|NCT02795429|155575763|FG002|Overall Study|Subject/guardian decision|1|||
48376964|NCT02795429|155575764|FG003|Overall Study|Subject/guardian decision|1|||
48376965|NCT02795429|155575765|FG004|Overall Study|Subject/guardian decision|3|||
48376966|NCT01658150|155575766|FG000|Overall Study|Withdrawal by Subject|1|||
48376967|NCT01716117|155575770|FG000|Overall Study|Death|5|||
48376968|NCT01716117|155575771|FG001|Overall Study|Death|2|||
48376969|NCT01716117|155575770|FG000|Overall Study|Withdrawal by Subject|2|||
48376970|NCT01716117|155575771|FG001|Overall Study|Withdrawal by Subject|0|||
48376971|NCT01016977|155575772|FG000|Overall Study|Lost to Follow-up|1|||
48376972|NCT01016977|155575773|FG001|Overall Study|Lost to Follow-up|0|||
48376973|NCT01016977|155575772|FG000|Overall Study|Withdrawal by Subject|2|||
48376974|NCT01016977|155575773|FG001|Overall Study|Withdrawal by Subject|2|||
48376975|NCT01146054|155575774|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
48376976|NCT01146054|155575774|FG000|Overall Study|Rapid tumor progression|2|||
48376977|NCT01146054|155575774|FG000|Overall Study|Other illness precluded treatment|2|||
48376978|NCT01146054|155575774|FG000|Overall Study|Lost to Follow-up|1|||
48376979|NCT04335812|155575775|FG000|Overall Study|Withdrawal by Subject|1|||
48376980|NCT04335812|155575776|FG001|Overall Study|Withdrawal by Subject|3|||
48376981|NCT04335812|155575775|FG000|Overall Study|Lost to Follow-up|12|||
48376982|NCT04335812|155575776|FG001|Overall Study|Lost to Follow-up|12|||
48376983|NCT04335812|155575775|FG000|Overall Study|Did not engage in the intervention|22|||
48376984|NCT04335812|155575776|FG001|Overall Study|Did not engage in the intervention|18|||
48376985|NCT00655863|155575782|FG000|Overall Study|Lost to Follow-up|0|||
48376986|NCT00655863|155575783|FG001|Overall Study|Lost to Follow-up|0|||
48376987|NCT00655863|155575784|FG002|Overall Study|Lost to Follow-up|1|||
48376988|NCT04975438|155575785|FG000|Overall Study|Lost to Follow-up|1|||
48376989|NCT04975438|155575786|FG001|Overall Study|Lost to Follow-up|0|||
48376990|NCT04975438|155575787|FG002|Overall Study|Lost to Follow-up|1|||
48376991|NCT04975438|155575788|FG003|Overall Study|Lost to Follow-up|0|||
48376992|NCT04975438|155575785|FG000|Overall Study|Withdrawal by Subject|1|||
48376993|NCT04975438|155575786|FG001|Overall Study|Withdrawal by Subject|0|||
48376994|NCT04975438|155575787|FG002|Overall Study|Withdrawal by Subject|0|||
48376995|NCT04975438|155575788|FG003|Overall Study|Withdrawal by Subject|0|||
48376996|NCT03588728|155575790|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
48376997|NCT03588728|155575791|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
48376998|NCT03588728|155575792|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
48376999|NCT03588728|155575793|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
48377000|NCT03588728|155575790|FG000|Overall Study|Lab shut down due to COVID-19|0|||
48377001|NCT03588728|155575791|FG001|Overall Study|Lab shut down due to COVID-19|0|||
48377002|NCT03588728|155575792|FG002|Overall Study|Lab shut down due to COVID-19|0|||
48377003|NCT03588728|155575793|FG003|Overall Study|Lab shut down due to COVID-19|1|||
48377004|NCT03588728|155575790|FG000|Overall Study|multiple technical issues|1|||
48377005|NCT03588728|155575791|FG001|Overall Study|multiple technical issues|0|||
48377006|NCT03588728|155575792|FG002|Overall Study|multiple technical issues|0|||
48377007|NCT03588728|155575793|FG003|Overall Study|multiple technical issues|0|||
48377008|NCT03588728|155575790|FG000|Overall Study|Hospitalized for COVID|1|||
48377009|NCT03588728|155575791|FG001|Overall Study|Hospitalized for COVID|0|||
48377010|NCT03588728|155575792|FG002|Overall Study|Hospitalized for COVID|0|||
48377011|NCT03588728|155575793|FG003|Overall Study|Hospitalized for COVID|0|||
48377012|NCT03588728|155575790|FG000|Overall Study|Schedule change unable to attend sessions|1|||
48377013|NCT03588728|155575791|FG001|Overall Study|Schedule change unable to attend sessions|0|||
48377014|NCT03588728|155575792|FG002|Overall Study|Schedule change unable to attend sessions|0|||
48377015|NCT03588728|155575793|FG003|Overall Study|Schedule change unable to attend sessions|0|||
48377016|NCT00395460|155575795|FG000|Overall Study|Withdrawal by Subject|1|||
48377017|NCT00395460|155575796|FG001|Overall Study|Withdrawal by Subject|0|||
48377018|NCT01136772|155575797|FG000|Overall Study|Adverse Event|15|||
48377019|NCT01136772|155575798|FG001|Overall Study|Adverse Event|14|||
48377020|NCT01136772|155575797|FG000|Overall Study|Lack of Efficacy|42|||
48377021|NCT01136772|155575798|FG001|Overall Study|Lack of Efficacy|39|||
48377022|NCT01136772|155575797|FG000|Overall Study|Administrative|14|||
48377023|NCT01136772|155575798|FG001|Overall Study|Administrative|12|||
48377024|NCT01136772|155575797|FG000|Overall Study|Withdrawal by Subject|33|||
48377025|NCT01136772|155575798|FG001|Overall Study|Withdrawal by Subject|36|||
48377026|NCT01136772|155575797|FG000|Overall Study|Did not receive injection|10|||
48377027|NCT01136772|155575798|FG001|Overall Study|Did not receive injection|7|||
48377028|NCT01136772|155575797|FG000|Overall Study|Did not follow up after first injection|2|||
48377029|NCT01136772|155575798|FG001|Overall Study|Did not follow up after first injection|2|||
48377030|NCT01100034|155575799|FG000|Overall Study|Lost to Follow-up|11|||
48377031|NCT01100034|155575799|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
48377032|NCT01100034|155575799|FG000|Overall Study|Withdrawal by Subject|4|||
48377033|NCT01100034|155575799|FG000|Overall Study|Sponsor decision|21|||
48377034|NCT01100034|155575799|FG000|Overall Study|Participated in another clinical trial|1|||
48377035|NCT01100034|155575799|FG000|Overall Study|Participants moved to another hospital|4|||
48377036|NCT01100034|155575799|FG000|Overall Study|Site closed due to non-responsiveness|1|||
48377037|NCT01259726|155575800|FG000|Overall Study|Death|1|||
48377038|NCT01259726|155575801|FG001|Overall Study|Death|0|||
48377039|NCT01259726|155575802|FG002|Overall Study|Death|0|||
48377040|NCT01259726|155575803|FG003|Overall Study|Death|0|||
48377041|NCT01259726|155575800|FG000|Overall Study|Physician Decision|2|||
48377042|NCT01259726|155575801|FG001|Overall Study|Physician Decision|0|||
48377043|NCT01259726|155575802|FG002|Overall Study|Physician Decision|1|||
48377044|NCT01259726|155575803|FG003|Overall Study|Physician Decision|1|||
48377045|NCT01259726|155575800|FG000|Overall Study|Withdrawal by Subject|1|||
48377046|NCT01259726|155575801|FG001|Overall Study|Withdrawal by Subject|3|||
48377047|NCT01259726|155575802|FG002|Overall Study|Withdrawal by Subject|2|||
48377048|NCT01259726|155575803|FG003|Overall Study|Withdrawal by Subject|1|||
48377049|NCT01259726|155575800|FG000|Overall Study|Lost to Follow-up|1|||
48377050|NCT01259726|155575801|FG001|Overall Study|Lost to Follow-up|1|||
48377051|NCT01259726|155575802|FG002|Overall Study|Lost to Follow-up|1|||
48377052|NCT01259726|155575803|FG003|Overall Study|Lost to Follow-up|3|||
48377053|NCT02319525|155575807|FG000|Overall Study|Withdrawal by Subject|2|||
48377054|NCT02319525|155575808|FG001|Overall Study|Withdrawal by Subject|1|||
48377055|NCT04964414|155575809|FG000|Overall Study|Lost to Follow-up|10|||
48377056|NCT04964414|155575810|FG001|Overall Study|Lost to Follow-up|8|||
48377057|NCT04964414|155575809|FG000|Overall Study|Withdrawal by Subject|1|||
48377058|NCT04964414|155575810|FG001|Overall Study|Withdrawal by Subject|1|||
48377059|NCT01128894|155575811|FG000|Overall Study|Adverse Event|31|||
48377060|NCT01128894|155575812|FG001|Overall Study|Adverse Event|41|||
48377061|NCT01128894|155575811|FG000|Overall Study|Protocol Violation|2|||
48377062|NCT01128894|155575812|FG001|Overall Study|Protocol Violation|1|||
48377063|NCT01128894|155575811|FG000|Overall Study|Noncompliance|4|||
48377064|NCT01128894|155575812|FG001|Overall Study|Noncompliance|5|||
48377065|NCT01128894|155575811|FG000|Overall Study|Lost to Follow-up|8|||
48377066|NCT01128894|155575812|FG001|Overall Study|Lost to Follow-up|8|||
48377067|NCT01128894|155575811|FG000|Overall Study|Withdrawal by Subject|10|||
48377068|NCT01128894|155575812|FG001|Overall Study|Withdrawal by Subject|12|||
48377069|NCT01128894|155575811|FG000|Overall Study|Physician Decision|2|||
48377070|NCT01128894|155575812|FG001|Overall Study|Physician Decision|1|||
48377071|NCT01128894|155575811|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
48377072|NCT01128894|155575812|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
48377073|NCT03881553|155575813|FG000|Overall Study|Discharged prior to participation|1|||
48377074|NCT03881553|155575814|FG001|Overall Study|Discharged prior to participation|1|||
48377075|NCT03881553|155575815|FG002|Overall Study|Discharged prior to participation|0|||
48377076|NCT03881553|155575813|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
48377077|NCT03881553|155575814|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
48377078|NCT03881553|155575815|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
48377079|NCT03437278|155575816|FG000|Overall Study|Adverse Event|0|||
48377080|NCT03437278|155575817|FG001|Overall Study|Adverse Event|0|||
48377081|NCT03437278|155575818|FG002|Overall Study|Adverse Event|1|||
48377082|NCT03437278|155575816|FG000|Overall Study|Progressive disease|1|||
48377083|NCT03437278|155575817|FG001|Overall Study|Progressive disease|0|||
48377084|NCT03437278|155575818|FG002|Overall Study|Progressive disease|0|||
48377085|NCT03437278|155575816|FG000|Overall Study|Physician Decision|1|||
48377086|NCT03437278|155575817|FG001|Overall Study|Physician Decision|0|||
48377087|NCT03437278|155575818|FG002|Overall Study|Physician Decision|1|||
48377088|NCT03153137|155575819|FG000|Overall Study|Lost to Follow-up|1|||
48377089|NCT03153137|155575820|FG001|Overall Study|Lost to Follow-up|0|||
48377090|NCT03153137|155575819|FG000|Overall Study|Withdrawal by Subject|2|||
48377091|NCT03153137|155575820|FG001|Overall Study|Withdrawal by Subject|1|||
48377092|NCT03153137|155575819|FG000|Overall Study|Physician Decision|0|||
48377093|NCT03153137|155575820|FG001|Overall Study|Physician Decision|3|||
48377094|NCT00195507|155575821|FG000|Overall Study|Adverse Event|24|||
48377095|NCT00195507|155575822|FG001|Overall Study|Adverse Event|13|||
48377096|NCT00195507|155575821|FG000|Overall Study|Death|0|||
48377097|NCT00195507|155575822|FG001|Overall Study|Death|1|||
48377098|NCT00195507|155575821|FG000|Overall Study|Failed to Return|4|||
48377099|NCT00195507|155575822|FG001|Overall Study|Failed to Return|3|||
48377100|NCT00195507|155575821|FG000|Overall Study|Physician Decision|1|||
48377101|NCT00195507|155575822|FG001|Overall Study|Physician Decision|2|||
48377102|NCT00195507|155575821|FG000|Overall Study|Lost to Follow-up|3|||
48377103|NCT00195507|155575822|FG001|Overall Study|Lost to Follow-up|2|||
48377104|NCT00195507|155575821|FG000|Overall Study|Protocol Violation|5|||
48377105|NCT00195507|155575822|FG001|Overall Study|Protocol Violation|4|||
48377106|NCT00195507|155575821|FG000|Overall Study|Lack of Efficacy|40|||
48377107|NCT00195507|155575822|FG001|Overall Study|Lack of Efficacy|67|||
48377108|NCT00195507|155575821|FG000|Overall Study|Withdrawal by Subject|16|||
48377109|NCT00195507|155575822|FG001|Overall Study|Withdrawal by Subject|23|||
48377110|NCT00195507|155575821|FG000|Overall Study|Protocol Deviation|6|||
48377111|NCT00195507|155575822|FG001|Overall Study|Protocol Deviation|3|||
48377112|NCT02168842|155575832|FG000|Overall Study|Withdrawal by Subject|5|||
48377113|NCT02168842|155575833|FG001|Overall Study|Withdrawal by Subject|3|||
48377114|NCT02168842|155575832|FG000|Overall Study|Lost to Follow-up|0|||
48377115|NCT02168842|155575833|FG001|Overall Study|Lost to Follow-up|2|||
48377116|NCT02168842|155575832|FG000|Overall Study|Death|2|||
48377117|NCT02168842|155575833|FG001|Overall Study|Death|1|||
48377118|NCT02168842|155575832|FG000|Overall Study|Physician Decision|1|||
48377119|NCT02168842|155575833|FG001|Overall Study|Physician Decision|2|||
48377120|NCT02147353|155575834|FG000|Overall Study|Lost to Follow-up|2|||
48377121|NCT02147353|155575835|FG001|Overall Study|Lost to Follow-up|0|||
48377122|NCT02147353|155575834|FG000|Overall Study|unable to make visits|4|||
48377123|NCT02147353|155575835|FG001|Overall Study|unable to make visits|0|||
48377124|NCT02147353|155575834|FG000|Overall Study|medication noncompliance|3|||
48377125|NCT02147353|155575835|FG001|Overall Study|medication noncompliance|0|||
48377126|NCT01759368|155575836|FG000|Overall Study|Lost to Follow-up|1|||
48377127|NCT01759368|155575837|FG001|Overall Study|Lost to Follow-up|0|||
48377128|NCT01313689|155575838|FG000|24-Week Randomization 1|Adverse Event|10|||
48377129|NCT01313689|155575839|FG001|24-Week Randomization 1|Adverse Event|5|||
48377130|NCT01313689|155575840|FG002|24-Week Randomization 1|Adverse Event|0|||
48377131|NCT01313689|155575841|FG003|24-Week Randomization 1|Adverse Event|0|||
48377132|NCT01313689|155575842|FG004|24-Week Randomization 1|Adverse Event|0|||
48377133|NCT01313689|155575838|FG000|24-Week Randomization 1|Physician Decision|4|||
48377134|NCT01313689|155575839|FG001|24-Week Randomization 1|Physician Decision|5|||
48377135|NCT01313689|155575840|FG002|24-Week Randomization 1|Physician Decision|0|||
48377136|NCT01313689|155575841|FG003|24-Week Randomization 1|Physician Decision|0|||
48377137|NCT01313689|155575842|FG004|24-Week Randomization 1|Physician Decision|0|||
48377138|NCT01313689|155575838|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
48377139|NCT01313689|155575839|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
48377140|NCT01313689|155575840|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
48377141|NCT01313689|155575841|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
48377142|NCT01313689|155575842|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
48377143|NCT01313689|155575838|FG000|24-Week Randomization 2|Adverse Event|0|||
48377144|NCT01313689|155575839|FG001|24-Week Randomization 2|Adverse Event|0|||
48377145|NCT01313689|155575840|FG002|24-Week Randomization 2|Adverse Event|2|||
48377146|NCT01313689|155575841|FG003|24-Week Randomization 2|Adverse Event|0|||
48377147|NCT01313689|155575842|FG004|24-Week Randomization 2|Adverse Event|8|||
48377148|NCT01313689|155575838|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
48377149|NCT01313689|155575839|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
48377150|NCT01313689|155575840|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
48377151|NCT01313689|155575841|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
48377152|NCT01313689|155575842|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
48377153|NCT01313689|155575838|FG000|24-Week Randomization 2|Physician Decision|0|||
48377154|NCT01313689|155575839|FG001|24-Week Randomization 2|Physician Decision|0|||
48377155|NCT01313689|155575840|FG002|24-Week Randomization 2|Physician Decision|0|||
48377156|NCT01313689|155575841|FG003|24-Week Randomization 2|Physician Decision|0|||
48377157|NCT01313689|155575842|FG004|24-Week Randomization 2|Physician Decision|4|||
48377158|NCT02294227|155575843|FG000|Overall Study|Death|0|||
48377159|NCT02294227|155575844|FG001|Overall Study|Death|0|||
48377160|NCT02294227|155575845|FG002|Overall Study|Death|1|||
48377161|NCT02294227|155575843|FG000|Overall Study|Subject/Guardian Decision|6|||
48377162|NCT02294227|155575844|FG001|Overall Study|Subject/Guardian Decision|3|||
48377163|NCT02294227|155575845|FG002|Overall Study|Subject/Guardian Decision|7|||
48377164|NCT02294227|155575843|FG000|Overall Study|Physician Decision|1|||
48377165|NCT02294227|155575844|FG001|Overall Study|Physician Decision|2|||
48377166|NCT02294227|155575845|FG002|Overall Study|Physician Decision|1|||
48377167|NCT02294227|155575843|FG000|Overall Study|Lost to Follow-up|1|||
48377168|NCT02294227|155575844|FG001|Overall Study|Lost to Follow-up|0|||
48377169|NCT02294227|155575845|FG002|Overall Study|Lost to Follow-up|0|||
48377170|NCT02294227|155575843|FG000|Overall Study|Lack of Efficacy|11|||
48377171|NCT02294227|155575844|FG001|Overall Study|Lack of Efficacy|12|||
48377172|NCT02294227|155575845|FG002|Overall Study|Lack of Efficacy|8|||
48377173|NCT02294227|155575843|FG000|Overall Study|Adverse Event|6|||
48377174|NCT02294227|155575844|FG001|Overall Study|Adverse Event|8|||
48377175|NCT02294227|155575845|FG002|Overall Study|Adverse Event|2|||
48377176|NCT00687973|155575846|FG000|Overall Study|Adverse Event|18|||
48377177|NCT00687973|155575847|FG001|Overall Study|Adverse Event|28|||
48377178|NCT00687973|155575846|FG000|Overall Study|Lack of Efficacy|2|||
48377179|NCT00687973|155575847|FG001|Overall Study|Lack of Efficacy|3|||
48377180|NCT00687973|155575846|FG000|Overall Study|Protocol Violation|1|||
48377181|NCT00687973|155575847|FG001|Overall Study|Protocol Violation|2|||
48377182|NCT00687973|155575846|FG000|Overall Study|Administrative Reasons|0|||
48377183|NCT00687973|155575847|FG001|Overall Study|Administrative Reasons|2|||
48377184|NCT00687973|155575846|FG000|Overall Study|Withdrawal by Subject|3|||
48377185|NCT00687973|155575847|FG001|Overall Study|Withdrawal by Subject|3|||
48377186|NCT01442779|155575850|FG000|Overall Study|Withdrawal by Subject|3|||
48377187|NCT01442779|155575850|FG000|Overall Study|Death|3|||
48377188|NCT01442779|155575850|FG000|Overall Study|Non-compliance|1|||
48377189|NCT00887432|155575851|FG000|Overall Study|Start Excluded Therapy|3|||
48377190|NCT00887432|155575852|FG001|Overall Study|Start Excluded Therapy|0|||
48377191|NCT00887432|155575851|FG000|Overall Study|Did not complete treatment|6|||
48377192|NCT00887432|155575852|FG001|Overall Study|Did not complete treatment|8|||
48377193|NCT00887432|155575851|FG000|Overall Study|Protocol Violation|2|||
48377194|NCT00887432|155575852|FG001|Overall Study|Protocol Violation|3|||
48377195|NCT00887432|155575851|FG000|Overall Study|Withdrawal by Subject|3|||
48377196|NCT00887432|155575852|FG001|Overall Study|Withdrawal by Subject|2|||
48377197|NCT00887432|155575851|FG000|Overall Study|Lost to Follow-up|1|||
48377198|NCT00887432|155575852|FG001|Overall Study|Lost to Follow-up|0|||
48377199|NCT00887432|155575851|FG000|Overall Study|No reason provided|0|||
48377200|NCT00887432|155575852|FG001|Overall Study|No reason provided|1|||
48377201|NCT01337115|155575853|FG000|Overall Study|Protocol Violation|2|||
48377202|NCT01337115|155575854|FG001|Overall Study|Protocol Violation|0|||
48377203|NCT00551460|155575855|FG000|Overall Study|Adverse Event|1|||
48377204|NCT00551460|155575855|FG000|Overall Study|Withdrawal by Subject|1|||
48377205|NCT00551460|155575855|FG000|Overall Study|Physician Decision|1|||
48377206|NCT00551460|155575855|FG000|Overall Study|Death|7|||
48377207|NCT00551460|155575855|FG000|Overall Study|Ineligible|4|||
48377208|NCT00551460|155575855|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
48377209|NCT00609765|155575856|FG000|Overall Study|Study ended prior to 12 months|1|||
48377210|NCT00866723|155575859|FG000|Overall Study|Withdrawal by Subject|1|||
48377211|NCT00866723|155575859|FG000|Overall Study|Disease Progression|4|||
48377212|NCT02308020|155575867|FG000|Overall Study|Lost to Follow-up|1|||
48377213|NCT02308020|155575868|FG001|Overall Study|Lost to Follow-up|7|||
48377214|NCT02308020|155575869|FG002|Overall Study|Lost to Follow-up|0|||
48377215|NCT02308020|155575870|FG003|Overall Study|Lost to Follow-up|0|||
48377216|NCT02308020|155575871|FG004|Overall Study|Lost to Follow-up|1|||
48377217|NCT02308020|155575872|FG005|Overall Study|Lost to Follow-up|2|||
48377218|NCT02308020|155575867|FG000|Overall Study|Sponsor Decision|0|||
48377219|NCT02308020|155575868|FG001|Overall Study|Sponsor Decision|8|||
48377220|NCT02308020|155575869|FG002|Overall Study|Sponsor Decision|0|||
48377221|NCT02308020|155575870|FG003|Overall Study|Sponsor Decision|2|||
48377222|NCT02308020|155575871|FG004|Overall Study|Sponsor Decision|2|||
48377223|NCT02308020|155575872|FG005|Overall Study|Sponsor Decision|1|||
48377224|NCT02308020|155575867|FG000|Overall Study|Withdrawal by Subject|3|||
48377225|NCT02308020|155575868|FG001|Overall Study|Withdrawal by Subject|5|||
48377226|NCT02308020|155575869|FG002|Overall Study|Withdrawal by Subject|3|||
48377227|NCT02308020|155575870|FG003|Overall Study|Withdrawal by Subject|2|||
48377228|NCT02308020|155575871|FG004|Overall Study|Withdrawal by Subject|1|||
48377229|NCT02308020|155575872|FG005|Overall Study|Withdrawal by Subject|2|||
48377230|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
48377231|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
48377232|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Death|0|||
48377233|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Death|2|||
48377234|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
48377235|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
48377236|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
48377237|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
48377238|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
48377239|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
48377240|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
48377241|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
48377242|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
48377243|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
48377244|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
48377245|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
48377246|NCT00343252|155575876|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
48377247|NCT00343252|155575877|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
48377248|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
48377249|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
48377250|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Death|3|||
48377251|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Death|3|||
48377252|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
48377253|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
48377254|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
48377255|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
48377256|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
48377257|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
48377258|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
48377259|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
48377260|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
48377261|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
48377262|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
48377263|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
48377264|NCT00343252|155575876|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
48377265|NCT00343252|155575877|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
48377266|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
48377267|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
48377268|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Death|4|||
48377269|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Death|5|||
48377270|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
48377271|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
48377272|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
48377273|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
48377274|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
48377275|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
48377276|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
48377277|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
48377278|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
48377279|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
48377280|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
48377281|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
48377282|NCT00343252|155575876|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
48377283|NCT00343252|155575877|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
48377284|NCT00400985|155575878|FG000|Overall Study|Withdrawal by Subject|5|||
48377285|NCT00400985|155575878|FG000|Overall Study|system modification|8|||
48377286|NCT00400985|155575878|FG000|Overall Study|Death|30|||
48377287|NCT00400985|155575878|FG000|Overall Study|Lost to Follow-up|9|||
48377288|NCT02893930|155575879|FG000|Overall Study|Adverse Event|3|||
48377289|NCT02893930|155575879|FG000|Overall Study|Death|1|||
48377290|NCT02893930|155575879|FG000|Overall Study|Disease progression|5|||
48377291|NCT02893930|155575879|FG000|Overall Study|Withdrawal by Subject|2|||
48377292|NCT02893930|155575879|FG000|Overall Study|Physician Decision|1|||
48377293|NCT02893930|155575879|FG000|Overall Study|Ineligible|1|||
48377294|NCT02446886|155575882|FG000|Overall Study|Adverse Event|1|||
48377295|NCT02446886|155575883|FG001|Overall Study|Adverse Event|3|||
48377296|NCT02446886|155575882|FG000|Overall Study|Withdrawal by Subject|1|||
48377297|NCT02446886|155575883|FG001|Overall Study|Withdrawal by Subject|1|||
48377298|NCT01013285|155575884|FG000|Overall Study|Death|48|||
48377299|NCT01013285|155575885|FG001|Overall Study|Death|89|||
48377300|NCT01794923|155575886|FG000|Overall Study|Adverse Event|0|||
48377301|NCT01794923|155575887|FG001|Overall Study|Adverse Event|0|||
48377302|NCT01794923|155575888|FG002|Overall Study|Adverse Event|1|||
48377303|NCT00561951|155575889|FG000|Overall Study|Adverse Event|11|||
48377304|NCT00561951|155575890|FG001|Overall Study|Adverse Event|14|||
48377305|NCT00561951|155575891|FG002|Overall Study|Adverse Event|14|||
48377306|NCT00561951|155575889|FG000|Overall Study|Lack of Efficacy|5|||
48377307|NCT00561951|155575890|FG001|Overall Study|Lack of Efficacy|3|||
48377308|NCT00561951|155575891|FG002|Overall Study|Lack of Efficacy|2|||
48377309|NCT00561951|155575889|FG000|Overall Study|Lost to Follow-up|1|||
48377310|NCT00561951|155575890|FG001|Overall Study|Lost to Follow-up|1|||
48377311|NCT00561951|155575891|FG002|Overall Study|Lost to Follow-up|0|||
48377312|NCT00561951|155575889|FG000|Overall Study|Withdrawal by Subject|10|||
48377313|NCT00561951|155575890|FG001|Overall Study|Withdrawal by Subject|9|||
48377314|NCT00561951|155575891|FG002|Overall Study|Withdrawal by Subject|10|||
48377315|NCT00561951|155575889|FG000|Overall Study|Protocol Violation|4|||
48377316|NCT00561951|155575890|FG001|Overall Study|Protocol Violation|3|||
48377317|NCT00561951|155575891|FG002|Overall Study|Protocol Violation|4|||
48377318|NCT00561951|155575889|FG000|Overall Study|Physician Decision|1|||
48377319|NCT00561951|155575890|FG001|Overall Study|Physician Decision|0|||
48377320|NCT00561951|155575891|FG002|Overall Study|Physician Decision|0|||
48377321|NCT00561951|155575889|FG000|Overall Study|Pregnancy|0|||
48377322|NCT00561951|155575890|FG001|Overall Study|Pregnancy|1|||
48377323|NCT00561951|155575891|FG002|Overall Study|Pregnancy|0|||
48377324|NCT00561951|155575889|FG000|Overall Study|Meet Withdrawal Criterion|0|||
48377325|NCT00561951|155575890|FG001|Overall Study|Meet Withdrawal Criterion|1|||
48377326|NCT00561951|155575891|FG002|Overall Study|Meet Withdrawal Criterion|1|||
48377327|NCT00561951|155575889|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
48377328|NCT00561951|155575890|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
48377329|NCT00561951|155575891|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
48377330|NCT00368992|155575892|FG000|Overall Study|Ineligible|5|||
48377331|NCT00368992|155575892|FG000|Overall Study|Refused treatment|3|||
48377332|NCT00368992|155575892|FG000|Overall Study|Lack of Efficacy|63|||
48377333|NCT00368992|155575892|FG000|Overall Study|Adverse Event|26|||
48377334|NCT00368992|155575892|FG000|Overall Study|Death|4|||
48377335|NCT00368992|155575892|FG000|Overall Study|Other|9|||
48377336|NCT02520284|155575893|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
48377337|NCT02520284|155575894|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
48377338|NCT02520284|155575895|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
48377339|NCT02520284|155575893|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
48377340|NCT02520284|155575894|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
48377341|NCT02520284|155575895|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
48377342|NCT02520284|155575893|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
48377343|NCT02520284|155575894|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
48377344|NCT02520284|155575895|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
48377345|NCT02520284|155575893|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
48377346|NCT02520284|155575894|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
48377347|NCT02520284|155575895|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
48377348|NCT02520284|155575893|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
48377349|NCT02520284|155575894|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
48377350|NCT02520284|155575895|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
48377351|NCT02520284|155575893|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
48377352|NCT02520284|155575894|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
48377353|NCT02520284|155575895|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
48377354|NCT02520284|155575893|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
48377355|NCT02520284|155575894|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
48377356|NCT02520284|155575895|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
48377357|NCT02520284|155575893|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
48377358|NCT02520284|155575894|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
48377359|NCT02520284|155575895|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
48377360|NCT02520284|155575893|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
48377361|NCT02520284|155575894|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
48377362|NCT02520284|155575895|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
48377363|NCT02520284|155575893|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
48377364|NCT02520284|155575894|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
48377365|NCT02520284|155575895|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
48377366|NCT02520284|155575893|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
48377367|NCT02520284|155575894|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
48377368|NCT02520284|155575895|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
48377369|NCT02668185|155575896|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
48377370|NCT02668185|155575897|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
48377371|NCT02668185|155575896|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
48377372|NCT02668185|155575897|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
48377373|NCT02668185|155575896|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
48377374|NCT02668185|155575897|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
48377375|NCT02668185|155575896|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
48377376|NCT02668185|155575897|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
48377377|NCT01013597|155575898|FG000|Overall Study|Withdrawal by Subject|1|||
48377378|NCT01898923|155575901|FG000|Overall Study|Lack of Efficacy|5|||
48377379|NCT01898923|155575902|FG001|Overall Study|Lack of Efficacy|6|||
48377380|NCT01898923|155575901|FG000|Overall Study|Adverse Event|3|||
48377381|NCT01898923|155575902|FG001|Overall Study|Adverse Event|1|||
48377382|NCT01898923|155575901|FG000|Overall Study|Lost to Follow-up|0|||
48377383|NCT01898923|155575902|FG001|Overall Study|Lost to Follow-up|1|||
48377384|NCT01898923|155575901|FG000|Overall Study|Withdrawal by Subject|4|||
48377385|NCT01898923|155575902|FG001|Overall Study|Withdrawal by Subject|7|||
48377386|NCT01898923|155575901|FG000|Overall Study|Physician Decision|3|||
48377387|NCT01898923|155575902|FG001|Overall Study|Physician Decision|4|||
48377388|NCT01898923|155575901|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
48377389|NCT01898923|155575902|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
48377390|NCT00381303|155575903|FG000|Overall Study|Lost to Follow-up|25|||
48377391|NCT00381303|155575904|FG001|Overall Study|Lost to Follow-up|9|||
48377392|NCT00381303|155575903|FG000|Overall Study|AE/HIV-related event|22|||
48377393|NCT00381303|155575904|FG001|Overall Study|AE/HIV-related event|6|||
48377394|NCT00381303|155575903|FG000|Overall Study|Non-Adherence|13|||
48377395|NCT00381303|155575904|FG001|Overall Study|Non-Adherence|6|||
48377396|NCT00381303|155575903|FG000|Overall Study|Withdrawal by Subject|13|||
48377397|NCT00381303|155575904|FG001|Overall Study|Withdrawal by Subject|6|||
48377398|NCT00381303|155575903|FG000|Overall Study|Virologic failure|6|||
48377399|NCT00381303|155575904|FG001|Overall Study|Virologic failure|4|||
48377400|NCT00381303|155575903|FG000|Overall Study|Ineligible to continue the trial|2|||
48377401|NCT00381303|155575904|FG001|Overall Study|Ineligible to continue the trial|1|||
48377402|NCT00381303|155575903|FG000|Overall Study|Pregnancy|2|||
48377403|NCT00381303|155575904|FG001|Overall Study|Pregnancy|0|||
48377404|NCT00381303|155575903|FG000|Overall Study|Physician Decision|1|||
48377405|NCT00381303|155575904|FG001|Overall Study|Physician Decision|0|||
48377406|NCT00381303|155575903|FG000|Overall Study|Physician's decision to close the site|3|||
48377407|NCT00381303|155575904|FG001|Overall Study|Physician's decision to close the site|1|||
48377408|NCT00381303|155575903|FG000|Overall Study|Subject moved out of state|2|||
48377409|NCT00381303|155575904|FG001|Overall Study|Subject moved out of state|0|||
48377410|NCT00381303|155575903|FG000|Overall Study|Subject taking too many different meds|1|||
48377411|NCT00381303|155575904|FG001|Overall Study|Subject taking too many different meds|0|||
48377412|NCT00381303|155575903|FG000|Overall Study|No virologic response by week 12|1|||
48377413|NCT00381303|155575904|FG001|Overall Study|No virologic response by week 12|0|||
48377414|NCT00381303|155575903|FG000|Overall Study|Subject was too busy for appointments|1|||
48377415|NCT00381303|155575904|FG001|Overall Study|Subject was too busy for appointments|0|||
48377416|NCT00381303|155575903|FG000|Overall Study|Subject did not continue visits|1|||
48377417|NCT00381303|155575904|FG001|Overall Study|Subject did not continue visits|0|||
48377418|NCT00381303|155575903|FG000|Overall Study|Subject primary physician's decision|1|||
48377419|NCT00381303|155575904|FG001|Overall Study|Subject primary physician's decision|0|||
48377420|NCT01211522|155575905|FG000|Overall Study|Withdrawal by Subject|3|||
48377421|NCT01211522|155575906|FG001|Overall Study|Withdrawal by Subject|7|||
48377422|NCT01211522|155575907|FG002|Overall Study|Withdrawal by Subject|5|||
48377423|NCT00372385|155575908|FG000|Overall Study|Adverse Event|6|||
48377424|NCT00372385|155575909|FG001|Overall Study|Adverse Event|11|||
48377425|NCT00372385|155575910|FG002|Overall Study|Adverse Event|9|||
48377426|NCT00372385|155575911|FG003|Overall Study|Adverse Event|7|||
48377427|NCT00372385|155575908|FG000|Overall Study|Noncompliance|0|||
48377428|NCT00372385|155575909|FG001|Overall Study|Noncompliance|1|||
48377429|NCT00372385|155575910|FG002|Overall Study|Noncompliance|1|||
48377430|NCT00372385|155575911|FG003|Overall Study|Noncompliance|1|||
48377431|NCT00372385|155575908|FG000|Overall Study|Physician Decision|1|||
48377432|NCT00372385|155575909|FG001|Overall Study|Physician Decision|0|||
48377433|NCT00372385|155575910|FG002|Overall Study|Physician Decision|0|||
48377434|NCT00372385|155575911|FG003|Overall Study|Physician Decision|0|||
48377435|NCT00372385|155575908|FG000|Overall Study|Lost to Follow-up|2|||
48377436|NCT00372385|155575909|FG001|Overall Study|Lost to Follow-up|0|||
48377437|NCT00372385|155575910|FG002|Overall Study|Lost to Follow-up|0|||
48377438|NCT00372385|155575911|FG003|Overall Study|Lost to Follow-up|0|||
48377439|NCT00372385|155575908|FG000|Overall Study|Withdrawal by Subject|2|||
48377440|NCT00372385|155575909|FG001|Overall Study|Withdrawal by Subject|1|||
48377441|NCT00372385|155575910|FG002|Overall Study|Withdrawal by Subject|0|||
48377442|NCT00372385|155575911|FG003|Overall Study|Withdrawal by Subject|0|||
48377443|NCT00372385|155575908|FG000|Overall Study|Refusal of Treatment|3|||
48377444|NCT00372385|155575909|FG001|Overall Study|Refusal of Treatment|6|||
48377445|NCT00372385|155575910|FG002|Overall Study|Refusal of Treatment|0|||
48377446|NCT00372385|155575911|FG003|Overall Study|Refusal of Treatment|0|||
48377447|NCT00372385|155575908|FG000|Overall Study|No Response|1|||
48377448|NCT00372385|155575909|FG001|Overall Study|No Response|1|||
48377449|NCT00372385|155575910|FG002|Overall Study|No Response|0|||
48377450|NCT00372385|155575911|FG003|Overall Study|No Response|0|||
48377451|NCT00372385|155575908|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
48377452|NCT00372385|155575909|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
48377453|NCT00372385|155575910|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
48377454|NCT00372385|155575911|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
48377455|NCT00372385|155575908|FG000|Overall Study|Virologic Stopping Rule|17|||
48377456|NCT00372385|155575909|FG001|Overall Study|Virologic Stopping Rule|0|||
48377457|NCT00372385|155575910|FG002|Overall Study|Virologic Stopping Rule|0|||
48377458|NCT00372385|155575911|FG003|Overall Study|Virologic Stopping Rule|0|||
48377459|NCT01139658|155575912|FG000|Overall Study|Adverse Event|10|||
48377460|NCT01139658|155575913|FG001|Overall Study|Adverse Event|27|||
48377461|NCT01139658|155575912|FG000|Overall Study|Lack of Efficacy|15|||
48377462|NCT01139658|155575913|FG001|Overall Study|Lack of Efficacy|7|||
48377463|NCT01139658|155575912|FG000|Overall Study|Withdrawal by Subject|2|||
48377464|NCT01139658|155575913|FG001|Overall Study|Withdrawal by Subject|4|||
48377465|NCT01139658|155575912|FG000|Overall Study|No documentation of treatment|1|||
48377466|NCT01139658|155575913|FG001|Overall Study|No documentation of treatment|0|||
48377467|NCT01139658|155575912|FG000|Overall Study|Other|28|||
48377468|NCT01139658|155575913|FG001|Overall Study|Other|75|||
48377469|NCT01777269|155575914|FG000|Overall Study|Adverse Event|24|||
48377470|NCT01777269|155575915|FG001|Overall Study|Adverse Event|33|||
48377471|NCT01777269|155575914|FG000|Overall Study|Lack of Efficacy|8|||
48377472|NCT01777269|155575915|FG001|Overall Study|Lack of Efficacy|10|||
48377473|NCT01777269|155575914|FG000|Overall Study|Protocol Violation|4|||
48377474|NCT01777269|155575915|FG001|Overall Study|Protocol Violation|4|||
48377475|NCT01777269|155575914|FG000|Overall Study|Participants reached stopping criteria|1|||
48377476|NCT01777269|155575915|FG001|Overall Study|Participants reached stopping criteria|1|||
48377477|NCT01777269|155575914|FG000|Overall Study|Lost to Follow-up|4|||
48377478|NCT01777269|155575915|FG001|Overall Study|Lost to Follow-up|0|||
48377479|NCT01777269|155575914|FG000|Overall Study|Physician Decision|5|||
48377480|NCT01777269|155575915|FG001|Overall Study|Physician Decision|2|||
48377481|NCT01777269|155575914|FG000|Overall Study|Withdrawal by Subject|9|||
48377482|NCT01777269|155575915|FG001|Overall Study|Withdrawal by Subject|9|||
48377483|NCT00409773|155577431|FG000|Overall Study|Adverse Event|3|||
48377484|NCT00409773|155577432|FG001|Overall Study|Adverse Event|4|||
48377485|NCT00409773|155577433|FG002|Overall Study|Adverse Event|4|||
48377486|NCT00409773|155577434|FG003|Overall Study|Adverse Event|2|||
48377487|NCT00409773|155577435|FG004|Overall Study|Adverse Event|6|||
48377488|NCT00409773|155577431|FG000|Overall Study|Lost to Follow-up|6|||
48377489|NCT00409773|155577432|FG001|Overall Study|Lost to Follow-up|1|||
48377490|NCT00409773|155577433|FG002|Overall Study|Lost to Follow-up|2|||
48377491|NCT00409773|155577434|FG003|Overall Study|Lost to Follow-up|3|||
48377492|NCT00409773|155577435|FG004|Overall Study|Lost to Follow-up|1|||
48377493|NCT00409773|155577431|FG000|Overall Study|Physician Decision|0|||
48377494|NCT00409773|155577432|FG001|Overall Study|Physician Decision|0|||
48377495|NCT00409773|155577433|FG002|Overall Study|Physician Decision|0|||
48377496|NCT00409773|155577434|FG003|Overall Study|Physician Decision|2|||
48377497|NCT00409773|155577435|FG004|Overall Study|Physician Decision|0|||
48377498|NCT00409773|155577431|FG000|Overall Study|Protocol Violation|0|||
48377499|NCT00409773|155577432|FG001|Overall Study|Protocol Violation|2|||
48377500|NCT00409773|155577433|FG002|Overall Study|Protocol Violation|3|||
48377501|NCT00409773|155577434|FG003|Overall Study|Protocol Violation|3|||
48377502|NCT00409773|155577435|FG004|Overall Study|Protocol Violation|1|||
48377503|NCT00409773|155577431|FG000|Overall Study|Withdrawal by Subject|0|||
48377504|NCT00409773|155577432|FG001|Overall Study|Withdrawal by Subject|0|||
48377505|NCT00409773|155577433|FG002|Overall Study|Withdrawal by Subject|0|||
48377506|NCT00409773|155577434|FG003|Overall Study|Withdrawal by Subject|2|||
48377507|NCT00409773|155577435|FG004|Overall Study|Withdrawal by Subject|1|||
48377508|NCT00409773|155577431|FG000|Overall Study|Lack of Eligibility|0|||
48377509|NCT00409773|155577432|FG001|Overall Study|Lack of Eligibility|0|||
48377510|NCT00409773|155577433|FG002|Overall Study|Lack of Eligibility|0|||
48377511|NCT00409773|155577434|FG003|Overall Study|Lack of Eligibility|0|||
48377512|NCT00409773|155577435|FG004|Overall Study|Lack of Eligibility|1|||
48377513|NCT01201343|155577436|FG000|Overall Study|Adverse Event|6|||
48377514|NCT01201343|155577436|FG000|Overall Study|Withdrawal by Subject|5|||
48377515|NCT01201343|155577436|FG000|Overall Study|Lost to Follow-up|2|||
48377516|NCT01201343|155577436|FG000|Overall Study|Lack of Efficacy|2|||
48377517|NCT01201343|155577436|FG000|Overall Study|Participant wrongly included in trial|1|||
48377518|NCT01201343|155577436|FG000|Overall Study|Randomized, not treated|3|||
48377519|NCT02164383|155577439|FG000|Overall Study|Lost to Follow-up|1|||
48377520|NCT02164383|155577440|FG001|Overall Study|Lost to Follow-up|0|||
48377521|NCT01440374|155577446|FG000|Part 1: Open-label Phase|Adverse Event|5|||
48377522|NCT01440374|155577447|FG001|Part 1: Open-label Phase|Adverse Event|0|||
48377523|NCT01440374|155577448|FG002|Part 1: Open-label Phase|Adverse Event|0|||
48377524|NCT01440374|155577449|FG003|Part 1: Open-label Phase|Adverse Event|0|||
48377525|NCT01440374|155577446|FG000|Part 1: Open-label Phase|Physician Decision|1|||
48377526|NCT01440374|155577447|FG001|Part 1: Open-label Phase|Physician Decision|0|||
48377527|NCT01440374|155577448|FG002|Part 1: Open-label Phase|Physician Decision|0|||
48377528|NCT01440374|155577449|FG003|Part 1: Open-label Phase|Physician Decision|0|||
48377529|NCT01440374|155577446|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
48377530|NCT01440374|155577447|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
48377531|NCT01440374|155577448|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
48377532|NCT01440374|155577449|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
48377533|NCT01440374|155577446|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
48377534|NCT01440374|155577447|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
48377535|NCT01440374|155577448|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
48377536|NCT01440374|155577449|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
48377537|NCT01440374|155577446|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
48377538|NCT01440374|155577447|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
48377539|NCT01440374|155577448|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
48377540|NCT01440374|155577449|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
48377541|NCT01440374|155577446|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
48377542|NCT01440374|155577447|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
48377543|NCT01440374|155577448|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
48377544|NCT01440374|155577449|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
48377545|NCT01440374|155577446|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
48377546|NCT01440374|155577447|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
48377547|NCT01440374|155577448|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
48377548|NCT01440374|155577449|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
48377549|NCT01440374|155577446|FG000|Part 2; Double-blind Phase|Not treated|0|||
48377550|NCT01440374|155577447|FG001|Part 2; Double-blind Phase|Not treated|0|||
48377551|NCT01440374|155577448|FG002|Part 2; Double-blind Phase|Not treated|1|||
48377552|NCT01440374|155577449|FG003|Part 2; Double-blind Phase|Not treated|0|||
48377553|NCT01440374|155577446|FG000|Part 3: Extension|Withdrawal by Subject|0|||
48377554|NCT01440374|155577447|FG001|Part 3: Extension|Withdrawal by Subject|0|||
48377555|NCT01440374|155577448|FG002|Part 3: Extension|Withdrawal by Subject|0|||
48377556|NCT01440374|155577449|FG003|Part 3: Extension|Withdrawal by Subject|5|||
48377557|NCT01440374|155577446|FG000|Part 3: Extension|Adverse Event|0|||
48377558|NCT01440374|155577447|FG001|Part 3: Extension|Adverse Event|0|||
48377559|NCT01440374|155577448|FG002|Part 3: Extension|Adverse Event|0|||
48377560|NCT01440374|155577449|FG003|Part 3: Extension|Adverse Event|13|||
48377561|NCT01440374|155577446|FG000|Part 3: Extension|Physician Decision|0|||
48377562|NCT01440374|155577447|FG001|Part 3: Extension|Physician Decision|0|||
48377563|NCT01440374|155577448|FG002|Part 3: Extension|Physician Decision|0|||
48377564|NCT01440374|155577449|FG003|Part 3: Extension|Physician Decision|14|||
48377565|NCT00743275|155577450|FG000|Overall Study|Protocol Violation|0|||
48377566|NCT00743275|155577451|FG001|Overall Study|Protocol Violation|1|||
48377567|NCT01828073|155577453|FG000|Overall Study|Lost to Follow-up|1|||
48377568|NCT01828073|155577454|FG001|Overall Study|Lost to Follow-up|2|||
48377569|NCT01060540|155577455|FG000|Overall Study|Withdrawal by Subject|10|||
48377570|NCT01060540|155577456|FG001|Overall Study|Withdrawal by Subject|20|||
48377571|NCT01060540|155577455|FG000|Overall Study|Lost to Follow-up|52|||
48377572|NCT01060540|155577456|FG001|Overall Study|Lost to Follow-up|43|||
48377573|NCT01060540|155577455|FG000|Overall Study|Death|2|||
48377574|NCT01060540|155577456|FG001|Overall Study|Death|1|||
48377575|NCT01060540|155577455|FG000|Overall Study|Physician Decision|0|||
48377576|NCT01060540|155577456|FG001|Overall Study|Physician Decision|1|||
48377577|NCT02186223|155577461|FG000|Overall Study|Not eligible for device placement|6|||
48377578|NCT02186223|155577461|FG000|Overall Study|Unable to obtain femoral access|3|||
48377579|NCT02186223|155577461|FG000|Overall Study|Death|3|||
48377580|NCT02186223|155577461|FG000|Overall Study|Device in place less than 48 hours|9|||
48377581|NCT00107120|155577462|FG000|Overall Study|Adverse Event|4|||
48377582|NCT00107120|155577463|FG001|Overall Study|Adverse Event|1|||
48377583|NCT00107120|155577462|FG000|Overall Study|Lack of Efficacy|5|||
48377584|NCT00107120|155577463|FG001|Overall Study|Lack of Efficacy|5|||
48377585|NCT00107120|155577462|FG000|Overall Study|Protocol Violation|3|||
48377586|NCT00107120|155577463|FG001|Overall Study|Protocol Violation|0|||
48377587|NCT00107120|155577462|FG000|Overall Study|Withdrawal by Subject|8|||
48377588|NCT00107120|155577463|FG001|Overall Study|Withdrawal by Subject|9|||
48377589|NCT00107120|155577462|FG000|Overall Study|Lost to Follow-up|8|||
48377590|NCT00107120|155577463|FG001|Overall Study|Lost to Follow-up|6|||
48377591|NCT00107120|155577462|FG000|Overall Study|Pregnancy|0|||
48377592|NCT00107120|155577463|FG001|Overall Study|Pregnancy|1|||
48377593|NCT00107120|155577462|FG000|Overall Study|moving away from site|1|||
48377594|NCT00107120|155577463|FG001|Overall Study|moving away from site|1|||
48377595|NCT00107120|155577462|FG000|Overall Study|death of parent|0|||
48377596|NCT00107120|155577463|FG001|Overall Study|death of parent|1|||
48377597|NCT00876928|155577464|FG000|Overall Study|Lost to Follow-up|2|||
48377598|NCT00876928|155577465|FG001|Overall Study|Lost to Follow-up|5|||
48377599|NCT00876928|155577464|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
48377600|NCT00876928|155577465|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
48377601|NCT00701779|155577466|FG000|Overall Study|Adverse Event|6|||
48377602|NCT00701779|155577466|FG000|Overall Study|Lost to Follow-up|1|||
48377603|NCT00701779|155577466|FG000|Overall Study|Withdrawal by Subject|2|||
48377604|NCT02245672|155577467|FG000|Overall Study|Adverse Event|4|||
48377605|NCT02245672|155577468|FG001|Overall Study|Adverse Event|4|||
48377606|NCT02245672|155577469|FG002|Overall Study|Adverse Event|4|||
48377607|NCT02245672|155577467|FG000|Overall Study|Lost to Follow-up|3|||
48377608|NCT02245672|155577468|FG001|Overall Study|Lost to Follow-up|5|||
48377609|NCT02245672|155577469|FG002|Overall Study|Lost to Follow-up|1|||
48377610|NCT02245672|155577467|FG000|Overall Study|Withdrawal by Subject|6|||
48377611|NCT02245672|155577468|FG001|Overall Study|Withdrawal by Subject|3|||
48377612|NCT02245672|155577469|FG002|Overall Study|Withdrawal by Subject|0|||
48377613|NCT02245672|155577467|FG000|Overall Study|Randomized in error (not treated)|0|||
48377614|NCT02245672|155577468|FG001|Overall Study|Randomized in error (not treated)|1|||
48377615|NCT02245672|155577469|FG002|Overall Study|Randomized in error (not treated)|0|||
48377616|NCT01620255|155577470|FG000|Overall Study|Withdrawal by Subject|4|||
48377617|NCT01620255|155577471|FG001|Overall Study|Withdrawal by Subject|1|||
48377618|NCT01620255|155577472|FG002|Overall Study|Withdrawal by Subject|1|||
48377619|NCT01620255|155577473|FG003|Overall Study|Withdrawal by Subject|2|||
48377620|NCT01620255|155577474|FG004|Overall Study|Withdrawal by Subject|4|||
48377621|NCT01620255|155577470|FG000|Overall Study|Participant underwent fecal transplant|0|||
48377622|NCT01620255|155577471|FG001|Overall Study|Participant underwent fecal transplant|0|||
48377623|NCT01620255|155577472|FG002|Overall Study|Participant underwent fecal transplant|1|||
48377624|NCT01620255|155577473|FG003|Overall Study|Participant underwent fecal transplant|0|||
48377625|NCT01620255|155577474|FG004|Overall Study|Participant underwent fecal transplant|0|||
48377626|NCT01620255|155577470|FG000|Overall Study|Non-compliance|0|||
48377627|NCT01620255|155577471|FG001|Overall Study|Non-compliance|1|||
48377628|NCT01620255|155577472|FG002|Overall Study|Non-compliance|0|||
48377629|NCT01620255|155577473|FG003|Overall Study|Non-compliance|0|||
48377630|NCT01620255|155577474|FG004|Overall Study|Non-compliance|0|||
48377631|NCT01620255|155577470|FG000|Overall Study|Adverse Event|0|||
48377632|NCT01620255|155577471|FG001|Overall Study|Adverse Event|4|||
48377633|NCT01620255|155577472|FG002|Overall Study|Adverse Event|0|||
48377634|NCT01620255|155577473|FG003|Overall Study|Adverse Event|1|||
48377635|NCT01620255|155577474|FG004|Overall Study|Adverse Event|1|||
48377636|NCT01620255|155577470|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
48377637|NCT01620255|155577471|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
48377638|NCT01620255|155577472|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
48377639|NCT01620255|155577473|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
48377640|NCT01620255|155577474|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
48377641|NCT03602066|155577475|FG000|Overall Study|Withdrawal by Subject|2|||
48377642|NCT03602066|155577476|FG001|Overall Study|Withdrawal by Subject|0|||
48377643|NCT03602066|155577475|FG000|Overall Study|Physician Decision|1|||
48377644|NCT03602066|155577476|FG001|Overall Study|Physician Decision|0|||
48377645|NCT00440700|155577477|FG000|Overall Study|Withdrawal by Subject|8|||
48377646|NCT00440700|155577478|FG001|Overall Study|Withdrawal by Subject|8|||
48377647|NCT00440700|155577479|FG002|Overall Study|Withdrawal by Subject|4|||
48377648|NCT02336178|155577480|FG000|Overall Study|Lost to Follow-up|1|||
48377649|NCT02336178|155577480|FG000|Overall Study|Protocol Violation|1|||
48377650|NCT02336178|155577480|FG000|Overall Study|Withdrawal by Subject|1|||
48377651|NCT02336178|155577480|FG000|Overall Study|Other|1|||
48377652|NCT03310268|155577481|FG000|Overall Study|(Not specified)|1|||
48377653|NCT03310268|155577482|FG001|Overall Study|(Not specified)|5|||
48377654|NCT03310268|155577483|FG002|Overall Study|(Not specified)|0|||
48377655|NCT01155375|155577488|FG000|Overall Study|Adverse Event|1|||
48377656|NCT01155375|155577489|FG001|Overall Study|Adverse Event|0|||
48377657|NCT01637623|155577492|FG000|Overall Study|Lost to Follow-up|0|||
48377658|NCT01637623|155577493|FG001|Overall Study|Lost to Follow-up|0|||
48377659|NCT01637623|155577494|FG002|Overall Study|Lost to Follow-up|2|||
48377660|NCT01637623|155577492|FG000|Overall Study|Physician Decision|1|||
48377661|NCT01637623|155577493|FG001|Overall Study|Physician Decision|0|||
48377662|NCT01637623|155577494|FG002|Overall Study|Physician Decision|1|||
48377663|NCT03249714|155577495|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
48377664|NCT03249714|155577496|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
48377665|NCT03249714|155577495|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
48377666|NCT03249714|155577496|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
48377667|NCT03249714|155577495|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
48377668|NCT03249714|155577496|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
48377669|NCT03249714|155577495|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
48377670|NCT03249714|155577496|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
48377671|NCT02634346|155577497|FG000|Overall Study|Withdrawal by Subject|8|||
48377672|NCT02634346|155577498|FG001|Overall Study|Withdrawal by Subject|9|||
48377673|NCT02634346|155577499|FG002|Overall Study|Withdrawal by Subject|8|||
48377674|NCT02634346|155577497|FG000|Overall Study|Adverse Event|2|||
48377675|NCT02634346|155577498|FG001|Overall Study|Adverse Event|2|||
48377676|NCT02634346|155577499|FG002|Overall Study|Adverse Event|7|||
48377677|NCT02634346|155577497|FG000|Overall Study|Lack of Efficacy|1|||
48377678|NCT02634346|155577498|FG001|Overall Study|Lack of Efficacy|2|||
48377679|NCT02634346|155577499|FG002|Overall Study|Lack of Efficacy|8|||
48377680|NCT02634346|155577497|FG000|Overall Study|Lost to Follow-up|1|||
48377681|NCT02634346|155577498|FG001|Overall Study|Lost to Follow-up|0|||
48377682|NCT02634346|155577499|FG002|Overall Study|Lost to Follow-up|0|||
48377683|NCT02634346|155577497|FG000|Overall Study|Protocol Violation|0|||
48377684|NCT02634346|155577498|FG001|Overall Study|Protocol Violation|1|||
48377685|NCT02634346|155577499|FG002|Overall Study|Protocol Violation|0|||
48377686|NCT01933113|155577507|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
48377687|NCT03587974|155577508|FG000|Overall Study|caregiver demented, care recipient died|3|||
48377688|NCT03587974|155577509|FG001|Overall Study|caregiver demented, care recipient died|3|||
48377689|NCT03587974|155577508|FG000|Overall Study|Withdrawal by Subject|2|||
48377690|NCT03587974|155577509|FG001|Overall Study|Withdrawal by Subject|1|||
48377691|NCT03486457|155577510|FG000|Up to Month 3|Adverse Event|2|||
48377692|NCT03486457|155577511|FG001|Up to Month 3|Adverse Event|5|||
48377693|NCT03486457|155577510|FG000|Up to Month 3|Lack of Efficacy|1|||
48377694|NCT03486457|155577511|FG001|Up to Month 3|Lack of Efficacy|0|||
48377695|NCT03486457|155577510|FG000|Up to Month 3|Withdrawal by Subject|1|||
48377696|NCT03486457|155577511|FG001|Up to Month 3|Withdrawal by Subject|0|||
48377697|NCT03486457|155577510|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
48377698|NCT03486457|155577511|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
48377699|NCT03486457|155577510|FG000|Up to Month 3|Other|1|||
48377700|NCT03486457|155577511|FG001|Up to Month 3|Other|0|||
48377701|NCT03486457|155577510|FG000|Month 3 to Month 6|Adverse Event|2|||
48377702|NCT03486457|155577511|FG001|Month 3 to Month 6|Adverse Event|0|||
48377703|NCT03486457|155577510|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
48377704|NCT03486457|155577511|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
48377705|NCT03486457|155577510|FG000|Month 3 to Month 6|Pregnancy|0|||
48377706|NCT03486457|155577511|FG001|Month 3 to Month 6|Pregnancy|1|||
48377707|NCT03486457|155577510|FG000|Month 3 to Month 6|Other|1|||
48377708|NCT03486457|155577511|FG001|Month 3 to Month 6|Other|0|||
48377709|NCT04754477|155577512|FG000|Overall Study|Withdrawal by Subject|1|||
48377710|NCT02960854|155577513|FG000|Overall Study|Not Disclosed|2|||
48377711|NCT02960854|155577514|FG001|Overall Study|Not Disclosed|2|||
48377712|NCT02960854|155577513|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
48377713|NCT02960854|155577514|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
48377714|NCT02960854|155577513|FG000|Overall Study|Subject Withdrew Consent|0|||
48377715|NCT02960854|155577514|FG001|Overall Study|Subject Withdrew Consent|1|||
48377716|NCT02960854|155577513|FG000|Overall Study|Death|4|||
48377717|NCT02960854|155577514|FG001|Overall Study|Death|6|||
48377718|NCT00221195|155577515|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
48377719|NCT00221195|155577516|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
48377720|NCT00221195|155577515|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
48377721|NCT00221195|155577516|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
48377722|NCT00221195|155577515|FG000|Washout Period (Months 7-9)|Death|0|||
48377723|NCT00221195|155577516|FG001|Washout Period (Months 7-9)|Death|1|||
48377724|NCT00221195|155577515|FG000|Therapy 2 (Months 10-15)|Death|1|||
48377725|NCT00221195|155577516|FG001|Therapy 2 (Months 10-15)|Death|0|||
48377726|NCT00221195|155577515|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
48377727|NCT00221195|155577516|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
48377728|NCT00093808|155577517|FG000|Overall Study|Cancel participation before receiving tx|1|||
48377729|NCT00093808|155577517|FG000|Overall Study|Protocol Violation|1|||
48377730|NCT02647866|155577518|FG000|Overall Study|Adverse Event|0|||
48377731|NCT02647866|155577519|FG001|Overall Study|Adverse Event|0|||
48377732|NCT02647866|155577520|FG002|Overall Study|Adverse Event|2|||
48377733|NCT02647866|155577521|FG003|Overall Study|Adverse Event|2|||
48377734|NCT02647866|155577522|FG004|Overall Study|Adverse Event|1|||
48377735|NCT02647866|155577518|FG000|Overall Study|Disease Worsening|3|||
48377736|NCT02647866|155577519|FG001|Overall Study|Disease Worsening|1|||
48377737|NCT02647866|155577520|FG002|Overall Study|Disease Worsening|0|||
48377738|NCT02647866|155577521|FG003|Overall Study|Disease Worsening|0|||
48377739|NCT02647866|155577522|FG004|Overall Study|Disease Worsening|1|||
48377740|NCT02647866|155577518|FG000|Overall Study|Withdrawal by Subject|1|||
48377741|NCT02647866|155577519|FG001|Overall Study|Withdrawal by Subject|1|||
48377742|NCT02647866|155577520|FG002|Overall Study|Withdrawal by Subject|2|||
48377743|NCT02647866|155577521|FG003|Overall Study|Withdrawal by Subject|4|||
48377744|NCT02647866|155577522|FG004|Overall Study|Withdrawal by Subject|4|||
48377745|NCT02647866|155577518|FG000|Overall Study|Physician Decision|0|||
48377746|NCT02647866|155577519|FG001|Overall Study|Physician Decision|1|||
48377747|NCT02647866|155577520|FG002|Overall Study|Physician Decision|1|||
48377748|NCT02647866|155577521|FG003|Overall Study|Physician Decision|0|||
48377749|NCT02647866|155577522|FG004|Overall Study|Physician Decision|2|||
48377750|NCT02647866|155577518|FG000|Overall Study|Death|0|||
48377751|NCT02647866|155577519|FG001|Overall Study|Death|1|||
48377752|NCT02647866|155577520|FG002|Overall Study|Death|0|||
48377753|NCT02647866|155577521|FG003|Overall Study|Death|0|||
48377754|NCT02647866|155577522|FG004|Overall Study|Death|0|||
48377755|NCT02647866|155577518|FG000|Overall Study|Subject moved to different country|1|||
48377756|NCT02647866|155577519|FG001|Overall Study|Subject moved to different country|0|||
48377757|NCT02647866|155577520|FG002|Overall Study|Subject moved to different country|0|||
48377758|NCT02647866|155577521|FG003|Overall Study|Subject moved to different country|0|||
48377759|NCT02647866|155577522|FG004|Overall Study|Subject moved to different country|0|||
48377760|NCT00701220|155577523|FG000|Overall Study|Withdrawal by Subject|0|||
48377761|NCT00701220|155577524|FG001|Overall Study|Withdrawal by Subject|2|||
48377762|NCT00701220|155577523|FG000|Overall Study|Protocol Violation|2|||
48377763|NCT00701220|155577524|FG001|Overall Study|Protocol Violation|0|||
48377764|NCT01180998|155577525|FG000|Overall Study|Poor Vision|0|||
48377765|NCT01180998|155577526|FG001|Overall Study|Poor Vision|2|||
48377766|NCT01180998|155577527|FG002|Overall Study|Poor Vision|2|||
48377767|NCT01180998|155577525|FG000|Overall Study|Lost to Follow-up|0|||
48377768|NCT01180998|155577526|FG001|Overall Study|Lost to Follow-up|0|||
48377769|NCT01180998|155577527|FG002|Overall Study|Lost to Follow-up|1|||
48377770|NCT01180998|155577525|FG000|Overall Study|Protocol Violation|1|||
48377771|NCT01180998|155577526|FG001|Overall Study|Protocol Violation|2|||
48377772|NCT01180998|155577527|FG002|Overall Study|Protocol Violation|0|||
48377773|NCT01180998|155577525|FG000|Overall Study|Withdrawal by Subject|0|||
48377774|NCT01180998|155577526|FG001|Overall Study|Withdrawal by Subject|0|||
48377775|NCT01180998|155577527|FG002|Overall Study|Withdrawal by Subject|1|||
48377776|NCT01180998|155577525|FG000|Overall Study|Poor comfort|3|||
48377777|NCT01180998|155577526|FG001|Overall Study|Poor comfort|0|||
48377778|NCT01180998|155577527|FG002|Overall Study|Poor comfort|4|||
48377779|NCT01180998|155577525|FG000|Overall Study|Poor lens handling|0|||
48377780|NCT01180998|155577526|FG001|Overall Study|Poor lens handling|0|||
48377781|NCT01180998|155577527|FG002|Overall Study|Poor lens handling|2|||
48377782|NCT00162032|155577528|FG000|Overall Study|Lost to Follow-up|4|||
48377783|NCT00162032|155577529|FG001|Overall Study|Lost to Follow-up|2|||
48377784|NCT00162032|155577528|FG000|Overall Study|Reason not specified|1|||
48377785|NCT00162032|155577529|FG001|Overall Study|Reason not specified|0|||
48377786|NCT00718640|155577534|FG000|Overall Study|Adverse Event|4|||
48377787|NCT00718640|155577534|FG000|Overall Study|Death|1|||
48377788|NCT00718640|155577534|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
48377789|NCT00655486|155577535|FG000|Overall Study|Adverse Event|10|||
48377790|NCT00655486|155577535|FG000|Overall Study|Lack of Efficacy|8|||
48377791|NCT00655486|155577535|FG000|Overall Study|Withdrawal by Subject|4|||
48377792|NCT00655486|155577535|FG000|Overall Study|Protocol Violation|1|||
48377793|NCT00655486|155577535|FG000|Overall Study|Unsatisfactory compliance|2|||
48377794|NCT00655486|155577535|FG000|Overall Study|Other: Pregnancy|1|||
48377795|NCT00655486|155577535|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
48377796|NCT00655486|155577535|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
48377797|NCT00744523|155577541|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
48377798|NCT00744523|155577542|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
48377799|NCT01139021|155577543|FG000|Overall Study|Adverse Event|0|||
48377800|NCT01139021|155577544|FG001|Overall Study|Adverse Event|0|||
48377801|NCT01139021|155577545|FG002|Overall Study|Adverse Event|0|||
48377802|NCT01139021|155577546|FG003|Overall Study|Adverse Event|0|||
48377803|NCT01139021|155577547|FG004|Overall Study|Adverse Event|1|||
48377804|NCT01139021|155577548|FG005|Overall Study|Adverse Event|0|||
48377805|NCT01139021|155577543|FG000|Overall Study|Lost to Follow-up|0|||
48377806|NCT01139021|155577544|FG001|Overall Study|Lost to Follow-up|0|||
48377807|NCT01139021|155577545|FG002|Overall Study|Lost to Follow-up|0|||
48377808|NCT01139021|155577546|FG003|Overall Study|Lost to Follow-up|0|||
48377809|NCT01139021|155577547|FG004|Overall Study|Lost to Follow-up|2|||
48377810|NCT01139021|155577548|FG005|Overall Study|Lost to Follow-up|0|||
48377811|NCT01139021|155577543|FG000|Overall Study|Protocol Violation|1|||
48377812|NCT01139021|155577544|FG001|Overall Study|Protocol Violation|0|||
48377813|NCT01139021|155577545|FG002|Overall Study|Protocol Violation|0|||
48377814|NCT01139021|155577546|FG003|Overall Study|Protocol Violation|0|||
48377815|NCT01139021|155577547|FG004|Overall Study|Protocol Violation|2|||
48377816|NCT01139021|155577548|FG005|Overall Study|Protocol Violation|0|||
48377817|NCT01139021|155577543|FG000|Overall Study|Withdrawal by Subject|0|||
48377818|NCT01139021|155577544|FG001|Overall Study|Withdrawal by Subject|0|||
48377819|NCT01139021|155577545|FG002|Overall Study|Withdrawal by Subject|0|||
48377820|NCT01139021|155577546|FG003|Overall Study|Withdrawal by Subject|1|||
48377821|NCT01139021|155577547|FG004|Overall Study|Withdrawal by Subject|4|||
48377822|NCT01139021|155577548|FG005|Overall Study|Withdrawal by Subject|0|||
48377823|NCT03603028|155577549|FG000|Overall Study|Withdrawal by Subject|1|||
48377824|NCT01037244|155577550|FG000|Overall Study|Adverse Event|3|||
48377825|NCT01037244|155577551|FG001|Overall Study|Adverse Event|2|||
48377826|NCT01037244|155577552|FG002|Overall Study|Adverse Event|6|||
48377827|NCT01037244|155577553|FG003|Overall Study|Adverse Event|3|||
48377828|NCT01037244|155577550|FG000|Overall Study|Lack of Efficacy|1|||
48377829|NCT01037244|155577551|FG001|Overall Study|Lack of Efficacy|1|||
48377830|NCT01037244|155577552|FG002|Overall Study|Lack of Efficacy|0|||
48377831|NCT01037244|155577553|FG003|Overall Study|Lack of Efficacy|1|||
48377832|NCT01037244|155577550|FG000|Overall Study|Lost to Follow-up|3|||
48377833|NCT01037244|155577551|FG001|Overall Study|Lost to Follow-up|3|||
48377834|NCT01037244|155577552|FG002|Overall Study|Lost to Follow-up|4|||
48377835|NCT01037244|155577553|FG003|Overall Study|Lost to Follow-up|4|||
48377836|NCT01037244|155577550|FG000|Overall Study|Withdrawal by Subject|1|||
48377837|NCT01037244|155577551|FG001|Overall Study|Withdrawal by Subject|5|||
48377838|NCT01037244|155577552|FG002|Overall Study|Withdrawal by Subject|3|||
48377839|NCT01037244|155577553|FG003|Overall Study|Withdrawal by Subject|5|||
48377840|NCT01037244|155577550|FG000|Overall Study|Partner Withdrew Consent|2|||
48377841|NCT01037244|155577551|FG001|Overall Study|Partner Withdrew Consent|1|||
48377842|NCT01037244|155577552|FG002|Overall Study|Partner Withdrew Consent|0|||
48377843|NCT01037244|155577553|FG003|Overall Study|Partner Withdrew Consent|0|||
48377844|NCT01037244|155577550|FG000|Overall Study|Various|3|||
48377845|NCT01037244|155577551|FG001|Overall Study|Various|2|||
48377846|NCT01037244|155577552|FG002|Overall Study|Various|1|||
48377847|NCT01037244|155577553|FG003|Overall Study|Various|1|||
48377848|NCT00690820|155577554|FG000|Period 1|Withdrawal by Subject|0|||
48377849|NCT00690820|155577555|FG001|Period 1|Withdrawal by Subject|1|||
48377850|NCT03658668|155577561|FG000|Overall Study|Time Commitment|1|||
48377851|NCT03658668|155577562|FG001|Overall Study|Time Commitment|1|||
48377852|NCT00756470|155577565|FG000|Overall Study|Withdrawal by Subject|1|||
48377853|NCT00756470|155577565|FG000|Overall Study|Adverse Event|4|||
48377854|NCT01978262|155577569|FG000|Overall Study|Withdrawal by Subject|9|||
48377855|NCT01978262|155577569|FG000|Overall Study|Lost to Follow-up|2|||
48377856|NCT03118674|155577570|FG000|Overall Study|Lost to Follow-up|2|||
48377857|NCT03118674|155577570|FG000|Overall Study|Screen Faliure|8|||
48377858|NCT03118674|155577570|FG000|Overall Study|Withdrawal by Subject|5|||
48377859|NCT03285178|155577571|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
48377860|NCT03285178|155577572|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48377861|NCT03285178|155577573|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48377862|NCT03285178|155577574|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48377863|NCT03285178|155577575|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48377864|NCT03285178|155577576|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48377865|NCT03285178|155577577|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
48377866|NCT03285178|155577571|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
48377867|NCT03285178|155577572|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48377868|NCT03285178|155577573|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48377869|NCT03285178|155577574|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48377870|NCT03285178|155577575|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48377871|NCT03285178|155577576|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48377872|NCT03285178|155577577|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
48377873|NCT03285178|155577571|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
48377874|NCT03285178|155577572|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
48377875|NCT03285178|155577573|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
48377876|NCT03285178|155577574|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
48377877|NCT03285178|155577575|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
48377878|NCT03285178|155577576|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
48377879|NCT03285178|155577577|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
48377880|NCT03285178|155577571|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
48377881|NCT03285178|155577572|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48377882|NCT03285178|155577573|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48377883|NCT03285178|155577574|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48377884|NCT03285178|155577575|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48377885|NCT03285178|155577576|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48377886|NCT03285178|155577577|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
48377887|NCT03285178|155577571|FG000|Single-Blind Run-In Period|Physician Decision|2|||
48377888|NCT03285178|155577572|FG001|Single-Blind Run-In Period|Physician Decision|0|||
48377889|NCT03285178|155577573|FG002|Single-Blind Run-In Period|Physician Decision|0|||
48377890|NCT03285178|155577574|FG003|Single-Blind Run-In Period|Physician Decision|0|||
48377891|NCT03285178|155577575|FG004|Single-Blind Run-In Period|Physician Decision|0|||
48377892|NCT03285178|155577576|FG005|Single-Blind Run-In Period|Physician Decision|0|||
48377893|NCT03285178|155577577|FG006|Single-Blind Run-In Period|Physician Decision|0|||
48377894|NCT03285178|155577571|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48377895|NCT03285178|155577572|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
48377896|NCT03285178|155577573|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
48377897|NCT03285178|155577574|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48377898|NCT03285178|155577575|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48377899|NCT03285178|155577576|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48377900|NCT03285178|155577577|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
48377901|NCT03285178|155577571|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48377902|NCT03285178|155577572|FG001|Double-Blind Treatment Period|Adverse Event|0|||
48377903|NCT03285178|155577573|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48377904|NCT03285178|155577574|FG003|Double-Blind Treatment Period|Adverse Event|0|||
48377905|NCT03285178|155577575|FG004|Double-Blind Treatment Period|Adverse Event|0|||
48377906|NCT03285178|155577576|FG005|Double-Blind Treatment Period|Adverse Event|0|||
48377907|NCT03285178|155577577|FG006|Double-Blind Treatment Period|Adverse Event|2|||
48377908|NCT03285178|155577571|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48377909|NCT03285178|155577572|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48377910|NCT03285178|155577573|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
48377911|NCT03285178|155577574|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
48377912|NCT03285178|155577575|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
48377913|NCT03285178|155577576|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
48377914|NCT03285178|155577577|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
48377915|NCT03285178|155577571|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48377916|NCT03285178|155577572|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48377917|NCT03285178|155577573|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48377918|NCT03285178|155577574|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48377919|NCT03285178|155577575|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48377920|NCT03285178|155577576|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
48377921|NCT03285178|155577577|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48377922|NCT03285178|155577571|FG000|Double-Blind Treatment Period|COVID-19|0|||
48377923|NCT03285178|155577572|FG001|Double-Blind Treatment Period|COVID-19|0|||
48377924|NCT03285178|155577573|FG002|Double-Blind Treatment Period|COVID-19|1|||
48377925|NCT03285178|155577574|FG003|Double-Blind Treatment Period|COVID-19|0|||
48377926|NCT03285178|155577575|FG004|Double-Blind Treatment Period|COVID-19|0|||
48377927|NCT03285178|155577576|FG005|Double-Blind Treatment Period|COVID-19|0|||
48377928|NCT03285178|155577577|FG006|Double-Blind Treatment Period|COVID-19|0|||
48377929|NCT02260882|155577581|FG000|Overall Study|Protocol Violation|0|||
48377930|NCT02260882|155577582|FG001|Overall Study|Protocol Violation|1|||
48377931|NCT02683941|155577583|FG000|Double-blind Phase|Adverse Event|0|||
48377932|NCT02683941|155577584|FG001|Double-blind Phase|Adverse Event|1|||
48377933|NCT02683941|155577583|FG000|Double-blind Phase|Withdrawal by Subject|4|||
48377934|NCT02683941|155577584|FG001|Double-blind Phase|Withdrawal by Subject|2|||
48377935|NCT02683941|155577583|FG000|Double-blind Phase|Lost to Follow-up|1|||
48377936|NCT02683941|155577584|FG001|Double-blind Phase|Lost to Follow-up|0|||
48377937|NCT02683941|155577583|FG000|Double-blind Phase|Disease Progression|5|||
48377938|NCT02683941|155577584|FG001|Double-blind Phase|Disease Progression|2|||
48377939|NCT02683941|155577583|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
48377940|NCT02683941|155577584|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
48377941|NCT02683941|155577583|FG000|Open-label Treatment Phase|Disease Progression|1|||
48377942|NCT02683941|155577584|FG001|Open-label Treatment Phase|Disease Progression|2|||
48377943|NCT02683941|155577583|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
48377944|NCT02683941|155577584|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
48377945|NCT02683941|155577583|FG000|Open-label Treatment Phase|Other|1|||
48377946|NCT02683941|155577584|FG001|Open-label Treatment Phase|Other|0|||
48377947|NCT02683941|155577583|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
48377948|NCT02683941|155577584|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
48377949|NCT02683941|155577583|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
48377950|NCT02683941|155577584|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
48377951|NCT02683941|155577583|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
48377952|NCT02683941|155577584|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
48377953|NCT02683941|155577583|FG000|Open-label Follow-up Phase|Other|8|||
48377954|NCT02683941|155577584|FG001|Open-label Follow-up Phase|Other|1|||
48377955|NCT02745392|155577585|FG000|Overall Study|Lost to Follow-up|0|||
48377956|NCT02745392|155577586|FG001|Overall Study|Lost to Follow-up|1|||
48377957|NCT02745392|155577587|FG002|Overall Study|Lost to Follow-up|0|||
48377958|NCT02745392|155577588|FG003|Overall Study|Lost to Follow-up|0|||
48377959|NCT02547233|155577589|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
48377960|NCT02547233|155577590|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
48377961|NCT02547233|155577589|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
48377962|NCT02547233|155577590|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
48377963|NCT02547233|155577589|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
48377964|NCT02547233|155577590|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
48377965|NCT02547233|155577589|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
48377966|NCT02547233|155577590|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
48377967|NCT02547233|155577589|FG000|12-month Follow-up|Withdrawal by Subject|10|||
48377968|NCT02547233|155577590|FG001|12-month Follow-up|Withdrawal by Subject|10|||
48692642|NCT03001557|156724546|FG005|Extension Phase|Lost to Follow-up|0|||
48377969|NCT02547233|155577589|FG000|12-month Follow-up|Lost to Follow-up|3|||
48377970|NCT02547233|155577590|FG001|12-month Follow-up|Lost to Follow-up|3|||
48377971|NCT02547233|155577589|FG000|12-month Follow-up|Lack of Efficacy|1|||
48377972|NCT02547233|155577590|FG001|12-month Follow-up|Lack of Efficacy|2|||
48377973|NCT02547233|155577589|FG000|12-month Follow-up|Protocol Violation|0|||
48377974|NCT02547233|155577590|FG001|12-month Follow-up|Protocol Violation|1|||
48377975|NCT02547233|155577589|FG000|12-month Follow-up|Other|0|||
48377976|NCT02547233|155577590|FG001|12-month Follow-up|Other|1|||
48377977|NCT03575143|155579046|FG000|Overall Study|Lost to Follow-up|0|||
48377978|NCT03575143|155579047|FG001|Overall Study|Lost to Follow-up|0|||
48377979|NCT03575143|155579048|FG002|Overall Study|Lost to Follow-up|4|||
48377980|NCT03575143|155579046|FG000|Overall Study|Withdrawal by Subject|0|||
48377981|NCT03575143|155579047|FG001|Overall Study|Withdrawal by Subject|0|||
48377982|NCT03575143|155579048|FG002|Overall Study|Withdrawal by Subject|5|||
48377983|NCT03575143|155579046|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
48377984|NCT03575143|155579047|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
48377985|NCT03575143|155579048|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
48377986|NCT00141726|155579051|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
48377987|NCT00892723|155579056|FG000|Overall Study|Lost to Follow-up|1|||
48377988|NCT00892723|155579057|FG001|Overall Study|Lost to Follow-up|3|||
48377989|NCT00892723|155579058|FG002|Overall Study|Lost to Follow-up|1|||
48377990|NCT00892723|155579056|FG000|Overall Study|Withdrawal by Subject|1|||
48377991|NCT00892723|155579057|FG001|Overall Study|Withdrawal by Subject|1|||
48377992|NCT00892723|155579058|FG002|Overall Study|Withdrawal by Subject|1|||
48377993|NCT00150969|155579061|FG000|24 Month Main Study|Adverse Event|3|||
48377994|NCT00150969|155579062|FG001|24 Month Main Study|Adverse Event|4|||
48377995|NCT00150969|155579061|FG000|24 Month Main Study|Death|1|||
48377996|NCT00150969|155579062|FG001|24 Month Main Study|Death|1|||
48377997|NCT00150969|155579061|FG000|24 Month Main Study|Lack of Efficacy|1|||
48377998|NCT00150969|155579062|FG001|24 Month Main Study|Lack of Efficacy|8|||
48377999|NCT00150969|155579061|FG000|24 Month Main Study|Lost to Follow-up|3|||
48378000|NCT00150969|155579062|FG001|24 Month Main Study|Lost to Follow-up|2|||
48378001|NCT00150969|155579061|FG000|24 Month Main Study|Protocol Violation|4|||
48378002|NCT00150969|155579062|FG001|24 Month Main Study|Protocol Violation|2|||
48378003|NCT00150969|155579061|FG000|24 Month Main Study|Withdrawal by Subject|7|||
48378004|NCT00150969|155579062|FG001|24 Month Main Study|Withdrawal by Subject|4|||
48378005|NCT00150969|155579061|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
48378006|NCT00150969|155579062|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
48378007|NCT00150969|155579061|FG000|24-48 Month Extension|Lack of Efficacy|0|||
48378008|NCT00150969|155579062|FG001|24-48 Month Extension|Lack of Efficacy|1|||
48378009|NCT00150969|155579061|FG000|24-48 Month Extension|Adverse Event|1|||
48378010|NCT00150969|155579062|FG001|24-48 Month Extension|Adverse Event|3|||
48378011|NCT00150969|155579061|FG000|24-48 Month Extension|Other Reason|81|||
48378012|NCT00150969|155579062|FG001|24-48 Month Extension|Other Reason|91|||
48378013|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
48378014|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
48378015|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
48378016|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
48378017|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
48378018|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
48378019|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
48378020|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
48378021|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
48378022|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
48378023|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
48378024|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
48378025|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
48378026|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
48378027|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
48378028|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
48378029|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
48378030|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
48378031|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
48378032|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
48378033|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
48378034|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
48378035|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
48378036|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
48378037|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
48378038|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
48378039|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
48378040|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
48378041|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
48378042|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
48378043|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Other|10|||
48378044|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Other|7|||
48378045|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Other|8|||
48378046|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Other|8|||
48378047|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Other|0|||
48378048|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
48378049|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
48378050|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
48378051|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
48378052|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
48378053|NCT00615836|155579066|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
48378054|NCT00615836|155579067|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
48378055|NCT00615836|155579068|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
48378056|NCT00615836|155579069|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
48378057|NCT00615836|155579070|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
48378058|NCT01272804|155579071|FG000|Overall Study|Adverse Event|1|||
48378059|NCT01272804|155579072|FG001|Overall Study|Adverse Event|0|||
48378060|NCT01272804|155579073|FG002|Overall Study|Adverse Event|0|||
48378061|NCT01272804|155579074|FG003|Overall Study|Adverse Event|0|||
48378062|NCT01272804|155579075|FG004|Overall Study|Adverse Event|2|||
48378063|NCT01272804|155579076|FG005|Overall Study|Adverse Event|1|||
48378064|NCT00406653|155579077|FG000|Induction Period|Adverse Event|1|||
48378065|NCT00406653|155579078|FG001|Induction Period|Adverse Event|10|||
48378066|NCT00406653|155579079|FG002|Induction Period|Adverse Event|4|||
48378067|NCT00406653|155579080|FG003|Induction Period|Adverse Event|11|||
48378068|NCT00406653|155579081|FG004|Induction Period|Adverse Event|0|||
48378069|NCT00406653|155579082|FG005|Induction Period|Adverse Event|0|||
48378070|NCT00406653|155579083|FG006|Induction Period|Adverse Event|0|||
48378071|NCT00406653|155579077|FG000|Induction Period|Lack of Efficacy|11|||
48378072|NCT00406653|155579078|FG001|Induction Period|Lack of Efficacy|14|||
48378073|NCT00406653|155579079|FG002|Induction Period|Lack of Efficacy|8|||
48378074|NCT00406653|155579080|FG003|Induction Period|Lack of Efficacy|10|||
48378075|NCT00406653|155579081|FG004|Induction Period|Lack of Efficacy|0|||
48378076|NCT00406653|155579082|FG005|Induction Period|Lack of Efficacy|0|||
48378077|NCT00406653|155579083|FG006|Induction Period|Lack of Efficacy|0|||
48378078|NCT00406653|155579077|FG000|Induction Period|Lost to Follow-up|0|||
48378079|NCT00406653|155579078|FG001|Induction Period|Lost to Follow-up|2|||
48378080|NCT00406653|155579079|FG002|Induction Period|Lost to Follow-up|0|||
48378081|NCT00406653|155579080|FG003|Induction Period|Lost to Follow-up|0|||
48378082|NCT00406653|155579081|FG004|Induction Period|Lost to Follow-up|0|||
48378083|NCT00406653|155579082|FG005|Induction Period|Lost to Follow-up|0|||
48378084|NCT00406653|155579083|FG006|Induction Period|Lost to Follow-up|0|||
48378085|NCT00406653|155579077|FG000|Induction Period|Withdrawal of Consent|2|||
48378086|NCT00406653|155579078|FG001|Induction Period|Withdrawal of Consent|5|||
48378087|NCT00406653|155579079|FG002|Induction Period|Withdrawal of Consent|1|||
48378088|NCT00406653|155579080|FG003|Induction Period|Withdrawal of Consent|2|||
48378089|NCT00406653|155579081|FG004|Induction Period|Withdrawal of Consent|0|||
48378090|NCT00406653|155579082|FG005|Induction Period|Withdrawal of Consent|0|||
48378091|NCT00406653|155579083|FG006|Induction Period|Withdrawal of Consent|0|||
48378092|NCT00406653|155579077|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
48378093|NCT00406653|155579078|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
48378094|NCT00406653|155579079|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
48378095|NCT00406653|155579080|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
48378096|NCT00406653|155579081|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
48378097|NCT00406653|155579082|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
48378098|NCT00406653|155579083|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
48378099|NCT00406653|155579077|FG000|Induction Period|Pregnancy|1|||
48378100|NCT00406653|155579078|FG001|Induction Period|Pregnancy|0|||
48378101|NCT00406653|155579079|FG002|Induction Period|Pregnancy|0|||
48378102|NCT00406653|155579080|FG003|Induction Period|Pregnancy|0|||
48378103|NCT00406653|155579081|FG004|Induction Period|Pregnancy|0|||
48378104|NCT00406653|155579082|FG005|Induction Period|Pregnancy|0|||
48378105|NCT00406653|155579083|FG006|Induction Period|Pregnancy|0|||
48378106|NCT00406653|155579077|FG000|Induction Period|Declined participation but followup done|0|||
48378107|NCT00406653|155579078|FG001|Induction Period|Declined participation but followup done|2|||
48378108|NCT00406653|155579079|FG002|Induction Period|Declined participation but followup done|1|||
48378109|NCT00406653|155579080|FG003|Induction Period|Declined participation but followup done|1|||
48378110|NCT00406653|155579081|FG004|Induction Period|Declined participation but followup done|0|||
48378111|NCT00406653|155579082|FG005|Induction Period|Declined participation but followup done|0|||
48378112|NCT00406653|155579083|FG006|Induction Period|Declined participation but followup done|0|||
48378113|NCT00406653|155579077|FG000|Induction Period|Given prohibited drug|0|||
48378114|NCT00406653|155579078|FG001|Induction Period|Given prohibited drug|1|||
48378115|NCT00406653|155579079|FG002|Induction Period|Given prohibited drug|2|||
48378116|NCT00406653|155579080|FG003|Induction Period|Given prohibited drug|0|||
48378117|NCT00406653|155579081|FG004|Induction Period|Given prohibited drug|0|||
48378118|NCT00406653|155579082|FG005|Induction Period|Given prohibited drug|0|||
48378119|NCT00406653|155579083|FG006|Induction Period|Given prohibited drug|0|||
48378120|NCT00406653|155579077|FG000|Induction Period|Incarcerated|0|||
48378121|NCT00406653|155579078|FG001|Induction Period|Incarcerated|0|||
48378122|NCT00406653|155579079|FG002|Induction Period|Incarcerated|1|||
48378123|NCT00406653|155579080|FG003|Induction Period|Incarcerated|0|||
48378124|NCT00406653|155579081|FG004|Induction Period|Incarcerated|0|||
48378125|NCT00406653|155579082|FG005|Induction Period|Incarcerated|0|||
48378126|NCT00406653|155579083|FG006|Induction Period|Incarcerated|0|||
48378127|NCT00406653|155579077|FG000|Induction Period|Patient relocated|0|||
48378128|NCT00406653|155579078|FG001|Induction Period|Patient relocated|0|||
48378129|NCT00406653|155579079|FG002|Induction Period|Patient relocated|1|||
48378130|NCT00406653|155579080|FG003|Induction Period|Patient relocated|0|||
48378131|NCT00406653|155579081|FG004|Induction Period|Patient relocated|0|||
48378132|NCT00406653|155579082|FG005|Induction Period|Patient relocated|0|||
48378133|NCT00406653|155579083|FG006|Induction Period|Patient relocated|0|||
48378134|NCT00406653|155579077|FG000|Maintenance Period|Adverse Event|0|||
48378135|NCT00406653|155579078|FG001|Maintenance Period|Adverse Event|0|||
48378136|NCT00406653|155579079|FG002|Maintenance Period|Adverse Event|0|||
48378137|NCT00406653|155579080|FG003|Maintenance Period|Adverse Event|0|||
48378138|NCT00406653|155579081|FG004|Maintenance Period|Adverse Event|1|||
48378139|NCT00406653|155579082|FG005|Maintenance Period|Adverse Event|1|||
48378140|NCT00406653|155579083|FG006|Maintenance Period|Adverse Event|0|||
48378141|NCT00406653|155579077|FG000|Maintenance Period|Lack of Efficacy|0|||
48378142|NCT00406653|155579078|FG001|Maintenance Period|Lack of Efficacy|0|||
48378143|NCT00406653|155579079|FG002|Maintenance Period|Lack of Efficacy|0|||
48378144|NCT00406653|155579080|FG003|Maintenance Period|Lack of Efficacy|0|||
48378145|NCT00406653|155579081|FG004|Maintenance Period|Lack of Efficacy|20|||
48378146|NCT00406653|155579082|FG005|Maintenance Period|Lack of Efficacy|26|||
48378147|NCT00406653|155579083|FG006|Maintenance Period|Lack of Efficacy|0|||
48378148|NCT00406653|155579077|FG000|Maintenance Period|Lost to Follow-up|0|||
48378149|NCT00406653|155579078|FG001|Maintenance Period|Lost to Follow-up|0|||
48378150|NCT00406653|155579079|FG002|Maintenance Period|Lost to Follow-up|0|||
48378151|NCT00406653|155579080|FG003|Maintenance Period|Lost to Follow-up|0|||
48378152|NCT00406653|155579081|FG004|Maintenance Period|Lost to Follow-up|2|||
48378153|NCT00406653|155579082|FG005|Maintenance Period|Lost to Follow-up|1|||
48378154|NCT00406653|155579083|FG006|Maintenance Period|Lost to Follow-up|0|||
48378155|NCT00406653|155579077|FG000|Maintenance Period|Withdrawal of Consent|0|||
48378156|NCT00406653|155579078|FG001|Maintenance Period|Withdrawal of Consent|0|||
48378157|NCT00406653|155579079|FG002|Maintenance Period|Withdrawal of Consent|0|||
48378158|NCT00406653|155579080|FG003|Maintenance Period|Withdrawal of Consent|0|||
48378159|NCT00406653|155579081|FG004|Maintenance Period|Withdrawal of Consent|2|||
48378160|NCT00406653|155579082|FG005|Maintenance Period|Withdrawal of Consent|0|||
48378161|NCT00406653|155579083|FG006|Maintenance Period|Withdrawal of Consent|0|||
48378162|NCT00406653|155579077|FG000|Maintenance Period|Pregnancy|0|||
48378163|NCT00406653|155579078|FG001|Maintenance Period|Pregnancy|0|||
48378164|NCT00406653|155579079|FG002|Maintenance Period|Pregnancy|0|||
48378165|NCT00406653|155579080|FG003|Maintenance Period|Pregnancy|0|||
48378166|NCT00406653|155579081|FG004|Maintenance Period|Pregnancy|0|||
48378167|NCT00406653|155579082|FG005|Maintenance Period|Pregnancy|1|||
48378168|NCT00406653|155579083|FG006|Maintenance Period|Pregnancy|0|||
48378169|NCT00406653|155579077|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
48378170|NCT00406653|155579078|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
48378171|NCT00406653|155579079|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
48378172|NCT00406653|155579080|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
48378173|NCT00406653|155579081|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
48378174|NCT00406653|155579082|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
48378175|NCT00406653|155579083|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
48378176|NCT00406653|155579077|FG000|Maintenance Period|Error in disease score evaluation|0|||
48378177|NCT00406653|155579078|FG001|Maintenance Period|Error in disease score evaluation|0|||
48378178|NCT00406653|155579079|FG002|Maintenance Period|Error in disease score evaluation|0|||
48378179|NCT00406653|155579080|FG003|Maintenance Period|Error in disease score evaluation|0|||
48378180|NCT00406653|155579081|FG004|Maintenance Period|Error in disease score evaluation|1|||
48378181|NCT00406653|155579082|FG005|Maintenance Period|Error in disease score evaluation|0|||
48378182|NCT00406653|155579083|FG006|Maintenance Period|Error in disease score evaluation|0|||
48378183|NCT00406653|155579077|FG000|Open-Label Period|Death|0|||
48378184|NCT00406653|155579078|FG001|Open-Label Period|Death|0|||
48378185|NCT00406653|155579079|FG002|Open-Label Period|Death|0|||
48378186|NCT00406653|155579080|FG003|Open-Label Period|Death|0|||
48378187|NCT00406653|155579081|FG004|Open-Label Period|Death|0|||
48378188|NCT00406653|155579082|FG005|Open-Label Period|Death|0|||
48378189|NCT00406653|155579083|FG006|Open-Label Period|Death|1|||
48378190|NCT00406653|155579077|FG000|Open-Label Period|Adverse Event|0|||
48378191|NCT00406653|155579078|FG001|Open-Label Period|Adverse Event|0|||
48378192|NCT00406653|155579079|FG002|Open-Label Period|Adverse Event|0|||
48378193|NCT00406653|155579080|FG003|Open-Label Period|Adverse Event|0|||
48378194|NCT00406653|155579081|FG004|Open-Label Period|Adverse Event|0|||
48378195|NCT00406653|155579082|FG005|Open-Label Period|Adverse Event|0|||
48378196|NCT00406653|155579083|FG006|Open-Label Period|Adverse Event|18|||
48378197|NCT00406653|155579077|FG000|Open-Label Period|Lack of Efficacy|0|||
48378198|NCT00406653|155579078|FG001|Open-Label Period|Lack of Efficacy|0|||
48378199|NCT00406653|155579079|FG002|Open-Label Period|Lack of Efficacy|0|||
48378200|NCT00406653|155579080|FG003|Open-Label Period|Lack of Efficacy|0|||
48378201|NCT00406653|155579081|FG004|Open-Label Period|Lack of Efficacy|0|||
48378202|NCT00406653|155579082|FG005|Open-Label Period|Lack of Efficacy|0|||
48378203|NCT00406653|155579083|FG006|Open-Label Period|Lack of Efficacy|160|||
48378204|NCT00406653|155579077|FG000|Open-Label Period|Lost to Follow-up|0|||
48378205|NCT00406653|155579078|FG001|Open-Label Period|Lost to Follow-up|0|||
48378206|NCT00406653|155579079|FG002|Open-Label Period|Lost to Follow-up|0|||
48378207|NCT00406653|155579080|FG003|Open-Label Period|Lost to Follow-up|0|||
48378208|NCT00406653|155579081|FG004|Open-Label Period|Lost to Follow-up|0|||
48378209|NCT00406653|155579082|FG005|Open-Label Period|Lost to Follow-up|0|||
48378210|NCT00406653|155579083|FG006|Open-Label Period|Lost to Follow-up|6|||
48378211|NCT00406653|155579077|FG000|Open-Label Period|Withdrawal of Consent|0|||
48378212|NCT00406653|155579078|FG001|Open-Label Period|Withdrawal of Consent|0|||
48378213|NCT00406653|155579079|FG002|Open-Label Period|Withdrawal of Consent|0|||
48378214|NCT00406653|155579080|FG003|Open-Label Period|Withdrawal of Consent|0|||
48378215|NCT00406653|155579081|FG004|Open-Label Period|Withdrawal of Consent|0|||
48378216|NCT00406653|155579082|FG005|Open-Label Period|Withdrawal of Consent|0|||
48378217|NCT00406653|155579083|FG006|Open-Label Period|Withdrawal of Consent|11|||
48378218|NCT00406653|155579077|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48378219|NCT00406653|155579078|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48378220|NCT00406653|155579079|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48378221|NCT00406653|155579080|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48378222|NCT00406653|155579081|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48378223|NCT00406653|155579082|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
48378224|NCT00406653|155579083|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
48378225|NCT00406653|155579077|FG000|Open-Label Period|Pregnancy|0|||
48378226|NCT00406653|155579078|FG001|Open-Label Period|Pregnancy|0|||
48378227|NCT00406653|155579079|FG002|Open-Label Period|Pregnancy|0|||
48378228|NCT00406653|155579080|FG003|Open-Label Period|Pregnancy|0|||
48378229|NCT00406653|155579081|FG004|Open-Label Period|Pregnancy|0|||
48378230|NCT00406653|155579082|FG005|Open-Label Period|Pregnancy|0|||
48378231|NCT00406653|155579083|FG006|Open-Label Period|Pregnancy|2|||
48378232|NCT00406653|155579077|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
48378233|NCT00406653|155579078|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
48378234|NCT00406653|155579079|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
48378235|NCT00406653|155579080|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
48378236|NCT00406653|155579081|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
48378237|NCT00406653|155579082|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
48378238|NCT00406653|155579083|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
48378239|NCT00406653|155579077|FG000|Open-Label Period|Declined participation but followup done|0|||
48378240|NCT00406653|155579078|FG001|Open-Label Period|Declined participation but followup done|0|||
48378241|NCT00406653|155579079|FG002|Open-Label Period|Declined participation but followup done|0|||
48378242|NCT00406653|155579080|FG003|Open-Label Period|Declined participation but followup done|0|||
48378243|NCT00406653|155579081|FG004|Open-Label Period|Declined participation but followup done|0|||
48378244|NCT00406653|155579082|FG005|Open-Label Period|Declined participation but followup done|0|||
48378245|NCT00406653|155579083|FG006|Open-Label Period|Declined participation but followup done|8|||
48378246|NCT00406653|155579077|FG000|Open-Label Period|Discontinued by Sponsor|0|||
48378247|NCT00406653|155579078|FG001|Open-Label Period|Discontinued by Sponsor|0|||
48378248|NCT00406653|155579079|FG002|Open-Label Period|Discontinued by Sponsor|0|||
48378249|NCT00406653|155579080|FG003|Open-Label Period|Discontinued by Sponsor|0|||
48378250|NCT00406653|155579081|FG004|Open-Label Period|Discontinued by Sponsor|0|||
48378251|NCT00406653|155579082|FG005|Open-Label Period|Discontinued by Sponsor|0|||
48378252|NCT00406653|155579083|FG006|Open-Label Period|Discontinued by Sponsor|1|||
48378253|NCT00406653|155579077|FG000|Open-Label Period|Refused followup|0|||
48378254|NCT00406653|155579078|FG001|Open-Label Period|Refused followup|0|||
48378255|NCT00406653|155579079|FG002|Open-Label Period|Refused followup|0|||
48378256|NCT00406653|155579080|FG003|Open-Label Period|Refused followup|0|||
48378257|NCT00406653|155579081|FG004|Open-Label Period|Refused followup|0|||
48378258|NCT00406653|155579082|FG005|Open-Label Period|Refused followup|0|||
48378259|NCT00406653|155579083|FG006|Open-Label Period|Refused followup|1|||
48378260|NCT02196714|155579092|FG000|Overall Study|Protocol Violation|0|||
48378261|NCT02196714|155579093|FG001|Overall Study|Protocol Violation|0|||
48378262|NCT02196714|155579094|FG002|Overall Study|Protocol Violation|1|||
48378263|NCT02196714|155579095|FG003|Overall Study|Protocol Violation|0|||
48378264|NCT01592864|155579096|FG000|Overall Study|Withdrawal by Subject|0|||
48378265|NCT01592864|155579097|FG001|Overall Study|Withdrawal by Subject|1|||
48378266|NCT00705523|155579098|FG000|Overall Study|Lost to Follow-up|2|||
48378267|NCT00705523|155579099|FG001|Overall Study|Lost to Follow-up|3|||
48378268|NCT04217590|155579104|FG000|Overall Study|Other|1|||
48378269|NCT04217590|155579105|FG001|Overall Study|Other|1|||
48378270|NCT04217590|155579104|FG000|Overall Study|Withdrawal by Subject|3|||
48378271|NCT04217590|155579105|FG001|Overall Study|Withdrawal by Subject|1|||
48378272|NCT04217590|155579104|FG000|Overall Study|Death|0|||
48378273|NCT04217590|155579105|FG001|Overall Study|Death|1|||
48378274|NCT01020448|155579108|FG000|Pre-assignment|Adverse Event|6|||
48378275|NCT01020448|155579108|FG000|Pre-assignment|Withdrawal by Subject|5|||
48378276|NCT01020448|155579108|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
48378277|NCT01020448|155579108|FG000|Treatment|Adverse Event|11|||
48378278|NCT01020448|155579108|FG000|Treatment|Consent Withdrawn|3|||
48378279|NCT01020448|155579108|FG000|Treatment|Disease Progression|2|||
48378280|NCT01020448|155579108|FG000|Treatment|Lack of Efficacy|8|||
48378281|NCT01020448|155579108|FG000|Treatment|Lost to Follow-up|2|||
48378282|NCT03294109|155579109|FG000|Overall Study|Withdrawal by Subject|6|||
48378283|NCT03294109|155579110|FG001|Overall Study|Withdrawal by Subject|5|||
48378284|NCT01881750|155579111|FG000|Overall Study|Changes in concomitant therapies|2|||
48378285|NCT01881750|155579112|FG001|Overall Study|Changes in concomitant therapies|3|||
48378286|NCT01881750|155579111|FG000|Overall Study|Lost to Follow-up|0|||
48378287|NCT01881750|155579112|FG001|Overall Study|Lost to Follow-up|1|||
48378288|NCT01505010|155579115|FG000|Overall Study|Protocol Violation|0|||
48378289|NCT01505010|155579116|FG001|Overall Study|Protocol Violation|1|||
48378290|NCT01505010|155579115|FG000|Overall Study|Lost to Follow-up|0|||
48378291|NCT01505010|155579116|FG001|Overall Study|Lost to Follow-up|1|||
48378292|NCT01106404|155579120|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
48378293|NCT01106404|155579121|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
48378294|NCT01106404|155579120|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
48378295|NCT01106404|155579121|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
48378296|NCT01106404|155579120|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
48378297|NCT01106404|155579121|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
48378298|NCT01106404|155579120|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
48378299|NCT01106404|155579121|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
48378300|NCT00388154|155579124|FG000|Overall Study|Withdrawal by Subject|1|||
48378301|NCT02240693|155579125|FG000|Overall Study|Adverse Event|0|||
48378302|NCT02240693|155579126|FG001|Overall Study|Adverse Event|0|||
48378303|NCT02240693|155579127|FG002|Overall Study|Adverse Event|0|||
48378304|NCT02240693|155579128|FG003|Overall Study|Adverse Event|0|||
48378305|NCT02240693|155579129|FG004|Overall Study|Adverse Event|1|||
48378306|NCT02240693|155579125|FG000|Overall Study|Withdrawal by Subject|0|||
48378307|NCT02240693|155579126|FG001|Overall Study|Withdrawal by Subject|0|||
48378308|NCT02240693|155579127|FG002|Overall Study|Withdrawal by Subject|2|||
48378309|NCT02240693|155579128|FG003|Overall Study|Withdrawal by Subject|1|||
48378310|NCT02240693|155579129|FG004|Overall Study|Withdrawal by Subject|0|||
48378311|NCT02240693|155579125|FG000|Overall Study|Other than specified|0|||
48378312|NCT02240693|155579126|FG001|Overall Study|Other than specified|0|||
48378313|NCT02240693|155579127|FG002|Overall Study|Other than specified|2|||
48378314|NCT02240693|155579128|FG003|Overall Study|Other than specified|0|||
48378315|NCT02240693|155579129|FG004|Overall Study|Other than specified|0|||
48378316|NCT02092220|155579132|FG000|Period 1|Unrelated Illness|0|||
48378317|NCT02092220|155579133|FG001|Period 1|Unrelated Illness|2|||
48378318|NCT02092220|155579132|FG000|Period 2|Severe Hypoglycaemia|1|||
48378319|NCT02092220|155579133|FG001|Period 2|Severe Hypoglycaemia|0|||
48378320|NCT02092220|155579132|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
48378321|NCT02092220|155579133|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
48378322|NCT03240874|155579134|FG000|Overall Study|Lost to Follow-up|0|||
48378323|NCT03240874|155579135|FG001|Overall Study|Lost to Follow-up|2|||
48378324|NCT03240874|155579136|FG002|Overall Study|Lost to Follow-up|4|||
48378325|NCT03240874|155579137|FG003|Overall Study|Lost to Follow-up|1|||
48378326|NCT02973048|155579138|FG000|Overall Study|Epidural catheter insertion failure|1|||
48378327|NCT02973048|155579139|FG001|Overall Study|Epidural catheter insertion failure|0|||
48378328|NCT02973048|155579138|FG000|Overall Study|Withdrawal by Subject|0|||
48378329|NCT02973048|155579139|FG001|Overall Study|Withdrawal by Subject|3|||
48378330|NCT00332189|155579140|FG000|Overall Study|Adverse Event|3|||
48378331|NCT00332189|155579140|FG000|Overall Study|Uncooperative/Noncompliant|3|||
48378332|NCT00332189|155579140|FG000|Overall Study|Withdrawal by Subject|9|||
48378333|NCT00332189|155579140|FG000|Overall Study|Lack of Efficacy|4|||
48378334|NCT00332189|155579140|FG000|Overall Study|Moved out of country|2|||
48378335|NCT02370043|155579141|FG000|Overall Study|Withdrawal by Subject|0|||
48378336|NCT02370043|155579142|FG001|Overall Study|Withdrawal by Subject|0|||
48378337|NCT02370043|155579143|FG002|Overall Study|Withdrawal by Subject|0|||
48378338|NCT02370043|155579144|FG003|Overall Study|Withdrawal by Subject|0|||
48426316|NCT02203838|155749551|FG001|Overall Study|Lack of Efficacy|0|||
48378339|NCT02370043|155579145|FG004|Overall Study|Withdrawal by Subject|1|||
48378340|NCT02370043|155579146|FG005|Overall Study|Withdrawal by Subject|1|||
48378341|NCT01313650|155579148|FG000|Overall Study|Adverse Event|9|||
48378342|NCT01313650|155579149|FG001|Overall Study|Adverse Event|34|||
48378343|NCT01313650|155579150|FG002|Overall Study|Adverse Event|24|||
48378344|NCT01313650|155579151|FG003|Overall Study|Adverse Event|23|||
48378345|NCT01313650|155579148|FG000|Overall Study|Lack of Efficacy|37|||
48378346|NCT01313650|155579149|FG001|Overall Study|Lack of Efficacy|20|||
48378347|NCT01313650|155579150|FG002|Overall Study|Lack of Efficacy|32|||
48378348|NCT01313650|155579151|FG003|Overall Study|Lack of Efficacy|20|||
48378349|NCT01313650|155579148|FG000|Overall Study|Lost to Follow-up|1|||
48378350|NCT01313650|155579149|FG001|Overall Study|Lost to Follow-up|0|||
48378351|NCT01313650|155579150|FG002|Overall Study|Lost to Follow-up|3|||
48378352|NCT01313650|155579151|FG003|Overall Study|Lost to Follow-up|2|||
48378353|NCT01313650|155579148|FG000|Overall Study|Withdrawal by Subject|16|||
48378354|NCT01313650|155579149|FG001|Overall Study|Withdrawal by Subject|20|||
48378355|NCT01313650|155579150|FG002|Overall Study|Withdrawal by Subject|15|||
48378356|NCT01313650|155579151|FG003|Overall Study|Withdrawal by Subject|15|||
48378357|NCT01313650|155579148|FG000|Overall Study|Protocol Violation|4|||
48378358|NCT01313650|155579149|FG001|Overall Study|Protocol Violation|7|||
48378359|NCT01313650|155579150|FG002|Overall Study|Protocol Violation|5|||
48378360|NCT01313650|155579151|FG003|Overall Study|Protocol Violation|6|||
48378361|NCT01313650|155579148|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
48378362|NCT01313650|155579149|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
48378363|NCT01313650|155579150|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
48378364|NCT01313650|155579151|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
48378365|NCT00026208|155579152|FG000|Overall Study|Complications of auto accident|1|||
48378366|NCT00026208|155579153|FG001|Overall Study|Complications of auto accident|0|||
48378367|NCT03346057|155579154|FG000|Overall Study|Death|1|||
48378368|NCT03346057|155579155|FG001|Overall Study|Death|2|||
48378369|NCT03346057|155579156|FG002|Overall Study|Death|0|||
48378370|NCT03346057|155579157|FG003|Overall Study|Death|0|||
48378371|NCT03346057|155579154|FG000|Overall Study|Lost to Follow-up|0|||
48378372|NCT03346057|155579155|FG001|Overall Study|Lost to Follow-up|2|||
48378373|NCT03346057|155579156|FG002|Overall Study|Lost to Follow-up|1|||
48378374|NCT03346057|155579157|FG003|Overall Study|Lost to Follow-up|0|||
48378375|NCT03346057|155579154|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
48378376|NCT03346057|155579155|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
48378377|NCT03346057|155579156|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
48378378|NCT03346057|155579157|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
48378379|NCT03346057|155579154|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
48378380|NCT03346057|155579155|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
48378381|NCT03346057|155579156|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
48378382|NCT03346057|155579157|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
48378383|NCT03346057|155579154|FG000|Overall Study|Physician Decision|3|||
48378384|NCT03346057|155579155|FG001|Overall Study|Physician Decision|2|||
48378385|NCT03346057|155579156|FG002|Overall Study|Physician Decision|0|||
48378386|NCT03346057|155579157|FG003|Overall Study|Physician Decision|2|||
48378387|NCT03346057|155579154|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
48378388|NCT03346057|155579155|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
48378389|NCT03346057|155579156|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
48378390|NCT03346057|155579157|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
48378391|NCT03346057|155579154|FG000|Overall Study|Withdrawal by Subject|1|||
48378392|NCT03346057|155579155|FG001|Overall Study|Withdrawal by Subject|0|||
48378393|NCT03346057|155579156|FG002|Overall Study|Withdrawal by Subject|0|||
48378394|NCT03346057|155579157|FG003|Overall Study|Withdrawal by Subject|0|||
48378395|NCT03739437|155579159|FG000|Overall Study|Lost to Follow-up|2|||
48378396|NCT03739437|155579160|FG001|Overall Study|Lost to Follow-up|5|||
48378397|NCT01117857|155579161|FG000|Overall Study|Lost to Follow-up|4|||
48378398|NCT01117857|155579161|FG000|Overall Study|Withdrawal by Subject|4|||
48378399|NCT01117857|155579161|FG000|Overall Study|Physician Decision|1|||
48378400|NCT00292461|155579162|FG000|Overall Study|Adverse Event|4|||
48378401|NCT00292461|155579163|FG001|Overall Study|Adverse Event|2|||
48378402|NCT00292461|155579162|FG000|Overall Study|Lack of Efficacy|1|||
48378403|NCT00292461|155579163|FG001|Overall Study|Lack of Efficacy|0|||
48378404|NCT00292461|155579162|FG000|Overall Study|Withdrawal by Subject|0|||
48378405|NCT00292461|155579163|FG001|Overall Study|Withdrawal by Subject|1|||
48378406|NCT00292461|155579162|FG000|Overall Study|Protocol Violation|4|||
48378407|NCT00292461|155579163|FG001|Overall Study|Protocol Violation|3|||
48378408|NCT00292461|155579162|FG000|Overall Study|Lost to Follow-up|1|||
48378409|NCT00292461|155579163|FG001|Overall Study|Lost to Follow-up|0|||
48378410|NCT01912456|155580739|FG000|Period 1|Physician Decision|0|||
48378411|NCT01912456|155580740|FG001|Period 1|Physician Decision|0|||
48378412|NCT01912456|155580741|FG002|Period 1|Physician Decision|1|||
48378413|NCT01912456|155580742|FG003|Period 1|Physician Decision|0|||
48378414|NCT01912456|155580739|FG000|Period 1|non-compliance|1|||
48378415|NCT01912456|155580740|FG001|Period 1|non-compliance|0|||
48378416|NCT01912456|155580741|FG002|Period 1|non-compliance|0|||
48378417|NCT01912456|155580742|FG003|Period 1|non-compliance|1|||
48378418|NCT01912456|155580739|FG000|Period 1|Adverse Event|1|||
48378419|NCT01912456|155580740|FG001|Period 1|Adverse Event|0|||
48378420|NCT01912456|155580741|FG002|Period 1|Adverse Event|0|||
48378421|NCT01912456|155580742|FG003|Period 1|Adverse Event|1|||
48378422|NCT01912456|155580739|FG000|Period 1|Withdrawal by Subject|0|||
48378423|NCT01912456|155580740|FG001|Period 1|Withdrawal by Subject|1|||
48378424|NCT01912456|155580741|FG002|Period 1|Withdrawal by Subject|1|||
48378425|NCT01912456|155580742|FG003|Period 1|Withdrawal by Subject|1|||
48378426|NCT01912456|155580739|FG000|Period 2|Lack of Efficacy|0|||
48378427|NCT01912456|155580740|FG001|Period 2|Lack of Efficacy|2|||
48378428|NCT01912456|155580741|FG002|Period 2|Lack of Efficacy|0|||
48378429|NCT01912456|155580742|FG003|Period 2|Lack of Efficacy|0|||
48378430|NCT01912456|155580739|FG000|Period 2|Adverse Event|0|||
48378431|NCT01912456|155580740|FG001|Period 2|Adverse Event|0|||
48378432|NCT01912456|155580741|FG002|Period 2|Adverse Event|0|||
48378433|NCT01912456|155580742|FG003|Period 2|Adverse Event|1|||
48378434|NCT00001962|155580744|FG000|Overall Study|Lack of Efficacy|18|||
48378435|NCT00001962|155580744|FG000|Overall Study|Lack of Accrual|6|||
48378436|NCT00001962|155580744|FG000|Overall Study|Death|1|||
48378437|NCT00001962|155580744|FG000|Overall Study|Lost to Follow-up|2|||
48378438|NCT00001962|155580744|FG000|Overall Study|Adverse Event|1|||
48378439|NCT01485354|155580745|FG000|Overall Study|Withdrawal by Subject|5|||
48378440|NCT02594163|155580746|FG000|Treatment Period|Progressive disease|2|||
48378441|NCT02594163|155580747|FG001|Treatment Period|Progressive disease|3|||
48378442|NCT02594163|155580746|FG000|Treatment Period|Adverse Event|1|||
48378443|NCT02594163|155580747|FG001|Treatment Period|Adverse Event|5|||
48378444|NCT02594163|155580746|FG000|Treatment Period|Physician Decision|1|||
48378445|NCT02594163|155580747|FG001|Treatment Period|Physician Decision|3|||
48378446|NCT02594163|155580746|FG000|Treatment Period|Study termination by sponsor|2|||
48378447|NCT02594163|155580747|FG001|Treatment Period|Study termination by sponsor|1|||
48378448|NCT02594163|155580746|FG000|Treatment Period|Other, Non-AE|1|||
48378449|NCT02594163|155580747|FG001|Treatment Period|Other, Non-AE|0|||
48378450|NCT02594163|155580746|FG000|Follow-up Period|Withdrawal by Subject|0|||
48378451|NCT02594163|155580747|FG001|Follow-up Period|Withdrawal by Subject|1|||
48378452|NCT02594163|155580746|FG000|Follow-up Period|Study Termination by Sponsor|6|||
48378453|NCT02594163|155580747|FG001|Follow-up Period|Study Termination by Sponsor|4|||
48378454|NCT02594163|155580746|FG000|Follow-up Period|Lost to Follow-up|1|||
48378455|NCT02594163|155580747|FG001|Follow-up Period|Lost to Follow-up|0|||
48378456|NCT02594163|155580746|FG000|Follow-up Period|Death|2|||
48378457|NCT02594163|155580747|FG001|Follow-up Period|Death|5|||
48378458|NCT02594163|155580746|FG000|Follow-up Period|Adverse Event|0|||
48378459|NCT02594163|155580747|FG001|Follow-up Period|Adverse Event|1|||
48378460|NCT02594163|155580746|FG000|Follow-up Period|Progressive Disease|2|||
48378461|NCT02594163|155580747|FG001|Follow-up Period|Progressive Disease|0|||
48378462|NCT02594163|155580746|FG000|Follow-up Period|Physician Decision|0|||
48378463|NCT02594163|155580747|FG001|Follow-up Period|Physician Decision|1|||
48378464|NCT03566810|155580750|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
48378465|NCT03566810|155580751|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
48378466|NCT03566810|155580752|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
48378467|NCT03566810|155580753|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
48378468|NCT00171704|155580756|FG000|Overall Study|Adverse Event|24|||
48378469|NCT00171704|155580757|FG001|Overall Study|Adverse Event|33|||
48378470|NCT00171704|155580756|FG000|Overall Study|Disease Progression|14|||
48378471|NCT00171704|155580757|FG001|Overall Study|Disease Progression|9|||
48378472|NCT00171704|155580756|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
48378473|NCT00171704|155580757|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
48378474|NCT00171704|155580756|FG000|Overall Study|Administrative Problems|2|||
48378475|NCT00171704|155580757|FG001|Overall Study|Administrative Problems|1|||
48378476|NCT00171704|155580756|FG000|Overall Study|Death|2|||
48378477|NCT00171704|155580757|FG001|Overall Study|Death|2|||
48378478|NCT00171704|155580756|FG000|Overall Study|Withdrawal by Subject|1|||
48378479|NCT00171704|155580757|FG001|Overall Study|Withdrawal by Subject|3|||
48378480|NCT00171704|155580756|FG000|Overall Study|Protocol Violation|0|||
48378481|NCT00171704|155580757|FG001|Overall Study|Protocol Violation|1|||
48378482|NCT02101034|155580758|FG000|Overall Study|Enrolled but did not start treatment|0|||
48378483|NCT02101034|155580759|FG001|Overall Study|Enrolled but did not start treatment|0|||
48378484|NCT02101034|155580760|FG002|Overall Study|Enrolled but did not start treatment|1|||
48378485|NCT02101034|155580761|FG003|Overall Study|Enrolled but did not start treatment|0|||
48415617|NCT04574999|155711176|FG001|Overall Study|Withdrawal by Subject|2|||
48378486|NCT02101034|155580762|FG004|Overall Study|Enrolled but did not start treatment|0|||
48378487|NCT00117845|155580763|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
48378488|NCT02647320|155580768|FG000|Overall Study|Adverse Event|0|||
48378489|NCT02647320|155580769|FG001|Overall Study|Adverse Event|1|||
48378490|NCT02647320|155580770|FG002|Overall Study|Adverse Event|3|||
48378491|NCT02647320|155580771|FG003|Overall Study|Adverse Event|2|||
48378492|NCT02647320|155580772|FG004|Overall Study|Adverse Event|1|||
48378493|NCT02647320|155580768|FG000|Overall Study|Protocol Violation|0|||
48378494|NCT02647320|155580769|FG001|Overall Study|Protocol Violation|0|||
48378495|NCT02647320|155580770|FG002|Overall Study|Protocol Violation|3|||
48378496|NCT02647320|155580771|FG003|Overall Study|Protocol Violation|0|||
48378497|NCT02647320|155580772|FG004|Overall Study|Protocol Violation|0|||
48378498|NCT02647320|155580768|FG000|Overall Study|Withdrawal by Subject|7|||
48378499|NCT02647320|155580769|FG001|Overall Study|Withdrawal by Subject|4|||
48378500|NCT02647320|155580770|FG002|Overall Study|Withdrawal by Subject|2|||
48378501|NCT02647320|155580771|FG003|Overall Study|Withdrawal by Subject|2|||
48378502|NCT02647320|155580772|FG004|Overall Study|Withdrawal by Subject|7|||
48378503|NCT02647320|155580768|FG000|Overall Study|Persistent hyperglycemia|0|||
48378504|NCT02647320|155580769|FG001|Overall Study|Persistent hyperglycemia|1|||
48378505|NCT02647320|155580770|FG002|Overall Study|Persistent hyperglycemia|1|||
48378506|NCT02647320|155580771|FG003|Overall Study|Persistent hyperglycemia|1|||
48378507|NCT02647320|155580772|FG004|Overall Study|Persistent hyperglycemia|1|||
48378508|NCT02647320|155580768|FG000|Overall Study|Study terminated by sponsor|1|||
48378509|NCT02647320|155580769|FG001|Overall Study|Study terminated by sponsor|1|||
48378510|NCT02647320|155580770|FG002|Overall Study|Study terminated by sponsor|1|||
48378511|NCT02647320|155580771|FG003|Overall Study|Study terminated by sponsor|1|||
48378512|NCT02647320|155580772|FG004|Overall Study|Study terminated by sponsor|2|||
48378513|NCT02647320|155580768|FG000|Overall Study|Reason not provided|0|||
48378514|NCT02647320|155580769|FG001|Overall Study|Reason not provided|0|||
48378515|NCT02647320|155580770|FG002|Overall Study|Reason not provided|1|||
48378516|NCT02647320|155580771|FG003|Overall Study|Reason not provided|0|||
48378517|NCT02647320|155580772|FG004|Overall Study|Reason not provided|2|||
48378518|NCT02647320|155580768|FG000|Overall Study|Lost to Follow-up|1|||
48378519|NCT02647320|155580769|FG001|Overall Study|Lost to Follow-up|1|||
48378520|NCT02647320|155580770|FG002|Overall Study|Lost to Follow-up|0|||
48378521|NCT02647320|155580771|FG003|Overall Study|Lost to Follow-up|0|||
48378522|NCT02647320|155580772|FG004|Overall Study|Lost to Follow-up|0|||
48378523|NCT02647320|155580768|FG000|Overall Study|Develop anemia|1|||
48378524|NCT02647320|155580769|FG001|Overall Study|Develop anemia|0|||
48378525|NCT02647320|155580770|FG002|Overall Study|Develop anemia|0|||
48378526|NCT02647320|155580771|FG003|Overall Study|Develop anemia|0|||
48378527|NCT02647320|155580772|FG004|Overall Study|Develop anemia|0|||
48378528|NCT02647320|155580768|FG000|Overall Study|Lack of Efficacy|0|||
48378529|NCT02647320|155580769|FG001|Overall Study|Lack of Efficacy|0|||
48378530|NCT02647320|155580770|FG002|Overall Study|Lack of Efficacy|0|||
48378531|NCT02647320|155580771|FG003|Overall Study|Lack of Efficacy|1|||
48378532|NCT02647320|155580772|FG004|Overall Study|Lack of Efficacy|0|||
48378533|NCT02647320|155580768|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
48378534|NCT02647320|155580769|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
48378535|NCT02647320|155580770|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
48378536|NCT02647320|155580771|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
48378537|NCT02647320|155580772|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
48378538|NCT03057977|155580773|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
48378539|NCT03057977|155580774|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
48378540|NCT03057977|155580773|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
48378541|NCT03057977|155580774|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
48378542|NCT03057977|155580773|FG000|Discontinuation From Treatment|Protocol Violation|6|||
48378543|NCT03057977|155580774|FG001|Discontinuation From Treatment|Protocol Violation|5|||
48378544|NCT03057977|155580773|FG000|Discontinuation From Treatment|Not treated|4|||
48378545|NCT03057977|155580774|FG001|Discontinuation From Treatment|Not treated|0|||
48378546|NCT03057977|155580773|FG000|Discontinuation From Treatment|Adverse Event|343|||
48378547|NCT03057977|155580774|FG001|Discontinuation From Treatment|Adverse Event|337|||
48378548|NCT03057977|155580773|FG000|Discontinuation From Treatment|Reason Unknown|0|||
48378549|NCT03057977|155580774|FG001|Discontinuation From Treatment|Reason Unknown|1|||
48378550|NCT03057977|155580773|FG000|Discontinuation From Treatment|Personal Reasons|1|||
48378551|NCT03057977|155580774|FG001|Discontinuation From Treatment|Personal Reasons|1|||
48378552|NCT03057977|155580773|FG000|Discontinuation From Treatment|Unblinded medication|1|||
48378553|NCT03057977|155580774|FG001|Discontinuation From Treatment|Unblinded medication|0|||
48378554|NCT03057977|155580773|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
48378555|NCT03057977|155580774|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
48378556|NCT03057977|155580773|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
48378557|NCT03057977|155580774|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
48378558|NCT03057977|155580773|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
48378559|NCT03057977|155580774|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
48415618|NCT04574999|155711175|FG000|Overall Study|Lost to Follow-up|1|||
48378560|NCT03057977|155580773|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
48378561|NCT03057977|155580774|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
48378562|NCT03057977|155580773|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
48378563|NCT03057977|155580774|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
48378564|NCT03057977|155580773|FG000|Discontinuation From Treatment|Not attending study visit|3|||
48378565|NCT03057977|155580774|FG001|Discontinuation From Treatment|Not attending study visit|10|||
48378566|NCT03057977|155580773|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
48378567|NCT03057977|155580774|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
48378568|NCT03057977|155580773|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
48378569|NCT03057977|155580774|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
48378570|NCT03057977|155580773|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
48378571|NCT03057977|155580774|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
48378572|NCT03057977|155580773|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
48378573|NCT03057977|155580774|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
48378574|NCT03057977|155580773|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
48378575|NCT03057977|155580774|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
48378576|NCT01072877|155580776|FG000|Overall Study|Lost to Follow-up|1|||
48378577|NCT01072877|155580777|FG001|Overall Study|Lost to Follow-up|1|||
48378578|NCT01072877|155580778|FG002|Overall Study|Lost to Follow-up|0|||
48378579|NCT01072877|155580779|FG003|Overall Study|Lost to Follow-up|2|||
48378580|NCT01072877|155580780|FG004|Overall Study|Lost to Follow-up|0|||
48378581|NCT01786174|155580781|FG000|Overall Study|Discontinued Study Drug|2|||
48378582|NCT01786174|155580782|FG001|Overall Study|Discontinued Study Drug|0|||
48378583|NCT01929980|155580783|FG000|Overall Study|Physician Decision|1|||
48378584|NCT00995020|155580784|FG000|Overall Study|margin analysis not performed|2|||
48378585|NCT00995020|155580785|FG001|Overall Study|margin analysis not performed|5|||
48378586|NCT00995020|155580784|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
48378587|NCT00995020|155580785|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
48378588|NCT01765192|155580787|FG000|Treatment Period 1|Adverse Event|0|||
48378589|NCT01765192|155580788|FG001|Treatment Period 1|Adverse Event|1|||
48378590|NCT01765192|155580787|FG000|Washout Period|Voluntary Withdrawal|1|||
48378591|NCT01765192|155580788|FG001|Washout Period|Voluntary Withdrawal|1|||
48378592|NCT01765192|155580787|FG000|Washout Period|Reason not specified|1|||
48378593|NCT01765192|155580788|FG001|Washout Period|Reason not specified|0|||
48378594|NCT01765192|155580787|FG000|Treatment Period 2|Reason not specified|0|||
48378595|NCT01765192|155580788|FG001|Treatment Period 2|Reason not specified|2|||
48378596|NCT01765192|155580787|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
48378597|NCT01765192|155580788|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
48378598|NCT03645057|155580789|FG000|Randomization to Baseline|Lost to Follow-up|1|||
48378599|NCT03645057|155580790|FG001|Randomization to Baseline|Lost to Follow-up|0|||
48378600|NCT03645057|155580791|FG002|Randomization to Baseline|Lost to Follow-up|1|||
48378601|NCT03645057|155580792|FG003|Randomization to Baseline|Lost to Follow-up|0|||
48378602|NCT03645057|155580789|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
48378603|NCT03645057|155580790|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
48378604|NCT03645057|155580791|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
48378605|NCT03645057|155580792|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
48378606|NCT03645057|155580789|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
48378607|NCT03645057|155580790|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
48378608|NCT03645057|155580791|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
48378609|NCT03645057|155580792|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
48378610|NCT03645057|155580789|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
48378611|NCT03645057|155580790|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
48378612|NCT03645057|155580791|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
48378613|NCT03645057|155580792|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
48378614|NCT01206777|155580793|FG000|Overall Study|Death|1|||
48378615|NCT01206777|155580793|FG000|Overall Study|Adverse Event|1|||
48378616|NCT00876694|155580794|FG000|Overall Study|Adverse Event|10|||
48378617|NCT00876694|155580795|FG001|Overall Study|Adverse Event|7|||
48378618|NCT00876694|155580794|FG000|Overall Study|Subject withdrew consent|6|||
48378619|NCT00876694|155580795|FG001|Overall Study|Subject withdrew consent|4|||
48378620|NCT00876694|155580794|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48378621|NCT00876694|155580795|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48378622|NCT00876694|155580794|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48378623|NCT00876694|155580795|FG001|Overall Study|Abnormal test procedure result(s)|0|||
48378624|NCT00876694|155580794|FG000|Overall Study|Administrative problems|1|||
48378625|NCT00876694|155580795|FG001|Overall Study|Administrative problems|1|||
48378626|NCT00876694|155580794|FG000|Overall Study|Death|1|||
48378627|NCT00876694|155580795|FG001|Overall Study|Death|0|||
48378628|NCT00288509|155580796|FG000|Treatment Cycle 1|Adverse Event|1|||
48378629|NCT00288509|155580796|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
48378630|NCT00288509|155580796|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
48378631|NCT00288509|155580796|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
48378632|NCT00288509|155580796|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
48378633|NCT00288509|155580796|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
48378634|NCT00288509|155580796|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
48378635|NCT00288509|155580796|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
48415619|NCT04574999|155711176|FG001|Overall Study|Lost to Follow-up|0|||
48378636|NCT00288509|155580796|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
48378637|NCT00288509|155580796|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
48378638|NCT00288509|155580796|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
48378639|NCT00288509|155580796|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
48378640|NCT00288509|155580796|FG000|Treatment Cycle 4|Physician Decision|4|||
48378641|NCT00288509|155580796|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
48378642|NCT00730171|155580802|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
48378643|NCT00730171|155580802|FG000|Overall Study|Adverse Event|193|||
48378644|NCT00730171|155580802|FG000|Overall Study|Protocol Violation|48|||
48378645|NCT00730171|155580802|FG000|Overall Study|Withdrawal by Subject|202|||
48378646|NCT00730171|155580802|FG000|Overall Study|Lost to Follow-up|121|||
48378647|NCT00730171|155580802|FG000|Overall Study|Insufficient Therapeutic Response|141|||
48378648|NCT00730171|155580802|FG000|Overall Study|Other|61|||
48378649|NCT01215422|155580803|FG000|Overall Study|Relocation|1|||
48378650|NCT01215422|155580804|FG001|Overall Study|Relocation|0|||
48378651|NCT01215422|155580805|FG002|Overall Study|Relocation|0|||
48378652|NCT01215422|155580806|FG003|Overall Study|Relocation|0|||
48378653|NCT01215422|155580803|FG000|Overall Study|Failed intubations|0|||
48378654|NCT01215422|155580804|FG001|Overall Study|Failed intubations|0|||
48378655|NCT01215422|155580805|FG002|Overall Study|Failed intubations|3|||
48378656|NCT01215422|155580806|FG003|Overall Study|Failed intubations|8|||
48378657|NCT01215422|155580803|FG000|Overall Study|Did not complete all intubations|7|||
48378658|NCT01215422|155580804|FG001|Overall Study|Did not complete all intubations|0|||
48378659|NCT01215422|155580805|FG002|Overall Study|Did not complete all intubations|0|||
48378660|NCT01215422|155580806|FG003|Overall Study|Did not complete all intubations|0|||
48378661|NCT00294554|155580807|FG000|Overall Study|Lack of Efficacy|0|||
48378662|NCT00294554|155580808|FG001|Overall Study|Lack of Efficacy|1|||
48378663|NCT00294554|155580807|FG000|Overall Study|Physician Decision|0|||
48378664|NCT00294554|155580808|FG001|Overall Study|Physician Decision|1|||
48378665|NCT02170389|155580811|FG000|Overall Study|Study terminated prior to start of treat|1|||
48378666|NCT02824263|155580812|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
48378667|NCT02824263|155580813|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
48378668|NCT02824263|155580812|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
48378669|NCT02824263|155580813|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
48378670|NCT03406260|155580814|FG000|Period 1|Adverse Event|0|||
48378671|NCT03406260|155580815|FG001|Period 1|Adverse Event|0|||
48378672|NCT03406260|155580816|FG002|Period 1|Adverse Event|0|||
48378673|NCT03406260|155580817|FG003|Period 1|Adverse Event|0|||
48378674|NCT03406260|155580818|FG004|Period 1|Adverse Event|1|||
48378675|NCT03406260|155580819|FG005|Period 1|Adverse Event|0|||
48378676|NCT00881608|155580820|FG000|Overall Study|Study prematurely terminated|11|||
48378677|NCT01313637|155580822|FG000|Overall Study|Adverse Event|17|||
48378678|NCT01313637|155580823|FG001|Overall Study|Adverse Event|24|||
48378679|NCT01313637|155580824|FG002|Overall Study|Adverse Event|25|||
48378680|NCT01313637|155580825|FG003|Overall Study|Adverse Event|18|||
48378681|NCT01313637|155580822|FG000|Overall Study|Lack of Efficacy|44|||
48378682|NCT01313637|155580823|FG001|Overall Study|Lack of Efficacy|38|||
48378683|NCT01313637|155580824|FG002|Overall Study|Lack of Efficacy|37|||
48378684|NCT01313637|155580825|FG003|Overall Study|Lack of Efficacy|24|||
48378685|NCT01313637|155580822|FG000|Overall Study|Protocol Violation|4|||
48378686|NCT01313637|155580823|FG001|Overall Study|Protocol Violation|3|||
48378687|NCT01313637|155580824|FG002|Overall Study|Protocol Violation|11|||
48378688|NCT01313637|155580825|FG003|Overall Study|Protocol Violation|5|||
48378689|NCT01313637|155580822|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
48378690|NCT01313637|155580823|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
48378691|NCT01313637|155580824|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
48378692|NCT01313637|155580825|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
48378693|NCT01313637|155580822|FG000|Overall Study|Lost to Follow-up|0|||
48378694|NCT01313637|155580823|FG001|Overall Study|Lost to Follow-up|2|||
48378695|NCT01313637|155580824|FG002|Overall Study|Lost to Follow-up|1|||
48378696|NCT01313637|155580825|FG003|Overall Study|Lost to Follow-up|3|||
48378697|NCT01313637|155580822|FG000|Overall Study|Withdrawal by Subject|11|||
48415620|NCT04574999|155711175|FG000|Overall Study|Personal problems|1|||
48378698|NCT01313637|155580823|FG001|Overall Study|Withdrawal by Subject|13|||
48378699|NCT01313637|155580824|FG002|Overall Study|Withdrawal by Subject|18|||
48378700|NCT01313637|155580825|FG003|Overall Study|Withdrawal by Subject|15|||
48378701|NCT03421431|155580830|FG000|Overall Study|Adverse Event|2|||
48378702|NCT03421431|155580831|FG001|Overall Study|Adverse Event|1|||
48378703|NCT03421431|155580832|FG002|Overall Study|Adverse Event|12|||
48378704|NCT03421431|155580830|FG000|Overall Study|Lost to Follow-up|1|||
48378705|NCT03421431|155580831|FG001|Overall Study|Lost to Follow-up|1|||
48378706|NCT03421431|155580832|FG002|Overall Study|Lost to Follow-up|1|||
48378707|NCT03421431|155580830|FG000|Overall Study|Withdrawal by Subject|3|||
48378708|NCT03421431|155580831|FG001|Overall Study|Withdrawal by Subject|2|||
48378709|NCT03421431|155580832|FG002|Overall Study|Withdrawal by Subject|1|||
48378710|NCT03421431|155580830|FG000|Overall Study|Protocol Violation|0|||
48378711|NCT03421431|155580831|FG001|Overall Study|Protocol Violation|1|||
48378712|NCT03421431|155580832|FG002|Overall Study|Protocol Violation|0|||
48378713|NCT03421431|155580830|FG000|Overall Study|Participant met Stopping Rules|0|||
48378714|NCT03421431|155580831|FG001|Overall Study|Participant met Stopping Rules|1|||
48378715|NCT03421431|155580832|FG002|Overall Study|Participant met Stopping Rules|0|||
48378716|NCT02604433|155580833|FG000|Overall Study|Withdrawal by Subject|37|||
48378717|NCT02604433|155580834|FG001|Overall Study|Withdrawal by Subject|16|||
48378718|NCT02604433|155580833|FG000|Overall Study|Adverse Event|4|||
48378719|NCT02604433|155580834|FG001|Overall Study|Adverse Event|0|||
48378720|NCT02604433|155580833|FG000|Overall Study|Other reasons|3|||
48378721|NCT02604433|155580834|FG001|Overall Study|Other reasons|5|||
48378722|NCT02604433|155580833|FG000|Overall Study|Death|4|||
48378723|NCT02604433|155580834|FG001|Overall Study|Death|1|||
48378724|NCT02604433|155580833|FG000|Overall Study|Transition to Rollover Protocol|169|||
48378725|NCT02604433|155580834|FG001|Overall Study|Transition to Rollover Protocol|82|||
48378726|NCT02604433|155580833|FG000|Overall Study|Physician Decision|1|||
48378727|NCT02604433|155580834|FG001|Overall Study|Physician Decision|1|||
48378728|NCT02604433|155580833|FG000|Overall Study|Lack of Efficacy|0|||
48378729|NCT02604433|155580834|FG001|Overall Study|Lack of Efficacy|1|||
48378730|NCT04508023|155580843|FG000|Overall Study|Withdrawal by Subject|1|||
48378731|NCT04508023|155580844|FG001|Overall Study|Withdrawal by Subject|2|||
48378732|NCT00796120|155580848|FG000|Overall Study|Death|3|||
48378733|NCT00796120|155580849|FG001|Overall Study|Death|0|||
48378734|NCT00796120|155580848|FG000|Overall Study|Adverse Event|11|||
48378735|NCT00796120|155580849|FG001|Overall Study|Adverse Event|6|||
48378736|NCT00796120|155580848|FG000|Overall Study|Progressive disease|22|||
48378737|NCT00796120|155580849|FG001|Overall Study|Progressive disease|13|||
48378738|NCT00796120|155580848|FG000|Overall Study|Participant refusal|3|||
48378739|NCT00796120|155580849|FG001|Overall Study|Participant refusal|4|||
48378740|NCT00796120|155580848|FG000|Overall Study|Other|6|||
48378741|NCT00796120|155580849|FG001|Overall Study|Other|17|||
48378742|NCT00796120|155580848|FG000|Overall Study|Physician Decision|16|||
48378743|NCT00796120|155580849|FG001|Overall Study|Physician Decision|17|||
48378744|NCT00796120|155580848|FG000|Overall Study|Randomized but not treated|0|||
48378745|NCT00796120|155580849|FG001|Overall Study|Randomized but not treated|3|||
48378746|NCT04526197|155580853|FG000|Period 1|Adverse Event|0|||
48378747|NCT04526197|155580854|FG001|Period 1|Adverse Event|1|||
48378748|NCT04526197|155580853|FG000|Period 1|Withdrawal by Subject|1|||
48378749|NCT04526197|155580854|FG001|Period 1|Withdrawal by Subject|0|||
48378750|NCT04526197|155580853|FG000|Period 2|Adverse Event|0|||
48378751|NCT04526197|155580854|FG001|Period 2|Adverse Event|1|||
48378752|NCT04526197|155580853|FG000|Period 2|Withdrawal by Subject|0|||
48378753|NCT04526197|155580854|FG001|Period 2|Withdrawal by Subject|1|||
48378754|NCT00838929|155580855|FG000|Overall Study|Protocol Violation|0|||
48378755|NCT00838929|155580856|FG001|Overall Study|Protocol Violation|1|||
48378756|NCT00838929|155580857|FG002|Overall Study|Protocol Violation|0|||
48378757|NCT00838929|155580855|FG000|Overall Study|Disease progression|0|||
48378758|NCT00838929|155580856|FG001|Overall Study|Disease progression|2|||
48378759|NCT00838929|155580857|FG002|Overall Study|Disease progression|1|||
48378760|NCT04427501|155580858|FG000|Overall Study|Death|0|||
48378761|NCT04427501|155580859|FG001|Overall Study|Death|0|||
48378762|NCT04427501|155580860|FG002|Overall Study|Death|0|||
48378763|NCT04427501|155580861|FG003|Overall Study|Death|0|||
48378764|NCT04427501|155580862|FG004|Overall Study|Death|0|||
48378765|NCT04427501|155580863|FG005|Overall Study|Death|15|||
48378766|NCT04427501|155580864|FG006|Overall Study|Death|0|||
48378767|NCT04427501|155580865|FG007|Overall Study|Death|0|||
48378768|NCT04427501|155580866|FG008|Overall Study|Death|0|||
48378769|NCT04427501|155580867|FG009|Overall Study|Death|0|||
48378770|NCT04427501|155580868|FG010|Overall Study|Death|0|||
48378771|NCT04427501|155580869|FG011|Overall Study|Death|0|||
48378772|NCT04427501|155580858|FG000|Overall Study|Lost to Follow-up|5|||
48378773|NCT04427501|155580859|FG001|Overall Study|Lost to Follow-up|1|||
48378774|NCT04427501|155580860|FG002|Overall Study|Lost to Follow-up|2|||
48378775|NCT04427501|155580861|FG003|Overall Study|Lost to Follow-up|0|||
48378776|NCT04427501|155580862|FG004|Overall Study|Lost to Follow-up|2|||
48378777|NCT04427501|155580863|FG005|Overall Study|Lost to Follow-up|11|||
48378778|NCT04427501|155580864|FG006|Overall Study|Lost to Follow-up|10|||
48378779|NCT04427501|155580865|FG007|Overall Study|Lost to Follow-up|10|||
48378780|NCT04427501|155580866|FG008|Overall Study|Lost to Follow-up|2|||
48378781|NCT04427501|155580867|FG009|Overall Study|Lost to Follow-up|5|||
48378782|NCT04427501|155580868|FG010|Overall Study|Lost to Follow-up|2|||
48378783|NCT04427501|155580869|FG011|Overall Study|Lost to Follow-up|0|||
48378784|NCT04427501|155580858|FG000|Overall Study|Physician Decision|0|||
48378785|NCT04427501|155580859|FG001|Overall Study|Physician Decision|3|||
48378786|NCT04427501|155580860|FG002|Overall Study|Physician Decision|0|||
48378787|NCT04427501|155580861|FG003|Overall Study|Physician Decision|0|||
48378788|NCT04427501|155580862|FG004|Overall Study|Physician Decision|0|||
48378789|NCT04427501|155580863|FG005|Overall Study|Physician Decision|0|||
48378790|NCT04427501|155580864|FG006|Overall Study|Physician Decision|2|||
48378791|NCT04427501|155580865|FG007|Overall Study|Physician Decision|0|||
48378792|NCT04427501|155580866|FG008|Overall Study|Physician Decision|0|||
48378793|NCT04427501|155580867|FG009|Overall Study|Physician Decision|0|||
48378794|NCT04427501|155580868|FG010|Overall Study|Physician Decision|0|||
48378795|NCT04427501|155580869|FG011|Overall Study|Physician Decision|0|||
48378796|NCT04427501|155580858|FG000|Overall Study|Withdrawal by Subject|9|||
48378797|NCT04427501|155580859|FG001|Overall Study|Withdrawal by Subject|2|||
48378798|NCT04427501|155580860|FG002|Overall Study|Withdrawal by Subject|2|||
48378799|NCT04427501|155580861|FG003|Overall Study|Withdrawal by Subject|3|||
48378800|NCT04427501|155580862|FG004|Overall Study|Withdrawal by Subject|7|||
48378801|NCT04427501|155580863|FG005|Overall Study|Withdrawal by Subject|25|||
48378802|NCT04427501|155580864|FG006|Overall Study|Withdrawal by Subject|15|||
48378803|NCT04427501|155580865|FG007|Overall Study|Withdrawal by Subject|7|||
48378804|NCT04427501|155580866|FG008|Overall Study|Withdrawal by Subject|4|||
48378805|NCT04427501|155580867|FG009|Overall Study|Withdrawal by Subject|1|||
48378806|NCT04427501|155580868|FG010|Overall Study|Withdrawal by Subject|4|||
48378807|NCT04427501|155580869|FG011|Overall Study|Withdrawal by Subject|0|||
48378808|NCT04427501|155580858|FG000|Overall Study|Other - as reported by the investigator|1|||
48378809|NCT04427501|155580859|FG001|Overall Study|Other - as reported by the investigator|0|||
48378810|NCT04427501|155580860|FG002|Overall Study|Other - as reported by the investigator|0|||
48378811|NCT04427501|155580861|FG003|Overall Study|Other - as reported by the investigator|0|||
48378812|NCT04427501|155580862|FG004|Overall Study|Other - as reported by the investigator|0|||
48378813|NCT04427501|155580863|FG005|Overall Study|Other - as reported by the investigator|6|||
48378814|NCT04427501|155580864|FG006|Overall Study|Other - as reported by the investigator|6|||
48378815|NCT04427501|155580865|FG007|Overall Study|Other - as reported by the investigator|0|||
48378816|NCT04427501|155580866|FG008|Overall Study|Other - as reported by the investigator|0|||
48378817|NCT04427501|155580867|FG009|Overall Study|Other - as reported by the investigator|0|||
48378818|NCT04427501|155580868|FG010|Overall Study|Other - as reported by the investigator|0|||
48378819|NCT04427501|155580869|FG011|Overall Study|Other - as reported by the investigator|0|||
48378820|NCT04427501|155580858|FG000|Overall Study|Other|0|||
48378821|NCT04427501|155580859|FG001|Overall Study|Other|0|||
48378822|NCT04427501|155580860|FG002|Overall Study|Other|0|||
48378823|NCT04427501|155580861|FG003|Overall Study|Other|0|||
48378824|NCT04427501|155580862|FG004|Overall Study|Other|0|||
48378825|NCT04427501|155580863|FG005|Overall Study|Other|0|||
48378826|NCT04427501|155580864|FG006|Overall Study|Other|0|||
48378827|NCT04427501|155580865|FG007|Overall Study|Other|0|||
48378828|NCT04427501|155580866|FG008|Overall Study|Other|0|||
48378829|NCT04427501|155580867|FG009|Overall Study|Other|0|||
48378830|NCT04427501|155580868|FG010|Overall Study|Other|0|||
48378831|NCT04427501|155580869|FG011|Overall Study|Other|1|||
48378832|NCT02374021|155580872|FG000|Overall Study|Adverse Event|1|||
48378833|NCT02374021|155580873|FG001|Overall Study|Adverse Event|0|||
48378834|NCT02374021|155580872|FG000|Overall Study|Lost to Follow-up|3|||
48378835|NCT02374021|155580873|FG001|Overall Study|Lost to Follow-up|2|||
48378836|NCT02374021|155580872|FG000|Overall Study|Physician Decision|0|||
48378837|NCT02374021|155580873|FG001|Overall Study|Physician Decision|3|||
48378838|NCT02374021|155580872|FG000|Overall Study|Withdrawal by Subject|6|||
48378839|NCT02374021|155580873|FG001|Overall Study|Withdrawal by Subject|5|||
48378840|NCT02374021|155580872|FG000|Overall Study|Poor Adherence|0|||
48378841|NCT02374021|155580873|FG001|Overall Study|Poor Adherence|1|||
48378842|NCT02374021|155580872|FG000|Overall Study|Scan protocol not followed|0|||
48378843|NCT02374021|155580873|FG001|Overall Study|Scan protocol not followed|1|||
48378844|NCT02374021|155580872|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
48378845|NCT02374021|155580873|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
48378846|NCT01163721|155580874|FG000|Overall Study|Adverse Event|5|||
48378847|NCT01163721|155580875|FG001|Overall Study|Adverse Event|6|||
48378848|NCT01163721|155580874|FG000|Overall Study|Withdrawal by Subject|3|||
48378849|NCT01163721|155580875|FG001|Overall Study|Withdrawal by Subject|4|||
48378850|NCT01163721|155580874|FG000|Overall Study|Lost to Follow-up|0|||
48378851|NCT01163721|155580875|FG001|Overall Study|Lost to Follow-up|1|||
48378852|NCT01163721|155580874|FG000|Overall Study|Physician Decision|0|||
48378853|NCT01163721|155580875|FG001|Overall Study|Physician Decision|1|||
48378854|NCT00364156|155580876|FG000|Overall Study|Withdrawal by Subject|73|||
48378855|NCT00364156|155580877|FG001|Overall Study|Withdrawal by Subject|80|||
48415621|NCT04574999|155711176|FG001|Overall Study|Personal problems|0|||
48378856|NCT00364156|155580876|FG000|Overall Study|Protocol Violation|6|||
48378857|NCT00364156|155580877|FG001|Overall Study|Protocol Violation|1|||
48378858|NCT01210118|155580880|FG000|Overall Study|Lost to Follow-up|1|||
48378859|NCT01210118|155580881|FG001|Overall Study|Lost to Follow-up|1|||
48378860|NCT01210118|155580880|FG000|Overall Study|Protocol Violation|1|||
48378861|NCT01210118|155580881|FG001|Overall Study|Protocol Violation|1|||
48378862|NCT01210118|155580880|FG000|Overall Study|Spontaneous abortion|1|||
48378863|NCT01210118|155580881|FG001|Overall Study|Spontaneous abortion|3|||
48378864|NCT00835120|155580884|FG000|Overall Study|Lack of Efficacy|1|||
48378865|NCT00835120|155580884|FG000|Overall Study|Lost to Follow-up|3|||
48378866|NCT00835120|155580884|FG000|Overall Study|Adverse Event|2|||
48378867|NCT00835120|155580884|FG000|Overall Study|Withdrawal by Subject|2|||
48378868|NCT00232141|155580889|FG000|Overall Study|Adverse Event|9|||
48415622|NCT04574999|155711175|FG000|Overall Study|Previous planned surgery|1|||
48378869|NCT00232141|155580890|FG001|Overall Study|Adverse Event|4|||
48378870|NCT00232141|155580889|FG000|Overall Study|Lack of Efficacy|0|||
48378871|NCT00232141|155580890|FG001|Overall Study|Lack of Efficacy|3|||
48378872|NCT00232141|155580889|FG000|Overall Study|Lost to Follow-up|9|||
48378873|NCT00232141|155580890|FG001|Overall Study|Lost to Follow-up|6|||
48378874|NCT00232141|155580889|FG000|Overall Study|Other|8|||
48378875|NCT00232141|155580890|FG001|Overall Study|Other|10|||
48378876|NCT00232141|155580889|FG000|Overall Study|Withdrawal by Subject|5|||
48378877|NCT00232141|155580890|FG001|Overall Study|Withdrawal by Subject|3|||
48378878|NCT01298518|155580891|FG000|Overall Study|Withdrawal by Subject|0|||
48378879|NCT01298518|155580892|FG001|Overall Study|Withdrawal by Subject|0|||
48378880|NCT01298518|155580893|FG002|Overall Study|Withdrawal by Subject|1|||
48378881|NCT03610165|155580894|FG000|Overall Study|Device didn't work|0|||
48378882|NCT03610165|155580895|FG001|Overall Study|Device didn't work|1|||
48378883|NCT04484831|155580902|FG000|Overall Study|Withdrawal by Subject|1|||
48378884|NCT04484831|155580903|FG001|Overall Study|Withdrawal by Subject|0|||
48378885|NCT04751656|155582423|FG000|Overall Study|Lost to Follow-up|1|||
48378886|NCT01340196|155582424|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
48378887|NCT02141984|155582426|FG000|Overall Study|Lack of Efficacy|2|||
48378888|NCT01177722|155582427|FG000|Overall Study|Serious Adverse Event|0|||
48378889|NCT01177722|155582428|FG001|Overall Study|Serious Adverse Event|0|||
48378890|NCT01177722|155582429|FG002|Overall Study|Serious Adverse Event|1|||
48378891|NCT01177722|155582430|FG003|Overall Study|Serious Adverse Event|0|||
48378892|NCT01177722|155582427|FG000|Overall Study|Protocol Violation|0|||
48378893|NCT01177722|155582428|FG001|Overall Study|Protocol Violation|0|||
48378894|NCT01177722|155582429|FG002|Overall Study|Protocol Violation|1|||
48378895|NCT01177722|155582430|FG003|Overall Study|Protocol Violation|0|||
48378896|NCT01177722|155582427|FG000|Overall Study|Lost to Follow-up|3|||
48378897|NCT01177722|155582428|FG001|Overall Study|Lost to Follow-up|4|||
48378898|NCT01177722|155582429|FG002|Overall Study|Lost to Follow-up|3|||
48378899|NCT01177722|155582430|FG003|Overall Study|Lost to Follow-up|1|||
48378900|NCT01177722|155582427|FG000|Overall Study|Withdrawal by Subject|10|||
48378901|NCT01177722|155582428|FG001|Overall Study|Withdrawal by Subject|6|||
48378902|NCT01177722|155582429|FG002|Overall Study|Withdrawal by Subject|4|||
48378903|NCT01177722|155582430|FG003|Overall Study|Withdrawal by Subject|6|||
48378904|NCT00604279|155582431|FG000|Overall Study|Lack of Efficacy|22|||
48378905|NCT00604279|155582432|FG001|Overall Study|Lack of Efficacy|9|||
48378906|NCT00604279|155582431|FG000|Overall Study|Lost to Follow-up|9|||
48378907|NCT00604279|155582432|FG001|Overall Study|Lost to Follow-up|14|||
48378908|NCT00604279|155582431|FG000|Overall Study|Pregnancy|2|||
48378909|NCT00604279|155582432|FG001|Overall Study|Pregnancy|0|||
48378910|NCT00604279|155582431|FG000|Overall Study|Protocol Violation|3|||
48378911|NCT00604279|155582432|FG001|Overall Study|Protocol Violation|1|||
48378912|NCT00604279|155582431|FG000|Overall Study|Withdrawal by Subject|16|||
48378913|NCT00604279|155582432|FG001|Overall Study|Withdrawal by Subject|5|||
48378914|NCT00604279|155582431|FG000|Overall Study|Adverse Event|4|||
48378915|NCT00604279|155582432|FG001|Overall Study|Adverse Event|5|||
48378916|NCT00604279|155582431|FG000|Overall Study|Other|8|||
48378917|NCT00604279|155582432|FG001|Overall Study|Other|4|||
48378918|NCT03442985|155582433|FG000|Overall Study|Sponsor Request|55|||
48378919|NCT03442985|155582434|FG001|Overall Study|Sponsor Request|60|||
48378920|NCT03442985|155582435|FG002|Overall Study|Sponsor Request|54|||
48378921|NCT03442985|155582433|FG000|Overall Study|Lost to Follow-up|5|||
48378922|NCT03442985|155582434|FG001|Overall Study|Lost to Follow-up|2|||
48378923|NCT03442985|155582435|FG002|Overall Study|Lost to Follow-up|7|||
48378924|NCT03442985|155582433|FG000|Overall Study|Withdrawal by Subject|2|||
48378925|NCT03442985|155582434|FG001|Overall Study|Withdrawal by Subject|3|||
48378926|NCT03442985|155582435|FG002|Overall Study|Withdrawal by Subject|4|||
48378927|NCT03442985|155582433|FG000|Overall Study|Adverse Event|0|||
48378928|NCT03442985|155582434|FG001|Overall Study|Adverse Event|1|||
48378929|NCT03442985|155582435|FG002|Overall Study|Adverse Event|0|||
48378930|NCT01174160|155582439|FG000|Overall Study|Adverse Event|1|||
48378931|NCT01174160|155582440|FG001|Overall Study|Adverse Event|0|||
48378932|NCT01174160|155582439|FG000|Overall Study|Lost to Follow-up|1|||
48378933|NCT01174160|155582440|FG001|Overall Study|Lost to Follow-up|0|||
48378934|NCT01174160|155582439|FG000|Overall Study|Physician Decision|1|||
48378935|NCT01174160|155582440|FG001|Overall Study|Physician Decision|0|||
48378936|NCT01174160|155582439|FG000|Overall Study|Protocol Violation|4|||
48378937|NCT01174160|155582440|FG001|Overall Study|Protocol Violation|6|||
48378938|NCT01174160|155582439|FG000|Overall Study|Withdrawal by Subject|1|||
48378939|NCT01174160|155582440|FG001|Overall Study|Withdrawal by Subject|0|||
48378940|NCT00795951|155582443|FG000|Overall Study|Lost to Follow-up|1|||
48378941|NCT00795951|155582443|FG000|Overall Study|Withdrawal by Subject|1|||
48378942|NCT01000636|155582444|FG000|Overall Study|Withdrawal by Subject|1|||
48378943|NCT01000636|155582444|FG000|Overall Study|Adverse Event|1|||
48378944|NCT01128738|155582445|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
48378945|NCT01128738|155582446|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
48378946|NCT01128738|155582445|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
48378947|NCT01128738|155582446|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
48378948|NCT01128738|155582445|FG000|Second TP|Lost to Follow-up|0|||
48378949|NCT01128738|155582446|FG001|Second TP|Lost to Follow-up|1|||
48378950|NCT01128738|155582445|FG000|Second TP|Withdrawal by Subject|0|||
48378951|NCT01128738|155582446|FG001|Second TP|Withdrawal by Subject|2|||
48378952|NCT01178671|155582447|FG000|Overall Study|Adverse Event|4|||
48378953|NCT01178671|155582448|FG001|Overall Study|Adverse Event|6|||
48378954|NCT01178671|155582447|FG000|Overall Study|Protocol Violation|1|||
48378955|NCT01178671|155582448|FG001|Overall Study|Protocol Violation|1|||
48378956|NCT01178671|155582447|FG000|Overall Study|Lack of Efficacy|0|||
48378957|NCT01178671|155582448|FG001|Overall Study|Lack of Efficacy|1|||
48378958|NCT01178671|155582447|FG000|Overall Study|Lost to Follow-up|3|||
48378959|NCT01178671|155582448|FG001|Overall Study|Lost to Follow-up|1|||
48378960|NCT01178671|155582447|FG000|Overall Study|Physician Decision|4|||
48378961|NCT01178671|155582448|FG001|Overall Study|Physician Decision|6|||
48378962|NCT02435966|155582449|FG000|Overall Study|Withdrawal by Subject|0|||
48378963|NCT02435966|155582450|FG001|Overall Study|Withdrawal by Subject|1|||
48378964|NCT02435966|155582451|FG002|Overall Study|Withdrawal by Subject|0|||
48378965|NCT00973362|155582452|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
48378966|NCT00973362|155582453|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
48378967|NCT00973362|155582452|FG000|Baseline Evaluation|No colposcopy visit|62|||
48378968|NCT00973362|155582453|FG001|Baseline Evaluation|No colposcopy visit|0|||
48378969|NCT00973362|155582452|FG000|Baseline Evaluation|Inevaluable|686|||
48378970|NCT00973362|155582453|FG001|Baseline Evaluation|Inevaluable|223|||
48378971|NCT00973362|155582452|FG000|3-Year Follow-up|Lost to Follow-up|17|||
48378972|NCT00973362|155582453|FG001|3-Year Follow-up|Lost to Follow-up|0|||
48378973|NCT01078675|155582454|FG000|Overall Study|Withdrawal by Subject|7|||
48378974|NCT01078675|155582455|FG001|Overall Study|Withdrawal by Subject|3|||
48378975|NCT01078675|155582454|FG000|Overall Study|Protocol Violation|56|||
48378976|NCT01078675|155582455|FG001|Overall Study|Protocol Violation|0|||
48378977|NCT01078675|155582454|FG000|Overall Study|Provided in CRF for specific reasons|2|||
48378978|NCT01078675|155582455|FG001|Overall Study|Provided in CRF for specific reasons|3|||
48378979|NCT01078675|155582454|FG000|Overall Study|Adverse Event|3|||
48378980|NCT01078675|155582455|FG001|Overall Study|Adverse Event|0|||
48378981|NCT01211197|155582456|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48378982|NCT01211197|155582457|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48378983|NCT01211197|155582458|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
48378984|NCT01211197|155582459|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48378985|NCT01211197|155582460|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48378986|NCT01211197|155582461|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48378987|NCT01211197|155582456|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
48378988|NCT01211197|155582457|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
48378989|NCT01211197|155582458|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
48378990|NCT01211197|155582459|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
48378991|NCT01211197|155582460|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
48378992|NCT01211197|155582461|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
48378993|NCT00887679|155582462|FG000|Overall Study|Withdrawal by Subject|1|||
48378994|NCT00887679|155582462|FG000|Overall Study|Lost to Follow-up|4|||
48378995|NCT00887679|155582462|FG000|Overall Study|Physician Decision|5|||
48378996|NCT04223830|155582468|FG000|Overall Study|Lost to Follow-up|9|||
48378997|NCT04223830|155582468|FG000|Overall Study|Adverse Event|1|||
48378998|NCT02974088|155582472|FG000|Overall Study|Lost to Follow-up|0|||
48378999|NCT02974088|155582473|FG001|Overall Study|Lost to Follow-up|2|||
48379000|NCT02974088|155582472|FG000|Overall Study|Adverse Event|0|||
48379001|NCT02974088|155582473|FG001|Overall Study|Adverse Event|1|||
48379002|NCT01776424|155582474|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
48379003|NCT01776424|155582475|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
48379004|NCT01776424|155582476|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
48379005|NCT01776424|155582474|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
48379006|NCT01776424|155582475|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
48379007|NCT01776424|155582476|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
48379008|NCT01776424|155582474|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
48379009|NCT01776424|155582475|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
48379010|NCT01776424|155582476|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
48379011|NCT01776424|155582474|FG000|LTOLE Part (Open Label)|Refused|5|||
48379012|NCT01776424|155582475|FG001|LTOLE Part (Open Label)|Refused|2|||
48379013|NCT01776424|155582476|FG002|LTOLE Part (Open Label)|Refused|11|||
48379014|NCT01776424|155582474|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
48379015|NCT01776424|155582475|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
48379016|NCT01776424|155582476|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
48379017|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
48379018|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
48379019|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
48379020|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
48379021|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
48426317|NCT02203838|155749552|FG002|Overall Study|Lack of Efficacy|1|||
48379022|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
48379023|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
48379024|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
48379025|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Death|1|||
48379026|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Death|1|||
48379027|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
48379028|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
48379029|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
48379030|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
48379031|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
48379032|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
48379033|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
48379034|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
48379035|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
48379036|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
48379037|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
48379038|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
48379039|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
48379040|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
48379041|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
48379042|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
48379043|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
48379044|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
48379045|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
48379046|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
48379047|NCT00559585|155582477|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
48379048|NCT00559585|155582478|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
48379049|NCT00559585|155582477|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
48379050|NCT00559585|155582478|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
48379051|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
48379052|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
48379053|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
48379054|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
48379055|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
48379056|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
48379057|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
48379058|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
48379059|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
48379060|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
48379061|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
48379062|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
48379063|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
48379064|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
48379065|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
48379066|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
48379067|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
48379068|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
48379069|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
48379070|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
48379071|NCT00559585|155582477|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
48379072|NCT00559585|155582478|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
48379073|NCT02465463|155582480|FG000|Overall Study|Lost to Follow-up|2|||
48379074|NCT02465463|155582481|FG001|Overall Study|Lost to Follow-up|1|||
48379075|NCT02465463|155582480|FG000|Overall Study|Death|1|||
48379076|NCT02465463|155582481|FG001|Overall Study|Death|0|||
48379077|NCT02465463|155582480|FG000|Overall Study|Protocol Violation|1|||
48379078|NCT02465463|155582481|FG001|Overall Study|Protocol Violation|0|||
48379079|NCT01630434|155582482|FG000|Overall Study|Donor lungs turned down|1|||
48379080|NCT01630434|155582483|FG001|Overall Study|Donor lungs turned down|0|||
48379081|NCT01630434|155582482|FG000|Overall Study|Protocol Violation|9|||
48379082|NCT01630434|155582483|FG001|Overall Study|Protocol Violation|4|||
48379083|NCT01630434|155582482|FG000|Overall Study|Death|20|||
48379084|NCT01630434|155582483|FG001|Overall Study|Death|26|||
48379085|NCT01026454|155582486|FG000|Second Intervention|Pregnancy|1|||
48379086|NCT01026454|155582487|FG001|Second Intervention|Pregnancy|1|||
48379087|NCT01975428|155582494|FG000|Overall Study|Lost to Follow-up|17|||
48379088|NCT01975428|155582495|FG001|Overall Study|Lost to Follow-up|4|||
48379089|NCT01975428|155582494|FG000|Overall Study|Withdrawal by Subject|3|||
48379090|NCT01975428|155582495|FG001|Overall Study|Withdrawal by Subject|10|||
48379091|NCT02804178|155582497|FG000|Overall Study|Adverse Event|1|||
48379092|NCT03370471|155582507|FG000|Overall Study|Withdrawal by Subject|6|||
48379093|NCT03370471|155582508|FG001|Overall Study|Withdrawal by Subject|1|||
48379094|NCT03370471|155582507|FG000|Overall Study|Unable to access veins for blood draw|0|||
48379095|NCT03370471|155582508|FG001|Overall Study|Unable to access veins for blood draw|1|||
48379096|NCT03370471|155582507|FG000|Overall Study|Screen fail|1|||
48379097|NCT03370471|155582508|FG001|Overall Study|Screen fail|0|||
48379098|NCT01765179|155582509|FG000|Overall Study|Adverse Event|3|||
48379099|NCT01765179|155582509|FG000|Overall Study|Lost to Follow-up|5|||
48379100|NCT01765179|155582509|FG000|Overall Study|Non-compliance with study drug|2|||
48379101|NCT01765179|155582509|FG000|Overall Study|Protocol Violation|1|||
48379102|NCT01765179|155582509|FG000|Overall Study|Withdrawal by Subject|8|||
48379103|NCT01765179|155582509|FG000|Overall Study|Hematocrit >54%|3|||
48379104|NCT01765179|155582509|FG000|Overall Study|prohibited med|1|||
48379105|NCT01765179|155582509|FG000|Overall Study|Out of country unable to finish study|1|||
48379106|NCT01765179|155582509|FG000|Overall Study|lack of venous access|1|||
48379107|NCT01765179|155582509|FG000|Overall Study|work conflict|1|||
48379108|NCT01765179|155582509|FG000|Overall Study|Ca elevated 10.6|1|||
48379109|NCT01699789|155582516|FG000|Overall Study|Withdrawal by Subject|18|||
48379110|NCT01699789|155582517|FG001|Overall Study|Withdrawal by Subject|23|||
48379111|NCT01699789|155582516|FG000|Overall Study|Death|1|||
48379112|NCT01699789|155582517|FG001|Overall Study|Death|2|||
48379113|NCT01699789|155582516|FG000|Overall Study|Lost to Follow-up|83|||
48379114|NCT01699789|155582517|FG001|Overall Study|Lost to Follow-up|101|||
48379115|NCT02411578|155582518|FG000|Crossover Trial Phase|Pregnancy|0|||
48379116|NCT02411578|155582519|FG001|Crossover Trial Phase|Pregnancy|1|||
48379117|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
48379118|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
48379119|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
48379120|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
48379121|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
48379122|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
48379123|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
48379124|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
48379125|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
48379126|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
48379127|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
48379128|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
48379129|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
48379130|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
48379131|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
48379132|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
48379133|NCT01231516|155582522|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
48379134|NCT01231516|155582523|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
48379135|NCT01231516|155582522|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
48379136|NCT01231516|155582523|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
48379137|NCT01231516|155582522|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
48379138|NCT01231516|155582523|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
48379139|NCT01231516|155582522|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
48379140|NCT01231516|155582523|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
48379141|NCT01231516|155582522|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
48379142|NCT01231516|155582523|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
48379143|NCT01231516|155582522|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
48379144|NCT01231516|155582523|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
48379145|NCT01231516|155582522|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
48379146|NCT01231516|155582523|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
48379147|NCT01231516|155582522|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
48379148|NCT01231516|155582523|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
48379149|NCT05266586|155582529|FG000|Overall Study|Adverse Event|2|||
48379150|NCT05266586|155582530|FG001|Overall Study|Adverse Event|2|||
48379151|NCT05266586|155582531|FG002|Overall Study|Adverse Event|1|||
48379152|NCT05266586|155582529|FG000|Overall Study|Withdrawal by Subject|1|||
48379153|NCT05266586|155582530|FG001|Overall Study|Withdrawal by Subject|0|||
48379154|NCT05266586|155582531|FG002|Overall Study|Withdrawal by Subject|1|||
48379155|NCT05266586|155582529|FG000|Overall Study|Non-compliance with study drug|0|||
48379156|NCT05266586|155582530|FG001|Overall Study|Non-compliance with study drug|1|||
48379157|NCT05266586|155582531|FG002|Overall Study|Non-compliance with study drug|0|||
48379158|NCT05266586|155582529|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
48379159|NCT05266586|155582530|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
48379160|NCT05266586|155582531|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
48379161|NCT02225353|155582532|FG000|Overall Study|Lost to Follow-up|0|||
48379162|NCT02225353|155582533|FG001|Overall Study|Lost to Follow-up|1|||
48379163|NCT02225353|155582534|FG002|Overall Study|Lost to Follow-up|3|||
48379164|NCT02225353|155582532|FG000|Overall Study|Protocol Violation|4|||
48379165|NCT02225353|155582533|FG001|Overall Study|Protocol Violation|5|||
48379166|NCT02225353|155582534|FG002|Overall Study|Protocol Violation|12|||
48379167|NCT01395316|155582535|FG000|Overall Study|Lost to Follow-up|2|||
48379168|NCT01395316|155582535|FG000|Overall Study|poor MRI quality|1|||
48379169|NCT01295281|155582537|FG000|First Intervention (7 Days)|Death|0|||
48379170|NCT01295281|155582538|FG001|First Intervention (7 Days)|Death|1|||
48379171|NCT00954421|155582539|FG000|Screening|screen failures|3|||
48379172|NCT00954421|155582539|FG000|6 Months of DBS|Withdrawal by Subject|1|||
48379173|NCT00954421|155582539|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
48379174|NCT02244996|155582540|FG000|Overall Study|Lack of Efficacy|2|||
48379175|NCT02244996|155582541|FG001|Overall Study|Lack of Efficacy|6|||
48379176|NCT04051827|155582542|FG000|Overall Study|Death|1|||
48379177|NCT04051827|155582542|FG000|Overall Study|Withdrawal by Subject|4|||
48379178|NCT04051827|155582542|FG000|Overall Study|Progressive disease|16|||
48379179|NCT04051827|155582542|FG000|Overall Study|Physician Decision|1|||
48379180|NCT04051827|155582542|FG000|Overall Study|Other|4|||
48379181|NCT02038920|155582543|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
48379182|NCT02038920|155582544|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
48379183|NCT02038920|155582545|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
48379184|NCT02038920|155582546|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
48379185|NCT02038920|155582547|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
48379186|NCT02038920|155582548|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
48379187|NCT02038920|155582543|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
48379188|NCT02038920|155582544|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48379189|NCT02038920|155582545|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48379190|NCT02038920|155582546|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48379191|NCT02038920|155582547|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48379192|NCT02038920|155582548|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
48379193|NCT02038920|155582543|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
48379194|NCT02038920|155582544|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
48379195|NCT02038920|155582545|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
48379196|NCT02038920|155582546|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
48379197|NCT02038920|155582547|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
48379198|NCT02038920|155582548|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
48379199|NCT02038920|155582543|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
48379200|NCT02038920|155582544|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
48379201|NCT02038920|155582545|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
48379202|NCT02038920|155582546|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
48379203|NCT02038920|155582547|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
48379204|NCT02038920|155582548|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
48379205|NCT02038920|155582543|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48379206|NCT02038920|155582544|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48379207|NCT02038920|155582545|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
48379208|NCT02038920|155582546|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48379209|NCT02038920|155582547|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48379210|NCT02038920|155582548|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
48379211|NCT02038920|155582543|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
48379212|NCT02038920|155582544|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
48379213|NCT02038920|155582545|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
48379214|NCT02038920|155582546|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
48379215|NCT02038920|155582547|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
48379216|NCT02038920|155582548|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
48379217|NCT02038920|155582543|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48379218|NCT02038920|155582544|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48379219|NCT02038920|155582545|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48379220|NCT02038920|155582546|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48379221|NCT02038920|155582547|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
48379222|NCT02038920|155582548|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
48379223|NCT02038920|155582543|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48379224|NCT02038920|155582544|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48379225|NCT02038920|155582545|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48426318|NCT02203838|155749553|FG003|Overall Study|Lack of Efficacy|1|||
48379226|NCT02038920|155582546|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48379227|NCT02038920|155582547|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
48379228|NCT02038920|155582548|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
48379229|NCT02038920|155582543|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48379230|NCT02038920|155582544|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48379231|NCT02038920|155582545|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48379232|NCT02038920|155582546|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48379233|NCT02038920|155582547|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
48379234|NCT02038920|155582548|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
48379235|NCT02038920|155582543|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48379236|NCT02038920|155582544|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48379237|NCT02038920|155582545|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48379238|NCT02038920|155582546|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48379239|NCT02038920|155582547|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
48379240|NCT02038920|155582548|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
48379241|NCT02038920|155582543|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48379242|NCT02038920|155582544|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48379243|NCT02038920|155582545|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48379244|NCT02038920|155582546|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48379245|NCT02038920|155582547|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
48379246|NCT02038920|155582548|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
48379247|NCT02038920|155582543|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48379248|NCT02038920|155582544|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48379249|NCT02038920|155582545|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48379250|NCT02038920|155582546|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48379251|NCT02038920|155582547|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
48379252|NCT02038920|155582548|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
48379253|NCT04824521|155582550|FG000|Overall Study|Lost to Follow-up|1|||
48379254|NCT01390181|155584469|FG000|Overall Study|Lost to Follow-up|1|||
48379255|NCT01390181|155584469|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
48379256|NCT01101477|155584471|FG000|Overall Study|Protocol Violation|5|||
48379257|NCT01101477|155584472|FG001|Overall Study|Protocol Violation|3|||
48379258|NCT01101477|155584473|FG002|Overall Study|Protocol Violation|1|||
48379259|NCT02720536|155584474|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
48379260|NCT02720536|155584474|FG000|Overall Study|PR - pregnancy|2|||
48379261|NCT02720536|155584474|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
48379262|NCT02720536|155584474|FG000|Overall Study|PR - death|1|||
48379263|NCT02720536|155584474|FG000|Overall Study|PR - adverse event|1|||
48379264|NCT02720536|155584474|FG000|Overall Study|PR - abnormal lab value(s)|1|||
48379265|NCT02720536|155584474|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
48379266|NCT00985166|155584475|FG000|Overall Study|Lost to Follow-up|3|||
48379267|NCT00985166|155584476|FG001|Overall Study|Lost to Follow-up|2|||
48379268|NCT00985166|155584477|FG002|Overall Study|Lost to Follow-up|2|||
48379269|NCT00985166|155584475|FG000|Overall Study|Withdrawal by Subject|3|||
48379270|NCT00985166|155584476|FG001|Overall Study|Withdrawal by Subject|2|||
48379271|NCT00985166|155584477|FG002|Overall Study|Withdrawal by Subject|0|||
48379272|NCT00985166|155584475|FG000|Overall Study|Test not done|2|||
48379273|NCT00985166|155584476|FG001|Overall Study|Test not done|0|||
48379274|NCT00985166|155584477|FG002|Overall Study|Test not done|4|||
48379275|NCT00985166|155584475|FG000|Overall Study|Other|1|||
48379276|NCT00985166|155584476|FG001|Overall Study|Other|0|||
48379277|NCT00985166|155584477|FG002|Overall Study|Other|1|||
48379278|NCT00300781|155584483|FG000|Overall Study|Disease Progression|55|||
48379279|NCT00300781|155584484|FG001|Overall Study|Disease Progression|52|||
48379280|NCT00300781|155584483|FG000|Overall Study|Adverse Event|5|||
48379281|NCT00300781|155584484|FG001|Overall Study|Adverse Event|6|||
48379282|NCT00300781|155584483|FG000|Overall Study|Withdrawal by Subject|1|||
48379283|NCT00300781|155584484|FG001|Overall Study|Withdrawal by Subject|2|||
48379284|NCT00300781|155584483|FG000|Overall Study|Physician Decision|1|||
48379285|NCT00300781|155584484|FG001|Overall Study|Physician Decision|0|||
48379286|NCT00300781|155584483|FG000|Overall Study|Not Recorded|0|||
48379287|NCT00300781|155584484|FG001|Overall Study|Not Recorded|1|||
48379288|NCT00300781|155584483|FG000|Overall Study|Symptomatic Deterioration|1|||
48379289|NCT00300781|155584484|FG001|Overall Study|Symptomatic Deterioration|0|||
48379290|NCT00300781|155584483|FG000|Overall Study|Lost to Follow-up|0|||
48379291|NCT00300781|155584484|FG001|Overall Study|Lost to Follow-up|1|||
48379292|NCT01717989|155584489|FG000|Overall Study|Ineligibility determined|6|||
48379293|NCT01717989|155584489|FG000|Overall Study|Protocol deviation|6|||
48379294|NCT01717989|155584489|FG000|Overall Study|Withdrawal by Subject|11|||
48379295|NCT01717989|155584489|FG000|Overall Study|Physician Decision|2|||
48379296|NCT01717989|155584489|FG000|Overall Study|Lost to Follow-up|11|||
48379297|NCT01717989|155584489|FG000|Overall Study|Death|439|||
48379298|NCT01717989|155584489|FG000|Overall Study|Protocol-specified criteria|551|||
48379299|NCT01717989|155584489|FG000|Overall Study|Other|40|||
48379300|NCT00792805|155584490|FG000|Overall Study|Adverse Event|12|||
48379301|NCT00792805|155584491|FG001|Overall Study|Adverse Event|10|||
48379302|NCT00792805|155584492|FG002|Overall Study|Adverse Event|10|||
48379303|NCT00792805|155584490|FG000|Overall Study|Subject withdrew consent|5|||
48379304|NCT00792805|155584491|FG001|Overall Study|Subject withdrew consent|6|||
48379305|NCT00792805|155584492|FG002|Overall Study|Subject withdrew consent|5|||
48379306|NCT00792805|155584490|FG000|Overall Study|Administrative problems|2|||
48379307|NCT00792805|155584491|FG001|Overall Study|Administrative problems|0|||
48379308|NCT00792805|155584492|FG002|Overall Study|Administrative problems|4|||
48379309|NCT00792805|155584490|FG000|Overall Study|Abnormal test procedure result(s)|1|||
48379310|NCT00792805|155584491|FG001|Overall Study|Abnormal test procedure result(s)|2|||
48379311|NCT00792805|155584492|FG002|Overall Study|Abnormal test procedure result(s)|0|||
48379312|NCT00792805|155584490|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48379313|NCT00792805|155584491|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
48379314|NCT00792805|155584492|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
48379315|NCT00792805|155584490|FG000|Overall Study|Lost to Follow-up|1|||
48379316|NCT00792805|155584491|FG001|Overall Study|Lost to Follow-up|1|||
48379317|NCT00792805|155584492|FG002|Overall Study|Lost to Follow-up|6|||
48379318|NCT00792805|155584490|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48379319|NCT00792805|155584491|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48379320|NCT00792805|155584492|FG002|Overall Study|Abnormal laboratory value(s)|1|||
48379321|NCT00792805|155584490|FG000|Overall Study|Protocol deviation|0|||
48379322|NCT00792805|155584491|FG001|Overall Study|Protocol deviation|1|||
48379323|NCT00792805|155584492|FG002|Overall Study|Protocol deviation|1|||
48379324|NCT03224325|155584493|FG000|Overall Study|Adverse Event|1|||
48379325|NCT03224325|155584494|FG001|Overall Study|Adverse Event|0|||
48379326|NCT03224325|155584495|FG002|Overall Study|Adverse Event|0|||
48379327|NCT03224325|155584496|FG003|Overall Study|Adverse Event|0|||
48379328|NCT03224325|155584497|FG004|Overall Study|Adverse Event|0|||
48379329|NCT03224325|155584498|FG005|Overall Study|Adverse Event|0|||
48379330|NCT03224325|155584499|FG006|Overall Study|Adverse Event|1|||
48379331|NCT03224325|155584493|FG000|Overall Study|Withdrawal by Subject|0|||
48379332|NCT03224325|155584494|FG001|Overall Study|Withdrawal by Subject|0|||
48379333|NCT03224325|155584495|FG002|Overall Study|Withdrawal by Subject|0|||
48379334|NCT03224325|155584496|FG003|Overall Study|Withdrawal by Subject|1|||
48379335|NCT03224325|155584497|FG004|Overall Study|Withdrawal by Subject|0|||
48379336|NCT03224325|155584498|FG005|Overall Study|Withdrawal by Subject|0|||
48379337|NCT03224325|155584499|FG006|Overall Study|Withdrawal by Subject|0|||
48379338|NCT02986334|155584500|FG000|Overall Study|Withdrawal by Subject|0|||
48379339|NCT02986334|155584501|FG001|Overall Study|Withdrawal by Subject|1|||
48379340|NCT02986334|155584502|FG002|Overall Study|Withdrawal by Subject|2|||
48379341|NCT02986334|155584500|FG000|Overall Study|Lost to Follow-up|1|||
48379342|NCT02986334|155584501|FG001|Overall Study|Lost to Follow-up|2|||
48379343|NCT02986334|155584502|FG002|Overall Study|Lost to Follow-up|1|||
48379344|NCT02986334|155584500|FG000|Overall Study|Adverse Event|0|||
48379345|NCT02986334|155584501|FG001|Overall Study|Adverse Event|2|||
48379346|NCT02986334|155584502|FG002|Overall Study|Adverse Event|1|||
48379347|NCT02986334|155584500|FG000|Overall Study|non compliance in phone ratings|2|||
48379348|NCT02986334|155584501|FG001|Overall Study|non compliance in phone ratings|1|||
48379349|NCT02986334|155584502|FG002|Overall Study|non compliance in phone ratings|2|||
48379350|NCT02986334|155584500|FG000|Overall Study|undisclosed comorbidities|0|||
48379351|NCT02986334|155584501|FG001|Overall Study|undisclosed comorbidities|1|||
48379352|NCT02986334|155584502|FG002|Overall Study|undisclosed comorbidities|1|||
48379353|NCT00120406|155584503|FG000|Overall Study|Death|9|||
48379354|NCT00120406|155584504|FG001|Overall Study|Death|4|||
48379355|NCT00120406|155584503|FG000|Overall Study|Withdrawal by Subject|5|||
48379356|NCT00120406|155584504|FG001|Overall Study|Withdrawal by Subject|7|||
48379357|NCT00120406|155584503|FG000|Overall Study|Lost to Follow-up|5|||
48379358|NCT00120406|155584504|FG001|Overall Study|Lost to Follow-up|2|||
48379359|NCT00120406|155584503|FG000|Overall Study|received non-study stent|0|||
48379360|NCT00120406|155584504|FG001|Overall Study|received non-study stent|2|||
48379361|NCT00120406|155584503|FG000|Overall Study|patient moved but has not withdrawn|0|||
48379362|NCT00120406|155584504|FG001|Overall Study|patient moved but has not withdrawn|1|||
48415623|NCT04574999|155711176|FG001|Overall Study|Previous planned surgery|0|||
48415624|NCT02185521|155711177|FG000|Overall Study|Withdrawal by Subject|1|||
48415625|NCT02185521|155711177|FG000|Overall Study|Protocol Violation|1|||
48379363|NCT01177787|155584511|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
48379364|NCT01177787|155584511|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
48379365|NCT01177787|155584511|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
48379366|NCT02901041|155584512|FG000|Overall Study|Withdrawal by PI|4|||
48379367|NCT02901041|155584513|FG001|Overall Study|Withdrawal by PI|8|||
48379368|NCT02901041|155584512|FG000|Overall Study|Withdrawal by Subject|7|||
48379369|NCT02901041|155584513|FG001|Overall Study|Withdrawal by Subject|3|||
48379370|NCT01480674|155584514|FG000|Overall Study|Death|23|||
48379371|NCT01480674|155584514|FG000|Overall Study|Lost to Follow-up|2|||
48379372|NCT01480674|155584514|FG000|Overall Study|visit not done|10|||
48415626|NCT00768222|155711181|FG000|Overall Study|Lost to Follow-up|1|||
48379373|NCT00975507|155584518|FG000|Overall Study|Adverse Event|1|||
48379374|NCT00975507|155584519|FG001|Overall Study|Adverse Event|0|||
48379375|NCT00975507|155584518|FG000|Overall Study|Lost to Follow-up|7|||
48379376|NCT00975507|155584519|FG001|Overall Study|Lost to Follow-up|1|||
48379377|NCT00975507|155584518|FG000|Overall Study|Protocol Violation|2|||
48379378|NCT00975507|155584519|FG001|Overall Study|Protocol Violation|0|||
48379379|NCT00975507|155584518|FG000|Overall Study|Withdrawal by Subject|10|||
48379380|NCT00975507|155584519|FG001|Overall Study|Withdrawal by Subject|3|||
48379381|NCT00887250|155584520|FG000|Overall Study|Adverse Event|3|||
48379382|NCT00887250|155584521|FG001|Overall Study|Adverse Event|0|||
48379383|NCT00887250|155584522|FG002|Overall Study|Adverse Event|7|||
48379384|NCT00887250|155584520|FG000|Overall Study|Lack of Efficacy|9|||
48379385|NCT00887250|155584521|FG001|Overall Study|Lack of Efficacy|6|||
48379386|NCT00887250|155584522|FG002|Overall Study|Lack of Efficacy|1|||
48379387|NCT00887250|155584520|FG000|Overall Study|Lost to Follow-up|2|||
48379388|NCT00887250|155584521|FG001|Overall Study|Lost to Follow-up|3|||
48379389|NCT00887250|155584522|FG002|Overall Study|Lost to Follow-up|1|||
48379390|NCT00887250|155584520|FG000|Overall Study|Protocol Violation|2|||
48379391|NCT00887250|155584521|FG001|Overall Study|Protocol Violation|2|||
48379392|NCT00887250|155584522|FG002|Overall Study|Protocol Violation|1|||
48379393|NCT00887250|155584520|FG000|Overall Study|Withdrawal by Subject|2|||
48415627|NCT00768222|155711182|FG001|Overall Study|Lost to Follow-up|1|||
48415628|NCT00768222|155711181|FG000|Overall Study|Withdrawal by Subject|3|||
48415629|NCT00768222|155711182|FG001|Overall Study|Withdrawal by Subject|1|||
48415630|NCT00768222|155711181|FG000|Overall Study|Protocol Violation|0|||
48415631|NCT00768222|155711182|FG001|Overall Study|Protocol Violation|2|||
48415632|NCT01717638|155711185|FG000|Overall Study|Lost to Follow-up|0|||
48415633|NCT01717638|155711186|FG001|Overall Study|Lost to Follow-up|0|||
48415634|NCT01717638|155711187|FG002|Overall Study|Lost to Follow-up|0|||
48415635|NCT01717638|155711188|FG003|Overall Study|Lost to Follow-up|0|||
48415636|NCT01717638|155711189|FG004|Overall Study|Lost to Follow-up|0|||
48415637|NCT01717638|155711190|FG005|Overall Study|Lost to Follow-up|1|||
48415638|NCT01717638|155711191|FG006|Overall Study|Lost to Follow-up|0|||
48415639|NCT01717638|155711192|FG007|Overall Study|Lost to Follow-up|0|||
48415640|NCT01717638|155711193|FG008|Overall Study|Lost to Follow-up|0|||
48415641|NCT01717638|155711194|FG009|Overall Study|Lost to Follow-up|0|||
48415642|NCT01717638|155711195|FG010|Overall Study|Lost to Follow-up|0|||
48415643|NCT01717638|155711196|FG011|Overall Study|Lost to Follow-up|0|||
48415644|NCT01717638|155711197|FG012|Overall Study|Lost to Follow-up|0|||
48415645|NCT01717638|155711185|FG000|Overall Study|Father in hospital|0|||
48415646|NCT01717638|155711186|FG001|Overall Study|Father in hospital|0|||
48415647|NCT01717638|155711187|FG002|Overall Study|Father in hospital|0|||
48415648|NCT01717638|155711188|FG003|Overall Study|Father in hospital|0|||
48415649|NCT01717638|155711189|FG004|Overall Study|Father in hospital|0|||
48415650|NCT01717638|155711190|FG005|Overall Study|Father in hospital|0|||
48415651|NCT01717638|155711191|FG006|Overall Study|Father in hospital|0|||
48415652|NCT01717638|155711192|FG007|Overall Study|Father in hospital|0|||
48415653|NCT01717638|155711193|FG008|Overall Study|Father in hospital|0|||
48415654|NCT01717638|155711194|FG009|Overall Study|Father in hospital|0|||
48415655|NCT01717638|155711195|FG010|Overall Study|Father in hospital|0|||
48415656|NCT01717638|155711196|FG011|Overall Study|Father in hospital|0|||
48415657|NCT01717638|155711197|FG012|Overall Study|Father in hospital|1|||
48415658|NCT01717638|155711185|FG000|Overall Study|Withdrawal by Subject|0|||
48415659|NCT01717638|155711186|FG001|Overall Study|Withdrawal by Subject|1|||
48415660|NCT01717638|155711187|FG002|Overall Study|Withdrawal by Subject|1|||
48415661|NCT01717638|155711188|FG003|Overall Study|Withdrawal by Subject|0|||
48415662|NCT01717638|155711189|FG004|Overall Study|Withdrawal by Subject|1|||
48415663|NCT01717638|155711190|FG005|Overall Study|Withdrawal by Subject|0|||
48415664|NCT01717638|155711191|FG006|Overall Study|Withdrawal by Subject|2|||
48415665|NCT01717638|155711192|FG007|Overall Study|Withdrawal by Subject|1|||
48415666|NCT01717638|155711193|FG008|Overall Study|Withdrawal by Subject|2|||
48415667|NCT01717638|155711194|FG009|Overall Study|Withdrawal by Subject|1|||
48415668|NCT01717638|155711195|FG010|Overall Study|Withdrawal by Subject|0|||
48415669|NCT01717638|155711196|FG011|Overall Study|Withdrawal by Subject|0|||
48415670|NCT01717638|155711197|FG012|Overall Study|Withdrawal by Subject|18|||
48415671|NCT03263091|155711198|FG000|OL Component|Withdrawal by Subject|1|||
48379394|NCT00887250|155584521|FG001|Overall Study|Withdrawal by Subject|1|||
48379395|NCT00887250|155584522|FG002|Overall Study|Withdrawal by Subject|2|||
48415672|NCT03263091|155711199|FG001|OL Component|Withdrawal by Subject|1|||
48415673|NCT03263091|155711200|FG002|OL Component|Withdrawal by Subject|0|||
48415674|NCT03263091|155711201|FG003|OL Component|Withdrawal by Subject|0|||
48415675|NCT03263091|155711202|FG004|OL Component|Withdrawal by Subject|0|||
48415676|NCT03263091|155711203|FG005|OL Component|Withdrawal by Subject|0|||
48415677|NCT03263091|155711198|FG000|OL Component|Physician Decision|0|||
48379396|NCT00887250|155584520|FG000|Overall Study|Patient uncooperative|0|||
48379397|NCT00887250|155584521|FG001|Overall Study|Patient uncooperative|0|||
48379398|NCT00887250|155584522|FG002|Overall Study|Patient uncooperative|1|||
48379399|NCT04615247|155584523|FG000|Overall Study|Adverse Event|0|||
48379400|NCT04615247|155584524|FG001|Overall Study|Adverse Event|2|||
48415678|NCT03263091|155711199|FG001|OL Component|Physician Decision|1|||
48415679|NCT03263091|155711200|FG002|OL Component|Physician Decision|2|||
48415680|NCT03263091|155711201|FG003|OL Component|Physician Decision|0|||
48415681|NCT03263091|155711202|FG004|OL Component|Physician Decision|0|||
48415682|NCT03263091|155711203|FG005|OL Component|Physician Decision|0|||
48415683|NCT03263091|155711198|FG000|OL Component|Death|1|||
48415684|NCT03263091|155711199|FG001|OL Component|Death|0|||
48415685|NCT03263091|155711200|FG002|OL Component|Death|0|||
48415686|NCT03263091|155711201|FG003|OL Component|Death|0|||
48415687|NCT03263091|155711202|FG004|OL Component|Death|0|||
48415688|NCT03263091|155711203|FG005|OL Component|Death|0|||
48415689|NCT03263091|155711198|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
48415690|NCT03263091|155711199|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
48415691|NCT03263091|155711200|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
48415692|NCT03263091|155711201|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
48415693|NCT03263091|155711202|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
48415694|NCT03263091|155711203|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
48415695|NCT03263091|155711198|FG000|OL High-EPO Component|Physician Decision|0|||
48415696|NCT03263091|155711199|FG001|OL High-EPO Component|Physician Decision|0|||
48415697|NCT03263091|155711200|FG002|OL High-EPO Component|Physician Decision|0|||
48415698|NCT03263091|155711201|FG003|OL High-EPO Component|Physician Decision|1|||
48415699|NCT03263091|155711202|FG004|OL High-EPO Component|Physician Decision|0|||
48415700|NCT03263091|155711203|FG005|OL High-EPO Component|Physician Decision|0|||
48415701|NCT03263091|155711198|FG000|OL High-EPO Component|Death|0|||
48415702|NCT03263091|155711199|FG001|OL High-EPO Component|Death|0|||
48415703|NCT03263091|155711200|FG002|OL High-EPO Component|Death|0|||
48415704|NCT03263091|155711201|FG003|OL High-EPO Component|Death|3|||
48415705|NCT03263091|155711202|FG004|OL High-EPO Component|Death|0|||
48415706|NCT03263091|155711203|FG005|OL High-EPO Component|Death|0|||
48415707|NCT03263091|155711198|FG000|DB Component|Withdrawal by Subject|0|||
48415708|NCT03263091|155711199|FG001|DB Component|Withdrawal by Subject|0|||
48415709|NCT03263091|155711200|FG002|DB Component|Withdrawal by Subject|0|||
48415710|NCT03263091|155711201|FG003|DB Component|Withdrawal by Subject|0|||
48415711|NCT03263091|155711202|FG004|DB Component|Withdrawal by Subject|22|||
48415712|NCT03263091|155711203|FG005|DB Component|Withdrawal by Subject|8|||
48415713|NCT03263091|155711198|FG000|DB Component|Physician Decision|0|||
48415714|NCT03263091|155711199|FG001|DB Component|Physician Decision|0|||
48415715|NCT03263091|155711200|FG002|DB Component|Physician Decision|0|||
48415716|NCT03263091|155711201|FG003|DB Component|Physician Decision|0|||
48415717|NCT03263091|155711202|FG004|DB Component|Physician Decision|3|||
48415718|NCT03263091|155711203|FG005|DB Component|Physician Decision|1|||
48415719|NCT03263091|155711198|FG000|DB Component|Adverse Event|0|||
48415720|NCT03263091|155711199|FG001|DB Component|Adverse Event|0|||
48415721|NCT03263091|155711200|FG002|DB Component|Adverse Event|0|||
48415722|NCT03263091|155711201|FG003|DB Component|Adverse Event|0|||
48415723|NCT03263091|155711202|FG004|DB Component|Adverse Event|2|||
48415724|NCT03263091|155711203|FG005|DB Component|Adverse Event|1|||
48415725|NCT03263091|155711198|FG000|DB Component|Lost to Follow-up|0|||
48415726|NCT03263091|155711199|FG001|DB Component|Lost to Follow-up|0|||
48415727|NCT03263091|155711200|FG002|DB Component|Lost to Follow-up|0|||
48415728|NCT03263091|155711201|FG003|DB Component|Lost to Follow-up|0|||
48415729|NCT03263091|155711202|FG004|DB Component|Lost to Follow-up|2|||
48415730|NCT03263091|155711203|FG005|DB Component|Lost to Follow-up|1|||
48415731|NCT03263091|155711198|FG000|DB Component|Death|0|||
48415732|NCT03263091|155711199|FG001|DB Component|Death|0|||
48415733|NCT03263091|155711200|FG002|DB Component|Death|0|||
48415734|NCT03263091|155711201|FG003|DB Component|Death|0|||
48415735|NCT03263091|155711202|FG004|DB Component|Death|7|||
48415736|NCT03263091|155711203|FG005|DB Component|Death|4|||
48415737|NCT03263091|155711198|FG000|DB Component|Other than specified|0|||
48415738|NCT03263091|155711199|FG001|DB Component|Other than specified|0|||
48415739|NCT03263091|155711200|FG002|DB Component|Other than specified|0|||
48415740|NCT03263091|155711201|FG003|DB Component|Other than specified|0|||
48415741|NCT03263091|155711202|FG004|DB Component|Other than specified|8|||
48415742|NCT03263091|155711203|FG005|DB Component|Other than specified|6|||
48415743|NCT03368859|155711204|FG000|Overall Study|Withdrew Consent|5|||
48415744|NCT03368859|155711205|FG001|Overall Study|Withdrew Consent|4|||
48415745|NCT03368859|155711204|FG000|Overall Study|Death|12|||
48415746|NCT03368859|155711205|FG001|Overall Study|Death|6|||
48415747|NCT03368859|155711204|FG000|Overall Study|Study terminated by Sponsor|18|||
48415748|NCT03368859|155711205|FG001|Overall Study|Study terminated by Sponsor|23|||
48415749|NCT03368859|155711204|FG000|Overall Study|Other|1|||
48415750|NCT03368859|155711205|FG001|Overall Study|Other|1|||
48415751|NCT01901224|155711207|FG000|Overall Study|study was not funded and terminated|2|||
48415752|NCT02300129|155711208|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
48415753|NCT02300129|155711209|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
48415754|NCT02300129|155711210|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
48415755|NCT02300129|155711211|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
48415756|NCT02300129|155711208|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
48415757|NCT02300129|155711209|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
48415758|NCT02300129|155711210|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
48415759|NCT02300129|155711211|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
48415760|NCT02300129|155711208|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
48415761|NCT02300129|155711209|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
48415762|NCT02300129|155711210|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
48415763|NCT02300129|155711211|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
48415764|NCT05408858|155711212|FG000|Overall Study|no longer met eligibility criteria|1|||
48415765|NCT02054702|155711217|FG000|Overall Study|Lost to Follow-up|3|||
48415766|NCT02054702|155711218|FG001|Overall Study|Lost to Follow-up|5|||
48415767|NCT02054702|155711217|FG000|Overall Study|Adverse Event|3|||
48415768|NCT02054702|155711218|FG001|Overall Study|Adverse Event|1|||
48415769|NCT02054702|155711217|FG000|Overall Study|Met Withdrawal Criteria|4|||
48415770|NCT02054702|155711218|FG001|Overall Study|Met Withdrawal Criteria|1|||
48415771|NCT02054702|155711217|FG000|Overall Study|Physician Decision|0|||
48415772|NCT02054702|155711218|FG001|Overall Study|Physician Decision|1|||
48415773|NCT02054702|155711217|FG000|Overall Study|Withdrawal by Subject|14|||
48415774|NCT02054702|155711218|FG001|Overall Study|Withdrawal by Subject|4|||
48415775|NCT01262898|155711221|FG000|Overall Study|Protocol Violation|1|||
48415776|NCT01262898|155711222|FG001|Overall Study|Protocol Violation|1|||
48415777|NCT01262898|155711223|FG002|Overall Study|Protocol Violation|0|||
48415778|NCT01262898|155711224|FG003|Overall Study|Protocol Violation|0|||
48415779|NCT01262898|155711221|FG000|Overall Study|Lost to Follow-up|1|||
48415780|NCT01262898|155711222|FG001|Overall Study|Lost to Follow-up|0|||
48415781|NCT01262898|155711223|FG002|Overall Study|Lost to Follow-up|0|||
48415782|NCT01262898|155711224|FG003|Overall Study|Lost to Follow-up|0|||
48415783|NCT01262898|155711221|FG000|Overall Study|Withdrawal by Subject|1|||
48415784|NCT01262898|155711222|FG001|Overall Study|Withdrawal by Subject|1|||
48415785|NCT01262898|155711223|FG002|Overall Study|Withdrawal by Subject|0|||
48415786|NCT01262898|155711224|FG003|Overall Study|Withdrawal by Subject|0|||
48415787|NCT02599402|155711225|FG000|Overall Study|Disease progression|153|||
48415788|NCT02599402|155711225|FG000|Overall Study|Study drug toxicity|201|||
48415789|NCT02599402|155711225|FG000|Overall Study|Death|26|||
48415790|NCT02599402|155711225|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
48415791|NCT02599402|155711225|FG000|Overall Study|Participant request to discontinue study treatment|13|||
48415792|NCT02599402|155711225|FG000|Overall Study|Participant withdrew consent|5|||
48415793|NCT02599402|155711225|FG000|Overall Study|Lost to Follow-up|1|||
48415794|NCT02599402|155711225|FG000|Overall Study|Maximum Clinical Benefit|7|||
48415795|NCT02599402|155711225|FG000|Overall Study|Poor/non-compliance|1|||
48415796|NCT02599402|155711225|FG000|Overall Study|Pregnancy|1|||
48415797|NCT02599402|155711225|FG000|Overall Study|Participant no longer met study criteria|7|||
48415798|NCT02599402|155711225|FG000|Overall Study|Other Reasons|95|||
48415799|NCT02945657|155711226|FG000|Overall Study|Adverse Event|1|||
48415800|NCT02945657|155711226|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
48415801|NCT01295125|155711231|FG000|Overall Study|Study stopped prematurely|9|||
48415802|NCT00283387|155711236|FG000|First Intervention|Subject non-compliant|1|||
48415803|NCT00283387|155711237|FG001|First Intervention|Subject non-compliant|1|||
48415804|NCT00283387|155711236|FG000|First Intervention|Withdrawal by Subject|0|||
48415805|NCT00283387|155711237|FG001|First Intervention|Withdrawal by Subject|1|||
48415806|NCT01829048|155711238|FG000|Overall Study|Withdrawal by Subject|0|||
48415807|NCT01829048|155711239|FG001|Overall Study|Withdrawal by Subject|0|||
48415808|NCT01829048|155711240|FG002|Overall Study|Withdrawal by Subject|0|||
48415809|NCT01829048|155711241|FG003|Overall Study|Withdrawal by Subject|2|||
48415810|NCT01829048|155711242|FG004|Overall Study|Withdrawal by Subject|0|||
48415811|NCT00892437|155711245|FG000|Randomized Phase|Randomized but not treated|6|||
48415812|NCT00892437|155711246|FG001|Randomized Phase|Randomized but not treated|0|||
48415813|NCT00892437|155711245|FG000|Randomized Phase|Adverse Event|2|||
48415814|NCT00892437|155711246|FG001|Randomized Phase|Adverse Event|2|||
48415815|NCT00892437|155711245|FG000|Randomized Phase|Lost to Follow-up|1|||
48415816|NCT00892437|155711246|FG001|Randomized Phase|Lost to Follow-up|3|||
48415817|NCT00892437|155711245|FG000|Randomized Phase|Investigator's Discretion|1|||
48415818|NCT00892437|155711246|FG001|Randomized Phase|Investigator's Discretion|0|||
48415819|NCT00892437|155711245|FG000|Randomized Phase|Withdrew Consent|1|||
48415820|NCT00892437|155711246|FG001|Randomized Phase|Withdrew Consent|0|||
48415821|NCT00892437|155711245|FG000|Open-Label Extension Phase|Adverse Event|4|||
48415822|NCT00892437|155711246|FG001|Open-Label Extension Phase|Adverse Event|2|||
48415823|NCT00892437|155711245|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
48415824|NCT00892437|155711246|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
48415825|NCT00892437|155711245|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
48415826|NCT00892437|155711246|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
48415827|NCT00892437|155711245|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
48415828|NCT00892437|155711246|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
48415829|NCT00892437|155711245|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
48415830|NCT00892437|155711246|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
48415831|NCT04927312|155711247|FG000|Overall Study|Adverse Event|1|||
48415832|NCT04927312|155711247|FG000|Overall Study|Death|1|||
48415833|NCT04927312|155711247|FG000|Overall Study|Withdrawal by Subject|1|||
48415834|NCT04927312|155711247|FG000|Overall Study|Other|1|||
48415835|NCT01478958|155711267|FG000|Overall Study|Withdrawal by Subject|1|||
48415836|NCT01478958|155711268|FG001|Overall Study|Withdrawal by Subject|1|||
48415837|NCT01478958|155711269|FG002|Overall Study|Withdrawal by Subject|1|||
48415838|NCT01478958|155711267|FG000|Overall Study|Weight loss|1|||
48415839|NCT01478958|155711268|FG001|Overall Study|Weight loss|0|||
48415840|NCT01478958|155711269|FG002|Overall Study|Weight loss|0|||
48415841|NCT01478958|155711267|FG000|Overall Study|Re-located|0|||
48415842|NCT01478958|155711268|FG001|Overall Study|Re-located|1|||
48415843|NCT01478958|155711269|FG002|Overall Study|Re-located|0|||
48415844|NCT01478958|155711267|FG000|Overall Study|Unable to comply|0|||
48415845|NCT01478958|155711268|FG001|Overall Study|Unable to comply|0|||
48415846|NCT01478958|155711269|FG002|Overall Study|Unable to comply|2|||
48415847|NCT00693706|155711271|FG000|Overall Study|Protocol Violation|0|||
48415848|NCT00693706|155711272|FG001|Overall Study|Protocol Violation|1|||
48415849|NCT00519077|155711277|FG000|Overall Study|Death|6|||
48415850|NCT00519077|155711277|FG000|Overall Study|Other|2|||
48415851|NCT01193335|155711278|FG000|After Infant Series|Lost to Follow-up|1|||
48415852|NCT01193335|155711279|FG001|After Infant Series|Lost to Follow-up|2|||
48415853|NCT01193335|155711278|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
48415854|NCT01193335|155711279|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
48415855|NCT01193335|155711278|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
48415856|NCT01193335|155711279|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
48415857|NCT01193335|155711278|FG000|1-Year Follow-up|Lost to Follow-up|4|||
48415858|NCT01193335|155711279|FG001|1-Year Follow-up|Lost to Follow-up|0|||
48415859|NCT01193335|155711278|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
48415860|NCT01193335|155711279|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
48415861|NCT01193335|155711278|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
48415862|NCT01193335|155711279|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
48415863|NCT02201940|155711280|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
48415864|NCT02201940|155711281|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
48415865|NCT02201940|155711280|FG000|Overall Study|Lack of Efficacy|2|||
48415866|NCT02201940|155711281|FG001|Overall Study|Lack of Efficacy|113|||
48415867|NCT02201940|155711280|FG000|Overall Study|Lost to Follow-up|5|||
48415868|NCT02201940|155711281|FG001|Overall Study|Lost to Follow-up|0|||
48415869|NCT02201940|155711280|FG000|Overall Study|Withdrew Consent|2|||
48415870|NCT02201940|155711281|FG001|Overall Study|Withdrew Consent|1|||
48415871|NCT02201940|155711280|FG000|Overall Study|Investigator's Discretion|1|||
48415872|NCT02201940|155711281|FG001|Overall Study|Investigator's Discretion|1|||
48415873|NCT02201940|155711280|FG000|Overall Study|Death|1|||
48415874|NCT02201940|155711281|FG001|Overall Study|Death|0|||
48415875|NCT02201940|155711280|FG000|Overall Study|Adverse Event|0|||
48415876|NCT02201940|155711281|FG001|Overall Study|Adverse Event|1|||
48415877|NCT01985321|155711286|FG000|Overall Study|Protocol Violation|4|||
48415878|NCT01985321|155711287|FG001|Overall Study|Protocol Violation|3|||
48415879|NCT01985321|155711286|FG000|Overall Study|Withdrawal by Subject|1|||
48415880|NCT01985321|155711287|FG001|Overall Study|Withdrawal by Subject|0|||
48415881|NCT01985321|155711286|FG000|Overall Study|Lost to Follow-up|5|||
48415882|NCT01985321|155711287|FG001|Overall Study|Lost to Follow-up|2|||
48415883|NCT01985321|155711286|FG000|Overall Study|Subject treated wrong type of sore|1|||
48415884|NCT01985321|155711287|FG001|Overall Study|Subject treated wrong type of sore|0|||
48415885|NCT03293680|155711292|FG000|Overall Study|Death|1|||
48415886|NCT03293680|155711292|FG000|Overall Study|Did not meet inclusion criteria|8|||
48415887|NCT01802281|155711293|FG000|Overall Study|Death|1|||
48415888|NCT01802281|155711294|FG001|Overall Study|Death|2|||
48415889|NCT01802281|155711293|FG000|Overall Study|Withdrawal by Subject|2|||
48415890|NCT01802281|155711294|FG001|Overall Study|Withdrawal by Subject|1|||
48415891|NCT01802281|155711293|FG000|Overall Study|Ineligible|5|||
48415892|NCT01802281|155711294|FG001|Overall Study|Ineligible|3|||
48415893|NCT03832387|155711298|FG000|Overall Study|Protocol Violation|2|||
48415894|NCT03832387|155711299|FG001|Overall Study|Protocol Violation|6|||
48415895|NCT03832387|155711298|FG000|Overall Study|EXCLUSION CRITERIA|3|||
48415896|NCT03832387|155711299|FG001|Overall Study|EXCLUSION CRITERIA|1|||
48415897|NCT00004980|155711304|FG000|Overall Study|Withdrawal by Subject|1|||
48415898|NCT00004980|155711305|FG001|Overall Study|Withdrawal by Subject|0|||
48415899|NCT00004980|155711304|FG000|Overall Study|memory difficulties|1|||
48415900|NCT00004980|155711305|FG001|Overall Study|memory difficulties|1|||
48415901|NCT00004980|155711304|FG000|Overall Study|Physician Decision|0|||
48415902|NCT00004980|155711305|FG001|Overall Study|Physician Decision|1|||
48415903|NCT01299025|155711306|FG000|Overall Study|Withdrawal by Subject|2|||
48415904|NCT01299025|155711307|FG001|Overall Study|Withdrawal by Subject|1|||
48415905|NCT01299025|155711306|FG000|Overall Study|Lost to Follow-up|1|||
48415906|NCT01299025|155711307|FG001|Overall Study|Lost to Follow-up|0|||
48415907|NCT03212261|155711308|FG000|Overall Study|Became ineligible d/t tech|2|||
48415908|NCT03212261|155711308|FG000|Overall Study|Tech Trouble- No first study visit|1|||
48415909|NCT03212261|155711308|FG000|Overall Study|Lost to Follow-up|7|||
48415910|NCT03212261|155711308|FG000|Overall Study|Family Emergency|1|||
48415911|NCT03212261|155711308|FG000|Overall Study|Too busy/ No time|5|||
48415912|NCT00609622|155711312|FG000|Overall Study|Adverse Event|14|||
48415913|NCT00609622|155711313|FG001|Overall Study|Adverse Event|10|||
48415914|NCT00609622|155711312|FG000|Overall Study|Withdrawal by Subject|4|||
48415915|NCT00609622|155711313|FG001|Overall Study|Withdrawal by Subject|20|||
48415916|NCT00609622|155711312|FG000|Overall Study|Death|1|||
48415917|NCT00609622|155711313|FG001|Overall Study|Death|4|||
48415918|NCT00609622|155711312|FG000|Overall Study|Protocol Violation|1|||
48415919|NCT00609622|155711313|FG001|Overall Study|Protocol Violation|1|||
48415920|NCT00609622|155711312|FG000|Overall Study|Objective progression or relapse|47|||
48415921|NCT00609622|155711313|FG001|Overall Study|Objective progression or relapse|41|||
48415922|NCT00609622|155711312|FG000|Overall Study|Study terminated by sponsor|16|||
48415923|NCT00609622|155711313|FG001|Overall Study|Study terminated by sponsor|3|||
48415924|NCT00609622|155711312|FG000|Overall Study|Other|7|||
48415925|NCT00609622|155711313|FG001|Overall Study|Other|14|||
48415926|NCT00609622|155711312|FG000|Overall Study|Global deterioration of health status|6|||
48415927|NCT00609622|155711313|FG001|Overall Study|Global deterioration of health status|2|||
48415928|NCT01650805|155711314|FG000|Overall Study|Withdrawal by Subject|1|||
48415929|NCT01650805|155711315|FG001|Overall Study|Withdrawal by Subject|0|||
48415930|NCT03367156|155713120|FG000|Overall Study|Lack of interest|3|||
48415931|NCT03367156|155713121|FG001|Overall Study|Lack of interest|1|||
48415932|NCT03367156|155713120|FG000|Overall Study|Death|2|||
48415933|NCT03367156|155713121|FG001|Overall Study|Death|0|||
48415934|NCT03367156|155713120|FG000|Overall Study|Lost to Follow-up|2|||
48415935|NCT03367156|155713121|FG001|Overall Study|Lost to Follow-up|1|||
48415936|NCT03367156|155713120|FG000|Overall Study|Became ineligible|1|||
48415937|NCT03367156|155713121|FG001|Overall Study|Became ineligible|2|||
48415938|NCT03367156|155713120|FG000|Overall Study|Hospitalization|1|||
48415939|NCT03367156|155713121|FG001|Overall Study|Hospitalization|0|||
48415940|NCT03367156|155713120|FG000|Overall Study|Concerned about Treatment|11|||
48415941|NCT03367156|155713121|FG001|Overall Study|Concerned about Treatment|3|||
48415942|NCT03367156|155713120|FG000|Overall Study|Started new treatment|4|||
48415943|NCT03367156|155713121|FG001|Overall Study|Started new treatment|1|||
48415944|NCT00469079|155713126|FG000|Overall Study|Lack of Efficacy|3|||
48415945|NCT00469079|155713127|FG001|Overall Study|Lack of Efficacy|8|||
48415946|NCT00469079|155713128|FG002|Overall Study|Lack of Efficacy|5|||
48415947|NCT00469079|155713126|FG000|Overall Study|Adverse Event|1|||
48415948|NCT00469079|155713127|FG001|Overall Study|Adverse Event|3|||
48415949|NCT00469079|155713128|FG002|Overall Study|Adverse Event|2|||
48415950|NCT00469079|155713126|FG000|Overall Study|Lost to Follow-up|4|||
48415951|NCT00469079|155713127|FG001|Overall Study|Lost to Follow-up|8|||
48415952|NCT00469079|155713128|FG002|Overall Study|Lost to Follow-up|10|||
48415953|NCT00469079|155713126|FG000|Overall Study|Withdrawal by Subject|1|||
48415954|NCT00469079|155713127|FG001|Overall Study|Withdrawal by Subject|2|||
48415955|NCT00469079|155713128|FG002|Overall Study|Withdrawal by Subject|2|||
48415956|NCT00469079|155713126|FG000|Overall Study|Ineligible|0|||
48415957|NCT00469079|155713127|FG001|Overall Study|Ineligible|1|||
48415958|NCT00469079|155713128|FG002|Overall Study|Ineligible|0|||
48415959|NCT00278629|155713129|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
48415960|NCT01719757|155713132|FG000|Overall Study|Adverse Event|38|||
48415961|NCT01719757|155713132|FG000|Overall Study|Withdrawal by Subject|15|||
48415962|NCT01719757|155713132|FG000|Overall Study|Lost to Follow-up|20|||
48415963|NCT01719757|155713132|FG000|Overall Study|Protocol Violation|1|||
48415964|NCT01719757|155713132|FG000|Overall Study|well controlled pain|27|||
48415965|NCT02698410|155713137|FG000|Overall Study|Adverse Event|2|||
48415966|NCT02698410|155713137|FG000|Overall Study|Withdrawal by Subject|1|||
48415967|NCT02698410|155713137|FG000|Overall Study|Other|1|||
48415968|NCT01123889|155713138|FG000|Overall Study|Lost to Follow-up|3|||
48415969|NCT01123889|155713139|FG001|Overall Study|Lost to Follow-up|1|||
48415970|NCT01896232|155713140|FG000|Overall Study|Death|6|||
48415971|NCT01896232|155713141|FG001|Overall Study|Death|10|||
48415972|NCT01896232|155713140|FG000|Overall Study|Withdrawal by Subject|32|||
48415973|NCT01896232|155713141|FG001|Overall Study|Withdrawal by Subject|31|||
48415974|NCT01896232|155713140|FG000|Overall Study|Sponsor Decision|2|||
48415975|NCT01896232|155713141|FG001|Overall Study|Sponsor Decision|0|||
48415976|NCT01896232|155713140|FG000|Overall Study|Lost to Follow-up|9|||
48415977|NCT01896232|155713141|FG001|Overall Study|Lost to Follow-up|12|||
48415978|NCT03116113|155713142|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48415979|NCT03116113|155713143|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48415980|NCT03116113|155713144|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48415981|NCT03116113|155713145|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48415982|NCT03116113|155713146|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48415983|NCT03116113|155713147|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48415984|NCT03116113|155713148|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
48415985|NCT03116113|155713149|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
48415986|NCT03116113|155713150|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
48415987|NCT03715465|155713153|FG000|Overall Study|Withdrawal by Subject|1|||
48415988|NCT03715465|155713154|FG001|Overall Study|Withdrawal by Subject|2|||
48415989|NCT02443402|155713155|FG000|Overall Study|Withdrawal by Subject|3|||
48415990|NCT02443402|155713156|FG001|Overall Study|Withdrawal by Subject|1|||
48415991|NCT02443402|155713155|FG000|Overall Study|Screen Failure|1|||
48415992|NCT02443402|155713156|FG001|Overall Study|Screen Failure|2|||
48415993|NCT02665689|155713159|FG000|Overall Study|Adverse Event|1|||
48415994|NCT02665689|155713160|FG001|Overall Study|Adverse Event|0|||
48415995|NCT02665689|155713159|FG000|Overall Study|Trial termination|1|||
48415996|NCT02665689|155713160|FG001|Overall Study|Trial termination|1|||
48415997|NCT02665689|155713159|FG000|Overall Study|Lost to Follow-up|0|||
48415998|NCT02665689|155713160|FG001|Overall Study|Lost to Follow-up|1|||
48415999|NCT02432807|155713161|FG000|Overall Study|Adverse Event|0|||
48416000|NCT02432807|155713162|FG001|Overall Study|Adverse Event|2|||
48416001|NCT02432807|155713161|FG000|Overall Study|Lost to Follow-up|1|||
48416002|NCT02432807|155713162|FG001|Overall Study|Lost to Follow-up|0|||
48416003|NCT02432807|155713161|FG000|Overall Study|Withdrawal by Subject|1|||
48416004|NCT02432807|155713162|FG001|Overall Study|Withdrawal by Subject|1|||
48416005|NCT02432807|155713161|FG000|Overall Study|Other|1|||
48416006|NCT02432807|155713162|FG001|Overall Study|Other|1|||
48416007|NCT00345605|155713167|FG000|Arm 1|Adverse Event|0|||
48416008|NCT00345605|155713168|FG001|Arm 1|Adverse Event|1|||
48416009|NCT00345605|155713167|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
48416010|NCT00345605|155713168|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
48416011|NCT01335971|155713169|FG000|Overall Study|Withdrawal by Subject|1|||
48416012|NCT01335971|155713170|FG001|Overall Study|Withdrawal by Subject|0|||
48416013|NCT01335971|155713171|FG002|Overall Study|Withdrawal by Subject|0|||
48416014|NCT01335971|155713169|FG000|Overall Study|Did not complete bronchoscopy|1|||
48416015|NCT01335971|155713170|FG001|Overall Study|Did not complete bronchoscopy|1|||
48416016|NCT01335971|155713171|FG002|Overall Study|Did not complete bronchoscopy|1|||
48416017|NCT02210780|155713172|FG000|Overall Study|Adverse Event|0|||
48416018|NCT02210780|155713173|FG001|Overall Study|Adverse Event|5|||
48416019|NCT02210780|155713172|FG000|Overall Study|Lost to Follow-up|2|||
48416020|NCT02210780|155713173|FG001|Overall Study|Lost to Follow-up|1|||
48416021|NCT02210780|155713172|FG000|Overall Study|Withdrawal by Subject|1|||
48416022|NCT02210780|155713173|FG001|Overall Study|Withdrawal by Subject|1|||
48416023|NCT02210780|155713172|FG000|Overall Study|Physician Decision|1|||
48416024|NCT02210780|155713173|FG001|Overall Study|Physician Decision|0|||
48416025|NCT02210780|155713172|FG000|Overall Study|Protocol Violation|1|||
48416026|NCT02210780|155713173|FG001|Overall Study|Protocol Violation|0|||
48416027|NCT02210780|155713172|FG000|Overall Study|Other than specified above|0|||
48416028|NCT02210780|155713173|FG001|Overall Study|Other than specified above|1|||
48416029|NCT02582515|155713177|FG000|Overall Study|Withdrawal by Subject|0|||
48416030|NCT02582515|155713178|FG001|Overall Study|Withdrawal by Subject|1|||
48416031|NCT01021007|155713179|FG000|Overall Study|Lost to Follow-up|1|||
48416032|NCT01021007|155713180|FG001|Overall Study|Lost to Follow-up|1|||
48416033|NCT01021007|155713179|FG000|Overall Study|Adverse Event|1|||
48416034|NCT01021007|155713180|FG001|Overall Study|Adverse Event|3|||
48416035|NCT01725165|155713181|FG000|Overall Study|Death|11|||
48416036|NCT01725165|155713182|FG001|Overall Study|Death|18|||
48416037|NCT03619213|155713185|FG000|Overall Study|Lost to Follow-up|2|||
48416038|NCT03619213|155713186|FG001|Overall Study|Lost to Follow-up|1|||
48416039|NCT03619213|155713185|FG000|Overall Study|Withdrawal by Subject|8|||
48416040|NCT03619213|155713186|FG001|Overall Study|Withdrawal by Subject|10|||
48416041|NCT00382967|155713187|FG000|Overall Study|Protocol Violation|1|||
48416042|NCT00382967|155713188|FG001|Overall Study|Protocol Violation|1|||
48416043|NCT00862251|155713189|FG000|Overall Study|Adverse Event|8|||
48416044|NCT00862251|155713190|FG001|Overall Study|Adverse Event|3|||
48416045|NCT00862251|155713191|FG002|Overall Study|Adverse Event|1|||
48416046|NCT00862251|155713189|FG000|Overall Study|Lost to Follow-up|0|||
48416047|NCT00862251|155713190|FG001|Overall Study|Lost to Follow-up|0|||
48416048|NCT00862251|155713191|FG002|Overall Study|Lost to Follow-up|1|||
48416049|NCT00862251|155713189|FG000|Overall Study|Protocol Violation|2|||
48416050|NCT00862251|155713190|FG001|Overall Study|Protocol Violation|0|||
48416051|NCT00862251|155713191|FG002|Overall Study|Protocol Violation|1|||
48416052|NCT00862251|155713189|FG000|Overall Study|Withdrawal by Subject|9|||
48416053|NCT00862251|155713190|FG001|Overall Study|Withdrawal by Subject|2|||
48416054|NCT00862251|155713191|FG002|Overall Study|Withdrawal by Subject|6|||
48416055|NCT00833092|155713194|FG000|Overall Study|Withdrawal by Subject|2|||
48416056|NCT00833092|155713195|FG001|Overall Study|Withdrawal by Subject|3|||
48416057|NCT00833092|155713194|FG000|Overall Study|Protocol Violation|2|||
48416058|NCT00833092|155713195|FG001|Overall Study|Protocol Violation|1|||
48416059|NCT00833092|155713194|FG000|Overall Study|Diarrhea|0|||
48416060|NCT00833092|155713195|FG001|Overall Study|Diarrhea|2|||
48416061|NCT00833092|155713194|FG000|Overall Study|constipation|0|||
48416062|NCT00833092|155713195|FG001|Overall Study|constipation|1|||
48416063|NCT00619229|155713196|FG000|Overall Study|Withdrawal by Subject|1|||
48416064|NCT00619229|155713197|FG001|Overall Study|Withdrawal by Subject|1|||
48416065|NCT00619229|155713196|FG000|Overall Study|Lost to Follow-up|1|||
48416066|NCT00619229|155713197|FG001|Overall Study|Lost to Follow-up|0|||
48416067|NCT00619229|155713196|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
48416068|NCT00619229|155713197|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
48416069|NCT00619229|155713196|FG000|Overall Study|Investigator planned Cataract Operation|1|||
48416070|NCT00619229|155713197|FG001|Overall Study|Investigator planned Cataract Operation|0|||
48416071|NCT01859403|155713200|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
48416072|NCT01859403|155713201|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
48416073|NCT01859403|155713200|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
48416074|NCT01859403|155713201|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
48416075|NCT01859403|155713200|FG000|Primary Endpoint Measure|Physician Decision|0|||
48416076|NCT01859403|155713201|FG001|Primary Endpoint Measure|Physician Decision|1|||
48416077|NCT01859403|155713200|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
48416078|NCT01859403|155713201|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
48416079|NCT00929240|155713203|FG000|Initial Treatment Phase|Adverse Event|31|||
48416080|NCT00929240|155713204|FG001|Initial Treatment Phase|Adverse Event|0|||
48416081|NCT00929240|155713205|FG002|Initial Treatment Phase|Adverse Event|0|||
48416082|NCT00929240|155713203|FG000|Initial Treatment Phase|Disease progression|41|||
48416083|NCT00929240|155713204|FG001|Initial Treatment Phase|Disease progression|0|||
48416084|NCT00929240|155713205|FG002|Initial Treatment Phase|Disease progression|0|||
48416085|NCT00929240|155713203|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
48416086|NCT00929240|155713204|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
48416087|NCT00929240|155713205|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
48416088|NCT00929240|155713203|FG000|Initial Treatment Phase|Protocol Violation|5|||
48416089|NCT00929240|155713204|FG001|Initial Treatment Phase|Protocol Violation|0|||
48416090|NCT00929240|155713205|FG002|Initial Treatment Phase|Protocol Violation|0|||
48416091|NCT00929240|155713203|FG000|Initial Treatment Phase|Death|2|||
48416092|NCT00929240|155713204|FG001|Initial Treatment Phase|Death|0|||
48416093|NCT00929240|155713205|FG002|Initial Treatment Phase|Death|0|||
48416094|NCT00929240|155713203|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
48416095|NCT00929240|155713204|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
48416096|NCT00929240|155713205|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
48416097|NCT00929240|155713203|FG000|Initial Treatment Phase|Physician Decision|4|||
48416098|NCT00929240|155713204|FG001|Initial Treatment Phase|Physician Decision|0|||
48416099|NCT00929240|155713205|FG002|Initial Treatment Phase|Physician Decision|0|||
48416100|NCT00929240|155713203|FG000|Maintenance Phase|Disease progression|0|||
48416101|NCT00929240|155713204|FG001|Maintenance Phase|Disease progression|73|||
48416102|NCT00929240|155713205|FG002|Maintenance Phase|Disease progression|60|||
48416103|NCT00929240|155713203|FG000|Maintenance Phase|Adverse Event|0|||
48416104|NCT00929240|155713204|FG001|Maintenance Phase|Adverse Event|9|||
48416105|NCT00929240|155713205|FG002|Maintenance Phase|Adverse Event|12|||
48416106|NCT00929240|155713203|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48416107|NCT00929240|155713204|FG001|Maintenance Phase|Withdrawal by Subject|2|||
48416108|NCT00929240|155713205|FG002|Maintenance Phase|Withdrawal by Subject|6|||
48416109|NCT00929240|155713203|FG000|Maintenance Phase|Protocol Violation|0|||
48416110|NCT00929240|155713204|FG001|Maintenance Phase|Protocol Violation|1|||
48416111|NCT00929240|155713205|FG002|Maintenance Phase|Protocol Violation|0|||
48416112|NCT00929240|155713203|FG000|Maintenance Phase|Health authority/Study termination|0|||
48416113|NCT00929240|155713204|FG001|Maintenance Phase|Health authority/Study termination|1|||
48416114|NCT00929240|155713205|FG002|Maintenance Phase|Health authority/Study termination|2|||
48416115|NCT00929240|155713203|FG000|Maintenance Phase|Physician Decision|0|||
48416116|NCT00929240|155713204|FG001|Maintenance Phase|Physician Decision|2|||
48416117|NCT00929240|155713205|FG002|Maintenance Phase|Physician Decision|1|||
48416118|NCT00929240|155713203|FG000|Maintenance Phase|Change of treatment|0|||
48416119|NCT00929240|155713204|FG001|Maintenance Phase|Change of treatment|4|||
48416120|NCT00929240|155713205|FG002|Maintenance Phase|Change of treatment|0|||
48416121|NCT00929240|155713203|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
48416122|NCT00929240|155713204|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
48416123|NCT00929240|155713205|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
48416124|NCT00929240|155713203|FG000|Maintenance Phase|Participant not treated|0|||
48416125|NCT00929240|155713204|FG001|Maintenance Phase|Participant not treated|2|||
48416126|NCT00929240|155713205|FG002|Maintenance Phase|Participant not treated|0|||
48416127|NCT03584009|155713206|FG000|Overall Study|Death|25|||
48416128|NCT03584009|155713207|FG001|Overall Study|Death|18|||
48416129|NCT03584009|155713206|FG000|Overall Study|Lost to Follow-up|0|||
48416130|NCT03584009|155713207|FG001|Overall Study|Lost to Follow-up|1|||
48416131|NCT03584009|155713206|FG000|Overall Study|Physician Decision|1|||
48416132|NCT03584009|155713207|FG001|Overall Study|Physician Decision|1|||
48416133|NCT03584009|155713206|FG000|Overall Study|Study Terminated by Sponsor|22|||
48416134|NCT03584009|155713207|FG001|Overall Study|Study Terminated by Sponsor|30|||
48416135|NCT03584009|155713206|FG000|Overall Study|Withdrawal by Subject|3|||
48416136|NCT03584009|155713207|FG001|Overall Study|Withdrawal by Subject|2|||
48416137|NCT04964258|155713208|FG000|Overall Study|Lost to Follow-up|1|||
48416138|NCT04964258|155713209|FG001|Overall Study|Lost to Follow-up|0|||
48416139|NCT04964258|155713210|FG002|Overall Study|Lost to Follow-up|0|||
48416140|NCT04964258|155713211|FG003|Overall Study|Lost to Follow-up|0|||
48416141|NCT04964258|155713212|FG004|Overall Study|Lost to Follow-up|0|||
48416142|NCT04964258|155713213|FG005|Overall Study|Lost to Follow-up|1|||
48416143|NCT04964258|155713214|FG006|Overall Study|Lost to Follow-up|0|||
48416144|NCT04964258|155713215|FG007|Overall Study|Lost to Follow-up|0|||
48416145|NCT04964258|155713216|FG008|Overall Study|Lost to Follow-up|0|||
48416146|NCT04964258|155713217|FG009|Overall Study|Lost to Follow-up|0|||
48416147|NCT04964258|155713218|FG010|Overall Study|Lost to Follow-up|0|||
48416148|NCT03427073|155713219|FG000|Overall Study|Disease Progression|1|||
48416149|NCT03427073|155713220|FG001|Overall Study|Disease Progression|1|||
48416150|NCT03427073|155713221|FG002|Overall Study|Disease Progression|1|||
48416151|NCT03427073|155713222|FG003|Overall Study|Disease Progression|3|||
48416152|NCT03427073|155713223|FG004|Overall Study|Disease Progression|3|||
48416153|NCT03427073|155713224|FG005|Overall Study|Disease Progression|4|||
48416154|NCT03427073|155713225|FG006|Overall Study|Disease Progression|2|||
48416155|NCT03427073|155713226|FG007|Overall Study|Disease Progression|3|||
48416156|NCT03427073|155713219|FG000|Overall Study|Physician Decision|0|||
48416157|NCT03427073|155713220|FG001|Overall Study|Physician Decision|0|||
48416158|NCT03427073|155713221|FG002|Overall Study|Physician Decision|0|||
48416159|NCT03427073|155713222|FG003|Overall Study|Physician Decision|0|||
48416160|NCT03427073|155713223|FG004|Overall Study|Physician Decision|0|||
48416161|NCT03427073|155713224|FG005|Overall Study|Physician Decision|0|||
48416162|NCT03427073|155713225|FG006|Overall Study|Physician Decision|1|||
48416163|NCT03427073|155713226|FG007|Overall Study|Physician Decision|1|||
48416164|NCT01794780|155713232|FG000|Overall Study|Adverse Event|0|||
48416165|NCT01794780|155713233|FG001|Overall Study|Adverse Event|1|||
48416166|NCT01794780|155713234|FG002|Overall Study|Adverse Event|2|||
48416167|NCT01794780|155713235|FG003|Overall Study|Adverse Event|0|||
48416168|NCT01794780|155713236|FG004|Overall Study|Adverse Event|0|||
48416169|NCT01794780|155713237|FG005|Overall Study|Adverse Event|0|||
48416170|NCT01794780|155713238|FG006|Overall Study|Adverse Event|0|||
48416171|NCT01794780|155713239|FG007|Overall Study|Adverse Event|0|||
48416172|NCT01794780|155713232|FG000|Overall Study|Death|0|||
48416173|NCT01794780|155713233|FG001|Overall Study|Death|2|||
48416174|NCT01794780|155713234|FG002|Overall Study|Death|14|||
48416175|NCT01794780|155713235|FG003|Overall Study|Death|1|||
48416176|NCT01794780|155713236|FG004|Overall Study|Death|0|||
48416177|NCT01794780|155713237|FG005|Overall Study|Death|9|||
48416178|NCT01794780|155713238|FG006|Overall Study|Death|4|||
48416179|NCT01794780|155713239|FG007|Overall Study|Death|0|||
48416180|NCT01794780|155713232|FG000|Overall Study|Lost to Follow-up|10|||
48416181|NCT01794780|155713233|FG001|Overall Study|Lost to Follow-up|64|||
48416182|NCT01794780|155713234|FG002|Overall Study|Lost to Follow-up|165|||
48416183|NCT01794780|155713235|FG003|Overall Study|Lost to Follow-up|53|||
48416184|NCT01794780|155713236|FG004|Overall Study|Lost to Follow-up|2|||
48416185|NCT01794780|155713237|FG005|Overall Study|Lost to Follow-up|99|||
48416186|NCT01794780|155713238|FG006|Overall Study|Lost to Follow-up|30|||
48416187|NCT01794780|155713239|FG007|Overall Study|Lost to Follow-up|5|||
48416188|NCT01794780|155713232|FG000|Overall Study|Withdrew informed consent|7|||
48416189|NCT01794780|155713233|FG001|Overall Study|Withdrew informed consent|17|||
48416190|NCT01794780|155713234|FG002|Overall Study|Withdrew informed consent|36|||
48416191|NCT01794780|155713235|FG003|Overall Study|Withdrew informed consent|9|||
48416192|NCT01794780|155713236|FG004|Overall Study|Withdrew informed consent|0|||
48416193|NCT01794780|155713237|FG005|Overall Study|Withdrew informed consent|48|||
48416194|NCT01794780|155713238|FG006|Overall Study|Withdrew informed consent|4|||
48416195|NCT01794780|155713239|FG007|Overall Study|Withdrew informed consent|3|||
48416196|NCT01794780|155713232|FG000|Overall Study|Other|0|||
48416197|NCT01794780|155713233|FG001|Overall Study|Other|12|||
48416198|NCT01794780|155713234|FG002|Overall Study|Other|25|||
48416199|NCT01794780|155713235|FG003|Overall Study|Other|20|||
48416200|NCT01794780|155713236|FG004|Overall Study|Other|1|||
48416201|NCT01794780|155713237|FG005|Overall Study|Other|24|||
48416202|NCT01794780|155713238|FG006|Overall Study|Other|4|||
48416203|NCT01794780|155713239|FG007|Overall Study|Other|1|||
48416204|NCT00805207|155713240|FG000|Overall Study|Protocol Violation|0|||
48416205|NCT00805207|155713241|FG001|Overall Study|Protocol Violation|0|||
48416206|NCT00805207|155713242|FG002|Overall Study|Protocol Violation|1|||
48416207|NCT00805207|155713243|FG003|Overall Study|Protocol Violation|0|||
48416208|NCT00805207|155713244|FG004|Overall Study|Protocol Violation|0|||
48416209|NCT00805207|155713245|FG005|Overall Study|Protocol Violation|0|||
48416210|NCT00805207|155713246|FG006|Overall Study|Protocol Violation|0|||
48416211|NCT00805207|155713247|FG007|Overall Study|Protocol Violation|0|||
48416212|NCT00805207|155713248|FG008|Overall Study|Protocol Violation|0|||
48416213|NCT00805207|155713240|FG000|Overall Study|Physician Decision|0|||
48416214|NCT00805207|155713241|FG001|Overall Study|Physician Decision|1|||
48416215|NCT00805207|155713242|FG002|Overall Study|Physician Decision|0|||
48416216|NCT00805207|155713243|FG003|Overall Study|Physician Decision|0|||
48416217|NCT00805207|155713244|FG004|Overall Study|Physician Decision|0|||
48416218|NCT00805207|155713245|FG005|Overall Study|Physician Decision|1|||
48416219|NCT00805207|155713246|FG006|Overall Study|Physician Decision|0|||
48416220|NCT00805207|155713247|FG007|Overall Study|Physician Decision|0|||
48416221|NCT00805207|155713248|FG008|Overall Study|Physician Decision|0|||
48416222|NCT00805207|155713240|FG000|Overall Study|Withdrawal by Subject|0|||
48416223|NCT00805207|155713241|FG001|Overall Study|Withdrawal by Subject|1|||
48416224|NCT00805207|155713242|FG002|Overall Study|Withdrawal by Subject|0|||
48416225|NCT00805207|155713243|FG003|Overall Study|Withdrawal by Subject|0|||
48416226|NCT00805207|155713244|FG004|Overall Study|Withdrawal by Subject|1|||
48416227|NCT00805207|155713245|FG005|Overall Study|Withdrawal by Subject|2|||
48416228|NCT00805207|155713246|FG006|Overall Study|Withdrawal by Subject|0|||
48416229|NCT00805207|155713247|FG007|Overall Study|Withdrawal by Subject|0|||
48416230|NCT00805207|155713248|FG008|Overall Study|Withdrawal by Subject|0|||
48416231|NCT00064701|155713249|FG000|One Year Post-transplant|Did not receive study drug|7|||
48416232|NCT00064701|155713250|FG001|One Year Post-transplant|Did not receive study drug|12|||
48416233|NCT00064701|155713251|FG002|One Year Post-transplant|Did not receive study drug|11|||
48416234|NCT00064701|155713249|FG000|One Year Post-transplant|Adverse Event|23|||
48416235|NCT00064701|155713250|FG001|One Year Post-transplant|Adverse Event|19|||
48416236|NCT00064701|155713251|FG002|One Year Post-transplant|Adverse Event|37|||
48416237|NCT00064701|155713249|FG000|One Year Post-transplant|Rejection|0|||
48416238|NCT00064701|155713250|FG001|One Year Post-transplant|Rejection|1|||
48416239|NCT00064701|155713251|FG002|One Year Post-transplant|Rejection|16|||
48416240|NCT00064701|155713249|FG000|One Year Post-transplant|Non-compliance|4|||
48416241|NCT00064701|155713250|FG001|One Year Post-transplant|Non-compliance|2|||
48416242|NCT00064701|155713251|FG002|One Year Post-transplant|Non-compliance|5|||
48416243|NCT00064701|155713249|FG000|One Year Post-transplant|Graft Failure|3|||
48416244|NCT00064701|155713250|FG001|One Year Post-transplant|Graft Failure|2|||
48416245|NCT00064701|155713251|FG002|One Year Post-transplant|Graft Failure|1|||
48416246|NCT00064701|155713249|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
48416247|NCT00064701|155713250|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
48416248|NCT00064701|155713251|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
48416249|NCT00064701|155713249|FG000|One Year Post-transplant|Lost to Follow-up|1|||
48416250|NCT00064701|155713250|FG001|One Year Post-transplant|Lost to Follow-up|0|||
48416251|NCT00064701|155713251|FG002|One Year Post-transplant|Lost to Follow-up|0|||
48416252|NCT00064701|155713249|FG000|One Year Post-transplant|Converted to rapamycin|1|||
48416253|NCT00064701|155713250|FG001|One Year Post-transplant|Converted to rapamycin|0|||
48416254|NCT00064701|155713251|FG002|One Year Post-transplant|Converted to rapamycin|0|||
48416255|NCT00064701|155713249|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
48416256|NCT00064701|155713250|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
48416257|NCT00064701|155713251|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
48416258|NCT00064701|155713249|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
48416259|NCT00064701|155713250|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
48416260|NCT00064701|155713251|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
48416261|NCT00064701|155713249|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
48416262|NCT00064701|155713250|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
48416263|NCT00064701|155713251|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
48416264|NCT00064701|155713249|FG000|One Year Post-transplant|Poor absorption|0|||
48416265|NCT00064701|155713250|FG001|One Year Post-transplant|Poor absorption|1|||
48416266|NCT00064701|155713251|FG002|One Year Post-transplant|Poor absorption|0|||
48416267|NCT00064701|155713249|FG000|One Year Post-transplant|Pancreas transplant|0|||
48416268|NCT00064701|155713250|FG001|One Year Post-transplant|Pancreas transplant|0|||
48416269|NCT00064701|155713251|FG002|One Year Post-transplant|Pancreas transplant|1|||
48416270|NCT00064701|155713249|FG000|Clinical Continuation Phase|Adverse Event|12|||
48416271|NCT00064701|155713250|FG001|Clinical Continuation Phase|Adverse Event|21|||
48416272|NCT00064701|155713251|FG002|Clinical Continuation Phase|Adverse Event|14|||
48416273|NCT00064701|155713249|FG000|Clinical Continuation Phase|Non-compliance|8|||
48416274|NCT00064701|155713250|FG001|Clinical Continuation Phase|Non-compliance|6|||
48416275|NCT00064701|155713251|FG002|Clinical Continuation Phase|Non-compliance|7|||
48416276|NCT00064701|155713249|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
48416277|NCT00064701|155713250|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
48416278|NCT00064701|155713251|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
48416279|NCT00064701|155713249|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
48416280|NCT00064701|155713250|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
48416281|NCT00064701|155713251|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
48416282|NCT00064701|155713249|FG000|Clinical Continuation Phase|Graft Failure|5|||
48416283|NCT00064701|155713250|FG001|Clinical Continuation Phase|Graft Failure|5|||
48416284|NCT00064701|155713251|FG002|Clinical Continuation Phase|Graft Failure|2|||
48416285|NCT00064701|155713249|FG000|Clinical Continuation Phase|Rejection|1|||
48416286|NCT00064701|155713250|FG001|Clinical Continuation Phase|Rejection|2|||
48416287|NCT00064701|155713251|FG002|Clinical Continuation Phase|Rejection|2|||
48416288|NCT00064701|155713249|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
48416289|NCT00064701|155713250|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
48416290|NCT00064701|155713251|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
48426319|NCT02203838|155749550|FG000|Overall Study|Adverse Event|46|||
48416291|NCT00064701|155713249|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
48416292|NCT00064701|155713250|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
48416293|NCT00064701|155713251|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
48416294|NCT00064701|155713249|FG000|Clinical Continuation Phase|Physician Decision|1|||
48416295|NCT00064701|155713250|FG001|Clinical Continuation Phase|Physician Decision|3|||
48416296|NCT00064701|155713251|FG002|Clinical Continuation Phase|Physician Decision|0|||
48416297|NCT00064701|155713249|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
48416298|NCT00064701|155713250|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
48416299|NCT00064701|155713251|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
48416300|NCT00064701|155713249|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
48416301|NCT00064701|155713250|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
48416302|NCT00064701|155713251|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
48416303|NCT00064701|155713249|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
48416304|NCT00064701|155713250|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
48416305|NCT00064701|155713251|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
48416306|NCT00064701|155713249|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
48416307|NCT00064701|155713250|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
48416308|NCT00064701|155713251|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
48416309|NCT00064701|155713249|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
48416310|NCT00064701|155713250|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
48416311|NCT00064701|155713251|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
48416312|NCT00064701|155713249|FG000|Clinical Continuation Phase|Patient opted out|0|||
48416313|NCT00064701|155713250|FG001|Clinical Continuation Phase|Patient opted out|0|||
48416314|NCT00064701|155713251|FG002|Clinical Continuation Phase|Patient opted out|1|||
48416315|NCT02485717|155713254|FG000|Overall Study|Lost to Follow-up|6|||
48416316|NCT02485717|155713255|FG001|Overall Study|Lost to Follow-up|0|||
48416317|NCT02485717|155713256|FG002|Overall Study|Lost to Follow-up|0|||
48416318|NCT02485717|155713254|FG000|Overall Study|Withdrawal by Subject|0|||
48416319|NCT02485717|155713255|FG001|Overall Study|Withdrawal by Subject|0|||
48416320|NCT02485717|155713256|FG002|Overall Study|Withdrawal by Subject|1|||
48416321|NCT02485717|155713254|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
48416322|NCT02485717|155713255|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
48416323|NCT02485717|155713256|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
48416324|NCT02485717|155713254|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
48416325|NCT02485717|155713255|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
48416326|NCT02485717|155713256|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
48416327|NCT00613626|155713257|FG000|Overall Study|Ineligible|0|||
48416328|NCT00613626|155713258|FG001|Overall Study|Ineligible|1|||
48416329|NCT00613626|155713259|FG002|Overall Study|Ineligible|0|||
48416330|NCT01564784|155713262|FG000|Overall Study|Other|1|||
48416331|NCT01564784|155713263|FG001|Overall Study|Other|0|||
48416332|NCT01564784|155713262|FG000|Overall Study|Subject refused further follow-up|1|||
48416333|NCT01564784|155713263|FG001|Overall Study|Subject refused further follow-up|6|||
48416334|NCT01564784|155713262|FG000|Overall Study|Lost to Follow-up|1|||
48416335|NCT01564784|155713263|FG001|Overall Study|Lost to Follow-up|1|||
48416336|NCT01564784|155713262|FG000|Overall Study|Death|131|||
48416337|NCT01564784|155713263|FG001|Overall Study|Death|126|||
48416338|NCT00784758|155713266|FG000|Overall Study|Withdrawal by Subject|3|||
48416339|NCT00784758|155713267|FG001|Overall Study|Withdrawal by Subject|0|||
48416340|NCT00784758|155713266|FG000|Overall Study|Adverse Event|1|||
48416341|NCT00784758|155713267|FG001|Overall Study|Adverse Event|0|||
48416342|NCT00467649|155713268|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
48416343|NCT00467649|155713269|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
48416344|NCT00467649|155713270|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
48416345|NCT00467649|155713271|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
48416346|NCT00467649|155713272|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
48416347|NCT00467649|155713273|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
48416348|NCT00467649|155713268|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
48416349|NCT00467649|155713269|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
48416350|NCT00467649|155713270|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
48416351|NCT00467649|155713271|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
48416352|NCT00467649|155713272|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
48416353|NCT00467649|155713273|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
48416354|NCT00467649|155713268|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
48416355|NCT00467649|155713269|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
48416356|NCT00467649|155713270|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
48416357|NCT00467649|155713271|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
48416358|NCT00467649|155713272|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
48416359|NCT00467649|155713273|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
48416360|NCT00467649|155713268|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
48416361|NCT00467649|155713269|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
48416362|NCT00467649|155713270|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
48416363|NCT00467649|155713271|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
48416364|NCT00467649|155713272|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
48416365|NCT00467649|155713273|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
48416366|NCT00467649|155713268|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48416367|NCT00467649|155713269|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48416368|NCT00467649|155713270|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48416369|NCT00467649|155713271|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
48416370|NCT00467649|155713272|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48416371|NCT00467649|155713273|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
48416372|NCT00467649|155713268|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48416373|NCT00467649|155713269|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48416374|NCT00467649|155713270|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48416375|NCT00467649|155713271|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
48416376|NCT00467649|155713272|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48416377|NCT00467649|155713273|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
48416378|NCT00467649|155713268|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48416379|NCT00467649|155713269|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48416380|NCT00467649|155713270|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48416381|NCT00467649|155713271|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48416382|NCT00467649|155713272|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
48416383|NCT00467649|155713273|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
48416384|NCT00754390|155713274|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
48416385|NCT00754390|155713274|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
48416386|NCT00754390|155713274|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
48416387|NCT00754390|155713274|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
48416388|NCT01624194|155713275|FG000|Overall Study|Lost to Follow-up|1|||
48416389|NCT01624194|155713276|FG001|Overall Study|Lost to Follow-up|0|||
48416390|NCT01624194|155713275|FG000|Overall Study|Withdrawal by Subject|1|||
48416391|NCT01624194|155713276|FG001|Overall Study|Withdrawal by Subject|0|||
48416392|NCT02498821|155713277|FG000|Overall Study|Screen failure|3|||
48416393|NCT02498821|155713278|FG001|Overall Study|Screen failure|5|||
48416394|NCT05480514|155713279|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
48416395|NCT05480514|155713280|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
48416396|NCT05480514|155713279|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
48416397|NCT05480514|155713280|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
48416398|NCT05480514|155713279|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
48416399|NCT05480514|155713280|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
48416400|NCT05480514|155713279|FG000|Period 1|Covid-19 Related|1|||
48416401|NCT05480514|155713280|FG001|Period 1|Covid-19 Related|0|||
48416402|NCT05480514|155713279|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
48416403|NCT05480514|155713280|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
48416404|NCT00986349|155713284|FG000|Overall Study|Unsuccessful implant procedure|3|||
48416405|NCT00986349|155713284|FG000|Overall Study|Adverse Event|2|||
48416406|NCT00986349|155713284|FG000|Overall Study|Physician Decision|1|||
48416407|NCT00986349|155713284|FG000|Overall Study|device migration|1|||
48416408|NCT03815175|155713285|FG000|Overall Study|Subject Lost to Follow-up|6|||
48416409|NCT03815175|155713285|FG000|Overall Study|Subject Withdrew Consent|48|||
48416410|NCT03815175|155713285|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
48416411|NCT03815175|155713285|FG000|Overall Study|Death|86|||
48416412|NCT03815175|155713285|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
48416413|NCT03815175|155713285|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
48416414|NCT03815175|155713285|FG000|Overall Study|Other Status Change Reason|1|||
48416415|NCT03815175|155713285|FG000|Overall Study|Missed Visit|12|||
48416416|NCT03577990|155713286|FG000|Overall Study|Lost to Follow-up|4|||
48416417|NCT03577990|155713287|FG001|Overall Study|Lost to Follow-up|6|||
48416418|NCT03577990|155713286|FG000|Overall Study|Withdrawal by Subject|4|||
48416419|NCT03577990|155713287|FG001|Overall Study|Withdrawal by Subject|7|||
48416420|NCT00883753|155713288|FG000|Overall Study|Adverse Event|37|||
48416421|NCT00883753|155713288|FG000|Overall Study|Death|2|||
48416422|NCT00883753|155713288|FG000|Overall Study|Insufficient therapeutic response|16|||
48416423|NCT00883753|155713288|FG000|Overall Study|Lost to Follow-up|4|||
48416424|NCT00883753|155713288|FG000|Overall Study|Violation of selection criteria at entry|7|||
48416425|NCT00883753|155713288|FG000|Overall Study|Protocol Violation|2|||
48416426|NCT00883753|155713288|FG000|Overall Study|Refused treatment|4|||
48416427|NCT00883753|155713288|FG000|Overall Study|Withdrew consent|10|||
48416428|NCT00883753|155713288|FG000|Overall Study|Investigator's decision|17|||
48416429|NCT00883753|155713288|FG000|Overall Study|Administrative/Other|8|||
48416430|NCT01607892|155713291|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
48416431|NCT01607892|155713292|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
48416432|NCT01607892|155713293|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
48416433|NCT01607892|155713294|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
48416434|NCT01607892|155713295|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
48416435|NCT01607892|155713291|FG000|Overall Study|Death|4|||
48416436|NCT01607892|155713292|FG001|Overall Study|Death|2|||
48416437|NCT01607892|155713293|FG002|Overall Study|Death|8|||
48416438|NCT01607892|155713294|FG003|Overall Study|Death|10|||
48416439|NCT01607892|155713295|FG004|Overall Study|Death|3|||
48416440|NCT01607892|155713291|FG000|Overall Study|Investigator discretion|2|||
48416441|NCT01607892|155713292|FG001|Overall Study|Investigator discretion|4|||
48416442|NCT01607892|155713293|FG002|Overall Study|Investigator discretion|4|||
48416443|NCT01607892|155713294|FG003|Overall Study|Investigator discretion|8|||
48416444|NCT01607892|155713295|FG004|Overall Study|Investigator discretion|0|||
48416445|NCT01607892|155713291|FG000|Overall Study|Other treatments became available|1|||
48416446|NCT01607892|155713292|FG001|Overall Study|Other treatments became available|1|||
48416447|NCT01607892|155713293|FG002|Overall Study|Other treatments became available|0|||
48416448|NCT01607892|155713294|FG003|Overall Study|Other treatments became available|0|||
48416449|NCT01607892|155713295|FG004|Overall Study|Other treatments became available|2|||
48416450|NCT01607892|155713291|FG000|Overall Study|Intercurrent illness|1|||
48416451|NCT01607892|155713292|FG001|Overall Study|Intercurrent illness|0|||
48416452|NCT01607892|155713293|FG002|Overall Study|Intercurrent illness|0|||
48416453|NCT01607892|155713294|FG003|Overall Study|Intercurrent illness|3|||
48416454|NCT01607892|155713295|FG004|Overall Study|Intercurrent illness|0|||
48416455|NCT01607892|155713291|FG000|Overall Study|Non-Compliance with study procedures|0|||
48416456|NCT01607892|155713292|FG001|Overall Study|Non-Compliance with study procedures|0|||
48416457|NCT01607892|155713293|FG002|Overall Study|Non-Compliance with study procedures|1|||
48416458|NCT01607892|155713294|FG003|Overall Study|Non-Compliance with study procedures|0|||
48416459|NCT01607892|155713295|FG004|Overall Study|Non-Compliance with study procedures|0|||
48416460|NCT01607892|155713291|FG000|Overall Study|Consent withdrawn by participant|9|||
48416461|NCT01607892|155713292|FG001|Overall Study|Consent withdrawn by participant|4|||
48416462|NCT01607892|155713293|FG002|Overall Study|Consent withdrawn by participant|24|||
48416463|NCT01607892|155713294|FG003|Overall Study|Consent withdrawn by participant|14|||
48416464|NCT01607892|155713295|FG004|Overall Study|Consent withdrawn by participant|4|||
48416465|NCT01607892|155713291|FG000|Overall Study|Disease progression|38|||
48416466|NCT01607892|155713292|FG001|Overall Study|Disease progression|13|||
48416467|NCT01607892|155713293|FG002|Overall Study|Disease progression|37|||
48416468|NCT01607892|155713294|FG003|Overall Study|Disease progression|57|||
48416469|NCT01607892|155713295|FG004|Overall Study|Disease progression|9|||
48416470|NCT01607892|155713291|FG000|Overall Study|Incidence or severity of Adverse events|3|||
48416471|NCT01607892|155713292|FG001|Overall Study|Incidence or severity of Adverse events|3|||
48416472|NCT01607892|155713293|FG002|Overall Study|Incidence or severity of Adverse events|7|||
48416473|NCT01607892|155713294|FG003|Overall Study|Incidence or severity of Adverse events|2|||
48416474|NCT01607892|155713295|FG004|Overall Study|Incidence or severity of Adverse events|6|||
48416475|NCT01028352|155715177|FG000|Overall Study|Ineligible due to baseline average pain|5|||
48416476|NCT01028352|155715177|FG000|Overall Study|Withdrawal by Subject|1|||
48416477|NCT01903876|155715178|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
48416478|NCT01903876|155715179|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
48416479|NCT01903876|155715178|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
48416480|NCT01903876|155715179|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
48416481|NCT00384956|155715181|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
48416482|NCT03487445|155715184|FG000|Randomization|Not treated for administrative reasons|1|||
48416483|NCT03487445|155715185|FG001|Randomization|Not treated for administrative reasons|0|||
48416484|NCT00097539|155715188|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
48416485|NCT00097539|155715189|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
48416486|NCT00097539|155715190|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
48416487|NCT00097539|155715191|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
48416488|NCT00097539|155715192|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
48416489|NCT00097539|155715193|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
48416490|NCT00097539|155715194|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
48416491|NCT00097539|155715188|FG000|Overall Study|Withdrawal by Subject|925|||
48416492|NCT00097539|155715189|FG001|Overall Study|Withdrawal by Subject|323|||
48416493|NCT00097539|155715190|FG002|Overall Study|Withdrawal by Subject|346|||
48416494|NCT00097539|155715191|FG003|Overall Study|Withdrawal by Subject|217|||
48416495|NCT00097539|155715192|FG004|Overall Study|Withdrawal by Subject|68|||
48416496|NCT00097539|155715193|FG005|Overall Study|Withdrawal by Subject|229|||
48416497|NCT00097539|155715194|FG006|Overall Study|Withdrawal by Subject|3|||
48416498|NCT00097539|155715188|FG000|Overall Study|Participant Non-compliant|2140|||
48416499|NCT00097539|155715189|FG001|Overall Study|Participant Non-compliant|567|||
48416500|NCT00097539|155715190|FG002|Overall Study|Participant Non-compliant|1067|||
48416501|NCT00097539|155715191|FG003|Overall Study|Participant Non-compliant|353|||
48416502|NCT00097539|155715192|FG004|Overall Study|Participant Non-compliant|136|||
48416503|NCT00097539|155715193|FG005|Overall Study|Participant Non-compliant|543|||
48416504|NCT00097539|155715194|FG006|Overall Study|Participant Non-compliant|18|||
48416505|NCT00097539|155715188|FG000|Overall Study|Lack of Efficacy|249|||
48416506|NCT00097539|155715189|FG001|Overall Study|Lack of Efficacy|122|||
48416507|NCT00097539|155715190|FG002|Overall Study|Lack of Efficacy|202|||
48416508|NCT00097539|155715191|FG003|Overall Study|Lack of Efficacy|105|||
48416509|NCT00097539|155715192|FG004|Overall Study|Lack of Efficacy|45|||
48416510|NCT00097539|155715193|FG005|Overall Study|Lack of Efficacy|228|||
48416511|NCT00097539|155715194|FG006|Overall Study|Lack of Efficacy|5|||
48416512|NCT00097539|155715188|FG000|Overall Study|Adverse Event|78|||
48416513|NCT00097539|155715189|FG001|Overall Study|Adverse Event|133|||
48416514|NCT00097539|155715190|FG002|Overall Study|Adverse Event|37|||
48416515|NCT00097539|155715191|FG003|Overall Study|Adverse Event|27|||
48416516|NCT00097539|155715192|FG004|Overall Study|Adverse Event|30|||
48416517|NCT00097539|155715193|FG005|Overall Study|Adverse Event|59|||
48416518|NCT00097539|155715194|FG006|Overall Study|Adverse Event|1|||
48416519|NCT00097539|155715188|FG000|Overall Study|Death|2|||
48416520|NCT00097539|155715189|FG001|Overall Study|Death|7|||
48416521|NCT00097539|155715190|FG002|Overall Study|Death|0|||
48416522|NCT00097539|155715191|FG003|Overall Study|Death|0|||
48416523|NCT00097539|155715192|FG004|Overall Study|Death|1|||
48416524|NCT00097539|155715193|FG005|Overall Study|Death|3|||
48416525|NCT00097539|155715194|FG006|Overall Study|Death|0|||
48416526|NCT00097539|155715188|FG000|Overall Study|Reasons Other Than Above|3602|||
48416527|NCT00097539|155715189|FG001|Overall Study|Reasons Other Than Above|1382|||
48416528|NCT00097539|155715190|FG002|Overall Study|Reasons Other Than Above|1757|||
48416529|NCT00097539|155715191|FG003|Overall Study|Reasons Other Than Above|692|||
48416530|NCT00097539|155715192|FG004|Overall Study|Reasons Other Than Above|361|||
48416531|NCT00097539|155715193|FG005|Overall Study|Reasons Other Than Above|1244|||
48416532|NCT00097539|155715194|FG006|Overall Study|Reasons Other Than Above|34|||
48416533|NCT00097539|155715188|FG000|Overall Study|Reason not Specified|111|||
48416534|NCT00097539|155715189|FG001|Overall Study|Reason not Specified|49|||
48416535|NCT00097539|155715190|FG002|Overall Study|Reason not Specified|53|||
48416536|NCT00097539|155715191|FG003|Overall Study|Reason not Specified|21|||
48416537|NCT00097539|155715192|FG004|Overall Study|Reason not Specified|11|||
48416538|NCT00097539|155715193|FG005|Overall Study|Reason not Specified|40|||
48416539|NCT00097539|155715194|FG006|Overall Study|Reason not Specified|2|||
48416540|NCT00364793|155715195|FG000|Overall Study|Adverse Event|2|||
48416541|NCT00364793|155715196|FG001|Overall Study|Adverse Event|0|||
48416542|NCT00364793|155715197|FG002|Overall Study|Adverse Event|0|||
48416543|NCT00364793|155715198|FG003|Overall Study|Adverse Event|0|||
48416544|NCT00364793|155715195|FG000|Overall Study|Death|1|||
48416545|NCT00364793|155715196|FG001|Overall Study|Death|0|||
48416546|NCT00364793|155715197|FG002|Overall Study|Death|1|||
48416547|NCT00364793|155715198|FG003|Overall Study|Death|0|||
48416548|NCT00364793|155715195|FG000|Overall Study|Lack of Efficacy|3|||
48416549|NCT00364793|155715196|FG001|Overall Study|Lack of Efficacy|3|||
48416550|NCT00364793|155715197|FG002|Overall Study|Lack of Efficacy|1|||
48416551|NCT00364793|155715198|FG003|Overall Study|Lack of Efficacy|1|||
48416552|NCT00364793|155715195|FG000|Overall Study|Lost to Follow-up|1|||
48416553|NCT00364793|155715196|FG001|Overall Study|Lost to Follow-up|0|||
48416554|NCT00364793|155715197|FG002|Overall Study|Lost to Follow-up|2|||
48416555|NCT00364793|155715198|FG003|Overall Study|Lost to Follow-up|0|||
48416556|NCT00364793|155715195|FG000|Overall Study|Poor or non-compliance|1|||
48416557|NCT00364793|155715196|FG001|Overall Study|Poor or non-compliance|1|||
48416558|NCT00364793|155715197|FG002|Overall Study|Poor or non-compliance|0|||
48416559|NCT00364793|155715198|FG003|Overall Study|Poor or non-compliance|1|||
48416560|NCT00364793|155715195|FG000|Overall Study|No longer meets criteria|0|||
48416561|NCT00364793|155715196|FG001|Overall Study|No longer meets criteria|0|||
48416562|NCT00364793|155715197|FG002|Overall Study|No longer meets criteria|0|||
48416563|NCT00364793|155715198|FG003|Overall Study|No longer meets criteria|1|||
48416564|NCT00364793|155715195|FG000|Overall Study|Withdrawal by Subject|0|||
48416565|NCT00364793|155715196|FG001|Overall Study|Withdrawal by Subject|1|||
48416566|NCT00364793|155715197|FG002|Overall Study|Withdrawal by Subject|0|||
48416567|NCT00364793|155715198|FG003|Overall Study|Withdrawal by Subject|0|||
48416568|NCT02966314|155715199|FG000|Overall Study|Lost to Follow-up|1|||
48416569|NCT02966314|155715200|FG001|Overall Study|Lost to Follow-up|0|||
48416570|NCT00391976|155715201|FG000|Overall Study|Adverse Event|0|||
48416571|NCT00391976|155715202|FG001|Overall Study|Adverse Event|0|||
48416572|NCT00391976|155715203|FG002|Overall Study|Adverse Event|1|||
48416573|NCT00391976|155715201|FG000|Overall Study|Withdrawal of consent|0|||
48416574|NCT00391976|155715202|FG001|Overall Study|Withdrawal of consent|1|||
48416575|NCT00391976|155715203|FG002|Overall Study|Withdrawal of consent|1|||
48416576|NCT00391976|155715201|FG000|Overall Study|Lost to Follow-up|1|||
48416577|NCT00391976|155715202|FG001|Overall Study|Lost to Follow-up|2|||
48416578|NCT00391976|155715203|FG002|Overall Study|Lost to Follow-up|0|||
48416579|NCT00391976|155715201|FG000|Overall Study|Inappropriate enrollment|1|||
48416580|NCT00391976|155715202|FG001|Overall Study|Inappropriate enrollment|1|||
48416581|NCT00391976|155715203|FG002|Overall Study|Inappropriate enrollment|0|||
48416582|NCT00391976|155715201|FG000|Overall Study|Protocol deviation/violation|4|||
48416583|NCT00391976|155715202|FG001|Overall Study|Protocol deviation/violation|2|||
48416584|NCT00391976|155715203|FG002|Overall Study|Protocol deviation/violation|1|||
48416585|NCT00391976|155715201|FG000|Overall Study|Recurrence/no eradication of infection|21|||
48416586|NCT00391976|155715202|FG001|Overall Study|Recurrence/no eradication of infection|19|||
48416587|NCT00391976|155715203|FG002|Overall Study|Recurrence/no eradication of infection|0|||
48416588|NCT00391976|155715201|FG000|Overall Study|Unable to classify|0|||
48416589|NCT00391976|155715202|FG001|Overall Study|Unable to classify|0|||
48416590|NCT00391976|155715203|FG002|Overall Study|Unable to classify|1|||
48416591|NCT00391976|155715201|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
48416592|NCT00391976|155715202|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
48416593|NCT00391976|155715203|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
48416594|NCT05127486|155715205|FG000|Overall Study|Adverse Event|2|||
48416595|NCT05127486|155715206|FG001|Overall Study|Adverse Event|4|||
48416596|NCT05127486|155715205|FG000|Overall Study|Lack of Efficacy|1|||
48416597|NCT05127486|155715206|FG001|Overall Study|Lack of Efficacy|0|||
48416598|NCT05127486|155715205|FG000|Overall Study|Pregnancy|0|||
48416599|NCT05127486|155715206|FG001|Overall Study|Pregnancy|1|||
48416600|NCT05127486|155715205|FG000|Overall Study|Physician Decision|4|||
48416601|NCT05127486|155715206|FG001|Overall Study|Physician Decision|1|||
48416602|NCT05127486|155715205|FG000|Overall Study|Withdrawal by Subject|14|||
48416603|NCT05127486|155715206|FG001|Overall Study|Withdrawal by Subject|13|||
48416604|NCT05127486|155715205|FG000|Overall Study|Lost to Follow-up|5|||
48416605|NCT05127486|155715206|FG001|Overall Study|Lost to Follow-up|8|||
48416606|NCT03180736|155715207|FG000|Overall Study|Adverse Event|3|||
48416607|NCT03180736|155715208|FG001|Overall Study|Adverse Event|4|||
48416608|NCT03180736|155715207|FG000|Overall Study|Death|10|||
48416609|NCT03180736|155715208|FG001|Overall Study|Death|7|||
48416610|NCT03180736|155715207|FG000|Overall Study|Withdrawal by Subject|5|||
48416611|NCT03180736|155715208|FG001|Overall Study|Withdrawal by Subject|12|||
48416612|NCT03180736|155715207|FG000|Overall Study|Lost to Follow-up|1|||
48416613|NCT03180736|155715208|FG001|Overall Study|Lost to Follow-up|0|||
48416614|NCT03180736|155715207|FG000|Overall Study|Lack of Efficacy|66|||
48416615|NCT03180736|155715208|FG001|Overall Study|Lack of Efficacy|87|||
48416616|NCT03180736|155715207|FG000|Overall Study|Physician Decision|4|||
48416617|NCT03180736|155715208|FG001|Overall Study|Physician Decision|7|||
48416618|NCT03180736|155715207|FG000|Overall Study|randomized but not treated|2|||
48416619|NCT03180736|155715208|FG001|Overall Study|randomized but not treated|3|||
48416620|NCT00363415|155715209|FG000|Overall Study|Progressive Disease|196|||
48416621|NCT00363415|155715210|FG001|Overall Study|Progressive Disease|107|||
48416622|NCT00363415|155715209|FG000|Overall Study|Sponsor Decision|67|||
48416623|NCT00363415|155715210|FG001|Overall Study|Sponsor Decision|31|||
48416624|NCT00363415|155715209|FG000|Overall Study|Death|32|||
48416625|NCT00363415|155715210|FG001|Overall Study|Death|29|||
48416626|NCT00363415|155715209|FG000|Overall Study|Adverse Event|24|||
48416627|NCT00363415|155715210|FG001|Overall Study|Adverse Event|15|||
48416628|NCT00363415|155715209|FG000|Overall Study|Physician Decision|18|||
48416629|NCT00363415|155715210|FG001|Overall Study|Physician Decision|35|||
48416630|NCT00363415|155715209|FG000|Overall Study|Entry Criteria Not Met|11|||
48416631|NCT00363415|155715210|FG001|Overall Study|Entry Criteria Not Met|10|||
48416632|NCT00363415|155715209|FG000|Overall Study|Withdrawal by Subject|9|||
48416633|NCT00363415|155715210|FG001|Overall Study|Withdrawal by Subject|15|||
48416634|NCT00363415|155715209|FG000|Overall Study|Lost to Follow-up|3|||
48416635|NCT00363415|155715210|FG001|Overall Study|Lost to Follow-up|3|||
48416636|NCT00363415|155715209|FG000|Overall Study|Protocol Violation|1|||
48416637|NCT00363415|155715210|FG001|Overall Study|Protocol Violation|4|||
48416638|NCT00870688|155715211|FG000|Overall Study|Lost to Follow-up|2|||
48416639|NCT00870688|155715211|FG000|Overall Study|Death, Unrelated|1|||
48416640|NCT00870688|155715211|FG000|Overall Study|Granules in the Stools|1|||
48416641|NCT01287754|155715212|FG000|Overall Study|Death|2|||
48416642|NCT01287754|155715213|FG001|Overall Study|Death|12|||
48416643|NCT01287754|155715212|FG000|Overall Study|Lost to Follow-up|1|||
48416644|NCT01287754|155715213|FG001|Overall Study|Lost to Follow-up|6|||
48416645|NCT01287754|155715212|FG000|Overall Study|Protocol Violation|0|||
48416646|NCT01287754|155715213|FG001|Overall Study|Protocol Violation|3|||
48416647|NCT05817045|155715214|FG000|Overall Study|Protocol Violation|0|||
48416648|NCT05817045|155715215|FG001|Overall Study|Protocol Violation|3|||
48416649|NCT05817045|155715214|FG000|Overall Study|Withdrawal by Subject|10|||
48416650|NCT05817045|155715215|FG001|Overall Study|Withdrawal by Subject|7|||
48416651|NCT05817045|155715214|FG000|Overall Study|Physician Decision|3|||
48416652|NCT05817045|155715215|FG001|Overall Study|Physician Decision|0|||
48416653|NCT05817045|155715214|FG000|Overall Study|Lost to Follow-up|0|||
48416654|NCT05817045|155715215|FG001|Overall Study|Lost to Follow-up|1|||
48416655|NCT05817045|155715214|FG000|Overall Study|Device Deficiency|1|||
48416656|NCT05817045|155715215|FG001|Overall Study|Device Deficiency|0|||
48416657|NCT05817045|155715214|FG000|Overall Study|System Error|1|||
48416658|NCT05817045|155715215|FG001|Overall Study|System Error|0|||
48416659|NCT00900796|155715216|FG000|Phase 1|Lacked sufficient information|4|||
48416660|NCT00900796|155715216|FG000|Phase 1|Missing information at Week 16|7|||
48426320|NCT02203838|155749551|FG001|Overall Study|Adverse Event|6|||
48416661|NCT00900796|155715216|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
48416662|NCT00900796|155715216|FG000|Phase 2|Lost to Follow-up|5|||
48416663|NCT03185130|155715217|FG000|Overall Study|Withdrawal by Subject|0|||
48416664|NCT03185130|155715218|FG001|Overall Study|Withdrawal by Subject|2|||
48416665|NCT01071070|155715221|FG000|Overall Study|Adverse Event|0|||
48416666|NCT01071070|155715222|FG001|Overall Study|Adverse Event|3|||
48416667|NCT01071070|155715221|FG000|Overall Study|Withdrawal by Subject|1|||
48416668|NCT01071070|155715222|FG001|Overall Study|Withdrawal by Subject|0|||
48416669|NCT01071070|155715221|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
48416670|NCT01071070|155715222|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
48416671|NCT01071070|155715221|FG000|Overall Study|Hypercalcemia|1|||
48416672|NCT01071070|155715222|FG001|Overall Study|Hypercalcemia|0|||
48416673|NCT00592683|155715223|FG000|Overall Study|Found ineligible|0|||
48416674|NCT00592683|155715224|FG001|Overall Study|Found ineligible|1|||
48416675|NCT00592683|155715223|FG000|Overall Study|Withdrawal by Subject|1|||
48416676|NCT00592683|155715224|FG001|Overall Study|Withdrawal by Subject|0|||
48416677|NCT00592683|155715223|FG000|Overall Study|Adverse Event|0|||
48416678|NCT00592683|155715224|FG001|Overall Study|Adverse Event|2|||
48416679|NCT00592683|155715223|FG000|Overall Study|Protocol Violation|1|||
48416680|NCT00592683|155715224|FG001|Overall Study|Protocol Violation|0|||
48416681|NCT00592683|155715223|FG000|Overall Study|Study drug expired|1|||
48416682|NCT00592683|155715224|FG001|Overall Study|Study drug expired|0|||
48416683|NCT00592683|155715223|FG000|Overall Study|Other|1|||
48416684|NCT00592683|155715224|FG001|Overall Study|Other|0|||
48416685|NCT00592683|155715223|FG000|Overall Study|Lost to Follow-up|0|||
48416686|NCT00592683|155715224|FG001|Overall Study|Lost to Follow-up|1|||
48416687|NCT00472303|155715225|FG000|Titration Phase|Adverse Event|22|||
48416688|NCT00472303|155715226|FG001|Titration Phase|Adverse Event|12|||
48416689|NCT00472303|155715227|FG002|Titration Phase|Adverse Event|0|||
48416690|NCT00472303|155715225|FG000|Titration Phase|Death|4|||
48416691|NCT00472303|155715226|FG001|Titration Phase|Death|2|||
48416692|NCT00472303|155715227|FG002|Titration Phase|Death|0|||
48416693|NCT00472303|155715225|FG000|Titration Phase|Lack of Efficacy|10|||
48416694|NCT00472303|155715226|FG001|Titration Phase|Lack of Efficacy|0|||
48416695|NCT00472303|155715227|FG002|Titration Phase|Lack of Efficacy|0|||
48416696|NCT00472303|155715225|FG000|Titration Phase|Withdrawal by Subject|16|||
48416697|NCT00472303|155715226|FG001|Titration Phase|Withdrawal by Subject|13|||
48416698|NCT00472303|155715227|FG002|Titration Phase|Withdrawal by Subject|0|||
48416699|NCT00472303|155715225|FG000|Titration Phase|Trial Medication non-compliant|4|||
48416700|NCT00472303|155715226|FG001|Titration Phase|Trial Medication non-compliant|1|||
48416701|NCT00472303|155715227|FG002|Titration Phase|Trial Medication non-compliant|0|||
48416702|NCT00472303|155715225|FG000|Titration Phase|Other|3|||
48416703|NCT00472303|155715226|FG001|Titration Phase|Other|1|||
48416704|NCT00472303|155715227|FG002|Titration Phase|Other|0|||
48416705|NCT00472303|155715225|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
48416706|NCT00472303|155715226|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
48416707|NCT00472303|155715227|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
48416708|NCT00472303|155715225|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
48416709|NCT00472303|155715226|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
48416710|NCT00472303|155715227|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
48416711|NCT00472303|155715225|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
48416712|NCT00472303|155715226|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
48416713|NCT00472303|155715227|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
48416714|NCT00472303|155715225|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
48416715|NCT00472303|155715226|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
48416716|NCT00472303|155715227|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
48416717|NCT00472303|155715225|FG000|Discontinuations After Titration Phase|Other|5|||
48416718|NCT00472303|155715226|FG001|Discontinuations After Titration Phase|Other|0|||
48416719|NCT00472303|155715227|FG002|Discontinuations After Titration Phase|Other|0|||
48416720|NCT00472303|155715225|FG000|Maintenance Phase|Adverse Event|5|||
48416721|NCT00472303|155715226|FG001|Maintenance Phase|Adverse Event|6|||
48416722|NCT00472303|155715227|FG002|Maintenance Phase|Adverse Event|6|||
48416723|NCT00472303|155715225|FG000|Maintenance Phase|Death|3|||
48416724|NCT00472303|155715226|FG001|Maintenance Phase|Death|0|||
48416725|NCT00472303|155715227|FG002|Maintenance Phase|Death|2|||
48416726|NCT00472303|155715225|FG000|Maintenance Phase|Lack of Efficacy|2|||
48416727|NCT00472303|155715226|FG001|Maintenance Phase|Lack of Efficacy|2|||
48416728|NCT00472303|155715227|FG002|Maintenance Phase|Lack of Efficacy|4|||
48416729|NCT00472303|155715225|FG000|Maintenance Phase|Withdrawal by Subject|6|||
48416730|NCT00472303|155715226|FG001|Maintenance Phase|Withdrawal by Subject|7|||
48416731|NCT00472303|155715227|FG002|Maintenance Phase|Withdrawal by Subject|3|||
48416732|NCT00472303|155715225|FG000|Maintenance Phase|Trial medication non-compliant|0|||
48416733|NCT00472303|155715226|FG001|Maintenance Phase|Trial medication non-compliant|0|||
48416734|NCT00472303|155715227|FG002|Maintenance Phase|Trial medication non-compliant|1|||
48416735|NCT00472303|155715225|FG000|Maintenance Phase|Resolution of pain|0|||
48416736|NCT00472303|155715226|FG001|Maintenance Phase|Resolution of pain|0|||
48416737|NCT00472303|155715227|FG002|Maintenance Phase|Resolution of pain|1|||
48416738|NCT00472303|155715225|FG000|Maintenance Phase|Other|1|||
48416739|NCT00472303|155715226|FG001|Maintenance Phase|Other|1|||
48416740|NCT00472303|155715227|FG002|Maintenance Phase|Other|0|||
48416741|NCT01122927|155715228|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
48416742|NCT01122927|155715229|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
48416743|NCT01122927|155715228|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
48416744|NCT01122927|155715229|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
48416745|NCT01122927|155715228|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
48416746|NCT01122927|155715229|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
48416747|NCT01122927|155715228|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
48416748|NCT01122927|155715229|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
48416749|NCT01122927|155715228|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
48416750|NCT01122927|155715229|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
48416751|NCT01122927|155715228|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
48416752|NCT01122927|155715229|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
48416753|NCT01122927|155715228|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
48416754|NCT01122927|155715229|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
48416755|NCT01122927|155715228|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
48416756|NCT01122927|155715229|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
48416757|NCT01122927|155715228|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
48416758|NCT01122927|155715229|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
48416759|NCT01122927|155715228|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
48416760|NCT01122927|155715229|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
48416761|NCT01122927|155715228|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
48416762|NCT01122927|155715229|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
48416763|NCT01122927|155715228|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
48416764|NCT01122927|155715229|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
48416765|NCT01287104|155715230|FG000|Overall Study|Patient developed progressive disease|1|||
48416766|NCT01287104|155715231|FG001|Overall Study|Patient developed progressive disease|1|||
48416767|NCT01287104|155715232|FG002|Overall Study|Patient developed progressive disease|3|||
48416768|NCT01287104|155715233|FG003|Overall Study|Patient developed progressive disease|2|||
48416769|NCT01287104|155715230|FG000|Overall Study|Donor anaphylaxis|0|||
48416770|NCT01287104|155715231|FG001|Overall Study|Donor anaphylaxis|1|||
48416771|NCT01287104|155715232|FG002|Overall Study|Donor anaphylaxis|0|||
48416772|NCT01287104|155715233|FG003|Overall Study|Donor anaphylaxis|1|||
48416773|NCT01287104|155715230|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
48416774|NCT01287104|155715231|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
48416775|NCT01287104|155715232|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
48416776|NCT01287104|155715233|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
48416777|NCT01287104|155715230|FG000|Overall Study|Low donor chimerism|0|||
48416778|NCT01287104|155715231|FG001|Overall Study|Low donor chimerism|1|||
48416779|NCT01287104|155715232|FG002|Overall Study|Low donor chimerism|0|||
48416780|NCT01287104|155715233|FG003|Overall Study|Low donor chimerism|0|||
48416781|NCT01287104|155715230|FG000|Overall Study|NK cells did not meet release criteria|0|||
48416782|NCT01287104|155715231|FG001|Overall Study|NK cells did not meet release criteria|1|||
48416783|NCT01287104|155715232|FG002|Overall Study|NK cells did not meet release criteria|0|||
48416784|NCT01287104|155715233|FG003|Overall Study|NK cells did not meet release criteria|0|||
48416785|NCT00503399|155715234|FG000|Overall Study|Death|2|||
48416786|NCT00503399|155715235|FG001|Overall Study|Death|1|||
48416787|NCT00503399|155715234|FG000|Overall Study|Protocol Violation|1|||
48416788|NCT00503399|155715235|FG001|Overall Study|Protocol Violation|0|||
48416789|NCT00503399|155715234|FG000|Overall Study|Withdrawal by Subject|4|||
48416790|NCT00503399|155715235|FG001|Overall Study|Withdrawal by Subject|2|||
48416791|NCT00503399|155715234|FG000|Overall Study|Adverse Event|0|||
48416792|NCT00503399|155715235|FG001|Overall Study|Adverse Event|3|||
48416793|NCT00503399|155715234|FG000|Overall Study|Lost to Follow-up|0|||
48416794|NCT00503399|155715235|FG001|Overall Study|Lost to Follow-up|2|||
48416795|NCT00768560|155715236|FG000|Intervention Set 1|Adverse Event|0|||
48416796|NCT00768560|155715237|FG001|Intervention Set 1|Adverse Event|1|||
48416797|NCT00768560|155715238|FG002|Intervention Set 1|Adverse Event|0|||
48416798|NCT00768560|155715239|FG003|Intervention Set 1|Adverse Event|0|||
48416799|NCT00768560|155715240|FG004|Intervention Set 1|Adverse Event|0|||
48416800|NCT00768560|155715241|FG005|Intervention Set 1|Adverse Event|0|||
48416801|NCT01244737|155715243|FG000|Overall Study|Physician Decision|2|||
48416802|NCT01244737|155715244|FG001|Overall Study|Physician Decision|18|||
48416803|NCT01244737|155715245|FG002|Overall Study|Physician Decision|5|||
48416804|NCT01244737|155715243|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
48416805|NCT01244737|155715244|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
48416806|NCT01244737|155715245|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
48416807|NCT01244737|155715243|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
48416808|NCT01244737|155715244|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
48416809|NCT01244737|155715245|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
48416810|NCT01244737|155715243|FG000|Overall Study|MIB immunopathology results not available|3|||
48416811|NCT01244737|155715244|FG001|Overall Study|MIB immunopathology results not available|2|||
48416812|NCT01244737|155715245|FG002|Overall Study|MIB immunopathology results not available|0|||
48416813|NCT01244737|155715243|FG000|Overall Study|PET data failure|0|||
48416814|NCT01244737|155715244|FG001|Overall Study|PET data failure|1|||
48416815|NCT01244737|155715245|FG002|Overall Study|PET data failure|0|||
48416816|NCT01244737|155715243|FG000|Overall Study|Withdrawal by Subject|0|||
48416817|NCT01244737|155715244|FG001|Overall Study|Withdrawal by Subject|0|||
48416818|NCT01244737|155715245|FG002|Overall Study|Withdrawal by Subject|1|||
48416819|NCT00389207|155715247|FG000|Overall Study|Adverse Event|26|||
48416820|NCT00389207|155715248|FG001|Overall Study|Adverse Event|32|||
48416821|NCT00389207|155715249|FG002|Overall Study|Adverse Event|10|||
48416822|NCT00389207|155715247|FG000|Overall Study|Protocol Violation|3|||
48416823|NCT00389207|155715248|FG001|Overall Study|Protocol Violation|1|||
48416824|NCT00389207|155715249|FG002|Overall Study|Protocol Violation|4|||
48416825|NCT00389207|155715247|FG000|Overall Study|Lost to Follow-up|12|||
48416826|NCT00389207|155715248|FG001|Overall Study|Lost to Follow-up|9|||
48416827|NCT00389207|155715249|FG002|Overall Study|Lost to Follow-up|7|||
48416828|NCT00389207|155715247|FG000|Overall Study|Withdrawal by Subject|5|||
48416829|NCT00389207|155715248|FG001|Overall Study|Withdrawal by Subject|7|||
48416830|NCT00389207|155715249|FG002|Overall Study|Withdrawal by Subject|11|||
48416831|NCT00389207|155715247|FG000|Overall Study|Other|17|||
48416832|NCT00389207|155715248|FG001|Overall Study|Other|23|||
48416833|NCT00389207|155715249|FG002|Overall Study|Other|9|||
48416834|NCT03040024|155715251|FG000|Overall Study|Adverse Event|0|||
48416835|NCT03040024|155715252|FG001|Overall Study|Adverse Event|1|||
48416836|NCT03040024|155715253|FG002|Overall Study|Adverse Event|0|||
48416837|NCT03040024|155715251|FG000|Overall Study|Death|0|||
48416838|NCT03040024|155715252|FG001|Overall Study|Death|1|||
48416839|NCT03040024|155715253|FG002|Overall Study|Death|0|||
48416840|NCT03040024|155715251|FG000|Overall Study|Physician Decision|0|||
48416841|NCT03040024|155715252|FG001|Overall Study|Physician Decision|0|||
48416842|NCT03040024|155715253|FG002|Overall Study|Physician Decision|1|||
48416843|NCT01073943|155715256|FG000|Overall Study|Withdrawal by Subject|8|||
48416844|NCT01073943|155715257|FG001|Overall Study|Withdrawal by Subject|2|||
48416845|NCT01073943|155715256|FG000|Overall Study|Protocol Violation|2|||
48416846|NCT01073943|155715257|FG001|Overall Study|Protocol Violation|1|||
48416847|NCT01073943|155715256|FG000|Overall Study|Adverse Event|1|||
48416848|NCT01073943|155715257|FG001|Overall Study|Adverse Event|1|||
48416849|NCT01073943|155715256|FG000|Overall Study|Lost to Follow-up|0|||
48416850|NCT01073943|155715257|FG001|Overall Study|Lost to Follow-up|2|||
48416851|NCT01073943|155715256|FG000|Overall Study|Power outage; colonoscopy not done|1|||
48416852|NCT01073943|155715257|FG001|Overall Study|Power outage; colonoscopy not done|0|||
48416853|NCT01073943|155715256|FG000|Overall Study|Subject forgot|0|||
48416854|NCT01073943|155715257|FG001|Overall Study|Subject forgot|1|||
48416855|NCT01073943|155715256|FG000|Overall Study|Unable to return for follow-up|0|||
48416856|NCT01073943|155715257|FG001|Overall Study|Unable to return for follow-up|1|||
48416857|NCT01073943|155715256|FG000|Overall Study|Could not tolerate prep|1|||
48416858|NCT01073943|155715257|FG001|Overall Study|Could not tolerate prep|0|||
48416859|NCT02388776|155715258|FG000|Overall Study|Death|1|||
48416860|NCT02388776|155715258|FG000|Overall Study|Lost to Follow-up|1|||
48416861|NCT05139030|155715259|FG000|Overall Study|Withdrawal by Subject|1|||
48416862|NCT05139030|155715260|FG001|Overall Study|Withdrawal by Subject|3|||
48416863|NCT05139030|155715259|FG000|Overall Study|Adverse Event|0|||
48416864|NCT05139030|155715260|FG001|Overall Study|Adverse Event|1|||
48416865|NCT05139030|155715259|FG000|Overall Study|Failure to meet continuation criteria|0|||
48416866|NCT05139030|155715260|FG001|Overall Study|Failure to meet continuation criteria|1|||
48416867|NCT03133767|155715261|FG000|Overall Study|Lost to Follow-up|38|||
48416868|NCT03133767|155715262|FG001|Overall Study|Lost to Follow-up|24|||
48416869|NCT03133767|155715261|FG000|Overall Study|Protocol Violation|0|||
48416870|NCT03133767|155715262|FG001|Overall Study|Protocol Violation|1|||
48416871|NCT02240706|155715265|FG000|Overall Study|Lack of Efficacy|2|||
48416872|NCT02240706|155715266|FG001|Overall Study|Lack of Efficacy|2|||
48416873|NCT02240706|155715267|FG002|Overall Study|Lack of Efficacy|2|||
48416874|NCT02240706|155715268|FG003|Overall Study|Lack of Efficacy|2|||
48416875|NCT02240706|155715269|FG004|Overall Study|Lack of Efficacy|5|||
48416876|NCT02240706|155715270|FG005|Overall Study|Lack of Efficacy|0|||
48416877|NCT02240706|155715271|FG006|Overall Study|Lack of Efficacy|0|||
48416878|NCT02240706|155715265|FG000|Overall Study|Adverse Event|1|||
48416879|NCT02240706|155715266|FG001|Overall Study|Adverse Event|0|||
48416880|NCT02240706|155715267|FG002|Overall Study|Adverse Event|1|||
48416881|NCT02240706|155715268|FG003|Overall Study|Adverse Event|0|||
48416882|NCT02240706|155715269|FG004|Overall Study|Adverse Event|2|||
48416883|NCT02240706|155715270|FG005|Overall Study|Adverse Event|0|||
48416884|NCT02240706|155715271|FG006|Overall Study|Adverse Event|0|||
48416885|NCT02240706|155715265|FG000|Overall Study|Progressive disease|0|||
48416886|NCT02240706|155715266|FG001|Overall Study|Progressive disease|0|||
48416887|NCT02240706|155715267|FG002|Overall Study|Progressive disease|0|||
48416888|NCT02240706|155715268|FG003|Overall Study|Progressive disease|0|||
48416889|NCT02240706|155715269|FG004|Overall Study|Progressive disease|1|||
48416890|NCT02240706|155715270|FG005|Overall Study|Progressive disease|0|||
48416891|NCT02240706|155715271|FG006|Overall Study|Progressive disease|0|||
48416892|NCT02240706|155715265|FG000|Overall Study|Dose limiting toxicity|0|||
48416893|NCT02240706|155715266|FG001|Overall Study|Dose limiting toxicity|0|||
48416894|NCT02240706|155715267|FG002|Overall Study|Dose limiting toxicity|0|||
48416895|NCT02240706|155715268|FG003|Overall Study|Dose limiting toxicity|0|||
48416896|NCT02240706|155715269|FG004|Overall Study|Dose limiting toxicity|1|||
48416897|NCT02240706|155715270|FG005|Overall Study|Dose limiting toxicity|0|||
48416898|NCT02240706|155715271|FG006|Overall Study|Dose limiting toxicity|0|||
48416899|NCT02240706|155715265|FG000|Overall Study|Refused to continue taking medication|0|||
48416900|NCT02240706|155715266|FG001|Overall Study|Refused to continue taking medication|1|||
48416901|NCT02240706|155715267|FG002|Overall Study|Refused to continue taking medication|3|||
48416902|NCT02240706|155715268|FG003|Overall Study|Refused to continue taking medication|1|||
48416903|NCT02240706|155715269|FG004|Overall Study|Refused to continue taking medication|2|||
48416904|NCT02240706|155715270|FG005|Overall Study|Refused to continue taking medication|0|||
48416905|NCT02240706|155715271|FG006|Overall Study|Refused to continue taking medication|0|||
48416906|NCT02240706|155715265|FG000|Overall Study|Insurance billing concerns|0|||
48416907|NCT02240706|155715266|FG001|Overall Study|Insurance billing concerns|0|||
48416908|NCT02240706|155715267|FG002|Overall Study|Insurance billing concerns|0|||
48416909|NCT02240706|155715268|FG003|Overall Study|Insurance billing concerns|1|||
48416910|NCT02240706|155715269|FG004|Overall Study|Insurance billing concerns|0|||
48416911|NCT02240706|155715270|FG005|Overall Study|Insurance billing concerns|0|||
48416912|NCT02240706|155715271|FG006|Overall Study|Insurance billing concerns|0|||
48416913|NCT05502289|155715272|FG000|Period 1|Out Of Window|1|||
48416914|NCT05502289|155715273|FG001|Period 1|Out Of Window|0|||
48416915|NCT01254344|155715274|FG000|Overall Study|Adverse Event|2|||
48416916|NCT01254344|155715275|FG001|Overall Study|Adverse Event|5|||
48416917|NCT01254344|155715274|FG000|Overall Study|Physician Decision|7|||
48416918|NCT01254344|155715275|FG001|Overall Study|Physician Decision|4|||
48416919|NCT01254344|155715274|FG000|Overall Study|Protocol Violation|1|||
48416920|NCT01254344|155715275|FG001|Overall Study|Protocol Violation|4|||
48416921|NCT01254344|155715274|FG000|Overall Study|Withdrawal by Subject|3|||
48416922|NCT01254344|155715275|FG001|Overall Study|Withdrawal by Subject|6|||
48416923|NCT01982630|155715276|FG000|Overall Study|Adverse Event|2|||
48416924|NCT01982630|155715277|FG001|Overall Study|Adverse Event|0|||
48416925|NCT01982630|155715278|FG002|Overall Study|Adverse Event|1|||
48416926|NCT01982630|155715279|FG003|Overall Study|Adverse Event|0|||
48416927|NCT01982630|155715280|FG004|Overall Study|Adverse Event|1|||
48416928|NCT01982630|155715281|FG005|Overall Study|Adverse Event|2|||
48416929|NCT01982630|155715282|FG006|Overall Study|Adverse Event|1|||
48416930|NCT01982630|155715283|FG007|Overall Study|Adverse Event|0|||
48416931|NCT01982630|155715276|FG000|Overall Study|Physician Decision|1|||
48416932|NCT01982630|155715277|FG001|Overall Study|Physician Decision|0|||
48416933|NCT01982630|155715278|FG002|Overall Study|Physician Decision|2|||
48416934|NCT01982630|155715279|FG003|Overall Study|Physician Decision|1|||
48416935|NCT01982630|155715280|FG004|Overall Study|Physician Decision|2|||
48416936|NCT01982630|155715281|FG005|Overall Study|Physician Decision|0|||
48416937|NCT01982630|155715282|FG006|Overall Study|Physician Decision|0|||
48416938|NCT01982630|155715283|FG007|Overall Study|Physician Decision|0|||
48416939|NCT01982630|155715276|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48416940|NCT01982630|155715277|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48416941|NCT01982630|155715278|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
48416942|NCT01982630|155715279|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48416943|NCT01982630|155715280|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48416944|NCT01982630|155715281|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48416945|NCT01982630|155715282|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48416946|NCT01982630|155715283|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
48416947|NCT01982630|155715276|FG000|Overall Study|Withdrawal by Subject|0|||
48416948|NCT01982630|155715277|FG001|Overall Study|Withdrawal by Subject|0|||
48416949|NCT01982630|155715278|FG002|Overall Study|Withdrawal by Subject|0|||
48416950|NCT01982630|155715279|FG003|Overall Study|Withdrawal by Subject|0|||
48416951|NCT01982630|155715280|FG004|Overall Study|Withdrawal by Subject|0|||
48416952|NCT01982630|155715281|FG005|Overall Study|Withdrawal by Subject|1|||
48416953|NCT01982630|155715282|FG006|Overall Study|Withdrawal by Subject|0|||
48416954|NCT01982630|155715283|FG007|Overall Study|Withdrawal by Subject|0|||
48416955|NCT00957853|155715284|FG000|Overall Study|Withdrawal by Subject|1|||
48416956|NCT00957853|155715285|FG001|Overall Study|Withdrawal by Subject|0|||
48416957|NCT00957853|155715286|FG002|Overall Study|Withdrawal by Subject|0|||
48416958|NCT00816036|155715287|FG000|Overall Study|Death|47|||
48416959|NCT00816036|155715288|FG001|Overall Study|Death|28|||
48416960|NCT00816036|155715287|FG000|Overall Study|Lost to Follow-up|75|||
48416961|NCT00816036|155715288|FG001|Overall Study|Lost to Follow-up|57|||
48416962|NCT00816036|155715287|FG000|Overall Study|Withdrawal by Subject|54|||
48416963|NCT00816036|155715288|FG001|Overall Study|Withdrawal by Subject|23|||
48416964|NCT03633331|155715289|FG000|Overall Study|Withdrawal by Subject|1|||
48416965|NCT03459040|155715290|FG000|Overall Study|Death|8|||
48416966|NCT03459040|155715290|FG000|Overall Study|Withdrawal by Subject|1|||
48416967|NCT02493751|155715291|FG000|Overall Study|Withdrawal by Subject|2|||
48416968|NCT02493751|155715292|FG001|Overall Study|Withdrawal by Subject|8|||
48416969|NCT02493751|155715291|FG000|Overall Study|Death|6|||
48416970|NCT02493751|155715292|FG001|Overall Study|Death|13|||
48416971|NCT02493751|155715291|FG000|Overall Study|Lost to Follow-up|2|||
48416972|NCT02493751|155715292|FG001|Overall Study|Lost to Follow-up|3|||
48416973|NCT02493751|155715291|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
48416974|NCT02493751|155715292|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
48416975|NCT01259466|155715293|FG000|Overall Study|Withdrawal by Subject|1|||
48416976|NCT01259466|155715294|FG001|Overall Study|Withdrawal by Subject|9|||
48416977|NCT04925570|155715295|FG000|Overall Study|Protocol Violation|24|||
48416978|NCT04925570|155715296|FG001|Overall Study|Protocol Violation|30|||
48416979|NCT04925570|155715295|FG000|Overall Study|Withdrawal by Subject|0|||
48416980|NCT04925570|155715296|FG001|Overall Study|Withdrawal by Subject|2|||
48416981|NCT00761215|155715297|FG000|Overall Study|Randomized but didn't receive drug|1|||
48416982|NCT00761215|155715298|FG001|Overall Study|Randomized but didn't receive drug|1|||
48416983|NCT00761215|155715299|FG002|Overall Study|Randomized but didn't receive drug|2|||
48416984|NCT00761215|155715297|FG000|Overall Study|Lost to Follow-up|6|||
48416985|NCT00761215|155715298|FG001|Overall Study|Lost to Follow-up|3|||
48416986|NCT00761215|155715299|FG002|Overall Study|Lost to Follow-up|6|||
48416987|NCT00761215|155715297|FG000|Overall Study|Withdrawal by Subject|1|||
48416988|NCT00761215|155715298|FG001|Overall Study|Withdrawal by Subject|0|||
48416989|NCT00761215|155715299|FG002|Overall Study|Withdrawal by Subject|0|||
48416990|NCT00761215|155715297|FG000|Overall Study|Bacteremia|1|||
48416991|NCT00761215|155715298|FG001|Overall Study|Bacteremia|0|||
48416992|NCT00761215|155715299|FG002|Overall Study|Bacteremia|0|||
48416993|NCT04488822|155715300|FG000|Overall Study|Adverse Event|8|||
48416994|NCT04488822|155715300|FG000|Overall Study|Withdrawal by Subject|1|||
48416995|NCT01361711|155715301|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
48416996|NCT01361711|155715301|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
48416997|NCT01361711|155715301|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
48416998|NCT01361711|155715301|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
48416999|NCT01361711|155715301|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
48417000|NCT01361711|155715301|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
48417001|NCT01361711|155715301|FG000|Completed Week 18 of Treatment|Other|9|||
48417002|NCT01361711|155715301|FG000|10 Year Follow-up|Still in follow-up|22|||
48417003|NCT01361711|155715301|FG000|10 Year Follow-up|Death|7|||
48417004|NCT01361711|155715301|FG000|10 Year Follow-up|Developed new cancer|1|||
48417005|NCT01361711|155715301|FG000|10 Year Follow-up|Lost to Follow-up|2|||
48417006|NCT01361711|155715301|FG000|10 Year Follow-up|New treatment started|6|||
48417007|NCT01361711|155715301|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
48417008|NCT01361711|155715301|FG000|10 Year Follow-up|Progressive Disease|1|||
48417009|NCT05593432|155715305|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
48417010|NCT05593432|155715306|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
48417011|NCT05593432|155715307|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
48417012|NCT05593432|155715308|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
48417013|NCT05593432|155715305|FG000|16-Week OLE Period|Lack of Efficacy|0|||
48417014|NCT05593432|155715306|FG001|16-Week OLE Period|Lack of Efficacy|0|||
48417015|NCT05593432|155715307|FG002|16-Week OLE Period|Lack of Efficacy|0|||
48417016|NCT05593432|155715308|FG003|16-Week OLE Period|Lack of Efficacy|1|||
48417017|NCT05593432|155715305|FG000|16-Week OLE Period|Lost to Follow-up|0|||
48417018|NCT05593432|155715306|FG001|16-Week OLE Period|Lost to Follow-up|0|||
48417019|NCT05593432|155715307|FG002|16-Week OLE Period|Lost to Follow-up|1|||
48417020|NCT05593432|155715308|FG003|16-Week OLE Period|Lost to Follow-up|2|||
48417021|NCT05593432|155715305|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
48417022|NCT05593432|155715306|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
48417023|NCT05593432|155715307|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
48417024|NCT05593432|155715308|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
48417025|NCT02986373|155715314|FG000|Overall Study|Adverse Event|4|||
48417026|NCT02986373|155715314|FG000|Overall Study|Lost to Follow-up|1|||
48417027|NCT02986373|155715314|FG000|Overall Study|Withdrawal by Subject|10|||
48417028|NCT02986373|155715314|FG000|Overall Study|Other|24|||
48417029|NCT04800315|155715318|FG000|Randomization|Did not receive study treatment|1|||
48417030|NCT04800315|155715319|FG001|Randomization|Did not receive study treatment|0|||
48417031|NCT04800315|155715320|FG002|Randomization|Did not receive study treatment|0|||
48417032|NCT04800315|155715321|FG003|Randomization|Did not receive study treatment|0|||
48417033|NCT04800315|155715318|FG000|Treatment Period|Adverse Event|4|||
48417034|NCT04800315|155715319|FG001|Treatment Period|Adverse Event|2|||
48417035|NCT04800315|155715320|FG002|Treatment Period|Adverse Event|1|||
48417036|NCT04800315|155715321|FG003|Treatment Period|Adverse Event|2|||
48417037|NCT04800315|155715318|FG000|Treatment Period|Lack of Efficacy|1|||
48417038|NCT04800315|155715319|FG001|Treatment Period|Lack of Efficacy|0|||
48417039|NCT04800315|155715320|FG002|Treatment Period|Lack of Efficacy|0|||
48417040|NCT04800315|155715321|FG003|Treatment Period|Lack of Efficacy|3|||
48417041|NCT04800315|155715318|FG000|Treatment Period|Lost to Follow-up|0|||
48417042|NCT04800315|155715319|FG001|Treatment Period|Lost to Follow-up|1|||
48417043|NCT04800315|155715320|FG002|Treatment Period|Lost to Follow-up|2|||
48417044|NCT04800315|155715321|FG003|Treatment Period|Lost to Follow-up|2|||
48417045|NCT04800315|155715318|FG000|Treatment Period|Withdrawal by participant|0|||
48417046|NCT04800315|155715319|FG001|Treatment Period|Withdrawal by participant|0|||
48417047|NCT04800315|155715320|FG002|Treatment Period|Withdrawal by participant|0|||
48417048|NCT04800315|155715321|FG003|Treatment Period|Withdrawal by participant|4|||
48417049|NCT04800315|155715318|FG000|Treatment Period|Other Reasons|0|||
48417050|NCT04800315|155715319|FG001|Treatment Period|Other Reasons|2|||
48417051|NCT04800315|155715320|FG002|Treatment Period|Other Reasons|0|||
48417052|NCT04800315|155715321|FG003|Treatment Period|Other Reasons|1|||
48417053|NCT01877655|155715326|FG000|Overall Study|Death|57|||
48417054|NCT01877655|155715327|FG001|Overall Study|Death|52|||
48417055|NCT01877655|155715326|FG000|Overall Study|Withdrawal by Subject|18|||
48417056|NCT01877655|155715327|FG001|Overall Study|Withdrawal by Subject|26|||
48417057|NCT01877655|155715326|FG000|Overall Study|Physician Decision|11|||
48417058|NCT01877655|155715327|FG001|Overall Study|Physician Decision|10|||
48417059|NCT01877655|155715326|FG000|Overall Study|Miscellaneous|4|||
48417060|NCT01877655|155715327|FG001|Overall Study|Miscellaneous|4|||
48417061|NCT01877655|155715326|FG000|Overall Study|Randomized but Never Received Drug|8|||
48417062|NCT01877655|155715327|FG001|Overall Study|Randomized but Never Received Drug|5|||
48417063|NCT01901328|155715328|FG000|Overall Study|Lost to Follow-up|1|||
48417064|NCT01901328|155715329|FG001|Overall Study|Lost to Follow-up|0|||
48417065|NCT01901328|155715328|FG000|Overall Study|Physician Decision|0|||
48417066|NCT01901328|155715329|FG001|Overall Study|Physician Decision|1|||
48417067|NCT01901328|155715328|FG000|Overall Study|Protocol Violation|1|||
48417068|NCT01901328|155715329|FG001|Overall Study|Protocol Violation|1|||
48417069|NCT01901328|155715328|FG000|Overall Study|Study Terminated by Sponsor|19|||
48417070|NCT01901328|155715329|FG001|Overall Study|Study Terminated by Sponsor|16|||
48417071|NCT01901328|155715328|FG000|Overall Study|Withdrawal by Subject|1|||
48417072|NCT01901328|155715329|FG001|Overall Study|Withdrawal by Subject|2|||
48417073|NCT01901328|155715328|FG000|Overall Study|Lack of Efficacy|0|||
48417074|NCT01901328|155715329|FG001|Overall Study|Lack of Efficacy|1|||
48417075|NCT04358458|155715330|FG000|Overall Study|Death|1|||
48417076|NCT04358458|155715331|FG001|Overall Study|Death|1|||
48417077|NCT04358458|155715332|FG002|Overall Study|Death|3|||
48417078|NCT04358458|155715333|FG003|Overall Study|Death|8|||
48417079|NCT04358458|155715334|FG004|Overall Study|Death|1|||
48417080|NCT04358458|155715335|FG005|Overall Study|Death|6|||
48417081|NCT04358458|155715336|FG006|Overall Study|Death|2|||
48417082|NCT04358458|155715337|FG007|Overall Study|Death|3|||
48417083|NCT04358458|155715330|FG000|Overall Study|Lost to Follow-up|0|||
48417084|NCT04358458|155715331|FG001|Overall Study|Lost to Follow-up|0|||
48417085|NCT04358458|155715332|FG002|Overall Study|Lost to Follow-up|0|||
48417086|NCT04358458|155715333|FG003|Overall Study|Lost to Follow-up|0|||
48417087|NCT04358458|155715334|FG004|Overall Study|Lost to Follow-up|0|||
48417088|NCT04358458|155715335|FG005|Overall Study|Lost to Follow-up|0|||
48417089|NCT04358458|155715336|FG006|Overall Study|Lost to Follow-up|0|||
48417090|NCT04358458|155715337|FG007|Overall Study|Lost to Follow-up|1|||
48417091|NCT04358458|155715330|FG000|Overall Study|Site is closing study participation|0|||
48417092|NCT04358458|155715331|FG001|Overall Study|Site is closing study participation|0|||
48417093|NCT04358458|155715332|FG002|Overall Study|Site is closing study participation|0|||
48417094|NCT04358458|155715333|FG003|Overall Study|Site is closing study participation|1|||
48417095|NCT04358458|155715334|FG004|Overall Study|Site is closing study participation|0|||
48417096|NCT04358458|155715335|FG005|Overall Study|Site is closing study participation|0|||
48417097|NCT04358458|155715336|FG006|Overall Study|Site is closing study participation|0|||
48417098|NCT04358458|155715337|FG007|Overall Study|Site is closing study participation|0|||
48417099|NCT04358458|155715330|FG000|Overall Study|Sponsor request|2|||
48417100|NCT04358458|155715331|FG001|Overall Study|Sponsor request|3|||
48417101|NCT04358458|155715332|FG002|Overall Study|Sponsor request|3|||
48417102|NCT04358458|155715333|FG003|Overall Study|Sponsor request|0|||
48417103|NCT04358458|155715334|FG004|Overall Study|Sponsor request|2|||
48417104|NCT04358458|155715335|FG005|Overall Study|Sponsor request|3|||
48417105|NCT04358458|155715336|FG006|Overall Study|Sponsor request|1|||
48417106|NCT04358458|155715337|FG007|Overall Study|Sponsor request|1|||
48417107|NCT04358458|155715330|FG000|Overall Study|Withdrawal by Subject|0|||
48417108|NCT04358458|155715331|FG001|Overall Study|Withdrawal by Subject|0|||
48417109|NCT04358458|155715332|FG002|Overall Study|Withdrawal by Subject|1|||
48417110|NCT04358458|155715333|FG003|Overall Study|Withdrawal by Subject|1|||
48417111|NCT04358458|155715334|FG004|Overall Study|Withdrawal by Subject|0|||
48417112|NCT04358458|155715335|FG005|Overall Study|Withdrawal by Subject|1|||
48417113|NCT04358458|155715336|FG006|Overall Study|Withdrawal by Subject|0|||
48417114|NCT04358458|155715337|FG007|Overall Study|Withdrawal by Subject|1|||
48417115|NCT04513158|155715338|FG000|Overall Study|Screen Failure|1|||
48417116|NCT02224664|155716887|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
48417117|NCT02224664|155716888|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
48417118|NCT02224664|155716889|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
48417119|NCT02224664|155716890|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
48417120|NCT02224664|155716891|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
48417121|NCT02224664|155716887|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
48417122|NCT02224664|155716888|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
48417123|NCT02224664|155716889|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
48417124|NCT02224664|155716890|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
48417125|NCT02224664|155716891|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
48417126|NCT02224664|155716887|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
48417127|NCT02224664|155716888|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
48417128|NCT02224664|155716889|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
48417129|NCT02224664|155716890|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
48417130|NCT02224664|155716891|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
48417131|NCT01445171|155716898|FG000|Overall Study|Lost to Follow-up|11|||
48417132|NCT01445171|155716898|FG000|Overall Study|Withdrawal by Subject|16|||
48417133|NCT01445171|155716898|FG000|Overall Study|Death|51|||
48417134|NCT01445171|155716898|FG000|Overall Study|Subjects declined to return for followup|9|||
48417135|NCT01445171|155716898|FG000|Overall Study|Consented but did not receive device|8|||
48417136|NCT00473694|155716903|FG000|Overall Study|Adverse Event|0|||
48417137|NCT00473694|155716904|FG001|Overall Study|Adverse Event|1|||
48417138|NCT00473694|155716905|FG002|Overall Study|Adverse Event|0|||
48417139|NCT00473694|155716906|FG003|Overall Study|Adverse Event|0|||
48417140|NCT00473694|155716903|FG000|Overall Study|Participants did not receive treatment|11|||
48417141|NCT00473694|155716904|FG001|Overall Study|Participants did not receive treatment|3|||
48417142|NCT00473694|155716905|FG002|Overall Study|Participants did not receive treatment|5|||
48417143|NCT00473694|155716906|FG003|Overall Study|Participants did not receive treatment|6|||
48417144|NCT00473694|155716903|FG000|Overall Study|Lost to Follow-up|0|||
48417145|NCT00473694|155716904|FG001|Overall Study|Lost to Follow-up|0|||
48417146|NCT00473694|155716905|FG002|Overall Study|Lost to Follow-up|0|||
48417147|NCT00473694|155716906|FG003|Overall Study|Lost to Follow-up|1|||
48417148|NCT02579603|155716907|FG000|Overall Study|Not treated|1|||
48417149|NCT02579603|155716908|FG001|Overall Study|Not treated|0|||
48417150|NCT02579603|155716907|FG000|Overall Study|Adverse Event|2|||
48417151|NCT02579603|155716908|FG001|Overall Study|Adverse Event|2|||
48417152|NCT02579603|155716907|FG000|Overall Study|Other than stated|1|||
48417153|NCT02579603|155716908|FG001|Overall Study|Other than stated|0|||
48417154|NCT02626338|155716909|FG000|Overall Study|Lack of Efficacy|3|||
48417155|NCT02626338|155716910|FG001|Overall Study|Lack of Efficacy|2|||
48417156|NCT02626338|155716911|FG002|Overall Study|Lack of Efficacy|0|||
48417157|NCT01217606|155716914|FG000|Initial Treatment Phase|Other Reasons|0|||
48417158|NCT01217606|155716915|FG001|Initial Treatment Phase|Other Reasons|2|||
48417159|NCT01217606|155716914|FG000|Initial Treatment Phase|Protocol Violation|3|||
48417160|NCT01217606|155716915|FG001|Initial Treatment Phase|Protocol Violation|2|||
48417161|NCT01217606|155716914|FG000|Initial Treatment Phase|Personal Reasons|0|||
48417162|NCT01217606|155716915|FG001|Initial Treatment Phase|Personal Reasons|2|||
48417163|NCT01217606|155716914|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
48417164|NCT01217606|155716915|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
48417165|NCT01217606|155716914|FG000|Initial Treatment Phase|Adverse Event|10|||
48417166|NCT01217606|155716915|FG001|Initial Treatment Phase|Adverse Event|6|||
48417167|NCT01217606|155716914|FG000|9-Month Masked Extension|Adverse Event|3|||
48417168|NCT01217606|155716915|FG001|9-Month Masked Extension|Adverse Event|6|||
48417169|NCT01217606|155716914|FG000|9-Month Masked Extension|Other Reasons|4|||
48417170|NCT01217606|155716915|FG001|9-Month Masked Extension|Other Reasons|4|||
48417171|NCT01217606|155716914|FG000|9-Month Masked Extension|Personal Reasons|2|||
48417172|NCT01217606|155716915|FG001|9-Month Masked Extension|Personal Reasons|1|||
48417173|NCT01217606|155716914|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
48417174|NCT01217606|155716915|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
48417175|NCT01217606|155716914|FG000|9-Month Masked Extension|Pregnancy|1|||
48417176|NCT01217606|155716915|FG001|9-Month Masked Extension|Pregnancy|0|||
48417177|NCT01217606|155716914|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
48417178|NCT01217606|155716915|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
48417179|NCT04331899|155716916|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
48417180|NCT04331899|155716917|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
48417181|NCT01973283|155716918|FG000|Overall Study|Lost to Follow-up|4|||
48417182|NCT00775021|155716919|FG000|First Intervention|Lost to Follow-up|1|||
48417183|NCT00775021|155716920|FG001|First Intervention|Lost to Follow-up|0|||
48417184|NCT00775021|155716919|FG000|Second Intervention|Adverse Event|0|||
48417185|NCT00775021|155716920|FG001|Second Intervention|Adverse Event|1|||
48417186|NCT05113940|155716926|FG000|Part A (18 Days)|Adverse Event|0|||
48417187|NCT05113940|155716927|FG001|Part A (18 Days)|Adverse Event|0|||
48417188|NCT05113940|155716928|FG002|Part A (18 Days)|Adverse Event|1|||
48417189|NCT05113940|155716929|FG003|Part A (18 Days)|Adverse Event|1|||
48417190|NCT05113940|155716930|FG004|Part A (18 Days)|Adverse Event|1|||
48417191|NCT05113940|155716931|FG005|Part A (18 Days)|Adverse Event|0|||
48417192|NCT05113940|155716932|FG006|Part A (18 Days)|Adverse Event|0|||
48417193|NCT05113940|155716933|FG007|Part A (18 Days)|Adverse Event|0|||
48417194|NCT05113940|155716934|FG008|Part A (18 Days)|Adverse Event|0|||
48417195|NCT05113940|155716935|FG009|Part A (18 Days)|Adverse Event|0|||
48417196|NCT05113940|155716936|FG010|Part A (18 Days)|Adverse Event|0|||
48417197|NCT05113940|155716937|FG011|Part A (18 Days)|Adverse Event|2|||
48417198|NCT05113940|155716938|FG012|Part A (18 Days)|Adverse Event|0|||
48417199|NCT05113940|155716939|FG013|Part A (18 Days)|Adverse Event|0|||
48417200|NCT05113940|155716940|FG014|Part A (18 Days)|Adverse Event|0|||
48417201|NCT05113940|155716926|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417202|NCT05113940|155716927|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417203|NCT05113940|155716928|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417204|NCT05113940|155716929|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417205|NCT05113940|155716930|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417206|NCT05113940|155716931|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417207|NCT05113940|155716932|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417208|NCT05113940|155716933|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417209|NCT05113940|155716934|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417210|NCT05113940|155716935|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417211|NCT05113940|155716936|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417212|NCT05113940|155716937|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417213|NCT05113940|155716938|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417214|NCT05113940|155716939|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
48417215|NCT05113940|155716940|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
48417216|NCT02725788|155716941|FG000|Overall Study|Lost to Follow-up|1|||
48417217|NCT02725788|155716942|FG001|Overall Study|Lost to Follow-up|1|||
48417218|NCT02725788|155716941|FG000|Overall Study|Protocol Violation|0|||
48417219|NCT02725788|155716942|FG001|Overall Study|Protocol Violation|1|||
48417220|NCT00442598|155716943|FG000|Overall Study|Adverse Event|1|||
48417221|NCT00442598|155716944|FG001|Overall Study|Adverse Event|0|||
48417222|NCT00442598|155716945|FG002|Overall Study|Adverse Event|0|||
48417223|NCT00442598|155716943|FG000|Overall Study|Tumor progression|3|||
48417224|NCT00442598|155716944|FG001|Overall Study|Tumor progression|4|||
48417225|NCT00442598|155716945|FG002|Overall Study|Tumor progression|0|||
48417226|NCT00442598|155716943|FG000|Overall Study|Clinical deterioration|1|||
48417227|NCT00442598|155716944|FG001|Overall Study|Clinical deterioration|2|||
48417228|NCT00442598|155716945|FG002|Overall Study|Clinical deterioration|0|||
48417229|NCT00442598|155716943|FG000|Overall Study|CA125 progression|0|||
48417230|NCT00442598|155716944|FG001|Overall Study|CA125 progression|1|||
48417231|NCT00442598|155716945|FG002|Overall Study|CA125 progression|0|||
48417232|NCT00442598|155716943|FG000|Overall Study|Reduced creatinine clearance|1|||
48417233|NCT00442598|155716944|FG001|Overall Study|Reduced creatinine clearance|0|||
48417234|NCT00442598|155716945|FG002|Overall Study|Reduced creatinine clearance|0|||
48417235|NCT00442598|155716943|FG000|Overall Study|Death|0|||
48417236|NCT00442598|155716944|FG001|Overall Study|Death|1|||
48417237|NCT00442598|155716945|FG002|Overall Study|Death|0|||
48417238|NCT01974323|155716946|FG000|Overall Study|Other Reasons|25|||
48417239|NCT01974323|155716947|FG001|Overall Study|Other Reasons|28|||
48417240|NCT01974323|155716946|FG000|Overall Study|Protocol Violation|2|||
48417241|NCT01974323|155716947|FG001|Overall Study|Protocol Violation|2|||
48417242|NCT01974323|155716946|FG000|Overall Study|Personal Reasons|15|||
48417243|NCT01974323|155716947|FG001|Overall Study|Personal Reasons|19|||
48417244|NCT01974323|155716946|FG000|Overall Study|Lost to Follow-up|45|||
48417245|NCT01974323|155716947|FG001|Overall Study|Lost to Follow-up|40|||
48417246|NCT01974323|155716946|FG000|Overall Study|Pregnancy|2|||
48417247|NCT01974323|155716947|FG001|Overall Study|Pregnancy|1|||
48417248|NCT01974323|155716946|FG000|Overall Study|Lack of Efficacy|1|||
48417249|NCT01974323|155716947|FG001|Overall Study|Lack of Efficacy|1|||
48417250|NCT01974323|155716946|FG000|Overall Study|Adverse Event|2|||
48417251|NCT01974323|155716947|FG001|Overall Study|Adverse Event|2|||
48417252|NCT00826514|155716954|FG000|Overall Study|Adverse Event|1|||
48417253|NCT00826514|155716955|FG001|Overall Study|Adverse Event|1|||
48417254|NCT00826514|155716954|FG000|Overall Study|Lack of Efficacy|0|||
48417255|NCT00826514|155716955|FG001|Overall Study|Lack of Efficacy|1|||
48417256|NCT00826514|155716954|FG000|Overall Study|Withdrawal by Subject|2|||
48417257|NCT00826514|155716955|FG001|Overall Study|Withdrawal by Subject|3|||
48417258|NCT03794986|155716957|FG000|Overall Study|0 Sessions Attended|34|||
48417259|NCT03794986|155716958|FG001|Overall Study|0 Sessions Attended|37|||
48417260|NCT03794986|155716957|FG000|Overall Study|Withdrawal by Subject|4|||
48417261|NCT03794986|155716958|FG001|Overall Study|Withdrawal by Subject|6|||
48417262|NCT03794986|155716957|FG000|Overall Study|Protocol Violation|1|||
48417263|NCT03794986|155716958|FG001|Overall Study|Protocol Violation|0|||
48417264|NCT01676961|155716959|FG000|Overall Study|Death|3|||
48417265|NCT01676961|155716959|FG000|Overall Study|Lost to Follow-up|1|||
48417266|NCT01676961|155716959|FG000|Overall Study|Withdrawal by Subject|1|||
48417267|NCT00629083|155716960|FG000|Overall Study|Adverse Event|0|||
48417268|NCT00629083|155716961|FG001|Overall Study|Adverse Event|2|||
48417269|NCT00629083|155716960|FG000|Overall Study|Lack of Efficacy|3|||
48417270|NCT00629083|155716961|FG001|Overall Study|Lack of Efficacy|1|||
48417271|NCT00629083|155716960|FG000|Overall Study|Withdrawal by Subject|10|||
48417272|NCT00629083|155716961|FG001|Overall Study|Withdrawal by Subject|2|||
48417273|NCT00629083|155716960|FG000|Overall Study|Lost to Follow-up|12|||
48417274|NCT00629083|155716961|FG001|Overall Study|Lost to Follow-up|8|||
48417275|NCT00629083|155716960|FG000|Overall Study|Moved out of country/state|2|||
48417276|NCT00629083|155716961|FG001|Overall Study|Moved out of country/state|1|||
48417277|NCT00629083|155716960|FG000|Overall Study|Refused to return for 12 month visit|1|||
48417278|NCT00629083|155716961|FG001|Overall Study|Refused to return for 12 month visit|0|||
48417279|NCT03075839|155716963|FG000|Overall Study|Lost to Follow-up|4|||
48417280|NCT00488631|155716964|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
48417281|NCT00488631|155716965|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
48417282|NCT00488631|155716966|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
48417283|NCT00488631|155716967|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
48417284|NCT00488631|155716968|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
48417285|NCT00488631|155716969|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
48417286|NCT00488631|155716970|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
48417287|NCT00488631|155716971|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
48417288|NCT00488631|155716972|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
48417289|NCT00488631|155716973|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
48417290|NCT00488631|155716964|FG000|Double Blind Period (Week 0-54)|Death|0|||
48417291|NCT00488631|155716965|FG001|Double Blind Period (Week 0-54)|Death|0|||
48417292|NCT00488631|155716966|FG002|Double Blind Period (Week 0-54)|Death|0|||
48417293|NCT00488631|155716967|FG003|Double Blind Period (Week 0-54)|Death|0|||
48417294|NCT00488631|155716968|FG004|Double Blind Period (Week 0-54)|Death|0|||
48417295|NCT00488631|155716969|FG005|Double Blind Period (Week 0-54)|Death|1|||
48417296|NCT00488631|155716970|FG006|Double Blind Period (Week 0-54)|Death|0|||
48417297|NCT00488631|155716971|FG007|Double Blind Period (Week 0-54)|Death|0|||
48417298|NCT00488631|155716972|FG008|Double Blind Period (Week 0-54)|Death|0|||
48417299|NCT00488631|155716973|FG009|Double Blind Period (Week 0-54)|Death|0|||
48417300|NCT00488631|155716964|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
48417301|NCT00488631|155716965|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
48417302|NCT00488631|155716966|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
48417303|NCT00488631|155716967|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
48417304|NCT00488631|155716968|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
48417305|NCT00488631|155716969|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
48417306|NCT00488631|155716970|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
48417307|NCT00488631|155716971|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
48417308|NCT00488631|155716972|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
48417309|NCT00488631|155716973|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
48417310|NCT00488631|155716964|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
48417311|NCT00488631|155716965|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
48417312|NCT00488631|155716966|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
48417313|NCT00488631|155716967|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48417314|NCT00488631|155716968|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
48417315|NCT00488631|155716969|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
48417316|NCT00488631|155716970|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48417317|NCT00488631|155716971|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48417318|NCT00488631|155716972|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48417319|NCT00488631|155716973|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
48417320|NCT00488631|155716964|FG000|Double Blind Period (Week 0-54)|Other|6|||
48417321|NCT00488631|155716965|FG001|Double Blind Period (Week 0-54)|Other|12|||
48417322|NCT00488631|155716966|FG002|Double Blind Period (Week 0-54)|Other|10|||
48417323|NCT00488631|155716967|FG003|Double Blind Period (Week 0-54)|Other|11|||
48417324|NCT00488631|155716968|FG004|Double Blind Period (Week 0-54)|Other|14|||
48417325|NCT00488631|155716969|FG005|Double Blind Period (Week 0-54)|Other|34|||
48417326|NCT00488631|155716970|FG006|Double Blind Period (Week 0-54)|Other|0|||
48417327|NCT00488631|155716971|FG007|Double Blind Period (Week 0-54)|Other|0|||
48417328|NCT00488631|155716972|FG008|Double Blind Period (Week 0-54)|Other|0|||
48417329|NCT00488631|155716973|FG009|Double Blind Period (Week 0-54)|Other|0|||
48417330|NCT00488631|155716964|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48417331|NCT00488631|155716965|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48417332|NCT00488631|155716966|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48417333|NCT00488631|155716967|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48417334|NCT00488631|155716968|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48417335|NCT00488631|155716969|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48417336|NCT00488631|155716970|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
48417337|NCT00488631|155716971|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
48417338|NCT00488631|155716972|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
48417339|NCT00488631|155716973|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
48417340|NCT00488631|155716964|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
48417341|NCT00488631|155716965|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
48417342|NCT00488631|155716966|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
48417343|NCT00488631|155716967|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
48417344|NCT00488631|155716968|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
48417345|NCT00488631|155716969|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
48417346|NCT00488631|155716970|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
48417347|NCT00488631|155716971|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
48417348|NCT00488631|155716972|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
48417349|NCT00488631|155716973|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
48417350|NCT00488631|155716964|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48417351|NCT00488631|155716965|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48417352|NCT00488631|155716966|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48417353|NCT00488631|155716967|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48417354|NCT00488631|155716968|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48417355|NCT00488631|155716969|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
48417356|NCT00488631|155716970|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
48417357|NCT00488631|155716971|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
48417358|NCT00488631|155716972|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
48417359|NCT00488631|155716973|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
48417360|NCT00488631|155716964|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48417361|NCT00488631|155716965|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48417362|NCT00488631|155716966|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48417363|NCT00488631|155716967|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48417364|NCT00488631|155716968|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48417365|NCT00488631|155716969|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48417366|NCT00488631|155716970|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
48417367|NCT00488631|155716971|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48417368|NCT00488631|155716972|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
48417369|NCT00488631|155716973|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
48417370|NCT00488631|155716964|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48417371|NCT00488631|155716965|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48417372|NCT00488631|155716966|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48417373|NCT00488631|155716967|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48417374|NCT00488631|155716968|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48417375|NCT00488631|155716969|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48417376|NCT00488631|155716970|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
48417377|NCT00488631|155716971|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
48417378|NCT00488631|155716972|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
48417379|NCT00488631|155716973|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
48417380|NCT01051739|155716977|FG000|Overall Study|Death|3|||
48417381|NCT01051739|155716978|FG001|Overall Study|Death|3|||
48417382|NCT01051739|155716977|FG000|Overall Study|Withdrawal by Subject|25|||
48417383|NCT01051739|155716978|FG001|Overall Study|Withdrawal by Subject|10|||
48417384|NCT03853694|155716979|FG000|Overall Study|Protocol Violation|3|||
48417385|NCT03853694|155716980|FG001|Overall Study|Protocol Violation|5|||
48417386|NCT03853694|155716981|FG002|Overall Study|Protocol Violation|3|||
48417387|NCT03853694|155716979|FG000|Overall Study|Delivered early|0|||
48417388|NCT03853694|155716980|FG001|Overall Study|Delivered early|1|||
48417389|NCT03853694|155716981|FG002|Overall Study|Delivered early|0|||
48417390|NCT03853694|155716979|FG000|Overall Study|not suitable to proceed|0|||
48417391|NCT03853694|155716980|FG001|Overall Study|not suitable to proceed|1|||
48417392|NCT03853694|155716981|FG002|Overall Study|not suitable to proceed|0|||
48417393|NCT03853694|155716979|FG000|Overall Study|difficult surgery|0|||
48417394|NCT03853694|155716980|FG001|Overall Study|difficult surgery|0|||
48417395|NCT03853694|155716981|FG002|Overall Study|difficult surgery|1|||
48417396|NCT03853694|155716979|FG000|Overall Study|Lost to Follow-up|0|||
48417397|NCT03853694|155716980|FG001|Overall Study|Lost to Follow-up|1|||
48417398|NCT03853694|155716981|FG002|Overall Study|Lost to Follow-up|0|||
48417399|NCT03853694|155716979|FG000|Overall Study|Withdrawal by Subject|0|||
48417400|NCT03853694|155716980|FG001|Overall Study|Withdrawal by Subject|1|||
48417401|NCT03853694|155716981|FG002|Overall Study|Withdrawal by Subject|0|||
48417402|NCT00824421|155716983|FG000|Overall Study|Adverse Event|6|||
48417403|NCT00824421|155716984|FG001|Overall Study|Adverse Event|6|||
48417404|NCT00824421|155716985|FG002|Overall Study|Adverse Event|6|||
48417405|NCT00824421|155716983|FG000|Overall Study|Death|0|||
48417406|NCT00824421|155716984|FG001|Overall Study|Death|1|||
48417407|NCT00824421|155716985|FG002|Overall Study|Death|0|||
48417408|NCT00824421|155716983|FG000|Overall Study|Lack of Efficacy|5|||
48417409|NCT00824421|155716984|FG001|Overall Study|Lack of Efficacy|7|||
48417410|NCT00824421|155716985|FG002|Overall Study|Lack of Efficacy|4|||
48417411|NCT00824421|155716983|FG000|Overall Study|Lost to Follow-up|2|||
48417412|NCT00824421|155716984|FG001|Overall Study|Lost to Follow-up|3|||
48417413|NCT00824421|155716985|FG002|Overall Study|Lost to Follow-up|0|||
48417414|NCT00824421|155716983|FG000|Overall Study|Pregnancy|1|||
48417415|NCT00824421|155716984|FG001|Overall Study|Pregnancy|0|||
48417416|NCT00824421|155716985|FG002|Overall Study|Pregnancy|1|||
48417417|NCT00824421|155716983|FG000|Overall Study|Withdrawal by Subject|2|||
48417418|NCT00824421|155716984|FG001|Overall Study|Withdrawal by Subject|3|||
48417419|NCT00824421|155716985|FG002|Overall Study|Withdrawal by Subject|3|||
48417420|NCT00824421|155716983|FG000|Overall Study|Randomized but not Treated|1|||
48417421|NCT00824421|155716984|FG001|Overall Study|Randomized but not Treated|1|||
48417422|NCT00824421|155716985|FG002|Overall Study|Randomized but not Treated|0|||
48417423|NCT00824421|155716983|FG000|Overall Study|Other|0|||
48417424|NCT00824421|155716984|FG001|Overall Study|Other|1|||
48417425|NCT00824421|155716985|FG002|Overall Study|Other|0|||
48417426|NCT01173653|155716986|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
48417427|NCT01173653|155716987|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
48417428|NCT01967225|155716990|FG000|Overall Study|Adverse Event|3|||
48417429|NCT01967225|155716991|FG001|Overall Study|Adverse Event|1|||
48417430|NCT01967225|155716990|FG000|Overall Study|Withdrawal by Subject|2|||
48417431|NCT01967225|155716991|FG001|Overall Study|Withdrawal by Subject|1|||
48417432|NCT01967225|155716990|FG000|Overall Study|Lack of Efficacy|1|||
48417433|NCT01967225|155716991|FG001|Overall Study|Lack of Efficacy|1|||
48417434|NCT01967225|155716990|FG000|Overall Study|Switching to other therapy|2|||
48417435|NCT01967225|155716991|FG001|Overall Study|Switching to other therapy|0|||
48417436|NCT01967225|155716990|FG000|Overall Study|Protocol driven decision point|1|||
48417437|NCT01967225|155716991|FG001|Overall Study|Protocol driven decision point|0|||
48417438|NCT01967225|155716990|FG000|Overall Study|Logistical difficulties|1|||
48417439|NCT01967225|155716991|FG001|Overall Study|Logistical difficulties|0|||
48417440|NCT01967225|155716990|FG000|Overall Study|Protocol Violation|2|||
48417441|NCT01967225|155716991|FG001|Overall Study|Protocol Violation|0|||
48417442|NCT02120417|155716992|FG000|Overall Study|Death|5|||
48417443|NCT02120417|155716993|FG001|Overall Study|Death|1|||
48417444|NCT02120417|155716992|FG000|Overall Study|Adverse Event|3|||
48417445|NCT02120417|155716993|FG001|Overall Study|Adverse Event|9|||
48417446|NCT02120417|155716992|FG000|Overall Study|Participant decision|4|||
48417447|NCT02120417|155716993|FG001|Overall Study|Participant decision|4|||
48417448|NCT02120417|155716992|FG000|Overall Study|Disease progression|41|||
48417449|NCT02120417|155716993|FG001|Overall Study|Disease progression|45|||
48417450|NCT02120417|155716992|FG000|Overall Study|Noncompliance with study treatment|0|||
48417451|NCT02120417|155716993|FG001|Overall Study|Noncompliance with study treatment|2|||
48417452|NCT02120417|155716992|FG000|Overall Study|Physician Decision|2|||
48417453|NCT02120417|155716993|FG001|Overall Study|Physician Decision|3|||
48417454|NCT02120417|155716992|FG000|Overall Study|Other unspecified|5|||
48417455|NCT02120417|155716993|FG001|Overall Study|Other unspecified|4|||
48417456|NCT02286102|155716994|FG000|Overall Study|Screen Failure|1|||
48417457|NCT02286102|155716995|FG001|Overall Study|Screen Failure|1|||
48417458|NCT00730236|155716997|FG000|Overall Study|Adverse Event|4|||
48417459|NCT00730236|155716997|FG000|Overall Study|Withdrawal by Subject|1|||
48417460|NCT00730236|155716997|FG000|Overall Study|Non-compliance|1|||
48417461|NCT00479466|155716998|FG000|Overall Study|Adverse Event|5|||
48417462|NCT00479466|155716999|FG001|Overall Study|Adverse Event|1|||
48417463|NCT00479466|155717000|FG002|Overall Study|Adverse Event|0|||
48417464|NCT00479466|155717001|FG003|Overall Study|Adverse Event|1|||
48417465|NCT00479466|155717002|FG004|Overall Study|Adverse Event|2|||
48417466|NCT00479466|155717003|FG005|Overall Study|Adverse Event|0|||
48417467|NCT00479466|155716998|FG000|Overall Study|Hyperglycemia|0|||
48417468|NCT00479466|155716999|FG001|Overall Study|Hyperglycemia|0|||
48417469|NCT00479466|155717000|FG002|Overall Study|Hyperglycemia|0|||
48417470|NCT00479466|155717001|FG003|Overall Study|Hyperglycemia|0|||
48417471|NCT00479466|155717002|FG004|Overall Study|Hyperglycemia|0|||
48417472|NCT00479466|155717003|FG005|Overall Study|Hyperglycemia|1|||
48417473|NCT00479466|155716998|FG000|Overall Study|Lack of Efficacy|2|||
48417474|NCT00479466|155716999|FG001|Overall Study|Lack of Efficacy|0|||
48417475|NCT00479466|155717000|FG002|Overall Study|Lack of Efficacy|1|||
48417476|NCT00479466|155717001|FG003|Overall Study|Lack of Efficacy|0|||
48417477|NCT00479466|155717002|FG004|Overall Study|Lack of Efficacy|0|||
48417478|NCT00479466|155717003|FG005|Overall Study|Lack of Efficacy|0|||
48417479|NCT00479466|155716998|FG000|Overall Study|Lost to Follow-up|0|||
48417480|NCT00479466|155716999|FG001|Overall Study|Lost to Follow-up|1|||
48417481|NCT00479466|155717000|FG002|Overall Study|Lost to Follow-up|1|||
48417482|NCT00479466|155717001|FG003|Overall Study|Lost to Follow-up|0|||
48417483|NCT00479466|155717002|FG004|Overall Study|Lost to Follow-up|2|||
48417484|NCT00479466|155717003|FG005|Overall Study|Lost to Follow-up|2|||
48417485|NCT00479466|155716998|FG000|Overall Study|Physician Decision|2|||
48417486|NCT00479466|155716999|FG001|Overall Study|Physician Decision|1|||
48417487|NCT00479466|155717000|FG002|Overall Study|Physician Decision|1|||
48417488|NCT00479466|155717001|FG003|Overall Study|Physician Decision|0|||
48417489|NCT00479466|155717002|FG004|Overall Study|Physician Decision|0|||
48417490|NCT00479466|155717003|FG005|Overall Study|Physician Decision|0|||
48417491|NCT00479466|155716998|FG000|Overall Study|Pregnancy|0|||
48417492|NCT00479466|155716999|FG001|Overall Study|Pregnancy|0|||
48417493|NCT00479466|155717000|FG002|Overall Study|Pregnancy|0|||
48417494|NCT00479466|155717001|FG003|Overall Study|Pregnancy|0|||
48417495|NCT00479466|155717002|FG004|Overall Study|Pregnancy|1|||
48417496|NCT00479466|155717003|FG005|Overall Study|Pregnancy|0|||
48417497|NCT00479466|155716998|FG000|Overall Study|Protocol Violation|1|||
48417498|NCT00479466|155716999|FG001|Overall Study|Protocol Violation|0|||
48417499|NCT00479466|155717000|FG002|Overall Study|Protocol Violation|0|||
48417500|NCT00479466|155717001|FG003|Overall Study|Protocol Violation|0|||
48417501|NCT00479466|155717002|FG004|Overall Study|Protocol Violation|0|||
48417502|NCT00479466|155717003|FG005|Overall Study|Protocol Violation|0|||
48417503|NCT00479466|155716998|FG000|Overall Study|Withdrawal by Subject|3|||
48417504|NCT00479466|155716999|FG001|Overall Study|Withdrawal by Subject|5|||
48417505|NCT00479466|155717000|FG002|Overall Study|Withdrawal by Subject|0|||
48417506|NCT00479466|155717001|FG003|Overall Study|Withdrawal by Subject|2|||
48417507|NCT00479466|155717002|FG004|Overall Study|Withdrawal by Subject|3|||
48417508|NCT00479466|155717003|FG005|Overall Study|Withdrawal by Subject|1|||
48417509|NCT01772134|155717011|FG000|Overall Study|Adverse Event|6|||
48417510|NCT01772134|155717012|FG001|Overall Study|Adverse Event|5|||
48417511|NCT01772134|155717013|FG002|Overall Study|Adverse Event|10|||
48417512|NCT01772134|155717011|FG000|Overall Study|Withdrew Consent|3|||
48417513|NCT01772134|155717012|FG001|Overall Study|Withdrew Consent|1|||
48417514|NCT01772134|155717013|FG002|Overall Study|Withdrew Consent|5|||
48417515|NCT01772134|155717011|FG000|Overall Study|Lost to Follow-up|2|||
48417516|NCT01772134|155717012|FG001|Overall Study|Lost to Follow-up|0|||
48417517|NCT01772134|155717013|FG002|Overall Study|Lost to Follow-up|0|||
48417518|NCT01772134|155717011|FG000|Overall Study|Protocol Deviation|4|||
48417519|NCT01772134|155717012|FG001|Overall Study|Protocol Deviation|3|||
48417520|NCT01772134|155717013|FG002|Overall Study|Protocol Deviation|3|||
48417521|NCT01772134|155717011|FG000|Overall Study|Lack of Efficacy|11|||
48417522|NCT01772134|155717012|FG001|Overall Study|Lack of Efficacy|5|||
48417523|NCT01772134|155717013|FG002|Overall Study|Lack of Efficacy|3|||
48417524|NCT01772134|155717011|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
48417525|NCT01772134|155717012|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
48417526|NCT01772134|155717013|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
48417527|NCT01772134|155717011|FG000|Overall Study|Randomized Study Medication Not Received|2|||
48417528|NCT01772134|155717012|FG001|Overall Study|Randomized Study Medication Not Received|0|||
48417529|NCT01772134|155717013|FG002|Overall Study|Randomized Study Medication Not Received|1|||
48417530|NCT02500550|155717014|FG000|Overall Study|Death|7|||
48417531|NCT03486314|155717015|FG000|Part A|Adverse Event|1|||
48417532|NCT03486314|155717016|FG001|Part A|Adverse Event|0|||
48417533|NCT03486314|155717017|FG002|Part A|Adverse Event|0|||
48417534|NCT03486314|155717015|FG000|Part A|Symptomatic Deterioration|2|||
48417535|NCT03486314|155717016|FG001|Part A|Symptomatic Deterioration|0|||
48417536|NCT03486314|155717017|FG002|Part A|Symptomatic Deterioration|0|||
48417537|NCT03830281|155717018|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
48417538|NCT03830281|155717019|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
48417539|NCT03830281|155717018|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
48417540|NCT03830281|155717019|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
48417541|NCT03830281|155717018|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
48417542|NCT03830281|155717019|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
48417543|NCT03830281|155717018|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
48417544|NCT03830281|155717019|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
48417545|NCT03830281|155717018|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
48417546|NCT03830281|155717019|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
48417547|NCT03830281|155717018|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
48417548|NCT03830281|155717019|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
48417549|NCT03830281|155717018|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
48417550|NCT03830281|155717019|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
48417551|NCT03830281|155717018|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
48417552|NCT03830281|155717019|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
48417553|NCT03830281|155717018|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
48417554|NCT03830281|155717019|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
48417555|NCT00594399|155717020|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
48417556|NCT00594399|155717021|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
48417557|NCT00594399|155717022|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
48417558|NCT00594399|155717020|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
48417559|NCT00594399|155717021|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
48417560|NCT00594399|155717022|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
48417561|NCT00594399|155717020|FG000|Initial 3 Month Counseling|Personal issues|2|||
48417562|NCT00594399|155717021|FG001|Initial 3 Month Counseling|Personal issues|0|||
48417563|NCT00594399|155717022|FG002|Initial 3 Month Counseling|Personal issues|0|||
48417564|NCT00594399|155717020|FG000|Initial 3 Month Counseling|Too busy|7|||
48417565|NCT00594399|155717021|FG001|Initial 3 Month Counseling|Too busy|1|||
48417566|NCT00594399|155717022|FG002|Initial 3 Month Counseling|Too busy|0|||
48417567|NCT00594399|155717020|FG000|Initial 3 Month Counseling|Pain|2|||
48417568|NCT00594399|155717021|FG001|Initial 3 Month Counseling|Pain|0|||
48417569|NCT00594399|155717022|FG002|Initial 3 Month Counseling|Pain|0|||
48417570|NCT00594399|155717020|FG000|Initial 3 Month Counseling|Moved|1|||
48417571|NCT00594399|155717021|FG001|Initial 3 Month Counseling|Moved|0|||
48417572|NCT00594399|155717022|FG002|Initial 3 Month Counseling|Moved|0|||
48417573|NCT00594399|155717020|FG000|Initial 3 Month Counseling|Family illness|1|||
48417574|NCT00594399|155717021|FG001|Initial 3 Month Counseling|Family illness|0|||
48417575|NCT00594399|155717022|FG002|Initial 3 Month Counseling|Family illness|0|||
48417576|NCT00594399|155717020|FG000|Rerandomization Arm 1 Only|Death|2|||
48417577|NCT00594399|155717021|FG001|Rerandomization Arm 1 Only|Death|1|||
48417578|NCT00594399|155717022|FG002|Rerandomization Arm 1 Only|Death|0|||
48417579|NCT00594399|155717020|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
48417580|NCT00594399|155717021|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
48417581|NCT00594399|155717022|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
48417582|NCT01440101|155717023|FG000|Overall Study|Adverse Event|2|||
48417583|NCT01440101|155717024|FG001|Overall Study|Adverse Event|0|||
48417584|NCT01440101|155717025|FG002|Overall Study|Adverse Event|0|||
48417585|NCT01440101|155717023|FG000|Overall Study|Withdrawal by Subject|0|||
48417586|NCT01440101|155717024|FG001|Overall Study|Withdrawal by Subject|3|||
48417587|NCT01440101|155717025|FG002|Overall Study|Withdrawal by Subject|1|||
48417588|NCT01440101|155717023|FG000|Overall Study|Other|0|||
48417589|NCT01440101|155717024|FG001|Overall Study|Other|1|||
48417590|NCT01440101|155717025|FG002|Overall Study|Other|0|||
48417591|NCT01491945|155717027|FG000|Overall Study|Death|30|||
48417592|NCT01491945|155717027|FG000|Overall Study|Withdrwan/LTF|16|||
48417593|NCT01491945|155717027|FG000|Overall Study|Conversion|4|||
48417594|NCT01491945|155717027|FG000|Overall Study|Missed Visit|1|||
48417595|NCT01499576|155717028|FG000|Overall Study|Physician Decision|12|||
48417596|NCT01499576|155717028|FG000|Overall Study|Withdrawal by Subject|9|||
48417597|NCT03517436|155717033|FG000|Overall Study|Death|3|||
48417598|NCT03517436|155717033|FG000|Overall Study|Withdrawal by Subject|4|||
48417599|NCT03517436|155717033|FG000|Overall Study|Did not receive study valve.|1|||
48417600|NCT00828451|155717038|FG000|Overall Study|Death|2|||
48417601|NCT00828451|155717038|FG000|Overall Study|Lack of intravenous line|7|||
48417602|NCT00828451|155717038|FG000|Overall Study|Withdrawal by Subject|1|||
48417603|NCT00828451|155717038|FG000|Overall Study|Deterioration in clinical status|1|||
48417604|NCT03567187|155717039|FG000|Overall Study|Lost to Follow-up|18|||
48417605|NCT00995371|155717041|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
48417606|NCT00995371|155717042|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
48417607|NCT01687673|155717043|FG000|Overall Study|Physician Decision|1|||
48417608|NCT03658889|155719286|FG000|Overall Study|Protocol Violation|2|||
48417609|NCT03658889|155719287|FG001|Overall Study|Protocol Violation|0|||
48417610|NCT02128490|155719290|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48417611|NCT02128490|155719291|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48417612|NCT02128490|155719292|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
48417613|NCT02128490|155719293|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
48417614|NCT02128490|155719294|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
48417615|NCT02128490|155719290|FG000|Overall Study|Major Protocol Deviation|1|||
48417616|NCT02128490|155719291|FG001|Overall Study|Major Protocol Deviation|2|||
48417617|NCT02128490|155719292|FG002|Overall Study|Major Protocol Deviation|0|||
48417618|NCT02128490|155719293|FG003|Overall Study|Major Protocol Deviation|2|||
48417619|NCT02128490|155719294|FG004|Overall Study|Major Protocol Deviation|2|||
48417620|NCT02128490|155719290|FG000|Overall Study|Lost to Follow-up|0|||
48417621|NCT02128490|155719291|FG001|Overall Study|Lost to Follow-up|0|||
48417622|NCT02128490|155719292|FG002|Overall Study|Lost to Follow-up|1|||
48417623|NCT02128490|155719293|FG003|Overall Study|Lost to Follow-up|1|||
48417624|NCT02128490|155719294|FG004|Overall Study|Lost to Follow-up|1|||
48417625|NCT02128490|155719290|FG000|Overall Study|Voluntary Withdrawal|3|||
48417626|NCT02128490|155719291|FG001|Overall Study|Voluntary Withdrawal|3|||
48417627|NCT02128490|155719292|FG002|Overall Study|Voluntary Withdrawal|1|||
48417628|NCT02128490|155719293|FG003|Overall Study|Voluntary Withdrawal|1|||
48417629|NCT02128490|155719294|FG004|Overall Study|Voluntary Withdrawal|2|||
48417630|NCT02128490|155719290|FG000|Overall Study|Lack of Efficacy|0|||
48417631|NCT02128490|155719291|FG001|Overall Study|Lack of Efficacy|1|||
48417632|NCT02128490|155719292|FG002|Overall Study|Lack of Efficacy|0|||
48417633|NCT02128490|155719293|FG003|Overall Study|Lack of Efficacy|0|||
48417634|NCT02128490|155719294|FG004|Overall Study|Lack of Efficacy|0|||
48417635|NCT02128490|155719290|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
48417636|NCT02128490|155719291|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
48426321|NCT02203838|155749552|FG002|Overall Study|Adverse Event|3|||
48417637|NCT02128490|155719292|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
48417638|NCT02128490|155719293|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
48417639|NCT02128490|155719294|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
48417640|NCT02128490|155719290|FG000|Overall Study|Other Miscellaneous Reasons|0|||
48417641|NCT02128490|155719291|FG001|Overall Study|Other Miscellaneous Reasons|0|||
48417642|NCT02128490|155719292|FG002|Overall Study|Other Miscellaneous Reasons|2|||
48417643|NCT02128490|155719293|FG003|Overall Study|Other Miscellaneous Reasons|1|||
48417644|NCT02128490|155719294|FG004|Overall Study|Other Miscellaneous Reasons|1|||
48417645|NCT00224016|155719295|FG000|Titration Period|Withdrawal by Subject|0|||
48417646|NCT00224016|155719296|FG001|Titration Period|Withdrawal by Subject|1|||
48417647|NCT00224016|155719295|FG000|Titration Period|Lost to Follow-up|1|||
48417648|NCT00224016|155719296|FG001|Titration Period|Lost to Follow-up|0|||
48417649|NCT00224016|155719295|FG000|Maintenance Period|Withdrawal by Subject|2|||
48417650|NCT00224016|155719296|FG001|Maintenance Period|Withdrawal by Subject|0|||
48417651|NCT00224016|155719295|FG000|Maintenance Period|Lost to Follow-up|0|||
48417652|NCT00224016|155719296|FG001|Maintenance Period|Lost to Follow-up|1|||
48417653|NCT03311126|155719298|FG000|Induction|Death|1|||
48417654|NCT03311126|155719298|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
48417655|NCT02251743|155719299|FG000|Overall Study|Withdrawal by Subject|1|||
48417656|NCT02251743|155719300|FG001|Overall Study|Withdrawal by Subject|1|||
48417657|NCT00613314|155719304|FG000|Overall Study|Adverse Event|5|||
48417658|NCT00613314|155719304|FG000|Overall Study|Protocol Violation|14|||
48417659|NCT00613314|155719304|FG000|Overall Study|Lost to Follow-up|46|||
48417660|NCT00613314|155719304|FG000|Overall Study|Other reason not defined above|90|||
48417661|NCT01154101|155719308|FG000|Overall Study|Adverse Event|0|||
48417662|NCT01154101|155719309|FG001|Overall Study|Adverse Event|2|||
48417663|NCT01154101|155719310|FG002|Overall Study|Adverse Event|1|||
48417664|NCT01154101|155719311|FG003|Overall Study|Adverse Event|1|||
48417665|NCT01154101|155719312|FG004|Overall Study|Adverse Event|0|||
48417666|NCT01154101|155719308|FG000|Overall Study|Lost to Follow-up|0|||
48417667|NCT01154101|155719309|FG001|Overall Study|Lost to Follow-up|1|||
48417668|NCT01154101|155719310|FG002|Overall Study|Lost to Follow-up|0|||
48417669|NCT01154101|155719311|FG003|Overall Study|Lost to Follow-up|1|||
48417670|NCT01154101|155719312|FG004|Overall Study|Lost to Follow-up|0|||
48417671|NCT01154101|155719308|FG000|Overall Study|Withdrawal by Subject|0|||
48417672|NCT01154101|155719309|FG001|Overall Study|Withdrawal by Subject|1|||
48417673|NCT01154101|155719310|FG002|Overall Study|Withdrawal by Subject|2|||
48417674|NCT01154101|155719311|FG003|Overall Study|Withdrawal by Subject|0|||
48417675|NCT01154101|155719312|FG004|Overall Study|Withdrawal by Subject|1|||
48417676|NCT04178590|155719313|FG000|Overall Study|Pregnancy|1|||
48417677|NCT04178590|155719313|FG000|Overall Study|Lost to Follow-up|1|||
48417678|NCT00996840|155719314|FG000|Overall Study|Adverse Event|0|||
48417679|NCT00996840|155719315|FG001|Overall Study|Adverse Event|1|||
48417680|NCT00996840|155719316|FG002|Overall Study|Adverse Event|0|||
48417681|NCT00996840|155719317|FG003|Overall Study|Adverse Event|0|||
48417682|NCT00996840|155719318|FG004|Overall Study|Adverse Event|0|||
48417683|NCT00996840|155719314|FG000|Overall Study|Physician Decision|0|||
48417684|NCT00996840|155719315|FG001|Overall Study|Physician Decision|0|||
48417685|NCT00996840|155719316|FG002|Overall Study|Physician Decision|1|||
48417686|NCT00996840|155719317|FG003|Overall Study|Physician Decision|1|||
48417687|NCT00996840|155719318|FG004|Overall Study|Physician Decision|2|||
48417688|NCT00996840|155719314|FG000|Overall Study|Withdrawal by Subject|1|||
48417689|NCT00996840|155719315|FG001|Overall Study|Withdrawal by Subject|1|||
48417690|NCT00996840|155719316|FG002|Overall Study|Withdrawal by Subject|0|||
48417691|NCT00996840|155719317|FG003|Overall Study|Withdrawal by Subject|0|||
48417692|NCT00996840|155719318|FG004|Overall Study|Withdrawal by Subject|0|||
48417693|NCT00817414|155719326|FG000|Overall Study|Adverse Event|1|||
48417694|NCT00817414|155719327|FG001|Overall Study|Adverse Event|1|||
48417695|NCT00817414|155719328|FG002|Overall Study|Adverse Event|1|||
48417696|NCT00817414|155719329|FG003|Overall Study|Adverse Event|0|||
48417697|NCT00817414|155719330|FG004|Overall Study|Adverse Event|0|||
48417698|NCT00817414|155719326|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
48417699|NCT00817414|155719327|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
48417700|NCT00817414|155719328|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
48417701|NCT00817414|155719329|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
48417702|NCT00817414|155719330|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
48417703|NCT00817414|155719326|FG000|Overall Study|Withdrawal by Subject|1|||
48417704|NCT00817414|155719327|FG001|Overall Study|Withdrawal by Subject|1|||
48417705|NCT00817414|155719328|FG002|Overall Study|Withdrawal by Subject|0|||
48417706|NCT00817414|155719329|FG003|Overall Study|Withdrawal by Subject|0|||
48417707|NCT00817414|155719330|FG004|Overall Study|Withdrawal by Subject|0|||
48417708|NCT00817414|155719326|FG000|Overall Study|Lost to Follow-up|0|||
48417709|NCT00817414|155719327|FG001|Overall Study|Lost to Follow-up|0|||
48417710|NCT00817414|155719328|FG002|Overall Study|Lost to Follow-up|1|||
48417711|NCT00817414|155719329|FG003|Overall Study|Lost to Follow-up|1|||
48417712|NCT00817414|155719330|FG004|Overall Study|Lost to Follow-up|1|||
48417713|NCT00817414|155719326|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
48417714|NCT00817414|155719327|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
48417715|NCT00817414|155719328|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
48417716|NCT00817414|155719329|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
48417717|NCT00817414|155719330|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
48417718|NCT00817414|155719326|FG000|Overall Study|Protocol Violation|0|||
48417719|NCT00817414|155719327|FG001|Overall Study|Protocol Violation|0|||
48417720|NCT00817414|155719328|FG002|Overall Study|Protocol Violation|0|||
48417721|NCT00817414|155719329|FG003|Overall Study|Protocol Violation|0|||
48417722|NCT00817414|155719330|FG004|Overall Study|Protocol Violation|1|||
48417723|NCT01503021|155719331|FG000|Overall Study|Adverse Event|7|||
48417724|NCT01503021|155719332|FG001|Overall Study|Adverse Event|6|||
48417725|NCT01503021|155719331|FG000|Overall Study|Death|0|||
48417726|NCT01503021|155719332|FG001|Overall Study|Death|2|||
48417727|NCT01503021|155719331|FG000|Overall Study|Lost to Follow-up|2|||
48417728|NCT01503021|155719332|FG001|Overall Study|Lost to Follow-up|0|||
48417729|NCT01503021|155719331|FG000|Overall Study|Physician Decision|3|||
48417730|NCT01503021|155719332|FG001|Overall Study|Physician Decision|0|||
48417731|NCT01503021|155719331|FG000|Overall Study|Protocol Violation|1|||
48417732|NCT01503021|155719332|FG001|Overall Study|Protocol Violation|3|||
48417733|NCT01503021|155719331|FG000|Overall Study|Withdrawal by Subject|9|||
48417734|NCT01503021|155719332|FG001|Overall Study|Withdrawal by Subject|8|||
48417735|NCT01503021|155719331|FG000|Overall Study|Moved, received transplant, etc.|5|||
48417736|NCT01503021|155719332|FG001|Overall Study|Moved, received transplant, etc.|7|||
48417737|NCT00886938|155719333|FG000|Overall Study|Adverse Event|1|||
48417738|NCT00886938|155719333|FG000|Overall Study|Withdrawal by Subject|1|||
48417739|NCT04938648|155719334|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
48417740|NCT04938648|155719335|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
48417741|NCT04938648|155719334|FG000|Overall Study|Patient too ill|0|||
48417742|NCT04938648|155719335|FG001|Overall Study|Patient too ill|1|||
48417743|NCT04938648|155719334|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
48417744|NCT04938648|155719335|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
48417745|NCT04938648|155719334|FG000|Overall Study|Patient did not have memory problems|1|||
48417746|NCT04938648|155719335|FG001|Overall Study|Patient did not have memory problems|1|||
48417747|NCT04938648|155719334|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
48417748|NCT04938648|155719335|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
48417749|NCT04938648|155719334|FG000|Overall Study|Care partner could not be reached|0|||
48417750|NCT04938648|155719335|FG001|Overall Study|Care partner could not be reached|1|||
48417751|NCT04938648|155719334|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
48417752|NCT04938648|155719335|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
48417753|NCT04938648|155719334|FG000|Overall Study|Withdrawal by Subject|2|||
48417754|NCT04938648|155719335|FG001|Overall Study|Withdrawal by Subject|1|||
48417755|NCT03941548|155719336|FG000|Overall Study|Adverse Event|0|||
48417756|NCT03941548|155719337|FG001|Overall Study|Adverse Event|1|||
48417757|NCT03941548|155719336|FG000|Overall Study|Lost to Follow-up|0|||
48417758|NCT03941548|155719337|FG001|Overall Study|Lost to Follow-up|1|||
48417759|NCT03941548|155719336|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
48417760|NCT03941548|155719337|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
48417761|NCT01059812|155719340|FG000|Overall Study|Adverse Event|9|||
48417762|NCT01059812|155719341|FG001|Overall Study|Adverse Event|5|||
48417763|NCT01059812|155719340|FG000|Overall Study|Lack of Efficacy|2|||
48417764|NCT01059812|155719341|FG001|Overall Study|Lack of Efficacy|2|||
48417765|NCT01059812|155719340|FG000|Overall Study|Protocol Violation|3|||
48417766|NCT01059812|155719341|FG001|Overall Study|Protocol Violation|1|||
48417767|NCT01059812|155719340|FG000|Overall Study|Withdrawal Criteria|9|||
48417768|NCT01059812|155719341|FG001|Overall Study|Withdrawal Criteria|4|||
48417769|NCT01059812|155719340|FG000|Overall Study|Unclassified|14|||
48417770|NCT01059812|155719341|FG001|Overall Study|Unclassified|4|||
48417771|NCT01451515|155719345|FG000|Overall Study|Death|0|||
48417772|NCT01451515|155719346|FG001|Overall Study|Death|1|||
48417773|NCT01451515|155719347|FG002|Overall Study|Death|0|||
48417774|NCT01451515|155719345|FG000|Overall Study|Withdrawal by Subject|0|||
48417775|NCT01451515|155719346|FG001|Overall Study|Withdrawal by Subject|1|||
48417776|NCT01451515|155719347|FG002|Overall Study|Withdrawal by Subject|0|||
48417777|NCT01451515|155719345|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
48417778|NCT01451515|155719346|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
48417779|NCT01451515|155719347|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
48417780|NCT01451515|155719345|FG000|Overall Study|Relapse (except CNS)|1|||
48417781|NCT01451515|155719346|FG001|Overall Study|Relapse (except CNS)|1|||
48417782|NCT01451515|155719347|FG002|Overall Study|Relapse (except CNS)|0|||
48417783|NCT01919307|155719348|FG000|Overall Study|Withdrawal by Subject|9|||
48417784|NCT00466505|155719354|FG000|Overall Study|disease progression|13|||
48417785|NCT00466505|155719354|FG000|Overall Study|Adverse Event|4|||
48417786|NCT00811252|155719355|FG000|Overall Study|Adverse Event|6|||
48417787|NCT00811252|155719356|FG001|Overall Study|Adverse Event|10|||
48417788|NCT00811252|155719357|FG002|Overall Study|Adverse Event|15|||
48417789|NCT00811252|155719355|FG000|Overall Study|Lack of Efficacy|7|||
48417790|NCT00811252|155719356|FG001|Overall Study|Lack of Efficacy|2|||
48417791|NCT00811252|155719357|FG002|Overall Study|Lack of Efficacy|0|||
48417792|NCT00811252|155719355|FG000|Overall Study|Protocol Violation|3|||
48417793|NCT00811252|155719356|FG001|Overall Study|Protocol Violation|3|||
48417794|NCT00811252|155719357|FG002|Overall Study|Protocol Violation|2|||
48417795|NCT00811252|155719355|FG000|Overall Study|Withdrawal of Consent|1|||
48417796|NCT00811252|155719356|FG001|Overall Study|Withdrawal of Consent|2|||
48417797|NCT00811252|155719357|FG002|Overall Study|Withdrawal of Consent|2|||
48417798|NCT00811252|155719355|FG000|Overall Study|Lost to Follow-up|0|||
48417799|NCT00811252|155719356|FG001|Overall Study|Lost to Follow-up|0|||
48417800|NCT00811252|155719357|FG002|Overall Study|Lost to Follow-up|2|||
48417801|NCT00811252|155719355|FG000|Overall Study|Administrative or Other Reasons|0|||
48417802|NCT00811252|155719356|FG001|Overall Study|Administrative or Other Reasons|3|||
48417803|NCT00811252|155719357|FG002|Overall Study|Administrative or Other Reasons|2|||
48417804|NCT00813748|155719359|FG000|Skin Test Substudy|Physician Decision|0|||
48417805|NCT00813748|155719360|FG001|Skin Test Substudy|Physician Decision|1|||
48417806|NCT01931865|155719362|FG000|Overall Study|Lost to Follow-up|2|||
48417807|NCT01931865|155719362|FG000|Overall Study|Withdrawal by Subject|2|||
48417808|NCT00504257|155719363|FG000|Overall Study|Withdrawal by Subject|2|||
48417809|NCT00504257|155719363|FG000|Overall Study|ineligible histology|2|||
48417810|NCT02561156|155719364|FG000|Part 2|Adverse Event|0|||
48417811|NCT02561156|155719365|FG001|Part 2|Adverse Event|0|||
48417812|NCT02561156|155719366|FG002|Part 2|Adverse Event|0|||
48417813|NCT02561156|155719367|FG003|Part 2|Adverse Event|0|||
48417814|NCT02561156|155719368|FG004|Part 2|Adverse Event|0|||
48417815|NCT02561156|155719369|FG005|Part 2|Adverse Event|0|||
48417816|NCT02561156|155719370|FG006|Part 2|Adverse Event|0|||
48417817|NCT02561156|155719371|FG007|Part 2|Adverse Event|0|||
48417818|NCT02561156|155719372|FG008|Part 2|Adverse Event|0|||
48417819|NCT02561156|155719373|FG009|Part 2|Adverse Event|0|||
48417820|NCT02561156|155719374|FG010|Part 2|Adverse Event|0|||
48417821|NCT02561156|155719375|FG011|Part 2|Adverse Event|1|||
48417822|NCT02561156|155719376|FG012|Part 2|Adverse Event|0|||
48417823|NCT04919564|155719378|FG000|Overall Study|Lost to Follow-up|1|||
48417824|NCT04919564|155719379|FG001|Overall Study|Lost to Follow-up|0|||
48417825|NCT04919564|155719378|FG000|Overall Study|Physician Decision|1|||
48417826|NCT04919564|155719379|FG001|Overall Study|Physician Decision|1|||
48417827|NCT02504541|155719385|FG000|Overall Study|Adverse Event|4|||
48417828|NCT02504541|155719385|FG000|Overall Study|Withdrawal by Subject|4|||
48417829|NCT02504541|155719385|FG000|Overall Study|Lost to Follow-up|1|||
48417830|NCT02504541|155719385|FG000|Overall Study|Met Stopping Criteria|1|||
48417831|NCT02504541|155719385|FG000|Overall Study|Protocol Violation|2|||
48417832|NCT02504541|155719385|FG000|Overall Study|Termination by Sponsor|1|||
48417833|NCT02504541|155719385|FG000|Overall Study|Other|2|||
48417834|NCT02504541|155719385|FG000|Overall Study|Multiple|5|||
48417835|NCT01937312|155719387|FG000|Overall Study|Adverse Event|10|||
48417836|NCT01937312|155719388|FG001|Overall Study|Adverse Event|1|||
48417837|NCT01937312|155719387|FG000|Overall Study|Lack of Efficacy|0|||
48417838|NCT01937312|155719388|FG001|Overall Study|Lack of Efficacy|1|||
48417839|NCT01937312|155719387|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
48417840|NCT01937312|155719388|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
48417841|NCT03401749|155719410|FG000|Overall Study|Lost to Follow-up|20|||
48417842|NCT03401749|155719411|FG001|Overall Study|Lost to Follow-up|16|||
48417843|NCT03401749|155719412|FG002|Overall Study|Lost to Follow-up|26|||
48417844|NCT00356915|155719413|FG000|Overall Study|Non compliance|1|||
48417845|NCT00356915|155719414|FG001|Overall Study|Non compliance|2|||
48417846|NCT00356915|155719415|FG002|Overall Study|Non compliance|1|||
48417847|NCT00356915|155719413|FG000|Overall Study|Protocol Violation|2|||
48417848|NCT00356915|155719414|FG001|Overall Study|Protocol Violation|3|||
48417849|NCT00356915|155719415|FG002|Overall Study|Protocol Violation|2|||
48417850|NCT00356915|155719413|FG000|Overall Study|Withdrawal by Subject|14|||
48417851|NCT00356915|155719414|FG001|Overall Study|Withdrawal by Subject|14|||
48417852|NCT00356915|155719415|FG002|Overall Study|Withdrawal by Subject|10|||
48417853|NCT00356915|155719413|FG000|Overall Study|Lack of Efficacy|0|||
48417854|NCT00356915|155719414|FG001|Overall Study|Lack of Efficacy|0|||
48417855|NCT00356915|155719415|FG002|Overall Study|Lack of Efficacy|3|||
48417856|NCT00356915|155719413|FG000|Overall Study|Lost to Follow-up|27|||
48417857|NCT00356915|155719414|FG001|Overall Study|Lost to Follow-up|34|||
48417858|NCT00356915|155719415|FG002|Overall Study|Lost to Follow-up|14|||
48417859|NCT00356915|155719413|FG000|Overall Study|Administrative Decision|0|||
48417860|NCT00356915|155719414|FG001|Overall Study|Administrative Decision|0|||
48417861|NCT00356915|155719415|FG002|Overall Study|Administrative Decision|1|||
48417862|NCT00356915|155719413|FG000|Overall Study|Physician Decision|0|||
48417863|NCT00356915|155719414|FG001|Overall Study|Physician Decision|2|||
48417864|NCT00356915|155719415|FG002|Overall Study|Physician Decision|0|||
48417865|NCT00356915|155719413|FG000|Overall Study|Adverse Event|21|||
48417866|NCT00356915|155719414|FG001|Overall Study|Adverse Event|31|||
48417867|NCT00356915|155719415|FG002|Overall Study|Adverse Event|8|||
48417868|NCT00356915|155719413|FG000|Overall Study|Miscellaneous reasons|11|||
48417869|NCT00356915|155719414|FG001|Overall Study|Miscellaneous reasons|8|||
48417870|NCT00356915|155719415|FG002|Overall Study|Miscellaneous reasons|3|||
48417871|NCT01307423|155719416|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
48417872|NCT01307423|155719417|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
48417873|NCT01307423|155719418|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
48417874|NCT01307423|155719419|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48417875|NCT01307423|155719420|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48417876|NCT01307423|155719421|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48417877|NCT01307423|155719422|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48417878|NCT01307423|155719423|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48417879|NCT01307423|155719424|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
48417880|NCT01307423|155719416|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
48417881|NCT01307423|155719417|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
48417882|NCT01307423|155719418|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
48417883|NCT01307423|155719419|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48417884|NCT01307423|155719420|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48417885|NCT01307423|155719421|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48417886|NCT01307423|155719422|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48417887|NCT01307423|155719423|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48417888|NCT01307423|155719424|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
48417889|NCT01307423|155719416|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
48417890|NCT01307423|155719417|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
48417891|NCT01307423|155719418|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
48417892|NCT01307423|155719419|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48417893|NCT01307423|155719420|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48417894|NCT01307423|155719421|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48417895|NCT01307423|155719422|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48417896|NCT01307423|155719423|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48417897|NCT01307423|155719424|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
48417898|NCT01307423|155719416|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48417899|NCT01307423|155719417|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48417900|NCT01307423|155719418|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
48417901|NCT01307423|155719419|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48417902|NCT01307423|155719420|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48417903|NCT01307423|155719421|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48417904|NCT01307423|155719422|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48417905|NCT01307423|155719423|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48417906|NCT01307423|155719424|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
48417907|NCT01307423|155719416|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
48417908|NCT01307423|155719417|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
48417909|NCT01307423|155719418|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
48417910|NCT01307423|155719419|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48417911|NCT01307423|155719420|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48417912|NCT01307423|155719421|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48417913|NCT01307423|155719422|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48417914|NCT01307423|155719423|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48417915|NCT01307423|155719424|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
48417916|NCT01307423|155719416|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
48417917|NCT01307423|155719417|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48417918|NCT01307423|155719418|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48417919|NCT01307423|155719419|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48417920|NCT01307423|155719420|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48417921|NCT01307423|155719421|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48417922|NCT01307423|155719422|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48417923|NCT01307423|155719423|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48417924|NCT01307423|155719424|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
48417925|NCT01307423|155719416|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
48417926|NCT01307423|155719417|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
48417927|NCT01307423|155719418|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48417928|NCT01307423|155719419|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48417929|NCT01307423|155719420|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48417930|NCT01307423|155719421|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48426322|NCT02203838|155749553|FG003|Overall Study|Adverse Event|2|||
48417931|NCT01307423|155719422|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48417932|NCT01307423|155719423|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48417933|NCT01307423|155719424|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
48417934|NCT01307423|155719416|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48417935|NCT01307423|155719417|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
48417936|NCT01307423|155719418|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
48417937|NCT01307423|155719419|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48417938|NCT01307423|155719420|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48417939|NCT01307423|155719421|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48417940|NCT01307423|155719422|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48417941|NCT01307423|155719423|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48417942|NCT01307423|155719424|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
48417943|NCT01307423|155719416|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48417944|NCT01307423|155719417|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
48417945|NCT01307423|155719418|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
48417946|NCT01307423|155719419|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
48417947|NCT01307423|155719420|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
48417948|NCT01307423|155719421|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48417949|NCT01307423|155719422|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48417950|NCT01307423|155719423|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48417951|NCT01307423|155719424|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
48417952|NCT01307423|155719416|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48417953|NCT01307423|155719417|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
48417954|NCT01307423|155719418|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
48417955|NCT01307423|155719419|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
48417956|NCT01307423|155719420|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
48417957|NCT01307423|155719421|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48417958|NCT01307423|155719422|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48417959|NCT01307423|155719423|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48417960|NCT01307423|155719424|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
48417961|NCT01307423|155719416|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48417962|NCT01307423|155719417|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48417963|NCT01307423|155719418|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48417964|NCT01307423|155719419|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48417965|NCT01307423|155719420|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48417966|NCT01307423|155719421|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
48417967|NCT01307423|155719422|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48417968|NCT01307423|155719423|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48417969|NCT01307423|155719424|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
48417970|NCT01307423|155719416|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48417971|NCT01307423|155719417|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
48417972|NCT01307423|155719418|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
48417973|NCT01307423|155719419|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48417974|NCT01307423|155719420|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48417975|NCT01307423|155719421|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
48417976|NCT01307423|155719422|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
48417977|NCT01307423|155719423|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48417978|NCT01307423|155719424|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
48417979|NCT01307423|155719416|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48417980|NCT01307423|155719417|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48417981|NCT01307423|155719418|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48417982|NCT01307423|155719419|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
48417983|NCT01307423|155719420|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48417984|NCT01307423|155719421|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48417985|NCT01307423|155719422|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48417986|NCT01307423|155719423|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48417987|NCT01307423|155719424|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
48417988|NCT01307423|155719416|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
48417989|NCT01307423|155719417|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
48417990|NCT01307423|155719418|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
48417991|NCT01307423|155719419|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
48417992|NCT01307423|155719420|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
48417993|NCT01307423|155719421|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
48417994|NCT01307423|155719422|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
48692643|NCT03001557|156724547|FG006|Extension Phase|Lost to Follow-up|2|||
48417995|NCT01307423|155719423|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
48417996|NCT01307423|155719424|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
48417997|NCT01307423|155719416|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48417998|NCT01307423|155719417|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48417999|NCT01307423|155719418|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48418000|NCT01307423|155719419|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48418001|NCT01307423|155719420|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48418002|NCT01307423|155719421|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
48418003|NCT01307423|155719422|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48418004|NCT01307423|155719423|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48418005|NCT01307423|155719424|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
48418006|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48418007|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
48418008|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
48418009|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48418010|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48418011|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48418012|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
48418013|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
48418014|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
48418015|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48418016|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
48418017|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
48418018|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48418019|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48418020|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48418021|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
48418022|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
48418023|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
48418024|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48418025|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48418026|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
48418027|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48418028|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48418029|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48418030|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48418031|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48418032|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
48418033|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48418034|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
48418035|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
48418036|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48418037|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48418038|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48418039|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
48418040|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
48418041|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
48418042|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48418043|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48418044|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48418045|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48418046|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48418047|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48418048|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
48418049|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48418050|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
48418051|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48418052|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
48418053|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
48418054|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48418055|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48418056|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48418057|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
48418058|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
48418059|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
48418060|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48418061|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
48418062|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
48418063|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48418064|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48418065|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48418066|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
48418067|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
48418068|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
48418069|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48418070|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
48418071|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
48418072|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48418073|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48418074|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48418075|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48418076|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48418077|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
48418078|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48418079|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
48418080|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
48418081|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48418082|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48418083|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48418084|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
48418085|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
48418086|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
48418087|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48418088|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
48418089|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
48418090|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48418091|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48418092|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48418093|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
48418094|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
48418095|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
48418096|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48418097|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48418098|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48418099|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48418100|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48418101|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48418102|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48418103|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
48418104|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
48418105|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48418106|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
48418107|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48418108|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48418109|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48418110|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48418111|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48418112|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48418113|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
48418114|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48418115|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
48418116|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48418117|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48418118|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48418119|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48418120|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48418121|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
48418122|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
48418123|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48418124|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
48418125|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
48418126|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48418127|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48418128|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48418129|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
48418130|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
48418131|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
48418132|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48418133|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48418134|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
48418135|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48418136|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48418137|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48418138|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48418139|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48418140|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
48418141|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48418142|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48418143|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48418144|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48418145|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48418146|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48418147|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48418148|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
48418149|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
48418150|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48418151|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
48418152|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
48418153|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48418154|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48418155|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48418156|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48418157|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
48418158|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
48418159|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48418160|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
48418161|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
48418162|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48418163|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48418164|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48418165|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48418166|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48418167|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
48418168|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48418169|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
48418170|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
48418171|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48418172|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48418173|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48418174|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48418175|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
48418176|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
48418177|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48418178|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
48418179|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48418180|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48418181|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48418182|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48418183|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48418184|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48418185|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
48418186|NCT01307423|155719416|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48418187|NCT01307423|155719417|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48418188|NCT01307423|155719418|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
48418189|NCT01307423|155719419|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48418190|NCT01307423|155719420|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48418191|NCT01307423|155719421|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48418192|NCT01307423|155719422|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
48418193|NCT01307423|155719423|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
48418194|NCT01307423|155719424|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
48418195|NCT02318602|155719425|FG000|Overall Study|Adverse Event|0|||
48418196|NCT02318602|155719426|FG001|Overall Study|Adverse Event|1|||
48418197|NCT02318602|155719427|FG002|Overall Study|Adverse Event|1|||
48418198|NCT02318602|155719425|FG000|Overall Study|Withdrawal by Subject|0|||
48418199|NCT02318602|155719426|FG001|Overall Study|Withdrawal by Subject|3|||
48418200|NCT02318602|155719427|FG002|Overall Study|Withdrawal by Subject|0|||
48418201|NCT02318602|155719425|FG000|Overall Study|Death|1|||
48418202|NCT02318602|155719426|FG001|Overall Study|Death|0|||
48418203|NCT02318602|155719427|FG002|Overall Study|Death|0|||
48418204|NCT02318602|155719425|FG000|Overall Study|Guardian decision to withdraw|0|||
48418205|NCT02318602|155719426|FG001|Overall Study|Guardian decision to withdraw|0|||
48418206|NCT02318602|155719427|FG002|Overall Study|Guardian decision to withdraw|1|||
48418207|NCT02371629|155719430|FG000|Overall Study|Patient decision|14|||
48418208|NCT02371629|155719431|FG001|Overall Study|Patient decision|10|||
48418209|NCT02371629|155719430|FG000|Overall Study|Adverse Event|8|||
48418210|NCT02371629|155719431|FG001|Overall Study|Adverse Event|8|||
48418211|NCT02371629|155719430|FG000|Overall Study|Physician Decision|2|||
48418212|NCT02371629|155719431|FG001|Overall Study|Physician Decision|3|||
48418213|NCT02371629|155719430|FG000|Overall Study|Death|1|||
48418214|NCT02371629|155719431|FG001|Overall Study|Death|1|||
48418215|NCT02371629|155719430|FG000|Overall Study|Noncompliance with study treatment|1|||
48418216|NCT02371629|155719431|FG001|Overall Study|Noncompliance with study treatment|0|||
48418217|NCT02371629|155719430|FG000|Overall Study|Lack of Efficacy|0|||
48418218|NCT02371629|155719431|FG001|Overall Study|Lack of Efficacy|2|||
48418219|NCT02371629|155719430|FG000|Overall Study|Protocol deviation|0|||
48418220|NCT02371629|155719431|FG001|Overall Study|Protocol deviation|1|||
48418221|NCT05089708|155719432|FG000|Overall Study|Lost to Follow-up|9|||
48418222|NCT05089708|155719433|FG001|Overall Study|Lost to Follow-up|7|||
48418223|NCT05089708|155719432|FG000|Overall Study|Withdrawal by Subject|3|||
48418224|NCT05089708|155719433|FG001|Overall Study|Withdrawal by Subject|1|||
48418225|NCT05089708|155719432|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
48418226|NCT05089708|155719433|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
48418227|NCT05089708|155719432|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
48418228|NCT05089708|155719433|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
48418229|NCT00201851|155719434|FG000|Overall Study|Lost to Follow-up|2|||
48418230|NCT00201851|155719435|FG001|Overall Study|Lost to Follow-up|1|||
48418231|NCT00201851|155719436|FG002|Overall Study|Lost to Follow-up|0|||
48418232|NCT00201851|155719434|FG000|Overall Study|Ineligible post enrollment|6|||
48418233|NCT00201851|155719435|FG001|Overall Study|Ineligible post enrollment|1|||
48418234|NCT00201851|155719436|FG002|Overall Study|Ineligible post enrollment|1|||
48418235|NCT00636818|155719437|FG000|Overall Study|Adverse Event|1|||
48418236|NCT00636818|155719437|FG000|Overall Study|Lost to Follow-up|2|||
48418237|NCT00636818|155719437|FG000|Overall Study|Entry Criteria Exclusion|3|||
48418238|NCT00636818|155719437|FG000|Overall Study|Protocol Violation|1|||
48418239|NCT00636818|155719437|FG000|Overall Study|Withdrawal by Subject|4|||
48418240|NCT02259231|155719438|FG000|Overall Study|Adverse Event|1|||
48418241|NCT02259231|155719439|FG001|Overall Study|Adverse Event|1|||
48418242|NCT02259231|155719440|FG002|Overall Study|Adverse Event|2|||
48418243|NCT02259231|155719441|FG003|Overall Study|Adverse Event|0|||
48418244|NCT02259231|155719442|FG004|Overall Study|Adverse Event|0|||
48418245|NCT02259231|155719443|FG005|Overall Study|Adverse Event|0|||
48418246|NCT02259231|155719444|FG006|Overall Study|Adverse Event|0|||
48418247|NCT02259231|155719438|FG000|Overall Study|Progressive Disease|4|||
48418248|NCT02259231|155719439|FG001|Overall Study|Progressive Disease|5|||
48418249|NCT02259231|155719440|FG002|Overall Study|Progressive Disease|4|||
48418250|NCT02259231|155719441|FG003|Overall Study|Progressive Disease|5|||
48418251|NCT02259231|155719442|FG004|Overall Study|Progressive Disease|4|||
48418252|NCT02259231|155719443|FG005|Overall Study|Progressive Disease|5|||
48418253|NCT02259231|155719444|FG006|Overall Study|Progressive Disease|4|||
48418254|NCT02259231|155719438|FG000|Overall Study|Sponsor termination of study|1|||
48418255|NCT02259231|155719439|FG001|Overall Study|Sponsor termination of study|0|||
48418256|NCT02259231|155719440|FG002|Overall Study|Sponsor termination of study|0|||
48418257|NCT02259231|155719441|FG003|Overall Study|Sponsor termination of study|1|||
48418258|NCT02259231|155719442|FG004|Overall Study|Sponsor termination of study|2|||
48418259|NCT02259231|155719443|FG005|Overall Study|Sponsor termination of study|1|||
48418260|NCT02259231|155719444|FG006|Overall Study|Sponsor termination of study|1|||
48418261|NCT00849212|155719445|FG000|Overall Study|Lack of Efficacy|1|||
48418262|NCT00849212|155719445|FG000|Overall Study|Withdrawal by Subject|3|||
48418263|NCT00849212|155719445|FG000|Overall Study|Adverse Event|2|||
48418264|NCT00849212|155719445|FG000|Overall Study|Miscellaneous|1|||
48418265|NCT00542828|155719446|FG000|Overall Study|Physician Decision|1|||
48418266|NCT00542828|155719446|FG000|Overall Study|Need for Prohibited Treatment|3|||
48418267|NCT00542828|155719446|FG000|Overall Study|Study Prematurely Discontinued|7|||
48418268|NCT00542828|155719446|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
48418269|NCT04246047|155719447|FG000|Overall Study|Death|50|||
48418270|NCT04246047|155719448|FG001|Overall Study|Death|77|||
48418271|NCT04246047|155719447|FG000|Overall Study|Lost to Follow-up|1|||
48418272|NCT04246047|155719448|FG001|Overall Study|Lost to Follow-up|3|||
48418273|NCT04246047|155719447|FG000|Overall Study|Physician Decision|4|||
48418274|NCT04246047|155719448|FG001|Overall Study|Physician Decision|10|||
48418275|NCT04246047|155719447|FG000|Overall Study|Withdrawal by Subject|19|||
48418276|NCT04246047|155719448|FG001|Overall Study|Withdrawal by Subject|26|||
48418277|NCT04246047|155719447|FG000|Overall Study|Ongoing|169|||
48418278|NCT04246047|155719448|FG001|Overall Study|Ongoing|135|||
48418279|NCT00246259|155719454|FG000|Overall Study|Other|3|||
48418280|NCT00246259|155719455|FG001|Overall Study|Other|3|||
48418281|NCT00246259|155719454|FG000|Overall Study|Not stable by Week 18|2|||
48418282|NCT00246259|155719455|FG001|Overall Study|Not stable by Week 18|1|||
48418283|NCT00246259|155719454|FG000|Overall Study|Participant non-compliant|4|||
48418284|NCT00246259|155719455|FG001|Overall Study|Participant non-compliant|9|||
48418285|NCT00246259|155719454|FG000|Overall Study|Lack of Efficacy|2|||
48418286|NCT00246259|155719455|FG001|Overall Study|Lack of Efficacy|2|||
48418287|NCT00246259|155719454|FG000|Overall Study|Investigator withdrew participant|2|||
48418288|NCT00246259|155719455|FG001|Overall Study|Investigator withdrew participant|0|||
48418289|NCT00246259|155719454|FG000|Overall Study|Adverse Event|5|||
48418290|NCT00246259|155719455|FG001|Overall Study|Adverse Event|0|||
48418291|NCT00246259|155719454|FG000|Overall Study|Lost to Follow-up|3|||
48418292|NCT00246259|155719455|FG001|Overall Study|Lost to Follow-up|4|||
48418293|NCT00246259|155719454|FG000|Overall Study|Withdrawal by Subject|5|||
48418294|NCT00246259|155719455|FG001|Overall Study|Withdrawal by Subject|1|||
48418295|NCT00246259|155719454|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
48418296|NCT00246259|155719455|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
48418297|NCT00752986|155719457|FG000|Overall Study|Withdrawal by Subject|2|||
48418298|NCT00752986|155719458|FG001|Overall Study|Withdrawal by Subject|1|||
48418299|NCT00752986|155719459|FG002|Overall Study|Withdrawal by Subject|2|||
48418300|NCT00752986|155719457|FG000|Overall Study|Protocol Violation|3|||
48418301|NCT00752986|155719458|FG001|Overall Study|Protocol Violation|0|||
48418302|NCT00752986|155719459|FG002|Overall Study|Protocol Violation|0|||
48418303|NCT02609399|155719461|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
48418304|NCT02609399|155719462|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
48418305|NCT02609399|155719461|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
48418306|NCT02609399|155719462|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
48418307|NCT02609399|155719461|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
48418308|NCT02609399|155719462|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
48418309|NCT03191786|155719463|FG000|Overall Study|Death|236|||
48418310|NCT03191786|155719464|FG001|Overall Study|Death|127|||
48418311|NCT03191786|155719463|FG000|Overall Study|Lost to Follow-up|9|||
48418312|NCT03191786|155719464|FG001|Overall Study|Lost to Follow-up|3|||
48418313|NCT03191786|155719463|FG000|Overall Study|Physician Decision|1|||
48418314|NCT03191786|155719464|FG001|Overall Study|Physician Decision|0|||
48418315|NCT03191786|155719463|FG000|Overall Study|Moved to Post Trial Access Program|30|||
48418316|NCT03191786|155719464|FG001|Overall Study|Moved to Post Trial Access Program|5|||
48418317|NCT03191786|155719463|FG000|Overall Study|Withdrawal by Subject|26|||
48418318|NCT03191786|155719464|FG001|Overall Study|Withdrawal by Subject|16|||
48418319|NCT02732951|155720835|FG000|Overall Study|Other than listed|1|||
48418320|NCT02732951|155720836|FG001|Overall Study|Other than listed|0|||
48418321|NCT02732951|155720835|FG000|Overall Study|Lost to Follow-up|0|||
48418322|NCT02732951|155720836|FG001|Overall Study|Lost to Follow-up|1|||
48418323|NCT02732951|155720835|FG000|Overall Study|Adverse Event|4|||
48418324|NCT02732951|155720836|FG001|Overall Study|Adverse Event|4|||
48418325|NCT02732951|155720835|FG000|Overall Study|Protocol Violation|0|||
48418326|NCT02732951|155720836|FG001|Overall Study|Protocol Violation|1|||
48418327|NCT01826214|155720838|FG000|Overall Study|Adverse Event|7|||
48418328|NCT01826214|155720839|FG001|Overall Study|Adverse Event|6|||
48418329|NCT01826214|155720838|FG000|Overall Study|Death|3|||
48418330|NCT01826214|155720839|FG001|Overall Study|Death|1|||
48418331|NCT01826214|155720838|FG000|Overall Study|Lost to Follow-up|1|||
48418332|NCT01826214|155720839|FG001|Overall Study|Lost to Follow-up|0|||
48418333|NCT01826214|155720838|FG000|Overall Study|Physician Decision|0|||
48418334|NCT01826214|155720839|FG001|Overall Study|Physician Decision|2|||
48418335|NCT01826214|155720838|FG000|Overall Study|Progressive disease|22|||
48418336|NCT01826214|155720839|FG001|Overall Study|Progressive disease|21|||
48418337|NCT01826214|155720838|FG000|Overall Study|Study terminated by Sponsor|0|||
48418338|NCT01826214|155720839|FG001|Overall Study|Study terminated by Sponsor|1|||
48418339|NCT01826214|155720838|FG000|Overall Study|Subject/guardian decision|2|||
48418340|NCT01826214|155720839|FG001|Overall Study|Subject/guardian decision|3|||
48418341|NCT00075881|155720840|FG000|Overall Study|Lack of Efficacy|18|||
48418342|NCT00075881|155720840|FG000|Overall Study|Adverse Event|7|||
48418343|NCT00075881|155720840|FG000|Overall Study|Death|1|||
48418344|NCT00075881|155720840|FG000|Overall Study|Withdrawal by Subject|2|||
48418345|NCT00075881|155720840|FG000|Overall Study|Protocol Violation|4|||
48418346|NCT00075881|155720840|FG000|Overall Study|other complicating disease|3|||
48418347|NCT00075881|155720840|FG000|Overall Study|other|4|||
48418348|NCT00075881|155720840|FG000|Overall Study|missing data|2|||
48418349|NCT00075881|155720840|FG000|Overall Study|Ineligible|1|||
48418350|NCT00075881|155720840|FG000|Overall Study|never start protocol therapy|1|||
48418351|NCT03019549|155720841|FG000|Washout|DId not meet genotype criteria|11|||
48418352|NCT03019549|155720841|FG000|Period 2|Adverse Event|2|||
48418353|NCT03019549|155720841|FG000|Period 2|Physician Decision|2|||
48692644|NCT03001557|156724548|FG007|Extension Phase|Lost to Follow-up|1|||
48418354|NCT03019549|155720841|FG000|Period 2|Withdrawal by Subject|1|||
48418355|NCT03263806|155720842|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
48418356|NCT03263806|155720843|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
48418357|NCT03263806|155720842|FG000|Overall Study|Withdrawal by Subject|0|||
48418358|NCT03263806|155720843|FG001|Overall Study|Withdrawal by Subject|1|||
48418359|NCT03263806|155720842|FG000|Overall Study|Study Termination|5|||
48418360|NCT03263806|155720843|FG001|Overall Study|Study Termination|6|||
48418361|NCT01412879|155720844|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
48418362|NCT01412879|155720845|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
48418363|NCT01412879|155720846|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
48418364|NCT01412879|155720844|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
48418365|NCT01412879|155720845|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
48418366|NCT01412879|155720846|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
48418367|NCT01412879|155720844|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
48418368|NCT01412879|155720845|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
48418369|NCT01412879|155720846|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
48418370|NCT01412879|155720844|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
48418371|NCT01412879|155720845|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
48418372|NCT01412879|155720846|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
48418373|NCT01412879|155720844|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
48418374|NCT01412879|155720845|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
48418375|NCT01412879|155720846|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
48418376|NCT04030195|155720847|FG000|Overall Study|Withdrawal by Subject|2|||
48418377|NCT04030195|155720848|FG001|Overall Study|Withdrawal by Subject|0|||
48418378|NCT04030195|155720849|FG002|Overall Study|Withdrawal by Subject|0|||
48418379|NCT02109029|155720850|FG000|Part B|Adverse Event|0|||
48418380|NCT02109029|155720851|FG001|Part B|Adverse Event|0|||
48418381|NCT02109029|155720852|FG002|Part B|Adverse Event|0|||
48418382|NCT02109029|155720853|FG003|Part B|Adverse Event|0|||
48418383|NCT02109029|155720854|FG004|Part B|Adverse Event|1|||
48418384|NCT02109029|155720855|FG005|Part B|Adverse Event|1|||
48418385|NCT04840667|155720856|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
48418386|NCT01672892|155720861|FG000|Overall Study|Protocol Violation|7|||
48418387|NCT01672892|155720862|FG001|Overall Study|Protocol Violation|3|||
48418388|NCT02243176|155720877|FG000|Overall Study|Other reason|1|||
48418389|NCT02243176|155720878|FG001|Overall Study|Other reason|2|||
48418390|NCT02243176|155720877|FG000|Overall Study|protocol specified withdrawal critera|1|||
48418391|NCT02243176|155720878|FG001|Overall Study|protocol specified withdrawal critera|3|||
48418392|NCT02243176|155720877|FG000|Overall Study|Protocol Violation|2|||
48418393|NCT02243176|155720878|FG001|Overall Study|Protocol Violation|1|||
48418394|NCT02243176|155720877|FG000|Overall Study|Withdrawal by Subject|8|||
48418395|NCT02243176|155720878|FG001|Overall Study|Withdrawal by Subject|7|||
48418396|NCT02243176|155720877|FG000|Overall Study|Adverse Event|2|||
48418397|NCT02243176|155720878|FG001|Overall Study|Adverse Event|2|||
48418398|NCT01024244|155720879|FG000|Overall Study|Adverse Event|1|||
48418399|NCT01024244|155720880|FG001|Overall Study|Adverse Event|2|||
48418400|NCT01024244|155720881|FG002|Overall Study|Adverse Event|0|||
48418401|NCT01024244|155720882|FG003|Overall Study|Adverse Event|1|||
48418402|NCT01024244|155720883|FG004|Overall Study|Adverse Event|2|||
48418403|NCT01024244|155720879|FG000|Overall Study|Entry Criteria Not Met|0|||
48418404|NCT01024244|155720880|FG001|Overall Study|Entry Criteria Not Met|1|||
48418405|NCT01024244|155720881|FG002|Overall Study|Entry Criteria Not Met|0|||
48418406|NCT01024244|155720882|FG003|Overall Study|Entry Criteria Not Met|0|||
48418407|NCT01024244|155720883|FG004|Overall Study|Entry Criteria Not Met|0|||
48418408|NCT01024244|155720879|FG000|Overall Study|Lack of Efficacy|1|||
48418409|NCT01024244|155720880|FG001|Overall Study|Lack of Efficacy|0|||
48418410|NCT01024244|155720881|FG002|Overall Study|Lack of Efficacy|0|||
48418411|NCT01024244|155720882|FG003|Overall Study|Lack of Efficacy|0|||
48418412|NCT01024244|155720883|FG004|Overall Study|Lack of Efficacy|0|||
48418413|NCT01024244|155720879|FG000|Overall Study|Protocol Violation|1|||
48418414|NCT01024244|155720880|FG001|Overall Study|Protocol Violation|0|||
48418415|NCT01024244|155720881|FG002|Overall Study|Protocol Violation|0|||
48418416|NCT01024244|155720882|FG003|Overall Study|Protocol Violation|0|||
48418417|NCT01024244|155720883|FG004|Overall Study|Protocol Violation|2|||
48418418|NCT01024244|155720879|FG000|Overall Study|Sponsor Decision|14|||
48418419|NCT01024244|155720880|FG001|Overall Study|Sponsor Decision|7|||
48418420|NCT01024244|155720881|FG002|Overall Study|Sponsor Decision|14|||
48418421|NCT01024244|155720882|FG003|Overall Study|Sponsor Decision|12|||
48418422|NCT01024244|155720883|FG004|Overall Study|Sponsor Decision|10|||
48418423|NCT01024244|155720879|FG000|Overall Study|Withdrawal by Subject|0|||
48418424|NCT01024244|155720880|FG001|Overall Study|Withdrawal by Subject|1|||
48418425|NCT01024244|155720881|FG002|Overall Study|Withdrawal by Subject|0|||
48418426|NCT01024244|155720882|FG003|Overall Study|Withdrawal by Subject|0|||
48418427|NCT01024244|155720883|FG004|Overall Study|Withdrawal by Subject|0|||
48418428|NCT01609933|155720886|FG000|Overall Study|Adverse Event|1|||
48418429|NCT01609933|155720886|FG000|Overall Study|Withdrawal by Subject|3|||
48418430|NCT01252966|155720887|FG000|Overall Study|Lost to Follow-up|16|||
48418431|NCT01252966|155720888|FG001|Overall Study|Lost to Follow-up|10|||
48418432|NCT01252966|155720887|FG000|Overall Study|Withdrawal by Subject|7|||
48418433|NCT01252966|155720888|FG001|Overall Study|Withdrawal by Subject|3|||
48418434|NCT03716726|155720890|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
48418435|NCT03716726|155720891|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
48418436|NCT03716726|155720890|FG000|12 Months Followup|Lost to Follow-up|10|||
48418437|NCT03716726|155720891|FG001|12 Months Followup|Lost to Follow-up|17|||
48418438|NCT01584024|155720892|FG000|Overall Study|Lost to Follow-up|10|||
48418439|NCT01584024|155720892|FG000|Overall Study|Withdrawal by Subject|3|||
48418440|NCT00942409|155720896|FG000|Overall Study|Lack of Efficacy|1|||
48418441|NCT00942409|155720896|FG000|Overall Study|study drug unavailable|2|||
48418442|NCT01486264|155720897|FG000|Overall Study|Death|1|||
48418443|NCT01486264|155720898|FG001|Overall Study|Death|1|||
48418444|NCT01486264|155720897|FG000|Overall Study|Adverse Event|3|||
48418445|NCT01486264|155720898|FG001|Overall Study|Adverse Event|3|||
48418446|NCT01486264|155720897|FG000|Overall Study|Lack of Efficacy|6|||
48418447|NCT01486264|155720898|FG001|Overall Study|Lack of Efficacy|10|||
48418448|NCT01486264|155720897|FG000|Overall Study|Withdrawal by Subject|7|||
48418449|NCT01486264|155720898|FG001|Overall Study|Withdrawal by Subject|18|||
48418450|NCT01486264|155720897|FG000|Overall Study|Physician Decision|1|||
48418451|NCT01486264|155720898|FG001|Overall Study|Physician Decision|1|||
48418452|NCT01486264|155720897|FG000|Overall Study|Protocol Violation|3|||
48418453|NCT01486264|155720898|FG001|Overall Study|Protocol Violation|0|||
48418454|NCT01486264|155720897|FG000|Overall Study|Lost to Follow-up|3|||
48418455|NCT01486264|155720898|FG001|Overall Study|Lost to Follow-up|2|||
48418456|NCT01486264|155720897|FG000|Overall Study|Other|5|||
48418457|NCT01486264|155720898|FG001|Overall Study|Other|11|||
48418458|NCT01486264|155720897|FG000|Overall Study|Not treated|0|||
48418459|NCT01486264|155720898|FG001|Overall Study|Not treated|1|||
48418460|NCT01531725|155720899|FG000|Overall Study|Protocol Violation|5|||
48418461|NCT04734873|155720901|FG000|Overall Study|Lost to Follow-up|1|||
48418462|NCT04734873|155720902|FG001|Overall Study|Lost to Follow-up|3|||
48418463|NCT04734873|155720903|FG002|Overall Study|Lost to Follow-up|2|||
48418464|NCT04734873|155720901|FG000|Overall Study|Randomized but not dosed|1|||
48418465|NCT04734873|155720902|FG001|Overall Study|Randomized but not dosed|0|||
48418466|NCT04734873|155720903|FG002|Overall Study|Randomized but not dosed|1|||
48418467|NCT00684814|155720905|FG000|Washout Period of 7 Days|Adverse Event|1|||
48418468|NCT00684814|155720906|FG001|Washout Period of 7 Days|Adverse Event|2|||
48418469|NCT00684814|155720905|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
48418470|NCT00684814|155720906|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
48418471|NCT00684814|155720905|FG000|Second Intervention|Adverse Event|1|||
48418472|NCT00684814|155720906|FG001|Second Intervention|Adverse Event|0|||
48418473|NCT03596164|155720907|FG000|Overall Study|Adverse Event|0|||
48418474|NCT03596164|155720908|FG001|Overall Study|Adverse Event|1|||
48418475|NCT03596164|155720907|FG000|Overall Study|Death|1|||
48418476|NCT03596164|155720908|FG001|Overall Study|Death|0|||
48418477|NCT00446030|155720909|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
48418478|NCT00446030|155720910|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
48418479|NCT00446030|155720909|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
48418480|NCT00446030|155720910|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
48418481|NCT00446030|155720909|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
48418482|NCT00446030|155720910|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
48418483|NCT00446030|155720909|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
48418484|NCT00446030|155720910|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
48418485|NCT00446030|155720909|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
48418486|NCT00446030|155720910|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
48418487|NCT00446030|155720909|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
48418488|NCT00446030|155720910|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
48418489|NCT00446030|155720909|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
48418490|NCT00446030|155720910|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
48418491|NCT00446030|155720909|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
48418492|NCT00446030|155720910|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
48418493|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
48418494|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
48418495|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
48418496|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
48418497|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
48418498|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
48418499|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
48418500|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
48418501|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
48418502|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
48418503|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
48426323|NCT02203838|155749550|FG000|Overall Study|Lost to Follow-up|39|||
48418504|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
48418505|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
48418506|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
48418507|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
48418508|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
48418509|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
48418510|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
48418511|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
48418512|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
48418513|NCT00446030|155720909|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
48418514|NCT00446030|155720910|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
48418515|NCT02886715|155720911|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48418516|NCT02886715|155720912|FG001|Overall Study|Non-Compliance With Study Drug|2|||
48418517|NCT02886715|155720913|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48418518|NCT02886715|155720911|FG000|Overall Study|Adverse Event|4|||
48418519|NCT02886715|155720912|FG001|Overall Study|Adverse Event|2|||
48418520|NCT02886715|155720913|FG002|Overall Study|Adverse Event|0|||
48418521|NCT02886715|155720911|FG000|Overall Study|Lack of Efficacy|0|||
48418522|NCT02886715|155720912|FG001|Overall Study|Lack of Efficacy|2|||
48418523|NCT02886715|155720913|FG002|Overall Study|Lack of Efficacy|1|||
48418524|NCT02886715|155720911|FG000|Overall Study|Lost to Follow-up|29|||
48418525|NCT02886715|155720912|FG001|Overall Study|Lost to Follow-up|26|||
48418526|NCT02886715|155720913|FG002|Overall Study|Lost to Follow-up|10|||
48418527|NCT02886715|155720911|FG000|Overall Study|Pregnancy|1|||
48418528|NCT02886715|155720912|FG001|Overall Study|Pregnancy|1|||
48418529|NCT02886715|155720913|FG002|Overall Study|Pregnancy|1|||
48418530|NCT02886715|155720911|FG000|Overall Study|Protocol Violation|3|||
48418531|NCT02886715|155720912|FG001|Overall Study|Protocol Violation|2|||
48418532|NCT02886715|155720913|FG002|Overall Study|Protocol Violation|1|||
48418533|NCT02886715|155720911|FG000|Overall Study|Withdrawal by Subject|20|||
48418534|NCT02886715|155720912|FG001|Overall Study|Withdrawal by Subject|18|||
48418535|NCT02886715|155720913|FG002|Overall Study|Withdrawal by Subject|5|||
48418536|NCT02886715|155720911|FG000|Overall Study|missing|7|||
48418537|NCT02886715|155720912|FG001|Overall Study|missing|2|||
48418538|NCT02886715|155720913|FG002|Overall Study|missing|2|||
48418539|NCT01120626|155720914|FG000|Overall Study|Withdrawal by Subject|1|||
48418540|NCT01120626|155720915|FG001|Overall Study|Withdrawal by Subject|0|||
48418541|NCT00858832|155720916|FG000|Overall Study|became ineligible: delivered vaginally|1|||
48418542|NCT00858832|155720917|FG001|Overall Study|became ineligible: delivered vaginally|0|||
48418543|NCT00858832|155720916|FG000|Overall Study|Adverse Event|0|||
48418544|NCT00858832|155720917|FG001|Overall Study|Adverse Event|1|||
48418545|NCT00509106|155720921|FG000|Overall Study|Adverse Event|3|||
48418546|NCT00509106|155720922|FG001|Overall Study|Adverse Event|2|||
48418547|NCT00509106|155720921|FG000|Overall Study|Noncompliance|0|||
48418548|NCT00509106|155720922|FG001|Overall Study|Noncompliance|1|||
48418549|NCT00509106|155720921|FG000|Overall Study|At the request of sponsor/investigator|1|||
48418550|NCT00509106|155720922|FG001|Overall Study|At the request of sponsor/investigator|2|||
48418551|NCT00509106|155720921|FG000|Overall Study|Withdrew consent|4|||
48418552|NCT00509106|155720922|FG001|Overall Study|Withdrew consent|8|||
48418553|NCT00509106|155720921|FG000|Overall Study|Lost to Follow-up|16|||
48418554|NCT00509106|155720922|FG001|Overall Study|Lost to Follow-up|10|||
48418555|NCT00509106|155720921|FG000|Overall Study|Other|1|||
48418556|NCT00509106|155720922|FG001|Overall Study|Other|0|||
48418557|NCT00509106|155720921|FG000|Overall Study|Death|6|||
48418558|NCT00509106|155720922|FG001|Overall Study|Death|6|||
48418559|NCT03826914|155720926|FG000|Overall Study|Withdrawal by Subject|1|||
48418560|NCT03826914|155720927|FG001|Overall Study|Withdrawal by Subject|1|||
48418561|NCT03301857|155720930|FG000|Overall Study|Death|0|||
48418562|NCT03301857|155720931|FG001|Overall Study|Death|2|||
48418563|NCT03301857|155720930|FG000|Overall Study|Lost to Follow-up|4|||
48418564|NCT03301857|155720931|FG001|Overall Study|Lost to Follow-up|2|||
48418565|NCT03301857|155720930|FG000|Overall Study|Decision by Sponsor|6|||
48418566|NCT03301857|155720931|FG001|Overall Study|Decision by Sponsor|0|||
48418567|NCT03301857|155720930|FG000|Overall Study|Withdrawal by Subject|12|||
48418568|NCT03301857|155720931|FG001|Overall Study|Withdrawal by Subject|4|||
48418569|NCT03022461|155720934|FG000|Overall Study|Death|3|||
48418570|NCT01009294|155720935|FG000|Overall Study|Study discontinued by Sponsor|6|||
48418571|NCT00587223|155720936|FG000|Overall Study|Adverse Event|1|||
48418572|NCT00561353|155720937|FG000|Overall Study|Subject reached a virologic endpoint|2|||
48418573|NCT00561353|155720938|FG001|Overall Study|Subject reached a virologic endpoint|1|||
48418574|NCT00561353|155720939|FG002|Overall Study|Subject reached a virologic endpoint|1|||
48418575|NCT00561353|155720940|FG003|Overall Study|Subject reached a virologic endpoint|4|||
48418576|NCT00561353|155720941|FG004|Overall Study|Subject reached a virologic endpoint|1|||
48418577|NCT00561353|155720942|FG005|Overall Study|Subject reached a virologic endpoint|3|||
48418578|NCT00561353|155720943|FG006|Overall Study|Subject reached a virologic endpoint|4|||
48418579|NCT00561353|155720944|FG007|Overall Study|Subject reached a virologic endpoint|4|||
48418580|NCT00561353|155720945|FG008|Overall Study|Subject reached a virologic endpoint|5|||
48418581|NCT00561353|155720946|FG009|Overall Study|Subject reached a virologic endpoint|0|||
48418582|NCT00561353|155720937|FG000|Overall Study|Subject ineligible to continue the trial|0|||
48418583|NCT00561353|155720938|FG001|Overall Study|Subject ineligible to continue the trial|0|||
48418584|NCT00561353|155720939|FG002|Overall Study|Subject ineligible to continue the trial|0|||
48418585|NCT00561353|155720940|FG003|Overall Study|Subject ineligible to continue the trial|0|||
48418586|NCT00561353|155720941|FG004|Overall Study|Subject ineligible to continue the trial|0|||
48418587|NCT00561353|155720942|FG005|Overall Study|Subject ineligible to continue the trial|1|||
48418588|NCT00561353|155720943|FG006|Overall Study|Subject ineligible to continue the trial|1|||
48418589|NCT00561353|155720944|FG007|Overall Study|Subject ineligible to continue the trial|0|||
48418590|NCT00561353|155720945|FG008|Overall Study|Subject ineligible to continue the trial|2|||
48418591|NCT00561353|155720946|FG009|Overall Study|Subject ineligible to continue the trial|1|||
48418592|NCT00561353|155720937|FG000|Overall Study|Other|1|||
48418593|NCT00561353|155720938|FG001|Overall Study|Other|0|||
48418594|NCT00561353|155720939|FG002|Overall Study|Other|1|||
48418595|NCT00561353|155720940|FG003|Overall Study|Other|0|||
48418596|NCT00561353|155720941|FG004|Overall Study|Other|0|||
48418597|NCT00561353|155720942|FG005|Overall Study|Other|2|||
48418598|NCT00561353|155720943|FG006|Overall Study|Other|0|||
48418599|NCT00561353|155720944|FG007|Overall Study|Other|0|||
48418600|NCT00561353|155720945|FG008|Overall Study|Other|0|||
48418601|NCT00561353|155720946|FG009|Overall Study|Other|0|||
48418602|NCT00561353|155720937|FG000|Overall Study|Adverse Event|0|||
48418603|NCT00561353|155720938|FG001|Overall Study|Adverse Event|0|||
48418604|NCT00561353|155720939|FG002|Overall Study|Adverse Event|0|||
48418605|NCT00561353|155720940|FG003|Overall Study|Adverse Event|2|||
48418606|NCT00561353|155720941|FG004|Overall Study|Adverse Event|0|||
48418607|NCT00561353|155720942|FG005|Overall Study|Adverse Event|0|||
48418608|NCT00561353|155720943|FG006|Overall Study|Adverse Event|1|||
48418609|NCT00561353|155720944|FG007|Overall Study|Adverse Event|0|||
48418610|NCT00561353|155720945|FG008|Overall Study|Adverse Event|0|||
48418611|NCT00561353|155720946|FG009|Overall Study|Adverse Event|1|||
48418612|NCT00561353|155720937|FG000|Overall Study|Lost to Follow-up|2|||
48418613|NCT00561353|155720938|FG001|Overall Study|Lost to Follow-up|0|||
48418614|NCT00561353|155720939|FG002|Overall Study|Lost to Follow-up|1|||
48418615|NCT00561353|155720940|FG003|Overall Study|Lost to Follow-up|0|||
48418616|NCT00561353|155720941|FG004|Overall Study|Lost to Follow-up|0|||
48418617|NCT00561353|155720942|FG005|Overall Study|Lost to Follow-up|0|||
48418618|NCT00561353|155720943|FG006|Overall Study|Lost to Follow-up|0|||
48418619|NCT00561353|155720944|FG007|Overall Study|Lost to Follow-up|0|||
48418620|NCT00561353|155720945|FG008|Overall Study|Lost to Follow-up|0|||
48418621|NCT00561353|155720946|FG009|Overall Study|Lost to Follow-up|0|||
48418622|NCT00561353|155720937|FG000|Overall Study|Withdrawal by Subject|0|||
48418623|NCT00561353|155720938|FG001|Overall Study|Withdrawal by Subject|2|||
48418624|NCT00561353|155720939|FG002|Overall Study|Withdrawal by Subject|0|||
48418625|NCT00561353|155720940|FG003|Overall Study|Withdrawal by Subject|0|||
48418626|NCT00561353|155720941|FG004|Overall Study|Withdrawal by Subject|0|||
48418627|NCT00561353|155720942|FG005|Overall Study|Withdrawal by Subject|0|||
48418628|NCT00561353|155720943|FG006|Overall Study|Withdrawal by Subject|0|||
48418629|NCT00561353|155720944|FG007|Overall Study|Withdrawal by Subject|0|||
48418630|NCT00561353|155720945|FG008|Overall Study|Withdrawal by Subject|0|||
48418631|NCT00561353|155720946|FG009|Overall Study|Withdrawal by Subject|0|||
48418632|NCT04332419|155720947|FG000|Overall Study|Withdrawal by Subject|1|||
48418633|NCT01824602|155720950|FG000|Overall Study|Withdrawal by Subject|0|||
48418634|NCT01824602|155720951|FG001|Overall Study|Withdrawal by Subject|0|||
48418635|NCT01824602|155720952|FG002|Overall Study|Withdrawal by Subject|1|||
48418636|NCT01824602|155720953|FG003|Overall Study|Withdrawal by Subject|2|||
48418637|NCT01824602|155720950|FG000|Overall Study|Patient non-compliance|0|||
48418638|NCT01824602|155720951|FG001|Overall Study|Patient non-compliance|0|||
48418639|NCT01824602|155720952|FG002|Overall Study|Patient non-compliance|1|||
48418640|NCT01824602|155720953|FG003|Overall Study|Patient non-compliance|0|||
48418641|NCT01824602|155720950|FG000|Overall Study|Adverse Event|1|||
48418642|NCT01824602|155720951|FG001|Overall Study|Adverse Event|0|||
48418643|NCT01824602|155720952|FG002|Overall Study|Adverse Event|2|||
48418644|NCT01824602|155720953|FG003|Overall Study|Adverse Event|2|||
48418645|NCT01824602|155720950|FG000|Overall Study|Treatment failure|0|||
48418646|NCT01824602|155720951|FG001|Overall Study|Treatment failure|0|||
48418647|NCT01824602|155720952|FG002|Overall Study|Treatment failure|0|||
48418648|NCT01824602|155720953|FG003|Overall Study|Treatment failure|1|||
48418649|NCT03138564|155720960|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
48418650|NCT03138564|155720961|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
48418651|NCT03138564|155720960|FG000|Overall Study|Lost to Follow-up|16|||
48418652|NCT03138564|155720961|FG001|Overall Study|Lost to Follow-up|2|||
48418653|NCT03138564|155720960|FG000|Overall Study|Withdrawal by Subject|48|||
48418654|NCT03138564|155720961|FG001|Overall Study|Withdrawal by Subject|4|||
48418655|NCT03138564|155720960|FG000|Overall Study|No longer met eligibility criteria|2|||
48426324|NCT02203838|155749551|FG001|Overall Study|Lost to Follow-up|3|||
48418656|NCT03138564|155720961|FG001|Overall Study|No longer met eligibility criteria|0|||
48418657|NCT03138564|155720960|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
48418658|NCT03138564|155720961|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
48418659|NCT03138564|155720960|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
48418660|NCT03138564|155720961|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
48418661|NCT03138564|155720960|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
48418662|NCT03138564|155720961|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
48418663|NCT03138564|155720960|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
48418664|NCT03138564|155720961|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
48418665|NCT00814710|155720962|FG000|Overall Study|Adverse Event|1|||
48418666|NCT00814710|155720963|FG001|Overall Study|Adverse Event|0|||
48418667|NCT00814710|155720962|FG000|Overall Study|Lost to Follow-up|7|||
48418668|NCT00814710|155720963|FG001|Overall Study|Lost to Follow-up|3|||
48418669|NCT03885284|155720964|FG000|Overall Study|Disease Progression|1|||
48418670|NCT03885284|155720965|FG001|Overall Study|Disease Progression|3|||
48418671|NCT03885284|155720964|FG000|Overall Study|Physician Decision|0|||
48418672|NCT03885284|155720965|FG001|Overall Study|Physician Decision|1|||
48418673|NCT01591330|155720966|FG000|Period 1|Adverse Event|1|||
48418674|NCT01591330|155720967|FG001|Period 1|Adverse Event|0|||
48418675|NCT01591330|155720968|FG002|Period 1|Adverse Event|0|||
48418676|NCT01591330|155720969|FG003|Period 1|Adverse Event|0|||
48418677|NCT01591330|155720966|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
48418678|NCT01591330|155720967|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
48418679|NCT01591330|155720968|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
48418680|NCT01591330|155720969|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
48418681|NCT01591330|155720966|FG000|Period 2|Adverse Event|1|||
48418682|NCT01591330|155720967|FG001|Period 2|Adverse Event|0|||
48418683|NCT01591330|155720968|FG002|Period 2|Adverse Event|0|||
48418684|NCT01591330|155720969|FG003|Period 2|Adverse Event|0|||
48418685|NCT02234622|155720973|FG000|Overall Study|Withdrawal by Subject|16|||
48418686|NCT02234622|155720974|FG001|Overall Study|Withdrawal by Subject|22|||
48418687|NCT02234622|155720973|FG000|Overall Study|Lost to Follow-up|27|||
48418688|NCT02234622|155720974|FG001|Overall Study|Lost to Follow-up|14|||
48418689|NCT00586690|155720975|FG000|Overall Study|Death|2|||
48418690|NCT00586690|155720976|FG001|Overall Study|Death|0|||
48418691|NCT00586690|155720975|FG000|Overall Study|Disease Progression|10|||
48418692|NCT00586690|155720976|FG001|Overall Study|Disease Progression|0|||
48418693|NCT00586690|155720975|FG000|Overall Study|Adverse Event|1|||
48418694|NCT00586690|155720976|FG001|Overall Study|Adverse Event|0|||
48418695|NCT00586690|155720975|FG000|Overall Study|Lack of Efficacy|2|||
48418696|NCT00586690|155720976|FG001|Overall Study|Lack of Efficacy|0|||
48418697|NCT00586690|155720975|FG000|Overall Study|Lab can't accommodate|1|||
48418698|NCT00586690|155720976|FG001|Overall Study|Lab can't accommodate|0|||
48418699|NCT03476239|155720977|FG000|Overall Study|Withdrawal by Subject|10|||
48418700|NCT03476239|155720977|FG000|Overall Study|Death|80|||
48418701|NCT03476239|155720977|FG000|Overall Study|Lost to Follow-up|8|||
48418702|NCT00618956|155720978|FG000|Overall Study|Adverse Event|10|||
48418703|NCT00618956|155720979|FG001|Overall Study|Adverse Event|34|||
48418704|NCT00618956|155720978|FG000|Overall Study|Lack of Efficacy|2|||
48418705|NCT00618956|155720979|FG001|Overall Study|Lack of Efficacy|1|||
48418706|NCT00618956|155720978|FG000|Overall Study|Withdrawal by Subject|5|||
48418707|NCT00618956|155720979|FG001|Overall Study|Withdrawal by Subject|7|||
48418708|NCT00618956|155720978|FG000|Overall Study|Lost to Follow-up|4|||
48418709|NCT00618956|155720979|FG001|Overall Study|Lost to Follow-up|5|||
48418710|NCT00618956|155720978|FG000|Overall Study|Protocol Violation|2|||
48418711|NCT00618956|155720979|FG001|Overall Study|Protocol Violation|2|||
48418712|NCT00618956|155720978|FG000|Overall Study|did not meet criteria, non-compliance|2|||
48418713|NCT00618956|155720979|FG001|Overall Study|did not meet criteria, non-compliance|1|||
48418714|NCT00524303|155720980|FG000|Overall Study|Lost to Follow-up|6|||
48418715|NCT00524303|155720981|FG001|Overall Study|Lost to Follow-up|0|||
48418716|NCT00524303|155720982|FG002|Overall Study|Lost to Follow-up|3|||
48418717|NCT00524303|155720980|FG000|Overall Study|Protocol Violation|0|||
48418718|NCT00524303|155720981|FG001|Overall Study|Protocol Violation|1|||
48418719|NCT00524303|155720982|FG002|Overall Study|Protocol Violation|1|||
48418720|NCT00524303|155720980|FG000|Overall Study|Withdrawal by Subject|3|||
48418721|NCT00524303|155720981|FG001|Overall Study|Withdrawal by Subject|0|||
48418722|NCT00524303|155720982|FG002|Overall Study|Withdrawal by Subject|4|||
48418723|NCT00524303|155720980|FG000|Overall Study|Death|0|||
48418724|NCT00524303|155720981|FG001|Overall Study|Death|2|||
48418725|NCT00524303|155720982|FG002|Overall Study|Death|3|||
48418726|NCT00524303|155720980|FG000|Overall Study|Adverse Event|1|||
48418727|NCT00524303|155720981|FG001|Overall Study|Adverse Event|2|||
48418728|NCT00524303|155720982|FG002|Overall Study|Adverse Event|3|||
48418729|NCT00524303|155720980|FG000|Overall Study|Did not Complete Study Dosing|1|||
48418730|NCT00524303|155720981|FG001|Overall Study|Did not Complete Study Dosing|0|||
48418731|NCT00524303|155720982|FG002|Overall Study|Did not Complete Study Dosing|0|||
48418732|NCT00524303|155720980|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
48418733|NCT00524303|155720981|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
48418734|NCT00524303|155720982|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
48418735|NCT00524303|155720980|FG000|Overall Study|Disease Progression|0|||
48418736|NCT00524303|155720981|FG001|Overall Study|Disease Progression|4|||
48418737|NCT00524303|155720982|FG002|Overall Study|Disease Progression|1|||
48418738|NCT00524303|155720980|FG000|Overall Study|Disease Recurrence|0|||
48418739|NCT00524303|155720981|FG001|Overall Study|Disease Recurrence|1|||
48418740|NCT00524303|155720982|FG002|Overall Study|Disease Recurrence|0|||
48418741|NCT00524303|155720980|FG000|Overall Study|Sponsor Request|0|||
48418742|NCT00524303|155720981|FG001|Overall Study|Sponsor Request|0|||
48418743|NCT00524303|155720982|FG002|Overall Study|Sponsor Request|1|||
48418744|NCT00524303|155720980|FG000|Overall Study|Physician Decision|0|||
48418745|NCT00524303|155720981|FG001|Overall Study|Physician Decision|0|||
48418746|NCT00524303|155720982|FG002|Overall Study|Physician Decision|1|||
48418747|NCT00524303|155720980|FG000|Overall Study|Completed 5 years|0|||
48418748|NCT00524303|155720981|FG001|Overall Study|Completed 5 years|0|||
48418749|NCT00524303|155720982|FG002|Overall Study|Completed 5 years|1|||
48418750|NCT02017444|155722458|FG000|Overall Study|Physician Decision|1|||
48418751|NCT02017444|155722459|FG001|Overall Study|Physician Decision|0|||
48418752|NCT02017444|155722458|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
48418753|NCT02017444|155722459|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
48418754|NCT00377962|155722460|FG000|Core Study: 0-12 Months|Adverse Event|18|||
48418755|NCT00377962|155722461|FG001|Core Study: 0-12 Months|Adverse Event|2|||
48418756|NCT00377962|155722460|FG000|Core Study: 0-12 Months|Death|3|||
48418757|NCT00377962|155722461|FG001|Core Study: 0-12 Months|Death|0|||
48418758|NCT00377962|155722460|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
48418759|NCT00377962|155722461|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
48418760|NCT00377962|155722460|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
48418761|NCT00377962|155722461|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
48418762|NCT00377962|155722460|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
48418763|NCT00377962|155722461|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
48418764|NCT00377962|155722460|FG000|Extension Study: 12-24 Months|Death|1|||
48418765|NCT00377962|155722461|FG001|Extension Study: 12-24 Months|Death|1|||
48418766|NCT00377962|155722460|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
48418767|NCT00377962|155722461|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
48418768|NCT00377962|155722460|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
48418769|NCT00377962|155722461|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
48418770|NCT00377962|155722460|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
48418771|NCT00377962|155722461|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
48418772|NCT00215150|155722462|FG000|Open Label Phase|Lost to Follow-up|7|||
48418773|NCT00215150|155722462|FG000|Open Label Phase|Withdrawal by Subject|1|||
48418774|NCT00215150|155722462|FG000|Open Label Phase|Did not complete a post base visit|13|||
48418775|NCT00215150|155722462|FG000|Open Label Phase|Did not meet randomization criteria|9|||
48418776|NCT00215150|155722462|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
48418777|NCT00215150|155722462|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
48418778|NCT00215150|155722462|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
48418779|NCT00374556|155722467|FG000|Overall Study|Lost to Follow-up|1|||
48418780|NCT00374556|155722468|FG001|Overall Study|Lost to Follow-up|0|||
48418781|NCT00374556|155722467|FG000|Overall Study|Removed at baseline due to medical cond|0|||
48418782|NCT00374556|155722468|FG001|Overall Study|Removed at baseline due to medical cond|1|||
48418783|NCT04426630|155722469|FG000|Overall Study|Death|4|||
48418784|NCT04426630|155722469|FG000|Overall Study|Lost to Follow-up|2|||
48418785|NCT00942162|155722472|FG000|Overall Study|Death|45|||
48418786|NCT00942162|155722473|FG001|Overall Study|Death|35|||
48418787|NCT00942162|155722474|FG002|Overall Study|Death|0|||
48418788|NCT00942162|155722472|FG000|Overall Study|Withdrawal by Subject|7|||
48418789|NCT00942162|155722473|FG001|Overall Study|Withdrawal by Subject|2|||
48418790|NCT00942162|155722474|FG002|Overall Study|Withdrawal by Subject|0|||
48418791|NCT00942162|155722472|FG000|Overall Study|Lost to Follow-up|4|||
48418792|NCT00942162|155722473|FG001|Overall Study|Lost to Follow-up|0|||
48418793|NCT00942162|155722474|FG002|Overall Study|Lost to Follow-up|0|||
48418794|NCT00942162|155722472|FG000|Overall Study|Other|14|||
48418795|NCT00942162|155722473|FG001|Overall Study|Other|13|||
48418796|NCT00942162|155722474|FG002|Overall Study|Other|2|||
48418797|NCT03874234|155722480|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418798|NCT03874234|155722481|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418799|NCT03874234|155722482|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418800|NCT03874234|155722483|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
48418801|NCT03874234|155722484|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418802|NCT03874234|155722485|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418803|NCT03874234|155722486|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418804|NCT03874234|155722487|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48426325|NCT02203838|155749552|FG002|Overall Study|Lost to Follow-up|2|||
48418805|NCT03874234|155722488|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418806|NCT03874234|155722489|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418807|NCT03874234|155722490|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418808|NCT03874234|155722491|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418809|NCT03874234|155722492|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
48418810|NCT03874234|155722480|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
48418811|NCT03874234|155722481|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418812|NCT03874234|155722482|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418813|NCT03874234|155722483|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418814|NCT03874234|155722484|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418815|NCT03874234|155722485|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418816|NCT03874234|155722486|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418817|NCT03874234|155722487|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418818|NCT03874234|155722488|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418819|NCT03874234|155722489|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418820|NCT03874234|155722490|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418821|NCT03874234|155722491|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418822|NCT03874234|155722492|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
48418823|NCT03874234|155722480|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418824|NCT03874234|155722481|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418825|NCT03874234|155722482|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418826|NCT03874234|155722483|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
48418827|NCT03874234|155722484|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418828|NCT03874234|155722485|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418829|NCT03874234|155722486|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418830|NCT03874234|155722487|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418831|NCT03874234|155722488|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418832|NCT03874234|155722489|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418833|NCT03874234|155722490|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418834|NCT03874234|155722491|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418835|NCT03874234|155722492|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
48418836|NCT03874234|155722480|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418837|NCT03874234|155722481|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418838|NCT03874234|155722482|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418839|NCT03874234|155722483|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418840|NCT03874234|155722484|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
48418841|NCT03874234|155722485|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418842|NCT03874234|155722486|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418843|NCT03874234|155722487|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418844|NCT03874234|155722488|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418845|NCT03874234|155722489|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418846|NCT03874234|155722490|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418847|NCT03874234|155722491|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418848|NCT03874234|155722492|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
48418849|NCT03874234|155722480|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418850|NCT03874234|155722481|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418851|NCT03874234|155722482|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418852|NCT03874234|155722483|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418853|NCT03874234|155722484|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418854|NCT03874234|155722485|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418855|NCT03874234|155722486|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418856|NCT03874234|155722487|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
48418857|NCT03874234|155722488|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418858|NCT03874234|155722489|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418859|NCT03874234|155722490|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418860|NCT03874234|155722491|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418861|NCT03874234|155722492|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
48418862|NCT03874234|155722480|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418863|NCT03874234|155722481|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418864|NCT03874234|155722482|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418865|NCT03874234|155722483|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418866|NCT03874234|155722484|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
48418867|NCT03874234|155722485|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
48418868|NCT03874234|155722486|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418869|NCT03874234|155722487|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418870|NCT03874234|155722488|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418871|NCT03874234|155722489|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418872|NCT03874234|155722490|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418873|NCT03874234|155722491|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418874|NCT03874234|155722492|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
48418875|NCT03874234|155722480|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418876|NCT03874234|155722481|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418877|NCT03874234|155722482|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418878|NCT03874234|155722483|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418879|NCT03874234|155722484|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418880|NCT03874234|155722485|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418881|NCT03874234|155722486|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
48418882|NCT03874234|155722487|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418883|NCT03874234|155722488|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418884|NCT03874234|155722489|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418885|NCT03874234|155722490|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418886|NCT03874234|155722491|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418887|NCT03874234|155722492|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
48418888|NCT03874234|155722480|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418889|NCT03874234|155722481|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418890|NCT03874234|155722482|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418891|NCT03874234|155722483|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418892|NCT03874234|155722484|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
48418893|NCT03874234|155722485|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418894|NCT03874234|155722486|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418895|NCT03874234|155722487|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418896|NCT03874234|155722488|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418897|NCT03874234|155722489|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418898|NCT03874234|155722490|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418899|NCT03874234|155722491|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418900|NCT03874234|155722492|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
48418901|NCT01157169|155722499|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
48418902|NCT01157169|155722500|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
48418903|NCT01157169|155722499|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
48418904|NCT01157169|155722500|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
48418905|NCT01756157|155722504|FG000|First Intervention Period|Withdrawal by Subject|1|||
48418906|NCT01756157|155722505|FG001|First Intervention Period|Withdrawal by Subject|0|||
48418907|NCT01756157|155722504|FG000|First Intervention Period|Lost to Follow-up|0|||
48418908|NCT01756157|155722505|FG001|First Intervention Period|Lost to Follow-up|2|||
48418909|NCT02799381|155722506|FG000|Overall Study|Withdrew consent|3|||
48418910|NCT02799381|155722507|FG001|Overall Study|Withdrew consent|2|||
48418911|NCT02799381|155722506|FG000|Overall Study|Adverse Event|0|||
48418912|NCT02799381|155722507|FG001|Overall Study|Adverse Event|1|||
48418913|NCT02799381|155722506|FG000|Overall Study|Participant did not take any study drug|1|||
48418914|NCT02799381|155722507|FG001|Overall Study|Participant did not take any study drug|0|||
48418915|NCT00783289|155722510|FG000|Overall Study|Protocol Violation|0|||
48418916|NCT00783289|155722511|FG001|Overall Study|Protocol Violation|1|||
48418917|NCT00783289|155722512|FG002|Overall Study|Protocol Violation|0|||
48418918|NCT00783289|155722513|FG003|Overall Study|Protocol Violation|0|||
48418919|NCT01981187|155722514|FG000|Overall Study|Participant/guardian decision|2|||
48418920|NCT01981187|155722514|FG000|Overall Study|Physician Decision|1|||
48418921|NCT01981187|155722514|FG000|Overall Study|Disease progression|2|||
48418922|NCT01981187|155722514|FG000|Overall Study|Adverse Event|7|||
48418923|NCT03846947|155722515|FG000|Overall Study|technical issues with imaging sequence|2|||
48418924|NCT00506389|155722516|FG000|In-treatment Period|Other|3|||
48418925|NCT00506389|155722517|FG001|In-treatment Period|Other|3|||
48418926|NCT00506389|155722518|FG002|In-treatment Period|Other|4|||
48418927|NCT00506389|155722516|FG000|In-treatment Period|Lost to Follow-up|0|||
48418928|NCT00506389|155722517|FG001|In-treatment Period|Lost to Follow-up|0|||
48418929|NCT00506389|155722518|FG002|In-treatment Period|Lost to Follow-up|1|||
48418930|NCT00506389|155722516|FG000|In-treatment Period|Lack of compliance|1|||
48418931|NCT00506389|155722517|FG001|In-treatment Period|Lack of compliance|0|||
48418932|NCT00506389|155722518|FG002|In-treatment Period|Lack of compliance|0|||
48418933|NCT00506389|155722516|FG000|In-treatment Period|Reasons not related to trial|4|||
48418934|NCT00506389|155722517|FG001|In-treatment Period|Reasons not related to trial|1|||
48418935|NCT00506389|155722518|FG002|In-treatment Period|Reasons not related to trial|0|||
48418936|NCT00506389|155722516|FG000|In-treatment Period|Withdrawal by Subject|3|||
48418937|NCT00506389|155722517|FG001|In-treatment Period|Withdrawal by Subject|3|||
48418938|NCT00506389|155722518|FG002|In-treatment Period|Withdrawal by Subject|4|||
48418939|NCT00506389|155722516|FG000|In-treatment Period|Lack of Efficacy|0|||
48418940|NCT00506389|155722517|FG001|In-treatment Period|Lack of Efficacy|2|||
48418941|NCT00506389|155722518|FG002|In-treatment Period|Lack of Efficacy|0|||
48418942|NCT00506389|155722516|FG000|In-treatment Period|Adverse Event|11|||
48418943|NCT00506389|155722517|FG001|In-treatment Period|Adverse Event|5|||
48418944|NCT00506389|155722518|FG002|In-treatment Period|Adverse Event|2|||
48418945|NCT00506389|155722516|FG000|In-treatment Period|Randomized but not treated|4|||
48418946|NCT00506389|155722517|FG001|In-treatment Period|Randomized but not treated|1|||
48418947|NCT00506389|155722518|FG002|In-treatment Period|Randomized but not treated|1|||
48418948|NCT00756002|155722520|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
48418949|NCT00756002|155722521|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
48418950|NCT00756002|155722520|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48418951|NCT00756002|155722521|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
48418952|NCT00756002|155722520|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
48418953|NCT00756002|155722521|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
48418954|NCT00756002|155722520|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
48418955|NCT00756002|155722521|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
48418956|NCT00756002|155722520|FG000|Double-Blind Treatment Period|Other|2|||
48418957|NCT00756002|155722521|FG001|Double-Blind Treatment Period|Other|2|||
48418958|NCT01925703|155722522|FG000|Overall Study|Physician Decision|1|||
48418959|NCT01925703|155722522|FG000|Overall Study|Lost to Follow-up|2|||
48418960|NCT01925703|155722522|FG000|Overall Study|Discharge prior to full iron repletion|1|||
48418961|NCT03215277|155722524|FG000|Overall Study|Adverse Event|2|||
48418962|NCT03215277|155722525|FG001|Overall Study|Adverse Event|3|||
48418963|NCT03215277|155722524|FG000|Overall Study|Death|1|||
48418964|NCT03215277|155722525|FG001|Overall Study|Death|0|||
48418965|NCT03215277|155722524|FG000|Overall Study|Lost to Follow-up|0|||
48418966|NCT03215277|155722525|FG001|Overall Study|Lost to Follow-up|1|||
48418967|NCT03215277|155722524|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
48418968|NCT03215277|155722525|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
48418969|NCT05309083|155722526|FG000|Overall Study|Withdrawal by Subject|2|||
48418970|NCT00117312|155722527|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
48418971|NCT00117312|155722528|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
48418972|NCT00117312|155722529|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
48418973|NCT00117312|155722530|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
48418974|NCT00117312|155722527|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
48418975|NCT00117312|155722528|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
48418976|NCT00117312|155722529|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
48418977|NCT00117312|155722530|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
48418978|NCT00117312|155722527|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
48418979|NCT00117312|155722528|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
48418980|NCT00117312|155722529|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
48418981|NCT00117312|155722530|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
48418982|NCT00117312|155722527|FG000|Overall Study|Other|0|||
48418983|NCT00117312|155722528|FG001|Overall Study|Other|1|||
48418984|NCT00117312|155722529|FG002|Overall Study|Other|3|||
48418985|NCT00117312|155722530|FG003|Overall Study|Other|1|||
48418986|NCT00117312|155722527|FG000|Overall Study|Patient choice|0|||
48418987|NCT00117312|155722528|FG001|Overall Study|Patient choice|0|||
48418988|NCT00117312|155722529|FG002|Overall Study|Patient choice|2|||
48418989|NCT00117312|155722530|FG003|Overall Study|Patient choice|1|||
48418990|NCT00117312|155722527|FG000|Overall Study|Adverse Event|0|||
48418991|NCT00117312|155722528|FG001|Overall Study|Adverse Event|2|||
48418992|NCT00117312|155722529|FG002|Overall Study|Adverse Event|0|||
48418993|NCT00117312|155722530|FG003|Overall Study|Adverse Event|0|||
48418994|NCT00117312|155722527|FG000|Overall Study|Protocol Violation|0|||
48418995|NCT00117312|155722528|FG001|Overall Study|Protocol Violation|1|||
48418996|NCT00117312|155722529|FG002|Overall Study|Protocol Violation|3|||
48418997|NCT00117312|155722530|FG003|Overall Study|Protocol Violation|0|||
48418998|NCT00117312|155722527|FG000|Overall Study|PSA decrease <=50%|0|||
48418999|NCT00117312|155722528|FG001|Overall Study|PSA decrease <=50%|2|||
48419000|NCT00117312|155722529|FG002|Overall Study|PSA decrease <=50%|2|||
48419001|NCT00117312|155722530|FG003|Overall Study|PSA decrease <=50%|4|||
48419002|NCT00117312|155722527|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
48419003|NCT00117312|155722528|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
48419004|NCT00117312|155722529|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
48419005|NCT00117312|155722530|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
48419006|NCT00117312|155722527|FG000|Overall Study|Hepatic abnormality|0|||
48419007|NCT00117312|155722528|FG001|Overall Study|Hepatic abnormality|1|||
48419008|NCT00117312|155722529|FG002|Overall Study|Hepatic abnormality|0|||
48419009|NCT00117312|155722530|FG003|Overall Study|Hepatic abnormality|1|||
48419010|NCT00117312|155722527|FG000|Overall Study|Withdrawal by Subject|0|||
48419011|NCT00117312|155722528|FG001|Overall Study|Withdrawal by Subject|2|||
48419012|NCT00117312|155722529|FG002|Overall Study|Withdrawal by Subject|0|||
48419013|NCT00117312|155722530|FG003|Overall Study|Withdrawal by Subject|0|||
48419014|NCT03406962|155722531|FG000|Overall Study|Death|2|||
48419015|NCT03406962|155722531|FG000|Overall Study|Adverse Event|1|||
48419016|NCT02499952|155722532|FG000|Overall Study|Lost to Follow-up|1|||
48419017|NCT02499952|155722532|FG000|Overall Study|Death|9|||
48419018|NCT01733329|155722533|FG000|Overall Study|Protocol Violation|1|||
48419019|NCT01733329|155722534|FG001|Overall Study|Protocol Violation|1|||
48419020|NCT01733329|155722533|FG000|Overall Study|Uterine artery injury|1|||
48419021|NCT01733329|155722534|FG001|Overall Study|Uterine artery injury|0|||
48419022|NCT00852930|155722535|FG000|Overall Study|Withdrawal by Subject|1|||
48419023|NCT00852930|155722536|FG001|Overall Study|Withdrawal by Subject|1|||
48419024|NCT00852930|155722537|FG002|Overall Study|Withdrawal by Subject|1|||
48419025|NCT00852930|155722535|FG000|Overall Study|Physician Decision|0|||
48419026|NCT00852930|155722536|FG001|Overall Study|Physician Decision|0|||
48419027|NCT00852930|155722537|FG002|Overall Study|Physician Decision|1|||
48419028|NCT00327444|155722540|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
48419029|NCT00327444|155722541|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
48419030|NCT00327444|155722540|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
48419031|NCT00327444|155722541|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
48419032|NCT00327444|155722540|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
48419033|NCT00327444|155722541|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
48419034|NCT00327444|155722540|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
48419035|NCT00327444|155722541|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
48419036|NCT00327444|155722540|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
48419037|NCT00327444|155722541|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
48419038|NCT00327444|155722540|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
48419039|NCT00327444|155722541|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
48419040|NCT00327444|155722540|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
48419041|NCT00327444|155722541|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
48419042|NCT00327444|155722540|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
48419043|NCT00327444|155722541|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
48419044|NCT04786210|155722542|FG000|Overall Study|Lost to Follow-up|2|||
48419045|NCT04786210|155722542|FG000|Overall Study|Withdrawal by Subject|4|||
48419046|NCT04814823|155722543|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
48419047|NCT00847613|155722548|FG000|Overall Study|Ongoing at cut-off date|250|||
48419048|NCT00847613|155722549|FG001|Overall Study|Ongoing at cut-off date|265|||
48419049|NCT00847613|155722550|FG002|Overall Study|Ongoing at cut-off date|64|||
48419050|NCT00847613|155722551|FG003|Overall Study|Ongoing at cut-off date|64|||
48419051|NCT00847613|155722548|FG000|Overall Study|Death|1|||
48419052|NCT00847613|155722549|FG001|Overall Study|Death|1|||
48419053|NCT00847613|155722550|FG002|Overall Study|Death|0|||
48419054|NCT00847613|155722551|FG003|Overall Study|Death|0|||
48419055|NCT00847613|155722548|FG000|Overall Study|Adverse Event|36|||
48419056|NCT00847613|155722549|FG001|Overall Study|Adverse Event|26|||
48419057|NCT00847613|155722550|FG002|Overall Study|Adverse Event|5|||
48419058|NCT00847613|155722551|FG003|Overall Study|Adverse Event|6|||
48419059|NCT00847613|155722548|FG000|Overall Study|Lack of Efficacy|7|||
48419060|NCT00847613|155722549|FG001|Overall Study|Lack of Efficacy|3|||
48419061|NCT00847613|155722550|FG002|Overall Study|Lack of Efficacy|3|||
48419062|NCT00847613|155722551|FG003|Overall Study|Lack of Efficacy|1|||
48419063|NCT00847613|155722548|FG000|Overall Study|Study terminated by Sponsor|1|||
48419064|NCT00847613|155722549|FG001|Overall Study|Study terminated by Sponsor|0|||
48419065|NCT00847613|155722550|FG002|Overall Study|Study terminated by Sponsor|2|||
48419066|NCT00847613|155722551|FG003|Overall Study|Study terminated by Sponsor|1|||
48419067|NCT00847613|155722548|FG000|Overall Study|Lost to Follow-up|5|||
48419068|NCT00847613|155722549|FG001|Overall Study|Lost to Follow-up|0|||
48419069|NCT00847613|155722550|FG002|Overall Study|Lost to Follow-up|0|||
48419070|NCT00847613|155722551|FG003|Overall Study|Lost to Follow-up|3|||
48419071|NCT00847613|155722548|FG000|Overall Study|Protocol Violation|6|||
48419072|NCT00847613|155722549|FG001|Overall Study|Protocol Violation|6|||
48419073|NCT00847613|155722550|FG002|Overall Study|Protocol Violation|3|||
48419074|NCT00847613|155722551|FG003|Overall Study|Protocol Violation|1|||
48419075|NCT00847613|155722548|FG000|Overall Study|Pregnancy|1|||
48419076|NCT00847613|155722549|FG001|Overall Study|Pregnancy|1|||
48419077|NCT00847613|155722550|FG002|Overall Study|Pregnancy|0|||
48419078|NCT00847613|155722551|FG003|Overall Study|Pregnancy|0|||
48419079|NCT00847613|155722548|FG000|Overall Study|Site closure|1|||
48419080|NCT00847613|155722549|FG001|Overall Study|Site closure|0|||
48419081|NCT00847613|155722550|FG002|Overall Study|Site closure|0|||
48419082|NCT00847613|155722551|FG003|Overall Study|Site closure|1|||
48419083|NCT00847613|155722548|FG000|Overall Study|Withdrawal by Subject|8|||
48419084|NCT00847613|155722549|FG001|Overall Study|Withdrawal by Subject|11|||
48419085|NCT00847613|155722550|FG002|Overall Study|Withdrawal by Subject|2|||
48419086|NCT00847613|155722551|FG003|Overall Study|Withdrawal by Subject|2|||
48419087|NCT00847613|155722548|FG000|Overall Study|Participant moved|4|||
48419088|NCT00847613|155722549|FG001|Overall Study|Participant moved|1|||
48419089|NCT00847613|155722550|FG002|Overall Study|Participant moved|0|||
48419090|NCT00847613|155722551|FG003|Overall Study|Participant moved|0|||
48419091|NCT00847613|155722548|FG000|Overall Study|Sponsor request|0|||
48419092|NCT00847613|155722549|FG001|Overall Study|Sponsor request|1|||
48419093|NCT00847613|155722550|FG002|Overall Study|Sponsor request|0|||
48419094|NCT00847613|155722551|FG003|Overall Study|Sponsor request|0|||
48419095|NCT00847613|155722548|FG000|Overall Study|Randomized, but not treated|0|||
48419096|NCT00847613|155722549|FG001|Overall Study|Randomized, but not treated|3|||
48419097|NCT00847613|155722550|FG002|Overall Study|Randomized, but not treated|0|||
48419098|NCT00847613|155722551|FG003|Overall Study|Randomized, but not treated|0|||
48419099|NCT00847613|155722548|FG000|Overall Study|Other|1|||
48419100|NCT00847613|155722549|FG001|Overall Study|Other|1|||
48419101|NCT00847613|155722550|FG002|Overall Study|Other|2|||
48419102|NCT00847613|155722551|FG003|Overall Study|Other|0|||
48419103|NCT00845429|155722552|FG000|Overall Study|Protocol Violation|5|||
48419104|NCT00845429|155722553|FG001|Overall Study|Protocol Violation|4|||
48419105|NCT00845429|155722554|FG002|Overall Study|Protocol Violation|7|||
48419106|NCT00845429|155722552|FG000|Overall Study|Lost to Follow-up|7|||
48419107|NCT00845429|155722553|FG001|Overall Study|Lost to Follow-up|9|||
48419108|NCT00845429|155722554|FG002|Overall Study|Lost to Follow-up|10|||
48419109|NCT00845429|155722552|FG000|Overall Study|Withdrawal by Subject|2|||
48419110|NCT00845429|155722553|FG001|Overall Study|Withdrawal by Subject|2|||
48419111|NCT00845429|155722554|FG002|Overall Study|Withdrawal by Subject|2|||
48419112|NCT00845429|155722552|FG000|Overall Study|Serious adverse event|0|||
48419113|NCT00845429|155722553|FG001|Overall Study|Serious adverse event|0|||
48419114|NCT00845429|155722554|FG002|Overall Study|Serious adverse event|1|||
48419115|NCT02111369|155722555|FG000|Overall Study|Lost to Follow-up|2|||
48419116|NCT02111369|155722555|FG000|Overall Study|Withdrawal by Subject|1|||
48419117|NCT01273818|155722556|FG000|Overall Study|Physician Decision|13|||
48419118|NCT01273818|155722557|FG001|Overall Study|Physician Decision|2|||
48419119|NCT01273818|155722558|FG002|Overall Study|Physician Decision|9|||
48419120|NCT00519623|155722565|FG000|Overall Study|Adverse Event|1|||
48419121|NCT01450540|155722572|FG000|Overall Study|Withdrawal by Subject|19|||
48419122|NCT01450540|155722573|FG001|Overall Study|Withdrawal by Subject|13|||
48419123|NCT01450540|155722572|FG000|Overall Study|protocol deviation|3|||
48419124|NCT01450540|155722573|FG001|Overall Study|protocol deviation|23|||
48419125|NCT00840463|155722576|FG000|Overall Study|Adverse Event|1|||
48419126|NCT00840463|155722577|FG001|Overall Study|Adverse Event|0|||
48419127|NCT02452359|155722578|FG000|Overall Study|Adverse Event|1|||
48419128|NCT02452359|155722578|FG000|Overall Study|Lost to Follow-up|15|||
48419129|NCT02452359|155722578|FG000|Overall Study|Pregnancy|1|||
48419130|NCT02452359|155722578|FG000|Overall Study|Withdrawal by Subject|4|||
48419131|NCT01006356|155723799|FG000|Overall Study|Adverse Event|6|||
48419132|NCT01006356|155723799|FG000|Overall Study|Physician Decision|1|||
48419133|NCT01006356|155723799|FG000|Overall Study|Paticipants did not cooperate|6|||
48419134|NCT01006356|155723799|FG000|Overall Study|Withdrawal by Subject|1|||
48419135|NCT01006356|155723799|FG000|Overall Study|Choice by participants|2|||
48419136|NCT01006356|155723799|FG000|Overall Study|Protocol Violation|3|||
48419137|NCT01006356|155723799|FG000|Overall Study|Other|23|||
48419138|NCT02638012|155723800|FG000|Overall Study|Lost to Follow-up|1|||
48419139|NCT04430348|155723803|FG000|Overall Study|Death|3|||
48419140|NCT04430348|155723804|FG001|Overall Study|Death|2|||
48419141|NCT04430348|155723805|FG002|Overall Study|Death|2|||
48419142|NCT04430348|155723806|FG003|Overall Study|Death|2|||
48419143|NCT04430348|155723807|FG004|Overall Study|Death|2|||
48419144|NCT04430348|155723808|FG005|Overall Study|Death|3|||
48419145|NCT04430348|155723803|FG000|Overall Study|Lost to Follow-up|0|||
48419146|NCT04430348|155723804|FG001|Overall Study|Lost to Follow-up|0|||
48419147|NCT04430348|155723805|FG002|Overall Study|Lost to Follow-up|0|||
48419148|NCT04430348|155723806|FG003|Overall Study|Lost to Follow-up|1|||
48419149|NCT04430348|155723807|FG004|Overall Study|Lost to Follow-up|0|||
48419150|NCT04430348|155723808|FG005|Overall Study|Lost to Follow-up|0|||
48419151|NCT04430348|155723803|FG000|Overall Study|Adverse Event|0|||
48419152|NCT04430348|155723804|FG001|Overall Study|Adverse Event|0|||
48419153|NCT04430348|155723805|FG002|Overall Study|Adverse Event|0|||
48419154|NCT04430348|155723806|FG003|Overall Study|Adverse Event|0|||
48419155|NCT04430348|155723807|FG004|Overall Study|Adverse Event|0|||
48419156|NCT04430348|155723808|FG005|Overall Study|Adverse Event|1|||
48419157|NCT04430348|155723803|FG000|Overall Study|Withdrawal by Subject|0|||
48419158|NCT04430348|155723804|FG001|Overall Study|Withdrawal by Subject|1|||
48419159|NCT04430348|155723805|FG002|Overall Study|Withdrawal by Subject|0|||
48419160|NCT04430348|155723806|FG003|Overall Study|Withdrawal by Subject|0|||
48419161|NCT04430348|155723807|FG004|Overall Study|Withdrawal by Subject|0|||
48419162|NCT04430348|155723808|FG005|Overall Study|Withdrawal by Subject|1|||
48419163|NCT04430348|155723803|FG000|Overall Study|Study Terminated by Sponsor|0|||
48419164|NCT04430348|155723804|FG001|Overall Study|Study Terminated by Sponsor|0|||
48419165|NCT04430348|155723805|FG002|Overall Study|Study Terminated by Sponsor|2|||
48419166|NCT04430348|155723806|FG003|Overall Study|Study Terminated by Sponsor|0|||
48419167|NCT04430348|155723807|FG004|Overall Study|Study Terminated by Sponsor|1|||
48419168|NCT04430348|155723808|FG005|Overall Study|Study Terminated by Sponsor|1|||
48419169|NCT02586207|155723813|FG000|Overall Study|Physician Decision|1|||
48419170|NCT02586207|155723813|FG000|Overall Study|Withdrawal by Subject|1|||
48419171|NCT02024464|155723816|FG000|Overall Study|Discontinued|5|||
48419172|NCT02024464|155723817|FG001|Overall Study|Discontinued|4|||
48419173|NCT02024464|155723816|FG000|Overall Study|Missed Visits|1|||
48419174|NCT02024464|155723817|FG001|Overall Study|Missed Visits|0|||
48419175|NCT02024464|155723816|FG000|Overall Study|Lost to Follow-up|4|||
48419176|NCT02024464|155723817|FG001|Overall Study|Lost to Follow-up|7|||
48419177|NCT03615222|155723820|FG000|Overall Study|Ineligible|26|||
48419178|NCT03615222|155723820|FG000|Overall Study|Withdrawal by Subject|7|||
48419179|NCT03615222|155723820|FG000|Overall Study|Death|1|||
48419180|NCT02900092|155723823|FG000|Overall Study|Adverse Event|1|||
48419181|NCT02360098|155723824|FG000|Overall Study|Physician Decision|7|||
48419182|NCT00917384|155723825|FG000|Overall Study|Lost to Follow-up|4|||
48419183|NCT00917384|155723826|FG001|Overall Study|Lost to Follow-up|2|||
48419184|NCT00917384|155723825|FG000|Overall Study|Withdrawal by Subject|10|||
48419185|NCT00917384|155723826|FG001|Overall Study|Withdrawal by Subject|2|||
48419186|NCT05299892|155723827|FG000|Overall Study|Withdrawal by Subject|2|||
48419187|NCT01389128|155723828|FG000|Overall Study|Fetal distress|1|||
48419188|NCT01389128|155723829|FG001|Overall Study|Fetal distress|0|||
48419189|NCT01389128|155723828|FG000|Overall Study|Cervix dilation stop|1|||
48419190|NCT01389128|155723829|FG001|Overall Study|Cervix dilation stop|2|||
48419191|NCT01389128|155723828|FG000|Overall Study|Rapid labor evolution|3|||
48419192|NCT01389128|155723829|FG001|Overall Study|Rapid labor evolution|2|||
48419193|NCT01389128|155723828|FG000|Overall Study|Intolerance to procedure|0|||
48419194|NCT01389128|155723829|FG001|Overall Study|Intolerance to procedure|2|||
48419195|NCT03717922|155723832|FG000|Overall Study|Lost to Follow-up|2|||
48419196|NCT03717922|155723833|FG001|Overall Study|Lost to Follow-up|2|||
48419197|NCT02397655|155723834|FG000|Overall Study|data not completed|1301|||
48419198|NCT01242111|155723835|FG000|Overall Study|Adverse Event|1|||
48419199|NCT01242111|155723835|FG000|Overall Study|Withdrawal by Subject|1|||
48419200|NCT01242111|155723835|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
48419201|NCT01844076|155723838|FG000|Overall Study|Adverse Event|1|||
48419202|NCT01844076|155723839|FG001|Overall Study|Adverse Event|0|||
48419203|NCT01844076|155723840|FG002|Overall Study|Adverse Event|0|||
48419204|NCT01844076|155723841|FG003|Overall Study|Adverse Event|0|||
48419205|NCT01844076|155723838|FG000|Overall Study|Withdrawal by Subject|1|||
48419206|NCT01844076|155723839|FG001|Overall Study|Withdrawal by Subject|0|||
48419207|NCT01844076|155723840|FG002|Overall Study|Withdrawal by Subject|0|||
48419208|NCT01844076|155723841|FG003|Overall Study|Withdrawal by Subject|0|||
48419209|NCT01773473|155723842|FG000|Overall Study|Adverse Event|3|||
48419210|NCT01773473|155723843|FG001|Overall Study|Adverse Event|2|||
48419211|NCT01773473|155723842|FG000|Overall Study|Protocol Violation|0|||
48419212|NCT01773473|155723843|FG001|Overall Study|Protocol Violation|4|||
48419213|NCT01773473|155723842|FG000|Overall Study|Physician Decision|3|||
48419214|NCT01773473|155723843|FG001|Overall Study|Physician Decision|5|||
48419215|NCT01773473|155723842|FG000|Overall Study|Sponsor Decision|2|||
48419216|NCT01773473|155723843|FG001|Overall Study|Sponsor Decision|0|||
48419217|NCT01773473|155723842|FG000|Overall Study|Lack of Efficacy|0|||
48419218|NCT01773473|155723843|FG001|Overall Study|Lack of Efficacy|1|||
48419219|NCT01773473|155723842|FG000|Overall Study|Non-Compliance with study drug|1|||
48419220|NCT01773473|155723843|FG001|Overall Study|Non-Compliance with study drug|4|||
48419221|NCT01773473|155723842|FG000|Overall Study|Withdrawal by Subject|5|||
48419222|NCT01773473|155723843|FG001|Overall Study|Withdrawal by Subject|3|||
48419223|NCT01773473|155723842|FG000|Overall Study|Lost to Follow-up|2|||
48419224|NCT01773473|155723843|FG001|Overall Study|Lost to Follow-up|0|||
48419225|NCT02750410|155723844|FG000|Double-Blind Treatment Period|Adverse Event|2|||
48419226|NCT02750410|155723845|FG001|Double-Blind Treatment Period|Adverse Event|2|||
48419227|NCT02750410|155723844|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48419228|NCT02750410|155723845|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
48419229|NCT02750410|155723844|FG000|Open-Label Extension Period|Adverse Event|5|||
48419230|NCT02750410|155723845|FG001|Open-Label Extension Period|Adverse Event|3|||
48419231|NCT02750410|155723844|FG000|Open-Label Extension Period|Protocol Violation|0|||
48419232|NCT02750410|155723845|FG001|Open-Label Extension Period|Protocol Violation|1|||
48419233|NCT02750410|155723844|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
48419234|NCT02750410|155723845|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
48419235|NCT02424149|155723846|FG000|Overall Study|surgery cancelled|2|||
48419236|NCT02424149|155723847|FG001|Overall Study|surgery cancelled|0|||
48419237|NCT02424149|155723846|FG000|Overall Study|Withdrawal by Subject|0|||
48419238|NCT02424149|155723847|FG001|Overall Study|Withdrawal by Subject|1|||
48419239|NCT01873950|155723855|FG000|Period 5|Withdrawal by Subject|0|||
48419240|NCT01873950|155723856|FG001|Period 5|Withdrawal by Subject|0|||
48419241|NCT01873950|155723857|FG002|Period 5|Withdrawal by Subject|0|||
48419242|NCT01873950|155723858|FG003|Period 5|Withdrawal by Subject|1|||
48419243|NCT01873950|155723859|FG004|Period 5|Withdrawal by Subject|0|||
48419244|NCT03240081|155723863|FG000|Overall Study|Withdrawal by Subject|0|||
48419245|NCT03240081|155723864|FG001|Overall Study|Withdrawal by Subject|2|||
48419246|NCT03240081|155723863|FG000|Overall Study|Lost to Follow-up|0|||
48419247|NCT03240081|155723864|FG001|Overall Study|Lost to Follow-up|1|||
48419248|NCT01480180|155723865|FG000|Main Phase|Withdrawal criteria|12|||
48419249|NCT01480180|155723866|FG001|Main Phase|Withdrawal criteria|1|||
48419250|NCT01480180|155723867|FG002|Main Phase|Withdrawal criteria|0|||
48419251|NCT01480180|155723868|FG003|Main Phase|Withdrawal criteria|0|||
48419252|NCT01480180|155723869|FG004|Main Phase|Withdrawal criteria|0|||
48419253|NCT01480180|155723870|FG005|Main Phase|Withdrawal criteria|0|||
48419254|NCT01480180|155723865|FG000|Main Phase|Lack of Efficacy|1|||
48419255|NCT01480180|155723866|FG001|Main Phase|Lack of Efficacy|0|||
48419256|NCT01480180|155723867|FG002|Main Phase|Lack of Efficacy|0|||
48419257|NCT01480180|155723868|FG003|Main Phase|Lack of Efficacy|0|||
48419258|NCT01480180|155723869|FG004|Main Phase|Lack of Efficacy|0|||
48419259|NCT01480180|155723870|FG005|Main Phase|Lack of Efficacy|0|||
48419260|NCT01480180|155723865|FG000|Main Phase|Non-compliance|3|||
48419261|NCT01480180|155723866|FG001|Main Phase|Non-compliance|0|||
48419262|NCT01480180|155723867|FG002|Main Phase|Non-compliance|0|||
48419263|NCT01480180|155723868|FG003|Main Phase|Non-compliance|0|||
48419264|NCT01480180|155723869|FG004|Main Phase|Non-compliance|0|||
48419265|NCT01480180|155723870|FG005|Main Phase|Non-compliance|0|||
48419266|NCT01480180|155723865|FG000|Main Phase|Unclassified|3|||
48419267|NCT01480180|155723866|FG001|Main Phase|Unclassified|0|||
48419268|NCT01480180|155723867|FG002|Main Phase|Unclassified|0|||
48419269|NCT01480180|155723868|FG003|Main Phase|Unclassified|0|||
48419270|NCT01480180|155723869|FG004|Main Phase|Unclassified|0|||
48419271|NCT01480180|155723870|FG005|Main Phase|Unclassified|0|||
48419272|NCT01480180|155723865|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
48419273|NCT01480180|155723866|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
48419274|NCT01480180|155723867|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
48419275|NCT01480180|155723868|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
48419276|NCT01480180|155723869|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
48419277|NCT01480180|155723870|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
48419278|NCT01480180|155723865|FG000|Extension Phase, Part 1|Unclassified|0|||
48419279|NCT01480180|155723866|FG001|Extension Phase, Part 1|Unclassified|0|||
48419280|NCT01480180|155723867|FG002|Extension Phase, Part 1|Unclassified|1|||
48419281|NCT01480180|155723868|FG003|Extension Phase, Part 1|Unclassified|0|||
48419282|NCT01480180|155723869|FG004|Extension Phase, Part 1|Unclassified|0|||
48419283|NCT01480180|155723870|FG005|Extension Phase, Part 1|Unclassified|0|||
48419284|NCT01480180|155723865|FG000|Extension Phase, Part 1|Adverse Event|0|||
48419285|NCT01480180|155723866|FG001|Extension Phase, Part 1|Adverse Event|0|||
48419286|NCT01480180|155723867|FG002|Extension Phase, Part 1|Adverse Event|4|||
48419287|NCT01480180|155723868|FG003|Extension Phase, Part 1|Adverse Event|1|||
48419288|NCT01480180|155723869|FG004|Extension Phase, Part 1|Adverse Event|0|||
48419289|NCT01480180|155723870|FG005|Extension Phase, Part 1|Adverse Event|0|||
48419290|NCT01480180|155723865|FG000|Extension Phase, Part 1|Change of treatment|0|||
48419291|NCT01480180|155723866|FG001|Extension Phase, Part 1|Change of treatment|0|||
48419292|NCT01480180|155723867|FG002|Extension Phase, Part 1|Change of treatment|0|||
48419293|NCT01480180|155723868|FG003|Extension Phase, Part 1|Change of treatment|9|||
48419294|NCT01480180|155723869|FG004|Extension Phase, Part 1|Change of treatment|0|||
48419295|NCT01480180|155723870|FG005|Extension Phase, Part 1|Change of treatment|0|||
48419296|NCT01480180|155723865|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
48419297|NCT01480180|155723866|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
48419298|NCT01480180|155723867|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
48419299|NCT01480180|155723868|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
48419300|NCT01480180|155723869|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
48419301|NCT01480180|155723870|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
48419302|NCT01480180|155723865|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
48419303|NCT01480180|155723866|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
48419304|NCT01480180|155723867|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
48419305|NCT01480180|155723868|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
48419306|NCT01480180|155723869|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
48419307|NCT01480180|155723870|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
48419308|NCT01480180|155723865|FG000|Extension Phase, Part 2|Unclassified|0|||
48419309|NCT01480180|155723866|FG001|Extension Phase, Part 2|Unclassified|0|||
48419310|NCT01480180|155723867|FG002|Extension Phase, Part 2|Unclassified|3|||
48419311|NCT01480180|155723868|FG003|Extension Phase, Part 2|Unclassified|1|||
48419312|NCT01480180|155723869|FG004|Extension Phase, Part 2|Unclassified|1|||
48419313|NCT01480180|155723870|FG005|Extension Phase, Part 2|Unclassified|0|||
48419314|NCT00971321|155723871|FG000|Up to Month 7|Withdrawal by Subject|1|||
48419315|NCT00971321|155723872|FG001|Up to Month 7|Withdrawal by Subject|0|||
48419316|NCT00971321|155723871|FG000|Up to Month 7|Migrated/moved from study area|3|||
48419317|NCT00971321|155723872|FG001|Up to Month 7|Migrated/moved from study area|2|||
48419318|NCT00971321|155723871|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
48419319|NCT00971321|155723872|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
48419320|NCT00971321|155723871|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
48419321|NCT00971321|155723872|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
48419322|NCT00971321|155723871|FG000|Up to Month 11-12|Lost to Follow-up|1|||
48419323|NCT00971321|155723872|FG001|Up to Month 11-12|Lost to Follow-up|0|||
48419324|NCT01716169|155723878|FG000|Overall Study|Adverse Event|1|||
48419325|NCT01716169|155723878|FG000|Overall Study|Lost to Follow-up|1|||
48419326|NCT01716169|155723878|FG000|Overall Study|Withdrawal by Subject|1|||
48419327|NCT01716169|155723878|FG000|Overall Study|inconsistent dressing application|1|||
48419328|NCT02111811|155723879|FG000|Treatment Phase|Lost to Follow-up|22|||
48419329|NCT02111811|155723880|FG001|Treatment Phase|Lost to Follow-up|18|||
48419330|NCT02111811|155723879|FG000|Treatment Phase|Death|2|||
48419331|NCT02111811|155723880|FG001|Treatment Phase|Death|0|||
48419332|NCT02111811|155723879|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
48419333|NCT02111811|155723880|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
48419334|NCT02111811|155723879|FG000|Follow up Period (Aim 2)|Death|2|||
48419335|NCT02111811|155723880|FG001|Follow up Period (Aim 2)|Death|0|||
48419336|NCT03443024|155723881|FG000|Overall Study|Adverse Event|2|||
48419337|NCT03443024|155723882|FG001|Overall Study|Adverse Event|4|||
48419338|NCT03443024|155723883|FG002|Overall Study|Adverse Event|3|||
48419339|NCT03443024|155723884|FG003|Overall Study|Adverse Event|1|||
48419340|NCT03443024|155723881|FG000|Overall Study|Lost to Follow-up|9|||
48419341|NCT03443024|155723882|FG001|Overall Study|Lost to Follow-up|9|||
48419342|NCT03443024|155723883|FG002|Overall Study|Lost to Follow-up|7|||
48419343|NCT03443024|155723884|FG003|Overall Study|Lost to Follow-up|5|||
48419344|NCT03443024|155723881|FG000|Overall Study|Withdrawal by Subject|8|||
48419345|NCT03443024|155723882|FG001|Overall Study|Withdrawal by Subject|15|||
48419346|NCT03443024|155723883|FG002|Overall Study|Withdrawal by Subject|9|||
48419347|NCT03443024|155723884|FG003|Overall Study|Withdrawal by Subject|23|||
48419348|NCT03443024|155723881|FG000|Overall Study|Physician Decision|1|||
48419349|NCT03443024|155723882|FG001|Overall Study|Physician Decision|2|||
48419350|NCT03443024|155723883|FG002|Overall Study|Physician Decision|0|||
48419351|NCT03443024|155723884|FG003|Overall Study|Physician Decision|1|||
48419352|NCT03443024|155723881|FG000|Overall Study|Sponsor Decision|1|||
48419353|NCT03443024|155723882|FG001|Overall Study|Sponsor Decision|1|||
48419354|NCT03443024|155723883|FG002|Overall Study|Sponsor Decision|0|||
48419355|NCT03443024|155723884|FG003|Overall Study|Sponsor Decision|0|||
48419356|NCT03443024|155723881|FG000|Overall Study|Protocol Deviation|0|||
48419357|NCT03443024|155723882|FG001|Overall Study|Protocol Deviation|0|||
48419358|NCT03443024|155723883|FG002|Overall Study|Protocol Deviation|0|||
48419359|NCT03443024|155723884|FG003|Overall Study|Protocol Deviation|2|||
48419360|NCT00624338|155723888|FG000|Overall Study|Adverse Event|14|||
48419361|NCT00624338|155723889|FG001|Overall Study|Adverse Event|14|||
48419362|NCT00624338|155723890|FG002|Overall Study|Adverse Event|18|||
48419363|NCT00624338|155723888|FG000|Overall Study|Lost to Follow-up|1|||
48419364|NCT00624338|155723889|FG001|Overall Study|Lost to Follow-up|0|||
48419365|NCT00624338|155723890|FG002|Overall Study|Lost to Follow-up|0|||
48419366|NCT00624338|155723888|FG000|Overall Study|Lack of Efficacy|11|||
48419367|NCT00624338|155723889|FG001|Overall Study|Lack of Efficacy|3|||
48419368|NCT00624338|155723890|FG002|Overall Study|Lack of Efficacy|14|||
48419369|NCT00624338|155723888|FG000|Overall Study|Protocol Violation|3|||
48419370|NCT00624338|155723889|FG001|Overall Study|Protocol Violation|3|||
48419371|NCT00624338|155723890|FG002|Overall Study|Protocol Violation|2|||
48419372|NCT00624338|155723888|FG000|Overall Study|Death|0|||
48419373|NCT00624338|155723889|FG001|Overall Study|Death|2|||
48419374|NCT00624338|155723890|FG002|Overall Study|Death|0|||
48419375|NCT00624338|155723888|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
48419376|NCT00624338|155723889|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
48419377|NCT00624338|155723890|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
48419378|NCT00624338|155723888|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
48419379|NCT00624338|155723889|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
48419380|NCT00624338|155723890|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
48419381|NCT00624338|155723888|FG000|Overall Study|Other|15|||
48419382|NCT00624338|155723889|FG001|Overall Study|Other|5|||
48419383|NCT00624338|155723890|FG002|Overall Study|Other|9|||
48419384|NCT00624338|155723888|FG000|Overall Study|Randomized but not treated|2|||
48419385|NCT00624338|155723889|FG001|Overall Study|Randomized but not treated|1|||
48419386|NCT00624338|155723890|FG002|Overall Study|Randomized but not treated|3|||
48419387|NCT01548638|155723891|FG000|Overall Study|Protocol Violation|3|||
48419388|NCT01548638|155723891|FG000|Overall Study|Withdrawal by Subject|1|||
48419389|NCT00002850|155723896|FG000|Overall Study|Death|4|||
48419390|NCT00002850|155723897|FG001|Overall Study|Death|1|||
48419391|NCT00002850|155723898|FG002|Overall Study|Death|3|||
48419392|NCT00002850|155723896|FG000|Overall Study|Protocol Violation|1|||
48419393|NCT00002850|155723897|FG001|Overall Study|Protocol Violation|0|||
48419394|NCT00002850|155723898|FG002|Overall Study|Protocol Violation|1|||
48419395|NCT00002850|155723896|FG000|Overall Study|Withdrawal by Subject|0|||
48419396|NCT00002850|155723897|FG001|Overall Study|Withdrawal by Subject|1|||
48419397|NCT00002850|155723898|FG002|Overall Study|Withdrawal by Subject|0|||
48419398|NCT03015532|155723899|FG000|Overall Study|Adverse Event|0|||
48419399|NCT03015532|155723900|FG001|Overall Study|Adverse Event|0|||
48419400|NCT03015532|155723901|FG002|Overall Study|Adverse Event|0|||
48419401|NCT03015532|155723902|FG003|Overall Study|Adverse Event|0|||
48419402|NCT03015532|155723903|FG004|Overall Study|Adverse Event|0|||
48419403|NCT03015532|155723904|FG005|Overall Study|Adverse Event|2|||
48419404|NCT03015532|155723905|FG006|Overall Study|Adverse Event|1|||
48419405|NCT03015532|155723906|FG007|Overall Study|Adverse Event|0|||
48419406|NCT03015532|155723899|FG000|Overall Study|Withdrawal by Subject|0|||
48419407|NCT03015532|155723900|FG001|Overall Study|Withdrawal by Subject|0|||
48419408|NCT03015532|155723901|FG002|Overall Study|Withdrawal by Subject|0|||
48419409|NCT03015532|155723902|FG003|Overall Study|Withdrawal by Subject|0|||
48419410|NCT03015532|155723903|FG004|Overall Study|Withdrawal by Subject|0|||
48419411|NCT03015532|155723904|FG005|Overall Study|Withdrawal by Subject|0|||
48419412|NCT03015532|155723905|FG006|Overall Study|Withdrawal by Subject|1|||
48419413|NCT03015532|155723906|FG007|Overall Study|Withdrawal by Subject|0|||
48419414|NCT01697345|155723908|FG000|Overall Study|Withdrawal by Subject|1|||
48419415|NCT01926886|155723909|FG000|Overall Study|Administrative/other|1|||
48419416|NCT01926886|155723910|FG001|Overall Study|Administrative/other|0|||
48419417|NCT01926886|155723909|FG000|Overall Study|Adverse event/intercurrent illness|4|||
48419418|NCT01926886|155723910|FG001|Overall Study|Adverse event/intercurrent illness|0|||
48419419|NCT01926886|155723909|FG000|Overall Study|Disease progression/recurrence|4|||
48419420|NCT01926886|155723910|FG001|Overall Study|Disease progression/recurrence|0|||
48419421|NCT01926886|155723909|FG000|Overall Study|Withdrawal by Subject|15|||
48419422|NCT01926886|155723910|FG001|Overall Study|Withdrawal by Subject|0|||
48419423|NCT01926886|155723909|FG000|Overall Study|Failure to return|3|||
48419424|NCT01926886|155723910|FG001|Overall Study|Failure to return|0|||
48419425|NCT01926886|155723909|FG000|Overall Study|Recurrence of disease|1|||
48419426|NCT01926886|155723910|FG001|Overall Study|Recurrence of disease|0|||
48419427|NCT01926886|155723909|FG000|Overall Study|Progression of disease|2|||
48419428|NCT01926886|155723910|FG001|Overall Study|Progression of disease|0|||
48419429|NCT01926886|155723909|FG000|Overall Study|Death|1|||
48419430|NCT01926886|155723910|FG001|Overall Study|Death|0|||
48419431|NCT01926886|155723909|FG000|Overall Study|Did not cooperate|1|||
48419432|NCT01926886|155723910|FG001|Overall Study|Did not cooperate|0|||
48419433|NCT00196937|155723919|FG000|Overall Study|Serious Adverse Event|1|||
48419434|NCT00196937|155723920|FG001|Overall Study|Serious Adverse Event|0|||
48419435|NCT00196937|155723921|FG002|Overall Study|Serious Adverse Event|0|||
48419436|NCT00196937|155723919|FG000|Overall Study|Non-serious adverse event|1|||
48419437|NCT00196937|155723920|FG001|Overall Study|Non-serious adverse event|1|||
48419438|NCT00196937|155723921|FG002|Overall Study|Non-serious adverse event|1|||
48419439|NCT00196937|155723919|FG000|Overall Study|Withdrawal by Subject|0|||
48419440|NCT00196937|155723920|FG001|Overall Study|Withdrawal by Subject|0|||
48419441|NCT00196937|155723921|FG002|Overall Study|Withdrawal by Subject|2|||
48419442|NCT00196937|155723919|FG000|Overall Study|Lost to Follow-up|4|||
48419443|NCT00196937|155723920|FG001|Overall Study|Lost to Follow-up|3|||
48419444|NCT00196937|155723921|FG002|Overall Study|Lost to Follow-up|3|||
48419445|NCT00196937|155723919|FG000|Overall Study|Other|3|||
48419446|NCT00196937|155723920|FG001|Overall Study|Other|1|||
48419447|NCT00196937|155723921|FG002|Overall Study|Other|1|||
48419448|NCT01748760|155723927|FG000|Overall Study|Withdrawal by Subject|1|||
48419449|NCT01748760|155723928|FG001|Overall Study|Withdrawal by Subject|1|||
48419450|NCT01748760|155723927|FG000|Overall Study|Lost to Follow-up|5|||
48419451|NCT01748760|155723928|FG001|Overall Study|Lost to Follow-up|1|||
48419452|NCT00964795|155723929|FG000|Overall Study|Withdrawal by Subject|79|||
48419453|NCT00964795|155723929|FG000|Overall Study|Adverse Event|12|||
48419454|NCT00964795|155723929|FG000|Overall Study|Death|14|||
48419455|NCT00964795|155723929|FG000|Overall Study|Lost to Follow-up|7|||
48419456|NCT00964795|155723929|FG000|Overall Study|Termination of Study by Sponsor|169|||
48419457|NCT00964795|155723929|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
48419458|NCT00964795|155723929|FG000|Overall Study|Other|23|||
48419459|NCT03245814|155723930|FG000|Overall Study|Lost to Follow-up|5|||
48419460|NCT03245814|155723931|FG001|Overall Study|Lost to Follow-up|8|||
48419461|NCT03245814|155723930|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
48419462|NCT03245814|155723931|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
48419463|NCT02522377|155723933|FG000|Overall Study|Withdrawal by Subject|1|||
48419464|NCT02522377|155723934|FG001|Overall Study|Withdrawal by Subject|0|||
48419465|NCT02522377|155723933|FG000|Overall Study|Remission Achieved|3|||
48419466|NCT02522377|155723934|FG001|Overall Study|Remission Achieved|0|||
48419467|NCT04538950|155723941|FG000|Overall Study|Pulmonary Issues|2|||
48419468|NCT04538950|155723941|FG000|Overall Study|illness|2|||
48419469|NCT01887210|155723945|FG000|Overall Study|Withdrawal by Subject|1|||
48419470|NCT01887210|155723946|FG001|Overall Study|Withdrawal by Subject|3|||
48419471|NCT01887210|155723945|FG000|Overall Study|Lost to Follow-up|0|||
48419472|NCT01887210|155723946|FG001|Overall Study|Lost to Follow-up|1|||
48419473|NCT02559505|155725572|FG000|Overall Study|Lost to Follow-up|23|||
48419474|NCT02559505|155725573|FG001|Overall Study|Lost to Follow-up|20|||
48419475|NCT02559505|155725572|FG000|Overall Study|Withdrawal by Subject|4|||
48419476|NCT02559505|155725573|FG001|Overall Study|Withdrawal by Subject|2|||
48419477|NCT00476086|155725587|FG000|Overall Study|Alternative therapy|1|||
48419478|NCT00476086|155725587|FG000|Overall Study|Progressive Disease|4|||
48419479|NCT02015819|155725590|FG000|Overall Study|Rickham catheter was misaligned|0|||
48419480|NCT02015819|155725591|FG001|Overall Study|Rickham catheter was misaligned|0|||
48419481|NCT02015819|155725592|FG002|Overall Study|Rickham catheter was misaligned|0|||
48419482|NCT02015819|155725593|FG003|Overall Study|Rickham catheter was misaligned|1|||
48419483|NCT02286960|155725598|FG000|Overall Study|Lost to Follow-up|3|||
48419484|NCT02286960|155725599|FG001|Overall Study|Lost to Follow-up|3|||
48419485|NCT01241786|155725600|FG000|Overall Study|Lack of Efficacy|5|||
48419486|NCT01165229|155725606|FG000|Overall Study|Serious Adverse Event|456|||
48419487|NCT01165229|155725607|FG001|Overall Study|Serious Adverse Event|487|||
48419488|NCT01165229|155725606|FG000|Overall Study|Non-Serious Adverse Event|47|||
48419489|NCT01165229|155725607|FG001|Overall Study|Non-Serious Adverse Event|15|||
48419490|NCT01165229|155725606|FG000|Overall Study|Protocol Violation|6|||
48419491|NCT01165229|155725607|FG001|Overall Study|Protocol Violation|8|||
48419492|NCT01165229|155725606|FG000|Overall Study|Withdrawal by Subject|387|||
48419493|NCT01165229|155725607|FG001|Overall Study|Withdrawal by Subject|396|||
48419494|NCT01165229|155725606|FG000|Overall Study|Migrated/moved from study area|51|||
48419495|NCT01165229|155725607|FG001|Overall Study|Migrated/moved from study area|46|||
48419496|NCT01165229|155725606|FG000|Overall Study|Lost to Follow-up|123|||
48419497|NCT01165229|155725607|FG001|Overall Study|Lost to Follow-up|133|||
48419498|NCT01165229|155725606|FG000|Overall Study|Suspected HZ Episode|2|||
48419499|NCT01165229|155725607|FG001|Overall Study|Suspected HZ Episode|2|||
48419500|NCT01165229|155725606|FG000|Overall Study|No reason from the subject|108|||
48419501|NCT01165229|155725607|FG001|Overall Study|No reason from the subject|102|||
48419502|NCT01165229|155725606|FG000|Overall Study|Unknown completion status|0|||
48419503|NCT01165229|155725607|FG001|Overall Study|Unknown completion status|1|||
48419504|NCT00609609|155725621|FG000|Overall Study|Withdrawal by Subject|2|||
48419505|NCT00609609|155725622|FG001|Overall Study|Withdrawal by Subject|0|||
48419506|NCT00609609|155725621|FG000|Overall Study|Progression|4|||
48419507|NCT00609609|155725622|FG001|Overall Study|Progression|2|||
48419508|NCT00637728|155725623|FG000|Double-blind Phase|Adverse Event|1|||
48419509|NCT00637728|155725624|FG001|Double-blind Phase|Adverse Event|0|||
48419510|NCT00637728|155725625|FG002|Double-blind Phase|Adverse Event|0|||
48419511|NCT00637728|155725623|FG000|Double-blind Phase|Non-compliance|2|||
48419512|NCT00637728|155725624|FG001|Double-blind Phase|Non-compliance|0|||
48419513|NCT00637728|155725625|FG002|Double-blind Phase|Non-compliance|0|||
48419514|NCT00637728|155725623|FG000|Double-blind Phase|Study Discontinued|1|||
48419515|NCT00637728|155725624|FG001|Double-blind Phase|Study Discontinued|1|||
48419516|NCT00637728|155725625|FG002|Double-blind Phase|Study Discontinued|0|||
48419517|NCT00670111|155725626|FG000|Enrollment to One Month|Testing Failure|0|||
48419518|NCT00670111|155725627|FG001|Enrollment to One Month|Testing Failure|0|||
48419519|NCT00670111|155725628|FG002|Enrollment to One Month|Testing Failure|13|||
48419520|NCT00670111|155725626|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
48419521|NCT00670111|155725627|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
48419522|NCT00670111|155725628|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
48419523|NCT00670111|155725626|FG000|Enrollment to One Month|Physician Decision|1|||
48419524|NCT00670111|155725627|FG001|Enrollment to One Month|Physician Decision|0|||
48419525|NCT00670111|155725628|FG002|Enrollment to One Month|Physician Decision|0|||
48419526|NCT05421754|155725638|FG000|Overall Study|Technical issue with sensor|1|||
48419527|NCT02580058|155725641|FG000|Overall Study|Adverse Event|16|||
48419528|NCT02580058|155725642|FG001|Overall Study|Adverse Event|30|||
48419529|NCT02580058|155725643|FG002|Overall Study|Adverse Event|20|||
48419530|NCT02580058|155725641|FG000|Overall Study|Death|4|||
48419531|NCT02580058|155725642|FG001|Overall Study|Death|4|||
48419532|NCT02580058|155725643|FG002|Overall Study|Death|5|||
48419533|NCT02580058|155725641|FG000|Overall Study|Physician Decision|1|||
48419534|NCT02580058|155725642|FG001|Overall Study|Physician Decision|3|||
48419535|NCT02580058|155725643|FG002|Overall Study|Physician Decision|11|||
48419536|NCT02580058|155725641|FG000|Overall Study|Other|5|||
48419537|NCT02580058|155725642|FG001|Overall Study|Other|1|||
48419538|NCT02580058|155725643|FG002|Overall Study|Other|3|||
48419539|NCT02580058|155725641|FG000|Overall Study|Withdrawal by Subject|4|||
48419540|NCT02580058|155725642|FG001|Overall Study|Withdrawal by Subject|7|||
48419541|NCT02580058|155725643|FG002|Overall Study|Withdrawal by Subject|31|||
48419542|NCT02580058|155725641|FG000|Overall Study|Global Deterioration of Health Status|19|||
48419543|NCT02580058|155725642|FG001|Overall Study|Global Deterioration of Health Status|18|||
48419544|NCT02580058|155725643|FG002|Overall Study|Global Deterioration of Health Status|24|||
48419545|NCT02580058|155725641|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
48419546|NCT02580058|155725642|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48419547|NCT02580058|155725643|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
48419548|NCT02580058|155725641|FG000|Overall Study|Progressive Disease|137|||
48419549|NCT02580058|155725642|FG001|Overall Study|Progressive Disease|125|||
48419550|NCT02580058|155725643|FG002|Overall Study|Progressive Disease|94|||
48419551|NCT02580058|155725641|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48419552|NCT02580058|155725642|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48419553|NCT02580058|155725643|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48419554|NCT00707577|155725644|FG000|Overall Study|Withdrawal by Subject|3|||
48419555|NCT00707577|155725645|FG001|Overall Study|Withdrawal by Subject|2|||
48419556|NCT00707577|155725644|FG000|Overall Study|Lost to Follow-up|34|||
48419557|NCT00707577|155725645|FG001|Overall Study|Lost to Follow-up|25|||
48419558|NCT00707577|155725644|FG000|Overall Study|Left employment|13|||
48419559|NCT00707577|155725645|FG001|Overall Study|Left employment|10|||
48419560|NCT00707577|155725644|FG000|Overall Study|Pregnancy|4|||
48419561|NCT00707577|155725645|FG001|Overall Study|Pregnancy|1|||
48419562|NCT01570491|155725654|FG000|Overall Study|Lost to Follow-up|3|||
48419563|NCT01570491|155725655|FG001|Overall Study|Lost to Follow-up|1|||
48419564|NCT01570491|155725654|FG000|Overall Study|treatment: not given or discontinued|2|||
48419565|NCT01570491|155725655|FG001|Overall Study|treatment: not given or discontinued|0|||
48419566|NCT00482001|155725656|FG000|Overall Study|Protocol Violation|1|||
48419567|NCT00482001|155725657|FG001|Overall Study|Protocol Violation|1|||
48419568|NCT00659438|155725658|FG000|Overall Study|Withdrawal by Subject|2|||
48419569|NCT00659438|155725659|FG001|Overall Study|Withdrawal by Subject|2|||
48419570|NCT00659438|155725658|FG000|Overall Study|Death|11|||
48419571|NCT00659438|155725659|FG001|Overall Study|Death|6|||
48419572|NCT00659438|155725658|FG000|Overall Study|Lost to Follow-up|1|||
48419573|NCT00659438|155725659|FG001|Overall Study|Lost to Follow-up|0|||
48419574|NCT04375878|155725661|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
48419575|NCT04375878|155725662|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
48419576|NCT04375878|155725663|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
48419577|NCT04375878|155725664|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
48419578|NCT04375878|155725665|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
48419579|NCT04375878|155725666|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
48419580|NCT04375878|155725661|FG000|Crossover First and Second Interventions|Adverse Event|0|||
48419581|NCT04375878|155725662|FG001|Crossover First and Second Interventions|Adverse Event|0|||
48419582|NCT04375878|155725663|FG002|Crossover First and Second Interventions|Adverse Event|1|||
48419583|NCT04375878|155725664|FG003|Crossover First and Second Interventions|Adverse Event|0|||
48419584|NCT04375878|155725665|FG004|Crossover First and Second Interventions|Adverse Event|0|||
48419585|NCT04375878|155725666|FG005|Crossover First and Second Interventions|Adverse Event|0|||
48419586|NCT04375878|155725661|FG000|Extension Phase|Withdrawal by Subject|0|||
48419587|NCT04375878|155725662|FG001|Extension Phase|Withdrawal by Subject|0|||
48419588|NCT04375878|155725663|FG002|Extension Phase|Withdrawal by Subject|0|||
48419589|NCT04375878|155725664|FG003|Extension Phase|Withdrawal by Subject|0|||
48419590|NCT04375878|155725665|FG004|Extension Phase|Withdrawal by Subject|1|||
48419591|NCT04375878|155725666|FG005|Extension Phase|Withdrawal by Subject|0|||
48419592|NCT03233048|155725672|FG000|Overall Study|Withdrawal by Subject|1|||
48419593|NCT02299934|155725673|FG000|Overall Study|Termination of study|13|||
48419594|NCT01856673|155725674|FG000|Overall Study|Withdrawal by Subject|44|||
48419595|NCT01856673|155725675|FG001|Overall Study|Withdrawal by Subject|50|||
48419596|NCT01856673|155725676|FG002|Overall Study|Withdrawal by Subject|33|||
48419597|NCT01856673|155725674|FG000|Overall Study|Lost to Follow-up|31|||
48419598|NCT01856673|155725675|FG001|Overall Study|Lost to Follow-up|34|||
48419599|NCT01856673|155725676|FG002|Overall Study|Lost to Follow-up|0|||
48419600|NCT01856673|155725674|FG000|Overall Study|Unknown reasons|9|||
48419601|NCT01856673|155725675|FG001|Overall Study|Unknown reasons|0|||
48419602|NCT01856673|155725676|FG002|Overall Study|Unknown reasons|0|||
48419603|NCT01856673|155725674|FG000|Overall Study|Psychologist decision|1|||
48419604|NCT01856673|155725675|FG001|Overall Study|Psychologist decision|0|||
48419605|NCT01856673|155725676|FG002|Overall Study|Psychologist decision|0|||
48419606|NCT01856673|155725674|FG000|Overall Study|Paperwork errors|8|||
48419607|NCT01856673|155725675|FG001|Overall Study|Paperwork errors|0|||
48419608|NCT01856673|155725676|FG002|Overall Study|Paperwork errors|0|||
48419609|NCT01856673|155725674|FG000|Overall Study|Death|1|||
48419610|NCT01856673|155725675|FG001|Overall Study|Death|1|||
48419611|NCT01856673|155725676|FG002|Overall Study|Death|0|||
48419612|NCT01856673|155725674|FG000|Overall Study|Protocol Violation|1|||
48419613|NCT01856673|155725675|FG001|Overall Study|Protocol Violation|0|||
48419614|NCT01856673|155725676|FG002|Overall Study|Protocol Violation|1|||
48419615|NCT00195351|155725677|FG000|Overall Study|Lost to Follow-up|9|||
48419616|NCT00195351|155725678|FG001|Overall Study|Lost to Follow-up|9|||
48419617|NCT00195351|155725677|FG000|Overall Study|Withdrawal by Subject|6|||
48419618|NCT00195351|155725678|FG001|Overall Study|Withdrawal by Subject|3|||
48419619|NCT00195351|155725677|FG000|Overall Study|Protocol Deviation|3|||
48419620|NCT00195351|155725678|FG001|Overall Study|Protocol Deviation|2|||
48419621|NCT00195351|155725677|FG000|Overall Study|Death|3|||
48419622|NCT00195351|155725678|FG001|Overall Study|Death|1|||
48419623|NCT00195351|155725677|FG000|Overall Study|Lack of Efficacy|0|||
48419624|NCT00195351|155725678|FG001|Overall Study|Lack of Efficacy|1|||
48419625|NCT00820040|155725682|FG000|Overall Study|Death|1|||
48419626|NCT00820040|155725682|FG000|Overall Study|Sponsor terminated study|1|||
48419627|NCT00820040|155725682|FG000|Overall Study|Screen failure|1|||
48419628|NCT00553787|155725691|FG000|Overall Study|Adverse Event|34|||
48419629|NCT00553787|155725692|FG001|Overall Study|Adverse Event|21|||
48419630|NCT00553787|155725693|FG002|Overall Study|Adverse Event|67|||
48419631|NCT00553787|155725691|FG000|Overall Study|Lost to Follow-up|132|||
48419632|NCT00553787|155725692|FG001|Overall Study|Lost to Follow-up|44|||
48419633|NCT00553787|155725693|FG002|Overall Study|Lost to Follow-up|78|||
48419634|NCT00553787|155725691|FG000|Overall Study|Withdrawal by Subject|151|||
48426326|NCT02203838|155749553|FG003|Overall Study|Lost to Follow-up|1|||
48419635|NCT00553787|155725692|FG001|Overall Study|Withdrawal by Subject|40|||
48419636|NCT00553787|155725693|FG002|Overall Study|Withdrawal by Subject|83|||
48419637|NCT00553787|155725691|FG000|Overall Study|Lack of Efficacy|31|||
48419638|NCT00553787|155725692|FG001|Overall Study|Lack of Efficacy|1|||
48419639|NCT00553787|155725693|FG002|Overall Study|Lack of Efficacy|3|||
48419640|NCT00553787|155725691|FG000|Overall Study|Pregnancy|0|||
48419641|NCT00553787|155725692|FG001|Overall Study|Pregnancy|1|||
48419642|NCT00553787|155725693|FG002|Overall Study|Pregnancy|2|||
48419643|NCT00553787|155725691|FG000|Overall Study|non compliance|4|||
48419644|NCT00553787|155725692|FG001|Overall Study|non compliance|0|||
48419645|NCT00553787|155725693|FG002|Overall Study|non compliance|11|||
48419646|NCT00553787|155725691|FG000|Overall Study|Requirement for restricted medication|8|||
48419647|NCT00553787|155725692|FG001|Overall Study|Requirement for restricted medication|7|||
48419648|NCT00553787|155725693|FG002|Overall Study|Requirement for restricted medication|5|||
48419649|NCT00553787|155725691|FG000|Overall Study|Other|18|||
48419650|NCT00553787|155725692|FG001|Overall Study|Other|10|||
48419651|NCT00553787|155725693|FG002|Overall Study|Other|13|||
48419652|NCT00667277|155725694|FG000|Overall Study|Withdrawal by Subject|2|||
48419653|NCT00519532|155725695|FG000|Overall Study|Adverse Event|11|||
48419654|NCT00519532|155725695|FG000|Overall Study|Withdrawal by Subject|5|||
48419655|NCT00519532|155725695|FG000|Overall Study|Lost to Follow-up|2|||
48419656|NCT03414359|155725696|FG000|Overall Study|Lack of Efficacy|1|||
48419657|NCT03414359|155725697|FG001|Overall Study|Lack of Efficacy|1|||
48419658|NCT03414359|155725696|FG000|Overall Study|Protocol Violation|0|||
48419659|NCT03414359|155725697|FG001|Overall Study|Protocol Violation|1|||
48419660|NCT00847561|155725698|FG000|Overall Study|Withdrawal by Subject|4|||
48419661|NCT00847561|155725699|FG001|Overall Study|Withdrawal by Subject|3|||
48419662|NCT00847561|155725698|FG000|Overall Study|Unable to schedule|9|||
48419663|NCT00847561|155725699|FG001|Overall Study|Unable to schedule|1|||
48419664|NCT02273973|155725700|FG000|Overall Study|Adverse Event|4|||
48419665|NCT02273973|155725701|FG001|Overall Study|Adverse Event|0|||
48419666|NCT02273973|155725700|FG000|Overall Study|Withdrawal by Subject|2|||
48419667|NCT02273973|155725701|FG001|Overall Study|Withdrawal by Subject|3|||
48419668|NCT02273973|155725700|FG000|Overall Study|Death|1|||
48419669|NCT02273973|155725701|FG001|Overall Study|Death|0|||
48419670|NCT02273973|155725700|FG000|Overall Study|Non-compliance|1|||
48419671|NCT02273973|155725701|FG001|Overall Study|Non-compliance|0|||
48419672|NCT02273973|155725700|FG000|Overall Study|Protocol Violation|1|||
48419673|NCT02273973|155725701|FG001|Overall Study|Protocol Violation|0|||
48419674|NCT02273973|155725700|FG000|Overall Study|Progression of disease|0|||
48419675|NCT02273973|155725701|FG001|Overall Study|Progression of disease|2|||
48419676|NCT02273973|155725700|FG000|Overall Study|Lost to Follow-up|0|||
48419677|NCT02273973|155725701|FG001|Overall Study|Lost to Follow-up|1|||
48419678|NCT02273973|155725700|FG000|Overall Study|Physician Decision|0|||
48419679|NCT02273973|155725701|FG001|Overall Study|Physician Decision|1|||
48419680|NCT02273973|155725700|FG000|Overall Study|Reason not specified|0|||
48419681|NCT02273973|155725701|FG001|Overall Study|Reason not specified|1|||
48419682|NCT01333189|155725705|FG000|Overall Study|Time constraints|1|||
48419683|NCT01333189|155725706|FG001|Overall Study|Time constraints|0|||
48419684|NCT01333189|155725705|FG000|Overall Study|Adverse Event|1|||
48419685|NCT01333189|155725706|FG001|Overall Study|Adverse Event|0|||
48419686|NCT01333189|155725705|FG000|Overall Study|Transportation difficulties|0|||
48419687|NCT01333189|155725706|FG001|Overall Study|Transportation difficulties|1|||
48419688|NCT01333189|155725705|FG000|Overall Study|Moved from region|0|||
48419689|NCT01333189|155725706|FG001|Overall Study|Moved from region|1|||
48419690|NCT01750918|155725707|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
48419691|NCT01750918|155725708|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
48419692|NCT01750918|155725709|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
48419693|NCT01750918|155725710|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
48419694|NCT01750918|155725711|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
48419695|NCT01750918|155725712|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
48419696|NCT01750918|155725713|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
48419697|NCT01750918|155725714|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
48419698|NCT01750918|155725707|FG000|Overall Study|Lost to Follow-up|0|||
48419699|NCT01750918|155725708|FG001|Overall Study|Lost to Follow-up|0|||
48419700|NCT01750918|155725709|FG002|Overall Study|Lost to Follow-up|2|||
48419701|NCT01750918|155725710|FG003|Overall Study|Lost to Follow-up|2|||
48419702|NCT01750918|155725711|FG004|Overall Study|Lost to Follow-up|0|||
48419703|NCT01750918|155725712|FG005|Overall Study|Lost to Follow-up|0|||
48419704|NCT01750918|155725713|FG006|Overall Study|Lost to Follow-up|0|||
48419705|NCT01750918|155725714|FG007|Overall Study|Lost to Follow-up|1|||
48419706|NCT01750918|155725707|FG000|Overall Study|Withdrawal by Subject|0|||
48419707|NCT01750918|155725708|FG001|Overall Study|Withdrawal by Subject|0|||
48419708|NCT01750918|155725709|FG002|Overall Study|Withdrawal by Subject|1|||
48419709|NCT01750918|155725710|FG003|Overall Study|Withdrawal by Subject|2|||
48419710|NCT01750918|155725711|FG004|Overall Study|Withdrawal by Subject|1|||
48419711|NCT01750918|155725712|FG005|Overall Study|Withdrawal by Subject|1|||
48419712|NCT01750918|155725713|FG006|Overall Study|Withdrawal by Subject|2|||
48419713|NCT01750918|155725714|FG007|Overall Study|Withdrawal by Subject|2|||
48419714|NCT02179398|155725722|FG000|Overall Study|Lack of obligatory data|3|||
48419715|NCT02179398|155725723|FG001|Overall Study|Lack of obligatory data|3|||
48419716|NCT02179398|155725722|FG000|Overall Study|Lost to Follow-up|0|||
48419717|NCT02179398|155725723|FG001|Overall Study|Lost to Follow-up|1|||
48419718|NCT03022422|155725726|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
48419719|NCT03022422|155725727|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
48419720|NCT03022422|155725728|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
48419721|NCT03022422|155725729|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
48419722|NCT03022422|155725730|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
48419723|NCT03022422|155725731|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
48419724|NCT03497689|155725736|FG000|Overall Study|Adverse Event|2|||
48419725|NCT03497689|155725736|FG000|Overall Study|Death|1|||
48419726|NCT03497689|155725736|FG000|Overall Study|Physician Decision|1|||
48419727|NCT03497689|155725736|FG000|Overall Study|Withdrawal by Subject|1|||
48419728|NCT03497689|155725736|FG000|Overall Study|Protocol Violation|2|||
48419729|NCT02032524|155725737|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
48419730|NCT02032524|155725738|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
48419731|NCT02032524|155725739|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
48419732|NCT02032524|155725740|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
48419733|NCT02032524|155725741|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
48419734|NCT02032524|155725742|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
48419735|NCT02032524|155725737|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
48419736|NCT02032524|155725738|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
48419737|NCT02032524|155725739|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
48419738|NCT02032524|155725740|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
48419739|NCT02032524|155725741|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
48419740|NCT02032524|155725742|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
48419741|NCT02032524|155725737|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
48419742|NCT02032524|155725738|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
48419743|NCT02032524|155725739|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
48419744|NCT02032524|155725740|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
48419745|NCT02032524|155725741|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
48419746|NCT02032524|155725742|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
48419747|NCT02032524|155725737|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
48419748|NCT02032524|155725738|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
48419749|NCT02032524|155725739|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
48419750|NCT02032524|155725740|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
48419751|NCT02032524|155725741|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
48419752|NCT02032524|155725742|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
48419753|NCT02032524|155725737|FG000|Period 2: LTS13769 Study|Other|0|||
48419754|NCT02032524|155725738|FG001|Period 2: LTS13769 Study|Other|0|||
48419755|NCT02032524|155725739|FG002|Period 2: LTS13769 Study|Other|0|||
48419756|NCT02032524|155725740|FG003|Period 2: LTS13769 Study|Other|0|||
48419757|NCT02032524|155725741|FG004|Period 2: LTS13769 Study|Other|0|||
48419758|NCT02032524|155725742|FG005|Period 2: LTS13769 Study|Other|1|||
48419759|NCT05847881|155725743|FG000|Overall Study|Principal Investigator Decision|8|||
48419760|NCT05847881|155725743|FG000|Overall Study|Withdrawal by Subject|2|||
48419761|NCT01614457|155727170|FG000|Overall Study|Non-Compliance|1|||
48419762|NCT01614457|155727171|FG001|Overall Study|Non-Compliance|0|||
48419763|NCT01614457|155727170|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
48419764|NCT01614457|155727171|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
48419765|NCT02981472|155727184|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
48419766|NCT02981472|155727185|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
48419767|NCT02981472|155727184|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
48419768|NCT02981472|155727185|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
48419769|NCT02981472|155727184|FG000|Treatment Period|Adverse Event|6|||
48419770|NCT02981472|155727185|FG001|Treatment Period|Adverse Event|1|||
48419771|NCT02981472|155727184|FG000|Treatment Period|Participant withdrew consent|1|||
48419772|NCT02981472|155727185|FG001|Treatment Period|Participant withdrew consent|0|||
48419773|NCT02981472|155727184|FG000|Treatment Period|Lost to Follow-up|0|||
48419774|NCT02981472|155727185|FG001|Treatment Period|Lost to Follow-up|1|||
48419775|NCT01713348|155727186|FG000|Overall Study|Withdrawal by Subject|3|||
48419776|NCT01713348|155727187|FG001|Overall Study|Withdrawal by Subject|2|||
48419777|NCT01713348|155727188|FG002|Overall Study|Withdrawal by Subject|2|||
48419778|NCT01713348|155727189|FG003|Overall Study|Withdrawal by Subject|0|||
48419779|NCT01713348|155727186|FG000|Overall Study|Lost to Follow-up|1|||
48419780|NCT01713348|155727187|FG001|Overall Study|Lost to Follow-up|0|||
48419781|NCT01713348|155727188|FG002|Overall Study|Lost to Follow-up|0|||
48419782|NCT01713348|155727189|FG003|Overall Study|Lost to Follow-up|0|||
48419783|NCT00621023|155727190|FG000|Overall Study|Death|5|||
48419784|NCT00621023|155727190|FG000|Overall Study|Follow up discontinued|1|||
48419785|NCT03095703|155727191|FG000|Overall Study|Withdrawal by Subject|1|||
48419786|NCT04723537|155727195|FG000|Overall Study|Withdrawal by Subject|3|||
48419787|NCT04723537|155727196|FG001|Overall Study|Withdrawal by Subject|0|||
48419788|NCT04723537|155727197|FG002|Overall Study|Withdrawal by Subject|0|||
48419789|NCT04723537|155727195|FG000|Overall Study|Physician Decision|0|||
48419790|NCT04723537|155727196|FG001|Overall Study|Physician Decision|0|||
48419791|NCT04723537|155727197|FG002|Overall Study|Physician Decision|1|||
48419792|NCT04723537|155727195|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
48419793|NCT04723537|155727196|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
48419794|NCT04723537|155727197|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
48419795|NCT02158533|155727198|FG000|Stage 1|Adverse Event|6|||
48419796|NCT02158533|155727199|FG001|Stage 1|Adverse Event|4|||
48419797|NCT02158533|155727200|FG002|Stage 1|Adverse Event|7|||
48419798|NCT02158533|155727201|FG003|Stage 1|Adverse Event|0|||
48419799|NCT02158533|155727202|FG004|Stage 1|Adverse Event|0|||
48419800|NCT02158533|155727203|FG005|Stage 1|Adverse Event|0|||
48419801|NCT02158533|155727198|FG000|Stage 1|Withdrawal by Subject|3|||
48419802|NCT02158533|155727199|FG001|Stage 1|Withdrawal by Subject|2|||
48419803|NCT02158533|155727200|FG002|Stage 1|Withdrawal by Subject|1|||
48419804|NCT02158533|155727201|FG003|Stage 1|Withdrawal by Subject|0|||
48419805|NCT02158533|155727202|FG004|Stage 1|Withdrawal by Subject|0|||
48419806|NCT02158533|155727203|FG005|Stage 1|Withdrawal by Subject|0|||
48419807|NCT02158533|155727198|FG000|Stage 1|Lack of Efficacy|1|||
48419808|NCT02158533|155727199|FG001|Stage 1|Lack of Efficacy|0|||
48419809|NCT02158533|155727200|FG002|Stage 1|Lack of Efficacy|0|||
48419810|NCT02158533|155727201|FG003|Stage 1|Lack of Efficacy|0|||
48419811|NCT02158533|155727202|FG004|Stage 1|Lack of Efficacy|0|||
48419812|NCT02158533|155727203|FG005|Stage 1|Lack of Efficacy|0|||
48419813|NCT02158533|155727198|FG000|Stage 1|Lost to Follow-up|3|||
48419814|NCT02158533|155727199|FG001|Stage 1|Lost to Follow-up|1|||
48419815|NCT02158533|155727200|FG002|Stage 1|Lost to Follow-up|0|||
48419816|NCT02158533|155727201|FG003|Stage 1|Lost to Follow-up|0|||
48419817|NCT02158533|155727202|FG004|Stage 1|Lost to Follow-up|0|||
48419818|NCT02158533|155727203|FG005|Stage 1|Lost to Follow-up|0|||
48419819|NCT02158533|155727198|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
48419820|NCT02158533|155727199|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
48419821|NCT02158533|155727200|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
48419822|NCT02158533|155727201|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
48419823|NCT02158533|155727202|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
48419824|NCT02158533|155727203|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
48419825|NCT02158533|155727198|FG000|Stage 1|Non-compliance with study visits|1|||
48419826|NCT02158533|155727199|FG001|Stage 1|Non-compliance with study visits|0|||
48419827|NCT02158533|155727200|FG002|Stage 1|Non-compliance with study visits|0|||
48419828|NCT02158533|155727201|FG003|Stage 1|Non-compliance with study visits|0|||
48419829|NCT02158533|155727202|FG004|Stage 1|Non-compliance with study visits|0|||
48419830|NCT02158533|155727203|FG005|Stage 1|Non-compliance with study visits|0|||
48419831|NCT02158533|155727198|FG000|Stage 2|Adverse Event|0|||
48419832|NCT02158533|155727199|FG001|Stage 2|Adverse Event|0|||
48419833|NCT02158533|155727200|FG002|Stage 2|Adverse Event|0|||
48419834|NCT02158533|155727201|FG003|Stage 2|Adverse Event|0|||
48419835|NCT02158533|155727202|FG004|Stage 2|Adverse Event|0|||
48419836|NCT02158533|155727203|FG005|Stage 2|Adverse Event|1|||
48419837|NCT02158533|155727198|FG000|Stage 2|Lack of Efficacy|0|||
48419838|NCT02158533|155727199|FG001|Stage 2|Lack of Efficacy|0|||
48419839|NCT02158533|155727200|FG002|Stage 2|Lack of Efficacy|0|||
48419840|NCT02158533|155727201|FG003|Stage 2|Lack of Efficacy|0|||
48419841|NCT02158533|155727202|FG004|Stage 2|Lack of Efficacy|1|||
48419842|NCT02158533|155727203|FG005|Stage 2|Lack of Efficacy|0|||
48419843|NCT02158533|155727198|FG000|Stage 2|Lost to Follow-up|0|||
48419844|NCT02158533|155727199|FG001|Stage 2|Lost to Follow-up|0|||
48419845|NCT02158533|155727200|FG002|Stage 2|Lost to Follow-up|0|||
48419846|NCT02158533|155727201|FG003|Stage 2|Lost to Follow-up|1|||
48419847|NCT02158533|155727202|FG004|Stage 2|Lost to Follow-up|1|||
48419848|NCT02158533|155727203|FG005|Stage 2|Lost to Follow-up|2|||
48419849|NCT02158533|155727198|FG000|Stage 2|Withdrawal by Subject|0|||
48419850|NCT02158533|155727199|FG001|Stage 2|Withdrawal by Subject|0|||
48419851|NCT02158533|155727200|FG002|Stage 2|Withdrawal by Subject|0|||
48419852|NCT02158533|155727201|FG003|Stage 2|Withdrawal by Subject|0|||
48419853|NCT02158533|155727202|FG004|Stage 2|Withdrawal by Subject|1|||
48419854|NCT02158533|155727203|FG005|Stage 2|Withdrawal by Subject|2|||
48419855|NCT02158533|155727198|FG000|Stage 2|Physician Decision|0|||
48419856|NCT02158533|155727199|FG001|Stage 2|Physician Decision|0|||
48419857|NCT02158533|155727200|FG002|Stage 2|Physician Decision|0|||
48419858|NCT02158533|155727201|FG003|Stage 2|Physician Decision|0|||
48419859|NCT02158533|155727202|FG004|Stage 2|Physician Decision|1|||
48419860|NCT02158533|155727203|FG005|Stage 2|Physician Decision|0|||
48419861|NCT02158533|155727198|FG000|Stage 2|Pregnancy|0|||
48419862|NCT02158533|155727199|FG001|Stage 2|Pregnancy|0|||
48419863|NCT02158533|155727200|FG002|Stage 2|Pregnancy|0|||
48419864|NCT02158533|155727201|FG003|Stage 2|Pregnancy|1|||
48419865|NCT02158533|155727202|FG004|Stage 2|Pregnancy|0|||
48419866|NCT02158533|155727203|FG005|Stage 2|Pregnancy|0|||
48419867|NCT02158533|155727198|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
48419868|NCT02158533|155727199|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
48419869|NCT02158533|155727200|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
48419870|NCT02158533|155727201|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
48419871|NCT02158533|155727202|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
48419872|NCT02158533|155727203|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
48419873|NCT02158533|155727198|FG000|Stage 2|Non-adherence with study visits|0|||
48419874|NCT02158533|155727199|FG001|Stage 2|Non-adherence with study visits|0|||
48419875|NCT02158533|155727200|FG002|Stage 2|Non-adherence with study visits|0|||
48419876|NCT02158533|155727201|FG003|Stage 2|Non-adherence with study visits|0|||
48419877|NCT02158533|155727202|FG004|Stage 2|Non-adherence with study visits|0|||
48419878|NCT02158533|155727203|FG005|Stage 2|Non-adherence with study visits|1|||
48419879|NCT03842709|155727211|FG000|Overall Study|Withdrawal by Subject|3|||
48419880|NCT03842709|155727212|FG001|Overall Study|Withdrawal by Subject|3|||
48419881|NCT03842709|155727211|FG000|Overall Study|Lost to Follow-up|1|||
48419882|NCT03842709|155727212|FG001|Overall Study|Lost to Follow-up|0|||
48419883|NCT00635102|155727219|FG000|Overall Study|Withdrawal by Subject|7|||
48419884|NCT00635102|155727220|FG001|Overall Study|Withdrawal by Subject|8|||
48419885|NCT00440401|155727221|FG000|Overall Study|Adverse Event|2|||
48419886|NCT00440401|155727222|FG001|Overall Study|Adverse Event|1|||
48419887|NCT00440401|155727221|FG000|Overall Study|Other|2|||
48419888|NCT00440401|155727222|FG001|Overall Study|Other|5|||
48419889|NCT00546351|155727223|FG000|Overall Study|Adverse Event|76|||
48419890|NCT00546351|155727223|FG000|Overall Study|Lack of Efficacy|15|||
48419891|NCT00546351|155727223|FG000|Overall Study|Withdrawal by Subject|109|||
48419892|NCT00546351|155727223|FG000|Overall Study|Lost to Follow-up|9|||
48419893|NCT00546351|155727223|FG000|Overall Study|Protocol Deviation|1|||
48419894|NCT00546351|155727223|FG000|Overall Study|Unsatisfactory compliance|9|||
48419895|NCT00546351|155727223|FG000|Overall Study|Other reasons for premature termination|17|||
48419896|NCT00500071|155727224|FG000|Screening and Washout Phase|Protocol Violation|1|||
48419897|NCT00500071|155727224|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
48419898|NCT00500071|155727224|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
48419899|NCT00500071|155727224|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
48419900|NCT00500071|155727224|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
48419901|NCT00500071|155727224|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
48419902|NCT00500071|155727224|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
48419903|NCT04112914|155727225|FG000|Overall Study|Lost to Follow-up|13|||
48419904|NCT04112914|155727226|FG001|Overall Study|Lost to Follow-up|9|||
48419905|NCT04112914|155727225|FG000|Overall Study|Withdrawal by Subject|1|||
48419906|NCT04112914|155727226|FG001|Overall Study|Withdrawal by Subject|0|||
48419907|NCT01486238|155727234|FG000|Overall Study|Death|0|||
48419908|NCT01486238|155727235|FG001|Overall Study|Death|2|||
48419909|NCT01486238|155727234|FG000|Overall Study|Withdrawal by Subject|2|||
48419910|NCT01486238|155727235|FG001|Overall Study|Withdrawal by Subject|1|||
48419911|NCT01486238|155727234|FG000|Overall Study|Lost to Follow-up|0|||
48419912|NCT01486238|155727235|FG001|Overall Study|Lost to Follow-up|3|||
48419913|NCT02835495|155727236|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
48419914|NCT02835495|155727237|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
48419915|NCT02835495|155727236|FG000|Overall Study|Declined in-person follow-up visit|4|||
48419916|NCT02835495|155727237|FG001|Overall Study|Declined in-person follow-up visit|2|||
48419917|NCT02614794|155727238|FG000|Overall Study|Death|258|||
48419918|NCT02614794|155727239|FG001|Overall Study|Death|151|||
48419919|NCT02614794|155727238|FG000|Overall Study|Study closure by Sponsor|119|||
48419920|NCT02614794|155727239|FG001|Overall Study|Study closure by Sponsor|45|||
48419921|NCT02614794|155727238|FG000|Overall Study|Withdrawal by Subject|24|||
48419922|NCT02614794|155727239|FG001|Overall Study|Withdrawal by Subject|5|||
48419923|NCT02614794|155727238|FG000|Overall Study|Lost to Follow-up|7|||
48419924|NCT02614794|155727239|FG001|Overall Study|Lost to Follow-up|0|||
48419925|NCT02614794|155727238|FG000|Overall Study|Physician Decision|1|||
48419926|NCT02614794|155727239|FG001|Overall Study|Physician Decision|1|||
48419927|NCT02614794|155727238|FG000|Overall Study|Hospital closure|1|||
48419928|NCT02614794|155727239|FG001|Overall Study|Hospital closure|0|||
48419929|NCT00095303|155727240|FG000|Main Study|Lost to Follow-up|91|||
48419930|NCT00095303|155727241|FG001|Main Study|Lost to Follow-up|87|||
48419931|NCT00095303|155727240|FG000|Follow Up Study|Lost to Follow-up|59|||
48419932|NCT00095303|155727241|FG001|Follow Up Study|Lost to Follow-up|58|||
48419933|NCT01364467|155727242|FG000|Overall Study|Lost to Follow-up|1|||
48419934|NCT01364467|155727243|FG001|Overall Study|Lost to Follow-up|2|||
48419935|NCT03228186|155727244|FG000|Overall Study|Patient never started treatment|1|||
48419936|NCT01634243|155727247|FG000|Overall Study|Adverse Event|5|||
48419937|NCT01634243|155727248|FG001|Overall Study|Adverse Event|5|||
48419938|NCT01634243|155727247|FG000|Overall Study|Lack of Efficacy|1|||
48419939|NCT01634243|155727248|FG001|Overall Study|Lack of Efficacy|0|||
48419940|NCT01670500|155727249|FG000|Overall Study|Withdrawal by Subject|1|||
48419941|NCT01670500|155727250|FG001|Overall Study|Withdrawal by Subject|0|||
48419942|NCT00491530|155727256|FG000|Overall Study|Adverse Event|6|||
48419943|NCT00491530|155727257|FG001|Overall Study|Adverse Event|1|||
48419944|NCT00491530|155727258|FG002|Overall Study|Adverse Event|2|||
48419945|NCT00491530|155727256|FG000|Overall Study|Withdrawal by Subject|3|||
48419946|NCT00491530|155727257|FG001|Overall Study|Withdrawal by Subject|0|||
48419947|NCT00491530|155727258|FG002|Overall Study|Withdrawal by Subject|0|||
48419948|NCT00491530|155727256|FG000|Overall Study|Lost to Follow-up|3|||
48419949|NCT00491530|155727257|FG001|Overall Study|Lost to Follow-up|2|||
48419950|NCT00491530|155727258|FG002|Overall Study|Lost to Follow-up|2|||
48419951|NCT00491530|155727256|FG000|Overall Study|Lack of Efficacy|0|||
48419952|NCT00491530|155727257|FG001|Overall Study|Lack of Efficacy|1|||
48419953|NCT00491530|155727258|FG002|Overall Study|Lack of Efficacy|0|||
48419954|NCT00491530|155727256|FG000|Overall Study|Investigator Discretion|0|||
48419955|NCT00491530|155727257|FG001|Overall Study|Investigator Discretion|1|||
48419956|NCT00491530|155727258|FG002|Overall Study|Investigator Discretion|0|||
48419957|NCT00491530|155727256|FG000|Overall Study|Patient Request|0|||
48419958|NCT00491530|155727257|FG001|Overall Study|Patient Request|1|||
48419959|NCT00491530|155727258|FG002|Overall Study|Patient Request|0|||
48419960|NCT00491530|155727256|FG000|Overall Study|Use of Prohibited Medication|0|||
48419961|NCT00491530|155727257|FG001|Overall Study|Use of Prohibited Medication|0|||
48419962|NCT00491530|155727258|FG002|Overall Study|Use of Prohibited Medication|1|||
48419963|NCT03114969|155727261|FG000|Overall Study|Lost to Follow-up|0|||
48419964|NCT03114969|155727262|FG001|Overall Study|Lost to Follow-up|0|||
48419965|NCT03114969|155727263|FG002|Overall Study|Lost to Follow-up|3|||
48419966|NCT03114969|155727264|FG003|Overall Study|Lost to Follow-up|2|||
48419967|NCT03114969|155727265|FG004|Overall Study|Lost to Follow-up|0|||
48419968|NCT03114969|155727266|FG005|Overall Study|Lost to Follow-up|0|||
48419969|NCT03114969|155727267|FG006|Overall Study|Lost to Follow-up|0|||
48419970|NCT03114969|155727268|FG007|Overall Study|Lost to Follow-up|0|||
48419971|NCT03114969|155727269|FG008|Overall Study|Lost to Follow-up|0|||
48419972|NCT03114969|155727261|FG000|Overall Study|Adverse Event|0|||
48419973|NCT03114969|155727262|FG001|Overall Study|Adverse Event|0|||
48419974|NCT03114969|155727263|FG002|Overall Study|Adverse Event|1|||
48419975|NCT03114969|155727264|FG003|Overall Study|Adverse Event|0|||
48419976|NCT03114969|155727265|FG004|Overall Study|Adverse Event|0|||
48419977|NCT03114969|155727266|FG005|Overall Study|Adverse Event|1|||
48419978|NCT03114969|155727267|FG006|Overall Study|Adverse Event|1|||
48419979|NCT03114969|155727268|FG007|Overall Study|Adverse Event|0|||
48419980|NCT03114969|155727269|FG008|Overall Study|Adverse Event|2|||
48419981|NCT02436239|155727270|FG000|Open-Lable Treatment Period|Adverse Event|12|||
48419982|NCT02436239|155727271|FG001|Open-Lable Treatment Period|Adverse Event|3|||
48419983|NCT02436239|155727272|FG002|Open-Lable Treatment Period|Adverse Event|4|||
48419984|NCT02436239|155727273|FG003|Open-Lable Treatment Period|Adverse Event|2|||
48419985|NCT02436239|155727270|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
48419986|NCT02436239|155727271|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
48419987|NCT02436239|155727272|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
48419988|NCT02436239|155727273|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
48419989|NCT02436239|155727270|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
48419990|NCT02436239|155727271|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
48419991|NCT02436239|155727272|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
48419992|NCT02436239|155727273|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
48419993|NCT02436239|155727270|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
48419994|NCT02436239|155727271|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
48419995|NCT02436239|155727272|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
48419996|NCT02436239|155727273|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
48419997|NCT02436239|155727270|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
48419998|NCT02436239|155727271|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
48419999|NCT02436239|155727272|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
48420000|NCT02436239|155727273|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
48420001|NCT02436239|155727270|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
48420002|NCT02436239|155727271|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
48420003|NCT02436239|155727272|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
48420004|NCT02436239|155727273|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
48420005|NCT02436239|155727270|FG000|Open-Lable Treatment Period|Other Reason|1|||
48420006|NCT02436239|155727271|FG001|Open-Lable Treatment Period|Other Reason|1|||
48420007|NCT02436239|155727272|FG002|Open-Lable Treatment Period|Other Reason|0|||
48420008|NCT02436239|155727273|FG003|Open-Lable Treatment Period|Other Reason|0|||
48420009|NCT02436239|155727270|FG000|Down-Taper Period|Withdrawal by Subject|4|||
48420010|NCT02436239|155727271|FG001|Down-Taper Period|Withdrawal by Subject|4|||
48420011|NCT02436239|155727272|FG002|Down-Taper Period|Withdrawal by Subject|1|||
48420012|NCT02436239|155727273|FG003|Down-Taper Period|Withdrawal by Subject|2|||
48420013|NCT00414440|155727276|FG000|Core Period|Withdrawal by Subject|70|||
48420014|NCT00414440|155727277|FG001|Core Period|Withdrawal by Subject|32|||
48420015|NCT00414440|155727276|FG000|Extension Period|Lost to Follow-up|44|||
48420016|NCT00414440|155727277|FG001|Extension Period|Lost to Follow-up|52|||
48420017|NCT00414440|155727276|FG000|Extension Period|Did not consent to continue follow up|61|||
48420018|NCT00414440|155727277|FG001|Extension Period|Did not consent to continue follow up|54|||
48420019|NCT00414440|155727276|FG000|Extension Period|Other|1|||
48420020|NCT00414440|155727277|FG001|Extension Period|Other|1|||
48420021|NCT00414440|155727276|FG000|Extension Period|Administrative|16|||
48420022|NCT00414440|155727277|FG001|Extension Period|Administrative|16|||
48420023|NCT00414440|155727276|FG000|Extension Period|Death|1|||
48420024|NCT00414440|155727277|FG001|Extension Period|Death|2|||
48420025|NCT00414440|155727276|FG000|Extension Period|Withdrawal by Subject|9|||
48420026|NCT00414440|155727277|FG001|Extension Period|Withdrawal by Subject|7|||
48420027|NCT00414440|155727276|FG000|Extension Period|Not included in follow up period|18|||
48420028|NCT00414440|155727277|FG001|Extension Period|Not included in follow up period|8|||
48420029|NCT01088412|155727278|FG000|Overall Study|Adverse Event|38|||
48420030|NCT01088412|155727279|FG001|Overall Study|Adverse Event|0|||
48420031|NCT01088412|155727280|FG002|Overall Study|Adverse Event|0|||
48420032|NCT01088412|155727278|FG000|Overall Study|Death|42|||
48420033|NCT01088412|155727279|FG001|Overall Study|Death|6|||
48420034|NCT01088412|155727280|FG002|Overall Study|Death|0|||
48420035|NCT01088412|155727278|FG000|Overall Study|Other Reason per Case Report Form|2089|||
48420036|NCT01088412|155727279|FG001|Overall Study|Other Reason per Case Report Form|103|||
48420037|NCT01088412|155727280|FG002|Overall Study|Other Reason per Case Report Form|9|||
48420038|NCT01088412|155727278|FG000|Overall Study|Withdrawal by Subject|1761|||
48420039|NCT01088412|155727279|FG001|Overall Study|Withdrawal by Subject|25|||
48420040|NCT01088412|155727280|FG002|Overall Study|Withdrawal by Subject|1|||
48420041|NCT01088412|155727278|FG000|Overall Study|Received Another GH Product|79|||
48420042|NCT01088412|155727279|FG001|Overall Study|Received Another GH Product|0|||
48420043|NCT01088412|155727280|FG002|Overall Study|Received Another GH Product|0|||
48420044|NCT01088412|155727278|FG000|Overall Study|Participant Moved|601|||
48420045|NCT01088412|155727279|FG001|Overall Study|Participant Moved|21|||
48420046|NCT01088412|155727280|FG002|Overall Study|Participant Moved|2|||
48420047|NCT01088412|155727278|FG000|Overall Study|Physician Decision|1041|||
48420048|NCT01088412|155727279|FG001|Overall Study|Physician Decision|8|||
48420049|NCT01088412|155727280|FG002|Overall Study|Physician Decision|4|||
48420050|NCT01088412|155727278|FG000|Overall Study|Sponsor Decision|4467|||
48420051|NCT01088412|155727279|FG001|Overall Study|Sponsor Decision|79|||
48420052|NCT01088412|155727280|FG002|Overall Study|Sponsor Decision|23|||
48420053|NCT01088412|155727278|FG000|Overall Study|Third Party Required to Change Brand|487|||
48420054|NCT01088412|155727279|FG001|Overall Study|Third Party Required to Change Brand|0|||
48420055|NCT01088412|155727280|FG002|Overall Study|Third Party Required to Change Brand|0|||
48420056|NCT01088412|155727278|FG000|Overall Study|Lost to Follow-up|3052|||
48420057|NCT01088412|155727279|FG001|Overall Study|Lost to Follow-up|130|||
48420058|NCT01088412|155727280|FG002|Overall Study|Lost to Follow-up|11|||
48420059|NCT01088412|155727278|FG000|Overall Study|Study Summary Not Completed|4360|||
48420060|NCT01088412|155727279|FG001|Overall Study|Study Summary Not Completed|64|||
48420061|NCT01088412|155727280|FG002|Overall Study|Study Summary Not Completed|22|||
48420062|NCT02285010|155727281|FG000|Overall Study|not abdominal hysterectomy|2|||
48420063|NCT02285010|155727282|FG001|Overall Study|not abdominal hysterectomy|0|||
48420064|NCT02285010|155727281|FG000|Overall Study|Not spinal anesthesia|3|||
48420065|NCT02285010|155727282|FG001|Overall Study|Not spinal anesthesia|1|||
48420066|NCT02515669|155727283|FG000|228 Week Open-Label Phase|Other|0|||
48420067|NCT02515669|155727284|FG001|228 Week Open-Label Phase|Other|0|||
48420068|NCT02515669|155727285|FG002|228 Week Open-Label Phase|Other|1|||
48420069|NCT02515669|155727286|FG003|228 Week Open-Label Phase|Other|4|||
48420070|NCT02515669|155727283|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
48420071|NCT02515669|155727284|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
48420072|NCT02515669|155727285|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
48420073|NCT02515669|155727286|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
48420074|NCT02515669|155727283|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
48420075|NCT02515669|155727284|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
48420076|NCT02515669|155727285|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
48420077|NCT02515669|155727286|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
48420078|NCT02515669|155727283|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
48420079|NCT02515669|155727284|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
48420080|NCT02515669|155727285|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
48420081|NCT02515669|155727286|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
48420082|NCT02515669|155727283|FG000|228 Week Open-Label Phase|Missing|0|||
48420083|NCT02515669|155727284|FG001|228 Week Open-Label Phase|Missing|2|||
48420084|NCT02515669|155727285|FG002|228 Week Open-Label Phase|Missing|2|||
48420085|NCT02515669|155727286|FG003|228 Week Open-Label Phase|Missing|2|||
48420086|NCT00393458|155727289|FG000|Overall Study|Adverse Event|35|||
48420087|NCT00393458|155727290|FG001|Overall Study|Adverse Event|24|||
48420088|NCT00393458|155727291|FG002|Overall Study|Adverse Event|40|||
48420089|NCT00393458|155727292|FG003|Overall Study|Adverse Event|35|||
48420090|NCT00393458|155727289|FG000|Overall Study|Subject withdrew consent|27|||
48420091|NCT00393458|155727290|FG001|Overall Study|Subject withdrew consent|40|||
48420092|NCT00393458|155727291|FG002|Overall Study|Subject withdrew consent|33|||
48420093|NCT00393458|155727292|FG003|Overall Study|Subject withdrew consent|50|||
48420094|NCT00393458|155727289|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
48420095|NCT00393458|155727290|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
48420096|NCT00393458|155727291|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
48420097|NCT00393458|155727292|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
48420098|NCT00393458|155727289|FG000|Overall Study|Protocol deviation|11|||
48420099|NCT00393458|155727290|FG001|Overall Study|Protocol deviation|11|||
48420100|NCT00393458|155727291|FG002|Overall Study|Protocol deviation|11|||
48420101|NCT00393458|155727292|FG003|Overall Study|Protocol deviation|10|||
48420102|NCT00393458|155727289|FG000|Overall Study|Administrative problems|7|||
48420103|NCT00393458|155727290|FG001|Overall Study|Administrative problems|8|||
48420104|NCT00393458|155727291|FG002|Overall Study|Administrative problems|5|||
48420105|NCT00393458|155727292|FG003|Overall Study|Administrative problems|2|||
48420106|NCT00393458|155727289|FG000|Overall Study|Lost to Follow-up|5|||
48420107|NCT00393458|155727290|FG001|Overall Study|Lost to Follow-up|6|||
48420108|NCT00393458|155727291|FG002|Overall Study|Lost to Follow-up|5|||
48420109|NCT00393458|155727292|FG003|Overall Study|Lost to Follow-up|3|||
48420110|NCT00393458|155727289|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48420111|NCT00393458|155727290|FG001|Overall Study|Abnormal laboratory value(s)|1|||
48420112|NCT00393458|155727291|FG002|Overall Study|Abnormal laboratory value(s)|0|||
48420113|NCT00393458|155727292|FG003|Overall Study|Abnormal laboratory value(s)|0|||
48420114|NCT00393458|155727289|FG000|Overall Study|Death|1|||
48420115|NCT00393458|155727290|FG001|Overall Study|Death|1|||
48420116|NCT00393458|155727291|FG002|Overall Study|Death|5|||
48420117|NCT00393458|155727292|FG003|Overall Study|Death|5|||
48420118|NCT00393458|155727289|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48420119|NCT00393458|155727290|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48420120|NCT00393458|155727291|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48420121|NCT00393458|155727292|FG003|Overall Study|Abnormal test procedure result(s)|2|||
48420122|NCT00393458|155727289|FG000|Overall Study|Subject no longer requires study drug|0|||
48420123|NCT00393458|155727290|FG001|Overall Study|Subject no longer requires study drug|1|||
48420124|NCT00393458|155727291|FG002|Overall Study|Subject no longer requires study drug|0|||
48420125|NCT00393458|155727292|FG003|Overall Study|Subject no longer requires study drug|0|||
48420126|NCT01507246|155727293|FG000|Overall Study|Required different surgical procedures|2|||
48420127|NCT01507246|155727294|FG001|Overall Study|Required different surgical procedures|1|||
48420128|NCT01739595|155727295|FG000|Overall Study|Adverse Event|3|||
48420129|NCT01739595|155727296|FG001|Overall Study|Adverse Event|0|||
48420130|NCT01739595|155727297|FG002|Overall Study|Adverse Event|0|||
48420131|NCT01739595|155727295|FG000|Overall Study|Lost to Follow-up|2|||
48420132|NCT01739595|155727296|FG001|Overall Study|Lost to Follow-up|0|||
48420133|NCT01739595|155727297|FG002|Overall Study|Lost to Follow-up|0|||
48420134|NCT01739595|155727295|FG000|Overall Study|Withdrawal by Subject|2|||
48420135|NCT01739595|155727296|FG001|Overall Study|Withdrawal by Subject|1|||
48420136|NCT01739595|155727297|FG002|Overall Study|Withdrawal by Subject|2|||
48420137|NCT01739595|155727295|FG000|Overall Study|Eligibility issue|3|||
48420138|NCT01739595|155727296|FG001|Overall Study|Eligibility issue|0|||
48420139|NCT01739595|155727297|FG002|Overall Study|Eligibility issue|0|||
48420140|NCT01739595|155727295|FG000|Overall Study|Protocol Violation|1|||
48420141|NCT01739595|155727296|FG001|Overall Study|Protocol Violation|0|||
48420142|NCT01739595|155727297|FG002|Overall Study|Protocol Violation|0|||
48420143|NCT01739595|155727295|FG000|Overall Study|Lab assessment|1|||
48420144|NCT01739595|155727296|FG001|Overall Study|Lab assessment|0|||
48420145|NCT01739595|155727297|FG002|Overall Study|Lab assessment|0|||
48420146|NCT01739595|155727295|FG000|Overall Study|Drug discrepancy|1|||
48420147|NCT01739595|155727296|FG001|Overall Study|Drug discrepancy|0|||
48420148|NCT01739595|155727297|FG002|Overall Study|Drug discrepancy|0|||
48420149|NCT00957372|155727298|FG000|PART I|Lost to Follow-up|0|||
48420150|NCT00957372|155727299|FG001|PART I|Lost to Follow-up|0|||
48420151|NCT00957372|155727300|FG002|PART I|Lost to Follow-up|1|||
48420152|NCT00957372|155727301|FG003|PART I|Lost to Follow-up|0|||
48420153|NCT00957372|155727298|FG000|PART II|Withdrawal by Subject|0|||
48420154|NCT00957372|155727299|FG001|PART II|Withdrawal by Subject|0|||
48420155|NCT00957372|155727300|FG002|PART II|Withdrawal by Subject|0|||
48420156|NCT00957372|155727301|FG003|PART II|Withdrawal by Subject|8|||
48420157|NCT00957372|155727298|FG000|PART II|Physician Decision|0|||
48420158|NCT00957372|155727299|FG001|PART II|Physician Decision|0|||
48420159|NCT00957372|155727300|FG002|PART II|Physician Decision|0|||
48420160|NCT00957372|155727301|FG003|PART II|Physician Decision|1|||
48420161|NCT00957372|155727298|FG000|PART II|Pregnancy|0|||
48420162|NCT00957372|155727299|FG001|PART II|Pregnancy|0|||
48420163|NCT00957372|155727300|FG002|PART II|Pregnancy|0|||
48420164|NCT00957372|155727301|FG003|PART II|Pregnancy|1|||
48420165|NCT00957372|155727298|FG000|PART II|Not Know|0|||
48420166|NCT00957372|155727299|FG001|PART II|Not Know|0|||
48420167|NCT00957372|155727300|FG002|PART II|Not Know|0|||
48420168|NCT00957372|155727301|FG003|PART II|Not Know|20|||
48420169|NCT00957372|155727298|FG000|PART II|Adverse Event|0|||
48420170|NCT00957372|155727299|FG001|PART II|Adverse Event|0|||
48420171|NCT00957372|155727300|FG002|PART II|Adverse Event|0|||
48420172|NCT00957372|155727301|FG003|PART II|Adverse Event|10|||
48420173|NCT00957372|155727298|FG000|PART II|Patient non-compliance|0|||
48420174|NCT00957372|155727299|FG001|PART II|Patient non-compliance|0|||
48420175|NCT00957372|155727300|FG002|PART II|Patient non-compliance|0|||
48420176|NCT00957372|155727301|FG003|PART II|Patient non-compliance|4|||
48420177|NCT02403206|155727308|FG000|Overall Study|Lost to Follow-up|4|||
48420178|NCT02403206|155727309|FG001|Overall Study|Lost to Follow-up|3|||
48420179|NCT02403206|155727308|FG000|Overall Study|Physician Decision|2|||
48420180|NCT02403206|155727309|FG001|Overall Study|Physician Decision|0|||
48420181|NCT02403206|155727308|FG000|Overall Study|Withdrawal by Subject|3|||
48420182|NCT02403206|155727309|FG001|Overall Study|Withdrawal by Subject|3|||
48420183|NCT02403206|155727308|FG000|Overall Study|Reason not given|2|||
48420184|NCT02403206|155727309|FG001|Overall Study|Reason not given|4|||
48420185|NCT01282814|155727310|FG000|First Intervention|Emesis During Dosing Interval|0|||
48420186|NCT01282814|155727311|FG001|First Intervention|Emesis During Dosing Interval|3|||
48420187|NCT01282814|155727310|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
48420188|NCT01282814|155727311|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
48420189|NCT01524289|155727314|FG000|Overall Study|Lost to Follow-up|0|||
48420190|NCT01524289|155727315|FG001|Overall Study|Lost to Follow-up|1|||
48420191|NCT01524289|155727314|FG000|Overall Study|Physician Decision|1|||
48420192|NCT01524289|155727315|FG001|Overall Study|Physician Decision|0|||
48420193|NCT01524289|155727314|FG000|Overall Study|Protocol Violation|5|||
48420194|NCT01524289|155727315|FG001|Overall Study|Protocol Violation|1|||
48420195|NCT01524289|155727314|FG000|Overall Study|Withdrawal by Subject|11|||
48420196|NCT01524289|155727315|FG001|Overall Study|Withdrawal by Subject|7|||
48420197|NCT01524289|155727314|FG000|Overall Study|Adverse Event|12|||
48420198|NCT01524289|155727315|FG001|Overall Study|Adverse Event|5|||
48420199|NCT01524289|155727314|FG000|Overall Study|Did not take study medication|1|||
48420200|NCT01524289|155727315|FG001|Overall Study|Did not take study medication|0|||
48420201|NCT02104180|155727316|FG000|Overall Study|Protocol Violation|1|||
48420202|NCT02104180|155727317|FG001|Overall Study|Protocol Violation|0|||
48420203|NCT01444391|155727318|FG000|Overall Study|Death|1|||
48420204|NCT03750838|155727319|FG000|Overall Study|Lost to Follow-up|10|||
48420205|NCT03750838|155727320|FG001|Overall Study|Lost to Follow-up|6|||
48420206|NCT03067311|155727323|FG000|Overall Study|Lost to Follow-up|1|||
48420207|NCT03067311|155727324|FG001|Overall Study|Lost to Follow-up|1|||
48420208|NCT03067311|155727323|FG000|Overall Study|Moved away|1|||
48420209|NCT03067311|155727324|FG001|Overall Study|Moved away|1|||
48420210|NCT01938625|155729219|FG000|Overall Study|Withdrawal by Subject|0|||
48420211|NCT01938625|155729220|FG001|Overall Study|Withdrawal by Subject|1|||
48420212|NCT01938625|155729219|FG000|Overall Study|Adverse Event|0|||
48420213|NCT01938625|155729220|FG001|Overall Study|Adverse Event|1|||
48420214|NCT00728416|155729226|FG000|Overall Study|Adverse Event|1|||
48420215|NCT00728416|155729227|FG001|Overall Study|Adverse Event|1|||
48420216|NCT00728416|155729226|FG000|Overall Study|Treatment Failure|0|||
48420217|NCT00728416|155729227|FG001|Overall Study|Treatment Failure|1|||
48420218|NCT00728416|155729226|FG000|Overall Study|Withdrawal by Subject|1|||
48420219|NCT00728416|155729227|FG001|Overall Study|Withdrawal by Subject|0|||
48420220|NCT00881205|155729228|FG000|Overall Study|Adverse Event|8|||
48420221|NCT00881205|155729229|FG001|Overall Study|Adverse Event|3|||
48420222|NCT00881205|155729228|FG000|Overall Study|Withdrawal by Subject|1|||
48420223|NCT00881205|155729229|FG001|Overall Study|Withdrawal by Subject|2|||
48420224|NCT00881205|155729228|FG000|Overall Study|Lost to Follow-up|0|||
48420225|NCT00881205|155729229|FG001|Overall Study|Lost to Follow-up|1|||
48420226|NCT00881205|155729228|FG000|Overall Study|Administrative problems|1|||
48420227|NCT00881205|155729229|FG001|Overall Study|Administrative problems|1|||
48420228|NCT00881205|155729228|FG000|Overall Study|Condition no longer requires drug|1|||
48420229|NCT00881205|155729229|FG001|Overall Study|Condition no longer requires drug|0|||
48420230|NCT00545818|155729233|FG000|Overall Study|Protocol Violation|1|||
48420231|NCT00545818|155729234|FG001|Overall Study|Protocol Violation|0|||
48420232|NCT00545818|155729233|FG000|Overall Study|Adverse Event|1|||
48420233|NCT00545818|155729234|FG001|Overall Study|Adverse Event|1|||
48420234|NCT00545818|155729233|FG000|Overall Study|Lost to Follow-up|1|||
48420235|NCT00545818|155729234|FG001|Overall Study|Lost to Follow-up|6|||
48420236|NCT00844883|155729238|FG000|Overall Study|Bridged to liver transplant|3|||
48420237|NCT00844883|155729238|FG000|Overall Study|Bridged to resection|1|||
48420238|NCT02498652|155729241|FG000|Overall Study|Protocol Violation|0|||
48420239|NCT02498652|155729242|FG001|Overall Study|Protocol Violation|1|||
48420240|NCT04334148|155729248|FG000|Overall Study|positive nasal swab at baseline|0|||
48420241|NCT04334148|155729249|FG001|Overall Study|positive nasal swab at baseline|1|||
48420242|NCT01508676|155729250|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
48420243|NCT01508676|155729251|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
48420244|NCT01508676|155729250|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
48420245|NCT01508676|155729251|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
48420246|NCT01508676|155729250|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
48420247|NCT01508676|155729251|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
48420248|NCT01508676|155729250|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
48420249|NCT01508676|155729251|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
48420250|NCT01508676|155729250|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
48420251|NCT01508676|155729251|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
48420252|NCT04101422|155729253|FG000|Overall Study|Ineligible|1|||
48420253|NCT04101422|155729254|FG001|Overall Study|Ineligible|0|||
48420254|NCT04101422|155729255|FG002|Overall Study|Ineligible|9|||
48420255|NCT04101422|155729256|FG003|Overall Study|Ineligible|0|||
48420256|NCT04101422|155729253|FG000|Overall Study|Withdrawal by Subject|0|||
48420257|NCT04101422|155729254|FG001|Overall Study|Withdrawal by Subject|0|||
48420258|NCT04101422|155729255|FG002|Overall Study|Withdrawal by Subject|1|||
48420259|NCT04101422|155729256|FG003|Overall Study|Withdrawal by Subject|0|||
48420260|NCT04101422|155729253|FG000|Overall Study|Not attending to the stimuli|0|||
48420261|NCT04101422|155729254|FG001|Overall Study|Not attending to the stimuli|0|||
48420262|NCT04101422|155729255|FG002|Overall Study|Not attending to the stimuli|4|||
48420263|NCT04101422|155729256|FG003|Overall Study|Not attending to the stimuli|0|||
48420264|NCT04101422|155729253|FG000|Overall Study|Did not download app|0|||
48420265|NCT04101422|155729254|FG001|Overall Study|Did not download app|0|||
48420266|NCT04101422|155729255|FG002|Overall Study|Did not download app|0|||
48420267|NCT04101422|155729256|FG003|Overall Study|Did not download app|17|||
48420268|NCT04101422|155729253|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
48420269|NCT04101422|155729254|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
48420270|NCT04101422|155729255|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
48420271|NCT04101422|155729256|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
48420272|NCT01720667|155729259|FG000|Overall Study|Adverse Event|1|||
48420273|NCT01720667|155729260|FG001|Overall Study|Adverse Event|1|||
48420274|NCT01720667|155729259|FG000|Overall Study|Withdrawal by Subject|3|||
48420275|NCT01720667|155729260|FG001|Overall Study|Withdrawal by Subject|0|||
48420276|NCT00850499|155729261|FG000|Overall Study|Adverse Event|3|||
48420277|NCT00850499|155729262|FG001|Overall Study|Adverse Event|1|||
48420278|NCT00850499|155729261|FG000|Overall Study|Lack of Efficacy|0|||
48420279|NCT00850499|155729262|FG001|Overall Study|Lack of Efficacy|1|||
48420280|NCT00552305|155729267|FG000|Overall Study|Adverse Event|43|||
48420281|NCT00552305|155729267|FG000|Overall Study|Lack of Efficacy|120|||
48420282|NCT00552305|155729267|FG000|Overall Study|Lost to Follow-up|4|||
48420283|NCT00552305|155729267|FG000|Overall Study|Protocol Violation|3|||
48420284|NCT00552305|155729267|FG000|Overall Study|Withdrawal by Subject|44|||
48420285|NCT00552305|155729267|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
48420286|NCT00552305|155729267|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
48420287|NCT00552305|155729267|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
48420288|NCT00552305|155729267|FG000|Overall Study|Unsatisfactory compliance|11|||
48420289|NCT00552305|155729267|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
48420290|NCT00552305|155729267|FG000|Overall Study|AE/Other: prohibited drug required|1|||
48420291|NCT00552305|155729267|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
48420292|NCT00552305|155729267|FG000|Overall Study|Other: Site closed|4|||
48420293|NCT00552305|155729267|FG000|Overall Study|Other: Personal problems|1|||
48420294|NCT00552305|155729267|FG000|Overall Study|Other: Unable to attend visits|1|||
48420295|NCT00552305|155729267|FG000|Overall Study|Other: Subject underwent surgery|4|||
48420296|NCT00552305|155729267|FG000|Overall Study|Other: Subject became pregnant|1|||
48420297|NCT00552305|155729267|FG000|Overall Study|Other: Health problems, not drug related|1|||
48420298|NCT00552305|155729267|FG000|Overall Study|Other: Subject moved from area|2|||
48420299|NCT00552305|155729267|FG000|Overall Study|Other: Subject incarcerated|1|||
48420300|NCT00552305|155729267|FG000|Overall Study|Other: Subject went to rehab|1|||
48420301|NCT04498910|155729268|FG000|Overall Study|Lost to Follow-up|0|||
48420302|NCT04498910|155729269|FG001|Overall Study|Lost to Follow-up|1|||
48420303|NCT04498910|155729268|FG000|Overall Study|Withdrawal by Subject|2|||
48420304|NCT04498910|155729269|FG001|Overall Study|Withdrawal by Subject|1|||
48420305|NCT04498910|155729268|FG000|Overall Study|Adverse Event|1|||
48420306|NCT04498910|155729269|FG001|Overall Study|Adverse Event|0|||
48420307|NCT02902809|155729274|FG000|Overall Study|Discontinuation of asthma program|28|||
48420308|NCT02782715|155729275|FG000|Overall Study|Withdrawal by Subject|1|||
48420309|NCT00069121|155729279|FG000|Overall Study|Death|286|||
48420310|NCT00069121|155729280|FG001|Overall Study|Death|242|||
48420311|NCT00069121|155729279|FG000|Overall Study|Withdrawal by Subject|18|||
48420312|NCT00069121|155729280|FG001|Overall Study|Withdrawal by Subject|20|||
48420313|NCT00069121|155729279|FG000|Overall Study|Lost to Follow-up|63|||
48420314|NCT00069121|155729280|FG001|Overall Study|Lost to Follow-up|63|||
48420315|NCT01208181|155729281|FG000|Part 1|Withdrawal by Subject|11|||
48420316|NCT01208181|155729282|FG001|Part 1|Withdrawal by Subject|10|||
48420317|NCT01208181|155729283|FG002|Part 1|Withdrawal by Subject|0|||
48420318|NCT01208181|155729284|FG003|Part 1|Withdrawal by Subject|0|||
48420319|NCT01208181|155729285|FG004|Part 1|Withdrawal by Subject|0|||
48420320|NCT01208181|155729281|FG000|Part 1|Technical problem|5|||
48420321|NCT01208181|155729282|FG001|Part 1|Technical problem|0|||
48420322|NCT01208181|155729283|FG002|Part 1|Technical problem|0|||
48420323|NCT01208181|155729284|FG003|Part 1|Technical problem|0|||
48420324|NCT01208181|155729285|FG004|Part 1|Technical problem|0|||
48420325|NCT01208181|155729281|FG000|Part 1|Protocol Violation|10|||
48420326|NCT01208181|155729282|FG001|Part 1|Protocol Violation|5|||
48420327|NCT01208181|155729283|FG002|Part 1|Protocol Violation|0|||
48420328|NCT01208181|155729284|FG003|Part 1|Protocol Violation|0|||
48420329|NCT01208181|155729285|FG004|Part 1|Protocol Violation|0|||
48420330|NCT01208181|155729281|FG000|Part 1|Physician Decision|4|||
48420331|NCT01208181|155729282|FG001|Part 1|Physician Decision|0|||
48420332|NCT01208181|155729283|FG002|Part 1|Physician Decision|0|||
48420333|NCT01208181|155729284|FG003|Part 1|Physician Decision|0|||
48420334|NCT01208181|155729285|FG004|Part 1|Physician Decision|0|||
48420335|NCT01208181|155729281|FG000|Part 1|Non-compliance with study drug|1|||
48420336|NCT01208181|155729282|FG001|Part 1|Non-compliance with study drug|1|||
48420337|NCT01208181|155729283|FG002|Part 1|Non-compliance with study drug|0|||
48420338|NCT01208181|155729284|FG003|Part 1|Non-compliance with study drug|0|||
48420339|NCT01208181|155729285|FG004|Part 1|Non-compliance with study drug|0|||
48420340|NCT01208181|155729281|FG000|Part 1|Lost to Follow-up|5|||
48420341|NCT01208181|155729282|FG001|Part 1|Lost to Follow-up|3|||
48420342|NCT01208181|155729283|FG002|Part 1|Lost to Follow-up|0|||
48420343|NCT01208181|155729284|FG003|Part 1|Lost to Follow-up|0|||
48420344|NCT01208181|155729285|FG004|Part 1|Lost to Follow-up|1|||
48420345|NCT01208181|155729281|FG000|Part 1|Lack of Efficacy|37|||
48420346|NCT01208181|155729282|FG001|Part 1|Lack of Efficacy|12|||
48420347|NCT01208181|155729283|FG002|Part 1|Lack of Efficacy|0|||
48420348|NCT01208181|155729284|FG003|Part 1|Lack of Efficacy|0|||
48420349|NCT01208181|155729285|FG004|Part 1|Lack of Efficacy|17|||
48420350|NCT01208181|155729281|FG000|Part 1|Adverse Event|26|||
48420351|NCT01208181|155729282|FG001|Part 1|Adverse Event|24|||
48420352|NCT01208181|155729283|FG002|Part 1|Adverse Event|0|||
48420353|NCT01208181|155729284|FG003|Part 1|Adverse Event|0|||
48420354|NCT01208181|155729285|FG004|Part 1|Adverse Event|4|||
48420355|NCT01208181|155729281|FG000|Part 2|Adverse Event|0|||
48420356|NCT01208181|155729282|FG001|Part 2|Adverse Event|0|||
48420357|NCT01208181|155729283|FG002|Part 2|Adverse Event|6|||
48420358|NCT01208181|155729284|FG003|Part 2|Adverse Event|7|||
48420359|NCT01208181|155729285|FG004|Part 2|Adverse Event|0|||
48420360|NCT01208181|155729281|FG000|Part 2|Withdrawal by Subject|0|||
48420361|NCT01208181|155729282|FG001|Part 2|Withdrawal by Subject|0|||
48420362|NCT01208181|155729283|FG002|Part 2|Withdrawal by Subject|1|||
48420363|NCT01208181|155729284|FG003|Part 2|Withdrawal by Subject|1|||
48420364|NCT01208181|155729285|FG004|Part 2|Withdrawal by Subject|0|||
48420365|NCT01208181|155729281|FG000|Part 2|Protocol Violation|0|||
48420366|NCT01208181|155729282|FG001|Part 2|Protocol Violation|0|||
48420367|NCT01208181|155729283|FG002|Part 2|Protocol Violation|1|||
48420368|NCT01208181|155729284|FG003|Part 2|Protocol Violation|0|||
48420369|NCT01208181|155729285|FG004|Part 2|Protocol Violation|0|||
48420370|NCT01208181|155729281|FG000|Part 2|Physician Decision|0|||
48420371|NCT01208181|155729282|FG001|Part 2|Physician Decision|0|||
48420372|NCT01208181|155729283|FG002|Part 2|Physician Decision|1|||
48420373|NCT01208181|155729284|FG003|Part 2|Physician Decision|2|||
48420374|NCT01208181|155729285|FG004|Part 2|Physician Decision|0|||
48420375|NCT01208181|155729281|FG000|Part 2|Non-compliance with study drug|0|||
48420376|NCT01208181|155729282|FG001|Part 2|Non-compliance with study drug|0|||
48420377|NCT01208181|155729283|FG002|Part 2|Non-compliance with study drug|1|||
48420378|NCT01208181|155729284|FG003|Part 2|Non-compliance with study drug|1|||
48420379|NCT01208181|155729285|FG004|Part 2|Non-compliance with study drug|0|||
48420380|NCT01208181|155729281|FG000|Part 2|Lost to Follow-up|0|||
48420381|NCT01208181|155729282|FG001|Part 2|Lost to Follow-up|0|||
48420382|NCT01208181|155729283|FG002|Part 2|Lost to Follow-up|1|||
48420383|NCT01208181|155729284|FG003|Part 2|Lost to Follow-up|2|||
48420384|NCT01208181|155729285|FG004|Part 2|Lost to Follow-up|0|||
48420385|NCT01208181|155729281|FG000|Part 2|Lack of Efficacy|0|||
48420386|NCT01208181|155729282|FG001|Part 2|Lack of Efficacy|0|||
48420387|NCT01208181|155729283|FG002|Part 2|Lack of Efficacy|5|||
48420388|NCT01208181|155729284|FG003|Part 2|Lack of Efficacy|7|||
48420389|NCT01208181|155729285|FG004|Part 2|Lack of Efficacy|0|||
48420390|NCT01457339|155729288|FG000|Period 3 (100 mg)|Adverse Event|0|||
48420391|NCT01457339|155729289|FG001|Period 3 (100 mg)|Adverse Event|1|||
48420392|NCT01457339|155729288|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
48420393|NCT01457339|155729289|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
48420394|NCT01457339|155729288|FG000|Period 6 (250 mg)|Family Emergency|1|||
48420395|NCT01457339|155729289|FG001|Period 6 (250 mg)|Family Emergency|0|||
48420396|NCT01457339|155729288|FG000|Period 6 (250 mg)|Personal appointment|0|||
48420397|NCT01457339|155729289|FG001|Period 6 (250 mg)|Personal appointment|1|||
48420398|NCT01478347|155729292|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
48420399|NCT01478347|155729292|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
48420400|NCT01478347|155729292|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
48420401|NCT03694522|155729293|FG000|Overall Study|Withdrawal by Subject|8|||
48420402|NCT03694522|155729294|FG001|Overall Study|Withdrawal by Subject|10|||
48420403|NCT03694522|155729293|FG000|Overall Study|Physician Decision|53|||
48420404|NCT03694522|155729294|FG001|Overall Study|Physician Decision|54|||
48420405|NCT03694522|155729293|FG000|Overall Study|Other|1|||
48420406|NCT03694522|155729294|FG001|Overall Study|Other|1|||
48420407|NCT03694522|155729293|FG000|Overall Study|Lost to Follow-up|0|||
48420408|NCT03694522|155729294|FG001|Overall Study|Lost to Follow-up|1|||
48420409|NCT00753922|155729295|FG000|Overall Study|Lost to Follow-up|155|||
48420410|NCT00753922|155729296|FG001|Overall Study|Lost to Follow-up|24|||
48420411|NCT00753922|155729297|FG002|Overall Study|Lost to Follow-up|28|||
48420412|NCT00753922|155729298|FG003|Overall Study|Lost to Follow-up|5|||
48420413|NCT00753922|155729295|FG000|Overall Study|Withdrawal by Subject|9|||
48420414|NCT00753922|155729296|FG001|Overall Study|Withdrawal by Subject|11|||
48420415|NCT00753922|155729297|FG002|Overall Study|Withdrawal by Subject|4|||
48420416|NCT00753922|155729298|FG003|Overall Study|Withdrawal by Subject|2|||
48420417|NCT00753922|155729295|FG000|Overall Study|Patient Non-compliance|55|||
48420418|NCT00753922|155729296|FG001|Overall Study|Patient Non-compliance|22|||
48420419|NCT00753922|155729297|FG002|Overall Study|Patient Non-compliance|14|||
48420420|NCT00753922|155729298|FG003|Overall Study|Patient Non-compliance|11|||
48420421|NCT00753922|155729295|FG000|Overall Study|Patients Not Completing Visit|11|||
48420422|NCT00753922|155729296|FG001|Overall Study|Patients Not Completing Visit|0|||
48420423|NCT00753922|155729297|FG002|Overall Study|Patients Not Completing Visit|1|||
48420424|NCT00753922|155729298|FG003|Overall Study|Patients Not Completing Visit|0|||
48420425|NCT00753922|155729295|FG000|Overall Study|Death|2|||
48420426|NCT00753922|155729296|FG001|Overall Study|Death|23|||
48420427|NCT00753922|155729297|FG002|Overall Study|Death|2|||
48420428|NCT00753922|155729298|FG003|Overall Study|Death|1|||
48420429|NCT00753922|155729295|FG000|Overall Study|Discontinuation Due to Explantation|14|||
48420430|NCT00753922|155729296|FG001|Overall Study|Discontinuation Due to Explantation|14|||
48420431|NCT00753922|155729297|FG002|Overall Study|Discontinuation Due to Explantation|14|||
48420432|NCT00753922|155729298|FG003|Overall Study|Discontinuation Due to Explantation|4|||
48420433|NCT01318902|155729299|FG000|Overall Study|Symptomatic Deterioration|0|||
48420434|NCT01318902|155729300|FG001|Overall Study|Symptomatic Deterioration|1|||
48420435|NCT01318902|155729301|FG002|Overall Study|Symptomatic Deterioration|1|||
48420436|NCT01318902|155729302|FG003|Overall Study|Symptomatic Deterioration|2|||
48420437|NCT01318902|155729299|FG000|Overall Study|Withdrawal by Patient|0|||
48420438|NCT01318902|155729300|FG001|Overall Study|Withdrawal by Patient|1|||
48420439|NCT01318902|155729301|FG002|Overall Study|Withdrawal by Patient|0|||
48420440|NCT01318902|155729302|FG003|Overall Study|Withdrawal by Patient|3|||
48420441|NCT01318902|155729299|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
48420442|NCT01318902|155729300|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
48420443|NCT01318902|155729301|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
48420444|NCT01318902|155729302|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
48420445|NCT01318902|155729299|FG000|Overall Study|Adverse Event|0|||
48420446|NCT01318902|155729300|FG001|Overall Study|Adverse Event|1|||
48420447|NCT01318902|155729301|FG002|Overall Study|Adverse Event|0|||
48420448|NCT01318902|155729302|FG003|Overall Study|Adverse Event|0|||
48420449|NCT01318902|155729299|FG000|Overall Study|Terminated by Sponsor|0|||
48420450|NCT01318902|155729300|FG001|Overall Study|Terminated by Sponsor|0|||
48420451|NCT01318902|155729301|FG002|Overall Study|Terminated by Sponsor|1|||
48420452|NCT01318902|155729302|FG003|Overall Study|Terminated by Sponsor|0|||
48420453|NCT01164501|155729303|FG000|Overall Study|Not treated|2|||
48420454|NCT01164501|155729304|FG001|Overall Study|Not treated|0|||
48420455|NCT01164501|155729305|FG002|Overall Study|Not treated|1|||
48420456|NCT01164501|155729303|FG000|Overall Study|Adverse Event|18|||
48420457|NCT01164501|155729304|FG001|Overall Study|Adverse Event|4|||
48420458|NCT01164501|155729305|FG002|Overall Study|Adverse Event|21|||
48420459|NCT01164501|155729303|FG000|Overall Study|Lack of Efficacy|0|||
48420460|NCT01164501|155729304|FG001|Overall Study|Lack of Efficacy|0|||
48420461|NCT01164501|155729305|FG002|Overall Study|Lack of Efficacy|1|||
48420462|NCT01164501|155729303|FG000|Overall Study|Non compliant with protocol|1|||
48420463|NCT01164501|155729304|FG001|Overall Study|Non compliant with protocol|1|||
48420464|NCT01164501|155729305|FG002|Overall Study|Non compliant with protocol|4|||
48420465|NCT01164501|155729303|FG000|Overall Study|Lost to Follow-up|3|||
48420466|NCT01164501|155729304|FG001|Overall Study|Lost to Follow-up|0|||
48420467|NCT01164501|155729305|FG002|Overall Study|Lost to Follow-up|3|||
48420468|NCT01164501|155729303|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
48420469|NCT01164501|155729304|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
48420470|NCT01164501|155729305|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
48420471|NCT01164501|155729303|FG000|Overall Study|Other reason not defined above|9|||
48420472|NCT01164501|155729304|FG001|Overall Study|Other reason not defined above|1|||
48420473|NCT01164501|155729305|FG002|Overall Study|Other reason not defined above|4|||
48420474|NCT01096667|155729306|FG000|Overall Study|Lost to Follow-up|1|||
48420475|NCT01096667|155729307|FG001|Overall Study|Lost to Follow-up|1|||
48420476|NCT01096667|155729308|FG002|Overall Study|Lost to Follow-up|1|||
48420477|NCT01096667|155729309|FG003|Overall Study|Lost to Follow-up|0|||
48420478|NCT01096667|155729310|FG004|Overall Study|Lost to Follow-up|0|||
48420479|NCT01096667|155729306|FG000|Overall Study|Withdrawal by Subject|1|||
48420480|NCT01096667|155729307|FG001|Overall Study|Withdrawal by Subject|0|||
48420481|NCT01096667|155729308|FG002|Overall Study|Withdrawal by Subject|0|||
48420482|NCT01096667|155729309|FG003|Overall Study|Withdrawal by Subject|1|||
48420483|NCT01096667|155729310|FG004|Overall Study|Withdrawal by Subject|0|||
48420484|NCT01096667|155729306|FG000|Overall Study|Reason not available|0|||
48420485|NCT01096667|155729307|FG001|Overall Study|Reason not available|1|||
48420486|NCT01096667|155729308|FG002|Overall Study|Reason not available|1|||
48420487|NCT01096667|155729309|FG003|Overall Study|Reason not available|1|||
48420488|NCT01096667|155729310|FG004|Overall Study|Reason not available|0|||
48420489|NCT01096667|155729306|FG000|Overall Study|Protocol Violation|0|||
48420490|NCT01096667|155729307|FG001|Overall Study|Protocol Violation|0|||
48420491|NCT01096667|155729308|FG002|Overall Study|Protocol Violation|0|||
48420492|NCT01096667|155729309|FG003|Overall Study|Protocol Violation|1|||
48420493|NCT01096667|155729310|FG004|Overall Study|Protocol Violation|0|||
48420494|NCT01096667|155729306|FG000|Overall Study|Not treated|1|||
48420495|NCT01096667|155729307|FG001|Overall Study|Not treated|0|||
48420496|NCT01096667|155729308|FG002|Overall Study|Not treated|0|||
48420497|NCT01096667|155729309|FG003|Overall Study|Not treated|0|||
48420498|NCT01096667|155729310|FG004|Overall Study|Not treated|0|||
48420499|NCT02453841|155729314|FG000|Overall Study|Protocol Violation|1|||
48420500|NCT02453841|155729314|FG000|Overall Study|Unable to obtain blood samples|2|||
48420501|NCT00857246|155729315|FG000|Induction Regimen|Adverse Event|1|||
48420502|NCT00857246|155729315|FG000|Induction Regimen|disease-related complications|1|||
48420503|NCT00857246|155729315|FG000|Induction Regimen|Withdrawal by Subject|1|||
48420504|NCT00857246|155729315|FG000|Surgery (Curative)|disease progression|6|||
48420505|NCT00857246|155729315|FG000|ChemoRT|Withdrawal by Subject|1|||
48420506|NCT00857246|155729315|FG000|ChemoRT|Adverse Event|2|||
48420507|NCT01919411|155729316|FG000|Overall Study|Lost to Follow-up|2|||
48420508|NCT01919411|155729317|FG001|Overall Study|Lost to Follow-up|4|||
48420509|NCT01919411|155729316|FG000|Overall Study|Physician Decision|1|||
48420510|NCT01919411|155729317|FG001|Overall Study|Physician Decision|0|||
48420511|NCT01919411|155729316|FG000|Overall Study|Protocol Violation|2|||
48420512|NCT01919411|155729317|FG001|Overall Study|Protocol Violation|1|||
48420513|NCT00144300|155729318|FG000|Overall Study|Adverse Event|18|||
48420514|NCT00144300|155729319|FG001|Overall Study|Adverse Event|16|||
48420515|NCT00144300|155729318|FG000|Overall Study|Protocol Violation|1|||
48420516|NCT00144300|155729319|FG001|Overall Study|Protocol Violation|3|||
48420517|NCT00144300|155729318|FG000|Overall Study|Lost to Follow-up|3|||
48420518|NCT00144300|155729319|FG001|Overall Study|Lost to Follow-up|0|||
48420519|NCT00144300|155729318|FG000|Overall Study|Withdrawal by Subject|6|||
48420520|NCT00144300|155729319|FG001|Overall Study|Withdrawal by Subject|6|||
48420521|NCT00144300|155729318|FG000|Overall Study|Other reason (not specified)|1|||
48420522|NCT00144300|155729319|FG001|Overall Study|Other reason (not specified)|3|||
48420523|NCT02426086|155729323|FG000|Overall Study|Death|33|||
48420524|NCT02426086|155729324|FG001|Overall Study|Death|36|||
48420525|NCT02426086|155729323|FG000|Overall Study|Lost to Follow-up|2|||
48420526|NCT02426086|155729324|FG001|Overall Study|Lost to Follow-up|0|||
48420527|NCT02426086|155729323|FG000|Overall Study|Study Terminated by Sponsor|5|||
48420528|NCT02426086|155729324|FG001|Overall Study|Study Terminated by Sponsor|14|||
48420529|NCT02426086|155729323|FG000|Overall Study|Withdrawal by Subject|8|||
48420530|NCT02426086|155729324|FG001|Overall Study|Withdrawal by Subject|9|||
48420531|NCT03478683|155729325|FG000|Overall Study|Adverse Event|5|||
48420532|NCT03478683|155729326|FG001|Overall Study|Adverse Event|3|||
48420533|NCT03478683|155729325|FG000|Overall Study|Lost to Follow-up|0|||
48420534|NCT03478683|155729326|FG001|Overall Study|Lost to Follow-up|5|||
48420535|NCT03478683|155729325|FG000|Overall Study|Physician Decision|1|||
48420536|NCT03478683|155729326|FG001|Overall Study|Physician Decision|3|||
48420537|NCT03478683|155729325|FG000|Overall Study|Withdrawal by Subject|7|||
48420538|NCT03478683|155729326|FG001|Overall Study|Withdrawal by Subject|7|||
48420539|NCT00231478|155729327|FG000|Overall Study|Protocol Violation|3|||
48420540|NCT00231478|155729328|FG001|Overall Study|Protocol Violation|2|||
48420541|NCT00231478|155729327|FG000|Overall Study|Refused Treatment|1|||
48420542|NCT00231478|155729328|FG001|Overall Study|Refused Treatment|1|||
48420543|NCT00231478|155729327|FG000|Overall Study|Withdrawal by Subject|1|||
48420544|NCT00231478|155729328|FG001|Overall Study|Withdrawal by Subject|0|||
48420545|NCT00231478|155729327|FG000|Overall Study|Adverse Event|0|||
48420546|NCT00231478|155729328|FG001|Overall Study|Adverse Event|1|||
48420547|NCT00231478|155729327|FG000|Overall Study|Administrative|3|||
48420548|NCT00231478|155729328|FG001|Overall Study|Administrative|2|||
48420549|NCT00853905|155729329|FG000|Overall Study|Lost to Follow-up|1|||
48420550|NCT00853905|155729330|FG001|Overall Study|Lost to Follow-up|3|||
48420551|NCT00853905|155729329|FG000|Overall Study|Withdrawal by Subject|0|||
48420552|NCT00853905|155729330|FG001|Overall Study|Withdrawal by Subject|1|||
48420553|NCT00853905|155729329|FG000|Overall Study|never had surgery|1|||
48420554|NCT00853905|155729330|FG001|Overall Study|never had surgery|0|||
48420555|NCT04090164|155729333|FG000|Overall Study|incomplete data on file|245|||
48420556|NCT04090164|155729334|FG001|Overall Study|incomplete data on file|0|||
48420557|NCT00408681|155729342|FG000|Overall Study|Lack of Efficacy|2|||
48420558|NCT00408681|155729342|FG000|Overall Study|Adverse Event|7|||
48420559|NCT05253807|155729352|FG000|Overall Study|Death|1|||
48420560|NCT05253807|155729353|FG001|Overall Study|Death|4|||
48420561|NCT05253807|155729352|FG000|Overall Study|Withdrawal by Subject|1|||
48420562|NCT05253807|155729353|FG001|Overall Study|Withdrawal by Subject|0|||
48420563|NCT05253807|155729352|FG000|Overall Study|Study Terminated by Sponsor|1|||
48420564|NCT05253807|155729353|FG001|Overall Study|Study Terminated by Sponsor|1|||
48420565|NCT02704429|155729356|FG000|Part A: 24 Weeks|Adverse Event|3|||
48420566|NCT02704429|155729357|FG001|Part A: 24 Weeks|Adverse Event|0|||
48420567|NCT02704429|155729356|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
48420568|NCT02704429|155729357|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
48420569|NCT00104104|155729361|FG000|Overall Study|Adverse Event|8|||
48420570|NCT00104104|155729362|FG001|Overall Study|Adverse Event|8|||
48420571|NCT00104104|155729361|FG000|Overall Study|Abnormal laboratory value(s)|20|||
48420572|NCT00104104|155729362|FG001|Overall Study|Abnormal laboratory value(s)|14|||
48420573|NCT00104104|155729361|FG000|Overall Study|Lack of Efficacy|0|||
48420574|NCT00104104|155729362|FG001|Overall Study|Lack of Efficacy|3|||
48420575|NCT00104104|155729361|FG000|Overall Study|Condition no longer requires study drug|7|||
48420576|NCT00104104|155729362|FG001|Overall Study|Condition no longer requires study drug|4|||
48420577|NCT00104104|155729361|FG000|Overall Study|Protocol Violation|5|||
48420578|NCT00104104|155729362|FG001|Overall Study|Protocol Violation|2|||
48420579|NCT00104104|155729361|FG000|Overall Study|Withdrawal by Subject|11|||
48420580|NCT00104104|155729362|FG001|Overall Study|Withdrawal by Subject|15|||
48420581|NCT00104104|155729361|FG000|Overall Study|Lost to Follow-up|3|||
48420582|NCT00104104|155729362|FG001|Overall Study|Lost to Follow-up|7|||
48420583|NCT00104104|155729361|FG000|Overall Study|Administrative problems|12|||
48420584|NCT00104104|155729362|FG001|Overall Study|Administrative problems|13|||
48420585|NCT00104104|155729361|FG000|Overall Study|Death|9|||
48420586|NCT00104104|155729362|FG001|Overall Study|Death|6|||
48420587|NCT01287117|155729364|FG000|Overall Study|Adverse Event|2|||
48420588|NCT01287117|155729365|FG001|Overall Study|Adverse Event|1|||
48420589|NCT01287117|155729366|FG002|Overall Study|Adverse Event|1|||
48420590|NCT01287117|155729367|FG003|Overall Study|Adverse Event|1|||
48420591|NCT01287117|155729364|FG000|Overall Study|Lost to Follow-up|1|||
48420592|NCT01287117|155729365|FG001|Overall Study|Lost to Follow-up|1|||
48420593|NCT01287117|155729366|FG002|Overall Study|Lost to Follow-up|0|||
48420594|NCT01287117|155729367|FG003|Overall Study|Lost to Follow-up|0|||
48420595|NCT01287117|155729364|FG000|Overall Study|Physician Decision|0|||
48420596|NCT01287117|155729365|FG001|Overall Study|Physician Decision|1|||
48420597|NCT01287117|155729366|FG002|Overall Study|Physician Decision|1|||
48420598|NCT01287117|155729367|FG003|Overall Study|Physician Decision|1|||
48420599|NCT01287117|155729364|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
48420600|NCT01287117|155729365|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
48420601|NCT01287117|155729366|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
48420602|NCT01287117|155729367|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
48420603|NCT01287117|155729364|FG000|Overall Study|Disease Progression|10|||
48420604|NCT01287117|155729365|FG001|Overall Study|Disease Progression|5|||
48420605|NCT01287117|155729366|FG002|Overall Study|Disease Progression|6|||
48420606|NCT01287117|155729367|FG003|Overall Study|Disease Progression|5|||
48420607|NCT00630032|155729368|FG000|Overall Study|Death|55|||
48420608|NCT00630032|155729369|FG001|Overall Study|Death|49|||
48420609|NCT00630032|155729368|FG000|Overall Study|Withdrawal by Subject|3|||
48420610|NCT00630032|155729369|FG001|Overall Study|Withdrawal by Subject|2|||
48420611|NCT00630032|155729368|FG000|Overall Study|Lost to Follow-up|18|||
48420612|NCT00630032|155729369|FG001|Overall Study|Lost to Follow-up|31|||
48420613|NCT00630032|155729368|FG000|Overall Study|Protocol Violation|1|||
48420614|NCT00630032|155729369|FG001|Overall Study|Protocol Violation|0|||
48420615|NCT00630032|155729368|FG000|Overall Study|Patient has moved|1|||
48420616|NCT00630032|155729369|FG001|Overall Study|Patient has moved|1|||
48420617|NCT00630032|155729368|FG000|Overall Study|Disease progression|1|||
48420618|NCT00630032|155729369|FG001|Overall Study|Disease progression|1|||
48420619|NCT00630032|155729368|FG000|Overall Study|End of monitoring in US centers|11|||
48420620|NCT00630032|155729369|FG001|Overall Study|End of monitoring in US centers|11|||
48420621|NCT04285723|155729371|FG000|Overall Study|Subject decision|1|||
48420622|NCT04285723|155729372|FG001|Overall Study|Subject decision|2|||
48420623|NCT04285723|155729371|FG000|Overall Study|Physician Decision|1|||
48420624|NCT04285723|155729372|FG001|Overall Study|Physician Decision|0|||
48420625|NCT04285723|155729371|FG000|Overall Study|No efficiency|1|||
48420626|NCT04285723|155729372|FG001|Overall Study|No efficiency|0|||
48420627|NCT00465738|155729373|FG000|Overall Study|Lost to Follow-up|2|||
48420628|NCT00465738|155729374|FG001|Overall Study|Lost to Follow-up|0|||
48420629|NCT00465738|155729373|FG000|Overall Study|Adverse Event|0|||
48420630|NCT00465738|155729374|FG001|Overall Study|Adverse Event|1|||
48420631|NCT00465738|155729373|FG000|Overall Study|Withdrawal by Subject|2|||
48420632|NCT00465738|155729374|FG001|Overall Study|Withdrawal by Subject|0|||
48420633|NCT00465738|155729373|FG000|Overall Study|Other|2|||
48420634|NCT00465738|155729374|FG001|Overall Study|Other|5|||
48420635|NCT00969618|155729375|FG000|Overall Study|Adverse Event|29|||
48420636|NCT00969618|155729375|FG000|Overall Study|Entry Criteria Not Met|3|||
48420637|NCT00969618|155729375|FG000|Overall Study|Lack of Efficacy|2|||
48420638|NCT00969618|155729375|FG000|Overall Study|Lost to Follow-up|7|||
48420639|NCT00969618|155729375|FG000|Overall Study|Physician Decision|1|||
48420640|NCT00969618|155729375|FG000|Overall Study|Protocol Violation|9|||
48420641|NCT00969618|155729375|FG000|Overall Study|Withdrawal by Subject|27|||
48420642|NCT01326962|155729376|FG000|Overall Study|Adverse Event|1|||
48420643|NCT01326962|155729376|FG000|Overall Study|Withdrawal by Subject|1|||
48420644|NCT01326962|155729376|FG000|Overall Study|Lost to Follow-up|3|||
48420645|NCT01326962|155729376|FG000|Overall Study|Other|2|||
48420646|NCT01056107|155731115|FG000|Overall Study|Withdrawal by Subject|0|||
48420647|NCT01056107|155731116|FG001|Overall Study|Withdrawal by Subject|1|||
48420648|NCT01056107|155731117|FG002|Overall Study|Withdrawal by Subject|3|||
48420649|NCT01056107|155731118|FG003|Overall Study|Withdrawal by Subject|0|||
48420650|NCT03270085|155731119|FG000|Overall Study|Withdrawal by Subject|1|||
48420651|NCT03270085|155731120|FG001|Overall Study|Withdrawal by Subject|0|||
48420652|NCT02629393|155731121|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
48420653|NCT02629393|155731121|FG000|Overall Study|Physician Decision|1|||
48420654|NCT00947154|155731122|FG000|Overall Study|Lost to Follow-up|1|||
48420655|NCT03952130|155731129|FG000|Overall Study|Adverse Event|0|||
48420656|NCT03952130|155731130|FG001|Overall Study|Adverse Event|1|||
48420657|NCT03952130|155731129|FG000|Overall Study|Lost to Follow-up|1|||
48420658|NCT03952130|155731130|FG001|Overall Study|Lost to Follow-up|0|||
48420659|NCT03952130|155731129|FG000|Overall Study|Withdrawal by Subject|1|||
48420660|NCT03952130|155731130|FG001|Overall Study|Withdrawal by Subject|5|||
48420661|NCT02786537|155731131|FG000|As Randomized|Adverse Event|0|||
48420662|NCT02786537|155731132|FG001|As Randomized|Adverse Event|11|||
48420663|NCT02786537|155731133|FG002|As Randomized|Adverse Event|0|||
48420664|NCT02786537|155731134|FG003|As Randomized|Adverse Event|4|||
48420665|NCT02786537|155731135|FG004|As Randomized|Adverse Event|6|||
48420666|NCT02786537|155731136|FG005|As Randomized|Adverse Event|2|||
48420667|NCT02786537|155731131|FG000|As Randomized|Lack of Efficacy|0|||
48420668|NCT02786537|155731132|FG001|As Randomized|Lack of Efficacy|0|||
48420669|NCT02786537|155731133|FG002|As Randomized|Lack of Efficacy|0|||
48420670|NCT02786537|155731134|FG003|As Randomized|Lack of Efficacy|1|||
48420671|NCT02786537|155731135|FG004|As Randomized|Lack of Efficacy|0|||
48420672|NCT02786537|155731136|FG005|As Randomized|Lack of Efficacy|0|||
48420673|NCT02786537|155731131|FG000|As Randomized|Withdrawal by Subject|1|||
48420674|NCT02786537|155731132|FG001|As Randomized|Withdrawal by Subject|2|||
48420675|NCT02786537|155731133|FG002|As Randomized|Withdrawal by Subject|0|||
48420676|NCT02786537|155731134|FG003|As Randomized|Withdrawal by Subject|1|||
48420677|NCT02786537|155731135|FG004|As Randomized|Withdrawal by Subject|1|||
48420678|NCT02786537|155731136|FG005|As Randomized|Withdrawal by Subject|0|||
48420679|NCT02786537|155731131|FG000|As Randomized|Death|0|||
48420680|NCT02786537|155731132|FG001|As Randomized|Death|2|||
48420681|NCT02786537|155731133|FG002|As Randomized|Death|0|||
48420682|NCT02786537|155731134|FG003|As Randomized|Death|3|||
48420683|NCT02786537|155731135|FG004|As Randomized|Death|1|||
48420684|NCT02786537|155731136|FG005|As Randomized|Death|0|||
48420685|NCT02786537|155731131|FG000|As Randomized|Non-compliance with study drug|1|||
48420686|NCT02786537|155731132|FG001|As Randomized|Non-compliance with study drug|11|||
48420687|NCT02786537|155731133|FG002|As Randomized|Non-compliance with study drug|0|||
48420688|NCT02786537|155731134|FG003|As Randomized|Non-compliance with study drug|1|||
48420689|NCT02786537|155731135|FG004|As Randomized|Non-compliance with study drug|0|||
48420690|NCT02786537|155731136|FG005|As Randomized|Non-compliance with study drug|1|||
48420691|NCT02786537|155731131|FG000|As Randomized|Lost to treatment follow-up|4|||
48420692|NCT02786537|155731132|FG001|As Randomized|Lost to treatment follow-up|32|||
48420693|NCT02786537|155731133|FG002|As Randomized|Lost to treatment follow-up|0|||
48420694|NCT02786537|155731134|FG003|As Randomized|Lost to treatment follow-up|24|||
48420695|NCT02786537|155731135|FG004|As Randomized|Lost to treatment follow-up|4|||
48420696|NCT02786537|155731136|FG005|As Randomized|Lost to treatment follow-up|4|||
48420697|NCT02786537|155731131|FG000|As Randomized|Incarceration|0|||
48420698|NCT02786537|155731132|FG001|As Randomized|Incarceration|1|||
48420699|NCT02786537|155731133|FG002|As Randomized|Incarceration|0|||
48420700|NCT02786537|155731134|FG003|As Randomized|Incarceration|0|||
48420701|NCT02786537|155731135|FG004|As Randomized|Incarceration|0|||
48420702|NCT02786537|155731136|FG005|As Randomized|Incarceration|0|||
48420703|NCT02786537|155731131|FG000|As Randomized|Opiate Dependency Relapse|0|||
48420704|NCT02786537|155731132|FG001|As Randomized|Opiate Dependency Relapse|1|||
48420705|NCT02786537|155731133|FG002|As Randomized|Opiate Dependency Relapse|0|||
48420706|NCT02786537|155731134|FG003|As Randomized|Opiate Dependency Relapse|0|||
48420707|NCT02786537|155731135|FG004|As Randomized|Opiate Dependency Relapse|0|||
48420708|NCT02786537|155731136|FG005|As Randomized|Opiate Dependency Relapse|0|||
48420709|NCT02786537|155731131|FG000|As Randomized|HCV drugs stolen from pt|0|||
48420710|NCT02786537|155731132|FG001|As Randomized|HCV drugs stolen from pt|1|||
48420711|NCT02786537|155731133|FG002|As Randomized|HCV drugs stolen from pt|0|||
48420712|NCT02786537|155731134|FG003|As Randomized|HCV drugs stolen from pt|0|||
48420713|NCT02786537|155731135|FG004|As Randomized|HCV drugs stolen from pt|0|||
48420714|NCT02786537|155731136|FG005|As Randomized|HCV drugs stolen from pt|0|||
48692645|NCT03001557|156724541|FG000|Extension Phase|Administrative Reason|0|||
48420715|NCT02786537|155731131|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
48420716|NCT02786537|155731132|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
48420717|NCT02786537|155731133|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
48420718|NCT02786537|155731134|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
48420719|NCT02786537|155731135|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
48420720|NCT02786537|155731136|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
48420721|NCT02786537|155731131|FG000|As Randomized|Subject lost insurance|0|||
48420722|NCT02786537|155731132|FG001|As Randomized|Subject lost insurance|0|||
48420723|NCT02786537|155731133|FG002|As Randomized|Subject lost insurance|0|||
48420724|NCT02786537|155731134|FG003|As Randomized|Subject lost insurance|1|||
48420725|NCT02786537|155731135|FG004|As Randomized|Subject lost insurance|0|||
48420726|NCT02786537|155731136|FG005|As Randomized|Subject lost insurance|0|||
48420727|NCT02786537|155731131|FG000|As Treated|Adverse Event|0|||
48420728|NCT02786537|155731132|FG001|As Treated|Adverse Event|11|||
48420729|NCT02786537|155731133|FG002|As Treated|Adverse Event|0|||
48420730|NCT02786537|155731134|FG003|As Treated|Adverse Event|4|||
48420731|NCT02786537|155731135|FG004|As Treated|Adverse Event|6|||
48420732|NCT02786537|155731136|FG005|As Treated|Adverse Event|2|||
48420733|NCT02786537|155731131|FG000|As Treated|Death|0|||
48420734|NCT02786537|155731132|FG001|As Treated|Death|2|||
48420735|NCT02786537|155731133|FG002|As Treated|Death|0|||
48420736|NCT02786537|155731134|FG003|As Treated|Death|3|||
48420737|NCT02786537|155731135|FG004|As Treated|Death|1|||
48420738|NCT02786537|155731136|FG005|As Treated|Death|0|||
48420739|NCT02786537|155731131|FG000|As Treated|Lack of Efficacy|0|||
48420740|NCT02786537|155731132|FG001|As Treated|Lack of Efficacy|0|||
48420741|NCT02786537|155731133|FG002|As Treated|Lack of Efficacy|0|||
48420742|NCT02786537|155731134|FG003|As Treated|Lack of Efficacy|1|||
48420743|NCT02786537|155731135|FG004|As Treated|Lack of Efficacy|0|||
48420744|NCT02786537|155731136|FG005|As Treated|Lack of Efficacy|0|||
48420745|NCT02786537|155731131|FG000|As Treated|Lost to Follow-up|4|||
48420746|NCT02786537|155731132|FG001|As Treated|Lost to Follow-up|32|||
48420747|NCT02786537|155731133|FG002|As Treated|Lost to Follow-up|0|||
48420748|NCT02786537|155731134|FG003|As Treated|Lost to Follow-up|25|||
48420749|NCT02786537|155731135|FG004|As Treated|Lost to Follow-up|4|||
48420750|NCT02786537|155731136|FG005|As Treated|Lost to Follow-up|4|||
48420751|NCT02786537|155731131|FG000|As Treated|Non-compliance with study drug|1|||
48420752|NCT02786537|155731132|FG001|As Treated|Non-compliance with study drug|11|||
48420753|NCT02786537|155731133|FG002|As Treated|Non-compliance with study drug|0|||
48420754|NCT02786537|155731134|FG003|As Treated|Non-compliance with study drug|1|||
48420755|NCT02786537|155731135|FG004|As Treated|Non-compliance with study drug|0|||
48420756|NCT02786537|155731136|FG005|As Treated|Non-compliance with study drug|1|||
48420757|NCT02786537|155731131|FG000|As Treated|Lost insurance|0|||
48420758|NCT02786537|155731132|FG001|As Treated|Lost insurance|0|||
48420759|NCT02786537|155731133|FG002|As Treated|Lost insurance|0|||
48420760|NCT02786537|155731134|FG003|As Treated|Lost insurance|1|||
48420761|NCT02786537|155731135|FG004|As Treated|Lost insurance|0|||
48420762|NCT02786537|155731136|FG005|As Treated|Lost insurance|0|||
48420763|NCT02786537|155731131|FG000|As Treated|Withdrawal by Subject|1|||
48420764|NCT02786537|155731132|FG001|As Treated|Withdrawal by Subject|2|||
48420765|NCT02786537|155731133|FG002|As Treated|Withdrawal by Subject|0|||
48420766|NCT02786537|155731134|FG003|As Treated|Withdrawal by Subject|0|||
48420767|NCT02786537|155731135|FG004|As Treated|Withdrawal by Subject|1|||
48420768|NCT02786537|155731136|FG005|As Treated|Withdrawal by Subject|0|||
48420769|NCT02786537|155731131|FG000|As Treated|Incarceration|0|||
48420770|NCT02786537|155731132|FG001|As Treated|Incarceration|1|||
48420771|NCT02786537|155731133|FG002|As Treated|Incarceration|0|||
48420772|NCT02786537|155731134|FG003|As Treated|Incarceration|0|||
48420773|NCT02786537|155731135|FG004|As Treated|Incarceration|0|||
48420774|NCT02786537|155731136|FG005|As Treated|Incarceration|0|||
48420775|NCT02786537|155731131|FG000|As Treated|Opiate dependency relapse|0|||
48420776|NCT02786537|155731132|FG001|As Treated|Opiate dependency relapse|1|||
48420777|NCT02786537|155731133|FG002|As Treated|Opiate dependency relapse|0|||
48420778|NCT02786537|155731134|FG003|As Treated|Opiate dependency relapse|0|||
48420779|NCT02786537|155731135|FG004|As Treated|Opiate dependency relapse|0|||
48420780|NCT02786537|155731136|FG005|As Treated|Opiate dependency relapse|0|||
48420781|NCT02786537|155731131|FG000|As Treated|Drugs stolen from patient|0|||
48420782|NCT02786537|155731132|FG001|As Treated|Drugs stolen from patient|1|||
48420783|NCT02786537|155731133|FG002|As Treated|Drugs stolen from patient|0|||
48420784|NCT02786537|155731134|FG003|As Treated|Drugs stolen from patient|0|||
48420785|NCT02786537|155731135|FG004|As Treated|Drugs stolen from patient|0|||
48420786|NCT02786537|155731136|FG005|As Treated|Drugs stolen from patient|0|||
48420787|NCT02786537|155731131|FG000|As Treated|Advised to stop tx after loss of meds|0|||
48420788|NCT02786537|155731132|FG001|As Treated|Advised to stop tx after loss of meds|1|||
48420789|NCT02786537|155731133|FG002|As Treated|Advised to stop tx after loss of meds|0|||
48420790|NCT02786537|155731134|FG003|As Treated|Advised to stop tx after loss of meds|0|||
48420791|NCT02786537|155731135|FG004|As Treated|Advised to stop tx after loss of meds|0|||
48420792|NCT02786537|155731136|FG005|As Treated|Advised to stop tx after loss of meds|0|||
48420793|NCT02082184|155731140|FG000|Overall Study|Adverse Event|1|||
48420794|NCT02082184|155731141|FG001|Overall Study|Adverse Event|0|||
48420795|NCT02082184|155731140|FG000|Overall Study|Medical diagnosis|1|||
48420796|NCT02082184|155731141|FG001|Overall Study|Medical diagnosis|2|||
48420797|NCT02082184|155731140|FG000|Overall Study|Device associated symptoms|5|||
48420798|NCT02082184|155731141|FG001|Overall Study|Device associated symptoms|0|||
48420799|NCT02082184|155731140|FG000|Overall Study|Withdrawal by Subject|3|||
48420800|NCT02082184|155731141|FG001|Overall Study|Withdrawal by Subject|2|||
48420801|NCT02082184|155731140|FG000|Overall Study|Protocol Violation|0|||
48420802|NCT02082184|155731141|FG001|Overall Study|Protocol Violation|6|||
48420803|NCT02082184|155731140|FG000|Overall Study|Lost to Follow-up|0|||
48420804|NCT02082184|155731141|FG001|Overall Study|Lost to Follow-up|2|||
48420805|NCT02082184|155731140|FG000|Overall Study|Subject non-compliance|0|||
48420806|NCT02082184|155731141|FG001|Overall Study|Subject non-compliance|1|||
48420807|NCT01362322|155731142|FG000|Overall Study|Withdrawal by Subject|3|||
48420808|NCT01362322|155731143|FG001|Overall Study|Withdrawal by Subject|1|||
48420809|NCT01362322|155731142|FG000|Overall Study|Lost to Follow-up|2|||
48420810|NCT01362322|155731143|FG001|Overall Study|Lost to Follow-up|6|||
48420811|NCT00265941|155731154|FG000|Overall Study|Protocol Violation|22|||
48420812|NCT00265941|155731155|FG001|Overall Study|Protocol Violation|25|||
48420813|NCT00265941|155731154|FG000|Overall Study|Lost to Follow-up|1|||
48420814|NCT00265941|155731155|FG001|Overall Study|Lost to Follow-up|1|||
48420815|NCT00149214|155731158|FG000|Overall Study|Adverse Event|12|||
48420816|NCT00149214|155731159|FG001|Overall Study|Adverse Event|9|||
48420817|NCT00149214|155731158|FG000|Overall Study|Withdrawal by Subject|4|||
48420818|NCT00149214|155731159|FG001|Overall Study|Withdrawal by Subject|1|||
48420819|NCT00149214|155731158|FG000|Overall Study|Physician Decision|3|||
48420820|NCT00149214|155731159|FG001|Overall Study|Physician Decision|3|||
48420821|NCT00149214|155731158|FG000|Overall Study|Sponsor Decision|0|||
48420822|NCT00149214|155731159|FG001|Overall Study|Sponsor Decision|1|||
48420823|NCT00149214|155731158|FG000|Overall Study|Progressive Disease|7|||
48420824|NCT00149214|155731159|FG001|Overall Study|Progressive Disease|3|||
48420825|NCT00174941|155731160|FG000|Overall Study|Adverse Event|1|||
48420826|NCT00174941|155731161|FG001|Overall Study|Adverse Event|10|||
48420827|NCT00174941|155731162|FG002|Overall Study|Adverse Event|2|||
48420828|NCT00174941|155731163|FG003|Overall Study|Adverse Event|13|||
48420829|NCT00174941|155731160|FG000|Overall Study|Protocol Violation|0|||
48420830|NCT00174941|155731161|FG001|Overall Study|Protocol Violation|1|||
48420831|NCT00174941|155731162|FG002|Overall Study|Protocol Violation|0|||
48420832|NCT00174941|155731163|FG003|Overall Study|Protocol Violation|1|||
48420833|NCT00174941|155731160|FG000|Overall Study|Lost to Follow-up|0|||
48420834|NCT00174941|155731161|FG001|Overall Study|Lost to Follow-up|3|||
48420835|NCT00174941|155731162|FG002|Overall Study|Lost to Follow-up|2|||
48420836|NCT00174941|155731163|FG003|Overall Study|Lost to Follow-up|5|||
48420837|NCT00174941|155731160|FG000|Overall Study|Personal Reason(s)|0|||
48420838|NCT00174941|155731161|FG001|Overall Study|Personal Reason(s)|14|||
48420839|NCT00174941|155731162|FG002|Overall Study|Personal Reason(s)|8|||
48420840|NCT00174941|155731163|FG003|Overall Study|Personal Reason(s)|22|||
48420841|NCT00174941|155731160|FG000|Overall Study|Gout Flare|0|||
48420842|NCT00174941|155731161|FG001|Overall Study|Gout Flare|4|||
48420843|NCT00174941|155731162|FG002|Overall Study|Gout Flare|4|||
48420844|NCT00174941|155731163|FG003|Overall Study|Gout Flare|8|||
48420845|NCT00174941|155731160|FG000|Overall Study|Reason Not Specified|1|||
48420846|NCT00174941|155731161|FG001|Overall Study|Reason Not Specified|6|||
48420847|NCT00174941|155731162|FG002|Overall Study|Reason Not Specified|2|||
48420848|NCT00174941|155731163|FG003|Overall Study|Reason Not Specified|9|||
48420849|NCT00283712|155731164|FG000|Overall Study|Death|0|||
48420850|NCT00283712|155731165|FG001|Overall Study|Death|1|||
48420851|NCT05590403|155731168|FG000|Overall Study|Lost to Follow-up|3|||
48420852|NCT05590403|155731169|FG001|Overall Study|Lost to Follow-up|0|||
48420853|NCT05590403|155731170|FG002|Overall Study|Lost to Follow-up|2|||
48420854|NCT05590403|155731171|FG003|Overall Study|Lost to Follow-up|0|||
48420855|NCT05590403|155731172|FG004|Overall Study|Lost to Follow-up|0|||
48420856|NCT05590403|155731168|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
48420857|NCT05590403|155731169|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
48420858|NCT05590403|155731170|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
48420859|NCT05590403|155731171|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
48420860|NCT05590403|155731172|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
48420861|NCT03126227|155731173|FG000|Overall Study|Adverse Event|43|||
48420862|NCT03126227|155731174|FG001|Overall Study|Adverse Event|4|||
48420863|NCT03126227|155731173|FG000|Overall Study|Death|0|||
48420864|NCT03126227|155731174|FG001|Overall Study|Death|1|||
48420865|NCT03126227|155731173|FG000|Overall Study|Lost to Follow-up|0|||
48420866|NCT03126227|155731174|FG001|Overall Study|Lost to Follow-up|1|||
48420867|NCT03126227|155731173|FG000|Overall Study|Physician Decision|2|||
48420868|NCT03126227|155731174|FG001|Overall Study|Physician Decision|0|||
48420869|NCT03126227|155731173|FG000|Overall Study|Protocol Violation|1|||
48420870|NCT03126227|155731174|FG001|Overall Study|Protocol Violation|0|||
48420871|NCT03126227|155731173|FG000|Overall Study|Withdrawal by Subject|19|||
48420872|NCT03126227|155731174|FG001|Overall Study|Withdrawal by Subject|3|||
48420873|NCT03126227|155731173|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
48420874|NCT03126227|155731174|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
48420875|NCT03126227|155731173|FG000|Overall Study|Lack of dosing compliance|2|||
48420876|NCT03126227|155731174|FG001|Overall Study|Lack of dosing compliance|0|||
48420877|NCT03126227|155731173|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
48426327|NCT02203838|155749550|FG000|Overall Study|Protocol Violation|7|||
48420878|NCT03126227|155731174|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
48420879|NCT03126227|155731173|FG000|Overall Study|Scheduling conflict|1|||
48420880|NCT03126227|155731174|FG001|Overall Study|Scheduling conflict|0|||
48420881|NCT01121406|155731178|FG000|Overall Study|Progressive disease RECIST|44|||
48420882|NCT01121406|155731179|FG001|Overall Study|Progressive disease RECIST|28|||
48420883|NCT01121406|155731178|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
48420884|NCT01121406|155731179|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
48420885|NCT01121406|155731178|FG000|Overall Study|Other AE|3|||
48420886|NCT01121406|155731179|FG001|Overall Study|Other AE|10|||
48420887|NCT01121406|155731178|FG000|Overall Study|Non-compliant with protocol|0|||
48420888|NCT01121406|155731179|FG001|Overall Study|Non-compliant with protocol|2|||
48420889|NCT01121406|155731178|FG000|Overall Study|Lost to Follow-up|0|||
48420890|NCT01121406|155731179|FG001|Overall Study|Lost to Follow-up|1|||
48420891|NCT01121406|155731178|FG000|Overall Study|Refused continuation of study med.|1|||
48420892|NCT01121406|155731179|FG001|Overall Study|Refused continuation of study med.|2|||
48420893|NCT01121406|155731178|FG000|Overall Study|Reason other than specified above|2|||
48420894|NCT01121406|155731179|FG001|Overall Study|Reason other than specified above|6|||
48420895|NCT01121406|155731178|FG000|Overall Study|Not treated|1|||
48420896|NCT01121406|155731179|FG001|Overall Study|Not treated|0|||
48420897|NCT02088034|155731183|FG000|Overall Study|Lost to Follow-up|1|||
48420898|NCT02088034|155731184|FG001|Overall Study|Lost to Follow-up|1|||
48420899|NCT02088034|155731185|FG002|Overall Study|Lost to Follow-up|0|||
48420900|NCT02088034|155731183|FG000|Overall Study|Pregnancy|2|||
48420901|NCT02088034|155731184|FG001|Overall Study|Pregnancy|1|||
48420902|NCT02088034|155731185|FG002|Overall Study|Pregnancy|2|||
48420903|NCT01380093|155731186|FG000|Naloxone Challenge Phase|Screen failures|21|||
48420904|NCT01380093|155731187|FG001|Naloxone Challenge Phase|Screen failures|0|||
48420905|NCT01380093|155731188|FG002|Naloxone Challenge Phase|Screen failures|0|||
48420906|NCT01380093|155731189|FG003|Naloxone Challenge Phase|Screen failures|0|||
48420907|NCT01380093|155731190|FG004|Naloxone Challenge Phase|Screen failures|0|||
48420908|NCT01380093|155731191|FG005|Naloxone Challenge Phase|Screen failures|0|||
48420909|NCT01380093|155731192|FG006|Naloxone Challenge Phase|Screen failures|0|||
48420910|NCT01380093|155731193|FG007|Naloxone Challenge Phase|Screen failures|0|||
48420911|NCT01380093|155731194|FG008|Naloxone Challenge Phase|Screen failures|0|||
48420912|NCT01380093|155731186|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48420913|NCT01380093|155731187|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
48420914|NCT01380093|155731188|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48420915|NCT01380093|155731189|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48420916|NCT01380093|155731190|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48420917|NCT01380093|155731191|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48420918|NCT01380093|155731192|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48420919|NCT01380093|155731193|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48420920|NCT01380093|155731194|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
48420921|NCT01380093|155731186|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48420922|NCT01380093|155731187|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
48420923|NCT01380093|155731188|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
48420924|NCT01380093|155731189|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48420925|NCT01380093|155731190|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48420926|NCT01380093|155731191|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48420927|NCT01380093|155731192|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48420928|NCT01380093|155731193|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48420929|NCT01380093|155731194|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
48420930|NCT01380093|155731186|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48420931|NCT01380093|155731187|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
48420932|NCT01380093|155731188|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48420933|NCT01380093|155731189|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48420934|NCT01380093|155731190|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48420935|NCT01380093|155731191|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48420936|NCT01380093|155731192|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48420937|NCT01380093|155731193|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48420938|NCT01380093|155731194|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
48420939|NCT01380093|155731186|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48420940|NCT01380093|155731187|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
48420941|NCT01380093|155731188|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
48420942|NCT01380093|155731189|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48420943|NCT01380093|155731190|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48420944|NCT01380093|155731191|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48420945|NCT01380093|155731192|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48420946|NCT01380093|155731193|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48420947|NCT01380093|155731194|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
48426328|NCT02203838|155749551|FG001|Overall Study|Protocol Violation|3|||
48420948|NCT01380093|155731186|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48420949|NCT01380093|155731187|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
48420950|NCT01380093|155731188|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
48420951|NCT01380093|155731189|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48420952|NCT01380093|155731190|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48420953|NCT01380093|155731191|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48420954|NCT01380093|155731192|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48420955|NCT01380093|155731193|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48420956|NCT01380093|155731194|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
48420957|NCT01380093|155731186|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
48420958|NCT01380093|155731187|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
48420959|NCT01380093|155731188|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
48420960|NCT01380093|155731189|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
48420961|NCT01380093|155731190|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
48420962|NCT01380093|155731191|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
48420963|NCT01380093|155731192|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
48420964|NCT01380093|155731193|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
48420965|NCT01380093|155731194|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
48420966|NCT01380093|155731186|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48420967|NCT01380093|155731187|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48420968|NCT01380093|155731188|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
48420969|NCT01380093|155731189|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48420970|NCT01380093|155731190|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48420971|NCT01380093|155731191|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48420972|NCT01380093|155731192|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48420973|NCT01380093|155731193|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48420974|NCT01380093|155731194|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
48420975|NCT01380093|155731186|FG000|Treatment Phase: Second Intervention|Other|0|||
48420976|NCT01380093|155731187|FG001|Treatment Phase: Second Intervention|Other|0|||
48420977|NCT01380093|155731188|FG002|Treatment Phase: Second Intervention|Other|0|||
48420978|NCT01380093|155731189|FG003|Treatment Phase: Second Intervention|Other|1|||
48420979|NCT01380093|155731190|FG004|Treatment Phase: Second Intervention|Other|0|||
48420980|NCT01380093|155731191|FG005|Treatment Phase: Second Intervention|Other|0|||
48420981|NCT01380093|155731192|FG006|Treatment Phase: Second Intervention|Other|0|||
48420982|NCT01380093|155731193|FG007|Treatment Phase: Second Intervention|Other|0|||
48420983|NCT01380093|155731194|FG008|Treatment Phase: Second Intervention|Other|0|||
48420984|NCT01380093|155731186|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
48420985|NCT01380093|155731187|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
48420986|NCT01380093|155731188|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
48420987|NCT01380093|155731189|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
48420988|NCT01380093|155731190|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
48420989|NCT01380093|155731191|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
48420990|NCT01380093|155731192|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
48420991|NCT01380093|155731193|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
48420992|NCT01380093|155731194|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
48420993|NCT01380093|155731186|FG000|Treatment Phase: Third Intervention|Other|0|||
48420994|NCT01380093|155731187|FG001|Treatment Phase: Third Intervention|Other|0|||
48420995|NCT01380093|155731188|FG002|Treatment Phase: Third Intervention|Other|0|||
48420996|NCT01380093|155731189|FG003|Treatment Phase: Third Intervention|Other|0|||
48420997|NCT01380093|155731190|FG004|Treatment Phase: Third Intervention|Other|0|||
48420998|NCT01380093|155731191|FG005|Treatment Phase: Third Intervention|Other|0|||
48420999|NCT01380093|155731192|FG006|Treatment Phase: Third Intervention|Other|0|||
48421000|NCT01380093|155731193|FG007|Treatment Phase: Third Intervention|Other|0|||
48421001|NCT01380093|155731194|FG008|Treatment Phase: Third Intervention|Other|1|||
48421002|NCT00091793|155731195|FG000|Overall Study|Adverse Event|1|||
48421003|NCT00091793|155731196|FG001|Overall Study|Adverse Event|2|||
48421004|NCT00091793|155731195|FG000|Overall Study|Withdrawal by Subject|10|||
48421005|NCT00091793|155731196|FG001|Overall Study|Withdrawal by Subject|15|||
48421006|NCT00091793|155731195|FG000|Overall Study|Ineligibility determined|2|||
48421007|NCT00091793|155731196|FG001|Overall Study|Ineligibility determined|0|||
48421008|NCT00091793|155731195|FG000|Overall Study|Lost to Follow-up|7|||
48421009|NCT00091793|155731196|FG001|Overall Study|Lost to Follow-up|5|||
48421010|NCT00091793|155731195|FG000|Overall Study|Noncompliance|2|||
48421011|NCT00091793|155731196|FG001|Overall Study|Noncompliance|0|||
48421012|NCT00091793|155731195|FG000|Overall Study|Other|2|||
48421013|NCT00091793|155731196|FG001|Overall Study|Other|0|||
48421014|NCT01025336|155731200|FG000|Overall Study|Protocol Violation|0|||
48421015|NCT01025336|155731201|FG001|Overall Study|Protocol Violation|0|||
48421016|NCT01025336|155731202|FG002|Overall Study|Protocol Violation|0|||
48421017|NCT01025336|155731203|FG003|Overall Study|Protocol Violation|2|||
48421018|NCT01025336|155731204|FG004|Overall Study|Protocol Violation|0|||
48421019|NCT00474253|155731212|FG000|Overall Study|Withdrew consent|2|||
48421020|NCT00474253|155731213|FG001|Overall Study|Withdrew consent|0|||
48421021|NCT00474253|155731212|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
48421022|NCT00474253|155731213|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
48421023|NCT00474253|155731212|FG000|Overall Study|Lost to Follow-up|1|||
48421024|NCT00474253|155731213|FG001|Overall Study|Lost to Follow-up|0|||
48421025|NCT00474253|155731212|FG000|Overall Study|Discharged prior to study completion|0|||
48421026|NCT00474253|155731213|FG001|Overall Study|Discharged prior to study completion|1|||
48421027|NCT03455543|155731217|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
48421028|NCT03455543|155731218|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
48421029|NCT03455543|155731219|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
48421030|NCT03455543|155731217|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
48421031|NCT03455543|155731218|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
48421032|NCT03455543|155731219|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
48421033|NCT03455543|155731217|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
48421034|NCT03455543|155731218|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
48421035|NCT03455543|155731219|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
48421036|NCT03455543|155731217|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
48421037|NCT03455543|155731218|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
48421038|NCT03455543|155731219|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
48421039|NCT03455543|155731217|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
48421040|NCT03455543|155731218|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
48421041|NCT03455543|155731219|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
48421042|NCT03455543|155731217|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
48421043|NCT03455543|155731218|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
48421044|NCT03455543|155731219|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
48421045|NCT03455543|155731217|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
48421046|NCT03455543|155731218|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
48421047|NCT03455543|155731219|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
48421048|NCT03455543|155731217|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
48421049|NCT03455543|155731218|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
48421050|NCT03455543|155731219|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
48421051|NCT03455543|155731217|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
48421052|NCT03455543|155731218|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
48421053|NCT03455543|155731219|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
48421054|NCT01325493|155731220|FG000|Overall Study|Protocol Violation|0|||
48421055|NCT01325493|155731221|FG001|Overall Study|Protocol Violation|1|||
48421056|NCT01325493|155731220|FG000|Overall Study|loss of neuromonitoring signals|0|||
48421057|NCT01325493|155731221|FG001|Overall Study|loss of neuromonitoring signals|2|||
48421058|NCT01325493|155731220|FG000|Overall Study|Allergy|1|||
48421059|NCT01325493|155731221|FG001|Overall Study|Allergy|0|||
48421060|NCT00465569|155731223|FG000|Overall Study|persistent eczema during dose escalation|1|||
48421061|NCT00465569|155731224|FG001|Overall Study|persistent eczema during dose escalation|0|||
48421062|NCT05370157|155731227|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
48421063|NCT05370157|155731228|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
48421064|NCT05370157|155731227|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
48421065|NCT05370157|155731228|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
48421066|NCT02732912|155731229|FG000|Overall Study|Discharged before night|2|||
48421067|NCT02732912|155731230|FG001|Overall Study|Discharged before night|6|||
48421068|NCT02732912|155731229|FG000|Overall Study|Incomplete completion of questionnaire|2|||
48421069|NCT02732912|155731230|FG001|Overall Study|Incomplete completion of questionnaire|3|||
48421070|NCT02732912|155731229|FG000|Overall Study|No outcome; discharged or refused|6|||
48421071|NCT02732912|155731230|FG001|Overall Study|No outcome; discharged or refused|9|||
48421072|NCT00942708|155731233|FG000|Overall Study|Withdrawal by Subject|1|||
48421073|NCT01426386|155731234|FG000|Overall Study|Adverse Event|0|||
48421074|NCT01426386|155731235|FG001|Overall Study|Adverse Event|1|||
48421075|NCT01426386|155731236|FG002|Overall Study|Adverse Event|0|||
48421076|NCT01426386|155731237|FG003|Overall Study|Adverse Event|0|||
48421077|NCT01426386|155731238|FG004|Overall Study|Adverse Event|0|||
48421078|NCT01426386|155731239|FG005|Overall Study|Adverse Event|0|||
48421079|NCT01426386|155731234|FG000|Overall Study|Did not attend scheduled visit|1|||
48421080|NCT01426386|155731235|FG001|Overall Study|Did not attend scheduled visit|4|||
48421081|NCT01426386|155731236|FG002|Overall Study|Did not attend scheduled visit|0|||
48421082|NCT01426386|155731237|FG003|Overall Study|Did not attend scheduled visit|0|||
48421083|NCT01426386|155731238|FG004|Overall Study|Did not attend scheduled visit|2|||
48421084|NCT01426386|155731239|FG005|Overall Study|Did not attend scheduled visit|1|||
48421085|NCT01426386|155731234|FG000|Overall Study|Poor response|2|||
48421086|NCT01426386|155731235|FG001|Overall Study|Poor response|1|||
48421087|NCT01426386|155731236|FG002|Overall Study|Poor response|2|||
48421088|NCT01426386|155731237|FG003|Overall Study|Poor response|0|||
48421089|NCT01426386|155731238|FG004|Overall Study|Poor response|1|||
48421090|NCT01426386|155731239|FG005|Overall Study|Poor response|0|||
48421091|NCT01426386|155731234|FG000|Overall Study|Personal reasons|0|||
48421092|NCT01426386|155731235|FG001|Overall Study|Personal reasons|0|||
48421093|NCT01426386|155731236|FG002|Overall Study|Personal reasons|0|||
48421094|NCT01426386|155731237|FG003|Overall Study|Personal reasons|0|||
48421095|NCT01426386|155731238|FG004|Overall Study|Personal reasons|1|||
48421096|NCT01426386|155731239|FG005|Overall Study|Personal reasons|0|||
48421097|NCT02519231|155731241|FG000|Overall Study|Lost to Follow-up|2|||
48421098|NCT02519231|155731242|FG001|Overall Study|Lost to Follow-up|5|||
48421099|NCT02519231|155731241|FG000|Overall Study|Withdrawal by Subject|0|||
48421100|NCT02519231|155731242|FG001|Overall Study|Withdrawal by Subject|1|||
48421101|NCT00447421|155731243|FG000|Overall Study|Lack of Efficacy|1|||
48421102|NCT00447421|155731243|FG000|Overall Study|Adverse Event|3|||
48421103|NCT00447421|155731243|FG000|Overall Study|Sponsor Decision|2|||
48421104|NCT02489630|155731248|FG000|Overall Study|Oversedation|1|||
48421105|NCT02489630|155731249|FG001|Overall Study|Oversedation|1|||
48421106|NCT02489630|155731248|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
48421107|NCT02489630|155731249|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
48421108|NCT02725177|155731253|FG000|Overall Study|Physician Decision|4|||
48421109|NCT02725177|155731253|FG000|Overall Study|Adverse Event|1|||
48421110|NCT00772967|155731256|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
48421111|NCT00772967|155731257|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
48421112|NCT00772967|155731258|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
48421113|NCT00772967|155731259|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
48421114|NCT00772967|155731260|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
48421115|NCT00772967|155731261|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
48421116|NCT00772967|155731256|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48421117|NCT00772967|155731257|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
48421118|NCT00772967|155731258|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48421119|NCT00772967|155731259|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48421120|NCT00772967|155731260|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48421121|NCT00772967|155731261|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
48421122|NCT00772967|155731256|FG000|Crossover Treatment 3|Adverse Event|0|||
48421123|NCT00772967|155731257|FG001|Crossover Treatment 3|Adverse Event|0|||
48421124|NCT00772967|155731258|FG002|Crossover Treatment 3|Adverse Event|0|||
48421125|NCT00772967|155731259|FG003|Crossover Treatment 3|Adverse Event|0|||
48421126|NCT00772967|155731260|FG004|Crossover Treatment 3|Adverse Event|1|||
48421127|NCT00772967|155731261|FG005|Crossover Treatment 3|Adverse Event|0|||
48421128|NCT02053246|155731262|FG000|Overall Study|Withdrawal by Subject|3|||
48421129|NCT02053246|155731262|FG000|Overall Study|Physician Decision|1|||
48421130|NCT02795156|155731264|FG000|Overall Study|Progressive Disease|22|||
48421131|NCT02795156|155731265|FG001|Overall Study|Progressive Disease|7|||
48421132|NCT02795156|155731266|FG002|Overall Study|Progressive Disease|34|||
48421133|NCT02795156|155731267|FG003|Overall Study|Progressive Disease|7|||
48421134|NCT02795156|155731264|FG000|Overall Study|Adverse Event|13|||
48421135|NCT02795156|155731265|FG001|Overall Study|Adverse Event|2|||
48421136|NCT02795156|155731266|FG002|Overall Study|Adverse Event|3|||
48421137|NCT02795156|155731267|FG003|Overall Study|Adverse Event|2|||
48421138|NCT02795156|155731264|FG000|Overall Study|Death|1|||
48421139|NCT02795156|155731265|FG001|Overall Study|Death|1|||
48421140|NCT02795156|155731266|FG002|Overall Study|Death|1|||
48421141|NCT02795156|155731267|FG003|Overall Study|Death|0|||
48421142|NCT02795156|155731264|FG000|Overall Study|Physician Decision|1|||
48421143|NCT02795156|155731265|FG001|Overall Study|Physician Decision|0|||
48421144|NCT02795156|155731266|FG002|Overall Study|Physician Decision|1|||
48421145|NCT02795156|155731267|FG003|Overall Study|Physician Decision|0|||
48421146|NCT02795156|155731264|FG000|Overall Study|Withdrawal by Subject|2|||
48421147|NCT02795156|155731265|FG001|Overall Study|Withdrawal by Subject|0|||
48421148|NCT02795156|155731266|FG002|Overall Study|Withdrawal by Subject|3|||
48421149|NCT02795156|155731267|FG003|Overall Study|Withdrawal by Subject|0|||
48421150|NCT01200511|155731268|FG000|Overall Study|Lost to Follow-up|3|||
48421151|NCT01200511|155731268|FG000|Overall Study|Withdrawal by Subject|1|||
48421152|NCT01200511|155731268|FG000|Overall Study|Adverse Event|1|||
48421153|NCT04024228|155732678|FG000|Overall Study|Adverse Event|1|||
48421154|NCT04024228|155732679|FG001|Overall Study|Adverse Event|0|||
48421155|NCT04024228|155732678|FG000|Overall Study|Protocol Deviation|0|||
48421156|NCT04024228|155732679|FG001|Overall Study|Protocol Deviation|2|||
48421157|NCT04024228|155732678|FG000|Overall Study|Withdrawal by Subject|3|||
48421158|NCT04024228|155732679|FG001|Overall Study|Withdrawal by Subject|4|||
48421159|NCT03199911|155732680|FG000|Overall Study|Lost to Follow-up|5|||
48421160|NCT03199911|155732681|FG001|Overall Study|Lost to Follow-up|5|||
48421161|NCT03199911|155732680|FG000|Overall Study|Did not proceed with surgery|2|||
48421162|NCT03199911|155732681|FG001|Overall Study|Did not proceed with surgery|1|||
48421163|NCT02333331|155732682|FG000|Overall Study|Adverse Event|1|||
48421164|NCT02333331|155732683|FG001|Overall Study|Adverse Event|0|||
48421165|NCT02333331|155732684|FG002|Overall Study|Adverse Event|4|||
48421166|NCT02333331|155732685|FG003|Overall Study|Adverse Event|1|||
48421167|NCT02333331|155732682|FG000|Overall Study|Death|0|||
48421168|NCT02333331|155732683|FG001|Overall Study|Death|0|||
48421169|NCT02333331|155732684|FG002|Overall Study|Death|2|||
48421170|NCT02333331|155732685|FG003|Overall Study|Death|0|||
48421171|NCT02333331|155732682|FG000|Overall Study|Lost to Follow-up|0|||
48421172|NCT02333331|155732683|FG001|Overall Study|Lost to Follow-up|0|||
48421173|NCT02333331|155732684|FG002|Overall Study|Lost to Follow-up|1|||
48421174|NCT02333331|155732685|FG003|Overall Study|Lost to Follow-up|0|||
48421175|NCT02333331|155732682|FG000|Overall Study|Physician Decision|0|||
48421176|NCT02333331|155732683|FG001|Overall Study|Physician Decision|1|||
48421177|NCT02333331|155732684|FG002|Overall Study|Physician Decision|0|||
48421178|NCT02333331|155732685|FG003|Overall Study|Physician Decision|0|||
48421179|NCT02333331|155732682|FG000|Overall Study|Protocol Deviation|0|||
48421180|NCT02333331|155732683|FG001|Overall Study|Protocol Deviation|3|||
48421181|NCT02333331|155732684|FG002|Overall Study|Protocol Deviation|2|||
48421182|NCT02333331|155732685|FG003|Overall Study|Protocol Deviation|1|||
48421183|NCT02333331|155732682|FG000|Overall Study|Patient/Guardian Decision|1|||
48421184|NCT02333331|155732683|FG001|Overall Study|Patient/Guardian Decision|2|||
48421185|NCT02333331|155732684|FG002|Overall Study|Patient/Guardian Decision|9|||
48421186|NCT02333331|155732685|FG003|Overall Study|Patient/Guardian Decision|1|||
48421187|NCT00573131|155732686|FG000|Overall Study|Withdrawal by Subject|10|||
48421188|NCT00573131|155732687|FG001|Overall Study|Withdrawal by Subject|8|||
48421189|NCT03952650|155732691|FG000|Overall Study|TRAVEL|0|||
48421190|NCT03952650|155732692|FG001|Overall Study|TRAVEL|4|||
48421191|NCT03952650|155732693|FG002|Overall Study|TRAVEL|0|||
48421192|NCT03952650|155732694|FG003|Overall Study|TRAVEL|4|||
48421193|NCT03952650|155732695|FG004|Overall Study|TRAVEL|0|||
48421194|NCT03952650|155732696|FG005|Overall Study|TRAVEL|3|||
48421195|NCT03952650|155732697|FG006|Overall Study|TRAVEL|2|||
48421196|NCT03952650|155732691|FG000|Overall Study|Withdrawal by Subject|0|||
48421197|NCT03952650|155732692|FG001|Overall Study|Withdrawal by Subject|2|||
48421198|NCT03952650|155732693|FG002|Overall Study|Withdrawal by Subject|0|||
48421199|NCT03952650|155732694|FG003|Overall Study|Withdrawal by Subject|3|||
48421200|NCT03952650|155732695|FG004|Overall Study|Withdrawal by Subject|0|||
48421201|NCT03952650|155732696|FG005|Overall Study|Withdrawal by Subject|1|||
48421202|NCT03952650|155732697|FG006|Overall Study|Withdrawal by Subject|1|||
48421203|NCT03952650|155732691|FG000|Overall Study|Lost to Follow-up|0|||
48421204|NCT03952650|155732692|FG001|Overall Study|Lost to Follow-up|1|||
48421205|NCT03952650|155732693|FG002|Overall Study|Lost to Follow-up|0|||
48421206|NCT03952650|155732694|FG003|Overall Study|Lost to Follow-up|0|||
48421207|NCT03952650|155732695|FG004|Overall Study|Lost to Follow-up|0|||
48421208|NCT03952650|155732696|FG005|Overall Study|Lost to Follow-up|1|||
48421209|NCT03952650|155732697|FG006|Overall Study|Lost to Follow-up|1|||
48421210|NCT03952650|155732691|FG000|Overall Study|Received wrong vaccine and travelled|0|||
48421211|NCT03952650|155732692|FG001|Overall Study|Received wrong vaccine and travelled|0|||
48421212|NCT03952650|155732693|FG002|Overall Study|Received wrong vaccine and travelled|0|||
48421213|NCT03952650|155732694|FG003|Overall Study|Received wrong vaccine and travelled|0|||
48421214|NCT03952650|155732695|FG004|Overall Study|Received wrong vaccine and travelled|0|||
48421215|NCT03952650|155732696|FG005|Overall Study|Received wrong vaccine and travelled|1|||
48421216|NCT03952650|155732697|FG006|Overall Study|Received wrong vaccine and travelled|0|||
48421217|NCT03952650|155732691|FG000|Overall Study|Unable to make study visit|0|||
48421218|NCT03952650|155732692|FG001|Overall Study|Unable to make study visit|0|||
48421219|NCT03952650|155732693|FG002|Overall Study|Unable to make study visit|0|||
48421220|NCT03952650|155732694|FG003|Overall Study|Unable to make study visit|0|||
48421221|NCT03952650|155732695|FG004|Overall Study|Unable to make study visit|0|||
48421222|NCT03952650|155732696|FG005|Overall Study|Unable to make study visit|1|||
48421223|NCT03952650|155732697|FG006|Overall Study|Unable to make study visit|0|||
48421224|NCT00201201|155732698|FG000|Overall Study|Death|0|||
48421225|NCT00201201|155732699|FG001|Overall Study|Death|2|||
48421226|NCT00201201|155732698|FG000|Overall Study|Withdrawal by Subject|5|||
48421227|NCT00201201|155732699|FG001|Overall Study|Withdrawal by Subject|5|||
48421228|NCT01357239|155732700|FG000|Stratum: All Patients|Adverse Event|0|||
48421229|NCT01357239|155732701|FG001|Stratum: All Patients|Adverse Event|0|||
48421230|NCT01357239|155732702|FG002|Stratum: All Patients|Adverse Event|1|||
48421231|NCT01357239|155732703|FG003|Stratum: All Patients|Adverse Event|1|||
48421232|NCT01357239|155732700|FG000|Stratum: All Patients|Subject withdrew consent|0|||
48421233|NCT01357239|155732701|FG001|Stratum: All Patients|Subject withdrew consent|0|||
48421234|NCT01357239|155732702|FG002|Stratum: All Patients|Subject withdrew consent|1|||
48421235|NCT01357239|155732703|FG003|Stratum: All Patients|Subject withdrew consent|1|||
48421236|NCT01357239|155732700|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
48421237|NCT01357239|155732701|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
48421238|NCT01357239|155732702|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
48421239|NCT01357239|155732703|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
48421240|NCT01357239|155732700|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
48421241|NCT01357239|155732701|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
48421242|NCT01357239|155732702|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
48421243|NCT01357239|155732703|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
48421244|NCT01357239|155732700|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
48421245|NCT01357239|155732701|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
48421246|NCT01357239|155732702|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
48421247|NCT01357239|155732703|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
48421248|NCT02723630|155732710|FG000|Intervention Period 1|Adverse Event|1|||
48421249|NCT02723630|155732711|FG001|Intervention Period 1|Adverse Event|0|||
48421250|NCT02723630|155732712|FG002|Intervention Period 1|Adverse Event|0|||
48421251|NCT02723630|155732713|FG003|Intervention Period 1|Adverse Event|0|||
48421252|NCT02723630|155732714|FG004|Intervention Period 1|Adverse Event|0|||
48421253|NCT02723630|155732715|FG005|Intervention Period 1|Adverse Event|0|||
48421254|NCT02723630|155732710|FG000|Intervention Period 3|consumption of restricted item|0|||
48421255|NCT02723630|155732711|FG001|Intervention Period 3|consumption of restricted item|1|||
48421256|NCT02723630|155732712|FG002|Intervention Period 3|consumption of restricted item|0|||
48421257|NCT02723630|155732713|FG003|Intervention Period 3|consumption of restricted item|0|||
48421258|NCT02723630|155732714|FG004|Intervention Period 3|consumption of restricted item|0|||
48421259|NCT02723630|155732715|FG005|Intervention Period 3|consumption of restricted item|0|||
48421260|NCT05372315|155732716|FG000|Overall Study|Withdrawal by Subject|1|||
48421261|NCT05372315|155732717|FG001|Overall Study|Withdrawal by Subject|0|||
48421262|NCT02240628|155732718|FG000|Overall Study|Physician Decision|6|||
48421263|NCT02240628|155732719|FG001|Overall Study|Physician Decision|5|||
48421264|NCT00650585|155732720|FG000|Overall Study|Lost to Follow-up|505|||
48421265|NCT00650585|155732721|FG001|Overall Study|Lost to Follow-up|482|||
48421266|NCT00650585|155732720|FG000|Overall Study|No parental consent|935|||
48421267|NCT00650585|155732721|FG001|Overall Study|No parental consent|866|||
48421268|NCT00650585|155732720|FG000|Overall Study|Excluded/ruled ineligible|357|||
48421269|NCT00650585|155732721|FG001|Overall Study|Excluded/ruled ineligible|129|||
48421270|NCT02385123|155732722|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
48421271|NCT04983901|155732725|FG000|Overall Study|Death|1|||
48421272|NCT04983901|155732726|FG001|Overall Study|Death|4|||
48421273|NCT04983901|155732725|FG000|Overall Study|Lost to Follow-up|3|||
48421274|NCT04983901|155732726|FG001|Overall Study|Lost to Follow-up|0|||
48421275|NCT04983901|155732725|FG000|Overall Study|Protocol Violation|1|||
48421276|NCT04983901|155732726|FG001|Overall Study|Protocol Violation|0|||
48421277|NCT04983901|155732725|FG000|Overall Study|Withdrawal by Subject|1|||
48421278|NCT04983901|155732726|FG001|Overall Study|Withdrawal by Subject|2|||
48421279|NCT01633060|155732727|FG000|Randomization Phase|Protocol deviation|1|||
48421280|NCT01633060|155732728|FG001|Randomization Phase|Protocol deviation|2|||
48421281|NCT01633060|155732727|FG000|Randomization Phase|Technical problem|0|||
48421282|NCT01633060|155732728|FG001|Randomization Phase|Technical problem|1|||
48421283|NCT01633060|155732727|FG000|Treatment Phase|Adverse Event|24|||
48421284|NCT01633060|155732728|FG001|Treatment Phase|Adverse Event|3|||
48421285|NCT01633060|155732727|FG000|Treatment Phase|Lost to Follow-up|1|||
48421286|NCT01633060|155732728|FG001|Treatment Phase|Lost to Follow-up|0|||
48421287|NCT01633060|155732727|FG000|Treatment Phase|Physician Decision|16|||
48421288|NCT01633060|155732728|FG001|Treatment Phase|Physician Decision|7|||
48421289|NCT01633060|155732727|FG000|Treatment Phase|Progressive Disease|210|||
48421290|NCT01633060|155732728|FG001|Treatment Phase|Progressive Disease|120|||
48421291|NCT01633060|155732727|FG000|Treatment Phase|Protocol Deviation|1|||
48421292|NCT01633060|155732728|FG001|Treatment Phase|Protocol Deviation|0|||
48421293|NCT01633060|155732727|FG000|Treatment Phase|Study Terminated by sponsor|7|||
48421294|NCT01633060|155732728|FG001|Treatment Phase|Study Terminated by sponsor|3|||
48421295|NCT01633060|155732727|FG000|Treatment Phase|Subject/guardian decision|25|||
48421296|NCT01633060|155732728|FG001|Treatment Phase|Subject/guardian decision|4|||
48421297|NCT01633060|155732727|FG000|Treatment Phase|Death|4|||
48421298|NCT01633060|155732728|FG001|Treatment Phase|Death|3|||
48421299|NCT01633060|155732727|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
48421300|NCT01633060|155732728|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48421301|NCT01633060|155732727|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
48421302|NCT01633060|155732728|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
48421303|NCT01633060|155732727|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
48421304|NCT01633060|155732728|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
48421305|NCT01633060|155732727|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
48421306|NCT01633060|155732728|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
48421307|NCT01633060|155732727|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
48421308|NCT01633060|155732728|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
48421309|NCT01633060|155732727|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
48421310|NCT01633060|155732728|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
48421311|NCT02859415|155732731|FG000|Overall Study|Physician Decision|1|||
48421312|NCT02859415|155732732|FG001|Overall Study|Physician Decision|0|||
48421313|NCT02859415|155732731|FG000|Overall Study|Off treatment due to cardiac event|0|||
48421314|NCT02859415|155732732|FG001|Overall Study|Off treatment due to cardiac event|1|||
48421315|NCT01743027|155732735|FG000|Overall Study|Adverse Event|2|||
48421316|NCT01743027|155732736|FG001|Overall Study|Adverse Event|0|||
48421317|NCT01743027|155732737|FG002|Overall Study|Adverse Event|0|||
48421318|NCT01743027|155732738|FG003|Overall Study|Adverse Event|0|||
48421319|NCT01743027|155732735|FG000|Overall Study|Lost to Follow-up|0|||
48421320|NCT01743027|155732736|FG001|Overall Study|Lost to Follow-up|0|||
48421321|NCT01743027|155732737|FG002|Overall Study|Lost to Follow-up|2|||
48421322|NCT01743027|155732738|FG003|Overall Study|Lost to Follow-up|0|||
48421323|NCT01743027|155732735|FG000|Overall Study|Progressive Disease|1|||
48421324|NCT01743027|155732736|FG001|Overall Study|Progressive Disease|4|||
48421325|NCT01743027|155732737|FG002|Overall Study|Progressive Disease|3|||
48421326|NCT01743027|155732738|FG003|Overall Study|Progressive Disease|0|||
48421327|NCT01743027|155732735|FG000|Overall Study|Protocol Violation|1|||
48421328|NCT01743027|155732736|FG001|Overall Study|Protocol Violation|1|||
48421329|NCT01743027|155732737|FG002|Overall Study|Protocol Violation|1|||
48421330|NCT01743027|155732738|FG003|Overall Study|Protocol Violation|0|||
48421331|NCT01743027|155732735|FG000|Overall Study|Withdrawal by Subject|1|||
48421332|NCT01743027|155732736|FG001|Overall Study|Withdrawal by Subject|0|||
48421333|NCT01743027|155732737|FG002|Overall Study|Withdrawal by Subject|3|||
48421334|NCT01743027|155732738|FG003|Overall Study|Withdrawal by Subject|1|||
48421335|NCT01753518|155732739|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
48421336|NCT01753518|155732740|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
48421337|NCT01753518|155732739|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
48421338|NCT01753518|155732740|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
48421339|NCT01753518|155732739|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
48421340|NCT01753518|155732740|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
48421341|NCT01753518|155732739|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
48421342|NCT01753518|155732740|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
48421343|NCT00532259|155732741|FG000|Overall Study|Withdrawal by Subject|2|||
48421344|NCT00532259|155732741|FG000|Overall Study|Adverse Event|1|||
48421345|NCT00532259|155732741|FG000|Overall Study|Death|1|||
48421346|NCT00532259|155732741|FG000|Overall Study|Lack of Efficacy|21|||
48421347|NCT00532259|155732741|FG000|Overall Study|Lost to Follow-up|3|||
48421348|NCT00532259|155732741|FG000|Overall Study|Physician Decision|3|||
48421349|NCT00532259|155732741|FG000|Overall Study|Protocol Violation|1|||
48421350|NCT01359982|155732744|FG000|Overall Study|Adverse Event|2|||
48421351|NCT01359982|155732745|FG001|Overall Study|Adverse Event|0|||
48421352|NCT01359982|155732746|FG002|Overall Study|Adverse Event|0|||
48421353|NCT01359982|155732747|FG003|Overall Study|Adverse Event|1|||
48421354|NCT01359982|155732748|FG004|Overall Study|Adverse Event|0|||
48421355|NCT01359982|155732749|FG005|Overall Study|Adverse Event|0|||
48421356|NCT01359982|155732744|FG000|Overall Study|Death|1|||
48421357|NCT01359982|155732745|FG001|Overall Study|Death|0|||
48421358|NCT01359982|155732746|FG002|Overall Study|Death|0|||
48421359|NCT01359982|155732747|FG003|Overall Study|Death|0|||
48421360|NCT01359982|155732748|FG004|Overall Study|Death|0|||
48421361|NCT01359982|155732749|FG005|Overall Study|Death|0|||
48421362|NCT01450137|155732751|FG000|Up to Week 12|Adverse Event|2|||
48421363|NCT01450137|155732752|FG001|Up to Week 12|Adverse Event|1|||
48421364|NCT01450137|155732751|FG000|Up to Week 12|Withdrawal by Subject|0|||
48421365|NCT01450137|155732752|FG001|Up to Week 12|Withdrawal by Subject|2|||
48421366|NCT01450137|155732751|FG000|Week 12 to Study End|Death|0|||
48421367|NCT01450137|155732752|FG001|Week 12 to Study End|Death|1|||
48421368|NCT01450137|155732751|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
48421369|NCT01450137|155732752|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
48421370|NCT01158950|155732757|FG000|1st Intervention (1 Day)|Physician Decision|1|||
48421371|NCT01158950|155732758|FG001|1st Intervention (1 Day)|Physician Decision|2|||
48421372|NCT02263365|155732759|FG000|Overall Study|Physician Decision|22|||
48421373|NCT02263365|155732760|FG001|Overall Study|Physician Decision|18|||
48421374|NCT02190591|155732763|FG000|Overall Study|Withdrawal by Subject|1|||
48421375|NCT02190591|155732764|FG001|Overall Study|Withdrawal by Subject|8|||
48421376|NCT02190591|155732763|FG000|Overall Study|Protocol Violation|1|||
48421377|NCT02190591|155732764|FG001|Overall Study|Protocol Violation|0|||
48421378|NCT02190591|155732763|FG000|Overall Study|did not use peanut ball as instructed|0|||
48421379|NCT02190591|155732764|FG001|Overall Study|did not use peanut ball as instructed|2|||
48421380|NCT02190591|155732763|FG000|Overall Study|face presentation so she was ineligible|0|||
48421381|NCT02190591|155732764|FG001|Overall Study|face presentation so she was ineligible|1|||
48421382|NCT00206518|155732765|FG000|Overall Study|Lack of Efficacy|6|||
48421383|NCT00206518|155732766|FG001|Overall Study|Lack of Efficacy|4|||
48421384|NCT00206518|155732765|FG000|Overall Study|Adverse Event|2|||
48421385|NCT00206518|155732766|FG001|Overall Study|Adverse Event|1|||
48421386|NCT00206518|155732765|FG000|Overall Study|Physician Decision|1|||
48421387|NCT00206518|155732766|FG001|Overall Study|Physician Decision|0|||
48421388|NCT00206518|155732765|FG000|Overall Study|Protocol Violation|1|||
48421389|NCT00206518|155732766|FG001|Overall Study|Protocol Violation|1|||
48421390|NCT03598777|155732767|FG000|Overall Study|Study Terminated by Sponsor|3|||
48421391|NCT03598777|155732768|FG001|Overall Study|Study Terminated by Sponsor|0|||
48421392|NCT03598777|155732769|FG002|Overall Study|Study Terminated by Sponsor|0|||
48421393|NCT03598777|155732770|FG003|Overall Study|Study Terminated by Sponsor|0|||
48421394|NCT03598777|155732771|FG004|Overall Study|Study Terminated by Sponsor|15|||
48421395|NCT03598777|155732767|FG000|Overall Study|Withdrawal by Subject|1|||
48421396|NCT03598777|155732768|FG001|Overall Study|Withdrawal by Subject|1|||
48421397|NCT03598777|155732769|FG002|Overall Study|Withdrawal by Subject|0|||
48421398|NCT03598777|155732770|FG003|Overall Study|Withdrawal by Subject|0|||
48421399|NCT03598777|155732771|FG004|Overall Study|Withdrawal by Subject|0|||
48421400|NCT03598777|155732767|FG000|Overall Study|Adverse Event|1|||
48421401|NCT03598777|155732768|FG001|Overall Study|Adverse Event|0|||
48421402|NCT03598777|155732769|FG002|Overall Study|Adverse Event|0|||
48421403|NCT03598777|155732770|FG003|Overall Study|Adverse Event|0|||
48421404|NCT03598777|155732771|FG004|Overall Study|Adverse Event|0|||
48421405|NCT03598777|155732767|FG000|Overall Study|Lost to Follow-up|1|||
48421406|NCT03598777|155732768|FG001|Overall Study|Lost to Follow-up|0|||
48421407|NCT03598777|155732769|FG002|Overall Study|Lost to Follow-up|0|||
48421408|NCT03598777|155732770|FG003|Overall Study|Lost to Follow-up|0|||
48421409|NCT03598777|155732771|FG004|Overall Study|Lost to Follow-up|0|||
48421410|NCT00072189|155732772|FG000|Overall Study|Withdrawal by Subject|1|||
48421411|NCT01933672|155732773|FG000|Metformin Run-in Period|Adverse Event|1|||
48421412|NCT01933672|155732774|FG001|Metformin Run-in Period|Adverse Event|0|||
48421413|NCT01933672|155732775|FG002|Metformin Run-in Period|Adverse Event|0|||
48421414|NCT01933672|155732776|FG003|Metformin Run-in Period|Adverse Event|0|||
48421415|NCT01933672|155732777|FG004|Metformin Run-in Period|Adverse Event|0|||
48421416|NCT01933672|155732778|FG005|Metformin Run-in Period|Adverse Event|0|||
48421417|NCT01933672|155732779|FG006|Metformin Run-in Period|Adverse Event|0|||
48421418|NCT01933672|155732773|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
48421419|NCT01933672|155732774|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48421420|NCT01933672|155732775|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48421421|NCT01933672|155732776|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48421422|NCT01933672|155732777|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48421423|NCT01933672|155732778|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48421424|NCT01933672|155732779|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
48421425|NCT01933672|155732773|FG000|Metformin Run-in Period|Other|5|||
48421426|NCT01933672|155732774|FG001|Metformin Run-in Period|Other|0|||
48421427|NCT01933672|155732775|FG002|Metformin Run-in Period|Other|0|||
48421428|NCT01933672|155732776|FG003|Metformin Run-in Period|Other|0|||
48421429|NCT01933672|155732777|FG004|Metformin Run-in Period|Other|0|||
48421430|NCT01933672|155732778|FG005|Metformin Run-in Period|Other|0|||
48421431|NCT01933672|155732779|FG006|Metformin Run-in Period|Other|0|||
48421432|NCT01933672|155732773|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421433|NCT01933672|155732774|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421434|NCT01933672|155732775|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421435|NCT01933672|155732776|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421436|NCT01933672|155732777|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
48421437|NCT01933672|155732778|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421438|NCT01933672|155732779|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421439|NCT01933672|155732773|FG000|First Intervention Period (12-16 Days)|Other|0|||
48421440|NCT01933672|155732774|FG001|First Intervention Period (12-16 Days)|Other|0|||
48421441|NCT01933672|155732775|FG002|First Intervention Period (12-16 Days)|Other|1|||
48421442|NCT01933672|155732776|FG003|First Intervention Period (12-16 Days)|Other|0|||
48421443|NCT01933672|155732777|FG004|First Intervention Period (12-16 Days)|Other|0|||
48421444|NCT01933672|155732778|FG005|First Intervention Period (12-16 Days)|Other|1|||
48421445|NCT01933672|155732779|FG006|First Intervention Period (12-16 Days)|Other|0|||
48421446|NCT01933672|155732773|FG000|Second Intervention Period (12-16 Days)|Other|0|||
48421447|NCT01933672|155732774|FG001|Second Intervention Period (12-16 Days)|Other|1|||
48421448|NCT01933672|155732775|FG002|Second Intervention Period (12-16 Days)|Other|1|||
48421449|NCT01933672|155732776|FG003|Second Intervention Period (12-16 Days)|Other|0|||
48421450|NCT01933672|155732777|FG004|Second Intervention Period (12-16 Days)|Other|0|||
48421451|NCT01933672|155732778|FG005|Second Intervention Period (12-16 Days)|Other|0|||
48421452|NCT01933672|155732779|FG006|Second Intervention Period (12-16 Days)|Other|0|||
48421453|NCT01933672|155732773|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421454|NCT01933672|155732774|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421455|NCT01933672|155732775|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421456|NCT01933672|155732776|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
48421457|NCT01933672|155732777|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421458|NCT01933672|155732778|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421459|NCT01933672|155732779|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
48421460|NCT01933672|155732773|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48421461|NCT01933672|155732774|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
48421462|NCT01933672|155732775|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48421463|NCT01933672|155732776|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48421464|NCT01933672|155732777|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48421465|NCT01933672|155732778|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48421466|NCT01933672|155732779|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
48421467|NCT01089725|155732782|FG000|Overall Study|Adverse Event|1|||
48421468|NCT01089725|155732783|FG001|Overall Study|Adverse Event|1|||
48421469|NCT01089725|155732784|FG002|Overall Study|Adverse Event|0|||
48421470|NCT01089725|155732785|FG003|Overall Study|Adverse Event|0|||
48421471|NCT01089725|155732786|FG004|Overall Study|Adverse Event|2|||
48421472|NCT01089725|155732782|FG000|Overall Study|Lack of Efficacy|4|||
48421473|NCT01089725|155732783|FG001|Overall Study|Lack of Efficacy|3|||
48421474|NCT01089725|155732784|FG002|Overall Study|Lack of Efficacy|1|||
48421475|NCT01089725|155732785|FG003|Overall Study|Lack of Efficacy|0|||
48421476|NCT01089725|155732786|FG004|Overall Study|Lack of Efficacy|4|||
48421477|NCT01089725|155732782|FG000|Overall Study|Lost to Follow-up|2|||
48421478|NCT01089725|155732783|FG001|Overall Study|Lost to Follow-up|2|||
48421479|NCT01089725|155732784|FG002|Overall Study|Lost to Follow-up|0|||
48421480|NCT01089725|155732785|FG003|Overall Study|Lost to Follow-up|3|||
48421481|NCT01089725|155732786|FG004|Overall Study|Lost to Follow-up|0|||
48421482|NCT01089725|155732782|FG000|Overall Study|Protocol Violation|0|||
48421483|NCT01089725|155732783|FG001|Overall Study|Protocol Violation|0|||
48421484|NCT01089725|155732784|FG002|Overall Study|Protocol Violation|1|||
48421485|NCT01089725|155732785|FG003|Overall Study|Protocol Violation|1|||
48421486|NCT01089725|155732786|FG004|Overall Study|Protocol Violation|0|||
48421487|NCT01089725|155732782|FG000|Overall Study|Withdrawal by Subject|5|||
48421488|NCT01089725|155732783|FG001|Overall Study|Withdrawal by Subject|5|||
48421489|NCT01089725|155732784|FG002|Overall Study|Withdrawal by Subject|4|||
48421490|NCT01089725|155732785|FG003|Overall Study|Withdrawal by Subject|5|||
48421491|NCT01089725|155732786|FG004|Overall Study|Withdrawal by Subject|4|||
48421492|NCT01089725|155732782|FG000|Overall Study|Study Terminated by Sponsor|51|||
48421493|NCT01089725|155732783|FG001|Overall Study|Study Terminated by Sponsor|56|||
48421494|NCT01089725|155732784|FG002|Overall Study|Study Terminated by Sponsor|53|||
48421495|NCT01089725|155732785|FG003|Overall Study|Study Terminated by Sponsor|68|||
48421496|NCT01089725|155732786|FG004|Overall Study|Study Terminated by Sponsor|68|||
48421497|NCT01089725|155732782|FG000|Overall Study|Randomized, but not treated|0|||
48421498|NCT01089725|155732783|FG001|Overall Study|Randomized, but not treated|1|||
48421499|NCT01089725|155732784|FG002|Overall Study|Randomized, but not treated|2|||
48421500|NCT01089725|155732785|FG003|Overall Study|Randomized, but not treated|1|||
48421501|NCT01089725|155732786|FG004|Overall Study|Randomized, but not treated|2|||
48421502|NCT01089725|155732782|FG000|Overall Study|Other|3|||
48421503|NCT01089725|155732783|FG001|Overall Study|Other|0|||
48421504|NCT01089725|155732784|FG002|Overall Study|Other|0|||
48421505|NCT01089725|155732785|FG003|Overall Study|Other|1|||
48421506|NCT01089725|155732786|FG004|Overall Study|Other|0|||
48421507|NCT01676116|155732787|FG000|Overall Study|Withdrawal criteria|2|||
48421508|NCT01676116|155732788|FG001|Overall Study|Withdrawal criteria|14|||
48421509|NCT01676116|155732787|FG000|Overall Study|Adverse Event|1|||
48421510|NCT01676116|155732788|FG001|Overall Study|Adverse Event|2|||
48421511|NCT01676116|155732787|FG000|Overall Study|Unclassified|4|||
48421512|NCT01676116|155732788|FG001|Overall Study|Unclassified|10|||
48421513|NCT01676116|155732787|FG000|Overall Study|Protocol Violation|9|||
48421514|NCT01676116|155732788|FG001|Overall Study|Protocol Violation|3|||
48421515|NCT01787591|155732793|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
48421516|NCT01787591|155732794|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
48421517|NCT01787591|155732795|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
48421518|NCT01787591|155732796|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
48421519|NCT02124798|155732798|FG000|Overall Study|Adverse Event|3|||
48421520|NCT02124798|155732798|FG000|Overall Study|Lost to Follow-up|1|||
48421521|NCT00907738|155732803|FG000|Overall Study|Adverse Event|2|||
48421522|NCT00907738|155732804|FG001|Overall Study|Adverse Event|0|||
48421523|NCT00907738|155732805|FG002|Overall Study|Adverse Event|1|||
48421524|NCT00907738|155732806|FG003|Overall Study|Adverse Event|0|||
48421525|NCT00907738|155732807|FG004|Overall Study|Adverse Event|0|||
48421526|NCT00907738|155732803|FG000|Overall Study|not specified or withdrew consent|3|||
48421527|NCT00907738|155732804|FG001|Overall Study|not specified or withdrew consent|0|||
48421528|NCT00907738|155732805|FG002|Overall Study|not specified or withdrew consent|0|||
48421529|NCT00907738|155732806|FG003|Overall Study|not specified or withdrew consent|0|||
48421530|NCT00907738|155732807|FG004|Overall Study|not specified or withdrew consent|0|||
48421531|NCT00907738|155732803|FG000|Overall Study|Disease progression|8|||
48421532|NCT00907738|155732804|FG001|Overall Study|Disease progression|1|||
48421533|NCT00907738|155732805|FG002|Overall Study|Disease progression|6|||
48421534|NCT00907738|155732806|FG003|Overall Study|Disease progression|4|||
48421535|NCT00907738|155732807|FG004|Overall Study|Disease progression|2|||
48421536|NCT02032875|155732812|FG000|Treatment Period|Adverse Event|1|||
48421537|NCT02032875|155732813|FG001|Treatment Period|Adverse Event|0|||
48421538|NCT02032875|155732812|FG000|Treatment Period|Liver transplant, No extension needed|0|||
48421539|NCT02032875|155732813|FG001|Treatment Period|Liver transplant, No extension needed|1|||
48421540|NCT02032875|155732812|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
48421541|NCT02032875|155732813|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
48421542|NCT02032875|155732812|FG000|Follow-up Period|Death|0|||
48421543|NCT02032875|155732813|FG001|Follow-up Period|Death|1|||
48421544|NCT02032875|155732812|FG000|Follow-up Period|Virologic Relapse|3|||
48421545|NCT02032875|155732813|FG001|Follow-up Period|Virologic Relapse|10|||
48421546|NCT01707147|155732814|FG000|Overall Study|Administered Trajenta prior to contract|5|||
48421547|NCT01707147|155732814|FG000|Overall Study|Patients who have not taken Trajenta|1|||
48421548|NCT01707147|155732814|FG000|Overall Study|Follow-up failure|17|||
48421549|NCT01707147|155732814|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
48421550|NCT00793585|155732815|FG000|Overall Study|Adverse Event|1|||
48421551|NCT00793585|155732816|FG001|Overall Study|Adverse Event|1|||
48421552|NCT00793585|155732815|FG000|Overall Study|Protocol Violation|1|||
48421553|NCT00793585|155732816|FG001|Overall Study|Protocol Violation|2|||
48421554|NCT02031146|155732817|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
48421555|NCT02031146|155732818|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
48421556|NCT02031146|155732819|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
48421557|NCT02031146|155732820|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
48421558|NCT02031146|155732821|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
48421559|NCT02031146|155732822|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
48421560|NCT02031146|155732823|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
48421561|NCT02903511|155732824|FG000|Overall Study|Withdrawal by Subject|1|||
48421562|NCT02903511|155732825|FG001|Overall Study|Withdrawal by Subject|0|||
48421563|NCT02903511|155732824|FG000|Overall Study|Lost to Follow-up|3|||
48421564|NCT02903511|155732825|FG001|Overall Study|Lost to Follow-up|2|||
48421565|NCT02707757|155732826|FG000|Overall Study|Protocol Violation|3|||
48421566|NCT02707757|155732827|FG001|Overall Study|Protocol Violation|2|||
48421567|NCT02707757|155732826|FG000|Overall Study|Withdrawal by Subject|2|||
48421568|NCT02707757|155732827|FG001|Overall Study|Withdrawal by Subject|0|||
48421569|NCT02707757|155732826|FG000|Overall Study|Death|0|||
48421570|NCT02707757|155732827|FG001|Overall Study|Death|1|||
48421571|NCT02707757|155732826|FG000|Overall Study|Adverse Event|6|||
48421572|NCT02707757|155732827|FG001|Overall Study|Adverse Event|4|||
48421573|NCT02707757|155732826|FG000|Overall Study|Renal transplant/elective operation|1|||
48421574|NCT02707757|155732827|FG001|Overall Study|Renal transplant/elective operation|5|||
48421575|NCT00815308|155732828|FG000|Overall Study|Adverse Event|4|||
48421576|NCT00815308|155732828|FG000|Overall Study|Withdrawal by Subject|0|||
48421577|NCT00815308|155732828|FG000|Overall Study|Protocol Violation|6|||
48421578|NCT01056523|155732831|FG000|Overall Study|Death|1|||
48421579|NCT01056523|155732832|FG001|Overall Study|Death|0|||
48421580|NCT01056523|155732833|FG002|Overall Study|Death|2|||
48421581|NCT01056523|155732834|FG003|Overall Study|Death|3|||
48421582|NCT01056523|155732835|FG004|Overall Study|Death|0|||
48421583|NCT01056523|155732836|FG005|Overall Study|Death|0|||
48421584|NCT01056523|155732837|FG006|Overall Study|Death|1|||
48421585|NCT02332915|155732838|FG000|Overall Study|Moved out of region|3|||
48421586|NCT02332915|155732839|FG001|Overall Study|Moved out of region|0|||
48421587|NCT02332915|155732838|FG000|Overall Study|Unrelated illness|1|||
48421588|NCT02332915|155732839|FG001|Overall Study|Unrelated illness|1|||
48421589|NCT02332915|155732838|FG000|Overall Study|Travel distance prohibitive|0|||
48421590|NCT02332915|155732839|FG001|Overall Study|Travel distance prohibitive|1|||
48421591|NCT02332915|155732838|FG000|Overall Study|did not meet inclusion criteria|2|||
48421592|NCT02332915|155732839|FG001|Overall Study|did not meet inclusion criteria|4|||
48421593|NCT03429556|155732840|FG000|Overall Study|Lost to Follow-up|0|||
48421594|NCT03429556|155732841|FG001|Overall Study|Lost to Follow-up|1|||
48421595|NCT03429556|155732842|FG002|Overall Study|Lost to Follow-up|0|||
48421596|NCT03429556|155732843|FG003|Overall Study|Lost to Follow-up|0|||
48421597|NCT01769404|155732846|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
48421598|NCT01769404|155732847|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
48421599|NCT01769404|155732846|FG000|Treatment Period 1|Withdrawal by Subject|3|||
48421600|NCT01769404|155732847|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48421601|NCT01769404|155732846|FG000|Treatment Period 1|Sponsor decision|1|||
48421602|NCT01769404|155732847|FG001|Treatment Period 1|Sponsor decision|0|||
48421603|NCT01769404|155732846|FG000|Treatment Period 2|Sponsor decision|7|||
48421604|NCT01769404|155732847|FG001|Treatment Period 2|Sponsor decision|0|||
48421605|NCT00377299|155732848|FG000|Overall Study|Lost to Follow-up|14|||
48421606|NCT00377299|155732849|FG001|Overall Study|Lost to Follow-up|19|||
48421607|NCT00377299|155732848|FG000|Overall Study|Adverse Event|0|||
48421608|NCT00377299|155732849|FG001|Overall Study|Adverse Event|1|||
48421609|NCT00377299|155732848|FG000|Overall Study|Withdrawal by Subject|5|||
48421610|NCT00377299|155732849|FG001|Overall Study|Withdrawal by Subject|4|||
48421611|NCT02522481|155732853|FG000|Overall Study|discontinued|1|||
48421612|NCT02522481|155732853|FG000|Overall Study|Not dosed|2|||
48421613|NCT03518840|155734392|FG000|Overall Study|Lost to Follow-up|6|||
48421614|NCT05165394|155734393|FG000|Overall Study|Withdrawal by Subject|5|||
48421615|NCT05165394|155734394|FG001|Overall Study|Withdrawal by Subject|1|||
48421616|NCT05165394|155734393|FG000|Overall Study|Lost to Follow-up|1|||
48421617|NCT05165394|155734394|FG001|Overall Study|Lost to Follow-up|2|||
48421618|NCT05165394|155734393|FG000|Overall Study|Other Than Specified|0|||
48421619|NCT05165394|155734394|FG001|Overall Study|Other Than Specified|1|||
48421620|NCT00001259|155734395|FG000|Study 2|Adverse Event|0|||
48421621|NCT00001259|155734396|FG001|Study 2|Adverse Event|0|||
48421622|NCT00001259|155734397|FG002|Study 2|Adverse Event|0|||
48421623|NCT00001259|155734398|FG003|Study 2|Adverse Event|0|||
48421624|NCT00001259|155734399|FG004|Study 2|Adverse Event|2|||
48421625|NCT00001259|155734400|FG005|Study 2|Adverse Event|0|||
48421626|NCT00001259|155734401|FG006|Study 2|Adverse Event|0|||
48421627|NCT03937986|155734406|FG000|Overall Study|COVID-19 Pandemic|1|||
48421628|NCT01853228|155734410|FG000|Phase 1|Lack of Efficacy|8|||
48421629|NCT01853228|155734411|FG001|Phase 1|Lack of Efficacy|0|||
48421630|NCT01853228|155734410|FG000|Phase 1|Other|1|||
48421631|NCT01853228|155734411|FG001|Phase 1|Other|0|||
48421632|NCT01853228|155734410|FG000|Phase 2|Physician Decision|0|||
48421633|NCT01853228|155734411|FG001|Phase 2|Physician Decision|1|||
48421634|NCT01853228|155734410|FG000|Phase 2|Proceed To Transplant|0|||
48421635|NCT01853228|155734411|FG001|Phase 2|Proceed To Transplant|3|||
48421636|NCT01853228|155734410|FG000|Phase 2|Lack of Efficacy|0|||
48421637|NCT01853228|155734411|FG001|Phase 2|Lack of Efficacy|4|||
48421638|NCT00663858|155734412|FG000|Overall Study|Adverse Event|9|||
48421639|NCT00663858|155734413|FG001|Overall Study|Adverse Event|1|||
48421640|NCT00663858|155734414|FG002|Overall Study|Adverse Event|6|||
48421641|NCT00663858|155734412|FG000|Overall Study|Lack of Efficacy|5|||
48421642|NCT00663858|155734413|FG001|Overall Study|Lack of Efficacy|1|||
48421643|NCT00663858|155734414|FG002|Overall Study|Lack of Efficacy|3|||
48421644|NCT00663858|155734412|FG000|Overall Study|Withdrawal by Subject|7|||
48421645|NCT00663858|155734413|FG001|Overall Study|Withdrawal by Subject|3|||
48421646|NCT00663858|155734414|FG002|Overall Study|Withdrawal by Subject|3|||
48421647|NCT00663858|155734412|FG000|Overall Study|Protocol Violation|5|||
48421648|NCT00663858|155734413|FG001|Overall Study|Protocol Violation|3|||
48421649|NCT00663858|155734414|FG002|Overall Study|Protocol Violation|4|||
48421650|NCT00663858|155734412|FG000|Overall Study|Other|8|||
48421651|NCT00663858|155734413|FG001|Overall Study|Other|2|||
48421652|NCT00663858|155734414|FG002|Overall Study|Other|4|||
48421653|NCT00443560|155734418|FG000|Overall Study|No intrathecal dose|58|||
48421654|NCT00443560|155734419|FG001|Overall Study|No intrathecal dose|26|||
48421655|NCT00443560|155734418|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
48421656|NCT00443560|155734419|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
48421657|NCT03060577|155734420|FG000|Overall Study|Withdrawal by Subject|25|||
48421658|NCT03060577|155734421|FG001|Overall Study|Withdrawal by Subject|5|||
48421659|NCT03060577|155734420|FG000|Overall Study|Physician Decision|4|||
48421660|NCT03060577|155734421|FG001|Overall Study|Physician Decision|3|||
48421661|NCT03060577|155734420|FG000|Overall Study|Lost to Follow-up|3|||
48421662|NCT03060577|155734421|FG001|Overall Study|Lost to Follow-up|0|||
48421663|NCT03060577|155734420|FG000|Overall Study|Death|7|||
48421664|NCT03060577|155734421|FG001|Overall Study|Death|1|||
48421665|NCT03060577|155734420|FG000|Overall Study|Adverse Event|9|||
48421666|NCT03060577|155734421|FG001|Overall Study|Adverse Event|1|||
48421667|NCT03060577|155734420|FG000|Overall Study|Inclusion/Exclusion|1|||
48421668|NCT03060577|155734421|FG001|Overall Study|Inclusion/Exclusion|0|||
48421669|NCT03060577|155734420|FG000|Overall Study|Other|8|||
48421670|NCT03060577|155734421|FG001|Overall Study|Other|2|||
48421671|NCT00686205|155734422|FG000|Overall Study|Protocol Violation|127|||
48421672|NCT00686205|155734423|FG001|Overall Study|Protocol Violation|0|||
48421673|NCT00686205|155734422|FG000|Overall Study|Withdrawal by Subject|2|||
48421674|NCT00686205|155734423|FG001|Overall Study|Withdrawal by Subject|0|||
48421675|NCT00686205|155734422|FG000|Overall Study|Specimen handling procedure altered|5878|||
48421676|NCT00686205|155734423|FG001|Overall Study|Specimen handling procedure altered|0|||
48421677|NCT00686205|155734422|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
48421678|NCT00686205|155734423|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
48421679|NCT02424539|155734426|FG000|Overall Study|Adverse Event|0|||
48421680|NCT02424539|155734427|FG001|Overall Study|Adverse Event|0|||
48421681|NCT02424539|155734428|FG002|Overall Study|Adverse Event|1|||
48421682|NCT02424539|155734426|FG000|Overall Study|Physician Decision|0|||
48421683|NCT02424539|155734427|FG001|Overall Study|Physician Decision|0|||
48421684|NCT02424539|155734428|FG002|Overall Study|Physician Decision|1|||
48421685|NCT02424539|155734426|FG000|Overall Study|Withdrawal by Subject|3|||
48421686|NCT02424539|155734427|FG001|Overall Study|Withdrawal by Subject|1|||
48421687|NCT02424539|155734428|FG002|Overall Study|Withdrawal by Subject|0|||
48421688|NCT02424539|155734426|FG000|Overall Study|Other: Reached stopping criteria|11|||
48421689|NCT02424539|155734427|FG001|Overall Study|Other: Reached stopping criteria|7|||
48421690|NCT02424539|155734428|FG002|Overall Study|Other: Reached stopping criteria|6|||
48421691|NCT00719810|155734429|FG000|Overall Study|Adverse Event|0|||
48421692|NCT00719810|155734430|FG001|Overall Study|Adverse Event|2|||
48421693|NCT00719810|155734431|FG002|Overall Study|Adverse Event|3|||
48421694|NCT00719810|155734429|FG000|Overall Study|Lost to Follow-up|2|||
48421695|NCT00719810|155734430|FG001|Overall Study|Lost to Follow-up|0|||
48421696|NCT00719810|155734431|FG002|Overall Study|Lost to Follow-up|3|||
48421697|NCT00719810|155734429|FG000|Overall Study|Physician Decision|0|||
48421698|NCT00719810|155734430|FG001|Overall Study|Physician Decision|1|||
48421699|NCT00719810|155734431|FG002|Overall Study|Physician Decision|0|||
48421700|NCT00719810|155734429|FG000|Overall Study|Withdrawal by Subject|1|||
48421701|NCT00719810|155734430|FG001|Overall Study|Withdrawal by Subject|1|||
48421702|NCT00719810|155734431|FG002|Overall Study|Withdrawal by Subject|2|||
48421703|NCT00791128|155734435|FG000|Overall Study|Adverse Event|4|||
48421704|NCT00791128|155734435|FG000|Overall Study|Device migration|2|||
48421705|NCT00791128|155734435|FG000|Overall Study|non-compliance by subject|2|||
48421706|NCT00791128|155734435|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
48421707|NCT04419506|155734441|FG000|Overall Study|Adverse Event|0|||
48421708|NCT04419506|155734442|FG001|Overall Study|Adverse Event|10|||
48421709|NCT04419506|155734443|FG002|Overall Study|Adverse Event|0|||
48421710|NCT04419506|155734444|FG003|Overall Study|Adverse Event|3|||
48421711|NCT04419506|155734441|FG000|Overall Study|Withdrawal by Subject|0|||
48421712|NCT04419506|155734442|FG001|Overall Study|Withdrawal by Subject|0|||
48421713|NCT04419506|155734443|FG002|Overall Study|Withdrawal by Subject|0|||
48421714|NCT04419506|155734444|FG003|Overall Study|Withdrawal by Subject|1|||
48421715|NCT04419506|155734441|FG000|Overall Study|poor-compliance|0|||
48421716|NCT04419506|155734442|FG001|Overall Study|poor-compliance|0|||
48421717|NCT04419506|155734443|FG002|Overall Study|poor-compliance|0|||
48421718|NCT04419506|155734444|FG003|Overall Study|poor-compliance|1|||
48421719|NCT00308620|155734447|FG000|Overall Study|Death|1|||
48421720|NCT00308620|155734448|FG001|Overall Study|Death|1|||
48421721|NCT00308620|155734449|FG002|Overall Study|Death|0|||
48421722|NCT00308620|155734447|FG000|Overall Study|Lost to Follow-up|0|||
48421723|NCT00308620|155734448|FG001|Overall Study|Lost to Follow-up|0|||
48421724|NCT00308620|155734449|FG002|Overall Study|Lost to Follow-up|1|||
48421725|NCT00550238|155734450|FG000|Overall Study|Adverse Event|88|||
48421726|NCT00550238|155734450|FG000|Overall Study|Death|34|||
48421727|NCT00550238|155734450|FG000|Overall Study|Disease progression|46|||
48421728|NCT00550238|155734450|FG000|Overall Study|Withdrawal by Subject|167|||
48421729|NCT00550238|155734450|FG000|Overall Study|Physician Decision|31|||
48421730|NCT00550238|155734450|FG000|Overall Study|Patient noncompliance|25|||
48421731|NCT00550238|155734450|FG000|Overall Study|Lost to Follow-up|13|||
48421732|NCT00550238|155734450|FG000|Overall Study|Sponsor decision|55|||
48421733|NCT01050062|155734451|FG000|Overall Study|Adverse Event|75|||
48421734|NCT01050062|155734452|FG001|Overall Study|Adverse Event|22|||
48421735|NCT01050062|155734451|FG000|Overall Study|Lost to Follow-up|83|||
48421736|NCT01050062|155734452|FG001|Overall Study|Lost to Follow-up|35|||
48421737|NCT01050062|155734451|FG000|Overall Study|Lack of Efficacy|22|||
48421738|NCT01050062|155734452|FG001|Overall Study|Lack of Efficacy|35|||
48421739|NCT01050062|155734451|FG000|Overall Study|Physician Decision|74|||
48421740|NCT01050062|155734452|FG001|Overall Study|Physician Decision|9|||
48421741|NCT01050062|155734451|FG000|Overall Study|Others|17|||
48421742|NCT01050062|155734452|FG001|Overall Study|Others|11|||
48421743|NCT02623361|155734455|FG000|Overall Study|Protocol Violation|0|||
48421744|NCT02623361|155734456|FG001|Overall Study|Protocol Violation|1|||
48421745|NCT02623361|155734455|FG000|Overall Study|Withdrawal by Subject|0|||
48421746|NCT02623361|155734456|FG001|Overall Study|Withdrawal by Subject|1|||
48421747|NCT03894540|155734457|FG000|Overall Study|Adverse Event|0|||
48421748|NCT03894540|155734458|FG001|Overall Study|Adverse Event|0|||
48421749|NCT03894540|155734459|FG002|Overall Study|Adverse Event|0|||
48421750|NCT03894540|155734460|FG003|Overall Study|Adverse Event|0|||
48421751|NCT03894540|155734461|FG004|Overall Study|Adverse Event|1|||
48421752|NCT03894540|155734462|FG005|Overall Study|Adverse Event|0|||
48421753|NCT03894540|155734457|FG000|Overall Study|Withdrawal by Subject|0|||
48421754|NCT03894540|155734458|FG001|Overall Study|Withdrawal by Subject|0|||
48421755|NCT03894540|155734459|FG002|Overall Study|Withdrawal by Subject|0|||
48421756|NCT03894540|155734460|FG003|Overall Study|Withdrawal by Subject|0|||
48421757|NCT03894540|155734461|FG004|Overall Study|Withdrawal by Subject|1|||
48421758|NCT03894540|155734462|FG005|Overall Study|Withdrawal by Subject|0|||
48421759|NCT03894540|155734457|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
48421760|NCT03894540|155734458|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
48421761|NCT03894540|155734459|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
48421762|NCT03894540|155734460|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
48421763|NCT03894540|155734461|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
48421764|NCT03894540|155734462|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
48421765|NCT03894540|155734457|FG000|Overall Study|Progressive Disease Clinical|1|||
48421766|NCT03894540|155734458|FG001|Overall Study|Progressive Disease Clinical|1|||
48421767|NCT03894540|155734459|FG002|Overall Study|Progressive Disease Clinical|0|||
48421768|NCT03894540|155734460|FG003|Overall Study|Progressive Disease Clinical|1|||
48426329|NCT02203838|155749552|FG002|Overall Study|Protocol Violation|0|||
48421769|NCT03894540|155734461|FG004|Overall Study|Progressive Disease Clinical|5|||
48421770|NCT03894540|155734462|FG005|Overall Study|Progressive Disease Clinical|1|||
48421771|NCT03894540|155734457|FG000|Overall Study|Study termination by sponsor|0|||
48421772|NCT03894540|155734458|FG001|Overall Study|Study termination by sponsor|0|||
48421773|NCT03894540|155734459|FG002|Overall Study|Study termination by sponsor|0|||
48421774|NCT03894540|155734460|FG003|Overall Study|Study termination by sponsor|0|||
48421775|NCT03894540|155734461|FG004|Overall Study|Study termination by sponsor|2|||
48421776|NCT03894540|155734462|FG005|Overall Study|Study termination by sponsor|0|||
48421777|NCT03000452|155734464|FG000|Treatment Period|Death|1|||
48421778|NCT03000452|155734464|FG000|Treatment Period|Progressive Disease (PD)|14|||
48421779|NCT03000452|155734464|FG000|Treatment Period|Physician Decision|1|||
48421780|NCT03000452|155734464|FG000|Treatment Period|Miscellaneous|2|||
48421781|NCT03000452|155734464|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
48421782|NCT03000452|155734464|FG000|Follow-Up Period|Death|3|||
48421783|NCT03000452|155734464|FG000|Follow-Up Period|Withdrawal by Subject|3|||
48421784|NCT03065530|155734465|FG000|Overall Study|Lack of Efficacy|1|||
48421785|NCT03065530|155734466|FG001|Overall Study|Lack of Efficacy|1|||
48421786|NCT03065530|155734467|FG002|Overall Study|Lack of Efficacy|0|||
48421787|NCT03065530|155734468|FG003|Overall Study|Lack of Efficacy|1|||
48421788|NCT03065530|155734465|FG000|Overall Study|Protocol Violation|1|||
48421789|NCT03065530|155734466|FG001|Overall Study|Protocol Violation|0|||
48421790|NCT03065530|155734467|FG002|Overall Study|Protocol Violation|1|||
48421791|NCT03065530|155734468|FG003|Overall Study|Protocol Violation|1|||
48421792|NCT00537745|155734469|FG000|Overall Study|Did not meet eligibility criteria|2|||
48421793|NCT00537745|155734469|FG000|Overall Study|Withdrawal by Subject|2|||
48421794|NCT00537745|155734469|FG000|Overall Study|Subject unable to provide Interlock info|1|||
48421795|NCT02717546|155734470|FG000|Overall Study|Lost to Follow-up|12|||
48421796|NCT00922935|155734471|FG000|Overall Study|Protocol Violation|0|||
48421797|NCT00922935|155734472|FG001|Overall Study|Protocol Violation|3|||
48421798|NCT00922935|155734473|FG002|Overall Study|Protocol Violation|0|||
48421799|NCT00922935|155734471|FG000|Overall Study|Physician Decision|1|||
48421800|NCT00922935|155734472|FG001|Overall Study|Physician Decision|1|||
48421801|NCT00922935|155734473|FG002|Overall Study|Physician Decision|0|||
48421802|NCT00922935|155734471|FG000|Overall Study|Lost to Follow-up|0|||
48421803|NCT00922935|155734472|FG001|Overall Study|Lost to Follow-up|1|||
48421804|NCT00922935|155734473|FG002|Overall Study|Lost to Follow-up|0|||
48421805|NCT02532543|155734474|FG000|Overall Study|Lost to Follow-up|0|||
48421806|NCT02532543|155734475|FG001|Overall Study|Lost to Follow-up|0|||
48421807|NCT02532543|155734476|FG002|Overall Study|Lost to Follow-up|1|||
48421808|NCT02532543|155734477|FG003|Overall Study|Lost to Follow-up|0|||
48421809|NCT04407507|155734478|FG000|Overall Study|Withdrawal by Subject|0|||
48421810|NCT04407507|155734479|FG001|Overall Study|Withdrawal by Subject|1|||
48421811|NCT00923091|155734486|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
48421812|NCT00923091|155734487|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
48421813|NCT00923091|155734488|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
48421814|NCT00923091|155734489|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
48421815|NCT00923091|155734490|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
48421816|NCT00923091|155734491|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
48421817|NCT00923091|155734492|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
48421818|NCT00923091|155734493|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
48421819|NCT00923091|155734494|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48421820|NCT00923091|155734495|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48421821|NCT00923091|155734496|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48421822|NCT00923091|155734497|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48421823|NCT00923091|155734498|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
48421824|NCT00923091|155734486|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
48421825|NCT00923091|155734487|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
48421826|NCT00923091|155734488|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
48421827|NCT00923091|155734489|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
48421828|NCT00923091|155734490|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
48421829|NCT00923091|155734491|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
48421830|NCT00923091|155734492|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
48421831|NCT00923091|155734493|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
48421832|NCT00923091|155734494|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48421833|NCT00923091|155734495|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48421834|NCT00923091|155734496|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48421835|NCT00923091|155734497|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48421836|NCT00923091|155734498|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
48421837|NCT00923091|155734486|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
48421838|NCT00923091|155734487|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
48421839|NCT00923091|155734488|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
48421840|NCT00923091|155734489|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
48421841|NCT00923091|155734490|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
48421842|NCT00923091|155734491|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
48421843|NCT00923091|155734492|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
48421844|NCT00923091|155734493|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
48421845|NCT00923091|155734494|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48421846|NCT00923091|155734495|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48421847|NCT00923091|155734496|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48421848|NCT00923091|155734497|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48421849|NCT00923091|155734498|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
48421850|NCT00923091|155734486|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421851|NCT00923091|155734487|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421852|NCT00923091|155734488|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421853|NCT00923091|155734489|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421854|NCT00923091|155734490|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421855|NCT00923091|155734491|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
48421856|NCT00923091|155734492|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421857|NCT00923091|155734493|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421858|NCT00923091|155734494|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421859|NCT00923091|155734495|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421860|NCT00923091|155734496|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421861|NCT00923091|155734497|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421862|NCT00923091|155734498|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
48421863|NCT00923091|155734486|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421864|NCT00923091|155734487|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
48421865|NCT00923091|155734488|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421866|NCT00923091|155734489|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
48421867|NCT00923091|155734490|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421868|NCT00923091|155734491|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
48421869|NCT00923091|155734492|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421870|NCT00923091|155734493|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421871|NCT00923091|155734494|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421872|NCT00923091|155734495|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421873|NCT00923091|155734496|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421874|NCT00923091|155734497|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421875|NCT00923091|155734498|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
48421876|NCT00923091|155734486|FG000|Period III (Single-Blind)|Adverse Event|5|||
48421877|NCT00923091|155734487|FG001|Period III (Single-Blind)|Adverse Event|0|||
48421878|NCT00923091|155734488|FG002|Period III (Single-Blind)|Adverse Event|0|||
48421879|NCT00923091|155734489|FG003|Period III (Single-Blind)|Adverse Event|0|||
48421880|NCT00923091|155734490|FG004|Period III (Single-Blind)|Adverse Event|0|||
48421881|NCT00923091|155734491|FG005|Period III (Single-Blind)|Adverse Event|0|||
48421882|NCT00923091|155734492|FG006|Period III (Single-Blind)|Adverse Event|0|||
48421883|NCT00923091|155734493|FG007|Period III (Single-Blind)|Adverse Event|0|||
48421884|NCT00923091|155734494|FG008|Period III (Single-Blind)|Adverse Event|0|||
48421885|NCT00923091|155734495|FG009|Period III (Single-Blind)|Adverse Event|0|||
48421886|NCT00923091|155734496|FG010|Period III (Single-Blind)|Adverse Event|0|||
48421887|NCT00923091|155734497|FG011|Period III (Single-Blind)|Adverse Event|0|||
48421888|NCT00923091|155734498|FG012|Period III (Single-Blind)|Adverse Event|0|||
48421889|NCT00923091|155734486|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
48421890|NCT00923091|155734487|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421891|NCT00923091|155734488|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421892|NCT00923091|155734489|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421893|NCT00923091|155734490|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421894|NCT00923091|155734491|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421895|NCT00923091|155734492|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421896|NCT00923091|155734493|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421897|NCT00923091|155734494|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421898|NCT00923091|155734495|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421899|NCT00923091|155734496|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421900|NCT00923091|155734497|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421901|NCT00923091|155734498|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
48421902|NCT00923091|155734486|FG000|Period III (Single-Blind)|Protocol Violation|3|||
48421903|NCT00923091|155734487|FG001|Period III (Single-Blind)|Protocol Violation|0|||
48421904|NCT00923091|155734488|FG002|Period III (Single-Blind)|Protocol Violation|0|||
48421905|NCT00923091|155734489|FG003|Period III (Single-Blind)|Protocol Violation|0|||
48421906|NCT00923091|155734490|FG004|Period III (Single-Blind)|Protocol Violation|0|||
48421907|NCT00923091|155734491|FG005|Period III (Single-Blind)|Protocol Violation|0|||
48421908|NCT00923091|155734492|FG006|Period III (Single-Blind)|Protocol Violation|0|||
48421909|NCT00923091|155734493|FG007|Period III (Single-Blind)|Protocol Violation|0|||
48421910|NCT00923091|155734494|FG008|Period III (Single-Blind)|Protocol Violation|0|||
48421911|NCT00923091|155734495|FG009|Period III (Single-Blind)|Protocol Violation|0|||
48421912|NCT00923091|155734496|FG010|Period III (Single-Blind)|Protocol Violation|0|||
48421913|NCT00923091|155734497|FG011|Period III (Single-Blind)|Protocol Violation|0|||
48421914|NCT00923091|155734498|FG012|Period III (Single-Blind)|Protocol Violation|0|||
48421915|NCT00923091|155734486|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
48421916|NCT00923091|155734487|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
48421917|NCT00923091|155734488|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
48421918|NCT00923091|155734489|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
48421919|NCT00923091|155734490|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
48421920|NCT00923091|155734491|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
48421921|NCT00923091|155734492|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
48421922|NCT00923091|155734493|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
48421923|NCT00923091|155734494|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
48421924|NCT00923091|155734495|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
48421925|NCT00923091|155734496|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
48421926|NCT00923091|155734497|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
48421927|NCT00923091|155734498|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
48421928|NCT00923091|155734486|FG000|Period IV (Double-Blind)|Adverse Event|2|||
48421929|NCT00923091|155734487|FG001|Period IV (Double-Blind)|Adverse Event|0|||
48421930|NCT00923091|155734488|FG002|Period IV (Double-Blind)|Adverse Event|0|||
48421931|NCT00923091|155734489|FG003|Period IV (Double-Blind)|Adverse Event|0|||
48421932|NCT00923091|155734490|FG004|Period IV (Double-Blind)|Adverse Event|0|||
48421933|NCT00923091|155734491|FG005|Period IV (Double-Blind)|Adverse Event|0|||
48421934|NCT00923091|155734492|FG006|Period IV (Double-Blind)|Adverse Event|0|||
48421935|NCT00923091|155734493|FG007|Period IV (Double-Blind)|Adverse Event|0|||
48421936|NCT00923091|155734494|FG008|Period IV (Double-Blind)|Adverse Event|0|||
48421937|NCT00923091|155734495|FG009|Period IV (Double-Blind)|Adverse Event|0|||
48421938|NCT00923091|155734496|FG010|Period IV (Double-Blind)|Adverse Event|0|||
48421939|NCT00923091|155734497|FG011|Period IV (Double-Blind)|Adverse Event|0|||
48421940|NCT00923091|155734498|FG012|Period IV (Double-Blind)|Adverse Event|0|||
48421941|NCT00923091|155734486|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421942|NCT00923091|155734487|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
48421943|NCT00923091|155734488|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421944|NCT00923091|155734489|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421945|NCT00923091|155734490|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421946|NCT00923091|155734491|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421947|NCT00923091|155734492|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421948|NCT00923091|155734493|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421949|NCT00923091|155734494|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421950|NCT00923091|155734495|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421951|NCT00923091|155734496|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421952|NCT00923091|155734497|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421953|NCT00923091|155734498|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
48421954|NCT00923091|155734486|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
48421955|NCT00923091|155734487|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
48421956|NCT00923091|155734488|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
48421957|NCT00923091|155734489|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
48421958|NCT00923091|155734490|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
48421959|NCT00923091|155734491|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
48421960|NCT00923091|155734492|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
48421961|NCT00923091|155734493|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
48421962|NCT00923091|155734494|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
48421963|NCT00923091|155734495|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
48421964|NCT00923091|155734496|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
48421965|NCT00923091|155734497|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
48421966|NCT00923091|155734498|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
48421967|NCT00923091|155734486|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421968|NCT00923091|155734487|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421969|NCT00923091|155734488|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421970|NCT00923091|155734489|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421971|NCT00923091|155734490|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421972|NCT00923091|155734491|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421973|NCT00923091|155734492|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421974|NCT00923091|155734493|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421975|NCT00923091|155734494|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
48421976|NCT00923091|155734495|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421977|NCT00923091|155734496|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421978|NCT00923091|155734497|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
48421979|NCT00923091|155734498|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
48421980|NCT00923091|155734486|FG000|Period V (Double -Blind)|Protocol Violation|0|||
48421981|NCT00923091|155734487|FG001|Period V (Double -Blind)|Protocol Violation|0|||
48421982|NCT00923091|155734488|FG002|Period V (Double -Blind)|Protocol Violation|0|||
48421983|NCT00923091|155734489|FG003|Period V (Double -Blind)|Protocol Violation|0|||
48421984|NCT00923091|155734490|FG004|Period V (Double -Blind)|Protocol Violation|0|||
48421985|NCT00923091|155734491|FG005|Period V (Double -Blind)|Protocol Violation|0|||
48421986|NCT00923091|155734492|FG006|Period V (Double -Blind)|Protocol Violation|0|||
48421987|NCT00923091|155734493|FG007|Period V (Double -Blind)|Protocol Violation|0|||
48421988|NCT00923091|155734494|FG008|Period V (Double -Blind)|Protocol Violation|0|||
48421989|NCT00923091|155734495|FG009|Period V (Double -Blind)|Protocol Violation|0|||
48421990|NCT00923091|155734496|FG010|Period V (Double -Blind)|Protocol Violation|0|||
48421991|NCT00923091|155734497|FG011|Period V (Double -Blind)|Protocol Violation|0|||
48421992|NCT00923091|155734498|FG012|Period V (Double -Blind)|Protocol Violation|1|||
48421993|NCT00923091|155734486|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
48421994|NCT00923091|155734487|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
48421995|NCT00923091|155734488|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
48421996|NCT00923091|155734489|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
48421997|NCT00923091|155734490|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
48421998|NCT00923091|155734491|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
48421999|NCT00923091|155734492|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
48422000|NCT00923091|155734493|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
48422001|NCT00923091|155734494|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
48422002|NCT00923091|155734495|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
48422003|NCT00923091|155734496|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
48422004|NCT00923091|155734497|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
48422005|NCT00923091|155734498|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
48422006|NCT00923091|155734486|FG000|Period VI (Open-Label)|Adverse Event|17|||
48422007|NCT00923091|155734487|FG001|Period VI (Open-Label)|Adverse Event|0|||
48422008|NCT00923091|155734488|FG002|Period VI (Open-Label)|Adverse Event|4|||
48422009|NCT00923091|155734489|FG003|Period VI (Open-Label)|Adverse Event|1|||
48422010|NCT00923091|155734490|FG004|Period VI (Open-Label)|Adverse Event|1|||
48422011|NCT00923091|155734491|FG005|Period VI (Open-Label)|Adverse Event|0|||
48422012|NCT00923091|155734492|FG006|Period VI (Open-Label)|Adverse Event|0|||
48422013|NCT00923091|155734493|FG007|Period VI (Open-Label)|Adverse Event|0|||
48422014|NCT00923091|155734494|FG008|Period VI (Open-Label)|Adverse Event|0|||
48422015|NCT00923091|155734495|FG009|Period VI (Open-Label)|Adverse Event|0|||
48422016|NCT00923091|155734496|FG010|Period VI (Open-Label)|Adverse Event|0|||
48422017|NCT00923091|155734497|FG011|Period VI (Open-Label)|Adverse Event|0|||
48422018|NCT00923091|155734498|FG012|Period VI (Open-Label)|Adverse Event|0|||
48422019|NCT00923091|155734486|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
48422020|NCT00923091|155734487|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
48422021|NCT00923091|155734488|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
48422022|NCT00923091|155734489|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422023|NCT00923091|155734490|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
48422024|NCT00923091|155734491|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422025|NCT00923091|155734492|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422026|NCT00923091|155734493|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422027|NCT00923091|155734494|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422028|NCT00923091|155734495|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422029|NCT00923091|155734496|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422030|NCT00923091|155734497|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422031|NCT00923091|155734498|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
48422032|NCT00923091|155734486|FG000|Period VI (Open-Label)|Protocol Violation|6|||
48422033|NCT00923091|155734487|FG001|Period VI (Open-Label)|Protocol Violation|1|||
48422034|NCT00923091|155734488|FG002|Period VI (Open-Label)|Protocol Violation|3|||
48422035|NCT00923091|155734489|FG003|Period VI (Open-Label)|Protocol Violation|1|||
48422036|NCT00923091|155734490|FG004|Period VI (Open-Label)|Protocol Violation|4|||
48422037|NCT00923091|155734491|FG005|Period VI (Open-Label)|Protocol Violation|0|||
48422038|NCT00923091|155734492|FG006|Period VI (Open-Label)|Protocol Violation|0|||
48422039|NCT00923091|155734493|FG007|Period VI (Open-Label)|Protocol Violation|0|||
48422040|NCT00923091|155734494|FG008|Period VI (Open-Label)|Protocol Violation|0|||
48422041|NCT00923091|155734495|FG009|Period VI (Open-Label)|Protocol Violation|0|||
48422042|NCT00923091|155734496|FG010|Period VI (Open-Label)|Protocol Violation|0|||
48422043|NCT00923091|155734497|FG011|Period VI (Open-Label)|Protocol Violation|0|||
48422044|NCT00923091|155734498|FG012|Period VI (Open-Label)|Protocol Violation|0|||
48422045|NCT00923091|155734486|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
48422046|NCT00923091|155734487|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
48422047|NCT00923091|155734488|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
48422048|NCT00923091|155734489|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
48422049|NCT00923091|155734490|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
48422050|NCT00923091|155734491|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
48422051|NCT00923091|155734492|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
48422052|NCT00923091|155734493|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
48422053|NCT00923091|155734494|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
48422054|NCT00923091|155734495|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
48422055|NCT00923091|155734496|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
48422056|NCT00923091|155734497|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
48422057|NCT00923091|155734498|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
48422058|NCT00923091|155734486|FG000|Period VI (Open-Label)|Other Reason|0|||
48422059|NCT00923091|155734487|FG001|Period VI (Open-Label)|Other Reason|0|||
48422060|NCT00923091|155734488|FG002|Period VI (Open-Label)|Other Reason|0|||
48422061|NCT00923091|155734489|FG003|Period VI (Open-Label)|Other Reason|1|||
48422062|NCT00923091|155734490|FG004|Period VI (Open-Label)|Other Reason|1|||
48422063|NCT00923091|155734491|FG005|Period VI (Open-Label)|Other Reason|0|||
48422064|NCT00923091|155734492|FG006|Period VI (Open-Label)|Other Reason|0|||
48422065|NCT00923091|155734493|FG007|Period VI (Open-Label)|Other Reason|0|||
48422066|NCT00923091|155734494|FG008|Period VI (Open-Label)|Other Reason|0|||
48422067|NCT00923091|155734495|FG009|Period VI (Open-Label)|Other Reason|0|||
48422068|NCT00923091|155734496|FG010|Period VI (Open-Label)|Other Reason|0|||
48422069|NCT00923091|155734497|FG011|Period VI (Open-Label)|Other Reason|0|||
48422070|NCT00923091|155734498|FG012|Period VI (Open-Label)|Other Reason|0|||
48422071|NCT00258154|155734499|FG000|Overall Study|Adverse Event|1|||
48422072|NCT00258154|155734500|FG001|Overall Study|Adverse Event|0|||
48422073|NCT00258154|155734499|FG000|Overall Study|Lost to Follow-up|0|||
48422074|NCT00258154|155734500|FG001|Overall Study|Lost to Follow-up|1|||
48422075|NCT00258154|155734499|FG000|Overall Study|Protocol Violation|2|||
48422076|NCT00258154|155734500|FG001|Overall Study|Protocol Violation|1|||
48422077|NCT00258154|155734499|FG000|Overall Study|Withdrawal by Subject|3|||
48422078|NCT00258154|155734500|FG001|Overall Study|Withdrawal by Subject|4|||
48422079|NCT00258154|155734499|FG000|Overall Study|Patient Moved|3|||
48422080|NCT00258154|155734500|FG001|Overall Study|Patient Moved|1|||
48422081|NCT01396525|155734501|FG000|Overall Study|Withdrawal by Subject|8|||
48422082|NCT01396525|155734501|FG000|Overall Study|Death|14|||
48422083|NCT01396525|155734501|FG000|Overall Study|Lost to Follow-up|4|||
48422084|NCT04601272|155734503|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
48422085|NCT04601272|155734504|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
48422086|NCT04601272|155734505|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
48422087|NCT00793104|155734508|FG000|Overall Study|Lost to Follow-up|1|||
48422088|NCT00871858|155734509|FG000|Overall Study|Protocol Violation|3|||
48422089|NCT00871858|155734510|FG001|Overall Study|Protocol Violation|4|||
48422090|NCT00871858|155734509|FG000|Overall Study|Adverse Event|1|||
48422091|NCT00871858|155734510|FG001|Overall Study|Adverse Event|1|||
48422092|NCT00871858|155734509|FG000|Overall Study|Withdrawal by Subject|1|||
48422093|NCT00871858|155734510|FG001|Overall Study|Withdrawal by Subject|1|||
48422094|NCT00871858|155734509|FG000|Overall Study|Lost to Follow-up|0|||
48422095|NCT00871858|155734510|FG001|Overall Study|Lost to Follow-up|1|||
48422096|NCT00003641|155734511|FG000|Overall Study|Withdrawal by Subject|0|||
48422097|NCT00003641|155734512|FG001|Overall Study|Withdrawal by Subject|100|||
48422098|NCT00003641|155734511|FG000|Overall Study|Adverse Event|0|||
48422099|NCT00003641|155734512|FG001|Overall Study|Adverse Event|38|||
48422100|NCT00003641|155734511|FG000|Overall Study|Disease progression|0|||
48422101|NCT00003641|155734512|FG001|Overall Study|Disease progression|2|||
48422102|NCT00003641|155734511|FG000|Overall Study|Unknown/missing|0|||
48422103|NCT00003641|155734512|FG001|Overall Study|Unknown/missing|22|||
48422104|NCT00003641|155734511|FG000|Overall Study|Should not receive interferon therapy|2|||
48422105|NCT00003641|155734512|FG001|Overall Study|Should not receive interferon therapy|0|||
48422106|NCT00003641|155734511|FG000|Overall Study|Never started interferon|567|||
48422107|NCT00003641|155734512|FG001|Overall Study|Never started interferon|12|||
48422108|NCT00376688|155734517|FG000|Overall Study|Adverse Event|3|||
48422109|NCT00376688|155734517|FG000|Overall Study|Death|1|||
48422110|NCT01821677|155734524|FG000|Overall Study|Adverse Event|4|||
48422111|NCT01821677|155734525|FG001|Overall Study|Adverse Event|6|||
48422112|NCT01821677|155734526|FG002|Overall Study|Adverse Event|5|||
48422113|NCT01821677|155734524|FG000|Overall Study|Physician Decision|1|||
48422114|NCT01821677|155734525|FG001|Overall Study|Physician Decision|4|||
48422115|NCT01821677|155734526|FG002|Overall Study|Physician Decision|1|||
48422116|NCT01821677|155734524|FG000|Overall Study|Non-compliance|0|||
48422117|NCT01821677|155734525|FG001|Overall Study|Non-compliance|1|||
48422118|NCT01821677|155734526|FG002|Overall Study|Non-compliance|2|||
48422119|NCT01821677|155734524|FG000|Overall Study|Lost to Follow-up|2|||
48422120|NCT01821677|155734525|FG001|Overall Study|Lost to Follow-up|1|||
48422121|NCT01821677|155734526|FG002|Overall Study|Lost to Follow-up|3|||
48422122|NCT01821677|155734524|FG000|Overall Study|Protocol Violation|0|||
48422123|NCT01821677|155734525|FG001|Overall Study|Protocol Violation|0|||
48422124|NCT01821677|155734526|FG002|Overall Study|Protocol Violation|2|||
48422125|NCT01821677|155734524|FG000|Overall Study|Withdrawal by Subject|7|||
48422126|NCT01821677|155734525|FG001|Overall Study|Withdrawal by Subject|3|||
48422127|NCT01821677|155734526|FG002|Overall Study|Withdrawal by Subject|2|||
48422128|NCT01821677|155734524|FG000|Overall Study|Other|9|||
48422129|NCT01821677|155734525|FG001|Overall Study|Other|0|||
48422130|NCT01821677|155734526|FG002|Overall Study|Other|0|||
48422131|NCT00538733|155734527|FG000|Overall Study|Adverse Event|8|||
48422132|NCT00538733|155734527|FG000|Overall Study|Death|1|||
48422133|NCT00538733|155734527|FG000|Overall Study|declined to participate|2|||
48422134|NCT00538733|155734527|FG000|Overall Study|still on therapy|1|||
48422135|NCT01137435|155734533|FG000|Overall Study|Lost to Follow-up|24|||
48422136|NCT01137435|155734533|FG000|Overall Study|Off label usage|4|||
48422137|NCT02675517|155734534|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
48422138|NCT02675517|155734534|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
48422139|NCT03607682|155734535|FG000|Overall Study|Withdrawal by Subject|1|||
48422140|NCT03607682|155734535|FG000|Overall Study|Disease progression|1|||
48422141|NCT01632878|155734536|FG000|Screening|Physician Decision|268|||
48422142|NCT01632878|155734536|FG000|Treatment|Lost to Follow-up|41|||
48422143|NCT01632878|155734536|FG000|Treatment|Withdrawal by Subject|36|||
48422144|NCT01632878|155734536|FG000|Treatment|Physician Decision|34|||
48422145|NCT01632878|155734536|FG000|Treatment|missing information|4|||
48422146|NCT01632878|155734536|FG000|Treatment|no information on study completion|43|||
48422147|NCT00336492|155734543|FG000|Overall Study|Adverse Event|4|||
48422148|NCT00336492|155734544|FG001|Overall Study|Adverse Event|3|||
48422149|NCT00336492|155734545|FG002|Overall Study|Adverse Event|6|||
48422150|NCT00336492|155734543|FG000|Overall Study|Lack of Efficacy|6|||
48422151|NCT00336492|155734544|FG001|Overall Study|Lack of Efficacy|1|||
48422152|NCT00336492|155734545|FG002|Overall Study|Lack of Efficacy|4|||
48422153|NCT00336492|155734543|FG000|Overall Study|Other|5|||
48422154|NCT00336492|155734544|FG001|Overall Study|Other|0|||
48422155|NCT00336492|155734545|FG002|Overall Study|Other|1|||
48422156|NCT02504892|155734546|FG000|Overall Study|Adverse event-pneumonitis|2|||
48422157|NCT01415440|155734547|FG000|Overall Study|Lost to Follow-up|0|||
48422158|NCT01415440|155734548|FG001|Overall Study|Lost to Follow-up|1|||
48422159|NCT01415440|155734549|FG002|Overall Study|Lost to Follow-up|2|||
48422160|NCT01415440|155734547|FG000|Overall Study|Physician Decision|3|||
48422161|NCT01415440|155734548|FG001|Overall Study|Physician Decision|0|||
48422162|NCT01415440|155734549|FG002|Overall Study|Physician Decision|0|||
48422163|NCT01415440|155734547|FG000|Overall Study|Withdrawal by Subject|1|||
48422164|NCT01415440|155734548|FG001|Overall Study|Withdrawal by Subject|0|||
48422165|NCT01415440|155734549|FG002|Overall Study|Withdrawal by Subject|0|||
48422166|NCT00095121|155734553|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
48422167|NCT00095121|155734554|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
48422168|NCT00095121|155734553|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
48422169|NCT00095121|155734554|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
48422170|NCT01118143|155734555|FG000|Overall Study|Withdrawal by Subject|2|||
48422171|NCT01118143|155734556|FG001|Overall Study|Withdrawal by Subject|5|||
48422172|NCT02746679|155734557|FG000|Overall Study|Lost to Follow-up|4|||
48422173|NCT02746679|155734558|FG001|Overall Study|Lost to Follow-up|6|||
48422174|NCT00487279|155734559|FG000|Overall Study|Death|1|||
48422175|NCT00487279|155734560|FG001|Overall Study|Death|0|||
48422176|NCT00487279|155734559|FG000|Overall Study|Withdrawal by Subject|0|||
48422177|NCT00487279|155734560|FG001|Overall Study|Withdrawal by Subject|2|||
48422178|NCT03366844|155736240|FG000|Overall Study|Physician Decision|1|||
48422179|NCT03366844|155736240|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
48422180|NCT00886821|155736241|FG000|Stage 2|Adverse Event|0|||
48422181|NCT00886821|155736242|FG001|Stage 2|Adverse Event|0|||
48422182|NCT00886821|155736243|FG002|Stage 2|Adverse Event|0|||
48422183|NCT00886821|155736244|FG003|Stage 2|Adverse Event|0|||
48422184|NCT00886821|155736245|FG004|Stage 2|Adverse Event|0|||
48422185|NCT00886821|155736246|FG005|Stage 2|Adverse Event|0|||
48422186|NCT00886821|155736247|FG006|Stage 2|Adverse Event|0|||
48422187|NCT00886821|155736248|FG007|Stage 2|Adverse Event|0|||
48422188|NCT00886821|155736249|FG008|Stage 2|Adverse Event|0|||
48422189|NCT00886821|155736250|FG009|Stage 2|Adverse Event|0|||
48422190|NCT00886821|155736251|FG010|Stage 2|Adverse Event|0|||
48422191|NCT00886821|155736252|FG011|Stage 2|Adverse Event|1|||
48422192|NCT00886821|155736253|FG012|Stage 2|Adverse Event|3|||
48422193|NCT00886821|155736254|FG013|Stage 2|Adverse Event|0|||
48422194|NCT00886821|155736241|FG000|Stage 2|Lost to Follow-up|0|||
48422195|NCT00886821|155736242|FG001|Stage 2|Lost to Follow-up|0|||
48422196|NCT00886821|155736243|FG002|Stage 2|Lost to Follow-up|0|||
48422197|NCT00886821|155736244|FG003|Stage 2|Lost to Follow-up|0|||
48422198|NCT00886821|155736245|FG004|Stage 2|Lost to Follow-up|0|||
48422199|NCT00886821|155736246|FG005|Stage 2|Lost to Follow-up|0|||
48422200|NCT00886821|155736247|FG006|Stage 2|Lost to Follow-up|0|||
48422201|NCT00886821|155736248|FG007|Stage 2|Lost to Follow-up|0|||
48422202|NCT00886821|155736249|FG008|Stage 2|Lost to Follow-up|0|||
48422203|NCT00886821|155736250|FG009|Stage 2|Lost to Follow-up|0|||
48422204|NCT00886821|155736251|FG010|Stage 2|Lost to Follow-up|0|||
48422205|NCT00886821|155736252|FG011|Stage 2|Lost to Follow-up|0|||
48422206|NCT00886821|155736253|FG012|Stage 2|Lost to Follow-up|2|||
48422207|NCT00886821|155736254|FG013|Stage 2|Lost to Follow-up|1|||
48422208|NCT02660580|155736255|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
48422209|NCT02660580|155736256|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
48422210|NCT02660580|155736257|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
48422211|NCT02660580|155736258|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
48422212|NCT02660580|155736259|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
48422213|NCT02660580|155736255|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
48422214|NCT02660580|155736256|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
48422215|NCT02660580|155736257|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
48422216|NCT02660580|155736258|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
48422217|NCT02660580|155736259|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
48422218|NCT02660580|155736255|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
48422219|NCT02660580|155736256|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
48422220|NCT02660580|155736257|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
48422221|NCT02660580|155736258|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
48422222|NCT02660580|155736259|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
48422223|NCT02660580|155736255|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
48422224|NCT02660580|155736256|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
48422225|NCT02660580|155736257|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
48422226|NCT02660580|155736258|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
48422227|NCT02660580|155736259|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
48422228|NCT02660580|155736255|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
48422229|NCT02660580|155736256|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
48422230|NCT02660580|155736257|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
48422231|NCT02660580|155736258|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
48422232|NCT02660580|155736259|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
48422233|NCT02660580|155736255|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
48422234|NCT02660580|155736256|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
48422235|NCT02660580|155736257|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
48422236|NCT02660580|155736258|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
48422237|NCT02660580|155736259|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
48422238|NCT02660580|155736255|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
48422239|NCT02660580|155736256|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
48422240|NCT02660580|155736257|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
48422241|NCT02660580|155736258|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
48422242|NCT02660580|155736259|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
48422243|NCT02660580|155736255|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
48422244|NCT02660580|155736256|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
48422245|NCT02660580|155736257|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
48422246|NCT02660580|155736258|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
48422247|NCT02660580|155736259|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
48422248|NCT02660580|155736255|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
48422249|NCT02660580|155736256|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
48422250|NCT02660580|155736257|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
48422251|NCT02660580|155736258|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
48422252|NCT02660580|155736259|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
48422253|NCT02660580|155736255|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
48422254|NCT02660580|155736256|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
48422255|NCT02660580|155736257|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
48422256|NCT02660580|155736258|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
48422257|NCT02660580|155736259|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
48422258|NCT02660580|155736255|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
48422259|NCT02660580|155736256|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
48422260|NCT02660580|155736257|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
48422261|NCT02660580|155736258|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
48422262|NCT02660580|155736259|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
48422263|NCT02660580|155736255|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
48422264|NCT02660580|155736256|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
48422265|NCT02660580|155736257|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
48422266|NCT02660580|155736258|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
48422267|NCT02660580|155736259|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
48422268|NCT02660580|155736255|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
48422269|NCT02660580|155736256|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
48422270|NCT02660580|155736257|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
48422271|NCT02660580|155736258|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
48422272|NCT02660580|155736259|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
48422273|NCT00128206|155736260|FG000|Overall Study|Lost to Follow-up|137|||
48422274|NCT00128206|155736261|FG001|Overall Study|Lost to Follow-up|118|||
48422275|NCT00128206|155736260|FG000|Overall Study|Adverse Event|0|||
48422276|NCT00128206|155736261|FG001|Overall Study|Adverse Event|2|||
48422277|NCT03167619|155736274|FG000|Overall Study|Death|11|||
48422278|NCT03167619|155736275|FG001|Overall Study|Death|8|||
48422279|NCT03167619|155736274|FG000|Overall Study|Withdrawal by Subject|1|||
48422280|NCT03167619|155736275|FG001|Overall Study|Withdrawal by Subject|2|||
48422281|NCT03167619|155736274|FG000|Overall Study|Physician Decision|0|||
48422282|NCT03167619|155736275|FG001|Overall Study|Physician Decision|1|||
48422283|NCT00641147|155736276|FG000|Completed 4 Months.|Physician Decision|1|||
48422284|NCT00641147|155736277|FG001|Completed 4 Months.|Physician Decision|0|||
48422285|NCT00641147|155736276|FG000|Completed 4 Months.|Adverse Event|1|||
48422286|NCT00641147|155736277|FG001|Completed 4 Months.|Adverse Event|0|||
48422287|NCT00641147|155736276|FG000|Completed 8 Months.|Physician Decision|2|||
48422288|NCT00641147|155736277|FG001|Completed 8 Months.|Physician Decision|1|||
48422289|NCT00641147|155736276|FG000|Completed 8 Months.|non compliance|1|||
48422290|NCT00641147|155736277|FG001|Completed 8 Months.|non compliance|0|||
48422291|NCT00641147|155736276|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
48422292|NCT00641147|155736277|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
48422293|NCT00641147|155736276|FG000|Completed 12 Months.|Physician Decision|1|||
48422294|NCT00641147|155736277|FG001|Completed 12 Months.|Physician Decision|1|||
48422295|NCT00641147|155736276|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
48422296|NCT00641147|155736277|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
48422297|NCT00641147|155736276|FG000|Completed 16 Months.|Physician Decision|1|||
48422298|NCT00641147|155736277|FG001|Completed 16 Months.|Physician Decision|0|||
48422299|NCT00641147|155736276|FG000|Completed 16 Months.|Lost to Follow-up|1|||
48422300|NCT00641147|155736277|FG001|Completed 16 Months.|Lost to Follow-up|0|||
48422301|NCT01416181|155736282|FG000|Part 1|Other|10|||
48422302|NCT01416181|155736283|FG001|Part 1|Other|24|||
48422303|NCT01416181|155736282|FG000|Part 1|Death|0|||
48422304|NCT01416181|155736283|FG001|Part 1|Death|1|||
48422305|NCT01416181|155736282|FG000|Part 1|Investigator Decision|7|||
48422306|NCT01416181|155736283|FG001|Part 1|Investigator Decision|6|||
48422307|NCT01416181|155736282|FG000|Part 1|Withdrawal by Subject|74|||
48422308|NCT01416181|155736283|FG001|Part 1|Withdrawal by Subject|48|||
48422309|NCT01416181|155736282|FG000|Part 1|Lack of Efficacy|16|||
48422310|NCT01416181|155736283|FG001|Part 1|Lack of Efficacy|8|||
48422311|NCT01416181|155736282|FG000|Part 1|Lost to Follow-up|1|||
48422312|NCT01416181|155736283|FG001|Part 1|Lost to Follow-up|1|||
48422313|NCT01416181|155736282|FG000|Part 1|Adverse Event|15|||
48422314|NCT01416181|155736283|FG001|Part 1|Adverse Event|18|||
48422315|NCT01416181|155736282|FG000|Part 1|Ongoing in Follow-Up|14|||
48422316|NCT01416181|155736283|FG001|Part 1|Ongoing in Follow-Up|8|||
48422317|NCT01416181|155736282|FG000|Part 2|Adverse Event|11|||
48422318|NCT01416181|155736283|FG001|Part 2|Adverse Event|4|||
48422319|NCT01416181|155736282|FG000|Part 2|Other|234|||
48422320|NCT01416181|155736283|FG001|Part 2|Other|267|||
48422321|NCT01416181|155736282|FG000|Part 2|Investigator Decision|6|||
48422322|NCT01416181|155736283|FG001|Part 2|Investigator Decision|7|||
48422323|NCT01416181|155736282|FG000|Part 2|Withdrawal by Subject|14|||
48422324|NCT01416181|155736283|FG001|Part 2|Withdrawal by Subject|5|||
48422325|NCT01416181|155736282|FG000|Part 2|Lack of Efficacy|4|||
48422326|NCT01416181|155736283|FG001|Part 2|Lack of Efficacy|1|||
48422327|NCT01416181|155736282|FG000|Part 2|Lost to Follow-up|2|||
48422328|NCT01416181|155736283|FG001|Part 2|Lost to Follow-up|2|||
48422329|NCT01821963|155736284|FG000|Overall Study|Adverse Event|1|||
48422330|NCT03090191|155736286|FG000|Overall Study|Adverse Event|90|||
48422331|NCT03090191|155736287|FG001|Overall Study|Adverse Event|72|||
48422332|NCT03090191|155736286|FG000|Overall Study|Death|365|||
48422333|NCT03090191|155736287|FG001|Overall Study|Death|358|||
48422334|NCT03090191|155736286|FG000|Overall Study|Lost to Follow-up|382|||
48422335|NCT03090191|155736287|FG001|Overall Study|Lost to Follow-up|394|||
48422336|NCT03090191|155736286|FG000|Overall Study|Physician Decision|77|||
48422337|NCT03090191|155736287|FG001|Overall Study|Physician Decision|66|||
48422338|NCT03090191|155736286|FG000|Overall Study|Protocol Violation|43|||
48422339|NCT03090191|155736287|FG001|Overall Study|Protocol Violation|52|||
48422340|NCT03090191|155736286|FG000|Overall Study|Withdrawal by Subject|2160|||
48422341|NCT03090191|155736287|FG001|Overall Study|Withdrawal by Subject|2133|||
48422342|NCT03090191|155736286|FG000|Overall Study|Site terminated|7|||
48422343|NCT03090191|155736287|FG001|Overall Study|Site terminated|8|||
48422344|NCT03090191|155736286|FG000|Overall Study|Other|66|||
48422345|NCT03090191|155736287|FG001|Overall Study|Other|60|||
48422346|NCT03090191|155736286|FG000|Overall Study|Withdrawn before any study vaccination|43|||
48422347|NCT03090191|155736287|FG001|Overall Study|Withdrawn before any study vaccination|52|||
48422348|NCT04329949|155736289|FG000|Overall Study|Death|36|||
48422349|NCT04329949|155736289|FG000|Overall Study|Withdrawal by Subject|4|||
48422350|NCT04329949|155736289|FG000|Overall Study|Termination of study by sponsor|3|||
48422351|NCT03976401|155736290|FG000|Overall Study|Adverse Event|2|||
48422352|NCT03976401|155736291|FG001|Overall Study|Adverse Event|0|||
48422353|NCT03976401|155736292|FG002|Overall Study|Adverse Event|4|||
48422354|NCT03976401|155736293|FG003|Overall Study|Adverse Event|1|||
48422355|NCT03976401|155736294|FG004|Overall Study|Adverse Event|1|||
48422356|NCT03976401|155736295|FG005|Overall Study|Adverse Event|0|||
48422357|NCT03976401|155736290|FG000|Overall Study|Withdrawal by Subject|0|||
48422358|NCT03976401|155736291|FG001|Overall Study|Withdrawal by Subject|1|||
48422359|NCT03976401|155736292|FG002|Overall Study|Withdrawal by Subject|0|||
48422360|NCT03976401|155736293|FG003|Overall Study|Withdrawal by Subject|0|||
48422361|NCT03976401|155736294|FG004|Overall Study|Withdrawal by Subject|0|||
48422362|NCT03976401|155736295|FG005|Overall Study|Withdrawal by Subject|1|||
48422363|NCT03976401|155736290|FG000|Overall Study|Physician Decision|0|||
48422364|NCT03976401|155736291|FG001|Overall Study|Physician Decision|0|||
48422365|NCT03976401|155736292|FG002|Overall Study|Physician Decision|1|||
48422366|NCT03976401|155736293|FG003|Overall Study|Physician Decision|0|||
48422367|NCT03976401|155736294|FG004|Overall Study|Physician Decision|0|||
48422368|NCT03976401|155736295|FG005|Overall Study|Physician Decision|0|||
48422369|NCT03976401|155736290|FG000|Overall Study|Lost to Follow-up|1|||
48422370|NCT03976401|155736291|FG001|Overall Study|Lost to Follow-up|2|||
48422371|NCT03976401|155736292|FG002|Overall Study|Lost to Follow-up|0|||
48422372|NCT03976401|155736293|FG003|Overall Study|Lost to Follow-up|0|||
48422373|NCT03976401|155736294|FG004|Overall Study|Lost to Follow-up|0|||
48422374|NCT03976401|155736295|FG005|Overall Study|Lost to Follow-up|0|||
48422375|NCT03976401|155736290|FG000|Overall Study|Protocol Violation|0|||
48422376|NCT03976401|155736291|FG001|Overall Study|Protocol Violation|1|||
48422377|NCT03976401|155736292|FG002|Overall Study|Protocol Violation|0|||
48422378|NCT03976401|155736293|FG003|Overall Study|Protocol Violation|0|||
48422379|NCT03976401|155736294|FG004|Overall Study|Protocol Violation|0|||
48422380|NCT03976401|155736295|FG005|Overall Study|Protocol Violation|0|||
48422381|NCT03976401|155736290|FG000|Overall Study|Withdrew Consent|0|||
48422382|NCT03976401|155736291|FG001|Overall Study|Withdrew Consent|0|||
48422383|NCT03976401|155736292|FG002|Overall Study|Withdrew Consent|0|||
48422384|NCT03976401|155736293|FG003|Overall Study|Withdrew Consent|1|||
48422385|NCT03976401|155736294|FG004|Overall Study|Withdrew Consent|0|||
48422386|NCT03976401|155736295|FG005|Overall Study|Withdrew Consent|0|||
48422387|NCT01736683|155736296|FG000|Overall Study|Disease Relapse|0|||
48422388|NCT01736683|155736297|FG001|Overall Study|Disease Relapse|0|||
48422389|NCT01736683|155736298|FG002|Overall Study|Disease Relapse|2|||
48422390|NCT01736683|155736299|FG003|Overall Study|Disease Relapse|1|||
48422391|NCT01736683|155736300|FG004|Overall Study|Disease Relapse|0|||
48422392|NCT01736683|155736296|FG000|Overall Study|Adverse Event|0|||
48422393|NCT01736683|155736297|FG001|Overall Study|Adverse Event|2|||
48422394|NCT01736683|155736298|FG002|Overall Study|Adverse Event|2|||
48422395|NCT01736683|155736299|FG003|Overall Study|Adverse Event|3|||
48422396|NCT01736683|155736300|FG004|Overall Study|Adverse Event|2|||
48422397|NCT01736683|155736296|FG000|Overall Study|Withdrawal by Subject|0|||
48422398|NCT01736683|155736297|FG001|Overall Study|Withdrawal by Subject|0|||
48422399|NCT01736683|155736298|FG002|Overall Study|Withdrawal by Subject|3|||
48422400|NCT01736683|155736299|FG003|Overall Study|Withdrawal by Subject|1|||
48422401|NCT01736683|155736300|FG004|Overall Study|Withdrawal by Subject|1|||
48422402|NCT01736683|155736296|FG000|Overall Study|Lack of Therapeutic Effect|7|||
48422403|NCT01736683|155736297|FG001|Overall Study|Lack of Therapeutic Effect|4|||
48422404|NCT01736683|155736298|FG002|Overall Study|Lack of Therapeutic Effect|13|||
48422405|NCT01736683|155736299|FG003|Overall Study|Lack of Therapeutic Effect|20|||
48422406|NCT01736683|155736300|FG004|Overall Study|Lack of Therapeutic Effect|1|||
48422407|NCT01736683|155736296|FG000|Overall Study|Progressive Disease|0|||
48422408|NCT01736683|155736297|FG001|Overall Study|Progressive Disease|0|||
48422409|NCT01736683|155736298|FG002|Overall Study|Progressive Disease|0|||
48422410|NCT01736683|155736299|FG003|Overall Study|Progressive Disease|1|||
48422411|NCT01736683|155736300|FG004|Overall Study|Progressive Disease|0|||
48422412|NCT01736683|155736296|FG000|Overall Study|Other|0|||
48422413|NCT01736683|155736297|FG001|Overall Study|Other|0|||
48422414|NCT01736683|155736298|FG002|Overall Study|Other|1|||
48422415|NCT01736683|155736299|FG003|Overall Study|Other|9|||
48422416|NCT01736683|155736300|FG004|Overall Study|Other|1|||
48422417|NCT01183858|155736301|FG000|Overall Study|Death not related to Progressive Disease|5|||
48422418|NCT01183858|155736302|FG001|Overall Study|Death not related to Progressive Disease|6|||
48422419|NCT01183858|155736301|FG000|Overall Study|Adverse Event|14|||
48422420|NCT01183858|155736302|FG001|Overall Study|Adverse Event|11|||
48422421|NCT01183858|155736301|FG000|Overall Study|Investigator's Decision|0|||
48422422|NCT01183858|155736302|FG001|Overall Study|Investigator's Decision|3|||
48422423|NCT01183858|155736301|FG000|Overall Study|Insufficient Therapeutic Response|2|||
48422424|NCT01183858|155736302|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48422425|NCT01183858|155736301|FG000|Overall Study|Refused Treatment|1|||
48422426|NCT01183858|155736302|FG001|Overall Study|Refused Treatment|4|||
48422427|NCT01183858|155736301|FG000|Overall Study|Withdrew Consent|4|||
48422428|NCT01183858|155736302|FG001|Overall Study|Withdrew Consent|4|||
48422429|NCT01183858|155736301|FG000|Overall Study|Discontinued Smoking|3|||
48422430|NCT01183858|155736302|FG001|Overall Study|Discontinued Smoking|1|||
48422431|NCT01183858|155736301|FG000|Overall Study|Protocol Violation|1|||
48422432|NCT01183858|155736302|FG001|Overall Study|Protocol Violation|0|||
48422433|NCT01183858|155736301|FG000|Overall Study|Administrative/Other|6|||
48422434|NCT01183858|155736302|FG001|Overall Study|Administrative/Other|6|||
48422435|NCT01183858|155736301|FG000|Overall Study|Progressive Disease|112|||
48422436|NCT01183858|155736302|FG001|Overall Study|Progressive Disease|115|||
48422437|NCT01183858|155736301|FG000|Overall Study|Death related to Progressive Disease|4|||
48422438|NCT01183858|155736302|FG001|Overall Study|Death related to Progressive Disease|5|||
48422439|NCT01183858|155736301|FG000|Overall Study|Lost to Follow-up|1|||
48422440|NCT01183858|155736302|FG001|Overall Study|Lost to Follow-up|1|||
48422441|NCT03043365|155736306|FG000|Weeks 0 to Week 8|Adverse Event|1|||
48422442|NCT03043365|155736307|FG001|Weeks 0 to Week 8|Adverse Event|3|||
48422443|NCT03043365|155736306|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
48422444|NCT03043365|155736307|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
48422445|NCT03043365|155736306|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
48422446|NCT03043365|155736307|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
48422447|NCT02873221|155736308|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
48422448|NCT02873221|155736309|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
48422449|NCT02873221|155736310|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
48422450|NCT02873221|155736308|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
48422451|NCT02873221|155736309|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
48422452|NCT02873221|155736310|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
48422453|NCT02873221|155736308|FG000|Treatment Period|Protocol Violation|2|||
48422454|NCT02873221|155736309|FG001|Treatment Period|Protocol Violation|5|||
48422455|NCT02873221|155736310|FG002|Treatment Period|Protocol Violation|8|||
48422456|NCT02873221|155736308|FG000|Treatment Period|Pregnancy|4|||
48422457|NCT02873221|155736309|FG001|Treatment Period|Pregnancy|6|||
48422458|NCT02873221|155736310|FG002|Treatment Period|Pregnancy|3|||
48422459|NCT02873221|155736308|FG000|Treatment Period|Lack of Qualifying Event|0|||
48422460|NCT02873221|155736309|FG001|Treatment Period|Lack of Qualifying Event|3|||
48422461|NCT02873221|155736310|FG002|Treatment Period|Lack of Qualifying Event|1|||
48422462|NCT02873221|155736308|FG000|Treatment Period|Withdrawal of Consent|52|||
48422463|NCT02873221|155736309|FG001|Treatment Period|Withdrawal of Consent|51|||
48422464|NCT02873221|155736310|FG002|Treatment Period|Withdrawal of Consent|41|||
48422465|NCT02873221|155736308|FG000|Treatment Period|Lack of Efficacy|0|||
48422466|NCT02873221|155736309|FG001|Treatment Period|Lack of Efficacy|17|||
48422467|NCT02873221|155736310|FG002|Treatment Period|Lack of Efficacy|12|||
48422468|NCT02873221|155736308|FG000|Treatment Period|Adverse Event|4|||
48422469|NCT02873221|155736309|FG001|Treatment Period|Adverse Event|9|||
48422470|NCT02873221|155736310|FG002|Treatment Period|Adverse Event|11|||
48422471|NCT02873221|155736308|FG000|Treatment Period|Lost to Follow-up|26|||
48422472|NCT02873221|155736309|FG001|Treatment Period|Lost to Follow-up|30|||
48422473|NCT02873221|155736310|FG002|Treatment Period|Lost to Follow-up|26|||
48422474|NCT02873221|155736308|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
48422475|NCT02873221|155736309|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
48422476|NCT02873221|155736310|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
48422477|NCT02873221|155736308|FG000|Safety Follow-up Period|Protocol Violation|0|||
48422478|NCT02873221|155736309|FG001|Safety Follow-up Period|Protocol Violation|0|||
48422479|NCT02873221|155736310|FG002|Safety Follow-up Period|Protocol Violation|1|||
48422480|NCT02873221|155736308|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
48422481|NCT02873221|155736309|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
48422482|NCT02873221|155736310|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
48422483|NCT02873221|155736308|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
48422484|NCT02873221|155736309|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
48422485|NCT02873221|155736310|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
48422486|NCT04530825|155736311|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
48422487|NCT04530825|155736312|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
48422488|NCT04530825|155736313|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
48422489|NCT04530825|155736314|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
48422490|NCT04530825|155736311|FG000|Overall Study|Did not complete follow-up|3|||
48422491|NCT04530825|155736312|FG001|Overall Study|Did not complete follow-up|0|||
48422492|NCT04530825|155736313|FG002|Overall Study|Did not complete follow-up|0|||
48422493|NCT04530825|155736314|FG003|Overall Study|Did not complete follow-up|0|||
48422494|NCT02640612|155736315|FG000|Overall Study|Adverse Event|6|||
48422495|NCT02640612|155736316|FG001|Overall Study|Adverse Event|7|||
48422496|NCT02640612|155736317|FG002|Overall Study|Adverse Event|2|||
48422497|NCT02640612|155736315|FG000|Overall Study|Death|1|||
48422498|NCT02640612|155736316|FG001|Overall Study|Death|0|||
48422499|NCT02640612|155736317|FG002|Overall Study|Death|0|||
48422500|NCT02640612|155736315|FG000|Overall Study|Withdrawal by Subject|10|||
48422501|NCT02640612|155736316|FG001|Overall Study|Withdrawal by Subject|3|||
48422502|NCT02640612|155736317|FG002|Overall Study|Withdrawal by Subject|3|||
48422503|NCT02640612|155736315|FG000|Overall Study|Lost to Follow-up|4|||
48422504|NCT02640612|155736316|FG001|Overall Study|Lost to Follow-up|1|||
48422505|NCT02640612|155736317|FG002|Overall Study|Lost to Follow-up|1|||
48422506|NCT02640612|155736315|FG000|Overall Study|Protocol Violation|0|||
48422507|NCT02640612|155736316|FG001|Overall Study|Protocol Violation|2|||
48422508|NCT02640612|155736317|FG002|Overall Study|Protocol Violation|0|||
48422509|NCT02640612|155736315|FG000|Overall Study|Lack of Efficacy|1|||
48422510|NCT02640612|155736316|FG001|Overall Study|Lack of Efficacy|1|||
48422511|NCT02640612|155736317|FG002|Overall Study|Lack of Efficacy|0|||
48422512|NCT03396471|155736322|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
48422513|NCT03396471|155736322|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
48422514|NCT03396471|155736322|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
48422515|NCT03396471|155736322|FG000|Study Treatment - Up to 22 Months|Death|2|||
48422516|NCT03396471|155736322|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
48422517|NCT03396471|155736322|FG000|Follow up - Up to 2 Years|Death|9|||
48422518|NCT03396471|155736322|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
48422519|NCT03396471|155736322|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
48422520|NCT03396471|155736322|FG000|Follow up - Up to 2 Years|study terminated|1|||
48422521|NCT03396471|155736322|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
48422522|NCT03396471|155736322|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
48422523|NCT04283461|155736324|FG000|Overall Study|Enrolled in separate trial|0|||
48422524|NCT04283461|155736325|FG001|Overall Study|Enrolled in separate trial|0|||
48422525|NCT04283461|155736326|FG002|Overall Study|Enrolled in separate trial|8|||
48422526|NCT04283461|155736327|FG003|Overall Study|Enrolled in separate trial|13|||
48422527|NCT04283461|155736328|FG004|Overall Study|Enrolled in separate trial|12|||
48422528|NCT04283461|155736329|FG005|Overall Study|Enrolled in separate trial|0|||
48422529|NCT04283461|155736330|FG006|Overall Study|Enrolled in separate trial|0|||
48422530|NCT04283461|155736331|FG007|Overall Study|Enrolled in separate trial|8|||
48422531|NCT04283461|155736332|FG008|Overall Study|Enrolled in separate trial|0|||
48422532|NCT04283461|155736333|FG009|Overall Study|Enrolled in separate trial|0|||
48422533|NCT04283461|155736334|FG010|Overall Study|Enrolled in separate trial|0|||
48422534|NCT04283461|155736335|FG011|Overall Study|Enrolled in separate trial|7|||
48422535|NCT04283461|155736336|FG012|Overall Study|Enrolled in separate trial|0|||
48422536|NCT03237845|155736337|FG000|Overall Study|Adverse Event|0|||
48422537|NCT03237845|155736338|FG001|Overall Study|Adverse Event|1|||
48422538|NCT03237845|155736337|FG000|Overall Study|Lost to Follow-up|13|||
48422539|NCT03237845|155736338|FG001|Overall Study|Lost to Follow-up|10|||
48422540|NCT03237845|155736337|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
48422541|NCT03237845|155736338|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
48422542|NCT03237845|155736337|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
48422543|NCT03237845|155736338|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
48422544|NCT03237845|155736337|FG000|Overall Study|Physician Decision|1|||
48422545|NCT03237845|155736338|FG001|Overall Study|Physician Decision|2|||
48422546|NCT03237845|155736337|FG000|Overall Study|Pregnancy|1|||
48422547|NCT03237845|155736338|FG001|Overall Study|Pregnancy|0|||
48422548|NCT03237845|155736337|FG000|Overall Study|Protocol Deviation|0|||
48422549|NCT03237845|155736338|FG001|Overall Study|Protocol Deviation|1|||
48422550|NCT03237845|155736337|FG000|Overall Study|Technical Problems|8|||
48422551|NCT03237845|155736338|FG001|Overall Study|Technical Problems|1|||
48422552|NCT03237845|155736337|FG000|Overall Study|Withdrawal by Subject|3|||
48422553|NCT03237845|155736338|FG001|Overall Study|Withdrawal by Subject|3|||
48422554|NCT03237845|155736337|FG000|Overall Study|Other Reasons|4|||
48422555|NCT03237845|155736338|FG001|Overall Study|Other Reasons|0|||
48422556|NCT01749735|155736339|FG000|Overall Study|Withdrawal by Subject|1|||
48422557|NCT01749735|155736340|FG001|Overall Study|Withdrawal by Subject|0|||
48422558|NCT01221233|155736341|FG000|Overall Study|Withdrawal by Subject|3|||
48422559|NCT01221233|155736342|FG001|Overall Study|Withdrawal by Subject|1|||
48422560|NCT02117050|155736343|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
48422561|NCT04382651|155736344|FG000|Overall Study|Death|26|||
48422562|NCT04382651|155736345|FG001|Overall Study|Death|23|||
48422563|NCT04382651|155736344|FG000|Overall Study|Lost to Follow-up|3|||
48422564|NCT04382651|155736345|FG001|Overall Study|Lost to Follow-up|4|||
48422565|NCT04382651|155736344|FG000|Overall Study|Withdrawal by Subject|2|||
48422566|NCT04382651|155736345|FG001|Overall Study|Withdrawal by Subject|0|||
48422567|NCT04382651|155736344|FG000|Overall Study|Physician Decision|0|||
48422568|NCT04382651|155736345|FG001|Overall Study|Physician Decision|1|||
48422569|NCT01770353|155736347|FG000|Overall Study|Progressive disease|2|||
48422570|NCT01770353|155736348|FG001|Overall Study|Progressive disease|1|||
48422571|NCT01770353|155736347|FG000|Overall Study|Adverse Event|0|||
48422572|NCT01770353|155736348|FG001|Overall Study|Adverse Event|1|||
48422573|NCT01770353|155736347|FG000|Overall Study|Protocol Violation|1|||
48422574|NCT01770353|155736348|FG001|Overall Study|Protocol Violation|0|||
48422575|NCT01770353|155736347|FG000|Overall Study|Physician Decision|0|||
48422576|NCT01770353|155736348|FG001|Overall Study|Physician Decision|3|||
48422577|NCT01770353|155736347|FG000|Overall Study|Clinical deterioration|3|||
48422578|NCT01770353|155736348|FG001|Overall Study|Clinical deterioration|6|||
48422579|NCT01770353|155736347|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
48422580|NCT01770353|155736348|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
48422581|NCT00306891|155736352|FG000|Part A|Withdrawal by Subject|1|||
48422582|NCT00306891|155736353|FG001|Part A|Withdrawal by Subject|1|||
48422583|NCT00306891|155736354|FG002|Part A|Withdrawal by Subject|0|||
48422584|NCT00306891|155736355|FG003|Part A|Withdrawal by Subject|0|||
48422585|NCT00306891|155736352|FG000|Part A|Condition under investigation worsened|2|||
48422586|NCT00306891|155736353|FG001|Part A|Condition under investigation worsened|2|||
48422587|NCT00306891|155736354|FG002|Part A|Condition under investigation worsened|0|||
48422588|NCT00306891|155736355|FG003|Part A|Condition under investigation worsened|0|||
48422589|NCT00306891|155736352|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
48422590|NCT00306891|155736353|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
48422591|NCT00306891|155736354|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
48422592|NCT00306891|155736355|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
48422593|NCT00306891|155736352|FG000|Part A|Partial bowel obstruction|1|||
48422594|NCT00306891|155736353|FG001|Part A|Partial bowel obstruction|0|||
48422595|NCT00306891|155736354|FG002|Part A|Partial bowel obstruction|0|||
48422596|NCT00306891|155736355|FG003|Part A|Partial bowel obstruction|0|||
48422597|NCT00306891|155736352|FG000|Part A|Reaccumul. of ascites following drainage|0|||
48422598|NCT00306891|155736353|FG001|Part A|Reaccumul. of ascites following drainage|1|||
48422599|NCT00306891|155736354|FG002|Part A|Reaccumul. of ascites following drainage|0|||
48422600|NCT00306891|155736355|FG003|Part A|Reaccumul. of ascites following drainage|0|||
48422601|NCT00306891|155736352|FG000|Part A|Suspicion of second malignancy|0|||
48422602|NCT00306891|155736353|FG001|Part A|Suspicion of second malignancy|1|||
48422603|NCT00306891|155736354|FG002|Part A|Suspicion of second malignancy|0|||
48422604|NCT00306891|155736355|FG003|Part A|Suspicion of second malignancy|0|||
48422605|NCT00306891|155736352|FG000|Part A|QTC interval outwith elig. criteria|1|||
48422606|NCT00306891|155736353|FG001|Part A|QTC interval outwith elig. criteria|0|||
48422607|NCT00306891|155736354|FG002|Part A|QTC interval outwith elig. criteria|0|||
48422608|NCT00306891|155736355|FG003|Part A|QTC interval outwith elig. criteria|0|||
48422609|NCT00306891|155736352|FG000|Part B|Death|0|||
48422610|NCT00306891|155736353|FG001|Part B|Death|0|||
48422611|NCT00306891|155736354|FG002|Part B|Death|1|||
48422612|NCT00306891|155736355|FG003|Part B|Death|2|||
48422613|NCT00306891|155736352|FG000|Part B|Adverse Event|0|||
48422614|NCT00306891|155736353|FG001|Part B|Adverse Event|0|||
48422615|NCT00306891|155736354|FG002|Part B|Adverse Event|5|||
48422616|NCT00306891|155736355|FG003|Part B|Adverse Event|5|||
48422617|NCT00306891|155736352|FG000|Part B|Withdrawal by Subject|0|||
48422618|NCT00306891|155736353|FG001|Part B|Withdrawal by Subject|0|||
48422619|NCT00306891|155736354|FG002|Part B|Withdrawal by Subject|3|||
48422620|NCT00306891|155736355|FG003|Part B|Withdrawal by Subject|1|||
48422621|NCT00306891|155736352|FG000|Part B|Condition under investigation worsened|0|||
48422622|NCT00306891|155736353|FG001|Part B|Condition under investigation worsened|0|||
48422623|NCT00306891|155736354|FG002|Part B|Condition under investigation worsened|2|||
48422624|NCT00306891|155736355|FG003|Part B|Condition under investigation worsened|8|||
48422625|NCT00306891|155736352|FG000|Part B|Development of study specific disc crit.|0|||
48422626|NCT00306891|155736353|FG001|Part B|Development of study specific disc crit.|0|||
48422627|NCT00306891|155736354|FG002|Part B|Development of study specific disc crit.|0|||
48422628|NCT00306891|155736355|FG003|Part B|Development of study specific disc crit.|1|||
48422629|NCT01751646|155736357|FG000|Overall Study|Lost to Follow-up|5|||
48422630|NCT01751646|155736358|FG001|Overall Study|Lost to Follow-up|1|||
48422631|NCT01751646|155736357|FG000|Overall Study|Withdrawal by Subject|0|||
48422632|NCT01751646|155736358|FG001|Overall Study|Withdrawal by Subject|4|||
48422633|NCT01751646|155736357|FG000|Overall Study|Starting hormone therapy|1|||
48422634|NCT01751646|155736358|FG001|Overall Study|Starting hormone therapy|0|||
48422635|NCT01751646|155736357|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
48422636|NCT01751646|155736358|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
48422637|NCT01751646|155736357|FG000|Overall Study|Inadvertent enrollment|1|||
48422638|NCT01751646|155736358|FG001|Overall Study|Inadvertent enrollment|1|||
48422639|NCT01751646|155736357|FG000|Overall Study|Moved out of the area|1|||
48422640|NCT01751646|155736358|FG001|Overall Study|Moved out of the area|5|||
48422641|NCT01751646|155736357|FG000|Overall Study|Inability to attend required visits|0|||
48422642|NCT01751646|155736358|FG001|Overall Study|Inability to attend required visits|1|||
48422643|NCT01751646|155736357|FG000|Overall Study|Off study due to multiple obligations|0|||
48422644|NCT01751646|155736358|FG001|Overall Study|Off study due to multiple obligations|1|||
48422645|NCT01751646|155736357|FG000|Overall Study|Fails to comply with study requirements|0|||
48422646|NCT01751646|155736358|FG001|Overall Study|Fails to comply with study requirements|1|||
48422647|NCT01751646|155736357|FG000|Overall Study|Childcare issues|1|||
48422648|NCT01751646|155736358|FG001|Overall Study|Childcare issues|1|||
48422649|NCT01845077|155736359|FG000|Washout Period|Lost to Follow-up|0|||
48422650|NCT01845077|155736360|FG001|Washout Period|Lost to Follow-up|1|||
48422651|NCT01845077|155736361|FG002|Washout Period|Lost to Follow-up|0|||
48422652|NCT01845077|155736362|FG003|Washout Period|Lost to Follow-up|1|||
48422653|NCT01845077|155736363|FG004|Washout Period|Lost to Follow-up|0|||
48422654|NCT01845077|155736364|FG005|Washout Period|Lost to Follow-up|1|||
48422655|NCT01845077|155736359|FG000|Washout Period|Adverse Event|1|||
48422656|NCT01845077|155736360|FG001|Washout Period|Adverse Event|0|||
48422657|NCT01845077|155736361|FG002|Washout Period|Adverse Event|0|||
48422658|NCT01845077|155736362|FG003|Washout Period|Adverse Event|0|||
48422659|NCT01845077|155736363|FG004|Washout Period|Adverse Event|0|||
48422660|NCT01845077|155736364|FG005|Washout Period|Adverse Event|0|||
48422661|NCT01845077|155736359|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
48422662|NCT01845077|155736360|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
48422663|NCT01845077|155736361|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
48422664|NCT01845077|155736362|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
48422665|NCT01845077|155736363|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
48422666|NCT01845077|155736364|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
48422667|NCT01845077|155736359|FG000|Washout Period|Protocol Violation|0|||
48422668|NCT01845077|155736360|FG001|Washout Period|Protocol Violation|0|||
48422669|NCT01845077|155736361|FG002|Washout Period|Protocol Violation|0|||
48422670|NCT01845077|155736362|FG003|Washout Period|Protocol Violation|1|||
48422671|NCT01845077|155736363|FG004|Washout Period|Protocol Violation|1|||
48422672|NCT01845077|155736364|FG005|Washout Period|Protocol Violation|0|||
48422673|NCT02973815|155736365|FG000|Post Intervention|Death|1|||
48422674|NCT02973815|155736366|FG001|Post Intervention|Death|0|||
48422675|NCT02973815|155736365|FG000|Post Intervention|Lost to Follow-up|7|||
48422676|NCT02973815|155736366|FG001|Post Intervention|Lost to Follow-up|24|||
48422677|NCT02973815|155736365|FG000|Follow-up|Lost to Follow-up|2|||
48422678|NCT02973815|155736366|FG001|Follow-up|Lost to Follow-up|0|||
48422679|NCT02792777|155736367|FG000|Overall Study|Withdrawal by Subject|2|||
48422680|NCT02792777|155736368|FG001|Overall Study|Withdrawal by Subject|0|||
48422681|NCT02792777|155736367|FG000|Overall Study|Recording malfunction|2|||
48422682|NCT02792777|155736368|FG001|Overall Study|Recording malfunction|0|||
48422683|NCT02792777|155736367|FG000|Overall Study|Later determined to be ineligible|2|||
48422684|NCT02792777|155736368|FG001|Overall Study|Later determined to be ineligible|0|||
48422685|NCT02792777|155736367|FG000|Overall Study|Participant interviewed twice|1|||
48422686|NCT02792777|155736368|FG001|Overall Study|Participant interviewed twice|0|||
48422687|NCT01589094|155736369|FG000|Overall Study|Did not receive treatment|2|||
48422688|NCT00658333|155736370|FG000|Overall Study|Adverse Event|2|||
48422689|NCT00658333|155736371|FG001|Overall Study|Adverse Event|1|||
48422690|NCT00638846|155736372|FG000|Overall Study|Adverse Event|0|||
48422691|NCT00638846|155736373|FG001|Overall Study|Adverse Event|1|||
48422692|NCT00638846|155736372|FG000|Overall Study|Lost to Follow-up|3|||
48422693|NCT00638846|155736373|FG001|Overall Study|Lost to Follow-up|2|||
48422694|NCT00638846|155736372|FG000|Overall Study|lens issue|1|||
48422695|NCT00638846|155736373|FG001|Overall Study|lens issue|3|||
48422696|NCT01171521|155736378|FG000|Overall Study|Lost to Follow-up|5|||
48422697|NCT01171521|155736378|FG000|Overall Study|screen failure|1|||
48422698|NCT02112448|155736383|FG000|Overall Study|lab values precluding use of ketorolac|2|||
48422699|NCT02112448|155736384|FG001|Overall Study|lab values precluding use of ketorolac|2|||
48422700|NCT02112448|155736383|FG000|Overall Study|Protocol Violation|1|||
48422701|NCT02112448|155736384|FG001|Overall Study|Protocol Violation|2|||
48422702|NCT02112448|155736383|FG000|Overall Study|Physician Decision|4|||
48422703|NCT02112448|155736384|FG001|Overall Study|Physician Decision|6|||
48422704|NCT02112448|155736383|FG000|Overall Study|required heparin so could not use ketoro|1|||
48422705|NCT02112448|155736384|FG001|Overall Study|required heparin so could not use ketoro|0|||
48422706|NCT01084252|155737974|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422707|NCT01084252|155737975|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422708|NCT01084252|155737976|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422709|NCT01084252|155737977|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422710|NCT01084252|155737978|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422711|NCT01084252|155737979|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422712|NCT01084252|155737980|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422713|NCT01084252|155737981|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422714|NCT01084252|155737982|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422715|NCT01084252|155737983|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422716|NCT01084252|155737984|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422717|NCT01084252|155737985|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422718|NCT01084252|155737986|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
48422719|NCT01084252|155737987|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
48422720|NCT05111249|155737988|FG000|Overall Study|Lost to Follow-up|0|||
48422721|NCT05111249|155737989|FG001|Overall Study|Lost to Follow-up|2|||
48422722|NCT05111249|155737988|FG000|Overall Study|Physician Decision|0|||
48422723|NCT05111249|155737989|FG001|Overall Study|Physician Decision|1|||
48422724|NCT05111249|155737988|FG000|Overall Study|Participant decision|1|||
48422725|NCT05111249|155737989|FG001|Overall Study|Participant decision|5|||
48422726|NCT05635838|155737990|FG000|16-Week DBVC Period|Adverse Event|2|||
48422727|NCT05635838|155737991|FG001|16-Week DBVC Period|Adverse Event|0|||
48422728|NCT05635838|155737992|FG002|16-Week DBVC Period|Adverse Event|0|||
48422729|NCT05635838|155737993|FG003|16-Week DBVC Period|Adverse Event|0|||
48692646|NCT03001557|156724542|FG001|Extension Phase|Administrative Reason|0|||
48422730|NCT05635838|155737990|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
48422731|NCT05635838|155737991|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
48422732|NCT05635838|155737992|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
48422733|NCT05635838|155737993|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
48422734|NCT05635838|155737990|FG000|16-Week DBVC Period|Physician Decision|0|||
48422735|NCT05635838|155737991|FG001|16-Week DBVC Period|Physician Decision|1|||
48422736|NCT05635838|155737992|FG002|16-Week DBVC Period|Physician Decision|0|||
48422737|NCT05635838|155737993|FG003|16-Week DBVC Period|Physician Decision|0|||
48422738|NCT05635838|155737990|FG000|16-Week DBVC Period|Protocol Violation|1|||
48422739|NCT05635838|155737991|FG001|16-Week DBVC Period|Protocol Violation|0|||
48422740|NCT05635838|155737992|FG002|16-Week DBVC Period|Protocol Violation|0|||
48422741|NCT05635838|155737993|FG003|16-Week DBVC Period|Protocol Violation|0|||
48422742|NCT05635838|155737990|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
48422743|NCT05635838|155737991|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
48422744|NCT05635838|155737992|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
48422745|NCT05635838|155737993|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
48422746|NCT05635838|155737990|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
48422747|NCT05635838|155737991|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
48422748|NCT05635838|155737992|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
48422749|NCT05635838|155737993|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
48422750|NCT05635838|155737990|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
48422751|NCT05635838|155737991|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
48422752|NCT05635838|155737992|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
48422753|NCT05635838|155737993|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
48422754|NCT05635838|155737990|FG000|16-Week OLE Period|Adverse Event|0|||
48422755|NCT05635838|155737991|FG001|16-Week OLE Period|Adverse Event|0|||
48422756|NCT05635838|155737992|FG002|16-Week OLE Period|Adverse Event|0|||
48422757|NCT05635838|155737993|FG003|16-Week OLE Period|Adverse Event|2|||
48422758|NCT05635838|155737990|FG000|16-Week OLE Period|Lost to Follow-up|0|||
48422759|NCT05635838|155737991|FG001|16-Week OLE Period|Lost to Follow-up|0|||
48422760|NCT05635838|155737992|FG002|16-Week OLE Period|Lost to Follow-up|1|||
48422761|NCT05635838|155737993|FG003|16-Week OLE Period|Lost to Follow-up|3|||
48422762|NCT05635838|155737990|FG000|16-Week OLE Period|Physician Decision|0|||
48422763|NCT05635838|155737991|FG001|16-Week OLE Period|Physician Decision|0|||
48422764|NCT05635838|155737992|FG002|16-Week OLE Period|Physician Decision|0|||
48422765|NCT05635838|155737993|FG003|16-Week OLE Period|Physician Decision|1|||
48422766|NCT05635838|155737990|FG000|16-Week OLE Period|Protocol Violation|0|||
48422767|NCT05635838|155737991|FG001|16-Week OLE Period|Protocol Violation|0|||
48422768|NCT05635838|155737992|FG002|16-Week OLE Period|Protocol Violation|1|||
48422769|NCT05635838|155737993|FG003|16-Week OLE Period|Protocol Violation|1|||
48422770|NCT05635838|155737990|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
48422771|NCT05635838|155737991|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
48422772|NCT05635838|155737992|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
48422773|NCT05635838|155737993|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
48422774|NCT05635838|155737990|FG000|16-Week OLE Period|Pregnancy|0|||
48422775|NCT05635838|155737991|FG001|16-Week OLE Period|Pregnancy|0|||
48422776|NCT05635838|155737992|FG002|16-Week OLE Period|Pregnancy|1|||
48422777|NCT05635838|155737993|FG003|16-Week OLE Period|Pregnancy|0|||
48422778|NCT00955110|155738000|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
48422779|NCT00955110|155738000|FG000|Treatment Phase|Adverse Event|2|||
48422780|NCT00955110|155738000|FG000|Treatment Phase|Administrative reasons|2|||
48422781|NCT00955110|155738000|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
48422782|NCT00955110|155738000|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
48422783|NCT03705494|155738015|FG000|Overall Study|Lost to Follow-up|2|||
48422784|NCT03705494|155738016|FG001|Overall Study|Lost to Follow-up|1|||
48422785|NCT03705494|155738015|FG000|Overall Study|Withdrawal by Subject|5|||
48422786|NCT03705494|155738016|FG001|Overall Study|Withdrawal by Subject|2|||
48422787|NCT03704051|155738017|FG000|Overall Study|Withdrawal by Subject|4|||
48422788|NCT03704051|155738018|FG001|Overall Study|Withdrawal by Subject|0|||
48422789|NCT00092547|155738023|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
48422790|NCT00092547|155738024|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
48422791|NCT00092547|155738025|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
48422792|NCT00092547|155738023|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
48422793|NCT00092547|155738024|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
48422794|NCT00092547|155738025|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
48422795|NCT00092547|155738023|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
48422796|NCT00092547|155738024|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
48422797|NCT00092547|155738025|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
48422798|NCT00092547|155738023|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
48422799|NCT00092547|155738024|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
48422800|NCT00092547|155738025|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
48422801|NCT00092547|155738023|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
48422802|NCT00092547|155738024|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
48422803|NCT00092547|155738025|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
48422804|NCT00092547|155738023|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
48422805|NCT00092547|155738024|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
48422806|NCT00092547|155738025|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
48422807|NCT00092547|155738023|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
48422808|NCT00092547|155738024|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
48422809|NCT00092547|155738025|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
48422810|NCT00092547|155738023|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
48422811|NCT00092547|155738024|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
48422812|NCT00092547|155738025|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
48422813|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
48422814|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
48422815|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
48422816|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
48422817|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
48422818|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
48422819|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
48422820|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
48422821|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
48422822|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
48422823|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
48422824|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
48422825|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
48422826|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
48422827|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
48422828|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
48422829|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
48422830|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
48422831|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
48422832|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
48422833|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
48422834|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
48422835|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
48422836|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
48422837|NCT00092547|155738023|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
48422838|NCT00092547|155738024|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
48422839|NCT00092547|155738025|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
48422840|NCT00092547|155738023|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
48422841|NCT00092547|155738024|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
48422842|NCT00092547|155738025|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
48422843|NCT00092547|155738023|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
48422844|NCT00092547|155738024|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
48422845|NCT00092547|155738025|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
48422846|NCT00092547|155738023|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
48422847|NCT00092547|155738024|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
48422848|NCT00092547|155738025|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
48422849|NCT00092547|155738023|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
48422850|NCT00092547|155738024|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
48422851|NCT00092547|155738025|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
48422852|NCT01371838|155738027|FG000|Overall Study|Withdrawal by Subject|27|||
48422853|NCT01371838|155738028|FG001|Overall Study|Withdrawal by Subject|33|||
48422854|NCT01371838|155738027|FG000|Overall Study|Lost to Follow-up|10|||
48422855|NCT01371838|155738028|FG001|Overall Study|Lost to Follow-up|20|||
48422856|NCT01371838|155738027|FG000|Overall Study|Death|3|||
48422857|NCT01371838|155738028|FG001|Overall Study|Death|4|||
48422858|NCT01371838|155738027|FG000|Overall Study|Protocol Violation|3|||
48422859|NCT01371838|155738028|FG001|Overall Study|Protocol Violation|0|||
48422860|NCT01371838|155738027|FG000|Overall Study|Investigator Decision|3|||
48422861|NCT01371838|155738028|FG001|Overall Study|Investigator Decision|8|||
48422862|NCT01371838|155738027|FG000|Overall Study|Last follow-up visit not conducted|2|||
48422863|NCT01371838|155738028|FG001|Overall Study|Last follow-up visit not conducted|0|||
48422864|NCT01371838|155738027|FG000|Overall Study|Lack of therapeutic response|0|||
48422865|NCT01371838|155738028|FG001|Overall Study|Lack of therapeutic response|1|||
48422866|NCT01371838|155738027|FG000|Overall Study|Surgery|1|||
48422867|NCT01371838|155738028|FG001|Overall Study|Surgery|0|||
48422868|NCT02465034|155738029|FG000|Overall Study|Withdrawal by Subject|1|||
48422869|NCT02465034|155738030|FG001|Overall Study|Withdrawal by Subject|1|||
48422870|NCT02465034|155738029|FG000|Overall Study|Screen fail|2|||
48422871|NCT02465034|155738030|FG001|Overall Study|Screen fail|0|||
48422872|NCT02465034|155738029|FG000|Overall Study|Could not be scheduled for study visit|0|||
48422873|NCT02465034|155738030|FG001|Overall Study|Could not be scheduled for study visit|5|||
48422874|NCT02421120|155738033|FG000|Overall Study|Adverse Event|1|||
48422875|NCT00893789|155738034|FG000|Overall Study|Withdrawal by Subject|3|||
48422876|NCT00893789|155738035|FG001|Overall Study|Withdrawal by Subject|1|||
48422877|NCT00893789|155738036|FG002|Overall Study|Withdrawal by Subject|3|||
48422878|NCT00893789|155738037|FG003|Overall Study|Withdrawal by Subject|1|||
48422879|NCT00893789|155738034|FG000|Overall Study|Noncompliance With Study Drug|1|||
48422880|NCT00893789|155738035|FG001|Overall Study|Noncompliance With Study Drug|0|||
48422881|NCT00893789|155738036|FG002|Overall Study|Noncompliance With Study Drug|1|||
48422882|NCT00893789|155738037|FG003|Overall Study|Noncompliance With Study Drug|2|||
48422883|NCT00893789|155738034|FG000|Overall Study|Noncompliance With Study Procedures|1|||
48422884|NCT00893789|155738035|FG001|Overall Study|Noncompliance With Study Procedures|0|||
48422885|NCT00893789|155738036|FG002|Overall Study|Noncompliance With Study Procedures|0|||
48422886|NCT00893789|155738037|FG003|Overall Study|Noncompliance With Study Procedures|0|||
48422887|NCT00893789|155738034|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
48422888|NCT00893789|155738035|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
48422889|NCT00893789|155738036|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
48422890|NCT00893789|155738037|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
48422891|NCT00893789|155738034|FG000|Overall Study|Adverse Event|0|||
48422892|NCT00893789|155738035|FG001|Overall Study|Adverse Event|2|||
48422893|NCT00893789|155738036|FG002|Overall Study|Adverse Event|1|||
48422894|NCT00893789|155738037|FG003|Overall Study|Adverse Event|5|||
48422895|NCT00893789|155738034|FG000|Overall Study|Protocol Violation|0|||
48422896|NCT00893789|155738035|FG001|Overall Study|Protocol Violation|1|||
48422897|NCT00893789|155738036|FG002|Overall Study|Protocol Violation|1|||
48422898|NCT00893789|155738037|FG003|Overall Study|Protocol Violation|4|||
48422899|NCT00893789|155738034|FG000|Overall Study|Lost to Follow-up|0|||
48422900|NCT00893789|155738035|FG001|Overall Study|Lost to Follow-up|0|||
48422901|NCT00893789|155738036|FG002|Overall Study|Lost to Follow-up|0|||
48422902|NCT00893789|155738037|FG003|Overall Study|Lost to Follow-up|1|||
48422903|NCT01408537|155738040|FG000|Overall Study|Withdrawal by Subject|2|||
48422904|NCT01408537|155738040|FG000|Overall Study|Protocol Violation|3|||
48422905|NCT01408537|155738040|FG000|Overall Study|Lost to Follow-up|3|||
48422906|NCT04075604|155738043|FG000|Overall Study|Adverse Event|0|||
48422907|NCT04075604|155738044|FG001|Overall Study|Adverse Event|0|||
48422908|NCT04075604|155738045|FG002|Overall Study|Adverse Event|3|||
48422909|NCT04075604|155738043|FG000|Overall Study|Participant request to discontinue study treatment|0|||
48422910|NCT04075604|155738044|FG001|Overall Study|Participant request to discontinue study treatment|0|||
48422911|NCT04075604|155738045|FG002|Overall Study|Participant request to discontinue study treatment|1|||
48422912|NCT04075604|155738043|FG000|Overall Study|Participant withdrew consent|0|||
48422913|NCT04075604|155738044|FG001|Overall Study|Participant withdrew consent|0|||
48422914|NCT04075604|155738045|FG002|Overall Study|Participant withdrew consent|1|||
48422915|NCT04075604|155738043|FG000|Overall Study|Other reasons|1|||
48422916|NCT04075604|155738044|FG001|Overall Study|Other reasons|0|||
48422917|NCT04075604|155738045|FG002|Overall Study|Other reasons|0|||
48422918|NCT04075604|155738043|FG000|Overall Study|Disease progression|0|||
48422919|NCT04075604|155738044|FG001|Overall Study|Disease progression|1|||
48422920|NCT04075604|155738045|FG002|Overall Study|Disease progression|0|||
48422921|NCT04075604|155738043|FG000|Overall Study|Study drug toxicity|0|||
48422922|NCT04075604|155738044|FG001|Overall Study|Study drug toxicity|5|||
48422923|NCT04075604|155738045|FG002|Overall Study|Study drug toxicity|1|||
48422924|NCT01845025|155738052|FG000|Overall Study|Adverse Event|6|||
48422925|NCT01845025|155738053|FG001|Overall Study|Adverse Event|3|||
48422926|NCT01845025|155738052|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48422927|NCT01845025|155738053|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48422928|NCT01845025|155738052|FG000|Overall Study|Withdrawal by Subject|48|||
48422929|NCT01845025|155738053|FG001|Overall Study|Withdrawal by Subject|44|||
48422930|NCT01845025|155738052|FG000|Overall Study|Lost to Follow-up|13|||
48422931|NCT01845025|155738053|FG001|Overall Study|Lost to Follow-up|13|||
48422932|NCT01845025|155738052|FG000|Overall Study|Administrative problems|8|||
48422933|NCT01845025|155738053|FG001|Overall Study|Administrative problems|8|||
48422934|NCT01845025|155738052|FG000|Overall Study|Death|2|||
48422935|NCT01845025|155738053|FG001|Overall Study|Death|0|||
48422936|NCT01845025|155738052|FG000|Overall Study|Protocol deviation|3|||
48422937|NCT01845025|155738053|FG001|Overall Study|Protocol deviation|6|||
48422938|NCT01845025|155738052|FG000|Overall Study|Missing|1|||
48422939|NCT01845025|155738053|FG001|Overall Study|Missing|1|||
48422940|NCT02441803|155738054|FG000|Overall Study|Physician Decision|0|||
48422941|NCT02441803|155738055|FG001|Overall Study|Physician Decision|2|||
48422942|NCT02441803|155738056|FG002|Overall Study|Physician Decision|2|||
48422943|NCT00537823|155738059|FG000|Overall Study|Adverse Event|2|||
48422944|NCT00537823|155738060|FG001|Overall Study|Adverse Event|0|||
48422945|NCT01645280|155738067|FG000|Overall Study|Death|0|||
48422946|NCT01645280|155738068|FG001|Overall Study|Death|1|||
48422947|NCT01645280|155738069|FG002|Overall Study|Death|0|||
48422948|NCT01645280|155738070|FG003|Overall Study|Death|0|||
48422949|NCT01645280|155738071|FG004|Overall Study|Death|0|||
48422950|NCT01645280|155738067|FG000|Overall Study|Withdrawal by Subject|4|||
48422951|NCT01645280|155738068|FG001|Overall Study|Withdrawal by Subject|0|||
48422952|NCT01645280|155738069|FG002|Overall Study|Withdrawal by Subject|2|||
48422953|NCT01645280|155738070|FG003|Overall Study|Withdrawal by Subject|4|||
48422954|NCT01645280|155738071|FG004|Overall Study|Withdrawal by Subject|5|||
48422955|NCT01645280|155738067|FG000|Overall Study|Lost to Follow-up|0|||
48422956|NCT01645280|155738068|FG001|Overall Study|Lost to Follow-up|0|||
48422957|NCT01645280|155738069|FG002|Overall Study|Lost to Follow-up|0|||
48422958|NCT01645280|155738070|FG003|Overall Study|Lost to Follow-up|2|||
48422959|NCT01645280|155738071|FG004|Overall Study|Lost to Follow-up|1|||
48422960|NCT01645280|155738067|FG000|Overall Study|Other|1|||
48422961|NCT01645280|155738068|FG001|Overall Study|Other|1|||
48422962|NCT01645280|155738069|FG002|Overall Study|Other|2|||
48422963|NCT01645280|155738070|FG003|Overall Study|Other|0|||
48422964|NCT01645280|155738071|FG004|Overall Study|Other|0|||
48422965|NCT01645280|155738067|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
48422966|NCT01645280|155738068|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
48422967|NCT01645280|155738069|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
48422968|NCT01645280|155738070|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
48422969|NCT01645280|155738071|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
48422970|NCT00949650|155738074|FG000|Overall Study|Progressive disease|188|||
48422971|NCT00949650|155738075|FG001|Overall Study|Progressive disease|19|||
48422972|NCT00949650|155738074|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
48422973|NCT00949650|155738075|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
48422974|NCT00949650|155738074|FG000|Overall Study|Other Adverse Event (AE)|28|||
48422975|NCT00949650|155738075|FG001|Overall Study|Other Adverse Event (AE)|17|||
48422976|NCT00949650|155738074|FG000|Overall Study|Protocol Violation|1|||
48422977|NCT00949650|155738075|FG001|Overall Study|Protocol Violation|4|||
48422978|NCT00949650|155738074|FG000|Overall Study|Refusal to continue medication|7|||
48422979|NCT00949650|155738075|FG001|Overall Study|Refusal to continue medication|11|||
48422980|NCT00949650|155738074|FG000|Overall Study|Not treated|1|||
48422981|NCT00949650|155738075|FG001|Overall Study|Not treated|4|||
48422982|NCT00949650|155738074|FG000|Overall Study|Other not specified above|5|||
48422983|NCT00949650|155738075|FG001|Overall Study|Other not specified above|0|||
48422984|NCT03671369|155738076|FG000|Overall Study|Other|1|||
48422985|NCT03671369|155738076|FG000|Overall Study|Withdrawal by Subject|289|||
48422986|NCT03671369|155738076|FG000|Overall Study|Not willing to be vaccinated|1|||
48422987|NCT02168946|155738080|FG000|Overall Study|Adverse Event|8|||
48422988|NCT02168946|155738081|FG001|Overall Study|Adverse Event|5|||
48422989|NCT02168946|155738080|FG000|Overall Study|Lost to Follow-up|3|||
48422990|NCT02168946|155738081|FG001|Overall Study|Lost to Follow-up|0|||
48422991|NCT02168946|155738080|FG000|Overall Study|Subject unable to come back for visits|1|||
48422992|NCT02168946|155738081|FG001|Overall Study|Subject unable to come back for visits|0|||
48422993|NCT01188798|155738083|FG000|Overall Study|Death|0|||
48422994|NCT01188798|155738084|FG001|Overall Study|Death|1|||
48422995|NCT01188798|155738083|FG000|Overall Study|Required additional transplant|1|||
48422996|NCT01188798|155738084|FG001|Overall Study|Required additional transplant|1|||
48422997|NCT01188798|155738083|FG000|Overall Study|Protocol closure|1|||
48422998|NCT01188798|155738084|FG001|Overall Study|Protocol closure|1|||
48422999|NCT03303339|155738089|FG000|Overall Study|Death|2|||
48423000|NCT03303339|155738090|FG001|Overall Study|Death|2|||
48423001|NCT03303339|155738091|FG002|Overall Study|Death|2|||
48423002|NCT03303339|155738092|FG003|Overall Study|Death|1|||
48423003|NCT03303339|155738093|FG004|Overall Study|Death|4|||
48423004|NCT03303339|155738094|FG005|Overall Study|Death|2|||
48423005|NCT03303339|155738095|FG006|Overall Study|Death|2|||
48423006|NCT03303339|155738096|FG007|Overall Study|Death|2|||
48423007|NCT03303339|155738097|FG008|Overall Study|Death|3|||
48423008|NCT03303339|155738098|FG009|Overall Study|Death|3|||
48423009|NCT03303339|155738099|FG010|Overall Study|Death|4|||
48423010|NCT03303339|155738100|FG011|Overall Study|Death|24|||
48423011|NCT03303339|155738089|FG000|Overall Study|Study Terminated by Sponsor|0|||
48423012|NCT03303339|155738090|FG001|Overall Study|Study Terminated by Sponsor|0|||
48423013|NCT03303339|155738091|FG002|Overall Study|Study Terminated by Sponsor|0|||
48423014|NCT03303339|155738092|FG003|Overall Study|Study Terminated by Sponsor|0|||
48423015|NCT03303339|155738093|FG004|Overall Study|Study Terminated by Sponsor|0|||
48423016|NCT03303339|155738094|FG005|Overall Study|Study Terminated by Sponsor|0|||
48423017|NCT03303339|155738095|FG006|Overall Study|Study Terminated by Sponsor|0|||
48423018|NCT03303339|155738096|FG007|Overall Study|Study Terminated by Sponsor|0|||
48423019|NCT03303339|155738097|FG008|Overall Study|Study Terminated by Sponsor|1|||
48423020|NCT03303339|155738098|FG009|Overall Study|Study Terminated by Sponsor|0|||
48423021|NCT03303339|155738099|FG010|Overall Study|Study Terminated by Sponsor|1|||
48423022|NCT03303339|155738100|FG011|Overall Study|Study Terminated by Sponsor|1|||
48423023|NCT03303339|155738089|FG000|Overall Study|Withdrawal by Subject|1|||
48423024|NCT03303339|155738090|FG001|Overall Study|Withdrawal by Subject|0|||
48423025|NCT03303339|155738091|FG002|Overall Study|Withdrawal by Subject|0|||
48423026|NCT03303339|155738092|FG003|Overall Study|Withdrawal by Subject|0|||
48423027|NCT03303339|155738093|FG004|Overall Study|Withdrawal by Subject|0|||
48423028|NCT03303339|155738094|FG005|Overall Study|Withdrawal by Subject|1|||
48423029|NCT03303339|155738095|FG006|Overall Study|Withdrawal by Subject|1|||
48423030|NCT03303339|155738096|FG007|Overall Study|Withdrawal by Subject|0|||
48423031|NCT03303339|155738097|FG008|Overall Study|Withdrawal by Subject|0|||
48423032|NCT03303339|155738098|FG009|Overall Study|Withdrawal by Subject|0|||
48423033|NCT03303339|155738099|FG010|Overall Study|Withdrawal by Subject|0|||
48423034|NCT03303339|155738100|FG011|Overall Study|Withdrawal by Subject|2|||
48423035|NCT03303339|155738089|FG000|Overall Study|Physician Decision|0|||
48423036|NCT03303339|155738090|FG001|Overall Study|Physician Decision|0|||
48423037|NCT03303339|155738091|FG002|Overall Study|Physician Decision|0|||
48423038|NCT03303339|155738092|FG003|Overall Study|Physician Decision|0|||
48423039|NCT03303339|155738093|FG004|Overall Study|Physician Decision|1|||
48423040|NCT03303339|155738094|FG005|Overall Study|Physician Decision|0|||
48423041|NCT03303339|155738095|FG006|Overall Study|Physician Decision|0|||
48423042|NCT03303339|155738096|FG007|Overall Study|Physician Decision|0|||
48423043|NCT03303339|155738097|FG008|Overall Study|Physician Decision|0|||
48423044|NCT03303339|155738098|FG009|Overall Study|Physician Decision|0|||
48423045|NCT03303339|155738099|FG010|Overall Study|Physician Decision|0|||
48423046|NCT03303339|155738100|FG011|Overall Study|Physician Decision|0|||
48423047|NCT03303339|155738089|FG000|Overall Study|Safety/Non-compliance|0|||
48423048|NCT03303339|155738090|FG001|Overall Study|Safety/Non-compliance|0|||
48423049|NCT03303339|155738091|FG002|Overall Study|Safety/Non-compliance|0|||
48423050|NCT03303339|155738092|FG003|Overall Study|Safety/Non-compliance|0|||
48423051|NCT03303339|155738093|FG004|Overall Study|Safety/Non-compliance|0|||
48423052|NCT03303339|155738094|FG005|Overall Study|Safety/Non-compliance|0|||
48423053|NCT03303339|155738095|FG006|Overall Study|Safety/Non-compliance|0|||
48423054|NCT03303339|155738096|FG007|Overall Study|Safety/Non-compliance|0|||
48423055|NCT03303339|155738097|FG008|Overall Study|Safety/Non-compliance|0|||
48423056|NCT03303339|155738098|FG009|Overall Study|Safety/Non-compliance|0|||
48423057|NCT03303339|155738099|FG010|Overall Study|Safety/Non-compliance|0|||
48423058|NCT03303339|155738100|FG011|Overall Study|Safety/Non-compliance|1|||
48423059|NCT00510692|155738108|FG000|Overall Study|Adverse Event|1|||
48423060|NCT00510692|155738109|FG001|Overall Study|Adverse Event|3|||
48423061|NCT00510692|155738108|FG000|Overall Study|Withdrawal by Subject|1|||
48423062|NCT00510692|155738109|FG001|Overall Study|Withdrawal by Subject|0|||
48423063|NCT00945191|155738110|FG000|Overall Study|Did not achieve a complete response|18|||
48423064|NCT00945191|155738110|FG000|Overall Study|Participant relocated to another state|1|||
48423065|NCT00945191|155738110|FG000|Overall Study|Disease progression|3|||
48423066|NCT00945191|155738110|FG000|Overall Study|Serious adverse event or adverse event|1|||
48423067|NCT00945191|155738110|FG000|Overall Study|Investigator's discretion|1|||
48423068|NCT02492711|155738113|FG000|Overall Study|Adverse Event|9|||
48423069|NCT02492711|155738114|FG001|Overall Study|Adverse Event|9|||
48423070|NCT02492711|155738115|FG002|Overall Study|Adverse Event|2|||
48423071|NCT02492711|155738113|FG000|Overall Study|Death|3|||
48423072|NCT02492711|155738114|FG001|Overall Study|Death|3|||
48423073|NCT02492711|155738115|FG002|Overall Study|Death|0|||
48423074|NCT02492711|155738113|FG000|Overall Study|Withdrawal by Subject|10|||
48423075|NCT02492711|155738114|FG001|Overall Study|Withdrawal by Subject|16|||
48423076|NCT02492711|155738115|FG002|Overall Study|Withdrawal by Subject|5|||
48423077|NCT02492711|155738113|FG000|Overall Study|Physician Decision|10|||
48423078|NCT02492711|155738114|FG001|Overall Study|Physician Decision|6|||
48423079|NCT02492711|155738115|FG002|Overall Study|Physician Decision|4|||
48423080|NCT02492711|155738113|FG000|Overall Study|Lost to Follow-up|0|||
48423081|NCT02492711|155738114|FG001|Overall Study|Lost to Follow-up|0|||
48423082|NCT02492711|155738115|FG002|Overall Study|Lost to Follow-up|1|||
48423083|NCT02492711|155738113|FG000|Overall Study|study treatment delay|2|||
48423084|NCT02492711|155738114|FG001|Overall Study|study treatment delay|1|||
48423085|NCT02492711|155738115|FG002|Overall Study|study treatment delay|0|||
48423086|NCT02492711|155738113|FG000|Overall Study|change in chemotherapy|0|||
48423087|NCT02492711|155738114|FG001|Overall Study|change in chemotherapy|1|||
48423088|NCT02492711|155738115|FG002|Overall Study|change in chemotherapy|0|||
48423089|NCT02492711|155738113|FG000|Overall Study|never treated|2|||
48423090|NCT02492711|155738114|FG001|Overall Study|never treated|4|||
48423091|NCT02492711|155738115|FG002|Overall Study|never treated|0|||
48423092|NCT02492711|155738113|FG000|Overall Study|Other|0|||
48423093|NCT02492711|155738114|FG001|Overall Study|Other|0|||
48423094|NCT02492711|155738115|FG002|Overall Study|Other|1|||
48423095|NCT00035815|155738121|FG000|Overall Study|Withdrawal by Subject|17|||
48423096|NCT00035815|155738122|FG001|Overall Study|Withdrawal by Subject|11|||
48423097|NCT02209597|155738123|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
48423098|NCT02209597|155738123|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
48423099|NCT02209597|155738123|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
48423100|NCT02209597|155738123|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
48423101|NCT01595646|155738124|FG000|Overall Study|Withdrawal by Subject|1|||
48423102|NCT01595646|155738125|FG001|Overall Study|Withdrawal by Subject|0|||
48423103|NCT01595646|155738126|FG002|Overall Study|Withdrawal by Subject|0|||
48423104|NCT03103750|155738128|FG000|Overall Study|Adverse Event|1|||
48423105|NCT03103750|155738129|FG001|Overall Study|Adverse Event|0|||
48423106|NCT03103750|155738128|FG000|Overall Study|Lost to Follow-up|1|||
48423107|NCT03103750|155738129|FG001|Overall Study|Lost to Follow-up|0|||
48423108|NCT03103750|155738128|FG000|Overall Study|PET Equipment Related|2|||
48423109|NCT03103750|155738129|FG001|Overall Study|PET Equipment Related|2|||
48423110|NCT01416610|155738141|FG000|Overall Study|Adverse Event|4|||
48423111|NCT01416610|155738141|FG000|Overall Study|Adverse Event -Patient decision|3|||
48423112|NCT01416610|155738141|FG000|Overall Study|Lack of Efficacy|4|||
48423113|NCT01416610|155738141|FG000|Overall Study|No reason given|5|||
48423114|NCT01416610|155738141|FG000|Overall Study|Withdrawal by Subject|13|||
48423115|NCT01416610|155738141|FG000|Overall Study|Lost to Follow-up|7|||
48423116|NCT01416610|155738141|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
48423117|NCT00642616|155738147|FG000|Overall Study|Adverse Event|2|||
48423118|NCT00642616|155738148|FG001|Overall Study|Adverse Event|0|||
48423119|NCT00642616|155738149|FG002|Overall Study|Adverse Event|1|||
48423120|NCT00642616|155738150|FG003|Overall Study|Adverse Event|0|||
48423121|NCT00642616|155738147|FG000|Overall Study|Study Terminated by Sponsor|7|||
48423122|NCT00642616|155738148|FG001|Overall Study|Study Terminated by Sponsor|6|||
48423123|NCT00642616|155738149|FG002|Overall Study|Study Terminated by Sponsor|4|||
48423124|NCT00642616|155738150|FG003|Overall Study|Study Terminated by Sponsor|5|||
48423125|NCT00642616|155738147|FG000|Overall Study|Withdrawal by Subject|0|||
48423126|NCT00642616|155738148|FG001|Overall Study|Withdrawal by Subject|1|||
48423127|NCT00642616|155738149|FG002|Overall Study|Withdrawal by Subject|1|||
48423128|NCT00642616|155738150|FG003|Overall Study|Withdrawal by Subject|1|||
48423129|NCT00642616|155738147|FG000|Overall Study|Protocol Violation|0|||
48423130|NCT00642616|155738148|FG001|Overall Study|Protocol Violation|0|||
48423131|NCT00642616|155738149|FG002|Overall Study|Protocol Violation|2|||
48423132|NCT00642616|155738150|FG003|Overall Study|Protocol Violation|0|||
48423133|NCT00642616|155738147|FG000|Overall Study|Physician Decision|0|||
48423134|NCT00642616|155738148|FG001|Overall Study|Physician Decision|0|||
48423135|NCT00642616|155738149|FG002|Overall Study|Physician Decision|1|||
48423136|NCT00642616|155738150|FG003|Overall Study|Physician Decision|1|||
48423137|NCT01161524|155738151|FG000|Core Study (23 Weeks)|Adverse Event|3|||
48423138|NCT01161524|155738152|FG001|Core Study (23 Weeks)|Adverse Event|0|||
48423139|NCT01161524|155738153|FG002|Core Study (23 Weeks)|Adverse Event|0|||
48423140|NCT01161524|155738151|FG000|Core Study (23 Weeks)|Other|1|||
48423141|NCT01161524|155738152|FG001|Core Study (23 Weeks)|Other|0|||
48423142|NCT01161524|155738153|FG002|Core Study (23 Weeks)|Other|0|||
48423143|NCT01161524|155738151|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
48423144|NCT01161524|155738152|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
48423145|NCT01161524|155738153|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
48423146|NCT01161524|155738151|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
48423147|NCT01161524|155738152|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
48423148|NCT01161524|155738153|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
48423149|NCT01161524|155738151|FG000|Core Study (23 Weeks)|Subject Choice|3|||
48423150|NCT01161524|155738152|FG001|Core Study (23 Weeks)|Subject Choice|2|||
48423151|NCT01161524|155738153|FG002|Core Study (23 Weeks)|Subject Choice|0|||
48423152|NCT01161524|155738151|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
48423153|NCT01161524|155738152|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
48423154|NCT01161524|155738153|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
48423155|NCT01161524|155738151|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
48423156|NCT01161524|155738152|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
48423157|NCT01161524|155738153|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
48423158|NCT01161524|155738151|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
48423159|NCT01161524|155738152|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
48423160|NCT01161524|155738153|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
48423161|NCT01161524|155738151|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
48423162|NCT01161524|155738152|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
48423163|NCT01161524|155738153|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
48423164|NCT01161524|155738151|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
48423165|NCT01161524|155738152|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
48423166|NCT01161524|155738153|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
48423167|NCT00734929|155738158|FG000|Overall Study|Lost to Follow-up|1|||
48423168|NCT00734929|155738159|FG001|Overall Study|Lost to Follow-up|2|||
48423169|NCT00734929|155738158|FG000|Overall Study|No intervention/ screen fail|5|||
48423170|NCT00734929|155738159|FG001|Overall Study|No intervention/ screen fail|3|||
48423171|NCT00914628|155739904|FG000|Overall Study|Death|35|||
48423172|NCT00914628|155739905|FG001|Overall Study|Death|17|||
48423173|NCT00914628|155739904|FG000|Overall Study|Medical decision|4|||
48423174|NCT00914628|155739905|FG001|Overall Study|Medical decision|0|||
48423175|NCT00914628|155739904|FG000|Overall Study|Protocol Violation|1|||
48379401|NCT04615247|155584523|FG000|Overall Study|Withdrawal by Subject|1|||
48379402|NCT04615247|155584524|FG001|Overall Study|Withdrawal by Subject|1|||
48379403|NCT03278106|155584527|FG000|Overall Study|No protocol treatment|1|||
48379404|NCT00823901|155584528|FG000|Overall Study|Adverse Event|1|||
48379405|NCT00823901|155584529|FG001|Overall Study|Adverse Event|1|||
48379406|NCT00823901|155584528|FG000|Overall Study|Lack of Efficacy|1|||
48379407|NCT00823901|155584529|FG001|Overall Study|Lack of Efficacy|0|||
48379408|NCT00823901|155584528|FG000|Overall Study|Lost to Follow-up|2|||
48379409|NCT00823901|155584529|FG001|Overall Study|Lost to Follow-up|1|||
48379410|NCT01369511|155584530|FG000|Overall Study|Adverse Event|1|||
48379411|NCT01369511|155584531|FG001|Overall Study|Adverse Event|1|||
48379412|NCT01369511|155584532|FG002|Overall Study|Adverse Event|5|||
48379413|NCT01369511|155584533|FG003|Overall Study|Adverse Event|0|||
48379414|NCT01369511|155584530|FG000|Overall Study|Entry criteria not met|2|||
48379415|NCT01369511|155584531|FG001|Overall Study|Entry criteria not met|0|||
48379416|NCT01369511|155584532|FG002|Overall Study|Entry criteria not met|0|||
48379417|NCT01369511|155584533|FG003|Overall Study|Entry criteria not met|1|||
48379418|NCT01369511|155584530|FG000|Overall Study|Lost to Follow-up|0|||
48379419|NCT01369511|155584531|FG001|Overall Study|Lost to Follow-up|1|||
48379420|NCT01369511|155584532|FG002|Overall Study|Lost to Follow-up|1|||
48379421|NCT01369511|155584533|FG003|Overall Study|Lost to Follow-up|2|||
48379422|NCT01369511|155584530|FG000|Overall Study|Protocol Violation|0|||
48379423|NCT01369511|155584531|FG001|Overall Study|Protocol Violation|1|||
48379424|NCT01369511|155584532|FG002|Overall Study|Protocol Violation|0|||
48379425|NCT01369511|155584533|FG003|Overall Study|Protocol Violation|2|||
48379426|NCT01369511|155584530|FG000|Overall Study|Physician Decision|3|||
48379427|NCT01369511|155584531|FG001|Overall Study|Physician Decision|4|||
48379428|NCT01369511|155584532|FG002|Overall Study|Physician Decision|0|||
48379429|NCT01369511|155584533|FG003|Overall Study|Physician Decision|0|||
48379430|NCT01369511|155584530|FG000|Overall Study|Sponsor decision|2|||
48379431|NCT01369511|155584531|FG001|Overall Study|Sponsor decision|0|||
48379432|NCT01369511|155584532|FG002|Overall Study|Sponsor decision|1|||
48379433|NCT01369511|155584533|FG003|Overall Study|Sponsor decision|0|||
48379434|NCT01369511|155584530|FG000|Overall Study|Withdrawal by Subject|5|||
48379435|NCT01369511|155584531|FG001|Overall Study|Withdrawal by Subject|6|||
48379436|NCT01369511|155584532|FG002|Overall Study|Withdrawal by Subject|4|||
48379437|NCT01369511|155584533|FG003|Overall Study|Withdrawal by Subject|6|||
48379438|NCT03952806|155584534|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
48379439|NCT03952806|155584535|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
48379440|NCT03952806|155584534|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
48379441|NCT03952806|155584535|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
48379442|NCT03952806|155584534|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
48379443|NCT03952806|155584535|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
48379444|NCT03952806|155584534|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
48379445|NCT03952806|155584535|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
48379446|NCT03952806|155584534|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
48379447|NCT03952806|155584535|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
48379448|NCT03952806|155584534|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
48379449|NCT03952806|155584535|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
48379450|NCT03952806|155584534|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
48379451|NCT03952806|155584535|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
48379452|NCT03952806|155584534|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
48379453|NCT03952806|155584535|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
48379454|NCT03952806|155584534|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
48379455|NCT03952806|155584535|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
48379456|NCT03952806|155584534|FG000|OLE Phase (48 Weeks)|Other|16|||
48379457|NCT03952806|155584535|FG001|OLE Phase (48 Weeks)|Other|13|||
48379458|NCT01774110|155584536|FG000|Overall Study|Lost to Follow-up|7|||
48379459|NCT00640016|155584537|FG000|Overall Study|Withdrawal by Subject|0|||
48379460|NCT00640016|155584538|FG001|Overall Study|Withdrawal by Subject|1|||
48379461|NCT00640016|155584539|FG002|Overall Study|Withdrawal by Subject|0|||
48379462|NCT00640016|155584540|FG003|Overall Study|Withdrawal by Subject|0|||
48379463|NCT00640016|155584537|FG000|Overall Study|Study termination|2|||
48379464|NCT00640016|155584538|FG001|Overall Study|Study termination|1|||
48379465|NCT00640016|155584539|FG002|Overall Study|Study termination|3|||
48379466|NCT00640016|155584540|FG003|Overall Study|Study termination|2|||
48379467|NCT00640016|155584537|FG000|Overall Study|Adverse Event|0|||
48379468|NCT00640016|155584538|FG001|Overall Study|Adverse Event|0|||
48379469|NCT00640016|155584539|FG002|Overall Study|Adverse Event|0|||
48379470|NCT00640016|155584540|FG003|Overall Study|Adverse Event|1|||
48379471|NCT02569957|155584541|FG000|Overall Study|Withdrawal by Subject|0|||
48379472|NCT02569957|155584542|FG001|Overall Study|Withdrawal by Subject|1|||
48379473|NCT00846391|155584543|FG000|Overall Study|Physician Decision|0|||
48379474|NCT00846391|155584544|FG001|Overall Study|Physician Decision|0|||
48379475|NCT00846391|155584545|FG002|Overall Study|Physician Decision|1|||
48379476|NCT00846391|155584543|FG000|Overall Study|Study Terminated by Sponsor|1|||
48423176|NCT00914628|155739905|FG001|Overall Study|Protocol Violation|0|||
48423177|NCT00914628|155739904|FG000|Overall Study|Lack of Efficacy|1|||
48423178|NCT00914628|155739905|FG001|Overall Study|Lack of Efficacy|0|||
48423179|NCT00914628|155739904|FG000|Overall Study|non-randomized|1|||
48423180|NCT00914628|155739905|FG001|Overall Study|non-randomized|0|||
48423181|NCT00914628|155739904|FG000|Overall Study|Relapse|1|||
48423182|NCT00914628|155739905|FG001|Overall Study|Relapse|2|||
48423183|NCT00914628|155739904|FG000|Overall Study|Study terminated by Sponsor|14|||
48423184|NCT00914628|155739905|FG001|Overall Study|Study terminated by Sponsor|8|||
48423185|NCT00914628|155739904|FG000|Overall Study|Patients who did not receive a single dose|7|||
48423186|NCT00914628|155739905|FG001|Overall Study|Patients who did not receive a single dose|1|||
48423187|NCT02400346|155739906|FG000|Overall Study|Adverse Event|24|||
48423188|NCT02400346|155739906|FG000|Overall Study|Lack of Efficacy|9|||
48423189|NCT02400346|155739906|FG000|Overall Study|Non-compliance with IMP|1|||
48423190|NCT02400346|155739906|FG000|Overall Study|Withdrawal by Subject|7|||
48423191|NCT02400346|155739906|FG000|Overall Study|Administrative or other reason(s)|2|||
48423192|NCT02400346|155739906|FG000|Overall Study|Lost to Follow-up|1|||
48423193|NCT01269125|155739909|FG000|Overall Study|Adverse Event|3|||
48423194|NCT01269125|155739910|FG001|Overall Study|Adverse Event|5|||
48423195|NCT01269125|155739911|FG002|Overall Study|Adverse Event|0|||
48423196|NCT01269125|155739909|FG000|Overall Study|Lost to Follow-up|4|||
48423197|NCT01269125|155739910|FG001|Overall Study|Lost to Follow-up|0|||
48423198|NCT01269125|155739911|FG002|Overall Study|Lost to Follow-up|0|||
48423199|NCT01348919|155739912|FG000|Overall Study|Adverse Event|3|||
48423200|NCT01348919|155739913|FG001|Overall Study|Adverse Event|1|||
48423201|NCT01348919|155739914|FG002|Overall Study|Adverse Event|0|||
48423202|NCT01348919|155739912|FG000|Overall Study|Withdrawal by Subject|0|||
48423203|NCT01348919|155739913|FG001|Overall Study|Withdrawal by Subject|1|||
48423204|NCT01348919|155739914|FG002|Overall Study|Withdrawal by Subject|0|||
48423205|NCT01348919|155739912|FG000|Overall Study|Disease progression|0|||
48423206|NCT01348919|155739913|FG001|Overall Study|Disease progression|1|||
48423207|NCT01348919|155739914|FG002|Overall Study|Disease progression|1|||
48423208|NCT03825042|155739915|FG000|Overall Study|Adverse Event|1|||
48423209|NCT03825042|155739916|FG001|Overall Study|Adverse Event|0|||
48423210|NCT03825042|155739915|FG000|Overall Study|Withdrawal by Subject|1|||
48423211|NCT03825042|155739916|FG001|Overall Study|Withdrawal by Subject|0|||
48423212|NCT02114203|155739917|FG000|Overall Study|Adverse Event|0|||
48423213|NCT02114203|155739918|FG001|Overall Study|Adverse Event|1|||
48423214|NCT02114203|155739919|FG002|Overall Study|Adverse Event|0|||
48423215|NCT02114203|155739917|FG000|Overall Study|Withdrawal by Subject|0|||
48423216|NCT02114203|155739918|FG001|Overall Study|Withdrawal by Subject|1|||
48423217|NCT02114203|155739919|FG002|Overall Study|Withdrawal by Subject|0|||
48423218|NCT01518699|155739921|FG000|Period 2|Protocol Violation|1|||
48423219|NCT01518699|155739922|FG001|Period 2|Protocol Violation|1|||
48423220|NCT01518699|155739923|FG002|Period 2|Protocol Violation|0|||
48423221|NCT01518699|155739924|FG003|Period 2|Protocol Violation|0|||
48423222|NCT01518699|155739925|FG004|Period 2|Protocol Violation|0|||
48423223|NCT01518699|155739926|FG005|Period 2|Protocol Violation|0|||
48423224|NCT01518699|155739921|FG000|Period 2|Lost to Follow-up|0|||
48423225|NCT01518699|155739922|FG001|Period 2|Lost to Follow-up|1|||
48423226|NCT01518699|155739923|FG002|Period 2|Lost to Follow-up|0|||
48423227|NCT01518699|155739924|FG003|Period 2|Lost to Follow-up|0|||
48423228|NCT01518699|155739925|FG004|Period 2|Lost to Follow-up|0|||
48423229|NCT01518699|155739926|FG005|Period 2|Lost to Follow-up|0|||
48423230|NCT01518699|155739921|FG000|Period 2|Adverse Event|1|||
48423231|NCT01518699|155739922|FG001|Period 2|Adverse Event|0|||
48423232|NCT01518699|155739923|FG002|Period 2|Adverse Event|0|||
48423233|NCT01518699|155739924|FG003|Period 2|Adverse Event|0|||
48423234|NCT01518699|155739925|FG004|Period 2|Adverse Event|0|||
48423235|NCT01518699|155739926|FG005|Period 2|Adverse Event|0|||
48423236|NCT01334125|155739933|FG000|Overall Study|Lost to Follow-up|3|||
48423237|NCT01334125|155739934|FG001|Overall Study|Lost to Follow-up|3|||
48423238|NCT02138110|155739935|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
48423239|NCT02138110|155739935|FG000|Overall Scaffold Implantation|Death|3|||
48423240|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
48423241|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
48423242|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
48423243|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
48423244|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
48423245|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
48423246|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
48423247|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
48423248|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
48423249|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
48423250|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
48423251|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
48423252|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
48423253|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
48423254|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
48423255|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
48423256|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
48423257|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
48423258|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Death|0|||
48423259|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Death|1|||
48423260|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Death|0|||
48423261|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
48423262|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
48423263|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
48423264|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
48423265|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
48423266|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
48423267|NCT00430781|155739936|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
48423268|NCT00430781|155739937|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
48423269|NCT00430781|155739938|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
48423270|NCT00430781|155739936|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
48423271|NCT00430781|155739937|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
48423272|NCT00430781|155739938|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
48423273|NCT00430781|155739936|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
48423274|NCT00430781|155739937|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
48423275|NCT00430781|155739938|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
48423276|NCT00430781|155739936|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
48423277|NCT00430781|155739937|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
48423278|NCT00430781|155739938|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
48423279|NCT00430781|155739936|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
48423280|NCT00430781|155739937|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
48423281|NCT00430781|155739938|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
48423282|NCT00430781|155739936|FG000|Final Analysis; 31 July 2008|Other|0|||
48423283|NCT00430781|155739937|FG001|Final Analysis; 31 July 2008|Other|1|||
48423284|NCT00430781|155739938|FG002|Final Analysis; 31 July 2008|Other|0|||
48423285|NCT00430781|155739936|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
48423286|NCT00430781|155739937|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
48423287|NCT00430781|155739938|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
48423288|NCT00430781|155739936|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
48423289|NCT00430781|155739937|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
48423290|NCT00430781|155739938|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
48423291|NCT00430781|155739936|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
48423292|NCT00430781|155739937|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
48423293|NCT00430781|155739938|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
48423294|NCT00430781|155739936|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
48423295|NCT00430781|155739937|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
48423296|NCT00430781|155739938|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
48423297|NCT00430781|155739936|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
48423298|NCT00430781|155739937|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
48423299|NCT00430781|155739938|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
48423300|NCT00430781|155739936|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
48423301|NCT00430781|155739937|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
48423302|NCT00430781|155739938|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
48423303|NCT00430781|155739936|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
48423304|NCT00430781|155739937|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
48423305|NCT00430781|155739938|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
48423306|NCT00882713|155739939|FG000|Overall Study|Adverse Event|2|||
48423307|NCT00882713|155739939|FG000|Overall Study|Death|3|||
48423308|NCT00882713|155739939|FG000|Overall Study|Administrative reasons|4|||
48423309|NCT00882713|155739939|FG000|Overall Study|refused treatment/withdrew consent|4|||
48423310|NCT00882713|155739939|FG000|Overall Study|Blood transfusion|2|||
48423311|NCT00882713|155739939|FG000|Overall Study|Insufficient therapeutic response|3|||
48423312|NCT00882713|155739939|FG000|Overall Study|Failure to return|2|||
48423313|NCT00882713|155739939|FG000|Overall Study|Other - Reasons|2|||
48423314|NCT02760602|155739940|FG000|Overall Study|Withdrawal by Subject|1|||
48423315|NCT02760602|155739941|FG001|Overall Study|Withdrawal by Subject|0|||
48423316|NCT02760602|155739940|FG000|Overall Study|Terminated by sponsor|12|||
48423317|NCT02760602|155739941|FG001|Overall Study|Terminated by sponsor|13|||
48423318|NCT02345161|155739949|FG000|Overall Study|Withdrawal by Subject|25|||
48423319|NCT02345161|155739950|FG001|Overall Study|Withdrawal by Subject|33|||
48423320|NCT02345161|155739949|FG000|Overall Study|Adverse Event|16|||
48423321|NCT02345161|155739950|FG001|Overall Study|Adverse Event|19|||
48423322|NCT02345161|155739949|FG000|Overall Study|Physician Decision|4|||
48423323|NCT02345161|155739950|FG001|Overall Study|Physician Decision|4|||
48423324|NCT02345161|155739949|FG000|Overall Study|Lost to Follow-up|0|||
48423325|NCT02345161|155739950|FG001|Overall Study|Lost to Follow-up|1|||
48423326|NCT02037919|155739953|FG000|Overall Study|Lost to Follow-up|30|||
48423327|NCT02037919|155739954|FG001|Overall Study|Lost to Follow-up|45|||
48423328|NCT00090285|155739964|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
48423329|NCT00090285|155739965|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
48423330|NCT00090285|155739966|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48423331|NCT00090285|155739967|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48423332|NCT00090285|155739968|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48423333|NCT00090285|155739969|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
48423334|NCT00090285|155739964|FG000|Base Study Vaccination Period|Adverse Event|2|||
48423335|NCT00090285|155739965|FG001|Base Study Vaccination Period|Adverse Event|4|||
48423336|NCT00090285|155739966|FG002|Base Study Vaccination Period|Adverse Event|0|||
48423337|NCT00090285|155739967|FG003|Base Study Vaccination Period|Adverse Event|0|||
48423338|NCT00090285|155739968|FG004|Base Study Vaccination Period|Adverse Event|0|||
48423339|NCT00090285|155739969|FG005|Base Study Vaccination Period|Adverse Event|0|||
48423340|NCT00090285|155739964|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
48423341|NCT00090285|155739965|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
48423342|NCT00090285|155739966|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
48423343|NCT00090285|155739967|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
48423344|NCT00090285|155739968|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
48423345|NCT00090285|155739969|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
48423346|NCT00090285|155739964|FG000|Base Study Vaccination Period|Protocol Violation|2|||
48423347|NCT00090285|155739965|FG001|Base Study Vaccination Period|Protocol Violation|3|||
48423348|NCT00090285|155739966|FG002|Base Study Vaccination Period|Protocol Violation|0|||
48423349|NCT00090285|155739967|FG003|Base Study Vaccination Period|Protocol Violation|0|||
48423350|NCT00090285|155739968|FG004|Base Study Vaccination Period|Protocol Violation|0|||
48423351|NCT00090285|155739969|FG005|Base Study Vaccination Period|Protocol Violation|0|||
48423352|NCT00090285|155739964|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
48423353|NCT00090285|155739965|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
48423354|NCT00090285|155739966|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
48423355|NCT00090285|155739967|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
48423356|NCT00090285|155739968|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
48423357|NCT00090285|155739969|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
48423358|NCT00090285|155739964|FG000|Base Study Vaccination Period|Uncooperative|2|||
48423359|NCT00090285|155739965|FG001|Base Study Vaccination Period|Uncooperative|2|||
48423360|NCT00090285|155739966|FG002|Base Study Vaccination Period|Uncooperative|0|||
48423361|NCT00090285|155739967|FG003|Base Study Vaccination Period|Uncooperative|0|||
48423362|NCT00090285|155739968|FG004|Base Study Vaccination Period|Uncooperative|0|||
48423363|NCT00090285|155739969|FG005|Base Study Vaccination Period|Uncooperative|0|||
48423364|NCT00090285|155739964|FG000|Base Study Vaccination Period|Moved|20|||
48423365|NCT00090285|155739965|FG001|Base Study Vaccination Period|Moved|21|||
48423366|NCT00090285|155739966|FG002|Base Study Vaccination Period|Moved|0|||
48423367|NCT00090285|155739967|FG003|Base Study Vaccination Period|Moved|0|||
48379477|NCT00846391|155584544|FG001|Overall Study|Study Terminated by Sponsor|2|||
48379478|NCT00846391|155584545|FG002|Overall Study|Study Terminated by Sponsor|2|||
48379479|NCT02027701|155584546|FG000|Overall Study|Adverse Event|3|||
48379480|NCT02027701|155584546|FG000|Overall Study|Lack of Efficacy|8|||
48379481|NCT02027701|155584546|FG000|Overall Study|Physician Decision|2|||
48379482|NCT02027701|155584546|FG000|Overall Study|Withdrawal by Subject|3|||
48379483|NCT01287065|155584547|FG000|Treatment Period 1|Adverse Event|0|||
48379484|NCT01287065|155584548|FG001|Treatment Period 1|Adverse Event|0|||
48379485|NCT01287065|155584549|FG002|Treatment Period 1|Adverse Event|0|||
48379486|NCT01287065|155584550|FG003|Treatment Period 1|Adverse Event|0|||
48379487|NCT01287065|155584551|FG004|Treatment Period 1|Adverse Event|1|||
48379488|NCT01287065|155584552|FG005|Treatment Period 1|Adverse Event|0|||
48379489|NCT01287065|155584547|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48379490|NCT01287065|155584548|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48379491|NCT01287065|155584549|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48379492|NCT01287065|155584550|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48379493|NCT01287065|155584551|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48379494|NCT01287065|155584552|FG005|Treatment Period 1|Withdrawal by Subject|1|||
48379495|NCT01214187|155584553|FG000|Overall Study|Adverse Event|6|||
48379496|NCT01214187|155584554|FG001|Overall Study|Adverse Event|2|||
48379497|NCT01214187|155584553|FG000|Overall Study|Death|1|||
48379498|NCT01214187|155584554|FG001|Overall Study|Death|1|||
48379499|NCT01214187|155584553|FG000|Overall Study|Withdrawal by Subject|0|||
48379500|NCT01214187|155584554|FG001|Overall Study|Withdrawal by Subject|3|||
48379501|NCT00820027|155584557|FG000|Overall Study|Adverse Event|15|||
48379502|NCT00820027|155584558|FG001|Overall Study|Adverse Event|8|||
48379503|NCT00820027|155584559|FG002|Overall Study|Adverse Event|10|||
48379504|NCT00820027|155584560|FG003|Overall Study|Adverse Event|5|||
48423368|NCT00090285|155739968|FG004|Base Study Vaccination Period|Moved|0|||
48423369|NCT00090285|155739969|FG005|Base Study Vaccination Period|Moved|0|||
48423370|NCT00090285|155739964|FG000|Base Study Vaccination Period|Site Terminated|1|||
48423371|NCT00090285|155739965|FG001|Base Study Vaccination Period|Site Terminated|0|||
48423372|NCT00090285|155739966|FG002|Base Study Vaccination Period|Site Terminated|0|||
48423373|NCT00090285|155739967|FG003|Base Study Vaccination Period|Site Terminated|0|||
48423374|NCT00090285|155739968|FG004|Base Study Vaccination Period|Site Terminated|0|||
48423375|NCT00090285|155739969|FG005|Base Study Vaccination Period|Site Terminated|0|||
48423376|NCT00090285|155739964|FG000|Base Study Vaccination Period|Other|2|||
48423377|NCT00090285|155739965|FG001|Base Study Vaccination Period|Other|2|||
48423378|NCT00090285|155739966|FG002|Base Study Vaccination Period|Other|0|||
48423379|NCT00090285|155739967|FG003|Base Study Vaccination Period|Other|0|||
48423380|NCT00090285|155739968|FG004|Base Study Vaccination Period|Other|0|||
48423381|NCT00090285|155739969|FG005|Base Study Vaccination Period|Other|0|||
48423382|NCT00090285|155739964|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
48423383|NCT00090285|155739965|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
48423384|NCT00090285|155739966|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
48423385|NCT00090285|155739967|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
48423386|NCT00090285|155739968|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
48423387|NCT00090285|155739969|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
48423388|NCT00090285|155739964|FG000|Base Study Vaccination Period|HIV positive|1|||
48423389|NCT00090285|155739965|FG001|Base Study Vaccination Period|HIV positive|1|||
48423390|NCT00090285|155739966|FG002|Base Study Vaccination Period|HIV positive|0|||
48423391|NCT00090285|155739967|FG003|Base Study Vaccination Period|HIV positive|0|||
48423392|NCT00090285|155739968|FG004|Base Study Vaccination Period|HIV positive|0|||
48423393|NCT00090285|155739969|FG005|Base Study Vaccination Period|HIV positive|0|||
48423394|NCT00090285|155739964|FG000|Base Study Follow-up Period|Adverse Event|3|||
48423395|NCT00090285|155739965|FG001|Base Study Follow-up Period|Adverse Event|10|||
48423396|NCT00090285|155739966|FG002|Base Study Follow-up Period|Adverse Event|0|||
48423397|NCT00090285|155739967|FG003|Base Study Follow-up Period|Adverse Event|0|||
48423398|NCT00090285|155739968|FG004|Base Study Follow-up Period|Adverse Event|0|||
48423399|NCT00090285|155739969|FG005|Base Study Follow-up Period|Adverse Event|0|||
48423400|NCT00090285|155739964|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
48423401|NCT00090285|155739965|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
48423402|NCT00090285|155739966|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
48423403|NCT00090285|155739967|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
48423404|NCT00090285|155739968|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
48423405|NCT00090285|155739969|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
48423406|NCT00090285|155739964|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
48423407|NCT00090285|155739965|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
48423408|NCT00090285|155739966|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
48423409|NCT00090285|155739967|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
48423410|NCT00090285|155739968|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
48423411|NCT00090285|155739969|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
48423412|NCT00090285|155739964|FG000|Base Study Follow-up Period|Moved|41|||
48423413|NCT00090285|155739965|FG001|Base Study Follow-up Period|Moved|36|||
48423414|NCT00090285|155739966|FG002|Base Study Follow-up Period|Moved|0|||
48423415|NCT00090285|155739967|FG003|Base Study Follow-up Period|Moved|0|||
48423416|NCT00090285|155739968|FG004|Base Study Follow-up Period|Moved|0|||
48423417|NCT00090285|155739969|FG005|Base Study Follow-up Period|Moved|0|||
48423418|NCT00090285|155739964|FG000|Base Study Follow-up Period|Other|2|||
48423419|NCT00090285|155739965|FG001|Base Study Follow-up Period|Other|0|||
48423420|NCT00090285|155739966|FG002|Base Study Follow-up Period|Other|0|||
48423421|NCT00090285|155739967|FG003|Base Study Follow-up Period|Other|0|||
48423422|NCT00090285|155739968|FG004|Base Study Follow-up Period|Other|0|||
48423423|NCT00090285|155739969|FG005|Base Study Follow-up Period|Other|0|||
48423424|NCT00090285|155739964|FG000|Base Study Follow-up Period|Protocol Violation|1|||
48423425|NCT00090285|155739965|FG001|Base Study Follow-up Period|Protocol Violation|0|||
48423426|NCT00090285|155739966|FG002|Base Study Follow-up Period|Protocol Violation|0|||
48423427|NCT00090285|155739967|FG003|Base Study Follow-up Period|Protocol Violation|0|||
48423428|NCT00090285|155739968|FG004|Base Study Follow-up Period|Protocol Violation|0|||
48423429|NCT00090285|155739969|FG005|Base Study Follow-up Period|Protocol Violation|0|||
48423430|NCT00090285|155739964|FG000|Base Study Follow-up Period|Uncooperative|3|||
48423431|NCT00090285|155739965|FG001|Base Study Follow-up Period|Uncooperative|4|||
48423432|NCT00090285|155739966|FG002|Base Study Follow-up Period|Uncooperative|0|||
48423433|NCT00090285|155739967|FG003|Base Study Follow-up Period|Uncooperative|0|||
48423434|NCT00090285|155739968|FG004|Base Study Follow-up Period|Uncooperative|0|||
48423435|NCT00090285|155739969|FG005|Base Study Follow-up Period|Uncooperative|0|||
48423436|NCT00090285|155739964|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
48423437|NCT00090285|155739965|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
48423438|NCT00090285|155739966|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
48423439|NCT00090285|155739967|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
48423440|NCT00090285|155739968|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
48423441|NCT00090285|155739969|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
48423442|NCT00090285|155739964|FG000|Extension 1|Adverse Event|0|||
48423443|NCT00090285|155739965|FG001|Extension 1|Adverse Event|0|||
48423444|NCT00090285|155739966|FG002|Extension 1|Adverse Event|2|||
48423445|NCT00090285|155739967|FG003|Extension 1|Adverse Event|0|||
48423446|NCT00090285|155739968|FG004|Extension 1|Adverse Event|0|||
48423447|NCT00090285|155739969|FG005|Extension 1|Adverse Event|0|||
48423448|NCT00090285|155739964|FG000|Extension 1|Lost to Follow-up|0|||
48423449|NCT00090285|155739965|FG001|Extension 1|Lost to Follow-up|0|||
48423450|NCT00090285|155739966|FG002|Extension 1|Lost to Follow-up|35|||
48423451|NCT00090285|155739967|FG003|Extension 1|Lost to Follow-up|0|||
48423452|NCT00090285|155739968|FG004|Extension 1|Lost to Follow-up|0|||
48423453|NCT00090285|155739969|FG005|Extension 1|Lost to Follow-up|0|||
48423454|NCT00090285|155739964|FG000|Extension 1|Withdrawal by Subject|0|||
48423455|NCT00090285|155739965|FG001|Extension 1|Withdrawal by Subject|0|||
48423456|NCT00090285|155739966|FG002|Extension 1|Withdrawal by Subject|13|||
48423457|NCT00090285|155739967|FG003|Extension 1|Withdrawal by Subject|1|||
48423458|NCT00090285|155739968|FG004|Extension 1|Withdrawal by Subject|0|||
48423459|NCT00090285|155739969|FG005|Extension 1|Withdrawal by Subject|0|||
48423460|NCT00090285|155739964|FG000|Extension 1|Other|0|||
48423461|NCT00090285|155739965|FG001|Extension 1|Other|0|||
48423462|NCT00090285|155739966|FG002|Extension 1|Other|4|||
48423463|NCT00090285|155739967|FG003|Extension 1|Other|0|||
48423464|NCT00090285|155739968|FG004|Extension 1|Other|0|||
48423465|NCT00090285|155739969|FG005|Extension 1|Other|0|||
48423466|NCT00090285|155739964|FG000|Extension 1|Moved|0|||
48423467|NCT00090285|155739965|FG001|Extension 1|Moved|0|||
48423468|NCT00090285|155739966|FG002|Extension 1|Moved|3|||
48423469|NCT00090285|155739967|FG003|Extension 1|Moved|0|||
48423470|NCT00090285|155739968|FG004|Extension 1|Moved|0|||
48423471|NCT00090285|155739969|FG005|Extension 1|Moved|0|||
48423472|NCT00090285|155739964|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
48423473|NCT00090285|155739965|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
48423474|NCT00090285|155739966|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
48423475|NCT00090285|155739967|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
48423476|NCT00090285|155739968|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
48423477|NCT00090285|155739969|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
48423478|NCT00090285|155739964|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48423479|NCT00090285|155739965|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48423480|NCT00090285|155739966|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48423481|NCT00090285|155739967|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
48423482|NCT00090285|155739968|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
48423483|NCT00090285|155739969|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
48423484|NCT00090285|155739964|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48423485|NCT00090285|155739965|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48423486|NCT00090285|155739966|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48423487|NCT00090285|155739967|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
48423488|NCT00090285|155739968|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
48423489|NCT00090285|155739969|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
48423490|NCT00090285|155739964|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
48423491|NCT00090285|155739965|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
48423492|NCT00090285|155739966|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
48423493|NCT00090285|155739967|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
48423494|NCT00090285|155739968|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
48423495|NCT00090285|155739969|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
48423496|NCT01458340|155739970|FG000|Overall Study|Adverse Event|5|||
48423497|NCT01458340|155739971|FG001|Overall Study|Adverse Event|4|||
48423498|NCT01458340|155739972|FG002|Overall Study|Adverse Event|2|||
48423499|NCT01458340|155739970|FG000|Overall Study|Lost to Follow-up|3|||
48423500|NCT01458340|155739971|FG001|Overall Study|Lost to Follow-up|3|||
48423501|NCT01458340|155739972|FG002|Overall Study|Lost to Follow-up|10|||
48423502|NCT01458340|155739970|FG000|Overall Study|Miscellaneous|0|||
48423503|NCT01458340|155739971|FG001|Overall Study|Miscellaneous|1|||
48423504|NCT01458340|155739972|FG002|Overall Study|Miscellaneous|0|||
48423505|NCT01458340|155739970|FG000|Overall Study|Physician Decision|1|||
48423506|NCT01458340|155739971|FG001|Overall Study|Physician Decision|1|||
48423507|NCT01458340|155739972|FG002|Overall Study|Physician Decision|2|||
48423508|NCT01458340|155739970|FG000|Overall Study|Protocol Violation|6|||
48423509|NCT01458340|155739971|FG001|Overall Study|Protocol Violation|6|||
48423510|NCT01458340|155739972|FG002|Overall Study|Protocol Violation|5|||
48423511|NCT01458340|155739970|FG000|Overall Study|Withdrawal by Subject|12|||
48423512|NCT01458340|155739971|FG001|Overall Study|Withdrawal by Subject|6|||
48423513|NCT01458340|155739972|FG002|Overall Study|Withdrawal by Subject|4|||
48423514|NCT01272180|155739973|FG000|Overall Study|Adverse Event|0|||
48423515|NCT01272180|155739974|FG001|Overall Study|Adverse Event|0|||
48423516|NCT01272180|155739975|FG002|Overall Study|Adverse Event|1|||
48423517|NCT01272180|155739976|FG003|Overall Study|Adverse Event|0|||
48423518|NCT01272180|155739973|FG000|Overall Study|Withdrawal by Subject|2|||
48423519|NCT01272180|155739974|FG001|Overall Study|Withdrawal by Subject|6|||
48423520|NCT01272180|155739975|FG002|Overall Study|Withdrawal by Subject|3|||
48423521|NCT01272180|155739976|FG003|Overall Study|Withdrawal by Subject|2|||
48423522|NCT01272180|155739973|FG000|Overall Study|Lost to Follow-up|15|||
48423523|NCT01272180|155739974|FG001|Overall Study|Lost to Follow-up|14|||
48423524|NCT01272180|155739975|FG002|Overall Study|Lost to Follow-up|8|||
48423525|NCT01272180|155739976|FG003|Overall Study|Lost to Follow-up|10|||
48423526|NCT01272180|155739973|FG000|Overall Study|Inappropriate enrollment|0|||
48423527|NCT01272180|155739974|FG001|Overall Study|Inappropriate enrollment|0|||
48423528|NCT01272180|155739975|FG002|Overall Study|Inappropriate enrollment|1|||
48423529|NCT01272180|155739976|FG003|Overall Study|Inappropriate enrollment|1|||
48423530|NCT01272180|155739973|FG000|Overall Study|Protocol Violation|0|||
48423531|NCT01272180|155739974|FG001|Overall Study|Protocol Violation|1|||
48423532|NCT01272180|155739975|FG002|Overall Study|Protocol Violation|0|||
48423533|NCT01272180|155739976|FG003|Overall Study|Protocol Violation|1|||
48423534|NCT03334214|155739977|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
48423535|NCT03334214|155739978|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
48423536|NCT03334214|155739977|FG000|Overall Study|Withdrawal by Subject|0|||
48423537|NCT03334214|155739978|FG001|Overall Study|Withdrawal by Subject|1|||
48423538|NCT03334214|155739977|FG000|Overall Study|Other|1|||
48423539|NCT03334214|155739978|FG001|Overall Study|Other|0|||
48423540|NCT02046564|155739980|FG000|Overall Study|Adverse Event|6|||
48423541|NCT02046564|155739981|FG001|Overall Study|Adverse Event|3|||
48423542|NCT02046564|155739980|FG000|Overall Study|Physician Decision|0|||
48423543|NCT02046564|155739981|FG001|Overall Study|Physician Decision|1|||
48423544|NCT02046564|155739980|FG000|Overall Study|Protocol Violation|3|||
48423545|NCT02046564|155739981|FG001|Overall Study|Protocol Violation|1|||
48423546|NCT02046564|155739980|FG000|Overall Study|Withdrawal by Subject|4|||
48423547|NCT02046564|155739981|FG001|Overall Study|Withdrawal by Subject|10|||
48423548|NCT02046564|155739980|FG000|Overall Study|Subject met withdrawal criteria|2|||
48423549|NCT02046564|155739981|FG001|Overall Study|Subject met withdrawal criteria|5|||
48423550|NCT01126619|155739984|FG000|Overall Study|Not eligible for the study|2|||
48423551|NCT01126619|155739984|FG000|Overall Study|Investigator decision|4|||
48423552|NCT01126619|155739984|FG000|Overall Study|Serious adverse event|1|||
48423553|NCT01126619|155739984|FG000|Overall Study|Withdrawal by Subject|9|||
48423554|NCT01126619|155739984|FG000|Overall Study|Non-compliance|1|||
48423555|NCT03988751|155739988|FG000|Overall Study|Withdrawal by Subject|1|||
48423556|NCT03988751|155739989|FG001|Overall Study|Withdrawal by Subject|0|||
48423557|NCT03988751|155739988|FG000|Overall Study|Protocol Violation|0|||
48423558|NCT03988751|155739989|FG001|Overall Study|Protocol Violation|1|||
48423559|NCT03700892|155739992|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
48423560|NCT03700892|155739993|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
48423561|NCT03700892|155739994|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
48423562|NCT01849848|155739995|FG000|Overall Study|Physician Decision|1|||
48423563|NCT01849848|155739995|FG000|Overall Study|Progression of the primary disease|3|||
48423564|NCT01070303|155739996|FG000|Overall Study|Adverse Event|39|||
48423565|NCT01070303|155739996|FG000|Overall Study|Withdrawal by Subject|20|||
48423566|NCT01070303|155739996|FG000|Overall Study|Lost to Follow-up|9|||
48423567|NCT01070303|155739996|FG000|Overall Study|Protocol Violation|0|||
48423568|NCT01070303|155739996|FG000|Overall Study|Lack of Efficacy|2|||
48423569|NCT01070303|155739996|FG000|Overall Study|Administrative Reason|1|||
48423570|NCT01070303|155739996|FG000|Overall Study|Other|18|||
48423571|NCT00546819|155739997|FG000|Overall Study|Adverse Event|2|||
48423572|NCT00546819|155739998|FG001|Overall Study|Adverse Event|3|||
48423573|NCT00546819|155739997|FG000|Overall Study|Lost to Follow-up|2|||
48423574|NCT00546819|155739998|FG001|Overall Study|Lost to Follow-up|1|||
48423575|NCT00546819|155739997|FG000|Overall Study|Withdrawal by Subject|4|||
48423576|NCT00546819|155739998|FG001|Overall Study|Withdrawal by Subject|2|||
48423577|NCT03849560|155739999|FG000|Overall Study|Withdrawal by Subject|1|||
48423578|NCT03849560|155740000|FG001|Overall Study|Withdrawal by Subject|0|||
48423579|NCT03849560|155740001|FG002|Overall Study|Withdrawal by Subject|0|||
48423580|NCT04651777|155740002|FG000|Overall Study|Adverse Event|1|||
48423581|NCT04651777|155740002|FG000|Overall Study|Withdrawal by Subject|2|||
48423582|NCT00184054|155740005|FG000|Overall Study|Adverse Event|1|||
48423583|NCT04222725|155740006|FG000|Overall Study|Adverse Event|0|||
48423584|NCT04222725|155740007|FG001|Overall Study|Adverse Event|1|||
48423585|NCT04222725|155740008|FG002|Overall Study|Adverse Event|0|||
48423586|NCT04222725|155740009|FG003|Overall Study|Adverse Event|0|||
48423587|NCT00450866|155740013|FG000|Overall Study|Adverse Event|0|||
48423588|NCT00450866|155740014|FG001|Overall Study|Adverse Event|1|||
48423589|NCT00450866|155740013|FG000|Overall Study|Withdrawal by Subject|5|||
48423590|NCT00450866|155740014|FG001|Overall Study|Withdrawal by Subject|2|||
48423591|NCT00450866|155740013|FG000|Overall Study|Death|1|||
48423592|NCT00450866|155740014|FG001|Overall Study|Death|0|||
48423593|NCT00450866|155740013|FG000|Overall Study|Physician Decision|1|||
48423594|NCT00450866|155740014|FG001|Overall Study|Physician Decision|0|||
48423595|NCT02795767|155740016|FG000|Overall Study|Received Commercial Emicizumab|1|||
48423596|NCT02795767|155740017|FG001|Overall Study|Received Commercial Emicizumab|0|||
48423597|NCT02795767|155740018|FG002|Overall Study|Received Commercial Emicizumab|0|||
48423598|NCT00611130|155740019|FG000|Overall Study|Lost to Follow-up|25|||
48423599|NCT00611130|155740020|FG001|Overall Study|Lost to Follow-up|29|||
48423600|NCT00611130|155740019|FG000|Overall Study|Protocol noncompliance|7|||
48423601|NCT00611130|155740020|FG001|Overall Study|Protocol noncompliance|6|||
48423602|NCT00611130|155740019|FG000|Overall Study|Withdrawal by Subject|6|||
48423603|NCT00611130|155740020|FG001|Overall Study|Withdrawal by Subject|5|||
48423604|NCT00611130|155740019|FG000|Overall Study|Other|5|||
48423605|NCT00611130|155740020|FG001|Overall Study|Other|4|||
48423606|NCT00611130|155740019|FG000|Overall Study|Incarceration|3|||
48423607|NCT00611130|155740020|FG001|Overall Study|Incarceration|2|||
48423608|NCT00611130|155740019|FG000|Overall Study|Administrative|1|||
48423609|NCT00611130|155740020|FG001|Overall Study|Administrative|1|||
48423610|NCT00611130|155740019|FG000|Overall Study|Adverse Event|1|||
48423611|NCT00611130|155740020|FG001|Overall Study|Adverse Event|0|||
48423612|NCT00611130|155740019|FG000|Overall Study|Death|1|||
48423613|NCT00611130|155740020|FG001|Overall Study|Death|0|||
48423614|NCT02760407|155740037|FG000|Overall Study|Death|2|||
48423615|NCT02760407|155740038|FG001|Overall Study|Death|3|||
48423616|NCT02760407|155740039|FG002|Overall Study|Death|1|||
48423617|NCT02760407|155740040|FG003|Overall Study|Death|1|||
48423618|NCT02760407|155740037|FG000|Overall Study|Lost to Follow-up|1|||
48423619|NCT02760407|155740038|FG001|Overall Study|Lost to Follow-up|7|||
48423620|NCT02760407|155740039|FG002|Overall Study|Lost to Follow-up|4|||
48423621|NCT02760407|155740040|FG003|Overall Study|Lost to Follow-up|6|||
48423622|NCT02760407|155740037|FG000|Overall Study|Withdrawal by Subject|25|||
48423623|NCT02760407|155740038|FG001|Overall Study|Withdrawal by Subject|31|||
48423624|NCT02760407|155740039|FG002|Overall Study|Withdrawal by Subject|37|||
48423625|NCT02760407|155740040|FG003|Overall Study|Withdrawal by Subject|25|||
48423626|NCT02760407|155740037|FG000|Overall Study|Violation of Eligibility criteria|0|||
48423627|NCT02760407|155740038|FG001|Overall Study|Violation of Eligibility criteria|0|||
48423628|NCT02760407|155740039|FG002|Overall Study|Violation of Eligibility criteria|1|||
48423629|NCT02760407|155740040|FG003|Overall Study|Violation of Eligibility criteria|1|||
48423630|NCT02760407|155740037|FG000|Overall Study|Personal reasons|0|||
48423631|NCT02760407|155740038|FG001|Overall Study|Personal reasons|0|||
48423632|NCT02760407|155740039|FG002|Overall Study|Personal reasons|0|||
48423633|NCT02760407|155740040|FG003|Overall Study|Personal reasons|1|||
48423634|NCT02760407|155740037|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
48423635|NCT02760407|155740038|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
48423636|NCT02760407|155740039|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
48423637|NCT02760407|155740040|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
48423638|NCT02760407|155740037|FG000|Overall Study|Use of prohibited Medication|0|||
48423639|NCT02760407|155740038|FG001|Overall Study|Use of prohibited Medication|0|||
48423640|NCT02760407|155740039|FG002|Overall Study|Use of prohibited Medication|1|||
48423641|NCT02760407|155740040|FG003|Overall Study|Use of prohibited Medication|0|||
48423642|NCT02760407|155740037|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
48423643|NCT02760407|155740038|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
48423644|NCT02760407|155740039|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
48423645|NCT02760407|155740040|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
48423646|NCT02760407|155740037|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
48423647|NCT02760407|155740038|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
48423648|NCT02760407|155740039|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
48423649|NCT02760407|155740040|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
48423650|NCT02760407|155740037|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
48423651|NCT02760407|155740038|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
48423652|NCT02760407|155740039|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
48423653|NCT02760407|155740040|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
48423654|NCT02760407|155740037|FG000|Overall Study|Inadequately Enrolled|0|||
48423655|NCT02760407|155740038|FG001|Overall Study|Inadequately Enrolled|0|||
48423656|NCT02760407|155740039|FG002|Overall Study|Inadequately Enrolled|0|||
48423657|NCT02760407|155740040|FG003|Overall Study|Inadequately Enrolled|1|||
48423658|NCT02760407|155740037|FG000|Overall Study|Withdrawal By PI's Decision|0|||
48423659|NCT02760407|155740038|FG001|Overall Study|Withdrawal By PI's Decision|1|||
48423660|NCT02760407|155740039|FG002|Overall Study|Withdrawal By PI's Decision|0|||
48423661|NCT02760407|155740040|FG003|Overall Study|Withdrawal By PI's Decision|0|||
48423662|NCT02760407|155740037|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
48423663|NCT02760407|155740038|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
48423664|NCT02760407|155740039|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
48423665|NCT02760407|155740040|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
48423666|NCT02760407|155740037|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
48423667|NCT02760407|155740038|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
48423668|NCT02760407|155740039|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
48423669|NCT02760407|155740040|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
48423670|NCT02760407|155740037|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
48423671|NCT02760407|155740038|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
48423672|NCT02760407|155740039|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
48423673|NCT02760407|155740040|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
48423674|NCT02760407|155740037|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
48423675|NCT02760407|155740038|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
48423676|NCT02760407|155740039|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
48423677|NCT02760407|155740040|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
48423678|NCT02760407|155740037|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
48423679|NCT02760407|155740038|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
48423680|NCT02760407|155740039|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
48423681|NCT02760407|155740040|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
48423682|NCT02760407|155740037|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
48423683|NCT02760407|155740038|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
48423684|NCT02760407|155740039|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
48423685|NCT02760407|155740040|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
48423686|NCT02760407|155740037|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
48423687|NCT02760407|155740038|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
48423688|NCT02760407|155740039|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
48423689|NCT02760407|155740040|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
48423690|NCT02760407|155740037|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
48423691|NCT02760407|155740038|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
48423692|NCT02760407|155740039|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
48423693|NCT02760407|155740040|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
48423694|NCT02760407|155740037|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
48423695|NCT02760407|155740038|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
48423696|NCT02760407|155740039|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
48423697|NCT02760407|155740040|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
48423698|NCT00872898|155740044|FG000|Part Two - Double Blind|Adverse Event|4|||
48423699|NCT00872898|155740045|FG001|Part Two - Double Blind|Adverse Event|3|||
48423700|NCT00872898|155740044|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
48423701|NCT00872898|155740045|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
48423702|NCT00872898|155740044|FG000|Part Two - Double Blind|Protocol Violation|1|||
48423703|NCT00872898|155740045|FG001|Part Two - Double Blind|Protocol Violation|0|||
48423704|NCT00872898|155740044|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
48423705|NCT00872898|155740045|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
48423706|NCT00872898|155740044|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
48423707|NCT00872898|155740045|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
48423708|NCT00872898|155740044|FG000|Part Two - Double Blind|Other reasons|2|||
48423709|NCT00872898|155740045|FG001|Part Two - Double Blind|Other reasons|0|||
48423710|NCT04579393|155740048|FG000|Overall Study|Withdrawal by Subject|2|||
48423711|NCT04579393|155740049|FG001|Overall Study|Withdrawal by Subject|2|||
48423712|NCT04579393|155740048|FG000|Overall Study|Death|1|||
48423713|NCT04579393|155740049|FG001|Overall Study|Death|3|||
48423714|NCT00501852|155740050|FG000|Overall Study|Adverse Event|3|||
48423715|NCT00501852|155740050|FG000|Overall Study|Withdrawal by Subject|2|||
48423716|NCT01927562|155740051|FG000|Overall Study|Lost to Follow-up|30|||
48423717|NCT01927562|155740051|FG000|Overall Study|Withdrawal by Subject|3|||
48423718|NCT01927562|155740051|FG000|Overall Study|Physician Decision|5|||
48423719|NCT00778999|155740052|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
48423720|NCT00778999|155740053|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
48423721|NCT00778999|155740052|FG000|Overall Study|Did not receive recFSH|14|||
48423722|NCT00778999|155740053|FG001|Overall Study|Did not receive recFSH|20|||
48423723|NCT00399802|155740054|FG000|Overall Study|Adverse Event|0|||
48423724|NCT00399802|155740055|FG001|Overall Study|Adverse Event|2|||
48423725|NCT00399802|155740054|FG000|Overall Study|Participant discontinued by mistake|0|||
48423726|NCT00399802|155740055|FG001|Overall Study|Participant discontinued by mistake|1|||
48423727|NCT00492921|155740056|FG000|Overall Study|Death|1|||
48423728|NCT00492921|155740057|FG001|Overall Study|Death|0|||
48423729|NCT00492921|155740058|FG002|Overall Study|Death|1|||
48423730|NCT00542815|155740059|FG000|Overall Study|Adverse Event|19|||
48423731|NCT00542815|155740060|FG001|Overall Study|Adverse Event|6|||
48423732|NCT00542815|155740061|FG002|Overall Study|Adverse Event|9|||
48423733|NCT00542815|155740059|FG000|Overall Study|Death|10|||
48423734|NCT00542815|155740060|FG001|Overall Study|Death|7|||
48423735|NCT00542815|155740061|FG002|Overall Study|Death|3|||
48423736|NCT00542815|155740059|FG000|Overall Study|Lack of Efficacy|9|||
48423737|NCT00542815|155740060|FG001|Overall Study|Lack of Efficacy|2|||
48423738|NCT00542815|155740061|FG002|Overall Study|Lack of Efficacy|0|||
48423739|NCT00542815|155740059|FG000|Overall Study|Physician Decision|2|||
48423740|NCT00542815|155740060|FG001|Overall Study|Physician Decision|1|||
48423741|NCT00542815|155740061|FG002|Overall Study|Physician Decision|0|||
48423742|NCT00542815|155740059|FG000|Overall Study|Protocol Violation|1|||
48423743|NCT00542815|155740060|FG001|Overall Study|Protocol Violation|1|||
48423744|NCT00542815|155740061|FG002|Overall Study|Protocol Violation|2|||
48423745|NCT00542815|155740059|FG000|Overall Study|Withdrawal by Subject|41|||
48423746|NCT00542815|155740060|FG001|Overall Study|Withdrawal by Subject|5|||
48423747|NCT00542815|155740061|FG002|Overall Study|Withdrawal by Subject|8|||
48423748|NCT00542815|155740059|FG000|Overall Study|Other reasons|24|||
48423749|NCT00542815|155740060|FG001|Overall Study|Other reasons|10|||
48423750|NCT00542815|155740061|FG002|Overall Study|Other reasons|10|||
48423751|NCT01276847|155740062|FG000|Overall Study|Withdrawal by Subject|1|||
48423752|NCT01276847|155740063|FG001|Overall Study|Withdrawal by Subject|0|||
48423753|NCT01276847|155740064|FG002|Overall Study|Withdrawal by Subject|0|||
48423754|NCT00875420|155740065|FG000|Overall Study|Adverse Event|0|||
48423755|NCT00875420|155740066|FG001|Overall Study|Adverse Event|1|||
48423756|NCT00875420|155740067|FG002|Overall Study|Adverse Event|1|||
48423757|NCT00875420|155740068|FG003|Overall Study|Adverse Event|0|||
48423758|NCT00875420|155740069|FG004|Overall Study|Adverse Event|0|||
48423759|NCT00875420|155740065|FG000|Overall Study|Inability to complete study procedures|1|||
48423760|NCT00875420|155740066|FG001|Overall Study|Inability to complete study procedures|0|||
48423761|NCT00875420|155740067|FG002|Overall Study|Inability to complete study procedures|1|||
48423762|NCT00875420|155740068|FG003|Overall Study|Inability to complete study procedures|1|||
48423763|NCT00875420|155740069|FG004|Overall Study|Inability to complete study procedures|1|||
48423764|NCT00875420|155740065|FG000|Overall Study|Lost to Follow-up|1|||
48423765|NCT00875420|155740066|FG001|Overall Study|Lost to Follow-up|0|||
48423766|NCT00875420|155740067|FG002|Overall Study|Lost to Follow-up|0|||
48423767|NCT00875420|155740068|FG003|Overall Study|Lost to Follow-up|0|||
48423768|NCT00875420|155740069|FG004|Overall Study|Lost to Follow-up|0|||
48423769|NCT00875420|155740065|FG000|Overall Study|Personal reason|0|||
48423770|NCT00875420|155740066|FG001|Overall Study|Personal reason|0|||
48423771|NCT00875420|155740067|FG002|Overall Study|Personal reason|0|||
48423772|NCT00875420|155740068|FG003|Overall Study|Personal reason|0|||
48423773|NCT00875420|155740069|FG004|Overall Study|Personal reason|1|||
48423774|NCT00875420|155740065|FG000|Overall Study|Prohibited medication|0|||
48423775|NCT00875420|155740066|FG001|Overall Study|Prohibited medication|0|||
48423776|NCT00875420|155740067|FG002|Overall Study|Prohibited medication|0|||
48423777|NCT00875420|155740068|FG003|Overall Study|Prohibited medication|1|||
48423778|NCT00875420|155740069|FG004|Overall Study|Prohibited medication|0|||
48423779|NCT00875420|155740065|FG000|Overall Study|Sponsor decision|0|||
48423780|NCT00875420|155740066|FG001|Overall Study|Sponsor decision|1|||
48423781|NCT00875420|155740067|FG002|Overall Study|Sponsor decision|0|||
48423782|NCT00875420|155740068|FG003|Overall Study|Sponsor decision|0|||
48423783|NCT00875420|155740069|FG004|Overall Study|Sponsor decision|0|||
48423784|NCT00875420|155740065|FG000|Overall Study|Withdrawal by Subject|0|||
48423785|NCT00875420|155740066|FG001|Overall Study|Withdrawal by Subject|0|||
48423786|NCT00875420|155740067|FG002|Overall Study|Withdrawal by Subject|1|||
48423787|NCT00875420|155740068|FG003|Overall Study|Withdrawal by Subject|0|||
48423788|NCT00875420|155740069|FG004|Overall Study|Withdrawal by Subject|0|||
48423789|NCT00231062|155740070|FG000|Overall Study|Physician Decision|6|||
48423790|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Adverse Event|37|||
48423791|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Adverse Event|0|||
48423792|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Adverse Event|0|||
48423793|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Adverse Event|0|||
48423794|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Death|2|||
48423795|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Death|0|||
48423796|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Death|0|||
48423797|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Death|0|||
48423798|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
48423799|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
48423800|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
48423801|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
48423802|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
48423803|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
48423804|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
48423805|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
48423806|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
48423807|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
48423808|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
48423809|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
48423810|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
48423811|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
48423812|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
48423813|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
48423814|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Physician Decision|4|||
48423815|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Physician Decision|0|||
48423816|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Physician Decision|0|||
48423817|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Physician Decision|0|||
48423818|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Pregnancy|1|||
48423819|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Pregnancy|0|||
48423820|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Pregnancy|0|||
48423821|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Pregnancy|0|||
48423822|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
48423823|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
48423824|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
48423825|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
48423826|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
48423827|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
48423828|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
48423829|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
48423830|NCT01855789|155740071|FG000|1) Baseline up to Week 24|Other|4|||
48423831|NCT01855789|155740072|FG001|1) Baseline up to Week 24|Other|0|||
48423832|NCT01855789|155740073|FG002|1) Baseline up to Week 24|Other|0|||
48423833|NCT01855789|155740074|FG003|1) Baseline up to Week 24|Other|0|||
48423834|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
48423835|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
48423836|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
48423837|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
48423838|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
48423839|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
48423840|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
48423841|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
48423842|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
48423843|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
48423844|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
48423845|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
48423846|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
48423847|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
48423848|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
48423849|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
48423850|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
48423851|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
48423852|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
48423853|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
48423854|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
48423855|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
48423856|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
48423857|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
48423858|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
48423859|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
48423860|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
48423861|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
48423862|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
48423863|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
48423864|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
48423865|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
48423866|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
48423867|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
48423868|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
48423869|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
48423870|NCT01855789|155740071|FG000|2) Week 24 up to End of Study|Other|0|||
48423871|NCT01855789|155740072|FG001|2) Week 24 up to End of Study|Other|0|||
48423872|NCT01855789|155740073|FG002|2) Week 24 up to End of Study|Other|0|||
48423873|NCT01855789|155740074|FG003|2) Week 24 up to End of Study|Other|1|||
48423874|NCT02269319|155740075|FG000|Overall Study|Lost to Follow-up|4|||
48423875|NCT02269319|155740076|FG001|Overall Study|Lost to Follow-up|3|||
48423876|NCT02269319|155740075|FG000|Overall Study|Adverse Event|0|||
48692647|NCT03001557|156724543|FG002|Extension Phase|Administrative Reason|0|||
48423877|NCT02269319|155740076|FG001|Overall Study|Adverse Event|1|||
48423878|NCT02269319|155740075|FG000|Overall Study|Instructions not followed|1|||
48423879|NCT02269319|155740076|FG001|Overall Study|Instructions not followed|0|||
48423880|NCT04430582|155740077|FG000|Overall Study|Found to meet exclusionary criteria|1|||
48423881|NCT04430582|155740078|FG001|Overall Study|Found to meet exclusionary criteria|0|||
48423882|NCT04430582|155740077|FG000|Overall Study|Withdrawal by Subject|0|||
48423883|NCT04430582|155740078|FG001|Overall Study|Withdrawal by Subject|1|||
48423884|NCT02658656|155740079|FG000|Screening|Failed eligibility criteria|0|||
48423885|NCT02658656|155740080|FG001|Screening|Failed eligibility criteria|0|||
48423886|NCT02658656|155740081|FG002|Screening|Failed eligibility criteria|263|||
48423887|NCT02658656|155740079|FG000|Randomization|Withdrawal by Subject|8|||
48423888|NCT02658656|155740080|FG001|Randomization|Withdrawal by Subject|7|||
48423889|NCT02658656|155740081|FG002|Randomization|Withdrawal by Subject|0|||
48423890|NCT02658656|155740079|FG000|Randomization|Lost to Follow-up|1|||
48423891|NCT02658656|155740080|FG001|Randomization|Lost to Follow-up|3|||
48423892|NCT02658656|155740081|FG002|Randomization|Lost to Follow-up|0|||
48423893|NCT02658656|155740079|FG000|Randomization|Adverse Event|4|||
48423894|NCT02658656|155740080|FG001|Randomization|Adverse Event|0|||
48423895|NCT02658656|155740081|FG002|Randomization|Adverse Event|0|||
48423896|NCT02658656|155740079|FG000|Randomization|Administrative Termination|3|||
48423897|NCT02658656|155740080|FG001|Randomization|Administrative Termination|1|||
48423898|NCT02658656|155740081|FG002|Randomization|Administrative Termination|0|||
48423899|NCT02658656|155740079|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
48423900|NCT02658656|155740080|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
48423901|NCT02658656|155740081|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
48423902|NCT02658656|155740079|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
48423903|NCT02658656|155740080|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
48423904|NCT02658656|155740081|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
48423905|NCT02658656|155740079|FG000|Randomization|Not eligible for Randomization|1|||
48423906|NCT02658656|155740080|FG001|Randomization|Not eligible for Randomization|0|||
48423907|NCT02658656|155740081|FG002|Randomization|Not eligible for Randomization|0|||
48423908|NCT02658656|155740079|FG000|Randomization|Protocol Violation|1|||
48423909|NCT02658656|155740080|FG001|Randomization|Protocol Violation|0|||
48423910|NCT02658656|155740081|FG002|Randomization|Protocol Violation|0|||
48423911|NCT01040832|155741469|FG000|Overall Study|Adverse Event|4|||
48423912|NCT01040832|155741470|FG001|Overall Study|Adverse Event|5|||
48423913|NCT01040832|155741469|FG000|Overall Study|Death|4|||
48423914|NCT01040832|155741470|FG001|Overall Study|Death|6|||
48423915|NCT01040832|155741469|FG000|Overall Study|Withdrawal by Subject|2|||
48423916|NCT01040832|155741470|FG001|Overall Study|Withdrawal by Subject|3|||
48423917|NCT01040832|155741469|FG000|Overall Study|Progressive disease|32|||
48423918|NCT01040832|155741470|FG001|Overall Study|Progressive disease|17|||
48423919|NCT01040832|155741469|FG000|Overall Study|Symptomatic deterioration|2|||
48423920|NCT01040832|155741470|FG001|Overall Study|Symptomatic deterioration|5|||
48423921|NCT01040832|155741469|FG000|Overall Study|Other|2|||
48423922|NCT01040832|155741470|FG001|Overall Study|Other|1|||
48423923|NCT02839746|155741472|FG000|Overall Study|Not met selection criteria|12|||
48423924|NCT01009463|155741477|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
48423925|NCT01009463|155741478|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48423926|NCT01009463|155741479|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48423927|NCT01009463|155741480|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48423928|NCT01009463|155741481|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
48423929|NCT01009463|155741477|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
48423930|NCT01009463|155741478|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
48423931|NCT01009463|155741479|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
48423932|NCT01009463|155741480|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
48423933|NCT01009463|155741481|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
48423934|NCT01009463|155741477|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
48423935|NCT01009463|155741478|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48423936|NCT01009463|155741479|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48423937|NCT01009463|155741480|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48423938|NCT01009463|155741481|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
48423939|NCT01009463|155741477|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
48423940|NCT01009463|155741478|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
48423941|NCT01009463|155741479|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
48423942|NCT01009463|155741480|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
48423943|NCT01009463|155741481|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
48423944|NCT01009463|155741477|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
48423945|NCT01009463|155741478|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48423946|NCT01009463|155741479|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48426330|NCT02203838|155749553|FG003|Overall Study|Protocol Violation|0|||
48423947|NCT01009463|155741480|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48423948|NCT01009463|155741481|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
48423949|NCT01009463|155741477|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
48423950|NCT01009463|155741478|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
48423951|NCT01009463|155741479|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
48423952|NCT01009463|155741480|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
48423953|NCT01009463|155741481|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
48423954|NCT01009463|155741477|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48423955|NCT01009463|155741478|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
48423956|NCT01009463|155741479|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
48423957|NCT01009463|155741480|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
48423958|NCT01009463|155741481|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
48423959|NCT01009463|155741477|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
48423960|NCT01009463|155741478|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
48423961|NCT01009463|155741479|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
48423962|NCT01009463|155741480|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
48423963|NCT01009463|155741481|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
48423964|NCT01009463|155741477|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
48423965|NCT01009463|155741478|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
48423966|NCT01009463|155741479|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
48423967|NCT01009463|155741480|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
48423968|NCT01009463|155741481|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
48423969|NCT01009463|155741477|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48423970|NCT01009463|155741478|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
48423971|NCT01009463|155741479|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
48423972|NCT01009463|155741480|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
48423973|NCT01009463|155741481|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
48423974|NCT01009463|155741477|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48423975|NCT01009463|155741478|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
48423976|NCT01009463|155741479|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48423977|NCT01009463|155741480|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
48423978|NCT01009463|155741481|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
48423979|NCT01009463|155741477|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48423980|NCT01009463|155741478|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
48423981|NCT01009463|155741479|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
48423982|NCT01009463|155741480|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
48423983|NCT01009463|155741481|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
48423984|NCT01009463|155741477|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
48423985|NCT01009463|155741478|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
48423986|NCT01009463|155741479|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
48423987|NCT01009463|155741480|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
48423988|NCT01009463|155741481|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
48423989|NCT01494038|155741482|FG000|Overall Study|Protocol Violation|1|||
48423990|NCT01494038|155741483|FG001|Overall Study|Protocol Violation|1|||
48423991|NCT01494038|155741482|FG000|Overall Study|Lost to Follow-up|18|||
48423992|NCT01494038|155741483|FG001|Overall Study|Lost to Follow-up|20|||
48423993|NCT01494038|155741482|FG000|Overall Study|Withdrawal by Subject|44|||
48423994|NCT01494038|155741483|FG001|Overall Study|Withdrawal by Subject|34|||
48423995|NCT01494038|155741482|FG000|Overall Study|Not able to get to clinic|21|||
48423996|NCT01494038|155741483|FG001|Overall Study|Not able to get to clinic|15|||
48423997|NCT01494038|155741482|FG000|Overall Study|Not willing to adhere to reqs|2|||
48423998|NCT01494038|155741483|FG001|Overall Study|Not willing to adhere to reqs|9|||
48423999|NCT01494038|155741482|FG000|Overall Study|Death|2|||
48424000|NCT01494038|155741483|FG001|Overall Study|Death|4|||
48424001|NCT04275310|155741485|FG000|Overall Study|Non-randomized due to running out of funding|4|||
48424002|NCT04275310|155741486|FG001|Overall Study|Non-randomized due to running out of funding|0|||
48424003|NCT03088605|155741491|FG000|Overall Study|Withdrawal by Subject|1|||
48424004|NCT03088605|155741492|FG001|Overall Study|Withdrawal by Subject|0|||
48424005|NCT00098345|155741493|FG000|Overall Study|Adverse Event|7|||
48424006|NCT00098345|155741493|FG000|Overall Study|Withdrawal by Subject|2|||
48424007|NCT00098345|155741493|FG000|Overall Study|progression|4|||
48424008|NCT03133481|155741494|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
48424009|NCT03133481|155741495|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
48424010|NCT00593112|155741496|FG000|Overall Study|Scan Anxiety|3|||
48424011|NCT00593112|155741497|FG001|Overall Study|Scan Anxiety|0|||
48424012|NCT00593112|155741496|FG000|Overall Study|Abnormal Scan|1|||
48424013|NCT00593112|155741497|FG001|Overall Study|Abnormal Scan|0|||
48424014|NCT00593112|155741496|FG000|Overall Study|Unreadable Scan|1|||
48424015|NCT00593112|155741497|FG001|Overall Study|Unreadable Scan|0|||
48424016|NCT00593112|155741496|FG000|Overall Study|Withdrawal by Subject|5|||
48424017|NCT00593112|155741497|FG001|Overall Study|Withdrawal by Subject|0|||
48424018|NCT00779038|155741498|FG000|Overall Study|Study Prematurely Terminated|13|||
48424019|NCT01184989|155741500|FG000|Overall Study|Adverse Event|11|||
48424020|NCT01184989|155741500|FG000|Overall Study|Withdrawal by Subject|1|||
48424021|NCT02927171|155741501|FG000|Overall Study|Lost to Follow-up|0|||
48424022|NCT02927171|155741502|FG001|Overall Study|Lost to Follow-up|1|||
48424023|NCT01319929|155741509|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
48424024|NCT01319929|155741510|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
48424025|NCT01319929|155741509|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
48424026|NCT01319929|155741510|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
48424027|NCT01319929|155741509|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
48424028|NCT01319929|155741510|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
48424029|NCT01319929|155741509|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
48424030|NCT01319929|155741510|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
48424031|NCT01319929|155741509|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
48424032|NCT01319929|155741510|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
48424033|NCT00234104|155741512|FG000|Overall Study|Adverse Event|4|||
48424034|NCT00234104|155741513|FG001|Overall Study|Adverse Event|0|||
48424035|NCT00234104|155741514|FG002|Overall Study|Adverse Event|3|||
48424036|NCT00234104|155741515|FG003|Overall Study|Adverse Event|5|||
48424037|NCT00234104|155741512|FG000|Overall Study|Protocol Violation|0|||
48424038|NCT00234104|155741513|FG001|Overall Study|Protocol Violation|0|||
48424039|NCT00234104|155741514|FG002|Overall Study|Protocol Violation|0|||
48424040|NCT00234104|155741515|FG003|Overall Study|Protocol Violation|1|||
48424041|NCT00234104|155741512|FG000|Overall Study|Physician Decision|0|||
48424042|NCT00234104|155741513|FG001|Overall Study|Physician Decision|1|||
48424043|NCT00234104|155741514|FG002|Overall Study|Physician Decision|2|||
48424044|NCT00234104|155741515|FG003|Overall Study|Physician Decision|2|||
48424045|NCT01873742|155741520|FG000|Overall Study|Lost to Follow-up|68|||
48424046|NCT01873742|155741521|FG001|Overall Study|Lost to Follow-up|76|||
48424047|NCT01507545|155741522|FG000|Overall Study|Withdrawal by Subject|6|||
48424048|NCT01507545|155741523|FG001|Overall Study|Withdrawal by Subject|2|||
48424049|NCT01507545|155741522|FG000|Overall Study|Lost to Follow-up|1|||
48424050|NCT01507545|155741523|FG001|Overall Study|Lost to Follow-up|0|||
48424051|NCT01507545|155741522|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
48424052|NCT01507545|155741523|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
48424053|NCT01507545|155741522|FG000|Overall Study|Progressive disease|60|||
48424054|NCT01507545|155741523|FG001|Overall Study|Progressive disease|27|||
48424055|NCT01507545|155741522|FG000|Overall Study|Other|6|||
48424056|NCT01507545|155741523|FG001|Overall Study|Other|4|||
48424057|NCT00790296|155741525|FG000|Overall Study|Did not meet study eligibility criteria|1|||
48424058|NCT00790296|155741526|FG001|Overall Study|Did not meet study eligibility criteria|1|||
48424059|NCT00790296|155741525|FG000|Overall Study|Adverse Event|0|||
48424060|NCT00790296|155741526|FG001|Overall Study|Adverse Event|1|||
48424061|NCT01541254|155741529|FG000|Overall Study|Withdrawal by Subject|1|||
48424062|NCT01541254|155741529|FG000|Overall Study|excluded - metal allergy|1|||
48424063|NCT01541254|155741529|FG000|Overall Study|enrolled after study closed|1|||
48424064|NCT01541254|155741529|FG000|Overall Study|GI bleed prior to procedure|1|||
48424065|NCT01541254|155741529|FG000|Overall Study|stent not required|1|||
48424066|NCT01541254|155741529|FG000|Overall Study|alternate stent used|1|||
48424067|NCT01022853|155741530|FG000|Overall Study|Progressive disease|2|||
48424068|NCT01022853|155741531|FG001|Overall Study|Progressive disease|3|||
48424069|NCT01022853|155741532|FG002|Overall Study|Progressive disease|11|||
48424070|NCT01022853|155741533|FG003|Overall Study|Progressive disease|7|||
48424071|NCT01022853|155741534|FG004|Overall Study|Progressive disease|1|||
48424072|NCT01022853|155741530|FG000|Overall Study|Dose-limiting toxicity|0|||
48424073|NCT01022853|155741531|FG001|Overall Study|Dose-limiting toxicity|0|||
48424074|NCT01022853|155741532|FG002|Overall Study|Dose-limiting toxicity|0|||
48424075|NCT01022853|155741533|FG003|Overall Study|Dose-limiting toxicity|0|||
48424076|NCT01022853|155741534|FG004|Overall Study|Dose-limiting toxicity|1|||
48424077|NCT01022853|155741530|FG000|Overall Study|Withdrawal by Subject|0|||
48424078|NCT01022853|155741531|FG001|Overall Study|Withdrawal by Subject|1|||
48424079|NCT01022853|155741532|FG002|Overall Study|Withdrawal by Subject|1|||
48424080|NCT01022853|155741533|FG003|Overall Study|Withdrawal by Subject|1|||
48424081|NCT01022853|155741534|FG004|Overall Study|Withdrawal by Subject|0|||
48424082|NCT01022853|155741530|FG000|Overall Study|Other not stated above|1|||
48424083|NCT01022853|155741531|FG001|Overall Study|Other not stated above|0|||
48424084|NCT01022853|155741532|FG002|Overall Study|Other not stated above|1|||
48424085|NCT01022853|155741533|FG003|Overall Study|Other not stated above|0|||
48424086|NCT01022853|155741534|FG004|Overall Study|Other not stated above|0|||
48424087|NCT00652093|155741537|FG000|Overall Study|Withdrawal by Subject|0|||
48424088|NCT00652093|155741538|FG001|Overall Study|Withdrawal by Subject|0|||
48424089|NCT00652093|155741539|FG002|Overall Study|Withdrawal by Subject|1|||
48424090|NCT00652093|155741540|FG003|Overall Study|Withdrawal by Subject|0|||
48424091|NCT00652093|155741541|FG004|Overall Study|Withdrawal by Subject|1|||
48424092|NCT00652093|155741542|FG005|Overall Study|Withdrawal by Subject|0|||
48424093|NCT00652093|155741537|FG000|Overall Study|Physician Decision|0|||
48424094|NCT00652093|155741538|FG001|Overall Study|Physician Decision|0|||
48424095|NCT00652093|155741539|FG002|Overall Study|Physician Decision|0|||
48424096|NCT00652093|155741540|FG003|Overall Study|Physician Decision|0|||
48424097|NCT00652093|155741541|FG004|Overall Study|Physician Decision|1|||
48424098|NCT00652093|155741542|FG005|Overall Study|Physician Decision|0|||
48424099|NCT04172831|155741547|FG000|Overall Study|Adverse Event|21|||
48424100|NCT04172831|155741548|FG001|Overall Study|Adverse Event|9|||
48424101|NCT04172831|155741547|FG000|Overall Study|Lack of Efficacy|2|||
48424102|NCT04172831|155741548|FG001|Overall Study|Lack of Efficacy|8|||
48424103|NCT04172831|155741547|FG000|Overall Study|Physician Decision|0|||
48424104|NCT04172831|155741548|FG001|Overall Study|Physician Decision|1|||
48424105|NCT04172831|155741547|FG000|Overall Study|Withdrawal by Subject|12|||
48424106|NCT04172831|155741548|FG001|Overall Study|Withdrawal by Subject|11|||
48424107|NCT04172831|155741547|FG000|Overall Study|Lost to Follow-up|4|||
48424108|NCT04172831|155741548|FG001|Overall Study|Lost to Follow-up|9|||
48424109|NCT04172831|155741547|FG000|Overall Study|COVID-19 related crisis|3|||
48424110|NCT04172831|155741548|FG001|Overall Study|COVID-19 related crisis|3|||
48424111|NCT04172831|155741547|FG000|Overall Study|Subject non-compliance|1|||
48424112|NCT04172831|155741548|FG001|Overall Study|Subject non-compliance|1|||
48424113|NCT04172831|155741547|FG000|Overall Study|Family emergency|1|||
48424114|NCT04172831|155741548|FG001|Overall Study|Family emergency|0|||
48424115|NCT01041573|155741549|FG000|Overall Study|Withdrawal by Subject|2|||
48424116|NCT01041573|155741550|FG001|Overall Study|Withdrawal by Subject|5|||
48424117|NCT01041573|155741551|FG002|Overall Study|Withdrawal by Subject|2|||
48424118|NCT01041573|155741552|FG003|Overall Study|Withdrawal by Subject|0|||
48424119|NCT01041573|155741549|FG000|Overall Study|Death|1|||
48424120|NCT01041573|155741550|FG001|Overall Study|Death|0|||
48424121|NCT01041573|155741551|FG002|Overall Study|Death|0|||
48424122|NCT01041573|155741552|FG003|Overall Study|Death|0|||
48424123|NCT01041573|155741549|FG000|Overall Study|Lost to Follow-up|0|||
48424124|NCT01041573|155741550|FG001|Overall Study|Lost to Follow-up|1|||
48424125|NCT01041573|155741551|FG002|Overall Study|Lost to Follow-up|2|||
48424126|NCT01041573|155741552|FG003|Overall Study|Lost to Follow-up|1|||
48424127|NCT01041573|155741549|FG000|Overall Study|Adverse Event|0|||
48424128|NCT01041573|155741550|FG001|Overall Study|Adverse Event|2|||
48424129|NCT01041573|155741551|FG002|Overall Study|Adverse Event|0|||
48424130|NCT01041573|155741552|FG003|Overall Study|Adverse Event|0|||
48424131|NCT01041573|155741549|FG000|Overall Study|relocation|1|||
48424132|NCT01041573|155741550|FG001|Overall Study|relocation|4|||
48424133|NCT01041573|155741551|FG002|Overall Study|relocation|3|||
48424134|NCT01041573|155741552|FG003|Overall Study|relocation|1|||
48424135|NCT01041573|155741549|FG000|Overall Study|further blood extraction|0|||
48424136|NCT01041573|155741550|FG001|Overall Study|further blood extraction|1|||
48424137|NCT01041573|155741551|FG002|Overall Study|further blood extraction|0|||
48424138|NCT01041573|155741552|FG003|Overall Study|further blood extraction|0|||
48424139|NCT01041573|155741549|FG000|Overall Study|positive to anti-HCV|1|||
48424140|NCT01041573|155741550|FG001|Overall Study|positive to anti-HCV|0|||
48424141|NCT01041573|155741551|FG002|Overall Study|positive to anti-HCV|0|||
48424142|NCT01041573|155741552|FG003|Overall Study|positive to anti-HCV|0|||
48424143|NCT03176966|155741553|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
48424144|NCT03176966|155741554|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
48424145|NCT03176966|155741553|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
48424146|NCT03176966|155741554|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
48424147|NCT03176966|155741553|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
48424148|NCT03176966|155741554|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
48424149|NCT03176966|155741553|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
48424150|NCT03176966|155741554|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
48424151|NCT03176966|155741553|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
48424152|NCT03176966|155741554|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
48424153|NCT03176966|155741553|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
48424154|NCT03176966|155741554|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
48424155|NCT03176966|155741553|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
48424156|NCT03176966|155741554|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
48424157|NCT01520922|155741558|FG000|Treatment Phase|Physician Decision|2|||
48424158|NCT01520922|155741559|FG001|Treatment Phase|Physician Decision|1|||
48424159|NCT01520922|155741558|FG000|Treatment Phase|Progression|0|||
48424160|NCT01520922|155741559|FG001|Treatment Phase|Progression|2|||
48424161|NCT01520922|155741558|FG000|Treatment Phase|Adverse Event|3|||
48424162|NCT01520922|155741559|FG001|Treatment Phase|Adverse Event|5|||
48424163|NCT01520922|155741558|FG000|Follow up|Lost to Follow-up|0|||
48424164|NCT01520922|155741559|FG001|Follow up|Lost to Follow-up|1|||
48424165|NCT01520922|155741558|FG000|Survival Follow-up|Withdrawal by Subject|1|||
48426408|NCT01096550|155749577|FG001|Overall Study|Lost to Follow-up|9|||
48424166|NCT01520922|155741559|FG001|Survival Follow-up|Withdrawal by Subject|0|||
48424167|NCT02955186|155741560|FG000|Overall Study|Withdrawal by Subject|6|||
48424168|NCT02955186|155741561|FG001|Overall Study|Withdrawal by Subject|2|||
48424169|NCT02955186|155741560|FG000|Overall Study|Protocol Violation|1|||
48424170|NCT02955186|155741561|FG001|Overall Study|Protocol Violation|0|||
48424171|NCT01721369|155741569|FG000|Overall Study|Not initial etiological diagnosis|12|||
48424172|NCT01618656|155741570|FG000|Overall Study|Withdrawal by Subject|7|||
48424173|NCT01618656|155741571|FG001|Overall Study|Withdrawal by Subject|3|||
48424174|NCT01618656|155741570|FG000|Overall Study|Physician Decision|1|||
48424175|NCT01618656|155741571|FG001|Overall Study|Physician Decision|1|||
48424176|NCT01696877|155741572|FG000|Overall Study|Adverse Event|0|||
48424177|NCT01696877|155741573|FG001|Overall Study|Adverse Event|1|||
48424178|NCT01899144|155741574|FG000|Treatment Period 2|Other|1|||
48424179|NCT01899144|155741574|FG000|Treatment Period 3|Other|2|||
48424180|NCT01899144|155741574|FG000|Treatment Period 5|Other|1|||
48424181|NCT00864227|155741577|FG000|Overall Study|Withdrawal by Subject|1|||
48424182|NCT00864227|155741577|FG000|Overall Study|Disease Relapse/Progression|3|||
48424183|NCT03321929|155741581|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
48424184|NCT00866294|155741582|FG000|Overall Study|Adverse Event|12|||
48424185|NCT00866294|155741583|FG001|Overall Study|Adverse Event|13|||
48424186|NCT00866294|155741584|FG002|Overall Study|Adverse Event|9|||
48424187|NCT00866294|155741582|FG000|Overall Study|Lack of Efficacy|7|||
48424188|NCT00866294|155741583|FG001|Overall Study|Lack of Efficacy|1|||
48424189|NCT00866294|155741584|FG002|Overall Study|Lack of Efficacy|0|||
48424190|NCT00866294|155741582|FG000|Overall Study|Protocol Violation|2|||
48424191|NCT00866294|155741583|FG001|Overall Study|Protocol Violation|0|||
48424192|NCT00866294|155741584|FG002|Overall Study|Protocol Violation|0|||
48424193|NCT00866294|155741582|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
48424194|NCT00866294|155741583|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48424195|NCT00866294|155741584|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
48424196|NCT00866294|155741582|FG000|Overall Study|Lost to Follow-up|1|||
48424197|NCT00866294|155741583|FG001|Overall Study|Lost to Follow-up|3|||
48424198|NCT00866294|155741584|FG002|Overall Study|Lost to Follow-up|0|||
48424199|NCT00866294|155741582|FG000|Overall Study|Physician Decision|6|||
48424200|NCT00866294|155741583|FG001|Overall Study|Physician Decision|2|||
48424201|NCT00866294|155741584|FG002|Overall Study|Physician Decision|1|||
48424202|NCT00616239|155741585|FG000|Overall Study|Withdrawal by Subject|2|||
48424203|NCT01052012|155741586|FG000|Overall Study|Not treated|2|||
48424204|NCT01052012|155741587|FG001|Overall Study|Not treated|5|||
48424205|NCT01052012|155741588|FG002|Overall Study|Not treated|0|||
48424206|NCT01052012|155741589|FG003|Overall Study|Not treated|0|||
48424207|NCT01052012|155741590|FG004|Overall Study|Not treated|11|||
48424208|NCT01052012|155741591|FG005|Overall Study|Not treated|8|||
48424209|NCT01052012|155741586|FG000|Overall Study|Adverse Event|1|||
48424210|NCT01052012|155741587|FG001|Overall Study|Adverse Event|0|||
48424211|NCT01052012|155741588|FG002|Overall Study|Adverse Event|0|||
48424212|NCT01052012|155741589|FG003|Overall Study|Adverse Event|1|||
48424213|NCT01052012|155741590|FG004|Overall Study|Adverse Event|0|||
48424214|NCT01052012|155741591|FG005|Overall Study|Adverse Event|0|||
48424215|NCT01052012|155741586|FG000|Overall Study|Lost to Follow-up|0|||
48424216|NCT01052012|155741587|FG001|Overall Study|Lost to Follow-up|0|||
48424217|NCT01052012|155741588|FG002|Overall Study|Lost to Follow-up|0|||
48424218|NCT01052012|155741589|FG003|Overall Study|Lost to Follow-up|0|||
48424219|NCT01052012|155741590|FG004|Overall Study|Lost to Follow-up|1|||
48424220|NCT01052012|155741591|FG005|Overall Study|Lost to Follow-up|0|||
48424221|NCT01052012|155741586|FG000|Overall Study|Withdrawal by Subject|1|||
48424222|NCT01052012|155741587|FG001|Overall Study|Withdrawal by Subject|1|||
48424223|NCT01052012|155741588|FG002|Overall Study|Withdrawal by Subject|0|||
48424224|NCT01052012|155741589|FG003|Overall Study|Withdrawal by Subject|0|||
48424225|NCT01052012|155741590|FG004|Overall Study|Withdrawal by Subject|3|||
48424226|NCT01052012|155741591|FG005|Overall Study|Withdrawal by Subject|1|||
48424227|NCT01052012|155741586|FG000|Overall Study|Physician Decision|0|||
48424228|NCT01052012|155741587|FG001|Overall Study|Physician Decision|0|||
48424229|NCT01052012|155741588|FG002|Overall Study|Physician Decision|0|||
48424230|NCT01052012|155741589|FG003|Overall Study|Physician Decision|0|||
48424231|NCT01052012|155741590|FG004|Overall Study|Physician Decision|0|||
48424232|NCT01052012|155741591|FG005|Overall Study|Physician Decision|1|||
48424233|NCT01052012|155741586|FG000|Overall Study|Other|0|||
48424234|NCT01052012|155741587|FG001|Overall Study|Other|0|||
48424235|NCT01052012|155741588|FG002|Overall Study|Other|0|||
48424236|NCT01052012|155741589|FG003|Overall Study|Other|0|||
48424237|NCT01052012|155741590|FG004|Overall Study|Other|1|||
48424238|NCT01052012|155741591|FG005|Overall Study|Other|0|||
48424239|NCT02369510|155741592|FG000|Overall Study|Spilled Medication|1|||
48424240|NCT02369510|155741593|FG001|Overall Study|Spilled Medication|2|||
48424241|NCT02369510|155741594|FG002|Overall Study|Spilled Medication|1|||
48424242|NCT02369510|155741592|FG000|Overall Study|Epidural Activation|1|||
48424243|NCT02369510|155741593|FG001|Overall Study|Epidural Activation|1|||
48424244|NCT02369510|155741594|FG002|Overall Study|Epidural Activation|5|||
48424245|NCT02873715|155741595|FG000|Overall Study|Lost to Follow-up|84|||
48424246|NCT02873715|155741596|FG001|Overall Study|Lost to Follow-up|94|||
48424247|NCT02873715|155741595|FG000|Overall Study|Withdrawal by Subject|7|||
48424248|NCT02873715|155741596|FG001|Overall Study|Withdrawal by Subject|26|||
48424249|NCT03575468|155741597|FG000|Overall Study|Withdrawal by Subject|3|||
48424250|NCT03575468|155741598|FG001|Overall Study|Withdrawal by Subject|0|||
48424251|NCT03575468|155741597|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
48424252|NCT03575468|155741598|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
48424253|NCT03575468|155741597|FG000|Overall Study|Lost to Follow-up|13|||
48424254|NCT03575468|155741598|FG001|Overall Study|Lost to Follow-up|17|||
48424255|NCT03280550|155741602|FG000|Overall Study|Withdrawal by Subject|2|||
48424256|NCT03280550|155741603|FG001|Overall Study|Withdrawal by Subject|2|||
48424257|NCT03280550|155741602|FG000|Overall Study|Physician Decision|0|||
48424258|NCT03280550|155741603|FG001|Overall Study|Physician Decision|1|||
48424259|NCT02714205|155741604|FG000|Overall Study|Cannot tolerate medication|1|||
48424260|NCT02714205|155741605|FG001|Overall Study|Cannot tolerate medication|0|||
48424261|NCT02714205|155741604|FG000|Overall Study|Adverse Event|2|||
48424262|NCT02714205|155741605|FG001|Overall Study|Adverse Event|0|||
48424263|NCT02714205|155741604|FG000|Overall Study|Too busy|1|||
48424264|NCT02714205|155741605|FG001|Overall Study|Too busy|0|||
48424265|NCT02714205|155741604|FG000|Overall Study|Incomplete outcome data|0|||
48424266|NCT02714205|155741605|FG001|Overall Study|Incomplete outcome data|1|||
48424267|NCT02342171|155743307|FG000|Overall Study|Death|4|||
48424268|NCT02342171|155743308|FG001|Overall Study|Death|87|||
48424269|NCT02342171|155743307|FG000|Overall Study|Received favipiravir|10|||
48424270|NCT02342171|155743308|FG001|Overall Study|Received favipiravir|0|||
48424271|NCT02342171|155743307|FG000|Overall Study|Missing cycle treshold value|1|||
48424272|NCT02342171|155743308|FG001|Overall Study|Missing cycle treshold value|0|||
48424273|NCT02342171|155743307|FG000|Overall Study|Unknown outcome|0|||
48424274|NCT02342171|155743308|FG001|Overall Study|Unknown outcome|1|||
48424275|NCT02342171|155743307|FG000|Overall Study|Missing age data|0|||
48424276|NCT02342171|155743308|FG001|Overall Study|Missing age data|1|||
48424277|NCT02517515|155743314|FG000|Overall Study|Adverse Event|0|||
48424278|NCT02517515|155743315|FG001|Overall Study|Adverse Event|1|||
48424279|NCT02517515|155743314|FG000|Overall Study|Withdrew Consent|0|||
48424280|NCT02517515|155743315|FG001|Overall Study|Withdrew Consent|1|||
48424281|NCT02517515|155743314|FG000|Overall Study|Lost to Follow-up|1|||
48424282|NCT02517515|155743315|FG001|Overall Study|Lost to Follow-up|0|||
48424283|NCT02517515|155743314|FG000|Overall Study|Other|1|||
48424284|NCT02517515|155743315|FG001|Overall Study|Other|0|||
48424285|NCT02089737|155743316|FG000|Overall Study|Survey form not completed|5|||
48424286|NCT02089737|155743316|FG000|Overall Study|Not treated|1|||
48424287|NCT01943539|155743317|FG000|Overall Study|Non-compliance with at-home intervention|4|||
48424288|NCT01943539|155743318|FG001|Overall Study|Non-compliance with at-home intervention|0|||
48424289|NCT02413255|155743319|FG000|Overall Study|Voluntary Withdrawal|0|||
48424290|NCT02413255|155743320|FG001|Overall Study|Voluntary Withdrawal|0|||
48424291|NCT02413255|155743321|FG002|Overall Study|Voluntary Withdrawal|0|||
48424292|NCT02413255|155743322|FG003|Overall Study|Voluntary Withdrawal|0|||
48424293|NCT02413255|155743323|FG004|Overall Study|Voluntary Withdrawal|0|||
48424294|NCT02413255|155743324|FG005|Overall Study|Voluntary Withdrawal|0|||
48424295|NCT02413255|155743325|FG006|Overall Study|Voluntary Withdrawal|0|||
48424296|NCT02413255|155743326|FG007|Overall Study|Voluntary Withdrawal|0|||
48424297|NCT02413255|155743327|FG008|Overall Study|Voluntary Withdrawal|0|||
48424298|NCT02413255|155743328|FG009|Overall Study|Voluntary Withdrawal|0|||
48424299|NCT02413255|155743329|FG010|Overall Study|Voluntary Withdrawal|0|||
48424300|NCT02413255|155743330|FG011|Overall Study|Voluntary Withdrawal|0|||
48424301|NCT02413255|155743331|FG012|Overall Study|Voluntary Withdrawal|0|||
48424302|NCT02413255|155743332|FG013|Overall Study|Voluntary Withdrawal|0|||
48424303|NCT02413255|155743333|FG014|Overall Study|Voluntary Withdrawal|1|||
48424304|NCT02413255|155743334|FG015|Overall Study|Voluntary Withdrawal|0|||
48424305|NCT02413255|155743335|FG016|Overall Study|Voluntary Withdrawal|0|||
48424306|NCT01277289|155743339|FG000|Overall Study|fragile vein|1|||
48424307|NCT01277289|155743340|FG001|Overall Study|fragile vein|0|||
48424308|NCT01277289|155743339|FG000|Overall Study|Physician Decision|1|||
48424309|NCT01277289|155743340|FG001|Overall Study|Physician Decision|0|||
48424310|NCT01277289|155743339|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
48424311|NCT01277289|155743340|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
48424312|NCT01277289|155743339|FG000|Overall Study|Protocol Violation|1|||
48424313|NCT01277289|155743340|FG001|Overall Study|Protocol Violation|1|||
48424314|NCT01277289|155743339|FG000|Overall Study|Adverse Event|2|||
48424315|NCT01277289|155743340|FG001|Overall Study|Adverse Event|1|||
48424316|NCT01277289|155743339|FG000|Overall Study|consent withdrawn|1|||
48424317|NCT01277289|155743340|FG001|Overall Study|consent withdrawn|1|||
48424318|NCT01277289|155743339|FG000|Overall Study|premature closure of the study|4|||
48424319|NCT01277289|155743340|FG001|Overall Study|premature closure of the study|2|||
48424320|NCT02874794|155743341|FG000|Overall Study|Physician Decision|3|||
48424321|NCT02874794|155743342|FG001|Overall Study|Physician Decision|2|||
48424322|NCT02874794|155743341|FG000|Overall Study|Withdrawal by Subject|2|||
48424323|NCT02874794|155743342|FG001|Overall Study|Withdrawal by Subject|8|||
48424324|NCT02874794|155743341|FG000|Overall Study|Death|2|||
48424325|NCT02874794|155743342|FG001|Overall Study|Death|1|||
48424326|NCT00537940|155743343|FG000|Overall Study|Adverse Event|20|||
48424327|NCT00537940|155743344|FG001|Overall Study|Adverse Event|19|||
48424328|NCT00537940|155743343|FG000|Overall Study|Lack of Efficacy|8|||
48424329|NCT00537940|155743344|FG001|Overall Study|Lack of Efficacy|16|||
48424330|NCT00537940|155743343|FG000|Overall Study|Lost to Follow-up|23|||
48424331|NCT00537940|155743344|FG001|Overall Study|Lost to Follow-up|29|||
48424332|NCT00537940|155743343|FG000|Overall Study|Withdrawal by Subject|113|||
48424333|NCT00537940|155743344|FG001|Overall Study|Withdrawal by Subject|95|||
48424334|NCT00537940|155743343|FG000|Overall Study|Protocol Violation|6|||
48424335|NCT00537940|155743344|FG001|Overall Study|Protocol Violation|4|||
48424336|NCT00537940|155743343|FG000|Overall Study|Pregnancy|1|||
48424337|NCT00537940|155743344|FG001|Overall Study|Pregnancy|1|||
48424338|NCT00537940|155743343|FG000|Overall Study|Study terminated by sponsor|2|||
48424339|NCT00537940|155743344|FG001|Overall Study|Study terminated by sponsor|3|||
48424340|NCT00537940|155743343|FG000|Overall Study|Other|10|||
48424341|NCT00537940|155743344|FG001|Overall Study|Other|12|||
48424342|NCT00698516|155743347|FG000|Overall Study|Study Termination|2|||
48424343|NCT00698516|155743347|FG000|Overall Study|Withdrawal by Subject|3|||
48424344|NCT00685178|155743349|FG000|Overall Study|Adverse Event|1|||
48424345|NCT00685178|155743350|FG001|Overall Study|Adverse Event|5|||
48424346|NCT00685178|155743351|FG002|Overall Study|Adverse Event|2|||
48424347|NCT00685178|155743352|FG003|Overall Study|Adverse Event|4|||
48424348|NCT00685178|155743349|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
48424349|NCT00685178|155743350|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
48424350|NCT00685178|155743351|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
48424351|NCT00685178|155743352|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
48424352|NCT00685178|155743349|FG000|Overall Study|voluntary study discharge|4|||
48424353|NCT00685178|155743350|FG001|Overall Study|voluntary study discharge|5|||
48424354|NCT00685178|155743351|FG002|Overall Study|voluntary study discharge|1|||
48424355|NCT00685178|155743352|FG003|Overall Study|voluntary study discharge|1|||
48424356|NCT00685178|155743349|FG000|Overall Study|incarcerated|1|||
48424357|NCT00685178|155743350|FG001|Overall Study|incarcerated|3|||
48424358|NCT00685178|155743351|FG002|Overall Study|incarcerated|7|||
48424359|NCT00685178|155743352|FG003|Overall Study|incarcerated|0|||
48424360|NCT00685178|155743349|FG000|Overall Study|administrative (disciplinary) discharge|0|||
48424361|NCT00685178|155743350|FG001|Overall Study|administrative (disciplinary) discharge|1|||
48424362|NCT00685178|155743351|FG002|Overall Study|administrative (disciplinary) discharge|0|||
48424363|NCT00685178|155743352|FG003|Overall Study|administrative (disciplinary) discharge|2|||
48424364|NCT00685178|155743349|FG000|Overall Study|Pregnancy|0|||
48424365|NCT00685178|155743350|FG001|Overall Study|Pregnancy|0|||
48424366|NCT00685178|155743351|FG002|Overall Study|Pregnancy|0|||
48424367|NCT00685178|155743352|FG003|Overall Study|Pregnancy|1|||
48424368|NCT01097616|155743357|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
48424369|NCT01097616|155743358|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
48424370|NCT01097616|155743359|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
48424371|NCT01097616|155743360|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48424372|NCT01097616|155743361|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48424373|NCT01097616|155743362|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48424374|NCT01097616|155743363|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48424375|NCT01097616|155743364|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
48424376|NCT01097616|155743357|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
48424377|NCT01097616|155743358|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
48424378|NCT01097616|155743359|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
48424379|NCT01097616|155743360|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48424380|NCT01097616|155743361|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48424381|NCT01097616|155743362|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48424382|NCT01097616|155743363|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48424383|NCT01097616|155743364|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
48424384|NCT01097616|155743357|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
48424385|NCT01097616|155743358|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
48424386|NCT01097616|155743359|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
48424387|NCT01097616|155743360|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48424388|NCT01097616|155743361|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48424389|NCT01097616|155743362|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48424390|NCT01097616|155743363|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48424391|NCT01097616|155743364|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
48424392|NCT01097616|155743357|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
48424393|NCT01097616|155743358|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
48424394|NCT01097616|155743359|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48424395|NCT01097616|155743360|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48424396|NCT01097616|155743361|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48424397|NCT01097616|155743362|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48424398|NCT01097616|155743363|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48424399|NCT01097616|155743364|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
48424400|NCT01097616|155743357|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
48424401|NCT01097616|155743358|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
48424402|NCT01097616|155743359|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
48424403|NCT01097616|155743360|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48424404|NCT01097616|155743361|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48424405|NCT01097616|155743362|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48424406|NCT01097616|155743363|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48424407|NCT01097616|155743364|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
48424408|NCT01097616|155743357|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
48424409|NCT01097616|155743358|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
48424410|NCT01097616|155743359|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48424411|NCT01097616|155743360|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48424412|NCT01097616|155743361|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48424413|NCT01097616|155743362|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48424414|NCT01097616|155743363|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48424415|NCT01097616|155743364|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
48424416|NCT01097616|155743357|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
48424417|NCT01097616|155743358|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
48424418|NCT01097616|155743359|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48424419|NCT01097616|155743360|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48424420|NCT01097616|155743361|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48424421|NCT01097616|155743362|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48424422|NCT01097616|155743363|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48424423|NCT01097616|155743364|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
48424424|NCT01097616|155743357|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48424425|NCT01097616|155743358|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48424426|NCT01097616|155743359|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
48424427|NCT01097616|155743360|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48424428|NCT01097616|155743361|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48424429|NCT01097616|155743362|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48424430|NCT01097616|155743363|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48424431|NCT01097616|155743364|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
48424432|NCT01097616|155743357|FG000|Optional DB EXT Phase|Adverse Event|0|||
48424433|NCT01097616|155743358|FG001|Optional DB EXT Phase|Adverse Event|7|||
48424434|NCT01097616|155743359|FG002|Optional DB EXT Phase|Adverse Event|2|||
48424435|NCT01097616|155743360|FG003|Optional DB EXT Phase|Adverse Event|0|||
48424436|NCT01097616|155743361|FG004|Optional DB EXT Phase|Adverse Event|0|||
48424437|NCT01097616|155743362|FG005|Optional DB EXT Phase|Adverse Event|0|||
48424438|NCT01097616|155743363|FG006|Optional DB EXT Phase|Adverse Event|0|||
48424439|NCT01097616|155743364|FG007|Optional DB EXT Phase|Adverse Event|0|||
48424440|NCT01097616|155743357|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
48424441|NCT01097616|155743358|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
48424442|NCT01097616|155743359|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
48424443|NCT01097616|155743360|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
48424444|NCT01097616|155743361|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
48424445|NCT01097616|155743362|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
48424446|NCT01097616|155743363|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
48424447|NCT01097616|155743364|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
48424448|NCT01097616|155743357|FG000|Optional DB EXT Phase|Protocol Violation|0|||
48424449|NCT01097616|155743358|FG001|Optional DB EXT Phase|Protocol Violation|2|||
48424450|NCT01097616|155743359|FG002|Optional DB EXT Phase|Protocol Violation|3|||
48424451|NCT01097616|155743360|FG003|Optional DB EXT Phase|Protocol Violation|0|||
48424452|NCT01097616|155743361|FG004|Optional DB EXT Phase|Protocol Violation|0|||
48424453|NCT01097616|155743362|FG005|Optional DB EXT Phase|Protocol Violation|0|||
48424454|NCT01097616|155743363|FG006|Optional DB EXT Phase|Protocol Violation|0|||
48424455|NCT01097616|155743364|FG007|Optional DB EXT Phase|Protocol Violation|0|||
48424456|NCT01097616|155743357|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
48424457|NCT01097616|155743358|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
48424458|NCT01097616|155743359|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
48424459|NCT01097616|155743360|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
48424460|NCT01097616|155743361|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
48424461|NCT01097616|155743362|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
48424462|NCT01097616|155743363|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
48424463|NCT01097616|155743364|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
48424464|NCT01097616|155743357|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
48424465|NCT01097616|155743358|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
48424466|NCT01097616|155743359|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
48424467|NCT01097616|155743360|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
48424468|NCT01097616|155743361|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
48424469|NCT01097616|155743362|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
48424470|NCT01097616|155743363|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
48424471|NCT01097616|155743364|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
48424472|NCT01097616|155743357|FG000|Optional DB EXT Phase|Physician Decision|1|||
48424473|NCT01097616|155743358|FG001|Optional DB EXT Phase|Physician Decision|0|||
48424474|NCT01097616|155743359|FG002|Optional DB EXT Phase|Physician Decision|0|||
48424475|NCT01097616|155743360|FG003|Optional DB EXT Phase|Physician Decision|0|||
48424476|NCT01097616|155743361|FG004|Optional DB EXT Phase|Physician Decision|0|||
48424477|NCT01097616|155743362|FG005|Optional DB EXT Phase|Physician Decision|0|||
48424478|NCT01097616|155743363|FG006|Optional DB EXT Phase|Physician Decision|0|||
48424479|NCT01097616|155743364|FG007|Optional DB EXT Phase|Physician Decision|0|||
48424480|NCT01097616|155743357|FG000|DB RO Phase|Adverse Event|0|||
48424481|NCT01097616|155743358|FG001|DB RO Phase|Adverse Event|0|||
48424482|NCT01097616|155743359|FG002|DB RO Phase|Adverse Event|0|||
48424483|NCT01097616|155743360|FG003|DB RO Phase|Adverse Event|0|||
48424484|NCT01097616|155743361|FG004|DB RO Phase|Adverse Event|0|||
48424485|NCT01097616|155743362|FG005|DB RO Phase|Adverse Event|0|||
48424486|NCT01097616|155743363|FG006|DB RO Phase|Adverse Event|1|||
48424487|NCT01097616|155743364|FG007|DB RO Phase|Adverse Event|0|||
48424488|NCT01097616|155743357|FG000|DB RO Phase|Withdrawal by Subject|0|||
48424489|NCT01097616|155743358|FG001|DB RO Phase|Withdrawal by Subject|0|||
48424490|NCT01097616|155743359|FG002|DB RO Phase|Withdrawal by Subject|0|||
48424491|NCT01097616|155743360|FG003|DB RO Phase|Withdrawal by Subject|0|||
48424492|NCT01097616|155743361|FG004|DB RO Phase|Withdrawal by Subject|0|||
48424493|NCT01097616|155743362|FG005|DB RO Phase|Withdrawal by Subject|1|||
48424494|NCT01097616|155743363|FG006|DB RO Phase|Withdrawal by Subject|0|||
48424495|NCT01097616|155743364|FG007|DB RO Phase|Withdrawal by Subject|0|||
48424496|NCT01097616|155743357|FG000|DB RO Phase|Lost to Follow-up|0|||
48424497|NCT01097616|155743358|FG001|DB RO Phase|Lost to Follow-up|0|||
48424498|NCT01097616|155743359|FG002|DB RO Phase|Lost to Follow-up|0|||
48424499|NCT01097616|155743360|FG003|DB RO Phase|Lost to Follow-up|1|||
48424500|NCT01097616|155743361|FG004|DB RO Phase|Lost to Follow-up|1|||
48424501|NCT01097616|155743362|FG005|DB RO Phase|Lost to Follow-up|0|||
48424502|NCT01097616|155743363|FG006|DB RO Phase|Lost to Follow-up|0|||
48424503|NCT01097616|155743364|FG007|DB RO Phase|Lost to Follow-up|1|||
48424504|NCT01097616|155743357|FG000|DB RO Phase|Not Treated in RO|0|||
48424505|NCT01097616|155743358|FG001|DB RO Phase|Not Treated in RO|0|||
48424506|NCT01097616|155743359|FG002|DB RO Phase|Not Treated in RO|0|||
48424507|NCT01097616|155743360|FG003|DB RO Phase|Not Treated in RO|0|||
48424508|NCT01097616|155743361|FG004|DB RO Phase|Not Treated in RO|0|||
48424509|NCT01097616|155743362|FG005|DB RO Phase|Not Treated in RO|1|||
48424510|NCT01097616|155743363|FG006|DB RO Phase|Not Treated in RO|0|||
48424511|NCT01097616|155743364|FG007|DB RO Phase|Not Treated in RO|0|||
48424512|NCT03472534|155743365|FG000|Overall Study|Withdrawal by Subject|9|||
48424513|NCT03472534|155743365|FG000|Overall Study|Adverse Event|2|||
48424514|NCT00909090|155743368|FG000|Overall Study|Lost to Follow-up|17|||
48424515|NCT00909090|155743369|FG001|Overall Study|Lost to Follow-up|17|||
48424516|NCT01174784|155743375|FG000|Overall Study|Screen fails|4|||
48424517|NCT00700752|155743383|FG000|First Intervention|Withdrawal by Subject|0|||
48424518|NCT00700752|155743384|FG001|First Intervention|Withdrawal by Subject|2|||
48424519|NCT03662334|155743385|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
48424520|NCT03662334|155743386|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
48424521|NCT00673673|155743391|FG000|Overall Study|Progressive disease|27|||
48424522|NCT00673673|155743391|FG000|Overall Study|Adverse Event|4|||
48424523|NCT00673673|155743391|FG000|Overall Study|Withdrawal by Subject|3|||
48424524|NCT00673673|155743391|FG000|Overall Study|Investigators' discretion|2|||
48424525|NCT04542291|155743392|FG000|Overall Study|Adverse Event|1|||
48424526|NCT04542291|155743392|FG000|Overall Study|Physician Decision|2|||
48424527|NCT00394914|155743393|FG000|Treatment Period|Adverse Event|0|||
48424528|NCT00394914|155743394|FG001|Treatment Period|Adverse Event|3|||
48424529|NCT00394914|155743395|FG002|Treatment Period|Adverse Event|1|||
48424530|NCT00394914|155743393|FG000|Treatment Period|Lost to Follow-up|0|||
48424531|NCT00394914|155743394|FG001|Treatment Period|Lost to Follow-up|1|||
48424532|NCT00394914|155743395|FG002|Treatment Period|Lost to Follow-up|0|||
48424533|NCT00394914|155743393|FG000|Treatment Period|Withdrawal by Subject|0|||
48424534|NCT00394914|155743394|FG001|Treatment Period|Withdrawal by Subject|2|||
48424535|NCT00394914|155743395|FG002|Treatment Period|Withdrawal by Subject|2|||
48424536|NCT00394914|155743393|FG000|Treatment Period|Noncompliance with protocol|0|||
48424537|NCT00394914|155743394|FG001|Treatment Period|Noncompliance with protocol|3|||
48424538|NCT00394914|155743395|FG002|Treatment Period|Noncompliance with protocol|2|||
48424539|NCT00394914|155743393|FG000|Treatment Period|Did not meet protocol eligibility|0|||
48424540|NCT00394914|155743394|FG001|Treatment Period|Did not meet protocol eligibility|1|||
48424541|NCT00394914|155743395|FG002|Treatment Period|Did not meet protocol eligibility|1|||
48424542|NCT02749721|155743397|FG000|Screening|Withdrawal by Subject|1|||
48424543|NCT02749721|155743397|FG000|Screening|Lost to Follow-up|2|||
48424544|NCT02749721|155743397|FG000|Screening|Protocol Violation|3|||
48424545|NCT02749721|155743397|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
48424546|NCT02749721|155743397|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
48424547|NCT00312377|155743398|FG000|Overall Study|Death|403|||
48424548|NCT00312377|155743399|FG001|Overall Study|Death|418|||
48424549|NCT00312377|155743398|FG000|Overall Study|Withdrawal by Subject|23|||
48424550|NCT00312377|155743399|FG001|Overall Study|Withdrawal by Subject|30|||
48424551|NCT00312377|155743398|FG000|Overall Study|Lost to Follow-up|9|||
48424552|NCT00312377|155743399|FG001|Overall Study|Lost to Follow-up|12|||
48424553|NCT00312377|155743398|FG000|Overall Study|Non-compliance|0|||
48424554|NCT00312377|155743399|FG001|Overall Study|Non-compliance|2|||
48424555|NCT00312377|155743398|FG000|Overall Study|Randomised but never received treatment|6|||
48424556|NCT00312377|155743399|FG001|Overall Study|Randomised but never received treatment|6|||
48424557|NCT00312377|155743398|FG000|Overall Study|Discontinue treatment survival follow up|202|||
48424558|NCT00312377|155743399|FG001|Overall Study|Discontinue treatment survival follow up|200|||
48424559|NCT00312377|155743398|FG000|Overall Study|Site ended participation in study|1|||
48424560|NCT00312377|155743399|FG001|Overall Study|Site ended participation in study|0|||
48424561|NCT04083222|155743402|FG000|Overall Study|Voluntary Withdrawal|0|||
48424562|NCT04083222|155743403|FG001|Overall Study|Voluntary Withdrawal|1|||
48424563|NCT04083222|155743402|FG000|Overall Study|Reason not Specified|0|||
48424564|NCT04083222|155743403|FG001|Overall Study|Reason not Specified|1|||
48424565|NCT00404768|155743404|FG000|Part A and B|Withdrawn due to labor progression|1|||
48424566|NCT00404768|155743405|FG001|Part A and B|Withdrawn due to labor progression|0|||
48424567|NCT00404768|155743406|FG002|Part A and B|Withdrawn due to labor progression|0|||
48424568|NCT00404768|155743407|FG003|Part A and B|Withdrawn due to labor progression|0|||
48424569|NCT00404768|155743404|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
48424570|NCT00404768|155743405|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
48424571|NCT00404768|155743406|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
48424572|NCT00404768|155743407|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
48424573|NCT00404768|155743404|FG000|Part C|Adverse Event|0|||
48424574|NCT00404768|155743405|FG001|Part C|Adverse Event|0|||
48424575|NCT00404768|155743406|FG002|Part C|Adverse Event|0|||
48424576|NCT00404768|155743407|FG003|Part C|Adverse Event|3|||
48424577|NCT00404768|155743404|FG000|Part C|Lost to Follow-up|0|||
48424578|NCT00404768|155743405|FG001|Part C|Lost to Follow-up|0|||
48424579|NCT00404768|155743406|FG002|Part C|Lost to Follow-up|3|||
48424580|NCT00404768|155743407|FG003|Part C|Lost to Follow-up|1|||
48424581|NCT00404768|155743404|FG000|Part C|Withdrawal by Subject|0|||
48424582|NCT00404768|155743405|FG001|Part C|Withdrawal by Subject|0|||
48424583|NCT00404768|155743406|FG002|Part C|Withdrawal by Subject|2|||
48424584|NCT00404768|155743407|FG003|Part C|Withdrawal by Subject|1|||
48424585|NCT00404768|155743404|FG000|Part C|Early withdrawal from study medication|0|||
48424586|NCT00404768|155743405|FG001|Part C|Early withdrawal from study medication|0|||
48424587|NCT00404768|155743406|FG002|Part C|Early withdrawal from study medication|1|||
48424588|NCT00404768|155743407|FG003|Part C|Early withdrawal from study medication|0|||
48424589|NCT00404768|155743404|FG000|Part C|Participant did not respond to therapy|0|||
48424590|NCT00404768|155743405|FG001|Part C|Participant did not respond to therapy|0|||
48424591|NCT00404768|155743406|FG002|Part C|Participant did not respond to therapy|1|||
48424592|NCT00404768|155743407|FG003|Part C|Participant did not respond to therapy|1|||
48424593|NCT00404768|155743404|FG000|Part C|Physician withdrew the study medication|0|||
48424594|NCT00404768|155743405|FG001|Part C|Physician withdrew the study medication|0|||
48424595|NCT00404768|155743406|FG002|Part C|Physician withdrew the study medication|1|||
48424596|NCT00404768|155743407|FG003|Part C|Physician withdrew the study medication|0|||
48424597|NCT00404768|155743404|FG000|Part C|Participant delivered baby|0|||
48424598|NCT00404768|155743405|FG001|Part C|Participant delivered baby|0|||
48424599|NCT00404768|155743406|FG002|Part C|Participant delivered baby|0|||
48424600|NCT00404768|155743407|FG003|Part C|Participant delivered baby|1|||
48424601|NCT00404768|155743404|FG000|Part C|Unsatisfactory uterine response to IP|0|||
48424602|NCT00404768|155743405|FG001|Part C|Unsatisfactory uterine response to IP|0|||
48424603|NCT00404768|155743406|FG002|Part C|Unsatisfactory uterine response to IP|0|||
48424604|NCT00404768|155743407|FG003|Part C|Unsatisfactory uterine response to IP|1|||
48424605|NCT00404768|155743404|FG000|Part C|Active labor|0|||
48424606|NCT00404768|155743405|FG001|Part C|Active labor|0|||
48424607|NCT00404768|155743406|FG002|Part C|Active labor|0|||
48424608|NCT00404768|155743407|FG003|Part C|Active labor|1|||
48424609|NCT00404768|155743404|FG000|Part C|Lack of Efficacy|0|||
48424610|NCT00404768|155743405|FG001|Part C|Lack of Efficacy|0|||
48424611|NCT00404768|155743406|FG002|Part C|Lack of Efficacy|0|||
48424612|NCT00404768|155743407|FG003|Part C|Lack of Efficacy|2|||
48424613|NCT00404768|155743404|FG000|Part C|Treatment failure|0|||
48424614|NCT00404768|155743405|FG001|Part C|Treatment failure|0|||
48424615|NCT00404768|155743406|FG002|Part C|Treatment failure|0|||
48424616|NCT00404768|155743407|FG003|Part C|Treatment failure|1|||
48424617|NCT00404768|155743404|FG000|Part C|Investigator discretion|0|||
48424618|NCT00404768|155743405|FG001|Part C|Investigator discretion|0|||
48424619|NCT00404768|155743406|FG002|Part C|Investigator discretion|0|||
48424620|NCT00404768|155743407|FG003|Part C|Investigator discretion|1|||
48424621|NCT00404768|155743404|FG000|Part C|Researcher suspended study medication|0|||
48424622|NCT00404768|155743405|FG001|Part C|Researcher suspended study medication|0|||
48424623|NCT00404768|155743406|FG002|Part C|Researcher suspended study medication|0|||
48424624|NCT00404768|155743407|FG003|Part C|Researcher suspended study medication|1|||
48424625|NCT01486316|155743408|FG000|Overall Study|Device explanted with/without re-implant|3|||
48424626|NCT01486316|155743409|FG001|Overall Study|Device explanted with/without re-implant|2|||
48424627|NCT01486316|155743410|FG002|Overall Study|Device explanted with/without re-implant|0|||
48424628|NCT01486316|155743411|FG003|Overall Study|Device explanted with/without re-implant|2|||
48424629|NCT01486316|155743408|FG000|Overall Study|Not meeting eligibility criteria|0|||
48424630|NCT01486316|155743409|FG001|Overall Study|Not meeting eligibility criteria|0|||
48424631|NCT01486316|155743410|FG002|Overall Study|Not meeting eligibility criteria|1|||
48424632|NCT01486316|155743411|FG003|Overall Study|Not meeting eligibility criteria|0|||
48424633|NCT01486316|155743408|FG000|Overall Study|Withdrawal by Subject|1|||
48424634|NCT01486316|155743409|FG001|Overall Study|Withdrawal by Subject|0|||
48424635|NCT01486316|155743410|FG002|Overall Study|Withdrawal by Subject|3|||
48424636|NCT01486316|155743411|FG003|Overall Study|Withdrawal by Subject|0|||
48424637|NCT01486316|155743408|FG000|Overall Study|Physician Decision|0|||
48424638|NCT01486316|155743409|FG001|Overall Study|Physician Decision|0|||
48424639|NCT01486316|155743410|FG002|Overall Study|Physician Decision|1|||
48424640|NCT01486316|155743411|FG003|Overall Study|Physician Decision|0|||
48424641|NCT01486316|155743408|FG000|Overall Study|Death|0|||
48424642|NCT01486316|155743409|FG001|Overall Study|Death|1|||
48424643|NCT01486316|155743410|FG002|Overall Study|Death|0|||
48424644|NCT01486316|155743411|FG003|Overall Study|Death|0|||
48424645|NCT00970294|155743414|FG000|Overall Study|Physician Decision|4|||
48424646|NCT00970294|155743414|FG000|Overall Study|Withdrawal by Subject|1|||
48424647|NCT03290300|155743415|FG000|Overall Study|Lost to Follow-up|3|||
48424648|NCT00803244|155743418|FG000|Overall Study|Adverse Event|1|||
48424649|NCT00803244|155743419|FG001|Overall Study|Adverse Event|2|||
48424650|NCT00803244|155743418|FG000|Overall Study|Withdrawal by Subject|2|||
48424651|NCT00803244|155743419|FG001|Overall Study|Withdrawal by Subject|3|||
48424652|NCT00803244|155743418|FG000|Overall Study|Any other reason not above-mentioned|4|||
48424653|NCT00803244|155743419|FG001|Overall Study|Any other reason not above-mentioned|10|||
48424654|NCT01863758|155743420|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
48424655|NCT01863758|155743420|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
48424656|NCT00751881|155743423|FG000|Core Treatment Period|Not treated|1|||
48424657|NCT00751881|155743424|FG001|Core Treatment Period|Not treated|1|||
48424658|NCT00751881|155743425|FG002|Core Treatment Period|Not treated|2|||
48424659|NCT00751881|155743423|FG000|Core Treatment Period|Adverse Event|26|||
48424660|NCT00751881|155743424|FG001|Core Treatment Period|Adverse Event|54|||
48424661|NCT00751881|155743425|FG002|Core Treatment Period|Adverse Event|58|||
48424662|NCT00751881|155743423|FG000|Core Treatment Period|Lack of Efficacy|37|||
48424663|NCT00751881|155743424|FG001|Core Treatment Period|Lack of Efficacy|30|||
48424664|NCT00751881|155743425|FG002|Core Treatment Period|Lack of Efficacy|20|||
48424665|NCT00751881|155743423|FG000|Core Treatment Period|Poor compliance to protocol|15|||
48424666|NCT00751881|155743424|FG001|Core Treatment Period|Poor compliance to protocol|3|||
48424667|NCT00751881|155743425|FG002|Core Treatment Period|Poor compliance to protocol|4|||
48424668|NCT00751881|155743423|FG000|Core Treatment Period|Lost to Follow-up|6|||
48424669|NCT00751881|155743424|FG001|Core Treatment Period|Lost to Follow-up|4|||
48424670|NCT00751881|155743425|FG002|Core Treatment Period|Lost to Follow-up|3|||
48424671|NCT00751881|155743423|FG000|Core Treatment Period|Other: protocol deviation|3|||
48424672|NCT00751881|155743424|FG001|Core Treatment Period|Other: protocol deviation|3|||
48424673|NCT00751881|155743425|FG002|Core Treatment Period|Other: protocol deviation|7|||
48424674|NCT00751881|155743423|FG000|Core Treatment Period|Other: wish to parent|5|||
48424675|NCT00751881|155743424|FG001|Core Treatment Period|Other: wish to parent|7|||
48424676|NCT00751881|155743425|FG002|Core Treatment Period|Other: wish to parent|4|||
48424677|NCT00751881|155743423|FG000|Core Treatment Period|Other: personal/family constraints|6|||
48424678|NCT00751881|155743424|FG001|Core Treatment Period|Other: personal/family constraints|7|||
48424679|NCT00751881|155743425|FG002|Core Treatment Period|Other: personal/family constraints|10|||
48424680|NCT00751881|155743423|FG000|Core Treatment Period|Other: MS treatment change|6|||
48424681|NCT00751881|155743424|FG001|Core Treatment Period|Other: MS treatment change|4|||
48424682|NCT00751881|155743425|FG002|Core Treatment Period|Other: MS treatment change|4|||
48424683|NCT00751881|155743423|FG000|Core Treatment Period|Other: tolerability complaints|2|||
48424684|NCT00751881|155743424|FG001|Core Treatment Period|Other: tolerability complaints|0|||
48424685|NCT00751881|155743425|FG002|Core Treatment Period|Other: tolerability complaints|0|||
48424686|NCT00751881|155743423|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
48424687|NCT00751881|155743424|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
48424688|NCT00751881|155743425|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
48424689|NCT00751881|155743423|FG000|Extension Study Period|Adverse Event|18|||
48426409|NCT02229864|155749578|FG000|Overall Study|Death|2|||
48424690|NCT00751881|155743424|FG001|Extension Study Period|Adverse Event|20|||
48424691|NCT00751881|155743425|FG002|Extension Study Period|Adverse Event|21|||
48424692|NCT00751881|155743423|FG000|Extension Study Period|Lack of Efficacy|14|||
48424693|NCT00751881|155743424|FG001|Extension Study Period|Lack of Efficacy|10|||
48424694|NCT00751881|155743425|FG002|Extension Study Period|Lack of Efficacy|20|||
48424695|NCT00751881|155743423|FG000|Extension Study Period|Lost to Follow-up|4|||
48424696|NCT00751881|155743424|FG001|Extension Study Period|Lost to Follow-up|9|||
48424697|NCT00751881|155743425|FG002|Extension Study Period|Lost to Follow-up|6|||
48424698|NCT00751881|155743423|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
48424699|NCT00751881|155743424|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
48424700|NCT00751881|155743425|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
48424701|NCT00751881|155743423|FG000|Extension Study Period|Other than specified above|26|||
48424702|NCT00751881|155743424|FG001|Extension Study Period|Other than specified above|30|||
48424703|NCT00751881|155743425|FG002|Extension Study Period|Other than specified above|18|||
48424704|NCT01422304|155743426|FG000|Overall Study|Adverse Event|0|||
48424705|NCT01422304|155743427|FG001|Overall Study|Adverse Event|1|||
48424706|NCT01422304|155743426|FG000|Overall Study|Lost to Follow-up|14|||
48424707|NCT01422304|155743427|FG001|Overall Study|Lost to Follow-up|20|||
48424708|NCT01422304|155743426|FG000|Overall Study|Never Entered Follow-up|2|||
48424709|NCT01422304|155743427|FG001|Overall Study|Never Entered Follow-up|1|||
48424710|NCT01422304|155743426|FG000|Overall Study|Protocol Violation|1|||
48424711|NCT01422304|155743427|FG001|Overall Study|Protocol Violation|0|||
48424712|NCT01422304|155743426|FG000|Overall Study|Withdrawal by Subject|4|||
48424713|NCT01422304|155743427|FG001|Overall Study|Withdrawal by Subject|2|||
48424714|NCT01422304|155743426|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
48424715|NCT01422304|155743427|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
48424716|NCT01422304|155743426|FG000|Overall Study|Not Treated|3|||
48424717|NCT01422304|155743427|FG001|Overall Study|Not Treated|11|||
48424718|NCT04655586|155743428|FG000|Overall Study|Physician Decision|1|||
48424719|NCT04655586|155743429|FG001|Overall Study|Physician Decision|3|||
48424720|NCT04655586|155743430|FG002|Overall Study|Physician Decision|4|||
48424721|NCT04655586|155743428|FG000|Overall Study|Withdrawal by Subject|1|||
48424722|NCT04655586|155743429|FG001|Overall Study|Withdrawal by Subject|3|||
48424723|NCT04655586|155743430|FG002|Overall Study|Withdrawal by Subject|1|||
48424724|NCT01260181|155743433|FG000|Overall Study|Decision of Investigator|1|||
48424725|NCT02961764|155743434|FG000|Overall Study|Protocol Violation|0|||
48424726|NCT02961764|155743435|FG001|Overall Study|Protocol Violation|1|||
48424727|NCT02961764|155743434|FG000|Overall Study|Death|2|||
48424728|NCT02961764|155743435|FG001|Overall Study|Death|0|||
48424729|NCT02961764|155743434|FG000|Overall Study|Lost to Follow-up|35|||
48424730|NCT02961764|155743435|FG001|Overall Study|Lost to Follow-up|24|||
48424731|NCT02961764|155743434|FG000|Overall Study|Withdrawal by Subject|2|||
48424732|NCT02961764|155743435|FG001|Overall Study|Withdrawal by Subject|0|||
48424733|NCT04770155|155743436|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48424734|NCT04770155|155743437|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48424735|NCT04770155|155743438|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48424736|NCT04770155|155743439|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48424737|NCT04770155|155743440|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48424738|NCT04770155|155743441|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48424739|NCT04770155|155743442|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48424740|NCT04770155|155743443|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
48424741|NCT00469014|155743444|FG000|Initial Phase Randomization|Disease Progression|0|||
48424742|NCT00469014|155743445|FG001|Initial Phase Randomization|Disease Progression|1|||
48424743|NCT00469014|155743446|FG002|Initial Phase Randomization|Disease Progression|1|||
48424744|NCT00469014|155743447|FG003|Initial Phase Randomization|Disease Progression|0|||
48424745|NCT00469014|155743444|FG000|Initial Phase Randomization|No Response|1|||
48424746|NCT00469014|155743445|FG001|Initial Phase Randomization|No Response|0|||
48424747|NCT00469014|155743446|FG002|Initial Phase Randomization|No Response|0|||
48424748|NCT00469014|155743447|FG003|Initial Phase Randomization|No Response|1|||
48424749|NCT00469014|155743444|FG000|Adaptive Randomization|Not Evaluable|1|||
48424750|NCT00469014|155743445|FG001|Adaptive Randomization|Not Evaluable|0|||
48424751|NCT00469014|155743446|FG002|Adaptive Randomization|Not Evaluable|0|||
48424752|NCT00469014|155743447|FG003|Adaptive Randomization|Not Evaluable|1|||
48424753|NCT00469014|155743444|FG000|Adaptive Randomization|No Response|0|||
48424754|NCT00469014|155743445|FG001|Adaptive Randomization|No Response|1|||
48424755|NCT00469014|155743446|FG002|Adaptive Randomization|No Response|0|||
48424756|NCT00469014|155743447|FG003|Adaptive Randomization|No Response|0|||
48424757|NCT00469014|155743444|FG000|Adaptive Randomization|Death|0|||
48424758|NCT00469014|155743445|FG001|Adaptive Randomization|Death|0|||
48424759|NCT00469014|155743446|FG002|Adaptive Randomization|Death|1|||
48424760|NCT00469014|155743447|FG003|Adaptive Randomization|Death|0|||
48424761|NCT03461289|155743449|FG000|Overall Study|Death|1|||
48424762|NCT04799782|155743453|FG000|Washout|Physician Decision|2|||
48424763|NCT04799782|155743454|FG001|Washout|Physician Decision|0|||
48424764|NCT04799782|155743453|FG000|Washout|Withdrawal by Subject|0|||
48424765|NCT04799782|155743454|FG001|Washout|Withdrawal by Subject|2|||
48424766|NCT04799782|155743453|FG000|Washout|Lost to Follow-up|0|||
48424767|NCT04799782|155743454|FG001|Washout|Lost to Follow-up|1|||
48424768|NCT02021812|155743455|FG000|Overall Study|Death|8|||
48424769|NCT02021812|155743455|FG000|Overall Study|Withdrawal by Subject|3|||
48424770|NCT02021812|155743455|FG000|Overall Study|Lost to Follow-up|2|||
48424771|NCT02021812|155743455|FG000|Overall Study|Refuse to return, COVD 19|2|||
48424772|NCT03241173|155743456|FG000|Overall Study|Death|3|||
48424773|NCT03241173|155743457|FG001|Overall Study|Death|2|||
48424774|NCT03241173|155743458|FG002|Overall Study|Death|4|||
48424775|NCT03241173|155743459|FG003|Overall Study|Death|4|||
48424776|NCT03241173|155743460|FG004|Overall Study|Death|2|||
48424777|NCT03241173|155743461|FG005|Overall Study|Death|2|||
48424778|NCT03241173|155743462|FG006|Overall Study|Death|3|||
48424779|NCT03241173|155743463|FG007|Overall Study|Death|1|||
48424780|NCT03241173|155743464|FG008|Overall Study|Death|0|||
48424781|NCT03241173|155743465|FG009|Overall Study|Death|5|||
48424782|NCT03241173|155743466|FG010|Overall Study|Death|4|||
48424783|NCT03241173|155743467|FG011|Overall Study|Death|3|||
48424784|NCT03241173|155743468|FG012|Overall Study|Death|0|||
48424785|NCT03241173|155743469|FG013|Overall Study|Death|0|||
48424786|NCT03241173|155743470|FG014|Overall Study|Death|0|||
48424787|NCT03241173|155743456|FG000|Overall Study|Withdrawal by Subject|0|||
48424788|NCT03241173|155743457|FG001|Overall Study|Withdrawal by Subject|0|||
48424789|NCT03241173|155743458|FG002|Overall Study|Withdrawal by Subject|1|||
48424790|NCT03241173|155743459|FG003|Overall Study|Withdrawal by Subject|0|||
48424791|NCT03241173|155743460|FG004|Overall Study|Withdrawal by Subject|0|||
48424792|NCT03241173|155743461|FG005|Overall Study|Withdrawal by Subject|1|||
48424793|NCT03241173|155743462|FG006|Overall Study|Withdrawal by Subject|0|||
48424794|NCT03241173|155743463|FG007|Overall Study|Withdrawal by Subject|0|||
48424795|NCT03241173|155743464|FG008|Overall Study|Withdrawal by Subject|0|||
48424796|NCT03241173|155743465|FG009|Overall Study|Withdrawal by Subject|0|||
48424797|NCT03241173|155743466|FG010|Overall Study|Withdrawal by Subject|0|||
48424798|NCT03241173|155743467|FG011|Overall Study|Withdrawal by Subject|0|||
48424799|NCT03241173|155743468|FG012|Overall Study|Withdrawal by Subject|0|||
48424800|NCT03241173|155743469|FG013|Overall Study|Withdrawal by Subject|0|||
48424801|NCT03241173|155743470|FG014|Overall Study|Withdrawal by Subject|0|||
48424802|NCT03241173|155743456|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
48424803|NCT03241173|155743457|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
48424804|NCT03241173|155743458|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48424805|NCT03241173|155743459|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
48424806|NCT03241173|155743460|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
48424807|NCT03241173|155743461|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
48424808|NCT03241173|155743462|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
48424809|NCT03241173|155743463|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
48424810|NCT03241173|155743464|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48424811|NCT03241173|155743465|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48424812|NCT03241173|155743466|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
48424813|NCT03241173|155743467|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
48424814|NCT03241173|155743468|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48424815|NCT03241173|155743469|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48424816|NCT03241173|155743470|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
48424817|NCT03241173|155743456|FG000|Overall Study|Lost to Follow-up|0|||
48424818|NCT03241173|155743457|FG001|Overall Study|Lost to Follow-up|0|||
48424819|NCT03241173|155743458|FG002|Overall Study|Lost to Follow-up|0|||
48424820|NCT03241173|155743459|FG003|Overall Study|Lost to Follow-up|0|||
48424821|NCT03241173|155743460|FG004|Overall Study|Lost to Follow-up|1|||
48424822|NCT03241173|155743461|FG005|Overall Study|Lost to Follow-up|0|||
48424823|NCT03241173|155743462|FG006|Overall Study|Lost to Follow-up|0|||
48424824|NCT03241173|155743463|FG007|Overall Study|Lost to Follow-up|0|||
48424825|NCT03241173|155743464|FG008|Overall Study|Lost to Follow-up|0|||
48424826|NCT03241173|155743465|FG009|Overall Study|Lost to Follow-up|1|||
48424827|NCT03241173|155743466|FG010|Overall Study|Lost to Follow-up|0|||
48424828|NCT03241173|155743467|FG011|Overall Study|Lost to Follow-up|0|||
48424829|NCT03241173|155743468|FG012|Overall Study|Lost to Follow-up|0|||
48424830|NCT03241173|155743469|FG013|Overall Study|Lost to Follow-up|0|||
48424831|NCT03241173|155743470|FG014|Overall Study|Lost to Follow-up|0|||
48424832|NCT02224846|155743471|FG000|Period 1 (Month 3)|Adverse Event|2|||
48424833|NCT02224846|155743472|FG001|Period 1 (Month 3)|Adverse Event|1|||
48424834|NCT02224846|155743471|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
48424835|NCT02224846|155743472|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
48424836|NCT02224846|155743471|FG000|Period 1 (Month 3)|Protocol Violation|4|||
48424837|NCT02224846|155743472|FG001|Period 1 (Month 3)|Protocol Violation|8|||
48424838|NCT02224846|155743471|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
48424839|NCT02224846|155743472|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
48424840|NCT02224846|155743471|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
48424841|NCT02224846|155743472|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
48424842|NCT02224846|155743471|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
48424843|NCT02224846|155743472|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
48424844|NCT02224846|155743471|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
48424845|NCT02224846|155743472|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
48424846|NCT02224846|155743471|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
48424847|NCT02224846|155743472|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
48424848|NCT02224846|155743471|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
48424849|NCT02224846|155743472|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
48424850|NCT02224846|155743471|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
48424851|NCT02224846|155743472|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
48424852|NCT02224846|155743471|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
48424853|NCT02224846|155743472|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
48424854|NCT02224846|155743471|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
48424855|NCT02224846|155743472|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
48424856|NCT02224846|155743471|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
48424857|NCT02224846|155743472|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
48424858|NCT02224846|155743471|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
48424859|NCT02224846|155743472|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
48424860|NCT02224846|155743471|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
48424861|NCT02224846|155743472|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
48424862|NCT02224846|155743471|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
48424863|NCT02224846|155743472|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
48424864|NCT02224846|155743471|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
48424865|NCT02224846|155743472|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
48424866|NCT00564629|155743473|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
48424867|NCT00564629|155743474|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
48424868|NCT04493619|155745043|FG000|Overall Study|Death|4|||
48424869|NCT04493619|155745044|FG001|Overall Study|Death|3|||
48424870|NCT04493619|155745045|FG002|Overall Study|Death|3|||
48424871|NCT04493619|155745046|FG003|Overall Study|Death|4|||
48424872|NCT04493619|155745043|FG000|Overall Study|Study discontinued early|10|||
48424873|NCT04493619|155745044|FG001|Overall Study|Study discontinued early|0|||
48424874|NCT04493619|155745045|FG002|Overall Study|Study discontinued early|4|||
48424875|NCT04493619|155745046|FG003|Overall Study|Study discontinued early|8|||
48424876|NCT04493619|155745043|FG000|Overall Study|Lost to Follow-up|0|||
48424877|NCT04493619|155745044|FG001|Overall Study|Lost to Follow-up|0|||
48424878|NCT04493619|155745045|FG002|Overall Study|Lost to Follow-up|0|||
48424879|NCT04493619|155745046|FG003|Overall Study|Lost to Follow-up|1|||
48424880|NCT02495077|155745049|FG000|Overall Study|Adverse Event|0|||
48424881|NCT02495077|155745050|FG001|Overall Study|Adverse Event|1|||
48424882|NCT02495077|155745051|FG002|Overall Study|Adverse Event|1|||
48424883|NCT02495077|155745052|FG003|Overall Study|Adverse Event|0|||
48424884|NCT02495077|155745049|FG000|Overall Study|Death|3|||
48424885|NCT02495077|155745050|FG001|Overall Study|Death|5|||
48424886|NCT02495077|155745051|FG002|Overall Study|Death|0|||
48424887|NCT02495077|155745052|FG003|Overall Study|Death|0|||
48424888|NCT02495077|155745049|FG000|Overall Study|Lost to Follow-up|6|||
48424889|NCT02495077|155745050|FG001|Overall Study|Lost to Follow-up|4|||
48424890|NCT02495077|155745051|FG002|Overall Study|Lost to Follow-up|0|||
48424891|NCT02495077|155745052|FG003|Overall Study|Lost to Follow-up|0|||
48424892|NCT02495077|155745049|FG000|Overall Study|Physician Decision|2|||
48424893|NCT02495077|155745050|FG001|Overall Study|Physician Decision|1|||
48424894|NCT02495077|155745051|FG002|Overall Study|Physician Decision|4|||
48424895|NCT02495077|155745052|FG003|Overall Study|Physician Decision|0|||
48424896|NCT02495077|155745049|FG000|Overall Study|Protocol Violation|0|||
48424897|NCT02495077|155745050|FG001|Overall Study|Protocol Violation|1|||
48424898|NCT02495077|155745051|FG002|Overall Study|Protocol Violation|0|||
48424899|NCT02495077|155745052|FG003|Overall Study|Protocol Violation|0|||
48424900|NCT02495077|155745049|FG000|Overall Study|Screen Failure|0|||
48424901|NCT02495077|155745050|FG001|Overall Study|Screen Failure|0|||
48424902|NCT02495077|155745051|FG002|Overall Study|Screen Failure|0|||
48424903|NCT02495077|155745052|FG003|Overall Study|Screen Failure|48|||
48424904|NCT02495077|155745049|FG000|Overall Study|Withdrawal by Subject|7|||
48424905|NCT02495077|155745050|FG001|Overall Study|Withdrawal by Subject|7|||
48424906|NCT02495077|155745051|FG002|Overall Study|Withdrawal by Subject|7|||
48424907|NCT02495077|155745052|FG003|Overall Study|Withdrawal by Subject|0|||
48424908|NCT02495077|155745049|FG000|Overall Study|Covid-19 research restrictions|1|||
48424909|NCT02495077|155745050|FG001|Overall Study|Covid-19 research restrictions|0|||
48426410|NCT02229864|155749578|FG000|Overall Study|Lost to Follow-up|1|||
48424910|NCT02495077|155745051|FG002|Overall Study|Covid-19 research restrictions|0|||
48424911|NCT02495077|155745052|FG003|Overall Study|Covid-19 research restrictions|0|||
48424912|NCT02495077|155745049|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
48424913|NCT02495077|155745050|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
48424914|NCT02495077|155745051|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
48424915|NCT02495077|155745052|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
48424916|NCT02495077|155745049|FG000|Overall Study|Incarcerated|0|||
48424917|NCT02495077|155745050|FG001|Overall Study|Incarcerated|1|||
48424918|NCT02495077|155745051|FG002|Overall Study|Incarcerated|0|||
48424919|NCT02495077|155745052|FG003|Overall Study|Incarcerated|0|||
48424920|NCT02495077|155745049|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
48424921|NCT02495077|155745050|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
48424922|NCT02495077|155745051|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
48424923|NCT02495077|155745052|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
48424924|NCT02495077|155745049|FG000|Overall Study|Timing of transplant and randomization|0|||
48424925|NCT02495077|155745050|FG001|Overall Study|Timing of transplant and randomization|0|||
48424926|NCT02495077|155745051|FG002|Overall Study|Timing of transplant and randomization|5|||
48424927|NCT02495077|155745052|FG003|Overall Study|Timing of transplant and randomization|0|||
48424928|NCT03032068|155745053|FG000|Overall Study|Adverse Event|1|||
48424929|NCT01300286|155745054|FG000|Overall Study|did not get dosed|1|||
48424930|NCT00744055|155745057|FG000|Overall Study|Withdrawal by Subject|6|||
48424931|NCT00744055|155745058|FG001|Overall Study|Withdrawal by Subject|9|||
48424932|NCT00744055|155745057|FG000|Overall Study|Lack of Efficacy|0|||
48424933|NCT00744055|155745058|FG001|Overall Study|Lack of Efficacy|1|||
48424934|NCT00744055|155745057|FG000|Overall Study|Physician Decision|0|||
48424935|NCT00744055|155745058|FG001|Overall Study|Physician Decision|2|||
48424936|NCT00744055|155745057|FG000|Overall Study|Protocol Violation|1|||
48424937|NCT00744055|155745058|FG001|Overall Study|Protocol Violation|1|||
48424938|NCT00744055|155745057|FG000|Overall Study|Lost to Follow-up|0|||
48424939|NCT00744055|155745058|FG001|Overall Study|Lost to Follow-up|1|||
48424940|NCT03635190|155745059|FG000|Overall Study|Lost to Follow-up|4|||
48424941|NCT03635190|155745059|FG000|Overall Study|Death|3|||
48424942|NCT03635190|155745059|FG000|Overall Study|Withdrawal by Subject|1|||
48424943|NCT03635190|155745059|FG000|Overall Study|Patient moved and did not return for follow up|1|||
48424944|NCT02767570|155745062|FG000|Overall Study|Lost to Follow-up|3|||
48424945|NCT02767570|155745063|FG001|Overall Study|Lost to Follow-up|0|||
48424946|NCT02767570|155745062|FG000|Overall Study|COVID shutdown|2|||
48424947|NCT02767570|155745063|FG001|Overall Study|COVID shutdown|5|||
48424948|NCT02767570|155745062|FG000|Overall Study|Increased pain|2|||
48424949|NCT02767570|155745063|FG001|Overall Study|Increased pain|0|||
48424950|NCT02767570|155745062|FG000|Overall Study|Withdrawal by Subject|1|||
48424951|NCT02767570|155745063|FG001|Overall Study|Withdrawal by Subject|3|||
48424952|NCT02767570|155745062|FG000|Overall Study|Unrelated medical issue|1|||
48424953|NCT02767570|155745063|FG001|Overall Study|Unrelated medical issue|1|||
48424954|NCT02767570|155745062|FG000|Overall Study|Received intra-articular injection|0|||
48424955|NCT02767570|155745063|FG001|Overall Study|Received intra-articular injection|1|||
48424956|NCT01330381|155745064|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
48424957|NCT01330381|155745065|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
48424958|NCT01330381|155745066|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
48424959|NCT01330381|155745064|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
48424960|NCT01330381|155745065|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
48424961|NCT01330381|155745066|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
48424962|NCT01330381|155745064|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
48424963|NCT01330381|155745065|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
48424964|NCT01330381|155745066|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
48424965|NCT01330381|155745064|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
48424966|NCT01330381|155745065|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
48424967|NCT01330381|155745066|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
48424968|NCT01330381|155745064|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
48424969|NCT01330381|155745065|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
48424970|NCT01330381|155745066|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
48424971|NCT01330381|155745064|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
48424972|NCT01330381|155745065|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
48424973|NCT01330381|155745066|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
48424974|NCT01330381|155745064|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
48424975|NCT01330381|155745065|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
48424976|NCT01330381|155745066|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
48424977|NCT01330381|155745064|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
48424978|NCT01330381|155745065|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
48424979|NCT01330381|155745066|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
48424980|NCT01330381|155745064|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
48424981|NCT01330381|155745065|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
48424982|NCT01330381|155745066|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
48424983|NCT01330381|155745064|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
48424984|NCT01330381|155745065|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
48424985|NCT01330381|155745066|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
48424986|NCT04003155|155745067|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
48424987|NCT04003155|155745068|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
48424988|NCT04003155|155745069|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
48424989|NCT04003155|155745070|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
48424990|NCT04003155|155745071|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
48424991|NCT04003155|155745067|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
48424992|NCT04003155|155745068|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
48424993|NCT04003155|155745069|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
48424994|NCT04003155|155745070|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
48424995|NCT04003155|155745071|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
48424996|NCT04003155|155745067|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
48424997|NCT04003155|155745068|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
48424998|NCT04003155|155745069|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
48424999|NCT04003155|155745070|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
48425000|NCT04003155|155745071|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
48425001|NCT04003155|155745067|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
48425002|NCT04003155|155745068|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
48425003|NCT04003155|155745069|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
48425004|NCT04003155|155745070|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
48425005|NCT04003155|155745071|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
48425006|NCT04003155|155745067|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
48425007|NCT04003155|155745068|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
48425008|NCT04003155|155745069|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
48425009|NCT04003155|155745070|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
48425010|NCT04003155|155745071|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
48425011|NCT04003155|155745067|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
48425012|NCT04003155|155745068|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
48425013|NCT04003155|155745069|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
48425014|NCT04003155|155745070|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
48425015|NCT04003155|155745071|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
48425016|NCT04003155|155745067|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
48425017|NCT04003155|155745068|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
48425018|NCT04003155|155745069|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
48425019|NCT04003155|155745070|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
48425020|NCT04003155|155745071|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
48425021|NCT04003155|155745067|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
48425022|NCT04003155|155745068|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
48425023|NCT04003155|155745069|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
48425024|NCT04003155|155745070|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
48425025|NCT04003155|155745071|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
48425026|NCT04003155|155745067|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
48425027|NCT04003155|155745068|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
48425028|NCT04003155|155745069|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
48425029|NCT04003155|155745070|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
48425030|NCT04003155|155745071|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
48425031|NCT03216265|155745073|FG000|Overall Study|Adverse Event|2|||
48425032|NCT03216265|155745074|FG001|Overall Study|Adverse Event|0|||
48425033|NCT03216265|155745075|FG002|Overall Study|Adverse Event|2|||
48425034|NCT03216265|155745073|FG000|Overall Study|Lost to Follow-up|0|||
48425035|NCT03216265|155745074|FG001|Overall Study|Lost to Follow-up|1|||
48425036|NCT03216265|155745075|FG002|Overall Study|Lost to Follow-up|0|||
48425037|NCT03216265|155745073|FG000|Overall Study|Withdrawal by Subject|0|||
48425038|NCT03216265|155745074|FG001|Overall Study|Withdrawal by Subject|0|||
48425039|NCT03216265|155745075|FG002|Overall Study|Withdrawal by Subject|1|||
48425040|NCT00401973|155745084|FG000|Overall Study|Adverse Event|2|||
48425041|NCT00401973|155745085|FG001|Overall Study|Adverse Event|8|||
48425042|NCT00401973|155745086|FG002|Overall Study|Adverse Event|4|||
48425043|NCT00401973|155745084|FG000|Overall Study|Clinical Relapse|0|||
48425044|NCT00401973|155745085|FG001|Overall Study|Clinical Relapse|1|||
48425045|NCT00401973|155745086|FG002|Overall Study|Clinical Relapse|1|||
48425046|NCT00401973|155745084|FG000|Overall Study|Lack of Efficacy|0|||
48425047|NCT00401973|155745085|FG001|Overall Study|Lack of Efficacy|0|||
48425048|NCT00401973|155745086|FG002|Overall Study|Lack of Efficacy|3|||
48425049|NCT00401973|155745084|FG000|Overall Study|Lost to Follow-up|2|||
48425050|NCT00401973|155745085|FG001|Overall Study|Lost to Follow-up|2|||
48425051|NCT00401973|155745086|FG002|Overall Study|Lost to Follow-up|2|||
48425052|NCT00401973|155745084|FG000|Overall Study|Physician Decision|2|||
48425053|NCT00401973|155745085|FG001|Overall Study|Physician Decision|0|||
48425054|NCT00401973|155745086|FG002|Overall Study|Physician Decision|1|||
48425055|NCT00401973|155745084|FG000|Overall Study|Protocol Violation|1|||
48425056|NCT00401973|155745085|FG001|Overall Study|Protocol Violation|2|||
48425057|NCT00401973|155745086|FG002|Overall Study|Protocol Violation|3|||
48425058|NCT00401973|155745084|FG000|Overall Study|Sponsor Decision|0|||
48425059|NCT00401973|155745085|FG001|Overall Study|Sponsor Decision|1|||
48425060|NCT00401973|155745086|FG002|Overall Study|Sponsor Decision|0|||
48425061|NCT00401973|155745084|FG000|Overall Study|Withdrawal by Subject|4|||
48425062|NCT00401973|155745085|FG001|Overall Study|Withdrawal by Subject|12|||
48425063|NCT00401973|155745086|FG002|Overall Study|Withdrawal by Subject|9|||
48425064|NCT03515538|155745087|FG000|Overall Study|Lack of Efficacy|2|||
48425065|NCT03515538|155745088|FG001|Overall Study|Lack of Efficacy|0|||
48425066|NCT03515538|155745089|FG002|Overall Study|Lack of Efficacy|2|||
48425067|NCT03515538|155745090|FG003|Overall Study|Lack of Efficacy|0|||
48425068|NCT03515538|155745087|FG000|Overall Study|Death|0|||
48425069|NCT03515538|155745088|FG001|Overall Study|Death|0|||
48425070|NCT03515538|155745089|FG002|Overall Study|Death|1|||
48425071|NCT03515538|155745090|FG003|Overall Study|Death|0|||
48425072|NCT03515538|155745087|FG000|Overall Study|Protocol Violation|0|||
48425073|NCT03515538|155745088|FG001|Overall Study|Protocol Violation|0|||
48425074|NCT03515538|155745089|FG002|Overall Study|Protocol Violation|0|||
48425075|NCT03515538|155745090|FG003|Overall Study|Protocol Violation|1|||
48425076|NCT03515538|155745087|FG000|Overall Study|Screen failure (baseline dropout)|0|||
48425077|NCT03515538|155745088|FG001|Overall Study|Screen failure (baseline dropout)|1|||
48425078|NCT03515538|155745089|FG002|Overall Study|Screen failure (baseline dropout)|0|||
48425079|NCT03515538|155745090|FG003|Overall Study|Screen failure (baseline dropout)|0|||
48425080|NCT03515538|155745087|FG000|Overall Study|Withdrawal by Subject|2|||
48425081|NCT03515538|155745088|FG001|Overall Study|Withdrawal by Subject|2|||
48425082|NCT03515538|155745089|FG002|Overall Study|Withdrawal by Subject|1|||
48425083|NCT03515538|155745090|FG003|Overall Study|Withdrawal by Subject|3|||
48425084|NCT03515538|155745087|FG000|Overall Study|Physician Decision|1|||
48425085|NCT03515538|155745088|FG001|Overall Study|Physician Decision|0|||
48425086|NCT03515538|155745089|FG002|Overall Study|Physician Decision|0|||
48425087|NCT03515538|155745090|FG003|Overall Study|Physician Decision|1|||
48425088|NCT04329923|155745099|FG000|Overall Study|Withdrawal by Subject|1|||
48425089|NCT04329923|155745100|FG001|Overall Study|Withdrawal by Subject|4|||
48425090|NCT04329923|155745101|FG002|Overall Study|Withdrawal by Subject|1|||
48425091|NCT04329923|155745102|FG003|Overall Study|Withdrawal by Subject|1|||
48425092|NCT04329923|155745103|FG004|Overall Study|Withdrawal by Subject|1|||
48425093|NCT04329923|155745104|FG005|Overall Study|Withdrawal by Subject|1|||
48425094|NCT04329923|155745099|FG000|Overall Study|early termination of study|0|||
48425095|NCT04329923|155745100|FG001|Overall Study|early termination of study|0|||
48425096|NCT04329923|155745101|FG002|Overall Study|early termination of study|0|||
48425097|NCT04329923|155745102|FG003|Overall Study|early termination of study|0|||
48425098|NCT04329923|155745103|FG004|Overall Study|early termination of study|1|||
48425099|NCT04329923|155745104|FG005|Overall Study|early termination of study|2|||
48425100|NCT04329923|155745099|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48425101|NCT04329923|155745100|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48425102|NCT04329923|155745101|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48425103|NCT04329923|155745102|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48425104|NCT04329923|155745103|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
48425105|NCT04329923|155745104|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
48425106|NCT00984659|155745105|FG000|2-week Run-in Period|Adverse Event|8|||
48425107|NCT00984659|155745106|FG001|2-week Run-in Period|Adverse Event|0|||
48425108|NCT00984659|155745107|FG002|2-week Run-in Period|Adverse Event|0|||
48425109|NCT00984659|155745108|FG003|2-week Run-in Period|Adverse Event|0|||
48425110|NCT00984659|155745105|FG000|2-week Run-in Period|Protocol Violation|5|||
48425111|NCT00984659|155745106|FG001|2-week Run-in Period|Protocol Violation|0|||
48425112|NCT00984659|155745107|FG002|2-week Run-in Period|Protocol Violation|0|||
48425113|NCT00984659|155745108|FG003|2-week Run-in Period|Protocol Violation|0|||
48425114|NCT00984659|155745105|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
48425115|NCT00984659|155745106|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
48425116|NCT00984659|155745107|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
48425117|NCT00984659|155745108|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
48425118|NCT00984659|155745105|FG000|2-week Run-in Period|Lost to Follow-up|3|||
48425119|NCT00984659|155745106|FG001|2-week Run-in Period|Lost to Follow-up|0|||
48425120|NCT00984659|155745107|FG002|2-week Run-in Period|Lost to Follow-up|0|||
48425121|NCT00984659|155745108|FG003|2-week Run-in Period|Lost to Follow-up|0|||
48425122|NCT00984659|155745105|FG000|2-week Run-in Period|Physician Decision|10|||
48425123|NCT00984659|155745106|FG001|2-week Run-in Period|Physician Decision|0|||
48425124|NCT00984659|155745107|FG002|2-week Run-in Period|Physician Decision|0|||
48425125|NCT00984659|155745108|FG003|2-week Run-in Period|Physician Decision|0|||
48425126|NCT00984659|155745105|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
48425127|NCT00984659|155745106|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
48425128|NCT00984659|155745107|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
48425129|NCT00984659|155745108|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
48425130|NCT00984659|155745105|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
48425131|NCT00984659|155745106|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48425132|NCT00984659|155745107|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48425133|NCT00984659|155745108|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
48425134|NCT00984659|155745105|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
48425135|NCT00984659|155745106|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
48425136|NCT00984659|155745107|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
48425137|NCT00984659|155745108|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
48425138|NCT00984659|155745105|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
48425139|NCT00984659|155745106|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
48425140|NCT00984659|155745107|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
48425141|NCT00984659|155745108|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
48425142|NCT00984659|155745105|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
48425143|NCT00984659|155745106|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
48425144|NCT00984659|155745107|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
48425145|NCT00984659|155745108|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
48425146|NCT00984659|155745105|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
48425147|NCT00984659|155745106|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
48425148|NCT00984659|155745107|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
48425149|NCT00984659|155745108|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
48425150|NCT00984659|155745105|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48425151|NCT00984659|155745106|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
48425152|NCT00984659|155745107|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
48425153|NCT00984659|155745108|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
48425154|NCT00891657|155745109|FG000|Overall Study|Withdrawal by Subject|1|||
48425155|NCT00891657|155745110|FG001|Overall Study|Withdrawal by Subject|1|||
48425156|NCT02296840|155745111|FG000|Overall Study|Adverse Event|1|||
48425157|NCT02296840|155745112|FG001|Overall Study|Adverse Event|1|||
48425158|NCT02296840|155745111|FG000|Overall Study|Protocol Violation|2|||
48425159|NCT02296840|155745112|FG001|Overall Study|Protocol Violation|1|||
48425160|NCT02296840|155745111|FG000|Overall Study|Lost to Follow-up|6|||
48425161|NCT02296840|155745112|FG001|Overall Study|Lost to Follow-up|17|||
48425162|NCT02612077|155745113|FG000|Overall Study|Adverse Event|3|||
48425163|NCT02612077|155745113|FG000|Overall Study|Withdrawal by Subject|9|||
48425164|NCT02612077|155745113|FG000|Overall Study|Protocol Violation|28|||
48425165|NCT02612077|155745113|FG000|Overall Study|Lost to Follow-up|20|||
48425166|NCT02612077|155745113|FG000|Overall Study|Death|377|||
48425167|NCT02612077|155745113|FG000|Overall Study|Moved or Changed Medical Team|23|||
48425168|NCT02612077|155745113|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
48425169|NCT02612077|155745113|FG000|Overall Study|Disease Progression|3|||
48425170|NCT02612077|155745113|FG000|Overall Study|Unknown reason|2|||
48425171|NCT01645930|155745115|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
48425172|NCT01645930|155745115|FG000|Overall Study|Progressive Disease|12|||
48425173|NCT01645930|155745115|FG000|Overall Study|Adverse Event|4|||
48425174|NCT01645930|155745115|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
48425175|NCT01645930|155745115|FG000|Overall Study|Withdrawal by Participant|2|||
48425176|NCT01645930|155745115|FG000|Overall Study|Reason not Defined|1|||
48425177|NCT00570739|155745116|FG000|Overall Study|Adverse Event|8|||
48425178|NCT00570739|155745117|FG001|Overall Study|Adverse Event|6|||
48425179|NCT00570739|155745118|FG002|Overall Study|Adverse Event|2|||
48425180|NCT00570739|155745119|FG003|Overall Study|Adverse Event|2|||
48425181|NCT00570739|155745116|FG000|Overall Study|Lost to Follow-up|4|||
48425182|NCT00570739|155745117|FG001|Overall Study|Lost to Follow-up|5|||
48425183|NCT00570739|155745118|FG002|Overall Study|Lost to Follow-up|4|||
48425184|NCT00570739|155745119|FG003|Overall Study|Lost to Follow-up|1|||
48425185|NCT00570739|155745116|FG000|Overall Study|Physician Decision|1|||
48425186|NCT00570739|155745117|FG001|Overall Study|Physician Decision|1|||
48425187|NCT00570739|155745118|FG002|Overall Study|Physician Decision|0|||
48425188|NCT00570739|155745119|FG003|Overall Study|Physician Decision|0|||
48425189|NCT00570739|155745116|FG000|Overall Study|Withdrawal by Subject|7|||
48425190|NCT00570739|155745117|FG001|Overall Study|Withdrawal by Subject|7|||
48425191|NCT00570739|155745118|FG002|Overall Study|Withdrawal by Subject|3|||
48425192|NCT00570739|155745119|FG003|Overall Study|Withdrawal by Subject|5|||
48425193|NCT00570739|155745116|FG000|Overall Study|Required restricted medication|0|||
48425194|NCT00570739|155745117|FG001|Overall Study|Required restricted medication|0|||
48425195|NCT00570739|155745118|FG002|Overall Study|Required restricted medication|1|||
48425196|NCT00570739|155745119|FG003|Overall Study|Required restricted medication|0|||
48425197|NCT00570739|155745116|FG000|Overall Study|Met discontinuation criteria|1|||
48425198|NCT00570739|155745117|FG001|Overall Study|Met discontinuation criteria|0|||
48425199|NCT00570739|155745118|FG002|Overall Study|Met discontinuation criteria|1|||
48425200|NCT00570739|155745119|FG003|Overall Study|Met discontinuation criteria|1|||
48425201|NCT00570739|155745116|FG000|Overall Study|Other|0|||
48425202|NCT00570739|155745117|FG001|Overall Study|Other|2|||
48425203|NCT00570739|155745118|FG002|Overall Study|Other|5|||
48425204|NCT00570739|155745119|FG003|Overall Study|Other|3|||
48425205|NCT00751101|155745120|FG000|Overall Study|Withdrawal by Subject|1|||
48425206|NCT00751101|155745121|FG001|Overall Study|Withdrawal by Subject|0|||
48425207|NCT00751101|155745120|FG000|Overall Study|No HFS / Never Started Patch/|0|||
48425208|NCT00751101|155745121|FG001|Overall Study|No HFS / Never Started Patch/|4|||
48425209|NCT00751101|155745120|FG000|Overall Study|Never began capecitabine|1|||
48425210|NCT00751101|155745121|FG001|Overall Study|Never began capecitabine|0|||
48425211|NCT00751101|155745120|FG000|Overall Study|Physician Decision|0|||
48425212|NCT00751101|155745121|FG001|Overall Study|Physician Decision|1|||
48425213|NCT02613572|155745124|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
48425214|NCT02613572|155745125|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
48425215|NCT02613572|155745126|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
48425216|NCT02613572|155745124|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
48425217|NCT02613572|155745125|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
48425218|NCT02613572|155745126|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
48425219|NCT01001494|155745130|FG000|Overall Study|Adverse Event|8|||
48425220|NCT01001494|155745131|FG001|Overall Study|Adverse Event|4|||
48425221|NCT01001494|155745132|FG002|Overall Study|Adverse Event|6|||
48425222|NCT01001494|155745130|FG000|Overall Study|Protocol Violation|0|||
48425223|NCT01001494|155745131|FG001|Overall Study|Protocol Violation|1|||
48425224|NCT01001494|155745132|FG002|Overall Study|Protocol Violation|1|||
48425225|NCT01001494|155745130|FG000|Overall Study|Lost to Follow-up|2|||
48425226|NCT01001494|155745131|FG001|Overall Study|Lost to Follow-up|0|||
48425227|NCT01001494|155745132|FG002|Overall Study|Lost to Follow-up|1|||
48425228|NCT01001494|155745130|FG000|Overall Study|Withdrawal by Subject|9|||
48425229|NCT01001494|155745131|FG001|Overall Study|Withdrawal by Subject|7|||
48425230|NCT01001494|155745132|FG002|Overall Study|Withdrawal by Subject|17|||
48425231|NCT01001494|155745130|FG000|Overall Study|COPD exacerbation|3|||
48425232|NCT01001494|155745131|FG001|Overall Study|COPD exacerbation|4|||
48425233|NCT01001494|155745132|FG002|Overall Study|COPD exacerbation|5|||
48425234|NCT01001494|155745130|FG000|Overall Study|Lack of Efficacy|2|||
48425235|NCT01001494|155745131|FG001|Overall Study|Lack of Efficacy|0|||
48425236|NCT01001494|155745132|FG002|Overall Study|Lack of Efficacy|8|||
48425237|NCT01001494|155745130|FG000|Overall Study|Other|0|||
48425238|NCT01001494|155745131|FG001|Overall Study|Other|1|||
48425239|NCT01001494|155745132|FG002|Overall Study|Other|3|||
48425240|NCT02119104|155745133|FG000|Overall Study|Protocol Violation|16|||
48425241|NCT04156646|155745134|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
48425242|NCT04156646|155745135|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
48425243|NCT00425438|155745138|FG000|Overall Study|Termination by Sponsor|25|||
48425244|NCT00425438|155745139|FG001|Overall Study|Termination by Sponsor|27|||
48425245|NCT02698423|155745140|FG000|Overall Study|Lost to Follow-up|19|||
48425246|NCT02698423|155745141|FG001|Overall Study|Lost to Follow-up|24|||
48425247|NCT02606877|155745146|FG000|Overall Study|Adverse Event|3|||
48425248|NCT02606877|155745147|FG001|Overall Study|Adverse Event|0|||
48425249|NCT02606877|155745146|FG000|Overall Study|Non-compliance with protocol|0|||
48425250|NCT02606877|155745147|FG001|Overall Study|Non-compliance with protocol|1|||
48425251|NCT02606877|155745146|FG000|Overall Study|Other than listed above|1|||
48425252|NCT02606877|155745147|FG001|Overall Study|Other than listed above|0|||
48425253|NCT03634072|155745158|FG000|Overall Study|Early termination of overall study|1|||
48425254|NCT03634072|155745159|FG001|Overall Study|Early termination of overall study|0|||
48425255|NCT00515463|155745163|FG000|Overall Study|Physician Decision|4|||
48425256|NCT00515463|155745164|FG001|Overall Study|Physician Decision|2|||
48425257|NCT00515463|155745163|FG000|Overall Study|Adverse Event|1|||
48425258|NCT00515463|155745164|FG001|Overall Study|Adverse Event|2|||
48425259|NCT00515463|155745163|FG000|Overall Study|Withdrawal by Subject|3|||
48425260|NCT00515463|155745164|FG001|Overall Study|Withdrawal by Subject|4|||
48425261|NCT00515463|155745163|FG000|Overall Study|Lost to Follow-up|6|||
48425262|NCT00515463|155745164|FG001|Overall Study|Lost to Follow-up|5|||
48425263|NCT00515463|155745163|FG000|Overall Study|Other|0|||
48425264|NCT00515463|155745164|FG001|Overall Study|Other|1|||
48425265|NCT01765764|155745165|FG000|Treatment Period|Adverse Event|1|||
48425266|NCT01765764|155745166|FG001|Treatment Period|Adverse Event|2|||
48425267|NCT01765764|155745167|FG002|Treatment Period|Adverse Event|1|||
48425268|NCT01765764|155745165|FG000|Treatment Period|Lost to Follow-up|0|||
48425269|NCT01765764|155745166|FG001|Treatment Period|Lost to Follow-up|3|||
48425270|NCT01765764|155745167|FG002|Treatment Period|Lost to Follow-up|2|||
48425271|NCT01765764|155745165|FG000|Treatment Period|Personal Reasons|1|||
48425272|NCT01765764|155745166|FG001|Treatment Period|Personal Reasons|2|||
48425273|NCT01765764|155745167|FG002|Treatment Period|Personal Reasons|1|||
48425274|NCT01765764|155745165|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
48425275|NCT01765764|155745166|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
48425276|NCT01765764|155745167|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
48425277|NCT00081289|155745168|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
48425278|NCT00081289|155745169|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
48425279|NCT00081289|155745168|FG000|Overall Study|Ineligible / no protocol treatment|3|||
48425280|NCT00081289|155745169|FG001|Overall Study|Ineligible / no protocol treatment|4|||
48425281|NCT01651260|155745172|FG000|Overall Study|unable to apply product|3|||
48425282|NCT01781026|155745177|FG000|Overall Study|Lack of Efficacy|2|||
48425283|NCT02144220|155745178|FG000|Overall Study|technology incompatibility|9|||
48425284|NCT02144220|155745178|FG000|Overall Study|Lack of Efficacy|4|||
48425285|NCT02144220|155745178|FG000|Overall Study|Physician Decision|3|||
48425286|NCT02144220|155745178|FG000|Overall Study|Withdrawal by Subject|2|||
48425287|NCT02144220|155745178|FG000|Overall Study|Protocol Violation|1|||
48425288|NCT01558089|155745179|FG000|Overall Study|Adverse Event|1|||
48425289|NCT01558089|155745179|FG000|Overall Study|Lack of Efficacy|1|||
48425290|NCT01558089|155745179|FG000|Overall Study|Lost to Follow-up|5|||
48425291|NCT01558089|155745179|FG000|Overall Study|Withdrawal by Subject|6|||
48425292|NCT00723840|155745180|FG000|Overall Study|Lost to Follow-up|2|||
48425293|NCT00723840|155745180|FG000|Overall Study|Failure to return|18|||
48425294|NCT00723840|155745180|FG000|Overall Study|Withdrawal by Subject|55|||
48425295|NCT00723840|155745180|FG000|Overall Study|Serious Adverse Events|3|||
48425296|NCT00723840|155745180|FG000|Overall Study|Other Medical Event|2|||
48425297|NCT00723840|155745180|FG000|Overall Study|Unspecified reason|2|||
48425298|NCT00916721|155745181|FG000|Overall Study|Lost to Follow-up|0|||
48425299|NCT00916721|155745182|FG001|Overall Study|Lost to Follow-up|1|||
48425300|NCT00916721|155745181|FG000|Overall Study|Adverse Event|6|||
48425301|NCT00916721|155745182|FG001|Overall Study|Adverse Event|3|||
48425302|NCT00916721|155745181|FG000|Overall Study|Withdrawal by Subject|2|||
48425303|NCT00916721|155745182|FG001|Overall Study|Withdrawal by Subject|2|||
48425304|NCT00916721|155745181|FG000|Overall Study|Protocol Violation|2|||
48425305|NCT00916721|155745182|FG001|Overall Study|Protocol Violation|4|||
48425306|NCT00375934|155746775|FG000|Overall Study|Adverse Event|1|||
48425307|NCT00375934|155746776|FG001|Overall Study|Adverse Event|1|||
48425308|NCT00375934|155746775|FG000|Overall Study|Withdrawal by Subject|2|||
48425309|NCT00375934|155746776|FG001|Overall Study|Withdrawal by Subject|2|||
48425310|NCT00375934|155746775|FG000|Overall Study|Lack of Efficacy|0|||
48425311|NCT00375934|155746776|FG001|Overall Study|Lack of Efficacy|2|||
48425312|NCT00375934|155746775|FG000|Overall Study|Physician Decision|0|||
48425313|NCT00375934|155746776|FG001|Overall Study|Physician Decision|1|||
48425314|NCT03191396|155746777|FG000|Overall Study|Lost to Follow-up|0|||
48425315|NCT03191396|155746778|FG001|Overall Study|Lost to Follow-up|3|||
48425316|NCT03191396|155746777|FG000|Overall Study|Withdrawal by Subject|3|||
48425317|NCT03191396|155746778|FG001|Overall Study|Withdrawal by Subject|2|||
48425318|NCT01266148|155746779|FG000|Overall Study|Adverse Event|2|||
48425319|NCT01266148|155746780|FG001|Overall Study|Adverse Event|0|||
48425320|NCT01266148|155746779|FG000|Overall Study|Ongoing rejection|1|||
48425321|NCT01266148|155746780|FG001|Overall Study|Ongoing rejection|0|||
48425322|NCT01266148|155746779|FG000|Overall Study|2 2R rejections|1|||
48425323|NCT01266148|155746780|FG001|Overall Study|2 2R rejections|0|||
48425324|NCT01266148|155746779|FG000|Overall Study|Death|2|||
48425325|NCT01266148|155746780|FG001|Overall Study|Death|3|||
48425326|NCT01266148|155746779|FG000|Overall Study|missing mGFR value + AE|1|||
48425327|NCT01266148|155746780|FG001|Overall Study|missing mGFR value + AE|0|||
48425328|NCT03692910|155746782|FG000|Overall Study|Lost to Follow-up|4|||
48425329|NCT03692910|155746783|FG001|Overall Study|Lost to Follow-up|0|||
48425330|NCT03692910|155746784|FG002|Overall Study|Lost to Follow-up|0|||
48425331|NCT03692910|155746782|FG000|Overall Study|Withdrawal by Subject|2|||
48425332|NCT03692910|155746783|FG001|Overall Study|Withdrawal by Subject|0|||
48425333|NCT03692910|155746784|FG002|Overall Study|Withdrawal by Subject|0|||
48425334|NCT02940886|155746785|FG000|Overall Study|Adverse Event|7|||
48425335|NCT02940886|155746786|FG001|Overall Study|Adverse Event|3|||
48425336|NCT02940886|155746785|FG000|Overall Study|Protocol Violation|0|||
48425337|NCT02940886|155746786|FG001|Overall Study|Protocol Violation|2|||
48426411|NCT01172288|155749579|FG000|Overall Study|Adverse Event|1|||
48425338|NCT02940886|155746785|FG000|Overall Study|Withdrawal by Subject|28|||
48425339|NCT02940886|155746786|FG001|Overall Study|Withdrawal by Subject|20|||
48425340|NCT02940886|155746785|FG000|Overall Study|Death|1|||
48425341|NCT02940886|155746786|FG001|Overall Study|Death|0|||
48425342|NCT02940886|155746785|FG000|Overall Study|Lack of Efficacy|1|||
48425343|NCT02940886|155746786|FG001|Overall Study|Lack of Efficacy|0|||
48425344|NCT02940886|155746785|FG000|Overall Study|Lost to Follow-up|49|||
48425345|NCT02940886|155746786|FG001|Overall Study|Lost to Follow-up|21|||
48425346|NCT02940886|155746785|FG000|Overall Study|Physician Decision|9|||
48425347|NCT02940886|155746786|FG001|Overall Study|Physician Decision|4|||
48425348|NCT02940886|155746785|FG000|Overall Study|Sponsor decision|0|||
48425349|NCT02940886|155746786|FG001|Overall Study|Sponsor decision|1|||
48425350|NCT02940886|155746785|FG000|Overall Study|No treatment|7|||
48425351|NCT02940886|155746786|FG001|Overall Study|No treatment|2|||
48425352|NCT02940886|155746785|FG000|Overall Study|Enrolment error|0|||
48425353|NCT02940886|155746786|FG001|Overall Study|Enrolment error|1|||
48425354|NCT02413398|155746790|FG000|Overall Study|Lost to Follow-up|2|||
48425355|NCT02413398|155746791|FG001|Overall Study|Lost to Follow-up|4|||
48425356|NCT02413398|155746790|FG000|Overall Study|Withdrawal by Subject|1|||
48425357|NCT02413398|155746791|FG001|Overall Study|Withdrawal by Subject|1|||
48425358|NCT02413398|155746790|FG000|Overall Study|Other Eligibility criteria|1|||
48425359|NCT02413398|155746791|FG001|Overall Study|Other Eligibility criteria|2|||
48425360|NCT03074162|155746794|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48425361|NCT03074162|155746795|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48425362|NCT03074162|155746796|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
48425363|NCT03074162|155746797|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48425364|NCT03074162|155746798|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48425365|NCT03074162|155746799|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
48425366|NCT03074162|155746794|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
48425367|NCT03074162|155746795|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
48425368|NCT03074162|155746796|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
48425369|NCT03074162|155746797|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
48425370|NCT03074162|155746798|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
48425371|NCT03074162|155746799|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
48425372|NCT03074162|155746794|FG000|Period 3|Withdrawal by Subject|1|||
48425373|NCT03074162|155746795|FG001|Period 3|Withdrawal by Subject|0|||
48425374|NCT03074162|155746796|FG002|Period 3|Withdrawal by Subject|0|||
48425375|NCT03074162|155746797|FG003|Period 3|Withdrawal by Subject|0|||
48425376|NCT03074162|155746798|FG004|Period 3|Withdrawal by Subject|1|||
48425377|NCT03074162|155746799|FG005|Period 3|Withdrawal by Subject|0|||
48425378|NCT04328623|155746804|FG000|Overall Study|Protocol Violation|0|||
48425379|NCT04328623|155746805|FG001|Overall Study|Protocol Violation|1|||
48425380|NCT00849693|155746808|FG000|Acute Treatment Phase|Adverse Event|12|||
48425381|NCT00849693|155746809|FG001|Acute Treatment Phase|Adverse Event|7|||
48425382|NCT00849693|155746810|FG002|Acute Treatment Phase|Adverse Event|6|||
48379505|NCT00820027|155584557|FG000|Overall Study|Lack of Efficacy|2|||
48379506|NCT00820027|155584558|FG001|Overall Study|Lack of Efficacy|1|||
48379507|NCT00820027|155584559|FG002|Overall Study|Lack of Efficacy|2|||
48379508|NCT00820027|155584560|FG003|Overall Study|Lack of Efficacy|2|||
48379509|NCT00820027|155584557|FG000|Overall Study|Physician Decision|0|||
48379510|NCT00820027|155584558|FG001|Overall Study|Physician Decision|1|||
48379511|NCT00820027|155584559|FG002|Overall Study|Physician Decision|1|||
48379512|NCT00820027|155584560|FG003|Overall Study|Physician Decision|0|||
48379513|NCT00820027|155584557|FG000|Overall Study|Protocol Violation|3|||
48379514|NCT00820027|155584558|FG001|Overall Study|Protocol Violation|0|||
48379515|NCT00820027|155584559|FG002|Overall Study|Protocol Violation|4|||
48379516|NCT00820027|155584560|FG003|Overall Study|Protocol Violation|0|||
48379517|NCT00820027|155584557|FG000|Overall Study|Withdrawal by Subject|6|||
48379518|NCT00820027|155584558|FG001|Overall Study|Withdrawal by Subject|4|||
48379519|NCT00820027|155584559|FG002|Overall Study|Withdrawal by Subject|4|||
48379520|NCT00820027|155584560|FG003|Overall Study|Withdrawal by Subject|6|||
48379521|NCT01388790|155584565|FG000|Overall Study|Ongoing at data cut-off date|8|||
48379522|NCT00908232|155584566|FG000|Cycle 1 to 4|Death|5|||
48379523|NCT00908232|155584567|FG001|Cycle 1 to 4|Death|0|||
48379524|NCT00908232|155584568|FG002|Cycle 1 to 4|Death|0|||
48379525|NCT00908232|155584569|FG003|Cycle 1 to 4|Death|0|||
48379526|NCT00908232|155584566|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
48379527|NCT00908232|155584567|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
48379528|NCT00908232|155584568|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
48379529|NCT00908232|155584569|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
48379530|NCT00908232|155584566|FG000|Cycle 1 to 4|Progressive Disease|6|||
48379531|NCT00908232|155584567|FG001|Cycle 1 to 4|Progressive Disease|0|||
48379532|NCT00908232|155584568|FG002|Cycle 1 to 4|Progressive Disease|0|||
48379533|NCT00908232|155584569|FG003|Cycle 1 to 4|Progressive Disease|0|||
48379534|NCT00908232|155584566|FG000|Cycle 1 to 4|Adverse Event|12|||
48379535|NCT00908232|155584567|FG001|Cycle 1 to 4|Adverse Event|0|||
48379536|NCT00908232|155584568|FG002|Cycle 1 to 4|Adverse Event|0|||
48379537|NCT00908232|155584569|FG003|Cycle 1 to 4|Adverse Event|0|||
48379538|NCT00908232|155584566|FG000|Cycle 1 to 4|Other|1|||
48379539|NCT00908232|155584567|FG001|Cycle 1 to 4|Other|0|||
48379540|NCT00908232|155584568|FG002|Cycle 1 to 4|Other|0|||
48379541|NCT00908232|155584569|FG003|Cycle 1 to 4|Other|0|||
48379542|NCT00908232|155584566|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
48379543|NCT00908232|155584567|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
48379544|NCT00908232|155584568|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
48379545|NCT00908232|155584569|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
48379546|NCT00908232|155584566|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
48379547|NCT00908232|155584567|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
48379548|NCT00908232|155584568|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
48379549|NCT00908232|155584569|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
48379550|NCT00908232|155584566|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
48379551|NCT00908232|155584567|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
48379552|NCT00908232|155584568|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
48379553|NCT00908232|155584569|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
48379554|NCT00908232|155584566|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
48379555|NCT00908232|155584567|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
48379556|NCT00908232|155584568|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
48379557|NCT00908232|155584569|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
48379558|NCT00908232|155584566|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
48379559|NCT00908232|155584567|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
48379560|NCT00908232|155584568|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
48379561|NCT00908232|155584569|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
48379562|NCT00908232|155584566|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
48379563|NCT00908232|155584567|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
48379564|NCT00908232|155584568|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
48379565|NCT00908232|155584569|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
48379566|NCT00908232|155584566|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
48379567|NCT00908232|155584567|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
48379568|NCT00908232|155584568|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
48379569|NCT00908232|155584569|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
48379570|NCT00908232|155584566|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
48379571|NCT00908232|155584567|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
48379572|NCT00908232|155584568|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
48379573|NCT00908232|155584569|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
48379574|NCT00537485|155584570|FG000|Overall Study|Adverse Event|10|||
48379575|NCT00537485|155584571|FG001|Overall Study|Adverse Event|5|||
48379576|NCT00537485|155584570|FG000|Overall Study|Withdrawal by Subject|3|||
48379577|NCT00537485|155584571|FG001|Overall Study|Withdrawal by Subject|2|||
48379578|NCT00537485|155584570|FG000|Overall Study|Withdrawal by Subject|1|||
48379579|NCT00537485|155584571|FG001|Overall Study|Withdrawal by Subject|3|||
48379580|NCT00537485|155584570|FG000|Overall Study|Physician Decision|1|||
48379581|NCT00537485|155584571|FG001|Overall Study|Physician Decision|0|||
48425383|NCT00849693|155746811|FG003|Acute Treatment Phase|Adverse Event|4|||
48425384|NCT00849693|155746808|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
48425385|NCT00849693|155746809|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
48425386|NCT00849693|155746810|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
48425387|NCT00849693|155746811|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
48425388|NCT00849693|155746808|FG000|Acute Treatment Phase|Protocol Violation|1|||
48425389|NCT00849693|155746809|FG001|Acute Treatment Phase|Protocol Violation|5|||
48425390|NCT00849693|155746810|FG002|Acute Treatment Phase|Protocol Violation|2|||
48425391|NCT00849693|155746811|FG003|Acute Treatment Phase|Protocol Violation|6|||
48425392|NCT00849693|155746808|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
48425393|NCT00849693|155746809|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
48425394|NCT00849693|155746810|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
48425395|NCT00849693|155746811|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
48425396|NCT00849693|155746808|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
48425397|NCT00849693|155746809|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
48425398|NCT00849693|155746810|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
48425399|NCT00849693|155746811|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
48425400|NCT00849693|155746808|FG000|Acute Treatment Phase|Physician Decision|2|||
48425401|NCT00849693|155746809|FG001|Acute Treatment Phase|Physician Decision|1|||
48425402|NCT00849693|155746810|FG002|Acute Treatment Phase|Physician Decision|2|||
48425403|NCT00849693|155746811|FG003|Acute Treatment Phase|Physician Decision|1|||
48425404|NCT00849693|155746808|FG000|Acute Treatment Phase|Sponsor decision|0|||
48425405|NCT00849693|155746809|FG001|Acute Treatment Phase|Sponsor decision|0|||
48425406|NCT00849693|155746810|FG002|Acute Treatment Phase|Sponsor decision|1|||
48425407|NCT00849693|155746811|FG003|Acute Treatment Phase|Sponsor decision|0|||
48425408|NCT00849693|155746808|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
48425409|NCT00849693|155746809|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
48425410|NCT00849693|155746810|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
48425411|NCT00849693|155746811|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
48425412|NCT00849693|155746808|FG000|Extension Phase|Adverse Event|4|||
48425413|NCT00849693|155746809|FG001|Extension Phase|Adverse Event|6|||
48425414|NCT00849693|155746810|FG002|Extension Phase|Adverse Event|3|||
48425415|NCT00849693|155746811|FG003|Extension Phase|Adverse Event|7|||
48425416|NCT00849693|155746808|FG000|Extension Phase|Lost to Follow-up|7|||
48425417|NCT00849693|155746809|FG001|Extension Phase|Lost to Follow-up|5|||
48425418|NCT00849693|155746810|FG002|Extension Phase|Lost to Follow-up|6|||
48425419|NCT00849693|155746811|FG003|Extension Phase|Lost to Follow-up|6|||
48425420|NCT00849693|155746808|FG000|Extension Phase|Protocol Violation|0|||
48425421|NCT00849693|155746809|FG001|Extension Phase|Protocol Violation|3|||
48425422|NCT00849693|155746810|FG002|Extension Phase|Protocol Violation|2|||
48425423|NCT00849693|155746811|FG003|Extension Phase|Protocol Violation|3|||
48425424|NCT00849693|155746808|FG000|Extension Phase|Withdrawal by Subject|6|||
48425425|NCT00849693|155746809|FG001|Extension Phase|Withdrawal by Subject|9|||
48425426|NCT00849693|155746810|FG002|Extension Phase|Withdrawal by Subject|10|||
48425427|NCT00849693|155746811|FG003|Extension Phase|Withdrawal by Subject|15|||
48425428|NCT00849693|155746808|FG000|Extension Phase|Parent or caregiver decision|9|||
48425429|NCT00849693|155746809|FG001|Extension Phase|Parent or caregiver decision|4|||
48425430|NCT00849693|155746810|FG002|Extension Phase|Parent or caregiver decision|10|||
48425431|NCT00849693|155746811|FG003|Extension Phase|Parent or caregiver decision|5|||
48425432|NCT00849693|155746808|FG000|Extension Phase|Physician Decision|1|||
48425433|NCT00849693|155746809|FG001|Extension Phase|Physician Decision|1|||
48425434|NCT00849693|155746810|FG002|Extension Phase|Physician Decision|2|||
48425435|NCT00849693|155746811|FG003|Extension Phase|Physician Decision|0|||
48425436|NCT00849693|155746808|FG000|Extension Phase|Sponsor decision|1|||
48425437|NCT00849693|155746809|FG001|Extension Phase|Sponsor decision|0|||
48425438|NCT00849693|155746810|FG002|Extension Phase|Sponsor decision|0|||
48425439|NCT00849693|155746811|FG003|Extension Phase|Sponsor decision|1|||
48425440|NCT00849693|155746808|FG000|Extension Phase|Lack of Efficacy|2|||
48425441|NCT00849693|155746809|FG001|Extension Phase|Lack of Efficacy|2|||
48425442|NCT00849693|155746810|FG002|Extension Phase|Lack of Efficacy|2|||
48425443|NCT00849693|155746811|FG003|Extension Phase|Lack of Efficacy|1|||
48425444|NCT03238248|155746812|FG000|Overall Study|Death|5|||
48425445|NCT03238248|155746812|FG000|Overall Study|Withdrawal by Subject|7|||
48425446|NCT03238248|155746812|FG000|Overall Study|Participant proceeding to transplant|10|||
48425447|NCT03238248|155746812|FG000|Overall Study|Lack of Efficacy|4|||
48425448|NCT03238248|155746812|FG000|Overall Study|Physician Decision|3|||
48425449|NCT03238248|155746812|FG000|Overall Study|Transitioning to another study|1|||
48425450|NCT03238248|155746812|FG000|Overall Study|No longer benefiting|1|||
48425451|NCT03238248|155746812|FG000|Overall Study|Other complicating disease|1|||
48425452|NCT03238248|155746812|FG000|Overall Study|Adverse Event|5|||
48425453|NCT03238248|155746812|FG000|Overall Study|Disease progression|26|||
48425454|NCT03238248|155746812|FG000|Overall Study|N/A participant is still on treatment|1|||
48425455|NCT03238248|155746812|FG000|Overall Study|Decline in condition|1|||
48425456|NCT03238248|155746812|FG000|Overall Study|Alternative therapy|2|||
48425457|NCT01062399|155746814|FG000|Overall Study|Protocol Violation|0|||
48425458|NCT01062399|155746815|FG001|Overall Study|Protocol Violation|1|||
48425459|NCT01062399|155746816|FG002|Overall Study|Protocol Violation|0|||
48425460|NCT01062399|155746817|FG003|Overall Study|Protocol Violation|6|||
48425461|NCT01062399|155746818|FG004|Overall Study|Protocol Violation|4|||
48425462|NCT01978912|155746824|FG000|Overall Study|Adverse Event|0|||
48425463|NCT01978912|155746825|FG001|Overall Study|Adverse Event|1|||
48425464|NCT01978912|155746826|FG002|Overall Study|Adverse Event|0|||
48425465|NCT01978912|155746827|FG003|Overall Study|Adverse Event|0|||
48425466|NCT01978912|155746824|FG000|Overall Study|Lost to Follow-up|1|||
48425467|NCT01978912|155746825|FG001|Overall Study|Lost to Follow-up|1|||
48425468|NCT01978912|155746826|FG002|Overall Study|Lost to Follow-up|0|||
48425469|NCT01978912|155746827|FG003|Overall Study|Lost to Follow-up|1|||
48425470|NCT01978912|155746824|FG000|Overall Study|Withdrawal by Subject|1|||
48425471|NCT01978912|155746825|FG001|Overall Study|Withdrawal by Subject|0|||
48425472|NCT01978912|155746826|FG002|Overall Study|Withdrawal by Subject|2|||
48425473|NCT01978912|155746827|FG003|Overall Study|Withdrawal by Subject|2|||
48425474|NCT01978912|155746824|FG000|Overall Study|Lumbar Surgery|1|||
48425475|NCT01978912|155746825|FG001|Overall Study|Lumbar Surgery|0|||
48425476|NCT01978912|155746826|FG002|Overall Study|Lumbar Surgery|1|||
48425477|NCT01978912|155746827|FG003|Overall Study|Lumbar Surgery|0|||
48425478|NCT01978912|155746824|FG000|Overall Study|Intradiscal Steroid Injection|0|||
48379582|NCT02349451|155584572|FG000|Overall Study|Withdrawal by Subject|0|||
48379583|NCT02349451|155584573|FG001|Overall Study|Withdrawal by Subject|1|||
48379584|NCT02349451|155584574|FG002|Overall Study|Withdrawal by Subject|2|||
48379585|NCT02349451|155584575|FG003|Overall Study|Withdrawal by Subject|1|||
48379586|NCT00261846|155584578|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
48379587|NCT00261846|155584579|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
48379588|NCT00261846|155584580|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
48379589|NCT00261846|155584581|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379590|NCT00261846|155584582|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379591|NCT00261846|155584583|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379592|NCT00261846|155584584|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379593|NCT00261846|155584585|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379594|NCT00261846|155584586|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379595|NCT00261846|155584587|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379596|NCT00261846|155584588|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379597|NCT00261846|155584589|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
48379598|NCT00261846|155584578|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379599|NCT00261846|155584579|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379600|NCT00261846|155584580|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379601|NCT00261846|155584581|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
48379602|NCT00261846|155584582|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379603|NCT00261846|155584583|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379604|NCT00261846|155584584|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379605|NCT00261846|155584585|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379606|NCT00261846|155584586|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
48379607|NCT00261846|155584587|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379608|NCT00261846|155584588|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379609|NCT00261846|155584589|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
48379610|NCT00261846|155584578|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48379611|NCT00261846|155584579|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48379612|NCT00261846|155584580|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48379613|NCT00261846|155584581|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
48379614|NCT00261846|155584582|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
48379615|NCT00261846|155584583|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
48379616|NCT00261846|155584584|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
48425479|NCT01978912|155746825|FG001|Overall Study|Intradiscal Steroid Injection|1|||
48425480|NCT01978912|155746826|FG002|Overall Study|Intradiscal Steroid Injection|0|||
48425481|NCT01978912|155746827|FG003|Overall Study|Intradiscal Steroid Injection|0|||
48425482|NCT00224107|155746828|FG000|Overall Study|Adverse Event|20|||
48425483|NCT00224107|155746829|FG001|Overall Study|Adverse Event|6|||
48425484|NCT00224107|155746828|FG000|Overall Study|Protocol Violation|2|||
48425485|NCT00224107|155746829|FG001|Overall Study|Protocol Violation|3|||
48425486|NCT00224107|155746828|FG000|Overall Study|Withdrawal by Subject|1|||
48425487|NCT00224107|155746829|FG001|Overall Study|Withdrawal by Subject|4|||
48425488|NCT00224107|155746828|FG000|Overall Study|Lack of Efficacy|2|||
48425489|NCT00224107|155746829|FG001|Overall Study|Lack of Efficacy|0|||
48425490|NCT00224107|155746828|FG000|Overall Study|Lost to Follow-up|4|||
48379617|NCT00261846|155584585|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
48425491|NCT00224107|155746829|FG001|Overall Study|Lost to Follow-up|0|||
48425492|NCT00224107|155746828|FG000|Overall Study|Physician Decision|1|||
48425493|NCT00224107|155746829|FG001|Overall Study|Physician Decision|0|||
48425494|NCT00224107|155746828|FG000|Overall Study|Other|1|||
48379618|NCT00261846|155584586|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48379619|NCT00261846|155584587|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
48379620|NCT00261846|155584588|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48379621|NCT00261846|155584589|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
48379622|NCT00261846|155584578|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48379623|NCT00261846|155584579|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48379624|NCT00261846|155584580|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48379625|NCT00261846|155584581|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
48379626|NCT00261846|155584582|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
48379627|NCT00261846|155584583|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48379628|NCT00261846|155584584|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
48379629|NCT00261846|155584585|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48379630|NCT00261846|155584586|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
48379631|NCT00261846|155584587|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
48379632|NCT00261846|155584588|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
48379633|NCT00261846|155584589|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
48379634|NCT00261846|155584578|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
48379635|NCT00261846|155584579|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
48379636|NCT00261846|155584580|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
48379637|NCT00261846|155584581|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
48379638|NCT00261846|155584582|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
48379639|NCT00261846|155584583|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
48379640|NCT00261846|155584584|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
48379641|NCT00261846|155584585|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
48379642|NCT00261846|155584586|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
48379643|NCT00261846|155584587|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
48379644|NCT00261846|155584588|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
48379645|NCT00261846|155584589|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
48379646|NCT00261846|155584578|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
48379647|NCT00261846|155584579|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
48379648|NCT00261846|155584580|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
48379649|NCT00261846|155584581|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
48379650|NCT00261846|155584582|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
48379651|NCT00261846|155584583|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
48379652|NCT00261846|155584584|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
48379653|NCT00261846|155584585|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
48379654|NCT00261846|155584586|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
48379655|NCT00261846|155584587|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
48379656|NCT00261846|155584588|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
48379657|NCT00261846|155584589|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
48379658|NCT00261846|155584578|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
48379659|NCT00261846|155584579|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
48379660|NCT00261846|155584580|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
48379661|NCT00261846|155584581|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
48379662|NCT00261846|155584582|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
48379663|NCT00261846|155584583|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
48379664|NCT00261846|155584584|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
48379665|NCT00261846|155584585|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
48379666|NCT00261846|155584586|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
48379667|NCT00261846|155584587|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
48379668|NCT00261846|155584588|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
48379669|NCT00261846|155584589|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
48379670|NCT03093350|155584590|FG000|Overall Study|Death|1|||
48379671|NCT03093350|155584590|FG000|Overall Study|Signed consent, never began treartment|1|||
48379672|NCT04209621|155584591|FG000|Overall Study|Death|1|||
48379673|NCT04209621|155584591|FG000|Overall Study|Study Terminated Early|2|||
48379674|NCT00711529|155584602|FG000|Overall Study|Protocol Violation|2|||
48379675|NCT00711529|155584603|FG001|Overall Study|Protocol Violation|0|||
48379676|NCT00711529|155584602|FG000|Overall Study|Withdrawal by Subject|2|||
48379677|NCT00711529|155584603|FG001|Overall Study|Withdrawal by Subject|6|||
48379678|NCT03740997|155584604|FG000|Overall Study|Withdrawal by Subject|1|||
48379679|NCT03740997|155584605|FG001|Overall Study|Withdrawal by Subject|0|||
48379680|NCT03740997|155584604|FG000|Overall Study|Participant was unable to complete study procedures|1|||
48379681|NCT03740997|155584605|FG001|Overall Study|Participant was unable to complete study procedures|0|||
48379682|NCT01740323|155584606|FG000|Overall Study|Adverse Event|1|||
48379683|NCT01740323|155584607|FG001|Overall Study|Adverse Event|0|||
48379684|NCT01740323|155584606|FG000|Overall Study|Randomized but did not take study drug|1|||
48379685|NCT01740323|155584607|FG001|Overall Study|Randomized but did not take study drug|0|||
48379686|NCT00323297|155584608|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
48379687|NCT00323297|155584609|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
48379688|NCT00323297|155584608|FG000|Part A (Double Blind Randomized)|Death|0|||
48379689|NCT00323297|155584609|FG001|Part A (Double Blind Randomized)|Death|1|||
48379690|NCT00323297|155584608|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
48379691|NCT00323297|155584609|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
48379692|NCT00323297|155584608|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
48379693|NCT00323297|155584609|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
48379694|NCT00323297|155584608|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
48379695|NCT00323297|155584609|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
48379696|NCT00323297|155584608|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
48379697|NCT00323297|155584609|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
48379698|NCT00323297|155584608|FG000|Part B (Open-label)|Death|0|||
48379699|NCT00323297|155584609|FG001|Part B (Open-label)|Death|1|||
48379700|NCT00323297|155584608|FG000|Part B (Open-label)|Reason unspecified|0|||
48379701|NCT00323297|155584609|FG001|Part B (Open-label)|Reason unspecified|1|||
48379702|NCT00323297|155584608|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
48379703|NCT00323297|155584609|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
48379704|NCT00323297|155584608|FG000|Part B (Open-label)|Lack of Efficacy|3|||
48379705|NCT00323297|155584609|FG001|Part B (Open-label)|Lack of Efficacy|1|||
48379706|NCT00323297|155584608|FG000|Part B (Open-label)|Adverse Event|5|||
48379707|NCT00323297|155584609|FG001|Part B (Open-label)|Adverse Event|5|||
48379708|NCT00323297|155584608|FG000|Part B (Open-label)|Protocol Violation|0|||
48379709|NCT00323297|155584609|FG001|Part B (Open-label)|Protocol Violation|1|||
48379710|NCT01176773|155584610|FG000|Overall Study|Screen Failure|2|||
48379711|NCT01176773|155584610|FG000|Overall Study|Withdrew consent|1|||
48379712|NCT03181451|155584622|FG000|Overall Study|Adverse Event|0|||
48379713|NCT03181451|155584623|FG001|Overall Study|Adverse Event|1|||
48379714|NCT03181451|155584624|FG002|Overall Study|Adverse Event|0|||
48379715|NCT03181451|155584622|FG000|Overall Study|Withdrawal by Subject|0|||
48379716|NCT03181451|155584623|FG001|Overall Study|Withdrawal by Subject|1|||
48379717|NCT03181451|155584624|FG002|Overall Study|Withdrawal by Subject|0|||
48379718|NCT03681951|155584627|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
48379719|NCT03681951|155584628|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48379720|NCT03681951|155584629|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48379721|NCT03681951|155584630|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48379722|NCT03681951|155584631|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48379723|NCT03681951|155584632|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48379724|NCT03681951|155584633|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48379725|NCT03681951|155584634|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
48379726|NCT03681951|155584627|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
48379727|NCT03681951|155584628|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48379728|NCT03681951|155584629|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48379729|NCT03681951|155584630|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48379730|NCT03681951|155584631|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48379731|NCT03681951|155584632|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48379732|NCT03681951|155584633|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48379733|NCT03681951|155584634|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
48379734|NCT03681951|155584627|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
48379735|NCT03681951|155584628|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48379736|NCT03681951|155584629|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48379737|NCT03681951|155584630|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48379738|NCT03681951|155584631|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48379739|NCT03681951|155584632|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48379740|NCT03681951|155584633|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48379741|NCT03681951|155584634|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
48379742|NCT00628251|155584635|FG000|Randomised Part|Withdrawal by Subject|0|||
48379743|NCT00628251|155584636|FG001|Randomised Part|Withdrawal by Subject|0|||
48379744|NCT00628251|155584637|FG002|Randomised Part|Withdrawal by Subject|1|||
48379745|NCT00628251|155584635|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
48379746|NCT00628251|155584636|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
48379747|NCT00628251|155584637|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
48379748|NCT00628251|155584635|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
48379749|NCT00628251|155584636|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
48379750|NCT00628251|155584637|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
48379751|NCT00628251|155584635|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
48379752|NCT00628251|155584636|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
48379753|NCT00628251|155584637|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
48379754|NCT00628251|155584635|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
48379755|NCT00628251|155584636|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
48379756|NCT00628251|155584637|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
48379757|NCT00628251|155584635|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
48379758|NCT00628251|155584636|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
48379759|NCT00628251|155584637|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
48379760|NCT02743819|155584638|FG000|Overall Study|Lack of Efficacy|5|||
48379761|NCT02743819|155584638|FG000|Overall Study|Death|2|||
48379762|NCT02743819|155584638|FG000|Overall Study|Adverse Event|1|||
48379763|NCT01290601|155584640|FG000|Overall Study|Adverse Event|0|||
48379764|NCT01290601|155584641|FG001|Overall Study|Adverse Event|2|||
48379765|NCT01290601|155584642|FG002|Overall Study|Adverse Event|0|||
48379766|NCT01290601|155584643|FG003|Overall Study|Adverse Event|0|||
48379767|NCT01290601|155584640|FG000|Overall Study|Lack of Efficacy|2|||
48379768|NCT01290601|155584641|FG001|Overall Study|Lack of Efficacy|1|||
48379769|NCT01290601|155584642|FG002|Overall Study|Lack of Efficacy|0|||
48425495|NCT00224107|155746829|FG001|Overall Study|Other|1|||
48425496|NCT04220866|155746830|FG000|Overall Study|Death|4|||
48425497|NCT04220866|155746831|FG001|Overall Study|Death|5|||
48425498|NCT04220866|155746830|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
48425499|NCT04220866|155746831|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
48425500|NCT04220866|155746830|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
48425501|NCT04220866|155746831|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
48425502|NCT04220866|155746830|FG000|Overall Study|Withdrawal by Subject|0|||
48425503|NCT04220866|155746831|FG001|Overall Study|Withdrawal by Subject|1|||
48425504|NCT02225223|155746835|FG000|Overall Study|Death|10|||
48425505|NCT02225223|155746836|FG001|Overall Study|Death|1|||
48425506|NCT02225223|155746835|FG000|Overall Study|Lost to Follow-up|5|||
48425507|NCT02225223|155746836|FG001|Overall Study|Lost to Follow-up|0|||
48425508|NCT02225223|155746835|FG000|Overall Study|Other|1|||
48425509|NCT02225223|155746836|FG001|Overall Study|Other|2|||
48425510|NCT02225223|155746835|FG000|Overall Study|Physician Decision|1|||
48425511|NCT02225223|155746836|FG001|Overall Study|Physician Decision|0|||
48425512|NCT02225223|155746835|FG000|Overall Study|Withdrawal by Subject|2|||
48425513|NCT02225223|155746836|FG001|Overall Study|Withdrawal by Subject|2|||
48425514|NCT01650779|155746838|FG000|Overall Study|Withdrawal by Subject|1|||
48425515|NCT01996319|155746841|FG000|Overall Study|Protocol Violation|1|||
48425516|NCT01996319|155746842|FG001|Overall Study|Protocol Violation|0|||
48425517|NCT01996319|155746841|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
48425518|NCT01996319|155746842|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
48425519|NCT01996319|155746841|FG000|Overall Study|Adverse Event|2|||
48425520|NCT01996319|155746842|FG001|Overall Study|Adverse Event|2|||
48425521|NCT04003636|155746843|FG000|Overall Study|Death|409|||
48425522|NCT04003636|155746844|FG001|Overall Study|Death|443|||
48425523|NCT04003636|155746843|FG000|Overall Study|Lost to Follow-up|0|||
48425524|NCT04003636|155746844|FG001|Overall Study|Lost to Follow-up|1|||
48425525|NCT04003636|155746843|FG000|Overall Study|Withdrawal by Subject|5|||
48425526|NCT04003636|155746844|FG001|Overall Study|Withdrawal by Subject|2|||
48425527|NCT04003636|155746843|FG000|Overall Study|Participant On-going|119|||
48425528|NCT04003636|155746844|FG001|Overall Study|Participant On-going|90|||
48425529|NCT00117338|155746845|FG000|Overall Study|Adverse Event|0|||
48425530|NCT00117338|155746846|FG001|Overall Study|Adverse Event|1|||
48425531|NCT00117338|155746845|FG000|Overall Study|Protocol Violation|3|||
48425532|NCT00117338|155746846|FG001|Overall Study|Protocol Violation|2|||
48425533|NCT00117338|155746845|FG000|Overall Study|Withdrawal by Subject|1|||
48425534|NCT00117338|155746846|FG001|Overall Study|Withdrawal by Subject|0|||
48425535|NCT00117338|155746845|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
48425536|NCT00117338|155746846|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
48425537|NCT00117338|155746845|FG000|Overall Study|Lack of Efficacy|0|||
48425538|NCT00117338|155746846|FG001|Overall Study|Lack of Efficacy|1|||
48379770|NCT01290601|155584643|FG003|Overall Study|Lack of Efficacy|0|||
48379771|NCT01290601|155584640|FG000|Overall Study|Lost to Follow-up|7|||
48379772|NCT01290601|155584641|FG001|Overall Study|Lost to Follow-up|2|||
48379773|NCT01290601|155584642|FG002|Overall Study|Lost to Follow-up|0|||
48379774|NCT01290601|155584643|FG003|Overall Study|Lost to Follow-up|0|||
48379775|NCT01290601|155584640|FG000|Overall Study|Other|1|||
48379776|NCT01290601|155584641|FG001|Overall Study|Other|0|||
48379777|NCT01290601|155584642|FG002|Overall Study|Other|0|||
48379778|NCT01290601|155584643|FG003|Overall Study|Other|0|||
48379779|NCT01290601|155584640|FG000|Overall Study|Protocol Violation|1|||
48379780|NCT01290601|155584641|FG001|Overall Study|Protocol Violation|0|||
48379781|NCT01290601|155584642|FG002|Overall Study|Protocol Violation|0|||
48379782|NCT01290601|155584643|FG003|Overall Study|Protocol Violation|0|||
48379783|NCT01431534|155584644|FG000|Treatment Phase|Adverse Event|0|||
48379784|NCT01431534|155584645|FG001|Treatment Phase|Adverse Event|0|||
48379785|NCT01431534|155584646|FG002|Treatment Phase|Adverse Event|1|||
48379786|NCT01431534|155584644|FG000|Treatment Phase|Progressive Disease|4|||
48379787|NCT01431534|155584645|FG001|Treatment Phase|Progressive Disease|3|||
48379788|NCT01431534|155584646|FG002|Treatment Phase|Progressive Disease|10|||
48379789|NCT00752622|155584658|FG000|Induction Phase|Adverse Event|3|||
48379790|NCT00752622|155584658|FG000|Induction Phase|Other|3|||
48379791|NCT00752622|155584658|FG000|Induction Phase|Non-responder|14|||
48379792|NCT00752622|155584658|FG000|Induction Phase|Withdrawal by Subject|1|||
48379793|NCT00752622|155584658|FG000|Induction Phase|Premature study termination|14|||
48379794|NCT00752622|155584658|FG000|Observational Phase|Premature Study Termination|36|||
48379795|NCT00752622|155584658|FG000|Observational Phase|Non-responder|2|||
48379796|NCT00752622|155584658|FG000|Observational Phase|Withdrawal by Subject|2|||
48379797|NCT00752622|155584658|FG000|Observational Phase|Adverse Event|1|||
48379798|NCT00752622|155584658|FG000|Observational Phase|Other|2|||
48379799|NCT00752622|155584658|FG000|Interventional Phase|Non-responder|2|||
48379800|NCT00752622|155584658|FG000|Interventional Phase|Physician Decision|1|||
48379801|NCT00752622|155584658|FG000|Interventional Phase|Premature Study Termination|5|||
48379802|NCT00576836|155584659|FG000|Overall Study|Death|0|||
48379803|NCT00576836|155584660|FG001|Overall Study|Death|1|||
48379804|NCT00576836|155584659|FG000|Overall Study|Physician Decision|0|||
48379805|NCT00576836|155584660|FG001|Overall Study|Physician Decision|1|||
48379806|NCT01272947|155584661|FG000|Overall Study|Abnormal Laboratory Value|2|||
48379807|NCT01272947|155584662|FG001|Overall Study|Abnormal Laboratory Value|2|||
48425539|NCT01342640|155746847|FG000|Overall Study|Adverse Event|3|||
48425540|NCT01342640|155746847|FG000|Overall Study|Protocol Violation|16|||
48425541|NCT01342640|155746847|FG000|Overall Study|Lost to Follow-up|21|||
48425542|NCT01342640|155746847|FG000|Overall Study|Other|1|||
48425543|NCT02345434|155746850|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
48425544|NCT02345434|155746851|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
48425545|NCT03865407|155746852|FG000|Overall Study|Adverse Event|1|||
48425546|NCT03865407|155746853|FG001|Overall Study|Adverse Event|0|||
48425547|NCT03865407|155746852|FG000|Overall Study|Withdrawal by Subject|1|||
48425548|NCT03865407|155746853|FG001|Overall Study|Withdrawal by Subject|0|||
48425549|NCT03865407|155746852|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
48425550|NCT03865407|155746853|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
48425551|NCT02052960|155746854|FG000|Overall Study|Adverse Event|19|||
48425552|NCT02052960|155746855|FG001|Overall Study|Adverse Event|17|||
48425553|NCT02052960|155746854|FG000|Overall Study|Protocol Violation|4|||
48425554|NCT02052960|155746855|FG001|Overall Study|Protocol Violation|3|||
48425555|NCT02052960|155746854|FG000|Overall Study|Withdrawal by Subject|6|||
48425556|NCT02052960|155746855|FG001|Overall Study|Withdrawal by Subject|11|||
48425557|NCT02052960|155746854|FG000|Overall Study|Other|25|||
48425558|NCT02052960|155746855|FG001|Overall Study|Other|15|||
48425559|NCT01302041|155746856|FG000|Overall Study|Death|5|||
48425560|NCT01302041|155746856|FG000|Overall Study|Withdrawal by Subject|4|||
48425561|NCT01302041|155746856|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
48425562|NCT01302041|155746856|FG000|Overall Study|Other-Miscellaneous Reason|2|||
48425563|NCT03964415|155746857|FG000|Overall Study|Sponsor's decision|1563|||
48425564|NCT03964415|155746858|FG001|Overall Study|Sponsor's decision|1528|||
48425565|NCT03964415|155746857|FG000|Overall Study|Lost to Follow-up|139|||
48425566|NCT03964415|155746858|FG001|Overall Study|Lost to Follow-up|146|||
48425567|NCT03964415|155746857|FG000|Overall Study|Withdrawal by Subject|68|||
48425568|NCT03964415|155746858|FG001|Overall Study|Withdrawal by Subject|72|||
48425569|NCT03964415|155746857|FG000|Overall Study|Physician Decision|34|||
48425570|NCT03964415|155746858|FG001|Overall Study|Physician Decision|48|||
48425571|NCT03964415|155746857|FG000|Overall Study|Adverse Event|3|||
48425572|NCT03964415|155746858|FG001|Overall Study|Adverse Event|0|||
48425573|NCT03964415|155746857|FG000|Overall Study|Death|4|||
48425574|NCT03964415|155746858|FG001|Overall Study|Death|6|||
48425575|NCT03964415|155746857|FG000|Overall Study|Protocol Violation|1|||
48425576|NCT03964415|155746858|FG001|Overall Study|Protocol Violation|4|||
48425577|NCT03964415|155746857|FG000|Overall Study|Other|35|||
48425578|NCT03964415|155746858|FG001|Overall Study|Other|38|||
48425579|NCT03964415|155746857|FG000|Overall Study|Randomized but not treated|6|||
48425580|NCT03964415|155746858|FG001|Overall Study|Randomized but not treated|7|||
48425581|NCT00149825|155746859|FG000|Overall Study|Intolerance to medication side effects|1|||
48425582|NCT00149825|155746860|FG001|Overall Study|Intolerance to medication side effects|2|||
48425583|NCT00149825|155746859|FG000|Overall Study|Time commitments|2|||
48425584|NCT00149825|155746860|FG001|Overall Study|Time commitments|1|||
48425585|NCT00149825|155746859|FG000|Overall Study|Not liking insomnia therapy|1|||
48425586|NCT00149825|155746860|FG001|Overall Study|Not liking insomnia therapy|0|||
48425587|NCT00149825|155746859|FG000|Overall Study|Other|1|||
48425588|NCT00149825|155746860|FG001|Overall Study|Other|0|||
48425589|NCT02983292|155746861|FG000|Overall Study|Participant unwell & cannot travel|2|||
48425590|NCT02983292|155746861|FG000|Overall Study|Lost to Follow-up|3|||
48425591|NCT02983292|155746861|FG000|Overall Study|Participant withdrew consent|2|||
48425592|NCT02983292|155746861|FG000|Overall Study|Revision|7|||
48425593|NCT02983292|155746861|FG000|Overall Study|Death|1|||
48425594|NCT02983292|155746861|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
48425595|NCT02983292|155746861|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
48425596|NCT02983292|155746861|FG000|Overall Study|Participant relocation|1|||
48425597|NCT01004146|155746871|FG000|Overall Study|Withdrawal by Subject|4|||
48425598|NCT01004146|155746872|FG001|Overall Study|Withdrawal by Subject|5|||
48425599|NCT01952015|155746875|FG000|Induction|Protocol Violation|1|||
48425600|NCT01952015|155746875|FG000|Maintenance|Adverse Event|2|||
48425601|NCT01952015|155746875|FG000|Treatment Period 3|Physician Decision|9|||
48425602|NCT01413178|155746876|FG000|Overall Study|Toxicity|1|||
48425603|NCT01413178|155746877|FG001|Overall Study|Toxicity|0|||
48425604|NCT01413178|155746876|FG000|Overall Study|Ineligible|0|||
48425605|NCT01413178|155746877|FG001|Overall Study|Ineligible|2|||
48425606|NCT00576693|155746878|FG000|Overall Study|Lost to Follow-up|7|||
48425607|NCT00576693|155746879|FG001|Overall Study|Lost to Follow-up|11|||
48425608|NCT00576693|155746878|FG000|Overall Study|Withdrawal by Subject|3|||
48425609|NCT00576693|155746879|FG001|Overall Study|Withdrawal by Subject|13|||
48425610|NCT04973228|155746880|FG000|Overall Study|Adverse Event|2|||
48425611|NCT04973228|155746881|FG001|Overall Study|Adverse Event|3|||
48425612|NCT04973228|155746880|FG000|Overall Study|Lack of Efficacy|1|||
48425613|NCT04973228|155746881|FG001|Overall Study|Lack of Efficacy|3|||
48425614|NCT04973228|155746880|FG000|Overall Study|Lost to Follow-up|12|||
48425615|NCT04973228|155746881|FG001|Overall Study|Lost to Follow-up|4|||
48425616|NCT04973228|155746880|FG000|Overall Study|Withdrawal by Subject|11|||
48425617|NCT04973228|155746881|FG001|Overall Study|Withdrawal by Subject|4|||
48425618|NCT04973228|155746880|FG000|Overall Study|Did not tolerate application|1|||
48425619|NCT04973228|155746881|FG001|Overall Study|Did not tolerate application|0|||
48425620|NCT04973228|155746880|FG000|Overall Study|Wanted to early terminate and use own product|0|||
48425621|NCT04973228|155746881|FG001|Overall Study|Wanted to early terminate and use own product|1|||
48425622|NCT04973228|155746880|FG000|Overall Study|Missed visits due to new work schedule|1|||
48425623|NCT04973228|155746881|FG001|Overall Study|Missed visits due to new work schedule|0|||
48425624|NCT03090737|155746882|FG000|Overall Study|Other reasons|1|||
48425625|NCT03090737|155746882|FG000|Overall Study|Completed treatment as per protocol|17|||
48425626|NCT03090737|155746882|FG000|Overall Study|Maximum clinical benefit|2|||
48425627|NCT03090737|155746882|FG000|Overall Study|Adverse event unrelated to study drug|7|||
48425628|NCT03090737|155746882|FG000|Overall Study|Study drug toxicity|4|||
48425629|NCT03090737|155746882|FG000|Overall Study|Disease progression|98|||
48425630|NCT00227877|155746883|FG000|Pre-visit Assessment|Technical difficulties|7|||
48425631|NCT00227877|155746884|FG001|Pre-visit Assessment|Technical difficulties|3|||
48425632|NCT00227877|155746885|FG002|Pre-visit Assessment|Technical difficulties|0|||
48425633|NCT00227877|155746886|FG003|Pre-visit Assessment|Technical difficulties|0|||
48425634|NCT00227877|155746883|FG000|Post-visit Checklist|Lost to Follow-up|24|||
48425635|NCT00227877|155746884|FG001|Post-visit Checklist|Lost to Follow-up|13|||
48425636|NCT00227877|155746885|FG002|Post-visit Checklist|Lost to Follow-up|1|||
48425637|NCT00227877|155746886|FG003|Post-visit Checklist|Lost to Follow-up|0|||
48425638|NCT00227877|155746883|FG000|3-months Follow-up|Completed late|135|||
48425639|NCT00227877|155746884|FG001|3-months Follow-up|Completed late|128|||
48425640|NCT00227877|155746885|FG002|3-months Follow-up|Completed late|34|||
48425641|NCT00227877|155746886|FG003|3-months Follow-up|Completed late|8|||
48425642|NCT00227877|155746883|FG000|3-months Follow-up|Lost to Follow-up|178|||
48425643|NCT00227877|155746884|FG001|3-months Follow-up|Lost to Follow-up|139|||
48425644|NCT00227877|155746885|FG002|3-months Follow-up|Lost to Follow-up|18|||
48425645|NCT00227877|155746886|FG003|3-months Follow-up|Lost to Follow-up|13|||
48425646|NCT00227877|155746883|FG000|12-months Follow-up|Completed late|78|||
48425647|NCT00227877|155746884|FG001|12-months Follow-up|Completed late|74|||
48425648|NCT00227877|155746885|FG002|12-months Follow-up|Completed late|1|||
48425649|NCT00227877|155746886|FG003|12-months Follow-up|Completed late|0|||
48425650|NCT00227877|155746883|FG000|12-months Follow-up|Lost to Follow-up|232|||
48425651|NCT00227877|155746884|FG001|12-months Follow-up|Lost to Follow-up|189|||
48425652|NCT00227877|155746885|FG002|12-months Follow-up|Lost to Follow-up|30|||
48425653|NCT00227877|155746886|FG003|12-months Follow-up|Lost to Follow-up|26|||
48425654|NCT04952389|155746887|FG000|Overall Study|Withdrawal by Subject|8|||
48425655|NCT04952389|155746888|FG001|Overall Study|Withdrawal by Subject|4|||
48425656|NCT02239094|155746889|FG000|Overall Study|Withdrawal by Subject|1|||
48425657|NCT02239094|155746889|FG000|Overall Study|Remitted before started|1|||
48425658|NCT02050048|155746890|FG000|Overall Study|Lost to Follow-up|0|||
48425659|NCT02050048|155746891|FG001|Overall Study|Lost to Follow-up|1|||
48425660|NCT02050048|155746890|FG000|Overall Study|Death|1|||
48425661|NCT02050048|155746891|FG001|Overall Study|Death|0|||
48425662|NCT02050048|155746890|FG000|Overall Study|Ineligible after ERCP|4|||
48425663|NCT02050048|155746891|FG001|Overall Study|Ineligible after ERCP|1|||
48425664|NCT01903434|155746897|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
48425665|NCT01903434|155746898|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
48425666|NCT01903434|155746897|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
48425667|NCT01903434|155746898|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
48425668|NCT01469052|155746899|FG000|Overall Study|Adverse Event|2|||
48425669|NCT01469052|155746900|FG001|Overall Study|Adverse Event|3|||
48425670|NCT01469052|155746901|FG002|Overall Study|Adverse Event|0|||
48425671|NCT01469052|155746902|FG003|Overall Study|Adverse Event|2|||
48425672|NCT01469052|155746903|FG004|Overall Study|Adverse Event|0|||
48425673|NCT01469052|155746904|FG005|Overall Study|Adverse Event|1|||
48425674|NCT01469052|155746899|FG000|Overall Study|Progressive disease|3|||
48425675|NCT01469052|155746900|FG001|Overall Study|Progressive disease|0|||
48425676|NCT01469052|155746901|FG002|Overall Study|Progressive disease|5|||
48425677|NCT01469052|155746902|FG003|Overall Study|Progressive disease|3|||
48425678|NCT01469052|155746903|FG004|Overall Study|Progressive disease|7|||
48425679|NCT01469052|155746904|FG005|Overall Study|Progressive disease|2|||
48425680|NCT01469052|155746899|FG000|Overall Study|Lack of Efficacy|0|||
48425681|NCT01469052|155746900|FG001|Overall Study|Lack of Efficacy|0|||
48425682|NCT01469052|155746901|FG002|Overall Study|Lack of Efficacy|0|||
48425683|NCT01469052|155746902|FG003|Overall Study|Lack of Efficacy|0|||
48425684|NCT01469052|155746903|FG004|Overall Study|Lack of Efficacy|0|||
48425685|NCT01469052|155746904|FG005|Overall Study|Lack of Efficacy|2|||
48425686|NCT01469052|155746899|FG000|Overall Study|Moved to rollover protocol|1|||
48425687|NCT01469052|155746900|FG001|Overall Study|Moved to rollover protocol|0|||
48425688|NCT01469052|155746901|FG002|Overall Study|Moved to rollover protocol|1|||
48425689|NCT01469052|155746902|FG003|Overall Study|Moved to rollover protocol|0|||
48425690|NCT01469052|155746903|FG004|Overall Study|Moved to rollover protocol|0|||
48425691|NCT01469052|155746904|FG005|Overall Study|Moved to rollover protocol|1|||
48425692|NCT01469052|155746899|FG000|Overall Study|Other|0|||
48425693|NCT01469052|155746900|FG001|Overall Study|Other|1|||
48425694|NCT01469052|155746901|FG002|Overall Study|Other|0|||
48425695|NCT01469052|155746902|FG003|Overall Study|Other|0|||
48425696|NCT01469052|155746903|FG004|Overall Study|Other|1|||
48425697|NCT01469052|155746904|FG005|Overall Study|Other|0|||
48425698|NCT03141307|155746905|FG000|In-Hospital|Withdrawal by Subject|0|||
48425699|NCT03141307|155746906|FG001|In-Hospital|Withdrawal by Subject|2|||
48425700|NCT03141307|155746905|FG000|In-Hospital|Protocol Violation|4|||
48425701|NCT03141307|155746906|FG001|In-Hospital|Protocol Violation|0|||
48425702|NCT03141307|155746905|FG000|Follow-Up|Lost to Follow-up|97|||
48425703|NCT03141307|155746906|FG001|Follow-Up|Lost to Follow-up|54|||
48425704|NCT01597193|155746909|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
48425705|NCT01597193|155746910|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
48425706|NCT01597193|155746911|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48425707|NCT01597193|155746912|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48425708|NCT01597193|155746913|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48425709|NCT01597193|155746914|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48425710|NCT01597193|155746915|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
48425711|NCT01597193|155746909|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
48425712|NCT01597193|155746910|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
48425713|NCT01597193|155746911|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
48425714|NCT01597193|155746912|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
48425715|NCT01597193|155746913|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
48425716|NCT01597193|155746914|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
48425717|NCT01597193|155746915|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
48425718|NCT01597193|155746909|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
48425719|NCT01597193|155746910|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
48425720|NCT01597193|155746911|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
48425721|NCT01597193|155746912|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
48425722|NCT01597193|155746913|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
48425723|NCT01597193|155746914|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
48425724|NCT01597193|155746915|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
48425725|NCT01597193|155746909|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48425726|NCT01597193|155746910|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48425727|NCT01597193|155746911|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48425728|NCT01597193|155746912|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48425729|NCT01597193|155746913|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48425730|NCT01597193|155746914|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
48425731|NCT01597193|155746915|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
48425732|NCT01597193|155746909|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48425733|NCT01597193|155746910|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48425734|NCT01597193|155746911|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48425735|NCT01597193|155746912|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
48425736|NCT01597193|155746913|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48425737|NCT01597193|155746914|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
48425738|NCT01597193|155746915|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
48425739|NCT01522651|155746916|FG000|Overall Study|Adverse Event|3|||
48425740|NCT01522651|155746917|FG001|Overall Study|Adverse Event|4|||
48425741|NCT01522651|155746918|FG002|Overall Study|Adverse Event|4|||
48425742|NCT01522651|155746919|FG003|Overall Study|Adverse Event|5|||
48425743|NCT01522651|155746920|FG004|Overall Study|Adverse Event|4|||
48425744|NCT01522651|155746916|FG000|Overall Study|Cardioversion|1|||
48425745|NCT01522651|155746917|FG001|Overall Study|Cardioversion|0|||
48425746|NCT01522651|155746918|FG002|Overall Study|Cardioversion|0|||
48425747|NCT01522651|155746919|FG003|Overall Study|Cardioversion|0|||
48425748|NCT01522651|155746920|FG004|Overall Study|Cardioversion|0|||
48425749|NCT01522651|155746916|FG000|Overall Study|Device Malfunction|0|||
48425750|NCT01522651|155746917|FG001|Overall Study|Device Malfunction|1|||
48425751|NCT01522651|155746918|FG002|Overall Study|Device Malfunction|0|||
48425752|NCT01522651|155746919|FG003|Overall Study|Device Malfunction|0|||
48425753|NCT01522651|155746920|FG004|Overall Study|Device Malfunction|0|||
48425754|NCT01522651|155746916|FG000|Overall Study|Investigator's Discretion|0|||
48425755|NCT01522651|155746917|FG001|Overall Study|Investigator's Discretion|1|||
48425756|NCT01522651|155746918|FG002|Overall Study|Investigator's Discretion|0|||
48425757|NCT01522651|155746919|FG003|Overall Study|Investigator's Discretion|0|||
48425758|NCT01522651|155746920|FG004|Overall Study|Investigator's Discretion|0|||
48425759|NCT01522651|155746916|FG000|Overall Study|Protocol Violation|3|||
48425760|NCT01522651|155746917|FG001|Overall Study|Protocol Violation|0|||
48425761|NCT01522651|155746918|FG002|Overall Study|Protocol Violation|0|||
48425762|NCT01522651|155746919|FG003|Overall Study|Protocol Violation|0|||
48425763|NCT01522651|155746920|FG004|Overall Study|Protocol Violation|0|||
48425764|NCT01522651|155746916|FG000|Overall Study|Reason Not Specified|0|||
48425765|NCT01522651|155746917|FG001|Overall Study|Reason Not Specified|0|||
48425766|NCT01522651|155746918|FG002|Overall Study|Reason Not Specified|0|||
48425767|NCT01522651|155746919|FG003|Overall Study|Reason Not Specified|1|||
48425768|NCT01522651|155746920|FG004|Overall Study|Reason Not Specified|0|||
48425769|NCT01522651|155746916|FG000|Overall Study|Participant Non-Compliance|1|||
48425770|NCT01522651|155746917|FG001|Overall Study|Participant Non-Compliance|0|||
48425771|NCT01522651|155746918|FG002|Overall Study|Participant Non-Compliance|0|||
48425772|NCT01522651|155746919|FG003|Overall Study|Participant Non-Compliance|0|||
48425773|NCT01522651|155746920|FG004|Overall Study|Participant Non-Compliance|0|||
48425774|NCT01522651|155746916|FG000|Overall Study|Withdrew Consent|1|||
48425775|NCT01522651|155746917|FG001|Overall Study|Withdrew Consent|1|||
48425776|NCT01522651|155746918|FG002|Overall Study|Withdrew Consent|0|||
48425777|NCT01522651|155746919|FG003|Overall Study|Withdrew Consent|1|||
48425778|NCT01522651|155746920|FG004|Overall Study|Withdrew Consent|1|||
48425779|NCT01522651|155746916|FG000|Overall Study|Randomized but Never Treated|0|||
48425780|NCT01522651|155746917|FG001|Overall Study|Randomized but Never Treated|1|||
48425781|NCT01522651|155746918|FG002|Overall Study|Randomized but Never Treated|0|||
48425782|NCT01522651|155746919|FG003|Overall Study|Randomized but Never Treated|1|||
48425783|NCT01522651|155746920|FG004|Overall Study|Randomized but Never Treated|1|||
48425784|NCT02508701|155746921|FG000|Overall Study|Lost to Follow-up|9|||
48425785|NCT02508701|155746922|FG001|Overall Study|Lost to Follow-up|5|||
48425786|NCT02508701|155746923|FG002|Overall Study|Lost to Follow-up|5|||
48425787|NCT02508701|155746924|FG003|Overall Study|Lost to Follow-up|3|||
48425788|NCT03184701|155746925|FG000|Overall Study|Death|3|||
48425789|NCT03184701|155746925|FG000|Overall Study|Physician Decision|3|||
48425790|NCT03184701|155746925|FG000|Overall Study|Withdrawal by Subject|6|||
48425791|NCT03184701|155746925|FG000|Overall Study|Lost to Follow-up|5|||
48425792|NCT04773041|155746937|FG000|Overall Study|Unable to data match|1|||
48425793|NCT04773041|155746938|FG001|Overall Study|Unable to data match|0|||
48425794|NCT04773041|155746939|FG002|Overall Study|Unable to data match|0|||
48425795|NCT00151411|155748224|FG000|Overall Study|Lost to Follow-up|15|||
48425796|NCT00151411|155748225|FG001|Overall Study|Lost to Follow-up|19|||
48425797|NCT00151411|155748224|FG000|Overall Study|Withdrawal by Subject|12|||
48425798|NCT00151411|155748225|FG001|Overall Study|Withdrawal by Subject|20|||
48425799|NCT00151411|155748224|FG000|Overall Study|Adverse Event|6|||
48425800|NCT00151411|155748225|FG001|Overall Study|Adverse Event|0|||
48425801|NCT00151411|155748224|FG000|Overall Study|Pregnancy|0|||
48425802|NCT00151411|155748225|FG001|Overall Study|Pregnancy|4|||
48425803|NCT02601001|155748226|FG000|Dosing Period 2|Adverse Event|0|||
48425804|NCT02601001|155748227|FG001|Dosing Period 2|Adverse Event|0|||
48425805|NCT02601001|155748228|FG002|Dosing Period 2|Adverse Event|0|||
48425806|NCT02601001|155748229|FG003|Dosing Period 2|Adverse Event|0|||
48425807|NCT02601001|155748230|FG004|Dosing Period 2|Adverse Event|0|||
48425808|NCT02601001|155748231|FG005|Dosing Period 2|Adverse Event|0|||
48425809|NCT02601001|155748232|FG006|Dosing Period 2|Adverse Event|1|||
48425810|NCT00417612|155748238|FG000|Overall Study|Errant diagnosis|0|||
48425811|NCT00417612|155748239|FG001|Overall Study|Errant diagnosis|1|||
48425812|NCT00417612|155748238|FG000|Overall Study|Adverse Event|2|||
48425813|NCT00417612|155748239|FG001|Overall Study|Adverse Event|0|||
48425814|NCT00417612|155748238|FG000|Overall Study|Protocol Violation|0|||
48425815|NCT00417612|155748239|FG001|Overall Study|Protocol Violation|2|||
48425816|NCT00417612|155748238|FG000|Overall Study|Lost to Follow-up|1|||
48425817|NCT00417612|155748239|FG001|Overall Study|Lost to Follow-up|0|||
48425818|NCT01713036|155748240|FG000|Overall Study|Death|1|||
48425819|NCT00634543|155748241|FG000|Overall Study|Other|1|||
48425820|NCT00634543|155748242|FG001|Overall Study|Other|2|||
48425821|NCT00634543|155748241|FG000|Overall Study|Protocol Violation|3|||
48425822|NCT00634543|155748242|FG001|Overall Study|Protocol Violation|3|||
48425823|NCT00634543|155748241|FG000|Overall Study|Adverse Event|11|||
48425824|NCT00634543|155748242|FG001|Overall Study|Adverse Event|11|||
48425825|NCT00634543|155748241|FG000|Overall Study|Withdrawal by Subject|4|||
48425826|NCT00634543|155748242|FG001|Overall Study|Withdrawal by Subject|4|||
48425827|NCT00634543|155748241|FG000|Overall Study|Lost to Follow-up|0|||
48425828|NCT00634543|155748242|FG001|Overall Study|Lost to Follow-up|1|||
48425829|NCT00077623|155748245|FG000|Overall Study|Adverse Event|1|||
48425830|NCT00077623|155748246|FG001|Overall Study|Adverse Event|0|||
48425831|NCT00077623|155748247|FG002|Overall Study|Adverse Event|1|||
48425832|NCT00077623|155748245|FG000|Overall Study|Withdrawal by Subject|2|||
48425833|NCT00077623|155748246|FG001|Overall Study|Withdrawal by Subject|10|||
48425834|NCT00077623|155748247|FG002|Overall Study|Withdrawal by Subject|1|||
48425835|NCT00077623|155748245|FG000|Overall Study|Other-Non safety reason|18|||
48425836|NCT00077623|155748246|FG001|Overall Study|Other-Non safety reason|15|||
48425837|NCT00077623|155748247|FG002|Overall Study|Other-Non safety reason|19|||
48425838|NCT00077623|155748245|FG000|Overall Study|Insufficient therapeutic response|2|||
48425839|NCT00077623|155748246|FG001|Overall Study|Insufficient therapeutic response|0|||
48425840|NCT00077623|155748247|FG002|Overall Study|Insufficient therapeutic response|0|||
48425841|NCT00077623|155748245|FG000|Overall Study|Death|12|||
48425842|NCT00077623|155748246|FG001|Overall Study|Death|18|||
48425843|NCT00077623|155748247|FG002|Overall Study|Death|11|||
48425844|NCT00077623|155748245|FG000|Overall Study|Failure to return|1|||
48425845|NCT00077623|155748246|FG001|Overall Study|Failure to return|0|||
48425846|NCT00077623|155748247|FG002|Overall Study|Failure to return|0|||
48425847|NCT02401256|155748248|FG000|Overall Study|Adverse Event|5|||
48425848|NCT02401256|155748248|FG000|Overall Study|Withdrawal by Subject|12|||
48425849|NCT00641043|155748251|FG000|Overall Study|Adverse Event|6|||
48425850|NCT00641043|155748252|FG001|Overall Study|Adverse Event|4|||
48425851|NCT00641043|155748251|FG000|Overall Study|Protocol Violation|2|||
48425852|NCT00641043|155748252|FG001|Overall Study|Protocol Violation|3|||
48425853|NCT00641043|155748251|FG000|Overall Study|Lost to Follow-up|3|||
48425854|NCT00641043|155748252|FG001|Overall Study|Lost to Follow-up|2|||
48425855|NCT00641043|155748251|FG000|Overall Study|Withdrawal by Subject|4|||
48425856|NCT00641043|155748252|FG001|Overall Study|Withdrawal by Subject|4|||
48425857|NCT00641043|155748251|FG000|Overall Study|Other incl. lack of efficacy|4|||
48425858|NCT00641043|155748252|FG001|Overall Study|Other incl. lack of efficacy|2|||
48425859|NCT00474630|155748253|FG000|Overall Study|Adverse Event|98|||
48425860|NCT00474630|155748254|FG001|Overall Study|Adverse Event|26|||
48425861|NCT00474630|155748253|FG000|Overall Study|Lost to Follow-up|22|||
48425862|NCT00474630|155748254|FG001|Overall Study|Lost to Follow-up|15|||
48425863|NCT00474630|155748253|FG000|Overall Study|Withdrawal by Subject|21|||
48425864|NCT00474630|155748254|FG001|Overall Study|Withdrawal by Subject|15|||
48425865|NCT00474630|155748253|FG000|Overall Study|Protocol Violation|3|||
48425866|NCT00474630|155748254|FG001|Overall Study|Protocol Violation|4|||
48425867|NCT00474630|155748253|FG000|Overall Study|Lack of Efficacy|5|||
48425868|NCT00474630|155748254|FG001|Overall Study|Lack of Efficacy|6|||
48425869|NCT00474630|155748253|FG000|Overall Study|Drug noncompliance, other|11|||
48425870|NCT00474630|155748254|FG001|Overall Study|Drug noncompliance, other|4|||
48425871|NCT03666143|155748255|FG000|Overall Study|Death|158|||
48425872|NCT03666143|155748255|FG000|Overall Study|Sponsor Decision|31|||
48425873|NCT03666143|155748255|FG000|Overall Study|Withdrawal by Subject|11|||
48425874|NCT03666143|155748255|FG000|Overall Study|Lost to Follow-up|5|||
48425875|NCT03666143|155748255|FG000|Overall Study|Physician Decision|1|||
48425876|NCT03666143|155748255|FG000|Overall Study|Rolled into extension study|9|||
48425877|NCT03666143|155748255|FG000|Overall Study|Progressive Disease|1|||
48425878|NCT02747043|155748258|FG000|Overall Study|Other|1|||
48425879|NCT02747043|155748259|FG001|Overall Study|Other|1|||
48425880|NCT02747043|155748258|FG000|Overall Study|Adverse Event|3|||
48425881|NCT02747043|155748259|FG001|Overall Study|Adverse Event|1|||
48425882|NCT02747043|155748258|FG000|Overall Study|Withdrawal by Subject|1|||
48425883|NCT02747043|155748259|FG001|Overall Study|Withdrawal by Subject|1|||
48425884|NCT02747043|155748258|FG000|Overall Study|Physician Decision|1|||
48425885|NCT02747043|155748259|FG001|Overall Study|Physician Decision|1|||
48425886|NCT02747043|155748258|FG000|Overall Study|Protocol Violation|0|||
48425887|NCT02747043|155748259|FG001|Overall Study|Protocol Violation|1|||
48425888|NCT02747043|155748258|FG000|Overall Study|Disease progression|4|||
48425889|NCT02747043|155748259|FG001|Overall Study|Disease progression|0|||
48425890|NCT01936649|155748260|FG000|Overall Study|Withdrawal by Subject|4|||
48425891|NCT01936649|155748260|FG000|Overall Study|Physician Decision|2|||
48425892|NCT01936649|155748260|FG000|Overall Study|Protocol Violation|2|||
48425893|NCT01936649|155748260|FG000|Overall Study|Other than specified above|5|||
48425894|NCT01512368|155748263|FG000|Overall Study|Protocol Violation|3|||
48425895|NCT00718861|155748265|FG000|Overall Study|Withdrawal by Subject|15|||
48425896|NCT00718861|155748266|FG001|Overall Study|Withdrawal by Subject|10|||
48425897|NCT00718861|155748265|FG000|Overall Study|Adverse Event|2|||
48425898|NCT00718861|155748266|FG001|Overall Study|Adverse Event|1|||
48425899|NCT00718861|155748265|FG000|Overall Study|Lost to Follow-up|2|||
48425900|NCT00718861|155748266|FG001|Overall Study|Lost to Follow-up|1|||
48425901|NCT00718861|155748265|FG000|Overall Study|Administrative Problems|1|||
48425902|NCT00718861|155748266|FG001|Overall Study|Administrative Problems|1|||
48425903|NCT00718861|155748265|FG000|Overall Study|Death|1|||
48425904|NCT00718861|155748266|FG001|Overall Study|Death|5|||
48425905|NCT02460822|155748272|FG000|Overall Study|Withdrawal by Subject|1|||
48425906|NCT02805907|155748275|FG000|Overall Study|Lost to Follow-up|3|||
48425907|NCT02805907|155748276|FG001|Overall Study|Lost to Follow-up|3|||
48425908|NCT01797783|155748278|FG000|Overall Study|Adverse Event|1|||
48425909|NCT01797783|155748279|FG001|Overall Study|Adverse Event|1|||
48425910|NCT01797783|155748278|FG000|Overall Study|Withdrawal by Subject|1|||
48425911|NCT01797783|155748279|FG001|Overall Study|Withdrawal by Subject|0|||
48425912|NCT02075255|155748280|FG000|Overall Study|Study specific withdrawal criteria|0|||
48425913|NCT02075255|155748281|FG001|Overall Study|Study specific withdrawal criteria|1|||
48425914|NCT02075255|155748282|FG002|Overall Study|Study specific withdrawal criteria|1|||
48425915|NCT02075255|155748280|FG000|Overall Study|Withdrawal by Subject|4|||
48425916|NCT02075255|155748281|FG001|Overall Study|Withdrawal by Subject|1|||
48425917|NCT02075255|155748282|FG002|Overall Study|Withdrawal by Subject|0|||
48425918|NCT02075255|155748280|FG000|Overall Study|Lost to Follow-up|0|||
48425919|NCT02075255|155748281|FG001|Overall Study|Lost to Follow-up|0|||
48425920|NCT02075255|155748282|FG002|Overall Study|Lost to Follow-up|1|||
48425921|NCT02075255|155748280|FG000|Overall Study|Adverse Event|0|||
48425922|NCT02075255|155748281|FG001|Overall Study|Adverse Event|0|||
48425923|NCT02075255|155748282|FG002|Overall Study|Adverse Event|1|||
48425924|NCT02075255|155748280|FG000|Overall Study|Death|0|||
48425925|NCT02075255|155748281|FG001|Overall Study|Death|2|||
48425926|NCT02075255|155748282|FG002|Overall Study|Death|0|||
48425927|NCT01302769|155748283|FG000|Overall Study|Lost to Follow-up|1|||
48425928|NCT01302769|155748284|FG001|Overall Study|Lost to Follow-up|1|||
48425929|NCT00309777|155748290|FG000|Overall Study|Adverse Event|13|||
48425930|NCT00309777|155748291|FG001|Overall Study|Adverse Event|2|||
48425931|NCT00309777|155748292|FG002|Overall Study|Adverse Event|8|||
48425932|NCT00309777|155748293|FG003|Overall Study|Adverse Event|1|||
48425933|NCT00309777|155748290|FG000|Overall Study|Protocol Violation|4|||
48425934|NCT00309777|155748291|FG001|Overall Study|Protocol Violation|1|||
48425935|NCT00309777|155748292|FG002|Overall Study|Protocol Violation|3|||
48425936|NCT00309777|155748293|FG003|Overall Study|Protocol Violation|1|||
48425937|NCT00309777|155748290|FG000|Overall Study|Withdrawal by Subject|6|||
48425938|NCT00309777|155748291|FG001|Overall Study|Withdrawal by Subject|5|||
48425939|NCT00309777|155748292|FG002|Overall Study|Withdrawal by Subject|7|||
48425940|NCT00309777|155748293|FG003|Overall Study|Withdrawal by Subject|2|||
48425941|NCT00309777|155748290|FG000|Overall Study|Lost to Follow-up|0|||
48425942|NCT00309777|155748291|FG001|Overall Study|Lost to Follow-up|0|||
48425943|NCT00309777|155748292|FG002|Overall Study|Lost to Follow-up|1|||
48425944|NCT00309777|155748293|FG003|Overall Study|Lost to Follow-up|0|||
48425945|NCT00309777|155748290|FG000|Overall Study|Death|0|||
48425946|NCT00309777|155748291|FG001|Overall Study|Death|1|||
48425947|NCT00309777|155748292|FG002|Overall Study|Death|0|||
48425948|NCT00309777|155748293|FG003|Overall Study|Death|0|||
48425949|NCT03494725|155748294|FG000|Overall Study|Withdrawal by Subject|0|||
48425950|NCT03494725|155748295|FG001|Overall Study|Withdrawal by Subject|2|||
48425951|NCT03494725|155748294|FG000|Overall Study|Antibiotic use|1|||
48425952|NCT03494725|155748295|FG001|Overall Study|Antibiotic use|0|||
48425953|NCT02853331|155748296|FG000|Overall Study|Death|59|||
48425954|NCT02853331|155748297|FG001|Overall Study|Death|95|||
48425955|NCT02853331|155748296|FG000|Overall Study|Withdrawal by Subject|5|||
48425956|NCT02853331|155748297|FG001|Overall Study|Withdrawal by Subject|9|||
48425957|NCT02853331|155748296|FG000|Overall Study|Ongoing in study|368|||
48425958|NCT02853331|155748297|FG001|Overall Study|Ongoing in study|325|||
48425959|NCT02062151|155748298|FG000|Overall Study|screen failure|1|||
48425960|NCT02335450|155748299|FG000|Overall Study|Pregnancy|1|||
48425961|NCT00455858|155748302|FG000|Overall Study|Lost to Follow-up|2|||
48425962|NCT00455858|155748302|FG000|Overall Study|Protocol Violation|1|||
48425963|NCT00455858|155748302|FG000|Overall Study|Lack of Efficacy|1|||
48425964|NCT00455858|155748302|FG000|Overall Study|Well controlled FPG without insulin|1|||
48425965|NCT00455858|155748302|FG000|Overall Study|Withdrawal|1|||
48425966|NCT05258058|155748303|FG000|Overall Study|Withdrawal by Subject|2|||
48425967|NCT01797432|155748310|FG000|Overall Study|Lost to Follow-up|1|||
48425968|NCT01797432|155748310|FG000|Overall Study|Adverse Event|1|||
48425969|NCT01797432|155748310|FG000|Overall Study|Withdrawal by Subject|1|||
48425970|NCT01797432|155748310|FG000|Overall Study|lived too far from study site|1|||
48425971|NCT03648996|155748312|FG000|Overall Study|Withdrawal by Subject|0|||
48425972|NCT03648996|155748313|FG001|Overall Study|Withdrawal by Subject|2|||
48425973|NCT03648996|155748314|FG002|Overall Study|Withdrawal by Subject|2|||
48425974|NCT03648996|155748312|FG000|Overall Study|Physician Decision|2|||
48425975|NCT03648996|155748313|FG001|Overall Study|Physician Decision|0|||
48425976|NCT03648996|155748314|FG002|Overall Study|Physician Decision|0|||
48425977|NCT00590681|155748324|FG000|Overall Study|Withdrawal by Subject|7|||
48425978|NCT00590681|155748324|FG000|Overall Study|Adverse Event|8|||
48425979|NCT00590681|155748324|FG000|Overall Study|Death|3|||
48425980|NCT00590681|155748324|FG000|Overall Study|Lost to Follow-up|1|||
48425981|NCT00590681|155748324|FG000|Overall Study|disease progression|1|||
48425982|NCT00530712|155748325|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
48425983|NCT00530712|155748325|FG000|30 Day Follow-up Visit|Missed Visit|5|||
48425984|NCT00530712|155748325|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
48425985|NCT00530712|155748325|FG000|6 Month Follow-up Visit|Missed Visit|3|||
48425986|NCT00530712|155748325|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
48425987|NCT00530712|155748325|FG000|6 Month Follow-up Visit|Death|2|||
48425988|NCT00530712|155748325|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
48425989|NCT00530712|155748325|FG000|12 Month Follow-up Visit|Missed Visit|3|||
48425990|NCT00530712|155748325|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
48425991|NCT00530712|155748325|FG000|12 Month Follow-up Visit|Death|9|||
48425992|NCT02749370|155748326|FG000|Overall Study|Withdrawal by Subject|11|||
48425993|NCT02749370|155748326|FG000|Overall Study|Lost to Follow-up|3|||
48425994|NCT01259297|155748332|FG000|Double Blind Randomized Period|Death|1|||
48425995|NCT01259297|155748333|FG001|Double Blind Randomized Period|Death|1|||
48425996|NCT01259297|155748334|FG002|Double Blind Randomized Period|Death|1|||
48425997|NCT01259297|155748335|FG003|Double Blind Randomized Period|Death|2|||
48425998|NCT01259297|155748336|FG004|Double Blind Randomized Period|Death|1|||
48425999|NCT01259297|155748337|FG005|Double Blind Randomized Period|Death|5|||
48426000|NCT01259297|155748338|FG006|Double Blind Randomized Period|Death|2|||
48426001|NCT01259297|155748339|FG007|Double Blind Randomized Period|Death|1|||
48426002|NCT01259297|155748332|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48426003|NCT01259297|155748333|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48426004|NCT01259297|155748334|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
48426005|NCT01259297|155748335|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
48426006|NCT01259297|155748336|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
48426007|NCT01259297|155748337|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48426008|NCT01259297|155748338|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48426009|NCT01259297|155748339|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
48426010|NCT01259297|155748332|FG000|Double Blind Randomized Period|Other reasons|0|||
48426011|NCT01259297|155748333|FG001|Double Blind Randomized Period|Other reasons|1|||
48426012|NCT01259297|155748334|FG002|Double Blind Randomized Period|Other reasons|0|||
48426013|NCT01259297|155748335|FG003|Double Blind Randomized Period|Other reasons|0|||
48426014|NCT01259297|155748336|FG004|Double Blind Randomized Period|Other reasons|1|||
48426015|NCT01259297|155748337|FG005|Double Blind Randomized Period|Other reasons|2|||
48426016|NCT01259297|155748338|FG006|Double Blind Randomized Period|Other reasons|3|||
48426017|NCT01259297|155748339|FG007|Double Blind Randomized Period|Other reasons|1|||
48426018|NCT02574312|155748340|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
48426019|NCT02574312|155748341|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
48426020|NCT01519427|155748342|FG000|Overall Study|disease progression|2|||
48426021|NCT03242759|155748343|FG000|Overall Study|Adverse Event|5|||
48426022|NCT03242759|155748344|FG001|Overall Study|Adverse Event|1|||
48426023|NCT03242759|155748343|FG000|Overall Study|Withdrawal by Subject|4|||
48426024|NCT03242759|155748344|FG001|Overall Study|Withdrawal by Subject|3|||
48426025|NCT03242759|155748343|FG000|Overall Study|Lost to Follow-up|3|||
48426026|NCT03242759|155748344|FG001|Overall Study|Lost to Follow-up|1|||
48426027|NCT03242759|155748343|FG000|Overall Study|Administrative problems|1|||
48426028|NCT03242759|155748344|FG001|Overall Study|Administrative problems|1|||
48426029|NCT03242759|155748343|FG000|Overall Study|Death|22|||
48426030|NCT03242759|155748344|FG001|Overall Study|Death|0|||
48426031|NCT03242759|155748343|FG000|Overall Study|Change visit schedule|0|||
48426032|NCT03242759|155748344|FG001|Overall Study|Change visit schedule|1|||
48426033|NCT03567291|155749463|FG000|Period I|Adverse Event|14|||
48426034|NCT03567291|155749464|FG001|Period I|Adverse Event|0|||
48426035|NCT03567291|155749465|FG002|Period I|Adverse Event|0|||
48426036|NCT03567291|155749466|FG003|Period I|Adverse Event|0|||
48426037|NCT03567291|155749463|FG000|Period I|Protocol Violation|1|||
48426038|NCT03567291|155749464|FG001|Period I|Protocol Violation|0|||
48426039|NCT03567291|155749465|FG002|Period I|Protocol Violation|0|||
48426040|NCT03567291|155749466|FG003|Period I|Protocol Violation|0|||
48426041|NCT03567291|155749463|FG000|Period I|Withdrawal by Subject|23|||
48426042|NCT03567291|155749464|FG001|Period I|Withdrawal by Subject|0|||
48426043|NCT03567291|155749465|FG002|Period I|Withdrawal by Subject|0|||
48426044|NCT03567291|155749466|FG003|Period I|Withdrawal by Subject|0|||
48426045|NCT03567291|155749463|FG000|Period I|Lost to Follow-up|2|||
48426046|NCT03567291|155749464|FG001|Period I|Lost to Follow-up|0|||
48426047|NCT03567291|155749465|FG002|Period I|Lost to Follow-up|0|||
48426048|NCT03567291|155749466|FG003|Period I|Lost to Follow-up|0|||
48426049|NCT03567291|155749463|FG000|Period I|Terminated by sponsor|44|||
48426050|NCT03567291|155749464|FG001|Period I|Terminated by sponsor|0|||
48426051|NCT03567291|155749465|FG002|Period I|Terminated by sponsor|0|||
48426052|NCT03567291|155749466|FG003|Period I|Terminated by sponsor|0|||
48426053|NCT03567291|155749463|FG000|Period I|Missing or unknown|7|||
48426054|NCT03567291|155749464|FG001|Period I|Missing or unknown|0|||
48426055|NCT03567291|155749465|FG002|Period I|Missing or unknown|0|||
48426056|NCT03567291|155749466|FG003|Period I|Missing or unknown|0|||
48426057|NCT03567291|155749463|FG000|Period II|Adverse Event|0|||
48426058|NCT03567291|155749464|FG001|Period II|Adverse Event|1|||
48426059|NCT03567291|155749465|FG002|Period II|Adverse Event|0|||
48426060|NCT03567291|155749466|FG003|Period II|Adverse Event|0|||
48426061|NCT03567291|155749463|FG000|Period II|Missing or unknown|0|||
48426062|NCT03567291|155749464|FG001|Period II|Missing or unknown|2|||
48426063|NCT03567291|155749465|FG002|Period II|Missing or unknown|1|||
48426064|NCT03567291|155749466|FG003|Period II|Missing or unknown|0|||
48426065|NCT03567291|155749463|FG000|Period III|Adverse Event|0|||
48426066|NCT03567291|155749464|FG001|Period III|Adverse Event|0|||
48426067|NCT03567291|155749465|FG002|Period III|Adverse Event|0|||
48426068|NCT03567291|155749466|FG003|Period III|Adverse Event|4|||
48426069|NCT03567291|155749463|FG000|Period III|Withdrawal by Subject|0|||
48426070|NCT03567291|155749464|FG001|Period III|Withdrawal by Subject|0|||
48426071|NCT03567291|155749465|FG002|Period III|Withdrawal by Subject|0|||
48426072|NCT03567291|155749466|FG003|Period III|Withdrawal by Subject|4|||
48426073|NCT03567291|155749463|FG000|Period III|Lost to Follow-up|0|||
48426074|NCT03567291|155749464|FG001|Period III|Lost to Follow-up|0|||
48426075|NCT03567291|155749465|FG002|Period III|Lost to Follow-up|0|||
48426076|NCT03567291|155749466|FG003|Period III|Lost to Follow-up|1|||
48426077|NCT03567291|155749463|FG000|Period III|Terminated by sponsor|0|||
48426078|NCT03567291|155749464|FG001|Period III|Terminated by sponsor|0|||
48426079|NCT03567291|155749465|FG002|Period III|Terminated by sponsor|0|||
48426080|NCT03567291|155749466|FG003|Period III|Terminated by sponsor|68|||
48426081|NCT03567291|155749463|FG000|Period III|Missing or unknown|0|||
48426082|NCT03567291|155749464|FG001|Period III|Missing or unknown|0|||
48426083|NCT03567291|155749465|FG002|Period III|Missing or unknown|0|||
48426084|NCT03567291|155749466|FG003|Period III|Missing or unknown|8|||
48426085|NCT02834403|155749467|FG000|Overall Study|Physician Decision|2|||
48426086|NCT02834403|155749468|FG001|Overall Study|Physician Decision|1|||
48426087|NCT02834403|155749469|FG002|Overall Study|Physician Decision|2|||
48426088|NCT02834403|155749470|FG003|Overall Study|Physician Decision|1|||
48426089|NCT02834403|155749471|FG004|Overall Study|Physician Decision|1|||
48426090|NCT02834403|155749472|FG005|Overall Study|Physician Decision|2|||
48426091|NCT02834403|155749473|FG006|Overall Study|Physician Decision|12|||
48426092|NCT02834403|155749467|FG000|Overall Study|Adverse Event|0|||
48426093|NCT02834403|155749468|FG001|Overall Study|Adverse Event|0|||
48426094|NCT02834403|155749469|FG002|Overall Study|Adverse Event|0|||
48426095|NCT02834403|155749470|FG003|Overall Study|Adverse Event|0|||
48426096|NCT02834403|155749471|FG004|Overall Study|Adverse Event|1|||
48426097|NCT02834403|155749472|FG005|Overall Study|Adverse Event|1|||
48426098|NCT02834403|155749473|FG006|Overall Study|Adverse Event|3|||
48426099|NCT02834403|155749467|FG000|Overall Study|Withdrawal by Subject|0|||
48426100|NCT02834403|155749468|FG001|Overall Study|Withdrawal by Subject|1|||
48426101|NCT02834403|155749469|FG002|Overall Study|Withdrawal by Subject|0|||
48426102|NCT02834403|155749470|FG003|Overall Study|Withdrawal by Subject|0|||
48426103|NCT02834403|155749471|FG004|Overall Study|Withdrawal by Subject|1|||
48426104|NCT02834403|155749472|FG005|Overall Study|Withdrawal by Subject|0|||
48426105|NCT02834403|155749473|FG006|Overall Study|Withdrawal by Subject|0|||
48426106|NCT02834403|155749467|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
48426107|NCT02834403|155749468|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
48426108|NCT02834403|155749469|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
48426109|NCT02834403|155749470|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
48426110|NCT02834403|155749471|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
48426111|NCT02834403|155749472|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
48426112|NCT02834403|155749473|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
48426113|NCT00907478|155749478|FG000|Overall Study|Ineligibility determined|0|||
48426114|NCT00907478|155749479|FG001|Overall Study|Ineligibility determined|0|||
48426115|NCT00907478|155749480|FG002|Overall Study|Ineligibility determined|1|||
48426116|NCT00907478|155749478|FG000|Overall Study|Noncompliance|0|||
48426117|NCT00907478|155749479|FG001|Overall Study|Noncompliance|0|||
48426118|NCT00907478|155749480|FG002|Overall Study|Noncompliance|1|||
48426119|NCT00907478|155749478|FG000|Overall Study|Adverse Event|3|||
48426120|NCT00907478|155749479|FG001|Overall Study|Adverse Event|1|||
48426121|NCT00907478|155749480|FG002|Overall Study|Adverse Event|2|||
48426122|NCT00907478|155749478|FG000|Overall Study|Withdrawal by Subject|8|||
48426123|NCT00907478|155749479|FG001|Overall Study|Withdrawal by Subject|9|||
48426124|NCT00907478|155749480|FG002|Overall Study|Withdrawal by Subject|6|||
48426125|NCT00907478|155749478|FG000|Overall Study|Requirement for alternative therapy|1|||
48426126|NCT00907478|155749479|FG001|Overall Study|Requirement for alternative therapy|2|||
48426127|NCT00907478|155749480|FG002|Overall Study|Requirement for alternative therapy|3|||
48426128|NCT00907478|155749478|FG000|Overall Study|Physician Decision|2|||
48426129|NCT00907478|155749479|FG001|Overall Study|Physician Decision|0|||
48426130|NCT00907478|155749480|FG002|Overall Study|Physician Decision|3|||
48426131|NCT00907478|155749478|FG000|Overall Study|Death|4|||
48426132|NCT00907478|155749479|FG001|Overall Study|Death|2|||
48426133|NCT00907478|155749480|FG002|Overall Study|Death|1|||
48426134|NCT00907478|155749478|FG000|Overall Study|Protocol-specified criteria|5|||
48426135|NCT00907478|155749479|FG001|Overall Study|Protocol-specified criteria|2|||
48426136|NCT00907478|155749480|FG002|Overall Study|Protocol-specified criteria|3|||
48426137|NCT00907478|155749478|FG000|Overall Study|Pregnancy|0|||
48426138|NCT00907478|155749479|FG001|Overall Study|Pregnancy|1|||
48426139|NCT00907478|155749480|FG002|Overall Study|Pregnancy|1|||
48426140|NCT00907478|155749478|FG000|Overall Study|Lost to Follow-up|1|||
48426141|NCT00907478|155749479|FG001|Overall Study|Lost to Follow-up|0|||
48426142|NCT00907478|155749480|FG002|Overall Study|Lost to Follow-up|0|||
48426143|NCT00907478|155749478|FG000|Overall Study|Other|3|||
48426144|NCT00907478|155749479|FG001|Overall Study|Other|0|||
48426145|NCT00907478|155749480|FG002|Overall Study|Other|1|||
48426146|NCT00859898|155749481|FG000|Overall Study|Lack of Efficacy|0|||
48426147|NCT00859898|155749482|FG001|Overall Study|Lack of Efficacy|1|||
48426148|NCT00859898|155749483|FG002|Overall Study|Lack of Efficacy|1|||
48426149|NCT00859898|155749481|FG000|Overall Study|Adverse Event|4|||
48426150|NCT00859898|155749482|FG001|Overall Study|Adverse Event|9|||
48426151|NCT00859898|155749483|FG002|Overall Study|Adverse Event|8|||
48426152|NCT00859898|155749481|FG000|Overall Study|Withdrawal by Subject|11|||
48426153|NCT00859898|155749482|FG001|Overall Study|Withdrawal by Subject|8|||
48426154|NCT00859898|155749483|FG002|Overall Study|Withdrawal by Subject|11|||
48426155|NCT00859898|155749481|FG000|Overall Study|Death|0|||
48426156|NCT00859898|155749482|FG001|Overall Study|Death|0|||
48426157|NCT00859898|155749483|FG002|Overall Study|Death|1|||
48426158|NCT00859898|155749481|FG000|Overall Study|Lost to Follow-up|10|||
48426159|NCT00859898|155749482|FG001|Overall Study|Lost to Follow-up|11|||
48426160|NCT00859898|155749483|FG002|Overall Study|Lost to Follow-up|5|||
48426161|NCT00859898|155749481|FG000|Overall Study|poor/non-compliance|2|||
48426162|NCT00859898|155749482|FG001|Overall Study|poor/non-compliance|0|||
48426163|NCT00859898|155749483|FG002|Overall Study|poor/non-compliance|0|||
48426164|NCT00859898|155749481|FG000|Overall Study|No longer meets criteria|0|||
48426165|NCT00859898|155749482|FG001|Overall Study|No longer meets criteria|1|||
48426166|NCT00859898|155749483|FG002|Overall Study|No longer meets criteria|0|||
48426167|NCT00859898|155749481|FG000|Overall Study|non-specified|1|||
48426168|NCT00859898|155749482|FG001|Overall Study|non-specified|1|||
48426169|NCT00859898|155749483|FG002|Overall Study|non-specified|1|||
48426170|NCT00858702|155749490|FG000|Overall Study|Lack of Efficacy|1|||
48426171|NCT00858702|155749491|FG001|Overall Study|Lack of Efficacy|0|||
48426172|NCT00858702|155749490|FG000|Overall Study|Protocol Violation|1|||
48426173|NCT00858702|155749491|FG001|Overall Study|Protocol Violation|1|||
48426174|NCT00858702|155749490|FG000|Overall Study|Other|2|||
48426175|NCT00858702|155749491|FG001|Overall Study|Other|1|||
48426176|NCT00858702|155749490|FG000|Overall Study|Withdrawal by Subject|1|||
48426177|NCT00858702|155749491|FG001|Overall Study|Withdrawal by Subject|0|||
48426178|NCT04045613|155749492|FG000|Overall Study|Adverse Event|2|||
48426179|NCT04045613|155749493|FG001|Overall Study|Adverse Event|2|||
48426180|NCT04045613|155749494|FG002|Overall Study|Adverse Event|1|||
48426181|NCT04045613|155749495|FG003|Overall Study|Adverse Event|1|||
48426182|NCT04045613|155749496|FG004|Overall Study|Adverse Event|0|||
48426183|NCT04045613|155749497|FG005|Overall Study|Adverse Event|0|||
48426184|NCT04045613|155749498|FG006|Overall Study|Adverse Event|1|||
48426185|NCT04045613|155749492|FG000|Overall Study|Withdrawal by Subject|0|||
48426186|NCT04045613|155749493|FG001|Overall Study|Withdrawal by Subject|5|||
48426187|NCT04045613|155749494|FG002|Overall Study|Withdrawal by Subject|0|||
48426188|NCT04045613|155749495|FG003|Overall Study|Withdrawal by Subject|0|||
48426189|NCT04045613|155749496|FG004|Overall Study|Withdrawal by Subject|0|||
48426190|NCT04045613|155749497|FG005|Overall Study|Withdrawal by Subject|1|||
48426191|NCT04045613|155749498|FG006|Overall Study|Withdrawal by Subject|0|||
48426192|NCT04045613|155749492|FG000|Overall Study|Physician Decision|2|||
48426193|NCT04045613|155749493|FG001|Overall Study|Physician Decision|0|||
48426194|NCT04045613|155749494|FG002|Overall Study|Physician Decision|0|||
48426195|NCT04045613|155749495|FG003|Overall Study|Physician Decision|0|||
48426196|NCT04045613|155749496|FG004|Overall Study|Physician Decision|1|||
48426197|NCT04045613|155749497|FG005|Overall Study|Physician Decision|0|||
48426198|NCT04045613|155749498|FG006|Overall Study|Physician Decision|0|||
48426199|NCT04045613|155749492|FG000|Overall Study|Death|3|||
48426200|NCT04045613|155749493|FG001|Overall Study|Death|0|||
48426201|NCT04045613|155749494|FG002|Overall Study|Death|0|||
48426202|NCT04045613|155749495|FG003|Overall Study|Death|0|||
48426203|NCT04045613|155749496|FG004|Overall Study|Death|0|||
48426204|NCT04045613|155749497|FG005|Overall Study|Death|0|||
48426205|NCT04045613|155749498|FG006|Overall Study|Death|1|||
48426206|NCT04045613|155749492|FG000|Overall Study|Other reasons|0|||
48426207|NCT04045613|155749493|FG001|Overall Study|Other reasons|1|||
48426208|NCT04045613|155749494|FG002|Overall Study|Other reasons|0|||
48426209|NCT04045613|155749495|FG003|Overall Study|Other reasons|0|||
48426210|NCT04045613|155749496|FG004|Overall Study|Other reasons|0|||
48426211|NCT04045613|155749497|FG005|Overall Study|Other reasons|0|||
48426212|NCT04045613|155749498|FG006|Overall Study|Other reasons|1|||
48426213|NCT04045613|155749492|FG000|Overall Study|Progressive disease: Clinical progression|1|||
48426214|NCT04045613|155749493|FG001|Overall Study|Progressive disease: Clinical progression|0|||
48426215|NCT04045613|155749494|FG002|Overall Study|Progressive disease: Clinical progression|3|||
48426216|NCT04045613|155749495|FG003|Overall Study|Progressive disease: Clinical progression|1|||
48426217|NCT04045613|155749496|FG004|Overall Study|Progressive disease: Clinical progression|1|||
48426218|NCT04045613|155749497|FG005|Overall Study|Progressive disease: Clinical progression|3|||
48426219|NCT04045613|155749498|FG006|Overall Study|Progressive disease: Clinical progression|3|||
48426220|NCT04045613|155749492|FG000|Overall Study|Progressive disease: Radiological progression|24|||
48426221|NCT04045613|155749493|FG001|Overall Study|Progressive disease: Radiological progression|6|||
48426412|NCT01172288|155749580|FG001|Overall Study|Adverse Event|0|||
48426222|NCT04045613|155749494|FG002|Overall Study|Progressive disease: Radiological progression|8|||
48426223|NCT04045613|155749495|FG003|Overall Study|Progressive disease: Radiological progression|0|||
48426224|NCT04045613|155749496|FG004|Overall Study|Progressive disease: Radiological progression|6|||
48426225|NCT04045613|155749497|FG005|Overall Study|Progressive disease: Radiological progression|6|||
48426226|NCT04045613|155749498|FG006|Overall Study|Progressive disease: Radiological progression|11|||
48426227|NCT00514449|155749499|FG000|Overall Study|Withdrawal by Subject|1|||
48426228|NCT00514449|155749500|FG001|Overall Study|Withdrawal by Subject|2|||
48426229|NCT00514449|155749499|FG000|Overall Study|Protocol Violation|1|||
48426230|NCT00514449|155749500|FG001|Overall Study|Protocol Violation|2|||
48426231|NCT00514449|155749499|FG000|Overall Study|Lost to Follow-up|1|||
48426232|NCT00514449|155749500|FG001|Overall Study|Lost to Follow-up|0|||
48426233|NCT00739297|155749501|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
48426234|NCT00739297|155749502|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
48426235|NCT00739297|155749503|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
48426236|NCT00739297|155749504|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
48426237|NCT00739297|155749505|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
48426238|NCT00739297|155749506|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
48426239|NCT00739297|155749507|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
48426240|NCT00739297|155749501|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48426241|NCT00739297|155749502|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48426242|NCT00739297|155749503|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48426243|NCT00739297|155749504|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48426244|NCT00739297|155749505|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
48426245|NCT00739297|155749506|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
48426246|NCT00739297|155749507|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
48426247|NCT00784784|155749508|FG000|Overall Study|Withdrawal by Subject|2|||
48426248|NCT00784784|155749509|FG001|Overall Study|Withdrawal by Subject|2|||
48426249|NCT00370149|155749514|FG000|Overall Study|Physician Decision|16|||
48426250|NCT00370149|155749515|FG001|Overall Study|Physician Decision|16|||
48426251|NCT00370149|155749514|FG000|Overall Study|Protocol Violation|1|||
48426252|NCT00370149|155749515|FG001|Overall Study|Protocol Violation|0|||
48426253|NCT00370149|155749514|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
48426254|NCT00370149|155749515|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
48426255|NCT00370149|155749514|FG000|Overall Study|Pre-existing infection|0|||
48426256|NCT00370149|155749515|FG001|Overall Study|Pre-existing infection|1|||
48426257|NCT00370149|155749514|FG000|Overall Study|Antibiotic coated dressing placed|0|||
48426258|NCT00370149|155749515|FG001|Overall Study|Antibiotic coated dressing placed|1|||
48426259|NCT05372575|155749516|FG000|Overall Study|Protocol Violation|7|||
48426260|NCT05372575|155749517|FG001|Overall Study|Protocol Violation|16|||
48426261|NCT00443430|155749520|FG000|Overall Study|Lack of Efficacy|3|||
48426262|NCT00443430|155749521|FG001|Overall Study|Lack of Efficacy|3|||
48426263|NCT00443430|155749520|FG000|Overall Study|Adverse Event|1|||
48426264|NCT00443430|155749521|FG001|Overall Study|Adverse Event|1|||
48426265|NCT01663740|155749522|FG000|Overall Study|Lost to Follow-up|1|||
48426266|NCT01663740|155749523|FG001|Overall Study|Lost to Follow-up|4|||
48426267|NCT01663740|155749522|FG000|Overall Study|Other|9|||
48426268|NCT01663740|155749523|FG001|Overall Study|Other|2|||
48426269|NCT01663740|155749522|FG000|Overall Study|Inclusion/Exclusion not met|1|||
48426270|NCT01663740|155749523|FG001|Overall Study|Inclusion/Exclusion not met|0|||
48426271|NCT01663740|155749522|FG000|Overall Study|Death|0|||
48426272|NCT01663740|155749523|FG001|Overall Study|Death|1|||
48426273|NCT01663740|155749522|FG000|Overall Study|Withdrawal by Subject|2|||
48426274|NCT01663740|155749523|FG001|Overall Study|Withdrawal by Subject|1|||
48426275|NCT01663740|155749522|FG000|Overall Study|No end of study status|3|||
48426276|NCT01663740|155749523|FG001|Overall Study|No end of study status|0|||
48426277|NCT00592501|155749524|FG000|Overall Study|Withdrawal by Subject|1|||
48426278|NCT00592501|155749524|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
48426279|NCT03894904|155749525|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
48426280|NCT03894904|155749526|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
48426281|NCT03894904|155749525|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
48426282|NCT03894904|155749526|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
48426283|NCT00053846|155749527|FG000|Overall Study|Changed mind|8|||
48426284|NCT00053846|155749528|FG001|Overall Study|Changed mind|13|||
48426285|NCT00053846|155749527|FG000|Overall Study|Became too ill|8|||
48426286|NCT00053846|155749528|FG001|Overall Study|Became too ill|7|||
48426287|NCT00053846|155749527|FG000|Overall Study|Expired|5|||
48426288|NCT00053846|155749528|FG001|Overall Study|Expired|0|||
48426289|NCT00053846|155749527|FG000|Overall Study|Became ineligible|3|||
48426290|NCT00053846|155749528|FG001|Overall Study|Became ineligible|1|||
48426291|NCT00053846|155749527|FG000|Overall Study|Did not return data|1|||
48426331|NCT02203838|155749550|FG000|Overall Study|Withdrawal by Subject|83|||
48426332|NCT02203838|155749551|FG001|Overall Study|Withdrawal by Subject|10|||
48426333|NCT02203838|155749552|FG002|Overall Study|Withdrawal by Subject|8|||
48426334|NCT02203838|155749553|FG003|Overall Study|Withdrawal by Subject|11|||
48426335|NCT02203838|155749550|FG000|Overall Study|Physician Decision|27|||
48426336|NCT02203838|155749551|FG001|Overall Study|Physician Decision|0|||
48426337|NCT02203838|155749552|FG002|Overall Study|Physician Decision|2|||
48426338|NCT02203838|155749553|FG003|Overall Study|Physician Decision|3|||
48426339|NCT02203838|155749550|FG000|Overall Study|Other|1|||
48426340|NCT02203838|155749551|FG001|Overall Study|Other|0|||
48426341|NCT02203838|155749552|FG002|Overall Study|Other|0|||
48426342|NCT02203838|155749553|FG003|Overall Study|Other|0|||
48426343|NCT00436215|155749554|FG000|Overall Study|Refused further treatment|3|||
48426344|NCT00436215|155749554|FG000|Overall Study|Small bowel obstruction|1|||
48426345|NCT03880227|155749555|FG000|First Visit|Withdrawal by Subject|1|||
48426346|NCT03880227|155749556|FG001|First Visit|Withdrawal by Subject|0|||
48426347|NCT03880227|155749557|FG002|First Visit|Withdrawal by Subject|0|||
48426348|NCT03880227|155749558|FG003|First Visit|Withdrawal by Subject|0|||
48426349|NCT03880227|155749555|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
48426350|NCT03880227|155749556|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
48426351|NCT03880227|155749557|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
48426352|NCT03880227|155749558|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
48426353|NCT03880227|155749555|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
48426354|NCT03880227|155749556|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
48426355|NCT03880227|155749557|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
48426356|NCT03880227|155749558|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
48426357|NCT03880227|155749555|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
48426358|NCT03880227|155749556|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
48426359|NCT03880227|155749557|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
48426360|NCT03880227|155749558|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
48426361|NCT00504166|155749559|FG000|Overall Study|Adverse Event|1|||
48426362|NCT00504166|155749560|FG001|Overall Study|Adverse Event|4|||
48426363|NCT00504166|155749559|FG000|Overall Study|Withdrawal by Subject|3|||
48426364|NCT00504166|155749560|FG001|Overall Study|Withdrawal by Subject|6|||
48426365|NCT00504166|155749559|FG000|Overall Study|Physician Decision|1|||
48426366|NCT00504166|155749560|FG001|Overall Study|Physician Decision|1|||
48426367|NCT00504166|155749559|FG000|Overall Study|Lost to Follow-up|1|||
48426368|NCT00504166|155749560|FG001|Overall Study|Lost to Follow-up|3|||
48426369|NCT03117049|155749570|FG000|Overall Study|Continued the follow-up period|109|||
48426370|NCT03117049|155749571|FG001|Overall Study|Continued the follow-up period|129|||
48426371|NCT03117049|155749570|FG000|Overall Study|Died|82|||
48426372|NCT03117049|155749571|FG001|Overall Study|Died|93|||
48426373|NCT03117049|155749570|FG000|Overall Study|Consent withdrawal|7|||
48426374|NCT03117049|155749571|FG001|Overall Study|Consent withdrawal|6|||
48426375|NCT03117049|155749570|FG000|Overall Study|Missing contact|3|||
48426376|NCT03117049|155749571|FG001|Overall Study|Missing contact|3|||
48426377|NCT00651118|155749572|FG000|Overall Study|Adverse Event|4|||
48426378|NCT00651118|155749573|FG001|Overall Study|Adverse Event|0|||
48426379|NCT00651118|155749574|FG002|Overall Study|Adverse Event|1|||
48426380|NCT00651118|155749575|FG003|Overall Study|Adverse Event|1|||
48426381|NCT00651118|155749572|FG000|Overall Study|Protocol Violation|2|||
48426382|NCT00651118|155749573|FG001|Overall Study|Protocol Violation|2|||
48426383|NCT00651118|155749574|FG002|Overall Study|Protocol Violation|6|||
48426384|NCT00651118|155749575|FG003|Overall Study|Protocol Violation|2|||
48426385|NCT00651118|155749572|FG000|Overall Study|Lost to Follow-up|2|||
48426386|NCT00651118|155749573|FG001|Overall Study|Lost to Follow-up|0|||
48426387|NCT00651118|155749574|FG002|Overall Study|Lost to Follow-up|1|||
48426388|NCT00651118|155749575|FG003|Overall Study|Lost to Follow-up|2|||
48426389|NCT00651118|155749572|FG000|Overall Study|administrative|1|||
48426390|NCT00651118|155749573|FG001|Overall Study|administrative|4|||
48426391|NCT00651118|155749574|FG002|Overall Study|administrative|2|||
48426392|NCT00651118|155749575|FG003|Overall Study|administrative|1|||
48426393|NCT00651118|155749572|FG000|Overall Study|Withdrawal by Subject|0|||
48426394|NCT00651118|155749573|FG001|Overall Study|Withdrawal by Subject|1|||
48426395|NCT00651118|155749574|FG002|Overall Study|Withdrawal by Subject|1|||
48426396|NCT00651118|155749575|FG003|Overall Study|Withdrawal by Subject|1|||
48426397|NCT01096550|155749576|FG000|Overall Study|discontinued site|10|||
48426398|NCT01096550|155749577|FG001|Overall Study|discontinued site|11|||
48426399|NCT01096550|155749576|FG000|Overall Study|non-regular treatment track at clinic|1|||
48426400|NCT01096550|155749577|FG001|Overall Study|non-regular treatment track at clinic|1|||
48426401|NCT01096550|155749576|FG000|Overall Study|clinic readmission|1|||
48426402|NCT01096550|155749577|FG001|Overall Study|clinic readmission|1|||
48426403|NCT01096550|155749576|FG000|Overall Study|Withdrawal by Subject|0|||
48426404|NCT01096550|155749577|FG001|Overall Study|Withdrawal by Subject|1|||
48426405|NCT01096550|155749576|FG000|Overall Study|non-African American participant|13|||
48426406|NCT01096550|155749577|FG001|Overall Study|non-African American participant|6|||
48426407|NCT01096550|155749576|FG000|Overall Study|Lost to Follow-up|12|||
48426415|NCT05094154|155749585|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
48426416|NCT05094154|155749586|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
48426417|NCT05094154|155749585|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
48426418|NCT05094154|155749586|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
48426419|NCT03196297|155749587|FG000|Main Period|Withdrawal by Subject|4|||
48426420|NCT03196297|155749587|FG000|Extension Period|Withdrawal by Subject|1|||
48426421|NCT03196297|155749587|FG000|Extension Period|Lack of Efficacy|2|||
48426422|NCT00839098|155749588|FG000|Overall Study|Withdrawal by Subject|2|||
48426423|NCT00839098|155749589|FG001|Overall Study|Withdrawal by Subject|1|||
48426424|NCT00839098|155749590|FG002|Overall Study|Withdrawal by Subject|7|||
48426425|NCT02160977|155749595|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
48426426|NCT02160977|155749596|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
48426427|NCT02160977|155749595|FG000|Three Months After Surgery|Lost to Follow-up|0|||
48426428|NCT02160977|155749596|FG001|Three Months After Surgery|Lost to Follow-up|2|||
48426429|NCT02160977|155749595|FG000|Six Months After Surgery|Lost to Follow-up|2|||
48426430|NCT02160977|155749596|FG001|Six Months After Surgery|Lost to Follow-up|1|||
48426431|NCT01894516|155751180|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
48426432|NCT01894516|155751181|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
48426433|NCT01894516|155751182|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
48426434|NCT01894516|155751183|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
48426435|NCT01894516|155751180|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
48426436|NCT01894516|155751181|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48426437|NCT01894516|155751182|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48426438|NCT01894516|155751183|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
48426439|NCT01894516|155751180|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
48426440|NCT01894516|155751181|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
48426441|NCT01894516|155751182|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
48426442|NCT01894516|155751183|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
48426443|NCT01894516|155751180|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
48426444|NCT01894516|155751181|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
48426445|NCT01894516|155751182|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
48426446|NCT01894516|155751183|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
48426447|NCT01894516|155751180|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
48426448|NCT01894516|155751181|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
48426449|NCT01894516|155751182|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
48426450|NCT01894516|155751183|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
48426451|NCT01894516|155751180|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
48426452|NCT01894516|155751181|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
48426453|NCT01894516|155751182|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
48426454|NCT01894516|155751183|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
48426455|NCT01894516|155751180|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
48426456|NCT01894516|155751181|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
48426457|NCT01894516|155751182|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
48426458|NCT01894516|155751183|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
48426459|NCT01894516|155751180|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48426460|NCT01894516|155751181|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48426461|NCT01894516|155751182|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
48426462|NCT01894516|155751183|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
48426463|NCT02100657|155751188|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
48426464|NCT02100657|155751189|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
48426465|NCT02100657|155751190|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
48426466|NCT02100657|155751188|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
48426467|NCT02100657|155751189|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
48426468|NCT02100657|155751190|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
48426469|NCT02100657|155751188|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
48426470|NCT02100657|155751189|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
48426471|NCT02100657|155751190|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
48426472|NCT02100657|155751188|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
48426473|NCT02100657|155751189|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
48426474|NCT02100657|155751190|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
48426475|NCT02100657|155751188|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
48426476|NCT02100657|155751189|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
48426477|NCT02100657|155751190|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
48426478|NCT02100657|155751188|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
48426479|NCT02100657|155751189|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
48426480|NCT02100657|155751190|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
48426481|NCT02100657|155751188|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
48426482|NCT02100657|155751189|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
48426483|NCT02100657|155751190|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
48426484|NCT02100657|155751188|FG000|Cohort 3: Dose Level 3|Death|0|||
48426485|NCT02100657|155751189|FG001|Cohort 3: Dose Level 3|Death|0|||
48426486|NCT02100657|155751190|FG002|Cohort 3: Dose Level 3|Death|1|||
48426487|NCT02100657|155751188|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
48426488|NCT02100657|155751189|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
48426489|NCT02100657|155751190|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
48426490|NCT02100657|155751188|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
48426491|NCT02100657|155751189|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
48426492|NCT02100657|155751190|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
48426493|NCT02100657|155751188|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
48426494|NCT02100657|155751189|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
48426495|NCT02100657|155751190|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
48426496|NCT02100657|155751188|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
48426497|NCT02100657|155751189|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
48426498|NCT02100657|155751190|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
48426499|NCT02100657|155751188|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
48426500|NCT02100657|155751189|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
48426501|NCT02100657|155751190|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
48426502|NCT02742649|155751192|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
48426503|NCT02742649|155751193|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
48426504|NCT02742649|155751194|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
48426505|NCT02742649|155751195|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
48426506|NCT02742649|155751196|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
48426507|NCT02742649|155751192|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48426508|NCT02742649|155751193|FG001|Double-Blind Treatment Period|Adverse Event|1|||
48426509|NCT02742649|155751194|FG002|Double-Blind Treatment Period|Adverse Event|0|||
48426510|NCT02742649|155751195|FG003|Double-Blind Treatment Period|Adverse Event|0|||
48426511|NCT02742649|155751196|FG004|Double-Blind Treatment Period|Adverse Event|0|||
48426512|NCT02742649|155751192|FG000|Open-Label Period|Lost to Follow-up|0|||
48426513|NCT02742649|155751193|FG001|Open-Label Period|Lost to Follow-up|0|||
48426514|NCT02742649|155751194|FG002|Open-Label Period|Lost to Follow-up|0|||
48426515|NCT02742649|155751195|FG003|Open-Label Period|Lost to Follow-up|0|||
48426516|NCT02742649|155751196|FG004|Open-Label Period|Lost to Follow-up|1|||
48426517|NCT03918642|155751199|FG000|Overall Study|Lost to Follow-up|12|||
48426518|NCT03918642|155751200|FG001|Overall Study|Lost to Follow-up|10|||
48426519|NCT01283581|155751203|FG000|Overall Study|Lost to Follow-up|8|||
48426520|NCT01283581|155751204|FG001|Overall Study|Lost to Follow-up|6|||
48426521|NCT01283581|155751205|FG002|Overall Study|Lost to Follow-up|8|||
48426522|NCT01283581|155751203|FG000|Overall Study|Withdrawal by Subject|2|||
48426523|NCT01283581|155751204|FG001|Overall Study|Withdrawal by Subject|5|||
48426524|NCT01283581|155751205|FG002|Overall Study|Withdrawal by Subject|2|||
48426525|NCT01283581|155751203|FG000|Overall Study|Adverse Event|1|||
48426526|NCT01283581|155751204|FG001|Overall Study|Adverse Event|1|||
48426527|NCT01283581|155751205|FG002|Overall Study|Adverse Event|4|||
48426528|NCT01283581|155751203|FG000|Overall Study|Physician Decision|0|||
48426529|NCT01283581|155751204|FG001|Overall Study|Physician Decision|1|||
48426530|NCT01283581|155751205|FG002|Overall Study|Physician Decision|2|||
48426531|NCT01283581|155751203|FG000|Overall Study|Protocol Violation|0|||
48426532|NCT01283581|155751204|FG001|Overall Study|Protocol Violation|1|||
48426533|NCT01283581|155751205|FG002|Overall Study|Protocol Violation|2|||
48426534|NCT01283581|155751203|FG000|Overall Study|Noncompliance|1|||
48426535|NCT01283581|155751204|FG001|Overall Study|Noncompliance|0|||
48426536|NCT01283581|155751205|FG002|Overall Study|Noncompliance|0|||
48426537|NCT01283581|155751203|FG000|Overall Study|Investigator unblinded|0|||
48426538|NCT01283581|155751204|FG001|Overall Study|Investigator unblinded|0|||
48426539|NCT01283581|155751205|FG002|Overall Study|Investigator unblinded|1|||
48426540|NCT01283581|155751203|FG000|Overall Study|"Early termination"|0|||
48426541|NCT01283581|155751204|FG001|Overall Study|"Early termination"|0|||
48426542|NCT01283581|155751205|FG002|Overall Study|"Early termination"|1|||
48426543|NCT01790438|155751206|FG000|Overall Study|Adverse Event|3|||
48426544|NCT01790438|155751207|FG001|Overall Study|Adverse Event|2|||
48426545|NCT01790438|155751206|FG000|Overall Study|Death|4|||
48426546|NCT01790438|155751207|FG001|Overall Study|Death|0|||
48426547|NCT01790438|155751206|FG000|Overall Study|Lost to Follow-up|5|||
48426548|NCT01790438|155751207|FG001|Overall Study|Lost to Follow-up|2|||
48426549|NCT01790438|155751206|FG000|Overall Study|Withdrawal by Subject|13|||
48426550|NCT01790438|155751207|FG001|Overall Study|Withdrawal by Subject|2|||
48426551|NCT01790438|155751206|FG000|Overall Study|Physician Decision|3|||
48426552|NCT01790438|155751207|FG001|Overall Study|Physician Decision|1|||
48426553|NCT01790438|155751206|FG000|Overall Study|Sponsor Decision|0|||
48426554|NCT01790438|155751207|FG001|Overall Study|Sponsor Decision|3|||
48426555|NCT01790438|155751206|FG000|Overall Study|Protocol Required Discontinuation|7|||
48426556|NCT01790438|155751207|FG001|Overall Study|Protocol Required Discontinuation|1|||
48426559|NCT00486226|155751213|FG000|Overall Study|Withdrawal by Subject|1|||
48426560|NCT00486226|155751213|FG000|Overall Study|Lost to Follow-up|8|||
48426561|NCT01712438|155751214|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
48426562|NCT01712438|155751214|FG000|Overall Study|Ongoing ITI treatment|6|||
48426563|NCT01712438|155751214|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
48426564|NCT01712438|155751214|FG000|Overall Study|Prematurely Discontinued|25|||
48426565|NCT01881620|155751219|FG000|Overall Study|Protocol Violation|4|||
48426566|NCT02948777|155751222|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
48426567|NCT01013883|155751227|FG000|Overall Study|Lost to Follow-up|2|||
48426568|NCT01013883|155751228|FG001|Overall Study|Lost to Follow-up|2|||
48426569|NCT02207530|155751236|FG000|Overall Study|Worsening condition under investigation|78|||
48426570|NCT02207530|155751236|FG000|Overall Study|Patient decision to stop study treatment|5|||
48426571|NCT02207530|155751236|FG000|Overall Study|Adverse Event|8|||
48426572|NCT02452970|155751237|FG000|Overall Study|Adverse Event|1|||
48426573|NCT02092389|155751238|FG000|Overall Study|Adverse Event|1|||
48426574|NCT02092389|155751238|FG000|Overall Study|Other|5|||
48426575|NCT04590937|155751239|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
48426576|NCT00365976|155751244|FG000|Overall Study|Withdrawal by Subject|1|||
48426577|NCT00365976|155751245|FG001|Overall Study|Withdrawal by Subject|5|||
48426578|NCT01345786|155751249|FG000|Overall Study|Adverse Event|0|||
48426579|NCT01345786|155751250|FG001|Overall Study|Adverse Event|1|||
48426580|NCT01345786|155751251|FG002|Overall Study|Adverse Event|3|||
48426581|NCT01345786|155751252|FG003|Overall Study|Adverse Event|1|||
48426582|NCT01345786|155751249|FG000|Overall Study|Subject withdrew consent|2|||
48426583|NCT01345786|155751250|FG001|Overall Study|Subject withdrew consent|2|||
48426584|NCT01345786|155751251|FG002|Overall Study|Subject withdrew consent|1|||
48426585|NCT01345786|155751252|FG003|Overall Study|Subject withdrew consent|0|||
48426586|NCT01345786|155751249|FG000|Overall Study|Noncompliance with protocol|1|||
48426587|NCT01345786|155751250|FG001|Overall Study|Noncompliance with protocol|0|||
48426588|NCT01345786|155751251|FG002|Overall Study|Noncompliance with protocol|1|||
48426589|NCT01345786|155751252|FG003|Overall Study|Noncompliance with protocol|0|||
48426590|NCT01345786|155751249|FG000|Overall Study|Administrative|3|||
48426591|NCT01345786|155751250|FG001|Overall Study|Administrative|5|||
48426592|NCT01345786|155751251|FG002|Overall Study|Administrative|0|||
48426593|NCT01345786|155751252|FG003|Overall Study|Administrative|0|||
48426594|NCT01345786|155751249|FG000|Overall Study|Lost to Follow-up|0|||
48426595|NCT01345786|155751250|FG001|Overall Study|Lost to Follow-up|0|||
48426596|NCT01345786|155751251|FG002|Overall Study|Lost to Follow-up|0|||
48426597|NCT01345786|155751252|FG003|Overall Study|Lost to Follow-up|2|||
48426598|NCT01327339|155751253|FG000|Overall Study|Protocol Violation|8|||
48426599|NCT02190435|155751254|FG000|Overall Study|First 12 patients were lead-ins|12|||
48426600|NCT02190435|155751255|FG001|Overall Study|First 12 patients were lead-ins|0|||
48426601|NCT02190435|155751254|FG000|Overall Study|3 consented screen fails|3|||
48426602|NCT02190435|155751255|FG001|Overall Study|3 consented screen fails|0|||
48426603|NCT03510663|155751256|FG000|Overall Study|Withdrawal by Subject|0|||
48426604|NCT03510663|155751257|FG001|Overall Study|Withdrawal by Subject|1|||
48426605|NCT03510663|155751258|FG002|Overall Study|Withdrawal by Subject|0|||
48426606|NCT03510663|155751259|FG003|Overall Study|Withdrawal by Subject|0|||
48426607|NCT03510663|155751260|FG004|Overall Study|Withdrawal by Subject|0|||
48426608|NCT03510663|155751261|FG005|Overall Study|Withdrawal by Subject|0|||
48426609|NCT03510663|155751262|FG006|Overall Study|Withdrawal by Subject|0|||
48426610|NCT03510663|155751263|FG007|Overall Study|Withdrawal by Subject|0|||
48426611|NCT01555463|155751276|FG000|Treatment|Adverse Event|6|||
48426612|NCT01555463|155751277|FG001|Treatment|Adverse Event|12|||
48426613|NCT01555463|155751276|FG000|Treatment|Withdrawal by Subject|24|||
48426614|NCT01555463|155751277|FG001|Treatment|Withdrawal by Subject|36|||
48426615|NCT01555463|155751276|FG000|Treatment|Lost to Follow-up|28|||
48426616|NCT01555463|155751277|FG001|Treatment|Lost to Follow-up|23|||
48426617|NCT01555463|155751276|FG000|Treatment|Protocol Violation|4|||
48426618|NCT01555463|155751277|FG001|Treatment|Protocol Violation|5|||
48426619|NCT01555463|155751276|FG000|Treatment|Other reason|2|||
48426620|NCT01555463|155751277|FG001|Treatment|Other reason|3|||
48426621|NCT01555463|155751276|FG000|Follow up|Adverse Event|2|||
48426622|NCT01555463|155751277|FG001|Follow up|Adverse Event|5|||
48426623|NCT01555463|155751276|FG000|Follow up|Death|0|||
48426624|NCT01555463|155751277|FG001|Follow up|Death|1|||
48426625|NCT01555463|155751276|FG000|Follow up|Withdrawal by Subject|22|||
48426626|NCT01555463|155751277|FG001|Follow up|Withdrawal by Subject|22|||
48426627|NCT01555463|155751276|FG000|Follow up|Lost to Follow-up|9|||
48426628|NCT01555463|155751277|FG001|Follow up|Lost to Follow-up|10|||
48426629|NCT01555463|155751276|FG000|Follow up|Protocol Violation|2|||
48426630|NCT01555463|155751277|FG001|Follow up|Protocol Violation|4|||
48426631|NCT01555463|155751276|FG000|Follow up|Other reason|3|||
48426632|NCT01555463|155751277|FG001|Follow up|Other reason|3|||
48426633|NCT00091390|155751284|FG000|Overall Study|Protocol Violation|1|||
48426634|NCT00091390|155751284|FG000|Overall Study|No protocol treatment|3|||
48426635|NCT02084134|155751285|FG000|Overall Study|Protocol Violation|4|||
48426636|NCT02084134|155751286|FG001|Overall Study|Protocol Violation|2|||
48426637|NCT02084134|155751285|FG000|Overall Study|Death|0|||
48426641|NCT04333433|155751291|FG000|Overall Study|Withdrawal by Subject|6|||
48426642|NCT04333433|155751292|FG001|Overall Study|Withdrawal by Subject|3|||
48426643|NCT04333433|155751291|FG000|Overall Study|Death|3|||
48426644|NCT04333433|155751292|FG001|Overall Study|Death|0|||
48426645|NCT04333433|155751291|FG000|Overall Study|Lost to Follow-up|6|||
48426646|NCT04333433|155751292|FG001|Overall Study|Lost to Follow-up|1|||
48426647|NCT04333433|155751291|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
48426648|NCT04333433|155751292|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
48426649|NCT02260193|155751293|FG000|Overall Study|Lack of Efficacy|0|||
48426650|NCT02260193|155751294|FG001|Overall Study|Lack of Efficacy|1|||
48426651|NCT02260193|155751295|FG002|Overall Study|Lack of Efficacy|6|||
48426652|NCT02260193|155751293|FG000|Overall Study|Adverse Event|3|||
48426653|NCT02260193|155751294|FG001|Overall Study|Adverse Event|4|||
48426654|NCT02260193|155751295|FG002|Overall Study|Adverse Event|1|||
48426655|NCT02260193|155751293|FG000|Overall Study|Protocol Violation|0|||
48426656|NCT02260193|155751294|FG001|Overall Study|Protocol Violation|4|||
48426657|NCT02260193|155751295|FG002|Overall Study|Protocol Violation|0|||
48426658|NCT02260193|155751293|FG000|Overall Study|Withdrawal by Subject|3|||
48426659|NCT02260193|155751294|FG001|Overall Study|Withdrawal by Subject|0|||
48426660|NCT02260193|155751295|FG002|Overall Study|Withdrawal by Subject|2|||
48426661|NCT02260193|155751293|FG000|Overall Study|Kidney Transplantation|0|||
48426662|NCT02260193|155751294|FG001|Overall Study|Kidney Transplantation|0|||
48426663|NCT02260193|155751295|FG002|Overall Study|Kidney Transplantation|1|||
48426664|NCT02807454|155751301|FG000|Overall Study|Adverse Event|1|||
48426665|NCT02807454|155751302|FG001|Overall Study|Adverse Event|0|||
48426666|NCT02807454|155751301|FG000|Overall Study|Withdrawal by Subject|0|||
48426667|NCT02807454|155751302|FG001|Overall Study|Withdrawal by Subject|1|||
48426668|NCT02807454|155751301|FG000|Overall Study|Progressive Disease|30|||
48426669|NCT02807454|155751302|FG001|Overall Study|Progressive Disease|3|||
48426670|NCT02807454|155751301|FG000|Overall Study|Other Reasons|1|||
48426671|NCT02807454|155751302|FG001|Overall Study|Other Reasons|1|||
48426672|NCT02275026|155751303|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
48426673|NCT02275026|155751303|FG000|Overall Study|Withdrawal by Subject|4|||
48426674|NCT02275026|155751303|FG000|Overall Study|Ineligible due to medical history|13|||
48426675|NCT02275026|155751303|FG000|Overall Study|MRI malfunction precluded testing|1|||
48426676|NCT02275026|155751303|FG000|Overall Study|Ineligible after MRI findings|1|||
48426677|NCT02275026|155751303|FG000|Overall Study|Lost to Follow-up|2|||
48426678|NCT02275026|155751303|FG000|Overall Study|Scanner failure|1|||
48426679|NCT05468086|155751306|FG000|Overall Study|Withdrawal by Subject|3|||
48426680|NCT05468086|155751306|FG000|Overall Study|Subject was found ineligible after consent|1|||
48426681|NCT00374907|155751315|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
48426682|NCT00374907|155751316|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
48426683|NCT00374907|155751315|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
48426684|NCT00374907|155751316|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
48426685|NCT00374907|155751315|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
48426686|NCT00374907|155751316|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
48426687|NCT00374907|155751315|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
48426688|NCT00374907|155751316|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
48426689|NCT00374907|155751315|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
48426690|NCT00374907|155751316|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
48426691|NCT00320385|155751317|FG000|Overall Study|Lost to Follow-up|7|||
48426692|NCT00320385|155751318|FG001|Overall Study|Lost to Follow-up|10|||
48426693|NCT00320385|155751317|FG000|Overall Study|Withdrawal by Subject|6|||
48426694|NCT00320385|155751318|FG001|Overall Study|Withdrawal by Subject|7|||
48426695|NCT00320385|155751317|FG000|Overall Study|Sponsor Terminated Study|2|||
48426696|NCT00320385|155751318|FG001|Overall Study|Sponsor Terminated Study|1|||
48426697|NCT00320385|155751317|FG000|Overall Study|Investigator Decision|0|||
48426698|NCT00320385|155751318|FG001|Overall Study|Investigator Decision|1|||
48426699|NCT00320385|155751317|FG000|Overall Study|Death|1|||
48426700|NCT00320385|155751318|FG001|Overall Study|Death|2|||
48426701|NCT00320385|155751317|FG000|Overall Study|Serious Adverse Event|1|||
48426702|NCT00320385|155751318|FG001|Overall Study|Serious Adverse Event|0|||
48426703|NCT00320385|155751317|FG000|Overall Study|Withdrew Consent|1|||
48426704|NCT00320385|155751318|FG001|Overall Study|Withdrew Consent|0|||
48426705|NCT00320385|155751317|FG000|Overall Study|Adverse Event|0|||
48426706|NCT00320385|155751318|FG001|Overall Study|Adverse Event|1|||
48426707|NCT01108809|155751320|FG000|Overall Study|Adverse Event|3|||
48426708|NCT01108809|155751320|FG000|Overall Study|Lost to Follow-up|1|||
48426709|NCT04370028|155751321|FG000|Overall Study|Withdrawal by Subject|695|||
48426710|NCT04370028|155751321|FG000|Overall Study|Protocol Violation|9|||
48426711|NCT04370028|155751321|FG000|Overall Study|Adverse Event|3|||
48426712|NCT00893113|155752831|FG000|Overall Study|Lost to Follow-up|4|||
48426713|NCT00893113|155752832|FG001|Overall Study|Lost to Follow-up|8|||
48426714|NCT00893113|155752831|FG000|Overall Study|Early Termination|1|||
48426715|NCT00893113|155752832|FG001|Overall Study|Early Termination|1|||
48426718|NCT01671085|155752833|FG000|Overall Study|Withdrawal by Subject|1|||
48426719|NCT01671085|155752834|FG001|Overall Study|Withdrawal by Subject|0|||
48426720|NCT01588197|155752835|FG000|Overall Study|Lack of Efficacy|0|||
48426721|NCT01588197|155752836|FG001|Overall Study|Lack of Efficacy|1|||
48426722|NCT01588197|155752835|FG000|Overall Study|No MRI|1|||
48426723|NCT01588197|155752836|FG001|Overall Study|No MRI|0|||
48426724|NCT01912872|155752843|FG000|Overall Study|Lost to Follow-up|2|||
48426725|NCT01912872|155752844|FG001|Overall Study|Lost to Follow-up|3|||
48426726|NCT01912872|155752845|FG002|Overall Study|Lost to Follow-up|5|||
48426727|NCT01912872|155752846|FG003|Overall Study|Lost to Follow-up|5|||
48426728|NCT01912872|155752843|FG000|Overall Study|Other unspecified|3|||
48426729|NCT01912872|155752844|FG001|Overall Study|Other unspecified|1|||
48426730|NCT01912872|155752845|FG002|Overall Study|Other unspecified|3|||
48426731|NCT01912872|155752846|FG003|Overall Study|Other unspecified|0|||
48426732|NCT01912872|155752843|FG000|Overall Study|Informed consent withdrawn|0|||
48426733|NCT01912872|155752844|FG001|Overall Study|Informed consent withdrawn|0|||
48426734|NCT01912872|155752845|FG002|Overall Study|Informed consent withdrawn|1|||
48426735|NCT01912872|155752846|FG003|Overall Study|Informed consent withdrawn|1|||
48426736|NCT01912872|155752843|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
48426737|NCT01912872|155752844|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
48426738|NCT01912872|155752845|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
48426739|NCT01912872|155752846|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
48426740|NCT01912872|155752843|FG000|Overall Study|Protocol Violation|0|||
48426741|NCT01912872|155752844|FG001|Overall Study|Protocol Violation|0|||
48426742|NCT01912872|155752845|FG002|Overall Study|Protocol Violation|1|||
48426743|NCT01912872|155752846|FG003|Overall Study|Protocol Violation|0|||
48426744|NCT01912872|155752843|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48426745|NCT01912872|155752844|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48426746|NCT01912872|155752845|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48426747|NCT01912872|155752846|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
48426748|NCT01912872|155752843|FG000|Overall Study|Withdrawal of study medication|0|||
48426749|NCT01912872|155752844|FG001|Overall Study|Withdrawal of study medication|0|||
48426750|NCT01912872|155752845|FG002|Overall Study|Withdrawal of study medication|0|||
48426751|NCT01912872|155752846|FG003|Overall Study|Withdrawal of study medication|2|||
48426752|NCT01912872|155752843|FG000|Overall Study|Missing|0|||
48426753|NCT01912872|155752844|FG001|Overall Study|Missing|0|||
48426754|NCT01912872|155752845|FG002|Overall Study|Missing|0|||
48426755|NCT01912872|155752846|FG003|Overall Study|Missing|1|||
48426756|NCT01666444|155752847|FG000|Overall Study|Did not initiate treatment|2|||
48426757|NCT01666444|155752848|FG001|Overall Study|Did not initiate treatment|1|||
48426758|NCT00950690|155752851|FG000|Overall Study|Death|4|||
48426759|NCT00950690|155752851|FG000|Overall Study|Adverse Event|15|||
48426760|NCT00950690|155752851|FG000|Overall Study|Lack of Efficacy|22|||
48426761|NCT00950690|155752851|FG000|Overall Study|Lost to Follow-up|40|||
48426762|NCT00950690|155752851|FG000|Overall Study|Other|163|||
48426763|NCT00592358|155752852|FG000|Overall Study|Withdrawal by Subject|2|||
48426764|NCT00592358|155752852|FG000|Overall Study|Adverse Event|1|||
48426765|NCT00592358|155752852|FG000|Overall Study|Lack of Efficacy|2|||
48426766|NCT00592358|155752852|FG000|Overall Study|Inability to swallow pills|1|||
48426767|NCT01993329|155752853|FG000|Period 2|Adverse Event|0|||
48426768|NCT01993329|155752854|FG001|Period 2|Adverse Event|0|||
48426769|NCT01993329|155752855|FG002|Period 2|Adverse Event|0|||
48426770|NCT01993329|155752856|FG003|Period 2|Adverse Event|0|||
48426771|NCT01993329|155752857|FG004|Period 2|Adverse Event|0|||
48426772|NCT01993329|155752858|FG005|Period 2|Adverse Event|1|||
48426773|NCT01993329|155752853|FG000|Wash-out|Personal reasons|0|||
48426774|NCT01993329|155752854|FG001|Wash-out|Personal reasons|1|||
48426775|NCT01993329|155752855|FG002|Wash-out|Personal reasons|0|||
48426776|NCT01993329|155752856|FG003|Wash-out|Personal reasons|0|||
48426777|NCT01993329|155752857|FG004|Wash-out|Personal reasons|0|||
48426778|NCT01993329|155752858|FG005|Wash-out|Personal reasons|0|||
48426779|NCT04760314|155752859|FG000|Induction Period|Withdrawal by Subject|0|||
48426780|NCT04760314|155752860|FG001|Induction Period|Withdrawal by Subject|1|||
48426781|NCT04760314|155752861|FG002|Induction Period|Withdrawal by Subject|1|||
48426782|NCT04760314|155752862|FG003|Induction Period|Withdrawal by Subject|0|||
48426783|NCT04760314|155752863|FG004|Induction Period|Withdrawal by Subject|0|||
48426784|NCT04760314|155752864|FG005|Induction Period|Withdrawal by Subject|0|||
48426785|NCT04760314|155752865|FG006|Induction Period|Withdrawal by Subject|0|||
48426786|NCT04760314|155752866|FG007|Induction Period|Withdrawal by Subject|0|||
48426787|NCT04760314|155752867|FG008|Induction Period|Withdrawal by Subject|0|||
48426788|NCT04760314|155752868|FG009|Induction Period|Withdrawal by Subject|0|||
48426789|NCT04760314|155752869|FG010|Induction Period|Withdrawal by Subject|0|||
48426790|NCT04760314|155752859|FG000|Induction Period|Adverse Event|0|||
48426791|NCT04760314|155752860|FG001|Induction Period|Adverse Event|0|||
48426792|NCT04760314|155752861|FG002|Induction Period|Adverse Event|2|||
48426793|NCT04760314|155752862|FG003|Induction Period|Adverse Event|0|||
48426794|NCT04760314|155752863|FG004|Induction Period|Adverse Event|0|||
48426795|NCT04760314|155752864|FG005|Induction Period|Adverse Event|0|||
48426796|NCT04760314|155752865|FG006|Induction Period|Adverse Event|0|||
48426801|NCT04760314|155752859|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
48426802|NCT04760314|155752860|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
48426803|NCT04760314|155752861|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
48426804|NCT04760314|155752862|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
48426805|NCT04760314|155752863|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
48426806|NCT04760314|155752864|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
48426807|NCT04760314|155752865|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
48426808|NCT04760314|155752866|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
48426809|NCT04760314|155752867|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
48426810|NCT04760314|155752868|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
48426811|NCT04760314|155752869|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
48426812|NCT04760314|155752859|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48426813|NCT04760314|155752860|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48426814|NCT04760314|155752861|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48426815|NCT04760314|155752862|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
48426816|NCT04760314|155752863|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48426817|NCT04760314|155752864|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
48426818|NCT04760314|155752865|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
48426819|NCT04760314|155752866|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48426820|NCT04760314|155752867|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48426821|NCT04760314|155752868|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48426822|NCT04760314|155752869|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
48426823|NCT04760314|155752859|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426824|NCT04760314|155752860|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426825|NCT04760314|155752861|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426826|NCT04760314|155752862|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426827|NCT04760314|155752863|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
48426828|NCT04760314|155752864|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426829|NCT04760314|155752865|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426830|NCT04760314|155752866|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426831|NCT04760314|155752867|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426832|NCT04760314|155752868|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426833|NCT04760314|155752869|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
48426834|NCT04760314|155752859|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
48426835|NCT04760314|155752860|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
48426836|NCT04760314|155752861|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
48426837|NCT04760314|155752862|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
48426838|NCT04760314|155752863|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
48426839|NCT04760314|155752864|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
48426840|NCT04760314|155752865|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
48426841|NCT04760314|155752866|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
48426842|NCT04760314|155752867|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
48426843|NCT04760314|155752868|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
48426844|NCT04760314|155752869|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
48426845|NCT04760314|155752859|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48426846|NCT04760314|155752860|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48426847|NCT04760314|155752861|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48426848|NCT04760314|155752862|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48426849|NCT04760314|155752863|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48426850|NCT04760314|155752864|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48426851|NCT04760314|155752865|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48426852|NCT04760314|155752866|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
48426853|NCT04760314|155752867|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
48426854|NCT04760314|155752868|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
48426855|NCT04760314|155752869|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
48426856|NCT04760314|155752859|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48426857|NCT04760314|155752860|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48426858|NCT04760314|155752861|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48426859|NCT04760314|155752862|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48426860|NCT04760314|155752863|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48426861|NCT04760314|155752864|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48426862|NCT04760314|155752865|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48426863|NCT04760314|155752866|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
48426864|NCT04760314|155752867|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
48426865|NCT04760314|155752868|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
48426866|NCT04760314|155752869|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
48426867|NCT04760314|155752859|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426868|NCT04760314|155752860|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426869|NCT04760314|155752861|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426870|NCT04760314|155752862|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426871|NCT04760314|155752863|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426872|NCT04760314|155752864|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426873|NCT04760314|155752865|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426874|NCT04760314|155752866|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
48426875|NCT04760314|155752867|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426876|NCT04760314|155752868|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426877|NCT04760314|155752869|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
48426878|NCT04760314|155752859|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426879|NCT04760314|155752860|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426880|NCT04760314|155752861|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426881|NCT04760314|155752862|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426882|NCT04760314|155752863|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426883|NCT04760314|155752864|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426884|NCT04760314|155752865|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426885|NCT04760314|155752866|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426886|NCT04760314|155752867|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
48426887|NCT04760314|155752868|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
48426888|NCT04760314|155752869|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
48426889|NCT03242928|155752870|FG000|Overall Study|Adverse Event|2|||
48426890|NCT03242928|155752871|FG001|Overall Study|Adverse Event|1|||
48426891|NCT03242928|155752870|FG000|Overall Study|Lost to Follow-up|2|||
48426892|NCT03242928|155752871|FG001|Overall Study|Lost to Follow-up|0|||
48426893|NCT03242928|155752870|FG000|Overall Study|Physician Decision|0|||
48426894|NCT03242928|155752871|FG001|Overall Study|Physician Decision|1|||
48426895|NCT03242928|155752870|FG000|Overall Study|Withdrawal by Subject|5|||
48426896|NCT03242928|155752871|FG001|Overall Study|Withdrawal by Subject|3|||
48426897|NCT02584634|155752872|FG000|Overall Study|Adverse Event|3|||
48426898|NCT02584634|155752873|FG001|Overall Study|Adverse Event|5|||
48426899|NCT02584634|155752872|FG000|Overall Study|Death|0|||
48426900|NCT02584634|155752873|FG001|Overall Study|Death|1|||
48426901|NCT02584634|155752872|FG000|Overall Study|Lost to Follow-up|0|||
48426902|NCT02584634|155752873|FG001|Overall Study|Lost to Follow-up|1|||
48426903|NCT02584634|155752872|FG000|Overall Study|Physician Decision|1|||
48426904|NCT02584634|155752873|FG001|Overall Study|Physician Decision|2|||
48426905|NCT02584634|155752872|FG000|Overall Study|Progressive disease|7|||
48426906|NCT02584634|155752873|FG001|Overall Study|Progressive disease|15|||
48426907|NCT02584634|155752872|FG000|Overall Study|Withdrawal by Subject|1|||
48426908|NCT02584634|155752873|FG001|Overall Study|Withdrawal by Subject|1|||
48426909|NCT02584634|155752872|FG000|Overall Study|Other|0|||
48426910|NCT02584634|155752873|FG001|Overall Study|Other|6|||
48426911|NCT02341014|155752874|FG000|Overall Study|Adverse Event|0|||
48426912|NCT02341014|155752875|FG001|Overall Study|Adverse Event|1|||
48426913|NCT02341014|155752876|FG002|Overall Study|Adverse Event|0|||
48426914|NCT02341014|155752877|FG003|Overall Study|Adverse Event|0|||
48426915|NCT02341014|155752878|FG004|Overall Study|Adverse Event|2|||
48426916|NCT00726323|155752879|FG000|Overall Study|Withdrawal by Subject|3|||
48426917|NCT00726323|155752880|FG001|Overall Study|Withdrawal by Subject|1|||
48426918|NCT00726323|155752879|FG000|Overall Study|Physician Decision|1|||
48426919|NCT00726323|155752880|FG001|Overall Study|Physician Decision|0|||
48426920|NCT00726323|155752879|FG000|Overall Study|Progressive disease|23|||
48426921|NCT00726323|155752880|FG001|Overall Study|Progressive disease|16|||
48426922|NCT00726323|155752879|FG000|Overall Study|Clinical progression|0|||
48426923|NCT00726323|155752880|FG001|Overall Study|Clinical progression|3|||
48426924|NCT00726323|155752879|FG000|Overall Study|Adverse Event|9|||
48426925|NCT00726323|155752880|FG001|Overall Study|Adverse Event|9|||
48426926|NCT00726323|155752879|FG000|Overall Study|Death|1|||
48426927|NCT00726323|155752880|FG001|Overall Study|Death|0|||
48426928|NCT00726323|155752879|FG000|Overall Study|Participant wished to discontinue|0|||
48426929|NCT00726323|155752880|FG001|Overall Study|Participant wished to discontinue|1|||
48426930|NCT00726323|155752879|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
48426931|NCT00726323|155752880|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
48426932|NCT01753115|155752881|FG000|Overall Study|Lost to Follow-up|3|||
48426933|NCT01753115|155752882|FG001|Overall Study|Lost to Follow-up|6|||
48426934|NCT01753115|155752883|FG002|Overall Study|Lost to Follow-up|8|||
48426935|NCT01753115|155752881|FG000|Overall Study|Withdrawal by Subject|6|||
48426936|NCT01753115|155752882|FG001|Overall Study|Withdrawal by Subject|5|||
48426937|NCT01753115|155752883|FG002|Overall Study|Withdrawal by Subject|6|||
48426938|NCT01753115|155752881|FG000|Overall Study|Subject non-compliant|3|||
48426939|NCT01753115|155752882|FG001|Overall Study|Subject non-compliant|3|||
48426940|NCT01753115|155752883|FG002|Overall Study|Subject non-compliant|0|||
48426941|NCT01753115|155752881|FG000|Overall Study|Used excluded drug|0|||
48426942|NCT01753115|155752882|FG001|Overall Study|Used excluded drug|1|||
48426943|NCT01753115|155752883|FG002|Overall Study|Used excluded drug|0|||
48426944|NCT04705597|155752884|FG000|Overall Study|Death|16|||
48426948|NCT04705597|155752884|FG000|Overall Study|Withdrawal by Subject|1|||
48426949|NCT04705597|155752885|FG001|Overall Study|Withdrawal by Subject|2|||
48426950|NCT02869867|155752888|FG000|Overall Study|Protocol Violation|1|||
48426951|NCT02869867|155752889|FG001|Overall Study|Protocol Violation|0|||
48426952|NCT02869867|155752888|FG000|Overall Study|Lost to Follow-up|5|||
48426953|NCT02869867|155752889|FG001|Overall Study|Lost to Follow-up|5|||
48426954|NCT00130208|155752891|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
48426955|NCT00130208|155752892|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
48426956|NCT00130208|155752891|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
48426957|NCT00130208|155752892|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
48426958|NCT00130208|155752891|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
48426959|NCT00130208|155752892|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
48426960|NCT00130208|155752891|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
48426961|NCT00130208|155752892|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
48426962|NCT00130208|155752891|FG000|Maintenance Period (26 Weeks)|Other|1|||
48426963|NCT00130208|155752892|FG001|Maintenance Period (26 Weeks)|Other|1|||
48426964|NCT00130208|155752891|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
48426965|NCT00130208|155752892|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
48426966|NCT00130208|155752891|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
48426967|NCT00130208|155752892|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
48426968|NCT00130208|155752891|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
48426969|NCT00130208|155752892|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
48426970|NCT00130208|155752891|FG000|Washout Period (8 Weeks)|Other|1|||
48426971|NCT00130208|155752892|FG001|Washout Period (8 Weeks)|Other|1|||
48426972|NCT01372878|155752893|FG000|Overall Study|Withdrawal by Subject|63|||
48426973|NCT01372878|155752893|FG000|Overall Study|Protocol Violation|17|||
48426974|NCT01372878|155752893|FG000|Overall Study|incomplete study procedure|104|||
48426975|NCT00069095|155752894|FG000|Primary Treatment Phase|Ongoing|0|||
48426976|NCT00069095|155752895|FG001|Primary Treatment Phase|Ongoing|0|||
48426977|NCT00069095|155752896|FG002|Primary Treatment Phase|Ongoing|5|||
48426978|NCT00069095|155752897|FG003|Primary Treatment Phase|Ongoing|7|||
48426979|NCT00069095|155752898|FG004|Primary Treatment Phase|Ongoing|7|||
48426980|NCT00069095|155752899|FG005|Primary Treatment Phase|Ongoing|4|||
48426981|NCT00069095|155752894|FG000|Primary Treatment Phase|Admin/Other|29|||
48426982|NCT00069095|155752895|FG001|Primary Treatment Phase|Admin/Other|38|||
48426983|NCT00069095|155752896|FG002|Primary Treatment Phase|Admin/Other|31|||
48426984|NCT00069095|155752897|FG003|Primary Treatment Phase|Admin/Other|45|||
48426985|NCT00069095|155752898|FG004|Primary Treatment Phase|Admin/Other|48|||
48426986|NCT00069095|155752899|FG005|Primary Treatment Phase|Admin/Other|42|||
48426987|NCT00069095|155752894|FG000|Primary Treatment Phase|Adverse Event|99|||
48426988|NCT00069095|155752895|FG001|Primary Treatment Phase|Adverse Event|92|||
48426989|NCT00069095|155752896|FG002|Primary Treatment Phase|Adverse Event|71|||
48426990|NCT00069095|155752897|FG003|Primary Treatment Phase|Adverse Event|72|||
48426991|NCT00069095|155752898|FG004|Primary Treatment Phase|Adverse Event|109|||
48426992|NCT00069095|155752899|FG005|Primary Treatment Phase|Adverse Event|101|||
48426993|NCT00069095|155752894|FG000|Primary Treatment Phase|Death|14|||
48426994|NCT00069095|155752895|FG001|Primary Treatment Phase|Death|8|||
48426995|NCT00069095|155752896|FG002|Primary Treatment Phase|Death|2|||
48426996|NCT00069095|155752897|FG003|Primary Treatment Phase|Death|5|||
48426997|NCT00069095|155752898|FG004|Primary Treatment Phase|Death|8|||
48426998|NCT00069095|155752899|FG005|Primary Treatment Phase|Death|8|||
48426999|NCT00069095|155752894|FG000|Primary Treatment Phase|Failure to return|5|||
48427000|NCT00069095|155752895|FG001|Primary Treatment Phase|Failure to return|5|||
48427001|NCT00069095|155752896|FG002|Primary Treatment Phase|Failure to return|0|||
48427002|NCT00069095|155752897|FG003|Primary Treatment Phase|Failure to return|0|||
48427003|NCT00069095|155752898|FG004|Primary Treatment Phase|Failure to return|0|||
48427004|NCT00069095|155752899|FG005|Primary Treatment Phase|Failure to return|2|||
48427005|NCT00069095|155752894|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
48427006|NCT00069095|155752895|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
48427007|NCT00069095|155752896|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
48427008|NCT00069095|155752897|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
48427009|NCT00069095|155752898|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
48427010|NCT00069095|155752899|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
48427011|NCT00069095|155752894|FG000|Primary Treatment Phase|Refused treatment|15|||
48427012|NCT00069095|155752895|FG001|Primary Treatment Phase|Refused treatment|26|||
48427013|NCT00069095|155752896|FG002|Primary Treatment Phase|Refused treatment|17|||
48427014|NCT00069095|155752897|FG003|Primary Treatment Phase|Refused treatment|31|||
48427015|NCT00069095|155752898|FG004|Primary Treatment Phase|Refused treatment|24|||
48427016|NCT00069095|155752899|FG005|Primary Treatment Phase|Refused treatment|27|||
48427017|NCT00069095|155752894|FG000|Primary Treatment Phase|Withdrew|2|||
48427018|NCT00069095|155752895|FG001|Primary Treatment Phase|Withdrew|3|||
48427019|NCT00069095|155752896|FG002|Primary Treatment Phase|Withdrew|8|||
48427020|NCT00069095|155752897|FG003|Primary Treatment Phase|Withdrew|2|||
48427021|NCT00069095|155752898|FG004|Primary Treatment Phase|Withdrew|4|||
48427022|NCT00069095|155752899|FG005|Primary Treatment Phase|Withdrew|9|||
48427023|NCT00069095|155752894|FG000|Primary Treatment Phase|Other Violation|0|||
48427024|NCT00069095|155752895|FG001|Primary Treatment Phase|Other Violation|1|||
48427025|NCT00069095|155752896|FG002|Primary Treatment Phase|Other Violation|1|||
48427026|NCT00069095|155752897|FG003|Primary Treatment Phase|Other Violation|1|||
48427027|NCT00069095|155752898|FG004|Primary Treatment Phase|Other Violation|0|||
48427028|NCT00069095|155752899|FG005|Primary Treatment Phase|Other Violation|1|||
48427029|NCT00069095|155752894|FG000|Primary Treatment Phase|Violation criteria|0|||
48427030|NCT00069095|155752895|FG001|Primary Treatment Phase|Violation criteria|2|||
48427031|NCT00069095|155752896|FG002|Primary Treatment Phase|Violation criteria|4|||
48427032|NCT00069095|155752897|FG003|Primary Treatment Phase|Violation criteria|3|||
48427033|NCT00069095|155752898|FG004|Primary Treatment Phase|Violation criteria|1|||
48427034|NCT00069095|155752899|FG005|Primary Treatment Phase|Violation criteria|5|||
48427035|NCT00069095|155752894|FG000|Post-study Treatment Phase|Missing reason|1|||
48427036|NCT00069095|155752895|FG001|Post-study Treatment Phase|Missing reason|3|||
48427037|NCT00069095|155752896|FG002|Post-study Treatment Phase|Missing reason|12|||
48427038|NCT00069095|155752897|FG003|Post-study Treatment Phase|Missing reason|8|||
48427039|NCT00069095|155752898|FG004|Post-study Treatment Phase|Missing reason|18|||
48427040|NCT00069095|155752899|FG005|Post-study Treatment Phase|Missing reason|17|||
48427041|NCT00069095|155752894|FG000|Post-study Treatment Phase|Adverse Event|2|||
48427042|NCT00069095|155752895|FG001|Post-study Treatment Phase|Adverse Event|3|||
48427043|NCT00069095|155752896|FG002|Post-study Treatment Phase|Adverse Event|1|||
48427044|NCT00069095|155752897|FG003|Post-study Treatment Phase|Adverse Event|0|||
48427045|NCT00069095|155752898|FG004|Post-study Treatment Phase|Adverse Event|5|||
48427046|NCT00069095|155752899|FG005|Post-study Treatment Phase|Adverse Event|1|||
48427047|NCT00069095|155752894|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
48427048|NCT00069095|155752895|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
48427049|NCT00069095|155752896|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
48427050|NCT00069095|155752897|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
48427051|NCT00069095|155752898|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
48427052|NCT00069095|155752899|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
48427053|NCT00069095|155752894|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
48427054|NCT00069095|155752895|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
48427055|NCT00069095|155752896|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
48427056|NCT00069095|155752897|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
48427057|NCT00069095|155752898|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
48427058|NCT00069095|155752899|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
48427059|NCT00069095|155752894|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
48427060|NCT00069095|155752895|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
48427061|NCT00069095|155752896|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
48427062|NCT00069095|155752897|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
48427063|NCT00069095|155752898|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
48427064|NCT00069095|155752899|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
48427065|NCT00069095|155752894|FG000|Post-study Treatment Phase|Participant had complete response|1|||
48427066|NCT00069095|155752895|FG001|Post-study Treatment Phase|Participant had complete response|1|||
48427067|NCT00069095|155752896|FG002|Post-study Treatment Phase|Participant had complete response|0|||
48427068|NCT00069095|155752897|FG003|Post-study Treatment Phase|Participant had complete response|0|||
48427069|NCT00069095|155752898|FG004|Post-study Treatment Phase|Participant had complete response|0|||
48427070|NCT00069095|155752899|FG005|Post-study Treatment Phase|Participant had complete response|0|||
48427071|NCT00069095|155752894|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48427072|NCT00069095|155752895|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
48427073|NCT00069095|155752896|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48427074|NCT00069095|155752897|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48427075|NCT00069095|155752898|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48427076|NCT00069095|155752899|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
48427077|NCT00069095|155752894|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
48427078|NCT00069095|155752895|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
48427079|NCT00069095|155752896|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
48427080|NCT00069095|155752897|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
48427081|NCT00069095|155752898|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
48427082|NCT00069095|155752899|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
48427083|NCT00069095|155752894|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
48427084|NCT00069095|155752895|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
48427085|NCT00069095|155752896|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
48427086|NCT00069095|155752897|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
48427087|NCT00069095|155752898|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
48427088|NCT00069095|155752899|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
48427089|NCT00069095|155752894|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
48427090|NCT00069095|155752895|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
48427091|NCT00069095|155752896|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
48427092|NCT00069095|155752897|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
48427093|NCT00069095|155752898|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
48427094|NCT00069095|155752899|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
48427095|NCT00069095|155752894|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48427096|NCT00069095|155752895|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48427097|NCT00069095|155752896|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48427098|NCT00069095|155752897|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
48427099|NCT00069095|155752898|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48427100|NCT00069095|155752899|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
48427101|NCT00069095|155752894|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
48427102|NCT00069095|155752895|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
48427103|NCT00069095|155752896|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
48427104|NCT00069095|155752897|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
48427105|NCT00069095|155752898|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
48427106|NCT00069095|155752899|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
48427107|NCT00069095|155752894|FG000|Post-study Treatment Phase|Surgery|0|||
48427108|NCT00069095|155752895|FG001|Post-study Treatment Phase|Surgery|0|||
48427109|NCT00069095|155752896|FG002|Post-study Treatment Phase|Surgery|0|||
48427110|NCT00069095|155752897|FG003|Post-study Treatment Phase|Surgery|1|||
48427111|NCT00069095|155752898|FG004|Post-study Treatment Phase|Surgery|1|||
48427112|NCT00069095|155752899|FG005|Post-study Treatment Phase|Surgery|0|||
48427113|NCT00069095|155752894|FG000|Post-study Treatment Phase|Death|0|||
48427114|NCT00069095|155752895|FG001|Post-study Treatment Phase|Death|0|||
48427115|NCT00069095|155752896|FG002|Post-study Treatment Phase|Death|0|||
48427116|NCT00069095|155752897|FG003|Post-study Treatment Phase|Death|0|||
48427117|NCT00069095|155752898|FG004|Post-study Treatment Phase|Death|1|||
48427118|NCT00069095|155752899|FG005|Post-study Treatment Phase|Death|0|||
48427119|NCT00069095|155752894|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
48427120|NCT00069095|155752895|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
48427121|NCT00069095|155752896|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
48427122|NCT00069095|155752897|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
48427123|NCT00069095|155752898|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
48427124|NCT00069095|155752899|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
48427125|NCT00069095|155752894|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48427126|NCT00069095|155752895|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48427127|NCT00069095|155752896|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48427128|NCT00069095|155752897|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48427129|NCT00069095|155752898|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
48427130|NCT00069095|155752899|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
48427131|NCT00069095|155752894|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48427132|NCT00069095|155752895|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48427133|NCT00069095|155752896|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48427134|NCT00069095|155752897|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48427135|NCT00069095|155752898|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
48427136|NCT00069095|155752899|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
48427137|NCT00069095|155752894|FG000|Post-study Treatment Phase|Investigator decision|0|||
48427138|NCT00069095|155752895|FG001|Post-study Treatment Phase|Investigator decision|0|||
48427139|NCT00069095|155752896|FG002|Post-study Treatment Phase|Investigator decision|0|||
48427140|NCT00069095|155752897|FG003|Post-study Treatment Phase|Investigator decision|0|||
48427141|NCT00069095|155752898|FG004|Post-study Treatment Phase|Investigator decision|0|||
48427142|NCT00069095|155752899|FG005|Post-study Treatment Phase|Investigator decision|1|||
48427143|NCT00069095|155752894|FG000|Follow-up Phase|Death|174|||
48427144|NCT00069095|155752895|FG001|Follow-up Phase|Death|206|||
48427145|NCT00069095|155752896|FG002|Follow-up Phase|Death|120|||
48427146|NCT00069095|155752897|FG003|Follow-up Phase|Death|112|||
48427147|NCT00069095|155752898|FG004|Follow-up Phase|Death|92|||
48427148|NCT00069095|155752899|FG005|Follow-up Phase|Death|101|||
48427149|NCT02616029|155752900|FG000|Overall Study|Adverse Event|1|||
48427150|NCT02616029|155752901|FG001|Overall Study|Adverse Event|0|||
48427151|NCT02616029|155752900|FG000|Overall Study|Death|0|||
48427152|NCT02616029|155752901|FG001|Overall Study|Death|1|||
48427153|NCT02616029|155752900|FG000|Overall Study|Protocol Violation|1|||
48427154|NCT02616029|155752901|FG001|Overall Study|Protocol Violation|0|||
48427155|NCT02616029|155752900|FG000|Overall Study|Withdrew Consent|1|||
48427156|NCT02616029|155752901|FG001|Overall Study|Withdrew Consent|0|||
48427157|NCT02616029|155752900|FG000|Overall Study|Enrolled and Never Treated|1|||
48427158|NCT02616029|155752901|FG001|Overall Study|Enrolled and Never Treated|1|||
48427159|NCT01505491|155752902|FG000|Overall Study|Other reason not listed|1|||
48427160|NCT01505491|155752903|FG001|Overall Study|Other reason not listed|0|||
48427161|NCT01505491|155752904|FG002|Overall Study|Other reason not listed|0|||
48427162|NCT01505491|155752902|FG000|Overall Study|Withdrawal by Subject|1|||
48427163|NCT01505491|155752903|FG001|Overall Study|Withdrawal by Subject|1|||
48427164|NCT01505491|155752904|FG002|Overall Study|Withdrawal by Subject|4|||
48427165|NCT01505491|155752902|FG000|Overall Study|Lost to Follow-up|0|||
48427166|NCT01505491|155752903|FG001|Overall Study|Lost to Follow-up|0|||
48427167|NCT01505491|155752904|FG002|Overall Study|Lost to Follow-up|1|||
48427168|NCT01214434|155752907|FG000|Overall Study|Withdrawal by Subject|1|||
48427169|NCT01214434|155752908|FG001|Overall Study|Withdrawal by Subject|0|||
48427170|NCT01214434|155752907|FG000|Overall Study|Lost to Follow-up|2|||
48427171|NCT01214434|155752908|FG001|Overall Study|Lost to Follow-up|2|||
48427172|NCT01214434|155752907|FG000|Overall Study|Site error|1|||
48427173|NCT01214434|155752908|FG001|Overall Study|Site error|0|||
48427174|NCT03792750|155752910|FG000|Overall Study|Death|3|||
48427175|NCT05232097|155752911|FG000|Overall Study|Physician Decision|1|||
48427176|NCT03485729|155752916|FG000|Overall Study|Withdrawal by Subject|0|||
48427177|NCT03485729|155752917|FG001|Overall Study|Withdrawal by Subject|0|||
48427178|NCT03485729|155752918|FG002|Overall Study|Withdrawal by Subject|1|||
48427179|NCT03485729|155752916|FG000|Overall Study|Disease progression|8|||
48427180|NCT03485729|155752917|FG001|Overall Study|Disease progression|13|||
48427181|NCT03485729|155752918|FG002|Overall Study|Disease progression|1|||
48427182|NCT03485729|155752916|FG000|Overall Study|Hospice care|1|||
48427183|NCT03485729|155752917|FG001|Overall Study|Hospice care|0|||
48427184|NCT03485729|155752918|FG002|Overall Study|Hospice care|0|||
48427185|NCT03485729|155752916|FG000|Overall Study|Poor performance status|1|||
48427186|NCT03485729|155752917|FG001|Overall Study|Poor performance status|0|||
48427187|NCT03485729|155752918|FG002|Overall Study|Poor performance status|0|||
48427188|NCT03485729|155752916|FG000|Overall Study|Illness|0|||
48427189|NCT03485729|155752917|FG001|Overall Study|Illness|1|||
48427190|NCT03485729|155752918|FG002|Overall Study|Illness|0|||
48427191|NCT02137772|155752919|FG000|Overall Study|Adverse Event|6|||
48427192|NCT02137772|155752920|FG001|Overall Study|Adverse Event|3|||
48427193|NCT02137772|155752919|FG000|Overall Study|Death|71|||
48427194|NCT02137772|155752920|FG001|Overall Study|Death|44|||
48427195|NCT02137772|155752919|FG000|Overall Study|Lost to Follow-up|8|||
48427196|NCT02137772|155752920|FG001|Overall Study|Lost to Follow-up|4|||
48427197|NCT02137772|155752919|FG000|Overall Study|Physician Decision|15|||
48427198|NCT02137772|155752920|FG001|Overall Study|Physician Decision|5|||
48427199|NCT02137772|155752919|FG000|Overall Study|Withdrawal by Subject|28|||
48427200|NCT02137772|155752920|FG001|Overall Study|Withdrawal by Subject|17|||
48427201|NCT02137772|155752919|FG000|Overall Study|Non-compliance with study drug|1|||
48427202|NCT02137772|155752920|FG001|Overall Study|Non-compliance with study drug|0|||
48427203|NCT02137772|155752919|FG000|Overall Study|Not treated|3|||
48427204|NCT02137772|155752920|FG001|Overall Study|Not treated|2|||
48427205|NCT01242020|155752921|FG000|Overall Study|Withdrawal by Subject|2|||
48427206|NCT01242020|155752922|FG001|Overall Study|Withdrawal by Subject|0|||
48427207|NCT01242020|155752921|FG000|Overall Study|Failed screening|1|||
48427208|NCT01242020|155752922|FG001|Overall Study|Failed screening|0|||
48427209|NCT01844700|155752923|FG000|Overall Study|Lack of Efficacy|1|||
48427210|NCT01844700|155752924|FG001|Overall Study|Lack of Efficacy|0|||
48427211|NCT01844700|155752923|FG000|Overall Study|refused medication switch|1|||
48427212|NCT01844700|155752924|FG001|Overall Study|refused medication switch|0|||
48427213|NCT01844700|155752923|FG000|Overall Study|Withdrawal by Subject|1|||
48427214|NCT01844700|155752924|FG001|Overall Study|Withdrawal by Subject|0|||
48427215|NCT01844700|155752923|FG000|Overall Study|stopped taking meds|0|||
48427216|NCT01844700|155752924|FG001|Overall Study|stopped taking meds|1|||
48427217|NCT03345836|155752925|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
48427218|NCT03345836|155752926|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
48427219|NCT03345836|155752927|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
48427220|NCT03345836|155752928|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
48427221|NCT03345836|155752929|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
48427222|NCT03345836|155752930|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
48427223|NCT03345836|155752925|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
48427224|NCT03345836|155752926|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
48427225|NCT03345836|155752927|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
48427226|NCT03345836|155752928|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
48427227|NCT03345836|155752929|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
48427228|NCT03345836|155752930|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
48427229|NCT03345836|155752925|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48427230|NCT03345836|155752926|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
48427231|NCT03345836|155752927|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48427232|NCT03345836|155752928|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48427233|NCT03345836|155752929|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48427234|NCT03345836|155752930|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
48427235|NCT03345836|155752925|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
48427236|NCT03345836|155752926|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
48427237|NCT03345836|155752927|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
48427238|NCT03345836|155752928|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
48427239|NCT03345836|155752929|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
48427240|NCT03345836|155752930|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
48427241|NCT03345836|155752925|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
48427242|NCT03345836|155752926|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
48427243|NCT03345836|155752927|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
48427244|NCT03345836|155752928|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
48427245|NCT03345836|155752929|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
48427246|NCT03345836|155752930|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
48427247|NCT03345836|155752925|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
48427248|NCT03345836|155752926|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
48427249|NCT03345836|155752927|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
48427250|NCT03345836|155752928|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
48427251|NCT03345836|155752929|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
48427252|NCT03345836|155752930|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
48427253|NCT03345836|155752925|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
48427254|NCT03345836|155752926|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
48427255|NCT03345836|155752927|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
48427256|NCT03345836|155752928|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
48427257|NCT03345836|155752929|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
48427258|NCT03345836|155752930|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
48427259|NCT03345836|155752925|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48427260|NCT03345836|155752926|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48427261|NCT03345836|155752927|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48427262|NCT03345836|155752928|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48427263|NCT03345836|155752929|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
48427264|NCT03345836|155752930|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
48427265|NCT03345836|155752925|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
48427266|NCT03345836|155752926|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
48427267|NCT03345836|155752927|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
48427268|NCT03345836|155752928|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
48427269|NCT03345836|155752929|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
48427270|NCT03345836|155752930|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
48427271|NCT03345836|155752925|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48427272|NCT03345836|155752926|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48427273|NCT03345836|155752927|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48427274|NCT03345836|155752928|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48427275|NCT03345836|155752929|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
48427276|NCT03345836|155752930|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
48427277|NCT03345836|155752925|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
48427278|NCT03345836|155752926|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
48427279|NCT03345836|155752927|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
48427280|NCT03345836|155752928|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
48427281|NCT03345836|155752929|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
48427282|NCT03345836|155752930|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
48427283|NCT02650284|155752933|FG000|Overall Study|Lost to Follow-up|3|||
48427284|NCT02650284|155752934|FG001|Overall Study|Lost to Follow-up|3|||
48427285|NCT02650284|155752933|FG000|Overall Study|Consent incorrectly taken|0|||
48427286|NCT02650284|155752934|FG001|Overall Study|Consent incorrectly taken|1|||
48427287|NCT01635933|155752935|FG000|Overall Study|Adverse Event|1|||
48427288|NCT01635933|155752936|FG001|Overall Study|Adverse Event|0|||
48427289|NCT01635933|155752935|FG000|Overall Study|Lost to Follow-up|0|||
48427290|NCT01635933|155752936|FG001|Overall Study|Lost to Follow-up|5|||
48427291|NCT01635933|155752935|FG000|Overall Study|Subject decision|1|||
48427292|NCT01635933|155752936|FG001|Overall Study|Subject decision|1|||
48427293|NCT01635933|155752935|FG000|Overall Study|Noncompliance|0|||
48427294|NCT01635933|155752936|FG001|Overall Study|Noncompliance|1|||
48427295|NCT01635933|155752935|FG000|Overall Study|No longer had transportation|0|||
48427296|NCT01635933|155752936|FG001|Overall Study|No longer had transportation|1|||
48427297|NCT01544595|155752938|FG000|Status at Week 68|Adverse Event|3|||
48427298|NCT01544595|155752939|FG001|Status at Week 68|Adverse Event|2|||
48427303|NCT01544595|155752938|FG000|Status at Week 68|Lack of Efficacy|1|||
48427304|NCT01544595|155752939|FG001|Status at Week 68|Lack of Efficacy|0|||
48427305|NCT01544595|155752940|FG002|Status at Week 68|Lack of Efficacy|0|||
48427306|NCT01544595|155752941|FG003|Status at Week 68|Lack of Efficacy|0|||
48427307|NCT01544595|155752942|FG004|Status at Week 68|Lack of Efficacy|0|||
48427308|NCT01544595|155752943|FG005|Status at Week 68|Lack of Efficacy|0|||
48427309|NCT01544595|155752938|FG000|Status at Week 68|Lost to Follow-up|1|||
48427310|NCT01544595|155752939|FG001|Status at Week 68|Lost to Follow-up|1|||
48427311|NCT01544595|155752940|FG002|Status at Week 68|Lost to Follow-up|0|||
48427312|NCT01544595|155752941|FG003|Status at Week 68|Lost to Follow-up|0|||
48427313|NCT01544595|155752942|FG004|Status at Week 68|Lost to Follow-up|0|||
48427314|NCT01544595|155752943|FG005|Status at Week 68|Lost to Follow-up|0|||
48427315|NCT01544595|155752938|FG000|Status at Week 68|Non-compliance with study treatment|1|||
48427316|NCT01544595|155752939|FG001|Status at Week 68|Non-compliance with study treatment|0|||
48427317|NCT01544595|155752940|FG002|Status at Week 68|Non-compliance with study treatment|0|||
48427318|NCT01544595|155752941|FG003|Status at Week 68|Non-compliance with study treatment|1|||
48427319|NCT01544595|155752942|FG004|Status at Week 68|Non-compliance with study treatment|0|||
48427320|NCT01544595|155752943|FG005|Status at Week 68|Non-compliance with study treatment|0|||
48427321|NCT01544595|155752938|FG000|Status at Week 68|Protocol Violation|2|||
48427322|NCT01544595|155752939|FG001|Status at Week 68|Protocol Violation|0|||
48427323|NCT01544595|155752940|FG002|Status at Week 68|Protocol Violation|1|||
48427324|NCT01544595|155752941|FG003|Status at Week 68|Protocol Violation|1|||
48427325|NCT01544595|155752942|FG004|Status at Week 68|Protocol Violation|0|||
48427326|NCT01544595|155752943|FG005|Status at Week 68|Protocol Violation|0|||
48427327|NCT01544595|155752938|FG000|Status at Week 68|Technical problems|1|||
48427328|NCT01544595|155752939|FG001|Status at Week 68|Technical problems|0|||
48427329|NCT01544595|155752940|FG002|Status at Week 68|Technical problems|0|||
48427330|NCT01544595|155752941|FG003|Status at Week 68|Technical problems|1|||
48427331|NCT01544595|155752942|FG004|Status at Week 68|Technical problems|0|||
48427332|NCT01544595|155752943|FG005|Status at Week 68|Technical problems|0|||
48427333|NCT01544595|155752938|FG000|Status at Week 68|Withdrawal by Subject|0|||
48427334|NCT01544595|155752939|FG001|Status at Week 68|Withdrawal by Subject|1|||
48427335|NCT01544595|155752940|FG002|Status at Week 68|Withdrawal by Subject|1|||
48427336|NCT01544595|155752941|FG003|Status at Week 68|Withdrawal by Subject|2|||
48427337|NCT01544595|155752942|FG004|Status at Week 68|Withdrawal by Subject|0|||
48427338|NCT01544595|155752943|FG005|Status at Week 68|Withdrawal by Subject|0|||
48427339|NCT01544595|155752938|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
48427340|NCT01544595|155752939|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
48427341|NCT01544595|155752940|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
48427342|NCT01544595|155752941|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
48427343|NCT01544595|155752942|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
48427344|NCT01544595|155752943|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
48427345|NCT01544595|155752938|FG000|Status at Week 156|Withdrawal by Subject|9|||
48427346|NCT01544595|155752939|FG001|Status at Week 156|Withdrawal by Subject|10|||
48427347|NCT01544595|155752940|FG002|Status at Week 156|Withdrawal by Subject|4|||
48427348|NCT01544595|155752941|FG003|Status at Week 156|Withdrawal by Subject|9|||
48427349|NCT01544595|155752942|FG004|Status at Week 156|Withdrawal by Subject|20|||
48427350|NCT01544595|155752943|FG005|Status at Week 156|Withdrawal by Subject|6|||
48427351|NCT01544595|155752938|FG000|Status at Week 156|Adverse Event|9|||
48427352|NCT01544595|155752939|FG001|Status at Week 156|Adverse Event|11|||
48427353|NCT01544595|155752940|FG002|Status at Week 156|Adverse Event|1|||
48427354|NCT01544595|155752941|FG003|Status at Week 156|Adverse Event|3|||
48427355|NCT01544595|155752942|FG004|Status at Week 156|Adverse Event|4|||
48427356|NCT01544595|155752943|FG005|Status at Week 156|Adverse Event|2|||
48427357|NCT01544595|155752938|FG000|Status at Week 156|Lost to Follow-up|4|||
48427358|NCT01544595|155752939|FG001|Status at Week 156|Lost to Follow-up|4|||
48427359|NCT01544595|155752940|FG002|Status at Week 156|Lost to Follow-up|0|||
48427360|NCT01544595|155752941|FG003|Status at Week 156|Lost to Follow-up|1|||
48427361|NCT01544595|155752942|FG004|Status at Week 156|Lost to Follow-up|4|||
48427362|NCT01544595|155752943|FG005|Status at Week 156|Lost to Follow-up|1|||
48427363|NCT01544595|155752938|FG000|Status at Week 156|Non-compliance with study treatement|0|||
48427364|NCT01544595|155752939|FG001|Status at Week 156|Non-compliance with study treatement|1|||
48427365|NCT01544595|155752940|FG002|Status at Week 156|Non-compliance with study treatement|0|||
48427366|NCT01544595|155752941|FG003|Status at Week 156|Non-compliance with study treatement|1|||
48427367|NCT01544595|155752942|FG004|Status at Week 156|Non-compliance with study treatement|0|||
48427368|NCT01544595|155752943|FG005|Status at Week 156|Non-compliance with study treatement|1|||
48427369|NCT01544595|155752938|FG000|Status at Week 156|Physician Decision|0|||
48427370|NCT01544595|155752939|FG001|Status at Week 156|Physician Decision|3|||
48427371|NCT01544595|155752940|FG002|Status at Week 156|Physician Decision|1|||
48427372|NCT01544595|155752941|FG003|Status at Week 156|Physician Decision|0|||
48427373|NCT01544595|155752942|FG004|Status at Week 156|Physician Decision|0|||
48427374|NCT01544595|155752943|FG005|Status at Week 156|Physician Decision|0|||
48427375|NCT01544595|155752938|FG000|Status at Week 156|Pregnancy|2|||
48427381|NCT01544595|155752938|FG000|Status at Week 156|Protocol Violation|3|||
48427382|NCT01544595|155752939|FG001|Status at Week 156|Protocol Violation|1|||
48427383|NCT01544595|155752940|FG002|Status at Week 156|Protocol Violation|2|||
48427384|NCT01544595|155752941|FG003|Status at Week 156|Protocol Violation|2|||
48427385|NCT01544595|155752942|FG004|Status at Week 156|Protocol Violation|0|||
48427386|NCT01544595|155752943|FG005|Status at Week 156|Protocol Violation|0|||
48427387|NCT01544595|155752938|FG000|Status at Week 156|Technical problems|3|||
48427388|NCT01544595|155752939|FG001|Status at Week 156|Technical problems|1|||
48427389|NCT01544595|155752940|FG002|Status at Week 156|Technical problems|0|||
48427390|NCT01544595|155752941|FG003|Status at Week 156|Technical problems|1|||
48427391|NCT01544595|155752942|FG004|Status at Week 156|Technical problems|0|||
48427392|NCT01544595|155752943|FG005|Status at Week 156|Technical problems|0|||
48427393|NCT01544595|155752938|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
48427394|NCT01544595|155752939|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
48427395|NCT01544595|155752940|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
48427396|NCT01544595|155752941|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
48427397|NCT01544595|155752942|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
48427398|NCT01544595|155752943|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
48427399|NCT01544595|155752938|FG000|Status at Week 156|Lack of Efficacy|1|||
48427400|NCT01544595|155752939|FG001|Status at Week 156|Lack of Efficacy|0|||
48427401|NCT01544595|155752940|FG002|Status at Week 156|Lack of Efficacy|1|||
48427402|NCT01544595|155752941|FG003|Status at Week 156|Lack of Efficacy|4|||
48427403|NCT01544595|155752942|FG004|Status at Week 156|Lack of Efficacy|10|||
48427404|NCT01544595|155752943|FG005|Status at Week 156|Lack of Efficacy|5|||
48427405|NCT01629667|155752946|FG000|Overall Study|Lost to Follow-up|0|||
48427406|NCT01629667|155752947|FG001|Overall Study|Lost to Follow-up|1|||
48427407|NCT01629667|155752948|FG002|Overall Study|Lost to Follow-up|1|||
48427408|NCT01629667|155752946|FG000|Overall Study|Withdrawal by Subject|31|||
48427409|NCT01629667|155752947|FG001|Overall Study|Withdrawal by Subject|20|||
48427410|NCT01629667|155752948|FG002|Overall Study|Withdrawal by Subject|28|||
48427411|NCT01629667|155752946|FG000|Overall Study|Death|1|||
48427412|NCT01629667|155752947|FG001|Overall Study|Death|5|||
48427413|NCT01629667|155752948|FG002|Overall Study|Death|3|||
48427414|NCT01629667|155752946|FG000|Overall Study|Randomized, not treated|2|||
48427415|NCT01629667|155752947|FG001|Overall Study|Randomized, not treated|1|||
48427416|NCT01629667|155752948|FG002|Overall Study|Randomized, not treated|0|||
48427417|NCT01629667|155752946|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
48427418|NCT01629667|155752947|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
48427419|NCT01629667|155752948|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
48427420|NCT01629667|155752946|FG000|Overall Study|Requiring lung transplant|2|||
48427421|NCT01629667|155752947|FG001|Overall Study|Requiring lung transplant|1|||
48427422|NCT01629667|155752948|FG002|Overall Study|Requiring lung transplant|3|||
48427423|NCT01629667|155752946|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
48427424|NCT01629667|155752947|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
48427425|NCT01629667|155752948|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
48427426|NCT01629667|155752946|FG000|Overall Study|Started other medicine|1|||
48427427|NCT01629667|155752947|FG001|Overall Study|Started other medicine|0|||
48427428|NCT01629667|155752948|FG002|Overall Study|Started other medicine|1|||
48427429|NCT01629667|155752946|FG000|Overall Study|Site error in safety follow-up|0|||
48427430|NCT01629667|155752947|FG001|Overall Study|Site error in safety follow-up|0|||
48427431|NCT01629667|155752948|FG002|Overall Study|Site error in safety follow-up|1|||
48427432|NCT01629667|155752946|FG000|Overall Study|Enrolled in another clinical study|0|||
48427433|NCT01629667|155752947|FG001|Overall Study|Enrolled in another clinical study|1|||
48427434|NCT01629667|155752948|FG002|Overall Study|Enrolled in another clinical study|0|||
48427435|NCT01629667|155752946|FG000|Overall Study|Code break|1|||
48427436|NCT01629667|155752947|FG001|Overall Study|Code break|0|||
48427437|NCT01629667|155752948|FG002|Overall Study|Code break|0|||
48427438|NCT01929044|155752951|FG000|Overall Study|Adverse Event|1|||
48427439|NCT01929044|155752952|FG001|Overall Study|Adverse Event|0|||
48427440|NCT01929044|155752951|FG000|Overall Study|Protocol Violation|9|||
48427441|NCT01929044|155752952|FG001|Overall Study|Protocol Violation|14|||
48427442|NCT01929044|155752951|FG000|Overall Study|Not Treated|1|||
48427443|NCT01929044|155752952|FG001|Overall Study|Not Treated|3|||
48427444|NCT01165203|155752953|FG000|Active Phase|Serious Adverse Event|1|||
48427445|NCT01165203|155752954|FG001|Active Phase|Serious Adverse Event|0|||
48427446|NCT01165203|155752953|FG000|Active Phase|Withdrawal by Subject|2|||
48427447|NCT01165203|155752954|FG001|Active Phase|Withdrawal by Subject|1|||
48427448|NCT01165203|155752953|FG000|Active Phase|Migrated/moved from study area|0|||
48427449|NCT01165203|155752954|FG001|Active Phase|Migrated/moved from study area|1|||
48427450|NCT01165203|155752953|FG000|Active Phase|Lost to Follow-up|2|||
48427451|NCT01165203|155752954|FG001|Active Phase|Lost to Follow-up|0|||
48427452|NCT01165203|155752953|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
48427453|NCT01165203|155752954|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
48427454|NCT01165203|155752953|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
48427455|NCT01165203|155752954|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
48427456|NCT01165203|155752953|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
48427457|NCT01165203|155752954|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
48427458|NCT01165203|155752953|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
48427459|NCT01165203|155752954|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
48427460|NCT01165203|155752953|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
48427461|NCT01165203|155752954|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
48427462|NCT00637273|155752962|FG000|Overall Study|Adverse Event|11|||
48427463|NCT00637273|155752963|FG001|Overall Study|Adverse Event|5|||
48427464|NCT00637273|155752964|FG002|Overall Study|Adverse Event|7|||
48427465|NCT00637273|155752962|FG000|Overall Study|Lost to Follow-up|8|||
48427466|NCT00637273|155752963|FG001|Overall Study|Lost to Follow-up|9|||
48427467|NCT00637273|155752964|FG002|Overall Study|Lost to Follow-up|13|||
48427468|NCT00637273|155752962|FG000|Overall Study|Protocol Violation|2|||
48427469|NCT00637273|155752963|FG001|Overall Study|Protocol Violation|4|||
48427470|NCT00637273|155752964|FG002|Overall Study|Protocol Violation|1|||
48427471|NCT00637273|155752962|FG000|Overall Study|Withdrawal of Consent|18|||
48427472|NCT00637273|155752963|FG001|Overall Study|Withdrawal of Consent|6|||
48427473|NCT00637273|155752964|FG002|Overall Study|Withdrawal of Consent|18|||
48427474|NCT00637273|155752962|FG000|Overall Study|Investigator Decision|1|||
48427475|NCT00637273|155752963|FG001|Overall Study|Investigator Decision|3|||
48427476|NCT00637273|155752964|FG002|Overall Study|Investigator Decision|1|||
48427477|NCT00637273|155752962|FG000|Overall Study|Administrative|2|||
48427478|NCT00637273|155752963|FG001|Overall Study|Administrative|0|||
48427479|NCT00637273|155752964|FG002|Overall Study|Administrative|0|||
48427480|NCT00637273|155752962|FG000|Overall Study|Loss of Glucose Control|1|||
48427481|NCT00637273|155752963|FG001|Overall Study|Loss of Glucose Control|1|||
48427482|NCT00637273|155752964|FG002|Overall Study|Loss of Glucose Control|1|||
48427483|NCT01454401|155752965|FG000|Overall Study|Death|1|||
48427484|NCT01454401|155752965|FG000|Overall Study|hospitalised|1|||
48427485|NCT01454401|155752965|FG000|Overall Study|osteomyelitis|2|||
48427486|NCT01454401|155752965|FG000|Overall Study|non-adherence|1|||
48427487|NCT03268746|155752968|FG000|Overall Study|Withdrawal by Subject|1|||
48427488|NCT00406640|155752969|FG000|Acute Phase|Adverse Event|18|||
48427489|NCT00406640|155752970|FG001|Acute Phase|Adverse Event|13|||
48427490|NCT00406640|155752969|FG000|Acute Phase|Failed to Return|5|||
48427491|NCT00406640|155752970|FG001|Acute Phase|Failed to Return|1|||
48427492|NCT00406640|155752969|FG000|Acute Phase|Physician Decision|0|||
48427493|NCT00406640|155752970|FG001|Acute Phase|Physician Decision|1|||
48427494|NCT00406640|155752969|FG000|Acute Phase|Lost to Follow-up|7|||
48427495|NCT00406640|155752970|FG001|Acute Phase|Lost to Follow-up|4|||
48427496|NCT00406640|155752969|FG000|Acute Phase|Protocol deviation|4|||
48427497|NCT00406640|155752970|FG001|Acute Phase|Protocol deviation|10|||
48427498|NCT00406640|155752969|FG000|Acute Phase|Protocol Violation|3|||
48427499|NCT00406640|155752970|FG001|Acute Phase|Protocol Violation|2|||
48427500|NCT00406640|155752969|FG000|Acute Phase|Withdrawal by Subject|11|||
48427501|NCT00406640|155752970|FG001|Acute Phase|Withdrawal by Subject|9|||
48427502|NCT00406640|155752969|FG000|Acute Phase|Lack of Efficacy|3|||
48427503|NCT00406640|155752970|FG001|Acute Phase|Lack of Efficacy|3|||
48427504|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
48427505|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
48427506|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|Death|1|||
48427507|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|Death|0|||
48427508|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
48427509|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
48427510|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
48427511|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
48427512|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
48427513|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
48427514|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|non-compliance|7|||
48427515|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|non-compliance|5|||
48427516|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
48427517|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
48427518|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
48427519|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
48427520|NCT00406640|155752969|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
48427521|NCT00406640|155752970|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
48427522|NCT00406640|155752969|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
48427523|NCT00406640|155752970|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
48427524|NCT00406640|155752969|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
48427525|NCT00406640|155752970|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
48427526|NCT00406640|155752969|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
48427527|NCT00406640|155752970|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
48427528|NCT00406640|155752969|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
48427529|NCT00406640|155752970|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
48427530|NCT00406640|155752969|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
48427531|NCT00406640|155752970|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
48427532|NCT00406640|155752969|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
48427533|NCT00406640|155752970|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
48427534|NCT00406640|155752969|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
48427535|NCT00406640|155752970|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
48427536|NCT00589472|155752971|FG000|Overall Study|Adverse Event|1|||
48427537|NCT02582749|155752972|FG000|Overall Study|Study terminated by funder|5|||
48427538|NCT02582749|155752973|FG001|Overall Study|Study terminated by funder|10|||
48427539|NCT02582749|155752972|FG000|Overall Study|Withdrawal by Subject|0|||
48427540|NCT02582749|155752973|FG001|Overall Study|Withdrawal by Subject|1|||
48427541|NCT01000064|155752974|FG000|Overall Study|Withdrawal by Subject|1|||
48427542|NCT01000064|155752975|FG001|Overall Study|Withdrawal by Subject|1|||
48427543|NCT01915849|155752976|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
48427544|NCT01915849|155752977|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
48427545|NCT01915849|155752978|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
48427546|NCT01915849|155752979|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
48427547|NCT01915849|155752976|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
48427548|NCT01915849|155752977|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48427549|NCT01915849|155752978|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48427550|NCT01915849|155752979|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
48427551|NCT01678807|155752980|FG000|Overall Study|Adverse Event|4|||
48427552|NCT01678807|155752981|FG001|Overall Study|Adverse Event|4|||
48427553|NCT01678807|155752982|FG002|Overall Study|Adverse Event|0|||
48427554|NCT01678807|155752980|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
48427555|NCT01678807|155752981|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
48427556|NCT01678807|155752982|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
48427557|NCT01259492|155754663|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
48427558|NCT01259492|155754664|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
48427559|NCT01259492|155754665|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
48427560|NCT01259492|155754666|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
48427561|NCT01259492|155754663|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
48427562|NCT01259492|155754664|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
48427563|NCT01259492|155754665|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
48427564|NCT01259492|155754666|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
48427565|NCT01259492|155754663|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
48427566|NCT01259492|155754664|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
48427567|NCT01259492|155754665|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
48427568|NCT01259492|155754666|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
48427569|NCT01259492|155754663|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
48427570|NCT01259492|155754664|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
48427571|NCT01259492|155754665|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
48427572|NCT01259492|155754666|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
48427573|NCT01259492|155754663|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
48427574|NCT01259492|155754664|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
48427575|NCT01259492|155754665|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
48427576|NCT01259492|155754666|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
48427577|NCT01259492|155754663|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
48427578|NCT01259492|155754664|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
48427579|NCT01259492|155754665|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
48427580|NCT01259492|155754666|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
48427581|NCT01259492|155754663|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
48427582|NCT01259492|155754664|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
48427583|NCT01259492|155754665|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
48427584|NCT01259492|155754666|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
48427585|NCT01259492|155754663|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
48427586|NCT01259492|155754664|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
48427587|NCT01259492|155754665|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
48427588|NCT01259492|155754666|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
48427589|NCT01259492|155754663|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
48427590|NCT01259492|155754664|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
48427591|NCT01259492|155754665|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
48427592|NCT01259492|155754666|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
48427593|NCT01259492|155754663|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
48427594|NCT01259492|155754664|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
48427595|NCT01259492|155754665|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
48427596|NCT01259492|155754666|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
48427597|NCT01259492|155754663|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
48427598|NCT01259492|155754664|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
48427599|NCT01259492|155754665|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
48427600|NCT01259492|155754666|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
48427601|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
48427602|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
48427603|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
48427604|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
48427605|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
48427606|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
48427607|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
48427608|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
48427609|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
48427610|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
48427611|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
48427612|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
48427613|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
48427614|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
48427615|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
48427616|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
48427617|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
48427618|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
48427619|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
48427620|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
48427621|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
48427622|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
48427623|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
48427624|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
48427625|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
48427626|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
48427627|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
48427628|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
48427629|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
48427630|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
48427631|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
48427632|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
48427633|NCT01259492|155754663|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
48427634|NCT01259492|155754664|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
48427635|NCT01259492|155754665|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
48427636|NCT01259492|155754666|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
48427637|NCT03042611|155754671|FG000|Core Phase|Withdrawal by Subject|13|||
48427638|NCT03042611|155754672|FG001|Core Phase|Withdrawal by Subject|4|||
48427639|NCT03042611|155754673|FG002|Core Phase|Withdrawal by Subject|0|||
48427640|NCT03042611|155754674|FG003|Core Phase|Withdrawal by Subject|0|||
48427641|NCT03042611|155754671|FG000|Core Phase|Death|232|||
48427642|NCT03042611|155754672|FG001|Core Phase|Death|110|||
48427643|NCT03042611|155754673|FG002|Core Phase|Death|0|||
48427644|NCT03042611|155754674|FG003|Core Phase|Death|0|||
48427645|NCT03042611|155754671|FG000|Core Phase|Lost to Follow-up|4|||
48427646|NCT03042611|155754672|FG001|Core Phase|Lost to Follow-up|7|||
48427647|NCT03042611|155754673|FG002|Core Phase|Lost to Follow-up|0|||
48427648|NCT03042611|155754674|FG003|Core Phase|Lost to Follow-up|0|||
48427649|NCT03042611|155754671|FG000|Core Phase|Physician Decision|7|||
48427650|NCT03042611|155754672|FG001|Core Phase|Physician Decision|2|||
48427651|NCT03042611|155754673|FG002|Core Phase|Physician Decision|0|||
48427652|NCT03042611|155754674|FG003|Core Phase|Physician Decision|0|||
48427653|NCT03042611|155754671|FG000|Core Phase|Study Closed|0|||
48427654|NCT03042611|155754672|FG001|Core Phase|Study Closed|1|||
48427655|NCT03042611|155754673|FG002|Core Phase|Study Closed|0|||
48427656|NCT03042611|155754674|FG003|Core Phase|Study Closed|0|||
48427657|NCT03042611|155754671|FG000|Extension Phase|Death|0|||
48427658|NCT03042611|155754672|FG001|Extension Phase|Death|0|||
48427659|NCT03042611|155754673|FG002|Extension Phase|Death|34|||
48427660|NCT03042611|155754674|FG003|Extension Phase|Death|16|||
48427661|NCT03042611|155754671|FG000|Extension Phase|Lost to Follow-up|0|||
48427662|NCT03042611|155754672|FG001|Extension Phase|Lost to Follow-up|0|||
48427663|NCT03042611|155754673|FG002|Extension Phase|Lost to Follow-up|1|||
48427664|NCT03042611|155754674|FG003|Extension Phase|Lost to Follow-up|1|||
48427665|NCT03042611|155754671|FG000|Extension Phase|Study Closed|0|||
48427666|NCT03042611|155754672|FG001|Extension Phase|Study Closed|0|||
48427667|NCT03042611|155754673|FG002|Extension Phase|Study Closed|17|||
48427668|NCT03042611|155754674|FG003|Extension Phase|Study Closed|11|||
48427669|NCT01254604|155754676|FG000|Overall Study|Lost to Follow-up|1|||
48427670|NCT01254604|155754677|FG001|Overall Study|Lost to Follow-up|1|||
48427673|NCT01254604|155754676|FG000|Overall Study|Withdrawal by Subject|2|||
48427674|NCT01254604|155754677|FG001|Overall Study|Withdrawal by Subject|4|||
48427675|NCT01254604|155754676|FG000|Overall Study|Adverse Event|3|||
48427676|NCT01254604|155754677|FG001|Overall Study|Adverse Event|2|||
48427677|NCT01306058|155754678|FG000|Overall Study|Death|1|||
48427678|NCT01306058|155754678|FG000|Overall Study|Enrolled but did not get treatment|1|||
48427679|NCT00084682|155754679|FG000|Overall Study|Withdrawal by Subject|1|||
48427680|NCT01166659|155754680|FG000|Overall Study|Subject Decision|8|||
48427681|NCT01166659|155754680|FG000|Overall Study|Investigator Decision|2|||
48427682|NCT01166659|155754680|FG000|Overall Study|Death|1|||
48427683|NCT01166659|155754680|FG000|Overall Study|Lost to Follow-up|1|||
48427684|NCT01166659|155754680|FG000|Overall Study|Study Closed at Site|1|||
48427685|NCT02750813|155754681|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
48427686|NCT02750813|155754682|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
48427687|NCT02750813|155754681|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
48427688|NCT02750813|155754682|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
48427689|NCT01984346|155754683|FG000|Overall Study|Physician Decision|4|||
48427690|NCT01984346|155754684|FG001|Overall Study|Physician Decision|2|||
48427691|NCT01984346|155754683|FG000|Overall Study|Withdrawal by Subject|2|||
48427692|NCT01984346|155754684|FG001|Overall Study|Withdrawal by Subject|2|||
48427693|NCT01984346|155754683|FG000|Overall Study|Enrollment Closed|8|||
48427694|NCT01984346|155754684|FG001|Overall Study|Enrollment Closed|1|||
48427695|NCT01984346|155754683|FG000|Overall Study|Insurance Coverage|1|||
48427696|NCT01984346|155754684|FG001|Overall Study|Insurance Coverage|0|||
48427697|NCT01984346|155754683|FG000|Overall Study|Intra-operative Exclusion|2|||
48427698|NCT01984346|155754684|FG001|Overall Study|Intra-operative Exclusion|0|||
48427699|NCT00536731|155754685|FG000|Overall Study|Adverse Event|3|||
48427700|NCT00536731|155754686|FG001|Overall Study|Adverse Event|2|||
48427701|NCT00536731|155754687|FG002|Overall Study|Adverse Event|3|||
48427702|NCT00536731|155754685|FG000|Overall Study|Withdrawal by Subject|0|||
48427703|NCT00536731|155754686|FG001|Overall Study|Withdrawal by Subject|2|||
48427704|NCT00536731|155754687|FG002|Overall Study|Withdrawal by Subject|0|||
48427705|NCT00536731|155754685|FG000|Overall Study|Intake of prohibited conc. medication|0|||
48427706|NCT00536731|155754686|FG001|Overall Study|Intake of prohibited conc. medication|0|||
48427707|NCT00536731|155754687|FG002|Overall Study|Intake of prohibited conc. medication|1|||
48427708|NCT00536731|155754685|FG000|Overall Study|Safety reasons|0|||
48427709|NCT00536731|155754686|FG001|Overall Study|Safety reasons|0|||
48427710|NCT00536731|155754687|FG002|Overall Study|Safety reasons|1|||
48427711|NCT00536731|155754685|FG000|Overall Study|Other|1|||
48427712|NCT00536731|155754686|FG001|Overall Study|Other|1|||
48427713|NCT00536731|155754687|FG002|Overall Study|Other|0|||
48427714|NCT01103349|155754699|FG000|Overall Study|Adverse Event|8|||
48427715|NCT01103349|155754700|FG001|Overall Study|Adverse Event|5|||
48427716|NCT01103349|155754701|FG002|Overall Study|Adverse Event|3|||
48427717|NCT01103349|155754699|FG000|Overall Study|Consent withdrawn|1|||
48427718|NCT01103349|155754700|FG001|Overall Study|Consent withdrawn|0|||
48427719|NCT01103349|155754701|FG002|Overall Study|Consent withdrawn|0|||
48427720|NCT01103349|155754699|FG000|Overall Study|Incorrectly included in the trial|1|||
48427721|NCT01103349|155754700|FG001|Overall Study|Incorrectly included in the trial|0|||
48427722|NCT01103349|155754701|FG002|Overall Study|Incorrectly included in the trial|0|||
48427723|NCT01103349|155754699|FG000|Overall Study|Withdrawal by Subject|1|||
48427724|NCT01103349|155754700|FG001|Overall Study|Withdrawal by Subject|1|||
48427725|NCT01103349|155754701|FG002|Overall Study|Withdrawal by Subject|0|||
48427726|NCT01103349|155754699|FG000|Overall Study|did not want to take trial medication|0|||
48427727|NCT01103349|155754700|FG001|Overall Study|did not want to take trial medication|1|||
48427728|NCT01103349|155754701|FG002|Overall Study|did not want to take trial medication|0|||
48427729|NCT01103349|155754699|FG000|Overall Study|forgot to take medication|0|||
48427730|NCT01103349|155754700|FG001|Overall Study|forgot to take medication|0|||
48427731|NCT01103349|155754701|FG002|Overall Study|forgot to take medication|1|||
48427732|NCT00390780|155754702|FG000|Overall Study|Not completed|10|||
48427733|NCT00390780|155754703|FG001|Overall Study|Not completed|4|||
48427734|NCT00390780|155754702|FG000|Overall Study|Protocol Violation|6|||
48427735|NCT00390780|155754703|FG001|Overall Study|Protocol Violation|4|||
48427736|NCT00390780|155754702|FG000|Overall Study|Lost to Follow-up|3|||
48427737|NCT00390780|155754703|FG001|Overall Study|Lost to Follow-up|6|||
48427738|NCT00390780|155754702|FG000|Overall Study|Adverse Event|2|||
48427739|NCT00390780|155754703|FG001|Overall Study|Adverse Event|3|||
48427740|NCT00390780|155754702|FG000|Overall Study|Death|1|||
48427741|NCT00390780|155754703|FG001|Overall Study|Death|3|||
48427742|NCT00390780|155754702|FG000|Overall Study|Withdrawal by Subject|1|||
48427743|NCT00390780|155754703|FG001|Overall Study|Withdrawal by Subject|2|||
48427744|NCT00390780|155754702|FG000|Overall Study|Inclusion criteria not satisfied|0|||
48427745|NCT00390780|155754703|FG001|Overall Study|Inclusion criteria not satisfied|2|||
48427746|NCT00390780|155754702|FG000|Overall Study|Lost to follow up and other reasons|0|||
48427747|NCT00390780|155754703|FG001|Overall Study|Lost to follow up and other reasons|1|||
48427748|NCT00390780|155754702|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
48427749|NCT00390780|155754703|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
48427750|NCT00390780|155754702|FG000|Overall Study|SAE, death|0|||
48427751|NCT00390780|155754703|FG001|Overall Study|SAE, death|1|||
48427752|NCT00273858|155754704|FG000|Overall Study|Not completed 24 month observation time|334|||
48427753|NCT00273858|155754704|FG000|Overall Study|Lost to Follow-up|101|||
48427754|NCT00273858|155754704|FG000|Overall Study|Withdrawal by Subject|21|||
48427755|NCT00273858|155754704|FG000|Overall Study|Adverse Event|81|||
48427756|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
48427757|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
48427758|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
48427759|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
48427760|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
48427761|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
48427762|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
48427763|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
48427764|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
48427765|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
48427766|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
48427767|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
48427768|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
48427769|NCT02232516|155754709|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
48427770|NCT02232516|155754709|FG000|Survival Follow-up|Death|15|||
48427771|NCT02232516|155754709|FG000|Survival Follow-up|Withdrawal by Subject|3|||
48427772|NCT02232516|155754709|FG000|Survival Follow-up|Lost to Follow-up|1|||
48427773|NCT02232516|155754709|FG000|Survival Follow-up|Still in follow-up|5|||
48427774|NCT00305006|155754718|FG000|Overall Study|Withdrawal by Subject|1|||
48427775|NCT00305006|155754719|FG001|Overall Study|Withdrawal by Subject|0|||
48427776|NCT00305006|155754718|FG000|Overall Study|Failure to complete pretest|0|||
48427777|NCT00305006|155754719|FG001|Overall Study|Failure to complete pretest|1|||
48427778|NCT02639182|155754720|FG000|Overall Study|Disease Progression|50|||
48427779|NCT02639182|155754721|FG001|Overall Study|Disease Progression|49|||
48427780|NCT02639182|155754720|FG000|Overall Study|Adverse Event|7|||
48427781|NCT02639182|155754721|FG001|Overall Study|Adverse Event|5|||
48427782|NCT02639182|155754720|FG000|Overall Study|Physician Decision|3|||
48427783|NCT02639182|155754721|FG001|Overall Study|Physician Decision|3|||
48427784|NCT02639182|155754720|FG000|Overall Study|Withdrew Consent|5|||
48427785|NCT02639182|155754721|FG001|Overall Study|Withdrew Consent|4|||
48427786|NCT02639182|155754720|FG000|Overall Study|Lost to Follow-up|0|||
48427787|NCT02639182|155754721|FG001|Overall Study|Lost to Follow-up|1|||
48427788|NCT02639182|155754720|FG000|Overall Study|Study Closure|1|||
48427789|NCT02639182|155754721|FG001|Overall Study|Study Closure|2|||
48427790|NCT02639182|155754720|FG000|Overall Study|Sponsor Ended Study|0|||
48427791|NCT02639182|155754721|FG001|Overall Study|Sponsor Ended Study|1|||
48427792|NCT02639182|155754720|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
48427793|NCT02639182|155754721|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
48427794|NCT01234402|155754724|FG000|Overall Study|Lost to Follow-up|0|||
48427795|NCT01234402|155754725|FG001|Overall Study|Lost to Follow-up|1|||
48427796|NCT01234402|155754726|FG002|Overall Study|Lost to Follow-up|3|||
48427797|NCT01234402|155754724|FG000|Overall Study|Withdrawal by Subject|1|||
48427798|NCT01234402|155754725|FG001|Overall Study|Withdrawal by Subject|3|||
48427799|NCT01234402|155754726|FG002|Overall Study|Withdrawal by Subject|4|||
48427800|NCT01234402|155754724|FG000|Overall Study|Never treated: Death|0|||
48427801|NCT01234402|155754725|FG001|Overall Study|Never treated: Death|0|||
48427802|NCT01234402|155754726|FG002|Overall Study|Never treated: Death|1|||
48427803|NCT01234402|155754724|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
48427804|NCT01234402|155754725|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
48427805|NCT01234402|155754726|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
48427806|NCT01234402|155754724|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
48427807|NCT01234402|155754725|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
48427808|NCT01234402|155754726|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
48427809|NCT02564120|155754727|FG000|Overall Study|Did not return release forms|160|||
48427810|NCT02564120|155754727|FG000|Overall Study|Death|58|||
48427811|NCT02564120|155754727|FG000|Overall Study|Withdrawal by Subject|204|||
48427812|NCT02564120|155754727|FG000|Overall Study|Other medical condition|24|||
48427813|NCT00328198|155754730|FG000|Treatment|Adverse Event|21|||
48427814|NCT00328198|155754730|FG000|Treatment|Death|1|||
48427815|NCT00328198|155754730|FG000|Treatment|Physician Decision|5|||
48427816|NCT00328198|155754730|FG000|Treatment|Withdrawal by Subject|5|||
48427817|NCT00328198|155754730|FG000|Treatment|Evidence of disease progression|2|||
48427818|NCT00328198|155754730|FG000|Treatment|Non-compliance|1|||
48427819|NCT00328198|155754730|FG000|Treatment|Confirmed complete response, MRD -|3|||
48427820|NCT00328198|155754730|FG000|Follow-up|Lost to Follow-up|4|||
48427821|NCT00328198|155754730|FG000|Follow-up|Death|31|||
48427822|NCT01809262|155754732|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427823|NCT01809262|155754733|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427824|NCT01809262|155754734|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427825|NCT01809262|155754735|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427826|NCT01809262|155754736|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
48427827|NCT01809262|155754737|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427828|NCT01809262|155754738|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427829|NCT01809262|155754739|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427830|NCT01809262|155754740|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427831|NCT01809262|155754741|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
48427832|NCT01809262|155754732|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427833|NCT01809262|155754733|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
48427834|NCT01809262|155754734|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427835|NCT01809262|155754735|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427836|NCT01809262|155754736|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427837|NCT01809262|155754737|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427838|NCT01809262|155754738|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427839|NCT01809262|155754739|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427840|NCT01809262|155754740|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427841|NCT01809262|155754741|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
48427842|NCT04230486|155754742|FG000|Overall Study|Screen Failure|1|||
48427843|NCT00611455|155754743|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
48427844|NCT00611455|155754744|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
48427845|NCT00611455|155754745|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
48427846|NCT00611455|155754743|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
48427847|NCT00611455|155754744|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48427848|NCT00611455|155754745|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48427849|NCT00611455|155754743|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
48427850|NCT00611455|155754744|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
48427851|NCT00611455|155754745|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
48427852|NCT00611455|155754743|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
48427853|NCT00611455|155754744|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
48427854|NCT00611455|155754745|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48427855|NCT00611455|155754743|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
48427856|NCT00611455|155754744|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
48427857|NCT00611455|155754745|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
48427858|NCT00611455|155754743|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
48427859|NCT00611455|155754744|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
48427860|NCT00611455|155754745|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
48427861|NCT00611455|155754743|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
48427862|NCT00611455|155754744|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
48427863|NCT00611455|155754745|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
48427864|NCT00611455|155754743|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
48427865|NCT00611455|155754744|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
48427866|NCT00611455|155754745|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
48427867|NCT00611455|155754743|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
48427868|NCT00611455|155754744|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
48427869|NCT00611455|155754745|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
48427870|NCT00611455|155754743|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
48427871|NCT00611455|155754744|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
48427872|NCT00611455|155754745|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
48427873|NCT00611455|155754743|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
48427874|NCT00611455|155754744|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
48427875|NCT00611455|155754745|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
48427876|NCT00611455|155754743|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
48427877|NCT00611455|155754744|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
48427878|NCT00611455|155754745|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
48427879|NCT00611455|155754743|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
48427880|NCT00611455|155754744|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
48427881|NCT00611455|155754745|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
48427882|NCT00611455|155754743|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
48427883|NCT00611455|155754744|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
48427884|NCT00611455|155754745|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
48427885|NCT00611455|155754743|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
48427886|NCT00611455|155754744|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
48427887|NCT00611455|155754745|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
48427888|NCT00611455|155754743|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
48427889|NCT00611455|155754744|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
48427890|NCT00611455|155754745|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
48427891|NCT00611455|155754743|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
48427892|NCT00611455|155754744|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
48427893|NCT00611455|155754745|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
48427894|NCT00611455|155754743|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
48427895|NCT00611455|155754744|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
48427896|NCT00611455|155754745|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
48427897|NCT00611455|155754743|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
48427898|NCT00611455|155754744|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
48427899|NCT00611455|155754745|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
48427900|NCT00611455|155754743|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
48427901|NCT00611455|155754744|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
48427902|NCT00611455|155754745|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
48427903|NCT00611455|155754743|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
48427904|NCT00611455|155754744|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
48427905|NCT00611455|155754745|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
48427906|NCT01097330|155754749|FG000|Overall Study|Study terminated early|7|||
48427907|NCT01097330|155754750|FG001|Overall Study|Study terminated early|5|||
48427908|NCT04983940|155754751|FG000|Overall Study|Lost to Follow-up|14|||
48427909|NCT04983940|155754751|FG000|Overall Study|Lack of Efficacy|2|||
48427910|NCT01455428|155754752|FG000|Overall Study|Protocol Violation|2|||
48427911|NCT01455428|155754753|FG001|Overall Study|Protocol Violation|1|||
48427912|NCT01455428|155754752|FG000|Overall Study|Adverse Event|6|||
48427913|NCT01455428|155754753|FG001|Overall Study|Adverse Event|2|||
48427914|NCT01455428|155754752|FG000|Overall Study|Lost to Follow-up|1|||
48427915|NCT01455428|155754753|FG001|Overall Study|Lost to Follow-up|1|||
48427916|NCT01455428|155754752|FG000|Overall Study|Withdrawal by Subject|2|||
48427917|NCT01455428|155754753|FG001|Overall Study|Withdrawal by Subject|5|||
48427918|NCT01455428|155754752|FG000|Overall Study|Did not meet entrance criteria|0|||
48427919|NCT01455428|155754753|FG001|Overall Study|Did not meet entrance criteria|2|||
48427920|NCT01455428|155754752|FG000|Overall Study|Insufficient clinical response|0|||
48427921|NCT01455428|155754753|FG001|Overall Study|Insufficient clinical response|2|||
48427922|NCT01455428|155754752|FG000|Overall Study|Did not receive treatment|1|||
48427923|NCT01455428|155754753|FG001|Overall Study|Did not receive treatment|1|||
48427924|NCT01455428|155754752|FG000|Overall Study|Other|2|||
48427925|NCT01455428|155754753|FG001|Overall Study|Other|4|||
48427926|NCT02086565|155754756|FG000|Overall Study|Lost to Follow-up|9|||
48427927|NCT02086565|155754757|FG001|Overall Study|Lost to Follow-up|7|||
48427928|NCT02086565|155754756|FG000|Overall Study|Withdrawal by Subject|2|||
48427929|NCT02086565|155754757|FG001|Overall Study|Withdrawal by Subject|1|||
48427930|NCT02086565|155754756|FG000|Overall Study|Death|3|||
48427931|NCT02086565|155754757|FG001|Overall Study|Death|2|||
48427932|NCT02086565|155754756|FG000|Overall Study|withdrawn by research team|2|||
48427933|NCT02086565|155754757|FG001|Overall Study|withdrawn by research team|2|||
48427934|NCT00942877|155754758|FG000|Overall Study|Refused further treatment|1|||
48427935|NCT00942877|155754759|FG001|Overall Study|Refused further treatment|1|||
48427936|NCT00942877|155754758|FG000|Overall Study|Patient was not treated|1|||
48427937|NCT00942877|155754759|FG001|Overall Study|Patient was not treated|0|||
48427938|NCT00942877|155754758|FG000|Overall Study|Adverse Event|1|||
48427939|NCT00942877|155754759|FG001|Overall Study|Adverse Event|0|||
48427940|NCT00942877|155754758|FG000|Overall Study|Progressive disease|42|||
48427941|NCT00942877|155754759|FG001|Overall Study|Progressive disease|3|||
48427942|NCT00844428|155754767|FG000|Screening Period|Screen Failure|3|||
48427943|NCT00844428|155754767|FG000|Extension Treatment Period|Death|1|||
48427944|NCT00844428|155754767|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
48427945|NCT02691247|155754768|FG000|Overall Study|Withdrawal by Subject|1|||
48427946|NCT02691247|155754769|FG001|Overall Study|Withdrawal by Subject|2|||
48427947|NCT02691247|155754770|FG002|Overall Study|Withdrawal by Subject|2|||
48427948|NCT02691247|155754768|FG000|Overall Study|Lost to Follow-up|2|||
48427949|NCT02691247|155754769|FG001|Overall Study|Lost to Follow-up|0|||
48427950|NCT02691247|155754770|FG002|Overall Study|Lost to Follow-up|1|||
48427951|NCT00829166|155754773|FG000|Overall Study|Death|305|||
48427952|NCT00829166|155754774|FG001|Overall Study|Death|333|||
48427953|NCT00829166|155754773|FG000|Overall Study|Lost to Follow-up|5|||
48427954|NCT00829166|155754774|FG001|Overall Study|Lost to Follow-up|4|||
48427955|NCT00829166|155754773|FG000|Overall Study|Physician's Decision|4|||
48427956|NCT00829166|155754774|FG001|Overall Study|Physician's Decision|3|||
48427957|NCT00829166|155754773|FG000|Overall Study|Subject's Decision|41|||
48427958|NCT00829166|155754774|FG001|Overall Study|Subject's Decision|55|||
48427959|NCT00829166|155754773|FG000|Overall Study|Sponsor's Decision|137|||
48427960|NCT00829166|155754774|FG001|Overall Study|Sponsor's Decision|98|||
48427961|NCT00829166|155754773|FG000|Overall Study|Reason Not Specified|3|||
48427962|NCT00829166|155754774|FG001|Overall Study|Reason Not Specified|3|||
48427963|NCT02538666|155754775|FG000|Pre-Treatment|Disease progression|1|||
48427964|NCT02538666|155754776|FG001|Pre-Treatment|Disease progression|0|||
48427966|NCT02538666|155754775|FG000|Pre-Treatment|no longer meets study criteria|1|||
48427967|NCT02538666|155754776|FG001|Pre-Treatment|no longer meets study criteria|0|||
48427968|NCT02538666|155754777|FG002|Pre-Treatment|no longer meets study criteria|0|||
48427969|NCT02538666|155754775|FG000|Pre-Treatment|Withdrew Consent|0|||
48427970|NCT02538666|155754776|FG001|Pre-Treatment|Withdrew Consent|1|||
48427971|NCT02538666|155754777|FG002|Pre-Treatment|Withdrew Consent|1|||
48427972|NCT02538666|155754775|FG000|Treatment|Disease progression|270|||
48427973|NCT02538666|155754776|FG001|Treatment|Disease progression|227|||
48427974|NCT02538666|155754777|FG002|Treatment|Disease progression|165|||
48427975|NCT02538666|155754775|FG000|Treatment|Study drug toxicity|1|||
48427976|NCT02538666|155754776|FG001|Treatment|Study drug toxicity|29|||
48427977|NCT02538666|155754777|FG002|Treatment|Study drug toxicity|92|||
48427978|NCT02538666|155754775|FG000|Treatment|Death|0|||
48427979|NCT02538666|155754776|FG001|Treatment|Death|2|||
48427980|NCT02538666|155754777|FG002|Treatment|Death|3|||
48427981|NCT02538666|155754775|FG000|Treatment|Adverse event unrelated to study drug|8|||
48427982|NCT02538666|155754776|FG001|Treatment|Adverse event unrelated to study drug|10|||
48427983|NCT02538666|155754777|FG002|Treatment|Adverse event unrelated to study drug|15|||
48427984|NCT02538666|155754775|FG000|Treatment|Participant request to discontinue study treatment|3|||
48427985|NCT02538666|155754776|FG001|Treatment|Participant request to discontinue study treatment|6|||
48427986|NCT02538666|155754777|FG002|Treatment|Participant request to discontinue study treatment|11|||
48427987|NCT02538666|155754775|FG000|Treatment|Participant withdrew consent|2|||
48427988|NCT02538666|155754776|FG001|Treatment|Participant withdrew consent|5|||
48427989|NCT02538666|155754777|FG002|Treatment|Participant withdrew consent|3|||
48427990|NCT02538666|155754775|FG000|Treatment|Lost to Follow-up|0|||
48427991|NCT02538666|155754776|FG001|Treatment|Lost to Follow-up|1|||
48427992|NCT02538666|155754777|FG002|Treatment|Lost to Follow-up|1|||
48427993|NCT02538666|155754775|FG000|Treatment|Maximum clinical benefit|4|||
48427994|NCT02538666|155754776|FG001|Treatment|Maximum clinical benefit|3|||
48427995|NCT02538666|155754777|FG002|Treatment|Maximum clinical benefit|4|||
48427996|NCT02538666|155754775|FG000|Treatment|Poor/non-compliance|0|||
48427997|NCT02538666|155754776|FG001|Treatment|Poor/non-compliance|1|||
48427998|NCT02538666|155754777|FG002|Treatment|Poor/non-compliance|0|||
48427999|NCT02538666|155754775|FG000|Treatment|Participant no longer meets study criteria|0|||
48428000|NCT02538666|155754776|FG001|Treatment|Participant no longer meets study criteria|2|||
48428001|NCT02538666|155754777|FG002|Treatment|Participant no longer meets study criteria|0|||
48428002|NCT02538666|155754775|FG000|Treatment|Administrative reason by sponsor|0|||
48428003|NCT02538666|155754776|FG001|Treatment|Administrative reason by sponsor|0|||
48428004|NCT02538666|155754777|FG002|Treatment|Administrative reason by sponsor|1|||
48428005|NCT02538666|155754775|FG000|Treatment|Other reasons|8|||
48428006|NCT02538666|155754776|FG001|Treatment|Other reasons|15|||
48428007|NCT02538666|155754777|FG002|Treatment|Other reasons|5|||
48428008|NCT02538666|155754775|FG000|Treatment|Not reported|2|||
48428009|NCT02538666|155754776|FG001|Treatment|Not reported|2|||
48428010|NCT02538666|155754777|FG002|Treatment|Not reported|2|||
48428011|NCT00222729|155754780|FG000|Overall Study|Adverse Event|3|||
48428012|NCT01963117|155754781|FG000|Overall Study|Death|1|||
48428013|NCT00515008|155754784|FG000|Overall Study|Lost to Follow-up|1|||
48428014|NCT00515008|155754785|FG001|Overall Study|Lost to Follow-up|0|||
48428015|NCT00515008|155754784|FG000|Overall Study|Declined|0|||
48428016|NCT00515008|155754785|FG001|Overall Study|Declined|3|||
48428017|NCT00515008|155754784|FG000|Overall Study|Left the Boston Area|1|||
48428018|NCT00515008|155754785|FG001|Overall Study|Left the Boston Area|1|||
48428019|NCT00515008|155754784|FG000|Overall Study|Scheduling conflict|1|||
48428020|NCT00515008|155754785|FG001|Overall Study|Scheduling conflict|0|||
48428021|NCT01070784|155754786|FG000|Overall Study|Withdrawal by Subject|6|||
48428022|NCT01070784|155754787|FG001|Overall Study|Withdrawal by Subject|9|||
48428023|NCT01070784|155754786|FG000|Overall Study|Adverse Event|14|||
48428024|NCT01070784|155754787|FG001|Overall Study|Adverse Event|9|||
48428025|NCT01780389|155754788|FG000|Overall Study|Adverse Event|1|||
48428026|NCT02518620|155754793|FG000|Overall Study|Adverse Event|23|||
48428027|NCT02518620|155754794|FG001|Overall Study|Adverse Event|11|||
48428028|NCT02518620|155754793|FG000|Overall Study|Lack of Efficacy|2|||
48428029|NCT02518620|155754794|FG001|Overall Study|Lack of Efficacy|0|||
48428030|NCT02518620|155754793|FG000|Overall Study|Non-Compliance with Study Drug|1|||
48428031|NCT02518620|155754794|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48428032|NCT02518620|155754793|FG000|Overall Study|Physician Decision|1|||
48428033|NCT02518620|155754794|FG001|Overall Study|Physician Decision|1|||
48428034|NCT02518620|155754793|FG000|Overall Study|Sponsor's Decision|0|||
48428035|NCT02518620|155754794|FG001|Overall Study|Sponsor's Decision|3|||
48428036|NCT02518620|155754793|FG000|Overall Study|Lost to Follow-up|1|||
48428037|NCT02518620|155754794|FG001|Overall Study|Lost to Follow-up|1|||
48428038|NCT02518620|155754793|FG000|Overall Study|Withdrawal by Subject|17|||
48428039|NCT02518620|155754794|FG001|Overall Study|Withdrawal by Subject|9|||
48428040|NCT02518620|155754793|FG000|Overall Study|Death|1|||
48428041|NCT02518620|155754794|FG001|Overall Study|Death|0|||
48428042|NCT02518620|155754793|FG000|Overall Study|Pregnancy Wish|3|||
48428043|NCT02518620|155754794|FG001|Overall Study|Pregnancy Wish|0|||
48428051|NCT00085540|155754798|FG000|Overall Study|Withdrawal by Subject|0|||
48428052|NCT00085540|155754799|FG001|Overall Study|Withdrawal by Subject|1|||
48428053|NCT00085540|155754798|FG000|Overall Study|Protocol Violation|0|||
48428054|NCT00085540|155754799|FG001|Overall Study|Protocol Violation|1|||
48428055|NCT05243550|155756448|FG000|Overall Study|Ongoing in the Study|171|||
48428056|NCT05243550|155756448|FG000|Overall Study|Withdrawal by Subject|10|||
48428057|NCT05243550|155756448|FG000|Overall Study|Lost to Follow-up|7|||
48428058|NCT05243550|155756448|FG000|Overall Study|Adverse Event|3|||
48428059|NCT05243550|155756448|FG000|Overall Study|Noncompliance|1|||
48428060|NCT05243550|155756448|FG000|Overall Study|Physician Decision|1|||
48428061|NCT05243550|155756448|FG000|Overall Study|Other Reason|4|||
48428062|NCT03391466|155756451|FG000|Overall Study|Death|82|||
48428063|NCT03391466|155756452|FG001|Overall Study|Death|85|||
48428064|NCT03391466|155756451|FG000|Overall Study|Still on study|93|||
48428065|NCT03391466|155756452|FG001|Overall Study|Still on study|74|||
48428066|NCT03391466|155756451|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
48428067|NCT03391466|155756452|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
48428068|NCT03391466|155756451|FG000|Overall Study|Lost to Follow-up|5|||
48428069|NCT03391466|155756452|FG001|Overall Study|Lost to Follow-up|5|||
48428070|NCT03391466|155756451|FG000|Overall Study|Investigator decision|0|||
48428071|NCT03391466|155756452|FG001|Overall Study|Investigator decision|1|||
48428072|NCT03391466|155756451|FG000|Overall Study|Other|0|||
48428073|NCT03391466|155756452|FG001|Overall Study|Other|1|||
48428074|NCT01850563|155756453|FG000|Overall Study|Not eligible|3|||
48428075|NCT01850563|155756454|FG001|Overall Study|Not eligible|0|||
48428076|NCT02090114|155756464|FG000|Overall Study|Withdrawal by Subject|3|||
48428077|NCT02090114|155756465|FG001|Overall Study|Withdrawal by Subject|6|||
48428078|NCT02090114|155756466|FG002|Overall Study|Withdrawal by Subject|2|||
48428079|NCT02090114|155756467|FG003|Overall Study|Withdrawal by Subject|1|||
48428080|NCT02090114|155756464|FG000|Overall Study|Physician Decision|5|||
48428081|NCT02090114|155756465|FG001|Overall Study|Physician Decision|0|||
48428082|NCT02090114|155756466|FG002|Overall Study|Physician Decision|1|||
48428083|NCT02090114|155756467|FG003|Overall Study|Physician Decision|1|||
48428084|NCT02090114|155756464|FG000|Overall Study|Adverse Event|1|||
48428085|NCT02090114|155756465|FG001|Overall Study|Adverse Event|2|||
48428086|NCT02090114|155756466|FG002|Overall Study|Adverse Event|2|||
48428087|NCT02090114|155756467|FG003|Overall Study|Adverse Event|0|||
48428088|NCT02090114|155756464|FG000|Overall Study|Progressive Disease|20|||
48428089|NCT02090114|155756465|FG001|Overall Study|Progressive Disease|21|||
48428090|NCT02090114|155756466|FG002|Overall Study|Progressive Disease|23|||
48428091|NCT02090114|155756467|FG003|Overall Study|Progressive Disease|6|||
48428092|NCT02090114|155756464|FG000|Overall Study|Death|1|||
48428093|NCT02090114|155756465|FG001|Overall Study|Death|0|||
48428094|NCT02090114|155756466|FG002|Overall Study|Death|1|||
48428095|NCT02090114|155756467|FG003|Overall Study|Death|0|||
48428096|NCT01356602|155756468|FG000|Overall Study|Protocol Deviation|0|||
48428097|NCT01356602|155756469|FG001|Overall Study|Protocol Deviation|1|||
48428098|NCT01356602|155756470|FG002|Overall Study|Protocol Deviation|1|||
48428099|NCT01356602|155756468|FG000|Overall Study|Administrative Problems|1|||
48428100|NCT01356602|155756469|FG001|Overall Study|Administrative Problems|4|||
48428101|NCT01356602|155756470|FG002|Overall Study|Administrative Problems|5|||
48428102|NCT01356602|155756468|FG000|Overall Study|Lost to Follow-up|4|||
48428103|NCT01356602|155756469|FG001|Overall Study|Lost to Follow-up|5|||
48428104|NCT01356602|155756470|FG002|Overall Study|Lost to Follow-up|6|||
48428105|NCT01356602|155756468|FG000|Overall Study|Withdrawal by Subject|4|||
48428106|NCT01356602|155756469|FG001|Overall Study|Withdrawal by Subject|3|||
48428107|NCT01356602|155756470|FG002|Overall Study|Withdrawal by Subject|7|||
48428108|NCT01356602|155756468|FG000|Overall Study|Lack of Efficacy|0|||
48428109|NCT01356602|155756469|FG001|Overall Study|Lack of Efficacy|1|||
48428110|NCT01356602|155756470|FG002|Overall Study|Lack of Efficacy|4|||
48428111|NCT01356602|155756468|FG000|Overall Study|Adverse Event|0|||
48428112|NCT01356602|155756469|FG001|Overall Study|Adverse Event|1|||
48428113|NCT01356602|155756470|FG002|Overall Study|Adverse Event|1|||
48428114|NCT00500149|155756471|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
48428115|NCT00500149|155756472|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
48428116|NCT00500149|155756471|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
48428117|NCT00500149|155756472|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
48428118|NCT00500149|155756471|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
48428119|NCT00500149|155756472|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
48428120|NCT00500149|155756471|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
48428121|NCT00500149|155756472|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
48428122|NCT00500149|155756471|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
48428123|NCT00500149|155756472|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
48428124|NCT00500149|155756471|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
48428125|NCT00500149|155756472|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
48428126|NCT00500149|155756471|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
48432066|NCT01683071|155769036|FG005|Part 1|Lack of Efficacy|0|||
48428127|NCT00500149|155756472|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
48428128|NCT04353661|155756475|FG000|Overall Study|Protocol Violation|0|||
48428129|NCT04353661|155756476|FG001|Overall Study|Protocol Violation|0|||
48428130|NCT04353661|155756477|FG002|Overall Study|Protocol Violation|1|||
48428131|NCT04353661|155756475|FG000|Overall Study|Study termination by the Sponsor|1|||
48428132|NCT04353661|155756476|FG001|Overall Study|Study termination by the Sponsor|1|||
48428133|NCT04353661|155756477|FG002|Overall Study|Study termination by the Sponsor|1|||
48428134|NCT02778867|155756478|FG000|Phase 1|Withdrawal by Subject|2|||
48428135|NCT02778867|155756479|FG001|Phase 1|Withdrawal by Subject|3|||
48428136|NCT02778867|155756480|FG002|Phase 1|Withdrawal by Subject|0|||
48428137|NCT02778867|155756481|FG003|Phase 1|Withdrawal by Subject|0|||
48428138|NCT02778867|155756478|FG000|Phase 2|Withdrawal by Subject|0|||
48428139|NCT02778867|155756479|FG001|Phase 2|Withdrawal by Subject|0|||
48428140|NCT02778867|155756480|FG002|Phase 2|Withdrawal by Subject|1|||
48428141|NCT02778867|155756481|FG003|Phase 2|Withdrawal by Subject|0|||
48428142|NCT02778867|155756478|FG000|Phase 2|Physician Decision|0|||
48428143|NCT02778867|155756479|FG001|Phase 2|Physician Decision|0|||
48428144|NCT02778867|155756480|FG002|Phase 2|Physician Decision|0|||
48428145|NCT02778867|155756481|FG003|Phase 2|Physician Decision|1|||
48428146|NCT02778867|155756478|FG000|Phase 2|Adverse Event|0|||
48428147|NCT02778867|155756479|FG001|Phase 2|Adverse Event|0|||
48428148|NCT02778867|155756480|FG002|Phase 2|Adverse Event|0|||
48428149|NCT02778867|155756481|FG003|Phase 2|Adverse Event|1|||
48428150|NCT01539837|155756482|FG000|Overall Study|reduce neutrophil level|0|||
48428151|NCT01539837|155756483|FG001|Overall Study|reduce neutrophil level|1|||
48428152|NCT01539837|155756484|FG002|Overall Study|reduce neutrophil level|1|||
48428153|NCT01539837|155756482|FG000|Overall Study|bad compliance|0|||
48428154|NCT01539837|155756483|FG001|Overall Study|bad compliance|0|||
48428155|NCT01539837|155756484|FG002|Overall Study|bad compliance|1|||
48428156|NCT00960440|155756485|FG000|Overall Study|Death|0|||
48428157|NCT00960440|155756486|FG001|Overall Study|Death|0|||
48428158|NCT00960440|155756487|FG002|Overall Study|Death|0|||
48428159|NCT00960440|155756488|FG003|Overall Study|Death|1|||
48428160|NCT00960440|155756485|FG000|Overall Study|Adverse Event|12|||
48428161|NCT00960440|155756486|FG001|Overall Study|Adverse Event|12|||
48428162|NCT00960440|155756487|FG002|Overall Study|Adverse Event|4|||
48428163|NCT00960440|155756488|FG003|Overall Study|Adverse Event|4|||
48428164|NCT00960440|155756485|FG000|Overall Study|Lack of Efficacy|2|||
48428165|NCT00960440|155756486|FG001|Overall Study|Lack of Efficacy|5|||
48428166|NCT00960440|155756487|FG002|Overall Study|Lack of Efficacy|3|||
48428167|NCT00960440|155756488|FG003|Overall Study|Lack of Efficacy|8|||
48428168|NCT00960440|155756485|FG000|Overall Study|Protocol Violation|2|||
48428169|NCT00960440|155756486|FG001|Overall Study|Protocol Violation|8|||
48428170|NCT00960440|155756487|FG002|Overall Study|Protocol Violation|3|||
48428171|NCT00960440|155756488|FG003|Overall Study|Protocol Violation|4|||
48428172|NCT00960440|155756485|FG000|Overall Study|Withdrawal by Subject|9|||
48428173|NCT00960440|155756486|FG001|Overall Study|Withdrawal by Subject|5|||
48428174|NCT00960440|155756487|FG002|Overall Study|Withdrawal by Subject|2|||
48428175|NCT00960440|155756488|FG003|Overall Study|Withdrawal by Subject|1|||
48428176|NCT00960440|155756485|FG000|Overall Study|Other|1|||
48428177|NCT00960440|155756486|FG001|Overall Study|Other|1|||
48428178|NCT00960440|155756487|FG002|Overall Study|Other|1|||
48428179|NCT00960440|155756488|FG003|Overall Study|Other|0|||
48428180|NCT03623321|155756489|FG000|Overall Study|Adverse Event|32|||
48428181|NCT03623321|155756489|FG000|Overall Study|Death|9|||
48428182|NCT03623321|155756489|FG000|Overall Study|Lack of Efficacy|9|||
48428183|NCT03623321|155756489|FG000|Overall Study|Lost to Follow-up|6|||
48428184|NCT03623321|155756489|FG000|Overall Study|Noncompliance with study drug|6|||
48428185|NCT03623321|155756489|FG000|Overall Study|Use of prohibited medication|3|||
48428186|NCT03623321|155756489|FG000|Overall Study|Physician Decision|5|||
48428187|NCT03623321|155756489|FG000|Overall Study|Protocol Violation|1|||
48428188|NCT03623321|155756489|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
48428189|NCT03623321|155756489|FG000|Overall Study|Not further specified|43|||
48428190|NCT01703286|155756490|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
48428191|NCT01703286|155756491|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
48428192|NCT01703286|155756492|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
48428193|NCT01703286|155756493|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
48428194|NCT01703286|155756494|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
48428195|NCT01703286|155756495|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
48428196|NCT01703286|155756490|FG000|Period 2 Including Washout|Adverse Event|0|||
48428197|NCT01703286|155756491|FG001|Period 2 Including Washout|Adverse Event|0|||
48428198|NCT01703286|155756492|FG002|Period 2 Including Washout|Adverse Event|0|||
48428199|NCT01703286|155756493|FG003|Period 2 Including Washout|Adverse Event|1|||
48428200|NCT01703286|155756494|FG004|Period 2 Including Washout|Adverse Event|0|||
48428201|NCT01703286|155756495|FG005|Period 2 Including Washout|Adverse Event|0|||
48428202|NCT00931892|155756496|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
48428203|NCT00931892|155756497|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
48428204|NCT02531373|155756498|FG000|Overall Study|Lack of Efficacy|0|||
48428240|NCT02531373|155756498|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
48428241|NCT02531373|155756499|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
48428242|NCT02531373|155756500|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
48428243|NCT02531373|155756501|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
48428244|NCT02531373|155756502|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
48428245|NCT02531373|155756503|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
48428246|NCT02531373|155756504|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
48428247|NCT02531373|155756505|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
48428248|NCT02531373|155756506|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
48428249|NCT02531373|155756498|FG000|Overall Study|Withdrawal by Subject|0|||
48428250|NCT02531373|155756499|FG001|Overall Study|Withdrawal by Subject|0|||
48428251|NCT02531373|155756500|FG002|Overall Study|Withdrawal by Subject|0|||
48428252|NCT02531373|155756501|FG003|Overall Study|Withdrawal by Subject|0|||
48428253|NCT02531373|155756502|FG004|Overall Study|Withdrawal by Subject|3|||
48428254|NCT02531373|155756503|FG005|Overall Study|Withdrawal by Subject|0|||
48428255|NCT02531373|155756504|FG006|Overall Study|Withdrawal by Subject|0|||
48428256|NCT02531373|155756505|FG007|Overall Study|Withdrawal by Subject|0|||
48428257|NCT02531373|155756506|FG008|Overall Study|Withdrawal by Subject|0|||
48428258|NCT05523362|155756507|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
48428259|NCT05523362|155756507|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
48428260|NCT05523362|155756507|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
48428261|NCT05523362|155756507|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
48428262|NCT00769704|155756511|FG000|Overall Study|Lost to Follow-up|3|||
48428263|NCT00769704|155756512|FG001|Overall Study|Lost to Follow-up|2|||
48428264|NCT00769704|155756511|FG000|Overall Study|Death|95|||
48428265|NCT00769704|155756512|FG001|Overall Study|Death|190|||
48428266|NCT00769704|155756511|FG000|Overall Study|Withdrawal by Subject|12|||
48428267|NCT00769704|155756512|FG001|Overall Study|Withdrawal by Subject|5|||
48428268|NCT00769704|155756511|FG000|Overall Study|Other|1|||
48428269|NCT00769704|155756512|FG001|Overall Study|Other|2|||
48428270|NCT01295905|155756517|FG000|Overall Study|Did not meet inclusion criteria|1|||
48428271|NCT01295905|155756518|FG001|Overall Study|Did not meet inclusion criteria|0|||
48428272|NCT01295905|155756517|FG000|Overall Study|Met exclusion criteria|1|||
48428273|NCT01295905|155756518|FG001|Overall Study|Met exclusion criteria|0|||
48428274|NCT02606045|155756519|FG000|Overall Study|Study closed before treament could begin|1|||
48428275|NCT02606045|155756520|FG001|Overall Study|Study closed before treament could begin|2|||
48428276|NCT02546856|155756521|FG000|4 Months Evaluation|Death|2|||
48428277|NCT02546856|155756522|FG001|4 Months Evaluation|Death|3|||
48428278|NCT02546856|155756521|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
48428279|NCT02546856|155756522|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
48428280|NCT02546856|155756521|FG000|4 Months Evaluation|Lost to Follow-up|3|||
48428281|NCT02546856|155756522|FG001|4 Months Evaluation|Lost to Follow-up|3|||
48428282|NCT02546856|155756521|FG000|4 Months Evaluation|Physician Decision|3|||
48428283|NCT02546856|155756522|FG001|4 Months Evaluation|Physician Decision|0|||
48428284|NCT02546856|155756521|FG000|4 Months Evaluation|Working or living abroad|5|||
48428285|NCT02546856|155756522|FG001|4 Months Evaluation|Working or living abroad|1|||
48428286|NCT02546856|155756521|FG000|4 Months Evaluation|reasons not due to titration|4|||
48428287|NCT02546856|155756522|FG001|4 Months Evaluation|reasons not due to titration|1|||
48428288|NCT02546856|155756521|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
48428289|NCT02546856|155756522|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
48428290|NCT02546856|155756521|FG000|6 Months Evaluation|Death|1|||
48428291|NCT02546856|155756522|FG001|6 Months Evaluation|Death|1|||
48428292|NCT02546856|155756521|FG000|6 Months Evaluation|Lost to Follow-up|1|||
48428293|NCT02546856|155756522|FG001|6 Months Evaluation|Lost to Follow-up|1|||
48428294|NCT02546856|155756521|FG000|6 Months Evaluation|Working or living abroad|6|||
48428295|NCT02546856|155756522|FG001|6 Months Evaluation|Working or living abroad|4|||
48428296|NCT02546856|155756521|FG000|6 Months Evaluation|reasons not due to titration|0|||
48428297|NCT02546856|155756522|FG001|6 Months Evaluation|reasons not due to titration|1|||
48428298|NCT04492722|155756527|FG000|Overall Study|Adverse Event|7|||
48428299|NCT04492722|155756528|FG001|Overall Study|Adverse Event|2|||
48428300|NCT04492722|155756529|FG002|Overall Study|Adverse Event|3|||
48428301|NCT04492722|155756530|FG003|Overall Study|Adverse Event|0|||
48428302|NCT04492722|155756527|FG000|Overall Study|Death|0|||
48428303|NCT04492722|155756528|FG001|Overall Study|Death|0|||
48428304|NCT04492722|155756529|FG002|Overall Study|Death|0|||
48428305|NCT04492722|155756530|FG003|Overall Study|Death|1|||
48428306|NCT04492722|155756527|FG000|Overall Study|Lost to Follow-up|0|||
48428307|NCT04492722|155756528|FG001|Overall Study|Lost to Follow-up|1|||
48428308|NCT04492722|155756529|FG002|Overall Study|Lost to Follow-up|0|||
48428309|NCT04492722|155756530|FG003|Overall Study|Lost to Follow-up|1|||
48428310|NCT04492722|155756527|FG000|Overall Study|Physician Decision|0|||
48428311|NCT04492722|155756528|FG001|Overall Study|Physician Decision|3|||
48428312|NCT04492722|155756529|FG002|Overall Study|Physician Decision|1|||
48428313|NCT04492722|155756530|FG003|Overall Study|Physician Decision|1|||
48428314|NCT04492722|155756527|FG000|Overall Study|Withdrawal by Subject|6|||
48432067|NCT01683071|155769031|FG000|Part 1|Withdrawal by Subject|1|||
48428315|NCT04492722|155756528|FG001|Overall Study|Withdrawal by Subject|6|||
48428316|NCT04492722|155756529|FG002|Overall Study|Withdrawal by Subject|0|||
48428317|NCT04492722|155756530|FG003|Overall Study|Withdrawal by Subject|3|||
48428318|NCT04492722|155756527|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
48428319|NCT04492722|155756528|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
48428320|NCT04492722|155756529|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
48428321|NCT04492722|155756530|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
48428322|NCT04492722|155756527|FG000|Overall Study|Due to Covid-19 pandemic|7|||
48428323|NCT04492722|155756528|FG001|Overall Study|Due to Covid-19 pandemic|3|||
48428324|NCT04492722|155756529|FG002|Overall Study|Due to Covid-19 pandemic|7|||
48428325|NCT04492722|155756530|FG003|Overall Study|Due to Covid-19 pandemic|6|||
48428326|NCT04492722|155756527|FG000|Overall Study|Failure to meet randomisation criteria|2|||
48428327|NCT04492722|155756528|FG001|Overall Study|Failure to meet randomisation criteria|3|||
48428328|NCT04492722|155756529|FG002|Overall Study|Failure to meet randomisation criteria|4|||
48428329|NCT04492722|155756530|FG003|Overall Study|Failure to meet randomisation criteria|2|||
48428330|NCT04492722|155756527|FG000|Overall Study|Early termination from the study|54|||
48428331|NCT04492722|155756528|FG001|Overall Study|Early termination from the study|51|||
48428332|NCT04492722|155756529|FG002|Overall Study|Early termination from the study|50|||
48428333|NCT04492722|155756530|FG003|Overall Study|Early termination from the study|50|||
48428334|NCT04492722|155756527|FG000|Overall Study|Missing|3|||
48428335|NCT04492722|155756528|FG001|Overall Study|Missing|0|||
48428336|NCT04492722|155756529|FG002|Overall Study|Missing|0|||
48428337|NCT04492722|155756530|FG003|Overall Study|Missing|5|||
48428338|NCT04492722|155756527|FG000|Overall Study|Participants who did not receive treatment|0|||
48428339|NCT04492722|155756528|FG001|Overall Study|Participants who did not receive treatment|1|||
48428340|NCT04492722|155756529|FG002|Overall Study|Participants who did not receive treatment|4|||
48428341|NCT04492722|155756530|FG003|Overall Study|Participants who did not receive treatment|0|||
48428342|NCT02284906|155756531|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48428343|NCT02284906|155756532|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
48428344|NCT02284906|155756533|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48428345|NCT02284906|155756531|FG000|Overall Study|Major Protocol Deviation|0|||
48428346|NCT02284906|155756532|FG001|Overall Study|Major Protocol Deviation|1|||
48428347|NCT02284906|155756533|FG002|Overall Study|Major Protocol Deviation|0|||
48428348|NCT02284906|155756531|FG000|Overall Study|Voluntary Withdrawal|2|||
48428349|NCT02284906|155756532|FG001|Overall Study|Voluntary Withdrawal|4|||
48428350|NCT02284906|155756533|FG002|Overall Study|Voluntary Withdrawal|5|||
48428351|NCT02284906|155756531|FG000|Overall Study|Study Termination|0|||
48428352|NCT02284906|155756532|FG001|Overall Study|Study Termination|11|||
48428353|NCT02284906|155756533|FG002|Overall Study|Study Termination|14|||
48428354|NCT02284906|155756531|FG000|Overall Study|Reason not Specified|1|||
48428355|NCT02284906|155756532|FG001|Overall Study|Reason not Specified|1|||
48428356|NCT02284906|155756533|FG002|Overall Study|Reason not Specified|0|||
48428357|NCT04429503|155756534|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
48428358|NCT04429503|155756535|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
48428359|NCT04429503|155756536|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
48428360|NCT04429503|155756534|FG000|Overall Study|Adverse Event|1|||
48428361|NCT04429503|155756535|FG001|Overall Study|Adverse Event|9|||
48428362|NCT04429503|155756536|FG002|Overall Study|Adverse Event|2|||
48428363|NCT04429503|155756534|FG000|Overall Study|Decision by the investigator/sponsor|2|||
48428364|NCT04429503|155756535|FG001|Overall Study|Decision by the investigator/sponsor|9|||
48428365|NCT04429503|155756536|FG002|Overall Study|Decision by the investigator/sponsor|3|||
48428366|NCT04429503|155756534|FG000|Overall Study|Withdrawal by Subject|9|||
48428367|NCT04429503|155756535|FG001|Overall Study|Withdrawal by Subject|17|||
48428368|NCT04429503|155756536|FG002|Overall Study|Withdrawal by Subject|8|||
48428369|NCT04429503|155756534|FG000|Overall Study|Lost to Follow-up|5|||
48428370|NCT04429503|155756535|FG001|Overall Study|Lost to Follow-up|19|||
48428371|NCT04429503|155756536|FG002|Overall Study|Lost to Follow-up|7|||
48428372|NCT04429503|155756534|FG000|Overall Study|Death|9|||
48428373|NCT04429503|155756535|FG001|Overall Study|Death|18|||
48428374|NCT04429503|155756536|FG002|Overall Study|Death|5|||
48428375|NCT01703819|155756537|FG000|Overall Study|Adverse Event|0|||
48428376|NCT01703819|155756538|FG001|Overall Study|Adverse Event|1|||
48428377|NCT01703819|155756537|FG000|Overall Study|Withdrawal by Subject|0|||
48428378|NCT01703819|155756538|FG001|Overall Study|Withdrawal by Subject|1|||
48428379|NCT01594476|155756543|FG000|Overall Study|Protocol Violation|1|||
48428380|NCT01594476|155756544|FG001|Overall Study|Protocol Violation|3|||
48428381|NCT01264965|155756555|FG000|Overall Study|Withdrawal by Subject|10|||
48428382|NCT01671488|155756556|FG000|Overall Study|Withdrawal by Subject|1|||
48428383|NCT01312428|155756557|FG000|Overall Study|Study Termination|3|||
48428384|NCT01312428|155756558|FG001|Overall Study|Study Termination|4|||
48428385|NCT02416908|155756559|FG000|Dose Escalation Phase|Adverse Event|0|||
48428386|NCT02416908|155756560|FG001|Dose Escalation Phase|Adverse Event|0|||
48428387|NCT02416908|155756561|FG002|Dose Escalation Phase|Adverse Event|3|||
48428388|NCT02416908|155756562|FG003|Dose Escalation Phase|Adverse Event|0|||
48428389|NCT02416908|155756559|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48428390|NCT02416908|155756560|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48428391|NCT02416908|155756561|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
48428392|NCT02416908|155756562|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48428393|NCT01106534|155756563|FG000|Overall Study|Withdrawal by Subject|18|||
48428394|NCT01106534|155756563|FG000|Overall Study|Lost to Follow-up|2|||
48428395|NCT01106534|155756563|FG000|Overall Study|Death|16|||
48428396|NCT01106534|155756563|FG000|Overall Study|Physician Decision|1|||
48428397|NCT03123939|155756564|FG000|Overall Study|Lack of Efficacy|6|||
48428398|NCT03123939|155756564|FG000|Overall Study|Death|5|||
48428399|NCT03123939|155756564|FG000|Overall Study|Physician Decision|2|||
48428400|NCT03123939|155756564|FG000|Overall Study|Subject/guardian decision|2|||
48428401|NCT03123939|155756564|FG000|Overall Study|Lost to Follow-up|1|||
48428402|NCT03123939|155756564|FG000|Overall Study|New therapy for study indication|1|||
48428403|NCT03123939|155756564|FG000|Overall Study|Protocol deviation|1|||
48428404|NCT03123939|155756564|FG000|Overall Study|Progressive disease|18|||
48428405|NCT03123939|155756564|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
48428406|NCT03123939|155756564|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
48428407|NCT00301067|155756570|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
48428408|NCT00301067|155756571|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
48428409|NCT00301067|155756572|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
48428410|NCT00301067|155756573|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
48428411|NCT00301067|155756570|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
48428412|NCT00301067|155756571|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
48428413|NCT00301067|155756572|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
48428414|NCT00301067|155756573|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
48428415|NCT00301067|155756570|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
48428416|NCT00301067|155756571|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
48428417|NCT00301067|155756572|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
48428418|NCT00301067|155756573|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
48428419|NCT00301067|155756570|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
48428420|NCT00301067|155756571|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
48428421|NCT00301067|155756572|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
48428422|NCT00301067|155756573|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
48428423|NCT00301067|155756570|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
48428424|NCT00301067|155756571|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
48428425|NCT00301067|155756572|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
48428426|NCT00301067|155756573|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
48428427|NCT00301067|155756570|FG000|Follow up Until Death|Alive at last data cut point|1|||
48428428|NCT00301067|155756571|FG001|Follow up Until Death|Alive at last data cut point|0|||
48428429|NCT00301067|155756572|FG002|Follow up Until Death|Alive at last data cut point|0|||
48428430|NCT00301067|155756573|FG003|Follow up Until Death|Alive at last data cut point|1|||
48428431|NCT02552355|155756574|FG000|Overall Study|Adverse Event|0|||
48428432|NCT02552355|155756575|FG001|Overall Study|Adverse Event|2|||
48428433|NCT02552355|155756576|FG002|Overall Study|Adverse Event|2|||
48428434|NCT02552355|155756577|FG003|Overall Study|Adverse Event|0|||
48428435|NCT02552355|155756574|FG000|Overall Study|Withdrawal by Subject|0|||
48428436|NCT02552355|155756575|FG001|Overall Study|Withdrawal by Subject|0|||
48428437|NCT02552355|155756576|FG002|Overall Study|Withdrawal by Subject|0|||
48428438|NCT02552355|155756577|FG003|Overall Study|Withdrawal by Subject|1|||
48428439|NCT00935220|155756587|FG000|Overall Study|Adverse Event|1|||
48428440|NCT00935220|155756587|FG000|Overall Study|Other reason (not specified)|1|||
48428441|NCT01095250|155756588|FG000|Overall Study|administrative reasons|8|||
48428442|NCT01095250|155756589|FG001|Overall Study|administrative reasons|10|||
48428443|NCT01095250|155756590|FG002|Overall Study|administrative reasons|7|||
48428444|NCT01095250|155756591|FG003|Overall Study|administrative reasons|5|||
48428445|NCT01095250|155756588|FG000|Overall Study|Withdrawal by Subject|0|||
48428446|NCT01095250|155756589|FG001|Overall Study|Withdrawal by Subject|0|||
48428447|NCT01095250|155756590|FG002|Overall Study|Withdrawal by Subject|1|||
48428448|NCT01095250|155756591|FG003|Overall Study|Withdrawal by Subject|0|||
48428449|NCT02815397|155756592|FG000|Overall Study|Physician Decision|2|||
48428450|NCT02213198|155756593|FG000|Baseline|No show for intake|7|||
48428451|NCT02213198|155756594|FG001|Baseline|No show for intake|9|||
48428452|NCT02213198|155756593|FG000|Baseline|Withdrawal by Subject|34|||
48428453|NCT02213198|155756594|FG001|Baseline|Withdrawal by Subject|11|||
48428454|NCT02213198|155756593|FG000|Baseline|transferred out of clinic|7|||
48428455|NCT02213198|155756594|FG001|Baseline|transferred out of clinic|9|||
48428456|NCT02213198|155756593|FG000|Baseline|Lost to Follow-up|40|||
48428457|NCT02213198|155756594|FG001|Baseline|Lost to Follow-up|21|||
48428458|NCT02213198|155756593|FG000|Baseline|incarcerated,violent|0|||
48428459|NCT02213198|155756594|FG001|Baseline|incarcerated,violent|1|||
48428460|NCT02213198|155756593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
48428461|NCT02213198|155756594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
48428462|NCT02213198|155756593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
48428463|NCT02213198|155756594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
48428464|NCT02213198|155756593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
48428465|NCT02213198|155756594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
48428466|NCT02213198|155756593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
48428467|NCT02213198|155756594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
48428468|NCT02213198|155756593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
48428469|NCT02213198|155756594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
48428470|NCT02213198|155756593|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
48428471|NCT02213198|155756594|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
48428472|NCT00798967|155756595|FG000|Overall Study|Adverse Event|2|||
48428473|NCT00798967|155756596|FG001|Overall Study|Adverse Event|3|||
48428474|NCT00798967|155756595|FG000|Overall Study|Withdrawal by Subject|0|||
48428475|NCT00798967|155756596|FG001|Overall Study|Withdrawal by Subject|1|||
48428476|NCT00798967|155756595|FG000|Overall Study|Physician Decision|1|||
48428477|NCT00798967|155756596|FG001|Overall Study|Physician Decision|0|||
48428478|NCT00798967|155756595|FG000|Overall Study|Randomized in error by site|1|||
48428479|NCT00798967|155756596|FG001|Overall Study|Randomized in error by site|0|||
48428480|NCT01605396|155756597|FG000|Overall Study|Adverse Event|5|||
48428481|NCT01605396|155756598|FG001|Overall Study|Adverse Event|3|||
48428482|NCT01605396|155756597|FG000|Overall Study|Lost to Follow-up|1|||
48428483|NCT01605396|155756598|FG001|Overall Study|Lost to Follow-up|0|||
48428484|NCT01605396|155756597|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48428485|NCT01605396|155756598|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48428486|NCT01605396|155756597|FG000|Overall Study|Physician Decision|2|||
48428487|NCT01605396|155756598|FG001|Overall Study|Physician Decision|2|||
48428488|NCT01605396|155756597|FG000|Overall Study|Progressive Disease|23|||
48428489|NCT01605396|155756598|FG001|Overall Study|Progressive Disease|27|||
48428490|NCT01605396|155756597|FG000|Overall Study|Withdrawal by Subject|4|||
48428491|NCT01605396|155756598|FG001|Overall Study|Withdrawal by Subject|2|||
48428492|NCT01605396|155756597|FG000|Overall Study|Transfer Off Study|4|||
48428493|NCT01605396|155756598|FG001|Overall Study|Transfer Off Study|5|||
48428494|NCT02926573|155757672|FG000|Overall Study|Nausea|1|||
48428495|NCT02926573|155757673|FG001|Overall Study|Nausea|0|||
48428496|NCT02926573|155757672|FG000|Overall Study|Remain intubated|2|||
48428497|NCT02926573|155757673|FG001|Overall Study|Remain intubated|2|||
48428498|NCT02926573|155757672|FG000|Overall Study|Change in surgery plan|3|||
48428499|NCT02926573|155757673|FG001|Overall Study|Change in surgery plan|1|||
48428500|NCT02926573|155757672|FG000|Overall Study|Change to outpatient status|5|||
48428501|NCT02926573|155757673|FG001|Overall Study|Change to outpatient status|1|||
48428502|NCT02926573|155757672|FG000|Overall Study|Withdrawal by Subject|0|||
48428503|NCT02926573|155757673|FG001|Overall Study|Withdrawal by Subject|2|||
48428504|NCT02926573|155757672|FG000|Overall Study|Return to operating room|0|||
48428505|NCT02926573|155757673|FG001|Overall Study|Return to operating room|2|||
48428506|NCT02926573|155757672|FG000|Overall Study|Delirium|0|||
48428507|NCT02926573|155757673|FG001|Overall Study|Delirium|1|||
48428508|NCT00406315|155757674|FG000|Overall Study|Death|1|||
48428509|NCT00406315|155757674|FG000|Overall Study|Adverse Event|39|||
48428510|NCT00406315|155757674|FG000|Overall Study|Laboratory Abnormality|4|||
48428511|NCT00406315|155757674|FG000|Overall Study|Lack of Efficacy|13|||
48428512|NCT00406315|155757674|FG000|Overall Study|Other|33|||
48428513|NCT00406315|155757674|FG000|Overall Study|Lost to Follow-up|21|||
48428514|NCT00406315|155757674|FG000|Overall Study|Withdrawal by Subject|30|||
48428515|NCT04314778|155757681|FG000|Overall Study|Lost to Follow-up|5|||
48428516|NCT04314778|155757682|FG001|Overall Study|Lost to Follow-up|3|||
48428517|NCT01734993|155757684|FG000|Overall Study|Adverse Event|1|||
48428518|NCT01734993|155757684|FG000|Overall Study|Lack of Efficacy|1|||
48428519|NCT02619253|155757688|FG000|Overall Study|Adverse Event|0|||
48428520|NCT02619253|155757689|FG001|Overall Study|Adverse Event|0|||
48428521|NCT02619253|155757690|FG002|Overall Study|Adverse Event|1|||
48428522|NCT02619253|155757691|FG003|Overall Study|Adverse Event|1|||
48428523|NCT02619253|155757692|FG004|Overall Study|Adverse Event|3|||
48428524|NCT02619253|155757688|FG000|Overall Study|Alternative Therapy|0|||
48428525|NCT02619253|155757689|FG001|Overall Study|Alternative Therapy|0|||
48428526|NCT02619253|155757690|FG002|Overall Study|Alternative Therapy|1|||
48428527|NCT02619253|155757691|FG003|Overall Study|Alternative Therapy|0|||
48428528|NCT02619253|155757692|FG004|Overall Study|Alternative Therapy|0|||
48428529|NCT02619253|155757688|FG000|Overall Study|Death|0|||
48428530|NCT02619253|155757689|FG001|Overall Study|Death|0|||
48428531|NCT02619253|155757690|FG002|Overall Study|Death|0|||
48428532|NCT02619253|155757691|FG003|Overall Study|Death|1|||
48428533|NCT02619253|155757692|FG004|Overall Study|Death|0|||
48428534|NCT02619253|155757688|FG000|Overall Study|Disease Progression|4|||
48428535|NCT02619253|155757689|FG001|Overall Study|Disease Progression|2|||
48428536|NCT02619253|155757690|FG002|Overall Study|Disease Progression|8|||
48428537|NCT02619253|155757691|FG003|Overall Study|Disease Progression|9|||
48428538|NCT02619253|155757692|FG004|Overall Study|Disease Progression|10|||
48428539|NCT02619253|155757688|FG000|Overall Study|Needed a disqualifying therapy|0|||
48428540|NCT02619253|155757689|FG001|Overall Study|Needed a disqualifying therapy|0|||
48428541|NCT02619253|155757690|FG002|Overall Study|Needed a disqualifying therapy|1|||
48428542|NCT02619253|155757691|FG003|Overall Study|Needed a disqualifying therapy|0|||
48428543|NCT02619253|155757692|FG004|Overall Study|Needed a disqualifying therapy|0|||
48428544|NCT02619253|155757688|FG000|Overall Study|Transferred to hospice|0|||
48428545|NCT02619253|155757689|FG001|Overall Study|Transferred to hospice|0|||
48428546|NCT02619253|155757690|FG002|Overall Study|Transferred to hospice|1|||
48428547|NCT02619253|155757691|FG003|Overall Study|Transferred to hospice|0|||
48428548|NCT02619253|155757692|FG004|Overall Study|Transferred to hospice|0|||
48428549|NCT02619253|155757688|FG000|Overall Study|Physician Decision|0|||
48428550|NCT02619253|155757689|FG001|Overall Study|Physician Decision|1|||
48428551|NCT02619253|155757690|FG002|Overall Study|Physician Decision|2|||
48428552|NCT02619253|155757691|FG003|Overall Study|Physician Decision|3|||
48428553|NCT02619253|155757692|FG004|Overall Study|Physician Decision|0|||
48428554|NCT02619253|155757688|FG000|Overall Study|Withdrawal by Subject|0|||
48428555|NCT02619253|155757689|FG001|Overall Study|Withdrawal by Subject|1|||
48428556|NCT02619253|155757690|FG002|Overall Study|Withdrawal by Subject|0|||
48428557|NCT02619253|155757691|FG003|Overall Study|Withdrawal by Subject|0|||
48428558|NCT02619253|155757692|FG004|Overall Study|Withdrawal by Subject|2|||
48428559|NCT02116972|155757693|FG000|Overall Study|Adverse Event|4|||
48428560|NCT02116972|155757694|FG001|Overall Study|Adverse Event|4|||
48428561|NCT02116972|155757695|FG002|Overall Study|Adverse Event|1|||
48428562|NCT02116972|155757693|FG000|Overall Study|Withdrawal by Subject|1|||
48428563|NCT02116972|155757694|FG001|Overall Study|Withdrawal by Subject|1|||
48428564|NCT02116972|155757695|FG002|Overall Study|Withdrawal by Subject|5|||
48428565|NCT02116972|155757693|FG000|Overall Study|Protocol Violation|1|||
48428566|NCT02116972|155757694|FG001|Overall Study|Protocol Violation|0|||
48428567|NCT02116972|155757695|FG002|Overall Study|Protocol Violation|1|||
48428568|NCT02116972|155757693|FG000|Overall Study|Lost to Follow-up|4|||
48428569|NCT02116972|155757694|FG001|Overall Study|Lost to Follow-up|3|||
48428570|NCT02116972|155757695|FG002|Overall Study|Lost to Follow-up|1|||
48428571|NCT02116972|155757693|FG000|Overall Study|Lack of Efficacy|6|||
48428572|NCT02116972|155757694|FG001|Overall Study|Lack of Efficacy|6|||
48428573|NCT02116972|155757695|FG002|Overall Study|Lack of Efficacy|5|||
48428574|NCT02116972|155757693|FG000|Overall Study|scheduling conflicts and relocation|3|||
48428575|NCT02116972|155757694|FG001|Overall Study|scheduling conflicts and relocation|3|||
48428576|NCT02116972|155757695|FG002|Overall Study|scheduling conflicts and relocation|6|||
48428577|NCT01400971|155757696|FG000|Overall Study|Death|82|||
48428578|NCT01400971|155757696|FG000|Overall Study|Lost to Follow-up|196|||
48428579|NCT01400971|155757696|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
48428580|NCT01400971|155757696|FG000|Overall Study|Physician Decision|57|||
48428581|NCT01400971|155757696|FG000|Overall Study|Withdrawal by Subject|158|||
48428582|NCT01400971|155757696|FG000|Overall Study|Other|422|||
48428583|NCT01757704|155757697|FG000|Overall Study|Protocol Violation|1|||
48428584|NCT01757704|155757698|FG001|Overall Study|Protocol Violation|3|||
48428585|NCT01975272|155757705|FG000|Overall Study|Excluded after protocol amendment|1|||
48428586|NCT01975272|155757706|FG001|Overall Study|Excluded after protocol amendment|1|||
48428587|NCT01975272|155757707|FG002|Overall Study|Excluded after protocol amendment|2|||
48428588|NCT00863928|155757708|FG000|Overall Study|Protocol Violation|26|||
48428589|NCT00863928|155757709|FG001|Overall Study|Protocol Violation|0|||
48428590|NCT00863928|155757708|FG000|Overall Study|Withdrawal by Subject|3|||
48428591|NCT00863928|155757709|FG001|Overall Study|Withdrawal by Subject|0|||
48428592|NCT00863928|155757708|FG000|Overall Study|surgery cancellation|4|||
48428593|NCT00863928|155757709|FG001|Overall Study|surgery cancellation|0|||
48428594|NCT00863928|155757708|FG000|Overall Study|medication allergy|3|||
48428595|NCT00863928|155757709|FG001|Overall Study|medication allergy|0|||
48428596|NCT02375698|155757710|FG000|Overall Study|Withdrawal by Subject|0|||
48428597|NCT02375698|155757711|FG001|Overall Study|Withdrawal by Subject|2|||
48428598|NCT02375698|155757710|FG000|Overall Study|Physician Decision|2|||
48428599|NCT02375698|155757711|FG001|Overall Study|Physician Decision|0|||
48428600|NCT00719732|155757715|FG000|Overall Study|Lost to Follow-up|20|||
48428601|NCT00719732|155757715|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
48428602|NCT00719732|155757715|FG000|Overall Study|Illness not associated with device|1|||
48428603|NCT04598165|155757716|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
48428604|NCT04598165|155757717|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
48428605|NCT04598165|155757716|FG000|Completed 6-week Follow-up|Death|2|||
48428606|NCT04598165|155757717|FG001|Completed 6-week Follow-up|Death|1|||
48428607|NCT04598165|155757716|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
48428608|NCT04598165|155757717|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
48428609|NCT04598165|155757716|FG000|Completed 6-week Follow-up|Ineligible|4|||
48428610|NCT04598165|155757717|FG001|Completed 6-week Follow-up|Ineligible|3|||
48428611|NCT04598165|155757716|FG000|Completed 6-week Follow-up|Partner refusal|0|||
48428612|NCT04598165|155757717|FG001|Completed 6-week Follow-up|Partner refusal|1|||
48428613|NCT04598165|155757716|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
48432068|NCT01683071|155769032|FG001|Part 1|Withdrawal by Subject|2|||
48428614|NCT04598165|155757717|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
48428615|NCT01323673|155757718|FG000|Overall Study|Adverse Event|0|||
48428616|NCT01323673|155757719|FG001|Overall Study|Adverse Event|1|||
48428617|NCT01323673|155757718|FG000|Overall Study|Lost to Follow-up|0|||
48428618|NCT01323673|155757719|FG001|Overall Study|Lost to Follow-up|1|||
48428619|NCT01323673|155757718|FG000|Overall Study|Protocol Violation|1|||
48428620|NCT01323673|155757719|FG001|Overall Study|Protocol Violation|0|||
48428621|NCT01323673|155757718|FG000|Overall Study|Withdrawal by Subject|2|||
48428622|NCT01323673|155757719|FG001|Overall Study|Withdrawal by Subject|3|||
48428623|NCT05091060|155757721|FG000|Overall Study|Lost to Follow-up|1|||
48428624|NCT00001262|155757722|FG000|Overall Study|Death|10|||
48428625|NCT00001262|155757723|FG001|Overall Study|Death|11|||
48428626|NCT00001262|155757724|FG002|Overall Study|Death|0|||
48428627|NCT00001262|155757722|FG000|Overall Study|Withdrawal by Subject|0|||
48428628|NCT00001262|155757723|FG001|Overall Study|Withdrawal by Subject|3|||
48428629|NCT00001262|155757724|FG002|Overall Study|Withdrawal by Subject|0|||
48428630|NCT01752842|155757725|FG000|Overall Study|Adverse Event|3|||
48428631|NCT01752842|155757726|FG001|Overall Study|Adverse Event|0|||
48428632|NCT01752842|155757725|FG000|Overall Study|Withdrawal by Subject|0|||
48428633|NCT01752842|155757726|FG001|Overall Study|Withdrawal by Subject|2|||
48428634|NCT01798706|155757727|FG000|Overall Study|Adverse Event|15|||
48428635|NCT01798706|155757728|FG001|Overall Study|Adverse Event|10|||
48428636|NCT01798706|155757727|FG000|Overall Study|Lack of Efficacy|0|||
48428637|NCT01798706|155757728|FG001|Overall Study|Lack of Efficacy|2|||
48428638|NCT01798706|155757727|FG000|Overall Study|Poor compliance to protocol|1|||
48428639|NCT01798706|155757728|FG001|Overall Study|Poor compliance to protocol|0|||
48428640|NCT01798706|155757727|FG000|Overall Study|Other than specified above|5|||
48428641|NCT01798706|155757728|FG001|Overall Study|Other than specified above|9|||
48428642|NCT03135028|155757731|FG000|Overall Study|Death|6|||
48428643|NCT03135028|155757731|FG000|Overall Study|Study Terminated by Sponsor|2|||
48428644|NCT03135028|155757731|FG000|Overall Study|Withdrew Consent|1|||
48428645|NCT00496873|155757732|FG000|Overall Study|Ineligible|2|||
48428646|NCT00496873|155757732|FG000|Overall Study|Death|2|||
48428647|NCT00496873|155757732|FG000|Overall Study|Withdrawal by Subject|3|||
48428648|NCT00783705|155757734|FG000|Overall Study|Adverse Event|2|||
48428649|NCT00783705|155757735|FG001|Overall Study|Adverse Event|0|||
48428650|NCT00783705|155757734|FG000|Overall Study|Withdrawal by Subject|3|||
48428651|NCT00783705|155757735|FG001|Overall Study|Withdrawal by Subject|2|||
48428652|NCT00783705|155757734|FG000|Overall Study|Lost to Follow-up|1|||
48428653|NCT00783705|155757735|FG001|Overall Study|Lost to Follow-up|3|||
48428654|NCT00748540|155757738|FG000|Overall Study|Physician Decision|1|||
48428655|NCT00992446|155757739|FG000|Overall Study|Disease Progression|1|||
48428656|NCT00992446|155757739|FG000|Overall Study|Withdrawal by Subject|2|||
48428657|NCT00992446|155757739|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
48428658|NCT04743635|155757740|FG000|Overall Study|Lost to Follow-up|2|||
48428659|NCT04743635|155757741|FG001|Overall Study|Lost to Follow-up|0|||
48428660|NCT02775864|155757742|FG000|Overall Study|Data ended end of 2010|1764|||
48428661|NCT02775864|155757743|FG001|Overall Study|Data ended end of 2010|2880|||
48428662|NCT02775864|155757744|FG002|Overall Study|Data ended end of 2010|1140|||
48428663|NCT02775864|155757745|FG003|Overall Study|Data ended end of 2010|1194|||
48428664|NCT02775864|155757742|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
48428665|NCT02775864|155757743|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
48428666|NCT02775864|155757744|FG002|Overall Study|Medicaid eligibility discontinued|720|||
48428667|NCT02775864|155757745|FG003|Overall Study|Medicaid eligibility discontinued|890|||
48428668|NCT00878072|155757746|FG000|Overall Study|Withdrew consent|2|||
48428669|NCT03238235|155757747|FG000|Overall Study|Adverse Event|2|||
48428670|NCT03238235|155757748|FG001|Overall Study|Adverse Event|0|||
48428671|NCT03238235|155757747|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
48428672|NCT03238235|155757748|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
48428673|NCT02379923|155757756|FG000|Overall Study|Death|5|||
48428674|NCT01954121|155757761|FG000|Overall Study|Lack of Efficacy|94|||
48428675|NCT01954121|155757762|FG001|Overall Study|Lack of Efficacy|41|||
48428676|NCT01954121|155757761|FG000|Overall Study|Protocol Violation|0|||
48428677|NCT01954121|155757762|FG001|Overall Study|Protocol Violation|2|||
48428678|NCT01954121|155757761|FG000|Overall Study|Lost to Follow-up|5|||
48428679|NCT01954121|155757762|FG001|Overall Study|Lost to Follow-up|6|||
48428680|NCT01954121|155757761|FG000|Overall Study|Withdrawal by Subject|18|||
48428681|NCT01954121|155757762|FG001|Overall Study|Withdrawal by Subject|12|||
48428682|NCT01954121|155757761|FG000|Overall Study|Pregnancy|1|||
48428683|NCT01954121|155757762|FG001|Overall Study|Pregnancy|1|||
48428684|NCT01954121|155757761|FG000|Overall Study|AE, serious fatal|1|||
48428685|NCT01954121|155757762|FG001|Overall Study|AE, serious fatal|0|||
48428686|NCT01954121|155757761|FG000|Overall Study|AE, non-serious non-fatal|5|||
48428687|NCT01954121|155757762|FG001|Overall Study|AE, non-serious non-fatal|22|||
48428688|NCT01954121|155757761|FG000|Overall Study|SAE, non-fatal|1|||
48428689|NCT01954121|155757762|FG001|Overall Study|SAE, non-fatal|4|||
48428690|NCT01954121|155757761|FG000|Overall Study|Non-compliant with study procedures|1|||
48432069|NCT01683071|155769033|FG002|Part 1|Withdrawal by Subject|2|||
48428691|NCT01954121|155757762|FG001|Overall Study|Non-compliant with study procedures|0|||
48428692|NCT01954121|155757761|FG000|Overall Study|Non-compliant patient|1|||
48428693|NCT01954121|155757762|FG001|Overall Study|Non-compliant patient|1|||
48428694|NCT01954121|155757761|FG000|Overall Study|Subject did not follow instructions|0|||
48428695|NCT01954121|155757762|FG001|Overall Study|Subject did not follow instructions|2|||
48428696|NCT03844633|155757765|FG000|1 Week FU|Lost to Follow-up|0|||
48428697|NCT03844633|155757766|FG001|1 Week FU|Lost to Follow-up|1|||
48428698|NCT03844633|155757767|FG002|1 Week FU|Lost to Follow-up|4|||
48428699|NCT03844633|155757765|FG000|12-month Follow-up|Lost to Follow-up|7|||
48428700|NCT03844633|155757766|FG001|12-month Follow-up|Lost to Follow-up|5|||
48428701|NCT03844633|155757767|FG002|12-month Follow-up|Lost to Follow-up|8|||
48428702|NCT01318083|155757768|FG000|Overall Study|Adverse Event|4|||
48428703|NCT01318083|155757769|FG001|Overall Study|Adverse Event|1|||
48428704|NCT01318083|155757770|FG002|Overall Study|Adverse Event|2|||
48428705|NCT01318083|155757768|FG000|Overall Study|Withdrawal by Subject|1|||
48428706|NCT01318083|155757769|FG001|Overall Study|Withdrawal by Subject|0|||
48428707|NCT01318083|155757770|FG002|Overall Study|Withdrawal by Subject|2|||
48428708|NCT01318083|155757768|FG000|Overall Study|Lack of Efficacy|0|||
48428709|NCT01318083|155757769|FG001|Overall Study|Lack of Efficacy|0|||
48428710|NCT01318083|155757770|FG002|Overall Study|Lack of Efficacy|1|||
48428711|NCT01318083|155757768|FG000|Overall Study|Treatment Complications|1|||
48428712|NCT01318083|155757769|FG001|Overall Study|Treatment Complications|0|||
48428713|NCT01318083|155757770|FG002|Overall Study|Treatment Complications|0|||
48428714|NCT01318083|155757768|FG000|Overall Study|Lack of Study Medication Compliance|0|||
48428715|NCT01318083|155757769|FG001|Overall Study|Lack of Study Medication Compliance|1|||
48428716|NCT01318083|155757770|FG002|Overall Study|Lack of Study Medication Compliance|0|||
48428717|NCT05896761|155757771|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
48428718|NCT05896761|155757772|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
48428719|NCT05896761|155757771|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
48428720|NCT05896761|155757772|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
48428721|NCT05301322|155757773|FG000|Overall Study|Adverse Event|7|||
48428722|NCT05301322|155757774|FG001|Overall Study|Adverse Event|3|||
48428723|NCT05301322|155757773|FG000|Overall Study|Death|0|||
48428724|NCT05301322|155757774|FG001|Overall Study|Death|1|||
48428725|NCT05301322|155757773|FG000|Overall Study|Lost to Follow-up|2|||
48428726|NCT05301322|155757774|FG001|Overall Study|Lost to Follow-up|1|||
48428727|NCT05301322|155757773|FG000|Overall Study|Protocol Violation|3|||
48428728|NCT05301322|155757774|FG001|Overall Study|Protocol Violation|1|||
48428729|NCT05301322|155757773|FG000|Overall Study|Withdrawal by Subject|3|||
48428730|NCT05301322|155757774|FG001|Overall Study|Withdrawal by Subject|0|||
48428731|NCT05301322|155757773|FG000|Overall Study|Other|4|||
48428732|NCT05301322|155757774|FG001|Overall Study|Other|0|||
48428733|NCT00872170|155757775|FG000|Overall Study|Adverse Event|1|||
48428734|NCT00872170|155757776|FG001|Overall Study|Adverse Event|0|||
48428735|NCT00426751|155757778|FG000|Overall Study|Adverse Event|8|||
48428736|NCT00426751|155757779|FG001|Overall Study|Adverse Event|1|||
48428737|NCT00426751|155757778|FG000|Overall Study|Lost to Follow-up|7|||
48428738|NCT00426751|155757779|FG001|Overall Study|Lost to Follow-up|6|||
48428739|NCT00426751|155757778|FG000|Overall Study|Consent Withdrawn|0|||
48428740|NCT00426751|155757779|FG001|Overall Study|Consent Withdrawn|1|||
48428741|NCT00426751|155757778|FG000|Overall Study|Other Reasons|7|||
48428742|NCT00426751|155757779|FG001|Overall Study|Other Reasons|12|||
48428743|NCT02761993|155757781|FG000|Overall Study|Adverse Event|0|||
48428744|NCT02761993|155757782|FG001|Overall Study|Adverse Event|2|||
48428745|NCT02761993|155757783|FG002|Overall Study|Adverse Event|0|||
48428746|NCT02761993|155757781|FG000|Overall Study|Lost to Follow-up|1|||
48428747|NCT02761993|155757782|FG001|Overall Study|Lost to Follow-up|3|||
48428748|NCT02761993|155757783|FG002|Overall Study|Lost to Follow-up|2|||
48428749|NCT02761993|155757781|FG000|Overall Study|Withdrawal by Subject|1|||
48428750|NCT02761993|155757782|FG001|Overall Study|Withdrawal by Subject|1|||
48428751|NCT02761993|155757783|FG002|Overall Study|Withdrawal by Subject|2|||
48428752|NCT03759379|155758960|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
48428753|NCT03759379|155758961|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
48428754|NCT03759379|155758960|FG000|Treatment Period|Death|2|||
48428755|NCT03759379|155758961|FG001|Treatment Period|Death|3|||
48428756|NCT03759379|155758960|FG000|Treatment Period|Lost to Follow-up|1|||
48428757|NCT03759379|155758961|FG001|Treatment Period|Lost to Follow-up|0|||
48428758|NCT03759379|155758960|FG000|Treatment Period|Physician Decision|0|||
48428759|NCT03759379|155758961|FG001|Treatment Period|Physician Decision|1|||
48428760|NCT03762850|155758964|FG000|Overall Study|Death|0|||
48428761|NCT03762850|155758965|FG001|Overall Study|Death|1|||
48428762|NCT03762850|155758964|FG000|Overall Study|Lost to Follow-up|0|||
48428763|NCT03762850|155758965|FG001|Overall Study|Lost to Follow-up|1|||
48428764|NCT03762850|155758964|FG000|Overall Study|Physician Decision|0|||
48428765|NCT03762850|155758965|FG001|Overall Study|Physician Decision|1|||
48428766|NCT03762850|155758964|FG000|Overall Study|Withdrawal by Subject|4|||
48428767|NCT03762850|155758965|FG001|Overall Study|Withdrawal by Subject|9|||
48428768|NCT04267562|155758966|FG000|Assessed for Eligibility|Screen Failure|64|||
48428769|NCT04267562|155758966|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
48428770|NCT04267562|155758966|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
48428771|NCT04267562|155758966|FG000|Assessed for Eligibility|Site closure|6|||
48428772|NCT04267562|155758966|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
48428773|NCT04267562|155758966|FG000|Assessed for Eligibility|Physician Decision|1|||
48428774|NCT04267562|155758966|FG000|Month 24|Elective hysterectomy|1|||
48428775|NCT04267562|155758966|FG000|Month 24|Lost to Follow-up|1|||
48428776|NCT04267562|155758966|FG000|Month 36|Elective hysterectomy|2|||
48428777|NCT04267562|155758966|FG000|Month 36|Lost to Follow-up|3|||
48428778|NCT02699515|155758967|FG000|Overall Study|Death|3|||
48428779|NCT02699515|155758968|FG001|Overall Study|Death|3|||
48428780|NCT02699515|155758969|FG002|Overall Study|Death|3|||
48428781|NCT02699515|155758970|FG003|Overall Study|Death|23|||
48428782|NCT02699515|155758971|FG004|Overall Study|Death|22|||
48428783|NCT02699515|155758972|FG005|Overall Study|Death|23|||
48428784|NCT02699515|155758973|FG006|Overall Study|Death|3|||
48428785|NCT02699515|155758974|FG007|Overall Study|Death|5|||
48428786|NCT02699515|155758967|FG000|Overall Study|Withdrawal by Subject|0|||
48428787|NCT02699515|155758968|FG001|Overall Study|Withdrawal by Subject|0|||
48428788|NCT02699515|155758969|FG002|Overall Study|Withdrawal by Subject|3|||
48428789|NCT02699515|155758970|FG003|Overall Study|Withdrawal by Subject|1|||
48428790|NCT02699515|155758971|FG004|Overall Study|Withdrawal by Subject|5|||
48428791|NCT02699515|155758972|FG005|Overall Study|Withdrawal by Subject|3|||
48428792|NCT02699515|155758973|FG006|Overall Study|Withdrawal by Subject|0|||
48428793|NCT02699515|155758974|FG007|Overall Study|Withdrawal by Subject|1|||
48428794|NCT02699515|155758967|FG000|Overall Study|Other|1|||
48428795|NCT02699515|155758968|FG001|Overall Study|Other|0|||
48428796|NCT02699515|155758969|FG002|Overall Study|Other|1|||
48428797|NCT02699515|155758970|FG003|Overall Study|Other|6|||
48428798|NCT02699515|155758971|FG004|Overall Study|Other|4|||
48428799|NCT02699515|155758972|FG005|Overall Study|Other|3|||
48428800|NCT02699515|155758973|FG006|Overall Study|Other|0|||
48428801|NCT02699515|155758974|FG007|Overall Study|Other|0|||
48428802|NCT01903811|155758975|FG000|Overall Study|No measurable disease|1|||
48428803|NCT01903811|155758976|FG001|Overall Study|No measurable disease|1|||
48428804|NCT01903811|155758975|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
48428805|NCT01903811|155758976|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
48428806|NCT01903811|155758975|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
48428807|NCT01903811|155758976|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
48428808|NCT01903811|155758975|FG000|Overall Study|Withdrawal by Subject|0|||
48428809|NCT01903811|155758976|FG001|Overall Study|Withdrawal by Subject|1|||
48428810|NCT04112316|155758979|FG000|First Period (8 Weeks)|Protocol Violation|1|||
48428811|NCT04112316|155758980|FG001|First Period (8 Weeks)|Protocol Violation|0|||
48428812|NCT04112316|155758979|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
48428813|NCT04112316|155758980|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
48428814|NCT01582282|155758982|FG000|Overall Study|Adverse Event|1|||
48428815|NCT01582282|155758983|FG001|Overall Study|Adverse Event|1|||
48428816|NCT01582282|155758984|FG002|Overall Study|Adverse Event|0|||
48428817|NCT01582282|155758982|FG000|Overall Study|Lost to Follow-up|1|||
48428818|NCT01582282|155758983|FG001|Overall Study|Lost to Follow-up|0|||
48428819|NCT01582282|155758984|FG002|Overall Study|Lost to Follow-up|0|||
48428820|NCT01582282|155758982|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
48428821|NCT01582282|155758983|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
48428822|NCT01582282|155758984|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
48428823|NCT04359823|155758991|FG000|Overall Study|Lost to Follow-up|0|||
48428824|NCT04359823|155758992|FG001|Overall Study|Lost to Follow-up|1|||
48428825|NCT04359823|155758991|FG000|Overall Study|Withdrawal by Subject|0|||
48428826|NCT04359823|155758992|FG001|Overall Study|Withdrawal by Subject|1|||
48428827|NCT01543490|155758995|FG000|Overall Study|Adverse Event|4|||
48428828|NCT01543490|155758996|FG001|Overall Study|Adverse Event|0|||
48428829|NCT01543490|155758995|FG000|Overall Study|Physician Decision|1|||
48428830|NCT01543490|155758996|FG001|Overall Study|Physician Decision|0|||
48428831|NCT01543490|155758995|FG000|Overall Study|Lack of Efficacy|3|||
48428832|NCT01543490|155758996|FG001|Overall Study|Lack of Efficacy|3|||
48428833|NCT01543490|155758995|FG000|Overall Study|Lost to Follow-up|5|||
48428834|NCT01543490|155758996|FG001|Overall Study|Lost to Follow-up|0|||
48428835|NCT01543490|155758995|FG000|Overall Study|Withdrawal by Subject|2|||
48428836|NCT01543490|155758996|FG001|Overall Study|Withdrawal by Subject|0|||
48428837|NCT01543490|155758995|FG000|Overall Study|Other-Various Administrative Reasons|1|||
48428838|NCT01543490|155758996|FG001|Overall Study|Other-Various Administrative Reasons|2|||
48428839|NCT01597622|155758998|FG000|Overall Study|Adverse Event|7|||
48428840|NCT01597622|155758998|FG000|Overall Study|Lack of Efficacy|3|||
48428841|NCT01597622|155758998|FG000|Overall Study|Protocol Violation|1|||
48428842|NCT01597622|155758998|FG000|Overall Study|Lost to Follow-up|1|||
48428843|NCT01597622|155758998|FG000|Overall Study|Investigator Discretion|5|||
48428844|NCT01597622|155758998|FG000|Overall Study|Withdrawal by Subject|20|||
48428845|NCT01597622|155758998|FG000|Overall Study|Death|1|||
48428852|NCT04549168|155758999|FG000|Randomization Phase|Withdrawal by Subject|0|||
48428853|NCT04549168|155759000|FG001|Randomization Phase|Withdrawal by Subject|2|||
48428854|NCT04549168|155759001|FG002|Randomization Phase|Withdrawal by Subject|1|||
48428855|NCT01981122|155759002|FG000|Overall Study|Withdrawal by Subject|0|||
48428856|NCT01981122|155759003|FG001|Overall Study|Withdrawal by Subject|2|||
48428857|NCT01981122|155759002|FG000|Overall Study|Protocol Violation|0|||
48428858|NCT01981122|155759003|FG001|Overall Study|Protocol Violation|1|||
48428859|NCT01981122|155759002|FG000|Overall Study|Lost to Follow-up|0|||
48428860|NCT01981122|155759003|FG001|Overall Study|Lost to Follow-up|1|||
48428861|NCT01981122|155759002|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
48428862|NCT01981122|155759003|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
48428863|NCT01981122|155759002|FG000|Overall Study|Death|14|||
48428864|NCT01981122|155759003|FG001|Overall Study|Death|15|||
48428865|NCT02433210|155759004|FG000|Overall Study|Physician Decision|1|||
48428866|NCT02433210|155759005|FG001|Overall Study|Physician Decision|0|||
48428867|NCT02433210|155759006|FG002|Overall Study|Physician Decision|0|||
48428868|NCT01520324|155759007|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
48428869|NCT01158534|155759009|FG000|Overall Study|Withdrawal by Subject|1|||
48428870|NCT01158534|155759009|FG000|Overall Study|Death|1|||
48428871|NCT01158534|155759009|FG000|Overall Study|Other|1|||
48428872|NCT01988012|155759010|FG000|Overall Study|Adverse Event|5|||
48428873|NCT01988012|155759010|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48428874|NCT01988012|155759010|FG000|Overall Study|Patient Withdrawal of Consent|4|||
48428875|NCT01988012|155759010|FG000|Overall Study|Lost to Follow-up|1|||
48428876|NCT01988012|155759010|FG000|Overall Study|Physician Decision|1|||
48428877|NCT01988012|155759010|FG000|Overall Study|Protocol Violation|1|||
48428878|NCT00521339|155759011|FG000|Treatment Phase|Adverse Event|2|||
48428879|NCT00521339|155759012|FG001|Treatment Phase|Adverse Event|0|||
48428880|NCT00521339|155759013|FG002|Treatment Phase|Adverse Event|0|||
48428881|NCT00521339|155759011|FG000|Treatment Phase|Intolerability to study drug|2|||
48428882|NCT00521339|155759012|FG001|Treatment Phase|Intolerability to study drug|0|||
48428883|NCT00521339|155759013|FG002|Treatment Phase|Intolerability to study drug|0|||
48428884|NCT00521339|155759011|FG000|Treatment Phase|Lack of Efficacy|3|||
48428885|NCT00521339|155759012|FG001|Treatment Phase|Lack of Efficacy|0|||
48428886|NCT00521339|155759013|FG002|Treatment Phase|Lack of Efficacy|0|||
48428887|NCT00521339|155759011|FG000|Treatment Phase|Withdrawal by Subject|3|||
48428888|NCT00521339|155759012|FG001|Treatment Phase|Withdrawal by Subject|0|||
48428889|NCT00521339|155759013|FG002|Treatment Phase|Withdrawal by Subject|0|||
48428890|NCT00521339|155759011|FG000|Treatment Phase|Lost to Follow-up|1|||
48428891|NCT00521339|155759012|FG001|Treatment Phase|Lost to Follow-up|0|||
48428892|NCT00521339|155759013|FG002|Treatment Phase|Lost to Follow-up|0|||
48428893|NCT00521339|155759011|FG000|Treatment Phase|Protocol Violation|1|||
48428894|NCT00521339|155759012|FG001|Treatment Phase|Protocol Violation|0|||
48428895|NCT00521339|155759013|FG002|Treatment Phase|Protocol Violation|0|||
48428896|NCT00521339|155759011|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
48428897|NCT00521339|155759012|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
48428898|NCT00521339|155759013|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
48428899|NCT00521339|155759011|FG000|Treatment Extension Phase|Death|0|||
48428900|NCT00521339|155759012|FG001|Treatment Extension Phase|Death|0|||
48428901|NCT00521339|155759013|FG002|Treatment Extension Phase|Death|1|||
48428902|NCT01614769|155759014|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
48428903|NCT01614769|155759015|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
48428904|NCT01614769|155759016|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
48428905|NCT01614769|155759017|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
48428906|NCT01614769|155759018|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
48428907|NCT01614769|155759019|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
48428908|NCT01614769|155759014|FG000|Period 1|Protocol Violation|0|||
48428909|NCT01614769|155759015|FG001|Period 1|Protocol Violation|0|||
48428910|NCT01614769|155759016|FG002|Period 1|Protocol Violation|0|||
48428911|NCT01614769|155759017|FG003|Period 1|Protocol Violation|1|||
48428912|NCT01614769|155759018|FG004|Period 1|Protocol Violation|0|||
48428913|NCT01614769|155759019|FG005|Period 1|Protocol Violation|0|||
48428914|NCT01614769|155759014|FG000|Period 1|Withdrawal by Subject|1|||
48428915|NCT01614769|155759015|FG001|Period 1|Withdrawal by Subject|0|||
48428916|NCT01614769|155759016|FG002|Period 1|Withdrawal by Subject|0|||
48428917|NCT01614769|155759017|FG003|Period 1|Withdrawal by Subject|0|||
48428918|NCT01614769|155759018|FG004|Period 1|Withdrawal by Subject|0|||
48428919|NCT01614769|155759019|FG005|Period 1|Withdrawal by Subject|0|||
48428920|NCT01614769|155759014|FG000|Period 3|Withdrawal by Subject|0|||
48428921|NCT01614769|155759015|FG001|Period 3|Withdrawal by Subject|0|||
48428922|NCT01614769|155759016|FG002|Period 3|Withdrawal by Subject|1|||
48428923|NCT01614769|155759017|FG003|Period 3|Withdrawal by Subject|0|||
48428924|NCT01614769|155759018|FG004|Period 3|Withdrawal by Subject|0|||
48428925|NCT01614769|155759019|FG005|Period 3|Withdrawal by Subject|0|||
48428926|NCT03010423|155759023|FG000|Overall Study|Study termination|8|||
48428927|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
48428928|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
48428929|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
48428930|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
48428931|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
48428932|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
48428933|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
48428934|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
48428935|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
48428936|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
48428937|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
48428938|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
48428939|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
48428940|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
48428941|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
48428942|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
48428943|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
48428944|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
48428945|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
48428946|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
48428947|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
48428948|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
48428949|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
48428950|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
48428951|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
48428952|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
48428953|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
48428954|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
48428955|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
48428956|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
48428957|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
48428958|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
48428959|NCT00958568|155759024|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
48428960|NCT00958568|155759025|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
48428961|NCT00958568|155759026|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
48428962|NCT00958568|155759027|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
48428963|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
48428964|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
48428965|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
48428966|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
48428967|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
48428968|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
48428969|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
48428970|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
48428971|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
48428972|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
48428973|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
48428974|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
48428975|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
48428976|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
48428977|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
48428978|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
48428979|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
48428980|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
48428981|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
48428982|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
48428983|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
48428984|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
48428985|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
48428986|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
48428987|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
48428988|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
48428989|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
48428990|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
48428991|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
48428992|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
48428993|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
48428994|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
48428995|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
48428996|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
48428997|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
48428998|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
48428999|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
48429000|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
48429001|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
48429002|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
48429003|NCT00958568|155759024|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
48429004|NCT00958568|155759025|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
48429005|NCT00958568|155759026|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
48429006|NCT00958568|155759027|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
48429007|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
48429008|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
48429009|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
48429010|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
48429011|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
48429012|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
48429013|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
48429014|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
48429015|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
48429016|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
48429017|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
48429018|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
48429019|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
48429020|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
48429021|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
48429022|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
48429023|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
48429024|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
48429025|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
48429026|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
48429027|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
48429028|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
48429029|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
48429030|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
48429031|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
48429032|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
48429033|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
48429034|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
48429035|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
48429036|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
48429037|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
48429038|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
48429039|NCT00958568|155759024|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
48429040|NCT00958568|155759025|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
48429041|NCT00958568|155759026|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
48429042|NCT00958568|155759027|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
48429043|NCT00850759|155759028|FG000|Overall Study|Lost to Follow-up|7|||
48429044|NCT00850759|155759029|FG001|Overall Study|Lost to Follow-up|5|||
48429045|NCT00850759|155759030|FG002|Overall Study|Lost to Follow-up|5|||
48429046|NCT00850759|155759031|FG003|Overall Study|Lost to Follow-up|3|||
48429047|NCT01849250|155759032|FG000|Overall Study|Withdrawal by Subject|1|||
48429048|NCT01849250|155759033|FG001|Overall Study|Withdrawal by Subject|0|||
48429049|NCT01849250|155759032|FG000|Overall Study|Not Evaluable|5|||
48429050|NCT01849250|155759033|FG001|Overall Study|Not Evaluable|3|||
48429051|NCT01849250|155759032|FG000|Overall Study|Screen Failure|1|||
48429052|NCT01849250|155759033|FG001|Overall Study|Screen Failure|0|||
48429053|NCT00367640|155759034|FG000|Overall Study|Adverse Event|3|||
48429054|NCT00367640|155759035|FG001|Overall Study|Adverse Event|6|||
48429055|NCT00367640|155759036|FG002|Overall Study|Adverse Event|8|||
48429056|NCT00367640|155759037|FG003|Overall Study|Adverse Event|0|||
48429057|NCT00367640|155759034|FG000|Overall Study|Withdrawal by Subject|8|||
48429058|NCT00367640|155759035|FG001|Overall Study|Withdrawal by Subject|11|||
48429059|NCT00367640|155759036|FG002|Overall Study|Withdrawal by Subject|8|||
48429060|NCT00367640|155759037|FG003|Overall Study|Withdrawal by Subject|6|||
48429061|NCT00367640|155759034|FG000|Overall Study|Any other reason not above-mentioned|7|||
48429062|NCT00367640|155759035|FG001|Overall Study|Any other reason not above-mentioned|5|||
48429063|NCT00367640|155759036|FG002|Overall Study|Any other reason not above-mentioned|3|||
48429064|NCT00367640|155759037|FG003|Overall Study|Any other reason not above-mentioned|4|||
48429065|NCT03408873|155759038|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
48429066|NCT03408873|155759038|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
48429067|NCT03408873|155759038|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
48429068|NCT03408873|155759038|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
48429069|NCT03408873|155759038|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
48429070|NCT03408873|155759038|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
48429071|NCT01971476|155759040|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
48429072|NCT01971476|155759041|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
48429073|NCT01971476|155759042|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
48429074|NCT01971476|155759040|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
48429075|NCT01971476|155759041|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
48429076|NCT01971476|155759042|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
48429077|NCT01971476|155759040|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
48429078|NCT01971476|155759041|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
48429079|NCT01971476|155759042|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
48429080|NCT02214186|155759045|FG000|Overall Study|Lost to Follow-up|1|||
48429081|NCT02214186|155759046|FG001|Overall Study|Lost to Follow-up|1|||
48429082|NCT02214186|155759045|FG000|Overall Study|Protocol Violation|1|||
48429083|NCT02214186|155759046|FG001|Overall Study|Protocol Violation|1|||
48429084|NCT01024465|155759049|FG000|Overall Study|Adverse Event|2|||
48429085|NCT01024465|155759049|FG000|Overall Study|Physician Decision|1|||
48429086|NCT02677896|155759050|FG000|Double Blind Period (up to 35 Months)|Death|113|||
48429087|NCT02677896|155759051|FG001|Double Blind Period (up to 35 Months)|Death|189|||
48429088|NCT02677896|155759050|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
48429089|NCT02677896|155759051|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
48429090|NCT02677896|155759050|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
48429091|NCT02677896|155759051|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
48429092|NCT02677896|155759050|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
48429093|NCT02677896|155759051|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
48429094|NCT02677896|155759050|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
48429095|NCT02677896|155759051|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
48429096|NCT02677896|155759050|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
48429097|NCT02677896|155759051|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
48429098|NCT02677896|155759050|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
48429099|NCT02677896|155759051|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
48429100|NCT02677896|155759050|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
48429101|NCT02677896|155759051|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
48429102|NCT02677896|155759050|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
48429103|NCT02677896|155759051|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
48429104|NCT02677896|155759050|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
48429105|NCT02677896|155759051|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
48429106|NCT02677896|155759050|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
48429107|NCT02677896|155759051|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
48429108|NCT02677896|155759050|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
48429109|NCT02677896|155759051|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
48429110|NCT02677896|155759050|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
48429111|NCT02677896|155759051|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
48429112|NCT02677896|155759050|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
48429113|NCT02677896|155759051|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
48429114|NCT00114972|155759052|FG000|Overall Study|Withdrawal by Subject|40|||
48429115|NCT00114972|155759053|FG001|Overall Study|Withdrawal by Subject|7|||
48429116|NCT00114972|155759052|FG000|Overall Study|Lost to Follow-up|8|||
48429117|NCT00114972|155759053|FG001|Overall Study|Lost to Follow-up|5|||
48429118|NCT00830037|155759054|FG000|Overall Study|Withdrawal by Subject|2|||
48429119|NCT00830037|155759055|FG001|Overall Study|Withdrawal by Subject|3|||
48429120|NCT00830037|155759054|FG000|Overall Study|Lost to Follow-up|1|||
48429121|NCT00830037|155759055|FG001|Overall Study|Lost to Follow-up|2|||
48429122|NCT00830037|155759054|FG000|Overall Study|Active when terminated by DSMB|15|||
48429123|NCT00830037|155759055|FG001|Overall Study|Active when terminated by DSMB|14|||
48429124|NCT01921270|155759058|FG000|Overall Study|Withdrawal by Subject|1|||
48429125|NCT02429427|155759061|FG000|Overall Study|Adverse Event|220|||
48429126|NCT02429427|155759062|FG001|Overall Study|Adverse Event|92|||
48429127|NCT02429427|155759061|FG000|Overall Study|Protocol Violation|10|||
48429128|NCT02429427|155759062|FG001|Overall Study|Protocol Violation|6|||
48429129|NCT02429427|155759061|FG000|Overall Study|Lost to Follow-up|15|||
48429130|NCT02429427|155759062|FG001|Overall Study|Lost to Follow-up|6|||
48429131|NCT02429427|155759061|FG000|Overall Study|Withdrawal by Subject|64|||
48429132|NCT02429427|155759062|FG001|Overall Study|Withdrawal by Subject|34|||
48429133|NCT02429427|155759061|FG000|Overall Study|Other|62|||
48429134|NCT02429427|155759062|FG001|Overall Study|Other|41|||
48429135|NCT02028338|155759063|FG000|Overall Study|Withdrawal by Subject|3|||
48429136|NCT02028338|155759064|FG001|Overall Study|Withdrawal by Subject|1|||
48429137|NCT02028338|155759063|FG000|Overall Study|Unable to contact participant|1|||
48429138|NCT02028338|155759064|FG001|Overall Study|Unable to contact participant|0|||
48429139|NCT03552549|155759065|FG000|Overall Study|Disease progression|25|||
48429140|NCT03552549|155759066|FG001|Overall Study|Disease progression|17|||
48429141|NCT03552549|155759065|FG000|Overall Study|Adverse event in first 12 months|12|||
48429142|NCT03552549|155759066|FG001|Overall Study|Adverse event in first 12 months|8|||
48429143|NCT03552549|155759065|FG000|Overall Study|Withdrawal by Subject|7|||
48429144|NCT03552549|155759066|FG001|Overall Study|Withdrawal by Subject|7|||
48429145|NCT03552549|155759065|FG000|Overall Study|Unknown (no reason provided)|4|||
48429146|NCT03552549|155759066|FG001|Overall Study|Unknown (no reason provided)|2|||
48429147|NCT03552549|155759065|FG000|Overall Study|Not in participant's best interest|2|||
48429148|NCT03552549|155759066|FG001|Overall Study|Not in participant's best interest|1|||
48429149|NCT03552549|155759065|FG000|Overall Study|Did not complete study treatment|2|||
48429150|NCT03552549|155759066|FG001|Overall Study|Did not complete study treatment|3|||
48429151|NCT03552549|155759065|FG000|Overall Study|Did not meet eligibility criteria|1|||
48429152|NCT03552549|155759066|FG001|Overall Study|Did not meet eligibility criteria|0|||
48429153|NCT03552549|155759065|FG000|Overall Study|Administrative|0|||
48429154|NCT03552549|155759066|FG001|Overall Study|Administrative|14|||
48429155|NCT03288779|155759067|FG000|Overall Study|Withdrawal by Subject|3|||
48429156|NCT02588248|155759070|FG000|Overall Study|Physician Decision|4|||
48429157|NCT02588248|155759071|FG001|Overall Study|Physician Decision|3|||
48429158|NCT01355068|155759075|FG000|First Intervention Period|Adverse Event|0|||
48429159|NCT01355068|155759076|FG001|First Intervention Period|Adverse Event|1|||
48429160|NCT01355068|155759075|FG000|First Intervention Period|Withdrawal by Subject|0|||
48429161|NCT01355068|155759076|FG001|First Intervention Period|Withdrawal by Subject|1|||
48429162|NCT02739594|155759079|FG000|Overall Study|Undesired Event|3|||
48429163|NCT02739594|155759080|FG001|Overall Study|Undesired Event|4|||
48429164|NCT02739594|155759079|FG000|Overall Study|Violation of Eligibility Criteria|1|||
48429165|NCT02739594|155759080|FG001|Overall Study|Violation of Eligibility Criteria|2|||
48429166|NCT02739594|155759079|FG000|Overall Study|Protocol Violation|5|||
48429167|NCT02739594|155759080|FG001|Overall Study|Protocol Violation|6|||
48429168|NCT02739594|155759079|FG000|Overall Study|Death|4|||
48429169|NCT02739594|155759080|FG001|Overall Study|Death|2|||
48429170|NCT02739594|155759079|FG000|Overall Study|Renal Insufficiency|4|||
48429171|NCT02739594|155759080|FG001|Overall Study|Renal Insufficiency|6|||
48429172|NCT02739594|155759079|FG000|Overall Study|Administrative Reasons|1|||
48429173|NCT02739594|155759080|FG001|Overall Study|Administrative Reasons|3|||
48429174|NCT02739594|155759079|FG000|Overall Study|Withdrawal by Subject|1|||
48429175|NCT02739594|155759080|FG001|Overall Study|Withdrawal by Subject|1|||
48429176|NCT02739594|155759079|FG000|Overall Study|Lost to Follow-up|0|||
48429177|NCT02739594|155759080|FG001|Overall Study|Lost to Follow-up|1|||
48429178|NCT02739594|155759079|FG000|Overall Study|Elevated Serum Creatinine|0|||
48429179|NCT02739594|155759080|FG001|Overall Study|Elevated Serum Creatinine|1|||
48429180|NCT02739594|155759079|FG000|Overall Study|Other|6|||
48429181|NCT02739594|155759080|FG001|Overall Study|Other|2|||
48429182|NCT03052608|155760317|FG000|Treatment Phase|Adverse Event|10|||
48429183|NCT03052608|155760318|FG001|Treatment Phase|Adverse Event|12|||
48429184|NCT03052608|155760317|FG000|Treatment Phase|Death|6|||
48429185|NCT03052608|155760318|FG001|Treatment Phase|Death|4|||
48429186|NCT03052608|155760317|FG000|Treatment Phase|Withdrawal by Subject|4|||
48429187|NCT03052608|155760318|FG001|Treatment Phase|Withdrawal by Subject|12|||
48429188|NCT03052608|155760317|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
48429189|NCT03052608|155760318|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
48429190|NCT03052608|155760317|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
48429191|NCT03052608|155760318|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
48429192|NCT03052608|155760317|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
48429193|NCT03052608|155760318|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
48429194|NCT03052608|155760317|FG000|Treatment Phase|Ongoing|103|||
48429195|NCT03052608|155760318|FG001|Treatment Phase|Ongoing|31|||
48429196|NCT03052608|155760317|FG000|Long-Term Follow-up Phase|Death|23|||
48429197|NCT03052608|155760318|FG001|Long-Term Follow-up Phase|Death|28|||
48429198|NCT03052608|155760317|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
48429199|NCT03052608|155760318|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
48429200|NCT03052608|155760317|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
48429201|NCT03052608|155760318|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
48429202|NCT03052608|155760317|FG000|Long-Term Follow-up Phase|Ongoing|122|||
48429203|NCT03052608|155760318|FG001|Long-Term Follow-up Phase|Ongoing|99|||
48429204|NCT00912015|155760320|FG000|Overall Study|Lack of Efficacy|1|||
48429205|NCT00912015|155760321|FG001|Overall Study|Lack of Efficacy|0|||
48429206|NCT00912015|155760322|FG002|Overall Study|Lack of Efficacy|0|||
48429208|NCT00912015|155760320|FG000|Overall Study|Withdrawal by Subject|8|||
48429209|NCT00912015|155760321|FG001|Overall Study|Withdrawal by Subject|8|||
48429210|NCT00912015|155760322|FG002|Overall Study|Withdrawal by Subject|3|||
48429211|NCT00912015|155760323|FG003|Overall Study|Withdrawal by Subject|0|||
48429212|NCT00912015|155760320|FG000|Overall Study|Protocol Violation|1|||
48429213|NCT00912015|155760321|FG001|Overall Study|Protocol Violation|0|||
48429214|NCT00912015|155760322|FG002|Overall Study|Protocol Violation|0|||
48429215|NCT00912015|155760323|FG003|Overall Study|Protocol Violation|1|||
48429216|NCT00912015|155760320|FG000|Overall Study|Adverse Event|6|||
48429217|NCT00912015|155760321|FG001|Overall Study|Adverse Event|0|||
48429218|NCT00912015|155760322|FG002|Overall Study|Adverse Event|0|||
48429219|NCT00912015|155760323|FG003|Overall Study|Adverse Event|1|||
48429220|NCT01058369|155760324|FG000|Overall Study|Adverse Event|1|||
48429221|NCT01058369|155760324|FG000|Overall Study|Early termination study|1|||
48429222|NCT00089843|155760327|FG000|Overall Study|Withdrawal by Subject|1|||
48429223|NCT00089843|155760328|FG001|Overall Study|Withdrawal by Subject|4|||
48429224|NCT00089843|155760329|FG002|Overall Study|Withdrawal by Subject|5|||
48429225|NCT00089843|155760330|FG003|Overall Study|Withdrawal by Subject|6|||
48429226|NCT00089843|155760327|FG000|Overall Study|Physician Decision|1|||
48429227|NCT00089843|155760328|FG001|Overall Study|Physician Decision|0|||
48429228|NCT00089843|155760329|FG002|Overall Study|Physician Decision|0|||
48429229|NCT00089843|155760330|FG003|Overall Study|Physician Decision|1|||
48429230|NCT01115569|155760333|FG000|Conversion/Titration Phase|Adverse Event|59|||
48429231|NCT01115569|155760334|FG001|Conversion/Titration Phase|Adverse Event|0|||
48429232|NCT01115569|155760333|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
48429233|NCT01115569|155760334|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
48429234|NCT01115569|155760333|FG000|Conversion/Titration Phase|Physician Decision|5|||
48429235|NCT01115569|155760334|FG001|Conversion/Titration Phase|Physician Decision|0|||
48429236|NCT01115569|155760333|FG000|Conversion/Titration Phase|Protocol Violation|68|||
48429237|NCT01115569|155760334|FG001|Conversion/Titration Phase|Protocol Violation|0|||
48429238|NCT01115569|155760333|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
48429239|NCT01115569|155760334|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
48429240|NCT01115569|155760333|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
48429241|NCT01115569|155760334|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
48429242|NCT01115569|155760333|FG000|Maintenance Phase|Adverse Event|0|||
48429243|NCT01115569|155760334|FG001|Maintenance Phase|Adverse Event|43|||
48429244|NCT01115569|155760333|FG000|Maintenance Phase|Lost to Follow-up|0|||
48429245|NCT01115569|155760334|FG001|Maintenance Phase|Lost to Follow-up|8|||
48429246|NCT01115569|155760333|FG000|Maintenance Phase|Physician Decision|0|||
48429247|NCT01115569|155760334|FG001|Maintenance Phase|Physician Decision|3|||
48429248|NCT01115569|155760333|FG000|Maintenance Phase|Protocol Violation|0|||
48429249|NCT01115569|155760334|FG001|Maintenance Phase|Protocol Violation|9|||
48429250|NCT01115569|155760333|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48429251|NCT01115569|155760334|FG001|Maintenance Phase|Withdrawal by Subject|27|||
48429252|NCT01115569|155760333|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
48429253|NCT01115569|155760334|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
48429254|NCT01115569|155760333|FG000|Maintenance Phase|Administrative|0|||
48429255|NCT01115569|155760334|FG001|Maintenance Phase|Administrative|1|||
48429256|NCT01701583|155760335|FG000|Overall Study|Withdrawal by Subject|2|||
48429257|NCT01701583|155760336|FG001|Overall Study|Withdrawal by Subject|0|||
48429258|NCT01958671|155760337|FG000|Overall Study|Adverse Event|1|||
48429259|NCT01958671|155760338|FG001|Overall Study|Adverse Event|1|||
48429260|NCT01958671|155760339|FG002|Overall Study|Adverse Event|5|||
48429261|NCT01958671|155760337|FG000|Overall Study|Death|1|||
48429262|NCT01958671|155760338|FG001|Overall Study|Death|0|||
48429263|NCT01958671|155760339|FG002|Overall Study|Death|0|||
48429264|NCT01958671|155760337|FG000|Overall Study|Excluded medication|0|||
48429265|NCT01958671|155760338|FG001|Overall Study|Excluded medication|0|||
48429266|NCT01958671|155760339|FG002|Overall Study|Excluded medication|1|||
48429267|NCT01958671|155760337|FG000|Overall Study|Hyperglycemia|0|||
48429268|NCT01958671|155760338|FG001|Overall Study|Hyperglycemia|0|||
48429269|NCT01958671|155760339|FG002|Overall Study|Hyperglycemia|2|||
48429270|NCT01958671|155760337|FG000|Overall Study|Lost to Follow-up|7|||
48429271|NCT01958671|155760338|FG001|Overall Study|Lost to Follow-up|11|||
48429272|NCT01958671|155760339|FG002|Overall Study|Lost to Follow-up|7|||
48429273|NCT01958671|155760337|FG000|Overall Study|Non-compliance with study drug|1|||
48429274|NCT01958671|155760338|FG001|Overall Study|Non-compliance with study drug|1|||
48429275|NCT01958671|155760339|FG002|Overall Study|Non-compliance with study drug|1|||
48429276|NCT01958671|155760337|FG000|Overall Study|Pregnancy|0|||
48429277|NCT01958671|155760338|FG001|Overall Study|Pregnancy|0|||
48429278|NCT01958671|155760339|FG002|Overall Study|Pregnancy|1|||
48429279|NCT01958671|155760337|FG000|Overall Study|Protocol Violation|0|||
48429280|NCT01958671|155760338|FG001|Overall Study|Protocol Violation|1|||
48429281|NCT01958671|155760339|FG002|Overall Study|Protocol Violation|0|||
48429282|NCT01958671|155760337|FG000|Overall Study|Study site terminated by sponsor|1|||
48429283|NCT01958671|155760338|FG001|Overall Study|Study site terminated by sponsor|0|||
48429284|NCT01958671|155760339|FG002|Overall Study|Study site terminated by sponsor|1|||
48429288|NCT01958671|155760337|FG000|Overall Study|Withdrawal by Subject|8|||
48429289|NCT01958671|155760338|FG001|Overall Study|Withdrawal by Subject|10|||
48429290|NCT01958671|155760339|FG002|Overall Study|Withdrawal by Subject|13|||
48429291|NCT02042404|155760345|FG000|Overall Study|Death|1|||
48429292|NCT02042404|155760346|FG001|Overall Study|Death|0|||
48429293|NCT02042404|155760345|FG000|Overall Study|Unrelated Adverse Event|3|||
48429294|NCT02042404|155760346|FG001|Overall Study|Unrelated Adverse Event|0|||
48429295|NCT02042404|155760345|FG000|Overall Study|Inability to meet time requirements|1|||
48429296|NCT02042404|155760346|FG001|Overall Study|Inability to meet time requirements|0|||
48429297|NCT02241512|155760347|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
48429298|NCT02241512|155760348|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
48429299|NCT04009096|155760349|FG000|Overall Study|Withdrawal by Subject|0|||
48429300|NCT04009096|155760350|FG001|Overall Study|Withdrawal by Subject|7|||
48429301|NCT04009096|155760351|FG002|Overall Study|Withdrawal by Subject|0|||
48429302|NCT04009096|155760349|FG000|Overall Study|Physician Decision|0|||
48429303|NCT04009096|155760350|FG001|Overall Study|Physician Decision|1|||
48429304|NCT04009096|155760351|FG002|Overall Study|Physician Decision|0|||
48429305|NCT00450372|155760354|FG000|Overall Study|Physician Decision|1|||
48429306|NCT01070550|155760355|FG000|Overall Study|Adverse Event|43|||
48429307|NCT01070550|155760356|FG001|Overall Study|Adverse Event|1|||
48429308|NCT01070550|155760357|FG002|Overall Study|Adverse Event|3|||
48429309|NCT01070550|155760358|FG003|Overall Study|Adverse Event|0|||
48429310|NCT01070550|155760359|FG004|Overall Study|Adverse Event|0|||
48429311|NCT01070550|155760360|FG005|Overall Study|Adverse Event|0|||
48429312|NCT01070550|155760355|FG000|Overall Study|Death|20|||
48429313|NCT01070550|155760356|FG001|Overall Study|Death|4|||
48429314|NCT01070550|155760357|FG002|Overall Study|Death|3|||
48429315|NCT01070550|155760358|FG003|Overall Study|Death|0|||
48429316|NCT01070550|155760359|FG004|Overall Study|Death|0|||
48429317|NCT01070550|155760360|FG005|Overall Study|Death|0|||
48429318|NCT01070550|155760355|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
48429319|NCT01070550|155760356|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
48429320|NCT01070550|155760357|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
48429321|NCT01070550|155760358|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48429322|NCT01070550|155760359|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48429323|NCT01070550|155760360|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
48429324|NCT01070550|155760355|FG000|Overall Study|Early termination|3|||
48429325|NCT01070550|155760356|FG001|Overall Study|Early termination|0|||
48429326|NCT01070550|155760357|FG002|Overall Study|Early termination|0|||
48429327|NCT01070550|155760358|FG003|Overall Study|Early termination|0|||
48429328|NCT01070550|155760359|FG004|Overall Study|Early termination|0|||
48429329|NCT01070550|155760360|FG005|Overall Study|Early termination|0|||
48429330|NCT01070550|155760355|FG000|Overall Study|Failed to return|450|||
48429331|NCT01070550|155760356|FG001|Overall Study|Failed to return|33|||
48429332|NCT01070550|155760357|FG002|Overall Study|Failed to return|144|||
48429333|NCT01070550|155760358|FG003|Overall Study|Failed to return|40|||
48429334|NCT01070550|155760359|FG004|Overall Study|Failed to return|1|||
48429335|NCT01070550|155760360|FG005|Overall Study|Failed to return|2|||
48429336|NCT01070550|155760355|FG000|Overall Study|Incomplete treatment|2|||
48429337|NCT01070550|155760356|FG001|Overall Study|Incomplete treatment|0|||
48429338|NCT01070550|155760357|FG002|Overall Study|Incomplete treatment|0|||
48429339|NCT01070550|155760358|FG003|Overall Study|Incomplete treatment|0|||
48429340|NCT01070550|155760359|FG004|Overall Study|Incomplete treatment|0|||
48429341|NCT01070550|155760360|FG005|Overall Study|Incomplete treatment|0|||
48429342|NCT01070550|155760355|FG000|Overall Study|Lab test not done|22|||
48429343|NCT01070550|155760356|FG001|Overall Study|Lab test not done|3|||
48429344|NCT01070550|155760357|FG002|Overall Study|Lab test not done|4|||
48429345|NCT01070550|155760358|FG003|Overall Study|Lab test not done|1|||
48429346|NCT01070550|155760359|FG004|Overall Study|Lab test not done|0|||
48429347|NCT01070550|155760360|FG005|Overall Study|Lab test not done|1|||
48429348|NCT01070550|155760355|FG000|Overall Study|Lack of Efficacy|65|||
48429349|NCT01070550|155760356|FG001|Overall Study|Lack of Efficacy|1|||
48429350|NCT01070550|155760357|FG002|Overall Study|Lack of Efficacy|5|||
48429351|NCT01070550|155760358|FG003|Overall Study|Lack of Efficacy|5|||
48429352|NCT01070550|155760359|FG004|Overall Study|Lack of Efficacy|0|||
48429353|NCT01070550|155760360|FG005|Overall Study|Lack of Efficacy|1|||
48429354|NCT01070550|155760355|FG000|Overall Study|Miscellaneous|12|||
48429355|NCT01070550|155760356|FG001|Overall Study|Miscellaneous|2|||
48429356|NCT01070550|155760357|FG002|Overall Study|Miscellaneous|3|||
48429357|NCT01070550|155760358|FG003|Overall Study|Miscellaneous|1|||
48429358|NCT01070550|155760359|FG004|Overall Study|Miscellaneous|0|||
48429359|NCT01070550|155760360|FG005|Overall Study|Miscellaneous|0|||
48429360|NCT01070550|155760355|FG000|Overall Study|New treatment started|3|||
48429361|NCT01070550|155760356|FG001|Overall Study|New treatment started|1|||
48429362|NCT01070550|155760357|FG002|Overall Study|New treatment started|0|||
48429363|NCT01070550|155760358|FG003|Overall Study|New treatment started|2|||
48429364|NCT01070550|155760359|FG004|Overall Study|New treatment started|0|||
48429365|NCT01070550|155760360|FG005|Overall Study|New treatment started|0|||
48429390|NCT01070550|155760355|FG000|Overall Study|Result not available|3|||
48429391|NCT01070550|155760356|FG001|Overall Study|Result not available|1|||
48429392|NCT01070550|155760357|FG002|Overall Study|Result not available|3|||
48429393|NCT01070550|155760358|FG003|Overall Study|Result not available|0|||
48429394|NCT01070550|155760359|FG004|Overall Study|Result not available|0|||
48429395|NCT01070550|155760360|FG005|Overall Study|Result not available|0|||
48429396|NCT01070550|155760355|FG000|Overall Study|Screen failure|1|||
48429397|NCT01070550|155760356|FG001|Overall Study|Screen failure|0|||
48429398|NCT01070550|155760357|FG002|Overall Study|Screen failure|0|||
48429399|NCT01070550|155760358|FG003|Overall Study|Screen failure|0|||
48429400|NCT01070550|155760359|FG004|Overall Study|Screen failure|0|||
48429401|NCT01070550|155760360|FG005|Overall Study|Screen failure|0|||
48429402|NCT01070550|155760355|FG000|Overall Study|Sponsor decision|1|||
48429403|NCT01070550|155760356|FG001|Overall Study|Sponsor decision|0|||
48429404|NCT01070550|155760357|FG002|Overall Study|Sponsor decision|0|||
48429405|NCT01070550|155760358|FG003|Overall Study|Sponsor decision|0|||
48429406|NCT01070550|155760359|FG004|Overall Study|Sponsor decision|0|||
48429407|NCT01070550|155760360|FG005|Overall Study|Sponsor decision|0|||
48429408|NCT01070550|155760355|FG000|Overall Study|Treatment duration shortened|1|||
48429409|NCT01070550|155760356|FG001|Overall Study|Treatment duration shortened|0|||
48429410|NCT01070550|155760357|FG002|Overall Study|Treatment duration shortened|0|||
48429411|NCT01070550|155760358|FG003|Overall Study|Treatment duration shortened|0|||
48429412|NCT01070550|155760359|FG004|Overall Study|Treatment duration shortened|0|||
48429413|NCT01070550|155760360|FG005|Overall Study|Treatment duration shortened|0|||
48429414|NCT01070550|155760355|FG000|Overall Study|Treatment interrupted|7|||
48429415|NCT01070550|155760356|FG001|Overall Study|Treatment interrupted|0|||
48429416|NCT01070550|155760357|FG002|Overall Study|Treatment interrupted|1|||
48429417|NCT01070550|155760358|FG003|Overall Study|Treatment interrupted|1|||
48429418|NCT01070550|155760359|FG004|Overall Study|Treatment interrupted|0|||
48429419|NCT01070550|155760360|FG005|Overall Study|Treatment interrupted|0|||
48429420|NCT01070550|155760355|FG000|Overall Study|Treatment not started|14|||
48429421|NCT01070550|155760356|FG001|Overall Study|Treatment not started|2|||
48429422|NCT01070550|155760357|FG002|Overall Study|Treatment not started|4|||
48429423|NCT01070550|155760358|FG003|Overall Study|Treatment not started|0|||
48429424|NCT01070550|155760359|FG004|Overall Study|Treatment not started|0|||
48429425|NCT01070550|155760360|FG005|Overall Study|Treatment not started|0|||
48429426|NCT01070550|155760355|FG000|Overall Study|Treatment restarted|0|||
48429427|NCT01070550|155760356|FG001|Overall Study|Treatment restarted|1|||
48429428|NCT01070550|155760357|FG002|Overall Study|Treatment restarted|0|||
48429429|NCT01070550|155760358|FG003|Overall Study|Treatment restarted|0|||
48429430|NCT01070550|155760359|FG004|Overall Study|Treatment restarted|0|||
48429431|NCT01070550|155760360|FG005|Overall Study|Treatment restarted|0|||
48429432|NCT01070550|155760355|FG000|Overall Study|Treatment stopped|3|||
48429433|NCT01070550|155760356|FG001|Overall Study|Treatment stopped|0|||
48429434|NCT01070550|155760357|FG002|Overall Study|Treatment stopped|0|||
48429435|NCT01070550|155760358|FG003|Overall Study|Treatment stopped|0|||
48429436|NCT01070550|155760359|FG004|Overall Study|Treatment stopped|0|||
48429437|NCT01070550|155760360|FG005|Overall Study|Treatment stopped|0|||
48429438|NCT01070550|155760355|FG000|Overall Study|Treatment unavailable|1|||
48429439|NCT01070550|155760356|FG001|Overall Study|Treatment unavailable|0|||
48429440|NCT01070550|155760357|FG002|Overall Study|Treatment unavailable|0|||
48429441|NCT01070550|155760358|FG003|Overall Study|Treatment unavailable|0|||
48429442|NCT01070550|155760359|FG004|Overall Study|Treatment unavailable|0|||
48429443|NCT01070550|155760360|FG005|Overall Study|Treatment unavailable|0|||
48429444|NCT01070550|155760355|FG000|Overall Study|Treatment was stopped early|7|||
48429445|NCT01070550|155760356|FG001|Overall Study|Treatment was stopped early|0|||
48429446|NCT01070550|155760357|FG002|Overall Study|Treatment was stopped early|0|||
48429447|NCT01070550|155760358|FG003|Overall Study|Treatment was stopped early|0|||
48429448|NCT01070550|155760359|FG004|Overall Study|Treatment was stopped early|0|||
48429449|NCT01070550|155760360|FG005|Overall Study|Treatment was stopped early|0|||
48429450|NCT01070550|155760355|FG000|Overall Study|Other|5|||
48429451|NCT01070550|155760356|FG001|Overall Study|Other|0|||
48429452|NCT01070550|155760357|FG002|Overall Study|Other|0|||
48429453|NCT01070550|155760358|FG003|Overall Study|Other|1|||
48429454|NCT01070550|155760359|FG004|Overall Study|Other|0|||
48429455|NCT01070550|155760360|FG005|Overall Study|Other|0|||
48429456|NCT01070550|155760355|FG000|Overall Study|Withdrawal by Subject|35|||
48429457|NCT01070550|155760356|FG001|Overall Study|Withdrawal by Subject|0|||
48429458|NCT01070550|155760357|FG002|Overall Study|Withdrawal by Subject|3|||
48429459|NCT01070550|155760358|FG003|Overall Study|Withdrawal by Subject|0|||
48429460|NCT01070550|155760359|FG004|Overall Study|Withdrawal by Subject|0|||
48429461|NCT01070550|155760360|FG005|Overall Study|Withdrawal by Subject|0|||
48429462|NCT00520676|155760365|FG000|Overall Study|Death|84|||
48429463|NCT00520676|155760366|FG001|Overall Study|Death|81|||
48429464|NCT00520676|155760365|FG000|Overall Study|Lost to Follow-up|6|||
48429465|NCT00520676|155760366|FG001|Overall Study|Lost to Follow-up|10|||
48429466|NCT00520676|155760365|FG000|Overall Study|Physician Decision|4|||
48429467|NCT00520676|155760366|FG001|Overall Study|Physician Decision|1|||
48429468|NCT00520676|155760365|FG000|Overall Study|Withdrawal by Subject|7|||
48429469|NCT00520676|155760366|FG001|Overall Study|Withdrawal by Subject|11|||
48429470|NCT01585961|155760367|FG000|Overall Study|Death|6|||
48429471|NCT01585961|155760367|FG000|Overall Study|Physician Decision|1|||
48429472|NCT01585961|155760367|FG000|Overall Study|Decision to use non-study catheter|1|||
48429473|NCT01585961|155760367|FG000|Overall Study|Withdrawal by Subject|1|||
48429474|NCT01585961|155760367|FG000|Overall Study|Lost to Follow-up|23|||
48429475|NCT01585961|155760367|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
48429476|NCT04410042|155760368|FG000|Overall Study|Not Eligible|1|||
48429477|NCT04410042|155760369|FG001|Overall Study|Not Eligible|1|||
48429478|NCT02179515|155760370|FG000|Overall Study|switched to alternative treatment|0|||
48429479|NCT02179515|155760371|FG001|Overall Study|switched to alternative treatment|1|||
48429480|NCT02179515|155760372|FG002|Overall Study|switched to alternative treatment|1|||
48429481|NCT02179515|155760370|FG000|Overall Study|Death|0|||
48429482|NCT02179515|155760371|FG001|Overall Study|Death|1|||
48429483|NCT02179515|155760372|FG002|Overall Study|Death|1|||
48429484|NCT02179515|155760370|FG000|Overall Study|refused further treatment|0|||
48429485|NCT02179515|155760371|FG001|Overall Study|refused further treatment|3|||
48429486|NCT02179515|155760372|FG002|Overall Study|refused further treatment|4|||
48429487|NCT02179515|155760370|FG000|Overall Study|Disease progression on study|2|||
48429488|NCT02179515|155760371|FG001|Overall Study|Disease progression on study|11|||
48429489|NCT02179515|155760372|FG002|Overall Study|Disease progression on study|8|||
48429490|NCT00109733|155760377|FG000|Overall Study|Protocol Violation|0|||
48429491|NCT00109733|155760378|FG001|Overall Study|Protocol Violation|1|||
48429492|NCT00109733|155760377|FG000|Overall Study|Stopped taking study drug|1|||
48429493|NCT00109733|155760378|FG001|Overall Study|Stopped taking study drug|1|||
48429494|NCT00109733|155760377|FG000|Overall Study|Non-compliant|0|||
48429495|NCT00109733|155760378|FG001|Overall Study|Non-compliant|1|||
48429496|NCT00109733|155760377|FG000|Overall Study|Could not commit time for study|1|||
48429497|NCT00109733|155760378|FG001|Overall Study|Could not commit time for study|1|||
48429498|NCT03235544|155760384|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
48429499|NCT03235544|155760385|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
48429500|NCT03235544|155760386|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
48429501|NCT03235544|155760387|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
48429502|NCT03235544|155760384|FG000|Overall Study|Death|11|||
48429503|NCT03235544|155760385|FG001|Overall Study|Death|23|||
48429504|NCT03235544|155760386|FG002|Overall Study|Death|11|||
48429505|NCT03235544|155760387|FG003|Overall Study|Death|20|||
48429506|NCT03235544|155760384|FG000|Overall Study|Lost to Follow-up|0|||
48429507|NCT03235544|155760385|FG001|Overall Study|Lost to Follow-up|1|||
48429508|NCT03235544|155760386|FG002|Overall Study|Lost to Follow-up|0|||
48429509|NCT03235544|155760387|FG003|Overall Study|Lost to Follow-up|1|||
48429510|NCT03235544|155760384|FG000|Overall Study|Withdrawal by Participant|0|||
48429511|NCT03235544|155760385|FG001|Overall Study|Withdrawal by Participant|0|||
48429512|NCT03235544|155760386|FG002|Overall Study|Withdrawal by Participant|1|||
48429513|NCT03235544|155760387|FG003|Overall Study|Withdrawal by Participant|0|||
48429514|NCT03235544|155760384|FG000|Overall Study|Reason not Specified|0|||
48429515|NCT03235544|155760385|FG001|Overall Study|Reason not Specified|4|||
48429516|NCT03235544|155760386|FG002|Overall Study|Reason not Specified|0|||
48429517|NCT03235544|155760387|FG003|Overall Study|Reason not Specified|1|||
48429518|NCT02234583|155760388|FG000|Overall Study|Adverse Event|172|||
48429519|NCT02234583|155760389|FG001|Overall Study|Adverse Event|156|||
48429520|NCT02234583|155760388|FG000|Overall Study|Withdrawal by Subject|109|||
48429521|NCT02234583|155760389|FG001|Overall Study|Withdrawal by Subject|157|||
48429522|NCT02234583|155760388|FG000|Overall Study|Lost to Follow-up|0|||
48429523|NCT02234583|155760389|FG001|Overall Study|Lost to Follow-up|1|||
48429524|NCT02234583|155760388|FG000|Overall Study|Lack of Efficacy|58|||
48429525|NCT02234583|155760389|FG001|Overall Study|Lack of Efficacy|103|||
48429526|NCT02234583|155760388|FG000|Overall Study|Protocol Violation|35|||
48429527|NCT02234583|155760389|FG001|Overall Study|Protocol Violation|42|||
48429528|NCT02234583|155760388|FG000|Overall Study|Other|39|||
48429529|NCT02234583|155760389|FG001|Overall Study|Other|97|||
48429530|NCT00771030|155760392|FG000|Overall Study|Adverse Event|0|||
48429531|NCT00771030|155760393|FG001|Overall Study|Adverse Event|1|||
48429532|NCT00771030|155760394|FG002|Overall Study|Adverse Event|0|||
48429533|NCT00771030|155760395|FG003|Overall Study|Adverse Event|0|||
48429534|NCT00771030|155760396|FG004|Overall Study|Adverse Event|0|||
48429535|NCT00771030|155760397|FG005|Overall Study|Adverse Event|0|||
48429536|NCT00771030|155760398|FG006|Overall Study|Adverse Event|0|||
48429537|NCT01651052|155760401|FG000|Overall Study|Death|21|||
48429538|NCT01651052|155760401|FG000|Overall Study|Explant|1|||
48429539|NCT01651052|155760401|FG000|Overall Study|Withdrawal by Subject|1|||
48429540|NCT01651052|155760401|FG000|Overall Study|Lost to Follow-up|3|||
48429541|NCT01905397|155760402|FG000|Overall Study|Death|0|||
48429542|NCT01905397|155760403|FG001|Overall Study|Death|1|||
48429543|NCT01905397|155760402|FG000|Overall Study|Withdrawal by Subject|2|||
48429544|NCT01905397|155760403|FG001|Overall Study|Withdrawal by Subject|0|||
48429545|NCT01905397|155760402|FG000|Overall Study|Surgery canceled/aborted|9|||
48429546|NCT01905397|155760403|FG001|Overall Study|Surgery canceled/aborted|5|||
48429547|NCT01905397|155760402|FG000|Overall Study|Incision < 7 cm|2|||
48429548|NCT01905397|155760403|FG001|Overall Study|Incision < 7 cm|0|||
48429549|NCT01905397|155760402|FG000|Overall Study|Wrong treatment|1|||
48429550|NCT01905397|155760403|FG001|Overall Study|Wrong treatment|1|||
48429551|NCT01905397|155760402|FG000|Overall Study|Device not applied|3|||
48429552|NCT01905397|155760403|FG001|Overall Study|Device not applied|0|||
48429553|NCT01905397|155760402|FG000|Overall Study|Dressing not applied in operating room|1|||
48429554|NCT01905397|155760403|FG001|Overall Study|Dressing not applied in operating room|0|||
48429555|NCT01905397|155760402|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
48429556|NCT01905397|155760403|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
48429557|NCT00938327|155760404|FG000|Overall Study|Adverse Event|2|||
48429558|NCT00938327|155760404|FG000|Overall Study|Protocol Violation|1|||
48429559|NCT00938327|155760404|FG000|Overall Study|Withdrawal by Subject|4|||
48429560|NCT00938327|155760404|FG000|Overall Study|Lost to Follow-up|37|||
48429561|NCT00938327|155760404|FG000|Overall Study|2nd dose received outside of the study|7|||
48429562|NCT00938327|155760404|FG000|Overall Study|Vaccine not received as out of stock|9|||
48429563|NCT03582033|155760406|FG000|Part A|Other|0|||
48429564|NCT03582033|155760407|FG001|Part A|Other|0|||
48429565|NCT03582033|155760408|FG002|Part A|Other|0|||
48429566|NCT03582033|155760409|FG003|Part A|Other|0|||
48429567|NCT03582033|155760410|FG004|Part A|Other|2|||
48429568|NCT03582033|155760411|FG005|Part A|Other|0|||
48429569|NCT03582033|155760412|FG006|Part A|Other|0|||
48429570|NCT03582033|155760413|FG007|Part A|Other|0|||
48429571|NCT03582033|155760414|FG008|Part A|Other|0|||
48429572|NCT03582033|155760415|FG009|Part A|Other|0|||
48429573|NCT03582033|155760406|FG000|Part A|Death|1|||
48429574|NCT03582033|155760407|FG001|Part A|Death|1|||
48429575|NCT03582033|155760408|FG002|Part A|Death|2|||
48429576|NCT03582033|155760409|FG003|Part A|Death|4|||
48429577|NCT03582033|155760410|FG004|Part A|Death|11|||
48429578|NCT03582033|155760411|FG005|Part A|Death|0|||
48429579|NCT03582033|155760412|FG006|Part A|Death|0|||
48429580|NCT03582033|155760413|FG007|Part A|Death|0|||
48429581|NCT03582033|155760414|FG008|Part A|Death|0|||
48429582|NCT03582033|155760415|FG009|Part A|Death|0|||
48429583|NCT03582033|155760406|FG000|Part A|Lost to Follow-up|0|||
48429584|NCT03582033|155760407|FG001|Part A|Lost to Follow-up|0|||
48429585|NCT03582033|155760408|FG002|Part A|Lost to Follow-up|0|||
48429586|NCT03582033|155760409|FG003|Part A|Lost to Follow-up|0|||
48429587|NCT03582033|155760410|FG004|Part A|Lost to Follow-up|1|||
48429588|NCT03582033|155760411|FG005|Part A|Lost to Follow-up|0|||
48429589|NCT03582033|155760412|FG006|Part A|Lost to Follow-up|0|||
48429590|NCT03582033|155760413|FG007|Part A|Lost to Follow-up|0|||
48429591|NCT03582033|155760414|FG008|Part A|Lost to Follow-up|0|||
48429592|NCT03582033|155760415|FG009|Part A|Lost to Follow-up|0|||
48429593|NCT03582033|155760406|FG000|Part A|Study terminated by sponsor|0|||
48429594|NCT03582033|155760407|FG001|Part A|Study terminated by sponsor|0|||
48429595|NCT03582033|155760408|FG002|Part A|Study terminated by sponsor|0|||
48429596|NCT03582033|155760409|FG003|Part A|Study terminated by sponsor|2|||
48429597|NCT03582033|155760410|FG004|Part A|Study terminated by sponsor|1|||
48429598|NCT03582033|155760411|FG005|Part A|Study terminated by sponsor|0|||
48429599|NCT03582033|155760412|FG006|Part A|Study terminated by sponsor|0|||
48429600|NCT03582033|155760413|FG007|Part A|Study terminated by sponsor|0|||
48429601|NCT03582033|155760414|FG008|Part A|Study terminated by sponsor|0|||
48429602|NCT03582033|155760415|FG009|Part A|Study terminated by sponsor|0|||
48429603|NCT03582033|155760406|FG000|Part A|Withdrawal by Subject|1|||
48429604|NCT03582033|155760407|FG001|Part A|Withdrawal by Subject|1|||
48429605|NCT03582033|155760408|FG002|Part A|Withdrawal by Subject|0|||
48429606|NCT03582033|155760409|FG003|Part A|Withdrawal by Subject|1|||
48429607|NCT03582033|155760410|FG004|Part A|Withdrawal by Subject|7|||
48429608|NCT03582033|155760411|FG005|Part A|Withdrawal by Subject|0|||
48429609|NCT03582033|155760412|FG006|Part A|Withdrawal by Subject|0|||
48429610|NCT03582033|155760413|FG007|Part A|Withdrawal by Subject|0|||
48429611|NCT03582033|155760414|FG008|Part A|Withdrawal by Subject|0|||
48429612|NCT03582033|155760415|FG009|Part A|Withdrawal by Subject|0|||
48429613|NCT03582033|155760406|FG000|Part B|Death|0|||
48429614|NCT03582033|155760407|FG001|Part B|Death|0|||
48429615|NCT03582033|155760408|FG002|Part B|Death|0|||
48429616|NCT03582033|155760409|FG003|Part B|Death|0|||
48429617|NCT03582033|155760410|FG004|Part B|Death|0|||
48429618|NCT03582033|155760411|FG005|Part B|Death|2|||
48429619|NCT03582033|155760412|FG006|Part B|Death|0|||
48429620|NCT03582033|155760413|FG007|Part B|Death|0|||
48429621|NCT03582033|155760414|FG008|Part B|Death|0|||
48429622|NCT03582033|155760415|FG009|Part B|Death|0|||
48429623|NCT03582033|155760406|FG000|Part B|Study terminated by sponsor|0|||
48429624|NCT03582033|155760407|FG001|Part B|Study terminated by sponsor|0|||
48429625|NCT03582033|155760408|FG002|Part B|Study terminated by sponsor|0|||
48429626|NCT03582033|155760409|FG003|Part B|Study terminated by sponsor|0|||
48429627|NCT03582033|155760410|FG004|Part B|Study terminated by sponsor|0|||
48429628|NCT03582033|155760411|FG005|Part B|Study terminated by sponsor|12|||
48429629|NCT03582033|155760412|FG006|Part B|Study terminated by sponsor|0|||
48429630|NCT03582033|155760413|FG007|Part B|Study terminated by sponsor|0|||
48429631|NCT03582033|155760414|FG008|Part B|Study terminated by sponsor|0|||
48429632|NCT03582033|155760415|FG009|Part B|Study terminated by sponsor|0|||
48429633|NCT03582033|155760406|FG000|Part B|Withdrawal by Subject|0|||
48429634|NCT03582033|155760407|FG001|Part B|Withdrawal by Subject|0|||
48429635|NCT03582033|155760408|FG002|Part B|Withdrawal by Subject|0|||
48429636|NCT03582033|155760409|FG003|Part B|Withdrawal by Subject|0|||
48429637|NCT03582033|155760410|FG004|Part B|Withdrawal by Subject|0|||
48429638|NCT03582033|155760411|FG005|Part B|Withdrawal by Subject|6|||
48429639|NCT03582033|155760412|FG006|Part B|Withdrawal by Subject|0|||
48429640|NCT03582033|155760413|FG007|Part B|Withdrawal by Subject|0|||
48429641|NCT03582033|155760414|FG008|Part B|Withdrawal by Subject|0|||
48429642|NCT03582033|155760415|FG009|Part B|Withdrawal by Subject|0|||
48429643|NCT03582033|155760406|FG000|Part C|Other|0|||
48429644|NCT03582033|155760407|FG001|Part C|Other|0|||
48429645|NCT03582033|155760408|FG002|Part C|Other|0|||
48429646|NCT03582033|155760409|FG003|Part C|Other|0|||
48429647|NCT03582033|155760410|FG004|Part C|Other|0|||
48429648|NCT03582033|155760411|FG005|Part C|Other|0|||
48429649|NCT03582033|155760412|FG006|Part C|Other|2|||
48429650|NCT03582033|155760413|FG007|Part C|Other|0|||
48429651|NCT03582033|155760414|FG008|Part C|Other|0|||
48429652|NCT03582033|155760415|FG009|Part C|Other|0|||
48429653|NCT03582033|155760406|FG000|Part C|Death|0|||
48429654|NCT03582033|155760407|FG001|Part C|Death|0|||
48429655|NCT03582033|155760408|FG002|Part C|Death|0|||
48429656|NCT03582033|155760409|FG003|Part C|Death|0|||
48429657|NCT03582033|155760410|FG004|Part C|Death|0|||
48429658|NCT03582033|155760411|FG005|Part C|Death|0|||
48429659|NCT03582033|155760412|FG006|Part C|Death|6|||
48429660|NCT03582033|155760413|FG007|Part C|Death|1|||
48429661|NCT03582033|155760414|FG008|Part C|Death|2|||
48429662|NCT03582033|155760415|FG009|Part C|Death|0|||
48429663|NCT03582033|155760406|FG000|Part C|Study terminated by sponsor|0|||
48429664|NCT03582033|155760407|FG001|Part C|Study terminated by sponsor|0|||
48429665|NCT03582033|155760408|FG002|Part C|Study terminated by sponsor|0|||
48429666|NCT03582033|155760409|FG003|Part C|Study terminated by sponsor|0|||
48429667|NCT03582033|155760410|FG004|Part C|Study terminated by sponsor|0|||
48429668|NCT03582033|155760411|FG005|Part C|Study terminated by sponsor|0|||
48429669|NCT03582033|155760412|FG006|Part C|Study terminated by sponsor|3|||
48429670|NCT03582033|155760413|FG007|Part C|Study terminated by sponsor|3|||
48429671|NCT03582033|155760414|FG008|Part C|Study terminated by sponsor|2|||
48429672|NCT03582033|155760415|FG009|Part C|Study terminated by sponsor|0|||
48429673|NCT03582033|155760406|FG000|Part C|Withdrawal by Subject|0|||
48429674|NCT03582033|155760407|FG001|Part C|Withdrawal by Subject|0|||
48429675|NCT03582033|155760408|FG002|Part C|Withdrawal by Subject|0|||
48429676|NCT03582033|155760409|FG003|Part C|Withdrawal by Subject|0|||
48429677|NCT03582033|155760410|FG004|Part C|Withdrawal by Subject|0|||
48429678|NCT03582033|155760411|FG005|Part C|Withdrawal by Subject|0|||
48429679|NCT03582033|155760412|FG006|Part C|Withdrawal by Subject|1|||
48429680|NCT03582033|155760413|FG007|Part C|Withdrawal by Subject|2|||
48429681|NCT03582033|155760414|FG008|Part C|Withdrawal by Subject|1|||
48429682|NCT03582033|155760415|FG009|Part C|Withdrawal by Subject|0|||
48429683|NCT03582033|155760406|FG000|Part D|Death|0|||
48429684|NCT03582033|155760407|FG001|Part D|Death|0|||
48429685|NCT03582033|155760408|FG002|Part D|Death|0|||
48429686|NCT03582033|155760409|FG003|Part D|Death|0|||
48429687|NCT03582033|155760410|FG004|Part D|Death|0|||
48429688|NCT03582033|155760411|FG005|Part D|Death|0|||
48429689|NCT03582033|155760412|FG006|Part D|Death|0|||
48429690|NCT03582033|155760413|FG007|Part D|Death|0|||
48429691|NCT03582033|155760414|FG008|Part D|Death|0|||
48429692|NCT03582033|155760415|FG009|Part D|Death|1|||
48429693|NCT03582033|155760406|FG000|Part D|Study terminated by sponsor|0|||
48429694|NCT03582033|155760407|FG001|Part D|Study terminated by sponsor|0|||
48429695|NCT03582033|155760408|FG002|Part D|Study terminated by sponsor|0|||
48429696|NCT03582033|155760409|FG003|Part D|Study terminated by sponsor|0|||
48429697|NCT03582033|155760410|FG004|Part D|Study terminated by sponsor|0|||
48429698|NCT03582033|155760411|FG005|Part D|Study terminated by sponsor|0|||
48429699|NCT03582033|155760412|FG006|Part D|Study terminated by sponsor|0|||
48429700|NCT03582033|155760413|FG007|Part D|Study terminated by sponsor|0|||
48429701|NCT03582033|155760414|FG008|Part D|Study terminated by sponsor|0|||
48429702|NCT03582033|155760415|FG009|Part D|Study terminated by sponsor|4|||
48429703|NCT03382899|155760416|FG000|Overall Study|Ineligibility Determined|0|||
48429704|NCT03382899|155760417|FG001|Overall Study|Ineligibility Determined|1|||
48429705|NCT03382899|155760416|FG000|Overall Study|Lost to Follow-up|0|||
48429706|NCT03382899|155760417|FG001|Overall Study|Lost to Follow-up|1|||
48429707|NCT03382899|155760416|FG000|Overall Study|Sponsor's decision|31|||
48429708|NCT03382899|155760417|FG001|Overall Study|Sponsor's decision|28|||
48429709|NCT03382899|155760416|FG000|Overall Study|Withdrawal by Subject|0|||
48429710|NCT03382899|155760417|FG001|Overall Study|Withdrawal by Subject|5|||
48429711|NCT02065869|155760418|FG000|Overall Study|Death|7|||
48429712|NCT02065869|155760418|FG000|Overall Study|Disease relapse|16|||
48429713|NCT02065869|155760418|FG000|Overall Study|Lost to Follow-up|4|||
48429714|NCT02065869|155760418|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
48429715|NCT02065869|155760418|FG000|Overall Study|Withdrawal by Subject|1|||
48429716|NCT00850460|155760423|FG000|Overall Study|Lost to Follow-up|4|||
48429717|NCT00850460|155760424|FG001|Overall Study|Lost to Follow-up|4|||
48429718|NCT00524745|155760425|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
48429719|NCT00524745|155760426|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
48429720|NCT00524745|155760427|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
48429721|NCT00524745|155760428|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
48429722|NCT01842620|155760429|FG000|Period 1|Withdrawal by Subject|1|||
48429723|NCT01842620|155760430|FG001|Period 1|Withdrawal by Subject|0|||
48429724|NCT04229446|155760431|FG000|Overall Study|Death|12|||
48429725|NCT04229446|155760432|FG001|Overall Study|Death|10|||
48429726|NCT04229446|155760431|FG000|Overall Study|Lost to Follow-up|5|||
48429727|NCT04229446|155760432|FG001|Overall Study|Lost to Follow-up|8|||
48429728|NCT00256867|155760433|FG000|Overall Study|Adverse Event|0|||
48429729|NCT00256867|155760434|FG001|Overall Study|Adverse Event|1|||
48429730|NCT00256867|155760435|FG002|Overall Study|Adverse Event|1|||
48429731|NCT00256867|155760436|FG003|Overall Study|Adverse Event|1|||
48429732|NCT00256867|155760437|FG004|Overall Study|Adverse Event|2|||
48429733|NCT00256867|155760438|FG005|Overall Study|Adverse Event|2|||
48429734|NCT00256867|155760439|FG006|Overall Study|Adverse Event|1|||
48429735|NCT00256867|155760440|FG007|Overall Study|Adverse Event|4|||
48429736|NCT00256867|155760433|FG000|Overall Study|Lost to Follow-up|2|||
48429737|NCT00256867|155760434|FG001|Overall Study|Lost to Follow-up|2|||
48429738|NCT00256867|155760435|FG002|Overall Study|Lost to Follow-up|2|||
48429739|NCT00256867|155760436|FG003|Overall Study|Lost to Follow-up|3|||
48429740|NCT00256867|155760437|FG004|Overall Study|Lost to Follow-up|2|||
48429741|NCT00256867|155760438|FG005|Overall Study|Lost to Follow-up|0|||
48429742|NCT00256867|155760439|FG006|Overall Study|Lost to Follow-up|1|||
48429743|NCT00256867|155760440|FG007|Overall Study|Lost to Follow-up|2|||
48429744|NCT00256867|155760433|FG000|Overall Study|Protocol Violation|0|||
48429745|NCT00256867|155760434|FG001|Overall Study|Protocol Violation|0|||
48429746|NCT00256867|155760435|FG002|Overall Study|Protocol Violation|0|||
48429747|NCT00256867|155760436|FG003|Overall Study|Protocol Violation|1|||
48429748|NCT00256867|155760437|FG004|Overall Study|Protocol Violation|0|||
48429749|NCT00256867|155760438|FG005|Overall Study|Protocol Violation|1|||
48429750|NCT00256867|155760439|FG006|Overall Study|Protocol Violation|0|||
48429751|NCT00256867|155760440|FG007|Overall Study|Protocol Violation|1|||
48429752|NCT00256867|155760433|FG000|Overall Study|Withdrawal by Subject|0|||
48429753|NCT00256867|155760434|FG001|Overall Study|Withdrawal by Subject|0|||
48429754|NCT00256867|155760435|FG002|Overall Study|Withdrawal by Subject|1|||
48429755|NCT00256867|155760436|FG003|Overall Study|Withdrawal by Subject|1|||
48429756|NCT00256867|155760437|FG004|Overall Study|Withdrawal by Subject|2|||
48429757|NCT00256867|155760438|FG005|Overall Study|Withdrawal by Subject|2|||
48429758|NCT00256867|155760439|FG006|Overall Study|Withdrawal by Subject|3|||
48429759|NCT00256867|155760440|FG007|Overall Study|Withdrawal by Subject|2|||
48429760|NCT00256867|155760433|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48429761|NCT00256867|155760434|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
48429762|NCT00256867|155760435|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48429763|NCT00256867|155760436|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48429764|NCT00256867|155760437|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48429765|NCT00256867|155760438|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48429766|NCT00256867|155760439|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48429767|NCT00256867|155760440|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
48429768|NCT00256867|155760433|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48429769|NCT00256867|155760434|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48429770|NCT00256867|155760435|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48429771|NCT00256867|155760436|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48429772|NCT00256867|155760437|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48429773|NCT00256867|155760438|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48429774|NCT00256867|155760439|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
48429775|NCT00256867|155760440|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
48429776|NCT00256867|155760433|FG000|Overall Study|Investigator's Decision|0|||
48429777|NCT00256867|155760434|FG001|Overall Study|Investigator's Decision|0|||
48429778|NCT00256867|155760435|FG002|Overall Study|Investigator's Decision|0|||
48429779|NCT00256867|155760436|FG003|Overall Study|Investigator's Decision|0|||
48429780|NCT00256867|155760437|FG004|Overall Study|Investigator's Decision|1|||
48429781|NCT00256867|155760438|FG005|Overall Study|Investigator's Decision|0|||
48429782|NCT00256867|155760439|FG006|Overall Study|Investigator's Decision|0|||
48429783|NCT00256867|155760440|FG007|Overall Study|Investigator's Decision|0|||
48429784|NCT00256867|155760433|FG000|Overall Study|Non-compliance with study medication|0|||
48429785|NCT00256867|155760434|FG001|Overall Study|Non-compliance with study medication|0|||
48429786|NCT00256867|155760435|FG002|Overall Study|Non-compliance with study medication|0|||
48429787|NCT00256867|155760436|FG003|Overall Study|Non-compliance with study medication|0|||
48432070|NCT01683071|155769034|FG003|Part 1|Withdrawal by Subject|1|||
48429788|NCT00256867|155760437|FG004|Overall Study|Non-compliance with study medication|0|||
48429789|NCT00256867|155760438|FG005|Overall Study|Non-compliance with study medication|0|||
48429790|NCT00256867|155760439|FG006|Overall Study|Non-compliance with study medication|0|||
48429791|NCT00256867|155760440|FG007|Overall Study|Non-compliance with study medication|1|||
48429792|NCT00256867|155760433|FG000|Overall Study|Participant travelled Overseas|0|||
48429793|NCT00256867|155760434|FG001|Overall Study|Participant travelled Overseas|1|||
48429794|NCT00256867|155760435|FG002|Overall Study|Participant travelled Overseas|0|||
48429795|NCT00256867|155760436|FG003|Overall Study|Participant travelled Overseas|0|||
48429796|NCT00256867|155760437|FG004|Overall Study|Participant travelled Overseas|0|||
48429797|NCT00256867|155760438|FG005|Overall Study|Participant travelled Overseas|0|||
48429798|NCT00256867|155760439|FG006|Overall Study|Participant travelled Overseas|0|||
48429799|NCT00256867|155760440|FG007|Overall Study|Participant travelled Overseas|0|||
48429800|NCT00256867|155760433|FG000|Overall Study|Participant out of assessment window|0|||
48429801|NCT00256867|155760434|FG001|Overall Study|Participant out of assessment window|0|||
48429802|NCT00256867|155760435|FG002|Overall Study|Participant out of assessment window|1|||
48429803|NCT00256867|155760436|FG003|Overall Study|Participant out of assessment window|0|||
48429804|NCT00256867|155760437|FG004|Overall Study|Participant out of assessment window|0|||
48429805|NCT00256867|155760438|FG005|Overall Study|Participant out of assessment window|0|||
48429806|NCT00256867|155760439|FG006|Overall Study|Participant out of assessment window|0|||
48429807|NCT00256867|155760440|FG007|Overall Study|Participant out of assessment window|0|||
48429808|NCT00256867|155760433|FG000|Overall Study|Withdrawal by participant|0|||
48429809|NCT00256867|155760434|FG001|Overall Study|Withdrawal by participant|0|||
48429810|NCT00256867|155760435|FG002|Overall Study|Withdrawal by participant|0|||
48429811|NCT00256867|155760436|FG003|Overall Study|Withdrawal by participant|0|||
48429812|NCT00256867|155760437|FG004|Overall Study|Withdrawal by participant|0|||
48429813|NCT00256867|155760438|FG005|Overall Study|Withdrawal by participant|1|||
48429814|NCT00256867|155760439|FG006|Overall Study|Withdrawal by participant|0|||
48429815|NCT00256867|155760440|FG007|Overall Study|Withdrawal by participant|0|||
48429816|NCT01937130|155760443|FG000|Overall Study|Withdrawal by Subject|0|||
48429817|NCT01937130|155760444|FG001|Overall Study|Withdrawal by Subject|0|||
48429818|NCT01937130|155760445|FG002|Overall Study|Withdrawal by Subject|0|||
48429819|NCT01937130|155760446|FG003|Overall Study|Withdrawal by Subject|1|||
48429820|NCT01937130|155760443|FG000|Overall Study|Adverse Event|0|||
48429821|NCT01937130|155760444|FG001|Overall Study|Adverse Event|1|||
48429822|NCT01937130|155760445|FG002|Overall Study|Adverse Event|0|||
48429823|NCT01937130|155760446|FG003|Overall Study|Adverse Event|1|||
48429824|NCT01937130|155760443|FG000|Overall Study|Death|1|||
48429825|NCT01937130|155760444|FG001|Overall Study|Death|1|||
48429826|NCT01937130|155760445|FG002|Overall Study|Death|1|||
48429827|NCT01937130|155760446|FG003|Overall Study|Death|0|||
48429828|NCT01937130|155760443|FG000|Overall Study|Lost to Follow-up|2|||
48429829|NCT01937130|155760444|FG001|Overall Study|Lost to Follow-up|0|||
48429830|NCT01937130|155760445|FG002|Overall Study|Lost to Follow-up|2|||
48429831|NCT01937130|155760446|FG003|Overall Study|Lost to Follow-up|0|||
48429832|NCT01937130|155760443|FG000|Overall Study|Physician Decision|0|||
48429833|NCT01937130|155760444|FG001|Overall Study|Physician Decision|1|||
48429834|NCT01937130|155760445|FG002|Overall Study|Physician Decision|0|||
48429835|NCT01937130|155760446|FG003|Overall Study|Physician Decision|0|||
48429836|NCT01937130|155760443|FG000|Overall Study|Patients unable to swallow|0|||
48429837|NCT01937130|155760444|FG001|Overall Study|Patients unable to swallow|1|||
48429838|NCT01937130|155760445|FG002|Overall Study|Patients unable to swallow|0|||
48429839|NCT01937130|155760446|FG003|Overall Study|Patients unable to swallow|0|||
48429840|NCT01937130|155760443|FG000|Overall Study|Patient lost to FU due to death|2|||
48429841|NCT01937130|155760444|FG001|Overall Study|Patient lost to FU due to death|0|||
48429842|NCT01937130|155760445|FG002|Overall Study|Patient lost to FU due to death|0|||
48429843|NCT01937130|155760446|FG003|Overall Study|Patient lost to FU due to death|0|||
48429844|NCT00633139|155760448|FG000|Overall Study|Non compliance|0|||
48429845|NCT00633139|155760449|FG001|Overall Study|Non compliance|0|||
48429846|NCT00633139|155760450|FG002|Overall Study|Non compliance|1|||
48429847|NCT00633139|155760448|FG000|Overall Study|Withdrawal by Subject|0|||
48429848|NCT00633139|155760449|FG001|Overall Study|Withdrawal by Subject|1|||
48429849|NCT00633139|155760450|FG002|Overall Study|Withdrawal by Subject|0|||
48429850|NCT01808118|155761870|FG000|Period 1|Adverse Event|15|||
48429851|NCT01808118|155761871|FG001|Period 1|Adverse Event|0|||
48429852|NCT01808118|155761872|FG002|Period 1|Adverse Event|0|||
48429853|NCT01808118|155761870|FG000|Period 1|Withdrew consent|24|||
48429854|NCT01808118|155761871|FG001|Period 1|Withdrew consent|0|||
48429855|NCT01808118|155761872|FG002|Period 1|Withdrew consent|0|||
48429856|NCT01808118|155761870|FG000|Period 1|Lost to Follow-up|9|||
48429857|NCT01808118|155761871|FG001|Period 1|Lost to Follow-up|0|||
48429858|NCT01808118|155761872|FG002|Period 1|Lost to Follow-up|0|||
48429859|NCT01808118|155761870|FG000|Period 1|Did not meet criteria for remission|303|||
48429860|NCT01808118|155761871|FG001|Period 1|Did not meet criteria for remission|0|||
48429861|NCT01808118|155761872|FG002|Period 1|Did not meet criteria for remission|0|||
48429862|NCT01808118|155761870|FG000|Period 1|Enrolled in error|7|||
48429865|NCT01808118|155761870|FG000|Period 1|Did not meet inclusion criteria|3|||
48429866|NCT01808118|155761871|FG001|Period 1|Did not meet inclusion criteria|0|||
48429867|NCT01808118|155761872|FG002|Period 1|Did not meet inclusion criteria|0|||
48429868|NCT01808118|155761870|FG000|Period 1|Non-conformance with inclusion criteria|3|||
48429869|NCT01808118|155761871|FG001|Period 1|Non-conformance with inclusion criteria|0|||
48429870|NCT01808118|155761872|FG002|Period 1|Non-conformance with inclusion criteria|0|||
48429871|NCT01808118|155761870|FG000|Period 1|Investigator decision: site closure|2|||
48429872|NCT01808118|155761871|FG001|Period 1|Investigator decision: site closure|0|||
48429873|NCT01808118|155761872|FG002|Period 1|Investigator decision: site closure|0|||
48429874|NCT01808118|155761870|FG000|Period 1|Non-compliance per sponsor|1|||
48429875|NCT01808118|155761871|FG001|Period 1|Non-compliance per sponsor|0|||
48429876|NCT01808118|155761872|FG002|Period 1|Non-compliance per sponsor|0|||
48429877|NCT01808118|155761870|FG000|Period 1|Lack of Efficacy|1|||
48429878|NCT01808118|155761871|FG001|Period 1|Lack of Efficacy|0|||
48429879|NCT01808118|155761872|FG002|Period 1|Lack of Efficacy|0|||
48429880|NCT01808118|155761870|FG000|Period 2|Adverse Event|0|||
48429881|NCT01808118|155761871|FG001|Period 2|Adverse Event|4|||
48429882|NCT01808118|155761872|FG002|Period 2|Adverse Event|0|||
48429883|NCT01808118|155761870|FG000|Period 2|Withdrew consent|0|||
48429884|NCT01808118|155761871|FG001|Period 2|Withdrew consent|7|||
48429885|NCT01808118|155761872|FG002|Period 2|Withdrew consent|6|||
48429886|NCT01808118|155761870|FG000|Period 2|Lost to Follow-up|0|||
48429887|NCT01808118|155761871|FG001|Period 2|Lost to Follow-up|0|||
48429888|NCT01808118|155761872|FG002|Period 2|Lost to Follow-up|2|||
48429889|NCT01808118|155761870|FG000|Period 2|Investigator no longer conducting trials|0|||
48429890|NCT01808118|155761871|FG001|Period 2|Investigator no longer conducting trials|1|||
48429891|NCT01808118|155761872|FG002|Period 2|Investigator no longer conducting trials|0|||
48429892|NCT01808118|155761870|FG000|Period 2|Switched to other therapy|0|||
48429893|NCT01808118|155761871|FG001|Period 2|Switched to other therapy|1|||
48429894|NCT01808118|155761872|FG002|Period 2|Switched to other therapy|0|||
48429895|NCT01998581|155761876|FG000|Overall Study|Refused repeat treatment|20|||
48429896|NCT01998581|155761877|FG001|Overall Study|Refused repeat treatment|4|||
48429897|NCT01998581|155761876|FG000|Overall Study|Protocol Violation|1|||
48429898|NCT01998581|155761877|FG001|Overall Study|Protocol Violation|0|||
48429899|NCT01998581|155761876|FG000|Overall Study|Withdrawal by Subject|8|||
48429900|NCT01998581|155761877|FG001|Overall Study|Withdrawal by Subject|1|||
48429901|NCT01998581|155761876|FG000|Overall Study|Lost to Follow-up|12|||
48429902|NCT01998581|155761877|FG001|Overall Study|Lost to Follow-up|4|||
48429903|NCT01998581|155761876|FG000|Overall Study|Adverse Event|1|||
48429904|NCT01998581|155761877|FG001|Overall Study|Adverse Event|1|||
48429905|NCT01998581|155761876|FG000|Overall Study|Other reasons|3|||
48429906|NCT01998581|155761877|FG001|Overall Study|Other reasons|2|||
48429907|NCT01998581|155761876|FG000|Overall Study|Randomized but withdrew before treatment|1|||
48429908|NCT01998581|155761877|FG001|Overall Study|Randomized but withdrew before treatment|0|||
48429909|NCT01798134|155761878|FG000|Overall Study|Lost to Follow-up|1|||
48429910|NCT01798134|155761878|FG000|Overall Study|Withdrawal by Subject|3|||
48429911|NCT01798134|155761878|FG000|Overall Study|Death|2|||
48429912|NCT01798134|155761878|FG000|Overall Study|Adverse Event|3|||
48429913|NCT01798134|155761878|FG000|Overall Study|Physician Decision|3|||
48429914|NCT01798134|155761878|FG000|Overall Study|Liver transplant/surgery|4|||
48429915|NCT03100942|155761883|FG000|Randomized Treatment Period|Withdrew Consent|4|||
48429916|NCT03100942|155761884|FG001|Randomized Treatment Period|Withdrew Consent|5|||
48429917|NCT03100942|155761885|FG002|Randomized Treatment Period|Withdrew Consent|3|||
48429918|NCT03100942|155761886|FG003|Randomized Treatment Period|Withdrew Consent|3|||
48429919|NCT03100942|155761887|FG004|Randomized Treatment Period|Withdrew Consent|0|||
48429920|NCT03100942|155761888|FG005|Randomized Treatment Period|Withdrew Consent|0|||
48429921|NCT03100942|155761889|FG006|Randomized Treatment Period|Withdrew Consent|0|||
48429922|NCT03100942|155761883|FG000|Randomized Treatment Period|Adverse Event|5|||
48429923|NCT03100942|155761884|FG001|Randomized Treatment Period|Adverse Event|2|||
48429924|NCT03100942|155761885|FG002|Randomized Treatment Period|Adverse Event|1|||
48429925|NCT03100942|155761886|FG003|Randomized Treatment Period|Adverse Event|0|||
48429926|NCT03100942|155761887|FG004|Randomized Treatment Period|Adverse Event|0|||
48429927|NCT03100942|155761888|FG005|Randomized Treatment Period|Adverse Event|0|||
48429928|NCT03100942|155761889|FG006|Randomized Treatment Period|Adverse Event|0|||
48429929|NCT03100942|155761883|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
48429930|NCT03100942|155761884|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
48429931|NCT03100942|155761885|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
48429932|NCT03100942|155761886|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
48429933|NCT03100942|155761887|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
48429934|NCT03100942|155761888|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
48429935|NCT03100942|155761889|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
48429936|NCT03100942|155761883|FG000|Randomized Treatment Period|Protocol Violation|0|||
48429937|NCT03100942|155761884|FG001|Randomized Treatment Period|Protocol Violation|1|||
48429938|NCT03100942|155761885|FG002|Randomized Treatment Period|Protocol Violation|1|||
48429939|NCT03100942|155761886|FG003|Randomized Treatment Period|Protocol Violation|1|||
48429940|NCT03100942|155761887|FG004|Randomized Treatment Period|Protocol Violation|0|||
48429941|NCT03100942|155761888|FG005|Randomized Treatment Period|Protocol Violation|0|||
48429942|NCT03100942|155761889|FG006|Randomized Treatment Period|Protocol Violation|0|||
48429943|NCT03100942|155761883|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
48429944|NCT03100942|155761884|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
48429945|NCT03100942|155761885|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
48429946|NCT03100942|155761886|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
48429947|NCT03100942|155761887|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
48429948|NCT03100942|155761888|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
48429949|NCT03100942|155761889|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
48429950|NCT03100942|155761883|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
48429951|NCT03100942|155761884|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48429952|NCT03100942|155761885|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48429953|NCT03100942|155761886|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
48429954|NCT03100942|155761887|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48429955|NCT03100942|155761888|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48429956|NCT03100942|155761889|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
48429957|NCT03100942|155761883|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48429958|NCT03100942|155761884|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48429959|NCT03100942|155761885|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48429960|NCT03100942|155761886|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48429961|NCT03100942|155761887|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48429962|NCT03100942|155761888|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
48429963|NCT03100942|155761889|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
48429964|NCT05058664|155761892|FG000|Overall Study|No follow-up data provided|4|||
48429965|NCT05058664|155761893|FG001|Overall Study|No follow-up data provided|0|||
48429966|NCT05058664|155761894|FG002|Overall Study|No follow-up data provided|2|||
48429967|NCT05058664|155761892|FG000|Overall Study|Withdrawal by Subject|0|||
48429968|NCT05058664|155761893|FG001|Overall Study|Withdrawal by Subject|0|||
48429969|NCT05058664|155761894|FG002|Overall Study|Withdrawal by Subject|1|||
48429970|NCT03648476|155761903|FG000|Overall Study|Withdrawal by Subject|2|||
48429971|NCT03648476|155761904|FG001|Overall Study|Withdrawal by Subject|1|||
48429972|NCT00879814|155761905|FG000|Overall Study|Adverse Event|0|||
48429973|NCT00879814|155761906|FG001|Overall Study|Adverse Event|1|||
48429974|NCT00879814|155761907|FG002|Overall Study|Adverse Event|0|||
48429975|NCT00879814|155761908|FG003|Overall Study|Adverse Event|0|||
48429976|NCT00879814|155761905|FG000|Overall Study|Lost to Follow-up|1|||
48429977|NCT00879814|155761906|FG001|Overall Study|Lost to Follow-up|0|||
48429978|NCT00879814|155761907|FG002|Overall Study|Lost to Follow-up|0|||
48429979|NCT00879814|155761908|FG003|Overall Study|Lost to Follow-up|2|||
48429980|NCT00879814|155761905|FG000|Overall Study|Participant Failed to Return|0|||
48429981|NCT00879814|155761906|FG001|Overall Study|Participant Failed to Return|0|||
48429982|NCT00879814|155761907|FG002|Overall Study|Participant Failed to Return|0|||
48429983|NCT00879814|155761908|FG003|Overall Study|Participant Failed to Return|1|||
48429984|NCT00879814|155761905|FG000|Overall Study|Withdrawal by Subject|3|||
48429985|NCT00879814|155761906|FG001|Overall Study|Withdrawal by Subject|1|||
48429986|NCT00879814|155761907|FG002|Overall Study|Withdrawal by Subject|1|||
48429987|NCT00879814|155761908|FG003|Overall Study|Withdrawal by Subject|2|||
48429988|NCT00879814|155761905|FG000|Overall Study|Physician Decision|0|||
48429989|NCT00879814|155761906|FG001|Overall Study|Physician Decision|0|||
48429990|NCT00879814|155761907|FG002|Overall Study|Physician Decision|1|||
48429991|NCT00879814|155761908|FG003|Overall Study|Physician Decision|0|||
48429992|NCT00879814|155761905|FG000|Overall Study|Other|0|||
48429993|NCT00879814|155761906|FG001|Overall Study|Other|0|||
48429994|NCT00879814|155761907|FG002|Overall Study|Other|1|||
48429995|NCT00879814|155761908|FG003|Overall Study|Other|0|||
48429996|NCT05434078|155761909|FG000|Overall Study|Lost to Follow-up|2|||
48429997|NCT05434078|155761910|FG001|Overall Study|Lost to Follow-up|1|||
48429998|NCT05434078|155761909|FG000|Overall Study|Withdrawal by Subject|1|||
48429999|NCT05434078|155761910|FG001|Overall Study|Withdrawal by Subject|0|||
48430000|NCT01728584|155761911|FG000|Overall Study|Adverse Event|1|||
48430001|NCT01728584|155761912|FG001|Overall Study|Adverse Event|0|||
48430002|NCT01728584|155761913|FG002|Overall Study|Adverse Event|0|||
48430003|NCT01728584|155761914|FG003|Overall Study|Adverse Event|0|||
48430004|NCT01728584|155761911|FG000|Overall Study|Physician Decision|4|||
48430005|NCT01728584|155761912|FG001|Overall Study|Physician Decision|0|||
48430006|NCT01728584|155761913|FG002|Overall Study|Physician Decision|1|||
48430007|NCT01728584|155761914|FG003|Overall Study|Physician Decision|0|||
48430008|NCT01728584|155761911|FG000|Overall Study|Withdrawal by Subject|1|||
48430009|NCT01728584|155761912|FG001|Overall Study|Withdrawal by Subject|0|||
48430010|NCT01728584|155761913|FG002|Overall Study|Withdrawal by Subject|0|||
48430011|NCT01728584|155761914|FG003|Overall Study|Withdrawal by Subject|0|||
48430012|NCT01728584|155761911|FG000|Overall Study|Screen failure|1|||
48430013|NCT01728584|155761912|FG001|Overall Study|Screen failure|0|||
48430016|NCT01728584|155761911|FG000|Overall Study|Other reason (not specified)|1|||
48430017|NCT01728584|155761912|FG001|Overall Study|Other reason (not specified)|0|||
48430018|NCT01728584|155761913|FG002|Overall Study|Other reason (not specified)|0|||
48430019|NCT01728584|155761914|FG003|Overall Study|Other reason (not specified)|1|||
48430020|NCT04964063|155761919|FG000|Overall Study|Adverse Event|4|||
48430021|NCT04964063|155761919|FG000|Overall Study|Lost to Follow-up|47|||
48430022|NCT04964063|155761919|FG000|Overall Study|Withdrawal by Subject|5|||
48430023|NCT04964063|155761919|FG000|Overall Study|Baseline Tasks Expired|41|||
48430024|NCT04964063|155761919|FG000|Overall Study|Participant withdrawn in error|1|||
48430025|NCT01035606|155761920|FG000|Overall Study|change in health, job demands,family|3|||
48430026|NCT01035606|155761921|FG001|Overall Study|change in health, job demands,family|3|||
48430027|NCT01035606|155761922|FG002|Overall Study|change in health, job demands,family|4|||
48430028|NCT03215264|155761931|FG000|Dose Level 2|Adverse Event|0|||
48430029|NCT03215264|155761932|FG001|Dose Level 2|Adverse Event|1|||
48430030|NCT03215264|155761933|FG002|Dose Level 2|Adverse Event|0|||
48430031|NCT03215264|155761931|FG000|Dose Level 3|Withdrawal by Subject|0|||
48430032|NCT03215264|155761932|FG001|Dose Level 3|Withdrawal by Subject|0|||
48430033|NCT03215264|155761933|FG002|Dose Level 3|Withdrawal by Subject|1|||
48430034|NCT00506077|155761934|FG000|Treatment Period 1|Adverse Event|2|||
48430035|NCT00506077|155761935|FG001|Treatment Period 1|Adverse Event|1|||
48430036|NCT00506077|155761934|FG000|Treatment Period 1|Lost to Follow-up|0|||
48430037|NCT00506077|155761935|FG001|Treatment Period 1|Lost to Follow-up|2|||
48430038|NCT00506077|155761934|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48430039|NCT00506077|155761935|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48430040|NCT00506077|155761934|FG000|Treatment Period 2|Adverse Event|0|||
48430041|NCT00506077|155761935|FG001|Treatment Period 2|Adverse Event|1|||
48430042|NCT00506077|155761934|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48430043|NCT00506077|155761935|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48430044|NCT02064439|155761936|FG000|Overall Study|Adverse Event|51|||
48430045|NCT02064439|155761937|FG001|Overall Study|Adverse Event|47|||
48430046|NCT02064439|155761938|FG002|Overall Study|Adverse Event|46|||
48430047|NCT02064439|155761936|FG000|Overall Study|Death|0|||
48430048|NCT02064439|155761937|FG001|Overall Study|Death|2|||
48430049|NCT02064439|155761938|FG002|Overall Study|Death|3|||
48430050|NCT02064439|155761936|FG000|Overall Study|Withdrawal by Subject|29|||
48430051|NCT02064439|155761937|FG001|Overall Study|Withdrawal by Subject|18|||
48430052|NCT02064439|155761938|FG002|Overall Study|Withdrawal by Subject|26|||
48430053|NCT02064439|155761936|FG000|Overall Study|Protocol Violation|3|||
48430054|NCT02064439|155761937|FG001|Overall Study|Protocol Violation|5|||
48430055|NCT02064439|155761938|FG002|Overall Study|Protocol Violation|3|||
48430056|NCT02064439|155761936|FG000|Overall Study|Lost to Follow-up|1|||
48430057|NCT02064439|155761937|FG001|Overall Study|Lost to Follow-up|3|||
48430058|NCT02064439|155761938|FG002|Overall Study|Lost to Follow-up|4|||
48430059|NCT02064439|155761936|FG000|Overall Study|Non-compliance with study medication|21|||
48430060|NCT02064439|155761937|FG001|Overall Study|Non-compliance with study medication|19|||
48430061|NCT02064439|155761938|FG002|Overall Study|Non-compliance with study medication|23|||
48430062|NCT02064439|155761936|FG000|Overall Study|Physician Decision|0|||
48430063|NCT02064439|155761937|FG001|Overall Study|Physician Decision|1|||
48430064|NCT02064439|155761938|FG002|Overall Study|Physician Decision|1|||
48430065|NCT02064439|155761936|FG000|Overall Study|Logistical difficulties|6|||
48430066|NCT02064439|155761937|FG001|Overall Study|Logistical difficulties|5|||
48430067|NCT02064439|155761938|FG002|Overall Study|Logistical difficulties|2|||
48430068|NCT02064439|155761936|FG000|Overall Study|Efficacy outcome reached|18|||
48430069|NCT02064439|155761937|FG001|Overall Study|Efficacy outcome reached|16|||
48430070|NCT02064439|155761938|FG002|Overall Study|Efficacy outcome reached|57|||
48430071|NCT02064439|155761936|FG000|Overall Study|Safety outcome reached|12|||
48430072|NCT02064439|155761937|FG001|Overall Study|Safety outcome reached|20|||
48430073|NCT02064439|155761938|FG002|Overall Study|Safety outcome reached|10|||
48430074|NCT02064439|155761936|FG000|Overall Study|Other|2|||
48430075|NCT02064439|155761937|FG001|Overall Study|Other|2|||
48430076|NCT02064439|155761938|FG002|Overall Study|Other|7|||
48430077|NCT02433288|155761939|FG000|Overall Study|Severe non-compliance to protocol|13|||
48430078|NCT02433288|155761940|FG001|Overall Study|Severe non-compliance to protocol|7|||
48430079|NCT02433288|155761939|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
48430080|NCT02433288|155761940|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
48430081|NCT02433288|155761939|FG000|Overall Study|Withdrawal by Subject|101|||
48430082|NCT02433288|155761940|FG001|Overall Study|Withdrawal by Subject|99|||
48430083|NCT02433288|155761939|FG000|Overall Study|Lost to Follow-up|2|||
48430084|NCT02433288|155761940|FG001|Overall Study|Lost to Follow-up|14|||
48430085|NCT02433288|155761939|FG000|Overall Study|Death|0|||
48430086|NCT02433288|155761940|FG001|Overall Study|Death|3|||
48430087|NCT01740440|155761945|FG000|Overall Study|Lost to Follow-up|3|||
48430088|NCT03196505|155761946|FG000|Overall Study|Physician Decision|26|||
48430089|NCT03196505|155761947|FG001|Overall Study|Physician Decision|26|||
48430090|NCT03116399|155761948|FG000|Overall Study|Death|8|||
48430091|NCT03116399|155761949|FG001|Overall Study|Death|3|||
48430092|NCT03116399|155761948|FG000|Overall Study|Lost to Follow-up|7|||
48430094|NCT03116399|155761948|FG000|Overall Study|Investigator Decision|1|||
48430095|NCT03116399|155761949|FG001|Overall Study|Investigator Decision|1|||
48430096|NCT03116399|155761948|FG000|Overall Study|Withdrawal by Subject|24|||
48430097|NCT03116399|155761949|FG001|Overall Study|Withdrawal by Subject|9|||
48430098|NCT02702193|155761958|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
48430099|NCT02702193|155761959|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
48430100|NCT02702193|155761958|FG000|4 Month Follow up|Withdrawal by Subject|1|||
48430101|NCT02702193|155761959|FG001|4 Month Follow up|Withdrawal by Subject|0|||
48430102|NCT02702193|155761958|FG000|4 Month Follow up|Lost to Follow-up|17|||
48430103|NCT02702193|155761959|FG001|4 Month Follow up|Lost to Follow-up|18|||
48430104|NCT02702193|155761958|FG000|8 Month Follow up|Withdrawal by Subject|1|||
48430105|NCT02702193|155761959|FG001|8 Month Follow up|Withdrawal by Subject|0|||
48430106|NCT02702193|155761958|FG000|8 Month Follow up|Lost to Follow-up|14|||
48430107|NCT02702193|155761959|FG001|8 Month Follow up|Lost to Follow-up|18|||
48430108|NCT02702193|155761958|FG000|12 Month Follow up|Withdrawal by Subject|1|||
48430109|NCT02702193|155761959|FG001|12 Month Follow up|Withdrawal by Subject|0|||
48430110|NCT02702193|155761958|FG000|12 Month Follow up|Lost to Follow-up|16|||
48430111|NCT02702193|155761959|FG001|12 Month Follow up|Lost to Follow-up|18|||
48430112|NCT00257192|155761963|FG000|Overall Study|Adverse Event|21|||
48430113|NCT00257192|155761964|FG001|Overall Study|Adverse Event|10|||
48430114|NCT00257192|155761963|FG000|Overall Study|Laboratory abnormality|1|||
48430115|NCT00257192|155761964|FG001|Overall Study|Laboratory abnormality|1|||
48430116|NCT00257192|155761963|FG000|Overall Study|Lost to Follow-up|3|||
48430117|NCT00257192|155761964|FG001|Overall Study|Lost to Follow-up|3|||
48430118|NCT00257192|155761963|FG000|Overall Study|Insufficient clinical response|18|||
48430119|NCT00257192|155761964|FG001|Overall Study|Insufficient clinical response|18|||
48430120|NCT00257192|155761963|FG000|Overall Study|Withdrawal by Subject|14|||
48430121|NCT00257192|155761964|FG001|Overall Study|Withdrawal by Subject|2|||
48430122|NCT00257192|155761963|FG000|Overall Study|Randomized but not treated|0|||
48430123|NCT00257192|155761964|FG001|Overall Study|Randomized but not treated|1|||
48430124|NCT00257192|155761963|FG000|Overall Study|Study terminated by sponsor|1|||
48430125|NCT00257192|155761964|FG001|Overall Study|Study terminated by sponsor|0|||
48430126|NCT00257192|155761963|FG000|Overall Study|Miscellaneous|0|||
48430127|NCT00257192|155761964|FG001|Overall Study|Miscellaneous|4|||
48430128|NCT04285346|155761967|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
48430129|NCT04285346|155761968|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
48430130|NCT04285346|155761967|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
48430131|NCT04285346|155761968|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
48430132|NCT04285346|155761967|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
48430133|NCT04285346|155761968|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
48430134|NCT02680847|155761969|FG000|Overall Study|Other|2|||
48430135|NCT02680847|155761970|FG001|Overall Study|Other|0|||
48430136|NCT02680847|155761971|FG002|Overall Study|Other|0|||
48430137|NCT02680847|155761969|FG000|Overall Study|No longer met eligibility criteria|2|||
48430138|NCT02680847|155761970|FG001|Overall Study|No longer met eligibility criteria|2|||
48430139|NCT02680847|155761971|FG002|Overall Study|No longer met eligibility criteria|0|||
48430140|NCT02680847|155761969|FG000|Overall Study|Unwilling to participate in study|1|||
48430141|NCT02680847|155761970|FG001|Overall Study|Unwilling to participate in study|1|||
48430142|NCT02680847|155761971|FG002|Overall Study|Unwilling to participate in study|0|||
48430143|NCT02680847|155761969|FG000|Overall Study|Lack of Efficacy|0|||
48430144|NCT02680847|155761970|FG001|Overall Study|Lack of Efficacy|0|||
48430145|NCT02680847|155761971|FG002|Overall Study|Lack of Efficacy|2|||
48430146|NCT02680847|155761969|FG000|Overall Study|Adverse Event|0|||
48430147|NCT02680847|155761970|FG001|Overall Study|Adverse Event|0|||
48430148|NCT02680847|155761971|FG002|Overall Study|Adverse Event|1|||
48430149|NCT00540449|155761975|FG000|Overall Study|Adverse Event|12|||
48430150|NCT00540449|155761976|FG001|Overall Study|Adverse Event|32|||
48430151|NCT00540449|155761975|FG000|Overall Study|Sponsor's Decision|1|||
48430152|NCT00540449|155761976|FG001|Overall Study|Sponsor's Decision|1|||
48430153|NCT00540449|155761975|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
48430154|NCT00540449|155761976|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
48430155|NCT00540449|155761975|FG000|Overall Study|Lost to Follow-up|19|||
48430156|NCT00540449|155761976|FG001|Overall Study|Lost to Follow-up|17|||
48430157|NCT00540449|155761975|FG000|Overall Study|Subject Non-Compliant|7|||
48430158|NCT00540449|155761976|FG001|Overall Study|Subject Non-Compliant|5|||
48430159|NCT00540449|155761975|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
48430160|NCT00540449|155761976|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
48430161|NCT00540449|155761975|FG000|Overall Study|Withdrawal by Subject|10|||
48430162|NCT00540449|155761976|FG001|Overall Study|Withdrawal by Subject|10|||
48430163|NCT00540449|155761975|FG000|Overall Study|Other|1|||
48430164|NCT00540449|155761976|FG001|Overall Study|Other|4|||
48430165|NCT00601523|155761977|FG000|Overall Study|Adverse Event|42|||
48430166|NCT00601523|155761978|FG001|Overall Study|Adverse Event|14|||
48430167|NCT00601523|155761977|FG000|Overall Study|Lack of Efficacy|3|||
48430168|NCT00601523|155761978|FG001|Overall Study|Lack of Efficacy|0|||
48430173|NCT00601523|155761977|FG000|Overall Study|Withdrawal by Subject|18|||
48430174|NCT00601523|155761978|FG001|Overall Study|Withdrawal by Subject|9|||
48430175|NCT00601523|155761977|FG000|Overall Study|Other|9|||
48430176|NCT00601523|155761978|FG001|Overall Study|Other|1|||
48430177|NCT03643432|155761981|FG000|Overall Study|Lost to Follow-up|1|||
48430178|NCT03643432|155761982|FG001|Overall Study|Lost to Follow-up|0|||
48430179|NCT00804193|155761983|FG000|Overall Study|Lack of baseline fungus|32|||
48430180|NCT00804193|155761984|FG001|Overall Study|Lack of baseline fungus|31|||
48430181|NCT00804193|155761985|FG002|Overall Study|Lack of baseline fungus|19|||
48430182|NCT00804193|155761983|FG000|Overall Study|Adverse Event|0|||
48430183|NCT00804193|155761984|FG001|Overall Study|Adverse Event|0|||
48430184|NCT00804193|155761985|FG002|Overall Study|Adverse Event|2|||
48430185|NCT00804193|155761983|FG000|Overall Study|Lack of Efficacy|1|||
48430186|NCT00804193|155761984|FG001|Overall Study|Lack of Efficacy|1|||
48430187|NCT00804193|155761985|FG002|Overall Study|Lack of Efficacy|3|||
48430188|NCT00804193|155761983|FG000|Overall Study|Protocol Violation|0|||
48430189|NCT00804193|155761984|FG001|Overall Study|Protocol Violation|8|||
48430190|NCT00804193|155761985|FG002|Overall Study|Protocol Violation|2|||
48430191|NCT00804193|155761983|FG000|Overall Study|Lost to Follow-up|3|||
48430192|NCT00804193|155761984|FG001|Overall Study|Lost to Follow-up|3|||
48430193|NCT00804193|155761985|FG002|Overall Study|Lost to Follow-up|4|||
48430194|NCT00804193|155761983|FG000|Overall Study|Withdrawal by Subject|3|||
48430195|NCT00804193|155761984|FG001|Overall Study|Withdrawal by Subject|1|||
48430196|NCT00804193|155761985|FG002|Overall Study|Withdrawal by Subject|2|||
48430197|NCT00237796|155761986|FG000|Overall Study|Baseline and one other ILSS required|10|||
48430198|NCT00237796|155761987|FG001|Overall Study|Baseline and one other ILSS required|5|||
48430199|NCT01193348|155761990|FG000|Screening Period|Screen Failure|5|||
48430200|NCT01193348|155761990|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
48430201|NCT01193348|155761990|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
48430202|NCT01193348|155761990|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
48430203|NCT01193348|155761990|FG000|Extension Treatment Period|Physician Decision|1|||
48430204|NCT01193348|155761990|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
48430205|NCT04594239|155761991|FG000|Overall Study|Withdrawal by Subject|3|||
48430206|NCT04594239|155761992|FG001|Overall Study|Withdrawal by Subject|4|||
48430207|NCT04594239|155761993|FG002|Overall Study|Withdrawal by Subject|2|||
48430208|NCT04594239|155761994|FG003|Overall Study|Withdrawal by Subject|4|||
48430209|NCT04594239|155761991|FG000|Overall Study|Lost to Follow-up|8|||
48430210|NCT04594239|155761992|FG001|Overall Study|Lost to Follow-up|5|||
48430211|NCT04594239|155761993|FG002|Overall Study|Lost to Follow-up|4|||
48430212|NCT04594239|155761994|FG003|Overall Study|Lost to Follow-up|6|||
48430213|NCT04594239|155761991|FG000|Overall Study|Subject relocated|0|||
48430214|NCT04594239|155761992|FG001|Overall Study|Subject relocated|0|||
48430215|NCT04594239|155761993|FG002|Overall Study|Subject relocated|0|||
48430216|NCT04594239|155761994|FG003|Overall Study|Subject relocated|1|||
48430217|NCT00968253|155761996|FG000|Overall Study|Death|0|||
48430218|NCT00968253|155761997|FG001|Overall Study|Death|0|||
48430219|NCT00968253|155761998|FG002|Overall Study|Death|2|||
48430220|NCT00968253|155761996|FG000|Overall Study|Withdrawal by Subject|0|||
48430221|NCT00968253|155761997|FG001|Overall Study|Withdrawal by Subject|0|||
48430222|NCT00968253|155761998|FG002|Overall Study|Withdrawal by Subject|1|||
48430223|NCT00968253|155761996|FG000|Overall Study|Disease Progression|0|||
48430224|NCT00968253|155761997|FG001|Overall Study|Disease Progression|3|||
48430225|NCT00968253|155761998|FG002|Overall Study|Disease Progression|3|||
48430226|NCT00968253|155761996|FG000|Overall Study|Adverse Event|0|||
48430227|NCT00968253|155761997|FG001|Overall Study|Adverse Event|0|||
48430228|NCT00968253|155761998|FG002|Overall Study|Adverse Event|1|||
48430229|NCT03596177|155761999|FG000|Single Blind Period|Withdrawal by Subject|1|||
48430230|NCT03596177|155762000|FG001|Single Blind Period|Withdrawal by Subject|1|||
48430231|NCT03596177|155761999|FG000|Single Blind Period|Other|1|||
48430232|NCT03596177|155762000|FG001|Single Blind Period|Other|0|||
48430233|NCT03596177|155761999|FG000|Double Blind Period|Withdrawal by Subject|0|||
48430234|NCT03596177|155762000|FG001|Double Blind Period|Withdrawal by Subject|1|||
48430235|NCT03596177|155761999|FG000|Double Blind Period|Other|0|||
48430236|NCT03596177|155762000|FG001|Double Blind Period|Other|4|||
48430237|NCT03596177|155761999|FG000|Double Blind Period|Death during safety follow-up|0|||
48430238|NCT03596177|155762000|FG001|Double Blind Period|Death during safety follow-up|1|||
48430239|NCT01909453|155762001|FG000|Overall Study|Ongoing|118|||
48430240|NCT01909453|155762002|FG001|Overall Study|Ongoing|103|||
48430241|NCT01909453|155762003|FG002|Overall Study|Ongoing|83|||
48430242|NCT01909453|155762004|FG003|Overall Study|Ongoing|164|||
48430243|NCT01909453|155762005|FG004|Overall Study|Ongoing|50|||
48430244|NCT01909453|155762001|FG000|Overall Study|Death|69|||
48430245|NCT01909453|155762002|FG001|Overall Study|Death|74|||
48430246|NCT01909453|155762003|FG002|Overall Study|Death|88|||
48430247|NCT01909453|155762004|FG003|Overall Study|Death|86|||
48430248|NCT01909453|155762005|FG004|Overall Study|Death|29|||
48430249|NCT01909453|155762001|FG000|Overall Study|Lost to Follow-up|3|||
48430250|NCT01909453|155762002|FG001|Overall Study|Lost to Follow-up|4|||
48430251|NCT01909453|155762003|FG002|Overall Study|Lost to Follow-up|4|||
48430254|NCT01909453|155762001|FG000|Overall Study|Withdrawal by Subject|2|||
48430255|NCT01909453|155762002|FG001|Overall Study|Withdrawal by Subject|13|||
48430256|NCT01909453|155762003|FG002|Overall Study|Withdrawal by Subject|16|||
48430257|NCT01909453|155762004|FG003|Overall Study|Withdrawal by Subject|5|||
48430258|NCT01909453|155762005|FG004|Overall Study|Withdrawal by Subject|4|||
48430259|NCT01897441|155762006|FG000|Overall Study|Lost to Follow-up|0|||
48430260|NCT01897441|155762007|FG001|Overall Study|Lost to Follow-up|0|||
48430261|NCT01897441|155762008|FG002|Overall Study|Lost to Follow-up|1|||
48430262|NCT01897441|155762009|FG003|Overall Study|Lost to Follow-up|0|||
48430263|NCT01897441|155762010|FG004|Overall Study|Lost to Follow-up|0|||
48430264|NCT01897441|155762011|FG005|Overall Study|Lost to Follow-up|0|||
48430265|NCT01897441|155762006|FG000|Overall Study|Withdrawal by Subject|0|||
48430266|NCT01897441|155762007|FG001|Overall Study|Withdrawal by Subject|0|||
48430267|NCT01897441|155762008|FG002|Overall Study|Withdrawal by Subject|0|||
48430268|NCT01897441|155762009|FG003|Overall Study|Withdrawal by Subject|0|||
48430269|NCT01897441|155762010|FG004|Overall Study|Withdrawal by Subject|1|||
48430270|NCT01897441|155762011|FG005|Overall Study|Withdrawal by Subject|0|||
48430271|NCT01897441|155762006|FG000|Overall Study|Withdrawn by Provider|0|||
48430272|NCT01897441|155762007|FG001|Overall Study|Withdrawn by Provider|2|||
48430273|NCT01897441|155762008|FG002|Overall Study|Withdrawn by Provider|0|||
48430274|NCT01897441|155762009|FG003|Overall Study|Withdrawn by Provider|0|||
48430275|NCT01897441|155762010|FG004|Overall Study|Withdrawn by Provider|0|||
48430276|NCT01897441|155762011|FG005|Overall Study|Withdrawn by Provider|0|||
48430277|NCT03422133|155762012|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
48430278|NCT03422133|155762013|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
48430279|NCT03569293|155763687|FG000|Overall Study|Adverse Event|4|||
48430280|NCT03569293|155763688|FG001|Overall Study|Adverse Event|1|||
48430281|NCT03569293|155763689|FG002|Overall Study|Adverse Event|5|||
48430282|NCT03569293|155763690|FG003|Overall Study|Adverse Event|1|||
48430283|NCT03569293|155763691|FG004|Overall Study|Adverse Event|0|||
48430284|NCT03569293|155763692|FG005|Overall Study|Adverse Event|0|||
48430285|NCT03569293|155763687|FG000|Overall Study|Withdrawal by Subject|16|||
48430286|NCT03569293|155763688|FG001|Overall Study|Withdrawal by Subject|2|||
48430287|NCT03569293|155763689|FG002|Overall Study|Withdrawal by Subject|4|||
48430288|NCT03569293|155763690|FG003|Overall Study|Withdrawal by Subject|1|||
48430289|NCT03569293|155763691|FG004|Overall Study|Withdrawal by Subject|0|||
48430290|NCT03569293|155763692|FG005|Overall Study|Withdrawal by Subject|0|||
48430291|NCT03569293|155763687|FG000|Overall Study|Lost to Follow-up|1|||
48430292|NCT03569293|155763688|FG001|Overall Study|Lost to Follow-up|3|||
48430293|NCT03569293|155763689|FG002|Overall Study|Lost to Follow-up|1|||
48430294|NCT03569293|155763690|FG003|Overall Study|Lost to Follow-up|1|||
48430295|NCT03569293|155763691|FG004|Overall Study|Lost to Follow-up|0|||
48430296|NCT03569293|155763692|FG005|Overall Study|Lost to Follow-up|0|||
48430297|NCT03569293|155763687|FG000|Overall Study|Other|8|||
48430298|NCT03569293|155763688|FG001|Overall Study|Other|2|||
48430299|NCT03569293|155763689|FG002|Overall Study|Other|1|||
48430300|NCT03569293|155763690|FG003|Overall Study|Other|1|||
48430301|NCT03569293|155763691|FG004|Overall Study|Other|0|||
48430302|NCT03569293|155763692|FG005|Overall Study|Other|0|||
48430303|NCT03569293|155763687|FG000|Overall Study|Ongoing at Time of Analysis|8|||
48430304|NCT03569293|155763688|FG001|Overall Study|Ongoing at Time of Analysis|1|||
48430305|NCT03569293|155763689|FG002|Overall Study|Ongoing at Time of Analysis|3|||
48430306|NCT03569293|155763690|FG003|Overall Study|Ongoing at Time of Analysis|0|||
48430307|NCT03569293|155763691|FG004|Overall Study|Ongoing at Time of Analysis|0|||
48430308|NCT03569293|155763692|FG005|Overall Study|Ongoing at Time of Analysis|0|||
48430309|NCT03132805|155763693|FG000|Overall Study|Lost to Follow-up|142|||
48430310|NCT03132805|155763694|FG001|Overall Study|Lost to Follow-up|141|||
48430311|NCT03132805|155763695|FG002|Overall Study|Lost to Follow-up|113|||
48587216|NCT01004432|156343157|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
48587217|NCT01004432|156343158|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
48587218|NCT01004432|156343159|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
48587219|NCT01004432|156343155|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
48587220|NCT01004432|156343156|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
48587221|NCT01004432|156343157|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
48587222|NCT01004432|156343158|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
48587223|NCT01004432|156343159|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
48430320|NCT02817555|155763698|FG000|Overall Study|Death|1|||
48430321|NCT02817555|155763699|FG001|Overall Study|Death|3|||
48430322|NCT02817555|155763698|FG000|Overall Study|moved away|1|||
48430323|NCT02817555|155763699|FG001|Overall Study|moved away|0|||
48430324|NCT02817555|155763698|FG000|Overall Study|transplant|1|||
48430325|NCT02817555|155763699|FG001|Overall Study|transplant|1|||
48430326|NCT02817555|155763698|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
48430327|NCT02817555|155763699|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
48430328|NCT00696657|155763700|FG000|Overall Study|Protocol Violation|0|||
48430329|NCT00696657|155763701|FG001|Overall Study|Protocol Violation|0|||
48430373|NCT02115815|155763711|FG000|Overall Study|Withdrawal by Subject|2|||
48430374|NCT02115815|155763712|FG001|Overall Study|Withdrawal by Subject|0|||
48430375|NCT02115815|155763713|FG002|Overall Study|Withdrawal by Subject|0|||
48430376|NCT02115815|155763714|FG003|Overall Study|Withdrawal by Subject|0|||
48430377|NCT02115815|155763715|FG004|Overall Study|Withdrawal by Subject|0|||
48430378|NCT02115815|155763716|FG005|Overall Study|Withdrawal by Subject|0|||
48430379|NCT02115815|155763717|FG006|Overall Study|Withdrawal by Subject|0|||
48430380|NCT02115815|155763711|FG000|Overall Study|Not enough drug to dose participant|0|||
48430381|NCT02115815|155763712|FG001|Overall Study|Not enough drug to dose participant|0|||
48430382|NCT02115815|155763713|FG002|Overall Study|Not enough drug to dose participant|0|||
48430383|NCT02115815|155763714|FG003|Overall Study|Not enough drug to dose participant|0|||
48430384|NCT02115815|155763715|FG004|Overall Study|Not enough drug to dose participant|0|||
48430385|NCT02115815|155763716|FG005|Overall Study|Not enough drug to dose participant|1|||
48430386|NCT02115815|155763717|FG006|Overall Study|Not enough drug to dose participant|0|||
48430387|NCT02115815|155763711|FG000|Overall Study|Missed appointment, randomized in error|0|||
48430388|NCT02115815|155763712|FG001|Overall Study|Missed appointment, randomized in error|0|||
48430389|NCT02115815|155763713|FG002|Overall Study|Missed appointment, randomized in error|0|||
48430390|NCT02115815|155763714|FG003|Overall Study|Missed appointment, randomized in error|0|||
48430391|NCT02115815|155763715|FG004|Overall Study|Missed appointment, randomized in error|0|||
48430392|NCT02115815|155763716|FG005|Overall Study|Missed appointment, randomized in error|1|||
48430393|NCT02115815|155763717|FG006|Overall Study|Missed appointment, randomized in error|0|||
48430394|NCT03493685|155763718|FG000|Overall Study|Death|4|||
48430395|NCT03493685|155763719|FG001|Overall Study|Death|3|||
48430396|NCT03493685|155763718|FG000|Overall Study|Lost to Follow-up|3|||
48430397|NCT03493685|155763719|FG001|Overall Study|Lost to Follow-up|2|||
48430398|NCT03493685|155763718|FG000|Overall Study|Physician Decision|2|||
48430399|NCT03493685|155763719|FG001|Overall Study|Physician Decision|0|||
48430400|NCT03493685|155763718|FG000|Overall Study|Withdrawal by Subject|7|||
48430401|NCT03493685|155763719|FG001|Overall Study|Withdrawal by Subject|11|||
48430402|NCT01605071|155763720|FG000|Overall Study|Withdrawal by Subject|3|||
48430403|NCT01605071|155763721|FG001|Overall Study|Withdrawal by Subject|2|||
48430404|NCT01441440|155763722|FG000|Overall Study|Death|1|||
48430405|NCT01441440|155763723|FG001|Overall Study|Death|0|||
48430406|NCT01441440|155763724|FG002|Overall Study|Death|1|||
48430407|NCT01441440|155763722|FG000|Overall Study|Adverse Event|2|||
48430408|NCT01441440|155763723|FG001|Overall Study|Adverse Event|9|||
48430409|NCT01441440|155763724|FG002|Overall Study|Adverse Event|9|||
48430410|NCT01441440|155763722|FG000|Overall Study|Lost to Follow-up|0|||
48430411|NCT01441440|155763723|FG001|Overall Study|Lost to Follow-up|2|||
48430412|NCT01441440|155763724|FG002|Overall Study|Lost to Follow-up|1|||
48430413|NCT01441440|155763722|FG000|Overall Study|Withdrawal by Subject|11|||
48430414|NCT01441440|155763723|FG001|Overall Study|Withdrawal by Subject|9|||
48430415|NCT01441440|155763724|FG002|Overall Study|Withdrawal by Subject|9|||
48430416|NCT01441440|155763722|FG000|Overall Study|Pregnancy|1|||
48430417|NCT01441440|155763723|FG001|Overall Study|Pregnancy|0|||
48430418|NCT01441440|155763724|FG002|Overall Study|Pregnancy|0|||
48430419|NCT01441440|155763722|FG000|Overall Study|Lack of Efficacy|1|||
48430420|NCT01441440|155763723|FG001|Overall Study|Lack of Efficacy|0|||
48430421|NCT01441440|155763724|FG002|Overall Study|Lack of Efficacy|1|||
48430422|NCT01441440|155763722|FG000|Overall Study|Moving|0|||
48430423|NCT01441440|155763723|FG001|Overall Study|Moving|1|||
48430424|NCT01441440|155763724|FG002|Overall Study|Moving|1|||
48430425|NCT01441440|155763722|FG000|Overall Study|Work-related matter|0|||
48430426|NCT01441440|155763723|FG001|Overall Study|Work-related matter|1|||
48430427|NCT01441440|155763724|FG002|Overall Study|Work-related matter|0|||
48430428|NCT01441440|155763722|FG000|Overall Study|Difficllty in keeping the schedule|1|||
48430429|NCT01441440|155763723|FG001|Overall Study|Difficllty in keeping the schedule|1|||
48430430|NCT01441440|155763724|FG002|Overall Study|Difficllty in keeping the schedule|0|||
48430431|NCT00943319|155763727|FG000|Overall Study|Death|1|||
48430432|NCT02043301|155763728|FG000|Overall Study|Discontinued|0|||
48430433|NCT02043301|155763729|FG001|Overall Study|Discontinued|1|||
48430434|NCT02043301|155763730|FG002|Overall Study|Discontinued|0|||
48430435|NCT03097328|155763731|FG000|Overall Study|Still on Therapy|2|||
48430436|NCT03097328|155763731|FG000|Overall Study|Progressive Disease|29|||
48430437|NCT03097328|155763731|FG000|Overall Study|Adverse Event|4|||
48430438|NCT03097328|155763731|FG000|Overall Study|Withdrawal by Subject|1|||
48430439|NCT03097328|155763731|FG000|Overall Study|Physician Decision|1|||
48430440|NCT03097328|155763731|FG000|Overall Study|Patient Decision|1|||
48430441|NCT03097328|155763731|FG000|Overall Study|Ineligible for Study Drug|1|||
48430442|NCT00883558|155763732|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
48430443|NCT00883558|155763733|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
48430444|NCT00883558|155763734|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
48430445|NCT00883558|155763732|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
48430446|NCT00883558|155763733|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
48430447|NCT00883558|155763734|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
48430448|NCT00883558|155763732|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
48430449|NCT00883558|155763733|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
48430450|NCT00883558|155763734|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
48430451|NCT00883558|155763732|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
48430452|NCT00883558|155763733|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
48430453|NCT00883558|155763734|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
48430454|NCT00883558|155763732|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
48430455|NCT00883558|155763733|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
48430456|NCT00883558|155763734|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
48430457|NCT01617681|155763740|FG000|Period 1 Double Blind|Adverse Event|2|||
48430458|NCT01617681|155763741|FG001|Period 1 Double Blind|Adverse Event|0|||
48430459|NCT01617681|155763742|FG002|Period 1 Double Blind|Adverse Event|0|||
48430460|NCT01617681|155763743|FG003|Period 1 Double Blind|Adverse Event|2|||
48430461|NCT01617681|155763744|FG004|Period 1 Double Blind|Adverse Event|0|||
48430462|NCT01617681|155763740|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
48430463|NCT01617681|155763741|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
48430464|NCT01617681|155763742|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
48430465|NCT01617681|155763743|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
48430466|NCT01617681|155763744|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
48430467|NCT01617681|155763740|FG000|Period 2 Open Label|Adverse Event|0|||
48430468|NCT01617681|155763741|FG001|Period 2 Open Label|Adverse Event|0|||
48430469|NCT01617681|155763742|FG002|Period 2 Open Label|Adverse Event|0|||
48430470|NCT01617681|155763743|FG003|Period 2 Open Label|Adverse Event|0|||
48430471|NCT01617681|155763744|FG004|Period 2 Open Label|Adverse Event|3|||
48430472|NCT01617681|155763740|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
48430473|NCT01617681|155763741|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
48430474|NCT01617681|155763742|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
48430475|NCT01617681|155763743|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
48430476|NCT01617681|155763744|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
48430477|NCT03484923|155763745|FG000|Overall Study|Adverse Event|3|||
48430478|NCT03484923|155763746|FG001|Overall Study|Adverse Event|3|||
48430479|NCT03484923|155763747|FG002|Overall Study|Adverse Event|5|||
48430480|NCT03484923|155763748|FG003|Overall Study|Adverse Event|11|||
48430481|NCT03484923|155763749|FG004|Overall Study|Adverse Event|1|||
48430482|NCT03484923|155763745|FG000|Overall Study|Death|2|||
48430483|NCT03484923|155763746|FG001|Overall Study|Death|2|||
48430484|NCT03484923|155763747|FG002|Overall Study|Death|3|||
48430485|NCT03484923|155763748|FG003|Overall Study|Death|0|||
48430486|NCT03484923|155763749|FG004|Overall Study|Death|1|||
48430487|NCT03484923|155763745|FG000|Overall Study|Physician Decision|6|||
48430488|NCT03484923|155763746|FG001|Overall Study|Physician Decision|7|||
48430489|NCT03484923|155763747|FG002|Overall Study|Physician Decision|6|||
48430490|NCT03484923|155763748|FG003|Overall Study|Physician Decision|3|||
48430491|NCT03484923|155763749|FG004|Overall Study|Physician Decision|2|||
48430492|NCT03484923|155763745|FG000|Overall Study|Progressive disease|33|||
48430493|NCT03484923|155763746|FG001|Overall Study|Progressive disease|28|||
48430494|NCT03484923|155763747|FG002|Overall Study|Progressive disease|26|||
48430495|NCT03484923|155763748|FG003|Overall Study|Progressive disease|30|||
48430496|NCT03484923|155763749|FG004|Overall Study|Progressive disease|16|||
48430497|NCT03484923|155763745|FG000|Overall Study|Subject Decision|1|||
48430498|NCT03484923|155763746|FG001|Overall Study|Subject Decision|3|||
48430499|NCT03484923|155763747|FG002|Overall Study|Subject Decision|3|||
48430500|NCT03484923|155763748|FG003|Overall Study|Subject Decision|0|||
48430501|NCT03484923|155763749|FG004|Overall Study|Subject Decision|1|||
48430502|NCT02577406|155763750|FG000|Randomized Period|Death|1|||
48430503|NCT02577406|155763751|FG001|Randomized Period|Death|0|||
48430504|NCT02577406|155763750|FG000|Randomized Period|Other reasons|0|||
48430505|NCT02577406|155763751|FG001|Randomized Period|Other reasons|20|||
48430506|NCT02577406|155763750|FG000|Treatment Period|Transition to commercially available treatment|1|||
48430507|NCT02577406|155763751|FG001|Treatment Period|Transition to commercially available treatment|0|||
48430508|NCT02577406|155763750|FG000|Treatment Period|Progressive disease|47|||
48430509|NCT02577406|155763751|FG001|Treatment Period|Progressive disease|36|||
48430510|NCT02577406|155763750|FG000|Treatment Period|Death|36|||
48430511|NCT02577406|155763751|FG001|Treatment Period|Death|23|||
48430512|NCT02577406|155763750|FG000|Treatment Period|Other reasons|3|||
48430513|NCT02577406|155763751|FG001|Treatment Period|Other reasons|37|||
48430514|NCT02577406|155763750|FG000|Treatment Period|Withdrawal by Subject|10|||
48430515|NCT02577406|155763751|FG001|Treatment Period|Withdrawal by Subject|24|||
48430516|NCT02577406|155763750|FG000|Treatment Period|Adverse Event|17|||
48430517|NCT02577406|155763751|FG001|Treatment Period|Adverse Event|12|||
48430518|NCT02577406|155763750|FG000|Treatment Period|Disease relapse|27|||
48430519|NCT02577406|155763751|FG001|Treatment Period|Disease relapse|1|||
48430520|NCT02577406|155763750|FG000|Treatment Period|HSCT|6|||
48430521|NCT02577406|155763751|FG001|Treatment Period|HSCT|2|||
48430522|NCT02577406|155763750|FG000|Treatment Period|Lost to Follow-up|0|||
48430523|NCT02577406|155763751|FG001|Treatment Period|Lost to Follow-up|1|||
48430524|NCT02577406|155763750|FG000|Treatment Period|Protocol Violation|0|||
48430525|NCT02577406|155763751|FG001|Treatment Period|Protocol Violation|1|||
48430526|NCT02855411|155763752|FG000|Overall Study|Study terminated by sponsor|21|||
48430527|NCT02855411|155763752|FG000|Overall Study|Does not meet entrance criteria|14|||
48430528|NCT05603143|155763753|FG000|Overall Study|Withdrew consent|6|||
48430529|NCT05603143|155763754|FG001|Overall Study|Withdrew consent|2|||
48430530|NCT05603143|155763753|FG000|Overall Study|Randomized but never treated|0|||
48430531|NCT05603143|155763754|FG001|Overall Study|Randomized but never treated|3|||
48430532|NCT05603143|155763753|FG000|Overall Study|Adverse Event|2|||
48430533|NCT05603143|155763754|FG001|Overall Study|Adverse Event|0|||
48430534|NCT05603143|155763753|FG000|Overall Study|Death|0|||
48430535|NCT05603143|155763754|FG001|Overall Study|Death|1|||
48430536|NCT05603143|155763753|FG000|Overall Study|Investigator's discretion|1|||
48430537|NCT05603143|155763754|FG001|Overall Study|Investigator's discretion|0|||
48430538|NCT05603143|155763753|FG000|Overall Study|Lost to Follow-up|0|||
48430539|NCT05603143|155763754|FG001|Overall Study|Lost to Follow-up|1|||
48430540|NCT05603143|155763753|FG000|Overall Study|Protocol Violation|0|||
48430541|NCT05603143|155763754|FG001|Overall Study|Protocol Violation|1|||
48430542|NCT03350750|155763755|FG000|Overall Study|Death|1|||
48430543|NCT03350750|155763756|FG001|Overall Study|Death|1|||
48430544|NCT00532948|155763760|FG000|Overall Study|Protocol Violation|1|||
48430545|NCT00532948|155763761|FG001|Overall Study|Protocol Violation|0|||
48430546|NCT00532948|155763762|FG002|Overall Study|Protocol Violation|0|||
48430547|NCT00532948|155763760|FG000|Overall Study|Death|3|||
48430548|NCT00532948|155763761|FG001|Overall Study|Death|3|||
48430549|NCT00532948|155763762|FG002|Overall Study|Death|4|||
48430550|NCT00532948|155763760|FG000|Overall Study|Violation of selection criteria at entry|0|||
48430551|NCT00532948|155763761|FG001|Overall Study|Violation of selection criteria at entry|1|||
48430552|NCT00532948|155763762|FG002|Overall Study|Violation of selection criteria at entry|0|||
48430553|NCT00532948|155763760|FG000|Overall Study|Failure to return|0|||
48430554|NCT00532948|155763761|FG001|Overall Study|Failure to return|1|||
48430555|NCT00532948|155763762|FG002|Overall Study|Failure to return|0|||
48430556|NCT03710603|155763765|FG000|Overall Study|Adverse Event|1|||
48430557|NCT03710603|155763766|FG001|Overall Study|Adverse Event|0|||
48430558|NCT03710603|155763765|FG000|Overall Study|Death|44|||
48430559|NCT03710603|155763766|FG001|Overall Study|Death|34|||
48430560|NCT03710603|155763765|FG000|Overall Study|Lost to Follow-up|3|||
48430561|NCT03710603|155763766|FG001|Overall Study|Lost to Follow-up|5|||
48430562|NCT03710603|155763765|FG000|Overall Study|Withdrawal by Subject|11|||
48430563|NCT03710603|155763766|FG001|Overall Study|Withdrawal by Subject|10|||
48430564|NCT02575079|155763767|FG000|Overall Study|Death|3|||
48430565|NCT02575079|155763768|FG001|Overall Study|Death|0|||
48430566|NCT02575079|155763767|FG000|Overall Study|Withdrawal by Subject|3|||
48430567|NCT02575079|155763768|FG001|Overall Study|Withdrawal by Subject|0|||
48430568|NCT00940342|155763769|FG000|Overall Study|Adverse Event|0|||
48430569|NCT00940342|155763770|FG001|Overall Study|Adverse Event|2|||
48430570|NCT00940342|155763771|FG002|Overall Study|Adverse Event|1|||
48430571|NCT05485779|155763772|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430572|NCT05485779|155763773|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430573|NCT05485779|155763774|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430574|NCT05485779|155763775|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430575|NCT05485779|155763776|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430576|NCT05485779|155763777|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430577|NCT05485779|155763778|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430578|NCT05485779|155763779|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
48430579|NCT05485779|155763780|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
48430580|NCT05485779|155763781|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430581|NCT05485779|155763782|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
48430582|NCT05485779|155763772|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430583|NCT05485779|155763773|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430584|NCT05485779|155763774|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430585|NCT05485779|155763775|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430586|NCT05485779|155763776|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430587|NCT05485779|155763777|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430588|NCT05485779|155763778|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430589|NCT05485779|155763779|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430590|NCT05485779|155763780|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430591|NCT05485779|155763781|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
48430592|NCT05485779|155763782|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
48430593|NCT05485779|155763772|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430594|NCT05485779|155763773|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430595|NCT05485779|155763774|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430596|NCT05485779|155763775|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
48430597|NCT05485779|155763776|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430667|NCT02951988|155763804|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
48430598|NCT05485779|155763777|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430599|NCT05485779|155763778|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430600|NCT05485779|155763779|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430601|NCT05485779|155763780|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430602|NCT05485779|155763781|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430603|NCT05485779|155763782|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
48430604|NCT00138151|155763785|FG000|Overall Study|Withdrawal by Subject|3|||
48430605|NCT00138151|155763785|FG000|Overall Study|Physician Decision|1|||
48430606|NCT00431847|155763786|FG000|Overall Study|completion of less than two study visits|6|||
48430607|NCT00431847|155763787|FG001|Overall Study|completion of less than two study visits|3|||
48430608|NCT00431847|155763788|FG002|Overall Study|completion of less than two study visits|4|||
48430609|NCT00431847|155763789|FG003|Overall Study|completion of less than two study visits|14|||
48430610|NCT00431847|155763790|FG004|Overall Study|completion of less than two study visits|0|||
48430611|NCT00431847|155763786|FG000|Overall Study|Protocol Violation|0|||
48430612|NCT00431847|155763787|FG001|Overall Study|Protocol Violation|0|||
48430613|NCT00431847|155763788|FG002|Overall Study|Protocol Violation|0|||
48430614|NCT00431847|155763789|FG003|Overall Study|Protocol Violation|0|||
48430615|NCT00431847|155763790|FG004|Overall Study|Protocol Violation|1|||
48430616|NCT00339183|155763791|FG000|Overall Study|Adverse Event|5|||
48430617|NCT00339183|155763792|FG001|Overall Study|Adverse Event|3|||
48430618|NCT00339183|155763791|FG000|Overall Study|Withdrawal by Subject|16|||
48430619|NCT00339183|155763792|FG001|Overall Study|Withdrawal by Subject|19|||
48430620|NCT00339183|155763791|FG000|Overall Study|Physician Decision|2|||
48430621|NCT00339183|155763792|FG001|Overall Study|Physician Decision|4|||
48430622|NCT00339183|155763791|FG000|Overall Study|Lost to Follow-up|17|||
48430623|NCT00339183|155763792|FG001|Overall Study|Lost to Follow-up|17|||
48430624|NCT00339183|155763791|FG000|Overall Study|Protocol-specified criteria|12|||
48430625|NCT00339183|155763792|FG001|Overall Study|Protocol-specified criteria|8|||
48430626|NCT00339183|155763791|FG000|Overall Study|Missing reason|3|||
48430627|NCT00339183|155763792|FG001|Overall Study|Missing reason|1|||
48430628|NCT00339183|155763791|FG000|Overall Study|Other|46|||
48430629|NCT00339183|155763792|FG001|Overall Study|Other|40|||
48430630|NCT00339183|155763791|FG000|Overall Study|Ongoing|20|||
48430631|NCT00339183|155763792|FG001|Overall Study|Ongoing|13|||
48430632|NCT01879618|155763794|FG000|Overall Study|Does not meet entrance criteria|1|||
48430633|NCT01879618|155763794|FG000|Overall Study|Withdrawal by Subject|1|||
48430634|NCT01879618|155763794|FG000|Overall Study|Surgery;changed schedule; not available|8|||
48430635|NCT01879618|155763794|FG000|Overall Study|Protocol Violation|6|||
48430636|NCT01879618|155763794|FG000|Overall Study|Adverse Event|5|||
48430637|NCT01379534|155763795|FG000|Treatment Phase|Withdrawal by Subject|2|||
48430638|NCT01379534|155763796|FG001|Treatment Phase|Withdrawal by Subject|2|||
48430639|NCT01379534|155763795|FG000|Treatment Phase|Progressive disease|13|||
48430640|NCT01379534|155763796|FG001|Treatment Phase|Progressive disease|22|||
48430641|NCT01379534|155763795|FG000|Treatment Phase|Adverse Event|7|||
48430642|NCT01379534|155763796|FG001|Treatment Phase|Adverse Event|7|||
48430643|NCT01379534|155763795|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
48430644|NCT01379534|155763796|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
48430645|NCT01379534|155763795|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
48430646|NCT01379534|155763796|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
48430647|NCT01379534|155763795|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
48430648|NCT01379534|155763796|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
48430649|NCT01379534|155763795|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
48430650|NCT01379534|155763796|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
48430651|NCT04967599|155763800|FG000|Overall Study|Lost to Follow-up|35|||
48430652|NCT04967599|155763801|FG001|Overall Study|Lost to Follow-up|19|||
48430653|NCT04967599|155763802|FG002|Overall Study|Lost to Follow-up|23|||
48430654|NCT03229759|155763803|FG000|Overall Study|Screen Failure|30|||
48430655|NCT02951988|155763804|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
48430656|NCT02951988|155763805|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
48430657|NCT02951988|155763806|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
48430658|NCT02951988|155763807|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
48430659|NCT02951988|155763804|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
48430660|NCT02951988|155763805|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
48430661|NCT02951988|155763806|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
48430662|NCT02951988|155763807|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
48430663|NCT02951988|155763804|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
48430664|NCT02951988|155763805|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
48430665|NCT02951988|155763806|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
48430666|NCT02951988|155763807|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
48430668|NCT02951988|155763805|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
48430669|NCT02951988|155763806|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
48430670|NCT02951988|155763807|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
48430671|NCT02951988|155763804|FG000|Open-Label Treatment Period|Protocol Violation|22|||
48430672|NCT02951988|155763805|FG001|Open-Label Treatment Period|Protocol Violation|0|||
48430673|NCT02951988|155763806|FG002|Open-Label Treatment Period|Protocol Violation|0|||
48430674|NCT02951988|155763807|FG003|Open-Label Treatment Period|Protocol Violation|0|||
48430675|NCT02951988|155763804|FG000|Open-Label Treatment Period|Pregnancy|2|||
48430676|NCT02951988|155763805|FG001|Open-Label Treatment Period|Pregnancy|0|||
48430677|NCT02951988|155763806|FG002|Open-Label Treatment Period|Pregnancy|0|||
48430678|NCT02951988|155763807|FG003|Open-Label Treatment Period|Pregnancy|0|||
48430679|NCT02951988|155763804|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
48430680|NCT02951988|155763805|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
48430681|NCT02951988|155763806|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
48430682|NCT02951988|155763807|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
48430683|NCT02951988|155763804|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
48430684|NCT02951988|155763805|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
48430685|NCT02951988|155763806|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
48430686|NCT02951988|155763807|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
48430687|NCT02951988|155763804|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
48430688|NCT02951988|155763805|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
48430689|NCT02951988|155763806|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
48430690|NCT02951988|155763807|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
48430691|NCT02951988|155763804|FG000|Open-Label Treatment Period|Adverse Event|45|||
48430692|NCT02951988|155763805|FG001|Open-Label Treatment Period|Adverse Event|0|||
48430693|NCT02951988|155763806|FG002|Open-Label Treatment Period|Adverse Event|0|||
48430694|NCT02951988|155763807|FG003|Open-Label Treatment Period|Adverse Event|0|||
48430695|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
48430696|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
48430697|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
48430698|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
48430699|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
48430700|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
48430701|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
48430702|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
48430703|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
48430704|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
48430705|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
48430706|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
48430707|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
48430708|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
48430709|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
48430710|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
48430711|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Pregnancy|0|||
48430712|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Pregnancy|1|||
48430713|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Pregnancy|1|||
48430714|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Pregnancy|0|||
48430715|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
48430716|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
48430717|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
48430718|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
48430719|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
48430720|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
48430721|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
48430722|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
48430723|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Adverse Event|0|||
48430724|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Adverse Event|8|||
48430725|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Adverse Event|3|||
48430726|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Adverse Event|6|||
48430727|NCT02951988|155763804|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
48430728|NCT02951988|155763805|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
48430729|NCT02951988|155763806|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
48430730|NCT02951988|155763807|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
48430731|NCT01465178|155763808|FG000|Overall Study|Withdrawal by Subject|1|||
48430732|NCT01465178|155763809|FG001|Overall Study|Withdrawal by Subject|0|||
48430733|NCT00527111|155763810|FG000|Overall Study|Adverse Event|14|||
48430734|NCT00527111|155763811|FG001|Overall Study|Adverse Event|13|||
48430735|NCT00527111|155763810|FG000|Overall Study|Death|0|||
48430736|NCT00527111|155763811|FG001|Overall Study|Death|1|||
48430737|NCT00527111|155763810|FG000|Overall Study|Investigator Request|2|||
48430738|NCT00527111|155763811|FG001|Overall Study|Investigator Request|1|||
48430739|NCT00527111|155763810|FG000|Overall Study|Patient Request|2|||
48430740|NCT00527111|155763811|FG001|Overall Study|Patient Request|5|||
48430741|NCT00527111|155763810|FG000|Overall Study|Other|2|||
48430742|NCT00527111|155763811|FG001|Overall Study|Other|2|||
48430743|NCT04072146|155763816|FG000|Overall Study|Adverse Event|0|||
48430744|NCT04072146|155763817|FG001|Overall Study|Adverse Event|1|||
48430745|NCT01617434|155763818|FG000|Overall Study|Adverse Event|12|||
48430746|NCT01617434|155763819|FG001|Overall Study|Adverse Event|3|||
48430747|NCT01617434|155763818|FG000|Overall Study|Protocol Violation|8|||
48430748|NCT01617434|155763819|FG001|Overall Study|Protocol Violation|7|||
48430749|NCT01617434|155763818|FG000|Overall Study|Withdrawal Criteria|12|||
48430750|NCT01617434|155763819|FG001|Overall Study|Withdrawal Criteria|37|||
48430751|NCT01617434|155763818|FG000|Overall Study|Unclassified|3|||
48430752|NCT01617434|155763819|FG001|Overall Study|Unclassified|4|||
48430753|NCT01987986|155763820|FG000|Overall Study|Lost to Follow-up|1|||
48430754|NCT01987986|155763821|FG001|Overall Study|Lost to Follow-up|0|||
48430755|NCT01987986|155763822|FG002|Overall Study|Lost to Follow-up|0|||
48430756|NCT01987986|155763823|FG003|Overall Study|Lost to Follow-up|0|||
48430757|NCT01987986|155763820|FG000|Overall Study|Adverse Event|1|||
48430758|NCT01987986|155763821|FG001|Overall Study|Adverse Event|0|||
48430759|NCT01987986|155763822|FG002|Overall Study|Adverse Event|2|||
48430760|NCT01987986|155763823|FG003|Overall Study|Adverse Event|0|||
48430761|NCT03283163|155763824|FG000|Overall Study|Lost to Follow-up|1|||
48430762|NCT03283163|155763824|FG000|Overall Study|other life commitments|6|||
48430763|NCT03283163|155763824|FG000|Overall Study|COVID-19 institution wide halting|1|||
48430764|NCT03283163|155763824|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
48430765|NCT03283163|155763824|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
48430766|NCT02993224|155763825|FG000|Core Phase - Period 1|Adverse Event|4|||
48430767|NCT02993224|155763825|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
48430768|NCT02993224|155763825|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
48430769|NCT02993224|155763825|FG000|Core Phase- Period 2|Adverse Event|1|||
48430770|NCT02993224|155763825|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
48430771|NCT02993224|155763825|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
48430772|NCT02993224|155763825|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
48430773|NCT02993224|155763825|FG000|Extension Phase|Adverse Event|3|||
48430774|NCT02993224|155763825|FG000|Extension Phase|Withdrawal by Subject|3|||
48430775|NCT02993224|155763825|FG000|Extension Phase|Lost to Follow-up|2|||
48430776|NCT02993224|155763825|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
48430777|NCT01096446|155763831|FG000|Overall Study|Death|1|||
48430778|NCT01096446|155763832|FG001|Overall Study|Death|0|||
48430779|NCT01096446|155763831|FG000|Overall Study|Protocol Violation|2|||
48430780|NCT01096446|155763832|FG001|Overall Study|Protocol Violation|0|||
48430781|NCT01228071|155765220|FG000|Overall Study|Protocol Violation|1|||
48430782|NCT01228071|155765220|FG000|Overall Study|Withdrawal by Subject|1|||
48430783|NCT00392171|155765221|FG000|Overall Study|Did not meet inclusion criteria|4|||
48430784|NCT00392171|155765221|FG000|Overall Study|Disease progression|101|||
48430785|NCT03041116|155765224|FG000|Double-blind|Death|0|||
48430786|NCT03041116|155765225|FG001|Double-blind|Death|2|||
48430787|NCT03041116|155765224|FG000|Double-blind|Withdrawal by Subject|0|||
48430788|NCT03041116|155765225|FG001|Double-blind|Withdrawal by Subject|4|||
48430789|NCT03041116|155765224|FG000|Open-label|Death|1|||
48430790|NCT03041116|155765225|FG001|Open-label|Death|0|||
48430791|NCT03041116|155765224|FG000|Open-label|Termination of the study by Sponsor|39|||
48430792|NCT03041116|155765225|FG001|Open-label|Termination of the study by Sponsor|37|||
48430793|NCT03041116|155765224|FG000|Open-label|Withdrawal by Subject|1|||
48430794|NCT03041116|155765225|FG001|Open-label|Withdrawal by Subject|0|||
48430795|NCT00833248|155765226|FG000|Overall Study|Adverse Event|3|||
48430796|NCT00833248|155765227|FG001|Overall Study|Adverse Event|0|||
48430797|NCT00833248|155765226|FG000|Overall Study|Protocol Violation|1|||
48430798|NCT00833248|155765227|FG001|Overall Study|Protocol Violation|2|||
48430799|NCT00833248|155765226|FG000|Overall Study|Withdrawal by Subject|0|||
48430800|NCT00833248|155765227|FG001|Overall Study|Withdrawal by Subject|1|||
48430801|NCT00615290|155765228|FG000|Overall Study|Adverse Event|2|||
48430802|NCT00615290|155765228|FG000|Overall Study|Lost to Follow-up|3|||
48430803|NCT00615290|155765228|FG000|Overall Study|Withdrawal by Subject|1|||
48430804|NCT00615290|155765228|FG000|Overall Study|Other|2|||
48430805|NCT03158688|155765229|FG000|Overall Study|Withdrawal by Subject|14|||
48430806|NCT03158688|155765230|FG001|Overall Study|Withdrawal by Subject|28|||
48430807|NCT03158688|155765229|FG000|Overall Study|Decision by sponsor|13|||
48430808|NCT03158688|155765230|FG001|Overall Study|Decision by sponsor|37|||
48430809|NCT03158688|155765229|FG000|Overall Study|Lost to Follow-up|4|||
48430810|NCT03158688|155765230|FG001|Overall Study|Lost to Follow-up|3|||
48430811|NCT03158688|155765229|FG000|Overall Study|Death|74|||
48430812|NCT03158688|155765230|FG001|Overall Study|Death|142|||
48430813|NCT02273050|155765231|FG000|Overall Study|Adverse Event|4|||
48430814|NCT02273050|155765232|FG001|Overall Study|Adverse Event|3|||
48430819|NCT02273050|155765231|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
48430820|NCT02273050|155765232|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
48430821|NCT02273050|155765233|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
48430822|NCT02273050|155765231|FG000|Overall Study|Lack of Efficacy|0|||
48430823|NCT02273050|155765232|FG001|Overall Study|Lack of Efficacy|1|||
48430824|NCT02273050|155765233|FG002|Overall Study|Lack of Efficacy|1|||
48430825|NCT02273050|155765231|FG000|Overall Study|Withdrawal by Subject|17|||
48430826|NCT02273050|155765232|FG001|Overall Study|Withdrawal by Subject|14|||
48430827|NCT02273050|155765233|FG002|Overall Study|Withdrawal by Subject|16|||
48430828|NCT02273050|155765231|FG000|Overall Study|Lost to Follow-up|0|||
48430829|NCT02273050|155765232|FG001|Overall Study|Lost to Follow-up|2|||
48430830|NCT02273050|155765233|FG002|Overall Study|Lost to Follow-up|3|||
48430831|NCT02273050|155765231|FG000|Overall Study|Protocol Violation|3|||
48430832|NCT02273050|155765232|FG001|Overall Study|Protocol Violation|1|||
48430833|NCT02273050|155765233|FG002|Overall Study|Protocol Violation|4|||
48430834|NCT03439748|155765240|FG000|Overall Study|Withdrawal by Subject|11|||
48430835|NCT03439748|155765241|FG001|Overall Study|Withdrawal by Subject|17|||
48430836|NCT05131451|155765246|FG000|Overall Study|Protocol Violation|1|||
48430837|NCT05131451|155765247|FG001|Overall Study|Protocol Violation|0|||
48430838|NCT00915005|155765248|FG000|Overall Study|Withdrawal by Subject|4|||
48430839|NCT00915005|155765249|FG001|Overall Study|Withdrawal by Subject|4|||
48430840|NCT00915005|155765248|FG000|Overall Study|Patient preferred protons therapy|6|||
48430841|NCT00915005|155765249|FG001|Overall Study|Patient preferred protons therapy|0|||
48430842|NCT00915005|155765248|FG000|Overall Study|Insurance denial|3|||
48430843|NCT00915005|155765249|FG001|Overall Study|Insurance denial|15|||
48430844|NCT01028651|155765250|FG000|Overall Study|Death|2|||
48430845|NCT01028651|155765250|FG000|Overall Study|Adverse Event|1|||
48430846|NCT03554005|155765251|FG000|Overall Study|Not in participant's best interest|0|||
48430847|NCT03554005|155765252|FG001|Overall Study|Not in participant's best interest|0|||
48430848|NCT03554005|155765253|FG002|Overall Study|Not in participant's best interest|0|||
48430849|NCT03554005|155765254|FG003|Overall Study|Not in participant's best interest|0|||
48430850|NCT03554005|155765255|FG004|Overall Study|Not in participant's best interest|0|||
48430851|NCT03554005|155765256|FG005|Overall Study|Not in participant's best interest|1|||
48430852|NCT03554005|155765251|FG000|Overall Study|Disease Progression|1|||
48430853|NCT03554005|155765252|FG001|Overall Study|Disease Progression|1|||
48430854|NCT03554005|155765253|FG002|Overall Study|Disease Progression|1|||
48430855|NCT03554005|155765254|FG003|Overall Study|Disease Progression|1|||
48430856|NCT03554005|155765255|FG004|Overall Study|Disease Progression|5|||
48430857|NCT03554005|155765256|FG005|Overall Study|Disease Progression|6|||
48430858|NCT03554005|155765251|FG000|Overall Study|Adverse Event|0|||
48430859|NCT03554005|155765252|FG001|Overall Study|Adverse Event|0|||
48430860|NCT03554005|155765253|FG002|Overall Study|Adverse Event|0|||
48430861|NCT03554005|155765254|FG003|Overall Study|Adverse Event|0|||
48430862|NCT03554005|155765255|FG004|Overall Study|Adverse Event|0|||
48430863|NCT03554005|155765256|FG005|Overall Study|Adverse Event|3|||
48430864|NCT03554005|155765251|FG000|Overall Study|Physician Decision|0|||
48430865|NCT03554005|155765252|FG001|Overall Study|Physician Decision|0|||
48430866|NCT03554005|155765253|FG002|Overall Study|Physician Decision|0|||
48430867|NCT03554005|155765254|FG003|Overall Study|Physician Decision|0|||
48430868|NCT03554005|155765255|FG004|Overall Study|Physician Decision|1|||
48430869|NCT03554005|155765256|FG005|Overall Study|Physician Decision|0|||
48430870|NCT03554005|155765251|FG000|Overall Study|Other|0|||
48430871|NCT03554005|155765252|FG001|Overall Study|Other|0|||
48430872|NCT03554005|155765253|FG002|Overall Study|Other|0|||
48430873|NCT03554005|155765254|FG003|Overall Study|Other|0|||
48430874|NCT03554005|155765255|FG004|Overall Study|Other|0|||
48430875|NCT03554005|155765256|FG005|Overall Study|Other|1|||
48430876|NCT00631488|155765260|FG000|Overall Study|Adverse Event|1|||
48430877|NCT00631488|155765261|FG001|Overall Study|Adverse Event|0|||
48430878|NCT00631488|155765262|FG002|Overall Study|Adverse Event|0|||
48430879|NCT00631488|155765260|FG000|Overall Study|Lost to Follow-up|2|||
48430880|NCT00631488|155765261|FG001|Overall Study|Lost to Follow-up|2|||
48430881|NCT00631488|155765262|FG002|Overall Study|Lost to Follow-up|0|||
48430882|NCT00631488|155765260|FG000|Overall Study|Physician Decision|1|||
48430883|NCT00631488|155765261|FG001|Overall Study|Physician Decision|0|||
48430884|NCT00631488|155765262|FG002|Overall Study|Physician Decision|1|||
48430885|NCT00631488|155765260|FG000|Overall Study|Protocol Violation|0|||
48430886|NCT00631488|155765261|FG001|Overall Study|Protocol Violation|0|||
48430887|NCT00631488|155765262|FG002|Overall Study|Protocol Violation|1|||
48430888|NCT00907881|155765267|FG000|Overall Study|Lost to Follow-up|59|||
48430889|NCT00907881|155765267|FG000|Overall Study|Noncompliance|5|||
48430890|NCT00907881|155765267|FG000|Overall Study|Withdrawal by Subject|5|||
48430891|NCT00907881|155765267|FG000|Overall Study|Protocol Violation|1|||
48430892|NCT00907881|155765267|FG000|Overall Study|Missing discontinuation information|15|||
48430893|NCT03430245|155765268|FG000|Overall Study|Withdrawal by Subject|6|||
48430894|NCT03430245|155765268|FG000|Overall Study|Lost to Follow-up|1|||
48430895|NCT01554956|155765269|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
48430896|NCT01554956|155765270|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
48430897|NCT01554956|155765271|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
48430898|NCT01554956|155765269|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
48430899|NCT01554956|155765270|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
48430900|NCT01554956|155765271|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
48430901|NCT01554956|155765269|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
48430902|NCT01554956|155765270|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
48430903|NCT01554956|155765271|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
48430904|NCT03603600|155765272|FG000|Overall Study|Withdrawal by Subject|5|||
48430905|NCT03603600|155765273|FG001|Overall Study|Withdrawal by Subject|7|||
48430906|NCT03603600|155765272|FG000|Overall Study|Lost to Follow-up|2|||
48430907|NCT03603600|155765273|FG001|Overall Study|Lost to Follow-up|3|||
48430908|NCT03603600|155765272|FG000|Overall Study|Death|3|||
48430909|NCT03603600|155765273|FG001|Overall Study|Death|1|||
48430910|NCT03603600|155765272|FG000|Overall Study|Physician Decision|2|||
48430911|NCT03603600|155765273|FG001|Overall Study|Physician Decision|1|||
48430912|NCT03603600|155765272|FG000|Overall Study|Other reason|1|||
48430913|NCT03603600|155765273|FG001|Overall Study|Other reason|0|||
48430914|NCT01576016|155765274|FG000|Lead Safety|Death|132|||
48430915|NCT01576016|155765275|FG001|Lead Safety|Death|0|||
48430916|NCT01576016|155765274|FG000|Lead Safety|Withdrawal by Subject|81|||
48430917|NCT01576016|155765275|FG001|Lead Safety|Withdrawal by Subject|0|||
48430918|NCT01576016|155765274|FG000|Lead Safety|System Explanted without Replacement|24|||
48430919|NCT01576016|155765275|FG001|Lead Safety|System Explanted without Replacement|0|||
48430920|NCT01576016|155765274|FG000|Lead Safety|Physician Decision|14|||
48430921|NCT01576016|155765275|FG001|Lead Safety|Physician Decision|0|||
48430922|NCT01576016|155765274|FG000|Lead Safety|Lost to Follow-up|13|||
48430923|NCT01576016|155765275|FG001|Lead Safety|Lost to Follow-up|0|||
48430924|NCT01576016|155765274|FG000|Lead Safety|Unsuccessful implant|2|||
48430925|NCT01576016|155765275|FG001|Lead Safety|Unsuccessful implant|0|||
48430926|NCT01576016|155765274|FG000|Lead Safety|Sponsor request|1|||
48430927|NCT01576016|155765275|FG001|Lead Safety|Sponsor request|0|||
48430928|NCT01576016|155765274|FG000|Lead Safety|Device replaced with CRT-D|1|||
48430929|NCT01576016|155765275|FG001|Lead Safety|Device replaced with CRT-D|0|||
48430930|NCT01576016|155765274|FG000|Lead Safety|Patient on Palliative Care|1|||
48430931|NCT01576016|155765275|FG001|Lead Safety|Patient on Palliative Care|0|||
48430932|NCT01576016|155765274|FG000|Lead Safety|Patient noncompliance|1|||
48430933|NCT01576016|155765275|FG001|Lead Safety|Patient noncompliance|0|||
48430934|NCT01576016|155765274|FG000|Lead Safety|Too far from study site|1|||
48430935|NCT01576016|155765275|FG001|Lead Safety|Too far from study site|0|||
48430936|NCT01576016|155765274|FG000|Lead Safety|System deactivated|1|||
48430937|NCT01576016|155765275|FG001|Lead Safety|System deactivated|0|||
48430938|NCT01576016|155765274|FG000|Lead Safety|Patient no longer followed by study PI|1|||
48430939|NCT01576016|155765275|FG001|Lead Safety|Patient no longer followed by study PI|0|||
48430940|NCT01576016|155765274|FG000|MRI Safety|Withdrawal by Subject|0|||
48430941|NCT01576016|155765275|FG001|MRI Safety|Withdrawal by Subject|10|||
48430942|NCT01576016|155765274|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
48430943|NCT01576016|155765275|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
48430944|NCT01576016|155765274|FG000|MRI Safety|Has not yet completed MRI scan|0|||
48430945|NCT01576016|155765275|FG001|MRI Safety|Has not yet completed MRI scan|56|||
48430946|NCT01576016|155765274|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
48430947|NCT01576016|155765275|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
48430948|NCT02145156|155765276|FG000|Overall Study|No match to vaccination records|60|||
48430949|NCT02145156|155765277|FG001|Overall Study|No match to vaccination records|52|||
48430950|NCT02145156|155765278|FG002|Overall Study|No match to vaccination records|41|||
48430951|NCT01120093|155765282|FG000|Treatment Period 1|Adverse Event|0|||
48430952|NCT01120093|155765283|FG001|Treatment Period 1|Adverse Event|0|||
48430953|NCT01120093|155765284|FG002|Treatment Period 1|Adverse Event|1|||
48430954|NCT01120093|155765285|FG003|Treatment Period 1|Adverse Event|0|||
48430955|NCT01120093|155765286|FG004|Treatment Period 1|Adverse Event|1|||
48430956|NCT01120093|155765282|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48430957|NCT01120093|155765283|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48430958|NCT01120093|155765284|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48430959|NCT01120093|155765285|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48430960|NCT01120093|155765286|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48430961|NCT01120093|155765282|FG000|Treatment Period 2|Adverse Event|0|||
48430962|NCT01120093|155765283|FG001|Treatment Period 2|Adverse Event|0|||
48430963|NCT01120093|155765284|FG002|Treatment Period 2|Adverse Event|0|||
48430964|NCT01120093|155765285|FG003|Treatment Period 2|Adverse Event|1|||
48430965|NCT01120093|155765286|FG004|Treatment Period 2|Adverse Event|0|||
48430966|NCT01120093|155765282|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48430967|NCT01120093|155765283|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48430968|NCT01120093|155765284|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48430969|NCT01120093|155765285|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48430970|NCT01120093|155765286|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48430971|NCT01120093|155765282|FG000|Treatment Period 3|Lack of Efficacy|0|||
48430972|NCT01120093|155765283|FG001|Treatment Period 3|Lack of Efficacy|0|||
48430973|NCT01120093|155765284|FG002|Treatment Period 3|Lack of Efficacy|0|||
48430974|NCT01120093|155765285|FG003|Treatment Period 3|Lack of Efficacy|1|||
48430975|NCT01120093|155765286|FG004|Treatment Period 3|Lack of Efficacy|0|||
48430976|NCT01120093|155765282|FG000|Treatment Period 3|Adverse Event|0|||
48430977|NCT01120093|155765283|FG001|Treatment Period 3|Adverse Event|0|||
48430978|NCT01120093|155765284|FG002|Treatment Period 3|Adverse Event|0|||
48430979|NCT01120093|155765285|FG003|Treatment Period 3|Adverse Event|0|||
48430980|NCT01120093|155765286|FG004|Treatment Period 3|Adverse Event|1|||
48430981|NCT01120093|155765282|FG000|Treatment Period 3|Withdrawal by Subject|0|||
48430982|NCT01120093|155765283|FG001|Treatment Period 3|Withdrawal by Subject|0|||
48430983|NCT01120093|155765284|FG002|Treatment Period 3|Withdrawal by Subject|1|||
48430984|NCT01120093|155765285|FG003|Treatment Period 3|Withdrawal by Subject|0|||
48430985|NCT01120093|155765286|FG004|Treatment Period 3|Withdrawal by Subject|0|||
48430986|NCT01120093|155765282|FG000|Treatment Period 4|Adverse Event|1|||
48430987|NCT01120093|155765283|FG001|Treatment Period 4|Adverse Event|0|||
48430988|NCT01120093|155765284|FG002|Treatment Period 4|Adverse Event|0|||
48430989|NCT01120093|155765285|FG003|Treatment Period 4|Adverse Event|0|||
48430990|NCT01120093|155765286|FG004|Treatment Period 4|Adverse Event|0|||
48430991|NCT01120093|155765282|FG000|Treatment Period 5|Adverse Event|0|||
48430992|NCT01120093|155765283|FG001|Treatment Period 5|Adverse Event|1|||
48430993|NCT01120093|155765284|FG002|Treatment Period 5|Adverse Event|0|||
48430994|NCT01120093|155765285|FG003|Treatment Period 5|Adverse Event|1|||
48430995|NCT01120093|155765286|FG004|Treatment Period 5|Adverse Event|0|||
48430996|NCT01519245|155765288|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
48430997|NCT01519245|155765289|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
48430998|NCT00988559|155765290|FG000|Overall Study|Withdrawal by Subject|1|||
48430999|NCT00988559|155765291|FG001|Overall Study|Withdrawal by Subject|1|||
48431000|NCT00988559|155765292|FG002|Overall Study|Withdrawal by Subject|0|||
48431001|NCT00988559|155765293|FG003|Overall Study|Withdrawal by Subject|1|||
48431002|NCT00988559|155765290|FG000|Overall Study|Pregnancy|0|||
48431003|NCT00988559|155765291|FG001|Overall Study|Pregnancy|1|||
48431004|NCT00988559|155765292|FG002|Overall Study|Pregnancy|1|||
48431005|NCT00988559|155765293|FG003|Overall Study|Pregnancy|0|||
48431006|NCT00988559|155765290|FG000|Overall Study|Lost to Follow-up|0|||
48431007|NCT00988559|155765291|FG001|Overall Study|Lost to Follow-up|0|||
48431008|NCT00988559|155765292|FG002|Overall Study|Lost to Follow-up|1|||
48431009|NCT00988559|155765293|FG003|Overall Study|Lost to Follow-up|0|||
48431010|NCT04238663|155765294|FG000|Overall Study|Lost to Follow-up|0|||
48431011|NCT04238663|155765295|FG001|Overall Study|Lost to Follow-up|1|||
48431012|NCT04238663|155765296|FG002|Overall Study|Lost to Follow-up|0|||
48431013|NCT00705224|155765297|FG000|Overall Study|Adverse Event|1|||
48431014|NCT00705224|155765297|FG000|Overall Study|Lack of Efficacy|2|||
48431015|NCT00705224|155765297|FG000|Overall Study|Withdrawal by Subject|3|||
48431016|NCT00705224|155765297|FG000|Overall Study|Lost to Follow-up|5|||
48431017|NCT02402218|155765298|FG000|Overall Study|Did not pickup study medication|12|||
48431018|NCT02402218|155765299|FG001|Overall Study|Did not pickup study medication|9|||
48431019|NCT02402218|155765300|FG002|Overall Study|Did not pickup study medication|13|||
48431020|NCT02402218|155765298|FG000|Overall Study|Lack of Efficacy|0|||
48431021|NCT02402218|155765299|FG001|Overall Study|Lack of Efficacy|1|||
48431022|NCT02402218|155765300|FG002|Overall Study|Lack of Efficacy|1|||
48431023|NCT02402218|155765298|FG000|Overall Study|Death|1|||
48431024|NCT02402218|155765299|FG001|Overall Study|Death|0|||
48431025|NCT02402218|155765300|FG002|Overall Study|Death|0|||
48431026|NCT02402218|155765298|FG000|Overall Study|Reinfection|0|||
48431027|NCT02402218|155765299|FG001|Overall Study|Reinfection|0|||
48431028|NCT02402218|155765300|FG002|Overall Study|Reinfection|1|||
48431029|NCT02402218|155765298|FG000|Overall Study|Adverse Event|0|||
48431030|NCT02402218|155765299|FG001|Overall Study|Adverse Event|2|||
48431031|NCT02402218|155765300|FG002|Overall Study|Adverse Event|1|||
48431032|NCT02402218|155765298|FG000|Overall Study|Withdrawal by Subject|1|||
48431033|NCT02402218|155765299|FG001|Overall Study|Withdrawal by Subject|1|||
48431034|NCT02402218|155765300|FG002|Overall Study|Withdrawal by Subject|1|||
48431035|NCT04070378|155765301|FG000|Overall Study|Withdrawal by Subject|2|||
48431036|NCT04070378|155765301|FG000|Overall Study|Screen Failure|6|||
48431037|NCT04070378|155765301|FG000|Overall Study|Physician Decision|1|||
48431038|NCT04070378|155765301|FG000|Overall Study|Adverse Event|1|||
48431039|NCT03827473|155765305|FG000|Overall Study|Withdrawal by Subject|1|||
48431040|NCT03827473|155765306|FG001|Overall Study|Withdrawal by Subject|0|||
48431041|NCT00952289|155765307|FG000|All Participants|Death|9|||
48431042|NCT00952289|155765308|FG001|All Participants|Death|9|||
48431043|NCT00952289|155765307|FG000|All Participants|Adverse Event|8|||
48431044|NCT00952289|155765308|FG001|All Participants|Adverse Event|8|||
48431045|NCT00952289|155765307|FG000|All Participants|Disease progression|3|||
48431046|NCT00952289|155765308|FG001|All Participants|Disease progression|12|||
48431047|NCT00952289|155765307|FG000|All Participants|Withdrawal by Subject|1|||
48431048|NCT00952289|155765308|FG001|All Participants|Withdrawal by Subject|10|||
48431049|NCT00952289|155765307|FG000|All Participants|Data lost during site relocation|0|||
48431050|NCT00952289|155765308|FG001|All Participants|Data lost during site relocation|1|||
48431051|NCT00952289|155765307|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
48431052|NCT00952289|155765308|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
48431053|NCT00952289|155765307|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
48431054|NCT00952289|155765308|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
48431055|NCT00952289|155765307|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
48431056|NCT00952289|155765308|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
48431057|NCT00952289|155765307|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
48431058|NCT00952289|155765308|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
48431059|NCT00952289|155765307|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
48431060|NCT00952289|155765308|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
48431061|NCT04436822|155765309|FG000|Overall Study|Physician Decision|2|||
48431062|NCT04436822|155765310|FG001|Overall Study|Physician Decision|0|||
48431063|NCT04436822|155765309|FG000|Overall Study|Sponsor request|1|||
48431064|NCT04436822|155765310|FG001|Overall Study|Sponsor request|0|||
48431065|NCT04436822|155765309|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48431066|NCT04436822|155765310|FG001|Overall Study|Withdrawal by parent/guardian|3|||
48431067|NCT04436822|155765309|FG000|Overall Study|Unsuccessful procedure|0|||
48431068|NCT04436822|155765310|FG001|Overall Study|Unsuccessful procedure|1|||
48431069|NCT04436822|155765309|FG000|Overall Study|Withdrawal due to Covid-19|8|||
48431070|NCT04436822|155765310|FG001|Overall Study|Withdrawal due to Covid-19|1|||
48431071|NCT04436822|155765309|FG000|Overall Study|Withdrawal by Subject|1|||
48431072|NCT04436822|155765310|FG001|Overall Study|Withdrawal by Subject|0|||
48431073|NCT04436822|155765309|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
48431074|NCT04436822|155765310|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
48431075|NCT03807739|155765311|FG000|Overall Study|Adverse Event|1|||
48431076|NCT03807739|155765312|FG001|Overall Study|Adverse Event|0|||
48431077|NCT03807739|155765313|FG002|Overall Study|Adverse Event|0|||
48431078|NCT03807739|155765314|FG003|Overall Study|Adverse Event|0|||
48431079|NCT03807739|155765311|FG000|Overall Study|Withdrawal by Subject|1|||
48431080|NCT03807739|155765312|FG001|Overall Study|Withdrawal by Subject|0|||
48431081|NCT03807739|155765313|FG002|Overall Study|Withdrawal by Subject|0|||
48431082|NCT03807739|155765314|FG003|Overall Study|Withdrawal by Subject|0|||
48431083|NCT00875017|155765315|FG000|First Intervention|Withdrawal by Subject|1|||
48431084|NCT00875017|155765316|FG001|First Intervention|Withdrawal by Subject|0|||
48431085|NCT00875017|155765317|FG002|First Intervention|Withdrawal by Subject|1|||
48431086|NCT00875017|155765318|FG003|First Intervention|Withdrawal by Subject|0|||
48431087|NCT00875017|155765319|FG004|First Intervention|Withdrawal by Subject|0|||
48431088|NCT00875017|155765320|FG005|First Intervention|Withdrawal by Subject|0|||
48431089|NCT00875017|155765315|FG000|First Intervention|Adverse Event|0|||
48431090|NCT00875017|155765316|FG001|First Intervention|Adverse Event|0|||
48431091|NCT00875017|155765317|FG002|First Intervention|Adverse Event|0|||
48431092|NCT00875017|155765318|FG003|First Intervention|Adverse Event|1|||
48431093|NCT00875017|155765319|FG004|First Intervention|Adverse Event|0|||
48431094|NCT00875017|155765320|FG005|First Intervention|Adverse Event|0|||
48431095|NCT00875017|155765315|FG000|First Intervention|Problems collecting rectal effluent|1|||
48431096|NCT00875017|155765316|FG001|First Intervention|Problems collecting rectal effluent|0|||
48431097|NCT00875017|155765317|FG002|First Intervention|Problems collecting rectal effluent|0|||
48431098|NCT00875017|155765318|FG003|First Intervention|Problems collecting rectal effluent|0|||
48431099|NCT00875017|155765319|FG004|First Intervention|Problems collecting rectal effluent|0|||
48431100|NCT00875017|155765320|FG005|First Intervention|Problems collecting rectal effluent|0|||
48431101|NCT00875017|155765315|FG000|First Intervention|Intolerance to nasogastric tube|0|||
48431102|NCT00875017|155765316|FG001|First Intervention|Intolerance to nasogastric tube|0|||
48431103|NCT00875017|155765317|FG002|First Intervention|Intolerance to nasogastric tube|0|||
48431104|NCT00875017|155765318|FG003|First Intervention|Intolerance to nasogastric tube|0|||
48431105|NCT00875017|155765319|FG004|First Intervention|Intolerance to nasogastric tube|1|||
48431106|NCT00875017|155765320|FG005|First Intervention|Intolerance to nasogastric tube|0|||
48431107|NCT00875017|155765315|FG000|Washout|Problem collecting rectal effluent|0|||
48431108|NCT00875017|155765316|FG001|Washout|Problem collecting rectal effluent|0|||
48431109|NCT00875017|155765317|FG002|Washout|Problem collecting rectal effluent|1|||
48431110|NCT00875017|155765318|FG003|Washout|Problem collecting rectal effluent|0|||
48431111|NCT00875017|155765319|FG004|Washout|Problem collecting rectal effluent|0|||
48431112|NCT00875017|155765320|FG005|Washout|Problem collecting rectal effluent|0|||
48431113|NCT00875017|155765315|FG000|Second Intervention|Adverse Event|0|||
48431114|NCT00875017|155765316|FG001|Second Intervention|Adverse Event|0|||
48431115|NCT00875017|155765317|FG002|Second Intervention|Adverse Event|0|||
48431116|NCT00875017|155765318|FG003|Second Intervention|Adverse Event|1|||
48431117|NCT00875017|155765319|FG004|Second Intervention|Adverse Event|0|||
48431118|NCT00875017|155765320|FG005|Second Intervention|Adverse Event|0|||
48431119|NCT00875017|155765315|FG000|Washout|Problems collecting rectal effluent|0|||
48431120|NCT00875017|155765316|FG001|Washout|Problems collecting rectal effluent|1|||
48431121|NCT00875017|155765317|FG002|Washout|Problems collecting rectal effluent|0|||
48431122|NCT00875017|155765318|FG003|Washout|Problems collecting rectal effluent|0|||
48431123|NCT00875017|155765319|FG004|Washout|Problems collecting rectal effluent|0|||
48431124|NCT00875017|155765320|FG005|Washout|Problems collecting rectal effluent|0|||
48431125|NCT00875017|155765315|FG000|Third Intervention|Adverse Event|0|||
48431126|NCT00875017|155765316|FG001|Third Intervention|Adverse Event|1|||
48431127|NCT00875017|155765317|FG002|Third Intervention|Adverse Event|1|||
48431128|NCT00875017|155765318|FG003|Third Intervention|Adverse Event|0|||
48431129|NCT00875017|155765319|FG004|Third Intervention|Adverse Event|0|||
48431130|NCT00875017|155765320|FG005|Third Intervention|Adverse Event|0|||
48431131|NCT00875017|155765315|FG000|Washout|Withdrawal by Subject|0|||
48431132|NCT00875017|155765316|FG001|Washout|Withdrawal by Subject|0|||
48431133|NCT00875017|155765317|FG002|Washout|Withdrawal by Subject|0|||
48431134|NCT00875017|155765318|FG003|Washout|Withdrawal by Subject|0|||
48431135|NCT00875017|155765319|FG004|Washout|Withdrawal by Subject|1|||
48431136|NCT00875017|155765320|FG005|Washout|Withdrawal by Subject|0|||
48431137|NCT00875017|155765315|FG000|Fourth Intervention|Inability to comply with fasting|0|||
48431138|NCT00875017|155765316|FG001|Fourth Intervention|Inability to comply with fasting|0|||
48431139|NCT00875017|155765317|FG002|Fourth Intervention|Inability to comply with fasting|0|||
48431140|NCT00875017|155765318|FG003|Fourth Intervention|Inability to comply with fasting|0|||
48431141|NCT00875017|155765319|FG004|Fourth Intervention|Inability to comply with fasting|0|||
48431142|NCT00875017|155765320|FG005|Fourth Intervention|Inability to comply with fasting|1|||
48431143|NCT03342469|155765323|FG000|Overall Study|Withdrawal by Subject|0|||
48431144|NCT03342469|155765324|FG001|Overall Study|Withdrawal by Subject|1|||
48431145|NCT03342469|155765325|FG002|Overall Study|Withdrawal by Subject|0|||
48431146|NCT03342469|155765326|FG003|Overall Study|Withdrawal by Subject|0|||
48431147|NCT02689219|155765327|FG000|Overall Study|Death|1|||
48431148|NCT02689219|155765328|FG001|Overall Study|Death|1|||
48431149|NCT02689219|155765327|FG000|Overall Study|Disease Progression|10|||
48431150|NCT02689219|155765328|FG001|Overall Study|Disease Progression|6|||
48431151|NCT03259334|155765329|FG000|Overall Study|Adverse Event|3|||
48431152|NCT03259334|155765330|FG001|Overall Study|Adverse Event|8|||
48431153|NCT03259334|155765331|FG002|Overall Study|Adverse Event|5|||
48431154|NCT03259334|155765329|FG000|Overall Study|Withdrawal by Subject|4|||
48431155|NCT03259334|155765330|FG001|Overall Study|Withdrawal by Subject|2|||
48431156|NCT03259334|155765331|FG002|Overall Study|Withdrawal by Subject|4|||
48431157|NCT03259334|155765329|FG000|Overall Study|Physician Decision|1|||
48431158|NCT03259334|155765330|FG001|Overall Study|Physician Decision|0|||
48431159|NCT03259334|155765331|FG002|Overall Study|Physician Decision|0|||
48431160|NCT03259334|155765329|FG000|Overall Study|Lost to Follow-up|0|||
48431161|NCT03259334|155765330|FG001|Overall Study|Lost to Follow-up|2|||
48431162|NCT03259334|155765331|FG002|Overall Study|Lost to Follow-up|1|||
48431163|NCT03259334|155765329|FG000|Overall Study|Protocol Deviation|0|||
48431164|NCT03259334|155765330|FG001|Overall Study|Protocol Deviation|3|||
48431165|NCT03259334|155765331|FG002|Overall Study|Protocol Deviation|2|||
48431166|NCT03259334|155765329|FG000|Overall Study|Lack of Efficacy|2|||
48431167|NCT03259334|155765330|FG001|Overall Study|Lack of Efficacy|0|||
48431168|NCT03259334|155765331|FG002|Overall Study|Lack of Efficacy|1|||
48431169|NCT03259334|155765329|FG000|Overall Study|Randomized but never treated|0|||
48431170|NCT03259334|155765330|FG001|Overall Study|Randomized but never treated|2|||
48431171|NCT03259334|155765331|FG002|Overall Study|Randomized but never treated|0|||
48431172|NCT02371759|155765334|FG000|Overall Study|Protocol Violation|3|||
48431173|NCT02371759|155765335|FG001|Overall Study|Protocol Violation|1|||
48431174|NCT02371759|155765336|FG002|Overall Study|Protocol Violation|1|||
48431175|NCT02371759|155765337|FG003|Overall Study|Protocol Violation|0|||
48431176|NCT02371759|155765338|FG004|Overall Study|Protocol Violation|3|||
48431177|NCT02371759|155765339|FG005|Overall Study|Protocol Violation|1|||
48431178|NCT02371759|155765340|FG006|Overall Study|Protocol Violation|0|||
48431179|NCT02371759|155765341|FG007|Overall Study|Protocol Violation|3|||
48431180|NCT02371759|155765334|FG000|Overall Study|Withdrawal by Subject|0|||
48431181|NCT02371759|155765335|FG001|Overall Study|Withdrawal by Subject|0|||
48431182|NCT02371759|155765336|FG002|Overall Study|Withdrawal by Subject|0|||
48431183|NCT02371759|155765337|FG003|Overall Study|Withdrawal by Subject|0|||
48431184|NCT02371759|155765338|FG004|Overall Study|Withdrawal by Subject|0|||
48431185|NCT02371759|155765339|FG005|Overall Study|Withdrawal by Subject|0|||
48431186|NCT02371759|155765340|FG006|Overall Study|Withdrawal by Subject|0|||
48431187|NCT02371759|155765341|FG007|Overall Study|Withdrawal by Subject|1|||
48431188|NCT00553059|155765342|FG000|Overall Study|Deemed ineligible|1|||
48431189|NCT00553059|155765343|FG001|Overall Study|Deemed ineligible|1|||
48431190|NCT00553059|155765342|FG000|Overall Study|Drug supply not available|0|||
48431191|NCT00553059|155765343|FG001|Overall Study|Drug supply not available|1|||
48431192|NCT01599754|155765344|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
48431193|NCT01599754|155765345|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
48431194|NCT01599754|155765344|FG000|Overall Study|Participant noncompliance|4|||
48431195|NCT01599754|155765345|FG001|Overall Study|Participant noncompliance|4|||
48431196|NCT01599754|155765344|FG000|Overall Study|Lost to Follow-up|13|||
48431197|NCT01599754|155765345|FG001|Overall Study|Lost to Follow-up|6|||
48431198|NCT01599754|155765344|FG000|Overall Study|Death|31|||
48431202|NCT01599754|155765344|FG000|Overall Study|Investigator decision|1|||
48431203|NCT01599754|155765345|FG001|Overall Study|Investigator decision|3|||
48431204|NCT01599754|155765344|FG000|Overall Study|Withdrawal by Subject|24|||
48431205|NCT01599754|155765345|FG001|Overall Study|Withdrawal by Subject|25|||
48431206|NCT01599754|155765344|FG000|Overall Study|Study terminated by sponsor|282|||
48431207|NCT01599754|155765345|FG001|Overall Study|Study terminated by sponsor|285|||
48431216|NCT04078152|155765351|FG000|Overall Study|Other|83|||
48431217|NCT04078152|155765352|FG001|Overall Study|Other|22|||
48431218|NCT04078152|155765353|FG002|Overall Study|Other|25|||
48431219|NCT04078152|155765351|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
48431220|NCT04078152|155765352|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
48431221|NCT04078152|155765353|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
48431222|NCT04078152|155765351|FG000|Overall Study|Withdrawal by Subject|5|||
48431223|NCT04078152|155765352|FG001|Overall Study|Withdrawal by Subject|0|||
48431224|NCT04078152|155765353|FG002|Overall Study|Withdrawal by Subject|1|||
48431225|NCT04078152|155765351|FG000|Overall Study|Death|10|||
48431226|NCT04078152|155765352|FG001|Overall Study|Death|2|||
48431227|NCT04078152|155765353|FG002|Overall Study|Death|12|||
48431228|NCT04078152|155765351|FG000|Overall Study|Adverse Event|1|||
48431229|NCT04078152|155765352|FG001|Overall Study|Adverse Event|0|||
48431230|NCT04078152|155765353|FG002|Overall Study|Adverse Event|0|||
48431231|NCT00243230|155765354|FG000|Double-Blind Period|Adverse Event|0|||
48431232|NCT00243230|155765355|FG001|Double-Blind Period|Adverse Event|2|||
48431233|NCT00243230|155765356|FG002|Double-Blind Period|Adverse Event|2|||
48431234|NCT00243230|155765357|FG003|Double-Blind Period|Adverse Event|0|||
48431235|NCT00243230|155765354|FG000|Double-Blind Period|Withdrawal by Subject|1|||
48431236|NCT00243230|155765355|FG001|Double-Blind Period|Withdrawal by Subject|0|||
48431237|NCT00243230|155765356|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48431238|NCT00243230|155765357|FG003|Double-Blind Period|Withdrawal by Subject|0|||
48431239|NCT00243230|155765354|FG000|Double-Blind Period|Protocol Violation|0|||
48431240|NCT00243230|155765355|FG001|Double-Blind Period|Protocol Violation|0|||
48431241|NCT00243230|155765356|FG002|Double-Blind Period|Protocol Violation|1|||
48431242|NCT00243230|155765357|FG003|Double-Blind Period|Protocol Violation|0|||
48431243|NCT00243230|155765354|FG000|Double-Blind Period|Randomized but Not Treated|0|||
48431244|NCT00243230|155765355|FG001|Double-Blind Period|Randomized but Not Treated|0|||
48431245|NCT00243230|155765356|FG002|Double-Blind Period|Randomized but Not Treated|2|||
48431246|NCT00243230|155765357|FG003|Double-Blind Period|Randomized but Not Treated|0|||
48431247|NCT00243230|155765354|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
48431248|NCT00243230|155765355|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
48431249|NCT00243230|155765356|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
48431250|NCT00243230|155765357|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
48431251|NCT00243230|155765354|FG000|Open Label Period|Adverse Event|0|||
48431252|NCT00243230|155765355|FG001|Open Label Period|Adverse Event|0|||
48431253|NCT00243230|155765356|FG002|Open Label Period|Adverse Event|0|||
48431254|NCT00243230|155765357|FG003|Open Label Period|Adverse Event|2|||
48431255|NCT00243230|155765354|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
48431256|NCT00243230|155765355|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
48431257|NCT00243230|155765356|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
48431258|NCT00243230|155765357|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
48431259|NCT00243230|155765354|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
48431260|NCT00243230|155765355|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
48431261|NCT00243230|155765356|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
48431262|NCT00243230|155765357|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
48431263|NCT00243230|155765354|FG000|Open Label Period|Lost to Follow-up|0|||
48431264|NCT00243230|155765355|FG001|Open Label Period|Lost to Follow-up|0|||
48431265|NCT00243230|155765356|FG002|Open Label Period|Lost to Follow-up|0|||
48431266|NCT00243230|155765357|FG003|Open Label Period|Lost to Follow-up|2|||
48431267|NCT00243230|155765354|FG000|Open Label Period|Withdrawal by Subject|0|||
48431268|NCT00243230|155765355|FG001|Open Label Period|Withdrawal by Subject|0|||
48431269|NCT00243230|155765356|FG002|Open Label Period|Withdrawal by Subject|0|||
48431270|NCT00243230|155765357|FG003|Open Label Period|Withdrawal by Subject|2|||
48431271|NCT00243230|155765354|FG000|Open Label Period|Protocol Violation|0|||
48431272|NCT00243230|155765355|FG001|Open Label Period|Protocol Violation|0|||
48431273|NCT00243230|155765356|FG002|Open Label Period|Protocol Violation|0|||
48431274|NCT00243230|155765357|FG003|Open Label Period|Protocol Violation|2|||
48431275|NCT00243230|155765354|FG000|Open Label Period|Administrative Reason|0|||
48431276|NCT00243230|155765355|FG001|Open Label Period|Administrative Reason|0|||
48431277|NCT00243230|155765356|FG002|Open Label Period|Administrative Reason|0|||
48431278|NCT00243230|155765357|FG003|Open Label Period|Administrative Reason|63|||
48431279|NCT02488759|155765359|FG000|Overall Study|Disease progression|73|||
48431280|NCT02488759|155765360|FG001|Overall Study|Disease progression|111|||
48431281|NCT02488759|155765361|FG002|Overall Study|Disease progression|62|||
48431282|NCT02488759|155765362|FG003|Overall Study|Disease progression|7|||
48431283|NCT02488759|155765363|FG004|Overall Study|Disease progression|4|||
48431284|NCT02488759|155765364|FG005|Overall Study|Disease progression|2|||
48431285|NCT02488759|155765359|FG000|Overall Study|Study drug toxicity|11|||
48431286|NCT02488759|155765360|FG001|Overall Study|Study drug toxicity|33|||
48431287|NCT02488759|155765361|FG002|Overall Study|Study drug toxicity|31|||
48431288|NCT02488759|155765362|FG003|Overall Study|Study drug toxicity|0|||
48431289|NCT02488759|155765363|FG004|Overall Study|Study drug toxicity|0|||
48431290|NCT02488759|155765364|FG005|Overall Study|Study drug toxicity|2|||
48431291|NCT02488759|155765359|FG000|Overall Study|Adverse event unrelated to study drug|9|||
48431292|NCT02488759|155765360|FG001|Overall Study|Adverse event unrelated to study drug|11|||
48431293|NCT02488759|155765361|FG002|Overall Study|Adverse event unrelated to study drug|7|||
48431294|NCT02488759|155765362|FG003|Overall Study|Adverse event unrelated to study drug|0|||
48431295|NCT02488759|155765363|FG004|Overall Study|Adverse event unrelated to study drug|1|||
48431296|NCT02488759|155765364|FG005|Overall Study|Adverse event unrelated to study drug|0|||
48431297|NCT02488759|155765359|FG000|Overall Study|Participant request to discontinue study treatment|6|||
48431298|NCT02488759|155765360|FG001|Overall Study|Participant request to discontinue study treatment|8|||
48431299|NCT02488759|155765361|FG002|Overall Study|Participant request to discontinue study treatment|4|||
48431300|NCT02488759|155765362|FG003|Overall Study|Participant request to discontinue study treatment|0|||
48431301|NCT02488759|155765363|FG004|Overall Study|Participant request to discontinue study treatment|0|||
48431302|NCT02488759|155765364|FG005|Overall Study|Participant request to discontinue study treatment|0|||
48431303|NCT02488759|155765359|FG000|Overall Study|Withdrawal by Subject|4|||
48431304|NCT02488759|155765360|FG001|Overall Study|Withdrawal by Subject|0|||
48431305|NCT02488759|155765361|FG002|Overall Study|Withdrawal by Subject|3|||
48431306|NCT02488759|155765362|FG003|Overall Study|Withdrawal by Subject|0|||
48431307|NCT02488759|155765363|FG004|Overall Study|Withdrawal by Subject|0|||
48431308|NCT02488759|155765364|FG005|Overall Study|Withdrawal by Subject|2|||
48431309|NCT02488759|155765359|FG000|Overall Study|Lost to Follow-up|0|||
48431310|NCT02488759|155765360|FG001|Overall Study|Lost to Follow-up|0|||
48431311|NCT02488759|155765361|FG002|Overall Study|Lost to Follow-up|2|||
48431312|NCT02488759|155765362|FG003|Overall Study|Lost to Follow-up|0|||
48431313|NCT02488759|155765363|FG004|Overall Study|Lost to Follow-up|0|||
48431314|NCT02488759|155765364|FG005|Overall Study|Lost to Follow-up|0|||
48431315|NCT02488759|155765359|FG000|Overall Study|Maximum clinical benefit|3|||
48431316|NCT02488759|155765360|FG001|Overall Study|Maximum clinical benefit|0|||
48431317|NCT02488759|155765361|FG002|Overall Study|Maximum clinical benefit|1|||
48431318|NCT02488759|155765362|FG003|Overall Study|Maximum clinical benefit|0|||
48431319|NCT02488759|155765363|FG004|Overall Study|Maximum clinical benefit|0|||
48431320|NCT02488759|155765364|FG005|Overall Study|Maximum clinical benefit|0|||
48431321|NCT02488759|155765359|FG000|Overall Study|Other reasons|7|||
48431322|NCT02488759|155765360|FG001|Overall Study|Other reasons|32|||
48431323|NCT02488759|155765361|FG002|Overall Study|Other reasons|23|||
48431324|NCT02488759|155765362|FG003|Overall Study|Other reasons|1|||
48431325|NCT02488759|155765363|FG004|Overall Study|Other reasons|1|||
48431326|NCT02488759|155765364|FG005|Overall Study|Other reasons|1|||
48431327|NCT01921257|155765365|FG000|Overall Study|Adverse Event|1|||
48431328|NCT01921257|155765365|FG000|Overall Study|Protocol Violation|1|||
48431329|NCT01921257|155765365|FG000|Overall Study|Withdrawal by Subject|1|||
48431330|NCT02531035|155767233|FG000|Overall Study|Death|0|||
48431331|NCT02531035|155767234|FG001|Overall Study|Death|1|||
48431332|NCT02531035|155767233|FG000|Overall Study|Protocol Violation|1|||
48431333|NCT02531035|155767234|FG001|Overall Study|Protocol Violation|1|||
48431334|NCT02531035|155767233|FG000|Overall Study|Noncompliance with study drug|8|||
48431335|NCT02531035|155767234|FG001|Overall Study|Noncompliance with study drug|3|||
48431336|NCT02531035|155767233|FG000|Overall Study|Physician Decision|1|||
48431337|NCT02531035|155767234|FG001|Overall Study|Physician Decision|0|||
48431338|NCT02531035|155767233|FG000|Overall Study|Adverse Event|16|||
48431339|NCT02531035|155767234|FG001|Overall Study|Adverse Event|45|||
48431340|NCT02531035|155767233|FG000|Overall Study|Other|3|||
48431341|NCT02531035|155767234|FG001|Overall Study|Other|2|||
48431342|NCT02531035|155767233|FG000|Overall Study|Withdrawal by Subject|42|||
48431343|NCT02531035|155767234|FG001|Overall Study|Withdrawal by Subject|32|||
48431344|NCT02531035|155767233|FG000|Overall Study|Lost to Follow-up|8|||
48431345|NCT02531035|155767234|FG001|Overall Study|Lost to Follow-up|10|||
48431346|NCT02531035|155767233|FG000|Overall Study|Randomized, not treated|2|||
48431347|NCT02531035|155767234|FG001|Overall Study|Randomized, not treated|1|||
48431348|NCT01989546|155767239|FG000|Overall Study|Clinical Progression|1|||
48431349|NCT01989546|155767239|FG000|Overall Study|Disease progression on study|8|||
48431350|NCT03123354|155767242|FG000|Overall Study|Physician Decision|6|||
48431351|NCT03622593|155767243|FG000|Overall Study|Withdrawal by Subject|11|||
48431352|NCT03622593|155767244|FG001|Overall Study|Withdrawal by Subject|9|||
48431353|NCT03622593|155767245|FG002|Overall Study|Withdrawal by Subject|13|||
48431354|NCT03622593|155767243|FG000|Overall Study|Death|12|||
48431355|NCT03622593|155767244|FG001|Overall Study|Death|9|||
48431356|NCT03622593|155767245|FG002|Overall Study|Death|10|||
48431357|NCT03622593|155767243|FG000|Overall Study|Lost to Follow-up|11|||
48431358|NCT03622593|155767244|FG001|Overall Study|Lost to Follow-up|5|||
48431359|NCT03622593|155767245|FG002|Overall Study|Lost to Follow-up|8|||
48431360|NCT03622593|155767243|FG000|Overall Study|Adverse Event|4|||
48431361|NCT03622593|155767244|FG001|Overall Study|Adverse Event|5|||
48431362|NCT03622593|155767245|FG002|Overall Study|Adverse Event|6|||
48431363|NCT03622593|155767243|FG000|Overall Study|Physician Decision|2|||
48431364|NCT03622593|155767244|FG001|Overall Study|Physician Decision|1|||
48431365|NCT03622593|155767245|FG002|Overall Study|Physician Decision|6|||
48431366|NCT03622593|155767243|FG000|Overall Study|Other|2|||
48431367|NCT03622593|155767244|FG001|Overall Study|Other|2|||
48431368|NCT03622593|155767245|FG002|Overall Study|Other|3|||
48431369|NCT03622593|155767243|FG000|Overall Study|Protocol Violation|0|||
48431370|NCT03622593|155767244|FG001|Overall Study|Protocol Violation|0|||
48431371|NCT03622593|155767245|FG002|Overall Study|Protocol Violation|1|||
48431372|NCT03622593|155767243|FG000|Overall Study|Pregnancy|0|||
48431373|NCT03622593|155767244|FG001|Overall Study|Pregnancy|0|||
48431374|NCT03622593|155767245|FG002|Overall Study|Pregnancy|1|||
48431375|NCT01675531|155767246|FG000|Overall Study|Adverse Event|9|||
48431376|NCT01675531|155767246|FG000|Overall Study|Withdrawal by Subject|7|||
48431377|NCT01675531|155767246|FG000|Overall Study|Lack of Efficacy|1|||
48431378|NCT01675531|155767246|FG000|Overall Study|Protocol Violation|8|||
48431379|NCT01839188|155767250|FG000|Overall Study|Withdrawal by Subject|1|||
48431380|NCT03885726|155767251|FG000|Overall Study|Staffing issues/lost interest|1|||
48431381|NCT03885726|155767251|FG000|Overall Study|Early discharge from hospital|3|||
48431382|NCT00532883|155767253|FG000|Overall Study|Adverse Event|1|||
48431383|NCT00532883|155767254|FG001|Overall Study|Adverse Event|0|||
48431384|NCT00532883|155767255|FG002|Overall Study|Adverse Event|0|||
48431385|NCT00532883|155767256|FG003|Overall Study|Adverse Event|1|||
48431386|NCT00532883|155767253|FG000|Overall Study|Lost to Follow-up|1|||
48431387|NCT00532883|155767254|FG001|Overall Study|Lost to Follow-up|1|||
48431388|NCT00532883|155767255|FG002|Overall Study|Lost to Follow-up|1|||
48431389|NCT00532883|155767256|FG003|Overall Study|Lost to Follow-up|0|||
48431390|NCT00532883|155767253|FG000|Overall Study|Withdrawal by Subject|0|||
48431391|NCT00532883|155767254|FG001|Overall Study|Withdrawal by Subject|1|||
48431392|NCT00532883|155767255|FG002|Overall Study|Withdrawal by Subject|1|||
48431393|NCT00532883|155767256|FG003|Overall Study|Withdrawal by Subject|0|||
48431394|NCT00532883|155767253|FG000|Overall Study|Subject was Nonadherent|0|||
48431395|NCT00532883|155767254|FG001|Overall Study|Subject was Nonadherent|1|||
48431396|NCT00532883|155767255|FG002|Overall Study|Subject was Nonadherent|1|||
48431397|NCT00532883|155767256|FG003|Overall Study|Subject was Nonadherent|0|||
48431398|NCT00532883|155767253|FG000|Overall Study|Early Study Termination|4|||
48431399|NCT00532883|155767254|FG001|Overall Study|Early Study Termination|4|||
48431400|NCT00532883|155767255|FG002|Overall Study|Early Study Termination|1|||
48431401|NCT00532883|155767256|FG003|Overall Study|Early Study Termination|4|||
48431402|NCT02184143|155767257|FG000|Overall Study|Withdrawal by Subject|4|||
48431403|NCT02184143|155767258|FG001|Overall Study|Withdrawal by Subject|4|||
48431404|NCT02184143|155767257|FG000|Overall Study|Lost to Follow-up|5|||
48431405|NCT02184143|155767258|FG001|Overall Study|Lost to Follow-up|3|||
48431406|NCT02184143|155767257|FG000|Overall Study|Death|1|||
48431407|NCT02184143|155767258|FG001|Overall Study|Death|0|||
48431408|NCT02985450|155767263|FG000|Overall Study|Lost to Follow-up|7|||
48431409|NCT00002663|155767264|FG000|Overall Study|Death|4|||
48431410|NCT00002663|155767265|FG001|Overall Study|Death|1|||
48431411|NCT00002663|155767266|FG002|Overall Study|Death|1|||
48431412|NCT00002663|155767267|FG003|Overall Study|Death|0|||
48431413|NCT00002663|155767268|FG004|Overall Study|Death|0|||
48431414|NCT00002663|155767269|FG005|Overall Study|Death|13|||
48431415|NCT00002663|155767270|FG006|Overall Study|Death|0|||
48431416|NCT00002663|155767271|FG007|Overall Study|Death|1|||
48431417|NCT00002663|155767272|FG008|Overall Study|Death|1|||
48431418|NCT00002663|155767273|FG009|Overall Study|Death|1|||
48431419|NCT00002663|155767264|FG000|Overall Study|Lost to Follow-up|3|||
48431420|NCT00002663|155767265|FG001|Overall Study|Lost to Follow-up|0|||
48431421|NCT00002663|155767266|FG002|Overall Study|Lost to Follow-up|0|||
48431422|NCT00002663|155767267|FG003|Overall Study|Lost to Follow-up|1|||
48431423|NCT00002663|155767268|FG004|Overall Study|Lost to Follow-up|0|||
48431424|NCT00002663|155767269|FG005|Overall Study|Lost to Follow-up|1|||
48431425|NCT00002663|155767270|FG006|Overall Study|Lost to Follow-up|0|||
48431426|NCT00002663|155767271|FG007|Overall Study|Lost to Follow-up|0|||
48431427|NCT00002663|155767272|FG008|Overall Study|Lost to Follow-up|0|||
48431428|NCT00002663|155767273|FG009|Overall Study|Lost to Follow-up|0|||
48431429|NCT00002663|155767264|FG000|Overall Study|Other|0|||
48431430|NCT00002663|155767265|FG001|Overall Study|Other|1|||
48431431|NCT00002663|155767266|FG002|Overall Study|Other|0|||
48431459|NCT00905307|155767274|FG000|Overall Study|Switched to Open Label Rescue|7|||
48431460|NCT00905307|155767275|FG001|Overall Study|Switched to Open Label Rescue|17|||
48431461|NCT00905307|155767276|FG002|Overall Study|Switched to Open Label Rescue|11|||
48431462|NCT00905307|155767277|FG003|Overall Study|Switched to Open Label Rescue|11|||
48431463|NCT00905307|155767278|FG004|Overall Study|Switched to Open Label Rescue|4|||
48431464|NCT00905307|155767279|FG005|Overall Study|Switched to Open Label Rescue|15|||
48431465|NCT00905307|155767274|FG000|Overall Study|Lost to Follow-up|0|||
48431466|NCT00905307|155767275|FG001|Overall Study|Lost to Follow-up|0|||
48431467|NCT00905307|155767276|FG002|Overall Study|Lost to Follow-up|0|||
48431468|NCT00905307|155767277|FG003|Overall Study|Lost to Follow-up|0|||
48431469|NCT00905307|155767278|FG004|Overall Study|Lost to Follow-up|1|||
48431470|NCT00905307|155767279|FG005|Overall Study|Lost to Follow-up|1|||
48431471|NCT00905307|155767274|FG000|Overall Study|Adverse Event|3|||
48431472|NCT00905307|155767275|FG001|Overall Study|Adverse Event|4|||
48431473|NCT00905307|155767276|FG002|Overall Study|Adverse Event|5|||
48431474|NCT00905307|155767277|FG003|Overall Study|Adverse Event|11|||
48431475|NCT00905307|155767278|FG004|Overall Study|Adverse Event|3|||
48431476|NCT00905307|155767279|FG005|Overall Study|Adverse Event|5|||
48431477|NCT00905307|155767274|FG000|Overall Study|Withdrawal by Subject|5|||
48431478|NCT00905307|155767275|FG001|Overall Study|Withdrawal by Subject|13|||
48431479|NCT00905307|155767276|FG002|Overall Study|Withdrawal by Subject|15|||
48431480|NCT00905307|155767277|FG003|Overall Study|Withdrawal by Subject|11|||
48431481|NCT00905307|155767278|FG004|Overall Study|Withdrawal by Subject|4|||
48431482|NCT00905307|155767279|FG005|Overall Study|Withdrawal by Subject|13|||
48431483|NCT00905307|155767274|FG000|Overall Study|Protocol Violation|1|||
48431484|NCT00905307|155767275|FG001|Overall Study|Protocol Violation|0|||
48431485|NCT00905307|155767276|FG002|Overall Study|Protocol Violation|1|||
48431486|NCT00905307|155767277|FG003|Overall Study|Protocol Violation|0|||
48431487|NCT00905307|155767278|FG004|Overall Study|Protocol Violation|0|||
48431488|NCT00905307|155767279|FG005|Overall Study|Protocol Violation|0|||
48431489|NCT00905307|155767274|FG000|Overall Study|Lack of Efficacy|6|||
48431490|NCT00905307|155767275|FG001|Overall Study|Lack of Efficacy|3|||
48431491|NCT00905307|155767276|FG002|Overall Study|Lack of Efficacy|5|||
48431492|NCT00905307|155767277|FG003|Overall Study|Lack of Efficacy|4|||
48431493|NCT00905307|155767278|FG004|Overall Study|Lack of Efficacy|4|||
48431494|NCT00905307|155767279|FG005|Overall Study|Lack of Efficacy|8|||
48431495|NCT02142894|155767280|FG000|Overall Study|Protocol Violation|8|||
48431496|NCT03161678|155767284|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
48431497|NCT03161678|155767285|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
48431498|NCT03161678|155767286|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48431499|NCT03161678|155767287|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
48431500|NCT03161678|155767288|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
48431501|NCT03161678|155767289|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
48431502|NCT03161678|155767284|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
48431503|NCT03161678|155767285|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
48431504|NCT03161678|155767286|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
48431505|NCT03161678|155767287|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
48431506|NCT03161678|155767288|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
48431507|NCT03161678|155767289|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
48431508|NCT03161678|155767284|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
48431509|NCT03161678|155767285|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
48431510|NCT03161678|155767286|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
48431511|NCT03161678|155767287|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
48431512|NCT03161678|155767288|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
48431513|NCT03161678|155767289|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
48431514|NCT03161678|155767284|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48431515|NCT03161678|155767285|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48431516|NCT03161678|155767286|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48431517|NCT03161678|155767287|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
48431518|NCT03161678|155767288|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48431519|NCT03161678|155767289|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
48431520|NCT03633227|155767292|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
48431521|NCT03633227|155767293|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
48431522|NCT03633227|155767292|FG000|Double Blind (DB), up to Week 48|Death|2|||
48431523|NCT03633227|155767293|FG001|Double Blind (DB), up to Week 48|Death|1|||
48431524|NCT03633227|155767292|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
48431525|NCT03633227|155767293|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
48431526|NCT03633227|155767292|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
48431527|NCT03633227|155767293|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
48431528|NCT03633227|155767292|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
48431529|NCT03633227|155767293|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
48431530|NCT03633227|155767292|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
48431531|NCT03633227|155767293|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
48431611|NCT01721408|155767330|FG000|Overall Study|Insufficient clinical response|15|||
48431532|NCT03633227|155767292|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
48431533|NCT03633227|155767293|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
48431534|NCT03633227|155767292|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
48431535|NCT03633227|155767293|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
48431536|NCT03633227|155767292|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
48431537|NCT03633227|155767293|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
48431538|NCT03633227|155767292|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
48431539|NCT03633227|155767293|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
48431540|NCT03633227|155767292|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
48431541|NCT03633227|155767293|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
48431542|NCT03633227|155767292|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
48431543|NCT03633227|155767293|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
48431544|NCT01425190|155767294|FG000|Overall Study|Full dose not consumed.|1|||
48431545|NCT01425190|155767295|FG001|Overall Study|Full dose not consumed.|0|||
48431546|NCT01425190|155767296|FG002|Overall Study|Full dose not consumed.|0|||
48431547|NCT05460871|155767297|FG000|Overall Study|Withdrawal by Subject|1|||
48431548|NCT05460871|155767298|FG001|Overall Study|Withdrawal by Subject|2|||
48431549|NCT01035255|155767299|FG000|Overall Study|Death|724|||
48431550|NCT01035255|155767300|FG001|Overall Study|Death|844|||
48431551|NCT01035255|155767299|FG000|Overall Study|Lost to Follow-up|2|||
48431552|NCT01035255|155767300|FG001|Overall Study|Lost to Follow-up|5|||
48431553|NCT01035255|155767299|FG000|Overall Study|patient's request|15|||
48431554|NCT01035255|155767300|FG001|Overall Study|patient's request|13|||
48431555|NCT01100307|155767301|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
48431556|NCT01100307|155767302|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
48431557|NCT01100307|155767301|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
48431558|NCT01100307|155767302|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
48431559|NCT01100307|155767301|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
48431560|NCT01100307|155767302|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
48431561|NCT01100307|155767301|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
48431562|NCT01100307|155767302|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
48431563|NCT01100307|155767301|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
48431564|NCT01100307|155767302|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
48431565|NCT01100307|155767301|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
48431566|NCT01100307|155767302|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
48431567|NCT00740779|155767303|FG000|Overall Study|Adverse Event|4|||
48431568|NCT00740779|155767304|FG001|Overall Study|Adverse Event|6|||
48431569|NCT00740779|155767305|FG002|Overall Study|Adverse Event|3|||
48431570|NCT00740779|155767303|FG000|Overall Study|Protocol Violation|1|||
48431571|NCT00740779|155767304|FG001|Overall Study|Protocol Violation|1|||
48431572|NCT00740779|155767305|FG002|Overall Study|Protocol Violation|1|||
48431573|NCT00740779|155767303|FG000|Overall Study|Lack of Efficacy|0|||
48431574|NCT00740779|155767304|FG001|Overall Study|Lack of Efficacy|0|||
48431575|NCT00740779|155767305|FG002|Overall Study|Lack of Efficacy|2|||
48431576|NCT00740779|155767303|FG000|Overall Study|Withdrawal by Subject|2|||
48431577|NCT00740779|155767304|FG001|Overall Study|Withdrawal by Subject|4|||
48431578|NCT00740779|155767305|FG002|Overall Study|Withdrawal by Subject|2|||
48431579|NCT00740779|155767303|FG000|Overall Study|Lost to Follow-up|2|||
48431580|NCT00740779|155767304|FG001|Overall Study|Lost to Follow-up|3|||
48431581|NCT00740779|155767305|FG002|Overall Study|Lost to Follow-up|5|||
48431582|NCT01477892|155767306|FG000|Overall Study|Withdrawal by Subject|0|||
48431583|NCT01477892|155767307|FG001|Overall Study|Withdrawal by Subject|2|||
48431584|NCT03375112|155767315|FG000|Overall Study|Withdrawal by Subject|3|||
48431585|NCT03375112|155767316|FG001|Overall Study|Withdrawal by Subject|0|||
48431586|NCT02566525|155767317|FG000|Overall Study|Protocol Violation|3|||
48431587|NCT02566525|155767318|FG001|Overall Study|Protocol Violation|5|||
48587224|NCT01004432|156343155|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
48587225|NCT01004432|156343156|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
48431590|NCT05836818|155767325|FG000|Overall Study|Physician Decision|1|||
48431591|NCT05836818|155767326|FG001|Overall Study|Physician Decision|1|||
48431592|NCT05836818|155767327|FG002|Overall Study|Physician Decision|0|||
48431593|NCT05836818|155767325|FG000|Overall Study|Withdrawal by Subject|0|||
48431594|NCT05836818|155767326|FG001|Overall Study|Withdrawal by Subject|0|||
48431595|NCT05836818|155767327|FG002|Overall Study|Withdrawal by Subject|1|||
48431596|NCT05836818|155767325|FG000|Overall Study|Later found to be previously vaccinated|0|||
48431597|NCT05836818|155767326|FG001|Overall Study|Later found to be previously vaccinated|1|||
48431598|NCT05836818|155767327|FG002|Overall Study|Later found to be previously vaccinated|3|||
48431599|NCT05836818|155767325|FG000|Overall Study|Pregnancy|0|||
48431600|NCT05836818|155767326|FG001|Overall Study|Pregnancy|1|||
48431601|NCT05836818|155767327|FG002|Overall Study|Pregnancy|0|||
48431602|NCT05836818|155767325|FG000|Overall Study|Allergic to vaccines|0|||
48431603|NCT05836818|155767326|FG001|Overall Study|Allergic to vaccines|1|||
48431604|NCT05836818|155767327|FG002|Overall Study|Allergic to vaccines|0|||
48431612|NCT01721408|155767331|FG001|Overall Study|Insufficient clinical response|6|||
48431613|NCT01721408|155767330|FG000|Overall Study|No longer willing to participate study|9|||
48431614|NCT01721408|155767331|FG001|Overall Study|No longer willing to participate study|10|||
48431615|NCT01721408|155767330|FG000|Overall Study|Protocol Violation|0|||
48431616|NCT01721408|155767331|FG001|Overall Study|Protocol Violation|2|||
48431617|NCT01721408|155767330|FG000|Overall Study|Other|3|||
48431618|NCT01721408|155767331|FG001|Overall Study|Other|3|||
48431619|NCT01721408|155767330|FG000|Overall Study|Lost to Follow-up|1|||
48431620|NCT01721408|155767331|FG001|Overall Study|Lost to Follow-up|2|||
48431621|NCT01721408|155767330|FG000|Overall Study|Does not meet entrance criteria|1|||
48431622|NCT01721408|155767331|FG001|Overall Study|Does not meet entrance criteria|0|||
48431623|NCT03136185|155767335|FG000|Overall Study|Adverse Event|0|||
48431624|NCT03136185|155767336|FG001|Overall Study|Adverse Event|1|||
48431625|NCT03136185|155767337|FG002|Overall Study|Adverse Event|3|||
48431626|NCT03136185|155767338|FG003|Overall Study|Adverse Event|1|||
48431627|NCT03136185|155767339|FG004|Overall Study|Adverse Event|2|||
48431628|NCT03136185|155767340|FG005|Overall Study|Adverse Event|2|||
48431629|NCT03136185|155767341|FG006|Overall Study|Adverse Event|5|||
48431630|NCT03136185|155767342|FG007|Overall Study|Adverse Event|1|||
48431631|NCT03136185|155767343|FG008|Overall Study|Adverse Event|1|||
48431632|NCT03136185|155767335|FG000|Overall Study|Death|0|||
48431633|NCT03136185|155767336|FG001|Overall Study|Death|0|||
48431634|NCT03136185|155767337|FG002|Overall Study|Death|0|||
48431635|NCT03136185|155767338|FG003|Overall Study|Death|1|||
48431636|NCT03136185|155767339|FG004|Overall Study|Death|1|||
48431637|NCT03136185|155767340|FG005|Overall Study|Death|0|||
48431638|NCT03136185|155767341|FG006|Overall Study|Death|1|||
48431639|NCT03136185|155767342|FG007|Overall Study|Death|0|||
48431640|NCT03136185|155767343|FG008|Overall Study|Death|0|||
48431641|NCT03136185|155767335|FG000|Overall Study|Physician Decision|3|||
48431642|NCT03136185|155767336|FG001|Overall Study|Physician Decision|1|||
48431643|NCT03136185|155767337|FG002|Overall Study|Physician Decision|1|||
48431644|NCT03136185|155767338|FG003|Overall Study|Physician Decision|2|||
48431645|NCT03136185|155767339|FG004|Overall Study|Physician Decision|1|||
48431646|NCT03136185|155767340|FG005|Overall Study|Physician Decision|2|||
48431647|NCT03136185|155767341|FG006|Overall Study|Physician Decision|1|||
48431648|NCT03136185|155767342|FG007|Overall Study|Physician Decision|0|||
48431649|NCT03136185|155767343|FG008|Overall Study|Physician Decision|1|||
48431650|NCT03136185|155767335|FG000|Overall Study|Protocol Defined Disease Progression|0|||
48431651|NCT03136185|155767336|FG001|Overall Study|Protocol Defined Disease Progression|0|||
48431652|NCT03136185|155767337|FG002|Overall Study|Protocol Defined Disease Progression|1|||
48431653|NCT03136185|155767338|FG003|Overall Study|Protocol Defined Disease Progression|0|||
48431654|NCT03136185|155767339|FG004|Overall Study|Protocol Defined Disease Progression|0|||
48431655|NCT03136185|155767340|FG005|Overall Study|Protocol Defined Disease Progression|1|||
48431656|NCT03136185|155767341|FG006|Overall Study|Protocol Defined Disease Progression|0|||
48431657|NCT03136185|155767342|FG007|Overall Study|Protocol Defined Disease Progression|1|||
48431658|NCT03136185|155767343|FG008|Overall Study|Protocol Defined Disease Progression|1|||
48431659|NCT03136185|155767335|FG000|Overall Study|Withdrawal by Subject|1|||
48431660|NCT03136185|155767336|FG001|Overall Study|Withdrawal by Subject|0|||
48431661|NCT03136185|155767337|FG002|Overall Study|Withdrawal by Subject|1|||
48431662|NCT03136185|155767338|FG003|Overall Study|Withdrawal by Subject|1|||
48431663|NCT03136185|155767339|FG004|Overall Study|Withdrawal by Subject|1|||
48431664|NCT03136185|155767340|FG005|Overall Study|Withdrawal by Subject|1|||
48431665|NCT03136185|155767341|FG006|Overall Study|Withdrawal by Subject|2|||
48431666|NCT03136185|155767342|FG007|Overall Study|Withdrawal by Subject|3|||
48431667|NCT03136185|155767343|FG008|Overall Study|Withdrawal by Subject|3|||
48431668|NCT03136185|155767335|FG000|Overall Study|Not Reported|4|||
48431669|NCT03136185|155767336|FG001|Overall Study|Not Reported|1|||
48431670|NCT03136185|155767337|FG002|Overall Study|Not Reported|0|||
48431671|NCT03136185|155767338|FG003|Overall Study|Not Reported|1|||
48431672|NCT03136185|155767339|FG004|Overall Study|Not Reported|0|||
48431673|NCT03136185|155767340|FG005|Overall Study|Not Reported|2|||
48431674|NCT03136185|155767341|FG006|Overall Study|Not Reported|1|||
48431675|NCT03136185|155767342|FG007|Overall Study|Not Reported|1|||
48431676|NCT03136185|155767343|FG008|Overall Study|Not Reported|0|||
48431677|NCT00337467|155767344|FG000|Overall Study|Adverse Event|3|||
48431678|NCT00337467|155767344|FG000|Overall Study|Subject Withdrew Consent|2|||
48431679|NCT00337467|155767344|FG000|Overall Study|Pregnancy|1|||
48431680|NCT00337467|155767344|FG000|Overall Study|Lost to Follow-up|2|||
48431681|NCT00337467|155767344|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
48431682|NCT02491073|155767351|FG000|Overall Study|screen failure|1|||
48431683|NCT02491073|155767352|FG001|Overall Study|screen failure|0|||
48431684|NCT01165021|155767353|FG000|Overall Study|Death|1|||
48431685|NCT05515601|155767357|FG000|Overall Study|Withdrawal by Subject|1|||
48431686|NCT05515601|155767358|FG001|Overall Study|Withdrawal by Subject|3|||
48431687|NCT05515601|155767359|FG002|Overall Study|Withdrawal by Subject|2|||
48431688|NCT05515601|155767360|FG003|Overall Study|Withdrawal by Subject|1|||
48431689|NCT05515601|155767361|FG004|Overall Study|Withdrawal by Subject|1|||
48431690|NCT05515601|155767362|FG005|Overall Study|Withdrawal by Subject|1|||
48431691|NCT05515601|155767357|FG000|Overall Study|Lost to Follow-up|0|||
48431692|NCT05515601|155767358|FG001|Overall Study|Lost to Follow-up|0|||
48431693|NCT05515601|155767359|FG002|Overall Study|Lost to Follow-up|0|||
48431694|NCT05515601|155767360|FG003|Overall Study|Lost to Follow-up|0|||
48431695|NCT05515601|155767361|FG004|Overall Study|Lost to Follow-up|1|||
48431696|NCT05515601|155767362|FG005|Overall Study|Lost to Follow-up|0|||
48431697|NCT00777491|155767363|FG000|Overall Study|Protocol Violation|0|||
48431698|NCT00777491|155767364|FG001|Overall Study|Protocol Violation|2|||
48431699|NCT00777491|155767363|FG000|Overall Study|Did not receive any protocol treatment|2|||
48431700|NCT00777491|155767364|FG001|Overall Study|Did not receive any protocol treatment|0|||
48431701|NCT01419665|155767365|FG000|Combination Treatment|Adverse Event|7|||
48431702|NCT01419665|155767366|FG001|Combination Treatment|Adverse Event|10|||
48431703|NCT01419665|155767365|FG000|Combination Treatment|Physician Decision|5|||
48431704|NCT01419665|155767366|FG001|Combination Treatment|Physician Decision|8|||
48431705|NCT01419665|155767365|FG000|Combination Treatment|Protocol Violation|6|||
48431706|NCT01419665|155767366|FG001|Combination Treatment|Protocol Violation|2|||
48431707|NCT01419665|155767365|FG000|Combination Treatment|disease progression|10|||
48431708|NCT01419665|155767366|FG001|Combination Treatment|disease progression|9|||
48431709|NCT01419665|155767365|FG000|Combination Treatment|Death|5|||
48431710|NCT01419665|155767366|FG001|Combination Treatment|Death|7|||
48431711|NCT01419665|155767365|FG000|Combination Treatment|administrative problems|0|||
48431712|NCT01419665|155767366|FG001|Combination Treatment|administrative problems|1|||
48431713|NCT01419665|155767365|FG000|Combination Treatment|Withdrawal by Subject|5|||
48431714|NCT01419665|155767366|FG001|Combination Treatment|Withdrawal by Subject|4|||
48431715|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
48431716|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
48431717|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
48431718|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
48431719|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
48431720|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
48431721|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
48431722|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
48431723|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
48431724|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
48431725|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
48431726|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
48431727|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|Death|1|||
48431728|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|Death|2|||
48431729|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
48431730|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
48431731|NCT01419665|155767365|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
48431732|NCT01419665|155767366|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
48431733|NCT01419665|155767365|FG000|Open Label Phase|Death|1|||
48431734|NCT01419665|155767366|FG001|Open Label Phase|Death|0|||
48431735|NCT01419665|155767365|FG000|Open Label Phase|disease progression|0|||
48431736|NCT01419665|155767366|FG001|Open Label Phase|disease progression|1|||
48431737|NCT04095286|155767367|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431738|NCT04095286|155767368|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
48431739|NCT04095286|155767369|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431740|NCT04095286|155767370|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431741|NCT04095286|155767371|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431742|NCT04095286|155767372|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431743|NCT04095286|155767367|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
48431744|NCT04095286|155767368|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48431745|NCT04095286|155767369|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48431746|NCT04095286|155767370|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48431747|NCT04095286|155767371|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48431748|NCT04095286|155767372|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
48431749|NCT04095286|155767367|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48431750|NCT04095286|155767368|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48431751|NCT04095286|155767369|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
48431752|NCT04095286|155767370|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48431753|NCT04095286|155767371|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48431754|NCT04095286|155767372|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
48431755|NCT04095286|155767367|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431756|NCT04095286|155767368|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431757|NCT04095286|155767369|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
48431758|NCT04095286|155767370|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431759|NCT04095286|155767371|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431760|NCT04095286|155767372|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
48431761|NCT04095286|155767367|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48431762|NCT04095286|155767368|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48431763|NCT04095286|155767369|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48431764|NCT04095286|155767370|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48431765|NCT04095286|155767371|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
48431766|NCT04095286|155767372|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
48431767|NCT00610935|155767373|FG000|Overall Study|Lost to Follow-up|0|||
48431768|NCT00610935|155767374|FG001|Overall Study|Lost to Follow-up|1|||
48431769|NCT00610935|155767373|FG000|Overall Study|Withdrawal by Subject|0|||
48431770|NCT00610935|155767374|FG001|Overall Study|Withdrawal by Subject|2|||
48431771|NCT00610935|155767373|FG000|Overall Study|Sponsor Discontinuation|1|||
48431772|NCT00610935|155767374|FG001|Overall Study|Sponsor Discontinuation|0|||
48431773|NCT00488618|155767376|FG000|Overall Study|Adverse Event|13|||
48431774|NCT00488618|155767377|FG001|Overall Study|Adverse Event|17|||
48431775|NCT00488618|155767376|FG000|Overall Study|Insufficient Therapeutic Response|18|||
48431776|NCT00488618|155767377|FG001|Overall Study|Insufficient Therapeutic Response|11|||
48431777|NCT00488618|155767376|FG000|Overall Study|Protocol Violation|0|||
48431778|NCT00488618|155767377|FG001|Overall Study|Protocol Violation|2|||
48431779|NCT00488618|155767376|FG000|Overall Study|Withdrawal of Consent|15|||
48431780|NCT00488618|155767377|FG001|Overall Study|Withdrawal of Consent|13|||
48431781|NCT00488618|155767376|FG000|Overall Study|Lost to Follow-up|1|||
48431782|NCT00488618|155767377|FG001|Overall Study|Lost to Follow-up|0|||
48431783|NCT01689207|155767378|FG000|Overall Study|Adverse Event|0|||
48431784|NCT01689207|155767379|FG001|Overall Study|Adverse Event|1|||
48431785|NCT01689207|155767380|FG002|Overall Study|Adverse Event|0|||
48431786|NCT01689207|155767381|FG003|Overall Study|Adverse Event|0|||
48431787|NCT01689207|155767382|FG004|Overall Study|Adverse Event|2|||
48431788|NCT01689207|155767383|FG005|Overall Study|Adverse Event|1|||
48431789|NCT01689207|155767384|FG006|Overall Study|Adverse Event|0|||
48431790|NCT01689207|155767385|FG007|Overall Study|Adverse Event|0|||
48431791|NCT01689207|155767386|FG008|Overall Study|Adverse Event|1|||
48431792|NCT01689207|155767387|FG009|Overall Study|Adverse Event|0|||
48431793|NCT01689207|155767388|FG010|Overall Study|Adverse Event|0|||
48431794|NCT00408421|155768942|FG000|Treatment Initial Randomization|Adverse Event|5|||
48431795|NCT00408421|155768943|FG001|Treatment Initial Randomization|Adverse Event|9|||
48431796|NCT00408421|155768944|FG002|Treatment Initial Randomization|Adverse Event|0|||
48431797|NCT00408421|155768942|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
48431798|NCT00408421|155768943|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
48431799|NCT00408421|155768944|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
48431800|NCT00408421|155768942|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
48431801|NCT00408421|155768943|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
48431802|NCT00408421|155768944|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
48431803|NCT00408421|155768942|FG000|Treatment Initial Randomization|Physician Decision|1|||
48431804|NCT00408421|155768943|FG001|Treatment Initial Randomization|Physician Decision|0|||
48431805|NCT00408421|155768944|FG002|Treatment Initial Randomization|Physician Decision|0|||
48431806|NCT00408421|155768942|FG000|Treatment Initial Randomization|Protocol Violation|0|||
48431807|NCT00408421|155768943|FG001|Treatment Initial Randomization|Protocol Violation|1|||
48431808|NCT00408421|155768944|FG002|Treatment Initial Randomization|Protocol Violation|0|||
48431809|NCT00408421|155768942|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
48431810|NCT00408421|155768943|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
48431811|NCT00408421|155768944|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
48431812|NCT00408421|155768942|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
48431813|NCT00408421|155768943|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
48431814|NCT00408421|155768944|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
48431815|NCT00408421|155768942|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
48431816|NCT00408421|155768943|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
48431817|NCT00408421|155768944|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
48431818|NCT00408421|155768942|FG000|Treatment Re-Randomization|Adverse Event|2|||
48431819|NCT00408421|155768943|FG001|Treatment Re-Randomization|Adverse Event|2|||
48431820|NCT00408421|155768944|FG002|Treatment Re-Randomization|Adverse Event|4|||
48431821|NCT00408421|155768942|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
48431822|NCT00408421|155768943|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
48431823|NCT00408421|155768944|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
48431824|NCT00408421|155768942|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
48431825|NCT00408421|155768943|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
48431826|NCT00408421|155768944|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
48431827|NCT00408421|155768942|FG000|Treatment Re-Randomization|Physician Decision|1|||
48431828|NCT00408421|155768943|FG001|Treatment Re-Randomization|Physician Decision|3|||
48431829|NCT00408421|155768944|FG002|Treatment Re-Randomization|Physician Decision|0|||
48431830|NCT00408421|155768942|FG000|Treatment Re-Randomization|Protocol Violation|1|||
48431831|NCT00408421|155768943|FG001|Treatment Re-Randomization|Protocol Violation|1|||
48431832|NCT00408421|155768944|FG002|Treatment Re-Randomization|Protocol Violation|0|||
48431833|NCT00408421|155768942|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
48431834|NCT00408421|155768943|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
48431835|NCT00408421|155768944|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
48431836|NCT02322892|155768945|FG000|Overall Study|Surgery cancelled|1|||
48431837|NCT02322892|155768946|FG001|Overall Study|Surgery cancelled|2|||
48431838|NCT02322892|155768945|FG000|Overall Study|Met exclusion criteria|0|||
48431839|NCT02322892|155768946|FG001|Overall Study|Met exclusion criteria|1|||
48431840|NCT02322892|155768945|FG000|Overall Study|Protocol Violation|1|||
48431841|NCT02322892|155768946|FG001|Overall Study|Protocol Violation|0|||
48431842|NCT02626819|155768949|FG000|Overall Study|Lost to Follow-up|3|||
48431843|NCT02626819|155768950|FG001|Overall Study|Lost to Follow-up|2|||
48431844|NCT02626819|155768949|FG000|Overall Study|Withdrawal by Subject|1|||
48431845|NCT02626819|155768950|FG001|Overall Study|Withdrawal by Subject|0|||
48431846|NCT02626819|155768949|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
48431847|NCT02626819|155768950|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
48431848|NCT02340819|155768951|FG000|Overall Study|Adverse Event|1|||
48431849|NCT02340819|155768951|FG000|Overall Study|Withdrawal by Subject|2|||
48431850|NCT02340819|155768951|FG000|Overall Study|Discontinued with other reason|1|||
48431851|NCT02361762|155768952|FG000|Overall Study|Withdrawal by Subject|0|||
48431852|NCT02361762|155768953|FG001|Overall Study|Withdrawal by Subject|1|||
48431853|NCT02361762|155768952|FG000|Overall Study|Lost to Follow-up|0|||
48431854|NCT02361762|155768953|FG001|Overall Study|Lost to Follow-up|1|||
48431855|NCT03314519|155768954|FG000|Overall Study|Protocol Violation|3|||
48431856|NCT03314519|155768955|FG001|Overall Study|Protocol Violation|2|||
48431857|NCT00414310|155768956|FG000|Overall Study|Not treated|1|||
48431858|NCT00414310|155768957|FG001|Overall Study|Not treated|0|||
48431859|NCT03276936|155768958|FG000|Overall Study|Adverse Event|4|||
48431860|NCT03276936|155768959|FG001|Overall Study|Adverse Event|2|||
48431861|NCT03276936|155768958|FG000|Overall Study|Lost to Follow-up|16|||
48431862|NCT03276936|155768959|FG001|Overall Study|Lost to Follow-up|13|||
48431863|NCT03276936|155768958|FG000|Overall Study|Withdrawal by Subject|30|||
48431864|NCT03276936|155768959|FG001|Overall Study|Withdrawal by Subject|20|||
48431865|NCT03276936|155768958|FG000|Overall Study|Not mentioned|6|||
48431866|NCT03276936|155768959|FG001|Overall Study|Not mentioned|3|||
48431867|NCT01345123|155768960|FG000|Overall Study|participants no longer with health plan|79|||
48431868|NCT01345123|155768961|FG001|Overall Study|participants no longer with health plan|85|||
48431869|NCT01345123|155768962|FG002|Overall Study|participants no longer with health plan|88|||
48431870|NCT01675011|155768963|FG000|Overall Study|Trial terminated by Sponsor|3|||
48431871|NCT01675011|155768964|FG001|Overall Study|Trial terminated by Sponsor|1|||
48431872|NCT02245568|155768965|FG000|Overall Study|Study terminated by Sponsor|346|||
48431873|NCT02245568|155768965|FG000|Overall Study|Adverse Event|144|||
48431874|NCT02245568|155768965|FG000|Overall Study|Lack of Efficacy|98|||
48431875|NCT02245568|155768965|FG000|Overall Study|Withdrawal by Caregiver|85|||
48431876|NCT02245568|155768965|FG000|Overall Study|Withdrawal by Subject|77|||
48431877|NCT02245568|155768965|FG000|Overall Study|Withdrawal by Legal Representative|31|||
48431878|NCT02245568|155768965|FG000|Overall Study|Missing (Site closure)|16|||
48431879|NCT02245568|155768965|FG000|Overall Study|Physician Decision|14|||
48431880|NCT02245568|155768965|FG000|Overall Study|Non-compliance with study drug|11|||
48431881|NCT02245568|155768965|FG000|Overall Study|Death|9|||
48431882|NCT02245568|155768965|FG000|Overall Study|Blue staining|6|||
48431883|NCT02245568|155768965|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
48431884|NCT02245568|155768965|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
48431885|NCT02245568|155768965|FG000|Overall Study|Lost to Follow-up|5|||
48431886|NCT02849990|155768966|FG000|Overall Study|Adverse Event|1|||
48431887|NCT02849990|155768966|FG000|Overall Study|Withdrawal by Subject|1|||
48431888|NCT01252134|155768967|FG000|Period 1, 8 Hours|Personal Reasons|0|||
48431889|NCT01252134|155768968|FG001|Period 1, 8 Hours|Personal Reasons|1|||
48431890|NCT01252134|155768969|FG002|Period 1, 8 Hours|Personal Reasons|1|||
48431891|NCT01252134|155768970|FG003|Period 1, 8 Hours|Personal Reasons|0|||
48431892|NCT01252134|155768971|FG004|Period 1, 8 Hours|Personal Reasons|0|||
48431893|NCT01252134|155768972|FG005|Period 1, 8 Hours|Personal Reasons|0|||
48431894|NCT03650452|155768973|FG000|Overall Study|Physician Decision|1|||
48431895|NCT03650452|155768974|FG001|Overall Study|Physician Decision|0|||
48431896|NCT03650452|155768973|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
48431897|NCT03650452|155768974|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
48431898|NCT03650452|155768973|FG000|Overall Study|Adverse Event|3|||
48431899|NCT03650452|155768974|FG001|Overall Study|Adverse Event|4|||
48431900|NCT03650452|155768973|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
48431901|NCT03650452|155768974|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
48431902|NCT02044159|155768975|FG000|Overall Study|Consent declined (deferred consent)|2|||
48431903|NCT02044159|155768976|FG001|Overall Study|Consent declined (deferred consent)|4|||
48431904|NCT02044159|155768975|FG000|Overall Study|No longer eligible, drug not given|1|||
48431905|NCT02044159|155768976|FG001|Overall Study|No longer eligible, drug not given|0|||
48431906|NCT02044159|155768975|FG000|Overall Study|Nurse declined to give study drug|1|||
48431907|NCT02044159|155768976|FG001|Overall Study|Nurse declined to give study drug|0|||
48431908|NCT00972244|155768977|FG000|Overall Study|Incorrect Enrolment|1|||
48431909|NCT00972244|155768978|FG001|Overall Study|Incorrect Enrolment|0|||
48431910|NCT00972244|155768979|FG002|Overall Study|Incorrect Enrolment|0|||
48431911|NCT00972244|155768980|FG003|Overall Study|Incorrect Enrolment|0|||
48431912|NCT00972244|155768981|FG004|Overall Study|Incorrect Enrolment|0|||
48431913|NCT00972244|155768977|FG000|Overall Study|Adverse Event|0|||
48431914|NCT00972244|155768978|FG001|Overall Study|Adverse Event|1|||
48431915|NCT00972244|155768979|FG002|Overall Study|Adverse Event|1|||
48431916|NCT00972244|155768980|FG003|Overall Study|Adverse Event|0|||
48431917|NCT00972244|155768981|FG004|Overall Study|Adverse Event|0|||
48431918|NCT00972244|155768977|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
48431919|NCT00972244|155768978|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
48431920|NCT00972244|155768979|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
48431921|NCT00972244|155768980|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
48431922|NCT00972244|155768981|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
48431923|NCT00972244|155768977|FG000|Overall Study|Withdrawal by Subject|1|||
48431924|NCT00972244|155768978|FG001|Overall Study|Withdrawal by Subject|2|||
48431925|NCT00972244|155768979|FG002|Overall Study|Withdrawal by Subject|1|||
48431926|NCT00972244|155768980|FG003|Overall Study|Withdrawal by Subject|0|||
48431927|NCT00972244|155768981|FG004|Overall Study|Withdrawal by Subject|1|||
48431928|NCT00972244|155768977|FG000|Overall Study|Safety|0|||
48431929|NCT00972244|155768978|FG001|Overall Study|Safety|0|||
48431930|NCT00972244|155768979|FG002|Overall Study|Safety|0|||
48431931|NCT00972244|155768980|FG003|Overall Study|Safety|0|||
48431932|NCT00972244|155768981|FG004|Overall Study|Safety|1|||
48431933|NCT00972244|155768977|FG000|Overall Study|Death|1|||
48431934|NCT00972244|155768978|FG001|Overall Study|Death|0|||
48431935|NCT00972244|155768979|FG002|Overall Study|Death|0|||
48431936|NCT00972244|155768980|FG003|Overall Study|Death|0|||
48431937|NCT00972244|155768981|FG004|Overall Study|Death|0|||
48431938|NCT00972244|155768977|FG000|Overall Study|Various|0|||
48431939|NCT00972244|155768978|FG001|Overall Study|Various|0|||
48431940|NCT00972244|155768979|FG002|Overall Study|Various|0|||
48431941|NCT00972244|155768980|FG003|Overall Study|Various|0|||
48431942|NCT00972244|155768981|FG004|Overall Study|Various|2|||
48431943|NCT01258348|155768988|FG000|Overall Study|Adverse Event|1|||
48431944|NCT01258348|155768989|FG001|Overall Study|Adverse Event|1|||
48431945|NCT01258348|155768990|FG002|Overall Study|Adverse Event|3|||
48431946|NCT01258348|155768991|FG003|Overall Study|Adverse Event|2|||
48431947|NCT01258348|155768992|FG004|Overall Study|Adverse Event|4|||
48431948|NCT01258348|155768988|FG000|Overall Study|Progressive Disease|0|||
48431949|NCT01258348|155768989|FG001|Overall Study|Progressive Disease|3|||
48431950|NCT01258348|155768990|FG002|Overall Study|Progressive Disease|0|||
48431951|NCT01258348|155768991|FG003|Overall Study|Progressive Disease|2|||
48431952|NCT01258348|155768992|FG004|Overall Study|Progressive Disease|2|||
48431953|NCT01258348|155768988|FG000|Overall Study|Physician Decision|0|||
48431954|NCT01258348|155768989|FG001|Overall Study|Physician Decision|0|||
48431955|NCT01258348|155768990|FG002|Overall Study|Physician Decision|0|||
48431956|NCT01258348|155768991|FG003|Overall Study|Physician Decision|2|||
48431957|NCT01258348|155768992|FG004|Overall Study|Physician Decision|0|||
48431958|NCT01258348|155768988|FG000|Overall Study|Withdrawal by Subject|0|||
48431959|NCT01258348|155768989|FG001|Overall Study|Withdrawal by Subject|1|||
48431960|NCT01258348|155768990|FG002|Overall Study|Withdrawal by Subject|0|||
48431961|NCT01258348|155768991|FG003|Overall Study|Withdrawal by Subject|0|||
48431962|NCT01258348|155768992|FG004|Overall Study|Withdrawal by Subject|0|||
48431963|NCT04426825|155768993|FG000|Overall Study|Death|17|||
48431964|NCT04426825|155768993|FG000|Overall Study|Lost to Follow-up|1|||
48431965|NCT04426825|155768993|FG000|Overall Study|Study terminated by sponsor|5|||
48431966|NCT01763905|155769000|FG000|Overall Study|Withdrawal by Subject|1|||
48431967|NCT01763905|155769001|FG001|Overall Study|Withdrawal by Subject|1|||
48431968|NCT01763905|155769002|FG002|Overall Study|Withdrawal by Subject|0|||
48431969|NCT01763905|155769003|FG003|Overall Study|Withdrawal by Subject|1|||
48431970|NCT01763905|155769000|FG000|Overall Study|Decision by sponsor|5|||
48431971|NCT01763905|155769001|FG001|Overall Study|Decision by sponsor|0|||
48431972|NCT01763905|155769002|FG002|Overall Study|Decision by sponsor|8|||
48431973|NCT01763905|155769003|FG003|Overall Study|Decision by sponsor|0|||
48431974|NCT01763905|155769000|FG000|Overall Study|Lost to Follow-up|0|||
48431975|NCT01763905|155769001|FG001|Overall Study|Lost to Follow-up|0|||
48431976|NCT01763905|155769002|FG002|Overall Study|Lost to Follow-up|1|||
48431977|NCT01763905|155769003|FG003|Overall Study|Lost to Follow-up|0|||
48431978|NCT04346628|155769004|FG000|Overall Study|Lost to Follow-up|4|||
48431979|NCT04346628|155769005|FG001|Overall Study|Lost to Follow-up|4|||
48431980|NCT04346628|155769004|FG000|Overall Study|Withdrew (had personal reasons)|2|||
48431981|NCT04346628|155769005|FG001|Overall Study|Withdrew (had personal reasons)|5|||
48431982|NCT04346628|155769004|FG000|Overall Study|Withdrew (medication intolerant)|0|||
48431983|NCT04346628|155769005|FG001|Overall Study|Withdrew (medication intolerant)|3|||
48431984|NCT04346628|155769004|FG000|Overall Study|Withdrew (declined intervention)|0|||
48431985|NCT04346628|155769005|FG001|Overall Study|Withdrew (declined intervention)|1|||
48431986|NCT00411788|155769006|FG000|Overall Study|Protocol Violation|1|||
48431987|NCT00411788|155769006|FG000|Overall Study|Adverse Event|1|||
48431988|NCT00316303|155769012|FG000|Overall Study|Lost to Follow-up|11|||
48431989|NCT00316303|155769013|FG001|Overall Study|Lost to Follow-up|16|||
48431990|NCT02345252|155769014|FG000|Double-Blind Phase|Adverse Event|2|||
48431991|NCT02345252|155769015|FG001|Double-Blind Phase|Adverse Event|3|||
48431992|NCT02345252|155769014|FG000|Double-Blind Phase|Death|1|||
48431993|NCT02345252|155769015|FG001|Double-Blind Phase|Death|2|||
48431994|NCT02345252|155769014|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48431995|NCT02345252|155769015|FG001|Double-Blind Phase|Lack of Efficacy|0|||
48431996|NCT02345252|155769014|FG000|Double-Blind Phase|Investigator's Discretion|4|||
48431997|NCT02345252|155769015|FG001|Double-Blind Phase|Investigator's Discretion|6|||
48431998|NCT02345252|155769014|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
48431999|NCT02345252|155769015|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
48432000|NCT02345252|155769014|FG000|Double-Blind Phase|Protocol Violation|2|||
48432001|NCT02345252|155769015|FG001|Double-Blind Phase|Protocol Violation|1|||
48432002|NCT02345252|155769014|FG000|Double-Blind Phase|Withdrew Consent|21|||
48432003|NCT02345252|155769015|FG001|Double-Blind Phase|Withdrew Consent|23|||
48432004|NCT02345252|155769014|FG000|Double-Blind Phase|Lost to Follow-up|8|||
48432005|NCT02345252|155769015|FG001|Double-Blind Phase|Lost to Follow-up|10|||
48432006|NCT02345252|155769014|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
48432007|NCT02345252|155769015|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
48432008|NCT00995345|155769016|FG000|Overall Study|Withdrawal by Subject|4|||
48432009|NCT00995345|155769017|FG001|Overall Study|Withdrawal by Subject|2|||
48432010|NCT00995345|155769018|FG002|Overall Study|Withdrawal by Subject|1|||
48432011|NCT00995345|155769019|FG003|Overall Study|Withdrawal by Subject|3|||
48432012|NCT00995345|155769020|FG004|Overall Study|Withdrawal by Subject|1|||
48432013|NCT00995345|155769016|FG000|Overall Study|Adverse Event|3|||
48432014|NCT00995345|155769017|FG001|Overall Study|Adverse Event|1|||
48432015|NCT00995345|155769018|FG002|Overall Study|Adverse Event|2|||
48432016|NCT00995345|155769019|FG003|Overall Study|Adverse Event|0|||
48432017|NCT00995345|155769020|FG004|Overall Study|Adverse Event|1|||
48432018|NCT00995345|155769016|FG000|Overall Study|Lost to Follow-up|2|||
48432019|NCT00995345|155769017|FG001|Overall Study|Lost to Follow-up|2|||
48432020|NCT00995345|155769018|FG002|Overall Study|Lost to Follow-up|2|||
48432021|NCT00995345|155769019|FG003|Overall Study|Lost to Follow-up|1|||
48432022|NCT00995345|155769020|FG004|Overall Study|Lost to Follow-up|0|||
48432023|NCT00995345|155769016|FG000|Overall Study|all other reasons combined|2|||
48432024|NCT00995345|155769017|FG001|Overall Study|all other reasons combined|2|||
48432025|NCT00995345|155769018|FG002|Overall Study|all other reasons combined|2|||
48432026|NCT00995345|155769019|FG003|Overall Study|all other reasons combined|1|||
48432027|NCT00995345|155769020|FG004|Overall Study|all other reasons combined|3|||
48432028|NCT02546674|155769023|FG000|Overall Study|Adverse Event|19|||
48432029|NCT02546674|155769023|FG000|Overall Study|Death|1|||
48432030|NCT02546674|155769023|FG000|Overall Study|Lost to Follow-up|1|||
48432031|NCT02546674|155769023|FG000|Overall Study|Physician Decision|13|||
48432032|NCT02546674|155769023|FG000|Overall Study|Pregnancy|1|||
48432033|NCT02546674|155769023|FG000|Overall Study|Progressive Disease|2|||
48432034|NCT02546674|155769023|FG000|Overall Study|Protocol Deviation|2|||
48432035|NCT02546674|155769023|FG000|Overall Study|Subject/Guardian Decision|6|||
48432036|NCT02546674|155769023|FG000|Overall Study|Withdrawal of Informed Consent|3|||
48432037|NCT01163253|155769024|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
48432038|NCT01163253|155769025|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
48432039|NCT01163253|155769024|FG000|Overall Study|Study Terminated by Sponsor|978|||
48432040|NCT01163253|155769025|FG001|Overall Study|Study Terminated by Sponsor|349|||
48432041|NCT01163253|155769024|FG000|Overall Study|Protocol Violation|43|||
48432042|NCT01163253|155769025|FG001|Overall Study|Protocol Violation|12|||
48432043|NCT01163253|155769024|FG000|Overall Study|Withdrawal by Subject|199|||
48432044|NCT01163253|155769025|FG001|Overall Study|Withdrawal by Subject|50|||
48432045|NCT01163253|155769024|FG000|Overall Study|Medication Error|1|||
48432046|NCT01163253|155769025|FG001|Overall Study|Medication Error|0|||
48432047|NCT01163253|155769024|FG000|Overall Study|Lost to Follow-up|125|||
48432048|NCT01163253|155769025|FG001|Overall Study|Lost to Follow-up|23|||
48432049|NCT01163253|155769024|FG000|Overall Study|Insufficient Clinical Response|423|||
48432050|NCT01163253|155769025|FG001|Overall Study|Insufficient Clinical Response|29|||
48432051|NCT01163253|155769024|FG000|Overall Study|Adverse Event|300|||
48432052|NCT01163253|155769025|FG001|Overall Study|Adverse Event|78|||
48432053|NCT01163253|155769024|FG000|Overall Study|Death|17|||
48432054|NCT01163253|155769025|FG001|Overall Study|Death|5|||
48432055|NCT01163253|155769024|FG000|Overall Study|Ongoing|13|||
48432056|NCT01163253|155769025|FG001|Overall Study|Ongoing|4|||
48432057|NCT01163253|155769024|FG000|Overall Study|Other Unspecified|170|||
48432058|NCT01163253|155769025|FG001|Overall Study|Other Unspecified|34|||
48432059|NCT01087528|155769028|FG000|Overall Study|Withdrawal by Subject|1|||
48432060|NCT01087528|155769028|FG000|Overall Study|Incomplete CE procedure|6|||
48432061|NCT01683071|155769031|FG000|Part 1|Lack of Efficacy|1|||
48432085|NCT01683071|155769031|FG000|Part 1|Early termination; met exclusion criteria|0|||
48432086|NCT01683071|155769032|FG001|Part 1|Early termination; met exclusion criteria|2|||
48432087|NCT01683071|155769033|FG002|Part 1|Early termination; met exclusion criteria|1|||
48432088|NCT01683071|155769034|FG003|Part 1|Early termination; met exclusion criteria|0|||
48432089|NCT01683071|155769035|FG004|Part 1|Early termination; met exclusion criteria|0|||
48432090|NCT01683071|155769036|FG005|Part 1|Early termination; met exclusion criteria|0|||
48432091|NCT01683071|155769031|FG000|Part 2|Lack of Efficacy|0|||
48432092|NCT01683071|155769032|FG001|Part 2|Lack of Efficacy|0|||
48432093|NCT01683071|155769033|FG002|Part 2|Lack of Efficacy|0|||
48432094|NCT01683071|155769034|FG003|Part 2|Lack of Efficacy|0|||
48432095|NCT01683071|155769035|FG004|Part 2|Lack of Efficacy|3|||
48432096|NCT01683071|155769036|FG005|Part 2|Lack of Efficacy|4|||
48432097|NCT01683071|155769031|FG000|Part 2|Lost to Follow-up|0|||
48432098|NCT01683071|155769032|FG001|Part 2|Lost to Follow-up|0|||
48432099|NCT01683071|155769033|FG002|Part 2|Lost to Follow-up|0|||
48432100|NCT01683071|155769034|FG003|Part 2|Lost to Follow-up|0|||
48432101|NCT01683071|155769035|FG004|Part 2|Lost to Follow-up|2|||
48432102|NCT01683071|155769036|FG005|Part 2|Lost to Follow-up|0|||
48432103|NCT01683071|155769031|FG000|Part 2|Withdrawal by Subject|0|||
48432104|NCT01683071|155769032|FG001|Part 2|Withdrawal by Subject|0|||
48432105|NCT01683071|155769033|FG002|Part 2|Withdrawal by Subject|0|||
48432106|NCT01683071|155769034|FG003|Part 2|Withdrawal by Subject|0|||
48432107|NCT01683071|155769035|FG004|Part 2|Withdrawal by Subject|3|||
48432108|NCT01683071|155769036|FG005|Part 2|Withdrawal by Subject|3|||
48432109|NCT01683071|155769031|FG000|Part 2|Surgery cancelled|0|||
48432110|NCT01683071|155769032|FG001|Part 2|Surgery cancelled|0|||
48432111|NCT01683071|155769033|FG002|Part 2|Surgery cancelled|0|||
48432112|NCT01683071|155769034|FG003|Part 2|Surgery cancelled|0|||
48432113|NCT01683071|155769035|FG004|Part 2|Surgery cancelled|4|||
48432114|NCT01683071|155769036|FG005|Part 2|Surgery cancelled|2|||
48432115|NCT01683071|155769031|FG000|Part 2|Did not receive study drug|0|||
48432116|NCT01683071|155769032|FG001|Part 2|Did not receive study drug|0|||
48432117|NCT01683071|155769033|FG002|Part 2|Did not receive study drug|0|||
48432118|NCT01683071|155769034|FG003|Part 2|Did not receive study drug|0|||
48432119|NCT01683071|155769035|FG004|Part 2|Did not receive study drug|2|||
48432120|NCT01683071|155769036|FG005|Part 2|Did not receive study drug|1|||
48432121|NCT01683071|155769031|FG000|Part 2|Met exclusion criterion|0|||
48432122|NCT01683071|155769032|FG001|Part 2|Met exclusion criterion|0|||
48432123|NCT01683071|155769033|FG002|Part 2|Met exclusion criterion|0|||
48432124|NCT01683071|155769034|FG003|Part 2|Met exclusion criterion|0|||
48432125|NCT01683071|155769035|FG004|Part 2|Met exclusion criterion|1|||
48432126|NCT01683071|155769036|FG005|Part 2|Met exclusion criterion|1|||
48432127|NCT01683071|155769031|FG000|Part 2|Protocol deviation|0|||
48432128|NCT01683071|155769032|FG001|Part 2|Protocol deviation|0|||
48432129|NCT01683071|155769033|FG002|Part 2|Protocol deviation|0|||
48432130|NCT01683071|155769034|FG003|Part 2|Protocol deviation|0|||
48432131|NCT01683071|155769035|FG004|Part 2|Protocol deviation|1|||
48432132|NCT01683071|155769036|FG005|Part 2|Protocol deviation|2|||
48432133|NCT01683071|155769031|FG000|Part 2|Withdrawal by investigator decision|0|||
48432134|NCT01683071|155769032|FG001|Part 2|Withdrawal by investigator decision|0|||
48432135|NCT01683071|155769033|FG002|Part 2|Withdrawal by investigator decision|0|||
48432136|NCT01683071|155769034|FG003|Part 2|Withdrawal by investigator decision|0|||
48432137|NCT01683071|155769035|FG004|Part 2|Withdrawal by investigator decision|1|||
48432138|NCT01683071|155769036|FG005|Part 2|Withdrawal by investigator decision|2|||
48432139|NCT00364845|155769037|FG000|Overall Study|Adverse Event|1|||
48432140|NCT00364845|155769038|FG001|Overall Study|Adverse Event|0|||
48432141|NCT00364845|155769037|FG000|Overall Study|Withdrawal by Subject|2|||
48432142|NCT00364845|155769038|FG001|Overall Study|Withdrawal by Subject|1|||
48432143|NCT00364845|155769037|FG000|Overall Study|Physician Decision|8|||
48432144|NCT00364845|155769038|FG001|Overall Study|Physician Decision|8|||
48432145|NCT00364845|155769037|FG000|Overall Study|Lost to Follow-up|0|||
48432146|NCT00364845|155769038|FG001|Overall Study|Lost to Follow-up|1|||
48432147|NCT00364845|155769037|FG000|Overall Study|Death|0|||
48432148|NCT00364845|155769038|FG001|Overall Study|Death|1|||
48432149|NCT05118386|155769041|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48432150|NCT05118386|155769042|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48432151|NCT05118386|155769043|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48432152|NCT05118386|155769044|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
48432153|NCT05118386|155769045|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48432154|NCT05118386|155769046|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
48432155|NCT05118386|155769041|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48432156|NCT05118386|155769042|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48432157|NCT05118386|155769043|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48432158|NCT05118386|155769044|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48432159|NCT05118386|155769045|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
48432160|NCT05118386|155769046|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
48432161|NCT01199263|155769047|FG000|Overall Study|Ineligible|0|||
48432212|NCT00430521|155769058|FG007|Overall Study|Withdrawal by Subject|2|||
48432213|NCT03987620|155769059|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
48432214|NCT03987620|155769060|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
48432215|NCT03987620|155769059|FG000|Overall Study|Adverse Event|3|||
48432216|NCT03987620|155769060|FG001|Overall Study|Adverse Event|0|||
48432217|NCT03987620|155769059|FG000|Overall Study|Lost to Follow-up|1|||
48432218|NCT03987620|155769060|FG001|Overall Study|Lost to Follow-up|2|||
48432219|NCT03987620|155769059|FG000|Overall Study|Physician Decision|0|||
48432220|NCT03987620|155769060|FG001|Overall Study|Physician Decision|1|||
48432221|NCT03987620|155769059|FG000|Overall Study|Pregnancy|1|||
48432222|NCT03987620|155769060|FG001|Overall Study|Pregnancy|0|||
48432223|NCT03987620|155769059|FG000|Overall Study|Withdrawal by Subject|7|||
48432224|NCT03987620|155769060|FG001|Overall Study|Withdrawal by Subject|1|||
48432225|NCT03987620|155769059|FG000|Overall Study|Other|2|||
48432226|NCT03987620|155769060|FG001|Overall Study|Other|5|||
48432227|NCT03255291|155769061|FG000|Overall Study|Determined to be ineligible|10|||
48432228|NCT03255291|155769062|FG001|Overall Study|Determined to be ineligible|12|||
48432229|NCT03255291|155769063|FG002|Overall Study|Determined to be ineligible|6|||
48432230|NCT03255291|155769064|FG003|Overall Study|Determined to be ineligible|6|||
48432231|NCT03255291|155769065|FG004|Overall Study|Determined to be ineligible|5|||
48432232|NCT03255291|155769066|FG005|Overall Study|Determined to be ineligible|10|||
48432233|NCT03255291|155769061|FG000|Overall Study|Baseline data collection issues|3|||
48432234|NCT03255291|155769062|FG001|Overall Study|Baseline data collection issues|0|||
48432235|NCT03255291|155769063|FG002|Overall Study|Baseline data collection issues|0|||
48432236|NCT03255291|155769064|FG003|Overall Study|Baseline data collection issues|0|||
48432237|NCT03255291|155769065|FG004|Overall Study|Baseline data collection issues|2|||
48432238|NCT03255291|155769066|FG005|Overall Study|Baseline data collection issues|0|||
48432239|NCT01655823|155769068|FG000|Overall Study|Lost to Follow-up|0|||
48432240|NCT01655823|155769069|FG001|Overall Study|Lost to Follow-up|1|||
48432241|NCT01655823|155769070|FG002|Overall Study|Lost to Follow-up|0|||
48432242|NCT01655823|155769071|FG003|Overall Study|Lost to Follow-up|0|||
48432243|NCT01655823|155769072|FG004|Overall Study|Lost to Follow-up|1|||
48432244|NCT01655823|155769068|FG000|Overall Study|Withdrawal by Subject|0|||
48432245|NCT01655823|155769069|FG001|Overall Study|Withdrawal by Subject|1|||
48432246|NCT01655823|155769070|FG002|Overall Study|Withdrawal by Subject|0|||
48432247|NCT01655823|155769071|FG003|Overall Study|Withdrawal by Subject|1|||
48432248|NCT01655823|155769072|FG004|Overall Study|Withdrawal by Subject|0|||
48432249|NCT00894413|155769075|FG000|Overall Study|Physician Decision|0|||
48432250|NCT00894413|155769076|FG001|Overall Study|Physician Decision|2|||
48432251|NCT00894413|155769075|FG000|Overall Study|Adverse Event|0|||
48432252|NCT00894413|155769076|FG001|Overall Study|Adverse Event|2|||
48432253|NCT00894413|155769075|FG000|Overall Study|Withdrawal by Subject|0|||
48432254|NCT00894413|155769076|FG001|Overall Study|Withdrawal by Subject|4|||
48432255|NCT04752189|155769078|FG000|Overall Study|Withdrawal by Subject|0|||
48432256|NCT04752189|155769079|FG001|Overall Study|Withdrawal by Subject|150|||
48432257|NCT04752189|155769078|FG000|Overall Study|Lost to Follow-up|261|||
48432258|NCT04752189|155769079|FG001|Overall Study|Lost to Follow-up|126|||
48432259|NCT01931462|155770832|FG000|Overall Study|Withdrawal by Subject|1|||
48432260|NCT02819310|155770835|FG000|Overall Study|Withdrawal by Subject|37|||
48432261|NCT02819310|155770835|FG000|Overall Study|Lost to Follow-up|16|||
48432262|NCT02819310|155770835|FG000|Overall Study|Adverse Event|13|||
48432263|NCT02819310|155770835|FG000|Overall Study|Lack of Efficacy|5|||
48432264|NCT02819310|155770835|FG000|Overall Study|Physician Decision|8|||
48432265|NCT02819310|155770835|FG000|Overall Study|Protocol Violation|30|||
48432266|NCT03488472|155770836|FG000|Overall Study|disease progression additional mets|1|||
48432267|NCT01428063|155770837|FG000|Overall Study|Lack of Efficacy|8|||
48432268|NCT01428063|155770838|FG001|Overall Study|Lack of Efficacy|4|||
48432269|NCT01428063|155770839|FG002|Overall Study|Lack of Efficacy|1|||
48432270|NCT01428063|155770837|FG000|Overall Study|Adverse Event|2|||
48432271|NCT01428063|155770838|FG001|Overall Study|Adverse Event|3|||
48432272|NCT01428063|155770839|FG002|Overall Study|Adverse Event|0|||
48432273|NCT01428063|155770837|FG000|Overall Study|Lost to Follow-up|0|||
48432274|NCT01428063|155770838|FG001|Overall Study|Lost to Follow-up|2|||
48432275|NCT01428063|155770839|FG002|Overall Study|Lost to Follow-up|0|||
48432276|NCT01428063|155770837|FG000|Overall Study|No longer meets study criteria|0|||
48432277|NCT01428063|155770838|FG001|Overall Study|No longer meets study criteria|1|||
48432278|NCT01428063|155770839|FG002|Overall Study|No longer meets study criteria|0|||
48432279|NCT00365716|155770840|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
48432280|NCT00365716|155770841|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
48432281|NCT00365716|155770842|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48432282|NCT00365716|155770843|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48432283|NCT00365716|155770844|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48432284|NCT00365716|155770845|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48432285|NCT00365716|155770846|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
48432286|NCT00365716|155770840|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48432287|NCT00365716|155770841|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
48432288|NCT00365716|155770842|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48432289|NCT00365716|155770843|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48432290|NCT00365716|155770844|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
48432291|NCT00365716|155770845|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48432292|NCT00365716|155770846|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
48432293|NCT00365716|155770840|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
48432294|NCT00365716|155770841|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
48432295|NCT00365716|155770842|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
48432296|NCT00365716|155770843|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
48432297|NCT00365716|155770844|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
48432298|NCT00365716|155770845|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
48432299|NCT00365716|155770846|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
48432300|NCT00365716|155770840|FG000|Base Study (Day 1 to Month 7)|Other|0|||
48432301|NCT00365716|155770841|FG001|Base Study (Day 1 to Month 7)|Other|1|||
48432302|NCT00365716|155770842|FG002|Base Study (Day 1 to Month 7)|Other|0|||
48432303|NCT00365716|155770843|FG003|Base Study (Day 1 to Month 7)|Other|0|||
48432304|NCT00365716|155770844|FG004|Base Study (Day 1 to Month 7)|Other|0|||
48432305|NCT00365716|155770845|FG005|Base Study (Day 1 to Month 7)|Other|0|||
48432306|NCT00365716|155770846|FG006|Base Study (Day 1 to Month 7)|Other|0|||
48432307|NCT00365716|155770840|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
48432308|NCT00365716|155770841|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
48432309|NCT00365716|155770842|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
48432310|NCT00365716|155770843|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
48432311|NCT00365716|155770844|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
48432312|NCT00365716|155770845|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
48432313|NCT00365716|155770846|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
48432314|NCT00365716|155770840|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
48432315|NCT00365716|155770841|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
48432316|NCT00365716|155770842|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
48432317|NCT00365716|155770843|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
48432318|NCT00365716|155770844|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
48432319|NCT00365716|155770845|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
48432320|NCT00365716|155770846|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
48432321|NCT00365716|155770840|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
48432322|NCT00365716|155770841|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
48432323|NCT00365716|155770842|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
48432324|NCT00365716|155770843|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
48432325|NCT00365716|155770844|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
48432326|NCT00365716|155770845|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
48432327|NCT00365716|155770846|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
48432328|NCT00365716|155770840|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
48432329|NCT00365716|155770841|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
48432330|NCT00365716|155770842|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
48432331|NCT00365716|155770843|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
48432332|NCT00365716|155770844|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
48432333|NCT00365716|155770845|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
48432334|NCT00365716|155770846|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
48432335|NCT00365716|155770840|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
48432336|NCT00365716|155770841|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
48432337|NCT00365716|155770842|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
48432338|NCT00365716|155770843|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
48432339|NCT00365716|155770844|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
48432340|NCT00365716|155770845|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
48432341|NCT00365716|155770846|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
48432342|NCT00365716|155770840|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
48432343|NCT00365716|155770841|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
48432344|NCT00365716|155770842|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
48432345|NCT00365716|155770843|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
48432346|NCT00365716|155770844|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
48432347|NCT00365716|155770845|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
48432348|NCT00365716|155770846|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
48432349|NCT00365716|155770840|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
48432350|NCT00365716|155770841|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48432351|NCT00365716|155770842|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48432352|NCT00365716|155770843|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48432353|NCT00365716|155770844|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
48432354|NCT00365716|155770845|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48432355|NCT00365716|155770846|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
48432437|NCT03504774|155770853|FG000|Overall Study|Protocol Violation|11|||
48432356|NCT00365716|155770840|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48432357|NCT00365716|155770841|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
48432358|NCT00365716|155770842|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
48432359|NCT00365716|155770843|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48432360|NCT00365716|155770844|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48432361|NCT00365716|155770845|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48432362|NCT00365716|155770846|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
48432363|NCT00365716|155770840|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
48432364|NCT00365716|155770841|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
48432365|NCT00365716|155770842|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
48432366|NCT00365716|155770843|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
48432367|NCT00365716|155770844|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
48432368|NCT00365716|155770845|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
48432369|NCT00365716|155770846|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
48432370|NCT00365716|155770840|FG000|Extension 1|Lost to Follow-up|0|||
48432371|NCT00365716|155770841|FG001|Extension 1|Lost to Follow-up|0|||
48432372|NCT00365716|155770842|FG002|Extension 1|Lost to Follow-up|0|||
48432373|NCT00365716|155770843|FG003|Extension 1|Lost to Follow-up|0|||
48432374|NCT00365716|155770844|FG004|Extension 1|Lost to Follow-up|0|||
48432375|NCT00365716|155770845|FG005|Extension 1|Lost to Follow-up|1|||
48432376|NCT00365716|155770846|FG006|Extension 1|Lost to Follow-up|0|||
48432377|NCT00365716|155770840|FG000|Extension 1|Other|0|||
48432378|NCT00365716|155770841|FG001|Extension 1|Other|0|||
48432379|NCT00365716|155770842|FG002|Extension 1|Other|0|||
48432380|NCT00365716|155770843|FG003|Extension 1|Other|0|||
48432381|NCT00365716|155770844|FG004|Extension 1|Other|0|||
48432382|NCT00365716|155770845|FG005|Extension 1|Other|9|||
48432383|NCT00365716|155770846|FG006|Extension 1|Other|0|||
48432384|NCT00365716|155770840|FG000|Extension 1|Moved|0|||
48432385|NCT00365716|155770841|FG001|Extension 1|Moved|0|||
48432386|NCT00365716|155770842|FG002|Extension 1|Moved|0|||
48432387|NCT00365716|155770843|FG003|Extension 1|Moved|0|||
48432388|NCT00365716|155770844|FG004|Extension 1|Moved|0|||
48432389|NCT00365716|155770845|FG005|Extension 1|Moved|4|||
48432390|NCT00365716|155770846|FG006|Extension 1|Moved|0|||
48432391|NCT00365716|155770840|FG000|Extension 1|Withdrawal by Subject|0|||
48432392|NCT00365716|155770841|FG001|Extension 1|Withdrawal by Subject|0|||
48432393|NCT00365716|155770842|FG002|Extension 1|Withdrawal by Subject|0|||
48432394|NCT00365716|155770843|FG003|Extension 1|Withdrawal by Subject|0|||
48432395|NCT00365716|155770844|FG004|Extension 1|Withdrawal by Subject|0|||
48432396|NCT00365716|155770845|FG005|Extension 1|Withdrawal by Subject|3|||
48432397|NCT00365716|155770846|FG006|Extension 1|Withdrawal by Subject|0|||
48432398|NCT00365716|155770840|FG000|Extension 1|Pregnancy|0|||
48432399|NCT00365716|155770841|FG001|Extension 1|Pregnancy|0|||
48432400|NCT00365716|155770842|FG002|Extension 1|Pregnancy|0|||
48432401|NCT00365716|155770843|FG003|Extension 1|Pregnancy|0|||
48432402|NCT00365716|155770844|FG004|Extension 1|Pregnancy|0|||
48432403|NCT00365716|155770845|FG005|Extension 1|Pregnancy|4|||
48432404|NCT00365716|155770846|FG006|Extension 1|Pregnancy|0|||
48432405|NCT00365716|155770840|FG000|Extension 1|Protocol Violation|0|||
48432406|NCT00365716|155770841|FG001|Extension 1|Protocol Violation|0|||
48432407|NCT00365716|155770842|FG002|Extension 1|Protocol Violation|0|||
48432408|NCT00365716|155770843|FG003|Extension 1|Protocol Violation|0|||
48432409|NCT00365716|155770844|FG004|Extension 1|Protocol Violation|0|||
48432410|NCT00365716|155770845|FG005|Extension 1|Protocol Violation|1|||
48432411|NCT00365716|155770846|FG006|Extension 1|Protocol Violation|0|||
48432412|NCT00365716|155770840|FG000|Extension 2|Lost to Follow-up|0|||
48432413|NCT00365716|155770841|FG001|Extension 2|Lost to Follow-up|0|||
48432414|NCT00365716|155770842|FG002|Extension 2|Lost to Follow-up|0|||
48432415|NCT00365716|155770843|FG003|Extension 2|Lost to Follow-up|0|||
48432416|NCT00365716|155770844|FG004|Extension 2|Lost to Follow-up|0|||
48432417|NCT00365716|155770845|FG005|Extension 2|Lost to Follow-up|0|||
48432418|NCT00365716|155770846|FG006|Extension 2|Lost to Follow-up|2|||
48432419|NCT00365716|155770840|FG000|Extension 2|Other|0|||
48432420|NCT00365716|155770841|FG001|Extension 2|Other|0|||
48432421|NCT00365716|155770842|FG002|Extension 2|Other|0|||
48432422|NCT00365716|155770843|FG003|Extension 2|Other|0|||
48432423|NCT00365716|155770844|FG004|Extension 2|Other|0|||
48432424|NCT00365716|155770845|FG005|Extension 2|Other|0|||
48432425|NCT00365716|155770846|FG006|Extension 2|Other|3|||
48432426|NCT00365716|155770840|FG000|Extension 2|Withdrawal by Subject|0|||
48432427|NCT00365716|155770841|FG001|Extension 2|Withdrawal by Subject|0|||
48432428|NCT00365716|155770842|FG002|Extension 2|Withdrawal by Subject|0|||
48432429|NCT00365716|155770843|FG003|Extension 2|Withdrawal by Subject|0|||
48432430|NCT00365716|155770844|FG004|Extension 2|Withdrawal by Subject|0|||
48432431|NCT00365716|155770845|FG005|Extension 2|Withdrawal by Subject|0|||
48432432|NCT00365716|155770846|FG006|Extension 2|Withdrawal by Subject|5|||
48432433|NCT03504774|155770853|FG000|Overall Study|Adverse Event|2|||
48432434|NCT03504774|155770854|FG001|Overall Study|Adverse Event|0|||
48432435|NCT03504774|155770853|FG000|Overall Study|Lost to Follow-up|0|||
48432436|NCT03504774|155770854|FG001|Overall Study|Lost to Follow-up|1|||
48432502|NCT01005719|155770891|FG004|Period 1|Delay in completing study procedures|0|||
48432503|NCT01005719|155770892|FG005|Period 1|Delay in completing study procedures|1|||
48432504|NCT01005719|155770887|FG000|Period 2|Adverse Event|0|||
48432505|NCT01005719|155770888|FG001|Period 2|Adverse Event|0|||
48432506|NCT01005719|155770889|FG002|Period 2|Adverse Event|0|||
48432507|NCT01005719|155770890|FG003|Period 2|Adverse Event|0|||
48432508|NCT01005719|155770891|FG004|Period 2|Adverse Event|1|||
48432509|NCT01005719|155770892|FG005|Period 2|Adverse Event|1|||
48432510|NCT02918266|155770893|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
48432511|NCT02918266|155770894|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48432512|NCT02918266|155770895|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48432513|NCT02918266|155770896|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48432514|NCT02918266|155770897|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48432515|NCT02918266|155770898|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48432516|NCT02918266|155770899|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
48432517|NCT02918266|155770900|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48432518|NCT02918266|155770901|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
48432519|NCT02918266|155770902|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48432520|NCT02918266|155770903|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
48432521|NCT02417233|155770904|FG000|Overall Study|Death|4|||
48432522|NCT02417233|155770905|FG001|Overall Study|Death|10|||
48432523|NCT02417233|155770906|FG002|Overall Study|Death|14|||
48432524|NCT02417233|155770904|FG000|Overall Study|Lost to Follow-up|27|||
48432525|NCT02417233|155770905|FG001|Overall Study|Lost to Follow-up|39|||
48432526|NCT02417233|155770906|FG002|Overall Study|Lost to Follow-up|34|||
48432527|NCT02417233|155770904|FG000|Overall Study|Protocol Violation|2|||
48432528|NCT02417233|155770905|FG001|Overall Study|Protocol Violation|0|||
48432529|NCT02417233|155770906|FG002|Overall Study|Protocol Violation|2|||
48432530|NCT02417233|155770904|FG000|Overall Study|Withdrawal by Subject|2|||
48432531|NCT02417233|155770905|FG001|Overall Study|Withdrawal by Subject|1|||
48432532|NCT02417233|155770906|FG002|Overall Study|Withdrawal by Subject|8|||
48432533|NCT02417233|155770904|FG000|Overall Study|Relocation out of study area|1|||
48432534|NCT02417233|155770905|FG001|Overall Study|Relocation out of study area|0|||
48432535|NCT02417233|155770906|FG002|Overall Study|Relocation out of study area|1|||
48432536|NCT02417233|155770904|FG000|Overall Study|Mentally unstable|0|||
48432537|NCT02417233|155770905|FG001|Overall Study|Mentally unstable|1|||
48432538|NCT02417233|155770906|FG002|Overall Study|Mentally unstable|0|||
48432539|NCT03649321|155770917|FG000|Overall Study|Withdrawal by Subject|1|||
48432540|NCT03649321|155770918|FG001|Overall Study|Withdrawal by Subject|0|||
48432541|NCT03649321|155770917|FG000|Overall Study|Death|1|||
48432542|NCT03649321|155770918|FG001|Overall Study|Death|0|||
48432543|NCT01293032|155770923|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
48432544|NCT01293032|155770924|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
48432545|NCT01293032|155770925|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
48432546|NCT01293032|155770926|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
48432547|NCT01293032|155770923|FG000|Treatment|Adverse Event|0|||
48432548|NCT01293032|155770924|FG001|Treatment|Adverse Event|0|||
48432549|NCT01293032|155770925|FG002|Treatment|Adverse Event|1|||
48432550|NCT01293032|155770926|FG003|Treatment|Adverse Event|1|||
48432551|NCT01293032|155770923|FG000|Treatment|Withdrawal by Subject|2|||
48432552|NCT01293032|155770924|FG001|Treatment|Withdrawal by Subject|4|||
48432553|NCT01293032|155770925|FG002|Treatment|Withdrawal by Subject|0|||
48432554|NCT01293032|155770926|FG003|Treatment|Withdrawal by Subject|0|||
48432555|NCT01293032|155770923|FG000|Treatment|Disease Progression, relapse|0|||
48432556|NCT01293032|155770924|FG001|Treatment|Disease Progression, relapse|1|||
48432557|NCT01293032|155770925|FG002|Treatment|Disease Progression, relapse|0|||
48432558|NCT01293032|155770926|FG003|Treatment|Disease Progression, relapse|0|||
48432559|NCT03799718|155770927|FG000|Overall Study|Adverse Event|2|||
48432560|NCT02202031|155770928|FG000|Overall Study|Lost to Follow-up|1|||
48432561|NCT02202031|155770929|FG001|Overall Study|Lost to Follow-up|0|||
48432562|NCT02202031|155770928|FG000|Overall Study|Too Busy|1|||
48432563|NCT02202031|155770929|FG001|Overall Study|Too Busy|3|||
48432564|NCT02202031|155770928|FG000|Overall Study|Illness/Medical Reason|0|||
48432565|NCT02202031|155770929|FG001|Overall Study|Illness/Medical Reason|2|||
48432566|NCT02202031|155770928|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
48432567|NCT02202031|155770929|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
48432568|NCT00321984|155770930|FG000|Overall Study|Adverse Event|9|||
48432569|NCT00321984|155770931|FG001|Overall Study|Adverse Event|6|||
48432570|NCT00321984|155770932|FG002|Overall Study|Adverse Event|8|||
48432571|NCT00321984|155770930|FG000|Overall Study|Protocol Violation|0|||
48432572|NCT00321984|155770931|FG001|Overall Study|Protocol Violation|1|||
48432573|NCT00321984|155770932|FG002|Overall Study|Protocol Violation|1|||
48432574|NCT00321984|155770930|FG000|Overall Study|Lost to Follow-up|2|||
48432575|NCT00321984|155770931|FG001|Overall Study|Lost to Follow-up|4|||
48432576|NCT00321984|155770932|FG002|Overall Study|Lost to Follow-up|2|||
48432577|NCT00321984|155770930|FG000|Overall Study|Withdrawal by Subject|8|||
48433654|NCT00789477|155774859|FG003|Overall Study|Other|3|||
48432578|NCT00321984|155770931|FG001|Overall Study|Withdrawal by Subject|6|||
48432579|NCT00321984|155770932|FG002|Overall Study|Withdrawal by Subject|5|||
48432580|NCT00321984|155770930|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
48432581|NCT00321984|155770931|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
48432582|NCT00321984|155770932|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
48432583|NCT00321984|155770930|FG000|Overall Study|Lack of Efficacy|3|||
48432584|NCT00321984|155770931|FG001|Overall Study|Lack of Efficacy|1|||
48432585|NCT00321984|155770932|FG002|Overall Study|Lack of Efficacy|3|||
48432586|NCT00321984|155770930|FG000|Overall Study|Noncompliant|0|||
48432587|NCT00321984|155770931|FG001|Overall Study|Noncompliant|0|||
48432588|NCT00321984|155770932|FG002|Overall Study|Noncompliant|2|||
48432589|NCT00321984|155770930|FG000|Overall Study|Pregnancy|0|||
48432590|NCT00321984|155770931|FG001|Overall Study|Pregnancy|1|||
48432591|NCT00321984|155770932|FG002|Overall Study|Pregnancy|0|||
48432592|NCT00321984|155770930|FG000|Overall Study|Per Subject Request|1|||
48432593|NCT00321984|155770931|FG001|Overall Study|Per Subject Request|0|||
48432594|NCT00321984|155770932|FG002|Overall Study|Per Subject Request|0|||
48432595|NCT00321984|155770930|FG000|Overall Study|Per Investigator Request|1|||
48432596|NCT00321984|155770931|FG001|Overall Study|Per Investigator Request|0|||
48432597|NCT00321984|155770932|FG002|Overall Study|Per Investigator Request|0|||
48432598|NCT00321984|155770930|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
48432599|NCT00321984|155770931|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
48432600|NCT00321984|155770932|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
48432601|NCT00862849|155770933|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48432602|NCT00862849|155770934|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
48432603|NCT00862849|155770935|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48432604|NCT00862849|155770936|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48432605|NCT00862849|155770937|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48432606|NCT00862849|155770938|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
48432607|NCT00862849|155770933|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48432608|NCT00862849|155770934|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
48432609|NCT00862849|155770935|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48432610|NCT00862849|155770936|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48432611|NCT00862849|155770937|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48432612|NCT00862849|155770938|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
48432613|NCT02868216|155770939|FG000|Overall Study|Death|0|||
48432614|NCT02868216|155770940|FG001|Overall Study|Death|1|||
48432615|NCT02868216|155770939|FG000|Overall Study|coronary artery bypass|1|||
48432616|NCT02868216|155770940|FG001|Overall Study|coronary artery bypass|0|||
48432617|NCT02868216|155770939|FG000|Overall Study|Withdrawal by Subject|7|||
48432618|NCT02868216|155770940|FG001|Overall Study|Withdrawal by Subject|5|||
48432619|NCT01201798|155770941|FG000|Overall Study|Adverse Event|2|||
48432620|NCT01201798|155770942|FG001|Overall Study|Adverse Event|0|||
48432621|NCT01201798|155770941|FG000|Overall Study|Lost to Follow-up|3|||
48432622|NCT01201798|155770942|FG001|Overall Study|Lost to Follow-up|5|||
48432623|NCT01201798|155770941|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
48432624|NCT01201798|155770942|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
48432625|NCT01201798|155770941|FG000|Overall Study|Noncompliance|1|||
48432626|NCT01201798|155770942|FG001|Overall Study|Noncompliance|0|||
48432627|NCT01201798|155770941|FG000|Overall Study|Protocol Violation|1|||
48432628|NCT01201798|155770942|FG001|Overall Study|Protocol Violation|1|||
48432629|NCT01201798|155770941|FG000|Overall Study|Treatment Failure|1|||
48432630|NCT01201798|155770942|FG001|Overall Study|Treatment Failure|8|||
48432631|NCT01401010|155770946|FG000|Overall Study|Could not interpret assay results|1|||
48432632|NCT01401010|155770947|FG001|Overall Study|Could not interpret assay results|0|||
48432633|NCT00807846|155770950|FG000|Overall Study|Adverse Event|5|||
48432634|NCT00807846|155770951|FG001|Overall Study|Adverse Event|0|||
48432635|NCT00807846|155770950|FG000|Overall Study|Lack of Efficacy|2|||
48432636|NCT00807846|155770951|FG001|Overall Study|Lack of Efficacy|0|||
48432637|NCT00807846|155770950|FG000|Overall Study|Protocol Violation|2|||
48432638|NCT00807846|155770951|FG001|Overall Study|Protocol Violation|1|||
48432639|NCT00807846|155770950|FG000|Overall Study|Withdrawal by Subject|2|||
48432640|NCT00807846|155770951|FG001|Overall Study|Withdrawal by Subject|1|||
48432641|NCT00807846|155770950|FG000|Overall Study|Other|1|||
48432642|NCT00807846|155770951|FG001|Overall Study|Other|2|||
48432643|NCT01081873|155770952|FG000|Overall Study|Death|86|||
48432644|NCT01081873|155770952|FG000|Overall Study|Withdrawal by Subject|10|||
48432645|NCT01081873|155770952|FG000|Overall Study|Lost to Follow-up|142|||
48432646|NCT01081873|155770952|FG000|Overall Study|Progression of prostate cancer|13|||
48432647|NCT01081873|155770952|FG000|Overall Study|Other|47|||
48432648|NCT03011840|155770953|FG000|Overall Study|Not received PIL in post PIL phase|0|||
48432649|NCT03011840|155770954|FG001|Overall Study|Not received PIL in post PIL phase|21|||
48432650|NCT03977727|155770955|FG000|Second Treatment|Lost to Follow-up|0|||
48432651|NCT03977727|155770956|FG001|Second Treatment|Lost to Follow-up|3|||
48432652|NCT03738566|155770957|FG000|Initial Study Phase|Withdrawal by Subject|1|||
48432653|NCT03738566|155770958|FG001|Initial Study Phase|Withdrawal by Subject|1|||
48432654|NCT03738566|155770959|FG002|Initial Study Phase|Withdrawal by Subject|2|||
48432655|NCT03738566|155770960|FG003|Initial Study Phase|Withdrawal by Subject|0|||
48432656|NCT03738566|155770957|FG000|Initial Study Phase|Death|0|||
48432657|NCT03738566|155770958|FG001|Initial Study Phase|Death|1|||
48432658|NCT03738566|155770959|FG002|Initial Study Phase|Death|0|||
48432659|NCT03738566|155770960|FG003|Initial Study Phase|Death|0|||
48432660|NCT03738566|155770957|FG000|Initial Study Phase|Treatment failure|5|||
48432661|NCT03738566|155770958|FG001|Initial Study Phase|Treatment failure|0|||
48432662|NCT03738566|155770959|FG002|Initial Study Phase|Treatment failure|0|||
48432663|NCT03738566|155770960|FG003|Initial Study Phase|Treatment failure|0|||
48432664|NCT03738566|155770957|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
48432665|NCT03738566|155770958|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
48432666|NCT03738566|155770959|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
48432667|NCT03738566|155770960|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
48432668|NCT01912768|155770964|FG000|Overall Study|Adverse Event|2|||
48432669|NCT01912768|155770965|FG001|Overall Study|Adverse Event|0|||
48432670|NCT01912768|155770964|FG000|Overall Study|Lost to Follow-up|2|||
48432671|NCT01912768|155770965|FG001|Overall Study|Lost to Follow-up|1|||
48432672|NCT01912768|155770964|FG000|Overall Study|Withdrawal by Subject|5|||
48432673|NCT01912768|155770965|FG001|Overall Study|Withdrawal by Subject|3|||
48432674|NCT01912768|155770964|FG000|Overall Study|Randomized in error|1|||
48432675|NCT01912768|155770965|FG001|Overall Study|Randomized in error|0|||
48432676|NCT01187901|155770966|FG000|Overall Study|Protocol Violation|1|||
48432677|NCT01187901|155770967|FG001|Overall Study|Protocol Violation|0|||
48432678|NCT01187901|155770966|FG000|Overall Study|Lost to Follow-up|1|||
48432679|NCT01187901|155770967|FG001|Overall Study|Lost to Follow-up|2|||
48432680|NCT01187901|155770966|FG000|Overall Study|Unrelated Health Reasons|1|||
48432681|NCT01187901|155770967|FG001|Overall Study|Unrelated Health Reasons|2|||
48432682|NCT01187901|155770966|FG000|Overall Study|Suspected Allergic Reaction|1|||
48432683|NCT01187901|155770967|FG001|Overall Study|Suspected Allergic Reaction|1|||
48432684|NCT01187901|155770966|FG000|Overall Study|Adverse Event|3|||
48432685|NCT01187901|155770967|FG001|Overall Study|Adverse Event|0|||
48432686|NCT01187901|155770966|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
48432687|NCT01187901|155770967|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
48432688|NCT01187901|155770966|FG000|Overall Study|Pregnancy|0|||
48432689|NCT01187901|155770967|FG001|Overall Study|Pregnancy|2|||
48432690|NCT04160468|155770968|FG000|Overall Study|Lost to Follow-up|19|||
48432691|NCT04160468|155770969|FG001|Overall Study|Lost to Follow-up|4|||
48432692|NCT04160468|155770968|FG000|Overall Study|Randomized but not dosed|6|||
48432693|NCT04160468|155770969|FG001|Overall Study|Randomized but not dosed|0|||
48432694|NCT04160468|155770968|FG000|Overall Study|Withdrawal by Subject|4|||
48432695|NCT04160468|155770969|FG001|Overall Study|Withdrawal by Subject|1|||
48432696|NCT04160468|155770968|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
48432697|NCT04160468|155770969|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
48432698|NCT04160468|155770968|FG000|Overall Study|Participant incarcerated|1|||
48432699|NCT04160468|155770969|FG001|Overall Study|Participant incarcerated|0|||
48432700|NCT02426658|155770970|FG000|Overall Study|Withdrawal by Subject|1|||
48432701|NCT02426658|155770970|FG000|Overall Study|Patient expired before treatment|2|||
48432702|NCT00524316|155770971|FG000|Overall Study|Withdrawal by Subject|2|||
48432703|NCT00524316|155770971|FG000|Overall Study|Adverse Event|7|||
48432704|NCT00524316|155770971|FG000|Overall Study|Disease Progression|7|||
48432705|NCT03141086|155770972|FG000|Overall Study|Study Terminated By Sponsor|1|||
48432706|NCT03141086|155770973|FG001|Overall Study|Study Terminated By Sponsor|1|||
48432707|NCT03141086|155770972|FG000|Overall Study|Withdrawal by Subject|0|||
48432708|NCT03141086|155770973|FG001|Overall Study|Withdrawal by Subject|1|||
48432709|NCT03141086|155770972|FG000|Overall Study|Protocol Violation|0|||
48432710|NCT03141086|155770973|FG001|Overall Study|Protocol Violation|1|||
48432711|NCT03141086|155770972|FG000|Overall Study|Adverse Event|0|||
48432712|NCT03141086|155770973|FG001|Overall Study|Adverse Event|2|||
48432713|NCT01402284|155770976|FG000|Overall Study|Withdrawal consent|2|||
48432714|NCT01402284|155770976|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
48432715|NCT01402284|155770976|FG000|Overall Study|Physician Decision|1|||
48432716|NCT01402284|155770976|FG000|Overall Study|Disease progression on study|10|||
48432717|NCT00540436|155770979|FG000|First 12-Week Treatment Period|Adverse Event|1|||
48432718|NCT00540436|155770979|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
48432719|NCT00540436|155770979|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
48432720|NCT00540436|155770979|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
48432721|NCT02928406|155770980|FG000|Overall Study|Death|780|||
48432722|NCT02928406|155770980|FG000|Overall Study|Progressive disease|3|||
48432723|NCT02928406|155770980|FG000|Overall Study|Lost to Follow-up|49|||
48432724|NCT02928406|155770980|FG000|Overall Study|Non-compliance|2|||
48432725|NCT02928406|155770980|FG000|Overall Study|Withdrawal by Subject|40|||
48432726|NCT02928406|155770980|FG000|Overall Study|Study terminated by sponsor|57|||
48432727|NCT02928406|155770980|FG000|Overall Study|Physician Decision|1|||
48432728|NCT02928406|155770980|FG000|Overall Study|Various reasons|72|||
48432729|NCT00488033|155770981|FG000|Overall Study|Withdrawal by Subject|1|||
48432730|NCT00488033|155770982|FG001|Overall Study|Withdrawal by Subject|0|||
48432731|NCT03260205|155770983|FG000|Overall Study|Adverse Event|2|||
48432732|NCT03260205|155770984|FG001|Overall Study|Adverse Event|0|||
48432733|NCT03260205|155770985|FG002|Overall Study|Adverse Event|2|||
48432734|NCT03260205|155770986|FG003|Overall Study|Adverse Event|2|||
48432735|NCT03260205|155770987|FG004|Overall Study|Adverse Event|4|||
48432736|NCT03260205|155770983|FG000|Overall Study|Lost to Follow-up|2|||
48432737|NCT03260205|155770984|FG001|Overall Study|Lost to Follow-up|2|||
48432738|NCT03260205|155770985|FG002|Overall Study|Lost to Follow-up|1|||
48432739|NCT03260205|155770986|FG003|Overall Study|Lost to Follow-up|1|||
48432740|NCT03260205|155770987|FG004|Overall Study|Lost to Follow-up|5|||
48432741|NCT03260205|155770983|FG000|Overall Study|Protocol Violation|0|||
48432742|NCT03260205|155770984|FG001|Overall Study|Protocol Violation|0|||
48432743|NCT03260205|155770985|FG002|Overall Study|Protocol Violation|2|||
48432744|NCT03260205|155770986|FG003|Overall Study|Protocol Violation|0|||
48432745|NCT03260205|155770987|FG004|Overall Study|Protocol Violation|1|||
48432746|NCT03260205|155770983|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
48432747|NCT03260205|155770984|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
48432748|NCT03260205|155770985|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
48432749|NCT03260205|155770986|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
48432750|NCT03260205|155770987|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
48432751|NCT03260205|155770983|FG000|Overall Study|Other: Unspecified|0|||
48432752|NCT03260205|155770984|FG001|Overall Study|Other: Unspecified|0|||
48432753|NCT03260205|155770985|FG002|Overall Study|Other: Unspecified|3|||
48432754|NCT03260205|155770986|FG003|Overall Study|Other: Unspecified|1|||
48432755|NCT03260205|155770987|FG004|Overall Study|Other: Unspecified|1|||
48432756|NCT03260205|155770983|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
48432757|NCT03260205|155770984|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
48432758|NCT03260205|155770985|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
48432759|NCT03260205|155770986|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
48432760|NCT03260205|155770987|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
48432761|NCT01423617|155770990|FG000|Overall Study|Lost to Follow-up|0|||
48432762|NCT01423617|155770991|FG001|Overall Study|Lost to Follow-up|1|||
48432763|NCT01515306|155770992|FG000|Overall Study|Adverse Event|3|||
48432764|NCT01515306|155770993|FG001|Overall Study|Adverse Event|2|||
48432765|NCT01515306|155770992|FG000|Overall Study|Progressive Disease|19|||
48432766|NCT01515306|155770993|FG001|Overall Study|Progressive Disease|9|||
48432767|NCT01515306|155770992|FG000|Overall Study|Withdrawal by Subject|1|||
48432768|NCT01515306|155770993|FG001|Overall Study|Withdrawal by Subject|2|||
48432769|NCT01515306|155770992|FG000|Overall Study|Physician Decision|1|||
48432770|NCT01515306|155770993|FG001|Overall Study|Physician Decision|1|||
48432771|NCT00634244|155770997|FG000|Overall Study|Never started treatment|0|||
48432772|NCT00634244|155770998|FG001|Overall Study|Never started treatment|1|||
48432773|NCT00634244|155770999|FG002|Overall Study|Never started treatment|0|||
48432774|NCT00634244|155770997|FG000|Overall Study|Death|1|||
48432775|NCT00634244|155770998|FG001|Overall Study|Death|6|||
48432776|NCT00634244|155770999|FG002|Overall Study|Death|0|||
48432777|NCT00634244|155770997|FG000|Overall Study|Adverse Event|0|||
48432778|NCT00634244|155770998|FG001|Overall Study|Adverse Event|2|||
48432779|NCT00634244|155770999|FG002|Overall Study|Adverse Event|0|||
48432780|NCT00634244|155770997|FG000|Overall Study|Withdrawal by Subject|0|||
48432781|NCT00634244|155770998|FG001|Overall Study|Withdrawal by Subject|1|||
48432782|NCT00634244|155770999|FG002|Overall Study|Withdrawal by Subject|0|||
48432783|NCT00634244|155770997|FG000|Overall Study|Physician Decision|0|||
48432784|NCT00634244|155770998|FG001|Overall Study|Physician Decision|1|||
48432785|NCT00634244|155770999|FG002|Overall Study|Physician Decision|0|||
48432786|NCT00634244|155770997|FG000|Overall Study|Disease progression/relapse|0|||
48432787|NCT00634244|155770998|FG001|Overall Study|Disease progression/relapse|1|||
48432788|NCT00634244|155770999|FG002|Overall Study|Disease progression/relapse|0|||
48432789|NCT00634244|155770997|FG000|Overall Study|Other complicating disease|0|||
48432790|NCT00634244|155770998|FG001|Overall Study|Other complicating disease|1|||
48432791|NCT00634244|155770999|FG002|Overall Study|Other complicating disease|0|||
48432792|NCT00369668|155771000|FG000|Overall Study|Lack of Efficacy|4|||
48432793|NCT00369668|155771001|FG001|Overall Study|Lack of Efficacy|5|||
48432794|NCT00369668|155771002|FG002|Overall Study|Lack of Efficacy|7|||
48432795|NCT01795898|155772942|FG000|Overall Study|Adverse Event|27|||
48432796|NCT01795898|155772942|FG000|Overall Study|Lost to Follow-up|20|||
48432797|NCT01795898|155772942|FG000|Overall Study|Withdrawal of consent|6|||
48432798|NCT01795898|155772942|FG000|Overall Study|Diagnosed with metastasis|1|||
48432799|NCT01795898|155772942|FG000|Overall Study|No pain|1|||
48432800|NCT01795898|155772942|FG000|Overall Study|Death|1|||
48432801|NCT01795898|155772942|FG000|Overall Study|Withdrew consent & had adverse events|3|||
48432802|NCT01795898|155772942|FG000|Overall Study|Physician Decision|1|||
48432803|NCT03539458|155772943|FG000|Overall Study|Death|1|||
48432804|NCT01826422|155772944|FG000|Overall Study|Withdrawal by Subject|1|||
48432805|NCT01826422|155772945|FG001|Overall Study|Withdrawal by Subject|3|||
48432806|NCT01395368|155772949|FG000|Overall Study|Physician Decision|14|||
48433655|NCT00789477|155774860|FG004|Overall Study|Other|0|||
48432807|NCT01395368|155772949|FG000|Overall Study|Withdrawal by Subject|2|||
48432808|NCT04263142|155772951|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
48432809|NCT04263142|155772952|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
48432810|NCT04263142|155772953|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
48432811|NCT04263142|155772954|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
48432812|NCT04263142|155772955|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
48432813|NCT04263142|155772951|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
48432814|NCT04263142|155772952|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
48432815|NCT04263142|155772953|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
48432816|NCT04263142|155772954|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
48432817|NCT04263142|155772955|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
48432818|NCT00372190|155772956|FG000|Overall Study|Lost to Follow-up|3|||
48432819|NCT00372190|155772957|FG001|Overall Study|Lost to Follow-up|1|||
48432820|NCT00718419|155772958|FG000|Overall Study|Adverse Event|2|||
48432821|NCT00718419|155772959|FG001|Overall Study|Adverse Event|1|||
48432822|NCT00718419|155772958|FG000|Overall Study|Physician Decision|1|||
48432823|NCT00718419|155772959|FG001|Overall Study|Physician Decision|6|||
48432824|NCT00718419|155772958|FG000|Overall Study|Sponsor decision|0|||
48432825|NCT00718419|155772959|FG001|Overall Study|Sponsor decision|1|||
48432826|NCT00718419|155772958|FG000|Overall Study|Withdrawal by Subject|0|||
48432827|NCT00718419|155772959|FG001|Overall Study|Withdrawal by Subject|5|||
48432828|NCT00718419|155772958|FG000|Overall Study|Progressive Disease|7|||
48432829|NCT00718419|155772959|FG001|Overall Study|Progressive Disease|25|||
48432830|NCT00718419|155772958|FG000|Overall Study|Death Due to Progressive Disease|2|||
48432831|NCT00718419|155772959|FG001|Overall Study|Death Due to Progressive Disease|0|||
48432832|NCT00718419|155772958|FG000|Overall Study|Death Due to Study Drug Related|0|||
48432833|NCT00718419|155772959|FG001|Overall Study|Death Due to Study Drug Related|1|||
48432834|NCT00718419|155772958|FG000|Overall Study|Death Due to Adverse Events|1|||
48432835|NCT00718419|155772959|FG001|Overall Study|Death Due to Adverse Events|0|||
48432836|NCT01597557|155772964|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
48432837|NCT01597557|155772965|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
48432838|NCT00782418|155772966|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
48432839|NCT00782418|155772967|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48432840|NCT00782418|155772968|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48432841|NCT00782418|155772969|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48432842|NCT00782418|155772970|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48432843|NCT00782418|155772971|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48432844|NCT00782418|155772972|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
48432845|NCT00782418|155772966|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
48432846|NCT00782418|155772967|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
48432847|NCT00782418|155772968|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
48432848|NCT00782418|155772969|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
48432849|NCT00782418|155772970|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
48432850|NCT00782418|155772971|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
48432851|NCT00782418|155772972|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
48432852|NCT03165721|155772975|FG000|Overall Study|Refused further treatment|3|||
48432853|NCT03165721|155772976|FG001|Overall Study|Refused further treatment|0|||
48432854|NCT03165721|155772977|FG002|Overall Study|Refused further treatment|0|||
48432855|NCT03165721|155772975|FG000|Overall Study|Physician Decision|1|||
48432856|NCT03165721|155772976|FG001|Overall Study|Physician Decision|0|||
48432857|NCT03165721|155772977|FG002|Overall Study|Physician Decision|0|||
48432858|NCT02488551|155772980|FG000|Overall Study|Lost to Follow-up|4|||
48432859|NCT02488551|155772981|FG001|Overall Study|Lost to Follow-up|7|||
48432860|NCT02488551|155772982|FG002|Overall Study|Lost to Follow-up|0|||
48432861|NCT02488551|155772983|FG003|Overall Study|Lost to Follow-up|0|||
48432862|NCT02488551|155772980|FG000|Overall Study|Military Deployment|1|||
48432863|NCT02488551|155772981|FG001|Overall Study|Military Deployment|1|||
48432864|NCT02488551|155772982|FG002|Overall Study|Military Deployment|0|||
48432865|NCT02488551|155772983|FG003|Overall Study|Military Deployment|0|||
48432866|NCT00798694|155772984|FG000|Overall Study|Lost to Follow-up|1|||
48432867|NCT00798694|155772985|FG001|Overall Study|Lost to Follow-up|1|||
48432868|NCT00798694|155772984|FG000|Overall Study|Physician Decision|1|||
48432869|NCT00798694|155772985|FG001|Overall Study|Physician Decision|0|||
48432870|NCT03364608|155772987|FG000|Overall Study|Withdrawal by Subject|4|||
48432871|NCT03364608|155772987|FG000|Overall Study|Protocol Violation|2|||
48432872|NCT03364608|155772987|FG000|Overall Study|Lost to Follow-up|2|||
48432873|NCT01753076|155772992|FG000|Overall Study|Adverse Event|17|||
48432874|NCT01753076|155772993|FG001|Overall Study|Adverse Event|18|||
48432875|NCT01753076|155772992|FG000|Overall Study|Lack of Efficacy|3|||
48432876|NCT01753076|155772993|FG001|Overall Study|Lack of Efficacy|1|||
48432877|NCT01753076|155772992|FG000|Overall Study|Lost to Follow-up|2|||
48432878|NCT01753076|155772993|FG001|Overall Study|Lost to Follow-up|1|||
48432879|NCT01753076|155772992|FG000|Overall Study|Physician Decision|4|||
48432880|NCT01753076|155772993|FG001|Overall Study|Physician Decision|2|||
48432881|NCT01753076|155772992|FG000|Overall Study|Withdrawal by Subject|14|||
48432882|NCT01753076|155772993|FG001|Overall Study|Withdrawal by Subject|24|||
48432883|NCT01753076|155772992|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
48432884|NCT01753076|155772993|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
48432885|NCT00436566|155772994|FG000|Overall Study|Withdrawal by Subject|2|||
48432886|NCT00436566|155772994|FG000|Overall Study|Protocol Violation|1|||
48432887|NCT02389816|155772995|FG000|Overall Study|Randomized but Not Treated|1|||
48432888|NCT02389816|155772996|FG001|Overall Study|Randomized but Not Treated|0|||
48432889|NCT02389816|155772997|FG002|Overall Study|Randomized but Not Treated|0|||
48432890|NCT02389816|155772995|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
48432891|NCT02389816|155772996|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
48432892|NCT02389816|155772997|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
48432893|NCT02389816|155772995|FG000|Overall Study|Major Protocol Deviation|1|||
48432894|NCT02389816|155772996|FG001|Overall Study|Major Protocol Deviation|0|||
48432895|NCT02389816|155772997|FG002|Overall Study|Major Protocol Deviation|0|||
48432896|NCT02389816|155772995|FG000|Overall Study|Lost to Follow-up|1|||
48432897|NCT02389816|155772996|FG001|Overall Study|Lost to Follow-up|0|||
48432898|NCT02389816|155772997|FG002|Overall Study|Lost to Follow-up|0|||
48432899|NCT02389816|155772995|FG000|Overall Study|Withdrawal of Consent|6|||
48432900|NCT02389816|155772996|FG001|Overall Study|Withdrawal of Consent|4|||
48432901|NCT02389816|155772997|FG002|Overall Study|Withdrawal of Consent|4|||
48432902|NCT02389816|155772995|FG000|Overall Study|Lack of Efficacy|1|||
48432903|NCT02389816|155772996|FG001|Overall Study|Lack of Efficacy|0|||
48432904|NCT02389816|155772997|FG002|Overall Study|Lack of Efficacy|0|||
48432905|NCT02389816|155772995|FG000|Overall Study|Non Compliance with Study Drug|1|||
48432906|NCT02389816|155772996|FG001|Overall Study|Non Compliance with Study Drug|1|||
48432907|NCT02389816|155772997|FG002|Overall Study|Non Compliance with Study Drug|1|||
48432908|NCT02389816|155772995|FG000|Overall Study|Reason not Specified|0|||
48432909|NCT02389816|155772996|FG001|Overall Study|Reason not Specified|2|||
48432910|NCT02389816|155772997|FG002|Overall Study|Reason not Specified|0|||
48432911|NCT00471536|155772998|FG000|Overall Study|Withdrawal by Subject|1|||
48432912|NCT02651194|155772999|FG000|Overall Study|Lost to Follow-up|3|||
48432913|NCT02651194|155772999|FG000|Overall Study|Other|2|||
48432914|NCT01259856|155773000|FG000|Overall Study|Adverse Event|12|||
48432915|NCT01259856|155773001|FG001|Overall Study|Adverse Event|9|||
48432916|NCT01259856|155773000|FG000|Overall Study|Death|0|||
48432917|NCT01259856|155773001|FG001|Overall Study|Death|1|||
48432918|NCT01259856|155773000|FG000|Overall Study|Lack of Efficacy|3|||
48432919|NCT01259856|155773001|FG001|Overall Study|Lack of Efficacy|1|||
48432920|NCT01259856|155773000|FG000|Overall Study|Lost to Follow-up|1|||
48432921|NCT01259856|155773001|FG001|Overall Study|Lost to Follow-up|1|||
48432922|NCT01259856|155773000|FG000|Overall Study|Physician Decision|2|||
48432923|NCT01259856|155773001|FG001|Overall Study|Physician Decision|1|||
48432924|NCT01259856|155773000|FG000|Overall Study|Withdrawal by Subject|9|||
48432925|NCT01259856|155773001|FG001|Overall Study|Withdrawal by Subject|10|||
48432926|NCT01259856|155773000|FG000|Overall Study|Treatment never started|0|||
48432927|NCT01259856|155773001|FG001|Overall Study|Treatment never started|6|||
48432928|NCT01259856|155773000|FG000|Overall Study|Study closure by sponsor|40|||
48432929|NCT01259856|155773001|FG001|Overall Study|Study closure by sponsor|41|||
48432930|NCT01259856|155773000|FG000|Overall Study|Patient developed other disease|0|||
48432931|NCT01259856|155773001|FG001|Overall Study|Patient developed other disease|1|||
48432932|NCT01259856|155773000|FG000|Overall Study|Transfer to another study|0|||
48432933|NCT01259856|155773001|FG001|Overall Study|Transfer to another study|1|||
48432934|NCT01259856|155773000|FG000|Overall Study|Unknown/missing|2|||
48432935|NCT01259856|155773001|FG001|Overall Study|Unknown/missing|2|||
48432936|NCT01860534|155773002|FG000|ROP #1|Needed treatment for ROP|0|||
48432937|NCT01860534|155773003|FG001|ROP #1|Needed treatment for ROP|1|||
48432938|NCT01860534|155773002|FG000|ROP #2|discharged prior to ROP #2|1|||
48432939|NCT01860534|155773003|FG001|ROP #2|discharged prior to ROP #2|0|||
48432940|NCT04504032|155773004|FG000|Overall Study|Adverse Event|1|||
48432941|NCT04504032|155773005|FG001|Overall Study|Adverse Event|2|||
48432942|NCT04504032|155773004|FG000|Overall Study|Lost to Follow-up|6|||
48432943|NCT04504032|155773005|FG001|Overall Study|Lost to Follow-up|9|||
48432944|NCT04504032|155773004|FG000|Overall Study|Protocol Violation|2|||
48432945|NCT04504032|155773005|FG001|Overall Study|Protocol Violation|0|||
48432946|NCT04504032|155773004|FG000|Overall Study|Study terminated by sponsor|1|||
48432947|NCT04504032|155773005|FG001|Overall Study|Study terminated by sponsor|2|||
48432948|NCT04504032|155773004|FG000|Overall Study|Withdrawal by Subject|9|||
48432949|NCT04504032|155773005|FG001|Overall Study|Withdrawal by Subject|11|||
48432950|NCT04504032|155773004|FG000|Overall Study|Disease progression prior to dosing|15|||
48432951|NCT04504032|155773005|FG001|Overall Study|Disease progression prior to dosing|3|||
48432952|NCT04504032|155773004|FG000|Overall Study|Drug supply issues|1|||
48432953|NCT04504032|155773005|FG001|Overall Study|Drug supply issues|1|||
48432954|NCT04504032|155773004|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
48432955|NCT04504032|155773005|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
48432956|NCT01842308|155773010|FG000|Overall Study|Withdrawal by Subject|0|||
48432957|NCT01842308|155773011|FG001|Overall Study|Withdrawal by Subject|0|||
48432958|NCT01842308|155773012|FG002|Overall Study|Withdrawal by Subject|0|||
48432959|NCT01842308|155773013|FG003|Overall Study|Withdrawal by Subject|0|||
48432960|NCT01842308|155773014|FG004|Overall Study|Withdrawal by Subject|1|||
48432961|NCT00788775|155773015|FG000|Overall Study|Progressive Disease|8|||
48432962|NCT00788775|155773016|FG001|Overall Study|Progressive Disease|6|||
48432963|NCT00788775|155773015|FG000|Overall Study|Withdrawal by Subject|0|||
48432964|NCT00788775|155773016|FG001|Overall Study|Withdrawal by Subject|2|||
48432965|NCT00788775|155773015|FG000|Overall Study|Patient Non-Compliance|1|||
48432966|NCT00788775|155773016|FG001|Overall Study|Patient Non-Compliance|0|||
48432967|NCT00788775|155773015|FG000|Overall Study|Patient's measurable disease resected.|1|||
48432968|NCT00788775|155773016|FG001|Overall Study|Patient's measurable disease resected.|0|||
48432969|NCT00578864|155773017|FG000|Overall Study|Death|1|||
48432970|NCT00578864|155773018|FG001|Overall Study|Death|0|||
48432971|NCT01702363|155773019|FG000|Overall Study|Adverse Event|14|||
48432972|NCT01702363|155773019|FG000|Overall Study|Lack of Efficacy|4|||
48432973|NCT01702363|155773019|FG000|Overall Study|Withdrawal by Subject|2|||
48432974|NCT00069576|155773028|FG000|Original Trial|Lost to Follow-up|25|||
48432975|NCT00069576|155773029|FG001|Original Trial|Lost to Follow-up|33|||
48432976|NCT00069576|155773028|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
48432977|NCT00069576|155773029|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
48432978|NCT00446446|155773031|FG000|Overall Study|Death|10|||
48432979|NCT00446446|155773031|FG000|Overall Study|Withdrawal by Subject|6|||
48432980|NCT00446446|155773031|FG000|Overall Study|Other|4|||
48432981|NCT00446446|155773031|FG000|Overall Study|Disease Progession|2|||
48432982|NCT00446446|155773031|FG000|Overall Study|Adverse Event|1|||
48432983|NCT00446446|155773031|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
48432984|NCT02509598|155773032|FG000|Overall Study|Withdrawal by Subject|1|||
48432985|NCT01952834|155773040|FG000|Overall Study|Adverse Event|1|||
48432986|NCT00303108|155773043|FG000|Overall Study|Adverse Event|5|||
48432987|NCT00303108|155773044|FG001|Overall Study|Adverse Event|6|||
48432988|NCT00303108|155773045|FG002|Overall Study|Adverse Event|7|||
48432989|NCT00303108|155773043|FG000|Overall Study|Patient Request|4|||
48432990|NCT00303108|155773044|FG001|Overall Study|Patient Request|2|||
48432991|NCT00303108|155773045|FG002|Overall Study|Patient Request|8|||
48432992|NCT00303108|155773043|FG000|Overall Study|Failed Entry|1|||
48432993|NCT00303108|155773044|FG001|Overall Study|Failed Entry|0|||
48432994|NCT00303108|155773045|FG002|Overall Study|Failed Entry|1|||
48432995|NCT00303108|155773043|FG000|Overall Study|ineligible|2|||
48432996|NCT00303108|155773044|FG001|Overall Study|ineligible|1|||
48432997|NCT00303108|155773045|FG002|Overall Study|ineligible|0|||
48432998|NCT03201198|155773046|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
48432999|NCT03201198|155773047|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
48433000|NCT03201198|155773046|FG000|Overall Study|Withdrawal by Subject|2|||
48433001|NCT03201198|155773047|FG001|Overall Study|Withdrawal by Subject|3|||
48433002|NCT02149836|155773050|FG000|Overall Study|Withdrawal by Subject|1|||
48433003|NCT03855137|155773054|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
48433004|NCT03855137|155773055|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
48433005|NCT03855137|155773056|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
48433006|NCT03855137|155773054|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
48433007|NCT03855137|155773055|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
48433008|NCT03855137|155773056|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
48433009|NCT03855137|155773054|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
48433010|NCT03855137|155773055|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
48433011|NCT03855137|155773056|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
48433012|NCT03855137|155773054|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
48433013|NCT03855137|155773055|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
48433014|NCT03855137|155773056|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
48433015|NCT03855137|155773054|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
48433016|NCT03855137|155773055|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
48433017|NCT03855137|155773056|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
48433018|NCT03855137|155773054|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
48433019|NCT03855137|155773055|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
48433020|NCT03855137|155773056|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
48433021|NCT03855137|155773054|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
48433022|NCT03855137|155773055|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
48433023|NCT03855137|155773056|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
48433024|NCT03855137|155773054|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
48433025|NCT03855137|155773055|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
48433026|NCT03855137|155773056|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
48433027|NCT03855137|155773054|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
48433028|NCT03855137|155773055|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
48433029|NCT03855137|155773056|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
48433030|NCT03855137|155773054|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
48433031|NCT03855137|155773055|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
48433032|NCT03855137|155773056|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
48433033|NCT01745393|155773057|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
48433034|NCT01745393|155773058|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
48433035|NCT01745393|155773057|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
48433036|NCT01745393|155773058|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
48433037|NCT01745393|155773057|FG000|12-month Follow-up|Lost to Follow-up|6|||
48433038|NCT01745393|155773058|FG001|12-month Follow-up|Lost to Follow-up|5|||
48433039|NCT04799405|155773059|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
48433040|NCT00471445|155773063|FG000|Overall Study|Withdrawal by Subject|1|||
48433041|NCT00471445|155773064|FG001|Overall Study|Withdrawal by Subject|1|||
48433042|NCT00471445|155773063|FG000|Overall Study|Ineligible|1|||
48433043|NCT00471445|155773064|FG001|Overall Study|Ineligible|0|||
48433044|NCT00471445|155773063|FG000|Overall Study|Protocol Violation|0|||
48433045|NCT00471445|155773064|FG001|Overall Study|Protocol Violation|1|||
48433046|NCT02427477|155773065|FG000|Period 1|Adverse Event|1|||
48433047|NCT02427477|155773066|FG001|Period 1|Adverse Event|0|||
48433048|NCT02280291|155773067|FG000|Overall Study|Lost to Follow-up|2|||
48433049|NCT02280291|155773068|FG001|Overall Study|Lost to Follow-up|1|||
48433050|NCT02280291|155773069|FG002|Overall Study|Lost to Follow-up|3|||
48433051|NCT02280291|155773070|FG003|Overall Study|Lost to Follow-up|8|||
48433052|NCT02280291|155773067|FG000|Overall Study|Protocol Violation|1|||
48433053|NCT02280291|155773068|FG001|Overall Study|Protocol Violation|0|||
48433054|NCT02280291|155773069|FG002|Overall Study|Protocol Violation|0|||
48433055|NCT02280291|155773070|FG003|Overall Study|Protocol Violation|0|||
48433056|NCT02280291|155773067|FG000|Overall Study|Other|1|||
48433057|NCT02280291|155773068|FG001|Overall Study|Other|1|||
48433058|NCT02280291|155773069|FG002|Overall Study|Other|0|||
48433059|NCT02280291|155773070|FG003|Overall Study|Other|0|||
48433060|NCT00986258|155773071|FG000|Observation Period|Not eligible to be dosed|11|||
48433061|NCT00986258|155773071|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
48433062|NCT00986258|155773071|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
48433063|NCT00986258|155773071|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
48433064|NCT00986258|155773071|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
48433065|NCT00986258|155773071|FG000|Titration and Optimal Dose Period|Other|1|||
48433066|NCT00986258|155773071|FG000|Maintenance Period|Adverse Event|5|||
48433067|NCT00986258|155773071|FG000|Maintenance Period|Lack of Efficacy|2|||
48433068|NCT00986258|155773071|FG000|Maintenance Period|Withdrawal by Subject|2|||
48433069|NCT00603980|155773075|FG000|Study Qualification|Protocol Violation|3|||
48433070|NCT00603980|155773075|FG000|Study Qualification|Inconsistent data reporting|13|||
48433071|NCT00603980|155773075|FG000|Main Study|14th subject completed trial|1|||
48433072|NCT03591146|155773078|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
48433073|NCT03591146|155773079|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
48433074|NCT03591146|155773080|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
48433075|NCT03591146|155773081|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
48433076|NCT03591146|155773082|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
48433077|NCT03591146|155773078|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
48433078|NCT03591146|155773079|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
48433079|NCT03591146|155773080|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
48433080|NCT03591146|155773081|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
48433081|NCT03591146|155773082|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
48433082|NCT03591146|155773078|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
48433083|NCT03591146|155773079|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
48433084|NCT03591146|155773080|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
48433085|NCT03591146|155773081|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
48433086|NCT03591146|155773082|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
48433087|NCT03591146|155773078|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
48433088|NCT03591146|155773079|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
48433089|NCT03591146|155773080|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
48433090|NCT03591146|155773081|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
48433091|NCT03591146|155773082|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
48433092|NCT04737031|155773083|FG000|Overall Study|Patients who did not have a treatment visit|0|||
48433093|NCT04737031|155773084|FG001|Overall Study|Patients who did not have a treatment visit|31|||
48433094|NCT04737031|155773085|FG002|Overall Study|Patients who did not have a treatment visit|93|||
48433095|NCT04737031|155773086|FG003|Overall Study|Patients who did not have a treatment visit|227|||
48433096|NCT02773238|155773087|FG000|Overall Study|Lack of Efficacy|4|||
48433097|NCT04369430|155773088|FG000|Overall Study|Adverse Event|2|||
48433098|NCT04369430|155773089|FG001|Overall Study|Adverse Event|3|||
48433099|NCT04369430|155773088|FG000|Overall Study|Death|1|||
48433100|NCT04369430|155773089|FG001|Overall Study|Death|0|||
48433101|NCT04369430|155773088|FG000|Overall Study|Withdrawal by Subject|4|||
48433102|NCT04369430|155773089|FG001|Overall Study|Withdrawal by Subject|3|||
48433103|NCT04369430|155773088|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
48433104|NCT04369430|155773089|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
48433105|NCT04369430|155773088|FG000|Overall Study|Lost to Follow-up|0|||
48433106|NCT04369430|155773089|FG001|Overall Study|Lost to Follow-up|1|||
48433107|NCT01208038|155773092|FG000|Overall Study|Withdrawal by Subject|1|||
48433108|NCT01029002|155773093|FG000|Overall Study|Lost to Follow-up|2|||
48433109|NCT01029002|155773094|FG001|Overall Study|Lost to Follow-up|4|||
48433110|NCT02683525|155773100|FG000|Overall Study|Lost to Follow-up|1|||
48433111|NCT02683525|155773100|FG000|Overall Study|Physician Decision|1|||
48433112|NCT02683525|155773100|FG000|Overall Study|Disease Progression|6|||
48433113|NCT02164513|155773105|FG000|Overall Study|Adverse Event|162|||
48433114|NCT02164513|155773106|FG001|Overall Study|Adverse Event|180|||
48433115|NCT02164513|155773107|FG002|Overall Study|Adverse Event|111|||
48433116|NCT02164513|155773105|FG000|Overall Study|Other: Study Closed or terminated|5|||
48433117|NCT02164513|155773106|FG001|Overall Study|Other: Study Closed or terminated|2|||
48433118|NCT02164513|155773107|FG002|Overall Study|Other: Study Closed or terminated|4|||
48433119|NCT02164513|155773105|FG000|Overall Study|Lost to Follow-up|30|||
48433120|NCT02164513|155773106|FG001|Overall Study|Lost to Follow-up|36|||
48433121|NCT02164513|155773107|FG002|Overall Study|Lost to Follow-up|22|||
48433122|NCT02164513|155773105|FG000|Overall Study|Physician Decision|47|||
48433123|NCT02164513|155773106|FG001|Overall Study|Physician Decision|57|||
48433124|NCT02164513|155773107|FG002|Overall Study|Physician Decision|28|||
48433125|NCT02164513|155773105|FG000|Overall Study|Withdrawal by Subject|192|||
48433126|NCT02164513|155773106|FG001|Overall Study|Withdrawal by Subject|261|||
48433127|NCT02164513|155773107|FG002|Overall Study|Withdrawal by Subject|130|||
48433128|NCT02164513|155773105|FG000|Overall Study|Other: Reason not provided by site|1|||
48433129|NCT02164513|155773106|FG001|Overall Study|Other: Reason not provided by site|0|||
48433130|NCT02164513|155773107|FG002|Overall Study|Other: Reason not provided by site|0|||
48433131|NCT01005732|155773108|FG000|Overall Study|Lost to Follow-up|10|||
48433132|NCT01005732|155773108|FG000|Overall Study|Death|1|||
48433133|NCT02635737|155773109|FG000|Overall Study|Protocol Violation|1|||
48433134|NCT03215706|155773110|FG000|Randomization|Adverse Event unrelated to study drug|1|||
48433135|NCT03215706|155773111|FG001|Randomization|Adverse Event unrelated to study drug|0|||
48433136|NCT03215706|155773110|FG000|Randomization|participant withdrew consent|1|||
48433137|NCT03215706|155773111|FG001|Randomization|participant withdrew consent|3|||
48433138|NCT03215706|155773110|FG000|Randomization|no longer meets study criteria|1|||
48433139|NCT03215706|155773111|FG001|Randomization|no longer meets study criteria|4|||
48433140|NCT03215706|155773110|FG000|Randomization|other reasons|0|||
48433141|NCT03215706|155773111|FG001|Randomization|other reasons|2|||
48433142|NCT03215706|155773110|FG000|Treatment Period|Disease Progression|150|||
48433143|NCT03215706|155773111|FG001|Treatment Period|Disease Progression|142|||
48433144|NCT03215706|155773110|FG000|Treatment Period|Study Drug Toxicity|53|||
48433145|NCT03215706|155773111|FG001|Treatment Period|Study Drug Toxicity|21|||
48433146|NCT03215706|155773110|FG000|Treatment Period|Death|2|||
48433147|NCT03215706|155773111|FG001|Treatment Period|Death|1|||
48433148|NCT03215706|155773110|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
48433149|NCT03215706|155773111|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
48433150|NCT03215706|155773110|FG000|Treatment Period|Request to D/C treatment|1|||
48433151|NCT03215706|155773111|FG001|Treatment Period|Request to D/C treatment|6|||
48433152|NCT03215706|155773110|FG000|Treatment Period|Participant withdrew consent|3|||
48433153|NCT03215706|155773111|FG001|Treatment Period|Participant withdrew consent|4|||
48433154|NCT03215706|155773110|FG000|Treatment Period|Lost to Follow-up|0|||
48433155|NCT03215706|155773111|FG001|Treatment Period|Lost to Follow-up|1|||
48433156|NCT03215706|155773110|FG000|Treatment Period|Other Reasons|4|||
48433157|NCT03215706|155773111|FG001|Treatment Period|Other Reasons|5|||
48433158|NCT03215706|155773110|FG000|Treatment Period|Ongoing in the treatment period|105|||
48433159|NCT03215706|155773111|FG001|Treatment Period|Ongoing in the treatment period|43|||
48433160|NCT05349838|155773112|FG000|Overall Study|Virological Failure|1|||
48433161|NCT05349838|155773113|FG001|Overall Study|Virological Failure|2|||
48433162|NCT05349838|155773112|FG000|Overall Study|Withdrawal by Subject|2|||
48433163|NCT05349838|155773113|FG001|Overall Study|Withdrawal by Subject|3|||
48433164|NCT05349838|155773112|FG000|Overall Study|Adverse Event|3|||
48433165|NCT05349838|155773113|FG001|Overall Study|Adverse Event|1|||
48433166|NCT05349838|155773112|FG000|Overall Study|Lost to Follow-up|1|||
48433167|NCT05349838|155773113|FG001|Overall Study|Lost to Follow-up|2|||
48433168|NCT05349838|155773112|FG000|Overall Study|Other reasons|5|||
48433169|NCT05349838|155773113|FG001|Overall Study|Other reasons|1|||
48587226|NCT01004432|156343157|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
48587227|NCT01004432|156343158|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
48587228|NCT01004432|156343159|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
48587229|NCT01004432|156343155|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
48587230|NCT01004432|156343156|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
48587231|NCT01004432|156343157|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
48433210|NCT01043185|155774723|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
48433211|NCT01043185|155774724|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
48433212|NCT01043185|155774725|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
48433213|NCT01043185|155774726|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
48433214|NCT01043185|155774727|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
48433215|NCT01043185|155774728|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
48433216|NCT01043185|155774729|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
48433217|NCT01043185|155774730|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
48433218|NCT01043185|155774731|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
48433219|NCT01043185|155774732|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
48433220|NCT02125331|155774735|FG000|Overall Study|Protocol Violation|1|||
48433221|NCT02125331|155774736|FG001|Overall Study|Protocol Violation|0|||
48433222|NCT02125331|155774735|FG000|Overall Study|technical problem|2|||
48433223|NCT02125331|155774736|FG001|Overall Study|technical problem|0|||
48433224|NCT02125331|155774735|FG000|Overall Study|screen failure|2|||
48433225|NCT02125331|155774736|FG001|Overall Study|screen failure|0|||
48433226|NCT00137436|155774737|FG000|Overall Study|Adverse Event|13|||
48433227|NCT00137436|155774737|FG000|Overall Study|Death|2|||
48433228|NCT00137436|155774737|FG000|Overall Study|Lack of Efficacy|17|||
48433229|NCT00137436|155774737|FG000|Overall Study|Withdrawal by Subject|6|||
48433230|NCT00137436|155774737|FG000|Overall Study|Other|5|||
48433231|NCT00165646|155774738|FG000|Overall Study|Adverse Event|1|||
48433232|NCT00165646|155774739|FG001|Overall Study|Adverse Event|1|||
48433233|NCT00165646|155774740|FG002|Overall Study|Adverse Event|1|||
48433234|NCT00165646|155774738|FG000|Overall Study|Lack of Efficacy|1|||
48433235|NCT00165646|155774739|FG001|Overall Study|Lack of Efficacy|2|||
48433236|NCT00165646|155774740|FG002|Overall Study|Lack of Efficacy|0|||
48433237|NCT00165646|155774738|FG000|Overall Study|Withdrawal by Subject|0|||
48433238|NCT00165646|155774739|FG001|Overall Study|Withdrawal by Subject|2|||
48433239|NCT00165646|155774740|FG002|Overall Study|Withdrawal by Subject|1|||
48433240|NCT00165646|155774738|FG000|Overall Study|Physician Decision|2|||
48433241|NCT00165646|155774739|FG001|Overall Study|Physician Decision|0|||
48433242|NCT00165646|155774740|FG002|Overall Study|Physician Decision|2|||
48433243|NCT00165646|155774738|FG000|Overall Study|Protocol Violation|1|||
48433244|NCT00165646|155774739|FG001|Overall Study|Protocol Violation|0|||
48433245|NCT00165646|155774740|FG002|Overall Study|Protocol Violation|0|||
48433246|NCT03009539|155774741|FG000|Overall Study|Lost to Follow-up|132|||
48433247|NCT03009539|155774742|FG001|Overall Study|Lost to Follow-up|113|||
48433248|NCT03009539|155774743|FG002|Overall Study|Lost to Follow-up|132|||
48433249|NCT03009539|155774744|FG003|Overall Study|Lost to Follow-up|113|||
48433250|NCT03151148|155774745|FG000|Overall Study|Lost to Follow-up|1|||
48433251|NCT03151148|155774746|FG001|Overall Study|Lost to Follow-up|0|||
48433252|NCT03151148|155774745|FG000|Overall Study|Withdrawal by Subject|1|||
48433253|NCT03151148|155774746|FG001|Overall Study|Withdrawal by Subject|0|||
48433254|NCT04657016|155774747|FG000|Overall Study|Adverse Event|2|||
48433255|NCT04657016|155774748|FG001|Overall Study|Adverse Event|4|||
48433256|NCT04657016|155774747|FG000|Overall Study|Death|1|||
48433257|NCT04657016|155774748|FG001|Overall Study|Death|1|||
48433258|NCT04657016|155774747|FG000|Overall Study|Lost to Follow-up|24|||
48433259|NCT04657016|155774748|FG001|Overall Study|Lost to Follow-up|12|||
48433260|NCT04657016|155774747|FG000|Overall Study|Physician Decision|1|||
48433261|NCT04657016|155774748|FG001|Overall Study|Physician Decision|2|||
48433262|NCT04657016|155774747|FG000|Overall Study|Pregnancy|2|||
48433263|NCT04657016|155774748|FG001|Overall Study|Pregnancy|2|||
48433264|NCT04657016|155774747|FG000|Overall Study|Protocol Deviation|1|||
48433265|NCT04657016|155774748|FG001|Overall Study|Protocol Deviation|0|||
48433266|NCT04657016|155774747|FG000|Overall Study|Withdrawal by Subject|28|||
48433267|NCT04657016|155774748|FG001|Overall Study|Withdrawal by Subject|14|||
48433268|NCT04657016|155774747|FG000|Overall Study|Other - as reported by the investigator|6|||
48433269|NCT04657016|155774748|FG001|Overall Study|Other - as reported by the investigator|0|||
48433270|NCT00701727|155774750|FG000|First Treatment Period|Adverse Event|0|||
48433271|NCT00701727|155774751|FG001|First Treatment Period|Adverse Event|0|||
48433272|NCT00701727|155774750|FG000|First Treatment Period|Withdrawal by Subject|1|||
48433273|NCT00701727|155774751|FG001|First Treatment Period|Withdrawal by Subject|0|||
48433274|NCT00701727|155774750|FG000|First Treatment Period|sponsor decision|0|||
48433275|NCT00701727|155774751|FG001|First Treatment Period|sponsor decision|1|||
48433276|NCT00701727|155774750|FG000|First Treatment Period|Lost to Follow-up|0|||
48433277|NCT00701727|155774751|FG001|First Treatment Period|Lost to Follow-up|1|||
48433278|NCT00701727|155774750|FG000|Second Treatment Period|Withdrawal by Subject|2|||
48433279|NCT00701727|155774751|FG001|Second Treatment Period|Withdrawal by Subject|0|||
48433280|NCT00710034|155774752|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
48433281|NCT00710034|155774753|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
48433282|NCT00710034|155774752|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
48433283|NCT00710034|155774753|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
48433284|NCT00710034|155774752|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
48433285|NCT00710034|155774753|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
48433286|NCT00710034|155774752|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
48433287|NCT00710034|155774753|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
48433288|NCT00710034|155774752|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
48433289|NCT00710034|155774753|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
48433290|NCT00710034|155774752|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
48433291|NCT00710034|155774753|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
48433292|NCT00710034|155774752|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
48433293|NCT00710034|155774753|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
48433294|NCT00710034|155774752|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
48433295|NCT00710034|155774753|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
48433296|NCT00710034|155774752|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
48433297|NCT00710034|155774753|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
48433298|NCT00710034|155774752|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
48433299|NCT00710034|155774753|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
48433300|NCT00710034|155774752|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
48433301|NCT00710034|155774753|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
48433302|NCT02078713|155774754|FG000|Overall Study|Lost to Follow-up|49|||
48433303|NCT02078713|155774755|FG001|Overall Study|Lost to Follow-up|55|||
48433304|NCT02078713|155774756|FG002|Overall Study|Lost to Follow-up|0|||
48433305|NCT02078713|155774757|FG003|Overall Study|Lost to Follow-up|0|||
48433306|NCT02078713|155774754|FG000|Overall Study|Pregnant at baseline|3|||
48433307|NCT02078713|155774755|FG001|Overall Study|Pregnant at baseline|5|||
48433308|NCT02078713|155774756|FG002|Overall Study|Pregnant at baseline|0|||
48433309|NCT02078713|155774757|FG003|Overall Study|Pregnant at baseline|0|||
48433310|NCT02078713|155774754|FG000|Overall Study|Enrolled twice|0|||
48433311|NCT02078713|155774755|FG001|Overall Study|Enrolled twice|1|||
48433312|NCT02078713|155774756|FG002|Overall Study|Enrolled twice|0|||
48433313|NCT02078713|155774757|FG003|Overall Study|Enrolled twice|0|||
48433314|NCT00028002|155774763|FG000|Overall Study|Withdrawal by Subject|3|||
48433315|NCT00028002|155774763|FG000|Overall Study|Ineligible|8|||
48433316|NCT01793051|155774764|FG000|Overall Study|Withdrawal by Subject|6|||
48433317|NCT01793051|155774765|FG001|Overall Study|Withdrawal by Subject|4|||
48433318|NCT01793051|155774764|FG000|Overall Study|Adverse Event|0|||
48433319|NCT01793051|155774765|FG001|Overall Study|Adverse Event|2|||
48433320|NCT01793051|155774764|FG000|Overall Study|Too ill to continue|1|||
48433321|NCT01793051|155774765|FG001|Overall Study|Too ill to continue|0|||
48433322|NCT01793051|155774764|FG000|Overall Study|Switched chemo|1|||
48433323|NCT01793051|155774765|FG001|Overall Study|Switched chemo|1|||
48433324|NCT01793051|155774764|FG000|Overall Study|Lack of compliance|1|||
48433325|NCT01793051|155774765|FG001|Overall Study|Lack of compliance|0|||
48433326|NCT01793051|155774764|FG000|Overall Study|Requested to be removed from the study|1|||
48433327|NCT01793051|155774765|FG001|Overall Study|Requested to be removed from the study|1|||
48433328|NCT01328249|155774768|FG000|Overall Study|Adverse Event|3|||
48433329|NCT01328249|155774769|FG001|Overall Study|Adverse Event|0|||
48433330|NCT01328249|155774768|FG000|Overall Study|Disease progression|1|||
48433331|NCT01328249|155774769|FG001|Overall Study|Disease progression|0|||
48433332|NCT01328249|155774768|FG000|Overall Study|Withdrawal by Subject|1|||
48433333|NCT01328249|155774769|FG001|Overall Study|Withdrawal by Subject|1|||
48433334|NCT01328249|155774768|FG000|Overall Study|Moved before end of treatment visit|1|||
48433335|NCT01328249|155774769|FG001|Overall Study|Moved before end of treatment visit|0|||
48433336|NCT01328249|155774768|FG000|Overall Study|Subject choice|1|||
48433337|NCT01328249|155774769|FG001|Overall Study|Subject choice|1|||
48433338|NCT01328249|155774768|FG000|Overall Study|Protocol Violation|0|||
48433339|NCT01328249|155774769|FG001|Overall Study|Protocol Violation|1|||
48433340|NCT00059215|155774771|FG000|Overall Study|Adverse Event|5|||
48433341|NCT00059215|155774772|FG001|Overall Study|Adverse Event|5|||
48433342|NCT00059215|155774773|FG002|Overall Study|Adverse Event|9|||
48433343|NCT00059215|155774774|FG003|Overall Study|Adverse Event|9|||
48433344|NCT00059215|155774771|FG000|Overall Study|Death|0|||
48433345|NCT00059215|155774772|FG001|Overall Study|Death|0|||
48433346|NCT00059215|155774773|FG002|Overall Study|Death|3|||
48433347|NCT00059215|155774774|FG003|Overall Study|Death|0|||
48433348|NCT00059215|155774771|FG000|Overall Study|Lost to Follow-up|1|||
48433349|NCT00059215|155774772|FG001|Overall Study|Lost to Follow-up|2|||
48433350|NCT00059215|155774773|FG002|Overall Study|Lost to Follow-up|0|||
48433351|NCT00059215|155774774|FG003|Overall Study|Lost to Follow-up|0|||
48433352|NCT00059215|155774771|FG000|Overall Study|Withdrawal by Subject|4|||
48433353|NCT00059215|155774772|FG001|Overall Study|Withdrawal by Subject|4|||
48433354|NCT00059215|155774773|FG002|Overall Study|Withdrawal by Subject|1|||
48433355|NCT00059215|155774774|FG003|Overall Study|Withdrawal by Subject|3|||
48433356|NCT00059215|155774771|FG000|Overall Study|Protocol Violation|1|||
48433357|NCT00059215|155774772|FG001|Overall Study|Protocol Violation|0|||
48433358|NCT00059215|155774773|FG002|Overall Study|Protocol Violation|1|||
48433359|NCT00059215|155774774|FG003|Overall Study|Protocol Violation|0|||
48433360|NCT00059215|155774771|FG000|Overall Study|Protocol entry criteria not met|1|||
48433361|NCT00059215|155774772|FG001|Overall Study|Protocol entry criteria not met|1|||
48433362|NCT00059215|155774773|FG002|Overall Study|Protocol entry criteria not met|0|||
48433363|NCT00059215|155774774|FG003|Overall Study|Protocol entry criteria not met|2|||
48433364|NCT00059215|155774771|FG000|Overall Study|Physician Decision|1|||
48433365|NCT00059215|155774772|FG001|Overall Study|Physician Decision|2|||
48433366|NCT00059215|155774773|FG002|Overall Study|Physician Decision|1|||
48433367|NCT00059215|155774774|FG003|Overall Study|Physician Decision|1|||
48433368|NCT04439838|155774775|FG000|Overall Study|Withdrawal by Subject|0|||
48433369|NCT04439838|155774776|FG001|Overall Study|Withdrawal by Subject|0|||
48433370|NCT04439838|155774777|FG002|Overall Study|Withdrawal by Subject|0|||
48433371|NCT04439838|155774778|FG003|Overall Study|Withdrawal by Subject|0|||
48433372|NCT04439838|155774779|FG004|Overall Study|Withdrawal by Subject|0|||
48433373|NCT04439838|155774780|FG005|Overall Study|Withdrawal by Subject|0|||
48433374|NCT04439838|155774781|FG006|Overall Study|Withdrawal by Subject|0|||
48433375|NCT04439838|155774782|FG007|Overall Study|Withdrawal by Subject|0|||
48433376|NCT04439838|155774783|FG008|Overall Study|Withdrawal by Subject|1|||
48433377|NCT01361009|155774784|FG000|Overall Study|Protocol Violation|116|||
48433378|NCT01830543|155774785|FG000|Overall Study|Subject Decision|19|||
48433379|NCT01830543|155774786|FG001|Overall Study|Subject Decision|21|||
48433380|NCT01830543|155774787|FG002|Overall Study|Subject Decision|57|||
48433381|NCT01830543|155774785|FG000|Overall Study|Adverse Event|91|||
48433382|NCT01830543|155774786|FG001|Overall Study|Adverse Event|77|||
48433383|NCT01830543|155774787|FG002|Overall Study|Adverse Event|76|||
48433384|NCT01830543|155774785|FG000|Overall Study|Death|20|||
48433385|NCT01830543|155774786|FG001|Overall Study|Death|22|||
48433386|NCT01830543|155774787|FG002|Overall Study|Death|22|||
48433387|NCT01830543|155774785|FG000|Overall Study|Protocol Violation|3|||
48433388|NCT01830543|155774786|FG001|Overall Study|Protocol Violation|7|||
48433389|NCT01830543|155774787|FG002|Overall Study|Protocol Violation|7|||
48433390|NCT01830543|155774785|FG000|Overall Study|Physician Decision|11|||
48433391|NCT01830543|155774786|FG001|Overall Study|Physician Decision|5|||
48433392|NCT01830543|155774787|FG002|Overall Study|Physician Decision|12|||
48433393|NCT01830543|155774785|FG000|Overall Study|Withdrawal by consent|3|||
48433394|NCT01830543|155774786|FG001|Overall Study|Withdrawal by consent|3|||
48433395|NCT01830543|155774787|FG002|Overall Study|Withdrawal by consent|3|||
48433396|NCT01830543|155774785|FG000|Overall Study|Other|12|||
48433397|NCT01830543|155774786|FG001|Overall Study|Other|17|||
48433398|NCT01830543|155774787|FG002|Overall Study|Other|37|||
48433399|NCT02023164|155774788|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
48433400|NCT02023164|155774789|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
48433401|NCT02436577|155774790|FG000|Overall Study|Protocol Deviation|0|||
48433402|NCT02436577|155774791|FG001|Overall Study|Protocol Deviation|1|||
48433403|NCT02436577|155774792|FG002|Overall Study|Protocol Deviation|0|||
48433404|NCT02436577|155774793|FG003|Overall Study|Protocol Deviation|0|||
48433405|NCT02436577|155774794|FG004|Overall Study|Protocol Deviation|0|||
48433406|NCT02436577|155774795|FG005|Overall Study|Protocol Deviation|0|||
48433407|NCT03703375|155774796|FG000|Randomization Period|Withdrawal by Subject|0|||
48433408|NCT03703375|155774797|FG001|Randomization Period|Withdrawal by Subject|0|||
48433409|NCT03703375|155774798|FG002|Randomization Period|Withdrawal by Subject|0|||
48433410|NCT03703375|155774799|FG003|Randomization Period|Withdrawal by Subject|1|||
48433411|NCT03703375|155774796|FG000|Randomization Period|Completed safety run-in treatment|7|||
48433412|NCT03703375|155774797|FG001|Randomization Period|Completed safety run-in treatment|0|||
48433413|NCT03703375|155774798|FG002|Randomization Period|Completed safety run-in treatment|0|||
48433414|NCT03703375|155774799|FG003|Randomization Period|Completed safety run-in treatment|0|||
48433415|NCT03703375|155774796|FG000|Treatment Period|Other Reasons|0|||
48433416|NCT03703375|155774797|FG001|Treatment Period|Other Reasons|1|||
48433417|NCT03703375|155774798|FG002|Treatment Period|Other Reasons|0|||
48433418|NCT03703375|155774799|FG003|Treatment Period|Other Reasons|3|||
48433419|NCT03703375|155774796|FG000|Treatment Period|Consent Withdrawal|0|||
48433420|NCT03703375|155774797|FG001|Treatment Period|Consent Withdrawal|0|||
48433421|NCT03703375|155774798|FG002|Treatment Period|Consent Withdrawal|0|||
48433422|NCT03703375|155774799|FG003|Treatment Period|Consent Withdrawal|1|||
48433423|NCT03703375|155774796|FG000|Treatment Period|Death|1|||
48433424|NCT03703375|155774797|FG001|Treatment Period|Death|0|||
48433425|NCT03703375|155774798|FG002|Treatment Period|Death|1|||
48433426|NCT03703375|155774799|FG003|Treatment Period|Death|2|||
48433427|NCT03703375|155774796|FG000|Treatment Period|Toxicity of Study Treatment|2|||
48433428|NCT03703375|155774797|FG001|Treatment Period|Toxicity of Study Treatment|0|||
48433429|NCT03703375|155774798|FG002|Treatment Period|Toxicity of Study Treatment|4|||
48433430|NCT03703375|155774799|FG003|Treatment Period|Toxicity of Study Treatment|1|||
48433431|NCT03703375|155774796|FG000|Treatment Period|Progression|32|||
48433432|NCT03703375|155774797|FG001|Treatment Period|Progression|1|||
48433433|NCT03703375|155774798|FG002|Treatment Period|Progression|7|||
48433434|NCT03703375|155774799|FG003|Treatment Period|Progression|11|||
48433435|NCT03703375|155774796|FG000|Treatment Period|Completed treatment|7|||
48433436|NCT03703375|155774797|FG001|Treatment Period|Completed treatment|2|||
48433437|NCT03703375|155774798|FG002|Treatment Period|Completed treatment|0|||
48433438|NCT03703375|155774799|FG003|Treatment Period|Completed treatment|0|||
48433439|NCT02678741|155774802|FG000|Overall Study|Death|4|||
48433440|NCT02678741|155774802|FG000|Overall Study|Withdrawal by Subject|1|||
48433441|NCT02678741|155774802|FG000|Overall Study|ineligible|3|||
48433442|NCT02678741|155774802|FG000|Overall Study|Not RECIST Measurable|2|||
48433443|NCT02678741|155774802|FG000|Overall Study|Lack of Efficacy|10|||
48433444|NCT01725152|155774803|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
48433445|NCT01725152|155774804|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
48433446|NCT01725152|155774803|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
48433447|NCT01725152|155774804|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
48433448|NCT01725152|155774803|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
48433449|NCT01725152|155774804|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
48433450|NCT01725152|155774803|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
48433451|NCT01725152|155774804|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
48433452|NCT01111539|155774805|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
48433453|NCT01111539|155774806|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48433454|NCT01111539|155774807|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48433455|NCT01111539|155774808|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48433456|NCT01111539|155774809|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
48433457|NCT01111539|155774805|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
48433458|NCT01111539|155774806|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48433459|NCT01111539|155774807|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48433460|NCT01111539|155774808|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48433461|NCT01111539|155774809|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
48433462|NCT01111539|155774805|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
48433463|NCT01111539|155774806|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48433464|NCT01111539|155774807|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48433465|NCT01111539|155774808|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48433466|NCT01111539|155774809|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
48433467|NCT01111539|155774805|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
48433468|NCT01111539|155774806|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
48433469|NCT01111539|155774807|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
48433470|NCT01111539|155774808|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
48433471|NCT01111539|155774809|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
48433472|NCT01111539|155774805|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
48433473|NCT01111539|155774806|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
48433474|NCT01111539|155774807|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
48433475|NCT01111539|155774808|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
48433476|NCT01111539|155774809|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
48433477|NCT01111539|155774805|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
48433478|NCT01111539|155774806|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48433479|NCT01111539|155774807|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48433480|NCT01111539|155774808|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48433481|NCT01111539|155774809|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
48433482|NCT01111539|155774805|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
48433483|NCT01111539|155774806|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
48433484|NCT01111539|155774807|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
48433485|NCT01111539|155774808|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
48433486|NCT01111539|155774809|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
48433487|NCT01111539|155774805|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48433488|NCT01111539|155774806|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48433489|NCT01111539|155774807|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
48433490|NCT01111539|155774808|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
48433491|NCT01111539|155774809|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
48433492|NCT01111539|155774805|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48433493|NCT01111539|155774806|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48433494|NCT01111539|155774807|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
48433495|NCT01111539|155774808|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
48433496|NCT01111539|155774809|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
48433497|NCT01111539|155774805|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
48433498|NCT01111539|155774806|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
48433499|NCT01111539|155774807|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
48433500|NCT01111539|155774808|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
48433501|NCT01111539|155774809|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
48433502|NCT01111539|155774805|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
48433503|NCT01111539|155774806|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
48433504|NCT01111539|155774807|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
48433505|NCT01111539|155774808|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
48433506|NCT01111539|155774809|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
48433507|NCT01111539|155774805|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
48433508|NCT01111539|155774806|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
48433509|NCT01111539|155774807|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
48433510|NCT01111539|155774808|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
48433511|NCT01111539|155774809|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
48433512|NCT01111539|155774805|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
48433513|NCT01111539|155774806|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
48433514|NCT01111539|155774807|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
48433515|NCT01111539|155774808|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
48433516|NCT01111539|155774809|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
48433517|NCT01111539|155774805|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48433518|NCT01111539|155774806|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48433519|NCT01111539|155774807|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48433520|NCT01111539|155774808|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
48433521|NCT01111539|155774809|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
48433522|NCT05674344|155774810|FG000|Overall Study|Screen Fail|21|||
48433523|NCT05674344|155774810|FG000|Overall Study|Incomplete study procedures|3|||
48433524|NCT02130427|155774818|FG000|Overall Study|Imaging results not interpretable|30|||
48433525|NCT00543569|155774823|FG000|Overall Study|Death|2|||
48433526|NCT00543569|155774824|FG001|Overall Study|Death|2|||
48433527|NCT00543569|155774825|FG002|Overall Study|Death|3|||
48433528|NCT00543569|155774826|FG003|Overall Study|Death|1|||
48433529|NCT00543569|155774823|FG000|Overall Study|Lost to Follow-up|0|||
48433530|NCT00543569|155774824|FG001|Overall Study|Lost to Follow-up|0|||
48433531|NCT00543569|155774825|FG002|Overall Study|Lost to Follow-up|1|||
48433532|NCT00543569|155774826|FG003|Overall Study|Lost to Follow-up|1|||
48433533|NCT00543569|155774823|FG000|Overall Study|Miscellaneous Reasons|7|||
48433534|NCT00543569|155774824|FG001|Overall Study|Miscellaneous Reasons|3|||
48433535|NCT00543569|155774825|FG002|Overall Study|Miscellaneous Reasons|11|||
48433536|NCT00543569|155774826|FG003|Overall Study|Miscellaneous Reasons|4|||
48433537|NCT00543569|155774823|FG000|Overall Study|Randomized but never received study drug|3|||
48433538|NCT00543569|155774824|FG001|Overall Study|Randomized but never received study drug|3|||
48433539|NCT00543569|155774825|FG002|Overall Study|Randomized but never received study drug|5|||
48433540|NCT00543569|155774826|FG003|Overall Study|Randomized but never received study drug|3|||
48433541|NCT02108600|155774827|FG000|Overall Study|Withdrawal by Subject|2|||
48433542|NCT02108600|155774828|FG001|Overall Study|Withdrawal by Subject|0|||
48433543|NCT02108600|155774827|FG000|Overall Study|Lost to Follow-up|1|||
48433544|NCT02108600|155774828|FG001|Overall Study|Lost to Follow-up|1|||
48433545|NCT01525849|155774829|FG000|Overall Study|Lost to Follow-up|3|||
48433546|NCT01525849|155774830|FG001|Overall Study|Lost to Follow-up|2|||
48433547|NCT01525849|155774829|FG000|Overall Study|Withdrawal by Subject|1|||
48433548|NCT01525849|155774830|FG001|Overall Study|Withdrawal by Subject|9|||
48433549|NCT01525849|155774829|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
48433550|NCT01525849|155774830|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
48433551|NCT01525849|155774829|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
48433552|NCT01525849|155774830|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
48433553|NCT01469013|155774834|FG000|Part A (Treatment Period)|Adverse Event|1|||
48433554|NCT01469013|155774835|FG001|Part A (Treatment Period)|Adverse Event|0|||
48433555|NCT01469013|155774836|FG002|Part A (Treatment Period)|Adverse Event|0|||
48433556|NCT01469013|155774837|FG003|Part A (Treatment Period)|Adverse Event|0|||
48433557|NCT01469013|155774838|FG004|Part A (Treatment Period)|Adverse Event|1|||
48433558|NCT01469013|155774839|FG005|Part A (Treatment Period)|Adverse Event|0|||
48433559|NCT01469013|155774840|FG006|Part A (Treatment Period)|Adverse Event|0|||
48433560|NCT01469013|155774841|FG007|Part A (Treatment Period)|Adverse Event|0|||
48433561|NCT01469013|155774842|FG008|Part A (Treatment Period)|Adverse Event|0|||
48433562|NCT01469013|155774843|FG009|Part A (Treatment Period)|Adverse Event|0|||
48433563|NCT01469013|155774844|FG010|Part A (Treatment Period)|Adverse Event|0|||
48433564|NCT01469013|155774845|FG011|Part A (Treatment Period)|Adverse Event|0|||
48433565|NCT01469013|155774846|FG012|Part A (Treatment Period)|Adverse Event|0|||
48433566|NCT01469013|155774834|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433567|NCT01469013|155774835|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433568|NCT01469013|155774836|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
48433569|NCT01469013|155774837|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433570|NCT01469013|155774838|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433571|NCT01469013|155774839|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433572|NCT01469013|155774840|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433573|NCT01469013|155774841|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433574|NCT01469013|155774842|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433575|NCT01469013|155774843|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433576|NCT01469013|155774844|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433577|NCT01469013|155774845|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433578|NCT01469013|155774846|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
48433579|NCT01469013|155774834|FG000|Part B (Extension Period)|Adverse Event|0|||
48433580|NCT01469013|155774835|FG001|Part B (Extension Period)|Adverse Event|0|||
48433581|NCT01469013|155774836|FG002|Part B (Extension Period)|Adverse Event|0|||
48433582|NCT01469013|155774837|FG003|Part B (Extension Period)|Adverse Event|0|||
48433583|NCT01469013|155774838|FG004|Part B (Extension Period)|Adverse Event|0|||
48433584|NCT01469013|155774839|FG005|Part B (Extension Period)|Adverse Event|2|||
48433585|NCT01469013|155774840|FG006|Part B (Extension Period)|Adverse Event|5|||
48433586|NCT01469013|155774841|FG007|Part B (Extension Period)|Adverse Event|5|||
48433587|NCT01469013|155774842|FG008|Part B (Extension Period)|Adverse Event|3|||
48433588|NCT01469013|155774843|FG009|Part B (Extension Period)|Adverse Event|3|||
48433589|NCT01469013|155774844|FG010|Part B (Extension Period)|Adverse Event|1|||
48433590|NCT01469013|155774845|FG011|Part B (Extension Period)|Adverse Event|6|||
48433591|NCT01469013|155774846|FG012|Part B (Extension Period)|Adverse Event|3|||
48433592|NCT01469013|155774834|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
48433593|NCT01469013|155774835|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
48433594|NCT01469013|155774836|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
48433595|NCT01469013|155774837|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
48433596|NCT01469013|155774838|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
48433597|NCT01469013|155774839|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
48433598|NCT01469013|155774840|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
48433599|NCT01469013|155774841|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
48433600|NCT01469013|155774842|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
48433601|NCT01469013|155774843|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
48433602|NCT01469013|155774844|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
48433603|NCT01469013|155774845|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
48433604|NCT01469013|155774846|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
48433605|NCT00525148|155774847|FG000|Overall Study|Other Adverse Event|3|||
48433606|NCT00525148|155774848|FG001|Overall Study|Other Adverse Event|5|||
48433607|NCT00525148|155774849|FG002|Overall Study|Other Adverse Event|1|||
48433608|NCT00525148|155774850|FG003|Overall Study|Other Adverse Event|8|||
48433609|NCT00525148|155774847|FG000|Overall Study|Progressive disease|18|||
48433610|NCT00525148|155774848|FG001|Overall Study|Progressive disease|30|||
48433611|NCT00525148|155774849|FG002|Overall Study|Progressive disease|6|||
48433612|NCT00525148|155774850|FG003|Overall Study|Progressive disease|49|||
48433613|NCT00525148|155774847|FG000|Overall Study|Refused continuation of study medication|0|||
48433614|NCT00525148|155774848|FG001|Overall Study|Refused continuation of study medication|2|||
48433615|NCT00525148|155774849|FG002|Overall Study|Refused continuation of study medication|0|||
48433616|NCT00525148|155774850|FG003|Overall Study|Refused continuation of study medication|1|||
48433617|NCT00525148|155774847|FG000|Overall Study|Other than stated|2|||
48433618|NCT00525148|155774848|FG001|Overall Study|Other than stated|1|||
48433619|NCT00525148|155774849|FG002|Overall Study|Other than stated|0|||
48433620|NCT00525148|155774850|FG003|Overall Study|Other than stated|3|||
48433621|NCT00789477|155774856|FG000|Overall Study|Withdrawal by Subject|2|||
48433622|NCT00789477|155774857|FG001|Overall Study|Withdrawal by Subject|1|||
48433623|NCT00789477|155774858|FG002|Overall Study|Withdrawal by Subject|3|||
48433624|NCT00789477|155774859|FG003|Overall Study|Withdrawal by Subject|2|||
48433625|NCT00789477|155774860|FG004|Overall Study|Withdrawal by Subject|3|||
48433626|NCT00789477|155774856|FG000|Overall Study|Protocol Violation|1|||
48433627|NCT00789477|155774857|FG001|Overall Study|Protocol Violation|0|||
48433628|NCT00789477|155774858|FG002|Overall Study|Protocol Violation|0|||
48433629|NCT00789477|155774859|FG003|Overall Study|Protocol Violation|1|||
48433630|NCT00789477|155774860|FG004|Overall Study|Protocol Violation|0|||
48433631|NCT00789477|155774856|FG000|Overall Study|Adverse Event|3|||
48433632|NCT00789477|155774857|FG001|Overall Study|Adverse Event|3|||
48433633|NCT00789477|155774858|FG002|Overall Study|Adverse Event|1|||
48433634|NCT00789477|155774859|FG003|Overall Study|Adverse Event|0|||
48433635|NCT00789477|155774860|FG004|Overall Study|Adverse Event|0|||
48433636|NCT00789477|155774856|FG000|Overall Study|Death|1|||
48433637|NCT00789477|155774857|FG001|Overall Study|Death|1|||
48433638|NCT00789477|155774858|FG002|Overall Study|Death|2|||
48433639|NCT00789477|155774859|FG003|Overall Study|Death|2|||
48433640|NCT00789477|155774860|FG004|Overall Study|Death|0|||
48433641|NCT00789477|155774856|FG000|Overall Study|Lost to Follow-up|0|||
48433642|NCT00789477|155774857|FG001|Overall Study|Lost to Follow-up|1|||
48433643|NCT00789477|155774858|FG002|Overall Study|Lost to Follow-up|4|||
48433644|NCT00789477|155774859|FG003|Overall Study|Lost to Follow-up|2|||
48433645|NCT00789477|155774860|FG004|Overall Study|Lost to Follow-up|4|||
48433646|NCT00789477|155774856|FG000|Overall Study|Lack of Efficacy|2|||
48433647|NCT00789477|155774857|FG001|Overall Study|Lack of Efficacy|0|||
48433648|NCT00789477|155774858|FG002|Overall Study|Lack of Efficacy|0|||
48433649|NCT00789477|155774859|FG003|Overall Study|Lack of Efficacy|0|||
48433650|NCT00789477|155774860|FG004|Overall Study|Lack of Efficacy|0|||
48433651|NCT00789477|155774856|FG000|Overall Study|Other|2|||
48433652|NCT00789477|155774857|FG001|Overall Study|Other|0|||
48433653|NCT00789477|155774858|FG002|Overall Study|Other|1|||
48433656|NCT02399813|155774863|FG000|Overall Study|Progressive Disease-Radiographic|2|||
48433657|NCT02399813|155774863|FG000|Overall Study|Death|20|||
48433658|NCT02399813|155774863|FG000|Overall Study|Withdrawal by Subject|3|||
48433659|NCT02399813|155774863|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
48433660|NCT02399813|155774863|FG000|Overall Study|Lost to Follow-up|2|||
48433661|NCT02399813|155774863|FG000|Overall Study|Other than specified|5|||
48433662|NCT00702052|155774866|FG000|Overall Study|Adverse Event|23|||
48433663|NCT00702052|155774866|FG000|Overall Study|Disease Progression|30|||
48433664|NCT00702052|155774866|FG000|Overall Study|Withdrawal by Subject|5|||
48433665|NCT01871896|155774867|FG000|Overall Study|Lost to Follow-up|1|||
48433666|NCT01627067|155774870|FG000|Overall Study|Screen Failure|1|||
48433667|NCT00926796|155774871|FG000|Overall Study|Did not receive randomized treatment|4|||
48433668|NCT00926796|155774872|FG001|Overall Study|Did not receive randomized treatment|7|||
48433669|NCT00926796|155774871|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
48433670|NCT00926796|155774872|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
48433671|NCT00926796|155774871|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
48433672|NCT00926796|155774872|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
48433673|NCT00926796|155774871|FG000|Overall Study|Adverse Event|7|||
48433674|NCT00926796|155774872|FG001|Overall Study|Adverse Event|14|||
48433675|NCT00926796|155774871|FG000|Overall Study|Lost to Follow-up|22|||
48433676|NCT00926796|155774872|FG001|Overall Study|Lost to Follow-up|13|||
48433677|NCT00926796|155774871|FG000|Overall Study|Protocol Violation|15|||
48433678|NCT00926796|155774872|FG001|Overall Study|Protocol Violation|11|||
48433679|NCT00926796|155774871|FG000|Overall Study|Withdrawal by Subject|1|||
48433680|NCT00926796|155774872|FG001|Overall Study|Withdrawal by Subject|0|||
48433681|NCT00142519|155774876|FG000|Overall Study|Not Treated|7|||
48433682|NCT00142519|155774877|FG001|Overall Study|Not Treated|9|||
48433683|NCT00142519|155774876|FG000|Overall Study|Protocol Violation|1|||
48433684|NCT00142519|155774877|FG001|Overall Study|Protocol Violation|0|||
48433685|NCT00142519|155774876|FG000|Overall Study|Withdrawal by Subject|10|||
48433686|NCT00142519|155774877|FG001|Overall Study|Withdrawal by Subject|7|||
48433687|NCT01468909|155774878|FG000|Overall Study|Never Treated|2|||
48433688|NCT01468909|155774879|FG001|Overall Study|Never Treated|2|||
48433689|NCT01341652|155774887|FG000|Overall Study|Incorrect Random Assignment|0|||
48433690|NCT01341652|155774888|FG001|Overall Study|Incorrect Random Assignment|1|||
48433691|NCT01341652|155774887|FG000|Overall Study|ineligible; presence metastatic disease|0|||
48433692|NCT01341652|155774888|FG001|Overall Study|ineligible; presence metastatic disease|1|||
48433693|NCT00101192|155774889|FG000|Overall Study|Ineligible|6|||
48433694|NCT00101192|155774889|FG000|Overall Study|Inevaluable|1|||
48433695|NCT01204658|155774898|FG000|Primary Phase|Adverse Event|0|||
48433696|NCT01204658|155774899|FG001|Primary Phase|Adverse Event|0|||
48433697|NCT01204658|155774900|FG002|Primary Phase|Adverse Event|1|||
48433698|NCT01204658|155774901|FG003|Primary Phase|Adverse Event|0|||
48433699|NCT00905021|155774902|FG000|Overall Study|Adverse Event|2|||
48433700|NCT01552928|155774904|FG000|Period 3|Adverse Event|0|||
48433701|NCT01552928|155774905|FG001|Period 3|Adverse Event|0|||
48433702|NCT01552928|155774906|FG002|Period 3|Adverse Event|1|||
48433703|NCT01552928|155774907|FG003|Period 3|Adverse Event|0|||
48433704|NCT00502307|155777119|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
48433705|NCT00502307|155777120|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
48433706|NCT00502307|155777121|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
48433707|NCT00502307|155777119|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
48433708|NCT00502307|155777120|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
48433709|NCT00502307|155777121|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
48433710|NCT00502307|155777119|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
48433711|NCT00502307|155777120|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
48433712|NCT00502307|155777121|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
48433713|NCT00502307|155777119|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
48433714|NCT00502307|155777120|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
48433715|NCT00502307|155777121|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
48433716|NCT00502307|155777119|FG000|Maintenance Period|Progressive disease|80|||
48433717|NCT00502307|155777120|FG001|Maintenance Period|Progressive disease|0|||
48433718|NCT00502307|155777121|FG002|Maintenance Period|Progressive disease|0|||
48433719|NCT00502307|155777119|FG000|Maintenance Period|Discontinued due to other reasons|68|||
48433720|NCT00502307|155777120|FG001|Maintenance Period|Discontinued due to other reasons|0|||
48433721|NCT00502307|155777121|FG002|Maintenance Period|Discontinued due to other reasons|0|||
48433722|NCT01863849|155777125|FG000|Overall Study|Lost to Follow-up|1|||
48433723|NCT01863849|155777126|FG001|Overall Study|Lost to Follow-up|0|||
48433724|NCT03072719|155777127|FG000|Overall Study|Adverse Event|1|||
48433725|NCT03072719|155777128|FG001|Overall Study|Adverse Event|1|||
48433726|NCT02324842|155777129|FG000|Overall Study|Lost to Follow-up|1|||
48433727|NCT02324842|155777130|FG001|Overall Study|Lost to Follow-up|1|||
48433728|NCT02324842|155777131|FG002|Overall Study|Lost to Follow-up|2|||
48433729|NCT02116660|155777133|FG000|Overall Study|Deteriorating renal function|0|||
48433730|NCT02116660|155777134|FG001|Overall Study|Deteriorating renal function|1|||
48433733|NCT02116660|155777133|FG000|Overall Study|Withdrawal by Subject|0|||
48433734|NCT02116660|155777134|FG001|Overall Study|Withdrawal by Subject|2|||
48433735|NCT02116660|155777133|FG000|Overall Study|Organization reason|1|||
48433736|NCT02116660|155777134|FG001|Overall Study|Organization reason|0|||
48433737|NCT02433379|155777154|FG000|Overall Study|Screen Failures|55|||
48433738|NCT02433379|155777154|FG000|Overall Study|Death|57|||
48433739|NCT02433379|155777154|FG000|Overall Study|Total Withdrawals|209|||
48433740|NCT01253044|155777160|FG000|Overall Study|Lost to Follow-up|38|||
48433741|NCT01253044|155777161|FG001|Overall Study|Lost to Follow-up|29|||
48433742|NCT00793819|155777162|FG000|Overall Study|Adverse Event|8|||
48433743|NCT00793819|155777163|FG001|Overall Study|Adverse Event|4|||
48433744|NCT00793819|155777162|FG000|Overall Study|Lack of Efficacy|1|||
48433745|NCT00793819|155777163|FG001|Overall Study|Lack of Efficacy|1|||
48433746|NCT00793819|155777162|FG000|Overall Study|Withdrawal by Subject|4|||
48433747|NCT00793819|155777163|FG001|Overall Study|Withdrawal by Subject|3|||
48433748|NCT00793819|155777162|FG000|Overall Study|Lost to Follow-up|1|||
48433749|NCT00793819|155777163|FG001|Overall Study|Lost to Follow-up|1|||
48433750|NCT02196038|155777166|FG000|Overall Study|Death|16|||
48433751|NCT02196038|155777167|FG001|Overall Study|Death|21|||
48433752|NCT02196038|155777166|FG000|Overall Study|Withdrawal by Subject|0|||
48433753|NCT02196038|155777167|FG001|Overall Study|Withdrawal by Subject|1|||
48433754|NCT02196038|155777166|FG000|Overall Study|Lost to Follow-up|1|||
48433755|NCT02196038|155777167|FG001|Overall Study|Lost to Follow-up|0|||
48433756|NCT04056455|155777168|FG000|Overall Study|Adverse Event|1|||
48433757|NCT04056455|155777169|FG001|Overall Study|Adverse Event|0|||
48433758|NCT00421343|155777170|FG000|Overall Study|Death|1|||
48433759|NCT00421343|155777170|FG000|Overall Study|Withdrawal by Subject|2|||
48433760|NCT00421343|155777170|FG000|Overall Study|Lost to Follow-up|3|||
48433761|NCT02512068|155777178|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
48433762|NCT02512068|155777179|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
48433763|NCT02512068|155777178|FG000|Overall Study|Major Protocol Deviation|1|||
48433764|NCT02512068|155777179|FG001|Overall Study|Major Protocol Deviation|0|||
48433765|NCT02512068|155777178|FG000|Overall Study|Voluntary Withdrawal|0|||
48433766|NCT02512068|155777179|FG001|Overall Study|Voluntary Withdrawal|1|||
48433767|NCT02512068|155777178|FG000|Overall Study|Lack of Efficacy|0|||
48433768|NCT02512068|155777179|FG001|Overall Study|Lack of Efficacy|1|||
48433769|NCT02512068|155777178|FG000|Overall Study|Reason Not Specified|3|||
48433770|NCT02512068|155777179|FG001|Overall Study|Reason Not Specified|5|||
48433771|NCT01810042|155777180|FG000|Overall Study|Lost to Follow-up|10|||
48433772|NCT01514188|155777192|FG000|Overall Study|Adverse Event|3|||
48433773|NCT01514188|155777193|FG001|Overall Study|Adverse Event|5|||
48433774|NCT01514188|155777192|FG000|Overall Study|Withdrawal by Subject|2|||
48433775|NCT01514188|155777193|FG001|Overall Study|Withdrawal by Subject|4|||
48433776|NCT01514188|155777192|FG000|Overall Study|Protocol Violation|2|||
48433777|NCT01514188|155777193|FG001|Overall Study|Protocol Violation|4|||
48433778|NCT01514188|155777192|FG000|Overall Study|Physician Decision|0|||
48433779|NCT01514188|155777193|FG001|Overall Study|Physician Decision|2|||
48433780|NCT01514188|155777192|FG000|Overall Study|Disease Progression|13|||
48433781|NCT01514188|155777193|FG001|Overall Study|Disease Progression|14|||
48433782|NCT01514188|155777192|FG000|Overall Study|Death|1|||
48433783|NCT01514188|155777193|FG001|Overall Study|Death|3|||
48433784|NCT01514188|155777192|FG000|Overall Study|Other|2|||
48433785|NCT01514188|155777193|FG001|Overall Study|Other|1|||
48433786|NCT01153763|155777194|FG000|Overall Study|Study Closed|16|||
48433787|NCT01153763|155777194|FG000|Overall Study|Lost to Follow-up|1|||
48433788|NCT01153763|155777194|FG000|Overall Study|Physician Decision|2|||
48433789|NCT01153763|155777194|FG000|Overall Study|Withdrawal by Subject|2|||
48433790|NCT01474746|155777195|FG000|Overall Study|Lost to Follow-up|1|||
48433791|NCT01474746|155777196|FG001|Overall Study|Lost to Follow-up|1|||
48433792|NCT01474746|155777195|FG000|Overall Study|Withdrawal by Subject|2|||
48433793|NCT01474746|155777196|FG001|Overall Study|Withdrawal by Subject|1|||
48433794|NCT01766336|155777197|FG000|Overall Study|Adverse Event|11|||
48433795|NCT01766336|155777198|FG001|Overall Study|Adverse Event|8|||
48433796|NCT01766336|155777197|FG000|Overall Study|Death|4|||
48433797|NCT01766336|155777198|FG001|Overall Study|Death|3|||
48433798|NCT01766336|155777197|FG000|Overall Study|Lost to Follow-up|1|||
48433799|NCT01766336|155777198|FG001|Overall Study|Lost to Follow-up|3|||
48433800|NCT01766336|155777197|FG000|Overall Study|Physician Decision|4|||
48433801|NCT01766336|155777198|FG001|Overall Study|Physician Decision|2|||
48433802|NCT01766336|155777197|FG000|Overall Study|Protocol Violation|0|||
48433803|NCT01766336|155777198|FG001|Overall Study|Protocol Violation|1|||
48433804|NCT01766336|155777197|FG000|Overall Study|Sponsor Decision|52|||
48433805|NCT01766336|155777198|FG001|Overall Study|Sponsor Decision|43|||
48433806|NCT01766336|155777197|FG000|Overall Study|Withdrawal by Subject|18|||
48433807|NCT01766336|155777198|FG001|Overall Study|Withdrawal by Subject|15|||
48433808|NCT04544709|155777199|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
48433809|NCT04360187|155777200|FG000|Double-Blind Treatment|Adverse Event|9|||
48433810|NCT04360187|155777201|FG001|Double-Blind Treatment|Adverse Event|11|||
48433811|NCT04360187|155777200|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
48433888|NCT03453151|155777240|FG000|Overall Study|Physician Decision|3|||
48433812|NCT04360187|155777201|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
48433813|NCT04360187|155777200|FG000|Double-Blind Treatment|Physician Decision|1|||
48433814|NCT04360187|155777201|FG001|Double-Blind Treatment|Physician Decision|0|||
48433815|NCT04360187|155777200|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
48433816|NCT04360187|155777201|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
48433817|NCT04360187|155777200|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
48433818|NCT04360187|155777201|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
48433819|NCT04360187|155777200|FG000|Follow-Up|Lost to Follow-up|1|||
48433820|NCT04360187|155777201|FG001|Follow-Up|Lost to Follow-up|0|||
48433821|NCT02435277|155777202|FG000|Overall Study|Adverse Event|1|||
48433822|NCT02435277|155777203|FG001|Overall Study|Adverse Event|1|||
48433823|NCT02435277|155777204|FG002|Overall Study|Adverse Event|0|||
48433824|NCT02435277|155777205|FG003|Overall Study|Adverse Event|0|||
48433825|NCT02435277|155777202|FG000|Overall Study|Withdrawal by Subject|1|||
48433826|NCT02435277|155777203|FG001|Overall Study|Withdrawal by Subject|0|||
48433827|NCT02435277|155777204|FG002|Overall Study|Withdrawal by Subject|0|||
48433828|NCT02435277|155777205|FG003|Overall Study|Withdrawal by Subject|0|||
48433829|NCT01577160|155777206|FG000|Overall Study|Adverse Event|9|||
48433830|NCT01577160|155777206|FG000|Overall Study|Lack of Efficacy|15|||
48433831|NCT01577160|155777206|FG000|Overall Study|Lost to Follow-up|40|||
48433832|NCT01577160|155777206|FG000|Overall Study|Withdrawal by Subject|18|||
48433833|NCT01577160|155777206|FG000|Overall Study|Subject Uncooperative|7|||
48433834|NCT01577160|155777206|FG000|Overall Study|Other|9|||
48433835|NCT01067508|155777207|FG000|Overall Study|Physician Decision|0|||
48433836|NCT01067508|155777208|FG001|Overall Study|Physician Decision|1|||
48433837|NCT01067508|155777207|FG000|Overall Study|Withdrawal by Subject|0|||
48433838|NCT01067508|155777208|FG001|Overall Study|Withdrawal by Subject|1|||
48433839|NCT00444626|155777211|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
48433840|NCT00444626|155777211|FG000|Initial Treatment Period|Adverse Event|1|||
48433841|NCT00444626|155777211|FG000|Initial Treatment Period|Lost to Follow-up|9|||
48433842|NCT04715230|155777212|FG000|Overall Study|Withdrawal by Subject|1|||
48433843|NCT04715230|155777213|FG001|Overall Study|Withdrawal by Subject|0|||
48433844|NCT04715230|155777214|FG002|Overall Study|Withdrawal by Subject|0|||
48433845|NCT04715230|155777212|FG000|Overall Study|Lost to Follow-up|0|||
48433846|NCT04715230|155777213|FG001|Overall Study|Lost to Follow-up|5|||
48433847|NCT04715230|155777214|FG002|Overall Study|Lost to Follow-up|1|||
48433848|NCT03126539|155777215|FG000|Overall Study|Lost to Follow-up|1|||
48433849|NCT03126539|155777216|FG001|Overall Study|Lost to Follow-up|1|||
48433850|NCT03126539|155777217|FG002|Overall Study|Lost to Follow-up|1|||
48433851|NCT03126539|155777218|FG003|Overall Study|Lost to Follow-up|0|||
48433852|NCT03126539|155777219|FG004|Overall Study|Lost to Follow-up|0|||
48433853|NCT01551758|155777220|FG000|Overall Study|Adverse Event|29|||
48433854|NCT01551758|155777221|FG001|Overall Study|Adverse Event|43|||
48433855|NCT01551758|155777220|FG000|Overall Study|Lack of Efficacy|0|||
48433856|NCT01551758|155777221|FG001|Overall Study|Lack of Efficacy|1|||
48433857|NCT01551758|155777220|FG000|Overall Study|Protocol Violation|5|||
48433858|NCT01551758|155777221|FG001|Overall Study|Protocol Violation|6|||
48433859|NCT01551758|155777220|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
48433860|NCT01551758|155777221|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
48433861|NCT01551758|155777220|FG000|Overall Study|Lost to Follow-up|29|||
48433862|NCT01551758|155777221|FG001|Overall Study|Lost to Follow-up|25|||
48433863|NCT01551758|155777220|FG000|Overall Study|Physician Decision|9|||
48433864|NCT01551758|155777221|FG001|Overall Study|Physician Decision|3|||
48433865|NCT01551758|155777220|FG000|Overall Study|Withdrawal by Subject|14|||
48433866|NCT01551758|155777221|FG001|Overall Study|Withdrawal by Subject|17|||
48433867|NCT03352414|155777225|FG000|Overall Study|Ineligible by operative criteria|12|||
48433868|NCT03352414|155777226|FG001|Overall Study|Ineligible by operative criteria|10|||
48433869|NCT02632110|155777227|FG000|Overall Study|Withdrawal by Subject|1|||
48433870|NCT02632110|155777228|FG001|Overall Study|Withdrawal by Subject|1|||
48433871|NCT02632110|155777229|FG002|Overall Study|Withdrawal by Subject|0|||
48433872|NCT02632110|155777230|FG003|Overall Study|Withdrawal by Subject|0|||
48433873|NCT02632110|155777231|FG004|Overall Study|Withdrawal by Subject|1|||
48433874|NCT02632110|155777232|FG005|Overall Study|Withdrawal by Subject|1|||
48433875|NCT02632110|155777233|FG006|Overall Study|Withdrawal by Subject|3|||
48433876|NCT02632110|155777234|FG007|Overall Study|Withdrawal by Subject|3|||
48433877|NCT02632110|155777235|FG008|Overall Study|Withdrawal by Subject|1|||
48433878|NCT02632110|155777236|FG009|Overall Study|Withdrawal by Subject|1|||
48433879|NCT00008138|155777239|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
48433880|NCT00008138|155777239|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
48433881|NCT00008138|155777239|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
48433882|NCT00008138|155777239|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
48433883|NCT00008138|155777239|FG000|Interval Debulking|Withdrawal by Subject|2|||
48433884|NCT00008138|155777239|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
48433885|NCT00008138|155777239|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
48433886|NCT00008138|155777239|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
48433887|NCT03453151|155777240|FG000|Overall Study|Withdrawal by Subject|1|||
48433901|NCT02618928|155777247|FG000|Overall Study|Insufficient Virological Response|1|||
48433902|NCT02618928|155777247|FG000|Overall Study|Withdrawal by Subject|2|||
48433903|NCT02618928|155777247|FG000|Overall Study|Death|3|||
48433904|NCT02618928|155777247|FG000|Overall Study|Other|11|||
48433905|NCT02618928|155777247|FG000|Overall Study|Missing|6|||
48433906|NCT02618928|155777247|FG000|Overall Study|Treatment Never Started|7|||
48433907|NCT00586924|155777248|FG000|Overall Study|Adverse event/serious adverse event|0|||
48433908|NCT00586924|155777249|FG001|Overall Study|Adverse event/serious adverse event|0|||
48433909|NCT00586924|155777250|FG002|Overall Study|Adverse event/serious adverse event|0|||
48433910|NCT00586924|155777251|FG003|Overall Study|Adverse event/serious adverse event|1|||
48433911|NCT00586924|155777252|FG004|Overall Study|Adverse event/serious adverse event|0|||
48433912|NCT00586924|155777253|FG005|Overall Study|Adverse event/serious adverse event|2|||
48433913|NCT00586924|155777248|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
48433914|NCT00586924|155777249|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
48433915|NCT00586924|155777250|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
48433916|NCT00586924|155777251|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
48433917|NCT00586924|155777252|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
48433918|NCT00586924|155777253|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
48433919|NCT00586924|155777248|FG000|Overall Study|Disease progression|0|||
48433920|NCT00586924|155777249|FG001|Overall Study|Disease progression|0|||
48433921|NCT00586924|155777250|FG002|Overall Study|Disease progression|0|||
48433922|NCT00586924|155777251|FG003|Overall Study|Disease progression|1|||
48433923|NCT00586924|155777252|FG004|Overall Study|Disease progression|1|||
48433924|NCT00586924|155777253|FG005|Overall Study|Disease progression|0|||
48433925|NCT00586924|155777248|FG000|Overall Study|Development of neutralizing antibodies|2|||
48433926|NCT00586924|155777249|FG001|Overall Study|Development of neutralizing antibodies|2|||
48433927|NCT00586924|155777250|FG002|Overall Study|Development of neutralizing antibodies|2|||
48433928|NCT00586924|155777251|FG003|Overall Study|Development of neutralizing antibodies|0|||
48433929|NCT00586924|155777252|FG004|Overall Study|Development of neutralizing antibodies|0|||
48433930|NCT00586924|155777253|FG005|Overall Study|Development of neutralizing antibodies|22|||
48433931|NCT00586924|155777248|FG000|Overall Study|Complete response|0|||
48433932|NCT00586924|155777249|FG001|Overall Study|Complete response|1|||
48433933|NCT00586924|155777250|FG002|Overall Study|Complete response|0|||
48433934|NCT00586924|155777251|FG003|Overall Study|Complete response|0|||
48433935|NCT00586924|155777252|FG004|Overall Study|Complete response|2|||
48433936|NCT00586924|155777253|FG005|Overall Study|Complete response|2|||
48433937|NCT00586924|155777248|FG000|Overall Study|Other|1|||
48433938|NCT00586924|155777249|FG001|Overall Study|Other|0|||
48433939|NCT00586924|155777250|FG002|Overall Study|Other|1|||
48433940|NCT00586924|155777251|FG003|Overall Study|Other|1|||
48433941|NCT00586924|155777252|FG004|Overall Study|Other|1|||
48433942|NCT00586924|155777253|FG005|Overall Study|Other|6|||
48433943|NCT01511419|155777254|FG000|Dose 2|Physician Decision|1|||
48433944|NCT01511419|155777255|FG001|Dose 2|Physician Decision|0|||
48433945|NCT03670641|155777256|FG000|Overall Study|Lost to Follow-up|3|||
48433946|NCT03691610|155777262|FG000|Overall Study|Adverse Event|0|||
48433947|NCT03691610|155777263|FG001|Overall Study|Adverse Event|1|||
48433948|NCT03691610|155777264|FG002|Overall Study|Adverse Event|0|||
48433949|NCT03691610|155777265|FG003|Overall Study|Adverse Event|0|||
48433950|NCT03691610|155777262|FG000|Overall Study|Protocol Deviation|15|||
48433951|NCT03691610|155777263|FG001|Overall Study|Protocol Deviation|8|||
48433952|NCT03691610|155777264|FG002|Overall Study|Protocol Deviation|1|||
48433953|NCT03691610|155777265|FG003|Overall Study|Protocol Deviation|2|||
48433954|NCT03691610|155777262|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
48433955|NCT03691610|155777263|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
48433956|NCT03691610|155777264|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
48433957|NCT03691610|155777265|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
48433958|NCT03691610|155777262|FG000|Overall Study|Lost to Follow-up|20|||
48433959|NCT03691610|155777263|FG001|Overall Study|Lost to Follow-up|11|||
48433960|NCT03691610|155777264|FG002|Overall Study|Lost to Follow-up|5|||
48433961|NCT03691610|155777265|FG003|Overall Study|Lost to Follow-up|2|||
48433962|NCT00620321|155777266|FG000|Overall Study|Adverse Event|1|||
48433963|NCT00620321|155777267|FG001|Overall Study|Adverse Event|1|||
48433964|NCT00620321|155777266|FG000|Overall Study|Death|1|||
48433965|NCT00620321|155777267|FG001|Overall Study|Death|1|||
48433966|NCT00620321|155777266|FG000|Overall Study|Physician Decision|0|||
48433967|NCT00620321|155777267|FG001|Overall Study|Physician Decision|7|||
48433968|NCT00620321|155777266|FG000|Overall Study|Progressive Disease|5|||
48433969|NCT00620321|155777267|FG001|Overall Study|Progressive Disease|5|||
48433970|NCT00620321|155777266|FG000|Overall Study|Sponsor Decision|0|||
48433971|NCT00620321|155777267|FG001|Overall Study|Sponsor Decision|1|||
48433972|NCT00620321|155777266|FG000|Overall Study|Withdrawal by Subject|1|||
48433973|NCT00620321|155777267|FG001|Overall Study|Withdrawal by Subject|1|||
48433974|NCT00786838|155777270|FG000|Overall Study|Physician Decision|4|||
48433975|NCT00786838|155777270|FG000|Overall Study|Death|4|||
48433976|NCT00786838|155777270|FG000|Overall Study|Adverse Event|6|||
48433977|NCT00786838|155777270|FG000|Overall Study|Progressive disease|31|||
48433978|NCT00786838|155777270|FG000|Overall Study|Withdrawal by Subject|4|||
48433979|NCT00937768|155777271|FG000|Overall Study|Refused Further Treatment|3|||
48433980|NCT00937768|155777272|FG001|Overall Study|Refused Further Treatment|2|||
48433981|NCT00937768|155777271|FG000|Overall Study|Disease Progression|1|||
48433982|NCT00937768|155777272|FG001|Overall Study|Disease Progression|1|||
48433983|NCT00937768|155777271|FG000|Overall Study|Alternate Treatment|0|||
48433984|NCT00937768|155777272|FG001|Overall Study|Alternate Treatment|1|||
48433985|NCT00937768|155777271|FG000|Overall Study|No Further Funding|4|||
48433986|NCT00937768|155777272|FG001|Overall Study|No Further Funding|4|||
48433987|NCT04570657|155777275|FG000|Overall Study|Adverse Event|0|||
48433988|NCT04570657|155777276|FG001|Overall Study|Adverse Event|0|||
48433989|NCT04570657|155777277|FG002|Overall Study|Adverse Event|1|||
48433990|NCT04570657|155777275|FG000|Overall Study|Lost to Follow-up|0|||
48433991|NCT04570657|155777276|FG001|Overall Study|Lost to Follow-up|0|||
48433992|NCT04570657|155777277|FG002|Overall Study|Lost to Follow-up|1|||
48433993|NCT04570657|155777275|FG000|Overall Study|Physician Decision|0|||
48433994|NCT04570657|155777276|FG001|Overall Study|Physician Decision|1|||
48433995|NCT04570657|155777277|FG002|Overall Study|Physician Decision|0|||
48433996|NCT04570657|155777275|FG000|Overall Study|Withdrawal by Subject|1|||
48433997|NCT04570657|155777276|FG001|Overall Study|Withdrawal by Subject|2|||
48433998|NCT04570657|155777277|FG002|Overall Study|Withdrawal by Subject|2|||
48433999|NCT02065622|155777278|FG000|Induction Study|Adverse Event|13|||
48434000|NCT02065622|155777279|FG001|Induction Study|Adverse Event|19|||
48434001|NCT02065622|155777280|FG002|Induction Study|Adverse Event|0|||
48434002|NCT02065622|155777281|FG003|Induction Study|Adverse Event|0|||
48434003|NCT02065622|155777282|FG004|Induction Study|Adverse Event|0|||
48434004|NCT02065622|155777278|FG000|Induction Study|Withdrawal by Subject|3|||
48434005|NCT02065622|155777279|FG001|Induction Study|Withdrawal by Subject|5|||
48434006|NCT02065622|155777280|FG002|Induction Study|Withdrawal by Subject|0|||
48434007|NCT02065622|155777281|FG003|Induction Study|Withdrawal by Subject|0|||
48434008|NCT02065622|155777282|FG004|Induction Study|Withdrawal by Subject|0|||
48434009|NCT02065622|155777278|FG000|Induction Study|Lost to Follow-up|1|||
48434010|NCT02065622|155777279|FG001|Induction Study|Lost to Follow-up|0|||
48434011|NCT02065622|155777280|FG002|Induction Study|Lost to Follow-up|0|||
48434012|NCT02065622|155777281|FG003|Induction Study|Lost to Follow-up|0|||
48434013|NCT02065622|155777282|FG004|Induction Study|Lost to Follow-up|0|||
48434014|NCT02065622|155777278|FG000|Induction Study|Lack of Efficacy|22|||
48434015|NCT02065622|155777279|FG001|Induction Study|Lack of Efficacy|27|||
48434016|NCT02065622|155777280|FG002|Induction Study|Lack of Efficacy|0|||
48434017|NCT02065622|155777281|FG003|Induction Study|Lack of Efficacy|0|||
48434018|NCT02065622|155777282|FG004|Induction Study|Lack of Efficacy|0|||
48434019|NCT02065622|155777278|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
48434020|NCT02065622|155777279|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
48434021|NCT02065622|155777280|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
48434022|NCT02065622|155777281|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
48434023|NCT02065622|155777282|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
48434024|NCT02065622|155777278|FG000|Induction Study|Subject Noncompliance|1|||
48434025|NCT02065622|155777279|FG001|Induction Study|Subject Noncompliance|1|||
48434026|NCT02065622|155777280|FG002|Induction Study|Subject Noncompliance|0|||
48434027|NCT02065622|155777281|FG003|Induction Study|Subject Noncompliance|0|||
48434028|NCT02065622|155777282|FG004|Induction Study|Subject Noncompliance|0|||
48434029|NCT02065622|155777278|FG000|Induction Study|Other, Not Specified|3|||
48434030|NCT02065622|155777279|FG001|Induction Study|Other, Not Specified|2|||
48434031|NCT02065622|155777280|FG002|Induction Study|Other, Not Specified|0|||
48434032|NCT02065622|155777281|FG003|Induction Study|Other, Not Specified|0|||
48434033|NCT02065622|155777282|FG004|Induction Study|Other, Not Specified|0|||
48434034|NCT02065622|155777278|FG000|Maintenance Study|Adverse Event|0|||
48434035|NCT02065622|155777279|FG001|Maintenance Study|Adverse Event|0|||
48434036|NCT02065622|155777280|FG002|Maintenance Study|Adverse Event|25|||
48434037|NCT02065622|155777281|FG003|Maintenance Study|Adverse Event|22|||
48434038|NCT02065622|155777282|FG004|Maintenance Study|Adverse Event|11|||
48434039|NCT02065622|155777278|FG000|Maintenance Study|Withdrawal by Subject|0|||
48434040|NCT02065622|155777279|FG001|Maintenance Study|Withdrawal by Subject|0|||
48434041|NCT02065622|155777280|FG002|Maintenance Study|Withdrawal by Subject|11|||
48434042|NCT02065622|155777281|FG003|Maintenance Study|Withdrawal by Subject|5|||
48434043|NCT02065622|155777282|FG004|Maintenance Study|Withdrawal by Subject|7|||
48434044|NCT02065622|155777278|FG000|Maintenance Study|Lost to Follow-up|0|||
48434045|NCT02065622|155777279|FG001|Maintenance Study|Lost to Follow-up|0|||
48434046|NCT02065622|155777280|FG002|Maintenance Study|Lost to Follow-up|4|||
48434047|NCT02065622|155777281|FG003|Maintenance Study|Lost to Follow-up|1|||
48434048|NCT02065622|155777282|FG004|Maintenance Study|Lost to Follow-up|1|||
48434049|NCT02065622|155777278|FG000|Maintenance Study|Lack of Efficacy|0|||
48434050|NCT02065622|155777279|FG001|Maintenance Study|Lack of Efficacy|0|||
48434051|NCT02065622|155777280|FG002|Maintenance Study|Lack of Efficacy|70|||
48434052|NCT02065622|155777281|FG003|Maintenance Study|Lack of Efficacy|55|||
48434053|NCT02065622|155777282|FG004|Maintenance Study|Lack of Efficacy|19|||
48434054|NCT02065622|155777278|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
48434055|NCT02065622|155777279|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
48434056|NCT02065622|155777280|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
48434057|NCT02065622|155777281|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
48434058|NCT02065622|155777282|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
48434059|NCT02065622|155777278|FG000|Maintenance Study|Subject Non-Compliance|0|||
48434060|NCT02065622|155777279|FG001|Maintenance Study|Subject Non-Compliance|0|||
48434061|NCT02065622|155777280|FG002|Maintenance Study|Subject Non-Compliance|1|||
48434062|NCT02065622|155777281|FG003|Maintenance Study|Subject Non-Compliance|3|||
48434063|NCT02065622|155777282|FG004|Maintenance Study|Subject Non-Compliance|2|||
48434064|NCT02065622|155777278|FG000|Maintenance Study|Other, Not Specified|0|||
48434065|NCT02065622|155777279|FG001|Maintenance Study|Other, Not Specified|0|||
48434066|NCT02065622|155777280|FG002|Maintenance Study|Other, Not Specified|6|||
48434067|NCT02065622|155777281|FG003|Maintenance Study|Other, Not Specified|14|||
48434068|NCT02065622|155777282|FG004|Maintenance Study|Other, Not Specified|2|||
48434069|NCT02065622|155777278|FG000|Maintenance Study|Unknown Reason|0|||
48434070|NCT02065622|155777279|FG001|Maintenance Study|Unknown Reason|0|||
48434071|NCT02065622|155777280|FG002|Maintenance Study|Unknown Reason|0|||
48434072|NCT02065622|155777281|FG003|Maintenance Study|Unknown Reason|1|||
48434073|NCT02065622|155777282|FG004|Maintenance Study|Unknown Reason|0|||
48434074|NCT00115804|155777289|FG000|Overall Study|Adverse Event|2|||
48434075|NCT01215734|155779113|FG000|Overall Study|Death|0|||
48434076|NCT01215734|155779114|FG001|Overall Study|Death|1|||
48434077|NCT00625365|155779117|FG000|Overall Study|Withdrawal by Subject|1|||
48434078|NCT00625365|155779117|FG000|Overall Study|No IV access|5|||
48434079|NCT00625365|155779117|FG000|Overall Study|VSD|1|||
48434080|NCT00366548|155779118|FG000|Infant Series|Adverse Event|1|||
48434081|NCT00366548|155779119|FG001|Infant Series|Adverse Event|3|||
48434082|NCT00366548|155779118|FG000|Infant Series|Protocol Violation|0|||
48434083|NCT00366548|155779119|FG001|Infant Series|Protocol Violation|1|||
48434084|NCT00366548|155779118|FG000|Infant Series|Withdrawal by Subject|3|||
48434085|NCT00366548|155779119|FG001|Infant Series|Withdrawal by Subject|1|||
48434086|NCT00366548|155779118|FG000|After Infant Series|Withdrawal by Subject|3|||
48434087|NCT00366548|155779119|FG001|After Infant Series|Withdrawal by Subject|1|||
48434088|NCT00366548|155779118|FG000|After Infant Series|Adverse Event|2|||
48434089|NCT00366548|155779119|FG001|After Infant Series|Adverse Event|0|||
48434090|NCT00366548|155779118|FG000|After Infant Series|Lost to Follow-up|1|||
48434091|NCT00366548|155779119|FG001|After Infant Series|Lost to Follow-up|0|||
48434092|NCT01781429|155779121|FG000|Overall Study|Death|0|||
48434093|NCT01781429|155779122|FG001|Overall Study|Death|0|||
48434094|NCT01781429|155779123|FG002|Overall Study|Death|0|||
48434095|NCT01781429|155779124|FG003|Overall Study|Death|0|||
48434096|NCT01781429|155779125|FG004|Overall Study|Death|0|||
48434097|NCT01781429|155779126|FG005|Overall Study|Death|0|||
48434098|NCT01781429|155779127|FG006|Overall Study|Death|0|||
48434099|NCT01781429|155779128|FG007|Overall Study|Death|0|||
48434100|NCT01781429|155779129|FG008|Overall Study|Death|0|||
48434101|NCT01781429|155779130|FG009|Overall Study|Death|1|||
48434102|NCT01781429|155779131|FG010|Overall Study|Death|0|||
48434103|NCT01781429|155779132|FG011|Overall Study|Death|0|||
48434104|NCT01781429|155779133|FG012|Overall Study|Death|1|||
48434105|NCT01781429|155779134|FG013|Overall Study|Death|0|||
48434106|NCT01781429|155779135|FG014|Overall Study|Death|1|||
48434107|NCT01781429|155779136|FG015|Overall Study|Death|0|||
48434108|NCT01781429|155779121|FG000|Overall Study|Withdrawal by Subject|0|||
48434109|NCT01781429|155779122|FG001|Overall Study|Withdrawal by Subject|0|||
48434110|NCT01781429|155779123|FG002|Overall Study|Withdrawal by Subject|0|||
48434111|NCT01781429|155779124|FG003|Overall Study|Withdrawal by Subject|0|||
48434112|NCT01781429|155779125|FG004|Overall Study|Withdrawal by Subject|0|||
48434113|NCT01781429|155779126|FG005|Overall Study|Withdrawal by Subject|0|||
48434114|NCT01781429|155779127|FG006|Overall Study|Withdrawal by Subject|0|||
48434115|NCT01781429|155779128|FG007|Overall Study|Withdrawal by Subject|0|||
48434116|NCT01781429|155779129|FG008|Overall Study|Withdrawal by Subject|1|||
48434117|NCT01781429|155779130|FG009|Overall Study|Withdrawal by Subject|3|||
48434118|NCT01781429|155779131|FG010|Overall Study|Withdrawal by Subject|1|||
48434119|NCT01781429|155779132|FG011|Overall Study|Withdrawal by Subject|1|||
48434120|NCT01781429|155779133|FG012|Overall Study|Withdrawal by Subject|5|||
48434121|NCT01781429|155779134|FG013|Overall Study|Withdrawal by Subject|2|||
48434122|NCT01781429|155779135|FG014|Overall Study|Withdrawal by Subject|3|||
48434123|NCT01781429|155779136|FG015|Overall Study|Withdrawal by Subject|0|||
48434124|NCT01781429|155779121|FG000|Overall Study|Disease Progression|1|||
48434125|NCT01781429|155779122|FG001|Overall Study|Disease Progression|0|||
48434126|NCT01781429|155779123|FG002|Overall Study|Disease Progression|1|||
48434127|NCT01781429|155779124|FG003|Overall Study|Disease Progression|1|||
48434128|NCT01781429|155779125|FG004|Overall Study|Disease Progression|1|||
48434129|NCT01781429|155779126|FG005|Overall Study|Disease Progression|4|||
48434130|NCT01781429|155779127|FG006|Overall Study|Disease Progression|7|||
48434131|NCT01781429|155779128|FG007|Overall Study|Disease Progression|4|||
48434132|NCT01781429|155779129|FG008|Overall Study|Disease Progression|6|||
48434133|NCT01781429|155779130|FG009|Overall Study|Disease Progression|15|||
48434140|NCT01781429|155779121|FG000|Overall Study|Unacceptable Toxicity|0|||
48434141|NCT01781429|155779122|FG001|Overall Study|Unacceptable Toxicity|0|||
48434142|NCT01781429|155779123|FG002|Overall Study|Unacceptable Toxicity|0|||
48434143|NCT01781429|155779124|FG003|Overall Study|Unacceptable Toxicity|0|||
48434144|NCT01781429|155779125|FG004|Overall Study|Unacceptable Toxicity|0|||
48434145|NCT01781429|155779126|FG005|Overall Study|Unacceptable Toxicity|0|||
48434146|NCT01781429|155779127|FG006|Overall Study|Unacceptable Toxicity|0|||
48434147|NCT01781429|155779128|FG007|Overall Study|Unacceptable Toxicity|0|||
48434148|NCT01781429|155779129|FG008|Overall Study|Unacceptable Toxicity|0|||
48434149|NCT01781429|155779130|FG009|Overall Study|Unacceptable Toxicity|0|||
48434150|NCT01781429|155779131|FG010|Overall Study|Unacceptable Toxicity|0|||
48434151|NCT01781429|155779132|FG011|Overall Study|Unacceptable Toxicity|2|||
48434152|NCT01781429|155779133|FG012|Overall Study|Unacceptable Toxicity|0|||
48434153|NCT01781429|155779134|FG013|Overall Study|Unacceptable Toxicity|0|||
48434154|NCT01781429|155779135|FG014|Overall Study|Unacceptable Toxicity|0|||
48434155|NCT01781429|155779136|FG015|Overall Study|Unacceptable Toxicity|0|||
48434156|NCT01781429|155779121|FG000|Overall Study|Patient Condition Changed|0|||
48434157|NCT01781429|155779122|FG001|Overall Study|Patient Condition Changed|0|||
48434158|NCT01781429|155779123|FG002|Overall Study|Patient Condition Changed|0|||
48434159|NCT01781429|155779124|FG003|Overall Study|Patient Condition Changed|0|||
48434160|NCT01781429|155779125|FG004|Overall Study|Patient Condition Changed|0|||
48434161|NCT01781429|155779126|FG005|Overall Study|Patient Condition Changed|0|||
48434162|NCT01781429|155779127|FG006|Overall Study|Patient Condition Changed|0|||
48434163|NCT01781429|155779128|FG007|Overall Study|Patient Condition Changed|0|||
48434164|NCT01781429|155779129|FG008|Overall Study|Patient Condition Changed|0|||
48434165|NCT01781429|155779130|FG009|Overall Study|Patient Condition Changed|4|||
48434166|NCT01781429|155779131|FG010|Overall Study|Patient Condition Changed|0|||
48434167|NCT01781429|155779132|FG011|Overall Study|Patient Condition Changed|1|||
48434168|NCT01781429|155779133|FG012|Overall Study|Patient Condition Changed|0|||
48434169|NCT01781429|155779134|FG013|Overall Study|Patient Condition Changed|1|||
48434170|NCT01781429|155779135|FG014|Overall Study|Patient Condition Changed|0|||
48434171|NCT01781429|155779136|FG015|Overall Study|Patient Condition Changed|0|||
48434172|NCT01781429|155779121|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
48434173|NCT01781429|155779122|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
48434174|NCT01781429|155779123|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
48434175|NCT01781429|155779124|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
48434176|NCT01781429|155779125|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
48434177|NCT01781429|155779126|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
48434178|NCT01781429|155779127|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
48434179|NCT01781429|155779128|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
48434180|NCT01781429|155779129|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
48434181|NCT01781429|155779130|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
48434182|NCT01781429|155779131|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
48434183|NCT01781429|155779132|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
48434184|NCT01781429|155779133|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
48434185|NCT01781429|155779134|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
48434186|NCT01781429|155779135|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
48434187|NCT01781429|155779136|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
48434188|NCT01781429|155779121|FG000|Overall Study|Enrolled, but not treated|0|||
48434189|NCT01781429|155779122|FG001|Overall Study|Enrolled, but not treated|0|||
48434190|NCT01781429|155779123|FG002|Overall Study|Enrolled, but not treated|0|||
48434191|NCT01781429|155779124|FG003|Overall Study|Enrolled, but not treated|0|||
48434192|NCT01781429|155779125|FG004|Overall Study|Enrolled, but not treated|0|||
48434193|NCT01781429|155779126|FG005|Overall Study|Enrolled, but not treated|0|||
48434194|NCT01781429|155779127|FG006|Overall Study|Enrolled, but not treated|0|||
48434195|NCT01781429|155779128|FG007|Overall Study|Enrolled, but not treated|0|||
48434196|NCT01781429|155779129|FG008|Overall Study|Enrolled, but not treated|0|||
48434197|NCT01781429|155779130|FG009|Overall Study|Enrolled, but not treated|0|||
48434198|NCT01781429|155779131|FG010|Overall Study|Enrolled, but not treated|1|||
48434199|NCT01781429|155779132|FG011|Overall Study|Enrolled, but not treated|0|||
48434200|NCT01781429|155779133|FG012|Overall Study|Enrolled, but not treated|0|||
48434201|NCT01781429|155779134|FG013|Overall Study|Enrolled, but not treated|0|||
48434202|NCT01781429|155779135|FG014|Overall Study|Enrolled, but not treated|0|||
48434203|NCT01781429|155779136|FG015|Overall Study|Enrolled, but not treated|0|||
48434204|NCT00262080|155779137|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
48434205|NCT00262080|155779138|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48434206|NCT00262080|155779139|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
48434207|NCT00262080|155779137|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
48434208|NCT00262080|155779138|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
48434209|NCT00262080|155779139|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
48434210|NCT00262080|155779137|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
48434211|NCT00262080|155779138|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
48434212|NCT00262080|155779139|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
48434213|NCT00262080|155779137|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
48434214|NCT00262080|155779138|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
48434215|NCT00262080|155779139|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
48434216|NCT00262080|155779137|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
48434217|NCT00262080|155779138|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
48434218|NCT00262080|155779139|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
48434219|NCT00262080|155779137|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
48434220|NCT00262080|155779138|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
48434221|NCT00262080|155779139|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
48434222|NCT01051986|155779140|FG000|Overall Study|Death|1|||
48434223|NCT01051986|155779141|FG001|Overall Study|Death|0|||
48434224|NCT01051986|155779140|FG000|Overall Study|Withdrawal by Subject|2|||
48434225|NCT01051986|155779141|FG001|Overall Study|Withdrawal by Subject|1|||
48434226|NCT01051986|155779140|FG000|Overall Study|Protocol Violation|2|||
48434227|NCT01051986|155779141|FG001|Overall Study|Protocol Violation|3|||
48434228|NCT02273752|155779142|FG000|Overall Study|Trial was terminated early|2|||
48434229|NCT00903032|155779143|FG000|Overall Study|Withdrawal by Subject|5|||
48434230|NCT00903032|155779144|FG001|Overall Study|Withdrawal by Subject|3|||
48434231|NCT00903032|155779143|FG000|Overall Study|Lost to Follow-up|2|||
48434232|NCT00903032|155779144|FG001|Overall Study|Lost to Follow-up|2|||
48434233|NCT03580382|155779148|FG000|Overall Study|Early Termination of Study|0|||
48434234|NCT03580382|155779149|FG001|Overall Study|Early Termination of Study|3|||
48434235|NCT02808312|155779150|FG000|Overall Study|Enrolled but Never Treated|0|||
48434236|NCT02808312|155779151|FG001|Overall Study|Enrolled but Never Treated|0|||
48434237|NCT02808312|155779152|FG002|Overall Study|Enrolled but Never Treated|1|||
48434238|NCT02808312|155779153|FG003|Overall Study|Enrolled but Never Treated|0|||
48434239|NCT02808312|155779154|FG004|Overall Study|Enrolled but Never Treated|0|||
48434240|NCT03628417|155779155|FG000|Overall Study|Death|1|||
48434241|NCT03628417|155779156|FG001|Overall Study|Death|1|||
48434242|NCT01876732|155779157|FG000|Overall Study|MMA was not over 800mg/dL|75|||
48434243|NCT01457118|155779158|FG000|Overall Study|Adverse Event|1|||
48434244|NCT01457118|155779159|FG001|Overall Study|Adverse Event|0|||
48434245|NCT01457118|155779160|FG002|Overall Study|Adverse Event|0|||
48434246|NCT01457118|155779161|FG003|Overall Study|Adverse Event|1|||
48434247|NCT01457118|155779158|FG000|Overall Study|Clinical Progression|0|||
48434248|NCT01457118|155779159|FG001|Overall Study|Clinical Progression|1|||
48434249|NCT01457118|155779160|FG002|Overall Study|Clinical Progression|0|||
48434250|NCT01457118|155779161|FG003|Overall Study|Clinical Progression|1|||
48434251|NCT01457118|155779158|FG000|Overall Study|Physician Decision|2|||
48434252|NCT01457118|155779159|FG001|Overall Study|Physician Decision|0|||
48434253|NCT01457118|155779160|FG002|Overall Study|Physician Decision|0|||
48434254|NCT01457118|155779161|FG003|Overall Study|Physician Decision|0|||
48434255|NCT01457118|155779158|FG000|Overall Study|Progressive Disease by RECIST|12|||
48434256|NCT01457118|155779159|FG001|Overall Study|Progressive Disease by RECIST|3|||
48434257|NCT01457118|155779160|FG002|Overall Study|Progressive Disease by RECIST|1|||
48434258|NCT01457118|155779161|FG003|Overall Study|Progressive Disease by RECIST|0|||
48434259|NCT01457118|155779158|FG000|Overall Study|Withdrawal by Subject|5|||
48434260|NCT01457118|155779159|FG001|Overall Study|Withdrawal by Subject|0|||
48434261|NCT01457118|155779160|FG002|Overall Study|Withdrawal by Subject|0|||
48434262|NCT01457118|155779161|FG003|Overall Study|Withdrawal by Subject|0|||
48434263|NCT00115349|155779162|FG000|Overall Study|Study closed due to low enrollment.|11|||
48434264|NCT00115349|155779163|FG001|Overall Study|Study closed due to low enrollment.|9|||
48434265|NCT05142332|155779164|FG000|Overall Study|Withdrawal by Subject|0|||
48434266|NCT05142332|155779165|FG001|Overall Study|Withdrawal by Subject|1|||
48434267|NCT05142332|155779166|FG002|Overall Study|Withdrawal by Subject|2|||
48434268|NCT05142332|155779167|FG003|Overall Study|Withdrawal by Subject|0|||
48434269|NCT05142332|155779168|FG004|Overall Study|Withdrawal by Subject|0|||
48434270|NCT05142332|155779169|FG005|Overall Study|Withdrawal by Subject|2|||
48434271|NCT05142332|155779170|FG006|Overall Study|Withdrawal by Subject|6|||
48434272|NCT05142332|155779164|FG000|Overall Study|Left ED|3|||
48434273|NCT05142332|155779165|FG001|Overall Study|Left ED|0|||
48434274|NCT05142332|155779166|FG002|Overall Study|Left ED|4|||
48434275|NCT05142332|155779167|FG003|Overall Study|Left ED|6|||
48434276|NCT05142332|155779168|FG004|Overall Study|Left ED|1|||
48434277|NCT05142332|155779169|FG005|Overall Study|Left ED|2|||
48434278|NCT05142332|155779170|FG006|Overall Study|Left ED|6|||
48434279|NCT05142332|155779164|FG000|Overall Study|Physician Decision|0|||
48434280|NCT05142332|155779165|FG001|Overall Study|Physician Decision|0|||
48434281|NCT05142332|155779166|FG002|Overall Study|Physician Decision|2|||
48434282|NCT05142332|155779167|FG003|Overall Study|Physician Decision|1|||
48434283|NCT05142332|155779168|FG004|Overall Study|Physician Decision|0|||
48434284|NCT05142332|155779169|FG005|Overall Study|Physician Decision|0|||
48434285|NCT05142332|155779170|FG006|Overall Study|Physician Decision|3|||
48434286|NCT05142332|155779164|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
48434287|NCT05142332|155779165|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
48434288|NCT05142332|155779166|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
48434289|NCT05142332|155779167|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
48434290|NCT05142332|155779168|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
48434291|NCT05142332|155779169|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
48434292|NCT05142332|155779170|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
48434293|NCT02750800|155779171|FG000|Overall Study|Adverse Event|18|||
48434294|NCT02750800|155779171|FG000|Overall Study|Lost to Follow-up|12|||
48434295|NCT02750800|155779171|FG000|Overall Study|Investigator decision|53|||
48434296|NCT02750800|155779171|FG000|Overall Study|Patient request|12|||
48434297|NCT02750800|155779171|FG000|Overall Study|Other, not specified|3|||
48434298|NCT01718509|155779172|FG000|Overall Study|Lost to Follow-up|18|||
48434299|NCT01718509|155779173|FG001|Overall Study|Lost to Follow-up|15|||
48434300|NCT01718509|155779172|FG000|Overall Study|Withdrawal by Subject|7|||
48434301|NCT01718509|155779173|FG001|Overall Study|Withdrawal by Subject|13|||
48434302|NCT01718509|155779172|FG000|Overall Study|Adverse Event|5|||
48434303|NCT01718509|155779173|FG001|Overall Study|Adverse Event|7|||
48434304|NCT01718509|155779172|FG000|Overall Study|Other|13|||
48434305|NCT01718509|155779173|FG001|Overall Study|Other|11|||
48434306|NCT01718509|155779172|FG000|Overall Study|Protocol Violation|4|||
48434307|NCT01718509|155779173|FG001|Overall Study|Protocol Violation|2|||
48434308|NCT01718509|155779172|FG000|Overall Study|Lack of Efficacy|1|||
48434309|NCT01718509|155779173|FG001|Overall Study|Lack of Efficacy|0|||
48434310|NCT02935634|155779177|FG000|Randomization|Participant withdrew consent|0|||
48434311|NCT02935634|155779178|FG001|Randomization|Participant withdrew consent|1|||
48434312|NCT02935634|155779179|FG002|Randomization|Participant withdrew consent|0|||
48434313|NCT02935634|155779180|FG003|Randomization|Participant withdrew consent|0|||
48434314|NCT02935634|155779181|FG004|Randomization|Participant withdrew consent|0|||
48434315|NCT02935634|155779182|FG005|Randomization|Participant withdrew consent|0|||
48434316|NCT02935634|155779177|FG000|Randomization|Death|2|||
48434317|NCT02935634|155779178|FG001|Randomization|Death|1|||
48434318|NCT02935634|155779179|FG002|Randomization|Death|1|||
48434319|NCT02935634|155779180|FG003|Randomization|Death|0|||
48434320|NCT02935634|155779181|FG004|Randomization|Death|0|||
48434321|NCT02935634|155779182|FG005|Randomization|Death|0|||
48434322|NCT02935634|155779177|FG000|Randomization|Other reasons|0|||
48434323|NCT02935634|155779178|FG001|Randomization|Other reasons|2|||
48434324|NCT02935634|155779179|FG002|Randomization|Other reasons|2|||
48434325|NCT02935634|155779180|FG003|Randomization|Other reasons|0|||
48434326|NCT02935634|155779181|FG004|Randomization|Other reasons|0|||
48434327|NCT02935634|155779182|FG005|Randomization|Other reasons|0|||
48434328|NCT02935634|155779177|FG000|Treatment: Track 1|Disease progression|15|||
48434329|NCT02935634|155779178|FG001|Treatment: Track 1|Disease progression|17|||
48434330|NCT02935634|155779179|FG002|Treatment: Track 1|Disease progression|28|||
48434331|NCT02935634|155779180|FG003|Treatment: Track 1|Disease progression|4|||
48434332|NCT02935634|155779181|FG004|Treatment: Track 1|Disease progression|6|||
48434333|NCT02935634|155779182|FG005|Treatment: Track 1|Disease progression|2|||
48434334|NCT02935634|155779177|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
48434335|NCT02935634|155779178|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
48434336|NCT02935634|155779179|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
48434337|NCT02935634|155779180|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
48434338|NCT02935634|155779181|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
48434339|NCT02935634|155779182|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
48434340|NCT02935634|155779177|FG000|Treatment: Track 1|Lost to Follow-up|1|||
48434341|NCT02935634|155779178|FG001|Treatment: Track 1|Lost to Follow-up|0|||
48434342|NCT02935634|155779179|FG002|Treatment: Track 1|Lost to Follow-up|0|||
48434343|NCT02935634|155779180|FG003|Treatment: Track 1|Lost to Follow-up|0|||
48434344|NCT02935634|155779181|FG004|Treatment: Track 1|Lost to Follow-up|0|||
48434345|NCT02935634|155779182|FG005|Treatment: Track 1|Lost to Follow-up|0|||
48434346|NCT02935634|155779177|FG000|Treatment: Track 1|Study drug toxicity|2|||
48434347|NCT02935634|155779178|FG001|Treatment: Track 1|Study drug toxicity|1|||
48434348|NCT02935634|155779179|FG002|Treatment: Track 1|Study drug toxicity|3|||
48434349|NCT02935634|155779180|FG003|Treatment: Track 1|Study drug toxicity|0|||
48434350|NCT02935634|155779181|FG004|Treatment: Track 1|Study drug toxicity|0|||
48434351|NCT02935634|155779182|FG005|Treatment: Track 1|Study drug toxicity|1|||
48434352|NCT02935634|155779177|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
48434353|NCT02935634|155779178|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
48434354|NCT02935634|155779179|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
48434355|NCT02935634|155779180|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
48434356|NCT02935634|155779181|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
48434357|NCT02935634|155779182|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
48434358|NCT02935634|155779177|FG000|Treatment: Track 1|Participant withdrew consent|2|||
48434359|NCT02935634|155779178|FG001|Treatment: Track 1|Participant withdrew consent|0|||
48434360|NCT02935634|155779179|FG002|Treatment: Track 1|Participant withdrew consent|1|||
48434361|NCT02935634|155779180|FG003|Treatment: Track 1|Participant withdrew consent|0|||
48434669|NCT04167306|155779285|FG002|Overall Study|non-compliance|1|||
48434362|NCT02935634|155779181|FG004|Treatment: Track 1|Participant withdrew consent|1|||
48434363|NCT02935634|155779182|FG005|Treatment: Track 1|Participant withdrew consent|0|||
48434364|NCT02935634|155779177|FG000|Treatment: Track 1|Other reasons|0|||
48434365|NCT02935634|155779178|FG001|Treatment: Track 1|Other reasons|0|||
48434366|NCT02935634|155779179|FG002|Treatment: Track 1|Other reasons|2|||
48434367|NCT02935634|155779180|FG003|Treatment: Track 1|Other reasons|0|||
48434368|NCT02935634|155779181|FG004|Treatment: Track 1|Other reasons|0|||
48434369|NCT02935634|155779182|FG005|Treatment: Track 1|Other reasons|0|||
48434370|NCT02935634|155779177|FG000|Treatment: Track 2|Disease progression|13|||
48434371|NCT02935634|155779178|FG001|Treatment: Track 2|Disease progression|26|||
48434372|NCT02935634|155779179|FG002|Treatment: Track 2|Disease progression|20|||
48434373|NCT02935634|155779180|FG003|Treatment: Track 2|Disease progression|5|||
48434374|NCT02935634|155779181|FG004|Treatment: Track 2|Disease progression|1|||
48434375|NCT02935634|155779182|FG005|Treatment: Track 2|Disease progression|4|||
48434376|NCT02935634|155779177|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
48434377|NCT02935634|155779178|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
48434378|NCT02935634|155779179|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
48434379|NCT02935634|155779180|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
48434380|NCT02935634|155779181|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
48434381|NCT02935634|155779182|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
48434382|NCT02935634|155779177|FG000|Treatment: Track 2|Study drug toxicity|7|||
48434383|NCT02935634|155779178|FG001|Treatment: Track 2|Study drug toxicity|3|||
48434384|NCT02935634|155779179|FG002|Treatment: Track 2|Study drug toxicity|0|||
48434385|NCT02935634|155779180|FG003|Treatment: Track 2|Study drug toxicity|0|||
48434386|NCT02935634|155779181|FG004|Treatment: Track 2|Study drug toxicity|0|||
48434387|NCT02935634|155779182|FG005|Treatment: Track 2|Study drug toxicity|0|||
48434388|NCT02935634|155779177|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
48434389|NCT02935634|155779178|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
48434390|NCT02935634|155779179|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
48434391|NCT02935634|155779180|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
48434392|NCT02935634|155779181|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
48434393|NCT02935634|155779182|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
48434394|NCT02935634|155779177|FG000|Treatment: Track 2|Participant withdrew consent|0|||
48434395|NCT02935634|155779178|FG001|Treatment: Track 2|Participant withdrew consent|1|||
48434396|NCT02935634|155779179|FG002|Treatment: Track 2|Participant withdrew consent|1|||
48434397|NCT02935634|155779180|FG003|Treatment: Track 2|Participant withdrew consent|0|||
48434398|NCT02935634|155779181|FG004|Treatment: Track 2|Participant withdrew consent|1|||
48434399|NCT02935634|155779182|FG005|Treatment: Track 2|Participant withdrew consent|0|||
48434400|NCT00913978|155779183|FG000|Overall Study|Surgeon choice|1|||
48434401|NCT00913978|155779184|FG001|Overall Study|Surgeon choice|3|||
48434402|NCT03150095|155779185|FG000|Overall Study|Death|0|||
48434403|NCT03150095|155779186|FG001|Overall Study|Death|1|||
48434404|NCT03150095|155779185|FG000|Overall Study|Lost to Follow-up|1|||
48434405|NCT03150095|155779186|FG001|Overall Study|Lost to Follow-up|1|||
48434406|NCT03150095|155779185|FG000|Overall Study|Withdrawal by Subject|4|||
48434407|NCT03150095|155779186|FG001|Overall Study|Withdrawal by Subject|0|||
48434408|NCT03150095|155779185|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
48434409|NCT03150095|155779186|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
48434410|NCT03471767|155779189|FG000|Overall Study|Withdrawal by Subject|3|||
48434411|NCT03471767|155779190|FG001|Overall Study|Withdrawal by Subject|1|||
48434412|NCT03471767|155779189|FG000|Overall Study|Adverse Event|1|||
48434413|NCT03471767|155779190|FG001|Overall Study|Adverse Event|0|||
48434414|NCT03471767|155779189|FG000|Overall Study|Lost to Follow-up|1|||
48434415|NCT03471767|155779190|FG001|Overall Study|Lost to Follow-up|0|||
48434416|NCT03471767|155779189|FG000|Overall Study|PI Withdrawal|1|||
48434417|NCT03471767|155779190|FG001|Overall Study|PI Withdrawal|3|||
48434418|NCT02605447|155779192|FG000|Overall Study|Death|66|||
48434419|NCT02605447|155779192|FG000|Overall Study|Physician Decision|1|||
48434420|NCT02605447|155779192|FG000|Overall Study|Lost to Follow-up|24|||
48434421|NCT02605447|155779192|FG000|Overall Study|Withdrawal by Subject|10|||
48434422|NCT02605447|155779192|FG000|Overall Study|Not disclosed|1|||
48434423|NCT00632463|155779198|FG000|Overall Study|Adverse Event|0|||
48434424|NCT00632463|155779199|FG001|Overall Study|Adverse Event|1|||
48434425|NCT00632463|155779200|FG002|Overall Study|Adverse Event|0|||
48434426|NCT01096849|155779211|FG000|Overall Study|Consent Withdrawn|1|||
48434427|NCT01096849|155779212|FG001|Overall Study|Consent Withdrawn|4|||
48434428|NCT01096849|155779213|FG002|Overall Study|Consent Withdrawn|2|||
48434429|NCT01096849|155779211|FG000|Overall Study|Lack of Efficacy|0|||
48434430|NCT01096849|155779212|FG001|Overall Study|Lack of Efficacy|2|||
48434431|NCT01096849|155779213|FG002|Overall Study|Lack of Efficacy|0|||
48434432|NCT01096849|155779211|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
48434433|NCT01096849|155779212|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
48434434|NCT01096849|155779213|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
48434435|NCT01096849|155779211|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
48434436|NCT01096849|155779212|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
48434437|NCT01096849|155779213|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
48434438|NCT01096849|155779211|FG000|Overall Study|Administrative Reasons|0|||
48434439|NCT01096849|155779212|FG001|Overall Study|Administrative Reasons|1|||
48434440|NCT01096849|155779213|FG002|Overall Study|Administrative Reasons|2|||
48434441|NCT01096849|155779211|FG000|Overall Study|Lost to Follow-up|1|||
48434442|NCT01096849|155779212|FG001|Overall Study|Lost to Follow-up|3|||
48434443|NCT01096849|155779213|FG002|Overall Study|Lost to Follow-up|1|||
48434444|NCT00536978|155779214|FG000|Overall Study|Not eligible for Adback Infusion|22|||
48434445|NCT01240811|155779223|FG000|Overall Study|Physician Decision|0|||
48434446|NCT01240811|155779224|FG001|Overall Study|Physician Decision|1|||
48434447|NCT01240811|155779225|FG002|Overall Study|Physician Decision|0|||
48434448|NCT01240811|155779223|FG000|Overall Study|Withdrawal by Subject|0|||
48434449|NCT01240811|155779224|FG001|Overall Study|Withdrawal by Subject|0|||
48434450|NCT01240811|155779225|FG002|Overall Study|Withdrawal by Subject|1|||
48434451|NCT01911845|155779226|FG000|Overall Study|Adverse Event|2|||
48434452|NCT01911845|155779226|FG000|Overall Study|Lost to Follow-up|1|||
48434453|NCT01911845|155779226|FG000|Overall Study|Other (not specified)|3|||
48434454|NCT03007953|155779227|FG000|Overall Study|Withdrawal by Subject|5|||
48434455|NCT03007953|155779228|FG001|Overall Study|Withdrawal by Subject|2|||
48434456|NCT03007953|155779227|FG000|Overall Study|Death|5|||
48434457|NCT03007953|155779228|FG001|Overall Study|Death|7|||
48434458|NCT03007953|155779227|FG000|Overall Study|Lost to Follow-up|3|||
48434459|NCT03007953|155779228|FG001|Overall Study|Lost to Follow-up|2|||
48434460|NCT03007953|155779227|FG000|Overall Study|Enrolled in Hospice|3|||
48434461|NCT03007953|155779228|FG001|Overall Study|Enrolled in Hospice|2|||
48434462|NCT02998554|155779231|FG000|Overall Study|Adverse Event|8|||
48434463|NCT02998554|155779232|FG001|Overall Study|Adverse Event|3|||
48434464|NCT02998554|155779231|FG000|Overall Study|Protocol deviation|1|||
48434465|NCT02998554|155779232|FG001|Overall Study|Protocol deviation|0|||
48434466|NCT02998554|155779231|FG000|Overall Study|Withdrawal by Subject|2|||
48434467|NCT02998554|155779232|FG001|Overall Study|Withdrawal by Subject|6|||
48434468|NCT02998554|155779231|FG000|Overall Study|Lost to Follow-up|0|||
48434469|NCT02998554|155779232|FG001|Overall Study|Lost to Follow-up|1|||
48434470|NCT02998554|155779231|FG000|Overall Study|Lack of Efficacy|0|||
48434471|NCT02998554|155779232|FG001|Overall Study|Lack of Efficacy|1|||
48434472|NCT00242580|155779234|FG000|Overall Study|Adverse Event|3|||
48434473|NCT00242580|155779235|FG001|Overall Study|Adverse Event|0|||
48434474|NCT00242580|155779236|FG002|Overall Study|Adverse Event|2|||
48434475|NCT00242580|155779234|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48434476|NCT00242580|155779235|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
48434477|NCT00242580|155779236|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
48434478|NCT00242580|155779234|FG000|Overall Study|Protocol Violation|0|||
48434479|NCT00242580|155779235|FG001|Overall Study|Protocol Violation|0|||
48434480|NCT00242580|155779236|FG002|Overall Study|Protocol Violation|1|||
48434481|NCT00242580|155779234|FG000|Overall Study|Subject withdrew consent|2|||
48434482|NCT00242580|155779235|FG001|Overall Study|Subject withdrew consent|2|||
48434483|NCT00242580|155779236|FG002|Overall Study|Subject withdrew consent|5|||
48434484|NCT00242580|155779234|FG000|Overall Study|Lost to Follow-up|0|||
48434485|NCT00242580|155779235|FG001|Overall Study|Lost to Follow-up|3|||
48434486|NCT00242580|155779236|FG002|Overall Study|Lost to Follow-up|0|||
48434487|NCT00242580|155779234|FG000|Overall Study|Death|1|||
48434488|NCT00242580|155779235|FG001|Overall Study|Death|2|||
48434489|NCT00242580|155779236|FG002|Overall Study|Death|1|||
48434490|NCT01079962|155779237|FG000|Overall Study|Adverse Event|2|||
48434491|NCT01079962|155779238|FG001|Overall Study|Adverse Event|2|||
48434492|NCT01079962|155779237|FG000|Overall Study|Withdrawal by Subject|5|||
48434493|NCT01079962|155779238|FG001|Overall Study|Withdrawal by Subject|7|||
48434494|NCT01079962|155779237|FG000|Overall Study|Protocol Violation|2|||
48434495|NCT01079962|155779238|FG001|Overall Study|Protocol Violation|2|||
48434496|NCT01079962|155779237|FG000|Overall Study|No blood pressure (BP) control|3|||
48434497|NCT01079962|155779238|FG001|Overall Study|No blood pressure (BP) control|0|||
48434498|NCT01079962|155779237|FG000|Overall Study|Inclusion/exclusion criteria|1|||
48434499|NCT01079962|155779238|FG001|Overall Study|Inclusion/exclusion criteria|3|||
48434500|NCT01079962|155779237|FG000|Overall Study|Participant not returning for next visit|1|||
48434501|NCT01079962|155779238|FG001|Overall Study|Participant not returning for next visit|0|||
48434502|NCT01079962|155779237|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
48434503|NCT01079962|155779238|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
48434504|NCT01331239|155779239|FG000|Part II: Core Study|Adverse Event|0|||
48434505|NCT01331239|155779240|FG001|Part II: Core Study|Adverse Event|3|||
48434506|NCT01331239|155779241|FG002|Part II: Core Study|Adverse Event|0|||
48434507|NCT01331239|155779239|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
48434508|NCT01331239|155779240|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
48434509|NCT01331239|155779241|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
48434510|NCT01331239|155779239|FG000|Part II: Core Study|Withdrawal by Subject|0|||
48434511|NCT01331239|155779240|FG001|Part II: Core Study|Withdrawal by Subject|2|||
48434512|NCT01331239|155779241|FG002|Part II: Core Study|Withdrawal by Subject|0|||
48434513|NCT01331239|155779239|FG000|Part II: Core Study|Administrative problems|0|||
48434514|NCT01331239|155779240|FG001|Part II: Core Study|Administrative problems|1|||
48434515|NCT01331239|155779241|FG002|Part II: Core Study|Administrative problems|0|||
48434516|NCT01072539|155779242|FG000|Overall Study|Treated prior to the Site Initiation|1|||
48434517|NCT01072539|155779242|FG000|Overall Study|Protocol Violation|2|||
48434518|NCT04937816|155779245|FG000|Overall Study|Study drug stopped, reason missing|5|||
48434519|NCT04937816|155779246|FG001|Overall Study|Study drug stopped, reason missing|3|||
48434520|NCT04937816|155779247|FG002|Overall Study|Study drug stopped, reason missing|4|||
48434521|NCT04937816|155779248|FG003|Overall Study|Study drug stopped, reason missing|6|||
48434522|NCT04937816|155779249|FG004|Overall Study|Study drug stopped, reason missing|1|||
48434523|NCT04937816|155779250|FG005|Overall Study|Study drug stopped, reason missing|0|||
48434524|NCT04937816|155779251|FG006|Overall Study|Study drug stopped, reason missing|0|||
48434525|NCT04937816|155779245|FG000|Overall Study|Other than stated below|173|||
48434526|NCT04937816|155779246|FG001|Overall Study|Other than stated below|143|||
48434527|NCT04937816|155779247|FG002|Overall Study|Other than stated below|125|||
48434528|NCT04937816|155779248|FG003|Overall Study|Other than stated below|44|||
48434529|NCT04937816|155779249|FG004|Overall Study|Other than stated below|45|||
48434530|NCT04937816|155779250|FG005|Overall Study|Other than stated below|28|||
48434531|NCT04937816|155779251|FG006|Overall Study|Other than stated below|31|||
48434532|NCT04937816|155779245|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
48434533|NCT04937816|155779246|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
48434534|NCT04937816|155779247|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
48434535|NCT04937816|155779248|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
48434536|NCT04937816|155779249|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
48434537|NCT04937816|155779250|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
48434538|NCT04937816|155779251|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
48434539|NCT04937816|155779245|FG000|Overall Study|Lost to Follow-up|15|||
48434540|NCT04937816|155779246|FG001|Overall Study|Lost to Follow-up|9|||
48434541|NCT04937816|155779247|FG002|Overall Study|Lost to Follow-up|6|||
48434542|NCT04937816|155779248|FG003|Overall Study|Lost to Follow-up|6|||
48434543|NCT04937816|155779249|FG004|Overall Study|Lost to Follow-up|16|||
48434544|NCT04937816|155779250|FG005|Overall Study|Lost to Follow-up|11|||
48434545|NCT04937816|155779251|FG006|Overall Study|Lost to Follow-up|17|||
48434546|NCT04937816|155779245|FG000|Overall Study|Protocol Violation|15|||
48434547|NCT04937816|155779246|FG001|Overall Study|Protocol Violation|15|||
48434548|NCT04937816|155779247|FG002|Overall Study|Protocol Violation|12|||
48434549|NCT04937816|155779248|FG003|Overall Study|Protocol Violation|30|||
48434550|NCT04937816|155779249|FG004|Overall Study|Protocol Violation|24|||
48434551|NCT04937816|155779250|FG005|Overall Study|Protocol Violation|5|||
48434552|NCT04937816|155779251|FG006|Overall Study|Protocol Violation|5|||
48434553|NCT04937816|155779245|FG000|Overall Study|Adverse Event|303|||
48434554|NCT04937816|155779246|FG001|Overall Study|Adverse Event|267|||
48434555|NCT04937816|155779247|FG002|Overall Study|Adverse Event|273|||
48434556|NCT04937816|155779248|FG003|Overall Study|Adverse Event|553|||
48434557|NCT04937816|155779249|FG004|Overall Study|Adverse Event|575|||
48434558|NCT04937816|155779250|FG005|Overall Study|Adverse Event|343|||
48434559|NCT04937816|155779251|FG006|Overall Study|Adverse Event|337|||
48434560|NCT04937816|155779245|FG000|Overall Study|Not treated|4|||
48434561|NCT04937816|155779246|FG001|Overall Study|Not treated|2|||
48434562|NCT04937816|155779247|FG002|Overall Study|Not treated|2|||
48434563|NCT04937816|155779248|FG003|Overall Study|Not treated|2|||
48434564|NCT04937816|155779249|FG004|Overall Study|Not treated|1|||
48434565|NCT04937816|155779250|FG005|Overall Study|Not treated|4|||
48434566|NCT04937816|155779251|FG006|Overall Study|Not treated|0|||
48434567|NCT00808249|155779260|FG000|Overall Study|Adverse Event|4|||
48434568|NCT00808249|155779261|FG001|Overall Study|Adverse Event|7|||
48434569|NCT00808249|155779262|FG002|Overall Study|Adverse Event|10|||
48434570|NCT00808249|155779263|FG003|Overall Study|Adverse Event|6|||
48434571|NCT00808249|155779260|FG000|Overall Study|Lost to Follow-up|2|||
48434572|NCT00808249|155779261|FG001|Overall Study|Lost to Follow-up|3|||
48434573|NCT00808249|155779262|FG002|Overall Study|Lost to Follow-up|3|||
48434574|NCT00808249|155779263|FG003|Overall Study|Lost to Follow-up|5|||
48434575|NCT00808249|155779260|FG000|Overall Study|Withdrawal by Subject|4|||
48434576|NCT00808249|155779261|FG001|Overall Study|Withdrawal by Subject|0|||
48434577|NCT00808249|155779262|FG002|Overall Study|Withdrawal by Subject|2|||
48434578|NCT00808249|155779263|FG003|Overall Study|Withdrawal by Subject|4|||
48434579|NCT00808249|155779260|FG000|Overall Study|Protocol Violation|3|||
48434580|NCT00808249|155779261|FG001|Overall Study|Protocol Violation|3|||
48434581|NCT00808249|155779262|FG002|Overall Study|Protocol Violation|3|||
48434582|NCT00808249|155779263|FG003|Overall Study|Protocol Violation|0|||
48434583|NCT00808249|155779260|FG000|Overall Study|Lack of Efficacy|1|||
48434584|NCT00808249|155779261|FG001|Overall Study|Lack of Efficacy|1|||
48434585|NCT00808249|155779262|FG002|Overall Study|Lack of Efficacy|0|||
48434586|NCT00808249|155779263|FG003|Overall Study|Lack of Efficacy|0|||
48434587|NCT00808249|155779260|FG000|Overall Study|study specific discontinuation criteria|1|||
48434588|NCT00808249|155779261|FG001|Overall Study|study specific discontinuation criteria|0|||
48434589|NCT00808249|155779262|FG002|Overall Study|study specific discontinuation criteria|1|||
48434590|NCT00808249|155779263|FG003|Overall Study|study specific discontinuation criteria|0|||
48434591|NCT00808249|155779260|FG000|Overall Study|All other reasons|2|||
48434592|NCT00808249|155779261|FG001|Overall Study|All other reasons|1|||
48434593|NCT00808249|155779262|FG002|Overall Study|All other reasons|3|||
48434594|NCT00808249|155779263|FG003|Overall Study|All other reasons|1|||
48434595|NCT01687413|155779266|FG000|Overall Study|Withdrawal by Subject|0|||
48434596|NCT01687413|155779267|FG001|Overall Study|Withdrawal by Subject|2|||
48434597|NCT01687413|155779266|FG000|Overall Study|Not eligible|0|||
48434598|NCT01687413|155779267|FG001|Overall Study|Not eligible|2|||
48434599|NCT01687413|155779266|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
48434600|NCT01687413|155779267|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
48434601|NCT01496430|155779268|FG000|Overall Study|Adverse Event|0|||
48434602|NCT01496430|155779269|FG001|Overall Study|Adverse Event|0|||
48434603|NCT01496430|155779270|FG002|Overall Study|Adverse Event|1|||
48434604|NCT01496430|155779268|FG000|Overall Study|Major Protocol Deviation|0|||
48434605|NCT01496430|155779269|FG001|Overall Study|Major Protocol Deviation|0|||
48434606|NCT01496430|155779270|FG002|Overall Study|Major Protocol Deviation|1|||
48434607|NCT01496430|155779268|FG000|Overall Study|Lost to Follow-up|2|||
48434608|NCT01496430|155779269|FG001|Overall Study|Lost to Follow-up|3|||
48434609|NCT01496430|155779270|FG002|Overall Study|Lost to Follow-up|1|||
48434610|NCT01496430|155779268|FG000|Overall Study|Voluntary Withdrawal|2|||
48434611|NCT01496430|155779269|FG001|Overall Study|Voluntary Withdrawal|1|||
48434612|NCT01496430|155779270|FG002|Overall Study|Voluntary Withdrawal|6|||
48434613|NCT01496430|155779268|FG000|Overall Study|Principal Investigator Discretion|0|||
48434614|NCT01496430|155779269|FG001|Overall Study|Principal Investigator Discretion|1|||
48434615|NCT01496430|155779270|FG002|Overall Study|Principal Investigator Discretion|1|||
48434616|NCT01496430|155779268|FG000|Overall Study|Other|2|||
48434617|NCT01496430|155779269|FG001|Overall Study|Other|0|||
48434618|NCT01496430|155779270|FG002|Overall Study|Other|0|||
48434619|NCT00946530|155779271|FG000|Overall Study|Withdrawal by Subject|0|||
48434620|NCT00946530|155779272|FG001|Overall Study|Withdrawal by Subject|3|||
48434621|NCT00946530|155779273|FG002|Overall Study|Withdrawal by Subject|0|||
48434622|NCT00946530|155779274|FG003|Overall Study|Withdrawal by Subject|3|||
48434623|NCT00946530|155779271|FG000|Overall Study|Physician Decision|1|||
48434624|NCT00946530|155779272|FG001|Overall Study|Physician Decision|1|||
48434625|NCT00946530|155779273|FG002|Overall Study|Physician Decision|1|||
48434626|NCT00946530|155779274|FG003|Overall Study|Physician Decision|1|||
48434627|NCT01008995|155779277|FG000|Controlled Period|Adverse Event|1|||
48434628|NCT01008995|155779278|FG001|Controlled Period|Adverse Event|2|||
48434629|NCT01008995|155779279|FG002|Controlled Period|Adverse Event|0|||
48434630|NCT01008995|155779280|FG003|Controlled Period|Adverse Event|0|||
48434631|NCT01008995|155779277|FG000|Controlled Period|Other|2|||
48434632|NCT01008995|155779278|FG001|Controlled Period|Other|1|||
48434633|NCT01008995|155779279|FG002|Controlled Period|Other|0|||
48434634|NCT01008995|155779280|FG003|Controlled Period|Other|0|||
48434635|NCT01008995|155779277|FG000|After Controlled Period|Adverse Event|0|||
48434636|NCT01008995|155779278|FG001|After Controlled Period|Adverse Event|0|||
48434637|NCT01008995|155779279|FG002|After Controlled Period|Adverse Event|1|||
48434638|NCT01008995|155779280|FG003|After Controlled Period|Adverse Event|1|||
48434639|NCT01008995|155779277|FG000|After Controlled Period|Other|0|||
48434640|NCT01008995|155779278|FG001|After Controlled Period|Other|0|||
48434641|NCT01008995|155779279|FG002|After Controlled Period|Other|1|||
48434642|NCT01008995|155779280|FG003|After Controlled Period|Other|0|||
48434643|NCT04167306|155779283|FG000|Overall Study|Lost to Follow-up|2|||
48434644|NCT04167306|155779284|FG001|Overall Study|Lost to Follow-up|2|||
48434645|NCT04167306|155779285|FG002|Overall Study|Lost to Follow-up|5|||
48434646|NCT04167306|155779286|FG003|Overall Study|Lost to Follow-up|5|||
48434647|NCT04167306|155779283|FG000|Overall Study|Adverse Event|13|||
48434648|NCT04167306|155779284|FG001|Overall Study|Adverse Event|14|||
48434649|NCT04167306|155779285|FG002|Overall Study|Adverse Event|5|||
48434650|NCT04167306|155779286|FG003|Overall Study|Adverse Event|4|||
48434651|NCT04167306|155779283|FG000|Overall Study|Withdrawal by Subject|4|||
48434652|NCT04167306|155779284|FG001|Overall Study|Withdrawal by Subject|6|||
48434653|NCT04167306|155779285|FG002|Overall Study|Withdrawal by Subject|8|||
48434654|NCT04167306|155779286|FG003|Overall Study|Withdrawal by Subject|3|||
48434655|NCT04167306|155779283|FG000|Overall Study|covid|1|||
48434656|NCT04167306|155779284|FG001|Overall Study|covid|1|||
48434657|NCT04167306|155779285|FG002|Overall Study|covid|2|||
48434658|NCT04167306|155779286|FG003|Overall Study|covid|1|||
48434659|NCT04167306|155779283|FG000|Overall Study|concomitant medication|0|||
48434660|NCT04167306|155779284|FG001|Overall Study|concomitant medication|0|||
48434661|NCT04167306|155779285|FG002|Overall Study|concomitant medication|0|||
48434662|NCT04167306|155779286|FG003|Overall Study|concomitant medication|1|||
48434663|NCT04167306|155779283|FG000|Overall Study|Alcohol treatment|0|||
48434664|NCT04167306|155779284|FG001|Overall Study|Alcohol treatment|4|||
48434665|NCT04167306|155779285|FG002|Overall Study|Alcohol treatment|3|||
48434666|NCT04167306|155779286|FG003|Overall Study|Alcohol treatment|2|||
48434667|NCT04167306|155779283|FG000|Overall Study|non-compliance|0|||
48434668|NCT04167306|155779284|FG001|Overall Study|non-compliance|0|||
48434671|NCT04167306|155779283|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
48434672|NCT04167306|155779284|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
48434673|NCT04167306|155779285|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
48434674|NCT04167306|155779286|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
48434675|NCT01232894|155779289|FG000|Overall Study|Lost to Follow-up|0|||
48434676|NCT01232894|155779290|FG001|Overall Study|Lost to Follow-up|1|||
48434677|NCT01232894|155779289|FG000|Overall Study|Death|1|||
48434678|NCT01232894|155779290|FG001|Overall Study|Death|0|||
48434679|NCT01232894|155779289|FG000|Overall Study|Protocol Violation|1|||
48434680|NCT01232894|155779290|FG001|Overall Study|Protocol Violation|1|||
48434681|NCT01232894|155779289|FG000|Overall Study|Withdrawal by Subject|8|||
48434682|NCT01232894|155779290|FG001|Overall Study|Withdrawal by Subject|5|||
48434683|NCT01232894|155779289|FG000|Overall Study|Physician Decision|2|||
48434684|NCT01232894|155779290|FG001|Overall Study|Physician Decision|1|||
48434685|NCT01767194|155779291|FG000|Overall Study|Adverse Event|1|||
48434686|NCT01767194|155779292|FG001|Overall Study|Adverse Event|1|||
48434687|NCT01767194|155779291|FG000|Overall Study|Death|0|||
48434688|NCT01767194|155779292|FG001|Overall Study|Death|1|||
48434689|NCT01767194|155779291|FG000|Overall Study|Lack of Efficacy|12|||
48434690|NCT01767194|155779292|FG001|Overall Study|Lack of Efficacy|11|||
48434691|NCT01767194|155779291|FG000|Overall Study|Physician Decision|2|||
48434692|NCT01767194|155779292|FG001|Overall Study|Physician Decision|23|||
48434693|NCT01767194|155779291|FG000|Overall Study|Withdrawal by Subject|0|||
48434694|NCT01767194|155779292|FG001|Overall Study|Withdrawal by Subject|1|||
48434695|NCT01767194|155779291|FG000|Overall Study|Ineligible|1|||
48434696|NCT01767194|155779292|FG001|Overall Study|Ineligible|1|||
48434697|NCT01767194|155779291|FG000|Overall Study|Refusal by patient/parent|2|||
48434698|NCT01767194|155779292|FG001|Overall Study|Refusal by patient/parent|4|||
48434699|NCT01767194|155779291|FG000|Overall Study|Criteria not met on time for next cycle|0|||
48434700|NCT01767194|155779292|FG001|Overall Study|Criteria not met on time for next cycle|1|||
48434701|NCT02953782|155779293|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
48434702|NCT02953782|155779294|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
48434703|NCT02953782|155779295|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
48434704|NCT02953782|155779296|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
48434705|NCT02953782|155779297|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
48434706|NCT02953782|155779298|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
48434707|NCT02953782|155779299|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
48434708|NCT02953782|155779300|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
48434709|NCT02953782|155779293|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
48434710|NCT02953782|155779294|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48434711|NCT02953782|155779295|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
48434712|NCT02953782|155779296|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48434713|NCT02953782|155779297|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
48434714|NCT02953782|155779298|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48434715|NCT02953782|155779299|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48434716|NCT02953782|155779300|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
48434717|NCT02953782|155779293|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48434718|NCT02953782|155779294|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
48434719|NCT02953782|155779295|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48434720|NCT02953782|155779296|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
48434721|NCT02953782|155779297|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
48434722|NCT02953782|155779298|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48434723|NCT02953782|155779299|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48434724|NCT02953782|155779300|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
48434725|NCT02953782|155779293|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48434726|NCT02953782|155779294|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48434727|NCT02953782|155779295|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
48434728|NCT02953782|155779296|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
48434729|NCT02953782|155779297|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48434730|NCT02953782|155779298|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48434731|NCT02953782|155779299|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48434732|NCT02953782|155779300|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
48434733|NCT02953782|155779293|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48434734|NCT02953782|155779294|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48434735|NCT02953782|155779295|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48434736|NCT02953782|155779296|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48434737|NCT02953782|155779297|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
48434738|NCT02953782|155779298|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
48434739|NCT02953782|155779299|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
48434740|NCT02953782|155779300|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
48434741|NCT02953782|155779293|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48434742|NCT02953782|155779294|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48434743|NCT02953782|155779295|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48434744|NCT02953782|155779296|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48434745|NCT02953782|155779297|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
48434746|NCT02953782|155779298|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
48434747|NCT02953782|155779299|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
48434748|NCT02953782|155779300|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
48434749|NCT02953782|155779293|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48434750|NCT02953782|155779294|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48434751|NCT02953782|155779295|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48434752|NCT02953782|155779296|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48434753|NCT02953782|155779297|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
48434754|NCT02953782|155779298|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
48434755|NCT02953782|155779299|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
48434756|NCT02953782|155779300|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
48434757|NCT02953782|155779293|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48434758|NCT02953782|155779294|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48434759|NCT02953782|155779295|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48434760|NCT02953782|155779296|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48434761|NCT02953782|155779297|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48434762|NCT02953782|155779298|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48434763|NCT02953782|155779299|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
48434764|NCT02953782|155779300|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
48434765|NCT03509207|155780506|FG000|Overall Study|Death|2|||
48434766|NCT01104558|155780507|FG000|Overall Study|Protocol Violation|6|||
48434767|NCT01104558|155780507|FG000|Overall Study|Missing of primary efficacy assessment|10|||
48434768|NCT01104558|155780507|FG000|Overall Study|Missing of genetic analysis results|1|||
48434769|NCT04494633|155780508|FG000|Overall Study|Lost to Follow-up|5|||
48434770|NCT04494633|155780509|FG001|Overall Study|Lost to Follow-up|3|||
48434771|NCT04494633|155780508|FG000|Overall Study|Protocol Violation|1|||
48434772|NCT04494633|155780509|FG001|Overall Study|Protocol Violation|1|||
48434773|NCT00315705|155780510|FG000|Phase 1|Refused further treatment|1|||
48434774|NCT00315705|155780510|FG000|Phase 1|Failure to achieve response|8|||
48434775|NCT00315705|155780510|FG000|Phase 1|Disease relapse|4|||
48434776|NCT00315705|155780510|FG000|Phase 1|Scheduled for transplant|9|||
48434777|NCT00315705|155780510|FG000|Phase 1|Death|3|||
48434778|NCT00315705|155780510|FG000|Phase 2|Physician Decision|4|||
48434779|NCT00315705|155780510|FG000|Phase 2|Adverse Event|1|||
48434780|NCT00315705|155780510|FG000|Phase 2|Failure to achieve response|3|||
48434781|NCT00315705|155780510|FG000|Phase 2|Disease relapse|1|||
48434782|NCT00315705|155780510|FG000|Phase 2|Scheduled for transplant|8|||
48434783|NCT00315705|155780510|FG000|Phase 2|Other|1|||
48434784|NCT00315705|155780510|FG000|Phase 2|Death|7|||
48434785|NCT00748553|155780511|FG000|Overall Study|Adverse Event|0|||
48434786|NCT00748553|155780512|FG001|Overall Study|Adverse Event|1|||
48434787|NCT00748553|155780511|FG000|Overall Study|disease progression|2|||
48434788|NCT00748553|155780512|FG001|Overall Study|disease progression|0|||
48434789|NCT00748553|155780511|FG000|Overall Study|noncompliance|1|||
48434790|NCT00748553|155780512|FG001|Overall Study|noncompliance|0|||
48434791|NCT00667251|155780513|FG000|Overall Study|Adverse Event|13|||
48434792|NCT00667251|155780514|FG001|Overall Study|Adverse Event|4|||
48434793|NCT00667251|155780513|FG000|Overall Study|Withdrawal by Subject|6|||
48434794|NCT00667251|155780514|FG001|Overall Study|Withdrawal by Subject|2|||
48434795|NCT00667251|155780513|FG000|Overall Study|Other/missing|46|||
48434796|NCT00667251|155780514|FG001|Overall Study|Other/missing|84|||
48434797|NCT00667251|155780513|FG000|Overall Study|Intercurrent Illness|4|||
48434798|NCT00667251|155780514|FG001|Overall Study|Intercurrent Illness|3|||
48434799|NCT00667251|155780513|FG000|Overall Study|Symptomatic progression|1|||
48434800|NCT00667251|155780514|FG001|Overall Study|Symptomatic progression|2|||
48434801|NCT01346371|155780515|FG000|Overall Study|Lost to Follow-up|2|||
48434802|NCT01346371|155780516|FG001|Overall Study|Lost to Follow-up|0|||
48434803|NCT01251276|155780517|FG000|Overall Study|Protocol Violation|1|||
48434804|NCT01251276|155780518|FG001|Overall Study|Protocol Violation|0|||
48434805|NCT01251276|155780517|FG000|Overall Study|Lost to Follow-up|0|||
48434806|NCT01251276|155780518|FG001|Overall Study|Lost to Follow-up|1|||
48434807|NCT02653976|155780519|FG000|Overall Study|Withdrawal by Subject|5|||
48434808|NCT02653976|155780519|FG000|Overall Study|Death|4|||
48434809|NCT00568958|155780520|FG000|Allocation|Withdrawal by Subject|7|||
48434810|NCT00568958|155780521|FG001|Allocation|Withdrawal by Subject|3|||
48434811|NCT00568958|155780520|FG000|Allocation|Physician Decision|2|||
48434812|NCT00568958|155780521|FG001|Allocation|Physician Decision|0|||
48434824|NCT01640925|155780523|FG001|Overall Study|Previously enrolled in this trial|11|||
48434825|NCT01754922|155780528|FG000|Overall Study|Adverse Event|0|||
48434826|NCT01754922|155780529|FG001|Overall Study|Adverse Event|1|||
48434827|NCT01944969|155780530|FG000|Overall Study|Adverse Event|1|||
48434828|NCT01944969|155780530|FG000|Overall Study|Lack of Efficacy|1|||
48434829|NCT01944969|155780530|FG000|Overall Study|Non-compliance with IMP|1|||
48434830|NCT01944969|155780530|FG000|Overall Study|Administrative or other reasons|23|||
48434831|NCT00288860|155780531|FG000|Overall Study|Did not complete intake|4|||
48434832|NCT00288860|155780532|FG001|Overall Study|Did not complete intake|8|||
48434833|NCT00288860|155780531|FG000|Overall Study|Death|4|||
48434834|NCT00288860|155780532|FG001|Overall Study|Death|3|||
48434835|NCT00288860|155780531|FG000|Overall Study|Withdrawal by Subject|20|||
48434836|NCT00288860|155780532|FG001|Overall Study|Withdrawal by Subject|15|||
48434837|NCT00288860|155780531|FG000|Overall Study|Lost to Follow-up|74|||
48434838|NCT00288860|155780532|FG001|Overall Study|Lost to Follow-up|71|||
48434839|NCT03298412|155780533|FG000|Run-in Period|Other, Not Specified|1|||
48434840|NCT03298412|155780533|FG000|Run-in Period|Disease Progression|1|||
48434841|NCT03298412|155780533|FG000|Run-in Period|Ineligibility Determined|1|||
48434842|NCT03298412|155780533|FG000|Run-in Period|Decision by Sponsor|6|||
48434843|NCT00882999|155780536|FG000|Overall Study|Adverse Event|0|||
48434844|NCT00882999|155780537|FG001|Overall Study|Adverse Event|0|||
48434845|NCT00882999|155780538|FG002|Overall Study|Adverse Event|0|||
48434846|NCT00882999|155780539|FG003|Overall Study|Adverse Event|0|||
48434847|NCT00882999|155780540|FG004|Overall Study|Adverse Event|1|||
48434848|NCT00882999|155780541|FG005|Overall Study|Adverse Event|0|||
48434849|NCT00882999|155780542|FG006|Overall Study|Adverse Event|0|||
48434850|NCT00882999|155780536|FG000|Overall Study|Death|0|||
48434851|NCT00882999|155780537|FG001|Overall Study|Death|1|||
48434852|NCT00882999|155780538|FG002|Overall Study|Death|0|||
48434853|NCT00882999|155780539|FG003|Overall Study|Death|0|||
48434854|NCT00882999|155780540|FG004|Overall Study|Death|0|||
48434855|NCT00882999|155780541|FG005|Overall Study|Death|0|||
48434856|NCT00882999|155780542|FG006|Overall Study|Death|0|||
48434857|NCT00882999|155780536|FG000|Overall Study|Withdrawal by Subject|7|||
48434858|NCT00882999|155780537|FG001|Overall Study|Withdrawal by Subject|6|||
48434859|NCT00882999|155780538|FG002|Overall Study|Withdrawal by Subject|3|||
48434860|NCT00882999|155780539|FG003|Overall Study|Withdrawal by Subject|3|||
48434861|NCT00882999|155780540|FG004|Overall Study|Withdrawal by Subject|6|||
48434862|NCT00882999|155780541|FG005|Overall Study|Withdrawal by Subject|5|||
48434863|NCT00882999|155780542|FG006|Overall Study|Withdrawal by Subject|5|||
48434864|NCT00882999|155780536|FG000|Overall Study|Lost to Follow-up|0|||
48434865|NCT00882999|155780537|FG001|Overall Study|Lost to Follow-up|1|||
48434866|NCT00882999|155780538|FG002|Overall Study|Lost to Follow-up|1|||
48434867|NCT00882999|155780539|FG003|Overall Study|Lost to Follow-up|2|||
48434868|NCT00882999|155780540|FG004|Overall Study|Lost to Follow-up|1|||
48434869|NCT00882999|155780541|FG005|Overall Study|Lost to Follow-up|1|||
48434870|NCT00882999|155780542|FG006|Overall Study|Lost to Follow-up|2|||
48434871|NCT00882999|155780536|FG000|Overall Study|Physician Decision|1|||
48434872|NCT00882999|155780537|FG001|Overall Study|Physician Decision|0|||
48434873|NCT00882999|155780538|FG002|Overall Study|Physician Decision|0|||
48434874|NCT00882999|155780539|FG003|Overall Study|Physician Decision|0|||
48434875|NCT00882999|155780540|FG004|Overall Study|Physician Decision|0|||
48434876|NCT00882999|155780541|FG005|Overall Study|Physician Decision|1|||
48434877|NCT00882999|155780542|FG006|Overall Study|Physician Decision|1|||
48434878|NCT03456713|155780544|FG000|Overall Study|Lost to Follow-up|1|||
48434879|NCT03456713|155780545|FG001|Overall Study|Lost to Follow-up|0|||
48434880|NCT03456713|155780546|FG002|Overall Study|Lost to Follow-up|0|||
48434881|NCT03456713|155780547|FG003|Overall Study|Lost to Follow-up|0|||
48434882|NCT01409031|155780548|FG000|Overall Study|transferred to other hosp|1|||
48434883|NCT01409031|155780549|FG001|Overall Study|transferred to other hosp|0|||
48434884|NCT04321252|155780556|FG000|Overall Study|Withdrawal by Subject|0|||
48434885|NCT04321252|155780557|FG001|Overall Study|Withdrawal by Subject|0|||
48434886|NCT04321252|155780558|FG002|Overall Study|Withdrawal by Subject|0|||
48434887|NCT04321252|155780559|FG003|Overall Study|Withdrawal by Subject|0|||
48434888|NCT04321252|155780560|FG004|Overall Study|Withdrawal by Subject|0|||
48434889|NCT04321252|155780561|FG005|Overall Study|Withdrawal by Subject|1|||
48434890|NCT04321252|155780562|FG006|Overall Study|Withdrawal by Subject|0|||
48434891|NCT04321252|155780563|FG007|Overall Study|Withdrawal by Subject|0|||
48434892|NCT04321252|155780564|FG008|Overall Study|Withdrawal by Subject|0|||
48434893|NCT01980706|155780569|FG000|Overall Study|Withdrawal by Subject|9|||
48434894|NCT01980706|155780570|FG001|Overall Study|Withdrawal by Subject|6|||
48434895|NCT01980706|155780571|FG002|Overall Study|Withdrawal by Subject|2|||
48434896|NCT01980706|155780569|FG000|Overall Study|Adverse Event|1|||
48434897|NCT01980706|155780570|FG001|Overall Study|Adverse Event|2|||
48434898|NCT01980706|155780571|FG002|Overall Study|Adverse Event|5|||
48434899|NCT01980706|155780569|FG000|Overall Study|Lost to Follow-up|3|||
48434900|NCT01980706|155780570|FG001|Overall Study|Lost to Follow-up|4|||
48434901|NCT01980706|155780571|FG002|Overall Study|Lost to Follow-up|3|||
48434902|NCT01980706|155780569|FG000|Overall Study|miscellaneous|4|||
48434929|NCT04580394|155780587|FG000|Washout (One Week)|Withdrawal by Subject|2|||
48434930|NCT00084929|155780588|FG000|Overall Study|ineligible - medical contraindication|1|||
48434931|NCT00084929|155780588|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
48434932|NCT00084929|155780588|FG000|Overall Study|Ineligible - Medical history|6|||
48434933|NCT00084929|155780588|FG000|Overall Study|Withdrawal by Subject|10|||
48434934|NCT00084929|155780588|FG000|Overall Study|Missing/incomplete CTC exam|9|||
48434935|NCT00084929|155780588|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
48434936|NCT03521687|155780591|FG000|Overall Study|Adverse Event|4|||
48434937|NCT03521687|155780591|FG000|Overall Study|Physician Decision|1|||
48434938|NCT00358917|155780595|FG000|Overall Study|Adverse Event|14|||
48434939|NCT00358917|155780596|FG001|Overall Study|Adverse Event|21|||
48434940|NCT00358917|155780595|FG000|Overall Study|Withdrawal by Subject|5|||
48434941|NCT00358917|155780596|FG001|Overall Study|Withdrawal by Subject|7|||
48434942|NCT00358917|155780595|FG000|Overall Study|Lost to Follow-up|20|||
48434943|NCT00358917|155780596|FG001|Overall Study|Lost to Follow-up|17|||
48434944|NCT00358917|155780595|FG000|Overall Study|Noncompliance|12|||
48434945|NCT00358917|155780596|FG001|Overall Study|Noncompliance|11|||
48434946|NCT00358917|155780595|FG000|Overall Study|Death|2|||
48434947|NCT00358917|155780596|FG001|Overall Study|Death|3|||
48434948|NCT00358917|155780595|FG000|Overall Study|Virologic failure|11|||
48434949|NCT00358917|155780596|FG001|Overall Study|Virologic failure|8|||
48434950|NCT00358917|155780595|FG000|Overall Study|Unable to Continue Participation|2|||
48434951|NCT00358917|155780596|FG001|Overall Study|Unable to Continue Participation|2|||
48434952|NCT00678587|155780597|FG000|Overall Study|Adverse Event|3|||
48434953|NCT00678587|155780598|FG001|Overall Study|Adverse Event|3|||
48434954|NCT00678587|155780597|FG000|Overall Study|Lack of Efficacy|1|||
48434955|NCT00678587|155780598|FG001|Overall Study|Lack of Efficacy|0|||
48434956|NCT00678587|155780597|FG000|Overall Study|Protocol Violation|2|||
48434957|NCT00678587|155780598|FG001|Overall Study|Protocol Violation|1|||
48434958|NCT00678587|155780597|FG000|Overall Study|Study Closed/Terminated|1|||
48434959|NCT00678587|155780598|FG001|Overall Study|Study Closed/Terminated|0|||
48434960|NCT00678587|155780597|FG000|Overall Study|Lost to Follow-up|3|||
48434961|NCT00678587|155780598|FG001|Overall Study|Lost to Follow-up|5|||
48434962|NCT00678587|155780597|FG000|Overall Study|Investigator Discretion|2|||
48434963|NCT00678587|155780598|FG001|Overall Study|Investigator Discretion|6|||
48434964|NCT00678587|155780597|FG000|Overall Study|Withdrew Consent|8|||
48434965|NCT00678587|155780598|FG001|Overall Study|Withdrew Consent|3|||
48434966|NCT01019486|155780601|FG000|Overall Study|Withdrawal by Subject|1|||
48434967|NCT01019486|155780602|FG001|Overall Study|Withdrawal by Subject|1|||
48434968|NCT01019486|155780603|FG002|Overall Study|Withdrawal by Subject|1|||
48434969|NCT00752609|155780604|FG000|Overall Study|Adverse Event|2|||
48434970|NCT00752609|155780605|FG001|Overall Study|Adverse Event|2|||
48434971|NCT00752609|155780604|FG000|Overall Study|Withdrawal by Subject|3|||
48434972|NCT00752609|155780605|FG001|Overall Study|Withdrawal by Subject|0|||
48434973|NCT00752609|155780604|FG000|Overall Study|Physician Decision|1|||
48434974|NCT00752609|155780605|FG001|Overall Study|Physician Decision|0|||
48434975|NCT00752609|155780604|FG000|Overall Study|Death|1|||
48434976|NCT00752609|155780605|FG001|Overall Study|Death|0|||
48434977|NCT00752609|155780604|FG000|Overall Study|Met exclusion criteria|1|||
48434978|NCT00752609|155780605|FG001|Overall Study|Met exclusion criteria|0|||
48434979|NCT00752609|155780604|FG000|Overall Study|Received Aranesp in error|1|||
48434980|NCT00752609|155780605|FG001|Overall Study|Received Aranesp in error|0|||
48434981|NCT00195260|155780606|FG000|Part 1: Dose Escalation|Adverse Event|0|||
48434982|NCT00195260|155780607|FG001|Part 1: Dose Escalation|Adverse Event|1|||
48434983|NCT00195260|155780608|FG002|Part 1: Dose Escalation|Adverse Event|0|||
48434984|NCT00195260|155780609|FG003|Part 1: Dose Escalation|Adverse Event|1|||
48434985|NCT00195260|155780610|FG004|Part 1: Dose Escalation|Adverse Event|1|||
48434986|NCT00195260|155780611|FG005|Part 1: Dose Escalation|Adverse Event|0|||
48434987|NCT00195260|155780612|FG006|Part 1: Dose Escalation|Adverse Event|3|||
48434988|NCT00195260|155780613|FG007|Part 1: Dose Escalation|Adverse Event|0|||
48434989|NCT00195260|155780614|FG008|Part 1: Dose Escalation|Adverse Event|0|||
48434990|NCT00195260|155780615|FG009|Part 1: Dose Escalation|Adverse Event|0|||
48434991|NCT00195260|155780616|FG010|Part 1: Dose Escalation|Adverse Event|0|||
48434992|NCT00195260|155780606|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48434993|NCT00195260|155780607|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48434994|NCT00195260|155780608|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48434995|NCT00195260|155780609|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48434996|NCT00195260|155780610|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
48434997|NCT00195260|155780611|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48434998|NCT00195260|155780612|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48434999|NCT00195260|155780613|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
48435000|NCT00195260|155780614|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48435001|NCT00195260|155780615|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48435002|NCT00195260|155780616|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
48435003|NCT00195260|155780606|FG000|Part 1: Dose Escalation|Death|0|||
48435004|NCT00195260|155780607|FG001|Part 1: Dose Escalation|Death|0|||
48435016|NCT00195260|155780608|FG002|Part 1: Dose Escalation|Disease Progression|5|||
48435017|NCT00195260|155780609|FG003|Part 1: Dose Escalation|Disease Progression|6|||
48435018|NCT00195260|155780610|FG004|Part 1: Dose Escalation|Disease Progression|4|||
48435019|NCT00195260|155780611|FG005|Part 1: Dose Escalation|Disease Progression|6|||
48435020|NCT00195260|155780612|FG006|Part 1: Dose Escalation|Disease Progression|7|||
48435021|NCT00195260|155780613|FG007|Part 1: Dose Escalation|Disease Progression|4|||
48435022|NCT00195260|155780614|FG008|Part 1: Dose Escalation|Disease Progression|0|||
48435023|NCT00195260|155780615|FG009|Part 1: Dose Escalation|Disease Progression|0|||
48435024|NCT00195260|155780616|FG010|Part 1: Dose Escalation|Disease Progression|0|||
48435025|NCT00195260|155780606|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
48435026|NCT00195260|155780607|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
48435027|NCT00195260|155780608|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
48435028|NCT00195260|155780609|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48435029|NCT00195260|155780610|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48435030|NCT00195260|155780611|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
48435031|NCT00195260|155780612|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48435032|NCT00195260|155780613|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48435033|NCT00195260|155780614|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48435034|NCT00195260|155780615|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48435035|NCT00195260|155780616|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
48435036|NCT00195260|155780606|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48435037|NCT00195260|155780607|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48435038|NCT00195260|155780608|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48435039|NCT00195260|155780609|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48435040|NCT00195260|155780610|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48435041|NCT00195260|155780611|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48435042|NCT00195260|155780612|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48435043|NCT00195260|155780613|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
48435044|NCT00195260|155780614|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
48435045|NCT00195260|155780615|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
48435046|NCT00195260|155780616|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
48435047|NCT00195260|155780606|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48435048|NCT00195260|155780607|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48435049|NCT00195260|155780608|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48435050|NCT00195260|155780609|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48435051|NCT00195260|155780610|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48435052|NCT00195260|155780611|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48435053|NCT00195260|155780612|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48435054|NCT00195260|155780613|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
48435055|NCT00195260|155780614|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
48435056|NCT00195260|155780615|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
48435057|NCT00195260|155780616|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
48435058|NCT00195260|155780606|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48435059|NCT00195260|155780607|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48435060|NCT00195260|155780608|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48435061|NCT00195260|155780609|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48435062|NCT00195260|155780610|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48435063|NCT00195260|155780611|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48435064|NCT00195260|155780612|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48435065|NCT00195260|155780613|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
48435066|NCT00195260|155780614|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
48435067|NCT00195260|155780615|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
48435068|NCT00195260|155780616|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
48435069|NCT00195260|155780606|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48435070|NCT00195260|155780607|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48435071|NCT00195260|155780608|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48435072|NCT00195260|155780609|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48435073|NCT00195260|155780610|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48435074|NCT00195260|155780611|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48435075|NCT00195260|155780612|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48435076|NCT00195260|155780613|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
48435077|NCT00195260|155780614|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
48435078|NCT00195260|155780615|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
48435079|NCT00195260|155780616|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
48435080|NCT03699631|155780622|FG000|Overall Study|Adverse Event|3|||
48435081|NCT00118482|155780623|FG000|Overall Study|Lost to Follow-up|7|||
48435082|NCT00118482|155780624|FG001|Overall Study|Lost to Follow-up|7|||
48435083|NCT00118482|155780623|FG000|Overall Study|Withdrawal by Subject|23|||
48435084|NCT00118482|155780624|FG001|Overall Study|Withdrawal by Subject|22|||
48435085|NCT03050359|155780625|FG000|Overall Study|Randomized But Not Treated|2|||
48435086|NCT03050359|155780626|FG001|Overall Study|Randomized But Not Treated|0|||
48435087|NCT03050359|155780625|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
48435088|NCT03050359|155780626|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
48435089|NCT03050359|155780625|FG000|Overall Study|Significant Protocol Deviation|2|||
48435090|NCT03050359|155780626|FG001|Overall Study|Significant Protocol Deviation|3|||
48435091|NCT03050359|155780625|FG000|Overall Study|Lost to Follow-up|2|||
48435092|NCT03050359|155780626|FG001|Overall Study|Lost to Follow-up|1|||
48435093|NCT03050359|155780625|FG000|Overall Study|Voluntary Withdrawal|4|||
48435094|NCT03050359|155780626|FG001|Overall Study|Voluntary Withdrawal|6|||
48435095|NCT03050359|155780625|FG000|Overall Study|Pregnancy|1|||
48435096|NCT03050359|155780626|FG001|Overall Study|Pregnancy|0|||
48435097|NCT03050359|155780625|FG000|Overall Study|Reason Not Specified|1|||
48435098|NCT03050359|155780626|FG001|Overall Study|Reason Not Specified|0|||
48435099|NCT02045212|155780631|FG000|Overall Study|Adverse Event|0|||
48435100|NCT02045212|155780632|FG001|Overall Study|Adverse Event|1|||
48435101|NCT02045212|155780631|FG000|Overall Study|Withdrawal by Subject|1|||
48435102|NCT02045212|155780632|FG001|Overall Study|Withdrawal by Subject|0|||
48435103|NCT02045212|155780631|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
48435104|NCT02045212|155780632|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
48435105|NCT00747617|155782385|FG000|Overall Study|Lost to Follow-up|3|||
48435106|NCT00747617|155782386|FG001|Overall Study|Lost to Follow-up|1|||
48435107|NCT00074412|155782387|FG000|Overall Study|Death|30|||
48435108|NCT00074412|155782388|FG001|Overall Study|Death|26|||
48435109|NCT00074412|155782387|FG000|Overall Study|Lost to Follow-up|52|||
48435110|NCT00074412|155782388|FG001|Overall Study|Lost to Follow-up|58|||
48435111|NCT02922634|155782389|FG000|Overall Study|Withdrawal by Subject|5|||
48435112|NCT02922634|155782389|FG000|Overall Study|Did not have their surgery|5|||
48435113|NCT00418834|155782390|FG000|Overall Study|Adverse Event|16|||
48435114|NCT00418834|155782391|FG001|Overall Study|Adverse Event|9|||
48435115|NCT00418834|155782390|FG000|Overall Study|Lost to Follow-up|0|||
48435116|NCT00418834|155782391|FG001|Overall Study|Lost to Follow-up|1|||
48435117|NCT00418834|155782390|FG000|Overall Study|Protocol Violation|4|||
48435118|NCT00418834|155782391|FG001|Overall Study|Protocol Violation|3|||
48435119|NCT00418834|155782390|FG000|Overall Study|Withdrawal by Subject|3|||
48435120|NCT00418834|155782391|FG001|Overall Study|Withdrawal by Subject|7|||
48435121|NCT01432262|155782392|FG000|Overall Study|Withdrawal by Subject|2|||
48435122|NCT01432262|155782393|FG001|Overall Study|Withdrawal by Subject|1|||
48435123|NCT02457182|155782397|FG000|Overall Study|Lost to Follow-up|1|||
48435124|NCT02457182|155782398|FG001|Overall Study|Lost to Follow-up|0|||
48435125|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
48435126|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
48435127|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
48435128|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
48435129|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Death|8|||
48435130|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Death|3|||
48435131|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
48435132|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
48435133|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
48435134|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
48435135|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
48435136|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
48435137|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
48435138|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
48435139|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
48435140|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
48435141|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
48435142|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
48435143|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
48435144|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
48435145|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
48435146|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
48435147|NCT00494871|155782401|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
48435148|NCT00494871|155782402|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
48435149|NCT00494871|155782401|FG000|Follow-up (FU) Period|Adverse Event|1|||
48435150|NCT00494871|155782402|FG001|Follow-up (FU) Period|Adverse Event|1|||
48435151|NCT00494871|155782401|FG000|Follow-up (FU) Period|Death|13|||
48435152|NCT00494871|155782402|FG001|Follow-up (FU) Period|Death|12|||
48435153|NCT00494871|155782401|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
48435154|NCT00494871|155782402|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
48435155|NCT00494871|155782401|FG000|Follow-up (FU) Period|Physician Decision|0|||
48435156|NCT00494871|155782402|FG001|Follow-up (FU) Period|Physician Decision|1|||
48435157|NCT00494871|155782401|FG000|Follow-up (FU) Period|Protocol Violation|1|||
48435158|NCT00494871|155782402|FG001|Follow-up (FU) Period|Protocol Violation|0|||
48435159|NCT00494871|155782401|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
48435160|NCT00494871|155782402|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
48435161|NCT00494871|155782401|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
48435162|NCT00494871|155782402|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
48435163|NCT02669862|155782405|FG000|Overall Study|Lost to Follow-up|0|||
48435164|NCT02669862|155782406|FG001|Overall Study|Lost to Follow-up|2|||
48435165|NCT02669862|155782407|FG002|Overall Study|Lost to Follow-up|1|||
48435166|NCT02669862|155782405|FG000|Overall Study|Withdrawal by Subject|2|||
48435167|NCT02669862|155782406|FG001|Overall Study|Withdrawal by Subject|2|||
48435168|NCT02669862|155782407|FG002|Overall Study|Withdrawal by Subject|3|||
48435169|NCT02669862|155782405|FG000|Overall Study|moved|0|||
48435170|NCT02669862|155782406|FG001|Overall Study|moved|1|||
48435171|NCT02669862|155782407|FG002|Overall Study|moved|0|||
48435172|NCT02669862|155782405|FG000|Overall Study|Protocol Violation|0|||
48435173|NCT02669862|155782406|FG001|Overall Study|Protocol Violation|0|||
48435174|NCT02669862|155782407|FG002|Overall Study|Protocol Violation|1|||
48435175|NCT02397694|155782408|FG000|Double-Blinded Phase|Adverse Event|1|||
48435176|NCT02397694|155782409|FG001|Double-Blinded Phase|Adverse Event|0|||
48435177|NCT02397694|155782408|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
48435178|NCT02397694|155782409|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
48435179|NCT02397694|155782408|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
48435180|NCT02397694|155782409|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
48435181|NCT02397694|155782408|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
48435182|NCT02397694|155782409|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
48435183|NCT02397694|155782408|FG000|Open Label Extension Phase|Protocol Violation|1|||
48435184|NCT02397694|155782409|FG001|Open Label Extension Phase|Protocol Violation|0|||
48435185|NCT02397694|155782408|FG000|Open Label Extension Phase|Withdrew Consent|3|||
48435186|NCT02397694|155782409|FG001|Open Label Extension Phase|Withdrew Consent|1|||
48435187|NCT02397694|155782408|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
48435188|NCT02397694|155782409|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
48435189|NCT04543955|155782412|FG000|Overall Study|Company cancelled study|1|||
48435190|NCT04543955|155782413|FG001|Overall Study|Company cancelled study|0|||
48435191|NCT01694420|155782414|FG000|Overall Study|Lost to Follow-up|3|||
48435192|NCT01755195|155782415|FG000|Overall Study|Participant noncompliance|2|||
48435193|NCT01755195|155782415|FG000|Overall Study|Switched to alternative treatment|4|||
48435194|NCT01755195|155782415|FG000|Overall Study|Withdrawal by Subject|1|||
48435195|NCT01755195|155782415|FG000|Overall Study|Participant refused to start treatment|1|||
48435196|NCT01755195|155782415|FG000|Overall Study|Participant has been consented for another trial|1|||
48435197|NCT01755195|155782415|FG000|Overall Study|Refused further treatment|3|||
48435198|NCT01755195|155782415|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
48435199|NCT00492856|155782416|FG000|Induction|Adverse Event|2|||
48435200|NCT00492856|155782417|FG001|Induction|Adverse Event|0|||
48435201|NCT00492856|155782418|FG002|Induction|Adverse Event|0|||
48435202|NCT00492856|155782419|FG003|Induction|Adverse Event|0|||
48435203|NCT00492856|155782416|FG000|Induction|Withdrawal by Subject|1|||
48435204|NCT00492856|155782417|FG001|Induction|Withdrawal by Subject|0|||
48435205|NCT00492856|155782418|FG002|Induction|Withdrawal by Subject|0|||
48435206|NCT00492856|155782419|FG003|Induction|Withdrawal by Subject|0|||
48435207|NCT00492856|155782416|FG000|Induction|Death|3|||
48435208|NCT00492856|155782417|FG001|Induction|Death|0|||
48435209|NCT00492856|155782418|FG002|Induction|Death|0|||
48435210|NCT00492856|155782419|FG003|Induction|Death|0|||
48435211|NCT00492856|155782416|FG000|Consolidation|Adverse Event|6|||
48435212|NCT00492856|155782417|FG001|Consolidation|Adverse Event|0|||
48435213|NCT00492856|155782418|FG002|Consolidation|Adverse Event|0|||
48435214|NCT00492856|155782419|FG003|Consolidation|Adverse Event|0|||
48435215|NCT00492856|155782416|FG000|Consolidation|Not protocol specified|2|||
48435216|NCT00492856|155782417|FG001|Consolidation|Not protocol specified|0|||
48435217|NCT00492856|155782418|FG002|Consolidation|Not protocol specified|0|||
48435218|NCT00492856|155782419|FG003|Consolidation|Not protocol specified|0|||
48435219|NCT00492856|155782416|FG000|Consolidation|Lost to Follow-up|1|||
48435220|NCT00492856|155782417|FG001|Consolidation|Lost to Follow-up|0|||
48435221|NCT00492856|155782418|FG002|Consolidation|Lost to Follow-up|0|||
48435222|NCT00492856|155782419|FG003|Consolidation|Lost to Follow-up|0|||
48435223|NCT00492856|155782416|FG000|Post-consolidation|Adverse Event|0|||
48435224|NCT00492856|155782417|FG001|Post-consolidation|Adverse Event|4|||
48435225|NCT00492856|155782418|FG002|Post-consolidation|Adverse Event|0|||
48435226|NCT00492856|155782419|FG003|Post-consolidation|Adverse Event|1|||
48435227|NCT00492856|155782416|FG000|Post-consolidation|Withdrawal by Subject|0|||
48435228|NCT00492856|155782417|FG001|Post-consolidation|Withdrawal by Subject|4|||
48435229|NCT00492856|155782418|FG002|Post-consolidation|Withdrawal by Subject|0|||
48435230|NCT00492856|155782419|FG003|Post-consolidation|Withdrawal by Subject|0|||
48435231|NCT00492856|155782416|FG000|Post-consolidation|Death|0|||
48435232|NCT00492856|155782417|FG001|Post-consolidation|Death|1|||
48435239|NCT00492856|155782416|FG000|Post-consolidation|Lost to Follow-up|0|||
48435240|NCT00492856|155782417|FG001|Post-consolidation|Lost to Follow-up|2|||
48435241|NCT00492856|155782418|FG002|Post-consolidation|Lost to Follow-up|0|||
48435242|NCT00492856|155782419|FG003|Post-consolidation|Lost to Follow-up|0|||
48435243|NCT00492856|155782416|FG000|Post-consolidation|Observation Arm|0|||
48435244|NCT00492856|155782417|FG001|Post-consolidation|Observation Arm|0|||
48435245|NCT00492856|155782418|FG002|Post-consolidation|Observation Arm|27|||
48435246|NCT00492856|155782419|FG003|Post-consolidation|Observation Arm|0|||
48435247|NCT01303380|155782420|FG000|Overall Study|Lack of compliance to study procedures|1|||
48435248|NCT00948818|155782422|FG000|Overall Study|Adverse Event|10|||
48435249|NCT00948818|155782423|FG001|Overall Study|Adverse Event|32|||
48435250|NCT00948818|155782422|FG000|Overall Study|Protocol Violation|9|||
48435251|NCT00948818|155782423|FG001|Overall Study|Protocol Violation|10|||
48435252|NCT00948818|155782422|FG000|Overall Study|Withdrawal by Subject|25|||
48435253|NCT00948818|155782423|FG001|Overall Study|Withdrawal by Subject|25|||
48435254|NCT00948818|155782422|FG000|Overall Study|Lost to Follow-up|10|||
48435255|NCT00948818|155782423|FG001|Overall Study|Lost to Follow-up|17|||
48435256|NCT00948818|155782422|FG000|Overall Study|Lack of Efficacy|4|||
48435257|NCT00948818|155782423|FG001|Overall Study|Lack of Efficacy|5|||
48435258|NCT00948818|155782422|FG000|Overall Study|Other Reason|4|||
48435259|NCT00948818|155782423|FG001|Overall Study|Other Reason|5|||
48435260|NCT01716533|155782427|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
48435261|NCT01716533|155782428|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
48435262|NCT01716533|155782429|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
48435263|NCT01716533|155782430|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
48435264|NCT01716533|155782427|FG000|Overall Study|Withdrawal by Subject|0|||
48435265|NCT01716533|155782428|FG001|Overall Study|Withdrawal by Subject|0|||
48435266|NCT01716533|155782429|FG002|Overall Study|Withdrawal by Subject|0|||
48435267|NCT01716533|155782430|FG003|Overall Study|Withdrawal by Subject|5|||
48435268|NCT01716533|155782427|FG000|Overall Study|Death|0|||
48435269|NCT01716533|155782428|FG001|Overall Study|Death|0|||
48435270|NCT01716533|155782429|FG002|Overall Study|Death|0|||
48435271|NCT01716533|155782430|FG003|Overall Study|Death|2|||
48435272|NCT01716533|155782427|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
48435273|NCT01716533|155782428|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
48435274|NCT01716533|155782429|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
48435275|NCT01716533|155782430|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
48435276|NCT02006667|155782432|FG000|Overall Study|Adverse Event|3|||
48435277|NCT02006667|155782432|FG000|Overall Study|Death|2|||
48435278|NCT02006667|155782432|FG000|Overall Study|Withdrawal by Subject|1|||
48435279|NCT00960934|155782441|FG000|Overall Study|Adverse Event|2|||
48435280|NCT00960934|155782442|FG001|Overall Study|Adverse Event|3|||
48435281|NCT00960934|155782443|FG002|Overall Study|Adverse Event|3|||
48435282|NCT00960934|155782444|FG003|Overall Study|Adverse Event|2|||
48435283|NCT00960934|155782445|FG004|Overall Study|Adverse Event|4|||
48435284|NCT00960934|155782446|FG005|Overall Study|Adverse Event|3|||
48435285|NCT00960934|155782441|FG000|Overall Study|Lack of Efficacy|1|||
48435286|NCT00960934|155782442|FG001|Overall Study|Lack of Efficacy|0|||
48435287|NCT00960934|155782443|FG002|Overall Study|Lack of Efficacy|0|||
48435288|NCT00960934|155782444|FG003|Overall Study|Lack of Efficacy|0|||
48435289|NCT00960934|155782445|FG004|Overall Study|Lack of Efficacy|0|||
48435290|NCT00960934|155782446|FG005|Overall Study|Lack of Efficacy|0|||
48435291|NCT00960934|155782441|FG000|Overall Study|Lost to Follow-up|0|||
48435292|NCT00960934|155782442|FG001|Overall Study|Lost to Follow-up|1|||
48435293|NCT00960934|155782443|FG002|Overall Study|Lost to Follow-up|0|||
48435294|NCT00960934|155782444|FG003|Overall Study|Lost to Follow-up|0|||
48435295|NCT00960934|155782445|FG004|Overall Study|Lost to Follow-up|0|||
48435296|NCT00960934|155782446|FG005|Overall Study|Lost to Follow-up|0|||
48435297|NCT00960934|155782441|FG000|Overall Study|Other|2|||
48435298|NCT00960934|155782442|FG001|Overall Study|Other|1|||
48435299|NCT00960934|155782443|FG002|Overall Study|Other|5|||
48435300|NCT00960934|155782444|FG003|Overall Study|Other|4|||
48435301|NCT00960934|155782445|FG004|Overall Study|Other|2|||
48435302|NCT00960934|155782446|FG005|Overall Study|Other|2|||
48435303|NCT00960934|155782441|FG000|Overall Study|Physician Decision|0|||
48435304|NCT00960934|155782442|FG001|Overall Study|Physician Decision|1|||
48435305|NCT00960934|155782443|FG002|Overall Study|Physician Decision|0|||
48435306|NCT00960934|155782444|FG003|Overall Study|Physician Decision|0|||
48435307|NCT00960934|155782445|FG004|Overall Study|Physician Decision|0|||
48435308|NCT00960934|155782446|FG005|Overall Study|Physician Decision|0|||
48435309|NCT00960934|155782441|FG000|Overall Study|Progressive Disease|1|||
48435310|NCT00960934|155782442|FG001|Overall Study|Progressive Disease|1|||
48435311|NCT00960934|155782443|FG002|Overall Study|Progressive Disease|0|||
48435312|NCT00960934|155782444|FG003|Overall Study|Progressive Disease|0|||
48435313|NCT00960934|155782445|FG004|Overall Study|Progressive Disease|1|||
48435314|NCT00960934|155782446|FG005|Overall Study|Progressive Disease|1|||
48435315|NCT00960934|155782441|FG000|Overall Study|Protocol Violation|3|||
48435316|NCT00960934|155782442|FG001|Overall Study|Protocol Violation|4|||
48435317|NCT00960934|155782443|FG002|Overall Study|Protocol Violation|0|||
48435321|NCT00960934|155782441|FG000|Overall Study|Withdrawal by Subject|5|||
48435322|NCT00960934|155782442|FG001|Overall Study|Withdrawal by Subject|6|||
48435323|NCT00960934|155782443|FG002|Overall Study|Withdrawal by Subject|4|||
48435324|NCT00960934|155782444|FG003|Overall Study|Withdrawal by Subject|5|||
48435325|NCT00960934|155782445|FG004|Overall Study|Withdrawal by Subject|5|||
48435326|NCT00960934|155782446|FG005|Overall Study|Withdrawal by Subject|7|||
48435327|NCT00960934|155782441|FG000|Overall Study|Study Terminated by Sponsor|50|||
48435328|NCT00960934|155782442|FG001|Overall Study|Study Terminated by Sponsor|46|||
48435329|NCT00960934|155782443|FG002|Overall Study|Study Terminated by Sponsor|52|||
48435330|NCT00960934|155782444|FG003|Overall Study|Study Terminated by Sponsor|50|||
48435331|NCT00960934|155782445|FG004|Overall Study|Study Terminated by Sponsor|49|||
48435332|NCT00960934|155782446|FG005|Overall Study|Study Terminated by Sponsor|49|||
48435333|NCT01429792|155782448|FG000|Overall Study|Other Reasons|67|||
48435334|NCT01429792|155782448|FG000|Overall Study|Unknown Disposition|94|||
48435335|NCT01429792|155782448|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
48435336|NCT01429792|155782448|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
48435337|NCT01429792|155782448|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
48435338|NCT01429792|155782448|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
48435339|NCT01429792|155782448|FG000|Overall Study|Withdrawal by Subject|70|||
48435340|NCT01429792|155782448|FG000|Overall Study|Lost to Follow-up|88|||
48435341|NCT01104584|155782452|FG000|Overall Study|Study drug never administered|21|||
48435342|NCT01104584|155782452|FG000|Overall Study|Study prematurely discontinued|2|||
48435343|NCT02370498|155782453|FG000|Overall Study|Adverse Event|10|||
48435344|NCT02370498|155782454|FG001|Overall Study|Adverse Event|8|||
48435345|NCT02370498|155782453|FG000|Overall Study|Death|263|||
48435346|NCT02370498|155782454|FG001|Overall Study|Death|265|||
48435347|NCT02370498|155782453|FG000|Overall Study|Protocol Violation|1|||
48435348|NCT02370498|155782454|FG001|Overall Study|Protocol Violation|2|||
48435349|NCT02370498|155782453|FG000|Overall Study|Withdrawal by Subject|7|||
48435350|NCT02370498|155782454|FG001|Overall Study|Withdrawal by Subject|12|||
48435351|NCT02370498|155782453|FG000|Overall Study|Sponsor's decision|15|||
48435352|NCT02370498|155782454|FG001|Overall Study|Sponsor's decision|9|||
48435353|NCT01263691|155782455|FG000|Overall Study|Lost to Follow-up|1|||
48435354|NCT01263691|155782456|FG001|Overall Study|Lost to Follow-up|0|||
48435355|NCT01263691|155782457|FG002|Overall Study|Lost to Follow-up|1|||
48435356|NCT01263691|155782458|FG003|Overall Study|Lost to Follow-up|1|||
48435357|NCT01263691|155782459|FG004|Overall Study|Lost to Follow-up|0|||
48435358|NCT01263691|155782460|FG005|Overall Study|Lost to Follow-up|0|||
48435359|NCT01263691|155782455|FG000|Overall Study|Withdrawal by Subject|1|||
48435360|NCT01263691|155782456|FG001|Overall Study|Withdrawal by Subject|0|||
48435361|NCT01263691|155782457|FG002|Overall Study|Withdrawal by Subject|0|||
48435362|NCT01263691|155782458|FG003|Overall Study|Withdrawal by Subject|0|||
48435363|NCT01263691|155782459|FG004|Overall Study|Withdrawal by Subject|0|||
48435364|NCT01263691|155782460|FG005|Overall Study|Withdrawal by Subject|0|||
48435365|NCT01263691|155782455|FG000|Overall Study|Adverse Event|1|||
48435366|NCT01263691|155782456|FG001|Overall Study|Adverse Event|0|||
48435367|NCT01263691|155782457|FG002|Overall Study|Adverse Event|0|||
48435368|NCT01263691|155782458|FG003|Overall Study|Adverse Event|0|||
48435369|NCT01263691|155782459|FG004|Overall Study|Adverse Event|0|||
48435370|NCT01263691|155782460|FG005|Overall Study|Adverse Event|0|||
48435371|NCT01397552|155782464|FG000|Overall Study|Adverse Event|1|||
48435372|NCT01397552|155782465|FG001|Overall Study|Adverse Event|0|||
48435373|NCT01397552|155782464|FG000|Overall Study|Withdrawal by Subject|2|||
48435374|NCT01397552|155782465|FG001|Overall Study|Withdrawal by Subject|1|||
48435375|NCT03888391|155782466|FG000|Overall Study|Lost to Follow-up|15|||
48435376|NCT02108951|155782467|FG000|Overall Study|Lost to Follow-up|1|||
48435377|NCT02108951|155782467|FG000|Overall Study|Patient's/guardian's decision|1|||
48435378|NCT02108951|155782467|FG000|Overall Study|Study Terminated by Sponsor|14|||
48435379|NCT02864940|155782468|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
48435380|NCT02864940|155782469|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
48435381|NCT02175771|155782470|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
48435382|NCT02175771|155782471|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48435383|NCT02175771|155782472|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48435384|NCT02175771|155782473|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48435385|NCT02175771|155782474|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48435386|NCT02175771|155782475|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48435387|NCT02175771|155782476|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48435388|NCT02175771|155782477|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48435389|NCT02175771|155782478|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48435390|NCT02175771|155782470|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
48435391|NCT02175771|155782471|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48435392|NCT02175771|155782472|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48435393|NCT02175771|155782473|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48435394|NCT02175771|155782474|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48435395|NCT02175771|155782475|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48435396|NCT02175771|155782476|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48435397|NCT02175771|155782477|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48435398|NCT02175771|155782478|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48435399|NCT02175771|155782470|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
48435400|NCT02175771|155782471|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48435401|NCT02175771|155782472|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48435402|NCT02175771|155782473|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48435403|NCT02175771|155782474|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48435404|NCT02175771|155782475|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48435405|NCT02175771|155782476|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48435406|NCT02175771|155782477|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48435407|NCT02175771|155782478|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48435408|NCT02175771|155782470|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
48435409|NCT02175771|155782471|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
48435410|NCT02175771|155782472|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
48435411|NCT02175771|155782473|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
48435412|NCT02175771|155782474|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
48435413|NCT02175771|155782475|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
48435414|NCT02175771|155782476|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
48435415|NCT02175771|155782477|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
48435416|NCT02175771|155782478|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
48435417|NCT02175771|155782470|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
48435418|NCT02175771|155782471|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48435419|NCT02175771|155782472|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48435420|NCT02175771|155782473|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48435421|NCT02175771|155782474|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48435422|NCT02175771|155782475|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48435423|NCT02175771|155782476|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48435424|NCT02175771|155782477|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48435425|NCT02175771|155782478|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48435426|NCT02175771|155782470|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
48435427|NCT02175771|155782471|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48435428|NCT02175771|155782472|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48435429|NCT02175771|155782473|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48435430|NCT02175771|155782474|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48435431|NCT02175771|155782475|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48435432|NCT02175771|155782476|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48435433|NCT02175771|155782477|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48435434|NCT02175771|155782478|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48435435|NCT02175771|155782470|FG000|Run-In Period (Pre-assignment)|Other|8|||
48435436|NCT02175771|155782471|FG001|Run-In Period (Pre-assignment)|Other|0|||
48435437|NCT02175771|155782472|FG002|Run-In Period (Pre-assignment)|Other|0|||
48435438|NCT02175771|155782473|FG003|Run-In Period (Pre-assignment)|Other|0|||
48435439|NCT02175771|155782474|FG004|Run-In Period (Pre-assignment)|Other|0|||
48435440|NCT02175771|155782475|FG005|Run-In Period (Pre-assignment)|Other|0|||
48435441|NCT02175771|155782476|FG006|Run-In Period (Pre-assignment)|Other|0|||
48435442|NCT02175771|155782477|FG007|Run-In Period (Pre-assignment)|Other|0|||
48435443|NCT02175771|155782478|FG008|Run-In Period (Pre-assignment)|Other|0|||
48435444|NCT02175771|155782470|FG000|Treatment Period|Adverse Event|0|||
48435445|NCT02175771|155782471|FG001|Treatment Period|Adverse Event|2|||
48435446|NCT02175771|155782472|FG002|Treatment Period|Adverse Event|1|||
48435447|NCT02175771|155782473|FG003|Treatment Period|Adverse Event|1|||
48435448|NCT02175771|155782474|FG004|Treatment Period|Adverse Event|1|||
48435449|NCT02175771|155782475|FG005|Treatment Period|Adverse Event|3|||
48435450|NCT02175771|155782476|FG006|Treatment Period|Adverse Event|2|||
48435451|NCT02175771|155782477|FG007|Treatment Period|Adverse Event|0|||
48435452|NCT02175771|155782478|FG008|Treatment Period|Adverse Event|1|||
48435453|NCT02175771|155782470|FG000|Treatment Period|Withdrawal by Subject|0|||
48435454|NCT02175771|155782471|FG001|Treatment Period|Withdrawal by Subject|9|||
48435455|NCT02175771|155782472|FG002|Treatment Period|Withdrawal by Subject|3|||
48435456|NCT02175771|155782473|FG003|Treatment Period|Withdrawal by Subject|6|||
48435457|NCT02175771|155782474|FG004|Treatment Period|Withdrawal by Subject|2|||
48435458|NCT02175771|155782475|FG005|Treatment Period|Withdrawal by Subject|4|||
48435459|NCT02175771|155782476|FG006|Treatment Period|Withdrawal by Subject|2|||
48435460|NCT02175771|155782477|FG007|Treatment Period|Withdrawal by Subject|9|||
48435461|NCT02175771|155782478|FG008|Treatment Period|Withdrawal by Subject|2|||
48435462|NCT02175771|155782470|FG000|Treatment Period|Noncompliance|0|||
48435463|NCT02175771|155782471|FG001|Treatment Period|Noncompliance|1|||
48435464|NCT02175771|155782472|FG002|Treatment Period|Noncompliance|2|||
48435479|NCT02175771|155782478|FG008|Treatment Period|Protocol Violation|0|||
48435480|NCT02175771|155782470|FG000|Treatment Period|Disease progression|0|||
48435481|NCT02175771|155782471|FG001|Treatment Period|Disease progression|0|||
48435482|NCT02175771|155782472|FG002|Treatment Period|Disease progression|0|||
48435483|NCT02175771|155782473|FG003|Treatment Period|Disease progression|0|||
48435484|NCT02175771|155782474|FG004|Treatment Period|Disease progression|0|||
48435485|NCT02175771|155782475|FG005|Treatment Period|Disease progression|0|||
48435486|NCT02175771|155782476|FG006|Treatment Period|Disease progression|0|||
48435487|NCT02175771|155782477|FG007|Treatment Period|Disease progression|2|||
48435488|NCT02175771|155782478|FG008|Treatment Period|Disease progression|0|||
48435489|NCT02175771|155782470|FG000|Treatment Period|Lost to Follow-up|0|||
48435490|NCT02175771|155782471|FG001|Treatment Period|Lost to Follow-up|3|||
48435491|NCT02175771|155782472|FG002|Treatment Period|Lost to Follow-up|1|||
48435492|NCT02175771|155782473|FG003|Treatment Period|Lost to Follow-up|3|||
48435493|NCT02175771|155782474|FG004|Treatment Period|Lost to Follow-up|1|||
48435494|NCT02175771|155782475|FG005|Treatment Period|Lost to Follow-up|2|||
48435495|NCT02175771|155782476|FG006|Treatment Period|Lost to Follow-up|1|||
48435496|NCT02175771|155782477|FG007|Treatment Period|Lost to Follow-up|2|||
48435497|NCT02175771|155782478|FG008|Treatment Period|Lost to Follow-up|2|||
48435498|NCT02175771|155782470|FG000|Treatment Period|Lack of Efficacy|0|||
48435499|NCT02175771|155782471|FG001|Treatment Period|Lack of Efficacy|0|||
48435500|NCT02175771|155782472|FG002|Treatment Period|Lack of Efficacy|0|||
48435501|NCT02175771|155782473|FG003|Treatment Period|Lack of Efficacy|0|||
48435502|NCT02175771|155782474|FG004|Treatment Period|Lack of Efficacy|0|||
48435503|NCT02175771|155782475|FG005|Treatment Period|Lack of Efficacy|1|||
48435504|NCT02175771|155782476|FG006|Treatment Period|Lack of Efficacy|0|||
48435505|NCT02175771|155782477|FG007|Treatment Period|Lack of Efficacy|1|||
48435506|NCT02175771|155782478|FG008|Treatment Period|Lack of Efficacy|0|||
48435507|NCT02175771|155782470|FG000|Treatment Period|Other|0|||
48435508|NCT02175771|155782471|FG001|Treatment Period|Other|1|||
48435509|NCT02175771|155782472|FG002|Treatment Period|Other|0|||
48435510|NCT02175771|155782473|FG003|Treatment Period|Other|3|||
48435511|NCT02175771|155782474|FG004|Treatment Period|Other|1|||
48435512|NCT02175771|155782475|FG005|Treatment Period|Other|0|||
48435513|NCT02175771|155782476|FG006|Treatment Period|Other|0|||
48435514|NCT02175771|155782477|FG007|Treatment Period|Other|2|||
48435515|NCT02175771|155782478|FG008|Treatment Period|Other|0|||
48435516|NCT03364673|155782479|FG000|Overall Study|Withdrawal by Subject|2|||
48435517|NCT03364673|155782479|FG000|Overall Study|Injury unrelated to study|3|||
48435518|NCT00781599|155782481|FG000|Overall Study|Lost to Follow-up|7|||
48435519|NCT00781599|155782482|FG001|Overall Study|Lost to Follow-up|4|||
48435520|NCT02237157|155782489|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
48435521|NCT02237157|155782490|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
48435522|NCT02237157|155782491|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
48435523|NCT02237157|155782492|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
48435524|NCT02237157|155782489|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
48435525|NCT02237157|155782490|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
48435526|NCT02237157|155782491|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
48435527|NCT02237157|155782492|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
48435528|NCT02020031|155782493|FG000|Overall Study|Physician Decision|1|||
48435529|NCT02020031|155782494|FG001|Overall Study|Physician Decision|1|||
48435530|NCT01994226|155782495|FG000|Overall Study|Protocol Violation|13|||
48435531|NCT01994226|155782496|FG001|Overall Study|Protocol Violation|10|||
48435532|NCT01994226|155782495|FG000|Overall Study|Early Cessation of treatment|6|||
48435533|NCT01994226|155782496|FG001|Overall Study|Early Cessation of treatment|11|||
48435534|NCT04146467|155782497|FG000|Overall Study|Adverse Event|0|||
48435535|NCT04146467|155782498|FG001|Overall Study|Adverse Event|1|||
48435536|NCT04146467|155782497|FG000|Overall Study|Lost to Follow-up|0|||
48435537|NCT04146467|155782498|FG001|Overall Study|Lost to Follow-up|2|||
48435538|NCT01608724|155782505|FG000|Overall Study|Withdrawal by Subject|131|||
48435539|NCT01608724|155782505|FG000|Overall Study|Lost to Follow-up|41|||
48435540|NCT01608724|155782505|FG000|Overall Study|Study-specific discontinuation criteria|32|||
48435541|NCT01608724|155782505|FG000|Overall Study|Adverse Event|29|||
48435542|NCT01608724|155782505|FG000|Overall Study|Protocol Violation|6|||
48435543|NCT01608724|155782505|FG000|Overall Study|bood sugar too high, etc.|3|||
48435544|NCT01608724|155782505|FG000|Overall Study|Safety reasons|1|||
48435545|NCT00125190|155782507|FG000|Overall Study|Subject/Parent Decision|7|||
48435546|NCT00125190|155782507|FG000|Overall Study|Non-compliance|2|||
48435547|NCT00125190|155782507|FG000|Overall Study|Adverse Event|1|||
48435548|NCT00125190|155782507|FG000|Overall Study|Other|1|||
48435549|NCT00125190|155782507|FG000|Overall Study|Lost to Follow-up|4|||
48435550|NCT03731364|155782508|FG000|Overall Study|Adverse Event|0|||
48435551|NCT03731364|155782509|FG001|Overall Study|Adverse Event|0|||
48435552|NCT03731364|155782510|FG002|Overall Study|Adverse Event|1|||
48435553|NCT03731364|155782511|FG003|Overall Study|Adverse Event|2|||
48435554|NCT03731364|155782512|FG004|Overall Study|Adverse Event|1|||
48435555|NCT02940626|155782513|FG000|Overall Study|Death|40|||
48435738|NCT00608530|155783756|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
48435739|NCT00608530|155783753|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
48435740|NCT00608530|155783754|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
48435741|NCT00608530|155783755|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
48435742|NCT00608530|155783756|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
48435743|NCT02493426|155783761|FG000|Overall Study|Withdrawal by Subject|0|||
48435744|NCT02493426|155783762|FG001|Overall Study|Withdrawal by Subject|1|||
48435745|NCT00712322|155783763|FG000|Overall Study|Protocol deviation|0|||
48435746|NCT00712322|155783764|FG001|Overall Study|Protocol deviation|1|||
48435747|NCT00712322|155783765|FG002|Overall Study|Protocol deviation|0|||
48435748|NCT03628508|155783780|FG000|Overall Study|Lost to Follow-up|1|||
48435749|NCT03970395|155783781|FG000|Overall Study|Withdrawal by Subject|3|||
48435750|NCT03970395|155783782|FG001|Overall Study|Withdrawal by Subject|4|||
48435751|NCT03970395|155783781|FG000|Overall Study|Lost to Follow-up|4|||
48435752|NCT03970395|155783782|FG001|Overall Study|Lost to Follow-up|8|||
48435753|NCT00621855|155783783|FG000|Overall Study|Adverse Event|32|||
48435754|NCT00621855|155783784|FG001|Overall Study|Adverse Event|31|||
48435755|NCT00621855|155783785|FG002|Overall Study|Adverse Event|48|||
48435756|NCT00621855|155783786|FG003|Overall Study|Adverse Event|34|||
48435757|NCT00621855|155783787|FG004|Overall Study|Adverse Event|31|||
48435758|NCT00621855|155783783|FG000|Overall Study|Lost to Follow-up|0|||
48435759|NCT00621855|155783784|FG001|Overall Study|Lost to Follow-up|1|||
48435760|NCT00621855|155783785|FG002|Overall Study|Lost to Follow-up|3|||
48435761|NCT00621855|155783786|FG003|Overall Study|Lost to Follow-up|4|||
48435762|NCT00621855|155783787|FG004|Overall Study|Lost to Follow-up|1|||
48435763|NCT00621855|155783783|FG000|Overall Study|Protocol Violation|16|||
48435764|NCT00621855|155783784|FG001|Overall Study|Protocol Violation|8|||
48435765|NCT00621855|155783785|FG002|Overall Study|Protocol Violation|6|||
48435766|NCT00621855|155783786|FG003|Overall Study|Protocol Violation|7|||
48435767|NCT00621855|155783787|FG004|Overall Study|Protocol Violation|8|||
48435768|NCT00621855|155783783|FG000|Overall Study|Withdrawal by Subject|16|||
48435769|NCT00621855|155783784|FG001|Overall Study|Withdrawal by Subject|11|||
48435770|NCT00621855|155783785|FG002|Overall Study|Withdrawal by Subject|13|||
48435771|NCT00621855|155783786|FG003|Overall Study|Withdrawal by Subject|13|||
48435772|NCT00621855|155783787|FG004|Overall Study|Withdrawal by Subject|9|||
48435773|NCT00621855|155783783|FG000|Overall Study|Other|9|||
48435774|NCT00621855|155783784|FG001|Overall Study|Other|7|||
48435775|NCT00621855|155783785|FG002|Overall Study|Other|6|||
48435776|NCT00621855|155783786|FG003|Overall Study|Other|5|||
48435777|NCT00621855|155783787|FG004|Overall Study|Other|4|||
48435778|NCT00621855|155783783|FG000|Overall Study|Patients did not receive study drug|3|||
48435779|NCT00621855|155783784|FG001|Overall Study|Patients did not receive study drug|3|||
48435780|NCT00621855|155783785|FG002|Overall Study|Patients did not receive study drug|5|||
48435781|NCT00621855|155783786|FG003|Overall Study|Patients did not receive study drug|4|||
48435782|NCT00621855|155783787|FG004|Overall Study|Patients did not receive study drug|2|||
48435783|NCT02128763|155783788|FG000|Overall Study|Death|1|||
48435784|NCT02128763|155783789|FG001|Overall Study|Death|0|||
48435785|NCT02128763|155783788|FG000|Overall Study|Lost to Follow-up|19|||
48435786|NCT02128763|155783789|FG001|Overall Study|Lost to Follow-up|16|||
48435787|NCT01996904|155783792|FG000|Overall Study|Lost to Follow-up|38|||
48435788|NCT01996904|155783793|FG001|Overall Study|Lost to Follow-up|27|||
48435789|NCT03245723|155783794|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
48435790|NCT03245723|155783795|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
48435791|NCT03245723|155783794|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
48435792|NCT03245723|155783795|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
48435793|NCT03245723|155783794|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
48435794|NCT03245723|155783795|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
48435795|NCT03245723|155783794|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
48435796|NCT03245723|155783795|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
48435797|NCT05554471|155783798|FG000|Overall Study|Physician Decision|2|||
48435798|NCT05554471|155783799|FG001|Overall Study|Physician Decision|1|||
48435799|NCT05554471|155783798|FG000|Overall Study|Lost to Follow-up|2|||
48435800|NCT05554471|155783799|FG001|Overall Study|Lost to Follow-up|1|||
48435801|NCT05554471|155783798|FG000|Overall Study|Death|0|||
48435802|NCT05554471|155783799|FG001|Overall Study|Death|1|||
48435803|NCT01934192|155783800|FG000|Overall Study|Protocol Violation|0|||
48435804|NCT01934192|155783801|FG001|Overall Study|Protocol Violation|0|||
48435805|NCT01934192|155783802|FG002|Overall Study|Protocol Violation|0|||
48435806|NCT01934192|155783803|FG003|Overall Study|Protocol Violation|1|||
48435807|NCT01934192|155783800|FG000|Overall Study|Other: reached stopping criteria|6|||
48435808|NCT01934192|155783801|FG001|Overall Study|Other: reached stopping criteria|5|||
48435809|NCT01934192|155783802|FG002|Overall Study|Other: reached stopping criteria|1|||
48435810|NCT01934192|155783803|FG003|Overall Study|Other: reached stopping criteria|0|||
48435811|NCT01934192|155783800|FG000|Overall Study|Physician Decision|3|||
48435812|NCT01934192|155783801|FG001|Overall Study|Physician Decision|2|||
48435813|NCT01934192|155783802|FG002|Overall Study|Physician Decision|0|||
48435828|NCT00403559|155783817|FG001|Overall Study|Withdrawal by Subject|0|||
48435829|NCT03105700|155783818|FG000|Overall Study|screen fail|3|||
48435830|NCT03105700|155783818|FG000|Overall Study|Lost to Follow-up|4|||
48435831|NCT00929734|155783819|FG000|Overall Study|Lost to Follow-up|2|||
48435832|NCT00929734|155783820|FG001|Overall Study|Lost to Follow-up|1|||
48435833|NCT00929734|155783819|FG000|Overall Study|Withdrawal by Subject|0|||
48435834|NCT00929734|155783820|FG001|Overall Study|Withdrawal by Subject|2|||
48435835|NCT01253421|155783821|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
48435836|NCT01253421|155783822|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
48435837|NCT01253421|155783823|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
48435838|NCT01253421|155783824|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
48435839|NCT01253421|155783825|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
48435840|NCT01253421|155783821|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
48435841|NCT01253421|155783822|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
48435842|NCT01253421|155783823|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
48435843|NCT01253421|155783824|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
48435844|NCT01253421|155783825|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
48435845|NCT01253421|155783821|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
48435846|NCT01253421|155783822|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
48435847|NCT01253421|155783823|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
48435848|NCT01253421|155783824|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
48435849|NCT01253421|155783825|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
48435850|NCT01253421|155783821|FG000|Assessment and Scheduling|Physician Decision|1|||
48435851|NCT01253421|155783822|FG001|Assessment and Scheduling|Physician Decision|0|||
48435852|NCT01253421|155783823|FG002|Assessment and Scheduling|Physician Decision|0|||
48435853|NCT01253421|155783824|FG003|Assessment and Scheduling|Physician Decision|0|||
48435854|NCT01253421|155783825|FG004|Assessment and Scheduling|Physician Decision|0|||
48435855|NCT01253421|155783821|FG000|Drug+Scanning Visit|Physician Decision|0|||
48435856|NCT01253421|155783822|FG001|Drug+Scanning Visit|Physician Decision|0|||
48435857|NCT01253421|155783823|FG002|Drug+Scanning Visit|Physician Decision|0|||
48435858|NCT01253421|155783824|FG003|Drug+Scanning Visit|Physician Decision|0|||
48435859|NCT01253421|155783825|FG004|Drug+Scanning Visit|Physician Decision|1|||
48435860|NCT00980980|155783831|FG000|Overall Study|Withdrawal by Hospital|0|||
48435861|NCT00980980|155783832|FG001|Overall Study|Withdrawal by Hospital|1|||
48435862|NCT00980980|155783833|FG002|Overall Study|Withdrawal by Hospital|0|||
48435863|NCT03666858|155783834|FG000|Cohort 1|Adverse Event|1|||
48435864|NCT03666858|155783835|FG001|Cohort 1|Adverse Event|0|||
48435865|NCT03666858|155783834|FG000|Cohort 2|Adverse Event|0|||
48435866|NCT03666858|155783835|FG001|Cohort 2|Adverse Event|1|||
48435867|NCT02921919|155783836|FG000|Overall Study|Other|5|||
48435868|NCT02921919|155783837|FG001|Overall Study|Other|6|||
48435869|NCT02921919|155783836|FG000|Overall Study|Lost to Follow-up|0|||
48435870|NCT02921919|155783837|FG001|Overall Study|Lost to Follow-up|1|||
48435871|NCT02921919|155783836|FG000|Overall Study|Withdrawal by Subject|5|||
48435872|NCT02921919|155783837|FG001|Overall Study|Withdrawal by Subject|1|||
48435873|NCT02921919|155783836|FG000|Overall Study|Disease Progression|47|||
48435874|NCT02921919|155783837|FG001|Overall Study|Disease Progression|38|||
48435875|NCT02921919|155783836|FG000|Overall Study|Physician Decision|3|||
48435876|NCT02921919|155783837|FG001|Overall Study|Physician Decision|2|||
48435877|NCT02921919|155783836|FG000|Overall Study|Adverse Event|6|||
48435878|NCT02921919|155783837|FG001|Overall Study|Adverse Event|4|||
48435879|NCT00121992|155783838|FG000|Overall Study|Treatment not received|2|||
48435880|NCT00121992|155783839|FG001|Overall Study|Treatment not received|11|||
48435881|NCT03442829|155783840|FG000|Overall Study|Scheduling clash|3|||
48435882|NCT03442829|155783841|FG001|Overall Study|Scheduling clash|1|||
48435883|NCT03442829|155783840|FG000|Overall Study|Illness unrelated to study|1|||
48435884|NCT03442829|155783841|FG001|Overall Study|Illness unrelated to study|1|||
48435885|NCT03282357|155783842|FG000|Overall Study|Lost to Follow-up|3|||
48435886|NCT03282357|155783842|FG000|Overall Study|Withdrawal by Subject|4|||
48435887|NCT03282357|155783842|FG000|Overall Study|Adverse Event|1|||
48435888|NCT03282357|155783842|FG000|Overall Study|Other|9|||
48435889|NCT00585923|155783843|FG000|Overall Study|Physician decided not to continue|31|||
48435890|NCT00585923|155783844|FG001|Overall Study|Physician decided not to continue|33|||
48435891|NCT00547378|155783845|FG000|Randomized Cohort|Withdrawal by Subject|7|||
48435892|NCT00547378|155783846|FG001|Randomized Cohort|Withdrawal by Subject|5|||
48435893|NCT00547378|155783847|FG002|Randomized Cohort|Withdrawal by Subject|0|||
48435894|NCT00547378|155783845|FG000|Randomized Cohort|Death|0|||
48435895|NCT00547378|155783846|FG001|Randomized Cohort|Death|1|||
48435896|NCT00547378|155783847|FG002|Randomized Cohort|Death|0|||
48435897|NCT00547378|155783845|FG000|Randomized Cohort|Lost to Follow-up|1|||
48435898|NCT00547378|155783846|FG001|Randomized Cohort|Lost to Follow-up|0|||
48435899|NCT00547378|155783847|FG002|Randomized Cohort|Lost to Follow-up|0|||
48435900|NCT00547378|155783845|FG000|Randomized Cohort|Adverse Event|1|||
48435901|NCT00547378|155783846|FG001|Randomized Cohort|Adverse Event|0|||
48435902|NCT00547378|155783847|FG002|Randomized Cohort|Adverse Event|0|||
48435903|NCT00547378|155783845|FG000|Randomized Cohort|Other reasons|2|||
48435904|NCT00547378|155783846|FG001|Randomized Cohort|Other reasons|0|||
48435911|NCT00547378|155783847|FG002|All Implanted Cohort|Adverse Event|17|||
48435912|NCT00547378|155783845|FG000|All Implanted Cohort|Lost to Follow-up|0|||
48435913|NCT00547378|155783846|FG001|All Implanted Cohort|Lost to Follow-up|1|||
48435914|NCT00547378|155783847|FG002|All Implanted Cohort|Lost to Follow-up|14|||
48435915|NCT00547378|155783845|FG000|All Implanted Cohort|Death|3|||
48435916|NCT00547378|155783846|FG001|All Implanted Cohort|Death|1|||
48435917|NCT00547378|155783847|FG002|All Implanted Cohort|Death|4|||
48435918|NCT00547378|155783845|FG000|All Implanted Cohort|Physician Decision|0|||
48435919|NCT00547378|155783846|FG001|All Implanted Cohort|Physician Decision|2|||
48435920|NCT00547378|155783847|FG002|All Implanted Cohort|Physician Decision|6|||
48435921|NCT00547378|155783845|FG000|All Implanted Cohort|Site closure|2|||
48435922|NCT00547378|155783846|FG001|All Implanted Cohort|Site closure|0|||
48435923|NCT00547378|155783847|FG002|All Implanted Cohort|Site closure|1|||
48435924|NCT00547378|155783845|FG000|All Implanted Cohort|Other reasons|1|||
48435925|NCT00547378|155783846|FG001|All Implanted Cohort|Other reasons|0|||
48435926|NCT00547378|155783847|FG002|All Implanted Cohort|Other reasons|1|||
48435927|NCT01586156|155783848|FG000|Overall Study|Pregnancy|0|||
48435928|NCT01586156|155783849|FG001|Overall Study|Pregnancy|1|||
48435929|NCT01586156|155783850|FG002|Overall Study|Pregnancy|0|||
48435930|NCT01449682|155783851|FG000|Overall Study|Death|0|||
48435931|NCT01449682|155783852|FG001|Overall Study|Death|1|||
48435932|NCT01449682|155783851|FG000|Overall Study|Adverse Event|1|||
48435933|NCT01449682|155783852|FG001|Overall Study|Adverse Event|0|||
48435934|NCT03550131|155783853|FG000|Overall Study|Lost to Follow-up|16|||
48435935|NCT03550131|155783854|FG001|Overall Study|Lost to Follow-up|24|||
48435936|NCT03550131|155783853|FG000|Overall Study|Withdrawal by Subject|36|||
48435937|NCT03550131|155783854|FG001|Overall Study|Withdrawal by Subject|28|||
48435938|NCT03550131|155783853|FG000|Overall Study|Illness of dyad member|10|||
48435939|NCT03550131|155783854|FG001|Overall Study|Illness of dyad member|2|||
48435940|NCT03550131|155783853|FG000|Overall Study|Death of person with dementia|4|||
48435941|NCT03550131|155783854|FG001|Overall Study|Death of person with dementia|8|||
48435942|NCT02112994|155783856|FG000|Overall Study|Progressive Disease|0|||
48435943|NCT02112994|155783857|FG001|Overall Study|Progressive Disease|0|||
48435944|NCT02112994|155783858|FG002|Overall Study|Progressive Disease|1|||
48435945|NCT02112994|155783856|FG000|Overall Study|Pregnancy|0|||
48435946|NCT02112994|155783857|FG001|Overall Study|Pregnancy|1|||
48435947|NCT02112994|155783858|FG002|Overall Study|Pregnancy|1|||
48435948|NCT02112994|155783856|FG000|Overall Study|Liver Transplant|0|||
48435949|NCT02112994|155783857|FG001|Overall Study|Liver Transplant|1|||
48435950|NCT02112994|155783858|FG002|Overall Study|Liver Transplant|0|||
48435951|NCT02112994|155783856|FG000|Overall Study|Withdrawal by Subject|0|||
48435952|NCT02112994|155783857|FG001|Overall Study|Withdrawal by Subject|0|||
48435953|NCT02112994|155783858|FG002|Overall Study|Withdrawal by Subject|1|||
48435954|NCT04105244|155783859|FG000|Overall Study|Withdrawal by Subject|10|||
48435955|NCT04105244|155783860|FG001|Overall Study|Withdrawal by Subject|12|||
48435956|NCT04105244|155783859|FG000|Overall Study|Lost to Follow-up|20|||
48435957|NCT04105244|155783860|FG001|Overall Study|Lost to Follow-up|15|||
48435958|NCT04105244|155783859|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
48435959|NCT04105244|155783860|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
48435960|NCT04105244|155783859|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
48435961|NCT04105244|155783860|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
48435962|NCT02768194|155783861|FG000|Period 1|Adverse Event|0|||
48435963|NCT02768194|155783862|FG001|Period 1|Adverse Event|0|||
48435964|NCT02768194|155783863|FG002|Period 1|Adverse Event|0|||
48435965|NCT02768194|155783864|FG003|Period 1|Adverse Event|1|||
48435966|NCT02768194|155783865|FG004|Period 1|Adverse Event|0|||
48435967|NCT02768194|155783866|FG005|Period 1|Adverse Event|0|||
48435968|NCT02768194|155783861|FG000|Period 2|Other (Reason not specified)|1|||
48435969|NCT02768194|155783862|FG001|Period 2|Other (Reason not specified)|0|||
48435970|NCT02768194|155783863|FG002|Period 2|Other (Reason not specified)|0|||
48435971|NCT02768194|155783864|FG003|Period 2|Other (Reason not specified)|0|||
48435972|NCT02768194|155783865|FG004|Period 2|Other (Reason not specified)|0|||
48435973|NCT02768194|155783866|FG005|Period 2|Other (Reason not specified)|0|||
48435974|NCT02768194|155783861|FG000|Period 3|Other (Reason not specified)|0|||
48435975|NCT02768194|155783862|FG001|Period 3|Other (Reason not specified)|1|||
48435976|NCT02768194|155783863|FG002|Period 3|Other (Reason not specified)|0|||
48435977|NCT02768194|155783864|FG003|Period 3|Other (Reason not specified)|0|||
48435978|NCT02768194|155783865|FG004|Period 3|Other (Reason not specified)|0|||
48435979|NCT02768194|155783866|FG005|Period 3|Other (Reason not specified)|0|||
48435980|NCT00975195|155783867|FG000|Overall Study|Adverse Event|108|||
48435981|NCT00975195|155783868|FG001|Overall Study|Adverse Event|101|||
48435982|NCT00975195|155783867|FG000|Overall Study|Lack of Efficacy|6|||
48435983|NCT00975195|155783868|FG001|Overall Study|Lack of Efficacy|6|||
48435984|NCT00975195|155783867|FG000|Overall Study|Protocol Violation|27|||
48435985|NCT00975195|155783868|FG001|Overall Study|Protocol Violation|23|||
48435986|NCT00975195|155783867|FG000|Overall Study|Lost to Follow-up|9|||
48435987|NCT00975195|155783868|FG001|Overall Study|Lost to Follow-up|7|||
48435988|NCT00975195|155783867|FG000|Overall Study|Withdrawal by Subject|48|||
48435989|NCT00975195|155783868|FG001|Overall Study|Withdrawal by Subject|61|||
48435990|NCT00975195|155783867|FG000|Overall Study|Other reason not defined above|29|||
48435991|NCT00975195|155783868|FG001|Overall Study|Other reason not defined above|33|||
48435992|NCT00975195|155783867|FG000|Overall Study|Not treated|1|||
48435993|NCT00975195|155783868|FG001|Overall Study|Not treated|2|||
48435994|NCT01318512|155783869|FG000|Maintenance Period (6 Months)|Death|2|||
48435995|NCT01318512|155783869|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
48435996|NCT04387136|155783874|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
48435997|NCT04387136|155783875|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
48435998|NCT02330549|155785736|FG000|Overall Study|Adverse Event|1|||
48435999|NCT02330549|155785737|FG001|Overall Study|Adverse Event|0|||
48436000|NCT02330549|155785736|FG000|Overall Study|Subject withdrew consent|2|||
48436001|NCT02330549|155785737|FG001|Overall Study|Subject withdrew consent|1|||
48436002|NCT02330549|155785736|FG000|Overall Study|Failure to meet randomization criteria|1|||
48436003|NCT02330549|155785737|FG001|Overall Study|Failure to meet randomization criteria|0|||
48436004|NCT00745368|155785746|FG000|Overall Study|Unable to provide sample|3|||
48436005|NCT00495495|155785748|FG000|Overall Study|Protocol Violation|99|||
48436006|NCT02364947|155785749|FG000|Overall Study|Withdrawal by Subject|10|||
48436007|NCT02364947|155785750|FG001|Overall Study|Withdrawal by Subject|8|||
48436008|NCT02364947|155785751|FG002|Overall Study|Withdrawal by Subject|9|||
48436009|NCT02364947|155785749|FG000|Overall Study|Adverse Event|45|||
48436010|NCT02364947|155785750|FG001|Overall Study|Adverse Event|33|||
48436011|NCT02364947|155785751|FG002|Overall Study|Adverse Event|11|||
48436012|NCT02364947|155785749|FG000|Overall Study|Protocol Violation|1|||
48436013|NCT02364947|155785750|FG001|Overall Study|Protocol Violation|1|||
48436014|NCT02364947|155785751|FG002|Overall Study|Protocol Violation|1|||
48436015|NCT02364947|155785749|FG000|Overall Study|Physician Decision|3|||
48436016|NCT02364947|155785750|FG001|Overall Study|Physician Decision|2|||
48436017|NCT02364947|155785751|FG002|Overall Study|Physician Decision|5|||
48436018|NCT02364947|155785749|FG000|Overall Study|Death|0|||
48436019|NCT02364947|155785750|FG001|Overall Study|Death|1|||
48436020|NCT02364947|155785751|FG002|Overall Study|Death|0|||
48436021|NCT02939937|155785757|FG000|Overall Study|Adverse Event|5|||
48436022|NCT02939937|155785758|FG001|Overall Study|Adverse Event|0|||
48436023|NCT02939937|155785757|FG000|Overall Study|Lost to Follow-up|1|||
48436024|NCT02939937|155785758|FG001|Overall Study|Lost to Follow-up|3|||
48436025|NCT00441441|155785762|FG000|Overall Study|Adverse Event|2|||
48436026|NCT00441441|155785763|FG001|Overall Study|Adverse Event|1|||
48436027|NCT00441441|155785762|FG000|Overall Study|Protocol Violation|4|||
48436028|NCT00441441|155785763|FG001|Overall Study|Protocol Violation|6|||
48436029|NCT00441441|155785762|FG000|Overall Study|Exacerbation of asthma|1|||
48436030|NCT00441441|155785763|FG001|Overall Study|Exacerbation of asthma|2|||
48436031|NCT00441441|155785762|FG000|Overall Study|Withdrawal by Subject|1|||
48436032|NCT00441441|155785763|FG001|Overall Study|Withdrawal by Subject|2|||
48436033|NCT00441441|155785762|FG000|Overall Study|Other|3|||
48436034|NCT00441441|155785763|FG001|Overall Study|Other|3|||
48436035|NCT01354353|155785764|FG000|Overall Study|Adverse Event|1|||
48436036|NCT01354353|155785765|FG001|Overall Study|Adverse Event|0|||
48436037|NCT01354353|155785766|FG002|Overall Study|Adverse Event|0|||
48436038|NCT01354353|155785767|FG003|Overall Study|Adverse Event|4|||
48436039|NCT01354353|155785768|FG004|Overall Study|Adverse Event|0|||
48436040|NCT01354353|155785769|FG005|Overall Study|Adverse Event|5|||
48436041|NCT01354353|155785764|FG000|Overall Study|Entry Criteria Not Met|0|||
48436042|NCT01354353|155785765|FG001|Overall Study|Entry Criteria Not Met|0|||
48436043|NCT01354353|155785766|FG002|Overall Study|Entry Criteria Not Met|0|||
48436044|NCT01354353|155785767|FG003|Overall Study|Entry Criteria Not Met|1|||
48436045|NCT01354353|155785768|FG004|Overall Study|Entry Criteria Not Met|1|||
48436046|NCT01354353|155785769|FG005|Overall Study|Entry Criteria Not Met|0|||
48436047|NCT01354353|155785764|FG000|Overall Study|Physician Decision|0|||
48436048|NCT01354353|155785765|FG001|Overall Study|Physician Decision|1|||
48436049|NCT01354353|155785766|FG002|Overall Study|Physician Decision|1|||
48436050|NCT01354353|155785767|FG003|Overall Study|Physician Decision|0|||
48436051|NCT01354353|155785768|FG004|Overall Study|Physician Decision|0|||
48436052|NCT01354353|155785769|FG005|Overall Study|Physician Decision|0|||
48436053|NCT01354353|155785764|FG000|Overall Study|Withdrawal by Subject|2|||
48436054|NCT01354353|155785765|FG001|Overall Study|Withdrawal by Subject|0|||
48436055|NCT01354353|155785766|FG002|Overall Study|Withdrawal by Subject|1|||
48436056|NCT01354353|155785767|FG003|Overall Study|Withdrawal by Subject|0|||
48436057|NCT01354353|155785768|FG004|Overall Study|Withdrawal by Subject|0|||
48436058|NCT01354353|155785769|FG005|Overall Study|Withdrawal by Subject|1|||
48436059|NCT00798655|155785772|FG000|Overall Study|Did not receive at least one dose of pan|2|||
48436060|NCT01030458|155785773|FG000|Overall Study|Lost to Follow-up|9|||
48436061|NCT01030458|155785774|FG001|Overall Study|Lost to Follow-up|10|||
48436062|NCT01030458|155785773|FG000|Overall Study|Withdrawal by Subject|2|||
48436063|NCT01030458|155785774|FG001|Overall Study|Withdrawal by Subject|3|||
48436064|NCT01030458|155785773|FG000|Overall Study|Logistical reasons|9|||
48436065|NCT01030458|155785774|FG001|Overall Study|Logistical reasons|5|||
48436066|NCT01030458|155785773|FG000|Overall Study|Moved or changed job|6|||
48436067|NCT01030458|155785774|FG001|Overall Study|Moved or changed job|13|||
48436068|NCT01030458|155785773|FG000|Overall Study|Side effect of medication|1|||
48436069|NCT01030458|155785774|FG001|Overall Study|Side effect of medication|1|||
48436070|NCT01623531|155785776|FG000|Overall Study|Death|1|||
48436071|NCT01623531|155785777|FG001|Overall Study|Death|0|||
48436072|NCT01623531|155785776|FG000|Overall Study|Protocol Violation|2|||
48436073|NCT01623531|155785777|FG001|Overall Study|Protocol Violation|1|||
48436074|NCT01623531|155785776|FG000|Overall Study|Missing data at primary outcome time poi|1|||
48436075|NCT01623531|155785777|FG001|Overall Study|Missing data at primary outcome time poi|1|||
48436076|NCT00623467|155785778|FG000|Overall Study|Lost to Follow-up|1|||
48436077|NCT00623467|155785778|FG000|Overall Study|Protocol Violation|4|||
48436078|NCT00623467|155785778|FG000|Overall Study|Withdrawal by Subject|2|||
48436079|NCT01202227|155785781|FG000|Overall Study|Adverse Event|16|||
48436080|NCT01202227|155785781|FG000|Overall Study|Withdrawal by Subject|2|||
48436081|NCT01202227|155785781|FG000|Overall Study|Lack of Efficacy|1|||
48436082|NCT00848549|155785782|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
48436083|NCT00848549|155785783|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
48436084|NCT00848549|155785782|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
48436085|NCT00848549|155785783|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
48436086|NCT00848549|155785782|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
48436087|NCT00848549|155785783|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
48436088|NCT00848549|155785782|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
48436089|NCT00848549|155785783|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
48436090|NCT00848549|155785782|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
48436091|NCT00848549|155785783|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
48436092|NCT00848549|155785782|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
48436093|NCT00848549|155785783|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
48436094|NCT00848549|155785782|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
48436095|NCT00848549|155785783|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
48436096|NCT00848549|155785782|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
48436097|NCT00848549|155785783|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
48436098|NCT00848549|155785782|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
48436099|NCT00848549|155785783|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
48436100|NCT00848549|155785782|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
48436101|NCT00848549|155785783|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
48436102|NCT00848549|155785782|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
48436103|NCT00848549|155785783|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
48436104|NCT00848549|155785782|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
48436105|NCT00848549|155785783|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
48436106|NCT00848549|155785782|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
48436107|NCT00848549|155785783|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
48436108|NCT00848549|155785782|FG000|E2090-E044-314 (Extension Study)|Other|5|||
48436109|NCT00848549|155785783|FG001|E2090-E044-314 (Extension Study)|Other|6|||
48436110|NCT01592409|155785785|FG000|Overall Study|Withdrawal by Subject|0|||
48436111|NCT01592409|155785786|FG001|Overall Study|Withdrawal by Subject|1|||
48436112|NCT04507867|155785789|FG000|Overall Study|Death|7|||
48436113|NCT04507867|155785790|FG001|Overall Study|Death|1|||
48436114|NCT01094730|155785791|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
48436115|NCT01094730|155785792|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
48436116|NCT01094730|155785791|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
48436117|NCT01094730|155785792|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
48436118|NCT01094730|155785791|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
48436119|NCT01094730|155785792|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
48436120|NCT01094730|155785791|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
48436121|NCT01094730|155785792|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
48436122|NCT01094730|155785791|FG000|Period 2 (14 Days)|Protocol Violation|2|||
48436123|NCT01094730|155785792|FG001|Period 2 (14 Days)|Protocol Violation|0|||
48436124|NCT01094730|155785791|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
48436125|NCT01094730|155785792|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
48436126|NCT01094730|155785791|FG000|Period 2 (14 Days)|Adverse Event|0|||
48436127|NCT01094730|155785792|FG001|Period 2 (14 Days)|Adverse Event|1|||
48436128|NCT01094730|155785791|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
48436129|NCT01094730|155785792|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
48436130|NCT00423735|155785793|FG000|Overall Study|Ineligible / No protocol treatment|8|||
48436131|NCT00423735|155785794|FG001|Overall Study|Ineligible / No protocol treatment|6|||
48436132|NCT00423735|155785795|FG002|Overall Study|Ineligible / No protocol treatment|0|||
48436133|NCT00617409|155785799|FG000|Overall Study|Withdrawal by Subject|4|||
48436134|NCT00617409|155785800|FG001|Overall Study|Withdrawal by Subject|1|||
48436135|NCT00617409|155785801|FG002|Overall Study|Withdrawal by Subject|2|||
48436136|NCT00617409|155785799|FG000|Overall Study|Adverse Event|0|||
48436137|NCT00617409|155785800|FG001|Overall Study|Adverse Event|2|||
48436164|NCT03491553|155785823|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
48436165|NCT03491553|155785818|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
48436166|NCT03491553|155785819|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
48436167|NCT03491553|155785820|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
48436168|NCT03491553|155785821|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
48436169|NCT03491553|155785822|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
48436170|NCT03491553|155785823|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
48436171|NCT01069523|155785824|FG000|Overall Study|Withdrawal by Subject|4|||
48436172|NCT01069523|155785825|FG001|Overall Study|Withdrawal by Subject|7|||
48436173|NCT01912729|155785828|FG000|Overall Study|Withdrawal by Subject|0|||
48436174|NCT01912729|155785829|FG001|Overall Study|Withdrawal by Subject|1|||
48436175|NCT03029650|155785830|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
48436176|NCT03029650|155785831|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
48436177|NCT03029650|155785830|FG000|Washout (1 Week)|Physician Decision|0|||
48436178|NCT03029650|155785831|FG001|Washout (1 Week)|Physician Decision|1|||
48436179|NCT04863014|155785834|FG000|Overall Study|Lost to Follow-up|3|||
48436180|NCT04863014|155785835|FG001|Overall Study|Lost to Follow-up|2|||
48436181|NCT04863014|155785834|FG000|Overall Study|Subject Decision|0|||
48436182|NCT04863014|155785835|FG001|Overall Study|Subject Decision|4|||
48436183|NCT04633473|155785836|FG000|Overall Study|Withdrawal by Subject|6|||
48436184|NCT00363246|155785837|FG000|Overall Study|Death|40|||
48436185|NCT00363246|155785837|FG000|Overall Study|Withdrawal by Subject|19|||
48436186|NCT00363246|155785837|FG000|Overall Study|Lost to Follow-up|14|||
48436187|NCT00363246|155785837|FG000|Overall Study|Bad health|6|||
48436188|NCT00363246|155785837|FG000|Overall Study|Stopped using wheelchair|11|||
48436189|NCT00363246|155785837|FG000|Overall Study|Subject expressed security concerns|2|||
48436190|NCT00363246|155785837|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
48436191|NCT00264849|155785844|FG000|Overall Study|Adverse Event|7|||
48436192|NCT00264849|155785845|FG001|Overall Study|Adverse Event|2|||
48436193|NCT00264849|155785844|FG000|Overall Study|Withdrawal by Subject|7|||
48436194|NCT00264849|155785845|FG001|Overall Study|Withdrawal by Subject|11|||
48436195|NCT00264849|155785844|FG000|Overall Study|Protocol Violation|5|||
48436196|NCT00264849|155785845|FG001|Overall Study|Protocol Violation|3|||
48436197|NCT00264849|155785844|FG000|Overall Study|Lack of Efficacy|1|||
48436198|NCT00264849|155785845|FG001|Overall Study|Lack of Efficacy|6|||
48436199|NCT00264849|155785844|FG000|Overall Study|Lost to Follow-up|0|||
48436200|NCT00264849|155785845|FG001|Overall Study|Lost to Follow-up|2|||
48436201|NCT00264849|155785844|FG000|Overall Study|Death|0|||
48436202|NCT00264849|155785845|FG001|Overall Study|Death|1|||
48436203|NCT00264849|155785844|FG000|Overall Study|Administrative Problems|2|||
48436204|NCT00264849|155785845|FG001|Overall Study|Administrative Problems|0|||
48436205|NCT00099359|155785846|FG000|Overall Study|Death|11|||
48436206|NCT00099359|155785847|FG001|Overall Study|Death|15|||
48436207|NCT00099359|155785848|FG002|Overall Study|Death|17|||
48436208|NCT00099359|155785846|FG000|Overall Study|Withdrawal by Subject|19|||
48436209|NCT00099359|155785847|FG001|Overall Study|Withdrawal by Subject|19|||
48436210|NCT00099359|155785848|FG002|Overall Study|Withdrawal by Subject|23|||
48436211|NCT00099359|155785846|FG000|Overall Study|Lost to Follow-up|15|||
48436212|NCT00099359|155785847|FG001|Overall Study|Lost to Follow-up|24|||
48436213|NCT00099359|155785848|FG002|Overall Study|Lost to Follow-up|24|||
48436214|NCT00099359|155785846|FG000|Overall Study|moved out of area|9|||
48436215|NCT00099359|155785847|FG001|Overall Study|moved out of area|7|||
48436216|NCT00099359|155785848|FG002|Overall Study|moved out of area|4|||
48436217|NCT01982773|155785851|FG000|Overall Study|Withdrawal by Subject|1|||
48436218|NCT01982773|155785852|FG001|Overall Study|Withdrawal by Subject|3|||
48436219|NCT01982773|155785851|FG000|Overall Study|Lost to Follow-up|7|||
48436220|NCT01982773|155785852|FG001|Overall Study|Lost to Follow-up|1|||
48436221|NCT00717366|155785853|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
48436222|NCT00717366|155785854|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
48436223|NCT00717366|155785853|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
48436224|NCT00717366|155785854|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
48436225|NCT00717366|155785853|FG000|Core Study Period (20 Weeks)|Death|0|||
48436226|NCT00717366|155785854|FG001|Core Study Period (20 Weeks)|Death|1|||
48436227|NCT00717366|155785853|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
48436228|NCT00717366|155785854|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
48436229|NCT00717366|155785853|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
48436230|NCT00717366|155785854|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
48436231|NCT00717366|155785853|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
48436232|NCT00717366|155785854|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
48436233|NCT00717366|155785853|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
48436234|NCT00717366|155785854|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
48436235|NCT01822691|155785855|FG000|Overall Study|Withdrawal by Subject|2|||
48436236|NCT02756650|155785856|FG000|Overall Study|Physician Decision|1|||
48436237|NCT02756650|155785856|FG000|Overall Study|Adverse Event|1|||
48436238|NCT01606761|155785859|FG000|Prior to Week 24|Lost to Follow-up|0|||
48436239|NCT01606761|155785860|FG001|Prior to Week 24|Lost to Follow-up|3|||
48436240|NCT01606761|155785861|FG002|Prior to Week 24|Lost to Follow-up|2|||
48436241|NCT01606761|155785862|FG003|Prior to Week 24|Lost to Follow-up|0|||
48436242|NCT01606761|155785863|FG004|Prior to Week 24|Lost to Follow-up|0|||
48436243|NCT01606761|155785859|FG000|Prior to Week 24|Withdrawal by Subject|12|||
48436244|NCT01606761|155785860|FG001|Prior to Week 24|Withdrawal by Subject|10|||
48436245|NCT01606761|155785861|FG002|Prior to Week 24|Withdrawal by Subject|9|||
48436246|NCT01606761|155785862|FG003|Prior to Week 24|Withdrawal by Subject|0|||
48436247|NCT01606761|155785863|FG004|Prior to Week 24|Withdrawal by Subject|0|||
48436248|NCT01606761|155785859|FG000|Prior to Week 24|Adverse Event|11|||
48436249|NCT01606761|155785860|FG001|Prior to Week 24|Adverse Event|18|||
48436250|NCT01606761|155785861|FG002|Prior to Week 24|Adverse Event|22|||
48436251|NCT01606761|155785862|FG003|Prior to Week 24|Adverse Event|0|||
48436252|NCT01606761|155785863|FG004|Prior to Week 24|Adverse Event|0|||
48436253|NCT01606761|155785859|FG000|Prior to Week 24|Lack of Efficacy|15|||
48436254|NCT01606761|155785860|FG001|Prior to Week 24|Lack of Efficacy|14|||
48436255|NCT01606761|155785861|FG002|Prior to Week 24|Lack of Efficacy|8|||
48436256|NCT01606761|155785862|FG003|Prior to Week 24|Lack of Efficacy|0|||
48436257|NCT01606761|155785863|FG004|Prior to Week 24|Lack of Efficacy|0|||
48436258|NCT01606761|155785859|FG000|Prior to Week 24|Physician Decision|0|||
48436259|NCT01606761|155785860|FG001|Prior to Week 24|Physician Decision|3|||
48436260|NCT01606761|155785861|FG002|Prior to Week 24|Physician Decision|1|||
48436261|NCT01606761|155785862|FG003|Prior to Week 24|Physician Decision|0|||
48436262|NCT01606761|155785863|FG004|Prior to Week 24|Physician Decision|0|||
48436263|NCT01606761|155785859|FG000|Prior to Week 24|Other|4|||
48436264|NCT01606761|155785860|FG001|Prior to Week 24|Other|7|||
48436265|NCT01606761|155785861|FG002|Prior to Week 24|Other|5|||
48436266|NCT01606761|155785862|FG003|Prior to Week 24|Other|0|||
48436267|NCT01606761|155785863|FG004|Prior to Week 24|Other|0|||
48436268|NCT01606761|155785859|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
48436269|NCT01606761|155785860|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
48436270|NCT01606761|155785861|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
48436271|NCT01606761|155785862|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
48436272|NCT01606761|155785863|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
48436273|NCT01606761|155785859|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
48436274|NCT01606761|155785860|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
48436275|NCT01606761|155785861|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
48436276|NCT01606761|155785862|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
48436277|NCT01606761|155785863|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
48436278|NCT01606761|155785859|FG000|Week 24 to Week 52|Adverse Event|0|||
48436279|NCT01606761|155785860|FG001|Week 24 to Week 52|Adverse Event|11|||
48436280|NCT01606761|155785861|FG002|Week 24 to Week 52|Adverse Event|14|||
48436281|NCT01606761|155785862|FG003|Week 24 to Week 52|Adverse Event|3|||
48436282|NCT01606761|155785863|FG004|Week 24 to Week 52|Adverse Event|15|||
48436283|NCT01606761|155785859|FG000|Week 24 to Week 52|Death|0|||
48436284|NCT01606761|155785860|FG001|Week 24 to Week 52|Death|0|||
48436285|NCT01606761|155785861|FG002|Week 24 to Week 52|Death|2|||
48436286|NCT01606761|155785862|FG003|Week 24 to Week 52|Death|1|||
48436287|NCT01606761|155785863|FG004|Week 24 to Week 52|Death|0|||
48436288|NCT01606761|155785859|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
48436289|NCT01606761|155785860|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
48436290|NCT01606761|155785861|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
48436291|NCT01606761|155785862|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
48436292|NCT01606761|155785863|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
48436293|NCT01606761|155785859|FG000|Week 24 to Week 52|Physician Decision|0|||
48436294|NCT01606761|155785860|FG001|Week 24 to Week 52|Physician Decision|1|||
48436295|NCT01606761|155785861|FG002|Week 24 to Week 52|Physician Decision|1|||
48436296|NCT01606761|155785862|FG003|Week 24 to Week 52|Physician Decision|0|||
48436297|NCT01606761|155785863|FG004|Week 24 to Week 52|Physician Decision|0|||
48436298|NCT01606761|155785859|FG000|Week 24 to Week 52|Other|0|||
48436299|NCT01606761|155785860|FG001|Week 24 to Week 52|Other|1|||
48436300|NCT01606761|155785861|FG002|Week 24 to Week 52|Other|5|||
48436301|NCT01606761|155785862|FG003|Week 24 to Week 52|Other|2|||
48436302|NCT01606761|155785863|FG004|Week 24 to Week 52|Other|2|||
48436303|NCT01606761|155785859|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
48436304|NCT01606761|155785860|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
48436305|NCT01606761|155785861|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
48436306|NCT01606761|155785862|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
48436307|NCT01606761|155785863|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
48436308|NCT01606761|155785859|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
48436309|NCT01606761|155785860|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
48436310|NCT01606761|155785861|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
48436311|NCT01606761|155785862|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
48436312|NCT01606761|155785863|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
48436313|NCT01606761|155785859|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
48436314|NCT01606761|155785860|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
48436315|NCT01606761|155785861|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
48436316|NCT01606761|155785862|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
48436317|NCT01606761|155785863|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
48436318|NCT01606761|155785859|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
48436319|NCT01606761|155785860|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
48436320|NCT01606761|155785861|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
48436321|NCT01606761|155785862|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
48436322|NCT01606761|155785863|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
48436323|NCT05319080|155785864|FG000|Overall Study|Withdrawal by Subject|2|||
48436324|NCT05319080|155785864|FG000|Overall Study|Physician Decision|4|||
48436325|NCT04465396|155785865|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
48436326|NCT04465396|155785866|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
48436327|NCT04465396|155785867|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
48436328|NCT04465396|155785868|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
48436329|NCT02648724|155785869|FG000|Overall Study|Withdrawal by Subject|0|||
48436330|NCT02648724|155785870|FG001|Overall Study|Withdrawal by Subject|1|||
48436331|NCT02648724|155785871|FG002|Overall Study|Withdrawal by Subject|1|||
48436332|NCT02648724|155785872|FG003|Overall Study|Withdrawal by Subject|0|||
48436333|NCT02648724|155785873|FG004|Overall Study|Withdrawal by Subject|1|||
48436334|NCT02648724|155785874|FG005|Overall Study|Withdrawal by Subject|0|||
48436335|NCT02648724|155785875|FG006|Overall Study|Withdrawal by Subject|0|||
48436336|NCT02648724|155785869|FG000|Overall Study|Progressive disease|2|||
48436337|NCT02648724|155785870|FG001|Overall Study|Progressive disease|2|||
48436338|NCT02648724|155785871|FG002|Overall Study|Progressive disease|2|||
48436339|NCT02648724|155785872|FG003|Overall Study|Progressive disease|3|||
48436340|NCT02648724|155785873|FG004|Overall Study|Progressive disease|22|||
48436341|NCT02648724|155785874|FG005|Overall Study|Progressive disease|7|||
48436342|NCT02648724|155785875|FG006|Overall Study|Progressive disease|8|||
48436343|NCT02648724|155785869|FG000|Overall Study|Other reason (unknown)|1|||
48436344|NCT02648724|155785870|FG001|Overall Study|Other reason (unknown)|0|||
48436345|NCT02648724|155785871|FG002|Overall Study|Other reason (unknown)|0|||
48436346|NCT02648724|155785872|FG003|Overall Study|Other reason (unknown)|0|||
48436347|NCT02648724|155785873|FG004|Overall Study|Other reason (unknown)|0|||
48436348|NCT02648724|155785874|FG005|Overall Study|Other reason (unknown)|0|||
48436349|NCT02648724|155785875|FG006|Overall Study|Other reason (unknown)|0|||
48436350|NCT02648724|155785869|FG000|Overall Study|Protocol Violation|0|||
48436351|NCT02648724|155785870|FG001|Overall Study|Protocol Violation|0|||
48436352|NCT02648724|155785871|FG002|Overall Study|Protocol Violation|0|||
48436353|NCT02648724|155785872|FG003|Overall Study|Protocol Violation|0|||
48436354|NCT02648724|155785873|FG004|Overall Study|Protocol Violation|1|||
48436355|NCT02648724|155785874|FG005|Overall Study|Protocol Violation|0|||
48436356|NCT02648724|155785875|FG006|Overall Study|Protocol Violation|0|||
48436357|NCT02648724|155785869|FG000|Overall Study|Death|0|||
48436358|NCT02648724|155785870|FG001|Overall Study|Death|0|||
48436359|NCT02648724|155785871|FG002|Overall Study|Death|0|||
48436360|NCT02648724|155785872|FG003|Overall Study|Death|0|||
48436361|NCT02648724|155785873|FG004|Overall Study|Death|0|||
48436362|NCT02648724|155785874|FG005|Overall Study|Death|0|||
48436363|NCT02648724|155785875|FG006|Overall Study|Death|3|||
48436364|NCT02648724|155785869|FG000|Overall Study|Physician Decision|0|||
48436365|NCT02648724|155785870|FG001|Overall Study|Physician Decision|0|||
48436366|NCT02648724|155785871|FG002|Overall Study|Physician Decision|0|||
48436367|NCT02648724|155785872|FG003|Overall Study|Physician Decision|0|||
48436368|NCT02648724|155785873|FG004|Overall Study|Physician Decision|1|||
48436369|NCT02648724|155785874|FG005|Overall Study|Physician Decision|0|||
48436370|NCT02648724|155785875|FG006|Overall Study|Physician Decision|1|||
48436371|NCT02648724|155785869|FG000|Overall Study|Transferred to named patient program|0|||
48436372|NCT02648724|155785870|FG001|Overall Study|Transferred to named patient program|0|||
48436373|NCT02648724|155785871|FG002|Overall Study|Transferred to named patient program|0|||
48436374|NCT02648724|155785872|FG003|Overall Study|Transferred to named patient program|0|||
48436375|NCT02648724|155785873|FG004|Overall Study|Transferred to named patient program|0|||
48436376|NCT02648724|155785874|FG005|Overall Study|Transferred to named patient program|1|||
48436377|NCT02648724|155785875|FG006|Overall Study|Transferred to named patient program|0|||
48436378|NCT04664855|155785876|FG000|Overall Study|Withdrawal by Subject|0|||
48436379|NCT04664855|155785877|FG001|Overall Study|Withdrawal by Subject|2|||
48436380|NCT03095521|155785881|FG000|Overall Study|Withdrawal by Subject|0|||
48436381|NCT03095521|155785882|FG001|Overall Study|Withdrawal by Subject|1|||
48436382|NCT03095521|155785881|FG000|Overall Study|Lost to Follow-up|0|||
48436383|NCT03095521|155785882|FG001|Overall Study|Lost to Follow-up|1|||
48436384|NCT03259490|155785883|FG000|Period 1|Withdrawal by Subject|0|||
48436385|NCT03259490|155785884|FG001|Period 1|Withdrawal by Subject|1|||
48436386|NCT03259490|155785883|FG000|Period 2|Protocol Violation|1|||
48436387|NCT03259490|155785884|FG001|Period 2|Protocol Violation|0|||
48436388|NCT03076190|155785885|FG000|Overall Study|Lost to Follow-up|9|||
48436389|NCT03076190|155785886|FG001|Overall Study|Lost to Follow-up|34|||
48436390|NCT03076190|155785885|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
48436391|NCT03076190|155785886|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
48436408|NCT05127421|155785891|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
48436409|NCT05127421|155785892|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
48436410|NCT05127421|155785889|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
48436411|NCT05127421|155785890|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
48436412|NCT05127421|155785891|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
48436413|NCT05127421|155785892|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
48436414|NCT05127421|155785889|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
48436415|NCT05127421|155785890|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
48436416|NCT05127421|155785891|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
48436417|NCT05127421|155785892|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
48436418|NCT05127421|155785889|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
48436419|NCT05127421|155785890|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
48436420|NCT05127421|155785891|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
48436421|NCT05127421|155785892|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
48436422|NCT05127421|155785889|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
48436423|NCT05127421|155785890|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
48436424|NCT05127421|155785891|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
48436425|NCT05127421|155785892|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
48436426|NCT02219087|155785893|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
48436427|NCT02219087|155785894|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
48436428|NCT00786032|155787423|FG000|Overall Study|Death|4|||
48436429|NCT00786032|155787423|FG000|Overall Study|Withdrawal by Subject|14|||
48436430|NCT00786032|155787423|FG000|Overall Study|Did not complete in the timeframe|6|||
48436431|NCT00683475|155787424|FG000|Overall Study|Withdrawal by Subject|1|||
48436432|NCT00683475|155787425|FG001|Overall Study|Withdrawal by Subject|0|||
48436433|NCT00683475|155787424|FG000|Overall Study|Never Treated: Adverse Event|2|||
48436434|NCT00683475|155787425|FG001|Overall Study|Never Treated: Adverse Event|3|||
48436435|NCT00683475|155787424|FG000|Overall Study|Never Treated: Progressive Disease|1|||
48436436|NCT00683475|155787425|FG001|Overall Study|Never Treated: Progressive Disease|0|||
48436437|NCT02625324|155787426|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
48436438|NCT02625324|155787426|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
48436439|NCT02625324|155787426|FG000|6-Month Follow-up Subject Accountability|Death|5|||
48436440|NCT02625324|155787426|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
48436441|NCT02625324|155787426|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
48436442|NCT02625324|155787426|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
48436443|NCT02625324|155787426|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
48436444|NCT02625324|155787426|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
48436445|NCT02625324|155787426|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
48436446|NCT02625324|155787426|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
48436447|NCT02625324|155787426|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
48436448|NCT02625324|155787426|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
48436449|NCT02625324|155787426|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
48436450|NCT02625324|155787426|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
48436451|NCT02625324|155787426|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
48436452|NCT02625324|155787426|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
48436453|NCT02625324|155787426|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
48436454|NCT00424528|155787427|FG000|Overall Study|Adverse Event|2|||
48436455|NCT00424528|155787428|FG001|Overall Study|Adverse Event|1|||
48436456|NCT00424528|155787429|FG002|Overall Study|Adverse Event|2|||
48436457|NCT00424528|155787427|FG000|Overall Study|Protocol Violation|1|||
48436458|NCT00424528|155787428|FG001|Overall Study|Protocol Violation|1|||
48436459|NCT00424528|155787429|FG002|Overall Study|Protocol Violation|0|||
48436460|NCT00424528|155787427|FG000|Overall Study|Lost to Follow-up|0|||
48436461|NCT00424528|155787428|FG001|Overall Study|Lost to Follow-up|1|||
48436462|NCT00424528|155787429|FG002|Overall Study|Lost to Follow-up|0|||
48436463|NCT00424528|155787427|FG000|Overall Study|noncompliance with study requirements|2|||
48436464|NCT00424528|155787428|FG001|Overall Study|noncompliance with study requirements|1|||
48436465|NCT00424528|155787429|FG002|Overall Study|noncompliance with study requirements|2|||
48436466|NCT00506948|155787432|FG000|Overall Study|Death|4|||
48436467|NCT00506948|155787432|FG000|Overall Study|Adverse Event|5|||
48436468|NCT00506948|155787432|FG000|Overall Study|Physician Decision|1|||
48436469|NCT02554253|155787433|FG000|Overall Study|ineligible after enrollment|1|||
48436470|NCT02554253|155787434|FG001|Overall Study|ineligible after enrollment|0|||
48436471|NCT02554253|155787433|FG000|Overall Study|converted to transcatheter procedure|0|||
48436472|NCT02554253|155787434|FG001|Overall Study|converted to transcatheter procedure|1|||
48436473|NCT02554253|155787433|FG000|Overall Study|received both drugs|0|||
48436474|NCT02554253|155787434|FG001|Overall Study|received both drugs|1|||
48436475|NCT01626352|155787437|FG000|Overall Study|Disease Progression|3|||
48436476|NCT01626352|155787437|FG000|Overall Study|Intercurrent Illness|2|||
48436477|NCT01626352|155787437|FG000|Overall Study|Death|2|||
48436559|NCT04402008|155787453|FG002|Overall Study|Other|0|||
48436478|NCT01626352|155787437|FG000|Overall Study|Withdrawal by Subject|1|||
48436479|NCT01626352|155787437|FG000|Overall Study|Non-Compliance|1|||
48436480|NCT01626352|155787437|FG000|Overall Study|Never Treated|1|||
48436481|NCT00831441|155787439|FG000|Randomized|Death|82|||
48436482|NCT00831441|155787440|FG001|Randomized|Death|81|||
48436483|NCT00831441|155787439|FG000|Randomized|Adverse Event|248|||
48436484|NCT00831441|155787440|FG001|Randomized|Adverse Event|321|||
48436485|NCT00831441|155787439|FG000|Randomized|Emergency procedure|2|||
48436486|NCT00831441|155787440|FG001|Randomized|Emergency procedure|2|||
48436487|NCT00831441|155787439|FG000|Randomized|Elective procedure|26|||
48436488|NCT00831441|155787440|FG001|Randomized|Elective procedure|25|||
48436489|NCT00831441|155787439|FG000|Randomized|Physician Decision|26|||
48436490|NCT00831441|155787440|FG001|Randomized|Physician Decision|35|||
48436491|NCT00831441|155787439|FG000|Randomized|No longer met criteria|13|||
48436492|NCT00831441|155787440|FG001|Randomized|No longer met criteria|19|||
48436493|NCT00831441|155787439|FG000|Randomized|Withdrawal by Subject|178|||
48436494|NCT00831441|155787440|FG001|Randomized|Withdrawal by Subject|212|||
48436495|NCT00831441|155787439|FG000|Randomized|Lost to Follow-up|26|||
48436496|NCT00831441|155787440|FG001|Randomized|Lost to Follow-up|35|||
48436497|NCT00831441|155787439|FG000|Randomized|Administrative reason by sponsor|2780|||
48436498|NCT00831441|155787440|FG001|Randomized|Administrative reason by sponsor|2671|||
48436499|NCT00831441|155787439|FG000|Randomized|poor/non-compliance|30|||
48436500|NCT00831441|155787440|FG001|Randomized|poor/non-compliance|38|||
48436501|NCT00831441|155787439|FG000|Randomized|non-specified|276|||
48436502|NCT00831441|155787440|FG001|Randomized|non-specified|266|||
48436503|NCT00831441|155787439|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
48436504|NCT00831441|155787440|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
48436505|NCT00831441|155787439|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
48436506|NCT00831441|155787440|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
48436507|NCT00831441|155787439|FG000|Follow Up (30 Days)|Death|63|||
48436508|NCT00831441|155787440|FG001|Follow Up (30 Days)|Death|86|||
48436509|NCT00831441|155787439|FG000|Follow Up (30 Days)|non-specified|16|||
48436510|NCT00831441|155787440|FG001|Follow Up (30 Days)|non-specified|26|||
48436511|NCT00831441|155787439|FG000|Follow Up (30 Days)|missing end of study status|0|||
48436512|NCT00831441|155787440|FG001|Follow Up (30 Days)|missing end of study status|1|||
48436513|NCT04348656|155787444|FG000|Overall Study|Withdrawal by Subject|2|||
48436514|NCT04348656|155787445|FG001|Overall Study|Withdrawal by Subject|0|||
48436515|NCT04348656|155787444|FG000|Overall Study|Lost to Follow-up|11|||
48436516|NCT04348656|155787445|FG001|Overall Study|Lost to Follow-up|6|||
48436517|NCT04017442|155787446|FG000|Overall Study|Withdrawal by Subject|0|||
48436518|NCT04017442|155787447|FG001|Overall Study|Withdrawal by Subject|3|||
48436519|NCT04017442|155787446|FG000|Overall Study|Lost to Follow-up|21|||
48436520|NCT04017442|155787447|FG001|Overall Study|Lost to Follow-up|19|||
48436521|NCT00643487|155787448|FG000|Overall Study|Technical difficulty|3|||
48436522|NCT04402008|155787451|FG000|Overall Study|Adverse Event|0|||
48436523|NCT04402008|155787452|FG001|Overall Study|Adverse Event|0|||
48436524|NCT04402008|155787453|FG002|Overall Study|Adverse Event|0|||
48436525|NCT04402008|155787454|FG003|Overall Study|Adverse Event|1|||
48436526|NCT04402008|155787455|FG004|Overall Study|Adverse Event|0|||
48436527|NCT04402008|155787456|FG005|Overall Study|Adverse Event|0|||
48436528|NCT04402008|155787457|FG006|Overall Study|Adverse Event|0|||
48436529|NCT04402008|155787451|FG000|Overall Study|Disease Progression|3|||
48436530|NCT04402008|155787452|FG001|Overall Study|Disease Progression|2|||
48436531|NCT04402008|155787453|FG002|Overall Study|Disease Progression|3|||
48436532|NCT04402008|155787454|FG003|Overall Study|Disease Progression|3|||
48436533|NCT04402008|155787455|FG004|Overall Study|Disease Progression|4|||
48436534|NCT04402008|155787456|FG005|Overall Study|Disease Progression|3|||
48436535|NCT04402008|155787457|FG006|Overall Study|Disease Progression|10|||
48436536|NCT04402008|155787451|FG000|Overall Study|Withdrawal by Subject|0|||
48436537|NCT04402008|155787452|FG001|Overall Study|Withdrawal by Subject|1|||
48436538|NCT04402008|155787453|FG002|Overall Study|Withdrawal by Subject|0|||
48436539|NCT04402008|155787454|FG003|Overall Study|Withdrawal by Subject|0|||
48436540|NCT04402008|155787455|FG004|Overall Study|Withdrawal by Subject|1|||
48436541|NCT04402008|155787456|FG005|Overall Study|Withdrawal by Subject|0|||
48436542|NCT04402008|155787457|FG006|Overall Study|Withdrawal by Subject|0|||
48436543|NCT04402008|155787451|FG000|Overall Study|Sponsor Decision|0|||
48436544|NCT04402008|155787452|FG001|Overall Study|Sponsor Decision|0|||
48436545|NCT04402008|155787453|FG002|Overall Study|Sponsor Decision|0|||
48436546|NCT04402008|155787454|FG003|Overall Study|Sponsor Decision|0|||
48436547|NCT04402008|155787455|FG004|Overall Study|Sponsor Decision|0|||
48436548|NCT04402008|155787456|FG005|Overall Study|Sponsor Decision|0|||
48436549|NCT04402008|155787457|FG006|Overall Study|Sponsor Decision|3|||
48436550|NCT04402008|155787451|FG000|Overall Study|Death|0|||
48436551|NCT04402008|155787452|FG001|Overall Study|Death|0|||
48436552|NCT04402008|155787453|FG002|Overall Study|Death|0|||
48436553|NCT04402008|155787454|FG003|Overall Study|Death|0|||
48436554|NCT04402008|155787455|FG004|Overall Study|Death|1|||
48436555|NCT04402008|155787456|FG005|Overall Study|Death|0|||
48436556|NCT04402008|155787457|FG006|Overall Study|Death|2|||
48436557|NCT04402008|155787451|FG000|Overall Study|Other|0|||
48436558|NCT04402008|155787452|FG001|Overall Study|Other|0|||
48436624|NCT00779324|155787483|FG001|Overall Study|Withdrawal by Subject|2|||
48436625|NCT00779324|155787482|FG000|Overall Study|Missed visit|1|||
48436626|NCT00779324|155787483|FG001|Overall Study|Missed visit|1|||
48436627|NCT04096326|155787484|FG000|Overall Study|Withdrawal by Subject|0|||
48436628|NCT04096326|155787485|FG001|Overall Study|Withdrawal by Subject|0|||
48436629|NCT04096326|155787486|FG002|Overall Study|Withdrawal by Subject|0|||
48436630|NCT04096326|155787487|FG003|Overall Study|Withdrawal by Subject|0|||
48436631|NCT04096326|155787488|FG004|Overall Study|Withdrawal by Subject|0|||
48436632|NCT04096326|155787489|FG005|Overall Study|Withdrawal by Subject|0|||
48436633|NCT04096326|155787490|FG006|Overall Study|Withdrawal by Subject|1|||
48436634|NCT04096326|155787491|FG007|Overall Study|Withdrawal by Subject|0|||
48436635|NCT04096326|155787492|FG008|Overall Study|Withdrawal by Subject|0|||
48436636|NCT04096326|155787493|FG009|Overall Study|Withdrawal by Subject|0|||
48436637|NCT04096326|155787484|FG000|Overall Study|Lost to Follow-up|0|||
48436638|NCT04096326|155787485|FG001|Overall Study|Lost to Follow-up|1|||
48436639|NCT04096326|155787486|FG002|Overall Study|Lost to Follow-up|0|||
48436640|NCT04096326|155787487|FG003|Overall Study|Lost to Follow-up|0|||
48436641|NCT04096326|155787488|FG004|Overall Study|Lost to Follow-up|0|||
48436642|NCT04096326|155787489|FG005|Overall Study|Lost to Follow-up|0|||
48436643|NCT04096326|155787490|FG006|Overall Study|Lost to Follow-up|0|||
48436644|NCT04096326|155787491|FG007|Overall Study|Lost to Follow-up|0|||
48436645|NCT04096326|155787492|FG008|Overall Study|Lost to Follow-up|0|||
48436646|NCT04096326|155787493|FG009|Overall Study|Lost to Follow-up|0|||
48436647|NCT04096326|155787484|FG000|Overall Study|COVID-19-related reasons|0|||
48436648|NCT04096326|155787485|FG001|Overall Study|COVID-19-related reasons|0|||
48436649|NCT04096326|155787486|FG002|Overall Study|COVID-19-related reasons|0|||
48436650|NCT04096326|155787487|FG003|Overall Study|COVID-19-related reasons|0|||
48436651|NCT04096326|155787488|FG004|Overall Study|COVID-19-related reasons|1|||
48436652|NCT04096326|155787489|FG005|Overall Study|COVID-19-related reasons|5|||
48436653|NCT04096326|155787490|FG006|Overall Study|COVID-19-related reasons|0|||
48436654|NCT04096326|155787491|FG007|Overall Study|COVID-19-related reasons|0|||
48436655|NCT04096326|155787492|FG008|Overall Study|COVID-19-related reasons|0|||
48436656|NCT04096326|155787493|FG009|Overall Study|COVID-19-related reasons|0|||
48436657|NCT02124707|155787498|FG000|Overall Study|Adverse Event|5|||
48436658|NCT02124707|155787498|FG000|Overall Study|Physician Decision|1|||
48436659|NCT02124707|155787498|FG000|Overall Study|Death|1|||
48436660|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
48436661|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
48436662|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
48436663|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
48436664|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
48436665|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
48436666|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
48436667|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
48436668|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
48436669|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
48436670|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
48436671|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
48436672|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
48436673|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
48436674|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
48436675|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
48436676|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
48436677|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
48436678|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
48436679|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
48436680|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
48436681|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
48436682|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
48436683|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
48436684|NCT01106625|155787501|FG000|Core Period: Baseline to Week 26|Other|8|||
48436685|NCT01106625|155787502|FG001|Core Period: Baseline to Week 26|Other|7|||
48436686|NCT01106625|155787503|FG002|Core Period: Baseline to Week 26|Other|4|||
48436687|NCT01106625|155787501|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
48436688|NCT01106625|155787502|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
48436689|NCT01106625|155787503|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
48436690|NCT01106625|155787501|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
48436691|NCT01106625|155787502|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
48436692|NCT01106625|155787503|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
48436693|NCT01106625|155787501|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
48436694|NCT01106625|155787502|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
48436695|NCT01106625|155787503|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
48436696|NCT01106625|155787501|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48436697|NCT01106625|155787502|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
48436698|NCT01106625|155787503|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
48436699|NCT01106625|155787501|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
48436700|NCT01106625|155787502|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48436701|NCT01106625|155787503|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
48436702|NCT01106625|155787501|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
48436703|NCT01106625|155787502|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
48436704|NCT01106625|155787503|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
48436705|NCT01106625|155787501|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
48436706|NCT01106625|155787502|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
48436707|NCT01106625|155787503|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
48436708|NCT01106625|155787501|FG000|Extension Period: Week 26 to Week 52|Other|5|||
48436709|NCT01106625|155787502|FG001|Extension Period: Week 26 to Week 52|Other|5|||
48436710|NCT01106625|155787503|FG002|Extension Period: Week 26 to Week 52|Other|4|||
48436711|NCT04397718|155787507|FG000|Overall Study|Death|7|||
48436712|NCT04397718|155787508|FG001|Overall Study|Death|11|||
48436713|NCT04397718|155787507|FG000|Overall Study|Lost to Follow-up|0|||
48436714|NCT04397718|155787508|FG001|Overall Study|Lost to Follow-up|4|||
48436715|NCT00077610|155787509|FG000|Overall Study|Adverse Event|9|||
48436716|NCT00077610|155787510|FG001|Overall Study|Adverse Event|7|||
48436717|NCT00077610|155787511|FG002|Overall Study|Adverse Event|1|||
48436718|NCT00077610|155787509|FG000|Overall Study|Lost to Follow-up|0|||
48436719|NCT00077610|155787510|FG001|Overall Study|Lost to Follow-up|1|||
48436720|NCT00077610|155787511|FG002|Overall Study|Lost to Follow-up|2|||
48436721|NCT00077610|155787509|FG000|Overall Study|Withdrawal by Subject|4|||
48436722|NCT00077610|155787510|FG001|Overall Study|Withdrawal by Subject|10|||
48436723|NCT00077610|155787511|FG002|Overall Study|Withdrawal by Subject|6|||
48436724|NCT00077610|155787509|FG000|Overall Study|Death|17|||
48436725|NCT00077610|155787510|FG001|Overall Study|Death|13|||
48436726|NCT00077610|155787511|FG002|Overall Study|Death|13|||
48436727|NCT00077610|155787509|FG000|Overall Study|Renal transplant|12|||
48436728|NCT00077610|155787510|FG001|Overall Study|Renal transplant|15|||
48436729|NCT00077610|155787511|FG002|Overall Study|Renal transplant|11|||
48436730|NCT00077610|155787509|FG000|Overall Study|Withdrew from dialysis care|5|||
48436731|NCT00077610|155787510|FG001|Overall Study|Withdrew from dialysis care|0|||
48436732|NCT00077610|155787511|FG002|Overall Study|Withdrew from dialysis care|3|||
48436733|NCT00077610|155787509|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48436734|NCT00077610|155787510|FG001|Overall Study|Insufficient Therapeutic Response|0|||
48436735|NCT00077610|155787511|FG002|Overall Study|Insufficient Therapeutic Response|0|||
48436736|NCT00077610|155787509|FG000|Overall Study|Multiple blood transfusions|0|||
48436737|NCT00077610|155787510|FG001|Overall Study|Multiple blood transfusions|0|||
48436738|NCT00077610|155787511|FG002|Overall Study|Multiple blood transfusions|1|||
48436739|NCT00077610|155787509|FG000|Overall Study|Principal Investigator's decision|1|||
48436740|NCT00077610|155787510|FG001|Overall Study|Principal Investigator's decision|0|||
48436741|NCT00077610|155787511|FG002|Overall Study|Principal Investigator's decision|1|||
48436742|NCT00077610|155787509|FG000|Overall Study|Worsening of health condition|1|||
48436743|NCT00077610|155787510|FG001|Overall Study|Worsening of health condition|1|||
48436744|NCT00077610|155787511|FG002|Overall Study|Worsening of health condition|0|||
48436745|NCT00077610|155787509|FG000|Overall Study|Given Epogen in hospital|1|||
48436746|NCT00077610|155787510|FG001|Overall Study|Given Epogen in hospital|0|||
48436747|NCT00077610|155787511|FG002|Overall Study|Given Epogen in hospital|0|||
48436748|NCT00077610|155787509|FG000|Overall Study|Transferred to other unit|0|||
48436749|NCT00077610|155787510|FG001|Overall Study|Transferred to other unit|0|||
48436750|NCT00077610|155787511|FG002|Overall Study|Transferred to other unit|1|||
48436751|NCT00077610|155787509|FG000|Overall Study|Transferred to nursing home|0|||
48436752|NCT00077610|155787510|FG001|Overall Study|Transferred to nursing home|0|||
48436753|NCT00077610|155787511|FG002|Overall Study|Transferred to nursing home|1|||
48436754|NCT00077610|155787509|FG000|Overall Study|Transfer to satellite unit|1|||
48436755|NCT00077610|155787510|FG001|Overall Study|Transfer to satellite unit|0|||
48436756|NCT00077610|155787511|FG002|Overall Study|Transfer to satellite unit|0|||
48436757|NCT00077610|155787509|FG000|Overall Study|Transfer to other center for surgery|1|||
48436758|NCT00077610|155787510|FG001|Overall Study|Transfer to other center for surgery|0|||
48436759|NCT00077610|155787511|FG002|Overall Study|Transfer to other center for surgery|0|||
48436760|NCT00077610|155787509|FG000|Overall Study|Change in dialysis modality|1|||
48436761|NCT00077610|155787510|FG001|Overall Study|Change in dialysis modality|0|||
48436762|NCT00077610|155787511|FG002|Overall Study|Change in dialysis modality|0|||
48436763|NCT00077610|155787509|FG000|Overall Study|Relocation|0|||
48436764|NCT00077610|155787510|FG001|Overall Study|Relocation|8|||
48436765|NCT00077610|155787511|FG002|Overall Study|Relocation|5|||
48436766|NCT00077610|155787509|FG000|Overall Study|Financial issues|0|||
48436767|NCT00077610|155787510|FG001|Overall Study|Financial issues|1|||
48436769|NCT00077610|155787509|FG000|Overall Study|Sponsors decision to withdraw|0|||
48436770|NCT00077610|155787510|FG001|Overall Study|Sponsors decision to withdraw|0|||
48436771|NCT00077610|155787511|FG002|Overall Study|Sponsors decision to withdraw|1|||
48436772|NCT01025817|155787512|FG000|Completed Study Medication|Adverse Event|66|||
48436773|NCT01025817|155787513|FG001|Completed Study Medication|Adverse Event|39|||
48436774|NCT01025817|155787512|FG000|Completed Study Medication|Protocol Deviation|9|||
48436775|NCT01025817|155787513|FG001|Completed Study Medication|Protocol Deviation|8|||
48436776|NCT01025817|155787512|FG000|Completed Study Medication|Withdrawal by Subject|8|||
48436777|NCT01025817|155787513|FG001|Completed Study Medication|Withdrawal by Subject|9|||
48436778|NCT01025817|155787512|FG000|Completed Study Medication|Administrative problems|7|||
48436779|NCT01025817|155787513|FG001|Completed Study Medication|Administrative problems|5|||
48436780|NCT01025817|155787512|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
48436781|NCT01025817|155787513|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
48436782|NCT01025817|155787512|FG000|Completed Study Medication|Abnormal test procedure|4|||
48436783|NCT01025817|155787513|FG001|Completed Study Medication|Abnormal test procedure|0|||
48436784|NCT01025817|155787512|FG000|Completed Study Medication|Graft loss|2|||
48436785|NCT01025817|155787513|FG001|Completed Study Medication|Graft loss|5|||
48436786|NCT01025817|155787512|FG000|Completed Study Medication|Death|2|||
48436787|NCT01025817|155787513|FG001|Completed Study Medication|Death|2|||
48436788|NCT01025817|155787512|FG000|Completed Study Medication|Abnormal lab values|0|||
48436789|NCT01025817|155787513|FG001|Completed Study Medication|Abnormal lab values|2|||
48436790|NCT01025817|155787512|FG000|Completed Study Medication|Subject no longer required study drug|0|||
48436791|NCT01025817|155787513|FG001|Completed Study Medication|Subject no longer required study drug|1|||
48436792|NCT01025817|155787512|FG000|Completed Study Medication|Lost to Follow-up|0|||
48436793|NCT01025817|155787513|FG001|Completed Study Medication|Lost to Follow-up|1|||
48436794|NCT01025817|155787512|FG000|Completed Study|Withdrawal by Subject|8|||
48436795|NCT01025817|155787513|FG001|Completed Study|Withdrawal by Subject|16|||
48436796|NCT01025817|155787512|FG000|Completed Study|Death|6|||
48436797|NCT01025817|155787513|FG001|Completed Study|Death|5|||
48436798|NCT01025817|155787512|FG000|Completed Study|Missing|2|||
48436799|NCT01025817|155787513|FG001|Completed Study|Missing|0|||
48436800|NCT01025817|155787512|FG000|Completed Study|Lost to Follow-up|0|||
48436801|NCT01025817|155787513|FG001|Completed Study|Lost to Follow-up|1|||
48436802|NCT00414960|155787514|FG000|Overall Study|Adverse Event|4|||
48436803|NCT00414960|155787515|FG001|Overall Study|Adverse Event|0|||
48436804|NCT00414960|155787514|FG000|Overall Study|Withdrawal by Subject|3|||
48436805|NCT00414960|155787515|FG001|Overall Study|Withdrawal by Subject|0|||
48436806|NCT00414960|155787514|FG000|Overall Study|Physician Decision|0|||
48436807|NCT00414960|155787515|FG001|Overall Study|Physician Decision|1|||
48436808|NCT01029886|155787521|FG000|Overall Study|Adverse Event|12|||
48436809|NCT01029886|155787522|FG001|Overall Study|Adverse Event|25|||
48436810|NCT01029886|155787521|FG000|Overall Study|Lost to Follow-up|1|||
48436811|NCT01029886|155787522|FG001|Overall Study|Lost to Follow-up|0|||
48436812|NCT01029886|155787521|FG000|Overall Study|Physician Decision|2|||
48436813|NCT01029886|155787522|FG001|Overall Study|Physician Decision|6|||
48436814|NCT01029886|155787521|FG000|Overall Study|Protocol Violation|17|||
48436815|NCT01029886|155787522|FG001|Overall Study|Protocol Violation|5|||
48436816|NCT01029886|155787521|FG000|Overall Study|Withdrawal by Subject|8|||
48436817|NCT01029886|155787522|FG001|Overall Study|Withdrawal by Subject|18|||
48436818|NCT01029886|155787521|FG000|Overall Study|Entry Criteria Not Met|13|||
48436819|NCT01029886|155787522|FG001|Overall Study|Entry Criteria Not Met|5|||
48436820|NCT01029886|155787521|FG000|Overall Study|Sponsor Decision|1|||
48436821|NCT01029886|155787522|FG001|Overall Study|Sponsor Decision|0|||
48436822|NCT01029886|155787521|FG000|Overall Study|Loss Glucose Control|7|||
48436823|NCT01029886|155787522|FG001|Overall Study|Loss Glucose Control|1|||
48436824|NCT01553916|155787523|FG000|Overall Study|Withdrawal by Subject|2|||
48436825|NCT01553916|155787523|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
48436826|NCT03294681|155787524|FG000|Overall Study|Withdrawal by Subject|1|||
48436827|NCT03089216|155787529|FG000|Overall Study|Adverse Event|0|||
48436828|NCT03089216|155787530|FG001|Overall Study|Adverse Event|0|||
48436829|NCT03089216|155787531|FG002|Overall Study|Adverse Event|0|||
48436830|NCT03089216|155787532|FG003|Overall Study|Adverse Event|1|||
48436831|NCT00171314|155787533|FG000|Overall Study|Adverse Event|44|||
48436832|NCT00171314|155787534|FG001|Overall Study|Adverse Event|41|||
48436833|NCT00171314|155787533|FG000|Overall Study|Lack of Efficacy|19|||
48436834|NCT00171314|155787534|FG001|Overall Study|Lack of Efficacy|14|||
48436835|NCT00171314|155787533|FG000|Overall Study|Withdrawal by Subject|9|||
48436836|NCT00171314|155787534|FG001|Overall Study|Withdrawal by Subject|6|||
48436837|NCT00171314|155787533|FG000|Overall Study|Abnormal Test Procedure Results|9|||
48436838|NCT00171314|155787534|FG001|Overall Study|Abnormal Test Procedure Results|3|||
48436839|NCT00171314|155787533|FG000|Overall Study|Protocol Violation|3|||
48436840|NCT00171314|155787534|FG001|Overall Study|Protocol Violation|7|||
48436841|NCT00171314|155787533|FG000|Overall Study|Administrative Problems|4|||
48436842|NCT00171314|155787534|FG001|Overall Study|Administrative Problems|3|||
48436843|NCT00171314|155787533|FG000|Overall Study|Lost to Follow-up|1|||
48436862|NCT04348591|155787543|FG001|Imaging Session (120 Min)|Physician Decision|1|||
48436863|NCT04348591|155787542|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
48436864|NCT04348591|155787543|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
48436865|NCT00622869|155787544|FG000|Overall Study|Subject Withdrew Consent|13|||
48436866|NCT00622869|155787545|FG001|Overall Study|Subject Withdrew Consent|17|||
48436867|NCT00622869|155787546|FG002|Overall Study|Subject Withdrew Consent|11|||
48436868|NCT00622869|155787544|FG000|Overall Study|Administrative Problems|11|||
48436869|NCT00622869|155787545|FG001|Overall Study|Administrative Problems|17|||
48436870|NCT00622869|155787546|FG002|Overall Study|Administrative Problems|13|||
48436871|NCT00622869|155787544|FG000|Overall Study|Death|12|||
48436872|NCT00622869|155787545|FG001|Overall Study|Death|15|||
48436873|NCT00622869|155787546|FG002|Overall Study|Death|10|||
48436874|NCT00622869|155787544|FG000|Overall Study|Lost to Follow-up|2|||
48436875|NCT00622869|155787545|FG001|Overall Study|Lost to Follow-up|4|||
48436876|NCT00622869|155787546|FG002|Overall Study|Lost to Follow-up|2|||
48436877|NCT00622869|155787544|FG000|Overall Study|Graft Loss|5|||
48436878|NCT00622869|155787545|FG001|Overall Study|Graft Loss|3|||
48436879|NCT00622869|155787546|FG002|Overall Study|Graft Loss|2|||
48436880|NCT00622869|155787544|FG000|Overall Study|Missing|0|||
48436881|NCT00622869|155787545|FG001|Overall Study|Missing|1|||
48436882|NCT00622869|155787546|FG002|Overall Study|Missing|1|||
48436883|NCT02509494|155787549|FG000|Overall Study|Lost to Follow-up|8|||
48436884|NCT02509494|155787550|FG001|Overall Study|Lost to Follow-up|47|||
48436885|NCT02509494|155787551|FG002|Overall Study|Lost to Follow-up|19|||
48436886|NCT02509494|155787552|FG003|Overall Study|Lost to Follow-up|6|||
48436887|NCT02509494|155787553|FG004|Overall Study|Lost to Follow-up|3|||
48436888|NCT02509494|155787554|FG005|Overall Study|Lost to Follow-up|3|||
48436889|NCT02509494|155787555|FG006|Overall Study|Lost to Follow-up|1|||
48436890|NCT02509494|155787556|FG007|Overall Study|Lost to Follow-up|3|||
48436891|NCT02509494|155787557|FG008|Overall Study|Lost to Follow-up|1|||
48436892|NCT02509494|155787549|FG000|Overall Study|Physician Decision|2|||
48436893|NCT02509494|155787550|FG001|Overall Study|Physician Decision|1|||
48436894|NCT02509494|155787551|FG002|Overall Study|Physician Decision|0|||
48436895|NCT02509494|155787552|FG003|Overall Study|Physician Decision|0|||
48436896|NCT02509494|155787553|FG004|Overall Study|Physician Decision|0|||
48436897|NCT02509494|155787554|FG005|Overall Study|Physician Decision|0|||
48436898|NCT02509494|155787555|FG006|Overall Study|Physician Decision|0|||
48436899|NCT02509494|155787556|FG007|Overall Study|Physician Decision|0|||
48436900|NCT02509494|155787557|FG008|Overall Study|Physician Decision|0|||
48436901|NCT02509494|155787549|FG000|Overall Study|Withdrawal by Subject|4|||
48436902|NCT02509494|155787550|FG001|Overall Study|Withdrawal by Subject|17|||
48436903|NCT02509494|155787551|FG002|Overall Study|Withdrawal by Subject|7|||
48436904|NCT02509494|155787552|FG003|Overall Study|Withdrawal by Subject|5|||
48436905|NCT02509494|155787553|FG004|Overall Study|Withdrawal by Subject|0|||
48436906|NCT02509494|155787554|FG005|Overall Study|Withdrawal by Subject|6|||
48436907|NCT02509494|155787555|FG006|Overall Study|Withdrawal by Subject|1|||
48436908|NCT02509494|155787556|FG007|Overall Study|Withdrawal by Subject|2|||
48436909|NCT02509494|155787557|FG008|Overall Study|Withdrawal by Subject|1|||
48436910|NCT02509494|155787549|FG000|Overall Study|Death|0|||
48436911|NCT02509494|155787550|FG001|Overall Study|Death|1|||
48436912|NCT02509494|155787551|FG002|Overall Study|Death|0|||
48436913|NCT02509494|155787552|FG003|Overall Study|Death|0|||
48436914|NCT02509494|155787553|FG004|Overall Study|Death|1|||
48436915|NCT02509494|155787554|FG005|Overall Study|Death|0|||
48436916|NCT02509494|155787555|FG006|Overall Study|Death|0|||
48436917|NCT02509494|155787556|FG007|Overall Study|Death|1|||
48436918|NCT02509494|155787557|FG008|Overall Study|Death|0|||
48436919|NCT02509494|155787549|FG000|Overall Study|Other|0|||
48436920|NCT02509494|155787550|FG001|Overall Study|Other|4|||
48436921|NCT02509494|155787551|FG002|Overall Study|Other|5|||
48436922|NCT02509494|155787552|FG003|Overall Study|Other|0|||
48436923|NCT02509494|155787553|FG004|Overall Study|Other|0|||
48436924|NCT02509494|155787554|FG005|Overall Study|Other|0|||
48436925|NCT02509494|155787555|FG006|Overall Study|Other|0|||
48436926|NCT02509494|155787556|FG007|Overall Study|Other|0|||
48436927|NCT02509494|155787557|FG008|Overall Study|Other|0|||
48436928|NCT02509494|155787549|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48436929|NCT02509494|155787550|FG001|Overall Study|Non-Compliance With Study Drug|11|||
48436930|NCT02509494|155787551|FG002|Overall Study|Non-Compliance With Study Drug|7|||
48436931|NCT02509494|155787552|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48436932|NCT02509494|155787553|FG004|Overall Study|Non-Compliance With Study Drug|1|||
48436933|NCT02509494|155787554|FG005|Overall Study|Non-Compliance With Study Drug|2|||
48436934|NCT02509494|155787555|FG006|Overall Study|Non-Compliance With Study Drug|1|||
48436935|NCT02509494|155787556|FG007|Overall Study|Non-Compliance With Study Drug|1|||
48436936|NCT02509494|155787557|FG008|Overall Study|Non-Compliance With Study Drug|0|||
48436937|NCT01778127|155787560|FG000|Overall Study|Lost to Follow-up|5|||
48436938|NCT01778127|155787561|FG001|Overall Study|Lost to Follow-up|1|||
48436939|NCT01778127|155787562|FG002|Overall Study|Lost to Follow-up|2|||
48436940|NCT01778127|155787560|FG000|Overall Study|Withdrawal by Subject|3|||
48436941|NCT01778127|155787561|FG001|Overall Study|Withdrawal by Subject|1|||
48436942|NCT01778127|155787562|FG002|Overall Study|Withdrawal by Subject|4|||
48436943|NCT02104804|155787566|FG000|Overall Study|Did not take study medication|0|||
48436944|NCT02104804|155787567|FG001|Overall Study|Did not take study medication|1|||
48436945|NCT02104804|155787566|FG000|Overall Study|Study specific discontinuation criteria|6|||
48436946|NCT02104804|155787567|FG001|Overall Study|Study specific discontinuation criteria|1|||
48436947|NCT02104804|155787566|FG000|Overall Study|Other listed|2|||
48436948|NCT02104804|155787567|FG001|Overall Study|Other listed|1|||
48436949|NCT02104804|155787566|FG000|Overall Study|Protocol Violation|0|||
48436950|NCT02104804|155787567|FG001|Overall Study|Protocol Violation|1|||
48436951|NCT02104804|155787566|FG000|Overall Study|Adverse Event|4|||
48436952|NCT02104804|155787567|FG001|Overall Study|Adverse Event|3|||
48436953|NCT02104804|155787566|FG000|Overall Study|Withdrawal by Subject|4|||
48436954|NCT02104804|155787567|FG001|Overall Study|Withdrawal by Subject|12|||
48436955|NCT01348425|155787568|FG000|Overall Study|Imaging was not taken.|1|||
48436956|NCT01348425|155787569|FG001|Overall Study|Imaging was not taken.|1|||
48436957|NCT02720016|155787570|FG000|Overall Study|Separation of couple|6|||
48436958|NCT02720016|155787571|FG001|Overall Study|Separation of couple|8|||
48436959|NCT02720016|155787572|FG002|Overall Study|Separation of couple|2|||
48436960|NCT02720016|155787570|FG000|Overall Study|Withdrawal by Subject|6|||
48436961|NCT02720016|155787571|FG001|Overall Study|Withdrawal by Subject|6|||
48436962|NCT02720016|155787572|FG002|Overall Study|Withdrawal by Subject|4|||
48436963|NCT02720016|155787570|FG000|Overall Study|Scheduling issues|2|||
48436964|NCT02720016|155787571|FG001|Overall Study|Scheduling issues|4|||
48436965|NCT02720016|155787572|FG002|Overall Study|Scheduling issues|7|||
48436966|NCT02720016|155787570|FG000|Overall Study|Childcare|2|||
48436967|NCT02720016|155787571|FG001|Overall Study|Childcare|0|||
48436968|NCT02720016|155787572|FG002|Overall Study|Childcare|2|||
48436969|NCT02720016|155787570|FG000|Overall Study|Withdrawal by PI|2|||
48436970|NCT02720016|155787571|FG001|Overall Study|Withdrawal by PI|2|||
48436971|NCT02720016|155787572|FG002|Overall Study|Withdrawal by PI|0|||
48436972|NCT02720016|155787570|FG000|Overall Study|Moved away|2|||
48436973|NCT02720016|155787571|FG001|Overall Study|Moved away|0|||
48436974|NCT02720016|155787572|FG002|Overall Study|Moved away|0|||
48436975|NCT02720016|155787570|FG000|Overall Study|Not Primary Health Concern|0|||
48436976|NCT02720016|155787571|FG001|Overall Study|Not Primary Health Concern|0|||
48436977|NCT02720016|155787572|FG002|Overall Study|Not Primary Health Concern|2|||
48436978|NCT02720016|155787570|FG000|Overall Study|Transportation issues|0|||
48436979|NCT02720016|155787571|FG001|Overall Study|Transportation issues|0|||
48436980|NCT02720016|155787572|FG002|Overall Study|Transportation issues|1|||
48436981|NCT02720016|155787570|FG000|Overall Study|Other|0|||
48436982|NCT02720016|155787571|FG001|Overall Study|Other|0|||
48436983|NCT02720016|155787572|FG002|Overall Study|Other|2|||
48436984|NCT04501679|155787577|FG000|Overall Study|Pregnancy|0|||
48436985|NCT04501679|155787578|FG001|Overall Study|Pregnancy|1|||
48436986|NCT04501679|155787577|FG000|Overall Study|Adverse Event|4|||
48436987|NCT04501679|155787578|FG001|Overall Study|Adverse Event|2|||
48436988|NCT04501679|155787577|FG000|Overall Study|Withdrawal by Subject|2|||
48436989|NCT04501679|155787578|FG001|Overall Study|Withdrawal by Subject|0|||
48436990|NCT04501679|155787577|FG000|Overall Study|Physician Decision|1|||
48436991|NCT04501679|155787578|FG001|Overall Study|Physician Decision|0|||
48436992|NCT04501679|155787577|FG000|Overall Study|Lost to Follow-up|2|||
48436993|NCT04501679|155787578|FG001|Overall Study|Lost to Follow-up|0|||
48436994|NCT02121756|155787583|FG000|Overall Study|Adverse Event|3|||
48436995|NCT02121756|155787584|FG001|Overall Study|Adverse Event|0|||
48436996|NCT02121756|155787583|FG000|Overall Study|Protocol Violation|1|||
48436997|NCT02121756|155787584|FG001|Overall Study|Protocol Violation|1|||
48436998|NCT02121756|155787583|FG000|Overall Study|Physician Decision|2|||
48436999|NCT02121756|155787584|FG001|Overall Study|Physician Decision|1|||
48437000|NCT00751114|155787585|FG000|Overall Study|Adverse Event|2|||
48437001|NCT00751114|155787586|FG001|Overall Study|Adverse Event|4|||
48437002|NCT00751114|155787585|FG000|Overall Study|Protocol Violation|8|||
48437003|NCT00751114|155787586|FG001|Overall Study|Protocol Violation|9|||
48437004|NCT00751114|155787585|FG000|Overall Study|Withdrawal by Subject|9|||
48437005|NCT00751114|155787586|FG001|Overall Study|Withdrawal by Subject|4|||
48437006|NCT00751114|155787585|FG000|Overall Study|Lost to Follow-up|4|||
48437007|NCT00751114|155787586|FG001|Overall Study|Lost to Follow-up|7|||
48437008|NCT00751114|155787585|FG000|Overall Study|Lack of Efficacy|0|||
48437009|NCT00751114|155787586|FG001|Overall Study|Lack of Efficacy|7|||
48437010|NCT00751114|155787585|FG000|Overall Study|Not Treated|13|||
48437011|NCT00751114|155787586|FG001|Overall Study|Not Treated|1|||
48437012|NCT00751114|155787585|FG000|Overall Study|Out of country for 2 months|1|||
48437013|NCT00751114|155787586|FG001|Overall Study|Out of country for 2 months|0|||
48437014|NCT00751114|155787585|FG000|Overall Study|Move to another city|1|||
48437015|NCT00751114|155787586|FG001|Overall Study|Move to another city|0|||
48437016|NCT00953043|155789528|FG000|Overall Study|Withdrawal by Subject|4|||
48437017|NCT00953043|155789529|FG001|Overall Study|Withdrawal by Subject|0|||
48437018|NCT00953043|155789528|FG000|Overall Study|Physician Decision|0|||
48437019|NCT00953043|155789529|FG001|Overall Study|Physician Decision|2|||
48437020|NCT02723604|155789533|FG000|Overall Study|ineligible|1|||
48437021|NCT02723604|155789533|FG000|Overall Study|never received treatment|1|||
48437022|NCT01953328|155789534|FG000|Overall Study|Withdrawal by Subject|0|||
48437023|NCT01953328|155789535|FG001|Overall Study|Withdrawal by Subject|0|||
48437024|NCT01953328|155789536|FG002|Overall Study|Withdrawal by Subject|0|||
48437025|NCT01953328|155789537|FG003|Overall Study|Withdrawal by Subject|0|||
48437026|NCT01953328|155789538|FG004|Overall Study|Withdrawal by Subject|1|||
48437027|NCT01953328|155789539|FG005|Overall Study|Withdrawal by Subject|0|||
48437028|NCT01953328|155789540|FG006|Overall Study|Withdrawal by Subject|0|||
48437029|NCT01953328|155789541|FG007|Overall Study|Withdrawal by Subject|0|||
48437030|NCT01953328|155789534|FG000|Overall Study|Lost to Follow-up|0|||
48437031|NCT01953328|155789535|FG001|Overall Study|Lost to Follow-up|0|||
48437032|NCT01953328|155789536|FG002|Overall Study|Lost to Follow-up|0|||
48437033|NCT01953328|155789537|FG003|Overall Study|Lost to Follow-up|0|||
48437034|NCT01953328|155789538|FG004|Overall Study|Lost to Follow-up|1|||
48437035|NCT01953328|155789539|FG005|Overall Study|Lost to Follow-up|0|||
48437036|NCT01953328|155789540|FG006|Overall Study|Lost to Follow-up|0|||
48437037|NCT01953328|155789541|FG007|Overall Study|Lost to Follow-up|0|||
48437038|NCT00352755|155789542|FG000|Overall Study|Physician Decision|1|||
48437039|NCT00352755|155789542|FG000|Overall Study|Adverse Event|1|||
48437040|NCT00311181|155789543|FG000|Overall Study|Final DFTs were not obtained|96|||
48437041|NCT02429258|155789544|FG000|Overall Study|Withdrawal by Subject|2|||
48437042|NCT02429258|155789545|FG001|Overall Study|Withdrawal by Subject|0|||
48437043|NCT02429258|155789544|FG000|Overall Study|Protocol Violation|0|||
48437044|NCT02429258|155789545|FG001|Overall Study|Protocol Violation|1|||
48437045|NCT03497429|155789547|FG000|Overall Study|Progressive disease|3|||
48437046|NCT03497429|155789548|FG001|Overall Study|Progressive disease|4|||
48437047|NCT03497429|155789547|FG000|Overall Study|Adverse Event|0|||
48437048|NCT03497429|155789548|FG001|Overall Study|Adverse Event|2|||
48437049|NCT00762372|155789549|FG000|Overall Study|Adverse Event|1|||
48437050|NCT00762372|155789550|FG001|Overall Study|Adverse Event|0|||
48437051|NCT00762372|155789551|FG002|Overall Study|Adverse Event|0|||
48437052|NCT03364335|155789552|FG000|Overall Study|Adverse Event|3|||
48437053|NCT03364335|155789553|FG001|Overall Study|Adverse Event|4|||
48437054|NCT03364335|155789554|FG002|Overall Study|Adverse Event|1|||
48437055|NCT03364335|155789555|FG003|Overall Study|Adverse Event|2|||
48437056|NCT03364335|155789556|FG004|Overall Study|Adverse Event|0|||
48437057|NCT03364335|155789552|FG000|Overall Study|Lost to Follow-up|7|||
48437058|NCT03364335|155789553|FG001|Overall Study|Lost to Follow-up|7|||
48437059|NCT03364335|155789554|FG002|Overall Study|Lost to Follow-up|10|||
48437060|NCT03364335|155789555|FG003|Overall Study|Lost to Follow-up|11|||
48437061|NCT03364335|155789556|FG004|Overall Study|Lost to Follow-up|11|||
48437062|NCT00523341|155789557|FG000|Overall Study|Withdrawal by Subject|399|||
48437063|NCT00523341|155789558|FG001|Overall Study|Withdrawal by Subject|427|||
48437064|NCT00523341|155789557|FG000|Overall Study|Other|181|||
48437065|NCT00523341|155789558|FG001|Overall Study|Other|198|||
48437066|NCT00523341|155789557|FG000|Overall Study|Adverse Event|122|||
48437067|NCT00523341|155789558|FG001|Overall Study|Adverse Event|155|||
48437068|NCT00523341|155789557|FG000|Overall Study|Death|101|||
48437069|NCT00523341|155789558|FG001|Overall Study|Death|110|||
48437070|NCT00523341|155789557|FG000|Overall Study|Lost to Follow-up|73|||
48437071|NCT00523341|155789558|FG001|Overall Study|Lost to Follow-up|61|||
48437072|NCT00523341|155789557|FG000|Overall Study|Non-compliance|20|||
48437073|NCT00523341|155789558|FG001|Overall Study|Non-compliance|13|||
48437074|NCT00523341|155789557|FG000|Overall Study|Physician Decision|14|||
48437075|NCT00523341|155789558|FG001|Overall Study|Physician Decision|13|||
48437076|NCT00523341|155789557|FG000|Overall Study|Requirement for Alternative Therapy|4|||
48437077|NCT00523341|155789558|FG001|Overall Study|Requirement for Alternative Therapy|14|||
48437078|NCT00523341|155789557|FG000|Overall Study|Protocol Deviation|6|||
48437079|NCT00523341|155789558|FG001|Overall Study|Protocol Deviation|5|||
48437080|NCT00523341|155789557|FG000|Overall Study|Ineligibility Determined|3|||
48437081|NCT00523341|155789558|FG001|Overall Study|Ineligibility Determined|4|||
48437082|NCT00523341|155789557|FG000|Overall Study|Disease Progression|1|||
48437083|NCT00523341|155789558|FG001|Overall Study|Disease Progression|0|||
48437084|NCT03987919|155789559|FG000|Overall Study|Adverse Event|1|||
48437085|NCT03987919|155789560|FG001|Overall Study|Adverse Event|4|||
48437086|NCT03987919|155789561|FG002|Overall Study|Adverse Event|1|||
48437087|NCT03987919|155789562|FG003|Overall Study|Adverse Event|3|||
48437088|NCT03987919|155789559|FG000|Overall Study|Death|4|||
48437089|NCT03987919|155789560|FG001|Overall Study|Death|4|||
48437090|NCT03987919|155789561|FG002|Overall Study|Death|4|||
48437091|NCT03987919|155789562|FG003|Overall Study|Death|1|||
48437092|NCT03987919|155789559|FG000|Overall Study|Lost to Follow-up|5|||
48437093|NCT03987919|155789560|FG001|Overall Study|Lost to Follow-up|6|||
48437094|NCT03987919|155789561|FG002|Overall Study|Lost to Follow-up|8|||
48437095|NCT03987919|155789562|FG003|Overall Study|Lost to Follow-up|12|||
48437096|NCT03987919|155789559|FG000|Overall Study|Physician Decision|0|||
48437097|NCT03987919|155789560|FG001|Overall Study|Physician Decision|2|||
48437098|NCT03987919|155789561|FG002|Overall Study|Physician Decision|0|||
48437099|NCT03987919|155789562|FG003|Overall Study|Physician Decision|4|||
48437100|NCT03987919|155789559|FG000|Overall Study|Pregnancy|1|||
48437116|NCT03987919|155789559|FG000|Overall Study|Other - as reported by the investigator|1|||
48437117|NCT03987919|155789560|FG001|Overall Study|Other - as reported by the investigator|3|||
48437118|NCT03987919|155789561|FG002|Overall Study|Other - as reported by the investigator|2|||
48437119|NCT03987919|155789562|FG003|Overall Study|Other - as reported by the investigator|0|||
48437120|NCT01194804|155789563|FG000|Overall Study|Withdrawal by Subject|1|||
48437121|NCT00051558|155789564|FG000|Overall Study|Adverse Event|30|||
48437122|NCT00051558|155789565|FG001|Overall Study|Adverse Event|18|||
48437123|NCT00051558|155789564|FG000|Overall Study|Withdrawal by Subject|29|||
48437124|NCT00051558|155789565|FG001|Overall Study|Withdrawal by Subject|42|||
48437125|NCT00051558|155789564|FG000|Overall Study|Death|9|||
48437126|NCT00051558|155789565|FG001|Overall Study|Death|15|||
48437127|NCT00051558|155789564|FG000|Overall Study|Lost to Follow-up|4|||
48437128|NCT00051558|155789565|FG001|Overall Study|Lost to Follow-up|13|||
48437129|NCT00051558|155789564|FG000|Overall Study|Protocol Violation|3|||
48437130|NCT00051558|155789565|FG001|Overall Study|Protocol Violation|4|||
48437131|NCT00051558|155789564|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
48437132|NCT00051558|155789565|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
48437133|NCT00051558|155789564|FG000|Overall Study|Sponsor Decision|6|||
48437134|NCT00051558|155789565|FG001|Overall Study|Sponsor Decision|1|||
48437135|NCT00051558|155789564|FG000|Overall Study|Other|2|||
48437136|NCT00051558|155789565|FG001|Overall Study|Other|1|||
48437137|NCT00051558|155789564|FG000|Overall Study|Significant Lab Value|2|||
48437138|NCT00051558|155789565|FG001|Overall Study|Significant Lab Value|0|||
48437139|NCT00051558|155789564|FG000|Overall Study|Physician Decision|5|||
48437140|NCT00051558|155789565|FG001|Overall Study|Physician Decision|0|||
48437141|NCT02702518|155789571|FG000|Overall Study|Lost to Follow-up|3|||
48437142|NCT02702518|155789572|FG001|Overall Study|Lost to Follow-up|4|||
48437143|NCT00423085|155789573|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
48437144|NCT00423085|155789574|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
48437145|NCT00423085|155789575|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
48437146|NCT00423085|155789576|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
48437147|NCT00423085|155789573|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
48437148|NCT00423085|155789574|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
48437149|NCT00423085|155789575|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
48437150|NCT00423085|155789576|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48437151|NCT00423085|155789573|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
48437152|NCT00423085|155789574|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
48437153|NCT00423085|155789575|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
48437154|NCT00423085|155789576|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
48437155|NCT00423085|155789573|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
48437156|NCT00423085|155789574|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
48437157|NCT00423085|155789575|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
48437158|NCT00423085|155789576|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
48437159|NCT00423085|155789573|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
48437160|NCT00423085|155789574|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
48437161|NCT00423085|155789575|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
48437162|NCT00423085|155789576|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
48437163|NCT00423085|155789573|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
48437164|NCT00423085|155789574|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
48437165|NCT00423085|155789575|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
48437166|NCT00423085|155789576|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
48437167|NCT00423085|155789573|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
48437168|NCT00423085|155789574|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
48437169|NCT00423085|155789575|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
48437170|NCT00423085|155789576|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
48437171|NCT00423085|155789573|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
48437172|NCT00423085|155789574|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
48437173|NCT00423085|155789575|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
48437174|NCT00423085|155789576|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
48437175|NCT00423085|155789573|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
48437176|NCT00423085|155789574|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
48437177|NCT00423085|155789575|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
48437178|NCT00423085|155789576|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
48437179|NCT00423085|155789573|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
48437180|NCT00423085|155789574|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
48437181|NCT00423085|155789575|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
48437182|NCT00423085|155789576|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
48437183|NCT00423085|155789573|FG000|52-Week Open-Label Extension Phase|Death|0|||
48437184|NCT00423085|155789574|FG001|52-Week Open-Label Extension Phase|Death|0|||
48437185|NCT00423085|155789575|FG002|52-Week Open-Label Extension Phase|Death|0|||
48437186|NCT00423085|155789576|FG003|52-Week Open-Label Extension Phase|Death|2|||
48437187|NCT01670656|155789577|FG000|Overall Study|Non-compliance with study drug|0|||
48437188|NCT01670656|155789578|FG001|Overall Study|Non-compliance with study drug|0|||
48437189|NCT01670656|155789579|FG002|Overall Study|Non-compliance with study drug|3|||
48437190|NCT01670656|155789580|FG003|Overall Study|Non-compliance with study drug|0|||
48437191|NCT01670656|155789581|FG004|Overall Study|Non-compliance with study drug|1|||
48437192|NCT01670656|155789577|FG000|Overall Study|Pregnancy|0|||
48437193|NCT01670656|155789578|FG001|Overall Study|Pregnancy|0|||
48437194|NCT01670656|155789579|FG002|Overall Study|Pregnancy|0|||
48437195|NCT01670656|155789580|FG003|Overall Study|Pregnancy|0|||
48437196|NCT01670656|155789581|FG004|Overall Study|Pregnancy|1|||
48437197|NCT01670656|155789577|FG000|Overall Study|Withdrawal by Subject|1|||
48437198|NCT01670656|155789578|FG001|Overall Study|Withdrawal by Subject|1|||
48437199|NCT01670656|155789579|FG002|Overall Study|Withdrawal by Subject|0|||
48437200|NCT01670656|155789580|FG003|Overall Study|Withdrawal by Subject|0|||
48437201|NCT01670656|155789581|FG004|Overall Study|Withdrawal by Subject|0|||
48437202|NCT01670656|155789577|FG000|Overall Study|Non-compliance with protocol|0|||
48437203|NCT01670656|155789578|FG001|Overall Study|Non-compliance with protocol|3|||
48437204|NCT01670656|155789579|FG002|Overall Study|Non-compliance with protocol|1|||
48437205|NCT01670656|155789580|FG003|Overall Study|Non-compliance with protocol|1|||
48437206|NCT01670656|155789581|FG004|Overall Study|Non-compliance with protocol|2|||
48437207|NCT01670656|155789577|FG000|Overall Study|Adverse Event|2|||
48437208|NCT01670656|155789578|FG001|Overall Study|Adverse Event|2|||
48437209|NCT01670656|155789579|FG002|Overall Study|Adverse Event|2|||
48437210|NCT01670656|155789580|FG003|Overall Study|Adverse Event|3|||
48437211|NCT01670656|155789581|FG004|Overall Study|Adverse Event|3|||
48437212|NCT01670656|155789577|FG000|Overall Study|Subject withdrew consent|0|||
48437213|NCT01670656|155789578|FG001|Overall Study|Subject withdrew consent|1|||
48437214|NCT01670656|155789579|FG002|Overall Study|Subject withdrew consent|2|||
48437215|NCT01670656|155789580|FG003|Overall Study|Subject withdrew consent|1|||
48437216|NCT01670656|155789581|FG004|Overall Study|Subject withdrew consent|1|||
48437217|NCT01670656|155789577|FG000|Overall Study|Lost to Follow-up|0|||
48437218|NCT01670656|155789578|FG001|Overall Study|Lost to Follow-up|0|||
48437219|NCT01670656|155789579|FG002|Overall Study|Lost to Follow-up|0|||
48437220|NCT01670656|155789580|FG003|Overall Study|Lost to Follow-up|0|||
48437221|NCT01670656|155789581|FG004|Overall Study|Lost to Follow-up|3|||
48437222|NCT01670656|155789577|FG000|Overall Study|Subject moved|0|||
48437223|NCT01670656|155789578|FG001|Overall Study|Subject moved|0|||
48437224|NCT01670656|155789579|FG002|Overall Study|Subject moved|0|||
48437225|NCT01670656|155789580|FG003|Overall Study|Subject moved|1|||
48437226|NCT01670656|155789581|FG004|Overall Study|Subject moved|0|||
48437227|NCT00165841|155789582|FG000|Overall Study|Adverse Event|2|||
48437228|NCT00165841|155789583|FG001|Overall Study|Adverse Event|3|||
48437229|NCT00165841|155789582|FG000|Overall Study|Lack of Efficacy|6|||
48437230|NCT00165841|155789583|FG001|Overall Study|Lack of Efficacy|33|||
48437231|NCT00165841|155789582|FG000|Overall Study|Lost to Follow-up|4|||
48437232|NCT00165841|155789583|FG001|Overall Study|Lost to Follow-up|4|||
48437233|NCT00165841|155789582|FG000|Overall Study|Withdrawal by Subject|7|||
48437234|NCT00165841|155789583|FG001|Overall Study|Withdrawal by Subject|8|||
48437235|NCT00165841|155789582|FG000|Overall Study|Physician Decision|1|||
48437236|NCT00165841|155789583|FG001|Overall Study|Physician Decision|0|||
48437237|NCT00165841|155789582|FG000|Overall Study|Protocol Violation|6|||
48437238|NCT00165841|155789583|FG001|Overall Study|Protocol Violation|8|||
48437239|NCT00165841|155789582|FG000|Overall Study|Other|3|||
48437240|NCT00165841|155789583|FG001|Overall Study|Other|5|||
48437241|NCT00165841|155789582|FG000|Overall Study|Medication Noncompliance|1|||
48437242|NCT00165841|155789583|FG001|Overall Study|Medication Noncompliance|1|||
48437243|NCT00789958|155789584|FG000|Overall Study|Adverse Event|3|||
48437244|NCT00789958|155789584|FG000|Overall Study|Withdrawal by Subject|4|||
48437245|NCT00789958|155789584|FG000|Overall Study|Progression|3|||
48437246|NCT00789958|155789584|FG000|Overall Study|not protocol specified|1|||
48437247|NCT00789958|155789584|FG000|Overall Study|Not eligible/not analyzable|26|||
48437248|NCT00296725|155789585|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
48437249|NCT00296725|155789585|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
48437250|NCT00296725|155789585|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
48437251|NCT02622724|155789588|FG000|Overall Study|Death|51|||
48437252|NCT02622724|155789589|FG001|Overall Study|Death|53|||
48437253|NCT02622724|155789588|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
48437254|NCT02622724|155789589|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
48437255|NCT02622724|155789588|FG000|Overall Study|Early termination of study|38|||
48437256|NCT02622724|155789589|FG001|Overall Study|Early termination of study|43|||
48437257|NCT00487084|155789590|FG000|Overall Study|Did not receive intervention|4|||
48437258|NCT00487084|155789591|FG001|Overall Study|Did not receive intervention|3|||
48437259|NCT00487084|155789592|FG002|Overall Study|Did not receive intervention|5|||
48437260|NCT00254293|155789593|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48437261|NCT00254293|155789594|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
48437262|NCT00254293|155789595|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48437263|NCT00254293|155789596|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
48437264|NCT00254293|155789597|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48437265|NCT00254293|155789598|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48437266|NCT00254293|155789599|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
48437267|NCT00254293|155789593|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48437268|NCT00254293|155789594|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48437269|NCT00254293|155789595|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
48437270|NCT00254293|155789596|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48437271|NCT00254293|155789597|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48437272|NCT00254293|155789598|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48437273|NCT00254293|155789599|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
48437274|NCT00254293|155789593|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48437275|NCT00254293|155789594|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48437276|NCT00254293|155789595|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
48437277|NCT00254293|155789596|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48437278|NCT00254293|155789597|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48437279|NCT00254293|155789598|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48437280|NCT00254293|155789599|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
48437281|NCT00254293|155789593|FG000|LTE Open Label Variable SC Dosing|Death|0|||
48437282|NCT00254293|155789594|FG001|LTE Open Label Variable SC Dosing|Death|0|||
48437283|NCT00254293|155789595|FG002|LTE Open Label Variable SC Dosing|Death|1|||
48437284|NCT00254293|155789596|FG003|LTE Open Label Variable SC Dosing|Death|0|||
48437285|NCT00254293|155789597|FG004|LTE Open Label Variable SC Dosing|Death|0|||
48437286|NCT00254293|155789598|FG005|LTE Open Label Variable SC Dosing|Death|0|||
48437287|NCT00254293|155789599|FG006|LTE Open Label Variable SC Dosing|Death|0|||
48437288|NCT00254293|155789593|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
48437289|NCT00254293|155789594|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
48437290|NCT00254293|155789595|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
48437291|NCT00254293|155789596|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
48437292|NCT00254293|155789597|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
48437293|NCT00254293|155789598|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
48437294|NCT00254293|155789599|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
48437295|NCT00254293|155789593|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
48437296|NCT00254293|155789594|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
48437297|NCT00254293|155789595|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
48437298|NCT00254293|155789596|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
48437299|NCT00254293|155789597|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
48437300|NCT00254293|155789598|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
48437301|NCT00254293|155789599|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
48437302|NCT00254293|155789593|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48437303|NCT00254293|155789594|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48437304|NCT00254293|155789595|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
48437305|NCT00254293|155789596|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48437306|NCT00254293|155789597|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48437307|NCT00254293|155789598|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48437308|NCT00254293|155789599|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
48437309|NCT00254293|155789593|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48437310|NCT00254293|155789594|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48437311|NCT00254293|155789595|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
48437312|NCT00254293|155789596|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48437313|NCT00254293|155789597|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48437314|NCT00254293|155789598|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48437315|NCT00254293|155789599|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
48437316|NCT00254293|155789593|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48437317|NCT00254293|155789594|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48437318|NCT00254293|155789595|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
48437319|NCT00254293|155789596|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48437320|NCT00254293|155789597|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48437321|NCT00254293|155789598|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48437322|NCT00254293|155789599|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
48437323|NCT00254293|155789593|FG000|LTE Open Label Variable SC Dosing|Other|0|||
48437324|NCT00254293|155789594|FG001|LTE Open Label Variable SC Dosing|Other|0|||
48437325|NCT00254293|155789595|FG002|LTE Open Label Variable SC Dosing|Other|2|||
48437326|NCT00254293|155789596|FG003|LTE Open Label Variable SC Dosing|Other|0|||
48437327|NCT00254293|155789597|FG004|LTE Open Label Variable SC Dosing|Other|0|||
48437328|NCT00254293|155789598|FG005|LTE Open Label Variable SC Dosing|Other|0|||
48437329|NCT00254293|155789599|FG006|LTE Open Label Variable SC Dosing|Other|0|||
48437330|NCT00254293|155789593|FG000|LTE Open Label Fixed Dosing|Death|0|||
48437331|NCT00254293|155789594|FG001|LTE Open Label Fixed Dosing|Death|0|||
48437332|NCT00254293|155789595|FG002|LTE Open Label Fixed Dosing|Death|0|||
48437333|NCT00254293|155789596|FG003|LTE Open Label Fixed Dosing|Death|0|||
48437334|NCT00254293|155789597|FG004|LTE Open Label Fixed Dosing|Death|0|||
48437335|NCT00254293|155789598|FG005|LTE Open Label Fixed Dosing|Death|0|||
48437336|NCT00254293|155789599|FG006|LTE Open Label Fixed Dosing|Death|3|||
48437337|NCT00254293|155789593|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
48437338|NCT00254293|155789594|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
48437339|NCT00254293|155789595|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
48437340|NCT00254293|155789596|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
48437341|NCT00254293|155789597|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
48437342|NCT00254293|155789598|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
48437343|NCT00254293|155789599|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
48437344|NCT00254293|155789593|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48437345|NCT00254293|155789594|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48437346|NCT00254293|155789595|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48437347|NCT00254293|155789596|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48437348|NCT00254293|155789597|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48437349|NCT00254293|155789598|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
48437350|NCT00254293|155789599|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
48437351|NCT00254293|155789593|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48437352|NCT00254293|155789594|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48437353|NCT00254293|155789595|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48437354|NCT00254293|155789596|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48437355|NCT00254293|155789597|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48437356|NCT00254293|155789598|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
48437357|NCT00254293|155789599|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
48437358|NCT00254293|155789593|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48437359|NCT00254293|155789594|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48437360|NCT00254293|155789595|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48437361|NCT00254293|155789596|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48437362|NCT00254293|155789597|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48437363|NCT00254293|155789598|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
48437364|NCT00254293|155789599|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
48437365|NCT00254293|155789593|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48437366|NCT00254293|155789594|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48437367|NCT00254293|155789595|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48437368|NCT00254293|155789596|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48437369|NCT00254293|155789597|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48437370|NCT00254293|155789598|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
48437371|NCT00254293|155789599|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
48437372|NCT00254293|155789593|FG000|LTE Open Label Fixed Dosing|Other|0|||
48437373|NCT00254293|155789594|FG001|LTE Open Label Fixed Dosing|Other|0|||
48437374|NCT00254293|155789595|FG002|LTE Open Label Fixed Dosing|Other|0|||
48437375|NCT00254293|155789596|FG003|LTE Open Label Fixed Dosing|Other|0|||
48437376|NCT00254293|155789597|FG004|LTE Open Label Fixed Dosing|Other|0|||
48437377|NCT00254293|155789598|FG005|LTE Open Label Fixed Dosing|Other|0|||
48437378|NCT00254293|155789599|FG006|LTE Open Label Fixed Dosing|Other|1|||
48437379|NCT02163993|155789600|FG000|Treatment Period|Adverse Event|0|||
48437380|NCT02163993|155789601|FG001|Treatment Period|Adverse Event|1|||
48437381|NCT02163993|155789602|FG002|Treatment Period|Adverse Event|0|||
48437382|NCT02163993|155789603|FG003|Treatment Period|Adverse Event|0|||
48437383|NCT02163993|155789604|FG004|Treatment Period|Adverse Event|1|||
48437384|NCT02163993|155789600|FG000|Treatment Period|Lost to Follow-up|2|||
48437385|NCT02163993|155789601|FG001|Treatment Period|Lost to Follow-up|3|||
48437386|NCT02163993|155789602|FG002|Treatment Period|Lost to Follow-up|1|||
48437387|NCT02163993|155789603|FG003|Treatment Period|Lost to Follow-up|3|||
48437388|NCT02163993|155789604|FG004|Treatment Period|Lost to Follow-up|1|||
48437389|NCT02163993|155789600|FG000|Treatment Period|Physician Decision|1|||
48437390|NCT02163993|155789601|FG001|Treatment Period|Physician Decision|0|||
48437391|NCT02163993|155789602|FG002|Treatment Period|Physician Decision|0|||
48437392|NCT02163993|155789603|FG003|Treatment Period|Physician Decision|0|||
48437393|NCT02163993|155789604|FG004|Treatment Period|Physician Decision|0|||
48437394|NCT02163993|155789600|FG000|Treatment Period|Protocol Violation|2|||
48437395|NCT02163993|155789601|FG001|Treatment Period|Protocol Violation|1|||
48437396|NCT02163993|155789602|FG002|Treatment Period|Protocol Violation|0|||
48437397|NCT02163993|155789603|FG003|Treatment Period|Protocol Violation|1|||
48437398|NCT02163993|155789604|FG004|Treatment Period|Protocol Violation|2|||
48437399|NCT02163993|155789600|FG000|Treatment Period|Withdrawal by Subject|6|||
48437400|NCT02163993|155789601|FG001|Treatment Period|Withdrawal by Subject|4|||
48437401|NCT02163993|155789602|FG002|Treatment Period|Withdrawal by Subject|1|||
48437402|NCT02163993|155789603|FG003|Treatment Period|Withdrawal by Subject|4|||
48437403|NCT02163993|155789604|FG004|Treatment Period|Withdrawal by Subject|1|||
48437404|NCT02163993|155789600|FG000|Treatment Period|Not treated|1|||
48437405|NCT02163993|155789601|FG001|Treatment Period|Not treated|0|||
48437406|NCT02163993|155789602|FG002|Treatment Period|Not treated|0|||
48437407|NCT02163993|155789603|FG003|Treatment Period|Not treated|1|||
48437408|NCT02163993|155789604|FG004|Treatment Period|Not treated|2|||
48437409|NCT02163993|155789600|FG000|Post-treatment Period|Adverse Event|0|||
48437410|NCT02163993|155789601|FG001|Post-treatment Period|Adverse Event|0|||
48437411|NCT02163993|155789602|FG002|Post-treatment Period|Adverse Event|1|||
48437412|NCT02163993|155789603|FG003|Post-treatment Period|Adverse Event|0|||
48437413|NCT02163993|155789604|FG004|Post-treatment Period|Adverse Event|0|||
48437414|NCT02163993|155789600|FG000|Post-treatment Period|Lost to Follow-up|2|||
48437415|NCT02163993|155789601|FG001|Post-treatment Period|Lost to Follow-up|2|||
48437416|NCT02163993|155789602|FG002|Post-treatment Period|Lost to Follow-up|3|||
48437417|NCT02163993|155789603|FG003|Post-treatment Period|Lost to Follow-up|1|||
48437418|NCT02163993|155789604|FG004|Post-treatment Period|Lost to Follow-up|0|||
48437419|NCT02163993|155789600|FG000|Post-treatment Period|Protocol Violation|0|||
48437420|NCT02163993|155789601|FG001|Post-treatment Period|Protocol Violation|0|||
48437421|NCT02163993|155789602|FG002|Post-treatment Period|Protocol Violation|0|||
48437422|NCT02163993|155789603|FG003|Post-treatment Period|Protocol Violation|0|||
48437423|NCT02163993|155789604|FG004|Post-treatment Period|Protocol Violation|1|||
48437424|NCT02163993|155789600|FG000|Post-treatment Period|Withdrawal by Subject|2|||
48437425|NCT02163993|155789601|FG001|Post-treatment Period|Withdrawal by Subject|4|||
48437426|NCT02163993|155789602|FG002|Post-treatment Period|Withdrawal by Subject|0|||
48437427|NCT02163993|155789603|FG003|Post-treatment Period|Withdrawal by Subject|1|||
48437428|NCT02163993|155789604|FG004|Post-treatment Period|Withdrawal by Subject|2|||
48437429|NCT00356863|155789605|FG000|Overall Study|Death|16|||
48437430|NCT00356863|155789606|FG001|Overall Study|Death|32|||
48437431|NCT00356863|155789605|FG000|Overall Study|Lost to Follow-up|76|||
48437432|NCT00356863|155789606|FG001|Overall Study|Lost to Follow-up|43|||
48437433|NCT03583372|155789611|FG000|Overall Study|Withdrawal by Subject|6|||
48437434|NCT03583372|155789612|FG001|Overall Study|Withdrawal by Subject|11|||
48437435|NCT03583372|155789613|FG002|Overall Study|Withdrawal by Subject|7|||
48437436|NCT03583372|155789614|FG003|Overall Study|Withdrawal by Subject|8|||
48437437|NCT03583372|155789611|FG000|Overall Study|Lost to Follow-up|4|||
48437438|NCT03583372|155789612|FG001|Overall Study|Lost to Follow-up|6|||
48437439|NCT03583372|155789613|FG002|Overall Study|Lost to Follow-up|3|||
48437440|NCT03583372|155789614|FG003|Overall Study|Lost to Follow-up|2|||
48437441|NCT03583372|155789611|FG000|Overall Study|Adverse Event|1|||
48437442|NCT03583372|155789612|FG001|Overall Study|Adverse Event|3|||
48437443|NCT03583372|155789613|FG002|Overall Study|Adverse Event|4|||
48437444|NCT03583372|155789614|FG003|Overall Study|Adverse Event|4|||
48437445|NCT03583372|155789611|FG000|Overall Study|Physician Decision|0|||
48437446|NCT03583372|155789612|FG001|Overall Study|Physician Decision|1|||
48437447|NCT03583372|155789613|FG002|Overall Study|Physician Decision|1|||
48437448|NCT03583372|155789614|FG003|Overall Study|Physician Decision|1|||
48437449|NCT03583372|155789611|FG000|Overall Study|Lack of Efficacy|0|||
48437450|NCT03583372|155789612|FG001|Overall Study|Lack of Efficacy|1|||
48437451|NCT03583372|155789613|FG002|Overall Study|Lack of Efficacy|0|||
48437452|NCT03583372|155789614|FG003|Overall Study|Lack of Efficacy|1|||
48437453|NCT03583372|155789611|FG000|Overall Study|Death|1|||
48437454|NCT03583372|155789612|FG001|Overall Study|Death|0|||
48437455|NCT03583372|155789613|FG002|Overall Study|Death|0|||
48437456|NCT03583372|155789614|FG003|Overall Study|Death|0|||
48437457|NCT03583372|155789611|FG000|Overall Study|Protocol Violation|0|||
48437458|NCT03583372|155789612|FG001|Overall Study|Protocol Violation|1|||
48437459|NCT03583372|155789613|FG002|Overall Study|Protocol Violation|0|||
48437460|NCT03583372|155789614|FG003|Overall Study|Protocol Violation|0|||
48437461|NCT03583372|155789611|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
48437462|NCT03583372|155789612|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
48437463|NCT03583372|155789613|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
48437464|NCT03583372|155789614|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
48437465|NCT03583372|155789611|FG000|Overall Study|Did Not Receive Study Drug|0|||
48437466|NCT03583372|155789612|FG001|Overall Study|Did Not Receive Study Drug|1|||
48437467|NCT03583372|155789613|FG002|Overall Study|Did Not Receive Study Drug|0|||
48437468|NCT03583372|155789614|FG003|Overall Study|Did Not Receive Study Drug|0|||
48437469|NCT03583372|155789611|FG000|Overall Study|Captured as Other in the Database|1|||
48437470|NCT03583372|155789612|FG001|Overall Study|Captured as Other in the Database|2|||
48437471|NCT03583372|155789613|FG002|Overall Study|Captured as Other in the Database|4|||
48437472|NCT03583372|155789614|FG003|Overall Study|Captured as Other in the Database|1|||
48437473|NCT02796391|155789615|FG000|Overall Study|Lost to Follow-up|2|||
48437474|NCT02796391|155789616|FG001|Overall Study|Lost to Follow-up|2|||
48437475|NCT02796391|155789617|FG002|Overall Study|Lost to Follow-up|13|||
48437476|NCT02796391|155789618|FG003|Overall Study|Lost to Follow-up|8|||
48437477|NCT02796391|155789619|FG004|Overall Study|Lost to Follow-up|14|||
48437478|NCT02796391|155789620|FG005|Overall Study|Lost to Follow-up|13|||
48437479|NCT02796391|155789615|FG000|Overall Study|COVID|0|||
48437480|NCT02796391|155789616|FG001|Overall Study|COVID|0|||
48437491|NCT02796391|155789615|FG000|Overall Study|Withdrawal by Subject|1|||
48437492|NCT02796391|155789616|FG001|Overall Study|Withdrawal by Subject|1|||
48437493|NCT02796391|155789617|FG002|Overall Study|Withdrawal by Subject|4|||
48437494|NCT02796391|155789618|FG003|Overall Study|Withdrawal by Subject|3|||
48437495|NCT02796391|155789619|FG004|Overall Study|Withdrawal by Subject|4|||
48437496|NCT02796391|155789620|FG005|Overall Study|Withdrawal by Subject|3|||
48437497|NCT02796391|155789615|FG000|Overall Study|Adverse Event|0|||
48437498|NCT02796391|155789616|FG001|Overall Study|Adverse Event|0|||
48437499|NCT02796391|155789617|FG002|Overall Study|Adverse Event|0|||
48437500|NCT02796391|155789618|FG003|Overall Study|Adverse Event|1|||
48437501|NCT02796391|155789619|FG004|Overall Study|Adverse Event|0|||
48437502|NCT02796391|155789620|FG005|Overall Study|Adverse Event|0|||
48437503|NCT02796391|155789615|FG000|Overall Study|Protocol Violation|0|||
48437504|NCT02796391|155789616|FG001|Overall Study|Protocol Violation|0|||
48437505|NCT02796391|155789617|FG002|Overall Study|Protocol Violation|0|||
48437506|NCT02796391|155789618|FG003|Overall Study|Protocol Violation|1|||
48437507|NCT02796391|155789619|FG004|Overall Study|Protocol Violation|0|||
48437508|NCT02796391|155789620|FG005|Overall Study|Protocol Violation|0|||
48437509|NCT02681055|155789621|FG000|Weeks 5-12|Adverse Event|1|||
48437510|NCT02695524|155789622|FG000|Overall Study|Lost to Follow-up|3|||
48437511|NCT02695524|155789623|FG001|Overall Study|Lost to Follow-up|2|||
48437512|NCT02695524|155789622|FG000|Overall Study|Death|0|||
48437513|NCT02695524|155789623|FG001|Overall Study|Death|1|||
48437514|NCT02586233|155789630|FG000|Overall Study|Randomized but did not receive treatment|0|||
48437515|NCT02586233|155789631|FG001|Overall Study|Randomized but did not receive treatment|1|||
48437516|NCT02586233|155789632|FG002|Overall Study|Randomized but did not receive treatment|0|||
48437517|NCT02586233|155789633|FG003|Overall Study|Randomized but did not receive treatment|0|||
48437518|NCT02586233|155789634|FG004|Overall Study|Randomized but did not receive treatment|0|||
48437519|NCT02586233|155789635|FG005|Overall Study|Randomized but did not receive treatment|2|||
48437520|NCT02586233|155789636|FG006|Overall Study|Randomized but did not receive treatment|2|||
48437521|NCT02586233|155789630|FG000|Overall Study|Death|0|||
48437522|NCT02586233|155789631|FG001|Overall Study|Death|1|||
48437523|NCT02586233|155789632|FG002|Overall Study|Death|0|||
48437524|NCT02586233|155789633|FG003|Overall Study|Death|0|||
48437525|NCT02586233|155789634|FG004|Overall Study|Death|2|||
48437526|NCT02586233|155789635|FG005|Overall Study|Death|0|||
48437527|NCT02586233|155789636|FG006|Overall Study|Death|0|||
48437528|NCT00579501|155789639|FG000|Overall Study|Death|1|||
48437529|NCT00579501|155789639|FG000|Overall Study|End of neoadjuvant therapy|25|||
48437530|NCT00579501|155789639|FG000|Overall Study|toxicity|1|||
48437531|NCT00579501|155789639|FG000|Overall Study|Secondary lesion|1|||
48437532|NCT00579501|155789639|FG000|Overall Study|Radiation therapy before surgery|1|||
48437533|NCT02208024|155789640|FG000|Overall Study|Withdrawal by Subject|1|||
48437534|NCT01217190|155789641|FG000|Second Dosing|Withdrawal by Subject|0|||
48437535|NCT01217190|155789642|FG001|Second Dosing|Withdrawal by Subject|2|||
48437536|NCT03558555|155789643|FG000|Overall Study|Lost to Follow-up|2|||
48437537|NCT03558555|155789644|FG001|Overall Study|Lost to Follow-up|1|||
48437538|NCT01658579|155789646|FG000|Treatment Period A|Other|0|||
48437539|NCT01658579|155789647|FG001|Treatment Period A|Other|0|||
48437540|NCT01658579|155789648|FG002|Treatment Period A|Other|1|||
48437541|NCT01658579|155789649|FG003|Treatment Period A|Other|1|||
48437542|NCT01658579|155789646|FG000|Treatment Period A|Adverse Event|1|||
48437543|NCT01658579|155789647|FG001|Treatment Period A|Adverse Event|0|||
48437544|NCT01658579|155789648|FG002|Treatment Period A|Adverse Event|0|||
48437545|NCT01658579|155789649|FG003|Treatment Period A|Adverse Event|0|||
48437546|NCT01658579|155789646|FG000|Treatment Period B|Other|0|||
48437547|NCT01658579|155789647|FG001|Treatment Period B|Other|0|||
48437548|NCT01658579|155789648|FG002|Treatment Period B|Other|0|||
48437549|NCT01658579|155789649|FG003|Treatment Period B|Other|1|||
48437550|NCT00844649|155789655|FG000|Overall Study|Progressive Disease|196|||
48437551|NCT00844649|155789656|FG001|Overall Study|Progressive Disease|245|||
48437552|NCT00844649|155789655|FG000|Overall Study|Adverse Event|128|||
48437553|NCT00844649|155789656|FG001|Overall Study|Adverse Event|73|||
48437554|NCT00844649|155789655|FG000|Overall Study|Physician Decision|25|||
48437555|NCT00844649|155789656|FG001|Overall Study|Physician Decision|18|||
48437556|NCT00844649|155789655|FG000|Overall Study|Protocol Violation|10|||
48437557|NCT00844649|155789656|FG001|Overall Study|Protocol Violation|6|||
48437558|NCT00844649|155789655|FG000|Overall Study|Withdrawal by Subject|28|||
48437559|NCT00844649|155789656|FG001|Overall Study|Withdrawal by Subject|39|||
48437560|NCT00844649|155789655|FG000|Overall Study|Other|7|||
48437561|NCT00844649|155789656|FG001|Overall Study|Other|10|||
48437562|NCT00844649|155789655|FG000|Overall Study|Withdrew prior to starting treatment|11|||
48437563|NCT00844649|155789656|FG001|Overall Study|Withdrew prior to starting treatment|27|||
48437564|NCT00642746|155789658|FG000|Overall Study|Patient unevaluable|1|||
48437565|NCT00642746|155789659|FG001|Overall Study|Patient unevaluable|0|||
48437566|NCT01357915|155789663|FG000|Overall Study|Lost to Follow-up|3|||
48437567|NCT01357915|155789664|FG001|Overall Study|Lost to Follow-up|0|||
48437568|NCT00305253|155789667|FG000|Overall Study|Withdrawal by Subject|0|||
48437569|NCT00305253|155789668|FG001|Overall Study|Withdrawal by Subject|1|||
48437570|NCT01996748|155789674|FG000|Overall Study|Personal reason|1|||
48437590|NCT03288493|155789690|FG004|Overall Study|Withdrawal by Subject|0|||
48437591|NCT03288493|155789691|FG005|Overall Study|Withdrawal by Subject|2|||
48437592|NCT03288493|155789692|FG006|Overall Study|Withdrawal by Subject|0|||
48437593|NCT03288493|155789686|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
48437594|NCT03288493|155789687|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
48437595|NCT03288493|155789688|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
48437596|NCT03288493|155789689|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
48437597|NCT03288493|155789690|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
48437598|NCT03288493|155789691|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
48437599|NCT03288493|155789692|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
48437600|NCT03288493|155789686|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
48437601|NCT03288493|155789687|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
48437602|NCT03288493|155789688|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
48437603|NCT03288493|155789689|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
48437604|NCT03288493|155789690|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
48437605|NCT03288493|155789691|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
48437606|NCT03288493|155789692|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
48437607|NCT03288493|155789686|FG000|Overall Study|Death|2|||
48437608|NCT03288493|155789687|FG001|Overall Study|Death|0|||
48437609|NCT03288493|155789688|FG002|Overall Study|Death|0|||
48437610|NCT03288493|155789689|FG003|Overall Study|Death|0|||
48437611|NCT03288493|155789690|FG004|Overall Study|Death|0|||
48437612|NCT03288493|155789691|FG005|Overall Study|Death|0|||
48437613|NCT03288493|155789692|FG006|Overall Study|Death|0|||
48437614|NCT03288493|155789686|FG000|Overall Study|other reason not listed above|2|||
48437615|NCT03288493|155789687|FG001|Overall Study|other reason not listed above|0|||
48437616|NCT03288493|155789688|FG002|Overall Study|other reason not listed above|0|||
48437617|NCT03288493|155789689|FG003|Overall Study|other reason not listed above|0|||
48437618|NCT03288493|155789690|FG004|Overall Study|other reason not listed above|0|||
48437619|NCT03288493|155789691|FG005|Overall Study|other reason not listed above|0|||
48437620|NCT03288493|155789692|FG006|Overall Study|other reason not listed above|0|||
48437621|NCT00910429|155789693|FG000|Overall Study|Death|18|||
48437622|NCT00910429|155789694|FG001|Overall Study|Death|12|||
48437623|NCT00910429|155789693|FG000|Overall Study|Withdrawal by Subject|3|||
48437624|NCT00910429|155789694|FG001|Overall Study|Withdrawal by Subject|2|||
48437625|NCT00910429|155789693|FG000|Overall Study|Protocol Violation|1|||
48437626|NCT00910429|155789694|FG001|Overall Study|Protocol Violation|0|||
48437627|NCT00910429|155789693|FG000|Overall Study|Lost to Follow-up|2|||
48437628|NCT00910429|155789694|FG001|Overall Study|Lost to Follow-up|1|||
48437629|NCT00910429|155789693|FG000|Overall Study|Adverse Event|10|||
48437630|NCT00910429|155789694|FG001|Overall Study|Adverse Event|5|||
48437631|NCT00910429|155789693|FG000|Overall Study|Drug non-compliance|1|||
48437632|NCT00910429|155789694|FG001|Overall Study|Drug non-compliance|0|||
48437633|NCT00910429|155789693|FG000|Overall Study|Lack of Efficacy|4|||
48437634|NCT00910429|155789694|FG001|Overall Study|Lack of Efficacy|1|||
48437635|NCT01317615|155789697|FG000|Overall Study|Disease progression|25|||
48437636|NCT01317615|155789697|FG000|Overall Study|New cancer therapy|5|||
48437637|NCT01317615|155789697|FG000|Overall Study|Death|6|||
48437638|NCT01317615|155789697|FG000|Overall Study|Withdrawal by Subject|5|||
48437639|NCT01317615|155789697|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48437640|NCT01317615|155789697|FG000|Overall Study|Adverse Event|7|||
48437641|NCT01968954|155789699|FG000|Overall Study|Adverse Event|6|||
48437642|NCT01968954|155789700|FG001|Overall Study|Adverse Event|3|||
48437643|NCT01968954|155789699|FG000|Overall Study|Death|1|||
48437644|NCT01968954|155789700|FG001|Overall Study|Death|2|||
48437645|NCT01968954|155789699|FG000|Overall Study|Lost to Follow-up|6|||
48437646|NCT01968954|155789700|FG001|Overall Study|Lost to Follow-up|4|||
48437647|NCT01968954|155789699|FG000|Overall Study|Withdrawal by Subject|20|||
48437648|NCT01968954|155789700|FG001|Overall Study|Withdrawal by Subject|23|||
48437649|NCT01968954|155789699|FG000|Overall Study|Other|7|||
48437650|NCT01968954|155789700|FG001|Overall Study|Other|8|||
48437651|NCT01968954|155789699|FG000|Overall Study|Protocol Violation|0|||
48437652|NCT01968954|155789700|FG001|Overall Study|Protocol Violation|1|||
48437653|NCT01968954|155789699|FG000|Overall Study|Did not met inclusion criteria|0|||
48437654|NCT01968954|155789700|FG001|Overall Study|Did not met inclusion criteria|2|||
48437655|NCT04191967|155791880|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
48437656|NCT04191967|155791880|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
48437813|NCT01885078|155791919|FG009|Step-down Period|Adverse Event|38|||
48437657|NCT02106455|155791883|FG000|Overall Study|Case Report Form Uncollected|6|||
48437658|NCT02106455|155791883|FG000|Overall Study|Protocol Deviation|2|||
48437659|NCT00853489|155791884|FG000|Overall Study|Lost to Follow-up|5|||
48437660|NCT00853489|155791885|FG001|Overall Study|Lost to Follow-up|2|||
48437661|NCT03331666|155791886|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
48437662|NCT03331666|155791887|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
48437663|NCT02326467|155791888|FG000|Overall Study|Withdrawal by Subject|1|||
48437664|NCT00434512|155791889|FG000|Overall Study|Migrated/moved from study area|0|||
48437665|NCT00434512|155791890|FG001|Overall Study|Migrated/moved from study area|0|||
48437666|NCT00434512|155791891|FG002|Overall Study|Migrated/moved from study area|0|||
48437667|NCT00434512|155791892|FG003|Overall Study|Migrated/moved from study area|1|||
48437668|NCT00434512|155791893|FG004|Overall Study|Migrated/moved from study area|1|||
48437669|NCT00434512|155791894|FG005|Overall Study|Migrated/moved from study area|1|||
48437670|NCT00434512|155791889|FG000|Overall Study|Other|0|||
48437671|NCT00434512|155791890|FG001|Overall Study|Other|1|||
48437672|NCT00434512|155791891|FG002|Overall Study|Other|0|||
48437673|NCT00434512|155791892|FG003|Overall Study|Other|0|||
48437674|NCT00434512|155791893|FG004|Overall Study|Other|0|||
48437675|NCT00434512|155791894|FG005|Overall Study|Other|0|||
48437676|NCT01000727|155791900|FG000|Overall Study|Lost to Follow-up|41|||
48437677|NCT01000727|155791901|FG001|Overall Study|Lost to Follow-up|43|||
48437678|NCT01000727|155791900|FG000|Overall Study|Withdrawal by Subject|111|||
48437679|NCT01000727|155791901|FG001|Overall Study|Withdrawal by Subject|109|||
48437680|NCT01000727|155791900|FG000|Overall Study|Study closed/terminated|23|||
48437681|NCT01000727|155791901|FG001|Overall Study|Study closed/terminated|24|||
48437682|NCT02338492|155791905|FG000|Overall Study|Death|32|||
48437683|NCT02338492|155791905|FG000|Overall Study|Adverse Event|3|||
48437684|NCT02338492|155791905|FG000|Overall Study|Lost to Follow-up|4|||
48437685|NCT02338492|155791905|FG000|Overall Study|Reason not captured above|6|||
48437686|NCT04124692|155791906|FG000|Overall Study|Medical reason|0|||
48437687|NCT04124692|155791907|FG001|Overall Study|Medical reason|1|||
48437688|NCT04124692|155791906|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
48437689|NCT04124692|155791907|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
48437690|NCT04124692|155791906|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
48437691|NCT04124692|155791907|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
48437692|NCT04124692|155791906|FG000|Overall Study|Lost to Follow-up|2|||
48437693|NCT04124692|155791907|FG001|Overall Study|Lost to Follow-up|4|||
48437694|NCT04124692|155791906|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
48437695|NCT04124692|155791907|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
48437696|NCT00756886|155791908|FG000|Overall Study|Lost to Follow-up|1|||
48437697|NCT00756886|155791909|FG001|Overall Study|Lost to Follow-up|0|||
48437698|NCT00756886|155791908|FG000|Overall Study|Adverse Event|0|||
48437699|NCT00756886|155791909|FG001|Overall Study|Adverse Event|3|||
48437700|NCT00756886|155791908|FG000|Overall Study|Lack of Efficacy|1|||
48437701|NCT00756886|155791909|FG001|Overall Study|Lack of Efficacy|0|||
48437702|NCT00756886|155791908|FG000|Overall Study|Ineligible|9|||
48437703|NCT00756886|155791909|FG001|Overall Study|Ineligible|4|||
48437704|NCT01885078|155791910|FG000|Treatment Period|Adverse Event|52|||
48437705|NCT01885078|155791911|FG001|Treatment Period|Adverse Event|136|||
48437706|NCT01885078|155791912|FG002|Treatment Period|Adverse Event|30|||
48437707|NCT01885078|155791913|FG003|Treatment Period|Adverse Event|73|||
48437708|NCT01885078|155791914|FG004|Treatment Period|Adverse Event|17|||
48437709|NCT01885078|155791915|FG005|Treatment Period|Adverse Event|72|||
48437710|NCT01885078|155791916|FG006|Treatment Period|Adverse Event|24|||
48437711|NCT01885078|155791917|FG007|Treatment Period|Adverse Event|5|||
48437712|NCT01885078|155791918|FG008|Treatment Period|Adverse Event|0|||
48437713|NCT01885078|155791919|FG009|Treatment Period|Adverse Event|0|||
48437714|NCT01885078|155791910|FG000|Treatment Period|Death|13|||
48437715|NCT01885078|155791911|FG001|Treatment Period|Death|33|||
48437716|NCT01885078|155791912|FG002|Treatment Period|Death|5|||
48437717|NCT01885078|155791913|FG003|Treatment Period|Death|9|||
48437718|NCT01885078|155791914|FG004|Treatment Period|Death|2|||
48437719|NCT01885078|155791915|FG005|Treatment Period|Death|10|||
48437720|NCT01885078|155791916|FG006|Treatment Period|Death|3|||
48437721|NCT01885078|155791917|FG007|Treatment Period|Death|2|||
48437722|NCT01885078|155791918|FG008|Treatment Period|Death|0|||
48437723|NCT01885078|155791919|FG009|Treatment Period|Death|0|||
48437724|NCT01885078|155791910|FG000|Treatment Period|Lack of Efficacy|12|||
48437725|NCT01885078|155791911|FG001|Treatment Period|Lack of Efficacy|33|||
48437726|NCT01885078|155791912|FG002|Treatment Period|Lack of Efficacy|10|||
48437727|NCT01885078|155791913|FG003|Treatment Period|Lack of Efficacy|23|||
48437728|NCT01885078|155791914|FG004|Treatment Period|Lack of Efficacy|24|||
48437729|NCT01885078|155791915|FG005|Treatment Period|Lack of Efficacy|58|||
48437730|NCT01885078|155791916|FG006|Treatment Period|Lack of Efficacy|9|||
48437731|NCT01885078|155791917|FG007|Treatment Period|Lack of Efficacy|5|||
48437732|NCT01885078|155791918|FG008|Treatment Period|Lack of Efficacy|0|||
48437733|NCT01885078|155791919|FG009|Treatment Period|Lack of Efficacy|0|||
48437734|NCT01885078|155791910|FG000|Treatment Period|Lost to Follow-up|16|||
48437735|NCT01885078|155791911|FG001|Treatment Period|Lost to Follow-up|19|||
48437736|NCT01885078|155791912|FG002|Treatment Period|Lost to Follow-up|7|||
48437737|NCT01885078|155791913|FG003|Treatment Period|Lost to Follow-up|9|||
48437738|NCT01885078|155791914|FG004|Treatment Period|Lost to Follow-up|2|||
48437739|NCT01885078|155791915|FG005|Treatment Period|Lost to Follow-up|8|||
48437740|NCT01885078|155791916|FG006|Treatment Period|Lost to Follow-up|2|||
48437741|NCT01885078|155791917|FG007|Treatment Period|Lost to Follow-up|0|||
48437742|NCT01885078|155791918|FG008|Treatment Period|Lost to Follow-up|0|||
48437743|NCT01885078|155791919|FG009|Treatment Period|Lost to Follow-up|0|||
48437744|NCT01885078|155791910|FG000|Treatment Period|Physician Decision|19|||
48437745|NCT01885078|155791911|FG001|Treatment Period|Physician Decision|21|||
48437746|NCT01885078|155791912|FG002|Treatment Period|Physician Decision|5|||
48437747|NCT01885078|155791913|FG003|Treatment Period|Physician Decision|12|||
48437748|NCT01885078|155791914|FG004|Treatment Period|Physician Decision|9|||
48437749|NCT01885078|155791915|FG005|Treatment Period|Physician Decision|24|||
48437750|NCT01885078|155791916|FG006|Treatment Period|Physician Decision|4|||
48437751|NCT01885078|155791917|FG007|Treatment Period|Physician Decision|3|||
48437752|NCT01885078|155791918|FG008|Treatment Period|Physician Decision|0|||
48437753|NCT01885078|155791919|FG009|Treatment Period|Physician Decision|0|||
48437754|NCT01885078|155791910|FG000|Treatment Period|Protocol Violation|3|||
48437755|NCT01885078|155791911|FG001|Treatment Period|Protocol Violation|5|||
48437756|NCT01885078|155791912|FG002|Treatment Period|Protocol Violation|0|||
48437757|NCT01885078|155791913|FG003|Treatment Period|Protocol Violation|3|||
48437758|NCT01885078|155791914|FG004|Treatment Period|Protocol Violation|1|||
48437759|NCT01885078|155791915|FG005|Treatment Period|Protocol Violation|6|||
48437760|NCT01885078|155791916|FG006|Treatment Period|Protocol Violation|0|||
48437761|NCT01885078|155791917|FG007|Treatment Period|Protocol Violation|0|||
48437762|NCT01885078|155791918|FG008|Treatment Period|Protocol Violation|0|||
48437763|NCT01885078|155791919|FG009|Treatment Period|Protocol Violation|0|||
48437764|NCT01885078|155791910|FG000|Treatment Period|Sponsor Decision|245|||
48437765|NCT01885078|155791911|FG001|Treatment Period|Sponsor Decision|648|||
48437766|NCT01885078|155791912|FG002|Treatment Period|Sponsor Decision|49|||
48437767|NCT01885078|155791913|FG003|Treatment Period|Sponsor Decision|90|||
48437768|NCT01885078|155791914|FG004|Treatment Period|Sponsor Decision|20|||
48437769|NCT01885078|155791915|FG005|Treatment Period|Sponsor Decision|38|||
48437770|NCT01885078|155791916|FG006|Treatment Period|Sponsor Decision|162|||
48437771|NCT01885078|155791917|FG007|Treatment Period|Sponsor Decision|3|||
48437772|NCT01885078|155791918|FG008|Treatment Period|Sponsor Decision|0|||
48437773|NCT01885078|155791919|FG009|Treatment Period|Sponsor Decision|0|||
48437774|NCT01885078|155791910|FG000|Treatment Period|Withdrawal by Subject|72|||
48437775|NCT01885078|155791911|FG001|Treatment Period|Withdrawal by Subject|132|||
48437776|NCT01885078|155791912|FG002|Treatment Period|Withdrawal by Subject|25|||
48437777|NCT01885078|155791913|FG003|Treatment Period|Withdrawal by Subject|63|||
48437778|NCT01885078|155791914|FG004|Treatment Period|Withdrawal by Subject|15|||
48437779|NCT01885078|155791915|FG005|Treatment Period|Withdrawal by Subject|34|||
48437780|NCT01885078|155791916|FG006|Treatment Period|Withdrawal by Subject|17|||
48437781|NCT01885078|155791917|FG007|Treatment Period|Withdrawal by Subject|10|||
48437782|NCT01885078|155791918|FG008|Treatment Period|Withdrawal by Subject|0|||
48437783|NCT01885078|155791919|FG009|Treatment Period|Withdrawal by Subject|0|||
48437784|NCT01885078|155791910|FG000|Treatment Period|Other|0|||
48437785|NCT01885078|155791911|FG001|Treatment Period|Other|0|||
48437786|NCT01885078|155791912|FG002|Treatment Period|Other|0|||
48437787|NCT01885078|155791913|FG003|Treatment Period|Other|1|||
48437788|NCT01885078|155791914|FG004|Treatment Period|Other|0|||
48437789|NCT01885078|155791915|FG005|Treatment Period|Other|0|||
48437790|NCT01885078|155791916|FG006|Treatment Period|Other|0|||
48437791|NCT01885078|155791917|FG007|Treatment Period|Other|0|||
48437792|NCT01885078|155791918|FG008|Treatment Period|Other|0|||
48437793|NCT01885078|155791919|FG009|Treatment Period|Other|0|||
48437794|NCT01885078|155791910|FG000|Step-down Period|Sponsor Decision|0|||
48437795|NCT01885078|155791911|FG001|Step-down Period|Sponsor Decision|0|||
48437796|NCT01885078|155791912|FG002|Step-down Period|Sponsor Decision|0|||
48437797|NCT01885078|155791913|FG003|Step-down Period|Sponsor Decision|0|||
48437798|NCT01885078|155791914|FG004|Step-down Period|Sponsor Decision|0|||
48437799|NCT01885078|155791915|FG005|Step-down Period|Sponsor Decision|0|||
48437800|NCT01885078|155791916|FG006|Step-down Period|Sponsor Decision|0|||
48437801|NCT01885078|155791917|FG007|Step-down Period|Sponsor Decision|0|||
48437802|NCT01885078|155791918|FG008|Step-down Period|Sponsor Decision|1|||
48437803|NCT01885078|155791919|FG009|Step-down Period|Sponsor Decision|1|||
48437804|NCT01885078|155791910|FG000|Step-down Period|Adverse Event|0|||
48437805|NCT01885078|155791911|FG001|Step-down Period|Adverse Event|0|||
48437806|NCT01885078|155791912|FG002|Step-down Period|Adverse Event|0|||
48437807|NCT01885078|155791913|FG003|Step-down Period|Adverse Event|0|||
48437808|NCT01885078|155791914|FG004|Step-down Period|Adverse Event|0|||
48437809|NCT01885078|155791915|FG005|Step-down Period|Adverse Event|0|||
48437810|NCT01885078|155791916|FG006|Step-down Period|Adverse Event|0|||
48437811|NCT01885078|155791917|FG007|Step-down Period|Adverse Event|0|||
48437812|NCT01885078|155791918|FG008|Step-down Period|Adverse Event|29|||
48437814|NCT01885078|155791910|FG000|Step-down Period|Withdrawal by Subject|0|||
48437815|NCT01885078|155791911|FG001|Step-down Period|Withdrawal by Subject|0|||
48437816|NCT01885078|155791912|FG002|Step-down Period|Withdrawal by Subject|0|||
48437817|NCT01885078|155791913|FG003|Step-down Period|Withdrawal by Subject|0|||
48437818|NCT01885078|155791914|FG004|Step-down Period|Withdrawal by Subject|0|||
48437819|NCT01885078|155791915|FG005|Step-down Period|Withdrawal by Subject|0|||
48437820|NCT01885078|155791916|FG006|Step-down Period|Withdrawal by Subject|0|||
48437821|NCT01885078|155791917|FG007|Step-down Period|Withdrawal by Subject|0|||
48437822|NCT01885078|155791918|FG008|Step-down Period|Withdrawal by Subject|25|||
48437823|NCT01885078|155791919|FG009|Step-down Period|Withdrawal by Subject|15|||
48437824|NCT01885078|155791910|FG000|Step-down Period|Physician Decision|0|||
48437825|NCT01885078|155791911|FG001|Step-down Period|Physician Decision|0|||
48437826|NCT01885078|155791912|FG002|Step-down Period|Physician Decision|0|||
48437827|NCT01885078|155791913|FG003|Step-down Period|Physician Decision|0|||
48437828|NCT01885078|155791914|FG004|Step-down Period|Physician Decision|0|||
48437829|NCT01885078|155791915|FG005|Step-down Period|Physician Decision|0|||
48437830|NCT01885078|155791916|FG006|Step-down Period|Physician Decision|0|||
48437831|NCT01885078|155791917|FG007|Step-down Period|Physician Decision|0|||
48437832|NCT01885078|155791918|FG008|Step-down Period|Physician Decision|7|||
48437833|NCT01885078|155791919|FG009|Step-down Period|Physician Decision|2|||
48437834|NCT01885078|155791910|FG000|Step-down Period|Death|0|||
48437835|NCT01885078|155791911|FG001|Step-down Period|Death|0|||
48437836|NCT01885078|155791912|FG002|Step-down Period|Death|0|||
48437837|NCT01885078|155791913|FG003|Step-down Period|Death|0|||
48437838|NCT01885078|155791914|FG004|Step-down Period|Death|0|||
48437839|NCT01885078|155791915|FG005|Step-down Period|Death|0|||
48437840|NCT01885078|155791916|FG006|Step-down Period|Death|0|||
48437841|NCT01885078|155791917|FG007|Step-down Period|Death|0|||
48437842|NCT01885078|155791918|FG008|Step-down Period|Death|4|||
48437843|NCT01885078|155791919|FG009|Step-down Period|Death|3|||
48437844|NCT01885078|155791910|FG000|Step-down Period|Lost to Follow-up|0|||
48437845|NCT01885078|155791911|FG001|Step-down Period|Lost to Follow-up|0|||
48437846|NCT01885078|155791912|FG002|Step-down Period|Lost to Follow-up|0|||
48437847|NCT01885078|155791913|FG003|Step-down Period|Lost to Follow-up|0|||
48437848|NCT01885078|155791914|FG004|Step-down Period|Lost to Follow-up|0|||
48437849|NCT01885078|155791915|FG005|Step-down Period|Lost to Follow-up|0|||
48437850|NCT01885078|155791916|FG006|Step-down Period|Lost to Follow-up|0|||
48437851|NCT01885078|155791917|FG007|Step-down Period|Lost to Follow-up|0|||
48437852|NCT01885078|155791918|FG008|Step-down Period|Lost to Follow-up|1|||
48437853|NCT01885078|155791919|FG009|Step-down Period|Lost to Follow-up|1|||
48437854|NCT01885078|155791910|FG000|Step-down Period|Lack of Efficacy|0|||
48437855|NCT01885078|155791911|FG001|Step-down Period|Lack of Efficacy|0|||
48437856|NCT01885078|155791912|FG002|Step-down Period|Lack of Efficacy|0|||
48437857|NCT01885078|155791913|FG003|Step-down Period|Lack of Efficacy|0|||
48437858|NCT01885078|155791914|FG004|Step-down Period|Lack of Efficacy|0|||
48437859|NCT01885078|155791915|FG005|Step-down Period|Lack of Efficacy|0|||
48437860|NCT01885078|155791916|FG006|Step-down Period|Lack of Efficacy|0|||
48437861|NCT01885078|155791917|FG007|Step-down Period|Lack of Efficacy|0|||
48437862|NCT01885078|155791918|FG008|Step-down Period|Lack of Efficacy|1|||
48437863|NCT01885078|155791919|FG009|Step-down Period|Lack of Efficacy|0|||
48437864|NCT01885078|155791910|FG000|Step-down Period|Protocol Violation|0|||
48437865|NCT01885078|155791911|FG001|Step-down Period|Protocol Violation|0|||
48437866|NCT01885078|155791912|FG002|Step-down Period|Protocol Violation|0|||
48437867|NCT01885078|155791913|FG003|Step-down Period|Protocol Violation|0|||
48437868|NCT01885078|155791914|FG004|Step-down Period|Protocol Violation|0|||
48437869|NCT01885078|155791915|FG005|Step-down Period|Protocol Violation|0|||
48437870|NCT01885078|155791916|FG006|Step-down Period|Protocol Violation|0|||
48437871|NCT01885078|155791917|FG007|Step-down Period|Protocol Violation|0|||
48437872|NCT01885078|155791918|FG008|Step-down Period|Protocol Violation|1|||
48437873|NCT01885078|155791919|FG009|Step-down Period|Protocol Violation|1|||
48437874|NCT00310388|155791920|FG000|Primary Reporting Phase|Adverse Event|101|||
48437875|NCT00310388|155791921|FG001|Primary Reporting Phase|Adverse Event|0|||
48437876|NCT00310388|155791920|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
48437877|NCT00310388|155791921|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
48437878|NCT00310388|155791920|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
48437879|NCT00310388|155791921|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
48437880|NCT00310388|155791920|FG000|Primary Reporting Phase|Protocol Violation|10|||
48437881|NCT00310388|155791921|FG001|Primary Reporting Phase|Protocol Violation|0|||
48437882|NCT00310388|155791920|FG000|Primary Reporting Phase|Pregnancy|3|||
48437883|NCT00310388|155791921|FG001|Primary Reporting Phase|Pregnancy|0|||
48437884|NCT00310388|155791920|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
48437885|NCT00310388|155791921|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
48437886|NCT00310388|155791920|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
48437887|NCT00310388|155791921|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
48437888|NCT00310388|155791920|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
48437889|NCT00310388|155791921|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
48437890|NCT00310388|155791920|FG000|Primary Reporting Phase|Physician Decision|2|||
48437891|NCT00310388|155791921|FG001|Primary Reporting Phase|Physician Decision|0|||
48437892|NCT00310388|155791920|FG000|Primary Reporting Phase|Request of the sponsor|19|||
48437893|NCT00310388|155791921|FG001|Primary Reporting Phase|Request of the sponsor|0|||
48437894|NCT00310388|155791920|FG000|Primary Reporting Phase|Failed to return|8|||
48437895|NCT00310388|155791921|FG001|Primary Reporting Phase|Failed to return|0|||
48437896|NCT00310388|155791920|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
48437897|NCT00310388|155791921|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
48437898|NCT00310388|155791920|FG000|Primary Reporting Phase|Participant request|2|||
48437899|NCT00310388|155791921|FG001|Primary Reporting Phase|Participant request|0|||
48437900|NCT00310388|155791920|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
48437901|NCT00310388|155791921|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
48437902|NCT00310388|155791920|FG000|Primary Reporting Phase|Discontinuation of study|1|||
48437903|NCT00310388|155791921|FG001|Primary Reporting Phase|Discontinuation of study|0|||
48437904|NCT00310388|155791920|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
48437905|NCT00310388|155791921|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
48437906|NCT00310388|155791920|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
48437907|NCT00310388|155791921|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
48437908|NCT00310388|155791920|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
48437909|NCT00310388|155791921|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
48437910|NCT00310388|155791920|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
48437911|NCT00310388|155791921|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
48437912|NCT00310388|155791920|FG000|Primary Reporting Phase|Participant passed away|1|||
48437913|NCT00310388|155791921|FG001|Primary Reporting Phase|Participant passed away|0|||
48437914|NCT00310388|155791920|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
48437915|NCT00310388|155791921|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
48437916|NCT00310388|155791920|FG000|Primary Reporting Phase|Missing|1|||
48437917|NCT00310388|155791921|FG001|Primary Reporting Phase|Missing|0|||
48437918|NCT00310388|155791920|FG000|Primary Reporting Phase|Other|1|||
48437919|NCT00310388|155791921|FG001|Primary Reporting Phase|Other|0|||
48437920|NCT00310388|155791920|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
48437921|NCT00310388|155791921|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
48437922|NCT00310388|155791920|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
48437923|NCT00310388|155791921|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
48437924|NCT00310388|155791920|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
48437925|NCT00310388|155791921|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
48437926|NCT00310388|155791920|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
48437927|NCT00310388|155791921|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
48437928|NCT01894477|155791924|FG000|Overall Study|Protocol Violation|0|||
48437929|NCT01894477|155791925|FG001|Overall Study|Protocol Violation|1|||
48437930|NCT01894477|155791924|FG000|Overall Study|protocol changed due SC changed to cord|0|||
48437931|NCT01894477|155791925|FG001|Overall Study|protocol changed due SC changed to cord|1|||
48437932|NCT00650091|155791926|FG000|Amended Study Design|Withdrawal by Subject|12|||
48437933|NCT00650091|155791927|FG001|Amended Study Design|Withdrawal by Subject|11|||
48437934|NCT00650091|155791928|FG002|Amended Study Design|Withdrawal by Subject|0|||
48437935|NCT00650091|155791926|FG000|Amended Study Design|Physician Decision|5|||
48437936|NCT00650091|155791927|FG001|Amended Study Design|Physician Decision|0|||
48437937|NCT00650091|155791928|FG002|Amended Study Design|Physician Decision|0|||
48437938|NCT00650091|155791926|FG000|Amended Study Design|Adverse Event|1|||
48437939|NCT00650091|155791927|FG001|Amended Study Design|Adverse Event|4|||
48437940|NCT00650091|155791928|FG002|Amended Study Design|Adverse Event|0|||
48437941|NCT00650091|155791926|FG000|Amended Study Design|Lung transplantation|4|||
48437942|NCT00650091|155791927|FG001|Amended Study Design|Lung transplantation|2|||
48437943|NCT00650091|155791928|FG002|Amended Study Design|Lung transplantation|0|||
48437944|NCT00650091|155791926|FG000|Amended Study Design|Other|1|||
48437945|NCT00650091|155791927|FG001|Amended Study Design|Other|3|||
48437946|NCT00650091|155791928|FG002|Amended Study Design|Other|0|||
48437947|NCT02561299|155791929|FG000|Overall Study|Death|2|||
48437948|NCT02561299|155791930|FG001|Overall Study|Death|4|||
48437949|NCT02561299|155791929|FG000|Overall Study|Lost to Follow-up|1|||
48437950|NCT02561299|155791930|FG001|Overall Study|Lost to Follow-up|0|||
48437951|NCT02561299|155791929|FG000|Overall Study|Withdrawal by Subject|2|||
48437952|NCT02561299|155791930|FG001|Overall Study|Withdrawal by Subject|2|||
48437953|NCT00630812|155791931|FG000|Randomisation to First Dose|Adverse Event|1|||
48437954|NCT00630812|155791932|FG001|Randomisation to First Dose|Adverse Event|1|||
48437955|NCT00630812|155791931|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
48437956|NCT00630812|155791932|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
48437957|NCT00630812|155791931|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
48437958|NCT00630812|155791932|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
48437959|NCT00630812|155791931|FG000|Randomisation to First Dose|Protocol Violation|4|||
48438038|NCT03115476|155791949|FG002|LP0084-1369|Death|2|||
48437960|NCT00630812|155791932|FG001|Randomisation to First Dose|Protocol Violation|1|||
48437961|NCT00630812|155791931|FG000|Double Blind Treatment Period|Adverse Event|13|||
48437962|NCT00630812|155791932|FG001|Double Blind Treatment Period|Adverse Event|5|||
48437963|NCT00630812|155791931|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
48437964|NCT00630812|155791932|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
48437965|NCT00630812|155791931|FG000|Double Blind Treatment Period|Physician Decision|2|||
48437966|NCT00630812|155791932|FG001|Double Blind Treatment Period|Physician Decision|1|||
48437967|NCT00630812|155791931|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48437968|NCT00630812|155791932|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48437969|NCT00630812|155791931|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
48437970|NCT00630812|155791932|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
48437971|NCT00630812|155791931|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
48437972|NCT00630812|155791932|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
48437973|NCT00630812|155791931|FG000|Double Blind Treatment Period|Non-compliance|0|||
48437974|NCT00630812|155791932|FG001|Double Blind Treatment Period|Non-compliance|1|||
48437975|NCT00259740|155791933|FG000|Overall Study|Physician Decision|1|||
48437976|NCT00259740|155791934|FG001|Overall Study|Physician Decision|1|||
48437977|NCT00259740|155791933|FG000|Overall Study|Adverse Event|0|||
48437978|NCT00259740|155791934|FG001|Overall Study|Adverse Event|2|||
48437979|NCT00259740|155791933|FG000|Overall Study|Withdrawal by Subject|2|||
48437980|NCT00259740|155791934|FG001|Overall Study|Withdrawal by Subject|6|||
48437981|NCT00259740|155791933|FG000|Overall Study|Death|1|||
48437982|NCT00259740|155791934|FG001|Overall Study|Death|1|||
48437983|NCT00259740|155791933|FG000|Overall Study|Disease progression|19|||
48437984|NCT00259740|155791934|FG001|Overall Study|Disease progression|36|||
48437985|NCT00259740|155791933|FG000|Overall Study|Ongoing|17|||
48437986|NCT00259740|155791934|FG001|Overall Study|Ongoing|3|||
48437987|NCT00259740|155791933|FG000|Overall Study|Other|3|||
48437988|NCT00259740|155791934|FG001|Overall Study|Other|0|||
48437989|NCT00259740|155791933|FG000|Overall Study|Requirement for alternative therapy|0|||
48437990|NCT00259740|155791934|FG001|Overall Study|Requirement for alternative therapy|4|||
48437991|NCT01479374|155791935|FG000|Overall Study|Adverse Event|2|||
48437992|NCT01479374|155791936|FG001|Overall Study|Adverse Event|1|||
48437993|NCT01479374|155791937|FG002|Overall Study|Adverse Event|0|||
48437994|NCT01479374|155791935|FG000|Overall Study|Lost to Follow-up|1|||
48437995|NCT01479374|155791936|FG001|Overall Study|Lost to Follow-up|2|||
48437996|NCT01479374|155791937|FG002|Overall Study|Lost to Follow-up|0|||
48437997|NCT01479374|155791935|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
48437998|NCT01479374|155791936|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
48437999|NCT01479374|155791937|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
48438000|NCT01479374|155791935|FG000|Overall Study|Other|0|||
48438001|NCT01479374|155791936|FG001|Overall Study|Other|4|||
48438002|NCT01479374|155791937|FG002|Overall Study|Other|5|||
48438003|NCT01397448|155791938|FG000|Overall Study|Adverse Event|4|||
48438004|NCT01397448|155791939|FG001|Overall Study|Adverse Event|4|||
48438005|NCT01397448|155791940|FG002|Overall Study|Adverse Event|6|||
48438006|NCT01397448|155791938|FG000|Overall Study|Withdrawal by Subject|4|||
48438007|NCT01397448|155791939|FG001|Overall Study|Withdrawal by Subject|4|||
48438008|NCT01397448|155791940|FG002|Overall Study|Withdrawal by Subject|3|||
48438009|NCT01397448|155791938|FG000|Overall Study|Lack of Efficacy|2|||
48438010|NCT01397448|155791939|FG001|Overall Study|Lack of Efficacy|0|||
48438011|NCT01397448|155791940|FG002|Overall Study|Lack of Efficacy|5|||
48438012|NCT01397448|155791938|FG000|Overall Study|Other|8|||
48438013|NCT01397448|155791939|FG001|Overall Study|Other|7|||
48438014|NCT01397448|155791940|FG002|Overall Study|Other|4|||
48438015|NCT00973921|155791942|FG000|Overall Study|IVUS results were not available|9|||
48438016|NCT05086289|155791943|FG000|Overall Study|Adverse Event|4|||
48438017|NCT05086289|155791944|FG001|Overall Study|Adverse Event|2|||
48438018|NCT05086289|155791943|FG000|Overall Study|Lost to Follow-up|2|||
48438019|NCT05086289|155791944|FG001|Overall Study|Lost to Follow-up|0|||
48438020|NCT05086289|155791943|FG000|Overall Study|Non-compliance with study drug|2|||
48438021|NCT05086289|155791944|FG001|Overall Study|Non-compliance with study drug|1|||
48438022|NCT05086289|155791943|FG000|Overall Study|Physician Decision|2|||
48438023|NCT05086289|155791944|FG001|Overall Study|Physician Decision|0|||
48438024|NCT05086289|155791943|FG000|Overall Study|Withdrawal by Subject|5|||
48438025|NCT05086289|155791944|FG001|Overall Study|Withdrawal by Subject|2|||
48438026|NCT00229203|155791945|FG000|Overall Study|Progressive disease|18|||
48438027|NCT00229203|155791946|FG001|Overall Study|Progressive disease|9|||
48438028|NCT00229203|155791945|FG000|Overall Study|Toxicity|6|||
48438029|NCT00229203|155791946|FG001|Overall Study|Toxicity|1|||
48438030|NCT00229203|155791945|FG000|Overall Study|Death|4|||
48438031|NCT00229203|155791946|FG001|Overall Study|Death|2|||
48438032|NCT00229203|155791945|FG000|Overall Study|Other|3|||
48438033|NCT00229203|155791946|FG001|Overall Study|Other|3|||
48438034|NCT00229203|155791945|FG000|Overall Study|Withdrawal by Subject|1|||
48438035|NCT00229203|155791946|FG001|Overall Study|Withdrawal by Subject|4|||
48438036|NCT03115476|155791947|FG000|LP0084-1369|Death|1|||
48438037|NCT03115476|155791948|FG001|LP0084-1369|Death|0|||
48438039|NCT03115476|155791947|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
48438040|NCT03115476|155791948|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
48438041|NCT03115476|155791949|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
48438042|NCT00488592|155791957|FG000|Overall Study|Withdrawal by Subject|1|||
48438043|NCT00488592|155791957|FG000|Overall Study|Disease progression|1|||
48438044|NCT00488592|155791957|FG000|Overall Study|Enrolled but not treated|1|||
48438045|NCT02785952|155791958|FG000|Overall Study|Adverse Event|31|||
48438046|NCT02785952|155791959|FG001|Overall Study|Adverse Event|19|||
48438047|NCT02785952|155791958|FG000|Overall Study|Refusal unrelated to adverse events|10|||
48438048|NCT02785952|155791959|FG001|Overall Study|Refusal unrelated to adverse events|5|||
48438049|NCT02785952|155791958|FG000|Overall Study|Disease progression/relapse|61|||
48438050|NCT02785952|155791959|FG001|Overall Study|Disease progression/relapse|89|||
48438051|NCT02785952|155791958|FG000|Overall Study|Death|11|||
48438052|NCT02785952|155791959|FG001|Overall Study|Death|7|||
48438053|NCT02785952|155791958|FG000|Overall Study|Other- not protocol specified|6|||
48438054|NCT02785952|155791959|FG001|Overall Study|Other- not protocol specified|4|||
48438055|NCT02785952|155791958|FG000|Overall Study|On protocol treatment|6|||
48438056|NCT02785952|155791959|FG001|Overall Study|On protocol treatment|3|||
48438057|NCT01324622|155791960|FG000|Overall Study|Lost to Follow-up|7|||
48438058|NCT01324622|155791961|FG001|Overall Study|Lost to Follow-up|7|||
48438059|NCT01324622|155791960|FG000|Overall Study|Death|1|||
48438060|NCT01324622|155791961|FG001|Overall Study|Death|0|||
48438061|NCT01324622|155791960|FG000|Overall Study|Lack of Efficacy|1|||
48438062|NCT01324622|155791961|FG001|Overall Study|Lack of Efficacy|0|||
48438063|NCT02358369|155791964|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
48438064|NCT02358369|155791965|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
48438065|NCT02358369|155791966|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
48438066|NCT02358369|155791967|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
48438067|NCT02358369|155791968|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
48438068|NCT02358369|155791964|FG000|Treatment Period A/B|Adverse Event|0|||
48438069|NCT02358369|155791965|FG001|Treatment Period A/B|Adverse Event|0|||
48438070|NCT02358369|155791966|FG002|Treatment Period A/B|Adverse Event|1|||
48438071|NCT02358369|155791967|FG003|Treatment Period A/B|Adverse Event|2|||
48438072|NCT02358369|155791968|FG004|Treatment Period A/B|Adverse Event|0|||
48438073|NCT02358369|155791964|FG000|Treatment Period A/B|Death|0|||
48438074|NCT02358369|155791965|FG001|Treatment Period A/B|Death|0|||
48438075|NCT02358369|155791966|FG002|Treatment Period A/B|Death|1|||
48438076|NCT02358369|155791967|FG003|Treatment Period A/B|Death|0|||
48438077|NCT02358369|155791968|FG004|Treatment Period A/B|Death|0|||
48438078|NCT02358369|155791964|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
48438079|NCT02358369|155791965|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
48438080|NCT02358369|155791966|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
48438081|NCT02358369|155791967|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
48438082|NCT02358369|155791968|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
48438083|NCT02358369|155791964|FG000|Treatment Period C|Adverse Event|0|||
48438084|NCT02358369|155791965|FG001|Treatment Period C|Adverse Event|0|||
48438085|NCT02358369|155791966|FG002|Treatment Period C|Adverse Event|0|||
48438086|NCT02358369|155791967|FG003|Treatment Period C|Adverse Event|0|||
48438087|NCT02358369|155791968|FG004|Treatment Period C|Adverse Event|7|||
48438088|NCT00755846|155791969|FG000|Overall Study|Adverse Event|0|||
48438089|NCT00755846|155791970|FG001|Overall Study|Adverse Event|0|||
48438090|NCT00755846|155791971|FG002|Overall Study|Adverse Event|0|||
48438091|NCT00755846|155791972|FG003|Overall Study|Adverse Event|1|||
48438092|NCT00755846|155791973|FG004|Overall Study|Adverse Event|3|||
48438093|NCT00755846|155791974|FG005|Overall Study|Adverse Event|2|||
48438094|NCT00755846|155791969|FG000|Overall Study|Protocol Violation|1|||
48438095|NCT00755846|155791970|FG001|Overall Study|Protocol Violation|1|||
48438096|NCT00755846|155791971|FG002|Overall Study|Protocol Violation|1|||
48438097|NCT00755846|155791972|FG003|Overall Study|Protocol Violation|1|||
48438098|NCT00755846|155791973|FG004|Overall Study|Protocol Violation|1|||
48438099|NCT00755846|155791974|FG005|Overall Study|Protocol Violation|1|||
48438100|NCT00755846|155791969|FG000|Overall Study|Lost to Follow-up|0|||
48438101|NCT00755846|155791970|FG001|Overall Study|Lost to Follow-up|2|||
48438102|NCT00755846|155791971|FG002|Overall Study|Lost to Follow-up|1|||
48438103|NCT00755846|155791972|FG003|Overall Study|Lost to Follow-up|0|||
48438104|NCT00755846|155791973|FG004|Overall Study|Lost to Follow-up|4|||
48438105|NCT00755846|155791974|FG005|Overall Study|Lost to Follow-up|2|||
48438106|NCT00755846|155791969|FG000|Overall Study|Withdrawal by Subject|2|||
48438107|NCT00755846|155791970|FG001|Overall Study|Withdrawal by Subject|3|||
48438108|NCT00755846|155791971|FG002|Overall Study|Withdrawal by Subject|5|||
48438109|NCT00755846|155791972|FG003|Overall Study|Withdrawal by Subject|2|||
48438110|NCT00755846|155791973|FG004|Overall Study|Withdrawal by Subject|0|||
48438111|NCT00755846|155791974|FG005|Overall Study|Withdrawal by Subject|1|||
48438112|NCT00755846|155791969|FG000|Overall Study|Hyperglycemic Rescue|21|||
48438113|NCT00755846|155791970|FG001|Overall Study|Hyperglycemic Rescue|7|||
48438114|NCT00755846|155791971|FG002|Overall Study|Hyperglycemic Rescue|5|||
48438115|NCT00755846|155791972|FG003|Overall Study|Hyperglycemic Rescue|8|||
48438116|NCT00755846|155791973|FG004|Overall Study|Hyperglycemic Rescue|8|||
48438117|NCT00755846|155791974|FG005|Overall Study|Hyperglycemic Rescue|7|||
48438118|NCT00755846|155791969|FG000|Overall Study|Physician Decision|1|||
48438119|NCT00755846|155791970|FG001|Overall Study|Physician Decision|3|||
48438120|NCT00755846|155791971|FG002|Overall Study|Physician Decision|0|||
48438121|NCT00755846|155791972|FG003|Overall Study|Physician Decision|1|||
48438122|NCT00755846|155791973|FG004|Overall Study|Physician Decision|0|||
48438123|NCT00755846|155791974|FG005|Overall Study|Physician Decision|1|||
48438124|NCT00755846|155791969|FG000|Overall Study|Administrative Error|0|||
48438125|NCT00755846|155791970|FG001|Overall Study|Administrative Error|1|||
48438126|NCT00755846|155791971|FG002|Overall Study|Administrative Error|0|||
48438127|NCT00755846|155791972|FG003|Overall Study|Administrative Error|0|||
48438128|NCT00755846|155791973|FG004|Overall Study|Administrative Error|0|||
48438129|NCT00755846|155791974|FG005|Overall Study|Administrative Error|0|||
48438130|NCT00755846|155791969|FG000|Overall Study|Participant Non-compliance|0|||
48438131|NCT00755846|155791970|FG001|Overall Study|Participant Non-compliance|0|||
48438132|NCT00755846|155791971|FG002|Overall Study|Participant Non-compliance|0|||
48438133|NCT00755846|155791972|FG003|Overall Study|Participant Non-compliance|0|||
48438134|NCT00755846|155791973|FG004|Overall Study|Participant Non-compliance|1|||
48438135|NCT00755846|155791974|FG005|Overall Study|Participant Non-compliance|0|||
48438136|NCT01431144|155791975|FG000|Overall Study|Implant mobility and removal|2|||
48438137|NCT01431144|155791976|FG001|Overall Study|Implant mobility and removal|0|||
48438138|NCT00645567|155791977|FG000|Overall Study|Adverse Event|1|||
48438139|NCT01021852|155791978|FG000|Treatment Period 1|Adverse Event|3|||
48438140|NCT01021852|155791979|FG001|Treatment Period 1|Adverse Event|1|||
48438141|NCT01021852|155791980|FG002|Treatment Period 1|Adverse Event|1|||
48438142|NCT01021852|155791981|FG003|Treatment Period 1|Adverse Event|0|||
48438143|NCT01021852|155791982|FG004|Treatment Period 1|Adverse Event|2|||
48438144|NCT01021852|155791983|FG005|Treatment Period 1|Adverse Event|2|||
48438145|NCT01021852|155791984|FG006|Treatment Period 1|Adverse Event|0|||
48438146|NCT01021852|155791985|FG007|Treatment Period 1|Adverse Event|0|||
48438147|NCT01021852|155791978|FG000|Treatment Period 1|Pregnancy|0|||
48438148|NCT01021852|155791979|FG001|Treatment Period 1|Pregnancy|0|||
48438149|NCT01021852|155791980|FG002|Treatment Period 1|Pregnancy|1|||
48438150|NCT01021852|155791981|FG003|Treatment Period 1|Pregnancy|0|||
48438151|NCT01021852|155791982|FG004|Treatment Period 1|Pregnancy|0|||
48438152|NCT01021852|155791983|FG005|Treatment Period 1|Pregnancy|0|||
48438153|NCT01021852|155791984|FG006|Treatment Period 1|Pregnancy|0|||
48438154|NCT01021852|155791985|FG007|Treatment Period 1|Pregnancy|0|||
48438155|NCT01021852|155791978|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48438156|NCT01021852|155791979|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48438157|NCT01021852|155791980|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48438158|NCT01021852|155791981|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48438159|NCT01021852|155791982|FG004|Treatment Period 1|Withdrawal by Subject|1|||
48438160|NCT01021852|155791983|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48438161|NCT01021852|155791984|FG006|Treatment Period 1|Withdrawal by Subject|0|||
48438162|NCT01021852|155791985|FG007|Treatment Period 1|Withdrawal by Subject|1|||
48438163|NCT01021852|155791978|FG000|Treatment Period 1|Not Treated|0|||
48438164|NCT01021852|155791979|FG001|Treatment Period 1|Not Treated|0|||
48438165|NCT01021852|155791980|FG002|Treatment Period 1|Not Treated|0|||
48438166|NCT01021852|155791981|FG003|Treatment Period 1|Not Treated|2|||
48438167|NCT01021852|155791982|FG004|Treatment Period 1|Not Treated|0|||
48438168|NCT01021852|155791983|FG005|Treatment Period 1|Not Treated|0|||
48438169|NCT01021852|155791984|FG006|Treatment Period 1|Not Treated|0|||
48438170|NCT01021852|155791985|FG007|Treatment Period 1|Not Treated|0|||
48438171|NCT01021852|155791978|FG000|Washout Period-Placebo|Adverse Event|0|||
48438172|NCT01021852|155791979|FG001|Washout Period-Placebo|Adverse Event|0|||
48438173|NCT01021852|155791980|FG002|Washout Period-Placebo|Adverse Event|0|||
48438174|NCT01021852|155791981|FG003|Washout Period-Placebo|Adverse Event|1|||
48438175|NCT01021852|155791982|FG004|Washout Period-Placebo|Adverse Event|0|||
48438176|NCT01021852|155791983|FG005|Washout Period-Placebo|Adverse Event|1|||
48438177|NCT01021852|155791984|FG006|Washout Period-Placebo|Adverse Event|0|||
48438178|NCT01021852|155791985|FG007|Washout Period-Placebo|Adverse Event|0|||
48438179|NCT01021852|155791978|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
48438180|NCT01021852|155791979|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
48438181|NCT01021852|155791980|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
48438182|NCT01021852|155791981|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
48438183|NCT01021852|155791982|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
48438184|NCT01021852|155791983|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
48438185|NCT01021852|155791984|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
48438186|NCT01021852|155791985|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
48438187|NCT01021852|155791978|FG000|Washout Period-Placebo|Protocol Violation|0|||
48438188|NCT01021852|155791979|FG001|Washout Period-Placebo|Protocol Violation|0|||
48438189|NCT01021852|155791980|FG002|Washout Period-Placebo|Protocol Violation|0|||
48438190|NCT01021852|155791981|FG003|Washout Period-Placebo|Protocol Violation|0|||
48438191|NCT01021852|155791982|FG004|Washout Period-Placebo|Protocol Violation|0|||
48438192|NCT01021852|155791983|FG005|Washout Period-Placebo|Protocol Violation|0|||
48438193|NCT01021852|155791984|FG006|Washout Period-Placebo|Protocol Violation|1|||
48438194|NCT01021852|155791985|FG007|Washout Period-Placebo|Protocol Violation|0|||
48438195|NCT01021852|155791978|FG000|Washout Period-No Drug|Adverse Event|1|||
48438196|NCT01021852|155791979|FG001|Washout Period-No Drug|Adverse Event|0|||
48438197|NCT01021852|155791980|FG002|Washout Period-No Drug|Adverse Event|0|||
48438198|NCT01021852|155791981|FG003|Washout Period-No Drug|Adverse Event|0|||
48438199|NCT01021852|155791982|FG004|Washout Period-No Drug|Adverse Event|0|||
48438200|NCT01021852|155791983|FG005|Washout Period-No Drug|Adverse Event|1|||
48438201|NCT01021852|155791984|FG006|Washout Period-No Drug|Adverse Event|0|||
48438202|NCT01021852|155791985|FG007|Washout Period-No Drug|Adverse Event|0|||
48438203|NCT01021852|155791978|FG000|Treatment Period 2|Adverse Event|0|||
48438204|NCT01021852|155791979|FG001|Treatment Period 2|Adverse Event|1|||
48438205|NCT01021852|155791980|FG002|Treatment Period 2|Adverse Event|0|||
48438206|NCT01021852|155791981|FG003|Treatment Period 2|Adverse Event|0|||
48438207|NCT01021852|155791982|FG004|Treatment Period 2|Adverse Event|1|||
48438208|NCT01021852|155791983|FG005|Treatment Period 2|Adverse Event|0|||
48438209|NCT01021852|155791984|FG006|Treatment Period 2|Adverse Event|1|||
48438210|NCT01021852|155791985|FG007|Treatment Period 2|Adverse Event|0|||
48438211|NCT01021852|155791978|FG000|Treatment Period 2|Lack of Efficacy|0|||
48438212|NCT01021852|155791979|FG001|Treatment Period 2|Lack of Efficacy|0|||
48438213|NCT01021852|155791980|FG002|Treatment Period 2|Lack of Efficacy|0|||
48438214|NCT01021852|155791981|FG003|Treatment Period 2|Lack of Efficacy|0|||
48438215|NCT01021852|155791982|FG004|Treatment Period 2|Lack of Efficacy|0|||
48438216|NCT01021852|155791983|FG005|Treatment Period 2|Lack of Efficacy|1|||
48438217|NCT01021852|155791984|FG006|Treatment Period 2|Lack of Efficacy|0|||
48438218|NCT01021852|155791985|FG007|Treatment Period 2|Lack of Efficacy|0|||
48438219|NCT01021852|155791978|FG000|Treatment Period 2|Physician Decision|0|||
48438220|NCT01021852|155791979|FG001|Treatment Period 2|Physician Decision|0|||
48438221|NCT01021852|155791980|FG002|Treatment Period 2|Physician Decision|1|||
48438222|NCT01021852|155791981|FG003|Treatment Period 2|Physician Decision|0|||
48438223|NCT01021852|155791982|FG004|Treatment Period 2|Physician Decision|0|||
48438224|NCT01021852|155791983|FG005|Treatment Period 2|Physician Decision|0|||
48438225|NCT01021852|155791984|FG006|Treatment Period 2|Physician Decision|0|||
48438226|NCT01021852|155791985|FG007|Treatment Period 2|Physician Decision|0|||
48438227|NCT01021852|155791978|FG000|Treatment Period 2|Protocol Violation|0|||
48438228|NCT01021852|155791979|FG001|Treatment Period 2|Protocol Violation|0|||
48438229|NCT01021852|155791980|FG002|Treatment Period 2|Protocol Violation|0|||
48438230|NCT01021852|155791981|FG003|Treatment Period 2|Protocol Violation|0|||
48438231|NCT01021852|155791982|FG004|Treatment Period 2|Protocol Violation|1|||
48438232|NCT01021852|155791983|FG005|Treatment Period 2|Protocol Violation|0|||
48438233|NCT01021852|155791984|FG006|Treatment Period 2|Protocol Violation|1|||
48438234|NCT01021852|155791985|FG007|Treatment Period 2|Protocol Violation|0|||
48438235|NCT01021852|155791978|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48438236|NCT01021852|155791979|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48438237|NCT01021852|155791980|FG002|Treatment Period 2|Withdrawal by Subject|0|||
48438238|NCT01021852|155791981|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48438239|NCT01021852|155791982|FG004|Treatment Period 2|Withdrawal by Subject|0|||
48438240|NCT01021852|155791983|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48438241|NCT01021852|155791984|FG006|Treatment Period 2|Withdrawal by Subject|1|||
48438242|NCT01021852|155791985|FG007|Treatment Period 2|Withdrawal by Subject|2|||
48438243|NCT01441115|155791992|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
48438244|NCT00434122|155791994|FG000|Overall Study|Non-compliance with protocol|0|||
48438245|NCT00434122|155791995|FG001|Overall Study|Non-compliance with protocol|1|||
48438246|NCT00434122|155791994|FG000|Overall Study|loss of subject contact|1|||
48438247|NCT00434122|155791995|FG001|Overall Study|loss of subject contact|1|||
48438248|NCT00434122|155791994|FG000|Overall Study|Personal reasons|1|||
48438249|NCT00434122|155791995|FG001|Overall Study|Personal reasons|1|||
48438250|NCT00434122|155791994|FG000|Overall Study|Large follicle size|2|||
48438251|NCT00434122|155791995|FG001|Overall Study|Large follicle size|2|||
48438252|NCT00434122|155791994|FG000|Overall Study|Low follicular response.|1|||
48438253|NCT00434122|155791995|FG001|Overall Study|Low follicular response.|2|||
48438254|NCT00434122|155791994|FG000|Overall Study|Travelling of subject.|1|||
48438255|NCT00434122|155791995|FG001|Overall Study|Travelling of subject.|0|||
48438256|NCT00255086|155791997|FG000|Overall Study|Adverse Event|1|||
48438257|NCT00255086|155791998|FG001|Overall Study|Adverse Event|1|||
48438258|NCT00255086|155791997|FG000|Overall Study|Protocol Violation|1|||
48438259|NCT00255086|155791998|FG001|Overall Study|Protocol Violation|1|||
48438260|NCT02559206|155791999|FG000|Overall Study|Adverse Event|0|||
48438261|NCT02559206|155792000|FG001|Overall Study|Adverse Event|4|||
48438262|NCT02559206|155792001|FG002|Overall Study|Adverse Event|1|||
48438263|NCT02559206|155792002|FG003|Overall Study|Adverse Event|5|||
48438264|NCT02559206|155792003|FG004|Overall Study|Adverse Event|3|||
48438265|NCT02559206|155792004|FG005|Overall Study|Adverse Event|0|||
48438266|NCT02559206|155792005|FG006|Overall Study|Adverse Event|1|||
48438267|NCT02559206|155792006|FG007|Overall Study|Adverse Event|0|||
48438268|NCT02559206|155791999|FG000|Overall Study|Protocol Violation|1|||
48438269|NCT02559206|155792000|FG001|Overall Study|Protocol Violation|0|||
48438343|NCT01963208|155792012|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
48438344|NCT01963208|155792007|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48438345|NCT01963208|155792008|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48438346|NCT01963208|155792009|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48438347|NCT01963208|155792010|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
48438348|NCT01963208|155792011|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48438349|NCT01963208|155792012|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
48438350|NCT01963208|155792007|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
48438351|NCT01963208|155792008|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
48438352|NCT01963208|155792009|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
48438353|NCT01963208|155792010|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
48438354|NCT01963208|155792011|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
48438355|NCT01963208|155792012|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
48438356|NCT01963208|155792007|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
48438357|NCT01963208|155792008|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
48438358|NCT01963208|155792009|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
48438359|NCT01963208|155792010|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
48438360|NCT01963208|155792011|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
48438361|NCT01963208|155792012|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
48438362|NCT01963208|155792007|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48438363|NCT01963208|155792008|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48438364|NCT01963208|155792009|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48438365|NCT01963208|155792010|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48438366|NCT01963208|155792011|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
48438367|NCT01963208|155792012|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
48438368|NCT01963208|155792007|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48438369|NCT01963208|155792008|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48438370|NCT01963208|155792009|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48438371|NCT01963208|155792010|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48438372|NCT01963208|155792011|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
48438373|NCT01963208|155792012|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
48438374|NCT01963208|155792007|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
48438375|NCT01963208|155792008|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
48438376|NCT01963208|155792009|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
48438377|NCT01963208|155792010|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
48438378|NCT01963208|155792011|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
48438379|NCT01963208|155792012|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
48438380|NCT01963208|155792007|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
48438381|NCT01963208|155792008|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
48438382|NCT01963208|155792009|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
48438383|NCT01963208|155792010|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
48438384|NCT01963208|155792011|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
48438385|NCT01963208|155792012|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
48438386|NCT01963208|155792007|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
48438387|NCT01963208|155792008|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
48438388|NCT01963208|155792009|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
48438389|NCT01963208|155792010|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
48438390|NCT01963208|155792011|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
48438391|NCT01963208|155792012|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
48438392|NCT00438399|155792016|FG000|Overall Study|Lost to Follow-up|2|||
48438393|NCT00438399|155792017|FG001|Overall Study|Lost to Follow-up|2|||
48438394|NCT00438399|155792018|FG002|Overall Study|Lost to Follow-up|1|||
48438395|NCT00438399|155792019|FG003|Overall Study|Lost to Follow-up|1|||
48438396|NCT00438399|155792020|FG004|Overall Study|Lost to Follow-up|1|||
48438397|NCT00438399|155792021|FG005|Overall Study|Lost to Follow-up|1|||
48438398|NCT00438399|155792016|FG000|Overall Study|Adverse Event|0|||
48438399|NCT00438399|155792017|FG001|Overall Study|Adverse Event|0|||
48438400|NCT00438399|155792018|FG002|Overall Study|Adverse Event|1|||
48438401|NCT00438399|155792019|FG003|Overall Study|Adverse Event|1|||
48438402|NCT00438399|155792020|FG004|Overall Study|Adverse Event|0|||
48438403|NCT00438399|155792021|FG005|Overall Study|Adverse Event|1|||
48438404|NCT00438399|155792016|FG000|Overall Study|Withdrawal by Subject|5|||
48438405|NCT00438399|155792017|FG001|Overall Study|Withdrawal by Subject|6|||
48438406|NCT00438399|155792018|FG002|Overall Study|Withdrawal by Subject|3|||
48438407|NCT00438399|155792019|FG003|Overall Study|Withdrawal by Subject|2|||
48438408|NCT00438399|155792020|FG004|Overall Study|Withdrawal by Subject|2|||
48438409|NCT00438399|155792021|FG005|Overall Study|Withdrawal by Subject|2|||
48438410|NCT00438399|155792016|FG000|Overall Study|Protocol Violation|0|||
48438411|NCT00438399|155792017|FG001|Overall Study|Protocol Violation|0|||
48438412|NCT00438399|155792018|FG002|Overall Study|Protocol Violation|1|||
48438413|NCT00438399|155792019|FG003|Overall Study|Protocol Violation|0|||
48438431|NCT00438399|155792019|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
48438432|NCT00438399|155792020|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
48438433|NCT00438399|155792021|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
48438434|NCT01364233|155792022|FG000|Overall Study|Lost to Follow-up|1|||
48438435|NCT00878215|155792023|FG000|Overall Study|Determined to be ineligible|0|||
48438436|NCT00878215|155792024|FG001|Overall Study|Determined to be ineligible|10|||
48438437|NCT00878215|155792025|FG002|Overall Study|Determined to be ineligible|0|||
48438438|NCT00878215|155792026|FG003|Overall Study|Determined to be ineligible|0|||
48438439|NCT04191577|155792037|FG000|Overall Study|Withdrawal by Subject|2|||
48438440|NCT04191577|155792038|FG001|Overall Study|Withdrawal by Subject|2|||
48438441|NCT04191577|155792039|FG002|Overall Study|Withdrawal by Subject|1|||
48438442|NCT04191577|155792037|FG000|Overall Study|Physician Decision|1|||
48438443|NCT04191577|155792038|FG001|Overall Study|Physician Decision|1|||
48438444|NCT04191577|155792039|FG002|Overall Study|Physician Decision|0|||
48438445|NCT04191577|155792037|FG000|Overall Study|Adverse Event|0|||
48438446|NCT04191577|155792038|FG001|Overall Study|Adverse Event|0|||
48438447|NCT04191577|155792039|FG002|Overall Study|Adverse Event|1|||
48438448|NCT04191577|155792037|FG000|Overall Study|Death|0|||
48438449|NCT04191577|155792038|FG001|Overall Study|Death|0|||
48438450|NCT04191577|155792039|FG002|Overall Study|Death|1|||
48438451|NCT04311177|155792040|FG000|Overall Study|Adverse Event|3|||
48438452|NCT04311177|155792041|FG001|Overall Study|Adverse Event|1|||
48438453|NCT04311177|155792040|FG000|Overall Study|Physician Decision|4|||
48438454|NCT04311177|155792041|FG001|Overall Study|Physician Decision|3|||
48438455|NCT04311177|155792040|FG000|Overall Study|Withdrawal by Subject|1|||
48438456|NCT04311177|155792041|FG001|Overall Study|Withdrawal by Subject|0|||
48438457|NCT00448916|155792047|FG000|Overall Study|Adverse Event|2|||
48438458|NCT00448916|155792048|FG001|Overall Study|Adverse Event|2|||
48438459|NCT00448916|155792049|FG002|Overall Study|Adverse Event|3|||
48438460|NCT00448916|155792050|FG003|Overall Study|Adverse Event|2|||
48438461|NCT00448916|155792047|FG000|Overall Study|Lack of Efficacy|1|||
48438462|NCT00448916|155792048|FG001|Overall Study|Lack of Efficacy|0|||
48438463|NCT00448916|155792049|FG002|Overall Study|Lack of Efficacy|2|||
48438464|NCT00448916|155792050|FG003|Overall Study|Lack of Efficacy|1|||
48438465|NCT00448916|155792047|FG000|Overall Study|Withdrawal by Subject|3|||
48438466|NCT00448916|155792048|FG001|Overall Study|Withdrawal by Subject|3|||
48438467|NCT00448916|155792049|FG002|Overall Study|Withdrawal by Subject|1|||
48438468|NCT00448916|155792050|FG003|Overall Study|Withdrawal by Subject|1|||
48438469|NCT00448916|155792047|FG000|Overall Study|Other|1|||
48438470|NCT00448916|155792048|FG001|Overall Study|Other|0|||
48438471|NCT00448916|155792049|FG002|Overall Study|Other|0|||
48438472|NCT00448916|155792050|FG003|Overall Study|Other|0|||
48438473|NCT00448916|155792047|FG000|Overall Study|Lost to Follow-up|0|||
48438474|NCT00448916|155792048|FG001|Overall Study|Lost to Follow-up|1|||
48438475|NCT00448916|155792049|FG002|Overall Study|Lost to Follow-up|0|||
48438476|NCT00448916|155792050|FG003|Overall Study|Lost to Follow-up|1|||
48438477|NCT00448916|155792047|FG000|Overall Study|Protocol Violation|0|||
48438478|NCT00448916|155792048|FG001|Overall Study|Protocol Violation|0|||
48438479|NCT00448916|155792049|FG002|Overall Study|Protocol Violation|0|||
48438480|NCT00448916|155792050|FG003|Overall Study|Protocol Violation|1|||
48438481|NCT03655717|155792053|FG000|Overall Study|Withdrawal by Subject|4|||
48438482|NCT03655717|155792054|FG001|Overall Study|Withdrawal by Subject|8|||
48438483|NCT03655717|155792055|FG002|Overall Study|Withdrawal by Subject|1|||
48438484|NCT03655717|155792056|FG003|Overall Study|Withdrawal by Subject|0|||
48438485|NCT03655717|155792057|FG004|Overall Study|Withdrawal by Subject|0|||
48438486|NCT03655717|155792058|FG005|Overall Study|Withdrawal by Subject|1|||
48438487|NCT03655717|155792059|FG006|Overall Study|Withdrawal by Subject|3|||
48438488|NCT03655717|155792060|FG007|Overall Study|Withdrawal by Subject|1|||
48438489|NCT03655717|155792061|FG008|Overall Study|Withdrawal by Subject|2|||
48438490|NCT03655717|155792062|FG009|Overall Study|Withdrawal by Subject|0|||
48438491|NCT03655717|155792063|FG010|Overall Study|Withdrawal by Subject|0|||
48438492|NCT03655717|155792064|FG011|Overall Study|Withdrawal by Subject|1|||
48438493|NCT03655717|155792065|FG012|Overall Study|Withdrawal by Subject|0|||
48438494|NCT03655717|155792066|FG013|Overall Study|Withdrawal by Subject|3|||
48438495|NCT03655717|155792067|FG014|Overall Study|Withdrawal by Subject|0|||
48438496|NCT03655717|155792068|FG015|Overall Study|Withdrawal by Subject|1|||
48438497|NCT03655717|155792069|FG016|Overall Study|Withdrawal by Subject|0|||
48438498|NCT03655717|155792070|FG017|Overall Study|Withdrawal by Subject|0|||
48438499|NCT03655717|155792071|FG018|Overall Study|Withdrawal by Subject|1|||
48438500|NCT03655717|155792072|FG019|Overall Study|Withdrawal by Subject|0|||
48438501|NCT03655717|155792073|FG020|Overall Study|Withdrawal by Subject|0|||
48438502|NCT03655717|155792074|FG021|Overall Study|Withdrawal by Subject|1|||
48438503|NCT03655717|155792075|FG022|Overall Study|Withdrawal by Subject|2|||
48438504|NCT03655717|155792076|FG023|Overall Study|Withdrawal by Subject|1|||
48438505|NCT03655717|155792077|FG024|Overall Study|Withdrawal by Subject|1|||
48438506|NCT03655717|155792078|FG025|Overall Study|Withdrawal by Subject|0|||
48438507|NCT03655717|155792053|FG000|Overall Study|Physician Decision|3|||
48438508|NCT03655717|155792054|FG001|Overall Study|Physician Decision|3|||
48438588|NCT00349752|155792093|FG000|Overall Study|Other: Non compliance|0|||
48438589|NCT00349752|155792094|FG001|Overall Study|Other: Non compliance|1|||
48438590|NCT00349752|155792093|FG000|Overall Study|Other: Patient stopped steroids|0|||
48438591|NCT00349752|155792094|FG001|Overall Study|Other: Patient stopped steroids|1|||
48438592|NCT00349752|155792093|FG000|Overall Study|Other: Patient's steroid use|1|||
48438593|NCT00349752|155792094|FG001|Overall Study|Other: Patient's steroid use|0|||
48438594|NCT00349752|155792093|FG000|Overall Study|Other: Ineligible|1|||
48438595|NCT00349752|155792094|FG001|Overall Study|Other: Ineligible|0|||
48438596|NCT00349752|155792093|FG000|Overall Study|Other: Inadvertently unblinded|1|||
48438597|NCT00349752|155792094|FG001|Overall Study|Other: Inadvertently unblinded|0|||
48438598|NCT00349752|155792093|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
48438599|NCT00349752|155792094|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
48438600|NCT01973452|155792095|FG000|Overall Study|Lack of Efficacy|0|||
48438601|NCT01973452|155792096|FG001|Overall Study|Lack of Efficacy|1|||
48438602|NCT01973452|155792095|FG000|Overall Study|Lost to Follow-up|1|||
48438603|NCT01973452|155792096|FG001|Overall Study|Lost to Follow-up|0|||
48438604|NCT01973452|155792095|FG000|Overall Study|Withdrawal by Subject|10|||
48438605|NCT01973452|155792096|FG001|Overall Study|Withdrawal by Subject|9|||
48438606|NCT01973452|155792095|FG000|Overall Study|Ineligible|1|||
48438607|NCT01973452|155792096|FG001|Overall Study|Ineligible|1|||
48438608|NCT01973452|155792095|FG000|Overall Study|Surgery canceled by participant|5|||
48438609|NCT01973452|155792096|FG001|Overall Study|Surgery canceled by participant|3|||
48438610|NCT00819585|155792097|FG000|Core Study|Adverse Event|2|||
48438611|NCT00819585|155792098|FG001|Core Study|Adverse Event|1|||
48438612|NCT00819585|155792099|FG002|Core Study|Adverse Event|1|||
48438613|NCT00819585|155792100|FG003|Core Study|Adverse Event|4|||
48438614|NCT00819585|155792101|FG004|Core Study|Adverse Event|1|||
48438615|NCT00819585|155792102|FG005|Core Study|Adverse Event|0|||
48438616|NCT00819585|155792103|FG006|Core Study|Adverse Event|2|||
48438617|NCT00819585|155792104|FG007|Core Study|Adverse Event|0|||
48438618|NCT00819585|155792105|FG008|Core Study|Adverse Event|0|||
48438619|NCT00819585|155792106|FG009|Core Study|Adverse Event|0|||
48438620|NCT00819585|155792107|FG010|Core Study|Adverse Event|0|||
48438621|NCT00819585|155792097|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
48438622|NCT00819585|155792098|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
48438623|NCT00819585|155792099|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
48438624|NCT00819585|155792100|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
48438625|NCT00819585|155792101|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
48438626|NCT00819585|155792102|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
48438627|NCT00819585|155792103|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
48438628|NCT00819585|155792104|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
48438629|NCT00819585|155792105|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
48438630|NCT00819585|155792106|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
48438631|NCT00819585|155792107|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
48438632|NCT00819585|155792097|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438633|NCT00819585|155792098|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
48438634|NCT00819585|155792099|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438635|NCT00819585|155792100|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438636|NCT00819585|155792101|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438637|NCT00819585|155792102|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438638|NCT00819585|155792103|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
48438639|NCT00819585|155792104|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438640|NCT00819585|155792105|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438641|NCT00819585|155792106|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438642|NCT00819585|155792107|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
48438643|NCT00819585|155792097|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
48438644|NCT00819585|155792098|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
48438645|NCT00819585|155792099|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
48438646|NCT00819585|155792100|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
48438647|NCT00819585|155792101|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
48438648|NCT00819585|155792102|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
48438649|NCT00819585|155792103|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
48438650|NCT00819585|155792104|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
48438651|NCT00819585|155792105|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
48438652|NCT00819585|155792106|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
48438653|NCT00819585|155792107|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
48438654|NCT00819585|155792097|FG000|Core Study|Subject Withdrew Consent|0|||
48438655|NCT00819585|155792098|FG001|Core Study|Subject Withdrew Consent|3|||
48438656|NCT00819585|155792099|FG002|Core Study|Subject Withdrew Consent|2|||
48438657|NCT00819585|155792100|FG003|Core Study|Subject Withdrew Consent|1|||
48438658|NCT00819585|155792101|FG004|Core Study|Subject Withdrew Consent|0|||
48438659|NCT00819585|155792102|FG005|Core Study|Subject Withdrew Consent|0|||
48438660|NCT00819585|155792103|FG006|Core Study|Subject Withdrew Consent|3|||
48438661|NCT00819585|155792104|FG007|Core Study|Subject Withdrew Consent|0|||
48438662|NCT00819585|155792105|FG008|Core Study|Subject Withdrew Consent|0|||
48438663|NCT00819585|155792106|FG009|Core Study|Subject Withdrew Consent|0|||
48438664|NCT00819585|155792107|FG010|Core Study|Subject Withdrew Consent|0|||
48438665|NCT00819585|155792097|FG000|Core Study|Lost to Follow-up|2|||
48438666|NCT00819585|155792098|FG001|Core Study|Lost to Follow-up|1|||
48438667|NCT00819585|155792099|FG002|Core Study|Lost to Follow-up|2|||
48438668|NCT00819585|155792100|FG003|Core Study|Lost to Follow-up|0|||
48438669|NCT00819585|155792101|FG004|Core Study|Lost to Follow-up|1|||
48438670|NCT00819585|155792102|FG005|Core Study|Lost to Follow-up|1|||
48438671|NCT00819585|155792103|FG006|Core Study|Lost to Follow-up|1|||
48438672|NCT00819585|155792104|FG007|Core Study|Lost to Follow-up|0|||
48438673|NCT00819585|155792105|FG008|Core Study|Lost to Follow-up|0|||
48438674|NCT00819585|155792106|FG009|Core Study|Lost to Follow-up|0|||
48438675|NCT00819585|155792107|FG010|Core Study|Lost to Follow-up|0|||
48438676|NCT00819585|155792097|FG000|Core Study|Administrative Problems|0|||
48438677|NCT00819585|155792098|FG001|Core Study|Administrative Problems|0|||
48438678|NCT00819585|155792099|FG002|Core Study|Administrative Problems|0|||
48438679|NCT00819585|155792100|FG003|Core Study|Administrative Problems|0|||
48438680|NCT00819585|155792101|FG004|Core Study|Administrative Problems|0|||
48438681|NCT00819585|155792102|FG005|Core Study|Administrative Problems|0|||
48438682|NCT00819585|155792103|FG006|Core Study|Administrative Problems|2|||
48438683|NCT00819585|155792104|FG007|Core Study|Administrative Problems|0|||
48438684|NCT00819585|155792105|FG008|Core Study|Administrative Problems|0|||
48438685|NCT00819585|155792106|FG009|Core Study|Administrative Problems|0|||
48438686|NCT00819585|155792107|FG010|Core Study|Administrative Problems|0|||
48438687|NCT00819585|155792097|FG000|Core Study|Death|0|||
48438688|NCT00819585|155792098|FG001|Core Study|Death|0|||
48438689|NCT00819585|155792099|FG002|Core Study|Death|0|||
48438690|NCT00819585|155792100|FG003|Core Study|Death|0|||
48438691|NCT00819585|155792101|FG004|Core Study|Death|0|||
48438692|NCT00819585|155792102|FG005|Core Study|Death|0|||
48438693|NCT00819585|155792103|FG006|Core Study|Death|1|||
48438694|NCT00819585|155792104|FG007|Core Study|Death|0|||
48438695|NCT00819585|155792105|FG008|Core Study|Death|0|||
48438696|NCT00819585|155792106|FG009|Core Study|Death|0|||
48438697|NCT00819585|155792107|FG010|Core Study|Death|0|||
48438698|NCT00819585|155792097|FG000|Core Study|Protocol Violation|0|||
48438699|NCT00819585|155792098|FG001|Core Study|Protocol Violation|0|||
48438700|NCT00819585|155792099|FG002|Core Study|Protocol Violation|1|||
48438701|NCT00819585|155792100|FG003|Core Study|Protocol Violation|0|||
48438702|NCT00819585|155792101|FG004|Core Study|Protocol Violation|0|||
48438703|NCT00819585|155792102|FG005|Core Study|Protocol Violation|1|||
48438704|NCT00819585|155792103|FG006|Core Study|Protocol Violation|3|||
48438705|NCT00819585|155792104|FG007|Core Study|Protocol Violation|0|||
48438706|NCT00819585|155792105|FG008|Core Study|Protocol Violation|0|||
48438707|NCT00819585|155792106|FG009|Core Study|Protocol Violation|0|||
48438708|NCT00819585|155792107|FG010|Core Study|Protocol Violation|0|||
48438709|NCT00819585|155792097|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
48438710|NCT00819585|155792098|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
48438711|NCT00819585|155792099|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
48438712|NCT00819585|155792100|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
48438713|NCT00819585|155792101|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
48438714|NCT00819585|155792102|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
48438715|NCT00819585|155792103|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
48438716|NCT00819585|155792104|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
48438717|NCT00819585|155792105|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
48438718|NCT00819585|155792106|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
48438719|NCT00819585|155792107|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
48438720|NCT00819585|155792097|FG000|Extension Study|Subject Withdrew Consent|0|||
48438721|NCT00819585|155792098|FG001|Extension Study|Subject Withdrew Consent|0|||
48438722|NCT00819585|155792099|FG002|Extension Study|Subject Withdrew Consent|0|||
48438723|NCT00819585|155792100|FG003|Extension Study|Subject Withdrew Consent|0|||
48438724|NCT00819585|155792101|FG004|Extension Study|Subject Withdrew Consent|0|||
48438725|NCT00819585|155792102|FG005|Extension Study|Subject Withdrew Consent|0|||
48438726|NCT00819585|155792103|FG006|Extension Study|Subject Withdrew Consent|0|||
48438727|NCT00819585|155792104|FG007|Extension Study|Subject Withdrew Consent|0|||
48438728|NCT00819585|155792105|FG008|Extension Study|Subject Withdrew Consent|3|||
48438729|NCT00819585|155792106|FG009|Extension Study|Subject Withdrew Consent|0|||
48438730|NCT00819585|155792107|FG010|Extension Study|Subject Withdrew Consent|1|||
48438731|NCT00819585|155792097|FG000|Extension Study|Lost to Follow-up|0|||
48438732|NCT00819585|155792098|FG001|Extension Study|Lost to Follow-up|0|||
48438733|NCT00819585|155792099|FG002|Extension Study|Lost to Follow-up|0|||
48438734|NCT00819585|155792100|FG003|Extension Study|Lost to Follow-up|0|||
48438735|NCT00819585|155792101|FG004|Extension Study|Lost to Follow-up|0|||
48438736|NCT00819585|155792102|FG005|Extension Study|Lost to Follow-up|0|||
48438737|NCT00819585|155792103|FG006|Extension Study|Lost to Follow-up|0|||
48438738|NCT00819585|155792104|FG007|Extension Study|Lost to Follow-up|0|||
48438739|NCT00819585|155792105|FG008|Extension Study|Lost to Follow-up|2|||
48438740|NCT00819585|155792106|FG009|Extension Study|Lost to Follow-up|1|||
48438741|NCT00819585|155792107|FG010|Extension Study|Lost to Follow-up|1|||
48438782|NCT00836277|155793894|FG000|Overall Study|Not evaluable for response|6|||
48438783|NCT00377611|155793900|FG000|Overall Study|Adverse Event|2|||
48438784|NCT00377611|155793901|FG001|Overall Study|Adverse Event|9|||
48438785|NCT00377611|155793900|FG000|Overall Study|Protocol Violation|2|||
48438786|NCT00377611|155793901|FG001|Overall Study|Protocol Violation|0|||
48438787|NCT00377611|155793900|FG000|Overall Study|Withdrawal by Subject|0|||
48438788|NCT00377611|155793901|FG001|Overall Study|Withdrawal by Subject|5|||
48438789|NCT00377611|155793900|FG000|Overall Study|Lost to Follow-up|18|||
48438790|NCT00377611|155793901|FG001|Overall Study|Lost to Follow-up|16|||
48438791|NCT00377611|155793900|FG000|Overall Study|Other|0|||
48438792|NCT00377611|155793901|FG001|Overall Study|Other|3|||
48438793|NCT00111917|155793902|FG000|Overall Study|Withdrawal by Subject|1|||
48438794|NCT00111917|155793903|FG001|Overall Study|Withdrawal by Subject|1|||
48438795|NCT03446651|155793906|FG000|Overall Study|Lost to Follow-up|4|||
48438796|NCT03446651|155793907|FG001|Overall Study|Lost to Follow-up|0|||
48438797|NCT03446651|155793906|FG000|Overall Study|Open Label Participants|5|||
48438798|NCT03446651|155793907|FG001|Overall Study|Open Label Participants|0|||
48438799|NCT00343291|155793908|FG000|Overall Study|Adverse Event|13|||
48438800|NCT00343291|155793909|FG001|Overall Study|Adverse Event|13|||
48438801|NCT00343291|155793908|FG000|Overall Study|Death|3|||
48438802|NCT00343291|155793909|FG001|Overall Study|Death|2|||
48438803|NCT00343291|155793908|FG000|Overall Study|Progressive disease|33|||
48438804|NCT00343291|155793909|FG001|Overall Study|Progressive disease|34|||
48438805|NCT00343291|155793908|FG000|Overall Study|Withdrawal by Subject|0|||
48438806|NCT00343291|155793909|FG001|Overall Study|Withdrawal by Subject|2|||
48438807|NCT00343291|155793908|FG000|Overall Study|Other|8|||
48438808|NCT00343291|155793909|FG001|Overall Study|Other|5|||
48438809|NCT04831515|155793910|FG000|First Intervention|Adverse Event|0|||
48438810|NCT04831515|155793911|FG001|First Intervention|Adverse Event|1|||
48438811|NCT00992784|155793917|FG000|Overall Study|Adverse Event|2|||
48438812|NCT00992784|155793918|FG001|Overall Study|Adverse Event|1|||
48438813|NCT00992784|155793919|FG002|Overall Study|Adverse Event|0|||
48438814|NCT00992784|155793917|FG000|Overall Study|Withdrawal by Subject|1|||
48438815|NCT00992784|155793918|FG001|Overall Study|Withdrawal by Subject|1|||
48438816|NCT00992784|155793919|FG002|Overall Study|Withdrawal by Subject|1|||
48438817|NCT00997321|155793922|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
48438818|NCT00997321|155793923|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
48438819|NCT01088438|155793938|FG000|Overall Study|Withdrawal by Subject|11|||
48438820|NCT01088438|155793939|FG001|Overall Study|Withdrawal by Subject|6|||
48438821|NCT01088438|155793938|FG000|Overall Study|Lost to Follow-up|18|||
48438822|NCT01088438|155793939|FG001|Overall Study|Lost to Follow-up|30|||
48438823|NCT01363713|155793940|FG000|Overall Study|Adverse Event|1|||
48438824|NCT01363713|155793940|FG000|Overall Study|Protocol Violation|3|||
48438825|NCT01363713|155793940|FG000|Overall Study|Withdrawal by Subject|2|||
48438826|NCT00289185|155793941|FG000|Overall Study|Withdrawal by Subject|4|||
48438827|NCT00289185|155793942|FG001|Overall Study|Withdrawal by Subject|8|||
48438828|NCT00289185|155793941|FG000|Overall Study|Lost to Follow-up|23|||
48438829|NCT00289185|155793942|FG001|Overall Study|Lost to Follow-up|17|||
48438830|NCT00289185|155793941|FG000|Overall Study|Death|1|||
48438831|NCT00289185|155793942|FG001|Overall Study|Death|1|||
48438832|NCT00511342|155793943|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
48438833|NCT00511342|155793944|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
48438834|NCT00511342|155793943|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
48438835|NCT00511342|155793944|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
48438836|NCT00511342|155793943|FG000|Overall Study|Pregnancy|0|||
48438837|NCT00511342|155793944|FG001|Overall Study|Pregnancy|1|||
48438838|NCT00511342|155793943|FG000|Overall Study|Pregnancy wish|0|||
48438839|NCT00511342|155793944|FG001|Overall Study|Pregnancy wish|1|||
48438840|NCT00511342|155793943|FG000|Overall Study|Lost to Follow-up|1|||
48438841|NCT00511342|155793944|FG001|Overall Study|Lost to Follow-up|5|||
48438842|NCT00511342|155793943|FG000|Overall Study|Other Reason|2|||
48438843|NCT00511342|155793944|FG001|Overall Study|Other Reason|2|||
48438844|NCT01124448|155793945|FG000|Overall Study|Lost to Follow-up|0|||
48438845|NCT01124448|155793946|FG001|Overall Study|Lost to Follow-up|3|||
48438846|NCT01124448|155793945|FG000|Overall Study|Protocol Violation|2|||
48438847|NCT01124448|155793946|FG001|Overall Study|Protocol Violation|0|||
48438848|NCT03198754|155793947|FG000|Overall Study|Withdrawal by Subject|5|||
48438849|NCT03198754|155793948|FG001|Overall Study|Withdrawal by Subject|4|||
48438850|NCT03198754|155793947|FG000|Overall Study|Lost to Follow-up|4|||
48438851|NCT03198754|155793948|FG001|Overall Study|Lost to Follow-up|3|||
48438852|NCT03198754|155793947|FG000|Overall Study|Ineligible|2|||
48438853|NCT03198754|155793948|FG001|Overall Study|Ineligible|1|||
48438854|NCT01594333|155793950|FG000|Overall Study|Death|96|||
48438855|NCT01594333|155793951|FG001|Overall Study|Death|83|||
48438856|NCT01594333|155793950|FG000|Overall Study|Lost to Follow-up|5|||
48438857|NCT01594333|155793951|FG001|Overall Study|Lost to Follow-up|5|||
48438858|NCT01594333|155793950|FG000|Overall Study|Withdrawal by Subject|60|||
48438859|NCT01594333|155793951|FG001|Overall Study|Withdrawal by Subject|63|||
48438860|NCT01797965|155793952|FG000|Overall Study|Adverse Event|104|||
48438875|NCT01797965|155793955|FG003|Overall Study|Investigator decision|0|||
48438876|NCT01797965|155793952|FG000|Overall Study|Death|2|||
48438877|NCT01797965|155793953|FG001|Overall Study|Death|4|||
48438878|NCT01797965|155793954|FG002|Overall Study|Death|0|||
48438879|NCT01797965|155793955|FG003|Overall Study|Death|0|||
48438880|NCT01797965|155793952|FG000|Overall Study|Disease progression, defined by protocol|3|||
48438881|NCT01797965|155793953|FG001|Overall Study|Disease progression, defined by protocol|1|||
48438882|NCT01797965|155793954|FG002|Overall Study|Disease progression, defined by protocol|0|||
48438883|NCT01797965|155793955|FG003|Overall Study|Disease progression, defined by protocol|0|||
48438884|NCT01797965|155793952|FG000|Overall Study|Reason Not Specified|280|||
48438885|NCT01797965|155793953|FG001|Overall Study|Reason Not Specified|295|||
48438886|NCT01797965|155793954|FG002|Overall Study|Reason Not Specified|0|||
48438887|NCT01797965|155793955|FG003|Overall Study|Reason Not Specified|15|||
48438888|NCT00479557|155793959|FG000|Overall Study|Death|0|||
48438889|NCT00479557|155793960|FG001|Overall Study|Death|0|||
48438890|NCT00479557|155793961|FG002|Overall Study|Death|0|||
48438891|NCT00479557|155793962|FG003|Overall Study|Death|0|||
48438892|NCT00479557|155793963|FG004|Overall Study|Death|0|||
48438893|NCT00479557|155793964|FG005|Overall Study|Death|1|||
48438894|NCT00479557|155793965|FG006|Overall Study|Death|0|||
48438895|NCT00479557|155793959|FG000|Overall Study|Lack of Efficacy|1|||
48438896|NCT00479557|155793960|FG001|Overall Study|Lack of Efficacy|0|||
48438897|NCT00479557|155793961|FG002|Overall Study|Lack of Efficacy|0|||
48438898|NCT00479557|155793962|FG003|Overall Study|Lack of Efficacy|0|||
48438899|NCT00479557|155793963|FG004|Overall Study|Lack of Efficacy|0|||
48438900|NCT00479557|155793964|FG005|Overall Study|Lack of Efficacy|0|||
48438901|NCT00479557|155793965|FG006|Overall Study|Lack of Efficacy|0|||
48438902|NCT00479557|155793959|FG000|Overall Study|Lost to Follow-up|0|||
48438903|NCT00479557|155793960|FG001|Overall Study|Lost to Follow-up|2|||
48438904|NCT00479557|155793961|FG002|Overall Study|Lost to Follow-up|0|||
48438905|NCT00479557|155793962|FG003|Overall Study|Lost to Follow-up|2|||
48438906|NCT00479557|155793963|FG004|Overall Study|Lost to Follow-up|0|||
48438907|NCT00479557|155793964|FG005|Overall Study|Lost to Follow-up|0|||
48438908|NCT00479557|155793965|FG006|Overall Study|Lost to Follow-up|0|||
48438909|NCT00479557|155793959|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
48438910|NCT00479557|155793960|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48438911|NCT00479557|155793961|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
48438912|NCT00479557|155793962|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
48438913|NCT00479557|155793963|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48438914|NCT00479557|155793964|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
48438915|NCT00479557|155793965|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
48438916|NCT00479557|155793959|FG000|Overall Study|AE not related to Study Drug|1|||
48438917|NCT00479557|155793960|FG001|Overall Study|AE not related to Study Drug|3|||
48438918|NCT00479557|155793961|FG002|Overall Study|AE not related to Study Drug|0|||
48438919|NCT00479557|155793962|FG003|Overall Study|AE not related to Study Drug|0|||
48438920|NCT00479557|155793963|FG004|Overall Study|AE not related to Study Drug|2|||
48438921|NCT00479557|155793964|FG005|Overall Study|AE not related to Study Drug|2|||
48438922|NCT00479557|155793965|FG006|Overall Study|AE not related to Study Drug|1|||
48438923|NCT00479557|155793959|FG000|Overall Study|Caregiver Request|2|||
48438924|NCT00479557|155793960|FG001|Overall Study|Caregiver Request|2|||
48438925|NCT00479557|155793961|FG002|Overall Study|Caregiver Request|2|||
48438926|NCT00479557|155793962|FG003|Overall Study|Caregiver Request|0|||
48438927|NCT00479557|155793963|FG004|Overall Study|Caregiver Request|1|||
48438928|NCT00479557|155793964|FG005|Overall Study|Caregiver Request|2|||
48438929|NCT00479557|155793965|FG006|Overall Study|Caregiver Request|0|||
48438930|NCT00479557|155793959|FG000|Overall Study|Investigator Request|0|||
48438931|NCT00479557|155793960|FG001|Overall Study|Investigator Request|0|||
48438932|NCT00479557|155793961|FG002|Overall Study|Investigator Request|1|||
48438933|NCT00479557|155793962|FG003|Overall Study|Investigator Request|0|||
48438934|NCT00479557|155793963|FG004|Overall Study|Investigator Request|0|||
48438935|NCT00479557|155793964|FG005|Overall Study|Investigator Request|0|||
48438936|NCT00479557|155793965|FG006|Overall Study|Investigator Request|0|||
48438937|NCT00479557|155793959|FG000|Overall Study|Subject Request|3|||
48438938|NCT00479557|155793960|FG001|Overall Study|Subject Request|0|||
48438939|NCT00479557|155793961|FG002|Overall Study|Subject Request|1|||
48438940|NCT00479557|155793962|FG003|Overall Study|Subject Request|1|||
48438941|NCT00479557|155793963|FG004|Overall Study|Subject Request|1|||
48438942|NCT00479557|155793964|FG005|Overall Study|Subject Request|4|||
48438943|NCT00479557|155793965|FG006|Overall Study|Subject Request|1|||
48438944|NCT00479557|155793959|FG000|Overall Study|Other|2|||
48438945|NCT00479557|155793960|FG001|Overall Study|Other|3|||
48438946|NCT00479557|155793961|FG002|Overall Study|Other|1|||
48438947|NCT00479557|155793962|FG003|Overall Study|Other|0|||
48438948|NCT00479557|155793963|FG004|Overall Study|Other|0|||
48438949|NCT00479557|155793964|FG005|Overall Study|Other|3|||
48438950|NCT00479557|155793965|FG006|Overall Study|Other|0|||
48438951|NCT01999946|155793966|FG000|Overall Study|Participant not released from jail|2|||
48438952|NCT01999946|155793967|FG001|Overall Study|Participant not released from jail|2|||
48438953|NCT01999946|155793968|FG002|Overall Study|Participant not released from jail|0|||
48438954|NCT01999946|155793966|FG000|Overall Study|Not included in primary outcome analysis|0|||
48438955|NCT01999946|155793967|FG001|Overall Study|Not included in primary outcome analysis|0|||
48438956|NCT01999946|155793968|FG002|Overall Study|Not included in primary outcome analysis|79|||
48438957|NCT01536119|155793970|FG000|Overall Study|Lost to Follow-up|17|||
48438958|NCT01536119|155793971|FG001|Overall Study|Lost to Follow-up|14|||
48438959|NCT00138424|155793972|FG000|Overall Study|Physician Decision|0|||
48438960|NCT00138424|155793973|FG001|Overall Study|Physician Decision|1|||
48438961|NCT00138424|155793974|FG002|Overall Study|Physician Decision|0|||
48438962|NCT00138424|155793975|FG003|Overall Study|Physician Decision|0|||
48438963|NCT03101514|155793976|FG000|Overall Study|Withdrawal by Subject|4|||
48438964|NCT03101514|155793976|FG000|Overall Study|Protocol Violation|2|||
48438965|NCT03101514|155793976|FG000|Overall Study|patient's information was incomplete|1|||
48438966|NCT01669811|155793981|FG000|Overall Study|Investigator decision|0|||
48438967|NCT01669811|155793982|FG001|Overall Study|Investigator decision|1|||
48438968|NCT01669811|155793981|FG000|Overall Study|Withdrawal by Subject|1|||
48438969|NCT01669811|155793982|FG001|Overall Study|Withdrawal by Subject|2|||
48438970|NCT01669811|155793981|FG000|Overall Study|Adverse Event|2|||
48438971|NCT01669811|155793982|FG001|Overall Study|Adverse Event|6|||
48438972|NCT01669811|155793981|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48438973|NCT01669811|155793982|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
48438974|NCT00986427|155793983|FG000|Overall Study|Lost to Follow-up|2|||
48438975|NCT00986427|155793984|FG001|Overall Study|Lost to Follow-up|0|||
48438976|NCT00986427|155793983|FG000|Overall Study|Lack of Efficacy|1|||
48438977|NCT00986427|155793984|FG001|Overall Study|Lack of Efficacy|0|||
48438978|NCT00986427|155793983|FG000|Overall Study|Withdrawal by Subject|1|||
48438979|NCT00986427|155793984|FG001|Overall Study|Withdrawal by Subject|0|||
48438980|NCT01265420|155793985|FG000|Overall Study|Lost to Follow-up|1|||
48438981|NCT00738374|155793986|FG000|Induction Treatment Phase|Adverse Event|14|||
48438982|NCT00738374|155793987|FG001|Induction Treatment Phase|Adverse Event|0|||
48438983|NCT00738374|155793988|FG002|Induction Treatment Phase|Adverse Event|0|||
48438984|NCT00738374|155793989|FG003|Induction Treatment Phase|Adverse Event|0|||
48438985|NCT00738374|155793986|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
48438986|NCT00738374|155793987|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
48438987|NCT00738374|155793988|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
48438988|NCT00738374|155793989|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
48438989|NCT00738374|155793986|FG000|Induction Treatment Phase|Physician Decision|2|||
48438990|NCT00738374|155793987|FG001|Induction Treatment Phase|Physician Decision|0|||
48438991|NCT00738374|155793988|FG002|Induction Treatment Phase|Physician Decision|0|||
48438992|NCT00738374|155793989|FG003|Induction Treatment Phase|Physician Decision|0|||
48438993|NCT00738374|155793986|FG000|Induction Treatment Phase|Protocol Violation|2|||
48438994|NCT00738374|155793987|FG001|Induction Treatment Phase|Protocol Violation|0|||
48438995|NCT00738374|155793988|FG002|Induction Treatment Phase|Protocol Violation|0|||
48438996|NCT00738374|155793989|FG003|Induction Treatment Phase|Protocol Violation|0|||
48438997|NCT00738374|155793986|FG000|Induction Treatment Phase|Non-compliance|1|||
48438998|NCT00738374|155793987|FG001|Induction Treatment Phase|Non-compliance|0|||
48438999|NCT00738374|155793988|FG002|Induction Treatment Phase|Non-compliance|0|||
48439000|NCT00738374|155793989|FG003|Induction Treatment Phase|Non-compliance|0|||
48439001|NCT00738374|155793986|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
48439002|NCT00738374|155793987|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
48439003|NCT00738374|155793988|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
48439004|NCT00738374|155793989|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
48439005|NCT00738374|155793986|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
48439006|NCT00738374|155793987|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
48439007|NCT00738374|155793988|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
48439008|NCT00738374|155793989|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
48439009|NCT00738374|155793986|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
48439010|NCT00738374|155793987|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
48439011|NCT00738374|155793988|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
48439012|NCT00738374|155793989|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
48439013|NCT00738374|155793986|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
48439014|NCT00738374|155793987|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
48439015|NCT00738374|155793988|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
48439016|NCT00738374|155793989|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
48439017|NCT00738374|155793986|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
48439018|NCT00738374|155793987|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
48439019|NCT00738374|155793988|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
48439020|NCT00738374|155793989|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
48439021|NCT00738374|155793986|FG000|Maintenance Treatment/Observation Phase|Other|0|||
48439022|NCT00738374|155793987|FG001|Maintenance Treatment/Observation Phase|Other|1|||
48439023|NCT00738374|155793988|FG002|Maintenance Treatment/Observation Phase|Other|0|||
48439024|NCT00738374|155793989|FG003|Maintenance Treatment/Observation Phase|Other|0|||
48439025|NCT00574496|155793990|FG000|Overall Study|Withdrawal by Subject|1|||
48439026|NCT00413062|155793991|FG000|Overall Study|Adverse event/serious adverse event|289|||
48439027|NCT00413062|155793992|FG001|Overall Study|Adverse event/serious adverse event|56|||
48439028|NCT00413062|155793991|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
48439029|NCT00413062|155793992|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
48439030|NCT00413062|155793991|FG000|Overall Study|Withdrawal of informed consent|111|||
48439031|NCT00413062|155793992|FG001|Overall Study|Withdrawal of informed consent|36|||
48439032|NCT00413062|155793991|FG000|Overall Study|Pregnancy|15|||
48439033|NCT00413062|155793992|FG001|Overall Study|Pregnancy|5|||
48439034|NCT00413062|155793991|FG000|Overall Study|Pregnancy wish|17|||
48439035|NCT00413062|155793992|FG001|Overall Study|Pregnancy wish|6|||
48439036|NCT00413062|155793991|FG000|Overall Study|Lost to Follow-up|175|||
48439037|NCT00413062|155793992|FG001|Overall Study|Lost to Follow-up|73|||
48439038|NCT00413062|155793991|FG000|Overall Study|Other reason|70|||
48439039|NCT00413062|155793992|FG001|Overall Study|Other reason|34|||
48439040|NCT02176291|155793993|FG000|Overall Study|Death|1|||
48439041|NCT02176291|155793994|FG001|Overall Study|Death|0|||
48439042|NCT02176291|155793993|FG000|Overall Study|non compliance with protocol|2|||
48439043|NCT02176291|155793994|FG001|Overall Study|non compliance with protocol|0|||
48439044|NCT02176291|155793993|FG000|Overall Study|Withdrawal by Subject|2|||
48439045|NCT02176291|155793994|FG001|Overall Study|Withdrawal by Subject|0|||
48439046|NCT00501046|155793995|FG000|Overall Study|Adverse Event|21|||
48439047|NCT00501046|155793996|FG001|Overall Study|Adverse Event|25|||
48439048|NCT00501046|155793995|FG000|Overall Study|Death|23|||
48439049|NCT00501046|155793996|FG001|Overall Study|Death|30|||
48439050|NCT00501046|155793995|FG000|Overall Study|Lost to Follow-up|14|||
48439051|NCT00501046|155793996|FG001|Overall Study|Lost to Follow-up|13|||
48439052|NCT00501046|155793995|FG000|Overall Study|Physician Decision|7|||
48439053|NCT00501046|155793996|FG001|Overall Study|Physician Decision|2|||
48439054|NCT00501046|155793995|FG000|Overall Study|Pregnancy|0|||
48439055|NCT00501046|155793996|FG001|Overall Study|Pregnancy|3|||
48439056|NCT00501046|155793995|FG000|Overall Study|Protocol Violation|2|||
48439057|NCT00501046|155793996|FG001|Overall Study|Protocol Violation|1|||
48439058|NCT00501046|155793995|FG000|Overall Study|Withdrawal by Subject|84|||
48439059|NCT00501046|155793996|FG001|Overall Study|Withdrawal by Subject|83|||
48439060|NCT00501046|155793995|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
48439061|NCT00501046|155793996|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
48439062|NCT00632541|155793997|FG000|Overall Study|Adverse Event|7|||
48439063|NCT00006604|155794002|FG000|Overall Study|Met study objective - no further FU|1|||
48439064|NCT00006604|155794003|FG001|Overall Study|Met study objective - no further FU|0|||
48439065|NCT00006604|155794004|FG002|Overall Study|Met study objective - no further FU|0|||
48439066|NCT00006604|155794005|FG003|Overall Study|Met study objective - no further FU|0|||
48439067|NCT00006604|155794006|FG004|Overall Study|Met study objective - no further FU|0|||
48439068|NCT00006604|155794007|FG005|Overall Study|Met study objective - no further FU|0|||
48439069|NCT00006604|155794008|FG006|Overall Study|Met study objective - no further FU|0|||
48439070|NCT00006604|155794009|FG007|Overall Study|Met study objective - no further FU|0|||
48439071|NCT00006604|155794010|FG008|Overall Study|Met study objective - no further FU|0|||
48439072|NCT00006604|155794011|FG009|Overall Study|Met study objective - no further FU|0|||
48439073|NCT00006604|155794012|FG010|Overall Study|Met study objective - no further FU|0|||
48439074|NCT00006604|155794013|FG011|Overall Study|Met study objective - no further FU|0|||
48439075|NCT00006604|155794014|FG012|Overall Study|Met study objective - no further FU|0|||
48439076|NCT00006604|155794015|FG013|Overall Study|Met study objective - no further FU|0|||
48439077|NCT00006604|155794016|FG014|Overall Study|Met study objective - no further FU|1|||
48439078|NCT00006604|155794017|FG015|Overall Study|Met study objective - no further FU|1|||
48439079|NCT00006604|155794018|FG016|Overall Study|Met study objective - no further FU|0|||
48439080|NCT00006604|155794002|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
48439081|NCT00006604|155794003|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
48439082|NCT00006604|155794004|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
48439083|NCT00006604|155794005|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
48439084|NCT00006604|155794006|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
48439085|NCT00006604|155794007|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
48439086|NCT00006604|155794008|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
48439087|NCT00006604|155794009|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
48439088|NCT00006604|155794010|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
48439089|NCT00006604|155794011|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
48439090|NCT00006604|155794012|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
48439091|NCT00006604|155794013|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
48439092|NCT00006604|155794014|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
48439093|NCT00006604|155794015|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
48439094|NCT00006604|155794016|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
48439095|NCT00006604|155794017|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
48439096|NCT00006604|155794018|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
48439097|NCT00006604|155794002|FG000|Overall Study|Death|0|||
48439098|NCT00006604|155794003|FG001|Overall Study|Death|0|||
48439099|NCT00006604|155794004|FG002|Overall Study|Death|0|||
48439100|NCT00006604|155794005|FG003|Overall Study|Death|0|||
48439101|NCT00006604|155794006|FG004|Overall Study|Death|0|||
48439102|NCT00006604|155794007|FG005|Overall Study|Death|0|||
48439103|NCT00006604|155794008|FG006|Overall Study|Death|0|||
48439104|NCT00006604|155794009|FG007|Overall Study|Death|0|||
48439105|NCT00006604|155794010|FG008|Overall Study|Death|0|||
48439106|NCT00006604|155794011|FG009|Overall Study|Death|1|||
48439107|NCT00006604|155794012|FG010|Overall Study|Death|1|||
48439108|NCT00006604|155794013|FG011|Overall Study|Death|1|||
48439109|NCT00006604|155794014|FG012|Overall Study|Death|0|||
48439110|NCT00006604|155794015|FG013|Overall Study|Death|0|||
48439111|NCT00006604|155794016|FG014|Overall Study|Death|0|||
48439112|NCT00006604|155794017|FG015|Overall Study|Death|0|||
48439113|NCT00006604|155794018|FG016|Overall Study|Death|0|||
48439114|NCT00006604|155794002|FG000|Overall Study|Severe debilitation, unable to continue|0|||
48439115|NCT00006604|155794003|FG001|Overall Study|Severe debilitation, unable to continue|0|||
48439116|NCT00006604|155794004|FG002|Overall Study|Severe debilitation, unable to continue|0|||
48439117|NCT00006604|155794005|FG003|Overall Study|Severe debilitation, unable to continue|0|||
48439118|NCT00006604|155794006|FG004|Overall Study|Severe debilitation, unable to continue|0|||
48439119|NCT00006604|155794007|FG005|Overall Study|Severe debilitation, unable to continue|0|||
48439120|NCT00006604|155794008|FG006|Overall Study|Severe debilitation, unable to continue|3|||
48439121|NCT00006604|155794009|FG007|Overall Study|Severe debilitation, unable to continue|0|||
48439122|NCT00006604|155794010|FG008|Overall Study|Severe debilitation, unable to continue|0|||
48439123|NCT00006604|155794011|FG009|Overall Study|Severe debilitation, unable to continue|5|||
48439124|NCT00006604|155794012|FG010|Overall Study|Severe debilitation, unable to continue|0|||
48439125|NCT00006604|155794013|FG011|Overall Study|Severe debilitation, unable to continue|2|||
48439126|NCT00006604|155794014|FG012|Overall Study|Severe debilitation, unable to continue|1|||
48439127|NCT00006604|155794015|FG013|Overall Study|Severe debilitation, unable to continue|0|||
48439128|NCT00006604|155794016|FG014|Overall Study|Severe debilitation, unable to continue|2|||
48439129|NCT00006604|155794017|FG015|Overall Study|Severe debilitation, unable to continue|0|||
48439130|NCT00006604|155794018|FG016|Overall Study|Severe debilitation, unable to continue|0|||
48439131|NCT00006604|155794002|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
48439132|NCT00006604|155794003|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
48439133|NCT00006604|155794004|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
48439134|NCT00006604|155794005|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
48439135|NCT00006604|155794006|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
48439136|NCT00006604|155794007|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
48439137|NCT00006604|155794008|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
48439138|NCT00006604|155794009|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
48439139|NCT00006604|155794010|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
48439140|NCT00006604|155794011|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
48439141|NCT00006604|155794012|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
48439142|NCT00006604|155794013|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
48439143|NCT00006604|155794014|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
48439144|NCT00006604|155794015|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
48439145|NCT00006604|155794016|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
48439146|NCT00006604|155794017|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
48439147|NCT00006604|155794018|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
48439148|NCT00006604|155794002|FG000|Overall Study|Site closing|0|||
48439149|NCT00006604|155794003|FG001|Overall Study|Site closing|0|||
48439150|NCT00006604|155794004|FG002|Overall Study|Site closing|1|||
48439151|NCT00006604|155794005|FG003|Overall Study|Site closing|1|||
48439152|NCT00006604|155794006|FG004|Overall Study|Site closing|0|||
48439153|NCT00006604|155794007|FG005|Overall Study|Site closing|0|||
48439154|NCT00006604|155794008|FG006|Overall Study|Site closing|0|||
48439155|NCT00006604|155794009|FG007|Overall Study|Site closing|1|||
48439156|NCT00006604|155794010|FG008|Overall Study|Site closing|0|||
48439157|NCT00006604|155794011|FG009|Overall Study|Site closing|0|||
48439158|NCT00006604|155794012|FG010|Overall Study|Site closing|0|||
48439159|NCT00006604|155794013|FG011|Overall Study|Site closing|1|||
48439160|NCT00006604|155794014|FG012|Overall Study|Site closing|1|||
48439161|NCT00006604|155794015|FG013|Overall Study|Site closing|1|||
48439162|NCT00006604|155794016|FG014|Overall Study|Site closing|0|||
48439163|NCT00006604|155794017|FG015|Overall Study|Site closing|0|||
48439164|NCT00006604|155794018|FG016|Overall Study|Site closing|1|||
48439165|NCT00006604|155794002|FG000|Overall Study|Withdrawal by Subject|1|||
48439166|NCT00006604|155794003|FG001|Overall Study|Withdrawal by Subject|0|||
48439167|NCT00006604|155794004|FG002|Overall Study|Withdrawal by Subject|2|||
48439168|NCT00006604|155794005|FG003|Overall Study|Withdrawal by Subject|0|||
48439169|NCT00006604|155794006|FG004|Overall Study|Withdrawal by Subject|1|||
48439170|NCT00006604|155794007|FG005|Overall Study|Withdrawal by Subject|2|||
48439171|NCT00006604|155794008|FG006|Overall Study|Withdrawal by Subject|2|||
48439172|NCT00006604|155794009|FG007|Overall Study|Withdrawal by Subject|0|||
48439173|NCT00006604|155794010|FG008|Overall Study|Withdrawal by Subject|1|||
48439174|NCT00006604|155794011|FG009|Overall Study|Withdrawal by Subject|3|||
48439175|NCT00006604|155794012|FG010|Overall Study|Withdrawal by Subject|2|||
48439176|NCT00006604|155794013|FG011|Overall Study|Withdrawal by Subject|0|||
48439177|NCT00006604|155794014|FG012|Overall Study|Withdrawal by Subject|1|||
48439178|NCT00006604|155794015|FG013|Overall Study|Withdrawal by Subject|2|||
48439179|NCT00006604|155794016|FG014|Overall Study|Withdrawal by Subject|1|||
48439180|NCT00006604|155794017|FG015|Overall Study|Withdrawal by Subject|0|||
48439181|NCT00006604|155794018|FG016|Overall Study|Withdrawal by Subject|1|||
48439182|NCT00006604|155794002|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
48439183|NCT00006604|155794003|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
48439184|NCT00006604|155794004|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
48439185|NCT00006604|155794005|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
48439186|NCT00006604|155794006|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
48439187|NCT00006604|155794007|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
48439188|NCT00006604|155794008|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
48439189|NCT00006604|155794009|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
48439190|NCT00006604|155794010|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
48439191|NCT00006604|155794011|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
48439192|NCT00006604|155794012|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
48439193|NCT00006604|155794013|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
48439194|NCT00006604|155794014|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
48439195|NCT00006604|155794015|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
48439196|NCT00006604|155794016|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
48439197|NCT00006604|155794017|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
48439198|NCT00006604|155794018|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
48439199|NCT00006604|155794002|FG000|Overall Study|Lost to Follow-up|0|||
48439200|NCT00006604|155794003|FG001|Overall Study|Lost to Follow-up|0|||
48439201|NCT00006604|155794004|FG002|Overall Study|Lost to Follow-up|0|||
48439202|NCT00006604|155794005|FG003|Overall Study|Lost to Follow-up|0|||
48439203|NCT00006604|155794006|FG004|Overall Study|Lost to Follow-up|0|||
48439204|NCT00006604|155794007|FG005|Overall Study|Lost to Follow-up|0|||
48439205|NCT00006604|155794008|FG006|Overall Study|Lost to Follow-up|0|||
48439206|NCT00006604|155794009|FG007|Overall Study|Lost to Follow-up|1|||
48439207|NCT00006604|155794010|FG008|Overall Study|Lost to Follow-up|0|||
48439208|NCT00006604|155794011|FG009|Overall Study|Lost to Follow-up|2|||
48439209|NCT00006604|155794012|FG010|Overall Study|Lost to Follow-up|0|||
48439210|NCT00006604|155794013|FG011|Overall Study|Lost to Follow-up|0|||
48439211|NCT00006604|155794014|FG012|Overall Study|Lost to Follow-up|0|||
48439212|NCT00006604|155794015|FG013|Overall Study|Lost to Follow-up|0|||
48439213|NCT00006604|155794016|FG014|Overall Study|Lost to Follow-up|0|||
48439214|NCT00006604|155794017|FG015|Overall Study|Lost to Follow-up|1|||
48439215|NCT00006604|155794018|FG016|Overall Study|Lost to Follow-up|3|||
48439216|NCT00006604|155794002|FG000|Overall Study|Other Reason|0|||
48439217|NCT00006604|155794003|FG001|Overall Study|Other Reason|0|||
48439218|NCT00006604|155794004|FG002|Overall Study|Other Reason|0|||
48439219|NCT00006604|155794005|FG003|Overall Study|Other Reason|0|||
48439220|NCT00006604|155794006|FG004|Overall Study|Other Reason|0|||
48439221|NCT00006604|155794007|FG005|Overall Study|Other Reason|1|||
48439222|NCT00006604|155794008|FG006|Overall Study|Other Reason|0|||
48439223|NCT00006604|155794009|FG007|Overall Study|Other Reason|0|||
48439224|NCT00006604|155794010|FG008|Overall Study|Other Reason|0|||
48439225|NCT00006604|155794011|FG009|Overall Study|Other Reason|1|||
48439226|NCT00006604|155794012|FG010|Overall Study|Other Reason|0|||
48439227|NCT00006604|155794013|FG011|Overall Study|Other Reason|0|||
48439228|NCT00006604|155794014|FG012|Overall Study|Other Reason|0|||
48439229|NCT00006604|155794015|FG013|Overall Study|Other Reason|0|||
48439230|NCT00006604|155794016|FG014|Overall Study|Other Reason|0|||
48439231|NCT00006604|155794017|FG015|Overall Study|Other Reason|0|||
48439232|NCT00006604|155794018|FG016|Overall Study|Other Reason|0|||
48439233|NCT02431468|155794019|FG000|Overall Study|Adverse Event|2|||
48439234|NCT02431468|155794020|FG001|Overall Study|Adverse Event|4|||
48439235|NCT02431468|155794021|FG002|Overall Study|Adverse Event|5|||
48439236|NCT02431468|155794019|FG000|Overall Study|Withdrawal by Subject|4|||
48439237|NCT02431468|155794020|FG001|Overall Study|Withdrawal by Subject|12|||
48439238|NCT02431468|155794021|FG002|Overall Study|Withdrawal by Subject|2|||
48439239|NCT02431468|155794019|FG000|Overall Study|noncompliance, investigator termination,|2|||
48439240|NCT02431468|155794020|FG001|Overall Study|noncompliance, investigator termination,|2|||
48439241|NCT02431468|155794021|FG002|Overall Study|noncompliance, investigator termination,|2|||
48439242|NCT03629041|155794022|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
48439243|NCT03629041|155794023|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
48439393|NCT00082758|155795987|FG000|Overall Study|Adverse Event|0|||
48439244|NCT03629041|155794024|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
48439245|NCT03629041|155794025|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
48439246|NCT01056341|155794026|FG000|Overall Study|Treatment Intolerance|0|||
48439247|NCT01056341|155794027|FG001|Overall Study|Treatment Intolerance|2|||
48439248|NCT01056341|155794028|FG002|Overall Study|Treatment Intolerance|0|||
48439249|NCT01056341|155794029|FG003|Overall Study|Treatment Intolerance|2|||
48439250|NCT01056341|155794030|FG004|Overall Study|Treatment Intolerance|0|||
48439251|NCT01056341|155794026|FG000|Overall Study|Lack of Efficacy|32|||
48439252|NCT01056341|155794027|FG001|Overall Study|Lack of Efficacy|30|||
48439253|NCT01056341|155794028|FG002|Overall Study|Lack of Efficacy|7|||
48439254|NCT01056341|155794029|FG003|Overall Study|Lack of Efficacy|25|||
48439255|NCT01056341|155794030|FG004|Overall Study|Lack of Efficacy|9|||
48439256|NCT01056341|155794026|FG000|Overall Study|Other reasons|4|||
48439257|NCT01056341|155794027|FG001|Overall Study|Other reasons|4|||
48439258|NCT01056341|155794028|FG002|Overall Study|Other reasons|8|||
48439259|NCT01056341|155794029|FG003|Overall Study|Other reasons|9|||
48439260|NCT01056341|155794030|FG004|Overall Study|Other reasons|5|||
48439261|NCT01361919|155794031|FG000|Overall Study|technical issues|10|||
48439262|NCT01361919|155794032|FG001|Overall Study|technical issues|12|||
48439263|NCT01361919|155794033|FG002|Overall Study|technical issues|10|||
48439264|NCT01391819|155794034|FG000|Overall Study|Withdrawal by Subject|56|||
48439265|NCT01391819|155794034|FG000|Overall Study|Migrated/moved from study area|82|||
48439266|NCT01391819|155794034|FG000|Overall Study|Lost to Follow-up|252|||
48439267|NCT01391819|155794034|FG000|Overall Study|Death|3|||
48439268|NCT01391819|155794034|FG000|Overall Study|Other|9|||
48439269|NCT03454412|155794040|FG000|Baseline Assesment|Physician Decision|12|||
48439270|NCT02475395|155794041|FG000|Overall Study|Protocol Violation|30|||
48439271|NCT02475395|155794042|FG001|Overall Study|Protocol Violation|3|||
48439272|NCT00393913|155794044|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
48439273|NCT00393913|155794044|FG000|Initial Assessment|Withdrawal by Subject|16|||
48439274|NCT00393913|155794044|FG000|CPAP|Withdrawal by Subject|3|||
48439275|NCT00393913|155794044|FG000|CPAP|Physician Decision|1|||
48439276|NCT00393913|155794044|FG000|CPAP|TEchnical problem with CPAP|3|||
48439277|NCT01086150|155794045|FG000|Overall Study|Withdrawal by Subject|0|||
48439278|NCT01086150|155794046|FG001|Overall Study|Withdrawal by Subject|4|||
48439279|NCT01086150|155794047|FG002|Overall Study|Withdrawal by Subject|1|||
48439280|NCT01086150|155794045|FG000|Overall Study|Lost to Follow-up|0|||
48439281|NCT01086150|155794046|FG001|Overall Study|Lost to Follow-up|1|||
48439282|NCT01086150|155794047|FG002|Overall Study|Lost to Follow-up|0|||
48439283|NCT01086150|155794045|FG000|Overall Study|Screen Failure|0|||
48439284|NCT01086150|155794046|FG001|Overall Study|Screen Failure|1|||
48439285|NCT01086150|155794047|FG002|Overall Study|Screen Failure|0|||
48439286|NCT01927419|155794048|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
48439287|NCT01927419|155794049|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
48439288|NCT01927419|155794048|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
48439289|NCT01927419|155794049|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
48439290|NCT01927419|155794048|FG000|Treatment Period|Disease progression|17|||
48439291|NCT01927419|155794049|FG001|Treatment Period|Disease progression|20|||
48439292|NCT01927419|155794048|FG000|Treatment Period|Study drug toxicity|48|||
48439293|NCT01927419|155794049|FG001|Treatment Period|Study drug toxicity|10|||
48439294|NCT01927419|155794048|FG000|Treatment Period|Death|0|||
48439295|NCT01927419|155794049|FG001|Treatment Period|Death|1|||
48439296|NCT01927419|155794048|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
48439297|NCT01927419|155794049|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
48439298|NCT01927419|155794048|FG000|Treatment Period|Participant request to discontinue|12|||
48439299|NCT01927419|155794049|FG001|Treatment Period|Participant request to discontinue|4|||
48439300|NCT01927419|155794048|FG000|Treatment Period|Withdrawal by Subject|1|||
48439301|NCT01927419|155794049|FG001|Treatment Period|Withdrawal by Subject|1|||
48439302|NCT01927419|155794048|FG000|Treatment Period|Maximum Clinical Benefit|6|||
48439303|NCT01927419|155794049|FG001|Treatment Period|Maximum Clinical Benefit|2|||
48439304|NCT01927419|155794048|FG000|Treatment Period|Other reasons|3|||
48439305|NCT01927419|155794049|FG001|Treatment Period|Other reasons|4|||
48439306|NCT01927419|155794048|FG000|Treatment Period|Not Reported|1|||
48439307|NCT01927419|155794049|FG001|Treatment Period|Not Reported|1|||
48439308|NCT03488251|155794052|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
48439309|NCT03488251|155794053|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
48439310|NCT03488251|155794054|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
48439311|NCT03488251|155794055|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
48439312|NCT03488251|155794052|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
48439313|NCT03488251|155794053|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
48439314|NCT03488251|155794054|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
48439315|NCT03488251|155794055|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
48439316|NCT03488251|155794052|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
48439317|NCT03488251|155794053|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
48439318|NCT03488251|155794054|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
48439319|NCT03488251|155794055|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
48439320|NCT03488251|155794052|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
48439321|NCT03488251|155794053|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
48439322|NCT03488251|155794054|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
48439323|NCT03488251|155794055|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
48439324|NCT03488251|155794052|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
48439325|NCT03488251|155794053|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
48439326|NCT03488251|155794054|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
48439327|NCT03488251|155794055|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
48439328|NCT03730194|155794056|FG000|First Stage Treatment|Withdrawal by Subject|1|||
48439329|NCT03730194|155794057|FG001|First Stage Treatment|Withdrawal by Subject|1|||
48439330|NCT03730194|155794058|FG002|First Stage Treatment|Withdrawal by Subject|0|||
48439331|NCT03730194|155794059|FG003|First Stage Treatment|Withdrawal by Subject|0|||
48439332|NCT03730194|155794060|FG004|First Stage Treatment|Withdrawal by Subject|0|||
48439333|NCT03730194|155794061|FG005|First Stage Treatment|Withdrawal by Subject|0|||
48439334|NCT03730194|155794056|FG000|First Stage Treatment|Protocol Violation|3|||
48439335|NCT03730194|155794057|FG001|First Stage Treatment|Protocol Violation|3|||
48439336|NCT03730194|155794058|FG002|First Stage Treatment|Protocol Violation|0|||
48439337|NCT03730194|155794059|FG003|First Stage Treatment|Protocol Violation|0|||
48439338|NCT03730194|155794060|FG004|First Stage Treatment|Protocol Violation|0|||
48439339|NCT03730194|155794061|FG005|First Stage Treatment|Protocol Violation|0|||
48439340|NCT01681576|155794064|FG000|Period 1|Adverse Event|1|||
48439341|NCT01681576|155794065|FG001|Period 1|Adverse Event|0|||
48439342|NCT01681576|155794064|FG000|Period 1|Protocol Deviation|1|||
48439343|NCT01681576|155794065|FG001|Period 1|Protocol Deviation|0|||
48439344|NCT01681576|155794064|FG000|Period 2|subject/guardian decision|3|||
48439345|NCT01681576|155794065|FG001|Period 2|subject/guardian decision|1|||
48439346|NCT01681576|155794064|FG000|Period 2|Non-compliance with study treatment|1|||
48439347|NCT01681576|155794065|FG001|Period 2|Non-compliance with study treatment|0|||
48439348|NCT03137121|155795944|FG000|Overall Study|Withdrawal by Subject|0|||
48439349|NCT03137121|155795945|FG001|Overall Study|Withdrawal by Subject|1|||
48439350|NCT03196193|155795948|FG000|Overall Study|Adverse Event|1|||
48439351|NCT03196193|155795949|FG001|Overall Study|Adverse Event|0|||
48439352|NCT03196193|155795948|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
48439353|NCT03196193|155795949|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
48439354|NCT02709083|155795950|FG000|Overall Study|Original PI left institution|7|||
48439355|NCT00111475|155795954|FG000|Overall Study|Lost to Follow-up|0|||
48439356|NCT00111475|155795955|FG001|Overall Study|Lost to Follow-up|0|||
48439357|NCT00111475|155795956|FG002|Overall Study|Lost to Follow-up|0|||
48439358|NCT00111475|155795957|FG003|Overall Study|Lost to Follow-up|0|||
48439359|NCT00111475|155795958|FG004|Overall Study|Lost to Follow-up|0|||
48439360|NCT00111475|155795959|FG005|Overall Study|Lost to Follow-up|1|||
48439361|NCT00111475|155795960|FG006|Overall Study|Lost to Follow-up|0|||
48439362|NCT00111475|155795961|FG007|Overall Study|Lost to Follow-up|0|||
48439363|NCT00111475|155795962|FG008|Overall Study|Lost to Follow-up|0|||
48439364|NCT00111475|155795963|FG009|Overall Study|Lost to Follow-up|0|||
48439365|NCT01956240|155795970|FG000|Overall Study|Lost to Follow-up|6|||
48439366|NCT01956240|155795971|FG001|Overall Study|Lost to Follow-up|20|||
48439367|NCT01956240|155795970|FG000|Overall Study|Adverse Event|17|||
48439368|NCT01956240|155795971|FG001|Overall Study|Adverse Event|4|||
48439369|NCT02387372|155795977|FG000|Overall Study|Not Treated|1|||
48439370|NCT02387372|155795978|FG001|Overall Study|Not Treated|0|||
48439371|NCT01757405|155795980|FG000|Overall Study|Lost to Follow-up|1|||
48439372|NCT01757405|155795981|FG001|Overall Study|Lost to Follow-up|1|||
48439373|NCT01757405|155795980|FG000|Overall Study|Withdrawal by Subject|0|||
48439374|NCT01757405|155795981|FG001|Overall Study|Withdrawal by Subject|1|||
48439375|NCT02168803|155795983|FG000|Overall Study|Lost to Follow-up|1|||
48439376|NCT02168803|155795984|FG001|Overall Study|Lost to Follow-up|0|||
48439377|NCT02168803|155795985|FG002|Overall Study|Lost to Follow-up|1|||
48439378|NCT02168803|155795983|FG000|Overall Study|Withdrawal by Subject|1|||
48439379|NCT02168803|155795984|FG001|Overall Study|Withdrawal by Subject|1|||
48439380|NCT02168803|155795985|FG002|Overall Study|Withdrawal by Subject|2|||
48439381|NCT02168803|155795983|FG000|Overall Study|Physician Decision|0|||
48439382|NCT02168803|155795984|FG001|Overall Study|Physician Decision|1|||
48439383|NCT02168803|155795985|FG002|Overall Study|Physician Decision|0|||
48439384|NCT02168803|155795983|FG000|Overall Study|Adverse Event|0|||
48439385|NCT02168803|155795984|FG001|Overall Study|Adverse Event|1|||
48439386|NCT02168803|155795985|FG002|Overall Study|Adverse Event|1|||
48439387|NCT02168803|155795983|FG000|Overall Study|Death|0|||
48439388|NCT02168803|155795984|FG001|Overall Study|Death|0|||
48439389|NCT02168803|155795985|FG002|Overall Study|Death|1|||
48439390|NCT02168803|155795983|FG000|Overall Study|Sponsor Decision|0|||
48439391|NCT02168803|155795984|FG001|Overall Study|Sponsor Decision|0|||
48439392|NCT02168803|155795985|FG002|Overall Study|Sponsor Decision|1|||
48439463|NCT02767856|155796038|FG001|Overall Study|Withdrawal by Subject|1|||
48439464|NCT01464788|155796041|FG000|Overall Study|Lost to Follow-up|0|||
48439465|NCT01464788|155796042|FG001|Overall Study|Lost to Follow-up|1|||
48439466|NCT01464788|155796043|FG002|Overall Study|Lost to Follow-up|0|||
48439467|NCT01464788|155796041|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
48439468|NCT01464788|155796042|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
48439469|NCT01464788|155796043|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
48439470|NCT01764256|155796047|FG000|Received All Vaccinations|Adverse Event|1|||
48439471|NCT01764256|155796048|FG001|Received All Vaccinations|Adverse Event|1|||
48439472|NCT01764256|155796049|FG002|Received All Vaccinations|Adverse Event|0|||
48439473|NCT01764256|155796050|FG003|Received All Vaccinations|Adverse Event|0|||
48439474|NCT01764256|155796047|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
48439475|NCT01764256|155796048|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
48439476|NCT01764256|155796049|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
48439477|NCT01764256|155796050|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
48439478|NCT01764256|155796047|FG000|Received All Vaccinations|Lost to Follow-up|1|||
48439479|NCT01764256|155796048|FG001|Received All Vaccinations|Lost to Follow-up|0|||
48439480|NCT01764256|155796049|FG002|Received All Vaccinations|Lost to Follow-up|0|||
48439481|NCT01764256|155796050|FG003|Received All Vaccinations|Lost to Follow-up|0|||
48439482|NCT01764256|155796047|FG000|Completed Study|Lost to Follow-up|0|||
48439483|NCT01764256|155796048|FG001|Completed Study|Lost to Follow-up|0|||
48439484|NCT01764256|155796049|FG002|Completed Study|Lost to Follow-up|0|||
48439485|NCT01764256|155796050|FG003|Completed Study|Lost to Follow-up|1|||
48439486|NCT04587453|155796051|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
48439487|NCT04587453|155796052|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
48439488|NCT02662985|155796053|FG000|Treatment Period 1|Adverse Event|0|||
48439489|NCT02662985|155796054|FG001|Treatment Period 1|Adverse Event|2|||
48439490|NCT02662985|155796053|FG000|Treatment Period 1|Protocol Violation|0|||
48439491|NCT02662985|155796054|FG001|Treatment Period 1|Protocol Violation|1|||
48439492|NCT02662985|155796053|FG000|Treatment Period 1|Physician Decision|1|||
48439493|NCT02662985|155796054|FG001|Treatment Period 1|Physician Decision|0|||
48439494|NCT02662985|155796053|FG000|Treatment Period 1|Withdrawal by Subject|0|||
48439495|NCT02662985|155796054|FG001|Treatment Period 1|Withdrawal by Subject|1|||
48439496|NCT02662985|155796053|FG000|Treatment Period 2|Lack of Efficacy|0|||
48439497|NCT02662985|155796054|FG001|Treatment Period 2|Lack of Efficacy|1|||
48439498|NCT02662985|155796053|FG000|Treatment Period 2|Lost to Follow-up|1|||
48439499|NCT02662985|155796054|FG001|Treatment Period 2|Lost to Follow-up|0|||
48439500|NCT02662985|155796053|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
48439501|NCT02662985|155796054|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
48439502|NCT02662985|155796053|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
48439503|NCT02662985|155796054|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
48439504|NCT02662985|155796053|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
48439505|NCT02662985|155796054|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
48439506|NCT02662985|155796053|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
48439507|NCT02662985|155796054|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
48439508|NCT02662985|155796053|FG000|Treatment Period 3 (Extension Period)|Death|0|||
48439509|NCT02662985|155796054|FG001|Treatment Period 3 (Extension Period)|Death|1|||
48439510|NCT02932332|155796055|FG000|Overall Study|Withdrawal by Subject|1|||
48439511|NCT02932332|155796056|FG001|Overall Study|Withdrawal by Subject|1|||
48439512|NCT02932332|155796057|FG002|Overall Study|Withdrawal by Subject|0|||
48439513|NCT02932332|155796058|FG003|Overall Study|Withdrawal by Subject|1|||
48439514|NCT02932332|155796055|FG000|Overall Study|Chest pain|0|||
48439515|NCT02932332|155796056|FG001|Overall Study|Chest pain|0|||
48439516|NCT02932332|155796057|FG002|Overall Study|Chest pain|0|||
48439517|NCT02932332|155796058|FG003|Overall Study|Chest pain|1|||
48439518|NCT02932332|155796055|FG000|Overall Study|Not Dyspneic cough|1|||
48439519|NCT02932332|155796056|FG001|Overall Study|Not Dyspneic cough|2|||
48439520|NCT02932332|155796057|FG002|Overall Study|Not Dyspneic cough|1|||
48439521|NCT02932332|155796058|FG003|Overall Study|Not Dyspneic cough|0|||
48439522|NCT01486784|155796060|FG000|Overall Study|Withdrawal by Subject|0|||
48439523|NCT01486784|155796061|FG001|Overall Study|Withdrawal by Subject|0|||
48439524|NCT01486784|155796062|FG002|Overall Study|Withdrawal by Subject|1|||
48439525|NCT01486784|155796063|FG003|Overall Study|Withdrawal by Subject|0|||
48439526|NCT01486784|155796064|FG004|Overall Study|Withdrawal by Subject|1|||
48439527|NCT01486784|155796065|FG005|Overall Study|Withdrawal by Subject|2|||
48439528|NCT01486784|155796060|FG000|Overall Study|Subject did not meet entry criteria|0|||
48439529|NCT01486784|155796061|FG001|Overall Study|Subject did not meet entry criteria|0|||
48439530|NCT01486784|155796062|FG002|Overall Study|Subject did not meet entry criteria|0|||
48439531|NCT01486784|155796063|FG003|Overall Study|Subject did not meet entry criteria|0|||
48439532|NCT01486784|155796064|FG004|Overall Study|Subject did not meet entry criteria|1|||
48439533|NCT01486784|155796065|FG005|Overall Study|Subject did not meet entry criteria|0|||
48439534|NCT01486784|155796060|FG000|Overall Study|Death|0|||
48439535|NCT01486784|155796061|FG001|Overall Study|Death|0|||
48439554|NCT01561560|155796071|FG000|Second Two Weeks of Wear|Adverse Event|0|||
48439555|NCT01561560|155796072|FG001|Second Two Weeks of Wear|Adverse Event|1|||
48439556|NCT03176277|155796073|FG000|Part A Dose Escalation Study|Adverse Event|1|||
48439557|NCT03176277|155796074|FG001|Part A Dose Escalation Study|Adverse Event|0|||
48439558|NCT03176277|155796075|FG002|Part A Dose Escalation Study|Adverse Event|1|||
48439559|NCT03176277|155796076|FG003|Part A Dose Escalation Study|Adverse Event|0|||
48439560|NCT03176277|155796073|FG000|Part A Dose Escalation Study|Physician Decision|1|||
48439561|NCT03176277|155796074|FG001|Part A Dose Escalation Study|Physician Decision|1|||
48439562|NCT03176277|155796075|FG002|Part A Dose Escalation Study|Physician Decision|2|||
48439563|NCT03176277|155796076|FG003|Part A Dose Escalation Study|Physician Decision|0|||
48439564|NCT03176277|155796073|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
48439565|NCT03176277|155796074|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
48439566|NCT03176277|155796075|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
48439567|NCT03176277|155796076|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
48439568|NCT03176277|155796073|FG000|Part A Dose Escalation Study|Progressive disease|3|||
48439569|NCT03176277|155796074|FG001|Part A Dose Escalation Study|Progressive disease|1|||
48439570|NCT03176277|155796075|FG002|Part A Dose Escalation Study|Progressive disease|3|||
48439571|NCT03176277|155796076|FG003|Part A Dose Escalation Study|Progressive disease|0|||
48439572|NCT05294211|155796079|FG000|Overall Study|Withdrawal by Subject|3|||
48439573|NCT05294211|155796079|FG000|Overall Study|Physician Decision|2|||
48439574|NCT05294211|155796079|FG000|Overall Study|Progressed to active labor|1|||
48439575|NCT05294211|155796079|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
48439576|NCT05294211|155796079|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
48439577|NCT00406783|155796080|FG000|Overall Study|Adverse Event|4|||
48439578|NCT00406783|155796081|FG001|Overall Study|Adverse Event|4|||
48439579|NCT00406783|155796080|FG000|Overall Study|Treatment Failure|2|||
48439580|NCT00406783|155796081|FG001|Overall Study|Treatment Failure|3|||
48439581|NCT00406783|155796080|FG000|Overall Study|Lost to Follow-up|3|||
48439582|NCT00406783|155796081|FG001|Overall Study|Lost to Follow-up|0|||
48439583|NCT00406783|155796080|FG000|Overall Study|Withdrawal by Subject|1|||
48439584|NCT00406783|155796081|FG001|Overall Study|Withdrawal by Subject|4|||
48439585|NCT00406783|155796080|FG000|Overall Study|Protocol Violation|4|||
48439586|NCT00406783|155796081|FG001|Overall Study|Protocol Violation|4|||
48439587|NCT00064350|155796082|FG000|Induction Treatment|Disease Progression|5|||
48439588|NCT00064350|155796083|FG001|Induction Treatment|Disease Progression|1|||
48439589|NCT00064350|155796084|FG002|Induction Treatment|Disease Progression|110|||
48439590|NCT00064350|155796082|FG000|Induction Treatment|Adverse Event|0|||
48439591|NCT00064350|155796083|FG001|Induction Treatment|Adverse Event|2|||
48439592|NCT00064350|155796084|FG002|Induction Treatment|Adverse Event|49|||
48439593|NCT00064350|155796082|FG000|Induction Treatment|Death|0|||
48439594|NCT00064350|155796083|FG001|Induction Treatment|Death|0|||
48439595|NCT00064350|155796084|FG002|Induction Treatment|Death|9|||
48439596|NCT00064350|155796082|FG000|Induction Treatment|Withdrawal by Subject|0|||
48439597|NCT00064350|155796083|FG001|Induction Treatment|Withdrawal by Subject|0|||
48439598|NCT00064350|155796084|FG002|Induction Treatment|Withdrawal by Subject|21|||
48439599|NCT00064350|155796082|FG000|Induction Treatment|Ineligible or never started treatment|3|||
48439600|NCT00064350|155796083|FG001|Induction Treatment|Ineligible or never started treatment|6|||
48439601|NCT00064350|155796084|FG002|Induction Treatment|Ineligible or never started treatment|34|||
48439602|NCT00064350|155796082|FG000|Induction Treatment|Other|0|||
48439603|NCT00064350|155796083|FG001|Induction Treatment|Other|0|||
48439604|NCT00064350|155796084|FG002|Induction Treatment|Other|13|||
48439605|NCT00064350|155796082|FG000|Randomization|Adverse Event|8|||
48439606|NCT00064350|155796083|FG001|Randomization|Adverse Event|3|||
48439607|NCT00064350|155796084|FG002|Randomization|Adverse Event|0|||
48439608|NCT00064350|155796082|FG000|Randomization|Death|3|||
48439609|NCT00064350|155796083|FG001|Randomization|Death|0|||
48439610|NCT00064350|155796084|FG002|Randomization|Death|0|||
48439611|NCT00064350|155796082|FG000|Randomization|Withdrawal by Subject|1|||
48439612|NCT00064350|155796083|FG001|Randomization|Withdrawal by Subject|0|||
48439613|NCT00064350|155796084|FG002|Randomization|Withdrawal by Subject|0|||
48439614|NCT00064350|155796082|FG000|Randomization|Ineligible or never started treatment|9|||
48439615|NCT00064350|155796083|FG001|Randomization|Ineligible or never started treatment|15|||
48439616|NCT00064350|155796084|FG002|Randomization|Ineligible or never started treatment|0|||
48439617|NCT00064350|155796082|FG000|Randomization|Other|5|||
48439618|NCT00064350|155796083|FG001|Randomization|Other|0|||
48439619|NCT00064350|155796084|FG002|Randomization|Other|0|||
48439620|NCT00064350|155796082|FG000|Cross-Over|Adverse Event|0|||
48439621|NCT00064350|155796083|FG001|Cross-Over|Adverse Event|1|||
48439622|NCT00064350|155796084|FG002|Cross-Over|Adverse Event|0|||
48439623|NCT00064350|155796082|FG000|Cross-Over|Death|1|||
48439624|NCT00064350|155796083|FG001|Cross-Over|Death|3|||
48439625|NCT00064350|155796084|FG002|Cross-Over|Death|0|||
48439626|NCT00064350|155796082|FG000|Cross-Over|Withdrawal by Subject|2|||
48439627|NCT00064350|155796083|FG001|Cross-Over|Withdrawal by Subject|2|||
48439628|NCT00064350|155796084|FG002|Cross-Over|Withdrawal by Subject|0|||
48439629|NCT00064350|155796082|FG000|Cross-Over|Ineligible or never started treatment|3|||
48439712|NCT01969799|155796099|FG001|Overall Study|Death|11|||
48439630|NCT00064350|155796083|FG001|Cross-Over|Ineligible or never started treatment|6|||
48439631|NCT00064350|155796084|FG002|Cross-Over|Ineligible or never started treatment|0|||
48439632|NCT00064350|155796082|FG000|Cross-Over|Other|0|||
48439633|NCT00064350|155796083|FG001|Cross-Over|Other|2|||
48439634|NCT00064350|155796084|FG002|Cross-Over|Other|0|||
48439635|NCT03334396|155796085|FG000|Overall Study|Adverse Event|1|||
48439636|NCT03334396|155796086|FG001|Overall Study|Adverse Event|0|||
48439637|NCT03334396|155796087|FG002|Overall Study|Adverse Event|1|||
48439638|NCT03334396|155796088|FG003|Overall Study|Adverse Event|0|||
48439639|NCT03334396|155796089|FG004|Overall Study|Adverse Event|0|||
48439640|NCT03334396|155796090|FG005|Overall Study|Adverse Event|0|||
48439641|NCT03334396|155796091|FG006|Overall Study|Adverse Event|0|||
48439642|NCT03334396|155796092|FG007|Overall Study|Adverse Event|0|||
48439643|NCT03334396|155796085|FG000|Overall Study|Lack of Efficacy|10|||
48439644|NCT03334396|155796086|FG001|Overall Study|Lack of Efficacy|4|||
48439645|NCT03334396|155796087|FG002|Overall Study|Lack of Efficacy|1|||
48439646|NCT03334396|155796088|FG003|Overall Study|Lack of Efficacy|3|||
48439647|NCT03334396|155796089|FG004|Overall Study|Lack of Efficacy|1|||
48439648|NCT03334396|155796090|FG005|Overall Study|Lack of Efficacy|0|||
48439649|NCT03334396|155796091|FG006|Overall Study|Lack of Efficacy|0|||
48439650|NCT03334396|155796092|FG007|Overall Study|Lack of Efficacy|1|||
48439651|NCT03334396|155796085|FG000|Overall Study|Lost to Follow-up|0|||
48439652|NCT03334396|155796086|FG001|Overall Study|Lost to Follow-up|0|||
48439653|NCT03334396|155796087|FG002|Overall Study|Lost to Follow-up|1|||
48439654|NCT03334396|155796088|FG003|Overall Study|Lost to Follow-up|0|||
48439655|NCT03334396|155796089|FG004|Overall Study|Lost to Follow-up|0|||
48439656|NCT03334396|155796090|FG005|Overall Study|Lost to Follow-up|0|||
48439657|NCT03334396|155796091|FG006|Overall Study|Lost to Follow-up|1|||
48439658|NCT03334396|155796092|FG007|Overall Study|Lost to Follow-up|0|||
48439659|NCT03334396|155796085|FG000|Overall Study|Physician Decision|1|||
48439660|NCT03334396|155796086|FG001|Overall Study|Physician Decision|0|||
48439661|NCT03334396|155796087|FG002|Overall Study|Physician Decision|0|||
48439662|NCT03334396|155796088|FG003|Overall Study|Physician Decision|0|||
48439663|NCT03334396|155796089|FG004|Overall Study|Physician Decision|0|||
48439664|NCT03334396|155796090|FG005|Overall Study|Physician Decision|0|||
48439665|NCT03334396|155796091|FG006|Overall Study|Physician Decision|0|||
48439666|NCT03334396|155796092|FG007|Overall Study|Physician Decision|0|||
48439667|NCT03334396|155796085|FG000|Overall Study|Withdrawal by Subject|10|||
48439668|NCT03334396|155796086|FG001|Overall Study|Withdrawal by Subject|5|||
48439669|NCT03334396|155796087|FG002|Overall Study|Withdrawal by Subject|7|||
48439670|NCT03334396|155796088|FG003|Overall Study|Withdrawal by Subject|2|||
48439671|NCT03334396|155796089|FG004|Overall Study|Withdrawal by Subject|2|||
48439672|NCT03334396|155796090|FG005|Overall Study|Withdrawal by Subject|1|||
48439673|NCT03334396|155796091|FG006|Overall Study|Withdrawal by Subject|2|||
48439674|NCT03334396|155796092|FG007|Overall Study|Withdrawal by Subject|0|||
48439675|NCT03334396|155796085|FG000|Overall Study|Pregnancy|0|||
48439676|NCT03334396|155796086|FG001|Overall Study|Pregnancy|1|||
48439677|NCT03334396|155796087|FG002|Overall Study|Pregnancy|0|||
48439678|NCT03334396|155796088|FG003|Overall Study|Pregnancy|0|||
48439679|NCT03334396|155796089|FG004|Overall Study|Pregnancy|0|||
48439680|NCT03334396|155796090|FG005|Overall Study|Pregnancy|0|||
48439681|NCT03334396|155796091|FG006|Overall Study|Pregnancy|0|||
48439682|NCT03334396|155796092|FG007|Overall Study|Pregnancy|0|||
48439683|NCT03334396|155796085|FG000|Overall Study|Ineligible|0|||
48439684|NCT03334396|155796086|FG001|Overall Study|Ineligible|1|||
48439685|NCT03334396|155796087|FG002|Overall Study|Ineligible|0|||
48439686|NCT03334396|155796088|FG003|Overall Study|Ineligible|0|||
48439687|NCT03334396|155796089|FG004|Overall Study|Ineligible|0|||
48439688|NCT03334396|155796090|FG005|Overall Study|Ineligible|0|||
48439689|NCT03334396|155796091|FG006|Overall Study|Ineligible|0|||
48439690|NCT03334396|155796092|FG007|Overall Study|Ineligible|0|||
48439691|NCT03334396|155796085|FG000|Overall Study|Started New Job|1|||
48439692|NCT03334396|155796086|FG001|Overall Study|Started New Job|0|||
48439693|NCT03334396|155796087|FG002|Overall Study|Started New Job|0|||
48439694|NCT03334396|155796088|FG003|Overall Study|Started New Job|0|||
48439695|NCT03334396|155796089|FG004|Overall Study|Started New Job|0|||
48439696|NCT03334396|155796090|FG005|Overall Study|Started New Job|0|||
48439697|NCT03334396|155796091|FG006|Overall Study|Started New Job|0|||
48439698|NCT03334396|155796092|FG007|Overall Study|Started New Job|0|||
48439699|NCT00353496|155796093|FG000|Overall Study|Adverse Event|1|||
48439700|NCT00353496|155796094|FG001|Overall Study|Adverse Event|0|||
48439701|NCT00353496|155796093|FG000|Overall Study|Protocol Violation|2|||
48439702|NCT00353496|155796094|FG001|Overall Study|Protocol Violation|2|||
48439703|NCT00353496|155796093|FG000|Overall Study|Withdrawal by Subject|3|||
48439704|NCT00353496|155796094|FG001|Overall Study|Withdrawal by Subject|4|||
48439705|NCT00353496|155796093|FG000|Overall Study|Physician Decision|6|||
48439706|NCT00353496|155796094|FG001|Overall Study|Physician Decision|9|||
48439707|NCT00353496|155796093|FG000|Overall Study|Not otherwise specified|4|||
48439708|NCT00353496|155796094|FG001|Overall Study|Not otherwise specified|2|||
48439709|NCT01969799|155796098|FG000|Overall Study|Adverse Event|0|||
48439710|NCT01969799|155796099|FG001|Overall Study|Adverse Event|1|||
48439711|NCT01969799|155796098|FG000|Overall Study|Death|16|||
48439726|NCT01617187|155796101|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
48439727|NCT01617187|155796102|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
48439728|NCT01617187|155796103|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
48439729|NCT01617187|155796100|FG000|Treatment Through Study Completion|Adverse Event|1|||
48439730|NCT01617187|155796101|FG001|Treatment Through Study Completion|Adverse Event|1|||
48439731|NCT01617187|155796102|FG002|Treatment Through Study Completion|Adverse Event|0|||
48439732|NCT01617187|155796103|FG003|Treatment Through Study Completion|Adverse Event|1|||
48439733|NCT01617187|155796100|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
48439734|NCT01617187|155796101|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
48439735|NCT01617187|155796102|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
48439736|NCT01617187|155796103|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
48439737|NCT01617187|155796100|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
48439738|NCT01617187|155796101|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
48439739|NCT01617187|155796102|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
48439740|NCT01617187|155796103|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
48439741|NCT01617187|155796100|FG000|Treatment Through Study Completion|Protocol Violation|1|||
48439742|NCT01617187|155796101|FG001|Treatment Through Study Completion|Protocol Violation|0|||
48439743|NCT01617187|155796102|FG002|Treatment Through Study Completion|Protocol Violation|0|||
48439744|NCT01617187|155796103|FG003|Treatment Through Study Completion|Protocol Violation|1|||
48439745|NCT01842607|155796104|FG000|Overall Study|Adverse Event|11|||
48439746|NCT01842607|155796104|FG000|Overall Study|Lack of Efficacy|19|||
48439747|NCT01842607|155796104|FG000|Overall Study|Protocol Violation|8|||
48439748|NCT01842607|155796104|FG000|Overall Study|Protocol defined stopping criteria|2|||
48439749|NCT01842607|155796104|FG000|Overall Study|Lost to Follow-up|3|||
48439750|NCT01842607|155796104|FG000|Overall Study|Physician Decision|9|||
48439751|NCT01842607|155796104|FG000|Overall Study|Withdrawal by Subject|14|||
48439752|NCT02815293|155796105|FG000|Overall Study|Study termination by sponsor|10|||
48439753|NCT02815293|155796106|FG001|Overall Study|Study termination by sponsor|7|||
48439754|NCT02815293|155796107|FG002|Overall Study|Study termination by sponsor|0|||
48439755|NCT02815293|155796105|FG000|Overall Study|Participants not randomized|0|||
48439756|NCT02815293|155796106|FG001|Overall Study|Participants not randomized|0|||
48439757|NCT02815293|155796107|FG002|Overall Study|Participants not randomized|18|||
48439758|NCT02815293|155796105|FG000|Overall Study|Adverse Event|0|||
48439759|NCT02815293|155796106|FG001|Overall Study|Adverse Event|1|||
48439760|NCT02815293|155796107|FG002|Overall Study|Adverse Event|0|||
48439761|NCT02927873|155796110|FG000|Overall Study|Lost to Follow-up|0|||
48439762|NCT02927873|155796111|FG001|Overall Study|Lost to Follow-up|1|||
48439763|NCT02927873|155796112|FG002|Overall Study|Lost to Follow-up|0|||
48439764|NCT02927873|155796113|FG003|Overall Study|Lost to Follow-up|0|||
48439765|NCT02927873|155796114|FG004|Overall Study|Lost to Follow-up|0|||
48439766|NCT02927873|155796115|FG005|Overall Study|Lost to Follow-up|0|||
48439767|NCT02927873|155796110|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48439768|NCT02927873|155796111|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
48439769|NCT02927873|155796112|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48439770|NCT02927873|155796113|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48439771|NCT02927873|155796114|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48439772|NCT02927873|155796115|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48439773|NCT02927873|155796110|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48439774|NCT02927873|155796111|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48439775|NCT02927873|155796112|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48439776|NCT02927873|155796113|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48439777|NCT02927873|155796114|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48439778|NCT02927873|155796115|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48439779|NCT02927873|155796110|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48439780|NCT02927873|155796111|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
48439781|NCT02927873|155796112|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48439782|NCT02927873|155796113|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48439783|NCT02927873|155796114|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48439784|NCT02927873|155796115|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
48439785|NCT02927873|155796110|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
48439786|NCT02927873|155796111|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48439787|NCT02927873|155796112|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48439788|NCT02927873|155796113|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48439789|NCT02927873|155796114|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48439790|NCT02927873|155796115|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
48439791|NCT02927873|155796110|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
48439792|NCT02927873|155796111|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48439793|NCT02927873|155796112|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48439794|NCT02927873|155796113|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48439795|NCT02927873|155796114|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48439796|NCT02927873|155796115|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
48439797|NCT01167582|155796116|FG000|Overall Study|Lost to Follow-up|0|||
48439798|NCT01167582|155796117|FG001|Overall Study|Lost to Follow-up|1|||
48439799|NCT00115765|155796118|FG000|Overall Study|Withdrawal by Subject|22|||
48439800|NCT00115765|155796119|FG001|Overall Study|Withdrawal by Subject|53|||
48439801|NCT00115765|155796120|FG002|Overall Study|Withdrawal by Subject|76|||
48439802|NCT00115765|155796121|FG003|Overall Study|Withdrawal by Subject|15|||
48439803|NCT00115765|155796118|FG000|Overall Study|Physician Decision|4|||
48439804|NCT00115765|155796119|FG001|Overall Study|Physician Decision|15|||
48439805|NCT00115765|155796120|FG002|Overall Study|Physician Decision|18|||
48439806|NCT00115765|155796121|FG003|Overall Study|Physician Decision|13|||
48439807|NCT00115765|155796118|FG000|Overall Study|Lost to Follow-up|3|||
48439808|NCT00115765|155796119|FG001|Overall Study|Lost to Follow-up|20|||
48439809|NCT00115765|155796120|FG002|Overall Study|Lost to Follow-up|18|||
48439810|NCT00115765|155796121|FG003|Overall Study|Lost to Follow-up|1|||
48439811|NCT00115765|155796118|FG000|Overall Study|Other|6|||
48439812|NCT00115765|155796119|FG001|Overall Study|Other|12|||
48439813|NCT00115765|155796120|FG002|Overall Study|Other|9|||
48439814|NCT00115765|155796121|FG003|Overall Study|Other|2|||
48439815|NCT01518244|155796124|FG000|Overall Study|Adverse Event|3|||
48439816|NCT02227108|155796125|FG000|Overall Study|Did not receive treatment|2|||
48439817|NCT02227108|155796125|FG000|Overall Study|Other|3|||
48439818|NCT02227108|155796125|FG000|Overall Study|Progressive disease|17|||
48439819|NCT02227108|155796125|FG000|Overall Study|Initiation of alternative therapy|2|||
48439820|NCT02227108|155796125|FG000|Overall Study|Investigator discretion|1|||
48439821|NCT02227108|155796125|FG000|Overall Study|Adverse Event|6|||
48439822|NCT00239837|155796127|FG000|Overall Study|Lost to Follow-up|3|||
48439823|NCT00239837|155796128|FG001|Overall Study|Lost to Follow-up|7|||
48439824|NCT00964158|155796129|FG000|Overall Study|Lost to Follow-up|0|||
48439825|NCT00964158|155796130|FG001|Overall Study|Lost to Follow-up|1|||
48439826|NCT00964158|155796131|FG002|Overall Study|Lost to Follow-up|2|||
48439827|NCT00964158|155796129|FG000|Overall Study|Withdrawal by Subject|0|||
48439828|NCT00964158|155796130|FG001|Overall Study|Withdrawal by Subject|0|||
48439829|NCT00964158|155796131|FG002|Overall Study|Withdrawal by Subject|6|||
48439830|NCT01026389|155798222|FG000|Overall Study|Withdrawal by Subject|1|||
48439831|NCT01026389|155798223|FG001|Overall Study|Withdrawal by Subject|3|||
48439832|NCT01026389|155798222|FG000|Overall Study|change of treatment, patient moved|4|||
48439833|NCT01026389|155798223|FG001|Overall Study|change of treatment, patient moved|2|||
48439834|NCT01995136|155798224|FG000|Overall Study|Change in residence|1|||
48439835|NCT03457103|155798225|FG000|Overall Study|illness/hospitalization|4|||
48439836|NCT03457103|155798226|FG001|Overall Study|illness/hospitalization|2|||
48439837|NCT03457103|155798225|FG000|Overall Study|Lost to Follow-up|2|||
48439838|NCT03457103|155798226|FG001|Overall Study|Lost to Follow-up|1|||
48439839|NCT03457103|155798225|FG000|Overall Study|Withdrawal by Subject|1|||
48439840|NCT03457103|155798226|FG001|Overall Study|Withdrawal by Subject|2|||
48439841|NCT03457103|155798225|FG000|Overall Study|financial/ insurance issues|1|||
48439842|NCT03457103|155798226|FG001|Overall Study|financial/ insurance issues|1|||
48439843|NCT01697267|155798227|FG000|Overall Study|Death|3|||
48439844|NCT01697267|155798228|FG001|Overall Study|Death|1|||
48439845|NCT01697267|155798227|FG000|Overall Study|Withdrawal by Subject|5|||
48439846|NCT01697267|155798228|FG001|Overall Study|Withdrawal by Subject|5|||
48439847|NCT01697267|155798227|FG000|Overall Study|Adverse Event|2|||
48439848|NCT01697267|155798228|FG001|Overall Study|Adverse Event|1|||
48439849|NCT01697267|155798227|FG000|Overall Study|Lost to Follow-up|2|||
48439850|NCT01697267|155798228|FG001|Overall Study|Lost to Follow-up|4|||
48439851|NCT01697267|155798227|FG000|Overall Study|Physician Decision|2|||
48439852|NCT01697267|155798228|FG001|Overall Study|Physician Decision|4|||
48439853|NCT03544268|155798229|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
48439854|NCT03544268|155798230|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
48439855|NCT03225716|155798233|FG000|Overall Study|Withdrawal by Subject|2|||
48439856|NCT03225716|155798234|FG001|Overall Study|Withdrawal by Subject|2|||
48439857|NCT03225716|155798235|FG002|Overall Study|Withdrawal by Subject|0|||
48439858|NCT03225716|155798233|FG000|Overall Study|Lack of Efficacy|1|||
48439859|NCT03225716|155798234|FG001|Overall Study|Lack of Efficacy|0|||
48439860|NCT03225716|155798235|FG002|Overall Study|Lack of Efficacy|0|||
48439861|NCT03225716|155798233|FG000|Overall Study|Adverse Event|2|||
48439862|NCT03225716|155798234|FG001|Overall Study|Adverse Event|0|||
48439863|NCT03225716|155798235|FG002|Overall Study|Adverse Event|1|||
48439864|NCT03225716|155798233|FG000|Overall Study|Study early termination by Sponsor|0|||
48439865|NCT03225716|155798234|FG001|Overall Study|Study early termination by Sponsor|0|||
48439866|NCT03225716|155798235|FG002|Overall Study|Study early termination by Sponsor|2|||
48439867|NCT02527148|155798236|FG000|Overall Study|Did not receive study intervention|1|||
48439868|NCT02527148|155798237|FG001|Overall Study|Did not receive study intervention|0|||
48439869|NCT01107405|155798242|FG000|Overall Study|Adverse Event|1|||
48439961|NCT01844830|155798274|FG001|Overall Study|Withdrawal by Subject|0|||
48439962|NCT04247815|155798275|FG000|Overall Study|Adverse Event|1|||
48439963|NCT04247815|155798276|FG001|Overall Study|Adverse Event|0|||
48439964|NCT04247815|155798275|FG000|Overall Study|Withdrawal by Subject|1|||
48439965|NCT04247815|155798276|FG001|Overall Study|Withdrawal by Subject|0|||
48439966|NCT04247815|155798275|FG000|Overall Study|Protocol Violation|0|||
48439967|NCT04247815|155798276|FG001|Overall Study|Protocol Violation|1|||
48439968|NCT00448760|155798282|FG000|Overall Study|Death|3|||
48439969|NCT01429077|155798285|FG000|Overall Study|Lost to Follow-up|0|||
48439970|NCT01429077|155798286|FG001|Overall Study|Lost to Follow-up|3|||
48439971|NCT01098461|155798291|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
48439972|NCT01098461|155798292|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
48439973|NCT01098461|155798293|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
48439974|NCT01098461|155798294|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
48439975|NCT01098461|155798291|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
48439976|NCT01098461|155798292|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
48439977|NCT01098461|155798293|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
48439978|NCT01098461|155798294|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
48439979|NCT01098461|155798291|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
48439980|NCT01098461|155798292|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
48439981|NCT01098461|155798293|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
48439982|NCT01098461|155798294|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
48439983|NCT01098461|155798291|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
48439984|NCT01098461|155798292|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
48439985|NCT01098461|155798293|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
48439986|NCT01098461|155798294|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
48439987|NCT01098461|155798291|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
48439988|NCT01098461|155798292|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
48439989|NCT01098461|155798293|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
48439990|NCT01098461|155798294|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
48439991|NCT01098461|155798291|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
48439992|NCT01098461|155798292|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
48439993|NCT01098461|155798293|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
48439994|NCT01098461|155798294|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
48439995|NCT01098461|155798291|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
48439996|NCT01098461|155798292|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
48439997|NCT01098461|155798293|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
48439998|NCT01098461|155798294|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
48439999|NCT00976950|155798295|FG000|Overall Study|Adverse Event|3|||
48440000|NCT00976950|155798295|FG000|Overall Study|Events with no relationship to Aptivus|3|||
48440001|NCT00441103|155798296|FG000|Overall Study|Adverse Event|2|||
48440002|NCT00441103|155798297|FG001|Overall Study|Adverse Event|1|||
48440003|NCT00441103|155798296|FG000|Overall Study|Death|1|||
48440004|NCT00441103|155798297|FG001|Overall Study|Death|0|||
48440005|NCT00441103|155798296|FG000|Overall Study|Disease Progression|2|||
48440006|NCT00441103|155798297|FG001|Overall Study|Disease Progression|0|||
48440007|NCT00441103|155798296|FG000|Overall Study|Lost to Follow-up|1|||
48440008|NCT00441103|155798297|FG001|Overall Study|Lost to Follow-up|0|||
48440009|NCT00441103|155798296|FG000|Overall Study|Protocol Violation|1|||
48440010|NCT00441103|155798297|FG001|Overall Study|Protocol Violation|0|||
48440011|NCT00441103|155798296|FG000|Overall Study|Participant unable to use Rebiject II|1|||
48440012|NCT00441103|155798297|FG001|Overall Study|Participant unable to use Rebiject II|0|||
48440013|NCT00441103|155798296|FG000|Overall Study|Participant refused MRI|1|||
48440014|NCT00441103|155798297|FG001|Overall Study|Participant refused MRI|0|||
48440015|NCT00441103|155798296|FG000|Overall Study|Inclusion criteria absent|1|||
48440016|NCT00441103|155798297|FG001|Overall Study|Inclusion criteria absent|0|||
48440017|NCT00441103|155798296|FG000|Overall Study|Non-compliant|0|||
48440018|NCT00441103|155798297|FG001|Overall Study|Non-compliant|1|||
48440019|NCT00441103|155798296|FG000|Overall Study|Participant decided to withdraw|1|||
48440020|NCT00441103|155798297|FG001|Overall Study|Participant decided to withdraw|0|||
48440021|NCT00441103|155798296|FG000|Overall Study|Participant's reason|0|||
48440022|NCT00441103|155798297|FG001|Overall Study|Participant's reason|1|||
48440023|NCT00441103|155798296|FG000|Overall Study|Participant decided to stop|0|||
48440024|NCT00441103|155798297|FG001|Overall Study|Participant decided to stop|1|||
48440025|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
48440026|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
48440027|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
48440028|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
48440029|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
48440030|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
48440031|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
48440032|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
48440033|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
48440034|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
48440035|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
48440036|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
48440037|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
48440038|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
48440039|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
48440040|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
48440041|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Missing|3|||
48440042|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Missing|1|||
48440043|NCT00838916|155798300|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
48440044|NCT00838916|155798301|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
48440045|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
48440046|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
48440047|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
48440048|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
48440049|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
48440050|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
48440051|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
48440052|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
48440053|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
48440054|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
48440055|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
48440056|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
48440057|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
48440058|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
48440059|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
48440060|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
48440061|NCT00838916|155798300|FG000|Follow-up Period (8 Weeks)|Missing|3|||
48440062|NCT00838916|155798301|FG001|Follow-up Period (8 Weeks)|Missing|0|||
48440063|NCT00012012|155798303|FG000|Overall Study|Protocol Violation|1|||
48440064|NCT00012012|155798304|FG001|Overall Study|Protocol Violation|1|||
48440065|NCT00012012|155798303|FG000|Overall Study|Withdrawal by Subject|0|||
48440066|NCT00012012|155798304|FG001|Overall Study|Withdrawal by Subject|2|||
48440067|NCT02159469|155798307|FG000|Overall Study|Missing Completion status|1|||
48440068|NCT02159469|155798307|FG000|Overall Study|Adverse Event|5|||
48440069|NCT02159469|155798307|FG000|Overall Study|Non-compliance|2|||
48440070|NCT02159469|155798307|FG000|Overall Study|Withdrawal by Subject|9|||
48440071|NCT02159469|155798307|FG000|Overall Study|Lost to Follow-up|1|||
48440072|NCT02159469|155798307|FG000|Overall Study|Sponsor's request|2|||
48440073|NCT02159469|155798307|FG000|Overall Study|Met Stopping Criteria|3|||
48440074|NCT02159469|155798307|FG000|Overall Study|Other|1|||
48440075|NCT02159469|155798307|FG000|Overall Study|Multiple|29|||
48440076|NCT02034474|155798308|FG000|Overall Study|Adverse Event|3|||
48440077|NCT02034474|155798309|FG001|Overall Study|Adverse Event|2|||
48440078|NCT02034474|155798308|FG000|Overall Study|Withdrawal by Subject|1|||
48440079|NCT02034474|155798309|FG001|Overall Study|Withdrawal by Subject|2|||
48440080|NCT03337139|155798311|FG000|Phase I|Withdrawal by Subject|10|||
48440081|NCT03337139|155798312|FG001|Phase I|Withdrawal by Subject|0|||
48440082|NCT02947022|155798313|FG000|Overall Study|Study Stopped|1|||
48440083|NCT03543358|155798314|FG000|Overall Study|Death|1|||
48440084|NCT03543358|155798315|FG001|Overall Study|Death|0|||
48440085|NCT03543358|155798314|FG000|Overall Study|Disease Progression|1|||
48440086|NCT03543358|155798315|FG001|Overall Study|Disease Progression|0|||
48440087|NCT03543358|155798314|FG000|Overall Study|Parent Study Closure|1|||
48440088|NCT03543358|155798315|FG001|Overall Study|Parent Study Closure|0|||
48440089|NCT02559713|155798319|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
48440090|NCT01766817|155798320|FG000|Overall Study|Drug-related adverse event|1|||
48440091|NCT01766817|155798321|FG001|Overall Study|Drug-related adverse event|2|||
48440092|NCT01766817|155798322|FG002|Overall Study|Drug-related adverse event|1|||
48440093|NCT01766817|155798320|FG000|Overall Study|Drug-unrelated adverse event|3|||
48440094|NCT01766817|155798321|FG001|Overall Study|Drug-unrelated adverse event|3|||
48440095|NCT01766817|155798322|FG002|Overall Study|Drug-unrelated adverse event|3|||
48440096|NCT01766817|155798320|FG000|Overall Study|Death|1|||
48440097|NCT01766817|155798321|FG001|Overall Study|Death|1|||
48440098|NCT01766817|155798322|FG002|Overall Study|Death|0|||
48440099|NCT01766817|155798320|FG000|Overall Study|Unable to take study drug|0|||
48440100|NCT01766817|155798321|FG001|Overall Study|Unable to take study drug|1|||
48440101|NCT01766817|155798322|FG002|Overall Study|Unable to take study drug|0|||
48440102|NCT01766817|155798320|FG000|Overall Study|Withdrawal by Subject|2|||
48440103|NCT01766817|155798321|FG001|Overall Study|Withdrawal by Subject|0|||
48440104|NCT01766817|155798322|FG002|Overall Study|Withdrawal by Subject|3|||
48440105|NCT01766817|155798320|FG000|Overall Study|Subject non-compliance|0|||
48440106|NCT01766817|155798321|FG001|Overall Study|Subject non-compliance|1|||
48440107|NCT01766817|155798322|FG002|Overall Study|Subject non-compliance|2|||
48440108|NCT01766817|155798320|FG000|Overall Study|Physician Decision|3|||
48440109|NCT01766817|155798321|FG001|Overall Study|Physician Decision|3|||
48440110|NCT01766817|155798322|FG002|Overall Study|Physician Decision|4|||
48440111|NCT01766817|155798320|FG000|Overall Study|Other|1|||
48440112|NCT01766817|155798321|FG001|Overall Study|Other|0|||
48440113|NCT01766817|155798322|FG002|Overall Study|Other|0|||
48440114|NCT00870818|155798324|FG000|Overall Study|Lost to Follow-up|3|||
48440115|NCT00870818|155798325|FG001|Overall Study|Lost to Follow-up|2|||
48440116|NCT00870818|155798326|FG002|Overall Study|Lost to Follow-up|1|||
48440117|NCT00870818|155798327|FG003|Overall Study|Lost to Follow-up|0|||
48440118|NCT00870818|155798328|FG004|Overall Study|Lost to Follow-up|0|||
48440119|NCT00870818|155798324|FG000|Overall Study|Withdrawal by Subject|0|||
48440120|NCT00870818|155798325|FG001|Overall Study|Withdrawal by Subject|0|||
48440121|NCT00870818|155798326|FG002|Overall Study|Withdrawal by Subject|1|||
48440122|NCT00870818|155798327|FG003|Overall Study|Withdrawal by Subject|2|||
48440123|NCT00870818|155798328|FG004|Overall Study|Withdrawal by Subject|0|||
48440124|NCT00870818|155798324|FG000|Overall Study|Terminated by sponsor|29|||
48440125|NCT00870818|155798325|FG001|Overall Study|Terminated by sponsor|70|||
48440126|NCT00870818|155798326|FG002|Overall Study|Terminated by sponsor|36|||
48440127|NCT00870818|155798327|FG003|Overall Study|Terminated by sponsor|36|||
48440128|NCT00870818|155798328|FG004|Overall Study|Terminated by sponsor|38|||
48440129|NCT00870818|155798324|FG000|Overall Study|Other|0|||
48440130|NCT00870818|155798325|FG001|Overall Study|Other|1|||
48440131|NCT00870818|155798326|FG002|Overall Study|Other|0|||
48440132|NCT00870818|155798327|FG003|Overall Study|Other|0|||
48440133|NCT00870818|155798328|FG004|Overall Study|Other|0|||
48440134|NCT00178464|155798329|FG000|Overall Study|Withdrawal by Subject|1|||
48440135|NCT00178464|155798329|FG000|Overall Study|Physician Decision|1|||
48440136|NCT04900038|155798332|FG000|Overall Study|Adverse Event|1|||
48440137|NCT04900038|155798333|FG001|Overall Study|Adverse Event|0|||
48440138|NCT04900038|155798334|FG002|Overall Study|Adverse Event|1|||
48440139|NCT04900038|155798335|FG003|Overall Study|Adverse Event|1|||
48440140|NCT04900038|155798332|FG000|Overall Study|Withdrawal by Subject|0|||
48440141|NCT04900038|155798333|FG001|Overall Study|Withdrawal by Subject|1|||
48440142|NCT04900038|155798334|FG002|Overall Study|Withdrawal by Subject|0|||
48440143|NCT04900038|155798335|FG003|Overall Study|Withdrawal by Subject|0|||
48440144|NCT04900038|155798332|FG000|Overall Study|Study terminated by sponsor|18|||
48440145|NCT04900038|155798333|FG001|Overall Study|Study terminated by sponsor|15|||
48440146|NCT04900038|155798334|FG002|Overall Study|Study terminated by sponsor|17|||
48440147|NCT04900038|155798335|FG003|Overall Study|Study terminated by sponsor|14|||
48440148|NCT04900038|155798332|FG000|Overall Study|Protocol Deviation|1|||
48440149|NCT04900038|155798333|FG001|Overall Study|Protocol Deviation|1|||
48440150|NCT04900038|155798334|FG002|Overall Study|Protocol Deviation|0|||
48440151|NCT04900038|155798335|FG003|Overall Study|Protocol Deviation|0|||
48440152|NCT04900038|155798332|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
48440153|NCT04900038|155798333|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
48440154|NCT04900038|155798334|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
48440155|NCT04900038|155798335|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
48440156|NCT04900038|155798332|FG000|Overall Study|Lost to Follow-up|0|||
48440157|NCT04900038|155798333|FG001|Overall Study|Lost to Follow-up|0|||
48440158|NCT04900038|155798334|FG002|Overall Study|Lost to Follow-up|0|||
48440159|NCT04900038|155798335|FG003|Overall Study|Lost to Follow-up|1|||
48440160|NCT00995670|155798336|FG000|Overall Study|Failed arterial cannulation|1|||
48440161|NCT00995670|155798337|FG001|Overall Study|Failed arterial cannulation|0|||
48440162|NCT00995670|155798338|FG002|Overall Study|Failed arterial cannulation|3|||
48440163|NCT02486952|155798341|FG000|Overall Study|Not Started Induction Therapy|3|||
48440164|NCT02486952|155798341|FG000|Overall Study|Adverse Event|1|||
48440165|NCT02486952|155798341|FG000|Overall Study|Death|15|||
48440166|NCT02486952|155798341|FG000|Overall Study|Lack of Efficacy|3|||
48440167|NCT02486952|155798341|FG000|Overall Study|Lost to Follow-up|26|||
48440168|NCT02486952|155798341|FG000|Overall Study|Other|2|||
48440169|NCT03589885|155798343|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
48440170|NCT03589885|155798344|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
48440171|NCT03589885|155798345|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
48440172|NCT03589885|155798346|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
48440173|NCT03589885|155798347|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
48440174|NCT03589885|155798343|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
48440175|NCT03589885|155798344|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
48440176|NCT03589885|155798345|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
48440177|NCT03589885|155798346|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
48440178|NCT03589885|155798347|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
48440179|NCT03589885|155798343|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
48440180|NCT03589885|155798344|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
48440181|NCT03589885|155798345|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
48440182|NCT03589885|155798346|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
48440183|NCT03589885|155798347|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
48440184|NCT03589885|155798343|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
48440185|NCT03589885|155798344|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
48440186|NCT03589885|155798345|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
48440187|NCT03589885|155798346|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
48440188|NCT03589885|155798347|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
48440189|NCT03589885|155798343|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
48440190|NCT03589885|155798344|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
48440191|NCT03589885|155798345|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
48440192|NCT03589885|155798346|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
48440193|NCT03589885|155798347|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
48440194|NCT03589885|155798343|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
48440195|NCT03589885|155798344|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
48440196|NCT03589885|155798345|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
48440197|NCT03589885|155798346|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
48440198|NCT03589885|155798347|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
48440199|NCT03589885|155798343|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
48440200|NCT03589885|155798344|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
48440201|NCT03589885|155798345|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
48440202|NCT03589885|155798346|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
48440203|NCT03589885|155798347|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
48440204|NCT03589885|155798343|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
48440205|NCT03589885|155798344|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
48440206|NCT03589885|155798345|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
48440207|NCT03589885|155798346|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
48440208|NCT03589885|155798347|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
48440209|NCT04111107|155798348|FG000|Overall Study|Withdrawal by Subject|6|||
48440210|NCT04111107|155798348|FG000|Overall Study|Declining Health|5|||
48440211|NCT01928485|155798349|FG000|Overall Study|Physician Decision|0|||
48440212|NCT01928485|155798350|FG001|Overall Study|Physician Decision|1|||
48440213|NCT03600714|155798351|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
48440214|NCT00675103|155798352|FG000|Overall Study|Lack of Efficacy|2|||
48440215|NCT00675103|155798352|FG000|Overall Study|Adverse Event|1|||
48440216|NCT03814590|155798355|FG000|Overall Study|Adverse Event|0|||
48440217|NCT03814590|155798356|FG001|Overall Study|Adverse Event|0|||
48440218|NCT03814590|155798357|FG002|Overall Study|Adverse Event|0|||
48440219|NCT03814590|155798358|FG003|Overall Study|Adverse Event|0|||
48440220|NCT03814590|155798359|FG004|Overall Study|Adverse Event|0|||
48440221|NCT03814590|155798360|FG005|Overall Study|Adverse Event|1|||
48440222|NCT03814590|155798361|FG006|Overall Study|Adverse Event|1|||
48440223|NCT03814590|155798362|FG007|Overall Study|Adverse Event|1|||
48440224|NCT03814590|155798363|FG008|Overall Study|Adverse Event|0|||
48440225|NCT03814590|155798364|FG009|Overall Study|Adverse Event|0|||
48440226|NCT03814590|155798365|FG010|Overall Study|Adverse Event|1|||
48440227|NCT03814590|155798366|FG011|Overall Study|Adverse Event|0|||
48440228|NCT03814590|155798367|FG012|Overall Study|Adverse Event|3|||
48440229|NCT03814590|155798368|FG013|Overall Study|Adverse Event|0|||
48440230|NCT03814590|155798355|FG000|Overall Study|Lost to Follow-up|0|||
48440231|NCT03814590|155798356|FG001|Overall Study|Lost to Follow-up|2|||
48440232|NCT03814590|155798357|FG002|Overall Study|Lost to Follow-up|1|||
48440233|NCT03814590|155798358|FG003|Overall Study|Lost to Follow-up|0|||
48440234|NCT03814590|155798359|FG004|Overall Study|Lost to Follow-up|1|||
48440235|NCT03814590|155798360|FG005|Overall Study|Lost to Follow-up|1|||
48440236|NCT03814590|155798361|FG006|Overall Study|Lost to Follow-up|1|||
48440237|NCT03814590|155798362|FG007|Overall Study|Lost to Follow-up|1|||
48440238|NCT03814590|155798363|FG008|Overall Study|Lost to Follow-up|0|||
48440239|NCT03814590|155798364|FG009|Overall Study|Lost to Follow-up|0|||
48440240|NCT03814590|155798365|FG010|Overall Study|Lost to Follow-up|1|||
48440241|NCT03814590|155798366|FG011|Overall Study|Lost to Follow-up|0|||
48440242|NCT03814590|155798367|FG012|Overall Study|Lost to Follow-up|0|||
48440243|NCT03814590|155798368|FG013|Overall Study|Lost to Follow-up|1|||
48440244|NCT03814590|155798355|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440245|NCT03814590|155798356|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440246|NCT03814590|155798357|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440247|NCT03814590|155798358|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440248|NCT03814590|155798359|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440249|NCT03814590|155798360|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440250|NCT03814590|155798361|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440251|NCT03814590|155798362|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440252|NCT03814590|155798363|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440253|NCT03814590|155798364|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
48440254|NCT03814590|155798365|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440255|NCT03814590|155798366|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440256|NCT03814590|155798367|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440257|NCT03814590|155798368|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
48440258|NCT03814590|155798355|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48440259|NCT03814590|155798356|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48440260|NCT03814590|155798357|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48440261|NCT03814590|155798358|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48440262|NCT03814590|155798359|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48440263|NCT03814590|155798360|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
48440264|NCT03814590|155798361|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
48440265|NCT03814590|155798362|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
48440266|NCT03814590|155798363|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48440267|NCT03814590|155798364|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
48440268|NCT03814590|155798365|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
48440269|NCT03814590|155798366|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
48440270|NCT03814590|155798367|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
48440271|NCT03814590|155798368|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
48440272|NCT03814590|155798355|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440273|NCT03814590|155798356|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440274|NCT03814590|155798357|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440275|NCT03814590|155798358|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440276|NCT03814590|155798359|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440277|NCT03814590|155798360|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440278|NCT03814590|155798361|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440279|NCT03814590|155798362|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48440280|NCT03814590|155798363|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440281|NCT03814590|155798364|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48440282|NCT03814590|155798365|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440283|NCT03814590|155798366|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440284|NCT03814590|155798367|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440285|NCT03814590|155798368|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48440286|NCT03814590|155798355|FG000|Overall Study|UNKNOWN REASON|0|||
48440287|NCT03814590|155798356|FG001|Overall Study|UNKNOWN REASON|0|||
48440288|NCT03814590|155798357|FG002|Overall Study|UNKNOWN REASON|0|||
48440289|NCT03814590|155798358|FG003|Overall Study|UNKNOWN REASON|0|||
48440290|NCT03814590|155798359|FG004|Overall Study|UNKNOWN REASON|0|||
48440291|NCT03814590|155798360|FG005|Overall Study|UNKNOWN REASON|0|||
48440292|NCT03814590|155798361|FG006|Overall Study|UNKNOWN REASON|0|||
48440293|NCT03814590|155798362|FG007|Overall Study|UNKNOWN REASON|1|||
48440294|NCT03814590|155798363|FG008|Overall Study|UNKNOWN REASON|0|||
48440295|NCT03814590|155798364|FG009|Overall Study|UNKNOWN REASON|0|||
48440296|NCT03814590|155798365|FG010|Overall Study|UNKNOWN REASON|0|||
48440297|NCT03814590|155798366|FG011|Overall Study|UNKNOWN REASON|0|||
48440298|NCT03814590|155798367|FG012|Overall Study|UNKNOWN REASON|0|||
48440299|NCT03814590|155798368|FG013|Overall Study|UNKNOWN REASON|0|||
48440300|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
48440301|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
48440302|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
48440303|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
48440304|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
48440305|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
48440306|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
48440307|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
48440308|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
48440309|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
48440310|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
48440311|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
48440312|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
48440313|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
48440314|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
48440315|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
48440607|NCT01199055|155799787|FG001|Overall Study|Physician Decision|1|||
48440316|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
48440317|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
48440318|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
48440319|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
48440320|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
48440321|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
48440322|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
48440323|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
48440324|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
48440325|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
48440326|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
48440327|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
48440328|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
48440329|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
48440330|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
48440331|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
48440332|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
48440333|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
48440334|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
48440335|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
48440336|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
48440337|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
48440338|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
48440339|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
48440340|NCT00383721|155798369|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
48440341|NCT00383721|155798370|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
48440342|NCT00383721|155798371|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
48440343|NCT00383721|155798372|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
48440344|NCT00383721|155798373|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
48440345|NCT00383721|155798369|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
48440346|NCT00383721|155798370|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
48440347|NCT00383721|155798371|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
48440348|NCT00383721|155798372|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
48440349|NCT00383721|155798373|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
48440350|NCT00383721|155798369|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
48440351|NCT00383721|155798370|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
48440352|NCT00383721|155798371|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
48440353|NCT00383721|155798372|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
48440354|NCT00383721|155798373|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
48440355|NCT00383721|155798369|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
48440356|NCT00383721|155798370|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
48440357|NCT00383721|155798371|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
48440358|NCT00383721|155798372|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
48440359|NCT00383721|155798373|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
48440360|NCT00383721|155798369|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
48440361|NCT00383721|155798370|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
48440362|NCT00383721|155798371|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
48440363|NCT00383721|155798372|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
48440364|NCT00383721|155798373|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
48440365|NCT00383721|155798369|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48440366|NCT00383721|155798370|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48440367|NCT00383721|155798371|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48440368|NCT00383721|155798372|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
48440369|NCT00383721|155798373|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
48440370|NCT00383721|155798369|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
48440371|NCT00383721|155798370|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48440372|NCT00383721|155798371|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
48440373|NCT00383721|155798372|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
48440374|NCT00383721|155798373|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
48440375|NCT00383721|155798369|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48440376|NCT00383721|155798370|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48440377|NCT00383721|155798371|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48440378|NCT00383721|155798372|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
48440379|NCT00383721|155798373|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
48440380|NCT00383721|155798369|FG000|26-Week Treatment Safety Extension|Administrative|1|||
48440381|NCT00383721|155798370|FG001|26-Week Treatment Safety Extension|Administrative|2|||
48440382|NCT00383721|155798371|FG002|26-Week Treatment Safety Extension|Administrative|3|||
48440383|NCT00383721|155798372|FG003|26-Week Treatment Safety Extension|Administrative|1|||
48440384|NCT00383721|155798373|FG004|26-Week Treatment Safety Extension|Administrative|0|||
48440385|NCT01767519|155798377|FG000|Overall Study|Other Reasons|4|||
48440386|NCT01767519|155798378|FG001|Overall Study|Other Reasons|4|||
48440387|NCT01767519|155798379|FG002|Overall Study|Other Reasons|2|||
48440388|NCT01767519|155798377|FG000|Overall Study|Protocol Violation|0|||
48440389|NCT01767519|155798378|FG001|Overall Study|Protocol Violation|3|||
48440390|NCT01767519|155798379|FG002|Overall Study|Protocol Violation|0|||
48440391|NCT01767519|155798377|FG000|Overall Study|Personal Reasons|1|||
48440392|NCT01767519|155798378|FG001|Overall Study|Personal Reasons|0|||
48440393|NCT01767519|155798379|FG002|Overall Study|Personal Reasons|0|||
48440394|NCT01767519|155798377|FG000|Overall Study|Lost to Follow-up|3|||
48440395|NCT01767519|155798378|FG001|Overall Study|Lost to Follow-up|1|||
48440396|NCT01767519|155798379|FG002|Overall Study|Lost to Follow-up|2|||
48440397|NCT01767519|155798377|FG000|Overall Study|Lack of Efficacy|1|||
48440398|NCT01767519|155798378|FG001|Overall Study|Lack of Efficacy|0|||
48440399|NCT01767519|155798379|FG002|Overall Study|Lack of Efficacy|0|||
48440400|NCT01767519|155798377|FG000|Overall Study|Adverse Event|5|||
48440401|NCT01767519|155798378|FG001|Overall Study|Adverse Event|5|||
48440402|NCT01767519|155798379|FG002|Overall Study|Adverse Event|1|||
48440403|NCT03519516|155798380|FG000|Overall Study|Adverse Event|0|||
48440404|NCT03519516|155798381|FG001|Overall Study|Adverse Event|1|||
48440405|NCT01935336|155798382|FG000|Overall Study|Adverse Event|1|||
48440406|NCT01935336|155798383|FG001|Overall Study|Adverse Event|0|||
48440407|NCT01935336|155798384|FG002|Overall Study|Adverse Event|0|||
48440408|NCT01935336|155798385|FG003|Overall Study|Adverse Event|0|||
48440409|NCT01935336|155798382|FG000|Overall Study|Progressive disease|5|||
48440410|NCT01935336|155798383|FG001|Overall Study|Progressive disease|3|||
48440411|NCT01935336|155798384|FG002|Overall Study|Progressive disease|47|||
48440412|NCT01935336|155798385|FG003|Overall Study|Progressive disease|66|||
48440413|NCT00507416|155798386|FG000|Overall Study|Adverse Event|58|||
48440414|NCT00507416|155798387|FG001|Overall Study|Adverse Event|67|||
48440415|NCT00507416|155798388|FG002|Overall Study|Adverse Event|65|||
48440416|NCT00507416|155798386|FG000|Overall Study|Protocol Violation|1|||
48440417|NCT00507416|155798387|FG001|Overall Study|Protocol Violation|2|||
48440418|NCT00507416|155798388|FG002|Overall Study|Protocol Violation|0|||
48440419|NCT00507416|155798386|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
48440420|NCT00507416|155798387|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
48440421|NCT00507416|155798388|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
48440422|NCT00507416|155798386|FG000|Overall Study|Progressive Disease|20|||
48440423|NCT00507416|155798387|FG001|Overall Study|Progressive Disease|10|||
48440424|NCT00507416|155798388|FG002|Overall Study|Progressive Disease|13|||
48440425|NCT00507416|155798386|FG000|Overall Study|Patient declined further treatment|18|||
48440426|NCT00507416|155798387|FG001|Overall Study|Patient declined further treatment|14|||
48440427|NCT00507416|155798388|FG002|Overall Study|Patient declined further treatment|11|||
48440428|NCT00507416|155798386|FG000|Overall Study|Other|11|||
48440429|NCT00507416|155798387|FG001|Overall Study|Other|16|||
48440430|NCT00507416|155798388|FG002|Overall Study|Other|13|||
48440431|NCT00507416|155798386|FG000|Overall Study|Did not Receive Study Treatment|3|||
48440432|NCT00507416|155798387|FG001|Overall Study|Did not Receive Study Treatment|9|||
48440433|NCT00507416|155798388|FG002|Overall Study|Did not Receive Study Treatment|4|||
48440434|NCT03712345|155799729|FG000|Overall Study|Failure to meet randomization criteria|0|||
48440435|NCT03712345|155799730|FG001|Overall Study|Failure to meet randomization criteria|0|||
48440436|NCT03712345|155799731|FG002|Overall Study|Failure to meet randomization criteria|1|||
48440437|NCT05254613|155799734|FG000|Overall Study|Lost to Follow-up|0|||
48440438|NCT05254613|155799735|FG001|Overall Study|Lost to Follow-up|0|||
48440439|NCT05254613|155799736|FG002|Overall Study|Lost to Follow-up|1|||
48440440|NCT02420223|155799737|FG000|Overall Study|Adverse Event|1|||
48440441|NCT02420223|155799738|FG001|Overall Study|Adverse Event|0|||
48440442|NCT02420223|155799737|FG000|Overall Study|Physician Decision|0|||
48440443|NCT02420223|155799738|FG001|Overall Study|Physician Decision|2|||
48440444|NCT01071096|155799739|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
48440445|NCT01071096|155799740|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
48440446|NCT00871377|155799742|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48440447|NCT00871377|155799743|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48440448|NCT00871377|155799744|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
48440449|NCT00871377|155799745|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48440450|NCT00871377|155799746|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48440451|NCT00871377|155799747|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
48440452|NCT00871377|155799742|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48440608|NCT01199055|155799788|FG002|Overall Study|Physician Decision|1|||
48440453|NCT00871377|155799743|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48440454|NCT00871377|155799744|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48440455|NCT00871377|155799745|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48440456|NCT00871377|155799746|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
48440457|NCT00871377|155799747|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
48440458|NCT00871377|155799742|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
48440459|NCT00871377|155799743|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440460|NCT00871377|155799744|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440461|NCT00871377|155799745|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440462|NCT00871377|155799746|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440463|NCT00871377|155799747|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440464|NCT00871377|155799742|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440465|NCT00871377|155799743|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440466|NCT00871377|155799744|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440467|NCT00871377|155799745|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440468|NCT00871377|155799746|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
48440469|NCT00871377|155799747|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
48440470|NCT00871377|155799742|FG000|Third Intervention (10 Weeks)|Death|0|||
48440471|NCT00871377|155799743|FG001|Third Intervention (10 Weeks)|Death|0|||
48440472|NCT00871377|155799744|FG002|Third Intervention (10 Weeks)|Death|0|||
48440473|NCT00871377|155799745|FG003|Third Intervention (10 Weeks)|Death|1|||
48440474|NCT00871377|155799746|FG004|Third Intervention (10 Weeks)|Death|0|||
48440475|NCT00871377|155799747|FG005|Third Intervention (10 Weeks)|Death|0|||
48440476|NCT01061736|155799750|FG000|Overall Study|Dose regimen not selected|0|||
48440477|NCT01061736|155799751|FG001|Overall Study|Dose regimen not selected|0|||
48440478|NCT01061736|155799752|FG002|Overall Study|Dose regimen not selected|0|||
48440479|NCT01061736|155799753|FG003|Overall Study|Dose regimen not selected|0|||
48440480|NCT01061736|155799754|FG004|Overall Study|Dose regimen not selected|0|||
48440481|NCT01061736|155799755|FG005|Overall Study|Dose regimen not selected|0|||
48440482|NCT01061736|155799756|FG006|Overall Study|Dose regimen not selected|79|||
48440483|NCT01061736|155799757|FG007|Overall Study|Dose regimen not selected|0|||
48440484|NCT01061736|155799758|FG008|Overall Study|Dose regimen not selected|0|||
48440485|NCT01061736|155799759|FG009|Overall Study|Dose regimen not selected|0|||
48440486|NCT01061736|155799750|FG000|Overall Study|Adverse Event|13|||
48440487|NCT01061736|155799751|FG001|Overall Study|Adverse Event|1|||
48440488|NCT01061736|155799752|FG002|Overall Study|Adverse Event|3|||
48440489|NCT01061736|155799753|FG003|Overall Study|Adverse Event|2|||
48440490|NCT01061736|155799754|FG004|Overall Study|Adverse Event|4|||
48440491|NCT01061736|155799755|FG005|Overall Study|Adverse Event|1|||
48440492|NCT01061736|155799756|FG006|Overall Study|Adverse Event|4|||
48440493|NCT01061736|155799757|FG007|Overall Study|Adverse Event|63|||
48440494|NCT01061736|155799758|FG008|Overall Study|Adverse Event|67|||
48440495|NCT01061736|155799759|FG009|Overall Study|Adverse Event|34|||
48440496|NCT01061736|155799750|FG000|Overall Study|Lack of Efficacy|0|||
48440497|NCT01061736|155799751|FG001|Overall Study|Lack of Efficacy|2|||
48440498|NCT01061736|155799752|FG002|Overall Study|Lack of Efficacy|1|||
48440499|NCT01061736|155799753|FG003|Overall Study|Lack of Efficacy|1|||
48440500|NCT01061736|155799754|FG004|Overall Study|Lack of Efficacy|1|||
48440501|NCT01061736|155799755|FG005|Overall Study|Lack of Efficacy|2|||
48440502|NCT01061736|155799756|FG006|Overall Study|Lack of Efficacy|1|||
48440503|NCT01061736|155799757|FG007|Overall Study|Lack of Efficacy|9|||
48440504|NCT01061736|155799758|FG008|Overall Study|Lack of Efficacy|9|||
48440505|NCT01061736|155799759|FG009|Overall Study|Lack of Efficacy|10|||
48440506|NCT01061736|155799750|FG000|Overall Study|Poor compliance to protocol|0|||
48440507|NCT01061736|155799751|FG001|Overall Study|Poor compliance to protocol|0|||
48440508|NCT01061736|155799752|FG002|Overall Study|Poor compliance to protocol|0|||
48440509|NCT01061736|155799753|FG003|Overall Study|Poor compliance to protocol|0|||
48440510|NCT01061736|155799754|FG004|Overall Study|Poor compliance to protocol|0|||
48440511|NCT01061736|155799755|FG005|Overall Study|Poor compliance to protocol|0|||
48440512|NCT01061736|155799756|FG006|Overall Study|Poor compliance to protocol|0|||
48440513|NCT01061736|155799757|FG007|Overall Study|Poor compliance to protocol|2|||
48440514|NCT01061736|155799758|FG008|Overall Study|Poor compliance to protocol|5|||
48440515|NCT01061736|155799759|FG009|Overall Study|Poor compliance to protocol|9|||
48440516|NCT01061736|155799750|FG000|Overall Study|Not treated|0|||
48440517|NCT01061736|155799751|FG001|Overall Study|Not treated|0|||
48440518|NCT01061736|155799752|FG002|Overall Study|Not treated|0|||
48440519|NCT01061736|155799753|FG003|Overall Study|Not treated|0|||
48440520|NCT01061736|155799754|FG004|Overall Study|Not treated|1|||
48440521|NCT01061736|155799755|FG005|Overall Study|Not treated|0|||
48440522|NCT01061736|155799756|FG006|Overall Study|Not treated|0|||
48440523|NCT01061736|155799757|FG007|Overall Study|Not treated|2|||
48440524|NCT01061736|155799758|FG008|Overall Study|Not treated|1|||
48440525|NCT01061736|155799759|FG009|Overall Study|Not treated|0|||
48440526|NCT01061736|155799750|FG000|Overall Study|Other than specified above|0|||
48440527|NCT01061736|155799751|FG001|Overall Study|Other than specified above|1|||
48440528|NCT01061736|155799752|FG002|Overall Study|Other than specified above|2|||
48440529|NCT01061736|155799753|FG003|Overall Study|Other than specified above|0|||
48440530|NCT01061736|155799754|FG004|Overall Study|Other than specified above|1|||
48440531|NCT01061736|155799755|FG005|Overall Study|Other than specified above|0|||
48440532|NCT01061736|155799756|FG006|Overall Study|Other than specified above|0|||
48440533|NCT01061736|155799757|FG007|Overall Study|Other than specified above|18|||
48440534|NCT01061736|155799758|FG008|Overall Study|Other than specified above|15|||
48440535|NCT01061736|155799759|FG009|Overall Study|Other than specified above|21|||
48440536|NCT00980343|155799763|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
48440537|NCT00980343|155799764|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
48440538|NCT03337152|155799765|FG000|Overall Study|Physician Decision|1|||
48440539|NCT03337152|155799766|FG001|Overall Study|Physician Decision|0|||
48440540|NCT03337152|155799765|FG000|Overall Study|Lost to Follow-up|1|||
48440541|NCT03337152|155799766|FG001|Overall Study|Lost to Follow-up|3|||
48440542|NCT03337152|155799765|FG000|Overall Study|Adverse Event|3|||
48440543|NCT03337152|155799766|FG001|Overall Study|Adverse Event|1|||
48440544|NCT03337152|155799765|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
48440545|NCT03337152|155799766|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
48440546|NCT00718666|155799769|FG000|Booster Phase Year 5|No active participation request|0|||
48440547|NCT00718666|155799770|FG001|Booster Phase Year 5|No active participation request|0|||
48440548|NCT00718666|155799771|FG002|Booster Phase Year 5|No active participation request|1|||
48440549|NCT00718666|155799769|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
48440550|NCT00718666|155799770|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
48440551|NCT00718666|155799771|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
48440552|NCT00718666|155799769|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
48440553|NCT00718666|155799770|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
48440554|NCT00718666|155799771|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
48440555|NCT00718666|155799769|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
48440556|NCT00718666|155799770|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
48440557|NCT00718666|155799771|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
48440558|NCT03004469|155799774|FG000|Overall Study|Adverse Event|6|||
48440559|NCT03004469|155799775|FG001|Overall Study|Adverse Event|4|||
48440560|NCT03004469|155799776|FG002|Overall Study|Adverse Event|6|||
48440561|NCT03004469|155799774|FG000|Overall Study|Lack of Efficacy|1|||
48440562|NCT03004469|155799775|FG001|Overall Study|Lack of Efficacy|0|||
48440563|NCT03004469|155799776|FG002|Overall Study|Lack of Efficacy|1|||
48440564|NCT03004469|155799774|FG000|Overall Study|Lost to Follow-up|23|||
48440565|NCT03004469|155799775|FG001|Overall Study|Lost to Follow-up|14|||
48440566|NCT03004469|155799776|FG002|Overall Study|Lost to Follow-up|6|||
48440567|NCT03004469|155799774|FG000|Overall Study|Non-Compliance with Study Drug|2|||
48440568|NCT03004469|155799775|FG001|Overall Study|Non-Compliance with Study Drug|0|||
48440569|NCT03004469|155799776|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48440570|NCT03004469|155799774|FG000|Overall Study|Protocol Violation|0|||
48440571|NCT03004469|155799775|FG001|Overall Study|Protocol Violation|0|||
48440572|NCT03004469|155799776|FG002|Overall Study|Protocol Violation|1|||
48440573|NCT03004469|155799774|FG000|Overall Study|Withdrawal by Subject|29|||
48440574|NCT03004469|155799775|FG001|Overall Study|Withdrawal by Subject|27|||
48440575|NCT03004469|155799776|FG002|Overall Study|Withdrawal by Subject|10|||
48440576|NCT03004469|155799774|FG000|Overall Study|Other unspecified reason|0|||
48440577|NCT03004469|155799775|FG001|Overall Study|Other unspecified reason|4|||
48440578|NCT03004469|155799776|FG002|Overall Study|Other unspecified reason|1|||
48440579|NCT01954251|155799777|FG000|Overall Study|Adverse Event|5|||
48440580|NCT01954251|155799778|FG001|Overall Study|Adverse Event|7|||
48440581|NCT01954251|155799777|FG000|Overall Study|Lost to Follow-up|6|||
48440582|NCT01954251|155799778|FG001|Overall Study|Lost to Follow-up|6|||
48440583|NCT01954251|155799777|FG000|Overall Study|Withdrawal by Subject|2|||
48440584|NCT01954251|155799778|FG001|Overall Study|Withdrawal by Subject|6|||
48440585|NCT03654755|155799781|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
48440586|NCT03654755|155799782|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
48440587|NCT03654755|155799783|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
48440588|NCT03654755|155799781|FG000|Overall Study|Withdrawal by Subject|2|||
48440589|NCT03654755|155799782|FG001|Overall Study|Withdrawal by Subject|4|||
48440590|NCT03654755|155799783|FG002|Overall Study|Withdrawal by Subject|8|||
48440591|NCT03654755|155799781|FG000|Overall Study|Lost to Follow-up|1|||
48440592|NCT03654755|155799782|FG001|Overall Study|Lost to Follow-up|3|||
48440593|NCT03654755|155799783|FG002|Overall Study|Lost to Follow-up|7|||
48440594|NCT03654755|155799781|FG000|Overall Study|Physician Decision|0|||
48440595|NCT03654755|155799782|FG001|Overall Study|Physician Decision|1|||
48440596|NCT03654755|155799783|FG002|Overall Study|Physician Decision|0|||
48440597|NCT03654755|155799781|FG000|Overall Study|Adverse Event|0|||
48440598|NCT03654755|155799782|FG001|Overall Study|Adverse Event|0|||
48440599|NCT03654755|155799783|FG002|Overall Study|Adverse Event|4|||
48440600|NCT03654755|155799781|FG000|Overall Study|Lack of Efficacy|0|||
48440601|NCT03654755|155799782|FG001|Overall Study|Lack of Efficacy|0|||
48440602|NCT03654755|155799783|FG002|Overall Study|Lack of Efficacy|1|||
48440603|NCT01199055|155799786|FG000|Overall Study|Death|0|||
48440604|NCT01199055|155799787|FG001|Overall Study|Death|1|||
48440605|NCT01199055|155799788|FG002|Overall Study|Death|0|||
48440606|NCT01199055|155799786|FG000|Overall Study|Physician Decision|0|||
48440703|NCT02293902|155799816|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
48440704|NCT02293902|155799817|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
48440705|NCT02293902|155799818|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
48440706|NCT02293902|155799819|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
48440707|NCT02293902|155799815|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
48440708|NCT02293902|155799816|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
48440709|NCT02293902|155799817|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
48440710|NCT02293902|155799818|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
48440711|NCT02293902|155799819|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
48440712|NCT01890512|155799820|FG000|Overall Study|Physician Decision|1|||
48440713|NCT01890512|155799820|FG000|Overall Study|Withdrawal by Subject|1|||
48440714|NCT01890512|155799820|FG000|Overall Study|Protocol Violation|1|||
48440715|NCT00946881|155799823|FG000|First Treatment|Withdrawal by Subject|1|||
48440716|NCT00946881|155799823|FG000|First Treatment|Patient relocated to another state|1|||
48440717|NCT00946881|155799823|FG000|Retreatment|Withdrawal by Subject|1|||
48440718|NCT00293423|155799824|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
48440719|NCT00293423|155799825|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
48440720|NCT00293423|155799824|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
48440721|NCT00293423|155799825|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
48440722|NCT00293423|155799824|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
48440723|NCT00293423|155799825|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
48440724|NCT00293423|155799824|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
48440725|NCT00293423|155799825|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
48440726|NCT00293423|155799824|FG000|Surgical Resection|processing error during surgical resection|1|||
48440727|NCT00293423|155799825|FG001|Surgical Resection|processing error during surgical resection|0|||
48440728|NCT00293423|155799824|FG000|Surgical Resection|Withdrawal by Subject|4|||
48440729|NCT00293423|155799825|FG001|Surgical Resection|Withdrawal by Subject|0|||
48440730|NCT00293423|155799824|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
48440731|NCT00293423|155799825|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
48440732|NCT00405821|155799828|FG000|Overall Study|Death|5|||
48440733|NCT00405821|155799829|FG001|Overall Study|Death|7|||
48440734|NCT00405821|155799828|FG000|Overall Study|Lost to Follow-up|7|||
48440735|NCT00405821|155799829|FG001|Overall Study|Lost to Follow-up|7|||
48440736|NCT00405821|155799828|FG000|Overall Study|Protocol Violation|1|||
48440737|NCT00405821|155799829|FG001|Overall Study|Protocol Violation|0|||
48440738|NCT00405821|155799828|FG000|Overall Study|initiated ART|9|||
48440739|NCT00405821|155799829|FG001|Overall Study|initiated ART|8|||
48440740|NCT00592553|155799830|FG000|Overall Study|Protocol Noncompliance|1|||
48440741|NCT00592553|155799831|FG001|Overall Study|Protocol Noncompliance|0|||
48440742|NCT00592553|155799832|FG002|Overall Study|Protocol Noncompliance|0|||
48440743|NCT00805545|155799835|FG000|Overall Study|Protocol Violation|3|||
48440744|NCT00805545|155799836|FG001|Overall Study|Protocol Violation|2|||
48440745|NCT00805545|155799835|FG000|Overall Study|Protocol Violation|3|||
48440746|NCT00805545|155799836|FG001|Overall Study|Protocol Violation|1|||
48440747|NCT02157506|155799843|FG000|Overall Study|Adverse Event|0|||
48440748|NCT02157506|155799844|FG001|Overall Study|Adverse Event|1|||
48440749|NCT02157506|155799845|FG002|Overall Study|Adverse Event|0|||
48440750|NCT02157506|155799846|FG003|Overall Study|Adverse Event|0|||
48440751|NCT02157506|155799847|FG004|Overall Study|Adverse Event|0|||
48440752|NCT02157506|155799843|FG000|Overall Study|Lost to Follow-up|0|||
48440753|NCT02157506|155799844|FG001|Overall Study|Lost to Follow-up|0|||
48440754|NCT02157506|155799845|FG002|Overall Study|Lost to Follow-up|1|||
48440755|NCT02157506|155799846|FG003|Overall Study|Lost to Follow-up|0|||
48440756|NCT02157506|155799847|FG004|Overall Study|Lost to Follow-up|0|||
48440757|NCT01182337|155799848|FG000|Overall Study|Withdrawal by Subject|3|||
48440758|NCT01182337|155799849|FG001|Overall Study|Withdrawal by Subject|1|||
48440759|NCT01182337|155799848|FG000|Overall Study|Lost to Follow-up|0|||
48440760|NCT01182337|155799849|FG001|Overall Study|Lost to Follow-up|1|||
48440761|NCT01401465|155799850|FG000|Treatment Period 1|Adverse Event|4|||
48440762|NCT01401465|155799851|FG001|Treatment Period 1|Adverse Event|1|||
48440763|NCT01401465|155799850|FG000|Treatment Period 1|Pregnancy|0|||
48440764|NCT01401465|155799851|FG001|Treatment Period 1|Pregnancy|1|||
48440765|NCT01401465|155799850|FG000|Treatment Period 1|Protocol Violation|5|||
48440766|NCT01401465|155799851|FG001|Treatment Period 1|Protocol Violation|0|||
48440767|NCT01401465|155799850|FG000|Treatment Period 1|Withdrawal by Subject|1|||
48440768|NCT01401465|155799851|FG001|Treatment Period 1|Withdrawal by Subject|4|||
48440769|NCT01401465|155799850|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
48440770|NCT01401465|155799851|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
48440771|NCT01401465|155799850|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
48440772|NCT01401465|155799851|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
48440773|NCT01401465|155799850|FG000|Treatment Period 1|Scheduling Difficulties|1|||
48440774|NCT01401465|155799851|FG001|Treatment Period 1|Scheduling Difficulties|1|||
48440775|NCT01401465|155799850|FG000|Treatment Period 2|Lost to Follow-up|0|||
48440776|NCT01401465|155799851|FG001|Treatment Period 2|Lost to Follow-up|1|||
48440777|NCT01401465|155799850|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48440778|NCT01401465|155799851|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48440779|NCT01115738|155799853|FG000|Overall Study|Death|1|||
48440780|NCT01115738|155799854|FG001|Overall Study|Death|0|||
48440781|NCT01115738|155799855|FG002|Overall Study|Death|0|||
48440782|NCT01115738|155799853|FG000|Overall Study|Lost to Follow-up|0|||
48440783|NCT01115738|155799854|FG001|Overall Study|Lost to Follow-up|0|||
48440784|NCT01115738|155799855|FG002|Overall Study|Lost to Follow-up|1|||
48440785|NCT01115738|155799853|FG000|Overall Study|Physician Decision|18|||
48440786|NCT01115738|155799854|FG001|Overall Study|Physician Decision|15|||
48440787|NCT01115738|155799855|FG002|Overall Study|Physician Decision|17|||
48440788|NCT01115738|155799853|FG000|Overall Study|Withdrawal by Subject|6|||
48440789|NCT01115738|155799854|FG001|Overall Study|Withdrawal by Subject|6|||
48440790|NCT01115738|155799855|FG002|Overall Study|Withdrawal by Subject|9|||
48440791|NCT00843843|155799861|FG000|Overall Study|Physician Decision|1|||
48440792|NCT00843843|155799862|FG001|Overall Study|Physician Decision|1|||
48440793|NCT00843843|155799861|FG000|Overall Study|Protocol Violation|1|||
48440794|NCT00843843|155799862|FG001|Overall Study|Protocol Violation|1|||
48440795|NCT01021813|155799865|FG000|DB Treatment Phase|Adverse Event|60|||
48440796|NCT01021813|155799866|FG001|DB Treatment Phase|Adverse Event|22|||
48440797|NCT01021813|155799867|FG002|DB Treatment Phase|Adverse Event|0|||
48440798|NCT01021813|155799868|FG003|DB Treatment Phase|Adverse Event|0|||
48440799|NCT01021813|155799869|FG004|DB Treatment Phase|Adverse Event|0|||
48440800|NCT01021813|155799865|FG000|DB Treatment Phase|Lack of Efficacy|44|||
48440801|NCT01021813|155799866|FG001|DB Treatment Phase|Lack of Efficacy|28|||
48440802|NCT01021813|155799867|FG002|DB Treatment Phase|Lack of Efficacy|0|||
48440803|NCT01021813|155799868|FG003|DB Treatment Phase|Lack of Efficacy|0|||
48440804|NCT01021813|155799869|FG004|DB Treatment Phase|Lack of Efficacy|0|||
48440805|NCT01021813|155799865|FG000|DB Treatment Phase|Lost to Follow-up|14|||
48440806|NCT01021813|155799866|FG001|DB Treatment Phase|Lost to Follow-up|12|||
48440807|NCT01021813|155799867|FG002|DB Treatment Phase|Lost to Follow-up|0|||
48440808|NCT01021813|155799868|FG003|DB Treatment Phase|Lost to Follow-up|0|||
48440809|NCT01021813|155799869|FG004|DB Treatment Phase|Lost to Follow-up|0|||
48440810|NCT01021813|155799865|FG000|DB Treatment Phase|Physician Decision|17|||
48440811|NCT01021813|155799866|FG001|DB Treatment Phase|Physician Decision|8|||
48440812|NCT01021813|155799867|FG002|DB Treatment Phase|Physician Decision|0|||
48440813|NCT01021813|155799868|FG003|DB Treatment Phase|Physician Decision|0|||
48440814|NCT01021813|155799869|FG004|DB Treatment Phase|Physician Decision|0|||
48440815|NCT01021813|155799865|FG000|DB Treatment Phase|Pregnancy|1|||
48440816|NCT01021813|155799866|FG001|DB Treatment Phase|Pregnancy|0|||
48440817|NCT01021813|155799867|FG002|DB Treatment Phase|Pregnancy|0|||
48440818|NCT01021813|155799868|FG003|DB Treatment Phase|Pregnancy|0|||
48440819|NCT01021813|155799869|FG004|DB Treatment Phase|Pregnancy|0|||
48440820|NCT01021813|155799865|FG000|DB Treatment Phase|Protocol Violation|4|||
48440821|NCT01021813|155799866|FG001|DB Treatment Phase|Protocol Violation|3|||
48440822|NCT01021813|155799867|FG002|DB Treatment Phase|Protocol Violation|0|||
48440823|NCT01021813|155799868|FG003|DB Treatment Phase|Protocol Violation|0|||
48440824|NCT01021813|155799869|FG004|DB Treatment Phase|Protocol Violation|0|||
48440825|NCT01021813|155799865|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
48440826|NCT01021813|155799866|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
48440827|NCT01021813|155799867|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
48440828|NCT01021813|155799868|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
48440829|NCT01021813|155799869|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
48440830|NCT01021813|155799865|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
48440831|NCT01021813|155799866|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
48440832|NCT01021813|155799867|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
48440833|NCT01021813|155799868|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
48440834|NCT01021813|155799869|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
48440835|NCT01021813|155799865|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
48440836|NCT01021813|155799866|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
48440837|NCT01021813|155799867|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
48440838|NCT01021813|155799868|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
48440839|NCT01021813|155799869|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
48440840|NCT01021813|155799865|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
48440841|NCT01021813|155799866|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
48440842|NCT01021813|155799867|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
48440843|NCT01021813|155799868|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
48440844|NCT01021813|155799869|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
48440845|NCT01021813|155799865|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
48440846|NCT01021813|155799866|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
48440847|NCT01021813|155799867|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
48440848|NCT01021813|155799868|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
48440849|NCT01021813|155799869|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
48440928|NCT00280150|155801440|FG003|Overall Study|Lack of Efficacy|3|||
48440850|NCT01021813|155799865|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
48440851|NCT01021813|155799866|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
48440852|NCT01021813|155799867|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
48440853|NCT01021813|155799868|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
48440854|NCT01021813|155799869|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
48440855|NCT03103906|155799874|FG000|Overall Study|Adverse Event|2|||
48440856|NCT03103906|155799875|FG001|Overall Study|Adverse Event|3|||
48440857|NCT03103906|155799874|FG000|Overall Study|Other|2|||
48440858|NCT03103906|155799875|FG001|Overall Study|Other|0|||
48440859|NCT04876599|155799876|FG000|Overall Study|Missed|2|||
48440860|NCT04876599|155799877|FG001|Overall Study|Missed|0|||
48440861|NCT04876599|155799876|FG000|Overall Study|Declined|2|||
48440862|NCT04876599|155799877|FG001|Overall Study|Declined|3|||
48440863|NCT00772382|155799881|FG000|Overall Study|Adverse Event|19|||
48440864|NCT00772382|155799881|FG000|Overall Study|Death|6|||
48440865|NCT00772382|155799881|FG000|Overall Study|Lack of Efficacy|4|||
48440866|NCT00772382|155799881|FG000|Overall Study|Physician Decision|5|||
48440867|NCT00772382|155799881|FG000|Overall Study|Protocol Violation|1|||
48440868|NCT00772382|155799881|FG000|Overall Study|Withdrawal by Subject|10|||
48440869|NCT00772382|155799881|FG000|Overall Study|Other Reasons|10|||
48440870|NCT02294318|155801419|FG000|Overall Study|Worsening of drinking|3|||
48440871|NCT02294318|155801420|FG001|Overall Study|Worsening of drinking|0|||
48440872|NCT02294318|155801419|FG000|Overall Study|Not exposed to intervention|0|||
48440873|NCT02294318|155801420|FG001|Overall Study|Not exposed to intervention|2|||
48440874|NCT01677624|155801421|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
48440875|NCT02616185|155801425|FG000|Overall Study|Death|0|||
48440876|NCT02616185|155801426|FG001|Overall Study|Death|0|||
48440877|NCT02616185|155801427|FG002|Overall Study|Death|0|||
48440878|NCT02616185|155801428|FG003|Overall Study|Death|1|||
48440879|NCT02616185|155801429|FG004|Overall Study|Death|2|||
48440880|NCT02616185|155801430|FG005|Overall Study|Death|0|||
48440881|NCT02616185|155801431|FG006|Overall Study|Death|0|||
48440882|NCT02616185|155801432|FG007|Overall Study|Death|2|||
48440883|NCT02616185|155801433|FG008|Overall Study|Death|1|||
48440884|NCT02616185|155801425|FG000|Overall Study|Study terminated by sponsor|0|||
48440885|NCT02616185|155801426|FG001|Overall Study|Study terminated by sponsor|0|||
48440886|NCT02616185|155801427|FG002|Overall Study|Study terminated by sponsor|1|||
48440887|NCT02616185|155801428|FG003|Overall Study|Study terminated by sponsor|0|||
48440888|NCT02616185|155801429|FG004|Overall Study|Study terminated by sponsor|0|||
48440889|NCT02616185|155801430|FG005|Overall Study|Study terminated by sponsor|0|||
48440890|NCT02616185|155801431|FG006|Overall Study|Study terminated by sponsor|5|||
48440891|NCT02616185|155801432|FG007|Overall Study|Study terminated by sponsor|2|||
48440892|NCT02616185|155801433|FG008|Overall Study|Study terminated by sponsor|0|||
48440893|NCT02616185|155801425|FG000|Overall Study|Participant refused further follow-up|1|||
48440894|NCT02616185|155801426|FG001|Overall Study|Participant refused further follow-up|1|||
48440895|NCT02616185|155801427|FG002|Overall Study|Participant refused further follow-up|2|||
48440896|NCT02616185|155801428|FG003|Overall Study|Participant refused further follow-up|3|||
48440897|NCT02616185|155801429|FG004|Overall Study|Participant refused further follow-up|4|||
48440898|NCT02616185|155801430|FG005|Overall Study|Participant refused further follow-up|0|||
48440899|NCT02616185|155801431|FG006|Overall Study|Participant refused further follow-up|3|||
48440900|NCT02616185|155801432|FG007|Overall Study|Participant refused further follow-up|4|||
48440901|NCT02616185|155801433|FG008|Overall Study|Participant refused further follow-up|3|||
48440902|NCT02616185|155801425|FG000|Overall Study|Not reported|0|||
48440903|NCT02616185|155801426|FG001|Overall Study|Not reported|0|||
48440904|NCT02616185|155801427|FG002|Overall Study|Not reported|0|||
48440905|NCT02616185|155801428|FG003|Overall Study|Not reported|1|||
48440906|NCT02616185|155801429|FG004|Overall Study|Not reported|3|||
48440907|NCT02616185|155801430|FG005|Overall Study|Not reported|1|||
48440908|NCT02616185|155801431|FG006|Overall Study|Not reported|0|||
48440909|NCT02616185|155801432|FG007|Overall Study|Not reported|5|||
48440910|NCT02616185|155801433|FG008|Overall Study|Not reported|2|||
48440911|NCT00333619|155801434|FG000|Overall Study|Death|12|||
48440912|NCT00333619|155801435|FG001|Overall Study|Death|6|||
48440913|NCT00333619|155801434|FG000|Overall Study|Withdrawal by Subject|6|||
48440914|NCT00333619|155801435|FG001|Overall Study|Withdrawal by Subject|1|||
48440915|NCT00333619|155801434|FG000|Overall Study|Lost to Follow-up|3|||
48440916|NCT00333619|155801435|FG001|Overall Study|Lost to Follow-up|3|||
48440917|NCT00574119|155801436|FG000|Overall Study|Adverse Event|1|||
48440918|NCT00574119|155801436|FG000|Overall Study|Protocol Violation|1|||
48440919|NCT00574119|155801436|FG000|Overall Study|Withdrawal by Subject|1|||
48440920|NCT00574119|155801436|FG000|Overall Study|Physician Decision|1|||
48440921|NCT00280150|155801437|FG000|Overall Study|Adverse Event|0|||
48440922|NCT00280150|155801438|FG001|Overall Study|Adverse Event|1|||
48440923|NCT00280150|155801439|FG002|Overall Study|Adverse Event|2|||
48440924|NCT00280150|155801440|FG003|Overall Study|Adverse Event|3|||
48440925|NCT00280150|155801437|FG000|Overall Study|Lack of Efficacy|0|||
48440926|NCT00280150|155801438|FG001|Overall Study|Lack of Efficacy|0|||
48440927|NCT00280150|155801439|FG002|Overall Study|Lack of Efficacy|0|||
48441010|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
48441011|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
48441012|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
48441013|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
48441014|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
48441015|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
48441016|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
48441017|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
48441018|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
48441019|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
48441020|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
48441021|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48441022|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48441023|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
48441024|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
48441025|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
48441026|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
48441027|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
48441028|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
48441029|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
48441030|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
48441031|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
48441032|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
48441033|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
48441034|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
48441035|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
48441036|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
48441037|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48441038|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48441039|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48441040|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48441041|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
48441042|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
48441043|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
48441044|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
48441045|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
48441046|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
48441047|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
48441048|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
48441049|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
48441050|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
48441051|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
48441052|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
48441053|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
48441054|NCT03444870|155801478|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
48441055|NCT03444870|155801479|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48441056|NCT03444870|155801480|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48441057|NCT03444870|155801481|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48441058|NCT03444870|155801482|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48441059|NCT03444870|155801483|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
48441060|NCT03444870|155801478|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48441061|NCT03444870|155801479|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48441062|NCT03444870|155801480|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48441063|NCT03444870|155801481|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
48441064|NCT03444870|155801482|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
48441065|NCT03444870|155801483|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
48441066|NCT03444870|155801478|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
48441067|NCT03444870|155801479|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
48441068|NCT03444870|155801480|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
48441069|NCT03444870|155801481|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
48441070|NCT03444870|155801482|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
48441071|NCT03444870|155801483|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
48441072|NCT03444870|155801478|FG000|Open-Label Extension (OLE) Period|Death|0|||
48441073|NCT03444870|155801479|FG001|Open-Label Extension (OLE) Period|Death|0|||
48441074|NCT03444870|155801480|FG002|Open-Label Extension (OLE) Period|Death|0|||
48441075|NCT03444870|155801481|FG003|Open-Label Extension (OLE) Period|Death|0|||
48441076|NCT03444870|155801482|FG004|Open-Label Extension (OLE) Period|Death|1|||
48441077|NCT03444870|155801483|FG005|Open-Label Extension (OLE) Period|Death|0|||
48441078|NCT00868166|155801484|FG000|Overall Study|Death|58|||
48441079|NCT00868166|155801485|FG001|Overall Study|Death|65|||
48441080|NCT00868166|155801484|FG000|Overall Study|Withdrawal by Subject|33|||
48441081|NCT00868166|155801485|FG001|Overall Study|Withdrawal by Subject|25|||
48441082|NCT00868166|155801484|FG000|Overall Study|Protocol Violation|1|||
48441083|NCT00868166|155801485|FG001|Overall Study|Protocol Violation|0|||
48441084|NCT00868166|155801484|FG000|Overall Study|Lost to Follow-up|1|||
48441085|NCT00868166|155801485|FG001|Overall Study|Lost to Follow-up|3|||
48441086|NCT00868166|155801484|FG000|Overall Study|Adverse Event|9|||
48441087|NCT00868166|155801485|FG001|Overall Study|Adverse Event|10|||
48441088|NCT00868166|155801484|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
48441089|NCT00868166|155801485|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
48441090|NCT00868166|155801484|FG000|Overall Study|Non-compliance with IMP|1|||
48441091|NCT00868166|155801485|FG001|Overall Study|Non-compliance with IMP|1|||
48441092|NCT01736254|155801486|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
48441093|NCT01736254|155801486|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
48441094|NCT01588353|155801487|FG000|Step2|Withdrawal by Subject|0|||
48441095|NCT01588353|155801488|FG001|Step2|Withdrawal by Subject|1|||
48441096|NCT01588353|155801489|FG002|Step2|Withdrawal by Subject|0|||
48441097|NCT01588353|155801487|FG000|Step3|Adverse Event|0|||
48441098|NCT01588353|155801488|FG001|Step3|Adverse Event|0|||
48441099|NCT01588353|155801489|FG002|Step3|Adverse Event|2|||
48441100|NCT03325556|155801490|FG000|Open-label Period|Lack of Response in OL period|70|||
48441101|NCT03325556|155801491|FG001|Open-label Period|Lack of Response in OL period|0|||
48441102|NCT03325556|155801492|FG002|Open-label Period|Lack of Response in OL period|0|||
48441103|NCT03325556|155801490|FG000|Open-label Period|Adverse Event|27|||
48441104|NCT03325556|155801491|FG001|Open-label Period|Adverse Event|0|||
48441105|NCT03325556|155801492|FG002|Open-label Period|Adverse Event|0|||
48441106|NCT03325556|155801490|FG000|Open-label Period|Death|1|||
48441107|NCT03325556|155801491|FG001|Open-label Period|Death|0|||
48441108|NCT03325556|155801492|FG002|Open-label Period|Death|0|||
48441109|NCT03325556|155801490|FG000|Open-label Period|Lost to Follow-up|1|||
48441110|NCT03325556|155801491|FG001|Open-label Period|Lost to Follow-up|0|||
48441111|NCT03325556|155801492|FG002|Open-label Period|Lost to Follow-up|0|||
48441112|NCT03325556|155801490|FG000|Open-label Period|Non-compliance with study drug|5|||
48441113|NCT03325556|155801491|FG001|Open-label Period|Non-compliance with study drug|0|||
48441114|NCT03325556|155801492|FG002|Open-label Period|Non-compliance with study drug|0|||
48441115|NCT03325556|155801490|FG000|Open-label Period|Use of prohibited medication|1|||
48441116|NCT03325556|155801491|FG001|Open-label Period|Use of prohibited medication|0|||
48441117|NCT03325556|155801492|FG002|Open-label Period|Use of prohibited medication|0|||
48441118|NCT03325556|155801490|FG000|Open-label Period|Protocol Violation|4|||
48441119|NCT03325556|155801491|FG001|Open-label Period|Protocol Violation|0|||
48441120|NCT03325556|155801492|FG002|Open-label Period|Protocol Violation|0|||
48441121|NCT03325556|155801490|FG000|Open-label Period|Withdrawal by Subject|17|||
48441122|NCT03325556|155801491|FG001|Open-label Period|Withdrawal by Subject|0|||
48441123|NCT03325556|155801492|FG002|Open-label Period|Withdrawal by Subject|0|||
48441124|NCT03325556|155801490|FG000|Open-label Period|Not otherwise specified|8|||
48441125|NCT03325556|155801491|FG001|Open-label Period|Not otherwise specified|0|||
48441126|NCT03325556|155801492|FG002|Open-label Period|Not otherwise specified|0|||
48441127|NCT03325556|155801490|FG000|Open-label Period|Administrative discont. at study termination|41|||
48441128|NCT03325556|155801491|FG001|Open-label Period|Administrative discont. at study termination|0|||
48441129|NCT03325556|155801492|FG002|Open-label Period|Administrative discont. at study termination|0|||
48441130|NCT03325556|155801490|FG000|Double-blind Period|Relapse|0|||
48441131|NCT03325556|155801491|FG001|Double-blind Period|Relapse|15|||
48441132|NCT03325556|155801492|FG002|Double-blind Period|Relapse|34|||
48441133|NCT03325556|155801490|FG000|Double-blind Period|Adverse Event|0|||
48441134|NCT03325556|155801491|FG001|Double-blind Period|Adverse Event|3|||
48441135|NCT03325556|155801492|FG002|Double-blind Period|Adverse Event|1|||
48441136|NCT03325556|155801490|FG000|Double-blind Period|Noncompliance with study drug|0|||
48441137|NCT03325556|155801491|FG001|Double-blind Period|Noncompliance with study drug|0|||
48441138|NCT03325556|155801492|FG002|Double-blind Period|Noncompliance with study drug|1|||
48441139|NCT03325556|155801490|FG000|Double-blind Period|Use of prohibited medication|0|||
48441140|NCT03325556|155801491|FG001|Double-blind Period|Use of prohibited medication|1|||
48441141|NCT03325556|155801492|FG002|Double-blind Period|Use of prohibited medication|0|||
48441142|NCT03325556|155801490|FG000|Double-blind Period|Physician Decision|0|||
48441143|NCT03325556|155801491|FG001|Double-blind Period|Physician Decision|0|||
48441144|NCT03325556|155801492|FG002|Double-blind Period|Physician Decision|1|||
48441145|NCT03325556|155801490|FG000|Double-blind Period|Withdrawal by Subject|0|||
48441146|NCT03325556|155801491|FG001|Double-blind Period|Withdrawal by Subject|6|||
48441147|NCT03325556|155801492|FG002|Double-blind Period|Withdrawal by Subject|4|||
48441148|NCT03325556|155801490|FG000|Double-blind Period|Not otherwise specified|0|||
48441149|NCT03325556|155801491|FG001|Double-blind Period|Not otherwise specified|1|||
48441150|NCT03325556|155801492|FG002|Double-blind Period|Not otherwise specified|5|||
48441151|NCT03325556|155801490|FG000|Double-blind Period|Administrative discont. at study termination|0|||
48441152|NCT03325556|155801491|FG001|Double-blind Period|Administrative discont. at study termination|35|||
48441153|NCT03325556|155801492|FG002|Double-blind Period|Administrative discont. at study termination|31|||
48441154|NCT01204697|155801493|FG000|Overall Study|Death|26|||
48441155|NCT01204697|155801494|FG001|Overall Study|Death|27|||
48441156|NCT01204697|155801493|FG000|Overall Study|Lost to Follow-up|3|||
48441157|NCT01204697|155801494|FG001|Overall Study|Lost to Follow-up|4|||
48441158|NCT01204697|155801493|FG000|Overall Study|Withdrawal by Subject|2|||
48441159|NCT01204697|155801494|FG001|Overall Study|Withdrawal by Subject|4|||
48441160|NCT01204697|155801493|FG000|Overall Study|Randomized, but not treated|0|||
48441161|NCT01204697|155801494|FG001|Overall Study|Randomized, but not treated|1|||
48441162|NCT01840228|155801500|FG000|Overall Study|Lost to Follow-up|1|||
48441163|NCT01840228|155801501|FG001|Overall Study|Lost to Follow-up|1|||
48441164|NCT01381718|155801502|FG000|Overall Study|Withdrawal by Subject|2|||
48441165|NCT01381718|155801503|FG001|Overall Study|Withdrawal by Subject|5|||
48441166|NCT01381718|155801502|FG000|Overall Study|Lost to Follow-up|3|||
48441167|NCT01381718|155801503|FG001|Overall Study|Lost to Follow-up|5|||
48441168|NCT01381718|155801502|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
48441169|NCT01381718|155801503|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
48441170|NCT01413542|155801510|FG000|Overall Study|Physician Decision|1|||
48441171|NCT01413542|155801511|FG001|Overall Study|Physician Decision|0|||
48441172|NCT01413542|155801512|FG002|Overall Study|Physician Decision|3|||
48441173|NCT01413542|155801513|FG003|Overall Study|Physician Decision|0|||
48441174|NCT01413542|155801510|FG000|Overall Study|Adverse Event|0|||
48441175|NCT01413542|155801511|FG001|Overall Study|Adverse Event|0|||
48441176|NCT01413542|155801512|FG002|Overall Study|Adverse Event|0|||
48441177|NCT01413542|155801513|FG003|Overall Study|Adverse Event|1|||
48441178|NCT04603391|155801514|FG000|First Intervention (4 Days)|Adverse Event|1|||
48441179|NCT04603391|155801515|FG001|First Intervention (4 Days)|Adverse Event|0|||
48441180|NCT04603391|155801514|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
48441181|NCT04603391|155801515|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
48441182|NCT02505542|155801516|FG000|Part A: Open-Label Period|Adverse Event|31|||
48441183|NCT02505542|155801517|FG001|Part A: Open-Label Period|Adverse Event|0|||
48441184|NCT02505542|155801518|FG002|Part A: Open-Label Period|Adverse Event|0|||
48441185|NCT02505542|155801519|FG003|Part A: Open-Label Period|Adverse Event|0|||
48441186|NCT02505542|155801516|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
48441187|NCT02505542|155801517|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
48441188|NCT02505542|155801518|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
48441189|NCT02505542|155801519|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
48441190|NCT02505542|155801516|FG000|Part A: Open-Label Period|Protocol Violation|1|||
48441191|NCT02505542|155801517|FG001|Part A: Open-Label Period|Protocol Violation|0|||
48441192|NCT02505542|155801518|FG002|Part A: Open-Label Period|Protocol Violation|0|||
48441193|NCT02505542|155801519|FG003|Part A: Open-Label Period|Protocol Violation|0|||
48441194|NCT02505542|155801516|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
48441195|NCT02505542|155801517|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
48441196|NCT02505542|155801518|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
48441197|NCT02505542|155801519|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
48441198|NCT02505542|155801516|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
48441199|NCT02505542|155801517|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
48441200|NCT02505542|155801518|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
48441201|NCT02505542|155801519|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
48441202|NCT02505542|155801516|FG000|Part A: Open-Label Period|New medical history available|1|||
48441203|NCT02505542|155801517|FG001|Part A: Open-Label Period|New medical history available|0|||
48441204|NCT02505542|155801518|FG002|Part A: Open-Label Period|New medical history available|0|||
48441205|NCT02505542|155801519|FG003|Part A: Open-Label Period|New medical history available|0|||
48441206|NCT02505542|155801516|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
48441207|NCT02505542|155801517|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
48441208|NCT02505542|155801518|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
48441209|NCT02505542|155801519|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
48441210|NCT02505542|155801516|FG000|Part A: Open-Label Period|Pregnancy|2|||
48441211|NCT02505542|155801517|FG001|Part A: Open-Label Period|Pregnancy|0|||
48441212|NCT02505542|155801518|FG002|Part A: Open-Label Period|Pregnancy|0|||
48441213|NCT02505542|155801519|FG003|Part A: Open-Label Period|Pregnancy|0|||
48441214|NCT02505542|155801516|FG000|Part A: Open-Label Period|Sponsor directive|1|||
48441215|NCT02505542|155801517|FG001|Part A: Open-Label Period|Sponsor directive|0|||
48441216|NCT02505542|155801518|FG002|Part A: Open-Label Period|Sponsor directive|0|||
48441217|NCT02505542|155801519|FG003|Part A: Open-Label Period|Sponsor directive|0|||
48441218|NCT02505542|155801516|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
48441219|NCT02505542|155801517|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
48441220|NCT02505542|155801518|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
48441221|NCT02505542|155801519|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
48441222|NCT02505542|155801516|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
48441223|NCT02505542|155801517|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
48441224|NCT02505542|155801518|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
48441225|NCT02505542|155801519|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
48441226|NCT02505542|155801516|FG000|Part A: Open-Label Period|Non-compliance|1|||
48441227|NCT02505542|155801517|FG001|Part A: Open-Label Period|Non-compliance|0|||
48441228|NCT02505542|155801518|FG002|Part A: Open-Label Period|Non-compliance|0|||
48441229|NCT02505542|155801519|FG003|Part A: Open-Label Period|Non-compliance|0|||
48441230|NCT02505542|155801516|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
48441231|NCT02505542|155801517|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
48441232|NCT02505542|155801518|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
48441233|NCT02505542|155801519|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
48441234|NCT02505542|155801516|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
48441235|NCT02505542|155801517|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
48441236|NCT02505542|155801518|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
48441237|NCT02505542|155801519|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
48441238|NCT02505542|155801516|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
48441239|NCT02505542|155801517|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
48441240|NCT02505542|155801518|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
48441241|NCT02505542|155801519|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
48441242|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Adverse Event|0|||
48441243|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Adverse Event|0|||
48441244|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Adverse Event|1|||
48441245|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Adverse Event|3|||
48441246|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
48441247|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
48441248|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
48441249|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
48441250|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
48441251|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
48441252|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
48441253|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
48441254|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
48441255|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
48441256|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
48441257|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
48441258|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
48441259|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
48441260|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
48441261|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
48441262|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
48441263|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
48441264|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
48441265|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
48441266|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
48441267|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
48441268|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
48441269|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
48441270|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Miscalculation|0|||
48441271|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Miscalculation|1|||
48441272|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Miscalculation|0|||
48441273|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Miscalculation|0|||
48441274|NCT02505542|155801516|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
48441275|NCT02505542|155801517|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
48441276|NCT02505542|155801518|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
48441277|NCT02505542|155801519|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
48441278|NCT03372603|155801520|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
48441279|NCT03372603|155801521|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
48441280|NCT03372603|155801520|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
48441281|NCT03372603|155801521|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
48441282|NCT03084718|155801522|FG000|Overall Study|Withdrawal by Subject|4|||
48441283|NCT03084718|155801523|FG001|Overall Study|Withdrawal by Subject|3|||
48441284|NCT03084718|155801524|FG002|Overall Study|Withdrawal by Subject|4|||
48441285|NCT03084718|155801525|FG003|Overall Study|Withdrawal by Subject|0|||
48441286|NCT03084718|155801526|FG004|Overall Study|Withdrawal by Subject|0|||
48441287|NCT03084718|155801522|FG000|Overall Study|Physician Decision|1|||
48441288|NCT03084718|155801523|FG001|Overall Study|Physician Decision|0|||
48441289|NCT03084718|155801524|FG002|Overall Study|Physician Decision|0|||
48441290|NCT03084718|155801525|FG003|Overall Study|Physician Decision|0|||
48441340|NCT01742078|155801542|FG008|Overall Study|Withdrawal by Subject|0|||
48441341|NCT00589979|155801544|FG000|Run-In Period|Adverse Event|5|||
48441342|NCT00589979|155801545|FG001|Run-In Period|Adverse Event|0|||
48441343|NCT00589979|155801546|FG002|Run-In Period|Adverse Event|0|||
48441344|NCT00589979|155801544|FG000|Run-In Period|Protocol Violation|3|||
48441345|NCT00589979|155801545|FG001|Run-In Period|Protocol Violation|0|||
48441346|NCT00589979|155801546|FG002|Run-In Period|Protocol Violation|0|||
48441347|NCT00589979|155801544|FG000|Run-In Period|Did not qualify for randomization|54|||
48441348|NCT00589979|155801545|FG001|Run-In Period|Did not qualify for randomization|0|||
48441349|NCT00589979|155801546|FG002|Run-In Period|Did not qualify for randomization|0|||
48441350|NCT00589979|155801544|FG000|Run-In Period|Withdrawal by Subject|10|||
48441351|NCT00589979|155801545|FG001|Run-In Period|Withdrawal by Subject|0|||
48441352|NCT00589979|155801546|FG002|Run-In Period|Withdrawal by Subject|0|||
48441353|NCT00589979|155801544|FG000|Run-In Period|Informed Consent Withdrawn|4|||
48441354|NCT00589979|155801545|FG001|Run-In Period|Informed Consent Withdrawn|0|||
48441355|NCT00589979|155801546|FG002|Run-In Period|Informed Consent Withdrawn|0|||
48441356|NCT00589979|155801544|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
48441357|NCT00589979|155801545|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
48441358|NCT00589979|155801546|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
48441359|NCT00589979|155801544|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
48441360|NCT00589979|155801545|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
48441361|NCT00589979|155801546|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
48441362|NCT00589979|155801544|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
48441363|NCT00589979|155801545|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
48441364|NCT00589979|155801546|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
48441365|NCT00589979|155801544|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
48441366|NCT00589979|155801545|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
48441367|NCT00589979|155801546|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
48441368|NCT00589979|155801544|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
48441369|NCT00589979|155801545|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
48441370|NCT00589979|155801546|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
48441371|NCT00589979|155801544|FG000|Double-Blind Treatment Period 2|Other|0|||
48441372|NCT00589979|155801545|FG001|Double-Blind Treatment Period 2|Other|0|||
48441373|NCT00589979|155801546|FG002|Double-Blind Treatment Period 2|Other|1|||
48441374|NCT00589979|155801544|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
48441375|NCT00589979|155801545|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
48441376|NCT00589979|155801546|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
48441377|NCT00589979|155801544|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
48441378|NCT00589979|155801545|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
48441379|NCT00589979|155801546|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
48441380|NCT02855450|155801547|FG000|Overall Study|Adverse Event|1|||
48441381|NCT02855450|155801548|FG001|Overall Study|Adverse Event|0|||
48441382|NCT02855450|155801547|FG000|Overall Study|Lost to Follow-up|4|||
48441383|NCT02855450|155801548|FG001|Overall Study|Lost to Follow-up|0|||
48441384|NCT04404010|155801549|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
48441385|NCT04404010|155801550|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
48441386|NCT02120157|155801551|FG000|Overall Study|Death|8|||
48441387|NCT01529385|155801552|FG000|Overall Study|Lost to Follow-up|2|||
48441388|NCT01529385|155801553|FG001|Overall Study|Lost to Follow-up|1|||
48441389|NCT03448224|155801554|FG000|Overall Study|Provided same answer to every question|1|||
48441390|NCT03448224|155801555|FG001|Overall Study|Provided same answer to every question|0|||
48441391|NCT02379390|155801556|FG000|Overall Study|Adverse Event|1|||
48441392|NCT02379390|155801557|FG001|Overall Study|Adverse Event|1|||
48441393|NCT02379390|155801556|FG000|Overall Study|Investigator's decision|1|||
48441394|NCT02379390|155801557|FG001|Overall Study|Investigator's decision|0|||
48441395|NCT02379390|155801556|FG000|Overall Study|Study Termination|0|||
48441396|NCT02379390|155801557|FG001|Overall Study|Study Termination|1|||
48441397|NCT00575094|155801558|FG000|Overall Study|Adverse Event|2|||
48441398|NCT00575094|155801558|FG000|Overall Study|Withdrawal by Subject|1|||
48441399|NCT02270684|155801559|FG000|Overall Study|Lost to Follow-up|0|||
48441400|NCT02270684|155801560|FG001|Overall Study|Lost to Follow-up|3|||
48441401|NCT02270684|155801559|FG000|Overall Study|Study terminated|1|||
48441402|NCT02270684|155801560|FG001|Overall Study|Study terminated|0|||
48441403|NCT00643604|155801561|FG000|Overall Study|Death|1|||
48441404|NCT02702011|155801562|FG000|Overall Study|Withdrawal by Subject|0|||
48441405|NCT02702011|155801563|FG001|Overall Study|Withdrawal by Subject|1|||
48441406|NCT02702011|155801564|FG002|Overall Study|Withdrawal by Subject|0|||
48441407|NCT02702011|155801565|FG003|Overall Study|Withdrawal by Subject|0|||
48441408|NCT01309841|155801570|FG000|Overall Study|Other|0|||
48441409|NCT01309841|155801571|FG001|Overall Study|Other|1|||
48441410|NCT01309841|155801572|FG002|Overall Study|Other|1|||
48441411|NCT01309841|155801570|FG000|Overall Study|Lost to Follow-up|7|||
48441412|NCT01309841|155801571|FG001|Overall Study|Lost to Follow-up|6|||
48441427|NCT01309841|155801571|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
48441428|NCT01309841|155801572|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
48441429|NCT01309841|155801570|FG000|Overall Study|Withdrawal by Subject|17|||
48441430|NCT01309841|155801571|FG001|Overall Study|Withdrawal by Subject|6|||
48441431|NCT01309841|155801572|FG002|Overall Study|Withdrawal by Subject|13|||
48441432|NCT01309841|155801570|FG000|Overall Study|Did Not Receive Treatment|2|||
48441433|NCT01309841|155801571|FG001|Overall Study|Did Not Receive Treatment|0|||
48441434|NCT01309841|155801572|FG002|Overall Study|Did Not Receive Treatment|1|||
48441435|NCT01309841|155801570|FG000|Overall Study|Severe non-compliance with protocol|0|||
48441436|NCT01309841|155801571|FG001|Overall Study|Severe non-compliance with protocol|5|||
48441437|NCT01309841|155801572|FG002|Overall Study|Severe non-compliance with protocol|2|||
48441438|NCT04092816|155803316|FG000|Overall Study|Lost to Follow-up|1|||
48441439|NCT04092816|155803317|FG001|Overall Study|Lost to Follow-up|2|||
48441440|NCT02115113|155803318|FG000|Participants in Run-in Period|Death|0|||
48441441|NCT02115113|155803319|FG001|Participants in Run-in Period|Death|0|||
48441442|NCT02115113|155803320|FG002|Participants in Run-in Period|Death|1|||
48441443|NCT02115113|155803318|FG000|Participants in Run-in Period|Administrative problems|0|||
48441444|NCT02115113|155803319|FG001|Participants in Run-in Period|Administrative problems|0|||
48441445|NCT02115113|155803320|FG002|Participants in Run-in Period|Administrative problems|1|||
48441446|NCT02115113|155803318|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
48441447|NCT02115113|155803319|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
48441448|NCT02115113|155803320|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
48441449|NCT02115113|155803318|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
48441450|NCT02115113|155803319|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
48441451|NCT02115113|155803320|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
48441452|NCT02115113|155803318|FG000|Participants Randomized|Lost to Follow-up|1|||
48441453|NCT02115113|155803319|FG001|Participants Randomized|Lost to Follow-up|0|||
48441454|NCT02115113|155803320|FG002|Participants Randomized|Lost to Follow-up|0|||
48441455|NCT02115113|155803318|FG000|Participants Randomized|Death|1|||
48441456|NCT02115113|155803319|FG001|Participants Randomized|Death|0|||
48441457|NCT02115113|155803320|FG002|Participants Randomized|Death|0|||
48441458|NCT00789191|155803322|FG000|Overall Study|Adverse Event|2|||
48441459|NCT00789191|155803323|FG001|Overall Study|Adverse Event|4|||
48441460|NCT00789191|155803322|FG000|Overall Study|Lack of Efficacy|0|||
48441461|NCT00789191|155803323|FG001|Overall Study|Lack of Efficacy|5|||
48441462|NCT00789191|155803322|FG000|Overall Study|Protocol Violation|5|||
48441463|NCT00789191|155803323|FG001|Overall Study|Protocol Violation|3|||
48441464|NCT00789191|155803322|FG000|Overall Study|Withdrawal Criteria|2|||
48441465|NCT00789191|155803323|FG001|Overall Study|Withdrawal Criteria|4|||
48441466|NCT00789191|155803322|FG000|Overall Study|Unclassified|5|||
48441467|NCT00789191|155803323|FG001|Overall Study|Unclassified|3|||
48441468|NCT01009983|155803324|FG000|Overall Study|necessary scans not completed|1|||
48441469|NCT02395653|155803325|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
48441470|NCT02395653|155803325|FG000|Overall Study|Consent Withdrawn at Screening|1|||
48441471|NCT02395653|155803325|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
48441472|NCT02395653|155803325|FG000|Overall Study|Investigator Decision at Screening|1|||
48441473|NCT02395653|155803325|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
48441474|NCT02395653|155803325|FG000|Overall Study|Withdrawal by Subject|1|||
48441475|NCT02395653|155803325|FG000|Overall Study|Lost to Follow-up|1|||
48441476|NCT02494778|155803326|FG000|Overall Study|Death|3|||
48441477|NCT02494778|155803326|FG000|Overall Study|Other|173|||
48441478|NCT02494778|155803326|FG000|Overall Study|Lack of Efficacy|4|||
48441479|NCT02494778|155803326|FG000|Overall Study|Adverse Event|18|||
48441480|NCT02494778|155803326|FG000|Overall Study|Withdrawal by Subject|20|||
48441481|NCT02494778|155803326|FG000|Overall Study|Lost to Follow-up|2|||
48441482|NCT02494778|155803326|FG000|Overall Study|Noncompliant with study drug admin.|1|||
48441483|NCT02871401|155803342|FG000|Overall Study|Adverse Event|1|||
48441484|NCT02871401|155803343|FG001|Overall Study|Adverse Event|0|||
48441485|NCT00485589|155803348|FG000|Overall Study|Death|2|||
48441486|NCT00485589|155803349|FG001|Overall Study|Death|2|||
48441487|NCT00485589|155803350|FG002|Overall Study|Death|0|||
48441488|NCT00485589|155803348|FG000|Overall Study|Failure to return|6|||
48441489|NCT00485589|155803349|FG001|Overall Study|Failure to return|5|||
48441490|NCT00485589|155803350|FG002|Overall Study|Failure to return|1|||
48441491|NCT00485589|155803348|FG000|Overall Study|Protocol Violation|1|||
48441492|NCT00485589|155803349|FG001|Overall Study|Protocol Violation|0|||
48441493|NCT00485589|155803350|FG002|Overall Study|Protocol Violation|0|||
48441494|NCT00485589|155803348|FG000|Overall Study|Violation of selection criteria at entry|0|||
48441495|NCT00485589|155803349|FG001|Overall Study|Violation of selection criteria at entry|3|||
48441496|NCT00485589|155803350|FG002|Overall Study|Violation of selection criteria at entry|1|||
48441497|NCT00485589|155803348|FG000|Overall Study|Administrative/Other|1|||
48441498|NCT00485589|155803349|FG001|Overall Study|Administrative/Other|2|||
48441499|NCT00485589|155803350|FG002|Overall Study|Administrative/Other|1|||
48441500|NCT00485589|155803348|FG000|Overall Study|Insufficient therapeutic response|10|||
48441501|NCT00485589|155803349|FG001|Overall Study|Insufficient therapeutic response|3|||
48441502|NCT00485589|155803350|FG002|Overall Study|Insufficient therapeutic response|1|||
48441503|NCT00485589|155803348|FG000|Overall Study|Refused treatment/did not cooperate|1|||
48441504|NCT00485589|155803349|FG001|Overall Study|Refused treatment/did not cooperate|0|||
48441505|NCT00485589|155803350|FG002|Overall Study|Refused treatment/did not cooperate|2|||
48441506|NCT00485589|155803348|FG000|Overall Study|Withdrawal by Subject|3|||
48441507|NCT00485589|155803349|FG001|Overall Study|Withdrawal by Subject|2|||
48441508|NCT00485589|155803350|FG002|Overall Study|Withdrawal by Subject|2|||
48441509|NCT00485589|155803348|FG000|Overall Study|Adverse Event|3|||
48441510|NCT00485589|155803349|FG001|Overall Study|Adverse Event|3|||
48441511|NCT00485589|155803350|FG002|Overall Study|Adverse Event|10|||
48441512|NCT01369849|155803351|FG000|Overall Study|Ineligible prior to treatment|0|||
48441513|NCT01369849|155803352|FG001|Overall Study|Ineligible prior to treatment|0|||
48441514|NCT01369849|155803353|FG002|Overall Study|Ineligible prior to treatment|1|||
48441515|NCT01369849|155803351|FG000|Overall Study|Ineligible after receiving treatment|0|||
48441516|NCT01369849|155803352|FG001|Overall Study|Ineligible after receiving treatment|1|||
48441517|NCT01369849|155803353|FG002|Overall Study|Ineligible after receiving treatment|0|||
48441518|NCT00817206|155803357|FG000|Overall Study|Adverse Event|10|||
48441519|NCT00817206|155803358|FG001|Overall Study|Adverse Event|3|||
48441520|NCT00817206|155803357|FG000|Overall Study|Protocol Violation|0|||
48441521|NCT00817206|155803358|FG001|Overall Study|Protocol Violation|2|||
48441522|NCT00817206|155803357|FG000|Overall Study|Lost to Follow-up|0|||
48441523|NCT00817206|155803358|FG001|Overall Study|Lost to Follow-up|1|||
48441524|NCT00817206|155803357|FG000|Overall Study|Death|2|||
48441525|NCT00817206|155803358|FG001|Overall Study|Death|0|||
48441526|NCT00817206|155803357|FG000|Overall Study|Withdrawal by Subject|7|||
48441527|NCT00817206|155803358|FG001|Overall Study|Withdrawal by Subject|3|||
48441528|NCT00817206|155803357|FG000|Overall Study|Physician Decision|2|||
48441529|NCT00817206|155803358|FG001|Overall Study|Physician Decision|0|||
48441530|NCT00126581|155803359|FG000|Overall Study|Adverse Event|3|||
48441531|NCT00126581|155803360|FG001|Overall Study|Adverse Event|7|||
48441532|NCT00126581|155803359|FG000|Overall Study|Death|3|||
48441533|NCT00126581|155803360|FG001|Overall Study|Death|2|||
48441534|NCT00126581|155803359|FG000|Overall Study|Withdrawal by Subject|1|||
48441535|NCT00126581|155803360|FG001|Overall Study|Withdrawal by Subject|4|||
48441536|NCT00126581|155803359|FG000|Overall Study|Alternative therapy|3|||
48441537|NCT00126581|155803360|FG001|Overall Study|Alternative therapy|3|||
48441538|NCT00126581|155803359|FG000|Overall Study|Other illness/MD discretion|3|||
48441539|NCT00126581|155803360|FG001|Overall Study|Other illness/MD discretion|4|||
48441540|NCT00400712|155803361|FG000|Overall Study|Death|1|||
48441541|NCT00400712|155803362|FG001|Overall Study|Death|0|||
48441542|NCT00400712|155803361|FG000|Overall Study|Withdrawal by Subject|11|||
48441543|NCT00400712|155803362|FG001|Overall Study|Withdrawal by Subject|12|||
48441544|NCT00400712|155803361|FG000|Overall Study|Physician Decision|5|||
48441545|NCT00400712|155803362|FG001|Overall Study|Physician Decision|4|||
48441546|NCT00634114|155803368|FG000|Overall Study|Adverse Event|6|||
48441547|NCT00634114|155803369|FG001|Overall Study|Adverse Event|8|||
48441548|NCT00634114|155803370|FG002|Overall Study|Adverse Event|3|||
48441549|NCT00634114|155803368|FG000|Overall Study|Withdrawal by Subject|9|||
48441550|NCT00634114|155803369|FG001|Overall Study|Withdrawal by Subject|6|||
48441551|NCT00634114|155803370|FG002|Overall Study|Withdrawal by Subject|11|||
48441552|NCT00634114|155803368|FG000|Overall Study|Lost to Follow-up|0|||
48441553|NCT00634114|155803369|FG001|Overall Study|Lost to Follow-up|0|||
48441554|NCT00634114|155803370|FG002|Overall Study|Lost to Follow-up|1|||
48441555|NCT00634114|155803368|FG000|Overall Study|Protocol Violation|3|||
48441556|NCT00634114|155803369|FG001|Overall Study|Protocol Violation|3|||
48441557|NCT00634114|155803370|FG002|Overall Study|Protocol Violation|1|||
48441558|NCT00634114|155803368|FG000|Overall Study|Pregnancy|1|||
48441559|NCT00634114|155803369|FG001|Overall Study|Pregnancy|0|||
48441560|NCT00634114|155803370|FG002|Overall Study|Pregnancy|0|||
48441561|NCT00634114|155803368|FG000|Overall Study|Incorrect enrolment|0|||
48441562|NCT00634114|155803369|FG001|Overall Study|Incorrect enrolment|1|||
48441563|NCT00634114|155803370|FG002|Overall Study|Incorrect enrolment|0|||
48441564|NCT00634114|155803368|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
48441565|NCT00634114|155803369|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
48441566|NCT00634114|155803370|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
48441567|NCT00634114|155803368|FG000|Overall Study|Difficult to continue|3|||
48441568|NCT00634114|155803369|FG001|Overall Study|Difficult to continue|1|||
48441569|NCT00634114|155803370|FG002|Overall Study|Difficult to continue|1|||
48441570|NCT00634114|155803368|FG000|Overall Study|Other reason|1|||
48441571|NCT00634114|155803369|FG001|Overall Study|Other reason|1|||
48441572|NCT00634114|155803370|FG002|Overall Study|Other reason|1|||
48441573|NCT01170702|155803371|FG000|Overall Study|Exclusion criteria met after consent|1|||
48441574|NCT01170702|155803372|FG001|Overall Study|Exclusion criteria met after consent|2|||
48441575|NCT01170702|155803373|FG002|Overall Study|Exclusion criteria met after consent|0|||
48441576|NCT01170702|155803374|FG003|Overall Study|Exclusion criteria met after consent|2|||
48441577|NCT00881361|155803382|FG000|Overall Study|Terminated prior to surgery|27|||
48441578|NCT00881361|155803383|FG001|Overall Study|Terminated prior to surgery|7|||
48441579|NCT00881361|155803384|FG002|Overall Study|Terminated prior to surgery|0|||
48441580|NCT00881361|155803382|FG000|Overall Study|Ineligible|17|||
48441581|NCT00881361|155803383|FG001|Overall Study|Ineligible|2|||
48441582|NCT00881361|155803384|FG002|Overall Study|Ineligible|2|||
48441583|NCT01511107|155803388|FG000|Overall Study|Ineligible|3|||
48441584|NCT01511107|155803389|FG001|Overall Study|Ineligible|2|||
48441585|NCT01511107|155803388|FG000|Overall Study|Lost to Follow-up|10|||
48441586|NCT01511107|155803389|FG001|Overall Study|Lost to Follow-up|19|||
48441587|NCT01511107|155803388|FG000|Overall Study|Withdrawal by Subject|9|||
48441588|NCT01511107|155803389|FG001|Overall Study|Withdrawal by Subject|20|||
48441589|NCT02180217|155803401|FG000|Overall Study|Adverse Event|3|||
48441590|NCT02180217|155803402|FG001|Overall Study|Adverse Event|2|||
48441591|NCT02180217|155803403|FG002|Overall Study|Adverse Event|22|||
48441592|NCT02180217|155803401|FG000|Overall Study|Death|1|||
48441593|NCT02180217|155803402|FG001|Overall Study|Death|1|||
48441594|NCT02180217|155803403|FG002|Overall Study|Death|0|||
48441595|NCT02180217|155803401|FG000|Overall Study|Withdrawal by Subject|1|||
48441596|NCT02180217|155803402|FG001|Overall Study|Withdrawal by Subject|1|||
48441597|NCT02180217|155803403|FG002|Overall Study|Withdrawal by Subject|4|||
48441598|NCT02180217|155803401|FG000|Overall Study|Subject/Guardian decision|5|||
48441599|NCT02180217|155803402|FG001|Overall Study|Subject/Guardian decision|3|||
48441600|NCT02180217|155803403|FG002|Overall Study|Subject/Guardian decision|6|||
48441601|NCT02180217|155803401|FG000|Overall Study|Physician Decision|1|||
48441602|NCT02180217|155803402|FG001|Overall Study|Physician Decision|1|||
48441603|NCT02180217|155803403|FG002|Overall Study|Physician Decision|6|||
48441604|NCT02180217|155803401|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48441605|NCT02180217|155803402|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48441606|NCT02180217|155803403|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
48441607|NCT02721251|155803405|FG000|Overall Study|Withdrawal by Subject|8|||
48441608|NCT02721251|155803406|FG001|Overall Study|Withdrawal by Subject|7|||
48441609|NCT02721251|155803407|FG002|Overall Study|Withdrawal by Subject|9|||
48441610|NCT02721251|155803405|FG000|Overall Study|poor adherence|2|||
48441611|NCT02721251|155803406|FG001|Overall Study|poor adherence|2|||
48441612|NCT02721251|155803407|FG002|Overall Study|poor adherence|2|||
48441613|NCT01714817|155803410|FG000|Year 1 Period|Lack of Efficacy|11|||
48441614|NCT01714817|155803411|FG001|Year 1 Period|Lack of Efficacy|9|||
48441615|NCT01714817|155803410|FG000|Year 1 Period|Adverse Event|20|||
48441616|NCT01714817|155803411|FG001|Year 1 Period|Adverse Event|17|||
48441617|NCT01714817|155803410|FG000|Year 1 Period|Withdrawal by Subject|6|||
48441618|NCT01714817|155803411|FG001|Year 1 Period|Withdrawal by Subject|7|||
48441619|NCT01714817|155803410|FG000|Year 1 Period|Death|1|||
48441620|NCT01714817|155803411|FG001|Year 1 Period|Death|1|||
48441621|NCT01714817|155803410|FG000|Year 1 Period|Lost to Follow-up|0|||
48441622|NCT01714817|155803411|FG001|Year 1 Period|Lost to Follow-up|2|||
48441623|NCT01714817|155803410|FG000|Year 1 Period|Poor / non-compliance|0|||
48441624|NCT01714817|155803411|FG001|Year 1 Period|Poor / non-compliance|1|||
48441625|NCT01714817|155803410|FG000|Year 1 Period|Pregnancy|2|||
48441626|NCT01714817|155803411|FG001|Year 1 Period|Pregnancy|0|||
48441627|NCT01714817|155803410|FG000|Year 1 Period|Participant no longer meets criteria|6|||
48441628|NCT01714817|155803411|FG001|Year 1 Period|Participant no longer meets criteria|2|||
48441629|NCT01714817|155803410|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
48441630|NCT01714817|155803411|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
48441631|NCT01714817|155803410|FG000|Year 1 Period|Change in Concomitant Medication|0|||
48441632|NCT01714817|155803411|FG001|Year 1 Period|Change in Concomitant Medication|1|||
48441633|NCT01714817|155803410|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
48441634|NCT01714817|155803411|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
48441635|NCT01714817|155803410|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
48441636|NCT01714817|155803411|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
48441637|NCT01714817|155803410|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
48441638|NCT01714817|155803411|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
48441639|NCT01714817|155803410|FG000|Year 2 Period|Lack of Efficacy|4|||
48441640|NCT01714817|155803411|FG001|Year 2 Period|Lack of Efficacy|12|||
48441641|NCT01714817|155803410|FG000|Year 2 Period|Adverse Event|7|||
48441642|NCT01714817|155803411|FG001|Year 2 Period|Adverse Event|6|||
48441643|NCT01714817|155803410|FG000|Year 2 Period|Participant request to stop treatment|4|||
48441644|NCT01714817|155803411|FG001|Year 2 Period|Participant request to stop treatment|4|||
48441645|NCT01714817|155803410|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
48441646|NCT01714817|155803411|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
48441647|NCT01714817|155803410|FG000|Year 2 Period|Participant withdrew consent|1|||
48441648|NCT01714817|155803411|FG001|Year 2 Period|Participant withdrew consent|5|||
48441649|NCT01714817|155803410|FG000|Year 2 Period|Participant no longer meets criteria|1|||
48441650|NCT01714817|155803411|FG001|Year 2 Period|Participant no longer meets criteria|4|||
48441651|NCT01714817|155803410|FG000|Year 2 Period|Lost to Follow-up|2|||
48441652|NCT01714817|155803411|FG001|Year 2 Period|Lost to Follow-up|0|||
48441653|NCT01714817|155803410|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
48441654|NCT01714817|155803411|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
48441678|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
48441679|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
48441680|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
48441681|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
48441682|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
48441683|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
48441684|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
48441685|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
48441686|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
48441687|NCT01714817|155803410|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
48441688|NCT01714817|155803411|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
48441689|NCT02921763|155803412|FG000|Overall Study|Adverse Event|4|||
48441690|NCT02921763|155803412|FG000|Overall Study|Lost to Follow-up|4|||
48441691|NCT02921763|155803412|FG000|Overall Study|Lack of Efficacy|3|||
48441692|NCT02921763|155803412|FG000|Overall Study|Protocol Violation|2|||
48441693|NCT02921763|155803412|FG000|Overall Study|Withdrawal by Subject|2|||
48441694|NCT02921763|155803412|FG000|Overall Study|Physician Decision|1|||
48441695|NCT02921763|155803412|FG000|Overall Study|No data obtained|2|||
48441696|NCT01374217|155803413|FG000|Overall Study|Lack of Efficacy|13|||
48441697|NCT00642018|155803414|FG000|Overall Study|Adverse Event|11|||
48441698|NCT00642018|155803415|FG001|Overall Study|Adverse Event|36|||
48441699|NCT00642018|155803414|FG000|Overall Study|Withdrawal by Subject|4|||
48441700|NCT00642018|155803415|FG001|Overall Study|Withdrawal by Subject|10|||
48441701|NCT00642018|155803414|FG000|Overall Study|Progressive Disease|13|||
48441702|NCT00642018|155803415|FG001|Overall Study|Progressive Disease|18|||
48441703|NCT00642018|155803414|FG000|Overall Study|Physician Decision|0|||
48441704|NCT00642018|155803415|FG001|Overall Study|Physician Decision|10|||
48441705|NCT00642018|155803414|FG000|Overall Study|Protocol Violation|0|||
48441706|NCT00642018|155803415|FG001|Overall Study|Protocol Violation|1|||
48441707|NCT00642018|155803414|FG000|Overall Study|Death|0|||
48441708|NCT00642018|155803415|FG001|Overall Study|Death|3|||
48441709|NCT00642018|155803414|FG000|Overall Study|Entry Criteria Not Met|0|||
48441710|NCT00642018|155803415|FG001|Overall Study|Entry Criteria Not Met|1|||
48441711|NCT03495817|155803416|FG000|26 Week Open Label|Adverse Event|3|||
48441712|NCT03495817|155803416|FG000|26 Week Open Label|Withdrawal by Subject|4|||
48441713|NCT03495817|155803416|FG000|26 Week Open Label|Lost to Follow-up|1|||
48441714|NCT03495817|155803416|FG000|26 Week Extension|Lost to Follow-up|2|||
48441715|NCT01740388|155803417|FG000|Overall Study|Withdrawal by Subject|1|||
48441716|NCT01740388|155803418|FG001|Overall Study|Withdrawal by Subject|2|||
48441717|NCT01740388|155803417|FG000|Overall Study|Lost to Follow-up|2|||
48441718|NCT01740388|155803418|FG001|Overall Study|Lost to Follow-up|0|||
48441719|NCT01740388|155803417|FG000|Overall Study|Physician Decision|2|||
48441720|NCT01740388|155803418|FG001|Overall Study|Physician Decision|6|||
48441721|NCT01740388|155803417|FG000|Overall Study|Subjects missing data, completed|41|||
48441722|NCT01740388|155803418|FG001|Overall Study|Subjects missing data, completed|36|||
48441723|NCT05200455|155803422|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
48441724|NCT00862121|155803423|FG000|Overall Study|Adverse Event|1|||
48441725|NCT00862121|155803424|FG001|Overall Study|Adverse Event|2|||
48441726|NCT00862121|155803423|FG000|Overall Study|Lack of Efficacy|0|||
48441727|NCT00862121|155803424|FG001|Overall Study|Lack of Efficacy|3|||
48441728|NCT00862121|155803423|FG000|Overall Study|Protocol Violation|0|||
48441729|NCT00862121|155803424|FG001|Overall Study|Protocol Violation|1|||
48441730|NCT00862121|155803423|FG000|Overall Study|Exclusion criterion violation|0|||
48441731|NCT00862121|155803424|FG001|Overall Study|Exclusion criterion violation|1|||
48441732|NCT00862121|155803423|FG000|Overall Study|Incorrect randomisation|0|||
48441733|NCT00862121|155803424|FG001|Overall Study|Incorrect randomisation|1|||
48441734|NCT01582971|155803425|FG000|Overall Study|Death|2|||
48441735|NCT01582971|155803426|FG001|Overall Study|Death|1|||
48441736|NCT01582971|155803425|FG000|Overall Study|Lost to Follow-up|18|||
48441737|NCT01582971|155803426|FG001|Overall Study|Lost to Follow-up|21|||
48441738|NCT01582971|155803425|FG000|Overall Study|Withdrawal by Subject|4|||
48441739|NCT01582971|155803426|FG001|Overall Study|Withdrawal by Subject|2|||
48441740|NCT01582971|155803425|FG000|Overall Study|Other|15|||
48441741|NCT01582971|155803426|FG001|Overall Study|Other|13|||
48441742|NCT03695393|155803427|FG000|Overall Study|Death|3|||
48441743|NCT03695393|155803428|FG001|Overall Study|Death|1|||
48441744|NCT03695393|155803427|FG000|Overall Study|Lost to Follow-up|0|||
48441745|NCT03695393|155803428|FG001|Overall Study|Lost to Follow-up|1|||
48441746|NCT04169061|155803431|FG000|Overall Study|Adverse Event|2|||
48441747|NCT04169061|155803431|FG000|Overall Study|Death|1|||
48441748|NCT04169061|155803431|FG000|Overall Study|Withdrawal by Subject|1|||
48441749|NCT04169061|155803431|FG000|Overall Study|Protocol Violation|1|||
48441750|NCT02007954|155803437|FG000|Overall Study|Received liver transplant|3|||
48441751|NCT02007954|155803437|FG000|Overall Study|Switch in treatment modality|2|||
48441752|NCT02007954|155803437|FG000|Overall Study|Disease progression and unrelated AE|1|||
48441754|NCT04585451|155803440|FG000|Overall Study|Withdrawal by Subject|26|||
48441755|NCT04585451|155803441|FG001|Overall Study|Withdrawal by Subject|0|||
48441756|NCT01641991|155803442|FG000|Overall Study|Physician Decision|0|||
48441757|NCT01641991|155803443|FG001|Overall Study|Physician Decision|1|||
48441758|NCT01641991|155803444|FG002|Overall Study|Physician Decision|7|||
48441759|NCT01641991|155803445|FG003|Overall Study|Physician Decision|5|||
48441760|NCT01641991|155803442|FG000|Overall Study|Withdrawal by Subject|4|||
48441761|NCT01641991|155803443|FG001|Overall Study|Withdrawal by Subject|2|||
48441762|NCT01641991|155803444|FG002|Overall Study|Withdrawal by Subject|1|||
48441763|NCT01641991|155803445|FG003|Overall Study|Withdrawal by Subject|5|||
48441764|NCT01641991|155803442|FG000|Overall Study|Adverse Event|2|||
48441765|NCT01641991|155803443|FG001|Overall Study|Adverse Event|1|||
48441766|NCT01641991|155803444|FG002|Overall Study|Adverse Event|2|||
48441767|NCT01641991|155803445|FG003|Overall Study|Adverse Event|1|||
48441768|NCT01641991|155803442|FG000|Overall Study|Lost to Follow-up|0|||
48441769|NCT01641991|155803443|FG001|Overall Study|Lost to Follow-up|2|||
48441770|NCT01641991|155803444|FG002|Overall Study|Lost to Follow-up|3|||
48441771|NCT01641991|155803445|FG003|Overall Study|Lost to Follow-up|1|||
48441772|NCT01641991|155803442|FG000|Overall Study|Protocol Violation|1|||
48441773|NCT01641991|155803443|FG001|Overall Study|Protocol Violation|1|||
48441774|NCT01641991|155803444|FG002|Overall Study|Protocol Violation|3|||
48441775|NCT01641991|155803445|FG003|Overall Study|Protocol Violation|0|||
48441776|NCT01641991|155803442|FG000|Overall Study|Pregnancy|0|||
48441777|NCT01641991|155803443|FG001|Overall Study|Pregnancy|0|||
48441778|NCT01641991|155803444|FG002|Overall Study|Pregnancy|1|||
48441779|NCT01641991|155803445|FG003|Overall Study|Pregnancy|0|||
48441780|NCT01641991|155803442|FG000|Overall Study|no longer eligible|2|||
48441781|NCT01641991|155803443|FG001|Overall Study|no longer eligible|1|||
48441782|NCT01641991|155803444|FG002|Overall Study|no longer eligible|0|||
48441783|NCT01641991|155803445|FG003|Overall Study|no longer eligible|4|||
48441784|NCT01054976|155803446|FG000|Overall Study|Adverse Event|16|||
48441785|NCT01054976|155803446|FG000|Overall Study|Uncooperative participations to study|7|||
48441786|NCT01054976|155803446|FG000|Overall Study|Withdrawal by Subject|4|||
48441787|NCT01054976|155803446|FG000|Overall Study|Other|8|||
48441788|NCT00213980|155803447|FG000|Overall Study|Withdrawal by Subject|3|||
48441789|NCT00213980|155803448|FG001|Overall Study|Withdrawal by Subject|1|||
48441790|NCT00213980|155803447|FG000|Overall Study|Adverse Event|1|||
48441791|NCT00213980|155803448|FG001|Overall Study|Adverse Event|1|||
48441792|NCT00213980|155803447|FG000|Overall Study|Disease progression|0|||
48441793|NCT00213980|155803448|FG001|Overall Study|Disease progression|2|||
48441794|NCT00213980|155803447|FG000|Overall Study|Developed ovarian cancer|1|||
48441795|NCT00213980|155803448|FG001|Overall Study|Developed ovarian cancer|0|||
48441796|NCT00213980|155803447|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
48441797|NCT00213980|155803448|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
48441798|NCT01295580|155803449|FG000|Overall Study|Protocol Violation|4|||
48441799|NCT01295580|155803450|FG001|Overall Study|Protocol Violation|2|||
48441800|NCT01295580|155803449|FG000|Overall Study|Withdrawal by Subject|1|||
48441801|NCT01295580|155803450|FG001|Overall Study|Withdrawal by Subject|4|||
48441802|NCT01295580|155803449|FG000|Overall Study|Adverse Event|2|||
48441803|NCT01295580|155803450|FG001|Overall Study|Adverse Event|1|||
48441804|NCT01295580|155803449|FG000|Overall Study|Lost to Follow-up|1|||
48441805|NCT01295580|155803450|FG001|Overall Study|Lost to Follow-up|0|||
48441806|NCT01295580|155803449|FG000|Overall Study|Lack of Efficacy|1|||
48441807|NCT01295580|155803450|FG001|Overall Study|Lack of Efficacy|0|||
48441808|NCT01295580|155803449|FG000|Overall Study|Other: inconvenience|1|||
48441809|NCT01295580|155803450|FG001|Overall Study|Other: inconvenience|0|||
48441810|NCT01295580|155803449|FG000|Overall Study|Other: family objection|0|||
48441811|NCT01295580|155803450|FG001|Overall Study|Other: family objection|1|||
48441812|NCT00673894|155803451|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
48441813|NCT00673894|155803452|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
48441814|NCT00673894|155803451|FG000|First Intervention 4 Weeks|Adverse Event|1|||
48441815|NCT00673894|155803452|FG001|First Intervention 4 Weeks|Adverse Event|0|||
48441816|NCT00493974|155803453|FG000|Overall Study|Death|1|||
48441817|NCT00493974|155803454|FG001|Overall Study|Death|2|||
48441818|NCT00493974|155803453|FG000|Overall Study|Withdrawal by Subject|8|||
48441819|NCT00493974|155803454|FG001|Overall Study|Withdrawal by Subject|6|||
48441820|NCT00493974|155803453|FG000|Overall Study|Lost to Follow-up|4|||
48441821|NCT00493974|155803454|FG001|Overall Study|Lost to Follow-up|6|||
48441822|NCT02555657|155803456|FG000|Overall Study|Death|274|||
48441823|NCT02555657|155803457|FG001|Overall Study|Death|262|||
48441824|NCT02555657|155803456|FG000|Overall Study|Physician Decision|0|||
48441825|NCT02555657|155803457|FG001|Overall Study|Physician Decision|1|||
48441826|NCT02555657|155803456|FG000|Overall Study|Sponsor Decision|27|||
48441827|NCT02555657|155803457|FG001|Overall Study|Sponsor Decision|15|||
48441828|NCT02555657|155803456|FG000|Overall Study|Withdrawal by Subject|11|||
48441829|NCT02555657|155803457|FG001|Overall Study|Withdrawal by Subject|32|||
48441830|NCT00892957|155803458|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
48441831|NCT00892957|155803459|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
48441832|NCT00892957|155803458|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
48441833|NCT00892957|155803459|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
48441834|NCT01195363|155803461|FG000|Overall Study|Lost to Follow-up|7|||
48441835|NCT01195363|155803462|FG001|Overall Study|Lost to Follow-up|4|||
48441836|NCT01195363|155803461|FG000|Overall Study|Adverse Event|3|||
48441837|NCT01195363|155803462|FG001|Overall Study|Adverse Event|1|||
48441838|NCT01195363|155803461|FG000|Overall Study|Lack of Efficacy|0|||
48441839|NCT01195363|155803462|FG001|Overall Study|Lack of Efficacy|4|||
48441840|NCT01195363|155803461|FG000|Overall Study|incarceration|1|||
48441841|NCT01195363|155803462|FG001|Overall Study|incarceration|0|||
48441842|NCT02807363|155803463|FG000|Dosing Period|Adverse Event|0|||
48441843|NCT02807363|155803464|FG001|Dosing Period|Adverse Event|1|||
48441844|NCT02807363|155803465|FG002|Dosing Period|Adverse Event|0|||
48441845|NCT02807363|155803466|FG003|Dosing Period|Adverse Event|0|||
48441846|NCT00326417|155803467|FG000|Overall Study|Withdrawal by Subject|0|||
48441847|NCT00326417|155803468|FG001|Overall Study|Withdrawal by Subject|0|||
48441848|NCT00326417|155803469|FG002|Overall Study|Withdrawal by Subject|1|||
48441849|NCT00326417|155803470|FG003|Overall Study|Withdrawal by Subject|0|||
48441850|NCT00326417|155803467|FG000|Overall Study|Arm Closed|7|||
48441851|NCT00326417|155803468|FG001|Overall Study|Arm Closed|0|||
48441852|NCT00326417|155803469|FG002|Overall Study|Arm Closed|0|||
48441853|NCT00326417|155803470|FG003|Overall Study|Arm Closed|3|||
48441854|NCT00326417|155803467|FG000|Overall Study|Death|7|||
48441855|NCT00326417|155803468|FG001|Overall Study|Death|0|||
48441856|NCT00326417|155803469|FG002|Overall Study|Death|0|||
48441857|NCT00326417|155803470|FG003|Overall Study|Death|0|||
48441858|NCT02188719|155803471|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
48441859|NCT02188719|155803472|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
48441860|NCT02188719|155803473|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
48441861|NCT02188719|155803474|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
48441862|NCT00966693|155803480|FG000|Overall Study|Adverse Event|0|||
48441863|NCT00966693|155803481|FG001|Overall Study|Adverse Event|0|||
48441864|NCT00966693|155803482|FG002|Overall Study|Adverse Event|1|||
48441865|NCT00966693|155803483|FG003|Overall Study|Adverse Event|2|||
48441866|NCT00966693|155803480|FG000|Overall Study|Death|0|||
48441867|NCT00966693|155803481|FG001|Overall Study|Death|0|||
48441868|NCT00966693|155803482|FG002|Overall Study|Death|1|||
48441869|NCT00966693|155803483|FG003|Overall Study|Death|0|||
48441870|NCT00966693|155803480|FG000|Overall Study|Withdrawal by Subject|1|||
48441871|NCT00966693|155803481|FG001|Overall Study|Withdrawal by Subject|0|||
48441872|NCT00966693|155803482|FG002|Overall Study|Withdrawal by Subject|0|||
48441873|NCT00966693|155803483|FG003|Overall Study|Withdrawal by Subject|5|||
48441874|NCT00966693|155803480|FG000|Overall Study|Disease Progression|0|||
48441875|NCT00966693|155803481|FG001|Overall Study|Disease Progression|0|||
48441876|NCT00966693|155803482|FG002|Overall Study|Disease Progression|1|||
48441877|NCT00966693|155803483|FG003|Overall Study|Disease Progression|16|||
48441878|NCT03136367|155803484|FG000|T1 Consultation|discontinued mistakenly included|2|||
48441879|NCT03136367|155803485|FG001|T1 Consultation|discontinued mistakenly included|6|||
48441880|NCT03136367|155803486|FG002|T1 Consultation|discontinued mistakenly included|1|||
48441881|NCT03136367|155803484|FG000|T1 Consultation|Discontinued other|0|||
48441882|NCT03136367|155803485|FG001|T1 Consultation|Discontinued other|1|||
48441883|NCT03136367|155803486|FG002|T1 Consultation|Discontinued other|0|||
48441884|NCT03136367|155803484|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
48441885|NCT03136367|155803485|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
48441886|NCT03136367|155803486|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
48441887|NCT03136367|155803484|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
48441888|NCT03136367|155803485|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
48441889|NCT03136367|155803486|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
48441890|NCT03136367|155803484|FG000|T2 Post-consultation|Discontinued other|0|||
48441891|NCT03136367|155803485|FG001|T2 Post-consultation|Discontinued other|2|||
48441892|NCT03136367|155803486|FG002|T2 Post-consultation|Discontinued other|6|||
48441893|NCT03136367|155803484|FG000|T2 Post-consultation|Discontinued transferred care|0|||
48441894|NCT03136367|155803485|FG001|T2 Post-consultation|Discontinued transferred care|0|||
48441895|NCT03136367|155803486|FG002|T2 Post-consultation|Discontinued transferred care|3|||
48441896|NCT03136367|155803484|FG000|T2 Post-consultation|Discontinued lost contact|0|||
48441897|NCT03136367|155803485|FG001|T2 Post-consultation|Discontinued lost contact|1|||
48441898|NCT03136367|155803486|FG002|T2 Post-consultation|Discontinued lost contact|0|||
48441899|NCT03136367|155803484|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
48441900|NCT03136367|155803485|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
48441901|NCT03136367|155803486|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
48441902|NCT03136367|155803484|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
48441903|NCT03136367|155803485|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
48441904|NCT03136367|155803486|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
48441905|NCT03136367|155803484|FG000|T3 1 Week After Surgery|other discontinued|2|||
48441906|NCT03136367|155803485|FG001|T3 1 Week After Surgery|other discontinued|4|||
48441907|NCT03136367|155803486|FG002|T3 1 Week After Surgery|other discontinued|3|||
48441908|NCT03136367|155803484|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
48441909|NCT03136367|155803485|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
48441910|NCT03136367|155803486|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
48441911|NCT03136367|155803484|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
48441912|NCT03136367|155803485|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
48441913|NCT03136367|155803486|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
48441914|NCT03136367|155803484|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
48441915|NCT03136367|155803485|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
48441916|NCT03136367|155803486|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
48441917|NCT03136367|155803484|FG000|T4 12 Weeks After Surgery|Death|0|||
48441918|NCT03136367|155803485|FG001|T4 12 Weeks After Surgery|Death|1|||
48441919|NCT03136367|155803486|FG002|T4 12 Weeks After Surgery|Death|3|||
48441920|NCT03136367|155803484|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
48441921|NCT03136367|155803485|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
48441922|NCT03136367|155803486|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
48441923|NCT03136367|155803484|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
48441924|NCT03136367|155803485|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
48441925|NCT03136367|155803486|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
48441926|NCT03136367|155803484|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
48441927|NCT03136367|155803485|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
48441928|NCT03136367|155803486|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
48441929|NCT03136367|155803484|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
48441930|NCT03136367|155803485|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
48441931|NCT03136367|155803486|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
48441932|NCT03136367|155803484|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
48441933|NCT03136367|155803485|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
48441934|NCT03136367|155803486|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
48441935|NCT03136367|155803484|FG000|T5 1 Year After Surgery|Death|0|||
48441936|NCT03136367|155803485|FG001|T5 1 Year After Surgery|Death|0|||
48441937|NCT03136367|155803486|FG002|T5 1 Year After Surgery|Death|1|||
48441938|NCT03136367|155803484|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
48441939|NCT03136367|155803485|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
48441940|NCT03136367|155803486|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
48441941|NCT03136367|155803484|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
48441942|NCT03136367|155803485|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
48441943|NCT03136367|155803486|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
48441944|NCT03136367|155803484|FG000|T5 1 Year After Surgery|study ended before due|31|||
48441945|NCT03136367|155803485|FG001|T5 1 Year After Surgery|study ended before due|103|||
48441946|NCT03136367|155803486|FG002|T5 1 Year After Surgery|study ended before due|110|||
48441947|NCT03136367|155803484|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
48441948|NCT03136367|155803485|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
48441949|NCT03136367|155803486|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
48441950|NCT01120379|155805370|FG000|One Year Timepoint|Withdrawal by Subject|41|||
48441951|NCT01120379|155805370|FG000|One Year Timepoint|Lost to Follow-up|115|||
48441952|NCT01120379|155805370|FG000|One Year Timepoint|Death|108|||
48441953|NCT01120379|155805370|FG000|One Year Timepoint|Physician Decision|9|||
48441954|NCT01120379|155805370|FG000|One Year Timepoint|Any other reason for early termination|5|||
48441955|NCT01120379|155805370|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
48441956|NCT01120379|155805370|FG000|Two Year Timepoint|Lost to Follow-up|87|||
48441957|NCT01120379|155805370|FG000|Two Year Timepoint|Death|123|||
48441958|NCT01120379|155805370|FG000|Two Year Timepoint|Physician Decision|12|||
48441959|NCT01120379|155805370|FG000|Two Year Timepoint|Any other reason for early termination|4|||
48441960|NCT01120379|155805370|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
48441961|NCT01120379|155805370|FG000|Three Year Timepoint|Lost to Follow-up|43|||
48441962|NCT01120379|155805370|FG000|Three Year Timepoint|Death|120|||
48441963|NCT01120379|155805370|FG000|Three Year Timepoint|Physician Decision|9|||
48441964|NCT01120379|155805370|FG000|Three Year Timepoint|Any other reason for early termination|17|||
48441965|NCT01120379|155805370|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
48441966|NCT01120379|155805370|FG000|Four Year Timepoint|Lost to Follow-up|10|||
48441967|NCT01120379|155805370|FG000|Four Year Timepoint|Death|131|||
48441968|NCT01120379|155805370|FG000|Four Year Timepoint|Physician Decision|5|||
48441969|NCT01120379|155805370|FG000|Four Year Timepoint|Any other reason for early termination|217|||
48441970|NCT04656418|155805371|FG000|Overall Study|Withdrawal by Subject|1|||
48441971|NCT04656418|155805372|FG001|Overall Study|Withdrawal by Subject|3|||
48441972|NCT02062463|155805373|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
48441973|NCT02062463|155805374|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
48441974|NCT02062463|155805375|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
48441975|NCT02062463|155805376|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
48441976|NCT02062463|155805373|FG000|Stage 2|Adverse Event|0|||
48441977|NCT02062463|155805374|FG001|Stage 2|Adverse Event|0|||
48441978|NCT02062463|155805375|FG002|Stage 2|Adverse Event|12|||
48442001|NCT02716194|155805378|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
48442002|NCT02716194|155805379|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
48442003|NCT01332019|155805383|FG000|Overall Study|Was Not Dosed|1|||
48442004|NCT01332019|155805384|FG001|Overall Study|Was Not Dosed|0|||
48442005|NCT01332019|155805383|FG000|Overall Study|Other|16|||
48442006|NCT01332019|155805384|FG001|Overall Study|Other|18|||
48442007|NCT01332019|155805383|FG000|Overall Study|Death|2|||
48442008|NCT01332019|155805384|FG001|Overall Study|Death|1|||
48442009|NCT01332019|155805383|FG000|Overall Study|Physician Decision|4|||
48442010|NCT01332019|155805384|FG001|Overall Study|Physician Decision|3|||
48442011|NCT01332019|155805383|FG000|Overall Study|Withdrawal by Subject|73|||
48442012|NCT01332019|155805384|FG001|Overall Study|Withdrawal by Subject|71|||
48442013|NCT01332019|155805383|FG000|Overall Study|Lost to Follow-up|4|||
48442014|NCT01332019|155805384|FG001|Overall Study|Lost to Follow-up|7|||
48442015|NCT01332019|155805383|FG000|Overall Study|Adverse Event|13|||
48442016|NCT01332019|155805384|FG001|Overall Study|Adverse Event|22|||
48442017|NCT00205699|155805385|FG000|Overall Study|Lost to Follow-up|1|||
48442018|NCT00205699|155805386|FG001|Overall Study|Lost to Follow-up|3|||
48442019|NCT00205699|155805387|FG002|Overall Study|Lost to Follow-up|5|||
48442020|NCT00205699|155805385|FG000|Overall Study|Adverse Event|1|||
48442021|NCT00205699|155805386|FG001|Overall Study|Adverse Event|0|||
48442022|NCT00205699|155805387|FG002|Overall Study|Adverse Event|0|||
48442023|NCT00205699|155805385|FG000|Overall Study|Withdrawal by Subject|1|||
48442024|NCT00205699|155805386|FG001|Overall Study|Withdrawal by Subject|2|||
48442025|NCT00205699|155805387|FG002|Overall Study|Withdrawal by Subject|1|||
48442026|NCT00205699|155805385|FG000|Overall Study|Lack of Efficacy|0|||
48442027|NCT00205699|155805386|FG001|Overall Study|Lack of Efficacy|1|||
48442028|NCT00205699|155805387|FG002|Overall Study|Lack of Efficacy|0|||
48442029|NCT01957709|155805388|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
48442030|NCT01610076|155805393|FG000|Overall Study|Technical issue with video|0|||
48442031|NCT01610076|155805394|FG001|Overall Study|Technical issue with video|1|||
48442032|NCT01610076|155805393|FG000|Overall Study|Lost to Follow-up|3|||
48442033|NCT01610076|155805394|FG001|Overall Study|Lost to Follow-up|4|||
48442034|NCT00793182|155805395|FG000|Overall Study|Adverse Event|0|||
48442035|NCT00793182|155805396|FG001|Overall Study|Adverse Event|1|||
48442036|NCT02614287|155805401|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
48442037|NCT02614287|155805402|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
48442038|NCT02614287|155805401|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
48442039|NCT02614287|155805402|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
48442040|NCT02614287|155805401|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
48442041|NCT02614287|155805402|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
48442042|NCT02614287|155805401|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
48442043|NCT02614287|155805402|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
48442044|NCT02614287|155805401|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
48442045|NCT02614287|155805402|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
48442046|NCT02614287|155805401|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
48442047|NCT02614287|155805402|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
48442048|NCT02614287|155805401|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
48442049|NCT02614287|155805402|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
48442050|NCT02614287|155805401|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
48442051|NCT02614287|155805402|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
48442052|NCT02394808|155805403|FG000|Period 1|Unsatisfactory lens fitting|0|||
48442053|NCT02394808|155805404|FG001|Period 1|Unsatisfactory lens fitting|1|||
48442054|NCT02394808|155805403|FG000|Period 2|Lost to Follow-up|1|||
48442055|NCT02394808|155805404|FG001|Period 2|Lost to Follow-up|0|||
48442056|NCT01879319|155805406|FG000|Overall Study|Withdrawal by Subject|1|||
48442057|NCT01879319|155805407|FG001|Overall Study|Withdrawal by Subject|0|||
48442058|NCT01879319|155805406|FG000|Overall Study|Lost to Follow-up|1|||
48442059|NCT01879319|155805407|FG001|Overall Study|Lost to Follow-up|5|||
48442060|NCT01103778|155805408|FG000|Overall Study|Lost to Follow-up|1|||
48442061|NCT01103778|155805408|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
48442062|NCT01103778|155805408|FG000|Overall Study|Screen failure|1|||
48442063|NCT03067129|155805409|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
48442064|NCT03067129|155805410|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
48442065|NCT03067129|155805411|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
48442066|NCT03067129|155805412|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
48442067|NCT03067129|155805409|FG000|Overall Study|Withdrawal by Subject|0|||
48442068|NCT03067129|155805410|FG001|Overall Study|Withdrawal by Subject|0|||
48442069|NCT03067129|155805411|FG002|Overall Study|Withdrawal by Subject|1|||
48442070|NCT03067129|155805412|FG003|Overall Study|Withdrawal by Subject|2|||
48442071|NCT03067129|155805409|FG000|Overall Study|Lost to Follow-up|5|||
48442072|NCT03067129|155805410|FG001|Overall Study|Lost to Follow-up|5|||
48442073|NCT03067129|155805411|FG002|Overall Study|Lost to Follow-up|4|||
48442074|NCT03067129|155805412|FG003|Overall Study|Lost to Follow-up|3|||
48442075|NCT05590767|155805415|FG000|Overall Study|Protocol Violation|1|||
48442200|NCT02726113|155805468|FG001|Total Enrollment|Physician Decision|1|||
48442201|NCT02726113|155805467|FG000|Total Enrollment|Protocol Violation|1|||
48442202|NCT02726113|155805468|FG001|Total Enrollment|Protocol Violation|0|||
48442203|NCT02726113|155805467|FG000|Total Enrollment|Withdrawal by Subject|2|||
48442204|NCT02726113|155805468|FG001|Total Enrollment|Withdrawal by Subject|1|||
48442205|NCT02726113|155805467|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
48442206|NCT02726113|155805468|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
48442207|NCT02726113|155805467|FG000|Genomic Analysis|Protocol Violation|1|||
48442208|NCT02726113|155805468|FG001|Genomic Analysis|Protocol Violation|0|||
48442209|NCT02726113|155805467|FG000|Genomic Analysis|Withdrawal by Subject|2|||
48442210|NCT02726113|155805468|FG001|Genomic Analysis|Withdrawal by Subject|1|||
48442211|NCT02726113|155805467|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
48442212|NCT02726113|155805468|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
48442213|NCT01763866|155805469|FG000|Overall Study|Withdrawal by Subject|2|||
48442214|NCT01763866|155805470|FG001|Overall Study|Withdrawal by Subject|1|||
48442215|NCT01763866|155805471|FG002|Overall Study|Withdrawal by Subject|4|||
48442216|NCT01763866|155805472|FG003|Overall Study|Withdrawal by Subject|0|||
48442217|NCT01763866|155805473|FG004|Overall Study|Withdrawal by Subject|0|||
48442218|NCT01763866|155805474|FG005|Overall Study|Withdrawal by Subject|3|||
48442219|NCT01763866|155805475|FG006|Overall Study|Withdrawal by Subject|4|||
48442220|NCT01763866|155805476|FG007|Overall Study|Withdrawal by Subject|0|||
48442221|NCT01763866|155805477|FG008|Overall Study|Withdrawal by Subject|1|||
48442222|NCT01763866|155805478|FG009|Overall Study|Withdrawal by Subject|1|||
48442223|NCT01763866|155805479|FG010|Overall Study|Withdrawal by Subject|2|||
48442224|NCT01763866|155805480|FG011|Overall Study|Withdrawal by Subject|2|||
48442225|NCT01763866|155805481|FG012|Overall Study|Withdrawal by Subject|2|||
48442226|NCT01763866|155805482|FG013|Overall Study|Withdrawal by Subject|0|||
48442227|NCT01763866|155805483|FG014|Overall Study|Withdrawal by Subject|6|||
48442228|NCT01763866|155805484|FG015|Overall Study|Withdrawal by Subject|3|||
48442229|NCT01763866|155805485|FG016|Overall Study|Withdrawal by Subject|0|||
48442230|NCT01763866|155805486|FG017|Overall Study|Withdrawal by Subject|1|||
48442231|NCT01763866|155805487|FG018|Overall Study|Withdrawal by Subject|1|||
48442232|NCT01763866|155805488|FG019|Overall Study|Withdrawal by Subject|1|||
48442233|NCT01763866|155805489|FG020|Overall Study|Withdrawal by Subject|2|||
48442234|NCT01763866|155805490|FG021|Overall Study|Withdrawal by Subject|1|||
48442235|NCT01763866|155805491|FG022|Overall Study|Withdrawal by Subject|2|||
48442236|NCT01763866|155805492|FG023|Overall Study|Withdrawal by Subject|1|||
48442237|NCT01763866|155805469|FG000|Overall Study|Decision by sponsor|0|||
48442238|NCT01763866|155805470|FG001|Overall Study|Decision by sponsor|0|||
48442239|NCT01763866|155805471|FG002|Overall Study|Decision by sponsor|1|||
48442240|NCT01763866|155805472|FG003|Overall Study|Decision by sponsor|0|||
48442241|NCT01763866|155805473|FG004|Overall Study|Decision by sponsor|2|||
48442242|NCT01763866|155805474|FG005|Overall Study|Decision by sponsor|0|||
48442243|NCT01763866|155805475|FG006|Overall Study|Decision by sponsor|2|||
48442244|NCT01763866|155805476|FG007|Overall Study|Decision by sponsor|0|||
48442245|NCT01763866|155805477|FG008|Overall Study|Decision by sponsor|2|||
48442246|NCT01763866|155805478|FG009|Overall Study|Decision by sponsor|0|||
48442247|NCT01763866|155805479|FG010|Overall Study|Decision by sponsor|6|||
48442248|NCT01763866|155805480|FG011|Overall Study|Decision by sponsor|0|||
48442249|NCT01763866|155805481|FG012|Overall Study|Decision by sponsor|1|||
48442250|NCT01763866|155805482|FG013|Overall Study|Decision by sponsor|0|||
48442251|NCT01763866|155805483|FG014|Overall Study|Decision by sponsor|5|||
48442252|NCT01763866|155805484|FG015|Overall Study|Decision by sponsor|0|||
48442253|NCT01763866|155805485|FG016|Overall Study|Decision by sponsor|0|||
48442254|NCT01763866|155805486|FG017|Overall Study|Decision by sponsor|0|||
48442255|NCT01763866|155805487|FG018|Overall Study|Decision by sponsor|4|||
48442256|NCT01763866|155805488|FG019|Overall Study|Decision by sponsor|0|||
48442257|NCT01763866|155805489|FG020|Overall Study|Decision by sponsor|2|||
48442258|NCT01763866|155805490|FG021|Overall Study|Decision by sponsor|0|||
48442259|NCT01763866|155805491|FG022|Overall Study|Decision by sponsor|1|||
48442260|NCT01763866|155805492|FG023|Overall Study|Decision by sponsor|0|||
48442261|NCT01763866|155805469|FG000|Overall Study|Lost to Follow-up|0|||
48442262|NCT01763866|155805470|FG001|Overall Study|Lost to Follow-up|0|||
48442263|NCT01763866|155805471|FG002|Overall Study|Lost to Follow-up|0|||
48442264|NCT01763866|155805472|FG003|Overall Study|Lost to Follow-up|0|||
48442265|NCT01763866|155805473|FG004|Overall Study|Lost to Follow-up|0|||
48442266|NCT01763866|155805474|FG005|Overall Study|Lost to Follow-up|0|||
48442267|NCT01763866|155805475|FG006|Overall Study|Lost to Follow-up|1|||
48442268|NCT01763866|155805476|FG007|Overall Study|Lost to Follow-up|0|||
48442269|NCT01763866|155805477|FG008|Overall Study|Lost to Follow-up|0|||
48442270|NCT01763866|155805478|FG009|Overall Study|Lost to Follow-up|0|||
48442271|NCT01763866|155805479|FG010|Overall Study|Lost to Follow-up|0|||
48442272|NCT01763866|155805480|FG011|Overall Study|Lost to Follow-up|0|||
48442273|NCT01763866|155805481|FG012|Overall Study|Lost to Follow-up|1|||
48442274|NCT01763866|155805482|FG013|Overall Study|Lost to Follow-up|0|||
48442275|NCT01763866|155805483|FG014|Overall Study|Lost to Follow-up|1|||
48442276|NCT01763866|155805484|FG015|Overall Study|Lost to Follow-up|0|||
48442277|NCT01763866|155805485|FG016|Overall Study|Lost to Follow-up|0|||
48442351|NCT00131664|155805515|FG003|First Period (First 6 Months)|Adverse Event|0|||
48442352|NCT00131664|155805516|FG004|First Period (First 6 Months)|Adverse Event|0|||
48442353|NCT00131664|155805517|FG005|First Period (First 6 Months)|Adverse Event|0|||
48442354|NCT00131664|155805512|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
48442355|NCT00131664|155805513|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
48442356|NCT00131664|155805514|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
48442357|NCT00131664|155805515|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
48442358|NCT00131664|155805516|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
48442359|NCT00131664|155805517|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
48442360|NCT00131664|155805512|FG000|First Period (First 6 Months)|Administrative reasons|2|||
48442361|NCT00131664|155805513|FG001|First Period (First 6 Months)|Administrative reasons|0|||
48442362|NCT00131664|155805514|FG002|First Period (First 6 Months)|Administrative reasons|5|||
48442363|NCT00131664|155805515|FG003|First Period (First 6 Months)|Administrative reasons|0|||
48442364|NCT00131664|155805516|FG004|First Period (First 6 Months)|Administrative reasons|0|||
48442365|NCT00131664|155805517|FG005|First Period (First 6 Months)|Administrative reasons|0|||
48442366|NCT00131664|155805512|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
48442367|NCT00131664|155805513|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
48442368|NCT00131664|155805514|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
48442369|NCT00131664|155805515|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
48442370|NCT00131664|155805516|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
48442371|NCT00131664|155805517|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
48442372|NCT00131664|155805512|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
48442373|NCT00131664|155805513|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
48442374|NCT00131664|155805514|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
48442375|NCT00131664|155805515|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
48442376|NCT00131664|155805516|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
48442377|NCT00131664|155805517|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
48442378|NCT00131664|155805512|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
48442379|NCT00131664|155805513|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48442380|NCT00131664|155805514|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48442381|NCT00131664|155805515|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48442382|NCT00131664|155805516|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48442383|NCT00131664|155805517|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
48442384|NCT00131664|155805512|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
48442385|NCT00131664|155805513|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
48442386|NCT00131664|155805514|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
48442387|NCT00131664|155805515|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
48442388|NCT00131664|155805516|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
48442389|NCT00131664|155805517|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
48442390|NCT00131664|155805512|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48442391|NCT00131664|155805513|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48442392|NCT00131664|155805514|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48442393|NCT00131664|155805515|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
48442394|NCT00131664|155805516|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48442395|NCT00131664|155805517|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
48442396|NCT00131664|155805512|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
48442397|NCT00131664|155805513|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
48442398|NCT00131664|155805514|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
48442399|NCT00131664|155805515|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
48442400|NCT00131664|155805516|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
48442401|NCT00131664|155805517|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
48442402|NCT01315847|155805518|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
48442403|NCT01315847|155805519|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
48442404|NCT01315847|155805518|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
48442405|NCT01315847|155805519|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
48442406|NCT00818207|155806957|FG000|Overall Study|Adverse Event|6|||
48442407|NCT00818207|155806958|FG001|Overall Study|Adverse Event|0|||
48442408|NCT00818207|155806957|FG000|Overall Study|Lost to Follow-up|160|||
48442409|NCT00818207|155806958|FG001|Overall Study|Lost to Follow-up|146|||
48442410|NCT00818207|155806957|FG000|Overall Study|Multiple reasons|11|||
48442411|NCT00818207|155806958|FG001|Overall Study|Multiple reasons|12|||
48442412|NCT00818207|155806957|FG000|Overall Study|Withdrawal by Subject|42|||
48442413|NCT00818207|155806958|FG001|Overall Study|Withdrawal by Subject|104|||
48442414|NCT00818207|155806957|FG000|Overall Study|Death|3|||
48442415|NCT00818207|155806958|FG001|Overall Study|Death|5|||
48442428|NCT03162055|155806961|FG000|Overall Study|Incorrect randomization|4|||
48442429|NCT03162055|155806962|FG001|Overall Study|Incorrect randomization|3|||
48442430|NCT03162055|155806961|FG000|Overall Study|Other|8|||
48442431|NCT03162055|155806962|FG001|Overall Study|Other|15|||
48442432|NCT03287245|155806963|FG000|Overall Study|Study terminated by sponsor|3|||
48442433|NCT03287245|155806964|FG001|Overall Study|Study terminated by sponsor|0|||
48442434|NCT03287245|155806965|FG002|Overall Study|Study terminated by sponsor|3|||
48442435|NCT03287245|155806966|FG003|Overall Study|Study terminated by sponsor|1|||
48442436|NCT03287245|155806963|FG000|Overall Study|Adverse Event|1|||
48442437|NCT03287245|155806964|FG001|Overall Study|Adverse Event|0|||
48442438|NCT03287245|155806965|FG002|Overall Study|Adverse Event|0|||
48442439|NCT03287245|155806966|FG003|Overall Study|Adverse Event|0|||
48442440|NCT03287245|155806963|FG000|Overall Study|Withdrawal by Subject|8|||
48442441|NCT03287245|155806964|FG001|Overall Study|Withdrawal by Subject|3|||
48442442|NCT03287245|155806965|FG002|Overall Study|Withdrawal by Subject|3|||
48442443|NCT03287245|155806966|FG003|Overall Study|Withdrawal by Subject|0|||
48442444|NCT03287245|155806963|FG000|Overall Study|Physician Decision|3|||
48442445|NCT03287245|155806964|FG001|Overall Study|Physician Decision|2|||
48442446|NCT03287245|155806965|FG002|Overall Study|Physician Decision|0|||
48442447|NCT03287245|155806966|FG003|Overall Study|Physician Decision|0|||
48442448|NCT02586077|155806967|FG000|Overall Study|Withdrawal by Subject|1|||
48442449|NCT02586077|155806967|FG000|Overall Study|Physician Decision|4|||
48442450|NCT02586077|155806967|FG000|Overall Study|Lost to Follow-up|3|||
48442451|NCT02701192|155806968|FG000|Overall Study|Protocol Violation|2|||
48442452|NCT02701192|155806968|FG000|Overall Study|Lost to Follow-up|4|||
48442453|NCT04031404|155806969|FG000|Baseline|Lost to Follow-up|0|||
48442454|NCT04031404|155806970|FG001|Baseline|Lost to Follow-up|1|||
48442455|NCT04031404|155806969|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
48442456|NCT04031404|155806970|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
48442457|NCT04031404|155806969|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
48442458|NCT04031404|155806970|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
48442459|NCT04031404|155806969|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
48442460|NCT04031404|155806970|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
48442461|NCT04031404|155806969|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
48442462|NCT04031404|155806970|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
48442463|NCT01207388|155806976|FG000|Overall Study|Death|67|||
48442464|NCT01207388|155806976|FG000|Overall Study|Withdrawal by Subject|1|||
48442465|NCT00363051|155806977|FG000|Overall Study|Adminstrative problems|1|||
48442466|NCT00363051|155806978|FG001|Overall Study|Adminstrative problems|1|||
48442467|NCT00363051|155806977|FG000|Overall Study|Adverse Event|21|||
48442468|NCT00363051|155806978|FG001|Overall Study|Adverse Event|12|||
48442469|NCT00363051|155806977|FG000|Overall Study|New Cancer Therapy|2|||
48442470|NCT00363051|155806978|FG001|Overall Study|New Cancer Therapy|1|||
48442471|NCT00363051|155806977|FG000|Overall Study|Withdrawal by Subject|11|||
48442472|NCT00363051|155806978|FG001|Overall Study|Withdrawal by Subject|3|||
48442473|NCT00363051|155806977|FG000|Overall Study|Lost to Follow-up|0|||
48442474|NCT00363051|155806978|FG001|Overall Study|Lost to Follow-up|1|||
48442475|NCT00363051|155806977|FG000|Overall Study|Protocol Violation|0|||
48442476|NCT00363051|155806978|FG001|Overall Study|Protocol Violation|2|||
48442477|NCT00363051|155806977|FG000|Overall Study|Death|3|||
48442478|NCT00363051|155806978|FG001|Overall Study|Death|2|||
48442479|NCT02924688|155806981|FG000|Overall Study|Adverse Event|9|||
48442480|NCT02924688|155806982|FG001|Overall Study|Adverse Event|3|||
48442481|NCT02924688|155806983|FG002|Overall Study|Adverse Event|2|||
48442482|NCT02924688|155806984|FG003|Overall Study|Adverse Event|2|||
48442483|NCT02924688|155806985|FG004|Overall Study|Adverse Event|3|||
48442484|NCT02924688|155806986|FG005|Overall Study|Adverse Event|2|||
48442485|NCT02924688|155806981|FG000|Overall Study|Lack of Efficacy|2|||
48442486|NCT02924688|155806982|FG001|Overall Study|Lack of Efficacy|3|||
48442487|NCT02924688|155806983|FG002|Overall Study|Lack of Efficacy|4|||
48442488|NCT02924688|155806984|FG003|Overall Study|Lack of Efficacy|2|||
48442489|NCT02924688|155806985|FG004|Overall Study|Lack of Efficacy|1|||
48442490|NCT02924688|155806986|FG005|Overall Study|Lack of Efficacy|1|||
48442491|NCT02924688|155806981|FG000|Overall Study|Protocol Violation|3|||
48442492|NCT02924688|155806982|FG001|Overall Study|Protocol Violation|7|||
48442493|NCT02924688|155806983|FG002|Overall Study|Protocol Violation|5|||
48442494|NCT02924688|155806984|FG003|Overall Study|Protocol Violation|6|||
48442495|NCT02924688|155806985|FG004|Overall Study|Protocol Violation|2|||
48442496|NCT02924688|155806986|FG005|Overall Study|Protocol Violation|2|||
48442497|NCT02924688|155806981|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
48442498|NCT02924688|155806982|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
48442499|NCT02924688|155806983|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
48442500|NCT02924688|155806984|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
48442501|NCT02924688|155806985|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
48442502|NCT02924688|155806986|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
48442503|NCT02924688|155806981|FG000|Overall Study|Lost to Follow-up|2|||
48442504|NCT02924688|155806982|FG001|Overall Study|Lost to Follow-up|4|||
48442534|NCT02293993|155806988|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
48442535|NCT02293993|155806989|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
48442536|NCT02293993|155806990|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
48442537|NCT02293993|155806987|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
48442538|NCT02293993|155806988|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
48442539|NCT02293993|155806989|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
48442540|NCT02293993|155806990|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
48442541|NCT03587584|155806991|FG000|Overall Study|SOC deviations|4|||
48442542|NCT03587584|155806992|FG001|Overall Study|SOC deviations|6|||
48442543|NCT03587584|155806991|FG000|Overall Study|Incomplete data|0|||
48442544|NCT03587584|155806992|FG001|Overall Study|Incomplete data|3|||
48442545|NCT03728140|155806995|FG000|Overall Study|Abnormal embryo transfer operation|10|||
48442546|NCT03728140|155806996|FG001|Overall Study|Abnormal embryo transfer operation|7|||
48442547|NCT00418379|155806999|FG000|Year 1|Adverse Event|9|||
48442548|NCT00418379|155807000|FG001|Year 1|Adverse Event|15|||
48442549|NCT00418379|155807001|FG002|Year 1|Adverse Event|3|||
48442550|NCT00418379|155806999|FG000|Year 1|Withdrawal by Subject|7|||
48442551|NCT00418379|155807000|FG001|Year 1|Withdrawal by Subject|8|||
48442552|NCT00418379|155807001|FG002|Year 1|Withdrawal by Subject|5|||
48442553|NCT00418379|155806999|FG000|Year 1|Any other reason not above-mentioned|2|||
48442554|NCT00418379|155807000|FG001|Year 1|Any other reason not above-mentioned|5|||
48442555|NCT00418379|155807001|FG002|Year 1|Any other reason not above-mentioned|7|||
48442556|NCT00418379|155806999|FG000|Year 2|Adverse Event|5|||
48442557|NCT00418379|155807000|FG001|Year 2|Adverse Event|2|||
48442558|NCT00418379|155807001|FG002|Year 2|Adverse Event|1|||
48442559|NCT00418379|155806999|FG000|Year 2|Withdrawal by Subject|1|||
48442560|NCT00418379|155807000|FG001|Year 2|Withdrawal by Subject|1|||
48442561|NCT00418379|155807001|FG002|Year 2|Withdrawal by Subject|3|||
48442562|NCT00418379|155806999|FG000|Year 2|Any other reason not above-mentioned|2|||
48442563|NCT00418379|155807000|FG001|Year 2|Any other reason not above-mentioned|1|||
48442564|NCT00418379|155807001|FG002|Year 2|Any other reason not above-mentioned|6|||
48442565|NCT00418379|155806999|FG000|Year 3|Withdrawal by Subject|1|||
48442566|NCT00418379|155807000|FG001|Year 3|Withdrawal by Subject|1|||
48442567|NCT00418379|155807001|FG002|Year 3|Withdrawal by Subject|2|||
48442568|NCT00418379|155806999|FG000|Year 3|Any other reason not above-mentioned|2|||
48442569|NCT00418379|155807000|FG001|Year 3|Any other reason not above-mentioned|1|||
48442570|NCT00418379|155807001|FG002|Year 3|Any other reason not above-mentioned|1|||
48442571|NCT00418379|155806999|FG000|Year 4|Adverse Event|0|||
48442572|NCT00418379|155807000|FG001|Year 4|Adverse Event|1|||
48442573|NCT00418379|155807001|FG002|Year 4|Adverse Event|0|||
48442574|NCT00418379|155806999|FG000|Year 4|Withdrawal by Subject|2|||
48442575|NCT00418379|155807000|FG001|Year 4|Withdrawal by Subject|3|||
48442576|NCT00418379|155807001|FG002|Year 4|Withdrawal by Subject|2|||
48442577|NCT00418379|155806999|FG000|Year 4|Any other reason not above-mentioned|1|||
48442578|NCT00418379|155807000|FG001|Year 4|Any other reason not above-mentioned|1|||
48442579|NCT00418379|155807001|FG002|Year 4|Any other reason not above-mentioned|0|||
48442580|NCT00418379|155806999|FG000|Year 5|Adverse Event|0|||
48442581|NCT00418379|155807000|FG001|Year 5|Adverse Event|1|||
48442582|NCT00418379|155807001|FG002|Year 5|Adverse Event|0|||
48442583|NCT00418379|155806999|FG000|Year 5|Any other reason not above-mentioned|2|||
48442584|NCT00418379|155807000|FG001|Year 5|Any other reason not above-mentioned|4|||
48442585|NCT00418379|155807001|FG002|Year 5|Any other reason not above-mentioned|3|||
48442586|NCT02034552|155807002|FG000|Overall Study|Never treated|3|||
48442587|NCT02034552|155807003|FG001|Overall Study|Never treated|2|||
48442588|NCT02034552|155807004|FG002|Overall Study|Never treated|0|||
48442589|NCT02034552|155807002|FG000|Overall Study|Radiological progression|3|||
48442590|NCT02034552|155807003|FG001|Overall Study|Radiological progression|5|||
48442591|NCT02034552|155807004|FG002|Overall Study|Radiological progression|4|||
48442592|NCT02034552|155807002|FG000|Overall Study|AE not assoc. with disease progression|1|||
48442593|NCT02034552|155807003|FG001|Overall Study|AE not assoc. with disease progression|4|||
48442594|NCT02034552|155807004|FG002|Overall Study|AE not assoc. with disease progression|2|||
48442595|NCT02034552|155807002|FG000|Overall Study|AE associated with disease progression|0|||
48442596|NCT02034552|155807003|FG001|Overall Study|AE associated with disease progression|1|||
48442597|NCT02034552|155807004|FG002|Overall Study|AE associated with disease progression|0|||
48442598|NCT02034552|155807002|FG000|Overall Study|Withdrawal by Subject|2|||
48442599|NCT02034552|155807003|FG001|Overall Study|Withdrawal by Subject|1|||
48442600|NCT02034552|155807004|FG002|Overall Study|Withdrawal by Subject|1|||
48442601|NCT02034552|155807002|FG000|Overall Study|Non-compliance with study drug|0|||
48442602|NCT02034552|155807003|FG001|Overall Study|Non-compliance with study drug|0|||
48442603|NCT02034552|155807004|FG002|Overall Study|Non-compliance with study drug|1|||
48442604|NCT02034552|155807002|FG000|Overall Study|Clinical progression|5|||
48442605|NCT02034552|155807003|FG001|Overall Study|Clinical progression|7|||
48442606|NCT02034552|155807004|FG002|Overall Study|Clinical progression|9|||
48442607|NCT01419015|155807005|FG000|Overall Study|Death|2|||
48442608|NCT01677507|155807006|FG000|Initial Assignment|Adverse Event|0|||
48442609|NCT01677507|155807007|FG001|Initial Assignment|Adverse Event|1|||
48442610|NCT01677507|155807006|FG000|Initial Assignment|Protocol Violation|0|||
48442611|NCT01677507|155807007|FG001|Initial Assignment|Protocol Violation|1|||
48442612|NCT01677507|155807006|FG000|Second Assigment|Withdrawal by Subject|2|||
48442613|NCT01677507|155807007|FG001|Second Assigment|Withdrawal by Subject|2|||
48442614|NCT01677507|155807006|FG000|Second Assigment|Adverse Event|1|||
48442615|NCT01677507|155807007|FG001|Second Assigment|Adverse Event|3|||
48442616|NCT01082367|155807010|FG000|Double-blind Period|Administrative problems|0|||
48442617|NCT01082367|155807011|FG001|Double-blind Period|Administrative problems|1|||
48442618|NCT01082367|155807010|FG000|Double-blind Period|Lack of Efficacy|5|||
48442619|NCT01082367|155807011|FG001|Double-blind Period|Lack of Efficacy|11|||
48442620|NCT01082367|155807010|FG000|Double-blind Period|Adverse Event|0|||
48442621|NCT01082367|155807011|FG001|Double-blind Period|Adverse Event|1|||
48442622|NCT01082367|155807010|FG000|Follow-up (F-U) Period|Administrative problems|1|||
48442623|NCT01082367|155807011|FG001|Follow-up (F-U) Period|Administrative problems|0|||
48442624|NCT01082367|155807010|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
48442625|NCT01082367|155807011|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
48442626|NCT01082367|155807010|FG000|Follow-up (F-U) Period|Adverse Event|0|||
48442627|NCT01082367|155807011|FG001|Follow-up (F-U) Period|Adverse Event|1|||
48442628|NCT00699842|155807012|FG000|Overall Study|Death|0|||
48442629|NCT00699842|155807013|FG001|Overall Study|Death|1|||
48442630|NCT00699842|155807014|FG002|Overall Study|Death|0|||
48442631|NCT00098020|155807015|FG000|Overall Study|Adverse Event|2|||
48442632|NCT00098020|155807015|FG000|Overall Study|Lost to Follow-up|1|||
48442633|NCT00098020|155807015|FG000|Overall Study|elevated liver enzymes|1|||
48442634|NCT00098020|155807015|FG000|Overall Study|Low urine PCR|1|||
48442635|NCT00098020|155807015|FG000|Overall Study|Low epidermal growth factor receptor|1|||
48442636|NCT01360762|155807018|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
48442637|NCT01360762|155807018|FG000|Main Study Period (12-month Treatment)|Death|5|||
48442638|NCT01360762|155807018|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
48442639|NCT01360762|155807018|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
48442640|NCT01360762|155807018|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
48442641|NCT01360762|155807018|FG000|Whole Study Period|Lost to Follow-up|10|||
48442642|NCT01360762|155807018|FG000|Whole Study Period|Death|7|||
48442643|NCT01360762|155807018|FG000|Whole Study Period|Patient relapsed|18|||
48442644|NCT01360762|155807018|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
48442645|NCT00992186|155807023|FG000|Overall Study|Withdrawal by Subject|2|||
48442646|NCT00992186|155807023|FG000|Overall Study|Protocol Violation|1|||
48442647|NCT00992186|155807023|FG000|Overall Study|Physician Decision|1|||
48442648|NCT00992186|155807023|FG000|Overall Study|Adverse Event|9|||
48442649|NCT00992186|155807023|FG000|Overall Study|Progressive Disease|30|||
48442650|NCT00992186|155807023|FG000|Overall Study|Refusal To Receive Study Agent|3|||
48442651|NCT03428997|155807024|FG000|Overall Study|Sponsor decision.|1|||
48442652|NCT03428997|155807024|FG000|Overall Study|Withdrawal by Subject|3|||
48442653|NCT03428997|155807024|FG000|Overall Study|Lost to Follow-up|4|||
48442654|NCT00318565|155807025|FG000|Overall Study|Excluded per protocol|24|||
48442655|NCT00936117|155807030|FG000|Overall Study|Adverse Event|7|||
48442656|NCT00936117|155807030|FG000|Overall Study|Unable to continue oral medication|3|||
48442657|NCT00426556|155807037|FG000|Phase I - Core Phase|Disease Progression|0|||
48442658|NCT00426556|155807038|FG001|Phase I - Core Phase|Disease Progression|6|||
48442659|NCT00426556|155807039|FG002|Phase I - Core Phase|Disease Progression|2|||
48442660|NCT00426556|155807040|FG003|Phase I - Core Phase|Disease Progression|0|||
48442661|NCT00426556|155807037|FG000|Phase I - Core Phase|Adverse Event|1|||
48442662|NCT00426556|155807038|FG001|Phase I - Core Phase|Adverse Event|3|||
48442663|NCT00426556|155807039|FG002|Phase I - Core Phase|Adverse Event|1|||
48442664|NCT00426556|155807040|FG003|Phase I - Core Phase|Adverse Event|0|||
48442665|NCT00426556|155807037|FG000|Phase I - Core Phase|Death|0|||
48442666|NCT00426556|155807038|FG001|Phase I - Core Phase|Death|1|||
48442667|NCT00426556|155807039|FG002|Phase I - Core Phase|Death|0|||
48442668|NCT00426556|155807040|FG003|Phase I - Core Phase|Death|0|||
48442669|NCT00426556|155807037|FG000|Phase I - Extension Phase|Adverse Event|0|||
48442670|NCT00426556|155807038|FG001|Phase I - Extension Phase|Adverse Event|1|||
48442671|NCT00426556|155807039|FG002|Phase I - Extension Phase|Adverse Event|1|||
48442672|NCT00426556|155807040|FG003|Phase I - Extension Phase|Adverse Event|0|||
48442673|NCT00426556|155807037|FG000|Phase I - Extension Phase|Disease Progression|5|||
48442674|NCT00426556|155807038|FG001|Phase I - Extension Phase|Disease Progression|5|||
48442675|NCT00426556|155807039|FG002|Phase I - Extension Phase|Disease Progression|6|||
48442676|NCT00426556|155807040|FG003|Phase I - Extension Phase|Disease Progression|0|||
48442677|NCT00426556|155807037|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
48442678|NCT00426556|155807038|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
48442679|NCT00426556|155807039|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
48442680|NCT00426556|155807040|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
48442681|NCT00426556|155807037|FG000|Phase II - Core Phase|Disease Progression|0|||
48442682|NCT00426556|155807038|FG001|Phase II - Core Phase|Disease Progression|0|||
48442683|NCT00426556|155807039|FG002|Phase II - Core Phase|Disease Progression|0|||
48442684|NCT00426556|155807040|FG003|Phase II - Core Phase|Disease Progression|16|||
48442685|NCT00426556|155807037|FG000|Phase II - Core Phase|Adverse Event|0|||
48442686|NCT00426556|155807038|FG001|Phase II - Core Phase|Adverse Event|0|||
48442687|NCT00426556|155807039|FG002|Phase II - Core Phase|Adverse Event|0|||
48442688|NCT00426556|155807040|FG003|Phase II - Core Phase|Adverse Event|8|||
48442689|NCT00426556|155807037|FG000|Phase II - Extension Phase|Disease Progression|0|||
48442690|NCT00426556|155807038|FG001|Phase II - Extension Phase|Disease Progression|0|||
48442691|NCT00426556|155807039|FG002|Phase II - Extension Phase|Disease Progression|0|||
48442692|NCT00426556|155807040|FG003|Phase II - Extension Phase|Disease Progression|21|||
48442693|NCT00426556|155807037|FG000|Phase II - Extension Phase|Adverse Event|0|||
48442694|NCT00426556|155807038|FG001|Phase II - Extension Phase|Adverse Event|0|||
48442695|NCT00426556|155807039|FG002|Phase II - Extension Phase|Adverse Event|0|||
48442696|NCT00426556|155807040|FG003|Phase II - Extension Phase|Adverse Event|2|||
48442697|NCT01803711|155807041|FG000|Overall Study|Adverse Event|1|||
48442698|NCT01803711|155807042|FG001|Overall Study|Adverse Event|1|||
48442699|NCT00305604|155807043|FG000|Overall Study|Adverse Event|6|||
48442700|NCT00305604|155807044|FG001|Overall Study|Adverse Event|3|||
48442701|NCT00305604|155807043|FG000|Overall Study|Lack of Efficacy|11|||
48442702|NCT00305604|155807044|FG001|Overall Study|Lack of Efficacy|18|||
48442703|NCT00305604|155807043|FG000|Overall Study|Lost to Follow-up|0|||
48442704|NCT00305604|155807044|FG001|Overall Study|Lost to Follow-up|4|||
48442705|NCT00305604|155807043|FG000|Overall Study|Protocol Violation|2|||
48442706|NCT00305604|155807044|FG001|Overall Study|Protocol Violation|1|||
48442707|NCT00305604|155807043|FG000|Overall Study|Withdrawal by Subject|12|||
48442708|NCT00305604|155807044|FG001|Overall Study|Withdrawal by Subject|21|||
48442709|NCT00305604|155807043|FG000|Overall Study|Patient moved|1|||
48442710|NCT00305604|155807044|FG001|Overall Study|Patient moved|0|||
48442711|NCT02146248|155807045|FG000|Overall Study|Withdrawal by Subject|2|||
48442712|NCT00844285|155807051|FG000|Overall Study|Other|0|||
48442713|NCT00844285|155807052|FG001|Overall Study|Other|1|||
48442714|NCT00844285|155807053|FG002|Overall Study|Other|0|||
48442715|NCT00844285|155807051|FG000|Overall Study|Other than specified|95|||
48442716|NCT00844285|155807052|FG001|Overall Study|Other than specified|129|||
48442717|NCT00844285|155807053|FG002|Overall Study|Other than specified|12|||
48442718|NCT00844285|155807051|FG000|Overall Study|Site closure|256|||
48442719|NCT00844285|155807052|FG001|Overall Study|Site closure|450|||
48442720|NCT00844285|155807053|FG002|Overall Study|Site closure|50|||
48442721|NCT00844285|155807051|FG000|Overall Study|Follow-up < 8 years|16|||
48442722|NCT00844285|155807052|FG001|Overall Study|Follow-up < 8 years|23|||
48442723|NCT00844285|155807053|FG002|Overall Study|Follow-up < 8 years|4|||
48442724|NCT00844285|155807051|FG000|Overall Study|Protocol Violation|26|||
48442725|NCT00844285|155807052|FG001|Overall Study|Protocol Violation|28|||
48442726|NCT00844285|155807053|FG002|Overall Study|Protocol Violation|54|||
48442727|NCT00844285|155807051|FG000|Overall Study|Death|22|||
48442728|NCT00844285|155807052|FG001|Overall Study|Death|21|||
48442729|NCT00844285|155807053|FG002|Overall Study|Death|8|||
48442730|NCT00844285|155807051|FG000|Overall Study|Withdrew Consent|344|||
48442731|NCT00844285|155807052|FG001|Overall Study|Withdrew Consent|466|||
48442732|NCT00844285|155807053|FG002|Overall Study|Withdrew Consent|70|||
48442733|NCT00844285|155807051|FG000|Overall Study|Lost to Follow-up|330|||
48442734|NCT00844285|155807052|FG001|Overall Study|Lost to Follow-up|486|||
48442735|NCT00844285|155807053|FG002|Overall Study|Lost to Follow-up|74|||
48442736|NCT01578785|155807054|FG000|Overall Study|Withdrawal by Subject|0|||
48442737|NCT01578785|155807055|FG001|Overall Study|Withdrawal by Subject|1|||
48442738|NCT01578785|155807054|FG000|Overall Study|Study terminated by sponsor|59|||
48442739|NCT01578785|155807055|FG001|Overall Study|Study terminated by sponsor|118|||
48442740|NCT00192036|155807059|FG000|Overall Study|Protocol Violation|3|||
48442741|NCT00192036|155807059|FG000|Overall Study|Adverse Event|6|||
48442742|NCT00192036|155807059|FG000|Overall Study|Patient/Physician Perception|1|||
48442743|NCT00192036|155807059|FG000|Overall Study|Objective Tumor Progression|4|||
48442744|NCT00192036|155807059|FG000|Overall Study|Clinical Disease Progression|1|||
48442745|NCT00192036|155807059|FG000|Overall Study|Death|1|||
48442746|NCT00192036|155807059|FG000|Overall Study|Unknown or Not Specified|5|||
48442747|NCT03371732|155807063|FG000|Overall Study|Withdrawal by Subject|9|||
48442748|NCT03371732|155807064|FG001|Overall Study|Withdrawal by Subject|3|||
48442749|NCT03371732|155807063|FG000|Overall Study|Refusal to continue|3|||
48442750|NCT03371732|155807064|FG001|Overall Study|Refusal to continue|4|||
48442751|NCT04682353|155807065|FG000|Overall Study|Lost to Follow-up|0|||
48442752|NCT04682353|155807066|FG001|Overall Study|Lost to Follow-up|1|||
48442753|NCT04682353|155807067|FG002|Overall Study|Lost to Follow-up|0|||
48442754|NCT04682353|155807068|FG003|Overall Study|Lost to Follow-up|1|||
48442755|NCT04682353|155807065|FG000|Overall Study|Personal reasons|0|||
48442756|NCT04682353|155807066|FG001|Overall Study|Personal reasons|1|||
48442757|NCT04682353|155807067|FG002|Overall Study|Personal reasons|0|||
48442758|NCT04682353|155807068|FG003|Overall Study|Personal reasons|0|||
48442759|NCT02585999|155808467|FG000|Overall Study|Lost to Follow-up|1|||
48442812|NCT00377429|155808497|FG000|Overall Study|Withdrawal by Subject|5|||
48442813|NCT00377429|155808497|FG000|Overall Study|Adverse Event|8|||
48442814|NCT00377429|155808497|FG000|Overall Study|Physician Decision|1|||
48442815|NCT00377429|155808497|FG000|Overall Study|Patient non-compliance|1|||
48442816|NCT00476996|155808498|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
48442817|NCT00476996|155808499|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
48442818|NCT00476996|155808500|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
48442819|NCT00476996|155808501|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
48442820|NCT00476996|155808498|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
48442821|NCT00476996|155808499|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
48442822|NCT00476996|155808500|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
48442823|NCT00476996|155808501|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
48442824|NCT00476996|155808498|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
48442825|NCT00476996|155808499|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
48442826|NCT00476996|155808500|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
48442827|NCT00476996|155808501|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
48442828|NCT00476996|155808498|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
48442829|NCT00476996|155808499|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
48442830|NCT00476996|155808500|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
48442831|NCT00476996|155808501|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
48442832|NCT00476996|155808498|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
48442833|NCT00476996|155808499|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
48442834|NCT00476996|155808500|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
48442835|NCT00476996|155808501|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
48442836|NCT00476996|155808498|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
48442837|NCT00476996|155808499|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
48442838|NCT00476996|155808500|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
48442839|NCT00476996|155808501|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
48442840|NCT00476996|155808498|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
48442841|NCT00476996|155808499|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
48442842|NCT00476996|155808500|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
48442843|NCT00476996|155808501|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
48442844|NCT00476996|155808498|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
48442845|NCT00476996|155808499|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
48442846|NCT00476996|155808500|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
48442847|NCT00476996|155808501|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
48442848|NCT00476996|155808498|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
48442849|NCT00476996|155808499|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
48442850|NCT00476996|155808500|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
48442851|NCT00476996|155808501|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
48442852|NCT00476996|155808498|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
48442853|NCT00476996|155808499|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
48442854|NCT00476996|155808500|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
48442855|NCT00476996|155808501|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
48442856|NCT00476996|155808498|FG000|OLE Phase (From Week 48)|Death|0|||
48442857|NCT00476996|155808499|FG001|OLE Phase (From Week 48)|Death|0|||
48442858|NCT00476996|155808500|FG002|OLE Phase (From Week 48)|Death|0|||
48442859|NCT00476996|155808501|FG003|OLE Phase (From Week 48)|Death|7|||
48442860|NCT00476996|155808498|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
48442861|NCT00476996|155808499|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
48442862|NCT00476996|155808500|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
48442863|NCT00476996|155808501|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
48442864|NCT00476996|155808498|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
48442865|NCT00476996|155808499|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
48442866|NCT00476996|155808500|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
48442867|NCT00476996|155808501|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
48442868|NCT00476996|155808498|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
48442869|NCT00476996|155808499|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
48442870|NCT00476996|155808500|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
48442871|NCT00476996|155808501|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
48442872|NCT00476996|155808498|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
48442873|NCT00476996|155808499|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
48442874|NCT00476996|155808500|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
48442875|NCT00476996|155808501|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
48442876|NCT01586806|155808504|FG000|Overall Study|Protocol Violation|0|||
48442877|NCT01586806|155808505|FG001|Overall Study|Protocol Violation|1|||
48442878|NCT01586806|155808506|FG002|Overall Study|Protocol Violation|0|||
48442879|NCT01586806|155808504|FG000|Overall Study|Withdrawal by Subject|1|||
48442880|NCT01586806|155808505|FG001|Overall Study|Withdrawal by Subject|0|||
48442881|NCT01586806|155808506|FG002|Overall Study|Withdrawal by Subject|0|||
48442882|NCT01586806|155808504|FG000|Overall Study|Lost to Follow-up|2|||
48442883|NCT01586806|155808505|FG001|Overall Study|Lost to Follow-up|3|||
48442884|NCT01586806|155808506|FG002|Overall Study|Lost to Follow-up|2|||
48442885|NCT01230749|155808507|FG000|Overall Study|Adverse Event|0|||
48442886|NCT01230749|155808508|FG001|Overall Study|Adverse Event|0|||
48442887|NCT01230749|155808509|FG002|Overall Study|Adverse Event|0|||
48442888|NCT01230749|155808510|FG003|Overall Study|Adverse Event|1|||
48442889|NCT01230749|155808507|FG000|Overall Study|Physician Decision|0|||
48442890|NCT01230749|155808508|FG001|Overall Study|Physician Decision|0|||
48442891|NCT01230749|155808509|FG002|Overall Study|Physician Decision|1|||
48442892|NCT01230749|155808510|FG003|Overall Study|Physician Decision|0|||
48442893|NCT01230749|155808507|FG000|Overall Study|Withdrawal by Subject|0|||
48442894|NCT01230749|155808508|FG001|Overall Study|Withdrawal by Subject|1|||
48442895|NCT01230749|155808509|FG002|Overall Study|Withdrawal by Subject|0|||
48442896|NCT01230749|155808510|FG003|Overall Study|Withdrawal by Subject|0|||
48442897|NCT01230749|155808507|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
48442898|NCT01230749|155808508|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
48442899|NCT01230749|155808509|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
48442900|NCT01230749|155808510|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
48442901|NCT00555906|155808513|FG000|Phase 1|Objective Progression or Relapse|3|||
48442902|NCT00555906|155808514|FG001|Phase 1|Objective Progression or Relapse|5|||
48442903|NCT00555906|155808515|FG002|Phase 1|Objective Progression or Relapse|3|||
48442904|NCT00555906|155808516|FG003|Phase 1|Objective Progression or Relapse|1|||
48442905|NCT00555906|155808517|FG004|Phase 1|Objective Progression or Relapse|0|||
48442906|NCT00555906|155808513|FG000|Phase 1|Global Deterioration of Health Status|0|||
48442907|NCT00555906|155808514|FG001|Phase 1|Global Deterioration of Health Status|1|||
48442908|NCT00555906|155808515|FG002|Phase 1|Global Deterioration of Health Status|1|||
48442909|NCT00555906|155808516|FG003|Phase 1|Global Deterioration of Health Status|1|||
48442910|NCT00555906|155808517|FG004|Phase 1|Global Deterioration of Health Status|0|||
48442911|NCT00555906|155808513|FG000|Phase 1|Adverse Event|0|||
48442912|NCT00555906|155808514|FG001|Phase 1|Adverse Event|0|||
48442913|NCT00555906|155808515|FG002|Phase 1|Adverse Event|3|||
48442914|NCT00555906|155808516|FG003|Phase 1|Adverse Event|2|||
48442915|NCT00555906|155808517|FG004|Phase 1|Adverse Event|0|||
48442916|NCT00555906|155808513|FG000|Phase 1|Withdrawal by Subject|0|||
48442917|NCT00555906|155808514|FG001|Phase 1|Withdrawal by Subject|0|||
48442918|NCT00555906|155808515|FG002|Phase 1|Withdrawal by Subject|0|||
48442919|NCT00555906|155808516|FG003|Phase 1|Withdrawal by Subject|1|||
48442920|NCT00555906|155808517|FG004|Phase 1|Withdrawal by Subject|0|||
48442921|NCT00555906|155808513|FG000|Phase 2|Adverse Event|0|||
48442922|NCT00555906|155808514|FG001|Phase 2|Adverse Event|0|||
48442923|NCT00555906|155808515|FG002|Phase 2|Adverse Event|0|||
48442924|NCT00555906|155808516|FG003|Phase 2|Adverse Event|0|||
48442925|NCT00555906|155808517|FG004|Phase 2|Adverse Event|4|||
48442926|NCT00555906|155808513|FG000|Phase 2|Global Deterioration of Health Status|0|||
48442927|NCT00555906|155808514|FG001|Phase 2|Global Deterioration of Health Status|0|||
48442928|NCT00555906|155808515|FG002|Phase 2|Global Deterioration of Health Status|0|||
48442929|NCT00555906|155808516|FG003|Phase 2|Global Deterioration of Health Status|0|||
48442930|NCT00555906|155808517|FG004|Phase 2|Global Deterioration of Health Status|2|||
48442931|NCT00555906|155808513|FG000|Phase 2|Objective Progression or Relapse|0|||
48442932|NCT00555906|155808514|FG001|Phase 2|Objective Progression or Relapse|0|||
48442933|NCT00555906|155808515|FG002|Phase 2|Objective Progression or Relapse|0|||
48442934|NCT00555906|155808516|FG003|Phase 2|Objective Progression or Relapse|0|||
48442935|NCT00555906|155808517|FG004|Phase 2|Objective Progression or Relapse|16|||
48442936|NCT00555906|155808513|FG000|Phase 2|Withdrawal by Subject|0|||
48442937|NCT00555906|155808514|FG001|Phase 2|Withdrawal by Subject|0|||
48442938|NCT00555906|155808515|FG002|Phase 2|Withdrawal by Subject|0|||
48442939|NCT00555906|155808516|FG003|Phase 2|Withdrawal by Subject|0|||
48442940|NCT00555906|155808517|FG004|Phase 2|Withdrawal by Subject|2|||
48442941|NCT00555906|155808513|FG000|Phase 2|Other|0|||
48442942|NCT00555906|155808514|FG001|Phase 2|Other|0|||
48442943|NCT00555906|155808515|FG002|Phase 2|Other|0|||
48442944|NCT00555906|155808516|FG003|Phase 2|Other|0|||
48442945|NCT00555906|155808517|FG004|Phase 2|Other|6|||
48442946|NCT00555906|155808513|FG000|Phase 2|Randomized but not Treated|0|||
48442947|NCT00555906|155808514|FG001|Phase 2|Randomized but not Treated|0|||
48442948|NCT00555906|155808515|FG002|Phase 2|Randomized but not Treated|0|||
48442949|NCT00555906|155808516|FG003|Phase 2|Randomized but not Treated|0|||
48442950|NCT00555906|155808517|FG004|Phase 2|Randomized but not Treated|2|||
48442951|NCT01033487|155808518|FG000|Fourth Intervention Period|Adverse Event|0|||
48442952|NCT01033487|155808519|FG001|Fourth Intervention Period|Adverse Event|0|||
48442953|NCT01033487|155808520|FG002|Fourth Intervention Period|Adverse Event|0|||
48442954|NCT01033487|155808521|FG003|Fourth Intervention Period|Adverse Event|0|||
48442955|NCT01033487|155808522|FG004|Fourth Intervention Period|Adverse Event|0|||
48442956|NCT01033487|155808523|FG005|Fourth Intervention Period|Adverse Event|0|||
48442957|NCT01033487|155808524|FG006|Fourth Intervention Period|Adverse Event|0|||
48442958|NCT01033487|155808525|FG007|Fourth Intervention Period|Adverse Event|0|||
48442959|NCT01033487|155808526|FG008|Fourth Intervention Period|Adverse Event|1|||
48442960|NCT01033487|155808527|FG009|Fourth Intervention Period|Adverse Event|0|||
48442961|NCT02193828|155808529|FG000|Overall Study|Withdrawal by Subject|0|||
48442962|NCT02193828|155808530|FG001|Overall Study|Withdrawal by Subject|0|||
48442963|NCT02193828|155808531|FG002|Overall Study|Withdrawal by Subject|1|||
48442964|NCT02193828|155808532|FG003|Overall Study|Withdrawal by Subject|1|||
48442965|NCT02802878|155808533|FG000|Overall Study|Withdrawal by Subject|3|||
48442966|NCT02802878|155808534|FG001|Overall Study|Withdrawal by Subject|3|||
48442967|NCT02802878|155808533|FG000|Overall Study|Protocol Violation|1|||
48442968|NCT02802878|155808534|FG001|Overall Study|Protocol Violation|0|||
48442969|NCT00729326|155808535|FG000|Overall Study|Lost to Follow-up|2|||
48442970|NCT00729326|155808536|FG001|Overall Study|Lost to Follow-up|0|||
48442971|NCT00729326|155808535|FG000|Overall Study|Physician Decision|0|||
48442972|NCT00729326|155808536|FG001|Overall Study|Physician Decision|1|||
48442973|NCT00729326|155808535|FG000|Overall Study|Protocol Violation|3|||
48442974|NCT00729326|155808536|FG001|Overall Study|Protocol Violation|2|||
48442975|NCT00729326|155808535|FG000|Overall Study|Subject Decision|4|||
48442976|NCT00729326|155808536|FG001|Overall Study|Subject Decision|4|||
48442977|NCT00729326|155808535|FG000|Overall Study|Sponsor Decision|1|||
48442978|NCT00729326|155808536|FG001|Overall Study|Sponsor Decision|2|||
48442979|NCT01769469|155808537|FG000|Overall Study|Consent Withdrawn|5|||
48442980|NCT01769469|155808537|FG000|Overall Study|Moved Out Of Area|3|||
48442981|NCT01769469|155808537|FG000|Overall Study|Lost to Follow-up|17|||
48442982|NCT01769469|155808537|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
48442983|NCT01769469|155808537|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
48442984|NCT00862654|155808539|FG000|Overall Study|Lack of Efficacy|1|||
48442985|NCT00862654|155808540|FG001|Overall Study|Lack of Efficacy|0|||
48442986|NCT00862654|155808541|FG002|Overall Study|Lack of Efficacy|1|||
48442987|NCT00862654|155808542|FG003|Overall Study|Lack of Efficacy|0|||
48442988|NCT00862654|155808539|FG000|Overall Study|Lost to Follow-up|1|||
48442989|NCT00862654|155808540|FG001|Overall Study|Lost to Follow-up|2|||
48442990|NCT00862654|155808541|FG002|Overall Study|Lost to Follow-up|1|||
48442991|NCT00862654|155808542|FG003|Overall Study|Lost to Follow-up|3|||
48442992|NCT00862654|155808539|FG000|Overall Study|Adverse Event|0|||
48442993|NCT00862654|155808540|FG001|Overall Study|Adverse Event|1|||
48442994|NCT00862654|155808541|FG002|Overall Study|Adverse Event|1|||
48442995|NCT00862654|155808542|FG003|Overall Study|Adverse Event|0|||
48442996|NCT00862654|155808539|FG000|Overall Study|Pregnancy|1|||
48442997|NCT00862654|155808540|FG001|Overall Study|Pregnancy|1|||
48442998|NCT00862654|155808541|FG002|Overall Study|Pregnancy|0|||
48442999|NCT00862654|155808542|FG003|Overall Study|Pregnancy|0|||
48443000|NCT00862654|155808539|FG000|Overall Study|Withdrawal by Subject|2|||
48443001|NCT00862654|155808540|FG001|Overall Study|Withdrawal by Subject|2|||
48443002|NCT00862654|155808541|FG002|Overall Study|Withdrawal by Subject|2|||
48443003|NCT00862654|155808542|FG003|Overall Study|Withdrawal by Subject|3|||
48443004|NCT00862654|155808539|FG000|Overall Study|Subject mistake|0|||
48443005|NCT00862654|155808540|FG001|Overall Study|Subject mistake|1|||
48443006|NCT00862654|155808541|FG002|Overall Study|Subject mistake|0|||
48443007|NCT00862654|155808542|FG003|Overall Study|Subject mistake|0|||
48443008|NCT00862654|155808539|FG000|Overall Study|Familly constraint|0|||
48443009|NCT00862654|155808540|FG001|Overall Study|Familly constraint|1|||
48443010|NCT00862654|155808541|FG002|Overall Study|Familly constraint|0|||
48443011|NCT00862654|155808542|FG003|Overall Study|Familly constraint|0|||
48443012|NCT00862654|155808539|FG000|Overall Study|Never used study drugs|1|||
48443013|NCT00862654|155808540|FG001|Overall Study|Never used study drugs|0|||
48443014|NCT00862654|155808541|FG002|Overall Study|Never used study drugs|0|||
48443015|NCT00862654|155808542|FG003|Overall Study|Never used study drugs|0|||
48443016|NCT00862654|155808539|FG000|Overall Study|Included after end of inclusions|0|||
48443017|NCT00862654|155808540|FG001|Overall Study|Included after end of inclusions|0|||
48443018|NCT00862654|155808541|FG002|Overall Study|Included after end of inclusions|1|||
48443019|NCT00862654|155808542|FG003|Overall Study|Included after end of inclusions|0|||
48443020|NCT01235728|155808543|FG000|Overall Study|Protocol Violation|0|||
48443021|NCT01235728|155808544|FG001|Overall Study|Protocol Violation|0|||
48443022|NCT01235728|155808545|FG002|Overall Study|Protocol Violation|0|||
48443023|NCT01235728|155808546|FG003|Overall Study|Protocol Violation|1|||
48443024|NCT01235728|155808547|FG004|Overall Study|Protocol Violation|0|||
48443025|NCT01235728|155808548|FG005|Overall Study|Protocol Violation|0|||
48443026|NCT01235728|155808549|FG006|Overall Study|Protocol Violation|0|||
48443027|NCT01235728|155808550|FG007|Overall Study|Protocol Violation|0|||
48443028|NCT03219567|155808561|FG000|Overall Study|Withdrawal by Subject|0|||
48443029|NCT03219567|155808562|FG001|Overall Study|Withdrawal by Subject|1|||
48443030|NCT02394795|155808565|FG000|Overall Study|Adverse Event|92|||
48443031|NCT02394795|155808566|FG001|Overall Study|Adverse Event|70|||
48443032|NCT02394795|155808565|FG000|Overall Study|Lost to Follow-up|0|||
48443033|NCT02394795|155808566|FG001|Overall Study|Lost to Follow-up|1|||
48443034|NCT02394795|155808565|FG000|Overall Study|Withdrawal by Subject|17|||
48443035|NCT02394795|155808566|FG001|Overall Study|Withdrawal by Subject|26|||
48443036|NCT02394795|155808565|FG000|Overall Study|Lack of Efficacy|181|||
48443076|NCT02849626|155808582|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
48443077|NCT02849626|155808579|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
48443078|NCT02849626|155808580|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
48443079|NCT02849626|155808581|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
48443080|NCT02849626|155808582|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
48443081|NCT02849626|155808579|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
48443082|NCT02849626|155808580|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
48443083|NCT02849626|155808581|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
48443084|NCT02849626|155808582|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
48443085|NCT02849626|155808579|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
48443086|NCT02849626|155808580|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
48443087|NCT02849626|155808581|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
48443088|NCT02849626|155808582|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
48443089|NCT02849626|155808579|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
48443090|NCT02849626|155808580|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
48443091|NCT02849626|155808581|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
48443092|NCT02849626|155808582|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
48443093|NCT02849626|155808579|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
48443094|NCT02849626|155808580|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
48443095|NCT02849626|155808581|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
48443096|NCT02849626|155808582|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
48443097|NCT02849626|155808579|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
48443098|NCT02849626|155808580|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
48443099|NCT02849626|155808581|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
48443100|NCT02849626|155808582|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
48443101|NCT02849626|155808579|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
48443102|NCT02849626|155808580|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
48443103|NCT02849626|155808581|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
48443104|NCT02849626|155808582|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
48443105|NCT02849626|155808579|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
48443106|NCT02849626|155808580|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
48443107|NCT02849626|155808581|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
48443108|NCT02849626|155808582|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
48443109|NCT02849626|155808579|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
48443110|NCT02849626|155808580|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
48443111|NCT02849626|155808581|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
48443112|NCT02849626|155808582|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
48443113|NCT00889681|155808583|FG000|Overall Study|Not meeting qualification Criteria|2|||
48443114|NCT00889681|155808583|FG000|Overall Study|Insurance disapproval|1|||
48443115|NCT00593840|155808584|FG000|Overall Study|Withdrawal by Subject|1|||
48443116|NCT01185704|155808585|FG000|Overall Study|Randomized but not treated|3|||
48443117|NCT01185704|155808586|FG001|Overall Study|Randomized but not treated|3|||
48443118|NCT01185704|155808585|FG000|Overall Study|Lack of ovarian response|5|||
48443119|NCT01185704|155808586|FG001|Overall Study|Lack of ovarian response|1|||
48443120|NCT01185704|155808585|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
48443121|NCT01185704|155808586|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
48443122|NCT01185704|155808585|FG000|Overall Study|Ectopic pregnancy|0|||
48443123|NCT01185704|155808586|FG001|Overall Study|Ectopic pregnancy|1|||
48443124|NCT00631540|155808587|FG000|Overall Study|Withdrawal by Subject|5|||
48443125|NCT00631540|155808587|FG000|Overall Study|Death|4|||
48443126|NCT00631540|155808587|FG000|Overall Study|Lost to Follow-up|2|||
48443127|NCT00631540|155808587|FG000|Overall Study|Core Lab Data Unavailable|3|||
48443128|NCT00871572|155808588|FG000|Overall Study|Adverse Event|0|||
48443129|NCT00871572|155808589|FG001|Overall Study|Adverse Event|2|||
48443130|NCT00871572|155808590|FG002|Overall Study|Adverse Event|0|||
48443131|NCT00871572|155808591|FG003|Overall Study|Adverse Event|3|||
48443132|NCT00871572|155808588|FG000|Overall Study|Investigator Decision|0|||
48443133|NCT00871572|155808589|FG001|Overall Study|Investigator Decision|1|||
48443134|NCT00871572|155808590|FG002|Overall Study|Investigator Decision|0|||
48443135|NCT00871572|155808591|FG003|Overall Study|Investigator Decision|1|||
48443136|NCT00871572|155808588|FG000|Overall Study|Lost to Follow-up|0|||
48443137|NCT00871572|155808589|FG001|Overall Study|Lost to Follow-up|1|||
48443138|NCT00871572|155808590|FG002|Overall Study|Lost to Follow-up|0|||
48443139|NCT00871572|155808591|FG003|Overall Study|Lost to Follow-up|1|||
48443140|NCT00871572|155808588|FG000|Overall Study|Protocol Violation|0|||
48443141|NCT00871572|155808589|FG001|Overall Study|Protocol Violation|0|||
48443142|NCT00871572|155808590|FG002|Overall Study|Protocol Violation|1|||
48443143|NCT00871572|155808591|FG003|Overall Study|Protocol Violation|1|||
48443144|NCT00871572|155808588|FG000|Overall Study|Sponsor Decision|1|||
48443145|NCT00871572|155808589|FG001|Overall Study|Sponsor Decision|0|||
48443146|NCT00871572|155808590|FG002|Overall Study|Sponsor Decision|0|||
48443147|NCT00871572|155808591|FG003|Overall Study|Sponsor Decision|0|||
48443148|NCT00871572|155808588|FG000|Overall Study|Withdrawal by Subject|1|||
48443149|NCT00871572|155808589|FG001|Overall Study|Withdrawal by Subject|2|||
48443150|NCT00871572|155808590|FG002|Overall Study|Withdrawal by Subject|3|||
48443151|NCT00871572|155808591|FG003|Overall Study|Withdrawal by Subject|1|||
48443152|NCT01313208|155808593|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
48443153|NCT01313208|155808594|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
48443154|NCT01313208|155808593|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
48443155|NCT01313208|155808594|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
48443156|NCT01313208|155808593|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
48443157|NCT01313208|155808594|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
48443158|NCT01313208|155808593|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
48443159|NCT01313208|155808594|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
48443160|NCT01313208|155808593|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
48443161|NCT01313208|155808594|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
48443162|NCT01313208|155808593|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
48443163|NCT01313208|155808594|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
48443164|NCT01313208|155808593|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
48443165|NCT01313208|155808594|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
48443166|NCT01313208|155808593|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
48443167|NCT01313208|155808594|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
48443168|NCT01313208|155808593|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
48443169|NCT01313208|155808594|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
48443170|NCT04354155|155808595|FG000|Overall Study|Withdrawal by Subject|1|||
48443171|NCT04354155|155808595|FG000|Overall Study|Did not meet criteria for study intervention|1|||
48443172|NCT01686958|155808596|FG000|Overall Study|Withdrawal by Subject|1|||
48443173|NCT00719953|155810278|FG000|Overall Study|Adverse Event|4|||
48443174|NCT01179347|155810279|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
48443175|NCT01179347|155810280|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
48443176|NCT01179347|155810279|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
48443177|NCT01179347|155810280|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
48443178|NCT01179347|155810279|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
48443179|NCT01179347|155810280|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
48443180|NCT01179347|155810279|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
48443181|NCT01179347|155810280|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
48443182|NCT01179347|155810279|FG000|Double-blind Period (12 Weeks)|Other|2|||
48443183|NCT01179347|155810280|FG001|Double-blind Period (12 Weeks)|Other|4|||
48443184|NCT01179347|155810279|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
48443185|NCT01179347|155810280|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
48443186|NCT01179347|155810279|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
48443187|NCT01179347|155810280|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
48443188|NCT01179347|155810279|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
48443189|NCT01179347|155810280|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
48443190|NCT01179347|155810279|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
48443191|NCT01179347|155810280|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
48443192|NCT01179347|155810279|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
48443193|NCT01179347|155810280|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
48443194|NCT01179347|155810279|FG000|Open-label Period (12 Weeks)|Other|7|||
48443195|NCT01179347|155810280|FG001|Open-label Period (12 Weeks)|Other|4|||
48443196|NCT01116687|155810281|FG000|Overall Study|Withdrawal by Subject|4|||
48443197|NCT01195831|155810282|FG000|Overall Study|Lost to Follow-up|2|||
48443198|NCT01195831|155810283|FG001|Overall Study|Lost to Follow-up|4|||
48443199|NCT01195831|155810282|FG000|Overall Study|Withdrawal by Subject|2|||
48443200|NCT01195831|155810283|FG001|Overall Study|Withdrawal by Subject|2|||
48443201|NCT01195831|155810282|FG000|Overall Study|Adverse Event|4|||
48443202|NCT01195831|155810283|FG001|Overall Study|Adverse Event|2|||
48443203|NCT01195831|155810282|FG000|Overall Study|Protocol Violation|0|||
48443204|NCT01195831|155810283|FG001|Overall Study|Protocol Violation|2|||
48443205|NCT02670915|155810284|FG000|Overall Study|Withdrawal by Subject|0|||
48443206|NCT02670915|155810285|FG001|Overall Study|Withdrawal by Subject|1|||
48443207|NCT02670915|155810286|FG002|Overall Study|Withdrawal by Subject|4|||
48443208|NCT02670915|155810284|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48443209|NCT02670915|155810285|FG001|Overall Study|Withdrawal by parent/guardian|4|||
48443210|NCT02670915|155810286|FG002|Overall Study|Withdrawal by parent/guardian|1|||
48443211|NCT02670915|155810284|FG000|Overall Study|Unclassified|0|||
48443212|NCT02670915|155810285|FG001|Overall Study|Unclassified|3|||
48443213|NCT02670915|155810286|FG002|Overall Study|Unclassified|0|||
48443214|NCT01337167|155810287|FG000|Infant Series|Adverse Event|1|||
48443215|NCT01337167|155810288|FG001|Infant Series|Adverse Event|1|||
48443216|NCT01337167|155810287|FG000|Infant Series|Death|1|||
48443217|NCT01337167|155810288|FG001|Infant Series|Death|1|||
48443218|NCT01337167|155810287|FG000|Infant Series|Lost to Follow-up|13|||
48443219|NCT01337167|155810288|FG001|Infant Series|Lost to Follow-up|7|||
48443519|NCT02853032|155810407|FG000|Overall Study|Adverse Event|4|||
48443220|NCT01337167|155810287|FG000|Infant Series|Non-compliance with study drug|2|||
48443221|NCT01337167|155810288|FG001|Infant Series|Non-compliance with study drug|1|||
48443222|NCT01337167|155810287|FG000|Infant Series|Physician Decision|3|||
48443223|NCT01337167|155810288|FG001|Infant Series|Physician Decision|1|||
48443224|NCT01337167|155810287|FG000|Infant Series|Protocol Violation|22|||
48443225|NCT01337167|155810288|FG001|Infant Series|Protocol Violation|9|||
48443226|NCT01337167|155810287|FG000|Infant Series|Withdrawal by Subject|15|||
48443227|NCT01337167|155810288|FG001|Infant Series|Withdrawal by Subject|4|||
48443228|NCT01337167|155810287|FG000|Infant Series|Randomized but not vaccinated|5|||
48443229|NCT01337167|155810288|FG001|Infant Series|Randomized but not vaccinated|3|||
48443230|NCT01337167|155810287|FG000|Interim Period|Lost to Follow-up|51|||
48443231|NCT01337167|155810288|FG001|Interim Period|Lost to Follow-up|23|||
48443232|NCT01337167|155810287|FG000|Interim Period|Non-compliance with study drug|1|||
48443233|NCT01337167|155810288|FG001|Interim Period|Non-compliance with study drug|0|||
48443234|NCT01337167|155810287|FG000|Interim Period|Physician Decision|6|||
48443235|NCT01337167|155810288|FG001|Interim Period|Physician Decision|3|||
48443236|NCT01337167|155810287|FG000|Interim Period|Protocol Violation|5|||
48443237|NCT01337167|155810288|FG001|Interim Period|Protocol Violation|3|||
48443238|NCT01337167|155810287|FG000|Interim Period|Withdrawal by Subject|18|||
48443239|NCT01337167|155810288|FG001|Interim Period|Withdrawal by Subject|10|||
48443240|NCT01337167|155810287|FG000|Interim Period|Other protocol criterion not met|0|||
48443241|NCT01337167|155810288|FG001|Interim Period|Other protocol criterion not met|1|||
48443242|NCT01337167|155810287|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
48443243|NCT01337167|155810288|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
48443244|NCT01337167|155810287|FG000|Toddler Vaccinations|Protocol Violation|0|||
48443245|NCT01337167|155810288|FG001|Toddler Vaccinations|Protocol Violation|1|||
48443246|NCT01337167|155810287|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
48443247|NCT01337167|155810288|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
48443248|NCT03833817|155810289|FG000|Overall Study|Withdrawal by Subject|3|||
48443249|NCT03833817|155810290|FG001|Overall Study|Withdrawal by Subject|3|||
48443250|NCT03833817|155810289|FG000|Overall Study|Lost to Follow-up|3|||
48443251|NCT03833817|155810290|FG001|Overall Study|Lost to Follow-up|3|||
48443252|NCT01975246|155810293|FG000|Overall Study|Adverse Event|2|||
48443253|NCT01975246|155810294|FG001|Overall Study|Adverse Event|1|||
48443254|NCT01975246|155810293|FG000|Overall Study|Lack of Efficacy|1|||
48443255|NCT01975246|155810294|FG001|Overall Study|Lack of Efficacy|0|||
48443256|NCT01975246|155810293|FG000|Overall Study|Protocol Violation|1|||
48443257|NCT01975246|155810294|FG001|Overall Study|Protocol Violation|0|||
48443258|NCT01975246|155810293|FG000|Overall Study|Other than stated|0|||
48443259|NCT01975246|155810294|FG001|Overall Study|Other than stated|1|||
48443260|NCT01646398|155810295|FG000|Overall Study|Withdrawal by Subject|1|||
48443261|NCT01646398|155810296|FG001|Overall Study|Withdrawal by Subject|0|||
48443262|NCT01263093|155810297|FG000|Washout|Physician Decision|1|||
48443263|NCT01263093|155810298|FG001|Washout|Physician Decision|0|||
48443264|NCT01263093|155810297|FG000|Period 2|Adverse Event|1|||
48443265|NCT01263093|155810298|FG001|Period 2|Adverse Event|0|||
48443266|NCT02174861|155810303|FG000|Overall Study|Decision by sponsor|8|||
48443267|NCT02174861|155810303|FG000|Overall Study|Withdrawal by Subject|124|||
48443268|NCT02174861|155810303|FG000|Overall Study|Lost to Follow-up|26|||
48443269|NCT00605722|155810304|FG000|Overall Study|Adverse Event|6|||
48443270|NCT00605722|155810304|FG000|Overall Study|Insufficient therapeutic response|44|||
48443271|NCT00605722|155810304|FG000|Overall Study|Failure to return|1|||
48443272|NCT00839423|155810307|FG000|Overall Study|Adverse Event|4|||
48443273|NCT00839423|155810308|FG001|Overall Study|Adverse Event|3|||
48443274|NCT00839423|155810309|FG002|Overall Study|Adverse Event|7|||
48443275|NCT00839423|155810310|FG003|Overall Study|Adverse Event|16|||
48443276|NCT00839423|155810307|FG000|Overall Study|Lack of Efficacy|6|||
48443277|NCT00839423|155810308|FG001|Overall Study|Lack of Efficacy|6|||
48443278|NCT00839423|155810309|FG002|Overall Study|Lack of Efficacy|3|||
48443279|NCT00839423|155810310|FG003|Overall Study|Lack of Efficacy|2|||
48443280|NCT00839423|155810307|FG000|Overall Study|Non-compliance|0|||
48443281|NCT00839423|155810308|FG001|Overall Study|Non-compliance|0|||
48443282|NCT00839423|155810309|FG002|Overall Study|Non-compliance|0|||
48443283|NCT00839423|155810310|FG003|Overall Study|Non-compliance|1|||
48443284|NCT00839423|155810307|FG000|Overall Study|Protocol Violation|0|||
48443285|NCT00839423|155810308|FG001|Overall Study|Protocol Violation|1|||
48443286|NCT00839423|155810309|FG002|Overall Study|Protocol Violation|2|||
48443287|NCT00839423|155810310|FG003|Overall Study|Protocol Violation|0|||
48443288|NCT00839423|155810307|FG000|Overall Study|Withdrawal of consent|4|||
48443289|NCT00839423|155810308|FG001|Overall Study|Withdrawal of consent|0|||
48443290|NCT00839423|155810309|FG002|Overall Study|Withdrawal of consent|4|||
48443291|NCT00839423|155810310|FG003|Overall Study|Withdrawal of consent|1|||
48443292|NCT00839423|155810307|FG000|Overall Study|Lost to Follow-up|1|||
48443293|NCT00839423|155810308|FG001|Overall Study|Lost to Follow-up|0|||
48443294|NCT00839423|155810309|FG002|Overall Study|Lost to Follow-up|1|||
48443295|NCT00839423|155810310|FG003|Overall Study|Lost to Follow-up|0|||
48443296|NCT00839423|155810307|FG000|Overall Study|Administrative or other reasons|3|||
48443297|NCT00839423|155810308|FG001|Overall Study|Administrative or other reasons|0|||
48443298|NCT00839423|155810309|FG002|Overall Study|Administrative or other reasons|1|||
48443299|NCT00839423|155810310|FG003|Overall Study|Administrative or other reasons|0|||
48443300|NCT00971425|155810311|FG000|Overall Study|Adverse Event|1|||
48443301|NCT00971425|155810312|FG001|Overall Study|Adverse Event|1|||
48443302|NCT00971425|155810311|FG000|Overall Study|Withdrawal by Subject|0|||
48443303|NCT00971425|155810312|FG001|Overall Study|Withdrawal by Subject|1|||
48443304|NCT00120289|155810315|FG000|Overall Study|Death|96|||
48443305|NCT00120289|155810316|FG001|Overall Study|Death|82|||
48443306|NCT00120289|155810315|FG000|Overall Study|Lost to Follow-up|11|||
48443307|NCT00120289|155810316|FG001|Overall Study|Lost to Follow-up|14|||
48443308|NCT00120289|155810315|FG000|Overall Study|Withdrawal by Subject|14|||
48443309|NCT00120289|155810316|FG001|Overall Study|Withdrawal by Subject|13|||
48443310|NCT01711541|155810318|FG000|Overall Study|Cancel prior to treatment|0|||
48443311|NCT01711541|155810319|FG001|Overall Study|Cancel prior to treatment|0|||
48443312|NCT01711541|155810320|FG002|Overall Study|Cancel prior to treatment|0|||
48443313|NCT01711541|155810321|FG003|Overall Study|Cancel prior to treatment|1|||
48443314|NCT01711541|155810322|FG004|Overall Study|Cancel prior to treatment|0|||
48443315|NCT01711541|155810318|FG000|Overall Study|Ineligible|0|||
48443316|NCT01711541|155810319|FG001|Overall Study|Ineligible|1|||
48443317|NCT01711541|155810320|FG002|Overall Study|Ineligible|0|||
48443318|NCT01711541|155810321|FG003|Overall Study|Ineligible|0|||
48443319|NCT01711541|155810322|FG004|Overall Study|Ineligible|0|||
48443320|NCT00877006|155810325|FG000|Treatment Period|Death|2|||
48443321|NCT00877006|155810326|FG001|Treatment Period|Death|1|||
48443322|NCT00877006|155810325|FG000|Treatment Period|Adverse Event|10|||
48443323|NCT00877006|155810326|FG001|Treatment Period|Adverse Event|3|||
48443324|NCT00877006|155810325|FG000|Treatment Period|Withdrawal by Subject|2|||
48443325|NCT00877006|155810326|FG001|Treatment Period|Withdrawal by Subject|3|||
48443326|NCT00877006|155810325|FG000|Treatment Period|Protocol Violation|1|||
48443327|NCT00877006|155810326|FG001|Treatment Period|Protocol Violation|0|||
48443328|NCT00877006|155810325|FG000|Treatment Period|Lost to Follow-up|0|||
48443329|NCT00877006|155810326|FG001|Treatment Period|Lost to Follow-up|1|||
48443330|NCT00877006|155810325|FG000|Treatment Period|Disease Progression|1|||
48443331|NCT00877006|155810326|FG001|Treatment Period|Disease Progression|2|||
48443332|NCT00877006|155810325|FG000|Treatment Period|Started New Treatment Regimen|2|||
48443333|NCT00877006|155810326|FG001|Treatment Period|Started New Treatment Regimen|5|||
48443334|NCT00877006|155810325|FG000|Treatment Period|Other|4|||
48443335|NCT00877006|155810326|FG001|Treatment Period|Other|4|||
48443336|NCT00877006|155810325|FG000|Treatment Period|Randomized but Not Treated|3|||
48443337|NCT00877006|155810326|FG001|Treatment Period|Randomized but Not Treated|8|||
48443338|NCT00877006|155810325|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
48443339|NCT00877006|155810326|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
48443340|NCT00877006|155810325|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
48443341|NCT00877006|155810326|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
48443342|NCT00877006|155810325|FG000|Long-Term Follow-up Period|Death|26|||
48443343|NCT00877006|155810326|FG001|Long-Term Follow-up Period|Death|18|||
48443344|NCT00877006|155810325|FG000|Long-Term Follow-up Period|Other|7|||
48443345|NCT00877006|155810326|FG001|Long-Term Follow-up Period|Other|9|||
48443346|NCT02310906|155810329|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
48443347|NCT02310906|155810330|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
48443348|NCT02310906|155810331|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
48443349|NCT02310906|155810332|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
48443350|NCT02310906|155810329|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
48443351|NCT02310906|155810330|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
48443352|NCT02310906|155810331|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
48443353|NCT02310906|155810332|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
48443354|NCT02310906|155810329|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
48443355|NCT02310906|155810330|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
48443356|NCT02310906|155810331|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
48443357|NCT02310906|155810332|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
48443358|NCT02310906|155810329|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
48443359|NCT02310906|155810330|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
48443360|NCT02310906|155810331|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
48443361|NCT02310906|155810332|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
48443362|NCT03819218|155810333|FG000|Overall Study|Protocol Violation|1|||
48443363|NCT02016898|155810335|FG000|Overall Study|Death|1|||
48443364|NCT02016898|155810336|FG001|Overall Study|Death|1|||
48443365|NCT02016898|155810335|FG000|Overall Study|Lost to Follow-up|4|||
48443366|NCT02016898|155810336|FG001|Overall Study|Lost to Follow-up|4|||
48443367|NCT00270998|155810344|FG000|3 Month Follow-up|Adverse Event|1|||
48443368|NCT00270998|155810345|FG001|3 Month Follow-up|Adverse Event|0|||
48443369|NCT00270998|155810346|FG002|3 Month Follow-up|Adverse Event|0|||
48443370|NCT00270998|155810344|FG000|3 Month Follow-up|Lack of Efficacy|1|||
48443371|NCT00270998|155810345|FG001|3 Month Follow-up|Lack of Efficacy|2|||
48443372|NCT00270998|155810346|FG002|3 Month Follow-up|Lack of Efficacy|1|||
48443373|NCT00270998|155810344|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
48443374|NCT00270998|155810345|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
48443375|NCT00270998|155810346|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
48443376|NCT00270998|155810344|FG000|3 Month Follow-up|Pessary did not fit|12|||
48443377|NCT00270998|155810345|FG001|3 Month Follow-up|Pessary did not fit|0|||
48443378|NCT00270998|155810346|FG002|3 Month Follow-up|Pessary did not fit|0|||
48443379|NCT00270998|155810344|FG000|3 Month Follow-up|Personal/family health|1|||
48443380|NCT00270998|155810345|FG001|3 Month Follow-up|Personal/family health|1|||
48443381|NCT00270998|155810346|FG002|3 Month Follow-up|Personal/family health|0|||
48443382|NCT00270998|155810344|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
48443383|NCT00270998|155810345|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
48443384|NCT00270998|155810346|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
48443385|NCT00270998|155810344|FG000|12 Month Follow-up|Lack of Efficacy|5|||
48443386|NCT00270998|155810345|FG001|12 Month Follow-up|Lack of Efficacy|4|||
48443387|NCT00270998|155810346|FG002|12 Month Follow-up|Lack of Efficacy|3|||
48443388|NCT00270998|155810344|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
48443389|NCT00270998|155810345|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
48443390|NCT00270998|155810346|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
48443391|NCT00270998|155810344|FG000|12 Month Follow-up|Pessary did not fit|1|||
48443392|NCT00270998|155810345|FG001|12 Month Follow-up|Pessary did not fit|0|||
48443393|NCT00270998|155810346|FG002|12 Month Follow-up|Pessary did not fit|0|||
48443394|NCT00270998|155810344|FG000|12 Month Follow-up|Personal/family health|0|||
48443395|NCT00270998|155810345|FG001|12 Month Follow-up|Personal/family health|5|||
48443396|NCT00270998|155810346|FG002|12 Month Follow-up|Personal/family health|1|||
48443397|NCT00270998|155810344|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
48443398|NCT00270998|155810345|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
48443399|NCT00270998|155810346|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
48443400|NCT03395223|155810347|FG000|Overall Study|Lost to Follow-up|3|||
48443401|NCT03395223|155810347|FG000|Overall Study|Other|1|||
48443402|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
48443403|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
48443404|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
48443405|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
48443406|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
48443407|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
48443408|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Death|1|||
48443409|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Death|3|||
48443410|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
48443411|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
48443412|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
48443413|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
48443414|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
48443415|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
48443416|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
48443417|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
48443418|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
48443419|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
48443420|NCT02553317|155810348|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
48443421|NCT02553317|155810349|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
48443422|NCT00764946|155810355|FG000|Overall Study|Lack of Efficacy|1|||
48443423|NCT00764946|155810356|FG001|Overall Study|Lack of Efficacy|0|||
48443424|NCT00764946|155810357|FG002|Overall Study|Lack of Efficacy|0|||
48443425|NCT00764946|155810355|FG000|Overall Study|Lost to Follow-up|3|||
48443426|NCT00764946|155810356|FG001|Overall Study|Lost to Follow-up|4|||
48443427|NCT00764946|155810357|FG002|Overall Study|Lost to Follow-up|0|||
48443428|NCT00764946|155810355|FG000|Overall Study|Physician Decision|2|||
48443429|NCT00764946|155810356|FG001|Overall Study|Physician Decision|4|||
48443430|NCT00764946|155810357|FG002|Overall Study|Physician Decision|0|||
48443431|NCT00764946|155810355|FG000|Overall Study|Adverse Event|3|||
48443432|NCT00764946|155810356|FG001|Overall Study|Adverse Event|2|||
48443433|NCT00764946|155810357|FG002|Overall Study|Adverse Event|1|||
48443434|NCT00764946|155810355|FG000|Overall Study|Withdrawal by Subject|3|||
48443435|NCT00764946|155810356|FG001|Overall Study|Withdrawal by Subject|6|||
48443436|NCT00764946|155810357|FG002|Overall Study|Withdrawal by Subject|2|||
48443437|NCT00764946|155810355|FG000|Overall Study|Never Treated|1|||
48443438|NCT00764946|155810356|FG001|Overall Study|Never Treated|1|||
48443439|NCT00764946|155810357|FG002|Overall Study|Never Treated|1|||
48443440|NCT01354431|155810358|FG000|Pre-Treatment Period|Not reported|1|||
48443441|NCT01354431|155810359|FG001|Pre-Treatment Period|Not reported|0|||
48443442|NCT01354431|155810360|FG002|Pre-Treatment Period|Not reported|0|||
48443443|NCT01354431|155810358|FG000|Treatment Period|Disease Progression|50|||
48443444|NCT01354431|155810359|FG001|Treatment Period|Disease Progression|40|||
48443445|NCT01354431|155810360|FG002|Treatment Period|Disease Progression|44|||
48443446|NCT01354431|155810358|FG000|Treatment Period|Study Drug Toxicity|5|||
48443447|NCT01354431|155810359|FG001|Treatment Period|Study Drug Toxicity|8|||
48443448|NCT01354431|155810360|FG002|Treatment Period|Study Drug Toxicity|4|||
48443449|NCT01354431|155810358|FG000|Treatment Period|Death|0|||
48443450|NCT01354431|155810359|FG001|Treatment Period|Death|1|||
48443451|NCT01354431|155810360|FG002|Treatment Period|Death|0|||
48443452|NCT01354431|155810358|FG000|Treatment Period|AE unrelated to study drug|1|||
48443453|NCT01354431|155810359|FG001|Treatment Period|AE unrelated to study drug|2|||
48443454|NCT01354431|155810360|FG002|Treatment Period|AE unrelated to study drug|5|||
48443455|NCT01354431|155810358|FG000|Treatment Period|Participant request to discontinue|2|||
48443456|NCT01354431|155810359|FG001|Treatment Period|Participant request to discontinue|2|||
48443457|NCT01354431|155810360|FG002|Treatment Period|Participant request to discontinue|1|||
48443458|NCT01354431|155810358|FG000|Treatment Period|Participant withdrew consent|0|||
48443459|NCT01354431|155810359|FG001|Treatment Period|Participant withdrew consent|1|||
48443460|NCT01354431|155810360|FG002|Treatment Period|Participant withdrew consent|0|||
48443461|NCT01354431|155810358|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
48443462|NCT01354431|155810359|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
48443463|NCT01354431|155810360|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
48443464|NCT01654523|155810361|FG000|Overall Study|Withdrawal by Subject|1|||
48443465|NCT02939599|155810367|FG000|Overall Study|Adverse Event|1|||
48443466|NCT02939599|155810368|FG001|Overall Study|Adverse Event|0|||
48443467|NCT02939599|155810367|FG000|Overall Study|Study Terminated By Sponsor|2|||
48443468|NCT02939599|155810368|FG001|Overall Study|Study Terminated By Sponsor|2|||
48443469|NCT01957787|155810369|FG000|Overall Study|Death|18|||
48443470|NCT01957787|155810369|FG000|Overall Study|Lost to Follow-up|3|||
48443471|NCT01957787|155810369|FG000|Overall Study|Withdrawal by Subject|3|||
48443472|NCT01957787|155810369|FG000|Overall Study|Entered Hospice or Similar Program|2|||
48443473|NCT01957787|155810369|FG000|Overall Study|Index Tumor(s) Resected|2|||
48443474|NCT01957787|155810369|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
48443475|NCT01957787|155810369|FG000|Overall Study|Local therapy, not cryoablation|6|||
48443476|NCT04176445|155810375|FG000|Overall Study|Adverse Event|0|||
48443477|NCT04176445|155810376|FG001|Overall Study|Adverse Event|1|||
48443478|NCT04176445|155810375|FG000|Overall Study|change plans weaning after first intervention|0|||
48443479|NCT04176445|155810376|FG001|Overall Study|change plans weaning after first intervention|1|||
48443480|NCT00187889|155810377|FG000|Overall Study|Withdrawal by Subject|6|||
48443481|NCT00187889|155810378|FG001|Overall Study|Withdrawal by Subject|4|||
48443482|NCT04046341|155810381|FG000|Overall Study|Lost to Follow-up|2|||
48443483|NCT04046341|155810381|FG000|Overall Study|Withdrawal by Subject|1|||
48443484|NCT02887859|155810386|FG000|Overall Study|Ongoing|6|||
48443485|NCT02887859|155810386|FG000|Overall Study|Adverse Event|7|||
48443486|NCT02887859|155810386|FG000|Overall Study|Death|1|||
48443487|NCT02887859|155810386|FG000|Overall Study|Physician Decision|1|||
48443488|NCT04377672|155810391|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
48443489|NCT03954444|155810392|FG000|Overall Study|Withdrawal by Subject|5|||
48443490|NCT03954444|155810393|FG001|Overall Study|Withdrawal by Subject|5|||
48443491|NCT03954444|155810394|FG002|Overall Study|Withdrawal by Subject|5|||
48443492|NCT03954444|155810392|FG000|Overall Study|Adverse Event|1|||
48443493|NCT03954444|155810393|FG001|Overall Study|Adverse Event|3|||
48443494|NCT03954444|155810394|FG002|Overall Study|Adverse Event|2|||
48443495|NCT03954444|155810392|FG000|Overall Study|Protocol Violation|0|||
48443496|NCT03954444|155810393|FG001|Overall Study|Protocol Violation|3|||
48443497|NCT03954444|155810394|FG002|Overall Study|Protocol Violation|5|||
48443498|NCT03954444|155810392|FG000|Overall Study|Use of prohibited therapy|1|||
48443499|NCT03954444|155810393|FG001|Overall Study|Use of prohibited therapy|1|||
48443500|NCT03954444|155810394|FG002|Overall Study|Use of prohibited therapy|2|||
48443501|NCT03954444|155810392|FG000|Overall Study|Lost to Follow-up|1|||
48443502|NCT03954444|155810393|FG001|Overall Study|Lost to Follow-up|0|||
48443503|NCT03954444|155810394|FG002|Overall Study|Lost to Follow-up|1|||
48443504|NCT03954444|155810392|FG000|Overall Study|Non-compliant with study drug application|2|||
48443505|NCT03954444|155810393|FG001|Overall Study|Non-compliant with study drug application|2|||
48443506|NCT03954444|155810394|FG002|Overall Study|Non-compliant with study drug application|0|||
48443507|NCT03954444|155810392|FG000|Overall Study|Administrative reasons|0|||
48443508|NCT03954444|155810393|FG001|Overall Study|Administrative reasons|0|||
48443509|NCT03954444|155810394|FG002|Overall Study|Administrative reasons|1|||
48443510|NCT03954444|155810392|FG000|Overall Study|Miscellaneous|3|||
48443511|NCT03954444|155810393|FG001|Overall Study|Miscellaneous|2|||
48443512|NCT03954444|155810394|FG002|Overall Study|Miscellaneous|1|||
48443513|NCT02447458|155810399|FG000|Overall Study|Other|0|||
48443514|NCT02447458|155810400|FG001|Overall Study|Other|0|||
48443515|NCT02447458|155810401|FG002|Overall Study|Other|1|||
48443516|NCT02447458|155810402|FG003|Overall Study|Other|0|||
48443517|NCT02447458|155810403|FG004|Overall Study|Other|0|||
48443518|NCT02447458|155810404|FG005|Overall Study|Other|0|||
48443615|NCT01175213|155812799|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
48443616|NCT01175213|155812800|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
48443617|NCT01175213|155812799|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
48443618|NCT01175213|155812800|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
48443619|NCT01175213|155812799|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
48443620|NCT01175213|155812800|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
48443621|NCT01175213|155812799|FG000|Safety Follow-up|Adverse Event|1|||
48443622|NCT01175213|155812800|FG001|Safety Follow-up|Adverse Event|0|||
48443623|NCT01245764|155812803|FG000|Study Phase A|Other|3|||
48443624|NCT01245764|155812804|FG001|Study Phase A|Other|2|||
48443625|NCT01245764|155812805|FG002|Study Phase A|Other|3|||
48443626|NCT01245764|155812806|FG003|Study Phase A|Other|1|||
48443627|NCT01245764|155812803|FG000|Study Phase A|Protocol Violation|6|||
48443628|NCT01245764|155812804|FG001|Study Phase A|Protocol Violation|3|||
48443629|NCT01245764|155812805|FG002|Study Phase A|Protocol Violation|2|||
48443630|NCT01245764|155812806|FG003|Study Phase A|Protocol Violation|2|||
48443631|NCT01245764|155812803|FG000|Study Phase A|Lost to Follow-up|0|||
48443632|NCT01245764|155812804|FG001|Study Phase A|Lost to Follow-up|0|||
48443633|NCT01245764|155812805|FG002|Study Phase A|Lost to Follow-up|5|||
48443634|NCT01245764|155812806|FG003|Study Phase A|Lost to Follow-up|0|||
48443635|NCT01357980|155812811|FG000|Overall Study|Lack of Efficacy|0|||
48443636|NCT01357980|155812812|FG001|Overall Study|Lack of Efficacy|1|||
48443637|NCT01357980|155812813|FG002|Overall Study|Lack of Efficacy|0|||
48443638|NCT01357980|155812814|FG003|Overall Study|Lack of Efficacy|0|||
48443639|NCT01357980|155812811|FG000|Overall Study|Consent withdrawn|0|||
48443640|NCT01357980|155812812|FG001|Overall Study|Consent withdrawn|0|||
48443641|NCT01357980|155812813|FG002|Overall Study|Consent withdrawn|1|||
48443642|NCT01357980|155812814|FG003|Overall Study|Consent withdrawn|0|||
48443643|NCT00387348|155812815|FG000|Overall Study|Death|1|||
48443644|NCT00387348|155812816|FG001|Overall Study|Death|1|||
48443645|NCT00387348|155812817|FG002|Overall Study|Death|0|||
48443646|NCT00387348|155812815|FG000|Overall Study|Physician Decision|1|||
48443647|NCT00387348|155812816|FG001|Overall Study|Physician Decision|0|||
48443648|NCT00387348|155812817|FG002|Overall Study|Physician Decision|1|||
48443649|NCT00387348|155812815|FG000|Overall Study|Withdrawal by Subject|0|||
48443650|NCT00387348|155812816|FG001|Overall Study|Withdrawal by Subject|2|||
48443651|NCT00387348|155812817|FG002|Overall Study|Withdrawal by Subject|2|||
48443652|NCT00387348|155812815|FG000|Overall Study|Adverse Event|1|||
48443653|NCT00387348|155812816|FG001|Overall Study|Adverse Event|0|||
48443654|NCT00387348|155812817|FG002|Overall Study|Adverse Event|1|||
48443655|NCT00505752|155812818|FG000|Overall Study|Adverse Event|1|||
48443656|NCT00505752|155812819|FG001|Overall Study|Adverse Event|0|||
48443657|NCT00505752|155812820|FG002|Overall Study|Adverse Event|1|||
48443658|NCT00505752|155812821|FG003|Overall Study|Adverse Event|0|||
48443659|NCT00505752|155812818|FG000|Overall Study|Lost to Follow-up|1|||
48443660|NCT00505752|155812819|FG001|Overall Study|Lost to Follow-up|0|||
48443661|NCT00505752|155812820|FG002|Overall Study|Lost to Follow-up|0|||
48443662|NCT00505752|155812821|FG003|Overall Study|Lost to Follow-up|0|||
48443663|NCT00505752|155812818|FG000|Overall Study|Lack of ovarian response|1|||
48443664|NCT00505752|155812819|FG001|Overall Study|Lack of ovarian response|3|||
48443665|NCT00505752|155812820|FG002|Overall Study|Lack of ovarian response|0|||
48443666|NCT00505752|155812821|FG003|Overall Study|Lack of ovarian response|0|||
48443667|NCT00505752|155812818|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48443668|NCT00505752|155812819|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48443669|NCT00505752|155812820|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
48443670|NCT00505752|155812821|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
48443671|NCT00505752|155812818|FG000|Overall Study|No oocytes retrieved|0|||
48443672|NCT00505752|155812819|FG001|Overall Study|No oocytes retrieved|2|||
48443673|NCT00505752|155812820|FG002|Overall Study|No oocytes retrieved|0|||
48443674|NCT00505752|155812821|FG003|Overall Study|No oocytes retrieved|1|||
48443675|NCT00505752|155812818|FG000|Overall Study|No Fertilization|1|||
48443676|NCT00505752|155812819|FG001|Overall Study|No Fertilization|1|||
48443677|NCT00505752|155812820|FG002|Overall Study|No Fertilization|2|||
48443678|NCT00505752|155812821|FG003|Overall Study|No Fertilization|1|||
48443679|NCT00505752|155812818|FG000|Overall Study|All embryos/blastocysts discarded|0|||
48443680|NCT00505752|155812819|FG001|Overall Study|All embryos/blastocysts discarded|0|||
48443681|NCT00505752|155812820|FG002|Overall Study|All embryos/blastocysts discarded|1|||
48443682|NCT00505752|155812821|FG003|Overall Study|All embryos/blastocysts discarded|1|||
48443683|NCT00505752|155812818|FG000|Overall Study|Other|1|||
48443684|NCT00505752|155812819|FG001|Overall Study|Other|2|||
48443685|NCT00505752|155812820|FG002|Overall Study|Other|1|||
48443686|NCT00505752|155812821|FG003|Overall Study|Other|2|||
48443687|NCT01624506|155812824|FG000|Overall Study|Lost to Follow-up|29|||
48443688|NCT01624506|155812825|FG001|Overall Study|Lost to Follow-up|15|||
48443689|NCT01624506|155812824|FG000|Overall Study|Withdrawal by Subject|9|||
48443690|NCT01624506|155812825|FG001|Overall Study|Withdrawal by Subject|2|||
48443691|NCT01624506|155812824|FG000|Overall Study|Death|1|||
48443692|NCT01624506|155812825|FG001|Overall Study|Death|0|||
48443693|NCT01624506|155812824|FG000|Overall Study|LINX explants|23|||
48443725|NCT03943446|155812831|FG001|Overall Study|Withdrawal by Subject|1|||
48443726|NCT03943446|155812832|FG002|Overall Study|Withdrawal by Subject|2|||
48443727|NCT03943446|155812830|FG000|Overall Study|Study Terminated by Sponsor|1|||
48443728|NCT03943446|155812831|FG001|Overall Study|Study Terminated by Sponsor|2|||
48443729|NCT03943446|155812832|FG002|Overall Study|Study Terminated by Sponsor|1|||
48443730|NCT03943446|155812830|FG000|Overall Study|Reason not Specified|5|||
48443731|NCT03943446|155812831|FG001|Overall Study|Reason not Specified|1|||
48443732|NCT03943446|155812832|FG002|Overall Study|Reason not Specified|3|||
48443733|NCT02119026|155812833|FG000|1st-line Treatment|Adverse Event|9|||
48443734|NCT02119026|155812834|FG001|1st-line Treatment|Adverse Event|14|||
48443735|NCT02119026|155812833|FG000|1st-line Treatment|Physician Decision|3|||
48443736|NCT02119026|155812834|FG001|1st-line Treatment|Physician Decision|8|||
48443737|NCT02119026|155812833|FG000|1st-line Treatment|Withdrawal by Subject|4|||
48443738|NCT02119026|155812834|FG001|1st-line Treatment|Withdrawal by Subject|10|||
48443739|NCT02119026|155812833|FG000|1st-line Treatment|Patient condition or compliance|6|||
48443740|NCT02119026|155812834|FG001|1st-line Treatment|Patient condition or compliance|4|||
48443741|NCT02119026|155812833|FG000|1st-line Treatment|Surgery of metastases|2|||
48443742|NCT02119026|155812834|FG001|1st-line Treatment|Surgery of metastases|1|||
48443743|NCT02119026|155812833|FG000|1st-line Treatment|Death|2|||
48443744|NCT02119026|155812834|FG001|1st-line Treatment|Death|1|||
48443745|NCT02119026|155812833|FG000|2nd-line Treatment|Lost to Follow-up|2|||
48443746|NCT02119026|155812834|FG001|2nd-line Treatment|Lost to Follow-up|0|||
48443747|NCT02119026|155812833|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
48443748|NCT02119026|155812834|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
48443749|NCT02119026|155812833|FG000|2nd-line Treatment|Adverse Event|4|||
48443750|NCT02119026|155812834|FG001|2nd-line Treatment|Adverse Event|1|||
48443751|NCT00340834|155812838|FG000|Core Phase of Study|Adverse Event|26|||
48443752|NCT00340834|155812839|FG001|Core Phase of Study|Adverse Event|9|||
48443753|NCT00340834|155812840|FG002|Core Phase of Study|Adverse Event|9|||
48443754|NCT00340834|155812841|FG003|Core Phase of Study|Adverse Event|0|||
48443755|NCT00340834|155812842|FG004|Core Phase of Study|Adverse Event|0|||
48443756|NCT00340834|155812838|FG000|Core Phase of Study|Withdrawal by Subject|11|||
48443757|NCT00340834|155812839|FG001|Core Phase of Study|Withdrawal by Subject|9|||
48443758|NCT00340834|155812840|FG002|Core Phase of Study|Withdrawal by Subject|16|||
48443759|NCT00340834|155812841|FG003|Core Phase of Study|Withdrawal by Subject|0|||
48443760|NCT00340834|155812842|FG004|Core Phase of Study|Withdrawal by Subject|0|||
48443761|NCT00340834|155812838|FG000|Core Phase of Study|Administrative Problems|6|||
48443762|NCT00340834|155812839|FG001|Core Phase of Study|Administrative Problems|2|||
48443763|NCT00340834|155812840|FG002|Core Phase of Study|Administrative Problems|7|||
48443764|NCT00340834|155812841|FG003|Core Phase of Study|Administrative Problems|0|||
48443765|NCT00340834|155812842|FG004|Core Phase of Study|Administrative Problems|0|||
48443766|NCT00340834|155812838|FG000|Core Phase of Study|Lack of Efficacy|3|||
48443767|NCT00340834|155812839|FG001|Core Phase of Study|Lack of Efficacy|3|||
48443768|NCT00340834|155812840|FG002|Core Phase of Study|Lack of Efficacy|7|||
48443769|NCT00340834|155812841|FG003|Core Phase of Study|Lack of Efficacy|0|||
48443770|NCT00340834|155812842|FG004|Core Phase of Study|Lack of Efficacy|0|||
48443771|NCT00340834|155812838|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
48443772|NCT00340834|155812839|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
48443773|NCT00340834|155812840|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
48443774|NCT00340834|155812841|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
48443775|NCT00340834|155812842|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
48443776|NCT00340834|155812838|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
48443777|NCT00340834|155812839|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
48443778|NCT00340834|155812840|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
48443779|NCT00340834|155812841|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
48443780|NCT00340834|155812842|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
48443781|NCT00340834|155812838|FG000|Core Phase of Study|Lost to Follow-up|1|||
48443782|NCT00340834|155812839|FG001|Core Phase of Study|Lost to Follow-up|1|||
48443783|NCT00340834|155812840|FG002|Core Phase of Study|Lost to Follow-up|4|||
48443784|NCT00340834|155812841|FG003|Core Phase of Study|Lost to Follow-up|0|||
48443785|NCT00340834|155812842|FG004|Core Phase of Study|Lost to Follow-up|0|||
48443786|NCT00340834|155812838|FG000|Core Phase of Study|Death|2|||
48443787|NCT00340834|155812839|FG001|Core Phase of Study|Death|0|||
48443788|NCT00340834|155812840|FG002|Core Phase of Study|Death|0|||
48443789|NCT00340834|155812841|FG003|Core Phase of Study|Death|0|||
48443790|NCT00340834|155812842|FG004|Core Phase of Study|Death|0|||
48443791|NCT00340834|155812838|FG000|Core Phase of Study|Protocol Violation|0|||
48443792|NCT00340834|155812839|FG001|Core Phase of Study|Protocol Violation|0|||
48443793|NCT00340834|155812840|FG002|Core Phase of Study|Protocol Violation|2|||
48443794|NCT00340834|155812841|FG003|Core Phase of Study|Protocol Violation|0|||
48443795|NCT00340834|155812842|FG004|Core Phase of Study|Protocol Violation|0|||
48443796|NCT00340834|155812838|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
48443797|NCT00340834|155812839|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
48443798|NCT00340834|155812840|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
48443799|NCT00340834|155812841|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
48443800|NCT00340834|155812842|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
48443801|NCT00340834|155812838|FG000|Extension Phase of Study|Subject withdrew consent|26|||
48443802|NCT00340834|155812839|FG001|Extension Phase of Study|Subject withdrew consent|31|||
48443803|NCT00340834|155812840|FG002|Extension Phase of Study|Subject withdrew consent|0|||
48443804|NCT00340834|155812841|FG003|Extension Phase of Study|Subject withdrew consent|12|||
48443805|NCT00340834|155812842|FG004|Extension Phase of Study|Subject withdrew consent|15|||
48443806|NCT00340834|155812838|FG000|Extension Phase of Study|Adverse Event|21|||
48443807|NCT00340834|155812839|FG001|Extension Phase of Study|Adverse Event|22|||
48443808|NCT00340834|155812840|FG002|Extension Phase of Study|Adverse Event|0|||
48443809|NCT00340834|155812841|FG003|Extension Phase of Study|Adverse Event|19|||
48443810|NCT00340834|155812842|FG004|Extension Phase of Study|Adverse Event|7|||
48443811|NCT00340834|155812838|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
48443812|NCT00340834|155812839|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
48443813|NCT00340834|155812840|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
48443814|NCT00340834|155812841|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
48443815|NCT00340834|155812842|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
48443816|NCT00340834|155812838|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
48443817|NCT00340834|155812839|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
48443818|NCT00340834|155812840|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
48443819|NCT00340834|155812841|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
48443820|NCT00340834|155812842|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
48443821|NCT00340834|155812838|FG000|Extension Phase of Study|Lost to Follow-up|1|||
48443822|NCT00340834|155812839|FG001|Extension Phase of Study|Lost to Follow-up|1|||
48443823|NCT00340834|155812840|FG002|Extension Phase of Study|Lost to Follow-up|0|||
48443824|NCT00340834|155812841|FG003|Extension Phase of Study|Lost to Follow-up|2|||
48443825|NCT00340834|155812842|FG004|Extension Phase of Study|Lost to Follow-up|3|||
48443826|NCT00340834|155812838|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
48443827|NCT00340834|155812839|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
48443828|NCT00340834|155812840|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
48443829|NCT00340834|155812841|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
48443830|NCT00340834|155812842|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
48443831|NCT00340834|155812838|FG000|Extension Phase of Study|Administrative problems|3|||
48443832|NCT00340834|155812839|FG001|Extension Phase of Study|Administrative problems|0|||
48443833|NCT00340834|155812840|FG002|Extension Phase of Study|Administrative problems|0|||
48443834|NCT00340834|155812841|FG003|Extension Phase of Study|Administrative problems|1|||
48443835|NCT00340834|155812842|FG004|Extension Phase of Study|Administrative problems|1|||
48443836|NCT00340834|155812838|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
48443837|NCT00340834|155812839|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
48443838|NCT00340834|155812840|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
48443839|NCT00340834|155812841|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
48443840|NCT00340834|155812842|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
48443841|NCT00340834|155812838|FG000|Extension Phase of Study|Protocol Violation|3|||
48443842|NCT00340834|155812839|FG001|Extension Phase of Study|Protocol Violation|0|||
48443843|NCT00340834|155812840|FG002|Extension Phase of Study|Protocol Violation|0|||
48443844|NCT00340834|155812841|FG003|Extension Phase of Study|Protocol Violation|0|||
48443845|NCT00340834|155812842|FG004|Extension Phase of Study|Protocol Violation|0|||
48443846|NCT00340834|155812838|FG000|Extension Phase of Study|Death|0|||
48443847|NCT00340834|155812839|FG001|Extension Phase of Study|Death|0|||
48443848|NCT00340834|155812840|FG002|Extension Phase of Study|Death|0|||
48443849|NCT00340834|155812841|FG003|Extension Phase of Study|Death|0|||
48443850|NCT00340834|155812842|FG004|Extension Phase of Study|Death|1|||
48443851|NCT00571688|155812843|FG000|Overall Study|Lost to Follow-up|3|||
48443852|NCT00571688|155812844|FG001|Overall Study|Lost to Follow-up|6|||
48443853|NCT00571688|155812843|FG000|Overall Study|subject did not tolerate Consta|1|||
48443854|NCT00571688|155812844|FG001|Overall Study|subject did not tolerate Consta|0|||
48443855|NCT00571688|155812843|FG000|Overall Study|subject moved out of the area|1|||
48443856|NCT00571688|155812844|FG001|Overall Study|subject moved out of the area|0|||
48443857|NCT01194869|155812845|FG000|Overall Study|Disease Progression|2|||
48443858|NCT01194869|155812845|FG000|Overall Study|Toxicity|2|||
48443859|NCT01453998|155812848|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
48443860|NCT01453998|155812849|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
48443861|NCT01453998|155812850|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
48443862|NCT03495453|155812860|FG000|Overall Study|Withdrawal by Subject|0|||
48443863|NCT03495453|155812861|FG001|Overall Study|Withdrawal by Subject|1|||
48443864|NCT00085917|155812862|FG000|Overall Study|Adverse Event|4|||
48443865|NCT00085917|155812863|FG001|Overall Study|Adverse Event|3|||
48443866|NCT00209170|155812864|FG000|Overall Study|Adverse Event|0|||
48443867|NCT00209170|155812865|FG001|Overall Study|Adverse Event|1|||
48443868|NCT00209170|155812864|FG000|Overall Study|Withdrawal by Subject|2|||
48443869|NCT00209170|155812865|FG001|Overall Study|Withdrawal by Subject|1|||
48443870|NCT00209170|155812864|FG000|Overall Study|Lack of Efficacy|0|||
48443871|NCT00209170|155812865|FG001|Overall Study|Lack of Efficacy|1|||
48443872|NCT02022033|155812866|FG000|Overall Study|Physician Decision|1|||
48443873|NCT02806947|155812867|FG000|Overall Study|Withdrawal by Subject|5|||
48443874|NCT02806947|155812868|FG001|Overall Study|Withdrawal by Subject|1|||
48443875|NCT00865189|155812869|FG000|Overall Study|Other|1|||
48443876|NCT00865189|155812870|FG001|Overall Study|Other|2|||
48443877|NCT00865189|155812869|FG000|Overall Study|Death|4|||
48443878|NCT00865189|155812870|FG001|Overall Study|Death|11|||
48443879|NCT00865189|155812869|FG000|Overall Study|Lost to Follow-up|6|||
48443880|NCT00865189|155812870|FG001|Overall Study|Lost to Follow-up|6|||
48443881|NCT00865189|155812869|FG000|Overall Study|Withdrawal by Subject|1|||
48443882|NCT00865189|155812870|FG001|Overall Study|Withdrawal by Subject|0|||
48443883|NCT00118911|155812878|FG000|Overall Study|Withdrawal by Subject|2|||
48443884|NCT00118911|155812879|FG001|Overall Study|Withdrawal by Subject|5|||
48443885|NCT02980692|155812880|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
48443886|NCT02980692|155812881|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
48443887|NCT02980692|155812882|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
48443888|NCT02980692|155812883|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
48443889|NCT02980692|155812884|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
48443890|NCT02980692|155812880|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
48443891|NCT02980692|155812881|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
48443892|NCT02980692|155812882|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
48443893|NCT02980692|155812883|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
48443894|NCT02980692|155812884|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
48443895|NCT02980692|155812880|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
48443896|NCT02980692|155812881|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
48443897|NCT02980692|155812882|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
48443898|NCT02980692|155812883|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
48443899|NCT02980692|155812884|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
48443900|NCT02980692|155812880|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
48443901|NCT02980692|155812881|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
48443902|NCT02980692|155812882|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
48443903|NCT02980692|155812883|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
48443904|NCT02980692|155812884|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
48443905|NCT02980692|155812880|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
48443906|NCT02980692|155812881|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
48443907|NCT02980692|155812882|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
48443908|NCT02980692|155812883|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
48443909|NCT02980692|155812884|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
48443910|NCT02980692|155812880|FG000|Double Blind Placebo Controlled Period|Other|1|||
48443911|NCT02980692|155812881|FG001|Double Blind Placebo Controlled Period|Other|0|||
48443912|NCT02980692|155812882|FG002|Double Blind Placebo Controlled Period|Other|0|||
48443913|NCT02980692|155812883|FG003|Double Blind Placebo Controlled Period|Other|0|||
48443914|NCT02980692|155812884|FG004|Double Blind Placebo Controlled Period|Other|1|||
48443915|NCT02980692|155812880|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
48443916|NCT02980692|155812881|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
48443917|NCT02980692|155812882|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
48443918|NCT02980692|155812883|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
48443919|NCT02980692|155812884|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
48443920|NCT02980692|155812880|FG000|Double-blind Follow-up Period|Adverse Event|0|||
48443921|NCT02980692|155812881|FG001|Double-blind Follow-up Period|Adverse Event|0|||
48443922|NCT02980692|155812882|FG002|Double-blind Follow-up Period|Adverse Event|0|||
48443923|NCT02980692|155812883|FG003|Double-blind Follow-up Period|Adverse Event|1|||
48443924|NCT02980692|155812884|FG004|Double-blind Follow-up Period|Adverse Event|1|||
48443925|NCT02980692|155812880|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
48443926|NCT02980692|155812881|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
48443927|NCT02980692|155812882|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
48443928|NCT02980692|155812883|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
48443929|NCT02980692|155812884|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
48443930|NCT02980692|155812880|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
48443931|NCT02980692|155812881|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
48443932|NCT02980692|155812882|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
48443933|NCT02980692|155812883|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
48444009|NCT03846219|155812930|FG002|Overall Study|Physician Decision|2|||
48443934|NCT02980692|155812884|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
48443935|NCT02980692|155812880|FG000|Double-blind Follow-up Period|Pregnancy|0|||
48443936|NCT02980692|155812881|FG001|Double-blind Follow-up Period|Pregnancy|0|||
48443937|NCT02980692|155812882|FG002|Double-blind Follow-up Period|Pregnancy|1|||
48443938|NCT02980692|155812883|FG003|Double-blind Follow-up Period|Pregnancy|1|||
48443939|NCT02980692|155812884|FG004|Double-blind Follow-up Period|Pregnancy|0|||
48443940|NCT02980692|155812880|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
48443941|NCT02980692|155812881|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
48443942|NCT02980692|155812882|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
48443943|NCT02980692|155812883|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
48443944|NCT02980692|155812884|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
48443945|NCT02980692|155812880|FG000|Double-blind Follow-up Period|Other|0|||
48443946|NCT02980692|155812881|FG001|Double-blind Follow-up Period|Other|0|||
48443947|NCT02980692|155812882|FG002|Double-blind Follow-up Period|Other|1|||
48443948|NCT02980692|155812883|FG003|Double-blind Follow-up Period|Other|1|||
48443949|NCT02980692|155812884|FG004|Double-blind Follow-up Period|Other|3|||
48443950|NCT00792701|155812885|FG000|Overall Study|Adverse Event|0|||
48443951|NCT00792701|155812886|FG001|Overall Study|Adverse Event|22|||
48443952|NCT00792701|155812885|FG000|Overall Study|Ineligible|1|||
48443953|NCT00792701|155812886|FG001|Overall Study|Ineligible|3|||
48443954|NCT00792701|155812885|FG000|Overall Study|Withdrawal by Subject|1|||
48443955|NCT00792701|155812886|FG001|Overall Study|Withdrawal by Subject|19|||
48443956|NCT00792701|155812885|FG000|Overall Study|Not protocol specified|17|||
48443957|NCT00792701|155812886|FG001|Overall Study|Not protocol specified|0|||
48443958|NCT02029638|155812889|FG000|Overall Study|Death|0|||
48443959|NCT02029638|155812890|FG001|Overall Study|Death|0|||
48443960|NCT02029638|155812891|FG002|Overall Study|Death|1|||
48443961|NCT02029638|155812889|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
48443962|NCT02029638|155812890|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
48443963|NCT02029638|155812891|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
48443964|NCT01153841|155812894|FG000|Overall Study|Adverse Event|1|||
48443965|NCT01153841|155812895|FG001|Overall Study|Adverse Event|0|||
48443966|NCT01153841|155812894|FG000|Overall Study|Withdrawal by Subject|1|||
48443967|NCT01153841|155812895|FG001|Overall Study|Withdrawal by Subject|0|||
48443968|NCT01153841|155812894|FG000|Overall Study|Protocol Violation|2|||
48443969|NCT01153841|155812895|FG001|Overall Study|Protocol Violation|0|||
48443970|NCT01153841|155812894|FG000|Overall Study|Lost to Follow-up|2|||
48443971|NCT01153841|155812895|FG001|Overall Study|Lost to Follow-up|0|||
48443972|NCT00691093|155812896|FG000|Overall Study|Adverse Event|1|||
48443973|NCT00691093|155812896|FG000|Overall Study|Lost to Follow-up|1|||
48443974|NCT00691093|155812896|FG000|Overall Study|Lack of Efficacy|1|||
48443975|NCT00691093|155812896|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
48443976|NCT01838590|155812908|FG000|Overall Study|Lack of Efficacy|12|||
48443977|NCT01838590|155812909|FG001|Overall Study|Lack of Efficacy|4|||
48443978|NCT01838590|155812908|FG000|Overall Study|Lost to Follow-up|0|||
48443979|NCT01838590|155812909|FG001|Overall Study|Lost to Follow-up|1|||
48443980|NCT02133742|155812912|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
48443981|NCT02133742|155812912|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
48443982|NCT02133742|155812912|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
48443983|NCT02133742|155812912|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
48443984|NCT02133742|155812912|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
48443985|NCT00435994|155812914|FG000|Overall Study|Lost to Follow-up|7|||
48443986|NCT00435994|155812915|FG001|Overall Study|Lost to Follow-up|0|||
48443987|NCT00435994|155812916|FG002|Overall Study|Lost to Follow-up|0|||
48443988|NCT03505749|155812917|FG000|Overall Study|Lost to Follow-up|7|||
48443989|NCT03505749|155812918|FG001|Overall Study|Lost to Follow-up|11|||
48443990|NCT03505749|155812917|FG000|Overall Study|Withdrawal by Subject|6|||
48443991|NCT03505749|155812918|FG001|Overall Study|Withdrawal by Subject|0|||
48443992|NCT03505749|155812917|FG000|Overall Study|Discharged from treatment|3|||
48443993|NCT03505749|155812918|FG001|Overall Study|Discharged from treatment|6|||
48443994|NCT01151540|155812919|FG000|Overall Study|Other|2|||
48443995|NCT01151540|155812919|FG000|Overall Study|Adverse event, non-fatal|4|||
48443996|NCT01151540|155812919|FG000|Overall Study|Withdrawal by Subject|7|||
48443997|NCT03479216|155812922|FG000|Overall Study|Withdrawal by Subject|3|||
48443998|NCT03479216|155812923|FG001|Overall Study|Withdrawal by Subject|2|||
48443999|NCT03479216|155812922|FG000|Overall Study|Physician Decision|2|||
48444000|NCT03479216|155812923|FG001|Overall Study|Physician Decision|3|||
48444001|NCT03846219|155812928|FG000|Overall Study|Withdrawal by Subject|3|||
48444002|NCT03846219|155812929|FG001|Overall Study|Withdrawal by Subject|2|||
48444003|NCT03846219|155812930|FG002|Overall Study|Withdrawal by Subject|2|||
48444004|NCT03846219|155812928|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
48444005|NCT03846219|155812929|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
48444006|NCT03846219|155812930|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
48444007|NCT03846219|155812928|FG000|Overall Study|Physician Decision|0|||
48444008|NCT03846219|155812929|FG001|Overall Study|Physician Decision|0|||
48444080|NCT01392378|155812951|FG000|After Infant Series|Lost to Follow-up|0|||
48444081|NCT01392378|155812952|FG001|After Infant Series|Lost to Follow-up|0|||
48444082|NCT01392378|155812953|FG002|After Infant Series|Lost to Follow-up|1|||
48444083|NCT01392378|155812954|FG003|After Infant Series|Lost to Follow-up|0|||
48444084|NCT01392378|155812955|FG004|After Infant Series|Lost to Follow-up|0|||
48444085|NCT01392378|155812951|FG000|After Infant Series|Withdrawal by Parent|0|||
48444086|NCT01392378|155812952|FG001|After Infant Series|Withdrawal by Parent|1|||
48444087|NCT01392378|155812953|FG002|After Infant Series|Withdrawal by Parent|1|||
48444088|NCT01392378|155812954|FG003|After Infant Series|Withdrawal by Parent|0|||
48444089|NCT01392378|155812955|FG004|After Infant Series|Withdrawal by Parent|1|||
48444090|NCT01392378|155812951|FG000|Toddler Dose|Lost to Follow-up|0|||
48444091|NCT01392378|155812952|FG001|Toddler Dose|Lost to Follow-up|0|||
48444092|NCT01392378|155812953|FG002|Toddler Dose|Lost to Follow-up|0|||
48444093|NCT01392378|155812954|FG003|Toddler Dose|Lost to Follow-up|1|||
48444094|NCT01392378|155812955|FG004|Toddler Dose|Lost to Follow-up|0|||
48444095|NCT01392378|155812951|FG000|Toddler Dose|Withdrawal by Parent|0|||
48444096|NCT01392378|155812952|FG001|Toddler Dose|Withdrawal by Parent|1|||
48444097|NCT01392378|155812953|FG002|Toddler Dose|Withdrawal by Parent|0|||
48444098|NCT01392378|155812954|FG003|Toddler Dose|Withdrawal by Parent|1|||
48444099|NCT01392378|155812955|FG004|Toddler Dose|Withdrawal by Parent|1|||
48444100|NCT02322411|155812958|FG000|Overall Study|Lost to Follow-up|4|||
48444101|NCT02322411|155812959|FG001|Overall Study|Lost to Follow-up|7|||
48444102|NCT02322411|155812958|FG000|Overall Study|Withdrawal by Subject|1|||
48444103|NCT02322411|155812959|FG001|Overall Study|Withdrawal by Subject|0|||
48444104|NCT00788697|155812967|FG000|Overall Study|No study drug administered|12|||
48444105|NCT00788697|155812967|FG000|Overall Study|Training Patients|74|||
48444106|NCT00788697|155812967|FG000|Overall Study|no truth standard procedure available|5|||
48444107|NCT00788697|155812967|FG000|Overall Study|Technically inadequate truth standard|1|||
48444108|NCT00788697|155812967|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
48444109|NCT02810951|155812968|FG000|Overall Study|Adverse Event|1|||
48444110|NCT01998880|155812970|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
48444111|NCT01998880|155812971|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
48444112|NCT01998880|155812970|FG000|Overall Study|Disease Progression|1|||
48444113|NCT01998880|155812971|FG001|Overall Study|Disease Progression|8|||
48444114|NCT01998880|155812970|FG000|Overall Study|Withdrew Consent|2|||
48444115|NCT01998880|155812971|FG001|Overall Study|Withdrew Consent|1|||
48444116|NCT01998880|155812970|FG000|Overall Study|Death|3|||
48444117|NCT01998880|155812971|FG001|Overall Study|Death|6|||
48444118|NCT01998880|155812970|FG000|Overall Study|Insufficient Therapeutic Response|1|||
48444119|NCT01998880|155812971|FG001|Overall Study|Insufficient Therapeutic Response|5|||
48444120|NCT01998880|155812970|FG000|Overall Study|Administrative/Other|1|||
48444121|NCT01998880|155812971|FG001|Overall Study|Administrative/Other|1|||
48444122|NCT01998880|155812970|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
48444123|NCT01998880|155812971|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
48444124|NCT01998880|155812970|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
48444125|NCT01998880|155812971|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
48444126|NCT01998880|155812970|FG000|Overall Study|Did Not Receive Treatment|3|||
48444127|NCT01998880|155812971|FG001|Overall Study|Did Not Receive Treatment|2|||
48444128|NCT03627494|155812972|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
48444129|NCT03627494|155812973|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444130|NCT03627494|155812974|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
48444131|NCT03627494|155812975|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444132|NCT03627494|155812976|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444133|NCT03627494|155812977|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444134|NCT03627494|155812978|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444135|NCT03627494|155812979|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444136|NCT03627494|155812980|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444137|NCT03627494|155812981|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444138|NCT03627494|155812982|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444139|NCT03627494|155812983|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
48444140|NCT03627494|155812972|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444141|NCT03627494|155812973|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444142|NCT03627494|155812974|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444143|NCT03627494|155812975|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444144|NCT03627494|155812976|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444145|NCT03627494|155812977|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444146|NCT03627494|155812978|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444147|NCT03627494|155812979|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444148|NCT03627494|155812980|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
48444149|NCT03627494|155812981|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444150|NCT03627494|155812982|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444151|NCT03627494|155812983|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
48444152|NCT03627494|155812972|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444153|NCT03627494|155812973|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444154|NCT03627494|155812974|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444232|NCT01281189|155815019|FG000|Overall Study|Other|8|||
48444155|NCT03627494|155812975|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444156|NCT03627494|155812976|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444157|NCT03627494|155812977|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444158|NCT03627494|155812978|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444159|NCT03627494|155812979|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444160|NCT03627494|155812980|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444161|NCT03627494|155812981|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
48444162|NCT03627494|155812982|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
48444163|NCT03627494|155812983|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
48444164|NCT01419080|155812984|FG000|Overall Study|Withdrawal by Subject|75|||
48444165|NCT01419080|155812984|FG000|Overall Study|Death|30|||
48444166|NCT01419080|155812984|FG000|Overall Study|Lost to Follow-up|23|||
48444167|NCT01419080|155812984|FG000|Overall Study|Too Ill|3|||
48444168|NCT03199638|155812985|FG000|Overall Study|inability to drink glutamine during regularly|0|||
48444169|NCT03199638|155812986|FG001|Overall Study|inability to drink glutamine during regularly|2|||
48444170|NCT00453180|155814981|FG000|Overall Study|Lost to Follow-up|2|||
48444171|NCT00453180|155814982|FG001|Overall Study|Lost to Follow-up|1|||
48444172|NCT00453180|155814981|FG000|Overall Study|Adverse Event|1|||
48444173|NCT00453180|155814982|FG001|Overall Study|Adverse Event|2|||
48444174|NCT01747811|155814983|FG000|Overall Study|Lack of Efficacy|2|||
48444175|NCT01747811|155814984|FG001|Overall Study|Lack of Efficacy|4|||
48444176|NCT00949910|155814986|FG000|Overall Study|Progressive Disease|3750|||
48444177|NCT00949910|155814986|FG000|Overall Study|Symptomatic Deterioration|1088|||
48444178|NCT00949910|155814986|FG000|Overall Study|Lost to Follow-up|100|||
48444179|NCT00949910|155814986|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
48444180|NCT00949910|155814986|FG000|Overall Study|Participant Refusal|390|||
48444181|NCT00949910|155814986|FG000|Overall Study|Death Due to Malignant Disease|456|||
48444182|NCT00949910|155814986|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
48444183|NCT00949910|155814986|FG000|Overall Study|Death Due to Adverse Event|115|||
48444184|NCT00949910|155814986|FG000|Overall Study|Death Due to Toxicity|3|||
48444185|NCT00949910|155814986|FG000|Overall Study|Death from Unknown Cause|5|||
48444186|NCT00949910|155814986|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
48444187|NCT00949910|155814986|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
48444188|NCT00949910|155814986|FG000|Overall Study|Switched to Commercial Treatment|4|||
48444189|NCT00949910|155814986|FG000|Overall Study|Violation of Eligibility|23|||
48444190|NCT00949910|155814986|FG000|Overall Study|Logistical Reasons|13|||
48444191|NCT00949910|155814986|FG000|Overall Study|Non-Compliance|10|||
48444192|NCT00949910|155814986|FG000|Overall Study|Prolonged Dosing Interruption|4|||
48444193|NCT00949910|155814986|FG000|Overall Study|Adverse Event|83|||
48444194|NCT00949910|155814986|FG000|Overall Study|Serious Adverse Event|6|||
48444195|NCT00949910|155814986|FG000|Overall Study|Physician/Participant Decision|7|||
48444196|NCT00949910|155814986|FG000|Overall Study|Other|4|||
48444197|NCT00949910|155814986|FG000|Overall Study|No Data|9|||
48444198|NCT03097614|155814997|FG000|Overall Study|Adverse Event|3|||
48444199|NCT01830816|155815001|FG000|Overall Study|Progressive Disease|12|||
48444200|NCT01830816|155815002|FG001|Overall Study|Progressive Disease|7|||
48444201|NCT01830816|155815003|FG002|Overall Study|Progressive Disease|7|||
48444202|NCT01830816|155815001|FG000|Overall Study|Adverse Event|3|||
48444203|NCT01830816|155815002|FG001|Overall Study|Adverse Event|4|||
48444204|NCT01830816|155815003|FG002|Overall Study|Adverse Event|0|||
48444205|NCT01830816|155815001|FG000|Overall Study|Study Terminated by Sponsor|1|||
48444206|NCT01830816|155815002|FG001|Overall Study|Study Terminated by Sponsor|1|||
48444207|NCT01830816|155815003|FG002|Overall Study|Study Terminated by Sponsor|0|||
48444208|NCT01830816|155815001|FG000|Overall Study|Withdrawal by Subject|1|||
48444209|NCT01830816|155815002|FG001|Overall Study|Withdrawal by Subject|1|||
48444210|NCT01830816|155815003|FG002|Overall Study|Withdrawal by Subject|0|||
48444211|NCT01830816|155815001|FG000|Overall Study|Lost to Follow-up|0|||
48444212|NCT01830816|155815002|FG001|Overall Study|Lost to Follow-up|1|||
48444213|NCT01830816|155815003|FG002|Overall Study|Lost to Follow-up|0|||
48444214|NCT01830816|155815001|FG000|Overall Study|Symptomatic Deterioration|1|||
48444215|NCT01830816|155815002|FG001|Overall Study|Symptomatic Deterioration|0|||
48444216|NCT01830816|155815003|FG002|Overall Study|Symptomatic Deterioration|0|||
48444217|NCT01830816|155815001|FG000|Overall Study|Reason not Specified|2|||
48444218|NCT01830816|155815002|FG001|Overall Study|Reason not Specified|0|||
48444219|NCT01830816|155815003|FG002|Overall Study|Reason not Specified|0|||
48444220|NCT03172481|155815004|FG000|Double-blind|Withdrawal by Subject|1|||
48444221|NCT03172481|155815005|FG001|Double-blind|Withdrawal by Subject|0|||
48444222|NCT01281189|155815019|FG000|Overall Study|Adverse Event|7|||
48444223|NCT01281189|155815020|FG001|Overall Study|Adverse Event|9|||
48444224|NCT01281189|155815019|FG000|Overall Study|Lost to Follow-up|6|||
48444225|NCT01281189|155815020|FG001|Overall Study|Lost to Follow-up|4|||
48444226|NCT01281189|155815019|FG000|Overall Study|Withdrawal by Subject|21|||
48444227|NCT01281189|155815020|FG001|Overall Study|Withdrawal by Subject|24|||
48444228|NCT01281189|155815019|FG000|Overall Study|Physician Decision|2|||
48444229|NCT01281189|155815020|FG001|Overall Study|Physician Decision|3|||
48444230|NCT01281189|155815019|FG000|Overall Study|Death|103|||
48444231|NCT01281189|155815020|FG001|Overall Study|Death|91|||
48444352|NCT01335698|155815074|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
48444353|NCT01335698|155815070|FG000|Treatment Stage 1|No longer meets study criteria|1|||
48444354|NCT01335698|155815071|FG001|Treatment Stage 1|No longer meets study criteria|1|||
48444355|NCT01335698|155815072|FG002|Treatment Stage 1|No longer meets study criteria|0|||
48444356|NCT01335698|155815073|FG003|Treatment Stage 1|No longer meets study criteria|1|||
48444357|NCT01335698|155815074|FG004|Treatment Stage 1|No longer meets study criteria|0|||
48444358|NCT01335698|155815070|FG000|Treatment Stage 1|Other|1|||
48444359|NCT01335698|155815071|FG001|Treatment Stage 1|Other|0|||
48444360|NCT01335698|155815072|FG002|Treatment Stage 1|Other|0|||
48444361|NCT01335698|155815073|FG003|Treatment Stage 1|Other|1|||
48444362|NCT01335698|155815074|FG004|Treatment Stage 1|Other|0|||
48444363|NCT01335698|155815070|FG000|Treatment Stage 2|Lack of Efficacy|2|||
48444364|NCT01335698|155815071|FG001|Treatment Stage 2|Lack of Efficacy|1|||
48444365|NCT01335698|155815072|FG002|Treatment Stage 2|Lack of Efficacy|3|||
48444366|NCT01335698|155815073|FG003|Treatment Stage 2|Lack of Efficacy|1|||
48444367|NCT01335698|155815074|FG004|Treatment Stage 2|Lack of Efficacy|0|||
48444368|NCT01335698|155815070|FG000|Treatment Stage 2|Adverse Event|2|||
48444369|NCT01335698|155815071|FG001|Treatment Stage 2|Adverse Event|0|||
48444370|NCT01335698|155815072|FG002|Treatment Stage 2|Adverse Event|0|||
48444371|NCT01335698|155815073|FG003|Treatment Stage 2|Adverse Event|3|||
48444372|NCT01335698|155815074|FG004|Treatment Stage 2|Adverse Event|0|||
48444373|NCT01335698|155815070|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
48444374|NCT01335698|155815071|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
48444375|NCT01335698|155815072|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
48444376|NCT01335698|155815073|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
48444377|NCT01335698|155815074|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
48444378|NCT01335698|155815070|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
48444379|NCT01335698|155815071|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
48444380|NCT01335698|155815072|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
48444381|NCT01335698|155815073|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
48444382|NCT01335698|155815074|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
48444383|NCT01335698|155815070|FG000|Treatment Stage 2|Lost to Follow-up|1|||
48444384|NCT01335698|155815071|FG001|Treatment Stage 2|Lost to Follow-up|0|||
48444385|NCT01335698|155815072|FG002|Treatment Stage 2|Lost to Follow-up|0|||
48444386|NCT01335698|155815073|FG003|Treatment Stage 2|Lost to Follow-up|0|||
48444387|NCT01335698|155815074|FG004|Treatment Stage 2|Lost to Follow-up|0|||
48444388|NCT01335698|155815070|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
48444389|NCT01335698|155815071|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
48444390|NCT01335698|155815072|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
48444391|NCT01335698|155815073|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
48444392|NCT01335698|155815074|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
48444393|NCT01335698|155815070|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
48444394|NCT01335698|155815071|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
48444395|NCT01335698|155815072|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
48444396|NCT01335698|155815073|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
48444397|NCT01335698|155815074|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
48444398|NCT01335698|155815070|FG000|Treatment Stage 2|Switched to another formulation|1|||
48444399|NCT01335698|155815071|FG001|Treatment Stage 2|Switched to another formulation|1|||
48444400|NCT01335698|155815072|FG002|Treatment Stage 2|Switched to another formulation|0|||
48444401|NCT01335698|155815073|FG003|Treatment Stage 2|Switched to another formulation|0|||
48444402|NCT01335698|155815074|FG004|Treatment Stage 2|Switched to another formulation|0|||
48444403|NCT02248857|155815075|FG000|3 Month|Withdrawal by Subject|9|||
48444404|NCT02248857|155815076|FG001|3 Month|Withdrawal by Subject|3|||
48444405|NCT02248857|155815077|FG002|3 Month|Withdrawal by Subject|4|||
48444406|NCT02248857|155815075|FG000|3 Month|Unable to reach for 3 month|35|||
48444407|NCT02248857|155815076|FG001|3 Month|Unable to reach for 3 month|29|||
48444408|NCT02248857|155815077|FG002|3 Month|Unable to reach for 3 month|26|||
48444409|NCT02248857|155815075|FG000|3 Month|Partially completed, unable to finish|2|||
48444410|NCT02248857|155815076|FG001|3 Month|Partially completed, unable to finish|2|||
48444411|NCT02248857|155815077|FG002|3 Month|Partially completed, unable to finish|1|||
48444412|NCT02248857|155815075|FG000|6 Month|Lost to Follow-up|27|||
48444413|NCT02248857|155815076|FG001|6 Month|Lost to Follow-up|26|||
48444414|NCT02248857|155815077|FG002|6 Month|Lost to Follow-up|15|||
48444415|NCT02248857|155815075|FG000|6 Month|Partially completed, unable to finish|0|||
48444416|NCT02248857|155815076|FG001|6 Month|Partially completed, unable to finish|1|||
48444417|NCT02248857|155815077|FG002|6 Month|Partially completed, unable to finish|0|||
48444418|NCT02248857|155815075|FG000|6 Month|Withdrawal by Subject|0|||
48444419|NCT02248857|155815076|FG001|6 Month|Withdrawal by Subject|2|||
48444420|NCT02248857|155815077|FG002|6 Month|Withdrawal by Subject|2|||
48444421|NCT02248857|155815075|FG000|6 Month|Death|1|||
48444422|NCT02248857|155815076|FG001|6 Month|Death|0|||
48444423|NCT02248857|155815077|FG002|6 Month|Death|0|||
48444424|NCT03700736|155815083|FG000|Overall Study|Pregnancy|1|||
48444425|NCT03700736|155815084|FG001|Overall Study|Pregnancy|1|||
48444426|NCT03700736|155815083|FG000|Overall Study|Withdrawal by Subject|2|||
48444427|NCT03700736|155815084|FG001|Overall Study|Withdrawal by Subject|6|||
48444428|NCT01255306|155815085|FG000|Overall Study|Physician Decision|1|||
48444429|NCT01255306|155815086|FG001|Overall Study|Physician Decision|1|||
48444430|NCT01575899|155815087|FG000|Overall Study|Lost to Follow-up|3|||
48444431|NCT01575899|155815088|FG001|Overall Study|Lost to Follow-up|4|||
48444432|NCT01575899|155815089|FG002|Overall Study|Lost to Follow-up|2|||
48444433|NCT01575899|155815087|FG000|Overall Study|Protocol Violation|2|||
48444434|NCT01575899|155815088|FG001|Overall Study|Protocol Violation|1|||
48444435|NCT01575899|155815089|FG002|Overall Study|Protocol Violation|0|||
48444436|NCT02671461|155815090|FG000|Treatment|Adverse Event|0|||
48444437|NCT02671461|155815091|FG001|Treatment|Adverse Event|0|||
48444438|NCT02671461|155815092|FG002|Treatment|Adverse Event|1|||
48444439|NCT02671461|155815090|FG000|Treatment|Administrative Reason by Sponsor|1|||
48444440|NCT02671461|155815091|FG001|Treatment|Administrative Reason by Sponsor|3|||
48444441|NCT02671461|155815092|FG002|Treatment|Administrative Reason by Sponsor|4|||
48444442|NCT02671461|155815090|FG000|Treatment|Randomized, not treated|1|||
48444443|NCT02671461|155815091|FG001|Treatment|Randomized, not treated|0|||
48444444|NCT02671461|155815092|FG002|Treatment|Randomized, not treated|0|||
48444445|NCT02671461|155815090|FG000|Follow-up|Withdrawal by Subject|1|||
48444446|NCT02671461|155815091|FG001|Follow-up|Withdrawal by Subject|0|||
48444447|NCT02671461|155815092|FG002|Follow-up|Withdrawal by Subject|0|||
48444448|NCT02671461|155815090|FG000|Follow-up|Lost to Follow-up|0|||
48444449|NCT02671461|155815091|FG001|Follow-up|Lost to Follow-up|0|||
48444450|NCT02671461|155815092|FG002|Follow-up|Lost to Follow-up|1|||
48444451|NCT02671461|155815090|FG000|Follow-up|Administrative Reason by Sponsor|0|||
48444452|NCT02671461|155815091|FG001|Follow-up|Administrative Reason by Sponsor|1|||
48444453|NCT02671461|155815092|FG002|Follow-up|Administrative Reason by Sponsor|0|||
48444454|NCT02261883|155815093|FG000|Overall Study|Death|3|||
48444455|NCT02261883|155815094|FG001|Overall Study|Death|2|||
48444456|NCT02261883|155815093|FG000|Overall Study|Physician Decision|1|||
48444457|NCT02261883|155815094|FG001|Overall Study|Physician Decision|0|||
48444458|NCT02261883|155815093|FG000|Overall Study|Protocol Violation|1|||
48444459|NCT02261883|155815094|FG001|Overall Study|Protocol Violation|0|||
48444460|NCT02261883|155815093|FG000|Overall Study|Withdrawal by Subject|0|||
48444461|NCT02261883|155815094|FG001|Overall Study|Withdrawal by Subject|1|||
48444462|NCT02261883|155815093|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
48444463|NCT02261883|155815094|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
48444464|NCT03097029|155815097|FG000|Overall Study|Withdrawal by Subject|1|||
48444465|NCT01626989|155815098|FG000|Screening Period|Screen Failure|15|||
48444466|NCT01626989|155815099|FG001|Screening Period|Screen Failure|0|||
48444467|NCT01626989|155815100|FG002|Screening Period|Screen Failure|0|||
48444468|NCT01626989|155815098|FG000|Screening Period|Withdrawal by Subject|2|||
48444469|NCT01626989|155815099|FG001|Screening Period|Withdrawal by Subject|0|||
48444470|NCT01626989|155815100|FG002|Screening Period|Withdrawal by Subject|0|||
48444471|NCT01412060|155815101|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
48444472|NCT01412060|155815102|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
48444473|NCT01412060|155815103|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
48444474|NCT01412060|155815101|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
48444475|NCT01412060|155815102|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
48444476|NCT01412060|155815103|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
48444477|NCT01412060|155815101|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
48444478|NCT01412060|155815102|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
48444479|NCT01412060|155815103|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
48444480|NCT01412060|155815101|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
48444481|NCT01412060|155815102|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
48444482|NCT01412060|155815103|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
48444483|NCT01412060|155815101|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
48444484|NCT01412060|155815102|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
48444485|NCT01412060|155815103|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
48444486|NCT01412060|155815101|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
48444487|NCT01412060|155815102|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
48444488|NCT01412060|155815103|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
48444489|NCT01412060|155815101|FG000|Period Between RIP and SP|Adverse Event|4|||
48444490|NCT01412060|155815102|FG001|Period Between RIP and SP|Adverse Event|0|||
48444491|NCT01412060|155815103|FG002|Period Between RIP and SP|Adverse Event|0|||
48444492|NCT01412060|155815101|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
48444493|NCT01412060|155815102|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
48444494|NCT01412060|155815103|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
48444495|NCT01412060|155815101|FG000|Period Between RIP and SP|Protocol Violation|2|||
48444496|NCT01412060|155815102|FG001|Period Between RIP and SP|Protocol Violation|0|||
48444497|NCT01412060|155815103|FG002|Period Between RIP and SP|Protocol Violation|0|||
48444498|NCT01412060|155815101|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
48444499|NCT01412060|155815102|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
48444500|NCT01412060|155815103|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
48444501|NCT01412060|155815101|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
48444502|NCT01412060|155815102|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
48444503|NCT01412060|155815103|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
48444504|NCT01412060|155815101|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
48444505|NCT01412060|155815102|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
48444506|NCT01412060|155815103|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
48444507|NCT01412060|155815101|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
48444508|NCT01412060|155815102|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
48444509|NCT01412060|155815103|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
48444510|NCT01412060|155815101|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
48444511|NCT01412060|155815102|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
48444512|NCT01412060|155815103|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
48444513|NCT01412060|155815101|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
48444514|NCT01412060|155815102|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
48444515|NCT01412060|155815103|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
48444516|NCT01412060|155815101|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
48444517|NCT01412060|155815102|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
48444518|NCT01412060|155815103|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
48444519|NCT01412060|155815101|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
48444520|NCT01412060|155815102|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
48444521|NCT01412060|155815103|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
48444522|NCT01412060|155815101|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
48444523|NCT01412060|155815102|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
48444524|NCT01412060|155815103|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
48444525|NCT01412060|155815101|FG000|Period Between SP and DBP|Protocol Violation|2|||
48444526|NCT01412060|155815102|FG001|Period Between SP and DBP|Protocol Violation|0|||
48444527|NCT01412060|155815103|FG002|Period Between SP and DBP|Protocol Violation|0|||
48444528|NCT01412060|155815101|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
48444529|NCT01412060|155815102|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
48444530|NCT01412060|155815103|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
48444531|NCT01412060|155815101|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
48444532|NCT01412060|155815102|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
48444533|NCT01412060|155815103|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
48444534|NCT01412060|155815101|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
48444535|NCT01412060|155815102|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
48444536|NCT01412060|155815103|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
48444537|NCT01412060|155815101|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
48444538|NCT01412060|155815102|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
48444539|NCT01412060|155815103|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
48444540|NCT01412060|155815101|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
48444541|NCT01412060|155815102|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
48444542|NCT01412060|155815103|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
48444543|NCT01412060|155815101|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
48444544|NCT01412060|155815102|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
48444545|NCT01412060|155815103|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
48444546|NCT01412060|155815101|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
48444547|NCT01412060|155815102|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
48444548|NCT01412060|155815103|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
48444549|NCT01412060|155815101|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
48444550|NCT01412060|155815102|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
48444551|NCT01412060|155815103|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
48444552|NCT01412060|155815101|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
48444553|NCT01412060|155815102|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
48444554|NCT01412060|155815103|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
48444555|NCT01412060|155815101|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
48444556|NCT01412060|155815102|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
48444557|NCT01412060|155815103|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
48444558|NCT02807844|155815104|FG000|Overall Study|Physician Decision|0|||
48444559|NCT02807844|155815105|FG001|Overall Study|Physician Decision|0|||
48444560|NCT02807844|155815106|FG002|Overall Study|Physician Decision|0|||
48444561|NCT02807844|155815107|FG003|Overall Study|Physician Decision|0|||
48444562|NCT02807844|155815108|FG004|Overall Study|Physician Decision|0|||
48444563|NCT02807844|155815109|FG005|Overall Study|Physician Decision|0|||
48444564|NCT02807844|155815110|FG006|Overall Study|Physician Decision|3|||
48444565|NCT02807844|155815111|FG007|Overall Study|Physician Decision|0|||
48444566|NCT02807844|155815112|FG008|Overall Study|Physician Decision|1|||
48444699|NCT02999100|155815154|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48444700|NCT02999100|155815155|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
48444701|NCT02999100|155815156|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48444702|NCT02999100|155815157|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48444703|NCT02999100|155815158|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
48444704|NCT00369967|155816923|FG000|Overall Study|Lost to Follow-up|23|||
48444705|NCT00369967|155816924|FG001|Overall Study|Lost to Follow-up|12|||
48444706|NCT00804843|155816928|FG000|Overall Study|Protocol Violation|1|||
48444707|NCT00804843|155816929|FG001|Overall Study|Protocol Violation|0|||
48444708|NCT00804843|155816928|FG000|Overall Study|Adverse Event|8|||
48444709|NCT00804843|155816929|FG001|Overall Study|Adverse Event|5|||
48444710|NCT00804843|155816928|FG000|Overall Study|Withdrawal by Subject|1|||
48444711|NCT00804843|155816929|FG001|Overall Study|Withdrawal by Subject|2|||
48444712|NCT00884221|155816930|FG000|Overall Study|Withdrawal by Subject|0|||
48444713|NCT00884221|155816931|FG001|Overall Study|Withdrawal by Subject|3|||
48444714|NCT00884221|155816930|FG000|Overall Study|Adverse Event|6|||
48444715|NCT00884221|155816931|FG001|Overall Study|Adverse Event|3|||
48444716|NCT00884221|155816930|FG000|Overall Study|Protocol Violation|16|||
48444717|NCT00884221|155816931|FG001|Overall Study|Protocol Violation|13|||
48444718|NCT00884221|155816930|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
48444719|NCT00884221|155816931|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
48444720|NCT01824693|155816932|FG000|Overall Study|Death|0|||
48444721|NCT01824693|155816933|FG001|Overall Study|Death|1|||
48444722|NCT01824693|155816934|FG002|Overall Study|Death|0|||
48444723|NCT01824693|155816932|FG000|Overall Study|Physician Decision|1|||
48444724|NCT01824693|155816933|FG001|Overall Study|Physician Decision|1|||
48444725|NCT01824693|155816934|FG002|Overall Study|Physician Decision|1|||
48444726|NCT01824693|155816932|FG000|Overall Study|Withdrawal by Subject|0|||
48444727|NCT01824693|155816933|FG001|Overall Study|Withdrawal by Subject|0|||
48444728|NCT01824693|155816934|FG002|Overall Study|Withdrawal by Subject|1|||
48444729|NCT01824693|155816932|FG000|Overall Study|Progressive Disease|0|||
48444730|NCT01824693|155816933|FG001|Overall Study|Progressive Disease|5|||
48444731|NCT01824693|155816934|FG002|Overall Study|Progressive Disease|0|||
48444732|NCT01824693|155816932|FG000|Overall Study|Ineligible|0|||
48444733|NCT01824693|155816933|FG001|Overall Study|Ineligible|0|||
48444734|NCT01824693|155816934|FG002|Overall Study|Ineligible|3|||
48444735|NCT01824693|155816932|FG000|Overall Study|No Transplant Planned|0|||
48444736|NCT01824693|155816933|FG001|Overall Study|No Transplant Planned|0|||
48444737|NCT01824693|155816934|FG002|Overall Study|No Transplant Planned|10|||
48444738|NCT00003476|155816935|FG000|Overall Study|Not evaluable|1|||
48444739|NCT02667457|155816938|FG000|Overall Study|Withdrawal by Subject|1|||
48444740|NCT02667457|155816939|FG001|Overall Study|Withdrawal by Subject|0|||
48444741|NCT02667457|155816938|FG000|Overall Study|Other Reason|0|||
48444742|NCT02667457|155816939|FG001|Overall Study|Other Reason|2|||
48444743|NCT02475850|155816940|FG000|Overall Study|Death|155|||
48444744|NCT02475850|155816941|FG001|Overall Study|Death|141|||
48444745|NCT02475850|155816940|FG000|Overall Study|Lost to Follow-up|217|||
48444746|NCT02475850|155816941|FG001|Overall Study|Lost to Follow-up|188|||
48444747|NCT02475850|155816940|FG000|Overall Study|Withdrawal by Subject|221|||
48444748|NCT02475850|155816941|FG001|Overall Study|Withdrawal by Subject|155|||
48444749|NCT00781963|155816947|FG000|Overall Study|Death|3|||
48444750|NCT00781963|155816948|FG001|Overall Study|Death|0|||
48444751|NCT00781963|155816947|FG000|Overall Study|Lost to Follow-up|2|||
48444752|NCT00781963|155816948|FG001|Overall Study|Lost to Follow-up|1|||
48444753|NCT00781963|155816947|FG000|Overall Study|Withdrawal by Subject|3|||
48444754|NCT00781963|155816948|FG001|Overall Study|Withdrawal by Subject|1|||
48444755|NCT00781963|155816947|FG000|Overall Study|Refused follow-up|9|||
48444756|NCT00781963|155816948|FG001|Overall Study|Refused follow-up|0|||
48444757|NCT03297216|155816949|FG000|Overall Study|Death|0|||
48444758|NCT03297216|155816950|FG001|Overall Study|Death|1|||
48444759|NCT03297216|155816949|FG000|Overall Study|Miscarriage|0|||
48444760|NCT03297216|155816950|FG001|Overall Study|Miscarriage|2|||
48444761|NCT03297216|155816949|FG000|Overall Study|Lost to Follow-up|3|||
48444762|NCT03297216|155816950|FG001|Overall Study|Lost to Follow-up|2|||
48444763|NCT00603733|155816951|FG000|Active Phase ITT|Adverse Event|8|||
48444764|NCT00603733|155816952|FG001|Active Phase ITT|Adverse Event|7|||
48444765|NCT00603733|155816951|FG000|Active Phase ITT|Withdrawal by Subject|0|||
48444766|NCT00603733|155816952|FG001|Active Phase ITT|Withdrawal by Subject|3|||
48444767|NCT00603733|155816951|FG000|Active Phase ITT|Lost to Follow-up|0|||
48444768|NCT00603733|155816952|FG001|Active Phase ITT|Lost to Follow-up|1|||
48444769|NCT00603733|155816951|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
48444770|NCT00603733|155816952|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
48444771|NCT00603733|155816951|FG000|Active Phase ITT|Lack of Efficacy|1|||
48444772|NCT00603733|155816952|FG001|Active Phase ITT|Lack of Efficacy|2|||
48444773|NCT00603733|155816951|FG000|Active Phase ITT|Subject moved, site closed|1|||
48444774|NCT00603733|155816952|FG001|Active Phase ITT|Subject moved, site closed|1|||
48444775|NCT00603733|155816951|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
48444776|NCT00603733|155816952|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
48444777|NCT00603733|155816951|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
48444778|NCT00603733|155816952|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
48444779|NCT00603733|155816951|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
48444780|NCT00603733|155816952|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
48444781|NCT00603733|155816951|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
48444782|NCT00603733|155816952|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
48444783|NCT00603733|155816951|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
48444784|NCT00603733|155816952|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
48444785|NCT00603733|155816951|FG000|Maintenance Phase ITT|Adverse Event|3|||
48444786|NCT00603733|155816952|FG001|Maintenance Phase ITT|Adverse Event|6|||
48444787|NCT00603733|155816951|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
48444788|NCT00603733|155816952|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
48444789|NCT00603733|155816951|FG000|Maintenance Phase ITT|Protocol Violation|1|||
48444790|NCT00603733|155816952|FG001|Maintenance Phase ITT|Protocol Violation|1|||
48444791|NCT00603733|155816951|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
48444792|NCT00603733|155816952|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
48444793|NCT00603733|155816951|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
48444794|NCT00603733|155816952|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
48444795|NCT00603733|155816951|FG000|Maintenance Phase ITT|Physician Decision|0|||
48444796|NCT00603733|155816952|FG001|Maintenance Phase ITT|Physician Decision|1|||
48444797|NCT00603733|155816951|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
48444798|NCT00603733|155816952|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
48444799|NCT02064205|155816953|FG000|Overall Study|Withdrawal by Subject|1|||
48444800|NCT03057951|155816954|FG000|Overall Study|Adverse Event|553|||
48444801|NCT03057951|155816955|FG001|Overall Study|Adverse Event|575|||
48444802|NCT03057951|155816954|FG000|Overall Study|Protocol Violation|30|||
48444803|NCT03057951|155816955|FG001|Overall Study|Protocol Violation|24|||
48444804|NCT03057951|155816954|FG000|Overall Study|Lost to Follow-up|6|||
48444805|NCT03057951|155816955|FG001|Overall Study|Lost to Follow-up|16|||
48444806|NCT03057951|155816954|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
48444807|NCT03057951|155816955|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
48444808|NCT03057951|155816954|FG000|Overall Study|Study drug stopped, reason missing|6|||
48444809|NCT03057951|155816955|FG001|Overall Study|Study drug stopped, reason missing|1|||
48444810|NCT03057951|155816954|FG000|Overall Study|Medical advice|6|||
48444811|NCT03057951|155816955|FG001|Overall Study|Medical advice|2|||
48444812|NCT03057951|155816954|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
48444813|NCT03057951|155816955|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
48444814|NCT03057951|155816954|FG000|Overall Study|Investigator decision|2|||
48444815|NCT03057951|155816955|FG001|Overall Study|Investigator decision|0|||
48444816|NCT03057951|155816954|FG000|Overall Study|Patient decision|5|||
48444817|NCT03057951|155816955|FG001|Overall Study|Patient decision|2|||
48444818|NCT03057951|155816954|FG000|Overall Study|Not attending study visits|3|||
48444819|NCT03057951|155816955|FG001|Overall Study|Not attending study visits|0|||
48444820|NCT03057951|155816954|FG000|Overall Study|Patient moved away|3|||
48444821|NCT03057951|155816955|FG001|Overall Study|Patient moved away|4|||
48444822|NCT03057951|155816954|FG000|Overall Study|Other reason than stated above|23|||
48444823|NCT03057951|155816955|FG001|Overall Study|Other reason than stated above|29|||
48444824|NCT03057951|155816954|FG000|Overall Study|Not treated|2|||
48444825|NCT03057951|155816955|FG001|Overall Study|Not treated|1|||
48444826|NCT03434418|155816959|FG000|Overall Study|Disease Progression|11|||
48444827|NCT03434418|155816959|FG000|Overall Study|Adverse Event|2|||
48444828|NCT03434418|155816959|FG000|Overall Study|Physician Decision|1|||
48444829|NCT03434418|155816959|FG000|Overall Study|Decline in Performance Status (PS)|1|||
48444830|NCT00225147|155816970|FG000|Open-label Phase|Lost to Follow-up|0|||
48444831|NCT00225147|155816971|FG001|Open-label Phase|Lost to Follow-up|0|||
48444832|NCT00225147|155816972|FG002|Open-label Phase|Lost to Follow-up|0|||
48444833|NCT00225147|155816973|FG003|Open-label Phase|Lost to Follow-up|4|||
48444834|NCT00225147|155816970|FG000|Open-label Phase|Withdrawal by Subject|0|||
48444835|NCT00225147|155816971|FG001|Open-label Phase|Withdrawal by Subject|0|||
48444836|NCT00225147|155816972|FG002|Open-label Phase|Withdrawal by Subject|0|||
48444837|NCT00225147|155816973|FG003|Open-label Phase|Withdrawal by Subject|6|||
48444838|NCT04019795|155816974|FG000|Overall Study|Withdrawal by Subject|1|||
48444839|NCT04019795|155816975|FG001|Overall Study|Withdrawal by Subject|2|||
48444840|NCT04019795|155816976|FG002|Overall Study|Withdrawal by Subject|2|||
48444841|NCT04019795|155816977|FG003|Overall Study|Withdrawal by Subject|1|||
48444842|NCT04019795|155816974|FG000|Overall Study|Lost to Follow-up|0|||
48444843|NCT04019795|155816975|FG001|Overall Study|Lost to Follow-up|1|||
48444844|NCT04019795|155816976|FG002|Overall Study|Lost to Follow-up|1|||
48444845|NCT04019795|155816977|FG003|Overall Study|Lost to Follow-up|2|||
48444846|NCT04019795|155816974|FG000|Overall Study|Treatment non-compliance|3|||
48444847|NCT04019795|155816975|FG001|Overall Study|Treatment non-compliance|1|||
48444848|NCT04019795|155816976|FG002|Overall Study|Treatment non-compliance|2|||
48444849|NCT04019795|155816977|FG003|Overall Study|Treatment non-compliance|0|||
48444850|NCT04019795|155816974|FG000|Overall Study|Physician Decision|0|||
48444851|NCT04019795|155816975|FG001|Overall Study|Physician Decision|0|||
48444900|NCT02137837|155816992|FG000|Overall Study|Refusal unrelated to adverse event|2|||
48444901|NCT02137837|155816993|FG001|Overall Study|Refusal unrelated to adverse event|2|||
48444902|NCT02137837|155816994|FG002|Overall Study|Refusal unrelated to adverse event|1|||
48444903|NCT02137837|155816992|FG000|Overall Study|Progression/relapse|9|||
48444904|NCT02137837|155816993|FG001|Overall Study|Progression/relapse|7|||
48444905|NCT02137837|155816994|FG002|Overall Study|Progression/relapse|7|||
48444906|NCT02137837|155816992|FG000|Overall Study|Not protocol specified|2|||
48444907|NCT02137837|155816993|FG001|Overall Study|Not protocol specified|1|||
48444908|NCT02137837|155816994|FG002|Overall Study|Not protocol specified|3|||
48444909|NCT00109772|155816999|FG000|Double-blind Treatment|Adverse Event|14|||
48444910|NCT00109772|155817000|FG001|Double-blind Treatment|Adverse Event|5|||
48444911|NCT00109772|155816999|FG000|Double-blind Treatment|Lack of Efficacy|1|||
48444912|NCT00109772|155817000|FG001|Double-blind Treatment|Lack of Efficacy|0|||
48444913|NCT00109772|155816999|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
48444914|NCT00109772|155817000|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
48444915|NCT00109772|155816999|FG000|Double-blind Treatment|Lost to Follow-up|2|||
48444916|NCT00109772|155817000|FG001|Double-blind Treatment|Lost to Follow-up|3|||
48444917|NCT00109772|155816999|FG000|Double-blind Treatment|Protocol Violation|0|||
48444918|NCT00109772|155817000|FG001|Double-blind Treatment|Protocol Violation|1|||
48444919|NCT00109772|155816999|FG000|Double-blind Treatment|Other|0|||
48444920|NCT00109772|155817000|FG001|Double-blind Treatment|Other|4|||
48444921|NCT00109772|155816999|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
48444922|NCT00109772|155817000|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
48444923|NCT00109772|155816999|FG000|Open-label Extension|Adverse Event|10|||
48444924|NCT00109772|155817000|FG001|Open-label Extension|Adverse Event|19|||
48444925|NCT00109772|155816999|FG000|Open-label Extension|Lack of Efficacy|19|||
48444926|NCT00109772|155817000|FG001|Open-label Extension|Lack of Efficacy|11|||
48444927|NCT00109772|155816999|FG000|Open-label Extension|Withdrawal by Subject|9|||
48444928|NCT00109772|155817000|FG001|Open-label Extension|Withdrawal by Subject|6|||
48444929|NCT00109772|155816999|FG000|Open-label Extension|Lost to Follow-up|1|||
48444930|NCT00109772|155817000|FG001|Open-label Extension|Lost to Follow-up|0|||
48444931|NCT00109772|155816999|FG000|Open-label Extension|Death|0|||
48444932|NCT00109772|155817000|FG001|Open-label Extension|Death|1|||
48444933|NCT00109772|155816999|FG000|Open-label Extension|Protocol Violation|2|||
48444934|NCT00109772|155817000|FG001|Open-label Extension|Protocol Violation|2|||
48444935|NCT00109772|155816999|FG000|Open-label Extension|Other|4|||
48444936|NCT00109772|155817000|FG001|Open-label Extension|Other|10|||
48444937|NCT01989754|155817001|FG000|Overall Study|Withdrawal by Subject|10|||
48444938|NCT01989754|155817002|FG001|Overall Study|Withdrawal by Subject|14|||
48444939|NCT01989754|155817001|FG000|Overall Study|Lost to Follow-up|28|||
48444940|NCT01989754|155817002|FG001|Overall Study|Lost to Follow-up|20|||
48444941|NCT01989754|155817001|FG000|Overall Study|Closed Site|1|||
48444942|NCT01989754|155817002|FG001|Overall Study|Closed Site|1|||
48444943|NCT02151682|155817004|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48444944|NCT02151682|155817005|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
48444945|NCT02151682|155817006|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48444946|NCT02151682|155817007|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48444947|NCT02151682|155817008|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48444948|NCT02151682|155817009|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
48444949|NCT02151682|155817004|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48444950|NCT02151682|155817005|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
48444951|NCT02151682|155817006|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48444952|NCT02151682|155817007|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48444953|NCT02151682|155817008|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48444954|NCT02151682|155817009|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
48444955|NCT02151682|155817004|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48444956|NCT02151682|155817005|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
48444957|NCT02151682|155817006|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48444958|NCT02151682|155817007|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48444959|NCT02151682|155817008|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48444960|NCT02151682|155817009|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
48444961|NCT02151682|155817004|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
48444962|NCT02151682|155817005|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
48444963|NCT02151682|155817006|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
48444964|NCT02151682|155817007|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
48444965|NCT02151682|155817008|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
48444966|NCT02151682|155817009|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
48444967|NCT02151682|155817004|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
48444968|NCT02151682|155817005|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48444969|NCT02151682|155817006|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48444970|NCT02151682|155817007|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48444971|NCT02151682|155817008|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48444972|NCT02151682|155817009|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
48444973|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48444974|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48444975|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
48444976|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48444977|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48444978|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
48444979|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
48444980|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
48444981|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
48444982|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
48444983|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
48444984|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
48444985|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
48444986|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
48444987|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
48444988|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
48444989|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
48444990|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
48444991|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48444992|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48444993|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
48444994|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48444995|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48444996|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
48444997|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48444998|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48444999|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
48445000|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48445001|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48445002|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
48445003|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48445004|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48445005|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
48445006|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48445007|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48445008|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
48445009|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
48445010|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
48445011|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
48445012|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
48445013|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
48445014|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
48445015|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
48445016|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
48445017|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
48445018|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
48445019|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
48445020|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
48445021|NCT02151682|155817004|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48445022|NCT02151682|155817005|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48445023|NCT02151682|155817006|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
48445024|NCT02151682|155817007|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48445025|NCT02151682|155817008|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48445026|NCT02151682|155817009|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
48445027|NCT02151682|155817004|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48445028|NCT02151682|155817005|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48445029|NCT02151682|155817006|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48445030|NCT02151682|155817007|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48445031|NCT02151682|155817008|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
48445032|NCT02151682|155817009|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
48445033|NCT02151682|155817004|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48445034|NCT02151682|155817005|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48445035|NCT02151682|155817006|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48445036|NCT02151682|155817007|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48445037|NCT02151682|155817008|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
48445038|NCT02151682|155817009|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
48445039|NCT02151682|155817004|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48445040|NCT02151682|155817005|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48445041|NCT02151682|155817006|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48445042|NCT02151682|155817007|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48445043|NCT02151682|155817008|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
48445044|NCT02151682|155817009|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
48445045|NCT02151682|155817004|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48445046|NCT02151682|155817005|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48445047|NCT02151682|155817006|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48445048|NCT02151682|155817007|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48445049|NCT02151682|155817008|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
48445050|NCT02151682|155817009|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
48445051|NCT01306032|155817010|FG000|First Intervention|Adverse Event|1|||
48445052|NCT01306032|155817011|FG001|First Intervention|Adverse Event|0|||
48445053|NCT01306032|155817012|FG002|First Intervention|Adverse Event|1|||
48445054|NCT01306032|155817013|FG003|First Intervention|Adverse Event|0|||
48445055|NCT01306032|155817014|FG004|First Intervention|Adverse Event|0|||
48445056|NCT01306032|155817015|FG005|First Intervention|Adverse Event|1|||
48445057|NCT01306032|155817010|FG000|First Intervention|Withdrawal by Subject|0|||
48445058|NCT01306032|155817011|FG001|First Intervention|Withdrawal by Subject|2|||
48445059|NCT01306032|155817012|FG002|First Intervention|Withdrawal by Subject|0|||
48445060|NCT01306032|155817013|FG003|First Intervention|Withdrawal by Subject|1|||
48445061|NCT01306032|155817014|FG004|First Intervention|Withdrawal by Subject|0|||
48445062|NCT01306032|155817015|FG005|First Intervention|Withdrawal by Subject|0|||
48445063|NCT01306032|155817010|FG000|First Intervention|Death|0|||
48445064|NCT01306032|155817011|FG001|First Intervention|Death|0|||
48445065|NCT01306032|155817012|FG002|First Intervention|Death|1|||
48445066|NCT01306032|155817013|FG003|First Intervention|Death|0|||
48445067|NCT01306032|155817014|FG004|First Intervention|Death|0|||
48445068|NCT01306032|155817015|FG005|First Intervention|Death|0|||
48445069|NCT01306032|155817010|FG000|First Intervention|Ineligible|0|||
48445070|NCT01306032|155817011|FG001|First Intervention|Ineligible|0|||
48445071|NCT01306032|155817012|FG002|First Intervention|Ineligible|0|||
48445072|NCT01306032|155817013|FG003|First Intervention|Ineligible|0|||
48445073|NCT01306032|155817014|FG004|First Intervention|Ineligible|0|||
48445074|NCT01306032|155817015|FG005|First Intervention|Ineligible|1|||
48445075|NCT01306032|155817010|FG000|First Intervention|Progressive disease|0|||
48445076|NCT01306032|155817011|FG001|First Intervention|Progressive disease|0|||
48445077|NCT01306032|155817012|FG002|First Intervention|Progressive disease|0|||
48445078|NCT01306032|155817013|FG003|First Intervention|Progressive disease|0|||
48445079|NCT01306032|155817014|FG004|First Intervention|Progressive disease|2|||
48445080|NCT01306032|155817015|FG005|First Intervention|Progressive disease|0|||
48445081|NCT01306032|155817010|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
48445082|NCT01306032|155817011|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
48445083|NCT01306032|155817012|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
48445084|NCT01306032|155817013|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
48445085|NCT01306032|155817014|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
48445086|NCT01306032|155817015|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
48445087|NCT01306032|155817010|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
48445088|NCT01306032|155817011|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
48445089|NCT01306032|155817012|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
48445090|NCT01306032|155817013|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
48445091|NCT01306032|155817014|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
48445092|NCT01306032|155817015|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
48445093|NCT01213264|155817016|FG000|Overall Study|Adverse Event|1|||
48445094|NCT01213264|155817017|FG001|Overall Study|Adverse Event|0|||
48445095|NCT01213264|155817018|FG002|Overall Study|Adverse Event|0|||
48445096|NCT01213264|155817016|FG000|Overall Study|Lost to Follow-up|1|||
48445097|NCT01213264|155817017|FG001|Overall Study|Lost to Follow-up|2|||
48445098|NCT01213264|155817018|FG002|Overall Study|Lost to Follow-up|6|||
48445099|NCT05441540|155817019|FG000|Overall Study|Withdrawal by Subject|2|||
48445100|NCT01359046|155817020|FG000|Overall Study|Did not receive allocated intervention|6|||
48445101|NCT01359046|155817021|FG001|Overall Study|Did not receive allocated intervention|6|||
48445102|NCT01359046|155817020|FG000|Overall Study|Physician Decision|1|||
48445103|NCT01359046|155817021|FG001|Overall Study|Physician Decision|11|||
48445104|NCT00168064|155817022|FG000|Overall Study|Adverse Event|26|||
48445105|NCT00168064|155817023|FG001|Overall Study|Adverse Event|22|||
48445106|NCT00168064|155817022|FG000|Overall Study|Withdrawal by Subject|3|||
48445107|NCT00168064|155817023|FG001|Overall Study|Withdrawal by Subject|4|||
48445108|NCT00168064|155817022|FG000|Overall Study|Lack of Efficacy|4|||
48445236|NCT00719862|155817078|FG000|Overall Study|Withdrawal by Subject|1|||
48445237|NCT00719862|155817079|FG001|Overall Study|Withdrawal by Subject|0|||
48445238|NCT00719862|155817078|FG000|Overall Study|Lost to Follow-up|0|||
48445239|NCT00719862|155817079|FG001|Overall Study|Lost to Follow-up|1|||
48445240|NCT00719862|155817078|FG000|Overall Study|Other|2|||
48445241|NCT00719862|155817079|FG001|Overall Study|Other|3|||
48445242|NCT00676208|155817080|FG000|Overall Study|Lost to Follow-up|0|||
48445243|NCT00676208|155817081|FG001|Overall Study|Lost to Follow-up|2|||
48445244|NCT00676208|155817080|FG000|Overall Study|Incomplete data|2|||
48445245|NCT00676208|155817081|FG001|Overall Study|Incomplete data|4|||
48445246|NCT03210220|155817082|FG000|Overall Study|Physician Decision|1|||
48445247|NCT03210220|155817083|FG001|Overall Study|Physician Decision|0|||
48445248|NCT04992546|155817084|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
48445249|NCT04992546|155817084|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
48445250|NCT04992546|155817084|FG000|Open-Label Treatment Period|Adverse Event|3|||
48445251|NCT04992546|155817084|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
48445252|NCT01184846|155817086|FG000|Overall Study|Adverse Event|2|||
48445253|NCT01184846|155817086|FG000|Overall Study|Insufficient response|1|||
48445254|NCT01946412|155817087|FG000|Overall Study|Adverse Event|1|||
48445255|NCT01946412|155817087|FG000|Overall Study|Non-Compliance|1|||
48445256|NCT01946412|155817087|FG000|Overall Study|Continued with commercial Kalydeco|2|||
48445257|NCT01946412|155817087|FG000|Overall Study|Difficulty in swallowing|1|||
48445258|NCT02091921|155817088|FG000|Overall Study|Adverse Event|3|||
48445259|NCT02224638|155817089|FG000|Overall Study|Adverse Event|1|||
48445260|NCT02224638|155817090|FG001|Overall Study|Adverse Event|1|||
48445261|NCT01296698|155817091|FG000|Overall Study|Adverse Event|1|||
48445262|NCT01296698|155817092|FG001|Overall Study|Adverse Event|0|||
48445263|NCT01296698|155817091|FG000|Overall Study|Death|1|||
48445264|NCT01296698|155817092|FG001|Overall Study|Death|0|||
48445265|NCT01296698|155817091|FG000|Overall Study|Lost to Follow-up|19|||
48445266|NCT01296698|155817092|FG001|Overall Study|Lost to Follow-up|1|||
48445267|NCT01296698|155817091|FG000|Overall Study|Withdrawal by Subject|12|||
48445268|NCT01296698|155817092|FG001|Overall Study|Withdrawal by Subject|0|||
48445269|NCT01296698|155817091|FG000|Overall Study|Difficulty Contacting Subject|2|||
48445270|NCT01296698|155817092|FG001|Overall Study|Difficulty Contacting Subject|0|||
48445271|NCT01296698|155817091|FG000|Overall Study|Study Terminated by Sponsor|209|||
48445272|NCT01296698|155817092|FG001|Overall Study|Study Terminated by Sponsor|12|||
48445273|NCT01146951|155818667|FG000|Overall Study|Adverse Event|4|||
48445274|NCT01146951|155818668|FG001|Overall Study|Adverse Event|1|||
48445275|NCT02198651|155818669|FG000|Lead-in Period|Withdrew consent|13|||
48445276|NCT02198651|155818670|FG001|Lead-in Period|Withdrew consent|0|||
48445277|NCT02198651|155818671|FG002|Lead-in Period|Withdrew consent|0|||
48445278|NCT02198651|155818672|FG003|Lead-in Period|Withdrew consent|0|||
48445279|NCT02198651|155818673|FG004|Lead-in Period|Withdrew consent|0|||
48445280|NCT02198651|155818669|FG000|Lead-in Period|Adverse Event|2|||
48445281|NCT02198651|155818670|FG001|Lead-in Period|Adverse Event|0|||
48445282|NCT02198651|155818671|FG002|Lead-in Period|Adverse Event|0|||
48445283|NCT02198651|155818672|FG003|Lead-in Period|Adverse Event|0|||
48445284|NCT02198651|155818673|FG004|Lead-in Period|Adverse Event|0|||
48445285|NCT02198651|155818669|FG000|Lead-in Period|Other, not specified|22|||
48445286|NCT02198651|155818670|FG001|Lead-in Period|Other, not specified|0|||
48445287|NCT02198651|155818671|FG002|Lead-in Period|Other, not specified|0|||
48445288|NCT02198651|155818672|FG003|Lead-in Period|Other, not specified|0|||
48445289|NCT02198651|155818673|FG004|Lead-in Period|Other, not specified|0|||
48445290|NCT02198651|155818669|FG000|Double-blind Period|Withdrew consent|0|||
48445291|NCT02198651|155818670|FG001|Double-blind Period|Withdrew consent|4|||
48445292|NCT02198651|155818671|FG002|Double-blind Period|Withdrew consent|0|||
48445293|NCT02198651|155818672|FG003|Double-blind Period|Withdrew consent|0|||
48445294|NCT02198651|155818673|FG004|Double-blind Period|Withdrew consent|0|||
48445295|NCT02198651|155818669|FG000|Double-blind Period|Adverse Event|0|||
48445296|NCT02198651|155818670|FG001|Double-blind Period|Adverse Event|1|||
48445297|NCT02198651|155818671|FG002|Double-blind Period|Adverse Event|0|||
48445298|NCT02198651|155818672|FG003|Double-blind Period|Adverse Event|0|||
48445299|NCT02198651|155818673|FG004|Double-blind Period|Adverse Event|0|||
48445300|NCT02198651|155818669|FG000|Double-blind Period|Other, not specified|0|||
48445301|NCT02198651|155818670|FG001|Double-blind Period|Other, not specified|4|||
48445302|NCT02198651|155818671|FG002|Double-blind Period|Other, not specified|1|||
48445303|NCT02198651|155818672|FG003|Double-blind Period|Other, not specified|0|||
48445304|NCT02198651|155818673|FG004|Double-blind Period|Other, not specified|0|||
48445305|NCT02198651|155818669|FG000|Open-label Rescue Period|Withdrew consent|0|||
48445306|NCT02198651|155818670|FG001|Open-label Rescue Period|Withdrew consent|0|||
48445307|NCT02198651|155818671|FG002|Open-label Rescue Period|Withdrew consent|0|||
48445308|NCT02198651|155818672|FG003|Open-label Rescue Period|Withdrew consent|2|||
48445309|NCT02198651|155818673|FG004|Open-label Rescue Period|Withdrew consent|0|||
48445310|NCT02198651|155818669|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
48445311|NCT02198651|155818670|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
48445312|NCT02198651|155818671|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
48445313|NCT02198651|155818672|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
48445314|NCT02198651|155818673|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
48445315|NCT02126670|155818681|FG000|Overall Study|Withdrawal by Subject|1|||
48445316|NCT02126670|155818682|FG001|Overall Study|Withdrawal by Subject|0|||
48445317|NCT02126670|155818683|FG002|Overall Study|Withdrawal by Subject|0|||
48445318|NCT02126670|155818684|FG003|Overall Study|Withdrawal by Subject|1|||
48445319|NCT02700919|155818685|FG000|Overall Study|Physician Decision|1|||
48445320|NCT02700919|155818686|FG001|Overall Study|Physician Decision|0|||
48445321|NCT02700919|155818687|FG002|Overall Study|Physician Decision|0|||
48445322|NCT02700919|155818685|FG000|Overall Study|Protocol Violation|1|||
48445323|NCT02700919|155818686|FG001|Overall Study|Protocol Violation|0|||
48445324|NCT02700919|155818687|FG002|Overall Study|Protocol Violation|0|||
48445325|NCT02700919|155818685|FG000|Overall Study|Adverse Event|1|||
48445326|NCT02700919|155818686|FG001|Overall Study|Adverse Event|3|||
48445327|NCT02700919|155818687|FG002|Overall Study|Adverse Event|1|||
48445328|NCT02700919|155818685|FG000|Overall Study|Withdrawal by Subject|5|||
48445329|NCT02700919|155818686|FG001|Overall Study|Withdrawal by Subject|8|||
48445330|NCT02700919|155818687|FG002|Overall Study|Withdrawal by Subject|2|||
48445331|NCT02700919|155818685|FG000|Overall Study|Lost to Follow-up|2|||
48445332|NCT02700919|155818686|FG001|Overall Study|Lost to Follow-up|0|||
48445333|NCT02700919|155818687|FG002|Overall Study|Lost to Follow-up|0|||
48445334|NCT02700919|155818685|FG000|Overall Study|Other|2|||
48445335|NCT02700919|155818686|FG001|Overall Study|Other|1|||
48445336|NCT02700919|155818687|FG002|Overall Study|Other|1|||
48445337|NCT04507776|155818692|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
48445338|NCT00830115|155818696|FG000|Overall Study|Adverse Event|2|||
48445339|NCT00830115|155818696|FG000|Overall Study|Improvement/recovery|1|||
48445340|NCT02501902|155818697|FG000|Overall Study|Subject Refused Further Follow-up|0|||
48445341|NCT02501902|155818698|FG001|Overall Study|Subject Refused Further Follow-up|0|||
48445342|NCT02501902|155818699|FG002|Overall Study|Subject Refused Further Follow-up|0|||
48445343|NCT02501902|155818700|FG003|Overall Study|Subject Refused Further Follow-up|0|||
48445344|NCT02501902|155818701|FG004|Overall Study|Subject Refused Further Follow-up|0|||
48445345|NCT02501902|155818702|FG005|Overall Study|Subject Refused Further Follow-up|0|||
48445346|NCT02501902|155818703|FG006|Overall Study|Subject Refused Further Follow-up|0|||
48445347|NCT02501902|155818704|FG007|Overall Study|Subject Refused Further Follow-up|1|||
48445348|NCT02501902|155818697|FG000|Overall Study|Study Terminated by Sponsor|0|||
48445349|NCT02501902|155818698|FG001|Overall Study|Study Terminated by Sponsor|3|||
48445350|NCT02501902|155818699|FG002|Overall Study|Study Terminated by Sponsor|0|||
48445351|NCT02501902|155818700|FG003|Overall Study|Study Terminated by Sponsor|1|||
48445352|NCT02501902|155818701|FG004|Overall Study|Study Terminated by Sponsor|1|||
48445353|NCT02501902|155818702|FG005|Overall Study|Study Terminated by Sponsor|0|||
48445354|NCT02501902|155818703|FG006|Overall Study|Study Terminated by Sponsor|2|||
48445355|NCT02501902|155818704|FG007|Overall Study|Study Terminated by Sponsor|4|||
48445356|NCT02501902|155818697|FG000|Overall Study|Death|3|||
48445357|NCT02501902|155818698|FG001|Overall Study|Death|4|||
48445358|NCT02501902|155818699|FG002|Overall Study|Death|4|||
48445359|NCT02501902|155818700|FG003|Overall Study|Death|10|||
48445360|NCT02501902|155818701|FG004|Overall Study|Death|10|||
48445361|NCT02501902|155818702|FG005|Overall Study|Death|11|||
48445362|NCT02501902|155818703|FG006|Overall Study|Death|7|||
48445363|NCT02501902|155818704|FG007|Overall Study|Death|15|||
48445364|NCT01779648|155818705|FG000|Overall Study|Protocol Violation|1|||
48445365|NCT01779648|155818706|FG001|Overall Study|Protocol Violation|0|||
48445366|NCT02384395|155818707|FG000|Overall Study|Physician Decision|4|||
48445367|NCT02384395|155818707|FG000|Overall Study|Withdrawal by Subject|3|||
48445368|NCT02384395|155818707|FG000|Overall Study|Lost to Follow-up|3|||
48445369|NCT02267278|155818710|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
48445370|NCT02267278|155818710|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
48445371|NCT02267278|155818710|FG000|Overall Study|Developed new cancer diagnoses|2|||
48445372|NCT02267278|155818710|FG000|Overall Study|prescribed prohibited medication|1|||
48445373|NCT02513771|155818713|FG000|Overall Study|Lost to Follow-up|1|||
48445374|NCT02513771|155818714|FG001|Overall Study|Lost to Follow-up|1|||
48445375|NCT02513771|155818713|FG000|Overall Study|Not being able to get to clinic|1|||
48445376|NCT02513771|155818714|FG001|Overall Study|Not being able to get to clinic|0|||
48445377|NCT00282568|155818715|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
48445378|NCT00282568|155818715|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
48445379|NCT00282568|155818715|FG000|Extended Treatment Period|Adverse Event|17|||
48445380|NCT00282568|155818715|FG000|Extended Treatment Period|Non-compliance|4|||
48445381|NCT00282568|155818715|FG000|Extended Treatment Period|Physician Decision|1|||
48445382|NCT00282568|155818715|FG000|Extended Treatment Period|Lost to Follow-up|2|||
48445383|NCT00830804|155818718|FG000|Overall Study|Lost to Follow-up|4|||
48445384|NCT00830804|155818718|FG000|Overall Study|Death|1|||
48445385|NCT00830804|155818718|FG000|Overall Study|Unable to get to clinic|7|||
48445386|NCT00830804|155818718|FG000|Overall Study|Consent withdrawn|2|||
48445387|NCT00830804|155818718|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
48445388|NCT01357889|155818721|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
48445389|NCT01357889|155818722|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
48445390|NCT01357889|155818721|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
48445391|NCT01357889|155818722|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
48445392|NCT01357889|155818721|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
48445393|NCT01357889|155818722|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
48445394|NCT01357889|155818721|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
48445395|NCT01357889|155818722|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
48445396|NCT01357889|155818721|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
48445397|NCT01357889|155818722|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
48445398|NCT01357889|155818721|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
48445399|NCT01357889|155818722|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
48445400|NCT01357889|155818721|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
48445401|NCT01357889|155818722|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
48445402|NCT01357889|155818721|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
48445403|NCT01357889|155818722|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
48445404|NCT01357889|155818721|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
48445405|NCT01357889|155818722|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
48445406|NCT01357889|155818721|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
48445407|NCT01357889|155818722|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
48445408|NCT01357889|155818721|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
48445409|NCT01357889|155818722|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
48445410|NCT01357889|155818721|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
48445411|NCT01357889|155818722|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
48445412|NCT01357889|155818721|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
48445413|NCT01357889|155818722|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
48445414|NCT03332303|155818723|FG000|Overall Study|Participant did not dose|1|||
48445415|NCT03332303|155818724|FG001|Overall Study|Participant did not dose|2|||
48445416|NCT03332303|155818725|FG002|Overall Study|Participant did not dose|0|||
48445417|NCT03332303|155818723|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
48445418|NCT03332303|155818724|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
48445419|NCT03332303|155818725|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
48445420|NCT03332303|155818723|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
48445421|NCT03332303|155818724|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
48445422|NCT03332303|155818725|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
48445423|NCT03332303|155818723|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
48445424|NCT03332303|155818724|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
48445425|NCT03332303|155818725|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
48445426|NCT03332303|155818723|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
48445427|NCT03332303|155818724|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
48445428|NCT03332303|155818725|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
48445429|NCT03332303|155818723|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
48445430|NCT03332303|155818724|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
48445431|NCT03332303|155818725|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
48445432|NCT03332303|155818723|FG000|Overall Study|Participant had a significant protocol deviation|0|||
48445433|NCT03332303|155818724|FG001|Overall Study|Participant had a significant protocol deviation|1|||
48445434|NCT03332303|155818725|FG002|Overall Study|Participant had a significant protocol deviation|0|||
48445435|NCT04685499|155818726|FG000|Overall Study|Study Terminated Early|1|||
48445436|NCT01928082|155818729|FG000|Overall Study|Study terminated.|1|||
48445437|NCT03549117|155818733|FG000|Overall Study|Withdrawal by Subject|1|||
48445438|NCT03549117|155818734|FG001|Overall Study|Withdrawal by Subject|0|||
48445439|NCT00293241|155818735|FG000|Overall Study|Lost to Follow-up|9|||
48445440|NCT00293241|155818736|FG001|Overall Study|Lost to Follow-up|16|||
48445441|NCT00293241|155818735|FG000|Overall Study|Physician Decision|23|||
48445442|NCT00293241|155818736|FG001|Overall Study|Physician Decision|17|||
48445443|NCT00293241|155818735|FG000|Overall Study|Withdrawal by Subject|4|||
48445444|NCT00293241|155818736|FG001|Overall Study|Withdrawal by Subject|8|||
48445445|NCT03803202|155818737|FG000|Overall Study|Other|0|||
48445446|NCT03803202|155818738|FG001|Overall Study|Other|1|||
48445447|NCT03803202|155818739|FG002|Overall Study|Other|0|||
48445448|NCT03803202|155818740|FG003|Overall Study|Other|0|||
48445449|NCT03803202|155818741|FG004|Overall Study|Other|0|||
48445450|NCT03803202|155818742|FG005|Overall Study|Other|0|||
48445451|NCT03803202|155818743|FG006|Overall Study|Other|0|||
48445452|NCT03803202|155818744|FG007|Overall Study|Other|0|||
48445453|NCT03803202|155818745|FG008|Overall Study|Other|0|||
48445454|NCT03803202|155818737|FG000|Overall Study|Death|0|||
48445455|NCT03803202|155818738|FG001|Overall Study|Death|0|||
48445456|NCT03803202|155818739|FG002|Overall Study|Death|0|||
48445494|NCT02661464|155818749|FG001|Overall Study|Participants terminated prematurely|52|||
48445495|NCT02661464|155818750|FG002|Overall Study|Participants terminated prematurely|1|||
48445496|NCT02661464|155818751|FG003|Overall Study|Participants terminated prematurely|1|||
48445497|NCT02661464|155818748|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
48445498|NCT02661464|155818749|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
48445499|NCT02661464|155818750|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
48445500|NCT02661464|155818751|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
48445501|NCT01203787|155818752|FG000|Overall Study|Death|12|||
48445502|NCT01203787|155818753|FG001|Overall Study|Death|10|||
48445503|NCT01203787|155818752|FG000|Overall Study|Withdrawal by Subject|6|||
48445504|NCT01203787|155818753|FG001|Overall Study|Withdrawal by Subject|2|||
48445505|NCT01203787|155818752|FG000|Overall Study|Lost to Follow-up|2|||
48445506|NCT01203787|155818753|FG001|Overall Study|Lost to Follow-up|0|||
48445507|NCT01203787|155818752|FG000|Overall Study|Adverse Event|11|||
48445508|NCT01203787|155818753|FG001|Overall Study|Adverse Event|15|||
48445509|NCT00903370|155818754|FG000|Overall Study|Death|13|||
48445510|NCT00903370|155818755|FG001|Overall Study|Death|10|||
48445511|NCT00903370|155818754|FG000|Overall Study|Withdrawal by Subject|9|||
48445512|NCT00903370|155818755|FG001|Overall Study|Withdrawal by Subject|6|||
48445513|NCT00903370|155818754|FG000|Overall Study|Lost to Follow-up|6|||
48445514|NCT00903370|155818755|FG001|Overall Study|Lost to Follow-up|8|||
48445515|NCT03148756|155818757|FG000|Overall Study|Study Terminated|0|||
48445516|NCT03148756|155818758|FG001|Overall Study|Study Terminated|1|||
48445517|NCT01532570|155818761|FG000|Overall Study|Lack of Efficacy|1|||
48445518|NCT01532570|155818762|FG001|Overall Study|Lack of Efficacy|0|||
48445519|NCT01532570|155818763|FG002|Overall Study|Lack of Efficacy|0|||
48445520|NCT01532570|155818764|FG003|Overall Study|Lack of Efficacy|0|||
48445521|NCT01532570|155818761|FG000|Overall Study|Withdrawal by Subject|0|||
48445522|NCT01532570|155818762|FG001|Overall Study|Withdrawal by Subject|1|||
48445523|NCT01532570|155818763|FG002|Overall Study|Withdrawal by Subject|0|||
48445524|NCT01532570|155818764|FG003|Overall Study|Withdrawal by Subject|0|||
48445525|NCT02177175|155818765|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
48445526|NCT02177175|155818766|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
48445527|NCT01924299|155818767|FG000|Period 2|Withdrawal by Subject|1|||
48445528|NCT01924299|155818768|FG001|Period 2|Withdrawal by Subject|0|||
48445529|NCT01924299|155818767|FG000|Period 2|Adverse Event|0|||
48445530|NCT01924299|155818768|FG001|Period 2|Adverse Event|1|||
48445531|NCT04199793|155818769|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
48445532|NCT04199793|155818770|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
48445533|NCT04199793|155818769|FG000|Overall Study|Withdrawal by Subject|1|||
48445534|NCT04199793|155818770|FG001|Overall Study|Withdrawal by Subject|1|||
48445535|NCT03820726|155818771|FG000|Overall Study|Other than listed|23|||
48445536|NCT03820726|155818771|FG000|Overall Study|Withdrawal by Subject|37|||
48445537|NCT03820726|155818771|FG000|Overall Study|Lost to Follow-up|3|||
48445538|NCT03820726|155818771|FG000|Overall Study|Protocol deviation|1|||
48445539|NCT03820726|155818771|FG000|Overall Study|Adverse Event|146|||
48445540|NCT03820726|155818771|FG000|Overall Study|Not treated|1|||
48445541|NCT01815580|155818776|FG000|Overall Study|Lost to Follow-up|4|||
48445542|NCT01815580|155818777|FG001|Overall Study|Lost to Follow-up|7|||
48445543|NCT01815580|155818776|FG000|Overall Study|Withdrawal by Subject|3|||
48445544|NCT01815580|155818777|FG001|Overall Study|Withdrawal by Subject|4|||
48445545|NCT01815580|155818776|FG000|Overall Study|Excluded from analysis|5|||
48445546|NCT01815580|155818777|FG001|Overall Study|Excluded from analysis|4|||
48445547|NCT00345540|155818782|FG000|Overall Study|Withdrawal by Subject|1|||
48445548|NCT01406652|155818783|FG000|Overall Study|Lost-to-follow-up|3|||
48445549|NCT01406652|155818784|FG001|Overall Study|Lost-to-follow-up|4|||
48445550|NCT01406652|155818783|FG000|Overall Study|Withdrawal by Subject|2|||
48445551|NCT01406652|155818784|FG001|Overall Study|Withdrawal by Subject|2|||
48445552|NCT01406652|155818783|FG000|Overall Study|Insufficient follow-up|5|||
48445553|NCT01406652|155818784|FG001|Overall Study|Insufficient follow-up|4|||
48445554|NCT01406652|155818783|FG000|Overall Study|Infection not sure|10|||
48445555|NCT01406652|155818784|FG001|Overall Study|Infection not sure|10|||
48445556|NCT00425100|155818785|FG000|Overall Study|Adverse Event|36|||
48445557|NCT00425100|155818785|FG000|Overall Study|Lack of Efficacy|4|||
48445558|NCT00425100|155818785|FG000|Overall Study|Lost to Follow-up|2|||
48445559|NCT00425100|155818785|FG000|Overall Study|Protocol Violation|4|||
48445560|NCT00425100|155818785|FG000|Overall Study|Withdrawal by Subject|7|||
48445561|NCT00888615|155818787|FG000|Overall Study|No treatment|2|||
48445562|NCT00659126|155818788|FG000|Overall Study|Adverse Event|2|||
48445563|NCT00659126|155818789|FG001|Overall Study|Adverse Event|2|||
48445564|NCT00659126|155818788|FG000|Overall Study|Screen failure|1|||
48445565|NCT00659126|155818789|FG001|Overall Study|Screen failure|1|||
48445566|NCT00659126|155818788|FG000|Overall Study|Technical problems with MRI|0|||
48445567|NCT00659126|155818789|FG001|Overall Study|Technical problems with MRI|1|||
48445568|NCT04095442|155820455|FG000|Overall Study|Lost to Follow-up|0|||
48445569|NCT04095442|155820456|FG001|Overall Study|Lost to Follow-up|1|||
48445570|NCT04095442|155820455|FG000|Overall Study|Screen failure|1|||
48445621|NCT00424346|155820462|FG001|Extension Phase|Administrative Problems|69|||
48445622|NCT00424346|155820463|FG002|Extension Phase|Administrative Problems|32|||
48445623|NCT00424346|155820464|FG003|Extension Phase|Administrative Problems|35|||
48445624|NCT00424346|155820461|FG000|Extension Phase|Death|0|||
48445625|NCT00424346|155820462|FG001|Extension Phase|Death|0|||
48445626|NCT00424346|155820463|FG002|Extension Phase|Death|0|||
48445627|NCT00424346|155820464|FG003|Extension Phase|Death|1|||
48445628|NCT00424346|155820461|FG000|Extension Phase|Protocol Violation|0|||
48445629|NCT00424346|155820462|FG001|Extension Phase|Protocol Violation|1|||
48445630|NCT00424346|155820463|FG002|Extension Phase|Protocol Violation|1|||
48445631|NCT00424346|155820464|FG003|Extension Phase|Protocol Violation|0|||
48445632|NCT01002742|155820467|FG000|Overall Study|Determined to be ineligible|0|||
48445633|NCT01002742|155820468|FG001|Overall Study|Determined to be ineligible|1|||
48445634|NCT03927911|155820470|FG000|Overall Study|problems with eDiary|0|||
48445635|NCT03927911|155820471|FG001|Overall Study|problems with eDiary|1|||
48445636|NCT03927911|155820472|FG002|Overall Study|problems with eDiary|0|||
48445637|NCT03927911|155820473|FG003|Overall Study|problems with eDiary|1|||
48445638|NCT03927911|155820474|FG004|Overall Study|problems with eDiary|0|||
48445639|NCT03927911|155820475|FG005|Overall Study|problems with eDiary|4|||
48445640|NCT03927911|155820470|FG000|Overall Study|Adverse Event|0|||
48445641|NCT03927911|155820471|FG001|Overall Study|Adverse Event|0|||
48445642|NCT03927911|155820472|FG002|Overall Study|Adverse Event|0|||
48445643|NCT03927911|155820473|FG003|Overall Study|Adverse Event|0|||
48445644|NCT03927911|155820474|FG004|Overall Study|Adverse Event|0|||
48445645|NCT03927911|155820475|FG005|Overall Study|Adverse Event|1|||
48445646|NCT03927911|155820470|FG000|Overall Study|not treated -study terminated by sponsor|0|||
48445647|NCT03927911|155820471|FG001|Overall Study|not treated -study terminated by sponsor|1|||
48445648|NCT03927911|155820472|FG002|Overall Study|not treated -study terminated by sponsor|0|||
48445649|NCT03927911|155820473|FG003|Overall Study|not treated -study terminated by sponsor|0|||
48445650|NCT03927911|155820474|FG004|Overall Study|not treated -study terminated by sponsor|0|||
48445651|NCT03927911|155820475|FG005|Overall Study|not treated -study terminated by sponsor|0|||
48445652|NCT03927911|155820470|FG000|Overall Study|Surgery cancelled|0|||
48445653|NCT03927911|155820471|FG001|Overall Study|Surgery cancelled|0|||
48445654|NCT03927911|155820472|FG002|Overall Study|Surgery cancelled|0|||
48445655|NCT03927911|155820473|FG003|Overall Study|Surgery cancelled|1|||
48445656|NCT03927911|155820474|FG004|Overall Study|Surgery cancelled|0|||
48445657|NCT03927911|155820475|FG005|Overall Study|Surgery cancelled|1|||
48445658|NCT03927911|155820470|FG000|Overall Study|Protocol Violation|0|||
48445659|NCT03927911|155820471|FG001|Overall Study|Protocol Violation|0|||
48445660|NCT03927911|155820472|FG002|Overall Study|Protocol Violation|0|||
48445661|NCT03927911|155820473|FG003|Overall Study|Protocol Violation|0|||
48445662|NCT03927911|155820474|FG004|Overall Study|Protocol Violation|0|||
48445663|NCT03927911|155820475|FG005|Overall Study|Protocol Violation|1|||
48445664|NCT00562640|155820476|FG000|Overall Study|Death|0|||
48445665|NCT00562640|155820477|FG001|Overall Study|Death|1|||
48445666|NCT00562640|155820478|FG002|Overall Study|Death|1|||
48445667|NCT00562640|155820479|FG003|Overall Study|Death|0|||
48445668|NCT02658968|155820482|FG000|Received Rituximab|Adverse Event|0|||
48445669|NCT02658968|155820483|FG001|Received Rituximab|Adverse Event|0|||
48445670|NCT02658968|155820484|FG002|Received Rituximab|Adverse Event|0|||
48445671|NCT02658968|155820485|FG003|Received Rituximab|Adverse Event|0|||
48445672|NCT02658968|155820486|FG004|Received Rituximab|Adverse Event|1|||
48445673|NCT02658968|155820482|FG000|Received Rituximab|Progressive disease|0|||
48445674|NCT02658968|155820483|FG001|Received Rituximab|Progressive disease|0|||
48445675|NCT02658968|155820484|FG002|Received Rituximab|Progressive disease|0|||
48445676|NCT02658968|155820485|FG003|Received Rituximab|Progressive disease|0|||
48445677|NCT02658968|155820486|FG004|Received Rituximab|Progressive disease|1|||
48445678|NCT02658968|155820482|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
48445679|NCT02658968|155820483|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
48445680|NCT02658968|155820484|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
48445681|NCT02658968|155820485|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
48445682|NCT02658968|155820486|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
48445683|NCT02658968|155820482|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
48445684|NCT02658968|155820483|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
48445685|NCT02658968|155820484|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
48445686|NCT02658968|155820485|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
48445687|NCT02658968|155820486|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
48445688|NCT02658968|155820482|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
48445689|NCT02658968|155820483|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
48445690|NCT02658968|155820484|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
48445691|NCT02658968|155820485|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
48445692|NCT02658968|155820486|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
48445693|NCT02658968|155820482|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
48445694|NCT02658968|155820483|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
48445695|NCT02658968|155820484|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
48445696|NCT02658968|155820485|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
48445697|NCT02658968|155820486|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
48445698|NCT02658968|155820482|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
48445699|NCT02658968|155820483|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
48445700|NCT02658968|155820484|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
48445701|NCT02658968|155820485|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
48445702|NCT02658968|155820486|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
48445703|NCT00696436|155820493|FG000|Overall Study|Adverse Event|7|||
48445704|NCT00696436|155820494|FG001|Overall Study|Adverse Event|9|||
48445705|NCT00696436|155820495|FG002|Overall Study|Adverse Event|8|||
48445706|NCT00696436|155820496|FG003|Overall Study|Adverse Event|6|||
48445707|NCT00696436|155820497|FG004|Overall Study|Adverse Event|4|||
48445708|NCT00696436|155820493|FG000|Overall Study|Protocol Violation|3|||
48445709|NCT00696436|155820494|FG001|Overall Study|Protocol Violation|2|||
48445710|NCT00696436|155820495|FG002|Overall Study|Protocol Violation|2|||
48445711|NCT00696436|155820496|FG003|Overall Study|Protocol Violation|0|||
48445712|NCT00696436|155820497|FG004|Overall Study|Protocol Violation|1|||
48445713|NCT00696436|155820493|FG000|Overall Study|Lost to Follow-up|1|||
48445714|NCT00696436|155820494|FG001|Overall Study|Lost to Follow-up|6|||
48445715|NCT00696436|155820495|FG002|Overall Study|Lost to Follow-up|2|||
48445716|NCT00696436|155820496|FG003|Overall Study|Lost to Follow-up|4|||
48445717|NCT00696436|155820497|FG004|Overall Study|Lost to Follow-up|3|||
48445718|NCT00696436|155820493|FG000|Overall Study|Withdrawal by Subject|4|||
48445719|NCT00696436|155820494|FG001|Overall Study|Withdrawal by Subject|11|||
48445720|NCT00696436|155820495|FG002|Overall Study|Withdrawal by Subject|5|||
48445721|NCT00696436|155820496|FG003|Overall Study|Withdrawal by Subject|7|||
48445722|NCT00696436|155820497|FG004|Overall Study|Withdrawal by Subject|1|||
48445723|NCT00696436|155820493|FG000|Overall Study|Lack of Efficacy|3|||
48445724|NCT00696436|155820494|FG001|Overall Study|Lack of Efficacy|1|||
48445725|NCT00696436|155820495|FG002|Overall Study|Lack of Efficacy|5|||
48445726|NCT00696436|155820496|FG003|Overall Study|Lack of Efficacy|2|||
48445727|NCT00696436|155820497|FG004|Overall Study|Lack of Efficacy|4|||
48445728|NCT00696436|155820493|FG000|Overall Study|Participant Unavailability|2|||
48445729|NCT00696436|155820494|FG001|Overall Study|Participant Unavailability|0|||
48445730|NCT00696436|155820495|FG002|Overall Study|Participant Unavailability|2|||
48445731|NCT00696436|155820496|FG003|Overall Study|Participant Unavailability|1|||
48445732|NCT00696436|155820497|FG004|Overall Study|Participant Unavailability|0|||
48445733|NCT00696436|155820493|FG000|Overall Study|Administrative Error|2|||
48445734|NCT00696436|155820494|FG001|Overall Study|Administrative Error|0|||
48445735|NCT00696436|155820495|FG002|Overall Study|Administrative Error|2|||
48445736|NCT00696436|155820496|FG003|Overall Study|Administrative Error|0|||
48445737|NCT00696436|155820497|FG004|Overall Study|Administrative Error|0|||
48445738|NCT00696436|155820493|FG000|Overall Study|Participant Non-compliance|0|||
48445739|NCT00696436|155820494|FG001|Overall Study|Participant Non-compliance|0|||
48445740|NCT00696436|155820495|FG002|Overall Study|Participant Non-compliance|1|||
48445741|NCT00696436|155820496|FG003|Overall Study|Participant Non-compliance|2|||
48445742|NCT00696436|155820497|FG004|Overall Study|Participant Non-compliance|0|||
48445743|NCT00696436|155820493|FG000|Overall Study|Administrative Decision|1|||
48445744|NCT00696436|155820494|FG001|Overall Study|Administrative Decision|0|||
48445745|NCT00696436|155820495|FG002|Overall Study|Administrative Decision|0|||
48445746|NCT00696436|155820496|FG003|Overall Study|Administrative Decision|0|||
48445747|NCT00696436|155820497|FG004|Overall Study|Administrative Decision|0|||
48445748|NCT00696436|155820493|FG000|Overall Study|Missing|0|||
48445749|NCT00696436|155820494|FG001|Overall Study|Missing|1|||
48445750|NCT00696436|155820495|FG002|Overall Study|Missing|1|||
48445751|NCT00696436|155820496|FG003|Overall Study|Missing|0|||
48445752|NCT00696436|155820497|FG004|Overall Study|Missing|0|||
48445753|NCT02150213|155820501|FG000|Overall Study|Lost to Follow-up|1|||
48445754|NCT02150213|155820501|FG000|Overall Study|Withdrawal by Subject|1|||
48445755|NCT02533401|155820506|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
48445756|NCT02533401|155820506|FG000|Overall Study|Death|5|||
48445757|NCT02533401|155820506|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
48445758|NCT02533401|155820506|FG000|Overall Study|Lost to Follow-up|1|||
48445759|NCT02533401|155820506|FG000|Overall Study|Violation of Selection Criteria|1|||
48445760|NCT00291499|155820507|FG000|Overall Study|Adverse Event|3|||
48445761|NCT00291499|155820508|FG001|Overall Study|Adverse Event|8|||
48445762|NCT00291499|155820507|FG000|Overall Study|Change to other therapy|2|||
48445763|NCT00291499|155820508|FG001|Overall Study|Change to other therapy|1|||
48445764|NCT00291499|155820507|FG000|Overall Study|Intercurrent illness|1|||
48445765|NCT00291499|155820508|FG001|Overall Study|Intercurrent illness|0|||
48445766|NCT00291499|155820507|FG000|Overall Study|Protocol Violation|2|||
48445767|NCT00291499|155820508|FG001|Overall Study|Protocol Violation|2|||
48445768|NCT00291499|155820507|FG000|Overall Study|Other reasons|1|||
48445769|NCT00291499|155820508|FG001|Overall Study|Other reasons|4|||
48445770|NCT05552859|155820509|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
48445771|NCT05552859|155820510|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
48445772|NCT04325906|155820511|FG000|Overall Study|Withdrawal by Subject|2|||
48445773|NCT04325906|155820512|FG001|Overall Study|Withdrawal by Subject|0|||
48445774|NCT00618995|155820515|FG000|Period 1|Adverse Event|0|||
48445775|NCT00618995|155820516|FG001|Period 1|Adverse Event|0|||
48445776|NCT00618995|155820517|FG002|Period 1|Adverse Event|1|||
48445777|NCT00618995|155820518|FG003|Period 1|Adverse Event|0|||
48445778|NCT00618995|155820515|FG000|Period 1|Protocol Violation|0|||
48445779|NCT00618995|155820516|FG001|Period 1|Protocol Violation|1|||
48445780|NCT00618995|155820517|FG002|Period 1|Protocol Violation|1|||
48445781|NCT00618995|155820518|FG003|Period 1|Protocol Violation|0|||
48445782|NCT00618995|155820515|FG000|Period 2|Protocol Violation|0|||
48445783|NCT00618995|155820516|FG001|Period 2|Protocol Violation|0|||
48445784|NCT00618995|155820517|FG002|Period 2|Protocol Violation|1|||
48445785|NCT00618995|155820518|FG003|Period 2|Protocol Violation|0|||
48445786|NCT00618995|155820515|FG000|Period 4|Adverse Event|1|||
48445787|NCT00618995|155820516|FG001|Period 4|Adverse Event|0|||
48445788|NCT00618995|155820517|FG002|Period 4|Adverse Event|0|||
48445789|NCT00618995|155820518|FG003|Period 4|Adverse Event|0|||
48445790|NCT00830960|155820523|FG000|Overall Study|Death|5|||
48445791|NCT00830960|155820524|FG001|Overall Study|Death|4|||
48445792|NCT00830960|155820525|FG002|Overall Study|Death|3|||
48445793|NCT00830960|155820526|FG003|Overall Study|Death|2|||
48445794|NCT00830960|155820527|FG004|Overall Study|Death|6|||
48445795|NCT00830960|155820528|FG005|Overall Study|Death|1|||
48445796|NCT00830960|155820523|FG000|Overall Study|Lost to Follow-up|1|||
48445797|NCT00830960|155820524|FG001|Overall Study|Lost to Follow-up|1|||
48445798|NCT00830960|155820525|FG002|Overall Study|Lost to Follow-up|1|||
48445799|NCT00830960|155820526|FG003|Overall Study|Lost to Follow-up|0|||
48445800|NCT00830960|155820527|FG004|Overall Study|Lost to Follow-up|0|||
48445801|NCT00830960|155820528|FG005|Overall Study|Lost to Follow-up|1|||
48445802|NCT00830960|155820523|FG000|Overall Study|Withdrawal by Subject|19|||
48445803|NCT00830960|155820524|FG001|Overall Study|Withdrawal by Subject|19|||
48445804|NCT00830960|155820525|FG002|Overall Study|Withdrawal by Subject|18|||
48445805|NCT00830960|155820526|FG003|Overall Study|Withdrawal by Subject|23|||
48445806|NCT00830960|155820527|FG004|Overall Study|Withdrawal by Subject|16|||
48445807|NCT00830960|155820528|FG005|Overall Study|Withdrawal by Subject|21|||
48445808|NCT00830960|155820523|FG000|Overall Study|Sponsor Decision|1|||
48445809|NCT00830960|155820524|FG001|Overall Study|Sponsor Decision|2|||
48445810|NCT00830960|155820525|FG002|Overall Study|Sponsor Decision|3|||
48445811|NCT00830960|155820526|FG003|Overall Study|Sponsor Decision|4|||
48445812|NCT00830960|155820527|FG004|Overall Study|Sponsor Decision|5|||
48445813|NCT00830960|155820528|FG005|Overall Study|Sponsor Decision|7|||
48445814|NCT00830960|155820523|FG000|Overall Study|No study drug received|7|||
48445815|NCT00830960|155820524|FG001|Overall Study|No study drug received|2|||
48445816|NCT00830960|155820525|FG002|Overall Study|No study drug received|4|||
48445817|NCT00830960|155820526|FG003|Overall Study|No study drug received|3|||
48445818|NCT00830960|155820527|FG004|Overall Study|No study drug received|5|||
48445819|NCT00830960|155820528|FG005|Overall Study|No study drug received|7|||
48445820|NCT03074149|155820529|FG000|Overall Study|Reason unknown|22|||
48445821|NCT03074149|155820530|FG001|Overall Study|Reason unknown|35|||
48445822|NCT03074149|155820529|FG000|Overall Study|Death|10|||
48445823|NCT03074149|155820530|FG001|Overall Study|Death|45|||
48445824|NCT00425113|155820531|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
48445825|NCT00425113|155820532|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
48445826|NCT00425113|155820531|FG000|Overall Study|diagnosis of abdominal TB|0|||
48445827|NCT00425113|155820532|FG001|Overall Study|diagnosis of abdominal TB|1|||
48445828|NCT00425113|155820531|FG000|Overall Study|missing study drug more than 14 days|0|||
48445829|NCT00425113|155820532|FG001|Overall Study|missing study drug more than 14 days|1|||
48445830|NCT00425113|155820531|FG000|Overall Study|Withdrawal by Subject|1|||
48445831|NCT00425113|155820532|FG001|Overall Study|Withdrawal by Subject|0|||
48445832|NCT05159362|155820534|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
48445833|NCT05159362|155820535|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
48445834|NCT05159362|155820536|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
48445835|NCT01376245|155820537|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
48445836|NCT01376245|155820538|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
48445837|NCT01376245|155820539|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
48445838|NCT01376245|155820540|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
48445839|NCT01376245|155820541|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
48445840|NCT01376245|155820537|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
48445841|NCT01376245|155820538|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
48445842|NCT01376245|155820539|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
48445843|NCT01376245|155820540|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
48445844|NCT01376245|155820541|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
48445845|NCT01376245|155820537|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
48445846|NCT01376245|155820538|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
48445847|NCT01376245|155820539|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
48445848|NCT01376245|155820540|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
48445849|NCT01376245|155820541|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
48445850|NCT01376245|155820537|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
48445851|NCT01376245|155820538|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
48445852|NCT01376245|155820539|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
48445853|NCT01376245|155820540|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
48445854|NCT01376245|155820541|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
48445855|NCT01376245|155820537|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
48445856|NCT01376245|155820538|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
48445857|NCT01376245|155820539|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
48445858|NCT01376245|155820540|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
48445859|NCT01376245|155820541|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
48445860|NCT01376245|155820537|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
48445861|NCT01376245|155820538|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
48445862|NCT01376245|155820539|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
48445863|NCT01376245|155820540|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
48445864|NCT01376245|155820541|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
48445865|NCT01376245|155820537|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
48445866|NCT01376245|155820538|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
48445867|NCT01376245|155820539|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
48445868|NCT01376245|155820540|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
48445869|NCT01376245|155820541|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
48445870|NCT01376245|155820537|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48445871|NCT01376245|155820538|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
48445872|NCT01376245|155820539|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48445873|NCT01376245|155820540|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
48445874|NCT01376245|155820541|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
48445875|NCT01376245|155820537|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48445876|NCT01376245|155820538|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
48445877|NCT01376245|155820539|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
48445878|NCT01376245|155820540|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
48445879|NCT01376245|155820541|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
48445880|NCT01376245|155820537|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48445881|NCT01376245|155820538|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
48445882|NCT01376245|155820539|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48445883|NCT01376245|155820540|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48445884|NCT01376245|155820541|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
48445885|NCT01376245|155820537|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
48445886|NCT01376245|155820538|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
48445887|NCT01376245|155820539|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
48445888|NCT01376245|155820540|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
48445889|NCT01376245|155820541|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
48445890|NCT01376245|155820537|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48445891|NCT01376245|155820538|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
48445892|NCT01376245|155820539|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
48445893|NCT01376245|155820540|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
48445894|NCT01376245|155820541|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
48445895|NCT01040845|155820542|FG000|Overall Study|Withdrawal by Subject|1|||
48445896|NCT01040845|155820543|FG001|Overall Study|Withdrawal by Subject|1|||
48445897|NCT01040845|155820542|FG000|Overall Study|Physician Decision|1|||
48445898|NCT01040845|155820543|FG001|Overall Study|Physician Decision|0|||
48445899|NCT00961116|155820544|FG000|Washout Period of 7 Days|Adverse Event|1|||
48445900|NCT00961116|155820545|FG001|Washout Period of 7 Days|Adverse Event|1|||
48445901|NCT00961116|155820544|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
48445902|NCT00961116|155820545|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48445903|NCT00961116|155820544|FG000|Washout Period of 7 Days|Protocol Violation|0|||
48445904|NCT00961116|155820545|FG001|Washout Period of 7 Days|Protocol Violation|1|||
48445905|NCT03407170|155820546|FG000|Overall Study|Adverse Event|1|||
48445906|NCT00050960|155820547|FG000|Overall Study|Progressive Disease|137|||
48445907|NCT00050960|155820548|FG001|Overall Study|Progressive Disease|93|||
48445908|NCT00050960|155820547|FG000|Overall Study|Stable Disease|19|||
48445909|NCT00050960|155820548|FG001|Overall Study|Stable Disease|48|||
48445910|NCT00050960|155820547|FG000|Overall Study|Partial Response|14|||
48445996|NCT05567393|155820575|FG008|Overall Study|Voluntary Withdrawal|0|||
48445997|NCT05567393|155820576|FG009|Overall Study|Voluntary Withdrawal|0|||
48445998|NCT05567393|155820577|FG010|Overall Study|Voluntary Withdrawal|0|||
48445999|NCT05567393|155820578|FG011|Overall Study|Voluntary Withdrawal|0|||
48446000|NCT05567393|155820579|FG012|Overall Study|Voluntary Withdrawal|0|||
48446001|NCT05567393|155820580|FG013|Overall Study|Voluntary Withdrawal|1|||
48446002|NCT05567393|155820581|FG014|Overall Study|Voluntary Withdrawal|0|||
48446003|NCT05567393|155820582|FG015|Overall Study|Voluntary Withdrawal|0|||
48446004|NCT05567393|155820583|FG016|Overall Study|Voluntary Withdrawal|0|||
48446005|NCT05567393|155820584|FG017|Overall Study|Voluntary Withdrawal|0|||
48446006|NCT01270958|155820590|FG000|Overall Study|Lost to Follow-up|2|||
48446007|NCT01270958|155820590|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
48446008|NCT05563714|155820593|FG000|Overall Study|Death|2|||
48446009|NCT05563714|155820594|FG001|Overall Study|Death|2|||
48446010|NCT05563714|155820595|FG002|Overall Study|Death|0|||
48446011|NCT05563714|155820596|FG003|Overall Study|Death|0|||
48446012|NCT05563714|155820593|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
48446013|NCT05563714|155820594|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
48446014|NCT05563714|155820595|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
48446015|NCT05563714|155820596|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
48446016|NCT05563714|155820593|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
48446017|NCT05563714|155820594|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
48446018|NCT05563714|155820595|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
48446019|NCT05563714|155820596|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
48446020|NCT05563714|155820593|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
48446021|NCT05563714|155820594|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
48446022|NCT05563714|155820595|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
48446023|NCT05563714|155820596|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
48446024|NCT05563714|155820593|FG000|Overall Study|Lost to Follow-up|22|||
48446025|NCT05563714|155820594|FG001|Overall Study|Lost to Follow-up|19|||
48446026|NCT05563714|155820595|FG002|Overall Study|Lost to Follow-up|0|||
48446027|NCT05563714|155820596|FG003|Overall Study|Lost to Follow-up|0|||
48446028|NCT00141037|155820599|FG000|Overall Study|Physician Decision|1|||
48446029|NCT00141037|155820600|FG001|Overall Study|Physician Decision|2|||
48446030|NCT00141037|155820599|FG000|Overall Study|Lost to Follow-up|3|||
48446031|NCT00141037|155820600|FG001|Overall Study|Lost to Follow-up|1|||
48446032|NCT00141037|155820599|FG000|Overall Study|Protocol Violation|0|||
48446033|NCT00141037|155820600|FG001|Overall Study|Protocol Violation|2|||
48446034|NCT00141037|155820599|FG000|Overall Study|Withdrawal by Subject|2|||
48446035|NCT00141037|155820600|FG001|Overall Study|Withdrawal by Subject|1|||
48446036|NCT00141037|155820599|FG000|Overall Study|Other|0|||
48446037|NCT00141037|155820600|FG001|Overall Study|Other|1|||
48446038|NCT00141037|155820599|FG000|Overall Study|Moved from area|1|||
48446039|NCT00141037|155820600|FG001|Overall Study|Moved from area|7|||
48446040|NCT00141037|155820599|FG000|Overall Study|Graft Failure|3|||
48446041|NCT00141037|155820600|FG001|Overall Study|Graft Failure|4|||
48446042|NCT00260429|155820603|FG000|Overall Study|failure to follow appointments|1|||
48446043|NCT00260429|155820604|FG001|Overall Study|failure to follow appointments|0|||
48446044|NCT00260429|155820603|FG000|Overall Study|scheduled hand surgery|1|||
48446045|NCT00260429|155820604|FG001|Overall Study|scheduled hand surgery|0|||
48446046|NCT00861380|155820605|FG000|Overall Study|Withdrawal Information not recorded|8427|||
48446047|NCT00861380|155820606|FG001|Overall Study|Withdrawal Information not recorded|9112|||
48446048|NCT00861380|155820607|FG002|Overall Study|Withdrawal Information not recorded|8872|||
48446049|NCT00861380|155820608|FG003|Overall Study|Withdrawal Information not recorded|3689|||
48446050|NCT00861380|155820609|FG004|Overall Study|Withdrawal Information not recorded|1812|||
48446051|NCT00861380|155820610|FG005|Overall Study|Withdrawal Information not recorded|6249|||
48446052|NCT00861380|155820611|FG006|Overall Study|Withdrawal Information not recorded|3020|||
48446053|NCT00628758|155820615|FG000|Overall Study|Adverse Event|2|||
48446054|NCT00628758|155820616|FG001|Overall Study|Adverse Event|3|||
48446055|NCT00628758|155820615|FG000|Overall Study|Withdrawal by Subject|6|||
48446056|NCT00628758|155820616|FG001|Overall Study|Withdrawal by Subject|3|||
48446057|NCT00628758|155820615|FG000|Overall Study|Death|1|||
48446058|NCT00628758|155820616|FG001|Overall Study|Death|0|||
48446059|NCT00628758|155820615|FG000|Overall Study|Protocol Violation|5|||
48446060|NCT00628758|155820616|FG001|Overall Study|Protocol Violation|1|||
48446061|NCT00628758|155820615|FG000|Overall Study|Lost to Follow-up|25|||
48446062|NCT00628758|155820616|FG001|Overall Study|Lost to Follow-up|31|||
48446063|NCT00628758|155820615|FG000|Overall Study|Pregnancy|2|||
48446064|NCT00628758|155820616|FG001|Overall Study|Pregnancy|2|||
48446065|NCT00628758|155820615|FG000|Overall Study|Investigator Moved|3|||
48446066|NCT00628758|155820616|FG001|Overall Study|Investigator Moved|0|||
48446087|NCT03287869|155822260|FG000|Overall Study|Non-Compliance With Study Drug|5|||
48446088|NCT03287869|155822261|FG001|Overall Study|Non-Compliance With Study Drug|9|||
48446089|NCT03287869|155822260|FG000|Overall Study|Progressive Disease|1|||
48446090|NCT03287869|155822261|FG001|Overall Study|Progressive Disease|0|||
48446091|NCT03287869|155822260|FG000|Overall Study|Protocol Deviation|2|||
48446092|NCT03287869|155822261|FG001|Overall Study|Protocol Deviation|1|||
48446093|NCT03287869|155822260|FG000|Overall Study|Withdrawal by Subject|36|||
48446094|NCT03287869|155822261|FG001|Overall Study|Withdrawal by Subject|43|||
48446095|NCT03287869|155822260|FG000|Overall Study|Early Closure of the Site|0|||
48446096|NCT03287869|155822261|FG001|Overall Study|Early Closure of the Site|1|||
48446097|NCT03287869|155822260|FG000|Overall Study|Physician Decision|5|||
48446098|NCT03287869|155822261|FG001|Overall Study|Physician Decision|5|||
48446099|NCT03287869|155822260|FG000|Overall Study|Reason not Specified|6|||
48446100|NCT03287869|155822261|FG001|Overall Study|Reason not Specified|3|||
48446101|NCT03488238|155822262|FG000|Overall Study|Equipment malfunction|1|||
48446102|NCT03488238|155822262|FG000|Overall Study|Adverse Event|1|||
48446103|NCT02282982|155822266|FG000|Overall Study|Lost to Follow-up|15|||
48446104|NCT02282982|155822266|FG000|Overall Study|Withdrew consent|2|||
48446105|NCT02282982|155822266|FG000|Overall Study|Death|4|||
48446106|NCT02282982|155822266|FG000|Overall Study|Lack of product|156|||
48446107|NCT02282982|155822266|FG000|Overall Study|Palivizumab is ended|11|||
48446108|NCT02282982|155822266|FG000|Overall Study|Other, not specified|18|||
48446109|NCT01297309|155822267|FG000|Overall Study|Eligibility failure|2|||
48446110|NCT01297309|155822267|FG000|Overall Study|Screen failure|2|||
48446111|NCT01297309|155822267|FG000|Overall Study|Withdrawal by Subject|5|||
48446112|NCT01297309|155822267|FG000|Overall Study|Adverse Event|1|||
48446113|NCT01297309|155822267|FG000|Overall Study|Investigator Decision|2|||
48446114|NCT01297309|155822267|FG000|Overall Study|Death|1|||
48446115|NCT01297309|155822267|FG000|Overall Study|Participant not entering extensionperiod|1|||
48446116|NCT03039738|155822268|FG000|Overall Study|Incomplete data sets|54|||
48446117|NCT03039738|155822269|FG001|Overall Study|Incomplete data sets|0|||
48446118|NCT00728936|155822271|FG000|Overall Study|Withdrawal by Subject|0|||
48446119|NCT00728936|155822272|FG001|Overall Study|Withdrawal by Subject|0|||
48446120|NCT00728936|155822273|FG002|Overall Study|Withdrawal by Subject|0|||
48446121|NCT00728936|155822274|FG003|Overall Study|Withdrawal by Subject|0|||
48446122|NCT00728936|155822275|FG004|Overall Study|Withdrawal by Subject|0|||
48446123|NCT00728936|155822276|FG005|Overall Study|Withdrawal by Subject|1|||
48446124|NCT00728936|155822277|FG006|Overall Study|Withdrawal by Subject|0|||
48446125|NCT00132314|155822278|FG000|Overall Study|Lost to Follow-up|70|||
48446126|NCT00132314|155822279|FG001|Overall Study|Lost to Follow-up|62|||
48446127|NCT00132314|155822278|FG000|Overall Study|Lacked SSN|1|||
48446128|NCT00132314|155822279|FG001|Overall Study|Lacked SSN|3|||
48446129|NCT00132314|155822278|FG000|Overall Study|Refused intervention at baseline|2|||
48446130|NCT00132314|155822279|FG001|Overall Study|Refused intervention at baseline|7|||
48446131|NCT00415519|155822283|FG000|Overall Study|Adverse Event|1|||
48446132|NCT00415519|155822284|FG001|Overall Study|Adverse Event|0|||
48446133|NCT00415519|155822283|FG000|Overall Study|Withdrawal by Subject|2|||
48446134|NCT00415519|155822284|FG001|Overall Study|Withdrawal by Subject|0|||
48446135|NCT00415519|155822283|FG000|Overall Study|Patient's convenience|1|||
48446136|NCT00415519|155822284|FG001|Overall Study|Patient's convenience|0|||
48446137|NCT01373918|155822285|FG000|Overall Study|Physician Decision|0|||
48446138|NCT01373918|155822286|FG001|Overall Study|Physician Decision|1|||
48446139|NCT03004976|155822287|FG000|Overall Study|Lost to Follow-up|7|||
48446140|NCT03004976|155822288|FG001|Overall Study|Lost to Follow-up|5|||
48446141|NCT03004976|155822287|FG000|Overall Study|Physician Decision|1|||
48446142|NCT03004976|155822288|FG001|Overall Study|Physician Decision|0|||
48446143|NCT03004976|155822287|FG000|Overall Study|Withdrawal by Subject|1|||
48446144|NCT03004976|155822288|FG001|Overall Study|Withdrawal by Subject|0|||
48446145|NCT03004976|155822287|FG000|Overall Study|Death|4|||
48446146|NCT03004976|155822288|FG001|Overall Study|Death|1|||
48446147|NCT01143714|155822292|FG000|Overall Study|Adverse Event|4|||
48446148|NCT01143714|155822293|FG001|Overall Study|Adverse Event|2|||
48446149|NCT01143714|155822292|FG000|Overall Study|Withdrawal by Subject|1|||
48446150|NCT01143714|155822293|FG001|Overall Study|Withdrawal by Subject|0|||
48446151|NCT01143714|155822292|FG000|Overall Study|Subject non-compliance|0|||
48446152|NCT01143714|155822293|FG001|Overall Study|Subject non-compliance|1|||
48446153|NCT01143714|155822292|FG000|Overall Study|wound closed = deemed healed|1|||
48446154|NCT01143714|155822293|FG001|Overall Study|wound closed = deemed healed|0|||
48446155|NCT01143714|155822292|FG000|Overall Study|wound size increased|1|||
48446156|NCT01143714|155822293|FG001|Overall Study|wound size increased|0|||
48446157|NCT01807949|155822294|FG000|Overall Study|Adverse Event|1|||
48446158|NCT01807949|155822295|FG001|Overall Study|Adverse Event|2|||
48446159|NCT01807949|155822296|FG002|Overall Study|Adverse Event|2|||
48446160|NCT01807949|155822294|FG000|Overall Study|Withdrawal by Subject|1|||
48446161|NCT01807949|155822295|FG001|Overall Study|Withdrawal by Subject|2|||
48446162|NCT01807949|155822296|FG002|Overall Study|Withdrawal by Subject|2|||
48446163|NCT01807949|155822294|FG000|Overall Study|Non-Compliance|0|||
48446164|NCT01807949|155822295|FG001|Overall Study|Non-Compliance|0|||
48446179|NCT00407550|155822298|FG001|Overall Study|Insurance or Other medical condition|1|||
48446180|NCT02141217|155822299|FG000|Overall Study|Adverse Event|1|||
48446181|NCT02141217|155822300|FG001|Overall Study|Adverse Event|2|||
48446182|NCT02141217|155822299|FG000|Overall Study|Protocol Violation|1|||
48446183|NCT02141217|155822300|FG001|Overall Study|Protocol Violation|4|||
48446184|NCT02141217|155822299|FG000|Overall Study|Withdrawal by Subject|6|||
48446185|NCT02141217|155822300|FG001|Overall Study|Withdrawal by Subject|0|||
48446186|NCT02141217|155822299|FG000|Overall Study|Lost to Follow-up|1|||
48446187|NCT02141217|155822300|FG001|Overall Study|Lost to Follow-up|1|||
48446188|NCT02141217|155822299|FG000|Overall Study|Physician Decision|1|||
48446189|NCT02141217|155822300|FG001|Overall Study|Physician Decision|0|||
48446190|NCT02141217|155822299|FG000|Overall Study|Surgical Intervention|1|||
48446191|NCT02141217|155822300|FG001|Overall Study|Surgical Intervention|1|||
48446192|NCT02759861|155822305|FG000|Overall Study|Death|1|||
48446193|NCT01522443|155822308|FG000|Overall Study|No longer receiving clinical benefit|36|||
48446194|NCT01522443|155822309|FG001|Overall Study|No longer receiving clinical benefit|28|||
48446195|NCT01522443|155822308|FG000|Overall Study|Adverse Event|10|||
48446196|NCT01522443|155822309|FG001|Overall Study|Adverse Event|15|||
48446197|NCT01522443|155822308|FG000|Overall Study|Withdrawal by Subject|5|||
48446198|NCT01522443|155822309|FG001|Overall Study|Withdrawal by Subject|8|||
48446199|NCT01522443|155822308|FG000|Overall Study|No study treatment given|1|||
48446200|NCT01522443|155822309|FG001|Overall Study|No study treatment given|1|||
48446201|NCT01522443|155822308|FG000|Overall Study|Other|1|||
48446202|NCT01522443|155822309|FG001|Overall Study|Other|3|||
48446203|NCT00990249|155822319|FG000|Overall Study|Disease Progression|8|||
48446204|NCT00990249|155822319|FG000|Overall Study|Non-Compliance|1|||
48446205|NCT00990249|155822319|FG000|Overall Study|Death|2|||
48446206|NCT00990249|155822319|FG000|Overall Study|Not treated|2|||
48446207|NCT00810810|155822320|FG000|Overall Study|Withdrawal by Subject|0|||
48446208|NCT00810810|155822321|FG001|Overall Study|Withdrawal by Subject|8|||
48446209|NCT00810810|155822322|FG002|Overall Study|Withdrawal by Subject|10|||
48446210|NCT00810810|155822323|FG003|Overall Study|Withdrawal by Subject|8|||
48446211|NCT00810810|155822320|FG000|Overall Study|Physician Decision|0|||
48446212|NCT00810810|155822321|FG001|Overall Study|Physician Decision|3|||
48446213|NCT00810810|155822322|FG002|Overall Study|Physician Decision|1|||
48446214|NCT00810810|155822323|FG003|Overall Study|Physician Decision|5|||
48446215|NCT02563925|155822326|FG000|Overall Study|Withdrawal by Subject|2|||
48446216|NCT01504971|155822333|FG000|Overall Study|Physician Decision|13|||
48446217|NCT01342952|155822334|FG000|Overall Study|Adverse Event|0|||
48446218|NCT01342952|155822335|FG001|Overall Study|Adverse Event|5|||
48446219|NCT01342952|155822336|FG002|Overall Study|Adverse Event|1|||
48446220|NCT01342952|155822337|FG003|Overall Study|Adverse Event|0|||
48446221|NCT01342952|155822334|FG000|Overall Study|Lost to Follow-up|0|||
48446222|NCT01342952|155822335|FG001|Overall Study|Lost to Follow-up|2|||
48446223|NCT01342952|155822336|FG002|Overall Study|Lost to Follow-up|0|||
48446224|NCT01342952|155822337|FG003|Overall Study|Lost to Follow-up|0|||
48446225|NCT01342952|155822334|FG000|Overall Study|Withdrawal by Subject|1|||
48446226|NCT01342952|155822335|FG001|Overall Study|Withdrawal by Subject|1|||
48446227|NCT01342952|155822336|FG002|Overall Study|Withdrawal by Subject|0|||
48446228|NCT01342952|155822337|FG003|Overall Study|Withdrawal by Subject|0|||
48446229|NCT01342952|155822334|FG000|Overall Study|Physician Decision|3|||
48446230|NCT01342952|155822335|FG001|Overall Study|Physician Decision|3|||
48446231|NCT01342952|155822336|FG002|Overall Study|Physician Decision|1|||
48446232|NCT01342952|155822337|FG003|Overall Study|Physician Decision|0|||
48446233|NCT02156804|155822338|FG000|Overall Study|Withdrawal by Subject|1|||
48446234|NCT03228394|155822339|FG000|Overall Study|Lost to Follow-up|0|||
48446235|NCT03228394|155822340|FG001|Overall Study|Lost to Follow-up|0|||
48446236|NCT03228394|155822341|FG002|Overall Study|Lost to Follow-up|1|||
48446237|NCT03228394|155822342|FG003|Overall Study|Lost to Follow-up|1|||
48446238|NCT03228394|155822343|FG004|Overall Study|Lost to Follow-up|0|||
48446239|NCT03228394|155822344|FG005|Overall Study|Lost to Follow-up|0|||
48446240|NCT03228394|155822345|FG006|Overall Study|Lost to Follow-up|2|||
48446241|NCT03228394|155822346|FG007|Overall Study|Lost to Follow-up|0|||
48446242|NCT03228394|155822339|FG000|Overall Study|Withdrawal by Subject|0|||
48446243|NCT03228394|155822340|FG001|Overall Study|Withdrawal by Subject|0|||
48446244|NCT03228394|155822341|FG002|Overall Study|Withdrawal by Subject|1|||
48446245|NCT03228394|155822342|FG003|Overall Study|Withdrawal by Subject|0|||
48446246|NCT03228394|155822343|FG004|Overall Study|Withdrawal by Subject|0|||
48446247|NCT03228394|155822344|FG005|Overall Study|Withdrawal by Subject|0|||
48446248|NCT03228394|155822345|FG006|Overall Study|Withdrawal by Subject|1|||
48446249|NCT03228394|155822346|FG007|Overall Study|Withdrawal by Subject|3|||
48446250|NCT03228394|155822339|FG000|Overall Study|Protocol Violation|0|||
48446251|NCT03228394|155822340|FG001|Overall Study|Protocol Violation|0|||
48446252|NCT03228394|155822341|FG002|Overall Study|Protocol Violation|0|||
48446253|NCT03228394|155822342|FG003|Overall Study|Protocol Violation|1|||
48446254|NCT03228394|155822343|FG004|Overall Study|Protocol Violation|0|||
48446255|NCT03228394|155822344|FG005|Overall Study|Protocol Violation|0|||
48446256|NCT03228394|155822345|FG006|Overall Study|Protocol Violation|0|||
48446257|NCT03228394|155822346|FG007|Overall Study|Protocol Violation|0|||
48446326|NCT00389441|155822364|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
48446327|NCT00389441|155822364|FG000|Overall Study|Clinical progression|1|||
48446328|NCT01732107|155822365|FG000|Overall Study|Adverse Event|2|||
48446329|NCT01732107|155822365|FG000|Overall Study|Disease Progression|8|||
48446330|NCT01732107|155822365|FG000|Overall Study|Physician Decision|1|||
48446331|NCT01732107|155822365|FG000|Overall Study|Withdrawal by Subject|2|||
48446332|NCT01162304|155822375|FG000|Overall Study|Beck scale to high|11|||
48446333|NCT00637377|155822379|FG000|Overall Study|Adverse Event|2|||
48446334|NCT00637377|155822380|FG001|Overall Study|Adverse Event|6|||
48446335|NCT00637377|155822381|FG002|Overall Study|Adverse Event|8|||
48446336|NCT00637377|155822382|FG003|Overall Study|Adverse Event|9|||
48446337|NCT00637377|155822379|FG000|Overall Study|Death|1|||
48446338|NCT00637377|155822380|FG001|Overall Study|Death|3|||
48446339|NCT00637377|155822381|FG002|Overall Study|Death|2|||
48446340|NCT00637377|155822382|FG003|Overall Study|Death|1|||
48446341|NCT00637377|155822379|FG000|Overall Study|Lack of Efficacy|0|||
48446342|NCT00637377|155822380|FG001|Overall Study|Lack of Efficacy|0|||
48446343|NCT00637377|155822381|FG002|Overall Study|Lack of Efficacy|1|||
48446344|NCT00637377|155822382|FG003|Overall Study|Lack of Efficacy|1|||
48446345|NCT00637377|155822379|FG000|Overall Study|Lost to Follow-up|4|||
48446346|NCT00637377|155822380|FG001|Overall Study|Lost to Follow-up|1|||
48446347|NCT00637377|155822381|FG002|Overall Study|Lost to Follow-up|2|||
48446348|NCT00637377|155822382|FG003|Overall Study|Lost to Follow-up|2|||
48446349|NCT00637377|155822379|FG000|Overall Study|Protocol Violation|2|||
48446350|NCT00637377|155822380|FG001|Overall Study|Protocol Violation|1|||
48446351|NCT00637377|155822381|FG002|Overall Study|Protocol Violation|1|||
48446352|NCT00637377|155822382|FG003|Overall Study|Protocol Violation|0|||
48446353|NCT00637377|155822379|FG000|Overall Study|Withdrawal by Subject|11|||
48446354|NCT00637377|155822380|FG001|Overall Study|Withdrawal by Subject|15|||
48446355|NCT00637377|155822381|FG002|Overall Study|Withdrawal by Subject|13|||
48446356|NCT00637377|155822382|FG003|Overall Study|Withdrawal by Subject|11|||
48446357|NCT00637377|155822379|FG000|Overall Study|Other (no further information available)|7|||
48446358|NCT00637377|155822380|FG001|Overall Study|Other (no further information available)|6|||
48446359|NCT00637377|155822381|FG002|Overall Study|Other (no further information available)|10|||
48446360|NCT00637377|155822382|FG003|Overall Study|Other (no further information available)|5|||
48446361|NCT01938001|155822387|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
48446362|NCT01938001|155822388|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
48446363|NCT01938001|155822387|FG000|Pre-Treatment|Death|1|||
48446364|NCT01938001|155822388|FG001|Pre-Treatment|Death|0|||
48446365|NCT01938001|155822387|FG000|Treatment|Death|2|||
48446366|NCT01938001|155822388|FG001|Treatment|Death|0|||
48446367|NCT01938001|155822387|FG000|Treatment|Adverse Event|14|||
48446368|NCT01938001|155822388|FG001|Treatment|Adverse Event|8|||
48446369|NCT01938001|155822387|FG000|Treatment|Progressive Disease|21|||
48446370|NCT01938001|155822388|FG001|Treatment|Progressive Disease|54|||
48446371|NCT01938001|155822387|FG000|Treatment|Withdrawal by Subject|13|||
48446372|NCT01938001|155822388|FG001|Treatment|Withdrawal by Subject|7|||
48446373|NCT01938001|155822387|FG000|Treatment|Other reasons|2|||
48446374|NCT01938001|155822388|FG001|Treatment|Other reasons|1|||
48446375|NCT00970268|155822389|FG000|Overall Study|Withdrawal by Subject|12|||
48446376|NCT00970268|155822390|FG001|Overall Study|Withdrawal by Subject|19|||
48446377|NCT00970268|155822389|FG000|Overall Study|Adverse Event|15|||
48446378|NCT00970268|155822390|FG001|Overall Study|Adverse Event|12|||
48446379|NCT00970268|155822389|FG000|Overall Study|Lack of Efficacy|3|||
48446380|NCT00970268|155822390|FG001|Overall Study|Lack of Efficacy|6|||
48446381|NCT00970268|155822389|FG000|Overall Study|Protocol Violation|4|||
48446382|NCT00970268|155822390|FG001|Overall Study|Protocol Violation|7|||
48446383|NCT00970268|155822389|FG000|Overall Study|Other Reason|3|||
48446384|NCT00970268|155822390|FG001|Overall Study|Other Reason|1|||
48446385|NCT00970268|155822389|FG000|Overall Study|COPD Exacerbation|4|||
48446386|NCT00970268|155822390|FG001|Overall Study|COPD Exacerbation|2|||
48446387|NCT00970268|155822389|FG000|Overall Study|Lost to Follow-up|1|||
48446388|NCT00970268|155822390|FG001|Overall Study|Lost to Follow-up|2|||
48446389|NCT00970268|155822389|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
48446390|NCT00970268|155822390|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
48446391|NCT03032510|155822391|FG000|Overall Study|Adverse Event|5|||
48446392|NCT03032510|155822392|FG001|Overall Study|Adverse Event|2|||
48446393|NCT03032510|155822391|FG000|Overall Study|Lost to Follow-up|8|||
48446394|NCT03032510|155822392|FG001|Overall Study|Lost to Follow-up|7|||
48446395|NCT03032510|155822391|FG000|Overall Study|Withdrawal by Subject|8|||
48446396|NCT03032510|155822392|FG001|Overall Study|Withdrawal by Subject|7|||
48446397|NCT03032510|155822391|FG000|Overall Study|Subject noncompliance|4|||
48446398|NCT03032510|155822392|FG001|Overall Study|Subject noncompliance|2|||
48446399|NCT03032510|155822391|FG000|Overall Study|Physician Decision|2|||
48446400|NCT03032510|155822392|FG001|Overall Study|Physician Decision|0|||
48446401|NCT03310580|155822396|FG000|Overall Study|Adverse Event|0|||
48446402|NCT03310580|155822397|FG001|Overall Study|Adverse Event|1|||
48446403|NCT03310580|155822398|FG002|Overall Study|Adverse Event|0|||
48446404|NCT02633046|155822399|FG000|Overall Study|Adverse Event|8|||
48446442|NCT02670928|155824349|FG001|Overall Study|Withdrawal by Subject|0|||
48446443|NCT02670928|155824348|FG000|Overall Study|Lost to Follow-up|1|||
48446444|NCT02670928|155824349|FG001|Overall Study|Lost to Follow-up|0|||
48446445|NCT02670928|155824348|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
48446446|NCT02670928|155824349|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
48446447|NCT04681729|155824350|FG000|Overall Study|Lack of Efficacy|2|||
48446448|NCT04681729|155824351|FG001|Overall Study|Lack of Efficacy|2|||
48446449|NCT04681729|155824350|FG000|Overall Study|Withdrawal by Subject|8|||
48446450|NCT04681729|155824351|FG001|Overall Study|Withdrawal by Subject|9|||
48446451|NCT02678312|155824352|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
48446452|NCT02678312|155824353|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
48446453|NCT02678312|155824354|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
48446454|NCT02678312|155824355|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
48446455|NCT02678312|155824356|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
48446456|NCT02678312|155824352|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
48446457|NCT02678312|155824353|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
48446458|NCT02678312|155824354|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
48446459|NCT02678312|155824355|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
48446460|NCT02678312|155824356|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
48446461|NCT02678312|155824352|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
48446462|NCT02678312|155824353|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
48446463|NCT02678312|155824354|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
48446464|NCT02678312|155824355|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
48446465|NCT02678312|155824356|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
48446466|NCT02678312|155824352|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
48446467|NCT02678312|155824353|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
48446468|NCT02678312|155824354|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
48446469|NCT02678312|155824355|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
48446470|NCT02678312|155824356|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
48446471|NCT02678312|155824352|FG000|Part 2 Double Blind Epoch|Death|0|||
48446472|NCT02678312|155824353|FG001|Part 2 Double Blind Epoch|Death|0|||
48446473|NCT02678312|155824354|FG002|Part 2 Double Blind Epoch|Death|0|||
48446474|NCT02678312|155824355|FG003|Part 2 Double Blind Epoch|Death|8|||
48446475|NCT02678312|155824356|FG004|Part 2 Double Blind Epoch|Death|12|||
48446476|NCT02678312|155824352|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
48446477|NCT02678312|155824353|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
48446478|NCT02678312|155824354|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
48446479|NCT02678312|155824355|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
48446480|NCT02678312|155824356|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
48446481|NCT02678312|155824352|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
48446482|NCT02678312|155824353|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
48446483|NCT02678312|155824354|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
48446484|NCT02678312|155824355|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
48446485|NCT02678312|155824356|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
48446486|NCT02678312|155824352|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
48446487|NCT02678312|155824353|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
48446488|NCT02678312|155824354|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
48446489|NCT02678312|155824355|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
48446490|NCT02678312|155824356|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
48446491|NCT00912340|155824359|FG000|Overall Study|Adverse Event|2|||
48446492|NCT00912340|155824360|FG001|Overall Study|Adverse Event|4|||
48446493|NCT00912340|155824361|FG002|Overall Study|Adverse Event|0|||
48446494|NCT00912340|155824359|FG000|Overall Study|Protocol revised to remove arm|0|||
48446495|NCT00912340|155824360|FG001|Overall Study|Protocol revised to remove arm|0|||
48446496|NCT00912340|155824361|FG002|Overall Study|Protocol revised to remove arm|4|||
48446497|NCT01517412|155824364|FG000|Overall Study|Adverse Event|10|||
48446498|NCT01517412|155824365|FG001|Overall Study|Adverse Event|11|||
48446499|NCT01517412|155824364|FG000|Overall Study|Lack of Efficacy|10|||
48446500|NCT01517412|155824365|FG001|Overall Study|Lack of Efficacy|5|||
48446501|NCT01517412|155824364|FG000|Overall Study|Poor compliance to protocol|8|||
48446502|NCT01517412|155824365|FG001|Overall Study|Poor compliance to protocol|3|||
48446503|NCT01517412|155824364|FG000|Overall Study|Other than specified above|8|||
48446504|NCT01517412|155824365|FG001|Overall Study|Other than specified above|5|||
48446505|NCT02591238|155824368|FG000|Overall Study|Pregnancy|1|||
48446506|NCT02591238|155824369|FG001|Overall Study|Pregnancy|0|||
48446507|NCT02591238|155824370|FG002|Overall Study|Pregnancy|0|||
48446508|NCT02591238|155824371|FG003|Overall Study|Pregnancy|0|||
48446509|NCT02591238|155824368|FG000|Overall Study|Withdrawal by Subject|0|||
48446510|NCT02591238|155824369|FG001|Overall Study|Withdrawal by Subject|0|||
48446511|NCT02591238|155824370|FG002|Overall Study|Withdrawal by Subject|0|||
48446512|NCT02591238|155824371|FG003|Overall Study|Withdrawal by Subject|1|||
48446513|NCT02591238|155824368|FG000|Overall Study|influenza|0|||
48446514|NCT02591238|155824369|FG001|Overall Study|influenza|0|||
48446515|NCT02591238|155824370|FG002|Overall Study|influenza|0|||
48446564|NCT02528253|155824375|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
48446565|NCT02528253|155824376|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
48446566|NCT02528253|155824377|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
48446567|NCT02528253|155824378|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
48446568|NCT02528253|155824379|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
48446569|NCT02759562|155824380|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
48446570|NCT02759562|155824381|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
48446571|NCT02759562|155824380|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
48446572|NCT02759562|155824381|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
48446573|NCT03628599|155824382|FG000|Overall Study|Adverse Event|0|||
48446574|NCT03628599|155824383|FG001|Overall Study|Adverse Event|1|||
48446575|NCT02966353|155824384|FG000|Overall Study|Withdrawal by Subject|7|||
48446576|NCT02966353|155824384|FG000|Overall Study|Adverse Event|4|||
48446577|NCT02966353|155824384|FG000|Overall Study|Death|4|||
48446578|NCT02966353|155824384|FG000|Overall Study|Physician Decision|3|||
48446579|NCT02966353|155824384|FG000|Overall Study|Progressive disease|2|||
48446580|NCT02966353|155824384|FG000|Overall Study|Protocol deviation|2|||
48446581|NCT01797445|155824385|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
48446582|NCT01797445|155824386|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
48446583|NCT01797445|155824385|FG000|Double-Blind Phase|Adverse Event|3|||
48446584|NCT01797445|155824386|FG001|Double-Blind Phase|Adverse Event|0|||
48446585|NCT01797445|155824385|FG000|Double-Blind Phase|Death|5|||
48446586|NCT01797445|155824386|FG001|Double-Blind Phase|Death|4|||
48446587|NCT01797445|155824385|FG000|Double-Blind Phase|Pregnancy|0|||
48446588|NCT01797445|155824386|FG001|Double-Blind Phase|Pregnancy|1|||
48446589|NCT01797445|155824385|FG000|Double-Blind Phase|Lack of Efficacy|1|||
48446590|NCT01797445|155824386|FG001|Double-Blind Phase|Lack of Efficacy|2|||
48446591|NCT01797445|155824385|FG000|Double-Blind Phase|Investigator's Discretion|15|||
48446592|NCT01797445|155824386|FG001|Double-Blind Phase|Investigator's Discretion|17|||
48446593|NCT01797445|155824385|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
48446594|NCT01797445|155824386|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
48446595|NCT01797445|155824385|FG000|Double-Blind Phase|Protocol Violation|0|||
48446596|NCT01797445|155824386|FG001|Double-Blind Phase|Protocol Violation|1|||
48446597|NCT01797445|155824385|FG000|Double-Blind Phase|Withdrew Consent|20|||
48446598|NCT01797445|155824386|FG001|Double-Blind Phase|Withdrew Consent|35|||
48446599|NCT01797445|155824385|FG000|Double-Blind Phase|Lost to Follow-up|34|||
48446600|NCT01797445|155824386|FG001|Double-Blind Phase|Lost to Follow-up|26|||
48446601|NCT01797445|155824385|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
48446602|NCT01797445|155824386|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
48446603|NCT04295356|155824387|FG000|Overall Study|Physician Decision|1|||
48446604|NCT04295356|155824388|FG001|Overall Study|Physician Decision|0|||
48446605|NCT04295356|155824387|FG000|Overall Study|Lost to Follow-up|0|||
48446606|NCT04295356|155824388|FG001|Overall Study|Lost to Follow-up|3|||
48446607|NCT04295356|155824387|FG000|Overall Study|Protocol Violation|0|||
48446608|NCT04295356|155824388|FG001|Overall Study|Protocol Violation|1|||
48446609|NCT01457924|155824389|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
48446610|NCT01457924|155824390|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
48446611|NCT01457924|155824391|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
48446612|NCT01457924|155824392|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
48446613|NCT01457924|155824393|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
48446614|NCT01457924|155824389|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
48446615|NCT01457924|155824390|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
48446616|NCT01457924|155824391|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
48446617|NCT01457924|155824392|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
48446618|NCT01457924|155824393|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
48446619|NCT01457924|155824389|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
48446620|NCT01457924|155824390|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
48446621|NCT01457924|155824391|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
48446622|NCT01457924|155824392|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
48446623|NCT01457924|155824393|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
48446624|NCT01457924|155824389|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
48446625|NCT01457924|155824390|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
48446626|NCT01457924|155824391|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
48446627|NCT01457924|155824392|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
48446628|NCT01457924|155824393|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
48446629|NCT01457924|155824389|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
48446630|NCT01457924|155824390|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
48446631|NCT01457924|155824391|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
48446632|NCT01457924|155824392|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
48446633|NCT01457924|155824393|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
48446634|NCT01457924|155824389|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
48446635|NCT01457924|155824390|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
48446703|NCT00813917|155824411|FG001|Overall Study|Adverse Event|1|||
48446636|NCT01457924|155824391|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
48446637|NCT01457924|155824392|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
48446638|NCT01457924|155824393|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
48446639|NCT01457924|155824389|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
48446640|NCT01457924|155824390|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
48446641|NCT01457924|155824391|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
48446642|NCT01457924|155824392|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
48446643|NCT01457924|155824393|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
48446644|NCT01457924|155824389|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
48446645|NCT01457924|155824390|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
48446646|NCT01457924|155824391|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
48446647|NCT01457924|155824392|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
48446648|NCT01457924|155824393|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
48446649|NCT01457924|155824389|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
48446650|NCT01457924|155824390|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
48446651|NCT01457924|155824391|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
48446652|NCT01457924|155824392|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
48446653|NCT01457924|155824393|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
48446654|NCT01457924|155824389|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
48446655|NCT01457924|155824390|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
48446656|NCT01457924|155824391|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
48446657|NCT01457924|155824392|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
48446658|NCT01457924|155824393|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
48446659|NCT01457924|155824389|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
48446660|NCT01457924|155824390|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
48446661|NCT01457924|155824391|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
48446662|NCT01457924|155824392|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
48446663|NCT01457924|155824393|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
48446664|NCT01457924|155824389|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
48446665|NCT01457924|155824390|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
48446666|NCT01457924|155824391|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
48446667|NCT01457924|155824392|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
48446668|NCT01457924|155824393|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
48446669|NCT01457924|155824389|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
48446670|NCT01457924|155824390|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
48446671|NCT01457924|155824391|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
48446672|NCT01457924|155824392|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
48446673|NCT01457924|155824393|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
48446674|NCT00724815|155824394|FG000|Overall Study|Randomized, not treated|31|||
48446675|NCT00724815|155824395|FG001|Overall Study|Randomized, not treated|30|||
48446676|NCT00724815|155824394|FG000|Overall Study|Adverse Event|5|||
48446677|NCT00724815|155824395|FG001|Overall Study|Adverse Event|3|||
48446678|NCT00724815|155824394|FG000|Overall Study|Lost to Follow-up|4|||
48446679|NCT00724815|155824395|FG001|Overall Study|Lost to Follow-up|1|||
48446680|NCT00724815|155824394|FG000|Overall Study|Other Various|3|||
48446681|NCT00724815|155824395|FG001|Overall Study|Other Various|5|||
48446682|NCT03235726|155824396|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446683|NCT03235726|155824397|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446684|NCT03235726|155824398|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446685|NCT03235726|155824399|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446686|NCT03235726|155824400|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
48446687|NCT03235726|155824401|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446688|NCT03235726|155824402|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446689|NCT03235726|155824403|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446690|NCT03235726|155824404|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446691|NCT03235726|155824405|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
48446692|NCT03235726|155824396|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446693|NCT03235726|155824397|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446694|NCT03235726|155824398|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446695|NCT03235726|155824399|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446696|NCT03235726|155824400|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
48446697|NCT03235726|155824401|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446698|NCT03235726|155824402|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446699|NCT03235726|155824403|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446700|NCT03235726|155824404|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446701|NCT03235726|155824405|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
48446702|NCT00813917|155824410|FG000|Overall Study|Adverse Event|0|||
48446704|NCT00813917|155824410|FG000|Overall Study|Withdrawal by Subject|3|||
48446705|NCT00813917|155824411|FG001|Overall Study|Withdrawal by Subject|4|||
48446706|NCT00813917|155824410|FG000|Overall Study|Lost to Follow-up|3|||
48446707|NCT00813917|155824411|FG001|Overall Study|Lost to Follow-up|1|||
48446708|NCT01369225|155824412|FG000|Overall Study|Withdrawal by Subject|1|||
48446709|NCT01369225|155824413|FG001|Overall Study|Withdrawal by Subject|0|||
48446710|NCT01369225|155824414|FG002|Overall Study|Withdrawal by Subject|2|||
48446711|NCT01369225|155824415|FG003|Overall Study|Withdrawal by Subject|1|||
48446712|NCT01369225|155824416|FG004|Overall Study|Withdrawal by Subject|0|||
48446713|NCT01369225|155824417|FG005|Overall Study|Withdrawal by Subject|0|||
48446714|NCT01369225|155824412|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
48446715|NCT01369225|155824413|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
48446716|NCT01369225|155824414|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
48446717|NCT01369225|155824415|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
48446718|NCT01369225|155824416|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
48446719|NCT01369225|155824417|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
48446720|NCT01369225|155824412|FG000|Overall Study|Other|1|||
48446721|NCT01369225|155824413|FG001|Overall Study|Other|0|||
48446722|NCT01369225|155824414|FG002|Overall Study|Other|0|||
48446723|NCT01369225|155824415|FG003|Overall Study|Other|0|||
48446724|NCT01369225|155824416|FG004|Overall Study|Other|1|||
48446725|NCT01369225|155824417|FG005|Overall Study|Other|0|||
48446726|NCT01369225|155824412|FG000|Overall Study|Adverse Event|0|||
48446727|NCT01369225|155824413|FG001|Overall Study|Adverse Event|0|||
48446728|NCT01369225|155824414|FG002|Overall Study|Adverse Event|0|||
48446729|NCT01369225|155824415|FG003|Overall Study|Adverse Event|1|||
48446730|NCT01369225|155824416|FG004|Overall Study|Adverse Event|1|||
48446731|NCT01369225|155824417|FG005|Overall Study|Adverse Event|0|||
48446732|NCT01438307|155824421|FG000|Overall Study|Death|1|||
48446733|NCT01438307|155824422|FG001|Overall Study|Death|1|||
48446734|NCT00973622|155824424|FG000|Overall Study|did not attend MRI|14|||
48446735|NCT00973622|155824425|FG001|Overall Study|did not attend MRI|3|||
48446736|NCT00973622|155824424|FG000|Overall Study|did not pass MRI screen|6|||
48446737|NCT00973622|155824425|FG001|Overall Study|did not pass MRI screen|0|||
48446738|NCT00973622|155824424|FG000|Overall Study|did not complete rTMS sessions|11|||
48446739|NCT00973622|155824425|FG001|Overall Study|did not complete rTMS sessions|2|||
48446740|NCT01467661|155824426|FG000|Overall Study|Adverse Event|16|||
48446741|NCT01467661|155824426|FG000|Overall Study|Withdrawal by Subject|1|||
48446742|NCT01467661|155824426|FG000|Overall Study|Lack of Efficacy|3|||
48446743|NCT01467661|155824426|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
48446744|NCT03673956|155824427|FG000|Overall Study|Lost to Follow-up|1|||
48446745|NCT03673956|155824428|FG001|Overall Study|Lost to Follow-up|0|||
48446746|NCT03673956|155824429|FG002|Overall Study|Lost to Follow-up|0|||
48446747|NCT03673956|155824430|FG003|Overall Study|Lost to Follow-up|0|||
48446748|NCT03673956|155824427|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
48446749|NCT03673956|155824428|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
48446750|NCT03673956|155824429|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
48446751|NCT03673956|155824430|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
48446752|NCT04397796|155824431|FG000|Overall Study|Death|3|||
48446753|NCT04397796|155824432|FG001|Overall Study|Death|1|||
48446754|NCT03037307|155824433|FG000|Period 1|Did Not Meet Study Criteria|0|||
48446755|NCT03037307|155824434|FG001|Period 1|Did Not Meet Study Criteria|0|||
48446756|NCT03037307|155824435|FG002|Period 1|Did Not Meet Study Criteria|0|||
48446757|NCT03037307|155824436|FG003|Period 1|Did Not Meet Study Criteria|1|||
48446758|NCT03037307|155824437|FG004|Period 1|Did Not Meet Study Criteria|0|||
48446759|NCT03037307|155824438|FG005|Period 1|Did Not Meet Study Criteria|0|||
48446760|NCT03814005|155824441|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
48446761|NCT03814005|155824442|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
48446762|NCT03814005|155824443|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
48446763|NCT03814005|155824441|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
48446764|NCT03814005|155824442|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
48446765|NCT03814005|155824443|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
48446766|NCT03814005|155824441|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
48446767|NCT03814005|155824442|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
48446768|NCT03814005|155824443|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
48446769|NCT03814005|155824441|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
48446770|NCT03814005|155824442|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
48446771|NCT03814005|155824443|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
48446772|NCT03814005|155824441|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
48446773|NCT03814005|155824442|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
48446774|NCT03814005|155824443|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
48446775|NCT03814005|155824441|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
48446776|NCT03814005|155824442|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
48446777|NCT03814005|155824443|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
48446778|NCT00510068|155824444|FG000|Double-blind Period|Disease progression|98|||
48446779|NCT00510068|155824445|FG001|Double-blind Period|Disease progression|169|||
48446780|NCT00510068|155824444|FG000|Double-blind Period|Final primary analysis|52|||
48446781|NCT00510068|155824445|FG001|Double-blind Period|Final primary analysis|18|||
48446782|NCT00510068|155824444|FG000|Double-blind Period|Adverse Event|37|||
48446783|NCT00510068|155824445|FG001|Double-blind Period|Adverse Event|7|||
48446784|NCT00510068|155824444|FG000|Double-blind Period|Withdrawal by Subject|8|||
48446785|NCT00510068|155824445|FG001|Double-blind Period|Withdrawal by Subject|6|||
48446786|NCT00510068|155824444|FG000|Double-blind Period|Death|4|||
48446787|NCT00510068|155824445|FG001|Double-blind Period|Death|3|||
48446788|NCT00510068|155824444|FG000|Double-blind Period|Abnormal test result (s)|1|||
48446789|NCT00510068|155824445|FG001|Double-blind Period|Abnormal test result (s)|0|||
48446790|NCT00510068|155824444|FG000|Double-blind Period|Lost to Follow-up|1|||
48446791|NCT00510068|155824445|FG001|Double-blind Period|Lost to Follow-up|0|||
48446792|NCT00510068|155824444|FG000|Double-blind Period|Protocol Violation|6|||
48446793|NCT00510068|155824445|FG001|Double-blind Period|Protocol Violation|0|||
48446794|NCT00510068|155824444|FG000|Open-label Period|Disease Progression|124|||
48446795|NCT00510068|155824445|FG001|Open-label Period|Disease Progression|0|||
48446796|NCT00510068|155824444|FG000|Open-label Period|Adverse Event|46|||
48446797|NCT00510068|155824445|FG001|Open-label Period|Adverse Event|0|||
48446798|NCT00510068|155824444|FG000|Open-label Period|Withdrawal by Subject|21|||
48446799|NCT00510068|155824445|FG001|Open-label Period|Withdrawal by Subject|0|||
48446800|NCT00510068|155824444|FG000|Open-label Period|Administrative problems|17|||
48446801|NCT00510068|155824445|FG001|Open-label Period|Administrative problems|0|||
48446802|NCT00510068|155824444|FG000|Open-label Period|Death|7|||
48446803|NCT00510068|155824445|FG001|Open-label Period|Death|0|||
48446804|NCT00510068|155824444|FG000|Open-label Period|New cancer therapy|7|||
48446805|NCT00510068|155824445|FG001|Open-label Period|New cancer therapy|0|||
48446806|NCT00510068|155824444|FG000|Open-label Period|Protocol Violation|2|||
48446807|NCT00510068|155824445|FG001|Open-label Period|Protocol Violation|0|||
48446808|NCT00510068|155824444|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
48446809|NCT00510068|155824445|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
48446810|NCT03483116|155824446|FG000|Overall Study|Adverse Event|0|||
48446811|NCT03483116|155824447|FG001|Overall Study|Adverse Event|1|||
48446812|NCT03483116|155824448|FG002|Overall Study|Adverse Event|0|||
48446813|NCT03483116|155824449|FG003|Overall Study|Adverse Event|1|||
48446814|NCT03483116|155824446|FG000|Overall Study|Protocol Violation|1|||
48446815|NCT03483116|155824447|FG001|Overall Study|Protocol Violation|0|||
48446816|NCT03483116|155824448|FG002|Overall Study|Protocol Violation|0|||
48446817|NCT03483116|155824449|FG003|Overall Study|Protocol Violation|7|||
48446818|NCT03483116|155824446|FG000|Overall Study|Lost to Follow-up|9|||
48446819|NCT03483116|155824447|FG001|Overall Study|Lost to Follow-up|4|||
48446820|NCT03483116|155824448|FG002|Overall Study|Lost to Follow-up|9|||
48446821|NCT03483116|155824449|FG003|Overall Study|Lost to Follow-up|5|||
48446822|NCT03483116|155824446|FG000|Overall Study|Death|1|||
48446823|NCT03483116|155824447|FG001|Overall Study|Death|0|||
48446824|NCT03483116|155824448|FG002|Overall Study|Death|2|||
48446825|NCT03483116|155824449|FG003|Overall Study|Death|1|||
48446826|NCT03483116|155824446|FG000|Overall Study|Withdrawal by Subject|14|||
48446827|NCT03483116|155824447|FG001|Overall Study|Withdrawal by Subject|16|||
48446828|NCT03483116|155824448|FG002|Overall Study|Withdrawal by Subject|14|||
48446829|NCT03483116|155824449|FG003|Overall Study|Withdrawal by Subject|16|||
48446830|NCT03483116|155824446|FG000|Overall Study|Unknown other reason|3|||
48446831|NCT03483116|155824447|FG001|Overall Study|Unknown other reason|2|||
48446832|NCT03483116|155824448|FG002|Overall Study|Unknown other reason|1|||
48446833|NCT03483116|155824449|FG003|Overall Study|Unknown other reason|1|||
48446834|NCT00225212|155824450|FG000|Overall Study|Disease progression|2|||
48446835|NCT00225212|155824450|FG000|Overall Study|Death|1|||
48446836|NCT00225212|155824450|FG000|Overall Study|Adverse Event|2|||
48446837|NCT00225212|155824450|FG000|Overall Study|Intercurrent illness|1|||
48446838|NCT03370913|155824452|FG000|Overall Study|Death|1|||
48446839|NCT03370913|155824452|FG000|Overall Study|Lost to Follow-up|1|||
48446840|NCT02443805|155824453|FG000|Overall Study|Adverse Event|100|||
48446841|NCT02443805|155824454|FG001|Overall Study|Adverse Event|18|||
48446842|NCT02443805|155824453|FG000|Overall Study|Withdrawal by Subject|73|||
48446843|NCT02443805|155824454|FG001|Overall Study|Withdrawal by Subject|74|||
48446844|NCT02443805|155824453|FG000|Overall Study|Lost to Follow-up|19|||
48446845|NCT02443805|155824454|FG001|Overall Study|Lost to Follow-up|14|||
48446846|NCT02443805|155824453|FG000|Overall Study|Pregnancy|6|||
48446847|NCT02443805|155824454|FG001|Overall Study|Pregnancy|5|||
48446848|NCT02443805|155824453|FG000|Overall Study|Protocol Violation|2|||
48446849|NCT02443805|155824454|FG001|Overall Study|Protocol Violation|4|||
48446850|NCT02443805|155824453|FG000|Overall Study|Lack of Efficacy|1|||
48446851|NCT02443805|155824454|FG001|Overall Study|Lack of Efficacy|1|||
48446852|NCT02443805|155824453|FG000|Overall Study|Non-compliance with study drug|6|||
48446853|NCT02443805|155824454|FG001|Overall Study|Non-compliance with study drug|4|||
48446854|NCT02443805|155824453|FG000|Overall Study|Withdrawal by parent/guardian|3|||
48446855|NCT02443805|155824454|FG001|Overall Study|Withdrawal by parent/guardian|5|||
48446856|NCT02443805|155824453|FG000|Overall Study|Any other reason not above-mentioned|3|||
48446857|NCT02443805|155824454|FG001|Overall Study|Any other reason not above-mentioned|2|||
48446858|NCT00105560|155824455|FG000|Overall Study|Lost to Follow-up|1|||
48446859|NCT01851863|155824456|FG000|Overall Study|Did not receive study medication|2|||
48446860|NCT01851863|155824457|FG001|Overall Study|Did not receive study medication|5|||
48446861|NCT01851863|155824458|FG002|Overall Study|Did not receive study medication|3|||
48446862|NCT01851863|155824459|FG003|Overall Study|Did not receive study medication|0|||
48446863|NCT01851863|155824456|FG000|Overall Study|Lost to Follow-up|3|||
48446864|NCT01851863|155824457|FG001|Overall Study|Lost to Follow-up|4|||
48446865|NCT01851863|155824458|FG002|Overall Study|Lost to Follow-up|2|||
48446866|NCT01851863|155824459|FG003|Overall Study|Lost to Follow-up|3|||
48446867|NCT01587274|155824460|FG000|Overall Study|Lost to Follow-up|4|||
48446868|NCT01587274|155824461|FG001|Overall Study|Lost to Follow-up|5|||
48446869|NCT01587274|155824462|FG002|Overall Study|Lost to Follow-up|3|||
48446870|NCT01963780|155824463|FG000|Overall Study|Death|7|||
48446871|NCT02925312|155824464|FG000|Overall Study|Lost to Follow-up|25|||
48446872|NCT02925312|155824465|FG001|Overall Study|Lost to Follow-up|0|||
48446873|NCT02925312|155824464|FG000|Overall Study|Adverse Event|2|||
48446874|NCT02925312|155824465|FG001|Overall Study|Adverse Event|0|||
48446875|NCT02120352|155824470|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
48446876|NCT02120352|155824471|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
48446877|NCT02120352|155824472|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
48446878|NCT02120352|155824473|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
48446879|NCT02120352|155824474|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
48446880|NCT02120352|155824475|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
48446881|NCT02120352|155824476|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
48446882|NCT02120352|155824470|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
48446883|NCT02120352|155824471|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48446884|NCT02120352|155824472|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48446885|NCT02120352|155824473|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48446886|NCT02120352|155824474|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48446887|NCT02120352|155824475|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48446888|NCT02120352|155824476|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
48446889|NCT02120352|155824470|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
48446890|NCT02120352|155824471|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
48446891|NCT02120352|155824472|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
48446892|NCT02120352|155824473|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
48446893|NCT02120352|155824474|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
48446894|NCT02120352|155824475|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
48446895|NCT02120352|155824476|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
48446896|NCT02120352|155824470|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
48446897|NCT02120352|155824471|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48446898|NCT02120352|155824472|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48446899|NCT02120352|155824473|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48446900|NCT02120352|155824474|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48446901|NCT02120352|155824475|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48446902|NCT02120352|155824476|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
48446903|NCT02120352|155824470|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
48446904|NCT02120352|155824471|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48446905|NCT02120352|155824472|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48446906|NCT02120352|155824473|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48446907|NCT02120352|155824474|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48446908|NCT02120352|155824475|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48446909|NCT02120352|155824476|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
48446910|NCT02120352|155824470|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
48446911|NCT02120352|155824471|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48446912|NCT02120352|155824472|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48446913|NCT02120352|155824473|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48446914|NCT02120352|155824474|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48446915|NCT02120352|155824475|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48446916|NCT02120352|155824476|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
48446917|NCT02120352|155824470|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
48446918|NCT02120352|155824471|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
48446919|NCT02120352|155824472|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
48446920|NCT02120352|155824473|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
48446921|NCT02120352|155824474|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
48446922|NCT02120352|155824475|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
48446923|NCT02120352|155824476|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
48446924|NCT02120352|155824470|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
48446925|NCT02120352|155824471|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
48446926|NCT02120352|155824472|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
48446927|NCT02120352|155824473|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
48446928|NCT02120352|155824474|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
48446929|NCT02120352|155824475|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
48446930|NCT02120352|155824476|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
48446931|NCT02120352|155824470|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48446932|NCT02120352|155824471|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
48446933|NCT02120352|155824472|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48446934|NCT02120352|155824473|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
48446935|NCT02120352|155824474|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48446936|NCT02120352|155824475|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48446937|NCT02120352|155824476|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
48446938|NCT02120352|155824470|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48446939|NCT02120352|155824471|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
48446940|NCT02120352|155824472|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
48446941|NCT02120352|155824473|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48446942|NCT02120352|155824474|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48446943|NCT02120352|155824475|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48446944|NCT02120352|155824476|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
48446945|NCT02120352|155824470|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48446946|NCT02120352|155824471|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48446947|NCT02120352|155824472|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
48446948|NCT02120352|155824473|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
48446949|NCT02120352|155824474|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48446950|NCT02120352|155824475|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48446951|NCT02120352|155824476|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
48446952|NCT02120352|155824470|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48446953|NCT02120352|155824471|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48446954|NCT02120352|155824472|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48446955|NCT02120352|155824473|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
48446956|NCT02120352|155824474|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48446957|NCT02120352|155824475|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48446958|NCT02120352|155824476|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
48446959|NCT02120352|155824470|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
48446960|NCT02120352|155824471|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
48446961|NCT02120352|155824472|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
48446962|NCT02120352|155824473|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
48446963|NCT02120352|155824474|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
48446964|NCT02120352|155824475|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
48446965|NCT02120352|155824476|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
48446966|NCT02120352|155824470|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48446967|NCT02120352|155824471|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
48446968|NCT02120352|155824472|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48446969|NCT02120352|155824473|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48446970|NCT02120352|155824474|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48446971|NCT02120352|155824475|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48446972|NCT02120352|155824476|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
48446973|NCT02120352|155824470|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
48446974|NCT02120352|155824471|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
48446975|NCT02120352|155824472|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
48446976|NCT02120352|155824473|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
48446977|NCT02120352|155824474|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
48446978|NCT02120352|155824475|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
48446979|NCT02120352|155824476|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
48446980|NCT02120352|155824470|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48446981|NCT02120352|155824471|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48446982|NCT02120352|155824472|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48446983|NCT02120352|155824473|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48446984|NCT02120352|155824474|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
48446985|NCT02120352|155824475|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48446986|NCT02120352|155824476|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
48446987|NCT02120352|155824470|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
48446988|NCT02120352|155824471|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
48446989|NCT02120352|155824472|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
48446990|NCT02120352|155824473|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
48447060|NCT03205982|155824497|FG001|Overall Study|Withdrawal by PI|1|||
48446991|NCT02120352|155824474|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
48446992|NCT02120352|155824475|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
48446993|NCT02120352|155824476|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
48446994|NCT02120352|155824470|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
48446995|NCT02120352|155824471|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
48446996|NCT02120352|155824472|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
48446997|NCT02120352|155824473|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
48446998|NCT02120352|155824474|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
48446999|NCT02120352|155824475|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
48447000|NCT02120352|155824476|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
48447001|NCT02120352|155824470|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
48447002|NCT02120352|155824471|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
48447003|NCT02120352|155824472|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
48447004|NCT02120352|155824473|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
48447005|NCT02120352|155824474|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
48447006|NCT02120352|155824475|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
48447007|NCT02120352|155824476|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
48447008|NCT02120352|155824470|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48447009|NCT02120352|155824471|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
48447010|NCT02120352|155824472|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
48447011|NCT02120352|155824473|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48447012|NCT02120352|155824474|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48447013|NCT02120352|155824475|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48447014|NCT02120352|155824476|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
48447015|NCT02120352|155824470|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
48447016|NCT02120352|155824471|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
48447017|NCT02120352|155824472|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
48447018|NCT02120352|155824473|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
48447019|NCT02120352|155824474|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
48447020|NCT02120352|155824475|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
48447021|NCT02120352|155824476|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
48447022|NCT02120352|155824470|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48447023|NCT02120352|155824471|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48447024|NCT02120352|155824472|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48447025|NCT02120352|155824473|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48447026|NCT02120352|155824474|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48447027|NCT02120352|155824475|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
48447028|NCT02120352|155824476|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
48447029|NCT01610206|155824477|FG000|Overall Study|Adverse Event|10|||
48447030|NCT01610206|155824478|FG001|Overall Study|Adverse Event|30|||
48447031|NCT00617591|155824479|FG000|Overall Study|Withdrew consent during Induction|4|||
48447032|NCT00617591|155824479|FG000|Overall Study|Withdrew consent during Maintenance|6|||
48447033|NCT04114539|155824481|FG000|Overall Study|Adverse Event|14|||
48447034|NCT04114539|155824481|FG000|Overall Study|Lost to Follow-up|2|||
48447035|NCT04114539|155824481|FG000|Overall Study|Non-compliance with Protocol|2|||
48447036|NCT04114539|155824481|FG000|Overall Study|Non-compliance with Study Drug|1|||
48447037|NCT04114539|155824481|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
48447038|NCT04114539|155824481|FG000|Overall Study|Withdrew consent|10|||
48447039|NCT04114539|155824481|FG000|Overall Study|Others not specified|5|||
48447040|NCT04114539|155824481|FG000|Overall Study|Investigator Decision|2|||
48447041|NCT00376246|155824482|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
48447042|NCT00376246|155824483|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
48447043|NCT00376246|155824482|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
48447044|NCT00376246|155824483|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
48447045|NCT00376246|155824482|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
48447046|NCT00376246|155824483|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
48447047|NCT03404518|155824486|FG000|Overall Study|Lost to Follow-up|28|||
48447048|NCT03404518|155824487|FG001|Overall Study|Lost to Follow-up|30|||
48447049|NCT03404518|155824486|FG000|Overall Study|Protocol Violation|13|||
48447050|NCT03404518|155824487|FG001|Overall Study|Protocol Violation|6|||
48447051|NCT04285853|155824494|FG000|Overall Study|Withdrawal by Subject|1|||
48447052|NCT04285853|155824495|FG001|Overall Study|Withdrawal by Subject|0|||
48447053|NCT04285853|155824494|FG000|Overall Study|Lost to Follow-up|9|||
48447054|NCT04285853|155824495|FG001|Overall Study|Lost to Follow-up|5|||
48447055|NCT03205982|155824496|FG000|Overall Study|Lost to Follow-up|20|||
48447056|NCT03205982|155824497|FG001|Overall Study|Lost to Follow-up|19|||
48447057|NCT03205982|155824496|FG000|Overall Study|Withdrawal by Subject|4|||
48447058|NCT03205982|155824497|FG001|Overall Study|Withdrawal by Subject|3|||
48447059|NCT03205982|155824496|FG000|Overall Study|Withdrawal by PI|0|||
48447107|NCT01253187|155825773|FG001|Period 3|difficulty with blood sampling|1|||
48447108|NCT01253187|155825774|FG002|Period 3|difficulty with blood sampling|0|||
48447109|NCT01253187|155825775|FG003|Period 3|difficulty with blood sampling|0|||
48447110|NCT01253187|155825776|FG004|Period 3|difficulty with blood sampling|0|||
48447111|NCT01253187|155825777|FG005|Period 3|difficulty with blood sampling|0|||
48447112|NCT01253187|155825772|FG000|Period 3|non-compliance|0|||
48447113|NCT01253187|155825773|FG001|Period 3|non-compliance|0|||
48447114|NCT01253187|155825774|FG002|Period 3|non-compliance|0|||
48447115|NCT01253187|155825775|FG003|Period 3|non-compliance|0|||
48447116|NCT01253187|155825776|FG004|Period 3|non-compliance|1|||
48447117|NCT01253187|155825777|FG005|Period 3|non-compliance|0|||
48447118|NCT01293006|155825778|FG000|Period 2|Lost to Follow-up|1|||
48447119|NCT01293006|155825779|FG001|Period 2|Lost to Follow-up|0|||
48447120|NCT01293006|155825780|FG002|Period 2|Lost to Follow-up|0|||
48447121|NCT01293006|155825781|FG003|Period 2|Lost to Follow-up|0|||
48447122|NCT00436982|155825784|FG000|Overall Study|Withdrawal by Subject|3|||
48447123|NCT00436982|155825785|FG001|Overall Study|Withdrawal by Subject|1|||
48447124|NCT00436982|155825784|FG000|Overall Study|Did not receive allocated intervention|0|||
48447125|NCT00436982|155825785|FG001|Overall Study|Did not receive allocated intervention|1|||
48447126|NCT00436982|155825784|FG000|Overall Study|no RSA data|1|||
48447127|NCT00436982|155825785|FG001|Overall Study|no RSA data|2|||
48447128|NCT00953225|155825786|FG000|Overall Study|Withdrawal by Subject|2|||
48447129|NCT00953225|155825787|FG001|Overall Study|Withdrawal by Subject|0|||
48447130|NCT00438464|155825788|FG000|Overall Study|Terminated Early|14|||
48447131|NCT00438464|155825789|FG001|Overall Study|Terminated Early|5|||
48447132|NCT00438464|155825788|FG000|Overall Study|Incomplete data submission|0|||
48447133|NCT00438464|155825789|FG001|Overall Study|Incomplete data submission|2|||
48447134|NCT02905825|155825795|FG000|Overall Study|Protocol Violation|11|||
48447135|NCT02905825|155825795|FG000|Overall Study|Device Malfunction|1|||
48447136|NCT01175590|155825799|FG000|Overall Study|Lost to Follow-up|1|||
48447137|NCT01175590|155825800|FG001|Overall Study|Lost to Follow-up|0|||
48447138|NCT01175590|155825799|FG000|Overall Study|Withdrawal by Subject|0|||
48447139|NCT01175590|155825800|FG001|Overall Study|Withdrawal by Subject|2|||
48447140|NCT01175590|155825799|FG000|Overall Study|Adverse Event|4|||
48447141|NCT01175590|155825800|FG001|Overall Study|Adverse Event|0|||
48447142|NCT01175590|155825799|FG000|Overall Study|Physician Decision|1|||
48447143|NCT01175590|155825800|FG001|Overall Study|Physician Decision|4|||
48447144|NCT01175590|155825799|FG000|Overall Study|Lack of Efficacy|1|||
48447145|NCT01175590|155825800|FG001|Overall Study|Lack of Efficacy|1|||
48447146|NCT01175590|155825799|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
48447147|NCT01175590|155825800|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
48447148|NCT01175590|155825799|FG000|Overall Study|Treated not as randomized|3|||
48447149|NCT01175590|155825800|FG001|Overall Study|Treated not as randomized|2|||
48447150|NCT01175590|155825799|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
48447151|NCT01175590|155825800|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
48447152|NCT01175590|155825799|FG000|Overall Study|Protocol Violation|0|||
48447153|NCT01175590|155825800|FG001|Overall Study|Protocol Violation|1|||
48447154|NCT00092677|155825801|FG000|Overall Study|Lost to Follow-up|0|||
48447155|NCT00092677|155825802|FG001|Overall Study|Lost to Follow-up|2|||
48447156|NCT00092677|155825801|FG000|Overall Study|Adminstrative|5|||
48447157|NCT00092677|155825802|FG001|Overall Study|Adminstrative|9|||
48447158|NCT01601704|155825803|FG000|Overall Study|Randomized but not dispensed study med|1|||
48447159|NCT01601704|155825804|FG001|Overall Study|Randomized but not dispensed study med|4|||
48447160|NCT01090102|155825805|FG000|First 12 Weeks|Withdrawal by Subject|1|||
48447161|NCT01090102|155825806|FG001|First 12 Weeks|Withdrawal by Subject|1|||
48447162|NCT01090102|155825805|FG000|First 12 Weeks|Adverse Event|2|||
48447163|NCT01090102|155825806|FG001|First 12 Weeks|Adverse Event|0|||
48447164|NCT01090102|155825805|FG000|First 12 Weeks|Death|1|||
48447165|NCT01090102|155825806|FG001|First 12 Weeks|Death|1|||
48447166|NCT01090102|155825805|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
48447167|NCT01090102|155825806|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
48447168|NCT03805971|155825816|FG000|Overall Study|Withdrawal by Subject|1|||
48447169|NCT03805971|155825816|FG000|Overall Study|Protocol Violation|2|||
48447170|NCT03351478|155825817|FG000|Overall Study|At the subject's own request|11|||
48447171|NCT03351478|155825818|FG001|Overall Study|At the subject's own request|12|||
48447172|NCT03351478|155825819|FG002|Overall Study|At the subject's own request|5|||
48447173|NCT03351478|155825817|FG000|Overall Study|Adverse Event|1|||
48447174|NCT03351478|155825818|FG001|Overall Study|Adverse Event|2|||
48447175|NCT03351478|155825819|FG002|Overall Study|Adverse Event|1|||
48447176|NCT03351478|155825817|FG000|Overall Study|Poor compliance to protocol|1|||
48447177|NCT03351478|155825818|FG001|Overall Study|Poor compliance to protocol|0|||
48447178|NCT03351478|155825819|FG002|Overall Study|Poor compliance to protocol|0|||
48447179|NCT03351478|155825817|FG000|Overall Study|Reason not Specified|1|||
48447180|NCT03351478|155825818|FG001|Overall Study|Reason not Specified|3|||
48447181|NCT03351478|155825819|FG002|Overall Study|Reason not Specified|0|||
48447182|NCT03351478|155825817|FG000|Overall Study|Lost to Follow-up|0|||
48447183|NCT03351478|155825818|FG001|Overall Study|Lost to Follow-up|0|||
48447184|NCT03351478|155825819|FG002|Overall Study|Lost to Follow-up|1|||
48447263|NCT00994162|155825866|FG000|Overall Study|Withdrawal by Subject|1|||
48447264|NCT00994162|155825866|FG000|Overall Study|Lost to Follow-up|2|||
48447265|NCT00994162|155825866|FG000|Overall Study|Product Complaint|1|||
48447266|NCT00994162|155825866|FG000|Overall Study|Poor Compliance|5|||
48447267|NCT00994162|155825866|FG000|Overall Study|Lack of Response|3|||
48447268|NCT00994162|155825866|FG000|Overall Study|Discharged from Hospital|4|||
48447269|NCT00994162|155825866|FG000|Overall Study|Death|2|||
48447270|NCT00994162|155825866|FG000|Overall Study|Care Transferred to Another Physician|2|||
48447271|NCT00994162|155825866|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
48447272|NCT00994162|155825866|FG000|Overall Study|Physician Decision|2|||
48447273|NCT00994162|155825866|FG000|Overall Study|Surrounding Wound Erythematous|1|||
48447274|NCT00994162|155825866|FG000|Overall Study|Machine Losing Vaccum|1|||
48447275|NCT00994162|155825866|FG000|Overall Study|Patient Lived Too Far Away|1|||
48447276|NCT00994162|155825866|FG000|Overall Study|Above Knee Amputation|1|||
48447277|NCT00994162|155825866|FG000|Overall Study|Reason Not Reported By Site|1|||
48447278|NCT00045630|155825867|FG000|Overall Study|Adverse Event|1|||
48447279|NCT00045630|155825867|FG000|Overall Study|Refusal unrelated to adverse event|1|||
48447280|NCT00045630|155825867|FG000|Overall Study|Progression/relapse|1|||
48447281|NCT00045630|155825867|FG000|Overall Study|Death|1|||
48447282|NCT00045630|155825867|FG000|Overall Study|Ineligible|2|||
48447283|NCT01142193|155825868|FG000|Overall Study|Adverse Event|12|||
48447284|NCT01142193|155825869|FG001|Overall Study|Adverse Event|4|||
48447285|NCT01142193|155825868|FG000|Overall Study|Lack of Efficacy|2|||
48447286|NCT01142193|155825869|FG001|Overall Study|Lack of Efficacy|1|||
48447287|NCT01142193|155825868|FG000|Overall Study|Physician Decision|1|||
48447288|NCT01142193|155825869|FG001|Overall Study|Physician Decision|1|||
48447289|NCT01142193|155825868|FG000|Overall Study|Withdrawal by Subject|4|||
48447290|NCT01142193|155825869|FG001|Overall Study|Withdrawal by Subject|3|||
48447291|NCT01142193|155825868|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
48447292|NCT01142193|155825869|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
48447293|NCT01142193|155825868|FG000|Overall Study|Other|1|||
48447294|NCT01142193|155825869|FG001|Overall Study|Other|2|||
48447295|NCT03549429|155825870|FG000|Overall Study|Protocol Violation|5|||
48447296|NCT03549429|155825871|FG001|Overall Study|Protocol Violation|3|||
48447297|NCT00924729|155825872|FG000|Overall Study|insufficient volume for analysis|1|||
48447298|NCT00924729|155825873|FG001|Overall Study|insufficient volume for analysis|0|||
48447299|NCT00924729|155825872|FG000|Overall Study|Protocol Violation|1|||
48447300|NCT00924729|155825873|FG001|Overall Study|Protocol Violation|0|||
48447301|NCT00802867|155825879|FG000|Overall Study|Lost to Follow-up|6|||
48447302|NCT00802867|155825879|FG000|Overall Study|Protocol Violation|6|||
48447303|NCT00802867|155825879|FG000|Overall Study|Withdrawal by Subject|1|||
48447304|NCT00493467|155825880|FG000|Overall Study|Death|1|||
48447305|NCT00282867|155825881|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
48447306|NCT00282867|155825882|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
48447307|NCT00282867|155825883|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
48447308|NCT00588523|155825884|FG000|Overall Study|Not treated|3|||
48447309|NCT01015820|155825885|FG000|Overall Study|Suboptimal measurements|1|||
48447310|NCT01015820|155825886|FG001|Overall Study|Suboptimal measurements|0|||
48447311|NCT00701441|155825887|FG000|Overall Study|failure in cpap compliance|0|||
48447312|NCT00701441|155825888|FG001|Overall Study|failure in cpap compliance|4|||
48447313|NCT00669032|155825891|FG000|Overall Study|Lost to Follow-up|6|||
48447314|NCT00669032|155825892|FG001|Overall Study|Lost to Follow-up|5|||
48447315|NCT00669032|155825891|FG000|Overall Study|Lack of Efficacy|8|||
48447316|NCT00669032|155825892|FG001|Overall Study|Lack of Efficacy|19|||
48447317|NCT00669032|155825891|FG000|Overall Study|Withdrawal by Subject|12|||
48447318|NCT00669032|155825892|FG001|Overall Study|Withdrawal by Subject|13|||
48447319|NCT00669032|155825891|FG000|Overall Study|Adverse Event|12|||
48447320|NCT00669032|155825892|FG001|Overall Study|Adverse Event|16|||
48447321|NCT00669032|155825891|FG000|Overall Study|Physician Decision|1|||
48447322|NCT00669032|155825892|FG001|Overall Study|Physician Decision|1|||
48447323|NCT00669032|155825891|FG000|Overall Study|No fulfilment of the selection criteria|5|||
48447324|NCT00669032|155825892|FG001|Overall Study|No fulfilment of the selection criteria|5|||
48447325|NCT02420795|155827455|FG000|Overall Study|Withdrawal by Subject|1|||
48447326|NCT02420795|155827456|FG001|Overall Study|Withdrawal by Subject|0|||
48447327|NCT02420795|155827457|FG002|Overall Study|Withdrawal by Subject|0|||
48447328|NCT02420795|155827455|FG000|Overall Study|Adverse Event|1|||
48447329|NCT02420795|155827456|FG001|Overall Study|Adverse Event|0|||
48447330|NCT02420795|155827457|FG002|Overall Study|Adverse Event|0|||
48447331|NCT02420795|155827455|FG000|Overall Study|Progressive disease|2|||
48447332|NCT02420795|155827456|FG001|Overall Study|Progressive disease|2|||
48447333|NCT02420795|155827457|FG002|Overall Study|Progressive disease|4|||
48447334|NCT02420795|155827455|FG000|Overall Study|Death|0|||
48447335|NCT02420795|155827456|FG001|Overall Study|Death|0|||
48447336|NCT02420795|155827457|FG002|Overall Study|Death|1|||
48447337|NCT01494987|155827459|FG000|Overall Study|Adverse Event|6|||
48447338|NCT01494987|155827460|FG001|Overall Study|Adverse Event|5|||
48447339|NCT01494987|155827459|FG000|Overall Study|Hyperglycemia|6|||
48447340|NCT01494987|155827460|FG001|Overall Study|Hyperglycemia|4|||
48447341|NCT01494987|155827459|FG000|Overall Study|Investigator's Discretion|1|||
48447342|NCT01494987|155827460|FG001|Overall Study|Investigator's Discretion|2|||
48447343|NCT01494987|155827459|FG000|Overall Study|Lost to Follow-up|1|||
48447344|NCT01494987|155827460|FG001|Overall Study|Lost to Follow-up|1|||
48447345|NCT01494987|155827459|FG000|Overall Study|Protocol Violation|3|||
48447346|NCT01494987|155827460|FG001|Overall Study|Protocol Violation|3|||
48447347|NCT01494987|155827459|FG000|Overall Study|Subject Non-Compliance|9|||
48447348|NCT01494987|155827460|FG001|Overall Study|Subject Non-Compliance|10|||
48447349|NCT01494987|155827459|FG000|Overall Study|Subject Withdrew Consent|2|||
48447350|NCT01494987|155827460|FG001|Overall Study|Subject Withdrew Consent|3|||
48447351|NCT02088541|155827467|FG000|Overall Study|Adverse Event|3|||
48447352|NCT02088541|155827468|FG001|Overall Study|Adverse Event|0|||
48447353|NCT02088541|155827469|FG002|Overall Study|Adverse Event|3|||
48447354|NCT02088541|155827470|FG003|Overall Study|Adverse Event|3|||
48447355|NCT02088541|155827471|FG004|Overall Study|Adverse Event|0|||
48447356|NCT02088541|155827467|FG000|Overall Study|Death|51|||
48447357|NCT02088541|155827468|FG001|Overall Study|Death|21|||
48447358|NCT02088541|155827469|FG002|Overall Study|Death|85|||
48447359|NCT02088541|155827470|FG003|Overall Study|Death|28|||
48447360|NCT02088541|155827471|FG004|Overall Study|Death|38|||
48447361|NCT02088541|155827467|FG000|Overall Study|Lost to Follow-up|2|||
48447362|NCT02088541|155827468|FG001|Overall Study|Lost to Follow-up|0|||
48447363|NCT02088541|155827469|FG002|Overall Study|Lost to Follow-up|1|||
48447364|NCT02088541|155827470|FG003|Overall Study|Lost to Follow-up|0|||
48447365|NCT02088541|155827471|FG004|Overall Study|Lost to Follow-up|0|||
48447366|NCT02088541|155827467|FG000|Overall Study|Physician Decision|2|||
48447367|NCT02088541|155827468|FG001|Overall Study|Physician Decision|1|||
48447368|NCT02088541|155827469|FG002|Overall Study|Physician Decision|2|||
48447369|NCT02088541|155827470|FG003|Overall Study|Physician Decision|0|||
48447370|NCT02088541|155827471|FG004|Overall Study|Physician Decision|2|||
48447371|NCT02088541|155827467|FG000|Overall Study|Disease progression|7|||
48447372|NCT02088541|155827468|FG001|Overall Study|Disease progression|1|||
48447373|NCT02088541|155827469|FG002|Overall Study|Disease progression|2|||
48447374|NCT02088541|155827470|FG003|Overall Study|Disease progression|3|||
48447375|NCT02088541|155827471|FG004|Overall Study|Disease progression|1|||
48447376|NCT02088541|155827467|FG000|Overall Study|Study terminated by sponsor|1|||
48447377|NCT02088541|155827468|FG001|Overall Study|Study terminated by sponsor|1|||
48447378|NCT02088541|155827469|FG002|Overall Study|Study terminated by sponsor|12|||
48447379|NCT02088541|155827470|FG003|Overall Study|Study terminated by sponsor|2|||
48447380|NCT02088541|155827471|FG004|Overall Study|Study terminated by sponsor|6|||
48447381|NCT02088541|155827467|FG000|Overall Study|Withdrawal by Subject|3|||
48447382|NCT02088541|155827468|FG001|Overall Study|Withdrawal by Subject|2|||
48447383|NCT02088541|155827469|FG002|Overall Study|Withdrawal by Subject|9|||
48447384|NCT02088541|155827470|FG003|Overall Study|Withdrawal by Subject|7|||
48447385|NCT02088541|155827471|FG004|Overall Study|Withdrawal by Subject|10|||
48447386|NCT02088541|155827467|FG000|Overall Study|Other|2|||
48447387|NCT02088541|155827468|FG001|Overall Study|Other|1|||
48447388|NCT02088541|155827469|FG002|Overall Study|Other|3|||
48447389|NCT02088541|155827470|FG003|Overall Study|Other|1|||
48447390|NCT02088541|155827471|FG004|Overall Study|Other|1|||
48447391|NCT05742841|155827472|FG000|Overall Study|Withdrawal by Subject|1|||
48447392|NCT05742841|155827472|FG000|Overall Study|Lost to Follow-up|1|||
48447393|NCT00801892|155827473|FG000|Main Study Period|Withdrawal by Subject|0|||
48447394|NCT00801892|155827474|FG001|Main Study Period|Withdrawal by Subject|1|||
48447395|NCT00801892|155827473|FG000|Sham Crossover Period|Lost to Follow-up|0|||
48447396|NCT00801892|155827474|FG001|Sham Crossover Period|Lost to Follow-up|2|||
48447397|NCT03472040|155827477|FG000|Overall Study|Physician Decision|0|||
48447398|NCT03472040|155827478|FG001|Overall Study|Physician Decision|3|||
48447399|NCT03472040|155827477|FG000|Overall Study|Withdrawal by Subject|10|||
48447400|NCT03472040|155827478|FG001|Overall Study|Withdrawal by Subject|23|||
48447401|NCT03472040|155827477|FG000|Overall Study|Perceived Lack of Efficacy|29|||
48447402|NCT03472040|155827478|FG001|Overall Study|Perceived Lack of Efficacy|30|||
48447403|NCT03472040|155827477|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
48447404|NCT03472040|155827478|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
48447405|NCT03472040|155827477|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
48447406|NCT03472040|155827478|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
48447407|NCT03472040|155827477|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
48447408|NCT03472040|155827478|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
48447409|NCT03472040|155827477|FG000|Overall Study|Subject Non-compliance|2|||
48447410|NCT03472040|155827478|FG001|Overall Study|Subject Non-compliance|5|||
48447411|NCT03472040|155827477|FG000|Overall Study|Discontinuation due to Rash|0|||
48447412|NCT03472040|155827478|FG001|Overall Study|Discontinuation due to Rash|1|||
48447413|NCT03472040|155827477|FG000|Overall Study|Subsequent Ineligibility|0|||
48447414|NCT03472040|155827478|FG001|Overall Study|Subsequent Ineligibility|2|||
48447415|NCT03472040|155827477|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
48447416|NCT03472040|155827478|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
48447475|NCT00712933|155827499|FG000|Overall Study|Participant received medication|1|||
48447476|NCT00712933|155827499|FG000|Overall Study|Physician Decision|36|||
48447477|NCT00712933|155827499|FG000|Overall Study|Protocol Violation|4|||
48447478|NCT00712933|155827499|FG000|Overall Study|Withdrawal by Subject|151|||
48447479|NCT00443846|155827500|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
48447480|NCT00443846|155827501|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
48447481|NCT00443846|155827500|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
48447482|NCT00443846|155827501|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
48447483|NCT00443846|155827500|FG000|Overall Study|Adverse Event|0|||
48447484|NCT00443846|155827501|FG001|Overall Study|Adverse Event|1|||
48447485|NCT00443846|155827500|FG000|Overall Study|Personal reason|8|||
48447486|NCT00443846|155827501|FG001|Overall Study|Personal reason|3|||
48447487|NCT00443846|155827500|FG000|Overall Study|Lost to Follow-up|1|||
48447488|NCT00443846|155827501|FG001|Overall Study|Lost to Follow-up|2|||
48447489|NCT01329341|155827504|FG000|Overall Study|Withdrawal by Subject|44|||
48447490|NCT01599806|155827510|FG000|Overall Study|Lost to Follow-up|20|||
48447491|NCT01599806|155827511|FG001|Overall Study|Lost to Follow-up|20|||
48447492|NCT01599806|155827510|FG000|Overall Study|Withdrawal by Subject|12|||
48447493|NCT01599806|155827511|FG001|Overall Study|Withdrawal by Subject|12|||
48447494|NCT01599806|155827510|FG000|Overall Study|Other Eligibility criteria|11|||
48447495|NCT01599806|155827511|FG001|Overall Study|Other Eligibility criteria|9|||
48447496|NCT02988219|155827512|FG000|Overall Study|Lack of Efficacy|1|||
48447497|NCT02988219|155827513|FG001|Overall Study|Lack of Efficacy|1|||
48447498|NCT02988219|155827512|FG000|Overall Study|Withdrawal by Subject|0|||
48447499|NCT02988219|155827513|FG001|Overall Study|Withdrawal by Subject|2|||
48447500|NCT03934541|155827516|FG000|Overall Study|Study Terminated by Sponsor|0|||
48447501|NCT03934541|155827517|FG001|Overall Study|Study Terminated by Sponsor|1|||
48447502|NCT03934541|155827518|FG002|Overall Study|Study Terminated by Sponsor|0|||
48447503|NCT03934541|155827519|FG003|Overall Study|Study Terminated by Sponsor|0|||
48447504|NCT00105183|155827524|FG000|Overall Study|Death|19|||
48447505|NCT00105183|155827525|FG001|Overall Study|Death|13|||
48447506|NCT00105183|155827526|FG002|Overall Study|Death|15|||
48447507|NCT00105183|155827524|FG000|Overall Study|Withdrawal by Subject|1|||
48447508|NCT00105183|155827525|FG001|Overall Study|Withdrawal by Subject|1|||
48447509|NCT00105183|155827526|FG002|Overall Study|Withdrawal by Subject|4|||
48447510|NCT00105183|155827524|FG000|Overall Study|Physician Decision|1|||
48447511|NCT00105183|155827525|FG001|Overall Study|Physician Decision|2|||
48447512|NCT00105183|155827526|FG002|Overall Study|Physician Decision|3|||
48447513|NCT00105183|155827524|FG000|Overall Study|Lost to Follow-up|0|||
48447514|NCT00105183|155827525|FG001|Overall Study|Lost to Follow-up|1|||
48447515|NCT00105183|155827526|FG002|Overall Study|Lost to Follow-up|1|||
48447516|NCT00105183|155827524|FG000|Overall Study|Other reason|1|||
48447517|NCT00105183|155827525|FG001|Overall Study|Other reason|2|||
48447518|NCT00105183|155827526|FG002|Overall Study|Other reason|0|||
48447519|NCT00555568|155827527|FG000|Overall Study|Lost to Follow-up|26|||
48447520|NCT00555568|155827528|FG001|Overall Study|Lost to Follow-up|16|||
48447521|NCT00555568|155827529|FG002|Overall Study|Lost to Follow-up|16|||
48447522|NCT04702984|155827537|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
48447523|NCT01135017|155827547|FG000|Overall Study|Adverse Event|3|||
48447524|NCT01135017|155827548|FG001|Overall Study|Adverse Event|8|||
48447525|NCT01135017|155827547|FG000|Overall Study|Other than above|3|||
48447526|NCT01135017|155827548|FG001|Overall Study|Other than above|4|||
48447527|NCT00050622|155827549|FG000|Overall Study|Adverse Event|1|||
48447528|NCT03841526|155827550|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
48447529|NCT03841526|155827551|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
48447530|NCT03841526|155827552|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
48447531|NCT03841526|155827553|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
48447532|NCT03841526|155827554|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
48447533|NCT03841526|155827555|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
48447534|NCT03841526|155827550|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
48447535|NCT03841526|155827551|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
48447536|NCT03841526|155827552|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
48447537|NCT03841526|155827553|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
48447538|NCT03841526|155827554|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
48447539|NCT03841526|155827555|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
48447540|NCT03841526|155827550|FG000|Outpatient Phase Treatment|Physician Decision|0|||
48447541|NCT03841526|155827551|FG001|Outpatient Phase Treatment|Physician Decision|1|||
48447542|NCT03841526|155827552|FG002|Outpatient Phase Treatment|Physician Decision|0|||
48447543|NCT03841526|155827553|FG003|Outpatient Phase Treatment|Physician Decision|0|||
48447544|NCT03841526|155827554|FG004|Outpatient Phase Treatment|Physician Decision|0|||
48447545|NCT03841526|155827555|FG005|Outpatient Phase Treatment|Physician Decision|0|||
48447546|NCT03841526|155827550|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
48447547|NCT03841526|155827551|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
48447548|NCT03841526|155827552|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
48447549|NCT03841526|155827553|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
48447550|NCT03841526|155827554|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
48447551|NCT03841526|155827555|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
48447552|NCT03000686|155827558|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
48447553|NCT03000686|155827559|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
48447554|NCT03000686|155827560|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
48447555|NCT03000686|155827561|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
48447556|NCT00841672|155827562|FG000|Overall Study|Adverse Event|7|||
48447557|NCT00841672|155827563|FG001|Overall Study|Adverse Event|16|||
48447558|NCT00841672|155827562|FG000|Overall Study|Abnormal test procedure result(s)|0|||
48447559|NCT00841672|155827563|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48447560|NCT00841672|155827562|FG000|Overall Study|Subject withdrew consent|2|||
48447561|NCT00841672|155827563|FG001|Overall Study|Subject withdrew consent|4|||
48447562|NCT00841672|155827562|FG000|Overall Study|Lost to Follow-up|1|||
48447563|NCT00841672|155827563|FG001|Overall Study|Lost to Follow-up|1|||
48447564|NCT00841672|155827562|FG000|Overall Study|Administrative problems|9|||
48447565|NCT00841672|155827563|FG001|Overall Study|Administrative problems|9|||
48447566|NCT00841672|155827562|FG000|Overall Study|Misrandomized|1|||
48447567|NCT00841672|155827563|FG001|Overall Study|Misrandomized|0|||
48447568|NCT00841672|155827562|FG000|Overall Study|Protocol Deviation|0|||
48447569|NCT00841672|155827563|FG001|Overall Study|Protocol Deviation|1|||
48447570|NCT00166517|155827566|FG000|Overall Study|Lost to Follow-up|1|||
48447571|NCT00166517|155827567|FG001|Overall Study|Lost to Follow-up|0|||
48447572|NCT00166517|155827566|FG000|Overall Study|Protocol Violation|4|||
48447573|NCT00166517|155827567|FG001|Overall Study|Protocol Violation|1|||
48447574|NCT00166517|155827566|FG000|Overall Study|Withdrawal by Subject|0|||
48447575|NCT00166517|155827567|FG001|Overall Study|Withdrawal by Subject|1|||
48447576|NCT01455415|155827575|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
48447577|NCT01455415|155827576|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
48447578|NCT01455415|155827575|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
48447579|NCT01455415|155827576|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
48447580|NCT01455415|155827575|FG000|Period 1|Drug Error not Associated to AE|0|||
48447581|NCT01455415|155827576|FG001|Period 1|Drug Error not Associated to AE|1|||
48447582|NCT01455415|155827575|FG000|Period 1|AE Not Related to Study Drug|2|||
48447583|NCT01455415|155827576|FG001|Period 1|AE Not Related to Study Drug|6|||
48447584|NCT01455415|155827575|FG000|Period 1|Withdrawal by Subject|4|||
48447585|NCT01455415|155827576|FG001|Period 1|Withdrawal by Subject|5|||
48447586|NCT01455415|155827575|FG000|Period 1|Unspecified Reason|1|||
48447587|NCT01455415|155827576|FG001|Period 1|Unspecified Reason|1|||
48447588|NCT01455415|155827575|FG000|Period 1|Protocol Violation|0|||
48447589|NCT01455415|155827576|FG001|Period 1|Protocol Violation|2|||
48447590|NCT01455415|155827575|FG000|Washout|AE Related to Study Drug|2|||
48447591|NCT01455415|155827576|FG001|Washout|AE Related to Study Drug|0|||
48447592|NCT01455415|155827575|FG000|Washout|Lost to Follow-up|1|||
48447593|NCT01455415|155827576|FG001|Washout|Lost to Follow-up|0|||
48447594|NCT01455415|155827575|FG000|Washout|Drug Error not Associated to AE|2|||
48447595|NCT01455415|155827576|FG001|Washout|Drug Error not Associated to AE|1|||
48447596|NCT01455415|155827575|FG000|Washout|AE Not Related to Study Drug|2|||
48447597|NCT01455415|155827576|FG001|Washout|AE Not Related to Study Drug|3|||
48447598|NCT01455415|155827575|FG000|Washout|Unspecified Reason|1|||
48447599|NCT01455415|155827576|FG001|Washout|Unspecified Reason|2|||
48447600|NCT01455415|155827575|FG000|Washout|Protocol Violation|0|||
48447601|NCT01455415|155827576|FG001|Washout|Protocol Violation|1|||
48447602|NCT01455415|155827575|FG000|Period 2|AE Related to Study Drug|1|||
48447603|NCT01455415|155827576|FG001|Period 2|AE Related to Study Drug|2|||
48447604|NCT01455415|155827575|FG000|Period 2|Lost to Follow-up|2|||
48447605|NCT01455415|155827576|FG001|Period 2|Lost to Follow-up|1|||
48447606|NCT01455415|155827575|FG000|Period 2|AE Not Related to Study Drug|2|||
48447607|NCT01455415|155827576|FG001|Period 2|AE Not Related to Study Drug|1|||
48447608|NCT01455415|155827575|FG000|Period 2|Lack of Efficacy|2|||
48447609|NCT01455415|155827576|FG001|Period 2|Lack of Efficacy|0|||
48447610|NCT01455415|155827575|FG000|Period 2|Withdrawal by Subject|2|||
48447611|NCT01455415|155827576|FG001|Period 2|Withdrawal by Subject|3|||
48447612|NCT01455415|155827575|FG000|Period 2|Unspecified Reason|2|||
48447613|NCT01455415|155827576|FG001|Period 2|Unspecified Reason|3|||
48447614|NCT01455415|155827575|FG000|Period 2|Protocol Violation|2|||
48447615|NCT01455415|155827576|FG001|Period 2|Protocol Violation|0|||
48447616|NCT01455415|155827575|FG000|Follow-up|AE Related to Study Drug|0|||
48447617|NCT01455415|155827576|FG001|Follow-up|AE Related to Study Drug|1|||
48447618|NCT01455415|155827575|FG000|Follow-up|Lack of Efficacy|0|||
48447619|NCT01455415|155827576|FG001|Follow-up|Lack of Efficacy|1|||
48447620|NCT01455415|155827575|FG000|Follow-up|Withdrawal by Subject|2|||
48447621|NCT01455415|155827576|FG001|Follow-up|Withdrawal by Subject|0|||
48447622|NCT01455415|155827575|FG000|Follow-up|Unspecified Reason|1|||
48447623|NCT01455415|155827576|FG001|Follow-up|Unspecified Reason|0|||
48447624|NCT03094611|155827577|FG000|Overall Study|Lack of Efficacy|1|||
48447625|NCT03094611|155827577|FG000|Overall Study|Stem Cell Transplant|1|||
48447626|NCT02186561|155827578|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
48447627|NCT02186561|155827578|FG000|Enrollment|Enrollment Cap Reached|5|||
48447628|NCT02186561|155827578|FG000|Enrollment|Insurance Denial|2|||
48447638|NCT02758613|155827585|FG000|Treatment|Physician and Sponsor Decision|1|||
48447639|NCT02758613|155827586|FG001|Treatment|Physician and Sponsor Decision|0|||
48447640|NCT02758613|155827587|FG002|Treatment|Physician and Sponsor Decision|0|||
48447641|NCT02758613|155827588|FG003|Treatment|Physician and Sponsor Decision|0|||
48447642|NCT02758613|155827585|FG000|Treatment|Withdrawal by Subject|1|||
48447643|NCT02758613|155827586|FG001|Treatment|Withdrawal by Subject|0|||
48447644|NCT02758613|155827587|FG002|Treatment|Withdrawal by Subject|1|||
48447645|NCT02758613|155827588|FG003|Treatment|Withdrawal by Subject|0|||
48447646|NCT00418717|155827590|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
48447647|NCT00418717|155827590|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
48447648|NCT01400139|155827592|FG000|HYD Core Study|Adverse Event|210|||
48447649|NCT01400139|155827592|FG000|HYD Core Study|Lack of Efficacy|59|||
48447650|NCT01400139|155827592|FG000|HYD Core Study|Withdrawal by Subject|114|||
48447651|NCT01400139|155827592|FG000|HYD Core Study|Lost to Follow-up|39|||
48447652|NCT01400139|155827592|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
48447653|NCT01400139|155827592|FG000|HYD Core Study|Administrative|56|||
48447654|NCT01400139|155827592|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
48447655|NCT01400139|155827592|FG000|HYD Extension Period|Adverse Event|8|||
48447656|NCT01400139|155827592|FG000|HYD Extension Period|Withdrawal by Subject|5|||
48447657|NCT01400139|155827592|FG000|HYD Extension Period|Administrative|10|||
48447658|NCT00351819|155827593|FG000|Overall Study|Lost to Follow-up|4|||
48447659|NCT00351819|155827594|FG001|Overall Study|Lost to Follow-up|4|||
48447660|NCT00351819|155827593|FG000|Overall Study|Withdrawal by Subject|0|||
48447661|NCT00351819|155827594|FG001|Overall Study|Withdrawal by Subject|4|||
48447662|NCT00351819|155827593|FG000|Overall Study|Elevated PSA|1|||
48447663|NCT00351819|155827594|FG001|Overall Study|Elevated PSA|1|||
48447664|NCT00351819|155827593|FG000|Overall Study|Traumatic ankle fracture|1|||
48447665|NCT00351819|155827594|FG001|Overall Study|Traumatic ankle fracture|0|||
48447666|NCT00351819|155827593|FG000|Overall Study|Unprofessional behavior|1|||
48447667|NCT00351819|155827594|FG001|Overall Study|Unprofessional behavior|0|||
48447668|NCT00351819|155827593|FG000|Overall Study|Non-compliance|0|||
48447669|NCT00351819|155827594|FG001|Overall Study|Non-compliance|1|||
48447670|NCT00351819|155827593|FG000|Overall Study|Incarcerated|0|||
48447671|NCT00351819|155827594|FG001|Overall Study|Incarcerated|1|||
48447672|NCT00351819|155827593|FG000|Overall Study|Enrolled in another trial|0|||
48447673|NCT00351819|155827594|FG001|Overall Study|Enrolled in another trial|1|||
48447674|NCT00249795|155827598|FG000|Overall Study|Not treated|16|||
48447675|NCT00249795|155827599|FG001|Overall Study|Not treated|14|||
48447676|NCT00249795|155827598|FG000|Overall Study|Symptomatic hypotension|127|||
48447677|NCT00249795|155827599|FG001|Overall Study|Symptomatic hypotension|64|||
48447678|NCT00249795|155827598|FG000|Overall Study|Other Serious Adverse Event|84|||
48447679|NCT00249795|155827599|FG001|Overall Study|Other Serious Adverse Event|93|||
48447680|NCT00249795|155827598|FG000|Overall Study|Qualifying condition not present|26|||
48447681|NCT00249795|155827599|FG001|Overall Study|Qualifying condition not present|29|||
48447682|NCT00249795|155827598|FG000|Overall Study|Withdrawal by Subject|678|||
48447683|NCT00249795|155827599|FG001|Overall Study|Withdrawal by Subject|742|||
48447684|NCT00249795|155827598|FG000|Overall Study|Thromboembolic / outcome event|39|||
48447685|NCT00249795|155827599|FG001|Overall Study|Thromboembolic / outcome event|45|||
48447686|NCT00249795|155827598|FG000|Overall Study|Oral anticoagulant required|2|||
48447687|NCT00249795|155827599|FG001|Overall Study|Oral anticoagulant required|0|||
48447688|NCT00249795|155827598|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
48447689|NCT00249795|155827599|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
48447690|NCT00249795|155827598|FG000|Overall Study|Non-compliance|71|||
48447691|NCT00249795|155827599|FG001|Overall Study|Non-compliance|69|||
48447692|NCT00249795|155827598|FG000|Overall Study|Study drug intolerance|3|||
48447693|NCT00249795|155827599|FG001|Overall Study|Study drug intolerance|3|||
48447694|NCT00249795|155827598|FG000|Overall Study|Other adverse events (non-serious)|188|||
48447695|NCT00249795|155827599|FG001|Overall Study|Other adverse events (non-serious)|159|||
48447696|NCT00249795|155827598|FG000|Overall Study|Physician withdrew consent|71|||
48447697|NCT00249795|155827599|FG001|Overall Study|Physician withdrew consent|63|||
48447698|NCT00249795|155827598|FG000|Overall Study|Surgery / procedure|4|||
48447699|NCT00249795|155827599|FG001|Overall Study|Surgery / procedure|5|||
48447700|NCT00249795|155827598|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
48447701|NCT00249795|155827599|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
48447702|NCT00249795|155827598|FG000|Overall Study|Lightheadedness / dizziness|15|||
48447703|NCT00249795|155827599|FG001|Overall Study|Lightheadedness / dizziness|11|||
48447704|NCT00249795|155827598|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
48447705|NCT00249795|155827599|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
48447706|NCT00249795|155827598|FG000|Overall Study|Other contraindicated medication|1|||
48447707|NCT00249795|155827599|FG001|Overall Study|Other contraindicated medication|1|||
48447708|NCT00249795|155827598|FG000|Overall Study|Event related to cardiac condition|17|||
48447709|NCT00249795|155827599|FG001|Overall Study|Event related to cardiac condition|16|||
48447710|NCT00249795|155827598|FG000|Overall Study|Patient not wish to continue after May08|4|||
48447711|NCT00249795|155827599|FG001|Overall Study|Patient not wish to continue after May08|6|||
48447712|NCT00249795|155827598|FG000|Overall Study|Site not agree to continue after May08|1|||
48447713|NCT00249795|155827599|FG001|Overall Study|Site not agree to continue after May08|1|||
48447714|NCT00249795|155827598|FG000|Overall Study|Lost to Follow-up|0|||
48447715|NCT00249795|155827599|FG001|Overall Study|Lost to Follow-up|2|||
48447716|NCT00249795|155827598|FG000|Overall Study|Missing|0|||
48447717|NCT00249795|155827599|FG001|Overall Study|Missing|1|||
48447718|NCT00615914|155827600|FG000|Overall Study|Adverse Event|274|||
48447719|NCT00615914|155827600|FG000|Overall Study|Death|20|||
48447720|NCT00615914|155827600|FG000|Overall Study|Lack of Efficacy|59|||
48447721|NCT00615914|155827600|FG000|Overall Study|Lost to Follow-up|187|||
48447722|NCT00615914|155827600|FG000|Overall Study|Withdrawal by Subject|16|||
48447723|NCT00615914|155827600|FG000|Overall Study|Physician Decision|4|||
48447724|NCT00615914|155827600|FG000|Overall Study|No data was collected.|65|||
48447725|NCT00615914|155827600|FG000|Overall Study|No treatment|2|||
48447726|NCT00615914|155827600|FG000|Overall Study|Irregularly enrolled patients|10|||
48447727|NCT00089999|155827604|FG000|Overall Study|Adverse Event|4|||
48447728|NCT00089999|155827605|FG001|Overall Study|Adverse Event|7|||
48447729|NCT00089999|155827604|FG000|Overall Study|Withdrawal by Subject|0|||
48447730|NCT00089999|155827605|FG001|Overall Study|Withdrawal by Subject|4|||
48447731|NCT00089999|155827604|FG000|Overall Study|Lost to Follow-up|2|||
48447732|NCT00089999|155827605|FG001|Overall Study|Lost to Follow-up|1|||
48447733|NCT00089999|155827604|FG000|Overall Study|Radiological Progression of Cancer|52|||
48447734|NCT00089999|155827605|FG001|Overall Study|Radiological Progression of Cancer|44|||
48447735|NCT00089999|155827604|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
48447736|NCT00089999|155827605|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
48447737|NCT00089999|155827604|FG000|Overall Study|Death|3|||
48447738|NCT00089999|155827605|FG001|Overall Study|Death|3|||
48447739|NCT00089999|155827604|FG000|Overall Study|Poor General Condition|1|||
48447740|NCT00089999|155827605|FG001|Overall Study|Poor General Condition|0|||
48447741|NCT00089999|155827604|FG000|Overall Study|Clinical Progression|1|||
48447742|NCT00089999|155827605|FG001|Overall Study|Clinical Progression|2|||
48447743|NCT00089999|155827604|FG000|Overall Study|Physician Decision|2|||
48447744|NCT00089999|155827605|FG001|Overall Study|Physician Decision|2|||
48447745|NCT00089999|155827604|FG000|Overall Study|Patient Underwent Surgery|2|||
48447746|NCT00089999|155827605|FG001|Overall Study|Patient Underwent Surgery|0|||
48447747|NCT00089999|155827604|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
48447748|NCT00089999|155827605|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
48447749|NCT02460978|155827606|FG000|Overall Study|Adverse Event|17|||
48447750|NCT02460978|155827607|FG001|Overall Study|Adverse Event|11|||
48447751|NCT02460978|155827608|FG002|Overall Study|Adverse Event|11|||
48447752|NCT02460978|155827606|FG000|Overall Study|Withdrawal by Subject|5|||
48447753|NCT02460978|155827607|FG001|Overall Study|Withdrawal by Subject|5|||
48447754|NCT02460978|155827608|FG002|Overall Study|Withdrawal by Subject|14|||
48447755|NCT02460978|155827606|FG000|Overall Study|Lost to Follow-up|2|||
48447756|NCT02460978|155827607|FG001|Overall Study|Lost to Follow-up|3|||
48447757|NCT02460978|155827608|FG002|Overall Study|Lost to Follow-up|1|||
48447758|NCT02460978|155827606|FG000|Overall Study|Protocol Violation|1|||
48447759|NCT02460978|155827607|FG001|Overall Study|Protocol Violation|1|||
48447760|NCT02460978|155827608|FG002|Overall Study|Protocol Violation|1|||
48447761|NCT02460978|155827606|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
48447762|NCT02460978|155827607|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
48447763|NCT02460978|155827608|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
48447764|NCT02460978|155827606|FG000|Overall Study|Pregnancy|0|||
48447765|NCT02460978|155827607|FG001|Overall Study|Pregnancy|0|||
48447766|NCT02460978|155827608|FG002|Overall Study|Pregnancy|2|||
48447767|NCT00719537|155827609|FG000|Overall Study|Withdrawal by Subject|1|||
48447768|NCT00719537|155827610|FG001|Overall Study|Withdrawal by Subject|0|||
48447769|NCT00719537|155827609|FG000|Overall Study|Lost to Follow-up|0|||
48447770|NCT00719537|155827610|FG001|Overall Study|Lost to Follow-up|1|||
48447771|NCT00996593|155827611|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
48447772|NCT00996593|155827611|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
48447773|NCT00996593|155827611|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
48447774|NCT00996593|155827611|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
48447775|NCT00996593|155827611|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
48447776|NCT00996593|155827611|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
48447777|NCT00996593|155827611|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
48447778|NCT00996593|155827611|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
48447779|NCT00996593|155827611|FG000|Long-Term Follow-Up|Site Closed|1|||
48587232|NCT01004432|156343158|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
48587233|NCT01004432|156343159|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
48587234|NCT01004432|156343155|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
48587235|NCT01004432|156343156|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
48587236|NCT01004432|156343157|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
48587237|NCT01004432|156343158|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
48587238|NCT01004432|156343159|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
48587239|NCT01004432|156343155|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
48587240|NCT01004432|156343156|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
48587241|NCT01004432|156343157|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
48587242|NCT01004432|156343158|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
48587243|NCT01004432|156343159|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
48587244|NCT01004432|156343155|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
48587245|NCT01004432|156343156|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
48587246|NCT01004432|156343157|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
48587247|NCT01004432|156343158|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
48587248|NCT01004432|156343159|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
48587249|NCT01004432|156343155|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
48587250|NCT01004432|156343156|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
48587251|NCT01004432|156343157|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
48587252|NCT01004432|156343158|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
48587253|NCT01004432|156343159|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
48587254|NCT01004432|156343155|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
48587255|NCT01004432|156343156|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
48587256|NCT01004432|156343157|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
48587257|NCT01004432|156343158|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
48449819|NCT01148693|155835508|FG000|Overall Study|Attempts for cannulation were failed|13|||
48449820|NCT01148693|155835509|FG001|Overall Study|Attempts for cannulation were failed|10|||
48449821|NCT03371251|155835510|FG000|Overall Study|Withdrawal by Subject|1|||
48449822|NCT03371251|155835511|FG001|Overall Study|Withdrawal by Subject|0|||
48449823|NCT03371251|155835512|FG002|Overall Study|Withdrawal by Subject|1|||
48449824|NCT03371251|155835513|FG003|Overall Study|Withdrawal by Subject|0|||
48449825|NCT03371251|155835514|FG004|Overall Study|Withdrawal by Subject|2|||
48449826|NCT03371251|155835515|FG005|Overall Study|Withdrawal by Subject|2|||
48449827|NCT03371251|155835510|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
48449828|NCT03371251|155835511|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
48449829|NCT03371251|155835512|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
48449830|NCT03371251|155835513|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
48449831|NCT03371251|155835514|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
48449832|NCT03371251|155835515|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
48449833|NCT03371251|155835510|FG000|Overall Study|Adverse Event|0|||
48449834|NCT03371251|155835511|FG001|Overall Study|Adverse Event|0|||
48449835|NCT03371251|155835512|FG002|Overall Study|Adverse Event|0|||
48449836|NCT03371251|155835513|FG003|Overall Study|Adverse Event|0|||
48449837|NCT03371251|155835514|FG004|Overall Study|Adverse Event|1|||
48449838|NCT03371251|155835515|FG005|Overall Study|Adverse Event|0|||
48449839|NCT03371251|155835510|FG000|Overall Study|Decision by Sponsor|0|||
48449840|NCT03371251|155835511|FG001|Overall Study|Decision by Sponsor|0|||
48449841|NCT03371251|155835512|FG002|Overall Study|Decision by Sponsor|0|||
48449842|NCT03371251|155835513|FG003|Overall Study|Decision by Sponsor|0|||
48449843|NCT03371251|155835514|FG004|Overall Study|Decision by Sponsor|2|||
48449844|NCT03371251|155835515|FG005|Overall Study|Decision by Sponsor|0|||
48449845|NCT00294684|155835518|FG000|Overall Study|Lost to Follow-up|5|||
48449846|NCT00294684|155835519|FG001|Overall Study|Lost to Follow-up|8|||
48449847|NCT01001234|155835521|FG000|Overall Study|Withdrawal by Subject|2|||
48449848|NCT01001234|155835522|FG001|Overall Study|Withdrawal by Subject|0|||
48449849|NCT01001234|155835523|FG002|Overall Study|Withdrawal by Subject|3|||
48449850|NCT01001234|155835524|FG003|Overall Study|Withdrawal by Subject|0|||
48449851|NCT01001234|155835525|FG004|Overall Study|Withdrawal by Subject|0|||
48449852|NCT01001234|155835521|FG000|Overall Study|Protocol Violation|34|||
48449853|NCT01001234|155835522|FG001|Overall Study|Protocol Violation|3|||
48449854|NCT01001234|155835523|FG002|Overall Study|Protocol Violation|19|||
48449855|NCT01001234|155835524|FG003|Overall Study|Protocol Violation|18|||
48449856|NCT01001234|155835525|FG004|Overall Study|Protocol Violation|0|||
48449857|NCT01001234|155835521|FG000|Overall Study|Lost to Follow-up|0|||
48449858|NCT01001234|155835522|FG001|Overall Study|Lost to Follow-up|0|||
48449859|NCT01001234|155835523|FG002|Overall Study|Lost to Follow-up|1|||
48449860|NCT01001234|155835524|FG003|Overall Study|Lost to Follow-up|2|||
48449861|NCT01001234|155835525|FG004|Overall Study|Lost to Follow-up|0|||
48449862|NCT01001234|155835521|FG000|Overall Study|Physician Decision|1|||
48449863|NCT01001234|155835522|FG001|Overall Study|Physician Decision|0|||
48449864|NCT01001234|155835523|FG002|Overall Study|Physician Decision|0|||
48449865|NCT01001234|155835524|FG003|Overall Study|Physician Decision|0|||
48449866|NCT01001234|155835525|FG004|Overall Study|Physician Decision|0|||
48449867|NCT01001234|155835521|FG000|Overall Study|Not Treated: Adverse Event|1|||
48449868|NCT01001234|155835522|FG001|Overall Study|Not Treated: Adverse Event|0|||
48449869|NCT01001234|155835523|FG002|Overall Study|Not Treated: Adverse Event|0|||
48449870|NCT01001234|155835524|FG003|Overall Study|Not Treated: Adverse Event|0|||
48449871|NCT01001234|155835525|FG004|Overall Study|Not Treated: Adverse Event|0|||
48449872|NCT01001234|155835521|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
48449873|NCT01001234|155835522|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
48449874|NCT01001234|155835523|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
48449875|NCT01001234|155835524|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
48449876|NCT01001234|155835525|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
48449877|NCT01001234|155835521|FG000|Overall Study|Not Treated: Protocol Violation|3|||
48449878|NCT01001234|155835522|FG001|Overall Study|Not Treated: Protocol Violation|0|||
48449879|NCT01001234|155835523|FG002|Overall Study|Not Treated: Protocol Violation|0|||
48449880|NCT01001234|155835524|FG003|Overall Study|Not Treated: Protocol Violation|0|||
48449881|NCT01001234|155835525|FG004|Overall Study|Not Treated: Protocol Violation|0|||
48449882|NCT01001234|155835521|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
48449883|NCT01001234|155835522|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
48449884|NCT01001234|155835523|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
48449885|NCT01001234|155835524|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
48449886|NCT01001234|155835525|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
48449887|NCT01001234|155835521|FG000|Overall Study|Not Treated: Pregnancy|3|||
48449888|NCT01001234|155835522|FG001|Overall Study|Not Treated: Pregnancy|0|||
48449889|NCT01001234|155835523|FG002|Overall Study|Not Treated: Pregnancy|0|||
48449890|NCT01001234|155835524|FG003|Overall Study|Not Treated: Pregnancy|0|||
48449891|NCT01001234|155835525|FG004|Overall Study|Not Treated: Pregnancy|0|||
48449892|NCT01001234|155835521|FG000|Overall Study|Not Treated: Physician Decision|37|||
48449893|NCT01001234|155835522|FG001|Overall Study|Not Treated: Physician Decision|4|||
48449894|NCT01001234|155835523|FG002|Overall Study|Not Treated: Physician Decision|0|||
48449895|NCT01001234|155835524|FG003|Overall Study|Not Treated: Physician Decision|0|||
48449896|NCT01001234|155835525|FG004|Overall Study|Not Treated: Physician Decision|0|||
48449897|NCT01001234|155835521|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
48449898|NCT01001234|155835522|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
48449899|NCT01001234|155835523|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
48449900|NCT01001234|155835524|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
48449901|NCT01001234|155835525|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
48449902|NCT01167153|155835528|FG000|Overall Study|Non-effective therapy|1|||
48449903|NCT01167153|155835529|FG001|Overall Study|Non-effective therapy|4|||
48449904|NCT01167153|155835528|FG000|Overall Study|AE including clinical laboratory AE|2|||
48449905|NCT01167153|155835529|FG001|Overall Study|AE including clinical laboratory AE|8|||
48449906|NCT01167153|155835528|FG000|Overall Study|Hypotension|1|||
48449907|NCT01167153|155835529|FG001|Overall Study|Hypotension|0|||
48449908|NCT01167153|155835528|FG000|Overall Study|Lost to Follow-up|7|||
48449909|NCT01167153|155835529|FG001|Overall Study|Lost to Follow-up|9|||
48449910|NCT01167153|155835528|FG000|Overall Study|Non-compliance to concomitant medication|0|||
48449911|NCT01167153|155835529|FG001|Overall Study|Non-compliance to concomitant medication|2|||
48449912|NCT01167153|155835528|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
48449913|NCT01167153|155835529|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
48449914|NCT01167153|155835528|FG000|Overall Study|Withdrawal consent|1|||
48449915|NCT01167153|155835529|FG001|Overall Study|Withdrawal consent|1|||
48449916|NCT01167153|155835528|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
48449917|NCT01167153|155835529|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
48449918|NCT04449276|155835530|FG000|Overall Study|Adverse Event|1|||
48449919|NCT04449276|155835531|FG001|Overall Study|Adverse Event|2|||
48449920|NCT04449276|155835532|FG002|Overall Study|Adverse Event|0|||
48449921|NCT04449276|155835533|FG003|Overall Study|Adverse Event|0|||
48449922|NCT04449276|155835534|FG004|Overall Study|Adverse Event|2|||
48449923|NCT04449276|155835535|FG005|Overall Study|Adverse Event|0|||
48449924|NCT04449276|155835536|FG006|Overall Study|Adverse Event|0|||
48449925|NCT04449276|155835537|FG007|Overall Study|Adverse Event|1|||
48449926|NCT04449276|155835530|FG000|Overall Study|Withdrawal by Subject|2|||
48449927|NCT04449276|155835531|FG001|Overall Study|Withdrawal by Subject|0|||
48449928|NCT04449276|155835532|FG002|Overall Study|Withdrawal by Subject|0|||
48449929|NCT04449276|155835533|FG003|Overall Study|Withdrawal by Subject|1|||
48449930|NCT04449276|155835534|FG004|Overall Study|Withdrawal by Subject|0|||
48449931|NCT04449276|155835535|FG005|Overall Study|Withdrawal by Subject|0|||
48449932|NCT04449276|155835536|FG006|Overall Study|Withdrawal by Subject|0|||
48449933|NCT04449276|155835537|FG007|Overall Study|Withdrawal by Subject|0|||
48449934|NCT04449276|155835530|FG000|Overall Study|Other|0|||
48449935|NCT04449276|155835531|FG001|Overall Study|Other|2|||
48449936|NCT04449276|155835532|FG002|Overall Study|Other|3|||
48449937|NCT04449276|155835533|FG003|Overall Study|Other|2|||
48449938|NCT04449276|155835534|FG004|Overall Study|Other|0|||
48449939|NCT04449276|155835535|FG005|Overall Study|Other|0|||
48449940|NCT04449276|155835536|FG006|Overall Study|Other|0|||
48449941|NCT04449276|155835537|FG007|Overall Study|Other|1|||
48449942|NCT01061567|155835538|FG000|Overall Study|Adverse Event|32|||
48449943|NCT01061567|155835538|FG000|Overall Study|Death|2|||
48449944|NCT01061567|155835538|FG000|Overall Study|Lack of Efficacy|3|||
48449945|NCT01061567|155835538|FG000|Overall Study|Lost to Follow-up|24|||
48449946|NCT01061567|155835538|FG000|Overall Study|Protocol Violation|1|||
48449947|NCT01061567|155835538|FG000|Overall Study|Withdrawal by Subject|11|||
48449948|NCT01061567|155835538|FG000|Overall Study|Other reason than stated above|3|||
48449949|NCT00563368|155835539|FG000|Overall Study|Lost to Follow-up|14|||
48449950|NCT00563368|155835540|FG001|Overall Study|Lost to Follow-up|14|||
48449951|NCT00563368|155835541|FG002|Overall Study|Lost to Follow-up|12|||
48449952|NCT00563368|155835542|FG003|Overall Study|Lost to Follow-up|6|||
48449953|NCT00563368|155835543|FG004|Overall Study|Lost to Follow-up|9|||
48449954|NCT00563368|155835544|FG005|Overall Study|Lost to Follow-up|8|||
48449955|NCT00563368|155835545|FG006|Overall Study|Lost to Follow-up|9|||
48449956|NCT00563368|155835539|FG000|Overall Study|Adverse Event|3|||
48449957|NCT00563368|155835540|FG001|Overall Study|Adverse Event|4|||
48449958|NCT00563368|155835541|FG002|Overall Study|Adverse Event|5|||
48449959|NCT00563368|155835542|FG003|Overall Study|Adverse Event|9|||
48449960|NCT00563368|155835543|FG004|Overall Study|Adverse Event|6|||
48449961|NCT00563368|155835544|FG005|Overall Study|Adverse Event|10|||
48449962|NCT00563368|155835545|FG006|Overall Study|Adverse Event|17|||
48449963|NCT00563368|155835539|FG000|Overall Study|Withdrawal by Subject|11|||
48449964|NCT00563368|155835540|FG001|Overall Study|Withdrawal by Subject|6|||
48449965|NCT00563368|155835541|FG002|Overall Study|Withdrawal by Subject|5|||
48449966|NCT00563368|155835542|FG003|Overall Study|Withdrawal by Subject|7|||
48449967|NCT00563368|155835543|FG004|Overall Study|Withdrawal by Subject|8|||
48449968|NCT00563368|155835544|FG005|Overall Study|Withdrawal by Subject|5|||
48449969|NCT00563368|155835545|FG006|Overall Study|Withdrawal by Subject|4|||
48449970|NCT00563368|155835539|FG000|Overall Study|protocol non-compliance|1|||
48449971|NCT00563368|155835540|FG001|Overall Study|protocol non-compliance|1|||
48449972|NCT00563368|155835541|FG002|Overall Study|protocol non-compliance|2|||
48449973|NCT00563368|155835542|FG003|Overall Study|protocol non-compliance|1|||
48449974|NCT00563368|155835543|FG004|Overall Study|protocol non-compliance|0|||
48449975|NCT00563368|155835544|FG005|Overall Study|protocol non-compliance|1|||
48449976|NCT00563368|155835545|FG006|Overall Study|protocol non-compliance|3|||
48449977|NCT00563368|155835539|FG000|Overall Study|Pregnancy|1|||
48449978|NCT00563368|155835540|FG001|Overall Study|Pregnancy|0|||
48449979|NCT00563368|155835541|FG002|Overall Study|Pregnancy|1|||
48449980|NCT00563368|155835542|FG003|Overall Study|Pregnancy|2|||
48449981|NCT00563368|155835543|FG004|Overall Study|Pregnancy|1|||
48449982|NCT00563368|155835544|FG005|Overall Study|Pregnancy|2|||
48449983|NCT00563368|155835545|FG006|Overall Study|Pregnancy|0|||
48449984|NCT00563368|155835539|FG000|Overall Study|requirement for restricted medication|0|||
48449985|NCT00563368|155835540|FG001|Overall Study|requirement for restricted medication|0|||
48449986|NCT00563368|155835541|FG002|Overall Study|requirement for restricted medication|2|||
48449987|NCT00563368|155835542|FG003|Overall Study|requirement for restricted medication|0|||
48449988|NCT00563368|155835543|FG004|Overall Study|requirement for restricted medication|0|||
48449989|NCT00563368|155835544|FG005|Overall Study|requirement for restricted medication|0|||
48449990|NCT00563368|155835545|FG006|Overall Study|requirement for restricted medication|0|||
48449991|NCT00563368|155835539|FG000|Overall Study|Other|5|||
48449992|NCT00563368|155835540|FG001|Overall Study|Other|5|||
48449993|NCT00563368|155835541|FG002|Overall Study|Other|3|||
48449994|NCT00563368|155835542|FG003|Overall Study|Other|4|||
48449995|NCT00563368|155835543|FG004|Overall Study|Other|4|||
48449996|NCT00563368|155835544|FG005|Overall Study|Other|4|||
48449997|NCT00563368|155835545|FG006|Overall Study|Other|0|||
48449998|NCT01831804|155835546|FG000|Overall Study|Adverse Event|0|||
48449999|NCT01831804|155835547|FG001|Overall Study|Adverse Event|0|||
48450000|NCT01831804|155835548|FG002|Overall Study|Adverse Event|0|||
48450001|NCT01831804|155835549|FG003|Overall Study|Adverse Event|0|||
48450002|NCT01831804|155835550|FG004|Overall Study|Adverse Event|0|||
48450003|NCT01831804|155835551|FG005|Overall Study|Adverse Event|0|||
48450004|NCT01831804|155835552|FG006|Overall Study|Adverse Event|1|||
48450005|NCT01831804|155835553|FG007|Overall Study|Adverse Event|0|||
48450006|NCT01831804|155835554|FG008|Overall Study|Adverse Event|1|||
48450007|NCT01831804|155835546|FG000|Overall Study|Protocol Violation|0|||
48450008|NCT01831804|155835547|FG001|Overall Study|Protocol Violation|0|||
48450009|NCT01831804|155835548|FG002|Overall Study|Protocol Violation|2|||
48450010|NCT01831804|155835549|FG003|Overall Study|Protocol Violation|0|||
48450011|NCT01831804|155835550|FG004|Overall Study|Protocol Violation|0|||
48450012|NCT01831804|155835551|FG005|Overall Study|Protocol Violation|0|||
48450013|NCT01831804|155835552|FG006|Overall Study|Protocol Violation|0|||
48450014|NCT01831804|155835553|FG007|Overall Study|Protocol Violation|0|||
48450015|NCT01831804|155835554|FG008|Overall Study|Protocol Violation|0|||
48450016|NCT01831804|155835546|FG000|Overall Study|Protocol defined stopping criteria|1|||
48450017|NCT01831804|155835547|FG001|Overall Study|Protocol defined stopping criteria|1|||
48450018|NCT01831804|155835548|FG002|Overall Study|Protocol defined stopping criteria|3|||
48450019|NCT01831804|155835549|FG003|Overall Study|Protocol defined stopping criteria|0|||
48450020|NCT01831804|155835550|FG004|Overall Study|Protocol defined stopping criteria|1|||
48450021|NCT01831804|155835551|FG005|Overall Study|Protocol defined stopping criteria|0|||
48450022|NCT01831804|155835552|FG006|Overall Study|Protocol defined stopping criteria|0|||
48450023|NCT01831804|155835553|FG007|Overall Study|Protocol defined stopping criteria|0|||
48450024|NCT01831804|155835554|FG008|Overall Study|Protocol defined stopping criteria|0|||
48450025|NCT01831804|155835546|FG000|Overall Study|Lost to Follow-up|0|||
48450026|NCT01831804|155835547|FG001|Overall Study|Lost to Follow-up|0|||
48450027|NCT01831804|155835548|FG002|Overall Study|Lost to Follow-up|1|||
48450028|NCT01831804|155835549|FG003|Overall Study|Lost to Follow-up|0|||
48450029|NCT01831804|155835550|FG004|Overall Study|Lost to Follow-up|0|||
48450030|NCT01831804|155835551|FG005|Overall Study|Lost to Follow-up|0|||
48450031|NCT01831804|155835552|FG006|Overall Study|Lost to Follow-up|0|||
48450032|NCT01831804|155835553|FG007|Overall Study|Lost to Follow-up|0|||
48450033|NCT01831804|155835554|FG008|Overall Study|Lost to Follow-up|1|||
48450034|NCT01831804|155835546|FG000|Overall Study|Investigator discretion|0|||
48450035|NCT01831804|155835547|FG001|Overall Study|Investigator discretion|0|||
48450036|NCT01831804|155835548|FG002|Overall Study|Investigator discretion|0|||
48450037|NCT01831804|155835549|FG003|Overall Study|Investigator discretion|0|||
48450038|NCT01831804|155835550|FG004|Overall Study|Investigator discretion|1|||
48450039|NCT01831804|155835551|FG005|Overall Study|Investigator discretion|0|||
48450040|NCT01831804|155835552|FG006|Overall Study|Investigator discretion|0|||
48450041|NCT01831804|155835553|FG007|Overall Study|Investigator discretion|1|||
48450042|NCT01831804|155835554|FG008|Overall Study|Investigator discretion|0|||
48450043|NCT01831804|155835546|FG000|Overall Study|Withdrew Consent|0|||
48450044|NCT01831804|155835547|FG001|Overall Study|Withdrew Consent|1|||
48450045|NCT01831804|155835548|FG002|Overall Study|Withdrew Consent|0|||
48450046|NCT01831804|155835549|FG003|Overall Study|Withdrew Consent|0|||
48450064|NCT01614795|155835557|FG000|Overall Study|Withdrawal by Subject|0|||
48450065|NCT01614795|155835558|FG001|Overall Study|Withdrawal by Subject|1|||
48450066|NCT01614795|155835559|FG002|Overall Study|Withdrawal by Subject|0|||
48450067|NCT01614795|155835560|FG003|Overall Study|Withdrawal by Subject|2|||
48450068|NCT01614795|155835557|FG000|Overall Study|Ineligible|0|||
48450069|NCT01614795|155835558|FG001|Overall Study|Ineligible|1|||
48450070|NCT01614795|155835559|FG002|Overall Study|Ineligible|0|||
48450071|NCT01614795|155835560|FG003|Overall Study|Ineligible|0|||
48450072|NCT01459068|155835563|FG000|Overall Study|Withdrawal by Subject|8|||
48450073|NCT01459068|155835564|FG001|Overall Study|Withdrawal by Subject|18|||
48450074|NCT01459068|155835563|FG000|Overall Study|Lost to Follow-up|31|||
48450075|NCT01459068|155835564|FG001|Overall Study|Lost to Follow-up|15|||
48450076|NCT01459068|155835563|FG000|Overall Study|Death|0|||
48450077|NCT01459068|155835564|FG001|Overall Study|Death|1|||
48450078|NCT00196196|155835569|FG000|Overall Study|Withdrawal by Subject|2|||
48450079|NCT00196196|155835569|FG000|Overall Study|Did not have required condition (hydroce|5|||
48450080|NCT02023112|155835570|FG000|Overall Study|Withdrawal by Subject|2|||
48450081|NCT02023112|155835571|FG001|Overall Study|Withdrawal by Subject|1|||
48450082|NCT01425749|155835572|FG000|Overall Study|progression of melanoma|0|||
48450083|NCT01425749|155835573|FG001|Overall Study|progression of melanoma|1|||
48450084|NCT02910219|155835574|FG000|Overall Study|Withdrawal by Subject|1|||
48450085|NCT02910219|155835575|FG001|Overall Study|Withdrawal by Subject|1|||
48450086|NCT00422903|155835576|FG000|Overall Study|Disease Progression|3|||
48450087|NCT00422903|155835577|FG001|Overall Study|Disease Progression|1|||
48450088|NCT00422903|155835576|FG000|Overall Study|Adverse Event|0|||
48450089|NCT00422903|155835577|FG001|Overall Study|Adverse Event|2|||
48450090|NCT00422903|155835576|FG000|Overall Study|Informed Consent Withdrawn|1|||
48450091|NCT00422903|155835577|FG001|Overall Study|Informed Consent Withdrawn|2|||
48450092|NCT01293084|155835578|FG000|Overall Study|Physician Decision|3|||
48450093|NCT01293084|155835578|FG000|Overall Study|Withdrawal by Subject|2|||
48450094|NCT02096042|155835581|FG000|Overall Study|Disease Progression|1|||
48450095|NCT02096042|155835582|FG001|Overall Study|Disease Progression|0|||
48450096|NCT02096042|155835583|FG002|Overall Study|Disease Progression|0|||
48450097|NCT02983799|155835584|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
48450098|NCT02983799|155835585|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
48450099|NCT02983799|155835586|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
48450100|NCT02983799|155835587|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
48450101|NCT02983799|155835588|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
48450102|NCT02983799|155835584|FG000|Overall Study|Death|20|||
48450103|NCT02983799|155835585|FG001|Overall Study|Death|5|||
48450104|NCT02983799|155835586|FG002|Overall Study|Death|23|||
48450105|NCT02983799|155835587|FG003|Overall Study|Death|47|||
48450106|NCT02983799|155835588|FG004|Overall Study|Death|7|||
48450107|NCT02983799|155835584|FG000|Overall Study|Withdrawal by Subject|1|||
48450108|NCT02983799|155835585|FG001|Overall Study|Withdrawal by Subject|0|||
48450109|NCT02983799|155835586|FG002|Overall Study|Withdrawal by Subject|3|||
48450110|NCT02983799|155835587|FG003|Overall Study|Withdrawal by Subject|4|||
48450111|NCT02983799|155835588|FG004|Overall Study|Withdrawal by Subject|1|||
48450112|NCT02983799|155835584|FG000|Overall Study|Protocol Violation|0|||
48450113|NCT02983799|155835585|FG001|Overall Study|Protocol Violation|1|||
48450114|NCT02983799|155835586|FG002|Overall Study|Protocol Violation|0|||
48450115|NCT02983799|155835587|FG003|Overall Study|Protocol Violation|0|||
48450116|NCT02983799|155835588|FG004|Overall Study|Protocol Violation|1|||
48450117|NCT02983799|155835584|FG000|Overall Study|Lost to Follow-up|1|||
48450118|NCT02983799|155835585|FG001|Overall Study|Lost to Follow-up|0|||
48450119|NCT02983799|155835586|FG002|Overall Study|Lost to Follow-up|1|||
48450120|NCT02983799|155835587|FG003|Overall Study|Lost to Follow-up|0|||
48450121|NCT02983799|155835588|FG004|Overall Study|Lost to Follow-up|0|||
48450122|NCT00651313|155835594|FG000|Overall Study|Adverse Event|0|||
48450123|NCT00651313|155835595|FG001|Overall Study|Adverse Event|1|||
48450124|NCT00651313|155835594|FG000|Overall Study|Withdrawal by Subject|3|||
48450125|NCT00651313|155835595|FG001|Overall Study|Withdrawal by Subject|1|||
48450126|NCT00651313|155835594|FG000|Overall Study|Lost to Follow-up|1|||
48450127|NCT00651313|155835595|FG001|Overall Study|Lost to Follow-up|1|||
48450128|NCT00651313|155835594|FG000|Overall Study|Adminstrative Discontinuation|2|||
48450129|NCT00651313|155835595|FG001|Overall Study|Adminstrative Discontinuation|3|||
48450130|NCT00981747|155835598|FG000|Losartan|Withdrawal by Subject|1|||
48450131|NCT00981747|155835598|FG000|Losartan|Death|1|||
48450132|NCT00981747|155835598|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
48450133|NCT03034057|155835603|FG000|Overall Study|Withdrawal by Subject|10|||
48450134|NCT03034057|155835603|FG000|Overall Study|Protocol Violation|1|||
48450135|NCT03034057|155835603|FG000|Overall Study|Not defined|2|||
48450136|NCT03034057|155835603|FG000|Overall Study|Lost to Follow-up|19|||
48450137|NCT03034057|155835603|FG000|Overall Study|Adverse Event|22|||
48450138|NCT03034057|155835603|FG000|Overall Study|Medication error without associated AE|1|||
48450139|NCT01814826|155835604|FG000|Overall Study|Other|3|||
48450140|NCT01814826|155835605|FG001|Overall Study|Other|5|||
48450141|NCT01814826|155835606|FG002|Overall Study|Other|0|||
48450142|NCT01814826|155835604|FG000|Overall Study|Death|29|||
48450145|NCT02917629|155835607|FG000|Overall Study|Withdrawal by Subject|0|||
48450146|NCT02917629|155835608|FG001|Overall Study|Withdrawal by Subject|1|||
48450147|NCT02571972|155835609|FG000|Overall Study|Protocol Violation|2|||
48450148|NCT02571972|155835609|FG000|Overall Study|Withdrawal by Subject|2|||
48450149|NCT01000025|155835610|FG000|Overall Study|Adverse Event|43|||
48450150|NCT01000025|155835611|FG001|Overall Study|Adverse Event|2|||
48450151|NCT01000025|155835610|FG000|Overall Study|Withdrawal by Subject|13|||
48450152|NCT01000025|155835611|FG001|Overall Study|Withdrawal by Subject|8|||
48450153|NCT01000025|155835610|FG000|Overall Study|Death|23|||
48450154|NCT01000025|155835611|FG001|Overall Study|Death|13|||
48450155|NCT01000025|155835610|FG000|Overall Study|Lack of Efficacy|363|||
48450156|NCT01000025|155835611|FG001|Overall Study|Lack of Efficacy|208|||
48450157|NCT01000025|155835610|FG000|Overall Study|Intercurrent Illness|26|||
48450158|NCT01000025|155835611|FG001|Overall Study|Intercurrent Illness|7|||
48450159|NCT04423757|155835612|FG000|Overall Study|Adverse Event|2|||
48450160|NCT04423757|155835613|FG001|Overall Study|Adverse Event|0|||
48450161|NCT04423757|155835612|FG000|Overall Study|Not treated|1|||
48450162|NCT04423757|155835613|FG001|Overall Study|Not treated|1|||
48450163|NCT03339401|155835620|FG000|Overall Study|Death|2|||
48450164|NCT03339401|155835621|FG001|Overall Study|Death|1|||
48450165|NCT03339401|155835620|FG000|Overall Study|Withdrawal by Subject|2|||
48450166|NCT03339401|155835621|FG001|Overall Study|Withdrawal by Subject|0|||
48450167|NCT03339401|155835620|FG000|Overall Study|Study terminated|4|||
48450168|NCT03339401|155835621|FG001|Overall Study|Study terminated|3|||
48450169|NCT03339401|155835620|FG000|Overall Study|Investigator Decision|1|||
48450170|NCT03339401|155835621|FG001|Overall Study|Investigator Decision|0|||
48450171|NCT00701103|155835622|FG000|Overall Study|Adverse Event|0|||
48450172|NCT00701103|155835623|FG001|Overall Study|Adverse Event|0|||
48450173|NCT00701103|155835624|FG002|Overall Study|Adverse Event|1|||
48450174|NCT00701103|155835625|FG003|Overall Study|Adverse Event|1|||
48450175|NCT00701103|155835626|FG004|Overall Study|Adverse Event|0|||
48450176|NCT00701103|155835627|FG005|Overall Study|Adverse Event|1|||
48450177|NCT00701103|155835628|FG006|Overall Study|Adverse Event|1|||
48450178|NCT00701103|155835629|FG007|Overall Study|Adverse Event|0|||
48450179|NCT00701103|155835630|FG008|Overall Study|Adverse Event|0|||
48450180|NCT00701103|155835631|FG009|Overall Study|Adverse Event|2|||
48450181|NCT00701103|155835632|FG010|Overall Study|Adverse Event|0|||
48450182|NCT00701103|155835622|FG000|Overall Study|Progressive Disease|5|||
48450183|NCT00701103|155835623|FG001|Overall Study|Progressive Disease|2|||
48450184|NCT00701103|155835624|FG002|Overall Study|Progressive Disease|6|||
48450185|NCT00701103|155835625|FG003|Overall Study|Progressive Disease|5|||
48450186|NCT00701103|155835626|FG004|Overall Study|Progressive Disease|6|||
48450187|NCT00701103|155835627|FG005|Overall Study|Progressive Disease|5|||
48450188|NCT00701103|155835628|FG006|Overall Study|Progressive Disease|7|||
48450189|NCT00701103|155835629|FG007|Overall Study|Progressive Disease|7|||
48450190|NCT00701103|155835630|FG008|Overall Study|Progressive Disease|8|||
48450191|NCT00701103|155835631|FG009|Overall Study|Progressive Disease|8|||
48450192|NCT00701103|155835632|FG010|Overall Study|Progressive Disease|11|||
48450193|NCT00701103|155835622|FG000|Overall Study|Withdrawal by Subject|0|||
48450194|NCT00701103|155835623|FG001|Overall Study|Withdrawal by Subject|1|||
48450195|NCT00701103|155835624|FG002|Overall Study|Withdrawal by Subject|1|||
48450196|NCT00701103|155835625|FG003|Overall Study|Withdrawal by Subject|0|||
48450197|NCT00701103|155835626|FG004|Overall Study|Withdrawal by Subject|0|||
48450198|NCT00701103|155835627|FG005|Overall Study|Withdrawal by Subject|0|||
48450199|NCT00701103|155835628|FG006|Overall Study|Withdrawal by Subject|0|||
48450200|NCT00701103|155835629|FG007|Overall Study|Withdrawal by Subject|0|||
48450201|NCT00701103|155835630|FG008|Overall Study|Withdrawal by Subject|0|||
48450202|NCT00701103|155835631|FG009|Overall Study|Withdrawal by Subject|0|||
48450203|NCT00701103|155835632|FG010|Overall Study|Withdrawal by Subject|0|||
48450204|NCT00701103|155835622|FG000|Overall Study|Other|0|||
48450205|NCT00701103|155835623|FG001|Overall Study|Other|0|||
48450206|NCT00701103|155835624|FG002|Overall Study|Other|0|||
48450207|NCT00701103|155835625|FG003|Overall Study|Other|0|||
48450208|NCT00701103|155835626|FG004|Overall Study|Other|0|||
48450209|NCT00701103|155835627|FG005|Overall Study|Other|0|||
48450210|NCT00701103|155835628|FG006|Overall Study|Other|0|||
48450211|NCT00701103|155835629|FG007|Overall Study|Other|0|||
48450212|NCT00701103|155835630|FG008|Overall Study|Other|1|||
48450213|NCT00701103|155835631|FG009|Overall Study|Other|1|||
48450214|NCT00701103|155835632|FG010|Overall Study|Other|0|||
48450215|NCT02762708|155835635|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
48450216|NCT02762708|155835636|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
48450217|NCT02762708|155835637|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
48450218|NCT02762708|155835638|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
48450219|NCT00718523|155835639|FG000|Overall Study|Withdrawal by Subject|5|||
48450220|NCT00718523|155835640|FG001|Overall Study|Withdrawal by Subject|7|||
48450221|NCT00718523|155835639|FG000|Overall Study|Death|13|||
48450222|NCT00718523|155835640|FG001|Overall Study|Death|17|||
48450223|NCT01929707|155835641|FG000|Intervention Period 1|Lost to Follow-up|0|||
48450224|NCT01929707|155835642|FG001|Intervention Period 1|Lost to Follow-up|0|||
48450225|NCT01929707|155835643|FG002|Intervention Period 1|Lost to Follow-up|0|||
48450226|NCT01929707|155835644|FG003|Intervention Period 1|Lost to Follow-up|1|||
48450227|NCT01929707|155835645|FG004|Intervention Period 1|Lost to Follow-up|0|||
48450228|NCT01929707|155835646|FG005|Intervention Period 1|Lost to Follow-up|0|||
48450229|NCT01929707|155835647|FG006|Intervention Period 1|Lost to Follow-up|0|||
48450230|NCT01929707|155835648|FG007|Intervention Period 1|Lost to Follow-up|0|||
48450231|NCT01929707|155835641|FG000|Intervention Period 1|Withdrawal by Subject|0|||
48450232|NCT01929707|155835642|FG001|Intervention Period 1|Withdrawal by Subject|0|||
48450233|NCT01929707|155835643|FG002|Intervention Period 1|Withdrawal by Subject|0|||
48450234|NCT01929707|155835644|FG003|Intervention Period 1|Withdrawal by Subject|2|||
48450235|NCT01929707|155835645|FG004|Intervention Period 1|Withdrawal by Subject|0|||
48450236|NCT01929707|155835646|FG005|Intervention Period 1|Withdrawal by Subject|0|||
48450237|NCT01929707|155835647|FG006|Intervention Period 1|Withdrawal by Subject|0|||
48450238|NCT01929707|155835648|FG007|Intervention Period 1|Withdrawal by Subject|0|||
48450239|NCT01929707|155835641|FG000|Intervention Period 2|Withdrawal by Subject|0|||
48450240|NCT01929707|155835642|FG001|Intervention Period 2|Withdrawal by Subject|0|||
48450241|NCT01929707|155835643|FG002|Intervention Period 2|Withdrawal by Subject|0|||
48450242|NCT01929707|155835644|FG003|Intervention Period 2|Withdrawal by Subject|0|||
48450243|NCT01929707|155835645|FG004|Intervention Period 2|Withdrawal by Subject|0|||
48450244|NCT01929707|155835646|FG005|Intervention Period 2|Withdrawal by Subject|2|||
48450245|NCT01929707|155835647|FG006|Intervention Period 2|Withdrawal by Subject|0|||
48450246|NCT01929707|155835648|FG007|Intervention Period 2|Withdrawal by Subject|0|||
48450247|NCT03271307|155835649|FG000|Overall Study|Lost to Follow-up|0|||
48450248|NCT03271307|155835650|FG001|Overall Study|Lost to Follow-up|0|||
48450249|NCT03271307|155835651|FG002|Overall Study|Lost to Follow-up|0|||
48450250|NCT03271307|155835652|FG003|Overall Study|Lost to Follow-up|28|||
48450251|NCT03271307|155835653|FG004|Overall Study|Lost to Follow-up|91|||
48450252|NCT01313078|155835654|FG000|Overall Study|Death|1|||
48450253|NCT01313078|155835654|FG000|Overall Study|Discontinued study drug|1|||
48450254|NCT01313078|155835654|FG000|Overall Study|Withdrawal by Subject|1|||
48450255|NCT00910728|155835661|FG000|Overall Study|Lack of Efficacy|2|||
48450256|NCT00910728|155835662|FG001|Overall Study|Lack of Efficacy|3|||
48450257|NCT00910728|155835663|FG002|Overall Study|Lack of Efficacy|1|||
48450258|NCT00910728|155835664|FG003|Overall Study|Lack of Efficacy|2|||
48450259|NCT00910728|155835665|FG004|Overall Study|Lack of Efficacy|1|||
48450260|NCT00910728|155835666|FG005|Overall Study|Lack of Efficacy|0|||
48450261|NCT00910728|155835667|FG006|Overall Study|Lack of Efficacy|2|||
48450262|NCT00910728|155835668|FG007|Overall Study|Lack of Efficacy|2|||
48450263|NCT00910728|155835669|FG008|Overall Study|Lack of Efficacy|2|||
48450264|NCT00910728|155835661|FG000|Overall Study|Withdrawal by Subject|0|||
48450265|NCT00910728|155835662|FG001|Overall Study|Withdrawal by Subject|0|||
48450266|NCT00910728|155835663|FG002|Overall Study|Withdrawal by Subject|0|||
48450267|NCT00910728|155835664|FG003|Overall Study|Withdrawal by Subject|0|||
48450268|NCT00910728|155835665|FG004|Overall Study|Withdrawal by Subject|3|||
48450269|NCT00910728|155835666|FG005|Overall Study|Withdrawal by Subject|1|||
48450270|NCT00910728|155835667|FG006|Overall Study|Withdrawal by Subject|2|||
48450271|NCT00910728|155835668|FG007|Overall Study|Withdrawal by Subject|0|||
48450272|NCT00910728|155835669|FG008|Overall Study|Withdrawal by Subject|0|||
48450273|NCT00910728|155835661|FG000|Overall Study|(not specified)|2|||
48450274|NCT00910728|155835662|FG001|Overall Study|(not specified)|0|||
48450275|NCT00910728|155835663|FG002|Overall Study|(not specified)|1|||
48450276|NCT00910728|155835664|FG003|Overall Study|(not specified)|0|||
48450277|NCT00910728|155835665|FG004|Overall Study|(not specified)|1|||
48450278|NCT00910728|155835666|FG005|Overall Study|(not specified)|0|||
48450279|NCT00910728|155835667|FG006|Overall Study|(not specified)|0|||
48450280|NCT00910728|155835668|FG007|Overall Study|(not specified)|0|||
48450281|NCT00910728|155835669|FG008|Overall Study|(not specified)|0|||
48450282|NCT00910728|155835661|FG000|Overall Study|Adverse Event|2|||
48450283|NCT00910728|155835662|FG001|Overall Study|Adverse Event|0|||
48450284|NCT00910728|155835663|FG002|Overall Study|Adverse Event|1|||
48450285|NCT00910728|155835664|FG003|Overall Study|Adverse Event|1|||
48450286|NCT00910728|155835665|FG004|Overall Study|Adverse Event|0|||
48450287|NCT00910728|155835666|FG005|Overall Study|Adverse Event|0|||
48450288|NCT00910728|155835667|FG006|Overall Study|Adverse Event|2|||
48450289|NCT00910728|155835668|FG007|Overall Study|Adverse Event|1|||
48450290|NCT00910728|155835669|FG008|Overall Study|Adverse Event|1|||
48450291|NCT03365947|155835670|FG000|Overall Study|Lost to Follow-up|0|||
48450292|NCT03365947|155835671|FG001|Overall Study|Lost to Follow-up|0|||
48450293|NCT03365947|155835672|FG002|Overall Study|Lost to Follow-up|0|||
48450294|NCT03365947|155835673|FG003|Overall Study|Lost to Follow-up|0|||
48450295|NCT03365947|155835674|FG004|Overall Study|Lost to Follow-up|0|||
48450296|NCT03365947|155835675|FG005|Overall Study|Lost to Follow-up|1|||
48450297|NCT03365947|155835676|FG006|Overall Study|Lost to Follow-up|0|||
48450298|NCT03365947|155835677|FG007|Overall Study|Lost to Follow-up|0|||
48450299|NCT03365947|155835678|FG008|Overall Study|Lost to Follow-up|0|||
48450300|NCT03365947|155835679|FG009|Overall Study|Lost to Follow-up|0|||
48450310|NCT01225172|155835690|FG000|Overall Study|Subject decision to stop|1|||
48450311|NCT01225172|155835691|FG001|Overall Study|Subject decision to stop|0|||
48450312|NCT01225172|155835690|FG000|Overall Study|Subject request to discontinue treatment|3|||
48450313|NCT01225172|155835691|FG001|Overall Study|Subject request to discontinue treatment|1|||
48450314|NCT01225172|155835690|FG000|Overall Study|Subject no longer meets study criteria|1|||
48450315|NCT01225172|155835691|FG001|Overall Study|Subject no longer meets study criteria|0|||
48450316|NCT01225172|155835690|FG000|Overall Study|Withdrawal by Subject|1|||
48450317|NCT01225172|155835691|FG001|Overall Study|Withdrawal by Subject|0|||
48450318|NCT00179517|155835697|FG000|Overall Study|Withdrawal by Subject|2|||
48450319|NCT00179517|155835698|FG001|Overall Study|Withdrawal by Subject|1|||
48450320|NCT00023712|155835699|FG000|Overall Study|Not platinum sensitive|1|||
48450321|NCT00023712|155835700|FG001|Overall Study|Not platinum sensitive|0|||
48450322|NCT00023712|155835699|FG000|Overall Study|Never treated|1|||
48450323|NCT00023712|155835700|FG001|Overall Study|Never treated|1|||
48450324|NCT02679781|155835701|FG000|Overall Study|Lost to Follow-up|1|||
48450325|NCT02679781|155835702|FG001|Overall Study|Lost to Follow-up|2|||
48450326|NCT02679781|155835701|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
48450327|NCT02679781|155835702|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
48450328|NCT01042938|155835703|FG000|Overall Study|Withdrawal by Subject|1|||
48450329|NCT01042938|155835704|FG001|Overall Study|Withdrawal by Subject|1|||
48450330|NCT01042938|155835703|FG000|Overall Study|Protocol Violation|1|||
48450331|NCT01042938|155835704|FG001|Overall Study|Protocol Violation|1|||
48450332|NCT01042938|155835703|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
48450333|NCT01042938|155835704|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
48450334|NCT01822223|155835705|FG000|Overall Study|Death|0|||
48450335|NCT01822223|155835706|FG001|Overall Study|Death|1|||
48450336|NCT04209400|155835709|FG000|Overall Study|Withdrawal by Subject|0|||
48450337|NCT04209400|155835710|FG001|Overall Study|Withdrawal by Subject|1|||
48450338|NCT00437203|155835711|FG000|Overall Study|Death|0|||
48450339|NCT00437203|155835712|FG001|Overall Study|Death|0|||
48450340|NCT00437203|155835713|FG002|Overall Study|Death|1|||
48450341|NCT00437203|155835714|FG003|Overall Study|Death|0|||
48450342|NCT00437203|155835715|FG004|Overall Study|Death|0|||
48450343|NCT00437203|155835716|FG005|Overall Study|Death|0|||
48450344|NCT00437203|155835717|FG006|Overall Study|Death|0|||
48450345|NCT00437203|155835718|FG007|Overall Study|Death|1|||
48450346|NCT00437203|155835719|FG008|Overall Study|Death|0|||
48450347|NCT00437203|155835720|FG009|Overall Study|Death|1|||
48450348|NCT00437203|155835711|FG000|Overall Study|Adverse Event|1|||
48450349|NCT00437203|155835712|FG001|Overall Study|Adverse Event|1|||
48450350|NCT00437203|155835713|FG002|Overall Study|Adverse Event|0|||
48450351|NCT00437203|155835714|FG003|Overall Study|Adverse Event|0|||
48450352|NCT00437203|155835715|FG004|Overall Study|Adverse Event|0|||
48450353|NCT00437203|155835716|FG005|Overall Study|Adverse Event|0|||
48450354|NCT00437203|155835717|FG006|Overall Study|Adverse Event|0|||
48450355|NCT00437203|155835718|FG007|Overall Study|Adverse Event|1|||
48450356|NCT00437203|155835719|FG008|Overall Study|Adverse Event|0|||
48450357|NCT00437203|155835720|FG009|Overall Study|Adverse Event|1|||
48450358|NCT00437203|155835711|FG000|Overall Study|Study terminated by sponsor|0|||
48450359|NCT00437203|155835712|FG001|Overall Study|Study terminated by sponsor|0|||
48450360|NCT00437203|155835713|FG002|Overall Study|Study terminated by sponsor|0|||
48450361|NCT00437203|155835714|FG003|Overall Study|Study terminated by sponsor|0|||
48450362|NCT00437203|155835715|FG004|Overall Study|Study terminated by sponsor|0|||
48450363|NCT00437203|155835716|FG005|Overall Study|Study terminated by sponsor|0|||
48450364|NCT00437203|155835717|FG006|Overall Study|Study terminated by sponsor|0|||
48450365|NCT00437203|155835718|FG007|Overall Study|Study terminated by sponsor|0|||
48450366|NCT00437203|155835719|FG008|Overall Study|Study terminated by sponsor|1|||
48450367|NCT00437203|155835720|FG009|Overall Study|Study terminated by sponsor|0|||
48450368|NCT00437203|155835711|FG000|Overall Study|Objective progression or relapse|5|||
48450369|NCT00437203|155835712|FG001|Overall Study|Objective progression or relapse|6|||
48450370|NCT00437203|155835713|FG002|Overall Study|Objective progression or relapse|2|||
48450371|NCT00437203|155835714|FG003|Overall Study|Objective progression or relapse|3|||
48450372|NCT00437203|155835715|FG004|Overall Study|Objective progression or relapse|3|||
48450373|NCT00437203|155835716|FG005|Overall Study|Objective progression or relapse|3|||
48450374|NCT00437203|155835717|FG006|Overall Study|Objective progression or relapse|6|||
48450375|NCT00437203|155835718|FG007|Overall Study|Objective progression or relapse|1|||
48450376|NCT00437203|155835719|FG008|Overall Study|Objective progression or relapse|2|||
48450377|NCT00437203|155835720|FG009|Overall Study|Objective progression or relapse|2|||
48450378|NCT00437203|155835711|FG000|Overall Study|Other|0|||
48450379|NCT00437203|155835712|FG001|Overall Study|Other|1|||
48450380|NCT00437203|155835713|FG002|Overall Study|Other|0|||
48450381|NCT00437203|155835714|FG003|Overall Study|Other|0|||
48450382|NCT00437203|155835715|FG004|Overall Study|Other|0|||
48450383|NCT00437203|155835716|FG005|Overall Study|Other|0|||
48450384|NCT00437203|155835717|FG006|Overall Study|Other|1|||
48450385|NCT00437203|155835718|FG007|Overall Study|Other|0|||
48450386|NCT00437203|155835719|FG008|Overall Study|Other|0|||
48450388|NCT03136484|155835721|FG000|Overall Study|Withdrawal by Subject|19|||
48450389|NCT03136484|155835722|FG001|Overall Study|Withdrawal by Subject|14|||
48450390|NCT03136484|155835721|FG000|Overall Study|Lost to Follow-up|7|||
48450391|NCT03136484|155835722|FG001|Overall Study|Lost to Follow-up|8|||
48450392|NCT03136484|155835721|FG000|Overall Study|Death|1|||
48450393|NCT03136484|155835722|FG001|Overall Study|Death|0|||
48450394|NCT00640146|155837460|FG000|Overall Study|Adverse Event|2|||
48450395|NCT00640146|155837461|FG001|Overall Study|Adverse Event|0|||
48450396|NCT00640146|155837460|FG000|Overall Study|Lost to Follow-up|0|||
48450397|NCT00640146|155837461|FG001|Overall Study|Lost to Follow-up|1|||
48450398|NCT00640146|155837460|FG000|Overall Study|Lack of Efficacy|0|||
48450399|NCT00640146|155837461|FG001|Overall Study|Lack of Efficacy|1|||
48450400|NCT00640146|155837460|FG000|Overall Study|Withdrawal by Subject|1|||
48450401|NCT00640146|155837461|FG001|Overall Study|Withdrawal by Subject|1|||
48450402|NCT00640146|155837460|FG000|Overall Study|Randomized but not treated|1|||
48450403|NCT00640146|155837461|FG001|Overall Study|Randomized but not treated|3|||
48450404|NCT01742091|155837462|FG000|Overall Study|Adverse Event|0|||
48450405|NCT01742091|155837463|FG001|Overall Study|Adverse Event|0|||
48450406|NCT01742091|155837464|FG002|Overall Study|Adverse Event|0|||
48450407|NCT01742091|155837465|FG003|Overall Study|Adverse Event|0|||
48450408|NCT01742091|155837466|FG004|Overall Study|Adverse Event|1|||
48450409|NCT01742091|155837467|FG005|Overall Study|Adverse Event|0|||
48450410|NCT01742091|155837462|FG000|Overall Study|Physician Decision|0|||
48450411|NCT01742091|155837463|FG001|Overall Study|Physician Decision|0|||
48450412|NCT01742091|155837464|FG002|Overall Study|Physician Decision|0|||
48450413|NCT01742091|155837465|FG003|Overall Study|Physician Decision|0|||
48450414|NCT01742091|155837466|FG004|Overall Study|Physician Decision|0|||
48450415|NCT01742091|155837467|FG005|Overall Study|Physician Decision|1|||
48450416|NCT01742091|155837462|FG000|Overall Study|Withdrawal by Subject|0|||
48450417|NCT01742091|155837463|FG001|Overall Study|Withdrawal by Subject|0|||
48450418|NCT01742091|155837464|FG002|Overall Study|Withdrawal by Subject|0|||
48450419|NCT01742091|155837465|FG003|Overall Study|Withdrawal by Subject|1|||
48450420|NCT01742091|155837466|FG004|Overall Study|Withdrawal by Subject|0|||
48450421|NCT01742091|155837467|FG005|Overall Study|Withdrawal by Subject|0|||
48450422|NCT01742091|155837462|FG000|Overall Study|Lost to Follow-up|0|||
48450423|NCT01742091|155837463|FG001|Overall Study|Lost to Follow-up|0|||
48450424|NCT01742091|155837464|FG002|Overall Study|Lost to Follow-up|0|||
48450425|NCT01742091|155837465|FG003|Overall Study|Lost to Follow-up|0|||
48450426|NCT01742091|155837466|FG004|Overall Study|Lost to Follow-up|0|||
48450427|NCT01742091|155837467|FG005|Overall Study|Lost to Follow-up|1|||
48450428|NCT00525785|155837471|FG000|Overall Study|Withdrawal by Subject|1|||
48450429|NCT00525785|155837471|FG000|Overall Study|Lack of Efficacy|1|||
48450430|NCT00525785|155837471|FG000|Overall Study|Physician Decision|1|||
48450431|NCT02455388|155837472|FG000|Overall Study|Protocol Violation|1|||
48450432|NCT02455388|155837473|FG001|Overall Study|Protocol Violation|0|||
48450433|NCT02455388|155837474|FG002|Overall Study|Protocol Violation|4|||
48450434|NCT02455388|155837472|FG000|Overall Study|Withdrawal by Subject|0|||
48450435|NCT02455388|155837473|FG001|Overall Study|Withdrawal by Subject|0|||
48450436|NCT02455388|155837474|FG002|Overall Study|Withdrawal by Subject|7|||
48450437|NCT03170258|155837480|FG000|Overall Study|Physician Decision|4|||
48450438|NCT03170258|155837481|FG001|Overall Study|Physician Decision|0|||
48450439|NCT03170258|155837480|FG000|Overall Study|Equipment issues|1|||
48450440|NCT03170258|155837481|FG001|Overall Study|Equipment issues|0|||
48450441|NCT03170258|155837480|FG000|Overall Study|Medication|1|||
48450442|NCT03170258|155837481|FG001|Overall Study|Medication|0|||
48450443|NCT03170258|155837480|FG000|Overall Study|Sleep issues|1|||
48450444|NCT03170258|155837481|FG001|Overall Study|Sleep issues|0|||
48450445|NCT04839393|155837502|FG000|Overall Study|Adverse Event|0|||
48450446|NCT04839393|155837503|FG001|Overall Study|Adverse Event|0|||
48450447|NCT04839393|155837504|FG002|Overall Study|Adverse Event|2|||
48450448|NCT04839393|155837502|FG000|Overall Study|Withdrawal by participant|0|||
48450449|NCT04839393|155837503|FG001|Overall Study|Withdrawal by participant|0|||
48450450|NCT04839393|155837504|FG002|Overall Study|Withdrawal by participant|1|||
48450451|NCT00762268|155837507|FG000|Overall Study|Withdrawal by Subject|3|||
48450452|NCT00762268|155837508|FG001|Overall Study|Withdrawal by Subject|3|||
48450453|NCT01001572|155837509|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
48450454|NCT01001572|155837510|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
48450455|NCT01001572|155837511|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
48450456|NCT01001572|155837509|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
48450457|NCT01001572|155837510|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
48450458|NCT01001572|155837511|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
48450459|NCT01001572|155837509|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
48450460|NCT01001572|155837510|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
48450461|NCT01001572|155837511|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
48450462|NCT01001572|155837509|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
48450463|NCT01001572|155837510|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
48450464|NCT01001572|155837511|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
48450465|NCT01001572|155837509|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
48450466|NCT01001572|155837510|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
48450467|NCT01001572|155837511|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
48450468|NCT01001572|155837509|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
48450469|NCT01001572|155837510|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
48450470|NCT01001572|155837511|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
48450471|NCT01001572|155837509|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
48450472|NCT01001572|155837510|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
48450473|NCT01001572|155837511|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
48450474|NCT01001572|155837509|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
48450475|NCT01001572|155837510|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
48450476|NCT01001572|155837511|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
48450477|NCT01001572|155837509|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48450478|NCT01001572|155837510|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
48450479|NCT01001572|155837511|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
48450480|NCT01001572|155837509|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48450481|NCT01001572|155837510|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
48450482|NCT01001572|155837511|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
48450483|NCT01001572|155837509|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
48450484|NCT01001572|155837510|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
48450485|NCT01001572|155837511|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
48450486|NCT01001572|155837509|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
48450487|NCT01001572|155837510|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
48450488|NCT01001572|155837511|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
48450489|NCT01001572|155837509|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
48450490|NCT01001572|155837510|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
48450491|NCT01001572|155837511|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
48450492|NCT01001572|155837509|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48450493|NCT01001572|155837510|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48450494|NCT01001572|155837511|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48450495|NCT01094808|155837513|FG000|Overall Study|Withdrawal by Subject|1|||
48450496|NCT01094808|155837514|FG001|Overall Study|Withdrawal by Subject|1|||
48450497|NCT01094808|155837515|FG002|Overall Study|Withdrawal by Subject|0|||
48450498|NCT01444898|155837516|FG000|Overall Study|Withdrawal by Subject|1|||
48450499|NCT01181141|155837517|FG000|Overall Study|Adverse Event|2|||
48450500|NCT01181141|155837518|FG001|Overall Study|Adverse Event|1|||
48450501|NCT01181141|155837517|FG000|Overall Study|Lack of Efficacy|1|||
48450502|NCT01181141|155837518|FG001|Overall Study|Lack of Efficacy|0|||
48450503|NCT01181141|155837517|FG000|Overall Study|Lost to Follow-up|1|||
48450504|NCT01181141|155837518|FG001|Overall Study|Lost to Follow-up|1|||
48450505|NCT01181141|155837517|FG000|Overall Study|Physician Decision|2|||
48450506|NCT01181141|155837518|FG001|Overall Study|Physician Decision|0|||
48450507|NCT01181141|155837517|FG000|Overall Study|Protocol Violation|3|||
48450508|NCT01181141|155837518|FG001|Overall Study|Protocol Violation|1|||
48450509|NCT01181141|155837517|FG000|Overall Study|Withdrawal by Subject|3|||
48450510|NCT01181141|155837518|FG001|Overall Study|Withdrawal by Subject|1|||
48450511|NCT02001688|155837522|FG000|Overall Study|Withdrawal by Subject|0|||
48450512|NCT02001688|155837523|FG001|Overall Study|Withdrawal by Subject|0|||
48450513|NCT02001688|155837524|FG002|Overall Study|Withdrawal by Subject|1|||
48450514|NCT02001688|155837522|FG000|Overall Study|Adverse Event|0|||
48450515|NCT02001688|155837523|FG001|Overall Study|Adverse Event|1|||
48450516|NCT02001688|155837524|FG002|Overall Study|Adverse Event|0|||
48450517|NCT01628393|155837525|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
48450518|NCT01628393|155837526|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48450519|NCT01628393|155837527|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48450520|NCT01628393|155837528|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48450521|NCT01628393|155837529|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
48450522|NCT01628393|155837525|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
48450523|NCT01628393|155837526|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
48450524|NCT01628393|155837527|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
48450525|NCT01628393|155837528|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
48450526|NCT01628393|155837529|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
48450527|NCT01628393|155837525|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
48450528|NCT01628393|155837526|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
48450529|NCT01628393|155837527|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
48450530|NCT01628393|155837528|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
48450531|NCT01628393|155837529|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
48450532|NCT01628393|155837525|FG000|Blinded Active Extension Period|Adverse Event|0|||
48450533|NCT01628393|155837526|FG001|Blinded Active Extension Period|Adverse Event|1|||
48450534|NCT01628393|155837527|FG002|Blinded Active Extension Period|Adverse Event|0|||
48450535|NCT01628393|155837528|FG003|Blinded Active Extension Period|Adverse Event|2|||
48450536|NCT01628393|155837529|FG004|Blinded Active Extension Period|Adverse Event|2|||
48450537|NCT01628393|155837525|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
48450538|NCT01628393|155837526|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
48450539|NCT01628393|155837527|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
48450540|NCT01628393|155837528|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
48450541|NCT01628393|155837529|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
48450542|NCT01628393|155837525|FG000|Blinded Active Extension Period|Physician Decision|0|||
48450543|NCT01628393|155837526|FG001|Blinded Active Extension Period|Physician Decision|3|||
48450544|NCT01628393|155837527|FG002|Blinded Active Extension Period|Physician Decision|0|||
48450545|NCT01628393|155837528|FG003|Blinded Active Extension Period|Physician Decision|1|||
48450546|NCT01628393|155837529|FG004|Blinded Active Extension Period|Physician Decision|0|||
48450547|NCT01628393|155837525|FG000|Blinded Active Extension Period|Protocol Violation|0|||
48450548|NCT01628393|155837526|FG001|Blinded Active Extension Period|Protocol Violation|0|||
48450549|NCT01628393|155837527|FG002|Blinded Active Extension Period|Protocol Violation|2|||
48450550|NCT01628393|155837528|FG003|Blinded Active Extension Period|Protocol Violation|1|||
48450551|NCT01628393|155837529|FG004|Blinded Active Extension Period|Protocol Violation|0|||
48450552|NCT01628393|155837525|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
48450553|NCT01628393|155837526|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
48450554|NCT01628393|155837527|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
48450555|NCT01628393|155837528|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
48450556|NCT01628393|155837529|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
48450557|NCT01548417|155837535|FG000|Overall Study|Withdrawal by Subject|0|||
48450558|NCT01548417|155837536|FG001|Overall Study|Withdrawal by Subject|2|||
48450559|NCT03725293|155837537|FG000|Overall Study|Physician Decision|9|||
48450560|NCT03725293|155837538|FG001|Overall Study|Physician Decision|6|||
48450561|NCT03725293|155837537|FG000|Overall Study|alternative vascular access needs|1|||
48450562|NCT03725293|155837538|FG001|Overall Study|alternative vascular access needs|2|||
48450563|NCT03725293|155837537|FG000|Overall Study|venous anatomy screen failures|2|||
48450564|NCT03725293|155837538|FG001|Overall Study|venous anatomy screen failures|1|||
48450565|NCT03447821|155837540|FG000|Overall Study|Withdrawal by Subject|1|||
48450566|NCT03447821|155837541|FG001|Overall Study|Withdrawal by Subject|1|||
48450567|NCT03447821|155837542|FG002|Overall Study|Withdrawal by Subject|0|||
48450568|NCT03447821|155837540|FG000|Overall Study|Lost to Follow-up|0|||
48450569|NCT03447821|155837541|FG001|Overall Study|Lost to Follow-up|0|||
48450570|NCT03447821|155837542|FG002|Overall Study|Lost to Follow-up|1|||
48450571|NCT03168555|155837544|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
48450572|NCT03168555|155837544|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
48450573|NCT03168555|155837544|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
48450574|NCT03168555|155837544|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
48450575|NCT02023268|155837545|FG000|Overall Study|Lack of Efficacy|0|||
48450576|NCT02023268|155837546|FG001|Overall Study|Lack of Efficacy|1|||
48450577|NCT02023268|155837545|FG000|Overall Study|Adverse Event|0|||
48450578|NCT02023268|155837546|FG001|Overall Study|Adverse Event|2|||
48450579|NCT02023268|155837545|FG000|Overall Study|Withdrawal by Subject|0|||
48450580|NCT02023268|155837546|FG001|Overall Study|Withdrawal by Subject|1|||
48450581|NCT01611298|155837555|FG000|Overall Study|Relapsed|2|||
48450582|NCT01975675|155837556|FG000|Overall Study|Death|0|||
48450583|NCT01975675|155837557|FG001|Overall Study|Death|1|||
48450584|NCT01975675|155837558|FG002|Overall Study|Death|0|||
48450585|NCT01975675|155837559|FG003|Overall Study|Death|0|||
48450586|NCT02709109|155837560|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
48450587|NCT02709109|155837561|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
48450588|NCT02709109|155837562|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
48450589|NCT02709109|155837563|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
48450590|NCT02709109|155837560|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
48450591|NCT02709109|155837561|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
48450592|NCT02709109|155837562|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
48450593|NCT02709109|155837563|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
48450594|NCT02709109|155837560|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
48450595|NCT02709109|155837561|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
48450596|NCT02709109|155837562|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
48450597|NCT02709109|155837563|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
48450598|NCT02709109|155837560|FG000|Washout Period (28 Days)|Other|2|||
48450599|NCT02709109|155837561|FG001|Washout Period (28 Days)|Other|2|||
48450600|NCT02709109|155837562|FG002|Washout Period (28 Days)|Other|3|||
48450601|NCT02709109|155837563|FG003|Washout Period (28 Days)|Other|0|||
48450602|NCT02709109|155837560|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
48450603|NCT02709109|155837561|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
48450604|NCT02709109|155837562|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
48450605|NCT02709109|155837563|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
48450606|NCT02709109|155837560|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
48450607|NCT02709109|155837561|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
48450608|NCT02709109|155837562|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
48450609|NCT02709109|155837563|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
48450610|NCT02709109|155837560|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
48450611|NCT02709109|155837561|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
48450612|NCT02709109|155837562|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
48450613|NCT02709109|155837563|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
48450614|NCT02709109|155837560|FG000|Treatment Period 2 (28 Days)|Other|0|||
48450615|NCT02709109|155837561|FG001|Treatment Period 2 (28 Days)|Other|0|||
48450616|NCT02709109|155837562|FG002|Treatment Period 2 (28 Days)|Other|1|||
48450617|NCT02709109|155837563|FG003|Treatment Period 2 (28 Days)|Other|0|||
48450618|NCT02290340|155837569|FG000|Overall Study|Lost to Follow-up|0|||
48450619|NCT02290340|155837570|FG001|Overall Study|Lost to Follow-up|0|||
48450620|NCT02290340|155837571|FG002|Overall Study|Lost to Follow-up|0|||
48450621|NCT02290340|155837572|FG003|Overall Study|Lost to Follow-up|1|||
48450622|NCT02290340|155837569|FG000|Overall Study|Withdrawal by Subject|1|||
48450623|NCT02290340|155837570|FG001|Overall Study|Withdrawal by Subject|0|||
48450624|NCT02290340|155837571|FG002|Overall Study|Withdrawal by Subject|0|||
48450625|NCT02290340|155837572|FG003|Overall Study|Withdrawal by Subject|0|||
48450626|NCT02290340|155837569|FG000|Overall Study|Other|1|||
48450627|NCT02290340|155837570|FG001|Overall Study|Other|0|||
48450628|NCT02290340|155837571|FG002|Overall Study|Other|0|||
48450629|NCT02290340|155837572|FG003|Overall Study|Other|1|||
48450630|NCT01468701|155837573|FG000|Overall Study|Not eligible|91|||
48450631|NCT01468701|155837574|FG001|Overall Study|Not eligible|140|||
48450632|NCT01468701|155837575|FG002|Overall Study|Not eligible|29|||
48450633|NCT01468701|155837576|FG003|Overall Study|Not eligible|12|||
48450634|NCT01468701|155837577|FG004|Overall Study|Not eligible|22|||
48450635|NCT01468701|155837578|FG005|Overall Study|Not eligible|2|||
48450636|NCT01468701|155837579|FG006|Overall Study|Not eligible|39|||
48450637|NCT01468701|155837580|FG007|Overall Study|Not eligible|1|||
48450638|NCT01468701|155837581|FG008|Overall Study|Not eligible|40|||
48450639|NCT01468701|155837582|FG009|Overall Study|Not eligible|126|||
48450640|NCT01468701|155837583|FG010|Overall Study|Not eligible|39|||
48450641|NCT01468701|155837584|FG011|Overall Study|Not eligible|33|||
48450642|NCT01468701|155837585|FG012|Overall Study|Not eligible|1|||
48450643|NCT01468701|155837586|FG013|Overall Study|Not eligible|19|||
48450644|NCT01468701|155837587|FG014|Overall Study|Not eligible|1|||
48450645|NCT01468701|155837588|FG015|Overall Study|Not eligible|32|||
48450646|NCT01468701|155837589|FG016|Overall Study|Not eligible|0|||
48450647|NCT01468701|155837573|FG000|Overall Study|Lost to Follow-up|306|||
48450648|NCT01468701|155837574|FG001|Overall Study|Lost to Follow-up|0|||
48450649|NCT01468701|155837575|FG002|Overall Study|Lost to Follow-up|0|||
48450650|NCT01468701|155837576|FG003|Overall Study|Lost to Follow-up|0|||
48450651|NCT01468701|155837577|FG004|Overall Study|Lost to Follow-up|0|||
48450652|NCT01468701|155837578|FG005|Overall Study|Lost to Follow-up|0|||
48450653|NCT01468701|155837579|FG006|Overall Study|Lost to Follow-up|0|||
48450654|NCT01468701|155837580|FG007|Overall Study|Lost to Follow-up|0|||
48450655|NCT01468701|155837581|FG008|Overall Study|Lost to Follow-up|215|||
48450656|NCT01468701|155837582|FG009|Overall Study|Lost to Follow-up|309|||
48450657|NCT01468701|155837583|FG010|Overall Study|Lost to Follow-up|224|||
48450658|NCT01468701|155837584|FG011|Overall Study|Lost to Follow-up|212|||
48450659|NCT01468701|155837585|FG012|Overall Study|Lost to Follow-up|11|||
48450660|NCT01468701|155837586|FG013|Overall Study|Lost to Follow-up|164|||
48450661|NCT01468701|155837587|FG014|Overall Study|Lost to Follow-up|17|||
48450662|NCT01468701|155837588|FG015|Overall Study|Lost to Follow-up|127|||
48450663|NCT01468701|155837589|FG016|Overall Study|Lost to Follow-up|1|||
48450664|NCT01468701|155837573|FG000|Overall Study|Withdrawal by Subject|165|||
48450665|NCT01468701|155837574|FG001|Overall Study|Withdrawal by Subject|0|||
48450666|NCT01468701|155837575|FG002|Overall Study|Withdrawal by Subject|0|||
48450667|NCT01468701|155837576|FG003|Overall Study|Withdrawal by Subject|0|||
48450668|NCT01468701|155837577|FG004|Overall Study|Withdrawal by Subject|0|||
48450669|NCT01468701|155837578|FG005|Overall Study|Withdrawal by Subject|0|||
48450670|NCT01468701|155837579|FG006|Overall Study|Withdrawal by Subject|0|||
48450671|NCT01468701|155837580|FG007|Overall Study|Withdrawal by Subject|0|||
48450672|NCT01468701|155837581|FG008|Overall Study|Withdrawal by Subject|83|||
48450673|NCT01468701|155837582|FG009|Overall Study|Withdrawal by Subject|88|||
48450674|NCT01468701|155837583|FG010|Overall Study|Withdrawal by Subject|100|||
48450675|NCT01468701|155837584|FG011|Overall Study|Withdrawal by Subject|114|||
48450676|NCT01468701|155837585|FG012|Overall Study|Withdrawal by Subject|9|||
48450677|NCT01468701|155837586|FG013|Overall Study|Withdrawal by Subject|47|||
48450678|NCT01468701|155837587|FG014|Overall Study|Withdrawal by Subject|6|||
48450679|NCT01468701|155837588|FG015|Overall Study|Withdrawal by Subject|31|||
48450680|NCT01468701|155837589|FG016|Overall Study|Withdrawal by Subject|0|||
48450681|NCT01468701|155837573|FG000|Overall Study|Other reasons than listed|437|||
48450682|NCT01468701|155837574|FG001|Overall Study|Other reasons than listed|0|||
48450683|NCT01468701|155837575|FG002|Overall Study|Other reasons than listed|0|||
48450684|NCT01468701|155837576|FG003|Overall Study|Other reasons than listed|0|||
48450685|NCT01468701|155837577|FG004|Overall Study|Other reasons than listed|0|||
48450686|NCT01468701|155837578|FG005|Overall Study|Other reasons than listed|0|||
48450687|NCT01468701|155837579|FG006|Overall Study|Other reasons than listed|0|||
48450688|NCT01468701|155837580|FG007|Overall Study|Other reasons than listed|0|||
48450689|NCT01468701|155837581|FG008|Overall Study|Other reasons than listed|318|||
48450690|NCT01468701|155837582|FG009|Overall Study|Other reasons than listed|658|||
48450691|NCT01468701|155837583|FG010|Overall Study|Other reasons than listed|433|||
48450692|NCT01468701|155837584|FG011|Overall Study|Other reasons than listed|504|||
48450693|NCT01468701|155837585|FG012|Overall Study|Other reasons than listed|28|||
48450694|NCT01468701|155837586|FG013|Overall Study|Other reasons than listed|239|||
48450695|NCT01468701|155837587|FG014|Overall Study|Other reasons than listed|39|||
48450696|NCT01468701|155837588|FG015|Overall Study|Other reasons than listed|172|||
48450697|NCT01468701|155837589|FG016|Overall Study|Other reasons than listed|0|||
48450698|NCT01468701|155837573|FG000|Overall Study|No end of study case report form|0|||
48450699|NCT01468701|155837574|FG001|Overall Study|No end of study case report form|0|||
48450700|NCT01468701|155837575|FG002|Overall Study|No end of study case report form|0|||
48450701|NCT01468701|155837576|FG003|Overall Study|No end of study case report form|0|||
48450702|NCT01468701|155837577|FG004|Overall Study|No end of study case report form|0|||
48450703|NCT01468701|155837578|FG005|Overall Study|No end of study case report form|0|||
48450704|NCT01468701|155837579|FG006|Overall Study|No end of study case report form|0|||
48450705|NCT01468701|155837580|FG007|Overall Study|No end of study case report form|0|||
48450706|NCT01468701|155837581|FG008|Overall Study|No end of study case report form|4|||
48450707|NCT01468701|155837582|FG009|Overall Study|No end of study case report form|1|||
48450708|NCT01468701|155837583|FG010|Overall Study|No end of study case report form|2|||
48450709|NCT01468701|155837584|FG011|Overall Study|No end of study case report form|3|||
48450710|NCT01468701|155837585|FG012|Overall Study|No end of study case report form|0|||
48450711|NCT01468701|155837586|FG013|Overall Study|No end of study case report form|1|||
48450712|NCT01468701|155837587|FG014|Overall Study|No end of study case report form|0|||
48450713|NCT01468701|155837588|FG015|Overall Study|No end of study case report form|0|||
48450714|NCT01468701|155837589|FG016|Overall Study|No end of study case report form|0|||
48450715|NCT01468701|155837573|FG000|Overall Study|Not being followed up|0|||
48450716|NCT01468701|155837574|FG001|Overall Study|Not being followed up|4963|||
48450717|NCT01468701|155837575|FG002|Overall Study|Not being followed up|1755|||
48450718|NCT01468701|155837576|FG003|Overall Study|Not being followed up|703|||
48450719|NCT01468701|155837577|FG004|Overall Study|Not being followed up|1714|||
48450720|NCT01468701|155837578|FG005|Overall Study|Not being followed up|126|||
48450721|NCT01468701|155837579|FG006|Overall Study|Not being followed up|1170|||
48450722|NCT01468701|155837580|FG007|Overall Study|Not being followed up|4|||
48450723|NCT01468701|155837581|FG008|Overall Study|Not being followed up|0|||
48450724|NCT01468701|155837582|FG009|Overall Study|Not being followed up|0|||
48450725|NCT01468701|155837583|FG010|Overall Study|Not being followed up|0|||
48450726|NCT01468701|155837584|FG011|Overall Study|Not being followed up|0|||
48450727|NCT01468701|155837585|FG012|Overall Study|Not being followed up|0|||
48450728|NCT01468701|155837586|FG013|Overall Study|Not being followed up|0|||
48450729|NCT01468701|155837587|FG014|Overall Study|Not being followed up|0|||
48450730|NCT01468701|155837588|FG015|Overall Study|Not being followed up|0|||
48450731|NCT01468701|155837589|FG016|Overall Study|Not being followed up|0|||
48450732|NCT01068717|155837590|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
48450733|NCT01068717|155837591|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
48450734|NCT01068717|155837592|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
48450735|NCT01068717|155837593|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
48450736|NCT01449955|155837598|FG000|Overall Study|Withdrawal by Subject|1|||
48450737|NCT01449955|155837599|FG001|Overall Study|Withdrawal by Subject|2|||
48450738|NCT02843178|155837604|FG000|Overall Study|Lost to Follow-up|8|||
48450739|NCT02843178|155837605|FG001|Overall Study|Lost to Follow-up|8|||
48450740|NCT02843178|155837606|FG002|Overall Study|Lost to Follow-up|6|||
48450741|NCT02843178|155837607|FG003|Overall Study|Lost to Follow-up|3|||
48450742|NCT02843178|155837604|FG000|Overall Study|Withdrawal by Subject|0|||
48450743|NCT02843178|155837605|FG001|Overall Study|Withdrawal by Subject|0|||
48450744|NCT02843178|155837606|FG002|Overall Study|Withdrawal by Subject|1|||
48450745|NCT02843178|155837607|FG003|Overall Study|Withdrawal by Subject|1|||
48450746|NCT03997760|155837615|FG000|Overall Study|Protocol Deviation|0|||
48450747|NCT03997760|155837616|FG001|Overall Study|Protocol Deviation|1|||
48450748|NCT03997760|155837617|FG002|Overall Study|Protocol Deviation|0|||
48450749|NCT03997760|155837618|FG003|Overall Study|Protocol Deviation|0|||
48450750|NCT00251589|155837619|FG000|Overall Study|Adverse Event|5|||
48450751|NCT00251589|155837620|FG001|Overall Study|Adverse Event|1|||
48450752|NCT00251589|155837621|FG002|Overall Study|Adverse Event|2|||
48450753|NCT00251589|155837622|FG003|Overall Study|Adverse Event|1|||
48450754|NCT00251589|155837619|FG000|Overall Study|Withdrawal by Subject|1|||
48450755|NCT00251589|155837620|FG001|Overall Study|Withdrawal by Subject|1|||
48450756|NCT00251589|155837621|FG002|Overall Study|Withdrawal by Subject|0|||
48450757|NCT00251589|155837622|FG003|Overall Study|Withdrawal by Subject|0|||
48450758|NCT00251589|155837619|FG000|Overall Study|Discontinued due to progressive disease|9|||
48450759|NCT00251589|155837620|FG001|Overall Study|Discontinued due to progressive disease|1|||
48450760|NCT00251589|155837621|FG002|Overall Study|Discontinued due to progressive disease|0|||
48450761|NCT00251589|155837622|FG003|Overall Study|Discontinued due to progressive disease|1|||
48450762|NCT00856986|155837623|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
48450763|NCT00856986|155837624|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
48450764|NCT00856986|155837625|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
48450765|NCT00856986|155837626|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
48450766|NCT00856986|155837627|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
48450767|NCT00856986|155837623|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
48450768|NCT00856986|155837624|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
48450769|NCT00856986|155837625|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
48450770|NCT00856986|155837626|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
48450771|NCT00856986|155837627|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
48450772|NCT00856986|155837623|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
48450773|NCT00856986|155837624|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
48450774|NCT00856986|155837625|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
48450775|NCT00856986|155837626|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
48450776|NCT00856986|155837627|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
48450777|NCT00856986|155837623|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
48450778|NCT00856986|155837624|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
48450779|NCT00856986|155837625|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
48450780|NCT00856986|155837626|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
48450781|NCT00856986|155837627|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
48450782|NCT00856986|155837623|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
48450783|NCT00856986|155837624|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
48450784|NCT00856986|155837625|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
48450785|NCT00856986|155837626|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
48450786|NCT00856986|155837627|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
48450787|NCT00856986|155837623|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
48450788|NCT00856986|155837624|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
48450789|NCT00856986|155837625|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
48450790|NCT00856986|155837626|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
48450791|NCT00856986|155837627|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
48450792|NCT00856986|155837623|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
48450793|NCT00856986|155837624|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
48450794|NCT00856986|155837625|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
48450795|NCT00856986|155837626|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
48450796|NCT00856986|155837627|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
48450797|NCT00856986|155837623|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
48450798|NCT00856986|155837624|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
48450799|NCT00856986|155837625|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
48450800|NCT00856986|155837626|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
48450801|NCT00856986|155837627|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
48450802|NCT00856986|155837623|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
48450803|NCT00856986|155837624|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
48450804|NCT00856986|155837625|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
48450805|NCT00856986|155837626|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
48450806|NCT00856986|155837627|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
48450807|NCT00856986|155837623|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
48450808|NCT00856986|155837624|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
48450809|NCT00856986|155837625|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
48450810|NCT00856986|155837626|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
48450811|NCT00856986|155837627|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
48450812|NCT00856986|155837623|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
48450813|NCT00856986|155837624|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
48450814|NCT00856986|155837625|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
48450815|NCT00856986|155837626|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
48450816|NCT00856986|155837627|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
48450817|NCT00856986|155837623|FG000|Main Period, Weeks 0-26|Unclassified|7|||
48450818|NCT00856986|155837624|FG001|Main Period, Weeks 0-26|Unclassified|6|||
48450819|NCT00856986|155837625|FG002|Main Period, Weeks 0-26|Unclassified|7|||
48450820|NCT00856986|155837626|FG003|Main Period, Weeks 0-26|Unclassified|0|||
48450821|NCT00856986|155837627|FG004|Main Period, Weeks 0-26|Unclassified|0|||
48450822|NCT00856986|155837623|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
48450823|NCT00856986|155837624|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
48450824|NCT00856986|155837625|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
48450825|NCT00856986|155837626|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
48450826|NCT00856986|155837627|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
48450827|NCT00856986|155837623|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
48450828|NCT00856986|155837624|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
48450829|NCT00856986|155837625|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
48450830|NCT00856986|155837626|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
48450831|NCT00856986|155837627|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
48450832|NCT00856986|155837623|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
48450833|NCT00856986|155837624|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
48450834|NCT00856986|155837625|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
48450835|NCT00856986|155837626|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
48450836|NCT00856986|155837627|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
48450837|NCT00856986|155837623|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
48450838|NCT00856986|155837624|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
48450839|NCT00856986|155837625|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
48450840|NCT00856986|155837626|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
48450841|NCT00856986|155837627|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
48450842|NCT00856986|155837623|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
48450843|NCT00856986|155837624|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
48450844|NCT00856986|155837625|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
48450845|NCT00856986|155837626|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
48450846|NCT00856986|155837627|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
48450847|NCT00856986|155837623|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
48450848|NCT00856986|155837624|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
48450849|NCT00856986|155837625|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
48450850|NCT00856986|155837626|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
48450851|NCT00856986|155837627|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
48450852|NCT02999191|155837628|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
48450853|NCT02999191|155837629|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
48450854|NCT02999191|155837630|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
48450855|NCT00565812|155837632|FG000|Overall Study|Death|2|||
48450856|NCT00565812|155837633|FG001|Overall Study|Death|1|||
48450857|NCT00565812|155837634|FG002|Overall Study|Death|3|||
48450858|NCT00565812|155837632|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
48450859|NCT00565812|155837633|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
48450860|NCT00565812|155837634|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
48450861|NCT00565812|155837632|FG000|Overall Study|Lost to Follow-up|10|||
48450862|NCT00565812|155837633|FG001|Overall Study|Lost to Follow-up|8|||
48450863|NCT00565812|155837634|FG002|Overall Study|Lost to Follow-up|8|||
48450864|NCT00565812|155837632|FG000|Overall Study|Withdrawal by Subject|58|||
48450865|NCT00565812|155837633|FG001|Overall Study|Withdrawal by Subject|47|||
48450866|NCT00565812|155837634|FG002|Overall Study|Withdrawal by Subject|48|||
48450867|NCT00565812|155837632|FG000|Overall Study|Work Schedule|5|||
48450868|NCT00565812|155837633|FG001|Overall Study|Work Schedule|3|||
48450869|NCT00565812|155837634|FG002|Overall Study|Work Schedule|1|||
48450870|NCT00565812|155837632|FG000|Overall Study|Protocol Violation|2|||
48450871|NCT00565812|155837633|FG001|Overall Study|Protocol Violation|6|||
48450872|NCT00565812|155837634|FG002|Overall Study|Protocol Violation|4|||
48450873|NCT00565812|155837632|FG000|Overall Study|Adverse Event|41|||
48450874|NCT00565812|155837633|FG001|Overall Study|Adverse Event|54|||
48450875|NCT00565812|155837634|FG002|Overall Study|Adverse Event|40|||
48450876|NCT00565812|155837632|FG000|Overall Study|Jury Duty|1|||
48450877|NCT00565812|155837633|FG001|Overall Study|Jury Duty|0|||
48450878|NCT00565812|155837634|FG002|Overall Study|Jury Duty|0|||
48450879|NCT00565812|155837632|FG000|Overall Study|Relocated Out of Area|5|||
48450880|NCT00565812|155837633|FG001|Overall Study|Relocated Out of Area|8|||
48450881|NCT00565812|155837634|FG002|Overall Study|Relocated Out of Area|9|||
48450882|NCT00565812|155837632|FG000|Overall Study|Sponsor Decision|1|||
48450883|NCT00565812|155837633|FG001|Overall Study|Sponsor Decision|5|||
48450884|NCT00565812|155837634|FG002|Overall Study|Sponsor Decision|1|||
48450885|NCT00565812|155837632|FG000|Overall Study|Domestic Reasons|7|||
48450886|NCT00565812|155837633|FG001|Overall Study|Domestic Reasons|1|||
48450887|NCT00565812|155837634|FG002|Overall Study|Domestic Reasons|3|||
48450888|NCT00565812|155837632|FG000|Overall Study|Research Site Closure|6|||
48450889|NCT00565812|155837633|FG001|Overall Study|Research Site Closure|1|||
48450890|NCT00565812|155837634|FG002|Overall Study|Research Site Closure|8|||
48450891|NCT00565812|155837632|FG000|Overall Study|Surgical Intervention|0|||
48450892|NCT00565812|155837633|FG001|Overall Study|Surgical Intervention|1|||
48450893|NCT00565812|155837634|FG002|Overall Study|Surgical Intervention|2|||
48450894|NCT00565812|155837632|FG000|Overall Study|Low Compliance|1|||
48450895|NCT00565812|155837633|FG001|Overall Study|Low Compliance|0|||
48450896|NCT00565812|155837634|FG002|Overall Study|Low Compliance|1|||
48450897|NCT00565812|155837632|FG000|Overall Study|Follow-up Visit Not Completed|2|||
48450898|NCT00565812|155837633|FG001|Overall Study|Follow-up Visit Not Completed|0|||
48450899|NCT00565812|155837634|FG002|Overall Study|Follow-up Visit Not Completed|1|||
48450900|NCT00565812|155837632|FG000|Overall Study|Physician Decision|2|||
48450901|NCT00565812|155837633|FG001|Overall Study|Physician Decision|0|||
48450902|NCT00565812|155837634|FG002|Overall Study|Physician Decision|0|||
48450926|NCT01316939|155839178|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
48450927|NCT01316939|155839179|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
48450928|NCT01316939|155839180|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
48450929|NCT01316939|155839178|FG000|Overall Study|Protocol Violation|0|||
48450930|NCT01316939|155839179|FG001|Overall Study|Protocol Violation|1|||
48450931|NCT01316939|155839180|FG002|Overall Study|Protocol Violation|0|||
48450932|NCT02254551|155839181|FG000|Dose Escalation|Physician Decision|1|||
48450933|NCT02254551|155839181|FG000|Dose Escalation|Dose-limiting toxicity|2|||
48450934|NCT00010803|155839183|FG000|Overall Study|Withdrawal by Subject|97|||
48450935|NCT00010803|155839184|FG001|Overall Study|Withdrawal by Subject|98|||
48450936|NCT01595438|155839188|FG000|Overall Study|Lost to Follow-up|20|||
48450937|NCT01595438|155839189|FG001|Overall Study|Lost to Follow-up|20|||
48450938|NCT01595438|155839188|FG000|Overall Study|Withdrawal by Subject|12|||
48450939|NCT01595438|155839189|FG001|Overall Study|Withdrawal by Subject|12|||
48450940|NCT01595438|155839188|FG000|Overall Study|Other Eligibility criteria|11|||
48450941|NCT01595438|155839189|FG001|Overall Study|Other Eligibility criteria|9|||
48450942|NCT01106391|155839202|FG000|Overall Study|Death|12|||
48450943|NCT01106391|155839202|FG000|Overall Study|Withdrawal by Subject|7|||
48450944|NCT00561340|155839203|FG000|Overall Study|refused to drink pediasure|6|||
48450945|NCT00561340|155839204|FG001|Overall Study|refused to drink pediasure|0|||
48450946|NCT00391807|155839205|FG000|Overall Study|Did not receive study medication|23|||
48450947|NCT00391807|155839205|FG000|Overall Study|Adverse Event|177|||
48450948|NCT00391807|155839205|FG000|Overall Study|Pregnancy|25|||
48450949|NCT00391807|155839205|FG000|Overall Study|Lost to Follow-up|227|||
48450950|NCT00391807|155839205|FG000|Overall Study|Withdrawal by Subject|147|||
48450951|NCT00391807|155839205|FG000|Overall Study|Protocol Violation|20|||
48450952|NCT00391807|155839205|FG000|Overall Study|Various|96|||
48450953|NCT00047008|155839206|FG000|Overall Study|Withdrawn consent|2|||
48450954|NCT00047008|155839207|FG001|Overall Study|Withdrawn consent|3|||
48450955|NCT00047008|155839206|FG000|Overall Study|Ineligible|9|||
48450956|NCT00047008|155839207|FG001|Overall Study|Ineligible|8|||
48450957|NCT00928512|155839215|FG000|Overall Study|Adverse Event|4|||
48450958|NCT00928512|155839216|FG001|Overall Study|Adverse Event|3|||
48450959|NCT00928512|155839217|FG002|Overall Study|Adverse Event|2|||
48450960|NCT00928512|155839218|FG003|Overall Study|Adverse Event|8|||
48450961|NCT00928512|155839219|FG004|Overall Study|Adverse Event|6|||
48450962|NCT00928512|155839215|FG000|Overall Study|Lack of Efficacy|2|||
48450963|NCT00928512|155839216|FG001|Overall Study|Lack of Efficacy|0|||
48450964|NCT00928512|155839217|FG002|Overall Study|Lack of Efficacy|4|||
48450965|NCT00928512|155839218|FG003|Overall Study|Lack of Efficacy|7|||
48450966|NCT00928512|155839219|FG004|Overall Study|Lack of Efficacy|3|||
48450967|NCT00928512|155839215|FG000|Overall Study|Protocol Violation|0|||
48450968|NCT00928512|155839216|FG001|Overall Study|Protocol Violation|1|||
48450969|NCT00928512|155839217|FG002|Overall Study|Protocol Violation|0|||
48450970|NCT00928512|155839218|FG003|Overall Study|Protocol Violation|1|||
48450971|NCT00928512|155839219|FG004|Overall Study|Protocol Violation|3|||
48450972|NCT00928512|155839215|FG000|Overall Study|Withdrawal by Subject|3|||
48450973|NCT00928512|155839216|FG001|Overall Study|Withdrawal by Subject|0|||
48450974|NCT00928512|155839217|FG002|Overall Study|Withdrawal by Subject|3|||
48450975|NCT00928512|155839218|FG003|Overall Study|Withdrawal by Subject|4|||
48450976|NCT00928512|155839219|FG004|Overall Study|Withdrawal by Subject|0|||
48450977|NCT00928512|155839215|FG000|Overall Study|Lost to Follow-up|1|||
48450978|NCT00928512|155839216|FG001|Overall Study|Lost to Follow-up|1|||
48450979|NCT00928512|155839217|FG002|Overall Study|Lost to Follow-up|2|||
48450980|NCT00928512|155839218|FG003|Overall Study|Lost to Follow-up|1|||
48450981|NCT00928512|155839219|FG004|Overall Study|Lost to Follow-up|3|||
48450982|NCT00928512|155839215|FG000|Overall Study|Administrative Problems|0|||
48450983|NCT00928512|155839216|FG001|Overall Study|Administrative Problems|1|||
48450984|NCT00928512|155839217|FG002|Overall Study|Administrative Problems|0|||
48450985|NCT00928512|155839218|FG003|Overall Study|Administrative Problems|0|||
48450986|NCT00928512|155839219|FG004|Overall Study|Administrative Problems|0|||
48450987|NCT01095666|155839220|FG000|Overall Study|Lack of Efficacy|0|||
48450988|NCT01095666|155839221|FG001|Overall Study|Lack of Efficacy|0|||
48450989|NCT01095666|155839222|FG002|Overall Study|Lack of Efficacy|1|||
48450990|NCT01095666|155839220|FG000|Overall Study|Adverse Event|2|||
48450991|NCT01095666|155839221|FG001|Overall Study|Adverse Event|1|||
48450992|NCT01095666|155839222|FG002|Overall Study|Adverse Event|3|||
48450993|NCT01095666|155839220|FG000|Overall Study|Lost to Follow-up|2|||
48450994|NCT01095666|155839221|FG001|Overall Study|Lost to Follow-up|2|||
48450995|NCT01095666|155839222|FG002|Overall Study|Lost to Follow-up|0|||
48450996|NCT01095666|155839220|FG000|Overall Study|Withdrawal by Subject|6|||
48450997|NCT01095666|155839221|FG001|Overall Study|Withdrawal by Subject|6|||
48450998|NCT01095666|155839222|FG002|Overall Study|Withdrawal by Subject|1|||
48450999|NCT01095666|155839220|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
48451000|NCT01095666|155839221|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
48451001|NCT01095666|155839222|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
48451002|NCT00431496|155839225|FG000|Overall Study|Adverse Event|3|||
48451003|NCT00431496|155839225|FG000|Overall Study|Lost to Follow-up|1|||
48451004|NCT00431496|155839225|FG000|Overall Study|Withdrawal by Subject|2|||
48451005|NCT00431496|155839225|FG000|Overall Study|Protocol-specified criteria|5|||
48451006|NCT04018612|155839226|FG000|Overall Study|Withdrawal by Subject|1|||
48451007|NCT04018612|155839227|FG001|Overall Study|Withdrawal by Subject|0|||
48451008|NCT04018612|155839228|FG002|Overall Study|Withdrawal by Subject|1|||
48451009|NCT01915095|155839229|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
48451010|NCT01915095|155839230|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
48451011|NCT01915095|155839231|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
48451012|NCT01915095|155839232|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
48451013|NCT01915095|155839233|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
48451014|NCT01079195|155839234|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
48451015|NCT01079195|155839234|FG000|Overall Study|No Documentation Available|437|||
48451016|NCT01079195|155839234|FG000|Overall Study|Adverse Event|157|||
48451017|NCT01079195|155839234|FG000|Overall Study|Reason Unknown|39|||
48451018|NCT01079195|155839234|FG000|Overall Study|Withdrawal by Subject|18|||
48451019|NCT01079195|155839234|FG000|Overall Study|Financial Reasons|15|||
48451020|NCT01079195|155839234|FG000|Overall Study|Lack of Effectiveness|12|||
48451021|NCT01079195|155839234|FG000|Overall Study|Physician Decision|4|||
48451022|NCT01079195|155839234|FG000|Overall Study|Improved Status of Participant|4|||
48451023|NCT01079195|155839234|FG000|Overall Study|No Follow-up Documentation Available|4|||
48451024|NCT01079195|155839234|FG000|Overall Study|Non-compliance|2|||
48451025|NCT00807014|155839235|FG000|Overall Study|Participant Considered Disease Cured|13|||
48451026|NCT00807014|155839236|FG001|Overall Study|Participant Considered Disease Cured|2|||
48451027|NCT00807014|155839235|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
48451028|NCT00807014|155839236|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
48451029|NCT00807014|155839235|FG000|Overall Study|Protocol Violation|2|||
48451030|NCT00807014|155839236|FG001|Overall Study|Protocol Violation|8|||
48451031|NCT00807014|155839235|FG000|Overall Study|Adverse Event|0|||
48451032|NCT00807014|155839236|FG001|Overall Study|Adverse Event|2|||
48451033|NCT00807014|155839235|FG000|Overall Study|Lost to Follow-up|9|||
48451034|NCT00807014|155839236|FG001|Overall Study|Lost to Follow-up|7|||
48451035|NCT00807014|155839235|FG000|Overall Study|Recovery|1|||
48451036|NCT00807014|155839236|FG001|Overall Study|Recovery|0|||
48451037|NCT00807014|155839235|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
48451038|NCT00807014|155839236|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
48451039|NCT02650895|155839242|FG000|Overall Study|Withdrawal by Subject|0|||
48451040|NCT02650895|155839243|FG001|Overall Study|Withdrawal by Subject|1|||
48451041|NCT02650895|155839244|FG002|Overall Study|Withdrawal by Subject|0|||
48451042|NCT02650895|155839245|FG003|Overall Study|Withdrawal by Subject|0|||
48451043|NCT02650895|155839246|FG004|Overall Study|Withdrawal by Subject|0|||
48451044|NCT02650895|155839247|FG005|Overall Study|Withdrawal by Subject|0|||
48451045|NCT00361218|155839250|FG000|Overall Study|Lost to Follow-up|11|||
48451046|NCT00361218|155839250|FG000|Overall Study|Personal Reasons|7|||
48451047|NCT00361218|155839250|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
48451048|NCT02067533|155839252|FG000|Overall Study|Lost to Follow-up|4|||
48451049|NCT02067533|155839253|FG001|Overall Study|Lost to Follow-up|2|||
48451070|NCT01947894|155839259|FG000|Overall Study|Other|3|||
48451071|NCT01947894|155839260|FG001|Overall Study|Other|4|||
48451072|NCT01947894|155839261|FG002|Overall Study|Other|3|||
48451073|NCT01947894|155839259|FG000|Overall Study|Withdrawal by Subject|12|||
48451074|NCT01947894|155839260|FG001|Overall Study|Withdrawal by Subject|4|||
48451075|NCT01947894|155839261|FG002|Overall Study|Withdrawal by Subject|1|||
48451076|NCT01947894|155839259|FG000|Overall Study|Death|12|||
48451077|NCT01947894|155839260|FG001|Overall Study|Death|1|||
48451085|NCT01947894|155839259|FG000|Overall Study|Switched to other growth hormone brand|53|||
48451086|NCT01947894|155839260|FG001|Overall Study|Switched to other growth hormone brand|8|||
48451087|NCT01947894|155839261|FG002|Overall Study|Switched to other growth hormone brand|23|||
48451088|NCT02671760|155839264|FG000|Overall Study|Lost to Follow-up|0|||
48451089|NCT02671760|155839265|FG001|Overall Study|Lost to Follow-up|1|||
48451090|NCT02671760|155839266|FG002|Overall Study|Lost to Follow-up|0|||
48451091|NCT00643448|155839275|FG000|Overall Study|Lack of Efficacy|2|||
48451092|NCT00643448|155839276|FG001|Overall Study|Lack of Efficacy|0|||
48451093|NCT00643448|155839277|FG002|Overall Study|Lack of Efficacy|4|||
48451094|NCT00643448|155839275|FG000|Overall Study|Adverse Event|2|||
48451095|NCT00643448|155839276|FG001|Overall Study|Adverse Event|2|||
48451096|NCT00643448|155839277|FG002|Overall Study|Adverse Event|2|||
48451097|NCT00643448|155839275|FG000|Overall Study|QTcF>550 ms|0|||
48451098|NCT00643448|155839276|FG001|Overall Study|QTcF>550 ms|3|||
48451099|NCT00643448|155839277|FG002|Overall Study|QTcF>550 ms|0|||
48451100|NCT02079519|155839278|FG000|Overall Study|Disease Progression|9|||
48451101|NCT02079519|155839278|FG000|Overall Study|Adverse Event|1|||
48451102|NCT01802515|155839279|FG000|Overall Study|Withdrawal by Subject|3|||
48451103|NCT01802515|155839280|FG001|Overall Study|Withdrawal by Subject|0|||
48451104|NCT01802515|155839281|FG002|Overall Study|Withdrawal by Subject|0|||
48451105|NCT02566109|155839282|FG000|Overall Study|Withdrawal by Subject|1|||
48451106|NCT02738580|155839285|FG000|Overall Study|Adverse Event|1|||
48451107|NCT02738580|155839286|FG001|Overall Study|Adverse Event|0|||
48451108|NCT02738580|155839285|FG000|Overall Study|Lack of Efficacy|3|||
48451109|NCT02738580|155839286|FG001|Overall Study|Lack of Efficacy|2|||
48451110|NCT02738580|155839285|FG000|Overall Study|Withdrawal by Subject|0|||
48451111|NCT02738580|155839286|FG001|Overall Study|Withdrawal by Subject|1|||
48451112|NCT02738580|155839285|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
48451113|NCT02738580|155839286|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
48451114|NCT03209362|155839287|FG000|Overall Study|Adverse Event|0|||
48451115|NCT03209362|155839288|FG001|Overall Study|Adverse Event|1|||
48451116|NCT03209362|155839287|FG000|Overall Study|Lost to Follow-up|0|||
48451117|NCT03209362|155839288|FG001|Overall Study|Lost to Follow-up|1|||
48451118|NCT03209362|155839287|FG000|Overall Study|Withdrawal by Subject|2|||
48451119|NCT03209362|155839288|FG001|Overall Study|Withdrawal by Subject|0|||
48451120|NCT03209362|155839287|FG000|Overall Study|Other|0|||
48451121|NCT03209362|155839288|FG001|Overall Study|Other|1|||
48451122|NCT02109744|155839289|FG000|Overall Study|Death|1|||
48451123|NCT02109744|155839290|FG001|Overall Study|Death|1|||
48451124|NCT02109744|155839289|FG000|Overall Study|no marrow exam|1|||
48451125|NCT02109744|155839290|FG001|Overall Study|no marrow exam|0|||
48451126|NCT00422669|155839293|FG000|Overall Study|The study was terminated early.|98|||
48451127|NCT00422669|155839294|FG001|Overall Study|The study was terminated early.|100|||
48451128|NCT00422669|155839295|FG002|Overall Study|The study was terminated early.|7|||
48451129|NCT00064077|155839296|FG000|Overall Study|Improper prior treatment|1|||
48451130|NCT00064077|155839297|FG001|Overall Study|Improper prior treatment|0|||
48451131|NCT00064077|155839298|FG002|Overall Study|Improper prior treatment|0|||
48451132|NCT00064077|155839299|FG003|Overall Study|Improper prior treatment|0|||
48451133|NCT00064077|155839296|FG000|Overall Study|Poor risk|2|||
48451134|NCT00064077|155839297|FG001|Overall Study|Poor risk|0|||
48451135|NCT00064077|155839298|FG002|Overall Study|Poor risk|1|||
48451136|NCT00064077|155839299|FG003|Overall Study|Poor risk|1|||
48451137|NCT00064077|155839296|FG000|Overall Study|Pathology|10|||
48451138|NCT00064077|155839297|FG001|Overall Study|Pathology|7|||
48451139|NCT00064077|155839298|FG002|Overall Study|Pathology|3|||
48451140|NCT00064077|155839299|FG003|Overall Study|Pathology|4|||
48451141|NCT00064077|155839296|FG000|Overall Study|No surgery|0|||
48451142|NCT00064077|155839297|FG001|Overall Study|No surgery|0|||
48451143|NCT00064077|155839298|FG002|Overall Study|No surgery|1|||
48451144|NCT00064077|155839299|FG003|Overall Study|No surgery|0|||
48451145|NCT00064077|155839296|FG000|Overall Study|No tumor|0|||
48451146|NCT00064077|155839297|FG001|Overall Study|No tumor|0|||
48451147|NCT00064077|155839298|FG002|Overall Study|No tumor|1|||
48451148|NCT00064077|155839299|FG003|Overall Study|No tumor|0|||
48451149|NCT00064077|155839296|FG000|Overall Study|Other reasons|2|||
48451150|NCT00064077|155839297|FG001|Overall Study|Other reasons|2|||
48451151|NCT00064077|155839298|FG002|Overall Study|Other reasons|1|||
48451152|NCT00064077|155839299|FG003|Overall Study|Other reasons|2|||
48451153|NCT01041404|155839300|FG000|Overall Study|Adverse Event|45|||
48451154|NCT01041404|155839301|FG001|Overall Study|Adverse Event|35|||
48451155|NCT01041404|155839300|FG000|Overall Study|Lack of Efficacy|200|||
48451156|NCT01041404|155839301|FG001|Overall Study|Lack of Efficacy|210|||
48451157|NCT01041404|155839300|FG000|Overall Study|Violation of Selection Criteria|0|||
48451158|NCT01041404|155839301|FG001|Overall Study|Violation of Selection Criteria|1|||
48451159|NCT01041404|155839300|FG000|Overall Study|Protocol Violation|4|||
48451160|NCT01041404|155839301|FG001|Overall Study|Protocol Violation|0|||
48451161|NCT01041404|155839300|FG000|Overall Study|Withdrawal by Subject|29|||
48451162|NCT01041404|155839301|FG001|Overall Study|Withdrawal by Subject|23|||
48451163|NCT01041404|155839300|FG000|Overall Study|Failure to Return|1|||
48451164|NCT01041404|155839301|FG001|Overall Study|Failure to Return|2|||
48451167|NCT01993667|155839302|FG000|Overall Study|Insufficient data to analyze|16|||
48451168|NCT01993667|155839303|FG001|Overall Study|Insufficient data to analyze|16|||
48451169|NCT01993667|155839302|FG000|Overall Study|Insufficient altitude reached|3|||
48451170|NCT01993667|155839303|FG001|Overall Study|Insufficient altitude reached|1|||
48451171|NCT01993667|155839302|FG000|Overall Study|Lost to Follow-up|2|||
48451172|NCT01993667|155839303|FG001|Overall Study|Lost to Follow-up|2|||
48451173|NCT00423592|155839304|FG000|Overall Study|Adverse Event (through Week 12)|2|||
48451174|NCT00423592|155839304|FG000|Overall Study|Adverse Event (post Week 12)|5|||
48451175|NCT01176240|155839305|FG000|Study 306A|Lack of Efficacy|2|||
48451176|NCT01176240|155839306|FG001|Study 306A|Lack of Efficacy|1|||
48451177|NCT01176240|155839305|FG000|Study 306A|Protocol Violation|0|||
48451178|NCT01176240|155839306|FG001|Study 306A|Protocol Violation|1|||
48451179|NCT01176240|155839305|FG000|Study 306A|Withdrawal by Subject|0|||
48451180|NCT01176240|155839306|FG001|Study 306A|Withdrawal by Subject|1|||
48451181|NCT01176240|155839305|FG000|Study 306A|Stop due to diverse problems|1|||
48451182|NCT01176240|155839306|FG001|Study 306A|Stop due to diverse problems|0|||
48451183|NCT01176240|155839305|FG000|Study 306B|Lack of Efficacy|5|||
48451184|NCT01176240|155839306|FG001|Study 306B|Lack of Efficacy|3|||
48451185|NCT01176240|155839305|FG000|Study 306B|Adverse Event|10|||
48451186|NCT01176240|155839306|FG001|Study 306B|Adverse Event|5|||
48451187|NCT01176240|155839305|FG000|Study 306B|Protocol Violation|2|||
48451188|NCT01176240|155839306|FG001|Study 306B|Protocol Violation|3|||
48451189|NCT01176240|155839305|FG000|Study 306B|Withdrawal by Subject|4|||
48451190|NCT01176240|155839306|FG001|Study 306B|Withdrawal by Subject|1|||
48451191|NCT01176240|155839305|FG000|Study 306B|Physician Decision|2|||
48451192|NCT01176240|155839306|FG001|Study 306B|Physician Decision|1|||
48451193|NCT01176240|155839305|FG000|Study 306B|Supine Hypertension|1|||
48451194|NCT01176240|155839306|FG001|Study 306B|Supine Hypertension|2|||
48451195|NCT01176240|155839305|FG000|Study 306B|Lost to Follow-up|0|||
48451196|NCT01176240|155839306|FG001|Study 306B|Lost to Follow-up|1|||
48451197|NCT01176240|155839305|FG000|Study 306B|withdrew prior to dosing|2|||
48451198|NCT01176240|155839306|FG001|Study 306B|withdrew prior to dosing|1|||
48451199|NCT00571519|155841596|FG000|Overall Study|Subject withdrew consent|0|||
48451200|NCT00571519|155841597|FG001|Overall Study|Subject withdrew consent|1|||
48451201|NCT00571519|155841598|FG002|Overall Study|Subject withdrew consent|0|||
48451202|NCT00571519|155841599|FG003|Overall Study|Subject withdrew consent|2|||
48451203|NCT00571519|155841600|FG004|Overall Study|Subject withdrew consent|1|||
48451204|NCT00571519|155841601|FG005|Overall Study|Subject withdrew consent|1|||
48451205|NCT00571519|155841602|FG006|Overall Study|Subject withdrew consent|2|||
48451206|NCT00571519|155841596|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
48451207|NCT00571519|155841597|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
48451208|NCT00571519|155841598|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
48451209|NCT00571519|155841599|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
48451210|NCT00571519|155841600|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
48451211|NCT00571519|155841601|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
48451212|NCT00571519|155841602|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
48451213|NCT00571519|155841596|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
48451214|NCT00571519|155841597|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
48451215|NCT00571519|155841598|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
48451216|NCT00571519|155841599|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
48451217|NCT00571519|155841600|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
48451218|NCT00571519|155841601|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
48451219|NCT00571519|155841602|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
48451220|NCT00571519|155841596|FG000|Overall Study|Termination of study by Sponsor|2|||
48451221|NCT00571519|155841597|FG001|Overall Study|Termination of study by Sponsor|7|||
48451222|NCT00571519|155841598|FG002|Overall Study|Termination of study by Sponsor|10|||
48451223|NCT00571519|155841599|FG003|Overall Study|Termination of study by Sponsor|24|||
48451224|NCT00571519|155841600|FG004|Overall Study|Termination of study by Sponsor|8|||
48451225|NCT00571519|155841601|FG005|Overall Study|Termination of study by Sponsor|9|||
48451226|NCT00571519|155841602|FG006|Overall Study|Termination of study by Sponsor|22|||
48451227|NCT00571519|155841596|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48451228|NCT00571519|155841597|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48451229|NCT00571519|155841598|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
48451230|NCT00571519|155841599|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48451231|NCT00571519|155841600|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48451232|NCT00571519|155841601|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48451233|NCT00571519|155841602|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
48451234|NCT00355134|155841603|FG000|Core Phase|Withdrawal by Subject|35|||
48451235|NCT00355134|155841604|FG001|Core Phase|Withdrawal by Subject|24|||
48451236|NCT00355134|155841605|FG002|Core Phase|Withdrawal by Subject|35|||
48451237|NCT00355134|155841606|FG003|Core Phase|Withdrawal by Subject|0|||
48451249|NCT00355134|155841603|FG000|Core Phase|Abnormal laboratory value(s)|19|||
48451250|NCT00355134|155841604|FG001|Core Phase|Abnormal laboratory value(s)|14|||
48451251|NCT00355134|155841605|FG002|Core Phase|Abnormal laboratory value(s)|2|||
48451252|NCT00355134|155841606|FG003|Core Phase|Abnormal laboratory value(s)|0|||
48451253|NCT00355134|155841607|FG004|Core Phase|Abnormal laboratory value(s)|0|||
48451254|NCT00355134|155841603|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
48451255|NCT00355134|155841604|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
48451256|NCT00355134|155841605|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
48451257|NCT00355134|155841606|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
48451258|NCT00355134|155841607|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
48451259|NCT00355134|155841603|FG000|Core Phase|Administrative problems|5|||
48451260|NCT00355134|155841604|FG001|Core Phase|Administrative problems|3|||
48451261|NCT00355134|155841605|FG002|Core Phase|Administrative problems|5|||
48451262|NCT00355134|155841606|FG003|Core Phase|Administrative problems|0|||
48451263|NCT00355134|155841607|FG004|Core Phase|Administrative problems|0|||
48451264|NCT00355134|155841603|FG000|Core Phase|Protocol Violation|3|||
48451265|NCT00355134|155841604|FG001|Core Phase|Protocol Violation|2|||
48451266|NCT00355134|155841605|FG002|Core Phase|Protocol Violation|2|||
48451267|NCT00355134|155841606|FG003|Core Phase|Protocol Violation|0|||
48451268|NCT00355134|155841607|FG004|Core Phase|Protocol Violation|0|||
48451269|NCT00355134|155841603|FG000|Core Phase|Abnormal test procedure result(s)|1|||
48451270|NCT00355134|155841604|FG001|Core Phase|Abnormal test procedure result(s)|2|||
48451271|NCT00355134|155841605|FG002|Core Phase|Abnormal test procedure result(s)|1|||
48451272|NCT00355134|155841606|FG003|Core Phase|Abnormal test procedure result(s)|0|||
48451273|NCT00355134|155841607|FG004|Core Phase|Abnormal test procedure result(s)|0|||
48451274|NCT00355134|155841603|FG000|Core Phase|Condition no longer requires study drug|1|||
48451275|NCT00355134|155841604|FG001|Core Phase|Condition no longer requires study drug|0|||
48451276|NCT00355134|155841605|FG002|Core Phase|Condition no longer requires study drug|1|||
48451277|NCT00355134|155841606|FG003|Core Phase|Condition no longer requires study drug|0|||
48451278|NCT00355134|155841607|FG004|Core Phase|Condition no longer requires study drug|0|||
48451279|NCT00355134|155841603|FG000|Extension Phase|Withdrawal by Subject|7|||
48451280|NCT00355134|155841604|FG001|Extension Phase|Withdrawal by Subject|11|||
48451281|NCT00355134|155841605|FG002|Extension Phase|Withdrawal by Subject|0|||
48451282|NCT00355134|155841606|FG003|Extension Phase|Withdrawal by Subject|7|||
48451283|NCT00355134|155841607|FG004|Extension Phase|Withdrawal by Subject|5|||
48451284|NCT00355134|155841603|FG000|Extension Phase|Adverse Event|13|||
48451285|NCT00355134|155841604|FG001|Extension Phase|Adverse Event|9|||
48451286|NCT00355134|155841605|FG002|Extension Phase|Adverse Event|0|||
48451287|NCT00355134|155841606|FG003|Extension Phase|Adverse Event|3|||
48451288|NCT00355134|155841607|FG004|Extension Phase|Adverse Event|5|||
48451289|NCT00355134|155841603|FG000|Extension Phase|Lost to Follow-up|2|||
48451290|NCT00355134|155841604|FG001|Extension Phase|Lost to Follow-up|6|||
48451291|NCT00355134|155841605|FG002|Extension Phase|Lost to Follow-up|0|||
48451292|NCT00355134|155841606|FG003|Extension Phase|Lost to Follow-up|2|||
48451293|NCT00355134|155841607|FG004|Extension Phase|Lost to Follow-up|4|||
48451294|NCT00355134|155841603|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
48451295|NCT00355134|155841604|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
48451296|NCT00355134|155841605|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
48451297|NCT00355134|155841606|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
48451298|NCT00355134|155841607|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
48451299|NCT00355134|155841603|FG000|Extension Phase|Administrative problems|2|||
48451300|NCT00355134|155841604|FG001|Extension Phase|Administrative problems|4|||
48451301|NCT00355134|155841605|FG002|Extension Phase|Administrative problems|0|||
48451302|NCT00355134|155841606|FG003|Extension Phase|Administrative problems|1|||
48451303|NCT00355134|155841607|FG004|Extension Phase|Administrative problems|1|||
48451304|NCT00355134|155841603|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
48451305|NCT00355134|155841604|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
48451306|NCT00355134|155841605|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
48451307|NCT00355134|155841606|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
48451308|NCT00355134|155841607|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
48451309|NCT00355134|155841603|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
48451310|NCT00355134|155841604|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
48451311|NCT00355134|155841605|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
48451312|NCT00355134|155841606|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
48451313|NCT00355134|155841607|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
48451314|NCT00355134|155841603|FG000|Extension Phase|Protocol Violation|0|||
48451315|NCT00355134|155841604|FG001|Extension Phase|Protocol Violation|0|||
48451316|NCT00355134|155841605|FG002|Extension Phase|Protocol Violation|0|||
48451317|NCT00355134|155841606|FG003|Extension Phase|Protocol Violation|1|||
48451318|NCT00355134|155841607|FG004|Extension Phase|Protocol Violation|0|||
48451319|NCT01451398|155841608|FG000|Overall Study|Adverse Event|7|||
48451320|NCT01451398|155841609|FG001|Overall Study|Adverse Event|9|||
48451321|NCT01451398|155841608|FG000|Overall Study|Protocol Violation|1|||
48451322|NCT01451398|155841609|FG001|Overall Study|Protocol Violation|2|||
48451324|NCT01451398|155841609|FG001|Overall Study|Physician Decision|1|||
48451325|NCT01451398|155841608|FG000|Overall Study|Withdrawal by Subject|10|||
48451326|NCT01451398|155841609|FG001|Overall Study|Withdrawal by Subject|14|||
48451327|NCT01451398|155841608|FG000|Overall Study|Lost to Follow-up|6|||
48451328|NCT01451398|155841609|FG001|Overall Study|Lost to Follow-up|4|||
48451329|NCT01451398|155841608|FG000|Overall Study|Non-compliance with study drug|1|||
48451330|NCT01451398|155841609|FG001|Overall Study|Non-compliance with study drug|3|||
48451331|NCT01451398|155841608|FG000|Overall Study|Non-compliance with protocol|1|||
48451332|NCT01451398|155841609|FG001|Overall Study|Non-compliance with protocol|1|||
48451333|NCT01451398|155841608|FG000|Overall Study|Moved out of country|0|||
48451334|NCT01451398|155841609|FG001|Overall Study|Moved out of country|1|||
48451335|NCT01451398|155841608|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
48451336|NCT01451398|155841609|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
48451337|NCT01451398|155841608|FG000|Overall Study|Lack of Efficacy|0|||
48451338|NCT01451398|155841609|FG001|Overall Study|Lack of Efficacy|1|||
48451339|NCT04058158|155841610|FG000|Period 1|Death|1|||
48451340|NCT04058158|155841611|FG001|Period 1|Death|0|||
48451341|NCT04058158|155841610|FG000|Period 1|Adverse Event|1|||
48451342|NCT04058158|155841611|FG001|Period 1|Adverse Event|1|||
48451343|NCT04058158|155841610|FG000|Period 1|Pregnancy|0|||
48451344|NCT04058158|155841611|FG001|Period 1|Pregnancy|1|||
48451345|NCT02009930|155841616|FG000|Overall Study|withdrawn|5|||
48451346|NCT01136746|155841617|FG000|Overall Study|Lost to Follow-up|0|||
48451347|NCT01136746|155841618|FG001|Overall Study|Lost to Follow-up|2|||
48451348|NCT01136746|155841617|FG000|Overall Study|Protocol Violation|2|||
48451349|NCT01136746|155841618|FG001|Overall Study|Protocol Violation|1|||
48451350|NCT01136746|155841617|FG000|Overall Study|Death|1|||
48451351|NCT01136746|155841618|FG001|Overall Study|Death|0|||
48451352|NCT03907969|155841619|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
48451353|NCT03907969|155841620|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
48451354|NCT03907969|155841621|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
48451355|NCT03907969|155841622|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
48451356|NCT03907969|155841623|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
48451357|NCT03907969|155841624|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
48451358|NCT03907969|155841625|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
48451359|NCT03907969|155841626|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
48451360|NCT03907969|155841627|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
48451361|NCT03907969|155841628|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
48451362|NCT03907969|155841629|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
48451363|NCT03907969|155841619|FG000|Monotherapy Part A|Progressive Disease|0|||
48451364|NCT03907969|155841620|FG001|Monotherapy Part A|Progressive Disease|1|||
48451365|NCT03907969|155841621|FG002|Monotherapy Part A|Progressive Disease|0|||
48451366|NCT03907969|155841622|FG003|Monotherapy Part A|Progressive Disease|0|||
48451367|NCT03907969|155841623|FG004|Monotherapy Part A|Progressive Disease|0|||
48451368|NCT03907969|155841624|FG005|Monotherapy Part A|Progressive Disease|1|||
48451369|NCT03907969|155841625|FG006|Monotherapy Part A|Progressive Disease|2|||
48451370|NCT03907969|155841626|FG007|Monotherapy Part A|Progressive Disease|0|||
48451371|NCT03907969|155841627|FG008|Monotherapy Part A|Progressive Disease|0|||
48451372|NCT03907969|155841628|FG009|Monotherapy Part A|Progressive Disease|0|||
48451373|NCT03907969|155841629|FG010|Monotherapy Part A|Progressive Disease|0|||
48451374|NCT03907969|155841619|FG000|Monotherapy Part A|Death|0|||
48451375|NCT03907969|155841620|FG001|Monotherapy Part A|Death|0|||
48451376|NCT03907969|155841621|FG002|Monotherapy Part A|Death|1|||
48451377|NCT03907969|155841622|FG003|Monotherapy Part A|Death|1|||
48451378|NCT03907969|155841623|FG004|Monotherapy Part A|Death|0|||
48451379|NCT03907969|155841624|FG005|Monotherapy Part A|Death|1|||
48451380|NCT03907969|155841625|FG006|Monotherapy Part A|Death|0|||
48451381|NCT03907969|155841626|FG007|Monotherapy Part A|Death|0|||
48451382|NCT03907969|155841627|FG008|Monotherapy Part A|Death|0|||
48451383|NCT03907969|155841628|FG009|Monotherapy Part A|Death|0|||
48451384|NCT03907969|155841629|FG010|Monotherapy Part A|Death|0|||
48451385|NCT03907969|155841619|FG000|Combination Therapy Part A|Adverse Event|0|||
48451386|NCT03907969|155841620|FG001|Combination Therapy Part A|Adverse Event|0|||
48451387|NCT03907969|155841621|FG002|Combination Therapy Part A|Adverse Event|0|||
48451388|NCT03907969|155841622|FG003|Combination Therapy Part A|Adverse Event|0|||
48451389|NCT03907969|155841623|FG004|Combination Therapy Part A|Adverse Event|0|||
48451390|NCT03907969|155841624|FG005|Combination Therapy Part A|Adverse Event|0|||
48451391|NCT03907969|155841625|FG006|Combination Therapy Part A|Adverse Event|0|||
48451392|NCT03907969|155841626|FG007|Combination Therapy Part A|Adverse Event|0|||
48451393|NCT03907969|155841627|FG008|Combination Therapy Part A|Adverse Event|0|||
48451394|NCT03907969|155841628|FG009|Combination Therapy Part A|Adverse Event|1|||
48451395|NCT03907969|155841629|FG010|Combination Therapy Part A|Adverse Event|1|||
48451396|NCT03907969|155841619|FG000|Combination Therapy Part A|Progressive disease|0|||
48451397|NCT03907969|155841620|FG001|Combination Therapy Part A|Progressive disease|0|||
48451398|NCT03907969|155841621|FG002|Combination Therapy Part A|Progressive disease|0|||
48451399|NCT03907969|155841622|FG003|Combination Therapy Part A|Progressive disease|0|||
48451400|NCT03907969|155841623|FG004|Combination Therapy Part A|Progressive disease|0|||
48451401|NCT03907969|155841624|FG005|Combination Therapy Part A|Progressive disease|0|||
48451402|NCT03907969|155841625|FG006|Combination Therapy Part A|Progressive disease|0|||
48451403|NCT03907969|155841626|FG007|Combination Therapy Part A|Progressive disease|1|||
48451404|NCT03907969|155841627|FG008|Combination Therapy Part A|Progressive disease|0|||
48451405|NCT03907969|155841628|FG009|Combination Therapy Part A|Progressive disease|2|||
48451406|NCT03907969|155841629|FG010|Combination Therapy Part A|Progressive disease|3|||
48451407|NCT03907969|155841619|FG000|Combination Therapy Part A|Death|0|||
48451408|NCT03907969|155841620|FG001|Combination Therapy Part A|Death|0|||
48451409|NCT03907969|155841621|FG002|Combination Therapy Part A|Death|0|||
48451410|NCT03907969|155841622|FG003|Combination Therapy Part A|Death|0|||
48451411|NCT03907969|155841623|FG004|Combination Therapy Part A|Death|0|||
48451412|NCT03907969|155841624|FG005|Combination Therapy Part A|Death|0|||
48451413|NCT03907969|155841625|FG006|Combination Therapy Part A|Death|0|||
48451414|NCT03907969|155841626|FG007|Combination Therapy Part A|Death|0|||
48451415|NCT03907969|155841627|FG008|Combination Therapy Part A|Death|1|||
48451416|NCT03907969|155841628|FG009|Combination Therapy Part A|Death|0|||
48451417|NCT03907969|155841629|FG010|Combination Therapy Part A|Death|1|||
48451418|NCT03907969|155841619|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
48451419|NCT03907969|155841620|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
48451420|NCT03907969|155841621|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
48451421|NCT03907969|155841622|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
48451422|NCT03907969|155841623|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
48451423|NCT03907969|155841624|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
48451424|NCT03907969|155841625|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
48451425|NCT03907969|155841626|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
48451426|NCT03907969|155841627|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
48451427|NCT03907969|155841628|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
48451428|NCT03907969|155841629|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
48451429|NCT03907969|155841619|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
48451430|NCT03907969|155841620|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
48451431|NCT03907969|155841621|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
48451432|NCT03907969|155841622|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
48451433|NCT03907969|155841623|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
48451434|NCT03907969|155841624|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
48451435|NCT03907969|155841625|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
48451436|NCT03907969|155841626|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
48451437|NCT03907969|155841627|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
48451438|NCT03907969|155841628|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
48451439|NCT03907969|155841629|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
48451440|NCT03907969|155841619|FG000|Combination Therapy Part A|Physician Decision|0|||
48451441|NCT03907969|155841620|FG001|Combination Therapy Part A|Physician Decision|0|||
48451442|NCT03907969|155841621|FG002|Combination Therapy Part A|Physician Decision|0|||
48451443|NCT03907969|155841622|FG003|Combination Therapy Part A|Physician Decision|0|||
48451444|NCT03907969|155841623|FG004|Combination Therapy Part A|Physician Decision|0|||
48451445|NCT03907969|155841624|FG005|Combination Therapy Part A|Physician Decision|0|||
48451446|NCT03907969|155841625|FG006|Combination Therapy Part A|Physician Decision|0|||
48451447|NCT03907969|155841626|FG007|Combination Therapy Part A|Physician Decision|1|||
48451448|NCT03907969|155841627|FG008|Combination Therapy Part A|Physician Decision|0|||
48451449|NCT03907969|155841628|FG009|Combination Therapy Part A|Physician Decision|0|||
48451450|NCT03907969|155841629|FG010|Combination Therapy Part A|Physician Decision|1|||
48451451|NCT02580240|155841634|FG000|Overall Study|Physician Decision|2|||
48451452|NCT02580240|155841635|FG001|Overall Study|Physician Decision|0|||
48451453|NCT00607919|155841636|FG000|Acute Phase|Adverse Event|9|||
48451454|NCT00607919|155841637|FG001|Acute Phase|Adverse Event|2|||
48451455|NCT00607919|155841636|FG000|Acute Phase|Entry Criteria Not Met|1|||
48451456|NCT00607919|155841637|FG001|Acute Phase|Entry Criteria Not Met|1|||
48451457|NCT00607919|155841636|FG000|Acute Phase|Lack of Efficacy|1|||
48451458|NCT00607919|155841637|FG001|Acute Phase|Lack of Efficacy|2|||
48451459|NCT00607919|155841636|FG000|Acute Phase|Lost to Follow-up|9|||
48451460|NCT00607919|155841637|FG001|Acute Phase|Lost to Follow-up|3|||
48451461|NCT00607919|155841636|FG000|Acute Phase|Parent/Caregiver Decision|6|||
48451462|NCT00607919|155841637|FG001|Acute Phase|Parent/Caregiver Decision|4|||
48451463|NCT00607919|155841636|FG000|Acute Phase|Protocol Violation|5|||
48451464|NCT00607919|155841637|FG001|Acute Phase|Protocol Violation|1|||
48451465|NCT00607919|155841636|FG000|Acute Phase|Withdrawal by Subject|3|||
48451466|NCT00607919|155841637|FG001|Acute Phase|Withdrawal by Subject|3|||
48451467|NCT00607919|155841636|FG000|Open-Label Phase|Adverse Event|1|||
48451468|NCT00607919|155841637|FG001|Open-Label Phase|Adverse Event|5|||
48451469|NCT00607919|155841636|FG000|Open-Label Phase|Lost to Follow-up|4|||
48451470|NCT00607919|155841637|FG001|Open-Label Phase|Lost to Follow-up|1|||
48451471|NCT00607919|155841636|FG000|Open-Label Phase|Protocol Violation|2|||
48451472|NCT00607919|155841637|FG001|Open-Label Phase|Protocol Violation|2|||
48451473|NCT00607919|155841636|FG000|Open-Label Phase|Withdrawal by Subject|2|||
48451474|NCT00607919|155841637|FG001|Open-Label Phase|Withdrawal by Subject|2|||
48451475|NCT00607919|155841636|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
48451476|NCT00607919|155841637|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
48451477|NCT02786836|155841638|FG000|Overall Study|Death|1|||
48451478|NCT02786836|155841638|FG000|Overall Study|Lack of Efficacy|2|||
48451479|NCT02786836|155841638|FG000|Overall Study|Protocol Violation|3|||
48451480|NCT02786836|155841638|FG000|Overall Study|Withdrawal by Subject|3|||
48451481|NCT02786836|155841638|FG000|Overall Study|Liver Transplantation|2|||
48451482|NCT02786836|155841638|FG000|Overall Study|Device or Pharmacy Issues|3|||
48451483|NCT02255760|155841639|FG000|Overall Study|Lost to Follow-up|0|||
48451484|NCT02255760|155841640|FG001|Overall Study|Lost to Follow-up|1|||
48451485|NCT02255760|155841641|FG002|Overall Study|Lost to Follow-up|0|||
48451486|NCT02255760|155841642|FG003|Overall Study|Lost to Follow-up|0|||
48451487|NCT02255760|155841643|FG004|Overall Study|Lost to Follow-up|0|||
48451488|NCT00618813|155841644|FG000|Overall Study|Lack of Efficacy|1|||
48451489|NCT00618813|155841644|FG000|Overall Study|Physician Decision|2|||
48451490|NCT00618813|155841644|FG000|Overall Study|Withdrawal by Subject|1|||
48451491|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
48451492|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
48451493|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
48451494|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
48451495|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
48451496|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
48451497|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
48451498|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
48451499|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
48451500|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
48451501|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
48451502|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
48451503|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
48451504|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
48451505|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
48451506|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
48451507|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
48451508|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
48451509|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
48451510|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
48451511|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
48451512|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
48451513|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
48451514|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
48451515|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Other|0|||
48451516|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Other|1|||
48451517|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Other|0|||
48451518|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Other|0|||
48451519|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
48451520|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
48451521|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
48451522|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
48451523|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
48451524|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
48451525|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
48451526|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
48451527|NCT01194414|155841645|FG000|24 Weeks Double Blind Period|Death|0|||
48451528|NCT01194414|155841646|FG001|24 Weeks Double Blind Period|Death|1|||
48451529|NCT01194414|155841647|FG002|24 Weeks Double Blind Period|Death|0|||
48451530|NCT01194414|155841648|FG003|24 Weeks Double Blind Period|Death|0|||
48451531|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
48451532|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
48451533|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
48451534|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
48451535|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
48451536|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
48451537|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
48451538|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
48451539|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
48451540|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
48451541|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
48451542|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
48451543|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
48451544|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
48451545|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
48451546|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
48451547|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
48451548|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
48451549|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
48451550|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
48451551|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
48451552|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
48451553|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
48451554|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
48451555|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Other|2|||
48451556|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Other|1|||
48451557|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Other|0|||
48451558|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Other|0|||
48451559|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
48451560|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
48451561|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
48451562|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
48451563|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
48451564|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
48451565|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
48451566|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
48451567|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
48451568|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
48451569|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
48451570|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
48451571|NCT01194414|155841645|FG000|72 Weeks Open Label Extension|Death|1|||
48451572|NCT01194414|155841646|FG001|72 Weeks Open Label Extension|Death|2|||
48451573|NCT01194414|155841647|FG002|72 Weeks Open Label Extension|Death|0|||
48451574|NCT01194414|155841648|FG003|72 Weeks Open Label Extension|Death|2|||
48451575|NCT02057068|155841649|FG000|Overall Study|Withdrawal by Subject|2|||
48451576|NCT02057068|155841650|FG001|Overall Study|Withdrawal by Subject|2|||
48451577|NCT02057068|155841649|FG000|Overall Study|Caregiver (CG) Health|0|||
48451578|NCT02057068|155841650|FG001|Overall Study|Caregiver (CG) Health|2|||
48451579|NCT02057068|155841649|FG000|Overall Study|Carepartner (CP) Health|4|||
48451580|NCT02057068|155841650|FG001|Overall Study|Carepartner (CP) Health|2|||
48451581|NCT02057068|155841649|FG000|Overall Study|Lost to Follow-up|2|||
48451582|NCT02057068|155841650|FG001|Overall Study|Lost to Follow-up|2|||
48451583|NCT04685538|155841651|FG000|Overall Study|Adverse Event|0|||
48451584|NCT04685538|155841652|FG001|Overall Study|Adverse Event|1|||
48451585|NCT04685538|155841651|FG000|Overall Study|Lost to Follow-up|0|||
48451586|NCT04685538|155841652|FG001|Overall Study|Lost to Follow-up|2|||
48451587|NCT02920450|155841653|FG000|Overall Study|Death|1|||
48451588|NCT02920450|155841654|FG001|Overall Study|Death|0|||
48451589|NCT02920450|155841655|FG002|Overall Study|Death|0|||
48451590|NCT02920450|155841656|FG003|Overall Study|Death|0|||
48451591|NCT02920450|155841653|FG000|Overall Study|Withdrawal by Subject|1|||
48451592|NCT02920450|155841654|FG001|Overall Study|Withdrawal by Subject|0|||
48451593|NCT02920450|155841655|FG002|Overall Study|Withdrawal by Subject|0|||
48451594|NCT02920450|155841656|FG003|Overall Study|Withdrawal by Subject|0|||
48451595|NCT01484561|155841663|FG000|Overall Study|Lack of Efficacy|3|||
48451596|NCT01484561|155841664|FG001|Overall Study|Lack of Efficacy|1|||
48451597|NCT01484561|155841663|FG000|Overall Study|Lost to Follow-up|1|||
48451598|NCT01484561|155841664|FG001|Overall Study|Lost to Follow-up|0|||
48451599|NCT01484561|155841663|FG000|Overall Study|Withdrawal by Subject|3|||
48451600|NCT01484561|155841664|FG001|Overall Study|Withdrawal by Subject|0|||
48451601|NCT01484561|155841663|FG000|Overall Study|Other|1|||
48451602|NCT01484561|155841664|FG001|Overall Study|Other|1|||
48451603|NCT01484561|155841663|FG000|Overall Study|Adverse Event|1|||
48451604|NCT01484561|155841664|FG001|Overall Study|Adverse Event|4|||
48451605|NCT01112982|155841665|FG000|Overall Study|Withdrawal by Subject|1|||
48451606|NCT01112982|155841665|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
48451607|NCT00432562|155841666|FG000|Overall Study|Death|3|||
48451608|NCT00432562|155841667|FG001|Overall Study|Death|0|||
48451609|NCT00114218|155841668|FG000|Overall Study|Wrong Cell Type|2|||
48451610|NCT00114218|155841668|FG000|Overall Study|Wrong Primary|1|||
48451611|NCT00114218|155841668|FG000|Overall Study|Never Treated|1|||
48451612|NCT00291187|155841669|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
48451613|NCT00291187|155841670|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
48451614|NCT00291187|155841671|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
48451615|NCT00291187|155841672|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
48451616|NCT00968708|155841673|FG000|Overall Study|Adverse Event|169|||
48451617|NCT00968708|155841674|FG001|Overall Study|Adverse Event|150|||
48451618|NCT00968708|155841673|FG000|Overall Study|Major Protocol Deviation|0|||
48451619|NCT00968708|155841674|FG001|Overall Study|Major Protocol Deviation|1|||
48451620|NCT00968708|155841673|FG000|Overall Study|Lost to Follow-up|19|||
48451621|NCT00968708|155841674|FG001|Overall Study|Lost to Follow-up|11|||
48451622|NCT00968708|155841673|FG000|Overall Study|Voluntary Withdrawal|104|||
48451623|NCT00968708|155841674|FG001|Overall Study|Voluntary Withdrawal|101|||
48451624|NCT00968708|155841673|FG000|Overall Study|Investigator Discretion|0|||
48451625|NCT00968708|155841674|FG001|Overall Study|Investigator Discretion|1|||
48451626|NCT00968708|155841673|FG000|Overall Study|Other|26|||
48451627|NCT00968708|155841674|FG001|Overall Study|Other|34|||
48451628|NCT02260388|155841678|FG000|Overall Study|Lost to Follow-up|2|||
48451629|NCT02260388|155841679|FG001|Overall Study|Lost to Follow-up|8|||
48451630|NCT02260388|155841680|FG002|Overall Study|Lost to Follow-up|3|||
48451631|NCT02260388|155841681|FG003|Overall Study|Lost to Follow-up|4|||
48451632|NCT01981109|155841682|FG000|Overall Study|Death|36|||
48451633|NCT01981109|155841682|FG000|Overall Study|Withdrawal by Subject|40|||
48451634|NCT01981109|155841682|FG000|Overall Study|Lost to Follow-up|9|||
48451635|NCT01981109|155841682|FG000|Overall Study|No Discontinuation Documentation|37|||
48451636|NCT01981109|155841682|FG000|Overall Study|Study Termination|100|||
48451637|NCT01981109|155841682|FG000|Overall Study|No data available|2|||
48451638|NCT04445688|155841683|FG000|Washout (One Week)|Adverse Event|2|||
48451639|NCT04445688|155841683|FG000|Washout (One Week)|Withdrawal by Subject|1|||
48451640|NCT02266004|155841684|FG000|Overall Study|unrelated adverse event|1|||
48451641|NCT02266004|155841684|FG000|Overall Study|Physician Decision|1|||
48451642|NCT00126672|155841686|FG000|Overall Study|Adverse Event|4|||
48451643|NCT00126672|155841686|FG000|Overall Study|Lost to Follow-up|4|||
48451644|NCT02076334|155841693|FG000|Overall Study|Protocol Violation|1|||
48451645|NCT02076334|155841694|FG001|Overall Study|Protocol Violation|0|||
48451646|NCT02076334|155841695|FG002|Overall Study|Protocol Violation|0|||
48451647|NCT02076334|155841696|FG003|Overall Study|Protocol Violation|0|||
48451648|NCT02076334|155841693|FG000|Overall Study|Lost to Follow-up|0|||
48451649|NCT02076334|155841694|FG001|Overall Study|Lost to Follow-up|1|||
48451650|NCT02076334|155841695|FG002|Overall Study|Lost to Follow-up|1|||
48451651|NCT02076334|155841696|FG003|Overall Study|Lost to Follow-up|0|||
48451652|NCT02076334|155841693|FG000|Overall Study|muscle soreness|0|||
48451653|NCT02076334|155841694|FG001|Overall Study|muscle soreness|0|||
48451654|NCT02076334|155841695|FG002|Overall Study|muscle soreness|0|||
48451655|NCT02076334|155841696|FG003|Overall Study|muscle soreness|1|||
48451656|NCT00753623|155841702|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
48451657|NCT00753623|155841703|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
48451658|NCT00753623|155841702|FG000|Phase I (14 Days)|Physician Decision|1|||
48451659|NCT00753623|155841703|FG001|Phase I (14 Days)|Physician Decision|2|||
48451660|NCT00753623|155841702|FG000|Phase I (14 Days)|Adverse Event|0|||
48451661|NCT00753623|155841703|FG001|Phase I (14 Days)|Adverse Event|1|||
48451662|NCT00753623|155841702|FG000|Washout (7 Days)|Physician Decision|1|||
48451663|NCT00753623|155841703|FG001|Washout (7 Days)|Physician Decision|0|||
48451664|NCT00753623|155841702|FG000|Phase II (14 Days)|Physician Decision|0|||
48451665|NCT00753623|155841703|FG001|Phase II (14 Days)|Physician Decision|1|||
48451666|NCT04153929|155841704|FG000|Overall Study|Other than listed|2|||
48451667|NCT04153929|155841705|FG001|Overall Study|Other than listed|2|||
48451668|NCT04153929|155841706|FG002|Overall Study|Other than listed|0|||
48451669|NCT04153929|155841707|FG003|Overall Study|Other than listed|1|||
48451670|NCT04153929|155841708|FG004|Overall Study|Other than listed|0|||
48451671|NCT04153929|155841709|FG005|Overall Study|Other than listed|2|||
48451672|NCT04153929|155841710|FG006|Overall Study|Other than listed|2|||
48451673|NCT04153929|155841711|FG007|Overall Study|Other than listed|1|||
48451674|NCT04153929|155841704|FG000|Overall Study|Lost to Follow-up|2|||
48451675|NCT04153929|155841705|FG001|Overall Study|Lost to Follow-up|1|||
48451676|NCT04153929|155841706|FG002|Overall Study|Lost to Follow-up|0|||
48451677|NCT04153929|155841707|FG003|Overall Study|Lost to Follow-up|1|||
48451678|NCT04153929|155841708|FG004|Overall Study|Lost to Follow-up|1|||
48451679|NCT04153929|155841709|FG005|Overall Study|Lost to Follow-up|0|||
48451680|NCT04153929|155841710|FG006|Overall Study|Lost to Follow-up|0|||
48451681|NCT04153929|155841711|FG007|Overall Study|Lost to Follow-up|0|||
48451682|NCT04153929|155841704|FG000|Overall Study|Withdrawal by Subject|3|||
48451683|NCT04153929|155841705|FG001|Overall Study|Withdrawal by Subject|1|||
48451684|NCT04153929|155841706|FG002|Overall Study|Withdrawal by Subject|0|||
48451685|NCT04153929|155841707|FG003|Overall Study|Withdrawal by Subject|3|||
48451686|NCT04153929|155841708|FG004|Overall Study|Withdrawal by Subject|1|||
48451687|NCT04153929|155841709|FG005|Overall Study|Withdrawal by Subject|0|||
48451688|NCT04153929|155841710|FG006|Overall Study|Withdrawal by Subject|1|||
48451689|NCT04153929|155841711|FG007|Overall Study|Withdrawal by Subject|0|||
48451690|NCT04153929|155841704|FG000|Overall Study|Protocol Violation|0|||
48451691|NCT04153929|155841705|FG001|Overall Study|Protocol Violation|0|||
48451692|NCT04153929|155841706|FG002|Overall Study|Protocol Violation|0|||
48451693|NCT04153929|155841707|FG003|Overall Study|Protocol Violation|0|||
48451694|NCT04153929|155841708|FG004|Overall Study|Protocol Violation|0|||
48451695|NCT04153929|155841709|FG005|Overall Study|Protocol Violation|0|||
48451696|NCT04153929|155841710|FG006|Overall Study|Protocol Violation|1|||
48451697|NCT04153929|155841711|FG007|Overall Study|Protocol Violation|2|||
48451698|NCT04153929|155841704|FG000|Overall Study|Adverse Event|3|||
48451699|NCT04153929|155841705|FG001|Overall Study|Adverse Event|5|||
48451700|NCT04153929|155841706|FG002|Overall Study|Adverse Event|5|||
48451701|NCT04153929|155841707|FG003|Overall Study|Adverse Event|11|||
48451702|NCT04153929|155841708|FG004|Overall Study|Adverse Event|15|||
48451703|NCT04153929|155841709|FG005|Overall Study|Adverse Event|4|||
48451704|NCT04153929|155841710|FG006|Overall Study|Adverse Event|8|||
48451705|NCT04153929|155841711|FG007|Overall Study|Adverse Event|2|||
48451706|NCT04153929|155841704|FG000|Overall Study|Not treated|1|||
48451707|NCT04153929|155841705|FG001|Overall Study|Not treated|0|||
48451708|NCT04153929|155841706|FG002|Overall Study|Not treated|0|||
48451709|NCT04153929|155841707|FG003|Overall Study|Not treated|0|||
48451710|NCT04153929|155841708|FG004|Overall Study|Not treated|0|||
48451711|NCT04153929|155841709|FG005|Overall Study|Not treated|0|||
48451712|NCT04153929|155841710|FG006|Overall Study|Not treated|1|||
48451713|NCT04153929|155841711|FG007|Overall Study|Not treated|0|||
48451714|NCT04083794|155841712|FG000|Overall Study|Lost to Follow-up|9|||
48451715|NCT03383614|155841713|FG000|Overall Study|Withdrawal by Subject|0|||
48451716|NCT03383614|155841714|FG001|Overall Study|Withdrawal by Subject|1|||
48451717|NCT03383614|155841715|FG002|Overall Study|Withdrawal by Subject|0|||
48451718|NCT03383614|155841716|FG003|Overall Study|Withdrawal by Subject|0|||
48451719|NCT01749800|155841717|FG000|Overall Study|not meeting inclusion criteria|3|||
48451720|NCT01749800|155841718|FG001|Overall Study|not meeting inclusion criteria|0|||
48451721|NCT01749800|155841719|FG002|Overall Study|not meeting inclusion criteria|0|||
48451722|NCT01749800|155841717|FG000|Overall Study|Withdrawal by Subject|0|||
48451723|NCT01749800|155841718|FG001|Overall Study|Withdrawal by Subject|1|||
48451724|NCT01749800|155841719|FG002|Overall Study|Withdrawal by Subject|0|||
48451725|NCT03639987|155841720|FG000|Overall Study|Study terminated by sponsor|26|||
48451726|NCT03639987|155841721|FG001|Overall Study|Study terminated by sponsor|25|||
48451727|NCT03639987|155841720|FG000|Overall Study|Lost to Follow-up|0|||
48451728|NCT03639987|155841721|FG001|Overall Study|Lost to Follow-up|1|||
48451729|NCT00814307|155841727|FG000|Overall Study|Randomized but not treated|1|||
48451730|NCT00814307|155841728|FG001|Overall Study|Randomized but not treated|0|||
48451731|NCT00814307|155841729|FG002|Overall Study|Randomized but not treated|0|||
48451732|NCT00814307|155841730|FG003|Overall Study|Randomized but not treated|0|||
48451733|NCT00814307|155841727|FG000|Overall Study|Adverse Event|3|||
48451734|NCT00814307|155841728|FG001|Overall Study|Adverse Event|9|||
48451735|NCT00814307|155841729|FG002|Overall Study|Adverse Event|3|||
48451736|NCT00814307|155841730|FG003|Overall Study|Adverse Event|2|||
48451737|NCT00814307|155841727|FG000|Overall Study|Lack of Efficacy|1|||
48451738|NCT00814307|155841728|FG001|Overall Study|Lack of Efficacy|1|||
48451739|NCT00814307|155841729|FG002|Overall Study|Lack of Efficacy|3|||
48451740|NCT00814307|155841730|FG003|Overall Study|Lack of Efficacy|4|||
48451741|NCT00814307|155841727|FG000|Overall Study|Other|1|||
48451742|NCT00814307|155841728|FG001|Overall Study|Other|2|||
48451743|NCT00814307|155841729|FG002|Overall Study|Other|0|||
48451744|NCT00814307|155841730|FG003|Overall Study|Other|1|||
48451745|NCT00814307|155841727|FG000|Overall Study|Protocol Violation|2|||
48451746|NCT00814307|155841728|FG001|Overall Study|Protocol Violation|8|||
48451747|NCT00814307|155841729|FG002|Overall Study|Protocol Violation|1|||
48451748|NCT00814307|155841730|FG003|Overall Study|Protocol Violation|1|||
48451749|NCT00814307|155841727|FG000|Overall Study|Withdrawal by Subject|4|||
48451750|NCT00814307|155841728|FG001|Overall Study|Withdrawal by Subject|6|||
48451751|NCT00814307|155841729|FG002|Overall Study|Withdrawal by Subject|0|||
48451752|NCT00814307|155841730|FG003|Overall Study|Withdrawal by Subject|2|||
48451753|NCT00814307|155841727|FG000|Overall Study|Death|0|||
48451754|NCT00814307|155841728|FG001|Overall Study|Death|1|||
48451755|NCT00814307|155841729|FG002|Overall Study|Death|0|||
48451756|NCT00814307|155841730|FG003|Overall Study|Death|0|||
48451757|NCT01302691|155841731|FG000|Overall Study|Adverse Event|2|||
48451758|NCT01302691|155841732|FG001|Overall Study|Adverse Event|0|||
48451759|NCT01302691|155841731|FG000|Overall Study|Death|0|||
48451760|NCT01302691|155841732|FG001|Overall Study|Death|1|||
48451761|NCT01302691|155841731|FG000|Overall Study|Lost to Follow-up|1|||
48451762|NCT01302691|155841732|FG001|Overall Study|Lost to Follow-up|0|||
48451763|NCT01302691|155841731|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
48451764|NCT01302691|155841732|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
48451765|NCT01302691|155841731|FG000|Overall Study|Physician Decision|0|||
48451766|NCT01302691|155841732|FG001|Overall Study|Physician Decision|1|||
48451767|NCT01302691|155841731|FG000|Overall Study|Protocol Violation|1|||
48451768|NCT01302691|155841732|FG001|Overall Study|Protocol Violation|0|||
48451769|NCT03693404|155841735|FG000|Overall Study|Withdrawal by Subject|1|||
48451770|NCT03693404|155841736|FG001|Overall Study|Withdrawal by Subject|0|||
48451771|NCT03693404|155841735|FG000|Overall Study|Lost to Follow-up|0|||
48451772|NCT03693404|155841736|FG001|Overall Study|Lost to Follow-up|5|||
48451773|NCT03693404|155841735|FG000|Overall Study|Excluded from Analysis|0|||
48451774|NCT03693404|155841736|FG001|Overall Study|Excluded from Analysis|1|||
48451775|NCT01906476|155841740|FG000|Overall Study|Lost to Follow-up|17|||
48451776|NCT01906476|155841741|FG001|Overall Study|Lost to Follow-up|16|||
48451777|NCT02517268|155841744|FG000|Overall Study|Withdrawal by Subject|1|||
48451778|NCT02517268|155841745|FG001|Overall Study|Withdrawal by Subject|0|||
48451779|NCT02177812|155841751|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48451780|NCT02177812|155841752|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48451781|NCT02177812|155841753|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48451782|NCT02177812|155841754|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48451783|NCT02177812|155841755|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48451784|NCT02177812|155841756|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
48451785|NCT02177812|155841757|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
48451786|NCT02177812|155841758|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
48451787|NCT02177812|155841759|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
48451788|NCT02177812|155841751|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48451789|NCT02177812|155841752|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48451790|NCT02177812|155841753|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48451791|NCT02177812|155841754|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48451792|NCT02177812|155841755|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48451793|NCT02177812|155841756|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
48451794|NCT02177812|155841757|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
48451795|NCT02177812|155841758|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48451796|NCT02177812|155841759|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
48451797|NCT02177812|155841751|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
48451798|NCT02177812|155841752|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
48451799|NCT02177812|155841753|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
48451800|NCT02177812|155841754|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
48451801|NCT02177812|155841755|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
48451802|NCT02177812|155841756|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
48451803|NCT02177812|155841757|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
48451804|NCT02177812|155841758|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
48451805|NCT02177812|155841759|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
48451806|NCT03446612|155841760|FG000|Overall Study|Protocol defined stopping criteria|0|||
48451807|NCT03446612|155841761|FG001|Overall Study|Protocol defined stopping criteria|1|||
48451808|NCT01931150|155841762|FG000|Overall Study|Withdrawal by Subject|1|||
48451809|NCT01931150|155841763|FG001|Overall Study|Withdrawal by Subject|2|||
48451810|NCT01448707|155841764|FG000|Overall Study|Adverse Event|3|||
48451811|NCT01448707|155841765|FG001|Overall Study|Adverse Event|1|||
48451812|NCT01448707|155841764|FG000|Overall Study|Lost to Follow-up|2|||
48451813|NCT01448707|155841765|FG001|Overall Study|Lost to Follow-up|6|||
48451814|NCT01448707|155841764|FG000|Overall Study|Withdrawal by Subject|6|||
48451815|NCT01448707|155841765|FG001|Overall Study|Withdrawal by Subject|7|||
48451816|NCT01448707|155841764|FG000|Overall Study|Other|7|||
48451817|NCT01448707|155841765|FG001|Overall Study|Other|4|||
48451818|NCT00653328|155841775|FG000|Overall Study|Withdrawal by Subject|1|||
48451819|NCT00653328|155841775|FG000|Overall Study|Adverse Event|2|||
48451820|NCT00653328|155841775|FG000|Overall Study|Disease progression|10|||
48451821|NCT00653328|155841775|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
48451822|NCT01809197|155841778|FG000|Overall Study|Lost to Follow-up|4|||
48451823|NCT01809197|155841779|FG001|Overall Study|Lost to Follow-up|2|||
48451824|NCT01809197|155841778|FG000|Overall Study|Adverse Event|2|||
48451825|NCT01809197|155841779|FG001|Overall Study|Adverse Event|3|||
48451826|NCT01809197|155841778|FG000|Overall Study|Failed slit lamp exam|1|||
48451827|NCT01809197|155841779|FG001|Overall Study|Failed slit lamp exam|0|||
48451828|NCT01809197|155841778|FG000|Overall Study|Non-Compliance|1|||
48451829|NCT01809197|155841779|FG001|Overall Study|Non-Compliance|1|||
48451830|NCT01809197|155841778|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
48451831|NCT01809197|155841779|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
48451832|NCT01809197|155841778|FG000|Overall Study|Withdrawal by Subject|1|||
48451833|NCT01809197|155841779|FG001|Overall Study|Withdrawal by Subject|1|||
48451834|NCT01809197|155841778|FG000|Overall Study|Product not available|0|||
48451835|NCT01809197|155841779|FG001|Overall Study|Product not available|1|||
48451836|NCT04968353|155841783|FG000|Overall Study|Non-compliance|1|||
48451837|NCT04968353|155841784|FG001|Overall Study|Non-compliance|0|||
48451838|NCT04968353|155841785|FG002|Overall Study|Non-compliance|2|||
48451839|NCT04968353|155841786|FG003|Overall Study|Non-compliance|0|||
48451840|NCT00255034|155843681|FG000|Overall Study|Withdrawal by Subject|15|||
48451841|NCT00255034|155843682|FG001|Overall Study|Withdrawal by Subject|38|||
48451842|NCT03788967|155843683|FG000|Overall Study|Lost to Follow-up|14|||
48451843|NCT03788967|155843684|FG001|Overall Study|Lost to Follow-up|10|||
48451844|NCT03788967|155843683|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
48451845|NCT03788967|155843684|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
48451846|NCT03788967|155843683|FG000|Overall Study|Participant Withdrawal of Consent|13|||
48451847|NCT03788967|155843684|FG001|Overall Study|Participant Withdrawal of Consent|5|||
48451848|NCT03788967|155843683|FG000|Overall Study|Adverse Event|1|||
48451849|NCT03788967|155843684|FG001|Overall Study|Adverse Event|1|||
48451850|NCT03788967|155843683|FG000|Overall Study|COVID-19|1|||
48451851|NCT03788967|155843684|FG001|Overall Study|COVID-19|2|||
48451852|NCT01412151|155843688|FG000|Week 0 - 306 - Treatment Period|Death|1|||
48451853|NCT01412151|155843688|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
48451854|NCT01412151|155843688|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
48451855|NCT01412151|155843688|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
48451856|NCT02687711|155843689|FG000|Overall Study|Adverse Event|89|||
48451857|NCT02687711|155843689|FG000|Overall Study|Lack of Efficacy|70|||
48451858|NCT02687711|155843689|FG000|Overall Study|Lost to Follow-up|20|||
48451859|NCT02687711|155843689|FG000|Overall Study|Consent withdrawn|15|||
48451860|NCT02687711|155843689|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
48451861|NCT02687711|155843689|FG000|Overall Study|Too expensive|4|||
48451862|NCT02687711|155843689|FG000|Overall Study|Participant moved abroad|1|||
48451863|NCT02687711|155843689|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
48451864|NCT02687711|155843689|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
48451865|NCT02687711|155843689|FG000|Overall Study|Disliked taste|1|||
48451866|NCT02687711|155843689|FG000|Overall Study|Low mood|1|||
48451867|NCT02687711|155843689|FG000|Overall Study|Side effects|1|||
48451868|NCT02687711|155843689|FG000|Overall Study|Change of Hospital|1|||
48451869|NCT02687711|155843689|FG000|Overall Study|Liver Encephalopathy|1|||
48451870|NCT02687711|155843689|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
48451871|NCT02687711|155843689|FG000|Overall Study|Withdrawn due to intake interruption|1|||
48451872|NCT02687711|155843689|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
48451873|NCT02687711|155843689|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
48451874|NCT02687711|155843689|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
48451875|NCT03621189|155843690|FG000|Overall Study|Withdrawal by Subject|0|||
48451876|NCT03621189|155843691|FG001|Overall Study|Withdrawal by Subject|3|||
48451877|NCT03621189|155843690|FG000|Overall Study|Physician Decision|0|||
48451878|NCT03621189|155843691|FG001|Overall Study|Physician Decision|2|||
48451879|NCT03706040|155843692|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
48451880|NCT03706040|155843693|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
48451881|NCT03706040|155843694|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
48451882|NCT03706040|155843695|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
48451883|NCT03706040|155843696|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
48451884|NCT03706040|155843697|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
48451885|NCT03706040|155843698|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
48451886|NCT03706040|155843692|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
48451887|NCT03706040|155843693|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
48451888|NCT03706040|155843694|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
48451889|NCT03706040|155843695|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
48451890|NCT03706040|155843696|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
48451891|NCT03706040|155843697|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
48451892|NCT03706040|155843698|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
48451893|NCT03706040|155843692|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
48451894|NCT03706040|155843693|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
48451895|NCT03706040|155843694|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
48451896|NCT03706040|155843695|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
48451897|NCT03706040|155843696|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
48451898|NCT03706040|155843697|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
48451899|NCT03706040|155843698|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
48451900|NCT03706040|155843692|FG000|Period A (Week 0 to Week 16)|Other|2|||
48451901|NCT03706040|155843693|FG001|Period A (Week 0 to Week 16)|Other|0|||
48451902|NCT03706040|155843694|FG002|Period A (Week 0 to Week 16)|Other|2|||
48451903|NCT03706040|155843695|FG003|Period A (Week 0 to Week 16)|Other|0|||
48451904|NCT03706040|155843696|FG004|Period A (Week 0 to Week 16)|Other|0|||
48451905|NCT03706040|155843697|FG005|Period A (Week 0 to Week 16)|Other|0|||
48451906|NCT03706040|155843698|FG006|Period A (Week 0 to Week 16)|Other|0|||
48451907|NCT03706040|155843692|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
48451908|NCT03706040|155843693|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
48451909|NCT03706040|155843694|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
48451910|NCT03706040|155843695|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
48451911|NCT03706040|155843696|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
48451912|NCT03706040|155843697|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
48451913|NCT03706040|155843698|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
48451914|NCT03706040|155843692|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
48451915|NCT03706040|155843693|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
48451916|NCT03706040|155843694|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
48451917|NCT03706040|155843695|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
48451918|NCT03706040|155843696|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
48451919|NCT03706040|155843697|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
48451920|NCT03706040|155843698|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
48451921|NCT03706040|155843692|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48451922|NCT03706040|155843693|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48451923|NCT03706040|155843694|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48451924|NCT03706040|155843695|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48451925|NCT03706040|155843696|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48451926|NCT03706040|155843697|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
48451927|NCT03706040|155843698|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
48451928|NCT03706040|155843692|FG000|Period B (Week 16 to Week 52)|Other|0|||
48451929|NCT03706040|155843693|FG001|Period B (Week 16 to Week 52)|Other|0|||
48451930|NCT03706040|155843694|FG002|Period B (Week 16 to Week 52)|Other|0|||
48451931|NCT03706040|155843695|FG003|Period B (Week 16 to Week 52)|Other|4|||
48451932|NCT03706040|155843696|FG004|Period B (Week 16 to Week 52)|Other|5|||
48451933|NCT03706040|155843697|FG005|Period B (Week 16 to Week 52)|Other|23|||
48451934|NCT03706040|155843698|FG006|Period B (Week 16 to Week 52)|Other|17|||
48451935|NCT04847141|155843699|FG000|Overall Study|Adverse Event|1|||
48451936|NCT04847141|155843700|FG001|Overall Study|Adverse Event|0|||
48451937|NCT04847141|155843701|FG002|Overall Study|Adverse Event|1|||
48451938|NCT04847141|155843699|FG000|Overall Study|Withdrawal by Subject|2|||
48451939|NCT04847141|155843700|FG001|Overall Study|Withdrawal by Subject|4|||
48451940|NCT04847141|155843701|FG002|Overall Study|Withdrawal by Subject|3|||
48451941|NCT04847141|155843699|FG000|Overall Study|Lost to Follow-up|7|||
48451942|NCT04847141|155843700|FG001|Overall Study|Lost to Follow-up|5|||
48451943|NCT04847141|155843701|FG002|Overall Study|Lost to Follow-up|7|||
48451944|NCT04847141|155843699|FG000|Overall Study|Reason not Specified|0|||
48451945|NCT04847141|155843700|FG001|Overall Study|Reason not Specified|1|||
48451946|NCT04847141|155843701|FG002|Overall Study|Reason not Specified|0|||
48451947|NCT02215616|155843702|FG000|Overall Study|Sponsor requested to stop study drug|0|||
48451948|NCT02215616|155843703|FG001|Overall Study|Sponsor requested to stop study drug|0|||
48451949|NCT02215616|155843704|FG002|Overall Study|Sponsor requested to stop study drug|1|||
48451950|NCT02215616|155843705|FG003|Overall Study|Sponsor requested to stop study drug|4|||
48451951|NCT02215616|155843702|FG000|Overall Study|Death|1|||
48451952|NCT02215616|155843703|FG001|Overall Study|Death|0|||
48451953|NCT02215616|155843704|FG002|Overall Study|Death|0|||
48451954|NCT02215616|155843705|FG003|Overall Study|Death|0|||
48451955|NCT02215616|155843702|FG000|Overall Study|Adverse Event|7|||
48451956|NCT02215616|155843703|FG001|Overall Study|Adverse Event|4|||
48451957|NCT02215616|155843704|FG002|Overall Study|Adverse Event|9|||
48451958|NCT02215616|155843705|FG003|Overall Study|Adverse Event|2|||
48451959|NCT02215616|155843702|FG000|Overall Study|Withdrawal by Subject|1|||
48451960|NCT02215616|155843703|FG001|Overall Study|Withdrawal by Subject|8|||
48451961|NCT02215616|155843704|FG002|Overall Study|Withdrawal by Subject|2|||
48451962|NCT02215616|155843705|FG003|Overall Study|Withdrawal by Subject|5|||
48451963|NCT02215616|155843702|FG000|Overall Study|Non-compliance|0|||
48451964|NCT02215616|155843703|FG001|Overall Study|Non-compliance|2|||
48451965|NCT02215616|155843704|FG002|Overall Study|Non-compliance|1|||
48451966|NCT02215616|155843705|FG003|Overall Study|Non-compliance|0|||
48451967|NCT02215616|155843702|FG000|Overall Study|Protocol Violation|0|||
48451968|NCT02215616|155843703|FG001|Overall Study|Protocol Violation|2|||
48451969|NCT02215616|155843704|FG002|Overall Study|Protocol Violation|0|||
48451970|NCT02215616|155843705|FG003|Overall Study|Protocol Violation|0|||
48451971|NCT02215616|155843702|FG000|Overall Study|Lost to Follow-up|1|||
48451972|NCT02215616|155843703|FG001|Overall Study|Lost to Follow-up|1|||
48451973|NCT02215616|155843704|FG002|Overall Study|Lost to Follow-up|0|||
48451974|NCT02215616|155843705|FG003|Overall Study|Lost to Follow-up|1|||
48451975|NCT02215616|155843702|FG000|Overall Study|Other than specified|1|||
48451976|NCT02215616|155843703|FG001|Overall Study|Other than specified|0|||
48451977|NCT02215616|155843704|FG002|Overall Study|Other than specified|1|||
48451978|NCT02215616|155843705|FG003|Overall Study|Other than specified|1|||
48451979|NCT00927758|155843706|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
48451980|NCT00927758|155843707|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
48451981|NCT00927758|155843708|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
48451982|NCT00927758|155843709|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
48451983|NCT00927758|155843710|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
48451984|NCT00927758|155843711|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
48451985|NCT00927758|155843706|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
48451986|NCT00927758|155843707|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
48451987|NCT00927758|155843708|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
48451988|NCT00927758|155843709|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
48451989|NCT00927758|155843710|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
48451990|NCT00927758|155843711|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
48451991|NCT01634113|155843712|FG000|Overall Study|Not treated|0|||
48451992|NCT01634113|155843713|FG001|Overall Study|Not treated|0|||
48451993|NCT01634113|155843714|FG002|Overall Study|Not treated|1|||
48451994|NCT00324740|155843715|FG000|Overall Study|Withdrawal by Subject|1|||
48452074|NCT00094835|155843737|FG004|Overall Study|Non-compliance|2|||
48451995|NCT00324740|155843716|FG001|Overall Study|Withdrawal by Subject|0|||
48451996|NCT00324740|155843717|FG002|Overall Study|Withdrawal by Subject|1|||
48451997|NCT02911519|155843718|FG000|Overall Study|Lost to Follow-up|2|||
48451998|NCT02911519|155843719|FG001|Overall Study|Lost to Follow-up|2|||
48451999|NCT02911519|155843718|FG000|Overall Study|Death|0|||
48452000|NCT02911519|155843719|FG001|Overall Study|Death|2|||
48452001|NCT01432457|155843720|FG000|Overall Study|Adverse Event|7|||
48452002|NCT01432457|155843721|FG001|Overall Study|Adverse Event|10|||
48452003|NCT01432457|155843722|FG002|Overall Study|Adverse Event|16|||
48452004|NCT01432457|155843720|FG000|Overall Study|Lack of Efficacy|2|||
48452005|NCT01432457|155843721|FG001|Overall Study|Lack of Efficacy|1|||
48452006|NCT01432457|155843722|FG002|Overall Study|Lack of Efficacy|1|||
48452007|NCT01432457|155843720|FG000|Overall Study|Lost to Follow-up|11|||
48452008|NCT01432457|155843721|FG001|Overall Study|Lost to Follow-up|15|||
48452009|NCT01432457|155843722|FG002|Overall Study|Lost to Follow-up|20|||
48452010|NCT01432457|155843720|FG000|Overall Study|Protocol Violation|3|||
48452011|NCT01432457|155843721|FG001|Overall Study|Protocol Violation|2|||
48452012|NCT01432457|155843722|FG002|Overall Study|Protocol Violation|6|||
48452013|NCT01432457|155843720|FG000|Overall Study|Withdrawal by Subject|6|||
48452014|NCT01432457|155843721|FG001|Overall Study|Withdrawal by Subject|11|||
48452015|NCT01432457|155843722|FG002|Overall Study|Withdrawal by Subject|9|||
48452016|NCT01432457|155843720|FG000|Overall Study|Reasons not defined|2|||
48452017|NCT01432457|155843721|FG001|Overall Study|Reasons not defined|3|||
48452018|NCT01432457|155843722|FG002|Overall Study|Reasons not defined|4|||
48452019|NCT01432457|155843720|FG000|Overall Study|Did not take study drug|6|||
48452020|NCT01432457|155843721|FG001|Overall Study|Did not take study drug|6|||
48452021|NCT01432457|155843722|FG002|Overall Study|Did not take study drug|3|||
48452022|NCT02848313|155843723|FG000|Overall Study|Adverse Event|1|||
48452023|NCT02848313|155843724|FG001|Overall Study|Adverse Event|2|||
48452024|NCT02848313|155843723|FG000|Overall Study|Lack of Efficacy|0|||
48452025|NCT02848313|155843724|FG001|Overall Study|Lack of Efficacy|1|||
48452026|NCT02848313|155843723|FG000|Overall Study|Withdrawal by Subject|1|||
48452027|NCT02848313|155843724|FG001|Overall Study|Withdrawal by Subject|1|||
48452028|NCT02848313|155843723|FG000|Overall Study|Lost to follow up|1|||
48452029|NCT02848313|155843724|FG001|Overall Study|Lost to follow up|0|||
48452030|NCT03892707|155843727|FG000|Overall Study|Screen failure|6|||
48452031|NCT03892707|155843728|FG001|Overall Study|Screen failure|0|||
48452032|NCT03892707|155843727|FG000|Overall Study|Pain resolution|0|||
48452033|NCT03892707|155843728|FG001|Overall Study|Pain resolution|4|||
48452034|NCT03892707|155843727|FG000|Overall Study|Withdrawal by Subject|0|||
48452035|NCT03892707|155843728|FG001|Overall Study|Withdrawal by Subject|1|||
48452036|NCT03892707|155843727|FG000|Overall Study|Other (long business trip)|0|||
48452037|NCT03892707|155843728|FG001|Overall Study|Other (long business trip)|1|||
48452038|NCT00212758|155843731|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
48452039|NCT00212758|155843732|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
48452040|NCT00212758|155843731|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
48452041|NCT00212758|155843732|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
48452042|NCT00094835|155843733|FG000|Overall Study|Physician Decision|1|||
48452043|NCT00094835|155843734|FG001|Overall Study|Physician Decision|0|||
48452044|NCT00094835|155843735|FG002|Overall Study|Physician Decision|0|||
48452045|NCT00094835|155843736|FG003|Overall Study|Physician Decision|0|||
48452046|NCT00094835|155843737|FG004|Overall Study|Physician Decision|0|||
48452047|NCT00094835|155843738|FG005|Overall Study|Physician Decision|1|||
48452048|NCT00094835|155843739|FG006|Overall Study|Physician Decision|0|||
48452049|NCT00094835|155843733|FG000|Overall Study|Withdrawal by Subject|0|||
48452050|NCT00094835|155843734|FG001|Overall Study|Withdrawal by Subject|0|||
48452051|NCT00094835|155843735|FG002|Overall Study|Withdrawal by Subject|0|||
48452052|NCT00094835|155843736|FG003|Overall Study|Withdrawal by Subject|0|||
48452053|NCT00094835|155843737|FG004|Overall Study|Withdrawal by Subject|0|||
48452054|NCT00094835|155843738|FG005|Overall Study|Withdrawal by Subject|0|||
48452055|NCT00094835|155843739|FG006|Overall Study|Withdrawal by Subject|1|||
48452056|NCT00094835|155843733|FG000|Overall Study|Lost to Follow-up|0|||
48452057|NCT00094835|155843734|FG001|Overall Study|Lost to Follow-up|0|||
48452058|NCT00094835|155843735|FG002|Overall Study|Lost to Follow-up|0|||
48452059|NCT00094835|155843736|FG003|Overall Study|Lost to Follow-up|0|||
48452060|NCT00094835|155843737|FG004|Overall Study|Lost to Follow-up|1|||
48452061|NCT00094835|155843738|FG005|Overall Study|Lost to Follow-up|0|||
48452062|NCT00094835|155843739|FG006|Overall Study|Lost to Follow-up|0|||
48452063|NCT00094835|155843733|FG000|Overall Study|Death|1|||
48452064|NCT00094835|155843734|FG001|Overall Study|Death|0|||
48452065|NCT00094835|155843735|FG002|Overall Study|Death|0|||
48452066|NCT00094835|155843736|FG003|Overall Study|Death|0|||
48452067|NCT00094835|155843737|FG004|Overall Study|Death|1|||
48452068|NCT00094835|155843738|FG005|Overall Study|Death|0|||
48452069|NCT00094835|155843739|FG006|Overall Study|Death|0|||
48452070|NCT00094835|155843733|FG000|Overall Study|Non-compliance|1|||
48452071|NCT00094835|155843734|FG001|Overall Study|Non-compliance|2|||
48452072|NCT00094835|155843735|FG002|Overall Study|Non-compliance|2|||
48452073|NCT00094835|155843736|FG003|Overall Study|Non-compliance|0|||
48452075|NCT00094835|155843738|FG005|Overall Study|Non-compliance|2|||
48452076|NCT00094835|155843739|FG006|Overall Study|Non-compliance|1|||
48452077|NCT00094835|155843733|FG000|Overall Study|Other|1|||
48452078|NCT00094835|155843734|FG001|Overall Study|Other|1|||
48452079|NCT00094835|155843735|FG002|Overall Study|Other|1|||
48452080|NCT00094835|155843736|FG003|Overall Study|Other|1|||
48452081|NCT00094835|155843737|FG004|Overall Study|Other|0|||
48452082|NCT00094835|155843738|FG005|Overall Study|Other|0|||
48452083|NCT00094835|155843739|FG006|Overall Study|Other|0|||
48452084|NCT02707601|155843740|FG000|Overall Study|Death|0|||
48452085|NCT02707601|155843741|FG001|Overall Study|Death|1|||
48452086|NCT02707601|155843740|FG000|Overall Study|Lack of Efficacy|0|||
48452087|NCT02707601|155843741|FG001|Overall Study|Lack of Efficacy|1|||
48452088|NCT02707601|155843740|FG000|Overall Study|Investigator's Discretion|1|||
48452089|NCT02707601|155843741|FG001|Overall Study|Investigator's Discretion|0|||
48452090|NCT02707601|155843740|FG000|Overall Study|Withdrew Consent|0|||
48452091|NCT02707601|155843741|FG001|Overall Study|Withdrew Consent|1|||
48452092|NCT02707601|155843740|FG000|Overall Study|Lost to Follow-up|1|||
48452093|NCT02707601|155843741|FG001|Overall Study|Lost to Follow-up|1|||
48452094|NCT02707601|155843740|FG000|Overall Study|Participants Randomized but Not Treated|2|||
48452095|NCT02707601|155843741|FG001|Overall Study|Participants Randomized but Not Treated|0|||
48452096|NCT00666536|155843742|FG000|Overall Study|Adverse Event|9|||
48452097|NCT00666536|155843743|FG001|Overall Study|Adverse Event|19|||
48452098|NCT00666536|155843742|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
48452099|NCT00666536|155843743|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
48452100|NCT00666536|155843742|FG000|Overall Study|Protocol deviation(s)|8|||
48452101|NCT00666536|155843743|FG001|Overall Study|Protocol deviation(s)|6|||
48452102|NCT00666536|155843742|FG000|Overall Study|Withdrawal by Subject|10|||
48452103|NCT00666536|155843743|FG001|Overall Study|Withdrawal by Subject|9|||
48452104|NCT00666536|155843742|FG000|Overall Study|Lost to Follow-up|4|||
48452105|NCT00666536|155843743|FG001|Overall Study|Lost to Follow-up|3|||
48452106|NCT01415908|155843746|FG000|Overall Study|Withdrawal by Subject|1|||
48452107|NCT01415908|155843747|FG001|Overall Study|Withdrawal by Subject|0|||
48452108|NCT01709708|155843748|FG000|Overall Study|Protocol Violation|1|||
48452109|NCT01709708|155843749|FG001|Overall Study|Protocol Violation|2|||
48452110|NCT01527110|155843750|FG000|Overall Study|Adverse Event|1|||
48452111|NCT00239356|155843755|FG000|Overall Study|Lack of Efficacy|1|||
48452112|NCT00239356|155843756|FG001|Overall Study|Lack of Efficacy|0|||
48452113|NCT00239356|155843755|FG000|Overall Study|Adverse Event|6|||
48452114|NCT00239356|155843756|FG001|Overall Study|Adverse Event|0|||
48452115|NCT00239356|155843755|FG000|Overall Study|Withdrawal by Subject|15|||
48452116|NCT00239356|155843756|FG001|Overall Study|Withdrawal by Subject|6|||
48452117|NCT00239356|155843755|FG000|Overall Study|Lost to Follow-up|3|||
48452118|NCT00239356|155843756|FG001|Overall Study|Lost to Follow-up|0|||
48452119|NCT00239356|155843755|FG000|Overall Study|poor/non-compliance|2|||
48452120|NCT00239356|155843756|FG001|Overall Study|poor/non-compliance|0|||
48452121|NCT00239356|155843755|FG000|Overall Study|Pregnancy|1|||
48452122|NCT00239356|155843756|FG001|Overall Study|Pregnancy|0|||
48452123|NCT00239356|155843755|FG000|Overall Study|Administrative reason|0|||
48452124|NCT00239356|155843756|FG001|Overall Study|Administrative reason|1|||
48452125|NCT00239356|155843755|FG000|Overall Study|Drug available on market|11|||
48452126|NCT00239356|155843756|FG001|Overall Study|Drug available on market|2|||
48452127|NCT01387074|155843757|FG000|Overall Study|Lost to Follow-up|7|||
48452128|NCT01387074|155843757|FG000|Overall Study|Lack of Efficacy|1|||
48452129|NCT01224106|155843758|FG000|Double-Blind Treatment Phase|Death|3|||
48452130|NCT01224106|155843759|FG001|Double-Blind Treatment Phase|Death|0|||
48452131|NCT01224106|155843760|FG002|Double-Blind Treatment Phase|Death|0|||
48452132|NCT01224106|155843761|FG003|Double-Blind Treatment Phase|Death|0|||
48452133|NCT01224106|155843762|FG004|Double-Blind Treatment Phase|Death|0|||
48452134|NCT01224106|155843758|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
48452135|NCT01224106|155843759|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
48452136|NCT01224106|155843760|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
48452137|NCT01224106|155843761|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
48452138|NCT01224106|155843762|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
48452139|NCT01224106|155843758|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
48452140|NCT01224106|155843759|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
48452141|NCT01224106|155843760|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
48452142|NCT01224106|155843761|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
48452143|NCT01224106|155843762|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
48452144|NCT01224106|155843758|FG000|Double-Blind Treatment Phase|Other|0|||
48452145|NCT01224106|155843759|FG001|Double-Blind Treatment Phase|Other|0|||
48452146|NCT01224106|155843760|FG002|Double-Blind Treatment Phase|Other|1|||
48452147|NCT01224106|155843761|FG003|Double-Blind Treatment Phase|Other|0|||
48452148|NCT01224106|155843762|FG004|Double-Blind Treatment Phase|Other|0|||
48452149|NCT01224106|155843758|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
48452150|NCT01224106|155843759|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
48452151|NCT01224106|155843760|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
48452152|NCT01224106|155843761|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
48452153|NCT01224106|155843762|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
48452154|NCT01224106|155843758|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
48452155|NCT01224106|155843759|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
48452156|NCT01224106|155843760|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
48452157|NCT01224106|155843761|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
48452158|NCT01224106|155843762|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
48452159|NCT01224106|155843758|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48452160|NCT01224106|155843759|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48452161|NCT01224106|155843760|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48452162|NCT01224106|155843761|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48452163|NCT01224106|155843762|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48452164|NCT01224106|155843758|FG000|Open-Label Extension (OLE) Phase|Death|0|||
48452165|NCT01224106|155843759|FG001|Open-Label Extension (OLE) Phase|Death|0|||
48452166|NCT01224106|155843760|FG002|Open-Label Extension (OLE) Phase|Death|0|||
48452167|NCT01224106|155843761|FG003|Open-Label Extension (OLE) Phase|Death|1|||
48452168|NCT01224106|155843762|FG004|Open-Label Extension (OLE) Phase|Death|3|||
48452169|NCT01224106|155843758|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
48452170|NCT01224106|155843759|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
48452171|NCT01224106|155843760|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
48452172|NCT01224106|155843761|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
48452173|NCT01224106|155843762|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
48452174|NCT01224106|155843758|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
48452175|NCT01224106|155843759|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
48452176|NCT01224106|155843760|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
48452177|NCT01224106|155843761|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
48452178|NCT01224106|155843762|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
48452179|NCT01224106|155843758|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
48452180|NCT01224106|155843759|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
48452181|NCT01224106|155843760|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
48452182|NCT01224106|155843761|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
48452183|NCT01224106|155843762|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
48452184|NCT01224106|155843758|FG000|Open-Label Extension (OLE) Phase|Other|0|||
48452185|NCT01224106|155843759|FG001|Open-Label Extension (OLE) Phase|Other|0|||
48452186|NCT01224106|155843760|FG002|Open-Label Extension (OLE) Phase|Other|0|||
48452187|NCT01224106|155843761|FG003|Open-Label Extension (OLE) Phase|Other|5|||
48452188|NCT01224106|155843762|FG004|Open-Label Extension (OLE) Phase|Other|3|||
48452189|NCT03051217|155843763|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
48452190|NCT03051217|155843764|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48452191|NCT03051217|155843765|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
48452192|NCT03051217|155843766|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48452193|NCT03051217|155843767|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48452194|NCT03051217|155843768|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48452195|NCT03051217|155843769|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
48452196|NCT03051217|155843763|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48452197|NCT03051217|155843764|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
48452198|NCT03051217|155843765|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48452199|NCT03051217|155843766|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48452200|NCT03051217|155843767|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48452201|NCT03051217|155843768|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48452202|NCT03051217|155843769|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
48452203|NCT03051217|155843763|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
48452204|NCT03051217|155843764|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
48452205|NCT03051217|155843765|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
48452206|NCT03051217|155843766|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48452207|NCT03051217|155843767|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48452208|NCT03051217|155843768|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48452209|NCT03051217|155843769|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
48452210|NCT03051217|155843763|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
48452211|NCT03051217|155843764|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
48452212|NCT03051217|155843765|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
48452213|NCT03051217|155843766|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
48452214|NCT03051217|155843767|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
48452215|NCT03051217|155843768|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
48452216|NCT03051217|155843769|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
48452217|NCT03051217|155843763|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48452218|NCT03051217|155843764|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48452290|NCT01685203|155843804|FG005|Overall Study|Patient's decision|1|||
48452219|NCT03051217|155843765|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48452220|NCT03051217|155843766|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
48452221|NCT03051217|155843767|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48452222|NCT03051217|155843768|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48452223|NCT03051217|155843769|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
48452224|NCT03051217|155843763|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48452225|NCT03051217|155843764|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48452226|NCT03051217|155843765|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48452227|NCT03051217|155843766|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
48452228|NCT03051217|155843767|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48452229|NCT03051217|155843768|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48452230|NCT03051217|155843769|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
48452231|NCT03051217|155843763|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48452232|NCT03051217|155843764|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48452233|NCT03051217|155843765|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48452234|NCT03051217|155843766|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48452235|NCT03051217|155843767|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
48452236|NCT03051217|155843768|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48452237|NCT03051217|155843769|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
48452238|NCT03051217|155843763|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48452239|NCT03051217|155843764|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48452240|NCT03051217|155843765|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48452241|NCT03051217|155843766|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48452242|NCT03051217|155843767|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48452243|NCT03051217|155843768|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
48452244|NCT03051217|155843769|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
48452245|NCT01156363|155843770|FG000|Overall Study|Adverse Event|6|||
48452246|NCT01156363|155843770|FG000|Overall Study|Insufficient Therapeutic Response|5|||
48452247|NCT01156363|155843770|FG000|Overall Study|Failure to Return|1|||
48452248|NCT01156363|155843770|FG000|Overall Study|Refused Treatment|4|||
48452249|NCT01156363|155843770|FG000|Overall Study|Other|6|||
48452250|NCT02773368|155843773|FG000|Overall Study|Lost to Follow-up|4|||
48452251|NCT02773368|155843774|FG001|Overall Study|Lost to Follow-up|1|||
48452252|NCT02773368|155843773|FG000|Overall Study|Withdrawal by Subject|5|||
48452253|NCT02773368|155843774|FG001|Overall Study|Withdrawal by Subject|1|||
48452254|NCT02773368|155843773|FG000|Overall Study|Unclassified|1|||
48452255|NCT02773368|155843774|FG001|Overall Study|Unclassified|1|||
48452256|NCT02773368|155843773|FG000|Overall Study|Missing|0|||
48452257|NCT02773368|155843774|FG001|Overall Study|Missing|1|||
48452258|NCT01057862|155843783|FG000|Overall Study|Withdrawal by Subject|1|||
48452259|NCT01057862|155843784|FG001|Overall Study|Withdrawal by Subject|2|||
48452260|NCT00845845|155843794|FG000|Overall Study|Lost to Follow-up|0|||
48452261|NCT00845845|155843795|FG001|Overall Study|Lost to Follow-up|4|||
48452262|NCT04186663|155843796|FG000|Overall Study|Lost to Follow-up|1|||
48452263|NCT04186663|155843796|FG000|Overall Study|Unable to complete blood draw|3|||
48452264|NCT01685203|155843799|FG000|Overall Study|Lost to Follow-up|3|||
48452265|NCT01685203|155843800|FG001|Overall Study|Lost to Follow-up|3|||
48452266|NCT01685203|155843801|FG002|Overall Study|Lost to Follow-up|0|||
48452267|NCT01685203|155843802|FG003|Overall Study|Lost to Follow-up|1|||
48452268|NCT01685203|155843803|FG004|Overall Study|Lost to Follow-up|0|||
48452269|NCT01685203|155843804|FG005|Overall Study|Lost to Follow-up|0|||
48452270|NCT01685203|155843805|FG006|Overall Study|Lost to Follow-up|0|||
48452271|NCT01685203|155843799|FG000|Overall Study|Adverse Event|0|||
48452272|NCT01685203|155843800|FG001|Overall Study|Adverse Event|0|||
48452273|NCT01685203|155843801|FG002|Overall Study|Adverse Event|0|||
48452274|NCT01685203|155843802|FG003|Overall Study|Adverse Event|0|||
48452275|NCT01685203|155843803|FG004|Overall Study|Adverse Event|0|||
48452276|NCT01685203|155843804|FG005|Overall Study|Adverse Event|2|||
48452277|NCT01685203|155843805|FG006|Overall Study|Adverse Event|0|||
48452278|NCT01685203|155843799|FG000|Overall Study|Adverse event and withdrew consent|1|||
48452279|NCT01685203|155843800|FG001|Overall Study|Adverse event and withdrew consent|0|||
48452280|NCT01685203|155843801|FG002|Overall Study|Adverse event and withdrew consent|0|||
48452281|NCT01685203|155843802|FG003|Overall Study|Adverse event and withdrew consent|0|||
48452282|NCT01685203|155843803|FG004|Overall Study|Adverse event and withdrew consent|0|||
48452283|NCT01685203|155843804|FG005|Overall Study|Adverse event and withdrew consent|0|||
48452284|NCT01685203|155843805|FG006|Overall Study|Adverse event and withdrew consent|0|||
48452285|NCT01685203|155843799|FG000|Overall Study|Patient's decision|0|||
48452286|NCT01685203|155843800|FG001|Overall Study|Patient's decision|0|||
48452287|NCT01685203|155843801|FG002|Overall Study|Patient's decision|0|||
48452288|NCT01685203|155843802|FG003|Overall Study|Patient's decision|0|||
48452289|NCT01685203|155843803|FG004|Overall Study|Patient's decision|0|||
48452291|NCT01685203|155843805|FG006|Overall Study|Patient's decision|0|||
48452292|NCT00383708|155843809|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
48452293|NCT00383708|155843809|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
48452294|NCT00383708|155843809|FG000|Run-in Period|Protocol Violation|4|||
48452295|NCT00383708|155843809|FG000|Run-in Period|Adverse Event|2|||
48452296|NCT00383708|155843809|FG000|Run-in Period|Claustrophobia|1|||
48452297|NCT00383708|155843809|FG000|Co-administration Period|Adverse Event|5|||
48452298|NCT02033850|155843812|FG000|Overall Study|Death|1|||
48452299|NCT02033850|155843813|FG001|Overall Study|Death|0|||
48452300|NCT02033850|155843812|FG000|Overall Study|unrelated medical reason|1|||
48452301|NCT02033850|155843813|FG001|Overall Study|unrelated medical reason|1|||
48452302|NCT00318370|155843814|FG000|Period 1|Lack of Efficacy|5|||
48452303|NCT00318370|155843815|FG001|Period 1|Lack of Efficacy|0|||
48452304|NCT00318370|155843816|FG002|Period 1|Lack of Efficacy|0|||
48452305|NCT00318370|155843814|FG000|Period 1|Physician Decision|1|||
48452306|NCT00318370|155843815|FG001|Period 1|Physician Decision|0|||
48452307|NCT00318370|155843816|FG002|Period 1|Physician Decision|0|||
48452308|NCT00318370|155843814|FG000|Period 1|Withdrawal by Subject|1|||
48452309|NCT00318370|155843815|FG001|Period 1|Withdrawal by Subject|0|||
48452310|NCT00318370|155843816|FG002|Period 1|Withdrawal by Subject|0|||
48452311|NCT00318370|155843814|FG000|Period 2|Adverse Event|0|||
48452312|NCT00318370|155843815|FG001|Period 2|Adverse Event|3|||
48452313|NCT00318370|155843816|FG002|Period 2|Adverse Event|0|||
48452314|NCT00318370|155843814|FG000|Period 2|Lack of Efficacy|0|||
48452315|NCT00318370|155843815|FG001|Period 2|Lack of Efficacy|5|||
48452316|NCT00318370|155843816|FG002|Period 2|Lack of Efficacy|0|||
48452317|NCT00318370|155843814|FG000|Period 2|Physician Decision|0|||
48452318|NCT00318370|155843815|FG001|Period 2|Physician Decision|1|||
48452319|NCT00318370|155843816|FG002|Period 2|Physician Decision|0|||
48452320|NCT00318370|155843814|FG000|Period 2|Withdrawal by Subject|0|||
48452321|NCT00318370|155843815|FG001|Period 2|Withdrawal by Subject|1|||
48452322|NCT00318370|155843816|FG002|Period 2|Withdrawal by Subject|0|||
48452323|NCT00318370|155843814|FG000|Period 2|Other|0|||
48452324|NCT00318370|155843815|FG001|Period 2|Other|1|||
48452325|NCT00318370|155843816|FG002|Period 2|Other|0|||
48452326|NCT00318370|155843814|FG000|Period 3|Adverse Event|0|||
48452327|NCT00318370|155843815|FG001|Period 3|Adverse Event|0|||
48452328|NCT00318370|155843816|FG002|Period 3|Adverse Event|1|||
48452329|NCT00318370|155843814|FG000|Period 3|Lack of Efficacy|0|||
48452330|NCT00318370|155843815|FG001|Period 3|Lack of Efficacy|0|||
48452331|NCT00318370|155843816|FG002|Period 3|Lack of Efficacy|24|||
48452332|NCT00318370|155843814|FG000|Period 3|Death|0|||
48452333|NCT00318370|155843815|FG001|Period 3|Death|0|||
48452334|NCT00318370|155843816|FG002|Period 3|Death|1|||
48452335|NCT00318370|155843814|FG000|Period 3|Physician Decision|0|||
48452336|NCT00318370|155843815|FG001|Period 3|Physician Decision|0|||
48452337|NCT00318370|155843816|FG002|Period 3|Physician Decision|1|||
48452338|NCT00318370|155843814|FG000|Period 3|Withdrawal by Subject|0|||
48452339|NCT00318370|155843815|FG001|Period 3|Withdrawal by Subject|0|||
48452340|NCT00318370|155843816|FG002|Period 3|Withdrawal by Subject|3|||
48452341|NCT00318370|155843814|FG000|Period 3|Other|0|||
48452342|NCT00318370|155843815|FG001|Period 3|Other|0|||
48452343|NCT00318370|155843816|FG002|Period 3|Other|3|||
48452344|NCT05041062|155843823|FG000|Overall Study|Adverse Event|2|||
48452345|NCT01202760|155843829|FG000|Overall Study|Entry Criteria Not Met|0|||
48452346|NCT01202760|155843830|FG001|Overall Study|Entry Criteria Not Met|3|||
48452347|NCT01202760|155843831|FG002|Overall Study|Entry Criteria Not Met|1|||
48452348|NCT01202760|155843829|FG000|Overall Study|Adverse Event|11|||
48452349|NCT01202760|155843830|FG001|Overall Study|Adverse Event|9|||
48452350|NCT01202760|155843831|FG002|Overall Study|Adverse Event|10|||
48452351|NCT01202760|155843829|FG000|Overall Study|Death|2|||
48452352|NCT01202760|155843830|FG001|Overall Study|Death|1|||
48452353|NCT01202760|155843831|FG002|Overall Study|Death|0|||
48452354|NCT01202760|155843829|FG000|Overall Study|Lack of Efficacy|6|||
48452355|NCT01202760|155843830|FG001|Overall Study|Lack of Efficacy|8|||
48452356|NCT01202760|155843831|FG002|Overall Study|Lack of Efficacy|7|||
48452357|NCT01202760|155843829|FG000|Overall Study|Lost to Follow-up|0|||
48452358|NCT01202760|155843830|FG001|Overall Study|Lost to Follow-up|2|||
48452359|NCT01202760|155843831|FG002|Overall Study|Lost to Follow-up|1|||
48452360|NCT01202760|155843829|FG000|Overall Study|Parent / Caregiver Decision|0|||
48452361|NCT01202760|155843830|FG001|Overall Study|Parent / Caregiver Decision|1|||
48452362|NCT01202760|155843831|FG002|Overall Study|Parent / Caregiver Decision|0|||
48452363|NCT01202760|155843829|FG000|Overall Study|Withdrawal by Subject|17|||
48452364|NCT01202760|155843830|FG001|Overall Study|Withdrawal by Subject|18|||
48452365|NCT01202760|155843831|FG002|Overall Study|Withdrawal by Subject|14|||
48452366|NCT01202760|155843829|FG000|Overall Study|Physician Decision|0|||
48452367|NCT01202760|155843830|FG001|Overall Study|Physician Decision|1|||
48452368|NCT01202760|155843831|FG002|Overall Study|Physician Decision|0|||
48452369|NCT01202760|155843829|FG000|Overall Study|Protocol Violation|7|||
48452370|NCT01202760|155843830|FG001|Overall Study|Protocol Violation|5|||
48452371|NCT01202760|155843831|FG002|Overall Study|Protocol Violation|2|||
48452372|NCT01202760|155843829|FG000|Overall Study|Sponsor Decision|4|||
48452373|NCT01202760|155843830|FG001|Overall Study|Sponsor Decision|4|||
48452374|NCT01202760|155843831|FG002|Overall Study|Sponsor Decision|0|||
48452375|NCT01750840|155843832|FG000|Overall Study|Lost to Follow-up|4|||
48452376|NCT02820038|155843833|FG000|Overall Study|Lost to Follow-up|7|||
48452377|NCT02820038|155843834|FG001|Overall Study|Lost to Follow-up|11|||
48452378|NCT02820038|155843835|FG002|Overall Study|Lost to Follow-up|2|||
48452379|NCT02820038|155843836|FG003|Overall Study|Lost to Follow-up|9|||
48452380|NCT02820038|155843833|FG000|Overall Study|Withdrawal by Subject|3|||
48452381|NCT02820038|155843834|FG001|Overall Study|Withdrawal by Subject|14|||
48452382|NCT02820038|155843835|FG002|Overall Study|Withdrawal by Subject|3|||
48452383|NCT02820038|155843836|FG003|Overall Study|Withdrawal by Subject|13|||
48452384|NCT03215667|155843837|FG000|Overall Study|Physician Decision|4|||
48452385|NCT00479167|155843838|FG000|Overall Study|Withdrawal by Subject|1|||
48452386|NCT01437267|155843839|FG000|Overall Study|Withdrawal by Subject|0|||
48452387|NCT01437267|155843840|FG001|Overall Study|Withdrawal by Subject|0|||
48452388|NCT01437267|155843841|FG002|Overall Study|Withdrawal by Subject|0|||
48452389|NCT01437267|155843842|FG003|Overall Study|Withdrawal by Subject|1|||
48452390|NCT01437267|155843843|FG004|Overall Study|Withdrawal by Subject|0|||
48452391|NCT01437267|155843844|FG005|Overall Study|Withdrawal by Subject|0|||
48452392|NCT01437267|155843839|FG000|Overall Study|Protocol Violation|0|||
48452393|NCT01437267|155843840|FG001|Overall Study|Protocol Violation|1|||
48452394|NCT01437267|155843841|FG002|Overall Study|Protocol Violation|0|||
48452395|NCT01437267|155843842|FG003|Overall Study|Protocol Violation|0|||
48452396|NCT01437267|155843843|FG004|Overall Study|Protocol Violation|0|||
48452397|NCT01437267|155843844|FG005|Overall Study|Protocol Violation|0|||
48452398|NCT03934203|155843850|FG000|Overall Study|Adverse Event|0|||
48452399|NCT03934203|155843851|FG001|Overall Study|Adverse Event|0|||
48452400|NCT03934203|155843852|FG002|Overall Study|Adverse Event|1|||
48452401|NCT03934203|155843853|FG003|Overall Study|Adverse Event|0|||
48452402|NCT03934203|155843854|FG004|Overall Study|Adverse Event|1|||
48452403|NCT03934203|155843855|FG005|Overall Study|Adverse Event|0|||
48452404|NCT03934203|155843856|FG006|Overall Study|Adverse Event|2|||
48452405|NCT03934203|155843857|FG007|Overall Study|Adverse Event|0|||
48452406|NCT03934203|155843858|FG008|Overall Study|Adverse Event|0|||
48452407|NCT03934203|155843859|FG009|Overall Study|Adverse Event|0|||
48452408|NCT03934203|155843860|FG010|Overall Study|Adverse Event|0|||
48452409|NCT03934203|155843861|FG011|Overall Study|Adverse Event|0|||
48452410|NCT03934203|155843862|FG012|Overall Study|Adverse Event|0|||
48452411|NCT03934203|155843863|FG013|Overall Study|Adverse Event|1|||
48452412|NCT03934203|155843864|FG014|Overall Study|Adverse Event|0|||
48452413|NCT01997281|155843865|FG000|Overall Study|Withdrawal by Subject|1|||
48452414|NCT01997281|155843866|FG001|Overall Study|Withdrawal by Subject|0|||
48452415|NCT00412113|155843873|FG000|Overall Study|Adverse Event|11|||
48452416|NCT00412113|155843874|FG001|Overall Study|Adverse Event|15|||
48452417|NCT00412113|155843873|FG000|Overall Study|did not receive treatment|1|||
48452418|NCT00412113|155843874|FG001|Overall Study|did not receive treatment|0|||
48452419|NCT00333970|155843875|FG000|Overall Study|Withdrawal by Subject|13|||
48452420|NCT00333970|155843876|FG001|Overall Study|Withdrawal by Subject|7|||
48452421|NCT01570309|155843877|FG000|Overall Study|Withdrawal by Subject|3|||
48452422|NCT01570309|155843878|FG001|Overall Study|Withdrawal by Subject|3|||
48452423|NCT01770145|155845720|FG000|Baseline|Adverse Event|20|||
48452424|NCT01770145|155845720|FG000|Baseline|Withdrawal by Subject|1|||
48452425|NCT01770145|155845720|FG000|Baseline|Lost to Follow-up|1|||
48452426|NCT01770145|155845720|FG000|Baseline|Unable to define optimal dose|4|||
48452427|NCT01770145|155845720|FG000|Treatment|Adverse Event|3|||
48452428|NCT01770145|155845720|FG000|Treatment|Withdrawal by Subject|1|||
48452429|NCT00439725|155845722|FG000|Treatment Period|Withdrawal by Subject|22|||
48452430|NCT00439725|155845723|FG001|Treatment Period|Withdrawal by Subject|19|||
48452431|NCT00439725|155845722|FG000|Treatment Period|Study terminated by sponsor|156|||
48452432|NCT00439725|155845723|FG001|Treatment Period|Study terminated by sponsor|148|||
48452433|NCT00439725|155845722|FG000|Treatment Period|Site closed by investigator|1|||
48452434|NCT00439725|155845723|FG001|Treatment Period|Site closed by investigator|2|||
48452435|NCT00439725|155845722|FG000|Treatment Period|Adverse Event|39|||
48452436|NCT00439725|155845723|FG001|Treatment Period|Adverse Event|18|||
48452437|NCT00439725|155845722|FG000|Treatment Period|Physician Decision|1|||
48452438|NCT00439725|155845723|FG001|Treatment Period|Physician Decision|1|||
48452439|NCT00439725|155845722|FG000|Treatment Period|Protocol Violation|2|||
48452440|NCT00439725|155845723|FG001|Treatment Period|Protocol Violation|1|||
48452441|NCT00439725|155845722|FG000|Treatment Period|Clinical endpoint reached|6|||
48452442|NCT00439725|155845723|FG001|Treatment Period|Clinical endpoint reached|50|||
48452443|NCT00439725|155845722|FG000|Treatment Period|Technical problems|1|||
48452444|NCT00439725|155845723|FG001|Treatment Period|Technical problems|0|||
48452445|NCT00439725|155845722|FG000|Treatment Period|Lost to Follow-up|1|||
48452446|NCT00439725|155845723|FG001|Treatment Period|Lost to Follow-up|1|||
48452447|NCT00439725|155845722|FG000|Treatment Period|Participant convenience|1|||
48452448|NCT00439725|155845723|FG001|Treatment Period|Participant convenience|0|||
48452449|NCT00439725|155845722|FG000|Treatment Period|Protocol driven decision point|1|||
48452450|NCT00439725|155845723|FG001|Treatment Period|Protocol driven decision point|1|||
48452451|NCT00439725|155845722|FG000|Treatment Period|Death|1|||
48452452|NCT00439725|155845723|FG001|Treatment Period|Death|1|||
48452453|NCT00439725|155845722|FG000|Treatment Period|Participant did not receive treatment|4|||
48452454|NCT00439725|155845723|FG001|Treatment Period|Participant did not receive treatment|4|||
48452455|NCT00439725|155845722|FG000|Observational Period|Withdrawal by Subject|2|||
48452456|NCT00439725|155845723|FG001|Observational Period|Withdrawal by Subject|2|||
48452457|NCT00439725|155845722|FG000|Observational Period|Lost to Follow-up|0|||
48452458|NCT00439725|155845723|FG001|Observational Period|Lost to Follow-up|1|||
48452459|NCT00439725|155845722|FG000|Observational Period|Death|0|||
48452460|NCT00439725|155845723|FG001|Observational Period|Death|2|||
48452461|NCT00439725|155845722|FG000|Observational Period|Study termination by sponsor|1|||
48452462|NCT00439725|155845723|FG001|Observational Period|Study termination by sponsor|1|||
48452463|NCT00439725|155845722|FG000|Observational Period|Clinical endpoint reached|3|||
48452464|NCT00439725|155845723|FG001|Observational Period|Clinical endpoint reached|1|||
48452465|NCT00439725|155845722|FG000|Observational Period|Technical problems|1|||
48452466|NCT00439725|155845723|FG001|Observational Period|Technical problems|0|||
48452467|NCT00439725|155845722|FG000|Observational Period|Participant convenience|1|||
48452468|NCT00439725|155845723|FG001|Observational Period|Participant convenience|0|||
48452469|NCT03077243|155845724|FG000|Overall Study|Death|1|||
48452470|NCT03077243|155845725|FG001|Overall Study|Death|2|||
48452471|NCT03077243|155845726|FG002|Overall Study|Death|0|||
48452472|NCT03077243|155845727|FG003|Overall Study|Death|0|||
48452473|NCT03077243|155845724|FG000|Overall Study|Withdrawal by Subject|1|||
48452474|NCT03077243|155845725|FG001|Overall Study|Withdrawal by Subject|3|||
48452475|NCT03077243|155845726|FG002|Overall Study|Withdrawal by Subject|0|||
48452476|NCT03077243|155845727|FG003|Overall Study|Withdrawal by Subject|0|||
48452477|NCT03077243|155845724|FG000|Overall Study|Physician Decision|1|||
48452478|NCT03077243|155845725|FG001|Overall Study|Physician Decision|0|||
48452479|NCT03077243|155845726|FG002|Overall Study|Physician Decision|0|||
48452480|NCT03077243|155845727|FG003|Overall Study|Physician Decision|0|||
48452481|NCT03077243|155845724|FG000|Overall Study|Research at two study sites terminated early|0|||
48452482|NCT03077243|155845725|FG001|Overall Study|Research at two study sites terminated early|0|||
48452483|NCT03077243|155845726|FG002|Overall Study|Research at two study sites terminated early|0|||
48452484|NCT03077243|155845727|FG003|Overall Study|Research at two study sites terminated early|69|||
48452485|NCT01544478|155845728|FG000|Overall Study|Adverse Event|1|||
48452486|NCT01544478|155845728|FG000|Overall Study|Death|1|||
48452487|NCT01544478|155845728|FG000|Overall Study|Lost to Follow-up|48|||
48452488|NCT01544478|155845728|FG000|Overall Study|Physician Decision|15|||
48452489|NCT01544478|155845728|FG000|Overall Study|Pregnancy|1|||
48452490|NCT01544478|155845728|FG000|Overall Study|Withdrawal by Subject|52|||
48452491|NCT02007252|155845729|FG000|Overall Study|Administrative problems|3|||
48452492|NCT02007252|155845730|FG001|Overall Study|Administrative problems|7|||
48452493|NCT02007252|155845729|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48452494|NCT02007252|155845730|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48452495|NCT02007252|155845729|FG000|Overall Study|Adverse Event|7|||
48452496|NCT02007252|155845730|FG001|Overall Study|Adverse Event|4|||
48452497|NCT04731922|155845731|FG000|Overall Study|Adverse Event|0|||
48452498|NCT04731922|155845732|FG001|Overall Study|Adverse Event|0|||
48452499|NCT04731922|155845733|FG002|Overall Study|Adverse Event|0|||
48452500|NCT04731922|155845734|FG003|Overall Study|Adverse Event|0|||
48452501|NCT04731922|155845735|FG004|Overall Study|Adverse Event|0|||
48452502|NCT04731922|155845736|FG005|Overall Study|Adverse Event|0|||
48452503|NCT04731922|155845737|FG006|Overall Study|Adverse Event|0|||
48452504|NCT04731922|155845738|FG007|Overall Study|Adverse Event|0|||
48452505|NCT04731922|155845739|FG008|Overall Study|Adverse Event|0|||
48452506|NCT04731922|155845740|FG009|Overall Study|Adverse Event|0|||
48452507|NCT04731922|155845741|FG010|Overall Study|Adverse Event|1|||
48452508|NCT04731922|155845742|FG011|Overall Study|Adverse Event|0|||
48452509|NCT04731922|155845743|FG012|Overall Study|Adverse Event|0|||
48452510|NCT04731922|155845744|FG013|Overall Study|Adverse Event|0|||
48452511|NCT04731922|155845745|FG014|Overall Study|Adverse Event|0|||
48452512|NCT04731922|155845746|FG015|Overall Study|Adverse Event|0|||
48452513|NCT04731922|155845747|FG016|Overall Study|Adverse Event|0|||
48452514|NCT04731922|155845731|FG000|Overall Study|Lost to Follow-up|0|||
48452515|NCT04731922|155845732|FG001|Overall Study|Lost to Follow-up|0|||
48452516|NCT04731922|155845733|FG002|Overall Study|Lost to Follow-up|0|||
48452517|NCT04731922|155845734|FG003|Overall Study|Lost to Follow-up|1|||
48452518|NCT04731922|155845735|FG004|Overall Study|Lost to Follow-up|0|||
48452519|NCT04731922|155845736|FG005|Overall Study|Lost to Follow-up|1|||
48452520|NCT04731922|155845737|FG006|Overall Study|Lost to Follow-up|0|||
48452521|NCT04731922|155845738|FG007|Overall Study|Lost to Follow-up|0|||
48452522|NCT04731922|155845739|FG008|Overall Study|Lost to Follow-up|0|||
48452523|NCT04731922|155845740|FG009|Overall Study|Lost to Follow-up|0|||
48452524|NCT04731922|155845741|FG010|Overall Study|Lost to Follow-up|0|||
48452525|NCT04731922|155845742|FG011|Overall Study|Lost to Follow-up|0|||
48452526|NCT04731922|155845743|FG012|Overall Study|Lost to Follow-up|0|||
48452527|NCT04731922|155845744|FG013|Overall Study|Lost to Follow-up|0|||
48452528|NCT04731922|155845745|FG014|Overall Study|Lost to Follow-up|0|||
48452529|NCT04731922|155845746|FG015|Overall Study|Lost to Follow-up|0|||
48452530|NCT04731922|155845747|FG016|Overall Study|Lost to Follow-up|0|||
48452531|NCT04731922|155845731|FG000|Overall Study|Withdrawal by Subject|1|||
48452532|NCT04731922|155845732|FG001|Overall Study|Withdrawal by Subject|0|||
48452533|NCT04731922|155845733|FG002|Overall Study|Withdrawal by Subject|0|||
48452534|NCT04731922|155845734|FG003|Overall Study|Withdrawal by Subject|0|||
48452535|NCT04731922|155845735|FG004|Overall Study|Withdrawal by Subject|1|||
48452536|NCT04731922|155845736|FG005|Overall Study|Withdrawal by Subject|0|||
48452537|NCT04731922|155845737|FG006|Overall Study|Withdrawal by Subject|1|||
48452538|NCT04731922|155845738|FG007|Overall Study|Withdrawal by Subject|0|||
48452539|NCT04731922|155845739|FG008|Overall Study|Withdrawal by Subject|0|||
48452540|NCT04731922|155845740|FG009|Overall Study|Withdrawal by Subject|0|||
48452541|NCT04731922|155845741|FG010|Overall Study|Withdrawal by Subject|0|||
48452542|NCT04731922|155845742|FG011|Overall Study|Withdrawal by Subject|0|||
48452543|NCT04731922|155845743|FG012|Overall Study|Withdrawal by Subject|0|||
48452544|NCT04731922|155845744|FG013|Overall Study|Withdrawal by Subject|1|||
48452545|NCT04731922|155845745|FG014|Overall Study|Withdrawal by Subject|0|||
48452546|NCT04731922|155845746|FG015|Overall Study|Withdrawal by Subject|0|||
48452547|NCT04731922|155845747|FG016|Overall Study|Withdrawal by Subject|0|||
48452548|NCT04731922|155845731|FG000|Overall Study|Other|0|||
48452549|NCT04731922|155845732|FG001|Overall Study|Other|0|||
48452550|NCT04731922|155845733|FG002|Overall Study|Other|0|||
48452551|NCT04731922|155845734|FG003|Overall Study|Other|0|||
48452552|NCT04731922|155845735|FG004|Overall Study|Other|0|||
48452553|NCT04731922|155845736|FG005|Overall Study|Other|0|||
48452554|NCT04731922|155845737|FG006|Overall Study|Other|1|||
48452555|NCT04731922|155845738|FG007|Overall Study|Other|0|||
48452556|NCT04731922|155845739|FG008|Overall Study|Other|0|||
48452557|NCT04731922|155845740|FG009|Overall Study|Other|0|||
48452558|NCT04731922|155845741|FG010|Overall Study|Other|0|||
48452559|NCT04731922|155845742|FG011|Overall Study|Other|0|||
48452560|NCT04731922|155845743|FG012|Overall Study|Other|0|||
48452561|NCT04731922|155845744|FG013|Overall Study|Other|0|||
48452562|NCT04731922|155845745|FG014|Overall Study|Other|0|||
48452563|NCT04731922|155845746|FG015|Overall Study|Other|0|||
48452564|NCT04731922|155845747|FG016|Overall Study|Other|0|||
48452565|NCT00527072|155845748|FG000|Overall Study|Adverse Event|13|||
48452566|NCT00527072|155845748|FG000|Overall Study|Lack of Efficacy|11|||
48452567|NCT00527072|155845748|FG000|Overall Study|Lost to Follow-up|3|||
48452568|NCT00527072|155845748|FG000|Overall Study|Protocol Violation|2|||
48452569|NCT00527072|155845748|FG000|Overall Study|Withdrawal by Subject|7|||
48452570|NCT03417505|155845749|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
48452571|NCT03417505|155845750|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
48452572|NCT00254163|155845751|FG000|Overall Study|Adverse Event|29|||
48452573|NCT00254163|155845752|FG001|Overall Study|Adverse Event|26|||
48452574|NCT00254163|155845751|FG000|Overall Study|Patient request/withdrew consent|6|||
48452575|NCT00254163|155845752|FG001|Overall Study|Patient request/withdrew consent|4|||
48452576|NCT00254163|155845751|FG000|Overall Study|Investigator request|1|||
48452577|NCT00254163|155845752|FG001|Overall Study|Investigator request|3|||
48452578|NCT00254163|155845751|FG000|Overall Study|Failed entry|1|||
48452579|NCT00254163|155845752|FG001|Overall Study|Failed entry|3|||
48452580|NCT00254163|155845751|FG000|Overall Study|Progressive disease|0|||
48452581|NCT00254163|155845752|FG001|Overall Study|Progressive disease|1|||
48452582|NCT00254163|155845751|FG000|Overall Study|Death|0|||
48452583|NCT00254163|155845752|FG001|Overall Study|Death|1|||
48452584|NCT00254163|155845751|FG000|Overall Study|Other|8|||
48452585|NCT00254163|155845752|FG001|Overall Study|Other|8|||
48452586|NCT01119963|155845753|FG000|Overall Study|Lost to Follow-up|1|||
48452587|NCT01119963|155845754|FG001|Overall Study|Lost to Follow-up|1|||
48452588|NCT02657434|155845755|FG000|Overall Study|Study Terminated By Sponsor|64|||
48452589|NCT02657434|155845756|FG001|Overall Study|Study Terminated By Sponsor|82|||
48452590|NCT02657434|155845755|FG000|Overall Study|Death|189|||
48452591|NCT02657434|155845756|FG001|Overall Study|Death|190|||
48452592|NCT02657434|155845755|FG000|Overall Study|Lost to Follow-up|2|||
48452593|NCT02657434|155845756|FG001|Overall Study|Lost to Follow-up|2|||
48452594|NCT02657434|155845755|FG000|Overall Study|Randomization by Error|2|||
48452595|NCT02657434|155845756|FG001|Overall Study|Randomization by Error|0|||
48452596|NCT02657434|155845755|FG000|Overall Study|Withdrawal by Subject|28|||
48452597|NCT02657434|155845756|FG001|Overall Study|Withdrawal by Subject|17|||
48452598|NCT02657434|155845755|FG000|Overall Study|Protocol Violation|1|||
48452599|NCT02657434|155845756|FG001|Overall Study|Protocol Violation|0|||
48452600|NCT02657434|155845755|FG000|Overall Study|Physician Decision|0|||
48452601|NCT02657434|155845756|FG001|Overall Study|Physician Decision|1|||
48452602|NCT04897594|155845762|FG000|Overall Study|Lost to Follow-up|0|||
48452603|NCT04897594|155845763|FG001|Overall Study|Lost to Follow-up|1|||
48452604|NCT04897594|155845764|FG002|Overall Study|Lost to Follow-up|1|||
48452605|NCT04897594|155845762|FG000|Overall Study|Sponsor Decision|0|||
48452606|NCT04897594|155845763|FG001|Overall Study|Sponsor Decision|0|||
48452607|NCT04897594|155845764|FG002|Overall Study|Sponsor Decision|1|||
48452608|NCT04897594|155845762|FG000|Overall Study|Withdrawal by Subject|1|||
48452609|NCT04897594|155845763|FG001|Overall Study|Withdrawal by Subject|0|||
48452610|NCT04897594|155845764|FG002|Overall Study|Withdrawal by Subject|1|||
48452611|NCT00810043|155845767|FG000|Overall Study|Withdrawal by Subject|1|||
48452612|NCT00810043|155845768|FG001|Overall Study|Withdrawal by Subject|0|||
48452613|NCT00810043|155845769|FG002|Overall Study|Withdrawal by Subject|2|||
48452614|NCT00810043|155845767|FG000|Overall Study|Lost to Follow-up|1|||
48452615|NCT00810043|155845768|FG001|Overall Study|Lost to Follow-up|0|||
48452616|NCT00810043|155845769|FG002|Overall Study|Lost to Follow-up|0|||
48452617|NCT00810043|155845767|FG000|Overall Study|Physician Decision|0|||
48452618|NCT00810043|155845768|FG001|Overall Study|Physician Decision|0|||
48452619|NCT00810043|155845769|FG002|Overall Study|Physician Decision|2|||
48452620|NCT00810043|155845767|FG000|Overall Study|Death|2|||
48452621|NCT00810043|155845768|FG001|Overall Study|Death|0|||
48452622|NCT00810043|155845769|FG002|Overall Study|Death|0|||
48452623|NCT00810043|155845767|FG000|Overall Study|Unrelated medical problem|0|||
48452624|NCT00810043|155845768|FG001|Overall Study|Unrelated medical problem|1|||
48452625|NCT00810043|155845769|FG002|Overall Study|Unrelated medical problem|0|||
48452626|NCT00810043|155845767|FG000|Overall Study|Non-medical problem|0|||
48452627|NCT00810043|155845768|FG001|Overall Study|Non-medical problem|0|||
48452628|NCT00810043|155845769|FG002|Overall Study|Non-medical problem|1|||
48452629|NCT00810043|155845767|FG000|Overall Study|No longer met enrollment criteria|0|||
48452630|NCT00810043|155845768|FG001|Overall Study|No longer met enrollment criteria|0|||
48452631|NCT00810043|155845769|FG002|Overall Study|No longer met enrollment criteria|3|||
48452632|NCT01665768|155845770|FG000|Overall Study|Adverse Event|3|||
48452633|NCT01665768|155845770|FG000|Overall Study|Lack of Efficacy|19|||
48452634|NCT01665768|155845770|FG000|Overall Study|Withdrawal by Subject|1|||
48452635|NCT03135262|155845771|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
48452636|NCT03135262|155845772|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
48452637|NCT03135262|155845773|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
48452638|NCT03135262|155845774|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
48452639|NCT03135262|155845775|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
48452640|NCT03135262|155845771|FG000|Overall Study|Progression of disease|0|||
48452641|NCT03135262|155845772|FG001|Overall Study|Progression of disease|0|||
48452642|NCT03135262|155845773|FG002|Overall Study|Progression of disease|0|||
48452643|NCT03135262|155845774|FG003|Overall Study|Progression of disease|1|||
48452644|NCT03135262|155845775|FG004|Overall Study|Progression of disease|0|||
48452645|NCT03135262|155845771|FG000|Overall Study|Death|6|||
48452646|NCT03135262|155845772|FG001|Overall Study|Death|2|||
48452647|NCT03135262|155845773|FG002|Overall Study|Death|2|||
48452648|NCT03135262|155845774|FG003|Overall Study|Death|2|||
48452649|NCT03135262|155845775|FG004|Overall Study|Death|0|||
48452650|NCT03135262|155845771|FG000|Overall Study|Withdrawal by Subject|0|||
48452651|NCT03135262|155845772|FG001|Overall Study|Withdrawal by Subject|0|||
48452652|NCT03135262|155845773|FG002|Overall Study|Withdrawal by Subject|1|||
48452653|NCT03135262|155845774|FG003|Overall Study|Withdrawal by Subject|0|||
48452654|NCT03135262|155845775|FG004|Overall Study|Withdrawal by Subject|1|||
48452655|NCT03135262|155845771|FG000|Overall Study|Study terminated by sponsor|2|||
48452656|NCT03135262|155845772|FG001|Overall Study|Study terminated by sponsor|4|||
48452657|NCT03135262|155845773|FG002|Overall Study|Study terminated by sponsor|4|||
48452658|NCT03135262|155845774|FG003|Overall Study|Study terminated by sponsor|3|||
48452659|NCT03135262|155845775|FG004|Overall Study|Study terminated by sponsor|0|||
48452660|NCT00641706|155845776|FG000|Overall Study|Adverse Event|2|||
48452661|NCT00641706|155845777|FG001|Overall Study|Adverse Event|1|||
48452662|NCT00641706|155845776|FG000|Overall Study|Withdrawal by Subject|6|||
48452663|NCT00641706|155845777|FG001|Overall Study|Withdrawal by Subject|1|||
48452664|NCT00641706|155845776|FG000|Overall Study|Clinical Decline|1|||
48452665|NCT00641706|155845777|FG001|Overall Study|Clinical Decline|0|||
48452666|NCT00641706|155845776|FG000|Overall Study|Lead Investigator Decision|0|||
48452667|NCT00641706|155845777|FG001|Overall Study|Lead Investigator Decision|1|||
48452668|NCT01989572|155845780|FG000|Overall Study|Lack of Efficacy|35|||
48452669|NCT01989572|155845781|FG001|Overall Study|Lack of Efficacy|48|||
48452670|NCT01989572|155845782|FG002|Overall Study|Lack of Efficacy|48|||
48452671|NCT01989572|155845783|FG003|Overall Study|Lack of Efficacy|43|||
48452672|NCT01989572|155845784|FG004|Overall Study|Lack of Efficacy|71|||
48452673|NCT01989572|155845785|FG005|Overall Study|Lack of Efficacy|79|||
48452674|NCT01989572|155845780|FG000|Overall Study|Adverse Event|2|||
48452675|NCT01989572|155845781|FG001|Overall Study|Adverse Event|1|||
48452676|NCT01989572|155845782|FG002|Overall Study|Adverse Event|3|||
48452677|NCT01989572|155845783|FG003|Overall Study|Adverse Event|0|||
48452678|NCT01989572|155845784|FG004|Overall Study|Adverse Event|3|||
48452679|NCT01989572|155845785|FG005|Overall Study|Adverse Event|0|||
48452680|NCT01989572|155845780|FG000|Overall Study|Death|0|||
48452681|NCT01989572|155845781|FG001|Overall Study|Death|0|||
48452682|NCT01989572|155845782|FG002|Overall Study|Death|0|||
48452683|NCT01989572|155845783|FG003|Overall Study|Death|0|||
48452684|NCT01989572|155845784|FG004|Overall Study|Death|1|||
48452685|NCT01989572|155845785|FG005|Overall Study|Death|0|||
48452686|NCT01989572|155845780|FG000|Overall Study|Withdrawal by Subject|4|||
48452687|NCT01989572|155845781|FG001|Overall Study|Withdrawal by Subject|1|||
48452688|NCT01989572|155845782|FG002|Overall Study|Withdrawal by Subject|5|||
48452689|NCT01989572|155845783|FG003|Overall Study|Withdrawal by Subject|1|||
48452690|NCT01989572|155845784|FG004|Overall Study|Withdrawal by Subject|12|||
48452691|NCT01989572|155845785|FG005|Overall Study|Withdrawal by Subject|4|||
48452692|NCT01989572|155845780|FG000|Overall Study|complicating disease|1|||
48452693|NCT01989572|155845781|FG001|Overall Study|complicating disease|1|||
48452694|NCT01989572|155845782|FG002|Overall Study|complicating disease|2|||
48452695|NCT01989572|155845783|FG003|Overall Study|complicating disease|0|||
48452696|NCT01989572|155845784|FG004|Overall Study|complicating disease|1|||
48452697|NCT01989572|155845785|FG005|Overall Study|complicating disease|0|||
48452698|NCT01989572|155845780|FG000|Overall Study|error|2|||
48452699|NCT01989572|155845781|FG001|Overall Study|error|1|||
48452700|NCT01989572|155845782|FG002|Overall Study|error|1|||
48452701|NCT01989572|155845783|FG003|Overall Study|error|1|||
48452702|NCT01989572|155845784|FG004|Overall Study|error|1|||
48452703|NCT01989572|155845785|FG005|Overall Study|error|1|||
48452704|NCT01989572|155845780|FG000|Overall Study|maximum dose reached|0|||
48452705|NCT01989572|155845781|FG001|Overall Study|maximum dose reached|1|||
48452706|NCT01989572|155845782|FG002|Overall Study|maximum dose reached|0|||
48452707|NCT01989572|155845783|FG003|Overall Study|maximum dose reached|0|||
48452708|NCT01989572|155845784|FG004|Overall Study|maximum dose reached|1|||
48452709|NCT01989572|155845785|FG005|Overall Study|maximum dose reached|0|||
48452710|NCT01989572|155845780|FG000|Overall Study|unknown/not specify|3|||
48452711|NCT01989572|155845781|FG001|Overall Study|unknown/not specify|4|||
48452712|NCT01989572|155845782|FG002|Overall Study|unknown/not specify|1|||
48452713|NCT01989572|155845783|FG003|Overall Study|unknown/not specify|3|||
48452714|NCT01989572|155845784|FG004|Overall Study|unknown/not specify|3|||
48452715|NCT01989572|155845785|FG005|Overall Study|unknown/not specify|5|||
48452716|NCT01989572|155845780|FG000|Overall Study|not start protocol therapy|5|||
48452717|NCT01989572|155845781|FG001|Overall Study|not start protocol therapy|1|||
48452718|NCT01989572|155845782|FG002|Overall Study|not start protocol therapy|2|||
48452719|NCT01989572|155845783|FG003|Overall Study|not start protocol therapy|3|||
48452720|NCT01989572|155845784|FG004|Overall Study|not start protocol therapy|4|||
48452721|NCT01989572|155845785|FG005|Overall Study|not start protocol therapy|18|||
48452722|NCT01989572|155845780|FG000|Overall Study|alternative therapy|3|||
48452723|NCT01989572|155845781|FG001|Overall Study|alternative therapy|0|||
48452724|NCT01989572|155845782|FG002|Overall Study|alternative therapy|0|||
48452725|NCT01989572|155845783|FG003|Overall Study|alternative therapy|0|||
48452726|NCT01989572|155845784|FG004|Overall Study|alternative therapy|1|||
48452727|NCT01989572|155845785|FG005|Overall Study|alternative therapy|3|||
48452728|NCT04583969|155845788|FG000|Overall Study|Death|31|||
48452729|NCT04583969|155845789|FG001|Overall Study|Death|38|||
48452730|NCT04583969|155845788|FG000|Overall Study|Lost to Follow-up|16|||
48452731|NCT04583969|155845789|FG001|Overall Study|Lost to Follow-up|13|||
48452732|NCT04583969|155845788|FG000|Overall Study|Protocol Violation|1|||
48452733|NCT04583969|155845789|FG001|Overall Study|Protocol Violation|0|||
48452734|NCT04583969|155845788|FG000|Overall Study|Withdrawal by Subject|3|||
48452735|NCT04583969|155845789|FG001|Overall Study|Withdrawal by Subject|3|||
48452736|NCT04583969|155845788|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
48452737|NCT04583969|155845789|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
48452738|NCT04583969|155845788|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
48452739|NCT04583969|155845789|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
48452740|NCT04583969|155845788|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
48452741|NCT04583969|155845789|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
48452742|NCT04583969|155845788|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
48452743|NCT04583969|155845789|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
48452744|NCT04583969|155845788|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
48452745|NCT04583969|155845789|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
48452746|NCT02143141|155845794|FG000|Overall Study|pain scores at 24 hours not collected|1|||
48452747|NCT02143141|155845795|FG001|Overall Study|pain scores at 24 hours not collected|0|||
48452748|NCT00246376|155845796|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
48452749|NCT00246376|155845797|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
48452750|NCT00246376|155845798|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
48452751|NCT00246376|155845799|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
48452752|NCT00246376|155845800|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
48452753|NCT00246376|155845796|FG000|Overall Study|Adverse Event|2|||
48452754|NCT00246376|155845797|FG001|Overall Study|Adverse Event|3|||
48452755|NCT00246376|155845798|FG002|Overall Study|Adverse Event|1|||
48452756|NCT00246376|155845799|FG003|Overall Study|Adverse Event|3|||
48452757|NCT00246376|155845800|FG004|Overall Study|Adverse Event|1|||
48452758|NCT00246376|155845796|FG000|Overall Study|Lost to Follow-up|2|||
48452759|NCT00246376|155845797|FG001|Overall Study|Lost to Follow-up|11|||
48452760|NCT00246376|155845798|FG002|Overall Study|Lost to Follow-up|11|||
48452761|NCT00246376|155845799|FG003|Overall Study|Lost to Follow-up|16|||
48452762|NCT00246376|155845800|FG004|Overall Study|Lost to Follow-up|13|||
48452763|NCT03363165|155845801|FG000|3-month Follow-up|Death|0|||
48452764|NCT03363165|155845802|FG001|3-month Follow-up|Death|1|||
48452765|NCT03363165|155845801|FG000|6-month Follow-up|Death|0|||
48452766|NCT03363165|155845802|FG001|6-month Follow-up|Death|1|||
48452767|NCT03363165|155845801|FG000|6-month Follow-up|Withdrawal by Subject|1|||
48452768|NCT03363165|155845802|FG001|6-month Follow-up|Withdrawal by Subject|1|||
48452769|NCT03363165|155845801|FG000|12-month Follow-up|Death|1|||
48452770|NCT03363165|155845802|FG001|12-month Follow-up|Death|1|||
48452771|NCT03363165|155845801|FG000|12-month Follow-up|Withdrawal by Subject|1|||
48452772|NCT03363165|155845802|FG001|12-month Follow-up|Withdrawal by Subject|1|||
48452773|NCT01585168|155845804|FG000|Overall Study|Lost to Follow-up|3|||
48452774|NCT01585168|155845805|FG001|Overall Study|Lost to Follow-up|1|||
48452775|NCT01585168|155845806|FG002|Overall Study|Lost to Follow-up|1|||
48452776|NCT01585168|155845807|FG003|Overall Study|Lost to Follow-up|1|||
48452777|NCT01855945|155845808|FG000|Overall Study|Adverse Event|0|||
48452778|NCT01855945|155845809|FG001|Overall Study|Adverse Event|0|||
48452779|NCT01855945|155845810|FG002|Overall Study|Adverse Event|0|||
48452780|NCT01855945|155845811|FG003|Overall Study|Adverse Event|0|||
48452781|NCT01855945|155845812|FG004|Overall Study|Adverse Event|0|||
48452782|NCT01855945|155845813|FG005|Overall Study|Adverse Event|0|||
48452783|NCT01855945|155845814|FG006|Overall Study|Adverse Event|1|||
48452784|NCT01855945|155845815|FG007|Overall Study|Adverse Event|0|||
48452785|NCT01855945|155845816|FG008|Overall Study|Adverse Event|0|||
48452786|NCT01855945|155845817|FG009|Overall Study|Adverse Event|0|||
48452787|NCT01855945|155845818|FG010|Overall Study|Adverse Event|0|||
48452788|NCT01855945|155845819|FG011|Overall Study|Adverse Event|0|||
48452789|NCT01855945|155845808|FG000|Overall Study|Death|0|||
48452790|NCT01855945|155845809|FG001|Overall Study|Death|0|||
48452791|NCT01855945|155845810|FG002|Overall Study|Death|0|||
48452792|NCT01855945|155845811|FG003|Overall Study|Death|0|||
48452793|NCT01855945|155845812|FG004|Overall Study|Death|0|||
48452794|NCT01855945|155845813|FG005|Overall Study|Death|0|||
48452795|NCT01855945|155845814|FG006|Overall Study|Death|2|||
48452796|NCT01855945|155845815|FG007|Overall Study|Death|0|||
48452797|NCT01855945|155845816|FG008|Overall Study|Death|0|||
48452798|NCT01855945|155845817|FG009|Overall Study|Death|0|||
48452799|NCT01855945|155845818|FG010|Overall Study|Death|0|||
48452800|NCT01855945|155845819|FG011|Overall Study|Death|0|||
48452801|NCT01855945|155845808|FG000|Overall Study|Lost to Follow-up|11|||
48452802|NCT01855945|155845809|FG001|Overall Study|Lost to Follow-up|10|||
48452803|NCT01855945|155845810|FG002|Overall Study|Lost to Follow-up|7|||
48452804|NCT01855945|155845811|FG003|Overall Study|Lost to Follow-up|3|||
48452805|NCT01855945|155845812|FG004|Overall Study|Lost to Follow-up|0|||
48452806|NCT01855945|155845813|FG005|Overall Study|Lost to Follow-up|3|||
48452807|NCT01855945|155845814|FG006|Overall Study|Lost to Follow-up|4|||
48452808|NCT01855945|155845815|FG007|Overall Study|Lost to Follow-up|7|||
48452809|NCT01855945|155845816|FG008|Overall Study|Lost to Follow-up|2|||
48452810|NCT01855945|155845817|FG009|Overall Study|Lost to Follow-up|0|||
48452811|NCT01855945|155845818|FG010|Overall Study|Lost to Follow-up|0|||
48452812|NCT01855945|155845819|FG011|Overall Study|Lost to Follow-up|2|||
48452813|NCT01855945|155845808|FG000|Overall Study|Other - Unclassified|1|||
48452814|NCT01855945|155845809|FG001|Overall Study|Other - Unclassified|1|||
48452815|NCT01855945|155845810|FG002|Overall Study|Other - Unclassified|1|||
48452816|NCT01855945|155845811|FG003|Overall Study|Other - Unclassified|0|||
48452817|NCT01855945|155845812|FG004|Overall Study|Other - Unclassified|0|||
48452818|NCT01855945|155845813|FG005|Overall Study|Other - Unclassified|0|||
48452819|NCT01855945|155845814|FG006|Overall Study|Other - Unclassified|2|||
48452820|NCT01855945|155845815|FG007|Overall Study|Other - Unclassified|1|||
48452821|NCT01855945|155845816|FG008|Overall Study|Other - Unclassified|0|||
48452822|NCT01855945|155845817|FG009|Overall Study|Other - Unclassified|0|||
48452823|NCT01855945|155845818|FG010|Overall Study|Other - Unclassified|1|||
48452824|NCT01855945|155845819|FG011|Overall Study|Other - Unclassified|0|||
48452825|NCT01855945|155845808|FG000|Overall Study|Withdrawal by Subject|4|||
48452826|NCT01855945|155845809|FG001|Overall Study|Withdrawal by Subject|0|||
48452827|NCT01855945|155845810|FG002|Overall Study|Withdrawal by Subject|4|||
48452828|NCT01855945|155845811|FG003|Overall Study|Withdrawal by Subject|1|||
48452829|NCT01855945|155845812|FG004|Overall Study|Withdrawal by Subject|1|||
48452830|NCT01855945|155845813|FG005|Overall Study|Withdrawal by Subject|0|||
48452831|NCT01855945|155845814|FG006|Overall Study|Withdrawal by Subject|1|||
48452832|NCT01855945|155845815|FG007|Overall Study|Withdrawal by Subject|0|||
48452833|NCT01855945|155845816|FG008|Overall Study|Withdrawal by Subject|0|||
48452834|NCT01855945|155845817|FG009|Overall Study|Withdrawal by Subject|2|||
48452835|NCT01855945|155845818|FG010|Overall Study|Withdrawal by Subject|4|||
48452836|NCT01855945|155845819|FG011|Overall Study|Withdrawal by Subject|1|||
48452837|NCT03146403|155845820|FG000|Overall Study|Withdrawal by Subject|0|||
48452838|NCT03146403|155845821|FG001|Overall Study|Withdrawal by Subject|3|||
48452839|NCT03146403|155845820|FG000|Overall Study|Lost to Follow-up|2|||
48452840|NCT03146403|155845821|FG001|Overall Study|Lost to Follow-up|0|||
48452841|NCT00770224|155845822|FG000|Step 1: Induction|Adverse Event|3|||
48452842|NCT00770224|155845823|FG001|Step 1: Induction|Adverse Event|0|||
48452843|NCT00770224|155845822|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
48452844|NCT00770224|155845823|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
48452845|NCT00770224|155845822|FG000|Step 1: Induction|Other reason not protocol specified|2|||
48452846|NCT00770224|155845823|FG001|Step 1: Induction|Other reason not protocol specified|0|||
48452847|NCT00770224|155845822|FG000|Step 1: Induction|Ineligible|2|||
48452848|NCT00770224|155845823|FG001|Step 1: Induction|Ineligible|0|||
48452849|NCT00770224|155845822|FG000|Step 1: Induction|No protocol treatment given|1|||
48452850|NCT00770224|155845823|FG001|Step 1: Induction|No protocol treatment given|0|||
48452851|NCT00770224|155845822|FG000|Step 2: Maintenance|Adverse Event|0|||
48452852|NCT00770224|155845823|FG001|Step 2: Maintenance|Adverse Event|10|||
48452853|NCT00770224|155845822|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
48452854|NCT00770224|155845823|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
48452855|NCT00770224|155845822|FG000|Step 2: Maintenance|Progression/relapse|0|||
48452856|NCT00770224|155845823|FG001|Step 2: Maintenance|Progression/relapse|1|||
48452857|NCT00770224|155845822|FG000|Step 2: Maintenance|Death|0|||
48452858|NCT00770224|155845823|FG001|Step 2: Maintenance|Death|2|||
48452859|NCT00770224|155845822|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
48452860|NCT00770224|155845823|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
48452861|NCT00770224|155845822|FG000|Step 2: Maintenance|Ineligible|0|||
48452862|NCT00770224|155845823|FG001|Step 2: Maintenance|Ineligible|2|||
48452863|NCT00636441|155845828|FG000|Overall Study|Adverse Event|0|||
48452864|NCT00636441|155845829|FG001|Overall Study|Adverse Event|1|||
48452865|NCT00636441|155845830|FG002|Overall Study|Adverse Event|1|||
48452866|NCT00636441|155845831|FG003|Overall Study|Adverse Event|0|||
48452867|NCT00636441|155845832|FG004|Overall Study|Adverse Event|0|||
48452868|NCT00636441|155845833|FG005|Overall Study|Adverse Event|1|||
48452869|NCT00636441|155845834|FG006|Overall Study|Adverse Event|0|||
48452870|NCT00636441|155845828|FG000|Overall Study|Late, ineligible|0|||
48452871|NCT00636441|155845829|FG001|Overall Study|Late, ineligible|0|||
48452872|NCT00636441|155845830|FG002|Overall Study|Late, ineligible|0|||
48452873|NCT00636441|155845831|FG003|Overall Study|Late, ineligible|0|||
48452874|NCT00636441|155845832|FG004|Overall Study|Late, ineligible|0|||
48452875|NCT00636441|155845833|FG005|Overall Study|Late, ineligible|0|||
48452876|NCT00636441|155845834|FG006|Overall Study|Late, ineligible|1|||
48452877|NCT00636441|155845828|FG000|Overall Study|Screen Failure|0|||
48452878|NCT00636441|155845829|FG001|Overall Study|Screen Failure|0|||
48452879|NCT00636441|155845830|FG002|Overall Study|Screen Failure|0|||
48452880|NCT00636441|155845831|FG003|Overall Study|Screen Failure|0|||
48452881|NCT00636441|155845832|FG004|Overall Study|Screen Failure|0|||
48452882|NCT00636441|155845833|FG005|Overall Study|Screen Failure|0|||
48452883|NCT00636441|155845834|FG006|Overall Study|Screen Failure|17|||
48452884|NCT00615459|155845836|FG000|Period I|Adverse Event|2|||
48452885|NCT00615459|155845837|FG001|Period I|Adverse Event|0|||
48452886|NCT00615459|155845838|FG002|Period I|Adverse Event|1|||
48452887|NCT00615459|155845839|FG003|Period I|Adverse Event|0|||
48452888|NCT00615459|155845836|FG000|Period I|Subject withdrew consent|1|||
48452889|NCT00615459|155845837|FG001|Period I|Subject withdrew consent|0|||
48452890|NCT00615459|155845838|FG002|Period I|Subject withdrew consent|0|||
48452891|NCT00615459|155845839|FG003|Period I|Subject withdrew consent|1|||
48452892|NCT00615459|155845836|FG000|Period I|Abnormal test procedure results|1|||
48452893|NCT00615459|155845837|FG001|Period I|Abnormal test procedure results|1|||
48452894|NCT00615459|155845838|FG002|Period I|Abnormal test procedure results|1|||
48452895|NCT00615459|155845839|FG003|Period I|Abnormal test procedure results|0|||
48452896|NCT00615459|155845836|FG000|Period II|Adverse Event|1|||
48452897|NCT00615459|155845837|FG001|Period II|Adverse Event|0|||
48452898|NCT00615459|155845838|FG002|Period II|Adverse Event|0|||
48452899|NCT00615459|155845839|FG003|Period II|Adverse Event|0|||
48452900|NCT00615459|155845836|FG000|Period II|Lost to Follow-up|0|||
48452901|NCT00615459|155845837|FG001|Period II|Lost to Follow-up|0|||
48452902|NCT00615459|155845838|FG002|Period II|Lost to Follow-up|0|||
48452903|NCT00615459|155845839|FG003|Period II|Lost to Follow-up|1|||
48452904|NCT00615459|155845836|FG000|Period III|Adverse Event|0|||
48452905|NCT00615459|155845837|FG001|Period III|Adverse Event|1|||
48452906|NCT00615459|155845838|FG002|Period III|Adverse Event|0|||
48452907|NCT00615459|155845839|FG003|Period III|Adverse Event|0|||
48452908|NCT00615459|155845836|FG000|Period III|Administrative problems|0|||
48452909|NCT00615459|155845837|FG001|Period III|Administrative problems|1|||
48452910|NCT00615459|155845838|FG002|Period III|Administrative problems|1|||
48452911|NCT00615459|155845839|FG003|Period III|Administrative problems|0|||
48452912|NCT00615459|155845836|FG000|Period III|Unsatisfactory therapeutic effect|0|||
48452913|NCT00615459|155845837|FG001|Period III|Unsatisfactory therapeutic effect|1|||
48452914|NCT00615459|155845838|FG002|Period III|Unsatisfactory therapeutic effect|0|||
48452915|NCT00615459|155845839|FG003|Period III|Unsatisfactory therapeutic effect|0|||
48452916|NCT00918346|155845842|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
48452917|NCT00918346|155845843|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
48452918|NCT02475629|155845844|FG000|Overall Study|Adverse Event|1|||
48452919|NCT02475629|155845844|FG000|Overall Study|Death|4|||
48452920|NCT02475629|155845844|FG000|Overall Study|Physician Decision|1|||
48452921|NCT02475629|155845844|FG000|Overall Study|Withdrawal by Subject|1|||
48452922|NCT02475629|155845844|FG000|Overall Study|Lost to Follow-up|1|||
48452923|NCT02475629|155845844|FG000|Overall Study|Subject non-compliance|1|||
48452924|NCT01421069|155845845|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
48452925|NCT01421069|155845845|FG000|Parent Study|Failed to return|3|||
48452926|NCT01421069|155845845|FG000|Parent Study|Withdrawal by Subject|1|||
48452927|NCT01421069|155845845|FG000|Parent Study|Lost to Follow-up|2|||
48452928|NCT01421069|155845845|FG000|Parent Study|Lack of Efficacy|1|||
48452929|NCT01421069|155845845|FG000|Overall Period for Extension Study|Other|2|||
48452930|NCT01421069|155845845|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
48452931|NCT01421069|155845845|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
48452932|NCT01421069|155845845|FG000|Overall Period for Extension Study|Pregnancy|1|||
48452933|NCT01421069|155845845|FG000|Overall Period for Extension Study|Adverse Event|1|||
48452934|NCT01421069|155845845|FG000|Overall Period for Extension Study|Protocol Violation|1|||
48452935|NCT01421069|155845845|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
48452936|NCT01421069|155845845|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
48452937|NCT01421069|155845845|FG000|Active Treatment Period|Other|1|||
48452938|NCT01421069|155845845|FG000|Active Treatment Period|No longer willing to participate in study|8|||
48452939|NCT01421069|155845845|FG000|Active Treatment Period|Insufficient clinical response|1|||
48452940|NCT01421069|155845845|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
48452941|NCT01421069|155845845|FG000|Active Treatment Period|Pregnancy|1|||
48452942|NCT01421069|155845845|FG000|Active Treatment Period|Adverse Event|1|||
48452943|NCT01421069|155845845|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
48452944|NCT01421069|155845845|FG000|Active Treatment Period|Enrolled in observational period|29|||
48452945|NCT01421069|155845845|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
48452946|NCT01421069|155845845|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
48452947|NCT01421069|155845845|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
48452948|NCT01421069|155845845|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
48452949|NCT01421069|155845845|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
48452950|NCT01421069|155845845|FG000|2b. Retreatment Period|Protocol Violation|1|||
48452951|NCT01421069|155845845|FG000|Observational Period|Other|1|||
48452952|NCT01421069|155845845|FG000|Observational Period|No longer willing to participate in study|4|||
48452953|NCT01421069|155845845|FG000|Observational Period|Lost to Follow-up|3|||
48452954|NCT03238352|155845846|FG000|Overall Study|Lost to Follow-up|0|||
48452955|NCT03238352|155845847|FG001|Overall Study|Lost to Follow-up|2|||
48452956|NCT03238352|155845848|FG002|Overall Study|Lost to Follow-up|1|||
48452957|NCT03238352|155845846|FG000|Overall Study|Withdrawal by Subject|0|||
48452958|NCT03238352|155845847|FG001|Overall Study|Withdrawal by Subject|1|||
48452959|NCT03238352|155845848|FG002|Overall Study|Withdrawal by Subject|0|||
48452960|NCT02896192|155845852|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
48452961|NCT02896192|155845852|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
48452962|NCT02896192|155845852|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
48452963|NCT01810380|155845857|FG000|Overall Study|Randomised not treated|2|||
48452964|NCT01810380|155845858|FG001|Overall Study|Randomised not treated|1|||
48452965|NCT01810380|155845859|FG002|Overall Study|Randomised not treated|1|||
48452966|NCT01810380|155845857|FG000|Overall Study|Adverse Event|11|||
48452967|NCT01810380|155845858|FG001|Overall Study|Adverse Event|14|||
48452968|NCT01810380|155845859|FG002|Overall Study|Adverse Event|4|||
48452969|NCT01810380|155845857|FG000|Overall Study|Lack of Efficacy|24|||
48452970|NCT01810380|155845858|FG001|Overall Study|Lack of Efficacy|10|||
48452971|NCT01810380|155845859|FG002|Overall Study|Lack of Efficacy|11|||
48452972|NCT01810380|155845857|FG000|Overall Study|Protocol Violation|1|||
48452973|NCT01810380|155845858|FG001|Overall Study|Protocol Violation|0|||
48452974|NCT01810380|155845859|FG002|Overall Study|Protocol Violation|1|||
48452975|NCT01810380|155845857|FG000|Overall Study|Withdrawal by Subject|6|||
48452976|NCT01810380|155845858|FG001|Overall Study|Withdrawal by Subject|0|||
48452977|NCT01810380|155845859|FG002|Overall Study|Withdrawal by Subject|6|||
48452978|NCT01810380|155845857|FG000|Overall Study|Administrative or other reasons|11|||
48452979|NCT01810380|155845858|FG001|Overall Study|Administrative or other reasons|13|||
48452980|NCT01810380|155845859|FG002|Overall Study|Administrative or other reasons|9|||
48452981|NCT00560794|155845860|FG000|Overall Study|Adverse Event|2|||
48452982|NCT00560794|155845860|FG000|Overall Study|Patient was not Compliant|1|||
48452983|NCT00560794|155845860|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
48452984|NCT00560794|155845860|FG000|Overall Study|Hematological Relapse|1|||
48452985|NCT00560794|155845860|FG000|Overall Study|Received Bone Marrow Transplant|6|||
48452986|NCT01190020|155845861|FG000|Overall Study|Adverse Event|2|||
48452987|NCT01190020|155845862|FG001|Overall Study|Adverse Event|0|||
48452988|NCT01190020|155845861|FG000|Overall Study|Lost to Follow-up|2|||
48452989|NCT01190020|155845862|FG001|Overall Study|Lost to Follow-up|0|||
48452990|NCT01190020|155845861|FG000|Overall Study|Withdrawal by Subject|3|||
48452991|NCT01190020|155845862|FG001|Overall Study|Withdrawal by Subject|0|||
48452992|NCT00441480|155845863|FG000|Overall Study|Protocol Violation|1|||
48452993|NCT00441480|155845864|FG001|Overall Study|Protocol Violation|1|||
48452994|NCT00441480|155845863|FG000|Overall Study|Withdrawal by Subject|2|||
48452995|NCT00441480|155845864|FG001|Overall Study|Withdrawal by Subject|3|||
48452996|NCT00614991|155845865|FG000|Overall Study|Adverse Event|3|||
48452997|NCT00614991|155845866|FG001|Overall Study|Adverse Event|3|||
48452998|NCT00614991|155845867|FG002|Overall Study|Adverse Event|0|||
48452999|NCT00614991|155845868|FG003|Overall Study|Adverse Event|0|||
48453000|NCT00614991|155845869|FG004|Overall Study|Adverse Event|1|||
48453001|NCT00614991|155845870|FG005|Overall Study|Adverse Event|0|||
48453002|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
48453003|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
48453004|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
48453005|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
48453006|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
48453007|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
48453008|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
48453009|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
48453010|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
48453011|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
48453012|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
48453013|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
48453014|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
48453015|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
48453016|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
48453017|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
48453018|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
48453019|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
48453020|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
48453021|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
48453022|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
48453023|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
48453024|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
48453025|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
48453026|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
48453027|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
48453028|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
48453029|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
48453030|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
48453031|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
48453032|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
48453033|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
48453034|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
48453035|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
48453036|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
48453037|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
48453038|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
48453039|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
48453040|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
48453041|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
48453042|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
48453043|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
48453044|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
48453045|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
48453046|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
48453047|NCT03689972|155845871|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
48453048|NCT03689972|155845872|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
48453049|NCT03689972|155845873|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
48453050|NCT03689972|155845874|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
48453051|NCT03689972|155845875|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
48453052|NCT03689972|155845871|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
48453053|NCT03689972|155845872|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
48453054|NCT03689972|155845873|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
48453055|NCT03689972|155845874|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
48453056|NCT03689972|155845875|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
48453057|NCT03689972|155845871|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
48453058|NCT03689972|155845872|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
48453059|NCT03689972|155845873|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
48453060|NCT03689972|155845874|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
48453061|NCT03689972|155845875|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
48453062|NCT03689972|155845871|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
48453063|NCT03689972|155845872|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
48453064|NCT03689972|155845873|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
48453065|NCT03689972|155845874|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
48453066|NCT03689972|155845875|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
48453067|NCT03689972|155845871|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
48453068|NCT03689972|155845872|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
48453069|NCT03689972|155845873|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
48453070|NCT03689972|155845874|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
48453071|NCT03689972|155845875|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
48453072|NCT03689972|155845871|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
48453073|NCT03689972|155845872|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
48453074|NCT03689972|155845873|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
48453075|NCT03689972|155845874|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
48453076|NCT03689972|155845875|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
48453077|NCT03689972|155845871|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
48453078|NCT03689972|155845872|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
48453079|NCT03689972|155845873|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
48453080|NCT03689972|155845874|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
48453081|NCT03689972|155845875|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
48453082|NCT03689972|155845871|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
48453083|NCT03689972|155845872|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
48453084|NCT03689972|155845873|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
48453085|NCT03689972|155845874|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
48453086|NCT03689972|155845875|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
48453087|NCT03689972|155845871|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
48453088|NCT03689972|155845872|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
48453089|NCT03689972|155845873|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
48453090|NCT03689972|155845874|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
48453091|NCT03689972|155845875|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
48453092|NCT03689972|155845871|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
48453093|NCT03689972|155845872|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
48453094|NCT03689972|155845873|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
48453095|NCT03689972|155845874|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
48453096|NCT03689972|155845875|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
48453097|NCT04857892|155845876|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
48453098|NCT04857892|155845877|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
48453099|NCT04857892|155845878|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
48453100|NCT04857892|155845879|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
48453101|NCT04857892|155845880|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
48453102|NCT04857892|155845876|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
48453103|NCT04857892|155845877|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
48453104|NCT04857892|155845878|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
48453105|NCT04857892|155845879|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
48453106|NCT04857892|155845880|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
48453107|NCT04857892|155845876|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
48453108|NCT04857892|155845877|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
48453109|NCT04857892|155845878|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
48453110|NCT04857892|155845879|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
48453111|NCT04857892|155845880|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
48453112|NCT00608842|155845881|FG000|Overall Study|Participant's Request|0|||
48453113|NCT00608842|155845882|FG001|Overall Study|Participant's Request|1|||
48453114|NCT00608842|155845883|FG002|Overall Study|Participant's Request|2|||
48453115|NCT00608842|155845884|FG003|Overall Study|Participant's Request|1|||
48453116|NCT00608842|155845881|FG000|Overall Study|Lost to Follow-up|1|||
48453117|NCT00608842|155845882|FG001|Overall Study|Lost to Follow-up|0|||
48453118|NCT00608842|155845883|FG002|Overall Study|Lost to Follow-up|0|||
48453119|NCT00608842|155845884|FG003|Overall Study|Lost to Follow-up|0|||
48453120|NCT02829775|155845885|FG000|Overall Study|Death|1|||
48453121|NCT02829775|155845885|FG000|Overall Study|Withdrawal by Subject|3|||
48453122|NCT02829775|155845885|FG000|Overall Study|Disease remission|1|||
48453123|NCT05166603|155845888|FG000|Overall Study|Withdrawal by Subject|68|||
48453124|NCT05166603|155845889|FG001|Overall Study|Withdrawal by Subject|0|||
48453125|NCT01512108|155848068|FG000|Overall Study|Adverse Event|9|||
48453126|NCT01512108|155848069|FG001|Overall Study|Adverse Event|4|||
48453127|NCT01512108|155848068|FG000|Overall Study|Protocol Violation|1|||
48453128|NCT01512108|155848069|FG001|Overall Study|Protocol Violation|2|||
48453129|NCT01512108|155848068|FG000|Overall Study|Withdrawal Criteria|1|||
48453130|NCT01512108|155848069|FG001|Overall Study|Withdrawal Criteria|0|||
48453131|NCT01512108|155848068|FG000|Overall Study|Unclassified|11|||
48453132|NCT01512108|155848069|FG001|Overall Study|Unclassified|3|||
48453133|NCT03682055|155848072|FG000|Overall Study|Lack of Efficacy|1|||
48453134|NCT03682055|155848073|FG001|Overall Study|Lack of Efficacy|2|||
48453135|NCT03682055|155848074|FG002|Overall Study|Lack of Efficacy|1|||
48453136|NCT03682055|155848075|FG003|Overall Study|Lack of Efficacy|2|||
48453137|NCT03682055|155848076|FG004|Overall Study|Lack of Efficacy|1|||
48453138|NCT03682055|155848077|FG005|Overall Study|Lack of Efficacy|3|||
48453139|NCT03682055|155848072|FG000|Overall Study|Withdrawal by Subject|0|||
48453140|NCT03682055|155848073|FG001|Overall Study|Withdrawal by Subject|0|||
48453141|NCT03682055|155848074|FG002|Overall Study|Withdrawal by Subject|0|||
48453142|NCT03682055|155848075|FG003|Overall Study|Withdrawal by Subject|0|||
48453143|NCT03682055|155848076|FG004|Overall Study|Withdrawal by Subject|0|||
48453144|NCT03682055|155848077|FG005|Overall Study|Withdrawal by Subject|1|||
48453145|NCT03682055|155848072|FG000|Overall Study|Termination of Study by Sponsor|0|||
48453146|NCT03682055|155848073|FG001|Overall Study|Termination of Study by Sponsor|0|||
48453147|NCT03682055|155848074|FG002|Overall Study|Termination of Study by Sponsor|0|||
48453148|NCT03682055|155848075|FG003|Overall Study|Termination of Study by Sponsor|0|||
48453149|NCT03682055|155848076|FG004|Overall Study|Termination of Study by Sponsor|0|||
48453150|NCT03682055|155848077|FG005|Overall Study|Termination of Study by Sponsor|3|||
48453151|NCT03127852|155848078|FG000|Overall Study|Withdrawal by Subject|4|||
48453152|NCT03127852|155848079|FG001|Overall Study|Withdrawal by Subject|1|||
48453153|NCT03127852|155848078|FG000|Overall Study|Death|1|||
48453154|NCT03127852|155848079|FG001|Overall Study|Death|1|||
48453155|NCT01135394|155848080|FG000|Screening|Lost to Follow-up|2|||
48453156|NCT01135394|155848080|FG000|Screening|Withdrawal by Subject|10|||
48453157|NCT01135394|155848080|FG000|Screening|Screening failure|16|||
48453158|NCT01135394|155848080|FG000|Screening|Physician Decision|5|||
48453159|NCT01135394|155848080|FG000|Baseline Assessment|Withdrawal by Subject|9|||
48453160|NCT01135394|155848080|FG000|Baseline Assessment|Physician Decision|3|||
48453161|NCT01135394|155848080|FG000|Baseline Assessment|Lost to Follow-up|2|||
48453162|NCT01135394|155848080|FG000|Baseline Assessment|Adverse Event|1|||
48453163|NCT01135394|155848080|FG000|Study Treatment|Withdrawal by Subject|1|||
48453164|NCT01135394|155848080|FG000|Study Treatment|Physician Decision|1|||
48453165|NCT01135394|155848080|FG000|Study Treatment|Adverse Event|2|||
48453166|NCT00796003|155848082|FG000|Overall Study|Disease Progression|2|||
48453167|NCT00796003|155848083|FG001|Overall Study|Disease Progression|13|||
48453168|NCT00796003|155848082|FG000|Overall Study|Adverse Event|1|||
48453169|NCT00796003|155848083|FG001|Overall Study|Adverse Event|7|||
48453170|NCT00796003|155848082|FG000|Overall Study|Specified organ function not met|0|||
48453171|NCT00796003|155848083|FG001|Overall Study|Specified organ function not met|1|||
48453172|NCT00796003|155848082|FG000|Overall Study|Physician Decision|0|||
48453173|NCT00796003|155848083|FG001|Overall Study|Physician Decision|4|||
48453174|NCT00796003|155848082|FG000|Overall Study|Withdrawal by Subject|0|||
48453175|NCT00796003|155848083|FG001|Overall Study|Withdrawal by Subject|1|||
48453176|NCT00796003|155848082|FG000|Overall Study|Other|0|||
48453177|NCT00796003|155848083|FG001|Overall Study|Other|1|||
48453178|NCT00796003|155848082|FG000|Overall Study|Participants Not treated|0|||
48453179|NCT00796003|155848083|FG001|Overall Study|Participants Not treated|2|||
48453180|NCT03597503|155848086|FG000|Overall Study|Withdrawal by Subject|0|||
48453181|NCT03597503|155848087|FG001|Overall Study|Withdrawal by Subject|2|||
48453182|NCT03597503|155848086|FG000|Overall Study|Lost to Follow-up|1|||
48453183|NCT03597503|155848087|FG001|Overall Study|Lost to Follow-up|2|||
48453184|NCT03597503|155848086|FG000|Overall Study|Protocol Violation|1|||
48453185|NCT03597503|155848087|FG001|Overall Study|Protocol Violation|0|||
48453186|NCT00323310|155848088|FG000|Overall Study|Withdrawal by Subject|1|||
48453187|NCT00323310|155848088|FG000|Overall Study|a parent refused blood draw|1|||
48453188|NCT00323310|155848088|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
48453189|NCT03510910|155848089|FG000|Overall Study|Incomplete Survey|2|||
48453190|NCT03510910|155848090|FG001|Overall Study|Incomplete Survey|3|||
48453191|NCT03984812|155848091|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453192|NCT03984812|155848092|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453193|NCT03984812|155848093|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
48453194|NCT03984812|155848094|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453195|NCT03984812|155848095|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453196|NCT03984812|155848096|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453197|NCT03984812|155848097|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453198|NCT03984812|155848098|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453199|NCT03984812|155848099|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453200|NCT03984812|155848100|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453201|NCT03984812|155848101|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
48453202|NCT02574481|155848102|FG000|Overall Study|Withdrawal by Subject|29|||
48453203|NCT02574481|155848103|FG001|Overall Study|Withdrawal by Subject|15|||
48453204|NCT02574481|155848104|FG002|Overall Study|Withdrawal by Subject|4|||
48453205|NCT02574481|155848105|FG003|Overall Study|Withdrawal by Subject|1|||
48453206|NCT02574481|155848102|FG000|Overall Study|Adverse Event|5|||
48453207|NCT02574481|155848103|FG001|Overall Study|Adverse Event|1|||
48453208|NCT02574481|155848104|FG002|Overall Study|Adverse Event|1|||
48453209|NCT02574481|155848105|FG003|Overall Study|Adverse Event|0|||
48453210|NCT02574481|155848102|FG000|Overall Study|Visit Missed|15|||
48453211|NCT02574481|155848103|FG001|Overall Study|Visit Missed|7|||
48453212|NCT02574481|155848104|FG002|Overall Study|Visit Missed|5|||
48453213|NCT02574481|155848105|FG003|Overall Study|Visit Missed|0|||
48453214|NCT02574481|155848102|FG000|Overall Study|Other|7|||
48453215|NCT02574481|155848103|FG001|Overall Study|Other|2|||
48453216|NCT02574481|155848104|FG002|Overall Study|Other|0|||
48453217|NCT02574481|155848105|FG003|Overall Study|Other|0|||
48453218|NCT02574481|155848102|FG000|Overall Study|Death|48|||
48453219|NCT02574481|155848103|FG001|Overall Study|Death|26|||
48453220|NCT02574481|155848104|FG002|Overall Study|Death|12|||
48453221|NCT02574481|155848105|FG003|Overall Study|Death|4|||
48453222|NCT02574481|155848102|FG000|Overall Study|Physician Decision|5|||
48453223|NCT02574481|155848103|FG001|Overall Study|Physician Decision|2|||
48453224|NCT02574481|155848104|FG002|Overall Study|Physician Decision|0|||
48453225|NCT02574481|155848105|FG003|Overall Study|Physician Decision|0|||
48453226|NCT02574481|155848102|FG000|Overall Study|Lost to Follow-up|5|||
48453227|NCT02574481|155848103|FG001|Overall Study|Lost to Follow-up|1|||
48453228|NCT02574481|155848104|FG002|Overall Study|Lost to Follow-up|3|||
48453229|NCT02574481|155848105|FG003|Overall Study|Lost to Follow-up|0|||
48453230|NCT01105936|155848109|FG000|Period 1|Adverse Event|0|||
48453231|NCT01105936|155848110|FG001|Period 1|Adverse Event|0|||
48453232|NCT01105936|155848111|FG002|Period 1|Adverse Event|0|||
48453233|NCT01105936|155848112|FG003|Period 1|Adverse Event|1|||
48453234|NCT01105936|155848109|FG000|Period 2|Adverse Event|1|||
48453235|NCT01105936|155848110|FG001|Period 2|Adverse Event|0|||
48453236|NCT01105936|155848111|FG002|Period 2|Adverse Event|0|||
48453237|NCT01105936|155848112|FG003|Period 2|Adverse Event|0|||
48453238|NCT01105936|155848109|FG000|Period 3|Protocol Violation|0|||
48453239|NCT01105936|155848110|FG001|Period 3|Protocol Violation|2|||
48453240|NCT01105936|155848111|FG002|Period 3|Protocol Violation|0|||
48453241|NCT01105936|155848112|FG003|Period 3|Protocol Violation|0|||
48453242|NCT01673490|155848113|FG000|Overall Study|Lost to Follow-up|1|||
48453243|NCT01673490|155848113|FG000|Overall Study|Adverse Event|3|||
48453244|NCT01673490|155848113|FG000|Overall Study|Withdrawal by Subject|3|||
48453245|NCT04134728|155848114|FG000|Overall Study|Adverse Event|3|||
48453246|NCT04134728|155848115|FG001|Overall Study|Adverse Event|2|||
48453247|NCT04134728|155848116|FG002|Overall Study|Adverse Event|9|||
48453248|NCT04134728|155848117|FG003|Overall Study|Adverse Event|0|||
48453249|NCT04134728|155848118|FG004|Overall Study|Adverse Event|0|||
48453250|NCT04134728|155848119|FG005|Overall Study|Adverse Event|0|||
48453251|NCT04134728|155848114|FG000|Overall Study|Lack of Efficacy|3|||
48453252|NCT04134728|155848115|FG001|Overall Study|Lack of Efficacy|3|||
48453253|NCT04134728|155848116|FG002|Overall Study|Lack of Efficacy|1|||
48453254|NCT04134728|155848117|FG003|Overall Study|Lack of Efficacy|2|||
48453255|NCT04134728|155848118|FG004|Overall Study|Lack of Efficacy|0|||
48453256|NCT04134728|155848119|FG005|Overall Study|Lack of Efficacy|0|||
48453257|NCT04134728|155848114|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
48453258|NCT04134728|155848115|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48453259|NCT04134728|155848116|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
48453260|NCT04134728|155848117|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48453261|NCT04134728|155848118|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48453262|NCT04134728|155848119|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
48453263|NCT04134728|155848114|FG000|Overall Study|Protocol Deviation|0|||
48453264|NCT04134728|155848115|FG001|Overall Study|Protocol Deviation|0|||
48453265|NCT04134728|155848116|FG002|Overall Study|Protocol Deviation|1|||
48453266|NCT04134728|155848117|FG003|Overall Study|Protocol Deviation|0|||
48453267|NCT04134728|155848118|FG004|Overall Study|Protocol Deviation|0|||
48453268|NCT04134728|155848119|FG005|Overall Study|Protocol Deviation|0|||
48453269|NCT04134728|155848114|FG000|Overall Study|Informed Consent Withdrawn|3|||
48453270|NCT04134728|155848115|FG001|Overall Study|Informed Consent Withdrawn|6|||
48453271|NCT04134728|155848116|FG002|Overall Study|Informed Consent Withdrawn|8|||
48453272|NCT04134728|155848117|FG003|Overall Study|Informed Consent Withdrawn|1|||
48453273|NCT04134728|155848118|FG004|Overall Study|Informed Consent Withdrawn|1|||
48453274|NCT04134728|155848119|FG005|Overall Study|Informed Consent Withdrawn|0|||
48453275|NCT04134728|155848114|FG000|Overall Study|Physician Decision|2|||
48453276|NCT04134728|155848115|FG001|Overall Study|Physician Decision|0|||
48453277|NCT04134728|155848116|FG002|Overall Study|Physician Decision|0|||
48453278|NCT04134728|155848117|FG003|Overall Study|Physician Decision|0|||
48453279|NCT04134728|155848118|FG004|Overall Study|Physician Decision|0|||
48453280|NCT04134728|155848119|FG005|Overall Study|Physician Decision|0|||
48453281|NCT04134728|155848114|FG000|Overall Study|Lost to Follow-up|1|||
48453282|NCT04134728|155848115|FG001|Overall Study|Lost to Follow-up|2|||
48453283|NCT04134728|155848116|FG002|Overall Study|Lost to Follow-up|1|||
48453284|NCT04134728|155848117|FG003|Overall Study|Lost to Follow-up|0|||
48453285|NCT04134728|155848118|FG004|Overall Study|Lost to Follow-up|0|||
48453286|NCT04134728|155848119|FG005|Overall Study|Lost to Follow-up|1|||
48453287|NCT04134728|155848114|FG000|Overall Study|Investigator Site Closed|0|||
48453288|NCT04134728|155848115|FG001|Overall Study|Investigator Site Closed|1|||
48453289|NCT04134728|155848116|FG002|Overall Study|Investigator Site Closed|1|||
48453290|NCT04134728|155848117|FG003|Overall Study|Investigator Site Closed|0|||
48453291|NCT04134728|155848118|FG004|Overall Study|Investigator Site Closed|0|||
48453292|NCT04134728|155848119|FG005|Overall Study|Investigator Site Closed|0|||
48453293|NCT00379236|155848120|FG000|Double-blind|Adverse Event|11|||
48453294|NCT00379236|155848121|FG001|Double-blind|Adverse Event|6|||
48453295|NCT00379236|155848122|FG002|Double-blind|Adverse Event|0|||
48453296|NCT00379236|155848120|FG000|Double-blind|Protocol Violation|3|||
48453297|NCT00379236|155848121|FG001|Double-blind|Protocol Violation|3|||
48453298|NCT00379236|155848122|FG002|Double-blind|Protocol Violation|0|||
48453299|NCT00379236|155848120|FG000|Double-blind|Withdrawal by Subject|12|||
48453300|NCT00379236|155848121|FG001|Double-blind|Withdrawal by Subject|13|||
48453301|NCT00379236|155848122|FG002|Double-blind|Withdrawal by Subject|0|||
48453302|NCT00379236|155848120|FG000|Double-blind|Lost to Follow-up|4|||
48453303|NCT00379236|155848121|FG001|Double-blind|Lost to Follow-up|3|||
48453304|NCT00379236|155848122|FG002|Double-blind|Lost to Follow-up|0|||
48453305|NCT00379236|155848120|FG000|Double-blind|Use of exclusionary medication|1|||
48453306|NCT00379236|155848121|FG001|Double-blind|Use of exclusionary medication|2|||
48453307|NCT00379236|155848122|FG002|Double-blind|Use of exclusionary medication|0|||
48453308|NCT00379236|155848120|FG000|Double-blind|Other|3|||
48453309|NCT00379236|155848121|FG001|Double-blind|Other|7|||
48453310|NCT00379236|155848122|FG002|Double-blind|Other|0|||
48453311|NCT00379236|155848120|FG000|Double-blind|Data could not be retrieved|2|||
48453312|NCT00379236|155848121|FG001|Double-blind|Data could not be retrieved|2|||
48453313|NCT00379236|155848122|FG002|Double-blind|Data could not be retrieved|0|||
48453314|NCT00379236|155848120|FG000|Open-label Extension|Adverse Event|0|||
48453315|NCT00379236|155848121|FG001|Open-label Extension|Adverse Event|0|||
48453316|NCT00379236|155848122|FG002|Open-label Extension|Adverse Event|13|||
48453317|NCT00379236|155848120|FG000|Open-label Extension|Protocol Violation|0|||
48453318|NCT00379236|155848121|FG001|Open-label Extension|Protocol Violation|0|||
48453319|NCT00379236|155848122|FG002|Open-label Extension|Protocol Violation|7|||
48453320|NCT00379236|155848120|FG000|Open-label Extension|Withdrawal by Subject|0|||
48453321|NCT00379236|155848121|FG001|Open-label Extension|Withdrawal by Subject|0|||
48453322|NCT00379236|155848122|FG002|Open-label Extension|Withdrawal by Subject|13|||
48453323|NCT00379236|155848120|FG000|Open-label Extension|Lost to Follow-up|0|||
48453324|NCT00379236|155848121|FG001|Open-label Extension|Lost to Follow-up|0|||
48453325|NCT00379236|155848122|FG002|Open-label Extension|Lost to Follow-up|12|||
48453326|NCT00379236|155848120|FG000|Open-label Extension|Use of exclusionary medication|0|||
48453327|NCT00379236|155848121|FG001|Open-label Extension|Use of exclusionary medication|0|||
48453328|NCT00379236|155848122|FG002|Open-label Extension|Use of exclusionary medication|3|||
48453329|NCT00379236|155848120|FG000|Open-label Extension|Other|0|||
48453330|NCT00379236|155848121|FG001|Open-label Extension|Other|0|||
48453331|NCT00379236|155848122|FG002|Open-label Extension|Other|7|||
48453332|NCT03565991|155848123|FG000|Overall Study|Other|11|||
48453333|NCT03565991|155848124|FG001|Overall Study|Other|0|||
48453334|NCT03565991|155848123|FG000|Overall Study|Global deterioration of health status|14|||
48453335|NCT03565991|155848124|FG001|Overall Study|Global deterioration of health status|4|||
48453336|NCT03565991|155848123|FG000|Overall Study|Withdrawal by Subject|2|||
48453337|NCT03565991|155848124|FG001|Overall Study|Withdrawal by Subject|6|||
48453338|NCT03565991|155848123|FG000|Overall Study|Progressive disease|121|||
48453339|NCT03565991|155848124|FG001|Overall Study|Progressive disease|29|||
48453340|NCT03565991|155848123|FG000|Overall Study|Death|3|||
48453341|NCT03565991|155848124|FG001|Overall Study|Death|0|||
48453342|NCT03565991|155848123|FG000|Overall Study|Adverse Event|7|||
48453343|NCT03565991|155848124|FG001|Overall Study|Adverse Event|2|||
48453344|NCT00520299|155848125|FG000|Overall Study|Withdrawal by Subject|0|||
48453345|NCT00520299|155848126|FG001|Overall Study|Withdrawal by Subject|0|||
48453346|NCT00520299|155848127|FG002|Overall Study|Withdrawal by Subject|2|||
48453347|NCT00520299|155848125|FG000|Overall Study|Progressive disease|0|||
48453348|NCT00520299|155848126|FG001|Overall Study|Progressive disease|3|||
48453349|NCT00520299|155848127|FG002|Overall Study|Progressive disease|4|||
48453350|NCT04624672|155848129|FG000|Overall Study|Early Study Closure|2|||
48453351|NCT04624672|155848130|FG001|Overall Study|Early Study Closure|1|||
48453352|NCT00106249|155848131|FG000|Overall Study|Lost to Follow-up|3|||
48453353|NCT00106249|155848132|FG001|Overall Study|Lost to Follow-up|2|||
48453354|NCT01235338|155848133|FG000|Overall Study|Adverse Event|3|||
48453355|NCT01235338|155848134|FG001|Overall Study|Adverse Event|2|||
48453356|NCT01235338|155848133|FG000|Overall Study|Protocol Violation|1|||
48453357|NCT01235338|155848134|FG001|Overall Study|Protocol Violation|1|||
48453358|NCT01235338|155848133|FG000|Overall Study|Withdrawal by Subject|5|||
48453359|NCT01235338|155848134|FG001|Overall Study|Withdrawal by Subject|0|||
48453360|NCT01235338|155848133|FG000|Overall Study|Exclusion criteria violations|1|||
48453361|NCT01235338|155848134|FG001|Overall Study|Exclusion criteria violations|1|||
48453362|NCT01235338|155848133|FG000|Overall Study|Positive drug screen|0|||
48453363|NCT01235338|155848134|FG001|Overall Study|Positive drug screen|1|||
48453364|NCT01235338|155848133|FG000|Overall Study|Prohibited meds|1|||
48453365|NCT01235338|155848134|FG001|Overall Study|Prohibited meds|0|||
48453366|NCT00948428|155848135|FG000|Overall Study|Withdrawal by Subject|6|||
48453367|NCT00948428|155848136|FG001|Overall Study|Withdrawal by Subject|12|||
48453368|NCT00948428|155848137|FG002|Overall Study|Withdrawal by Subject|7|||
48453369|NCT00948428|155848135|FG000|Overall Study|Adverse Event|6|||
48453370|NCT00948428|155848136|FG001|Overall Study|Adverse Event|3|||
48453371|NCT00948428|155848137|FG002|Overall Study|Adverse Event|0|||
48453372|NCT00948428|155848135|FG000|Overall Study|Lost to Follow-up|2|||
48453373|NCT00948428|155848136|FG001|Overall Study|Lost to Follow-up|1|||
48453374|NCT00948428|155848137|FG002|Overall Study|Lost to Follow-up|1|||
48453375|NCT00948428|155848135|FG000|Overall Study|Death|2|||
48453376|NCT00948428|155848136|FG001|Overall Study|Death|0|||
48453377|NCT00948428|155848137|FG002|Overall Study|Death|0|||
48453378|NCT00948428|155848135|FG000|Overall Study|Intercurrent Illness|1|||
48453379|NCT00948428|155848136|FG001|Overall Study|Intercurrent Illness|0|||
48453380|NCT00948428|155848137|FG002|Overall Study|Intercurrent Illness|0|||
48453381|NCT00948428|155848135|FG000|Overall Study|Non-compliance|1|||
48453382|NCT00948428|155848136|FG001|Overall Study|Non-compliance|2|||
48453383|NCT00948428|155848137|FG002|Overall Study|Non-compliance|0|||
48453384|NCT03518034|155848138|FG000|Overall Study|Not Treated|5|||
48453385|NCT03518034|155848139|FG001|Overall Study|Not Treated|1|||
48453386|NCT03518034|155848138|FG000|Overall Study|Withdrawal by Subject|309|||
48453387|NCT03518034|155848139|FG001|Overall Study|Withdrawal by Subject|351|||
48453388|NCT03518034|155848138|FG000|Overall Study|Lost to Follow-up|446|||
48453389|NCT03518034|155848139|FG001|Overall Study|Lost to Follow-up|458|||
48453390|NCT03518034|155848138|FG000|Overall Study|Adverse Event|138|||
48453391|NCT03518034|155848139|FG001|Overall Study|Adverse Event|130|||
48453392|NCT03518034|155848138|FG000|Overall Study|Lack of Efficacy|11|||
48453393|NCT03518034|155848139|FG001|Overall Study|Lack of Efficacy|23|||
48453394|NCT03518034|155848138|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
48453395|NCT03518034|155848139|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
48453396|NCT03518034|155848138|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
48453397|NCT03518034|155848139|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
48453398|NCT03518034|155848138|FG000|Overall Study|Other, Not Specified|84|||
48453399|NCT03518034|155848139|FG001|Overall Study|Other, Not Specified|53|||
48453400|NCT03518034|155848138|FG000|Overall Study|Reason Missing|2|||
48453401|NCT03518034|155848139|FG001|Overall Study|Reason Missing|3|||
48453402|NCT04067011|155848142|FG000|Overall Study|Not Treated|8|||
48453403|NCT04067011|155848143|FG001|Overall Study|Not Treated|7|||
48453404|NCT04067011|155848144|FG002|Overall Study|Not Treated|5|||
48453405|NCT04067011|155848142|FG000|Overall Study|Adverse Event|2|||
48453406|NCT04067011|155848143|FG001|Overall Study|Adverse Event|1|||
48453407|NCT04067011|155848144|FG002|Overall Study|Adverse Event|0|||
48453408|NCT04067011|155848142|FG000|Overall Study|Withdrawal by Subject|6|||
48453409|NCT04067011|155848143|FG001|Overall Study|Withdrawal by Subject|2|||
48453410|NCT04067011|155848144|FG002|Overall Study|Withdrawal by Subject|1|||
48453411|NCT04067011|155848142|FG000|Overall Study|Lost to Follow-up|0|||
48453412|NCT04067011|155848143|FG001|Overall Study|Lost to Follow-up|0|||
48453413|NCT04067011|155848144|FG002|Overall Study|Lost to Follow-up|1|||
48453414|NCT04067011|155848142|FG000|Overall Study|Physician Decision|1|||
48453415|NCT04067011|155848143|FG001|Overall Study|Physician Decision|1|||
48453416|NCT04067011|155848144|FG002|Overall Study|Physician Decision|0|||
48453417|NCT04067011|155848142|FG000|Overall Study|Other Reasons|2|||
48453418|NCT04067011|155848143|FG001|Overall Study|Other Reasons|0|||
48453419|NCT04067011|155848144|FG002|Overall Study|Other Reasons|1|||
48453420|NCT04067011|155848142|FG000|Overall Study|Missing|0|||
48453421|NCT04067011|155848143|FG001|Overall Study|Missing|2|||
48453422|NCT04067011|155848144|FG002|Overall Study|Missing|0|||
48453423|NCT00608881|155848145|FG000|Overall Study|Death|22|||
48453424|NCT00608881|155848146|FG001|Overall Study|Death|13|||
48453425|NCT00608881|155848145|FG000|Overall Study|Adverse Event|5|||
48453426|NCT00608881|155848146|FG001|Overall Study|Adverse Event|3|||
48453427|NCT00608881|155848145|FG000|Overall Study|Lost to Follow-up|28|||
48453428|NCT00608881|155848146|FG001|Overall Study|Lost to Follow-up|14|||
48453429|NCT00608881|155848145|FG000|Overall Study|Withdrawal by Subject|18|||
48453430|NCT00608881|155848146|FG001|Overall Study|Withdrawal by Subject|29|||
48453431|NCT00608881|155848145|FG000|Overall Study|Physician Decision|5|||
48453432|NCT00608881|155848146|FG001|Overall Study|Physician Decision|5|||
48453433|NCT00608881|155848145|FG000|Overall Study|Institutionalized|1|||
48453434|NCT00608881|155848146|FG001|Overall Study|Institutionalized|2|||
48453435|NCT00367341|155848149|FG000|Overall Study|Physician Decision|1|||
48453436|NCT00367341|155848150|FG001|Overall Study|Physician Decision|0|||
48453437|NCT00367341|155848149|FG000|Overall Study|Protocol Violation|1|||
48453438|NCT00367341|155848150|FG001|Overall Study|Protocol Violation|0|||
48453439|NCT00517413|155848151|FG000|Overall Study|Adverse Event|7|||
48453440|NCT00517413|155848151|FG000|Overall Study|Death|13|||
48453441|NCT00517413|155848151|FG000|Overall Study|Protocol Violation|15|||
48453442|NCT00517413|155848151|FG000|Overall Study|Withdrawal by Subject|2|||
48453443|NCT00517413|155848151|FG000|Overall Study|Failure to return|1|||
48453444|NCT00517413|155848151|FG000|Overall Study|Other-Reasons|23|||
48453445|NCT00369278|155848152|FG000|Overall Study|Adverse Event|14|||
48453446|NCT00369278|155848153|FG001|Overall Study|Adverse Event|11|||
48453447|NCT00369278|155848152|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
48453448|NCT00369278|155848153|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
48453449|NCT00369278|155848152|FG000|Overall Study|Protocol Violation|2|||
48453450|NCT00369278|155848153|FG001|Overall Study|Protocol Violation|1|||
48453451|NCT00369278|155848152|FG000|Overall Study|Withdrawal by Subject|2|||
48453452|NCT00369278|155848153|FG001|Overall Study|Withdrawal by Subject|2|||
48453453|NCT00369278|155848152|FG000|Overall Study|Lost to Follow-up|1|||
48453454|NCT00369278|155848153|FG001|Overall Study|Lost to Follow-up|0|||
48453455|NCT00369278|155848152|FG000|Overall Study|Graft loss|1|||
48453456|NCT00369278|155848153|FG001|Overall Study|Graft loss|2|||
48453457|NCT00865046|155848156|FG000|Overall Study|Lost to Follow-up|1|||
48453458|NCT00865046|155848157|FG001|Overall Study|Lost to Follow-up|4|||
48453459|NCT00865046|155848158|FG002|Overall Study|Lost to Follow-up|0|||
48453460|NCT00865046|155848156|FG000|Overall Study|Death|0|||
48453461|NCT00865046|155848157|FG001|Overall Study|Death|1|||
48453462|NCT00865046|155848158|FG002|Overall Study|Death|1|||
48453463|NCT00865046|155848156|FG000|Overall Study|Withdrawal by Subject|5|||
48453464|NCT00865046|155848157|FG001|Overall Study|Withdrawal by Subject|0|||
48453465|NCT00865046|155848158|FG002|Overall Study|Withdrawal by Subject|0|||
48453466|NCT01249157|155848162|FG000|Overall Study|Withdrawal by Subject|1|||
48453467|NCT03796195|155848165|FG000|Overall Study|Study closed early|1|||
48453468|NCT01390038|155848171|FG000|Overall Study|Death|1|||
48453469|NCT01390038|155848171|FG000|Overall Study|Lost to Follow-up|1|||
48453470|NCT01390038|155848171|FG000|Overall Study|Withdrawal by Subject|4|||
48453471|NCT01390038|155848171|FG000|Overall Study|Simpliciti System Removal|2|||
48453472|NCT03799627|155848175|FG000|Overall Study|Adverse Event|1|||
48453473|NCT03799627|155848176|FG001|Overall Study|Adverse Event|2|||
48453474|NCT03799627|155848177|FG002|Overall Study|Adverse Event|0|||
48453475|NCT03799627|155848178|FG003|Overall Study|Adverse Event|0|||
48453476|NCT03799627|155848179|FG004|Overall Study|Adverse Event|2|||
48453477|NCT03799627|155848180|FG005|Overall Study|Adverse Event|5|||
48453478|NCT03799627|155848181|FG006|Overall Study|Adverse Event|0|||
48453479|NCT03799627|155848182|FG007|Overall Study|Adverse Event|2|||
48453480|NCT03799627|155848183|FG008|Overall Study|Adverse Event|0|||
48453481|NCT03799627|155848175|FG000|Overall Study|Physician Decision|2|||
48453482|NCT03799627|155848176|FG001|Overall Study|Physician Decision|2|||
48453483|NCT03799627|155848177|FG002|Overall Study|Physician Decision|0|||
48453484|NCT03799627|155848178|FG003|Overall Study|Physician Decision|0|||
48453485|NCT03799627|155848179|FG004|Overall Study|Physician Decision|2|||
48453486|NCT03799627|155848180|FG005|Overall Study|Physician Decision|2|||
48453487|NCT03799627|155848181|FG006|Overall Study|Physician Decision|0|||
48453488|NCT03799627|155848182|FG007|Overall Study|Physician Decision|0|||
48453489|NCT03799627|155848183|FG008|Overall Study|Physician Decision|0|||
48453490|NCT03799627|155848175|FG000|Overall Study|Withdrawal by Subject|1|||
48453491|NCT03799627|155848176|FG001|Overall Study|Withdrawal by Subject|1|||
48453492|NCT03799627|155848177|FG002|Overall Study|Withdrawal by Subject|0|||
48453493|NCT03799627|155848178|FG003|Overall Study|Withdrawal by Subject|2|||
48453494|NCT03799627|155848179|FG004|Overall Study|Withdrawal by Subject|0|||
48453495|NCT03799627|155848180|FG005|Overall Study|Withdrawal by Subject|3|||
48453496|NCT03799627|155848181|FG006|Overall Study|Withdrawal by Subject|0|||
48453497|NCT03799627|155848182|FG007|Overall Study|Withdrawal by Subject|0|||
48453498|NCT03799627|155848183|FG008|Overall Study|Withdrawal by Subject|0|||
48453499|NCT03799627|155848175|FG000|Overall Study|Lack of Efficacy|0|||
48453500|NCT03799627|155848176|FG001|Overall Study|Lack of Efficacy|0|||
48453501|NCT03799627|155848177|FG002|Overall Study|Lack of Efficacy|0|||
48453502|NCT03799627|155848178|FG003|Overall Study|Lack of Efficacy|1|||
48453503|NCT03799627|155848179|FG004|Overall Study|Lack of Efficacy|0|||
48453504|NCT03799627|155848180|FG005|Overall Study|Lack of Efficacy|0|||
48453505|NCT03799627|155848181|FG006|Overall Study|Lack of Efficacy|0|||
48453506|NCT03799627|155848182|FG007|Overall Study|Lack of Efficacy|0|||
48453507|NCT03799627|155848183|FG008|Overall Study|Lack of Efficacy|0|||
48453508|NCT03799627|155848175|FG000|Overall Study|Lost to Follow-up|0|||
48453509|NCT03799627|155848176|FG001|Overall Study|Lost to Follow-up|0|||
48453510|NCT03799627|155848177|FG002|Overall Study|Lost to Follow-up|0|||
48453511|NCT03799627|155848178|FG003|Overall Study|Lost to Follow-up|0|||
48453512|NCT03799627|155848179|FG004|Overall Study|Lost to Follow-up|0|||
48453513|NCT03799627|155848180|FG005|Overall Study|Lost to Follow-up|0|||
48453514|NCT03799627|155848181|FG006|Overall Study|Lost to Follow-up|1|||
48453515|NCT03799627|155848182|FG007|Overall Study|Lost to Follow-up|0|||
48453516|NCT03799627|155848183|FG008|Overall Study|Lost to Follow-up|1|||
48453517|NCT03799627|155848175|FG000|Overall Study|Death|0|||
48453518|NCT03799627|155848176|FG001|Overall Study|Death|0|||
48453519|NCT03799627|155848177|FG002|Overall Study|Death|0|||
48453520|NCT03799627|155848178|FG003|Overall Study|Death|1|||
48453521|NCT03799627|155848179|FG004|Overall Study|Death|0|||
48453522|NCT03799627|155848180|FG005|Overall Study|Death|0|||
48453523|NCT03799627|155848181|FG006|Overall Study|Death|0|||
48453524|NCT03799627|155848182|FG007|Overall Study|Death|0|||
48453525|NCT03799627|155848183|FG008|Overall Study|Death|0|||
48453526|NCT03799627|155848175|FG000|Overall Study|Study Drug Put on Hold|1|||
48453527|NCT03799627|155848176|FG001|Overall Study|Study Drug Put on Hold|0|||
48453528|NCT03799627|155848177|FG002|Overall Study|Study Drug Put on Hold|0|||
48453529|NCT03799627|155848178|FG003|Overall Study|Study Drug Put on Hold|0|||
48453530|NCT03799627|155848179|FG004|Overall Study|Study Drug Put on Hold|0|||
48453531|NCT03799627|155848180|FG005|Overall Study|Study Drug Put on Hold|0|||
48453532|NCT03799627|155848181|FG006|Overall Study|Study Drug Put on Hold|0|||
48453533|NCT03799627|155848182|FG007|Overall Study|Study Drug Put on Hold|0|||
48453534|NCT03799627|155848183|FG008|Overall Study|Study Drug Put on Hold|0|||
48453535|NCT03799627|155848175|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
48453536|NCT03799627|155848176|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
48453537|NCT03799627|155848177|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
48453538|NCT03799627|155848178|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
48453539|NCT03799627|155848179|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
48453540|NCT03799627|155848180|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
48453541|NCT03799627|155848181|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
48453542|NCT03799627|155848182|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
48453543|NCT03799627|155848183|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
48453544|NCT03799627|155848175|FG000|Overall Study|Kidney Transplantation|1|||
48453545|NCT03799627|155848176|FG001|Overall Study|Kidney Transplantation|0|||
48453546|NCT03799627|155848177|FG002|Overall Study|Kidney Transplantation|0|||
48453547|NCT03799627|155848178|FG003|Overall Study|Kidney Transplantation|1|||
48453548|NCT03799627|155848179|FG004|Overall Study|Kidney Transplantation|1|||
48453549|NCT03799627|155848180|FG005|Overall Study|Kidney Transplantation|0|||
48453550|NCT03799627|155848181|FG006|Overall Study|Kidney Transplantation|0|||
48453551|NCT03799627|155848182|FG007|Overall Study|Kidney Transplantation|0|||
48453552|NCT03799627|155848183|FG008|Overall Study|Kidney Transplantation|0|||
48453553|NCT03799627|155848175|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
48453554|NCT03799627|155848176|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
48453555|NCT03799627|155848177|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
48453556|NCT03799627|155848178|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
48453557|NCT03799627|155848179|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
48453558|NCT03799627|155848180|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
48453559|NCT03799627|155848181|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
48453560|NCT03799627|155848182|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
48453561|NCT03799627|155848183|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
48453562|NCT03799627|155848175|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48453563|NCT03799627|155848176|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
48453564|NCT03799627|155848177|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48453565|NCT03799627|155848178|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48453566|NCT03799627|155848179|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48453567|NCT03799627|155848180|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48453568|NCT03799627|155848181|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48453569|NCT03799627|155848182|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48453570|NCT03799627|155848183|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
48453571|NCT03799627|155848175|FG000|Overall Study|Met Exclusion Criteria|0|||
48453572|NCT03799627|155848176|FG001|Overall Study|Met Exclusion Criteria|0|||
48453573|NCT03799627|155848177|FG002|Overall Study|Met Exclusion Criteria|0|||
48453574|NCT03799627|155848178|FG003|Overall Study|Met Exclusion Criteria|1|||
48453575|NCT03799627|155848179|FG004|Overall Study|Met Exclusion Criteria|0|||
48453576|NCT03799627|155848180|FG005|Overall Study|Met Exclusion Criteria|0|||
48453577|NCT03799627|155848181|FG006|Overall Study|Met Exclusion Criteria|0|||
48453578|NCT03799627|155848182|FG007|Overall Study|Met Exclusion Criteria|0|||
48453579|NCT03799627|155848183|FG008|Overall Study|Met Exclusion Criteria|0|||
48453580|NCT03799627|155848175|FG000|Overall Study|Investigational Product Noncompliance|0|||
48453581|NCT03799627|155848176|FG001|Overall Study|Investigational Product Noncompliance|0|||
48453582|NCT03799627|155848177|FG002|Overall Study|Investigational Product Noncompliance|0|||
48453583|NCT03799627|155848178|FG003|Overall Study|Investigational Product Noncompliance|1|||
48453584|NCT03799627|155848179|FG004|Overall Study|Investigational Product Noncompliance|0|||
48453585|NCT03799627|155848180|FG005|Overall Study|Investigational Product Noncompliance|0|||
48453586|NCT03799627|155848181|FG006|Overall Study|Investigational Product Noncompliance|0|||
48453587|NCT03799627|155848182|FG007|Overall Study|Investigational Product Noncompliance|0|||
48453588|NCT03799627|155848183|FG008|Overall Study|Investigational Product Noncompliance|0|||
48453589|NCT03799627|155848175|FG000|Overall Study|Participant Relocation|0|||
48453590|NCT03799627|155848176|FG001|Overall Study|Participant Relocation|0|||
48453591|NCT03799627|155848177|FG002|Overall Study|Participant Relocation|0|||
48453592|NCT03799627|155848178|FG003|Overall Study|Participant Relocation|1|||
48453593|NCT03799627|155848179|FG004|Overall Study|Participant Relocation|0|||
48453594|NCT03799627|155848180|FG005|Overall Study|Participant Relocation|1|||
48453595|NCT03799627|155848181|FG006|Overall Study|Participant Relocation|0|||
48453596|NCT03799627|155848182|FG007|Overall Study|Participant Relocation|0|||
48453597|NCT03799627|155848183|FG008|Overall Study|Participant Relocation|0|||
48453598|NCT03799627|155848175|FG000|Overall Study|Eurofin Issue|0|||
48453599|NCT03799627|155848176|FG001|Overall Study|Eurofin Issue|0|||
48453600|NCT03799627|155848177|FG002|Overall Study|Eurofin Issue|0|||
48453601|NCT03799627|155848178|FG003|Overall Study|Eurofin Issue|0|||
48453602|NCT03799627|155848179|FG004|Overall Study|Eurofin Issue|1|||
48453603|NCT03799627|155848180|FG005|Overall Study|Eurofin Issue|0|||
48453604|NCT03799627|155848181|FG006|Overall Study|Eurofin Issue|0|||
48453605|NCT03799627|155848182|FG007|Overall Study|Eurofin Issue|0|||
48453606|NCT03799627|155848183|FG008|Overall Study|Eurofin Issue|0|||
48453607|NCT03799627|155848175|FG000|Overall Study|Noncompliance with Site Instructions|0|||
48453608|NCT03799627|155848176|FG001|Overall Study|Noncompliance with Site Instructions|0|||
48453609|NCT03799627|155848177|FG002|Overall Study|Noncompliance with Site Instructions|0|||
48453610|NCT03799627|155848178|FG003|Overall Study|Noncompliance with Site Instructions|0|||
48453611|NCT03799627|155848179|FG004|Overall Study|Noncompliance with Site Instructions|1|||
48453612|NCT03799627|155848180|FG005|Overall Study|Noncompliance with Site Instructions|0|||
48453613|NCT03799627|155848181|FG006|Overall Study|Noncompliance with Site Instructions|0|||
48453614|NCT03799627|155848182|FG007|Overall Study|Noncompliance with Site Instructions|0|||
48453615|NCT03799627|155848183|FG008|Overall Study|Noncompliance with Site Instructions|0|||
48453616|NCT03799627|155848175|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48453617|NCT03799627|155848176|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48453618|NCT03799627|155848177|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48453619|NCT03799627|155848178|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48453620|NCT03799627|155848179|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
48453621|NCT03799627|155848180|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48453622|NCT03799627|155848181|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48453623|NCT03799627|155848182|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48453624|NCT03799627|155848183|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
48453625|NCT03799627|155848175|FG000|Overall Study|Changes In Hemoglobin Values|1|||
48453626|NCT03799627|155848176|FG001|Overall Study|Changes In Hemoglobin Values|2|||
48453627|NCT03799627|155848177|FG002|Overall Study|Changes In Hemoglobin Values|1|||
48453628|NCT03799627|155848178|FG003|Overall Study|Changes In Hemoglobin Values|0|||
48453629|NCT03799627|155848179|FG004|Overall Study|Changes In Hemoglobin Values|0|||
48453630|NCT03799627|155848180|FG005|Overall Study|Changes In Hemoglobin Values|2|||
48453631|NCT03799627|155848181|FG006|Overall Study|Changes In Hemoglobin Values|1|||
48453632|NCT03799627|155848182|FG007|Overall Study|Changes In Hemoglobin Values|0|||
48453633|NCT03799627|155848183|FG008|Overall Study|Changes In Hemoglobin Values|1|||
48453634|NCT00062647|155848188|FG000|Overall Study|Death|2|||
48453635|NCT00062647|155848189|FG001|Overall Study|Death|2|||
48453636|NCT00062647|155848188|FG000|Overall Study|Adverse Event|1|||
48453637|NCT00062647|155848189|FG001|Overall Study|Adverse Event|1|||
48453638|NCT00062647|155848188|FG000|Overall Study|Withdrawal by Subject|2|||
48453639|NCT00062647|155848189|FG001|Overall Study|Withdrawal by Subject|1|||
48453640|NCT00062647|155848188|FG000|Overall Study|Protocol Violation|1|||
48453641|NCT00062647|155848189|FG001|Overall Study|Protocol Violation|0|||
48453642|NCT00062647|155848188|FG000|Overall Study|Lost to Follow-up|1|||
48453643|NCT00062647|155848189|FG001|Overall Study|Lost to Follow-up|2|||
48453644|NCT00062647|155848188|FG000|Overall Study|Failed continuation criteria|4|||
48453645|NCT00062647|155848189|FG001|Overall Study|Failed continuation criteria|2|||
48453646|NCT00062647|155848188|FG000|Overall Study|Other|4|||
48453647|NCT00062647|155848189|FG001|Overall Study|Other|4|||
48453648|NCT00062647|155848188|FG000|Overall Study|Never received study treatment|1|||
48453649|NCT00062647|155848189|FG001|Overall Study|Never received study treatment|1|||
48453650|NCT04445051|155848191|FG000|Overall Study|Adverse Event|0|||
48453651|NCT04445051|155848192|FG001|Overall Study|Adverse Event|0|||
48453652|NCT04445051|155848193|FG002|Overall Study|Adverse Event|1|||
48453653|NCT04445051|155848194|FG003|Overall Study|Adverse Event|0|||
48453654|NCT04445051|155848195|FG004|Overall Study|Adverse Event|0|||
48453655|NCT04445051|155848196|FG005|Overall Study|Adverse Event|0|||
48453656|NCT01197794|155848200|FG000|Overall Study|Adverse Event|3|||
48453657|NCT01197794|155848201|FG001|Overall Study|Adverse Event|2|||
48453658|NCT01197794|155848202|FG002|Overall Study|Adverse Event|4|||
48453659|NCT01197794|155848203|FG003|Overall Study|Adverse Event|4|||
48453660|NCT01197794|155848204|FG004|Overall Study|Adverse Event|4|||
48453661|NCT01197794|155848205|FG005|Overall Study|Adverse Event|2|||
48453662|NCT01197794|155848206|FG006|Overall Study|Adverse Event|3|||
48453663|NCT01197794|155848200|FG000|Overall Study|Protocol Violation|0|||
48453664|NCT01197794|155848201|FG001|Overall Study|Protocol Violation|0|||
48453665|NCT01197794|155848202|FG002|Overall Study|Protocol Violation|0|||
48453666|NCT01197794|155848203|FG003|Overall Study|Protocol Violation|0|||
48453667|NCT01197794|155848204|FG004|Overall Study|Protocol Violation|2|||
48453668|NCT01197794|155848205|FG005|Overall Study|Protocol Violation|0|||
48453669|NCT01197794|155848206|FG006|Overall Study|Protocol Violation|1|||
48453670|NCT01197794|155848200|FG000|Overall Study|Development of study withdrawal criteria|3|||
48453671|NCT01197794|155848201|FG001|Overall Study|Development of study withdrawal criteria|0|||
48453672|NCT01197794|155848202|FG002|Overall Study|Development of study withdrawal criteria|0|||
48453673|NCT01197794|155848203|FG003|Overall Study|Development of study withdrawal criteria|1|||
48453674|NCT01197794|155848204|FG004|Overall Study|Development of study withdrawal criteria|0|||
48453675|NCT01197794|155848205|FG005|Overall Study|Development of study withdrawal criteria|0|||
48453676|NCT01197794|155848206|FG006|Overall Study|Development of study withdrawal criteria|1|||
48453677|NCT01197794|155848200|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
48453678|NCT01197794|155848201|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
48453679|NCT01197794|155848202|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
48453680|NCT01197794|155848203|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
48453681|NCT01197794|155848204|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
48453682|NCT01197794|155848205|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
48453683|NCT01197794|155848206|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
48453684|NCT01197794|155848200|FG000|Overall Study|Withdrawal by Subject|3|||
48453685|NCT01197794|155848201|FG001|Overall Study|Withdrawal by Subject|3|||
48453686|NCT01197794|155848202|FG002|Overall Study|Withdrawal by Subject|4|||
48453687|NCT01197794|155848203|FG003|Overall Study|Withdrawal by Subject|1|||
48453688|NCT01197794|155848204|FG004|Overall Study|Withdrawal by Subject|1|||
48453689|NCT01197794|155848205|FG005|Overall Study|Withdrawal by Subject|5|||
48453690|NCT01197794|155848206|FG006|Overall Study|Withdrawal by Subject|6|||
48453691|NCT01197794|155848200|FG000|Overall Study|Lost to Follow-up|1|||
48453692|NCT01197794|155848201|FG001|Overall Study|Lost to Follow-up|1|||
48453693|NCT01197794|155848202|FG002|Overall Study|Lost to Follow-up|0|||
48453694|NCT01197794|155848203|FG003|Overall Study|Lost to Follow-up|1|||
48453695|NCT01197794|155848204|FG004|Overall Study|Lost to Follow-up|0|||
48453696|NCT01197794|155848205|FG005|Overall Study|Lost to Follow-up|1|||
48453697|NCT01197794|155848206|FG006|Overall Study|Lost to Follow-up|0|||
48453698|NCT01197794|155848200|FG000|Overall Study|Other|1|||
48453699|NCT01197794|155848201|FG001|Overall Study|Other|1|||
48453700|NCT01197794|155848202|FG002|Overall Study|Other|3|||
48453701|NCT01197794|155848203|FG003|Overall Study|Other|0|||
48453702|NCT01197794|155848204|FG004|Overall Study|Other|2|||
48453703|NCT01197794|155848205|FG005|Overall Study|Other|2|||
48453704|NCT01197794|155848206|FG006|Overall Study|Other|4|||
48453705|NCT02392468|155848215|FG000|Overall Study|Adverse Event|0|||
48453706|NCT02392468|155848216|FG001|Overall Study|Adverse Event|1|||
48453707|NCT02392468|155848217|FG002|Overall Study|Adverse Event|0|||
48453708|NCT02392468|155848218|FG003|Overall Study|Adverse Event|0|||
48453709|NCT02392468|155848219|FG004|Overall Study|Adverse Event|0|||
48453710|NCT02392468|155848220|FG005|Overall Study|Adverse Event|1|||
48453711|NCT02092324|155848221|FG000|Overall Study|Adverse Event|1|||
48453712|NCT02092324|155848221|FG000|Overall Study|Lack of Efficacy|6|||
48453713|NCT02092324|155848221|FG000|Overall Study|Proceed to Transplant|3|||
48453714|NCT02092324|155848221|FG000|Overall Study|Physician Decision|7|||
48453715|NCT02092324|155848221|FG000|Overall Study|Misdiagnosis|2|||
48453716|NCT00368472|155848226|FG000|Overall Study|Adverse Event|22|||
48453717|NCT00368472|155848226|FG000|Overall Study|Medication non-compliance|4|||
48453718|NCT00368472|155848226|FG000|Overall Study|Protocol Violation|2|||
48453719|NCT00368472|155848226|FG000|Overall Study|Request of Investigator or Sponsor|3|||
48453720|NCT00368472|155848226|FG000|Overall Study|Withdrawal by Subject|40|||
48453721|NCT00368472|155848226|FG000|Overall Study|Diary non-compliance|1|||
48453722|NCT00368472|155848226|FG000|Overall Study|Other|32|||
48453723|NCT00368472|155848226|FG000|Overall Study|Missing Final Disposition Date|1|||
48453724|NCT03039569|155848227|FG000|Overall Study|Lost to Follow-up|5|||
48453725|NCT03039569|155848228|FG001|Overall Study|Lost to Follow-up|4|||
48453726|NCT00002981|155848229|FG000|Overall Study|Inevaluable|6|||
48453727|NCT03457636|155848232|FG000|Overall Study|Lost to Follow-up|2|||
48453728|NCT03619837|155848236|FG000|Screening|received organs from HCV-negative donors|47|||
48453729|NCT03619837|155848236|FG000|Screening|died on the wait-list|2|||
48453730|NCT03619837|155848236|FG000|Screening|remained on the wait list|40|||
48453731|NCT03619837|155848236|FG000|Screening|didn't meet eligibility criteria|3|||
48453732|NCT03619837|155848236|FG000|Screening|withdrew consent|2|||
48453733|NCT03619837|155848236|FG000|Screening|never listed for HCV-viremic donor|1|||
48453734|NCT03619837|155848236|FG000|Screening|developed exclusion criteria|2|||
48453735|NCT03619837|155848236|FG000|Screening|excluded by the investigator due to non-compliance|1|||
48453736|NCT02384993|155848237|FG000|Overall Study|Adverse Event|0|||
48453737|NCT02384993|155848238|FG001|Overall Study|Adverse Event|1|||
48453738|NCT02724111|155848239|FG000|Overall Study|Protocol Violation|2|||
48453739|NCT02724111|155848240|FG001|Overall Study|Protocol Violation|5|||
48453740|NCT04095793|155848241|FG000|Overall Study|Adverse Event|3|||
48453741|NCT04095793|155848241|FG000|Overall Study|Study Terminated by Sponsor|103|||
48453742|NCT04095793|155848241|FG000|Overall Study|Withdrawal by Subject|4|||
48453743|NCT02332798|155848244|FG000|Overall Study|Unwilling to Participate in Study|0|||
48453744|NCT02332798|155848245|FG001|Overall Study|Unwilling to Participate in Study|1|||
48453745|NCT02332798|155848246|FG002|Overall Study|Unwilling to Participate in Study|1|||
48453746|NCT02332798|155848244|FG000|Overall Study|Positive Urine Drug Test|0|||
48453747|NCT02332798|155848245|FG001|Overall Study|Positive Urine Drug Test|1|||
48453748|NCT02332798|155848246|FG002|Overall Study|Positive Urine Drug Test|0|||
48453749|NCT02332798|155848244|FG000|Overall Study|Abnormal Laboratory Findings|1|||
48453750|NCT02332798|155848245|FG001|Overall Study|Abnormal Laboratory Findings|0|||
48453751|NCT02332798|155848246|FG002|Overall Study|Abnormal Laboratory Findings|0|||
48453752|NCT00422240|155848252|FG000|Overall Study|Lack of Efficacy|1|||
48453753|NCT00422240|155848253|FG001|Overall Study|Lack of Efficacy|2|||
48453754|NCT00422240|155848254|FG002|Overall Study|Lack of Efficacy|0|||
48453755|NCT00422240|155848255|FG003|Overall Study|Lack of Efficacy|1|||
48453756|NCT00422240|155848252|FG000|Overall Study|Adverse Event|11|||
48453757|NCT00422240|155848253|FG001|Overall Study|Adverse Event|4|||
48453758|NCT00422240|155848254|FG002|Overall Study|Adverse Event|5|||
48453759|NCT00422240|155848255|FG003|Overall Study|Adverse Event|2|||
48453760|NCT00422240|155848252|FG000|Overall Study|Subject request|21|||
48453761|NCT00422240|155848253|FG001|Overall Study|Subject request|17|||
48453762|NCT00422240|155848254|FG002|Overall Study|Subject request|18|||
48453763|NCT00422240|155848255|FG003|Overall Study|Subject request|30|||
48453764|NCT00422240|155848252|FG000|Overall Study|Protocol Violation|0|||
48453765|NCT00422240|155848253|FG001|Overall Study|Protocol Violation|1|||
48453766|NCT00422240|155848254|FG002|Overall Study|Protocol Violation|0|||
48453767|NCT00422240|155848255|FG003|Overall Study|Protocol Violation|1|||
48453768|NCT00422240|155848252|FG000|Overall Study|Lost to Follow-up|31|||
48453769|NCT00422240|155848253|FG001|Overall Study|Lost to Follow-up|32|||
48453770|NCT00422240|155848254|FG002|Overall Study|Lost to Follow-up|19|||
48453771|NCT00422240|155848255|FG003|Overall Study|Lost to Follow-up|34|||
48453772|NCT00422240|155848252|FG000|Overall Study|Other|1|||
48453773|NCT00422240|155848253|FG001|Overall Study|Other|0|||
48453774|NCT00422240|155848254|FG002|Overall Study|Other|0|||
48453775|NCT00422240|155848255|FG003|Overall Study|Other|1|||
48453776|NCT00422240|155848252|FG000|Overall Study|Pregnancy|3|||
48453777|NCT00422240|155848253|FG001|Overall Study|Pregnancy|1|||
48453778|NCT00422240|155848254|FG002|Overall Study|Pregnancy|1|||
48453779|NCT00422240|155848255|FG003|Overall Study|Pregnancy|2|||
48453780|NCT02688153|155849917|FG000|Overall Study|Death|7|||
48453781|NCT02688153|155849918|FG001|Overall Study|Death|5|||
48453782|NCT02688153|155849917|FG000|Overall Study|Withdrawal by Subject|4|||
48453783|NCT02688153|155849918|FG001|Overall Study|Withdrawal by Subject|2|||
48453784|NCT02688153|155849917|FG000|Overall Study|Valve Explant|1|||
48453785|NCT02688153|155849918|FG001|Overall Study|Valve Explant|0|||
48453786|NCT02688153|155849917|FG000|Overall Study|Conversion to Commercial Valve|3|||
48453787|NCT02688153|155849918|FG001|Overall Study|Conversion to Commercial Valve|0|||
48453788|NCT02043509|155849919|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
48453789|NCT02043509|155849920|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
48453790|NCT02043509|155849919|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
48453791|NCT02043509|155849920|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
48453792|NCT02043509|155849919|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
48453793|NCT02043509|155849920|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
48453794|NCT02043509|155849919|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
48453795|NCT02043509|155849920|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
48453796|NCT00191386|155849921|FG000|Overall Study|Adverse Event|16|||
48453797|NCT00191386|155849921|FG000|Overall Study|Lost to Follow-up|1|||
48453798|NCT00191386|155849921|FG000|Overall Study|Entry Criteria Exclusion|3|||
48453799|NCT00191386|155849921|FG000|Overall Study|Protocol Violation|18|||
48453800|NCT00191386|155849921|FG000|Overall Study|Withdrawal by Subject|96|||
48453801|NCT00191386|155849921|FG000|Overall Study|Physician Decision|11|||
48453802|NCT00191386|155849921|FG000|Overall Study|Lack of Efficacy|15|||
48453803|NCT00446641|155849922|FG000|Overall Study|Withdrawal by Subject|8|||
48453804|NCT00446641|155849923|FG001|Overall Study|Withdrawal by Subject|3|||
48453805|NCT00446641|155849922|FG000|Overall Study|poor compliance|8|||
48453806|NCT00446641|155849923|FG001|Overall Study|poor compliance|6|||
48453807|NCT00446641|155849922|FG000|Overall Study|Lost to Follow-up|1|||
48453808|NCT00446641|155849923|FG001|Overall Study|Lost to Follow-up|1|||
48453809|NCT01826448|155849929|FG000|Overall Study|Adverse Event|1|||
48453810|NCT01826448|155849930|FG001|Overall Study|Adverse Event|3|||
48453811|NCT01826448|155849929|FG000|Overall Study|Disease progression|2|||
48453812|NCT01826448|155849930|FG001|Overall Study|Disease progression|4|||
48453813|NCT01826448|155849929|FG000|Overall Study|Withdrawal by Subject|1|||
48453814|NCT01826448|155849930|FG001|Overall Study|Withdrawal by Subject|0|||
48453815|NCT01826448|155849929|FG000|Overall Study|Physician Decision|0|||
48453816|NCT01826448|155849930|FG001|Overall Study|Physician Decision|1|||
48453817|NCT01826448|155849929|FG000|Overall Study|2 active cancers|0|||
48453818|NCT01826448|155849930|FG001|Overall Study|2 active cancers|1|||
48453819|NCT01352845|155849931|FG000|Overall Study|Lost to Follow-up|313|||
48453820|NCT01352845|155849932|FG001|Overall Study|Lost to Follow-up|92|||
48453821|NCT01352845|155849931|FG000|Overall Study|No Longer Willing to Participate|205|||
48453822|NCT01352845|155849932|FG001|Overall Study|No Longer Willing to Participate|58|||
48453823|NCT01352845|155849931|FG000|Overall Study|Withdrawal by Subject|48|||
48453824|NCT01352845|155849932|FG001|Overall Study|Withdrawal by Subject|16|||
48453825|NCT01352845|155849931|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
48453826|NCT01352845|155849932|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
48453827|NCT01352845|155849931|FG000|Overall Study|Pregnancy|27|||
48453828|NCT01352845|155849932|FG001|Overall Study|Pregnancy|7|||
48453829|NCT01352845|155849931|FG000|Overall Study|Adverse Event|22|||
48453830|NCT01352845|155849932|FG001|Overall Study|Adverse Event|6|||
48453831|NCT01352845|155849931|FG000|Overall Study|Other|17|||
48453832|NCT01352845|155849932|FG001|Overall Study|Other|7|||
48453833|NCT01352845|155849931|FG000|Overall Study|Protocol Violation|12|||
48453834|NCT01352845|155849932|FG001|Overall Study|Protocol Violation|6|||
48453835|NCT01352845|155849931|FG000|Overall Study|Death|3|||
48453836|NCT01352845|155849932|FG001|Overall Study|Death|0|||
48453837|NCT02204410|155849933|FG000|Overall Study|Lost to Follow-up|5|||
48453838|NCT02204410|155849933|FG000|Overall Study|Physician Decision|2|||
48453839|NCT02204410|155849933|FG000|Overall Study|Protocol Violation|1|||
48453840|NCT02204410|155849933|FG000|Overall Study|Withdrawal by Subject|3|||
48453841|NCT02959970|155849943|FG000|Overall Study|Adverse Event|1|||
48453842|NCT02959970|155849944|FG001|Overall Study|Adverse Event|0|||
48453843|NCT02959970|155849943|FG000|Overall Study|Withdrawal by Subject|0|||
48453844|NCT02959970|155849944|FG001|Overall Study|Withdrawal by Subject|2|||
48453845|NCT02959970|155849943|FG000|Overall Study|Lost to Follow-up|1|||
48453846|NCT02959970|155849944|FG001|Overall Study|Lost to Follow-up|5|||
48453847|NCT02327078|155849945|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
48453848|NCT02327078|155849946|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
48453849|NCT02327078|155849947|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
48453850|NCT02327078|155849948|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
48453851|NCT02327078|155849949|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
48453852|NCT02327078|155849950|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
48453853|NCT02327078|155849951|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
48453854|NCT02327078|155849952|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
48453855|NCT02327078|155849953|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
48453856|NCT02327078|155849945|FG000|Overall Study|Death|2|||
48453857|NCT02327078|155849946|FG001|Overall Study|Death|4|||
48453858|NCT02327078|155849947|FG002|Overall Study|Death|10|||
48453859|NCT02327078|155849948|FG003|Overall Study|Death|6|||
48453860|NCT02327078|155849949|FG004|Overall Study|Death|4|||
48453861|NCT02327078|155849950|FG005|Overall Study|Death|3|||
48453862|NCT02327078|155849951|FG006|Overall Study|Death|2|||
48453863|NCT02327078|155849952|FG007|Overall Study|Death|51|||
48453864|NCT02327078|155849953|FG008|Overall Study|Death|97|||
48453865|NCT02327078|155849945|FG000|Overall Study|Lost to Follow-up|0|||
48453866|NCT02327078|155849946|FG001|Overall Study|Lost to Follow-up|1|||
48453867|NCT02327078|155849947|FG002|Overall Study|Lost to Follow-up|1|||
48453868|NCT02327078|155849948|FG003|Overall Study|Lost to Follow-up|0|||
48453869|NCT02327078|155849949|FG004|Overall Study|Lost to Follow-up|0|||
48453870|NCT02327078|155849950|FG005|Overall Study|Lost to Follow-up|0|||
48453871|NCT02327078|155849951|FG006|Overall Study|Lost to Follow-up|0|||
48453872|NCT02327078|155849952|FG007|Overall Study|Lost to Follow-up|2|||
48453873|NCT02327078|155849953|FG008|Overall Study|Lost to Follow-up|5|||
48453874|NCT02327078|155849945|FG000|Overall Study|Site Terminated by Sponsor|1|||
48453875|NCT02327078|155849946|FG001|Overall Study|Site Terminated by Sponsor|0|||
48453876|NCT02327078|155849947|FG002|Overall Study|Site Terminated by Sponsor|1|||
48453877|NCT02327078|155849948|FG003|Overall Study|Site Terminated by Sponsor|4|||
48453878|NCT02327078|155849949|FG004|Overall Study|Site Terminated by Sponsor|0|||
48453879|NCT02327078|155849950|FG005|Overall Study|Site Terminated by Sponsor|0|||
48453880|NCT02327078|155849951|FG006|Overall Study|Site Terminated by Sponsor|0|||
48453881|NCT02327078|155849952|FG007|Overall Study|Site Terminated by Sponsor|11|||
48453882|NCT02327078|155849953|FG008|Overall Study|Site Terminated by Sponsor|25|||
48453883|NCT02327078|155849945|FG000|Overall Study|Physician Decision|0|||
48453884|NCT02327078|155849946|FG001|Overall Study|Physician Decision|0|||
48453885|NCT02327078|155849947|FG002|Overall Study|Physician Decision|0|||
48453886|NCT02327078|155849948|FG003|Overall Study|Physician Decision|1|||
48453887|NCT02327078|155849949|FG004|Overall Study|Physician Decision|0|||
48453888|NCT02327078|155849950|FG005|Overall Study|Physician Decision|0|||
48453889|NCT02327078|155849951|FG006|Overall Study|Physician Decision|0|||
48453890|NCT02327078|155849952|FG007|Overall Study|Physician Decision|0|||
48453891|NCT02327078|155849953|FG008|Overall Study|Physician Decision|1|||
48453892|NCT02327078|155849945|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
48453893|NCT02327078|155849946|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
48453894|NCT02327078|155849947|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
48453895|NCT02327078|155849948|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
48453896|NCT02327078|155849949|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
48453897|NCT02327078|155849950|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
48453898|NCT02327078|155849951|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
48453899|NCT02327078|155849952|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
48453900|NCT02327078|155849953|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
48453901|NCT02327078|155849945|FG000|Overall Study|Reason not Specified|0|||
48453902|NCT02327078|155849946|FG001|Overall Study|Reason not Specified|0|||
48453903|NCT02327078|155849947|FG002|Overall Study|Reason not Specified|0|||
48453904|NCT02327078|155849948|FG003|Overall Study|Reason not Specified|0|||
48453905|NCT02327078|155849949|FG004|Overall Study|Reason not Specified|0|||
48453906|NCT02327078|155849950|FG005|Overall Study|Reason not Specified|0|||
48453907|NCT02327078|155849951|FG006|Overall Study|Reason not Specified|0|||
48453908|NCT02327078|155849952|FG007|Overall Study|Reason not Specified|5|||
48453909|NCT02327078|155849953|FG008|Overall Study|Reason not Specified|12|||
48453910|NCT03250624|155849965|FG000|Overall Study|Lack of Efficacy|1|||
48453911|NCT03250624|155849966|FG001|Overall Study|Lack of Efficacy|4|||
48453912|NCT03250624|155849965|FG000|Overall Study|Adverse Event|0|||
48453913|NCT03250624|155849966|FG001|Overall Study|Adverse Event|1|||
48453914|NCT03250624|155849965|FG000|Overall Study|Other|1|||
48453915|NCT03250624|155849966|FG001|Overall Study|Other|2|||
48453916|NCT02809118|155849970|FG000|Overall Study|Withdrawal by Subject|0|||
48453917|NCT02809118|155849971|FG001|Overall Study|Withdrawal by Subject|1|||
48453918|NCT02809118|155849972|FG002|Overall Study|Withdrawal by Subject|1|||
48453919|NCT00093470|155849975|FG000|Overall Study|Disease progression|39|||
48453920|NCT00093470|155849976|FG001|Overall Study|Disease progression|0|||
48453921|NCT00093470|155849975|FG000|Overall Study|Adverse Event|15|||
48453922|NCT00093470|155849976|FG001|Overall Study|Adverse Event|0|||
48453923|NCT00093470|155849975|FG000|Overall Study|Death|2|||
48453924|NCT00093470|155849976|FG001|Overall Study|Death|0|||
48453925|NCT00093470|155849975|FG000|Overall Study|Withdrawal by Subject|8|||
48453926|NCT00093470|155849976|FG001|Overall Study|Withdrawal by Subject|0|||
48453927|NCT00093470|155849975|FG000|Overall Study|Alternative therapy|2|||
48453928|NCT00093470|155849976|FG001|Overall Study|Alternative therapy|0|||
48453929|NCT00093470|155849975|FG000|Overall Study|Other complicating disease|3|||
48453930|NCT00093470|155849976|FG001|Overall Study|Other complicating disease|0|||
48453931|NCT00093470|155849975|FG000|Overall Study|Physician Decision|2|||
48453932|NCT00093470|155849976|FG001|Overall Study|Physician Decision|0|||
48453933|NCT00093470|155849975|FG000|Overall Study|Never started treatment|1|||
48453934|NCT00093470|155849976|FG001|Overall Study|Never started treatment|0|||
48453935|NCT00093470|155849975|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
48453936|NCT00093470|155849976|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
48453937|NCT00247273|155849977|FG000|Overall Study|Adverse Event|85|||
48453938|NCT00247273|155849978|FG001|Overall Study|Adverse Event|80|||
48453939|NCT00247273|155849977|FG000|Overall Study|Physician Decision|6|||
48453940|NCT00247273|155849978|FG001|Overall Study|Physician Decision|3|||
48453941|NCT00247273|155849977|FG000|Overall Study|Lost to Follow-up|7|||
48453942|NCT00247273|155849978|FG001|Overall Study|Lost to Follow-up|7|||
48453943|NCT00247273|155849977|FG000|Overall Study|Withdrawal by Subject|46|||
48453944|NCT00247273|155849978|FG001|Overall Study|Withdrawal by Subject|47|||
48453945|NCT00247273|155849977|FG000|Overall Study|Did not take any study drug|2|||
48453946|NCT00247273|155849978|FG001|Overall Study|Did not take any study drug|0|||
48453947|NCT00524043|155849979|FG000|Overall Study|Lack of Efficacy|15|||
48453948|NCT00524043|155849980|FG001|Overall Study|Lack of Efficacy|13|||
48453949|NCT00524043|155849981|FG002|Overall Study|Lack of Efficacy|14|||
48453950|NCT00524043|155849979|FG000|Overall Study|Withdrawal by Subject|5|||
48453951|NCT00524043|155849980|FG001|Overall Study|Withdrawal by Subject|7|||
48453952|NCT00524043|155849981|FG002|Overall Study|Withdrawal by Subject|7|||
48453953|NCT00524043|155849979|FG000|Overall Study|Adverse Event|5|||
48453954|NCT00524043|155849980|FG001|Overall Study|Adverse Event|2|||
48453955|NCT00524043|155849981|FG002|Overall Study|Adverse Event|7|||
48453956|NCT00524043|155849979|FG000|Overall Study|Lost to Follow-up|3|||
48453957|NCT00524043|155849980|FG001|Overall Study|Lost to Follow-up|5|||
48453958|NCT00524043|155849981|FG002|Overall Study|Lost to Follow-up|3|||
48453959|NCT00524043|155849979|FG000|Overall Study|Various (eg, incarceration)|2|||
48453960|NCT00524043|155849980|FG001|Overall Study|Various (eg, incarceration)|1|||
48453961|NCT00524043|155849981|FG002|Overall Study|Various (eg, incarceration)|0|||
48453962|NCT00985738|155849983|FG000|Overall Study|Study closed prematurely|8|||
48453963|NCT00985738|155849984|FG001|Overall Study|Study closed prematurely|8|||
48453964|NCT00606177|155849991|FG000|Overall Study|Adverse Event|9|||
48453965|NCT00606177|155849992|FG001|Overall Study|Adverse Event|5|||
48453966|NCT00606177|155849991|FG000|Overall Study|Lack of Efficacy|3|||
48453967|NCT00606177|155849992|FG001|Overall Study|Lack of Efficacy|7|||
48453968|NCT00606177|155849991|FG000|Overall Study|Physician Decision|1|||
48453969|NCT00606177|155849992|FG001|Overall Study|Physician Decision|0|||
48453970|NCT00606177|155849991|FG000|Overall Study|Protocol Violation|1|||
48453971|NCT00606177|155849992|FG001|Overall Study|Protocol Violation|4|||
48453972|NCT00606177|155849991|FG000|Overall Study|Withdrawal by Subject|5|||
48453973|NCT00606177|155849992|FG001|Overall Study|Withdrawal by Subject|6|||
48453974|NCT00606177|155849991|FG000|Overall Study|Progression to depressive phase|6|||
48453975|NCT00606177|155849992|FG001|Overall Study|Progression to depressive phase|1|||
48453976|NCT00606177|155849991|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
48453977|NCT00606177|155849992|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
48453978|NCT00606177|155849991|FG000|Overall Study|Change of residence or other commitments|1|||
48453979|NCT00606177|155849992|FG001|Overall Study|Change of residence or other commitments|1|||
48453980|NCT02244619|155849995|FG000|Overall Study|Did not receive study intervention|8|||
48453981|NCT02244619|155849996|FG001|Overall Study|Did not receive study intervention|21|||
48453982|NCT00445341|155849997|FG000|Overall Study|refused further treatment|1|||
48453983|NCT00445341|155849997|FG000|Overall Study|taken off treatment too early|1|||
48453984|NCT02873208|155850000|FG000|Overall Study|Withdrawal by Subject|36|||
48453985|NCT02873208|155850000|FG000|Overall Study|Lost to Follow-up|22|||
48453986|NCT02873208|155850000|FG000|Overall Study|Adverse Event|15|||
48453987|NCT02873208|155850000|FG000|Overall Study|Non-compliance with study drug|12|||
48453988|NCT02873208|155850000|FG000|Overall Study|Protocol Violation|8|||
48453989|NCT02873208|155850000|FG000|Overall Study|Pregnancy|2|||
48453990|NCT02873208|155850000|FG000|Overall Study|Incarceration|1|||
48453991|NCT02873208|155850000|FG000|Overall Study|Lack of Efficacy|1|||
48453992|NCT02873208|155850000|FG000|Overall Study|Physician Decision|1|||
48453993|NCT00732641|155850007|FG000|Overall Study|Relapse or Progressive Disease|65|||
48453994|NCT00732641|155850008|FG001|Overall Study|Relapse or Progressive Disease|101|||
48453995|NCT00732641|155850007|FG000|Overall Study|Serious Adverse Events|12|||
48453996|NCT00732641|155850008|FG001|Overall Study|Serious Adverse Events|3|||
48453997|NCT00732641|155850007|FG000|Overall Study|Physician Decision|6|||
48453998|NCT00732641|155850008|FG001|Overall Study|Physician Decision|0|||
48453999|NCT00732641|155850007|FG000|Overall Study|Withdrawal by Subject|4|||
48454000|NCT00732641|155850008|FG001|Overall Study|Withdrawal by Subject|2|||
48454001|NCT00732641|155850007|FG000|Overall Study|Unable to Complete|1|||
48454002|NCT00732641|155850008|FG001|Overall Study|Unable to Complete|1|||
48454003|NCT00732641|155850007|FG000|Overall Study|Other|18|||
48454004|NCT00732641|155850008|FG001|Overall Study|Other|5|||
48454005|NCT00420342|155850009|FG000|Overall Study|Lost to Follow-up|1|||
48454006|NCT00420342|155850010|FG001|Overall Study|Lost to Follow-up|0|||
48454007|NCT00420342|155850011|FG002|Overall Study|Lost to Follow-up|1|||
48454008|NCT00420342|155850009|FG000|Overall Study|Withdrawal by Subject|0|||
48454009|NCT00420342|155850010|FG001|Overall Study|Withdrawal by Subject|2|||
48454010|NCT00420342|155850011|FG002|Overall Study|Withdrawal by Subject|0|||
48454011|NCT00003838|155850012|FG000|Overall Study|Death|0|||
48454012|NCT00003838|155850013|FG001|Overall Study|Death|12|||
48454013|NCT00003838|155850014|FG002|Overall Study|Death|7|||
48454014|NCT00003838|155850012|FG000|Overall Study|Lost to Follow-up|0|||
48454015|NCT00003838|155850013|FG001|Overall Study|Lost to Follow-up|1|||
48454016|NCT00003838|155850014|FG002|Overall Study|Lost to Follow-up|1|||
48454017|NCT00003838|155850012|FG000|Overall Study|Disease Progression|0|||
48454018|NCT00003838|155850013|FG001|Overall Study|Disease Progression|12|||
48454019|NCT00003838|155850014|FG002|Overall Study|Disease Progression|0|||
48454020|NCT01024920|155850015|FG000|Overall Study|Progressive disease|47|||
48454021|NCT01024920|155850016|FG001|Overall Study|Progressive disease|25|||
48454022|NCT01024920|155850015|FG000|Overall Study|Adverse Event|8|||
48454023|NCT01024920|155850016|FG001|Overall Study|Adverse Event|4|||
48454024|NCT01024920|155850015|FG000|Overall Study|Lost to Follow-up|0|||
48454025|NCT01024920|155850016|FG001|Overall Study|Lost to Follow-up|1|||
48454026|NCT01024920|155850015|FG000|Overall Study|Patient refusal to continue|4|||
48454027|NCT01024920|155850016|FG001|Overall Study|Patient refusal to continue|0|||
48454028|NCT01024920|155850015|FG000|Overall Study|Other than listed|5|||
48454029|NCT01024920|155850016|FG001|Overall Study|Other than listed|1|||
48454030|NCT01024920|155850015|FG000|Overall Study|Not treated|3|||
48454031|NCT01024920|155850016|FG001|Overall Study|Not treated|0|||
48454032|NCT01024920|155850015|FG000|Overall Study|Protocol Violation|0|||
48454033|NCT01024920|155850016|FG001|Overall Study|Protocol Violation|1|||
48454034|NCT01688999|155850017|FG000|Overall Study|Withdrawal by Subject|5|||
48454035|NCT01688999|155850018|FG001|Overall Study|Withdrawal by Subject|1|||
48454036|NCT01688999|155850019|FG002|Overall Study|Withdrawal by Subject|1|||
48454037|NCT01688999|155850017|FG000|Overall Study|Adverse Event|2|||
48454038|NCT01688999|155850018|FG001|Overall Study|Adverse Event|0|||
48454039|NCT01688999|155850019|FG002|Overall Study|Adverse Event|2|||
48454040|NCT01688999|155850017|FG000|Overall Study|Ineligible/Not treated|1|||
48454041|NCT01688999|155850018|FG001|Overall Study|Ineligible/Not treated|0|||
48454042|NCT01688999|155850019|FG002|Overall Study|Ineligible/Not treated|0|||
48454043|NCT02708966|155850020|FG000|Overall Study|Lost to Follow-up|2|||
48454044|NCT02708966|155850021|FG001|Overall Study|Lost to Follow-up|2|||
48454045|NCT02959190|155850023|FG000|Open Label|Adverse Event|5|||
48454046|NCT02959190|155850024|FG001|Open Label|Adverse Event|7|||
48454047|NCT02959190|155850025|FG002|Open Label|Adverse Event|3|||
48454048|NCT02959190|155850026|FG003|Open Label|Adverse Event|4|||
48454049|NCT02959190|155850023|FG000|Open Label|Pregnancy|0|||
48454050|NCT02959190|155850024|FG001|Open Label|Pregnancy|1|||
48454051|NCT02959190|155850025|FG002|Open Label|Pregnancy|0|||
48454052|NCT02959190|155850026|FG003|Open Label|Pregnancy|0|||
48454053|NCT02959190|155850023|FG000|Open Label|Withdrawal by Subject|2|||
48454054|NCT02959190|155850024|FG001|Open Label|Withdrawal by Subject|8|||
48454055|NCT02959190|155850025|FG002|Open Label|Withdrawal by Subject|0|||
48454056|NCT02959190|155850026|FG003|Open Label|Withdrawal by Subject|0|||
48454057|NCT02959190|155850023|FG000|Open Label|Physician Decision|0|||
48454058|NCT02959190|155850024|FG001|Open Label|Physician Decision|0|||
48454059|NCT02959190|155850025|FG002|Open Label|Physician Decision|1|||
48454060|NCT02959190|155850026|FG003|Open Label|Physician Decision|0|||
48454061|NCT02959190|155850023|FG000|Open Label|Protocol Violation|0|||
48454062|NCT02959190|155850024|FG001|Open Label|Protocol Violation|0|||
48454063|NCT02959190|155850025|FG002|Open Label|Protocol Violation|0|||
48454064|NCT02959190|155850026|FG003|Open Label|Protocol Violation|2|||
48454065|NCT02959190|155850023|FG000|Post Treatment Follow Up|Adverse Event|1|||
48454066|NCT02959190|155850024|FG001|Post Treatment Follow Up|Adverse Event|1|||
48454067|NCT02959190|155850025|FG002|Post Treatment Follow Up|Adverse Event|0|||
48454068|NCT02959190|155850026|FG003|Post Treatment Follow Up|Adverse Event|0|||
48454069|NCT02959190|155850023|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
48454070|NCT02959190|155850024|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
48454071|NCT02959190|155850025|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
48454072|NCT02959190|155850026|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
48454073|NCT03039790|155850027|FG000|Overall Study|Lost to Follow-up|2|||
48454074|NCT03039790|155850028|FG001|Overall Study|Lost to Follow-up|0|||
48454075|NCT03039790|155850029|FG002|Overall Study|Lost to Follow-up|1|||
48454076|NCT03039790|155850030|FG003|Overall Study|Lost to Follow-up|1|||
48454077|NCT03039790|155850031|FG004|Overall Study|Lost to Follow-up|0|||
48454078|NCT03039790|155850032|FG005|Overall Study|Lost to Follow-up|1|||
48454079|NCT03039790|155850033|FG006|Overall Study|Lost to Follow-up|1|||
48454080|NCT03039790|155850034|FG007|Overall Study|Lost to Follow-up|1|||
48454081|NCT03039790|155850035|FG008|Overall Study|Lost to Follow-up|0|||
48454082|NCT03039790|155850036|FG009|Overall Study|Lost to Follow-up|1|||
48454083|NCT03039790|155850037|FG010|Overall Study|Lost to Follow-up|1|||
48454084|NCT03039790|155850038|FG011|Overall Study|Lost to Follow-up|0|||
48454085|NCT03039790|155850039|FG012|Overall Study|Lost to Follow-up|1|||
48454086|NCT03039790|155850040|FG013|Overall Study|Lost to Follow-up|0|||
48454087|NCT03039790|155850041|FG014|Overall Study|Lost to Follow-up|3|||
48454088|NCT03039790|155850042|FG015|Overall Study|Lost to Follow-up|1|||
48454089|NCT03039790|155850043|FG016|Overall Study|Lost to Follow-up|2|||
48454090|NCT03039790|155850044|FG017|Overall Study|Lost to Follow-up|2|||
48454091|NCT03039790|155850045|FG018|Overall Study|Lost to Follow-up|1|||
48454092|NCT03039790|155850046|FG019|Overall Study|Lost to Follow-up|3|||
48454093|NCT03039790|155850027|FG000|Overall Study|Withdrawal of Consent|1|||
48454094|NCT03039790|155850028|FG001|Overall Study|Withdrawal of Consent|0|||
48454095|NCT03039790|155850029|FG002|Overall Study|Withdrawal of Consent|0|||
48454096|NCT03039790|155850030|FG003|Overall Study|Withdrawal of Consent|1|||
48454097|NCT03039790|155850031|FG004|Overall Study|Withdrawal of Consent|0|||
48454098|NCT03039790|155850032|FG005|Overall Study|Withdrawal of Consent|0|||
48454099|NCT03039790|155850033|FG006|Overall Study|Withdrawal of Consent|0|||
48454100|NCT03039790|155850034|FG007|Overall Study|Withdrawal of Consent|0|||
48454101|NCT03039790|155850035|FG008|Overall Study|Withdrawal of Consent|0|||
48454102|NCT03039790|155850036|FG009|Overall Study|Withdrawal of Consent|1|||
48454103|NCT03039790|155850037|FG010|Overall Study|Withdrawal of Consent|0|||
48454104|NCT03039790|155850038|FG011|Overall Study|Withdrawal of Consent|0|||
48454105|NCT03039790|155850039|FG012|Overall Study|Withdrawal of Consent|2|||
48454106|NCT03039790|155850040|FG013|Overall Study|Withdrawal of Consent|0|||
48454107|NCT03039790|155850041|FG014|Overall Study|Withdrawal of Consent|1|||
48454108|NCT03039790|155850042|FG015|Overall Study|Withdrawal of Consent|5|||
48454109|NCT03039790|155850043|FG016|Overall Study|Withdrawal of Consent|3|||
48454110|NCT03039790|155850044|FG017|Overall Study|Withdrawal of Consent|0|||
48454111|NCT03039790|155850045|FG018|Overall Study|Withdrawal of Consent|2|||
48454112|NCT03039790|155850046|FG019|Overall Study|Withdrawal of Consent|5|||
48454113|NCT03039790|155850027|FG000|Overall Study|Death|0|||
48454114|NCT03039790|155850028|FG001|Overall Study|Death|0|||
48454115|NCT03039790|155850029|FG002|Overall Study|Death|0|||
48454116|NCT03039790|155850030|FG003|Overall Study|Death|0|||
48454117|NCT03039790|155850031|FG004|Overall Study|Death|0|||
48454118|NCT03039790|155850032|FG005|Overall Study|Death|0|||
48454119|NCT03039790|155850033|FG006|Overall Study|Death|0|||
48454120|NCT03039790|155850034|FG007|Overall Study|Death|0|||
48454121|NCT03039790|155850035|FG008|Overall Study|Death|0|||
48454122|NCT03039790|155850036|FG009|Overall Study|Death|0|||
48454123|NCT03039790|155850037|FG010|Overall Study|Death|0|||
48454124|NCT03039790|155850038|FG011|Overall Study|Death|0|||
48454125|NCT03039790|155850039|FG012|Overall Study|Death|0|||
48454126|NCT03039790|155850040|FG013|Overall Study|Death|0|||
48454127|NCT03039790|155850041|FG014|Overall Study|Death|0|||
48454128|NCT03039790|155850042|FG015|Overall Study|Death|1|||
48454129|NCT03039790|155850043|FG016|Overall Study|Death|3|||
48454130|NCT03039790|155850044|FG017|Overall Study|Death|0|||
48454131|NCT03039790|155850045|FG018|Overall Study|Death|2|||
48454132|NCT03039790|155850046|FG019|Overall Study|Death|0|||
48454133|NCT03039790|155850027|FG000|Overall Study|Reason, not Specified|1|||
48454134|NCT03039790|155850028|FG001|Overall Study|Reason, not Specified|0|||
48454135|NCT03039790|155850029|FG002|Overall Study|Reason, not Specified|0|||
48454136|NCT03039790|155850030|FG003|Overall Study|Reason, not Specified|0|||
48454137|NCT03039790|155850031|FG004|Overall Study|Reason, not Specified|0|||
48454138|NCT03039790|155850032|FG005|Overall Study|Reason, not Specified|0|||
48454139|NCT03039790|155850033|FG006|Overall Study|Reason, not Specified|0|||
48454140|NCT03039790|155850034|FG007|Overall Study|Reason, not Specified|0|||
48454141|NCT03039790|155850035|FG008|Overall Study|Reason, not Specified|0|||
48454142|NCT03039790|155850036|FG009|Overall Study|Reason, not Specified|0|||
48454143|NCT03039790|155850037|FG010|Overall Study|Reason, not Specified|0|||
48454144|NCT03039790|155850038|FG011|Overall Study|Reason, not Specified|0|||
48454145|NCT03039790|155850039|FG012|Overall Study|Reason, not Specified|0|||
48454146|NCT03039790|155850040|FG013|Overall Study|Reason, not Specified|0|||
48454147|NCT03039790|155850041|FG014|Overall Study|Reason, not Specified|0|||
48454148|NCT03039790|155850042|FG015|Overall Study|Reason, not Specified|0|||
48454149|NCT03039790|155850043|FG016|Overall Study|Reason, not Specified|2|||
48454150|NCT03039790|155850044|FG017|Overall Study|Reason, not Specified|0|||
48454151|NCT03039790|155850045|FG018|Overall Study|Reason, not Specified|1|||
48454152|NCT03039790|155850046|FG019|Overall Study|Reason, not Specified|0|||
48454153|NCT02623699|155850051|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454154|NCT02623699|155850052|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
48454155|NCT02623699|155850053|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454156|NCT02623699|155850054|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454157|NCT02623699|155850055|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454158|NCT02623699|155850056|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454159|NCT02623699|155850057|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454160|NCT02623699|155850058|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454161|NCT02623699|155850059|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454162|NCT02623699|155850060|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454163|NCT02623699|155850061|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454164|NCT02623699|155850062|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
48454165|NCT02623699|155850051|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454166|NCT02623699|155850052|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454167|NCT02623699|155850053|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454168|NCT02623699|155850054|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454169|NCT02623699|155850055|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454170|NCT02623699|155850056|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454171|NCT02623699|155850057|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
48454172|NCT02623699|155850058|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454173|NCT02623699|155850059|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454174|NCT02623699|155850060|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454175|NCT02623699|155850061|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454176|NCT02623699|155850062|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
48454177|NCT02623699|155850051|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454178|NCT02623699|155850052|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454179|NCT02623699|155850053|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454180|NCT02623699|155850054|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454181|NCT02623699|155850055|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454182|NCT02623699|155850056|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
48454183|NCT02623699|155850057|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454184|NCT02623699|155850058|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454185|NCT02623699|155850059|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454186|NCT02623699|155850060|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454187|NCT02623699|155850061|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454188|NCT02623699|155850062|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
48454189|NCT02623699|155850051|FG000|Part B (Up to 289 Days)|Death|0|||
48454190|NCT02623699|155850052|FG001|Part B (Up to 289 Days)|Death|0|||
48454191|NCT02623699|155850053|FG002|Part B (Up to 289 Days)|Death|0|||
48454192|NCT02623699|155850054|FG003|Part B (Up to 289 Days)|Death|0|||
48454193|NCT02623699|155850055|FG004|Part B (Up to 289 Days)|Death|0|||
48454194|NCT02623699|155850056|FG005|Part B (Up to 289 Days)|Death|1|||
48454195|NCT02623699|155850057|FG006|Part B (Up to 289 Days)|Death|1|||
48454196|NCT02623699|155850058|FG007|Part B (Up to 289 Days)|Death|0|||
48454197|NCT02623699|155850059|FG008|Part B (Up to 289 Days)|Death|1|||
48454198|NCT02623699|155850060|FG009|Part B (Up to 289 Days)|Death|0|||
48454199|NCT02623699|155850061|FG010|Part B (Up to 289 Days)|Death|0|||
48454200|NCT02623699|155850062|FG011|Part B (Up to 289 Days)|Death|0|||
48454201|NCT02623699|155850051|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
48454202|NCT02623699|155850052|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
48454203|NCT02623699|155850053|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
48454204|NCT02623699|155850054|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
48454205|NCT02623699|155850055|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
48454206|NCT02623699|155850056|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
48454207|NCT02623699|155850057|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
48454208|NCT02623699|155850058|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
48454209|NCT02623699|155850059|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
48454210|NCT02623699|155850060|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
48454211|NCT02623699|155850061|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
48454212|NCT02623699|155850062|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
48454213|NCT02623699|155850051|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454214|NCT02623699|155850052|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454215|NCT02623699|155850053|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454216|NCT02623699|155850054|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454217|NCT02623699|155850055|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454218|NCT02623699|155850056|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454219|NCT02623699|155850057|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454220|NCT02623699|155850058|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454221|NCT02623699|155850059|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454222|NCT02623699|155850060|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
48454223|NCT02623699|155850061|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
48454224|NCT02623699|155850062|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
48454225|NCT02623699|155850051|FG000|Part C (Up to 236 Days)|Death|0|||
48454226|NCT02623699|155850052|FG001|Part C (Up to 236 Days)|Death|0|||
48454227|NCT02623699|155850053|FG002|Part C (Up to 236 Days)|Death|0|||
48454228|NCT02623699|155850054|FG003|Part C (Up to 236 Days)|Death|0|||
48454229|NCT02623699|155850055|FG004|Part C (Up to 236 Days)|Death|0|||
48454230|NCT02623699|155850056|FG005|Part C (Up to 236 Days)|Death|0|||
48454231|NCT02623699|155850057|FG006|Part C (Up to 236 Days)|Death|0|||
48454232|NCT02623699|155850058|FG007|Part C (Up to 236 Days)|Death|0|||
48454233|NCT02623699|155850059|FG008|Part C (Up to 236 Days)|Death|0|||
48454234|NCT02623699|155850060|FG009|Part C (Up to 236 Days)|Death|0|||
48454235|NCT02623699|155850061|FG010|Part C (Up to 236 Days)|Death|0|||
48454236|NCT02623699|155850062|FG011|Part C (Up to 236 Days)|Death|1|||
48454237|NCT02623699|155850051|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
48454238|NCT02623699|155850052|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
48454239|NCT02623699|155850053|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
48454240|NCT02623699|155850054|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
48454241|NCT02623699|155850055|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
48454242|NCT02623699|155850056|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
48454243|NCT02623699|155850057|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
48454244|NCT02623699|155850058|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
48454245|NCT02623699|155850059|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
48454246|NCT02623699|155850060|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
48454247|NCT02623699|155850061|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
48454248|NCT02623699|155850062|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
48454249|NCT00033371|155850063|FG000|Overall Study|Adverse Event|1|||
48454250|NCT00033371|155850064|FG001|Overall Study|Adverse Event|5|||
48454251|NCT00033371|155850063|FG000|Overall Study|Lost to Follow-up|2|||
48454252|NCT00033371|155850064|FG001|Overall Study|Lost to Follow-up|1|||
48454253|NCT00033371|155850063|FG000|Overall Study|Withdrawal by Subject|3|||
48454254|NCT00033371|155850064|FG001|Overall Study|Withdrawal by Subject|3|||
48454255|NCT00033371|155850063|FG000|Overall Study|Disease Progression|0|||
48454256|NCT00033371|155850064|FG001|Overall Study|Disease Progression|1|||
48454257|NCT00899678|155850065|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
48454258|NCT00899678|155850066|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
48454259|NCT00899678|155850067|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
48454260|NCT00899678|155850065|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
48454261|NCT00899678|155850066|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
48454262|NCT00899678|155850067|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
48454263|NCT00899678|155850065|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
48454264|NCT00899678|155850066|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
48454265|NCT00899678|155850067|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
48454266|NCT00899678|155850065|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
48454267|NCT00899678|155850066|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
48454268|NCT00899678|155850067|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
48454269|NCT00899678|155850065|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
48454270|NCT00899678|155850066|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
48454271|NCT00899678|155850067|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
48454272|NCT00899678|155850065|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
48454273|NCT00899678|155850066|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
48454274|NCT00899678|155850067|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
48454275|NCT00899678|155850065|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
48454276|NCT00899678|155850066|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
48454277|NCT00899678|155850067|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
48454278|NCT00899678|155850065|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
48454279|NCT00899678|155850066|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
48454280|NCT00899678|155850067|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
48454281|NCT00899678|155850065|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
48454282|NCT00899678|155850066|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
48454283|NCT00899678|155850067|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
48454284|NCT02699125|155850068|FG000|Placebo|Lost to Follow-up|2|||
48454285|NCT02699125|155850069|FG001|Placebo|Lost to Follow-up|0|||
48454286|NCT02699125|155850068|FG000|Placebo|Protocol Violation|1|||
48454287|NCT02699125|155850069|FG001|Placebo|Protocol Violation|0|||
48454288|NCT02699125|155850068|FG000|Placebo|Withdrawal by Subject|0|||
48454289|NCT02699125|155850069|FG001|Placebo|Withdrawal by Subject|4|||
48454290|NCT02699125|155850068|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
48454291|NCT02699125|155850069|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
48454292|NCT00572728|155850070|FG000|Overall Study|Withdrawal by Subject|10|||
48454293|NCT00572728|155850070|FG000|Overall Study|Ineligible|3|||
48454294|NCT00572728|155850070|FG000|Overall Study|Enrolled under Amendment 4|5|||
48454295|NCT00572728|155850070|FG000|Overall Study|Offstudy due to complicating disease|1|||
48454296|NCT00572728|155850070|FG000|Overall Study|FLT1 not completed|4|||
48454297|NCT00572728|155850070|FG000|Overall Study|First Chemotherapy not initiated|2|||
48454298|NCT00572728|155850070|FG000|Overall Study|FLT2 not completed|5|||
48454299|NCT00572728|155850070|FG000|Overall Study|Second chemotherapy not initiated|1|||
48454300|NCT00572728|155850070|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
48454301|NCT00572728|155850070|FG000|Overall Study|Pathology missing|1|||
48454302|NCT03630016|155850075|FG000|Overall Study|Poor Sensor Placement|1|||
48454303|NCT00255008|155850078|FG000|Overall Study|Adverse Event|1|||
48454304|NCT00255008|155850079|FG001|Overall Study|Adverse Event|1|||
48454305|NCT00255008|155850080|FG002|Overall Study|Adverse Event|2|||
48454306|NCT00255008|155850081|FG003|Overall Study|Adverse Event|0|||
48454307|NCT00255008|155850078|FG000|Overall Study|Lost to Follow-up|1|||
48454308|NCT00255008|155850079|FG001|Overall Study|Lost to Follow-up|0|||
48454309|NCT00255008|155850080|FG002|Overall Study|Lost to Follow-up|1|||
48454310|NCT00255008|155850081|FG003|Overall Study|Lost to Follow-up|2|||
48454311|NCT00255008|155850078|FG000|Overall Study|Did not meet viral reduction criteria|4|||
48454312|NCT00255008|155850079|FG001|Overall Study|Did not meet viral reduction criteria|5|||
48454313|NCT00255008|155850080|FG002|Overall Study|Did not meet viral reduction criteria|0|||
48454314|NCT00255008|155850081|FG003|Overall Study|Did not meet viral reduction criteria|1|||
48454315|NCT00255008|155850078|FG000|Overall Study|Withdrew consent|0|||
48454316|NCT00255008|155850079|FG001|Overall Study|Withdrew consent|0|||
48454317|NCT00255008|155850080|FG002|Overall Study|Withdrew consent|2|||
48454318|NCT00255008|155850081|FG003|Overall Study|Withdrew consent|0|||
48454319|NCT00255008|155850078|FG000|Overall Study|Sponsor request|18|||
48454320|NCT00255008|155850079|FG001|Overall Study|Sponsor request|3|||
48454321|NCT00255008|155850080|FG002|Overall Study|Sponsor request|8|||
48454322|NCT00255008|155850081|FG003|Overall Study|Sponsor request|17|||
48454323|NCT00255008|155850078|FG000|Overall Study|Adverse lab experience|1|||
48454324|NCT00255008|155850079|FG001|Overall Study|Adverse lab experience|0|||
48454325|NCT00255008|155850080|FG002|Overall Study|Adverse lab experience|0|||
48454326|NCT00255008|155850081|FG003|Overall Study|Adverse lab experience|0|||
48454327|NCT00255008|155850078|FG000|Overall Study|Other|7|||
48454328|NCT00255008|155850079|FG001|Overall Study|Other|0|||
48454329|NCT00255008|155850080|FG002|Overall Study|Other|3|||
48454330|NCT00255008|155850081|FG003|Overall Study|Other|2|||
48454331|NCT05083949|155850082|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
48454332|NCT05083949|155850083|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
48454333|NCT05083949|155850082|FG000|Period 1|Adverse Event|1|||
48454334|NCT05083949|155850083|FG001|Period 1|Adverse Event|1|||
48454335|NCT05083949|155850082|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
48454336|NCT05083949|155850083|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
48454337|NCT05083949|155850082|FG000|Period 2|Adverse Event|0|||
48454338|NCT05083949|155850083|FG001|Period 2|Adverse Event|2|||
48454339|NCT01833806|155850084|FG000|Overall Study|Alternative treatment|2|||
48454340|NCT01833806|155850084|FG000|Overall Study|Death|5|||
48454341|NCT01833806|155850084|FG000|Overall Study|Physician Decision|1|||
48454342|NCT01833806|155850084|FG000|Overall Study|Lost to Follow-up|1|||
48454343|NCT03128307|155850088|FG000|Overall Study|Lost to Follow-up|29|||
48454344|NCT03128307|155850088|FG000|Overall Study|Withdrawal by Subject|5|||
48454345|NCT01201967|155850091|FG000|Overall Study|Lost to Follow-up|6|||
48454346|NCT01201967|155850092|FG001|Overall Study|Lost to Follow-up|5|||
48454347|NCT00107172|155850093|FG000|Overall Study|Withdrawal by Subject|1|||
48454348|NCT00107172|155850094|FG001|Overall Study|Withdrawal by Subject|0|||
48454349|NCT00107172|155850093|FG000|Overall Study|Death|0|||
48454350|NCT00107172|155850094|FG001|Overall Study|Death|2|||
48454351|NCT00107172|155850093|FG000|Overall Study|Other Reason|4|||
48454352|NCT00107172|155850094|FG001|Overall Study|Other Reason|3|||
48454353|NCT01927068|155850095|FG000|Overall Study|Death|37|||
48454354|NCT01927068|155850096|FG001|Overall Study|Death|3|||
48454355|NCT01927068|155850095|FG000|Overall Study|Withdrawal by Subject|50|||
48454356|NCT01927068|155850096|FG001|Overall Study|Withdrawal by Subject|3|||
48454357|NCT01927068|155850095|FG000|Overall Study|Lost to Follow-up|10|||
48454358|NCT01927068|155850096|FG001|Overall Study|Lost to Follow-up|2|||
48454359|NCT01927068|155850095|FG000|Overall Study|Physician Decision|9|||
48454360|NCT01927068|155850096|FG001|Overall Study|Physician Decision|0|||
48454361|NCT01927068|155850095|FG000|Overall Study|Missed last follow-up visit|2|||
48454362|NCT01927068|155850096|FG001|Overall Study|Missed last follow-up visit|0|||
48454363|NCT00880607|155850099|FG000|Overall Study|Physician Decision|2|||
48454364|NCT00880607|155850100|FG001|Overall Study|Physician Decision|2|||
48454365|NCT00880607|155850099|FG000|Overall Study|Protocol Violation|2|||
48454366|NCT00880607|155850100|FG001|Overall Study|Protocol Violation|1|||
48454367|NCT00880607|155850099|FG000|Overall Study|surgery did not extend past L1 level|3|||
48454368|NCT00880607|155850100|FG001|Overall Study|surgery did not extend past L1 level|0|||
48454369|NCT01300767|155850101|FG000|Overall Study|Discomfort|2|||
48454370|NCT01300767|155850101|FG000|Overall Study|Biomicroscopy|1|||
48454371|NCT01300767|155850101|FG000|Overall Study|Unacceptable fit|1|||
48454372|NCT00595868|155851979|FG000|Overall Study|Lost to Follow-up|45|||
48454373|NCT00595868|155851980|FG001|Overall Study|Lost to Follow-up|50|||
48454374|NCT04268303|155851981|FG000|Overall Study|Lost to Follow-up|1|||
48454375|NCT04268303|155851982|FG001|Overall Study|Lost to Follow-up|1|||
48454376|NCT04268303|155851983|FG002|Overall Study|Lost to Follow-up|2|||
48454377|NCT04268303|155851981|FG000|Overall Study|Withdrawal by Subject|0|||
48454378|NCT04268303|155851982|FG001|Overall Study|Withdrawal by Subject|1|||
48454379|NCT04268303|155851983|FG002|Overall Study|Withdrawal by Subject|1|||
48454380|NCT04268303|155851981|FG000|Overall Study|Adverse Event|2|||
48454381|NCT04268303|155851982|FG001|Overall Study|Adverse Event|0|||
48454382|NCT04268303|155851983|FG002|Overall Study|Adverse Event|0|||
48454383|NCT00859573|155851984|FG000|Overall Study|Withdrawal by Subject|4|||
48454384|NCT00859573|155851985|FG001|Overall Study|Withdrawal by Subject|1|||
48454385|NCT00859573|155851984|FG000|Overall Study|Physician Decision|1|||
48454386|NCT00859573|155851985|FG001|Overall Study|Physician Decision|1|||
48454387|NCT02944513|155851987|FG000|Overall Study|Withdrawal by Subject|4|||
48454388|NCT02944513|155851988|FG001|Overall Study|Withdrawal by Subject|1|||
48454389|NCT00937326|155851992|FG000|Overall Study|Adverse Event|0|||
48454390|NCT00937326|155851993|FG001|Overall Study|Adverse Event|3|||
48454391|NCT00937326|155851994|FG002|Overall Study|Adverse Event|1|||
48454392|NCT00937326|155851995|FG003|Overall Study|Adverse Event|1|||
48454393|NCT00937326|155851996|FG004|Overall Study|Adverse Event|2|||
48454394|NCT00937326|155851992|FG000|Overall Study|Death|0|||
48454395|NCT00937326|155851993|FG001|Overall Study|Death|0|||
48454396|NCT00937326|155851994|FG002|Overall Study|Death|1|||
48454397|NCT00937326|155851995|FG003|Overall Study|Death|0|||
48454398|NCT00937326|155851996|FG004|Overall Study|Death|0|||
48454399|NCT00937326|155851992|FG000|Overall Study|Withdrawal by Subject|3|||
48454400|NCT00937326|155851993|FG001|Overall Study|Withdrawal by Subject|4|||
48454401|NCT00937326|155851994|FG002|Overall Study|Withdrawal by Subject|1|||
48454402|NCT00937326|155851995|FG003|Overall Study|Withdrawal by Subject|4|||
48454403|NCT00937326|155851996|FG004|Overall Study|Withdrawal by Subject|3|||
48454404|NCT00937326|155851992|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
48454405|NCT00937326|155851993|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
48454406|NCT00937326|155851994|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
48454407|NCT00937326|155851995|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
48454408|NCT00937326|155851996|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
48454409|NCT03382262|155851999|FG000|Overall Study|Physician Decision|0|||
48454410|NCT03382262|155852000|FG001|Overall Study|Physician Decision|0|||
48454411|NCT03382262|155852001|FG002|Overall Study|Physician Decision|1|||
48454412|NCT03382262|155852002|FG003|Overall Study|Physician Decision|0|||
48454413|NCT03382262|155851999|FG000|Overall Study|Withdrawal by Subject|0|||
48454414|NCT03382262|155852000|FG001|Overall Study|Withdrawal by Subject|0|||
48454415|NCT03382262|155852001|FG002|Overall Study|Withdrawal by Subject|0|||
48454416|NCT03382262|155852002|FG003|Overall Study|Withdrawal by Subject|1|||
48454417|NCT02578992|155852003|FG000|Overall Study|equipment not available or malfunction|3|||
48454418|NCT02578992|155852004|FG001|Overall Study|equipment not available or malfunction|3|||
48454419|NCT02940860|155852007|FG000|Overall Study|Non-serious AE|1|||
48454420|NCT02940860|155852008|FG001|Overall Study|Non-serious AE|2|||
48454421|NCT02940860|155852007|FG000|Overall Study|Serious AE|7|||
48454422|NCT02940860|155852008|FG001|Overall Study|Serious AE|3|||
48454423|NCT02940860|155852007|FG000|Overall Study|Withdrawal by Subject|19|||
48454424|NCT02940860|155852008|FG001|Overall Study|Withdrawal by Subject|9|||
48454425|NCT02940860|155852007|FG000|Overall Study|Lost to Follow-up|13|||
48454426|NCT02940860|155852008|FG001|Overall Study|Lost to Follow-up|7|||
48454427|NCT02940860|155852007|FG000|Overall Study|Physician Decision|5|||
48454428|NCT02940860|155852008|FG001|Overall Study|Physician Decision|3|||
48454429|NCT02940860|155852007|FG000|Overall Study|Sponsor Decision|0|||
48454430|NCT02940860|155852008|FG001|Overall Study|Sponsor Decision|1|||
48454431|NCT02940860|155852007|FG000|Overall Study|Protocol Violation|0|||
48454432|NCT02940860|155852008|FG001|Overall Study|Protocol Violation|2|||
48454433|NCT02940860|155852007|FG000|Overall Study|Death|3|||
48454434|NCT02940860|155852008|FG001|Overall Study|Death|2|||
48454435|NCT02940860|155852007|FG000|Overall Study|Moved, poor venous access, transport|6|||
48454436|NCT02940860|155852008|FG001|Overall Study|Moved, poor venous access, transport|4|||
48454437|NCT02940860|155852007|FG000|Overall Study|Not treated|2|||
48454438|NCT02940860|155852008|FG001|Overall Study|Not treated|2|||
48454439|NCT03654560|155852012|FG000|Overall Study|Death|3|||
48454440|NCT03654560|155852013|FG001|Overall Study|Death|1|||
48454441|NCT03654560|155852012|FG000|Overall Study|Lost to Follow-up|1|||
48454442|NCT03654560|155852013|FG001|Overall Study|Lost to Follow-up|0|||
48454443|NCT01843205|155852019|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
48454444|NCT01843205|155852020|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
48454445|NCT03938636|155852021|FG000|Overall Study|Protocol Violation|0|||
48454446|NCT03938636|155852022|FG001|Overall Study|Protocol Violation|1|||
48454447|NCT03938636|155852023|FG002|Overall Study|Protocol Violation|1|||
48454448|NCT03938636|155852021|FG000|Overall Study|Subject withdrew due to death in family|0|||
48454449|NCT03938636|155852022|FG001|Overall Study|Subject withdrew due to death in family|1|||
48454450|NCT03938636|155852023|FG002|Overall Study|Subject withdrew due to death in family|0|||
48454451|NCT03938636|155852021|FG000|Overall Study|Missed visit|0|||
48454452|NCT03938636|155852022|FG001|Overall Study|Missed visit|1|||
48454453|NCT03938636|155852023|FG002|Overall Study|Missed visit|0|||
48454454|NCT03938636|155852021|FG000|Overall Study|Adverse Event|0|||
48454455|NCT03938636|155852022|FG001|Overall Study|Adverse Event|0|||
48454456|NCT03938636|155852023|FG002|Overall Study|Adverse Event|1|||
48454457|NCT03938636|155852021|FG000|Overall Study|Lost to Follow-up|0|||
48454458|NCT03938636|155852022|FG001|Overall Study|Lost to Follow-up|0|||
48454459|NCT03938636|155852023|FG002|Overall Study|Lost to Follow-up|1|||
48454460|NCT00711412|155852024|FG000|Induction Treatment|Death|2|||
48454461|NCT00711412|155852024|FG000|Induction Treatment|Adverse Event|1|||
48454462|NCT00711412|155852024|FG000|Induction Treatment|Other|1|||
48454463|NCT00711412|155852024|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
48454464|NCT00711412|155852024|FG000|Evaluated for Combination Treatment|Death|1|||
48454465|NCT00711412|155852024|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
48454466|NCT00711412|155852024|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
48454467|NCT00711412|155852024|FG000|Combination Treatment|Progressive Disease|1|||
48454468|NCT00711412|155852024|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
48454469|NCT00711412|155852024|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
48454470|NCT00711412|155852024|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
48454471|NCT00711412|155852024|FG000|Evaluation for Response and Surgery|Death|1|||
48454472|NCT00711412|155852024|FG000|Survival Follow up Until Death|Other|12|||
48454473|NCT00446797|155852025|FG000|Overall Study|Lack of Efficacy|0|||
48454474|NCT00446797|155852026|FG001|Overall Study|Lack of Efficacy|2|||
48454475|NCT00446797|155852025|FG000|Overall Study|Lost to Follow-up|5|||
48454476|NCT00446797|155852026|FG001|Overall Study|Lost to Follow-up|3|||
48454477|NCT00446797|155852025|FG000|Overall Study|Withdrawal by Subject|2|||
48454478|NCT00446797|155852026|FG001|Overall Study|Withdrawal by Subject|2|||
48454479|NCT00446797|155852025|FG000|Overall Study|Protocol Violation|1|||
48454480|NCT00446797|155852026|FG001|Overall Study|Protocol Violation|3|||
48454481|NCT00446797|155852025|FG000|Overall Study|subject entered at another site|0|||
48454482|NCT00446797|155852026|FG001|Overall Study|subject entered at another site|1|||
48454483|NCT00446797|155852025|FG000|Overall Study|did not meet entrance criteria|0|||
48454484|NCT00446797|155852026|FG001|Overall Study|did not meet entrance criteria|1|||
48454485|NCT00441727|155852027|FG000|Overall Study|Protocol Violation|19|||
48454486|NCT00441727|155852028|FG001|Overall Study|Protocol Violation|28|||
48454487|NCT00441727|155852029|FG002|Overall Study|Protocol Violation|32|||
48454488|NCT00441727|155852027|FG000|Overall Study|Adverse Event|26|||
48454489|NCT00441727|155852028|FG001|Overall Study|Adverse Event|33|||
48454490|NCT00441727|155852029|FG002|Overall Study|Adverse Event|28|||
48454491|NCT00441727|155852027|FG000|Overall Study|Lack of Efficacy|7|||
48454492|NCT00441727|155852028|FG001|Overall Study|Lack of Efficacy|8|||
48454493|NCT00441727|155852029|FG002|Overall Study|Lack of Efficacy|48|||
48454494|NCT00441727|155852027|FG000|Overall Study|Withdrawal by Subject|40|||
48454495|NCT00441727|155852028|FG001|Overall Study|Withdrawal by Subject|34|||
48454496|NCT00441727|155852029|FG002|Overall Study|Withdrawal by Subject|47|||
48454497|NCT00441727|155852027|FG000|Overall Study|Lost to Follow-up|5|||
48454498|NCT00441727|155852028|FG001|Overall Study|Lost to Follow-up|6|||
48454499|NCT00441727|155852029|FG002|Overall Study|Lost to Follow-up|5|||
48454500|NCT00441727|155852027|FG000|Overall Study|Safety Reasons|3|||
48454501|NCT00441727|155852028|FG001|Overall Study|Safety Reasons|1|||
48454502|NCT00441727|155852029|FG002|Overall Study|Safety Reasons|3|||
48454503|NCT00441727|155852027|FG000|Overall Study|Various reason specified|6|||
48454504|NCT00441727|155852028|FG001|Overall Study|Various reason specified|8|||
48454505|NCT00441727|155852029|FG002|Overall Study|Various reason specified|5|||
48454506|NCT02147691|155852031|FG000|Overall Study|Withdrawal by Subject|2|||
48454507|NCT02147691|155852032|FG001|Overall Study|Withdrawal by Subject|0|||
48454508|NCT02147691|155852031|FG000|Overall Study|Adverse Event|2|||
48454509|NCT02147691|155852032|FG001|Overall Study|Adverse Event|0|||
48454510|NCT02147691|155852031|FG000|Overall Study|Lost to Follow-up|0|||
48454511|NCT02147691|155852032|FG001|Overall Study|Lost to Follow-up|1|||
48454512|NCT02580591|155852035|FG000|Overall Study|Adverse Event|0|||
48454513|NCT02580591|155852036|FG001|Overall Study|Adverse Event|1|||
48454514|NCT02580591|155852037|FG002|Overall Study|Adverse Event|2|||
48454515|NCT02580591|155852038|FG003|Overall Study|Adverse Event|5|||
48454516|NCT02580591|155852035|FG000|Overall Study|Protocol Violation|3|||
48454517|NCT02580591|155852036|FG001|Overall Study|Protocol Violation|2|||
48454518|NCT02580591|155852037|FG002|Overall Study|Protocol Violation|1|||
48454519|NCT02580591|155852038|FG003|Overall Study|Protocol Violation|1|||
48454520|NCT02580591|155852035|FG000|Overall Study|Lost to Follow-up|5|||
48454521|NCT02580591|155852036|FG001|Overall Study|Lost to Follow-up|3|||
48454522|NCT02580591|155852037|FG002|Overall Study|Lost to Follow-up|3|||
48454523|NCT02580591|155852038|FG003|Overall Study|Lost to Follow-up|1|||
48454524|NCT02580591|155852035|FG000|Overall Study|Withdrawal by Subject|6|||
48454525|NCT02580591|155852036|FG001|Overall Study|Withdrawal by Subject|1|||
48454526|NCT02580591|155852037|FG002|Overall Study|Withdrawal by Subject|2|||
48454527|NCT02580591|155852038|FG003|Overall Study|Withdrawal by Subject|3|||
48454528|NCT02580591|155852035|FG000|Overall Study|Not treated|1|||
48454529|NCT02580591|155852036|FG001|Overall Study|Not treated|1|||
48454530|NCT02580591|155852037|FG002|Overall Study|Not treated|0|||
48454531|NCT02580591|155852038|FG003|Overall Study|Not treated|0|||
48454532|NCT02580591|155852035|FG000|Overall Study|Other than specified|3|||
48454533|NCT02580591|155852036|FG001|Overall Study|Other than specified|2|||
48454534|NCT02580591|155852037|FG002|Overall Study|Other than specified|5|||
48454535|NCT02580591|155852038|FG003|Overall Study|Other than specified|2|||
48454536|NCT00429572|155852042|FG000|Overall Study|Disease progression|1|||
48454537|NCT01712490|155852043|FG000|Overall Study|Ongoing|601|||
48454538|NCT01712490|155852044|FG001|Overall Study|Ongoing|586|||
48454539|NCT01712490|155852043|FG000|Overall Study|Other|11|||
48454540|NCT01712490|155852044|FG001|Overall Study|Other|11|||
48454541|NCT01712490|155852043|FG000|Overall Study|Withdrawal by Subject|36|||
48454542|NCT01712490|155852044|FG001|Overall Study|Withdrawal by Subject|44|||
48454543|NCT01712490|155852043|FG000|Overall Study|Lost to Follow-up|16|||
48454544|NCT01712490|155852044|FG001|Overall Study|Lost to Follow-up|29|||
48454545|NCT02910089|155852046|FG000|Overall Study|Lost insurance eligibility|22|||
48454546|NCT02910089|155852047|FG001|Overall Study|Lost insurance eligibility|16|||
48454547|NCT02768103|155852049|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
48454548|NCT00611767|155852074|FG000|Overall Study|Withdrawal by Subject|4|||
48454549|NCT00611767|155852075|FG001|Overall Study|Withdrawal by Subject|1|||
48454550|NCT00611767|155852074|FG000|Overall Study|Thiopental not available|3|||
48454551|NCT00611767|155852075|FG001|Overall Study|Thiopental not available|0|||
48454552|NCT00611767|155852074|FG000|Overall Study|didn't like the medication|1|||
48454553|NCT00611767|155852075|FG001|Overall Study|didn't like the medication|1|||
48454554|NCT00611767|155852074|FG000|Overall Study|Physician Decision|1|||
48454555|NCT00611767|155852075|FG001|Overall Study|Physician Decision|0|||
48454556|NCT04599972|155852077|FG000|Overall Study|Withdrawal by Subject|6|||
48454557|NCT04599972|155852078|FG001|Overall Study|Withdrawal by Subject|1|||
48454558|NCT04599972|155852077|FG000|Overall Study|Adverse Event|1|||
48454559|NCT04599972|155852078|FG001|Overall Study|Adverse Event|1|||
48454560|NCT04599972|155852077|FG000|Overall Study|Lost to Follow-up|1|||
48454561|NCT04599972|155852078|FG001|Overall Study|Lost to Follow-up|6|||
48454562|NCT04599972|155852077|FG000|Overall Study|Protocol Violation|1|||
48454563|NCT04599972|155852078|FG001|Overall Study|Protocol Violation|0|||
48454564|NCT04599972|155852077|FG000|Overall Study|Other reason|1|||
48454565|NCT04599972|155852078|FG001|Overall Study|Other reason|0|||
48454566|NCT03342404|155852079|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
48454567|NCT03342404|155852080|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
48454568|NCT03342404|155852079|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
48454569|NCT03342404|155852080|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
48454570|NCT03342404|155852079|FG000|Blinded Treatment Phase|Adverse Event|5|||
48454571|NCT03342404|155852080|FG001|Blinded Treatment Phase|Adverse Event|4|||
48454572|NCT03342404|155852079|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
48454573|NCT03342404|155852080|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
48454574|NCT03342404|155852079|FG000|Blinded Treatment Phase|Other reasons|1|||
48454575|NCT03342404|155852080|FG001|Blinded Treatment Phase|Other reasons|0|||
48454576|NCT03342404|155852079|FG000|Blinded Treatment Phase|Physician Decision|1|||
48454577|NCT03342404|155852080|FG001|Blinded Treatment Phase|Physician Decision|0|||
48454578|NCT03342404|155852079|FG000|Blinded Treatment Phase|Death|1|||
48454579|NCT03342404|155852080|FG001|Blinded Treatment Phase|Death|0|||
48454580|NCT03342404|155852079|FG000|Open-Label Phase|Lost to Follow-up|0|||
48454581|NCT03342404|155852080|FG001|Open-Label Phase|Lost to Follow-up|1|||
48454582|NCT03342404|155852079|FG000|Open-Label Phase|Other reasons|0|||
48454583|NCT03342404|155852080|FG001|Open-Label Phase|Other reasons|1|||
48454584|NCT03342404|155852079|FG000|Open-Label Phase|Adverse Event|0|||
48454585|NCT03342404|155852080|FG001|Open-Label Phase|Adverse Event|3|||
48454586|NCT03342404|155852079|FG000|Open-Label Phase|Withdrawal by Subject|0|||
48454587|NCT03342404|155852080|FG001|Open-Label Phase|Withdrawal by Subject|6|||
48454588|NCT02017704|155852081|FG000|Overall Study|Withdrawal by Subject|2|||
48454589|NCT02017704|155852082|FG001|Overall Study|Withdrawal by Subject|0|||
48454590|NCT03369704|155852083|FG000|Treatment Epoch|technical problems|1|||
48454591|NCT03369704|155852084|FG001|Treatment Epoch|technical problems|0|||
48454592|NCT03369704|155852083|FG000|Treatment Epoch|Protocol Violation|1|||
48454593|NCT03369704|155852084|FG001|Treatment Epoch|Protocol Violation|0|||
48454594|NCT03369704|155852083|FG000|Treatment Epoch|Lost to Follow-up|0|||
48454595|NCT03369704|155852084|FG001|Treatment Epoch|Lost to Follow-up|1|||
48454596|NCT03369704|155852083|FG000|Treatment Epoch|Lack of Efficacy|0|||
48454597|NCT03369704|155852084|FG001|Treatment Epoch|Lack of Efficacy|2|||
48454598|NCT03369704|155852083|FG000|Treatment Epoch|Adverse Event|2|||
48454599|NCT03369704|155852084|FG001|Treatment Epoch|Adverse Event|0|||
48454600|NCT03369704|155852083|FG000|Follow-up Epoch|Lost to Follow-up|1|||
48454601|NCT03369704|155852084|FG001|Follow-up Epoch|Lost to Follow-up|0|||
48454602|NCT01025232|155852088|FG000|Overall Study|Study drug no longer available|3|||
48454603|NCT01025232|155852089|FG001|Overall Study|Study drug no longer available|6|||
48454604|NCT01055457|155852090|FG000|Overall Study|Lost to Follow-up|0|||
48454605|NCT01055457|155852091|FG001|Overall Study|Lost to Follow-up|1|||
48454606|NCT01055457|155852092|FG002|Overall Study|Lost to Follow-up|0|||
48454607|NCT01055457|155852093|FG003|Overall Study|Lost to Follow-up|0|||
48454608|NCT01055457|155852094|FG004|Overall Study|Lost to Follow-up|0|||
48454609|NCT01055457|155852095|FG005|Overall Study|Lost to Follow-up|1|||
48454610|NCT01055457|155852096|FG006|Overall Study|Lost to Follow-up|0|||
48454611|NCT01055457|155852097|FG007|Overall Study|Lost to Follow-up|0|||
48454612|NCT01055457|155852098|FG008|Overall Study|Lost to Follow-up|0|||
48454613|NCT01055457|155852099|FG009|Overall Study|Lost to Follow-up|0|||
48454614|NCT01055457|155852090|FG000|Overall Study|Protocol Violation|0|||
48454615|NCT01055457|155852091|FG001|Overall Study|Protocol Violation|0|||
48454616|NCT01055457|155852092|FG002|Overall Study|Protocol Violation|1|||
48454617|NCT01055457|155852093|FG003|Overall Study|Protocol Violation|1|||
48454618|NCT01055457|155852094|FG004|Overall Study|Protocol Violation|1|||
48454619|NCT01055457|155852095|FG005|Overall Study|Protocol Violation|2|||
48454620|NCT01055457|155852096|FG006|Overall Study|Protocol Violation|1|||
48454621|NCT01055457|155852097|FG007|Overall Study|Protocol Violation|0|||
48454622|NCT01055457|155852098|FG008|Overall Study|Protocol Violation|0|||
48454623|NCT01055457|155852099|FG009|Overall Study|Protocol Violation|1|||
48454624|NCT01055457|155852090|FG000|Overall Study|Subject Disinterest|0|||
48454625|NCT01055457|155852091|FG001|Overall Study|Subject Disinterest|0|||
48454626|NCT01055457|155852092|FG002|Overall Study|Subject Disinterest|0|||
48454627|NCT01055457|155852093|FG003|Overall Study|Subject Disinterest|0|||
48454628|NCT01055457|155852094|FG004|Overall Study|Subject Disinterest|0|||
48454629|NCT01055457|155852095|FG005|Overall Study|Subject Disinterest|0|||
48454630|NCT01055457|155852096|FG006|Overall Study|Subject Disinterest|0|||
48454631|NCT01055457|155852097|FG007|Overall Study|Subject Disinterest|1|||
48454632|NCT01055457|155852098|FG008|Overall Study|Subject Disinterest|0|||
48454633|NCT01055457|155852099|FG009|Overall Study|Subject Disinterest|0|||
48454634|NCT01055457|155852090|FG000|Overall Study|Subject Ineligible|1|||
48454635|NCT01055457|155852091|FG001|Overall Study|Subject Ineligible|0|||
48454636|NCT01055457|155852092|FG002|Overall Study|Subject Ineligible|1|||
48454637|NCT01055457|155852093|FG003|Overall Study|Subject Ineligible|0|||
48454638|NCT01055457|155852094|FG004|Overall Study|Subject Ineligible|1|||
48454639|NCT01055457|155852095|FG005|Overall Study|Subject Ineligible|0|||
48454640|NCT01055457|155852096|FG006|Overall Study|Subject Ineligible|0|||
48454641|NCT01055457|155852097|FG007|Overall Study|Subject Ineligible|0|||
48454642|NCT01055457|155852098|FG008|Overall Study|Subject Ineligible|0|||
48454643|NCT01055457|155852099|FG009|Overall Study|Subject Ineligible|0|||
48454644|NCT01055457|155852090|FG000|Overall Study|Discomfort|0|||
48454645|NCT01055457|155852091|FG001|Overall Study|Discomfort|0|||
48454646|NCT01055457|155852092|FG002|Overall Study|Discomfort|0|||
48454647|NCT01055457|155852093|FG003|Overall Study|Discomfort|0|||
48454648|NCT01055457|155852094|FG004|Overall Study|Discomfort|1|||
48454649|NCT01055457|155852095|FG005|Overall Study|Discomfort|0|||
48454650|NCT01055457|155852096|FG006|Overall Study|Discomfort|0|||
48454651|NCT01055457|155852097|FG007|Overall Study|Discomfort|0|||
48454652|NCT01055457|155852098|FG008|Overall Study|Discomfort|0|||
48454653|NCT01055457|155852099|FG009|Overall Study|Discomfort|0|||
48454654|NCT01055457|155852090|FG000|Overall Study|Pregnancy|0|||
48454655|NCT01055457|155852091|FG001|Overall Study|Pregnancy|0|||
48454656|NCT01055457|155852092|FG002|Overall Study|Pregnancy|0|||
48454657|NCT01055457|155852093|FG003|Overall Study|Pregnancy|1|||
48454658|NCT01055457|155852094|FG004|Overall Study|Pregnancy|0|||
48454659|NCT01055457|155852095|FG005|Overall Study|Pregnancy|0|||
48454660|NCT01055457|155852096|FG006|Overall Study|Pregnancy|0|||
48454661|NCT01055457|155852097|FG007|Overall Study|Pregnancy|0|||
48454662|NCT01055457|155852098|FG008|Overall Study|Pregnancy|0|||
48454663|NCT01055457|155852099|FG009|Overall Study|Pregnancy|0|||
48454664|NCT01055457|155852090|FG000|Overall Study|Adverse Event|0|||
48454665|NCT01055457|155852091|FG001|Overall Study|Adverse Event|0|||
48454666|NCT01055457|155852092|FG002|Overall Study|Adverse Event|0|||
48454667|NCT01055457|155852093|FG003|Overall Study|Adverse Event|1|||
48454668|NCT01055457|155852094|FG004|Overall Study|Adverse Event|0|||
48454669|NCT01055457|155852095|FG005|Overall Study|Adverse Event|0|||
48454670|NCT01055457|155852096|FG006|Overall Study|Adverse Event|0|||
48454671|NCT01055457|155852097|FG007|Overall Study|Adverse Event|0|||
48454672|NCT01055457|155852098|FG008|Overall Study|Adverse Event|0|||
48454673|NCT01055457|155852099|FG009|Overall Study|Adverse Event|0|||
48454674|NCT04055844|155852100|FG000|Overall Study|Adverse Event|12|||
48454675|NCT04055844|155852100|FG000|Overall Study|Poor Performance|1|||
48454676|NCT04055844|155852100|FG000|Overall Study|Death|1|||
48454677|NCT01039428|155852105|FG000|Overall Study|Protocol Violation|1|||
48454678|NCT01039428|155852106|FG001|Overall Study|Protocol Violation|0|||
48454679|NCT01039428|155852105|FG000|Overall Study|Withdrawal by Subject|1|||
48454680|NCT01039428|155852106|FG001|Overall Study|Withdrawal by Subject|0|||
48454681|NCT01313039|155852107|FG000|Overall Study|Physician Decision|1|||
48454682|NCT01313039|155852107|FG000|Overall Study|Adverse Event|1|||
48454683|NCT00981682|155852112|FG000|Overall Study|Adverse Event|48|||
48454684|NCT00981682|155852112|FG000|Overall Study|Withdrawal by Subject|52|||
48454685|NCT00981682|155852112|FG000|Overall Study|Lost to Follow-up|14|||
48454686|NCT00981682|155852112|FG000|Overall Study|Lack of Efficacy|13|||
48454687|NCT00981682|155852112|FG000|Overall Study|Protocol Violation|6|||
48454688|NCT00981682|155852112|FG000|Overall Study|administrative|9|||
48454689|NCT01922739|155852113|FG000|Titration/Adjustment Period|Adverse Event|3|||
48454690|NCT01922739|155852113|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
48454691|NCT01922739|155852113|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
48454692|NCT01922739|155852113|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
48454693|NCT01922739|155852113|FG000|Open-label Treatment Period|Adverse Event|6|||
48454694|NCT01922739|155852113|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
48454695|NCT01922739|155852113|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
48454696|NCT01922739|155852113|FG000|Open-label Treatment Period|Protocol Violation|5|||
48454697|NCT01922739|155852113|FG000|Open-label Treatment Period|Pregnancy|1|||
48454698|NCT01922739|155852113|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
48454699|NCT01922739|155852113|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
48454700|NCT01922739|155852113|FG000|Open-label Treatment Period|Physician Decision|1|||
48454701|NCT01922739|155852113|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
48454702|NCT00044213|155852114|FG000|Overall Study|Withdrawal by Subject|50|||
48454703|NCT00044213|155852115|FG001|Overall Study|Withdrawal by Subject|65|||
48454704|NCT00044213|155852116|FG002|Overall Study|Withdrawal by Subject|91|||
48454705|NCT00044213|155852117|FG003|Overall Study|Withdrawal by Subject|83|||
48454706|NCT00044213|155852114|FG000|Overall Study|Death|42|||
48454707|NCT00044213|155852115|FG001|Overall Study|Death|42|||
48454708|NCT00044213|155852116|FG002|Overall Study|Death|42|||
48454709|NCT00044213|155852117|FG003|Overall Study|Death|49|||
48454710|NCT00044213|155852114|FG000|Overall Study|Lost to Follow-up|8|||
48454711|NCT00044213|155852115|FG001|Overall Study|Lost to Follow-up|5|||
48454712|NCT00044213|155852116|FG002|Overall Study|Lost to Follow-up|5|||
48454713|NCT00044213|155852117|FG003|Overall Study|Lost to Follow-up|4|||
48454714|NCT03148795|155852124|FG000|Overall Study|Progressive Disease|1|||
48454715|NCT01102140|155852125|FG000|Overall Study|Lost to Follow-up|1|||
48454716|NCT01102140|155852126|FG001|Overall Study|Lost to Follow-up|0|||
48454717|NCT01102140|155852125|FG000|Overall Study|Investigator terminated study|2|||
48454718|NCT01102140|155852126|FG001|Overall Study|Investigator terminated study|2|||
48454719|NCT05406440|155852127|FG000|Overall Study|Lost to Follow-up|0|||
48454720|NCT05406440|155852128|FG001|Overall Study|Lost to Follow-up|0|||
48454721|NCT05406440|155852129|FG002|Overall Study|Lost to Follow-up|0|||
48454722|NCT05406440|155852130|FG003|Overall Study|Lost to Follow-up|0|||
48454723|NCT05406440|155852131|FG004|Overall Study|Lost to Follow-up|2|||
48454724|NCT05406440|155852132|FG005|Overall Study|Lost to Follow-up|0|||
48454725|NCT05406440|155852133|FG006|Overall Study|Lost to Follow-up|0|||
48454726|NCT05406440|155852127|FG000|Overall Study|Physician Decision|0|||
48454727|NCT05406440|155852128|FG001|Overall Study|Physician Decision|0|||
48454728|NCT05406440|155852129|FG002|Overall Study|Physician Decision|0|||
48454729|NCT05406440|155852130|FG003|Overall Study|Physician Decision|0|||
48454730|NCT05406440|155852131|FG004|Overall Study|Physician Decision|1|||
48454731|NCT05406440|155852132|FG005|Overall Study|Physician Decision|0|||
48454732|NCT05406440|155852133|FG006|Overall Study|Physician Decision|0|||
48454733|NCT05406440|155852127|FG000|Overall Study|Withdrawal by Subject|0|||
48454734|NCT05406440|155852128|FG001|Overall Study|Withdrawal by Subject|0|||
48454735|NCT05406440|155852129|FG002|Overall Study|Withdrawal by Subject|0|||
48454736|NCT05406440|155852130|FG003|Overall Study|Withdrawal by Subject|0|||
48454737|NCT05406440|155852131|FG004|Overall Study|Withdrawal by Subject|0|||
48454738|NCT05406440|155852132|FG005|Overall Study|Withdrawal by Subject|2|||
48454739|NCT05406440|155852133|FG006|Overall Study|Withdrawal by Subject|0|||
48454740|NCT00441012|155852137|FG000|Overall Study|Adverse Event|0|||
48454741|NCT00441012|155852138|FG001|Overall Study|Adverse Event|1|||
48454742|NCT00441012|155852137|FG000|Overall Study|Lost to Follow-up|3|||
48454743|NCT00441012|155852138|FG001|Overall Study|Lost to Follow-up|3|||
48454744|NCT00441012|155852137|FG000|Overall Study|Protocol Violation|10|||
48454745|NCT00441012|155852138|FG001|Overall Study|Protocol Violation|9|||
48454746|NCT00441012|155852137|FG000|Overall Study|Withdrawal by Subject|4|||
48454747|NCT00441012|155852138|FG001|Overall Study|Withdrawal by Subject|0|||
48454748|NCT00441012|155852137|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
48454749|NCT00441012|155852138|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
48454750|NCT03964493|155852139|FG000|Overall Study|Withdrawal by Subject|4|||
48454751|NCT03964493|155852140|FG001|Overall Study|Withdrawal by Subject|1|||
48454752|NCT03964493|155852139|FG000|Overall Study|Lost to Follow-up|13|||
48454753|NCT03964493|155852140|FG001|Overall Study|Lost to Follow-up|4|||
48454754|NCT00741260|155852143|FG000|Overall Study|Disease Progression|3|||
48454755|NCT00741260|155852144|FG001|Overall Study|Disease Progression|5|||
48454756|NCT00741260|155852145|FG002|Overall Study|Disease Progression|3|||
48454757|NCT00741260|155852146|FG003|Overall Study|Disease Progression|3|||
48454758|NCT00741260|155852147|FG004|Overall Study|Disease Progression|5|||
48454759|NCT00741260|155852148|FG005|Overall Study|Disease Progression|37|||
48454760|NCT00741260|155852149|FG006|Overall Study|Disease Progression|4|||
48454761|NCT00741260|155852143|FG000|Overall Study|Death|0|||
48454762|NCT00741260|155852144|FG001|Overall Study|Death|1|||
48454763|NCT00741260|155852145|FG002|Overall Study|Death|0|||
48454764|NCT00741260|155852146|FG003|Overall Study|Death|1|||
48454765|NCT00741260|155852147|FG004|Overall Study|Death|2|||
48454766|NCT00741260|155852148|FG005|Overall Study|Death|2|||
48454767|NCT00741260|155852149|FG006|Overall Study|Death|1|||
48454768|NCT00741260|155852143|FG000|Overall Study|Withdrawal by Subject|0|||
48454769|NCT00741260|155852144|FG001|Overall Study|Withdrawal by Subject|0|||
48454770|NCT00741260|155852145|FG002|Overall Study|Withdrawal by Subject|0|||
48454771|NCT00741260|155852146|FG003|Overall Study|Withdrawal by Subject|0|||
48454772|NCT00741260|155852147|FG004|Overall Study|Withdrawal by Subject|1|||
48454773|NCT00741260|155852148|FG005|Overall Study|Withdrawal by Subject|3|||
48454774|NCT00741260|155852149|FG006|Overall Study|Withdrawal by Subject|1|||
48454775|NCT00741260|155852143|FG000|Overall Study|Physician Decision|1|||
48454776|NCT00741260|155852144|FG001|Overall Study|Physician Decision|1|||
48454777|NCT00741260|155852145|FG002|Overall Study|Physician Decision|0|||
48454778|NCT00741260|155852146|FG003|Overall Study|Physician Decision|0|||
48454779|NCT00741260|155852147|FG004|Overall Study|Physician Decision|0|||
48454780|NCT00741260|155852148|FG005|Overall Study|Physician Decision|0|||
48454781|NCT00741260|155852149|FG006|Overall Study|Physician Decision|0|||
48454782|NCT00741260|155852143|FG000|Overall Study|Other|2|||
48454783|NCT00741260|155852144|FG001|Overall Study|Other|1|||
48454784|NCT00741260|155852145|FG002|Overall Study|Other|1|||
48454785|NCT00741260|155852146|FG003|Overall Study|Other|2|||
48454786|NCT00741260|155852147|FG004|Overall Study|Other|1|||
48454787|NCT00741260|155852148|FG005|Overall Study|Other|3|||
48454788|NCT00741260|155852149|FG006|Overall Study|Other|1|||
48454789|NCT02470429|155852150|FG000|Overall Study|Adverse Event|1|||
48454790|NCT02470429|155852151|FG001|Overall Study|Adverse Event|0|||
48454791|NCT02470429|155852150|FG000|Overall Study|Withdrawal by Subject|1|||
48454792|NCT02470429|155852151|FG001|Overall Study|Withdrawal by Subject|0|||
48454793|NCT02224274|155852154|FG000|Overall Study|Death|1|||
48454794|NCT02224274|155852155|FG001|Overall Study|Death|0|||
48454795|NCT04021706|155853681|FG000|Overall Study|Adverse Event|2|||
48454796|NCT04021706|155853682|FG001|Overall Study|Adverse Event|0|||
48454797|NCT04021706|155853681|FG000|Overall Study|Withdrawal by Subject|1|||
48454798|NCT04021706|155853682|FG001|Overall Study|Withdrawal by Subject|2|||
48454799|NCT04021706|155853681|FG000|Overall Study|Physician Decision|1|||
48454800|NCT04021706|155853682|FG001|Overall Study|Physician Decision|0|||
48454801|NCT04432376|155853684|FG000|Double-blind Treatment Period|Adverse Event|2|||
48454802|NCT04432376|155853685|FG001|Double-blind Treatment Period|Adverse Event|6|||
48454803|NCT04432376|155853686|FG002|Double-blind Treatment Period|Adverse Event|0|||
48454804|NCT04432376|155853684|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
48454805|NCT04432376|155853685|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
48454806|NCT04432376|155853686|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
48454807|NCT04432376|155853684|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
48454808|NCT04432376|155853685|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
48454809|NCT04432376|155853686|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48454810|NCT04432376|155853684|FG000|Double-blind Treatment Period|Protocol Violation|0|||
48454811|NCT04432376|155853685|FG001|Double-blind Treatment Period|Protocol Violation|1|||
48454812|NCT04432376|155853686|FG002|Double-blind Treatment Period|Protocol Violation|0|||
48454813|NCT04432376|155853684|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
48454814|NCT04432376|155853685|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
48454815|NCT04432376|155853686|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
48454816|NCT04914819|155853687|FG000|Overall Study|Pregnancy|3|||
48454817|NCT04914819|155853688|FG001|Overall Study|Pregnancy|1|||
48454818|NCT04914819|155853687|FG000|Overall Study|Discontinued study|4|||
48454819|NCT04914819|155853688|FG001|Overall Study|Discontinued study|1|||
48454820|NCT04914819|155853687|FG000|Overall Study|Lost to Follow-up|7|||
48454821|NCT04914819|155853688|FG001|Overall Study|Lost to Follow-up|0|||
48454822|NCT00790218|155853690|FG000|Overall Study|Death|1|||
48454823|NCT00790218|155853691|FG001|Overall Study|Death|0|||
48454824|NCT00790218|155853692|FG002|Overall Study|Death|0|||
48454825|NCT00086385|155853693|FG000|Overall Study|Death|2|||
48454826|NCT00086385|155853694|FG001|Overall Study|Death|2|||
48454827|NCT00086385|155853695|FG002|Overall Study|Death|1|||
48454828|NCT00086385|155853696|FG003|Overall Study|Death|1|||
48454829|NCT02715804|155853705|FG000|Overall Study|Death|222|||
48454830|NCT02715804|155853706|FG001|Overall Study|Death|106|||
48454831|NCT02715804|155853705|FG000|Overall Study|Withdrawal by Subject|5|||
48454832|NCT02715804|155853706|FG001|Overall Study|Withdrawal by Subject|4|||
48454833|NCT02715804|155853705|FG000|Overall Study|Other than specified|2|||
48454834|NCT02715804|155853706|FG001|Overall Study|Other than specified|3|||
48454835|NCT04038385|155853708|FG000|Overall Study|Completed baseline assessment only|7|||
48454836|NCT04038385|155853709|FG001|Overall Study|Completed baseline assessment only|4|||
48454837|NCT04038385|155853708|FG000|Overall Study|Moved out of area|4|||
48454838|NCT04038385|155853709|FG001|Overall Study|Moved out of area|2|||
48454839|NCT04038385|155853708|FG000|Overall Study|Discontinued study involvement|6|||
48454840|NCT04038385|155853709|FG001|Overall Study|Discontinued study involvement|1|||
48454841|NCT03424044|155853710|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48454842|NCT03424044|155853711|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48454843|NCT03424044|155853712|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
48454844|NCT03424044|155853713|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48454845|NCT03424044|155853714|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48454846|NCT03424044|155853715|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48454847|NCT03424044|155853716|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48454848|NCT03424044|155853717|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48454849|NCT03424044|155853718|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
48454850|NCT03424044|155853710|FG000|First Intervention (76 Hours)|Adverse Event|0|||
48454851|NCT03424044|155853711|FG001|First Intervention (76 Hours)|Adverse Event|0|||
48454852|NCT03424044|155853712|FG002|First Intervention (76 Hours)|Adverse Event|0|||
48454853|NCT03424044|155853713|FG003|First Intervention (76 Hours)|Adverse Event|0|||
48454854|NCT03424044|155853714|FG004|First Intervention (76 Hours)|Adverse Event|1|||
48454855|NCT03424044|155853715|FG005|First Intervention (76 Hours)|Adverse Event|0|||
48454856|NCT03424044|155853716|FG006|First Intervention (76 Hours)|Adverse Event|0|||
48454857|NCT03424044|155853717|FG007|First Intervention (76 Hours)|Adverse Event|0|||
48454858|NCT03424044|155853718|FG008|First Intervention (76 Hours)|Adverse Event|0|||
48454859|NCT03424044|155853710|FG000|First Intervention (76 Hours)|device issues|0|||
48454860|NCT03424044|155853711|FG001|First Intervention (76 Hours)|device issues|0|||
48454861|NCT03424044|155853712|FG002|First Intervention (76 Hours)|device issues|0|||
48454862|NCT03424044|155853713|FG003|First Intervention (76 Hours)|device issues|0|||
48454863|NCT03424044|155853714|FG004|First Intervention (76 Hours)|device issues|0|||
48454864|NCT03424044|155853715|FG005|First Intervention (76 Hours)|device issues|0|||
48454865|NCT03424044|155853716|FG006|First Intervention (76 Hours)|device issues|1|||
48454866|NCT03424044|155853717|FG007|First Intervention (76 Hours)|device issues|1|||
48454867|NCT03424044|155853718|FG008|First Intervention (76 Hours)|device issues|1|||
48454868|NCT03424044|155853710|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
48454869|NCT03424044|155853711|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
48454870|NCT03424044|155853712|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
48454871|NCT03424044|155853713|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
48454872|NCT03424044|155853714|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
48454873|NCT03424044|155853715|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
48454874|NCT03424044|155853716|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
48454875|NCT03424044|155853717|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
48454876|NCT03424044|155853718|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
48454877|NCT03424044|155853710|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48454878|NCT03424044|155853711|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48454879|NCT03424044|155853712|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48454880|NCT03424044|155853713|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
48454881|NCT03424044|155853714|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48454882|NCT03424044|155853715|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48454883|NCT03424044|155853716|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48454884|NCT03424044|155853717|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48454885|NCT03424044|155853718|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
48454886|NCT00209092|155853722|FG000|Overall Study|Progression of disease|7|||
48454887|NCT00209092|155853723|FG001|Overall Study|Progression of disease|1|||
48454888|NCT00209092|155853722|FG000|Overall Study|Adverse Event|0|||
48454889|NCT00209092|155853723|FG001|Overall Study|Adverse Event|1|||
48454890|NCT00209092|155853722|FG000|Overall Study|Withdrawal by Subject|1|||
48454891|NCT00209092|155853723|FG001|Overall Study|Withdrawal by Subject|0|||
48454892|NCT00509028|155853724|FG000|Overall Study|Adverse Event|2|||
48454893|NCT00509028|155853725|FG001|Overall Study|Adverse Event|0|||
48454894|NCT00509028|155853724|FG000|Overall Study|Withdrawal by Subject|4|||
48454895|NCT00509028|155853725|FG001|Overall Study|Withdrawal by Subject|3|||
48454896|NCT00509028|155853724|FG000|Overall Study|Lost to Follow-up|0|||
48454897|NCT00509028|155853725|FG001|Overall Study|Lost to Follow-up|1|||
48454898|NCT00509028|155853724|FG000|Overall Study|Protocol Violation|4|||
48454899|NCT00509028|155853725|FG001|Overall Study|Protocol Violation|2|||
48454900|NCT00509028|155853724|FG000|Overall Study|Non-compliance|2|||
48454901|NCT00509028|155853725|FG001|Overall Study|Non-compliance|1|||
48454902|NCT02116361|155853727|FG000|Overall Study|Pregnancy|0|||
48454903|NCT02116361|155853728|FG001|Overall Study|Pregnancy|0|||
48454904|NCT02116361|155853729|FG002|Overall Study|Pregnancy|0|||
48454905|NCT02116361|155853730|FG003|Overall Study|Pregnancy|1|||
48454906|NCT02116361|155853727|FG000|Overall Study|Protocol Violation|1|||
48454907|NCT02116361|155853728|FG001|Overall Study|Protocol Violation|0|||
48454908|NCT02116361|155853729|FG002|Overall Study|Protocol Violation|0|||
48454909|NCT02116361|155853730|FG003|Overall Study|Protocol Violation|2|||
48454910|NCT02116361|155853727|FG000|Overall Study|Physician Decision|2|||
48454911|NCT02116361|155853728|FG001|Overall Study|Physician Decision|3|||
48454912|NCT02116361|155853729|FG002|Overall Study|Physician Decision|0|||
48454913|NCT02116361|155853730|FG003|Overall Study|Physician Decision|0|||
48454914|NCT02116361|155853727|FG000|Overall Study|Adverse Event|1|||
48454915|NCT02116361|155853728|FG001|Overall Study|Adverse Event|0|||
48454916|NCT02116361|155853729|FG002|Overall Study|Adverse Event|0|||
48454917|NCT02116361|155853730|FG003|Overall Study|Adverse Event|3|||
48454918|NCT02116361|155853727|FG000|Overall Study|Other Reasons|3|||
48454919|NCT02116361|155853728|FG001|Overall Study|Other Reasons|3|||
48454920|NCT02116361|155853729|FG002|Overall Study|Other Reasons|3|||
48454921|NCT02116361|155853730|FG003|Overall Study|Other Reasons|3|||
48454922|NCT02116361|155853727|FG000|Overall Study|Lack of Efficacy|5|||
48454923|NCT02116361|155853728|FG001|Overall Study|Lack of Efficacy|7|||
48454924|NCT02116361|155853729|FG002|Overall Study|Lack of Efficacy|4|||
48454925|NCT02116361|155853730|FG003|Overall Study|Lack of Efficacy|3|||
48454926|NCT02116361|155853727|FG000|Overall Study|Lost to Follow-up|4|||
48454927|NCT02116361|155853728|FG001|Overall Study|Lost to Follow-up|5|||
48454928|NCT02116361|155853729|FG002|Overall Study|Lost to Follow-up|7|||
48454929|NCT02116361|155853730|FG003|Overall Study|Lost to Follow-up|5|||
48454930|NCT02116361|155853727|FG000|Overall Study|Personal Reasons|6|||
48454931|NCT02116361|155853728|FG001|Overall Study|Personal Reasons|6|||
48454932|NCT02116361|155853729|FG002|Overall Study|Personal Reasons|4|||
48454933|NCT02116361|155853730|FG003|Overall Study|Personal Reasons|9|||
48454934|NCT02116361|155853727|FG000|Overall Study|Investigator Decision - Relapse|9|||
48454935|NCT02116361|155853728|FG001|Overall Study|Investigator Decision - Relapse|7|||
48454936|NCT02116361|155853729|FG002|Overall Study|Investigator Decision - Relapse|8|||
48454937|NCT02116361|155853730|FG003|Overall Study|Investigator Decision - Relapse|5|||
48454938|NCT00136357|155853731|FG000|Overall Study|Withdrawal by Subject|3|||
48454939|NCT00136357|155853732|FG001|Overall Study|Withdrawal by Subject|2|||
48454940|NCT02025530|155853733|FG000|Overall Study|No longer met elligibility criteria|5|||
48454941|NCT02025530|155853734|FG001|Overall Study|No longer met elligibility criteria|1|||
48454942|NCT01355497|155853737|FG000|Overall Study|Death|19|||
48454943|NCT01355497|155853738|FG001|Overall Study|Death|18|||
48454944|NCT01355497|155853737|FG000|Overall Study|Lost to Follow-up|3|||
48454945|NCT01355497|155853738|FG001|Overall Study|Lost to Follow-up|0|||
48454946|NCT01355497|155853737|FG000|Overall Study|Protocol Violation|0|||
48454947|NCT01355497|155853738|FG001|Overall Study|Protocol Violation|1|||
48454948|NCT01355497|155853737|FG000|Overall Study|other-not provided|9|||
48454949|NCT01355497|155853738|FG001|Overall Study|other-not provided|4|||
48454950|NCT01355497|155853737|FG000|Overall Study|Withdrawal by Subject|12|||
48454951|NCT01355497|155853738|FG001|Overall Study|Withdrawal by Subject|20|||
48454952|NCT01355497|155853737|FG000|Overall Study|noncompliance|1|||
48454953|NCT01355497|155853738|FG001|Overall Study|noncompliance|2|||
48454954|NCT01355497|155853737|FG000|Overall Study|progressive disease|11|||
48454955|NCT01355497|155853738|FG001|Overall Study|progressive disease|8|||
48454956|NCT01355497|155853737|FG000|Overall Study|Adverse Event|11|||
48454957|NCT01355497|155853738|FG001|Overall Study|Adverse Event|10|||
48454958|NCT00511108|155853739|FG000|Overall Study|Adverse Event|2|||
48454959|NCT00511108|155853740|FG001|Overall Study|Adverse Event|0|||
48454960|NCT00511108|155853741|FG002|Overall Study|Adverse Event|1|||
48454961|NCT00511108|155853742|FG003|Overall Study|Adverse Event|2|||
48454962|NCT00511108|155853739|FG000|Overall Study|Lost to Follow-up|0|||
48454963|NCT00511108|155853740|FG001|Overall Study|Lost to Follow-up|2|||
48454964|NCT00511108|155853741|FG002|Overall Study|Lost to Follow-up|1|||
48454965|NCT00511108|155853742|FG003|Overall Study|Lost to Follow-up|0|||
48454966|NCT00511108|155853739|FG000|Overall Study|Physician Decision|0|||
48454967|NCT00511108|155853740|FG001|Overall Study|Physician Decision|0|||
48454968|NCT00511108|155853741|FG002|Overall Study|Physician Decision|0|||
48454969|NCT00511108|155853742|FG003|Overall Study|Physician Decision|1|||
48454970|NCT00511108|155853739|FG000|Overall Study|Withdrawal by Subject|4|||
48454971|NCT00511108|155853740|FG001|Overall Study|Withdrawal by Subject|0|||
48454972|NCT00511108|155853741|FG002|Overall Study|Withdrawal by Subject|3|||
48454973|NCT00511108|155853742|FG003|Overall Study|Withdrawal by Subject|2|||
48454974|NCT01678313|155853747|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
48454975|NCT01678313|155853748|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
48454976|NCT01678313|155853747|FG000|Completed the 3-month Therapy|Physician Decision|3|||
48455055|NCT01764022|155853779|FG001|Overall Study|Lost to Follow-up|0|||
48454977|NCT01678313|155853748|FG001|Completed the 3-month Therapy|Physician Decision|4|||
48454978|NCT01678313|155853747|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
48454979|NCT01678313|155853748|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
48454980|NCT01678313|155853747|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
48454981|NCT01678313|155853748|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
48454982|NCT01266070|155853749|FG000|Overall Study|Adverse Event|3|||
48454983|NCT01266070|155853749|FG000|Overall Study|Protocol Violation|1|||
48454984|NCT03006926|155853750|FG000|Overall Study|Adverse Event|0|||
48454985|NCT03006926|155853751|FG001|Overall Study|Adverse Event|27|||
48454986|NCT03006926|155853750|FG000|Overall Study|Withdrawal by Subject|0|||
48454987|NCT03006926|155853751|FG001|Overall Study|Withdrawal by Subject|1|||
48454988|NCT03006926|155853750|FG000|Overall Study|Radiological Disease Progression|0|||
48454989|NCT03006926|155853751|FG001|Overall Study|Radiological Disease Progression|52|||
48454990|NCT03006926|155853750|FG000|Overall Study|Clinical Disease Progression|0|||
48454991|NCT03006926|155853751|FG001|Overall Study|Clinical Disease Progression|10|||
48454992|NCT03006926|155853750|FG000|Overall Study|Other|0|||
48454993|NCT03006926|155853751|FG001|Overall Study|Other|8|||
48454994|NCT00732238|155853752|FG000|Overall Study|Bacteremia|4|||
48454995|NCT00732238|155853753|FG001|Overall Study|Bacteremia|1|||
48454996|NCT00732238|155853752|FG000|Overall Study|Asymptomatic bacteriuria|1|||
48454997|NCT00732238|155853753|FG001|Overall Study|Asymptomatic bacteriuria|0|||
48454998|NCT01192100|155853756|FG000|Overall Study|Withdrawal by Subject|0|||
48454999|NCT01192100|155853757|FG001|Overall Study|Withdrawal by Subject|0|||
48455000|NCT01192100|155853758|FG002|Overall Study|Withdrawal by Subject|0|||
48455001|NCT01192100|155853759|FG003|Overall Study|Withdrawal by Subject|0|||
48455002|NCT01192100|155853760|FG004|Overall Study|Withdrawal by Subject|1|||
48455003|NCT01192100|155853761|FG005|Overall Study|Withdrawal by Subject|0|||
48455004|NCT01192100|155853756|FG000|Overall Study|Protocol Violation|0|||
48455005|NCT01192100|155853757|FG001|Overall Study|Protocol Violation|0|||
48455006|NCT01192100|155853758|FG002|Overall Study|Protocol Violation|0|||
48455007|NCT01192100|155853759|FG003|Overall Study|Protocol Violation|1|||
48455008|NCT01192100|155853760|FG004|Overall Study|Protocol Violation|0|||
48455009|NCT01192100|155853761|FG005|Overall Study|Protocol Violation|0|||
48455010|NCT02977507|155853764|FG000|Overall Study|Protocol Deviation|1|||
48455011|NCT02977507|155853765|FG001|Overall Study|Protocol Deviation|0|||
48455012|NCT02977507|155853764|FG000|Overall Study|Lost to Follow-up|1|||
48455013|NCT02977507|155853765|FG001|Overall Study|Lost to Follow-up|0|||
48455014|NCT00537771|155853769|FG000|Overall Study|Withdrawal by Subject|6|||
48455015|NCT00537771|155853770|FG001|Overall Study|Withdrawal by Subject|23|||
48455016|NCT00537771|155853769|FG000|Overall Study|Adverse Event|8|||
48455017|NCT00537771|155853770|FG001|Overall Study|Adverse Event|15|||
48455018|NCT00537771|155853769|FG000|Overall Study|Lost to Follow-up|9|||
48455019|NCT00537771|155853770|FG001|Overall Study|Lost to Follow-up|15|||
48455020|NCT00537771|155853769|FG000|Overall Study|Protocol Violation|2|||
48455021|NCT00537771|155853770|FG001|Overall Study|Protocol Violation|6|||
48455022|NCT00537771|155853769|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
48455023|NCT00537771|155853770|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
48455024|NCT02465489|155853771|FG000|Overall Study|Adverse Event|5|||
48455025|NCT01600105|155853774|FG000|Total Participants|Withdrawal by Subject|1|||
48455026|NCT01600105|155853775|FG001|Total Participants|Withdrawal by Subject|0|||
48455027|NCT01600105|155853774|FG000|Total Participants|No images in PACS|10|||
48455028|NCT01600105|155853775|FG001|Total Participants|No images in PACS|0|||
48455029|NCT01600105|155853774|FG000|Total Participants|Insufficient image quality|30|||
48455030|NCT01600105|155853775|FG001|Total Participants|Insufficient image quality|10|||
48455031|NCT01600105|155853774|FG000|Sub Study I|Insufficient image quality|0|||
48455032|NCT01600105|155853775|FG001|Sub Study I|Insufficient image quality|10|||
48455033|NCT01600105|155853774|FG000|Sub Study II|Withdrawal by Subject|1|||
48455034|NCT01600105|155853775|FG001|Sub Study II|Withdrawal by Subject|0|||
48455035|NCT01600105|155853774|FG000|Sub Study II|No images in PACS|1|||
48455036|NCT01600105|155853775|FG001|Sub Study II|No images in PACS|0|||
48455037|NCT01600105|155853774|FG000|Sub Study II|Insufficient image quality|3|||
48455038|NCT01600105|155853775|FG001|Sub Study II|Insufficient image quality|0|||
48455039|NCT01600105|155853774|FG000|Sub Study III|Insufficient image quality|5|||
48455040|NCT01600105|155853775|FG001|Sub Study III|Insufficient image quality|0|||
48455041|NCT01600105|155853774|FG000|Sub Study V|Poor Image Quality|2|||
48455042|NCT01600105|155853775|FG001|Sub Study V|Poor Image Quality|0|||
48455043|NCT01263444|155853776|FG000|Overall Study|Adverse Event|8|||
48455044|NCT01263444|155853776|FG000|Overall Study|Withdrawal by Subject|1|||
48455045|NCT01263444|155853776|FG000|Overall Study|Protocol Violation|1|||
48455046|NCT01764022|155853778|FG000|Overall Study|Death|3|||
48455047|NCT01764022|155853779|FG001|Overall Study|Death|5|||
48455048|NCT01764022|155853778|FG000|Overall Study|Withdrawal by Subject|2|||
48455049|NCT01764022|155853779|FG001|Overall Study|Withdrawal by Subject|6|||
48455050|NCT01764022|155853778|FG000|Overall Study|Lack of Efficacy|0|||
48455051|NCT01764022|155853779|FG001|Overall Study|Lack of Efficacy|1|||
48455052|NCT01764022|155853778|FG000|Overall Study|Physician Decision|0|||
48455053|NCT01764022|155853779|FG001|Overall Study|Physician Decision|2|||
48455054|NCT01764022|155853778|FG000|Overall Study|Lost to Follow-up|2|||
48455056|NCT01764022|155853778|FG000|Overall Study|Protocol Violation|1|||
48455057|NCT01764022|155853779|FG001|Overall Study|Protocol Violation|0|||
48455058|NCT01899768|155853780|FG000|Part A|Adverse Event|2|||
48455059|NCT01899768|155853780|FG000|Part A|Withdrawal by Subject|1|||
48455060|NCT01899768|155853780|FG000|Part B|Adverse Event|1|||
48455061|NCT01899768|155853780|FG000|Part B|Withdrawal by Subject|1|||
48455062|NCT00552344|155853788|FG000|Overall Study|Lack of Efficacy|55|||
48455063|NCT00552344|155853788|FG000|Overall Study|Loss of efficacy|75|||
48455064|NCT00552344|155853788|FG000|Overall Study|Lost to Follow-up|8|||
48455065|NCT00552344|155853788|FG000|Overall Study|Withdrawal by Subject|48|||
48455066|NCT00552344|155853788|FG000|Overall Study|SAE, non-fatal|6|||
48455067|NCT00552344|155853788|FG000|Overall Study|AE, non-serious non-fatal|38|||
48455068|NCT00552344|155853788|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
48455069|NCT00552344|155853788|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
48455070|NCT00552344|155853788|FG000|Overall Study|Other Reason|22|||
48455071|NCT00744991|155853789|FG000|Overall Study|Progressive Disease|11|||
48455072|NCT00744991|155853789|FG000|Overall Study|Withdrawal by Subject|8|||
48455073|NCT00744991|155853789|FG000|Overall Study|Physician Decision|3|||
48455074|NCT00744991|155853789|FG000|Overall Study|Adverse Event|2|||
48455075|NCT00744991|155853789|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
48455076|NCT02996500|155853791|FG000|Overall Study|Adverse Event|1|||
48455077|NCT02996500|155853792|FG001|Overall Study|Adverse Event|1|||
48455078|NCT02996500|155853793|FG002|Overall Study|Adverse Event|4|||
48455079|NCT02996500|155853794|FG003|Overall Study|Adverse Event|3|||
48455080|NCT02996500|155853795|FG004|Overall Study|Adverse Event|1|||
48455081|NCT02996500|155853796|FG005|Overall Study|Adverse Event|2|||
48455082|NCT02996500|155853791|FG000|Overall Study|Lack of Efficacy|0|||
48455083|NCT02996500|155853792|FG001|Overall Study|Lack of Efficacy|0|||
48455084|NCT02996500|155853793|FG002|Overall Study|Lack of Efficacy|0|||
48455085|NCT02996500|155853794|FG003|Overall Study|Lack of Efficacy|0|||
48455086|NCT02996500|155853795|FG004|Overall Study|Lack of Efficacy|2|||
48455087|NCT02996500|155853796|FG005|Overall Study|Lack of Efficacy|0|||
48455088|NCT02996500|155853791|FG000|Overall Study|Lost to Follow-up|1|||
48455089|NCT02996500|155853792|FG001|Overall Study|Lost to Follow-up|0|||
48455090|NCT02996500|155853793|FG002|Overall Study|Lost to Follow-up|0|||
48455091|NCT02996500|155853794|FG003|Overall Study|Lost to Follow-up|0|||
48455092|NCT02996500|155853795|FG004|Overall Study|Lost to Follow-up|0|||
48455093|NCT02996500|155853796|FG005|Overall Study|Lost to Follow-up|1|||
48455094|NCT02996500|155853791|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
48455095|NCT02996500|155853792|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
48455096|NCT02996500|155853793|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
48455097|NCT02996500|155853794|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
48455098|NCT02996500|155853795|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
48455099|NCT02996500|155853796|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
48455100|NCT02996500|155853791|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48455101|NCT02996500|155853792|FG001|Overall Study|Non-Compliance With Study Drug|0|||
48455102|NCT02996500|155853793|FG002|Overall Study|Non-Compliance With Study Drug|0|||
48455103|NCT02996500|155853794|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48455104|NCT02996500|155853795|FG004|Overall Study|Non-Compliance With Study Drug|0|||
48455105|NCT02996500|155853796|FG005|Overall Study|Non-Compliance With Study Drug|1|||
48455106|NCT02996500|155853791|FG000|Overall Study|Progressive Disease|1|||
48455107|NCT02996500|155853792|FG001|Overall Study|Progressive Disease|0|||
48455108|NCT02996500|155853793|FG002|Overall Study|Progressive Disease|0|||
48455109|NCT02996500|155853794|FG003|Overall Study|Progressive Disease|0|||
48455110|NCT02996500|155853795|FG004|Overall Study|Progressive Disease|0|||
48455111|NCT02996500|155853796|FG005|Overall Study|Progressive Disease|0|||
48455112|NCT02996500|155853791|FG000|Overall Study|Other|2|||
48455113|NCT02996500|155853792|FG001|Overall Study|Other|0|||
48455114|NCT02996500|155853793|FG002|Overall Study|Other|2|||
48455115|NCT02996500|155853794|FG003|Overall Study|Other|0|||
48455116|NCT02996500|155853795|FG004|Overall Study|Other|0|||
48455117|NCT02996500|155853796|FG005|Overall Study|Other|0|||
48455118|NCT02996500|155853791|FG000|Overall Study|Protocol Violation|0|||
48455119|NCT02996500|155853792|FG001|Overall Study|Protocol Violation|0|||
48455120|NCT02996500|155853793|FG002|Overall Study|Protocol Violation|0|||
48455121|NCT02996500|155853794|FG003|Overall Study|Protocol Violation|1|||
48455122|NCT02996500|155853795|FG004|Overall Study|Protocol Violation|0|||
48455123|NCT02996500|155853796|FG005|Overall Study|Protocol Violation|0|||
48455124|NCT02996500|155853791|FG000|Overall Study|Withdrawal by Subject|3|||
48455125|NCT02996500|155853792|FG001|Overall Study|Withdrawal by Subject|0|||
48455126|NCT02996500|155853793|FG002|Overall Study|Withdrawal by Subject|3|||
48455127|NCT02996500|155853794|FG003|Overall Study|Withdrawal by Subject|0|||
48455128|NCT02996500|155853795|FG004|Overall Study|Withdrawal by Subject|2|||
48455129|NCT02996500|155853796|FG005|Overall Study|Withdrawal by Subject|0|||
48455130|NCT01678560|155853797|FG000|Overall Study|Physician Decision|4|||
48455131|NCT01678560|155853798|FG001|Overall Study|Physician Decision|4|||
48455132|NCT01678560|155853797|FG000|Overall Study|Death|0|||
48455133|NCT01678560|155853798|FG001|Overall Study|Death|1|||
48455134|NCT01678560|155853797|FG000|Overall Study|Withdrawal by Subject|0|||
48455135|NCT01678560|155853798|FG001|Overall Study|Withdrawal by Subject|1|||
48455136|NCT04498468|155853799|FG000|Overall Study|Lost to Follow-up|3|||
48455137|NCT00262314|155853802|FG000|Overall Study|Changing physicians|38|||
48455138|NCT00262314|155853802|FG000|Overall Study|Death|12|||
48455139|NCT00262314|155853802|FG000|Overall Study|Patient's decision|92|||
48455140|NCT00262314|155853802|FG000|Overall Study|Other|95|||
48455141|NCT00262314|155853802|FG000|Overall Study|Lost to Follow-up|70|||
48455142|NCT00262314|155853802|FG000|Overall Study|Administrative withdrawal|30|||
48455143|NCT03074318|155853803|FG000|Overall Study|Adverse Event|0|||
48455144|NCT03074318|155853804|FG001|Overall Study|Adverse Event|1|||
48455145|NCT03074318|155853805|FG002|Overall Study|Adverse Event|1|||
48455146|NCT03074318|155853806|FG003|Overall Study|Adverse Event|1|||
48455147|NCT03074318|155853803|FG000|Overall Study|Death|1|||
48455148|NCT03074318|155853804|FG001|Overall Study|Death|0|||
48455149|NCT03074318|155853805|FG002|Overall Study|Death|0|||
48455150|NCT03074318|155853806|FG003|Overall Study|Death|0|||
48455151|NCT03074318|155853803|FG000|Overall Study|Withdrawal by Subject|1|||
48455152|NCT03074318|155853804|FG001|Overall Study|Withdrawal by Subject|2|||
48455153|NCT03074318|155853805|FG002|Overall Study|Withdrawal by Subject|2|||
48455154|NCT03074318|155853806|FG003|Overall Study|Withdrawal by Subject|4|||
48455155|NCT03074318|155853803|FG000|Overall Study|Trial Closure|2|||
48455156|NCT03074318|155853804|FG001|Overall Study|Trial Closure|2|||
48455157|NCT03074318|155853805|FG002|Overall Study|Trial Closure|3|||
48455158|NCT03074318|155853806|FG003|Overall Study|Trial Closure|11|||
48455159|NCT01838213|155853807|FG000|Overall Study|Ineligible|166|||
48455160|NCT01838213|155853808|FG001|Overall Study|Ineligible|191|||
48455161|NCT05104749|155853809|FG000|Overall Study|Lost to Follow-up|2|||
48455162|NCT05104749|155853810|FG001|Overall Study|Lost to Follow-up|3|||
48455163|NCT03399786|155853811|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
48455164|NCT03399786|155853812|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48455165|NCT03399786|155853813|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48455166|NCT03399786|155853814|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
48455167|NCT03399786|155853811|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
48455168|NCT03399786|155853812|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
48455169|NCT03399786|155853813|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
48455170|NCT03399786|155853814|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
48455171|NCT03399786|155853811|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
48455172|NCT03399786|155853812|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
48455173|NCT03399786|155853813|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
48455174|NCT03399786|155853814|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
48455175|NCT01607073|155853815|FG000|Overall Study|Adverse Event|1|||
48455176|NCT00796224|155853816|FG000|Overall Study|Adverse Event|1|||
48455177|NCT00796224|155853817|FG001|Overall Study|Adverse Event|0|||
48455178|NCT00796224|155853816|FG000|Overall Study|Protocol Violation|0|||
48455179|NCT00796224|155853817|FG001|Overall Study|Protocol Violation|1|||
48455180|NCT02963766|155853822|FG000|Double-Blind Period|Adverse Event|1|||
48455181|NCT02963766|155853823|FG001|Double-Blind Period|Adverse Event|0|||
48455182|NCT02963766|155853824|FG002|Double-Blind Period|Adverse Event|1|||
48455183|NCT02963766|155853822|FG000|Double-Blind Period|Physician Decision|1|||
48455184|NCT02963766|155853823|FG001|Double-Blind Period|Physician Decision|0|||
48455185|NCT02963766|155853824|FG002|Double-Blind Period|Physician Decision|0|||
48455186|NCT02963766|155853822|FG000|Double-Blind Period|Withdrawal by Subject|1|||
48455187|NCT02963766|155853823|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48455188|NCT02963766|155853824|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48455189|NCT02963766|155853822|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
48455190|NCT02963766|155853823|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
48455191|NCT02963766|155853824|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
48455192|NCT02963766|155853822|FG000|Double-Blind Period|Protocol Violation|1|||
48455193|NCT02963766|155853823|FG001|Double-Blind Period|Protocol Violation|0|||
48455194|NCT02963766|155853824|FG002|Double-Blind Period|Protocol Violation|0|||
48455195|NCT02963766|155853822|FG000|Double-Blind Period|Lost to Follow-up|0|||
48455196|NCT02963766|155853823|FG001|Double-Blind Period|Lost to Follow-up|1|||
48455197|NCT02963766|155853824|FG002|Double-Blind Period|Lost to Follow-up|0|||
48455198|NCT02963766|155853822|FG000|Open Label Extension (OLE)|Physician Decision|1|||
48455199|NCT02963766|155853823|FG001|Open Label Extension (OLE)|Physician Decision|2|||
48455200|NCT02963766|155853824|FG002|Open Label Extension (OLE)|Physician Decision|2|||
48455201|NCT02963766|155853822|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
48455202|NCT02963766|155853823|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
48455203|NCT02963766|155853824|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
48455204|NCT00398138|155853825|FG000|Overall Study|Adverse Event|2|||
48455205|NCT02943668|155853826|FG000|Overall Study|Disease Progression|1|||
48455206|NCT00499460|155853827|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
48455207|NCT00499460|155853828|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
48455208|NCT00499460|155853827|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
48455209|NCT00499460|155853828|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
48455210|NCT00499460|155853827|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
48455211|NCT00499460|155853828|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
48455212|NCT04157751|155853834|FG000|Overall Study|Withdrawal by Subject|12|||
48455213|NCT04157751|155853835|FG001|Overall Study|Withdrawal by Subject|17|||
48455214|NCT04157751|155853834|FG000|Overall Study|Lost to Follow-up|6|||
48455215|NCT04157751|155853835|FG001|Overall Study|Lost to Follow-up|2|||
48455216|NCT04157751|155853834|FG000|Overall Study|Adverse Event|34|||
48455217|NCT04157751|155853835|FG001|Overall Study|Adverse Event|23|||
48455218|NCT04157751|155853834|FG000|Overall Study|Not treated|1|||
48455219|NCT04157751|155853835|FG001|Overall Study|Not treated|5|||
48455220|NCT04157751|155853834|FG000|Overall Study|Other reason not stated above|10|||
48455221|NCT04157751|155853835|FG001|Overall Study|Other reason not stated above|10|||
48455222|NCT01305941|155855341|FG000|Overall Study|Adverse Event|6|||
48455223|NCT01305941|155855341|FG000|Overall Study|Clinical decline|2|||
48455224|NCT01305941|155855341|FG000|Overall Study|Withdrawal by Subject|1|||
48455225|NCT01305941|155855341|FG000|Overall Study|Death|1|||
48455226|NCT02971007|155855342|FG000|Overall Study|Adverse Event|1|||
48455227|NCT02971007|155855343|FG001|Overall Study|Adverse Event|0|||
48455228|NCT02971007|155855344|FG002|Overall Study|Adverse Event|0|||
48455229|NCT02971007|155855342|FG000|Overall Study|Lost to Follow-up|0|||
48455230|NCT02971007|155855343|FG001|Overall Study|Lost to Follow-up|1|||
48455231|NCT02971007|155855344|FG002|Overall Study|Lost to Follow-up|1|||
48455232|NCT02971007|155855342|FG000|Overall Study|Withdrawal by Subject|0|||
48455233|NCT02971007|155855343|FG001|Overall Study|Withdrawal by Subject|1|||
48455234|NCT02971007|155855344|FG002|Overall Study|Withdrawal by Subject|0|||
48455235|NCT02971007|155855342|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
48455236|NCT02971007|155855343|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
48455237|NCT02971007|155855344|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
48455238|NCT02971007|155855342|FG000|Overall Study|Patient discontinued study drug|0|||
48455239|NCT02971007|155855343|FG001|Overall Study|Patient discontinued study drug|1|||
48455240|NCT02971007|155855344|FG002|Overall Study|Patient discontinued study drug|0|||
48455241|NCT01690988|155855345|FG000|Overall Study|Withdrawal by Subject|2|||
48455242|NCT01690988|155855346|FG001|Overall Study|Withdrawal by Subject|2|||
48455243|NCT01690988|155855347|FG002|Overall Study|Withdrawal by Subject|3|||
48455244|NCT01690988|155855345|FG000|Overall Study|Physician Decision|0|||
48455245|NCT01690988|155855346|FG001|Overall Study|Physician Decision|0|||
48455246|NCT01690988|155855347|FG002|Overall Study|Physician Decision|1|||
48455247|NCT01690988|155855345|FG000|Overall Study|Operation Cancelled|1|||
48455248|NCT01690988|155855346|FG001|Overall Study|Operation Cancelled|1|||
48455249|NCT01690988|155855347|FG002|Overall Study|Operation Cancelled|0|||
48455250|NCT01690988|155855345|FG000|Overall Study|Determined ineligible|1|||
48455251|NCT01690988|155855346|FG001|Overall Study|Determined ineligible|0|||
48455252|NCT01690988|155855347|FG002|Overall Study|Determined ineligible|0|||
48455253|NCT01690988|155855345|FG000|Overall Study|Death|1|||
48455254|NCT01690988|155855346|FG001|Overall Study|Death|1|||
48455255|NCT01690988|155855347|FG002|Overall Study|Death|1|||
48455256|NCT01690988|155855345|FG000|Overall Study|Sedated|1|||
48455257|NCT01690988|155855346|FG001|Overall Study|Sedated|1|||
48455258|NCT01690988|155855347|FG002|Overall Study|Sedated|2|||
48455259|NCT01237223|155855352|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
48455260|NCT01237223|155855353|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48455261|NCT01237223|155855354|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48455262|NCT01237223|155855355|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48455263|NCT01237223|155855356|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48455264|NCT01237223|155855357|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
48455265|NCT01237223|155855352|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
48455266|NCT01237223|155855353|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48455267|NCT01237223|155855354|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48455268|NCT01237223|155855355|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48455269|NCT01237223|155855356|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48455270|NCT01237223|155855357|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
48455271|NCT01237223|155855352|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
48455272|NCT01237223|155855353|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48455273|NCT01237223|155855354|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48455274|NCT01237223|155855355|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48455275|NCT01237223|155855356|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48455276|NCT01237223|155855357|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
48455277|NCT01237223|155855352|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
48455278|NCT01237223|155855353|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48455279|NCT01237223|155855354|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48455280|NCT01237223|155855355|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48455281|NCT01237223|155855356|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48455282|NCT01237223|155855357|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
48455283|NCT01237223|155855352|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
48455284|NCT01237223|155855353|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48455285|NCT01237223|155855354|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48455286|NCT01237223|155855355|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48455287|NCT01237223|155855356|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48455288|NCT01237223|155855357|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
48455289|NCT01237223|155855352|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
48455290|NCT01237223|155855353|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
48455291|NCT01237223|155855354|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
48455292|NCT01237223|155855355|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
48455293|NCT01237223|155855356|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
48455294|NCT01237223|155855357|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
48455295|NCT01237223|155855352|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
48455296|NCT01237223|155855353|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
48455297|NCT01237223|155855354|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
48455298|NCT01237223|155855355|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
48455299|NCT01237223|155855356|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
48455300|NCT01237223|155855357|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
48455301|NCT01237223|155855352|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
48455302|NCT01237223|155855353|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
48455303|NCT01237223|155855354|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
48455304|NCT01237223|155855355|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
48455305|NCT01237223|155855356|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
48455306|NCT01237223|155855357|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
48455307|NCT01237223|155855352|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48455308|NCT01237223|155855353|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48455309|NCT01237223|155855354|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48455310|NCT01237223|155855355|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48455311|NCT01237223|155855356|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
48455312|NCT01237223|155855357|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
48455313|NCT01237223|155855352|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
48455314|NCT01237223|155855353|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
48455315|NCT01237223|155855354|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
48455316|NCT01237223|155855355|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
48455317|NCT01237223|155855356|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
48455318|NCT01237223|155855357|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
48455319|NCT00688623|155855358|FG000|Overall Study|Adverse Event|22|||
48455320|NCT00688623|155855358|FG000|Overall Study|abnormal lab value|1|||
48455321|NCT00688623|155855358|FG000|Overall Study|Withdrawal by Subject|4|||
48455322|NCT00688623|155855358|FG000|Overall Study|Death|3|||
48455323|NCT00688623|155855358|FG000|Overall Study|disease progression|23|||
48455324|NCT00688623|155855358|FG000|Overall Study|Protocol Violation|2|||
48455325|NCT02443155|155855359|FG000|Overall Study|Adverse Event|3|||
48455326|NCT02443155|155855360|FG001|Overall Study|Adverse Event|4|||
48455327|NCT02443155|155855361|FG002|Overall Study|Adverse Event|1|||
48455328|NCT02443155|155855362|FG003|Overall Study|Adverse Event|2|||
48455329|NCT02443155|155855359|FG000|Overall Study|Unclassified|0|||
48455330|NCT02443155|155855360|FG001|Overall Study|Unclassified|0|||
48455331|NCT02443155|155855361|FG002|Overall Study|Unclassified|2|||
48455332|NCT02443155|155855362|FG003|Overall Study|Unclassified|1|||
48455333|NCT02443155|155855359|FG000|Overall Study|Withdrawal by Subject|4|||
48455334|NCT02443155|155855360|FG001|Overall Study|Withdrawal by Subject|7|||
48455335|NCT02443155|155855361|FG002|Overall Study|Withdrawal by Subject|3|||
48455336|NCT02443155|155855362|FG003|Overall Study|Withdrawal by Subject|9|||
48455337|NCT02443155|155855359|FG000|Overall Study|Pregnancy|3|||
48455338|NCT02443155|155855360|FG001|Overall Study|Pregnancy|1|||
48455339|NCT02443155|155855361|FG002|Overall Study|Pregnancy|1|||
48455340|NCT02443155|155855362|FG003|Overall Study|Pregnancy|2|||
48455341|NCT02443155|155855359|FG000|Overall Study|Lost to Follow-up|1|||
48455342|NCT02443155|155855360|FG001|Overall Study|Lost to Follow-up|2|||
48455343|NCT02443155|155855361|FG002|Overall Study|Lost to Follow-up|0|||
48455344|NCT02443155|155855362|FG003|Overall Study|Lost to Follow-up|1|||
48455345|NCT02443155|155855359|FG000|Overall Study|Protocol Violation|1|||
48455346|NCT02443155|155855360|FG001|Overall Study|Protocol Violation|0|||
48455347|NCT02443155|155855361|FG002|Overall Study|Protocol Violation|1|||
48455348|NCT02443155|155855362|FG003|Overall Study|Protocol Violation|1|||
48455349|NCT02443155|155855359|FG000|Overall Study|Death|0|||
48455350|NCT02443155|155855360|FG001|Overall Study|Death|0|||
48455351|NCT02443155|155855361|FG002|Overall Study|Death|1|||
48455352|NCT02443155|155855362|FG003|Overall Study|Death|0|||
48455353|NCT01376388|155855364|FG000|Overall Study|Adverse Event|13|||
48455354|NCT01376388|155855364|FG000|Overall Study|Lack of Efficacy|2|||
48455355|NCT01376388|155855364|FG000|Overall Study|Withdrawal by Subject|3|||
48455356|NCT02853123|155855365|FG000|Treatment Period 1|Adverse Event|0|||
48455357|NCT02853123|155855366|FG001|Treatment Period 1|Adverse Event|3|||
48455358|NCT02853123|155855365|FG000|Washout Period|Worsening of COPD|0|||
48455359|NCT02853123|155855366|FG001|Washout Period|Worsening of COPD|3|||
48455360|NCT02853123|155855365|FG000|Washout Period|Adverse Event|1|||
48455361|NCT02853123|155855366|FG001|Washout Period|Adverse Event|0|||
48455362|NCT00063986|155855367|FG000|Overall Study|Withdrawal by Subject|1|||
48455363|NCT00063986|155855367|FG000|Overall Study|Ineligible|1|||
48455364|NCT00063986|155855367|FG000|Overall Study|Intra-operatively ineligible|4|||
48455365|NCT01462045|155855368|FG000|Overall Study|Family matter|0|||
48455366|NCT01462045|155855369|FG001|Overall Study|Family matter|1|||
48455367|NCT01462045|155855370|FG002|Overall Study|Family matter|0|||
48455368|NCT05283499|155855378|FG000|Overall Study|Did not receive intervention|1|||
48455369|NCT05283499|155855379|FG001|Overall Study|Did not receive intervention|2|||
48455370|NCT02408484|155855380|FG000|Overall Study|Withdrawal by Subject|3|||
48455371|NCT02408484|155855380|FG000|Overall Study|Not treated during study period|1|||
48455372|NCT01782885|155855383|FG000|Overall Study|Lost to Follow-up|4|||
48455373|NCT01782885|155855384|FG001|Overall Study|Lost to Follow-up|6|||
48455374|NCT00557323|155855387|FG000|Overall Study|Death|3|||
48455375|NCT00557323|155855387|FG000|Overall Study|Withdrawal by Subject|2|||
48455376|NCT00557323|155855387|FG000|Overall Study|Administrative change|2|||
48455377|NCT00693693|155855392|FG000|Overall Study|Lost to Follow-up|1|||
48455378|NCT00693693|155855393|FG001|Overall Study|Lost to Follow-up|1|||
48455379|NCT00693693|155855394|FG002|Overall Study|Lost to Follow-up|2|||
48455380|NCT01855425|155855397|FG000|Overall Study|Physician Decision|20|||
48455381|NCT00638690|155855398|FG000|Overall Study|Death|655|||
48455382|NCT00638690|155855399|FG001|Overall Study|Death|335|||
48455383|NCT00638690|155855398|FG000|Overall Study|Withdrawal by Subject|22|||
48455384|NCT00638690|155855399|FG001|Overall Study|Withdrawal by Subject|5|||
48455385|NCT00638690|155855398|FG000|Overall Study|Lost to Follow-up|4|||
48455386|NCT00638690|155855399|FG001|Overall Study|Lost to Follow-up|2|||
48455387|NCT01641081|155855405|FG000|Period 1|Sponsor request (potential unblinding)|0|||
48455388|NCT01641081|155855406|FG001|Period 1|Sponsor request (potential unblinding)|0|||
48455389|NCT01641081|155855407|FG002|Period 1|Sponsor request (potential unblinding)|0|||
48455390|NCT01641081|155855408|FG003|Period 1|Sponsor request (potential unblinding)|0|||
48455391|NCT01641081|155855409|FG004|Period 1|Sponsor request (potential unblinding)|0|||
48455392|NCT01641081|155855410|FG005|Period 1|Sponsor request (potential unblinding)|0|||
48455393|NCT01641081|155855411|FG006|Period 1|Sponsor request (potential unblinding)|1|||
48455394|NCT01641081|155855412|FG007|Period 1|Sponsor request (potential unblinding)|0|||
48455395|NCT01641081|155855413|FG008|Period 1|Sponsor request (potential unblinding)|0|||
48455396|NCT01641081|155855414|FG009|Period 1|Sponsor request (potential unblinding)|0|||
48455397|NCT01641081|155855405|FG000|Period 1|Protocol Violation|0|||
48455398|NCT01641081|155855406|FG001|Period 1|Protocol Violation|0|||
48455399|NCT01641081|155855407|FG002|Period 1|Protocol Violation|0|||
48455400|NCT01641081|155855408|FG003|Period 1|Protocol Violation|0|||
48455401|NCT01641081|155855409|FG004|Period 1|Protocol Violation|1|||
48455402|NCT01641081|155855410|FG005|Period 1|Protocol Violation|0|||
48455403|NCT01641081|155855411|FG006|Period 1|Protocol Violation|0|||
48455404|NCT01641081|155855412|FG007|Period 1|Protocol Violation|1|||
48455405|NCT01641081|155855413|FG008|Period 1|Protocol Violation|0|||
48455406|NCT01641081|155855414|FG009|Period 1|Protocol Violation|0|||
48455407|NCT01641081|155855405|FG000|Period 1|Adverse Event|1|||
48455408|NCT01641081|155855406|FG001|Period 1|Adverse Event|0|||
48455409|NCT01641081|155855407|FG002|Period 1|Adverse Event|0|||
48455410|NCT01641081|155855408|FG003|Period 1|Adverse Event|0|||
48455411|NCT01641081|155855409|FG004|Period 1|Adverse Event|0|||
48455412|NCT01641081|155855410|FG005|Period 1|Adverse Event|0|||
48455413|NCT01641081|155855411|FG006|Period 1|Adverse Event|0|||
48455414|NCT01641081|155855412|FG007|Period 1|Adverse Event|2|||
48455415|NCT01641081|155855413|FG008|Period 1|Adverse Event|0|||
48455416|NCT01641081|155855414|FG009|Period 1|Adverse Event|0|||
48455417|NCT01641081|155855405|FG000|Period 2|Adverse Event|0|||
48455418|NCT01641081|155855406|FG001|Period 2|Adverse Event|0|||
48455419|NCT01641081|155855407|FG002|Period 2|Adverse Event|0|||
48455420|NCT01641081|155855408|FG003|Period 2|Adverse Event|0|||
48455421|NCT01641081|155855409|FG004|Period 2|Adverse Event|0|||
48455422|NCT01641081|155855410|FG005|Period 2|Adverse Event|1|||
48455423|NCT01641081|155855411|FG006|Period 2|Adverse Event|0|||
48455424|NCT01641081|155855412|FG007|Period 2|Adverse Event|0|||
48455425|NCT01641081|155855413|FG008|Period 2|Adverse Event|0|||
48455426|NCT01641081|155855414|FG009|Period 2|Adverse Event|0|||
48455427|NCT01641081|155855405|FG000|Period 2|Withdrawal by Subject|0|||
48455428|NCT01641081|155855406|FG001|Period 2|Withdrawal by Subject|0|||
48455429|NCT01641081|155855407|FG002|Period 2|Withdrawal by Subject|0|||
48455430|NCT01641081|155855408|FG003|Period 2|Withdrawal by Subject|1|||
48455431|NCT01641081|155855409|FG004|Period 2|Withdrawal by Subject|0|||
48455432|NCT01641081|155855410|FG005|Period 2|Withdrawal by Subject|0|||
48455433|NCT01641081|155855411|FG006|Period 2|Withdrawal by Subject|2|||
48455434|NCT01641081|155855412|FG007|Period 2|Withdrawal by Subject|0|||
48455435|NCT01641081|155855413|FG008|Period 2|Withdrawal by Subject|0|||
48455436|NCT01641081|155855414|FG009|Period 2|Withdrawal by Subject|0|||
48455437|NCT01641081|155855405|FG000|Period 2|Protocol Violation|1|||
48455438|NCT01641081|155855406|FG001|Period 2|Protocol Violation|0|||
48455439|NCT01641081|155855407|FG002|Period 2|Protocol Violation|0|||
48455440|NCT01641081|155855408|FG003|Period 2|Protocol Violation|0|||
48455441|NCT01641081|155855409|FG004|Period 2|Protocol Violation|0|||
48455442|NCT01641081|155855410|FG005|Period 2|Protocol Violation|0|||
48455443|NCT01641081|155855411|FG006|Period 2|Protocol Violation|0|||
48455444|NCT01641081|155855412|FG007|Period 2|Protocol Violation|0|||
48455445|NCT01641081|155855413|FG008|Period 2|Protocol Violation|0|||
48455446|NCT01641081|155855414|FG009|Period 2|Protocol Violation|0|||
48455447|NCT01641081|155855405|FG000|Period 3|Adverse Event|0|||
48455448|NCT01641081|155855406|FG001|Period 3|Adverse Event|0|||
48455449|NCT01641081|155855407|FG002|Period 3|Adverse Event|1|||
48455450|NCT01641081|155855408|FG003|Period 3|Adverse Event|0|||
48455451|NCT01641081|155855409|FG004|Period 3|Adverse Event|0|||
48455452|NCT01641081|155855410|FG005|Period 3|Adverse Event|0|||
48455453|NCT01641081|155855411|FG006|Period 3|Adverse Event|0|||
48455454|NCT01641081|155855412|FG007|Period 3|Adverse Event|0|||
48455455|NCT01641081|155855413|FG008|Period 3|Adverse Event|0|||
48455456|NCT01641081|155855414|FG009|Period 3|Adverse Event|0|||
48455457|NCT01641081|155855405|FG000|Period 3|Withdrawal by Subject|0|||
48455458|NCT01641081|155855406|FG001|Period 3|Withdrawal by Subject|0|||
48455459|NCT01641081|155855407|FG002|Period 3|Withdrawal by Subject|0|||
48455460|NCT01641081|155855408|FG003|Period 3|Withdrawal by Subject|0|||
48455461|NCT01641081|155855409|FG004|Period 3|Withdrawal by Subject|0|||
48455462|NCT01641081|155855410|FG005|Period 3|Withdrawal by Subject|0|||
48455463|NCT01641081|155855411|FG006|Period 3|Withdrawal by Subject|0|||
48455464|NCT01641081|155855412|FG007|Period 3|Withdrawal by Subject|0|||
48455465|NCT01641081|155855413|FG008|Period 3|Withdrawal by Subject|1|||
48455466|NCT01641081|155855414|FG009|Period 3|Withdrawal by Subject|0|||
48455467|NCT01641081|155855405|FG000|Period 4|Adverse Event|0|||
48455468|NCT01641081|155855406|FG001|Period 4|Adverse Event|1|||
48455469|NCT01641081|155855407|FG002|Period 4|Adverse Event|0|||
48455470|NCT01641081|155855408|FG003|Period 4|Adverse Event|1|||
48455471|NCT01641081|155855409|FG004|Period 4|Adverse Event|0|||
48455472|NCT01641081|155855410|FG005|Period 4|Adverse Event|0|||
48455473|NCT01641081|155855411|FG006|Period 4|Adverse Event|0|||
48455474|NCT01641081|155855412|FG007|Period 4|Adverse Event|0|||
48455475|NCT01641081|155855413|FG008|Period 4|Adverse Event|0|||
48455476|NCT01641081|155855414|FG009|Period 4|Adverse Event|0|||
48455477|NCT01641081|155855405|FG000|Period 5|Adverse Event|0|||
48455478|NCT01641081|155855406|FG001|Period 5|Adverse Event|0|||
48455479|NCT01641081|155855407|FG002|Period 5|Adverse Event|2|||
48455480|NCT01641081|155855408|FG003|Period 5|Adverse Event|0|||
48455481|NCT01641081|155855409|FG004|Period 5|Adverse Event|0|||
48455482|NCT01641081|155855410|FG005|Period 5|Adverse Event|0|||
48455483|NCT01641081|155855411|FG006|Period 5|Adverse Event|0|||
48455484|NCT01641081|155855412|FG007|Period 5|Adverse Event|0|||
48455485|NCT01641081|155855413|FG008|Period 5|Adverse Event|0|||
48455486|NCT01641081|155855414|FG009|Period 5|Adverse Event|0|||
48455487|NCT00224003|155855427|FG000|Overall Study|Adverse Event|1|||
48455488|NCT00224003|155855427|FG000|Overall Study|Protocol Violation|2|||
48455489|NCT00224003|155855427|FG000|Overall Study|Withdrawal by Subject|1|||
48455490|NCT00224003|155855427|FG000|Overall Study|unk|3|||
48455491|NCT01512693|155855431|FG000|Overall Study|Withdrawal by Subject|0|||
48455492|NCT01512693|155855432|FG001|Overall Study|Withdrawal by Subject|1|||
48455493|NCT01975376|155855433|FG000|Overall Study|Adverse Event|5|||
48455494|NCT01975376|155855434|FG001|Overall Study|Adverse Event|5|||
48455495|NCT01975376|155855433|FG000|Overall Study|Death|65|||
48455496|NCT01975376|155855434|FG001|Overall Study|Death|72|||
48455497|NCT01975376|155855433|FG000|Overall Study|Lost to Follow-up|70|||
48455498|NCT01975376|155855434|FG001|Overall Study|Lost to Follow-up|66|||
48455499|NCT01975376|155855433|FG000|Overall Study|Withdrew consent|68|||
48455500|NCT01975376|155855434|FG001|Overall Study|Withdrew consent|62|||
48455501|NCT01975376|155855433|FG000|Overall Study|Other|2|||
48455502|NCT01975376|155855434|FG001|Overall Study|Other|4|||
48455503|NCT01975376|155855433|FG000|Overall Study|Randomized, Not Treated|16|||
48455504|NCT01975376|155855434|FG001|Overall Study|Randomized, Not Treated|8|||
48455505|NCT04489940|155855435|FG000|Overall Study|Other|2|||
48455506|NCT04489940|155855435|FG000|Overall Study|Withdrawal by Subject|2|||
48455507|NCT04489940|155855435|FG000|Overall Study|Death|5|||
48455508|NCT04489940|155855435|FG000|Overall Study|Lost to Follow-up|1|||
48455509|NCT02725268|155855436|FG000|Overall Study|Death|58|||
48455510|NCT02725268|155855437|FG001|Overall Study|Death|59|||
48455511|NCT02725268|155855438|FG002|Overall Study|Death|30|||
48455512|NCT02725268|155855439|FG003|Overall Study|Death|16|||
48455513|NCT02725268|155855436|FG000|Overall Study|Lost to Follow-up|4|||
48455514|NCT02725268|155855437|FG001|Overall Study|Lost to Follow-up|3|||
48455515|NCT02725268|155855438|FG002|Overall Study|Lost to Follow-up|0|||
48455516|NCT02725268|155855439|FG003|Overall Study|Lost to Follow-up|1|||
48455517|NCT02725268|155855436|FG000|Overall Study|Site Terminated by Sponsor|0|||
48455518|NCT02725268|155855437|FG001|Overall Study|Site Terminated by Sponsor|1|||
48455519|NCT02725268|155855438|FG002|Overall Study|Site Terminated by Sponsor|0|||
48455520|NCT02725268|155855439|FG003|Overall Study|Site Terminated by Sponsor|0|||
48455521|NCT02725268|155855436|FG000|Overall Study|Withdrawal by Subject|8|||
48455522|NCT02725268|155855437|FG001|Overall Study|Withdrawal by Subject|6|||
48455523|NCT02725268|155855438|FG002|Overall Study|Withdrawal by Subject|8|||
48455524|NCT02725268|155855439|FG003|Overall Study|Withdrawal by Subject|1|||
48455525|NCT02725268|155855436|FG000|Overall Study|Reason not Specified|2|||
48455526|NCT02725268|155855437|FG001|Overall Study|Reason not Specified|1|||
48455527|NCT02725268|155855438|FG002|Overall Study|Reason not Specified|0|||
48455528|NCT02725268|155855439|FG003|Overall Study|Reason not Specified|0|||
48455529|NCT01624467|155855440|FG000|Overall Study|Withdrawal by Subject|2|||
48455530|NCT01624467|155855440|FG000|Overall Study|Lost to Follow-up|1|||
48455531|NCT01624467|155855440|FG000|Overall Study|Adverse Event|7|||
48455532|NCT01624467|155855440|FG000|Overall Study|Progressive Disease|19|||
48455533|NCT01624467|155855440|FG000|Overall Study|Per Sponsor Requirement|1|||
48455534|NCT01624467|155855440|FG000|Overall Study|Subject Withdrew from Treatment|1|||
48455535|NCT02201472|155855443|FG000|Overall Study|Lack of Efficacy|2|||
48455536|NCT00117572|155855447|FG000|Overall Study|Site withdrew before starting treatment|2|||
48455537|NCT00117572|155855448|FG001|Overall Study|Site withdrew before starting treatment|3|||
48455538|NCT00117572|155855447|FG000|Overall Study|Withdrawal by Subject|3|||
48455539|NCT00117572|155855448|FG001|Overall Study|Withdrawal by Subject|3|||
48455540|NCT00117572|155855447|FG000|Overall Study|Protocol Violation|1|||
48455541|NCT00117572|155855448|FG001|Overall Study|Protocol Violation|0|||
48455542|NCT04973085|155855454|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
48455543|NCT04973085|155855455|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
48455544|NCT00322387|155855456|FG000|Treatment Period|Adverse Event|0|||
48455545|NCT00322387|155855457|FG001|Treatment Period|Adverse Event|1|||
48455546|NCT00322387|155855456|FG000|Follow-up Period|Final assessment not done|1|||
48455547|NCT00322387|155855457|FG001|Follow-up Period|Final assessment not done|3|||
48455548|NCT00322387|155855456|FG000|Follow-up Period|Death|1|||
48455549|NCT00322387|155855457|FG001|Follow-up Period|Death|0|||
48455550|NCT00654368|155855462|FG000|Overall Study|Ineligibility determined|6|||
48455551|NCT00654368|155855463|FG001|Overall Study|Ineligibility determined|0|||
48455552|NCT00654368|155855464|FG002|Overall Study|Ineligibility determined|0|||
48455553|NCT00654368|155855462|FG000|Overall Study|Protocol deviation|3|||
48455554|NCT00654368|155855463|FG001|Overall Study|Protocol deviation|2|||
48455555|NCT00654368|155855464|FG002|Overall Study|Protocol deviation|1|||
48455556|NCT00654368|155855462|FG000|Overall Study|Non-compliance|2|||
48455557|NCT00654368|155855463|FG001|Overall Study|Non-compliance|1|||
48455558|NCT00654368|155855464|FG002|Overall Study|Non-compliance|2|||
48455559|NCT00654368|155855462|FG000|Overall Study|Withdrawal by Subject|5|||
48455560|NCT00654368|155855463|FG001|Overall Study|Withdrawal by Subject|2|||
48455561|NCT00654368|155855464|FG002|Overall Study|Withdrawal by Subject|2|||
48455562|NCT00654368|155855462|FG000|Overall Study|Disease progression|21|||
48455563|NCT00654368|155855463|FG001|Overall Study|Disease progression|31|||
48455564|NCT00654368|155855464|FG002|Overall Study|Disease progression|13|||
48455565|NCT00654368|155855462|FG000|Overall Study|Requirement for alternative therapy|1|||
48455566|NCT00654368|155855463|FG001|Overall Study|Requirement for alternative therapy|1|||
48455567|NCT00654368|155855464|FG002|Overall Study|Requirement for alternative therapy|1|||
48455568|NCT00654368|155855462|FG000|Overall Study|Physician Decision|0|||
48455569|NCT00654368|155855463|FG001|Overall Study|Physician Decision|0|||
48455570|NCT00654368|155855464|FG002|Overall Study|Physician Decision|2|||
48455571|NCT00654368|155855462|FG000|Overall Study|Death|1|||
48455572|NCT00654368|155855463|FG001|Overall Study|Death|0|||
48455573|NCT00654368|155855464|FG002|Overall Study|Death|0|||
48455574|NCT00654368|155855462|FG000|Overall Study|Pregnancy|0|||
48455575|NCT00654368|155855463|FG001|Overall Study|Pregnancy|0|||
48455576|NCT00654368|155855464|FG002|Overall Study|Pregnancy|2|||
48455577|NCT00654368|155855462|FG000|Overall Study|Other|0|||
48455578|NCT00654368|155855463|FG001|Overall Study|Other|2|||
48455579|NCT00654368|155855464|FG002|Overall Study|Other|3|||
48455580|NCT00654368|155855462|FG000|Overall Study|Adverse Event|14|||
48455581|NCT00654368|155855463|FG001|Overall Study|Adverse Event|9|||
48455582|NCT00654368|155855464|FG002|Overall Study|Adverse Event|6|||
48455583|NCT02640755|155855471|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
48455584|NCT02640755|155855472|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
48455585|NCT02640755|155855471|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
48455586|NCT02640755|155855472|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
48455587|NCT02640755|155855471|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
48455588|NCT02640755|155855472|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
48455589|NCT00959894|155857593|FG000|Overall Study|Lost to Follow-up|10|||
48455590|NCT00959894|155857593|FG000|Overall Study|Adverse Event|3|||
48455591|NCT00959894|155857593|FG000|Overall Study|Withdrawal by Subject|1|||
48455592|NCT00959894|155857593|FG000|Overall Study|Need for contraindicated medication|1|||
48455593|NCT00959894|155857593|FG000|Overall Study|Subject moved out of town|1|||
48455594|NCT00653068|155857595|FG000|Overall Study|Death|9|||
48455595|NCT00653068|155857595|FG000|Overall Study|Lack of Efficacy|34|||
48455596|NCT00653068|155857595|FG000|Overall Study|Physician Decision|4|||
48455597|NCT00653068|155857595|FG000|Overall Study|Withdrawal by Subject|1|||
48455598|NCT00653068|155857595|FG000|Overall Study|Ineligible|2|||
48455599|NCT01117181|155857598|FG000|Overall Study|Lost to Follow-up|1|||
48455600|NCT01117181|155857599|FG001|Overall Study|Lost to Follow-up|0|||
48455601|NCT01117181|155857598|FG000|Overall Study|Withdrawal by Subject|0|||
48455602|NCT01117181|155857599|FG001|Overall Study|Withdrawal by Subject|2|||
48455603|NCT01510028|155857602|FG000|Overall Study|Lack of Efficacy|1|||
48455604|NCT01510028|155857603|FG001|Overall Study|Lack of Efficacy|0|||
48455605|NCT01510028|155857604|FG002|Overall Study|Lack of Efficacy|0|||
48455606|NCT01510028|155857605|FG003|Overall Study|Lack of Efficacy|0|||
48455607|NCT00633893|155857606|FG000|Overall Study|Death|1|||
48455608|NCT00633893|155857607|FG001|Overall Study|Death|3|||
48455609|NCT00633893|155857608|FG002|Overall Study|Death|9|||
48455610|NCT00633893|155857606|FG000|Overall Study|Adverse Event|65|||
48455611|NCT00633893|155857607|FG001|Overall Study|Adverse Event|58|||
48455612|NCT00633893|155857608|FG002|Overall Study|Adverse Event|126|||
48455613|NCT00633893|155857606|FG000|Overall Study|Withdrawal by Subject|7|||
48455614|NCT00633893|155857607|FG001|Overall Study|Withdrawal by Subject|12|||
48455615|NCT00633893|155857608|FG002|Overall Study|Withdrawal by Subject|6|||
48455616|NCT00633893|155857606|FG000|Overall Study|Lost to Follow-up|2|||
48455617|NCT00633893|155857607|FG001|Overall Study|Lost to Follow-up|4|||
48455618|NCT00633893|155857608|FG002|Overall Study|Lost to Follow-up|8|||
48455619|NCT00633893|155857606|FG000|Overall Study|Poor/non-compliance|5|||
48455620|NCT00633893|155857607|FG001|Overall Study|Poor/non-compliance|12|||
48455621|NCT00633893|155857608|FG002|Overall Study|Poor/non-compliance|3|||
48455622|NCT00633893|155857606|FG000|Overall Study|Pregnancy|2|||
48455623|NCT00633893|155857607|FG001|Overall Study|Pregnancy|1|||
48455624|NCT00633893|155857608|FG002|Overall Study|Pregnancy|1|||
48455625|NCT00633893|155857606|FG000|Overall Study|Not meet/no longer meets criteria|4|||
48455626|NCT00633893|155857607|FG001|Overall Study|Not meet/no longer meets criteria|6|||
48455627|NCT00633893|155857608|FG002|Overall Study|Not meet/no longer meets criteria|4|||
48455628|NCT00633893|155857606|FG000|Overall Study|Other|28|||
48455629|NCT00633893|155857607|FG001|Overall Study|Other|33|||
48455630|NCT00633893|155857608|FG002|Overall Study|Other|31|||
48455631|NCT00425945|155857609|FG000|Overall Study|Concern about Supplement|2|||
48455632|NCT00425945|155857610|FG001|Overall Study|Concern about Supplement|0|||
48455633|NCT00425945|155857609|FG000|Overall Study|Inconvenience|0|||
48455634|NCT00425945|155857610|FG001|Overall Study|Inconvenience|2|||
48455635|NCT00425945|155857609|FG000|Overall Study|Lost to Follow-up|0|||
48455636|NCT00425945|155857610|FG001|Overall Study|Lost to Follow-up|2|||
48455637|NCT00425945|155857609|FG000|Overall Study|Began hypertension medication|1|||
48455638|NCT00425945|155857610|FG001|Overall Study|Began hypertension medication|0|||
48455639|NCT00425945|155857609|FG000|Overall Study|Began cancer treatments|1|||
48455640|NCT00425945|155857610|FG001|Overall Study|Began cancer treatments|0|||
48455641|NCT00425945|155857609|FG000|Overall Study|Moved from area|0|||
48455642|NCT00425945|155857610|FG001|Overall Study|Moved from area|1|||
48455643|NCT02741310|155857611|FG000|Overall Study|Sponsor Decision|2|||
48455644|NCT02741310|155857612|FG001|Overall Study|Sponsor Decision|2|||
48455645|NCT03285490|155857620|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
48455646|NCT03285490|155857621|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
48455647|NCT03285490|155857620|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
48455648|NCT03285490|155857621|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
48455649|NCT02728206|155857622|FG000|Overall Study|Death|1|||
48455650|NCT01047436|155857625|FG000|Overall Study|Protocol Violation|1|||
48455651|NCT01047436|155857626|FG001|Overall Study|Protocol Violation|0|||
48455652|NCT04539262|155857627|FG000|Overall Study|Adverse Event|0|||
48455653|NCT04539262|155857628|FG001|Overall Study|Adverse Event|0|||
48455654|NCT04539262|155857629|FG002|Overall Study|Adverse Event|1|||
48455655|NCT04539262|155857630|FG003|Overall Study|Adverse Event|0|||
48455656|NCT04539262|155857631|FG004|Overall Study|Adverse Event|0|||
48455657|NCT04539262|155857632|FG005|Overall Study|Adverse Event|0|||
48455658|NCT04539262|155857633|FG006|Overall Study|Adverse Event|0|||
48455659|NCT04539262|155857634|FG007|Overall Study|Adverse Event|0|||
48455660|NCT04539262|155857627|FG000|Overall Study|Withdrew Consent|0|||
48455661|NCT04539262|155857628|FG001|Overall Study|Withdrew Consent|0|||
48455662|NCT04539262|155857629|FG002|Overall Study|Withdrew Consent|0|||
48455663|NCT04539262|155857630|FG003|Overall Study|Withdrew Consent|1|||
48455664|NCT04539262|155857631|FG004|Overall Study|Withdrew Consent|0|||
48455665|NCT04539262|155857632|FG005|Overall Study|Withdrew Consent|0|||
48455666|NCT04539262|155857633|FG006|Overall Study|Withdrew Consent|0|||
48455667|NCT04539262|155857634|FG007|Overall Study|Withdrew Consent|0|||
48455668|NCT04539262|155857627|FG000|Overall Study|Randomized, Not treated|0|||
48455669|NCT04539262|155857628|FG001|Overall Study|Randomized, Not treated|1|||
48455670|NCT04539262|155857629|FG002|Overall Study|Randomized, Not treated|0|||
48455671|NCT04539262|155857630|FG003|Overall Study|Randomized, Not treated|0|||
48455672|NCT04539262|155857631|FG004|Overall Study|Randomized, Not treated|0|||
48455673|NCT04539262|155857632|FG005|Overall Study|Randomized, Not treated|0|||
48455674|NCT04539262|155857633|FG006|Overall Study|Randomized, Not treated|1|||
48455675|NCT04539262|155857634|FG007|Overall Study|Randomized, Not treated|0|||
48455676|NCT02635867|155857636|FG000|Overall Study|Lost to Follow-up|4|||
48455677|NCT02635867|155857637|FG001|Overall Study|Lost to Follow-up|3|||
48455678|NCT02635867|155857638|FG002|Overall Study|Lost to Follow-up|3|||
48455679|NCT02635867|155857639|FG003|Overall Study|Lost to Follow-up|4|||
48455680|NCT02635867|155857640|FG004|Overall Study|Lost to Follow-up|1|||
48455681|NCT04159701|155857645|FG000|Period 1: Treatment Period|Pregnancy|1|||
48455682|NCT04159701|155857646|FG001|Period 1: Treatment Period|Pregnancy|0|||
48455683|NCT04159701|155857645|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
48455684|NCT04159701|155857646|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
48455685|NCT04159701|155857645|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
48455686|NCT04159701|155857646|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
48455687|NCT04159701|155857645|FG000|Washout Period|site terminated by sponsor|0|||
48455688|NCT04159701|155857646|FG001|Washout Period|site terminated by sponsor|1|||
48455689|NCT04159701|155857645|FG000|Washout Period|study terminated by sponsor|10|||
48455690|NCT04159701|155857646|FG001|Washout Period|study terminated by sponsor|3|||
48455691|NCT04159701|155857645|FG000|Washout Period|Withdrawal by Subject|1|||
48455692|NCT04159701|155857646|FG001|Washout Period|Withdrawal by Subject|0|||
48455693|NCT04159701|155857645|FG000|Washout Period|Inadvertent Enrollment|1|||
48455694|NCT04159701|155857646|FG001|Washout Period|Inadvertent Enrollment|0|||
48455695|NCT04159701|155857645|FG000|Washout Period|Miscellaneous|1|||
48455696|NCT04159701|155857646|FG001|Washout Period|Miscellaneous|0|||
48455697|NCT04159701|155857645|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
48455698|NCT04159701|155857646|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
48455699|NCT04159701|155857645|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
48455700|NCT04159701|155857646|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
48455701|NCT04159701|155857645|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
48455702|NCT04159701|155857646|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
48455703|NCT04159701|155857645|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
48455704|NCT04159701|155857646|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
48455705|NCT04159701|155857645|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
48455706|NCT04159701|155857646|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
48455707|NCT01819194|155857647|FG000|Overall Study|Loss of study articles|2|||
48455708|NCT01849562|155857648|FG000|Overall Study|Lost to Follow-up|1|||
48455709|NCT01849562|155857649|FG001|Overall Study|Lost to Follow-up|0|||
48455710|NCT01849562|155857650|FG002|Overall Study|Lost to Follow-up|0|||
48455711|NCT01849562|155857648|FG000|Overall Study|Non-compliance with Study Drug|1|||
48455712|NCT01849562|155857649|FG001|Overall Study|Non-compliance with Study Drug|0|||
48455713|NCT01849562|155857650|FG002|Overall Study|Non-compliance with Study Drug|0|||
48455714|NCT04737759|155857655|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
48455715|NCT04737759|155857656|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
48455716|NCT04737759|155857655|FG000|Overall Study|Death|2|||
48455717|NCT04737759|155857656|FG001|Overall Study|Death|0|||
48455718|NCT04737759|155857655|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
48455719|NCT04737759|155857656|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
48455720|NCT04737759|155857655|FG000|Overall Study|Lost to Follow-up|4|||
48455721|NCT04737759|155857656|FG001|Overall Study|Lost to Follow-up|12|||
48455722|NCT00633360|155857657|FG000|Overall Study|Lost to Follow-up|1|||
48455723|NCT00633360|155857658|FG001|Overall Study|Lost to Follow-up|1|||
48455724|NCT00633360|155857657|FG000|Overall Study|Adverse Event|3|||
48455725|NCT00633360|155857658|FG001|Overall Study|Adverse Event|1|||
48455726|NCT00633360|155857657|FG000|Overall Study|Protocol Violation|0|||
48455727|NCT00633360|155857658|FG001|Overall Study|Protocol Violation|1|||
48455728|NCT00329784|155857659|FG000|Overall Study|Lost to Follow-up|0|||
48455729|NCT00329784|155857660|FG001|Overall Study|Lost to Follow-up|1|||
48455730|NCT00329784|155857661|FG002|Overall Study|Lost to Follow-up|0|||
48455731|NCT00329784|155857662|FG003|Overall Study|Lost to Follow-up|0|||
48455732|NCT00329784|155857659|FG000|Overall Study|Withdrawal by Subject|4|||
48455733|NCT00329784|155857660|FG001|Overall Study|Withdrawal by Subject|2|||
48455734|NCT00329784|155857661|FG002|Overall Study|Withdrawal by Subject|0|||
48455735|NCT00329784|155857662|FG003|Overall Study|Withdrawal by Subject|0|||
48455736|NCT00329784|155857659|FG000|Overall Study|Other|1|||
48455737|NCT00329784|155857660|FG001|Overall Study|Other|2|||
48455738|NCT00329784|155857661|FG002|Overall Study|Other|0|||
48455739|NCT00329784|155857662|FG003|Overall Study|Other|0|||
48455740|NCT01505114|155857663|FG000|Overall Study|Withdrawal by Subject|5|||
48455741|NCT01505114|155857664|FG001|Overall Study|Withdrawal by Subject|4|||
48455742|NCT01505114|155857665|FG002|Overall Study|Withdrawal by Subject|4|||
48455743|NCT01505114|155857666|FG003|Overall Study|Withdrawal by Subject|7|||
48455744|NCT01505114|155857663|FG000|Overall Study|Death|1|||
48455745|NCT01505114|155857664|FG001|Overall Study|Death|0|||
48455746|NCT01505114|155857665|FG002|Overall Study|Death|0|||
48455747|NCT01505114|155857666|FG003|Overall Study|Death|1|||
48455748|NCT01505114|155857663|FG000|Overall Study|unable to adhere to visit schedule|3|||
48455749|NCT01505114|155857664|FG001|Overall Study|unable to adhere to visit schedule|2|||
48455750|NCT01505114|155857665|FG002|Overall Study|unable to adhere to visit schedule|3|||
48455751|NCT01505114|155857666|FG003|Overall Study|unable to adhere to visit schedule|3|||
48455752|NCT01505114|155857663|FG000|Overall Study|Lost to Follow-up|11|||
48455753|NCT01505114|155857664|FG001|Overall Study|Lost to Follow-up|5|||
48455754|NCT01505114|155857665|FG002|Overall Study|Lost to Follow-up|8|||
48455755|NCT01505114|155857666|FG003|Overall Study|Lost to Follow-up|7|||
48455756|NCT01505114|155857663|FG000|Overall Study|relocated|4|||
48455757|NCT01505114|155857664|FG001|Overall Study|relocated|2|||
48455758|NCT01505114|155857665|FG002|Overall Study|relocated|2|||
48455759|NCT01505114|155857666|FG003|Overall Study|relocated|3|||
48455760|NCT01505114|155857663|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
48455761|NCT01505114|155857664|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
48455762|NCT01505114|155857665|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
48455763|NCT01505114|155857666|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
48455764|NCT01505114|155857663|FG000|Overall Study|staff safety concerns|0|||
48455765|NCT01505114|155857664|FG001|Overall Study|staff safety concerns|0|||
48455766|NCT01505114|155857665|FG002|Overall Study|staff safety concerns|0|||
48455767|NCT01505114|155857666|FG003|Overall Study|staff safety concerns|1|||
48455768|NCT01505114|155857663|FG000|Overall Study|investigator decision|1|||
48455769|NCT01505114|155857664|FG001|Overall Study|investigator decision|0|||
48455770|NCT01505114|155857665|FG002|Overall Study|investigator decision|1|||
48455771|NCT01505114|155857666|FG003|Overall Study|investigator decision|0|||
48455772|NCT00481988|155857667|FG000|Overall Study|Withdrawal by Subject|1|||
48455773|NCT00481988|155857668|FG001|Overall Study|Withdrawal by Subject|1|||
48455774|NCT00654420|155857669|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
48455775|NCT00654420|155857670|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
48455776|NCT00654420|155857671|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
48455777|NCT00654420|155857672|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
48455778|NCT00654420|155857669|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
48455779|NCT00654420|155857670|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
48455780|NCT00654420|155857671|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
48455781|NCT00654420|155857672|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
48455782|NCT00654420|155857669|FG000|Phase II|Adverse Event|0|||
48455783|NCT00654420|155857670|FG001|Phase II|Adverse Event|0|||
48455784|NCT00654420|155857671|FG002|Phase II|Adverse Event|3|||
48455785|NCT00654420|155857672|FG003|Phase II|Adverse Event|3|||
48455786|NCT00654420|155857669|FG000|Phase II|Lost to Follow-up|0|||
48455787|NCT00654420|155857670|FG001|Phase II|Lost to Follow-up|0|||
48455788|NCT00654420|155857671|FG002|Phase II|Lost to Follow-up|0|||
48455789|NCT00654420|155857672|FG003|Phase II|Lost to Follow-up|1|||
48455790|NCT00654420|155857669|FG000|Phase II|Physician Decision|0|||
48455791|NCT00654420|155857670|FG001|Phase II|Physician Decision|0|||
48455792|NCT00654420|155857671|FG002|Phase II|Physician Decision|0|||
48455793|NCT00654420|155857672|FG003|Phase II|Physician Decision|4|||
48455794|NCT00654420|155857669|FG000|Phase II|Progressive Disease|0|||
48455795|NCT00654420|155857670|FG001|Phase II|Progressive Disease|0|||
48455796|NCT00654420|155857671|FG002|Phase II|Progressive Disease|29|||
48455797|NCT00654420|155857672|FG003|Phase II|Progressive Disease|29|||
48455798|NCT00654420|155857669|FG000|Phase II|Withdrawal by Subject|0|||
48455799|NCT00654420|155857670|FG001|Phase II|Withdrawal by Subject|0|||
48455800|NCT00654420|155857671|FG002|Phase II|Withdrawal by Subject|4|||
48455801|NCT00654420|155857672|FG003|Phase II|Withdrawal by Subject|1|||
48455802|NCT00654420|155857669|FG000|Phase II|Missing Disposition Record|0|||
48455803|NCT00654420|155857670|FG001|Phase II|Missing Disposition Record|0|||
48455804|NCT00654420|155857671|FG002|Phase II|Missing Disposition Record|1|||
48455805|NCT00654420|155857672|FG003|Phase II|Missing Disposition Record|0|||
48455806|NCT02252588|155857675|FG000|Overall Study|Withdrawal by Subject|4|||
48455807|NCT02252588|155857676|FG001|Overall Study|Withdrawal by Subject|0|||
48455808|NCT01235507|155857686|FG000|Overall Study|Adverse Event|1|||
48455809|NCT01235507|155857686|FG000|Overall Study|Withdrawal by Subject|1|||
48455810|NCT00610207|155857687|FG000|Overall Study|Lost to Follow-up|3|||
48455811|NCT02348840|155857688|FG000|Overall Study|Withdrawal by Subject|2|||
48455812|NCT02348840|155857689|FG001|Overall Study|Withdrawal by Subject|1|||
48455813|NCT02348840|155857690|FG002|Overall Study|Withdrawal by Subject|0|||
48455814|NCT02348840|155857691|FG003|Overall Study|Withdrawal by Subject|0|||
48455815|NCT03748420|155857692|FG000|Overall Study|No 12 month medication adherence data available|0|||
48455816|NCT03748420|155857693|FG001|Overall Study|No 12 month medication adherence data available|1|||
48455817|NCT03748420|155857692|FG000|Overall Study|Death|24|||
48455818|NCT03748420|155857693|FG001|Overall Study|Death|28|||
48455819|NCT03748420|155857692|FG000|Overall Study|Lost to Follow-up|231|||
48455820|NCT03748420|155857693|FG001|Overall Study|Lost to Follow-up|230|||
48455821|NCT00373880|155857695|FG000|Overall Study|Physician Decision|3|||
48455822|NCT00373880|155857695|FG000|Overall Study|Arrested|1|||
48455823|NCT00373880|155857695|FG000|Overall Study|Protocol Violation|14|||
48455824|NCT04007367|155857697|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
48455825|NCT04007367|155857698|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
48455826|NCT04007367|155857699|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
48455827|NCT04007367|155857697|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
48455828|NCT04007367|155857698|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
48455829|NCT04007367|155857699|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
48455830|NCT04007367|155857697|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
48455831|NCT04007367|155857698|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
48455832|NCT04007367|155857699|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
48455833|NCT04007367|155857697|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
48455834|NCT04007367|155857698|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
48455835|NCT04007367|155857699|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
48455836|NCT04007367|155857697|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
48455837|NCT04007367|155857698|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
48455838|NCT04007367|155857699|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
48455839|NCT03236506|155857700|FG000|Overall Study|Death|1|||
48455840|NCT03236506|155857701|FG001|Overall Study|Death|1|||
48455841|NCT03236506|155857702|FG002|Overall Study|Death|1|||
48455842|NCT03236506|155857700|FG000|Overall Study|Withdrawal by Subject|3|||
48455843|NCT03236506|155857701|FG001|Overall Study|Withdrawal by Subject|3|||
48455844|NCT03236506|155857702|FG002|Overall Study|Withdrawal by Subject|4|||
48455845|NCT03236506|155857700|FG000|Overall Study|Did not initiate treatment|2|||
48455846|NCT03236506|155857701|FG001|Overall Study|Did not initiate treatment|1|||
48455847|NCT03236506|155857702|FG002|Overall Study|Did not initiate treatment|2|||
48455848|NCT01466062|155857703|FG000|Overall Study|Adverse Event|1|||
48455849|NCT01466062|155857703|FG000|Overall Study|Withdrawal by Subject|1|||
48455850|NCT00118040|155857704|FG000|Overall Study|Adverse Event|0|||
48455851|NCT00118040|155857705|FG001|Overall Study|Adverse Event|1|||
48455852|NCT00118040|155857706|FG002|Overall Study|Adverse Event|0|||
48455853|NCT00118040|155857704|FG000|Overall Study|Withdrawal by Subject|0|||
48455854|NCT00118040|155857705|FG001|Overall Study|Withdrawal by Subject|0|||
48455855|NCT00118040|155857706|FG002|Overall Study|Withdrawal by Subject|2|||
48455856|NCT00118040|155857704|FG000|Overall Study|Medical Contraindication|0|||
48455857|NCT00118040|155857705|FG001|Overall Study|Medical Contraindication|0|||
48455858|NCT00118040|155857706|FG002|Overall Study|Medical Contraindication|1|||
48455859|NCT00118040|155857704|FG000|Overall Study|Non-Compliant Participant|1|||
48455860|NCT00118040|155857705|FG001|Overall Study|Non-Compliant Participant|1|||
48455861|NCT00118040|155857706|FG002|Overall Study|Non-Compliant Participant|2|||
48455862|NCT00118040|155857704|FG000|Overall Study|Other|0|||
48455863|NCT00118040|155857705|FG001|Overall Study|Other|0|||
48455864|NCT00118040|155857706|FG002|Overall Study|Other|1|||
48455865|NCT02253992|155857720|FG000|Overall Study|Study drug toxicity|1|||
48455866|NCT02253992|155857721|FG001|Overall Study|Study drug toxicity|0|||
48455867|NCT02253992|155857722|FG002|Overall Study|Study drug toxicity|10|||
48455868|NCT02253992|155857720|FG000|Overall Study|Disease progression|4|||
48455869|NCT02253992|155857721|FG001|Overall Study|Disease progression|3|||
48455870|NCT02253992|155857722|FG002|Overall Study|Disease progression|98|||
48455871|NCT02253992|155857720|FG000|Overall Study|Withdrawal by Subject|0|||
48455872|NCT02253992|155857721|FG001|Overall Study|Withdrawal by Subject|0|||
48455873|NCT02253992|155857722|FG002|Overall Study|Withdrawal by Subject|3|||
48455874|NCT02253992|155857720|FG000|Overall Study|Adverse Event|0|||
48455875|NCT02253992|155857721|FG001|Overall Study|Adverse Event|0|||
48455876|NCT02253992|155857722|FG002|Overall Study|Adverse Event|8|||
48455877|NCT02253992|155857720|FG000|Overall Study|Death|0|||
48455878|NCT02253992|155857721|FG001|Overall Study|Death|0|||
48455879|NCT02253992|155857722|FG002|Overall Study|Death|1|||
48455880|NCT02253992|155857720|FG000|Overall Study|Subject discontinued study drug|1|||
48455881|NCT02253992|155857721|FG001|Overall Study|Subject discontinued study drug|0|||
48455882|NCT02253992|155857722|FG002|Overall Study|Subject discontinued study drug|1|||
48455883|NCT02253992|155857720|FG000|Overall Study|Completed treatment as per protocol|0|||
48455884|NCT02253992|155857721|FG001|Overall Study|Completed treatment as per protocol|1|||
48455885|NCT02253992|155857722|FG002|Overall Study|Completed treatment as per protocol|22|||
48455886|NCT02253992|155857720|FG000|Overall Study|Other|0|||
48455887|NCT02253992|155857721|FG001|Overall Study|Other|0|||
48455888|NCT02253992|155857722|FG002|Overall Study|Other|1|||
48455889|NCT00887068|155857734|FG000|Overall Study|Withdrawal by Subject|2|||
48455890|NCT00887068|155857735|FG001|Overall Study|Withdrawal by Subject|0|||
48455891|NCT00887068|155857734|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
48455892|NCT00887068|155857735|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
48455893|NCT04363944|155857736|FG000|Overall Study|Withdrawal by Subject|2|||
48455894|NCT04363944|155857737|FG001|Overall Study|Withdrawal by Subject|0|||
48455895|NCT01828567|155857738|FG000|Overall Study|Lost to Follow-up|27|||
48455896|NCT01828567|155857739|FG001|Overall Study|Lost to Follow-up|9|||
48455897|NCT01828567|155857738|FG000|Overall Study|Excluded - did not meet criteria|4|||
48455898|NCT01828567|155857739|FG001|Overall Study|Excluded - did not meet criteria|1|||
48455899|NCT01188811|155857744|FG000|Overall Study|Withdrawal by Subject|0|||
48455900|NCT01188811|155857745|FG001|Overall Study|Withdrawal by Subject|2|||
48455901|NCT01188811|155857744|FG000|Overall Study|Adverse Event|6|||
48455902|NCT01188811|155857745|FG001|Overall Study|Adverse Event|0|||
48455903|NCT05179057|155857749|FG000|Overall Study|Adverse Event|3|||
48455904|NCT05179057|155857750|FG001|Overall Study|Adverse Event|2|||
48455905|NCT05179057|155857749|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
48455906|NCT05179057|155857750|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
48455907|NCT05179057|155857749|FG000|Overall Study|Study terminated|13|||
48455908|NCT05179057|155857750|FG001|Overall Study|Study terminated|7|||
48455909|NCT05179057|155857749|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
48455910|NCT05179057|155857750|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
48455911|NCT05179057|155857749|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
48455912|NCT05179057|155857750|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
48455913|NCT01602744|155857751|FG000|Overall Study|Death|17|||
48455914|NCT01602744|155857752|FG001|Overall Study|Death|15|||
48455915|NCT01602744|155857751|FG000|Overall Study|Lost to Follow-up|13|||
48455916|NCT01602744|155857752|FG001|Overall Study|Lost to Follow-up|8|||
48455917|NCT00804986|155857753|FG000|Overall Study|Adverse Event|0|||
48455918|NCT00804986|155857754|FG001|Overall Study|Adverse Event|1|||
48455919|NCT00804986|155857755|FG002|Overall Study|Adverse Event|2|||
48455920|NCT00804986|155857756|FG003|Overall Study|Adverse Event|1|||
48455921|NCT00804986|155857757|FG004|Overall Study|Adverse Event|3|||
48455922|NCT00804986|155857758|FG005|Overall Study|Adverse Event|0|||
48455923|NCT00804986|155857753|FG000|Overall Study|Lack of Efficacy|0|||
48455924|NCT00804986|155857754|FG001|Overall Study|Lack of Efficacy|0|||
48455925|NCT00804986|155857755|FG002|Overall Study|Lack of Efficacy|0|||
48455926|NCT00804986|155857756|FG003|Overall Study|Lack of Efficacy|1|||
48455927|NCT00804986|155857757|FG004|Overall Study|Lack of Efficacy|0|||
48455928|NCT00804986|155857758|FG005|Overall Study|Lack of Efficacy|3|||
48455929|NCT00804986|155857753|FG000|Overall Study|Lost to Follow-up|0|||
48455930|NCT00804986|155857754|FG001|Overall Study|Lost to Follow-up|0|||
48455931|NCT00804986|155857755|FG002|Overall Study|Lost to Follow-up|0|||
48455932|NCT00804986|155857756|FG003|Overall Study|Lost to Follow-up|1|||
48455933|NCT00804986|155857757|FG004|Overall Study|Lost to Follow-up|1|||
48455934|NCT00804986|155857758|FG005|Overall Study|Lost to Follow-up|3|||
48455935|NCT00804986|155857753|FG000|Overall Study|Protocol Violation|0|||
48455936|NCT00804986|155857754|FG001|Overall Study|Protocol Violation|1|||
48455937|NCT00804986|155857755|FG002|Overall Study|Protocol Violation|0|||
48455938|NCT00804986|155857756|FG003|Overall Study|Protocol Violation|1|||
48455939|NCT00804986|155857757|FG004|Overall Study|Protocol Violation|0|||
48455940|NCT00804986|155857758|FG005|Overall Study|Protocol Violation|0|||
48455941|NCT00804986|155857753|FG000|Overall Study|Withdrawal by Subject|0|||
48455942|NCT00804986|155857754|FG001|Overall Study|Withdrawal by Subject|3|||
48455943|NCT00804986|155857755|FG002|Overall Study|Withdrawal by Subject|0|||
48455944|NCT00804986|155857756|FG003|Overall Study|Withdrawal by Subject|3|||
48455945|NCT00804986|155857757|FG004|Overall Study|Withdrawal by Subject|5|||
48455946|NCT00804986|155857758|FG005|Overall Study|Withdrawal by Subject|3|||
48455947|NCT00804986|155857753|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
48455948|NCT00804986|155857754|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
48455949|NCT00804986|155857755|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
48455950|NCT00804986|155857756|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
48455951|NCT00804986|155857757|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
48455952|NCT00804986|155857758|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
48455953|NCT00804986|155857753|FG000|Overall Study|Sponsor Decision|0|||
48455954|NCT00804986|155857754|FG001|Overall Study|Sponsor Decision|1|||
48455955|NCT00804986|155857755|FG002|Overall Study|Sponsor Decision|0|||
48455956|NCT00804986|155857756|FG003|Overall Study|Sponsor Decision|0|||
48455957|NCT00804986|155857757|FG004|Overall Study|Sponsor Decision|0|||
48455958|NCT00804986|155857758|FG005|Overall Study|Sponsor Decision|0|||
48455959|NCT00804986|155857753|FG000|Overall Study|Physician Decision|1|||
48455960|NCT00804986|155857754|FG001|Overall Study|Physician Decision|0|||
48455961|NCT00804986|155857755|FG002|Overall Study|Physician Decision|0|||
48455962|NCT00804986|155857756|FG003|Overall Study|Physician Decision|0|||
48455963|NCT00804986|155857757|FG004|Overall Study|Physician Decision|0|||
48455964|NCT00804986|155857758|FG005|Overall Study|Physician Decision|0|||
48455965|NCT02187224|155857759|FG000|Overall Study|Did not show up for test day|1|||
48455966|NCT02187224|155857760|FG001|Overall Study|Did not show up for test day|0|||
48455967|NCT02975349|155857761|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48455968|NCT02975349|155857762|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48455969|NCT02975349|155857763|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
48455970|NCT02975349|155857764|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
48455971|NCT02975349|155857765|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48455972|NCT02975349|155857766|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48455973|NCT02975349|155857761|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48455974|NCT02975349|155857762|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48455975|NCT02975349|155857763|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48455976|NCT02975349|155857764|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48455977|NCT02975349|155857765|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48455978|NCT02975349|155857766|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48455979|NCT02975349|155857761|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
48455980|NCT02975349|155857762|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
48455981|NCT02975349|155857763|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
48455982|NCT02975349|155857764|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
48455983|NCT02975349|155857765|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
48455984|NCT02975349|155857766|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
48455985|NCT02975349|155857761|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
48455986|NCT02975349|155857762|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
48455987|NCT02975349|155857763|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
48455988|NCT02975349|155857764|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
48455989|NCT02975349|155857765|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
48455990|NCT02975349|155857766|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
48455991|NCT02975349|155857761|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
48455992|NCT02975349|155857762|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
48455993|NCT02975349|155857763|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
48455994|NCT02975349|155857764|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
48455995|NCT02975349|155857765|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
48455996|NCT02975349|155857766|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
48455997|NCT02975349|155857761|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
48455998|NCT02975349|155857762|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
48455999|NCT02975349|155857763|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
48456000|NCT02975349|155857764|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
48456001|NCT02975349|155857765|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
48456002|NCT02975349|155857766|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
48456003|NCT02975349|155857761|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48456004|NCT02975349|155857762|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48456005|NCT02975349|155857763|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
48456006|NCT02975349|155857764|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48456007|NCT02975349|155857765|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48456008|NCT02975349|155857766|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
48456009|NCT02975349|155857761|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48456010|NCT02975349|155857762|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
48456011|NCT02975349|155857763|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48456012|NCT02975349|155857764|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48456013|NCT02975349|155857765|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48456014|NCT02975349|155857766|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
48456015|NCT02975349|155857761|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48456016|NCT02975349|155857762|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48456017|NCT02975349|155857763|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48456018|NCT02975349|155857764|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
48456019|NCT02975349|155857765|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48456020|NCT02975349|155857766|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
48456021|NCT02985684|155857767|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
48456022|NCT02985684|155857767|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
48456023|NCT02985684|155857767|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
48456024|NCT02774291|155857774|FG000|Overall Study|Lost to Follow-up|1|||
48456025|NCT00126425|155857775|FG000|Overall Study|Withdrawal by Subject|17|||
48456026|NCT00126425|155857776|FG001|Overall Study|Withdrawal by Subject|1|||
48456027|NCT00126425|155857775|FG000|Overall Study|Lost to Follow-up|8|||
48456028|NCT00126425|155857776|FG001|Overall Study|Lost to Follow-up|4|||
48456029|NCT00126425|155857775|FG000|Overall Study|Protocol Violation|9|||
48456030|NCT00126425|155857776|FG001|Overall Study|Protocol Violation|6|||
48456031|NCT00126425|155857775|FG000|Overall Study|Adverse Event|1|||
48456032|NCT00126425|155857776|FG001|Overall Study|Adverse Event|0|||
48456033|NCT00126425|155857775|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
48456034|NCT00126425|155857776|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
48456035|NCT00126425|155857775|FG000|Overall Study|Other|5|||
48456036|NCT00126425|155857776|FG001|Overall Study|Other|0|||
48456037|NCT04964557|155857777|FG000|Overall Study|Withdrawal by Subject|3|||
48456038|NCT04964557|155857778|FG001|Overall Study|Withdrawal by Subject|2|||
48456039|NCT04964557|155857777|FG000|Overall Study|Lost to Follow-up|1|||
48456040|NCT04964557|155857778|FG001|Overall Study|Lost to Follow-up|2|||
48456041|NCT04964557|155857777|FG000|Overall Study|Physician Decision|2|||
48456042|NCT04964557|155857778|FG001|Overall Study|Physician Decision|0|||
48456043|NCT04964557|155857777|FG000|Overall Study|Death|3|||
48456044|NCT04964557|155857778|FG001|Overall Study|Death|0|||
48456045|NCT04964557|155857777|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
48456046|NCT04964557|155857778|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
48456047|NCT00880100|155859270|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
48456048|NCT00880100|155859270|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
48456049|NCT00880100|155859270|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
48456050|NCT01431521|155859273|FG000|Overall Study|Withdrawal by Subject|0|||
48456051|NCT01431521|155859274|FG001|Overall Study|Withdrawal by Subject|0|||
48456052|NCT01431521|155859275|FG002|Overall Study|Withdrawal by Subject|1|||
48456053|NCT01431521|155859276|FG003|Overall Study|Withdrawal by Subject|0|||
48456054|NCT05154578|155859277|FG000|Overall Study|Withdrawal by Subject|2|||
48456055|NCT05154578|155859278|FG001|Overall Study|Withdrawal by Subject|3|||
48456056|NCT05154578|155859279|FG002|Overall Study|Withdrawal by Subject|2|||
48456057|NCT05154578|155859280|FG003|Overall Study|Withdrawal by Subject|4|||
48456058|NCT05154578|155859281|FG004|Overall Study|Withdrawal by Subject|0|||
48456059|NCT05154578|155859277|FG000|Overall Study|Lost to Follow-up|0|||
48456060|NCT05154578|155859278|FG001|Overall Study|Lost to Follow-up|1|||
48456061|NCT05154578|155859279|FG002|Overall Study|Lost to Follow-up|0|||
48456062|NCT05154578|155859280|FG003|Overall Study|Lost to Follow-up|3|||
48456063|NCT05154578|155859281|FG004|Overall Study|Lost to Follow-up|0|||
48456064|NCT05154578|155859277|FG000|Overall Study|Adverse Event|0|||
48456065|NCT05154578|155859278|FG001|Overall Study|Adverse Event|0|||
48456066|NCT05154578|155859279|FG002|Overall Study|Adverse Event|0|||
48456067|NCT05154578|155859280|FG003|Overall Study|Adverse Event|1|||
48456068|NCT05154578|155859281|FG004|Overall Study|Adverse Event|0|||
48456069|NCT05154578|155859277|FG000|Overall Study|Relocated to another province|0|||
48456070|NCT05154578|155859278|FG001|Overall Study|Relocated to another province|0|||
48456071|NCT05154578|155859279|FG002|Overall Study|Relocated to another province|1|||
48456072|NCT05154578|155859280|FG003|Overall Study|Relocated to another province|0|||
48456073|NCT05154578|155859281|FG004|Overall Study|Relocated to another province|1|||
48456074|NCT05154578|155859277|FG000|Overall Study|Baby loss|0|||
48456075|NCT05154578|155859278|FG001|Overall Study|Baby loss|1|||
48456076|NCT05154578|155859279|FG002|Overall Study|Baby loss|0|||
48456077|NCT05154578|155859280|FG003|Overall Study|Baby loss|0|||
48456078|NCT05154578|155859281|FG004|Overall Study|Baby loss|0|||
48456079|NCT00693420|155859284|FG000|Overall Study|Adverse Event|4|||
48456080|NCT00693420|155859285|FG001|Overall Study|Adverse Event|4|||
48456081|NCT00693420|155859284|FG000|Overall Study|Lost to Follow-up|0|||
48456082|NCT00693420|155859285|FG001|Overall Study|Lost to Follow-up|3|||
48456083|NCT00693420|155859284|FG000|Overall Study|Withdrawal by Subject|1|||
48456084|NCT00693420|155859285|FG001|Overall Study|Withdrawal by Subject|0|||
48456085|NCT00693420|155859284|FG000|Overall Study|Protocol Violation|0|||
48456086|NCT00693420|155859285|FG001|Overall Study|Protocol Violation|2|||
48456087|NCT00693420|155859284|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
48456088|NCT00693420|155859285|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
48456089|NCT00693420|155859284|FG000|Overall Study|Personal Reasons|1|||
48456090|NCT00693420|155859285|FG001|Overall Study|Personal Reasons|4|||
48456091|NCT01473355|155859292|FG000|Overall Study|Protocol Violation|2|||
48456092|NCT01473355|155859292|FG000|Overall Study|Adverse Event|2|||
48456093|NCT01473355|155859292|FG000|Overall Study|Lost to Follow-up|2|||
48456094|NCT01405027|155859295|FG000|Overall Study|Withdrawn consent|3|||
48456095|NCT01405027|155859296|FG001|Overall Study|Withdrawn consent|0|||
48456096|NCT01405027|155859295|FG000|Overall Study|Lost to Follow-up|16|||
48456097|NCT01405027|155859296|FG001|Overall Study|Lost to Follow-up|24|||
48456098|NCT01405027|155859295|FG000|Overall Study|Investigator judgement|0|||
48456099|NCT01405027|155859296|FG001|Overall Study|Investigator judgement|2|||
48456100|NCT01405027|155859295|FG000|Overall Study|Death|1|||
48456101|NCT01405027|155859296|FG001|Overall Study|Death|0|||
48456102|NCT01405027|155859295|FG000|Overall Study|Other or Unknown|12|||
48456103|NCT01405027|155859296|FG001|Overall Study|Other or Unknown|25|||
48456104|NCT02436915|155859303|FG000|Overall Study|Withdrawal by Subject|0|||
48456105|NCT02436915|155859304|FG001|Overall Study|Withdrawal by Subject|1|||
48456106|NCT02158728|155859305|FG000|Overall Study|no procedure according to CIP done|3|||
48456107|NCT02158728|155859305|FG000|Overall Study|no qualified dataset|24|||
48456108|NCT01518309|155859309|FG000|Overall Study|Adverse Event|6|||
48456109|NCT01518309|155859309|FG000|Overall Study|Death|6|||
48456110|NCT01518309|155859309|FG000|Overall Study|Lack of Efficacy|7|||
48456111|NCT01518309|155859309|FG000|Overall Study|Withdrawal by Subject|6|||
48456112|NCT01518309|155859309|FG000|Overall Study|Physician Decision|3|||
48456113|NCT01518309|155859309|FG000|Overall Study|Sponsor Decision|2|||
48456114|NCT01518309|155859309|FG000|Overall Study|Not in Predefined Categories|9|||
48456115|NCT02044822|155859313|FG000|Overall Study|Study Terminated by Sponsor|77|||
48456116|NCT02044822|155859313|FG000|Overall Study|Investigator's Discretion|10|||
48456117|NCT02044822|155859313|FG000|Overall Study|Withdrew Consent|3|||
48456118|NCT02044822|155859313|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
48456119|NCT02044822|155859313|FG000|Overall Study|Lost to Follow-up|1|||
48456120|NCT03745989|155859315|FG000|Overall Study|Death|3|||
48456121|NCT03745989|155859316|FG001|Overall Study|Death|7|||
48456122|NCT03745989|155859317|FG002|Overall Study|Death|4|||
48456123|NCT03745989|155859315|FG000|Overall Study|Lost to Follow-up|0|||
48456124|NCT03745989|155859316|FG001|Overall Study|Lost to Follow-up|2|||
48456125|NCT03745989|155859317|FG002|Overall Study|Lost to Follow-up|0|||
48456126|NCT03745989|155859315|FG000|Overall Study|Sponsor Decision|0|||
48456127|NCT03745989|155859316|FG001|Overall Study|Sponsor Decision|2|||
48456128|NCT03745989|155859317|FG002|Overall Study|Sponsor Decision|8|||
48456129|NCT03745989|155859315|FG000|Overall Study|Withdrawal by Subject|0|||
48456130|NCT03745989|155859316|FG001|Overall Study|Withdrawal by Subject|1|||
48456131|NCT03745989|155859317|FG002|Overall Study|Withdrawal by Subject|3|||
48456132|NCT01929018|155859318|FG000|Overall Study|Lost to Follow-up|1|||
48456133|NCT01929018|155859319|FG001|Overall Study|Lost to Follow-up|0|||
48456134|NCT01929018|155859318|FG000|Overall Study|Hospitalization|0|||
48456135|NCT01929018|155859319|FG001|Overall Study|Hospitalization|1|||
48456136|NCT01366534|155859320|FG000|Overall Study|Lost to Follow-up|1|||
48456137|NCT01366534|155859321|FG001|Overall Study|Lost to Follow-up|0|||
48456138|NCT01366534|155859322|FG002|Overall Study|Lost to Follow-up|0|||
48456139|NCT01366534|155859320|FG000|Overall Study|Migrated|1|||
48456140|NCT01366534|155859321|FG001|Overall Study|Migrated|1|||
48456141|NCT01366534|155859322|FG002|Overall Study|Migrated|0|||
48456142|NCT01366534|155859320|FG000|Overall Study|Declined challenged|0|||
48456143|NCT01366534|155859321|FG001|Overall Study|Declined challenged|1|||
48456144|NCT01366534|155859322|FG002|Overall Study|Declined challenged|0|||
48456145|NCT02668692|155859323|FG000|Overall Study|Adverse Event|1|||
48456146|NCT02668692|155859324|FG001|Overall Study|Adverse Event|0|||
48456147|NCT02280096|155859325|FG000|Overall Study|Pregnancy|1|||
48456148|NCT02280096|155859326|FG001|Overall Study|Pregnancy|0|||
48456149|NCT02280096|155859325|FG000|Overall Study|Functional neurological disorder|1|||
48456150|NCT02280096|155859326|FG001|Overall Study|Functional neurological disorder|0|||
48456151|NCT02280096|155859325|FG000|Overall Study|Lack of attachment|0|||
48456152|NCT02280096|155859326|FG001|Overall Study|Lack of attachment|1|||
48456153|NCT01098032|155859327|FG000|Overall Study|Withdrawal by Subject|1|||
48456154|NCT01098032|155859328|FG001|Overall Study|Withdrawal by Subject|1|||
48456155|NCT00085644|155859330|FG000|Double-Blind Period|Adverse Event|5|||
48456156|NCT00085644|155859331|FG001|Double-Blind Period|Adverse Event|2|||
48456157|NCT00085644|155859332|FG002|Double-Blind Period|Adverse Event|0|||
48456158|NCT00085644|155859330|FG000|Double-Blind Period|Withdrawal by Subject|3|||
48456159|NCT00085644|155859331|FG001|Double-Blind Period|Withdrawal by Subject|0|||
48456160|NCT00085644|155859332|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48456161|NCT00085644|155859330|FG000|Double-Blind Period|Lost to Follow-up|2|||
48456162|NCT00085644|155859331|FG001|Double-Blind Period|Lost to Follow-up|1|||
48456163|NCT00085644|155859332|FG002|Double-Blind Period|Lost to Follow-up|0|||
48456164|NCT00085644|155859330|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
48456165|NCT00085644|155859331|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
48456166|NCT00085644|155859332|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
48456167|NCT00085644|155859330|FG000|Double-Blind Period|Contemplating pregnancy|1|||
48456168|NCT00085644|155859331|FG001|Double-Blind Period|Contemplating pregnancy|0|||
48456169|NCT00085644|155859332|FG002|Double-Blind Period|Contemplating pregnancy|0|||
48456170|NCT00085644|155859330|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
48456171|NCT00085644|155859331|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
48456172|NCT00085644|155859332|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
48456173|NCT00085644|155859330|FG000|Open-Label Period|Adverse Event|0|||
48456174|NCT00085644|155859331|FG001|Open-Label Period|Adverse Event|0|||
48456175|NCT00085644|155859332|FG002|Open-Label Period|Adverse Event|38|||
48456176|NCT00085644|155859330|FG000|Open-Label Period|Withdrawal by Subject|0|||
48456177|NCT00085644|155859331|FG001|Open-Label Period|Withdrawal by Subject|0|||
48456178|NCT00085644|155859332|FG002|Open-Label Period|Withdrawal by Subject|29|||
48456179|NCT00085644|155859330|FG000|Open-Label Period|Lost to Follow-up|0|||
48456180|NCT00085644|155859331|FG001|Open-Label Period|Lost to Follow-up|0|||
48456181|NCT00085644|155859332|FG002|Open-Label Period|Lost to Follow-up|13|||
48456182|NCT00085644|155859330|FG000|Open-Label Period|Lack of Efficacy|0|||
48456183|NCT00085644|155859331|FG001|Open-Label Period|Lack of Efficacy|0|||
48456184|NCT00085644|155859332|FG002|Open-Label Period|Lack of Efficacy|15|||
48456185|NCT00085644|155859330|FG000|Open-Label Period|Pregnancy|0|||
48456186|NCT00085644|155859331|FG001|Open-Label Period|Pregnancy|0|||
48456187|NCT00085644|155859332|FG002|Open-Label Period|Pregnancy|3|||
48456188|NCT00085644|155859330|FG000|Open-Label Period|Contemplating pregnancy|0|||
48456189|NCT00085644|155859331|FG001|Open-Label Period|Contemplating pregnancy|0|||
48456190|NCT00085644|155859332|FG002|Open-Label Period|Contemplating pregnancy|3|||
48456191|NCT00085644|155859330|FG000|Open-Label Period|Protocol Violation|0|||
48456192|NCT00085644|155859331|FG001|Open-Label Period|Protocol Violation|0|||
48456193|NCT00085644|155859332|FG002|Open-Label Period|Protocol Violation|4|||
48456194|NCT00085644|155859330|FG000|Open-Label Period|Personal reason|0|||
48456195|NCT00085644|155859331|FG001|Open-Label Period|Personal reason|0|||
48456196|NCT00085644|155859332|FG002|Open-Label Period|Personal reason|4|||
48456197|NCT00376675|155859340|FG000|Overall Study|Withdrawal by Subject|9|||
48456198|NCT00376675|155859341|FG001|Overall Study|Withdrawal by Subject|2|||
48456199|NCT00376675|155859340|FG000|Overall Study|Adverse Event|10|||
48456200|NCT00376675|155859341|FG001|Overall Study|Adverse Event|5|||
48456201|NCT00376675|155859340|FG000|Overall Study|Other Reason|1|||
48456202|NCT00376675|155859341|FG001|Overall Study|Other Reason|7|||
48456203|NCT00090766|155859342|FG000|Overall Study|Nephrectomy Planned|0|||
48456204|NCT00090766|155859343|FG001|Overall Study|Nephrectomy Planned|0|||
48456205|NCT00090766|155859344|FG002|Overall Study|Nephrectomy Planned|1|||
48456206|NCT00090766|155859342|FG000|Overall Study|Death|1|||
48456207|NCT00090766|155859343|FG001|Overall Study|Death|0|||
48456208|NCT00090766|155859344|FG002|Overall Study|Death|0|||
48456209|NCT00090766|155859342|FG000|Overall Study|Admin|0|||
48456210|NCT00090766|155859343|FG001|Overall Study|Admin|2|||
48456211|NCT00090766|155859344|FG002|Overall Study|Admin|0|||
48456212|NCT00090766|155859342|FG000|Overall Study|Lost to Follow-up|2|||
48456213|NCT00090766|155859343|FG001|Overall Study|Lost to Follow-up|0|||
48456214|NCT00090766|155859344|FG002|Overall Study|Lost to Follow-up|2|||
48456215|NCT00707486|155859345|FG000|Overall Study|Withdrawal by Subject|1|||
48456216|NCT00959699|155859346|FG000|Treatment Period|Adverse Event|3|||
48456217|NCT00959699|155859347|FG001|Treatment Period|Adverse Event|13|||
48456218|NCT00959699|155859346|FG000|Treatment Period|Lack of Efficacy|15|||
48456219|NCT00959699|155859347|FG001|Treatment Period|Lack of Efficacy|6|||
48456220|NCT00959699|155859346|FG000|Treatment Period|Lost to Follow-up|0|||
48456221|NCT00959699|155859347|FG001|Treatment Period|Lost to Follow-up|1|||
48456222|NCT00959699|155859346|FG000|Treatment Period|Withdrawal by Subject|1|||
48456223|NCT00959699|155859347|FG001|Treatment Period|Withdrawal by Subject|3|||
48456224|NCT00959699|155859346|FG000|Treatment Period|Non-Compliance with Protocol|0|||
48456225|NCT00959699|155859347|FG001|Treatment Period|Non-Compliance with Protocol|1|||
48456226|NCT00959699|155859346|FG000|Treatment Period|Did not receive treatment|0|||
48456227|NCT00959699|155859347|FG001|Treatment Period|Did not receive treatment|1|||
48456228|NCT00959699|155859346|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
48456229|NCT00959699|155859347|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
48456230|NCT00959699|155859346|FG000|Follow-up Period|Lost to Follow-up|3|||
48456231|NCT00959699|155859347|FG001|Follow-up Period|Lost to Follow-up|2|||
48456232|NCT00959699|155859346|FG000|Follow-up Period|Withdrawal by Subject|3|||
48456233|NCT00959699|155859347|FG001|Follow-up Period|Withdrawal by Subject|4|||
48456234|NCT04228445|155859350|FG000|Overall Study|Lost to Follow-up|1|||
48456235|NCT04228445|155859351|FG001|Overall Study|Lost to Follow-up|1|||
48456236|NCT04228445|155859350|FG000|Overall Study|Physician Decision|1|||
48456237|NCT04228445|155859351|FG001|Overall Study|Physician Decision|2|||
48456238|NCT04228445|155859350|FG000|Overall Study|Withdrawal by Subject|0|||
48456239|NCT04228445|155859351|FG001|Overall Study|Withdrawal by Subject|1|||
48456240|NCT04228445|155859350|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
48456241|NCT04228445|155859351|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
48456242|NCT00606294|155859352|FG000|Overall Study|Withdrawal by Subject|36|||
48456243|NCT00606294|155859353|FG001|Overall Study|Withdrawal by Subject|0|||
48456244|NCT03924427|155859358|FG000|Overall Study|Adverse Event|4|||
48456245|NCT03924427|155859358|FG000|Overall Study|Lack of Efficacy|1|||
48456246|NCT03924427|155859358|FG000|Overall Study|Withdrawal by Subject|1|||
48456247|NCT03418376|155859359|FG000|Overall Study|Musculoskeletal injury|1|||
48456248|NCT03418376|155859360|FG001|Overall Study|Musculoskeletal injury|2|||
48456249|NCT03418376|155859361|FG002|Overall Study|Musculoskeletal injury|1|||
48456250|NCT03418376|155859362|FG003|Overall Study|Musculoskeletal injury|0|||
48456251|NCT03418376|155859359|FG000|Overall Study|Personal reasons|0|||
48456252|NCT03418376|155859360|FG001|Overall Study|Personal reasons|2|||
48456253|NCT03418376|155859361|FG002|Overall Study|Personal reasons|2|||
48456254|NCT03418376|155859362|FG003|Overall Study|Personal reasons|1|||
48456255|NCT03418376|155859359|FG000|Overall Study|Exacerbation|0|||
48456256|NCT03418376|155859360|FG001|Overall Study|Exacerbation|1|||
48456257|NCT03418376|155859361|FG002|Overall Study|Exacerbation|0|||
48456258|NCT03418376|155859362|FG003|Overall Study|Exacerbation|0|||
48456259|NCT00952419|155859365|FG000|Overall Study|Adverse Event|2|||
48456260|NCT00952419|155859366|FG001|Overall Study|Adverse Event|0|||
48456261|NCT00952419|155859367|FG002|Overall Study|Adverse Event|0|||
48456262|NCT00952419|155859365|FG000|Overall Study|Protocol Violation|3|||
48456263|NCT00952419|155859366|FG001|Overall Study|Protocol Violation|7|||
48456264|NCT00952419|155859367|FG002|Overall Study|Protocol Violation|0|||
48456265|NCT00952419|155859365|FG000|Overall Study|Withdrawal by Subject|1|||
48456266|NCT00952419|155859366|FG001|Overall Study|Withdrawal by Subject|3|||
48456267|NCT00952419|155859367|FG002|Overall Study|Withdrawal by Subject|0|||
48456268|NCT01976624|155859368|FG000|Overall Study|Participants contraindicated|2|||
48456269|NCT01976624|155859368|FG000|Overall Study|Participants age less than 19 years|12|||
48456270|NCT01436357|155859373|FG000|Overall Study|Death|5|||
48456271|NCT01436357|155859374|FG001|Overall Study|Death|1|||
48456272|NCT01436357|155859373|FG000|Overall Study|Enrolled but not vaccinated|1|||
48456273|NCT01436357|155859374|FG001|Overall Study|Enrolled but not vaccinated|1|||
48456274|NCT01436357|155859373|FG000|Overall Study|Incarceration|18|||
48456275|NCT01436357|155859374|FG001|Overall Study|Incarceration|20|||
48456276|NCT01436357|155859373|FG000|Overall Study|Lost to Follow-up|67|||
48456277|NCT01436357|155859374|FG001|Overall Study|Lost to Follow-up|61|||
48456278|NCT01436357|155859373|FG000|Overall Study|Protocol Violation|1|||
48456279|NCT01436357|155859374|FG001|Overall Study|Protocol Violation|0|||
48456280|NCT01436357|155859373|FG000|Overall Study|Withdrawal by Subject|26|||
48456281|NCT01436357|155859374|FG001|Overall Study|Withdrawal by Subject|38|||
48456282|NCT01436357|155859373|FG000|Overall Study|Physician Decision|3|||
48456283|NCT01436357|155859374|FG001|Overall Study|Physician Decision|4|||
48456284|NCT01436357|155859373|FG000|Overall Study|Moved out of area|1|||
48456285|NCT01436357|155859374|FG001|Overall Study|Moved out of area|2|||
48456286|NCT01436357|155859373|FG000|Overall Study|Subject in rehab|0|||
48456287|NCT01436357|155859374|FG001|Overall Study|Subject in rehab|1|||
48456288|NCT01316380|155859375|FG000|Overall Study|Adverse Event|0|||
48456289|NCT01316380|155859376|FG001|Overall Study|Adverse Event|2|||
48456290|NCT01316380|155859377|FG002|Overall Study|Adverse Event|1|||
48456291|NCT01316380|155859375|FG000|Overall Study|Protocol Violation|0|||
48456292|NCT01316380|155859376|FG001|Overall Study|Protocol Violation|0|||
48456293|NCT01316380|155859377|FG002|Overall Study|Protocol Violation|1|||
48456294|NCT01316380|155859375|FG000|Overall Study|Withdrawal by Subject|1|||
48456295|NCT01316380|155859376|FG001|Overall Study|Withdrawal by Subject|2|||
48456296|NCT01316380|155859377|FG002|Overall Study|Withdrawal by Subject|0|||
48456297|NCT01316380|155859375|FG000|Overall Study|Other|0|||
48456298|NCT01316380|155859376|FG001|Overall Study|Other|1|||
48456299|NCT01316380|155859377|FG002|Overall Study|Other|1|||
48456300|NCT01316380|155859375|FG000|Overall Study|Not treated|1|||
48456301|NCT01316380|155859376|FG001|Overall Study|Not treated|0|||
48456302|NCT01316380|155859377|FG002|Overall Study|Not treated|0|||
48456303|NCT01226472|155859383|FG000|Overall Study|Progressive Disease|1|||
48456304|NCT01347840|155859384|FG000|Overall Study|Withdrawal by Subject|1|||
48456305|NCT00149890|155859391|FG000|Overall Study|Adverse Event|1|||
48456306|NCT00149890|155859392|FG001|Overall Study|Adverse Event|8|||
48456307|NCT00149890|155859391|FG000|Overall Study|Lack of Efficacy|8|||
48456308|NCT00149890|155859392|FG001|Overall Study|Lack of Efficacy|9|||
48456309|NCT00149890|155859391|FG000|Overall Study|Protocol Violation|1|||
48456310|NCT00149890|155859392|FG001|Overall Study|Protocol Violation|0|||
48456311|NCT00149890|155859391|FG000|Overall Study|Lost to Follow-up|1|||
48456312|NCT00149890|155859392|FG001|Overall Study|Lost to Follow-up|0|||
48456313|NCT00149890|155859391|FG000|Overall Study|Graft Loss|2|||
48456314|NCT00149890|155859392|FG001|Overall Study|Graft Loss|1|||
48456315|NCT01894776|155859393|FG000|Overall Study|Withdrawal by Subject|1|||
48456316|NCT01010776|155859394|FG000|Main Phase|Withdrawal by Subject|14|||
48456317|NCT01010776|155859394|FG000|Main Phase|Lack of Efficacy|8|||
48456318|NCT01010776|155859394|FG000|Main Phase|Adverse Event|7|||
48456319|NCT01010776|155859394|FG000|Main Phase|Lost to Follow-up|6|||
48456320|NCT01010776|155859394|FG000|Main Phase|Non-compliance to study medication|5|||
48456321|NCT01010776|155859394|FG000|Main Phase|Selection failure|2|||
48456322|NCT01010776|155859394|FG000|Main Phase|Inform consent withdrawal|1|||
48456323|NCT01010776|155859394|FG000|Main Phase|Other|1|||
48456324|NCT01010776|155859394|FG000|Main Phase|Did not received study medication|5|||
48456325|NCT01010776|155859394|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
48456326|NCT01010776|155859394|FG000|Extension Phase|Other|3|||
48456327|NCT03573804|155859395|FG000|Overall Study|claustrophobia or MRI table problems|10|||
48456328|NCT02485860|155859396|FG000|Overall Study|Lost to Follow-up|4|||
48456329|NCT02485860|155859397|FG001|Overall Study|Lost to Follow-up|1|||
48456330|NCT02485860|155859396|FG000|Overall Study|Physician Decision|1|||
48456331|NCT02485860|155859397|FG001|Overall Study|Physician Decision|2|||
48456332|NCT02485860|155859396|FG000|Overall Study|Health context (COVID-19)|1|||
48456333|NCT02485860|155859397|FG001|Overall Study|Health context (COVID-19)|0|||
48456334|NCT03325010|155859401|FG000|Overall Study|Adverse Event|3|||
48456335|NCT03325010|155859402|FG001|Overall Study|Adverse Event|8|||
48456336|NCT03325010|155859401|FG000|Overall Study|Protocol Violation|1|||
48456337|NCT03325010|155859402|FG001|Overall Study|Protocol Violation|8|||
48456338|NCT03325010|155859401|FG000|Overall Study|Withdrawal by Subject|1|||
48456339|NCT03325010|155859402|FG001|Overall Study|Withdrawal by Subject|3|||
48456340|NCT03325010|155859401|FG000|Overall Study|Lost to Follow-up|1|||
48456341|NCT03325010|155859402|FG001|Overall Study|Lost to Follow-up|0|||
48456342|NCT03325010|155859401|FG000|Overall Study|Physician Decision|1|||
48456343|NCT03325010|155859402|FG001|Overall Study|Physician Decision|1|||
48456344|NCT03325010|155859401|FG000|Overall Study|Lack of Efficacy|2|||
48456345|NCT03325010|155859402|FG001|Overall Study|Lack of Efficacy|0|||
48456346|NCT00471315|155859404|FG000|Overall Study|Adverse Event|7|||
48456347|NCT00471315|155859404|FG000|Overall Study|Withdrawal by Subject|1|||
48456348|NCT00410514|155859407|FG000|Overall Study|Adverse Event|2|||
48456349|NCT00410514|155859408|FG001|Overall Study|Adverse Event|2|||
48456350|NCT00410514|155859409|FG002|Overall Study|Adverse Event|2|||
48456351|NCT00410514|155859407|FG000|Overall Study|Protocol Violation|0|||
48456352|NCT00410514|155859408|FG001|Overall Study|Protocol Violation|1|||
48456353|NCT00410514|155859409|FG002|Overall Study|Protocol Violation|1|||
48456354|NCT00410514|155859407|FG000|Overall Study|Lost to Follow-up|0|||
48456355|NCT00410514|155859408|FG001|Overall Study|Lost to Follow-up|0|||
48456356|NCT00410514|155859409|FG002|Overall Study|Lost to Follow-up|2|||
48456357|NCT00410514|155859407|FG000|Overall Study|Non-compliant with study procedures|0|||
48456358|NCT00410514|155859408|FG001|Overall Study|Non-compliant with study procedures|0|||
48456359|NCT00410514|155859409|FG002|Overall Study|Non-compliant with study procedures|2|||
48456360|NCT03277794|155859413|FG000|Overall Study|Lost to Follow-up|2|||
48456361|NCT03277794|155859414|FG001|Overall Study|Lost to Follow-up|4|||
48456362|NCT03277794|155859413|FG000|Overall Study|Withdrew due to high acuity|1|||
48456363|NCT03277794|155859414|FG001|Overall Study|Withdrew due to high acuity|0|||
48456364|NCT00113555|155859416|FG000|Overall Study|Baseline Failure|59|||
48456365|NCT00113555|155859416|FG000|Overall Study|Permanently Explanted|7|||
48456366|NCT00113555|155859416|FG000|Overall Study|Death|1|||
48456367|NCT00113555|155859416|FG000|Overall Study|Missed Followup|4|||
48456368|NCT00113555|155859416|FG000|Overall Study|Lost to Follow-up|8|||
48456369|NCT00712270|155859417|FG000|Overall Study|Withdrawal by Subject|11|||
48456370|NCT00712270|155859417|FG000|Overall Study|Screen Failure|3|||
48456371|NCT00691054|155859418|FG000|Overall Study|Withdrawal by Subject|1|||
48456372|NCT03050307|155860740|FG000|Overall Study|Adverse Event|4|||
48456373|NCT03050307|155860741|FG001|Overall Study|Adverse Event|2|||
48456374|NCT03050307|155860740|FG000|Overall Study|Significant Protocol Deviation|0|||
48456375|NCT03050307|155860741|FG001|Overall Study|Significant Protocol Deviation|1|||
48456376|NCT03050307|155860740|FG000|Overall Study|Lost to Follow-up|0|||
48456377|NCT03050307|155860741|FG001|Overall Study|Lost to Follow-up|1|||
48456378|NCT03050307|155860740|FG000|Overall Study|Voluntary Withdrawal|3|||
48456379|NCT03050307|155860741|FG001|Overall Study|Voluntary Withdrawal|4|||
48456380|NCT03050307|155860740|FG000|Overall Study|Reason not Specified|1|||
48456381|NCT03050307|155860741|FG001|Overall Study|Reason not Specified|1|||
48456382|NCT00608244|155860742|FG000|Overall Study|Adverse Event|1|||
48456383|NCT00608244|155860742|FG000|Overall Study|Low trough levels|1|||
48456384|NCT00430027|155860743|FG000|Overall Study|Study terminated|8|||
48456385|NCT01625611|155860749|FG000|Overall Study|No adlib drinks Lab 1|3|||
48456386|NCT01625611|155860750|FG001|Overall Study|No adlib drinks Lab 1|0|||
48456387|NCT01625611|155860749|FG000|Overall Study|Technical issues with PET|1|||
48456388|NCT01625611|155860750|FG001|Overall Study|Technical issues with PET|0|||
48456389|NCT01625611|155860749|FG000|Overall Study|Unable to complete study procedures|1|||
48456390|NCT01625611|155860750|FG001|Overall Study|Unable to complete study procedures|0|||
48456391|NCT01625611|155860749|FG000|Overall Study|Withdrawal by Subject|3|||
48456392|NCT01625611|155860750|FG001|Overall Study|Withdrawal by Subject|0|||
48456393|NCT02603172|155860751|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48456394|NCT02603172|155860752|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48456395|NCT02603172|155860753|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
48456396|NCT02603172|155860754|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48456397|NCT02603172|155860755|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48456398|NCT02603172|155860756|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48456399|NCT02603172|155860757|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48456400|NCT02603172|155860758|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
48456401|NCT00863317|155860763|FG000|Overall Study|Lost to Follow-up|8|||
48456402|NCT00863317|155860764|FG001|Overall Study|Lost to Follow-up|9|||
48456403|NCT00732472|155860767|FG000|Overall Study|Adverse Event|0|||
48456404|NCT00732472|155860768|FG001|Overall Study|Adverse Event|1|||
48456405|NCT00732472|155860769|FG002|Overall Study|Adverse Event|1|||
48456406|NCT00732472|155860770|FG003|Overall Study|Adverse Event|1|||
48456407|NCT00732472|155860767|FG000|Overall Study|Protocol Violation|0|||
48456408|NCT00732472|155860768|FG001|Overall Study|Protocol Violation|0|||
48456409|NCT00732472|155860769|FG002|Overall Study|Protocol Violation|0|||
48456410|NCT00732472|155860770|FG003|Overall Study|Protocol Violation|1|||
48456411|NCT00732472|155860767|FG000|Overall Study|Withdrawal by Subject|0|||
48456412|NCT00732472|155860768|FG001|Overall Study|Withdrawal by Subject|2|||
48456413|NCT00732472|155860769|FG002|Overall Study|Withdrawal by Subject|0|||
48456414|NCT00732472|155860770|FG003|Overall Study|Withdrawal by Subject|1|||
48456415|NCT01572480|155860771|FG000|Participants Enrolled|Withdrawal by Subject|1|||
48456416|NCT01572480|155860771|FG000|Drug Administration|Discontinued drug/Off Study|1|||
48456417|NCT01572480|155860771|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
48456418|NCT01572480|155860771|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
48456419|NCT01553591|155860772|FG000|Overall Study|Voluntarily withdrew|94|||
48456420|NCT01553591|155860773|FG001|Overall Study|Voluntarily withdrew|79|||
48456421|NCT01553591|155860774|FG002|Overall Study|Voluntarily withdrew|96|||
48456422|NCT01553591|155860772|FG000|Overall Study|Adverse Event|36|||
48456423|NCT01553591|155860773|FG001|Overall Study|Adverse Event|45|||
48456424|NCT01553591|155860774|FG002|Overall Study|Adverse Event|16|||
48456425|NCT01553591|155860772|FG000|Overall Study|Lost to Follow-up|25|||
48456426|NCT01553591|155860773|FG001|Overall Study|Lost to Follow-up|23|||
48456427|NCT01553591|155860774|FG002|Overall Study|Lost to Follow-up|16|||
48456428|NCT01553591|155860772|FG000|Overall Study|Physician decision: other|11|||
48456429|NCT01553591|155860773|FG001|Overall Study|Physician decision: other|14|||
48456430|NCT01553591|155860774|FG002|Overall Study|Physician decision: other|16|||
48456431|NCT01553591|155860772|FG000|Overall Study|Physician decision: lack of efficacy|2|||
48456432|NCT01553591|155860773|FG001|Overall Study|Physician decision: lack of efficacy|3|||
48456433|NCT01553591|155860774|FG002|Overall Study|Physician decision: lack of efficacy|7|||
48456434|NCT01553591|155860772|FG000|Overall Study|Protocol Violation|3|||
48456435|NCT01553591|155860773|FG001|Overall Study|Protocol Violation|4|||
48456436|NCT01553591|155860774|FG002|Overall Study|Protocol Violation|4|||
48456437|NCT01553591|155860772|FG000|Overall Study|Sponsor decision|1|||
48456438|NCT01553591|155860773|FG001|Overall Study|Sponsor decision|0|||
48456439|NCT01553591|155860774|FG002|Overall Study|Sponsor decision|3|||
48456440|NCT01553591|155860772|FG000|Overall Study|Randomized and never dispensed drug|0|||
48456441|NCT01553591|155860773|FG001|Overall Study|Randomized and never dispensed drug|1|||
48456442|NCT01553591|155860774|FG002|Overall Study|Randomized and never dispensed drug|0|||
48456443|NCT01017549|155860777|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
48456444|NCT01017549|155860777|FG000|One-year Follow-up|Lost to Follow-up|2|||
48456445|NCT01017549|155860777|FG000|One-year Follow-up|Withdrawal by Subject|5|||
48456446|NCT01017549|155860777|FG000|5 Year Follow-up|Lost to Follow-up|9|||
48456447|NCT01017549|155860777|FG000|5 Year Follow-up|Mastectomy|3|||
48456448|NCT03152110|155860785|FG000|Overall Study|Withdrawal by Subject|3|||
48456449|NCT04476108|155860786|FG000|Overall Study|Adverse Event|4|||
48456450|NCT04476108|155860787|FG001|Overall Study|Adverse Event|1|||
48456451|NCT04476108|155860786|FG000|Overall Study|Lost to Follow-up|1|||
48456452|NCT04476108|155860787|FG001|Overall Study|Lost to Follow-up|0|||
48456453|NCT04476108|155860786|FG000|Overall Study|Inadvertent Enrollment|1|||
48456454|NCT04476108|155860787|FG001|Overall Study|Inadvertent Enrollment|0|||
48456455|NCT04476108|155860786|FG000|Overall Study|Protocol Violation|1|||
48456456|NCT04476108|155860787|FG001|Overall Study|Protocol Violation|1|||
48456457|NCT04476108|155860786|FG000|Overall Study|Withdrawal by Subject|1|||
48456458|NCT04476108|155860787|FG001|Overall Study|Withdrawal by Subject|1|||
48456459|NCT00312728|155860788|FG000|Overall Study|Progressive disease|53|||
48456460|NCT00312728|155860788|FG000|Overall Study|Adverse Event|32|||
48456461|NCT00312728|155860788|FG000|Overall Study|Withdrawal by Subject|10|||
48456462|NCT00312728|155860788|FG000|Overall Study|Required non-protocol cancer treatment|2|||
48456463|NCT00312728|155860788|FG000|Overall Study|Protocol Violation|2|||
48456464|NCT00312728|155860788|FG000|Overall Study|Other|10|||
48456465|NCT00312728|155860788|FG000|Overall Study|Other|1|||
48456466|NCT00397631|155860789|FG000|Overall Study|Adverse Event|5|||
48456467|NCT00397631|155860790|FG001|Overall Study|Adverse Event|6|||
48456468|NCT00397631|155860789|FG000|Overall Study|Lack of Efficacy|7|||
48456469|NCT00397631|155860790|FG001|Overall Study|Lack of Efficacy|10|||
48456470|NCT00397631|155860789|FG000|Overall Study|Lost to Follow-up|8|||
48456471|NCT00397631|155860790|FG001|Overall Study|Lost to Follow-up|9|||
48456472|NCT00397631|155860789|FG000|Overall Study|Physician Decision|2|||
48456473|NCT00397631|155860790|FG001|Overall Study|Physician Decision|0|||
48456474|NCT00397631|155860789|FG000|Overall Study|Protocol Violation|0|||
48456475|NCT00397631|155860790|FG001|Overall Study|Protocol Violation|1|||
48456476|NCT00397631|155860789|FG000|Overall Study|Withdrawal by Subject|7|||
48456477|NCT00397631|155860790|FG001|Overall Study|Withdrawal by Subject|14|||
48456478|NCT00397631|155860789|FG000|Overall Study|protocol discontinuation criteria|1|||
48456479|NCT00397631|155860790|FG001|Overall Study|protocol discontinuation criteria|4|||
48456480|NCT01634100|155860794|FG000|Overall Study|Withdrawal by Subject|1|||
48456481|NCT01634100|155860795|FG001|Overall Study|Withdrawal by Subject|0|||
48456482|NCT01634100|155860796|FG002|Overall Study|Withdrawal by Subject|1|||
48456483|NCT01634100|155860797|FG003|Overall Study|Withdrawal by Subject|0|||
48456484|NCT01634100|155860798|FG004|Overall Study|Withdrawal by Subject|0|||
48456485|NCT01634100|155860799|FG005|Overall Study|Withdrawal by Subject|0|||
48456486|NCT00471276|155860800|FG000|Overall Study|Death|2|||
48456487|NCT00471276|155860800|FG000|Overall Study|Adverse Event|16|||
48456488|NCT00471276|155860800|FG000|Overall Study|Protocol Violation|1|||
48456489|NCT00471276|155860800|FG000|Overall Study|Objective progression or relapse|54|||
48456490|NCT00471276|155860800|FG000|Overall Study|Global deterioration of health status|1|||
48456491|NCT00471276|155860800|FG000|Overall Study|Other|3|||
48456492|NCT00471276|155860800|FG000|Overall Study|Refused treatment|6|||
48456493|NCT00832091|155860804|FG000|Overall Study|Adverse Event|1|||
48456494|NCT00832091|155860805|FG001|Overall Study|Adverse Event|1|||
48456495|NCT00832091|155860804|FG000|Overall Study|Protocol Violation|1|||
48456496|NCT00832091|155860805|FG001|Overall Study|Protocol Violation|0|||
48456497|NCT00832091|155860804|FG000|Overall Study|Withdrawal by Subject|2|||
48456498|NCT00832091|155860805|FG001|Overall Study|Withdrawal by Subject|1|||
48456499|NCT00832091|155860804|FG000|Overall Study|Prohibited Medication|1|||
48456500|NCT00832091|155860805|FG001|Overall Study|Prohibited Medication|0|||
48456501|NCT00623766|155860806|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
48456502|NCT00623766|155860807|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
48456503|NCT00623766|155860806|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
48456504|NCT00623766|155860807|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
48456505|NCT00623766|155860806|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
48456506|NCT00623766|155860807|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
48456507|NCT00623766|155860806|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
48456508|NCT00623766|155860807|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
48456509|NCT00623766|155860806|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
48456510|NCT00623766|155860807|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
48456511|NCT02750501|155860808|FG000|Overall Study|Adverse Event|4|||
48456512|NCT02750501|155860808|FG000|Overall Study|Physician Decision|1|||
48456513|NCT02750501|155860808|FG000|Overall Study|Protocol Violation|1|||
48456514|NCT02750501|155860808|FG000|Overall Study|G-tube came out|1|||
48456515|NCT02750501|155860808|FG000|Overall Study|Non-compliant use of PERT|1|||
48456516|NCT03860844|155860821|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
48456517|NCT03860844|155860822|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
48456518|NCT03860844|155860823|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
48456519|NCT03860844|155860821|FG000|Overall Study|Progressive disease|5|||
48456520|NCT03860844|155860822|FG001|Overall Study|Progressive disease|3|||
48456521|NCT03860844|155860823|FG002|Overall Study|Progressive disease|4|||
48456522|NCT03860844|155860821|FG000|Overall Study|Other, Not related to COVID-19|0|||
48456523|NCT03860844|155860822|FG001|Overall Study|Other, Not related to COVID-19|1|||
48456524|NCT03860844|155860823|FG002|Overall Study|Other, Not related to COVID-19|0|||
48456525|NCT04350372|155860824|FG000|Overall Study|Death|1|||
48456526|NCT00839436|155860826|FG000|Overall Study|Developed exclusionary condition|1|||
48456527|NCT00839436|155860827|FG001|Overall Study|Developed exclusionary condition|0|||
48456528|NCT00839436|155860828|FG002|Overall Study|Developed exclusionary condition|0|||
48456529|NCT00839436|155860826|FG000|Overall Study|Withdrawal by Subject|0|||
48456530|NCT00839436|155860827|FG001|Overall Study|Withdrawal by Subject|1|||
48456531|NCT00839436|155860828|FG002|Overall Study|Withdrawal by Subject|0|||
48456532|NCT00839436|155860826|FG000|Overall Study|Study drug no longer available|0|||
48456533|NCT00839436|155860827|FG001|Overall Study|Study drug no longer available|0|||
48456534|NCT00839436|155860828|FG002|Overall Study|Study drug no longer available|1|||
48456535|NCT01804842|155860829|FG000|Overall Study|Adverse Event|1|||
48456536|NCT01804842|155860830|FG001|Overall Study|Adverse Event|1|||
48456537|NCT01804842|155860831|FG002|Overall Study|Adverse Event|0|||
48456538|NCT01804842|155860829|FG000|Overall Study|Lost to Follow-up|1|||
48456539|NCT01804842|155860830|FG001|Overall Study|Lost to Follow-up|0|||
48456540|NCT01804842|155860831|FG002|Overall Study|Lost to Follow-up|0|||
48456541|NCT01804842|155860829|FG000|Overall Study|Non-Compliance|1|||
48456542|NCT01804842|155860830|FG001|Overall Study|Non-Compliance|1|||
48456543|NCT01804842|155860831|FG002|Overall Study|Non-Compliance|0|||
48456544|NCT01804842|155860829|FG000|Overall Study|Personal Reason|0|||
48456545|NCT01804842|155860830|FG001|Overall Study|Personal Reason|0|||
48456546|NCT01804842|155860831|FG002|Overall Study|Personal Reason|1|||
48456547|NCT03887052|155860833|FG000|Overall Study|Adverse Event|2|||
48456548|NCT03887052|155860833|FG000|Overall Study|Physician Decision|2|||
48456549|NCT03887052|155860833|FG000|Overall Study|Withdrawal by Subject|3|||
48456550|NCT03887052|155860833|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
48456551|NCT03887052|155860833|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
48456552|NCT04728815|155860835|FG000|Overall Study|Lost to Follow-up|3|||
48456553|NCT04728815|155860836|FG001|Overall Study|Lost to Follow-up|0|||
48456554|NCT04728815|155860837|FG002|Overall Study|Lost to Follow-up|0|||
48456555|NCT04728815|155860838|FG003|Overall Study|Lost to Follow-up|1|||
48456556|NCT04728815|155860839|FG004|Overall Study|Lost to Follow-up|1|||
48456557|NCT04728815|155860840|FG005|Overall Study|Lost to Follow-up|0|||
48456558|NCT04728815|155860841|FG006|Overall Study|Lost to Follow-up|2|||
48456559|NCT04728815|155860842|FG007|Overall Study|Lost to Follow-up|0|||
48456560|NCT04728815|155860835|FG000|Overall Study|Physician Decision|0|||
48456561|NCT04728815|155860836|FG001|Overall Study|Physician Decision|0|||
48456562|NCT04728815|155860837|FG002|Overall Study|Physician Decision|1|||
48456563|NCT04728815|155860838|FG003|Overall Study|Physician Decision|0|||
48456564|NCT04728815|155860839|FG004|Overall Study|Physician Decision|0|||
48456565|NCT04728815|155860840|FG005|Overall Study|Physician Decision|0|||
48456566|NCT04728815|155860841|FG006|Overall Study|Physician Decision|0|||
48456567|NCT04728815|155860842|FG007|Overall Study|Physician Decision|0|||
48456568|NCT04728815|155860835|FG000|Overall Study|Treatment drop|0|||
48456569|NCT04728815|155860836|FG001|Overall Study|Treatment drop|2|||
48456570|NCT04728815|155860837|FG002|Overall Study|Treatment drop|1|||
48456571|NCT04728815|155860838|FG003|Overall Study|Treatment drop|0|||
48456572|NCT04728815|155860839|FG004|Overall Study|Treatment drop|3|||
48456573|NCT04728815|155860840|FG005|Overall Study|Treatment drop|1|||
48456574|NCT04728815|155860841|FG006|Overall Study|Treatment drop|3|||
48456575|NCT04728815|155860842|FG007|Overall Study|Treatment drop|0|||
48456576|NCT04728815|155860835|FG000|Overall Study|Study drop|0|||
48456577|NCT04728815|155860836|FG001|Overall Study|Study drop|3|||
48456578|NCT04728815|155860837|FG002|Overall Study|Study drop|3|||
48456579|NCT04728815|155860838|FG003|Overall Study|Study drop|0|||
48456580|NCT04728815|155860839|FG004|Overall Study|Study drop|0|||
48456581|NCT04728815|155860840|FG005|Overall Study|Study drop|0|||
48456582|NCT04728815|155860841|FG006|Overall Study|Study drop|7|||
48456583|NCT04728815|155860842|FG007|Overall Study|Study drop|0|||
48456584|NCT01131078|155860849|FG000|Overall Study|Adverse Event|22|||
48456585|NCT01131078|155860850|FG001|Overall Study|Adverse Event|12|||
48456586|NCT01131078|155860851|FG002|Overall Study|Adverse Event|17|||
48456587|NCT01131078|155860849|FG000|Overall Study|Progressive Disease|58|||
48456588|NCT01131078|155860850|FG001|Overall Study|Progressive Disease|77|||
48456589|NCT01131078|155860851|FG002|Overall Study|Progressive Disease|71|||
48456590|NCT01131078|155860849|FG000|Overall Study|Protocol Violation|1|||
48456591|NCT01131078|155860850|FG001|Overall Study|Protocol Violation|0|||
48456592|NCT01131078|155860851|FG002|Overall Study|Protocol Violation|0|||
48456593|NCT01131078|155860849|FG000|Overall Study|Lost to Follow-up|1|||
48456594|NCT01131078|155860850|FG001|Overall Study|Lost to Follow-up|1|||
48456595|NCT01131078|155860851|FG002|Overall Study|Lost to Follow-up|1|||
48456596|NCT01131078|155860849|FG000|Overall Study|Withdrawal by Subject|2|||
48456597|NCT01131078|155860850|FG001|Overall Study|Withdrawal by Subject|4|||
48456598|NCT01131078|155860851|FG002|Overall Study|Withdrawal by Subject|3|||
48456599|NCT01131078|155860849|FG000|Overall Study|Non-compliance|3|||
48456600|NCT01131078|155860850|FG001|Overall Study|Non-compliance|0|||
48456601|NCT01131078|155860851|FG002|Overall Study|Non-compliance|0|||
48456602|NCT01131078|155860849|FG000|Overall Study|Physician Decision|10|||
48456603|NCT01131078|155860850|FG001|Overall Study|Physician Decision|6|||
48456604|NCT01131078|155860851|FG002|Overall Study|Physician Decision|8|||
48456605|NCT01131078|155860849|FG000|Overall Study|Death|4|||
48456606|NCT01131078|155860850|FG001|Overall Study|Death|0|||
48456607|NCT01131078|155860851|FG002|Overall Study|Death|2|||
48456608|NCT01131078|155860849|FG000|Overall Study|Other|0|||
48456609|NCT01131078|155860850|FG001|Overall Study|Other|1|||
48456610|NCT01131078|155860851|FG002|Overall Study|Other|0|||
48456611|NCT01885104|155860855|FG000|Overall Study|Withdrawal of Consent|1|||
48456612|NCT01885104|155860856|FG001|Overall Study|Withdrawal of Consent|0|||
48456613|NCT01885104|155860855|FG000|Overall Study|Lost to Follow-up|0|||
48456614|NCT01885104|155860856|FG001|Overall Study|Lost to Follow-up|1|||
48456615|NCT01885104|155860855|FG000|Overall Study|Physician Decision|1|||
48456616|NCT01885104|155860856|FG001|Overall Study|Physician Decision|0|||
48456617|NCT04063865|155860858|FG000|Overall Study|Physician Decision|1|||
48456618|NCT04063865|155860859|FG001|Overall Study|Physician Decision|3|||
48456619|NCT04063865|155860858|FG000|Overall Study|Study Closed Prior to Completion|4|||
48456620|NCT04063865|155860859|FG001|Overall Study|Study Closed Prior to Completion|4|||
48456621|NCT04063865|155860858|FG000|Overall Study|Withdrawal by Subject|1|||
48456622|NCT04063865|155860859|FG001|Overall Study|Withdrawal by Subject|1|||
48456623|NCT00609167|155860860|FG000|Overall Study|Withdrawal by Subject|1|||
48456624|NCT00609167|155860861|FG001|Overall Study|Withdrawal by Subject|0|||
48456625|NCT00609167|155860860|FG000|Overall Study|Lack of Efficacy|1|||
48456626|NCT00609167|155860861|FG001|Overall Study|Lack of Efficacy|0|||
48456627|NCT00609167|155860860|FG000|Overall Study|Adverse Event|5|||
48456628|NCT00609167|155860861|FG001|Overall Study|Adverse Event|1|||
48456629|NCT00609167|155860860|FG000|Overall Study|Disease Progression|1|||
48456630|NCT00609167|155860861|FG001|Overall Study|Disease Progression|0|||
48456631|NCT00609167|155860860|FG000|Overall Study|Stem Cell Transplant|0|||
48456632|NCT00609167|155860861|FG001|Overall Study|Stem Cell Transplant|6|||
48456633|NCT01307046|155860862|FG000|Overall Study|Adverse Event|3|||
48456634|NCT01307046|155860863|FG001|Overall Study|Adverse Event|3|||
48456635|NCT01307046|155860862|FG000|Overall Study|Lack of Efficacy|0|||
48456636|NCT01307046|155860863|FG001|Overall Study|Lack of Efficacy|2|||
48456637|NCT01307046|155860862|FG000|Overall Study|Physician Decision|2|||
48456638|NCT01307046|155860863|FG001|Overall Study|Physician Decision|0|||
48456639|NCT01307046|155860862|FG000|Overall Study|Withdrawal by Subject|1|||
48456640|NCT01307046|155860863|FG001|Overall Study|Withdrawal by Subject|1|||
48456641|NCT01307046|155860862|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
48456642|NCT01307046|155860863|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
48456643|NCT01307046|155860862|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
48456644|NCT01307046|155860863|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
48456645|NCT00320190|155860865|FG000|First 12 Months|Completed but did not enter extension|5|||
48456646|NCT00320190|155860866|FG001|First 12 Months|Completed but did not enter extension|3|||
48456647|NCT00320190|155860865|FG000|First 12 Months|Sponsor terminated study|2|||
48456648|NCT00320190|155860866|FG001|First 12 Months|Sponsor terminated study|2|||
48456649|NCT00320190|155860865|FG000|First 12 Months|Lost to Follow-up|0|||
48456650|NCT00320190|155860866|FG001|First 12 Months|Lost to Follow-up|1|||
48456651|NCT00320190|155860865|FG000|First 12 Months|Enrollment failure|0|||
48456652|NCT00320190|155860866|FG001|First 12 Months|Enrollment failure|1|||
48456653|NCT00320190|155860865|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
48456654|NCT00320190|155860866|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
48456655|NCT00320190|155860865|FG000|First 12 Months|Investigator request|0|||
48456656|NCT00320190|155860866|FG001|First 12 Months|Investigator request|1|||
48456657|NCT00320190|155860865|FG000|First 12 Months|Study drug toxicity|0|||
48456658|NCT00320190|155860866|FG001|First 12 Months|Study drug toxicity|1|||
48456659|NCT00320190|155860865|FG000|First 12 Months|Withdrawal by Subject|0|||
48456660|NCT00320190|155860866|FG001|First 12 Months|Withdrawal by Subject|1|||
48456661|NCT00320190|155860865|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
48456662|NCT00320190|155860866|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
48456663|NCT00320190|155860865|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
48456664|NCT00320190|155860866|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
48456665|NCT00320190|155860865|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
48456666|NCT00320190|155860866|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
48456667|NCT01040728|155860867|FG000|Overall Study|Adverse Event|4|||
48456668|NCT01040728|155860868|FG001|Overall Study|Adverse Event|8|||
48456669|NCT01040728|155860869|FG002|Overall Study|Adverse Event|0|||
48456670|NCT01040728|155860870|FG003|Overall Study|Adverse Event|4|||
48456671|NCT01040728|155860867|FG000|Overall Study|Withdrawal by Subject|0|||
48456672|NCT01040728|155860868|FG001|Overall Study|Withdrawal by Subject|1|||
48456673|NCT01040728|155860869|FG002|Overall Study|Withdrawal by Subject|1|||
48456674|NCT01040728|155860870|FG003|Overall Study|Withdrawal by Subject|0|||
48456675|NCT01040728|155860867|FG000|Overall Study|Protocol Violation|0|||
48456676|NCT01040728|155860868|FG001|Overall Study|Protocol Violation|0|||
48456677|NCT01040728|155860869|FG002|Overall Study|Protocol Violation|0|||
48456678|NCT01040728|155860870|FG003|Overall Study|Protocol Violation|1|||
48456679|NCT01040728|155860867|FG000|Overall Study|Lack of Efficacy|0|||
48456680|NCT01040728|155860868|FG001|Overall Study|Lack of Efficacy|1|||
48456681|NCT01040728|155860869|FG002|Overall Study|Lack of Efficacy|0|||
48456682|NCT01040728|155860870|FG003|Overall Study|Lack of Efficacy|1|||
48456683|NCT01040728|155860867|FG000|Overall Study|Other reasons not listed above|0|||
48456684|NCT01040728|155860868|FG001|Overall Study|Other reasons not listed above|1|||
48456685|NCT01040728|155860869|FG002|Overall Study|Other reasons not listed above|0|||
48456686|NCT01040728|155860870|FG003|Overall Study|Other reasons not listed above|0|||
48456687|NCT00415623|155860874|FG000|Overall Study|Adverse Event|3|||
48456688|NCT00415623|155860875|FG001|Overall Study|Adverse Event|4|||
48456689|NCT00415623|155860874|FG000|Overall Study|Death|1|||
48456690|NCT00415623|155860875|FG001|Overall Study|Death|0|||
48456691|NCT00415623|155860874|FG000|Overall Study|Withdrawal by Subject|1|||
48456692|NCT00415623|155860875|FG001|Overall Study|Withdrawal by Subject|1|||
48456693|NCT05116683|155860876|FG000|Overall Study|Physician Decision|4|||
48456694|NCT01435122|155860879|FG000|Overall Study|Early withdrawal due to toxicity|8|||
48456695|NCT00462488|155862625|FG000|Overall Study|Protocol Violation|1|||
48456696|NCT00462488|155862626|FG001|Overall Study|Protocol Violation|0|||
48456697|NCT00462488|155862625|FG000|Overall Study|Lack of Efficacy|19|||
48456698|NCT00462488|155862626|FG001|Overall Study|Lack of Efficacy|17|||
48456699|NCT02000219|155862628|FG000|14-Week Study Period|Physician Decision|1|||
48456700|NCT02000219|155862628|FG000|14-Week Study Period|Adverse Event|1|||
48456701|NCT02000219|155862628|FG000|14-Week Study Period|Underwent transplantation|1|||
48456702|NCT02000219|155862628|FG000|Continuation Period|Withdrawal by Subject|1|||
48456703|NCT02000219|155862628|FG000|Continuation Period|Had liver transplant|2|||
48456704|NCT02000219|155862628|FG000|Continuation Period|Non-compliance with study drug|2|||
48456705|NCT02667236|155862629|FG000|Overall Study|Adverse Event|1|||
48456706|NCT02667236|155862630|FG001|Overall Study|Adverse Event|1|||
48456707|NCT02667236|155862629|FG000|Overall Study|Withdrawal by Subject|2|||
48456708|NCT02667236|155862630|FG001|Overall Study|Withdrawal by Subject|0|||
48456709|NCT02579863|155862632|FG000|Overall Study|Final Disposition Unknown|2|||
48456710|NCT02579863|155862633|FG001|Overall Study|Final Disposition Unknown|1|||
48456711|NCT02579863|155862632|FG000|Overall Study|Adverse Event|18|||
48456712|NCT02579863|155862633|FG001|Overall Study|Adverse Event|11|||
48456713|NCT02579863|155862632|FG000|Overall Study|Death|31|||
48456714|NCT02579863|155862633|FG001|Overall Study|Death|29|||
48456715|NCT02579863|155862632|FG000|Overall Study|Lost to Follow-up|2|||
48456716|NCT02579863|155862633|FG001|Overall Study|Lost to Follow-up|1|||
48456717|NCT02579863|155862632|FG000|Overall Study|Physician Decision|1|||
48456718|NCT02579863|155862633|FG001|Overall Study|Physician Decision|2|||
48456719|NCT02579863|155862632|FG000|Overall Study|Screen Failure|0|||
48456720|NCT02579863|155862633|FG001|Overall Study|Screen Failure|2|||
48456721|NCT02579863|155862632|FG000|Overall Study|Study Terminated at Selected Sites|82|||
48456722|NCT02579863|155862633|FG001|Overall Study|Study Terminated at Selected Sites|88|||
48456723|NCT02579863|155862632|FG000|Overall Study|Withdrawal by Subject|20|||
48456724|NCT02579863|155862633|FG001|Overall Study|Withdrawal by Subject|20|||
48456725|NCT05091918|155862636|FG000|Overall Study|Adverse Event|1|||
48456726|NCT05091918|155862636|FG000|Overall Study|Withdrawal by Subject|81|||
48456727|NCT03878160|155862639|FG000|Overall Study|Lost to Follow-up|1|||
48456728|NCT03878160|155862640|FG001|Overall Study|Lost to Follow-up|1|||
48456729|NCT03878160|155862641|FG002|Overall Study|Lost to Follow-up|1|||
48456730|NCT03878160|155862639|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
48456731|NCT03878160|155862640|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
48456732|NCT03878160|155862641|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
48456733|NCT03991936|155862646|FG000|Overall Study|Lost to Follow-up|1|||
48456734|NCT03991936|155862647|FG001|Overall Study|Lost to Follow-up|1|||
48456735|NCT03991936|155862648|FG002|Overall Study|Lost to Follow-up|1|||
48456736|NCT03991936|155862649|FG003|Overall Study|Lost to Follow-up|1|||
48456737|NCT03991936|155862650|FG004|Overall Study|Lost to Follow-up|1|||
48456738|NCT00216086|155862651|FG000|Overall Study|Protocol Violation|1|||
48456739|NCT00216086|155862651|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
48456740|NCT00216086|155862651|FG000|Overall Study|Social Reasons|2|||
48456741|NCT01100658|155862652|FG000|Overall Study|Withdrawal by Subject|1|||
48456742|NCT00364832|155862653|FG000|Core Period|Early Withdrawals|2|||
48456743|NCT00364832|155862654|FG001|Core Period|Early Withdrawals|2|||
48456744|NCT00364832|155862655|FG002|Core Period|Early Withdrawals|1|||
48456745|NCT00364832|155862656|FG003|Core Period|Early Withdrawals|1|||
48456746|NCT00364832|155862657|FG004|Core Period|Early Withdrawals|0|||
48456747|NCT00364832|155862658|FG005|Core Period|Early Withdrawals|0|||
48456748|NCT00364832|155862659|FG006|Core Period|Early Withdrawals|4|||
48456749|NCT00364832|155862660|FG007|Core Period|Early Withdrawals|1|||
48456750|NCT00364832|155862661|FG008|Core Period|Early Withdrawals|0|||
48456751|NCT00364832|155862662|FG009|Core Period|Early Withdrawals|0|||
48456752|NCT00364832|155862663|FG010|Core Period|Early Withdrawals|0|||
48456753|NCT00364832|155862664|FG011|Core Period|Early Withdrawals|0|||
48456754|NCT00364832|155862653|FG000|Extension Year 1|Early Withdrawals|0|||
48456755|NCT00364832|155862654|FG001|Extension Year 1|Early Withdrawals|0|||
48456756|NCT00364832|155862655|FG002|Extension Year 1|Early Withdrawals|0|||
48456757|NCT00364832|155862656|FG003|Extension Year 1|Early Withdrawals|0|||
48456758|NCT00364832|155862657|FG004|Extension Year 1|Early Withdrawals|0|||
48456759|NCT00364832|155862658|FG005|Extension Year 1|Early Withdrawals|0|||
48456760|NCT00364832|155862659|FG006|Extension Year 1|Early Withdrawals|0|||
48456761|NCT00364832|155862660|FG007|Extension Year 1|Early Withdrawals|0|||
48456762|NCT00364832|155862661|FG008|Extension Year 1|Early Withdrawals|0|||
48456763|NCT00364832|155862662|FG009|Extension Year 1|Early Withdrawals|4|||
48456764|NCT00364832|155862663|FG010|Extension Year 1|Early Withdrawals|2|||
48456765|NCT00364832|155862664|FG011|Extension Year 1|Early Withdrawals|10|||
48456766|NCT00364832|155862653|FG000|Extension Year 2|Early Withdrawals|0|||
48456767|NCT00364832|155862654|FG001|Extension Year 2|Early Withdrawals|0|||
48456768|NCT00364832|155862655|FG002|Extension Year 2|Early Withdrawals|0|||
48456769|NCT00364832|155862656|FG003|Extension Year 2|Early Withdrawals|0|||
48456770|NCT00364832|155862657|FG004|Extension Year 2|Early Withdrawals|0|||
48456771|NCT00364832|155862658|FG005|Extension Year 2|Early Withdrawals|0|||
48456772|NCT00364832|155862659|FG006|Extension Year 2|Early Withdrawals|0|||
48456773|NCT00364832|155862660|FG007|Extension Year 2|Early Withdrawals|0|||
48456774|NCT00364832|155862661|FG008|Extension Year 2|Early Withdrawals|0|||
48456775|NCT00364832|155862662|FG009|Extension Year 2|Early Withdrawals|5|||
48456776|NCT00364832|155862663|FG010|Extension Year 2|Early Withdrawals|5|||
48456777|NCT00364832|155862664|FG011|Extension Year 2|Early Withdrawals|3|||
48456778|NCT03687827|155862668|FG000|Treatment Period 1|Death|0|||
48456779|NCT03687827|155862669|FG001|Treatment Period 1|Death|1|||
48456780|NCT03687827|155862668|FG000|Treatment Period 1|Lost to Follow-up|2|||
48456781|NCT03687827|155862669|FG001|Treatment Period 1|Lost to Follow-up|2|||
48456782|NCT03687827|155862668|FG000|Treatment Period 1|Physician Decision|5|||
48456783|NCT03687827|155862669|FG001|Treatment Period 1|Physician Decision|2|||
48456784|NCT03687827|155862668|FG000|Treatment Period 1|Withdrawal by Subject|7|||
48456785|NCT03687827|155862669|FG001|Treatment Period 1|Withdrawal by Subject|3|||
48456786|NCT03687827|155862668|FG000|Treatment Period 2|Physician Decision|4|||
48456787|NCT03687827|155862669|FG001|Treatment Period 2|Physician Decision|1|||
48456788|NCT03687827|155862668|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48456789|NCT03687827|155862669|FG001|Treatment Period 2|Withdrawal by Subject|2|||
48456790|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
48456791|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
48456792|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
48456793|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
48456794|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
48456795|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
48456796|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
48456797|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
48456798|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
48456799|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
48456800|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
48456801|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
48456802|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
48456803|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
48456804|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
48456805|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
48456806|NCT01291511|155862671|FG000|Cross-Titration and Stabilization Phase|Death|1|||
48456807|NCT01291511|155862672|FG001|Cross-Titration and Stabilization Phase|Death|0|||
48456808|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
48456809|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
48456810|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
48456811|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
48456812|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
48456813|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
48456814|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
48456815|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
48456816|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
48456817|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
48456818|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
48456819|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
48456820|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
48456821|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
48456822|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
48456823|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
48456824|NCT01291511|155862671|FG000|Double-blind Relapse Prevention Phase|Death|1|||
48456825|NCT01291511|155862672|FG001|Double-blind Relapse Prevention Phase|Death|0|||
48456826|NCT00729560|155862675|FG000|Overall Study|Withdrawal by Subject|3|||
48456827|NCT00764322|155862676|FG000|Overall Study|Withdrawal by Subject|11|||
48456828|NCT00764322|155862676|FG000|Overall Study|No CYP2D6 genotyping|9|||
48456829|NCT04005755|155862685|FG000|Overall Study|Adverse Event|6|||
48456830|NCT04005755|155862685|FG000|Overall Study|Physician Decision|3|||
48456831|NCT04005755|155862685|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
48456832|NCT04005755|155862685|FG000|Overall Study|Withdrawal by Subject|3|||
48456833|NCT04005755|155862685|FG000|Overall Study|Lost to Follow-up|1|||
48456834|NCT00958191|155862689|FG000|Overall Study|Death|4|||
48456835|NCT00958191|155862689|FG000|Overall Study|Lost to Follow-up|5|||
48456836|NCT00958191|155862689|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
48456837|NCT00958191|155862689|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
48456838|NCT00958191|155862689|FG000|Overall Study|Revision of study device|4|||
48456839|NCT00958191|155862689|FG000|Overall Study|Site termination|11|||
48456840|NCT00958191|155862689|FG000|Overall Study|No 5 yr x-rays|56|||
48456841|NCT00515099|155862690|FG000|Overall Study|Lost to Follow-up|0|||
48456842|NCT00515099|155862691|FG001|Overall Study|Lost to Follow-up|4|||
48456843|NCT00515099|155862690|FG000|Overall Study|Withdrawal by Subject|2|||
48456844|NCT00515099|155862691|FG001|Overall Study|Withdrawal by Subject|0|||
48456845|NCT00515099|155862690|FG000|Overall Study|IRB Recommendation|1|||
48456846|NCT00515099|155862691|FG001|Overall Study|IRB Recommendation|0|||
48456847|NCT04362189|155862692|FG000|Overall Study|Lost to Follow-up|0|||
48456848|NCT04362189|155862693|FG001|Overall Study|Lost to Follow-up|1|||
48456849|NCT04362189|155862692|FG000|Overall Study|Withdrawal by Subject|1|||
48456850|NCT04362189|155862693|FG001|Overall Study|Withdrawal by Subject|0|||
48456851|NCT04362189|155862692|FG000|Overall Study|FDA Clinical Hold|7|||
48456852|NCT04362189|155862693|FG001|Overall Study|FDA Clinical Hold|2|||
48456853|NCT04362189|155862692|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
48456854|NCT04362189|155862693|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
48456855|NCT04362189|155862692|FG000|Overall Study|Adverse Event|0|||
48456856|NCT04362189|155862693|FG001|Overall Study|Adverse Event|2|||
48456857|NCT04362189|155862692|FG000|Overall Study|Death|4|||
48456858|NCT04362189|155862693|FG001|Overall Study|Death|1|||
48456859|NCT02718625|155862694|FG000|Overall Study|Adverse Event|0|||
48456860|NCT02718625|155862695|FG001|Overall Study|Adverse Event|1|||
48456861|NCT02718625|155862694|FG000|Overall Study|Termination of Study by Sponsor|0|||
48456862|NCT02718625|155862695|FG001|Overall Study|Termination of Study by Sponsor|1|||
48456863|NCT01925014|155862696|FG000|Overall Study|Inappropriate enrollment|4|||
48456864|NCT01925014|155862697|FG001|Overall Study|Inappropriate enrollment|6|||
48456865|NCT01925014|155862696|FG000|Overall Study|Withdrawal by Subject|5|||
48456866|NCT01925014|155862697|FG001|Overall Study|Withdrawal by Subject|13|||
48456867|NCT00372489|155862703|FG000|Overall Study|Adverse Event|18|||
48456868|NCT00372489|155862703|FG000|Overall Study|Lack of Efficacy|1|||
48456869|NCT00372489|155862703|FG000|Overall Study|Lost to Follow-up|3|||
48456870|NCT00372489|155862703|FG000|Overall Study|Physician Decision|3|||
48456871|NCT00372489|155862703|FG000|Overall Study|Withdrawal by Subject|5|||
48456872|NCT00372489|155862703|FG000|Overall Study|Patient Relocation|2|||
48456873|NCT00372489|155862703|FG000|Overall Study|Renal transplant|6|||
48456874|NCT00372489|155862703|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
48456875|NCT00736450|155862704|FG000|Overall Study|Not ABC gene eligible|19|||
48456876|NCT00736450|155862704|FG000|Overall Study|Withdrawal by Subject|5|||
48456877|NCT00736450|155862704|FG000|Overall Study|Physician Decision|1|||
48456878|NCT02120469|155862705|FG000|Overall Study|HER-2/neu-amplified|1|||
48456879|NCT02120469|155862706|FG001|Overall Study|HER-2/neu-amplified|0|||
48456880|NCT02120469|155862707|FG002|Overall Study|HER-2/neu-amplified|1|||
48456881|NCT01387594|155862708|FG000|Overall Study|Withdrawal by Subject|0|||
48456882|NCT01387594|155862709|FG001|Overall Study|Withdrawal by Subject|2|||
48456883|NCT01387594|155862708|FG000|Overall Study|Lost to Follow-up|0|||
48456884|NCT01387594|155862709|FG001|Overall Study|Lost to Follow-up|1|||
48456885|NCT02332876|155862711|FG000|Overall Study|Lost to Follow-up|1|||
48456886|NCT02332876|155862712|FG001|Overall Study|Lost to Follow-up|1|||
48456887|NCT02415595|155862713|FG000|Overall Study|Administrative reason by sponsor|39|||
48456888|NCT02415595|155862714|FG001|Overall Study|Administrative reason by sponsor|40|||
48456889|NCT02415595|155862715|FG002|Overall Study|Administrative reason by sponsor|41|||
48456890|NCT02415595|155862716|FG003|Overall Study|Administrative reason by sponsor|39|||
48456891|NCT02415595|155862713|FG000|Overall Study|Adverse Event|1|||
48456892|NCT02415595|155862714|FG001|Overall Study|Adverse Event|3|||
48456893|NCT02415595|155862715|FG002|Overall Study|Adverse Event|5|||
48456894|NCT02415595|155862716|FG003|Overall Study|Adverse Event|10|||
48456895|NCT02415595|155862713|FG000|Overall Study|Lack of Efficacy|4|||
48456896|NCT02415595|155862714|FG001|Overall Study|Lack of Efficacy|4|||
48456897|NCT02415595|155862715|FG002|Overall Study|Lack of Efficacy|0|||
48456898|NCT02415595|155862716|FG003|Overall Study|Lack of Efficacy|0|||
48456899|NCT02415595|155862713|FG000|Overall Study|Lost to Follow-up|1|||
48456900|NCT02415595|155862714|FG001|Overall Study|Lost to Follow-up|3|||
48456901|NCT02415595|155862715|FG002|Overall Study|Lost to Follow-up|1|||
48456902|NCT02415595|155862716|FG003|Overall Study|Lost to Follow-up|1|||
48456903|NCT02415595|155862713|FG000|Overall Study|Poor/Non-compliance|1|||
48456904|NCT02415595|155862714|FG001|Overall Study|Poor/Non-compliance|0|||
48456905|NCT02415595|155862715|FG002|Overall Study|Poor/Non-compliance|1|||
48456906|NCT02415595|155862716|FG003|Overall Study|Poor/Non-compliance|0|||
48456907|NCT02415595|155862713|FG000|Overall Study|Reached stopping criteria|0|||
48456908|NCT02415595|155862714|FG001|Overall Study|Reached stopping criteria|1|||
48456909|NCT02415595|155862715|FG002|Overall Study|Reached stopping criteria|1|||
48456910|NCT02415595|155862716|FG003|Overall Study|Reached stopping criteria|0|||
48456911|NCT02415595|155862713|FG000|Overall Study|Withdrawal by Subject|4|||
48456912|NCT02415595|155862714|FG001|Overall Study|Withdrawal by Subject|0|||
48456913|NCT02415595|155862715|FG002|Overall Study|Withdrawal by Subject|1|||
48456914|NCT02415595|155862716|FG003|Overall Study|Withdrawal by Subject|3|||
48456915|NCT02415595|155862713|FG000|Overall Study|Other|0|||
48456916|NCT02415595|155862714|FG001|Overall Study|Other|1|||
48456917|NCT02415595|155862715|FG002|Overall Study|Other|1|||
48456918|NCT02415595|155862716|FG003|Overall Study|Other|0|||
48456919|NCT02614261|155862719|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
48456920|NCT02614261|155862720|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
48456921|NCT02614261|155862721|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
48456922|NCT02614261|155862722|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
48456923|NCT02614261|155862719|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
48456924|NCT02614261|155862720|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48456925|NCT02614261|155862721|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48456926|NCT02614261|155862722|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
48456927|NCT02614261|155862719|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
48456928|NCT02614261|155862720|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
48456929|NCT02614261|155862721|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
48456930|NCT02614261|155862722|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48456931|NCT02614261|155862719|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
48456932|NCT02614261|155862720|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
48456933|NCT02614261|155862721|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
48456934|NCT02614261|155862722|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
48456935|NCT02614261|155862719|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
48456936|NCT02614261|155862720|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
48456937|NCT02614261|155862721|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
48456938|NCT02614261|155862722|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
48456939|NCT02614261|155862719|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
48456940|NCT02614261|155862720|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
48456941|NCT02614261|155862721|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
48456942|NCT02614261|155862722|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
48456943|NCT02614261|155862719|FG000|Double-Blind Treatment Phase|Screen failure|0|||
48456944|NCT02614261|155862720|FG001|Double-Blind Treatment Phase|Screen failure|1|||
48456945|NCT02614261|155862721|FG002|Double-Blind Treatment Phase|Screen failure|2|||
48456946|NCT02614261|155862722|FG003|Double-Blind Treatment Phase|Screen failure|0|||
48456947|NCT02614261|155862719|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
48456948|NCT02614261|155862720|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
48456949|NCT02614261|155862721|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
48456950|NCT02614261|155862722|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
48456951|NCT02614261|155862719|FG000|Open-Label Extension Phase|Adverse Event|23|||
48456952|NCT02614261|155862720|FG001|Open-Label Extension Phase|Adverse Event|12|||
48456953|NCT02614261|155862721|FG002|Open-Label Extension Phase|Adverse Event|11|||
48456954|NCT02614261|155862722|FG003|Open-Label Extension Phase|Adverse Event|0|||
48457031|NCT00998985|155862733|FG010|Overall Study|Protocol Violation|0|||
48456955|NCT02614261|155862719|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
48456956|NCT02614261|155862720|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
48456957|NCT02614261|155862721|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
48456958|NCT02614261|155862722|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
48456959|NCT02614261|155862719|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
48456960|NCT02614261|155862720|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
48456961|NCT02614261|155862721|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
48456962|NCT02614261|155862722|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
48456963|NCT02614261|155862719|FG000|Open-Label Extension Phase|Physician Decision|2|||
48456964|NCT02614261|155862720|FG001|Open-Label Extension Phase|Physician Decision|0|||
48456965|NCT02614261|155862721|FG002|Open-Label Extension Phase|Physician Decision|0|||
48456966|NCT02614261|155862722|FG003|Open-Label Extension Phase|Physician Decision|0|||
48456967|NCT02614261|155862719|FG000|Open-Label Extension Phase|Pregnancy|1|||
48456968|NCT02614261|155862720|FG001|Open-Label Extension Phase|Pregnancy|2|||
48456969|NCT02614261|155862721|FG002|Open-Label Extension Phase|Pregnancy|1|||
48456970|NCT02614261|155862722|FG003|Open-Label Extension Phase|Pregnancy|0|||
48456971|NCT02614261|155862719|FG000|Open-Label Extension Phase|Protocol Violation|3|||
48456972|NCT02614261|155862720|FG001|Open-Label Extension Phase|Protocol Violation|4|||
48456973|NCT02614261|155862721|FG002|Open-Label Extension Phase|Protocol Violation|1|||
48456974|NCT02614261|155862722|FG003|Open-Label Extension Phase|Protocol Violation|0|||
48456975|NCT02614261|155862719|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
48456976|NCT02614261|155862720|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
48456977|NCT02614261|155862721|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
48456978|NCT02614261|155862722|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
48456979|NCT02614261|155862719|FG000|Follow-up Phase|Adverse Event|2|||
48456980|NCT02614261|155862720|FG001|Follow-up Phase|Adverse Event|0|||
48456981|NCT02614261|155862721|FG002|Follow-up Phase|Adverse Event|1|||
48456982|NCT02614261|155862722|FG003|Follow-up Phase|Adverse Event|0|||
48456983|NCT02614261|155862719|FG000|Follow-up Phase|Lost to Follow-up|12|||
48456984|NCT02614261|155862720|FG001|Follow-up Phase|Lost to Follow-up|5|||
48456985|NCT02614261|155862721|FG002|Follow-up Phase|Lost to Follow-up|2|||
48456986|NCT02614261|155862722|FG003|Follow-up Phase|Lost to Follow-up|0|||
48456987|NCT02614261|155862719|FG000|Follow-up Phase|Physician Decision|5|||
48456988|NCT02614261|155862720|FG001|Follow-up Phase|Physician Decision|1|||
48456989|NCT02614261|155862721|FG002|Follow-up Phase|Physician Decision|0|||
48456990|NCT02614261|155862722|FG003|Follow-up Phase|Physician Decision|0|||
48456991|NCT02614261|155862719|FG000|Follow-up Phase|Pregnancy|0|||
48456992|NCT02614261|155862720|FG001|Follow-up Phase|Pregnancy|1|||
48456993|NCT02614261|155862721|FG002|Follow-up Phase|Pregnancy|0|||
48456994|NCT02614261|155862722|FG003|Follow-up Phase|Pregnancy|0|||
48456995|NCT02614261|155862719|FG000|Follow-up Phase|Protocol Violation|1|||
48456996|NCT02614261|155862720|FG001|Follow-up Phase|Protocol Violation|0|||
48456997|NCT02614261|155862721|FG002|Follow-up Phase|Protocol Violation|0|||
48456998|NCT02614261|155862722|FG003|Follow-up Phase|Protocol Violation|0|||
48456999|NCT02614261|155862719|FG000|Follow-up Phase|Withdrawal by Subject|12|||
48457000|NCT02614261|155862720|FG001|Follow-up Phase|Withdrawal by Subject|4|||
48457001|NCT02614261|155862721|FG002|Follow-up Phase|Withdrawal by Subject|11|||
48457002|NCT02614261|155862722|FG003|Follow-up Phase|Withdrawal by Subject|0|||
48457003|NCT02614261|155862719|FG000|Israel Addendum|Withdrawal by Subject|0|||
48457004|NCT02614261|155862720|FG001|Israel Addendum|Withdrawal by Subject|0|||
48457005|NCT02614261|155862721|FG002|Israel Addendum|Withdrawal by Subject|0|||
48457006|NCT02614261|155862722|FG003|Israel Addendum|Withdrawal by Subject|4|||
48457007|NCT00998985|155862723|FG000|Overall Study|Withdrawal by Subject|0|||
48457008|NCT00998985|155862724|FG001|Overall Study|Withdrawal by Subject|0|||
48457009|NCT00998985|155862725|FG002|Overall Study|Withdrawal by Subject|0|||
48457010|NCT00998985|155862726|FG003|Overall Study|Withdrawal by Subject|0|||
48457011|NCT00998985|155862727|FG004|Overall Study|Withdrawal by Subject|0|||
48457012|NCT00998985|155862728|FG005|Overall Study|Withdrawal by Subject|0|||
48457013|NCT00998985|155862729|FG006|Overall Study|Withdrawal by Subject|0|||
48457014|NCT00998985|155862730|FG007|Overall Study|Withdrawal by Subject|0|||
48457015|NCT00998985|155862731|FG008|Overall Study|Withdrawal by Subject|1|||
48457016|NCT00998985|155862732|FG009|Overall Study|Withdrawal by Subject|0|||
48457017|NCT00998985|155862733|FG010|Overall Study|Withdrawal by Subject|0|||
48457018|NCT00998985|155862734|FG011|Overall Study|Withdrawal by Subject|0|||
48457019|NCT00998985|155862735|FG012|Overall Study|Withdrawal by Subject|0|||
48457020|NCT00998985|155862736|FG013|Overall Study|Withdrawal by Subject|0|||
48457021|NCT00998985|155862723|FG000|Overall Study|Protocol Violation|0|||
48457022|NCT00998985|155862724|FG001|Overall Study|Protocol Violation|0|||
48457023|NCT00998985|155862725|FG002|Overall Study|Protocol Violation|0|||
48457024|NCT00998985|155862726|FG003|Overall Study|Protocol Violation|0|||
48457025|NCT00998985|155862727|FG004|Overall Study|Protocol Violation|0|||
48457026|NCT00998985|155862728|FG005|Overall Study|Protocol Violation|1|||
48457027|NCT00998985|155862729|FG006|Overall Study|Protocol Violation|0|||
48457028|NCT00998985|155862730|FG007|Overall Study|Protocol Violation|0|||
48457029|NCT00998985|155862731|FG008|Overall Study|Protocol Violation|0|||
48457030|NCT00998985|155862732|FG009|Overall Study|Protocol Violation|0|||
48457032|NCT00998985|155862734|FG011|Overall Study|Protocol Violation|0|||
48457033|NCT00998985|155862735|FG012|Overall Study|Protocol Violation|0|||
48457034|NCT00998985|155862736|FG013|Overall Study|Protocol Violation|0|||
48457035|NCT03073200|155862737|FG000|Double Blind Treatment Period|Protocol Violation|1|||
48457036|NCT03073200|155862738|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48457037|NCT03073200|155862739|FG002|Double Blind Treatment Period|Protocol Violation|0|||
48457038|NCT03073200|155862740|FG003|Double Blind Treatment Period|Protocol Violation|0|||
48457039|NCT03073200|155862741|FG004|Double Blind Treatment Period|Protocol Violation|0|||
48457040|NCT03073200|155862742|FG005|Double Blind Treatment Period|Protocol Violation|0|||
48457041|NCT03073200|155862743|FG006|Double Blind Treatment Period|Protocol Violation|0|||
48457042|NCT03073200|155862744|FG007|Double Blind Treatment Period|Protocol Violation|0|||
48457043|NCT03073200|155862745|FG008|Double Blind Treatment Period|Protocol Violation|0|||
48457044|NCT03073200|155862746|FG009|Double Blind Treatment Period|Protocol Violation|0|||
48457045|NCT03073200|155862747|FG010|Double Blind Treatment Period|Protocol Violation|0|||
48457046|NCT03073200|155862748|FG011|Double Blind Treatment Period|Protocol Violation|0|||
48457047|NCT03073200|155862749|FG012|Double Blind Treatment Period|Protocol Violation|0|||
48457048|NCT03073200|155862750|FG013|Double Blind Treatment Period|Protocol Violation|0|||
48457049|NCT03073200|155862751|FG014|Double Blind Treatment Period|Protocol Violation|0|||
48457050|NCT03073200|155862737|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457051|NCT03073200|155862738|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
48457052|NCT03073200|155862739|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457053|NCT03073200|155862740|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457054|NCT03073200|155862741|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457055|NCT03073200|155862742|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457056|NCT03073200|155862743|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457057|NCT03073200|155862744|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457058|NCT03073200|155862745|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457059|NCT03073200|155862746|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457060|NCT03073200|155862747|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457061|NCT03073200|155862748|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457062|NCT03073200|155862749|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457063|NCT03073200|155862750|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457064|NCT03073200|155862751|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
48457065|NCT03073200|155862737|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
48457066|NCT03073200|155862738|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457067|NCT03073200|155862739|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457068|NCT03073200|155862740|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457069|NCT03073200|155862741|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457070|NCT03073200|155862742|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457071|NCT03073200|155862743|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457072|NCT03073200|155862744|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457073|NCT03073200|155862745|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457074|NCT03073200|155862746|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457075|NCT03073200|155862747|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457076|NCT03073200|155862748|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457077|NCT03073200|155862749|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457078|NCT03073200|155862750|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457079|NCT03073200|155862751|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
48457080|NCT03073200|155862737|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457081|NCT03073200|155862738|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457082|NCT03073200|155862739|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457083|NCT03073200|155862740|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
48457084|NCT03073200|155862741|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
48457085|NCT03073200|155862742|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457086|NCT03073200|155862743|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457087|NCT03073200|155862744|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457088|NCT03073200|155862745|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457089|NCT03073200|155862746|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457090|NCT03073200|155862747|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457091|NCT03073200|155862748|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457092|NCT03073200|155862749|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457093|NCT03073200|155862750|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457094|NCT03073200|155862751|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
48457095|NCT03073200|155862737|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
48457096|NCT03073200|155862738|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
48457097|NCT03073200|155862739|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
48457098|NCT03073200|155862740|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
48457099|NCT03073200|155862741|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
48457100|NCT03073200|155862742|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
48457101|NCT03073200|155862743|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
48457102|NCT03073200|155862744|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
48457103|NCT03073200|155862745|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
48457104|NCT03073200|155862746|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
48457105|NCT03073200|155862747|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
48457106|NCT03073200|155862748|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
48457107|NCT03073200|155862749|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
48457108|NCT03073200|155862750|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
48457109|NCT03073200|155862751|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
48457110|NCT03073200|155862737|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457111|NCT03073200|155862738|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457112|NCT03073200|155862739|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457113|NCT03073200|155862740|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457114|NCT03073200|155862741|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
48457115|NCT03073200|155862742|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457116|NCT03073200|155862743|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457117|NCT03073200|155862744|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457118|NCT03073200|155862745|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457119|NCT03073200|155862746|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457120|NCT03073200|155862747|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457121|NCT03073200|155862748|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457122|NCT03073200|155862749|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457123|NCT03073200|155862750|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457124|NCT03073200|155862751|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
48457125|NCT03073200|155862737|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457126|NCT03073200|155862738|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457127|NCT03073200|155862739|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457128|NCT03073200|155862740|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
48457129|NCT03073200|155862741|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
48457130|NCT03073200|155862742|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457131|NCT03073200|155862743|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457132|NCT03073200|155862744|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457133|NCT03073200|155862745|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457134|NCT03073200|155862746|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457135|NCT03073200|155862747|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457136|NCT03073200|155862748|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457137|NCT03073200|155862749|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457138|NCT03073200|155862750|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457139|NCT03073200|155862751|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
48457140|NCT03073200|155862737|FG000|Extension Period|Lost to Follow-up|0|||
48457141|NCT03073200|155862738|FG001|Extension Period|Lost to Follow-up|0|||
48457142|NCT03073200|155862739|FG002|Extension Period|Lost to Follow-up|0|||
48457143|NCT03073200|155862740|FG003|Extension Period|Lost to Follow-up|0|||
48457144|NCT03073200|155862741|FG004|Extension Period|Lost to Follow-up|0|||
48457145|NCT03073200|155862742|FG005|Extension Period|Lost to Follow-up|0|||
48457146|NCT03073200|155862743|FG006|Extension Period|Lost to Follow-up|1|||
48457147|NCT03073200|155862744|FG007|Extension Period|Lost to Follow-up|1|||
48457148|NCT03073200|155862745|FG008|Extension Period|Lost to Follow-up|0|||
48457149|NCT03073200|155862746|FG009|Extension Period|Lost to Follow-up|0|||
48457150|NCT03073200|155862747|FG010|Extension Period|Lost to Follow-up|0|||
48457151|NCT03073200|155862748|FG011|Extension Period|Lost to Follow-up|0|||
48457152|NCT03073200|155862749|FG012|Extension Period|Lost to Follow-up|0|||
48457153|NCT03073200|155862750|FG013|Extension Period|Lost to Follow-up|0|||
48457154|NCT03073200|155862751|FG014|Extension Period|Lost to Follow-up|0|||
48457155|NCT03073200|155862737|FG000|Extension Period|Sponsor Decision|0|||
48457156|NCT03073200|155862738|FG001|Extension Period|Sponsor Decision|0|||
48457157|NCT03073200|155862739|FG002|Extension Period|Sponsor Decision|0|||
48457158|NCT03073200|155862740|FG003|Extension Period|Sponsor Decision|0|||
48457159|NCT03073200|155862741|FG004|Extension Period|Sponsor Decision|0|||
48457160|NCT03073200|155862742|FG005|Extension Period|Sponsor Decision|0|||
48457161|NCT03073200|155862743|FG006|Extension Period|Sponsor Decision|0|||
48457162|NCT03073200|155862744|FG007|Extension Period|Sponsor Decision|0|||
48457163|NCT03073200|155862745|FG008|Extension Period|Sponsor Decision|1|||
48457164|NCT03073200|155862746|FG009|Extension Period|Sponsor Decision|0|||
48457165|NCT03073200|155862747|FG010|Extension Period|Sponsor Decision|0|||
48457166|NCT03073200|155862748|FG011|Extension Period|Sponsor Decision|0|||
48457167|NCT03073200|155862749|FG012|Extension Period|Sponsor Decision|0|||
48457168|NCT03073200|155862750|FG013|Extension Period|Sponsor Decision|0|||
48457169|NCT03073200|155862751|FG014|Extension Period|Sponsor Decision|0|||
48457170|NCT03073200|155862737|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
48457171|NCT03073200|155862738|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
48457172|NCT03073200|155862739|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
48457173|NCT03073200|155862740|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
48457174|NCT03073200|155862741|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
48457175|NCT03073200|155862742|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
48457176|NCT03073200|155862743|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
48457177|NCT03073200|155862744|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
48457178|NCT03073200|155862745|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
48457179|NCT03073200|155862746|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
48457180|NCT03073200|155862747|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
48457181|NCT03073200|155862748|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
48457182|NCT03073200|155862749|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
48457183|NCT03073200|155862750|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
48457184|NCT03073200|155862751|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
48457185|NCT03073200|155862737|FG000|Extension Period|Withdrawal by Subject|0|||
48457186|NCT03073200|155862738|FG001|Extension Period|Withdrawal by Subject|0|||
48457187|NCT03073200|155862739|FG002|Extension Period|Withdrawal by Subject|0|||
48457188|NCT03073200|155862740|FG003|Extension Period|Withdrawal by Subject|0|||
48457189|NCT03073200|155862741|FG004|Extension Period|Withdrawal by Subject|0|||
48457190|NCT03073200|155862742|FG005|Extension Period|Withdrawal by Subject|0|||
48457191|NCT03073200|155862743|FG006|Extension Period|Withdrawal by Subject|1|||
48457192|NCT03073200|155862744|FG007|Extension Period|Withdrawal by Subject|2|||
48457193|NCT03073200|155862745|FG008|Extension Period|Withdrawal by Subject|0|||
48457194|NCT03073200|155862746|FG009|Extension Period|Withdrawal by Subject|0|||
48457195|NCT03073200|155862747|FG010|Extension Period|Withdrawal by Subject|0|||
48457196|NCT03073200|155862748|FG011|Extension Period|Withdrawal by Subject|0|||
48457197|NCT03073200|155862749|FG012|Extension Period|Withdrawal by Subject|0|||
48457198|NCT03073200|155862750|FG013|Extension Period|Withdrawal by Subject|0|||
48457199|NCT03073200|155862751|FG014|Extension Period|Withdrawal by Subject|0|||
48457200|NCT03073200|155862737|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457201|NCT03073200|155862738|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457202|NCT03073200|155862739|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457203|NCT03073200|155862740|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457204|NCT03073200|155862741|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457205|NCT03073200|155862742|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457206|NCT03073200|155862743|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457207|NCT03073200|155862744|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457208|NCT03073200|155862745|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457209|NCT03073200|155862746|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457210|NCT03073200|155862747|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457211|NCT03073200|155862748|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
48457212|NCT03073200|155862749|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457213|NCT03073200|155862750|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457214|NCT03073200|155862751|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
48457215|NCT03073200|155862737|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457216|NCT03073200|155862738|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457217|NCT03073200|155862739|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457218|NCT03073200|155862740|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457219|NCT03073200|155862741|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457220|NCT03073200|155862742|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457221|NCT03073200|155862743|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457222|NCT03073200|155862744|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457223|NCT03073200|155862745|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457224|NCT03073200|155862746|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457225|NCT03073200|155862747|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457226|NCT03073200|155862748|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
48457227|NCT03073200|155862749|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457228|NCT03073200|155862750|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457229|NCT03073200|155862751|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
48457230|NCT03073200|155862737|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457231|NCT03073200|155862738|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457232|NCT03073200|155862739|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457233|NCT03073200|155862740|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457234|NCT03073200|155862741|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457235|NCT03073200|155862742|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457236|NCT03073200|155862743|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457504|NCT01365091|155862782|FG003|Period 1|Withdrawal by Subject|0|||
48457237|NCT03073200|155862744|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457238|NCT03073200|155862745|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457239|NCT03073200|155862746|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457240|NCT03073200|155862747|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
48457241|NCT03073200|155862748|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
48457242|NCT03073200|155862749|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457243|NCT03073200|155862750|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457244|NCT03073200|155862751|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
48457245|NCT03073200|155862737|FG000|Randomized Withdrawal Period|Adverse Event|0|||
48457246|NCT03073200|155862738|FG001|Randomized Withdrawal Period|Adverse Event|0|||
48457247|NCT03073200|155862739|FG002|Randomized Withdrawal Period|Adverse Event|0|||
48457248|NCT03073200|155862740|FG003|Randomized Withdrawal Period|Adverse Event|0|||
48457249|NCT03073200|155862741|FG004|Randomized Withdrawal Period|Adverse Event|0|||
48457250|NCT03073200|155862742|FG005|Randomized Withdrawal Period|Adverse Event|0|||
48457251|NCT03073200|155862743|FG006|Randomized Withdrawal Period|Adverse Event|0|||
48457252|NCT03073200|155862744|FG007|Randomized Withdrawal Period|Adverse Event|0|||
48457253|NCT03073200|155862745|FG008|Randomized Withdrawal Period|Adverse Event|0|||
48457254|NCT03073200|155862746|FG009|Randomized Withdrawal Period|Adverse Event|0|||
48457255|NCT03073200|155862747|FG010|Randomized Withdrawal Period|Adverse Event|1|||
48457256|NCT03073200|155862748|FG011|Randomized Withdrawal Period|Adverse Event|0|||
48457257|NCT03073200|155862749|FG012|Randomized Withdrawal Period|Adverse Event|0|||
48457258|NCT03073200|155862750|FG013|Randomized Withdrawal Period|Adverse Event|0|||
48457259|NCT03073200|155862751|FG014|Randomized Withdrawal Period|Adverse Event|0|||
48457260|NCT03073200|155862737|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457261|NCT03073200|155862738|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457262|NCT03073200|155862739|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457263|NCT03073200|155862740|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457264|NCT03073200|155862741|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457265|NCT03073200|155862742|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457266|NCT03073200|155862743|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457267|NCT03073200|155862744|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457268|NCT03073200|155862745|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457269|NCT03073200|155862746|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457270|NCT03073200|155862747|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457271|NCT03073200|155862748|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457272|NCT03073200|155862749|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457273|NCT03073200|155862750|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
48457274|NCT03073200|155862751|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
48457275|NCT03073200|155862737|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457276|NCT03073200|155862738|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457277|NCT03073200|155862739|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457278|NCT03073200|155862740|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457279|NCT03073200|155862741|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457280|NCT03073200|155862742|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457281|NCT03073200|155862743|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457282|NCT03073200|155862744|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457283|NCT03073200|155862745|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457284|NCT03073200|155862746|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457285|NCT03073200|155862747|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457286|NCT03073200|155862748|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457287|NCT03073200|155862749|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457288|NCT03073200|155862750|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
48457289|NCT03073200|155862751|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
48457290|NCT03073200|155862737|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457291|NCT03073200|155862738|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457292|NCT03073200|155862739|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457293|NCT03073200|155862740|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457294|NCT03073200|155862741|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457295|NCT03073200|155862742|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457296|NCT03073200|155862743|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457297|NCT03073200|155862744|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457298|NCT03073200|155862745|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457299|NCT03073200|155862746|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457300|NCT03073200|155862747|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457301|NCT03073200|155862748|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457302|NCT03073200|155862749|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457303|NCT03073200|155862750|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
48457505|NCT01365091|155862779|FG000|Period 1|Personal reasons|0|||
48457304|NCT03073200|155862751|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
48457305|NCT03073200|155862737|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457306|NCT03073200|155862738|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457307|NCT03073200|155862739|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457308|NCT03073200|155862740|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457309|NCT03073200|155862741|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457310|NCT03073200|155862742|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457311|NCT03073200|155862743|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457312|NCT03073200|155862744|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457313|NCT03073200|155862745|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457314|NCT03073200|155862746|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457315|NCT03073200|155862747|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457316|NCT03073200|155862748|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457317|NCT03073200|155862749|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457318|NCT03073200|155862750|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
48457319|NCT03073200|155862751|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
48457320|NCT03073200|155862737|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457321|NCT03073200|155862738|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457322|NCT03073200|155862739|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457323|NCT03073200|155862740|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457324|NCT03073200|155862741|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457325|NCT03073200|155862742|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457326|NCT03073200|155862743|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457327|NCT03073200|155862744|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457328|NCT03073200|155862745|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457329|NCT03073200|155862746|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457330|NCT03073200|155862747|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457331|NCT03073200|155862748|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457332|NCT03073200|155862749|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457333|NCT03073200|155862750|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
48457334|NCT03073200|155862751|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
48457335|NCT03073200|155862737|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457336|NCT03073200|155862738|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457337|NCT03073200|155862739|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457338|NCT03073200|155862740|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457339|NCT03073200|155862741|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457340|NCT03073200|155862742|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457341|NCT03073200|155862743|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457342|NCT03073200|155862744|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457343|NCT03073200|155862745|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457344|NCT03073200|155862746|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457345|NCT03073200|155862747|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457346|NCT03073200|155862748|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457347|NCT03073200|155862749|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457348|NCT03073200|155862750|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
48457349|NCT03073200|155862751|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
48457350|NCT03073200|155862737|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457351|NCT03073200|155862738|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457352|NCT03073200|155862739|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457353|NCT03073200|155862740|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457354|NCT03073200|155862741|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457355|NCT03073200|155862742|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457356|NCT03073200|155862743|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457357|NCT03073200|155862744|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457358|NCT03073200|155862745|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457359|NCT03073200|155862746|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457360|NCT03073200|155862747|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457361|NCT03073200|155862748|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457362|NCT03073200|155862749|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457363|NCT03073200|155862750|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
48457364|NCT03073200|155862751|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
48457365|NCT03073200|155862737|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457366|NCT03073200|155862738|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457367|NCT03073200|155862739|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457368|NCT03073200|155862740|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457369|NCT03073200|155862741|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457370|NCT03073200|155862742|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457371|NCT03073200|155862743|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457372|NCT03073200|155862744|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457373|NCT03073200|155862745|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457374|NCT03073200|155862746|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457375|NCT03073200|155862747|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457376|NCT03073200|155862748|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457377|NCT03073200|155862749|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457378|NCT03073200|155862750|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
48457379|NCT03073200|155862751|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
48457380|NCT04474366|155862752|FG000|Overall Study|Lost to Follow-up|2|||
48457381|NCT04474366|155862753|FG001|Overall Study|Lost to Follow-up|5|||
48457382|NCT03099304|155862756|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
48457383|NCT03099304|155862757|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
48457384|NCT03099304|155862758|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
48457385|NCT03099304|155862759|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
48457386|NCT03099304|155862760|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
48457387|NCT03099304|155862761|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
48457388|NCT03099304|155862756|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
48457389|NCT03099304|155862757|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
48457390|NCT03099304|155862758|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
48457391|NCT03099304|155862759|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
48457392|NCT03099304|155862760|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
48457393|NCT03099304|155862761|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
48457394|NCT03099304|155862756|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
48457395|NCT03099304|155862757|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
48457396|NCT03099304|155862758|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
48457397|NCT03099304|155862759|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
48457398|NCT03099304|155862760|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
48457399|NCT03099304|155862761|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
48457400|NCT03099304|155862756|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
48457401|NCT03099304|155862757|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
48457402|NCT03099304|155862758|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
48457403|NCT03099304|155862759|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
48457404|NCT03099304|155862760|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
48457405|NCT03099304|155862761|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
48457406|NCT03099304|155862756|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
48457407|NCT03099304|155862757|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
48457408|NCT03099304|155862758|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
48457409|NCT03099304|155862759|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
48457410|NCT03099304|155862760|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
48457411|NCT03099304|155862761|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
48457412|NCT03099304|155862756|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48457413|NCT03099304|155862757|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48457414|NCT03099304|155862758|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
48457415|NCT03099304|155862759|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48457416|NCT03099304|155862760|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48457417|NCT03099304|155862761|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
48457418|NCT03099304|155862756|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
48457419|NCT03099304|155862757|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
48457420|NCT03099304|155862758|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
48457421|NCT03099304|155862759|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
48457422|NCT03099304|155862760|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
48457423|NCT03099304|155862761|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
48457424|NCT03099304|155862756|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
48457425|NCT03099304|155862757|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
48457426|NCT03099304|155862758|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
48457427|NCT03099304|155862759|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
48457428|NCT03099304|155862760|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
48457429|NCT03099304|155862761|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
48457430|NCT03099304|155862756|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
48457431|NCT03099304|155862757|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
48457432|NCT03099304|155862758|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
48457433|NCT03099304|155862759|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
48457434|NCT03099304|155862760|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
48457435|NCT03099304|155862761|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
48457436|NCT03099304|155862756|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
48457437|NCT03099304|155862757|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
48457438|NCT03099304|155862758|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
48457439|NCT03099304|155862759|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
48457440|NCT03099304|155862760|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
48457441|NCT03099304|155862761|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
48457442|NCT03099304|155862756|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
48457443|NCT03099304|155862757|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
48457444|NCT03099304|155862758|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
48457445|NCT03099304|155862759|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
48457446|NCT03099304|155862760|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
48457447|NCT03099304|155862761|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
48457448|NCT03099304|155862756|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
48457449|NCT03099304|155862757|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
48457450|NCT03099304|155862758|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
48457451|NCT03099304|155862759|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
48457452|NCT03099304|155862760|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
48457453|NCT03099304|155862761|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
48457454|NCT03099304|155862756|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
48457455|NCT03099304|155862757|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
48457456|NCT03099304|155862758|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
48457457|NCT03099304|155862759|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
48457458|NCT03099304|155862760|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
48457459|NCT03099304|155862761|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
48457460|NCT03099304|155862756|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
48457461|NCT03099304|155862757|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
48457462|NCT03099304|155862758|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
48457463|NCT03099304|155862759|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
48457464|NCT03099304|155862760|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
48457465|NCT03099304|155862761|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
48457466|NCT03099304|155862756|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
48457467|NCT03099304|155862757|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
48457468|NCT03099304|155862758|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
48457469|NCT03099304|155862759|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
48457470|NCT03099304|155862760|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
48457471|NCT03099304|155862761|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
48457472|NCT03099304|155862756|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
48457473|NCT03099304|155862757|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
48457474|NCT03099304|155862758|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
48457475|NCT03099304|155862759|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
48457476|NCT03099304|155862760|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
48457477|NCT03099304|155862761|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
48457478|NCT03099304|155862756|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
48457479|NCT03099304|155862757|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
48457480|NCT03099304|155862758|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
48457481|NCT03099304|155862759|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
48457482|NCT03099304|155862760|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
48457483|NCT03099304|155862761|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
48457484|NCT02583711|155862770|FG000|Overall Study|Withdrawal by Subject|0|||
48457485|NCT02583711|155862771|FG001|Overall Study|Withdrawal by Subject|10|||
48457486|NCT02583711|155862772|FG002|Overall Study|Withdrawal by Subject|0|||
48457487|NCT01868594|155862777|FG000|Overall Study|Do not meet inclusion criteria|4|||
48457488|NCT01868594|155862778|FG001|Overall Study|Do not meet inclusion criteria|3|||
48457489|NCT01365091|155862779|FG000|Period 1|Adverse Event|1|||
48457490|NCT01365091|155862780|FG001|Period 1|Adverse Event|0|||
48457491|NCT01365091|155862781|FG002|Period 1|Adverse Event|2|||
48457492|NCT01365091|155862782|FG003|Period 1|Adverse Event|3|||
48457493|NCT01365091|155862779|FG000|Period 1|Positive test result for drugs of abuse|1|||
48457494|NCT01365091|155862780|FG001|Period 1|Positive test result for drugs of abuse|0|||
48457495|NCT01365091|155862781|FG002|Period 1|Positive test result for drugs of abuse|0|||
48457496|NCT01365091|155862782|FG003|Period 1|Positive test result for drugs of abuse|0|||
48457497|NCT01365091|155862779|FG000|Period 1|No longer met study criteria|0|||
48457498|NCT01365091|155862780|FG001|Period 1|No longer met study criteria|1|||
48457499|NCT01365091|155862781|FG002|Period 1|No longer met study criteria|0|||
48457500|NCT01365091|155862782|FG003|Period 1|No longer met study criteria|0|||
48457501|NCT01365091|155862779|FG000|Period 1|Withdrawal by Subject|0|||
48457502|NCT01365091|155862780|FG001|Period 1|Withdrawal by Subject|1|||
48457503|NCT01365091|155862781|FG002|Period 1|Withdrawal by Subject|0|||
48457506|NCT01365091|155862780|FG001|Period 1|Personal reasons|0|||
48457507|NCT01365091|155862781|FG002|Period 1|Personal reasons|1|||
48457508|NCT01365091|155862782|FG003|Period 1|Personal reasons|0|||
48457509|NCT01365091|155862779|FG000|Period 2|Withdrawal by Subject|1|||
48457510|NCT01365091|155862780|FG001|Period 2|Withdrawal by Subject|0|||
48457511|NCT01365091|155862781|FG002|Period 2|Withdrawal by Subject|0|||
48457512|NCT01365091|155862782|FG003|Period 2|Withdrawal by Subject|0|||
48457513|NCT01365091|155862779|FG000|Period 2|Adverse Event|0|||
48457514|NCT01365091|155862780|FG001|Period 2|Adverse Event|0|||
48457515|NCT01365091|155862781|FG002|Period 2|Adverse Event|1|||
48457516|NCT01365091|155862782|FG003|Period 2|Adverse Event|0|||
48457517|NCT00068822|155862783|FG000|First Randomized Intervention|Lost to Follow-up|1|||
48457518|NCT00068822|155862784|FG001|First Randomized Intervention|Lost to Follow-up|2|||
48457519|NCT01700140|155862786|FG000|Overall Study|Use of rescue drugs|3|||
48457520|NCT01700140|155862787|FG001|Overall Study|Use of rescue drugs|3|||
48457521|NCT01700140|155862788|FG002|Overall Study|Use of rescue drugs|1|||
48457522|NCT01700140|155862786|FG000|Overall Study|Discontinuation of radiotherapy|1|||
48457523|NCT01700140|155862787|FG001|Overall Study|Discontinuation of radiotherapy|0|||
48457524|NCT01700140|155862788|FG002|Overall Study|Discontinuation of radiotherapy|0|||
48457525|NCT01700140|155862786|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
48457526|NCT01700140|155862787|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
48457527|NCT01700140|155862788|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
48457528|NCT01700140|155862786|FG000|Overall Study|Aggravation of symptoms|1|||
48457529|NCT01700140|155862787|FG001|Overall Study|Aggravation of symptoms|0|||
48457530|NCT01700140|155862788|FG002|Overall Study|Aggravation of symptoms|0|||
48457531|NCT01700140|155862786|FG000|Overall Study|Adverse Event|0|||
48457532|NCT01700140|155862787|FG001|Overall Study|Adverse Event|1|||
48457533|NCT01700140|155862788|FG002|Overall Study|Adverse Event|0|||
48457534|NCT01700140|155862786|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
48457535|NCT01700140|155862787|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
48457536|NCT01700140|155862788|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
48457537|NCT03458234|155862789|FG000|Overall Study|Withdrawal by Subject|1|||
48457538|NCT01060124|155862791|FG000|Overall Study|Other|16|||
48457539|NCT01060124|155862791|FG000|Overall Study|Adverse Event|14|||
48457540|NCT01060124|155862791|FG000|Overall Study|Withdrawal by Subject|7|||
48457541|NCT05307523|155862795|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
48457542|NCT05307523|155862796|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
48457543|NCT05307523|155862795|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
48457544|NCT05307523|155862796|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
48457545|NCT02343952|155862797|FG000|Study Treatment|Disease Progression|23|||
48457546|NCT02343952|155862797|FG000|Study Treatment|Death|3|||
48457547|NCT02343952|155862797|FG000|Study Treatment|Adverse Event|19|||
48457548|NCT02343952|155862797|FG000|Study Treatment|Withdrawal by Subject|7|||
48457549|NCT02343952|155862797|FG000|Study Treatment|other complicating Diseases|1|||
48457550|NCT02343952|155862797|FG000|Follow up|Withdrawal by Subject|3|||
48457551|NCT02343952|155862797|FG000|Follow up|Death|33|||
48457552|NCT02343952|155862797|FG000|Follow up|Patient does not meet eligibility for study.|1|||
48457553|NCT02343952|155862797|FG000|Follow up|Research department closed by the practice.|5|||
48457554|NCT02343952|155862797|FG000|Follow up|Patient went home to Russia|1|||
48457555|NCT02343952|155862797|FG000|Follow up|Disease Progression|1|||
48457556|NCT02343952|155862797|FG000|Follow up|study terminated|1|||
48457557|NCT02254304|155864069|FG000|Overall Study|Adverse Event|2|||
48457558|NCT02254304|155864070|FG001|Overall Study|Adverse Event|1|||
48457559|NCT02254304|155864069|FG000|Overall Study|Lost to Follow-up|2|||
48457560|NCT02254304|155864070|FG001|Overall Study|Lost to Follow-up|2|||
48457561|NCT02254304|155864069|FG000|Overall Study|Protocol Violation|1|||
48457562|NCT02254304|155864070|FG001|Overall Study|Protocol Violation|0|||
48457563|NCT02254304|155864069|FG000|Overall Study|Withdrawal by Subject|3|||
48457564|NCT02254304|155864070|FG001|Overall Study|Withdrawal by Subject|0|||
48457565|NCT02254304|155864069|FG000|Overall Study|Injection site pain and Injection fear|1|||
48457566|NCT02254304|155864070|FG001|Overall Study|Injection site pain and Injection fear|0|||
48457567|NCT02254304|155864069|FG000|Overall Study|Personal causes|4|||
48457568|NCT02254304|155864070|FG001|Overall Study|Personal causes|1|||
48457569|NCT02254304|155864069|FG000|Overall Study|Personal decision|1|||
48457570|NCT02254304|155864070|FG001|Overall Study|Personal decision|0|||
48457571|NCT02365506|155864071|FG000|Overall Study|Investigator's Discretion|0|||
48457572|NCT02365506|155864072|FG001|Overall Study|Investigator's Discretion|0|||
48457573|NCT02365506|155864073|FG002|Overall Study|Investigator's Discretion|1|||
48457574|NCT02431793|155864074|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
48457575|NCT02431793|155864075|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
48457576|NCT02431793|155864076|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
48457577|NCT02431793|155864074|FG000|Overall Study|Withdrawal by Subject|7|||
48457578|NCT02431793|155864075|FG001|Overall Study|Withdrawal by Subject|5|||
48457579|NCT02431793|155864076|FG002|Overall Study|Withdrawal by Subject|5|||
48457580|NCT02431793|155864074|FG000|Overall Study|Lost to Follow-up|101|||
48457581|NCT02431793|155864075|FG001|Overall Study|Lost to Follow-up|122|||
48457582|NCT02431793|155864076|FG002|Overall Study|Lost to Follow-up|104|||
48457583|NCT01495689|155864077|FG000|Overall Study|Death|0|||
48457584|NCT01495689|155864078|FG001|Overall Study|Death|1|||
48457585|NCT01495689|155864077|FG000|Overall Study|Withdrawal by Subject|3|||
48457586|NCT01495689|155864078|FG001|Overall Study|Withdrawal by Subject|0|||
48457587|NCT01495689|155864077|FG000|Overall Study|Lost to Follow-up|7|||
48457588|NCT01495689|155864078|FG001|Overall Study|Lost to Follow-up|6|||
48457589|NCT00038142|155864089|FG000|Overall Study|Ineligible|1|||
48457590|NCT00038142|155864090|FG001|Overall Study|Ineligible|0|||
48457591|NCT00038142|155864089|FG000|Overall Study|Progressive Disease|11|||
48457592|NCT00038142|155864090|FG001|Overall Study|Progressive Disease|7|||
48457593|NCT00038142|155864089|FG000|Overall Study|Death|1|||
48457594|NCT00038142|155864090|FG001|Overall Study|Death|0|||
48457595|NCT00038142|155864089|FG000|Overall Study|Adverse Event|1|||
48457596|NCT00038142|155864090|FG001|Overall Study|Adverse Event|0|||
48457597|NCT00038142|155864089|FG000|Overall Study|Unknown Reason|8|||
48457598|NCT00038142|155864090|FG001|Overall Study|Unknown Reason|0|||
48457599|NCT02954952|155864111|FG000|Overall Study|Withdrawal by Subject|1|||
48457600|NCT02954952|155864112|FG001|Overall Study|Withdrawal by Subject|0|||
48457601|NCT02954952|155864113|FG002|Overall Study|Withdrawal by Subject|0|||
48457602|NCT02954952|155864111|FG000|Overall Study|No data collected|0|||
48457603|NCT02954952|155864112|FG001|Overall Study|No data collected|1|||
48457604|NCT02954952|155864113|FG002|Overall Study|No data collected|0|||
48457605|NCT01685372|155864117|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
48457606|NCT01685372|155864118|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
48457607|NCT01408732|155864119|FG000|Overall Study|Withdrawal by Subject|2|||
48457608|NCT01408732|155864120|FG001|Overall Study|Withdrawal by Subject|2|||
48457609|NCT02354690|155864124|FG000|Overall Study|Physician Decision|1|||
48457610|NCT02756845|155864127|FG000|Overall Study|Death|12|||
48457611|NCT02756845|155864128|FG001|Overall Study|Death|2|||
48457612|NCT02756845|155864127|FG000|Overall Study|Withdrawal by Subject|1|||
48457613|NCT02756845|155864128|FG001|Overall Study|Withdrawal by Subject|0|||
48457614|NCT00498368|155864129|FG000|Overall Study|Withdrawal by Subject|3|||
48457615|NCT00498368|155864130|FG001|Overall Study|Withdrawal by Subject|2|||
48457616|NCT02736929|155864131|FG000|Main Study|Lost to Follow-up|7|||
48457617|NCT02736929|155864132|FG001|Main Study|Lost to Follow-up|1|||
48457618|NCT02736929|155864133|FG002|Main Study|Lost to Follow-up|0|||
48457619|NCT02736929|155864131|FG000|Main Study|Withdrawal by Subject|1|||
48457620|NCT02736929|155864132|FG001|Main Study|Withdrawal by Subject|1|||
48457621|NCT02736929|155864133|FG002|Main Study|Withdrawal by Subject|0|||
48457622|NCT02736929|155864131|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
48457623|NCT02736929|155864132|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
48457624|NCT02736929|155864133|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
48457625|NCT00285649|155864134|FG000|Overall Study|Lost to Follow-up|6|||
48457626|NCT00285649|155864135|FG001|Overall Study|Lost to Follow-up|4|||
48457627|NCT00285649|155864136|FG002|Overall Study|Lost to Follow-up|4|||
48457628|NCT00285649|155864134|FG000|Overall Study|Withdrawal by Subject|3|||
48457629|NCT00285649|155864135|FG001|Overall Study|Withdrawal by Subject|2|||
48457630|NCT00285649|155864136|FG002|Overall Study|Withdrawal by Subject|2|||
48457631|NCT02972593|155864137|FG000|Overall Study|Lost to Follow-up|19|||
48457632|NCT02972593|155864138|FG001|Overall Study|Lost to Follow-up|15|||
48457633|NCT02972593|155864137|FG000|Overall Study|Protocol Violation|1|||
48457634|NCT02972593|155864138|FG001|Overall Study|Protocol Violation|0|||
48457635|NCT01818765|155864142|FG000|Overall Study|Death|2|||
48457636|NCT01347073|155864144|FG000|Overall Study|Adverse Event|1|||
48457637|NCT01347073|155864144|FG000|Overall Study|Liver Transplant|1|||
48457638|NCT02865928|155864149|FG000|Overall Study|Withdrawal by Subject|1|||
48457639|NCT02865928|155864150|FG001|Overall Study|Withdrawal by Subject|0|||
48457640|NCT02865928|155864149|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
48457641|NCT02865928|155864150|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
48457642|NCT02865928|155864149|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
48457643|NCT02865928|155864150|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
48457644|NCT04259346|155864153|FG000|Overall Study|Lost to Follow-up|1|||
48457645|NCT04259346|155864154|FG001|Overall Study|Lost to Follow-up|3|||
48457646|NCT04259346|155864153|FG000|Overall Study|Protocol Violation|1|||
48457647|NCT04259346|155864154|FG001|Overall Study|Protocol Violation|0|||
48457648|NCT04259346|155864153|FG000|Overall Study|Withdrawal by Subject|1|||
48457649|NCT04259346|155864154|FG001|Overall Study|Withdrawal by Subject|0|||
48457650|NCT04259346|155864153|FG000|Overall Study|Adverse Event|1|||
48457651|NCT04259346|155864154|FG001|Overall Study|Adverse Event|1|||
48457652|NCT01487863|155864155|FG000|Overall Study|Death|19|||
48457653|NCT01487863|155864156|FG001|Overall Study|Death|19|||
48457654|NCT03512275|155864161|FG000|Overall Study|Withdrawal by Subject|1|||
48457655|NCT03512275|155864162|FG001|Overall Study|Withdrawal by Subject|3|||
48457656|NCT03512275|155864161|FG000|Overall Study|Physician Decision|0|||
48457657|NCT03512275|155864162|FG001|Overall Study|Physician Decision|1|||
48457658|NCT03512275|155864161|FG000|Overall Study|Lost to Follow-up|0|||
48457659|NCT03512275|155864162|FG001|Overall Study|Lost to Follow-up|3|||
48457660|NCT03512275|155864161|FG000|Overall Study|Other|1|||
48457661|NCT03512275|155864162|FG001|Overall Study|Other|0|||
48457662|NCT04757376|155864163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
48457663|NCT04757376|155864164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
48457664|NCT04757376|155864165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
48457665|NCT04757376|155864166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
48457666|NCT04757376|155864167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
48457667|NCT04757376|155864163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
48457668|NCT04757376|155864164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
48457669|NCT04757376|155864165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
48457670|NCT04757376|155864166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
48457671|NCT04757376|155864167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
48457672|NCT04757376|155864163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
48457673|NCT04757376|155864164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
48457674|NCT04757376|155864165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
48457675|NCT04757376|155864166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
48457676|NCT04757376|155864167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
48457677|NCT04757376|155864163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
48457678|NCT04757376|155864164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
48457679|NCT04757376|155864165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
48457680|NCT04757376|155864166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
48457681|NCT04757376|155864167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
48457682|NCT04757376|155864163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
48457683|NCT04757376|155864164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
48457684|NCT04757376|155864165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
48457685|NCT04757376|155864166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
48457686|NCT04757376|155864167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
48457687|NCT04757376|155864163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
48457688|NCT04757376|155864164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
48457689|NCT04757376|155864165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
48457690|NCT04757376|155864166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
48457691|NCT04757376|155864167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
48457692|NCT04757376|155864163|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
48457693|NCT04757376|155864164|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
48457694|NCT04757376|155864165|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
48457695|NCT04757376|155864166|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
48457696|NCT04757376|155864167|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
48457697|NCT04757376|155864163|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
48457698|NCT04757376|155864164|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
48457699|NCT04757376|155864165|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
48457700|NCT04757376|155864166|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
48457701|NCT04757376|155864167|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
48457702|NCT03898323|155864168|FG000|Overall Study|Physician Decision|1|||
48457703|NCT02574520|155864170|FG000|Overall Study|Not dosed|2|||
48457704|NCT02574520|155864171|FG001|Overall Study|Not dosed|0|||
48457705|NCT02574520|155864172|FG002|Overall Study|Not dosed|5|||
48457706|NCT02574520|155864173|FG003|Overall Study|Not dosed|4|||
48457707|NCT02574520|155864170|FG000|Overall Study|Adverse Event|0|||
48457708|NCT02574520|155864171|FG001|Overall Study|Adverse Event|0|||
48457709|NCT02574520|155864172|FG002|Overall Study|Adverse Event|0|||
48457710|NCT02574520|155864173|FG003|Overall Study|Adverse Event|1|||
48457711|NCT02574520|155864170|FG000|Overall Study|Withdrawal by Subject|0|||
48457712|NCT02574520|155864171|FG001|Overall Study|Withdrawal by Subject|0|||
48457713|NCT02574520|155864172|FG002|Overall Study|Withdrawal by Subject|0|||
48457714|NCT02574520|155864173|FG003|Overall Study|Withdrawal by Subject|1|||
48457715|NCT02574520|155864170|FG000|Overall Study|Other|0|||
48457716|NCT02574520|155864171|FG001|Overall Study|Other|0|||
48457717|NCT02574520|155864172|FG002|Overall Study|Other|0|||
48457718|NCT02574520|155864173|FG003|Overall Study|Other|2|||
48457719|NCT01012037|155864176|FG000|Overall Study|Adverse Event|0|||
48457720|NCT01012037|155864177|FG001|Overall Study|Adverse Event|8|||
48457721|NCT01012037|155864178|FG002|Overall Study|Adverse Event|3|||
48457722|NCT01012037|155864176|FG000|Overall Study|Protocol Violation|0|||
48457723|NCT01012037|155864177|FG001|Overall Study|Protocol Violation|3|||
48457724|NCT01012037|155864178|FG002|Overall Study|Protocol Violation|5|||
48457725|NCT01012037|155864176|FG000|Overall Study|Withdrawal by Subject|0|||
48457726|NCT01012037|155864177|FG001|Overall Study|Withdrawal by Subject|4|||
48457727|NCT01012037|155864178|FG002|Overall Study|Withdrawal by Subject|1|||
48457728|NCT01012037|155864176|FG000|Overall Study|Other reason (not specified)|1|||
48457729|NCT01012037|155864177|FG001|Overall Study|Other reason (not specified)|1|||
48457730|NCT01012037|155864178|FG002|Overall Study|Other reason (not specified)|1|||
48457731|NCT01474889|155864182|FG000|Overall Study|Physician Decision|1|||
48457732|NCT01474889|155864183|FG001|Overall Study|Physician Decision|0|||
48457733|NCT01474889|155864184|FG002|Overall Study|Physician Decision|0|||
48457734|NCT01474889|155864182|FG000|Overall Study|Did not meet inclusion|1|||
48457735|NCT01474889|155864183|FG001|Overall Study|Did not meet inclusion|0|||
48457736|NCT01474889|155864184|FG002|Overall Study|Did not meet inclusion|0|||
48457737|NCT01474889|155864182|FG000|Overall Study|Withdrawal by Subject|0|||
48457738|NCT01474889|155864183|FG001|Overall Study|Withdrawal by Subject|1|||
48457739|NCT01474889|155864184|FG002|Overall Study|Withdrawal by Subject|0|||
48457740|NCT00901394|155864185|FG000|Overall Study|Physician Decision|1|||
48457741|NCT00901394|155864186|FG001|Overall Study|Physician Decision|1|||
48457742|NCT00901394|155864187|FG002|Overall Study|Physician Decision|2|||
48457743|NCT00122317|155864192|FG000|Overall Study|Death|3|||
48457744|NCT00122317|155864192|FG000|Overall Study|Adverse Event|4|||
48457745|NCT00122317|155864192|FG000|Overall Study|Physician Decision|2|||
48457746|NCT00122317|155864192|FG000|Overall Study|patient non-compliance|1|||
48457747|NCT00122317|155864192|FG000|Overall Study|Withdrawal by Subject|1|||
48457748|NCT02886338|155864193|FG000|Overall Study|Withdrawal by Subject|1|||
48457749|NCT03267576|155864200|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
48457750|NCT03267576|155864201|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
48457751|NCT03267576|155864200|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
48457752|NCT03267576|155864201|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
48457753|NCT00777257|155864202|FG000|Overall Study|Adverse Event|3|||
48457754|NCT00777257|155864203|FG001|Overall Study|Adverse Event|1|||
48457755|NCT00777257|155864204|FG002|Overall Study|Adverse Event|0|||
48457756|NCT00777257|155864202|FG000|Overall Study|Lost to Follow-up|3|||
48457757|NCT00777257|155864203|FG001|Overall Study|Lost to Follow-up|3|||
48457758|NCT00777257|155864204|FG002|Overall Study|Lost to Follow-up|2|||
48457759|NCT00777257|155864202|FG000|Overall Study|Protocol Violation|2|||
48457760|NCT00777257|155864203|FG001|Overall Study|Protocol Violation|2|||
48457761|NCT00777257|155864204|FG002|Overall Study|Protocol Violation|2|||
48457762|NCT00777257|155864202|FG000|Overall Study|Withdrawal by Subject|3|||
48457763|NCT00777257|155864203|FG001|Overall Study|Withdrawal by Subject|6|||
48457764|NCT00777257|155864204|FG002|Overall Study|Withdrawal by Subject|5|||
48457765|NCT03662789|155864206|FG000|Overall Study|Lost to Follow-up|1|||
48457766|NCT03662789|155864207|FG001|Overall Study|Lost to Follow-up|2|||
48457767|NCT03662789|155864206|FG000|Overall Study|Could not perform treadmill test|4|||
48457768|NCT03662789|155864207|FG001|Overall Study|Could not perform treadmill test|4|||
48457769|NCT03662789|155864206|FG000|Overall Study|Death|0|||
48457770|NCT03662789|155864207|FG001|Overall Study|Death|1|||
48457771|NCT02692560|155864210|FG000|Overall Study|Withdrawal by Subject|0|||
48457772|NCT02692560|155864211|FG001|Overall Study|Withdrawal by Subject|6|||
48457773|NCT04412668|155864216|FG000|Overall Study|Death - multiple comorbidities|2|||
48457774|NCT04412668|155864217|FG001|Overall Study|Death - multiple comorbidities|0|||
48457775|NCT04412668|155864218|FG002|Overall Study|Death - multiple comorbidities|0|||
48457776|NCT04412668|155864216|FG000|Overall Study|Withdrawal by Subject|3|||
48457777|NCT04412668|155864217|FG001|Overall Study|Withdrawal by Subject|0|||
48457778|NCT04412668|155864218|FG002|Overall Study|Withdrawal by Subject|0|||
48457779|NCT04412668|155864216|FG000|Overall Study|Other than Specified|2|||
48457780|NCT04412668|155864217|FG001|Overall Study|Other than Specified|0|||
48457781|NCT04412668|155864218|FG002|Overall Study|Other than Specified|0|||
48457782|NCT03954704|155864219|FG000|Overall Study|Death|1|||
48457783|NCT03954704|155864220|FG001|Overall Study|Death|1|||
48457784|NCT03954704|155864221|FG002|Overall Study|Death|1|||
48457785|NCT03954704|155864222|FG003|Overall Study|Death|3|||
48457786|NCT03954704|155864223|FG004|Overall Study|Death|2|||
48457787|NCT03954704|155864224|FG005|Overall Study|Death|2|||
48457788|NCT03954704|155864225|FG006|Overall Study|Death|0|||
48457789|NCT03954704|155864219|FG000|Overall Study|Withdrew Consent|0|||
48457790|NCT03954704|155864220|FG001|Overall Study|Withdrew Consent|0|||
48457791|NCT03954704|155864221|FG002|Overall Study|Withdrew Consent|1|||
48457792|NCT03954704|155864222|FG003|Overall Study|Withdrew Consent|0|||
48457793|NCT03954704|155864223|FG004|Overall Study|Withdrew Consent|0|||
48457794|NCT03954704|155864224|FG005|Overall Study|Withdrew Consent|1|||
48457795|NCT03954704|155864225|FG006|Overall Study|Withdrew Consent|0|||
48457796|NCT03954704|155864219|FG000|Overall Study|Lost to Follow-up|0|||
48457797|NCT03954704|155864220|FG001|Overall Study|Lost to Follow-up|0|||
48457798|NCT03954704|155864221|FG002|Overall Study|Lost to Follow-up|0|||
48457799|NCT03954704|155864222|FG003|Overall Study|Lost to Follow-up|0|||
48457800|NCT03954704|155864223|FG004|Overall Study|Lost to Follow-up|0|||
48457801|NCT03954704|155864224|FG005|Overall Study|Lost to Follow-up|0|||
48457802|NCT03954704|155864225|FG006|Overall Study|Lost to Follow-up|1|||
48457803|NCT03954704|155864219|FG000|Overall Study|Study Terminated by Sponsor|0|||
48457804|NCT03954704|155864220|FG001|Overall Study|Study Terminated by Sponsor|0|||
48457805|NCT03954704|155864221|FG002|Overall Study|Study Terminated by Sponsor|1|||
48457806|NCT03954704|155864222|FG003|Overall Study|Study Terminated by Sponsor|0|||
48457807|NCT03954704|155864223|FG004|Overall Study|Study Terminated by Sponsor|1|||
48457808|NCT03954704|155864224|FG005|Overall Study|Study Terminated by Sponsor|4|||
48457809|NCT03954704|155864225|FG006|Overall Study|Study Terminated by Sponsor|2|||
48457810|NCT03954704|155864219|FG000|Overall Study|Enrolled but not Treated|0|||
48457811|NCT03954704|155864220|FG001|Overall Study|Enrolled but not Treated|0|||
48457812|NCT03954704|155864221|FG002|Overall Study|Enrolled but not Treated|0|||
48457813|NCT03954704|155864222|FG003|Overall Study|Enrolled but not Treated|0|||
48457814|NCT03954704|155864223|FG004|Overall Study|Enrolled but not Treated|0|||
48457815|NCT03954704|155864224|FG005|Overall Study|Enrolled but not Treated|1|||
48457816|NCT03954704|155864225|FG006|Overall Study|Enrolled but not Treated|0|||
48457817|NCT00102804|155864226|FG000|Overall Study|Progressive Disease (PD)|307|||
48457818|NCT00102804|155864227|FG001|Overall Study|Progressive Disease (PD)|196|||
48457819|NCT00102804|155864226|FG000|Overall Study|Withdrawal by Subject|46|||
48457820|NCT00102804|155864227|FG001|Overall Study|Withdrawal by Subject|7|||
48457821|NCT00102804|155864226|FG000|Overall Study|Adverse Event|37|||
48457822|NCT00102804|155864227|FG001|Overall Study|Adverse Event|3|||
48457823|NCT00102804|155864226|FG000|Overall Study|Physician Decision|24|||
48457824|NCT00102804|155864227|FG001|Overall Study|Physician Decision|6|||
48457825|NCT00102804|155864226|FG000|Overall Study|Death|5|||
48457826|NCT00102804|155864227|FG001|Overall Study|Death|6|||
48457827|NCT00102804|155864226|FG000|Overall Study|Enrollment Criteria Not Met|6|||
48457828|NCT00102804|155864227|FG001|Overall Study|Enrollment Criteria Not Met|0|||
48457829|NCT00102804|155864226|FG000|Overall Study|Lost to Follow-up|4|||
48457830|NCT00102804|155864227|FG001|Overall Study|Lost to Follow-up|1|||
48457831|NCT00102804|155864226|FG000|Overall Study|Protocol Violation|2|||
48457832|NCT00102804|155864227|FG001|Overall Study|Protocol Violation|1|||
48457833|NCT00102804|155864226|FG000|Overall Study|Satisfactory Response|2|||
48457834|NCT00102804|155864227|FG001|Overall Study|Satisfactory Response|0|||
48457835|NCT00102804|155864226|FG000|Overall Study|Sponsor Decision|1|||
48457836|NCT00102804|155864227|FG001|Overall Study|Sponsor Decision|0|||
48457837|NCT00102804|155864226|FG000|Overall Study|Alive, Receiving Treatment|7|||
48457838|NCT00102804|155864227|FG001|Overall Study|Alive, Receiving Treatment|2|||
48457839|NCT02038790|155865921|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
48457840|NCT02038790|155865922|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
48457841|NCT00948194|155865925|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
48457842|NCT00948194|155865926|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
48457843|NCT00464620|155865930|FG000|Overall Study|Physician Decision|1|||
48457844|NCT00464620|155865931|FG001|Overall Study|Physician Decision|0|||
48457845|NCT00464620|155865932|FG002|Overall Study|Physician Decision|0|||
48457846|NCT00464620|155865930|FG000|Overall Study|Withdrawal by Subject|1|||
48457847|NCT00464620|155865931|FG001|Overall Study|Withdrawal by Subject|0|||
48457848|NCT00464620|155865932|FG002|Overall Study|Withdrawal by Subject|3|||
48457849|NCT00464620|155865930|FG000|Overall Study|Ineligible sarcoma subtype|0|||
48457850|NCT00464620|155865931|FG001|Overall Study|Ineligible sarcoma subtype|2|||
48457851|NCT00464620|155865932|FG002|Overall Study|Ineligible sarcoma subtype|2|||
48457852|NCT00464620|155865930|FG000|Overall Study|Use of prohibited concomitant medication|0|||
48457853|NCT00464620|155865931|FG001|Overall Study|Use of prohibited concomitant medication|0|||
48457854|NCT00464620|155865932|FG002|Overall Study|Use of prohibited concomitant medication|2|||
48457855|NCT00634751|155865935|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
48457856|NCT00634751|155865936|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
48457857|NCT00634751|155865937|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
48457858|NCT00634751|155865938|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
48457859|NCT00634751|155865935|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
48457860|NCT00634751|155865936|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
48457861|NCT00634751|155865937|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
48457862|NCT00634751|155865938|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
48457863|NCT00634751|155865935|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
48457864|NCT00634751|155865936|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
48457865|NCT00634751|155865937|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
48457866|NCT00634751|155865938|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
48457867|NCT00402285|155865941|FG000|Overall Study|insufficient RNA quality|7|||
48457868|NCT00402285|155865942|FG001|Overall Study|insufficient RNA quality|6|||
48457869|NCT00402285|155865943|FG002|Overall Study|insufficient RNA quality|2|||
48457870|NCT04402385|155865944|FG000|Overall Study|Withdrawal by Subject|4|||
48457871|NCT04402385|155865945|FG001|Overall Study|Withdrawal by Subject|4|||
48457872|NCT04402385|155865944|FG000|Overall Study|Lost to Follow-up|1|||
48457873|NCT04402385|155865945|FG001|Overall Study|Lost to Follow-up|1|||
48457874|NCT04402385|155865944|FG000|Overall Study|Physician Decision|0|||
48457875|NCT04402385|155865945|FG001|Overall Study|Physician Decision|1|||
48457876|NCT00233324|155865948|FG000|Main Study|Death|68|||
48457877|NCT00233324|155865949|FG001|Main Study|Death|60|||
48457878|NCT00233324|155865950|FG002|Main Study|Death|62|||
48457879|NCT00233324|155865951|FG003|Main Study|Death|47|||
48457880|NCT00233324|155865948|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
48457881|NCT00233324|155865949|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
48457882|NCT00233324|155865950|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
48457883|NCT00233324|155865951|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
48457884|NCT00233324|155865948|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
48457885|NCT00233324|155865949|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
48457886|NCT00233324|155865950|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
48457887|NCT00233324|155865951|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
48457888|NCT00405275|155865952|FG000|Overall Study|Death|1|||
48457889|NCT00405275|155865953|FG001|Overall Study|Death|0|||
48457890|NCT00405275|155865952|FG000|Overall Study|Lost to Follow-up|5|||
48457891|NCT00405275|155865953|FG001|Overall Study|Lost to Follow-up|1|||
48457892|NCT00405275|155865952|FG000|Overall Study|Withdrawal by Subject|7|||
48457893|NCT00405275|155865953|FG001|Overall Study|Withdrawal by Subject|9|||
48457894|NCT00405275|155865952|FG000|Overall Study|Unwilling to continue|10|||
48457895|NCT00405275|155865953|FG001|Overall Study|Unwilling to continue|9|||
48457896|NCT00673816|155865957|FG000|Overall Study|Adverse Event|1|||
48457897|NCT00673816|155865957|FG000|Overall Study|Withdrawal by Subject|1|||
48457898|NCT02658149|155865964|FG000|Overall Study|Physician Decision|1|||
48457899|NCT02658149|155865965|FG001|Overall Study|Physician Decision|0|||
48457900|NCT00610714|155865966|FG000|Overall Study|Adverse Event|3|||
48457901|NCT00610714|155865967|FG001|Overall Study|Adverse Event|1|||
48457902|NCT00610714|155865966|FG000|Overall Study|Death|12|||
48457903|NCT00610714|155865967|FG001|Overall Study|Death|18|||
48457904|NCT00610714|155865966|FG000|Overall Study|Withdrawal by Subject|9|||
48457905|NCT00610714|155865967|FG001|Overall Study|Withdrawal by Subject|3|||
48457906|NCT00610714|155865966|FG000|Overall Study|Study completion at 120 PFS events|2|||
48457907|NCT00610714|155865967|FG001|Overall Study|Study completion at 120 PFS events|2|||
48457908|NCT01675141|155865968|FG000|Overall Study|Lenalidomide outside NIH|3|||
48457909|NCT01675141|155865968|FG000|Overall Study|Withdrawal by Subject|3|||
48457910|NCT01675141|155865968|FG000|Overall Study|Physician Decision|4|||
48457911|NCT01675141|155865968|FG000|Overall Study|No treatment, per protocol|1|||
48457912|NCT01327573|155865971|FG000|Overall Study|Physician Decision|3|||
48457913|NCT01327573|155865972|FG001|Overall Study|Physician Decision|1|||
48457914|NCT00939341|155865973|FG000|Overall Study|Adverse Event|15|||
48457915|NCT00939341|155865973|FG000|Overall Study|Pregnancy|1|||
48457916|NCT00939341|155865973|FG000|Overall Study|Lost to Follow-up|23|||
48457917|NCT00939341|155865973|FG000|Overall Study|Withdrawal by Subject|13|||
48457918|NCT00939341|155865973|FG000|Overall Study|Protocol Violation|6|||
48457919|NCT00939341|155865973|FG000|Overall Study|Incorrect enrolment|8|||
48457920|NCT01023516|155865974|FG000|Overall Study|Voluntary discontinuation|7|||
48457921|NCT01023516|155865975|FG001|Overall Study|Voluntary discontinuation|5|||
48457922|NCT01023516|155865974|FG000|Overall Study|Adverse Event|9|||
48457923|NCT01023516|155865975|FG001|Overall Study|Adverse Event|6|||
48457924|NCT01023516|155865974|FG000|Overall Study|Safety reason|0|||
48457925|NCT01023516|155865975|FG001|Overall Study|Safety reason|3|||
48457926|NCT01023516|155865974|FG000|Overall Study|Study-specific criteria|4|||
48457927|NCT01023516|155865975|FG001|Overall Study|Study-specific criteria|2|||
48457928|NCT01023516|155865974|FG000|Overall Study|Incorrect enrolment|4|||
48457929|NCT01023516|155865975|FG001|Overall Study|Incorrect enrolment|2|||
48457930|NCT00976963|155865979|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
48457931|NCT00976963|155865980|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
48457932|NCT00976963|155865979|FG000|Overall Study|administrative error|1|||
48457933|NCT00976963|155865980|FG001|Overall Study|administrative error|0|||
48457934|NCT00976963|155865979|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
48457935|NCT00976963|155865980|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
48457936|NCT02871791|155865986|FG000|Phase 1b|Death|0|||
48457937|NCT02871791|155865987|FG001|Phase 1b|Death|1|||
48457938|NCT02871791|155865986|FG000|Phase 1b|progressive disease|6|||
48457939|NCT02871791|155865987|FG001|Phase 1b|progressive disease|2|||
48457940|NCT02871791|155865986|FG000|Phase 2|Death|1|||
48457941|NCT02871791|155865987|FG001|Phase 2|Death|0|||
48457942|NCT02871791|155865986|FG000|Phase 2|Lost to Follow-up|2|||
48457943|NCT02871791|155865987|FG001|Phase 2|Lost to Follow-up|0|||
48457944|NCT02723019|155865990|FG000|Overall Study|Death|17|||
48457945|NCT02723019|155865991|FG001|Overall Study|Death|13|||
48457946|NCT02723019|155865990|FG000|Overall Study|Withdrawal by Subject|11|||
48457947|NCT02723019|155865991|FG001|Overall Study|Withdrawal by Subject|7|||
48457948|NCT02723019|155865990|FG000|Overall Study|Lost to Follow-up|57|||
48457949|NCT02723019|155865991|FG001|Overall Study|Lost to Follow-up|70|||
48457950|NCT02182999|155865996|FG000|Overall Study|Adverse Event|4|||
48457951|NCT02182999|155865997|FG001|Overall Study|Adverse Event|3|||
48457952|NCT02182999|155865996|FG000|Overall Study|Physician Decision|1|||
48457953|NCT02182999|155865997|FG001|Overall Study|Physician Decision|0|||
48457954|NCT03442595|155865999|FG000|Overall Study|Lost to Follow-up|94|||
48457955|NCT03442595|155866000|FG001|Overall Study|Lost to Follow-up|0|||
48457956|NCT02015104|155866001|FG000|Overall Study|Withdrew consent after first dose drug|1|||
48457957|NCT02015104|155866002|FG001|Overall Study|Withdrew consent after first dose drug|0|||
48457958|NCT02015104|155866001|FG000|Overall Study|Withdrew consent prior to treatment|0|||
48457959|NCT02015104|155866002|FG001|Overall Study|Withdrew consent prior to treatment|1|||
48457960|NCT00592072|155866003|FG000|Wash Out Period|Lost to Follow-up|1|||
48457961|NCT00592072|155866004|FG001|Wash Out Period|Lost to Follow-up|1|||
48457962|NCT04043416|155866007|FG000|Washout|Change in health condition|0|||
48457963|NCT04043416|155866008|FG001|Washout|Change in health condition|1|||
48457964|NCT00338806|155866009|FG000|Acute Phase|Withdrawal by Subject|0|||
48457965|NCT00338806|155866010|FG001|Acute Phase|Withdrawal by Subject|1|||
48457966|NCT00338806|155866009|FG000|Follow-up|Lost to Follow-up|1|||
48457967|NCT00338806|155866010|FG001|Follow-up|Lost to Follow-up|3|||
48457968|NCT01662986|155866013|FG000|Overall Study|Adverse Event|5|||
48457969|NCT01662986|155866014|FG001|Overall Study|Adverse Event|4|||
48457970|NCT01662986|155866013|FG000|Overall Study|Protocol Violation|2|||
48457971|NCT01662986|155866014|FG001|Overall Study|Protocol Violation|3|||
48457972|NCT01662986|155866013|FG000|Overall Study|Lost to Follow-up|5|||
48457973|NCT01662986|155866014|FG001|Overall Study|Lost to Follow-up|4|||
48457974|NCT01662986|155866013|FG000|Overall Study|Withdrawal by Subject|2|||
48457975|NCT01662986|155866014|FG001|Overall Study|Withdrawal by Subject|2|||
48457976|NCT01662986|155866013|FG000|Overall Study|Not Treated|1|||
48457977|NCT01662986|155866014|FG001|Overall Study|Not Treated|0|||
48457978|NCT01662986|155866013|FG000|Overall Study|Other than stated above|3|||
48457979|NCT01662986|155866014|FG001|Overall Study|Other than stated above|0|||
48457980|NCT00486889|155866021|FG000|Overall Study|Death|3|||
48457981|NCT00486889|155866021|FG000|Overall Study|Non-compliant|2|||
48457982|NCT00486889|155866021|FG000|Overall Study|Withdrawal by Subject|6|||
48457983|NCT00893763|155866022|FG000|Overall Study|extubated|110|||
48457984|NCT00893763|155866023|FG001|Overall Study|extubated|110|||
48457985|NCT02159365|155866024|FG000|Overall Study|Disease Progression|23|||
48457986|NCT02159365|155866024|FG000|Overall Study|Other reasons|11|||
48457987|NCT02159365|155866024|FG000|Overall Study|Administrative reason by Sponsor|9|||
48457988|NCT02159365|155866024|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
48457989|NCT02159365|155866024|FG000|Overall Study|Study drug toxicity|7|||
48457990|NCT02159365|155866024|FG000|Overall Study|Maximum clinical benefit|3|||
48457991|NCT02159365|155866024|FG000|Overall Study|Subject request to discontinue treatment|3|||
48457992|NCT02159365|155866024|FG000|Overall Study|Subject withdrew consent|3|||
48457993|NCT02159365|155866024|FG000|Overall Study|Death|1|||
48457994|NCT02159365|155866024|FG000|Overall Study|Lost to Follow-up|1|||
48457995|NCT03198728|155866027|FG000|Overall Study|Adverse Event|10|||
48457996|NCT03198728|155866028|FG001|Overall Study|Adverse Event|5|||
48457997|NCT03198728|155866027|FG000|Overall Study|Lost to Follow-up|21|||
48457998|NCT03198728|155866028|FG001|Overall Study|Lost to Follow-up|7|||
48457999|NCT03198728|155866027|FG000|Overall Study|Physician Decision|7|||
48458000|NCT03198728|155866028|FG001|Overall Study|Physician Decision|2|||
48458001|NCT03198728|155866027|FG000|Overall Study|Withdrawal by Subject|14|||
48458002|NCT03198728|155866028|FG001|Overall Study|Withdrawal by Subject|10|||
48458003|NCT01594411|155866029|FG000|Overall Study|Lost to Follow-up|2|||
48458004|NCT00796549|155866030|FG000|Overall Study|Adverse Event|11|||
48458005|NCT00796549|155866030|FG000|Overall Study|not entered|149|||
48458006|NCT00796549|155866030|FG000|Overall Study|Other|2|||
48458007|NCT00796549|155866030|FG000|Overall Study|Progressive disease|56|||
48458008|NCT03797144|155866031|FG000|Enrollment|Protocol Violation|4|||
48458009|NCT03797144|155866032|FG001|Enrollment|Protocol Violation|1|||
48458010|NCT03797144|155866031|FG000|Surgery|Protocol Violation|1|||
48458011|NCT03797144|155866032|FG001|Surgery|Protocol Violation|0|||
48458012|NCT03797144|155866031|FG000|3 Month|Early termination cut-off date|2|||
48458013|NCT03797144|155866032|FG001|3 Month|Early termination cut-off date|0|||
48458014|NCT03797144|155866031|FG000|12 Month|Early termination cut-off date|8|||
48458015|NCT03797144|155866032|FG001|12 Month|Early termination cut-off date|9|||
48458016|NCT03797144|155866031|FG000|24 Month|Early termination cut-off date|1|||
48458017|NCT03797144|155866032|FG001|24 Month|Early termination cut-off date|1|||
48458018|NCT01878175|155866033|FG000|Overall Study|Developed contraindicated health problem|2|||
48458019|NCT00952588|155866034|FG000|Overall Study|Death|28|||
48458020|NCT00952588|155866035|FG001|Overall Study|Death|13|||
48458021|NCT00952588|155866034|FG000|Overall Study|Withdrawal by Subject|2|||
48458022|NCT00952588|155866035|FG001|Overall Study|Withdrawal by Subject|5|||
48458023|NCT00952588|155866034|FG000|Overall Study|Adverse Event|2|||
48458024|NCT00952588|155866035|FG001|Overall Study|Adverse Event|3|||
48458025|NCT00952588|155866034|FG000|Overall Study|Lost to Follow-up|2|||
48458026|NCT00952588|155866035|FG001|Overall Study|Lost to Follow-up|0|||
48458027|NCT00952588|155866034|FG000|Overall Study|Physician Decision|0|||
48458028|NCT00952588|155866035|FG001|Overall Study|Physician Decision|1|||
48458029|NCT00952588|155866034|FG000|Overall Study|Lack of Efficacy|2|||
48458030|NCT00952588|155866035|FG001|Overall Study|Lack of Efficacy|2|||
48458031|NCT00606229|155866037|FG000|Overall Study|Adverse Event|11|||
48458032|NCT00606229|155866037|FG000|Overall Study|Lack of Efficacy|1|||
48458033|NCT00606229|155866037|FG000|Overall Study|Withdrawal by Subject|4|||
48458034|NCT00606229|155866037|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
48458035|NCT00606229|155866037|FG000|Overall Study|change of residence or other commitments|2|||
48458036|NCT03523715|155866038|FG000|Overall Study|Lost to Follow-up|11|||
48458037|NCT03523715|155866039|FG001|Overall Study|Lost to Follow-up|14|||
48458038|NCT03523715|155866038|FG000|Overall Study|Did not meet inclusion criteria|1|||
48458039|NCT03523715|155866039|FG001|Overall Study|Did not meet inclusion criteria|0|||
48458040|NCT03523715|155866038|FG000|Overall Study|Internally inconsistent reporting|0|||
48458041|NCT03523715|155866039|FG001|Overall Study|Internally inconsistent reporting|2|||
48458042|NCT05654662|155866040|FG000|Overall Study|Withdrawal by Subject|1|||
48458043|NCT05654662|155866041|FG001|Overall Study|Withdrawal by Subject|0|||
48458044|NCT05654662|155866040|FG000|Overall Study|A death in the family|1|||
48458045|NCT05654662|155866041|FG001|Overall Study|A death in the family|0|||
48458046|NCT00394654|155866043|FG000|Overall Study|Lost to Follow-up|1|||
48458047|NCT00394654|155866044|FG001|Overall Study|Lost to Follow-up|0|||
48458048|NCT00394654|155866043|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
48458049|NCT00394654|155866044|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
48458050|NCT02933489|155866045|FG000|Overall Study|Ineligible|3|||
48458051|NCT02933489|155866046|FG001|Overall Study|Ineligible|3|||
48458052|NCT02933489|155866045|FG000|Overall Study|Withdrawal by Subject|27|||
48458053|NCT02933489|155866046|FG001|Overall Study|Withdrawal by Subject|18|||
48458054|NCT02933489|155866045|FG000|Overall Study|Unable to complete exams (other)|14|||
48458055|NCT02933489|155866046|FG001|Overall Study|Unable to complete exams (other)|7|||
48458056|NCT00636155|155866047|FG000|Overall Study|Adverse Event|8|||
48458057|NCT00636155|155866047|FG000|Overall Study|Lack of Efficacy|1|||
48458058|NCT00636155|155866047|FG000|Overall Study|Withdrawal by Subject|3|||
48458059|NCT00636155|155866047|FG000|Overall Study|Stem cell transplant|1|||
48458060|NCT00636155|155866047|FG000|Overall Study|Physician Decision|5|||
48458061|NCT01424306|155866048|FG000|Overall Study|Protocol Violation|0|||
48458062|NCT01424306|155866049|FG001|Overall Study|Protocol Violation|0|||
48458063|NCT01424306|155866050|FG002|Overall Study|Protocol Violation|0|||
48458064|NCT01424306|155866051|FG003|Overall Study|Protocol Violation|0|||
48458065|NCT01424306|155866052|FG004|Overall Study|Protocol Violation|1|||
48458066|NCT01424306|155866053|FG005|Overall Study|Protocol Violation|0|||
48458067|NCT02352090|155866054|FG000|Overall Study|general malaise|1|||
48458068|NCT02352090|155866055|FG001|Overall Study|general malaise|0|||
48458069|NCT02352090|155866056|FG002|Overall Study|general malaise|0|||
48458070|NCT02352090|155866054|FG000|Overall Study|non-specified mild side-effects|0|||
48458071|NCT02352090|155866055|FG001|Overall Study|non-specified mild side-effects|0|||
48458072|NCT02352090|155866056|FG002|Overall Study|non-specified mild side-effects|2|||
48458073|NCT03231228|155866063|FG000|Overall Study|Lost to Follow-up|2|||
48458074|NCT03231228|155866064|FG001|Overall Study|Lost to Follow-up|0|||
48458075|NCT03231228|155866063|FG000|Overall Study|Physician Decision|1|||
48458076|NCT03231228|155866064|FG001|Overall Study|Physician Decision|0|||
48458077|NCT03077711|155866065|FG000|Overall Study|Lost to Follow-up|2|||
48458078|NCT03077711|155866066|FG001|Overall Study|Lost to Follow-up|2|||
48458079|NCT03077711|155866065|FG000|Overall Study|noncompliant taking medication|2|||
48458080|NCT03077711|155866066|FG001|Overall Study|noncompliant taking medication|0|||
48458081|NCT00590031|155866069|FG000|Overall Study|Adverse Event|3|||
48458082|NCT00590031|155866069|FG000|Overall Study|Withdrawal by Subject|1|||
48458083|NCT00590031|155866069|FG000|Overall Study|Metastatic Disease|1|||
48458084|NCT00590031|155866069|FG000|Overall Study|Admin Hold|1|||
48458085|NCT01610414|155866070|FG000|Study Start - Month 13|Serious Adverse Event|65|||
48458086|NCT01610414|155866071|FG001|Study Start - Month 13|Serious Adverse Event|67|||
48458087|NCT01610414|155866070|FG000|Study Start - Month 13|Adverse Event|14|||
48458088|NCT01610414|155866071|FG001|Study Start - Month 13|Adverse Event|14|||
48458089|NCT01610414|155866070|FG000|Study Start - Month 13|Protocol Violation|3|||
48458090|NCT01610414|155866071|FG001|Study Start - Month 13|Protocol Violation|1|||
48458091|NCT01610414|155866070|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
48458092|NCT01610414|155866071|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
48458093|NCT01610414|155866070|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
48458094|NCT01610414|155866071|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
48458095|NCT01610414|155866070|FG000|Study Start - Month 13|Lost to Follow-up|4|||
48458096|NCT01610414|155866071|FG001|Study Start - Month 13|Lost to Follow-up|6|||
48458097|NCT01610414|155866070|FG000|Study Start - Month 13|Suspected HZ episode|1|||
48458098|NCT01610414|155866071|FG001|Study Start - Month 13|Suspected HZ episode|3|||
48458099|NCT01610414|155866070|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
48458100|NCT01610414|155866071|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
48458101|NCT01610414|155866070|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
48458102|NCT01610414|155866071|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
48458103|NCT01610414|155866070|FG000|Month 13 - Month 25|Adverse Event|8|||
48458104|NCT01610414|155866071|FG001|Month 13 - Month 25|Adverse Event|4|||
48458105|NCT01610414|155866070|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
48458106|NCT01610414|155866071|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
48458107|NCT01610414|155866070|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
48458108|NCT01610414|155866071|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
48458109|NCT01610414|155866070|FG000|Month 13 - Month 25|Protocol Violation|0|||
48458110|NCT01610414|155866071|FG001|Month 13 - Month 25|Protocol Violation|2|||
48458111|NCT01610414|155866070|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
48458112|NCT01610414|155866071|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
48458113|NCT01610414|155866070|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
48458114|NCT01610414|155866071|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
48458115|NCT01610414|155866070|FG000|After Month 25|Study end not reached|48|||
48458116|NCT01610414|155866071|FG001|After Month 25|Study end not reached|53|||
48458117|NCT02177786|155867834|FG000|Overall Study|Withdrew Consent|2|||
48458118|NCT02177786|155867835|FG001|Overall Study|Withdrew Consent|6|||
48458119|NCT02177786|155867836|FG002|Overall Study|Withdrew Consent|9|||
48458120|NCT02177786|155867837|FG003|Overall Study|Withdrew Consent|5|||
48458121|NCT02177786|155867834|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
48458122|NCT02177786|155867835|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
48458123|NCT02177786|155867836|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
48458124|NCT02177786|155867837|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
48458125|NCT02177786|155867834|FG000|Overall Study|Adverse Event|1|||
48458126|NCT02177786|155867835|FG001|Overall Study|Adverse Event|1|||
48458127|NCT02177786|155867836|FG002|Overall Study|Adverse Event|2|||
48458128|NCT02177786|155867837|FG003|Overall Study|Adverse Event|3|||
48458129|NCT02177786|155867834|FG000|Overall Study|Death|1|||
48458130|NCT02177786|155867835|FG001|Overall Study|Death|1|||
48458131|NCT02177786|155867836|FG002|Overall Study|Death|1|||
48458132|NCT02177786|155867837|FG003|Overall Study|Death|1|||
48458133|NCT02177786|155867834|FG000|Overall Study|Lost to Follow-up|0|||
48458134|NCT02177786|155867835|FG001|Overall Study|Lost to Follow-up|0|||
48458135|NCT02177786|155867836|FG002|Overall Study|Lost to Follow-up|2|||
48458136|NCT02177786|155867837|FG003|Overall Study|Lost to Follow-up|2|||
48458137|NCT02177786|155867834|FG000|Overall Study|Non-Compliance with Study Drug|0|||
48458138|NCT02177786|155867835|FG001|Overall Study|Non-Compliance with Study Drug|1|||
48458139|NCT02177786|155867836|FG002|Overall Study|Non-Compliance with Study Drug|0|||
48458140|NCT02177786|155867837|FG003|Overall Study|Non-Compliance with Study Drug|1|||
48458141|NCT02177786|155867834|FG000|Overall Study|Protocol Violation|0|||
48458142|NCT02177786|155867835|FG001|Overall Study|Protocol Violation|0|||
48458143|NCT02177786|155867836|FG002|Overall Study|Protocol Violation|2|||
48458144|NCT02177786|155867837|FG003|Overall Study|Protocol Violation|0|||
48458145|NCT02177786|155867834|FG000|Overall Study|Progressive Disease|0|||
48458146|NCT02177786|155867835|FG001|Overall Study|Progressive Disease|1|||
48458147|NCT02177786|155867836|FG002|Overall Study|Progressive Disease|0|||
48458148|NCT02177786|155867837|FG003|Overall Study|Progressive Disease|0|||
48458149|NCT02177786|155867834|FG000|Overall Study|Missing study completion status|0|||
48458150|NCT02177786|155867835|FG001|Overall Study|Missing study completion status|1|||
48458151|NCT02177786|155867836|FG002|Overall Study|Missing study completion status|0|||
48458152|NCT02177786|155867837|FG003|Overall Study|Missing study completion status|0|||
48458153|NCT03950440|155867838|FG000|Overall Study|Death|8|||
48458154|NCT03950440|155867839|FG001|Overall Study|Death|2|||
48458155|NCT03950440|155867840|FG002|Overall Study|Death|1|||
48458156|NCT02892734|155867841|FG000|Treatment on Study|Progressive Disease|2|||
48458157|NCT02892734|155867841|FG000|Follow up for 2 Years|Death|2|||
48458158|NCT02892734|155867841|FG000|Follow up for 2 Years|Study closed early|1|||
48458159|NCT01957215|155867846|FG000|Overall Study|Adverse Event|2|||
48458160|NCT01957215|155867847|FG001|Overall Study|Adverse Event|2|||
48458161|NCT01957215|155867846|FG000|Overall Study|Lost to Follow-up|3|||
48458162|NCT01957215|155867847|FG001|Overall Study|Lost to Follow-up|3|||
48458163|NCT01957215|155867846|FG000|Overall Study|Protocol Violation|1|||
48458164|NCT01957215|155867847|FG001|Overall Study|Protocol Violation|2|||
48458165|NCT01957215|155867846|FG000|Overall Study|Withdrawal by Subject|7|||
48458166|NCT01957215|155867847|FG001|Overall Study|Withdrawal by Subject|5|||
48458167|NCT00784459|155867850|FG000|Overall Study|Adverse Event|0|||
48458168|NCT00784459|155867851|FG001|Overall Study|Adverse Event|2|||
48458169|NCT02691468|155867852|FG000|Overall Study|Bronchial blocker use|2|||
48458170|NCT02691468|155867853|FG001|Overall Study|Bronchial blocker use|1|||
48458171|NCT02691468|155867852|FG000|Overall Study|Lost to Follow-up|2|||
48458172|NCT02691468|155867853|FG001|Overall Study|Lost to Follow-up|1|||
48458173|NCT02691468|155867852|FG000|Overall Study|Failure to advance FOB|2|||
48458174|NCT02691468|155867853|FG001|Overall Study|Failure to advance FOB|0|||
48458175|NCT01642004|155867854|FG000|Randomization|Adverse Event unrelated to study drug|1|||
48458176|NCT01642004|155867855|FG001|Randomization|Adverse Event unrelated to study drug|0|||
48458177|NCT01642004|155867854|FG000|Randomization|Participant withdrew consent|1|||
48458178|NCT01642004|155867855|FG001|Randomization|Participant withdrew consent|6|||
48458179|NCT01642004|155867854|FG000|Randomization|No longer meets study criteria|2|||
48458180|NCT01642004|155867855|FG001|Randomization|No longer meets study criteria|2|||
48458181|NCT01642004|155867854|FG000|Treatment|Disease progression|95|||
48458182|NCT01642004|155867855|FG001|Treatment|Disease progression|79|||
48458183|NCT01642004|155867854|FG000|Treatment|Study drug toxicity|10|||
48458184|NCT01642004|155867855|FG001|Treatment|Study drug toxicity|13|||
48458185|NCT01642004|155867854|FG000|Treatment|Death|1|||
48458186|NCT01642004|155867855|FG001|Treatment|Death|1|||
48458187|NCT01642004|155867854|FG000|Treatment|Adverse event unrelated to study drug|9|||
48458188|NCT01642004|155867855|FG001|Treatment|Adverse event unrelated to study drug|13|||
48458189|NCT01642004|155867854|FG000|Treatment|Maximum clinical benefit|1|||
48458190|NCT01642004|155867855|FG001|Treatment|Maximum clinical benefit|9|||
48458191|NCT01642004|155867854|FG000|Treatment|Poor/non-compliance|1|||
48458192|NCT01642004|155867855|FG001|Treatment|Poor/non-compliance|0|||
48458193|NCT01642004|155867854|FG000|Treatment|No longer meets study criteria|1|||
48458194|NCT01642004|155867855|FG001|Treatment|No longer meets study criteria|2|||
48458195|NCT01642004|155867854|FG000|Treatment|Other reasons|2|||
48458196|NCT01642004|155867855|FG001|Treatment|Other reasons|0|||
48458197|NCT01642004|155867854|FG000|Treatment|Not reported|0|||
48458198|NCT01642004|155867855|FG001|Treatment|Not reported|3|||
48458199|NCT01642004|155867854|FG000|Treatment|Participant request to discontinue study treatment|6|||
48458200|NCT01642004|155867855|FG001|Treatment|Participant request to discontinue study treatment|4|||
48458201|NCT01642004|155867854|FG000|Treatment|Participant withdrew consent|5|||
48458202|NCT01642004|155867855|FG001|Treatment|Participant withdrew consent|5|||
48458203|NCT02203916|155867857|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
48458204|NCT02203916|155867858|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
48458205|NCT02203916|155867859|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
48458206|NCT02203916|155867857|FG000|Overall Study|Major Protocol Deviation|1|||
48458207|NCT02203916|155867858|FG001|Overall Study|Major Protocol Deviation|1|||
48458208|NCT02203916|155867859|FG002|Overall Study|Major Protocol Deviation|0|||
48458209|NCT02203916|155867857|FG000|Overall Study|Lost to Follow-up|0|||
48458210|NCT02203916|155867858|FG001|Overall Study|Lost to Follow-up|1|||
48458211|NCT02203916|155867859|FG002|Overall Study|Lost to Follow-up|0|||
48458212|NCT02203916|155867857|FG000|Overall Study|Voluntary Withdrawal|3|||
48458213|NCT02203916|155867858|FG001|Overall Study|Voluntary Withdrawal|3|||
48458214|NCT02203916|155867859|FG002|Overall Study|Voluntary Withdrawal|8|||
48458215|NCT02203916|155867857|FG000|Overall Study|Lack of Efficacy|3|||
48458216|NCT02203916|155867858|FG001|Overall Study|Lack of Efficacy|0|||
48458217|NCT02203916|155867859|FG002|Overall Study|Lack of Efficacy|0|||
48458218|NCT02203916|155867857|FG000|Overall Study|Reason Not Specified|0|||
48458219|NCT02203916|155867858|FG001|Overall Study|Reason Not Specified|2|||
48458220|NCT02203916|155867859|FG002|Overall Study|Reason Not Specified|1|||
48458221|NCT00621244|155867860|FG000|Overall Study|Withdrawal by Subject|7|||
48458222|NCT00621244|155867861|FG001|Overall Study|Withdrawal by Subject|3|||
48458223|NCT00621244|155867862|FG002|Overall Study|Withdrawal by Subject|3|||
48458224|NCT00621244|155867863|FG003|Overall Study|Withdrawal by Subject|3|||
48458225|NCT00621244|155867860|FG000|Overall Study|Disease progression|44|||
48458226|NCT00621244|155867861|FG001|Overall Study|Disease progression|20|||
48458227|NCT00621244|155867862|FG002|Overall Study|Disease progression|20|||
48458228|NCT00621244|155867863|FG003|Overall Study|Disease progression|15|||
48458229|NCT00621244|155867860|FG000|Overall Study|Death|3|||
48458230|NCT00621244|155867861|FG001|Overall Study|Death|3|||
48458231|NCT00621244|155867862|FG002|Overall Study|Death|1|||
48458232|NCT00621244|155867863|FG003|Overall Study|Death|1|||
48458233|NCT00621244|155867860|FG000|Overall Study|Adverse Event|27|||
48458234|NCT00621244|155867861|FG001|Overall Study|Adverse Event|7|||
48458235|NCT00621244|155867862|FG002|Overall Study|Adverse Event|9|||
48458236|NCT00621244|155867863|FG003|Overall Study|Adverse Event|2|||
48458237|NCT00621244|155867860|FG000|Overall Study|Administrative problems|5|||
48458238|NCT00621244|155867861|FG001|Overall Study|Administrative problems|1|||
48458239|NCT00621244|155867862|FG002|Overall Study|Administrative problems|0|||
48458240|NCT00621244|155867863|FG003|Overall Study|Administrative problems|2|||
48458241|NCT03733249|155867864|FG000|Overall Study|Death|7|||
48458242|NCT03733249|155867864|FG000|Overall Study|Disease relapse|16|||
48458243|NCT03733249|155867864|FG000|Overall Study|Lost to Follow-up|4|||
48458244|NCT03733249|155867864|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
48458245|NCT03733249|155867864|FG000|Overall Study|Withdrawal by Subject|1|||
48458246|NCT02447952|155867865|FG000|Overall Study|Adverse Event|2|||
48458247|NCT02447952|155867865|FG000|Overall Study|Physician Decision|1|||
48458248|NCT02447952|155867865|FG000|Overall Study|Withdrawal by Subject|4|||
48458249|NCT01756833|155867874|FG000|Overall Study|Withdrawal by Subject|4|||
48458250|NCT01756833|155867875|FG001|Overall Study|Withdrawal by Subject|3|||
48458251|NCT02139280|155867876|FG000|Overall Study|No longer eligible|2|||
48458252|NCT02139280|155867877|FG001|Overall Study|No longer eligible|0|||
48458253|NCT00550615|155867878|FG000|Overall Study|Withdrawal by Subject|0|||
48458254|NCT00550615|155867879|FG001|Overall Study|Withdrawal by Subject|0|||
48458255|NCT00550615|155867880|FG002|Overall Study|Withdrawal by Subject|2|||
48458256|NCT00550615|155867881|FG003|Overall Study|Withdrawal by Subject|3|||
48458257|NCT00550615|155867878|FG000|Overall Study|Not evaluable|0|||
48458258|NCT00550615|155867879|FG001|Overall Study|Not evaluable|0|||
48458259|NCT00550615|155867880|FG002|Overall Study|Not evaluable|2|||
48458260|NCT00550615|155867881|FG003|Overall Study|Not evaluable|7|||
48458261|NCT00398086|155867884|FG000|Overall Study|Unacceptable Toxicity|2|||
48458262|NCT00398086|155867885|FG001|Overall Study|Unacceptable Toxicity|8|||
48458263|NCT00398086|155867886|FG002|Overall Study|Unacceptable Toxicity|2|||
48458264|NCT00398086|155867884|FG000|Overall Study|Adverse Event|1|||
48458265|NCT00398086|155867885|FG001|Overall Study|Adverse Event|4|||
48458266|NCT00398086|155867886|FG002|Overall Study|Adverse Event|0|||
48458267|NCT00398086|155867884|FG000|Overall Study|Physician Decision|1|||
48458268|NCT00398086|155867885|FG001|Overall Study|Physician Decision|4|||
48458269|NCT00398086|155867886|FG002|Overall Study|Physician Decision|0|||
48458270|NCT00398086|155867884|FG000|Overall Study|Withdrawal by Subject|5|||
48458271|NCT00398086|155867885|FG001|Overall Study|Withdrawal by Subject|7|||
48458272|NCT00398086|155867886|FG002|Overall Study|Withdrawal by Subject|0|||
48458273|NCT01950364|155867897|FG000|Overall Study|Adverse Event|3|||
48458274|NCT01950364|155867898|FG001|Overall Study|Adverse Event|0|||
48458275|NCT01950364|155867897|FG000|Overall Study|Stem Cell Transplant|2|||
48458276|NCT01950364|155867898|FG001|Overall Study|Stem Cell Transplant|6|||
48458277|NCT01950364|155867897|FG000|Overall Study|Disease Progression|5|||
48458278|NCT01950364|155867898|FG001|Overall Study|Disease Progression|2|||
48458279|NCT01950364|155867897|FG000|Overall Study|Withdrawal by Subject|0|||
48458280|NCT01950364|155867898|FG001|Overall Study|Withdrawal by Subject|1|||
48458281|NCT01950364|155867897|FG000|Overall Study|Protocol Violation|0|||
48458282|NCT01950364|155867898|FG001|Overall Study|Protocol Violation|1|||
48458283|NCT00033293|155867900|FG000|Overall Study|Death|0|||
48458284|NCT00033293|155867901|FG001|Overall Study|Death|1|||
48458285|NCT00033293|155867900|FG000|Overall Study|Lack of Efficacy|5|||
48458286|NCT00033293|155867901|FG001|Overall Study|Lack of Efficacy|8|||
48458287|NCT00033293|155867900|FG000|Overall Study|Lost to Follow-up|0|||
48458288|NCT00033293|155867901|FG001|Overall Study|Lost to Follow-up|1|||
48458289|NCT00033293|155867900|FG000|Overall Study|Physician Decision|3|||
48458290|NCT00033293|155867901|FG001|Overall Study|Physician Decision|1|||
48458291|NCT00033293|155867900|FG000|Overall Study|Withdrawal by Subject|1|||
48458292|NCT00033293|155867901|FG001|Overall Study|Withdrawal by Subject|0|||
48458293|NCT00033293|155867900|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
48458294|NCT00033293|155867901|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
48458295|NCT00033293|155867900|FG000|Overall Study|Treatment refused|0|||
48458296|NCT00033293|155867901|FG001|Overall Study|Treatment refused|6|||
48458297|NCT02087241|155867902|FG000|Overall Study|Death|2|||
48458298|NCT02087241|155867903|FG001|Overall Study|Death|1|||
48458299|NCT02087241|155867904|FG002|Overall Study|Death|1|||
48458300|NCT02087241|155867905|FG003|Overall Study|Death|1|||
48458301|NCT02087241|155867902|FG000|Overall Study|Withdrawal by Subject|1|||
48458302|NCT02087241|155867903|FG001|Overall Study|Withdrawal by Subject|0|||
48458303|NCT02087241|155867904|FG002|Overall Study|Withdrawal by Subject|0|||
48458304|NCT02087241|155867905|FG003|Overall Study|Withdrawal by Subject|1|||
48458305|NCT02087241|155867902|FG000|Overall Study|Progressive Disease|0|||
48458306|NCT02087241|155867903|FG001|Overall Study|Progressive Disease|0|||
48458307|NCT02087241|155867904|FG002|Overall Study|Progressive Disease|0|||
48458308|NCT02087241|155867905|FG003|Overall Study|Progressive Disease|1|||
48458309|NCT02087241|155867902|FG000|Overall Study|Study Terminated by Sponsor|0|||
48458310|NCT02087241|155867903|FG001|Overall Study|Study Terminated by Sponsor|2|||
48458311|NCT02087241|155867904|FG002|Overall Study|Study Terminated by Sponsor|0|||
48458312|NCT02087241|155867905|FG003|Overall Study|Study Terminated by Sponsor|4|||
48458313|NCT02181504|155867906|FG000|Overall Study|Adverse Event|1|||
48458314|NCT02181504|155867907|FG001|Overall Study|Adverse Event|1|||
48458315|NCT02181504|155867908|FG002|Overall Study|Adverse Event|1|||
48458316|NCT01708915|155867913|FG000|Overall Study|Adverse Event|1|||
48458317|NCT01708915|155867914|FG001|Overall Study|Adverse Event|0|||
48458318|NCT01708915|155867915|FG002|Overall Study|Adverse Event|9|||
48458319|NCT01708915|155867916|FG003|Overall Study|Adverse Event|13|||
48458320|NCT01708915|155867913|FG000|Overall Study|Lack of Efficacy|84|||
48458321|NCT01708915|155867914|FG001|Overall Study|Lack of Efficacy|60|||
48458322|NCT01708915|155867915|FG002|Overall Study|Lack of Efficacy|35|||
48458323|NCT01708915|155867916|FG003|Overall Study|Lack of Efficacy|15|||
48458324|NCT01708915|155867913|FG000|Overall Study|Protocol Violation|0|||
48458325|NCT01708915|155867914|FG001|Overall Study|Protocol Violation|0|||
48458326|NCT01708915|155867915|FG002|Overall Study|Protocol Violation|0|||
48458327|NCT01708915|155867916|FG003|Overall Study|Protocol Violation|1|||
48458328|NCT01708915|155867913|FG000|Overall Study|Withdrawal by Subject|0|||
48458329|NCT01708915|155867914|FG001|Overall Study|Withdrawal by Subject|1|||
48458330|NCT01708915|155867915|FG002|Overall Study|Withdrawal by Subject|2|||
48458331|NCT01708915|155867916|FG003|Overall Study|Withdrawal by Subject|2|||
48458332|NCT01708915|155867913|FG000|Overall Study|Other reasons than stated above|1|||
48458333|NCT01708915|155867914|FG001|Overall Study|Other reasons than stated above|1|||
48458334|NCT01708915|155867915|FG002|Overall Study|Other reasons than stated above|0|||
48458335|NCT01708915|155867916|FG003|Overall Study|Other reasons than stated above|2|||
48458336|NCT03935594|155867917|FG000|Overall Study|Physician Decision|3|||
48458337|NCT01369069|155867918|FG000|Overall Study|Lost to Follow-up|8|||
48458338|NCT01369069|155867919|FG001|Overall Study|Lost to Follow-up|9|||
48458339|NCT01369069|155867918|FG000|Overall Study|Withdrawal by Subject|9|||
48458340|NCT01369069|155867919|FG001|Overall Study|Withdrawal by Subject|7|||
48458341|NCT03858686|155867920|FG000|Period 1|Adverse Event|1|||
48458342|NCT03858686|155867921|FG001|Period 1|Adverse Event|1|||
48458343|NCT03858686|155867920|FG000|Period 1|Lack of compliance|0|||
48458344|NCT03858686|155867921|FG001|Period 1|Lack of compliance|1|||
48458345|NCT03858686|155867920|FG000|Period 1|Adverse Event|0|||
48458346|NCT03858686|155867921|FG001|Period 1|Adverse Event|1|||
48458347|NCT03858686|155867920|FG000|Period 2|Adverse Event|0|||
48458348|NCT03858686|155867921|FG001|Period 2|Adverse Event|1|||
48458349|NCT02573012|155867922|FG000|Overall Study|Adverse Event|5|||
48458350|NCT02573012|155867923|FG001|Overall Study|Adverse Event|5|||
48458351|NCT02573012|155867922|FG000|Overall Study|Lack of Efficacy|5|||
48458352|NCT02573012|155867923|FG001|Overall Study|Lack of Efficacy|4|||
48458353|NCT02573012|155867922|FG000|Overall Study|Non-compliance|1|||
48458354|NCT02573012|155867923|FG001|Overall Study|Non-compliance|2|||
48458355|NCT02573012|155867922|FG000|Overall Study|Withdrawal by Subject|2|||
48458356|NCT02573012|155867923|FG001|Overall Study|Withdrawal by Subject|2|||
48458357|NCT02573012|155867922|FG000|Overall Study|Study Ended per Protocol|1|||
48458358|NCT02573012|155867923|FG001|Overall Study|Study Ended per Protocol|0|||
48458359|NCT02573012|155867922|FG000|Overall Study|Physician Decision|1|||
48458360|NCT02573012|155867923|FG001|Overall Study|Physician Decision|2|||
48458361|NCT00882362|155867927|FG000|Overall Study|Adverse Event|13|||
48458362|NCT00882362|155867928|FG001|Overall Study|Adverse Event|10|||
48458363|NCT00882362|155867927|FG000|Overall Study|Withdrawal by Subject|13|||
48458364|NCT00882362|155867928|FG001|Overall Study|Withdrawal by Subject|10|||
48458365|NCT00882362|155867927|FG000|Overall Study|Lack of Efficacy|3|||
48458366|NCT00882362|155867928|FG001|Overall Study|Lack of Efficacy|0|||
48458367|NCT00882362|155867927|FG000|Overall Study|Protocol Violation|7|||
48458368|NCT00882362|155867928|FG001|Overall Study|Protocol Violation|2|||
48458369|NCT00882362|155867927|FG000|Overall Study|Pregnancy|1|||
48458370|NCT00882362|155867928|FG001|Overall Study|Pregnancy|0|||
48458371|NCT00882362|155867927|FG000|Overall Study|Physician Decision|5|||
48458372|NCT00882362|155867928|FG001|Overall Study|Physician Decision|1|||
48458373|NCT00882362|155867927|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
48458374|NCT00882362|155867928|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
48458375|NCT00882362|155867927|FG000|Overall Study|change of residence or other commitments|5|||
48458376|NCT00882362|155867928|FG001|Overall Study|change of residence or other commitments|0|||
48458377|NCT00542425|155867929|FG000|Initial 24 Weeks|Administrative reasons|0|||
48458378|NCT00542425|155867930|FG001|Initial 24 Weeks|Administrative reasons|0|||
48458379|NCT00542425|155867931|FG002|Initial 24 Weeks|Administrative reasons|1|||
48458380|NCT00542425|155867932|FG003|Initial 24 Weeks|Administrative reasons|1|||
48458381|NCT00542425|155867933|FG004|Initial 24 Weeks|Administrative reasons|0|||
48458382|NCT00542425|155867929|FG000|Initial 24 Weeks|Adverse Event|0|||
48458383|NCT00542425|155867930|FG001|Initial 24 Weeks|Adverse Event|1|||
48458384|NCT00542425|155867931|FG002|Initial 24 Weeks|Adverse Event|1|||
48458385|NCT00542425|155867932|FG003|Initial 24 Weeks|Adverse Event|3|||
48458386|NCT00542425|155867933|FG004|Initial 24 Weeks|Adverse Event|2|||
48458387|NCT00542425|155867929|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
48458388|NCT00542425|155867930|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
48458389|NCT00542425|155867931|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
48458390|NCT00542425|155867932|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
48458391|NCT00542425|155867933|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
48458392|NCT00542425|155867929|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
48458393|NCT00542425|155867930|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
48458394|NCT00542425|155867931|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
48458395|NCT00542425|155867932|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
48458396|NCT00542425|155867933|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
48458397|NCT00542425|155867929|FG000|Initial 24 Weeks|Non-compliance|0|||
48458398|NCT00542425|155867930|FG001|Initial 24 Weeks|Non-compliance|0|||
48458399|NCT00542425|155867931|FG002|Initial 24 Weeks|Non-compliance|0|||
48458400|NCT00542425|155867932|FG003|Initial 24 Weeks|Non-compliance|1|||
48458401|NCT00542425|155867933|FG004|Initial 24 Weeks|Non-compliance|1|||
48458402|NCT00542425|155867929|FG000|Initial 24 Weeks|Protocol Violation|0|||
48458403|NCT00542425|155867930|FG001|Initial 24 Weeks|Protocol Violation|0|||
48458404|NCT00542425|155867931|FG002|Initial 24 Weeks|Protocol Violation|0|||
48458405|NCT00542425|155867932|FG003|Initial 24 Weeks|Protocol Violation|1|||
48458406|NCT00542425|155867933|FG004|Initial 24 Weeks|Protocol Violation|0|||
48458407|NCT00542425|155867929|FG000|Initial 24 Weeks|Refusal of treatment|2|||
48458408|NCT00542425|155867930|FG001|Initial 24 Weeks|Refusal of treatment|2|||
48458409|NCT00542425|155867931|FG002|Initial 24 Weeks|Refusal of treatment|1|||
48458410|NCT00542425|155867932|FG003|Initial 24 Weeks|Refusal of treatment|4|||
48458411|NCT00542425|155867933|FG004|Initial 24 Weeks|Refusal of treatment|1|||
48458412|NCT00542425|155867929|FG000|Initial 24 Weeks|Other|0|||
48458413|NCT00542425|155867930|FG001|Initial 24 Weeks|Other|2|||
48458414|NCT00542425|155867931|FG002|Initial 24 Weeks|Other|1|||
48458415|NCT00542425|155867932|FG003|Initial 24 Weeks|Other|0|||
48458416|NCT00542425|155867933|FG004|Initial 24 Weeks|Other|0|||
48458417|NCT00542425|155867929|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
48458418|NCT00542425|155867930|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
48458419|NCT00542425|155867931|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
48458420|NCT00542425|155867932|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
48458421|NCT00542425|155867933|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
48458422|NCT00542425|155867929|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
48458423|NCT00542425|155867930|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
48458424|NCT00542425|155867931|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
48458425|NCT00542425|155867932|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
48458426|NCT00542425|155867933|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
48458427|NCT00542425|155867929|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
48458428|NCT00542425|155867930|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
48458429|NCT00542425|155867931|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
48458430|NCT00542425|155867932|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
48458431|NCT00542425|155867933|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
48458432|NCT00542425|155867929|FG000|Extended 24 Weeks of Treatment|Other|1|||
48458433|NCT00542425|155867930|FG001|Extended 24 Weeks of Treatment|Other|1|||
48458434|NCT00542425|155867931|FG002|Extended 24 Weeks of Treatment|Other|0|||
48458435|NCT00542425|155867932|FG003|Extended 24 Weeks of Treatment|Other|0|||
48458436|NCT00542425|155867933|FG004|Extended 24 Weeks of Treatment|Other|1|||
48458437|NCT01268514|155867935|FG000|Overall Study|Adverse Event|20|||
48458438|NCT01268514|155867935|FG000|Overall Study|Death|8|||
48458439|NCT01268514|155867935|FG000|Overall Study|Lost to Follow-up|5|||
48458440|NCT01268514|155867935|FG000|Overall Study|Withdrawal by Subject|3|||
48458441|NCT01268514|155867935|FG000|Overall Study|Withdrawal by Surgeon|5|||
48458442|NCT01846208|155867936|FG000|Overall Study|Withdrew prior to treatment|1|||
48458443|NCT01846208|155867937|FG001|Overall Study|Withdrew prior to treatment|1|||
48458444|NCT01846208|155867938|FG002|Overall Study|Withdrew prior to treatment|1|||
48458445|NCT01846208|155867936|FG000|Overall Study|Dosing Symptoms|1|||
48458446|NCT01846208|155867937|FG001|Overall Study|Dosing Symptoms|2|||
48458447|NCT01846208|155867938|FG002|Overall Study|Dosing Symptoms|6|||
48458448|NCT01846208|155867936|FG000|Overall Study|Withdrawal by Subject|5|||
48458449|NCT01846208|155867937|FG001|Overall Study|Withdrawal by Subject|0|||
48458450|NCT01846208|155867938|FG002|Overall Study|Withdrawal by Subject|0|||
48458451|NCT01846208|155867936|FG000|Overall Study|Non-compliance|1|||
48458452|NCT01846208|155867937|FG001|Overall Study|Non-compliance|1|||
48458453|NCT01846208|155867938|FG002|Overall Study|Non-compliance|0|||
48458454|NCT01846208|155867936|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
48458455|NCT01846208|155867937|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
48458456|NCT01846208|155867938|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
48458457|NCT01846208|155867936|FG000|Overall Study|Refused SU OFC|0|||
48458458|NCT01846208|155867937|FG001|Overall Study|Refused SU OFC|0|||
48458459|NCT01846208|155867938|FG002|Overall Study|Refused SU OFC|1|||
48458460|NCT01432938|155867939|FG000|First Intervention|Protocol Violation|1|||
48458461|NCT01432938|155867940|FG001|First Intervention|Protocol Violation|0|||
48458462|NCT01432938|155867939|FG000|First Intervention|Physician Decision|1|||
48458463|NCT01432938|155867940|FG001|First Intervention|Physician Decision|0|||
48458464|NCT01432938|155867939|FG000|Second Intervention|Adverse Event|1|||
48458465|NCT01432938|155867940|FG001|Second Intervention|Adverse Event|0|||
48458466|NCT01440972|155867941|FG000|Overall Study|Withdrawal by Subject|3|||
48458467|NCT01440972|155867942|FG001|Overall Study|Withdrawal by Subject|2|||
48458468|NCT01875874|155867943|FG000|Overall Study|Death|3|||
48458469|NCT01601873|155867944|FG000|Overall Study|Lost to Follow-up|2|||
48458470|NCT01601873|155867945|FG001|Overall Study|Lost to Follow-up|3|||
48458471|NCT01680991|155867946|FG000|Overall Study|Adverse Event|1|||
48458472|NCT01680991|155867947|FG001|Overall Study|Adverse Event|0|||
48458473|NCT01680991|155867948|FG002|Overall Study|Adverse Event|0|||
48458474|NCT01680991|155867946|FG000|Overall Study|Death|1|||
48458475|NCT01680991|155867947|FG001|Overall Study|Death|0|||
48458476|NCT01680991|155867948|FG002|Overall Study|Death|1|||
48458477|NCT01680991|155867946|FG000|Overall Study|Protocol Violation|0|||
48458478|NCT01680991|155867947|FG001|Overall Study|Protocol Violation|1|||
48458479|NCT01680991|155867948|FG002|Overall Study|Protocol Violation|0|||
48458480|NCT01680991|155867946|FG000|Overall Study|Withdrawal by Subject|5|||
48458481|NCT01680991|155867947|FG001|Overall Study|Withdrawal by Subject|1|||
48458482|NCT01680991|155867948|FG002|Overall Study|Withdrawal by Subject|0|||
48458483|NCT01680991|155867946|FG000|Overall Study|Progressive disease (PD)|0|||
48458484|NCT01680991|155867947|FG001|Overall Study|Progressive disease (PD)|10|||
48458485|NCT01680991|155867948|FG002|Overall Study|Progressive disease (PD)|0|||
48458486|NCT01680991|155867946|FG000|Overall Study|Physician Decision|0|||
48458487|NCT01680991|155867947|FG001|Overall Study|Physician Decision|7|||
48458488|NCT01680991|155867948|FG002|Overall Study|Physician Decision|2|||
48458489|NCT01680991|155867946|FG000|Overall Study|Bad physical condition|0|||
48458490|NCT01680991|155867947|FG001|Overall Study|Bad physical condition|0|||
48458491|NCT01680991|155867948|FG002|Overall Study|Bad physical condition|1|||
48458492|NCT01680991|155867946|FG000|Overall Study|PD confirmed in other hospital|1|||
48458493|NCT01680991|155867947|FG001|Overall Study|PD confirmed in other hospital|0|||
48458494|NCT01680991|155867948|FG002|Overall Study|PD confirmed in other hospital|0|||
48458495|NCT01681836|155867953|FG000|Second Intervention|Withdrawal by Subject|0|||
48458496|NCT01681836|155867954|FG001|Second Intervention|Withdrawal by Subject|1|||
48458497|NCT02096471|155867957|FG000|Overall Study|Adverse Event|1|||
48458498|NCT02096471|155867957|FG000|Overall Study|Lack of Efficacy|7|||
48458499|NCT02096471|155867957|FG000|Overall Study|Withdrawal by Subject|3|||
48458500|NCT02096471|155867957|FG000|Overall Study|Non-Compliant|2|||
48458501|NCT01332851|155867959|FG000|Overall Study|Withdrawal by Subject|4|||
48458502|NCT01332851|155867960|FG001|Overall Study|Withdrawal by Subject|2|||
48458503|NCT01332851|155867959|FG000|Overall Study|Lost to Follow-up|7|||
48458504|NCT01332851|155867960|FG001|Overall Study|Lost to Follow-up|11|||
48458505|NCT03864627|155867961|FG000|Overall Study|Adverse Event|0|||
48458506|NCT03864627|155867962|FG001|Overall Study|Adverse Event|1|||
48458507|NCT03864627|155867961|FG000|Overall Study|Lack of Efficacy|0|||
48458508|NCT03864627|155867962|FG001|Overall Study|Lack of Efficacy|1|||
48458509|NCT03864627|155867961|FG000|Overall Study|Lost to Follow-up|0|||
48458510|NCT03864627|155867962|FG001|Overall Study|Lost to Follow-up|1|||
48458511|NCT03864627|155867961|FG000|Overall Study|Withdrawal by Subject|4|||
48458512|NCT03864627|155867962|FG001|Overall Study|Withdrawal by Subject|8|||
48458513|NCT03864627|155867961|FG000|Overall Study|Study terminated by sponsor|0|||
48458514|NCT03864627|155867962|FG001|Overall Study|Study terminated by sponsor|1|||
48458515|NCT01809327|155867963|FG000|Overall Study|Lost to Follow-up|5|||
48458516|NCT01809327|155867964|FG001|Overall Study|Lost to Follow-up|2|||
48458517|NCT01809327|155867965|FG002|Overall Study|Lost to Follow-up|4|||
48458518|NCT01809327|155867966|FG003|Overall Study|Lost to Follow-up|2|||
48458519|NCT01809327|155867967|FG004|Overall Study|Lost to Follow-up|3|||
48458520|NCT01809327|155867963|FG000|Overall Study|Withdrawal by Subject|6|||
48458521|NCT01809327|155867964|FG001|Overall Study|Withdrawal by Subject|4|||
48458522|NCT01809327|155867965|FG002|Overall Study|Withdrawal by Subject|4|||
48458523|NCT01809327|155867966|FG003|Overall Study|Withdrawal by Subject|2|||
48458524|NCT01809327|155867967|FG004|Overall Study|Withdrawal by Subject|5|||
48458525|NCT01809327|155867963|FG000|Overall Study|Adverse Event|4|||
48458526|NCT01809327|155867964|FG001|Overall Study|Adverse Event|3|||
48458527|NCT01809327|155867965|FG002|Overall Study|Adverse Event|7|||
48458528|NCT01809327|155867966|FG003|Overall Study|Adverse Event|4|||
48458529|NCT01809327|155867967|FG004|Overall Study|Adverse Event|8|||
48458530|NCT01809327|155867963|FG000|Overall Study|Death|1|||
48458531|NCT01809327|155867964|FG001|Overall Study|Death|0|||
48458532|NCT01809327|155867965|FG002|Overall Study|Death|0|||
48458533|NCT01809327|155867966|FG003|Overall Study|Death|0|||
48458534|NCT01809327|155867967|FG004|Overall Study|Death|0|||
48458535|NCT01809327|155867963|FG000|Overall Study|Protocol Violation|0|||
48458536|NCT01809327|155867964|FG001|Overall Study|Protocol Violation|1|||
48458537|NCT01809327|155867965|FG002|Overall Study|Protocol Violation|0|||
48458538|NCT01809327|155867966|FG003|Overall Study|Protocol Violation|0|||
48458539|NCT01809327|155867967|FG004|Overall Study|Protocol Violation|0|||
48458540|NCT01809327|155867963|FG000|Overall Study|Physician Decision|1|||
48458541|NCT01809327|155867964|FG001|Overall Study|Physician Decision|1|||
48458542|NCT01809327|155867965|FG002|Overall Study|Physician Decision|0|||
48458543|NCT01809327|155867966|FG003|Overall Study|Physician Decision|0|||
48458544|NCT01809327|155867967|FG004|Overall Study|Physician Decision|0|||
48458545|NCT01809327|155867963|FG000|Overall Study|Pregnancy|1|||
48458546|NCT01809327|155867964|FG001|Overall Study|Pregnancy|0|||
48458547|NCT01809327|155867965|FG002|Overall Study|Pregnancy|0|||
48458548|NCT01809327|155867966|FG003|Overall Study|Pregnancy|0|||
48458549|NCT01809327|155867967|FG004|Overall Study|Pregnancy|0|||
48458550|NCT01809327|155867963|FG000|Overall Study|Other|14|||
48458551|NCT01809327|155867964|FG001|Overall Study|Other|15|||
48458552|NCT01809327|155867965|FG002|Overall Study|Other|7|||
48458553|NCT01809327|155867966|FG003|Overall Study|Other|4|||
48458554|NCT01809327|155867967|FG004|Overall Study|Other|9|||
48458555|NCT03196973|155867968|FG000|Overall Study|Adverse Event|1|||
48458556|NCT03196973|155867969|FG001|Overall Study|Adverse Event|1|||
48458557|NCT03196973|155867970|FG002|Overall Study|Adverse Event|2|||
48458558|NCT03196973|155867968|FG000|Overall Study|Lack of Efficacy|2|||
48458559|NCT03196973|155867969|FG001|Overall Study|Lack of Efficacy|6|||
48458560|NCT03196973|155867970|FG002|Overall Study|Lack of Efficacy|1|||
48458561|NCT03196973|155867968|FG000|Overall Study|Lost to Follow-up|4|||
48458562|NCT03196973|155867969|FG001|Overall Study|Lost to Follow-up|3|||
48458563|NCT03196973|155867970|FG002|Overall Study|Lost to Follow-up|2|||
48458564|NCT03196973|155867968|FG000|Overall Study|Consent withdrawn|2|||
48458565|NCT03196973|155867969|FG001|Overall Study|Consent withdrawn|1|||
48458566|NCT03196973|155867970|FG002|Overall Study|Consent withdrawn|0|||
48458567|NCT03196973|155867968|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
48458568|NCT03196973|155867969|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
48458569|NCT03196973|155867970|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
48458570|NCT00374127|155867971|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
48458571|NCT00374127|155867971|FG000|Overall Study|Blood could not be drawn.|2|||
48458572|NCT00374127|155867971|FG000|Overall Study|Protocol Violation|5|||
48458573|NCT00374127|155867971|FG000|Overall Study|Pregnancy|1|||
48458574|NCT01388491|155867973|FG000|Overall Study|Adverse Event|10|||
48458575|NCT01388491|155867974|FG001|Overall Study|Adverse Event|9|||
48458576|NCT01388491|155867973|FG000|Overall Study|Sponsor Request|9|||
48458577|NCT01388491|155867974|FG001|Overall Study|Sponsor Request|7|||
48458578|NCT01388491|155867973|FG000|Overall Study|Withdrawal by Subject|6|||
48458579|NCT01388491|155867974|FG001|Overall Study|Withdrawal by Subject|10|||
48458580|NCT01388491|155867973|FG000|Overall Study|Lost to Follow-up|4|||
48458581|NCT01388491|155867974|FG001|Overall Study|Lost to Follow-up|3|||
48458582|NCT01388491|155867973|FG000|Overall Study|Protocol Violation|2|||
48458583|NCT01388491|155867974|FG001|Overall Study|Protocol Violation|0|||
48458584|NCT01388491|155867973|FG000|Overall Study|Noncompliance|2|||
48458585|NCT01388491|155867974|FG001|Overall Study|Noncompliance|0|||
48458586|NCT01388491|155867973|FG000|Overall Study|Pregnancy|1|||
48458587|NCT01388491|155867974|FG001|Overall Study|Pregnancy|0|||
48458588|NCT04035473|155867979|FG000|Screening/Baseline|Death|0|||
48458589|NCT04035473|155867980|FG001|Screening/Baseline|Death|1|||
48458590|NCT04035473|155867979|FG000|Screening/Baseline|Adverse Event|0|||
48458591|NCT04035473|155867980|FG001|Screening/Baseline|Adverse Event|1|||
48458592|NCT04035473|155867979|FG000|Follow-up Period|Adverse Event|2|||
48458593|NCT04035473|155867980|FG001|Follow-up Period|Adverse Event|0|||
48458594|NCT00112840|155867984|FG000|Overall Study|Physician Decision|1|||
48458595|NCT00112840|155867985|FG001|Overall Study|Physician Decision|0|||
48458596|NCT00112840|155867986|FG002|Overall Study|Physician Decision|0|||
48458597|NCT00112840|155867984|FG000|Overall Study|Withdrawal by Subject|1|||
48458598|NCT00112840|155867985|FG001|Overall Study|Withdrawal by Subject|0|||
48458599|NCT00112840|155867986|FG002|Overall Study|Withdrawal by Subject|1|||
48458600|NCT00112840|155867984|FG000|Overall Study|Protocol Violation|0|||
48458601|NCT00112840|155867985|FG001|Overall Study|Protocol Violation|0|||
48458602|NCT00112840|155867986|FG002|Overall Study|Protocol Violation|5|||
48458603|NCT00636506|155867988|FG000|Overall Study|Lost to Follow-up|8|||
48458604|NCT00636506|155867988|FG000|Overall Study|Explanted|1|||
48458605|NCT00636506|155867988|FG000|Overall Study|Withdrawal by Subject|6|||
48458606|NCT00636506|155867988|FG000|Overall Study|Procedure aborted|1|||
48458607|NCT02299206|155867989|FG000|Overall Study|Lost to Follow-up|1|||
48458608|NCT02299206|155867989|FG000|Overall Study|Withdrawal by Subject|1|||
48458609|NCT02736474|155867990|FG000|Overall Study|Lost to Follow-up|0|||
48458610|NCT02736474|155867991|FG001|Overall Study|Lost to Follow-up|1|||
48458611|NCT02705755|155867994|FG000|Part A (6 Days)|Adverse Event|1|||
48458612|NCT02705755|155867995|FG001|Part A (6 Days)|Adverse Event|0|||
48458613|NCT02705755|155867996|FG002|Part A (6 Days)|Adverse Event|0|||
48458614|NCT02705755|155867997|FG003|Part A (6 Days)|Adverse Event|0|||
48458615|NCT02705755|155867994|FG000|Part A (6 Days)|Physician Decision|3|||
48458616|NCT02705755|155867995|FG001|Part A (6 Days)|Physician Decision|0|||
48458617|NCT02705755|155867996|FG002|Part A (6 Days)|Physician Decision|0|||
48458618|NCT02705755|155867997|FG003|Part A (6 Days)|Physician Decision|0|||
48458619|NCT02705755|155867994|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
48458620|NCT02705755|155867995|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
48458621|NCT02705755|155867996|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
48458622|NCT02705755|155867997|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
48458623|NCT02705755|155867994|FG000|Part C (20 Weeks)|Physician Decision|0|||
48458624|NCT02705755|155867995|FG001|Part C (20 Weeks)|Physician Decision|0|||
48458625|NCT02705755|155867996|FG002|Part C (20 Weeks)|Physician Decision|0|||
48458626|NCT02705755|155867997|FG003|Part C (20 Weeks)|Physician Decision|2|||
48458627|NCT02705755|155867994|FG000|Part C (20 Weeks)|Adverse Event|0|||
48458628|NCT02705755|155867995|FG001|Part C (20 Weeks)|Adverse Event|0|||
48458629|NCT02705755|155867996|FG002|Part C (20 Weeks)|Adverse Event|0|||
48458630|NCT02705755|155867997|FG003|Part C (20 Weeks)|Adverse Event|6|||
48458631|NCT02705755|155867994|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
48458632|NCT02705755|155867995|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
48458633|NCT02705755|155867996|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
48458634|NCT02705755|155867997|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
48458635|NCT00731666|155869495|FG000|Overall Study|Adverse Event|2|||
48458636|NCT00731666|155869495|FG000|Overall Study|Lost to Follow-up|8|||
48458637|NCT00731666|155869495|FG000|Overall Study|Withdrawal by Subject|2|||
48458638|NCT00608894|155869499|FG000|Overall Study|Withdrawal by Subject|0|||
48458639|NCT00608894|155869500|FG001|Overall Study|Withdrawal by Subject|2|||
48458640|NCT01308853|155869508|FG000|Overall Study|Adverse Event|1|||
48458641|NCT01308853|155869508|FG000|Overall Study|Lost to Follow-up|2|||
48458642|NCT01308853|155869508|FG000|Overall Study|Insertion of permanent implants|1|||
48458643|NCT00444951|155869509|FG000|Overall Study|Lost to Follow-up|1|||
48458644|NCT00444951|155869510|FG001|Overall Study|Lost to Follow-up|1|||
48458645|NCT00444951|155869511|FG002|Overall Study|Lost to Follow-up|0|||
48458646|NCT00444951|155869509|FG000|Overall Study|Withdrawal by Subject|4|||
48458647|NCT00444951|155869510|FG001|Overall Study|Withdrawal by Subject|5|||
48458648|NCT00444951|155869511|FG002|Overall Study|Withdrawal by Subject|3|||
48458649|NCT01784211|155869515|FG000|Part A (Days 1-15)|Adverse Event|1|||
48458650|NCT01784211|155869516|FG001|Part A (Days 1-15)|Adverse Event|1|||
48458651|NCT01784211|155869517|FG002|Part A (Days 1-15)|Adverse Event|0|||
48458652|NCT01784211|155869518|FG003|Part A (Days 1-15)|Adverse Event|0|||
48458653|NCT01784211|155869519|FG004|Part A (Days 1-15)|Adverse Event|0|||
48458654|NCT01784211|155869520|FG005|Part A (Days 1-15)|Adverse Event|0|||
48458655|NCT01784211|155869515|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
48458656|NCT01784211|155869516|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
48458657|NCT01784211|155869517|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
48458658|NCT01784211|155869518|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
48458659|NCT01784211|155869519|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
48458660|NCT01784211|155869520|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
48458661|NCT00939055|155869521|FG000|Overall Study|Discontinuation prior to procedure|4|||
48458662|NCT00939055|155869522|FG001|Overall Study|Discontinuation prior to procedure|0|||
48458663|NCT00809614|155869525|FG000|Overall Study|Lack of Efficacy|2|||
48458664|NCT00809614|155869526|FG001|Overall Study|Lack of Efficacy|3|||
48458665|NCT00809614|155869525|FG000|Overall Study|Withdrawal by Subject|1|||
48458666|NCT00809614|155869526|FG001|Overall Study|Withdrawal by Subject|1|||
48458667|NCT00584987|155869527|FG000|Overall Study|Protocol Violation|1|||
48458668|NCT00584987|155869528|FG001|Overall Study|Protocol Violation|1|||
48458669|NCT00584987|155869529|FG002|Overall Study|Protocol Violation|1|||
48458670|NCT00584987|155869530|FG003|Overall Study|Protocol Violation|0|||
48458671|NCT00584987|155869527|FG000|Overall Study|Adverse Event|0|||
48458672|NCT00584987|155869528|FG001|Overall Study|Adverse Event|0|||
48458673|NCT00584987|155869529|FG002|Overall Study|Adverse Event|0|||
48458674|NCT00584987|155869530|FG003|Overall Study|Adverse Event|1|||
48458675|NCT00589602|155869531|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
48458676|NCT01263470|155869535|FG000|Overall Study|Adverse Event|2|||
48458677|NCT01263470|155869536|FG001|Overall Study|Adverse Event|2|||
48458678|NCT01263470|155869537|FG002|Overall Study|Adverse Event|1|||
48458679|NCT01263470|155869538|FG003|Overall Study|Adverse Event|1|||
48458680|NCT01263470|155869539|FG004|Overall Study|Adverse Event|2|||
48458681|NCT01263470|155869540|FG005|Overall Study|Adverse Event|2|||
48458682|NCT01263470|155869535|FG000|Overall Study|Protocol Violation|0|||
48458683|NCT01263470|155869536|FG001|Overall Study|Protocol Violation|1|||
48458684|NCT01263470|155869537|FG002|Overall Study|Protocol Violation|0|||
48458685|NCT01263470|155869538|FG003|Overall Study|Protocol Violation|0|||
48458686|NCT01263470|155869539|FG004|Overall Study|Protocol Violation|0|||
48458687|NCT01263470|155869540|FG005|Overall Study|Protocol Violation|1|||
48458688|NCT01263470|155869535|FG000|Overall Study|Withdrawal by Subject|0|||
48458689|NCT01263470|155869536|FG001|Overall Study|Withdrawal by Subject|1|||
48458690|NCT01263470|155869537|FG002|Overall Study|Withdrawal by Subject|1|||
48458691|NCT01263470|155869538|FG003|Overall Study|Withdrawal by Subject|2|||
48458692|NCT01263470|155869539|FG004|Overall Study|Withdrawal by Subject|0|||
48458693|NCT01263470|155869540|FG005|Overall Study|Withdrawal by Subject|2|||
48458694|NCT01263470|155869535|FG000|Overall Study|Lack of Efficacy|0|||
48458695|NCT01263470|155869536|FG001|Overall Study|Lack of Efficacy|0|||
48458696|NCT01263470|155869537|FG002|Overall Study|Lack of Efficacy|2|||
48458697|NCT01263470|155869538|FG003|Overall Study|Lack of Efficacy|0|||
48458698|NCT01263470|155869539|FG004|Overall Study|Lack of Efficacy|0|||
48458699|NCT01263470|155869540|FG005|Overall Study|Lack of Efficacy|0|||
48458700|NCT01263470|155869535|FG000|Overall Study|Participant Unavailability|0|||
48458701|NCT01263470|155869536|FG001|Overall Study|Participant Unavailability|1|||
48458702|NCT01263470|155869537|FG002|Overall Study|Participant Unavailability|0|||
48458703|NCT01263470|155869538|FG003|Overall Study|Participant Unavailability|0|||
48458704|NCT01263470|155869539|FG004|Overall Study|Participant Unavailability|0|||
48458705|NCT01263470|155869540|FG005|Overall Study|Participant Unavailability|0|||
48458706|NCT01263470|155869535|FG000|Overall Study|Study Drug Non-compliance|0|||
48458707|NCT01263470|155869536|FG001|Overall Study|Study Drug Non-compliance|0|||
48458708|NCT01263470|155869537|FG002|Overall Study|Study Drug Non-compliance|0|||
48458709|NCT01263470|155869538|FG003|Overall Study|Study Drug Non-compliance|0|||
48458710|NCT01263470|155869539|FG004|Overall Study|Study Drug Non-compliance|1|||
48458711|NCT01263470|155869540|FG005|Overall Study|Study Drug Non-compliance|0|||
48458712|NCT00413777|155869543|FG000|Fixed-dose Period|Lost to Follow-up|1|||
48458713|NCT00413777|155869544|FG001|Fixed-dose Period|Lost to Follow-up|1|||
48458714|NCT00413777|155869543|FG000|Fixed-dose Period|Adverse Event|2|||
48458715|NCT00413777|155869544|FG001|Fixed-dose Period|Adverse Event|1|||
48458716|NCT00413777|155869543|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
48458717|NCT00413777|155869544|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
48458718|NCT00413777|155869543|FG000|Fixed-dose Period|Withdrew Consent|0|||
48458719|NCT00413777|155869544|FG001|Fixed-dose Period|Withdrew Consent|1|||
48458720|NCT02565576|155869545|FG000|Overall Study|abnormal lab value|2|||
48458721|NCT02565576|155869546|FG001|Overall Study|abnormal lab value|0|||
48458722|NCT02565576|155869545|FG000|Overall Study|subject / guardian decision|1|||
48458723|NCT02565576|155869546|FG001|Overall Study|subject / guardian decision|3|||
48458724|NCT02565576|155869545|FG000|Overall Study|Lost to Follow-up|1|||
48458725|NCT02565576|155869546|FG001|Overall Study|Lost to Follow-up|0|||
48458726|NCT02565576|155869545|FG000|Overall Study|Death|0|||
48458727|NCT02565576|155869546|FG001|Overall Study|Death|2|||
48458728|NCT02565576|155869545|FG000|Overall Study|Adverse Event|1|||
48458729|NCT02565576|155869546|FG001|Overall Study|Adverse Event|0|||
48458730|NCT00981292|155869547|FG000|Day 1|Protocol Violation|1|||
48458731|NCT00981292|155869548|FG001|Day 1|Protocol Violation|0|||
48458732|NCT00981292|155869549|FG002|Day 1|Protocol Violation|0|||
48458733|NCT00981292|155869550|FG003|Day 1|Protocol Violation|0|||
48458734|NCT00981292|155869551|FG004|Day 1|Protocol Violation|0|||
48458735|NCT00981292|155869552|FG005|Day 1|Protocol Violation|2|||
48458736|NCT00981292|155869547|FG000|Day 2|Protocol Violation|2|||
48458737|NCT00981292|155869548|FG001|Day 2|Protocol Violation|0|||
48458738|NCT00981292|155869549|FG002|Day 2|Protocol Violation|0|||
48458739|NCT00981292|155869550|FG003|Day 2|Protocol Violation|0|||
48458740|NCT00981292|155869551|FG004|Day 2|Protocol Violation|0|||
48458741|NCT00981292|155869552|FG005|Day 2|Protocol Violation|0|||
48458742|NCT00981292|155869547|FG000|Day 3|Protocol Violation|0|||
48458743|NCT00981292|155869548|FG001|Day 3|Protocol Violation|0|||
48458744|NCT00981292|155869549|FG002|Day 3|Protocol Violation|0|||
48458745|NCT00981292|155869550|FG003|Day 3|Protocol Violation|0|||
48458746|NCT00981292|155869551|FG004|Day 3|Protocol Violation|0|||
48458747|NCT00981292|155869552|FG005|Day 3|Protocol Violation|1|||
48458748|NCT00424099|155869557|FG000|Overall Study|Adverse Event|0|||
48458749|NCT00424099|155869558|FG001|Overall Study|Adverse Event|1|||
48458750|NCT00424099|155869559|FG002|Overall Study|Adverse Event|1|||
48458751|NCT00424099|155869560|FG003|Overall Study|Adverse Event|0|||
48458752|NCT00424099|155869557|FG000|Overall Study|Death|0|||
48458753|NCT00424099|155869558|FG001|Overall Study|Death|1|||
48458754|NCT00424099|155869559|FG002|Overall Study|Death|0|||
48458755|NCT00424099|155869560|FG003|Overall Study|Death|0|||
48458756|NCT00424099|155869557|FG000|Overall Study|Illness|2|||
48458757|NCT00424099|155869558|FG001|Overall Study|Illness|0|||
48458758|NCT00424099|155869559|FG002|Overall Study|Illness|1|||
48458759|NCT00424099|155869560|FG003|Overall Study|Illness|4|||
48458760|NCT00424099|155869557|FG000|Overall Study|Lost to Follow-up|0|||
48458761|NCT00424099|155869558|FG001|Overall Study|Lost to Follow-up|0|||
48458762|NCT00424099|155869559|FG002|Overall Study|Lost to Follow-up|3|||
48458763|NCT00424099|155869560|FG003|Overall Study|Lost to Follow-up|0|||
48458764|NCT00424099|155869557|FG000|Overall Study|Hospitalized|1|||
48458765|NCT00424099|155869558|FG001|Overall Study|Hospitalized|2|||
48458766|NCT00424099|155869559|FG002|Overall Study|Hospitalized|1|||
48458767|NCT00424099|155869560|FG003|Overall Study|Hospitalized|3|||
48458768|NCT00424099|155869557|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
48458769|NCT00424099|155869558|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
48458770|NCT00424099|155869559|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
48458771|NCT00424099|155869560|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
48458772|NCT00424099|155869557|FG000|Overall Study|Withdrawal by Subject|1|||
48458773|NCT00424099|155869558|FG001|Overall Study|Withdrawal by Subject|9|||
48458774|NCT00424099|155869559|FG002|Overall Study|Withdrawal by Subject|4|||
48458775|NCT00424099|155869560|FG003|Overall Study|Withdrawal by Subject|6|||
48458776|NCT00424099|155869557|FG000|Overall Study|Physician Decision|0|||
48458777|NCT00424099|155869558|FG001|Overall Study|Physician Decision|0|||
48458778|NCT00424099|155869559|FG002|Overall Study|Physician Decision|1|||
48458779|NCT00424099|155869560|FG003|Overall Study|Physician Decision|0|||
48458780|NCT00424099|155869557|FG000|Overall Study|Missing|0|||
48458781|NCT00424099|155869558|FG001|Overall Study|Missing|0|||
48458782|NCT00424099|155869559|FG002|Overall Study|Missing|1|||
48458783|NCT00424099|155869560|FG003|Overall Study|Missing|0|||
48458784|NCT03377452|155869561|FG000|Overall Study|Refused assessment|0|||
48458785|NCT03377452|155869562|FG001|Overall Study|Refused assessment|2|||
48458786|NCT03377452|155869561|FG000|Overall Study|Lost to Follow-up|5|||
48458787|NCT03377452|155869562|FG001|Overall Study|Lost to Follow-up|4|||
48458788|NCT02155712|155869563|FG000|Overall Study|Death|12|||
48458789|NCT02155712|155869564|FG001|Overall Study|Death|0|||
48458790|NCT02155712|155869563|FG000|Overall Study|Lost to Follow-up|37|||
48458791|NCT02155712|155869564|FG001|Overall Study|Lost to Follow-up|22|||
48458792|NCT02155712|155869563|FG000|Overall Study|Revision of device|4|||
48458793|NCT02155712|155869564|FG001|Overall Study|Revision of device|3|||
48458794|NCT02155712|155869563|FG000|Overall Study|Withdrawal by Subject|39|||
48458795|NCT02155712|155869564|FG001|Overall Study|Withdrawal by Subject|21|||
48458796|NCT02155712|155869563|FG000|Overall Study|Site termination|77|||
48458797|NCT02155712|155869564|FG001|Overall Study|Site termination|19|||
48458798|NCT02155712|155869563|FG000|Overall Study|Sponsor terminated study early|150|||
48458799|NCT02155712|155869564|FG001|Overall Study|Sponsor terminated study early|0|||
48458800|NCT02155712|155869563|FG000|Overall Study|Missed final 5-year protocol visit|0|||
48458801|NCT02155712|155869564|FG001|Overall Study|Missed final 5-year protocol visit|32|||
48458802|NCT02155712|155869563|FG000|Overall Study|Censored because surgery cancelled|6|||
48458803|NCT02155712|155869564|FG001|Overall Study|Censored because surgery cancelled|10|||
48458804|NCT02155712|155869563|FG000|Overall Study|Censored because study device was not implanted|61|||
48458805|NCT02155712|155869564|FG001|Overall Study|Censored because study device was not implanted|66|||
48458806|NCT02155712|155869563|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
48458807|NCT02155712|155869564|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
48458808|NCT02559115|155869565|FG000|Overall Study|Withdrawal by Subject|3|||
48458809|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
48458810|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
48458811|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
48458812|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
48458813|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
48458814|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
48458815|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
48458816|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
48458817|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
48458818|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
48458819|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
48458820|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
48458821|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
48458822|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
48458823|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
48458824|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
48458825|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
48458826|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
48458827|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
48458828|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
48458829|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
48458830|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
48458831|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
48458832|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
48458833|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
48458834|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
48458835|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
48458836|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
48458837|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
48458838|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
48458839|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
48458840|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
48458841|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
48458842|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
48458843|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
48458844|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
48458845|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
48458846|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
48458847|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
48458848|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
48458849|NCT03605836|155869566|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
48458850|NCT03605836|155869567|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
48458851|NCT03605836|155869568|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
48458852|NCT03605836|155869569|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
48458853|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
48458854|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
48458855|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
48458856|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
48458857|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
48458858|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
48458859|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
48458860|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
48458861|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
48458862|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
48458863|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
48458864|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
48458865|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
48458866|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
48458867|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
48458868|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
48458869|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
48458870|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
48458871|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
48458872|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
48458873|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
48458874|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
48458875|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
48458876|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
48458877|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
48458878|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
48458879|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
48458880|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
48458881|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
48458882|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
48458883|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
48458884|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
48458885|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
48458886|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
48458887|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
48458888|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
48458889|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
48458890|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
48458891|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
48458892|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
48458893|NCT03605836|155869566|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
48458894|NCT03605836|155869567|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
48458895|NCT03605836|155869568|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
48458896|NCT03605836|155869569|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
48458897|NCT02148952|155869575|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
48458898|NCT02148952|155869576|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
48458899|NCT02148952|155869575|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
48458900|NCT02148952|155869576|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
48458901|NCT02148952|155869575|FG000|Follow-Up|Lost to Follow-up|219|||
48458902|NCT02148952|155869576|FG001|Follow-Up|Lost to Follow-up|231|||
48458903|NCT02148952|155869575|FG000|Follow-Up|Withdrawal by Subject|46|||
48458904|NCT02148952|155869576|FG001|Follow-Up|Withdrawal by Subject|48|||
48458905|NCT05333289|155869577|FG000|Overall Study|Other|1|||
48458906|NCT05333289|155869578|FG001|Overall Study|Other|0|||
48458907|NCT05333289|155869579|FG002|Overall Study|Other|0|||
48458908|NCT05333289|155869580|FG003|Overall Study|Other|1|||
48458909|NCT05333289|155869581|FG004|Overall Study|Other|1|||
48458910|NCT05333289|155869582|FG005|Overall Study|Other|2|||
48458911|NCT05333289|155869583|FG006|Overall Study|Other|2|||
48458912|NCT05333289|155869584|FG007|Overall Study|Other|0|||
48458913|NCT05333289|155869577|FG000|Overall Study|Withdrawal by Subject|1|||
48458914|NCT05333289|155869578|FG001|Overall Study|Withdrawal by Subject|2|||
48458915|NCT05333289|155869579|FG002|Overall Study|Withdrawal by Subject|2|||
48458916|NCT05333289|155869580|FG003|Overall Study|Withdrawal by Subject|1|||
48458917|NCT05333289|155869581|FG004|Overall Study|Withdrawal by Subject|1|||
48458918|NCT05333289|155869582|FG005|Overall Study|Withdrawal by Subject|2|||
48458919|NCT05333289|155869583|FG006|Overall Study|Withdrawal by Subject|1|||
48458920|NCT05333289|155869584|FG007|Overall Study|Withdrawal by Subject|3|||
48458921|NCT05333289|155869577|FG000|Overall Study|Protocol Violation|1|||
48458922|NCT05333289|155869578|FG001|Overall Study|Protocol Violation|0|||
48458923|NCT05333289|155869579|FG002|Overall Study|Protocol Violation|0|||
48458924|NCT05333289|155869580|FG003|Overall Study|Protocol Violation|0|||
48458925|NCT05333289|155869581|FG004|Overall Study|Protocol Violation|0|||
48458926|NCT05333289|155869582|FG005|Overall Study|Protocol Violation|0|||
48458927|NCT05333289|155869583|FG006|Overall Study|Protocol Violation|0|||
48458928|NCT05333289|155869584|FG007|Overall Study|Protocol Violation|0|||
48458929|NCT05333289|155869577|FG000|Overall Study|Physician Decision|0|||
48458930|NCT05333289|155869578|FG001|Overall Study|Physician Decision|0|||
48458931|NCT05333289|155869579|FG002|Overall Study|Physician Decision|1|||
48458932|NCT05333289|155869580|FG003|Overall Study|Physician Decision|0|||
48458933|NCT05333289|155869581|FG004|Overall Study|Physician Decision|0|||
48458934|NCT05333289|155869582|FG005|Overall Study|Physician Decision|2|||
48458935|NCT05333289|155869583|FG006|Overall Study|Physician Decision|0|||
48458936|NCT05333289|155869584|FG007|Overall Study|Physician Decision|0|||
48458937|NCT05333289|155869577|FG000|Overall Study|Lost to Follow-up|6|||
48458938|NCT05333289|155869578|FG001|Overall Study|Lost to Follow-up|0|||
48458939|NCT05333289|155869579|FG002|Overall Study|Lost to Follow-up|1|||
48458940|NCT05333289|155869580|FG003|Overall Study|Lost to Follow-up|6|||
48458941|NCT05333289|155869581|FG004|Overall Study|Lost to Follow-up|3|||
48458942|NCT05333289|155869582|FG005|Overall Study|Lost to Follow-up|3|||
48458943|NCT05333289|155869583|FG006|Overall Study|Lost to Follow-up|2|||
48458944|NCT05333289|155869584|FG007|Overall Study|Lost to Follow-up|1|||
48458945|NCT05333289|155869577|FG000|Overall Study|Death|1|||
48458946|NCT05333289|155869578|FG001|Overall Study|Death|0|||
48458947|NCT05333289|155869579|FG002|Overall Study|Death|0|||
48458948|NCT05333289|155869580|FG003|Overall Study|Death|0|||
48458949|NCT05333289|155869581|FG004|Overall Study|Death|0|||
48458950|NCT05333289|155869582|FG005|Overall Study|Death|0|||
48458951|NCT05333289|155869583|FG006|Overall Study|Death|0|||
48458952|NCT05333289|155869584|FG007|Overall Study|Death|0|||
48458953|NCT02010567|155869587|FG000|Overall Study|Adverse Event|0|||
48458954|NCT02010567|155869588|FG001|Overall Study|Adverse Event|0|||
48458955|NCT02010567|155869589|FG002|Overall Study|Adverse Event|1|||
48458956|NCT02010567|155869590|FG003|Overall Study|Adverse Event|0|||
48458957|NCT02010567|155869591|FG004|Overall Study|Adverse Event|1|||
48458958|NCT03330106|155869592|FG000|Part A|Withdrawal by Subject|1|||
48458959|NCT03330106|155869593|FG001|Part A|Withdrawal by Subject|1|||
48458960|NCT03330106|155869594|FG002|Part A|Withdrawal by Subject|0|||
48458961|NCT03330106|155869595|FG003|Part A|Withdrawal by Subject|0|||
48458962|NCT03330106|155869592|FG000|Part A|Death|2|||
48458963|NCT03330106|155869593|FG001|Part A|Death|1|||
48458964|NCT03330106|155869594|FG002|Part A|Death|0|||
48458965|NCT03330106|155869595|FG003|Part A|Death|0|||
48458966|NCT03330106|155869592|FG000|Part A|Adverse Event|0|||
48458967|NCT03330106|155869593|FG001|Part A|Adverse Event|1|||
48458968|NCT03330106|155869594|FG002|Part A|Adverse Event|0|||
48458969|NCT03330106|155869595|FG003|Part A|Adverse Event|0|||
48458970|NCT03330106|155869592|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
48458971|NCT03330106|155869593|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
48458972|NCT03330106|155869594|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
48458973|NCT03330106|155869595|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
48458974|NCT03330106|155869592|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
48458975|NCT03330106|155869593|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
48458976|NCT03330106|155869594|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
48458977|NCT03330106|155869595|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
48458978|NCT03330106|155869592|FG000|Part A|Progressive Disease|0|||
48458979|NCT03330106|155869593|FG001|Part A|Progressive Disease|1|||
48458980|NCT03330106|155869594|FG002|Part A|Progressive Disease|0|||
48458981|NCT03330106|155869595|FG003|Part A|Progressive Disease|0|||
48458982|NCT03330106|155869592|FG000|Part B|Lost to Follow-up|0|||
48458983|NCT03330106|155869593|FG001|Part B|Lost to Follow-up|0|||
48458984|NCT03330106|155869594|FG002|Part B|Lost to Follow-up|0|||
48458985|NCT03330106|155869595|FG003|Part B|Lost to Follow-up|1|||
48458986|NCT03330106|155869592|FG000|Part B|Withdrawal by Subject|0|||
48458987|NCT03330106|155869593|FG001|Part B|Withdrawal by Subject|0|||
48458988|NCT03330106|155869594|FG002|Part B|Withdrawal by Subject|4|||
48458989|NCT03330106|155869595|FG003|Part B|Withdrawal by Subject|0|||
48458990|NCT03330106|155869592|FG000|Part B|Death|0|||
48458991|NCT03330106|155869593|FG001|Part B|Death|0|||
48458992|NCT03330106|155869594|FG002|Part B|Death|2|||
48458993|NCT03330106|155869595|FG003|Part B|Death|0|||
48458994|NCT03330106|155869592|FG000|Part B|Clinical Progression|0|||
48458995|NCT03330106|155869593|FG001|Part B|Clinical Progression|0|||
48458996|NCT03330106|155869594|FG002|Part B|Clinical Progression|1|||
48458997|NCT03330106|155869595|FG003|Part B|Clinical Progression|1|||
48458998|NCT03330106|155869592|FG000|Part B|Symptomatic Deterioration|0|||
48458999|NCT03330106|155869593|FG001|Part B|Symptomatic Deterioration|0|||
48459000|NCT03330106|155869594|FG002|Part B|Symptomatic Deterioration|0|||
48459001|NCT03330106|155869595|FG003|Part B|Symptomatic Deterioration|1|||
48459002|NCT03330106|155869592|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
48459003|NCT03330106|155869593|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
48459004|NCT03330106|155869594|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
48459005|NCT03330106|155869595|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
48459006|NCT03330106|155869592|FG000|Part B|Progressive Disease|0|||
48459007|NCT03330106|155869593|FG001|Part B|Progressive Disease|0|||
48459008|NCT03330106|155869594|FG002|Part B|Progressive Disease|11|||
48459009|NCT03330106|155869595|FG003|Part B|Progressive Disease|4|||
48459010|NCT04247828|155869596|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
48459011|NCT04051944|155869597|FG000|Overall Study|Study ending|1|||
48459012|NCT04051944|155869598|FG001|Overall Study|Study ending|1|||
48459013|NCT04051944|155869597|FG000|Overall Study|Early study termination by participant|1|||
48459014|NCT04051944|155869598|FG001|Overall Study|Early study termination by participant|0|||
48459015|NCT04051944|155869597|FG000|Overall Study|Withdrawal by Subject|2|||
48459016|NCT04051944|155869598|FG001|Overall Study|Withdrawal by Subject|2|||
48459017|NCT04051944|155869597|FG000|Overall Study|Lack of Efficacy|3|||
48459018|NCT04051944|155869598|FG001|Overall Study|Lack of Efficacy|0|||
48459019|NCT04051944|155869597|FG000|Overall Study|Adverse event, non- fatal|1|||
48459020|NCT04051944|155869598|FG001|Overall Study|Adverse event, non- fatal|1|||
48459021|NCT03344562|155869602|FG000|Overall Study|Withdrawal by Subject|2|||
48459022|NCT03344562|155869603|FG001|Overall Study|Withdrawal by Subject|0|||
48459023|NCT03742271|155869612|FG000|Overall Study|Unsatisfactory Visual Response|1|||
48459024|NCT03742271|155869612|FG000|Overall Study|Withdrawal by Subject|3|||
48459025|NCT03742271|155869612|FG000|Overall Study|Lost to Follow-up|4|||
48459026|NCT03742271|155869612|FG000|Overall Study|Failed Insertion & removal|3|||
48459027|NCT03742271|155869612|FG000|Overall Study|Protocol Violation|1|||
48459028|NCT00472043|155869613|FG000|Overall Study|Withdrawal by Subject|1|||
48459029|NCT00472043|155869614|FG001|Overall Study|Withdrawal by Subject|0|||
48459030|NCT00472043|155869613|FG000|Overall Study|Death|1|||
48459031|NCT00472043|155869614|FG001|Overall Study|Death|0|||
48459032|NCT04048876|155869617|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
48459033|NCT04048876|155869618|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
48459034|NCT04048876|155869619|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
48459035|NCT04048876|155869620|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
48459036|NCT04048876|155869617|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
48459037|NCT04048876|155869618|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
48459038|NCT04048876|155869619|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
48459039|NCT04048876|155869620|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
48459040|NCT04048876|155869617|FG000|Placebo Controlled Phase|Adverse Event|0|||
48459041|NCT04048876|155869618|FG001|Placebo Controlled Phase|Adverse Event|1|||
48459042|NCT04048876|155869619|FG002|Placebo Controlled Phase|Adverse Event|0|||
48459043|NCT04048876|155869620|FG003|Placebo Controlled Phase|Adverse Event|0|||
48459044|NCT04048876|155869617|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
48459045|NCT04048876|155869618|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
48459046|NCT04048876|155869619|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
48459047|NCT04048876|155869620|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
48459048|NCT02875366|155869626|FG000|Overall Study|Adverse Event|0|||
48459049|NCT02875366|155869627|FG001|Overall Study|Adverse Event|2|||
48459050|NCT02875366|155869626|FG000|Overall Study|Noncompliance|0|||
48459051|NCT02875366|155869627|FG001|Overall Study|Noncompliance|1|||
48459052|NCT00683774|155869628|FG000|Overall Study|Withdrawal by Subject|0|||
48459053|NCT00683774|155869629|FG001|Overall Study|Withdrawal by Subject|1|||
48459054|NCT00683774|155869628|FG000|Overall Study|Physician Decision|3|||
48459055|NCT00683774|155869629|FG001|Overall Study|Physician Decision|0|||
48459056|NCT00826540|155869631|FG000|Overall Study|ineligible|3|||
48459057|NCT00826540|155869631|FG000|Overall Study|Withdrawal by Subject|1|||
48459058|NCT02802735|155869632|FG000|Overall Study|Withdrawal by Subject|0|||
48459059|NCT02802735|155869633|FG001|Overall Study|Withdrawal by Subject|1|||
48459060|NCT02802735|155869634|FG002|Overall Study|Withdrawal by Subject|0|||
48459061|NCT02802735|155869635|FG003|Overall Study|Withdrawal by Subject|0|||
48459062|NCT02802735|155869636|FG004|Overall Study|Withdrawal by Subject|0|||
48459063|NCT01166386|155869637|FG000|Overall Study|Withdrawal by Subject|3|||
48459064|NCT01166386|155869638|FG001|Overall Study|Withdrawal by Subject|5|||
48459065|NCT02545049|155869639|FG000|Overall Study|Withdrawal by Subject|1|||
48459066|NCT02545049|155869640|FG001|Overall Study|Withdrawal by Subject|7|||
48459067|NCT02545049|155869639|FG000|Overall Study|Lost to Follow-up|4|||
48459068|NCT02545049|155869640|FG001|Overall Study|Lost to Follow-up|6|||
48459069|NCT02545049|155869639|FG000|Overall Study|GCP violations|37|||
48459070|NCT02545049|155869640|FG001|Overall Study|GCP violations|48|||
48459071|NCT00984009|155869641|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
48459072|NCT03922711|155869642|FG000|Overall Study|Adverse Event|3|||
48459073|NCT03922711|155869643|FG001|Overall Study|Adverse Event|2|||
48459074|NCT03922711|155869644|FG002|Overall Study|Adverse Event|2|||
48459075|NCT03922711|155869642|FG000|Overall Study|Protocol Violation|1|||
48459076|NCT03922711|155869643|FG001|Overall Study|Protocol Violation|0|||
48459077|NCT03922711|155869644|FG002|Overall Study|Protocol Violation|0|||
48459078|NCT03922711|155869642|FG000|Overall Study|Withdrawal by Subject|0|||
48459079|NCT03922711|155869643|FG001|Overall Study|Withdrawal by Subject|3|||
48459080|NCT03922711|155869644|FG002|Overall Study|Withdrawal by Subject|1|||
48459081|NCT03922711|155869642|FG000|Overall Study|Not further specified|0|||
48459082|NCT03922711|155869643|FG001|Overall Study|Not further specified|0|||
48459083|NCT03922711|155869644|FG002|Overall Study|Not further specified|1|||
48459084|NCT02371980|155871335|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
48459085|NCT02371980|155871336|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
48459086|NCT02371980|155871337|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
48459087|NCT02371980|155871338|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
48459088|NCT02371980|155871339|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
48459089|NCT02371980|155871335|FG000|Open-label Period|Significant Protocol Deviation|19|||
48459090|NCT02371980|155871336|FG001|Open-label Period|Significant Protocol Deviation|0|||
48459091|NCT02371980|155871337|FG002|Open-label Period|Significant Protocol Deviation|0|||
48459092|NCT02371980|155871338|FG003|Open-label Period|Significant Protocol Deviation|0|||
48459093|NCT02371980|155871339|FG004|Open-label Period|Significant Protocol Deviation|0|||
48459094|NCT02371980|155871335|FG000|Open-label Period|Noncompliance with Study Drug|10|||
48459095|NCT02371980|155871336|FG001|Open-label Period|Noncompliance with Study Drug|0|||
48459096|NCT02371980|155871337|FG002|Open-label Period|Noncompliance with Study Drug|0|||
48459097|NCT02371980|155871338|FG003|Open-label Period|Noncompliance with Study Drug|0|||
48459098|NCT02371980|155871339|FG004|Open-label Period|Noncompliance with Study Drug|0|||
48459099|NCT02371980|155871335|FG000|Open-label Period|Lost to Follow-up|55|||
48459100|NCT02371980|155871336|FG001|Open-label Period|Lost to Follow-up|0|||
48459101|NCT02371980|155871337|FG002|Open-label Period|Lost to Follow-up|0|||
48459102|NCT02371980|155871338|FG003|Open-label Period|Lost to Follow-up|0|||
48459103|NCT02371980|155871339|FG004|Open-label Period|Lost to Follow-up|0|||
48459104|NCT02371980|155871335|FG000|Open-label Period|Voluntary Withdrawal|91|||
48459105|NCT02371980|155871336|FG001|Open-label Period|Voluntary Withdrawal|0|||
48459106|NCT02371980|155871337|FG002|Open-label Period|Voluntary Withdrawal|0|||
48459107|NCT02371980|155871338|FG003|Open-label Period|Voluntary Withdrawal|0|||
48459108|NCT02371980|155871339|FG004|Open-label Period|Voluntary Withdrawal|0|||
48459109|NCT02371980|155871335|FG000|Open-label Period|Pregnancy|1|||
48459110|NCT02371980|155871336|FG001|Open-label Period|Pregnancy|0|||
48459111|NCT02371980|155871337|FG002|Open-label Period|Pregnancy|0|||
48459112|NCT02371980|155871338|FG003|Open-label Period|Pregnancy|0|||
48459113|NCT02371980|155871339|FG004|Open-label Period|Pregnancy|0|||
48459114|NCT02371980|155871335|FG000|Open-label Period|Lack of Efficacy|116|||
48459115|NCT02371980|155871336|FG001|Open-label Period|Lack of Efficacy|0|||
48459116|NCT02371980|155871337|FG002|Open-label Period|Lack of Efficacy|0|||
48459117|NCT02371980|155871338|FG003|Open-label Period|Lack of Efficacy|0|||
48459118|NCT02371980|155871339|FG004|Open-label Period|Lack of Efficacy|0|||
48459119|NCT02371980|155871335|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
48459120|NCT02371980|155871336|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
48459121|NCT02371980|155871337|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
48459122|NCT02371980|155871338|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
48459123|NCT02371980|155871339|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
48459124|NCT02371980|155871335|FG000|Open-label Period|Reason not Specified|9|||
48459125|NCT02371980|155871336|FG001|Open-label Period|Reason not Specified|0|||
48459126|NCT02371980|155871337|FG002|Open-label Period|Reason not Specified|0|||
48459127|NCT02371980|155871338|FG003|Open-label Period|Reason not Specified|0|||
48459128|NCT02371980|155871339|FG004|Open-label Period|Reason not Specified|0|||
48459129|NCT02371980|155871335|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
48459130|NCT02371980|155871336|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
48459131|NCT02371980|155871337|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
48459132|NCT02371980|155871338|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
48459133|NCT02371980|155871339|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
48459134|NCT02371980|155871335|FG000|Double-blind Period|Significant Protocol Deviation|0|||
48459135|NCT02371980|155871336|FG001|Double-blind Period|Significant Protocol Deviation|2|||
48459136|NCT02371980|155871337|FG002|Double-blind Period|Significant Protocol Deviation|7|||
48459137|NCT02371980|155871338|FG003|Double-blind Period|Significant Protocol Deviation|3|||
48459138|NCT02371980|155871339|FG004|Double-blind Period|Significant Protocol Deviation|3|||
48459139|NCT02371980|155871335|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
48459140|NCT02371980|155871336|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
48459141|NCT02371980|155871337|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
48459142|NCT02371980|155871338|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
48459143|NCT02371980|155871339|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
48459144|NCT02371980|155871335|FG000|Double-blind Period|Lost to Follow-up|0|||
48459145|NCT02371980|155871336|FG001|Double-blind Period|Lost to Follow-up|8|||
48459146|NCT02371980|155871337|FG002|Double-blind Period|Lost to Follow-up|8|||
48459147|NCT02371980|155871338|FG003|Double-blind Period|Lost to Follow-up|6|||
48459148|NCT02371980|155871339|FG004|Double-blind Period|Lost to Follow-up|5|||
48459149|NCT02371980|155871335|FG000|Double-blind Period|Voluntary Withdrawal|0|||
48459150|NCT02371980|155871336|FG001|Double-blind Period|Voluntary Withdrawal|12|||
48459151|NCT02371980|155871337|FG002|Double-blind Period|Voluntary Withdrawal|8|||
48459152|NCT02371980|155871338|FG003|Double-blind Period|Voluntary Withdrawal|9|||
48459153|NCT02371980|155871339|FG004|Double-blind Period|Voluntary Withdrawal|11|||
48459154|NCT02371980|155871335|FG000|Double-blind Period|Relapse|0|||
48459155|NCT02371980|155871336|FG001|Double-blind Period|Relapse|50|||
48459156|NCT02371980|155871337|FG002|Double-blind Period|Relapse|25|||
48459157|NCT02371980|155871338|FG003|Double-blind Period|Relapse|25|||
48459158|NCT02371980|155871339|FG004|Double-blind Period|Relapse|26|||
48459159|NCT02371980|155871335|FG000|Double-blind Period|Reason not Specified|0|||
48459160|NCT02371980|155871336|FG001|Double-blind Period|Reason not Specified|3|||
48459161|NCT02371980|155871337|FG002|Double-blind Period|Reason not Specified|3|||
48459162|NCT02371980|155871338|FG003|Double-blind Period|Reason not Specified|2|||
48459163|NCT02371980|155871339|FG004|Double-blind Period|Reason not Specified|1|||
48459164|NCT02371980|155871335|FG000|Double-blind Period|Missing|0|||
48459165|NCT02371980|155871336|FG001|Double-blind Period|Missing|1|||
48459166|NCT02371980|155871337|FG002|Double-blind Period|Missing|0|||
48459167|NCT02371980|155871338|FG003|Double-blind Period|Missing|0|||
48459168|NCT02371980|155871339|FG004|Double-blind Period|Missing|0|||
48459169|NCT04315298|155871340|FG000|Overall Study|Withdrawal by Subject|0|||
48459170|NCT04315298|155871341|FG001|Overall Study|Withdrawal by Subject|0|||
48459171|NCT04315298|155871342|FG002|Overall Study|Withdrawal by Subject|0|||
48459172|NCT04315298|155871343|FG003|Overall Study|Withdrawal by Subject|2|||
48459173|NCT04315298|155871344|FG004|Overall Study|Withdrawal by Subject|2|||
48459174|NCT04315298|155871345|FG005|Overall Study|Withdrawal by Subject|2|||
48459175|NCT04315298|155871346|FG006|Overall Study|Withdrawal by Subject|0|||
48459176|NCT04315298|155871347|FG007|Overall Study|Withdrawal by Subject|1|||
48459177|NCT04315298|155871348|FG008|Overall Study|Withdrawal by Subject|1|||
48459178|NCT04315298|155871349|FG009|Overall Study|Withdrawal by Subject|1|||
48459179|NCT04315298|155871350|FG010|Overall Study|Withdrawal by Subject|0|||
48459180|NCT04315298|155871351|FG011|Overall Study|Withdrawal by Subject|0|||
48459181|NCT04315298|155871352|FG012|Overall Study|Withdrawal by Subject|0|||
48459182|NCT04315298|155871353|FG013|Overall Study|Withdrawal by Subject|0|||
48459183|NCT04315298|155871354|FG014|Overall Study|Withdrawal by Subject|0|||
48459184|NCT04315298|155871355|FG015|Overall Study|Withdrawal by Subject|0|||
48459185|NCT04315298|155871356|FG016|Overall Study|Withdrawal by Subject|0|||
48459186|NCT04315298|155871357|FG017|Overall Study|Withdrawal by Subject|0|||
48459187|NCT04315298|155871358|FG018|Overall Study|Withdrawal by Subject|0|||
48459188|NCT04315298|155871340|FG000|Overall Study|Physician Decision|0|||
48459189|NCT04315298|155871341|FG001|Overall Study|Physician Decision|0|||
48459190|NCT04315298|155871342|FG002|Overall Study|Physician Decision|0|||
48459191|NCT04315298|155871343|FG003|Overall Study|Physician Decision|0|||
48459192|NCT04315298|155871344|FG004|Overall Study|Physician Decision|1|||
48459193|NCT04315298|155871345|FG005|Overall Study|Physician Decision|0|||
48459194|NCT04315298|155871346|FG006|Overall Study|Physician Decision|0|||
48459195|NCT04315298|155871347|FG007|Overall Study|Physician Decision|0|||
48459196|NCT04315298|155871348|FG008|Overall Study|Physician Decision|0|||
48459197|NCT04315298|155871349|FG009|Overall Study|Physician Decision|0|||
48459198|NCT04315298|155871350|FG010|Overall Study|Physician Decision|0|||
48459199|NCT04315298|155871351|FG011|Overall Study|Physician Decision|0|||
48459200|NCT04315298|155871352|FG012|Overall Study|Physician Decision|0|||
48459201|NCT04315298|155871353|FG013|Overall Study|Physician Decision|0|||
48459202|NCT04315298|155871354|FG014|Overall Study|Physician Decision|0|||
48459203|NCT04315298|155871355|FG015|Overall Study|Physician Decision|0|||
48459204|NCT04315298|155871356|FG016|Overall Study|Physician Decision|0|||
48459205|NCT04315298|155871357|FG017|Overall Study|Physician Decision|0|||
48459206|NCT04315298|155871358|FG018|Overall Study|Physician Decision|0|||
48459207|NCT04315298|155871340|FG000|Overall Study|Lost to Follow-up|5|||
48459208|NCT04315298|155871341|FG001|Overall Study|Lost to Follow-up|10|||
48459209|NCT04315298|155871342|FG002|Overall Study|Lost to Follow-up|6|||
48459210|NCT04315298|155871343|FG003|Overall Study|Lost to Follow-up|8|||
48459211|NCT04315298|155871344|FG004|Overall Study|Lost to Follow-up|12|||
48459212|NCT04315298|155871345|FG005|Overall Study|Lost to Follow-up|13|||
48459213|NCT04315298|155871346|FG006|Overall Study|Lost to Follow-up|9|||
48459214|NCT04315298|155871347|FG007|Overall Study|Lost to Follow-up|16|||
48459215|NCT04315298|155871348|FG008|Overall Study|Lost to Follow-up|14|||
48459216|NCT04315298|155871349|FG009|Overall Study|Lost to Follow-up|0|||
48459217|NCT04315298|155871350|FG010|Overall Study|Lost to Follow-up|2|||
48459218|NCT04315298|155871351|FG011|Overall Study|Lost to Follow-up|1|||
48459219|NCT04315298|155871352|FG012|Overall Study|Lost to Follow-up|0|||
48459220|NCT04315298|155871353|FG013|Overall Study|Lost to Follow-up|0|||
48459221|NCT04315298|155871354|FG014|Overall Study|Lost to Follow-up|0|||
48459222|NCT04315298|155871355|FG015|Overall Study|Lost to Follow-up|2|||
48459223|NCT04315298|155871356|FG016|Overall Study|Lost to Follow-up|0|||
48459224|NCT04315298|155871357|FG017|Overall Study|Lost to Follow-up|0|||
48459225|NCT04315298|155871358|FG018|Overall Study|Lost to Follow-up|0|||
48459226|NCT04315298|155871340|FG000|Overall Study|Death|24|||
48459227|NCT04315298|155871341|FG001|Overall Study|Death|60|||
48459228|NCT04315298|155871342|FG002|Overall Study|Death|49|||
48459229|NCT04315298|155871343|FG003|Overall Study|Death|59|||
48459230|NCT04315298|155871344|FG004|Overall Study|Death|70|||
48459231|NCT04315298|155871345|FG005|Overall Study|Death|114|||
48459232|NCT04315298|155871346|FG006|Overall Study|Death|9|||
48459233|NCT04315298|155871347|FG007|Overall Study|Death|12|||
48459234|NCT04315298|155871348|FG008|Overall Study|Death|21|||
48459235|NCT04315298|155871349|FG009|Overall Study|Death|16|||
48459236|NCT04315298|155871350|FG010|Overall Study|Death|40|||
48459237|NCT04315298|155871351|FG011|Overall Study|Death|40|||
48459238|NCT04315298|155871352|FG012|Overall Study|Death|3|||
48459239|NCT04315298|155871353|FG013|Overall Study|Death|4|||
48459240|NCT04315298|155871354|FG014|Overall Study|Death|6|||
48459241|NCT04315298|155871355|FG015|Overall Study|Death|4|||
48459242|NCT04315298|155871356|FG016|Overall Study|Death|3|||
48459243|NCT04315298|155871357|FG017|Overall Study|Death|1|||
48459244|NCT04315298|155871358|FG018|Overall Study|Death|0|||
48459245|NCT01199198|155871359|FG000|Overall Study|Adverse Event|3|||
48459246|NCT01199198|155871360|FG001|Overall Study|Adverse Event|0|||
48459247|NCT01199198|155871359|FG000|Overall Study|Lost to Follow-up|1|||
48459248|NCT01199198|155871360|FG001|Overall Study|Lost to Follow-up|5|||
48459249|NCT01199198|155871359|FG000|Overall Study|Withdrawal by Subject|1|||
48459250|NCT01199198|155871360|FG001|Overall Study|Withdrawal by Subject|2|||
48459251|NCT01199198|155871359|FG000|Overall Study|ICU Transfer|1|||
48459252|NCT01199198|155871360|FG001|Overall Study|ICU Transfer|2|||
48459253|NCT01199198|155871359|FG000|Overall Study|Hospice-care transfer|1|||
48459254|NCT01199198|155871360|FG001|Overall Study|Hospice-care transfer|2|||
48459255|NCT00088595|155871361|FG000|Overall Study|Adverse Event|11|||
48459256|NCT00088595|155871361|FG000|Overall Study|Withdrawal by Subject|8|||
48459257|NCT00088595|155871361|FG000|Overall Study|Ongoing (After Core)|7|||
48459258|NCT00088595|155871361|FG000|Overall Study|New Cancer Therapy|2|||
48459259|NCT01998906|155871362|FG000|Overall Study|Participants ongoing in follow-up|77|||
48459260|NCT01998906|155871363|FG001|Overall Study|Participants ongoing in follow-up|60|||
48459261|NCT01998906|155871364|FG002|Overall Study|Participants ongoing in follow-up|58|||
48459262|NCT01998906|155871362|FG000|Overall Study|Death|21|||
48459263|NCT01998906|155871363|FG001|Overall Study|Death|30|||
48459264|NCT01998906|155871364|FG002|Overall Study|Death|17|||
48459265|NCT01998906|155871362|FG000|Overall Study|Lack of Efficacy|10|||
48459266|NCT01998906|155871363|FG001|Overall Study|Lack of Efficacy|9|||
48459267|NCT01998906|155871364|FG002|Overall Study|Lack of Efficacy|8|||
48459268|NCT01998906|155871362|FG000|Overall Study|Failure to return|0|||
48459269|NCT01998906|155871363|FG001|Overall Study|Failure to return|2|||
48459270|NCT01998906|155871364|FG002|Overall Study|Failure to return|4|||
48459271|NCT01998906|155871362|FG000|Overall Study|Violation of Selection Criteria|0|||
48459272|NCT01998906|155871363|FG001|Overall Study|Violation of Selection Criteria|0|||
48459273|NCT01998906|155871364|FG002|Overall Study|Violation of Selection Criteria|1|||
48459274|NCT01998906|155871362|FG000|Overall Study|Withdrawal by Subject|1|||
48459275|NCT01998906|155871363|FG001|Overall Study|Withdrawal by Subject|4|||
48459276|NCT01998906|155871364|FG002|Overall Study|Withdrawal by Subject|3|||
48459277|NCT01998906|155871362|FG000|Overall Study|Administrative/Other|2|||
48459278|NCT01998906|155871363|FG001|Overall Study|Administrative/Other|1|||
48459279|NCT01998906|155871364|FG002|Overall Study|Administrative/Other|3|||
48459280|NCT01998906|155871362|FG000|Overall Study|Other|3|||
48459281|NCT01998906|155871363|FG001|Overall Study|Other|8|||
48459282|NCT01998906|155871364|FG002|Overall Study|Other|4|||
48459283|NCT02903966|155871367|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
48459284|NCT02903966|155871368|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
48459285|NCT02903966|155871367|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
48459286|NCT02903966|155871368|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
48459287|NCT02903966|155871367|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
48459288|NCT02903966|155871368|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
48459289|NCT02471586|155871370|FG000|Overall Study|Lost to Follow-up|3|||
48459290|NCT02471586|155871371|FG001|Overall Study|Lost to Follow-up|8|||
48459291|NCT02471586|155871372|FG002|Overall Study|Lost to Follow-up|4|||
48459292|NCT02471586|155871370|FG000|Overall Study|Death|2|||
48459293|NCT02471586|155871371|FG001|Overall Study|Death|2|||
48459294|NCT02471586|155871372|FG002|Overall Study|Death|0|||
48459295|NCT02996110|155871373|FG000|Pre-Treatment|Other Reasons|0|||
48459296|NCT02996110|155871374|FG001|Pre-Treatment|Other Reasons|1|||
48459297|NCT02996110|155871375|FG002|Pre-Treatment|Other Reasons|0|||
48459298|NCT02996110|155871376|FG003|Pre-Treatment|Other Reasons|0|||
48459299|NCT02996110|155871377|FG004|Pre-Treatment|Other Reasons|1|||
48459300|NCT02996110|155871373|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
48459301|NCT02996110|155871374|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
48459302|NCT02996110|155871375|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
48459303|NCT02996110|155871376|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
48459304|NCT02996110|155871377|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
48459305|NCT02996110|155871373|FG000|Track 1|Disease Progression|15|||
48459306|NCT02996110|155871374|FG001|Track 1|Disease Progression|17|||
48459307|NCT02996110|155871375|FG002|Track 1|Disease Progression|0|||
48459308|NCT02996110|155871376|FG003|Track 1|Disease Progression|0|||
48459309|NCT02996110|155871377|FG004|Track 1|Disease Progression|0|||
48459310|NCT02996110|155871373|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
48459311|NCT02996110|155871374|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
48459312|NCT02996110|155871375|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
48459313|NCT02996110|155871376|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
48459314|NCT02996110|155871377|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
48459315|NCT02996110|155871373|FG000|Track 1|Study Drug Toxicity|5|||
48459316|NCT02996110|155871374|FG001|Track 1|Study Drug Toxicity|3|||
48459317|NCT02996110|155871375|FG002|Track 1|Study Drug Toxicity|0|||
48459318|NCT02996110|155871376|FG003|Track 1|Study Drug Toxicity|0|||
48459319|NCT02996110|155871377|FG004|Track 1|Study Drug Toxicity|0|||
48459320|NCT02996110|155871373|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
48459321|NCT02996110|155871374|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
48459322|NCT02996110|155871375|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
48459323|NCT02996110|155871376|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
48459324|NCT02996110|155871377|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
48459325|NCT02996110|155871373|FG000|Track 1|Administrative Reason by Sponsor|0|||
48459326|NCT02996110|155871374|FG001|Track 1|Administrative Reason by Sponsor|1|||
48459327|NCT02996110|155871375|FG002|Track 1|Administrative Reason by Sponsor|0|||
48459328|NCT02996110|155871376|FG003|Track 1|Administrative Reason by Sponsor|0|||
48459329|NCT02996110|155871377|FG004|Track 1|Administrative Reason by Sponsor|0|||
48459330|NCT02996110|155871373|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
48459331|NCT02996110|155871374|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
48459332|NCT02996110|155871375|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
48459333|NCT02996110|155871376|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
48459334|NCT02996110|155871377|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
48459335|NCT02996110|155871373|FG000|Track 2|Disease Progression|33|||
48459336|NCT02996110|155871374|FG001|Track 2|Disease Progression|26|||
48459337|NCT02996110|155871375|FG002|Track 2|Disease Progression|19|||
48459338|NCT02996110|155871376|FG003|Track 2|Disease Progression|16|||
48459339|NCT02996110|155871377|FG004|Track 2|Disease Progression|15|||
48459340|NCT02996110|155871373|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
48459341|NCT02996110|155871374|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
48459342|NCT02996110|155871375|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
48459343|NCT02996110|155871376|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
48459344|NCT02996110|155871377|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
48459345|NCT02996110|155871373|FG000|Track 2|Death|0|||
48459346|NCT02996110|155871374|FG001|Track 2|Death|0|||
48459347|NCT02996110|155871375|FG002|Track 2|Death|1|||
48459348|NCT02996110|155871376|FG003|Track 2|Death|0|||
48459349|NCT02996110|155871377|FG004|Track 2|Death|1|||
48459350|NCT02996110|155871373|FG000|Track 2|Study Drug Toxicity|4|||
48459351|NCT02996110|155871374|FG001|Track 2|Study Drug Toxicity|1|||
48459352|NCT02996110|155871375|FG002|Track 2|Study Drug Toxicity|4|||
48459353|NCT02996110|155871376|FG003|Track 2|Study Drug Toxicity|1|||
48459354|NCT02996110|155871377|FG004|Track 2|Study Drug Toxicity|0|||
48459355|NCT02996110|155871373|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
48459356|NCT02996110|155871374|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
48459357|NCT02996110|155871375|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
48459358|NCT02996110|155871376|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
48459359|NCT02996110|155871377|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
48459360|NCT02996110|155871373|FG000|Track 2|Participant Withdrew Consent|1|||
48459361|NCT02996110|155871374|FG001|Track 2|Participant Withdrew Consent|2|||
48459362|NCT02996110|155871375|FG002|Track 2|Participant Withdrew Consent|3|||
48459363|NCT02996110|155871376|FG003|Track 2|Participant Withdrew Consent|1|||
48459364|NCT02996110|155871377|FG004|Track 2|Participant Withdrew Consent|1|||
48459365|NCT02996110|155871373|FG000|Track 2|Other Reasons|0|||
48459366|NCT02996110|155871374|FG001|Track 2|Other Reasons|0|||
48459367|NCT02996110|155871375|FG002|Track 2|Other Reasons|1|||
48459368|NCT02996110|155871376|FG003|Track 2|Other Reasons|0|||
48459369|NCT02996110|155871377|FG004|Track 2|Other Reasons|1|||
48459370|NCT01320033|155871378|FG000|Overall Study|Lack of Efficacy|0|||
48459371|NCT01320033|155871379|FG001|Overall Study|Lack of Efficacy|0|||
48459372|NCT01320033|155871380|FG002|Overall Study|Lack of Efficacy|1|||
48459373|NCT01320033|155871378|FG000|Overall Study|Adverse Event|9|||
48459374|NCT01320033|155871379|FG001|Overall Study|Adverse Event|7|||
48459375|NCT01320033|155871380|FG002|Overall Study|Adverse Event|8|||
48459376|NCT01320033|155871378|FG000|Overall Study|Withdrawal by Subject|22|||
48459377|NCT01320033|155871379|FG001|Overall Study|Withdrawal by Subject|23|||
48459378|NCT01320033|155871380|FG002|Overall Study|Withdrawal by Subject|23|||
48459379|NCT01320033|155871378|FG000|Overall Study|Protocol Violation|3|||
48459380|NCT01320033|155871379|FG001|Overall Study|Protocol Violation|5|||
48459381|NCT01320033|155871380|FG002|Overall Study|Protocol Violation|3|||
48459382|NCT01320033|155871378|FG000|Overall Study|Lost to Follow-up|22|||
48459383|NCT01320033|155871379|FG001|Overall Study|Lost to Follow-up|26|||
48459384|NCT01320033|155871380|FG002|Overall Study|Lost to Follow-up|17|||
48459385|NCT01320033|155871378|FG000|Overall Study|Other|2|||
48459386|NCT01320033|155871379|FG001|Overall Study|Other|3|||
48459387|NCT01320033|155871380|FG002|Overall Study|Other|1|||
48459388|NCT02094612|155871384|FG000|Overall Study|Lost to Follow-up|47|||
48459389|NCT02094612|155871385|FG001|Overall Study|Lost to Follow-up|47|||
48459390|NCT02094612|155871384|FG000|Overall Study|Never started ADHD medication|32|||
48459391|NCT02094612|155871385|FG001|Overall Study|Never started ADHD medication|23|||
48459392|NCT00378534|155871386|FG000|Overall Study|Participants did not receive transplant|3|||
48459393|NCT00378534|155871387|FG001|Overall Study|Participants did not receive transplant|0|||
48459394|NCT03345849|155871388|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
48459395|NCT03345849|155871389|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
48459396|NCT03345849|155871390|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
48459397|NCT03345849|155871391|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
48459398|NCT03345849|155871388|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
48459399|NCT03345849|155871389|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
48459400|NCT03345849|155871390|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
48459401|NCT03345849|155871391|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
48459402|NCT03345849|155871388|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
48459403|NCT03345849|155871389|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
48459404|NCT03345849|155871390|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
48459405|NCT03345849|155871391|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
48459406|NCT03345849|155871388|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
48459407|NCT03345849|155871389|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
48459408|NCT03345849|155871390|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
48459409|NCT03345849|155871391|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
48459410|NCT03345849|155871388|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
48459411|NCT03345849|155871389|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
48459412|NCT03345849|155871390|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
48459413|NCT03345849|155871391|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
48459414|NCT03345849|155871388|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
48459415|NCT03345849|155871389|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
48459416|NCT03345849|155871390|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
48459417|NCT03345849|155871391|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
48459418|NCT03345849|155871388|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
48459419|NCT03345849|155871389|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
48459420|NCT03345849|155871390|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
48459421|NCT03345849|155871391|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
48459422|NCT03345849|155871388|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
48459423|NCT03345849|155871389|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
48459424|NCT03345849|155871390|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
48459425|NCT03345849|155871391|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
48459426|NCT03345849|155871388|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
48459427|NCT03345849|155871389|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
48459428|NCT03345849|155871390|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
48459429|NCT03345849|155871391|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
48459430|NCT03345849|155871388|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
48459431|NCT03345849|155871389|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
48459432|NCT03345849|155871390|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
48459433|NCT03345849|155871391|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
48459434|NCT03345849|155871388|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
48459435|NCT03345849|155871389|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
48459436|NCT03345849|155871390|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
48459437|NCT03345849|155871391|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
48459438|NCT03261037|155871392|FG000|Overall Study|Withdrawal by Subject|2|||
48459439|NCT03261037|155871393|FG001|Overall Study|Withdrawal by Subject|13|||
48459440|NCT03261037|155871394|FG002|Overall Study|Withdrawal by Subject|0|||
48459441|NCT03261037|155871395|FG003|Overall Study|Withdrawal by Subject|18|||
48459442|NCT03261037|155871392|FG000|Overall Study|Non-compliance with study procedures|0|||
48459443|NCT03261037|155871393|FG001|Overall Study|Non-compliance with study procedures|2|||
48459444|NCT03261037|155871394|FG002|Overall Study|Non-compliance with study procedures|0|||
48459445|NCT03261037|155871395|FG003|Overall Study|Non-compliance with study procedures|6|||
48459446|NCT03261037|155871392|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
48459447|NCT03261037|155871393|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
48459448|NCT03261037|155871394|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
48459449|NCT03261037|155871395|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
48459450|NCT03261037|155871392|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
48459451|NCT03261037|155871393|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
48459452|NCT03261037|155871394|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
48459453|NCT03261037|155871395|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
48459454|NCT03261037|155871392|FG000|Overall Study|Diagnosed but protocol deviation|1|||
48459455|NCT03261037|155871393|FG001|Overall Study|Diagnosed but protocol deviation|0|||
48459456|NCT03261037|155871394|FG002|Overall Study|Diagnosed but protocol deviation|0|||
48459457|NCT03261037|155871395|FG003|Overall Study|Diagnosed but protocol deviation|0|||
48459458|NCT03261037|155871392|FG000|Overall Study|Participant did not want to continue the study|0|||
48459459|NCT03261037|155871393|FG001|Overall Study|Participant did not want to continue the study|1|||
48459460|NCT03261037|155871394|FG002|Overall Study|Participant did not want to continue the study|0|||
48459461|NCT03261037|155871395|FG003|Overall Study|Participant did not want to continue the study|0|||
48459462|NCT03261037|155871392|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
48459463|NCT03261037|155871393|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
48459464|NCT03261037|155871394|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
48459465|NCT03261037|155871395|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
48459466|NCT03261037|155871392|FG000|Overall Study|Participant presented clinical improvement|0|||
48459467|NCT03261037|155871393|FG001|Overall Study|Participant presented clinical improvement|2|||
48459468|NCT03261037|155871394|FG002|Overall Study|Participant presented clinical improvement|0|||
48459469|NCT03261037|155871395|FG003|Overall Study|Participant presented clinical improvement|0|||
48459470|NCT03261037|155871392|FG000|Overall Study|Technical difficulties|0|||
48459471|NCT03261037|155871393|FG001|Overall Study|Technical difficulties|0|||
48459472|NCT03261037|155871394|FG002|Overall Study|Technical difficulties|0|||
48459473|NCT03261037|155871395|FG003|Overall Study|Technical difficulties|1|||
48459474|NCT03261037|155871392|FG000|Overall Study|Equipment failed to work|0|||
48459475|NCT03261037|155871393|FG001|Overall Study|Equipment failed to work|0|||
48459476|NCT03261037|155871394|FG002|Overall Study|Equipment failed to work|0|||
48459477|NCT03261037|155871395|FG003|Overall Study|Equipment failed to work|1|||
48459478|NCT03261037|155871392|FG000|Overall Study|End of study for participant and no follow up|0|||
48459479|NCT03261037|155871393|FG001|Overall Study|End of study for participant and no follow up|0|||
48459480|NCT03261037|155871394|FG002|Overall Study|End of study for participant and no follow up|0|||
48459481|NCT03261037|155871395|FG003|Overall Study|End of study for participant and no follow up|1|||
48459482|NCT03261037|155871392|FG000|Overall Study|Participant was too weak to continue in study|1|||
48459483|NCT03261037|155871393|FG001|Overall Study|Participant was too weak to continue in study|0|||
48459484|NCT03261037|155871394|FG002|Overall Study|Participant was too weak to continue in study|0|||
48459485|NCT03261037|155871395|FG003|Overall Study|Participant was too weak to continue in study|0|||
48459486|NCT02943577|155871396|FG000|Overall Study|Protocol Violation|0|||
48459487|NCT02943577|155871397|FG001|Overall Study|Protocol Violation|1|||
48459488|NCT02943577|155871396|FG000|Overall Study|Adverse Event|3|||
48459489|NCT02943577|155871397|FG001|Overall Study|Adverse Event|2|||
48459490|NCT02943577|155871396|FG000|Overall Study|Lost to Follow-up|0|||
48459491|NCT02943577|155871397|FG001|Overall Study|Lost to Follow-up|1|||
48459492|NCT02943577|155871396|FG000|Overall Study|Withdrawal by Subject|1|||
48459493|NCT02943577|155871397|FG001|Overall Study|Withdrawal by Subject|1|||
48459494|NCT02943577|155871396|FG000|Overall Study|Pregnancy|1|||
48459495|NCT02943577|155871397|FG001|Overall Study|Pregnancy|0|||
48459496|NCT01080625|155871401|FG000|Overall Study|Physician Decision|0|||
48459497|NCT01080625|155871402|FG001|Overall Study|Physician Decision|2|||
48459498|NCT01080625|155871403|FG002|Overall Study|Physician Decision|1|||
48459499|NCT02100813|155871404|FG000|Overall Study|Adverse Event|0|||
48459500|NCT02100813|155871405|FG001|Overall Study|Adverse Event|0|||
48459501|NCT02100813|155871406|FG002|Overall Study|Adverse Event|0|||
48459502|NCT02100813|155871407|FG003|Overall Study|Adverse Event|0|||
48459503|NCT02100813|155871408|FG004|Overall Study|Adverse Event|0|||
48459504|NCT02100813|155871409|FG005|Overall Study|Adverse Event|0|||
48459505|NCT02100813|155871410|FG006|Overall Study|Adverse Event|0|||
48459506|NCT02100813|155871411|FG007|Overall Study|Adverse Event|1|||
48459507|NCT02274311|155871412|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
48459508|NCT01536418|155871413|FG000|Overall Study|Protocol Violation|2|||
48459509|NCT01536418|155871414|FG001|Overall Study|Protocol Violation|3|||
48459510|NCT01536418|155871413|FG000|Overall Study|Physician Decision|1|||
48459511|NCT01536418|155871414|FG001|Overall Study|Physician Decision|3|||
48459512|NCT01536418|155871413|FG000|Overall Study|Study closed/terminated|41|||
48459513|NCT01536418|155871414|FG001|Overall Study|Study closed/terminated|37|||
48459514|NCT01536418|155871413|FG000|Overall Study|Lack of Efficacy|10|||
48459515|NCT01536418|155871414|FG001|Overall Study|Lack of Efficacy|16|||
48459516|NCT01536418|155871413|FG000|Overall Study|Adverse Event|9|||
48459517|NCT01536418|155871414|FG001|Overall Study|Adverse Event|4|||
48459518|NCT01536418|155871413|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
48459519|NCT01536418|155871414|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
48459520|NCT01536418|155871413|FG000|Overall Study|Withdrawal by Subject|5|||
48459521|NCT01536418|155871414|FG001|Overall Study|Withdrawal by Subject|3|||
48459522|NCT00735072|155871420|FG000|Overall Study|interrupted study med during ARV change|1|||
48459523|NCT00735072|155871421|FG001|Overall Study|interrupted study med during ARV change|0|||
48459524|NCT00735072|155871420|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
48459525|NCT00735072|155871421|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
48459526|NCT00911144|155871422|FG000|Overall Study|Withdrawal by Subject|16|||
48459527|NCT00911144|155871423|FG001|Overall Study|Withdrawal by Subject|5|||
48459528|NCT01131130|155871425|FG000|Period 1 - Baseline|Pregnancy|1|||
48459529|NCT01131130|155871425|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
48459530|NCT03598140|155871426|FG000|Overall Study|enrolled but didn't start|1|||
48459531|NCT03598140|155871427|FG001|Overall Study|enrolled but didn't start|0|||
48459532|NCT00939094|155871428|FG000|Overall Study|Adverse Event|9|||
48459533|NCT00939094|155871429|FG001|Overall Study|Adverse Event|0|||
48459534|NCT00939094|155871428|FG000|Overall Study|Withdrawal by Subject|1|||
48459535|NCT00939094|155871429|FG001|Overall Study|Withdrawal by Subject|6|||
48459536|NCT00939094|155871428|FG000|Overall Study|Lost to Follow-up|1|||
48459537|NCT00939094|155871429|FG001|Overall Study|Lost to Follow-up|1|||
48459538|NCT00939094|155871428|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
48459539|NCT00939094|155871429|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
48459540|NCT00939094|155871428|FG000|Overall Study|Severe non-compliance to protocol|0|||
48459541|NCT00939094|155871429|FG001|Overall Study|Severe non-compliance to protocol|1|||
48459542|NCT00939094|155871428|FG000|Overall Study|Study stopped by sponsor|0|||
48459543|NCT00939094|155871429|FG001|Overall Study|Study stopped by sponsor|2|||
48459544|NCT00939094|155871428|FG000|Overall Study|Abnormal ECG findings|1|||
48459545|NCT00939094|155871429|FG001|Overall Study|Abnormal ECG findings|0|||
48459546|NCT03619902|155871431|FG000|Overall Study|Termination of Study by Investigator|1|||
48459547|NCT03619902|155871431|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
48459548|NCT01624974|155871432|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
48459549|NCT01624974|155871433|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
48459550|NCT01624974|155871432|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
48459551|NCT01624974|155871433|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
48459552|NCT01624974|155871432|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
48459553|NCT01624974|155871433|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
48459554|NCT01624974|155871432|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
48459555|NCT01624974|155871433|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
48459556|NCT01624974|155871432|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
48459557|NCT01624974|155871433|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
48459558|NCT01624974|155871432|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
48459559|NCT01624974|155871433|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
48459560|NCT01624974|155871432|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
48459561|NCT01624974|155871433|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
48459562|NCT01624974|155871432|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
48459563|NCT01624974|155871433|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
48459564|NCT01624974|155871432|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
48459565|NCT01624974|155871433|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
48459566|NCT01624974|155871432|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
48459567|NCT01624974|155871433|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
48459568|NCT01624974|155871432|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
48459569|NCT01624974|155871433|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
48459570|NCT01624974|155871432|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
48459571|NCT01624974|155871433|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
48459572|NCT02463331|155871434|FG000|Overall Study|Adverse Event|4|||
48459573|NCT02463331|155871435|FG001|Overall Study|Adverse Event|2|||
48459574|NCT02463331|155871434|FG000|Overall Study|Lost to Follow-up|1|||
48459575|NCT02463331|155871435|FG001|Overall Study|Lost to Follow-up|1|||
48459576|NCT02463331|155871434|FG000|Overall Study|Pregnancy|2|||
48459577|NCT02463331|155871435|FG001|Overall Study|Pregnancy|3|||
48459578|NCT02463331|155871434|FG000|Overall Study|Lack of Efficacy|6|||
48459579|NCT02463331|155871435|FG001|Overall Study|Lack of Efficacy|0|||
48459580|NCT02463331|155871434|FG000|Overall Study|Physician Decision|3|||
48459581|NCT02463331|155871435|FG001|Overall Study|Physician Decision|0|||
48459582|NCT00715949|155871436|FG000|Overall Study|could not finish first test|4|||
48459583|NCT00420212|155871439|FG000|Overall Study|Adverse Event|22|||
48459584|NCT00420212|155871440|FG001|Overall Study|Adverse Event|40|||
48459585|NCT00420212|155871441|FG002|Overall Study|Adverse Event|36|||
48459586|NCT00420212|155871439|FG000|Overall Study|Lost to Follow-up|9|||
48459587|NCT00420212|155871440|FG001|Overall Study|Lost to Follow-up|11|||
48459588|NCT00420212|155871441|FG002|Overall Study|Lost to Follow-up|11|||
48459589|NCT00420212|155871439|FG000|Overall Study|Withdrawal by Subject|31|||
48459590|NCT00420212|155871440|FG001|Overall Study|Withdrawal by Subject|22|||
48459591|NCT00420212|155871441|FG002|Overall Study|Withdrawal by Subject|19|||
48459592|NCT00420212|155871439|FG000|Overall Study|Physician Decision|4|||
48459593|NCT00420212|155871440|FG001|Overall Study|Physician Decision|4|||
48459594|NCT00420212|155871441|FG002|Overall Study|Physician Decision|3|||
48459595|NCT00420212|155871439|FG000|Overall Study|Protocol Violation|4|||
48459596|NCT00420212|155871440|FG001|Overall Study|Protocol Violation|4|||
48459597|NCT00420212|155871441|FG002|Overall Study|Protocol Violation|8|||
48459598|NCT00420212|155871439|FG000|Overall Study|Death|0|||
48459599|NCT00420212|155871440|FG001|Overall Study|Death|0|||
48459600|NCT00420212|155871441|FG002|Overall Study|Death|1|||
48459601|NCT00420212|155871439|FG000|Overall Study|Other-Unspecified|21|||
48459602|NCT00420212|155871440|FG001|Overall Study|Other-Unspecified|14|||
48459603|NCT00420212|155871441|FG002|Overall Study|Other-Unspecified|18|||
48459604|NCT02390362|155871442|FG000|Overall Study|Withdrawal by Subject|0|||
48459605|NCT02390362|155871443|FG001|Overall Study|Withdrawal by Subject|1|||
48459606|NCT00957034|155871444|FG000|Overall Study|Adverse Event|0|||
48459607|NCT00957034|155871445|FG001|Overall Study|Adverse Event|1|||
48459608|NCT00957034|155871446|FG002|Overall Study|Adverse Event|1|||
48459609|NCT00957034|155871444|FG000|Overall Study|Sponsor Terminated Study|6|||
48459610|NCT00957034|155871445|FG001|Overall Study|Sponsor Terminated Study|1|||
48459611|NCT00957034|155871446|FG002|Overall Study|Sponsor Terminated Study|5|||
48459612|NCT00957034|155871444|FG000|Overall Study|Withdrawal by Subject|0|||
48459613|NCT00957034|155871445|FG001|Overall Study|Withdrawal by Subject|2|||
48459614|NCT00957034|155871446|FG002|Overall Study|Withdrawal by Subject|0|||
48460051|NCT00414973|155873218|FG002|Overall Study|Protocol Violation|0|||
48459615|NCT04009824|155871447|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
48459616|NCT04009824|155871448|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
48459617|NCT04009824|155871449|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
48459618|NCT04009824|155871450|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
48459619|NCT04009824|155871451|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
48459620|NCT03147495|155871452|FG000|Overall Study|Physician Decision|0|||
48459621|NCT03147495|155871453|FG001|Overall Study|Physician Decision|6|||
48459622|NCT01024946|155871454|FG000|Overall Study|Screen Failure|3|||
48459623|NCT01024946|155871454|FG000|Overall Study|Withdrawal by Subject|1|||
48459624|NCT01024946|155871454|FG000|Overall Study|Adverse Event|1|||
48459625|NCT01326910|155871455|FG000|Overall Study|Withdrawal by Subject|3|||
48459626|NCT01326910|155871456|FG001|Overall Study|Withdrawal by Subject|2|||
48459627|NCT01326910|155871455|FG000|Overall Study|Protocol Violation|1|||
48459628|NCT01326910|155871456|FG001|Overall Study|Protocol Violation|1|||
48459629|NCT02483611|155871459|FG000|Overall Study|Protocol Violation|0|||
48459630|NCT02483611|155871460|FG001|Overall Study|Protocol Violation|0|||
48459631|NCT02483611|155871461|FG002|Overall Study|Protocol Violation|1|||
48459632|NCT02274766|155871462|FG000|Overall Study|Withdrawal by Subject|3|||
48459633|NCT02274766|155871463|FG001|Overall Study|Withdrawal by Subject|6|||
48459634|NCT02274766|155871462|FG000|Overall Study|Did Not Receive Study Drug|1|||
48459635|NCT02274766|155871463|FG001|Overall Study|Did Not Receive Study Drug|1|||
48459636|NCT02274766|155871462|FG000|Overall Study|Subject Unwilling to Proceed|0|||
48459637|NCT02274766|155871463|FG001|Overall Study|Subject Unwilling to Proceed|1|||
48459638|NCT02274766|155871462|FG000|Overall Study|Adverse Event|0|||
48459639|NCT02274766|155871463|FG001|Overall Study|Adverse Event|1|||
48459640|NCT01222416|155871464|FG000|Overall Study|ineligible;metastasis|3|||
48459641|NCT01222416|155871465|FG001|Overall Study|ineligible;metastasis|0|||
48459642|NCT01222416|155871464|FG000|Overall Study|Adverse Event|4|||
48459643|NCT01222416|155871465|FG001|Overall Study|Adverse Event|0|||
48459644|NCT01222416|155871464|FG000|Overall Study|Withdrawal by Subject|5|||
48459645|NCT01222416|155871465|FG001|Overall Study|Withdrawal by Subject|0|||
48459646|NCT01222416|155871464|FG000|Overall Study|scheduling|6|||
48459647|NCT01222416|155871465|FG001|Overall Study|scheduling|0|||
48459648|NCT01222416|155871464|FG000|Overall Study|missed view/scan|1|||
48459649|NCT01222416|155871465|FG001|Overall Study|missed view/scan|0|||
48459650|NCT01222416|155871464|FG000|Overall Study|Death|1|||
48459651|NCT01222416|155871465|FG001|Overall Study|Death|0|||
48459652|NCT02607735|155871466|FG000|Primary Study|Randomized but Never Treated|1|||
48459653|NCT02607735|155871467|FG001|Primary Study|Randomized but Never Treated|0|||
48459654|NCT02607735|155871468|FG002|Primary Study|Randomized but Never Treated|0|||
48459655|NCT02607735|155871466|FG000|Primary Study|Lost to Follow-up|4|||
48459656|NCT02607735|155871467|FG001|Primary Study|Lost to Follow-up|0|||
48459657|NCT02607735|155871468|FG002|Primary Study|Lost to Follow-up|0|||
48459658|NCT02607735|155871466|FG000|Primary Study|Withdrew Consent|2|||
48459659|NCT02607735|155871467|FG001|Primary Study|Withdrew Consent|0|||
48459660|NCT02607735|155871468|FG002|Primary Study|Withdrew Consent|0|||
48459661|NCT02607735|155871466|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
48459662|NCT02607735|155871467|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
48459663|NCT02607735|155871468|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
48459664|NCT02607735|155871466|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
48459665|NCT02607735|155871467|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
48459666|NCT02607735|155871468|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
48459667|NCT03032523|155871469|FG000|Overall Study|Withdrawal by Subject|2|||
48459668|NCT03032523|155871470|FG001|Overall Study|Withdrawal by Subject|2|||
48459669|NCT03032523|155871469|FG000|Overall Study|Physician Decision|1|||
48459670|NCT03032523|155871470|FG001|Overall Study|Physician Decision|0|||
48459671|NCT04921969|155871471|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48459672|NCT04921969|155871472|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
48459673|NCT04921969|155871473|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
48459674|NCT04921969|155871474|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48459675|NCT04921969|155871475|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48459676|NCT04921969|155871476|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48459677|NCT04921969|155871477|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
48459678|NCT04921969|155871471|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
48459679|NCT04921969|155871472|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48459680|NCT04921969|155871473|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48459681|NCT04921969|155871474|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48459682|NCT04921969|155871475|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48459683|NCT04921969|155871476|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48459684|NCT04921969|155871477|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
48459685|NCT04921969|155871471|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
48459686|NCT04921969|155871472|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
48459687|NCT04921969|155871473|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
48459688|NCT04921969|155871474|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48459689|NCT04921969|155871475|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48459690|NCT04921969|155871476|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48459691|NCT04921969|155871477|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
48459692|NCT04921969|155871471|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48459693|NCT04921969|155871472|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
48459694|NCT04921969|155871473|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
48459695|NCT04921969|155871474|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48459696|NCT04921969|155871475|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48459697|NCT04921969|155871476|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48459698|NCT04921969|155871477|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
48459699|NCT04921969|155871471|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48459700|NCT04921969|155871472|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48459701|NCT04921969|155871473|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
48459702|NCT04921969|155871474|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48459703|NCT04921969|155871475|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48459704|NCT04921969|155871476|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48459705|NCT04921969|155871477|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
48459706|NCT04921969|155871471|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
48459707|NCT04921969|155871472|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
48459708|NCT04921969|155871473|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
48459709|NCT04921969|155871474|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48459710|NCT04921969|155871475|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48459711|NCT04921969|155871476|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48459712|NCT04921969|155871477|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
48459713|NCT04921969|155871471|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
48459714|NCT04921969|155871472|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
48459715|NCT04921969|155871473|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48459716|NCT04921969|155871474|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48459717|NCT04921969|155871475|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48459718|NCT04921969|155871476|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48459719|NCT04921969|155871477|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
48459720|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48459721|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48459722|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48459723|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48459724|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48459725|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
48459726|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
48459727|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48459728|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48459729|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48459730|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
48459731|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
48459732|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
48459733|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
48459734|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48459735|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48459736|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
48459737|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
48459738|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|3|||
48459739|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|13|||
48459740|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
48459741|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48459742|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48459743|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48459744|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
48459745|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48459746|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
48459747|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
48459748|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48459749|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48459750|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
48459751|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
48459752|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
48459753|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
48459754|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|13|||
48459755|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
48459756|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
48459757|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
48459758|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
48459759|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
48459760|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
48459761|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
48459762|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48459763|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48459764|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48459765|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
48459766|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48459767|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48459768|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
48459769|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48459770|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48459771|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48459772|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48459773|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
48459774|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|1|||
48459775|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|2|||
48459776|NCT04921969|155871471|FG000|LTS Period (Weeks 8 to 52)|Ongoing|0|||
48459777|NCT04921969|155871472|FG001|LTS Period (Weeks 8 to 52)|Ongoing|0|||
48459778|NCT04921969|155871473|FG002|LTS Period (Weeks 8 to 52)|Ongoing|0|||
48459779|NCT04921969|155871474|FG003|LTS Period (Weeks 8 to 52)|Ongoing|14|||
48459780|NCT04921969|155871475|FG004|LTS Period (Weeks 8 to 52)|Ongoing|12|||
48459781|NCT04921969|155871476|FG005|LTS Period (Weeks 8 to 52)|Ongoing|55|||
48459782|NCT04921969|155871477|FG006|LTS Period (Weeks 8 to 52)|Ongoing|54|||
48459783|NCT02590406|155871480|FG000|Overall Study|Adverse Event|1|||
48459784|NCT02590406|155871481|FG001|Overall Study|Adverse Event|0|||
48459785|NCT02590406|155871480|FG000|Overall Study|Saturometer malfunction|0|||
48459786|NCT02590406|155871481|FG001|Overall Study|Saturometer malfunction|1|||
48459787|NCT02712008|155873147|FG000|Baseline (Day 1) up to Week 12|Death|3|||
48459788|NCT02712008|155873148|FG001|Baseline (Day 1) up to Week 12|Death|0|||
48459789|NCT02712008|155873149|FG002|Baseline (Day 1) up to Week 12|Death|0|||
48459790|NCT02712008|155873150|FG003|Baseline (Day 1) up to Week 12|Death|0|||
48459791|NCT02712008|155873151|FG004|Baseline (Day 1) up to Week 12|Death|0|||
48459792|NCT02712008|155873152|FG005|Baseline (Day 1) up to Week 12|Death|0|||
48459793|NCT02712008|155873153|FG006|Baseline (Day 1) up to Week 12|Death|0|||
48459794|NCT02712008|155873154|FG007|Baseline (Day 1) up to Week 12|Death|0|||
48459795|NCT02712008|155873147|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48459796|NCT02712008|155873148|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
48459797|NCT02712008|155873149|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
48459798|NCT02712008|155873150|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48459799|NCT02712008|155873151|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48459800|NCT02712008|155873152|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48459801|NCT02712008|155873153|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48459802|NCT02712008|155873154|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
48459803|NCT02712008|155873147|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
48459804|NCT02712008|155873148|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48459805|NCT02712008|155873149|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
48459806|NCT02712008|155873150|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48459807|NCT02712008|155873151|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48459808|NCT02712008|155873152|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48459809|NCT02712008|155873153|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48459810|NCT02712008|155873154|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
48459811|NCT02712008|155873147|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48459812|NCT02712008|155873148|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48459813|NCT02712008|155873149|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
48459814|NCT02712008|155873150|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48459815|NCT02712008|155873151|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48459816|NCT02712008|155873152|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48459817|NCT02712008|155873153|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48459818|NCT02712008|155873154|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
48459819|NCT02712008|155873147|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48459820|NCT02712008|155873148|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
48459821|NCT02712008|155873149|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48459822|NCT02712008|155873150|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48459823|NCT02712008|155873151|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48459824|NCT02712008|155873152|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48459825|NCT02712008|155873153|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48459826|NCT02712008|155873154|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
48459827|NCT02712008|155873147|FG000|From Week 12 up to Week 36|Adverse Event|0|||
48459828|NCT02712008|155873148|FG001|From Week 12 up to Week 36|Adverse Event|0|||
48459829|NCT02712008|155873149|FG002|From Week 12 up to Week 36|Adverse Event|0|||
48459830|NCT02712008|155873150|FG003|From Week 12 up to Week 36|Adverse Event|0|||
48459831|NCT02712008|155873151|FG004|From Week 12 up to Week 36|Adverse Event|1|||
48459832|NCT02712008|155873152|FG005|From Week 12 up to Week 36|Adverse Event|0|||
48459833|NCT02712008|155873153|FG006|From Week 12 up to Week 36|Adverse Event|0|||
48459834|NCT02712008|155873154|FG007|From Week 12 up to Week 36|Adverse Event|2|||
48459835|NCT02712008|155873147|FG000|From Week 12 up to Week 36|Death|1|||
48459836|NCT02712008|155873148|FG001|From Week 12 up to Week 36|Death|0|||
48459837|NCT02712008|155873149|FG002|From Week 12 up to Week 36|Death|0|||
48459838|NCT02712008|155873150|FG003|From Week 12 up to Week 36|Death|0|||
48459839|NCT02712008|155873151|FG004|From Week 12 up to Week 36|Death|0|||
48459840|NCT02712008|155873152|FG005|From Week 12 up to Week 36|Death|0|||
48459841|NCT02712008|155873153|FG006|From Week 12 up to Week 36|Death|1|||
48459842|NCT02712008|155873154|FG007|From Week 12 up to Week 36|Death|0|||
48459843|NCT02712008|155873147|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
48459844|NCT02712008|155873148|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
48459845|NCT02712008|155873149|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
48459846|NCT02712008|155873150|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
48459847|NCT02712008|155873151|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
48459848|NCT02712008|155873152|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
48459849|NCT02712008|155873153|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
48459850|NCT02712008|155873154|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
48459851|NCT02712008|155873147|FG000|From Week 12 up to Week 36|Physician Decision|0|||
48459852|NCT02712008|155873148|FG001|From Week 12 up to Week 36|Physician Decision|0|||
48459853|NCT02712008|155873149|FG002|From Week 12 up to Week 36|Physician Decision|0|||
48459854|NCT02712008|155873150|FG003|From Week 12 up to Week 36|Physician Decision|1|||
48459855|NCT02712008|155873151|FG004|From Week 12 up to Week 36|Physician Decision|1|||
48459856|NCT02712008|155873152|FG005|From Week 12 up to Week 36|Physician Decision|0|||
48459857|NCT02712008|155873153|FG006|From Week 12 up to Week 36|Physician Decision|0|||
48459858|NCT02712008|155873154|FG007|From Week 12 up to Week 36|Physician Decision|0|||
48459859|NCT02712008|155873147|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48459860|NCT02712008|155873148|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48459861|NCT02712008|155873149|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48459862|NCT02712008|155873150|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48459863|NCT02712008|155873151|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48459864|NCT02712008|155873152|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
48459865|NCT02712008|155873153|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
48459866|NCT02712008|155873154|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
48459867|NCT01685060|155873156|FG000|Overall Study|Rollover patients|16|||
48459868|NCT01685060|155873156|FG000|Overall Study|Adverse Event|12|||
48459869|NCT01685060|155873156|FG000|Overall Study|Progressive disease|69|||
48459870|NCT01685060|155873156|FG000|Overall Study|Physician Decision|14|||
48459871|NCT01685060|155873156|FG000|Overall Study|Subject/guardian decision|20|||
48459872|NCT01685060|155873156|FG000|Overall Study|Lost to Follow-up|1|||
48459873|NCT01685060|155873156|FG000|Overall Study|Death|8|||
48459874|NCT02531633|155873159|FG000|Part A (52 Weeks)|Sponsor request|24|||
48459875|NCT02531633|155873160|FG001|Part A (52 Weeks)|Sponsor request|24|||
48459876|NCT02531633|155873161|FG002|Part A (52 Weeks)|Sponsor request|18|||
48459877|NCT02531633|155873162|FG003|Part A (52 Weeks)|Sponsor request|18|||
48459878|NCT02531633|155873163|FG004|Part A (52 Weeks)|Sponsor request|19|||
48459879|NCT02531633|155873164|FG005|Part A (52 Weeks)|Sponsor request|0|||
48459880|NCT02531633|155873165|FG006|Part A (52 Weeks)|Sponsor request|0|||
48459881|NCT02531633|155873166|FG007|Part A (52 Weeks)|Sponsor request|0|||
48459882|NCT02531633|155873167|FG008|Part A (52 Weeks)|Sponsor request|0|||
48459883|NCT02531633|155873168|FG009|Part A (52 Weeks)|Sponsor request|0|||
48459884|NCT02531633|155873159|FG000|Part A (52 Weeks)|Protocol Violation|1|||
48459885|NCT02531633|155873160|FG001|Part A (52 Weeks)|Protocol Violation|0|||
48459886|NCT02531633|155873161|FG002|Part A (52 Weeks)|Protocol Violation|0|||
48459887|NCT02531633|155873162|FG003|Part A (52 Weeks)|Protocol Violation|0|||
48459888|NCT02531633|155873163|FG004|Part A (52 Weeks)|Protocol Violation|0|||
48459889|NCT02531633|155873164|FG005|Part A (52 Weeks)|Protocol Violation|0|||
48459890|NCT02531633|155873165|FG006|Part A (52 Weeks)|Protocol Violation|0|||
48459891|NCT02531633|155873166|FG007|Part A (52 Weeks)|Protocol Violation|0|||
48459892|NCT02531633|155873167|FG008|Part A (52 Weeks)|Protocol Violation|0|||
48459893|NCT02531633|155873168|FG009|Part A (52 Weeks)|Protocol Violation|0|||
48459894|NCT02531633|155873159|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
48459895|NCT02531633|155873160|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
48459896|NCT02531633|155873161|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
48459897|NCT02531633|155873162|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
48459898|NCT02531633|155873163|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
48459899|NCT02531633|155873164|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
48459900|NCT02531633|155873165|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
48459901|NCT02531633|155873166|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
48459902|NCT02531633|155873167|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
48459903|NCT02531633|155873168|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
48459904|NCT02531633|155873159|FG000|Part A (52 Weeks)|Physician Decision|1|||
48459905|NCT02531633|155873160|FG001|Part A (52 Weeks)|Physician Decision|4|||
48459906|NCT02531633|155873161|FG002|Part A (52 Weeks)|Physician Decision|3|||
48459907|NCT02531633|155873162|FG003|Part A (52 Weeks)|Physician Decision|1|||
48459908|NCT02531633|155873163|FG004|Part A (52 Weeks)|Physician Decision|0|||
48459909|NCT02531633|155873164|FG005|Part A (52 Weeks)|Physician Decision|0|||
48459910|NCT02531633|155873165|FG006|Part A (52 Weeks)|Physician Decision|0|||
48459911|NCT02531633|155873166|FG007|Part A (52 Weeks)|Physician Decision|0|||
48459912|NCT02531633|155873167|FG008|Part A (52 Weeks)|Physician Decision|0|||
48459913|NCT02531633|155873168|FG009|Part A (52 Weeks)|Physician Decision|0|||
48459914|NCT02531633|155873159|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
48459915|NCT02531633|155873160|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
48459916|NCT02531633|155873161|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
48459917|NCT02531633|155873162|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
48459918|NCT02531633|155873163|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
48459919|NCT02531633|155873164|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
48459920|NCT02531633|155873165|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
48459921|NCT02531633|155873166|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
48459922|NCT02531633|155873167|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
48459923|NCT02531633|155873168|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
48459924|NCT02531633|155873159|FG000|Part A (52 Weeks)|Other|2|||
48459925|NCT02531633|155873160|FG001|Part A (52 Weeks)|Other|0|||
48459926|NCT02531633|155873161|FG002|Part A (52 Weeks)|Other|0|||
48459927|NCT02531633|155873162|FG003|Part A (52 Weeks)|Other|0|||
48459928|NCT02531633|155873163|FG004|Part A (52 Weeks)|Other|0|||
48459929|NCT02531633|155873164|FG005|Part A (52 Weeks)|Other|0|||
48459930|NCT02531633|155873165|FG006|Part A (52 Weeks)|Other|0|||
48459931|NCT02531633|155873166|FG007|Part A (52 Weeks)|Other|0|||
48459932|NCT02531633|155873167|FG008|Part A (52 Weeks)|Other|0|||
48459933|NCT02531633|155873168|FG009|Part A (52 Weeks)|Other|0|||
48459934|NCT02531633|155873159|FG000|Part B (104 Weeks)|Sponsor request|0|||
48459935|NCT02531633|155873160|FG001|Part B (104 Weeks)|Sponsor request|0|||
48459936|NCT02531633|155873161|FG002|Part B (104 Weeks)|Sponsor request|0|||
48459937|NCT02531633|155873162|FG003|Part B (104 Weeks)|Sponsor request|0|||
48459938|NCT02531633|155873163|FG004|Part B (104 Weeks)|Sponsor request|0|||
48459939|NCT02531633|155873164|FG005|Part B (104 Weeks)|Sponsor request|8|||
48459940|NCT02531633|155873165|FG006|Part B (104 Weeks)|Sponsor request|5|||
48459941|NCT02531633|155873166|FG007|Part B (104 Weeks)|Sponsor request|3|||
48459942|NCT02531633|155873167|FG008|Part B (104 Weeks)|Sponsor request|5|||
48459943|NCT02531633|155873168|FG009|Part B (104 Weeks)|Sponsor request|4|||
48459944|NCT02531633|155873159|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
48459945|NCT02531633|155873160|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
48459946|NCT02531633|155873161|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
48459947|NCT02531633|155873162|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
48459948|NCT02531633|155873163|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
48459949|NCT02531633|155873164|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
48459950|NCT02531633|155873165|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
48459951|NCT02531633|155873166|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
48459952|NCT02531633|155873167|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
48459953|NCT02531633|155873168|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
48459954|NCT00364611|155873169|FG000|Overall Study|Did not receive study medication|0|||
48459955|NCT00364611|155873170|FG001|Overall Study|Did not receive study medication|1|||
48459956|NCT00364611|155873169|FG000|Overall Study|Adverse Event|7|||
48459957|NCT00364611|155873170|FG001|Overall Study|Adverse Event|4|||
48459958|NCT00364611|155873169|FG000|Overall Study|Participant's Request|3|||
48459959|NCT00364611|155873170|FG001|Overall Study|Participant's Request|4|||
48459960|NCT00364611|155873169|FG000|Overall Study|Disease Progression|38|||
48459961|NCT00364611|155873170|FG001|Overall Study|Disease Progression|8|||
48459962|NCT00364611|155873169|FG000|Overall Study|Investigator decision|2|||
48459963|NCT00364611|155873170|FG001|Overall Study|Investigator decision|2|||
48459964|NCT00364611|155873169|FG000|Overall Study|Found Ineligible|1|||
48459965|NCT00364611|155873170|FG001|Overall Study|Found Ineligible|0|||
48459966|NCT00364611|155873169|FG000|Overall Study|Presumed CR on Study|0|||
48459967|NCT00364611|155873170|FG001|Overall Study|Presumed CR on Study|1|||
48459968|NCT00364611|155873169|FG000|Overall Study|Receiving Liver Ablation|0|||
48459969|NCT00364611|155873170|FG001|Overall Study|Receiving Liver Ablation|1|||
48459970|NCT03661983|155873171|FG000|Open Label Stabilization Phase|Adverse Event|5|||
48459971|NCT03661983|155873172|FG001|Open Label Stabilization Phase|Adverse Event|0|||
48459972|NCT03661983|155873173|FG002|Open Label Stabilization Phase|Adverse Event|0|||
48459973|NCT03661983|155873174|FG003|Open Label Stabilization Phase|Adverse Event|0|||
48459974|NCT03661983|155873171|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
48459975|NCT03661983|155873172|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
48459976|NCT03661983|155873173|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
48459977|NCT03661983|155873174|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
48459978|NCT03661983|155873171|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
48459979|NCT03661983|155873172|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
48459980|NCT03661983|155873173|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
48459981|NCT03661983|155873174|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
48459982|NCT03661983|155873171|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
48459983|NCT03661983|155873172|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
48459984|NCT03661983|155873173|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
48459985|NCT03661983|155873174|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
48459986|NCT03661983|155873171|FG000|Double-blind Randomized Phase|Adverse Event|0|||
48459987|NCT03661983|155873172|FG001|Double-blind Randomized Phase|Adverse Event|1|||
48459988|NCT03661983|155873173|FG002|Double-blind Randomized Phase|Adverse Event|0|||
48459989|NCT03661983|155873174|FG003|Double-blind Randomized Phase|Adverse Event|0|||
48459990|NCT03661983|155873171|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
48459991|NCT03661983|155873172|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
48459992|NCT03661983|155873173|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
48459993|NCT03661983|155873174|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
48459994|NCT03661983|155873171|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
48459995|NCT03661983|155873172|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
48459996|NCT03661983|155873173|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
48459997|NCT03661983|155873174|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
48459998|NCT03661983|155873171|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
48459999|NCT03661983|155873172|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
48460000|NCT03661983|155873173|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
48460001|NCT03661983|155873174|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
48460002|NCT02828644|155873178|FG000|Overall Study|Lost to Follow-up|23|||
48460003|NCT02828644|155873179|FG001|Overall Study|Lost to Follow-up|22|||
48460004|NCT02045979|155873180|FG000|Overall Study|Informed Consent Withdrawn|2|||
48460005|NCT02045979|155873181|FG001|Overall Study|Informed Consent Withdrawn|0|||
48460006|NCT02045979|155873182|FG002|Overall Study|Informed Consent Withdrawn|1|||
48460007|NCT02045979|155873180|FG000|Overall Study|not specified above|0|||
48460008|NCT02045979|155873181|FG001|Overall Study|not specified above|1|||
48460009|NCT02045979|155873182|FG002|Overall Study|not specified above|0|||
48460010|NCT01938391|155873190|FG000|6 Month Follow up|Withdrawal by Subject|1|||
48460011|NCT01938391|155873190|FG000|12 Month Follow up|Physician Decision|1|||
48460012|NCT01938391|155873190|FG000|12 Month Follow up|Withdrawal by Subject|1|||
48460013|NCT04249076|155873194|FG000|Overall Study|Adverse Event|1|||
48460014|NCT04249076|155873195|FG001|Overall Study|Adverse Event|1|||
48460015|NCT04249076|155873194|FG000|Overall Study|Protocol Violation|1|||
48460016|NCT04249076|155873195|FG001|Overall Study|Protocol Violation|2|||
48460017|NCT04249076|155873194|FG000|Overall Study|Lack of Efficacy|0|||
48460018|NCT04249076|155873195|FG001|Overall Study|Lack of Efficacy|1|||
48460019|NCT04249076|155873194|FG000|Overall Study|Withdrawal by Subject|0|||
48460020|NCT04249076|155873195|FG001|Overall Study|Withdrawal by Subject|1|||
48460021|NCT00290355|155873202|FG000|Overall Study|Serious adverse event|7|||
48460022|NCT00290355|155873203|FG001|Overall Study|Serious adverse event|4|||
48460023|NCT00290355|155873202|FG000|Overall Study|Study product reactogenicity|1|||
48460024|NCT00290355|155873203|FG001|Overall Study|Study product reactogenicity|0|||
48460025|NCT00290355|155873202|FG000|Overall Study|Protocol Violation|1|||
48460026|NCT00290355|155873203|FG001|Overall Study|Protocol Violation|0|||
48460027|NCT00290355|155873202|FG000|Overall Study|Withdrawal by Subject|2|||
48460028|NCT00290355|155873203|FG001|Overall Study|Withdrawal by Subject|0|||
48460029|NCT00290355|155873202|FG000|Overall Study|Migrated / moved from the study area|1|||
48460030|NCT00290355|155873203|FG001|Overall Study|Migrated / moved from the study area|0|||
48460031|NCT00290355|155873202|FG000|Overall Study|Lost to Follow-up|3|||
48460032|NCT00290355|155873203|FG001|Overall Study|Lost to Follow-up|1|||
48460033|NCT00290355|155873202|FG000|Overall Study|Other|2|||
48460034|NCT00290355|155873203|FG001|Overall Study|Other|0|||
48460035|NCT02289833|155873210|FG000|Overall Study|Study discontinuation|0|||
48460036|NCT02289833|155873211|FG001|Overall Study|Study discontinuation|1|||
48460037|NCT02289833|155873210|FG000|Overall Study|Lost to Follow-up|4|||
48460038|NCT02289833|155873211|FG001|Overall Study|Lost to Follow-up|0|||
48460039|NCT02289833|155873210|FG000|Overall Study|Death|23|||
48460040|NCT02289833|155873211|FG001|Overall Study|Death|16|||
48460041|NCT00414973|155873216|FG000|Overall Study|Withdrawal by Subject|14|||
48460042|NCT00414973|155873217|FG001|Overall Study|Withdrawal by Subject|4|||
48460043|NCT00414973|155873218|FG002|Overall Study|Withdrawal by Subject|1|||
48460044|NCT00414973|155873219|FG003|Overall Study|Withdrawal by Subject|0|||
48460045|NCT00414973|155873216|FG000|Overall Study|Adverse Event|10|||
48460046|NCT00414973|155873217|FG001|Overall Study|Adverse Event|0|||
48460047|NCT00414973|155873218|FG002|Overall Study|Adverse Event|1|||
48460048|NCT00414973|155873219|FG003|Overall Study|Adverse Event|0|||
48460049|NCT00414973|155873216|FG000|Overall Study|Protocol Violation|3|||
48460050|NCT00414973|155873217|FG001|Overall Study|Protocol Violation|4|||
48460052|NCT00414973|155873219|FG003|Overall Study|Protocol Violation|0|||
48460053|NCT00414973|155873216|FG000|Overall Study|Lost to Follow-up|0|||
48460054|NCT00414973|155873217|FG001|Overall Study|Lost to Follow-up|2|||
48460055|NCT00414973|155873218|FG002|Overall Study|Lost to Follow-up|0|||
48460056|NCT00414973|155873219|FG003|Overall Study|Lost to Follow-up|0|||
48460057|NCT00414973|155873216|FG000|Overall Study|Sponsor Decision|1|||
48460058|NCT00414973|155873217|FG001|Overall Study|Sponsor Decision|0|||
48460059|NCT00414973|155873218|FG002|Overall Study|Sponsor Decision|0|||
48460060|NCT00414973|155873219|FG003|Overall Study|Sponsor Decision|0|||
48460061|NCT00414973|155873216|FG000|Overall Study|Death|0|||
48460062|NCT00414973|155873217|FG001|Overall Study|Death|0|||
48460063|NCT00414973|155873218|FG002|Overall Study|Death|1|||
48460064|NCT00414973|155873219|FG003|Overall Study|Death|0|||
48460065|NCT00170846|155873220|FG000|Overall Study|Subject withdrew Informed Consent|5|||
48460066|NCT00170846|155873221|FG001|Overall Study|Subject withdrew Informed Consent|12|||
48460067|NCT00170846|155873222|FG002|Overall Study|Subject withdrew Informed Consent|8|||
48460068|NCT00170846|155873220|FG000|Overall Study|Lost to Follow-up|6|||
48460069|NCT00170846|155873221|FG001|Overall Study|Lost to Follow-up|3|||
48460070|NCT00170846|155873222|FG002|Overall Study|Lost to Follow-up|2|||
48460071|NCT00170846|155873220|FG000|Overall Study|Death|0|||
48460072|NCT00170846|155873221|FG001|Overall Study|Death|3|||
48460073|NCT00170846|155873222|FG002|Overall Study|Death|3|||
48460074|NCT00170846|155873220|FG000|Overall Study|Reason Missing|0|||
48460075|NCT00170846|155873221|FG001|Overall Study|Reason Missing|1|||
48460076|NCT00170846|155873222|FG002|Overall Study|Reason Missing|0|||
48460077|NCT02516306|155873223|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
48460078|NCT02516306|155873224|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
48460079|NCT00528840|155873231|FG000|Overall Study|Lost to Follow-up|10|||
48460080|NCT00528840|155873231|FG000|Overall Study|Adverse Event|1|||
48460081|NCT00528840|155873231|FG000|Overall Study|Withdrawal by Subject|17|||
48460082|NCT00528840|155873231|FG000|Overall Study|Death|2|||
48460083|NCT00528840|155873231|FG000|Overall Study|Administrative Reasons|1|||
48460084|NCT00528840|155873231|FG000|Overall Study|Other|2|||
48460085|NCT01657253|155873232|FG000|Overall Study|Lost to Follow-up|6|||
48460086|NCT01657253|155873233|FG001|Overall Study|Lost to Follow-up|5|||
48460087|NCT01657253|155873232|FG000|Overall Study|Withdrawal by Subject|11|||
48460088|NCT01657253|155873233|FG001|Overall Study|Withdrawal by Subject|12|||
48460089|NCT01657253|155873232|FG000|Overall Study|Adverse Event|0|||
48460090|NCT01657253|155873233|FG001|Overall Study|Adverse Event|1|||
48460091|NCT01970540|155873241|FG000|Overall Study|Non-treatment-related AE|0|||
48460092|NCT01970540|155873242|FG001|Overall Study|Non-treatment-related AE|0|||
48460093|NCT01970540|155873243|FG002|Overall Study|Non-treatment-related AE|1|||
48460094|NCT01970540|155873241|FG000|Overall Study|Progressive disease|55|||
48460095|NCT01970540|155873242|FG001|Overall Study|Progressive disease|23|||
48460096|NCT01970540|155873243|FG002|Overall Study|Progressive disease|10|||
48460097|NCT01970540|155873241|FG000|Overall Study|Treatment delay over protocol|0|||
48460098|NCT01970540|155873242|FG001|Overall Study|Treatment delay over protocol|0|||
48460099|NCT01970540|155873243|FG002|Overall Study|Treatment delay over protocol|1|||
48460100|NCT01970540|155873241|FG000|Overall Study|Physician Decision|7|||
48460101|NCT01970540|155873242|FG001|Overall Study|Physician Decision|2|||
48460102|NCT01970540|155873243|FG002|Overall Study|Physician Decision|0|||
48460103|NCT01970540|155873241|FG000|Overall Study|Clinical progression|0|||
48460104|NCT01970540|155873242|FG001|Overall Study|Clinical progression|1|||
48460105|NCT01970540|155873243|FG002|Overall Study|Clinical progression|1|||
48460106|NCT01970540|155873241|FG000|Overall Study|End of study|2|||
48460107|NCT01970540|155873242|FG001|Overall Study|End of study|0|||
48460108|NCT01970540|155873243|FG002|Overall Study|End of study|2|||
48460109|NCT01970540|155873241|FG000|Overall Study|Adverse Event|0|||
48460110|NCT01970540|155873242|FG001|Overall Study|Adverse Event|2|||
48460111|NCT01970540|155873243|FG002|Overall Study|Adverse Event|1|||
48460112|NCT01970540|155873241|FG000|Overall Study|Treatment-related AE|4|||
48460113|NCT01970540|155873242|FG001|Overall Study|Treatment-related AE|0|||
48460114|NCT01970540|155873243|FG002|Overall Study|Treatment-related AE|2|||
48460115|NCT01970540|155873241|FG000|Overall Study|Withdrawal by Subject|4|||
48460116|NCT01970540|155873242|FG001|Overall Study|Withdrawal by Subject|0|||
48460117|NCT01970540|155873243|FG002|Overall Study|Withdrawal by Subject|1|||
48460118|NCT01970540|155873241|FG000|Overall Study|Clinical deterioration|1|||
48460119|NCT01970540|155873242|FG001|Overall Study|Clinical deterioration|0|||
48460120|NCT01970540|155873243|FG002|Overall Study|Clinical deterioration|0|||
48460121|NCT03323086|155873244|FG000|Overall Study|Lost to Follow-up|3|||
48460122|NCT03323086|155873245|FG001|Overall Study|Lost to Follow-up|2|||
48460123|NCT02382276|155873255|FG000|Overall Study|Withdrawal by Subject|4|||
48460124|NCT02382276|155873256|FG001|Overall Study|Withdrawal by Subject|8|||
48460125|NCT02382276|155873257|FG002|Overall Study|Withdrawal by Subject|5|||
48460126|NCT02382276|155873255|FG000|Overall Study|Adverse Event|7|||
48460127|NCT02382276|155873256|FG001|Overall Study|Adverse Event|2|||
48460128|NCT02382276|155873257|FG002|Overall Study|Adverse Event|32|||
48460129|NCT02382276|155873255|FG000|Overall Study|Physician Decision|0|||
48460130|NCT02382276|155873256|FG001|Overall Study|Physician Decision|0|||
48460131|NCT02382276|155873257|FG002|Overall Study|Physician Decision|2|||
48460132|NCT01142791|155873258|FG000|Overall Study|Alternative Treatment|1|||
48460133|NCT01142791|155873259|FG001|Overall Study|Alternative Treatment|0|||
48460134|NCT01142791|155873258|FG000|Overall Study|Lost to Follow-up|1|||
48460135|NCT01142791|155873259|FG001|Overall Study|Lost to Follow-up|0|||
48460136|NCT01142791|155873258|FG000|Overall Study|Withdrawal by Subject|5|||
48460137|NCT01142791|155873259|FG001|Overall Study|Withdrawal by Subject|0|||
48460138|NCT01142791|155873258|FG000|Overall Study|Received only 1 sonication|0|||
48460139|NCT01142791|155873259|FG001|Overall Study|Received only 1 sonication|6|||
48460140|NCT02608892|155873260|FG000|Overall Study|Lost to Follow-up|1|||
48460141|NCT02608892|155873261|FG001|Overall Study|Lost to Follow-up|0|||
48460142|NCT01646255|155873266|FG000|Overall Study|Adverse Event|7|||
48460143|NCT01646255|155873267|FG001|Overall Study|Adverse Event|8|||
48460144|NCT01646255|155873266|FG000|Overall Study|Lack of Efficacy|2|||
48460145|NCT01646255|155873267|FG001|Overall Study|Lack of Efficacy|0|||
48460146|NCT01646255|155873266|FG000|Overall Study|Withdrawal by Subject|10|||
48460147|NCT01646255|155873267|FG001|Overall Study|Withdrawal by Subject|6|||
48460148|NCT01646255|155873266|FG000|Overall Study|Compliance is not well|1|||
48460149|NCT01646255|155873267|FG001|Overall Study|Compliance is not well|0|||
48460150|NCT01646255|155873266|FG000|Overall Study|Inclusion Criteria Deviation|1|||
48460151|NCT01646255|155873267|FG001|Overall Study|Inclusion Criteria Deviation|0|||
48460152|NCT05375838|155873272|FG000|Overall Study|Other|0|||
48460153|NCT05375838|155873273|FG001|Overall Study|Other|0|||
48460154|NCT05375838|155873274|FG002|Overall Study|Other|0|||
48460155|NCT05375838|155873275|FG003|Overall Study|Other|1|||
48460156|NCT05375838|155873276|FG004|Overall Study|Other|1|||
48460157|NCT05375838|155873277|FG005|Overall Study|Other|0|||
48460158|NCT05375838|155873272|FG000|Overall Study|Withdrawal by Subject|2|||
48460159|NCT05375838|155873273|FG001|Overall Study|Withdrawal by Subject|1|||
48460160|NCT05375838|155873274|FG002|Overall Study|Withdrawal by Subject|3|||
48460161|NCT05375838|155873275|FG003|Overall Study|Withdrawal by Subject|2|||
48460162|NCT05375838|155873276|FG004|Overall Study|Withdrawal by Subject|2|||
48460163|NCT05375838|155873277|FG005|Overall Study|Withdrawal by Subject|0|||
48460164|NCT05375838|155873272|FG000|Overall Study|Protocol Violation|0|||
48460165|NCT05375838|155873273|FG001|Overall Study|Protocol Violation|0|||
48460166|NCT05375838|155873274|FG002|Overall Study|Protocol Violation|0|||
48460167|NCT05375838|155873275|FG003|Overall Study|Protocol Violation|0|||
48460168|NCT05375838|155873276|FG004|Overall Study|Protocol Violation|1|||
48460169|NCT05375838|155873277|FG005|Overall Study|Protocol Violation|0|||
48460170|NCT05375838|155873272|FG000|Overall Study|Physician Decision|0|||
48460171|NCT05375838|155873273|FG001|Overall Study|Physician Decision|1|||
48460172|NCT05375838|155873274|FG002|Overall Study|Physician Decision|0|||
48460173|NCT05375838|155873275|FG003|Overall Study|Physician Decision|0|||
48460174|NCT05375838|155873276|FG004|Overall Study|Physician Decision|0|||
48460175|NCT05375838|155873277|FG005|Overall Study|Physician Decision|1|||
48460176|NCT05375838|155873272|FG000|Overall Study|Lost to Follow-up|2|||
48460177|NCT05375838|155873273|FG001|Overall Study|Lost to Follow-up|7|||
48460178|NCT05375838|155873274|FG002|Overall Study|Lost to Follow-up|0|||
48460179|NCT05375838|155873275|FG003|Overall Study|Lost to Follow-up|4|||
48460180|NCT05375838|155873276|FG004|Overall Study|Lost to Follow-up|2|||
48460181|NCT05375838|155873277|FG005|Overall Study|Lost to Follow-up|3|||
48460182|NCT00957723|155873278|FG000|Overall Study|Death|3|||
48460183|NCT00957723|155873278|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
48460184|NCT00957723|155873278|FG000|Overall Study|Lost to Follow-up|8|||
48460185|NCT00957723|155873278|FG000|Overall Study|Withdrawal by Subject|24|||
48460186|NCT00957723|155873278|FG000|Overall Study|Investigative Site Terminated|61|||
48460187|NCT00957723|155873278|FG000|Overall Study|Intercurrent Illness|2|||
48460188|NCT00957723|155873278|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
48460189|NCT00286156|155873281|FG000|Overall Study|Missed 12 month visit|0|||
48460190|NCT00286156|155873282|FG001|Overall Study|Missed 12 month visit|0|||
48460191|NCT00286156|155873283|FG002|Overall Study|Missed 12 month visit|1|||
48460192|NCT00286156|155873281|FG000|Overall Study|AE: pulmonary embolus|0|||
48460193|NCT00286156|155873282|FG001|Overall Study|AE: pulmonary embolus|1|||
48460194|NCT00286156|155873283|FG002|Overall Study|AE: pulmonary embolus|0|||
48460195|NCT00286156|155873281|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
48460196|NCT00286156|155873282|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
48460197|NCT00286156|155873283|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
48460198|NCT00286156|155873281|FG000|Overall Study|AE: pneumonia|1|||
48460199|NCT00286156|155873282|FG001|Overall Study|AE: pneumonia|0|||
48460200|NCT00286156|155873283|FG002|Overall Study|AE: pneumonia|0|||
48460201|NCT05049122|155875711|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
48460202|NCT05049122|155875711|FG000|Overall Study|Participant moved|1|||
48460203|NCT05049122|155875711|FG000|Overall Study|At the direction of the doctor|1|||
48460204|NCT00443534|155875712|FG000|Overall Study|Lack of Efficacy|67|||
48460205|NCT00443534|155875712|FG000|Overall Study|Adverse Event|16|||
48460206|NCT00443534|155875712|FG000|Overall Study|Death|9|||
48460207|NCT00443534|155875712|FG000|Overall Study|Withdrawal by Subject|8|||
48460208|NCT00443534|155875712|FG000|Overall Study|Study Terminated by Sponsor|12|||
48460209|NCT00443534|155875712|FG000|Overall Study|Other|10|||
48460210|NCT00443534|155875712|FG000|Overall Study|Enrolled, Not Treated|1|||
48460211|NCT00846027|155875717|FG000|Overall Study|Death|3|||
48460212|NCT00846027|155875717|FG000|Overall Study|Disease Progression|30|||
48460213|NCT00846027|155875717|FG000|Overall Study|Toxicity|12|||
48460214|NCT00846027|155875717|FG000|Overall Study|Patient Decision|7|||
48460215|NCT00846027|155875717|FG000|Overall Study|Investigator Discretion|29|||
48460216|NCT00846027|155875717|FG000|Overall Study|Protocol Violation|2|||
48460217|NCT00846027|155875717|FG000|Overall Study|Subject Not Treated|7|||
48460218|NCT01081951|155875720|FG000|Overall Study|Death|54|||
48460219|NCT01081951|155875721|FG001|Overall Study|Death|47|||
48460220|NCT01081951|155875720|FG000|Overall Study|Withdrawal by Subject|2|||
48460221|NCT01081951|155875721|FG001|Overall Study|Withdrawal by Subject|6|||
48460222|NCT01081951|155875720|FG000|Overall Study|Allocated treatment but did not take it|0|||
48460223|NCT01081951|155875721|FG001|Overall Study|Allocated treatment but did not take it|1|||
48460224|NCT01081951|155875720|FG000|Overall Study|Lost to Follow-up|0|||
48460225|NCT01081951|155875721|FG001|Overall Study|Lost to Follow-up|1|||
48460226|NCT01944462|155875726|FG000|PPPP Educational Program|Lost to Follow-up|60|||
48460227|NCT04785144|155875727|FG000|Overall Study|Withdrawal by Subject|4|||
48460228|NCT04785144|155875728|FG001|Overall Study|Withdrawal by Subject|1|||
48460229|NCT04785144|155875729|FG002|Overall Study|Withdrawal by Subject|0|||
48460230|NCT04785144|155875730|FG003|Overall Study|Withdrawal by Subject|0|||
48460231|NCT04785144|155875731|FG004|Overall Study|Withdrawal by Subject|0|||
48460232|NCT04785144|155875732|FG005|Overall Study|Withdrawal by Subject|2|||
48460233|NCT04785144|155875733|FG006|Overall Study|Withdrawal by Subject|2|||
48460234|NCT04785144|155875734|FG007|Overall Study|Withdrawal by Subject|0|||
48460235|NCT04785144|155875735|FG008|Overall Study|Withdrawal by Subject|1|||
48460236|NCT04785144|155875736|FG009|Overall Study|Withdrawal by Subject|0|||
48460237|NCT04785144|155875727|FG000|Overall Study|Lost to Follow-up|1|||
48460238|NCT04785144|155875728|FG001|Overall Study|Lost to Follow-up|0|||
48460239|NCT04785144|155875729|FG002|Overall Study|Lost to Follow-up|0|||
48460240|NCT04785144|155875730|FG003|Overall Study|Lost to Follow-up|0|||
48460241|NCT04785144|155875731|FG004|Overall Study|Lost to Follow-up|1|||
48460242|NCT04785144|155875732|FG005|Overall Study|Lost to Follow-up|2|||
48460243|NCT04785144|155875733|FG006|Overall Study|Lost to Follow-up|1|||
48460244|NCT04785144|155875734|FG007|Overall Study|Lost to Follow-up|2|||
48460245|NCT04785144|155875735|FG008|Overall Study|Lost to Follow-up|4|||
48460246|NCT04785144|155875736|FG009|Overall Study|Lost to Follow-up|1|||
48460247|NCT04785144|155875727|FG000|Overall Study|Protocol Violation|0|||
48460248|NCT04785144|155875728|FG001|Overall Study|Protocol Violation|0|||
48460249|NCT04785144|155875729|FG002|Overall Study|Protocol Violation|0|||
48460250|NCT04785144|155875730|FG003|Overall Study|Protocol Violation|0|||
48460251|NCT04785144|155875731|FG004|Overall Study|Protocol Violation|0|||
48460252|NCT04785144|155875732|FG005|Overall Study|Protocol Violation|0|||
48460253|NCT04785144|155875733|FG006|Overall Study|Protocol Violation|1|||
48460254|NCT04785144|155875734|FG007|Overall Study|Protocol Violation|0|||
48460255|NCT04785144|155875735|FG008|Overall Study|Protocol Violation|0|||
48460256|NCT04785144|155875736|FG009|Overall Study|Protocol Violation|0|||
48460257|NCT04785144|155875727|FG000|Overall Study|Physician Decision|0|||
48460258|NCT04785144|155875728|FG001|Overall Study|Physician Decision|0|||
48460259|NCT04785144|155875729|FG002|Overall Study|Physician Decision|0|||
48460260|NCT04785144|155875730|FG003|Overall Study|Physician Decision|0|||
48460261|NCT04785144|155875731|FG004|Overall Study|Physician Decision|0|||
48460262|NCT04785144|155875732|FG005|Overall Study|Physician Decision|0|||
48460263|NCT04785144|155875733|FG006|Overall Study|Physician Decision|0|||
48460264|NCT04785144|155875734|FG007|Overall Study|Physician Decision|0|||
48460265|NCT04785144|155875735|FG008|Overall Study|Physician Decision|0|||
48460266|NCT04785144|155875736|FG009|Overall Study|Physician Decision|1|||
48460267|NCT04785144|155875727|FG000|Overall Study|Unable to continue due to work schedule|0|||
48460268|NCT04785144|155875728|FG001|Overall Study|Unable to continue due to work schedule|0|||
48460269|NCT04785144|155875729|FG002|Overall Study|Unable to continue due to work schedule|0|||
48460270|NCT04785144|155875730|FG003|Overall Study|Unable to continue due to work schedule|0|||
48460271|NCT04785144|155875731|FG004|Overall Study|Unable to continue due to work schedule|0|||
48460272|NCT04785144|155875732|FG005|Overall Study|Unable to continue due to work schedule|0|||
48460273|NCT04785144|155875733|FG006|Overall Study|Unable to continue due to work schedule|0|||
48460274|NCT04785144|155875734|FG007|Overall Study|Unable to continue due to work schedule|0|||
48460275|NCT04785144|155875735|FG008|Overall Study|Unable to continue due to work schedule|0|||
48460276|NCT04785144|155875736|FG009|Overall Study|Unable to continue due to work schedule|1|||
48460277|NCT01108263|155875737|FG000|Overall Study|Adverse Event|0|||
48460278|NCT01108263|155875738|FG001|Overall Study|Adverse Event|1|||
48460279|NCT02870348|155875739|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
48460280|NCT03233308|155875740|FG000|Overall Study|Adverse Event|1|||
48460281|NCT03233308|155875740|FG000|Overall Study|Protocol Violation|1|||
48460282|NCT03287830|155875748|FG000|Overall Study|Withdrawal by Subject|1|||
48460283|NCT03287830|155875749|FG001|Overall Study|Withdrawal by Subject|1|||
48460284|NCT03287830|155875748|FG000|Overall Study|not meeting inclusion criteria|5|||
48460285|NCT03287830|155875749|FG001|Overall Study|not meeting inclusion criteria|12|||
48460286|NCT02060903|155875750|FG000|Overall Study|Lost to Follow-up|4|||
48460287|NCT02060903|155875751|FG001|Overall Study|Lost to Follow-up|0|||
48460288|NCT02060903|155875750|FG000|Overall Study|Withdrawal by Subject|0|||
48460289|NCT02060903|155875751|FG001|Overall Study|Withdrawal by Subject|7|||
48460290|NCT00474539|155875752|FG000|Infant Series|Withdrawal by Subject|3|||
48460291|NCT00474539|155875753|FG001|Infant Series|Withdrawal by Subject|4|||
48460292|NCT00474539|155875752|FG000|Infant Series|Randomization error|5|||
48460293|NCT00474539|155875753|FG001|Infant Series|Randomization error|0|||
48460294|NCT00474539|155875752|FG000|Infant Series|Lost to Follow-up|2|||
48460295|NCT00474539|155875753|FG001|Infant Series|Lost to Follow-up|1|||
48460296|NCT00474539|155875752|FG000|Infant Series|Protocol Violation|0|||
48460297|NCT00474539|155875753|FG001|Infant Series|Protocol Violation|1|||
48460298|NCT00474539|155875752|FG000|After Infant Series|Lost to Follow-up|3|||
48460299|NCT00474539|155875753|FG001|After Infant Series|Lost to Follow-up|0|||
48460300|NCT00474539|155875752|FG000|After Infant Series|Withdrawal by Subject|1|||
48460301|NCT00474539|155875753|FG001|After Infant Series|Withdrawal by Subject|0|||
48460302|NCT00474539|155875752|FG000|Toddler Dose|Protocol Violation|1|||
48460303|NCT00474539|155875753|FG001|Toddler Dose|Protocol Violation|0|||
48460304|NCT03483012|155875758|FG000|Overall Study|Lack of Efficacy|6|||
48460305|NCT04652102|155875763|FG000|Overall Study|Adverse Event|14|||
48460306|NCT04652102|155875764|FG001|Overall Study|Adverse Event|13|||
48460307|NCT04652102|155875763|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
48460308|NCT04652102|155875764|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
48460309|NCT04652102|155875763|FG000|Overall Study|Physician Decision|78|||
48460310|NCT04652102|155875764|FG001|Overall Study|Physician Decision|40|||
48460311|NCT04652102|155875763|FG000|Overall Study|Study Ended by Sponsor|64|||
48460312|NCT04652102|155875764|FG001|Overall Study|Study Ended by Sponsor|17|||
48460313|NCT04652102|155875763|FG000|Overall Study|Withdrawal by Subject|4625|||
48460314|NCT04652102|155875764|FG001|Overall Study|Withdrawal by Subject|5594|||
48460315|NCT04652102|155875763|FG000|Overall Study|Lost to Follow-up|2019|||
48460316|NCT04652102|155875764|FG001|Overall Study|Lost to Follow-up|1082|||
48460317|NCT04652102|155875763|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
48460318|NCT04652102|155875764|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
48460319|NCT04652102|155875763|FG000|Overall Study|Miscellaneous|80|||
48460320|NCT04652102|155875764|FG001|Overall Study|Miscellaneous|64|||
48460321|NCT02005211|155875765|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48460322|NCT02005211|155875766|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48460323|NCT02005211|155875767|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48460324|NCT02005211|155875768|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48460325|NCT02005211|155875769|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
48460326|NCT02005211|155875770|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48460327|NCT02005211|155875771|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
48460328|NCT02607865|155875772|FG000|Overall Study|Lost to Follow-up|9|||
48460329|NCT02607865|155875773|FG001|Overall Study|Lost to Follow-up|7|||
48460330|NCT02607865|155875774|FG002|Overall Study|Lost to Follow-up|7|||
48460331|NCT02607865|155875775|FG003|Overall Study|Lost to Follow-up|5|||
48460332|NCT02607865|155875772|FG000|Overall Study|Withdrawal by Subject|18|||
48460333|NCT02607865|155875773|FG001|Overall Study|Withdrawal by Subject|18|||
48460334|NCT02607865|155875774|FG002|Overall Study|Withdrawal by Subject|17|||
48460335|NCT02607865|155875775|FG003|Overall Study|Withdrawal by Subject|8|||
48460336|NCT02607865|155875772|FG000|Overall Study|Death|5|||
48460337|NCT02607865|155875773|FG001|Overall Study|Death|4|||
48460338|NCT02607865|155875774|FG002|Overall Study|Death|1|||
48460339|NCT02607865|155875775|FG003|Overall Study|Death|3|||
48460340|NCT02607865|155875772|FG000|Overall Study|Unclassified|1|||
48460341|NCT02607865|155875773|FG001|Overall Study|Unclassified|1|||
48460342|NCT02607865|155875774|FG002|Overall Study|Unclassified|2|||
48460343|NCT02607865|155875775|FG003|Overall Study|Unclassified|0|||
48460344|NCT03227692|155875776|FG000|Overall Study|Protocol Violation|1|||
48460345|NCT03227692|155875777|FG001|Overall Study|Protocol Violation|1|||
48460346|NCT03227692|155875776|FG000|Overall Study|Lost to Follow-up|4|||
48460347|NCT03227692|155875777|FG001|Overall Study|Lost to Follow-up|2|||
48460348|NCT03227692|155875776|FG000|Overall Study|Adverse Event|0|||
48460349|NCT03227692|155875777|FG001|Overall Study|Adverse Event|2|||
48460350|NCT03685643|155875778|FG000|Overall Study|Lost to Follow-up|14|||
48460351|NCT03685643|155875779|FG001|Overall Study|Lost to Follow-up|22|||
48460352|NCT01057394|155875780|FG000|Overall Study|Not eligible|0|||
48460353|NCT01057394|155875781|FG001|Overall Study|Not eligible|2|||
48460354|NCT01566981|155875784|FG000|Overall Study|Lost to Follow-up|5|||
48460355|NCT01566981|155875785|FG001|Overall Study|Lost to Follow-up|8|||
48460356|NCT00886587|155875786|FG000|Overall Study|Adverse Event|2|||
48460357|NCT00886587|155875787|FG001|Overall Study|Adverse Event|1|||
48460358|NCT00886587|155875786|FG000|Overall Study|Protocol Violation|2|||
48460359|NCT00886587|155875787|FG001|Overall Study|Protocol Violation|0|||
48460360|NCT00886587|155875786|FG000|Overall Study|Withdrawal by Subject|0|||
48460361|NCT00886587|155875787|FG001|Overall Study|Withdrawal by Subject|1|||
48460362|NCT01108068|155875788|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
48460363|NCT01108068|155875789|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
48460364|NCT04107935|155875790|FG000|Overall Study|Death|1|||
48460365|NCT04107935|155875791|FG001|Overall Study|Death|0|||
48460366|NCT01376908|155875793|FG000|Overall Study|Protocol Violation|1|||
48460367|NCT01376908|155875794|FG001|Overall Study|Protocol Violation|1|||
48460368|NCT01376908|155875793|FG000|Overall Study|Withdrawal by Subject|1|||
48460369|NCT01376908|155875794|FG001|Overall Study|Withdrawal by Subject|2|||
48460370|NCT00656799|155875797|FG000|Overall Study|Death|2|||
48460371|NCT00877890|155875798|FG000|Overall Study|Adverse Event|6|||
48460372|NCT00877890|155875799|FG001|Overall Study|Adverse Event|6|||
48460373|NCT00877890|155875798|FG000|Overall Study|Lost to Follow-up|5|||
48460374|NCT00877890|155875799|FG001|Overall Study|Lost to Follow-up|5|||
48460375|NCT00877890|155875798|FG000|Overall Study|Protocol Violation|0|||
48460376|NCT00877890|155875799|FG001|Overall Study|Protocol Violation|1|||
48460377|NCT00877890|155875798|FG000|Overall Study|Withdrawal of Consent|6|||
48460378|NCT00877890|155875799|FG001|Overall Study|Withdrawal of Consent|12|||
48460379|NCT00877890|155875798|FG000|Overall Study|Investigator Decision|0|||
48460380|NCT00877890|155875799|FG001|Overall Study|Investigator Decision|2|||
48460381|NCT00877890|155875798|FG000|Overall Study|Loss of Glucose Control|3|||
48460382|NCT00877890|155875799|FG001|Overall Study|Loss of Glucose Control|4|||
48460383|NCT00742391|155875802|FG000|Overall Study|Adverse Event|2|||
48460384|NCT00742391|155875803|FG001|Overall Study|Adverse Event|1|||
48460385|NCT00742391|155875802|FG000|Overall Study|Lost to Follow-up|1|||
48460386|NCT00742391|155875803|FG001|Overall Study|Lost to Follow-up|0|||
48460387|NCT00742391|155875802|FG000|Overall Study|Protocol Violation|1|||
48460388|NCT00742391|155875803|FG001|Overall Study|Protocol Violation|0|||
48460389|NCT00281528|155875804|FG000|Overall Study|Progressive Disease|28|||
48460390|NCT00281528|155875805|FG001|Overall Study|Progressive Disease|18|||
48460391|NCT00281528|155875806|FG002|Overall Study|Progressive Disease|27|||
48460392|NCT00281528|155875804|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
48460393|NCT00281528|155875805|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
48460394|NCT00281528|155875806|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
48460395|NCT00281528|155875804|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
48460396|NCT00281528|155875805|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
48460397|NCT00281528|155875806|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
48460398|NCT00281528|155875804|FG000|Overall Study|Physician Decision|11|||
48460399|NCT00281528|155875805|FG001|Overall Study|Physician Decision|4|||
48460400|NCT00281528|155875806|FG002|Overall Study|Physician Decision|5|||
48460401|NCT00281528|155875804|FG000|Overall Study|Protocol Violation|1|||
48460402|NCT00281528|155875805|FG001|Overall Study|Protocol Violation|0|||
48460403|NCT00281528|155875806|FG002|Overall Study|Protocol Violation|1|||
48460404|NCT00281528|155875804|FG000|Overall Study|Withdrawal by Subject|5|||
48460405|NCT00281528|155875805|FG001|Overall Study|Withdrawal by Subject|5|||
48460406|NCT00281528|155875806|FG002|Overall Study|Withdrawal by Subject|7|||
48460407|NCT00281528|155875804|FG000|Overall Study|Other|6|||
48460408|NCT00281528|155875805|FG001|Overall Study|Other|3|||
48460409|NCT00281528|155875806|FG002|Overall Study|Other|5|||
48460410|NCT02394028|155875807|FG000|Induction Phase|Adverse Event|2|||
48460411|NCT02394028|155875808|FG001|Induction Phase|Adverse Event|4|||
48460412|NCT02394028|155875809|FG002|Induction Phase|Adverse Event|1|||
48460413|NCT02394028|155875810|FG003|Induction Phase|Adverse Event|2|||
48460414|NCT02394028|155875811|FG004|Induction Phase|Adverse Event|5|||
48460415|NCT02394028|155875812|FG005|Induction Phase|Adverse Event|2|||
48460416|NCT02394028|155875813|FG006|Induction Phase|Adverse Event|0|||
48460417|NCT02394028|155875814|FG007|Induction Phase|Adverse Event|0|||
48460418|NCT02394028|155875815|FG008|Induction Phase|Adverse Event|0|||
48460419|NCT02394028|155875816|FG009|Induction Phase|Adverse Event|0|||
48460420|NCT02394028|155875817|FG010|Induction Phase|Adverse Event|0|||
48460421|NCT02394028|155875807|FG000|Induction Phase|Lack of Efficacy|3|||
48460422|NCT02394028|155875808|FG001|Induction Phase|Lack of Efficacy|6|||
48460423|NCT02394028|155875809|FG002|Induction Phase|Lack of Efficacy|2|||
48460424|NCT02394028|155875810|FG003|Induction Phase|Lack of Efficacy|17|||
48460425|NCT02394028|155875811|FG004|Induction Phase|Lack of Efficacy|14|||
48460426|NCT02394028|155875812|FG005|Induction Phase|Lack of Efficacy|8|||
48460427|NCT02394028|155875813|FG006|Induction Phase|Lack of Efficacy|17|||
48460428|NCT02394028|155875814|FG007|Induction Phase|Lack of Efficacy|23|||
48460429|NCT02394028|155875815|FG008|Induction Phase|Lack of Efficacy|0|||
48460430|NCT02394028|155875816|FG009|Induction Phase|Lack of Efficacy|0|||
48460431|NCT02394028|155875817|FG010|Induction Phase|Lack of Efficacy|0|||
48460432|NCT02394028|155875807|FG000|Induction Phase|Lost to Follow-up|1|||
48460433|NCT02394028|155875808|FG001|Induction Phase|Lost to Follow-up|0|||
48460434|NCT02394028|155875809|FG002|Induction Phase|Lost to Follow-up|0|||
48460435|NCT02394028|155875810|FG003|Induction Phase|Lost to Follow-up|1|||
48460436|NCT02394028|155875811|FG004|Induction Phase|Lost to Follow-up|0|||
48460437|NCT02394028|155875812|FG005|Induction Phase|Lost to Follow-up|0|||
48460438|NCT02394028|155875813|FG006|Induction Phase|Lost to Follow-up|1|||
48460439|NCT02394028|155875814|FG007|Induction Phase|Lost to Follow-up|0|||
48460440|NCT02394028|155875815|FG008|Induction Phase|Lost to Follow-up|0|||
48460441|NCT02394028|155875816|FG009|Induction Phase|Lost to Follow-up|0|||
48460442|NCT02394028|155875817|FG010|Induction Phase|Lost to Follow-up|0|||
48460443|NCT02394028|155875807|FG000|Induction Phase|Non-compliance|0|||
48460444|NCT02394028|155875808|FG001|Induction Phase|Non-compliance|1|||
48460445|NCT02394028|155875809|FG002|Induction Phase|Non-compliance|3|||
48460446|NCT02394028|155875810|FG003|Induction Phase|Non-compliance|1|||
48460447|NCT02394028|155875811|FG004|Induction Phase|Non-compliance|3|||
48460448|NCT02394028|155875812|FG005|Induction Phase|Non-compliance|0|||
48460449|NCT02394028|155875813|FG006|Induction Phase|Non-compliance|1|||
48460450|NCT02394028|155875814|FG007|Induction Phase|Non-compliance|1|||
48460451|NCT02394028|155875815|FG008|Induction Phase|Non-compliance|0|||
48460452|NCT02394028|155875816|FG009|Induction Phase|Non-compliance|0|||
48460453|NCT02394028|155875817|FG010|Induction Phase|Non-compliance|0|||
48460454|NCT02394028|155875807|FG000|Induction Phase|Physician Decision|0|||
48460455|NCT02394028|155875808|FG001|Induction Phase|Physician Decision|0|||
48460456|NCT02394028|155875809|FG002|Induction Phase|Physician Decision|1|||
48460457|NCT02394028|155875810|FG003|Induction Phase|Physician Decision|4|||
48460458|NCT02394028|155875811|FG004|Induction Phase|Physician Decision|0|||
48460459|NCT02394028|155875812|FG005|Induction Phase|Physician Decision|2|||
48460460|NCT02394028|155875813|FG006|Induction Phase|Physician Decision|1|||
48460461|NCT02394028|155875814|FG007|Induction Phase|Physician Decision|0|||
48460462|NCT02394028|155875815|FG008|Induction Phase|Physician Decision|0|||
48460463|NCT02394028|155875816|FG009|Induction Phase|Physician Decision|0|||
48460464|NCT02394028|155875817|FG010|Induction Phase|Physician Decision|0|||
48460465|NCT02394028|155875807|FG000|Induction Phase|Protocol Violation|0|||
48460466|NCT02394028|155875808|FG001|Induction Phase|Protocol Violation|2|||
48460467|NCT02394028|155875809|FG002|Induction Phase|Protocol Violation|0|||
48460468|NCT02394028|155875810|FG003|Induction Phase|Protocol Violation|3|||
48460469|NCT02394028|155875811|FG004|Induction Phase|Protocol Violation|0|||
48460470|NCT02394028|155875812|FG005|Induction Phase|Protocol Violation|1|||
48460471|NCT02394028|155875813|FG006|Induction Phase|Protocol Violation|1|||
48460472|NCT02394028|155875814|FG007|Induction Phase|Protocol Violation|0|||
48460473|NCT02394028|155875815|FG008|Induction Phase|Protocol Violation|0|||
48460474|NCT02394028|155875816|FG009|Induction Phase|Protocol Violation|0|||
48460475|NCT02394028|155875817|FG010|Induction Phase|Protocol Violation|0|||
48460476|NCT02394028|155875807|FG000|Induction Phase|Withdrawal by Subject|1|||
48460477|NCT02394028|155875808|FG001|Induction Phase|Withdrawal by Subject|2|||
48460478|NCT02394028|155875809|FG002|Induction Phase|Withdrawal by Subject|4|||
48460479|NCT02394028|155875810|FG003|Induction Phase|Withdrawal by Subject|6|||
48460480|NCT02394028|155875811|FG004|Induction Phase|Withdrawal by Subject|7|||
48460481|NCT02394028|155875812|FG005|Induction Phase|Withdrawal by Subject|4|||
48460482|NCT02394028|155875813|FG006|Induction Phase|Withdrawal by Subject|3|||
48460483|NCT02394028|155875814|FG007|Induction Phase|Withdrawal by Subject|6|||
48460484|NCT02394028|155875815|FG008|Induction Phase|Withdrawal by Subject|0|||
48460485|NCT02394028|155875816|FG009|Induction Phase|Withdrawal by Subject|0|||
48460486|NCT02394028|155875817|FG010|Induction Phase|Withdrawal by Subject|0|||
48460487|NCT02394028|155875807|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460488|NCT02394028|155875808|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460489|NCT02394028|155875809|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460490|NCT02394028|155875810|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460491|NCT02394028|155875811|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460492|NCT02394028|155875812|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460493|NCT02394028|155875813|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
48460494|NCT02394028|155875814|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460495|NCT02394028|155875815|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460496|NCT02394028|155875816|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460497|NCT02394028|155875817|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
48460498|NCT02394028|155875807|FG000|Induction Phase|Sponsor decision|0|||
48460499|NCT02394028|155875808|FG001|Induction Phase|Sponsor decision|1|||
48460500|NCT02394028|155875809|FG002|Induction Phase|Sponsor decision|2|||
48460501|NCT02394028|155875810|FG003|Induction Phase|Sponsor decision|0|||
48460502|NCT02394028|155875811|FG004|Induction Phase|Sponsor decision|0|||
48460503|NCT02394028|155875812|FG005|Induction Phase|Sponsor decision|0|||
48460504|NCT02394028|155875813|FG006|Induction Phase|Sponsor decision|0|||
48460505|NCT02394028|155875814|FG007|Induction Phase|Sponsor decision|0|||
48460506|NCT02394028|155875815|FG008|Induction Phase|Sponsor decision|0|||
48460507|NCT02394028|155875816|FG009|Induction Phase|Sponsor decision|0|||
48460508|NCT02394028|155875817|FG010|Induction Phase|Sponsor decision|0|||
48460509|NCT02394028|155875807|FG000|Induction Phase|Technical reason|0|||
48460510|NCT02394028|155875808|FG001|Induction Phase|Technical reason|0|||
48460511|NCT02394028|155875809|FG002|Induction Phase|Technical reason|0|||
48460512|NCT02394028|155875810|FG003|Induction Phase|Technical reason|1|||
48460513|NCT02394028|155875811|FG004|Induction Phase|Technical reason|0|||
48460514|NCT02394028|155875812|FG005|Induction Phase|Technical reason|0|||
48460515|NCT02394028|155875813|FG006|Induction Phase|Technical reason|0|||
48460516|NCT02394028|155875814|FG007|Induction Phase|Technical reason|0|||
48460517|NCT02394028|155875815|FG008|Induction Phase|Technical reason|0|||
48460518|NCT02394028|155875816|FG009|Induction Phase|Technical reason|0|||
48460519|NCT02394028|155875817|FG010|Induction Phase|Technical reason|0|||
48460520|NCT02394028|155875807|FG000|Induction Phase|:ack of calculation|0|||
48460521|NCT02394028|155875808|FG001|Induction Phase|:ack of calculation|0|||
48460522|NCT02394028|155875809|FG002|Induction Phase|:ack of calculation|0|||
48460523|NCT02394028|155875810|FG003|Induction Phase|:ack of calculation|0|||
48460524|NCT02394028|155875811|FG004|Induction Phase|:ack of calculation|0|||
48460525|NCT02394028|155875812|FG005|Induction Phase|:ack of calculation|0|||
48460526|NCT02394028|155875813|FG006|Induction Phase|:ack of calculation|0|||
48460527|NCT02394028|155875814|FG007|Induction Phase|:ack of calculation|1|||
48460528|NCT02394028|155875815|FG008|Induction Phase|:ack of calculation|0|||
48460529|NCT02394028|155875816|FG009|Induction Phase|:ack of calculation|0|||
48460530|NCT02394028|155875817|FG010|Induction Phase|:ack of calculation|0|||
48460531|NCT02394028|155875807|FG000|Maintenance Phase|Protocol Violation|0|||
48460532|NCT02394028|155875808|FG001|Maintenance Phase|Protocol Violation|0|||
48460533|NCT02394028|155875809|FG002|Maintenance Phase|Protocol Violation|0|||
48460534|NCT02394028|155875810|FG003|Maintenance Phase|Protocol Violation|0|||
48460535|NCT02394028|155875811|FG004|Maintenance Phase|Protocol Violation|0|||
48460536|NCT02394028|155875812|FG005|Maintenance Phase|Protocol Violation|0|||
48460537|NCT02394028|155875813|FG006|Maintenance Phase|Protocol Violation|0|||
48460538|NCT02394028|155875814|FG007|Maintenance Phase|Protocol Violation|0|||
48460539|NCT02394028|155875815|FG008|Maintenance Phase|Protocol Violation|0|||
48460540|NCT02394028|155875816|FG009|Maintenance Phase|Protocol Violation|0|||
48460541|NCT02394028|155875817|FG010|Maintenance Phase|Protocol Violation|1|||
48460542|NCT02394028|155875807|FG000|Maintenance Phase|Physician Decision|0|||
48460543|NCT02394028|155875808|FG001|Maintenance Phase|Physician Decision|0|||
48460544|NCT02394028|155875809|FG002|Maintenance Phase|Physician Decision|0|||
48460545|NCT02394028|155875810|FG003|Maintenance Phase|Physician Decision|0|||
48460546|NCT02394028|155875811|FG004|Maintenance Phase|Physician Decision|0|||
48460547|NCT02394028|155875812|FG005|Maintenance Phase|Physician Decision|0|||
48460548|NCT02394028|155875813|FG006|Maintenance Phase|Physician Decision|0|||
48460549|NCT02394028|155875814|FG007|Maintenance Phase|Physician Decision|0|||
48460550|NCT02394028|155875815|FG008|Maintenance Phase|Physician Decision|1|||
48460551|NCT02394028|155875816|FG009|Maintenance Phase|Physician Decision|3|||
48460552|NCT02394028|155875817|FG010|Maintenance Phase|Physician Decision|2|||
48460553|NCT02394028|155875807|FG000|Maintenance Phase|Lack of Efficacy|0|||
48460554|NCT02394028|155875808|FG001|Maintenance Phase|Lack of Efficacy|0|||
48460555|NCT02394028|155875809|FG002|Maintenance Phase|Lack of Efficacy|0|||
48460556|NCT02394028|155875810|FG003|Maintenance Phase|Lack of Efficacy|0|||
48460557|NCT02394028|155875811|FG004|Maintenance Phase|Lack of Efficacy|0|||
48460558|NCT02394028|155875812|FG005|Maintenance Phase|Lack of Efficacy|0|||
48460559|NCT02394028|155875813|FG006|Maintenance Phase|Lack of Efficacy|0|||
48460560|NCT02394028|155875814|FG007|Maintenance Phase|Lack of Efficacy|0|||
48460561|NCT02394028|155875815|FG008|Maintenance Phase|Lack of Efficacy|7|||
48460562|NCT02394028|155875816|FG009|Maintenance Phase|Lack of Efficacy|25|||
48460563|NCT02394028|155875817|FG010|Maintenance Phase|Lack of Efficacy|33|||
48460564|NCT02394028|155875807|FG000|Maintenance Phase|Death|0|||
48460565|NCT02394028|155875808|FG001|Maintenance Phase|Death|0|||
48460566|NCT02394028|155875809|FG002|Maintenance Phase|Death|0|||
48460567|NCT02394028|155875810|FG003|Maintenance Phase|Death|0|||
48460568|NCT02394028|155875811|FG004|Maintenance Phase|Death|0|||
48460569|NCT02394028|155875812|FG005|Maintenance Phase|Death|0|||
48460570|NCT02394028|155875813|FG006|Maintenance Phase|Death|0|||
48460571|NCT02394028|155875814|FG007|Maintenance Phase|Death|0|||
48460572|NCT02394028|155875815|FG008|Maintenance Phase|Death|0|||
48460573|NCT02394028|155875816|FG009|Maintenance Phase|Death|0|||
48460574|NCT02394028|155875817|FG010|Maintenance Phase|Death|1|||
48460575|NCT02394028|155875807|FG000|Maintenance Phase|Adverse Event|0|||
48460576|NCT02394028|155875808|FG001|Maintenance Phase|Adverse Event|0|||
48460577|NCT02394028|155875809|FG002|Maintenance Phase|Adverse Event|0|||
48460578|NCT02394028|155875810|FG003|Maintenance Phase|Adverse Event|0|||
48460579|NCT02394028|155875811|FG004|Maintenance Phase|Adverse Event|0|||
48460580|NCT02394028|155875812|FG005|Maintenance Phase|Adverse Event|0|||
48460581|NCT02394028|155875813|FG006|Maintenance Phase|Adverse Event|0|||
48460582|NCT02394028|155875814|FG007|Maintenance Phase|Adverse Event|0|||
48460583|NCT02394028|155875815|FG008|Maintenance Phase|Adverse Event|1|||
48460584|NCT02394028|155875816|FG009|Maintenance Phase|Adverse Event|1|||
48460585|NCT02394028|155875817|FG010|Maintenance Phase|Adverse Event|3|||
48460586|NCT02394028|155875807|FG000|Maintenance Phase|Site closure|0|||
48460587|NCT02394028|155875808|FG001|Maintenance Phase|Site closure|0|||
48460588|NCT02394028|155875809|FG002|Maintenance Phase|Site closure|0|||
48460589|NCT02394028|155875810|FG003|Maintenance Phase|Site closure|0|||
48460590|NCT02394028|155875811|FG004|Maintenance Phase|Site closure|0|||
48460591|NCT02394028|155875812|FG005|Maintenance Phase|Site closure|0|||
48460592|NCT02394028|155875813|FG006|Maintenance Phase|Site closure|0|||
48460593|NCT02394028|155875814|FG007|Maintenance Phase|Site closure|0|||
48460594|NCT02394028|155875815|FG008|Maintenance Phase|Site closure|0|||
48460595|NCT02394028|155875816|FG009|Maintenance Phase|Site closure|1|||
48460596|NCT02394028|155875817|FG010|Maintenance Phase|Site closure|0|||
48460597|NCT02394028|155875807|FG000|Maintenance Phase|Withdrawal by Subject|0|||
48460598|NCT02394028|155875808|FG001|Maintenance Phase|Withdrawal by Subject|0|||
48460599|NCT02394028|155875809|FG002|Maintenance Phase|Withdrawal by Subject|0|||
48460600|NCT02394028|155875810|FG003|Maintenance Phase|Withdrawal by Subject|0|||
48460601|NCT02394028|155875811|FG004|Maintenance Phase|Withdrawal by Subject|0|||
48460602|NCT02394028|155875812|FG005|Maintenance Phase|Withdrawal by Subject|0|||
48460603|NCT02394028|155875813|FG006|Maintenance Phase|Withdrawal by Subject|0|||
48460604|NCT02394028|155875814|FG007|Maintenance Phase|Withdrawal by Subject|0|||
48460605|NCT02394028|155875815|FG008|Maintenance Phase|Withdrawal by Subject|3|||
48460606|NCT02394028|155875816|FG009|Maintenance Phase|Withdrawal by Subject|12|||
48460607|NCT02394028|155875817|FG010|Maintenance Phase|Withdrawal by Subject|12|||
48460608|NCT02967562|155875818|FG000|Overall Study|Consent not obtained|1|||
48460609|NCT02967562|155875819|FG001|Overall Study|Consent not obtained|0|||
48460610|NCT02967562|155875818|FG000|Overall Study|High leak precluding analysis|1|||
48460611|NCT02967562|155875819|FG001|Overall Study|High leak precluding analysis|1|||
48460612|NCT03595176|155875820|FG000|Overall Study|Death|0|||
48460613|NCT03595176|155875821|FG001|Overall Study|Death|2|||
48460614|NCT03595176|155875820|FG000|Overall Study|Lost to Follow-up|0|||
48460615|NCT03595176|155875821|FG001|Overall Study|Lost to Follow-up|1|||
48460616|NCT02543801|155875822|FG000|Overall Study|Protocol Violation|1|||
48460617|NCT02543801|155875823|FG001|Overall Study|Protocol Violation|2|||
48460618|NCT02543801|155875824|FG002|Overall Study|Protocol Violation|0|||
48460619|NCT02543801|155875825|FG003|Overall Study|Protocol Violation|0|||
48460620|NCT01426009|155875826|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
48460621|NCT01426009|155875826|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
48460622|NCT01426009|155875826|FG000|Washout 1|Withdrawal by Subject|1|||
48460623|NCT01426009|155875826|FG000|Washout 1|Personal Reasons|1|||
48460624|NCT01426009|155875826|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
48460625|NCT01426009|155875826|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
48460626|NCT01426009|155875826|FG000|Washout 2|electrive surgery|1|||
48460627|NCT01426009|155875826|FG000|Washout 3|personal reasons|1|||
48460628|NCT01426009|155875826|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
48460629|NCT01426009|155875826|FG000|Washout 4|Lost to Follow-up|1|||
48460630|NCT02178592|155875829|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
48460631|NCT02178592|155875830|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
48460632|NCT02178592|155875829|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
48460633|NCT02178592|155875830|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
48460634|NCT02178592|155875829|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
48460635|NCT02178592|155875830|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
48460636|NCT02178592|155875829|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
48460637|NCT02178592|155875830|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
48460638|NCT02178592|155875829|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
48460639|NCT02178592|155875830|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
48460640|NCT02178592|155875829|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
48460641|NCT02178592|155875830|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
48460642|NCT02178592|155875829|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
48460643|NCT02178592|155875830|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
48460644|NCT02178592|155875829|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
48460645|NCT02178592|155875830|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
48460646|NCT02178592|155875829|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
48460647|NCT02178592|155875830|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
48460648|NCT02178592|155875829|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
48460649|NCT02178592|155875830|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
48460650|NCT02178592|155875829|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
48460651|NCT02178592|155875830|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
48460652|NCT02178592|155875829|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
48460653|NCT02178592|155875830|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
48460654|NCT01468844|155875831|FG000|Overall Study|Adverse Event|1|||
48460655|NCT01468844|155875832|FG001|Overall Study|Adverse Event|0|||
48460656|NCT01468844|155875831|FG000|Overall Study|Withdrawal by Subject|1|||
48460657|NCT01468844|155875832|FG001|Overall Study|Withdrawal by Subject|0|||
48460658|NCT00783263|155875845|FG000|Overall Study|Adverse Event|3|||
48460659|NCT00783263|155875846|FG001|Overall Study|Adverse Event|0|||
48460660|NCT00783263|155875847|FG002|Overall Study|Adverse Event|2|||
48460661|NCT00783263|155875848|FG003|Overall Study|Adverse Event|1|||
48460662|NCT00783263|155875845|FG000|Overall Study|Lost to Follow-up|1|||
48460663|NCT00783263|155875846|FG001|Overall Study|Lost to Follow-up|1|||
48460664|NCT00783263|155875847|FG002|Overall Study|Lost to Follow-up|0|||
48460665|NCT00783263|155875848|FG003|Overall Study|Lost to Follow-up|0|||
48460666|NCT00783263|155875845|FG000|Overall Study|Withdrawal by Subject|0|||
48460667|NCT00783263|155875846|FG001|Overall Study|Withdrawal by Subject|1|||
48460668|NCT00783263|155875847|FG002|Overall Study|Withdrawal by Subject|1|||
48460669|NCT00783263|155875848|FG003|Overall Study|Withdrawal by Subject|2|||
48460670|NCT00081263|155875849|FG000|Overall Study|clerical error|1|||
48460671|NCT00081263|155875850|FG001|Overall Study|clerical error|0|||
48460672|NCT00081263|155875849|FG000|Overall Study|wrong cell type|7|||
48460673|NCT00081263|155875850|FG001|Overall Study|wrong cell type|5|||
48460674|NCT00081263|155875849|FG000|Overall Study|improper pre-protocol therapy|0|||
48460675|NCT00081263|155875850|FG001|Overall Study|improper pre-protocol therapy|1|||
48460676|NCT00081263|155875849|FG000|Overall Study|Inadequate pathology|0|||
48460677|NCT00081263|155875850|FG001|Overall Study|Inadequate pathology|1|||
48460678|NCT00081263|155875849|FG000|Overall Study|Never treated|4|||
48460679|NCT00081263|155875850|FG001|Overall Study|Never treated|5|||
48460680|NCT00081263|155875849|FG000|Overall Study|Inadequate data|5|||
48460681|NCT00081263|155875850|FG001|Overall Study|Inadequate data|10|||
48460682|NCT02520141|155875851|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
48460683|NCT00508820|155875857|FG000|Overall Study|Adverse Event|6|||
48460684|NCT00508820|155875858|FG001|Overall Study|Adverse Event|10|||
48460685|NCT00508820|155875857|FG000|Overall Study|Death|6|||
48460686|NCT00508820|155875858|FG001|Overall Study|Death|8|||
48460687|NCT00508820|155875857|FG000|Overall Study|Lost to Follow-up|1|||
48460688|NCT00508820|155875858|FG001|Overall Study|Lost to Follow-up|1|||
48460689|NCT00508820|155875857|FG000|Overall Study|Physician Decision|8|||
48460690|NCT00508820|155875858|FG001|Overall Study|Physician Decision|2|||
48460691|NCT00508820|155875857|FG000|Overall Study|Pregnancy|0|||
48460692|NCT00508820|155875858|FG001|Overall Study|Pregnancy|2|||
48460693|NCT00508820|155875857|FG000|Overall Study|Protocol Violation|2|||
48460694|NCT00508820|155875858|FG001|Overall Study|Protocol Violation|0|||
48460695|NCT00508820|155875857|FG000|Overall Study|Withdrawal by Subject|10|||
48460696|NCT00508820|155875858|FG001|Overall Study|Withdrawal by Subject|12|||
48460697|NCT00508820|155875857|FG000|Overall Study|Other|11|||
48460698|NCT00508820|155875858|FG001|Overall Study|Other|2|||
48460699|NCT00508820|155875857|FG000|Overall Study|Noncompliance|1|||
48460700|NCT00508820|155875858|FG001|Overall Study|Noncompliance|0|||
48460701|NCT00508820|155875857|FG000|Overall Study|Requirement for alternative therapy|7|||
48460702|NCT00508820|155875858|FG001|Overall Study|Requirement for alternative therapy|15|||
48460703|NCT00508820|155875857|FG000|Overall Study|Protocol-specified Criteria|3|||
48460704|NCT00508820|155875858|FG001|Overall Study|Protocol-specified Criteria|12|||
48460705|NCT02036476|155875859|FG000|Overall Study|Withdrawal by Subject|2|||
48460706|NCT02036476|155875859|FG000|Overall Study|Progressive Disease|4|||
48460707|NCT02036476|155875859|FG000|Overall Study|Unacceptable Toxicity|2|||
48460708|NCT01225211|155875860|FG000|Overall Study|Adverse Event|0|||
48460709|NCT01225211|155875861|FG001|Overall Study|Adverse Event|0|||
48460710|NCT01225211|155875862|FG002|Overall Study|Adverse Event|1|||
48460711|NCT01225211|155875863|FG003|Overall Study|Adverse Event|0|||
48460712|NCT01225211|155875864|FG004|Overall Study|Adverse Event|0|||
48460713|NCT01225211|155875865|FG005|Overall Study|Adverse Event|0|||
48460714|NCT01225211|155875866|FG006|Overall Study|Adverse Event|0|||
48460715|NCT01225211|155875867|FG007|Overall Study|Adverse Event|0|||
48460716|NCT01225211|155875868|FG008|Overall Study|Adverse Event|0|||
48460717|NCT01225211|155875869|FG009|Overall Study|Adverse Event|1|||
48460718|NCT01225211|155875860|FG000|Overall Study|Withdrawal by Subject|0|||
48460719|NCT01225211|155875861|FG001|Overall Study|Withdrawal by Subject|0|||
48460720|NCT01225211|155875862|FG002|Overall Study|Withdrawal by Subject|0|||
48460721|NCT01225211|155875863|FG003|Overall Study|Withdrawal by Subject|0|||
48460722|NCT01225211|155875864|FG004|Overall Study|Withdrawal by Subject|0|||
48460723|NCT01225211|155875865|FG005|Overall Study|Withdrawal by Subject|0|||
48460724|NCT01225211|155875866|FG006|Overall Study|Withdrawal by Subject|1|||
48460725|NCT01225211|155875867|FG007|Overall Study|Withdrawal by Subject|0|||
48460726|NCT01225211|155875868|FG008|Overall Study|Withdrawal by Subject|1|||
48460727|NCT01225211|155875869|FG009|Overall Study|Withdrawal by Subject|3|||
48460728|NCT01225211|155875860|FG000|Overall Study|Other|0|||
48460729|NCT01225211|155875861|FG001|Overall Study|Other|0|||
48460730|NCT01225211|155875862|FG002|Overall Study|Other|0|||
48460731|NCT01225211|155875863|FG003|Overall Study|Other|0|||
48460732|NCT01225211|155875864|FG004|Overall Study|Other|0|||
48460733|NCT01225211|155875865|FG005|Overall Study|Other|0|||
48460734|NCT01225211|155875866|FG006|Overall Study|Other|0|||
48460735|NCT01225211|155875867|FG007|Overall Study|Other|0|||
48460736|NCT01225211|155875868|FG008|Overall Study|Other|0|||
48460737|NCT01225211|155875869|FG009|Overall Study|Other|1|||
48460738|NCT02355665|155875873|FG000|Overall Study|Adverse Event|16|||
48460739|NCT02355665|155875874|FG001|Overall Study|Adverse Event|24|||
48460740|NCT02355665|155875873|FG000|Overall Study|Protocol Violation|2|||
48460741|NCT02355665|155875874|FG001|Overall Study|Protocol Violation|0|||
48460742|NCT02355665|155875873|FG000|Overall Study|Withdrawal by Subject|90|||
48460743|NCT02355665|155875874|FG001|Overall Study|Withdrawal by Subject|100|||
48460744|NCT02355665|155875873|FG000|Overall Study|Lost to Follow-up|131|||
48460745|NCT02355665|155875874|FG001|Overall Study|Lost to Follow-up|103|||
48460746|NCT02355665|155875873|FG000|Overall Study|Death|4|||
48460747|NCT02355665|155875874|FG001|Overall Study|Death|2|||
48460748|NCT02355665|155875873|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
48460749|NCT02355665|155875874|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
48460750|NCT02735044|155875875|FG000|Overall Study|Adverse Event|3|||
48460751|NCT02735044|155875876|FG001|Overall Study|Adverse Event|3|||
48460752|NCT02735044|155875875|FG000|Overall Study|Lack of Efficacy|1|||
48460753|NCT02735044|155875876|FG001|Overall Study|Lack of Efficacy|0|||
48460754|NCT02735044|155875875|FG000|Overall Study|Poor compliance to protocol|7|||
48460755|NCT02735044|155875876|FG001|Overall Study|Poor compliance to protocol|7|||
48460756|NCT02735044|155875875|FG000|Overall Study|Randomized and not treated|0|||
48460757|NCT02735044|155875876|FG001|Overall Study|Randomized and not treated|2|||
48460758|NCT02735044|155875875|FG000|Overall Study|Other, not specified above|5|||
48460759|NCT02735044|155875876|FG001|Overall Study|Other, not specified above|11|||
48460760|NCT01984294|155875877|FG000|Overall Study|Randomized but Never Treated|0|||
48460761|NCT01984294|155875878|FG001|Overall Study|Randomized but Never Treated|0|||
48460762|NCT01984294|155875879|FG002|Overall Study|Randomized but Never Treated|1|||
48460763|NCT01984294|155875877|FG000|Overall Study|Lack of Efficacy|4|||
48460764|NCT01984294|155875878|FG001|Overall Study|Lack of Efficacy|2|||
48460765|NCT01984294|155875879|FG002|Overall Study|Lack of Efficacy|6|||
48460766|NCT01984294|155875877|FG000|Overall Study|Adverse Event|0|||
48460767|NCT01984294|155875878|FG001|Overall Study|Adverse Event|1|||
48460768|NCT01984294|155875879|FG002|Overall Study|Adverse Event|0|||
48460769|NCT00517634|155875885|FG000|Second Treatment Period|Withdrawal by Subject|0|||
48460770|NCT00517634|155875886|FG001|Second Treatment Period|Withdrawal by Subject|0|||
48460771|NCT00517634|155875887|FG002|Second Treatment Period|Withdrawal by Subject|0|||
48460772|NCT00517634|155875888|FG003|Second Treatment Period|Withdrawal by Subject|0|||
48460773|NCT00517634|155875889|FG004|Second Treatment Period|Withdrawal by Subject|1|||
48460774|NCT00517634|155875890|FG005|Second Treatment Period|Withdrawal by Subject|0|||
48460775|NCT01156012|155875891|FG000|Overall Study|Adverse Event|3|||
48460776|NCT01156012|155875892|FG001|Overall Study|Adverse Event|1|||
48460777|NCT01156012|155875891|FG000|Overall Study|Lost to Follow-up|1|||
48460778|NCT01156012|155875892|FG001|Overall Study|Lost to Follow-up|0|||
48460779|NCT01156012|155875891|FG000|Overall Study|Withdrawal by Subject|1|||
48460780|NCT01156012|155875892|FG001|Overall Study|Withdrawal by Subject|0|||
48460781|NCT01156012|155875891|FG000|Overall Study|use of commercial drug instead of study|0|||
48460782|NCT01156012|155875892|FG001|Overall Study|use of commercial drug instead of study|1|||
48460783|NCT01156012|155875891|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
48460784|NCT01156012|155875892|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
48460785|NCT00626795|155875893|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
48460786|NCT00626795|155875894|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
48460787|NCT00626795|155875895|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
48460788|NCT00626795|155875893|FG000|Blinded Treatment|Lack of Efficacy|2|||
48460789|NCT00626795|155875894|FG001|Blinded Treatment|Lack of Efficacy|0|||
48460790|NCT00626795|155875895|FG002|Blinded Treatment|Lack of Efficacy|0|||
48460791|NCT00626795|155875893|FG000|Blinded Treatment|Unacceptable adverse event|0|||
48460792|NCT00626795|155875894|FG001|Blinded Treatment|Unacceptable adverse event|0|||
48460793|NCT00626795|155875895|FG002|Blinded Treatment|Unacceptable adverse event|1|||
48460794|NCT00626795|155875893|FG000|Blinded Treatment|Protocol Violation|0|||
48460795|NCT00626795|155875894|FG001|Blinded Treatment|Protocol Violation|1|||
48460796|NCT00626795|155875895|FG002|Blinded Treatment|Protocol Violation|1|||
48460797|NCT00626795|155875893|FG000|Blinded Treatment|Withdrawal by Subject|1|||
48460798|NCT00626795|155875894|FG001|Blinded Treatment|Withdrawal by Subject|1|||
48460799|NCT00626795|155875895|FG002|Blinded Treatment|Withdrawal by Subject|0|||
48460800|NCT00626795|155875893|FG000|Blinded Treatment|Other reasons|2|||
48460801|NCT00626795|155875894|FG001|Blinded Treatment|Other reasons|0|||
48460802|NCT00626795|155875895|FG002|Blinded Treatment|Other reasons|2|||
48460803|NCT00626795|155875893|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
48460804|NCT00626795|155875894|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
48460805|NCT00626795|155875895|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
48460806|NCT04129242|155875896|FG000|Overall Study|Physician Decision|1|||
48460807|NCT04129242|155875897|FG001|Overall Study|Physician Decision|1|||
48460808|NCT04129242|155875896|FG000|Overall Study|Protocol Violation|0|||
48460809|NCT04129242|155875897|FG001|Overall Study|Protocol Violation|1|||
48460810|NCT00908895|155877939|FG000|Overall Study|Lost to Follow-up|1|||
48460811|NCT00908895|155877940|FG001|Overall Study|Lost to Follow-up|3|||
48460812|NCT00908895|155877939|FG000|Overall Study|algodystrophy|2|||
48460813|NCT00908895|155877940|FG001|Overall Study|algodystrophy|2|||
48460814|NCT00908895|155877939|FG000|Overall Study|Adverse Event|1|||
48460815|NCT00908895|155877940|FG001|Overall Study|Adverse Event|1|||
48460816|NCT01997892|155877941|FG000|Overall Study|Physician Decision|2|||
48460817|NCT01997892|155877941|FG000|Overall Study|Lost to Follow-up|6|||
48460818|NCT01997892|155877941|FG000|Overall Study|Death|14|||
48460819|NCT01997892|155877941|FG000|Overall Study|Renal transplant|8|||
48460820|NCT01997892|155877941|FG000|Overall Study|Other|3|||
48460821|NCT01997892|155877941|FG000|Overall Study|Study completion data not recorded|35|||
48460822|NCT01693562|155877943|FG000|Escalation Phase|Withdrawal by Subject|0|||
48460823|NCT01693562|155877944|FG001|Escalation Phase|Withdrawal by Subject|1|||
48460824|NCT01693562|155877945|FG002|Escalation Phase|Withdrawal by Subject|0|||
48460825|NCT01693562|155877946|FG003|Escalation Phase|Withdrawal by Subject|0|||
48460826|NCT01693562|155877947|FG004|Escalation Phase|Withdrawal by Subject|0|||
48460827|NCT01693562|155877948|FG005|Escalation Phase|Withdrawal by Subject|2|||
48460828|NCT01693562|155877949|FG006|Escalation Phase|Withdrawal by Subject|0|||
48460829|NCT01693562|155877950|FG007|Escalation Phase|Withdrawal by Subject|0|||
48460830|NCT01693562|155877951|FG008|Escalation Phase|Withdrawal by Subject|0|||
48460831|NCT01693562|155877952|FG009|Escalation Phase|Withdrawal by Subject|0|||
48460832|NCT01693562|155877953|FG010|Escalation Phase|Withdrawal by Subject|0|||
48460833|NCT01693562|155877954|FG011|Escalation Phase|Withdrawal by Subject|0|||
48460834|NCT01693562|155877955|FG012|Escalation Phase|Withdrawal by Subject|0|||
48460835|NCT01693562|155877956|FG013|Escalation Phase|Withdrawal by Subject|0|||
48460836|NCT01693562|155877957|FG014|Escalation Phase|Withdrawal by Subject|0|||
48460837|NCT01693562|155877958|FG015|Escalation Phase|Withdrawal by Subject|0|||
48460838|NCT01693562|155877959|FG016|Escalation Phase|Withdrawal by Subject|0|||
48460839|NCT01693562|155877960|FG017|Escalation Phase|Withdrawal by Subject|0|||
48460840|NCT01693562|155877961|FG018|Escalation Phase|Withdrawal by Subject|0|||
48460841|NCT01693562|155877962|FG019|Escalation Phase|Withdrawal by Subject|0|||
48460842|NCT01693562|155877963|FG020|Escalation Phase|Withdrawal by Subject|0|||
48460843|NCT01693562|155877964|FG021|Escalation Phase|Withdrawal by Subject|0|||
48460844|NCT01693562|155877965|FG022|Escalation Phase|Withdrawal by Subject|0|||
48460845|NCT01693562|155877943|FG000|Escalation Phase|Death|4|||
48460846|NCT01693562|155877944|FG001|Escalation Phase|Death|2|||
48460847|NCT01693562|155877945|FG002|Escalation Phase|Death|0|||
48460848|NCT01693562|155877946|FG003|Escalation Phase|Death|3|||
48460849|NCT01693562|155877947|FG004|Escalation Phase|Death|6|||
48460850|NCT01693562|155877948|FG005|Escalation Phase|Death|4|||
48460851|NCT01693562|155877949|FG006|Escalation Phase|Death|0|||
48460852|NCT01693562|155877950|FG007|Escalation Phase|Death|0|||
48460853|NCT01693562|155877951|FG008|Escalation Phase|Death|0|||
48460854|NCT01693562|155877952|FG009|Escalation Phase|Death|0|||
48460855|NCT01693562|155877953|FG010|Escalation Phase|Death|0|||
48460856|NCT01693562|155877954|FG011|Escalation Phase|Death|0|||
48460857|NCT01693562|155877955|FG012|Escalation Phase|Death|0|||
48460858|NCT01693562|155877956|FG013|Escalation Phase|Death|0|||
48460859|NCT01693562|155877957|FG014|Escalation Phase|Death|0|||
48460860|NCT01693562|155877958|FG015|Escalation Phase|Death|0|||
48460861|NCT01693562|155877959|FG016|Escalation Phase|Death|0|||
48460862|NCT01693562|155877960|FG017|Escalation Phase|Death|0|||
48460863|NCT01693562|155877961|FG018|Escalation Phase|Death|0|||
48460864|NCT01693562|155877962|FG019|Escalation Phase|Death|0|||
48460865|NCT01693562|155877963|FG020|Escalation Phase|Death|0|||
48460866|NCT01693562|155877964|FG021|Escalation Phase|Death|0|||
48460867|NCT01693562|155877965|FG022|Escalation Phase|Death|0|||
48460868|NCT01693562|155877943|FG000|Escalation Phase|Lost to Follow-up|0|||
48460869|NCT01693562|155877944|FG001|Escalation Phase|Lost to Follow-up|1|||
48460870|NCT01693562|155877945|FG002|Escalation Phase|Lost to Follow-up|1|||
48460871|NCT01693562|155877946|FG003|Escalation Phase|Lost to Follow-up|0|||
48460872|NCT01693562|155877947|FG004|Escalation Phase|Lost to Follow-up|0|||
48460873|NCT01693562|155877948|FG005|Escalation Phase|Lost to Follow-up|0|||
48460874|NCT01693562|155877949|FG006|Escalation Phase|Lost to Follow-up|0|||
48460875|NCT01693562|155877950|FG007|Escalation Phase|Lost to Follow-up|0|||
48460876|NCT01693562|155877951|FG008|Escalation Phase|Lost to Follow-up|0|||
48460877|NCT01693562|155877952|FG009|Escalation Phase|Lost to Follow-up|0|||
48460878|NCT01693562|155877953|FG010|Escalation Phase|Lost to Follow-up|0|||
48460879|NCT01693562|155877954|FG011|Escalation Phase|Lost to Follow-up|0|||
48460880|NCT01693562|155877955|FG012|Escalation Phase|Lost to Follow-up|0|||
48460881|NCT01693562|155877956|FG013|Escalation Phase|Lost to Follow-up|0|||
48460882|NCT01693562|155877957|FG014|Escalation Phase|Lost to Follow-up|0|||
48460883|NCT01693562|155877958|FG015|Escalation Phase|Lost to Follow-up|0|||
48460884|NCT01693562|155877959|FG016|Escalation Phase|Lost to Follow-up|0|||
48460885|NCT01693562|155877960|FG017|Escalation Phase|Lost to Follow-up|0|||
48460886|NCT01693562|155877961|FG018|Escalation Phase|Lost to Follow-up|0|||
48460887|NCT01693562|155877962|FG019|Escalation Phase|Lost to Follow-up|0|||
48460888|NCT01693562|155877963|FG020|Escalation Phase|Lost to Follow-up|0|||
48460889|NCT01693562|155877964|FG021|Escalation Phase|Lost to Follow-up|0|||
48460890|NCT01693562|155877965|FG022|Escalation Phase|Lost to Follow-up|0|||
48460891|NCT01693562|155877943|FG000|Escalation Phase|Other|0|||
48460892|NCT01693562|155877944|FG001|Escalation Phase|Other|0|||
48460893|NCT01693562|155877945|FG002|Escalation Phase|Other|2|||
48460894|NCT01693562|155877946|FG003|Escalation Phase|Other|0|||
48460895|NCT01693562|155877947|FG004|Escalation Phase|Other|0|||
48460896|NCT01693562|155877948|FG005|Escalation Phase|Other|1|||
48460897|NCT01693562|155877949|FG006|Escalation Phase|Other|0|||
48460898|NCT01693562|155877950|FG007|Escalation Phase|Other|0|||
48460899|NCT01693562|155877951|FG008|Escalation Phase|Other|0|||
48460900|NCT01693562|155877952|FG009|Escalation Phase|Other|0|||
48460901|NCT01693562|155877953|FG010|Escalation Phase|Other|0|||
48460902|NCT01693562|155877954|FG011|Escalation Phase|Other|0|||
48460903|NCT01693562|155877955|FG012|Escalation Phase|Other|0|||
48460904|NCT01693562|155877956|FG013|Escalation Phase|Other|0|||
48460905|NCT01693562|155877957|FG014|Escalation Phase|Other|0|||
48460906|NCT01693562|155877958|FG015|Escalation Phase|Other|0|||
48460907|NCT01693562|155877959|FG016|Escalation Phase|Other|0|||
48460908|NCT01693562|155877960|FG017|Escalation Phase|Other|0|||
48460909|NCT01693562|155877961|FG018|Escalation Phase|Other|0|||
48460910|NCT01693562|155877962|FG019|Escalation Phase|Other|0|||
48460911|NCT01693562|155877963|FG020|Escalation Phase|Other|0|||
48460912|NCT01693562|155877964|FG021|Escalation Phase|Other|0|||
48460913|NCT01693562|155877965|FG022|Escalation Phase|Other|0|||
48460914|NCT01693562|155877943|FG000|Exploration Phase|Withdrawal by Subject|0|||
48460915|NCT01693562|155877944|FG001|Exploration Phase|Withdrawal by Subject|0|||
48460916|NCT01693562|155877945|FG002|Exploration Phase|Withdrawal by Subject|0|||
48460917|NCT01693562|155877946|FG003|Exploration Phase|Withdrawal by Subject|0|||
48460918|NCT01693562|155877947|FG004|Exploration Phase|Withdrawal by Subject|0|||
48460919|NCT01693562|155877948|FG005|Exploration Phase|Withdrawal by Subject|0|||
48460920|NCT01693562|155877949|FG006|Exploration Phase|Withdrawal by Subject|2|||
48460921|NCT01693562|155877950|FG007|Exploration Phase|Withdrawal by Subject|0|||
48460922|NCT01693562|155877951|FG008|Exploration Phase|Withdrawal by Subject|0|||
48460923|NCT01693562|155877952|FG009|Exploration Phase|Withdrawal by Subject|0|||
48460924|NCT01693562|155877953|FG010|Exploration Phase|Withdrawal by Subject|0|||
48460925|NCT01693562|155877954|FG011|Exploration Phase|Withdrawal by Subject|0|||
48460926|NCT01693562|155877955|FG012|Exploration Phase|Withdrawal by Subject|0|||
48460927|NCT01693562|155877956|FG013|Exploration Phase|Withdrawal by Subject|0|||
48460928|NCT01693562|155877957|FG014|Exploration Phase|Withdrawal by Subject|0|||
48460929|NCT01693562|155877958|FG015|Exploration Phase|Withdrawal by Subject|0|||
48460930|NCT01693562|155877959|FG016|Exploration Phase|Withdrawal by Subject|0|||
48460931|NCT01693562|155877960|FG017|Exploration Phase|Withdrawal by Subject|0|||
48460932|NCT01693562|155877961|FG018|Exploration Phase|Withdrawal by Subject|0|||
48460933|NCT01693562|155877962|FG019|Exploration Phase|Withdrawal by Subject|0|||
48460934|NCT01693562|155877963|FG020|Exploration Phase|Withdrawal by Subject|0|||
48460935|NCT01693562|155877964|FG021|Exploration Phase|Withdrawal by Subject|0|||
48460936|NCT01693562|155877965|FG022|Exploration Phase|Withdrawal by Subject|0|||
48460937|NCT01693562|155877943|FG000|Exploration Phase|Death|0|||
48460938|NCT01693562|155877944|FG001|Exploration Phase|Death|0|||
48460939|NCT01693562|155877945|FG002|Exploration Phase|Death|0|||
48460940|NCT01693562|155877946|FG003|Exploration Phase|Death|0|||
48460941|NCT01693562|155877947|FG004|Exploration Phase|Death|0|||
48460942|NCT01693562|155877948|FG005|Exploration Phase|Death|0|||
48460943|NCT01693562|155877949|FG006|Exploration Phase|Death|17|||
48460944|NCT01693562|155877950|FG007|Exploration Phase|Death|0|||
48460945|NCT01693562|155877951|FG008|Exploration Phase|Death|0|||
48460946|NCT01693562|155877952|FG009|Exploration Phase|Death|0|||
48460947|NCT01693562|155877953|FG010|Exploration Phase|Death|0|||
48460948|NCT01693562|155877954|FG011|Exploration Phase|Death|0|||
48460949|NCT01693562|155877955|FG012|Exploration Phase|Death|0|||
48460950|NCT01693562|155877956|FG013|Exploration Phase|Death|0|||
48460951|NCT01693562|155877957|FG014|Exploration Phase|Death|0|||
48460952|NCT01693562|155877958|FG015|Exploration Phase|Death|0|||
48460953|NCT01693562|155877959|FG016|Exploration Phase|Death|0|||
48460954|NCT01693562|155877960|FG017|Exploration Phase|Death|0|||
48460955|NCT01693562|155877961|FG018|Exploration Phase|Death|0|||
48460956|NCT01693562|155877962|FG019|Exploration Phase|Death|0|||
48460957|NCT01693562|155877963|FG020|Exploration Phase|Death|0|||
48460958|NCT01693562|155877964|FG021|Exploration Phase|Death|0|||
48460959|NCT01693562|155877965|FG022|Exploration Phase|Death|0|||
48460960|NCT01693562|155877943|FG000|Exploration Phase|Other|0|||
48460961|NCT01693562|155877944|FG001|Exploration Phase|Other|0|||
48460962|NCT01693562|155877945|FG002|Exploration Phase|Other|0|||
48460963|NCT01693562|155877946|FG003|Exploration Phase|Other|0|||
48460964|NCT01693562|155877947|FG004|Exploration Phase|Other|0|||
48460965|NCT01693562|155877948|FG005|Exploration Phase|Other|0|||
48460966|NCT01693562|155877949|FG006|Exploration Phase|Other|2|||
48460967|NCT01693562|155877950|FG007|Exploration Phase|Other|0|||
48460968|NCT01693562|155877951|FG008|Exploration Phase|Other|0|||
48460969|NCT01693562|155877952|FG009|Exploration Phase|Other|0|||
48460970|NCT01693562|155877953|FG010|Exploration Phase|Other|0|||
48460971|NCT01693562|155877954|FG011|Exploration Phase|Other|0|||
48460972|NCT01693562|155877955|FG012|Exploration Phase|Other|0|||
48460973|NCT01693562|155877956|FG013|Exploration Phase|Other|0|||
48460974|NCT01693562|155877957|FG014|Exploration Phase|Other|0|||
48460975|NCT01693562|155877958|FG015|Exploration Phase|Other|0|||
48460976|NCT01693562|155877959|FG016|Exploration Phase|Other|0|||
48460977|NCT01693562|155877960|FG017|Exploration Phase|Other|0|||
48460978|NCT01693562|155877961|FG018|Exploration Phase|Other|0|||
48460979|NCT01693562|155877962|FG019|Exploration Phase|Other|0|||
48460980|NCT01693562|155877963|FG020|Exploration Phase|Other|0|||
48460981|NCT01693562|155877964|FG021|Exploration Phase|Other|0|||
48460982|NCT01693562|155877965|FG022|Exploration Phase|Other|0|||
48460983|NCT01693562|155877943|FG000|Expansion Phase|Withdrawal by Subject|0|||
48460984|NCT01693562|155877944|FG001|Expansion Phase|Withdrawal by Subject|0|||
48460985|NCT01693562|155877945|FG002|Expansion Phase|Withdrawal by Subject|0|||
48460986|NCT01693562|155877946|FG003|Expansion Phase|Withdrawal by Subject|0|||
48460987|NCT01693562|155877947|FG004|Expansion Phase|Withdrawal by Subject|0|||
48460988|NCT01693562|155877948|FG005|Expansion Phase|Withdrawal by Subject|0|||
48460989|NCT01693562|155877949|FG006|Expansion Phase|Withdrawal by Subject|0|||
48460990|NCT01693562|155877950|FG007|Expansion Phase|Withdrawal by Subject|16|||
48460991|NCT01693562|155877951|FG008|Expansion Phase|Withdrawal by Subject|2|||
48460992|NCT01693562|155877952|FG009|Expansion Phase|Withdrawal by Subject|54|||
48460993|NCT01693562|155877953|FG010|Expansion Phase|Withdrawal by Subject|2|||
48460994|NCT01693562|155877954|FG011|Expansion Phase|Withdrawal by Subject|2|||
48460995|NCT01693562|155877955|FG012|Expansion Phase|Withdrawal by Subject|3|||
48460996|NCT01693562|155877956|FG013|Expansion Phase|Withdrawal by Subject|5|||
48460997|NCT01693562|155877957|FG014|Expansion Phase|Withdrawal by Subject|16|||
48460998|NCT01693562|155877958|FG015|Expansion Phase|Withdrawal by Subject|7|||
48460999|NCT01693562|155877959|FG016|Expansion Phase|Withdrawal by Subject|40|||
48461000|NCT01693562|155877960|FG017|Expansion Phase|Withdrawal by Subject|4|||
48461001|NCT01693562|155877961|FG018|Expansion Phase|Withdrawal by Subject|8|||
48461002|NCT01693562|155877962|FG019|Expansion Phase|Withdrawal by Subject|3|||
48461003|NCT01693562|155877963|FG020|Expansion Phase|Withdrawal by Subject|1|||
48461004|NCT01693562|155877964|FG021|Expansion Phase|Withdrawal by Subject|8|||
48461005|NCT01693562|155877965|FG022|Expansion Phase|Withdrawal by Subject|1|||
48461006|NCT01693562|155877943|FG000|Expansion Phase|Death|0|||
48461007|NCT01693562|155877944|FG001|Expansion Phase|Death|0|||
48461008|NCT01693562|155877945|FG002|Expansion Phase|Death|0|||
48461009|NCT01693562|155877946|FG003|Expansion Phase|Death|0|||
48461010|NCT01693562|155877947|FG004|Expansion Phase|Death|0|||
48461011|NCT01693562|155877948|FG005|Expansion Phase|Death|0|||
48461012|NCT01693562|155877949|FG006|Expansion Phase|Death|0|||
48461013|NCT01693562|155877950|FG007|Expansion Phase|Death|42|||
48461014|NCT01693562|155877951|FG008|Expansion Phase|Death|17|||
48461015|NCT01693562|155877952|FG009|Expansion Phase|Death|208|||
48461016|NCT01693562|155877953|FG010|Expansion Phase|Death|30|||
48461017|NCT01693562|155877954|FG011|Expansion Phase|Death|8|||
48461018|NCT01693562|155877955|FG012|Expansion Phase|Death|19|||
48461019|NCT01693562|155877956|FG013|Expansion Phase|Death|42|||
48461020|NCT01693562|155877957|FG014|Expansion Phase|Death|23|||
48461021|NCT01693562|155877958|FG015|Expansion Phase|Death|23|||
48461022|NCT01693562|155877959|FG016|Expansion Phase|Death|128|||
48461023|NCT01693562|155877960|FG017|Expansion Phase|Death|16|||
48461024|NCT01693562|155877961|FG018|Expansion Phase|Death|36|||
48461025|NCT01693562|155877962|FG019|Expansion Phase|Death|16|||
48461026|NCT01693562|155877963|FG020|Expansion Phase|Death|17|||
48461027|NCT01693562|155877964|FG021|Expansion Phase|Death|35|||
48461028|NCT01693562|155877965|FG022|Expansion Phase|Death|7|||
48461029|NCT01693562|155877943|FG000|Expansion Phase|Lost to Follow-up|0|||
48461030|NCT01693562|155877944|FG001|Expansion Phase|Lost to Follow-up|0|||
48461031|NCT01693562|155877945|FG002|Expansion Phase|Lost to Follow-up|0|||
48461032|NCT01693562|155877946|FG003|Expansion Phase|Lost to Follow-up|0|||
48461033|NCT01693562|155877947|FG004|Expansion Phase|Lost to Follow-up|0|||
48461034|NCT01693562|155877948|FG005|Expansion Phase|Lost to Follow-up|0|||
48461035|NCT01693562|155877949|FG006|Expansion Phase|Lost to Follow-up|0|||
48461036|NCT01693562|155877950|FG007|Expansion Phase|Lost to Follow-up|1|||
48461037|NCT01693562|155877951|FG008|Expansion Phase|Lost to Follow-up|2|||
48461038|NCT01693562|155877952|FG009|Expansion Phase|Lost to Follow-up|10|||
48461039|NCT01693562|155877953|FG010|Expansion Phase|Lost to Follow-up|4|||
48461040|NCT01693562|155877954|FG011|Expansion Phase|Lost to Follow-up|4|||
48461041|NCT01693562|155877955|FG012|Expansion Phase|Lost to Follow-up|1|||
48461042|NCT01693562|155877956|FG013|Expansion Phase|Lost to Follow-up|3|||
48461043|NCT01693562|155877957|FG014|Expansion Phase|Lost to Follow-up|0|||
48461044|NCT01693562|155877958|FG015|Expansion Phase|Lost to Follow-up|1|||
48461045|NCT01693562|155877959|FG016|Expansion Phase|Lost to Follow-up|1|||
48461046|NCT01693562|155877960|FG017|Expansion Phase|Lost to Follow-up|0|||
48461047|NCT01693562|155877961|FG018|Expansion Phase|Lost to Follow-up|2|||
48461048|NCT01693562|155877962|FG019|Expansion Phase|Lost to Follow-up|1|||
48461049|NCT01693562|155877963|FG020|Expansion Phase|Lost to Follow-up|2|||
48461050|NCT01693562|155877964|FG021|Expansion Phase|Lost to Follow-up|2|||
48461051|NCT01693562|155877965|FG022|Expansion Phase|Lost to Follow-up|1|||
48461052|NCT01693562|155877943|FG000|Expansion Phase|Other|0|||
48461053|NCT01693562|155877944|FG001|Expansion Phase|Other|0|||
48461054|NCT01693562|155877945|FG002|Expansion Phase|Other|0|||
48461055|NCT01693562|155877946|FG003|Expansion Phase|Other|0|||
48461056|NCT01693562|155877947|FG004|Expansion Phase|Other|0|||
48461057|NCT01693562|155877948|FG005|Expansion Phase|Other|0|||
48461058|NCT01693562|155877949|FG006|Expansion Phase|Other|0|||
48461059|NCT01693562|155877950|FG007|Expansion Phase|Other|3|||
48461060|NCT01693562|155877951|FG008|Expansion Phase|Other|1|||
48461061|NCT01693562|155877952|FG009|Expansion Phase|Other|28|||
48461062|NCT01693562|155877953|FG010|Expansion Phase|Other|4|||
48461063|NCT01693562|155877954|FG011|Expansion Phase|Other|7|||
48461064|NCT01693562|155877955|FG012|Expansion Phase|Other|0|||
48461065|NCT01693562|155877956|FG013|Expansion Phase|Other|1|||
48461066|NCT01693562|155877957|FG014|Expansion Phase|Other|1|||
48461067|NCT01693562|155877958|FG015|Expansion Phase|Other|0|||
48461068|NCT01693562|155877959|FG016|Expansion Phase|Other|28|||
48461069|NCT01693562|155877960|FG017|Expansion Phase|Other|0|||
48461070|NCT01693562|155877961|FG018|Expansion Phase|Other|1|||
48461071|NCT01693562|155877962|FG019|Expansion Phase|Other|0|||
48461072|NCT01693562|155877963|FG020|Expansion Phase|Other|1|||
48461073|NCT01693562|155877964|FG021|Expansion Phase|Other|17|||
48461074|NCT01693562|155877965|FG022|Expansion Phase|Other|1|||
48461075|NCT02710422|155877966|FG000|Overall Study|Termination of study|9|||
48461076|NCT02710422|155877967|FG001|Overall Study|Termination of study|9|||
48461077|NCT05466240|155877968|FG000|Overall Study|Adverse Event|1|||
48461078|NCT05466240|155877969|FG001|Overall Study|Adverse Event|0|||
48461079|NCT05466240|155877968|FG000|Overall Study|Withdrawal by Subject|1|||
48461080|NCT05466240|155877969|FG001|Overall Study|Withdrawal by Subject|0|||
48461081|NCT01599585|155877976|FG000|Overall Study|Withdrawal by Subject|16|||
48461082|NCT01599585|155877977|FG001|Overall Study|Withdrawal by Subject|9|||
48461083|NCT01599585|155877976|FG000|Overall Study|Lost to Follow-up|3|||
48461084|NCT01599585|155877977|FG001|Overall Study|Lost to Follow-up|5|||
48461085|NCT01599585|155877976|FG000|Overall Study|randomized did not start treatment|3|||
48461086|NCT01599585|155877977|FG001|Overall Study|randomized did not start treatment|3|||
48461087|NCT00137267|155877980|FG000|Overall Study|Lost to Follow-up|15|||
48461088|NCT00137267|155877981|FG001|Overall Study|Lost to Follow-up|21|||
48461089|NCT00853112|155877982|FG000|Overall Study|Randomized but not treated|0|||
48461090|NCT00853112|155877983|FG001|Overall Study|Randomized but not treated|1|||
48461091|NCT00853112|155877984|FG002|Overall Study|Randomized but not treated|0|||
48461092|NCT00853112|155877985|FG003|Overall Study|Randomized but not treated|2|||
48461093|NCT00853112|155877986|FG004|Overall Study|Randomized but not treated|0|||
48461094|NCT00853112|155877987|FG005|Overall Study|Randomized but not treated|0|||
48461095|NCT00853112|155877988|FG006|Overall Study|Randomized but not treated|1|||
48461096|NCT02477800|155877989|FG000|Placebo-Controlled Period|Adverse Event|16|||
48461097|NCT02477800|155877990|FG001|Placebo-Controlled Period|Adverse Event|25|||
48461098|NCT02477800|155877991|FG002|Placebo-Controlled Period|Adverse Event|28|||
48461099|NCT02477800|155877992|FG003|Placebo-Controlled Period|Adverse Event|0|||
48461100|NCT02477800|155877993|FG004|Placebo-Controlled Period|Adverse Event|0|||
48461101|NCT02477800|155877994|FG005|Placebo-Controlled Period|Adverse Event|0|||
48461102|NCT02477800|155877995|FG006|Placebo-Controlled Period|Adverse Event|0|||
48461103|NCT02477800|155877989|FG000|Placebo-Controlled Period|Change of Treatment|1|||
48461104|NCT02477800|155877990|FG001|Placebo-Controlled Period|Change of Treatment|2|||
48461105|NCT02477800|155877991|FG002|Placebo-Controlled Period|Change of Treatment|1|||
48461106|NCT02477800|155877992|FG003|Placebo-Controlled Period|Change of Treatment|0|||
48461107|NCT02477800|155877993|FG004|Placebo-Controlled Period|Change of Treatment|0|||
48461108|NCT02477800|155877994|FG005|Placebo-Controlled Period|Change of Treatment|0|||
48461109|NCT02477800|155877995|FG006|Placebo-Controlled Period|Change of Treatment|0|||
48461110|NCT02477800|155877989|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
48461111|NCT02477800|155877990|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
48461112|NCT02477800|155877991|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
48461113|NCT02477800|155877992|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
48461114|NCT02477800|155877993|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
48461115|NCT02477800|155877994|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
48461116|NCT02477800|155877995|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
48461117|NCT02477800|155877989|FG000|Placebo-Controlled Period|Death|0|||
48461118|NCT02477800|155877990|FG001|Placebo-Controlled Period|Death|3|||
48461119|NCT02477800|155877991|FG002|Placebo-Controlled Period|Death|2|||
48461120|NCT02477800|155877992|FG003|Placebo-Controlled Period|Death|0|||
48461121|NCT02477800|155877993|FG004|Placebo-Controlled Period|Death|0|||
48461122|NCT02477800|155877994|FG005|Placebo-Controlled Period|Death|0|||
48461123|NCT02477800|155877995|FG006|Placebo-Controlled Period|Death|0|||
48461124|NCT02477800|155877989|FG000|Placebo-Controlled Period|Disease Progression|1|||
48461125|NCT02477800|155877990|FG001|Placebo-Controlled Period|Disease Progression|0|||
48461126|NCT02477800|155877991|FG002|Placebo-Controlled Period|Disease Progression|1|||
48461127|NCT02477800|155877992|FG003|Placebo-Controlled Period|Disease Progression|0|||
48461128|NCT02477800|155877993|FG004|Placebo-Controlled Period|Disease Progression|0|||
48461129|NCT02477800|155877994|FG005|Placebo-Controlled Period|Disease Progression|0|||
48461130|NCT02477800|155877995|FG006|Placebo-Controlled Period|Disease Progression|0|||
48461131|NCT02477800|155877989|FG000|Placebo-Controlled Period|Investigator Decision|3|||
48461132|NCT02477800|155877990|FG001|Placebo-Controlled Period|Investigator Decision|2|||
48461133|NCT02477800|155877991|FG002|Placebo-Controlled Period|Investigator Decision|1|||
48461134|NCT02477800|155877992|FG003|Placebo-Controlled Period|Investigator Decision|0|||
48461135|NCT02477800|155877993|FG004|Placebo-Controlled Period|Investigator Decision|0|||
48461136|NCT02477800|155877994|FG005|Placebo-Controlled Period|Investigator Decision|0|||
48461137|NCT02477800|155877995|FG006|Placebo-Controlled Period|Investigator Decision|0|||
48461138|NCT02477800|155877989|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
48461139|NCT02477800|155877990|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
48461140|NCT02477800|155877991|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
48461141|NCT02477800|155877992|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
48461142|NCT02477800|155877993|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
48461143|NCT02477800|155877994|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
48461144|NCT02477800|155877995|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
48461145|NCT02477800|155877989|FG000|Placebo-Controlled Period|Relocation|2|||
48461146|NCT02477800|155877990|FG001|Placebo-Controlled Period|Relocation|0|||
48461147|NCT02477800|155877991|FG002|Placebo-Controlled Period|Relocation|0|||
48461148|NCT02477800|155877992|FG003|Placebo-Controlled Period|Relocation|0|||
48461149|NCT02477800|155877993|FG004|Placebo-Controlled Period|Relocation|0|||
48461150|NCT02477800|155877994|FG005|Placebo-Controlled Period|Relocation|0|||
48461151|NCT02477800|155877995|FG006|Placebo-Controlled Period|Relocation|0|||
48461152|NCT02477800|155877989|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
48461153|NCT02477800|155877990|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
48461154|NCT02477800|155877991|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
48461155|NCT02477800|155877992|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
48461156|NCT02477800|155877993|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
48461157|NCT02477800|155877994|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
48461158|NCT02477800|155877995|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
48461159|NCT02477800|155877989|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
48461160|NCT02477800|155877990|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
48461161|NCT02477800|155877991|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48461162|NCT02477800|155877992|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48461163|NCT02477800|155877993|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48461164|NCT02477800|155877994|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48461165|NCT02477800|155877995|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
48461166|NCT02477800|155877989|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
48461167|NCT02477800|155877990|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
48461168|NCT02477800|155877991|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
48461169|NCT02477800|155877992|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
48461170|NCT02477800|155877993|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
48461171|NCT02477800|155877994|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
48461172|NCT02477800|155877995|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
48461173|NCT02477800|155877989|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
48461174|NCT02477800|155877990|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
48461175|NCT02477800|155877991|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
48461176|NCT02477800|155877992|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48461177|NCT02477800|155877993|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48461178|NCT02477800|155877994|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48461179|NCT02477800|155877995|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
48461180|NCT02477800|155877989|FG000|Placebo-Controlled Period|Reason not Specified|161|||
48461181|NCT02477800|155877990|FG001|Placebo-Controlled Period|Reason not Specified|161|||
48461182|NCT02477800|155877991|FG002|Placebo-Controlled Period|Reason not Specified|189|||
48461183|NCT02477800|155877992|FG003|Placebo-Controlled Period|Reason not Specified|0|||
48461184|NCT02477800|155877993|FG004|Placebo-Controlled Period|Reason not Specified|0|||
48461185|NCT02477800|155877994|FG005|Placebo-Controlled Period|Reason not Specified|0|||
48461186|NCT02477800|155877995|FG006|Placebo-Controlled Period|Reason not Specified|0|||
48461187|NCT02477800|155877989|FG000|Long Term Extension Period|Adverse Event|0|||
48461188|NCT02477800|155877990|FG001|Long Term Extension Period|Adverse Event|0|||
48461189|NCT02477800|155877991|FG002|Long Term Extension Period|Adverse Event|0|||
48461190|NCT02477800|155877992|FG003|Long Term Extension Period|Adverse Event|6|||
48461191|NCT02477800|155877993|FG004|Long Term Extension Period|Adverse Event|2|||
48461192|NCT02477800|155877994|FG005|Long Term Extension Period|Adverse Event|4|||
48461193|NCT02477800|155877995|FG006|Long Term Extension Period|Adverse Event|3|||
48461194|NCT02477800|155877989|FG000|Long Term Extension Period|Death|0|||
48461195|NCT02477800|155877990|FG001|Long Term Extension Period|Death|0|||
48461196|NCT02477800|155877991|FG002|Long Term Extension Period|Death|0|||
48461197|NCT02477800|155877992|FG003|Long Term Extension Period|Death|1|||
48461198|NCT02477800|155877993|FG004|Long Term Extension Period|Death|1|||
48461199|NCT02477800|155877994|FG005|Long Term Extension Period|Death|1|||
48461200|NCT02477800|155877995|FG006|Long Term Extension Period|Death|2|||
48461201|NCT02477800|155877989|FG000|Long Term Extension Period|Consent Withdrawn|0|||
48461202|NCT02477800|155877990|FG001|Long Term Extension Period|Consent Withdrawn|0|||
48461203|NCT02477800|155877991|FG002|Long Term Extension Period|Consent Withdrawn|0|||
48461204|NCT02477800|155877992|FG003|Long Term Extension Period|Consent Withdrawn|10|||
48461205|NCT02477800|155877993|FG004|Long Term Extension Period|Consent Withdrawn|4|||
48461206|NCT02477800|155877994|FG005|Long Term Extension Period|Consent Withdrawn|13|||
48461207|NCT02477800|155877995|FG006|Long Term Extension Period|Consent Withdrawn|16|||
48461208|NCT02477800|155877989|FG000|Long Term Extension Period|Disease Progression|0|||
48461209|NCT02477800|155877990|FG001|Long Term Extension Period|Disease Progression|0|||
48461210|NCT02477800|155877991|FG002|Long Term Extension Period|Disease Progression|0|||
48461211|NCT02477800|155877992|FG003|Long Term Extension Period|Disease Progression|3|||
48461212|NCT02477800|155877993|FG004|Long Term Extension Period|Disease Progression|1|||
48461285|NCT00811395|155878018|FG004|Extension Treatment|Adverse Event|0|||
48461213|NCT02477800|155877994|FG005|Long Term Extension Period|Disease Progression|1|||
48461214|NCT02477800|155877995|FG006|Long Term Extension Period|Disease Progression|0|||
48461215|NCT02477800|155877989|FG000|Long Term Extension Period|Investigator Decision|0|||
48461216|NCT02477800|155877990|FG001|Long Term Extension Period|Investigator Decision|0|||
48461217|NCT02477800|155877991|FG002|Long Term Extension Period|Investigator Decision|0|||
48461218|NCT02477800|155877992|FG003|Long Term Extension Period|Investigator Decision|0|||
48461219|NCT02477800|155877993|FG004|Long Term Extension Period|Investigator Decision|0|||
48461220|NCT02477800|155877994|FG005|Long Term Extension Period|Investigator Decision|0|||
48461221|NCT02477800|155877995|FG006|Long Term Extension Period|Investigator Decision|2|||
48461222|NCT02477800|155877989|FG000|Long Term Extension Period|Lost to Follow-up|0|||
48461223|NCT02477800|155877990|FG001|Long Term Extension Period|Lost to Follow-up|0|||
48461224|NCT02477800|155877991|FG002|Long Term Extension Period|Lost to Follow-up|0|||
48461225|NCT02477800|155877992|FG003|Long Term Extension Period|Lost to Follow-up|0|||
48461226|NCT02477800|155877993|FG004|Long Term Extension Period|Lost to Follow-up|1|||
48461227|NCT02477800|155877994|FG005|Long Term Extension Period|Lost to Follow-up|3|||
48461228|NCT02477800|155877995|FG006|Long Term Extension Period|Lost to Follow-up|0|||
48461229|NCT02477800|155877989|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
48461230|NCT02477800|155877990|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
48461231|NCT02477800|155877991|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
48461232|NCT02477800|155877992|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
48461233|NCT02477800|155877993|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
48461234|NCT02477800|155877994|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
48461235|NCT02477800|155877995|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
48461236|NCT02477800|155877989|FG000|Long Term Extension Period|Study Visit Burden|0|||
48461237|NCT02477800|155877990|FG001|Long Term Extension Period|Study Visit Burden|0|||
48461238|NCT02477800|155877991|FG002|Long Term Extension Period|Study Visit Burden|0|||
48461239|NCT02477800|155877992|FG003|Long Term Extension Period|Study Visit Burden|3|||
48461240|NCT02477800|155877993|FG004|Long Term Extension Period|Study Visit Burden|0|||
48461241|NCT02477800|155877994|FG005|Long Term Extension Period|Study Visit Burden|2|||
48461242|NCT02477800|155877995|FG006|Long Term Extension Period|Study Visit Burden|2|||
48461243|NCT02477800|155877989|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
48461244|NCT02477800|155877990|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
48461245|NCT02477800|155877991|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
48461246|NCT02477800|155877992|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
48461247|NCT02477800|155877993|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
48461248|NCT02477800|155877994|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
48461249|NCT02477800|155877995|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
48461250|NCT02477800|155877989|FG000|Long Term Extension Period|Reason not Specified|0|||
48461251|NCT02477800|155877990|FG001|Long Term Extension Period|Reason not Specified|0|||
48461252|NCT02477800|155877991|FG002|Long Term Extension Period|Reason not Specified|0|||
48461253|NCT02477800|155877992|FG003|Long Term Extension Period|Reason not Specified|126|||
48461254|NCT02477800|155877993|FG004|Long Term Extension Period|Reason not Specified|140|||
48461255|NCT02477800|155877994|FG005|Long Term Extension Period|Reason not Specified|270|||
48461256|NCT02477800|155877995|FG006|Long Term Extension Period|Reason not Specified|224|||
48461257|NCT00129376|155877996|FG000|Overall Study|Adverse Event|1|||
48461258|NCT00129376|155877996|FG000|Overall Study|Lack of Efficacy|1|||
48461259|NCT02061540|155878003|FG000|Overall Study|Adverse Event|2|||
48461260|NCT02061540|155878003|FG000|Overall Study|Withdrawal by Subject|2|||
48461261|NCT02449915|155878005|FG000|Overall Study|Exclusion criteria - drug use|1|||
48461262|NCT02449915|155878006|FG001|Overall Study|Exclusion criteria - drug use|0|||
48461263|NCT02449915|155878005|FG000|Overall Study|Withdrawal by Subject|0|||
48461264|NCT02449915|155878006|FG001|Overall Study|Withdrawal by Subject|2|||
48461265|NCT02449915|155878005|FG000|Overall Study|Intraoperative surgical findings|1|||
48461266|NCT02449915|155878006|FG001|Overall Study|Intraoperative surgical findings|1|||
48461267|NCT02449915|155878005|FG000|Overall Study|Abnormal preop lab|0|||
48461268|NCT02449915|155878006|FG001|Overall Study|Abnormal preop lab|1|||
48461269|NCT01227252|155878008|FG000|Overall Study|Sponsor Decision|0|||
48461270|NCT01227252|155878009|FG001|Overall Study|Sponsor Decision|1|||
48461271|NCT01227252|155878010|FG002|Overall Study|Sponsor Decision|0|||
48461272|NCT01227252|155878011|FG003|Overall Study|Sponsor Decision|0|||
48461273|NCT01227252|155878008|FG000|Overall Study|Lost to Follow-up|0|||
48461274|NCT01227252|155878009|FG001|Overall Study|Lost to Follow-up|1|||
48461275|NCT01227252|155878010|FG002|Overall Study|Lost to Follow-up|0|||
48461276|NCT01227252|155878011|FG003|Overall Study|Lost to Follow-up|0|||
48461277|NCT01227252|155878008|FG000|Overall Study|Withdrawal by Subject|0|||
48461278|NCT01227252|155878009|FG001|Overall Study|Withdrawal by Subject|1|||
48461279|NCT01227252|155878010|FG002|Overall Study|Withdrawal by Subject|0|||
48461280|NCT01227252|155878011|FG003|Overall Study|Withdrawal by Subject|0|||
48461281|NCT00811395|155878014|FG000|Extension Treatment|Adverse Event|1|||
48461282|NCT00811395|155878015|FG001|Extension Treatment|Adverse Event|2|||
48461283|NCT00811395|155878016|FG002|Extension Treatment|Adverse Event|2|||
48461284|NCT00811395|155878017|FG003|Extension Treatment|Adverse Event|2|||
48461286|NCT00811395|155878019|FG005|Extension Treatment|Adverse Event|1|||
48461287|NCT00811395|155878014|FG000|Extension Treatment|Progressive disease|1|||
48461288|NCT00811395|155878015|FG001|Extension Treatment|Progressive disease|1|||
48461289|NCT00811395|155878016|FG002|Extension Treatment|Progressive disease|0|||
48461290|NCT00811395|155878017|FG003|Extension Treatment|Progressive disease|0|||
48461291|NCT00811395|155878018|FG004|Extension Treatment|Progressive disease|0|||
48461292|NCT00811395|155878019|FG005|Extension Treatment|Progressive disease|0|||
48461293|NCT00811395|155878014|FG000|Extension Treatment|Participant did not wish to continue|0|||
48461294|NCT00811395|155878015|FG001|Extension Treatment|Participant did not wish to continue|3|||
48461295|NCT00811395|155878016|FG002|Extension Treatment|Participant did not wish to continue|0|||
48461296|NCT00811395|155878017|FG003|Extension Treatment|Participant did not wish to continue|1|||
48461297|NCT00811395|155878018|FG004|Extension Treatment|Participant did not wish to continue|0|||
48461298|NCT00811395|155878019|FG005|Extension Treatment|Participant did not wish to continue|1|||
48461299|NCT00811395|155878014|FG000|Extension Treatment|Other than above|0|||
48461300|NCT00811395|155878015|FG001|Extension Treatment|Other than above|0|||
48461301|NCT00811395|155878016|FG002|Extension Treatment|Other than above|1|||
48461302|NCT00811395|155878017|FG003|Extension Treatment|Other than above|0|||
48461303|NCT00811395|155878018|FG004|Extension Treatment|Other than above|0|||
48461304|NCT00811395|155878019|FG005|Extension Treatment|Other than above|0|||
48461305|NCT01034709|155878022|FG000|Overall Study|Protocol Violation|9|||
48461306|NCT01034709|155878023|FG001|Overall Study|Protocol Violation|16|||
48461307|NCT01947127|155878024|FG000|Overall Study|Protocol Violation|18|||
48461308|NCT01947127|155878025|FG001|Overall Study|Protocol Violation|38|||
48461309|NCT01947127|155878024|FG000|Overall Study|Withdrawal by Subject|1|||
48461310|NCT01947127|155878025|FG001|Overall Study|Withdrawal by Subject|1|||
48461311|NCT01947127|155878024|FG000|Overall Study|Data loss|4|||
48461312|NCT01947127|155878025|FG001|Overall Study|Data loss|4|||
48461313|NCT01196091|155878026|FG000|Overall Study|Adverse Event|22|||
48461314|NCT01196091|155878027|FG001|Overall Study|Adverse Event|27|||
48461315|NCT01196091|155878028|FG002|Overall Study|Adverse Event|26|||
48461316|NCT01196091|155878026|FG000|Overall Study|Death|3|||
48461317|NCT01196091|155878027|FG001|Overall Study|Death|2|||
48461318|NCT01196091|155878028|FG002|Overall Study|Death|2|||
48461319|NCT01196091|155878026|FG000|Overall Study|Entry Criteria Not Met|11|||
48461320|NCT01196091|155878027|FG001|Overall Study|Entry Criteria Not Met|11|||
48461321|NCT01196091|155878028|FG002|Overall Study|Entry Criteria Not Met|10|||
48461322|NCT01196091|155878026|FG000|Overall Study|Lack of Efficacy|15|||
48461323|NCT01196091|155878027|FG001|Overall Study|Lack of Efficacy|12|||
48461324|NCT01196091|155878028|FG002|Overall Study|Lack of Efficacy|17|||
48461325|NCT01196091|155878026|FG000|Overall Study|Lost to Follow-up|5|||
48461326|NCT01196091|155878027|FG001|Overall Study|Lost to Follow-up|5|||
48461327|NCT01196091|155878028|FG002|Overall Study|Lost to Follow-up|6|||
48461328|NCT01196091|155878026|FG000|Overall Study|Parent/Caregiver Decision|0|||
48461329|NCT01196091|155878027|FG001|Overall Study|Parent/Caregiver Decision|0|||
48461330|NCT01196091|155878028|FG002|Overall Study|Parent/Caregiver Decision|1|||
48461331|NCT01196091|155878026|FG000|Overall Study|Withdrawal by Subject|16|||
48461332|NCT01196091|155878027|FG001|Overall Study|Withdrawal by Subject|19|||
48461333|NCT01196091|155878028|FG002|Overall Study|Withdrawal by Subject|22|||
48461334|NCT01196091|155878026|FG000|Overall Study|Physician Decision|3|||
48461335|NCT01196091|155878027|FG001|Overall Study|Physician Decision|3|||
48461336|NCT01196091|155878028|FG002|Overall Study|Physician Decision|4|||
48461337|NCT01196091|155878026|FG000|Overall Study|Protocol Violation|1|||
48461338|NCT01196091|155878027|FG001|Overall Study|Protocol Violation|3|||
48461339|NCT01196091|155878028|FG002|Overall Study|Protocol Violation|3|||
48461340|NCT01196091|155878026|FG000|Overall Study|Sponsor Decision|6|||
48461341|NCT01196091|155878027|FG001|Overall Study|Sponsor Decision|5|||
48461342|NCT01196091|155878028|FG002|Overall Study|Sponsor Decision|4|||
48461343|NCT01196091|155878026|FG000|Overall Study|Excluded Site|5|||
48461344|NCT01196091|155878027|FG001|Overall Study|Excluded Site|11|||
48461345|NCT01196091|155878028|FG002|Overall Study|Excluded Site|8|||
48461346|NCT01196091|155878026|FG000|Overall Study|Randomized, No Study Drug Received|1|||
48461347|NCT01196091|155878027|FG001|Overall Study|Randomized, No Study Drug Received|0|||
48461348|NCT01196091|155878028|FG002|Overall Study|Randomized, No Study Drug Received|1|||
48461349|NCT03696576|155878029|FG000|Overall Study|Soreness of throat after therapy|1|||
48461350|NCT03696576|155878030|FG001|Overall Study|Soreness of throat after therapy|1|||
48461351|NCT03696576|155878029|FG000|Overall Study|Lost to Follow-up|2|||
48461352|NCT03696576|155878030|FG001|Overall Study|Lost to Follow-up|4|||
48461353|NCT00850135|155878031|FG000|Overall Study|Physician Decision|1|||
48461354|NCT02202161|155878034|FG000|Overall Study|Adverse Event|1|||
48461355|NCT02202161|155878035|FG001|Overall Study|Adverse Event|1|||
48461356|NCT02202161|155878036|FG002|Overall Study|Adverse Event|0|||
48461357|NCT02202161|155878037|FG003|Overall Study|Adverse Event|0|||
48461358|NCT02202161|155878038|FG004|Overall Study|Adverse Event|0|||
48461359|NCT02202161|155878039|FG005|Overall Study|Adverse Event|1|||
48461360|NCT02202161|155878040|FG006|Overall Study|Adverse Event|0|||
48461361|NCT02202161|155878041|FG007|Overall Study|Adverse Event|0|||
48461362|NCT02202161|155878034|FG000|Overall Study|Did not meet continuation criteria|0|||
48461363|NCT02202161|155878035|FG001|Overall Study|Did not meet continuation criteria|0|||
48461364|NCT02202161|155878036|FG002|Overall Study|Did not meet continuation criteria|0|||
48461365|NCT02202161|155878037|FG003|Overall Study|Did not meet continuation criteria|0|||
48461366|NCT02202161|155878038|FG004|Overall Study|Did not meet continuation criteria|0|||
48461367|NCT02202161|155878039|FG005|Overall Study|Did not meet continuation criteria|0|||
48461368|NCT02202161|155878040|FG006|Overall Study|Did not meet continuation criteria|0|||
48461369|NCT02202161|155878041|FG007|Overall Study|Did not meet continuation criteria|3|||
48461370|NCT02202161|155878034|FG000|Overall Study|Physician Decision|0|||
48461371|NCT02202161|155878035|FG001|Overall Study|Physician Decision|0|||
48461372|NCT02202161|155878036|FG002|Overall Study|Physician Decision|0|||
48461373|NCT02202161|155878037|FG003|Overall Study|Physician Decision|0|||
48461374|NCT02202161|155878038|FG004|Overall Study|Physician Decision|0|||
48461375|NCT02202161|155878039|FG005|Overall Study|Physician Decision|0|||
48461376|NCT02202161|155878040|FG006|Overall Study|Physician Decision|0|||
48461377|NCT02202161|155878041|FG007|Overall Study|Physician Decision|3|||
48461378|NCT02202161|155878034|FG000|Overall Study|Withdrawal by Subject|0|||
48461379|NCT02202161|155878035|FG001|Overall Study|Withdrawal by Subject|0|||
48461380|NCT02202161|155878036|FG002|Overall Study|Withdrawal by Subject|0|||
48461381|NCT02202161|155878037|FG003|Overall Study|Withdrawal by Subject|0|||
48461382|NCT02202161|155878038|FG004|Overall Study|Withdrawal by Subject|1|||
48461383|NCT02202161|155878039|FG005|Overall Study|Withdrawal by Subject|0|||
48461384|NCT02202161|155878040|FG006|Overall Study|Withdrawal by Subject|0|||
48461385|NCT02202161|155878041|FG007|Overall Study|Withdrawal by Subject|0|||
48461386|NCT00772889|155878042|FG000|Overall Study|Adverse Event|7|||
48461387|NCT00772889|155878043|FG001|Overall Study|Adverse Event|4|||
48461388|NCT00772889|155878044|FG002|Overall Study|Adverse Event|0|||
48461389|NCT00772889|155878042|FG000|Overall Study|Withdrawal by Subject|9|||
48461390|NCT00772889|155878043|FG001|Overall Study|Withdrawal by Subject|8|||
48461391|NCT00772889|155878044|FG002|Overall Study|Withdrawal by Subject|9|||
48461392|NCT00772889|155878042|FG000|Overall Study|Lost to Follow-up|6|||
48461393|NCT00772889|155878043|FG001|Overall Study|Lost to Follow-up|6|||
48461394|NCT00772889|155878044|FG002|Overall Study|Lost to Follow-up|7|||
48461395|NCT00355615|155878045|FG000|Randomized Double Blind Period|Adverse Event|1|||
48461396|NCT00355615|155878046|FG001|Randomized Double Blind Period|Adverse Event|0|||
48461397|NCT00355615|155878047|FG002|Randomized Double Blind Period|Adverse Event|0|||
48461398|NCT00355615|155878048|FG003|Randomized Double Blind Period|Adverse Event|0|||
48461399|NCT00355615|155878049|FG004|Randomized Double Blind Period|Adverse Event|0|||
48461400|NCT00355615|155878045|FG000|Randomized Double Blind Period|Protocol Violation|0|||
48461401|NCT00355615|155878046|FG001|Randomized Double Blind Period|Protocol Violation|0|||
48461402|NCT00355615|155878047|FG002|Randomized Double Blind Period|Protocol Violation|1|||
48461403|NCT00355615|155878048|FG003|Randomized Double Blind Period|Protocol Violation|1|||
48461404|NCT00355615|155878049|FG004|Randomized Double Blind Period|Protocol Violation|0|||
48461405|NCT00355615|155878045|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
48461406|NCT00355615|155878046|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
48461407|NCT00355615|155878047|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
48461408|NCT00355615|155878048|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
48461409|NCT00355615|155878049|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
48461410|NCT00355615|155878045|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
48461411|NCT00355615|155878046|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
48461412|NCT00355615|155878047|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
48461413|NCT00355615|155878048|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
48461414|NCT00355615|155878049|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
48461415|NCT00355615|155878045|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
48461416|NCT00355615|155878046|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
48461417|NCT00355615|155878047|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
48461418|NCT00355615|155878048|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
48461419|NCT00355615|155878049|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
48461420|NCT00355615|155878045|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
48461421|NCT00355615|155878046|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
48461422|NCT00355615|155878047|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
48461423|NCT00355615|155878048|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
48461424|NCT00355615|155878049|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
48461425|NCT01603628|155878050|FG000|Overall Study|Personal Reasons|1|||
48461426|NCT01603628|155878051|FG001|Overall Study|Personal Reasons|1|||
48461427|NCT01603628|155878052|FG002|Overall Study|Personal Reasons|2|||
48461428|NCT01603628|155878050|FG000|Overall Study|Protocol Violation|1|||
48461429|NCT01603628|155878051|FG001|Overall Study|Protocol Violation|1|||
48461430|NCT01603628|155878052|FG002|Overall Study|Protocol Violation|0|||
48461431|NCT01603628|155878050|FG000|Overall Study|Lost to Follow-up|0|||
48461432|NCT01603628|155878051|FG001|Overall Study|Lost to Follow-up|1|||
48461433|NCT01603628|155878052|FG002|Overall Study|Lost to Follow-up|0|||
48461434|NCT01603628|155878050|FG000|Overall Study|Other Miscellaneous Reason|1|||
48461435|NCT01603628|155878051|FG001|Overall Study|Other Miscellaneous Reason|0|||
48461436|NCT01603628|155878052|FG002|Overall Study|Other Miscellaneous Reason|0|||
48461437|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Adverse Event|30|||
48461438|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Adverse Event|25|||
48461439|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Adverse Event|23|||
48461440|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Adverse Event|14|||
48461441|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Death|0|||
48461442|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Death|0|||
48461443|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Death|1|||
48461444|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Death|0|||
48461445|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Physician Decision|0|||
48461446|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Physician Decision|1|||
48461447|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Physician Decision|0|||
48461448|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Physician Decision|1|||
48461449|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
48461450|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
48461451|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
48461452|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
48461453|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Other|6|||
48461454|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Other|1|||
48461455|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Other|0|||
48461456|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Other|2|||
48461457|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
48461458|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
48461459|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
48461460|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
48461461|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
48461462|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
48461463|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
48461464|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
48461465|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
48461466|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
48461467|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
48461468|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
48461469|NCT00242710|155878053|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
48461470|NCT00242710|155878054|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
48461471|NCT00242710|155878055|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
48461472|NCT00242710|155878056|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
48461473|NCT00242710|155878053|FG000|Period Between Core Study and Extension|Adverse Event|2|||
48461474|NCT00242710|155878054|FG001|Period Between Core Study and Extension|Adverse Event|3|||
48461475|NCT00242710|155878055|FG002|Period Between Core Study and Extension|Adverse Event|5|||
48461476|NCT00242710|155878056|FG003|Period Between Core Study and Extension|Adverse Event|2|||
48461477|NCT00242710|155878053|FG000|Period Between Core Study and Extension|Physician Decision|1|||
48461478|NCT00242710|155878054|FG001|Period Between Core Study and Extension|Physician Decision|1|||
48461479|NCT00242710|155878055|FG002|Period Between Core Study and Extension|Physician Decision|0|||
48461480|NCT00242710|155878056|FG003|Period Between Core Study and Extension|Physician Decision|0|||
48461481|NCT00242710|155878053|FG000|Period Between Core Study and Extension|Other|24|||
48461482|NCT00242710|155878054|FG001|Period Between Core Study and Extension|Other|24|||
48461483|NCT00242710|155878055|FG002|Period Between Core Study and Extension|Other|9|||
48461484|NCT00242710|155878056|FG003|Period Between Core Study and Extension|Other|11|||
48461485|NCT00242710|155878053|FG000|Period Between Core Study and Extension|Extension not Available|17|||
48461486|NCT00242710|155878054|FG001|Period Between Core Study and Extension|Extension not Available|21|||
48461487|NCT00242710|155878055|FG002|Period Between Core Study and Extension|Extension not Available|8|||
48461488|NCT00242710|155878056|FG003|Period Between Core Study and Extension|Extension not Available|7|||
48461489|NCT00242710|155878053|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
48461490|NCT00242710|155878054|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
48461491|NCT00242710|155878055|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
48461492|NCT00242710|155878056|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
48461493|NCT00242710|155878053|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
48461494|NCT00242710|155878054|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
48461495|NCT00242710|155878055|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
48461496|NCT00242710|155878056|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
48461497|NCT00242710|155878053|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
48461498|NCT00242710|155878054|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
48461499|NCT00242710|155878055|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
48461500|NCT00242710|155878056|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
48461501|NCT00242710|155878053|FG000|Study Extension (up to Year 2)|Death|0|||
48461502|NCT00242710|155878054|FG001|Study Extension (up to Year 2)|Death|0|||
48461503|NCT00242710|155878055|FG002|Study Extension (up to Year 2)|Death|0|||
48461504|NCT00242710|155878056|FG003|Study Extension (up to Year 2)|Death|1|||
48461505|NCT00242710|155878053|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
48461506|NCT00242710|155878054|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
48461507|NCT00242710|155878055|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
48461508|NCT00242710|155878056|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
48461509|NCT00242710|155878053|FG000|Study Extension (up to Year 2)|Other|3|||
48461510|NCT00242710|155878054|FG001|Study Extension (up to Year 2)|Other|5|||
48461511|NCT00242710|155878055|FG002|Study Extension (up to Year 2)|Other|4|||
48461512|NCT00242710|155878056|FG003|Study Extension (up to Year 2)|Other|3|||
48461513|NCT00242710|155878053|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
48461514|NCT00242710|155878054|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
48461515|NCT00242710|155878055|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
48461516|NCT00242710|155878056|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
48461517|NCT00242710|155878053|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
48461518|NCT00242710|155878054|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
48461519|NCT00242710|155878055|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
48461520|NCT00242710|155878056|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
48461521|NCT03083470|155878057|FG000|Overall Study|Lost to Follow-up|0|||
48461522|NCT03083470|155878058|FG001|Overall Study|Lost to Follow-up|0|||
48461523|NCT03083470|155878059|FG002|Overall Study|Lost to Follow-up|0|||
48461524|NCT03083470|155878060|FG003|Overall Study|Lost to Follow-up|0|||
48461525|NCT03083470|155878061|FG004|Overall Study|Lost to Follow-up|1|||
48461526|NCT03083470|155878057|FG000|Overall Study|Withdrawal by Subject|0|||
48461527|NCT03083470|155878058|FG001|Overall Study|Withdrawal by Subject|0|||
48461528|NCT03083470|155878059|FG002|Overall Study|Withdrawal by Subject|0|||
48461529|NCT03083470|155878060|FG003|Overall Study|Withdrawal by Subject|0|||
48461530|NCT03083470|155878061|FG004|Overall Study|Withdrawal by Subject|1|||
48461531|NCT00256204|155878062|FG000|Overall Study|Adverse Event|10|||
48461532|NCT00256204|155878063|FG001|Overall Study|Adverse Event|14|||
48461533|NCT00256204|155878064|FG002|Overall Study|Adverse Event|16|||
48461534|NCT00256204|155878065|FG003|Overall Study|Adverse Event|14|||
48461535|NCT00256204|155878062|FG000|Overall Study|Death|0|||
48461536|NCT00256204|155878063|FG001|Overall Study|Death|1|||
48461537|NCT00256204|155878064|FG002|Overall Study|Death|0|||
48461538|NCT00256204|155878065|FG003|Overall Study|Death|0|||
48461539|NCT00256204|155878062|FG000|Overall Study|Lost to Follow-up|1|||
48461540|NCT00256204|155878063|FG001|Overall Study|Lost to Follow-up|1|||
48461541|NCT00256204|155878064|FG002|Overall Study|Lost to Follow-up|1|||
48461542|NCT00256204|155878065|FG003|Overall Study|Lost to Follow-up|2|||
48461543|NCT00256204|155878062|FG000|Overall Study|Protocol Violation|1|||
48461544|NCT00256204|155878063|FG001|Overall Study|Protocol Violation|0|||
48461545|NCT00256204|155878064|FG002|Overall Study|Protocol Violation|2|||
48461546|NCT00256204|155878065|FG003|Overall Study|Protocol Violation|1|||
48461547|NCT00256204|155878062|FG000|Overall Study|Physician Decision|0|||
48461548|NCT00256204|155878063|FG001|Overall Study|Physician Decision|0|||
48461549|NCT00256204|155878064|FG002|Overall Study|Physician Decision|1|||
48461550|NCT00256204|155878065|FG003|Overall Study|Physician Decision|2|||
48461551|NCT00256204|155878062|FG000|Overall Study|Withdrawal by Subject|17|||
48461552|NCT00256204|155878063|FG001|Overall Study|Withdrawal by Subject|6|||
48461553|NCT00256204|155878064|FG002|Overall Study|Withdrawal by Subject|7|||
48461554|NCT00256204|155878065|FG003|Overall Study|Withdrawal by Subject|5|||
48461555|NCT00256204|155878062|FG000|Overall Study|Need for additional prohibited treatment|38|||
48461556|NCT00256204|155878063|FG001|Overall Study|Need for additional prohibited treatment|28|||
48461557|NCT00256204|155878064|FG002|Overall Study|Need for additional prohibited treatment|27|||
48461558|NCT00256204|155878065|FG003|Overall Study|Need for additional prohibited treatment|25|||
48461559|NCT01766401|155878066|FG000|Overall Study|Adverse Event|7|||
48461560|NCT01766401|155878067|FG001|Overall Study|Adverse Event|22|||
48461561|NCT01766401|155878066|FG000|Overall Study|Lack of Efficacy|1|||
48461562|NCT01766401|155878067|FG001|Overall Study|Lack of Efficacy|2|||
48461563|NCT01766401|155878066|FG000|Overall Study|Protocol Violation|3|||
48461564|NCT01766401|155878067|FG001|Overall Study|Protocol Violation|8|||
48461565|NCT01766401|155878066|FG000|Overall Study|Withdrawal by Subject|15|||
48461566|NCT01766401|155878067|FG001|Overall Study|Withdrawal by Subject|12|||
48461567|NCT01766401|155878066|FG000|Overall Study|Lost to Follow-up|10|||
48461568|NCT01766401|155878067|FG001|Overall Study|Lost to Follow-up|11|||
48461569|NCT01766401|155878066|FG000|Overall Study|Pregnancy|1|||
48461570|NCT01766401|155878067|FG001|Overall Study|Pregnancy|1|||
48461571|NCT02177942|155878068|FG000|Overall Study|Adverse Event|1|||
48461572|NCT02177942|155878069|FG001|Overall Study|Adverse Event|0|||
48461573|NCT02177942|155878068|FG000|Overall Study|Lost to Follow-up|1|||
48461574|NCT02177942|155878069|FG001|Overall Study|Lost to Follow-up|1|||
48461575|NCT02177942|155878068|FG000|Overall Study|Protocol Violation|4|||
48461576|NCT02177942|155878069|FG001|Overall Study|Protocol Violation|6|||
48461577|NCT02177942|155878068|FG000|Overall Study|Withdrawal by Subject|71|||
48461578|NCT02177942|155878069|FG001|Overall Study|Withdrawal by Subject|81|||
48461579|NCT04430036|155878075|FG000|Safety Run in Phase|Progression of disease|2|||
48461580|NCT01526928|155878076|FG000|Overall Study|Progressive Disease|35|||
48461581|NCT01526928|155878077|FG001|Overall Study|Progressive Disease|17|||
48461582|NCT01526928|155878078|FG002|Overall Study|Progressive Disease|150|||
48461583|NCT01526928|155878079|FG003|Overall Study|Progressive Disease|182|||
48461584|NCT01526928|155878080|FG004|Overall Study|Progressive Disease|76|||
48461585|NCT01526928|155878081|FG005|Overall Study|Progressive Disease|4|||
48461586|NCT01526928|155878076|FG000|Overall Study|Adverse Event|2|||
48461587|NCT01526928|155878077|FG001|Overall Study|Adverse Event|1|||
48461588|NCT01526928|155878078|FG002|Overall Study|Adverse Event|29|||
48461589|NCT01526928|155878079|FG003|Overall Study|Adverse Event|40|||
48461590|NCT01526928|155878080|FG004|Overall Study|Adverse Event|13|||
48461591|NCT01526928|155878081|FG005|Overall Study|Adverse Event|2|||
48461592|NCT01526928|155878076|FG000|Overall Study|Death|0|||
48461593|NCT01526928|155878077|FG001|Overall Study|Death|0|||
48461594|NCT01526928|155878078|FG002|Overall Study|Death|3|||
48461595|NCT01526928|155878079|FG003|Overall Study|Death|0|||
48461596|NCT01526928|155878080|FG004|Overall Study|Death|0|||
48461597|NCT01526928|155878081|FG005|Overall Study|Death|0|||
48461598|NCT01526928|155878076|FG000|Overall Study|Withdrawal by Subject|1|||
48461599|NCT01526928|155878077|FG001|Overall Study|Withdrawal by Subject|0|||
48461600|NCT01526928|155878078|FG002|Overall Study|Withdrawal by Subject|13|||
48461601|NCT01526928|155878079|FG003|Overall Study|Withdrawal by Subject|11|||
48461602|NCT01526928|155878080|FG004|Overall Study|Withdrawal by Subject|3|||
48461603|NCT01526928|155878081|FG005|Overall Study|Withdrawal by Subject|0|||
48461604|NCT01526928|155878076|FG000|Overall Study|Physician Decision|0|||
48461605|NCT01526928|155878077|FG001|Overall Study|Physician Decision|0|||
48461606|NCT01526928|155878078|FG002|Overall Study|Physician Decision|2|||
48461607|NCT01526928|155878079|FG003|Overall Study|Physician Decision|5|||
48461608|NCT01526928|155878080|FG004|Overall Study|Physician Decision|0|||
48461609|NCT01526928|155878081|FG005|Overall Study|Physician Decision|0|||
48461610|NCT01526928|155878076|FG000|Overall Study|Other Reason|0|||
48461611|NCT01526928|155878077|FG001|Overall Study|Other Reason|1|||
48461612|NCT01526928|155878078|FG002|Overall Study|Other Reason|11|||
48461613|NCT01526928|155878079|FG003|Overall Study|Other Reason|4|||
48461614|NCT01526928|155878080|FG004|Overall Study|Other Reason|1|||
48461615|NCT01526928|155878081|FG005|Overall Study|Other Reason|0|||
48461616|NCT01526928|155878076|FG000|Overall Study|Lost to Follow-up|0|||
48461617|NCT01526928|155878077|FG001|Overall Study|Lost to Follow-up|0|||
48461618|NCT01526928|155878078|FG002|Overall Study|Lost to Follow-up|0|||
48461619|NCT01526928|155878079|FG003|Overall Study|Lost to Follow-up|1|||
48461620|NCT01526928|155878080|FG004|Overall Study|Lost to Follow-up|0|||
48461621|NCT01526928|155878081|FG005|Overall Study|Lost to Follow-up|0|||
48461622|NCT01526928|155878076|FG000|Overall Study|Protocol Deviation|0|||
48461623|NCT01526928|155878077|FG001|Overall Study|Protocol Deviation|0|||
48461624|NCT01526928|155878078|FG002|Overall Study|Protocol Deviation|0|||
48461625|NCT01526928|155878079|FG003|Overall Study|Protocol Deviation|2|||
48461626|NCT01526928|155878080|FG004|Overall Study|Protocol Deviation|0|||
48461627|NCT01526928|155878081|FG005|Overall Study|Protocol Deviation|0|||
48461628|NCT01526928|155878076|FG000|Overall Study|Missing|0|||
48461629|NCT01526928|155878077|FG001|Overall Study|Missing|0|||
48461630|NCT01526928|155878078|FG002|Overall Study|Missing|1|||
48461631|NCT01526928|155878079|FG003|Overall Study|Missing|0|||
48461632|NCT01526928|155878080|FG004|Overall Study|Missing|2|||
48461633|NCT01526928|155878081|FG005|Overall Study|Missing|0|||
48461634|NCT00836953|155878084|FG000|Overall Study|Withdrawal by Subject|1|||
48461635|NCT00836953|155878084|FG000|Overall Study|Lost to Follow-up|1|||
48461636|NCT01842334|155878091|FG000|Overall Study|Withdrawal by Subject|3|||
48461637|NCT01842334|155878092|FG001|Overall Study|Withdrawal by Subject|3|||
48461638|NCT01842334|155878091|FG000|Overall Study|Moved away mid-study|0|||
48461639|NCT01842334|155878092|FG001|Overall Study|Moved away mid-study|1|||
48461640|NCT01425528|155878093|FG000|Overall Study|Withdrawal by Subject|1|||
48461641|NCT01425528|155878094|FG001|Overall Study|Withdrawal by Subject|1|||
48461642|NCT01948791|155878095|FG000|Overall Study|Adverse Event|12|||
48461643|NCT01948791|155878095|FG000|Overall Study|Lack of Efficacy|3|||
48461644|NCT01948791|155878095|FG000|Overall Study|Protocol Violation|2|||
48461645|NCT01948791|155878095|FG000|Overall Study|Withdrawal by Subject|5|||
48461646|NCT01948791|155878095|FG000|Overall Study|Lost to Follow-up|6|||
48461647|NCT01948791|155878095|FG000|Overall Study|Management issues|1|||
48461648|NCT01948791|155878095|FG000|Overall Study|Others|7|||
48461649|NCT01948791|155878095|FG000|Overall Study|Screening failure|35|||
48461650|NCT03323385|155878100|FG000|Overall Study|Withdrawal by Subject|1|||
48461651|NCT03323385|155878101|FG001|Overall Study|Withdrawal by Subject|2|||
48461652|NCT03323385|155878100|FG000|Overall Study|Noncompliance|0|||
48461653|NCT03323385|155878101|FG001|Overall Study|Noncompliance|1|||
48461654|NCT00935701|155878102|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
48461655|NCT02142712|155878103|FG000|Overall Study|Lost to Follow-up|1|||
48461656|NCT02142712|155878104|FG001|Overall Study|Lost to Follow-up|1|||
48461657|NCT02142712|155878105|FG002|Overall Study|Lost to Follow-up|1|||
48461658|NCT02142712|155878106|FG003|Overall Study|Lost to Follow-up|0|||
48461659|NCT00631969|155878110|FG000|Overall Study|Adverse Event|3|||
48461660|NCT00631969|155878111|FG001|Overall Study|Adverse Event|1|||
48461661|NCT00631969|155878110|FG000|Overall Study|Lack of Efficacy|2|||
48461662|NCT00631969|155878111|FG001|Overall Study|Lack of Efficacy|8|||
48461663|NCT00631969|155878110|FG000|Overall Study|Lost to Follow-up|2|||
48461664|NCT00631969|155878111|FG001|Overall Study|Lost to Follow-up|1|||
48461665|NCT00631969|155878110|FG000|Overall Study|Protocol Violation|1|||
48461666|NCT00631969|155878111|FG001|Overall Study|Protocol Violation|1|||
48461667|NCT00631969|155878110|FG000|Overall Study|Consent Withdrawn|5|||
48461668|NCT00631969|155878111|FG001|Overall Study|Consent Withdrawn|7|||
48461669|NCT00631969|155878110|FG000|Overall Study|Noncompliant With Study Medication|0|||
48461670|NCT00631969|155878111|FG001|Overall Study|Noncompliant With Study Medication|1|||
48461671|NCT00631969|155878110|FG000|Overall Study|No Drug Exposure|2|||
48461672|NCT00631969|155878111|FG001|Overall Study|No Drug Exposure|2|||
48461673|NCT01981096|155878115|FG000|Overall Study|Parent illness|1|||
48461674|NCT01981096|155878116|FG001|Overall Study|Parent illness|0|||
48461675|NCT01981096|155878115|FG000|Overall Study|Withdrawal by Subject|0|||
48461676|NCT01981096|155878116|FG001|Overall Study|Withdrawal by Subject|1|||
48461677|NCT01981096|155878115|FG000|Overall Study|Lost to Follow-up|2|||
48461678|NCT01981096|155878116|FG001|Overall Study|Lost to Follow-up|0|||
48461679|NCT00703781|155878117|FG000|Overall Study|Withdrawal by Subject|1|||
48461680|NCT00703781|155878118|FG001|Overall Study|Withdrawal by Subject|2|||
48461681|NCT00703781|155878117|FG000|Overall Study|Cancelled surgery|1|||
48461682|NCT00703781|155878118|FG001|Overall Study|Cancelled surgery|0|||
48461683|NCT02168816|155878119|FG000|Overall Study|Lost to Follow-up|2|||
48461684|NCT02168816|155878120|FG001|Overall Study|Lost to Follow-up|2|||
48461685|NCT01241318|155878123|FG000|Overall Study|Woman: false pregnancies|27|||
48461686|NCT01241318|155878124|FG001|Overall Study|Woman: false pregnancies|15|||
48461687|NCT01241318|155878123|FG000|Overall Study|Woman: miscarriage/abortion|46|||
48461688|NCT01241318|155878124|FG001|Overall Study|Woman: miscarriage/abortion|38|||
48461689|NCT01241318|155878123|FG000|Overall Study|Withdrawal by Subject|175|||
48461690|NCT01241318|155878124|FG001|Overall Study|Withdrawal by Subject|46|||
48461691|NCT01241318|155878123|FG000|Overall Study|Lost to Follow-up|740|||
48461692|NCT01241318|155878124|FG001|Overall Study|Lost to Follow-up|455|||
48461693|NCT01241318|155878123|FG000|Overall Study|Death|2|||
48461694|NCT01241318|155878124|FG001|Overall Study|Death|4|||
48461695|NCT01241318|155878123|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
48461696|NCT01241318|155878124|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
48461697|NCT01241318|155878123|FG000|Overall Study|Woman: Stillborn infant|129|||
48461698|NCT01241318|155878124|FG001|Overall Study|Woman: Stillborn infant|146|||
48461699|NCT02994927|155878126|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48461700|NCT02994927|155878127|FG001|Overall Study|Withdrawal by parent/guardian|1|||
48461701|NCT02994927|155878126|FG000|Overall Study|Did not meet eligibility criteria|0|||
48461702|NCT02994927|155878127|FG001|Overall Study|Did not meet eligibility criteria|1|||
48461703|NCT02994927|155878126|FG000|Overall Study|Physician Decision|4|||
48461704|NCT02994927|155878127|FG001|Overall Study|Physician Decision|3|||
48461705|NCT02994927|155878126|FG000|Overall Study|Death|4|||
48461706|NCT02994927|155878127|FG001|Overall Study|Death|2|||
48461707|NCT02994927|155878126|FG000|Overall Study|Adverse Event|2|||
48461708|NCT02994927|155878127|FG001|Overall Study|Adverse Event|1|||
48461709|NCT02994927|155878126|FG000|Overall Study|Withdrawal by Subject|3|||
48461710|NCT02994927|155878127|FG001|Overall Study|Withdrawal by Subject|6|||
48461711|NCT02994927|155878126|FG000|Overall Study|Lost to Follow-up|2|||
48461712|NCT02994927|155878127|FG001|Overall Study|Lost to Follow-up|1|||
48461713|NCT02993783|155878142|FG000|Overall Study|Reason not Specified|6|||
48461714|NCT02993783|155878143|FG001|Overall Study|Reason not Specified|9|||
48461715|NCT01021293|155878144|FG000|Overall Study|Serious Adverse Event|2|||
48461716|NCT01021293|155878145|FG001|Overall Study|Serious Adverse Event|1|||
48461717|NCT01021293|155878144|FG000|Overall Study|Adverse Event|2|||
48461718|NCT01021293|155878145|FG001|Overall Study|Adverse Event|1|||
48461719|NCT01021293|155878144|FG000|Overall Study|Withdrawal by Subject|1|||
48461720|NCT01021293|155878145|FG001|Overall Study|Withdrawal by Subject|3|||
48461721|NCT01021293|155878144|FG000|Overall Study|Migrated/moved from study area|6|||
48461722|NCT01021293|155878145|FG001|Overall Study|Migrated/moved from study area|18|||
48461723|NCT01021293|155878144|FG000|Overall Study|Lost to Follow-up|1|||
48461724|NCT01021293|155878145|FG001|Overall Study|Lost to Follow-up|1|||
48461725|NCT02417935|155878146|FG000|Treatment Period|Adverse Event|12|||
48461726|NCT02417935|155878147|FG001|Treatment Period|Adverse Event|10|||
48461727|NCT02417935|155878146|FG000|Treatment Period|Lost to Follow-up|1|||
48461728|NCT02417935|155878147|FG001|Treatment Period|Lost to Follow-up|0|||
48461729|NCT02417935|155878146|FG000|Treatment Period|Entry Criteria not met|0|||
48461730|NCT02417935|155878147|FG001|Treatment Period|Entry Criteria not met|1|||
48461731|NCT02417935|155878146|FG000|Treatment Period|Protocol Violation|2|||
48461732|NCT02417935|155878147|FG001|Treatment Period|Protocol Violation|1|||
48461733|NCT02417935|155878146|FG000|Treatment Period|Withdrawal by Subject|3|||
48461734|NCT02417935|155878147|FG001|Treatment Period|Withdrawal by Subject|3|||
48461735|NCT02417935|155878146|FG000|Treatment Period|Physician Decision|3|||
48461736|NCT02417935|155878147|FG001|Treatment Period|Physician Decision|1|||
48461737|NCT02141854|155878148|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
48461738|NCT02141854|155878149|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48461739|NCT02141854|155878150|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48461740|NCT02141854|155878151|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48461741|NCT02141854|155878152|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48461742|NCT02141854|155878153|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
48461743|NCT02141854|155878148|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
48461744|NCT02141854|155878149|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48461745|NCT02141854|155878150|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48461746|NCT02141854|155878151|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48461747|NCT02141854|155878152|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48461748|NCT02141854|155878153|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
48461749|NCT02141854|155878148|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
48461750|NCT02141854|155878149|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48461751|NCT02141854|155878150|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48461752|NCT02141854|155878151|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48461753|NCT02141854|155878152|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48461754|NCT02141854|155878153|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
48461755|NCT02141854|155878148|FG000|Run-In Period (Pre-assignment)|Other|14|||
48461756|NCT02141854|155878149|FG001|Run-In Period (Pre-assignment)|Other|0|||
48461757|NCT02141854|155878150|FG002|Run-In Period (Pre-assignment)|Other|0|||
48461758|NCT02141854|155878151|FG003|Run-In Period (Pre-assignment)|Other|0|||
48461759|NCT02141854|155878152|FG004|Run-In Period (Pre-assignment)|Other|0|||
48461760|NCT02141854|155878153|FG005|Run-In Period (Pre-assignment)|Other|0|||
48461761|NCT02141854|155878148|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
48461762|NCT02141854|155878149|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
48461763|NCT02141854|155878150|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
48461764|NCT02141854|155878151|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
48461765|NCT02141854|155878152|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
48461766|NCT02141854|155878153|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
48461767|NCT02141854|155878148|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
48461768|NCT02141854|155878149|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48461769|NCT02141854|155878150|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48461770|NCT02141854|155878151|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48461771|NCT02141854|155878152|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48461772|NCT02141854|155878153|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
48461773|NCT02141854|155878148|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
48461774|NCT02141854|155878149|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48461775|NCT02141854|155878150|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48461776|NCT02141854|155878151|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48461777|NCT02141854|155878152|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48461778|NCT02141854|155878153|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
48461779|NCT02141854|155878148|FG000|Treatment Period|Protocol Violation|0|||
48461780|NCT02141854|155878149|FG001|Treatment Period|Protocol Violation|1|||
48461781|NCT02141854|155878150|FG002|Treatment Period|Protocol Violation|0|||
48461782|NCT02141854|155878151|FG003|Treatment Period|Protocol Violation|2|||
48461783|NCT02141854|155878152|FG004|Treatment Period|Protocol Violation|2|||
48461784|NCT02141854|155878153|FG005|Treatment Period|Protocol Violation|1|||
48461785|NCT02141854|155878148|FG000|Treatment Period|Noncompliance|0|||
48461786|NCT02141854|155878149|FG001|Treatment Period|Noncompliance|0|||
48461787|NCT02141854|155878150|FG002|Treatment Period|Noncompliance|0|||
48461788|NCT02141854|155878151|FG003|Treatment Period|Noncompliance|1|||
48461789|NCT02141854|155878152|FG004|Treatment Period|Noncompliance|0|||
48461790|NCT02141854|155878153|FG005|Treatment Period|Noncompliance|0|||
48461791|NCT02141854|155878148|FG000|Treatment Period|Lack of Efficacy|0|||
48461792|NCT02141854|155878149|FG001|Treatment Period|Lack of Efficacy|0|||
48461793|NCT02141854|155878150|FG002|Treatment Period|Lack of Efficacy|0|||
48461794|NCT02141854|155878151|FG003|Treatment Period|Lack of Efficacy|1|||
48461795|NCT02141854|155878152|FG004|Treatment Period|Lack of Efficacy|1|||
48461796|NCT02141854|155878153|FG005|Treatment Period|Lack of Efficacy|7|||
48461797|NCT02141854|155878148|FG000|Treatment Period|Pregnancy|0|||
48461798|NCT02141854|155878149|FG001|Treatment Period|Pregnancy|1|||
48461799|NCT02141854|155878150|FG002|Treatment Period|Pregnancy|0|||
48461800|NCT02141854|155878151|FG003|Treatment Period|Pregnancy|0|||
48461801|NCT02141854|155878152|FG004|Treatment Period|Pregnancy|0|||
48461802|NCT02141854|155878153|FG005|Treatment Period|Pregnancy|0|||
48461803|NCT02141854|155878148|FG000|Treatment Period|Other|0|||
48461804|NCT02141854|155878149|FG001|Treatment Period|Other|1|||
48461805|NCT02141854|155878150|FG002|Treatment Period|Other|2|||
48461806|NCT02141854|155878151|FG003|Treatment Period|Other|0|||
48461807|NCT02141854|155878152|FG004|Treatment Period|Other|1|||
48461808|NCT02141854|155878153|FG005|Treatment Period|Other|2|||
48461809|NCT02141854|155878148|FG000|Treatment Period|Adverse Event|0|||
48461810|NCT02141854|155878149|FG001|Treatment Period|Adverse Event|2|||
48461811|NCT02141854|155878150|FG002|Treatment Period|Adverse Event|2|||
48461812|NCT02141854|155878151|FG003|Treatment Period|Adverse Event|0|||
48461813|NCT02141854|155878152|FG004|Treatment Period|Adverse Event|2|||
48461814|NCT02141854|155878153|FG005|Treatment Period|Adverse Event|2|||
48461815|NCT02141854|155878148|FG000|Treatment Period|Withdrawal by Subject|0|||
48461816|NCT02141854|155878149|FG001|Treatment Period|Withdrawal by Subject|2|||
48461817|NCT02141854|155878150|FG002|Treatment Period|Withdrawal by Subject|3|||
48461818|NCT02141854|155878151|FG003|Treatment Period|Withdrawal by Subject|3|||
48461819|NCT02141854|155878152|FG004|Treatment Period|Withdrawal by Subject|4|||
48461820|NCT02141854|155878153|FG005|Treatment Period|Withdrawal by Subject|7|||
48461821|NCT02141854|155878148|FG000|Treatment Period|Disease progression|0|||
48461822|NCT02141854|155878149|FG001|Treatment Period|Disease progression|2|||
48461823|NCT02141854|155878150|FG002|Treatment Period|Disease progression|1|||
48461824|NCT02141854|155878151|FG003|Treatment Period|Disease progression|3|||
48461825|NCT02141854|155878152|FG004|Treatment Period|Disease progression|0|||
48461826|NCT02141854|155878153|FG005|Treatment Period|Disease progression|18|||
48461827|NCT02141854|155878148|FG000|Treatment Period|Lost to Follow-up|0|||
48461828|NCT02141854|155878149|FG001|Treatment Period|Lost to Follow-up|1|||
48461829|NCT02141854|155878150|FG002|Treatment Period|Lost to Follow-up|1|||
48461830|NCT02141854|155878151|FG003|Treatment Period|Lost to Follow-up|1|||
48461831|NCT02141854|155878152|FG004|Treatment Period|Lost to Follow-up|0|||
48461832|NCT02141854|155878153|FG005|Treatment Period|Lost to Follow-up|1|||
48461833|NCT03818399|155879548|FG000|Overall Study|Lost to Follow-up|11|||
48461834|NCT03818399|155879548|FG000|Overall Study|Withdrawal by Subject|1|||
48461835|NCT03818399|155879548|FG000|Overall Study|Protocol Violation|2|||
48461836|NCT00934791|155879549|FG000|Overall Study|Withdrawal by Subject|1|||
48461837|NCT00934791|155879550|FG001|Overall Study|Withdrawal by Subject|0|||
48461838|NCT02425891|155879551|FG000|Overall Study|Death|333|||
48461839|NCT02425891|155879552|FG001|Overall Study|Death|314|||
48461840|NCT02425891|155879551|FG000|Overall Study|Lost to Follow-up|4|||
48461841|NCT02425891|155879552|FG001|Overall Study|Lost to Follow-up|6|||
48461842|NCT02425891|155879551|FG000|Overall Study|Non-Compliance|1|||
48461843|NCT02425891|155879552|FG001|Overall Study|Non-Compliance|1|||
48461844|NCT02425891|155879551|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
48461845|NCT02425891|155879552|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
48461846|NCT02425891|155879551|FG000|Overall Study|Physician Decision|0|||
48461847|NCT02425891|155879552|FG001|Overall Study|Physician Decision|1|||
48461848|NCT02425891|155879551|FG000|Overall Study|Protocol Violation|1|||
48461849|NCT02425891|155879552|FG001|Overall Study|Protocol Violation|1|||
48461850|NCT02425891|155879551|FG000|Overall Study|Study Terminated By Sponsor|85|||
48461851|NCT02425891|155879552|FG001|Overall Study|Study Terminated By Sponsor|95|||
48461852|NCT02425891|155879551|FG000|Overall Study|Withdrawal by Subject|27|||
48461853|NCT02425891|155879552|FG001|Overall Study|Withdrawal by Subject|32|||
48461854|NCT04124952|155879553|FG000|Overall Study|Lost to Follow-up|1|||
48461855|NCT00672139|155879558|FG000|Overall Study|Death|14|||
48461856|NCT00672139|155879559|FG001|Overall Study|Death|23|||
48461857|NCT00672139|155879558|FG000|Overall Study|Withdrawal by Subject|2|||
48461858|NCT00672139|155879559|FG001|Overall Study|Withdrawal by Subject|11|||
48461859|NCT00672139|155879558|FG000|Overall Study|Adverse Event|4|||
48461860|NCT00672139|155879559|FG001|Overall Study|Adverse Event|7|||
48461861|NCT00672139|155879558|FG000|Overall Study|Physician Decision|2|||
48461862|NCT00672139|155879559|FG001|Overall Study|Physician Decision|0|||
48461863|NCT00672139|155879558|FG000|Overall Study|Lack of Efficacy|4|||
48461864|NCT00672139|155879559|FG001|Overall Study|Lack of Efficacy|1|||
48461865|NCT00672139|155879558|FG000|Overall Study|Protocol Violation|1|||
48461866|NCT00672139|155879559|FG001|Overall Study|Protocol Violation|1|||
48461867|NCT00672139|155879558|FG000|Overall Study|hospice discharge, caregiver requests|3|||
48461868|NCT00672139|155879559|FG001|Overall Study|hospice discharge, caregiver requests|2|||
48461869|NCT00696774|155879561|FG000|Period II|Adverse Event|0|||
48461870|NCT00696774|155879562|FG001|Period II|Adverse Event|0|||
48461871|NCT00696774|155879563|FG002|Period II|Adverse Event|15|||
48461872|NCT00696774|155879561|FG000|Period II|Lost to Follow-up|0|||
48461873|NCT00696774|155879562|FG001|Period II|Lost to Follow-up|0|||
48461874|NCT00696774|155879563|FG002|Period II|Lost to Follow-up|4|||
48461875|NCT00696774|155879561|FG000|Period II|Protocol Violation|0|||
48461876|NCT00696774|155879562|FG001|Period II|Protocol Violation|0|||
48461877|NCT00696774|155879563|FG002|Period II|Protocol Violation|11|||
48461878|NCT00696774|155879561|FG000|Period II|Withdrawal by Subject|0|||
48461879|NCT00696774|155879562|FG001|Period II|Withdrawal by Subject|0|||
48461880|NCT00696774|155879563|FG002|Period II|Withdrawal by Subject|4|||
48461881|NCT00696774|155879561|FG000|Period II|Sponsor Decision|0|||
48461882|NCT00696774|155879562|FG001|Period II|Sponsor Decision|0|||
48461883|NCT00696774|155879563|FG002|Period II|Sponsor Decision|0|||
48461884|NCT00696774|155879561|FG000|Period II|Lack of Efficacy|0|||
48461885|NCT00696774|155879562|FG001|Period II|Lack of Efficacy|0|||
48461886|NCT00696774|155879563|FG002|Period II|Lack of Efficacy|2|||
48461887|NCT00696774|155879561|FG000|Period III|Adverse Event|1|||
48461888|NCT00696774|155879562|FG001|Period III|Adverse Event|1|||
48461889|NCT00696774|155879563|FG002|Period III|Adverse Event|0|||
48461890|NCT00696774|155879561|FG000|Period III|Lost to Follow-up|2|||
48461891|NCT00696774|155879562|FG001|Period III|Lost to Follow-up|1|||
48461892|NCT00696774|155879563|FG002|Period III|Lost to Follow-up|0|||
48461893|NCT00696774|155879561|FG000|Period III|Protocol Violation|1|||
48461894|NCT00696774|155879562|FG001|Period III|Protocol Violation|1|||
48461895|NCT00696774|155879563|FG002|Period III|Protocol Violation|0|||
48461896|NCT00696774|155879561|FG000|Period III|Withdrawal by Subject|1|||
48461897|NCT00696774|155879562|FG001|Period III|Withdrawal by Subject|2|||
48461898|NCT00696774|155879563|FG002|Period III|Withdrawal by Subject|0|||
48461899|NCT00696774|155879561|FG000|Period III|Sponsor Decision|2|||
48461900|NCT00696774|155879562|FG001|Period III|Sponsor Decision|0|||
48461901|NCT00696774|155879563|FG002|Period III|Sponsor Decision|0|||
48461902|NCT00696774|155879561|FG000|Period III|Lack of Efficacy|0|||
48461903|NCT00696774|155879562|FG001|Period III|Lack of Efficacy|2|||
48461904|NCT00696774|155879563|FG002|Period III|Lack of Efficacy|0|||
48461905|NCT01021553|155879564|FG000|Overall Study|Adverse Event|1|||
48461906|NCT01021553|155879565|FG001|Overall Study|Adverse Event|0|||
48461907|NCT01021553|155879566|FG002|Overall Study|Adverse Event|0|||
48461908|NCT01021553|155879564|FG000|Overall Study|Lack of Efficacy|2|||
48461909|NCT01021553|155879565|FG001|Overall Study|Lack of Efficacy|2|||
48461910|NCT01021553|155879566|FG002|Overall Study|Lack of Efficacy|0|||
48461911|NCT01021553|155879564|FG000|Overall Study|Protocol Violation|0|||
48461912|NCT01021553|155879565|FG001|Overall Study|Protocol Violation|2|||
48461913|NCT01021553|155879566|FG002|Overall Study|Protocol Violation|2|||
48461914|NCT01021553|155879564|FG000|Overall Study|Lost to Follow-up|0|||
48461915|NCT01021553|155879565|FG001|Overall Study|Lost to Follow-up|0|||
48461916|NCT01021553|155879566|FG002|Overall Study|Lost to Follow-up|1|||
48461917|NCT01021553|155879564|FG000|Overall Study|Withdrawal by Subject|1|||
48461918|NCT01021553|155879565|FG001|Overall Study|Withdrawal by Subject|1|||
48461919|NCT01021553|155879566|FG002|Overall Study|Withdrawal by Subject|0|||
48461920|NCT03481634|155879570|FG000|Overall Study|Withdrawal by Subject|16|||
48461921|NCT03481634|155879571|FG001|Overall Study|Withdrawal by Subject|19|||
48461922|NCT03481634|155879572|FG002|Overall Study|Withdrawal by Subject|14|||
48461923|NCT03481634|155879570|FG000|Overall Study|Protocol Violation|1|||
48461924|NCT03481634|155879571|FG001|Overall Study|Protocol Violation|0|||
48461925|NCT03481634|155879572|FG002|Overall Study|Protocol Violation|1|||
48461926|NCT03481634|155879570|FG000|Overall Study|Progressive disease|0|||
48461927|NCT03481634|155879571|FG001|Overall Study|Progressive disease|1|||
48461928|NCT03481634|155879572|FG002|Overall Study|Progressive disease|0|||
48461929|NCT03481634|155879570|FG000|Overall Study|Physician Decision|3|||
48461930|NCT03481634|155879571|FG001|Overall Study|Physician Decision|0|||
48461931|NCT03481634|155879572|FG002|Overall Study|Physician Decision|1|||
48461932|NCT03481634|155879570|FG000|Overall Study|Lost to Follow-up|3|||
48461933|NCT03481634|155879571|FG001|Overall Study|Lost to Follow-up|4|||
48461934|NCT03481634|155879572|FG002|Overall Study|Lost to Follow-up|4|||
48461935|NCT03481634|155879570|FG000|Overall Study|Death|4|||
48461936|NCT03481634|155879571|FG001|Overall Study|Death|8|||
48461937|NCT03481634|155879572|FG002|Overall Study|Death|7|||
48461938|NCT03481634|155879570|FG000|Overall Study|Adverse Event|6|||
48461939|NCT03481634|155879571|FG001|Overall Study|Adverse Event|3|||
48461940|NCT03481634|155879572|FG002|Overall Study|Adverse Event|7|||
48461941|NCT00942422|155879573|FG000|Overall Study|Withdrawal by Subject|1|||
48461942|NCT00942422|155879573|FG000|Overall Study|Death|1|||
48461943|NCT00942422|155879573|FG000|Overall Study|Progressive diease|1|||
48461944|NCT00518336|155879576|FG000|Year 7|Lost to Follow-up|2|||
48461945|NCT00518336|155879577|FG001|Year 7|Lost to Follow-up|0|||
48461946|NCT00518336|155879576|FG000|Year 7|Could not attend in time|0|||
48461947|NCT00518336|155879577|FG001|Year 7|Could not attend in time|3|||
48461948|NCT00518336|155879576|FG000|Year 8|Lost to Follow-up|1|||
48461949|NCT00518336|155879577|FG001|Year 8|Lost to Follow-up|1|||
48461950|NCT00518336|155879576|FG000|Year 8|Could not attend in time|0|||
48461951|NCT00518336|155879577|FG001|Year 8|Could not attend in time|1|||
48461952|NCT00518336|155879576|FG000|Year 9|Migrated/moved from study area|1|||
48461953|NCT00518336|155879577|FG001|Year 9|Migrated/moved from study area|1|||
48461954|NCT00518336|155879576|FG000|Year 9|Lost to Follow-up|3|||
48461955|NCT00518336|155879577|FG001|Year 9|Lost to Follow-up|0|||
48461956|NCT00518336|155879576|FG000|Year 9|Personal reasons|1|||
48461957|NCT00518336|155879577|FG001|Year 9|Personal reasons|0|||
48461958|NCT02975206|155879578|FG000|Overall Study|Withdrawal by Subject|14|||
48461959|NCT02975206|155879579|FG001|Overall Study|Withdrawal by Subject|11|||
48461960|NCT02975206|155879580|FG002|Overall Study|Withdrawal by Subject|11|||
48461961|NCT02975206|155879578|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
48461962|NCT02975206|155879579|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
48461963|NCT02975206|155879580|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
48461964|NCT00866606|155879581|FG000|Overall Study|Lost to Follow-up|3|||
48461965|NCT00866606|155879581|FG000|Overall Study|Adverse Event|1|||
48461966|NCT01852591|155879588|FG000|Overall Study|Withdrawal by Subject|2|||
48461967|NCT01852591|155879588|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
48461968|NCT01058356|155879597|FG000|Overall Study|Adverse Event|5|||
48461969|NCT01058356|155879597|FG000|Overall Study|Administration of contraindicated drugs|12|||
48461970|NCT01058356|155879597|FG000|Overall Study|Withdrawal by Subject|21|||
48461971|NCT01058356|155879597|FG000|Overall Study|Lost to Follow-up|4|||
48461972|NCT01682759|155879598|FG000|Overall Study|Death|2|||
48461973|NCT01682759|155879599|FG001|Overall Study|Death|1|||
48461974|NCT01682759|155879598|FG000|Overall Study|Lost to Follow-up|10|||
48461975|NCT01682759|155879599|FG001|Overall Study|Lost to Follow-up|13|||
48461976|NCT01682759|155879598|FG000|Overall Study|Physician Decision|1|||
48461977|NCT01682759|155879599|FG001|Overall Study|Physician Decision|1|||
48461978|NCT01682759|155879598|FG000|Overall Study|Withdrawal by Subject|56|||
48461979|NCT01682759|155879599|FG001|Overall Study|Withdrawal by Subject|55|||
48461980|NCT00397891|155879602|FG000|Overall Study|Withdrawal by Subject|1|||
48461981|NCT00397891|155879603|FG001|Overall Study|Withdrawal by Subject|0|||
48461982|NCT00397891|155879604|FG002|Overall Study|Withdrawal by Subject|0|||
48461983|NCT00397891|155879605|FG003|Overall Study|Withdrawal by Subject|0|||
48461984|NCT00397891|155879606|FG004|Overall Study|Withdrawal by Subject|1|||
48461985|NCT03395704|155879609|FG000|Overall Study|Adverse Event|2|||
48461986|NCT03395704|155879610|FG001|Overall Study|Adverse Event|1|||
48461987|NCT03395704|155879609|FG000|Overall Study|Withdrawal by Subject|2|||
48461988|NCT03395704|155879610|FG001|Overall Study|Withdrawal by Subject|1|||
48461989|NCT03395704|155879609|FG000|Overall Study|Physician Decision|0|||
48461990|NCT03395704|155879610|FG001|Overall Study|Physician Decision|1|||
48461991|NCT00392210|155879613|FG000|First Voiding Trial|Physician Decision|2|||
48461992|NCT00392210|155879614|FG001|First Voiding Trial|Physician Decision|2|||
48461993|NCT00266695|155879615|FG000|Overall Study|Adverse Event|1|||
48461994|NCT00266695|155879615|FG000|Overall Study|Death|9|||
48461995|NCT00266695|155879615|FG000|Overall Study|Physician Decision|1|||
48461996|NCT00266695|155879615|FG000|Overall Study|Lost to Follow-up|3|||
48461997|NCT00266695|155879615|FG000|Overall Study|Withdrawal by Subject|15|||
48461998|NCT00606021|155879616|FG000|Induction Phase|Death|73|||
48461999|NCT00606021|155879617|FG001|Induction Phase|Death|0|||
48462000|NCT00606021|155879618|FG002|Induction Phase|Death|0|||
48462001|NCT00606021|155879616|FG000|Induction Phase|Physician Decision|2|||
48462002|NCT00606021|155879617|FG001|Induction Phase|Physician Decision|0|||
48462003|NCT00606021|155879618|FG002|Induction Phase|Physician Decision|0|||
48462004|NCT00606021|155879616|FG000|Induction Phase|Withdrawal by Subject|2|||
48462005|NCT00606021|155879617|FG001|Induction Phase|Withdrawal by Subject|0|||
48462006|NCT00606021|155879618|FG002|Induction Phase|Withdrawal by Subject|0|||
48462007|NCT00606021|155879616|FG000|Induction Phase|Lost to Follow-up|10|||
48462008|NCT00606021|155879617|FG001|Induction Phase|Lost to Follow-up|0|||
48462009|NCT00606021|155879618|FG002|Induction Phase|Lost to Follow-up|0|||
48462010|NCT00606021|155879616|FG000|Maintenance Phase|Death|0|||
48462011|NCT00606021|155879617|FG001|Maintenance Phase|Death|17|||
48462012|NCT00606021|155879618|FG002|Maintenance Phase|Death|15|||
48462013|NCT00606021|155879616|FG000|Maintenance Phase|Physician Decision|0|||
48462014|NCT00606021|155879617|FG001|Maintenance Phase|Physician Decision|1|||
48462015|NCT00606021|155879618|FG002|Maintenance Phase|Physician Decision|0|||
48462016|NCT00606021|155879616|FG000|Maintenance Phase|Lost to Follow-up|0|||
48462017|NCT00606021|155879617|FG001|Maintenance Phase|Lost to Follow-up|5|||
48462018|NCT00606021|155879618|FG002|Maintenance Phase|Lost to Follow-up|2|||
48462019|NCT00887913|155879619|FG000|Overall Study|Withdrawal by Subject|6|||
48462020|NCT00686699|155879623|FG000|Treatment Period 1|Adverse Event|0|||
48462021|NCT00686699|155879624|FG001|Treatment Period 1|Adverse Event|2|||
48462022|NCT03049852|155879625|FG000|Overall Study|Lost to Follow-up|0|||
48462023|NCT03049852|155879626|FG001|Overall Study|Lost to Follow-up|1|||
48462024|NCT03049852|155879627|FG002|Overall Study|Lost to Follow-up|0|||
48462025|NCT00736385|155879628|FG000|Overall Study|Withdrawal by Subject|2|||
48462026|NCT00736385|155879629|FG001|Overall Study|Withdrawal by Subject|2|||
48462027|NCT00736385|155879628|FG000|Overall Study|Adverse Event|0|||
48462028|NCT00736385|155879629|FG001|Overall Study|Adverse Event|1|||
48462029|NCT02067104|155879630|FG000|Overall Study|Study termination due to low accrual|4|||
48462030|NCT02067104|155879631|FG001|Overall Study|Study termination due to low accrual|5|||
48462031|NCT00695318|155879632|FG000|Overall Study|Lost to Follow-up|1|||
48462032|NCT00695318|155879633|FG001|Overall Study|Lost to Follow-up|0|||
48462033|NCT00695318|155879632|FG000|Overall Study|Withdrawal by Subject|2|||
48462034|NCT00695318|155879633|FG001|Overall Study|Withdrawal by Subject|0|||
48462035|NCT00695318|155879632|FG000|Overall Study|Death|1|||
48462036|NCT00695318|155879633|FG001|Overall Study|Death|1|||
48462037|NCT00695318|155879632|FG000|Overall Study|Study Terminated|1|||
48462038|NCT00695318|155879633|FG001|Overall Study|Study Terminated|0|||
48462039|NCT02192190|155879634|FG000|Overall Study|Adverse Event|1|||
48462040|NCT02192190|155879635|FG001|Overall Study|Adverse Event|1|||
48462041|NCT02192190|155879636|FG002|Overall Study|Adverse Event|0|||
48462042|NCT02192190|155879637|FG003|Overall Study|Adverse Event|0|||
48462043|NCT02192190|155879638|FG004|Overall Study|Adverse Event|0|||
48462044|NCT02192190|155879639|FG005|Overall Study|Adverse Event|0|||
48462045|NCT02192190|155879634|FG000|Overall Study|Lost to Follow-up|3|||
48462046|NCT02192190|155879635|FG001|Overall Study|Lost to Follow-up|3|||
48462047|NCT02192190|155879636|FG002|Overall Study|Lost to Follow-up|2|||
48462048|NCT02192190|155879637|FG003|Overall Study|Lost to Follow-up|1|||
48462049|NCT02192190|155879638|FG004|Overall Study|Lost to Follow-up|4|||
48462050|NCT02192190|155879639|FG005|Overall Study|Lost to Follow-up|3|||
48462051|NCT02192190|155879634|FG000|Overall Study|Physician Decision|2|||
48462052|NCT02192190|155879635|FG001|Overall Study|Physician Decision|0|||
48462053|NCT02192190|155879636|FG002|Overall Study|Physician Decision|0|||
48462054|NCT02192190|155879637|FG003|Overall Study|Physician Decision|0|||
48462055|NCT02192190|155879638|FG004|Overall Study|Physician Decision|0|||
48462056|NCT02192190|155879639|FG005|Overall Study|Physician Decision|0|||
48462057|NCT02192190|155879634|FG000|Overall Study|Terminated by Sponsor|43|||
48462058|NCT02192190|155879635|FG001|Overall Study|Terminated by Sponsor|23|||
48462059|NCT02192190|155879636|FG002|Overall Study|Terminated by Sponsor|20|||
48462060|NCT02192190|155879637|FG003|Overall Study|Terminated by Sponsor|23|||
48462061|NCT02192190|155879638|FG004|Overall Study|Terminated by Sponsor|21|||
48462062|NCT02192190|155879639|FG005|Overall Study|Terminated by Sponsor|23|||
48462063|NCT02192190|155879634|FG000|Overall Study|Withdrawal by Subject|4|||
48462064|NCT02192190|155879635|FG001|Overall Study|Withdrawal by Subject|1|||
48462065|NCT02192190|155879636|FG002|Overall Study|Withdrawal by Subject|2|||
48462066|NCT02192190|155879637|FG003|Overall Study|Withdrawal by Subject|1|||
48462067|NCT02192190|155879638|FG004|Overall Study|Withdrawal by Subject|5|||
48462068|NCT02192190|155879639|FG005|Overall Study|Withdrawal by Subject|3|||
48462069|NCT02192190|155879634|FG000|Overall Study|Could not Keep Visit Schedule|1|||
48462070|NCT02192190|155879635|FG001|Overall Study|Could not Keep Visit Schedule|0|||
48462071|NCT02192190|155879636|FG002|Overall Study|Could not Keep Visit Schedule|0|||
48462072|NCT02192190|155879637|FG003|Overall Study|Could not Keep Visit Schedule|0|||
48462073|NCT02192190|155879638|FG004|Overall Study|Could not Keep Visit Schedule|0|||
48462074|NCT02192190|155879639|FG005|Overall Study|Could not Keep Visit Schedule|0|||
48462075|NCT02192190|155879634|FG000|Overall Study|Positive Drug Screen|0|||
48462076|NCT02192190|155879635|FG001|Overall Study|Positive Drug Screen|0|||
48462077|NCT02192190|155879636|FG002|Overall Study|Positive Drug Screen|0|||
48462078|NCT02192190|155879637|FG003|Overall Study|Positive Drug Screen|1|||
48462079|NCT02192190|155879638|FG004|Overall Study|Positive Drug Screen|0|||
48462080|NCT02192190|155879639|FG005|Overall Study|Positive Drug Screen|0|||
48462081|NCT02192190|155879634|FG000|Overall Study|Inadequate Pain Relief|0|||
48462082|NCT02192190|155879635|FG001|Overall Study|Inadequate Pain Relief|1|||
48462083|NCT02192190|155879636|FG002|Overall Study|Inadequate Pain Relief|1|||
48462084|NCT02192190|155879637|FG003|Overall Study|Inadequate Pain Relief|0|||
48462085|NCT02192190|155879638|FG004|Overall Study|Inadequate Pain Relief|0|||
48462086|NCT02192190|155879639|FG005|Overall Study|Inadequate Pain Relief|0|||
48462087|NCT03756285|155879640|FG000|Overall Study|Lost to Follow-up|0|||
48462088|NCT03756285|155879641|FG001|Overall Study|Lost to Follow-up|1|||
48462089|NCT03756285|155879640|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
48462090|NCT03756285|155879641|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
48462091|NCT03756285|155879640|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
48462092|NCT03756285|155879641|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
48462093|NCT03607994|155879642|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
48462094|NCT03607994|155879643|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
48462095|NCT00806494|155879645|FG000|Overall Study|Adverse Event|29|||
48462096|NCT00806494|155879645|FG000|Overall Study|Lack of Efficacy|6|||
48462097|NCT00806494|155879645|FG000|Overall Study|Lost to Follow-up|10|||
48462098|NCT00806494|155879645|FG000|Overall Study|Other|30|||
48462099|NCT00806494|155879645|FG000|Overall Study|Withdrawal by Subject|5|||
48462100|NCT01289028|155879650|FG000|Overall Study|Progressive Disease|49|||
48462101|NCT01289028|155879650|FG000|Overall Study|Adverse Event|14|||
48462102|NCT01289028|155879650|FG000|Overall Study|Withdrawal by Subject|6|||
48462103|NCT01289028|155879650|FG000|Overall Study|Death|4|||
48462104|NCT01289028|155879650|FG000|Overall Study|Lack of Efficacy|2|||
48462105|NCT01289028|155879650|FG000|Overall Study|No longer required|2|||
48462106|NCT01289028|155879650|FG000|Overall Study|Lost to Follow-up|2|||
48462107|NCT01289028|155879650|FG000|Overall Study|New Cancer Therapy|2|||
48462108|NCT01289028|155879650|FG000|Overall Study|Abnormal Lab Value|1|||
48462109|NCT01289028|155879650|FG000|Overall Study|Missing reason for discon|1|||
48462110|NCT01279954|155879658|FG000|Overall Study|Lack of Efficacy|3|||
48462111|NCT01279954|155879659|FG001|Overall Study|Lack of Efficacy|4|||
48462112|NCT01078974|155879660|FG000|Overall Study|Adverse Event|3|||
48462113|NCT02140762|155879661|FG000|Overall Study|Adverse Event|1|||
48462114|NCT02140762|155879662|FG001|Overall Study|Adverse Event|1|||
48462115|NCT02140762|155879661|FG000|Overall Study|Lost to Follow-up|9|||
48462116|NCT02140762|155879662|FG001|Overall Study|Lost to Follow-up|5|||
48462117|NCT02140762|155879661|FG000|Overall Study|Protocol Violation|1|||
48462118|NCT02140762|155879662|FG001|Overall Study|Protocol Violation|1|||
48462119|NCT02140762|155879661|FG000|Overall Study|Withdrawal by Subject|6|||
48462120|NCT02140762|155879662|FG001|Overall Study|Withdrawal by Subject|4|||
48462121|NCT02140762|155879661|FG000|Overall Study|Other|0|||
48462122|NCT02140762|155879662|FG001|Overall Study|Other|1|||
48462123|NCT01454531|155879665|FG000|Overall Study|Adverse Event|14|||
48462124|NCT01454531|155879665|FG000|Overall Study|Withdrawal by Subject|5|||
48462125|NCT01454531|155879665|FG000|Overall Study|Lost to Follow-up|1|||
48462126|NCT01454531|155879665|FG000|Overall Study|Physician Decision|1|||
48462127|NCT01454531|155879665|FG000|Overall Study|Delay in IMP administration|1|||
48462128|NCT01454531|155879665|FG000|Overall Study|Other|1|||
48462129|NCT03452397|155879667|FG000|Overall Study|Adverse Event|1|||
48462130|NCT03452397|155879668|FG001|Overall Study|Adverse Event|0|||
48462131|NCT03452397|155879669|FG002|Overall Study|Adverse Event|0|||
48462132|NCT03452397|155879670|FG003|Overall Study|Adverse Event|0|||
48462133|NCT03452397|155879667|FG000|Overall Study|Administrative reason|0|||
48462134|NCT03452397|155879668|FG001|Overall Study|Administrative reason|0|||
48462135|NCT03452397|155879669|FG002|Overall Study|Administrative reason|1|||
48462136|NCT03452397|155879670|FG003|Overall Study|Administrative reason|1|||
48462137|NCT03452397|155879667|FG000|Overall Study|Withdrawal by Subject|0|||
48462138|NCT03452397|155879668|FG001|Overall Study|Withdrawal by Subject|0|||
48462139|NCT03452397|155879669|FG002|Overall Study|Withdrawal by Subject|1|||
48462140|NCT03452397|155879670|FG003|Overall Study|Withdrawal by Subject|0|||
48462141|NCT00362297|155879671|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
48462142|NCT00362297|155879672|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
48462143|NCT05643170|155880937|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
48462144|NCT05643170|155880937|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
48462145|NCT01432756|155880940|FG000|Overall Study|Lost to Follow-up|1|||
48462146|NCT01432756|155880941|FG001|Overall Study|Lost to Follow-up|0|||
48462147|NCT01432756|155880942|FG002|Overall Study|Lost to Follow-up|2|||
48462148|NCT01432756|155880943|FG003|Overall Study|Lost to Follow-up|1|||
48462149|NCT02358863|155880944|FG000|Overall Study|Physician Decision|3|||
48462150|NCT01696396|155880952|FG000|Overall Study|Withdrawal by Subject|19|||
48462151|NCT01696396|155880953|FG001|Overall Study|Withdrawal by Subject|5|||
48462152|NCT01696396|155880954|FG002|Overall Study|Withdrawal by Subject|19|||
48462153|NCT01696396|155880955|FG003|Overall Study|Withdrawal by Subject|11|||
48462154|NCT01696396|155880952|FG000|Overall Study|Decision by Sponsor|3|||
48462155|NCT01696396|155880953|FG001|Overall Study|Decision by Sponsor|1|||
48462156|NCT01696396|155880954|FG002|Overall Study|Decision by Sponsor|2|||
48462157|NCT01696396|155880955|FG003|Overall Study|Decision by Sponsor|2|||
48462158|NCT01696396|155880952|FG000|Overall Study|Lost to Follow-up|9|||
48462159|NCT01696396|155880953|FG001|Overall Study|Lost to Follow-up|1|||
48462160|NCT01696396|155880954|FG002|Overall Study|Lost to Follow-up|4|||
48462161|NCT01696396|155880955|FG003|Overall Study|Lost to Follow-up|1|||
48462162|NCT01696396|155880952|FG000|Overall Study|Death|0|||
48462163|NCT01696396|155880953|FG001|Overall Study|Death|0|||
48462164|NCT01696396|155880954|FG002|Overall Study|Death|1|||
48462165|NCT01696396|155880955|FG003|Overall Study|Death|0|||
48462166|NCT00621764|155880958|FG000|Overall Study|Protocol Violation|0|||
48462167|NCT00621764|155880959|FG001|Overall Study|Protocol Violation|0|||
48462168|NCT00621764|155880960|FG002|Overall Study|Protocol Violation|0|||
48462169|NCT00621764|155880961|FG003|Overall Study|Protocol Violation|1|||
48462170|NCT02499172|155880962|FG000|Overall Study|Financial reason|0|||
48462171|NCT02499172|155880963|FG001|Overall Study|Financial reason|0|||
48462172|NCT02499172|155880964|FG002|Overall Study|Financial reason|523|||
48462173|NCT02499172|155880965|FG003|Overall Study|Financial reason|436|||
48462174|NCT02499172|155880962|FG000|Overall Study|Lost to Follow-up|65|||
48462175|NCT02499172|155880963|FG001|Overall Study|Lost to Follow-up|64|||
48462176|NCT02499172|155880964|FG002|Overall Study|Lost to Follow-up|0|||
48462177|NCT02499172|155880965|FG003|Overall Study|Lost to Follow-up|0|||
48462178|NCT02583399|155880966|FG000|Overall Study|Able to be discharged|3|||
48462179|NCT02583399|155880966|FG000|Overall Study|Wanted to use a restricted medication|3|||
48462180|NCT03557801|155880973|FG000|Overall Study|Protocol Violation|1|||
48462181|NCT03557801|155880974|FG001|Overall Study|Protocol Violation|0|||
48462182|NCT03557801|155880975|FG002|Overall Study|Protocol Violation|0|||
48462183|NCT03557801|155880973|FG000|Overall Study|Withdrawal by Subject|1|||
48462184|NCT03557801|155880974|FG001|Overall Study|Withdrawal by Subject|0|||
48462185|NCT03557801|155880975|FG002|Overall Study|Withdrawal by Subject|3|||
48462186|NCT03557801|155880973|FG000|Overall Study|Lost to Follow-up|0|||
48462187|NCT03557801|155880974|FG001|Overall Study|Lost to Follow-up|1|||
48462188|NCT03557801|155880975|FG002|Overall Study|Lost to Follow-up|0|||
48462189|NCT04905563|155880977|FG000|Overall Study|Withdrawal by Subject|1|||
48462190|NCT04905563|155880978|FG001|Overall Study|Withdrawal by Subject|0|||
48462191|NCT04905563|155880977|FG000|Overall Study|Standard of care orders entered by resident|1|||
48462192|NCT04905563|155880978|FG001|Overall Study|Standard of care orders entered by resident|0|||
48462193|NCT04905563|155880977|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
48462194|NCT04905563|155880978|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
48462195|NCT04905563|155880977|FG000|Overall Study|Withdrawal by Subject|0|||
48462196|NCT04905563|155880978|FG001|Overall Study|Withdrawal by Subject|1|||
48462197|NCT02881151|155880979|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
48462198|NCT01904760|155880982|FG000|Overall Study|Protocol Violation|1|||
48462199|NCT01904760|155880983|FG001|Overall Study|Protocol Violation|0|||
48462200|NCT00697255|155880984|FG000|Stage 1a|Insufficient ovarian response|1|||
48462201|NCT00697255|155880985|FG001|Stage 1a|Insufficient ovarian response|0|||
48462202|NCT00697255|155880984|FG000|Stage 1a|Multifollicular growth|1|||
48462203|NCT00697255|155880985|FG001|Stage 1a|Multifollicular growth|0|||
48462204|NCT00697255|155880984|FG000|Stage 1a|Not growing of dominant follicle|1|||
48462205|NCT00697255|155880985|FG001|Stage 1a|Not growing of dominant follicle|0|||
48462206|NCT00697255|155880984|FG000|Stage 1b|Not growing of dominant follicle|0|||
48462207|NCT00697255|155880985|FG001|Stage 1b|Not growing of dominant follicle|1|||
48462208|NCT00697255|155880984|FG000|Stage 1b|Insufficient ovarian response|0|||
48462209|NCT00697255|155880985|FG001|Stage 1b|Insufficient ovarian response|1|||
48462210|NCT03137433|155880986|FG000|Overall Study|Withdrawal by Subject|11|||
48462211|NCT03137433|155880987|FG001|Overall Study|Withdrawal by Subject|11|||
48462212|NCT03137433|155880986|FG000|Overall Study|Lost to Follow-up|5|||
48462213|NCT03137433|155880987|FG001|Overall Study|Lost to Follow-up|6|||
48462214|NCT03137433|155880986|FG000|Overall Study|Physician Decision|2|||
48462215|NCT03137433|155880987|FG001|Overall Study|Physician Decision|0|||
48462216|NCT03137433|155880986|FG000|Overall Study|Moved out of study area|1|||
48462217|NCT03137433|155880987|FG001|Overall Study|Moved out of study area|0|||
48462218|NCT03137433|155880986|FG000|Overall Study|Too far out of window due to COVID|0|||
48462219|NCT03137433|155880987|FG001|Overall Study|Too far out of window due to COVID|1|||
48462220|NCT00638989|155880988|FG000|Overall Study|Lost to Follow-up|0|||
48462221|NCT00638989|155880989|FG001|Overall Study|Lost to Follow-up|0|||
48462222|NCT00638989|155880990|FG002|Overall Study|Lost to Follow-up|1|||
48462223|NCT04554394|155880996|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
48462224|NCT04554394|155880997|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
48462225|NCT04554394|155880996|FG000|Overall Study|Withdrawal by Subject|2|||
48462226|NCT04554394|155880997|FG001|Overall Study|Withdrawal by Subject|2|||
48462227|NCT04554394|155880996|FG000|Overall Study|Lost to Follow-up|2|||
48462228|NCT04554394|155880997|FG001|Overall Study|Lost to Follow-up|2|||
48462229|NCT04554394|155880996|FG000|Overall Study|Physician Decision|1|||
48462230|NCT04554394|155880997|FG001|Overall Study|Physician Decision|1|||
48462231|NCT00082628|155880998|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
48462232|NCT00082628|155880999|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
48462233|NCT00082628|155881000|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
48462234|NCT00082628|155881001|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
48462235|NCT00082628|155881002|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
48462236|NCT00082628|155880998|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
48462237|NCT00082628|155880999|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
48462238|NCT00082628|155881000|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
48462239|NCT00082628|155881001|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
48462240|NCT00082628|155881002|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
48462241|NCT00082628|155880998|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
48462242|NCT00082628|155880999|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
48462243|NCT00082628|155881000|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
48462244|NCT00082628|155881001|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
48462245|NCT00082628|155881002|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
48462246|NCT00082628|155880998|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
48462247|NCT00082628|155880999|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
48462248|NCT00082628|155881000|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
48462249|NCT00082628|155881001|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
48462250|NCT00082628|155881002|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
48462251|NCT00082628|155880998|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
48462252|NCT00082628|155880999|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
48462253|NCT00082628|155881000|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
48462254|NCT00082628|155881001|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
48462255|NCT00082628|155881002|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
48462256|NCT00082628|155880998|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
48462257|NCT00082628|155880999|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
48462258|NCT00082628|155881000|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
48462259|NCT00082628|155881001|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
48462260|NCT00082628|155881002|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
48462261|NCT00082628|155880998|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
48462262|NCT00082628|155880999|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
48462263|NCT00082628|155881000|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
48462264|NCT00082628|155881001|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
48462265|NCT00082628|155881002|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
48462266|NCT00890201|155881003|FG000|Overall Study|Protocol Violation|5|||
48462267|NCT00890201|155881004|FG001|Overall Study|Protocol Violation|56|||
48462268|NCT01362049|155881005|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
48462269|NCT01362049|155881006|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
48462270|NCT01362049|155881007|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
48462271|NCT01362049|155881008|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
48462272|NCT01362049|155881005|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
48462273|NCT01362049|155881006|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
48462274|NCT01362049|155881007|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
48462275|NCT01362049|155881008|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
48462276|NCT02098733|155881009|FG000|Overall Study|Data Not Available|5|||
48462277|NCT02098733|155881009|FG000|Overall Study|Lost to Follow-up|5|||
48462278|NCT02610231|155881010|FG000|Overall Study|Withdrawal by Subject|27|||
48462279|NCT02610231|155881010|FG000|Overall Study|Adverse Event|20|||
48462280|NCT02610231|155881010|FG000|Overall Study|Death|5|||
48462281|NCT02610231|155881010|FG000|Overall Study|Surgery|2|||
48462282|NCT02610231|155881010|FG000|Overall Study|Physician Decision|1|||
48462283|NCT02610231|155881010|FG000|Overall Study|Non Compliance|2|||
48462284|NCT02610231|155881010|FG000|Overall Study|Other|3|||
48462285|NCT02442765|155881011|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
48462286|NCT02442765|155881012|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
48462287|NCT02442765|155881013|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
48462288|NCT02442765|155881014|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
48462289|NCT02442765|155881015|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
48462290|NCT02442765|155881016|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
48462291|NCT02442765|155881017|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
48462292|NCT02442765|155881018|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
48462293|NCT02442765|155881011|FG000|Stage 2- (Days 43 to 85)|Death|0|||
48462294|NCT02442765|155881012|FG001|Stage 2- (Days 43 to 85)|Death|0|||
48462295|NCT02442765|155881013|FG002|Stage 2- (Days 43 to 85)|Death|0|||
48462296|NCT02442765|155881014|FG003|Stage 2- (Days 43 to 85)|Death|1|||
48462297|NCT02442765|155881015|FG004|Stage 2- (Days 43 to 85)|Death|1|||
48462298|NCT02442765|155881016|FG005|Stage 2- (Days 43 to 85)|Death|0|||
48462299|NCT02442765|155881017|FG006|Stage 2- (Days 43 to 85)|Death|2|||
48462300|NCT02442765|155881018|FG007|Stage 2- (Days 43 to 85)|Death|0|||
48462301|NCT02442765|155881011|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48462302|NCT02442765|155881012|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48462303|NCT02442765|155881013|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48462304|NCT02442765|155881014|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
48462305|NCT02442765|155881015|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48462306|NCT02442765|155881016|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48462307|NCT02442765|155881017|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48462308|NCT02442765|155881018|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
48462309|NCT02442765|155881011|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48462310|NCT02442765|155881012|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48462311|NCT02442765|155881013|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48462312|NCT02442765|155881014|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
48462313|NCT02442765|155881015|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48462314|NCT02442765|155881016|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48462315|NCT02442765|155881017|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48462316|NCT02442765|155881018|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
48462317|NCT02442765|155881011|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48462318|NCT02442765|155881012|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48462319|NCT02442765|155881013|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48462320|NCT02442765|155881014|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
48462321|NCT02442765|155881015|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48462322|NCT02442765|155881016|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
48462323|NCT02442765|155881017|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
48462324|NCT02442765|155881018|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
48462325|NCT02442765|155881011|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48462326|NCT02442765|155881012|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48462327|NCT02442765|155881013|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48462328|NCT02442765|155881014|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
48462329|NCT02442765|155881015|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48462330|NCT02442765|155881016|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
48462331|NCT02442765|155881017|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
48462332|NCT02442765|155881018|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
48462333|NCT02442765|155881011|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48462334|NCT02442765|155881012|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48462335|NCT02442765|155881013|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48462336|NCT02442765|155881014|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48462337|NCT02442765|155881015|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
48462489|NCT00303329|155883361|FG001|Overall Study|Adverse Event|14|||
48462338|NCT02442765|155881016|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
48462339|NCT02442765|155881017|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
48462340|NCT02442765|155881018|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
48462341|NCT02442765|155881011|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48462342|NCT02442765|155881012|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48462343|NCT02442765|155881013|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48462344|NCT02442765|155881014|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48462345|NCT02442765|155881015|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
48462346|NCT02442765|155881016|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48462347|NCT02442765|155881017|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
48462348|NCT02442765|155881018|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
48462349|NCT04815291|155881026|FG000|Overall Study|Lost to Follow-up|1|||
48462350|NCT04815291|155881026|FG000|Overall Study|Physician Decision|4|||
48462351|NCT04815291|155881026|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
48462352|NCT00537810|155881028|FG000|Overall Study|Withdrawal by Subject|4|||
48462353|NCT00537810|155881029|FG001|Overall Study|Withdrawal by Subject|11|||
48462354|NCT00537810|155881030|FG002|Overall Study|Withdrawal by Subject|4|||
48462355|NCT00537810|155881031|FG003|Overall Study|Withdrawal by Subject|3|||
48462356|NCT00537810|155881028|FG000|Overall Study|Medically withdrawn|2|||
48462357|NCT00537810|155881029|FG001|Overall Study|Medically withdrawn|2|||
48462358|NCT00537810|155881030|FG002|Overall Study|Medically withdrawn|0|||
48462359|NCT00537810|155881031|FG003|Overall Study|Medically withdrawn|1|||
48462360|NCT00989664|155881033|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
48462361|NCT00989664|155881033|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
48462362|NCT00989664|155881033|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
48462363|NCT00989664|155881033|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
48462364|NCT00989664|155881033|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
48462365|NCT00989664|155881033|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
48462366|NCT00989664|155881033|FG000|Long-Term Follow-Up|Death|3|||
48462367|NCT00098865|155881034|FG000|Overall Study|Progressive Disease|6|||
48462368|NCT00098865|155881034|FG000|Overall Study|Adverse Event|2|||
48462369|NCT00098865|155881034|FG000|Overall Study|Alternative Therapy|1|||
48462370|NCT02309372|155881039|FG000|Overall Study|Lost to Follow-up|3|||
48462371|NCT02309372|155881040|FG001|Overall Study|Lost to Follow-up|2|||
48462372|NCT01183104|155881042|FG000|Overall Study|Adverse Event|8|||
48462373|NCT01183104|155881043|FG001|Overall Study|Adverse Event|6|||
48462374|NCT01183104|155881042|FG000|Overall Study|Death|0|||
48462375|NCT01183104|155881043|FG001|Overall Study|Death|1|||
48462376|NCT01183104|155881042|FG000|Overall Study|Lost to Follow-up|14|||
48462377|NCT01183104|155881043|FG001|Overall Study|Lost to Follow-up|7|||
48462378|NCT01183104|155881042|FG000|Overall Study|Physician Decision|5|||
48462379|NCT01183104|155881043|FG001|Overall Study|Physician Decision|8|||
48462380|NCT01183104|155881042|FG000|Overall Study|Withdrawal by Subject|6|||
48462381|NCT01183104|155881043|FG001|Overall Study|Withdrawal by Subject|11|||
48462382|NCT01183104|155881042|FG000|Overall Study|Nonparticipation in Extension Study|39|||
48462383|NCT01183104|155881043|FG001|Overall Study|Nonparticipation in Extension Study|50|||
48462384|NCT01183104|155881042|FG000|Overall Study|Did not receive study drug|5|||
48462385|NCT01183104|155881043|FG001|Overall Study|Did not receive study drug|9|||
48462386|NCT01066546|155881044|FG000|Overall Study|Study terminated by sponsor|5|||
48462387|NCT02853318|155881046|FG000|Overall Study|Withdrawal by Subject|1|||
48462388|NCT00252499|155881050|FG000|Overall Study|Lost to Follow-up|1|||
48462389|NCT00252499|155881051|FG001|Overall Study|Lost to Follow-up|0|||
48462390|NCT00252499|155881052|FG002|Overall Study|Lost to Follow-up|0|||
48462391|NCT01882439|155881053|FG000|Overall Study|Adverse event related to study drug|3|||
48462392|NCT01882439|155881054|FG001|Overall Study|Adverse event related to study drug|8|||
48462393|NCT01882439|155881055|FG002|Overall Study|Adverse event related to study drug|1|||
48462394|NCT01882439|155881056|FG003|Overall Study|Adverse event related to study drug|2|||
48462395|NCT01882439|155881053|FG000|Overall Study|Pregnancy|0|||
48462396|NCT01882439|155881054|FG001|Overall Study|Pregnancy|1|||
48462397|NCT01882439|155881055|FG002|Overall Study|Pregnancy|0|||
48462398|NCT01882439|155881056|FG003|Overall Study|Pregnancy|0|||
48462399|NCT01882439|155881053|FG000|Overall Study|Protocol Violation|2|||
48462400|NCT01882439|155881054|FG001|Overall Study|Protocol Violation|2|||
48462401|NCT01882439|155881055|FG002|Overall Study|Protocol Violation|0|||
48462402|NCT01882439|155881056|FG003|Overall Study|Protocol Violation|1|||
48462403|NCT01882439|155881053|FG000|Overall Study|No longer willing to participate|1|||
48462404|NCT01882439|155881054|FG001|Overall Study|No longer willing to participate|4|||
48462405|NCT01882439|155881055|FG002|Overall Study|No longer willing to participate|2|||
48462406|NCT01882439|155881056|FG003|Overall Study|No longer willing to participate|3|||
48462407|NCT01882439|155881053|FG000|Overall Study|Medication error with no associated AE|0|||
48462408|NCT01882439|155881054|FG001|Overall Study|Medication error with no associated AE|0|||
48462409|NCT01882439|155881055|FG002|Overall Study|Medication error with no associated AE|2|||
48462410|NCT01882439|155881056|FG003|Overall Study|Medication error with no associated AE|0|||
48462411|NCT01882439|155881053|FG000|Overall Study|Insufficient clinical response|1|||
48462412|NCT01882439|155881054|FG001|Overall Study|Insufficient clinical response|4|||
48462413|NCT01882439|155881055|FG002|Overall Study|Insufficient clinical response|4|||
48462414|NCT01882439|155881056|FG003|Overall Study|Insufficient clinical response|2|||
48462415|NCT01882439|155881053|FG000|Overall Study|Adverse event unrelated to study drug|2|||
48462416|NCT01882439|155881054|FG001|Overall Study|Adverse event unrelated to study drug|2|||
48462417|NCT01882439|155881055|FG002|Overall Study|Adverse event unrelated to study drug|1|||
48462418|NCT01882439|155881056|FG003|Overall Study|Adverse event unrelated to study drug|1|||
48462419|NCT01775995|155881059|FG000|Overall Study|Lost to Follow-up|1|||
48462420|NCT01775995|155881060|FG001|Overall Study|Lost to Follow-up|1|||
48462421|NCT01469637|155881065|FG000|First Intervention|Unacceptable behavior|0|||
48462422|NCT01469637|155881066|FG001|First Intervention|Unacceptable behavior|1|||
48462423|NCT01469637|155881065|FG000|Second Intervention|Incarcerated|1|||
48462424|NCT01469637|155881066|FG001|Second Intervention|Incarcerated|0|||
48462425|NCT01843933|155881067|FG000|Overall Study|Data lost|6|||
48462426|NCT01843933|155881068|FG001|Overall Study|Data lost|4|||
48462427|NCT00424463|155881069|FG000|Overall Study|Adverse Event|2|||
48462428|NCT00424463|155881070|FG001|Overall Study|Adverse Event|3|||
48462429|NCT00424463|155881071|FG002|Overall Study|Adverse Event|2|||
48462430|NCT00424463|155881069|FG000|Overall Study|Physician Decision|0|||
48462431|NCT00424463|155881070|FG001|Overall Study|Physician Decision|2|||
48462432|NCT00424463|155881071|FG002|Overall Study|Physician Decision|2|||
48462433|NCT00424463|155881069|FG000|Overall Study|Withdrawal by Subject|4|||
48462434|NCT00424463|155881070|FG001|Overall Study|Withdrawal by Subject|2|||
48462435|NCT00424463|155881071|FG002|Overall Study|Withdrawal by Subject|5|||
48462436|NCT00424463|155881069|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
48462437|NCT00424463|155881070|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
48462438|NCT00424463|155881071|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
48462439|NCT00424463|155881069|FG000|Overall Study|Patient's convenience|0|||
48462440|NCT00424463|155881070|FG001|Overall Study|Patient's convenience|0|||
48462441|NCT00424463|155881071|FG002|Overall Study|Patient's convenience|1|||
48462442|NCT02504424|155881076|FG000|Overall Study|Withdrawal by Subject|2|||
48462443|NCT00440232|155881079|FG000|Overall Study|Lost to Follow-up|1|||
48462444|NCT00440232|155881080|FG001|Overall Study|Lost to Follow-up|1|||
48462445|NCT00440232|155881079|FG000|Overall Study|Unable to treat within allowed time|0|||
48462446|NCT00440232|155881080|FG001|Overall Study|Unable to treat within allowed time|1|||
48462447|NCT00440232|155881079|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
48462448|NCT00440232|155881080|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
48462449|NCT00121485|155883335|FG000|Overall Study|Not implanted|1|||
48462450|NCT00121485|155883336|FG001|Overall Study|Not implanted|5|||
48462451|NCT00121485|155883335|FG000|Overall Study|Crossover|0|||
48462452|NCT00121485|155883336|FG001|Overall Study|Crossover|2|||
48462453|NCT03267511|155883339|FG000|Overall Study|Lost to Follow-up|0|||
48462454|NCT03267511|155883340|FG001|Overall Study|Lost to Follow-up|0|||
48462455|NCT03267511|155883341|FG002|Overall Study|Lost to Follow-up|0|||
48462456|NCT03267511|155883342|FG003|Overall Study|Lost to Follow-up|1|||
48462457|NCT00439309|155883343|FG000|Follow-Up|Death|1|||
48462458|NCT00439309|155883344|FG001|Follow-Up|Death|0|||
48462459|NCT00439309|155883343|FG000|Follow-Up|Lost to Follow-up|2|||
48462460|NCT00439309|155883344|FG001|Follow-Up|Lost to Follow-up|0|||
48462461|NCT00439309|155883343|FG000|Follow-Up|Withdrawal by Subject|0|||
48462462|NCT00439309|155883344|FG001|Follow-Up|Withdrawal by Subject|1|||
48462463|NCT00439309|155883343|FG000|Follow-Up|Late response by subject|0|||
48462464|NCT00439309|155883344|FG001|Follow-Up|Late response by subject|1|||
48462465|NCT01977040|155883345|FG000|Overall Study|Vasa previa not confirmed|2|||
48462466|NCT01572844|155883346|FG000|Overall Study|Physician Decision|1|||
48462467|NCT01572844|155883347|FG001|Overall Study|Physician Decision|1|||
48462468|NCT01603615|155883352|FG000|Overall Study|Did not Receive Treatment|7|||
48462469|NCT01603615|155883352|FG000|Overall Study|Lost to Follow-up|9|||
48462470|NCT01603615|155883352|FG000|Overall Study|Personal Reasons|17|||
48462471|NCT01603615|155883352|FG000|Overall Study|Other Miscellaneous|1|||
48462472|NCT02759939|155883353|FG000|Overall Study|Missing data on first outcome assessed|11|||
48462473|NCT02759939|155883354|FG001|Overall Study|Missing data on first outcome assessed|2|||
48462474|NCT02759939|155883355|FG002|Overall Study|Missing data on first outcome assessed|5|||
48462475|NCT02759939|155883356|FG003|Overall Study|Missing data on first outcome assessed|2|||
48462476|NCT02759939|155883353|FG000|Overall Study|Ineligible for T2 and T3|310|||
48462477|NCT02759939|155883354|FG001|Overall Study|Ineligible for T2 and T3|179|||
48462478|NCT02759939|155883355|FG002|Overall Study|Ineligible for T2 and T3|366|||
48462479|NCT02759939|155883356|FG003|Overall Study|Ineligible for T2 and T3|391|||
48462480|NCT02759939|155883353|FG000|Overall Study|Lost to Follow-up|735|||
48462481|NCT02759939|155883354|FG001|Overall Study|Lost to Follow-up|791|||
48462482|NCT02759939|155883355|FG002|Overall Study|Lost to Follow-up|783|||
48462483|NCT02759939|155883356|FG003|Overall Study|Lost to Follow-up|650|||
48462484|NCT03419741|155883357|FG000|Overall Study|Adverse Event|1|||
48462485|NCT03419741|155883358|FG001|Overall Study|Adverse Event|0|||
48462486|NCT03419741|155883357|FG000|Overall Study|Withdrawal by Subject|1|||
48462487|NCT03419741|155883358|FG001|Overall Study|Withdrawal by Subject|2|||
48462488|NCT00303329|155883360|FG000|Overall Study|Adverse Event|7|||
48462490|NCT00303329|155883360|FG000|Overall Study|Abnormal Laboratory Values|0|||
48462491|NCT00303329|155883361|FG001|Overall Study|Abnormal Laboratory Values|1|||
48462492|NCT00303329|155883360|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
48462493|NCT00303329|155883361|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48462494|NCT00303329|155883360|FG000|Overall Study|Condition no longer requires study drug|0|||
48462495|NCT00303329|155883361|FG001|Overall Study|Condition no longer requires study drug|8|||
48462496|NCT00303329|155883360|FG000|Overall Study|Protocol Violation|3|||
48462497|NCT00303329|155883361|FG001|Overall Study|Protocol Violation|0|||
48462498|NCT00303329|155883360|FG000|Overall Study|Withdrawal by Subject|9|||
48462499|NCT00303329|155883361|FG001|Overall Study|Withdrawal by Subject|15|||
48462500|NCT00303329|155883360|FG000|Overall Study|Lost to Follow-up|0|||
48462501|NCT00303329|155883361|FG001|Overall Study|Lost to Follow-up|1|||
48462502|NCT00303329|155883360|FG000|Overall Study|Administrative problems|1|||
48462503|NCT00303329|155883361|FG001|Overall Study|Administrative problems|0|||
48462504|NCT00303329|155883360|FG000|Overall Study|Death|2|||
48462505|NCT00303329|155883361|FG001|Overall Study|Death|12|||
48462506|NCT00303329|155883360|FG000|Overall Study|Stopped at end of core|3|||
48462507|NCT00303329|155883361|FG001|Overall Study|Stopped at end of core|9|||
48462508|NCT00303329|155883360|FG000|Overall Study|Stopped at end of extension 1|1|||
48462509|NCT00303329|155883361|FG001|Overall Study|Stopped at end of extension 1|0|||
48462510|NCT04354870|155883378|FG000|Overall Study|Lost to Follow-up|32|||
48462511|NCT04354870|155883379|FG001|Overall Study|Lost to Follow-up|12|||
48462512|NCT04354870|155883378|FG000|Overall Study|Withdrawal by Subject|10|||
48462513|NCT04354870|155883379|FG001|Overall Study|Withdrawal by Subject|16|||
48462514|NCT04354870|155883378|FG000|Overall Study|Did not complete all study visits|6|||
48462515|NCT04354870|155883379|FG001|Overall Study|Did not complete all study visits|5|||
48462516|NCT04735432|155883380|FG000|Overall Study|Other - due to personal reason|1|||
48462517|NCT04735432|155883381|FG001|Overall Study|Other - due to personal reason|0|||
48462518|NCT04735432|155883380|FG000|Overall Study|Adverse Event|2|||
48462519|NCT04735432|155883381|FG001|Overall Study|Adverse Event|0|||
48462520|NCT02807376|155883386|FG000|Overall Study|Intra-operative exclusion criteria|3|||
48462521|NCT02807376|155883387|FG001|Overall Study|Intra-operative exclusion criteria|0|||
48462522|NCT02807376|155883386|FG000|Overall Study|Lost to Follow-up|0|||
48462523|NCT02807376|155883387|FG001|Overall Study|Lost to Follow-up|1|||
48462524|NCT01453439|155883388|FG000|Treatment Phase|Withdrawal by Subject|13|||
48462525|NCT01453439|155883389|FG001|Treatment Phase|Withdrawal by Subject|10|||
48462526|NCT01453439|155883388|FG000|Treatment Phase|Suicidal Ideation|2|||
48462527|NCT01453439|155883389|FG001|Treatment Phase|Suicidal Ideation|0|||
48462528|NCT01453439|155883388|FG000|Treatment Phase|Need for higher level of care|1|||
48462529|NCT01453439|155883389|FG001|Treatment Phase|Need for higher level of care|1|||
48462530|NCT01453439|155883388|FG000|Treatment Phase|Therapist conflict of interest|1|||
48462531|NCT01453439|155883389|FG001|Treatment Phase|Therapist conflict of interest|0|||
48462532|NCT01453439|155883388|FG000|Follow-up|Withdrawal by Subject|0|||
48462533|NCT01453439|155883389|FG001|Follow-up|Withdrawal by Subject|1|||
48462534|NCT01453439|155883388|FG000|Follow-up|Lost to Follow-up|5|||
48462535|NCT01453439|155883389|FG001|Follow-up|Lost to Follow-up|10|||
48462536|NCT02646891|155883392|FG000|Overall Study|Adverse Event|0|||
48462537|NCT02646891|155883393|FG001|Overall Study|Adverse Event|1|||
48462538|NCT02646891|155883394|FG002|Overall Study|Adverse Event|0|||
48462539|NCT02646891|155883395|FG003|Overall Study|Adverse Event|0|||
48462540|NCT02646891|155883396|FG004|Overall Study|Adverse Event|0|||
48462541|NCT02646891|155883397|FG005|Overall Study|Adverse Event|0|||
48462542|NCT02646891|155883398|FG006|Overall Study|Adverse Event|0|||
48462543|NCT02646891|155883399|FG007|Overall Study|Adverse Event|0|||
48462544|NCT02646891|155883400|FG008|Overall Study|Adverse Event|0|||
48462545|NCT02646891|155883401|FG009|Overall Study|Adverse Event|0|||
48462546|NCT02646891|155883392|FG000|Overall Study|Lost to Follow-up|0|||
48462547|NCT02646891|155883393|FG001|Overall Study|Lost to Follow-up|0|||
48462548|NCT02646891|155883394|FG002|Overall Study|Lost to Follow-up|0|||
48462549|NCT02646891|155883395|FG003|Overall Study|Lost to Follow-up|0|||
48462550|NCT02646891|155883396|FG004|Overall Study|Lost to Follow-up|0|||
48462551|NCT02646891|155883397|FG005|Overall Study|Lost to Follow-up|0|||
48462552|NCT02646891|155883398|FG006|Overall Study|Lost to Follow-up|2|||
48462553|NCT02646891|155883399|FG007|Overall Study|Lost to Follow-up|2|||
48462554|NCT02646891|155883400|FG008|Overall Study|Lost to Follow-up|2|||
48462555|NCT02646891|155883401|FG009|Overall Study|Lost to Follow-up|2|||
48462556|NCT02646891|155883392|FG000|Overall Study|Protocol Violation|0|||
48462557|NCT02646891|155883393|FG001|Overall Study|Protocol Violation|0|||
48462558|NCT02646891|155883394|FG002|Overall Study|Protocol Violation|0|||
48462559|NCT02646891|155883395|FG003|Overall Study|Protocol Violation|0|||
48462560|NCT02646891|155883396|FG004|Overall Study|Protocol Violation|0|||
48462561|NCT02646891|155883397|FG005|Overall Study|Protocol Violation|0|||
48462562|NCT02646891|155883398|FG006|Overall Study|Protocol Violation|1|||
48462563|NCT02646891|155883399|FG007|Overall Study|Protocol Violation|1|||
48462564|NCT02646891|155883400|FG008|Overall Study|Protocol Violation|0|||
48462565|NCT02646891|155883401|FG009|Overall Study|Protocol Violation|0|||
48462566|NCT02646891|155883392|FG000|Overall Study|Withdrawal by Subject|2|||
48462567|NCT02646891|155883393|FG001|Overall Study|Withdrawal by Subject|0|||
48462568|NCT02646891|155883394|FG002|Overall Study|Withdrawal by Subject|1|||
48462569|NCT02646891|155883395|FG003|Overall Study|Withdrawal by Subject|0|||
48462570|NCT02646891|155883396|FG004|Overall Study|Withdrawal by Subject|0|||
48462571|NCT02646891|155883397|FG005|Overall Study|Withdrawal by Subject|0|||
48462572|NCT02646891|155883398|FG006|Overall Study|Withdrawal by Subject|5|||
48462573|NCT02646891|155883399|FG007|Overall Study|Withdrawal by Subject|9|||
48462574|NCT02646891|155883400|FG008|Overall Study|Withdrawal by Subject|7|||
48462575|NCT02646891|155883401|FG009|Overall Study|Withdrawal by Subject|3|||
48462576|NCT02646891|155883392|FG000|Overall Study|Death|0|||
48462577|NCT02646891|155883393|FG001|Overall Study|Death|0|||
48462578|NCT02646891|155883394|FG002|Overall Study|Death|0|||
48462579|NCT02646891|155883395|FG003|Overall Study|Death|0|||
48462580|NCT02646891|155883396|FG004|Overall Study|Death|0|||
48462581|NCT02646891|155883397|FG005|Overall Study|Death|0|||
48462582|NCT02646891|155883398|FG006|Overall Study|Death|1|||
48462583|NCT02646891|155883399|FG007|Overall Study|Death|1|||
48462584|NCT02646891|155883400|FG008|Overall Study|Death|1|||
48462585|NCT02646891|155883401|FG009|Overall Study|Death|0|||
48462586|NCT03225833|155883402|FG000|Overall Study|Adverse Event|0|||
48462587|NCT03225833|155883403|FG001|Overall Study|Adverse Event|1|||
48462588|NCT03225833|155883404|FG002|Overall Study|Adverse Event|2|||
48462589|NCT03225833|155883405|FG003|Overall Study|Adverse Event|0|||
48462590|NCT03225833|155883406|FG004|Overall Study|Adverse Event|0|||
48462591|NCT03225833|155883407|FG005|Overall Study|Adverse Event|2|||
48462592|NCT03225833|155883402|FG000|Overall Study|Withdrawal by Subject|1|||
48462593|NCT03225833|155883403|FG001|Overall Study|Withdrawal by Subject|0|||
48462594|NCT03225833|155883404|FG002|Overall Study|Withdrawal by Subject|0|||
48462595|NCT03225833|155883405|FG003|Overall Study|Withdrawal by Subject|0|||
48462596|NCT03225833|155883406|FG004|Overall Study|Withdrawal by Subject|1|||
48462597|NCT03225833|155883407|FG005|Overall Study|Withdrawal by Subject|0|||
48462598|NCT03225833|155883402|FG000|Overall Study|Termination of Study by Sponsor|4|||
48462599|NCT03225833|155883403|FG001|Overall Study|Termination of Study by Sponsor|0|||
48462600|NCT03225833|155883404|FG002|Overall Study|Termination of Study by Sponsor|0|||
48462601|NCT03225833|155883405|FG003|Overall Study|Termination of Study by Sponsor|0|||
48462602|NCT03225833|155883406|FG004|Overall Study|Termination of Study by Sponsor|0|||
48462603|NCT03225833|155883407|FG005|Overall Study|Termination of Study by Sponsor|7|||
48462604|NCT03225833|155883402|FG000|Overall Study|Sponsor Decision|0|||
48462605|NCT03225833|155883403|FG001|Overall Study|Sponsor Decision|0|||
48462606|NCT03225833|155883404|FG002|Overall Study|Sponsor Decision|0|||
48462607|NCT03225833|155883405|FG003|Overall Study|Sponsor Decision|0|||
48462608|NCT03225833|155883406|FG004|Overall Study|Sponsor Decision|0|||
48462609|NCT03225833|155883407|FG005|Overall Study|Sponsor Decision|1|||
48462610|NCT00808028|155883408|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
48462611|NCT00808028|155883409|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
48462612|NCT00808028|155883410|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
48462613|NCT00808028|155883411|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
48462614|NCT00808028|155883408|FG000|Stage 1 (6 Months)|Other|1|||
48462615|NCT00808028|155883409|FG001|Stage 1 (6 Months)|Other|0|||
48462616|NCT00808028|155883410|FG002|Stage 1 (6 Months)|Other|2|||
48462617|NCT00808028|155883411|FG003|Stage 1 (6 Months)|Other|4|||
48462618|NCT00808028|155883408|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
48462619|NCT00808028|155883409|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
48462620|NCT00808028|155883410|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
48462621|NCT00808028|155883411|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
48462622|NCT00808028|155883408|FG000|Stage 1 (6 Months)|Adverse Event|0|||
48462623|NCT00808028|155883409|FG001|Stage 1 (6 Months)|Adverse Event|0|||
48462624|NCT00808028|155883410|FG002|Stage 1 (6 Months)|Adverse Event|1|||
48462625|NCT00808028|155883411|FG003|Stage 1 (6 Months)|Adverse Event|2|||
48462626|NCT00808028|155883408|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
48462627|NCT00808028|155883409|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
48462628|NCT00808028|155883410|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
48462629|NCT00808028|155883411|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
48462630|NCT00808028|155883408|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
48462631|NCT00808028|155883409|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
48462632|NCT00808028|155883410|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
48462633|NCT00808028|155883411|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
48462634|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
48462635|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
48462636|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
48462637|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
48462638|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
48462639|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
48462640|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
48462641|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
48462642|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
48462643|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
48462644|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
48462645|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
48462646|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
48462647|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
48462648|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
48462649|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
48462650|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
48462651|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
48462652|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
48462653|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
48462654|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
48462655|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
48462656|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
48462657|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
48462658|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
48462659|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
48462660|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
48462661|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
48462662|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
48462663|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
48462664|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
48462665|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
48462666|NCT00808028|155883408|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
48462667|NCT00808028|155883409|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
48462668|NCT00808028|155883410|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
48462669|NCT00808028|155883411|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
48462670|NCT01058395|155883414|FG000|Overall Study|Death|2|||
48462671|NCT01058395|155883415|FG001|Overall Study|Death|1|||
48462672|NCT01058395|155883414|FG000|Overall Study|Lost to Follow-up|1|||
48462673|NCT01058395|155883415|FG001|Overall Study|Lost to Follow-up|0|||
48462674|NCT00963820|155883419|FG000|Dose Escalation Phase|Progressive Disease|3|||
48462675|NCT00963820|155883420|FG001|Dose Escalation Phase|Progressive Disease|3|||
48462676|NCT00963820|155883421|FG002|Dose Escalation Phase|Progressive Disease|3|||
48462677|NCT00963820|155883422|FG003|Dose Escalation Phase|Progressive Disease|3|||
48462678|NCT00963820|155883423|FG004|Dose Escalation Phase|Progressive Disease|4|||
48462679|NCT00963820|155883424|FG005|Dose Escalation Phase|Progressive Disease|3|||
48462680|NCT00963820|155883425|FG006|Dose Escalation Phase|Progressive Disease|3|||
48462681|NCT00963820|155883426|FG007|Dose Escalation Phase|Progressive Disease|2|||
48462682|NCT00963820|155883427|FG008|Dose Escalation Phase|Progressive Disease|0|||
48462683|NCT00963820|155883428|FG009|Dose Escalation Phase|Progressive Disease|0|||
48462684|NCT00963820|155883429|FG010|Dose Escalation Phase|Progressive Disease|0|||
48462685|NCT00963820|155883430|FG011|Dose Escalation Phase|Progressive Disease|0|||
48462686|NCT00963820|155883419|FG000|Dose Escalation Phase|Adverse Event|0|||
48462687|NCT00963820|155883420|FG001|Dose Escalation Phase|Adverse Event|0|||
48462688|NCT00963820|155883421|FG002|Dose Escalation Phase|Adverse Event|0|||
48462689|NCT00963820|155883422|FG003|Dose Escalation Phase|Adverse Event|0|||
48462690|NCT00963820|155883423|FG004|Dose Escalation Phase|Adverse Event|0|||
48462691|NCT00963820|155883424|FG005|Dose Escalation Phase|Adverse Event|0|||
48462692|NCT00963820|155883425|FG006|Dose Escalation Phase|Adverse Event|3|||
48462693|NCT00963820|155883426|FG007|Dose Escalation Phase|Adverse Event|1|||
48462694|NCT00963820|155883427|FG008|Dose Escalation Phase|Adverse Event|0|||
48462695|NCT00963820|155883428|FG009|Dose Escalation Phase|Adverse Event|0|||
48462696|NCT00963820|155883429|FG010|Dose Escalation Phase|Adverse Event|0|||
48462697|NCT00963820|155883430|FG011|Dose Escalation Phase|Adverse Event|0|||
48462698|NCT00963820|155883419|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
48462699|NCT00963820|155883420|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
48462700|NCT00963820|155883421|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
48462701|NCT00963820|155883422|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
48462702|NCT00963820|155883423|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
48462703|NCT00963820|155883424|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
48462704|NCT00963820|155883425|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
48462705|NCT00963820|155883426|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
48462706|NCT00963820|155883427|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
48462707|NCT00963820|155883428|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
48462708|NCT00963820|155883429|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
48462709|NCT00963820|155883430|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
48462710|NCT00963820|155883419|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462711|NCT00963820|155883420|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462712|NCT00963820|155883421|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462713|NCT00963820|155883422|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462714|NCT00963820|155883423|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462715|NCT00963820|155883424|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462716|NCT00963820|155883425|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
48462717|NCT00963820|155883426|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462718|NCT00963820|155883427|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462719|NCT00963820|155883428|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462720|NCT00963820|155883429|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462721|NCT00963820|155883430|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
48462722|NCT00963820|155883419|FG000|Expansion Phase|Progressive Disease|0|||
48462723|NCT00963820|155883420|FG001|Expansion Phase|Progressive Disease|0|||
48462724|NCT00963820|155883421|FG002|Expansion Phase|Progressive Disease|0|||
48462725|NCT00963820|155883422|FG003|Expansion Phase|Progressive Disease|0|||
48462726|NCT00963820|155883423|FG004|Expansion Phase|Progressive Disease|0|||
48462727|NCT00963820|155883424|FG005|Expansion Phase|Progressive Disease|0|||
48462728|NCT00963820|155883425|FG006|Expansion Phase|Progressive Disease|0|||
48462729|NCT00963820|155883426|FG007|Expansion Phase|Progressive Disease|0|||
48462730|NCT00963820|155883427|FG008|Expansion Phase|Progressive Disease|8|||
48462731|NCT00963820|155883428|FG009|Expansion Phase|Progressive Disease|6|||
48462732|NCT00963820|155883429|FG010|Expansion Phase|Progressive Disease|4|||
48462733|NCT00963820|155883430|FG011|Expansion Phase|Progressive Disease|2|||
48462734|NCT00963820|155883419|FG000|Expansion Phase|Adverse Event|0|||
48462735|NCT00963820|155883420|FG001|Expansion Phase|Adverse Event|0|||
48462736|NCT00963820|155883421|FG002|Expansion Phase|Adverse Event|0|||
48462737|NCT00963820|155883422|FG003|Expansion Phase|Adverse Event|0|||
48462738|NCT00963820|155883423|FG004|Expansion Phase|Adverse Event|0|||
48462739|NCT00963820|155883424|FG005|Expansion Phase|Adverse Event|0|||
48462740|NCT00963820|155883425|FG006|Expansion Phase|Adverse Event|0|||
48462741|NCT00963820|155883426|FG007|Expansion Phase|Adverse Event|0|||
48462742|NCT00963820|155883427|FG008|Expansion Phase|Adverse Event|1|||
48462743|NCT00963820|155883428|FG009|Expansion Phase|Adverse Event|3|||
48462744|NCT00963820|155883429|FG010|Expansion Phase|Adverse Event|0|||
48462745|NCT00963820|155883430|FG011|Expansion Phase|Adverse Event|0|||
48462746|NCT00963820|155883419|FG000|Expansion Phase|Withdrawal by Subject|0|||
48462747|NCT00963820|155883420|FG001|Expansion Phase|Withdrawal by Subject|0|||
48462748|NCT00963820|155883421|FG002|Expansion Phase|Withdrawal by Subject|0|||
48462749|NCT00963820|155883422|FG003|Expansion Phase|Withdrawal by Subject|0|||
48462750|NCT00963820|155883423|FG004|Expansion Phase|Withdrawal by Subject|0|||
48462751|NCT00963820|155883424|FG005|Expansion Phase|Withdrawal by Subject|0|||
48462752|NCT00963820|155883425|FG006|Expansion Phase|Withdrawal by Subject|0|||
48462753|NCT00963820|155883426|FG007|Expansion Phase|Withdrawal by Subject|0|||
48462754|NCT00963820|155883427|FG008|Expansion Phase|Withdrawal by Subject|1|||
48462755|NCT00963820|155883428|FG009|Expansion Phase|Withdrawal by Subject|0|||
48462756|NCT00963820|155883429|FG010|Expansion Phase|Withdrawal by Subject|1|||
48462757|NCT00963820|155883430|FG011|Expansion Phase|Withdrawal by Subject|1|||
48462758|NCT00963820|155883419|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462759|NCT00963820|155883420|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462760|NCT00963820|155883421|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462761|NCT00963820|155883422|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462762|NCT00963820|155883423|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462763|NCT00963820|155883424|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462764|NCT00963820|155883425|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462765|NCT00963820|155883426|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462766|NCT00963820|155883427|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462767|NCT00963820|155883428|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462768|NCT00963820|155883429|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
48462769|NCT00963820|155883430|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
48462770|NCT02561273|155883451|FG000|Overall Study|Protocol Violation|1|||
48462771|NCT02561273|155883452|FG001|Overall Study|Protocol Violation|0|||
48462772|NCT00545740|155883455|FG000|Overall Study|Lack of Efficacy|34|||
48462773|NCT00545740|155883456|FG001|Overall Study|Lack of Efficacy|35|||
48462774|NCT00545740|155883457|FG002|Overall Study|Lack of Efficacy|47|||
48462775|NCT00545740|155883458|FG003|Overall Study|Lack of Efficacy|36|||
48462776|NCT00545740|155883455|FG000|Overall Study|Withdrawal by Subject|17|||
48462777|NCT00545740|155883456|FG001|Overall Study|Withdrawal by Subject|15|||
48462778|NCT00545740|155883457|FG002|Overall Study|Withdrawal by Subject|16|||
48462779|NCT00545740|155883458|FG003|Overall Study|Withdrawal by Subject|18|||
48462780|NCT00545740|155883455|FG000|Overall Study|Adverse Event|10|||
48462781|NCT00545740|155883456|FG001|Overall Study|Adverse Event|18|||
48462782|NCT00545740|155883457|FG002|Overall Study|Adverse Event|19|||
48462783|NCT00545740|155883458|FG003|Overall Study|Adverse Event|9|||
48462784|NCT00545740|155883455|FG000|Overall Study|Lost to Follow-up|7|||
48462785|NCT00545740|155883456|FG001|Overall Study|Lost to Follow-up|5|||
48462786|NCT00545740|155883457|FG002|Overall Study|Lost to Follow-up|5|||
48462787|NCT00545740|155883458|FG003|Overall Study|Lost to Follow-up|6|||
48462788|NCT00545740|155883455|FG000|Overall Study|Protocol Violation|1|||
48462789|NCT00545740|155883456|FG001|Overall Study|Protocol Violation|3|||
48462790|NCT00545740|155883457|FG002|Overall Study|Protocol Violation|1|||
48462791|NCT00545740|155883458|FG003|Overall Study|Protocol Violation|0|||
48462792|NCT00545740|155883455|FG000|Overall Study|Non-compliance|0|||
48462793|NCT00545740|155883456|FG001|Overall Study|Non-compliance|2|||
48462794|NCT00545740|155883457|FG002|Overall Study|Non-compliance|1|||
48462795|NCT00545740|155883458|FG003|Overall Study|Non-compliance|0|||
48462796|NCT00545740|155883455|FG000|Overall Study|Moved|2|||
48462797|NCT00545740|155883456|FG001|Overall Study|Moved|0|||
48462798|NCT00545740|155883457|FG002|Overall Study|Moved|1|||
48462799|NCT00545740|155883458|FG003|Overall Study|Moved|0|||
48462800|NCT00545740|155883455|FG000|Overall Study|Diverticulitis attack|0|||
48462801|NCT00545740|155883456|FG001|Overall Study|Diverticulitis attack|0|||
48462802|NCT00545740|155883457|FG002|Overall Study|Diverticulitis attack|1|||
48462803|NCT00545740|155883458|FG003|Overall Study|Diverticulitis attack|1|||
48462804|NCT00545740|155883455|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
48462805|NCT00545740|155883456|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
48462806|NCT00545740|155883457|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
48462807|NCT00545740|155883458|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
48462808|NCT00545740|155883455|FG000|Overall Study|Site closure|1|||
48462809|NCT00545740|155883456|FG001|Overall Study|Site closure|0|||
48462810|NCT00545740|155883457|FG002|Overall Study|Site closure|0|||
48462811|NCT00545740|155883458|FG003|Overall Study|Site closure|0|||
48462812|NCT00545740|155883455|FG000|Overall Study|Missed visit|1|||
48462813|NCT00545740|155883456|FG001|Overall Study|Missed visit|0|||
48462814|NCT00545740|155883457|FG002|Overall Study|Missed visit|0|||
48462815|NCT00545740|155883458|FG003|Overall Study|Missed visit|0|||
48462816|NCT00545740|155883455|FG000|Overall Study|Physician Decision|0|||
48462817|NCT00545740|155883456|FG001|Overall Study|Physician Decision|0|||
48462818|NCT00545740|155883457|FG002|Overall Study|Physician Decision|3|||
48462819|NCT00545740|155883458|FG003|Overall Study|Physician Decision|0|||
48462820|NCT00545740|155883455|FG000|Overall Study|Accepted only monthly telephone calls|1|||
48462821|NCT00545740|155883456|FG001|Overall Study|Accepted only monthly telephone calls|0|||
48462822|NCT00545740|155883457|FG002|Overall Study|Accepted only monthly telephone calls|0|||
48462823|NCT00545740|155883458|FG003|Overall Study|Accepted only monthly telephone calls|0|||
48462824|NCT00545740|155883455|FG000|Overall Study|Sponsor decision|0|||
48462825|NCT00545740|155883456|FG001|Overall Study|Sponsor decision|1|||
48462826|NCT00545740|155883457|FG002|Overall Study|Sponsor decision|0|||
48462827|NCT00545740|155883458|FG003|Overall Study|Sponsor decision|0|||
48462828|NCT00545740|155883455|FG000|Overall Study|Lack of time|0|||
48462829|NCT00545740|155883456|FG001|Overall Study|Lack of time|1|||
48462830|NCT00545740|155883457|FG002|Overall Study|Lack of time|0|||
48462831|NCT00545740|155883458|FG003|Overall Study|Lack of time|0|||
48462832|NCT00545740|155883455|FG000|Overall Study|Non-adherence to visits|0|||
48462833|NCT00545740|155883456|FG001|Overall Study|Non-adherence to visits|1|||
48462834|NCT00545740|155883457|FG002|Overall Study|Non-adherence to visits|0|||
48462835|NCT00545740|155883458|FG003|Overall Study|Non-adherence to visits|0|||
48462836|NCT00545740|155883455|FG000|Overall Study|Patient difficulties|0|||
48462837|NCT00545740|155883456|FG001|Overall Study|Patient difficulties|1|||
48462838|NCT00545740|155883457|FG002|Overall Study|Patient difficulties|0|||
48462839|NCT00545740|155883458|FG003|Overall Study|Patient difficulties|0|||
48462840|NCT00545740|155883455|FG000|Overall Study|Husband against study|0|||
48462841|NCT00545740|155883456|FG001|Overall Study|Husband against study|0|||
48462842|NCT00545740|155883457|FG002|Overall Study|Husband against study|1|||
48462843|NCT00545740|155883458|FG003|Overall Study|Husband against study|0|||
48462844|NCT03018340|155883459|FG000|Overall Study|Adverse Event|1|||
48462845|NCT03018340|155883460|FG001|Overall Study|Adverse Event|2|||
48462846|NCT03018340|155883459|FG000|Overall Study|Withdrawal by Subject|0|||
48462847|NCT03018340|155883460|FG001|Overall Study|Withdrawal by Subject|8|||
48462848|NCT03018340|155883459|FG000|Overall Study|Lack of Efficacy|0|||
48462849|NCT03018340|155883460|FG001|Overall Study|Lack of Efficacy|1|||
48462850|NCT03018340|155883459|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
48462851|NCT03018340|155883460|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
48462852|NCT03018340|155883459|FG000|Overall Study|Lost to Follow-up|1|||
48462853|NCT03018340|155883460|FG001|Overall Study|Lost to Follow-up|7|||
48462854|NCT03018340|155883459|FG000|Overall Study|Protocol Violation|3|||
48462855|NCT03018340|155883460|FG001|Overall Study|Protocol Violation|7|||
48462856|NCT03018340|155883459|FG000|Overall Study|Not further specified|0|||
48462857|NCT03018340|155883460|FG001|Overall Study|Not further specified|1|||
48462858|NCT01836549|155883461|FG000|Overall Study|Did not receive study drug|0|||
48462859|NCT01836549|155883462|FG001|Overall Study|Did not receive study drug|0|||
48462860|NCT01836549|155883463|FG002|Overall Study|Did not receive study drug|1|||
48462861|NCT01836549|155883464|FG003|Overall Study|Did not receive study drug|0|||
48462862|NCT01836549|155883465|FG004|Overall Study|Did not receive study drug|0|||
48462863|NCT01836549|155883466|FG005|Overall Study|Did not receive study drug|0|||
48462864|NCT01836549|155883467|FG006|Overall Study|Did not receive study drug|0|||
48462865|NCT01836549|155883461|FG000|Overall Study|Patient declared ineligible|0|||
48462866|NCT01836549|155883462|FG001|Overall Study|Patient declared ineligible|0|||
48462867|NCT01836549|155883463|FG002|Overall Study|Patient declared ineligible|0|||
48462868|NCT01836549|155883464|FG003|Overall Study|Patient declared ineligible|1|||
48462869|NCT01836549|155883465|FG004|Overall Study|Patient declared ineligible|0|||
48462870|NCT01836549|155883466|FG005|Overall Study|Patient declared ineligible|0|||
48462871|NCT01836549|155883467|FG006|Overall Study|Patient declared ineligible|0|||
48462872|NCT01836549|155883461|FG000|Overall Study|Patient inevaluable to start therapy|0|||
48462873|NCT01836549|155883462|FG001|Overall Study|Patient inevaluable to start therapy|0|||
48462874|NCT01836549|155883463|FG002|Overall Study|Patient inevaluable to start therapy|0|||
48462875|NCT01836549|155883464|FG003|Overall Study|Patient inevaluable to start therapy|0|||
48462876|NCT01836549|155883465|FG004|Overall Study|Patient inevaluable to start therapy|0|||
48462877|NCT01836549|155883466|FG005|Overall Study|Patient inevaluable to start therapy|0|||
48462878|NCT01836549|155883467|FG006|Overall Study|Patient inevaluable to start therapy|1|||
48462879|NCT01969565|155883470|FG000|Overall Study|Withdrawal by Subject|1|||
48462880|NCT02324049|155883471|FG000|Part C|Study terminated|11|||
48462881|NCT01738594|155883473|FG000|Registration and Treatment Start|Adverse Event|0|||
48462882|NCT01738594|155883474|FG001|Registration and Treatment Start|Adverse Event|1|||
48462883|NCT01738594|155883475|FG002|Registration and Treatment Start|Adverse Event|0|||
48462884|NCT01738594|155883476|FG003|Registration and Treatment Start|Adverse Event|0|||
48462885|NCT01738594|155883477|FG004|Registration and Treatment Start|Adverse Event|0|||
48462886|NCT01738594|155883478|FG005|Registration and Treatment Start|Adverse Event|0|||
48462887|NCT01738594|155883479|FG006|Registration and Treatment Start|Adverse Event|0|||
48462888|NCT01738594|155883480|FG007|Registration and Treatment Start|Adverse Event|0|||
48462889|NCT01738594|155883473|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48462890|NCT01738594|155883474|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48462891|NCT01738594|155883475|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48462892|NCT01738594|155883476|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48462893|NCT01738594|155883477|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48462894|NCT01738594|155883478|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
48462895|NCT01738594|155883479|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48462896|NCT01738594|155883480|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
48462897|NCT01738594|155883473|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
48462898|NCT01738594|155883474|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
48462899|NCT01738594|155883475|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
48462900|NCT01738594|155883476|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
48462901|NCT01738594|155883477|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
48462902|NCT01738594|155883478|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
48462903|NCT01738594|155883479|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
48462904|NCT01738594|155883480|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
48462905|NCT01738594|155883473|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48462906|NCT01738594|155883474|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48462907|NCT01738594|155883475|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48462908|NCT01738594|155883476|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48462909|NCT01738594|155883477|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48462910|NCT01738594|155883478|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
48462911|NCT01738594|155883479|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48462912|NCT01738594|155883480|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
48462913|NCT01738594|155883473|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48462914|NCT01738594|155883474|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48462915|NCT01738594|155883475|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48462916|NCT01738594|155883476|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48462917|NCT01738594|155883477|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48462918|NCT01738594|155883478|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
48462919|NCT01738594|155883479|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48462920|NCT01738594|155883480|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
48462921|NCT01738594|155883473|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48462922|NCT01738594|155883474|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48462923|NCT01738594|155883475|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48462924|NCT01738594|155883476|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48462925|NCT01738594|155883477|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
48462926|NCT01738594|155883478|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48462927|NCT01738594|155883479|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48462928|NCT01738594|155883480|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
48462929|NCT01738594|155883473|FG000|Follow up for 1 Year|Death|0|||
48462930|NCT01738594|155883474|FG001|Follow up for 1 Year|Death|0|||
48462931|NCT01738594|155883475|FG002|Follow up for 1 Year|Death|0|||
48462932|NCT01738594|155883476|FG003|Follow up for 1 Year|Death|0|||
48462933|NCT01738594|155883477|FG004|Follow up for 1 Year|Death|0|||
48462934|NCT01738594|155883478|FG005|Follow up for 1 Year|Death|1|||
48462935|NCT01738594|155883479|FG006|Follow up for 1 Year|Death|0|||
48462936|NCT01738594|155883480|FG007|Follow up for 1 Year|Death|0|||
48462937|NCT01738594|155883473|FG000|Follow up for 1 Year|Other|0|||
48462938|NCT01738594|155883474|FG001|Follow up for 1 Year|Other|0|||
48462939|NCT01738594|155883475|FG002|Follow up for 1 Year|Other|0|||
48462940|NCT01738594|155883476|FG003|Follow up for 1 Year|Other|0|||
48462941|NCT01738594|155883477|FG004|Follow up for 1 Year|Other|0|||
48462942|NCT01738594|155883478|FG005|Follow up for 1 Year|Other|2|||
48462943|NCT01738594|155883479|FG006|Follow up for 1 Year|Other|0|||
48462944|NCT01738594|155883480|FG007|Follow up for 1 Year|Other|0|||
48462945|NCT04062240|155883481|FG000|Overall Study|equipment malfunction|1|||
48462946|NCT00579527|155883483|FG000|Overall Study|Death|4|||
48462947|NCT01195636|155883484|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
48462948|NCT01195636|155883485|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
48462949|NCT01195636|155883484|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
48462950|NCT01195636|155883485|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
48462951|NCT01195636|155883484|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48462952|NCT01195636|155883485|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
48462953|NCT01195636|155883484|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
48462954|NCT01195636|155883485|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
48462955|NCT01195636|155883484|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
48462956|NCT01195636|155883485|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
48462957|NCT01195636|155883484|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
48462958|NCT01195636|155883485|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
48462959|NCT01195636|155883484|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
48462960|NCT01195636|155883485|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
48462961|NCT01195636|155883484|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
48462962|NCT01195636|155883485|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
48462963|NCT03961529|155883487|FG000|Overall Study|Adverse Event|13|||
48462964|NCT03961529|155883488|FG001|Overall Study|Adverse Event|5|||
48462965|NCT03961529|155883489|FG002|Overall Study|Adverse Event|2|||
48462966|NCT03961529|155883487|FG000|Overall Study|Withdrawal by Subject|17|||
48462967|NCT03961529|155883488|FG001|Overall Study|Withdrawal by Subject|2|||
48462968|NCT03961529|155883489|FG002|Overall Study|Withdrawal by Subject|1|||
48462969|NCT03961529|155883487|FG000|Overall Study|Withdrawal by parent/guardian|0|||
48462970|NCT03961529|155883488|FG001|Overall Study|Withdrawal by parent/guardian|7|||
48462971|NCT03961529|155883489|FG002|Overall Study|Withdrawal by parent/guardian|0|||
48462972|NCT03961529|155883487|FG000|Overall Study|Physician Decision|2|||
48462973|NCT03961529|155883488|FG001|Overall Study|Physician Decision|1|||
48462974|NCT03961529|155883489|FG002|Overall Study|Physician Decision|1|||
48462975|NCT03961529|155883487|FG000|Overall Study|Lost to Follow-up|2|||
48462976|NCT03961529|155883488|FG001|Overall Study|Lost to Follow-up|1|||
48462977|NCT03961529|155883489|FG002|Overall Study|Lost to Follow-up|0|||
48462978|NCT03961529|155883487|FG000|Overall Study|Lack of Efficacy|2|||
48462979|NCT03961529|155883488|FG001|Overall Study|Lack of Efficacy|0|||
48462980|NCT03961529|155883489|FG002|Overall Study|Lack of Efficacy|1|||
48462981|NCT03961529|155883487|FG000|Overall Study|Other|6|||
48462982|NCT03961529|155883488|FG001|Overall Study|Other|1|||
48462983|NCT03961529|155883489|FG002|Overall Study|Other|0|||
48462984|NCT03644173|155883490|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
48462985|NCT03644173|155883490|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
48462986|NCT03644173|155883490|FG000|Participants at the 1-month Follow up|Death|2|||
48462987|NCT03644173|155883490|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
48462988|NCT00403390|155883491|FG000|Overall Study|Withdrawal by Subject|1|||
48462989|NCT00403390|155883492|FG001|Overall Study|Withdrawal by Subject|0|||
48462990|NCT00403390|155883491|FG000|Overall Study|samples lost|1|||
48462991|NCT00403390|155883492|FG001|Overall Study|samples lost|0|||
48462992|NCT00403390|155883491|FG000|Overall Study|non-compliant|1|||
48462993|NCT00403390|155883492|FG001|Overall Study|non-compliant|0|||
48462994|NCT00381706|155883493|FG000|Overall Study|Never treated|7|||
48462995|NCT00381706|155883494|FG001|Overall Study|Never treated|2|||
48462996|NCT00381706|155883495|FG002|Overall Study|Never treated|1|||
48462997|NCT03500419|155883496|FG000|Overall Study|Withdrawal by Subject|2|||
48462998|NCT03500419|155883497|FG001|Overall Study|Withdrawal by Subject|25|||
48462999|NCT01796106|155883498|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
48463000|NCT01796106|155883499|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
48463001|NCT01234337|155883501|FG000|Overall Study|Adverse Event|58|||
48463002|NCT01234337|155883502|FG001|Overall Study|Adverse Event|21|||
48463003|NCT01234337|155883501|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
48463004|NCT01234337|155883502|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
48463005|NCT01234337|155883501|FG000|Overall Study|Investi. decision not protocol driven|5|||
48463318|NCT01117428|155885613|FG005|Overall Study|Adverse Event|2|||
48463006|NCT01234337|155883502|FG001|Overall Study|Investi. decision not protocol driven|6|||
48463007|NCT01234337|155883501|FG000|Overall Study|Non-compliant with study medication|3|||
48463008|NCT01234337|155883502|FG001|Overall Study|Non-compliant with study medication|2|||
48463009|NCT01234337|155883501|FG000|Overall Study|Randomized but not treated|6|||
48463010|NCT01234337|155883502|FG001|Overall Study|Randomized but not treated|4|||
48463011|NCT01234337|155883501|FG000|Overall Study|Lost to Follow-up|0|||
48463012|NCT01234337|155883502|FG001|Overall Study|Lost to Follow-up|1|||
48463013|NCT01234337|155883501|FG000|Overall Study|Protocol Violation|2|||
48463014|NCT01234337|155883502|FG001|Overall Study|Protocol Violation|3|||
48463015|NCT01234337|155883501|FG000|Overall Study|Withdrawal by Subject|11|||
48463016|NCT01234337|155883502|FG001|Overall Study|Withdrawal by Subject|9|||
48463017|NCT01234337|155883501|FG000|Overall Study|Death|0|||
48463018|NCT01234337|155883502|FG001|Overall Study|Death|1|||
48463019|NCT01234337|155883501|FG000|Overall Study|Switch to commercial drug|0|||
48463020|NCT01234337|155883502|FG001|Overall Study|Switch to commercial drug|1|||
48463021|NCT00994890|155883506|FG000|Overall Study|Adverse Event|13|||
48463022|NCT00994890|155883507|FG001|Overall Study|Adverse Event|9|||
48463023|NCT00994890|155883508|FG002|Overall Study|Adverse Event|11|||
48463024|NCT00994890|155883506|FG000|Overall Study|Lack of Efficacy|0|||
48463025|NCT00994890|155883507|FG001|Overall Study|Lack of Efficacy|0|||
48463026|NCT00994890|155883508|FG002|Overall Study|Lack of Efficacy|1|||
48463027|NCT00994890|155883506|FG000|Overall Study|Lost to Follow-up|6|||
48463028|NCT00994890|155883507|FG001|Overall Study|Lost to Follow-up|1|||
48463029|NCT00994890|155883508|FG002|Overall Study|Lost to Follow-up|3|||
48463030|NCT00994890|155883506|FG000|Overall Study|No longer willing to participate|8|||
48463031|NCT00994890|155883507|FG001|Overall Study|No longer willing to participate|5|||
48463032|NCT00994890|155883508|FG002|Overall Study|No longer willing to participate|13|||
48463033|NCT00994890|155883506|FG000|Overall Study|Protocol Violation|2|||
48463034|NCT00994890|155883507|FG001|Overall Study|Protocol Violation|4|||
48463035|NCT00994890|155883508|FG002|Overall Study|Protocol Violation|0|||
48463036|NCT00994890|155883506|FG000|Overall Study|Study terminated by sponsor|199|||
48463037|NCT00994890|155883507|FG001|Overall Study|Study terminated by sponsor|201|||
48463038|NCT00994890|155883508|FG002|Overall Study|Study terminated by sponsor|197|||
48463039|NCT00994890|155883506|FG000|Overall Study|Randomized, but not treated|1|||
48463040|NCT00994890|155883507|FG001|Overall Study|Randomized, but not treated|0|||
48463041|NCT00994890|155883508|FG002|Overall Study|Randomized, but not treated|0|||
48463042|NCT00994890|155883506|FG000|Overall Study|Other|2|||
48463043|NCT00994890|155883507|FG001|Overall Study|Other|2|||
48463044|NCT00994890|155883508|FG002|Overall Study|Other|1|||
48463045|NCT03480841|155883509|FG000|Overall Study|Lost to Follow-up|2|||
48463046|NCT02380703|155883510|FG000|Overall Study|Withdrawal by Subject|12|||
48463047|NCT02380703|155883511|FG001|Overall Study|Withdrawal by Subject|9|||
48463048|NCT02380703|155883510|FG000|Overall Study|Lost to Follow-up|12|||
48463049|NCT02380703|155883511|FG001|Overall Study|Lost to Follow-up|12|||
48463050|NCT02380703|155883510|FG000|Overall Study|Caregiver death|1|||
48463051|NCT02380703|155883511|FG001|Overall Study|Caregiver death|0|||
48463052|NCT02380703|155883510|FG000|Overall Study|Person with dementia (PWD) death|7|||
48463053|NCT02380703|155883511|FG001|Overall Study|Person with dementia (PWD) death|8|||
48463054|NCT02380703|155883510|FG000|Overall Study|Entered Long-term Care|4|||
48463055|NCT02380703|155883511|FG001|Overall Study|Entered Long-term Care|7|||
48463056|NCT01987609|155883512|FG000|Overall Study|Adverse Event|1|||
48463057|NCT02850276|155883513|FG000|Overall Study|screen failure|43|||
48463058|NCT02850276|155883513|FG000|Overall Study|Withdrawal by Subject|14|||
48463059|NCT02850276|155883513|FG000|Overall Study|Physician Decision|2|||
48463060|NCT02850276|155883513|FG000|Overall Study|Lost to Follow-up|2|||
48463061|NCT00434876|155883514|FG000|Overall Study|Lost to Follow-up|1|||
48463062|NCT00434876|155883515|FG001|Overall Study|Lost to Follow-up|1|||
48463063|NCT02709889|155883516|FG000|Overall Study|Withdrawal by Subject|11|||
48463064|NCT02709889|155883517|FG001|Overall Study|Withdrawal by Subject|10|||
48463065|NCT02709889|155883518|FG002|Overall Study|Withdrawal by Subject|2|||
48463066|NCT02709889|155883519|FG003|Overall Study|Withdrawal by Subject|12|||
48463067|NCT02709889|155883516|FG000|Overall Study|Death|25|||
48463068|NCT02709889|155883517|FG001|Overall Study|Death|38|||
48463069|NCT02709889|155883518|FG002|Overall Study|Death|4|||
48463070|NCT02709889|155883519|FG003|Overall Study|Death|44|||
48463071|NCT02709889|155883516|FG000|Overall Study|Physician Decision|1|||
48463072|NCT02709889|155883517|FG001|Overall Study|Physician Decision|2|||
48463073|NCT02709889|155883518|FG002|Overall Study|Physician Decision|3|||
48463074|NCT02709889|155883519|FG003|Overall Study|Physician Decision|5|||
48463075|NCT02709889|155883516|FG000|Overall Study|Lost to Follow-up|2|||
48463076|NCT02709889|155883517|FG001|Overall Study|Lost to Follow-up|0|||
48463077|NCT02709889|155883518|FG002|Overall Study|Lost to Follow-up|0|||
48463078|NCT02709889|155883519|FG003|Overall Study|Lost to Follow-up|4|||
48463079|NCT02709889|155883516|FG000|Overall Study|Study Terminated by Sponsor|4|||
48463080|NCT02709889|155883517|FG001|Overall Study|Study Terminated by Sponsor|6|||
48463081|NCT02709889|155883518|FG002|Overall Study|Study Terminated by Sponsor|2|||
48463082|NCT02709889|155883519|FG003|Overall Study|Study Terminated by Sponsor|17|||
48463083|NCT02709889|155883516|FG000|Overall Study|Other, Not Specified|0|||
48463084|NCT02709889|155883517|FG001|Overall Study|Other, Not Specified|1|||
48463085|NCT02709889|155883518|FG002|Overall Study|Other, Not Specified|1|||
48463086|NCT02709889|155883519|FG003|Overall Study|Other, Not Specified|6|||
48463087|NCT01899729|155883520|FG000|Overall Study|Adverse Event|1|||
48463088|NCT01899729|155883521|FG001|Overall Study|Adverse Event|0|||
48463089|NCT01899729|155883522|FG002|Overall Study|Adverse Event|0|||
48463090|NCT01899729|155883523|FG003|Overall Study|Adverse Event|0|||
48463091|NCT01899729|155883524|FG004|Overall Study|Adverse Event|1|||
48463092|NCT01899729|155883520|FG000|Overall Study|Withdrawal by Subject|1|||
48463093|NCT01899729|155883521|FG001|Overall Study|Withdrawal by Subject|2|||
48463094|NCT01899729|155883522|FG002|Overall Study|Withdrawal by Subject|0|||
48463095|NCT01899729|155883523|FG003|Overall Study|Withdrawal by Subject|0|||
48463096|NCT01899729|155883524|FG004|Overall Study|Withdrawal by Subject|0|||
48463097|NCT01899729|155883520|FG000|Overall Study|Lack of Efficacy|0|||
48463098|NCT01899729|155883521|FG001|Overall Study|Lack of Efficacy|0|||
48463099|NCT01899729|155883522|FG002|Overall Study|Lack of Efficacy|2|||
48463100|NCT01899729|155883523|FG003|Overall Study|Lack of Efficacy|0|||
48463101|NCT01899729|155883524|FG004|Overall Study|Lack of Efficacy|1|||
48463102|NCT00095836|155883525|FG000|Overall Study|Lost to Follow-up|1|||
48463103|NCT00095836|155883525|FG000|Overall Study|Adverse Event|1|||
48463104|NCT00095836|155883525|FG000|Overall Study|Death|2|||
48463105|NCT00962780|155883528|FG000|Overall Study|Death|0|||
48463106|NCT00962780|155883529|FG001|Overall Study|Death|1|||
48463107|NCT00962780|155883528|FG000|Overall Study|Protocol Violation|9|||
48463108|NCT00962780|155883529|FG001|Overall Study|Protocol Violation|4|||
48463109|NCT00962780|155883528|FG000|Overall Study|Withdrawal by Subject|1|||
48463110|NCT00962780|155883529|FG001|Overall Study|Withdrawal by Subject|8|||
48463111|NCT00962780|155883528|FG000|Overall Study|Other|0|||
48463112|NCT00962780|155883529|FG001|Overall Study|Other|1|||
48463113|NCT00242658|155883530|FG000|Overall Study|Lost to Follow-up|22|||
48463114|NCT00242658|155883531|FG001|Overall Study|Lost to Follow-up|19|||
48463115|NCT04490499|155883532|FG000|Overall Study|Withdrawal by Subject|2|||
48463116|NCT02646332|155883533|FG000|Overall Study|Lost to Follow-up|0|||
48463117|NCT02646332|155883534|FG001|Overall Study|Lost to Follow-up|3|||
48463118|NCT02363322|155883535|FG000|Overall Study|Lost to Follow-up|1|||
48463119|NCT02363322|155883536|FG001|Overall Study|Lost to Follow-up|0|||
48463120|NCT01997333|155883541|FG000|Randomization and Treatment|Disease Progression|70|||
48463121|NCT01997333|155883542|FG001|Randomization and Treatment|Disease Progression|159|||
48463122|NCT01997333|155883541|FG000|Randomization and Treatment|Adverse Event|10|||
48463123|NCT01997333|155883542|FG001|Randomization and Treatment|Adverse Event|32|||
48463124|NCT01997333|155883541|FG000|Randomization and Treatment|Physician Decision|0|||
48463125|NCT01997333|155883542|FG001|Randomization and Treatment|Physician Decision|4|||
48463126|NCT01997333|155883541|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
48463127|NCT01997333|155883542|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
48463128|NCT01997333|155883541|FG000|Randomization and Treatment|Did not receive treatment|17|||
48463129|NCT01997333|155883542|FG001|Randomization and Treatment|Did not receive treatment|5|||
48463130|NCT01997333|155883541|FG000|Survival Follow up|Withdrawal by Subject|15|||
48463131|NCT01997333|155883542|FG001|Survival Follow up|Withdrawal by Subject|6|||
48463132|NCT01997333|155883541|FG000|Survival Follow up|Lost to Follow-up|0|||
48463133|NCT01997333|155883542|FG001|Survival Follow up|Lost to Follow-up|6|||
48463134|NCT01997333|155883541|FG000|Survival Follow up|Various|1|||
48463135|NCT01997333|155883542|FG001|Survival Follow up|Various|2|||
48463136|NCT02269709|155883543|FG000|Time of Enrollment|Withdrawal by Subject|3|||
48463137|NCT02269709|155883543|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
48463138|NCT02269709|155883543|FG000|Six Month Follow-up|Lost to Follow-up|12|||
48463139|NCT02055976|155883544|FG000|Overall Study|Other|0|||
48463140|NCT02055976|155883545|FG001|Overall Study|Other|0|||
48463141|NCT02055976|155883546|FG002|Overall Study|Other|1|||
48463142|NCT02055976|155883547|FG003|Overall Study|Other|0|||
48463143|NCT02055976|155883548|FG004|Overall Study|Other|0|||
48463144|NCT02055976|155883549|FG005|Overall Study|Other|0|||
48463145|NCT02055976|155883550|FG006|Overall Study|Other|0|||
48463146|NCT02055976|155883551|FG007|Overall Study|Other|0|||
48463147|NCT02055976|155883552|FG008|Overall Study|Other|0|||
48463148|NCT02055976|155883544|FG000|Overall Study|Adverse Event|0|||
48463149|NCT02055976|155883545|FG001|Overall Study|Adverse Event|0|||
48463150|NCT02055976|155883546|FG002|Overall Study|Adverse Event|0|||
48463151|NCT02055976|155883547|FG003|Overall Study|Adverse Event|0|||
48463152|NCT02055976|155883548|FG004|Overall Study|Adverse Event|0|||
48463153|NCT02055976|155883549|FG005|Overall Study|Adverse Event|1|||
48463154|NCT02055976|155883550|FG006|Overall Study|Adverse Event|1|||
48463155|NCT02055976|155883551|FG007|Overall Study|Adverse Event|0|||
48463156|NCT02055976|155883552|FG008|Overall Study|Adverse Event|0|||
48463157|NCT02055976|155883544|FG000|Overall Study|Does not meet entrance criteria|0|||
48463158|NCT02055976|155883545|FG001|Overall Study|Does not meet entrance criteria|0|||
48463159|NCT02055976|155883546|FG002|Overall Study|Does not meet entrance criteria|0|||
48463160|NCT02055976|155883547|FG003|Overall Study|Does not meet entrance criteria|0|||
48463161|NCT02055976|155883548|FG004|Overall Study|Does not meet entrance criteria|0|||
48463162|NCT02055976|155883549|FG005|Overall Study|Does not meet entrance criteria|0|||
48463163|NCT02055976|155883550|FG006|Overall Study|Does not meet entrance criteria|1|||
48463164|NCT02055976|155883551|FG007|Overall Study|Does not meet entrance criteria|0|||
48463165|NCT02055976|155883552|FG008|Overall Study|Does not meet entrance criteria|0|||
48463166|NCT02055976|155883544|FG000|Overall Study|Lost to Follow-up|0|||
48463167|NCT02055976|155883545|FG001|Overall Study|Lost to Follow-up|0|||
48463168|NCT02055976|155883546|FG002|Overall Study|Lost to Follow-up|0|||
48463169|NCT02055976|155883547|FG003|Overall Study|Lost to Follow-up|1|||
48463170|NCT02055976|155883548|FG004|Overall Study|Lost to Follow-up|0|||
48463171|NCT02055976|155883549|FG005|Overall Study|Lost to Follow-up|0|||
48463172|NCT02055976|155883550|FG006|Overall Study|Lost to Follow-up|0|||
48463173|NCT02055976|155883551|FG007|Overall Study|Lost to Follow-up|0|||
48463174|NCT02055976|155883552|FG008|Overall Study|Lost to Follow-up|0|||
48463175|NCT01535638|155883553|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
48463176|NCT01535638|155883554|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
48463177|NCT01535638|155883555|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
48463178|NCT01535638|155883556|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
48463179|NCT01535638|155883557|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
48463180|NCT01535638|155883558|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
48463181|NCT01535638|155883553|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
48463182|NCT01535638|155883554|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
48463183|NCT01535638|155883555|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
48463184|NCT01535638|155883556|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
48463185|NCT01535638|155883557|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
48463186|NCT01535638|155883558|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
48463187|NCT00643851|155883559|FG000|Overall Study|Death|0|||
48463188|NCT00643851|155883560|FG001|Overall Study|Death|1|||
48463189|NCT00643851|155883561|FG002|Overall Study|Death|0|||
48463190|NCT00643851|155883559|FG000|Overall Study|Lack of Efficacy|0|||
48463191|NCT00643851|155883560|FG001|Overall Study|Lack of Efficacy|1|||
48463192|NCT00643851|155883561|FG002|Overall Study|Lack of Efficacy|0|||
48463193|NCT00643851|155883559|FG000|Overall Study|Adverse Event|2|||
48463194|NCT00643851|155883560|FG001|Overall Study|Adverse Event|6|||
48463195|NCT00643851|155883561|FG002|Overall Study|Adverse Event|6|||
48463196|NCT00643851|155883559|FG000|Overall Study|Lost to Follow-up|4|||
48463197|NCT00643851|155883560|FG001|Overall Study|Lost to Follow-up|6|||
48463198|NCT00643851|155883561|FG002|Overall Study|Lost to Follow-up|9|||
48463199|NCT00643851|155883559|FG000|Overall Study|Withdrawal by Subject|8|||
48463200|NCT00643851|155883560|FG001|Overall Study|Withdrawal by Subject|15|||
48463201|NCT00643851|155883561|FG002|Overall Study|Withdrawal by Subject|9|||
48463202|NCT00643851|155883559|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
48463203|NCT00643851|155883560|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
48463204|NCT00643851|155883561|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
48463205|NCT00827112|155883562|FG000|Overall Study|Adverse Event|2|||
48463206|NCT00827112|155883563|FG001|Overall Study|Adverse Event|0|||
48463207|NCT00827112|155883562|FG000|Overall Study|Lack of Efficacy|2|||
48463208|NCT00827112|155883563|FG001|Overall Study|Lack of Efficacy|0|||
48463209|NCT00827112|155883562|FG000|Overall Study|Lost to Follow-up|3|||
48463210|NCT00827112|155883563|FG001|Overall Study|Lost to Follow-up|2|||
48463211|NCT00827112|155883562|FG000|Overall Study|Pregnancy|0|||
48463212|NCT00827112|155883563|FG001|Overall Study|Pregnancy|1|||
48463213|NCT00827112|155883562|FG000|Overall Study|Protocol Violation|0|||
48463214|NCT00827112|155883563|FG001|Overall Study|Protocol Violation|2|||
48463215|NCT00827112|155883562|FG000|Overall Study|Withdrawal by Subject|2|||
48463216|NCT00827112|155883563|FG001|Overall Study|Withdrawal by Subject|1|||
48463217|NCT00827112|155883562|FG000|Overall Study|Randomized but not treated|5|||
48463218|NCT00827112|155883563|FG001|Overall Study|Randomized but not treated|3|||
48463219|NCT00827112|155883562|FG000|Overall Study|Other|1|||
48463220|NCT00827112|155883563|FG001|Overall Study|Other|3|||
48463221|NCT01673373|155885569|FG000|Overall Study|Death|2|||
48463222|NCT00003389|155885570|FG000|Overall Study|Disease progression|6|||
48463223|NCT00003389|155885571|FG001|Overall Study|Disease progression|1|||
48463224|NCT00003389|155885570|FG000|Overall Study|Adverse Event|13|||
48463225|NCT00003389|155885571|FG001|Overall Study|Adverse Event|2|||
48463226|NCT00003389|155885570|FG000|Overall Study|Death|0|||
48463227|NCT00003389|155885571|FG001|Overall Study|Death|3|||
48463228|NCT00003389|155885570|FG000|Overall Study|Withdrawal by Subject|12|||
48463229|NCT00003389|155885571|FG001|Overall Study|Withdrawal by Subject|5|||
48463230|NCT00003389|155885570|FG000|Overall Study|Alternative therapy|2|||
48463231|NCT00003389|155885571|FG001|Overall Study|Alternative therapy|1|||
48463232|NCT00003389|155885570|FG000|Overall Study|Complicating disease|1|||
48463233|NCT00003389|155885571|FG001|Overall Study|Complicating disease|0|||
48463234|NCT00003389|155885570|FG000|Overall Study|Off-treatment reason missing|31|||
48463235|NCT00003389|155885571|FG001|Overall Study|Off-treatment reason missing|21|||
48463236|NCT00003389|155885570|FG000|Overall Study|Ineligible|33|||
48463237|NCT00003389|155885571|FG001|Overall Study|Ineligible|27|||
48463238|NCT03793010|155885574|FG000|Overall Study|Withdrawal by Subject|5|||
48463239|NCT03793010|155885575|FG001|Overall Study|Withdrawal by Subject|7|||
48463240|NCT03793010|155885574|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
48463241|NCT03793010|155885575|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
48463242|NCT03793010|155885574|FG000|Overall Study|Lost to Follow-up|1|||
48463243|NCT03793010|155885575|FG001|Overall Study|Lost to Follow-up|2|||
48463244|NCT03793010|155885574|FG000|Overall Study|Patient couldn't sit still for injection|1|||
48463245|NCT03793010|155885575|FG001|Overall Study|Patient couldn't sit still for injection|0|||
48463246|NCT03793010|155885574|FG000|Overall Study|Withdrew to pursue other treatment|1|||
48463247|NCT03793010|155885575|FG001|Overall Study|Withdrew to pursue other treatment|0|||
48463248|NCT03793010|155885574|FG000|Overall Study|Did not meet eligibility criteria|1|||
48463249|NCT03793010|155885575|FG001|Overall Study|Did not meet eligibility criteria|0|||
48463250|NCT00366444|155885578|FG000|Overall Study|Withdrawal by Subject|1|||
48463251|NCT00366444|155885579|FG001|Overall Study|Withdrawal by Subject|1|||
48463252|NCT00366444|155885578|FG000|Overall Study|Lack of Efficacy|0|||
48463253|NCT00366444|155885579|FG001|Overall Study|Lack of Efficacy|1|||
48463254|NCT00305773|155885580|FG000|Overall Study|Death|3|||
48463255|NCT00305773|155885581|FG001|Overall Study|Death|2|||
48463256|NCT00305773|155885580|FG000|Overall Study|Adverse Event|1|||
48463257|NCT00305773|155885581|FG001|Overall Study|Adverse Event|2|||
48463258|NCT00305773|155885580|FG000|Overall Study|Alternative Treatment|4|||
48463259|NCT00305773|155885581|FG001|Overall Study|Alternative Treatment|4|||
48463260|NCT00305773|155885580|FG000|Overall Study|Physician Decision|1|||
48463261|NCT00305773|155885581|FG001|Overall Study|Physician Decision|1|||
48463262|NCT00305773|155885580|FG000|Overall Study|Withdrawal by Subject|1|||
48463263|NCT00305773|155885581|FG001|Overall Study|Withdrawal by Subject|4|||
48463264|NCT00305773|155885580|FG000|Overall Study|Disease Progression|1|||
48463265|NCT00305773|155885581|FG001|Overall Study|Disease Progression|3|||
48463266|NCT00305773|155885580|FG000|Overall Study|All other reasons|3|||
48463267|NCT00305773|155885581|FG001|Overall Study|All other reasons|2|||
48463268|NCT01077193|155885583|FG000|Overall Study|Lost to Follow-up|1|||
48463269|NCT01077193|155885583|FG000|Overall Study|Withdrawal by Subject|2|||
48463270|NCT01077193|155885583|FG000|Overall Study|Lack of Efficacy|1|||
48463271|NCT01077193|155885583|FG000|Overall Study|Study Terminated by Sponsor|40|||
48463272|NCT01051856|155885585|FG000|Overall Study|Withdrawal by Subject|1|||
48463273|NCT01051856|155885586|FG001|Overall Study|Withdrawal by Subject|0|||
48463274|NCT02243306|155885587|FG000|Overall Study|Adverse Event|0|||
48463275|NCT02243306|155885588|FG001|Overall Study|Adverse Event|1|||
48463276|NCT02243306|155885587|FG000|Overall Study|Other: Reached stopping criteria|0|||
48463277|NCT02243306|155885588|FG001|Overall Study|Other: Reached stopping criteria|1|||
48463278|NCT02243306|155885587|FG000|Overall Study|Physician Decision|0|||
48463279|NCT02243306|155885588|FG001|Overall Study|Physician Decision|1|||
48463280|NCT02176226|155885589|FG000|Overall Study|Lost to Follow-up|3|||
48463281|NCT02176226|155885589|FG000|Overall Study|Withdrew prior to treatment|6|||
48463282|NCT01072500|155885592|FG000|Overall Study|Death|2|||
48463283|NCT01072500|155885593|FG001|Overall Study|Death|2|||
48463284|NCT01072500|155885592|FG000|Overall Study|Lost to Follow-up|5|||
48463285|NCT01072500|155885593|FG001|Overall Study|Lost to Follow-up|2|||
48463286|NCT01072500|155885592|FG000|Overall Study|Withdrawal by Subject|17|||
48463287|NCT01072500|155885593|FG001|Overall Study|Withdrawal by Subject|10|||
48463288|NCT02908841|155885594|FG000|Overall Study|Physician Decision|4|||
48463289|NCT02908841|155885595|FG001|Overall Study|Physician Decision|0|||
48463290|NCT00103207|155885596|FG000|Overall Study|Adverse Event|3|||
48463291|NCT00103207|155885596|FG000|Overall Study|Death|1|||
48463292|NCT00103207|155885596|FG000|Overall Study|Withdrawal by Subject|2|||
48463293|NCT00103207|155885596|FG000|Overall Study|Other complicating disease|1|||
48463294|NCT00103207|155885596|FG000|Overall Study|Ineligible|4|||
48463295|NCT00103207|155885596|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
48463296|NCT01266876|155885597|FG000|Overall Study|Adverse Event|0|||
48463297|NCT01266876|155885598|FG001|Overall Study|Adverse Event|0|||
48463298|NCT01266876|155885599|FG002|Overall Study|Adverse Event|0|||
48463299|NCT01266876|155885600|FG003|Overall Study|Adverse Event|1|||
48463300|NCT01266876|155885601|FG004|Overall Study|Adverse Event|0|||
48463301|NCT00750867|155885602|FG000|Overall Study|Adverse Event|2|||
48463302|NCT03018028|155885603|FG000|Overall Study|Withdrawal by Subject|3|||
48463303|NCT03018028|155885604|FG001|Overall Study|Withdrawal by Subject|0|||
48463304|NCT03018028|155885605|FG002|Overall Study|Withdrawal by Subject|1|||
48463305|NCT03018028|155885606|FG003|Overall Study|Withdrawal by Subject|2|||
48463306|NCT03018028|155885607|FG004|Overall Study|Withdrawal by Subject|0|||
48463307|NCT01117428|155885608|FG000|Overall Study|Lack of Efficacy|1|||
48463308|NCT01117428|155885609|FG001|Overall Study|Lack of Efficacy|0|||
48463309|NCT01117428|155885610|FG002|Overall Study|Lack of Efficacy|0|||
48463310|NCT01117428|155885611|FG003|Overall Study|Lack of Efficacy|0|||
48463311|NCT01117428|155885612|FG004|Overall Study|Lack of Efficacy|0|||
48463312|NCT01117428|155885613|FG005|Overall Study|Lack of Efficacy|0|||
48463313|NCT01117428|155885608|FG000|Overall Study|Adverse Event|4|||
48463314|NCT01117428|155885609|FG001|Overall Study|Adverse Event|0|||
48463315|NCT01117428|155885610|FG002|Overall Study|Adverse Event|0|||
48463316|NCT01117428|155885611|FG003|Overall Study|Adverse Event|0|||
48463317|NCT01117428|155885612|FG004|Overall Study|Adverse Event|1|||
48463319|NCT01117428|155885608|FG000|Overall Study|Death|0|||
48463320|NCT01117428|155885609|FG001|Overall Study|Death|1|||
48463321|NCT01117428|155885610|FG002|Overall Study|Death|2|||
48463322|NCT01117428|155885611|FG003|Overall Study|Death|0|||
48463323|NCT01117428|155885612|FG004|Overall Study|Death|0|||
48463324|NCT01117428|155885613|FG005|Overall Study|Death|1|||
48463325|NCT01117428|155885608|FG000|Overall Study|Physician Decision|0|||
48463326|NCT01117428|155885609|FG001|Overall Study|Physician Decision|1|||
48463327|NCT01117428|155885610|FG002|Overall Study|Physician Decision|0|||
48463328|NCT01117428|155885611|FG003|Overall Study|Physician Decision|0|||
48463329|NCT01117428|155885612|FG004|Overall Study|Physician Decision|0|||
48463330|NCT01117428|155885613|FG005|Overall Study|Physician Decision|0|||
48463331|NCT01117428|155885608|FG000|Overall Study|Withdrawal by Subject|0|||
48463332|NCT01117428|155885609|FG001|Overall Study|Withdrawal by Subject|0|||
48463333|NCT01117428|155885610|FG002|Overall Study|Withdrawal by Subject|1|||
48463334|NCT01117428|155885611|FG003|Overall Study|Withdrawal by Subject|0|||
48463335|NCT01117428|155885612|FG004|Overall Study|Withdrawal by Subject|0|||
48463336|NCT01117428|155885613|FG005|Overall Study|Withdrawal by Subject|0|||
48463337|NCT01117428|155885608|FG000|Overall Study|Progressive disease|15|||
48463338|NCT01117428|155885609|FG001|Overall Study|Progressive disease|27|||
48463339|NCT01117428|155885610|FG002|Overall Study|Progressive disease|10|||
48463340|NCT01117428|155885611|FG003|Overall Study|Progressive disease|12|||
48463341|NCT01117428|155885612|FG004|Overall Study|Progressive disease|16|||
48463342|NCT01117428|155885613|FG005|Overall Study|Progressive disease|17|||
48463343|NCT01060150|155885617|FG000|Overall Study|Adverse Event|6|||
48463344|NCT01060150|155885617|FG000|Overall Study|Lost to Follow-up|1|||
48463345|NCT01060150|155885617|FG000|Overall Study|Protocol Violation|6|||
48463346|NCT01060150|155885617|FG000|Overall Study|Withdrawal by Subject|8|||
48463347|NCT01060150|155885617|FG000|Overall Study|Enrolled, but not treated|2|||
48463348|NCT01957111|155885618|FG000|Overall Study|Withdrawal by Subject|1|||
48463349|NCT01957111|155885619|FG001|Overall Study|Withdrawal by Subject|1|||
48463350|NCT01497899|155885620|FG000|Double-Blind Phase|Randomized but not Treated|1|||
48463351|NCT01497899|155885621|FG001|Double-Blind Phase|Randomized but not Treated|0|||
48463352|NCT01497899|155885622|FG002|Double-Blind Phase|Randomized but not Treated|0|||
48463353|NCT01497899|155885623|FG003|Double-Blind Phase|Randomized but not Treated|0|||
48463354|NCT01497899|155885620|FG000|Double-Blind Phase|Adverse Event|1|||
48463355|NCT01497899|155885621|FG001|Double-Blind Phase|Adverse Event|0|||
48463356|NCT01497899|155885622|FG002|Double-Blind Phase|Adverse Event|0|||
48463357|NCT01497899|155885623|FG003|Double-Blind Phase|Adverse Event|0|||
48463358|NCT01497899|155885620|FG000|Double-Blind Phase|Lack of Efficacy|0|||
48463359|NCT01497899|155885621|FG001|Double-Blind Phase|Lack of Efficacy|1|||
48463360|NCT01497899|155885622|FG002|Double-Blind Phase|Lack of Efficacy|0|||
48463361|NCT01497899|155885623|FG003|Double-Blind Phase|Lack of Efficacy|0|||
48463362|NCT01497899|155885620|FG000|Double-Blind Phase|Investigator's Discretion|1|||
48463363|NCT01497899|155885621|FG001|Double-Blind Phase|Investigator's Discretion|0|||
48463364|NCT01497899|155885622|FG002|Double-Blind Phase|Investigator's Discretion|0|||
48463365|NCT01497899|155885623|FG003|Double-Blind Phase|Investigator's Discretion|0|||
48463366|NCT01497899|155885620|FG000|Double-Blind Phase|Withdrew Consent|0|||
48463367|NCT01497899|155885621|FG001|Double-Blind Phase|Withdrew Consent|1|||
48463368|NCT01497899|155885622|FG002|Double-Blind Phase|Withdrew Consent|0|||
48463369|NCT01497899|155885623|FG003|Double-Blind Phase|Withdrew Consent|0|||
48463370|NCT01497899|155885620|FG000|Double-Blind Phase|Lost to Follow-up|3|||
48463371|NCT01497899|155885621|FG001|Double-Blind Phase|Lost to Follow-up|2|||
48463372|NCT01497899|155885622|FG002|Double-Blind Phase|Lost to Follow-up|0|||
48463373|NCT01497899|155885623|FG003|Double-Blind Phase|Lost to Follow-up|0|||
48463374|NCT01497899|155885620|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
48463375|NCT01497899|155885621|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
48463376|NCT01497899|155885622|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
48463377|NCT01497899|155885623|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
48463378|NCT01497899|155885620|FG000|Open-Label Extension Phase|Adverse Event|1|||
48463379|NCT01497899|155885621|FG001|Open-Label Extension Phase|Adverse Event|0|||
48463380|NCT01497899|155885622|FG002|Open-Label Extension Phase|Adverse Event|0|||
48463381|NCT01497899|155885623|FG003|Open-Label Extension Phase|Adverse Event|0|||
48463382|NCT01497899|155885620|FG000|Open-Label Extension Phase|Death|1|||
48463383|NCT01497899|155885621|FG001|Open-Label Extension Phase|Death|0|||
48463384|NCT01497899|155885622|FG002|Open-Label Extension Phase|Death|0|||
48463385|NCT01497899|155885623|FG003|Open-Label Extension Phase|Death|0|||
48463386|NCT01497899|155885620|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
48463387|NCT01497899|155885621|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
48463388|NCT01497899|155885622|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
48463389|NCT01497899|155885623|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
48463390|NCT01497899|155885620|FG000|Open-Label Extension Phase|Pregnancy|0|||
48463391|NCT01497899|155885621|FG001|Open-Label Extension Phase|Pregnancy|1|||
48463392|NCT01497899|155885622|FG002|Open-Label Extension Phase|Pregnancy|1|||
48463393|NCT01497899|155885623|FG003|Open-Label Extension Phase|Pregnancy|0|||
48463394|NCT01497899|155885620|FG000|Open-Label Extension Phase|Protocol Violation|0|||
48463395|NCT01497899|155885621|FG001|Open-Label Extension Phase|Protocol Violation|0|||
48463396|NCT01497899|155885622|FG002|Open-Label Extension Phase|Protocol Violation|1|||
48463397|NCT01497899|155885623|FG003|Open-Label Extension Phase|Protocol Violation|0|||
48463398|NCT01497899|155885620|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
48463399|NCT01497899|155885621|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
48463400|NCT01497899|155885622|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
48463401|NCT01497899|155885623|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
48463402|NCT02364999|155885626|FG000|Overall Study|Death|136|||
48463403|NCT02364999|155885627|FG001|Overall Study|Death|138|||
48463404|NCT02364999|155885626|FG000|Overall Study|Lost to Follow-up|10|||
48463405|NCT02364999|155885627|FG001|Overall Study|Lost to Follow-up|15|||
48463406|NCT02364999|155885626|FG000|Overall Study|Protocol Violation|3|||
48463407|NCT02364999|155885627|FG001|Overall Study|Protocol Violation|2|||
48463408|NCT02364999|155885626|FG000|Overall Study|Withdrawal by Subject|14|||
48463409|NCT02364999|155885627|FG001|Overall Study|Withdrawal by Subject|14|||
48463410|NCT02364999|155885626|FG000|Overall Study|Other|0|||
48463411|NCT02364999|155885627|FG001|Overall Study|Other|1|||
48463412|NCT02364999|155885626|FG000|Overall Study|Randomized but did not receive treatment|2|||
48463413|NCT02364999|155885627|FG001|Overall Study|Randomized but did not receive treatment|3|||
48463414|NCT02555722|155885642|FG000|Week 2|Adverse Event|0|||
48463415|NCT02555722|155885643|FG001|Week 2|Adverse Event|1|||
48463416|NCT02555722|155885642|FG000|Week 2|Withdrawal by Subject|1|||
48463417|NCT02555722|155885643|FG001|Week 2|Withdrawal by Subject|0|||
48463418|NCT02555722|155885642|FG000|Month 1|Lens Discomfort|1|||
48463419|NCT02555722|155885643|FG001|Month 1|Lens Discomfort|0|||
48463420|NCT02555722|155885642|FG000|Month 2|Withdrawal by Subject|3|||
48463421|NCT02555722|155885643|FG001|Month 2|Withdrawal by Subject|0|||
48463422|NCT02555722|155885642|FG000|Month 2|Lost to Follow-up|1|||
48463423|NCT02555722|155885643|FG001|Month 2|Lost to Follow-up|0|||
48463424|NCT04212221|155885645|FG000|Overall Study|Remained on Treatment|0|||
48463425|NCT04212221|155885646|FG001|Overall Study|Remained on Treatment|0|||
48463426|NCT04212221|155885647|FG002|Overall Study|Remained on Treatment|0|||
48463427|NCT04212221|155885648|FG003|Overall Study|Remained on Treatment|1|||
48463428|NCT04212221|155885649|FG004|Overall Study|Remained on Treatment|0|||
48463429|NCT04212221|155885650|FG005|Overall Study|Remained on Treatment|0|||
48463430|NCT04212221|155885651|FG006|Overall Study|Remained on Treatment|3|||
48463431|NCT04212221|155885652|FG007|Overall Study|Remained on Treatment|9|||
48463432|NCT04212221|155885645|FG000|Overall Study|Adverse Event|0|||
48463433|NCT04212221|155885646|FG001|Overall Study|Adverse Event|0|||
48463434|NCT04212221|155885647|FG002|Overall Study|Adverse Event|0|||
48463435|NCT04212221|155885648|FG003|Overall Study|Adverse Event|0|||
48463436|NCT04212221|155885649|FG004|Overall Study|Adverse Event|0|||
48463437|NCT04212221|155885650|FG005|Overall Study|Adverse Event|0|||
48463438|NCT04212221|155885651|FG006|Overall Study|Adverse Event|2|||
48463439|NCT04212221|155885652|FG007|Overall Study|Adverse Event|3|||
48463440|NCT04212221|155885645|FG000|Overall Study|Death|0|||
48463441|NCT04212221|155885646|FG001|Overall Study|Death|0|||
48463442|NCT04212221|155885647|FG002|Overall Study|Death|0|||
48463443|NCT04212221|155885648|FG003|Overall Study|Death|0|||
48463444|NCT04212221|155885649|FG004|Overall Study|Death|0|||
48463445|NCT04212221|155885650|FG005|Overall Study|Death|0|||
48463446|NCT04212221|155885651|FG006|Overall Study|Death|0|||
48463447|NCT04212221|155885652|FG007|Overall Study|Death|2|||
48463448|NCT04212221|155885645|FG000|Overall Study|Disease progression according to irRECIST|1|||
48463449|NCT04212221|155885646|FG001|Overall Study|Disease progression according to irRECIST|2|||
48463450|NCT04212221|155885647|FG002|Overall Study|Disease progression according to irRECIST|3|||
48463451|NCT04212221|155885648|FG003|Overall Study|Disease progression according to irRECIST|3|||
48463452|NCT04212221|155885649|FG004|Overall Study|Disease progression according to irRECIST|2|||
48463453|NCT04212221|155885650|FG005|Overall Study|Disease progression according to irRECIST|2|||
48463454|NCT04212221|155885651|FG006|Overall Study|Disease progression according to irRECIST|21|||
48463455|NCT04212221|155885652|FG007|Overall Study|Disease progression according to irRECIST|17|||
48463456|NCT04212221|155885645|FG000|Overall Study|Global Deterioration of Health Status|0|||
48463457|NCT04212221|155885646|FG001|Overall Study|Global Deterioration of Health Status|0|||
48463458|NCT04212221|155885647|FG002|Overall Study|Global Deterioration of Health Status|0|||
48463459|NCT04212221|155885648|FG003|Overall Study|Global Deterioration of Health Status|0|||
48463460|NCT04212221|155885649|FG004|Overall Study|Global Deterioration of Health Status|0|||
48463461|NCT04212221|155885650|FG005|Overall Study|Global Deterioration of Health Status|0|||
48463462|NCT04212221|155885651|FG006|Overall Study|Global Deterioration of Health Status|0|||
48463463|NCT04212221|155885652|FG007|Overall Study|Global Deterioration of Health Status|2|||
48463464|NCT04212221|155885645|FG000|Overall Study|Investigator's Decision|0|||
48463465|NCT04212221|155885646|FG001|Overall Study|Investigator's Decision|0|||
48463466|NCT04212221|155885647|FG002|Overall Study|Investigator's Decision|0|||
48463467|NCT04212221|155885648|FG003|Overall Study|Investigator's Decision|1|||
48463468|NCT04212221|155885649|FG004|Overall Study|Investigator's Decision|0|||
48463469|NCT04212221|155885650|FG005|Overall Study|Investigator's Decision|0|||
48463470|NCT04212221|155885651|FG006|Overall Study|Investigator's Decision|3|||
48463471|NCT04212221|155885652|FG007|Overall Study|Investigator's Decision|0|||
48463472|NCT04212221|155885645|FG000|Overall Study|Participant refused to continue treatment|0|||
48463473|NCT04212221|155885646|FG001|Overall Study|Participant refused to continue treatment|1|||
48463474|NCT04212221|155885647|FG002|Overall Study|Participant refused to continue treatment|0|||
48463475|NCT04212221|155885648|FG003|Overall Study|Participant refused to continue treatment|1|||
48463476|NCT04212221|155885649|FG004|Overall Study|Participant refused to continue treatment|1|||
48463477|NCT04212221|155885650|FG005|Overall Study|Participant refused to continue treatment|2|||
48463478|NCT04212221|155885651|FG006|Overall Study|Participant refused to continue treatment|4|||
48463479|NCT04212221|155885652|FG007|Overall Study|Participant refused to continue treatment|2|||
48463480|NCT04212221|155885645|FG000|Overall Study|Protocol Violation|0|||
48463481|NCT04212221|155885646|FG001|Overall Study|Protocol Violation|0|||
48463482|NCT04212221|155885647|FG002|Overall Study|Protocol Violation|0|||
48463483|NCT04212221|155885648|FG003|Overall Study|Protocol Violation|0|||
48463484|NCT04212221|155885649|FG004|Overall Study|Protocol Violation|0|||
48463485|NCT04212221|155885650|FG005|Overall Study|Protocol Violation|0|||
48463486|NCT04212221|155885651|FG006|Overall Study|Protocol Violation|0|||
48463487|NCT04212221|155885652|FG007|Overall Study|Protocol Violation|1|||
48463488|NCT02909504|155885660|FG000|Overall Study|Adverse Event|2|||
48463489|NCT02909504|155885660|FG000|Overall Study|Lack of Efficacy|3|||
48463490|NCT02909504|155885660|FG000|Overall Study|Withdrawal by Subject|4|||
48463491|NCT02909504|155885660|FG000|Overall Study|Pregnancy|1|||
48463492|NCT02909504|155885660|FG000|Overall Study|Subject moved|1|||
48463493|NCT02909504|155885660|FG000|Overall Study|Lost to Follow-up|1|||
48463494|NCT03137173|155885661|FG000|Overall Study|Withdrawal by Subject|8|||
48463495|NCT03137173|155885662|FG001|Overall Study|Withdrawal by Subject|13|||
48463496|NCT03137173|155885661|FG000|Overall Study|Death|1|||
48463497|NCT03137173|155885662|FG001|Overall Study|Death|3|||
48463498|NCT03137173|155885661|FG000|Overall Study|Physician Decision|1|||
48463499|NCT03137173|155885662|FG001|Overall Study|Physician Decision|0|||
48463500|NCT03137173|155885661|FG000|Overall Study|Lost to Follow-up|13|||
48463501|NCT03137173|155885662|FG001|Overall Study|Lost to Follow-up|18|||
48463502|NCT03137173|155885661|FG000|Overall Study|Other reasons|3|||
48463503|NCT03137173|155885662|FG001|Overall Study|Other reasons|2|||
48463504|NCT04411472|155885663|FG000|Overall Study|Adverse Event|5|||
48463505|NCT04411472|155885664|FG001|Overall Study|Adverse Event|10|||
48463506|NCT04411472|155885665|FG002|Overall Study|Adverse Event|1|||
48463507|NCT04411472|155885666|FG003|Overall Study|Adverse Event|0|||
48463508|NCT04411472|155885667|FG004|Overall Study|Adverse Event|0|||
48463509|NCT04411472|155885668|FG005|Overall Study|Adverse Event|0|||
48463510|NCT04411472|155885663|FG000|Overall Study|Protocol Violation|1|||
48463511|NCT04411472|155885664|FG001|Overall Study|Protocol Violation|0|||
48463512|NCT04411472|155885665|FG002|Overall Study|Protocol Violation|0|||
48463513|NCT04411472|155885666|FG003|Overall Study|Protocol Violation|0|||
48463514|NCT04411472|155885667|FG004|Overall Study|Protocol Violation|0|||
48463515|NCT04411472|155885668|FG005|Overall Study|Protocol Violation|0|||
48463516|NCT04411472|155885663|FG000|Overall Study|Withdrawal by Subject|0|||
48463517|NCT04411472|155885664|FG001|Overall Study|Withdrawal by Subject|1|||
48463518|NCT04411472|155885665|FG002|Overall Study|Withdrawal by Subject|0|||
48463519|NCT04411472|155885666|FG003|Overall Study|Withdrawal by Subject|1|||
48463520|NCT04411472|155885667|FG004|Overall Study|Withdrawal by Subject|0|||
48463521|NCT04411472|155885668|FG005|Overall Study|Withdrawal by Subject|0|||
48463522|NCT04411472|155885663|FG000|Overall Study|Physician Decision|1|||
48463523|NCT04411472|155885664|FG001|Overall Study|Physician Decision|0|||
48463524|NCT04411472|155885665|FG002|Overall Study|Physician Decision|0|||
48463525|NCT04411472|155885666|FG003|Overall Study|Physician Decision|0|||
48463526|NCT04411472|155885667|FG004|Overall Study|Physician Decision|0|||
48463527|NCT04411472|155885668|FG005|Overall Study|Physician Decision|0|||
48463528|NCT04411472|155885663|FG000|Overall Study|Study terminated by sponsor|17|||
48463529|NCT04411472|155885664|FG001|Overall Study|Study terminated by sponsor|20|||
48463530|NCT04411472|155885665|FG002|Overall Study|Study terminated by sponsor|3|||
48463531|NCT04411472|155885666|FG003|Overall Study|Study terminated by sponsor|0|||
48463532|NCT04411472|155885667|FG004|Overall Study|Study terminated by sponsor|0|||
48463533|NCT04411472|155885668|FG005|Overall Study|Study terminated by sponsor|0|||
48463534|NCT05060003|155885670|FG000|Overall Study|ctDNA negative|7|||
48463535|NCT01888965|155885671|FG000|Overall Study|Adverse Event|5|||
48463536|NCT01888965|155885671|FG000|Overall Study|Lack of Efficacy|4|||
48463537|NCT04610827|155885672|FG000|Overall Study|Withdrawal by Subject|1|||
48463538|NCT04610827|155885673|FG001|Overall Study|Withdrawal by Subject|1|||
48463539|NCT04610827|155885674|FG002|Overall Study|Withdrawal by Subject|0|||
48463540|NCT00426842|155885675|FG000|Overall Study|Lost to Follow-up|1|||
48463541|NCT00819052|155885676|FG000|Overall Study|Adverse Event|0|||
48463542|NCT00819052|155885677|FG001|Overall Study|Adverse Event|5|||
48463543|NCT00819052|155885676|FG000|Overall Study|Protocol Violation|1|||
48463544|NCT00819052|155885677|FG001|Overall Study|Protocol Violation|2|||
48463545|NCT00819052|155885676|FG000|Overall Study|Lost to Follow-up|1|||
48463546|NCT00819052|155885677|FG001|Overall Study|Lost to Follow-up|2|||
48463547|NCT00819052|155885676|FG000|Overall Study|Withdrawal by Subject|1|||
48463548|NCT00819052|155885677|FG001|Overall Study|Withdrawal by Subject|2|||
48463549|NCT00819052|155885676|FG000|Overall Study|Lack of Efficacy|1|||
48463550|NCT00819052|155885677|FG001|Overall Study|Lack of Efficacy|1|||
48463551|NCT00819052|155885676|FG000|Overall Study|Pregnancy|1|||
48463552|NCT00819052|155885677|FG001|Overall Study|Pregnancy|2|||
48463553|NCT00819052|155885676|FG000|Overall Study|Death or events leading to death|1|||
48463554|NCT00819052|155885677|FG001|Overall Study|Death or events leading to death|0|||
48463555|NCT03258762|155885678|FG000|Overall Study|Lost to Follow-up|0|||
48463556|NCT03258762|155885679|FG001|Overall Study|Lost to Follow-up|1|||
48463557|NCT00125268|155885684|FG000|Overall Study|Withdrawal by Subject|1|||
48463558|NCT00125268|155885685|FG001|Overall Study|Withdrawal by Subject|1|||
48463559|NCT01277666|155885686|FG000|Overall Study|Adverse Event|26|||
48463560|NCT01277666|155885687|FG001|Overall Study|Adverse Event|25|||
48463561|NCT01277666|155885688|FG002|Overall Study|Adverse Event|20|||
48463562|NCT01277666|155885686|FG000|Overall Study|Lack of Efficacy|8|||
48463563|NCT01277666|155885687|FG001|Overall Study|Lack of Efficacy|20|||
48463564|NCT01277666|155885688|FG002|Overall Study|Lack of Efficacy|12|||
48463565|NCT01277666|155885686|FG000|Overall Study|Protocol Violation|2|||
48463566|NCT01277666|155885687|FG001|Overall Study|Protocol Violation|3|||
48463567|NCT01277666|155885688|FG002|Overall Study|Protocol Violation|2|||
48463568|NCT01277666|155885686|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
48463569|NCT01277666|155885687|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
48463570|NCT01277666|155885688|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
48463571|NCT01277666|155885686|FG000|Overall Study|Lost to Follow-up|1|||
48463572|NCT01277666|155885687|FG001|Overall Study|Lost to Follow-up|1|||
48463573|NCT01277666|155885688|FG002|Overall Study|Lost to Follow-up|2|||
48463574|NCT01277666|155885686|FG000|Overall Study|Withdrawal by Subject|7|||
48463575|NCT01277666|155885687|FG001|Overall Study|Withdrawal by Subject|8|||
48463576|NCT01277666|155885688|FG002|Overall Study|Withdrawal by Subject|6|||
48463577|NCT01277666|155885686|FG000|Overall Study|Death|0|||
48463578|NCT01277666|155885687|FG001|Overall Study|Death|0|||
48463579|NCT01277666|155885688|FG002|Overall Study|Death|1|||
48463580|NCT00967343|155885689|FG000|Overall Study|Study termination by sponsor|12|||
48463581|NCT00967343|155885689|FG000|Overall Study|Death|24|||
48463582|NCT00967343|155885689|FG000|Overall Study|Relapse|1|||
48463583|NCT00967343|155885689|FG000|Overall Study|Lost to Follow-up|1|||
48463584|NCT01365468|155885690|FG000|Overall Study|Physician Decision|1|||
48463585|NCT01365468|155885691|FG001|Overall Study|Physician Decision|0|||
48463586|NCT01365468|155885690|FG000|Overall Study|Disease progression|1|||
48463587|NCT01365468|155885691|FG001|Overall Study|Disease progression|0|||
48463588|NCT01365468|155885690|FG000|Overall Study|Lost to Follow-up|2|||
48463589|NCT01365468|155885691|FG001|Overall Study|Lost to Follow-up|0|||
48463590|NCT01747655|155885692|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
48463591|NCT01747655|155885693|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
48463592|NCT01747655|155885692|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
48463593|NCT01747655|155885693|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
48463594|NCT01747655|155885692|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
48463595|NCT01747655|155885693|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
48463596|NCT03524664|155885694|FG000|Overall Study|Withdrawal by Subject|1|||
48463597|NCT03524664|155885695|FG001|Overall Study|Withdrawal by Subject|2|||
48463598|NCT03524664|155885694|FG000|Overall Study|Lost to Follow-up|4|||
48463599|NCT03524664|155885695|FG001|Overall Study|Lost to Follow-up|13|||
48463600|NCT01711359|155885696|FG000|Treatment Period|Withdrawal by Subject|18|||
48463601|NCT01711359|155885697|FG001|Treatment Period|Withdrawal by Subject|7|||
48463602|NCT01711359|155885698|FG002|Treatment Period|Withdrawal by Subject|13|||
48463603|NCT01711359|155885696|FG000|Treatment Period|Lack of Efficacy|13|||
48463604|NCT01711359|155885697|FG001|Treatment Period|Lack of Efficacy|2|||
48463605|NCT01711359|155885698|FG002|Treatment Period|Lack of Efficacy|2|||
48463606|NCT01711359|155885696|FG000|Treatment Period|Adverse Event|8|||
48463607|NCT01711359|155885697|FG001|Treatment Period|Adverse Event|10|||
48463608|NCT01711359|155885698|FG002|Treatment Period|Adverse Event|24|||
48463609|NCT01711359|155885696|FG000|Treatment Period|Physician Decision|4|||
48463610|NCT01711359|155885697|FG001|Treatment Period|Physician Decision|3|||
48463611|NCT01711359|155885698|FG002|Treatment Period|Physician Decision|2|||
48463612|NCT01711359|155885696|FG000|Treatment Period|Death|3|||
48463613|NCT01711359|155885697|FG001|Treatment Period|Death|0|||
48463614|NCT01711359|155885698|FG002|Treatment Period|Death|0|||
48463615|NCT01711359|155885696|FG000|Treatment Period|Entry Criteria Not Met|1|||
48463616|NCT01711359|155885697|FG001|Treatment Period|Entry Criteria Not Met|0|||
48463617|NCT01711359|155885698|FG002|Treatment Period|Entry Criteria Not Met|0|||
48463618|NCT01711359|155885696|FG000|Treatment Period|Sponsor Decision|1|||
48463619|NCT01711359|155885697|FG001|Treatment Period|Sponsor Decision|0|||
48463620|NCT01711359|155885698|FG002|Treatment Period|Sponsor Decision|0|||
48463621|NCT01711359|155885696|FG000|Treatment Period|Lost to Follow-up|1|||
48463622|NCT01711359|155885697|FG001|Treatment Period|Lost to Follow-up|1|||
48463623|NCT01711359|155885698|FG002|Treatment Period|Lost to Follow-up|1|||
48463624|NCT01711359|155885696|FG000|Treatment Period|Randomized, Not Treated|3|||
48463625|NCT01711359|155885697|FG001|Treatment Period|Randomized, Not Treated|1|||
48463626|NCT01711359|155885698|FG002|Treatment Period|Randomized, Not Treated|0|||
48463627|NCT00982111|155885703|FG000|Overall Study|Adverse Event|1|||
48463628|NCT00982111|155885704|FG001|Overall Study|Adverse Event|1|||
48463629|NCT00982111|155885703|FG000|Overall Study|Progressive Disease|46|||
48463630|NCT00982111|155885704|FG001|Overall Study|Progressive Disease|39|||
48463631|NCT00982111|155885703|FG000|Overall Study|Lost to Follow-up|9|||
48463632|NCT00982111|155885704|FG001|Overall Study|Lost to Follow-up|6|||
48463633|NCT00982111|155885703|FG000|Overall Study|New Anti-Cancer Therapy|5|||
48463634|NCT00982111|155885704|FG001|Overall Study|New Anti-Cancer Therapy|5|||
48463635|NCT00982111|155885703|FG000|Overall Study|Medical Decision|1|||
48463636|NCT00982111|155885704|FG001|Overall Study|Medical Decision|0|||
48463637|NCT00982111|155885703|FG000|Overall Study|Withdrawal by Subject|17|||
48463638|NCT00982111|155885704|FG001|Overall Study|Withdrawal by Subject|19|||
48463639|NCT00982111|155885703|FG000|Overall Study|Global Study End|0|||
48463640|NCT00982111|155885704|FG001|Overall Study|Global Study End|1|||
48463641|NCT00982111|155885703|FG000|Overall Study|Sponsor's Decision|0|||
48463642|NCT00982111|155885704|FG001|Overall Study|Sponsor's Decision|1|||
48463643|NCT04604015|155885705|FG000|Overall Study|Incomplete Data Collection|33|||
48463644|NCT01594749|155885706|FG000|Overall Study|Adverse Event|2|||
48463645|NCT01594749|155885707|FG001|Overall Study|Adverse Event|1|||
48463646|NCT01594749|155885706|FG000|Overall Study|Withdrawal by Subject|2|||
48463647|NCT01594749|155885707|FG001|Overall Study|Withdrawal by Subject|2|||
48463648|NCT01594749|155885706|FG000|Overall Study|Protocol Violation|2|||
48463649|NCT01594749|155885707|FG001|Overall Study|Protocol Violation|0|||
48463650|NCT01594749|155885706|FG000|Overall Study|Physician Decision|1|||
48463651|NCT01594749|155885707|FG001|Overall Study|Physician Decision|1|||
48463652|NCT01594749|155885706|FG000|Overall Study|Non-compliance with Protocol|0|||
48463653|NCT01594749|155885707|FG001|Overall Study|Non-compliance with Protocol|1|||
48463654|NCT01594749|155885706|FG000|Overall Study|Lost to Follow-up|1|||
48463655|NCT01594749|155885707|FG001|Overall Study|Lost to Follow-up|0|||
48463656|NCT01594749|155885706|FG000|Overall Study|Death|9|||
48463657|NCT01594749|155885707|FG001|Overall Study|Death|3|||
48463658|NCT01594749|155885706|FG000|Overall Study|Not Treated|4|||
48463659|NCT01594749|155885707|FG001|Overall Study|Not Treated|10|||
48463660|NCT01594749|155885706|FG000|Overall Study|Lost Source Documentation|1|||
48463661|NCT01594749|155885707|FG001|Overall Study|Lost Source Documentation|0|||
48463662|NCT00089505|155885708|FG000|Overall Study|Death|4|||
48463663|NCT00089505|155885709|FG001|Overall Study|Death|1|||
48463664|NCT00089505|155885710|FG002|Overall Study|Death|5|||
48463665|NCT00089505|155885711|FG003|Overall Study|Death|8|||
48463666|NCT00089505|155885708|FG000|Overall Study|Withdrawal by Subject|3|||
48463667|NCT00089505|155885709|FG001|Overall Study|Withdrawal by Subject|0|||
48463668|NCT00089505|155885710|FG002|Overall Study|Withdrawal by Subject|6|||
48463669|NCT00089505|155885711|FG003|Overall Study|Withdrawal by Subject|6|||
48463670|NCT00089505|155885708|FG000|Overall Study|Lost to Follow-up|1|||
48463671|NCT00089505|155885709|FG001|Overall Study|Lost to Follow-up|1|||
48463672|NCT00089505|155885710|FG002|Overall Study|Lost to Follow-up|9|||
48463673|NCT00089505|155885711|FG003|Overall Study|Lost to Follow-up|7|||
48463674|NCT00089505|155885708|FG000|Overall Study|Physician Decision|1|||
48463675|NCT00089505|155885709|FG001|Overall Study|Physician Decision|0|||
48463676|NCT00089505|155885710|FG002|Overall Study|Physician Decision|0|||
48463677|NCT00089505|155885711|FG003|Overall Study|Physician Decision|0|||
48463678|NCT00089505|155885708|FG000|Overall Study|Protocol Violation|0|||
48463679|NCT00089505|155885709|FG001|Overall Study|Protocol Violation|0|||
48463680|NCT00089505|155885710|FG002|Overall Study|Protocol Violation|1|||
48463681|NCT00089505|155885711|FG003|Overall Study|Protocol Violation|0|||
48463682|NCT01482598|155885712|FG000|Overall Study|Death|7|||
48463683|NCT01482598|155885713|FG001|Overall Study|Death|10|||
48463684|NCT01482598|155885712|FG000|Overall Study|Physician Decision|0|||
48463685|NCT01482598|155885713|FG001|Overall Study|Physician Decision|3|||
48463686|NCT01482598|155885712|FG000|Overall Study|Withdrawal by Subject|4|||
48463687|NCT01482598|155885713|FG001|Overall Study|Withdrawal by Subject|5|||
48463688|NCT01482598|155885712|FG000|Overall Study|Lost to Follow-up|5|||
48463689|NCT01482598|155885713|FG001|Overall Study|Lost to Follow-up|4|||
48463690|NCT01070381|155885716|FG000|Period 2, 1 Week of Wear|Handling|0|||
48463691|NCT01070381|155885717|FG001|Period 2, 1 Week of Wear|Handling|1|||
48463692|NCT01070381|155885716|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
48463693|NCT01070381|155885717|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
48463694|NCT01475214|155885718|FG000|Overall Study|Lost to Follow-up|1|||
48463695|NCT01475214|155885719|FG001|Overall Study|Lost to Follow-up|0|||
48463696|NCT01475214|155885720|FG002|Overall Study|Lost to Follow-up|1|||
48463697|NCT01475214|155885718|FG000|Overall Study|Physician Decision|2|||
48463698|NCT01475214|155885719|FG001|Overall Study|Physician Decision|0|||
48463699|NCT01475214|155885720|FG002|Overall Study|Physician Decision|0|||
48463700|NCT01475214|155885718|FG000|Overall Study|Withdrawal by Subject|2|||
48463701|NCT01475214|155885719|FG001|Overall Study|Withdrawal by Subject|4|||
48463702|NCT01475214|155885720|FG002|Overall Study|Withdrawal by Subject|1|||
48463703|NCT01385098|155885721|FG000|Overall Study|Adverse Event|10|||
48463704|NCT01385098|155885721|FG000|Overall Study|Lost to Follow-up|4|||
48463705|NCT02475564|155885722|FG000|Overall Study|Withdrawal by Subject|1|||
48463706|NCT02475564|155885723|FG001|Overall Study|Withdrawal by Subject|0|||
48463707|NCT02475564|155885722|FG000|Overall Study|Lost to Follow-up|2|||
48463708|NCT02475564|155885723|FG001|Overall Study|Lost to Follow-up|1|||
48463709|NCT02475564|155885722|FG000|Overall Study|Intense Menstrual bleeding|1|||
48463710|NCT02475564|155885723|FG001|Overall Study|Intense Menstrual bleeding|0|||
48463711|NCT01906489|155885732|FG000|Overall Study|Adverse Event|10|||
48463712|NCT01906489|155885733|FG001|Overall Study|Adverse Event|3|||
48463713|NCT01906489|155885732|FG000|Overall Study|Worsening of CKD|6|||
48463714|NCT01906489|155885733|FG001|Overall Study|Worsening of CKD|4|||
48463715|NCT01906489|155885732|FG000|Overall Study|Withdrawal by Subject|5|||
48463716|NCT01906489|155885733|FG001|Overall Study|Withdrawal by Subject|0|||
48463717|NCT01906489|155885732|FG000|Overall Study|Worsening of Anemia|1|||
48463718|NCT01906489|155885733|FG001|Overall Study|Worsening of Anemia|0|||
48463719|NCT01906489|155885732|FG000|Overall Study|Protocol Violation|0|||
48463720|NCT01906489|155885733|FG001|Overall Study|Protocol Violation|1|||
48463721|NCT01906489|155885732|FG000|Overall Study|Non- Compliance|1|||
48463722|NCT01906489|155885733|FG001|Overall Study|Non- Compliance|0|||
48463723|NCT01906489|155885732|FG000|Overall Study|Sponsor Decision|1|||
48463724|NCT01906489|155885733|FG001|Overall Study|Sponsor Decision|0|||
48463725|NCT01906489|155885732|FG000|Overall Study|Lost to Follow-up|1|||
48463726|NCT01906489|155885733|FG001|Overall Study|Lost to Follow-up|1|||
48463727|NCT01906489|155885732|FG000|Overall Study|Other|1|||
48463728|NCT01906489|155885733|FG001|Overall Study|Other|0|||
48463729|NCT01004159|155887098|FG000|Overall Study|Adverse Event|2|||
48463730|NCT01004159|155887098|FG000|Overall Study|Disease Progression|18|||
48463731|NCT02679222|155887102|FG000|Overall Study|No time for project|1|||
48463732|NCT04097925|155887103|FG000|Overall Study|Withdrawal by Subject|1|||
48463733|NCT00732199|155887104|FG000|Overall Study|Withdrawal by Subject|25|||
48463734|NCT00732199|155887105|FG001|Overall Study|Withdrawal by Subject|18|||
48463735|NCT00732199|155887104|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
48463736|NCT00732199|155887105|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
48463737|NCT04005885|155887107|FG000|First Intervention|Withdrawal by Subject|1|||
48463738|NCT04005885|155887108|FG001|First Intervention|Withdrawal by Subject|1|||
48463739|NCT04005885|155887107|FG000|Second Intervention|Withdrawal by Subject|0|||
48463740|NCT04005885|155887108|FG001|Second Intervention|Withdrawal by Subject|2|||
48463741|NCT02059174|155887114|FG000|Period 1|Withdrawal by Subject|0|||
48463742|NCT02059174|155887115|FG001|Period 1|Withdrawal by Subject|2|||
48463743|NCT02059174|155887114|FG000|Period 2|Withdrawal by Subject|0|||
48463744|NCT02059174|155887115|FG001|Period 2|Withdrawal by Subject|2|||
48463745|NCT02059174|155887114|FG000|Period 2|Protocol Violation|1|||
48463746|NCT02059174|155887115|FG001|Period 2|Protocol Violation|0|||
48463747|NCT02059174|155887114|FG000|Period 3|Physician Decision|1|||
48463748|NCT02059174|155887115|FG001|Period 3|Physician Decision|0|||
48463749|NCT02306148|155887116|FG000|Overall Study|Adverse Event|12|||
48463750|NCT02306148|155887117|FG001|Overall Study|Adverse Event|6|||
48463751|NCT02306148|155887116|FG000|Overall Study|Lost to Follow-up|1|||
48463752|NCT02306148|155887117|FG001|Overall Study|Lost to Follow-up|4|||
48463753|NCT02608099|155887118|FG000|Overall Study|Ablation procedure not initiated|3|||
48463754|NCT02608099|155887119|FG001|Overall Study|Ablation procedure not initiated|2|||
48463755|NCT03347279|155887124|FG000|Overall Study|Withdrawal by Subject|8|||
48463756|NCT03347279|155887125|FG001|Overall Study|Withdrawal by Subject|15|||
48463757|NCT03347279|155887124|FG000|Overall Study|Death|0|||
48463758|NCT03347279|155887125|FG001|Overall Study|Death|2|||
48463759|NCT03347279|155887124|FG000|Overall Study|Lost to Follow-up|5|||
48463760|NCT03347279|155887125|FG001|Overall Study|Lost to Follow-up|2|||
48463761|NCT03347279|155887124|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
48463762|NCT03347279|155887125|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
48463763|NCT00963469|155887129|FG000|Overall Study|Adverse Event|15|||
48463764|NCT00963469|155887130|FG001|Overall Study|Adverse Event|11|||
48463765|NCT00963469|155887131|FG002|Overall Study|Adverse Event|1|||
48463766|NCT00963469|155887129|FG000|Overall Study|Lack of Efficacy|10|||
48463767|NCT00963469|155887130|FG001|Overall Study|Lack of Efficacy|7|||
48463768|NCT00963469|155887131|FG002|Overall Study|Lack of Efficacy|2|||
48463769|NCT00963469|155887129|FG000|Overall Study|Lost to Follow-up|1|||
48463770|NCT00963469|155887130|FG001|Overall Study|Lost to Follow-up|1|||
48463771|NCT00963469|155887131|FG002|Overall Study|Lost to Follow-up|0|||
48463772|NCT00963469|155887129|FG000|Overall Study|Protocol Violation|5|||
48463773|NCT00963469|155887130|FG001|Overall Study|Protocol Violation|5|||
48463774|NCT00963469|155887131|FG002|Overall Study|Protocol Violation|3|||
48463775|NCT00963469|155887129|FG000|Overall Study|Withdrawal by Subject|4|||
48463776|NCT00963469|155887130|FG001|Overall Study|Withdrawal by Subject|1|||
48463777|NCT00963469|155887131|FG002|Overall Study|Withdrawal by Subject|1|||
48463778|NCT00963469|155887129|FG000|Overall Study|Pre-randomization Adverse Event|1|||
48463779|NCT00963469|155887130|FG001|Overall Study|Pre-randomization Adverse Event|2|||
48463780|NCT00963469|155887131|FG002|Overall Study|Pre-randomization Adverse Event|0|||
48463781|NCT00963469|155887129|FG000|Overall Study|Moved|1|||
48463782|NCT00963469|155887130|FG001|Overall Study|Moved|0|||
48463783|NCT00963469|155887131|FG002|Overall Study|Moved|0|||
48463784|NCT00963469|155887129|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
48463785|NCT00963469|155887130|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
48463786|NCT00963469|155887131|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
48463787|NCT03763942|155887132|FG000|Overall Study|Lost to Follow-up|114|||
48463788|NCT03763942|155887133|FG001|Overall Study|Lost to Follow-up|54|||
48463789|NCT03763942|155887132|FG000|Overall Study|Protocol Violation|1|||
48463790|NCT03763942|155887133|FG001|Overall Study|Protocol Violation|0|||
48463791|NCT03763942|155887132|FG000|Overall Study|Withdrawal by Subject|2|||
48463792|NCT03763942|155887133|FG001|Overall Study|Withdrawal by Subject|0|||
48463793|NCT03763942|155887132|FG000|Overall Study|Other|2|||
48463794|NCT03763942|155887133|FG001|Overall Study|Other|3|||
48463795|NCT02987205|155887134|FG000|Overall Study|Adverse Event|1|||
48463796|NCT02987205|155887134|FG000|Overall Study|Withdrawal by Subject|3|||
48463797|NCT02145429|155887135|FG000|Overall Study|Death|4|||
48463798|NCT02145429|155887136|FG001|Overall Study|Death|5|||
48463799|NCT02145429|155887135|FG000|Overall Study|Lost to Follow-up|4|||
48463800|NCT02145429|155887136|FG001|Overall Study|Lost to Follow-up|3|||
48463801|NCT02145429|155887135|FG000|Overall Study|Withdrawal by Subject|8|||
48463802|NCT02145429|155887136|FG001|Overall Study|Withdrawal by Subject|3|||
48463803|NCT01542632|155887141|FG000|Overall Study|Withdrawal of Consent|0|||
48463804|NCT01542632|155887142|FG001|Overall Study|Withdrawal of Consent|0|||
48463805|NCT01542632|155887143|FG002|Overall Study|Withdrawal of Consent|0|||
48463806|NCT01542632|155887144|FG003|Overall Study|Withdrawal of Consent|2|||
48463807|NCT01542632|155887145|FG004|Overall Study|Withdrawal of Consent|3|||
48463808|NCT01542632|155887146|FG005|Overall Study|Withdrawal of Consent|0|||
48463809|NCT01542632|155887141|FG000|Overall Study|Adverse Event|0|||
48463810|NCT01542632|155887142|FG001|Overall Study|Adverse Event|0|||
48463811|NCT01542632|155887143|FG002|Overall Study|Adverse Event|1|||
48463812|NCT01542632|155887144|FG003|Overall Study|Adverse Event|0|||
48463813|NCT01542632|155887145|FG004|Overall Study|Adverse Event|0|||
48463814|NCT01542632|155887146|FG005|Overall Study|Adverse Event|0|||
48463815|NCT01542632|155887141|FG000|Overall Study|Lost to Follow-up|0|||
48463816|NCT01542632|155887142|FG001|Overall Study|Lost to Follow-up|1|||
48463817|NCT01542632|155887143|FG002|Overall Study|Lost to Follow-up|0|||
48463818|NCT01542632|155887144|FG003|Overall Study|Lost to Follow-up|0|||
48463819|NCT01542632|155887145|FG004|Overall Study|Lost to Follow-up|0|||
48463820|NCT01542632|155887146|FG005|Overall Study|Lost to Follow-up|0|||
48463821|NCT01542632|155887141|FG000|Overall Study|Sponsor/Investigator Decision|0|||
48463822|NCT01542632|155887142|FG001|Overall Study|Sponsor/Investigator Decision|0|||
48463823|NCT01542632|155887143|FG002|Overall Study|Sponsor/Investigator Decision|0|||
48463824|NCT01542632|155887144|FG003|Overall Study|Sponsor/Investigator Decision|0|||
48463825|NCT01542632|155887145|FG004|Overall Study|Sponsor/Investigator Decision|1|||
48463826|NCT01542632|155887146|FG005|Overall Study|Sponsor/Investigator Decision|0|||
48463827|NCT01797302|155887147|FG000|Overall Study|Lost to Follow-up|16|||
48463828|NCT01797302|155887148|FG001|Overall Study|Lost to Follow-up|23|||
48463829|NCT01797302|155887149|FG002|Overall Study|Lost to Follow-up|22|||
48463830|NCT01797302|155887147|FG000|Overall Study|Withdrawal by Subject|1|||
48463831|NCT01797302|155887148|FG001|Overall Study|Withdrawal by Subject|3|||
48463832|NCT01797302|155887149|FG002|Overall Study|Withdrawal by Subject|4|||
48463833|NCT03228836|155887151|FG000|Overall Study|Adverse Event|3|||
48463834|NCT03228836|155887151|FG000|Overall Study|Withdrawal by Subject|1|||
48463835|NCT03228836|155887151|FG000|Overall Study|Death|1|||
48463836|NCT03228836|155887151|FG000|Overall Study|Physician Decision|1|||
48463837|NCT03228836|155887151|FG000|Overall Study|Disease Progression|7|||
48463838|NCT03228836|155887151|FG000|Overall Study|Other|4|||
48463839|NCT01222767|155887155|FG000|Overall Study|Progressive disease|13|||
48463840|NCT01222767|155887155|FG000|Overall Study|Adverse Event|2|||
48463841|NCT01222767|155887155|FG000|Overall Study|Surgical resection|1|||
48463842|NCT01222767|155887155|FG000|Overall Study|Never treated|1|||
48463843|NCT02773849|155887156|FG000|Overall Study|Lost to Follow-up|11|||
48463844|NCT02773849|155887156|FG000|Overall Study|Death|26|||
48463845|NCT02773849|155887156|FG000|Overall Study|Withdrawal by Subject|5|||
48463846|NCT02773849|155887156|FG000|Overall Study|Withdrawal of Consent|9|||
48463847|NCT02773849|155887156|FG000|Overall Study|Other: not due to lack of tolerability|11|||
48463848|NCT01412333|155887157|FG000|Overall Study|Adverse Event|40|||
48463849|NCT01412333|155887158|FG001|Overall Study|Adverse Event|42|||
48463850|NCT01412333|155887157|FG000|Overall Study|Death|5|||
48463851|NCT01412333|155887158|FG001|Overall Study|Death|6|||
48463852|NCT01412333|155887157|FG000|Overall Study|Lack of Efficacy|22|||
48463853|NCT01412333|155887158|FG001|Overall Study|Lack of Efficacy|10|||
48463854|NCT01412333|155887157|FG000|Overall Study|Lost to Follow-up|15|||
48463855|NCT01412333|155887158|FG001|Overall Study|Lost to Follow-up|12|||
48463856|NCT01412333|155887157|FG000|Overall Study|Non-Compliance|3|||
48463857|NCT01412333|155887158|FG001|Overall Study|Non-Compliance|7|||
48463858|NCT01412333|155887157|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48463859|NCT01412333|155887158|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48463860|NCT01412333|155887157|FG000|Overall Study|Other|30|||
48463861|NCT01412333|155887158|FG001|Overall Study|Other|33|||
48463862|NCT01412333|155887157|FG000|Overall Study|Physician Decision|11|||
48463863|NCT01412333|155887158|FG001|Overall Study|Physician Decision|16|||
48463864|NCT01412333|155887157|FG000|Overall Study|Pregnancy|6|||
48463865|NCT01412333|155887158|FG001|Overall Study|Pregnancy|4|||
48463866|NCT01412333|155887157|FG000|Overall Study|Protocol Violation|1|||
48463867|NCT01412333|155887158|FG001|Overall Study|Protocol Violation|2|||
48463868|NCT01412333|155887157|FG000|Overall Study|Study Terminated By Sponsor|3|||
48463869|NCT01412333|155887158|FG001|Overall Study|Study Terminated By Sponsor|2|||
48463870|NCT01412333|155887157|FG000|Overall Study|Withdrawal by Subject|51|||
48463871|NCT01412333|155887158|FG001|Overall Study|Withdrawal by Subject|54|||
48463872|NCT01412333|155887157|FG000|Overall Study|Missing|1|||
48463873|NCT01412333|155887158|FG001|Overall Study|Missing|3|||
48463874|NCT01326481|155887159|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
48463875|NCT00307736|155887160|FG000|Overall Study|Adverse Event|0|||
48463876|NCT00307736|155887161|FG001|Overall Study|Adverse Event|0|||
48463877|NCT00307736|155887162|FG002|Overall Study|Adverse Event|1|||
48463878|NCT00307736|155887163|FG003|Overall Study|Adverse Event|3|||
48463879|NCT00307736|155887160|FG000|Overall Study|Withdrawal by Subject|0|||
48463880|NCT00307736|155887161|FG001|Overall Study|Withdrawal by Subject|0|||
48463881|NCT00307736|155887162|FG002|Overall Study|Withdrawal by Subject|2|||
48463882|NCT00307736|155887163|FG003|Overall Study|Withdrawal by Subject|0|||
48463883|NCT00606931|155887174|FG000|Overall Study|Withdrawal by Subject|3|||
48463884|NCT00808132|155887175|FG000|Overall Study|Adverse Event|34|||
48463885|NCT00808132|155887176|FG001|Overall Study|Adverse Event|33|||
48463886|NCT00808132|155887177|FG002|Overall Study|Adverse Event|16|||
48463887|NCT00808132|155887178|FG003|Overall Study|Adverse Event|31|||
48463888|NCT00808132|155887179|FG004|Overall Study|Adverse Event|33|||
48463889|NCT00808132|155887175|FG000|Overall Study|Death|0|||
48463890|NCT00808132|155887176|FG001|Overall Study|Death|0|||
48463891|NCT00808132|155887177|FG002|Overall Study|Death|0|||
48463892|NCT00808132|155887178|FG003|Overall Study|Death|0|||
48463893|NCT00808132|155887179|FG004|Overall Study|Death|1|||
48463894|NCT00808132|155887175|FG000|Overall Study|Physician Decision|0|||
48463895|NCT00808132|155887176|FG001|Overall Study|Physician Decision|1|||
48463896|NCT00808132|155887177|FG002|Overall Study|Physician Decision|0|||
48463897|NCT00808132|155887178|FG003|Overall Study|Physician Decision|0|||
48463898|NCT00808132|155887179|FG004|Overall Study|Physician Decision|0|||
48463899|NCT00808132|155887175|FG000|Overall Study|Lost to Follow-up|8|||
48463900|NCT00808132|155887176|FG001|Overall Study|Lost to Follow-up|10|||
48463901|NCT00808132|155887177|FG002|Overall Study|Lost to Follow-up|11|||
48463902|NCT00808132|155887178|FG003|Overall Study|Lost to Follow-up|8|||
48463903|NCT00808132|155887179|FG004|Overall Study|Lost to Follow-up|9|||
48463904|NCT00808132|155887175|FG000|Overall Study|Protocol Violation|8|||
48463905|NCT00808132|155887176|FG001|Overall Study|Protocol Violation|9|||
48463906|NCT00808132|155887177|FG002|Overall Study|Protocol Violation|4|||
48463907|NCT00808132|155887178|FG003|Overall Study|Protocol Violation|9|||
48463908|NCT00808132|155887179|FG004|Overall Study|Protocol Violation|5|||
48463909|NCT00808132|155887175|FG000|Overall Study|Withdrawal by Subject|27|||
48463910|NCT00808132|155887176|FG001|Overall Study|Withdrawal by Subject|18|||
48463911|NCT00808132|155887177|FG002|Overall Study|Withdrawal by Subject|2|||
48463912|NCT00808132|155887178|FG003|Overall Study|Withdrawal by Subject|7|||
48463913|NCT00808132|155887179|FG004|Overall Study|Withdrawal by Subject|16|||
48463914|NCT00808132|155887175|FG000|Overall Study|Other|6|||
48463915|NCT00808132|155887176|FG001|Overall Study|Other|4|||
48463916|NCT00808132|155887177|FG002|Overall Study|Other|6|||
48463917|NCT00808132|155887178|FG003|Overall Study|Other|2|||
48463918|NCT00808132|155887179|FG004|Overall Study|Other|15|||
48463919|NCT00808132|155887175|FG000|Overall Study|Randomized, but not treated|10|||
48463920|NCT00808132|155887176|FG001|Overall Study|Randomized, but not treated|7|||
48463921|NCT00808132|155887177|FG002|Overall Study|Randomized, but not treated|9|||
48463922|NCT00808132|155887178|FG003|Overall Study|Randomized, but not treated|8|||
48463923|NCT00808132|155887179|FG004|Overall Study|Randomized, but not treated|9|||
48463924|NCT00808132|155887175|FG000|Overall Study|Unsatisfactory response|5|||
48463925|NCT00808132|155887176|FG001|Overall Study|Unsatisfactory response|6|||
48463926|NCT00808132|155887177|FG002|Overall Study|Unsatisfactory response|6|||
48463927|NCT00808132|155887178|FG003|Overall Study|Unsatisfactory response|4|||
48463928|NCT00808132|155887179|FG004|Overall Study|Unsatisfactory response|12|||
48463929|NCT01351415|155887180|FG000|Overall Study|Withdrawal by Subject|15|||
48463930|NCT01351415|155887181|FG001|Overall Study|Withdrawal by Subject|17|||
48463931|NCT01351415|155887180|FG000|Overall Study|Trial termination by the Sponsor|28|||
48463932|NCT01351415|155887181|FG001|Overall Study|Trial termination by the Sponsor|19|||
48463933|NCT01351415|155887180|FG000|Overall Study|Lost to Follow-up|5|||
48463934|NCT01351415|155887181|FG001|Overall Study|Lost to Follow-up|7|||
48463935|NCT01351415|155887180|FG000|Overall Study|Death|190|||
48463936|NCT01351415|155887181|FG001|Overall Study|Death|187|||
48463937|NCT01351415|155887180|FG000|Overall Study|Physician Decision|2|||
48463938|NCT01351415|155887181|FG001|Overall Study|Physician Decision|3|||
48463939|NCT01351415|155887180|FG000|Overall Study|Reason unknown|0|||
48463940|NCT01351415|155887181|FG001|Overall Study|Reason unknown|2|||
48463941|NCT01351415|155887180|FG000|Overall Study|Never Started|5|||
48463942|NCT01351415|155887181|FG001|Overall Study|Never Started|5|||
48463943|NCT01849289|155887184|FG000|Overall Study|Adverse Event|3|||
48463944|NCT01849289|155887185|FG001|Overall Study|Adverse Event|3|||
48463945|NCT01849289|155887184|FG000|Overall Study|Protocol Violation|3|||
48463946|NCT01849289|155887185|FG001|Overall Study|Protocol Violation|3|||
48463947|NCT01849289|155887184|FG000|Overall Study|Withdrawal criteria|1|||
48463948|NCT01849289|155887185|FG001|Overall Study|Withdrawal criteria|0|||
48463949|NCT01849289|155887184|FG000|Overall Study|Unclassified|25|||
48463950|NCT01849289|155887185|FG001|Overall Study|Unclassified|18|||
48463951|NCT01590810|155887188|FG000|Overall Study|Physician Decision|0|||
48463952|NCT01590810|155887189|FG001|Overall Study|Physician Decision|1|||
48463953|NCT01590810|155887190|FG002|Overall Study|Physician Decision|1|||
48463954|NCT01590810|155887191|FG003|Overall Study|Physician Decision|0|||
48463955|NCT01590810|155887192|FG004|Overall Study|Physician Decision|0|||
48463956|NCT03125902|155887193|FG000|Overall Study|Adverse Event|0|||
48463957|NCT03125902|155887194|FG001|Overall Study|Adverse Event|1|||
48463958|NCT03125902|155887193|FG000|Overall Study|Death|119|||
48463959|NCT03125902|155887194|FG001|Overall Study|Death|229|||
48463960|NCT03125902|155887193|FG000|Overall Study|Lost to Follow-up|4|||
48463961|NCT03125902|155887194|FG001|Overall Study|Lost to Follow-up|13|||
48463962|NCT03125902|155887193|FG000|Overall Study|Other|0|||
48463963|NCT03125902|155887194|FG001|Overall Study|Other|4|||
48463964|NCT03125902|155887193|FG000|Overall Study|Physician Decision|2|||
48463965|NCT03125902|155887194|FG001|Overall Study|Physician Decision|1|||
48463966|NCT03125902|155887193|FG000|Overall Study|Progressive Disease|0|||
48463967|NCT03125902|155887194|FG001|Overall Study|Progressive Disease|3|||
48463968|NCT03125902|155887193|FG000|Overall Study|Study Terminated By Sponsor|74|||
48463969|NCT03125902|155887194|FG001|Overall Study|Study Terminated By Sponsor|143|||
48463970|NCT03125902|155887193|FG000|Overall Study|Withdrawal by Subject|21|||
48463971|NCT03125902|155887194|FG001|Overall Study|Withdrawal by Subject|37|||
48463972|NCT01815099|155887195|FG000|Overall Study|Lack of Efficacy|1|||
48463973|NCT01815099|155887195|FG000|Overall Study|unable to attend study visits|1|||
48463974|NCT00523744|155887197|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
48463975|NCT00523744|155887197|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
48463976|NCT00523744|155887197|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
48463977|NCT00523744|155887197|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
48463978|NCT00523744|155887197|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
48463979|NCT00523744|155887197|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
48463980|NCT03769753|155887198|FG000|Overall Study|Not Treated|6|||
48463981|NCT03769753|155887198|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
48463982|NCT02694562|155887199|FG000|Overall Study|Death|8|||
48463983|NCT02694562|155887199|FG000|Overall Study|Protocol Violation|4|||
48463984|NCT02694562|155887199|FG000|Overall Study|Lost to Follow-up|3|||
48463985|NCT02694562|155887199|FG000|Overall Study|Screen Failure|2|||
48463986|NCT02694562|155887199|FG000|Overall Study|Physician Decision|1|||
48463987|NCT01373294|155887200|FG000|Overall Study|Adverse Event|1|||
48463988|NCT01373294|155887201|FG001|Overall Study|Adverse Event|0|||
48463989|NCT00423267|155887202|FG000|Period A|Withdrawal by Subject|0|||
48463990|NCT00423267|155887203|FG001|Period A|Withdrawal by Subject|1|||
48463991|NCT00423267|155887202|FG000|Period A|Non-compliance with protocol|1|||
48463992|NCT00423267|155887203|FG001|Period A|Non-compliance with protocol|0|||
48463993|NCT00423267|155887202|FG000|Period A|Administrative|1|||
48463994|NCT00423267|155887203|FG001|Period A|Administrative|0|||
48463995|NCT01038635|155887204|FG000|Overall Study|Disease Progression|2|||
48463996|NCT01038635|155887205|FG001|Overall Study|Disease Progression|0|||
48463997|NCT01038635|155887206|FG002|Overall Study|Disease Progression|0|||
48463998|NCT01038635|155887207|FG003|Overall Study|Disease Progression|0|||
48463999|NCT01038635|155887208|FG004|Overall Study|Disease Progression|0|||
48464000|NCT01038635|155887209|FG005|Overall Study|Disease Progression|0|||
48464001|NCT01038635|155887210|FG006|Overall Study|Disease Progression|1|||
48464002|NCT01038635|155887211|FG007|Overall Study|Disease Progression|4|||
48464003|NCT01038635|155887212|FG008|Overall Study|Disease Progression|0|||
48464004|NCT01038635|155887204|FG000|Overall Study|Death|0|||
48464005|NCT01038635|155887205|FG001|Overall Study|Death|0|||
48464006|NCT01038635|155887206|FG002|Overall Study|Death|0|||
48464007|NCT01038635|155887207|FG003|Overall Study|Death|0|||
48464008|NCT01038635|155887208|FG004|Overall Study|Death|1|||
48464009|NCT01038635|155887209|FG005|Overall Study|Death|0|||
48464010|NCT01038635|155887210|FG006|Overall Study|Death|1|||
48464011|NCT01038635|155887211|FG007|Overall Study|Death|1|||
48464012|NCT01038635|155887212|FG008|Overall Study|Death|2|||
48464013|NCT03702166|155887213|FG000|Overall Study|Lost to Follow-up|1|||
48464014|NCT03702166|155887213|FG000|Overall Study|Withdrawal by Subject|1|||
48464015|NCT01333865|155887214|FG000|Overall Study|Adverse Event|2|||
48464016|NCT00106626|155887215|FG000|Overall Study|Adverse Event|5|||
48464017|NCT00106626|155887216|FG001|Overall Study|Adverse Event|4|||
48464018|NCT00106626|155887217|FG002|Overall Study|Adverse Event|3|||
48464019|NCT00106626|155887218|FG003|Overall Study|Adverse Event|3|||
48464020|NCT00106626|155887215|FG000|Overall Study|Progressive Disease|4|||
48464021|NCT00106626|155887216|FG001|Overall Study|Progressive Disease|1|||
48464022|NCT00106626|155887217|FG002|Overall Study|Progressive Disease|9|||
48464023|NCT00106626|155887218|FG003|Overall Study|Progressive Disease|10|||
48464024|NCT00106626|155887215|FG000|Overall Study|Received radiation on new therapy|1|||
48464025|NCT00106626|155887216|FG001|Overall Study|Received radiation on new therapy|0|||
48464026|NCT00106626|155887217|FG002|Overall Study|Received radiation on new therapy|0|||
48464027|NCT00106626|155887218|FG003|Overall Study|Received radiation on new therapy|0|||
48464028|NCT00106626|155887215|FG000|Overall Study|> 14 day delay in therapy start|0|||
48464029|NCT00106626|155887216|FG001|Overall Study|> 14 day delay in therapy start|1|||
48464030|NCT00106626|155887217|FG002|Overall Study|> 14 day delay in therapy start|0|||
48464031|NCT00106626|155887218|FG003|Overall Study|> 14 day delay in therapy start|0|||
48464032|NCT00684073|155887219|FG000|Selection|Selection/non-selection criteria|3|||
48464033|NCT00684073|155887219|FG000|Selection|Death|1|||
48464034|NCT00684073|155887219|FG000|Selection|noncompliance|1|||
48464035|NCT00684073|155887219|FG000|Selection|Lost to Follow-up|1|||
48464036|NCT00684073|155887219|FG000|Selection|request of the sponsor|1|||
48464037|NCT00684073|155887219|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
48464038|NCT01657903|155887223|FG000|Overall Study|Lost to Follow-up|1|||
48464039|NCT01657903|155887223|FG000|Overall Study|Withdrawal by Subject|1|||
48464040|NCT01259388|155887224|FG000|Overall Study|Adverse Event|3|||
48464041|NCT01259388|155887225|FG001|Overall Study|Adverse Event|0|||
48464042|NCT01259388|155887224|FG000|Overall Study|Withdrawal by Subject|1|||
48464043|NCT01259388|155887225|FG001|Overall Study|Withdrawal by Subject|1|||
48464044|NCT01259388|155887224|FG000|Overall Study|Physician Decision|1|||
48464045|NCT01259388|155887225|FG001|Overall Study|Physician Decision|0|||
48464046|NCT03512028|155887228|FG000|Overall Study|Withdrawal by Subject|2|||
48464047|NCT03512028|155887229|FG001|Overall Study|Withdrawal by Subject|0|||
48464048|NCT03512028|155887228|FG000|Overall Study|Protocol Violation|2|||
48464049|NCT03512028|155887229|FG001|Overall Study|Protocol Violation|0|||
48464050|NCT02743494|155887230|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
48464051|NCT02743494|155887231|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
48464052|NCT02743494|155887230|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
48464053|NCT02743494|155887231|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
48464054|NCT02743494|155887230|FG000|Treatment Period|Completed treatment|229|||
48464055|NCT02743494|155887231|FG001|Treatment Period|Completed treatment|99|||
48464056|NCT02743494|155887230|FG000|Treatment Period|Disease recurrence|149|||
48464057|NCT02743494|155887231|FG001|Treatment Period|Disease recurrence|113|||
48464058|NCT02743494|155887230|FG000|Treatment Period|Study drug toxicity|57|||
48464059|NCT02743494|155887231|FG001|Treatment Period|Study drug toxicity|8|||
48464060|NCT02743494|155887230|FG000|Treatment Period|Death|1|||
48464061|NCT02743494|155887231|FG001|Treatment Period|Death|0|||
48464062|NCT02743494|155887230|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
48464063|NCT02743494|155887231|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
48464064|NCT02743494|155887230|FG000|Treatment Period|Participant request to discontinue treatment|30|||
48464065|NCT02743494|155887231|FG001|Treatment Period|Participant request to discontinue treatment|5|||
48464066|NCT02743494|155887230|FG000|Treatment Period|Participant withdrew consent|12|||
48464067|NCT02743494|155887231|FG001|Treatment Period|Participant withdrew consent|4|||
48464068|NCT02743494|155887230|FG000|Treatment Period|Lost to Follow-up|0|||
48464069|NCT02743494|155887231|FG001|Treatment Period|Lost to Follow-up|1|||
48464070|NCT02743494|155887230|FG000|Treatment Period|Poor/Non-compliance|1|||
48464071|NCT02743494|155887231|FG001|Treatment Period|Poor/Non-compliance|0|||
48464072|NCT02743494|155887230|FG000|Treatment Period|Other reasons|7|||
48464073|NCT02743494|155887231|FG001|Treatment Period|Other reasons|2|||
48464074|NCT00554840|155887232|FG000|Overall Study|Physician Decision|0|||
48464075|NCT00554840|155887233|FG001|Overall Study|Physician Decision|1|||
48464076|NCT03529162|155887236|FG000|Overall Study|Lost to Follow-up|2|||
48464077|NCT03529162|155887237|FG001|Overall Study|Lost to Follow-up|2|||
48464078|NCT03044730|155887238|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
48464079|NCT03044730|155887238|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
48464080|NCT03044730|155887238|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
48464081|NCT03044730|155887238|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
48464082|NCT03044730|155887238|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
48464083|NCT03044730|155887238|FG000|Cycles 4 and Beyond|Adverse Event|1|||
48464084|NCT03044730|155887238|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
48464085|NCT03044730|155887238|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
48464086|NCT03044730|155887238|FG000|On Follow-up for 2 Years|Death|17|||
48464087|NCT01592773|155889815|FG000|Overall Study|Study Terminated by Sponsor|582|||
48464088|NCT01592773|155889815|FG000|Overall Study|Withdrawal by Subject|35|||
48464089|NCT01592773|155889815|FG000|Overall Study|Lost to Follow-up|19|||
48464090|NCT01592773|155889815|FG000|Overall Study|Adverse Event|17|||
48464091|NCT01592773|155889815|FG000|Overall Study|Lack of Efficacy|9|||
48464092|NCT01592773|155889815|FG000|Overall Study|Protocol Violation|2|||
48464093|NCT01592773|155889815|FG000|Overall Study|Inclusion/exclusion not meet|1|||
48464094|NCT01592773|155889815|FG000|Overall Study|Other Reason|1|||
48464095|NCT01293123|155889818|FG000|Overall Study|Lost to Follow-up|0|||
48464096|NCT01293123|155889819|FG001|Overall Study|Lost to Follow-up|1|||
48464097|NCT00669240|155889823|FG000|Overall Study|Lack of Efficacy|33|||
48464098|NCT00669240|155889823|FG000|Overall Study|Withdrawal by Subject|42|||
48464099|NCT00669240|155889823|FG000|Overall Study|Lost to Follow-up|34|||
48464100|NCT00669240|155889823|FG000|Overall Study|Adverse Event|21|||
48464101|NCT00669240|155889823|FG000|Overall Study|Other|19|||
48464102|NCT00669240|155889823|FG000|Overall Study|Enrolled but not treated|15|||
48464103|NCT00669240|155889823|FG000|Overall Study|Enrolled but no dosing record|1|||
48464104|NCT04397757|155889825|FG000|Overall Study|Death|3|||
48464105|NCT04397757|155889826|FG001|Overall Study|Death|11|||
48464106|NCT04397757|155889825|FG000|Overall Study|Withdrawal by Subject|2|||
48464107|NCT04397757|155889826|FG001|Overall Study|Withdrawal by Subject|0|||
48464108|NCT04397757|155889825|FG000|Overall Study|Lost to Follow-up|4|||
48464109|NCT04397757|155889826|FG001|Overall Study|Lost to Follow-up|3|||
48464110|NCT03384316|155889827|FG000|Overall Study|Screen failure|0|||
48464111|NCT03384316|155889828|FG001|Overall Study|Screen failure|1|||
48464112|NCT04880642|155889833|FG000|Randomization|Withdrawal by Subject|2|||
48464113|NCT04880642|155889834|FG001|Randomization|Withdrawal by Subject|3|||
48464114|NCT04880642|155889833|FG000|Treatment Period|Adverse Event|0|||
48464115|NCT04880642|155889834|FG001|Treatment Period|Adverse Event|1|||
48464116|NCT04880642|155889833|FG000|Treatment Period|Death|6|||
48464117|NCT04880642|155889834|FG001|Treatment Period|Death|6|||
48464118|NCT04880642|155889833|FG000|Treatment Period|Lost to Follow-up|1|||
48464119|NCT04880642|155889834|FG001|Treatment Period|Lost to Follow-up|0|||
48464120|NCT04880642|155889833|FG000|Treatment Period|Protocol Violation|0|||
48464121|NCT04880642|155889834|FG001|Treatment Period|Protocol Violation|1|||
48464122|NCT04880642|155889833|FG000|Treatment Period|Withdrawal by Subject|5|||
48464123|NCT04880642|155889834|FG001|Treatment Period|Withdrawal by Subject|3|||
48464124|NCT04880642|155889833|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
48464125|NCT04880642|155889834|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
48464126|NCT04880642|155889833|FG000|Follow-up|Death|4|||
48464127|NCT04880642|155889834|FG001|Follow-up|Death|3|||
48464128|NCT04880642|155889833|FG000|Follow-up|Withdrawal by Subject|1|||
48464129|NCT04880642|155889834|FG001|Follow-up|Withdrawal by Subject|0|||
48464130|NCT00141297|155889835|FG000|Overall Study|Adverse Event|0|||
48464131|NCT00141297|155889836|FG001|Overall Study|Adverse Event|0|||
48464132|NCT00141297|155889837|FG002|Overall Study|Adverse Event|1|||
48464133|NCT00141297|155889838|FG003|Overall Study|Adverse Event|0|||
48464134|NCT00141297|155889839|FG004|Overall Study|Adverse Event|1|||
48464135|NCT00141297|155889840|FG005|Overall Study|Adverse Event|1|||
48464136|NCT00141297|155889841|FG006|Overall Study|Adverse Event|0|||
48464137|NCT00141297|155889842|FG007|Overall Study|Adverse Event|1|||
48464138|NCT00141297|155889843|FG008|Overall Study|Adverse Event|1|||
48464139|NCT00141297|155889844|FG009|Overall Study|Adverse Event|0|||
48464140|NCT00141297|155889835|FG000|Overall Study|Death|1|||
48464141|NCT00141297|155889836|FG001|Overall Study|Death|0|||
48464142|NCT00141297|155889837|FG002|Overall Study|Death|0|||
48464143|NCT00141297|155889838|FG003|Overall Study|Death|0|||
48464144|NCT00141297|155889839|FG004|Overall Study|Death|0|||
48464145|NCT00141297|155889840|FG005|Overall Study|Death|0|||
48464146|NCT00141297|155889841|FG006|Overall Study|Death|0|||
48464147|NCT00141297|155889842|FG007|Overall Study|Death|0|||
48464148|NCT00141297|155889843|FG008|Overall Study|Death|1|||
48464149|NCT00141297|155889844|FG009|Overall Study|Death|0|||
48464150|NCT00141297|155889835|FG000|Overall Study|Withdrawal by Subject|0|||
48464151|NCT00141297|155889836|FG001|Overall Study|Withdrawal by Subject|0|||
48464152|NCT00141297|155889837|FG002|Overall Study|Withdrawal by Subject|0|||
48464153|NCT00141297|155889838|FG003|Overall Study|Withdrawal by Subject|0|||
48464154|NCT00141297|155889839|FG004|Overall Study|Withdrawal by Subject|0|||
48464155|NCT00141297|155889840|FG005|Overall Study|Withdrawal by Subject|0|||
48464156|NCT00141297|155889841|FG006|Overall Study|Withdrawal by Subject|0|||
48464157|NCT00141297|155889842|FG007|Overall Study|Withdrawal by Subject|0|||
48464158|NCT00141297|155889843|FG008|Overall Study|Withdrawal by Subject|1|||
48464159|NCT00141297|155889844|FG009|Overall Study|Withdrawal by Subject|0|||
48464160|NCT00141297|155889835|FG000|Overall Study|Other|0|||
48464161|NCT00141297|155889836|FG001|Overall Study|Other|0|||
48464162|NCT00141297|155889837|FG002|Overall Study|Other|0|||
48464163|NCT00141297|155889838|FG003|Overall Study|Other|1|||
48464164|NCT00141297|155889839|FG004|Overall Study|Other|5|||
48464165|NCT00141297|155889840|FG005|Overall Study|Other|0|||
48464166|NCT00141297|155889841|FG006|Overall Study|Other|0|||
48464167|NCT00141297|155889842|FG007|Overall Study|Other|0|||
48464168|NCT00141297|155889843|FG008|Overall Study|Other|2|||
48464169|NCT00141297|155889844|FG009|Overall Study|Other|0|||
48464170|NCT00141297|155889835|FG000|Overall Study|Progressive Disease|2|||
48464171|NCT00141297|155889836|FG001|Overall Study|Progressive Disease|3|||
48464172|NCT00141297|155889837|FG002|Overall Study|Progressive Disease|6|||
48464173|NCT00141297|155889838|FG003|Overall Study|Progressive Disease|2|||
48464174|NCT00141297|155889839|FG004|Overall Study|Progressive Disease|15|||
48464175|NCT00141297|155889840|FG005|Overall Study|Progressive Disease|2|||
48464176|NCT00141297|155889841|FG006|Overall Study|Progressive Disease|3|||
48464177|NCT00141297|155889842|FG007|Overall Study|Progressive Disease|3|||
48464178|NCT00141297|155889843|FG008|Overall Study|Progressive Disease|15|||
48464179|NCT00141297|155889844|FG009|Overall Study|Progressive Disease|6|||
48464180|NCT00141297|155889835|FG000|Overall Study|Transitioned|0|||
48464181|NCT00141297|155889836|FG001|Overall Study|Transitioned|0|||
48464182|NCT00141297|155889837|FG002|Overall Study|Transitioned|0|||
48464183|NCT00141297|155889838|FG003|Overall Study|Transitioned|0|||
48464184|NCT00141297|155889839|FG004|Overall Study|Transitioned|1|||
48464185|NCT00141297|155889840|FG005|Overall Study|Transitioned|0|||
48464186|NCT00141297|155889841|FG006|Overall Study|Transitioned|0|||
48464187|NCT00141297|155889842|FG007|Overall Study|Transitioned|0|||
48464188|NCT00141297|155889843|FG008|Overall Study|Transitioned|0|||
48464189|NCT00141297|155889844|FG009|Overall Study|Transitioned|0|||
48464190|NCT01474993|155889845|FG000|Overall Study|Lost to Follow-up|1|||
48464191|NCT01474993|155889846|FG001|Overall Study|Lost to Follow-up|2|||
48464192|NCT01474993|155889845|FG000|Overall Study|Adverse Event|0|||
48464193|NCT01474993|155889846|FG001|Overall Study|Adverse Event|1|||
48464194|NCT02275052|155889847|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48464195|NCT02275052|155889848|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
48464196|NCT02275052|155889849|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48464197|NCT02275052|155889850|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
48464198|NCT02275052|155889847|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
48464199|NCT02275052|155889848|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
48464200|NCT02275052|155889849|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
48464201|NCT02275052|155889850|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
48464202|NCT02275052|155889847|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
48464203|NCT02275052|155889848|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
48464204|NCT02275052|155889849|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48464205|NCT02275052|155889850|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
48464206|NCT02275052|155889847|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
48464207|NCT02275052|155889848|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
48464208|NCT02275052|155889849|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
48464209|NCT02275052|155889850|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
48464210|NCT02275052|155889847|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
48464211|NCT02275052|155889848|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
48464212|NCT02275052|155889849|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
48464213|NCT02275052|155889850|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
48464214|NCT02275052|155889847|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
48464215|NCT02275052|155889848|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
48464216|NCT02275052|155889849|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
48464217|NCT02275052|155889850|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
48464218|NCT02275052|155889847|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
48464219|NCT02275052|155889848|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
48464220|NCT02275052|155889849|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
48464221|NCT02275052|155889850|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
48464222|NCT02275052|155889847|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48464223|NCT02275052|155889848|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
48464224|NCT02275052|155889849|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
48464225|NCT02275052|155889850|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
48464226|NCT02275052|155889847|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48464227|NCT02275052|155889848|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
48464228|NCT02275052|155889849|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
48464229|NCT02275052|155889850|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
48464230|NCT02275052|155889847|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
48464231|NCT02275052|155889848|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
48464232|NCT02275052|155889849|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
48464233|NCT02275052|155889850|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
48464234|NCT02275052|155889847|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48464235|NCT02275052|155889848|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48464236|NCT02275052|155889849|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
48464237|NCT02275052|155889850|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
48464238|NCT03055806|155889853|FG000|Overall Study|Adverse Event|0|||
48464239|NCT03055806|155889854|FG001|Overall Study|Adverse Event|0|||
48464240|NCT03055806|155889855|FG002|Overall Study|Adverse Event|1|||
48464241|NCT03055806|155889856|FG003|Overall Study|Adverse Event|1|||
48464242|NCT03055806|155889853|FG000|Overall Study|Lost to Follow-up|0|||
48464243|NCT03055806|155889854|FG001|Overall Study|Lost to Follow-up|3|||
48464244|NCT03055806|155889855|FG002|Overall Study|Lost to Follow-up|6|||
48464245|NCT03055806|155889856|FG003|Overall Study|Lost to Follow-up|7|||
48464246|NCT03055806|155889853|FG000|Overall Study|Physician Decision|1|||
48464247|NCT03055806|155889854|FG001|Overall Study|Physician Decision|0|||
48464248|NCT03055806|155889855|FG002|Overall Study|Physician Decision|0|||
48464249|NCT03055806|155889856|FG003|Overall Study|Physician Decision|1|||
48464250|NCT03055806|155889853|FG000|Overall Study|Protocol Violation|1|||
48464251|NCT03055806|155889854|FG001|Overall Study|Protocol Violation|0|||
48464252|NCT03055806|155889855|FG002|Overall Study|Protocol Violation|0|||
48464253|NCT03055806|155889856|FG003|Overall Study|Protocol Violation|0|||
48464254|NCT03055806|155889853|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
48464255|NCT03055806|155889854|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
48464256|NCT03055806|155889855|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
48464257|NCT03055806|155889856|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
48464258|NCT03055806|155889853|FG000|Overall Study|Withdrawal of consent to continue study|2|||
48464259|NCT03055806|155889854|FG001|Overall Study|Withdrawal of consent to continue study|3|||
48464260|NCT03055806|155889855|FG002|Overall Study|Withdrawal of consent to continue study|4|||
48464261|NCT03055806|155889856|FG003|Overall Study|Withdrawal of consent to continue study|6|||
48464262|NCT03055806|155889853|FG000|Overall Study|Partner not willing to try intercourse|1|||
48464263|NCT03055806|155889854|FG001|Overall Study|Partner not willing to try intercourse|0|||
48464264|NCT03055806|155889855|FG002|Overall Study|Partner not willing to try intercourse|0|||
48464265|NCT03055806|155889856|FG003|Overall Study|Partner not willing to try intercourse|0|||
48464266|NCT00125138|155889857|FG000|Overall Study|Adverse Event|1|||
48464267|NCT00125138|155889858|FG001|Overall Study|Adverse Event|0|||
48464268|NCT00125138|155889859|FG002|Overall Study|Adverse Event|3|||
48464269|NCT00125138|155889860|FG003|Overall Study|Adverse Event|2|||
48464270|NCT00125138|155889857|FG000|Overall Study|Withdrawal by Subject|2|||
48464271|NCT00125138|155889858|FG001|Overall Study|Withdrawal by Subject|3|||
48464272|NCT00125138|155889859|FG002|Overall Study|Withdrawal by Subject|1|||
48464273|NCT00125138|155889860|FG003|Overall Study|Withdrawal by Subject|1|||
48464274|NCT00125138|155889857|FG000|Overall Study|Lack of Efficacy|0|||
48464275|NCT00125138|155889858|FG001|Overall Study|Lack of Efficacy|0|||
48464276|NCT00125138|155889859|FG002|Overall Study|Lack of Efficacy|0|||
48464277|NCT00125138|155889860|FG003|Overall Study|Lack of Efficacy|1|||
48464278|NCT00125138|155889857|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
48464279|NCT00125138|155889858|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
48464280|NCT00125138|155889859|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
48464281|NCT00125138|155889860|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
48464282|NCT02630459|155889861|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48464283|NCT02630459|155889862|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
48464284|NCT02630459|155889863|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48464285|NCT02630459|155889864|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
48464286|NCT02630459|155889865|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48464287|NCT02630459|155889866|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48464288|NCT02630459|155889867|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48464289|NCT02630459|155889868|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
48464290|NCT02630459|155889861|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48464291|NCT02630459|155889862|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48464292|NCT02630459|155889863|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
48464293|NCT02630459|155889864|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48464294|NCT02630459|155889865|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48464295|NCT02630459|155889866|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48464296|NCT02630459|155889867|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48464297|NCT02630459|155889868|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
48464298|NCT02630459|155889861|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
48464299|NCT02630459|155889862|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
48464300|NCT02630459|155889863|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
48464301|NCT02630459|155889864|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
48464302|NCT02630459|155889865|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
48464303|NCT02630459|155889866|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
48464304|NCT02630459|155889867|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
48464305|NCT02630459|155889868|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
48464306|NCT02630459|155889861|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
48464307|NCT02630459|155889862|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48464308|NCT02630459|155889863|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48464309|NCT02630459|155889864|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48464310|NCT02630459|155889865|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48464311|NCT02630459|155889866|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48464312|NCT02630459|155889867|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48464313|NCT02630459|155889868|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
48464314|NCT02630459|155889861|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48464315|NCT02630459|155889862|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48464316|NCT02630459|155889863|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48464317|NCT02630459|155889864|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48464318|NCT02630459|155889865|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
48464319|NCT02630459|155889866|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
48464320|NCT02630459|155889867|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48464321|NCT02630459|155889868|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
48464322|NCT02630459|155889861|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48464323|NCT02630459|155889862|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48464324|NCT02630459|155889863|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48464325|NCT02630459|155889864|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48464326|NCT02630459|155889865|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
48464327|NCT02630459|155889866|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
48464328|NCT02630459|155889867|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48464329|NCT02630459|155889868|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
48464330|NCT02630459|155889861|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48464331|NCT02630459|155889862|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48464332|NCT02630459|155889863|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48464333|NCT02630459|155889864|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48464334|NCT02630459|155889865|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
48464335|NCT02630459|155889866|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48464336|NCT02630459|155889867|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48464337|NCT02630459|155889868|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
48464338|NCT01218477|155889871|FG000|Overall Study|Disease progression|2|||
48464339|NCT01218477|155889872|FG001|Overall Study|Disease progression|3|||
48464340|NCT01218477|155889873|FG002|Overall Study|Disease progression|6|||
48464341|NCT01218477|155889874|FG003|Overall Study|Disease progression|2|||
48464342|NCT01218477|155889871|FG000|Overall Study|Study drug toxicity|0|||
48464343|NCT01218477|155889872|FG001|Overall Study|Study drug toxicity|2|||
48464344|NCT01218477|155889873|FG002|Overall Study|Study drug toxicity|5|||
48464345|NCT01218477|155889874|FG003|Overall Study|Study drug toxicity|0|||
48464346|NCT01218477|155889871|FG000|Overall Study|No longer meets study criteria|1|||
48464347|NCT01218477|155889872|FG001|Overall Study|No longer meets study criteria|0|||
48464348|NCT01218477|155889873|FG002|Overall Study|No longer meets study criteria|0|||
48464349|NCT01218477|155889874|FG003|Overall Study|No longer meets study criteria|0|||
48464350|NCT01218477|155889871|FG000|Overall Study|Withdrawal by Subject|0|||
48464351|NCT01218477|155889872|FG001|Overall Study|Withdrawal by Subject|0|||
48464352|NCT01218477|155889873|FG002|Overall Study|Withdrawal by Subject|1|||
48464353|NCT01218477|155889874|FG003|Overall Study|Withdrawal by Subject|0|||
48464354|NCT01218477|155889871|FG000|Overall Study|Prepared for cell transplantation|0|||
48464355|NCT01218477|155889872|FG001|Overall Study|Prepared for cell transplantation|1|||
48464356|NCT01218477|155889873|FG002|Overall Study|Prepared for cell transplantation|1|||
48464357|NCT01218477|155889874|FG003|Overall Study|Prepared for cell transplantation|0|||
48464358|NCT01218477|155889871|FG000|Overall Study|Administrative reason by sponsor|0|||
48464359|NCT01218477|155889872|FG001|Overall Study|Administrative reason by sponsor|0|||
48464360|NCT01218477|155889873|FG002|Overall Study|Administrative reason by sponsor|1|||
48464361|NCT01218477|155889874|FG003|Overall Study|Administrative reason by sponsor|0|||
48464362|NCT01218477|155889871|FG000|Overall Study|Maximum clinical benefit|0|||
48464363|NCT01218477|155889872|FG001|Overall Study|Maximum clinical benefit|2|||
48464364|NCT01218477|155889873|FG002|Overall Study|Maximum clinical benefit|0|||
48464365|NCT01218477|155889874|FG003|Overall Study|Maximum clinical benefit|0|||
48464366|NCT02135848|155889875|FG000|Overall Study|Adverse Event|2|||
48464367|NCT02135848|155889876|FG001|Overall Study|Adverse Event|0|||
48464368|NCT02135848|155889875|FG000|Overall Study|Withdrawal by Subject|1|||
48464369|NCT02135848|155889876|FG001|Overall Study|Withdrawal by Subject|1|||
48464370|NCT00787527|155889880|FG000|Overall Study|Toxicity|3|||
48464371|NCT02381795|155889881|FG000|Overall Study|Withdrawal by Subject|1|||
48464372|NCT02381795|155889881|FG000|Overall Study|Study Terminated|2|||
48464373|NCT00083616|155889882|FG000|Overall Study|Disease Progression|16|||
48464374|NCT00083616|155889882|FG000|Overall Study|Lost to Follow-up|1|||
48464375|NCT00083616|155889882|FG000|Overall Study|Physician Decision|2|||
48464376|NCT00083616|155889882|FG000|Overall Study|Withdrawal by Subject|3|||
48464377|NCT00083616|155889882|FG000|Overall Study|Ineligibility determined|2|||
48464378|NCT00083616|155889882|FG000|Overall Study|Non-compliance|1|||
48464379|NCT00083616|155889882|FG000|Overall Study|Other|6|||
48464380|NCT01488994|155889883|FG000|Overall Study|Withdrawal by Subject|0|||
48464381|NCT01488994|155889884|FG001|Overall Study|Withdrawal by Subject|1|||
48464382|NCT00829010|155889885|FG000|Overall Study|Adverse Event|1|||
48464383|NCT00829010|155889886|FG001|Overall Study|Adverse Event|0|||
48464384|NCT00829010|155889887|FG002|Overall Study|Adverse Event|0|||
48464385|NCT00829010|155889888|FG003|Overall Study|Adverse Event|0|||
48464386|NCT00829010|155889889|FG004|Overall Study|Adverse Event|0|||
48464387|NCT00829010|155889885|FG000|Overall Study|Withdrawal by Subject|0|||
48464388|NCT00829010|155889886|FG001|Overall Study|Withdrawal by Subject|1|||
48464389|NCT00829010|155889887|FG002|Overall Study|Withdrawal by Subject|1|||
48464390|NCT00829010|155889888|FG003|Overall Study|Withdrawal by Subject|0|||
48464391|NCT00829010|155889889|FG004|Overall Study|Withdrawal by Subject|2|||
48464392|NCT00829010|155889885|FG000|Overall Study|Lost to Follow-up|1|||
48464393|NCT00829010|155889886|FG001|Overall Study|Lost to Follow-up|0|||
48464394|NCT00829010|155889887|FG002|Overall Study|Lost to Follow-up|2|||
48464395|NCT00829010|155889888|FG003|Overall Study|Lost to Follow-up|0|||
48464396|NCT00829010|155889889|FG004|Overall Study|Lost to Follow-up|0|||
48464397|NCT00829010|155889885|FG000|Overall Study|Fatality|5|||
48464398|NCT00829010|155889886|FG001|Overall Study|Fatality|4|||
48464399|NCT00829010|155889887|FG002|Overall Study|Fatality|0|||
48464400|NCT00829010|155889888|FG003|Overall Study|Fatality|3|||
48464401|NCT00829010|155889889|FG004|Overall Study|Fatality|0|||
48464402|NCT00829010|155889885|FG000|Overall Study|Migrated/Moved from study area|3|||
48464403|NCT00829010|155889886|FG001|Overall Study|Migrated/Moved from study area|4|||
48464404|NCT00829010|155889887|FG002|Overall Study|Migrated/Moved from study area|0|||
48464405|NCT00829010|155889888|FG003|Overall Study|Migrated/Moved from study area|5|||
48464406|NCT00829010|155889889|FG004|Overall Study|Migrated/Moved from study area|0|||
48464407|NCT01611558|155889890|FG000|Induction Phase|Study drug toxicity|15|||
48464408|NCT01611558|155889890|FG000|Induction Phase|Disease progression|18|||
48464409|NCT01611558|155889890|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
48464410|NCT01611558|155889890|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
48464411|NCT01611558|155889890|FG000|Induction Phase|Death|1|||
48464412|NCT01611558|155889890|FG000|Maintenance Phase|Withdrawal by Subject|1|||
48464413|NCT01611558|155889890|FG000|Maintenance Phase|Elevated Uric acid|1|||
48464414|NCT03798366|155889900|FG000|Overall Study|Lost to Follow-up|0|||
48464415|NCT03798366|155889901|FG001|Overall Study|Lost to Follow-up|1|||
48464416|NCT01562327|155889904|FG000|Overall Study|Adverse Event|2|||
48464417|NCT01562327|155889904|FG000|Overall Study|Lack of Efficacy|1|||
48464418|NCT01562327|155889904|FG000|Overall Study|Participant drop-out|1|||
48464419|NCT01562327|155889904|FG000|Overall Study|Infusion not received at 6 month window|4|||
48464420|NCT02117024|155889905|FG000|Overall Study|Progressive Disease|26|||
48464421|NCT02117024|155889906|FG001|Overall Study|Progressive Disease|9|||
48464422|NCT02117024|155889905|FG000|Overall Study|Significant Clinical Progression|7|||
48464423|NCT02117024|155889906|FG001|Overall Study|Significant Clinical Progression|4|||
48464424|NCT02117024|155889905|FG000|Overall Study|Death|5|||
48464425|NCT02117024|155889906|FG001|Overall Study|Death|0|||
48464426|NCT02117024|155889905|FG000|Overall Study|Withdrawal by Subject|3|||
48464427|NCT02117024|155889906|FG001|Overall Study|Withdrawal by Subject|1|||
48464428|NCT02117024|155889905|FG000|Overall Study|Protocol Violation|1|||
48464429|NCT02117024|155889906|FG001|Overall Study|Protocol Violation|0|||
48464430|NCT02117024|155889905|FG000|Overall Study|Adverse Event|1|||
48464431|NCT02117024|155889906|FG001|Overall Study|Adverse Event|2|||
48464432|NCT02117024|155889905|FG000|Overall Study|Randomized in Error|1|||
48464433|NCT02117024|155889906|FG001|Overall Study|Randomized in Error|0|||
48464434|NCT02117024|155889905|FG000|Overall Study|Patient returned to primary oncologist|0|||
48464435|NCT02117024|155889906|FG001|Overall Study|Patient returned to primary oncologist|1|||
48464436|NCT02117024|155889905|FG000|Overall Study|Patient took treatment break|0|||
48464437|NCT02117024|155889906|FG001|Overall Study|Patient took treatment break|1|||
48464438|NCT02117024|155889905|FG000|Overall Study|Physician Decision|0|||
48464439|NCT02117024|155889906|FG001|Overall Study|Physician Decision|2|||
48464440|NCT02500706|155889909|FG000|Overall Study|Adverse Event|0|||
48464441|NCT02500706|155889910|FG001|Overall Study|Adverse Event|0|||
48464442|NCT02500706|155889911|FG002|Overall Study|Adverse Event|1|||
48464443|NCT02500706|155889909|FG000|Overall Study|Lost to Follow-up|0|||
48464444|NCT02500706|155889910|FG001|Overall Study|Lost to Follow-up|1|||
48464445|NCT02500706|155889911|FG002|Overall Study|Lost to Follow-up|1|||
48464446|NCT02500706|155889909|FG000|Overall Study|Withdrawal by Subject|4|||
48464447|NCT02500706|155889910|FG001|Overall Study|Withdrawal by Subject|6|||
48464448|NCT02500706|155889911|FG002|Overall Study|Withdrawal by Subject|4|||
48464449|NCT02500706|155889909|FG000|Overall Study|Unclassified|0|||
48464450|NCT02500706|155889910|FG001|Overall Study|Unclassified|0|||
48464451|NCT02500706|155889911|FG002|Overall Study|Unclassified|1|||
48464452|NCT01683058|155889922|FG000|Overall Study|Lost to Follow-up|9|||
48464453|NCT01683058|155889922|FG000|Overall Study|Adverse Event|6|||
48464454|NCT01683058|155889922|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
48464455|NCT01683058|155889922|FG000|Overall Study|Withdrawal by Subject|7|||
48464456|NCT01683058|155889922|FG000|Overall Study|Lack of Efficacy|2|||
48464457|NCT02260791|155889923|FG000|Overall Study|Lost to Follow-up|4|||
48464458|NCT02260791|155889924|FG001|Overall Study|Lost to Follow-up|4|||
48464459|NCT02260791|155889923|FG000|Overall Study|Lack of Efficacy|2|||
48464460|NCT02260791|155889924|FG001|Overall Study|Lack of Efficacy|1|||
48464461|NCT02260791|155889923|FG000|Overall Study|Adverse Event|13|||
48464462|NCT02260791|155889924|FG001|Overall Study|Adverse Event|9|||
48464463|NCT02260791|155889923|FG000|Overall Study|Death|1|||
48464464|NCT02260791|155889924|FG001|Overall Study|Death|0|||
48464465|NCT02260791|155889923|FG000|Overall Study|Withdrawal by Subject|11|||
48464466|NCT02260791|155889924|FG001|Overall Study|Withdrawal by Subject|16|||
48464467|NCT02260791|155889923|FG000|Overall Study|Screen failure|0|||
48464468|NCT02260791|155889924|FG001|Overall Study|Screen failure|1|||
48464469|NCT02260791|155889923|FG000|Overall Study|Protocol deviation|2|||
48464470|NCT02260791|155889924|FG001|Overall Study|Protocol deviation|3|||
48464471|NCT02405091|155889927|FG000|Overall Study|Adverse Event|16|||
48464472|NCT02405091|155889928|FG001|Overall Study|Adverse Event|10|||
48464473|NCT02405091|155889929|FG002|Overall Study|Adverse Event|0|||
48464474|NCT02405091|155889927|FG000|Overall Study|Protocol Violation|1|||
48464475|NCT02405091|155889928|FG001|Overall Study|Protocol Violation|0|||
48464476|NCT02405091|155889929|FG002|Overall Study|Protocol Violation|0|||
48464477|NCT02405091|155889927|FG000|Overall Study|Noncompliance|1|||
48464478|NCT02405091|155889928|FG001|Overall Study|Noncompliance|6|||
48464479|NCT02405091|155889929|FG002|Overall Study|Noncompliance|2|||
48464480|NCT02405091|155889927|FG000|Overall Study|Withdrawal by Subject|4|||
48464481|NCT02405091|155889928|FG001|Overall Study|Withdrawal by Subject|8|||
48464482|NCT02405091|155889929|FG002|Overall Study|Withdrawal by Subject|0|||
48464483|NCT02405091|155889927|FG000|Overall Study|Death|0|||
48464484|NCT02405091|155889928|FG001|Overall Study|Death|1|||
48464485|NCT02405091|155889929|FG002|Overall Study|Death|0|||
48464486|NCT02405091|155889927|FG000|Overall Study|Lost to Follow-up|5|||
48464487|NCT02405091|155889928|FG001|Overall Study|Lost to Follow-up|6|||
48464488|NCT02405091|155889929|FG002|Overall Study|Lost to Follow-up|0|||
48464489|NCT02405091|155889927|FG000|Overall Study|Physician Decision|2|||
48464490|NCT02405091|155889928|FG001|Overall Study|Physician Decision|2|||
48464491|NCT02405091|155889929|FG002|Overall Study|Physician Decision|0|||
48464492|NCT03490734|155889932|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
48464493|NCT03490734|155889933|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
48464494|NCT03490734|155889934|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
48464495|NCT03490734|155889935|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
48464496|NCT03490734|155889932|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
48464497|NCT03490734|155889933|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
48464498|NCT03490734|155889934|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
48464499|NCT03490734|155889935|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
48464500|NCT03490734|155889932|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
48464501|NCT03490734|155889933|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
48464502|NCT03490734|155889934|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
48464503|NCT03490734|155889935|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
48464504|NCT03490734|155889932|FG000|Post-intervention Scan Visit|Adverse Event|2|||
48464505|NCT03490734|155889933|FG001|Post-intervention Scan Visit|Adverse Event|0|||
48464506|NCT03490734|155889934|FG002|Post-intervention Scan Visit|Adverse Event|0|||
48464507|NCT03490734|155889935|FG003|Post-intervention Scan Visit|Adverse Event|0|||
48464508|NCT03490734|155889932|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
48464509|NCT03490734|155889933|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
48464510|NCT03490734|155889934|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
48464511|NCT03490734|155889935|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
48464512|NCT03490734|155889932|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
48464513|NCT03490734|155889933|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
48464514|NCT03490734|155889934|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
48464515|NCT03490734|155889935|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
48464516|NCT00087685|155889945|FG000|Overall Study|Adverse Event|5|||
48464517|NCT00087685|155889945|FG000|Overall Study|Non-Compliance|1|||
48464518|NCT00087685|155889945|FG000|Overall Study|Progressive Disease|5|||
48464519|NCT00087685|155889945|FG000|Overall Study|Withdrawal by Subject|3|||
48464520|NCT00620815|155889946|FG000|Overall Study|Adverse Event|1|||
48464521|NCT00620815|155889947|FG001|Overall Study|Adverse Event|1|||
48464522|NCT00620815|155889948|FG002|Overall Study|Adverse Event|2|||
48464523|NCT00620815|155889946|FG000|Overall Study|Withdrawal by Subject|1|||
48464524|NCT00620815|155889947|FG001|Overall Study|Withdrawal by Subject|2|||
48464525|NCT00620815|155889948|FG002|Overall Study|Withdrawal by Subject|0|||
48464526|NCT00620815|155889946|FG000|Overall Study|Lost to Follow-up|1|||
48464527|NCT00620815|155889947|FG001|Overall Study|Lost to Follow-up|6|||
48464528|NCT00620815|155889948|FG002|Overall Study|Lost to Follow-up|3|||
48464529|NCT00620815|155889946|FG000|Overall Study|Inappropriate enrolment|0|||
48464530|NCT00620815|155889947|FG001|Overall Study|Inappropriate enrolment|0|||
48464531|NCT00620815|155889948|FG002|Overall Study|Inappropriate enrolment|1|||
48464532|NCT00620815|155889946|FG000|Overall Study|Protocol Violation|1|||
48464533|NCT00620815|155889947|FG001|Overall Study|Protocol Violation|2|||
48464534|NCT00620815|155889948|FG002|Overall Study|Protocol Violation|1|||
48464535|NCT00983827|155889950|FG000|Overall Study|Withdrawal by Subject|1|||
48464536|NCT00925522|155889957|FG000|Overall Study|study closed -- business decision|20|||
48464537|NCT01888367|155889961|FG000|Overall Study|Physician Decision|3|||
48464538|NCT01888367|155889962|FG001|Overall Study|Physician Decision|4|||
48464539|NCT01888367|155889963|FG002|Overall Study|Physician Decision|2|||
48464540|NCT01888367|155889961|FG000|Overall Study|Death|2|||
48464541|NCT01888367|155889962|FG001|Overall Study|Death|0|||
48464542|NCT01888367|155889963|FG002|Overall Study|Death|1|||
48464543|NCT01888367|155889961|FG000|Overall Study|Withdrawal by Subject|1|||
48464544|NCT01888367|155889962|FG001|Overall Study|Withdrawal by Subject|0|||
48464545|NCT01888367|155889963|FG002|Overall Study|Withdrawal by Subject|1|||
48464546|NCT01888367|155889961|FG000|Overall Study|Lost to Follow-up|1|||
48464547|NCT01888367|155889962|FG001|Overall Study|Lost to Follow-up|1|||
48464548|NCT01888367|155889963|FG002|Overall Study|Lost to Follow-up|0|||
48464549|NCT01888367|155889961|FG000|Overall Study|Protocol Violation|0|||
48464550|NCT01888367|155889962|FG001|Overall Study|Protocol Violation|0|||
48464551|NCT01888367|155889963|FG002|Overall Study|Protocol Violation|1|||
48464552|NCT01888367|155889961|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
48464553|NCT01888367|155889962|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
48464554|NCT01888367|155889963|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
48464555|NCT02728804|155889964|FG000|Overall Study|Ineligible|3|||
48464556|NCT02728804|155889964|FG000|Overall Study|Did not complete baseline questionnaire|9|||
48464557|NCT02728804|155889964|FG000|Overall Study|Death|99|||
48464558|NCT00591786|155889967|FG000|Overall Study|Withdrawal of Informed Consent|0|||
48464559|NCT00591786|155889968|FG001|Overall Study|Withdrawal of Informed Consent|0|||
48464560|NCT00591786|155889969|FG002|Overall Study|Withdrawal of Informed Consent|1|||
48464561|NCT00591786|155889970|FG003|Overall Study|Withdrawal of Informed Consent|0|||
48464562|NCT00591786|155889971|FG004|Overall Study|Withdrawal of Informed Consent|0|||
48464563|NCT00591786|155889972|FG005|Overall Study|Withdrawal of Informed Consent|0|||
48464564|NCT00591786|155889973|FG006|Overall Study|Withdrawal of Informed Consent|0|||
48464565|NCT00591786|155889974|FG007|Overall Study|Withdrawal of Informed Consent|0|||
48464566|NCT00591786|155889975|FG008|Overall Study|Withdrawal of Informed Consent|0|||
48464567|NCT00591786|155889976|FG009|Overall Study|Withdrawal of Informed Consent|0|||
48464568|NCT00950755|155889977|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
48464569|NCT00950755|155889977|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
48464570|NCT00950755|155889977|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
48464571|NCT00950755|155889977|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
48464572|NCT00950755|155889977|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
48464573|NCT00950755|155889977|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
48464574|NCT00950755|155889977|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
48464575|NCT00950755|155889977|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
48464576|NCT00950755|155889977|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
48464577|NCT00950755|155889977|FG000|Long-Term Follow-Up|Death|8|||
48464578|NCT01854918|155889978|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
48464579|NCT01854918|155889979|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
48464580|NCT01854918|155889978|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
48464581|NCT01854918|155889979|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
48464582|NCT01854918|155889978|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
48464583|NCT01854918|155889979|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
48464584|NCT01854918|155889978|FG000|SOC-controlled Period (Year 1)|Death|5|||
48464585|NCT01854918|155889979|FG001|SOC-controlled Period (Year 1)|Death|5|||
48464586|NCT01854918|155889978|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
48464587|NCT01854918|155889979|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
48464588|NCT01854918|155889978|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
48464589|NCT01854918|155889979|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
48464590|NCT01854918|155889978|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
48464591|NCT01854918|155889979|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
48464592|NCT01854918|155889978|FG000|All-IP Period (Years 2 and 3)|Death|5|||
48464593|NCT01854918|155889979|FG001|All-IP Period (Years 2 and 3)|Death|16|||
48464594|NCT03590613|155889980|FG000|Period 2, 4 Days|Physician Decision|0|||
48464595|NCT03590613|155889981|FG001|Period 2, 4 Days|Physician Decision|0|||
48464596|NCT03590613|155889982|FG002|Period 2, 4 Days|Physician Decision|0|||
48464597|NCT03590613|155889983|FG003|Period 2, 4 Days|Physician Decision|1|||
48464598|NCT00784836|155889984|FG000|Overall Study|Early Study Termination|3|||
48464599|NCT01920061|155889986|FG000|Overall Study|Death|1|||
48464600|NCT01920061|155889987|FG001|Overall Study|Death|1|||
48464601|NCT01920061|155889988|FG002|Overall Study|Death|0|||
48464602|NCT01920061|155889989|FG003|Overall Study|Death|1|||
48464603|NCT01920061|155889990|FG004|Overall Study|Death|1|||
48464604|NCT01920061|155889991|FG005|Overall Study|Death|0|||
48464605|NCT01920061|155889992|FG006|Overall Study|Death|0|||
48464606|NCT01920061|155889993|FG007|Overall Study|Death|1|||
48464607|NCT01920061|155889994|FG008|Overall Study|Death|0|||
48464608|NCT01920061|155889995|FG009|Overall Study|Death|1|||
48464609|NCT01920061|155889996|FG010|Overall Study|Death|0|||
48464610|NCT01920061|155889997|FG011|Overall Study|Death|1|||
48464611|NCT01920061|155889998|FG012|Overall Study|Death|0|||
48464612|NCT01920061|155889999|FG013|Overall Study|Death|2|||
48464613|NCT01920061|155890000|FG014|Overall Study|Death|0|||
48464614|NCT01920061|155890001|FG015|Overall Study|Death|0|||
48464615|NCT01920061|155890002|FG016|Overall Study|Death|0|||
48464616|NCT01920061|155890003|FG017|Overall Study|Death|0|||
48464617|NCT01920061|155890004|FG018|Overall Study|Death|1|||
48464618|NCT01920061|155890005|FG019|Overall Study|Death|0|||
48464619|NCT01920061|155889986|FG000|Overall Study|Lost to Follow-up|0|||
48464620|NCT01920061|155889987|FG001|Overall Study|Lost to Follow-up|2|||
48464621|NCT01920061|155889988|FG002|Overall Study|Lost to Follow-up|0|||
48464622|NCT01920061|155889989|FG003|Overall Study|Lost to Follow-up|0|||
48464623|NCT01920061|155889990|FG004|Overall Study|Lost to Follow-up|0|||
48464624|NCT01920061|155889991|FG005|Overall Study|Lost to Follow-up|0|||
48464625|NCT01920061|155889992|FG006|Overall Study|Lost to Follow-up|1|||
48464626|NCT01920061|155889993|FG007|Overall Study|Lost to Follow-up|0|||
48464627|NCT01920061|155889994|FG008|Overall Study|Lost to Follow-up|0|||
48464628|NCT01920061|155889995|FG009|Overall Study|Lost to Follow-up|0|||
48464629|NCT01920061|155889996|FG010|Overall Study|Lost to Follow-up|3|||
48464630|NCT01920061|155889997|FG011|Overall Study|Lost to Follow-up|0|||
48464631|NCT01920061|155889998|FG012|Overall Study|Lost to Follow-up|0|||
48464632|NCT01920061|155889999|FG013|Overall Study|Lost to Follow-up|0|||
48464633|NCT01920061|155890000|FG014|Overall Study|Lost to Follow-up|0|||
48464634|NCT01920061|155890001|FG015|Overall Study|Lost to Follow-up|0|||
48464635|NCT01920061|155890002|FG016|Overall Study|Lost to Follow-up|0|||
48464636|NCT01920061|155890003|FG017|Overall Study|Lost to Follow-up|1|||
48464637|NCT01920061|155890004|FG018|Overall Study|Lost to Follow-up|4|||
48464638|NCT01920061|155890005|FG019|Overall Study|Lost to Follow-up|3|||
48464639|NCT01920061|155889986|FG000|Overall Study|Other|1|||
48464640|NCT01920061|155889987|FG001|Overall Study|Other|1|||
48464641|NCT01920061|155889988|FG002|Overall Study|Other|2|||
48464642|NCT01920061|155889989|FG003|Overall Study|Other|1|||
48464643|NCT01920061|155889990|FG004|Overall Study|Other|0|||
48464644|NCT01920061|155889991|FG005|Overall Study|Other|1|||
48464645|NCT01920061|155889992|FG006|Overall Study|Other|0|||
48464646|NCT01920061|155889993|FG007|Overall Study|Other|0|||
48464647|NCT01920061|155889994|FG008|Overall Study|Other|0|||
48464648|NCT01920061|155889995|FG009|Overall Study|Other|1|||
48464649|NCT01920061|155889996|FG010|Overall Study|Other|1|||
48464650|NCT01920061|155889997|FG011|Overall Study|Other|2|||
48464651|NCT01920061|155889998|FG012|Overall Study|Other|1|||
48464652|NCT01920061|155889999|FG013|Overall Study|Other|4|||
48464653|NCT01920061|155890000|FG014|Overall Study|Other|0|||
48464654|NCT01920061|155890001|FG015|Overall Study|Other|1|||
48464655|NCT01920061|155890002|FG016|Overall Study|Other|1|||
48464656|NCT01920061|155890003|FG017|Overall Study|Other|0|||
48464657|NCT01920061|155890004|FG018|Overall Study|Other|1|||
48464658|NCT01920061|155890005|FG019|Overall Study|Other|1|||
48464659|NCT01920061|155889986|FG000|Overall Study|Participant refused further follow-up|0|||
48464660|NCT01920061|155889987|FG001|Overall Study|Participant refused further follow-up|0|||
48464661|NCT01920061|155889988|FG002|Overall Study|Participant refused further follow-up|0|||
48464662|NCT01920061|155889989|FG003|Overall Study|Participant refused further follow-up|0|||
48464663|NCT01920061|155889990|FG004|Overall Study|Participant refused further follow-up|1|||
48464664|NCT01920061|155889991|FG005|Overall Study|Participant refused further follow-up|1|||
48464665|NCT01920061|155889992|FG006|Overall Study|Participant refused further follow-up|0|||
48464666|NCT01920061|155889993|FG007|Overall Study|Participant refused further follow-up|0|||
48464667|NCT01920061|155889994|FG008|Overall Study|Participant refused further follow-up|1|||
48464668|NCT01920061|155889995|FG009|Overall Study|Participant refused further follow-up|0|||
48464669|NCT01920061|155889996|FG010|Overall Study|Participant refused further follow-up|1|||
48464670|NCT01920061|155889997|FG011|Overall Study|Participant refused further follow-up|0|||
48464671|NCT01920061|155889998|FG012|Overall Study|Participant refused further follow-up|1|||
48464672|NCT01920061|155889999|FG013|Overall Study|Participant refused further follow-up|0|||
48464673|NCT01920061|155890000|FG014|Overall Study|Participant refused further follow-up|1|||
48464674|NCT01920061|155890001|FG015|Overall Study|Participant refused further follow-up|2|||
48464675|NCT01920061|155890002|FG016|Overall Study|Participant refused further follow-up|1|||
48464676|NCT01920061|155890003|FG017|Overall Study|Participant refused further follow-up|1|||
48464677|NCT01920061|155890004|FG018|Overall Study|Participant refused further follow-up|0|||
48464678|NCT01920061|155890005|FG019|Overall Study|Participant refused further follow-up|0|||
48464679|NCT00364351|155892203|FG000|Overall Study|Adverse Event|90|||
48464680|NCT00364351|155892204|FG001|Overall Study|Adverse Event|44|||
48464681|NCT00364351|155892203|FG000|Overall Study|Condition under investigation worsened|469|||
48464682|NCT00364351|155892204|FG001|Overall Study|Condition under investigation worsened|497|||
48464683|NCT00364351|155892203|FG000|Overall Study|Prohibited concomitant medication|0|||
48464684|NCT00364351|155892204|FG001|Overall Study|Prohibited concomitant medication|2|||
48464685|NCT00364351|155892203|FG000|Overall Study|Lost to Follow-up|1|||
48464686|NCT00364351|155892204|FG001|Overall Study|Lost to Follow-up|1|||
48464687|NCT00364351|155892203|FG000|Overall Study|Withdrawal by Subject|30|||
48464688|NCT00364351|155892204|FG001|Overall Study|Withdrawal by Subject|29|||
48464689|NCT00364351|155892203|FG000|Overall Study|Incorrect enrollment|1|||
48464690|NCT00364351|155892204|FG001|Overall Study|Incorrect enrollment|1|||
48464691|NCT00364351|155892203|FG000|Overall Study|Sponsor decision|1|||
48464692|NCT00364351|155892204|FG001|Overall Study|Sponsor decision|0|||
48464693|NCT00364351|155892203|FG000|Overall Study|Poor treatment compliance|0|||
48464694|NCT00364351|155892204|FG001|Overall Study|Poor treatment compliance|3|||
48464695|NCT00364351|155892203|FG000|Overall Study|Investigator error|0|||
48464696|NCT00364351|155892204|FG001|Overall Study|Investigator error|2|||
48464697|NCT00364351|155892203|FG000|Overall Study|Patient could not travel to site|0|||
48464698|NCT00364351|155892204|FG001|Overall Study|Patient could not travel to site|1|||
48464699|NCT00364351|155892203|FG000|Overall Study|Randomised treatment not started|0|||
48464700|NCT00364351|155892204|FG001|Overall Study|Randomised treatment not started|3|||
48464701|NCT00413231|155892205|FG000|0 to 30-day Post Treatment|Death|5|||
48464702|NCT00413231|155892205|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
48464703|NCT00413231|155892205|FG000|30-day to 365-day Post Treatment|Death|13|||
48464704|NCT00413231|155892205|FG000|365-day to 60-month Post Treatment|Death|36|||
48464705|NCT00413231|155892205|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
48464706|NCT00413231|155892205|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
48464707|NCT00413231|155892205|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
48464708|NCT00087594|155892206|FG000|Overall Study|Adverse Event|2|||
48464709|NCT00087594|155892207|FG001|Overall Study|Adverse Event|3|||
48464710|NCT00087594|155892206|FG000|Overall Study|Lost to Follow-up|0|||
48464711|NCT00087594|155892207|FG001|Overall Study|Lost to Follow-up|2|||
48464712|NCT00087594|155892206|FG000|Overall Study|Withdrawal by Subject|4|||
48464713|NCT00087594|155892207|FG001|Overall Study|Withdrawal by Subject|2|||
48464714|NCT00087594|155892206|FG000|Overall Study|Lack of Efficacy|2|||
48464715|NCT00087594|155892207|FG001|Overall Study|Lack of Efficacy|5|||
48464716|NCT04657003|155892217|FG000|Overall Study|Adverse Event|5|||
48464717|NCT04657003|155892218|FG001|Overall Study|Adverse Event|1|||
48464718|NCT04657003|155892219|FG002|Overall Study|Adverse Event|5|||
48464719|NCT04657003|155892217|FG000|Overall Study|Death|0|||
48464720|NCT04657003|155892218|FG001|Overall Study|Death|2|||
48464721|NCT04657003|155892219|FG002|Overall Study|Death|0|||
48464722|NCT04657003|155892217|FG000|Overall Study|Lost to Follow-up|8|||
48464723|NCT04657003|155892218|FG001|Overall Study|Lost to Follow-up|4|||
48464724|NCT04657003|155892219|FG002|Overall Study|Lost to Follow-up|10|||
48464725|NCT04657003|155892217|FG000|Overall Study|Other - As Reported by Investigator|3|||
48464726|NCT04657003|155892218|FG001|Overall Study|Other - As Reported by Investigator|2|||
48464727|NCT04657003|155892219|FG002|Overall Study|Other - As Reported by Investigator|2|||
48464728|NCT04657003|155892217|FG000|Overall Study|Pregnancy|2|||
48464729|NCT04657003|155892218|FG001|Overall Study|Pregnancy|0|||
48464730|NCT04657003|155892219|FG002|Overall Study|Pregnancy|2|||
48464731|NCT04657003|155892217|FG000|Overall Study|Withdrawal by Subject|16|||
48464732|NCT04657003|155892218|FG001|Overall Study|Withdrawal by Subject|7|||
48464733|NCT04657003|155892219|FG002|Overall Study|Withdrawal by Subject|10|||
48464734|NCT01952041|155892220|FG000|Overall Study|Lost to Follow-up|9|||
48464735|NCT01952041|155892221|FG001|Overall Study|Lost to Follow-up|16|||
48464736|NCT01952041|155892220|FG000|Overall Study|Withdrawal by Subject|7|||
48464737|NCT01952041|155892221|FG001|Overall Study|Withdrawal by Subject|5|||
48464738|NCT01952041|155892220|FG000|Overall Study|Death|1|||
48464739|NCT01952041|155892221|FG001|Overall Study|Death|0|||
48464740|NCT03824704|155892222|FG000|Overall Study|Study Terminated by Sponsor|1|||
48464741|NCT00626327|155892229|FG000|Overall Study|Withdrawal by Subject|21|||
48464742|NCT00626327|155892230|FG001|Overall Study|Withdrawal by Subject|29|||
48464743|NCT00626327|155892231|FG002|Overall Study|Withdrawal by Subject|30|||
48464744|NCT00626327|155892229|FG000|Overall Study|Adverse Event|1|||
48464745|NCT00626327|155892230|FG001|Overall Study|Adverse Event|0|||
48464746|NCT00626327|155892231|FG002|Overall Study|Adverse Event|0|||
48464747|NCT00626327|155892229|FG000|Overall Study|Lost to Follow-up|24|||
48464748|NCT00626327|155892230|FG001|Overall Study|Lost to Follow-up|21|||
48464749|NCT00626327|155892231|FG002|Overall Study|Lost to Follow-up|23|||
48464750|NCT00626327|155892229|FG000|Overall Study|Inappropriate enrollment|4|||
48464751|NCT00626327|155892230|FG001|Overall Study|Inappropriate enrollment|5|||
48464752|NCT00626327|155892231|FG002|Overall Study|Inappropriate enrollment|3|||
48464753|NCT00626327|155892229|FG000|Overall Study|Administrative Reason|2|||
48464754|NCT00626327|155892230|FG001|Overall Study|Administrative Reason|0|||
48464755|NCT00626327|155892231|FG002|Overall Study|Administrative Reason|6|||
48464756|NCT00626327|155892229|FG000|Overall Study|Protocol Violation|26|||
48464757|NCT00626327|155892230|FG001|Overall Study|Protocol Violation|4|||
48464758|NCT00626327|155892231|FG002|Overall Study|Protocol Violation|26|||
48464759|NCT01736176|155892232|FG000|Overall Study|Adverse Event|3|||
48464760|NCT01736176|155892232|FG000|Overall Study|Withdrawal by Subject|4|||
48464761|NCT01736176|155892232|FG000|Overall Study|Lack of Efficacy|3|||
48464762|NCT01736176|155892232|FG000|Overall Study|Unable to Complete PEG Placement|1|||
48464763|NCT00945945|155892233|FG000|Overall Study|Adverse Event|15|||
48464764|NCT00945945|155892234|FG001|Overall Study|Adverse Event|35|||
48464765|NCT00945945|155892233|FG000|Overall Study|Withdrawal by Subject|7|||
48464766|NCT00945945|155892234|FG001|Overall Study|Withdrawal by Subject|10|||
48464767|NCT00945945|155892233|FG000|Overall Study|Lost to Follow-up|4|||
48464768|NCT00945945|155892234|FG001|Overall Study|Lost to Follow-up|5|||
48464769|NCT00945945|155892233|FG000|Overall Study|Lack of Efficacy|6|||
48464770|NCT00945945|155892234|FG001|Overall Study|Lack of Efficacy|2|||
48464771|NCT00945945|155892233|FG000|Overall Study|Protocol Violation|4|||
48464772|NCT00945945|155892234|FG001|Overall Study|Protocol Violation|2|||
48464773|NCT00945945|155892233|FG000|Overall Study|Entry Criteria Not Met|0|||
48464774|NCT00945945|155892234|FG001|Overall Study|Entry Criteria Not Met|1|||
48464775|NCT00535236|155892240|FG000|Overall Study|Adverse Event|1|||
48464776|NCT00535236|155892241|FG001|Overall Study|Adverse Event|0|||
48464777|NCT00535236|155892242|FG002|Overall Study|Adverse Event|9|||
48464778|NCT00535236|155892243|FG003|Overall Study|Adverse Event|3|||
48464779|NCT00535236|155892244|FG004|Overall Study|Adverse Event|3|||
48464780|NCT00535236|155892245|FG005|Overall Study|Adverse Event|0|||
48464781|NCT00535236|155892246|FG006|Overall Study|Adverse Event|5|||
48464782|NCT00535236|155892247|FG007|Overall Study|Adverse Event|1|||
48464783|NCT00535236|155892248|FG008|Overall Study|Adverse Event|2|||
48464784|NCT00535236|155892249|FG009|Overall Study|Adverse Event|1|||
48464785|NCT00535236|155892240|FG000|Overall Study|Lost to Follow-up|1|||
48464786|NCT00535236|155892241|FG001|Overall Study|Lost to Follow-up|2|||
48464787|NCT00535236|155892242|FG002|Overall Study|Lost to Follow-up|0|||
48464788|NCT00535236|155892243|FG003|Overall Study|Lost to Follow-up|0|||
48464789|NCT00535236|155892244|FG004|Overall Study|Lost to Follow-up|2|||
48464790|NCT00535236|155892245|FG005|Overall Study|Lost to Follow-up|0|||
48464791|NCT00535236|155892246|FG006|Overall Study|Lost to Follow-up|0|||
48464792|NCT00535236|155892247|FG007|Overall Study|Lost to Follow-up|0|||
48464793|NCT00535236|155892248|FG008|Overall Study|Lost to Follow-up|6|||
48464794|NCT00535236|155892249|FG009|Overall Study|Lost to Follow-up|1|||
48464795|NCT00535236|155892240|FG000|Overall Study|Physician Decision|0|||
48464796|NCT00535236|155892241|FG001|Overall Study|Physician Decision|0|||
48464797|NCT00535236|155892242|FG002|Overall Study|Physician Decision|0|||
48464798|NCT00535236|155892243|FG003|Overall Study|Physician Decision|0|||
48464799|NCT00535236|155892244|FG004|Overall Study|Physician Decision|1|||
48464800|NCT00535236|155892245|FG005|Overall Study|Physician Decision|0|||
48464801|NCT00535236|155892246|FG006|Overall Study|Physician Decision|1|||
48464802|NCT00535236|155892247|FG007|Overall Study|Physician Decision|0|||
48464803|NCT00535236|155892248|FG008|Overall Study|Physician Decision|0|||
48464804|NCT00535236|155892249|FG009|Overall Study|Physician Decision|0|||
48464805|NCT00535236|155892240|FG000|Overall Study|Protocol Violation|2|||
48464806|NCT00535236|155892241|FG001|Overall Study|Protocol Violation|0|||
48464807|NCT00535236|155892242|FG002|Overall Study|Protocol Violation|1|||
48464808|NCT00535236|155892243|FG003|Overall Study|Protocol Violation|0|||
48464809|NCT00535236|155892244|FG004|Overall Study|Protocol Violation|0|||
48464810|NCT00535236|155892245|FG005|Overall Study|Protocol Violation|0|||
48464811|NCT00535236|155892246|FG006|Overall Study|Protocol Violation|0|||
48464812|NCT00535236|155892247|FG007|Overall Study|Protocol Violation|0|||
48464813|NCT00535236|155892248|FG008|Overall Study|Protocol Violation|1|||
48464814|NCT00535236|155892249|FG009|Overall Study|Protocol Violation|0|||
48464815|NCT00535236|155892240|FG000|Overall Study|Withdrawal by Subject|3|||
48464816|NCT00535236|155892241|FG001|Overall Study|Withdrawal by Subject|0|||
48464817|NCT00535236|155892242|FG002|Overall Study|Withdrawal by Subject|2|||
48464818|NCT00535236|155892243|FG003|Overall Study|Withdrawal by Subject|1|||
48464819|NCT00535236|155892244|FG004|Overall Study|Withdrawal by Subject|6|||
48464820|NCT00535236|155892245|FG005|Overall Study|Withdrawal by Subject|1|||
48464821|NCT00535236|155892246|FG006|Overall Study|Withdrawal by Subject|5|||
48464822|NCT00535236|155892247|FG007|Overall Study|Withdrawal by Subject|0|||
48464823|NCT00535236|155892248|FG008|Overall Study|Withdrawal by Subject|4|||
48464824|NCT00535236|155892249|FG009|Overall Study|Withdrawal by Subject|2|||
48464825|NCT01654224|155892253|FG000|Overall Study|Lost to Follow-up|2|||
48464826|NCT01654224|155892254|FG001|Overall Study|Lost to Follow-up|2|||
48464827|NCT01654224|155892253|FG000|Overall Study|Did not receive allocation|1|||
48464828|NCT01654224|155892254|FG001|Overall Study|Did not receive allocation|8|||
48464829|NCT01654224|155892253|FG000|Overall Study|Insufficient blood sample|3|||
48464830|NCT01654224|155892254|FG001|Overall Study|Insufficient blood sample|2|||
48464831|NCT00104299|155892255|FG000|Overall Study|Adverse Event|3|||
48464832|NCT00104299|155892256|FG001|Overall Study|Adverse Event|1|||
48464833|NCT00104299|155892255|FG000|Overall Study|Death|2|||
48464834|NCT00104299|155892256|FG001|Overall Study|Death|2|||
48464835|NCT00104299|155892255|FG000|Overall Study|Withdrawal by Subject|2|||
48464836|NCT00104299|155892256|FG001|Overall Study|Withdrawal by Subject|6|||
48464837|NCT00104299|155892255|FG000|Overall Study|Physician Decision|1|||
48464838|NCT00104299|155892256|FG001|Overall Study|Physician Decision|1|||
48464839|NCT00104299|155892255|FG000|Overall Study|To have renal transplant|1|||
48464840|NCT00104299|155892256|FG001|Overall Study|To have renal transplant|0|||
48464841|NCT02906644|155892257|FG000|First 2 Weeks|Withdrawal by Subject|0|||
48464842|NCT02906644|155892258|FG001|First 2 Weeks|Withdrawal by Subject|2|||
48464843|NCT02906644|155892257|FG000|First 2 Weeks|Physician Decision|1|||
48464844|NCT02906644|155892258|FG001|First 2 Weeks|Physician Decision|1|||
48464845|NCT02906644|155892257|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
48464846|NCT02906644|155892258|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
48464847|NCT02906644|155892257|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
48464848|NCT02906644|155892258|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
48464849|NCT02452034|155892259|FG000|Overall Study|Adverse Event|0|||
48464850|NCT02452034|155892260|FG001|Overall Study|Adverse Event|0|||
48464851|NCT02452034|155892261|FG002|Overall Study|Adverse Event|0|||
48464852|NCT02452034|155892262|FG003|Overall Study|Adverse Event|0|||
48464853|NCT02452034|155892263|FG004|Overall Study|Adverse Event|0|||
48464854|NCT02452034|155892264|FG005|Overall Study|Adverse Event|1|||
48464855|NCT02452034|155892259|FG000|Overall Study|Death|0|||
48464856|NCT02452034|155892260|FG001|Overall Study|Death|0|||
48464857|NCT02452034|155892261|FG002|Overall Study|Death|0|||
48464858|NCT02452034|155892262|FG003|Overall Study|Death|0|||
48464859|NCT02452034|155892263|FG004|Overall Study|Death|1|||
48464860|NCT02452034|155892264|FG005|Overall Study|Death|1|||
48464861|NCT02452034|155892259|FG000|Overall Study|Physician Decision|0|||
48464862|NCT02452034|155892260|FG001|Overall Study|Physician Decision|1|||
48464863|NCT02452034|155892261|FG002|Overall Study|Physician Decision|1|||
48464864|NCT02452034|155892262|FG003|Overall Study|Physician Decision|0|||
48464865|NCT02452034|155892263|FG004|Overall Study|Physician Decision|0|||
48464866|NCT02452034|155892264|FG005|Overall Study|Physician Decision|0|||
48464867|NCT02452034|155892259|FG000|Overall Study|Protocol Violation|0|||
48464868|NCT02452034|155892260|FG001|Overall Study|Protocol Violation|0|||
48464869|NCT02452034|155892261|FG002|Overall Study|Protocol Violation|0|||
48464870|NCT02452034|155892262|FG003|Overall Study|Protocol Violation|0|||
48464871|NCT02452034|155892263|FG004|Overall Study|Protocol Violation|0|||
48464872|NCT02452034|155892264|FG005|Overall Study|Protocol Violation|1|||
48464873|NCT02452034|155892259|FG000|Overall Study|Screen Failure|1|||
48464874|NCT02452034|155892260|FG001|Overall Study|Screen Failure|0|||
48464875|NCT02452034|155892261|FG002|Overall Study|Screen Failure|0|||
48464876|NCT02452034|155892262|FG003|Overall Study|Screen Failure|1|||
48464877|NCT02452034|155892263|FG004|Overall Study|Screen Failure|0|||
48464878|NCT02452034|155892264|FG005|Overall Study|Screen Failure|0|||
48464879|NCT02452034|155892259|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
48464880|NCT02452034|155892260|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
48464881|NCT02452034|155892261|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
48464882|NCT02452034|155892262|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
48464883|NCT02452034|155892263|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
48464884|NCT02452034|155892264|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
48464885|NCT00166504|155892267|FG000|Overall Study|Adverse Event|3|||
48464886|NCT00166504|155892268|FG001|Overall Study|Adverse Event|3|||
48464887|NCT00166504|155892267|FG000|Overall Study|Lost to Follow-up|1|||
48464888|NCT00166504|155892268|FG001|Overall Study|Lost to Follow-up|1|||
48464889|NCT00166504|155892267|FG000|Overall Study|Withdrawal by Subject|1|||
48464890|NCT00166504|155892268|FG001|Overall Study|Withdrawal by Subject|0|||
48464891|NCT01716585|155892269|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
48464892|NCT01716585|155892270|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
48464893|NCT01716585|155892269|FG000|Double-blind Treatment|Adverse Event|2|||
48464894|NCT01716585|155892270|FG001|Double-blind Treatment|Adverse Event|1|||
48464895|NCT01716585|155892269|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
48464896|NCT01716585|155892270|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
48464897|NCT01716585|155892269|FG000|Double-blind Treatment|Lost to Follow-up|2|||
48464898|NCT01716585|155892270|FG001|Double-blind Treatment|Lost to Follow-up|0|||
48464899|NCT01716585|155892269|FG000|Double-blind Treatment|Subject Noncompliant|1|||
48464900|NCT01716585|155892270|FG001|Double-blind Treatment|Subject Noncompliant|0|||
48464901|NCT01716585|155892269|FG000|Double-blind Treatment|Other|1|||
48464902|NCT01716585|155892270|FG001|Double-blind Treatment|Other|0|||
48464903|NCT01716585|155892269|FG000|Open-label Treatment|Adverse Event|0|||
48464904|NCT01716585|155892270|FG001|Open-label Treatment|Adverse Event|2|||
48464905|NCT01716585|155892269|FG000|Open-label Treatment|Virologic Failure|0|||
48464906|NCT01716585|155892270|FG001|Open-label Treatment|Virologic Failure|2|||
48464907|NCT01716585|155892269|FG000|Open-label Treatment|Withdrawal by Subject|0|||
48464908|NCT01716585|155892270|FG001|Open-label Treatment|Withdrawal by Subject|3|||
48464909|NCT03558503|155892271|FG000|Overall Study|Adverse Event|1|||
48464910|NCT03558503|155892271|FG000|Overall Study|Death|1|||
48464911|NCT03558503|155892271|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
48464912|NCT02200510|155892272|FG000|Overall Study|Death|1|||
48464913|NCT02200510|155892273|FG001|Overall Study|Death|1|||
48464914|NCT02200510|155892272|FG000|Overall Study|Protocol Violation|0|||
48464915|NCT02200510|155892273|FG001|Overall Study|Protocol Violation|1|||
48464916|NCT02200510|155892272|FG000|Overall Study|Lost to Follow-up|7|||
48464917|NCT02200510|155892273|FG001|Overall Study|Lost to Follow-up|1|||
48464918|NCT02200510|155892272|FG000|Overall Study|potential COI - joined study team|1|||
48464919|NCT02200510|155892273|FG001|Overall Study|potential COI - joined study team|0|||
48464920|NCT03288987|155892275|FG000|Overall Study|Protocol Violation|10|||
48464921|NCT03288987|155892276|FG001|Overall Study|Protocol Violation|4|||
48464922|NCT00033514|155892278|FG000|Overall Study|Lost to Follow-up|1|||
48464923|NCT00033514|155892279|FG001|Overall Study|Lost to Follow-up|1|||
48464924|NCT00033514|155892278|FG000|Overall Study|Withdrawal by Subject|0|||
48464925|NCT00033514|155892279|FG001|Overall Study|Withdrawal by Subject|3|||
48464926|NCT00723489|155892283|FG000|Overall Study|Physician Decision|0|||
48464927|NCT00723489|155892284|FG001|Overall Study|Physician Decision|1|||
48464928|NCT00723489|155892285|FG002|Overall Study|Physician Decision|0|||
48464929|NCT00723489|155892286|FG003|Overall Study|Physician Decision|0|||
48464930|NCT00723489|155892283|FG000|Overall Study|Pregnancy|0|||
48464931|NCT00723489|155892284|FG001|Overall Study|Pregnancy|0|||
48464932|NCT00723489|155892285|FG002|Overall Study|Pregnancy|0|||
48464933|NCT00723489|155892286|FG003|Overall Study|Pregnancy|1|||
48464934|NCT00723489|155892283|FG000|Overall Study|Withdrawal by Subject|0|||
48464935|NCT00723489|155892284|FG001|Overall Study|Withdrawal by Subject|0|||
48464936|NCT00723489|155892285|FG002|Overall Study|Withdrawal by Subject|0|||
48464937|NCT00723489|155892286|FG003|Overall Study|Withdrawal by Subject|1|||
48464938|NCT00723489|155892283|FG000|Overall Study|Seropositive at baseline|1|||
48464939|NCT00723489|155892284|FG001|Overall Study|Seropositive at baseline|0|||
48464940|NCT00723489|155892285|FG002|Overall Study|Seropositive at baseline|0|||
48464941|NCT00723489|155892286|FG003|Overall Study|Seropositive at baseline|0|||
48464942|NCT00723489|155892283|FG000|Overall Study|Prohibited Medication|0|||
48464943|NCT00723489|155892284|FG001|Overall Study|Prohibited Medication|0|||
48464944|NCT00723489|155892285|FG002|Overall Study|Prohibited Medication|0|||
48464945|NCT00723489|155892286|FG003|Overall Study|Prohibited Medication|1|||
48464946|NCT00723489|155892283|FG000|Overall Study|Samples Collected Out of Window|0|||
48464947|NCT00723489|155892284|FG001|Overall Study|Samples Collected Out of Window|3|||
48464948|NCT00723489|155892285|FG002|Overall Study|Samples Collected Out of Window|0|||
48464949|NCT00723489|155892286|FG003|Overall Study|Samples Collected Out of Window|0|||
48464950|NCT00948389|155892288|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
48464951|NCT00948389|155892289|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
48464952|NCT00948389|155892290|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
48464953|NCT00948389|155892291|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
48464954|NCT00948389|155892292|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
48464955|NCT00948389|155892288|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
48464956|NCT00948389|155892289|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
48464957|NCT00948389|155892290|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
48464958|NCT00948389|155892291|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
48464959|NCT00948389|155892292|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
48464960|NCT00948389|155892288|FG000|Overall Study|Both Progression and Toxicity|1|||
48464961|NCT00948389|155892289|FG001|Overall Study|Both Progression and Toxicity|0|||
48464962|NCT00948389|155892290|FG002|Overall Study|Both Progression and Toxicity|0|||
48464963|NCT00948389|155892291|FG003|Overall Study|Both Progression and Toxicity|0|||
48464964|NCT00948389|155892292|FG004|Overall Study|Both Progression and Toxicity|0|||
48464965|NCT00917553|155892294|FG000|Overall Study|Lost to Follow-up|2|||
48464966|NCT00917553|155892295|FG001|Overall Study|Lost to Follow-up|1|||
48464967|NCT02519777|155892303|FG000|Overall Study|Death|1|||
48464968|NCT02519777|155892304|FG001|Overall Study|Death|0|||
48464969|NCT02519777|155892305|FG002|Overall Study|Death|0|||
48464970|NCT02519777|155892303|FG000|Overall Study|Lost to Follow-up|0|||
48464971|NCT02519777|155892304|FG001|Overall Study|Lost to Follow-up|4|||
48464972|NCT02519777|155892305|FG002|Overall Study|Lost to Follow-up|2|||
48464973|NCT02519777|155892303|FG000|Overall Study|Withdrawal by Subject|3|||
48464974|NCT02519777|155892304|FG001|Overall Study|Withdrawal by Subject|1|||
48464975|NCT02519777|155892305|FG002|Overall Study|Withdrawal by Subject|0|||
48464976|NCT02519777|155892303|FG000|Overall Study|Severe Debilitation|1|||
48464977|NCT02519777|155892304|FG001|Overall Study|Severe Debilitation|1|||
48464978|NCT02519777|155892305|FG002|Overall Study|Severe Debilitation|1|||
48464979|NCT02519777|155892303|FG000|Overall Study|Not able to get to clinic|1|||
48464980|NCT02519777|155892304|FG001|Overall Study|Not able to get to clinic|2|||
48464981|NCT02519777|155892305|FG002|Overall Study|Not able to get to clinic|1|||
48464982|NCT02041533|155892308|FG000|Pre-Treatment Period|Disease Progression|1|||
48464983|NCT02041533|155892309|FG001|Pre-Treatment Period|Disease Progression|1|||
48464984|NCT02041533|155892308|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
48464985|NCT02041533|155892309|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
48464986|NCT02041533|155892308|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
48464987|NCT02041533|155892309|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
48464988|NCT02041533|155892308|FG000|Treatment Period|Disease progression|189|||
48464989|NCT02041533|155892309|FG001|Treatment Period|Disease progression|146|||
48464990|NCT02041533|155892308|FG000|Treatment Period|Study drug toxicity|30|||
48464991|NCT02041533|155892309|FG001|Treatment Period|Study drug toxicity|34|||
48464992|NCT02041533|155892308|FG000|Treatment Period|Death|1|||
48464993|NCT02041533|155892309|FG001|Treatment Period|Death|0|||
48464994|NCT02041533|155892308|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
48464995|NCT02041533|155892309|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
48464996|NCT02041533|155892308|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
48464997|NCT02041533|155892309|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
48464998|NCT02041533|155892308|FG000|Treatment Period|Participant withdrew consent|2|||
48464999|NCT02041533|155892309|FG001|Treatment Period|Participant withdrew consent|2|||
48465000|NCT02041533|155892308|FG000|Treatment Period|Maximum clinical benefit|0|||
48465001|NCT02041533|155892309|FG001|Treatment Period|Maximum clinical benefit|18|||
48465002|NCT02041533|155892308|FG000|Treatment Period|Poor/Non-compliance|1|||
48465003|NCT02041533|155892309|FG001|Treatment Period|Poor/Non-compliance|0|||
48465004|NCT02041533|155892308|FG000|Treatment Period|Administrative reason by sponsor|1|||
48465005|NCT02041533|155892309|FG001|Treatment Period|Administrative reason by sponsor|0|||
48465006|NCT02041533|155892308|FG000|Treatment Period|Other reasons|9|||
48465007|NCT02041533|155892309|FG001|Treatment Period|Other reasons|2|||
48465008|NCT02041533|155892308|FG000|Treatment Period|Not Reported|0|||
48465009|NCT02041533|155892309|FG001|Treatment Period|Not Reported|1|||
48465010|NCT02813681|155892319|FG000|Overall Study|Physician Decision|5|||
48465011|NCT02813681|155892320|FG001|Overall Study|Physician Decision|5|||
48465012|NCT02813681|155892321|FG002|Overall Study|Physician Decision|0|||
48465013|NCT02813681|155892319|FG000|Overall Study|Lost to Follow-up|0|||
48465014|NCT02813681|155892320|FG001|Overall Study|Lost to Follow-up|1|||
48465015|NCT02813681|155892321|FG002|Overall Study|Lost to Follow-up|0|||
48465016|NCT00374452|155892324|FG000|Overall Study|Left clinic before intervention started|4|||
48465017|NCT00374452|155892325|FG001|Overall Study|Left clinic before intervention started|1|||
48465018|NCT00374452|155892324|FG000|Overall Study|Change in job role before intervention|0|||
48465019|NCT00374452|155892325|FG001|Overall Study|Change in job role before intervention|1|||
48465020|NCT00374452|155892324|FG000|Overall Study|Left clinic after intervention started|1|||
48465021|NCT00374452|155892325|FG001|Overall Study|Left clinic after intervention started|1|||
48465022|NCT00374452|155892324|FG000|Overall Study|Withdrawal by Subject|0|||
48465023|NCT00374452|155892325|FG001|Overall Study|Withdrawal by Subject|2|||
48465024|NCT00283062|155892326|FG000|Overall Study|Did not receive any study medication|5|||
48465025|NCT00283062|155892327|FG001|Overall Study|Did not receive any study medication|4|||
48465026|NCT00283062|155892328|FG002|Overall Study|Did not receive any study medication|36|||
48465027|NCT00283062|155892329|FG003|Overall Study|Did not receive any study medication|45|||
48465028|NCT00283062|155892326|FG000|Overall Study|Adverse Event|2|||
48465029|NCT00283062|155892327|FG001|Overall Study|Adverse Event|0|||
48465030|NCT00283062|155892328|FG002|Overall Study|Adverse Event|1|||
48465031|NCT00283062|155892329|FG003|Overall Study|Adverse Event|0|||
48465032|NCT00283062|155892326|FG000|Overall Study|Lost to Follow-up|1|||
48465033|NCT00283062|155892327|FG001|Overall Study|Lost to Follow-up|0|||
48465034|NCT00283062|155892328|FG002|Overall Study|Lost to Follow-up|1|||
48465035|NCT00283062|155892329|FG003|Overall Study|Lost to Follow-up|0|||
48465036|NCT00283062|155892326|FG000|Overall Study|Progressive disease|0|||
48465037|NCT00283062|155892327|FG001|Overall Study|Progressive disease|0|||
48465038|NCT00283062|155892328|FG002|Overall Study|Progressive disease|1|||
48465039|NCT00283062|155892329|FG003|Overall Study|Progressive disease|0|||
48465040|NCT00283062|155892326|FG000|Overall Study|Participant did not wish to continue|3|||
48465041|NCT00283062|155892327|FG001|Overall Study|Participant did not wish to continue|2|||
48465042|NCT00283062|155892328|FG002|Overall Study|Participant did not wish to continue|1|||
48465043|NCT00283062|155892329|FG003|Overall Study|Participant did not wish to continue|0|||
48465044|NCT00283062|155892326|FG000|Overall Study|Undefined|0|||
48465045|NCT00283062|155892327|FG001|Overall Study|Undefined|1|||
48465046|NCT00283062|155892328|FG002|Overall Study|Undefined|1|||
48465047|NCT00283062|155892329|FG003|Overall Study|Undefined|4|||
48465048|NCT00283062|155892326|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
48465049|NCT00283062|155892327|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
48465050|NCT00283062|155892328|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
48465051|NCT00283062|155892329|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
48465052|NCT03289676|155892332|FG000|Overall Study|Withdrawal by Subject|2|||
48465053|NCT03289676|155892333|FG001|Overall Study|Withdrawal by Subject|0|||
48465054|NCT03289676|155892332|FG000|Overall Study|Protocol Violation|2|||
48465055|NCT03289676|155892333|FG001|Overall Study|Protocol Violation|0|||
48465056|NCT03289676|155892332|FG000|Overall Study|Lost to Follow-up|0|||
48465057|NCT03289676|155892333|FG001|Overall Study|Lost to Follow-up|1|||
48465058|NCT02698176|155892334|FG000|Overall Study|Progressive disease|4|||
48465059|NCT02698176|155892335|FG001|Overall Study|Progressive disease|3|||
48465060|NCT02698176|155892336|FG002|Overall Study|Progressive disease|1|||
48465061|NCT02698176|155892337|FG003|Overall Study|Progressive disease|0|||
48465062|NCT02698176|155892334|FG000|Overall Study|Adverse Event|2|||
48465063|NCT02698176|155892335|FG001|Overall Study|Adverse Event|0|||
48465064|NCT02698176|155892336|FG002|Overall Study|Adverse Event|0|||
48465065|NCT02698176|155892337|FG003|Overall Study|Adverse Event|0|||
48465066|NCT02698176|155892334|FG000|Overall Study|Clinical progression|3|||
48465067|NCT02698176|155892335|FG001|Overall Study|Clinical progression|0|||
48465068|NCT02698176|155892336|FG002|Overall Study|Clinical progression|0|||
48465069|NCT02698176|155892337|FG003|Overall Study|Clinical progression|0|||
48465070|NCT01230827|155892338|FG000|Overall Study|Lost to Follow-up|0|||
48465071|NCT01230827|155892339|FG001|Overall Study|Lost to Follow-up|0|||
48465072|NCT01230827|155892340|FG002|Overall Study|Lost to Follow-up|1|||
48465073|NCT01230827|155892341|FG003|Overall Study|Lost to Follow-up|3|||
48465074|NCT01230827|155892338|FG000|Overall Study|Withdrawal by Subject|1|||
48465075|NCT01230827|155892339|FG001|Overall Study|Withdrawal by Subject|0|||
48465076|NCT01230827|155892340|FG002|Overall Study|Withdrawal by Subject|3|||
48465077|NCT01230827|155892341|FG003|Overall Study|Withdrawal by Subject|2|||
48465078|NCT01230827|155892338|FG000|Overall Study|Lack of Efficacy|14|||
48465079|NCT01230827|155892339|FG001|Overall Study|Lack of Efficacy|1|||
48465080|NCT01230827|155892340|FG002|Overall Study|Lack of Efficacy|2|||
48465081|NCT01230827|155892341|FG003|Overall Study|Lack of Efficacy|3|||
48465082|NCT01230827|155892338|FG000|Overall Study|Adverse Event|4|||
48465083|NCT01230827|155892339|FG001|Overall Study|Adverse Event|2|||
48465084|NCT01230827|155892340|FG002|Overall Study|Adverse Event|3|||
48465085|NCT01230827|155892341|FG003|Overall Study|Adverse Event|7|||
48465086|NCT01230827|155892338|FG000|Overall Study|Recovery|0|||
48465087|NCT01230827|155892339|FG001|Overall Study|Recovery|6|||
48465088|NCT01230827|155892340|FG002|Overall Study|Recovery|0|||
48465089|NCT01230827|155892341|FG003|Overall Study|Recovery|0|||
48465090|NCT01230827|155892338|FG000|Overall Study|Study terminated by Sponsor|0|||
48465091|NCT01230827|155892339|FG001|Overall Study|Study terminated by Sponsor|2|||
48465092|NCT01230827|155892340|FG002|Overall Study|Study terminated by Sponsor|56|||
48465093|NCT01230827|155892341|FG003|Overall Study|Study terminated by Sponsor|63|||
48465094|NCT01029691|155892342|FG000|Continued APAP to Delivery|Death|0|||
48465095|NCT01029691|155892343|FG001|Continued APAP to Delivery|Death|0|||
48465096|NCT01029691|155892344|FG002|Continued APAP to Delivery|Death|1|||
48465097|NCT00760994|155892350|FG000|Overall Study|Lost to Follow-up|4|||
48465098|NCT00760994|155892351|FG001|Overall Study|Lost to Follow-up|4|||
48465099|NCT00760994|155892352|FG002|Overall Study|Lost to Follow-up|3|||
48465100|NCT01521494|155892353|FG000|Overall Study|Adverse Event|1|||
48465101|NCT01521494|155892354|FG001|Overall Study|Adverse Event|2|||
48465102|NCT01521494|155892355|FG002|Overall Study|Adverse Event|9|||
48465103|NCT01521494|155892356|FG003|Overall Study|Adverse Event|6|||
48465104|NCT01521494|155892357|FG004|Overall Study|Adverse Event|2|||
48465105|NCT01521494|155892353|FG000|Overall Study|Lack of Efficacy|0|||
48465106|NCT01521494|155892354|FG001|Overall Study|Lack of Efficacy|0|||
48465107|NCT01521494|155892355|FG002|Overall Study|Lack of Efficacy|0|||
48465108|NCT01521494|155892356|FG003|Overall Study|Lack of Efficacy|0|||
48465109|NCT01521494|155892357|FG004|Overall Study|Lack of Efficacy|2|||
48465110|NCT01521494|155892353|FG000|Overall Study|Withdrawal by Subject|1|||
48465111|NCT01521494|155892354|FG001|Overall Study|Withdrawal by Subject|1|||
48465112|NCT01521494|155892355|FG002|Overall Study|Withdrawal by Subject|0|||
48465113|NCT01521494|155892356|FG003|Overall Study|Withdrawal by Subject|2|||
48465114|NCT01521494|155892357|FG004|Overall Study|Withdrawal by Subject|0|||
48465115|NCT01521494|155892353|FG000|Overall Study|Decrease in serum phosphate|0|||
48465116|NCT01521494|155892354|FG001|Overall Study|Decrease in serum phosphate|2|||
48465117|NCT01521494|155892355|FG002|Overall Study|Decrease in serum phosphate|3|||
48465118|NCT01521494|155892356|FG003|Overall Study|Decrease in serum phosphate|12|||
48465119|NCT01521494|155892357|FG004|Overall Study|Decrease in serum phosphate|0|||
48465120|NCT01521494|155892353|FG000|Overall Study|Decrease in serum calcium|0|||
48465121|NCT01521494|155892354|FG001|Overall Study|Decrease in serum calcium|0|||
48465122|NCT01521494|155892355|FG002|Overall Study|Decrease in serum calcium|0|||
48465123|NCT01521494|155892356|FG003|Overall Study|Decrease in serum calcium|1|||
48465124|NCT01521494|155892357|FG004|Overall Study|Decrease in serum calcium|1|||
48465125|NCT01521494|155892353|FG000|Overall Study|Physician Decision|0|||
48465126|NCT01521494|155892354|FG001|Overall Study|Physician Decision|0|||
48465127|NCT01521494|155892355|FG002|Overall Study|Physician Decision|0|||
48465128|NCT01521494|155892356|FG003|Overall Study|Physician Decision|0|||
48465129|NCT01521494|155892357|FG004|Overall Study|Physician Decision|2|||
48465130|NCT00554229|155892368|FG000|Overall Study|Lost to Follow-up|3|||
48465131|NCT00554229|155892369|FG001|Overall Study|Lost to Follow-up|6|||
48465132|NCT00554229|155892368|FG000|Overall Study|Withdrawal by Subject|29|||
48465133|NCT00554229|155892369|FG001|Overall Study|Withdrawal by Subject|37|||
48465134|NCT00554229|155892368|FG000|Overall Study|Adverse Event|71|||
48465135|NCT00554229|155892369|FG001|Overall Study|Adverse Event|39|||
48465136|NCT00554229|155892368|FG000|Overall Study|Protocol Violation|3|||
48465137|NCT00554229|155892369|FG001|Overall Study|Protocol Violation|3|||
48465138|NCT00554229|155892368|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
48465139|NCT00554229|155892369|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
48465140|NCT00554229|155892368|FG000|Overall Study|Randomised but no treatment received|1|||
48465141|NCT00554229|155892369|FG001|Overall Study|Randomised but no treatment received|0|||
48465142|NCT02129192|155892370|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
48465143|NCT02129192|155892371|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
48465144|NCT03370133|155892372|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
48465145|NCT03370133|155892373|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
48465146|NCT03370133|155892374|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
48465147|NCT03370133|155892375|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
48465148|NCT03370133|155892376|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
48465149|NCT03370133|155892377|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
48465150|NCT03370133|155892372|FG000|Initial Treatment Period (WK 16)|Death|1|||
48465151|NCT03370133|155892373|FG001|Initial Treatment Period (WK 16)|Death|1|||
48465152|NCT03370133|155892374|FG002|Initial Treatment Period (WK 16)|Death|1|||
48465153|NCT03370133|155892375|FG003|Initial Treatment Period (WK 16)|Death|0|||
48465154|NCT03370133|155892376|FG004|Initial Treatment Period (WK 16)|Death|0|||
48465155|NCT03370133|155892377|FG005|Initial Treatment Period (WK 16)|Death|0|||
48465156|NCT03370133|155892372|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
48465157|NCT03370133|155892373|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
48465158|NCT03370133|155892374|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
48465159|NCT03370133|155892375|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
48465160|NCT03370133|155892376|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
48465161|NCT03370133|155892377|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
48465162|NCT03370133|155892372|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48465163|NCT03370133|155892373|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48465164|NCT03370133|155892374|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
48465165|NCT03370133|155892375|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48465166|NCT03370133|155892376|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48465167|NCT03370133|155892377|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
48465168|NCT03370133|155892372|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48465169|NCT03370133|155892373|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
48465170|NCT03370133|155892374|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48465171|NCT03370133|155892375|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48465172|NCT03370133|155892376|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48465173|NCT03370133|155892377|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
48465174|NCT03370133|155892372|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
48465175|NCT03370133|155892373|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
48465176|NCT03370133|155892374|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
48465177|NCT03370133|155892375|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
48465178|NCT03370133|155892376|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
48465179|NCT03370133|155892377|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
48465180|NCT03370133|155892372|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
48465181|NCT03370133|155892373|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
48465182|NCT03370133|155892374|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
48465183|NCT03370133|155892375|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
48465184|NCT03370133|155892376|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
48465185|NCT03370133|155892377|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
48465186|NCT03370133|155892372|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
48465187|NCT03370133|155892373|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
48465188|NCT03370133|155892374|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
48465189|NCT03370133|155892375|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
48465190|NCT03370133|155892376|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
48465191|NCT03370133|155892377|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
48465192|NCT03370133|155892372|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
48465193|NCT03370133|155892373|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
48465194|NCT03370133|155892374|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
48465195|NCT03370133|155892375|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
48465196|NCT03370133|155892376|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
48465197|NCT03370133|155892377|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
48465198|NCT03370133|155892372|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
48465199|NCT03370133|155892373|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
48465200|NCT03370133|155892374|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
48465201|NCT03370133|155892375|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
48465202|NCT03370133|155892376|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
48465203|NCT03370133|155892377|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
48465204|NCT03370133|155892372|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
48465205|NCT03370133|155892373|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
48465206|NCT03370133|155892374|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
48465207|NCT03370133|155892375|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
48465208|NCT03370133|155892376|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
48465209|NCT03370133|155892377|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
48465210|NCT03370133|155892372|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
48465211|NCT03370133|155892373|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
48465212|NCT03370133|155892374|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
48465213|NCT03370133|155892375|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
48465214|NCT03370133|155892376|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
48465215|NCT03370133|155892377|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
48465216|NCT03370133|155892372|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
48465217|NCT03370133|155892373|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
48465218|NCT03370133|155892374|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
48465219|NCT03370133|155892375|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
48465294|NCT04586920|155894664|FG016|Overall Study|Lost to Follow-up|0|||
48465220|NCT03370133|155892376|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
48465221|NCT03370133|155892377|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
48465222|NCT03370133|155892372|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48465223|NCT03370133|155892373|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48465224|NCT03370133|155892374|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48465225|NCT03370133|155892375|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48465226|NCT03370133|155892376|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
48465227|NCT03370133|155892377|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
48465228|NCT03370133|155892372|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48465229|NCT03370133|155892373|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48465230|NCT03370133|155892374|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48465231|NCT03370133|155892375|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48465232|NCT03370133|155892376|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
48465233|NCT03370133|155892377|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
48465234|NCT00689728|155892382|FG000|Double-Blind Treatment|Adverse Event|1|||
48465235|NCT00689728|155892383|FG001|Double-Blind Treatment|Adverse Event|0|||
48465236|NCT00689728|155892384|FG002|Double-Blind Treatment|Adverse Event|0|||
48465237|NCT00689728|155892382|FG000|Double-Blind Treatment|Protocol Violation|0|||
48465238|NCT00689728|155892383|FG001|Double-Blind Treatment|Protocol Violation|0|||
48465239|NCT00689728|155892384|FG002|Double-Blind Treatment|Protocol Violation|1|||
48465240|NCT00689728|155892382|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
48465241|NCT00689728|155892383|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
48465242|NCT00689728|155892384|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
48465243|NCT00689728|155892382|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
48465244|NCT00689728|155892383|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
48465245|NCT00689728|155892384|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
48465246|NCT00689728|155892382|FG000|Rescue|Adverse Event|0|||
48465247|NCT00689728|155892383|FG001|Rescue|Adverse Event|1|||
48465248|NCT00689728|155892384|FG002|Rescue|Adverse Event|0|||
48465249|NCT00689728|155892382|FG000|Rescue|Withdrawal by Subject|1|||
48465250|NCT00689728|155892383|FG001|Rescue|Withdrawal by Subject|1|||
48465251|NCT00689728|155892384|FG002|Rescue|Withdrawal by Subject|1|||
48465252|NCT00689728|155892382|FG000|Optional Follow-Up|Adverse Event|1|||
48465253|NCT00689728|155892383|FG001|Optional Follow-Up|Adverse Event|0|||
48465254|NCT00689728|155892384|FG002|Optional Follow-Up|Adverse Event|0|||
48465255|NCT00689728|155892382|FG000|Optional Follow-Up|Lack of Efficacy|0|||
48465256|NCT00689728|155892383|FG001|Optional Follow-Up|Lack of Efficacy|1|||
48465257|NCT00689728|155892384|FG002|Optional Follow-Up|Lack of Efficacy|1|||
48465258|NCT00689728|155892382|FG000|Optional Follow-Up|Lost to Follow-up|0|||
48465259|NCT00689728|155892383|FG001|Optional Follow-Up|Lost to Follow-up|1|||
48465260|NCT00689728|155892384|FG002|Optional Follow-Up|Lost to Follow-up|1|||
48465261|NCT00689728|155892382|FG000|Optional Follow-Up|Protocol Violation|0|||
48465262|NCT00689728|155892383|FG001|Optional Follow-Up|Protocol Violation|0|||
48465263|NCT00689728|155892384|FG002|Optional Follow-Up|Protocol Violation|1|||
48465264|NCT00689728|155892382|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
48465265|NCT00689728|155892383|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
48465266|NCT00689728|155892384|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
48465267|NCT03655951|155892385|FG000|Overall Study|Lost to Follow-up|39|||
48465268|NCT03655951|155892386|FG001|Overall Study|Lost to Follow-up|20|||
48465269|NCT03655951|155892385|FG000|Overall Study|Withdrawal by Subject|0|||
48465270|NCT03655951|155892386|FG001|Overall Study|Withdrawal by Subject|1|||
48465271|NCT04806334|155892398|FG000|Overall Study|Withdrawal by Subject|1|||
48465272|NCT03958149|155894642|FG000|Overall Study|Withdrawal by Subject|0|||
48465273|NCT03958149|155894643|FG001|Overall Study|Withdrawal by Subject|1|||
48465274|NCT03037489|155894644|FG000|Overall Study|Adverse Event|4|||
48465275|NCT03037489|155894645|FG001|Overall Study|Adverse Event|0|||
48465276|NCT03037489|155894644|FG000|Overall Study|Withdrawal by Subject|3|||
48465277|NCT03037489|155894645|FG001|Overall Study|Withdrawal by Subject|0|||
48465278|NCT04586920|155894648|FG000|Overall Study|Lost to Follow-up|0|||
48465279|NCT04586920|155894649|FG001|Overall Study|Lost to Follow-up|0|||
48465280|NCT04586920|155894650|FG002|Overall Study|Lost to Follow-up|0|||
48465281|NCT04586920|155894651|FG003|Overall Study|Lost to Follow-up|0|||
48465282|NCT04586920|155894652|FG004|Overall Study|Lost to Follow-up|0|||
48465283|NCT04586920|155894653|FG005|Overall Study|Lost to Follow-up|0|||
48465284|NCT04586920|155894654|FG006|Overall Study|Lost to Follow-up|1|||
48465285|NCT04586920|155894655|FG007|Overall Study|Lost to Follow-up|1|||
48465286|NCT04586920|155894656|FG008|Overall Study|Lost to Follow-up|0|||
48465287|NCT04586920|155894657|FG009|Overall Study|Lost to Follow-up|1|||
48465288|NCT04586920|155894658|FG010|Overall Study|Lost to Follow-up|0|||
48465289|NCT04586920|155894659|FG011|Overall Study|Lost to Follow-up|0|||
48465290|NCT04586920|155894660|FG012|Overall Study|Lost to Follow-up|0|||
48465291|NCT04586920|155894661|FG013|Overall Study|Lost to Follow-up|1|||
48465292|NCT04586920|155894662|FG014|Overall Study|Lost to Follow-up|0|||
48465293|NCT04586920|155894663|FG015|Overall Study|Lost to Follow-up|0|||
48465295|NCT04586920|155894665|FG017|Overall Study|Lost to Follow-up|0|||
48465296|NCT04586920|155894648|FG000|Overall Study|Withdrawal by Subject|0|||
48465297|NCT04586920|155894649|FG001|Overall Study|Withdrawal by Subject|0|||
48465298|NCT04586920|155894650|FG002|Overall Study|Withdrawal by Subject|0|||
48465299|NCT04586920|155894651|FG003|Overall Study|Withdrawal by Subject|0|||
48465300|NCT04586920|155894652|FG004|Overall Study|Withdrawal by Subject|0|||
48465301|NCT04586920|155894653|FG005|Overall Study|Withdrawal by Subject|0|||
48465302|NCT04586920|155894654|FG006|Overall Study|Withdrawal by Subject|0|||
48465303|NCT04586920|155894655|FG007|Overall Study|Withdrawal by Subject|1|||
48465304|NCT04586920|155894656|FG008|Overall Study|Withdrawal by Subject|0|||
48465305|NCT04586920|155894657|FG009|Overall Study|Withdrawal by Subject|1|||
48465306|NCT04586920|155894658|FG010|Overall Study|Withdrawal by Subject|0|||
48465307|NCT04586920|155894659|FG011|Overall Study|Withdrawal by Subject|1|||
48465308|NCT04586920|155894660|FG012|Overall Study|Withdrawal by Subject|0|||
48465309|NCT04586920|155894661|FG013|Overall Study|Withdrawal by Subject|0|||
48465310|NCT04586920|155894662|FG014|Overall Study|Withdrawal by Subject|0|||
48465311|NCT04586920|155894663|FG015|Overall Study|Withdrawal by Subject|0|||
48465312|NCT04586920|155894664|FG016|Overall Study|Withdrawal by Subject|0|||
48465313|NCT04586920|155894665|FG017|Overall Study|Withdrawal by Subject|0|||
48465314|NCT01004861|155894669|FG000|Overall Study|Disease progression|3|||
48465315|NCT01004861|155894670|FG001|Overall Study|Disease progression|4|||
48465316|NCT01004861|155894671|FG002|Overall Study|Disease progression|5|||
48465317|NCT01004861|155894672|FG003|Overall Study|Disease progression|4|||
48465318|NCT01004861|155894673|FG004|Overall Study|Disease progression|4|||
48465319|NCT01004861|155894674|FG005|Overall Study|Disease progression|4|||
48465320|NCT01004861|155894675|FG006|Overall Study|Disease progression|5|||
48465321|NCT01004861|155894676|FG007|Overall Study|Disease progression|1|||
48465322|NCT01004861|155894677|FG008|Overall Study|Disease progression|4|||
48465323|NCT01004861|155894678|FG009|Overall Study|Disease progression|7|||
48465324|NCT01004861|155894679|FG010|Overall Study|Disease progression|6|||
48465325|NCT01004861|155894680|FG011|Overall Study|Disease progression|3|||
48465326|NCT01004861|155894681|FG012|Overall Study|Disease progression|8|||
48465327|NCT01004861|155894669|FG000|Overall Study|Physician Decision|0|||
48465328|NCT01004861|155894670|FG001|Overall Study|Physician Decision|2|||
48465329|NCT01004861|155894671|FG002|Overall Study|Physician Decision|1|||
48465330|NCT01004861|155894672|FG003|Overall Study|Physician Decision|1|||
48465331|NCT01004861|155894673|FG004|Overall Study|Physician Decision|1|||
48465332|NCT01004861|155894674|FG005|Overall Study|Physician Decision|0|||
48465333|NCT01004861|155894675|FG006|Overall Study|Physician Decision|0|||
48465334|NCT01004861|155894676|FG007|Overall Study|Physician Decision|1|||
48465335|NCT01004861|155894677|FG008|Overall Study|Physician Decision|0|||
48465336|NCT01004861|155894678|FG009|Overall Study|Physician Decision|0|||
48465337|NCT01004861|155894679|FG010|Overall Study|Physician Decision|0|||
48465338|NCT01004861|155894680|FG011|Overall Study|Physician Decision|0|||
48465339|NCT01004861|155894681|FG012|Overall Study|Physician Decision|3|||
48465340|NCT01004861|155894669|FG000|Overall Study|Adverse Event|0|||
48465341|NCT01004861|155894670|FG001|Overall Study|Adverse Event|0|||
48465342|NCT01004861|155894671|FG002|Overall Study|Adverse Event|0|||
48465343|NCT01004861|155894672|FG003|Overall Study|Adverse Event|1|||
48465344|NCT01004861|155894673|FG004|Overall Study|Adverse Event|0|||
48465345|NCT01004861|155894674|FG005|Overall Study|Adverse Event|2|||
48465346|NCT01004861|155894675|FG006|Overall Study|Adverse Event|1|||
48465347|NCT01004861|155894676|FG007|Overall Study|Adverse Event|1|||
48465348|NCT01004861|155894677|FG008|Overall Study|Adverse Event|13|||
48465349|NCT01004861|155894678|FG009|Overall Study|Adverse Event|1|||
48465350|NCT01004861|155894679|FG010|Overall Study|Adverse Event|1|||
48465351|NCT01004861|155894680|FG011|Overall Study|Adverse Event|0|||
48465352|NCT01004861|155894681|FG012|Overall Study|Adverse Event|2|||
48465353|NCT01004861|155894669|FG000|Overall Study|Protocol Violation|0|||
48465354|NCT01004861|155894670|FG001|Overall Study|Protocol Violation|0|||
48465355|NCT01004861|155894671|FG002|Overall Study|Protocol Violation|0|||
48465356|NCT01004861|155894672|FG003|Overall Study|Protocol Violation|0|||
48465357|NCT01004861|155894673|FG004|Overall Study|Protocol Violation|1|||
48465358|NCT01004861|155894674|FG005|Overall Study|Protocol Violation|0|||
48465359|NCT01004861|155894675|FG006|Overall Study|Protocol Violation|0|||
48465360|NCT01004861|155894676|FG007|Overall Study|Protocol Violation|0|||
48465361|NCT01004861|155894677|FG008|Overall Study|Protocol Violation|0|||
48465362|NCT01004861|155894678|FG009|Overall Study|Protocol Violation|0|||
48465363|NCT01004861|155894679|FG010|Overall Study|Protocol Violation|0|||
48465364|NCT01004861|155894680|FG011|Overall Study|Protocol Violation|0|||
48465365|NCT01004861|155894681|FG012|Overall Study|Protocol Violation|0|||
48465366|NCT01004861|155894669|FG000|Overall Study|Lost to Follow-up|0|||
48465367|NCT01004861|155894670|FG001|Overall Study|Lost to Follow-up|0|||
48465368|NCT01004861|155894671|FG002|Overall Study|Lost to Follow-up|0|||
48465369|NCT01004861|155894672|FG003|Overall Study|Lost to Follow-up|0|||
48465370|NCT01004861|155894673|FG004|Overall Study|Lost to Follow-up|0|||
48465371|NCT01004861|155894674|FG005|Overall Study|Lost to Follow-up|0|||
48465372|NCT01004861|155894675|FG006|Overall Study|Lost to Follow-up|0|||
48465373|NCT01004861|155894676|FG007|Overall Study|Lost to Follow-up|1|||
48465374|NCT01004861|155894677|FG008|Overall Study|Lost to Follow-up|3|||
48465375|NCT01004861|155894678|FG009|Overall Study|Lost to Follow-up|0|||
48465376|NCT01004861|155894679|FG010|Overall Study|Lost to Follow-up|0|||
48465377|NCT01004861|155894680|FG011|Overall Study|Lost to Follow-up|1|||
48465378|NCT01004861|155894681|FG012|Overall Study|Lost to Follow-up|0|||
48465379|NCT01004861|155894669|FG000|Overall Study|Non-compliance|0|||
48465380|NCT01004861|155894670|FG001|Overall Study|Non-compliance|0|||
48465381|NCT01004861|155894671|FG002|Overall Study|Non-compliance|0|||
48465382|NCT01004861|155894672|FG003|Overall Study|Non-compliance|0|||
48465383|NCT01004861|155894673|FG004|Overall Study|Non-compliance|0|||
48465384|NCT01004861|155894674|FG005|Overall Study|Non-compliance|0|||
48465385|NCT01004861|155894675|FG006|Overall Study|Non-compliance|0|||
48465386|NCT01004861|155894676|FG007|Overall Study|Non-compliance|0|||
48465387|NCT01004861|155894677|FG008|Overall Study|Non-compliance|5|||
48465388|NCT01004861|155894678|FG009|Overall Study|Non-compliance|0|||
48465389|NCT01004861|155894679|FG010|Overall Study|Non-compliance|0|||
48465390|NCT01004861|155894680|FG011|Overall Study|Non-compliance|0|||
48465391|NCT01004861|155894681|FG012|Overall Study|Non-compliance|1|||
48465392|NCT01004861|155894669|FG000|Overall Study|Other|0|||
48465393|NCT01004861|155894670|FG001|Overall Study|Other|0|||
48465394|NCT01004861|155894671|FG002|Overall Study|Other|0|||
48465395|NCT01004861|155894672|FG003|Overall Study|Other|0|||
48465396|NCT01004861|155894673|FG004|Overall Study|Other|0|||
48465397|NCT01004861|155894674|FG005|Overall Study|Other|0|||
48465398|NCT01004861|155894675|FG006|Overall Study|Other|0|||
48465399|NCT01004861|155894676|FG007|Overall Study|Other|0|||
48465400|NCT01004861|155894677|FG008|Overall Study|Other|0|||
48465401|NCT01004861|155894678|FG009|Overall Study|Other|2|||
48465402|NCT01004861|155894679|FG010|Overall Study|Other|1|||
48465403|NCT01004861|155894680|FG011|Overall Study|Other|2|||
48465404|NCT01004861|155894681|FG012|Overall Study|Other|3|||
48465405|NCT01004861|155894669|FG000|Overall Study|Patient decision|0|||
48465406|NCT01004861|155894670|FG001|Overall Study|Patient decision|0|||
48465407|NCT01004861|155894671|FG002|Overall Study|Patient decision|0|||
48465408|NCT01004861|155894672|FG003|Overall Study|Patient decision|0|||
48465409|NCT01004861|155894673|FG004|Overall Study|Patient decision|1|||
48465410|NCT01004861|155894674|FG005|Overall Study|Patient decision|0|||
48465411|NCT01004861|155894675|FG006|Overall Study|Patient decision|1|||
48465412|NCT01004861|155894676|FG007|Overall Study|Patient decision|0|||
48465413|NCT01004861|155894677|FG008|Overall Study|Patient decision|7|||
48465414|NCT01004861|155894678|FG009|Overall Study|Patient decision|1|||
48465415|NCT01004861|155894679|FG010|Overall Study|Patient decision|1|||
48465416|NCT01004861|155894680|FG011|Overall Study|Patient decision|2|||
48465417|NCT01004861|155894681|FG012|Overall Study|Patient decision|3|||
48465418|NCT01004861|155894669|FG000|Overall Study|Transitioned to Phase 4 study|0|||
48465419|NCT01004861|155894670|FG001|Overall Study|Transitioned to Phase 4 study|0|||
48465420|NCT01004861|155894671|FG002|Overall Study|Transitioned to Phase 4 study|0|||
48465421|NCT01004861|155894672|FG003|Overall Study|Transitioned to Phase 4 study|0|||
48465422|NCT01004861|155894673|FG004|Overall Study|Transitioned to Phase 4 study|0|||
48465423|NCT01004861|155894674|FG005|Overall Study|Transitioned to Phase 4 study|0|||
48465424|NCT01004861|155894675|FG006|Overall Study|Transitioned to Phase 4 study|0|||
48465425|NCT01004861|155894676|FG007|Overall Study|Transitioned to Phase 4 study|0|||
48465426|NCT01004861|155894677|FG008|Overall Study|Transitioned to Phase 4 study|2|||
48465427|NCT01004861|155894678|FG009|Overall Study|Transitioned to Phase 4 study|0|||
48465428|NCT01004861|155894679|FG010|Overall Study|Transitioned to Phase 4 study|0|||
48465429|NCT01004861|155894680|FG011|Overall Study|Transitioned to Phase 4 study|0|||
48465430|NCT01004861|155894681|FG012|Overall Study|Transitioned to Phase 4 study|0|||
48465431|NCT01004861|155894669|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465432|NCT01004861|155894670|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465433|NCT01004861|155894671|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465434|NCT01004861|155894672|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465435|NCT01004861|155894673|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465436|NCT01004861|155894674|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465437|NCT01004861|155894675|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465438|NCT01004861|155894676|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465439|NCT01004861|155894677|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
48465440|NCT01004861|155894678|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465441|NCT01004861|155894679|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465442|NCT01004861|155894680|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465443|NCT01004861|155894681|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
48465444|NCT01004861|155894669|FG000|Overall Study|Patient withdrew|0|||
48465445|NCT01004861|155894670|FG001|Overall Study|Patient withdrew|0|||
48465446|NCT01004861|155894671|FG002|Overall Study|Patient withdrew|0|||
48465447|NCT01004861|155894672|FG003|Overall Study|Patient withdrew|0|||
48465448|NCT01004861|155894673|FG004|Overall Study|Patient withdrew|0|||
48465449|NCT01004861|155894674|FG005|Overall Study|Patient withdrew|0|||
48465450|NCT01004861|155894675|FG006|Overall Study|Patient withdrew|0|||
48465451|NCT01004861|155894676|FG007|Overall Study|Patient withdrew|0|||
48465452|NCT01004861|155894677|FG008|Overall Study|Patient withdrew|1|||
48465453|NCT01004861|155894678|FG009|Overall Study|Patient withdrew|0|||
48465454|NCT01004861|155894679|FG010|Overall Study|Patient withdrew|0|||
48465455|NCT01004861|155894680|FG011|Overall Study|Patient withdrew|0|||
48465456|NCT01004861|155894681|FG012|Overall Study|Patient withdrew|0|||
48465457|NCT01004861|155894669|FG000|Overall Study|Surgical resection|0|||
48465458|NCT01004861|155894670|FG001|Overall Study|Surgical resection|0|||
48465459|NCT01004861|155894671|FG002|Overall Study|Surgical resection|0|||
48465460|NCT01004861|155894672|FG003|Overall Study|Surgical resection|0|||
48465461|NCT01004861|155894673|FG004|Overall Study|Surgical resection|0|||
48465462|NCT01004861|155894674|FG005|Overall Study|Surgical resection|0|||
48465463|NCT01004861|155894675|FG006|Overall Study|Surgical resection|0|||
48465464|NCT01004861|155894676|FG007|Overall Study|Surgical resection|0|||
48465465|NCT01004861|155894677|FG008|Overall Study|Surgical resection|1|||
48465466|NCT01004861|155894678|FG009|Overall Study|Surgical resection|0|||
48465467|NCT01004861|155894679|FG010|Overall Study|Surgical resection|0|||
48465468|NCT01004861|155894680|FG011|Overall Study|Surgical resection|0|||
48465469|NCT01004861|155894681|FG012|Overall Study|Surgical resection|0|||
48465470|NCT01004861|155894669|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465471|NCT01004861|155894670|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465472|NCT01004861|155894671|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465473|NCT01004861|155894672|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465474|NCT01004861|155894673|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465475|NCT01004861|155894674|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465476|NCT01004861|155894675|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465477|NCT01004861|155894676|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465478|NCT01004861|155894677|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
48465479|NCT01004861|155894678|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465480|NCT01004861|155894679|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465481|NCT01004861|155894680|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465482|NCT01004861|155894681|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
48465483|NCT01004861|155894669|FG000|Overall Study|Study termination by Sponsor|0|||
48465484|NCT01004861|155894670|FG001|Overall Study|Study termination by Sponsor|0|||
48465485|NCT01004861|155894671|FG002|Overall Study|Study termination by Sponsor|0|||
48465486|NCT01004861|155894672|FG003|Overall Study|Study termination by Sponsor|0|||
48465487|NCT01004861|155894673|FG004|Overall Study|Study termination by Sponsor|0|||
48465488|NCT01004861|155894674|FG005|Overall Study|Study termination by Sponsor|0|||
48465489|NCT01004861|155894675|FG006|Overall Study|Study termination by Sponsor|0|||
48465490|NCT01004861|155894676|FG007|Overall Study|Study termination by Sponsor|0|||
48465491|NCT01004861|155894677|FG008|Overall Study|Study termination by Sponsor|1|||
48465492|NCT01004861|155894678|FG009|Overall Study|Study termination by Sponsor|0|||
48465493|NCT01004861|155894679|FG010|Overall Study|Study termination by Sponsor|0|||
48465494|NCT01004861|155894680|FG011|Overall Study|Study termination by Sponsor|0|||
48465495|NCT01004861|155894681|FG012|Overall Study|Study termination by Sponsor|0|||
48465496|NCT02630823|155894682|FG000|Overall Study|Withdrawal by Subject|1|||
48465497|NCT02630823|155894682|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
48465498|NCT02554721|155894683|FG000|Overall Study|Adverse Event|1|||
48465499|NCT02554721|155894684|FG001|Overall Study|Adverse Event|0|||
48465500|NCT02554721|155894685|FG002|Overall Study|Adverse Event|0|||
48465501|NCT02554721|155894686|FG003|Overall Study|Adverse Event|0|||
48465502|NCT02554721|155894687|FG004|Overall Study|Adverse Event|1|||
48465503|NCT02554721|155894683|FG000|Overall Study|Noncompliance|0|||
48465504|NCT02554721|155894684|FG001|Overall Study|Noncompliance|0|||
48465505|NCT02554721|155894685|FG002|Overall Study|Noncompliance|0|||
48465506|NCT02554721|155894686|FG003|Overall Study|Noncompliance|0|||
48465507|NCT02554721|155894687|FG004|Overall Study|Noncompliance|1|||
48465508|NCT05009251|155894688|FG000|Overall Study|Protocol Violation|100|||
48465509|NCT05009251|155894689|FG001|Overall Study|Protocol Violation|105|||
48465510|NCT05009251|155894690|FG002|Overall Study|Protocol Violation|119|||
48465511|NCT05009251|155894691|FG003|Overall Study|Protocol Violation|120|||
48465512|NCT05009251|155894692|FG004|Overall Study|Protocol Violation|119|||
48465513|NCT05009251|155894688|FG000|Overall Study|Death|25|||
48465514|NCT05009251|155894689|FG001|Overall Study|Death|22|||
48465515|NCT05009251|155894690|FG002|Overall Study|Death|24|||
48465516|NCT05009251|155894691|FG003|Overall Study|Death|19|||
48465517|NCT05009251|155894692|FG004|Overall Study|Death|15|||
48465518|NCT01640353|155894693|FG000|Overall Study|Withdrew prior to treatment|10|||
48465519|NCT01640353|155894693|FG000|Overall Study|Withdrawn from analysis at term site|12|||
48465520|NCT01640353|155894693|FG000|Overall Study|Withdrawal by Subject|5|||
48465521|NCT01640353|155894693|FG000|Overall Study|Death|2|||
48465522|NCT01640353|155894693|FG000|Overall Study|Early site termination|3|||
48465523|NCT01640353|155894693|FG000|Overall Study|Lost to Follow-up|12|||
48465524|NCT01640353|155894693|FG000|Overall Study|Physician Decision|1|||
48465525|NCT01524900|155894694|FG000|Overall Study|Lost to Follow-up|3|||
48465526|NCT01524900|155894695|FG001|Overall Study|Lost to Follow-up|12|||
48465527|NCT01524900|155894696|FG002|Overall Study|Lost to Follow-up|1|||
48465528|NCT01524900|155894697|FG003|Overall Study|Lost to Follow-up|0|||
48465529|NCT01524900|155894698|FG004|Overall Study|Lost to Follow-up|0|||
48465530|NCT01524900|155894694|FG000|Overall Study|Other reason than stated above|1|||
48465531|NCT01524900|155894695|FG001|Overall Study|Other reason than stated above|1|||
48465532|NCT01524900|155894696|FG002|Overall Study|Other reason than stated above|0|||
48465533|NCT01524900|155894697|FG003|Overall Study|Other reason than stated above|0|||
48465534|NCT01524900|155894698|FG004|Overall Study|Other reason than stated above|0|||
48465535|NCT01524900|155894694|FG000|Overall Study|No reason documented|2|||
48465536|NCT01524900|155894695|FG001|Overall Study|No reason documented|1|||
48465537|NCT01524900|155894696|FG002|Overall Study|No reason documented|0|||
48465538|NCT01524900|155894697|FG003|Overall Study|No reason documented|1|||
48465539|NCT01524900|155894698|FG004|Overall Study|No reason documented|0|||
48465540|NCT00959192|155894699|FG000|Overall Study|Adverse Event|1|||
48465541|NCT00959192|155894700|FG001|Overall Study|Adverse Event|1|||
48465542|NCT00959192|155894701|FG002|Overall Study|Adverse Event|1|||
48465543|NCT00959192|155894702|FG003|Overall Study|Adverse Event|0|||
48465544|NCT00959192|155894699|FG000|Overall Study|Investigator Request|1|||
48465545|NCT00959192|155894700|FG001|Overall Study|Investigator Request|0|||
48465546|NCT00959192|155894701|FG002|Overall Study|Investigator Request|0|||
48465547|NCT00959192|155894702|FG003|Overall Study|Investigator Request|0|||
48465548|NCT00959192|155894699|FG000|Overall Study|Caregiver Request|0|||
48465549|NCT00959192|155894700|FG001|Overall Study|Caregiver Request|0|||
48465550|NCT00959192|155894701|FG002|Overall Study|Caregiver Request|2|||
48465551|NCT00959192|155894702|FG003|Overall Study|Caregiver Request|1|||
48465552|NCT04450394|155894709|FG000|Overall Study|Adverse Event|2|||
48465553|NCT04450394|155894710|FG001|Overall Study|Adverse Event|0|||
48465554|NCT04450394|155894711|FG002|Overall Study|Adverse Event|0|||
48465555|NCT04450394|155894709|FG000|Overall Study|Death|0|||
48465556|NCT04450394|155894710|FG001|Overall Study|Death|1|||
48465557|NCT04450394|155894711|FG002|Overall Study|Death|0|||
48465558|NCT04450394|155894709|FG000|Overall Study|Lost to Follow-up|0|||
48465559|NCT04450394|155894710|FG001|Overall Study|Lost to Follow-up|3|||
48465560|NCT04450394|155894711|FG002|Overall Study|Lost to Follow-up|0|||
48465561|NCT04450394|155894709|FG000|Overall Study|Physician Decision|0|||
48465562|NCT04450394|155894710|FG001|Overall Study|Physician Decision|1|||
48465563|NCT04450394|155894711|FG002|Overall Study|Physician Decision|0|||
48465564|NCT04450394|155894709|FG000|Overall Study|Protocol Violation|2|||
48465565|NCT04450394|155894710|FG001|Overall Study|Protocol Violation|0|||
48465566|NCT04450394|155894711|FG002|Overall Study|Protocol Violation|0|||
48465567|NCT04450394|155894709|FG000|Overall Study|Withdrawal by Subject|6|||
48465568|NCT04450394|155894710|FG001|Overall Study|Withdrawal by Subject|9|||
48465569|NCT04450394|155894711|FG002|Overall Study|Withdrawal by Subject|0|||
48465570|NCT01823991|155894712|FG000|Overall Study|Withdrawal by Subject|8|||
48465571|NCT01823991|155894713|FG001|Overall Study|Withdrawal by Subject|5|||
48465572|NCT00768040|155894714|FG000|Overall Study|Adverse Event|3|||
48465573|NCT00768040|155894715|FG001|Overall Study|Adverse Event|2|||
48465574|NCT00768040|155894714|FG000|Overall Study|Abnormal laboratory value|1|||
48465575|NCT00768040|155894715|FG001|Overall Study|Abnormal laboratory value|1|||
48465576|NCT05158244|155894716|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
48465577|NCT05158244|155894717|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
48465578|NCT05158244|155894718|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
48465579|NCT05158244|155894719|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
48465580|NCT05158244|155894720|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
48465581|NCT05158244|155894716|FG000|Overall Study|Withdrawal by Subject|0|||
48465582|NCT05158244|155894717|FG001|Overall Study|Withdrawal by Subject|0|||
48465583|NCT05158244|155894718|FG002|Overall Study|Withdrawal by Subject|1|||
48465584|NCT05158244|155894719|FG003|Overall Study|Withdrawal by Subject|0|||
48465585|NCT05158244|155894720|FG004|Overall Study|Withdrawal by Subject|0|||
48465586|NCT02194699|155894721|FG000|Randomised|Did not receive treatment|1|||
48465587|NCT02194699|155894722|FG001|Randomised|Did not receive treatment|5|||
48465588|NCT02194699|155894721|FG000|Randomised|Without potential for 52 weeks of IP|5|||
48465589|NCT02194699|155894722|FG001|Randomised|Without potential for 52 weeks of IP|5|||
48465590|NCT02194699|155894721|FG000|Randomised|Duplicate patient|2|||
48465591|NCT02194699|155894722|FG001|Randomised|Duplicate patient|1|||
48465592|NCT02194699|155894721|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
48465593|NCT02194699|155894722|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
48465594|NCT02194699|155894721|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
48465595|NCT02194699|155894722|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
48465596|NCT02194699|155894721|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
48465597|NCT02194699|155894722|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
48465598|NCT02194699|155894721|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
48465599|NCT02194699|155894722|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
48465600|NCT02194699|155894721|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
48465601|NCT02194699|155894722|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
48465602|NCT02194699|155894721|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
48465603|NCT02194699|155894722|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
48465604|NCT01066819|155894726|FG000|Overall Study|Adverse Event|18|||
48465605|NCT01066819|155894727|FG001|Overall Study|Adverse Event|1|||
48465606|NCT01066819|155894728|FG002|Overall Study|Adverse Event|6|||
48465607|NCT01066819|155894729|FG003|Overall Study|Adverse Event|0|||
48465608|NCT01066819|155894730|FG004|Overall Study|Adverse Event|0|||
48465609|NCT01066819|155894731|FG005|Overall Study|Adverse Event|0|||
48465610|NCT01066819|155894726|FG000|Overall Study|Death|5|||
48465611|NCT01066819|155894727|FG001|Overall Study|Death|0|||
48465612|NCT01066819|155894728|FG002|Overall Study|Death|1|||
48465613|NCT01066819|155894729|FG003|Overall Study|Death|0|||
48465614|NCT01066819|155894730|FG004|Overall Study|Death|0|||
48465615|NCT01066819|155894731|FG005|Overall Study|Death|0|||
48465616|NCT01066819|155894726|FG000|Overall Study|Lack of Efficacy|22|||
48465617|NCT01066819|155894727|FG001|Overall Study|Lack of Efficacy|1|||
48465618|NCT01066819|155894728|FG002|Overall Study|Lack of Efficacy|2|||
48465619|NCT01066819|155894729|FG003|Overall Study|Lack of Efficacy|1|||
48465620|NCT01066819|155894730|FG004|Overall Study|Lack of Efficacy|0|||
48465621|NCT01066819|155894731|FG005|Overall Study|Lack of Efficacy|0|||
48465622|NCT01066819|155894726|FG000|Overall Study|Physician Decision|6|||
48465623|NCT01066819|155894727|FG001|Overall Study|Physician Decision|2|||
48465624|NCT01066819|155894728|FG002|Overall Study|Physician Decision|3|||
48465625|NCT01066819|155894729|FG003|Overall Study|Physician Decision|0|||
48465626|NCT01066819|155894730|FG004|Overall Study|Physician Decision|0|||
48465627|NCT01066819|155894731|FG005|Overall Study|Physician Decision|0|||
48465628|NCT01066819|155894726|FG000|Overall Study|Protocol Violation|12|||
48465629|NCT01066819|155894727|FG001|Overall Study|Protocol Violation|6|||
48465630|NCT01066819|155894728|FG002|Overall Study|Protocol Violation|0|||
48465631|NCT01066819|155894729|FG003|Overall Study|Protocol Violation|0|||
48465632|NCT01066819|155894730|FG004|Overall Study|Protocol Violation|0|||
48465633|NCT01066819|155894731|FG005|Overall Study|Protocol Violation|0|||
48465634|NCT01066819|155894726|FG000|Overall Study|Withdrawal by Subject|29|||
48465635|NCT01066819|155894727|FG001|Overall Study|Withdrawal by Subject|11|||
48465636|NCT01066819|155894728|FG002|Overall Study|Withdrawal by Subject|6|||
48465637|NCT01066819|155894729|FG003|Overall Study|Withdrawal by Subject|0|||
48465638|NCT01066819|155894730|FG004|Overall Study|Withdrawal by Subject|0|||
48465639|NCT01066819|155894731|FG005|Overall Study|Withdrawal by Subject|0|||
48465640|NCT01066819|155894726|FG000|Overall Study|Administrative|6|||
48465641|NCT01066819|155894727|FG001|Overall Study|Administrative|4|||
48465642|NCT01066819|155894728|FG002|Overall Study|Administrative|2|||
48465643|NCT01066819|155894729|FG003|Overall Study|Administrative|0|||
48465644|NCT01066819|155894730|FG004|Overall Study|Administrative|0|||
48465645|NCT01066819|155894731|FG005|Overall Study|Administrative|0|||
48465646|NCT01066819|155894726|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
48465647|NCT01066819|155894727|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
48465648|NCT01066819|155894728|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
48465649|NCT01066819|155894729|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
48465650|NCT01066819|155894730|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
48465651|NCT01066819|155894731|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
48465652|NCT01066819|155894726|FG000|Overall Study|Early termination|2|||
48465653|NCT01066819|155894727|FG001|Overall Study|Early termination|0|||
48465654|NCT01066819|155894728|FG002|Overall Study|Early termination|0|||
48465655|NCT01066819|155894729|FG003|Overall Study|Early termination|0|||
48465656|NCT01066819|155894730|FG004|Overall Study|Early termination|0|||
48465657|NCT01066819|155894731|FG005|Overall Study|Early termination|0|||
48465658|NCT01066819|155894726|FG000|Overall Study|Failed to return|298|||
48465659|NCT01066819|155894727|FG001|Overall Study|Failed to return|107|||
48465660|NCT01066819|155894728|FG002|Overall Study|Failed to return|68|||
48465661|NCT01066819|155894729|FG003|Overall Study|Failed to return|7|||
48465662|NCT01066819|155894730|FG004|Overall Study|Failed to return|2|||
48465663|NCT01066819|155894731|FG005|Overall Study|Failed to return|3|||
48465664|NCT01066819|155894726|FG000|Overall Study|Lab test not done|9|||
48465665|NCT01066819|155894727|FG001|Overall Study|Lab test not done|0|||
48465666|NCT01066819|155894728|FG002|Overall Study|Lab test not done|2|||
48465667|NCT01066819|155894729|FG003|Overall Study|Lab test not done|1|||
48465668|NCT01066819|155894730|FG004|Overall Study|Lab test not done|0|||
48465669|NCT01066819|155894731|FG005|Overall Study|Lab test not done|0|||
48465670|NCT01066819|155894726|FG000|Overall Study|Miscellaneous|28|||
48465671|NCT01066819|155894727|FG001|Overall Study|Miscellaneous|10|||
48465672|NCT01066819|155894728|FG002|Overall Study|Miscellaneous|18|||
48465673|NCT01066819|155894729|FG003|Overall Study|Miscellaneous|1|||
48465674|NCT01066819|155894730|FG004|Overall Study|Miscellaneous|0|||
48465675|NCT01066819|155894731|FG005|Overall Study|Miscellaneous|0|||
48465676|NCT01066819|155894726|FG000|Overall Study|Non responders|123|||
48465677|NCT01066819|155894727|FG001|Overall Study|Non responders|2|||
48465678|NCT01066819|155894728|FG002|Overall Study|Non responders|7|||
48465679|NCT01066819|155894729|FG003|Overall Study|Non responders|2|||
48465680|NCT01066819|155894730|FG004|Overall Study|Non responders|0|||
48465681|NCT01066819|155894731|FG005|Overall Study|Non responders|1|||
48465682|NCT01066819|155894726|FG000|Overall Study|Not categorised|9|||
48465683|NCT01066819|155894727|FG001|Overall Study|Not categorised|2|||
48465684|NCT01066819|155894728|FG002|Overall Study|Not categorised|6|||
48465685|NCT01066819|155894729|FG003|Overall Study|Not categorised|1|||
48465686|NCT01066819|155894730|FG004|Overall Study|Not categorised|0|||
48465687|NCT01066819|155894731|FG005|Overall Study|Not categorised|0|||
48465688|NCT01066819|155894726|FG000|Overall Study|Relapse|16|||
48465689|NCT01066819|155894727|FG001|Overall Study|Relapse|4|||
48465690|NCT01066819|155894728|FG002|Overall Study|Relapse|3|||
48465691|NCT01066819|155894729|FG003|Overall Study|Relapse|0|||
48465692|NCT01066819|155894730|FG004|Overall Study|Relapse|0|||
48465693|NCT01066819|155894731|FG005|Overall Study|Relapse|0|||
48465694|NCT01066819|155894726|FG000|Overall Study|Results not available|1|||
48465695|NCT01066819|155894727|FG001|Overall Study|Results not available|0|||
48465696|NCT01066819|155894728|FG002|Overall Study|Results not available|0|||
48465697|NCT01066819|155894729|FG003|Overall Study|Results not available|0|||
48465698|NCT01066819|155894730|FG004|Overall Study|Results not available|0|||
48465699|NCT01066819|155894731|FG005|Overall Study|Results not available|0|||
48465700|NCT01066819|155894726|FG000|Overall Study|Screen failure|1|||
48465701|NCT01066819|155894727|FG001|Overall Study|Screen failure|0|||
48465702|NCT01066819|155894728|FG002|Overall Study|Screen failure|0|||
48465703|NCT01066819|155894729|FG003|Overall Study|Screen failure|0|||
48465704|NCT01066819|155894730|FG004|Overall Study|Screen failure|0|||
48465705|NCT01066819|155894731|FG005|Overall Study|Screen failure|0|||
48465706|NCT01066819|155894726|FG000|Overall Study|Spontaneous cure|1|||
48465707|NCT01066819|155894727|FG001|Overall Study|Spontaneous cure|0|||
48465708|NCT01066819|155894728|FG002|Overall Study|Spontaneous cure|0|||
48465709|NCT01066819|155894729|FG003|Overall Study|Spontaneous cure|0|||
48465710|NCT01066819|155894730|FG004|Overall Study|Spontaneous cure|0|||
48465711|NCT01066819|155894731|FG005|Overall Study|Spontaneous cure|0|||
48465712|NCT01066819|155894726|FG000|Overall Study|Treatment never started|85|||
48465713|NCT01066819|155894727|FG001|Overall Study|Treatment never started|19|||
48465714|NCT01066819|155894728|FG002|Overall Study|Treatment never started|19|||
48465715|NCT01066819|155894729|FG003|Overall Study|Treatment never started|3|||
48465716|NCT01066819|155894730|FG004|Overall Study|Treatment never started|2|||
48465717|NCT01066819|155894731|FG005|Overall Study|Treatment never started|2|||
48465718|NCT01066819|155894726|FG000|Overall Study|Treatment stopped|12|||
48465719|NCT01066819|155894727|FG001|Overall Study|Treatment stopped|1|||
48465720|NCT01066819|155894728|FG002|Overall Study|Treatment stopped|2|||
48465721|NCT01066819|155894729|FG003|Overall Study|Treatment stopped|1|||
48465722|NCT01066819|155894730|FG004|Overall Study|Treatment stopped|0|||
48465723|NCT01066819|155894731|FG005|Overall Study|Treatment stopped|0|||
48465724|NCT01066819|155894726|FG000|Overall Study|Other|5|||
48465725|NCT01066819|155894727|FG001|Overall Study|Other|1|||
48465726|NCT01066819|155894728|FG002|Overall Study|Other|1|||
48465727|NCT01066819|155894729|FG003|Overall Study|Other|0|||
48465728|NCT01066819|155894730|FG004|Overall Study|Other|0|||
48465729|NCT01066819|155894731|FG005|Overall Study|Other|0|||
48465730|NCT03322540|155894733|FG000|Overall Study|Death|21|||
48465731|NCT03322540|155894734|FG001|Overall Study|Death|28|||
48465732|NCT03322540|155894733|FG000|Overall Study|Lost to Follow-up|0|||
48465733|NCT03322540|155894734|FG001|Overall Study|Lost to Follow-up|1|||
48465734|NCT03322540|155894733|FG000|Overall Study|Physician Decision|7|||
48465735|NCT03322540|155894734|FG001|Overall Study|Physician Decision|6|||
48465736|NCT03322540|155894733|FG000|Overall Study|Withdrawal by Subject|3|||
48465737|NCT03322540|155894734|FG001|Overall Study|Withdrawal by Subject|1|||
48465738|NCT03322540|155894733|FG000|Overall Study|Study terminated by sponsor|0|||
48465739|NCT03322540|155894734|FG001|Overall Study|Study terminated by sponsor|1|||
48465740|NCT04047472|155894741|FG000|Overall Study|Adverse Event|3|||
48465741|NCT04047472|155894742|FG001|Overall Study|Adverse Event|3|||
48465742|NCT04047472|155894741|FG000|Overall Study|Death|0|||
48465743|NCT04047472|155894742|FG001|Overall Study|Death|1|||
48465744|NCT04047472|155894741|FG000|Overall Study|Lost to Follow-up|1|||
48465745|NCT04047472|155894742|FG001|Overall Study|Lost to Follow-up|0|||
48465746|NCT04047472|155894741|FG000|Overall Study|Physician Decision|1|||
48465747|NCT04047472|155894742|FG001|Overall Study|Physician Decision|2|||
48465748|NCT04047472|155894741|FG000|Overall Study|Protocol Violation|1|||
48465749|NCT04047472|155894742|FG001|Overall Study|Protocol Violation|0|||
48465750|NCT04047472|155894741|FG000|Overall Study|Withdrawal by Subject|10|||
48465751|NCT04047472|155894742|FG001|Overall Study|Withdrawal by Subject|10|||
48465752|NCT01853397|155894745|FG000|Overall Study|Withdrawal by Subject|0|||
48465753|NCT01853397|155894746|FG001|Overall Study|Withdrawal by Subject|0|||
48465754|NCT01853397|155894747|FG002|Overall Study|Withdrawal by Subject|0|||
48465755|NCT01853397|155894748|FG003|Overall Study|Withdrawal by Subject|1|||
48465756|NCT01853397|155894745|FG000|Overall Study|Subject Noncompliance|0|||
48465757|NCT01853397|155894746|FG001|Overall Study|Subject Noncompliance|0|||
48465758|NCT01853397|155894747|FG002|Overall Study|Subject Noncompliance|0|||
48465759|NCT01853397|155894748|FG003|Overall Study|Subject Noncompliance|1|||
48465760|NCT01724021|155894750|FG000|Overall Study|Adverse Event|11|||
48465761|NCT01724021|155894751|FG001|Overall Study|Adverse Event|6|||
48465762|NCT01724021|155894750|FG000|Overall Study|Death|46|||
48465763|NCT01724021|155894751|FG001|Overall Study|Death|58|||
48465764|NCT01724021|155894750|FG000|Overall Study|Participant request/ Withdrew consent|18|||
48465765|NCT01724021|155894751|FG001|Overall Study|Participant request/ Withdrew consent|14|||
48465766|NCT01724021|155894750|FG000|Overall Study|Lost to Follow-up|15|||
48465767|NCT01724021|155894751|FG001|Overall Study|Lost to Follow-up|15|||
48465768|NCT01724021|155894750|FG000|Overall Study|Reason Not Specified|36|||
48465769|NCT01724021|155894751|FG001|Overall Study|Reason Not Specified|39|||
48465770|NCT01724021|155894750|FG000|Overall Study|Missing|1|||
48465771|NCT01724021|155894751|FG001|Overall Study|Missing|1|||
48465772|NCT01005875|155894757|FG000|Overall Study|Death|3|||
48465773|NCT00203294|155894760|FG000|Overall Study|Withdrawal by Subject|8|||
48465774|NCT00203294|155894761|FG001|Overall Study|Withdrawal by Subject|13|||
48465775|NCT05047601|155894778|FG000|Overall Study|Lost to Follow-up|9|||
48465776|NCT05047601|155894779|FG001|Overall Study|Lost to Follow-up|11|||
48465777|NCT05047601|155894780|FG002|Overall Study|Lost to Follow-up|7|||
48465778|NCT05047601|155894778|FG000|Overall Study|Withdrawal by Subject|25|||
48465779|NCT05047601|155894779|FG001|Overall Study|Withdrawal by Subject|36|||
48465780|NCT05047601|155894780|FG002|Overall Study|Withdrawal by Subject|23|||
48465781|NCT05047601|155894778|FG000|Overall Study|Other|10|||
48465782|NCT05047601|155894779|FG001|Overall Study|Other|6|||
48465783|NCT05047601|155894780|FG002|Overall Study|Other|5|||
48465784|NCT02795182|155894781|FG000|Overall Study|Death|5|||
48465785|NCT02795182|155894782|FG001|Overall Study|Death|4|||
48465786|NCT02795182|155894783|FG002|Overall Study|Death|4|||
48465787|NCT02795182|155894784|FG003|Overall Study|Death|18|||
48465788|NCT02795182|155894781|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
48465789|NCT02795182|155894782|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
48465790|NCT02795182|155894783|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
48465791|NCT02795182|155894784|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
48465792|NCT02795182|155894781|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
48465793|NCT02795182|155894782|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
48465794|NCT02795182|155894783|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
48465795|NCT02795182|155894784|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
48465796|NCT02795182|155894781|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
48465797|NCT02795182|155894782|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
48465798|NCT02795182|155894783|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
48465799|NCT02795182|155894784|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
48465800|NCT02795182|155894781|FG000|Overall Study|Withdrawal by Subject|4|||
48465801|NCT02795182|155894782|FG001|Overall Study|Withdrawal by Subject|0|||
48465802|NCT02795182|155894783|FG002|Overall Study|Withdrawal by Subject|0|||
48465803|NCT02795182|155894784|FG003|Overall Study|Withdrawal by Subject|3|||
48465804|NCT02795182|155894781|FG000|Overall Study|Lost to Follow-up|0|||
48465805|NCT02795182|155894782|FG001|Overall Study|Lost to Follow-up|0|||
48465806|NCT02795182|155894783|FG002|Overall Study|Lost to Follow-up|1|||
48465807|NCT02795182|155894784|FG003|Overall Study|Lost to Follow-up|1|||
48465808|NCT02795182|155894781|FG000|Overall Study|Roll Over to Long Term Extension|3|||
48465809|NCT02795182|155894782|FG001|Overall Study|Roll Over to Long Term Extension|3|||
48465810|NCT02795182|155894783|FG002|Overall Study|Roll Over to Long Term Extension|2|||
48465811|NCT02795182|155894784|FG003|Overall Study|Roll Over to Long Term Extension|5|||
48465812|NCT02795182|155894781|FG000|Overall Study|Progressive Disease|0|||
48465813|NCT02795182|155894782|FG001|Overall Study|Progressive Disease|1|||
48465814|NCT02795182|155894783|FG002|Overall Study|Progressive Disease|0|||
48465815|NCT02795182|155894784|FG003|Overall Study|Progressive Disease|4|||
48465816|NCT02795182|155894781|FG000|Overall Study|Physician Decision|0|||
48465817|NCT02795182|155894782|FG001|Overall Study|Physician Decision|0|||
48465818|NCT02795182|155894783|FG002|Overall Study|Physician Decision|0|||
48465819|NCT02795182|155894784|FG003|Overall Study|Physician Decision|1|||
48465820|NCT00247962|155894791|FG000|Overall Study|Adverse Event|15|||
48465821|NCT00247962|155894792|FG001|Overall Study|Adverse Event|12|||
48465822|NCT00247962|155894791|FG000|Overall Study|Lost to Follow-up|3|||
48465823|NCT00247962|155894792|FG001|Overall Study|Lost to Follow-up|1|||
48465824|NCT00247962|155894791|FG000|Overall Study|Physician Decision|0|||
48465825|NCT00247962|155894792|FG001|Overall Study|Physician Decision|1|||
48465826|NCT00247962|155894791|FG000|Overall Study|Protocol Violation|1|||
48465827|NCT00247962|155894792|FG001|Overall Study|Protocol Violation|1|||
48465828|NCT00247962|155894791|FG000|Overall Study|Withdrawal by Subject|3|||
48465829|NCT00247962|155894792|FG001|Overall Study|Withdrawal by Subject|2|||
48465830|NCT00247962|155894791|FG000|Overall Study|Lack of Efficacy|4|||
48465831|NCT00247962|155894792|FG001|Overall Study|Lack of Efficacy|2|||
48465832|NCT03525613|155894794|FG000|Overall Study|Adverse Event|11|||
48465833|NCT03525613|155894795|FG001|Overall Study|Adverse Event|8|||
48465834|NCT03525613|155894796|FG002|Overall Study|Adverse Event|3|||
48465835|NCT03525613|155894797|FG003|Overall Study|Adverse Event|3|||
48465836|NCT03525613|155894794|FG000|Overall Study|Lost to Follow-up|4|||
48465837|NCT03525613|155894795|FG001|Overall Study|Lost to Follow-up|5|||
48465838|NCT03525613|155894796|FG002|Overall Study|Lost to Follow-up|3|||
48465839|NCT03525613|155894797|FG003|Overall Study|Lost to Follow-up|2|||
48465840|NCT03525613|155894794|FG000|Overall Study|Physician Decision|0|||
48465841|NCT03525613|155894795|FG001|Overall Study|Physician Decision|1|||
48465842|NCT03525613|155894796|FG002|Overall Study|Physician Decision|0|||
48465843|NCT03525613|155894797|FG003|Overall Study|Physician Decision|1|||
48465844|NCT03525613|155894794|FG000|Overall Study|Consent Withdrawal|25|||
48465845|NCT03525613|155894795|FG001|Overall Study|Consent Withdrawal|16|||
48465846|NCT03525613|155894796|FG002|Overall Study|Consent Withdrawal|12|||
48465847|NCT03525613|155894797|FG003|Overall Study|Consent Withdrawal|9|||
48465848|NCT03525613|155894794|FG000|Overall Study|Death|20|||
48465849|NCT03525613|155894795|FG001|Overall Study|Death|9|||
48465850|NCT03525613|155894796|FG002|Overall Study|Death|7|||
48465851|NCT03525613|155894797|FG003|Overall Study|Death|1|||
48465852|NCT03525613|155894794|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
48465853|NCT03525613|155894795|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
48465854|NCT03525613|155894796|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
48465855|NCT03525613|155894797|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
48465856|NCT03480360|155894800|FG000|Overall Study|Death|2|||
48465857|NCT01314261|155894803|FG000|Overall Study|Adverse Event|1|||
48465858|NCT01314261|155894804|FG001|Overall Study|Adverse Event|0|||
48465859|NCT01314261|155894805|FG002|Overall Study|Adverse Event|0|||
48465860|NCT01314261|155894806|FG003|Overall Study|Adverse Event|0|||
48465861|NCT01314261|155894803|FG000|Overall Study|Withdrawal by Subject|0|||
48465862|NCT01314261|155894804|FG001|Overall Study|Withdrawal by Subject|3|||
48465863|NCT01314261|155894805|FG002|Overall Study|Withdrawal by Subject|1|||
48465864|NCT01314261|155894806|FG003|Overall Study|Withdrawal by Subject|0|||
48465865|NCT01314261|155894803|FG000|Overall Study|Lost to Follow-up|1|||
48465866|NCT01314261|155894804|FG001|Overall Study|Lost to Follow-up|0|||
48465867|NCT01314261|155894805|FG002|Overall Study|Lost to Follow-up|2|||
48465868|NCT01314261|155894806|FG003|Overall Study|Lost to Follow-up|2|||
48465869|NCT01314261|155894803|FG000|Overall Study|Virologic Failure|0|||
48465870|NCT01314261|155894804|FG001|Overall Study|Virologic Failure|1|||
48465871|NCT01314261|155894805|FG002|Overall Study|Virologic Failure|0|||
48465872|NCT01314261|155894806|FG003|Overall Study|Virologic Failure|1|||
48465873|NCT00877929|155894807|FG000|Overall Study|Adverse Event|11|||
48465874|NCT00877929|155894808|FG001|Overall Study|Adverse Event|20|||
48465875|NCT00877929|155894807|FG000|Overall Study|Protocol Violation|3|||
48465876|NCT00877929|155894808|FG001|Overall Study|Protocol Violation|3|||
48465877|NCT00877929|155894807|FG000|Overall Study|Lost to Follow-up|0|||
48465878|NCT00877929|155894808|FG001|Overall Study|Lost to Follow-up|1|||
48465879|NCT00877929|155894807|FG000|Overall Study|Withdrawal by Subject|4|||
48465880|NCT00877929|155894808|FG001|Overall Study|Withdrawal by Subject|4|||
48465881|NCT00877929|155894807|FG000|Overall Study|Lack of Efficacy|0|||
48465882|NCT00877929|155894808|FG001|Overall Study|Lack of Efficacy|1|||
48465883|NCT00877929|155894807|FG000|Overall Study|Other reason (not specified)|2|||
48465884|NCT00877929|155894808|FG001|Overall Study|Other reason (not specified)|6|||
48465885|NCT01231620|155894809|FG000|Overall Study|Physician Decision|3|||
48465886|NCT01231620|155894810|FG001|Overall Study|Physician Decision|5|||
48465887|NCT01231620|155894811|FG002|Overall Study|Physician Decision|10|||
48465888|NCT01231620|155894809|FG000|Overall Study|Death|12|||
48465889|NCT01231620|155894810|FG001|Overall Study|Death|14|||
48465890|NCT01231620|155894811|FG002|Overall Study|Death|11|||
48465891|NCT01231620|155894809|FG000|Overall Study|Adverse Event|2|||
48465892|NCT01231620|155894810|FG001|Overall Study|Adverse Event|2|||
48465893|NCT01231620|155894811|FG002|Overall Study|Adverse Event|1|||
48465894|NCT01231620|155894809|FG000|Overall Study|Withdrawal by Subject|6|||
48465895|NCT01231620|155894810|FG001|Overall Study|Withdrawal by Subject|6|||
48465896|NCT01231620|155894811|FG002|Overall Study|Withdrawal by Subject|8|||
48465897|NCT01231620|155894809|FG000|Overall Study|Lost to Follow-up|3|||
48465898|NCT01231620|155894810|FG001|Overall Study|Lost to Follow-up|4|||
48465899|NCT01231620|155894811|FG002|Overall Study|Lost to Follow-up|9|||
48465900|NCT01140646|155894812|FG000|Overall Study|Adverse Event|4|||
48465901|NCT01140646|155894812|FG000|Overall Study|Refused Further Treatment|5|||
48465902|NCT02400281|155894813|FG000|Overall Study|Adverse Event|0|||
48465903|NCT02400281|155894814|FG001|Overall Study|Adverse Event|0|||
48465904|NCT02400281|155894815|FG002|Overall Study|Adverse Event|1|||
48465905|NCT02400281|155894816|FG003|Overall Study|Adverse Event|0|||
48465906|NCT02400281|155894817|FG004|Overall Study|Adverse Event|1|||
48465907|NCT02400281|155894818|FG005|Overall Study|Adverse Event|0|||
48465908|NCT02400281|155894813|FG000|Overall Study|Physician Decision|0|||
48465909|NCT02400281|155894814|FG001|Overall Study|Physician Decision|0|||
48465910|NCT02400281|155894815|FG002|Overall Study|Physician Decision|1|||
48465911|NCT02400281|155894816|FG003|Overall Study|Physician Decision|0|||
48465912|NCT02400281|155894817|FG004|Overall Study|Physician Decision|0|||
48465913|NCT02400281|155894818|FG005|Overall Study|Physician Decision|0|||
48465914|NCT04524507|155894819|FG000|Overall Study|Lost to Follow-up|2|||
48465915|NCT04524507|155894820|FG001|Overall Study|Lost to Follow-up|4|||
48465916|NCT04524507|155894819|FG000|Overall Study|Withdrawal by Subject|2|||
48465917|NCT04524507|155894820|FG001|Overall Study|Withdrawal by Subject|9|||
48465918|NCT04524507|155894819|FG000|Overall Study|Death|2|||
48465919|NCT04524507|155894820|FG001|Overall Study|Death|10|||
48465920|NCT00412360|155894823|FG000|Overall Study|Lost to Follow-up|0|||
48465921|NCT00412360|155894824|FG001|Overall Study|Lost to Follow-up|1|||
48465922|NCT00412360|155894823|FG000|Overall Study|Not Transplanted|1|||
48465923|NCT00412360|155894824|FG001|Overall Study|Not Transplanted|2|||
48465924|NCT02711306|155894830|FG000|Overall Study|Withdrawal by Subject|2|||
48465925|NCT02711306|155894831|FG001|Overall Study|Withdrawal by Subject|2|||
48465926|NCT02576652|155894832|FG000|Overall Study|Withdrawal by Subject|2|||
48465927|NCT02354599|155894835|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
48465928|NCT02354599|155894836|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
48465929|NCT02354599|155894837|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
48465930|NCT02354599|155894838|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
48465931|NCT02354599|155894839|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
48465932|NCT02354599|155894840|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
48465933|NCT02354599|155894835|FG000|Overall Study|Withdrawal by Subject|1|||
48465934|NCT02354599|155894836|FG001|Overall Study|Withdrawal by Subject|1|||
48465935|NCT02354599|155894837|FG002|Overall Study|Withdrawal by Subject|0|||
48465936|NCT02354599|155894838|FG003|Overall Study|Withdrawal by Subject|0|||
48465937|NCT02354599|155894839|FG004|Overall Study|Withdrawal by Subject|0|||
48465938|NCT02354599|155894840|FG005|Overall Study|Withdrawal by Subject|0|||
48465939|NCT02146352|155894841|FG000|Overall Study|Death|1|||
48465940|NCT02146352|155894841|FG000|Overall Study|Patient entered hospice care|1|||
48465941|NCT02811640|155894842|FG000|Overall Study|Technology malfunction|2|||
48465942|NCT00598585|155894843|FG000|Overall Study|Lost to Follow-up|1|||
48465943|NCT00598585|155894844|FG001|Overall Study|Lost to Follow-up|0|||
48465944|NCT00842829|155894847|FG000|Dose Titration Period|Adverse Event|11|||
48465945|NCT00842829|155894848|FG001|Dose Titration Period|Adverse Event|10|||
48465946|NCT00842829|155894849|FG002|Dose Titration Period|Adverse Event|0|||
48465947|NCT00842829|155894847|FG000|Dose Titration Period|Lack of Efficacy|4|||
48465948|NCT00842829|155894848|FG001|Dose Titration Period|Lack of Efficacy|1|||
48465949|NCT00842829|155894849|FG002|Dose Titration Period|Lack of Efficacy|0|||
48465950|NCT00842829|155894847|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
48465951|NCT00842829|155894848|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
48465952|NCT00842829|155894849|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
48465953|NCT00842829|155894847|FG000|Dose Titration Period|Withdrawal by Subject|2|||
48465954|NCT00842829|155894848|FG001|Dose Titration Period|Withdrawal by Subject|6|||
48465955|NCT00842829|155894849|FG002|Dose Titration Period|Withdrawal by Subject|0|||
48465956|NCT00842829|155894847|FG000|Dose Titration Period|Other|5|||
48465957|NCT00842829|155894848|FG001|Dose Titration Period|Other|4|||
48465958|NCT00842829|155894849|FG002|Dose Titration Period|Other|0|||
48465959|NCT00842829|155894847|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
48465960|NCT00842829|155894848|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
48465961|NCT00842829|155894849|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
48465962|NCT00842829|155894847|FG000|Dose Titration Period|Non-compliance to study drug|2|||
48465963|NCT00842829|155894848|FG001|Dose Titration Period|Non-compliance to study drug|1|||
48465964|NCT00842829|155894849|FG002|Dose Titration Period|Non-compliance to study drug|0|||
48465965|NCT00842829|155894847|FG000|Treatment Period|Adverse Event|0|||
48465966|NCT00842829|155894848|FG001|Treatment Period|Adverse Event|0|||
48465967|NCT00842829|155894849|FG002|Treatment Period|Adverse Event|15|||
48465968|NCT00842829|155894847|FG000|Treatment Period|Lack of Efficacy|0|||
48465969|NCT00842829|155894848|FG001|Treatment Period|Lack of Efficacy|0|||
48465970|NCT00842829|155894849|FG002|Treatment Period|Lack of Efficacy|6|||
48465971|NCT00842829|155894847|FG000|Treatment Period|Unstable persistent cancer pain|0|||
48465972|NCT00842829|155894848|FG001|Treatment Period|Unstable persistent cancer pain|0|||
48465973|NCT00842829|155894849|FG002|Treatment Period|Unstable persistent cancer pain|5|||
48465974|NCT00842829|155894847|FG000|Treatment Period|Withdrawal by Subject|0|||
48465975|NCT00842829|155894848|FG001|Treatment Period|Withdrawal by Subject|0|||
48465976|NCT00842829|155894849|FG002|Treatment Period|Withdrawal by Subject|11|||
48465977|NCT00842829|155894847|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
48465978|NCT00842829|155894848|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
48465979|NCT00842829|155894849|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
48465980|NCT00842829|155894847|FG000|Treatment Period|Protocol Violation|0|||
48465981|NCT00842829|155894848|FG001|Treatment Period|Protocol Violation|0|||
48465982|NCT00842829|155894849|FG002|Treatment Period|Protocol Violation|2|||
48465983|NCT00842829|155894847|FG000|Treatment Period|Other|0|||
48465984|NCT00842829|155894848|FG001|Treatment Period|Other|0|||
48465985|NCT00842829|155894849|FG002|Treatment Period|Other|18|||
48465986|NCT00842829|155894847|FG000|Treatment Period|Non-compliance to study procedures|0|||
48465987|NCT00842829|155894848|FG001|Treatment Period|Non-compliance to study procedures|0|||
48465988|NCT00842829|155894849|FG002|Treatment Period|Non-compliance to study procedures|4|||
48465989|NCT00842829|155894847|FG000|Treatment Period|Unclear completion status|0|||
48465990|NCT00842829|155894848|FG001|Treatment Period|Unclear completion status|0|||
48465991|NCT00842829|155894849|FG002|Treatment Period|Unclear completion status|1|||
48465992|NCT00842829|155894847|FG000|Continuation Period|Adverse Event|0|||
48465993|NCT00842829|155894848|FG001|Continuation Period|Adverse Event|0|||
48465994|NCT00842829|155894849|FG002|Continuation Period|Adverse Event|32|||
48465995|NCT00842829|155894847|FG000|Continuation Period|Lack of Efficacy|0|||
48465996|NCT00842829|155894848|FG001|Continuation Period|Lack of Efficacy|0|||
48465997|NCT00842829|155894849|FG002|Continuation Period|Lack of Efficacy|6|||
48465998|NCT00842829|155894847|FG000|Continuation Period|Unstable persistent cancer pain|0|||
48465999|NCT00842829|155894848|FG001|Continuation Period|Unstable persistent cancer pain|0|||
48466000|NCT00842829|155894849|FG002|Continuation Period|Unstable persistent cancer pain|3|||
48466001|NCT00842829|155894847|FG000|Continuation Period|Withdrawal by Subject|0|||
48466002|NCT00842829|155894848|FG001|Continuation Period|Withdrawal by Subject|0|||
48466003|NCT00842829|155894849|FG002|Continuation Period|Withdrawal by Subject|10|||
48466004|NCT00842829|155894847|FG000|Continuation Period|Other|0|||
48466005|NCT00842829|155894848|FG001|Continuation Period|Other|0|||
48466006|NCT00842829|155894849|FG002|Continuation Period|Other|7|||
48466007|NCT00842829|155894847|FG000|Continuation Period|Non-compliance to study procedures|0|||
48466008|NCT00842829|155894848|FG001|Continuation Period|Non-compliance to study procedures|0|||
48466009|NCT00842829|155894849|FG002|Continuation Period|Non-compliance to study procedures|2|||
48466010|NCT00842829|155894847|FG000|Continuation Period|Non-compliance to study drug|0|||
48466011|NCT00842829|155894848|FG001|Continuation Period|Non-compliance to study drug|0|||
48466012|NCT00842829|155894849|FG002|Continuation Period|Non-compliance to study drug|1|||
48466013|NCT03077646|155894850|FG000|Overall Study|Lost to Follow-up|29|||
48466014|NCT03077646|155894851|FG001|Overall Study|Lost to Follow-up|30|||
48466015|NCT03077646|155894852|FG002|Overall Study|Lost to Follow-up|31|||
48466016|NCT02972658|155896474|FG000|Overall Study|Adverse Event|0|||
48466017|NCT02972658|155896475|FG001|Overall Study|Adverse Event|3|||
48466018|NCT02972658|155896476|FG002|Overall Study|Adverse Event|0|||
48466019|NCT02972658|155896477|FG003|Overall Study|Adverse Event|2|||
48466020|NCT02972658|155896474|FG000|Overall Study|Other-determined by Investigator|1|||
48466021|NCT02972658|155896475|FG001|Overall Study|Other-determined by Investigator|1|||
48466022|NCT02972658|155896476|FG002|Overall Study|Other-determined by Investigator|0|||
48466023|NCT02972658|155896477|FG003|Overall Study|Other-determined by Investigator|0|||
48466024|NCT02972658|155896474|FG000|Overall Study|Death|0|||
48466025|NCT02972658|155896475|FG001|Overall Study|Death|0|||
48466026|NCT02972658|155896476|FG002|Overall Study|Death|0|||
48466027|NCT02972658|155896477|FG003|Overall Study|Death|1|||
48466028|NCT02972658|155896474|FG000|Overall Study|Lost to Follow-up|0|||
48466029|NCT02972658|155896475|FG001|Overall Study|Lost to Follow-up|1|||
48466030|NCT02972658|155896476|FG002|Overall Study|Lost to Follow-up|1|||
48466031|NCT02972658|155896477|FG003|Overall Study|Lost to Follow-up|2|||
48466032|NCT02972658|155896474|FG000|Overall Study|Progressive Disease|0|||
48466033|NCT02972658|155896475|FG001|Overall Study|Progressive Disease|1|||
48466034|NCT02972658|155896476|FG002|Overall Study|Progressive Disease|0|||
48466035|NCT02972658|155896477|FG003|Overall Study|Progressive Disease|1|||
48466036|NCT02972658|155896474|FG000|Overall Study|Withdrawal by Subject|4|||
48466037|NCT02972658|155896475|FG001|Overall Study|Withdrawal by Subject|4|||
48466038|NCT02972658|155896476|FG002|Overall Study|Withdrawal by Subject|1|||
48466039|NCT02972658|155896477|FG003|Overall Study|Withdrawal by Subject|6|||
48466040|NCT02972658|155896474|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
48466041|NCT02972658|155896475|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
48466042|NCT02972658|155896476|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
48466043|NCT02972658|155896477|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
48466044|NCT02972658|155896474|FG000|Overall Study|Sponsor Decision|70|||
48466045|NCT02972658|155896475|FG001|Overall Study|Sponsor Decision|127|||
48466046|NCT02972658|155896476|FG002|Overall Study|Sponsor Decision|72|||
48466047|NCT02972658|155896477|FG003|Overall Study|Sponsor Decision|119|||
48466048|NCT02146274|155896478|FG000|Overall Study|Protocol Violation|73|||
48466049|NCT02039687|155896481|FG000|Overall Study|Adverse Event|0|||
48466050|NCT02039687|155896482|FG001|Overall Study|Adverse Event|0|||
48466051|NCT02039687|155896483|FG002|Overall Study|Adverse Event|1|||
48466052|NCT02039687|155896484|FG003|Overall Study|Adverse Event|0|||
48466053|NCT02039687|155896481|FG000|Overall Study|Withdrawal by Subject|0|||
48466054|NCT02039687|155896482|FG001|Overall Study|Withdrawal by Subject|1|||
48466055|NCT02039687|155896483|FG002|Overall Study|Withdrawal by Subject|0|||
48466056|NCT02039687|155896484|FG003|Overall Study|Withdrawal by Subject|0|||
48466057|NCT02039687|155896481|FG000|Overall Study|treatment assignment could not be confir|0|||
48466058|NCT02039687|155896482|FG001|Overall Study|treatment assignment could not be confir|0|||
48466059|NCT02039687|155896483|FG002|Overall Study|treatment assignment could not be confir|2|||
48466060|NCT02039687|155896484|FG003|Overall Study|treatment assignment could not be confir|0|||
48466061|NCT02408016|155896485|FG000|Overall Study|Death|6|||
48466062|NCT02408016|155896486|FG001|Overall Study|Death|1|||
48466063|NCT02408016|155896487|FG002|Overall Study|Death|0|||
48466064|NCT02408016|155896485|FG000|Overall Study|Physician Decision|0|||
48466065|NCT02408016|155896486|FG001|Overall Study|Physician Decision|2|||
48466066|NCT02408016|155896487|FG002|Overall Study|Physician Decision|0|||
48466067|NCT00805194|155896495|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
48466068|NCT00805194|155896496|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
48466069|NCT00805194|155896495|FG000|Overall Study|Worsening or AE of underlying disease|64|||
48466070|NCT00805194|155896496|FG001|Overall Study|Worsening or AE of underlying disease|70|||
48466071|NCT00805194|155896495|FG000|Overall Study|Other AE|84|||
48466072|NCT00805194|155896496|FG001|Overall Study|Other AE|73|||
48466073|NCT00805194|155896495|FG000|Overall Study|Protocol Violation|9|||
48466074|NCT00805194|155896496|FG001|Overall Study|Protocol Violation|9|||
48466075|NCT00805194|155896495|FG000|Overall Study|Lost to Follow-up|5|||
48466076|NCT00805194|155896496|FG001|Overall Study|Lost to Follow-up|5|||
48466077|NCT00805194|155896495|FG000|Overall Study|Withdrawal by Subject|60|||
48466078|NCT00805194|155896496|FG001|Overall Study|Withdrawal by Subject|42|||
48466079|NCT00805194|155896495|FG000|Overall Study|Not treated|3|||
48466080|NCT00805194|155896496|FG001|Overall Study|Not treated|4|||
48466081|NCT00805194|155896495|FG000|Overall Study|Reasons other than stated above|20|||
48466082|NCT00805194|155896496|FG001|Overall Study|Reasons other than stated above|16|||
48466083|NCT01616173|155896500|FG000|Overall Study|Lost to Follow-up|0|||
48466084|NCT01616173|155896501|FG001|Overall Study|Lost to Follow-up|2|||
48466085|NCT01616173|155896502|FG002|Overall Study|Lost to Follow-up|0|||
48466086|NCT01038609|155896503|FG000|Overall Study|Adverse Event|0|||
48466087|NCT01038609|155896504|FG001|Overall Study|Adverse Event|0|||
48466088|NCT01038609|155896505|FG002|Overall Study|Adverse Event|1|||
48466089|NCT01038609|155896506|FG003|Overall Study|Adverse Event|0|||
48466090|NCT01038609|155896507|FG004|Overall Study|Adverse Event|0|||
48466091|NCT01038609|155896503|FG000|Overall Study|Dosing Error|0|||
48466092|NCT01038609|155896504|FG001|Overall Study|Dosing Error|0|||
48466093|NCT01038609|155896505|FG002|Overall Study|Dosing Error|0|||
48466094|NCT01038609|155896506|FG003|Overall Study|Dosing Error|1|||
48466095|NCT01038609|155896507|FG004|Overall Study|Dosing Error|1|||
48466096|NCT01038609|155896503|FG000|Overall Study|Death in the Family|1|||
48466097|NCT01038609|155896504|FG001|Overall Study|Death in the Family|0|||
48466098|NCT01038609|155896505|FG002|Overall Study|Death in the Family|0|||
48466099|NCT01038609|155896506|FG003|Overall Study|Death in the Family|0|||
48466100|NCT01038609|155896507|FG004|Overall Study|Death in the Family|0|||
48466101|NCT01038609|155896503|FG000|Overall Study|Refusal of Blood Draws|0|||
48466102|NCT01038609|155896504|FG001|Overall Study|Refusal of Blood Draws|1|||
48466103|NCT01038609|155896505|FG002|Overall Study|Refusal of Blood Draws|0|||
48466104|NCT01038609|155896506|FG003|Overall Study|Refusal of Blood Draws|0|||
48466105|NCT01038609|155896507|FG004|Overall Study|Refusal of Blood Draws|0|||
48466106|NCT02545504|155896508|FG000|Overall Study|Death|174|||
48466107|NCT02545504|155896509|FG001|Overall Study|Death|168|||
48466108|NCT02545504|155896508|FG000|Overall Study|Unknown reason|30|||
48466109|NCT02545504|155896509|FG001|Overall Study|Unknown reason|32|||
48466110|NCT02545504|155896508|FG000|Overall Study|Withdrew consent|9|||
48466111|NCT02545504|155896509|FG001|Overall Study|Withdrew consent|11|||
48466112|NCT02545504|155896508|FG000|Overall Study|Investigator's discretion|3|||
48466113|NCT02545504|155896509|FG001|Overall Study|Investigator's discretion|1|||
48466114|NCT02545504|155896508|FG000|Overall Study|Lost to Follow-up|2|||
48466115|NCT02545504|155896509|FG001|Overall Study|Lost to Follow-up|2|||
48466116|NCT02242305|155896516|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
48466117|NCT02242305|155896517|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
48466118|NCT02242305|155896516|FG000|Overall Study|Adverse Event|1|||
48466119|NCT02242305|155896517|FG001|Overall Study|Adverse Event|0|||
48466120|NCT02242305|155896516|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
48466121|NCT02242305|155896517|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
48466122|NCT02242305|155896516|FG000|Overall Study|Subject withdraws inform consent|0|||
48466123|NCT02242305|155896517|FG001|Overall Study|Subject withdraws inform consent|4|||
48466124|NCT02242305|155896516|FG000|Overall Study|Lost to Follow-up|2|||
48466125|NCT02242305|155896517|FG001|Overall Study|Lost to Follow-up|0|||
48466126|NCT01632345|155896518|FG000|Treatment: Part I|Adverse Event|1|||
48466127|NCT01632345|155896519|FG001|Treatment: Part I|Adverse Event|4|||
48466128|NCT01632345|155896520|FG002|Treatment: Part I|Adverse Event|2|||
48466129|NCT01632345|155896521|FG003|Treatment: Part I|Adverse Event|1|||
48466130|NCT01632345|155896522|FG004|Treatment: Part I|Adverse Event|3|||
48466131|NCT01632345|155896523|FG005|Treatment: Part I|Adverse Event|0|||
48466132|NCT01632345|155896524|FG006|Treatment: Part I|Adverse Event|0|||
48466133|NCT01632345|155896518|FG000|Treatment: Part I|Lack of Efficacy|0|||
48466134|NCT01632345|155896519|FG001|Treatment: Part I|Lack of Efficacy|1|||
48466135|NCT01632345|155896520|FG002|Treatment: Part I|Lack of Efficacy|0|||
48466136|NCT01632345|155896521|FG003|Treatment: Part I|Lack of Efficacy|1|||
48466137|NCT01632345|155896522|FG004|Treatment: Part I|Lack of Efficacy|1|||
48466138|NCT01632345|155896523|FG005|Treatment: Part I|Lack of Efficacy|0|||
48466139|NCT01632345|155896524|FG006|Treatment: Part I|Lack of Efficacy|0|||
48466140|NCT01632345|155896518|FG000|Treatment: Part I|Lost to Follow-up|3|||
48466141|NCT01632345|155896519|FG001|Treatment: Part I|Lost to Follow-up|2|||
48466142|NCT01632345|155896520|FG002|Treatment: Part I|Lost to Follow-up|1|||
48466143|NCT01632345|155896521|FG003|Treatment: Part I|Lost to Follow-up|3|||
48466144|NCT01632345|155896522|FG004|Treatment: Part I|Lost to Follow-up|4|||
48466145|NCT01632345|155896523|FG005|Treatment: Part I|Lost to Follow-up|0|||
48466146|NCT01632345|155896524|FG006|Treatment: Part I|Lost to Follow-up|0|||
48466147|NCT01632345|155896518|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
48466148|NCT01632345|155896519|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
48466149|NCT01632345|155896520|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
48466150|NCT01632345|155896521|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
48466151|NCT01632345|155896522|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
48466152|NCT01632345|155896523|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
48466153|NCT01632345|155896524|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
48466154|NCT01632345|155896518|FG000|Treatment: Part I|Physician Decision|2|||
48466155|NCT01632345|155896519|FG001|Treatment: Part I|Physician Decision|1|||
48466156|NCT01632345|155896520|FG002|Treatment: Part I|Physician Decision|0|||
48466157|NCT01632345|155896521|FG003|Treatment: Part I|Physician Decision|0|||
48466158|NCT01632345|155896522|FG004|Treatment: Part I|Physician Decision|1|||
48466159|NCT01632345|155896523|FG005|Treatment: Part I|Physician Decision|0|||
48466160|NCT01632345|155896524|FG006|Treatment: Part I|Physician Decision|0|||
48466161|NCT01632345|155896518|FG000|Treatment: Part I|Pregnancy|0|||
48466162|NCT01632345|155896519|FG001|Treatment: Part I|Pregnancy|1|||
48466163|NCT01632345|155896520|FG002|Treatment: Part I|Pregnancy|0|||
48466164|NCT01632345|155896521|FG003|Treatment: Part I|Pregnancy|0|||
48466165|NCT01632345|155896522|FG004|Treatment: Part I|Pregnancy|0|||
48466166|NCT01632345|155896523|FG005|Treatment: Part I|Pregnancy|0|||
48466167|NCT01632345|155896524|FG006|Treatment: Part I|Pregnancy|0|||
48466168|NCT01632345|155896518|FG000|Treatment: Part I|Protocol Deviation|0|||
48466169|NCT01632345|155896519|FG001|Treatment: Part I|Protocol Deviation|0|||
48466170|NCT01632345|155896520|FG002|Treatment: Part I|Protocol Deviation|1|||
48466171|NCT01632345|155896521|FG003|Treatment: Part I|Protocol Deviation|1|||
48466172|NCT01632345|155896522|FG004|Treatment: Part I|Protocol Deviation|0|||
48466173|NCT01632345|155896523|FG005|Treatment: Part I|Protocol Deviation|0|||
48466174|NCT01632345|155896524|FG006|Treatment: Part I|Protocol Deviation|0|||
48466175|NCT01632345|155896518|FG000|Treatment: Part I|Withdrawal by Subject|3|||
48466176|NCT01632345|155896519|FG001|Treatment: Part I|Withdrawal by Subject|4|||
48466177|NCT01632345|155896520|FG002|Treatment: Part I|Withdrawal by Subject|4|||
48466178|NCT01632345|155896521|FG003|Treatment: Part I|Withdrawal by Subject|1|||
48466179|NCT01632345|155896522|FG004|Treatment: Part I|Withdrawal by Subject|4|||
48466180|NCT01632345|155896523|FG005|Treatment: Part I|Withdrawal by Subject|0|||
48466181|NCT01632345|155896524|FG006|Treatment: Part I|Withdrawal by Subject|0|||
48466182|NCT01632345|155896518|FG000|Treatment: Part II|Adverse Event|0|||
48466183|NCT01632345|155896519|FG001|Treatment: Part II|Adverse Event|0|||
48466184|NCT01632345|155896520|FG002|Treatment: Part II|Adverse Event|0|||
48466185|NCT01632345|155896521|FG003|Treatment: Part II|Adverse Event|0|||
48466186|NCT01632345|155896522|FG004|Treatment: Part II|Adverse Event|0|||
48466187|NCT01632345|155896523|FG005|Treatment: Part II|Adverse Event|3|||
48466188|NCT01632345|155896524|FG006|Treatment: Part II|Adverse Event|8|||
48466189|NCT01632345|155896518|FG000|Treatment: Part II|Lost to Follow-up|0|||
48466190|NCT01632345|155896519|FG001|Treatment: Part II|Lost to Follow-up|0|||
48466191|NCT01632345|155896520|FG002|Treatment: Part II|Lost to Follow-up|0|||
48466192|NCT01632345|155896521|FG003|Treatment: Part II|Lost to Follow-up|0|||
48466193|NCT01632345|155896522|FG004|Treatment: Part II|Lost to Follow-up|0|||
48466194|NCT01632345|155896523|FG005|Treatment: Part II|Lost to Follow-up|3|||
48466195|NCT01632345|155896524|FG006|Treatment: Part II|Lost to Follow-up|1|||
48466196|NCT01632345|155896518|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
48466197|NCT01632345|155896519|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
48466198|NCT01632345|155896520|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
48466199|NCT01632345|155896521|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
48466200|NCT01632345|155896522|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
48466201|NCT01632345|155896523|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
48466202|NCT01632345|155896524|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
48466203|NCT01632345|155896518|FG000|Treatment: Part II|Withdrawal by Subject|0|||
48466204|NCT01632345|155896519|FG001|Treatment: Part II|Withdrawal by Subject|0|||
48466205|NCT01632345|155896520|FG002|Treatment: Part II|Withdrawal by Subject|0|||
48466206|NCT01632345|155896521|FG003|Treatment: Part II|Withdrawal by Subject|0|||
48466207|NCT01632345|155896522|FG004|Treatment: Part II|Withdrawal by Subject|0|||
48466208|NCT01632345|155896523|FG005|Treatment: Part II|Withdrawal by Subject|2|||
48466209|NCT01632345|155896524|FG006|Treatment: Part II|Withdrawal by Subject|2|||
48466210|NCT02132312|155896525|FG000|Overall Study|Adverse Event|2|||
48466211|NCT02132312|155896526|FG001|Overall Study|Adverse Event|0|||
48466212|NCT02132312|155896525|FG000|Overall Study|Physician Decision|1|||
48466213|NCT02132312|155896526|FG001|Overall Study|Physician Decision|1|||
48466214|NCT02132312|155896525|FG000|Overall Study|Protocol Violation|0|||
48466215|NCT02132312|155896526|FG001|Overall Study|Protocol Violation|1|||
48466216|NCT02132312|155896525|FG000|Overall Study|Withdrawal by Subject|1|||
48466217|NCT02132312|155896526|FG001|Overall Study|Withdrawal by Subject|0|||
48466218|NCT02132312|155896525|FG000|Overall Study|Lost to Follow-up|2|||
48466219|NCT02132312|155896526|FG001|Overall Study|Lost to Follow-up|1|||
48466220|NCT05405985|155896529|FG000|Overall Study|Withdrawal by Subject|1|||
48466221|NCT05405985|155896530|FG001|Overall Study|Withdrawal by Subject|0|||
48466222|NCT00565721|155896538|FG000|Overall Study|Screen Failure|2|||
48466223|NCT00565721|155896538|FG000|Overall Study|Lost to Follow-up|6|||
48466224|NCT00565721|155896538|FG000|Overall Study|Technical Problems|1|||
48466225|NCT00565721|155896538|FG000|Overall Study|Physician Decision|2|||
48466226|NCT00565721|155896538|FG000|Overall Study|Other reasons|6|||
48466227|NCT00286234|155896541|FG000|Overall Study|Protocol Violation|1|||
48466228|NCT00286234|155896542|FG001|Overall Study|Protocol Violation|2|||
48466229|NCT00286234|155896543|FG002|Overall Study|Protocol Violation|0|||
48466230|NCT00286234|155896544|FG003|Overall Study|Protocol Violation|1|||
48466231|NCT00286234|155896541|FG000|Overall Study|Physician Decision|1|||
48466232|NCT00286234|155896542|FG001|Overall Study|Physician Decision|0|||
48466233|NCT00286234|155896543|FG002|Overall Study|Physician Decision|0|||
48466234|NCT00286234|155896544|FG003|Overall Study|Physician Decision|1|||
48466235|NCT00286234|155896541|FG000|Overall Study|Adverse Event|0|||
48466236|NCT00286234|155896542|FG001|Overall Study|Adverse Event|0|||
48466237|NCT00286234|155896543|FG002|Overall Study|Adverse Event|0|||
48466238|NCT00286234|155896544|FG003|Overall Study|Adverse Event|1|||
48466239|NCT00286234|155896541|FG000|Overall Study|Adverse Event|0|||
48466240|NCT00286234|155896542|FG001|Overall Study|Adverse Event|0|||
48466241|NCT00286234|155896543|FG002|Overall Study|Adverse Event|0|||
48466242|NCT00286234|155896544|FG003|Overall Study|Adverse Event|1|||
48466243|NCT02924129|155896545|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
48466244|NCT02924129|155896546|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
48466245|NCT02924129|155896545|FG000|Overall Study|Withdrawal by Subject|2|||
48466246|NCT02924129|155896546|FG001|Overall Study|Withdrawal by Subject|2|||
48466247|NCT02924129|155896545|FG000|Overall Study|Physician Decision|1|||
48466248|NCT02924129|155896546|FG001|Overall Study|Physician Decision|0|||
48466249|NCT02924129|155896545|FG000|Overall Study|Missed Visit|0|||
48466250|NCT02924129|155896546|FG001|Overall Study|Missed Visit|1|||
48466251|NCT00352027|155896554|FG000|Overall Study|Progressive disease|3|||
48466252|NCT00702949|155896559|FG000|Overall Study|Refusal|3|||
48466253|NCT00702949|155896560|FG001|Overall Study|Refusal|2|||
48466254|NCT00702949|155896561|FG002|Overall Study|Refusal|2|||
48466255|NCT00702949|155896559|FG000|Overall Study|Adverse Event|1|||
48466256|NCT00702949|155896560|FG001|Overall Study|Adverse Event|6|||
48466257|NCT00702949|155896561|FG002|Overall Study|Adverse Event|3|||
48466258|NCT00702949|155896559|FG000|Overall Study|Other Medical Reason/unknown|1|||
48466259|NCT00702949|155896560|FG001|Overall Study|Other Medical Reason/unknown|1|||
48466260|NCT00702949|155896561|FG002|Overall Study|Other Medical Reason/unknown|3|||
48466261|NCT01200758|155896562|FG000|Stage I|Death|0|||
48466262|NCT01200758|155896563|FG001|Stage I|Death|1|||
48466263|NCT01200758|155896564|FG002|Stage I|Death|0|||
48466264|NCT01200758|155896565|FG003|Stage I|Death|0|||
48466265|NCT01200758|155896562|FG000|Stage I|Physician Decision|1|||
48466266|NCT01200758|155896563|FG001|Stage I|Physician Decision|1|||
48466267|NCT01200758|155896564|FG002|Stage I|Physician Decision|0|||
48466268|NCT01200758|155896565|FG003|Stage I|Physician Decision|0|||
48466269|NCT01200758|155896562|FG000|Stage I|Lack of Efficacy|2|||
48466270|NCT01200758|155896563|FG001|Stage I|Lack of Efficacy|1|||
48466271|NCT01200758|155896564|FG002|Stage I|Lack of Efficacy|0|||
48466272|NCT01200758|155896565|FG003|Stage I|Lack of Efficacy|0|||
48466273|NCT01200758|155896562|FG000|Stage I|Adverse Event|5|||
48466274|NCT01200758|155896563|FG001|Stage I|Adverse Event|5|||
48466275|NCT01200758|155896564|FG002|Stage I|Adverse Event|0|||
48466276|NCT01200758|155896565|FG003|Stage I|Adverse Event|0|||
48466277|NCT01200758|155896562|FG000|Stage I|Withdrawal by Subject|1|||
48466278|NCT01200758|155896563|FG001|Stage I|Withdrawal by Subject|2|||
48466279|NCT01200758|155896564|FG002|Stage I|Withdrawal by Subject|0|||
48466280|NCT01200758|155896565|FG003|Stage I|Withdrawal by Subject|0|||
48466281|NCT01200758|155896562|FG000|Stage I|Disease Progression|9|||
48466282|NCT01200758|155896563|FG001|Stage I|Disease Progression|7|||
48466283|NCT01200758|155896564|FG002|Stage I|Disease Progression|0|||
48466284|NCT01200758|155896565|FG003|Stage I|Disease Progression|0|||
48466285|NCT01200758|155896562|FG000|Stage 2|Disease Progression|0|||
48466286|NCT01200758|155896563|FG001|Stage 2|Disease Progression|0|||
48466287|NCT01200758|155896564|FG002|Stage 2|Disease Progression|16|||
48466288|NCT01200758|155896565|FG003|Stage 2|Disease Progression|21|||
48466289|NCT01200758|155896562|FG000|Stage 2|Lack of Efficacy|0|||
48466290|NCT01200758|155896563|FG001|Stage 2|Lack of Efficacy|0|||
48466291|NCT01200758|155896564|FG002|Stage 2|Lack of Efficacy|4|||
48466292|NCT01200758|155896565|FG003|Stage 2|Lack of Efficacy|2|||
48466293|NCT01200758|155896562|FG000|Stage 2|Physician Decision|0|||
48466294|NCT01200758|155896563|FG001|Stage 2|Physician Decision|0|||
48466295|NCT01200758|155896564|FG002|Stage 2|Physician Decision|5|||
48466296|NCT01200758|155896565|FG003|Stage 2|Physician Decision|7|||
48466297|NCT01200758|155896562|FG000|Stage 2|Adverse Event|0|||
48466298|NCT01200758|155896563|FG001|Stage 2|Adverse Event|0|||
48466299|NCT01200758|155896564|FG002|Stage 2|Adverse Event|5|||
48466300|NCT01200758|155896565|FG003|Stage 2|Adverse Event|9|||
48466301|NCT01200758|155896562|FG000|Stage 2|Withdrawal by Subject|0|||
48466302|NCT01200758|155896563|FG001|Stage 2|Withdrawal by Subject|0|||
48466303|NCT01200758|155896564|FG002|Stage 2|Withdrawal by Subject|4|||
48466304|NCT01200758|155896565|FG003|Stage 2|Withdrawal by Subject|1|||
48466305|NCT01200758|155896562|FG000|Stage 2|Lost to Follow-up|0|||
48466306|NCT01200758|155896563|FG001|Stage 2|Lost to Follow-up|0|||
48466307|NCT01200758|155896564|FG002|Stage 2|Lost to Follow-up|3|||
48466308|NCT01200758|155896565|FG003|Stage 2|Lost to Follow-up|1|||
48466309|NCT01200758|155896562|FG000|Stage 2|Protocol Violation|0|||
48466310|NCT01200758|155896563|FG001|Stage 2|Protocol Violation|0|||
48466311|NCT01200758|155896564|FG002|Stage 2|Protocol Violation|1|||
48466312|NCT01200758|155896565|FG003|Stage 2|Protocol Violation|4|||
48466313|NCT01200758|155896562|FG000|Stage 2|Death|0|||
48466314|NCT01200758|155896563|FG001|Stage 2|Death|0|||
48466315|NCT01200758|155896564|FG002|Stage 2|Death|3|||
48466316|NCT01200758|155896565|FG003|Stage 2|Death|5|||
48466317|NCT01371721|155896566|FG000|Overall Study|Adverse Event|5|||
48466318|NCT01371721|155896567|FG001|Overall Study|Adverse Event|4|||
48466319|NCT01371721|155896568|FG002|Overall Study|Adverse Event|5|||
48466320|NCT01371721|155896566|FG000|Overall Study|Protocol Violation|6|||
48466321|NCT01371721|155896567|FG001|Overall Study|Protocol Violation|4|||
48466322|NCT01371721|155896568|FG002|Overall Study|Protocol Violation|5|||
48466323|NCT01371721|155896566|FG000|Overall Study|Lost to Follow-up|8|||
48466324|NCT01371721|155896567|FG001|Overall Study|Lost to Follow-up|2|||
48466325|NCT01371721|155896568|FG002|Overall Study|Lost to Follow-up|6|||
48466326|NCT01371721|155896566|FG000|Overall Study|Withdrawal by Subject|5|||
48466327|NCT01371721|155896567|FG001|Overall Study|Withdrawal by Subject|7|||
48466328|NCT01371721|155896568|FG002|Overall Study|Withdrawal by Subject|11|||
48466329|NCT01371721|155896566|FG000|Overall Study|Other|2|||
48466330|NCT01371721|155896567|FG001|Overall Study|Other|3|||
48466331|NCT01371721|155896568|FG002|Overall Study|Other|0|||
48466332|NCT01371721|155896566|FG000|Overall Study|Lack of Efficacy|2|||
48466333|NCT01371721|155896567|FG001|Overall Study|Lack of Efficacy|4|||
48466334|NCT01371721|155896568|FG002|Overall Study|Lack of Efficacy|3|||
48466335|NCT01371721|155896566|FG000|Overall Study|Randomized but not treated|1|||
48466336|NCT01371721|155896567|FG001|Overall Study|Randomized but not treated|0|||
48466337|NCT01371721|155896568|FG002|Overall Study|Randomized but not treated|0|||
48466338|NCT00545584|155896573|FG000|Overall Study|Only one reason for discontinuation|62|||
48466339|NCT00545584|155896574|FG001|Overall Study|Only one reason for discontinuation|61|||
48466340|NCT00545584|155896575|FG002|Overall Study|Only one reason for discontinuation|48|||
48466341|NCT00545584|155896573|FG000|Overall Study|Two or more reasons for discontinuation|17|||
48466342|NCT00545584|155896574|FG001|Overall Study|Two or more reasons for discontinuation|19|||
48466343|NCT00545584|155896575|FG002|Overall Study|Two or more reasons for discontinuation|8|||
48466344|NCT00135694|155896579|FG000|Overall Study|Adverse Event|17|||
48466345|NCT00135694|155896580|FG001|Overall Study|Adverse Event|4|||
48466346|NCT00135694|155896581|FG002|Overall Study|Adverse Event|0|||
48466347|NCT00135694|155896579|FG000|Overall Study|Death|14|||
48466348|NCT00135694|155896580|FG001|Overall Study|Death|1|||
48466349|NCT00135694|155896581|FG002|Overall Study|Death|2|||
48466350|NCT00135694|155896579|FG000|Overall Study|Lost to Follow-up|8|||
48466351|NCT00135694|155896580|FG001|Overall Study|Lost to Follow-up|7|||
48466352|NCT00135694|155896581|FG002|Overall Study|Lost to Follow-up|1|||
48466353|NCT00135694|155896579|FG000|Overall Study|Withdrawal by Subject|41|||
48466354|NCT00135694|155896580|FG001|Overall Study|Withdrawal by Subject|7|||
48466355|NCT00135694|155896581|FG002|Overall Study|Withdrawal by Subject|4|||
48466356|NCT00135694|155896579|FG000|Overall Study|Protocol Violation|19|||
48466357|NCT00135694|155896580|FG001|Overall Study|Protocol Violation|1|||
48466358|NCT00135694|155896581|FG002|Overall Study|Protocol Violation|0|||
48466359|NCT00135694|155896579|FG000|Overall Study|Hepatitis C related reasons|39|||
48466360|NCT00135694|155896580|FG001|Overall Study|Hepatitis C related reasons|1|||
48466361|NCT00135694|155896581|FG002|Overall Study|Hepatitis C related reasons|0|||
48466362|NCT00135694|155896579|FG000|Overall Study|Ineligible for Random assignment|42|||
48466363|NCT00135694|155896580|FG001|Overall Study|Ineligible for Random assignment|0|||
48466364|NCT00135694|155896581|FG002|Overall Study|Ineligible for Random assignment|0|||
48466365|NCT02584660|155896582|FG000|Overall Study|Adverse Event|4|||
48466366|NCT02584660|155896583|FG001|Overall Study|Adverse Event|0|||
48466367|NCT02584660|155896582|FG000|Overall Study|Lost to Follow-up|3|||
48466368|NCT02584660|155896583|FG001|Overall Study|Lost to Follow-up|4|||
48466369|NCT02584660|155896582|FG000|Overall Study|Protocol Violation|0|||
48466370|NCT02584660|155896583|FG001|Overall Study|Protocol Violation|1|||
48466371|NCT02584660|155896582|FG000|Overall Study|Withdrawal by Subject|0|||
48466372|NCT02584660|155896583|FG001|Overall Study|Withdrawal by Subject|2|||
48466373|NCT02584660|155896582|FG000|Overall Study|Other|0|||
48466374|NCT02584660|155896583|FG001|Overall Study|Other|1|||
48466375|NCT00461552|155896584|FG000|Overall Study|Drug Dispensing error|0|||
48466376|NCT00461552|155896585|FG001|Overall Study|Drug Dispensing error|2|||
48466377|NCT00660816|155896586|FG000|Overall Study|Adverse Event|1|||
48466378|NCT00660816|155896587|FG001|Overall Study|Adverse Event|2|||
48466379|NCT00660816|155896586|FG000|Overall Study|Withdrawal by Subject|1|||
48466380|NCT00660816|155896587|FG001|Overall Study|Withdrawal by Subject|0|||
48466381|NCT00660816|155896586|FG000|Overall Study|Death|0|||
48466382|NCT00660816|155896587|FG001|Overall Study|Death|2|||
48466383|NCT00660816|155896586|FG000|Overall Study|Lack of Efficacy|1|||
48466384|NCT00660816|155896587|FG001|Overall Study|Lack of Efficacy|0|||
48466385|NCT00660816|155896586|FG000|Overall Study|Physician Decision|0|||
48466386|NCT00660816|155896587|FG001|Overall Study|Physician Decision|2|||
48466387|NCT00660816|155896586|FG000|Overall Study|Protocol Violation|1|||
48466388|NCT00660816|155896587|FG001|Overall Study|Protocol Violation|0|||
48466389|NCT00660816|155896586|FG000|Overall Study|Disease Progression|16|||
48466390|NCT00660816|155896587|FG001|Overall Study|Disease Progression|12|||
48466391|NCT00660816|155896586|FG000|Overall Study|Complicating Disease|0|||
48466392|NCT00660816|155896587|FG001|Overall Study|Complicating Disease|1|||
48466393|NCT05890105|155896588|FG000|Overall Study|Adverse Event|1|||
48466394|NCT05890105|155896589|FG001|Overall Study|Adverse Event|0|||
48466395|NCT05890105|155896590|FG002|Overall Study|Adverse Event|0|||
48466396|NCT05890105|155896588|FG000|Overall Study|Other|1|||
48466397|NCT05890105|155896589|FG001|Overall Study|Other|2|||
48466398|NCT05890105|155896590|FG002|Overall Study|Other|0|||
48466399|NCT01875731|155896597|FG000|Overall Study|Fail to obtain lab sample|1|||
48466400|NCT01875731|155896598|FG001|Overall Study|Fail to obtain lab sample|0|||
48466401|NCT04557189|155896599|FG000|Overall Study|Adverse Event|0|||
48466402|NCT04557189|155896600|FG001|Overall Study|Adverse Event|1|||
48466403|NCT04557189|155896599|FG000|Overall Study|Lost to Follow-up|1|||
48466404|NCT04557189|155896600|FG001|Overall Study|Lost to Follow-up|1|||
48466405|NCT04557189|155896599|FG000|Overall Study|Withdrawal by Subject|2|||
48466406|NCT04557189|155896600|FG001|Overall Study|Withdrawal by Subject|1|||
48466407|NCT04557189|155896599|FG000|Overall Study|Reason not Specified|3|||
48466408|NCT04557189|155896600|FG001|Overall Study|Reason not Specified|6|||
48466409|NCT00660829|155896601|FG000|Overall Study|Adverse Event|3|||
48466410|NCT00660829|155896602|FG001|Overall Study|Adverse Event|4|||
48466411|NCT00660829|155896601|FG000|Overall Study|Lack of Efficacy|2|||
48466412|NCT00660829|155896602|FG001|Overall Study|Lack of Efficacy|3|||
48466413|NCT00660829|155896601|FG000|Overall Study|Non-Compliance|0|||
48466414|NCT00660829|155896602|FG001|Overall Study|Non-Compliance|4|||
48466415|NCT00660829|155896601|FG000|Overall Study|Withdrawal by Subject|1|||
48466416|NCT00660829|155896602|FG001|Overall Study|Withdrawal by Subject|2|||
48466417|NCT00660829|155896601|FG000|Overall Study|Lost to Follow-up|3|||
48466418|NCT00660829|155896602|FG001|Overall Study|Lost to Follow-up|2|||
48466419|NCT00660829|155896601|FG000|Overall Study|Other|9|||
48466420|NCT00660829|155896602|FG001|Overall Study|Other|4|||
48466421|NCT02561572|155896603|FG000|Overall Study|Inadequate time before surgery|2|||
48466422|NCT02561572|155896604|FG001|Overall Study|Inadequate time before surgery|1|||
48466423|NCT02561572|155896603|FG000|Overall Study|Protocol Violation|0|||
48466424|NCT02561572|155896604|FG001|Overall Study|Protocol Violation|1|||
48466425|NCT02918006|155896607|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
48466426|NCT02918006|155896608|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
48466427|NCT02918006|155896609|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
48466428|NCT02918006|155896607|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
48466429|NCT02918006|155896608|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
48466430|NCT02918006|155896609|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
48466431|NCT02918006|155896607|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
48466432|NCT02918006|155896608|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
48466433|NCT02918006|155896609|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
48466434|NCT02918006|155896607|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
48466435|NCT02918006|155896608|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
48466436|NCT02918006|155896609|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
48466437|NCT02918006|155896607|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
48466438|NCT02918006|155896608|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
48466439|NCT02918006|155896609|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
48466440|NCT02918006|155896607|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
48466441|NCT02918006|155896608|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
48466442|NCT02918006|155896609|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
48466443|NCT02918006|155896607|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
48466444|NCT02918006|155896608|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
48466445|NCT02918006|155896609|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
48466446|NCT02918006|155896607|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
48466447|NCT02918006|155896608|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
48466448|NCT02918006|155896609|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
48466449|NCT02918006|155896607|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
48466450|NCT02918006|155896608|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
48466451|NCT02918006|155896609|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
48466452|NCT00795717|155896610|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
48466453|NCT00795717|155896611|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
48466454|NCT00795717|155896610|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
48466455|NCT00795717|155896611|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
48466456|NCT00795717|155896610|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
48466457|NCT00795717|155896611|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
48466458|NCT00795717|155896610|FG000|Phase II|too busy|0|||
48466459|NCT00795717|155896611|FG001|Phase II|too busy|1|||
48466460|NCT00851721|155898400|FG000|Overall Study|planned surgery|1|||
48466461|NCT00851721|155898401|FG001|Overall Study|planned surgery|0|||
48466462|NCT00851721|155898400|FG000|Overall Study|Death|1|||
48466463|NCT00851721|155898401|FG001|Overall Study|Death|0|||
48466464|NCT00851721|155898400|FG000|Overall Study|Adverse Event|0|||
48466465|NCT00851721|155898401|FG001|Overall Study|Adverse Event|1|||
48466466|NCT00665002|155898402|FG000|Overall Study|Progression/relapse during treatment|11|||
48466467|NCT00665002|155898402|FG000|Overall Study|Cytogenetic resistance|1|||
48466468|NCT03650387|155898403|FG000|Overall Study|Withdrawal by Subject|13|||
48466469|NCT03650387|155898403|FG000|Overall Study|Lost to Follow-up|12|||
48466470|NCT03650387|155898403|FG000|Overall Study|Adverse Event (Not related)|1|||
48466471|NCT03650387|155898403|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
48466472|NCT01539720|155898404|FG000|Overall Study|Screen Fail|15|||
48466473|NCT01539720|155898405|FG001|Overall Study|Screen Fail|3|||
48466474|NCT01539720|155898404|FG000|Overall Study|Lost to Follow-up|14|||
48466475|NCT01539720|155898405|FG001|Overall Study|Lost to Follow-up|7|||
48466476|NCT00417248|155898406|FG000|Overall Study|Study Terminated|6|||
48466477|NCT00417248|155898406|FG000|Overall Study|Death|1|||
48466478|NCT00417248|155898406|FG000|Overall Study|Lack of Efficacy|1|||
48466479|NCT02505945|155898413|FG000|Overall Study|Withdrawal by Subject|13|||
48466480|NCT02505945|155898414|FG001|Overall Study|Withdrawal by Subject|2|||
48466481|NCT02505945|155898413|FG000|Overall Study|Adverse Event|1|||
48466482|NCT02505945|155898414|FG001|Overall Study|Adverse Event|0|||
48466483|NCT02505945|155898413|FG000|Overall Study|Physician Decision|2|||
48466484|NCT02505945|155898414|FG001|Overall Study|Physician Decision|1|||
48466485|NCT02505945|155898413|FG000|Overall Study|Lost to Follow-up|6|||
48466486|NCT02505945|155898414|FG001|Overall Study|Lost to Follow-up|1|||
48466487|NCT00661362|155898415|FG000|Overall Study|Adverse Event|5|||
48466488|NCT00661362|155898416|FG001|Overall Study|Adverse Event|4|||
48466489|NCT00661362|155898415|FG000|Overall Study|Incorrect enrollment|2|||
48466490|NCT00661362|155898416|FG001|Overall Study|Incorrect enrollment|0|||
48466491|NCT00661362|155898415|FG000|Overall Study|Study specific discontinuation criteria|4|||
48466492|NCT00661362|155898416|FG001|Overall Study|Study specific discontinuation criteria|11|||
48466493|NCT00661362|155898415|FG000|Overall Study|Withdrawal by Subject|13|||
48466494|NCT00661362|155898416|FG001|Overall Study|Withdrawal by Subject|23|||
48466495|NCT00661362|155898415|FG000|Overall Study|Lost to Follow-up|3|||
48466496|NCT00661362|155898416|FG001|Overall Study|Lost to Follow-up|1|||
48466497|NCT00661362|155898415|FG000|Overall Study|Severe non-compliance to protocol|0|||
48466498|NCT00661362|155898416|FG001|Overall Study|Severe non-compliance to protocol|1|||
48466499|NCT00661362|155898415|FG000|Overall Study|Safety reasons|1|||
48466500|NCT00661362|155898416|FG001|Overall Study|Safety reasons|0|||
48466501|NCT00661362|155898415|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
48466502|NCT00661362|155898416|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
48466503|NCT00679354|155898417|FG000|Overall Study|Death|3|||
48466504|NCT00679354|155898417|FG000|Overall Study|Lack of Efficacy|22|||
48466505|NCT00679354|155898417|FG000|Overall Study|Physician Decision|4|||
48466506|NCT00679354|155898417|FG000|Overall Study|Ineligible|1|||
48466507|NCT00718887|155898418|FG000|Overall Study|Withdrawal by Subject|3|||
48466508|NCT00718887|155898419|FG001|Overall Study|Withdrawal by Subject|2|||
48466509|NCT00718887|155898418|FG000|Overall Study|Not identified|2|||
48466510|NCT00718887|155898419|FG001|Overall Study|Not identified|7|||
48466511|NCT00775138|155898420|FG000|Overall Study|Withdrawal by Subject|0|||
48466512|NCT00775138|155898421|FG001|Overall Study|Withdrawal by Subject|0|||
48466513|NCT00775138|155898422|FG002|Overall Study|Withdrawal by Subject|2|||
48466514|NCT00775138|155898423|FG003|Overall Study|Withdrawal by Subject|2|||
48466515|NCT00775138|155898420|FG000|Overall Study|Adverse Event|0|||
48466516|NCT00775138|155898421|FG001|Overall Study|Adverse Event|0|||
48466517|NCT00775138|155898422|FG002|Overall Study|Adverse Event|1|||
48466518|NCT00775138|155898423|FG003|Overall Study|Adverse Event|0|||
48466519|NCT04601194|155898425|FG000|Overall Study|Lost to Follow-up|7|||
48466520|NCT02074059|155898426|FG000|Overall Study|Death|0|||
48466521|NCT02074059|155898427|FG001|Overall Study|Death|0|||
48466522|NCT02074059|155898428|FG002|Overall Study|Death|0|||
48466523|NCT02074059|155898429|FG003|Overall Study|Death|0|||
48466524|NCT02074059|155898430|FG004|Overall Study|Death|1|||
48466525|NCT02074059|155898431|FG005|Overall Study|Death|1|||
48466526|NCT00348686|155898436|FG000|Overall Study|Withdrawal by Subject|45|||
48466527|NCT00348686|155898436|FG000|Overall Study|Adverse Event|5|||
48466528|NCT00348686|155898436|FG000|Overall Study|Protocol Violation|6|||
48466529|NCT00348686|155898436|FG000|Overall Study|Lost to Follow-up|2|||
48466530|NCT00348686|155898436|FG000|Overall Study|Multiple Reasons|8|||
48466531|NCT00955682|155898437|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
48466532|NCT00955682|155898438|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
48466533|NCT04034225|155898439|FG000|Overall Study|Death|3|||
48466534|NCT04034225|155898439|FG000|Overall Study|Withdrawal by Subject|2|||
48466535|NCT04034225|155898439|FG000|Overall Study|Study termination by Sponsor|18|||
48466536|NCT04034225|155898439|FG000|Overall Study|Physician Decision|1|||
48466537|NCT04034225|155898439|FG000|Overall Study|Lack of Efficacy|1|||
48466538|NCT03328325|155898441|FG000|Overall Study|Lost to Follow-up|4|||
48466539|NCT03328325|155898441|FG000|Overall Study|Physician Decision|1|||
48466540|NCT03328325|155898441|FG000|Overall Study|Withdrawal by Subject|3|||
48466541|NCT03328325|155898441|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
48466542|NCT00699582|155898442|FG000|Overall Study|Adverse Event|4|||
48466543|NCT00699582|155898443|FG001|Overall Study|Adverse Event|11|||
48466544|NCT00699582|155898444|FG002|Overall Study|Adverse Event|23|||
48466545|NCT00699582|155898442|FG000|Overall Study|Withdrawal by Subject|6|||
48466546|NCT00699582|155898443|FG001|Overall Study|Withdrawal by Subject|7|||
48466547|NCT00699582|155898444|FG002|Overall Study|Withdrawal by Subject|4|||
48466548|NCT00699582|155898442|FG000|Overall Study|Lack of Efficacy|1|||
48466549|NCT00699582|155898443|FG001|Overall Study|Lack of Efficacy|0|||
48466550|NCT00699582|155898444|FG002|Overall Study|Lack of Efficacy|1|||
48466551|NCT00699582|155898442|FG000|Overall Study|Progressive Disease|1|||
48466552|NCT00699582|155898443|FG001|Overall Study|Progressive Disease|0|||
48466553|NCT00699582|155898444|FG002|Overall Study|Progressive Disease|0|||
48466554|NCT00699582|155898442|FG000|Overall Study|Administrative/Other|4|||
48466555|NCT00699582|155898443|FG001|Overall Study|Administrative/Other|3|||
48466556|NCT00699582|155898444|FG002|Overall Study|Administrative/Other|0|||
48466557|NCT00699582|155898442|FG000|Overall Study|Randomized, Not Treated|2|||
48466558|NCT00699582|155898443|FG001|Overall Study|Randomized, Not Treated|1|||
48466559|NCT00699582|155898444|FG002|Overall Study|Randomized, Not Treated|0|||
48466560|NCT04118127|155898446|FG000|Overall Study|Trial terminated by sponsor|0|||
48466561|NCT04118127|155898447|FG001|Overall Study|Trial terminated by sponsor|12|||
48466562|NCT04118127|155898446|FG000|Overall Study|Adverse Event|1|||
48466563|NCT04118127|155898447|FG001|Overall Study|Adverse Event|2|||
48466564|NCT04118127|155898446|FG000|Overall Study|Physician Decision|0|||
48466565|NCT04118127|155898447|FG001|Overall Study|Physician Decision|1|||
48466566|NCT04118127|155898446|FG000|Overall Study|Withdrawal by Subject|2|||
48466567|NCT04118127|155898447|FG001|Overall Study|Withdrawal by Subject|1|||
48466568|NCT03759340|155898448|FG000|Overall Study|Adverse Event|2|||
48466569|NCT03759340|155898448|FG000|Overall Study|Lost to Follow-up|1|||
48466570|NCT03759340|155898448|FG000|Overall Study|Withdrawal by Subject|15|||
48466571|NCT03759340|155898448|FG000|Overall Study|Study Terminated by Sponsor|38|||
48466572|NCT01638546|155898451|FG000|Overall Study|Adverse Event|1|||
48466573|NCT01638546|155898452|FG001|Overall Study|Adverse Event|3|||
48466574|NCT01003691|155898453|FG000|Overall Study|Adverse Event|0|||
48466575|NCT01003691|155898454|FG001|Overall Study|Adverse Event|0|||
48466576|NCT01003691|155898455|FG002|Overall Study|Adverse Event|0|||
48466577|NCT01003691|155898456|FG003|Overall Study|Adverse Event|1|||
48466578|NCT03969589|155898457|FG000|Overall Study|Lost to Follow-up|3|||
48466579|NCT03969589|155898458|FG001|Overall Study|Lost to Follow-up|2|||
48466580|NCT03969589|155898457|FG000|Overall Study|Declined Follow-Up|0|||
48466581|NCT03969589|155898458|FG001|Overall Study|Declined Follow-Up|1|||
48466582|NCT00553319|155898476|FG000|Overall Study|Lost to Follow-up|10|||
48466583|NCT00553319|155898477|FG001|Overall Study|Lost to Follow-up|9|||
48466584|NCT00553319|155898478|FG002|Overall Study|Lost to Follow-up|5|||
48466585|NCT00553319|155898476|FG000|Overall Study|wanted treatment elsewhere|2|||
48466586|NCT00553319|155898477|FG001|Overall Study|wanted treatment elsewhere|1|||
48466587|NCT00553319|155898478|FG002|Overall Study|wanted treatment elsewhere|1|||
48466588|NCT00553319|155898476|FG000|Overall Study|non-compliance|0|||
48466589|NCT00553319|155898477|FG001|Overall Study|non-compliance|0|||
48466590|NCT00553319|155898478|FG002|Overall Study|non-compliance|2|||
48466591|NCT00553319|155898476|FG000|Overall Study|incarceration|1|||
48466592|NCT00553319|155898477|FG001|Overall Study|incarceration|0|||
48466593|NCT00553319|155898478|FG002|Overall Study|incarceration|0|||
48466594|NCT00553319|155898476|FG000|Overall Study|moved|1|||
48466595|NCT00553319|155898477|FG001|Overall Study|moved|0|||
48466596|NCT00553319|155898478|FG002|Overall Study|moved|1|||
48466597|NCT01731600|155898488|FG000|Overall Study|Adverse Event|2|||
48466598|NCT01731600|155898489|FG001|Overall Study|Adverse Event|0|||
48466599|NCT01731600|155898488|FG000|Overall Study|Withdrawal criteria|1|||
48466600|NCT01731600|155898489|FG001|Overall Study|Withdrawal criteria|0|||
48466601|NCT01731600|155898488|FG000|Overall Study|Other reasons|3|||
48466602|NCT01731600|155898489|FG001|Overall Study|Other reasons|0|||
48466603|NCT02993731|155898491|FG000|Overall Study|Study Termination|101|||
48466604|NCT02993731|155898492|FG001|Overall Study|Study Termination|105|||
48466605|NCT03091920|155898493|FG000|Overall Study|Adverse Event|0|||
48466606|NCT03091920|155898494|FG001|Overall Study|Adverse Event|1|||
48466607|NCT03091920|155898495|FG002|Overall Study|Adverse Event|0|||
48466608|NCT02058966|155898496|FG000|Open-Label Methamphetamine|Adverse Event|1|||
48466609|NCT02058966|155898496|FG000|First Intervention|Withdrawal by Subject|1|||
48466610|NCT04678557|155898497|FG000|Overall Study|Withdrawal by Subject|1|||
48466611|NCT04678557|155898498|FG001|Overall Study|Withdrawal by Subject|0|||
48466612|NCT04678557|155898497|FG000|Overall Study|Lack of Efficacy|0|||
48466613|NCT04678557|155898498|FG001|Overall Study|Lack of Efficacy|13|||
48466614|NCT04678557|155898497|FG000|Overall Study|Safety Evaluation|0|||
48466615|NCT04678557|155898498|FG001|Overall Study|Safety Evaluation|1|||
48466616|NCT00765726|155898499|FG000|Overall Study|Withdrawal by Subject|1|||
48466617|NCT00765726|155898499|FG000|Overall Study|Discontinuation of study by sponsor|8|||
48466618|NCT03143855|155898500|FG000|Overall Study|Withdrawal by Subject|4|||
48466619|NCT03143855|155898501|FG001|Overall Study|Withdrawal by Subject|3|||
48466620|NCT03143855|155898500|FG000|Overall Study|Protocol Violation|1|||
48466621|NCT03143855|155898501|FG001|Overall Study|Protocol Violation|0|||
48466622|NCT03143855|155898500|FG000|Overall Study|Participant experienced withdrawal|0|||
48466623|NCT03143855|155898501|FG001|Overall Study|Participant experienced withdrawal|1|||
48466624|NCT00453349|155898502|FG000|Randomized|Adverse Event|12|||
48466625|NCT00453349|155898503|FG001|Randomized|Adverse Event|11|||
48466626|NCT00453349|155898502|FG000|Randomized|Lack of Efficacy|2|||
48466627|NCT00453349|155898503|FG001|Randomized|Lack of Efficacy|1|||
48466628|NCT00453349|155898502|FG000|Randomized|Lost to Follow-up|7|||
48466629|NCT00453349|155898503|FG001|Randomized|Lost to Follow-up|5|||
48466630|NCT00453349|155898502|FG000|Randomized|Protocol Violation|1|||
48466631|NCT00453349|155898503|FG001|Randomized|Protocol Violation|1|||
48466632|NCT00453349|155898502|FG000|Randomized|Withdrawal by Subject|3|||
48466633|NCT00453349|155898503|FG001|Randomized|Withdrawal by Subject|5|||
48466634|NCT00453349|155898502|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
48466635|NCT00453349|155898503|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
48466636|NCT00453349|155898502|FG000|Completed Study|Adverse Event|12|||
48466637|NCT00453349|155898503|FG001|Completed Study|Adverse Event|11|||
48466638|NCT00453349|155898502|FG000|Completed Study|Lack of Efficacy|2|||
48466639|NCT00453349|155898503|FG001|Completed Study|Lack of Efficacy|1|||
48466640|NCT00453349|155898502|FG000|Completed Study|Lost to Follow-up|7|||
48466641|NCT00453349|155898503|FG001|Completed Study|Lost to Follow-up|5|||
48466642|NCT00453349|155898502|FG000|Completed Study|Protocol Violation|1|||
48466643|NCT00453349|155898503|FG001|Completed Study|Protocol Violation|1|||
48466644|NCT00453349|155898502|FG000|Completed Study|Withdrawal by Subject|3|||
48466645|NCT00453349|155898503|FG001|Completed Study|Withdrawal by Subject|5|||
48466646|NCT00453349|155898502|FG000|Completed Study|Lost to follow up after study treatment|2|||
48466647|NCT00453349|155898503|FG001|Completed Study|Lost to follow up after study treatment|11|||
48466648|NCT04369742|155898505|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
48466649|NCT04369742|155898506|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
48466650|NCT04369742|155898505|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
48466651|NCT04369742|155898506|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
48466652|NCT03575975|155898507|FG000|Overall Study|Lost to Follow-up|1|||
48466653|NCT03575975|155898508|FG001|Overall Study|Lost to Follow-up|0|||
48466654|NCT03575975|155898509|FG002|Overall Study|Lost to Follow-up|0|||
48466655|NCT00805142|155898510|FG000|Titration Period|Adverse Event|3|||
48466656|NCT00805142|155898511|FG001|Titration Period|Adverse Event|3|||
48466657|NCT00805142|155898510|FG000|Titration Period|Lack of Efficacy|1|||
48466658|NCT00805142|155898511|FG001|Titration Period|Lack of Efficacy|1|||
48466659|NCT00805142|155898510|FG000|Titration Period|Lost to Follow-up|0|||
48466660|NCT00805142|155898511|FG001|Titration Period|Lost to Follow-up|1|||
48466661|NCT00805142|155898510|FG000|Titration Period|Disease Progression|2|||
48466662|NCT00805142|155898511|FG001|Titration Period|Disease Progression|1|||
48466663|NCT00805142|155898510|FG000|Titration Period|Withdrawal of consent|0|||
48466664|NCT00805142|155898511|FG001|Titration Period|Withdrawal of consent|1|||
48466665|NCT00805142|155898510|FG000|Titration Period|Other|0|||
48466666|NCT00805142|155898511|FG001|Titration Period|Other|3|||
48466667|NCT00805142|155898510|FG000|Maintenance Period|Adverse Event|0|||
48466668|NCT00805142|155898511|FG001|Maintenance Period|Adverse Event|1|||
48466669|NCT00805142|155898510|FG000|Maintenance Period|Other|0|||
48466670|NCT00805142|155898511|FG001|Maintenance Period|Other|1|||
48466671|NCT00280059|155898512|FG000|Efficacy Assessment Phase|Death|2|||
48466672|NCT00280059|155898513|FG001|Efficacy Assessment Phase|Death|0|||
48466673|NCT00280059|155898512|FG000|Efficacy Assessment Phase|Adverse Event|33|||
48466674|NCT00280059|155898513|FG001|Efficacy Assessment Phase|Adverse Event|31|||
48466675|NCT00280059|155898512|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
48466676|NCT00280059|155898513|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
48466677|NCT00280059|155898512|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
48466678|NCT00280059|155898513|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
48466679|NCT00280059|155898512|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
48466680|NCT00280059|155898513|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
48466681|NCT00280059|155898512|FG000|Efficacy Assessment Phase|Other|7|||
48466682|NCT00280059|155898513|FG001|Efficacy Assessment Phase|Other|8|||
48466683|NCT00280059|155898512|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
48466684|NCT00280059|155898513|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
48466685|NCT02576951|155898516|FG000|Overall Study|Lost to Follow-up|0|||
48466686|NCT02576951|155898517|FG001|Overall Study|Lost to Follow-up|0|||
48466687|NCT02576951|155898518|FG002|Overall Study|Lost to Follow-up|2|||
48466688|NCT02576951|155898519|FG003|Overall Study|Lost to Follow-up|2|||
48466689|NCT02576951|155898516|FG000|Overall Study|Withdrawal by Subject|1|||
48466690|NCT02576951|155898517|FG001|Overall Study|Withdrawal by Subject|0|||
48466691|NCT02576951|155898518|FG002|Overall Study|Withdrawal by Subject|0|||
48466692|NCT02576951|155898519|FG003|Overall Study|Withdrawal by Subject|2|||
48466693|NCT02576951|155898516|FG000|Overall Study|Protocol Violation|0|||
48466694|NCT02576951|155898517|FG001|Overall Study|Protocol Violation|0|||
48466695|NCT02576951|155898518|FG002|Overall Study|Protocol Violation|0|||
48466696|NCT02576951|155898519|FG003|Overall Study|Protocol Violation|1|||
48466697|NCT00495794|155898522|FG000|Overall Study|Pharmacist did not activate patient|522|||
48466698|NCT00495794|155898523|FG001|Overall Study|Pharmacist did not activate patient|0|||
48466699|NCT01362062|155898524|FG000|Overall Study|Adverse Event|1|||
48466700|NCT01362062|155898525|FG001|Overall Study|Adverse Event|0|||
48466701|NCT01362062|155898524|FG000|Overall Study|Lost to Follow-up|11|||
48466702|NCT01362062|155898525|FG001|Overall Study|Lost to Follow-up|0|||
48466703|NCT01362062|155898524|FG000|Overall Study|Withdrawal by Subject|2|||
48466704|NCT01362062|155898525|FG001|Overall Study|Withdrawal by Subject|0|||
48466705|NCT01362062|155898524|FG000|Overall Study|Non-compliant participant|2|||
48466706|NCT01362062|155898525|FG001|Overall Study|Non-compliant participant|0|||
48466707|NCT01362062|155898524|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
48466708|NCT01362062|155898525|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
48466709|NCT01362062|155898524|FG000|Overall Study|Had significant improvement|9|||
48466710|NCT01362062|155898525|FG001|Overall Study|Had significant improvement|0|||
48466711|NCT00465894|155898526|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
48466712|NCT00465894|155898527|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
48466713|NCT00465894|155898526|FG000|Treatment For 12 Weeks|Family Issues|1|||
48466714|NCT00465894|155898527|FG001|Treatment For 12 Weeks|Family Issues|1|||
48466715|NCT00465894|155898526|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
48466716|NCT00465894|155898527|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
48466717|NCT02612194|155898530|FG000|Overall Study|Death|5|||
48466718|NCT02612194|155898531|FG001|Overall Study|Death|0|||
48466719|NCT02612194|155898532|FG002|Overall Study|Death|2|||
48466720|NCT02612194|155898530|FG000|Overall Study|Early Study Termination|1|||
48466721|NCT02612194|155898531|FG001|Overall Study|Early Study Termination|0|||
48466722|NCT02612194|155898532|FG002|Overall Study|Early Study Termination|0|||
48466723|NCT00540228|155898533|FG000|Overall Study|Adverse Event|2|||
48466724|NCT00540228|155898534|FG001|Overall Study|Adverse Event|0|||
48466725|NCT00540228|155898535|FG002|Overall Study|Adverse Event|0|||
48466726|NCT00540228|155898536|FG003|Overall Study|Adverse Event|0|||
48466727|NCT00540228|155898537|FG004|Overall Study|Adverse Event|0|||
48466728|NCT00540228|155898533|FG000|Overall Study|Lost to Follow-up|1|||
48466729|NCT00540228|155898534|FG001|Overall Study|Lost to Follow-up|1|||
48466730|NCT00540228|155898535|FG002|Overall Study|Lost to Follow-up|0|||
48466731|NCT00540228|155898536|FG003|Overall Study|Lost to Follow-up|0|||
48466732|NCT00540228|155898537|FG004|Overall Study|Lost to Follow-up|0|||
48466733|NCT02173158|155898538|FG000|Efficacy Phase|Adverse Event|1|||
48466734|NCT02312934|155898539|FG000|Overall Study|Lost to Follow-up|1|||
48466735|NCT02312934|155898540|FG001|Overall Study|Lost to Follow-up|0|||
48466736|NCT02312934|155898539|FG000|Overall Study|Physician Decision|1|||
48466737|NCT02312934|155898540|FG001|Overall Study|Physician Decision|0|||
48466738|NCT02719028|155900142|FG000|Overall Study|Adverse Event|2|||
48466739|NCT02719028|155900143|FG001|Overall Study|Adverse Event|1|||
48466740|NCT02719028|155900144|FG002|Overall Study|Adverse Event|4|||
48466741|NCT02719028|155900145|FG003|Overall Study|Adverse Event|8|||
48466742|NCT02719028|155900142|FG000|Overall Study|Physician Decision|0|||
48466743|NCT02719028|155900143|FG001|Overall Study|Physician Decision|1|||
48466744|NCT02719028|155900144|FG002|Overall Study|Physician Decision|1|||
48466745|NCT02719028|155900145|FG003|Overall Study|Physician Decision|1|||
48466746|NCT02719028|155900142|FG000|Overall Study|Use of prohibited medication|0|||
48466747|NCT02719028|155900143|FG001|Overall Study|Use of prohibited medication|0|||
48466748|NCT02719028|155900144|FG002|Overall Study|Use of prohibited medication|1|||
48466749|NCT02719028|155900145|FG003|Overall Study|Use of prohibited medication|0|||
48466750|NCT02719028|155900142|FG000|Overall Study|Protocol Violation|0|||
48466751|NCT02719028|155900143|FG001|Overall Study|Protocol Violation|0|||
48466752|NCT02719028|155900144|FG002|Overall Study|Protocol Violation|0|||
48466753|NCT02719028|155900145|FG003|Overall Study|Protocol Violation|1|||
48466754|NCT04237298|155900146|FG000|Overall Study|Lost to Follow-up|4|||
48466755|NCT04237298|155900147|FG001|Overall Study|Lost to Follow-up|5|||
48466756|NCT00186121|155900149|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
48466757|NCT00186121|155900149|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
48466758|NCT00186121|155900149|FG000|Overall Study|Not eligible (no treatment)|1|||
48466759|NCT00298766|155900150|FG000|Overall Study|Adverse Event|18|||
48466760|NCT00298766|155900150|FG000|Overall Study|Death|2|||
48466761|NCT00298766|155900150|FG000|Overall Study|Withdrawal by Subject|9|||
48466762|NCT00298766|155900150|FG000|Overall Study|Treatment ongoing|4|||
48466763|NCT00298766|155900150|FG000|Overall Study|Progression of amyloid markers|4|||
48466764|NCT00298766|155900150|FG000|Overall Study|Deterioration in KPS and organ function|1|||
48466765|NCT00298766|155900150|FG000|Overall Study|Subjects overall condition deterioration|4|||
48466766|NCT00298766|155900150|FG000|Overall Study|Other|4|||
48466767|NCT03287960|155900151|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
48466768|NCT03287960|155900151|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
48466769|NCT04856163|155900153|FG000|Overall Study|Lost to Follow-up|97|||
48466770|NCT04856163|155900154|FG001|Overall Study|Lost to Follow-up|100|||
48466771|NCT03432819|155900157|FG000|Overall Study|Lost to Follow-up|2|||
48466772|NCT03432819|155900158|FG001|Overall Study|Lost to Follow-up|2|||
48466773|NCT03432819|155900157|FG000|Overall Study|Withdrawal by Subject|5|||
48466774|NCT03432819|155900158|FG001|Overall Study|Withdrawal by Subject|3|||
48466775|NCT01258738|155900159|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
48466776|NCT01258738|155900160|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
48466777|NCT01258738|155900159|FG000|Double-blind Period|Withdrawal by Subject|2|||
48466778|NCT01258738|155900160|FG001|Double-blind Period|Withdrawal by Subject|2|||
48466779|NCT01258738|155900159|FG000|Double-blind Period|Protocol Violation|1|||
48466780|NCT01258738|155900160|FG001|Double-blind Period|Protocol Violation|1|||
48466781|NCT01258738|155900159|FG000|Double-blind Period|Adverse Event|3|||
48466782|NCT01258738|155900160|FG001|Double-blind Period|Adverse Event|1|||
48466783|NCT01258738|155900159|FG000|Open-label Period|Did not meet inclusion criteria|0|||
48466784|NCT01258738|155900160|FG001|Open-label Period|Did not meet inclusion criteria|1|||
48466785|NCT01258738|155900159|FG000|Open-label Period|Insufficient clinical response|5|||
48466786|NCT01258738|155900160|FG001|Open-label Period|Insufficient clinical response|3|||
48466787|NCT01258738|155900159|FG000|Open-label Period|Lost to Follow-up|0|||
48466788|NCT01258738|155900160|FG001|Open-label Period|Lost to Follow-up|2|||
48466789|NCT01258738|155900159|FG000|Open-label Period|Withdrawal by Subject|5|||
48466790|NCT01258738|155900160|FG001|Open-label Period|Withdrawal by Subject|6|||
48466791|NCT01258738|155900159|FG000|Open-label Period|Protocol Violation|2|||
48466792|NCT01258738|155900160|FG001|Open-label Period|Protocol Violation|2|||
48466793|NCT01258738|155900159|FG000|Open-label Period|Adverse Event|4|||
48466794|NCT01258738|155900160|FG001|Open-label Period|Adverse Event|5|||
48466795|NCT01258738|155900159|FG000|Open-label Period|Other Reasons|0|||
48466796|NCT01258738|155900160|FG001|Open-label Period|Other Reasons|1|||
48466797|NCT01258738|155900159|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
48466798|NCT01258738|155900160|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
48466799|NCT02418000|155900162|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
48466800|NCT02418000|155900163|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
48466801|NCT02418000|155900164|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
48466802|NCT02418000|155900165|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
48466803|NCT02418000|155900166|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
48466804|NCT02418000|155900162|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
48466805|NCT02418000|155900163|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
48466806|NCT02418000|155900164|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
48466807|NCT02418000|155900165|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
48466808|NCT02418000|155900166|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
48466809|NCT02418000|155900162|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
48466810|NCT02418000|155900163|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
48466811|NCT02418000|155900164|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
48466812|NCT02418000|155900165|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
48466813|NCT02418000|155900166|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
48466814|NCT02418000|155900162|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
48466815|NCT02418000|155900163|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
48466816|NCT02418000|155900164|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
48466817|NCT02418000|155900165|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
48466818|NCT02418000|155900166|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
48466819|NCT02418000|155900162|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
48466820|NCT02418000|155900163|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
48466821|NCT02418000|155900164|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
48466822|NCT02418000|155900165|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
48466823|NCT02418000|155900166|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
48466824|NCT02418000|155900162|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466825|NCT02418000|155900163|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466826|NCT02418000|155900164|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
48466827|NCT02418000|155900165|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466828|NCT02418000|155900166|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466829|NCT02418000|155900162|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466830|NCT02418000|155900163|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466831|NCT02418000|155900164|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466832|NCT02418000|155900165|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
48466833|NCT02418000|155900166|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466834|NCT02418000|155900162|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
48466835|NCT02418000|155900163|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
48466836|NCT02418000|155900164|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
48466837|NCT02418000|155900165|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
48466838|NCT02418000|155900166|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
48466839|NCT02418000|155900162|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466840|NCT02418000|155900163|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466841|NCT02418000|155900164|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466842|NCT02418000|155900165|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
48466843|NCT02418000|155900166|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
48466844|NCT00689611|155900167|FG000|Overall Study|Death|6|||
48466845|NCT00689611|155900168|FG001|Overall Study|Death|9|||
48466846|NCT00689611|155900167|FG000|Overall Study|Withdrawal by Subject|8|||
48466847|NCT00689611|155900168|FG001|Overall Study|Withdrawal by Subject|9|||
48466848|NCT00689611|155900167|FG000|Overall Study|Lost to Follow-up|27|||
48466849|NCT00689611|155900168|FG001|Overall Study|Lost to Follow-up|28|||
48466850|NCT04382066|155900169|FG000|Overall Study|Adverse Event|1|||
48466851|NCT04382066|155900170|FG001|Overall Study|Adverse Event|0|||
48466852|NCT04382066|155900171|FG002|Overall Study|Adverse Event|0|||
48466853|NCT04382066|155900169|FG000|Overall Study|Death|1|||
48466854|NCT04382066|155900170|FG001|Overall Study|Death|0|||
48466855|NCT04382066|155900171|FG002|Overall Study|Death|1|||
48466856|NCT00508001|155900173|FG000|Overall Study|Adverse Event|2|||
48466857|NCT00508001|155900174|FG001|Overall Study|Adverse Event|0|||
48466858|NCT00508001|155900175|FG002|Overall Study|Adverse Event|4|||
48466859|NCT00508001|155900173|FG000|Overall Study|condition under investigation worsened|13|||
48466860|NCT00508001|155900174|FG001|Overall Study|condition under investigation worsened|7|||
48466861|NCT00508001|155900175|FG002|Overall Study|condition under investigation worsened|1|||
48466862|NCT00508001|155900173|FG000|Overall Study|Death|0|||
48466863|NCT00508001|155900174|FG001|Overall Study|Death|1|||
48466864|NCT00508001|155900175|FG002|Overall Study|Death|1|||
48466865|NCT00508001|155900173|FG000|Overall Study|Withdrawal by Subject|4|||
48466866|NCT00508001|155900174|FG001|Overall Study|Withdrawal by Subject|4|||
48466867|NCT00508001|155900175|FG002|Overall Study|Withdrawal by Subject|1|||
48466868|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Adverse Event|6|||
48466869|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Adverse Event|6|||
48466870|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Death|14|||
48466871|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Death|11|||
48466872|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
48466873|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
48466874|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
48466875|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
48466876|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
48466877|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
48466878|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Disease Progression|1|||
48466879|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Disease Progression|0|||
48466880|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
48466881|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
48466882|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
48466883|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
48466884|NCT04419558|155900176|FG000|DB Period (48 Weeks)|Participant Decision|4|||
48466885|NCT04419558|155900177|FG001|DB Period (48 Weeks)|Participant Decision|3|||
48466886|NCT04419558|155900176|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
48466887|NCT04419558|155900177|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
48466888|NCT04419558|155900176|FG000|OLE Period (48 Weeks)|Death|4|||
48466889|NCT04419558|155900177|FG001|OLE Period (48 Weeks)|Death|6|||
48466890|NCT04419558|155900176|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
48466891|NCT04419558|155900177|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
48466892|NCT04419558|155900176|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
48466893|NCT04419558|155900177|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
48466894|NCT01990339|155900195|FG000|Overall Study|Data Not Available|49|||
48466895|NCT01990339|155900195|FG000|Overall Study|Voluntary Withdrawal|1402|||
48466896|NCT01990339|155900195|FG000|Overall Study|Lost to Follow-up|861|||
48466897|NCT00529152|155900196|FG000|Overall Study|Adverse Event|2|||
48466898|NCT00529152|155900196|FG000|Overall Study|Withdrawal by Subject|2|||
48466899|NCT00529152|155900196|FG000|Overall Study|Lost to Follow-up|1|||
48466900|NCT04491591|155900201|FG000|Overall Study|Accidently randomized|3|||
48466901|NCT04491591|155900202|FG001|Overall Study|Accidently randomized|1|||
48466902|NCT04491591|155900203|FG002|Overall Study|Accidently randomized|0|||
48466903|NCT04491591|155900201|FG000|Overall Study|Did not complete survey|28|||
48466904|NCT04491591|155900202|FG001|Overall Study|Did not complete survey|20|||
48466905|NCT04491591|155900203|FG002|Overall Study|Did not complete survey|3|||
48466906|NCT01365182|155900204|FG000|Overall Study|Withdrawal by Subject|10|||
48466907|NCT01365182|155900205|FG001|Overall Study|Withdrawal by Subject|13|||
48466908|NCT01365182|155900206|FG002|Overall Study|Withdrawal by Subject|12|||
48466909|NCT01265511|155900207|FG000|Overall Study|Lack of Efficacy|2|||
48466910|NCT01265511|155900208|FG001|Overall Study|Lack of Efficacy|1|||
48466911|NCT01265511|155900207|FG000|Overall Study|Met stopping rules|0|||
48466912|NCT01265511|155900208|FG001|Overall Study|Met stopping rules|2|||
48466913|NCT00526227|155900209|FG000|Overall Study|Device not implanted|1|||
48466914|NCT00526227|155900209|FG000|Overall Study|Death|1|||
48466915|NCT02127931|155900210|FG000|Overall Study|Glitch in Game|1|||
48466916|NCT00405756|155900214|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
48466917|NCT00405756|155900215|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
48466918|NCT00405756|155900216|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
48466919|NCT00405756|155900214|FG000|Double-blind Treatment|Adverse Event|31|||
48466920|NCT00405756|155900215|FG001|Double-blind Treatment|Adverse Event|27|||
48466921|NCT00405756|155900216|FG002|Double-blind Treatment|Adverse Event|12|||
48466922|NCT00405756|155900214|FG000|Double-blind Treatment|Disease Progression|47|||
48466923|NCT00405756|155900215|FG001|Double-blind Treatment|Disease Progression|81|||
48466924|NCT00405756|155900216|FG002|Double-blind Treatment|Disease Progression|102|||
48466925|NCT00405756|155900214|FG000|Double-blind Treatment|Lack of Efficacy|1|||
48466926|NCT00405756|155900215|FG001|Double-blind Treatment|Lack of Efficacy|4|||
48466927|NCT00405756|155900216|FG002|Double-blind Treatment|Lack of Efficacy|2|||
48466928|NCT00405756|155900214|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
48466929|NCT00405756|155900215|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
48466930|NCT00405756|155900216|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
48466931|NCT00405756|155900214|FG000|Double-blind Treatment|Lost to Follow-up|1|||
48466932|NCT00405756|155900215|FG001|Double-blind Treatment|Lost to Follow-up|0|||
48466933|NCT00405756|155900216|FG002|Double-blind Treatment|Lost to Follow-up|0|||
48466934|NCT00405756|155900214|FG000|Double-blind Treatment|Death|4|||
48466935|NCT00405756|155900215|FG001|Double-blind Treatment|Death|4|||
48466936|NCT00405756|155900216|FG002|Double-blind Treatment|Death|4|||
48466937|NCT00405756|155900214|FG000|Double-blind Treatment|Protocol Violation|1|||
48466938|NCT00405756|155900215|FG001|Double-blind Treatment|Protocol Violation|0|||
48466939|NCT00405756|155900216|FG002|Double-blind Treatment|Protocol Violation|2|||
48466940|NCT00405756|155900214|FG000|Double-blind Treatment|Other|7|||
48466941|NCT00405756|155900215|FG001|Double-blind Treatment|Other|4|||
48466942|NCT00405756|155900216|FG002|Double-blind Treatment|Other|4|||
48466943|NCT00405756|155900214|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
48466944|NCT00405756|155900215|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
48466945|NCT00405756|155900216|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
48466946|NCT00405756|155900214|FG000|Open-label Extension|Adverse Event|1|||
48466947|NCT00405756|155900215|FG001|Open-label Extension|Adverse Event|3|||
48466948|NCT00405756|155900216|FG002|Open-label Extension|Adverse Event|7|||
48466949|NCT00405756|155900214|FG000|Open-label Extension|Disease Progression|8|||
48466950|NCT00405756|155900215|FG001|Open-label Extension|Disease Progression|23|||
48466951|NCT00405756|155900216|FG002|Open-label Extension|Disease Progression|26|||
48466952|NCT00405756|155900214|FG000|Open-label Extension|Withdrawal by Subject|2|||
48466953|NCT00405756|155900215|FG001|Open-label Extension|Withdrawal by Subject|3|||
48466954|NCT00405756|155900216|FG002|Open-label Extension|Withdrawal by Subject|3|||
48466955|NCT00405756|155900214|FG000|Open-label Extension|Death|1|||
48466956|NCT00405756|155900215|FG001|Open-label Extension|Death|2|||
48466957|NCT00405756|155900216|FG002|Open-label Extension|Death|4|||
48466958|NCT00405756|155900214|FG000|Open-label Extension|Other|0|||
48466959|NCT00405756|155900215|FG001|Open-label Extension|Other|1|||
48466960|NCT00405756|155900216|FG002|Open-label Extension|Other|7|||
48466961|NCT00405756|155900214|FG000|Follow-up|Ongoing in Follow-up Period|52|||
48466962|NCT00405756|155900215|FG001|Follow-up|Ongoing in Follow-up Period|51|||
48466963|NCT00405756|155900216|FG002|Follow-up|Ongoing in Follow-up Period|60|||
48466964|NCT00405756|155900214|FG000|Follow-up|Death|21|||
48466965|NCT00405756|155900215|FG001|Follow-up|Death|31|||
48466966|NCT00405756|155900216|FG002|Follow-up|Death|24|||
48466967|NCT00405756|155900214|FG000|Follow-up|Lost to Follow-up|2|||
48466968|NCT00405756|155900215|FG001|Follow-up|Lost to Follow-up|8|||
48466969|NCT00405756|155900216|FG002|Follow-up|Lost to Follow-up|4|||
48466970|NCT03604159|155900217|FG000|Overall Study|Lost to Follow-up|6|||
48466971|NCT03604159|155900218|FG001|Overall Study|Lost to Follow-up|7|||
48466972|NCT01636076|155900219|FG000|Overall Study|Terminated by sponsor|1|||
48466973|NCT01636076|155900220|FG001|Overall Study|Terminated by sponsor|1|||
48466974|NCT01636076|155900219|FG000|Overall Study|Lack of Efficacy|0|||
48466975|NCT01636076|155900220|FG001|Overall Study|Lack of Efficacy|1|||
48466976|NCT01636076|155900219|FG000|Overall Study|Lost to Follow-up|1|||
48466977|NCT01636076|155900220|FG001|Overall Study|Lost to Follow-up|0|||
48466978|NCT01636076|155900219|FG000|Overall Study|Physician Decision|1|||
48466979|NCT01636076|155900220|FG001|Overall Study|Physician Decision|1|||
48466980|NCT01636076|155900219|FG000|Overall Study|Non-compliance with study treatment|1|||
48466981|NCT01636076|155900220|FG001|Overall Study|Non-compliance with study treatment|1|||
48466982|NCT01636076|155900219|FG000|Overall Study|Adverse Event|6|||
48466983|NCT01636076|155900220|FG001|Overall Study|Adverse Event|11|||
48466984|NCT01636076|155900219|FG000|Overall Study|Withdrawal by Subject|7|||
48466985|NCT01636076|155900220|FG001|Overall Study|Withdrawal by Subject|10|||
48466986|NCT01130831|155900221|FG000|Overall Study|Withdrawal by Subject|7|||
48466987|NCT01130831|155900221|FG000|Overall Study|Death|4|||
48466988|NCT01130831|155900221|FG000|Overall Study|Information was missing|3|||
48466989|NCT01159665|155900222|FG000|Overall Study|Withdrawal by Subject|0|||
48466990|NCT01159665|155900223|FG001|Overall Study|Withdrawal by Subject|1|||
48466991|NCT01159665|155900224|FG002|Overall Study|Withdrawal by Subject|0|||
48466992|NCT01159665|155900225|FG003|Overall Study|Withdrawal by Subject|0|||
48466993|NCT01159665|155900226|FG004|Overall Study|Withdrawal by Subject|0|||
48466994|NCT01159665|155900227|FG005|Overall Study|Withdrawal by Subject|0|||
48466995|NCT00951912|155900231|FG000|Overall Study|Lack of Efficacy|1|||
48466996|NCT00951912|155900232|FG001|Overall Study|Lack of Efficacy|0|||
48466997|NCT00951912|155900233|FG002|Overall Study|Lack of Efficacy|0|||
48466998|NCT00951912|155900231|FG000|Overall Study|Adverse Event|0|||
48466999|NCT00951912|155900232|FG001|Overall Study|Adverse Event|1|||
48467000|NCT00951912|155900233|FG002|Overall Study|Adverse Event|1|||
48467001|NCT00951912|155900231|FG000|Overall Study|Lost to Follow-up|2|||
48467002|NCT00951912|155900232|FG001|Overall Study|Lost to Follow-up|2|||
48467003|NCT00951912|155900233|FG002|Overall Study|Lost to Follow-up|0|||
48467004|NCT00951912|155900231|FG000|Overall Study|Physician Decision|1|||
48467005|NCT00951912|155900232|FG001|Overall Study|Physician Decision|0|||
48467006|NCT00951912|155900233|FG002|Overall Study|Physician Decision|1|||
48467007|NCT00951912|155900231|FG000|Overall Study|Withdrawal by Subject|1|||
48467008|NCT00951912|155900232|FG001|Overall Study|Withdrawal by Subject|1|||
48467009|NCT00951912|155900233|FG002|Overall Study|Withdrawal by Subject|0|||
48467010|NCT00951912|155900231|FG000|Overall Study|Other:Depression|1|||
48467011|NCT00951912|155900232|FG001|Overall Study|Other:Depression|0|||
48467012|NCT00951912|155900233|FG002|Overall Study|Other:Depression|0|||
48467013|NCT00951912|155900231|FG000|Overall Study|Other: Colon cancer|1|||
48467014|NCT00951912|155900232|FG001|Overall Study|Other: Colon cancer|0|||
48467015|NCT00951912|155900233|FG002|Overall Study|Other: Colon cancer|0|||
48467016|NCT00951912|155900231|FG000|Overall Study|Other: Stroke|0|||
48467017|NCT00951912|155900232|FG001|Overall Study|Other: Stroke|1|||
48467018|NCT00951912|155900233|FG002|Overall Study|Other: Stroke|0|||
48467019|NCT02441517|155900234|FG000|Overall Study|Lost to Follow-up|1|||
48467020|NCT02441517|155900234|FG000|Overall Study|Withdrawal by Subject|2|||
48467021|NCT02441517|155900234|FG000|Overall Study|Study Terminated by Sponsor|1|||
48467022|NCT03417999|155900235|FG000|Overall Study|Withdrawal by Subject|1|||
48467023|NCT03417999|155900236|FG001|Overall Study|Withdrawal by Subject|0|||
48467024|NCT03417999|155900237|FG002|Overall Study|Withdrawal by Subject|0|||
48467025|NCT03417999|155900235|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
48467026|NCT03417999|155900236|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
48467027|NCT03417999|155900237|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
48467028|NCT03417999|155900235|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
48467029|NCT03417999|155900236|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
48467030|NCT03417999|155900237|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
48467031|NCT03417999|155900235|FG000|Overall Study|Inadequate study staff available to process samples|0|||
48467032|NCT03417999|155900236|FG001|Overall Study|Inadequate study staff available to process samples|0|||
48467033|NCT03417999|155900237|FG002|Overall Study|Inadequate study staff available to process samples|1|||
48467034|NCT01393444|155900238|FG000|Overall Study|Withdrawal by Subject|1|||
48467035|NCT01393444|155900238|FG000|Overall Study|Determined ineligible during screening.|2|||
48467036|NCT01513460|155900243|FG000|Overall Study|Death|0|||
48467037|NCT01513460|155900244|FG001|Overall Study|Death|0|||
48467038|NCT01513460|155900245|FG002|Overall Study|Death|1|||
48467039|NCT01513460|155900243|FG000|Overall Study|Lost to Follow-up|0|||
48467040|NCT01513460|155900244|FG001|Overall Study|Lost to Follow-up|0|||
48467041|NCT01513460|155900245|FG002|Overall Study|Lost to Follow-up|2|||
48467042|NCT01513460|155900243|FG000|Overall Study|Abnormal laboratory value|1|||
48467043|NCT01513460|155900244|FG001|Overall Study|Abnormal laboratory value|0|||
48467044|NCT01513460|155900245|FG002|Overall Study|Abnormal laboratory value|1|||
48467045|NCT01513460|155900243|FG000|Overall Study|Lack of Efficacy|1|||
48467046|NCT01513460|155900244|FG001|Overall Study|Lack of Efficacy|2|||
48467047|NCT01513460|155900245|FG002|Overall Study|Lack of Efficacy|5|||
48467048|NCT01513460|155900243|FG000|Overall Study|Protocol deviations|3|||
48467049|NCT01513460|155900244|FG001|Overall Study|Protocol deviations|4|||
48467050|NCT01513460|155900245|FG002|Overall Study|Protocol deviations|3|||
48467051|NCT01513460|155900243|FG000|Overall Study|Withdrawal by Subject|7|||
48467052|NCT01513460|155900244|FG001|Overall Study|Withdrawal by Subject|8|||
48467053|NCT01513460|155900245|FG002|Overall Study|Withdrawal by Subject|21|||
48467054|NCT01513460|155900243|FG000|Overall Study|Adverse Event|16|||
48467055|NCT01513460|155900244|FG001|Overall Study|Adverse Event|18|||
48467056|NCT01513460|155900245|FG002|Overall Study|Adverse Event|23|||
48467057|NCT01513460|155900243|FG000|Overall Study|Abnormal test procedure|1|||
48467058|NCT01513460|155900244|FG001|Overall Study|Abnormal test procedure|0|||
48467059|NCT01513460|155900245|FG002|Overall Study|Abnormal test procedure|0|||
48467060|NCT00489216|155900248|FG000|Overall Study|Adverse Event|1|||
48467061|NCT02207413|155900249|FG000|Overall Study|Withdrawal by Subject|1|||
48467062|NCT02207413|155900250|FG001|Overall Study|Withdrawal by Subject|0|||
48467063|NCT02207413|155900251|FG002|Overall Study|Withdrawal by Subject|0|||
48467064|NCT02207413|155900252|FG003|Overall Study|Withdrawal by Subject|0|||
48467065|NCT02207413|155900253|FG004|Overall Study|Withdrawal by Subject|3|||
48467066|NCT02207413|155900254|FG005|Overall Study|Withdrawal by Subject|7|||
48467067|NCT02207413|155900249|FG000|Overall Study|Lost to Follow-up|0|||
48467068|NCT02207413|155900250|FG001|Overall Study|Lost to Follow-up|0|||
48467069|NCT02207413|155900251|FG002|Overall Study|Lost to Follow-up|0|||
48467070|NCT02207413|155900252|FG003|Overall Study|Lost to Follow-up|1|||
48467071|NCT02207413|155900253|FG004|Overall Study|Lost to Follow-up|1|||
48467072|NCT02207413|155900254|FG005|Overall Study|Lost to Follow-up|5|||
48467073|NCT02207413|155900249|FG000|Overall Study|Adverse Event|0|||
48467074|NCT02207413|155900250|FG001|Overall Study|Adverse Event|0|||
48467075|NCT02207413|155900251|FG002|Overall Study|Adverse Event|0|||
48467076|NCT02207413|155900252|FG003|Overall Study|Adverse Event|0|||
48467077|NCT02207413|155900253|FG004|Overall Study|Adverse Event|2|||
48467078|NCT02207413|155900254|FG005|Overall Study|Adverse Event|1|||
48467079|NCT02207413|155900249|FG000|Overall Study|Migrated/moved from study area|0|||
48467080|NCT02207413|155900250|FG001|Overall Study|Migrated/moved from study area|0|||
48467081|NCT02207413|155900251|FG002|Overall Study|Migrated/moved from study area|0|||
48467082|NCT02207413|155900252|FG003|Overall Study|Migrated/moved from study area|0|||
48467083|NCT02207413|155900253|FG004|Overall Study|Migrated/moved from study area|1|||
48467084|NCT02207413|155900254|FG005|Overall Study|Migrated/moved from study area|0|||
48467085|NCT02260804|155900260|FG000|Induction Study Period|Protocol Violation|2|||
48467086|NCT02260804|155900261|FG001|Induction Study Period|Protocol Violation|0|||
48467087|NCT02260804|155900260|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
48467088|NCT02260804|155900261|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
48467089|NCT02260804|155900260|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
48467090|NCT02260804|155900261|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
48467091|NCT02260804|155900260|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
48467092|NCT02260804|155900261|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
48467093|NCT02260804|155900260|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
48467094|NCT02260804|155900261|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
48467095|NCT02260804|155900260|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
48467096|NCT02260804|155900261|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
48467097|NCT02260804|155900260|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
48467098|NCT02260804|155900261|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
48467099|NCT02260804|155900260|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
48467100|NCT02260804|155900261|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
48467101|NCT02260804|155900260|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
48467102|NCT02260804|155900261|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
48467103|NCT02260804|155900260|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
48467104|NCT02260804|155900261|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
48467105|NCT02260804|155900260|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
48467106|NCT02260804|155900261|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
48467107|NCT00758394|155900262|FG000|2nd Intervention Order|Lost to Follow-up|0|||
48467108|NCT00758394|155900263|FG001|2nd Intervention Order|Lost to Follow-up|1|||
48467109|NCT00758394|155900264|FG002|2nd Intervention Order|Lost to Follow-up|0|||
48467110|NCT00758394|155900265|FG003|2nd Intervention Order|Lost to Follow-up|0|||
48467111|NCT00758394|155900262|FG000|3rd Intervention|Lost to Follow-up|1|||
48467112|NCT00758394|155900263|FG001|3rd Intervention|Lost to Follow-up|0|||
48467113|NCT00758394|155900264|FG002|3rd Intervention|Lost to Follow-up|0|||
48467114|NCT00758394|155900265|FG003|3rd Intervention|Lost to Follow-up|1|||
48467115|NCT02539160|155900268|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
48467116|NCT02539160|155900269|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
48467117|NCT02539160|155900270|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
48467118|NCT02539160|155900271|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
48467119|NCT02539160|155900268|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
48467120|NCT02539160|155900269|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
48467121|NCT02539160|155900270|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
48467122|NCT02539160|155900271|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
48467123|NCT02539160|155900268|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
48467124|NCT02539160|155900269|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
48467125|NCT02539160|155900270|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
48467126|NCT02539160|155900271|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
48467127|NCT01681004|155900272|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
48467128|NCT01681004|155900273|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
48467129|NCT01681004|155900272|FG000|Study Completion|Lost to Follow-up|8|||
48467130|NCT01681004|155900273|FG001|Study Completion|Lost to Follow-up|3|||
48467131|NCT01681004|155900272|FG000|Study Completion|Physician Decision|1|||
48467132|NCT01681004|155900273|FG001|Study Completion|Physician Decision|3|||
48467133|NCT01681004|155900272|FG000|Study Completion|Site Termination|2|||
48467134|NCT01681004|155900273|FG001|Study Completion|Site Termination|1|||
48467135|NCT01681004|155900272|FG000|Study Completion|Death|1|||
48467136|NCT01681004|155900273|FG001|Study Completion|Death|1|||
48467137|NCT00129220|155900274|FG000|Study Period II|Adverse Event|9|||
48467138|NCT00129220|155900275|FG001|Study Period II|Adverse Event|5|||
48467139|NCT00129220|155900276|FG002|Study Period II|Adverse Event|7|||
48467140|NCT00129220|155900274|FG000|Study Period II|Lack of Efficacy|15|||
48467141|NCT00129220|155900275|FG001|Study Period II|Lack of Efficacy|1|||
48467142|NCT00129220|155900276|FG002|Study Period II|Lack of Efficacy|28|||
48467143|NCT00129220|155900274|FG000|Study Period II|Entry Criteria Not Met|2|||
48467144|NCT00129220|155900275|FG001|Study Period II|Entry Criteria Not Met|0|||
48467145|NCT00129220|155900276|FG002|Study Period II|Entry Criteria Not Met|2|||
48467146|NCT00129220|155900274|FG000|Study Period II|Protocol Violation|4|||
48467147|NCT00129220|155900275|FG001|Study Period II|Protocol Violation|2|||
48467148|NCT00129220|155900276|FG002|Study Period II|Protocol Violation|1|||
48467149|NCT00129220|155900274|FG000|Study Period II|Physician Decision|0|||
48467150|NCT00129220|155900275|FG001|Study Period II|Physician Decision|1|||
48467151|NCT00129220|155900276|FG002|Study Period II|Physician Decision|0|||
48467152|NCT00129220|155900274|FG000|Study Period II|Withdrawal by Subject|1|||
48467153|NCT00129220|155900275|FG001|Study Period II|Withdrawal by Subject|3|||
48467154|NCT00129220|155900276|FG002|Study Period II|Withdrawal by Subject|4|||
48467155|NCT00129220|155900274|FG000|Study Period II|Reason Not Specified|2|||
48467156|NCT00129220|155900275|FG001|Study Period II|Reason Not Specified|0|||
48467157|NCT00129220|155900276|FG002|Study Period II|Reason Not Specified|5|||
48467158|NCT00129220|155900274|FG000|Study Period III|Adverse Event|1|||
48467159|NCT00129220|155900275|FG001|Study Period III|Adverse Event|0|||
48467160|NCT00129220|155900276|FG002|Study Period III|Adverse Event|3|||
48467161|NCT00129220|155900274|FG000|Study Period III|Protocol Violation|1|||
48467162|NCT00129220|155900275|FG001|Study Period III|Protocol Violation|1|||
48467163|NCT00129220|155900276|FG002|Study Period III|Protocol Violation|2|||
48467164|NCT00129220|155900274|FG000|Study Period III|Withdrawal by Subject|1|||
48467165|NCT00129220|155900275|FG001|Study Period III|Withdrawal by Subject|0|||
48467166|NCT00129220|155900276|FG002|Study Period III|Withdrawal by Subject|3|||
48467167|NCT00129220|155900274|FG000|Study Period III|Sponsor Decision|1|||
48467168|NCT00129220|155900275|FG001|Study Period III|Sponsor Decision|0|||
48467169|NCT00129220|155900276|FG002|Study Period III|Sponsor Decision|0|||
48467170|NCT00129220|155900274|FG000|Study Period III|Reason Not Specified|9|||
48467171|NCT00129220|155900275|FG001|Study Period III|Reason Not Specified|0|||
48467172|NCT00129220|155900276|FG002|Study Period III|Reason Not Specified|2|||
48467173|NCT01790633|155900278|FG000|Overall Study|Protocol Violation|1|||
48467174|NCT01790633|155900279|FG001|Overall Study|Protocol Violation|2|||
48467175|NCT01790633|155900278|FG000|Overall Study|Did not have serology performed|47|||
48467176|NCT01790633|155900279|FG001|Overall Study|Did not have serology performed|0|||
48467177|NCT01790633|155900278|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
48467178|NCT01790633|155900279|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
48467179|NCT00740116|155902017|FG000|Overall Study|Withdrawal by Subject|1|||
48467180|NCT00740116|155902018|FG001|Overall Study|Withdrawal by Subject|1|||
48467181|NCT00740116|155902017|FG000|Overall Study|Protocol Violation|1|||
48467182|NCT00740116|155902018|FG001|Overall Study|Protocol Violation|4|||
48467183|NCT00960323|155902019|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
48467184|NCT02785588|155902020|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
48467185|NCT02785588|155902020|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
48467186|NCT03424811|155902021|FG000|Overall Study|Lost to Follow-up|9|||
48467187|NCT03424811|155902022|FG001|Overall Study|Lost to Follow-up|0|||
48467188|NCT03031327|155902023|FG000|Overall Study|Withdrawal by Subject|0|||
48467189|NCT03031327|155902024|FG001|Overall Study|Withdrawal by Subject|1|||
48467190|NCT03031327|155902025|FG002|Overall Study|Withdrawal by Subject|1|||
48467191|NCT00211536|155902026|FG000|Overall Study|Withdrawal by Subject|2|||
48467192|NCT00211536|155902027|FG001|Overall Study|Withdrawal by Subject|2|||
48467193|NCT00211536|155902026|FG000|Overall Study|Physician Decision|0|||
48467194|NCT00211536|155902027|FG001|Overall Study|Physician Decision|5|||
48467195|NCT00211536|155902026|FG000|Overall Study|Adverse Event|2|||
48467196|NCT00211536|155902027|FG001|Overall Study|Adverse Event|0|||
48467197|NCT02155660|155902029|FG000|Overall Study|Other Reason|8|||
48467198|NCT02155660|155902030|FG001|Overall Study|Other Reason|6|||
48467199|NCT02155660|155902031|FG002|Overall Study|Other Reason|10|||
48467200|NCT02155660|155902032|FG003|Overall Study|Other Reason|10|||
48467201|NCT02155660|155902029|FG000|Overall Study|Study-specific withdrawal criteria|0|||
48467202|NCT02155660|155902030|FG001|Overall Study|Study-specific withdrawal criteria|1|||
48467203|NCT02155660|155902031|FG002|Overall Study|Study-specific withdrawal criteria|1|||
48467204|NCT02155660|155902032|FG003|Overall Study|Study-specific withdrawal criteria|1|||
48467205|NCT02155660|155902029|FG000|Overall Study|Severe non-compliance|0|||
48467206|NCT02155660|155902030|FG001|Overall Study|Severe non-compliance|4|||
48467207|NCT02155660|155902031|FG002|Overall Study|Severe non-compliance|0|||
48467208|NCT02155660|155902032|FG003|Overall Study|Severe non-compliance|1|||
48467209|NCT02155660|155902029|FG000|Overall Study|Adverse Event|2|||
48467210|NCT02155660|155902030|FG001|Overall Study|Adverse Event|6|||
48467211|NCT02155660|155902031|FG002|Overall Study|Adverse Event|3|||
48467212|NCT02155660|155902032|FG003|Overall Study|Adverse Event|1|||
48467213|NCT02155660|155902029|FG000|Overall Study|Lost to Follow-up|3|||
48467214|NCT02155660|155902030|FG001|Overall Study|Lost to Follow-up|6|||
48467215|NCT02155660|155902031|FG002|Overall Study|Lost to Follow-up|5|||
48467216|NCT02155660|155902032|FG003|Overall Study|Lost to Follow-up|8|||
48467217|NCT02155660|155902029|FG000|Overall Study|Death|17|||
48467218|NCT02155660|155902030|FG001|Overall Study|Death|19|||
48467219|NCT02155660|155902031|FG002|Overall Study|Death|17|||
48467220|NCT02155660|155902032|FG003|Overall Study|Death|19|||
48467221|NCT02155660|155902029|FG000|Overall Study|Withdrawal by Subject|28|||
48467222|NCT02155660|155902030|FG001|Overall Study|Withdrawal by Subject|31|||
48467223|NCT02155660|155902031|FG002|Overall Study|Withdrawal by Subject|24|||
48467224|NCT02155660|155902032|FG003|Overall Study|Withdrawal by Subject|21|||
48467225|NCT01087944|155902035|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
48467226|NCT01087944|155902036|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
48467227|NCT01087944|155902035|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
48467228|NCT01087944|155902036|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
48467229|NCT01569568|155902037|FG000|Overall Study|Physician Decision|0|||
48467230|NCT01569568|155902038|FG001|Overall Study|Physician Decision|2|||
48467231|NCT03812224|155902045|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
48467232|NCT03812224|155902046|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
48467233|NCT03812224|155902045|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
48467234|NCT03812224|155902046|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
48467235|NCT03812224|155902045|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
48467236|NCT03812224|155902046|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
48467237|NCT03812224|155902045|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
48467238|NCT03812224|155902046|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
48467239|NCT00303719|155902049|FG000|Overall Study|Not evaluable, prior therapies|0|||
48467240|NCT00303719|155902050|FG001|Overall Study|Not evaluable, prior therapies|30|||
48467241|NCT00303719|155902049|FG000|Overall Study|Lost to Follow-up|0|||
48467242|NCT00303719|155902050|FG001|Overall Study|Lost to Follow-up|7|||
48467243|NCT03730987|155902054|FG000|Overall Study|Lost to Follow-up|2|||
48467244|NCT03730987|155902055|FG001|Overall Study|Lost to Follow-up|0|||
48467245|NCT03730987|155902056|FG002|Overall Study|Lost to Follow-up|2|||
48467246|NCT03730987|155902057|FG003|Overall Study|Lost to Follow-up|0|||
48467247|NCT01641952|155902058|FG000|Overall Study|Lost to Follow-up|28|||
48467248|NCT01641952|155902058|FG000|Overall Study|Adverse Event|6|||
48467249|NCT00656136|155902061|FG000|Overall Study|Progressive disease|177|||
48467250|NCT00656136|155902062|FG001|Overall Study|Progressive disease|322|||
48467251|NCT00656136|155902061|FG000|Overall Study|Other Adverse Event|5|||
48467252|NCT00656136|155902062|FG001|Overall Study|Other Adverse Event|51|||
48467253|NCT00656136|155902061|FG000|Overall Study|Protocol Violation|2|||
48467254|NCT00656136|155902062|FG001|Overall Study|Protocol Violation|3|||
48467255|NCT00656136|155902061|FG000|Overall Study|Patient refused to take study medication|7|||
48467256|NCT00656136|155902062|FG001|Overall Study|Patient refused to take study medication|10|||
48467257|NCT00656136|155902061|FG000|Overall Study|Unknown and others|4|||
48467258|NCT00656136|155902062|FG001|Overall Study|Unknown and others|4|||
48467259|NCT02500901|155902063|FG000|Overall Study|Disease ProgressionDD|2|||
48467260|NCT02087085|155902064|FG000|Overall Study|Adverse Event|10|||
48467261|NCT02087085|155902065|FG001|Overall Study|Adverse Event|14|||
48467262|NCT02087085|155902064|FG000|Overall Study|Lack of Efficacy|4|||
48467263|NCT02087085|155902065|FG001|Overall Study|Lack of Efficacy|3|||
48467264|NCT02087085|155902064|FG000|Overall Study|Lost to Follow-up|6|||
48467265|NCT02087085|155902065|FG001|Overall Study|Lost to Follow-up|4|||
48467266|NCT02087085|155902064|FG000|Overall Study|Withdrawal by Subject|9|||
48467267|NCT02087085|155902065|FG001|Overall Study|Withdrawal by Subject|11|||
48467268|NCT02087085|155902064|FG000|Overall Study|Protocol Violation|1|||
48467269|NCT02087085|155902065|FG001|Overall Study|Protocol Violation|0|||
48467270|NCT02087085|155902064|FG000|Overall Study|Study Terminated by Sponsor|87|||
48467271|NCT02087085|155902065|FG001|Overall Study|Study Terminated by Sponsor|80|||
48467272|NCT02087085|155902064|FG000|Overall Study|Other Miscellaneous Reasons|3|||
48467273|NCT02087085|155902065|FG001|Overall Study|Other Miscellaneous Reasons|4|||
48467274|NCT01191190|155902067|FG000|Overall Study|Withdrawal by Subject|1|||
48467275|NCT01425268|155902069|FG000|Overall Study|Withdrawal by Subject|2|||
48467276|NCT01425268|155902070|FG001|Overall Study|Withdrawal by Subject|0|||
48467277|NCT01425268|155902069|FG000|Overall Study|Sponsor Decision|5|||
48467278|NCT01425268|155902070|FG001|Overall Study|Sponsor Decision|0|||
48467279|NCT01425268|155902069|FG000|Overall Study|Physician Decision|1|||
48467280|NCT01425268|155902070|FG001|Overall Study|Physician Decision|0|||
48467281|NCT00719706|155902071|FG000|Overall Study|Adverse Event|5|||
48467282|NCT00719706|155902072|FG001|Overall Study|Adverse Event|4|||
48467283|NCT00719706|155902071|FG000|Overall Study|Withdrawal by Subject|1|||
48467284|NCT00719706|155902072|FG001|Overall Study|Withdrawal by Subject|2|||
48467285|NCT00719706|155902071|FG000|Overall Study|Protocol Violation|3|||
48467286|NCT00719706|155902072|FG001|Overall Study|Protocol Violation|0|||
48467287|NCT00361504|155902073|FG000|Overall Study|Withdrawal by Subject|94|||
48467288|NCT00361504|155902074|FG001|Overall Study|Withdrawal by Subject|31|||
48467289|NCT00361504|155902073|FG000|Overall Study|Lost to Follow-up|40|||
48467290|NCT00361504|155902074|FG001|Overall Study|Lost to Follow-up|7|||
48467291|NCT00361504|155902073|FG000|Overall Study|Adverse Event|203|||
48467292|NCT00361504|155902074|FG001|Overall Study|Adverse Event|82|||
48467293|NCT00361504|155902073|FG000|Overall Study|Lack of Efficacy|72|||
48467294|NCT00361504|155902074|FG001|Overall Study|Lack of Efficacy|7|||
48467295|NCT00361504|155902073|FG000|Overall Study|Resolution of Pain|2|||
48467296|NCT00361504|155902074|FG001|Overall Study|Resolution of Pain|0|||
48467297|NCT00361504|155902073|FG000|Overall Study|Study medication non compliant|42|||
48467298|NCT00361504|155902074|FG001|Overall Study|Study medication non compliant|15|||
48467299|NCT00361504|155902073|FG000|Overall Study|All other|28|||
48467300|NCT00361504|155902074|FG001|Overall Study|All other|3|||
48467301|NCT00408408|155902075|FG000|Overall Study|No follow up data|2|||
48467302|NCT00408408|155902076|FG001|Overall Study|No follow up data|3|||
48467303|NCT00408408|155902077|FG002|Overall Study|No follow up data|0|||
48467304|NCT00408408|155902078|FG003|Overall Study|No follow up data|7|||
48467305|NCT00408408|155902079|FG004|Overall Study|No follow up data|5|||
48467306|NCT00408408|155902080|FG005|Overall Study|No follow up data|3|||
48467307|NCT00401726|155902081|FG000|Overall Study|Adverse Event|34|||
48467308|NCT00401726|155902082|FG001|Overall Study|Adverse Event|45|||
48467309|NCT00401726|155902081|FG000|Overall Study|Death|0|||
48467310|NCT00401726|155902082|FG001|Overall Study|Death|3|||
48467311|NCT00401726|155902081|FG000|Overall Study|Sponsor Request|0|||
48467312|NCT00401726|155902082|FG001|Overall Study|Sponsor Request|1|||
48467313|NCT00401726|155902081|FG000|Overall Study|Physician Decision|3|||
48467314|NCT00401726|155902082|FG001|Overall Study|Physician Decision|6|||
48467315|NCT00401726|155902081|FG000|Overall Study|Lost to Follow-up|23|||
48467316|NCT00401726|155902082|FG001|Overall Study|Lost to Follow-up|20|||
48467317|NCT00401726|155902081|FG000|Overall Study|Protocol Violation|6|||
48467318|NCT00401726|155902082|FG001|Overall Study|Protocol Violation|3|||
48467319|NCT00401726|155902081|FG000|Overall Study|Withdrawal by Subject|18|||
48467320|NCT00401726|155902082|FG001|Overall Study|Withdrawal by Subject|24|||
48467321|NCT00401726|155902081|FG000|Overall Study|Lack of Efficacy|4|||
48467322|NCT00401726|155902082|FG001|Overall Study|Lack of Efficacy|6|||
48467323|NCT00401726|155902081|FG000|Overall Study|Protocol Deviation|9|||
48467324|NCT00401726|155902082|FG001|Overall Study|Protocol Deviation|4|||
48467325|NCT03172026|155902088|FG000|Overall Study|Withdrawal by Subject|1|||
48467326|NCT03172026|155902089|FG001|Overall Study|Withdrawal by Subject|0|||
48467327|NCT03172026|155902088|FG000|Overall Study|COVID restrictions|1|||
48467328|NCT03172026|155902089|FG001|Overall Study|COVID restrictions|0|||
48467329|NCT00612456|155902093|FG000|Overall Study|Adverse Event|1|||
48467330|NCT00612456|155902094|FG001|Overall Study|Adverse Event|0|||
48467331|NCT00612456|155902095|FG002|Overall Study|Adverse Event|0|||
48467332|NCT00612456|155902093|FG000|Overall Study|Lack of Efficacy|1|||
48467333|NCT00612456|155902094|FG001|Overall Study|Lack of Efficacy|1|||
48467334|NCT00612456|155902095|FG002|Overall Study|Lack of Efficacy|0|||
48467335|NCT00612456|155902093|FG000|Overall Study|Withdrawal by Subject|0|||
48467336|NCT00612456|155902094|FG001|Overall Study|Withdrawal by Subject|1|||
48467337|NCT00612456|155902095|FG002|Overall Study|Withdrawal by Subject|0|||
48467338|NCT03907072|155902096|FG000|Overall Study|Study Terminated by Sponsor|2|||
48467339|NCT03907072|155902097|FG001|Overall Study|Study Terminated by Sponsor|2|||
48467340|NCT03907072|155902098|FG002|Overall Study|Study Terminated by Sponsor|2|||
48467341|NCT00568399|155902104|FG000|Overall Study|Death|2|||
48467342|NCT00568399|155902104|FG000|Overall Study|Adverse Event|5|||
48467343|NCT00568399|155902104|FG000|Overall Study|Withdrawal by Subject|8|||
48467344|NCT01430559|155902105|FG000|Overall Study|Adverse Event|7|||
48467345|NCT01430559|155902106|FG001|Overall Study|Adverse Event|3|||
48467346|NCT01430559|155902105|FG000|Overall Study|Entry criteria not met|1|||
48467347|NCT01430559|155902106|FG001|Overall Study|Entry criteria not met|1|||
48467348|NCT01430559|155902105|FG000|Overall Study|Lost to Follow-up|1|||
48467349|NCT01430559|155902106|FG001|Overall Study|Lost to Follow-up|0|||
48467350|NCT01430559|155902105|FG000|Overall Study|Medication error|1|||
48467351|NCT01430559|155902106|FG001|Overall Study|Medication error|0|||
48467352|NCT01430559|155902105|FG000|Overall Study|Withdrawal by Subject|3|||
48467353|NCT01430559|155902106|FG001|Overall Study|Withdrawal by Subject|2|||
48467354|NCT01430559|155902105|FG000|Overall Study|Protocol Violation|1|||
48467355|NCT01430559|155902106|FG001|Overall Study|Protocol Violation|0|||
48467356|NCT01430559|155902105|FG000|Overall Study|Other|3|||
48467357|NCT01430559|155902106|FG001|Overall Study|Other|3|||
48467358|NCT01430559|155902105|FG000|Overall Study|Randomized, Not Treated|3|||
48467359|NCT01430559|155902106|FG001|Overall Study|Randomized, Not Treated|3|||
48467360|NCT02463097|155902107|FG000|Overall Study|Withdrawal by Subject|1|||
48467361|NCT01177943|155902108|FG000|First Intervention|Withdrawal by Subject|2|||
48467362|NCT01177943|155902109|FG001|First Intervention|Withdrawal by Subject|0|||
48467363|NCT01552408|155902116|FG000|Overall Study|Lost to Follow-up|2|||
48467364|NCT01552408|155902117|FG001|Overall Study|Lost to Follow-up|0|||
48467365|NCT01552408|155902116|FG000|Overall Study|Relocation|0|||
48467366|NCT01552408|155902117|FG001|Overall Study|Relocation|1|||
48467367|NCT01552408|155902116|FG000|Overall Study|Withdrawal by Subject|2|||
48467368|NCT01552408|155902117|FG001|Overall Study|Withdrawal by Subject|1|||
48467369|NCT02195531|155902125|FG000|Overall Study|Withdrawal by Subject|1|||
48467370|NCT02195531|155902126|FG001|Overall Study|Withdrawal by Subject|1|||
48467371|NCT02195531|155902127|FG002|Overall Study|Withdrawal by Subject|1|||
48467372|NCT03205605|155902132|FG000|Overall Study|Withdrawal by Subject|1|||
48467373|NCT01284127|155902133|FG000|Overall Study|Adverse Event|2|||
48467374|NCT01284127|155902133|FG000|Overall Study|Withdrawal by Subject|4|||
48467375|NCT01284127|155902133|FG000|Overall Study|Physician Decision|1|||
48467376|NCT01021423|155902138|FG000|Overall Study|Study terminated|4|||
48467377|NCT01021423|155902139|FG001|Overall Study|Study terminated|5|||
48467378|NCT03417102|155902140|FG000|Overall Study|Adverse Event|0|||
48467379|NCT03417102|155902141|FG001|Overall Study|Adverse Event|1|||
48467380|NCT03417102|155902140|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
48467381|NCT03417102|155902141|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
48467382|NCT03417102|155902140|FG000|Overall Study|Other|0|||
48467383|NCT03417102|155902141|FG001|Overall Study|Other|1|||
48467384|NCT00422942|155902142|FG000|Overall Study|Study terminated by Sponsor|3|||
48467385|NCT03039699|155902143|FG000|Overall Study|Incorrect inclusion|5|||
48467386|NCT03039699|155902144|FG001|Overall Study|Incorrect inclusion|4|||
48467387|NCT03039699|155902143|FG000|Overall Study|Lack of data to assess study endpoint|5|||
48467388|NCT03039699|155902144|FG001|Overall Study|Lack of data to assess study endpoint|3|||
48467389|NCT03039699|155902143|FG000|Overall Study|Bacterial infection|12|||
48467390|NCT03039699|155902144|FG001|Overall Study|Bacterial infection|28|||
48467391|NCT02911285|155902157|FG000|Overall Study|Lost to Follow-up|8|||
48467392|NCT02911285|155902158|FG001|Overall Study|Lost to Follow-up|5|||
48467393|NCT02911285|155902157|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
48467394|NCT02911285|155902158|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
48467395|NCT01397409|155902159|FG000|Stage 2|Adverse Event|0|||
48467396|NCT01397409|155902160|FG001|Stage 2|Adverse Event|0|||
48467397|NCT01397409|155902161|FG002|Stage 2|Adverse Event|0|||
48467398|NCT01397409|155902162|FG003|Stage 2|Adverse Event|0|||
48467399|NCT01397409|155902163|FG004|Stage 2|Adverse Event|6|||
48467400|NCT01397409|155902164|FG005|Stage 2|Adverse Event|3|||
48467401|NCT01397409|155902165|FG006|Stage 2|Adverse Event|0|||
48467402|NCT01397409|155902166|FG007|Stage 2|Adverse Event|0|||
48467403|NCT01397409|155902167|FG008|Stage 2|Adverse Event|0|||
48467404|NCT01397409|155902168|FG009|Stage 2|Adverse Event|0|||
48467405|NCT01397409|155902159|FG000|Stage 2|Personal Reasons|0|||
48467406|NCT01397409|155902160|FG001|Stage 2|Personal Reasons|0|||
48467407|NCT01397409|155902161|FG002|Stage 2|Personal Reasons|0|||
48467408|NCT01397409|155902162|FG003|Stage 2|Personal Reasons|0|||
48467409|NCT01397409|155902163|FG004|Stage 2|Personal Reasons|1|||
48467410|NCT01397409|155902164|FG005|Stage 2|Personal Reasons|0|||
48467411|NCT01397409|155902165|FG006|Stage 2|Personal Reasons|0|||
48467412|NCT01397409|155902166|FG007|Stage 2|Personal Reasons|0|||
48467413|NCT01397409|155902167|FG008|Stage 2|Personal Reasons|0|||
48467414|NCT01397409|155902168|FG009|Stage 2|Personal Reasons|0|||
48467415|NCT01397409|155902159|FG000|Stage 2|Other Miscellaneous Reasons|0|||
48467416|NCT01397409|155902160|FG001|Stage 2|Other Miscellaneous Reasons|0|||
48467417|NCT01397409|155902161|FG002|Stage 2|Other Miscellaneous Reasons|0|||
48467418|NCT01397409|155902162|FG003|Stage 2|Other Miscellaneous Reasons|0|||
48467419|NCT01397409|155902163|FG004|Stage 2|Other Miscellaneous Reasons|1|||
48467420|NCT01397409|155902164|FG005|Stage 2|Other Miscellaneous Reasons|1|||
48467421|NCT01397409|155902165|FG006|Stage 2|Other Miscellaneous Reasons|0|||
48467422|NCT01397409|155902166|FG007|Stage 2|Other Miscellaneous Reasons|0|||
48467423|NCT01397409|155902167|FG008|Stage 2|Other Miscellaneous Reasons|0|||
48467424|NCT01397409|155902168|FG009|Stage 2|Other Miscellaneous Reasons|0|||
48467425|NCT01397409|155902159|FG000|Stage 3|Adverse Event|0|||
48467426|NCT01397409|155902160|FG001|Stage 3|Adverse Event|0|||
48467427|NCT01397409|155902161|FG002|Stage 3|Adverse Event|0|||
48467428|NCT01397409|155902162|FG003|Stage 3|Adverse Event|0|||
48467429|NCT01397409|155902163|FG004|Stage 3|Adverse Event|0|||
48467430|NCT01397409|155902164|FG005|Stage 3|Adverse Event|0|||
48467431|NCT01397409|155902165|FG006|Stage 3|Adverse Event|0|||
48467432|NCT01397409|155902166|FG007|Stage 3|Adverse Event|1|||
48467433|NCT01397409|155902167|FG008|Stage 3|Adverse Event|0|||
48467434|NCT01397409|155902168|FG009|Stage 3|Adverse Event|0|||
48467435|NCT01397409|155902159|FG000|Stage 3|Other Miscellaneous Reasons|0|||
48467436|NCT01397409|155902160|FG001|Stage 3|Other Miscellaneous Reasons|0|||
48467437|NCT01397409|155902161|FG002|Stage 3|Other Miscellaneous Reasons|0|||
48467438|NCT01397409|155902162|FG003|Stage 3|Other Miscellaneous Reasons|0|||
48467439|NCT01397409|155902163|FG004|Stage 3|Other Miscellaneous Reasons|0|||
48467440|NCT01397409|155902164|FG005|Stage 3|Other Miscellaneous Reasons|0|||
48467441|NCT01397409|155902165|FG006|Stage 3|Other Miscellaneous Reasons|0|||
48467442|NCT01397409|155902166|FG007|Stage 3|Other Miscellaneous Reasons|1|||
48467443|NCT01397409|155902167|FG008|Stage 3|Other Miscellaneous Reasons|0|||
48467444|NCT01397409|155902168|FG009|Stage 3|Other Miscellaneous Reasons|0|||
48467445|NCT01728454|155902169|FG000|Stage 1 and 2|Pregnancy|1|||
48467446|NCT01728454|155902170|FG001|Stage 1 and 2|Pregnancy|0|||
48467447|NCT01728454|155902171|FG002|Stage 1 and 2|Pregnancy|0|||
48467448|NCT01728454|155902169|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
48467449|NCT01728454|155902170|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
48467450|NCT01728454|155902171|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
48467451|NCT01728454|155902169|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
48467452|NCT01728454|155902170|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
48467453|NCT01728454|155902171|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
48467454|NCT01728454|155902169|FG000|Stage 1 and 2|Lost to Follow-up|1|||
48467455|NCT01728454|155902170|FG001|Stage 1 and 2|Lost to Follow-up|1|||
48467456|NCT01728454|155902171|FG002|Stage 1 and 2|Lost to Follow-up|0|||
48467457|NCT01728454|155902169|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
48467458|NCT01728454|155902170|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
48467459|NCT01728454|155902171|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
48467460|NCT01728454|155902169|FG000|Stage 3|Reason Missing|0|||
48467461|NCT01728454|155902170|FG001|Stage 3|Reason Missing|0|||
48467462|NCT01728454|155902171|FG002|Stage 3|Reason Missing|1|||
48467463|NCT01728454|155902169|FG000|Stage 3|Subject Required Other Treatment|0|||
48467464|NCT01728454|155902170|FG001|Stage 3|Subject Required Other Treatment|1|||
48467465|NCT01728454|155902171|FG002|Stage 3|Subject Required Other Treatment|0|||
48467466|NCT01728454|155902169|FG000|Stage 3|Pregnancy|1|||
48467467|NCT01728454|155902170|FG001|Stage 3|Pregnancy|0|||
48467468|NCT01728454|155902171|FG002|Stage 3|Pregnancy|0|||
48467469|NCT01728454|155902169|FG000|Stage 3|Withdrew Consent|1|||
48467470|NCT01728454|155902170|FG001|Stage 3|Withdrew Consent|0|||
48467471|NCT01728454|155902171|FG002|Stage 3|Withdrew Consent|1|||
48467472|NCT01728454|155902169|FG000|Stage 3|Non-compliance with Protocol|0|||
48467473|NCT01728454|155902170|FG001|Stage 3|Non-compliance with Protocol|0|||
48467474|NCT01728454|155902171|FG002|Stage 3|Non-compliance with Protocol|1|||
48467475|NCT01728454|155902169|FG000|Stage 3|Lost to Follow-up|0|||
48467476|NCT01728454|155902170|FG001|Stage 3|Lost to Follow-up|3|||
48467477|NCT01728454|155902171|FG002|Stage 3|Lost to Follow-up|1|||
48467478|NCT01728454|155902169|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
48467479|NCT01728454|155902170|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
48467480|NCT01728454|155902171|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
48467481|NCT00701064|155902174|FG000|Overall Study|Protocol Violation|1|||
48467482|NCT00701064|155902175|FG001|Overall Study|Protocol Violation|1|||
48467483|NCT00701064|155902174|FG000|Overall Study|Withdrawal by Subject|1|||
48467484|NCT00701064|155902175|FG001|Overall Study|Withdrawal by Subject|1|||
48467485|NCT00701064|155902174|FG000|Overall Study|initiated other PTSD treatment|2|||
48467486|NCT00701064|155902175|FG001|Overall Study|initiated other PTSD treatment|2|||
48467487|NCT00689299|155902176|FG000|Overall Study|Adverse Event|2|||
48467488|NCT00689299|155902177|FG001|Overall Study|Adverse Event|1|||
48467489|NCT00689299|155902178|FG002|Overall Study|Adverse Event|1|||
48467490|NCT00689299|155902176|FG000|Overall Study|Lost to Follow-up|0|||
48467491|NCT00689299|155902177|FG001|Overall Study|Lost to Follow-up|1|||
48467492|NCT00689299|155902178|FG002|Overall Study|Lost to Follow-up|1|||
48467493|NCT00689299|155902176|FG000|Overall Study|Withdrawal by Subject|4|||
48467494|NCT00689299|155902177|FG001|Overall Study|Withdrawal by Subject|1|||
48467495|NCT00689299|155902178|FG002|Overall Study|Withdrawal by Subject|3|||
48467496|NCT00689299|155902176|FG000|Overall Study|Protocol Violation|1|||
48467497|NCT00689299|155902177|FG001|Overall Study|Protocol Violation|0|||
48467498|NCT00689299|155902178|FG002|Overall Study|Protocol Violation|0|||
48467499|NCT01190839|155902181|FG000|Overall Study|Adverse Event|32|||
48467500|NCT01190839|155902182|FG001|Overall Study|Adverse Event|41|||
48467501|NCT01190839|155902181|FG000|Overall Study|Protocol Violation|2|||
48467502|NCT01190839|155902182|FG001|Overall Study|Protocol Violation|2|||
48467503|NCT01190839|155902181|FG000|Overall Study|Lost to Follow-up|7|||
48467504|NCT01190839|155902182|FG001|Overall Study|Lost to Follow-up|1|||
48467505|NCT01190839|155902181|FG000|Overall Study|Death|1|||
48467506|NCT01190839|155902182|FG001|Overall Study|Death|0|||
48467507|NCT01190839|155902181|FG000|Overall Study|Trial stopped by Sponsor|71|||
48467508|NCT01190839|155902182|FG001|Overall Study|Trial stopped by Sponsor|68|||
48467509|NCT01190839|155902181|FG000|Overall Study|Undefined|35|||
48467510|NCT01190839|155902182|FG001|Overall Study|Undefined|31|||
48467511|NCT01190839|155902181|FG000|Overall Study|Randomized but not treated|2|||
48467512|NCT01190839|155902182|FG001|Overall Study|Randomized but not treated|4|||
48467513|NCT02613910|155902185|FG000|Overall Study|Termination of study|1|||
48467514|NCT00386152|155903531|FG000|Overall Study|Adverse Event|6|||
48467515|NCT00386152|155903532|FG001|Overall Study|Adverse Event|5|||
48467516|NCT00386152|155903533|FG002|Overall Study|Adverse Event|4|||
48467517|NCT00386152|155903531|FG000|Overall Study|Chang from original chemo stratification|4|||
48467518|NCT00386152|155903532|FG001|Overall Study|Chang from original chemo stratification|5|||
48467519|NCT00386152|155903533|FG002|Overall Study|Chang from original chemo stratification|6|||
48467520|NCT00386152|155903531|FG000|Overall Study|Death|3|||
48467521|NCT00386152|155903532|FG001|Overall Study|Death|0|||
48467522|NCT00386152|155903533|FG002|Overall Study|Death|1|||
48467523|NCT00386152|155903531|FG000|Overall Study|Disease progression|7|||
48467524|NCT00386152|155903532|FG001|Overall Study|Disease progression|4|||
48467525|NCT00386152|155903533|FG002|Overall Study|Disease progression|5|||
48467526|NCT00386152|155903531|FG000|Overall Study|Physician Decision|13|||
48467527|NCT00386152|155903532|FG001|Overall Study|Physician Decision|10|||
48467528|NCT00386152|155903533|FG002|Overall Study|Physician Decision|4|||
48467529|NCT00386152|155903531|FG000|Overall Study|Lost to Follow-up|1|||
48467530|NCT00386152|155903532|FG001|Overall Study|Lost to Follow-up|0|||
48467531|NCT00386152|155903533|FG002|Overall Study|Lost to Follow-up|0|||
48467532|NCT00386152|155903531|FG000|Overall Study|Completed chemotherapy|4|||
48467533|NCT00386152|155903532|FG001|Overall Study|Completed chemotherapy|5|||
48467534|NCT00386152|155903533|FG002|Overall Study|Completed chemotherapy|1|||
48467535|NCT00386152|155903531|FG000|Overall Study|Protocol Violation|3|||
48467536|NCT00386152|155903532|FG001|Overall Study|Protocol Violation|5|||
48467537|NCT00386152|155903533|FG002|Overall Study|Protocol Violation|2|||
48467538|NCT00386152|155903531|FG000|Overall Study|Withdrawal by Subject|3|||
48467539|NCT00386152|155903532|FG001|Overall Study|Withdrawal by Subject|6|||
48467540|NCT00386152|155903533|FG002|Overall Study|Withdrawal by Subject|10|||
48467541|NCT01370499|155903534|FG000|Overall Study|Adverse Event|38|||
48467542|NCT01370499|155903535|FG001|Overall Study|Adverse Event|12|||
48467543|NCT01370499|155903534|FG000|Overall Study|Lack of Efficacy|4|||
48467544|NCT01370499|155903535|FG001|Overall Study|Lack of Efficacy|2|||
48467545|NCT01370499|155903534|FG000|Overall Study|Lost to Follow-up|2|||
48467546|NCT01370499|155903535|FG001|Overall Study|Lost to Follow-up|1|||
48467547|NCT01370499|155903534|FG000|Overall Study|Physician Decision|3|||
48467548|NCT01370499|155903535|FG001|Overall Study|Physician Decision|3|||
48467549|NCT01370499|155903534|FG000|Overall Study|Protocol Violation|5|||
48467550|NCT01370499|155903535|FG001|Overall Study|Protocol Violation|4|||
48467551|NCT01370499|155903534|FG000|Overall Study|Withdrawal by Subject|18|||
48467552|NCT01370499|155903535|FG001|Overall Study|Withdrawal by Subject|7|||
48467553|NCT01370499|155903534|FG000|Overall Study|Sponsor Decision|41|||
48467554|NCT01370499|155903535|FG001|Overall Study|Sponsor Decision|15|||
48467555|NCT04511533|155903536|FG000|Treatment|Other|2|||
48467556|NCT04511533|155903536|FG000|Treatment|Withdrawal by Subject|11|||
48467557|NCT04511533|155903536|FG000|Treatment|Death|5|||
48467558|NCT04511533|155903536|FG000|Treatment|Physician Decision|1|||
48467559|NCT04511533|155903536|FG000|Treatment|Progressive Disease|61|||
48467560|NCT04511533|155903536|FG000|Follow-Up|Other|7|||
48467561|NCT04511533|155903536|FG000|Follow-Up|Withdrawal by Subject|5|||
48467562|NCT04511533|155903536|FG000|Follow-Up|Lost to Follow-up|2|||
48467563|NCT04511533|155903536|FG000|Follow-Up|Death|4|||
48467564|NCT01982942|155903537|FG000|Overall Study|Adverse Event|10|||
48467565|NCT01982942|155903538|FG001|Overall Study|Adverse Event|5|||
48467566|NCT01982942|155903537|FG000|Overall Study|Lost to Follow-up|4|||
48467567|NCT01982942|155903538|FG001|Overall Study|Lost to Follow-up|3|||
48467568|NCT01982942|155903537|FG000|Overall Study|Multiple sclerosis progression|3|||
48467569|NCT01982942|155903538|FG001|Overall Study|Multiple sclerosis progression|2|||
48467570|NCT01982942|155903537|FG000|Overall Study|Wanted to try therapy not permitted|1|||
48467571|NCT01982942|155903538|FG001|Overall Study|Wanted to try therapy not permitted|0|||
48467572|NCT01982942|155903537|FG000|Overall Study|Subject declined future visits|0|||
48467573|NCT01982942|155903538|FG001|Overall Study|Subject declined future visits|1|||
48467574|NCT01982942|155903537|FG000|Overall Study|Left geographical area|2|||
48467575|NCT01982942|155903538|FG001|Overall Study|Left geographical area|0|||
48467576|NCT01982942|155903537|FG000|Overall Study|Too many pills|1|||
48467577|NCT01982942|155903538|FG001|Overall Study|Too many pills|0|||
48467578|NCT01982942|155903537|FG000|Overall Study|MS Relapse|0|||
48467579|NCT01982942|155903538|FG001|Overall Study|MS Relapse|1|||
48467580|NCT01982942|155903537|FG000|Overall Study|Chose to join a stem cell trial|0|||
48467581|NCT01982942|155903538|FG001|Overall Study|Chose to join a stem cell trial|1|||
48467582|NCT01982942|155903537|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
48467583|NCT01982942|155903538|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
48467584|NCT01224171|155903539|FG000|Overall Study|Adverse Event|8|||
48467585|NCT01224171|155903540|FG001|Overall Study|Adverse Event|4|||
48467586|NCT01224171|155903539|FG000|Overall Study|Protocol Violation|0|||
48467587|NCT01224171|155903540|FG001|Overall Study|Protocol Violation|1|||
48467588|NCT01224171|155903539|FG000|Overall Study|Lack of Efficacy|5|||
48467589|NCT01224171|155903540|FG001|Overall Study|Lack of Efficacy|1|||
48467590|NCT01224171|155903539|FG000|Overall Study|Withdrawal of Consent|2|||
48467591|NCT01224171|155903540|FG001|Overall Study|Withdrawal of Consent|4|||
48467592|NCT01224171|155903539|FG000|Overall Study|Lost to Follow-up|0|||
48467593|NCT01224171|155903540|FG001|Overall Study|Lost to Follow-up|3|||
48467594|NCT02185040|155903541|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
48467595|NCT02185040|155903542|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
48467596|NCT02185040|155903543|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
48467597|NCT02185040|155903544|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
48467598|NCT02185040|155903545|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
48467599|NCT02185040|155903546|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
48467600|NCT02185040|155903547|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
48467601|NCT02185040|155903541|FG000|Part 1 Treatment Phase|Adverse Event|1|||
48467602|NCT02185040|155903542|FG001|Part 1 Treatment Phase|Adverse Event|0|||
48467603|NCT02185040|155903543|FG002|Part 1 Treatment Phase|Adverse Event|0|||
48467604|NCT02185040|155903544|FG003|Part 1 Treatment Phase|Adverse Event|2|||
48467605|NCT02185040|155903545|FG004|Part 1 Treatment Phase|Adverse Event|3|||
48467606|NCT02185040|155903546|FG005|Part 1 Treatment Phase|Adverse Event|0|||
48467607|NCT02185040|155903547|FG006|Part 1 Treatment Phase|Adverse Event|0|||
48467608|NCT02185040|155903541|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48467609|NCT02185040|155903542|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
48467610|NCT02185040|155903543|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48467611|NCT02185040|155903544|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48467612|NCT02185040|155903545|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48467613|NCT02185040|155903546|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48467614|NCT02185040|155903547|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
48467615|NCT02185040|155903541|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
48467616|NCT02185040|155903542|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
48467617|NCT02185040|155903543|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
48467618|NCT02185040|155903544|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
48467619|NCT02185040|155903545|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
48467620|NCT02185040|155903546|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
48467621|NCT02185040|155903547|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
48467622|NCT02185040|155903541|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
48467623|NCT02185040|155903542|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
48467624|NCT02185040|155903543|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
48467625|NCT02185040|155903544|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
48467626|NCT02185040|155903545|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
48467627|NCT02185040|155903546|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
48467628|NCT02185040|155903547|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
48467629|NCT02185040|155903541|FG000|Active Treatment Extension Phase|Adverse Event|0|||
48467630|NCT02185040|155903542|FG001|Active Treatment Extension Phase|Adverse Event|0|||
48467631|NCT02185040|155903543|FG002|Active Treatment Extension Phase|Adverse Event|0|||
48467632|NCT02185040|155903544|FG003|Active Treatment Extension Phase|Adverse Event|0|||
48467633|NCT02185040|155903545|FG004|Active Treatment Extension Phase|Adverse Event|0|||
48467634|NCT02185040|155903546|FG005|Active Treatment Extension Phase|Adverse Event|1|||
48467635|NCT02185040|155903547|FG006|Active Treatment Extension Phase|Adverse Event|4|||
48467636|NCT02185040|155903541|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
48467637|NCT02185040|155903542|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
48467638|NCT02185040|155903543|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
48467639|NCT02185040|155903544|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
48467640|NCT02185040|155903545|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
48467641|NCT02185040|155903546|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
48467642|NCT02185040|155903547|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
48467643|NCT02185040|155903541|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
48467644|NCT02185040|155903542|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
48467645|NCT02185040|155903543|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
48467646|NCT02185040|155903544|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
48467647|NCT02185040|155903545|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
48467648|NCT02185040|155903546|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
48467649|NCT02185040|155903547|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
48467650|NCT00635804|155903549|FG000|Overall Study|Adverse Event|0|||
48467651|NCT00635804|155903550|FG001|Overall Study|Adverse Event|0|||
48467652|NCT00635804|155903551|FG002|Overall Study|Adverse Event|0|||
48467653|NCT00635804|155903552|FG003|Overall Study|Adverse Event|0|||
48467654|NCT00635804|155903553|FG004|Overall Study|Adverse Event|0|||
48467655|NCT00635804|155903554|FG005|Overall Study|Adverse Event|1|||
48467656|NCT00635804|155903555|FG006|Overall Study|Adverse Event|0|||
48467657|NCT00635804|155903556|FG007|Overall Study|Adverse Event|0|||
48467658|NCT00635804|155903549|FG000|Overall Study|Withdrawal by Subject|1|||
48467659|NCT00635804|155903550|FG001|Overall Study|Withdrawal by Subject|0|||
48467660|NCT00635804|155903551|FG002|Overall Study|Withdrawal by Subject|0|||
48467661|NCT00635804|155903552|FG003|Overall Study|Withdrawal by Subject|0|||
48467662|NCT00635804|155903553|FG004|Overall Study|Withdrawal by Subject|0|||
48467663|NCT00635804|155903554|FG005|Overall Study|Withdrawal by Subject|0|||
48467664|NCT00635804|155903555|FG006|Overall Study|Withdrawal by Subject|0|||
48467665|NCT00635804|155903556|FG007|Overall Study|Withdrawal by Subject|0|||
48467666|NCT02718131|155903567|FG000|Overall Study|Withdrawal by Subject|1|||
48467667|NCT02718131|155903568|FG001|Overall Study|Withdrawal by Subject|0|||
48467668|NCT02718131|155903567|FG000|Overall Study|Adverse Event|1|||
48467669|NCT02718131|155903568|FG001|Overall Study|Adverse Event|0|||
48467670|NCT02718131|155903567|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
48467671|NCT02718131|155903568|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
48467672|NCT01667731|155903569|FG000|Overall Study|Enrolled but not treated|0|||
48467673|NCT01667731|155903570|FG001|Overall Study|Enrolled but not treated|0|||
48467674|NCT01667731|155903571|FG002|Overall Study|Enrolled but not treated|0|||
48467675|NCT01667731|155903572|FG003|Overall Study|Enrolled but not treated|0|||
48467676|NCT01667731|155903573|FG004|Overall Study|Enrolled but not treated|1|||
48467677|NCT01667731|155903569|FG000|Overall Study|Efficacy Failure|1|||
48467678|NCT01667731|155903570|FG001|Overall Study|Efficacy Failure|12|||
48467679|NCT01667731|155903571|FG002|Overall Study|Efficacy Failure|0|||
48467680|NCT01667731|155903572|FG003|Overall Study|Efficacy Failure|1|||
48467681|NCT01667731|155903573|FG004|Overall Study|Efficacy Failure|24|||
48467682|NCT01667731|155903569|FG000|Overall Study|Lost to Follow-up|2|||
48467683|NCT01667731|155903570|FG001|Overall Study|Lost to Follow-up|3|||
48467684|NCT01667731|155903571|FG002|Overall Study|Lost to Follow-up|1|||
48467685|NCT01667731|155903572|FG003|Overall Study|Lost to Follow-up|1|||
48467686|NCT01667731|155903573|FG004|Overall Study|Lost to Follow-up|2|||
48467687|NCT01667731|155903569|FG000|Overall Study|Subject Withdrew Consent|2|||
48467688|NCT01667731|155903570|FG001|Overall Study|Subject Withdrew Consent|0|||
48467689|NCT01667731|155903571|FG002|Overall Study|Subject Withdrew Consent|1|||
48467690|NCT01667731|155903572|FG003|Overall Study|Subject Withdrew Consent|0|||
48467691|NCT01667731|155903573|FG004|Overall Study|Subject Withdrew Consent|1|||
48467692|NCT01667731|155903569|FG000|Overall Study|Death|0|||
48467693|NCT01667731|155903570|FG001|Overall Study|Death|1|||
48467694|NCT01667731|155903571|FG002|Overall Study|Death|0|||
48467695|NCT01667731|155903572|FG003|Overall Study|Death|0|||
48467696|NCT01667731|155903573|FG004|Overall Study|Death|0|||
48467697|NCT01097057|155903577|FG000|Overall Study|Physician Decision|3|||
48467698|NCT00887822|155903582|FG000|Overall Study|Insufficient therapeutic response|53|||
48467699|NCT00887822|155903583|FG001|Overall Study|Insufficient therapeutic response|55|||
48467700|NCT00887822|155903582|FG000|Overall Study|Adverse Event|14|||
48467701|NCT00887822|155903583|FG001|Overall Study|Adverse Event|17|||
48467702|NCT00887822|155903582|FG000|Overall Study|Failure to return|11|||
48467703|NCT00887822|155903583|FG001|Overall Study|Failure to return|11|||
48467704|NCT00887822|155903582|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
48467705|NCT00887822|155903583|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
48467706|NCT00887822|155903582|FG000|Overall Study|Administrative/Other than specified|5|||
48467707|NCT00887822|155903583|FG001|Overall Study|Administrative/Other than specified|4|||
48467708|NCT00887822|155903582|FG000|Overall Study|Death|2|||
48467709|NCT00887822|155903583|FG001|Overall Study|Death|3|||
48467710|NCT00887822|155903582|FG000|Overall Study|Protocol Violation|0|||
48467711|NCT00887822|155903583|FG001|Overall Study|Protocol Violation|1|||
48467712|NCT00887822|155903582|FG000|Overall Study|Randomized but not treated|0|||
48467713|NCT00887822|155903583|FG001|Overall Study|Randomized but not treated|1|||
48467714|NCT01101321|155903584|FG000|Period 1|Withdrawal by Subject|1|||
48467715|NCT01101321|155903585|FG001|Period 1|Withdrawal by Subject|1|||
48467716|NCT01101321|155903584|FG000|Period 1|Adverse Event|3|||
48467717|NCT01101321|155903585|FG001|Period 1|Adverse Event|3|||
48467718|NCT03672006|155903589|FG000|Overall Study|exclusion criteria met|0|||
48467719|NCT03672006|155903590|FG001|Overall Study|exclusion criteria met|1|||
48467720|NCT04235959|155903591|FG000|Overall Study|Protocol Violation|0|||
48467721|NCT04235959|155903592|FG001|Overall Study|Protocol Violation|1|||
48467722|NCT04235959|155903593|FG002|Overall Study|Protocol Violation|0|||
48467723|NCT04235959|155903591|FG000|Overall Study|Adverse Event|1|||
48467724|NCT04235959|155903592|FG001|Overall Study|Adverse Event|0|||
48467725|NCT04235959|155903593|FG002|Overall Study|Adverse Event|0|||
48467726|NCT01219959|155903601|FG000|Overall Study|Adverse Event|6|||
48467727|NCT01219959|155903602|FG001|Overall Study|Adverse Event|14|||
48467728|NCT01219959|155903601|FG000|Overall Study|Physician Decision|0|||
48467729|NCT01219959|155903602|FG001|Overall Study|Physician Decision|4|||
48467730|NCT01219959|155903601|FG000|Overall Study|Withdrawal by Subject|0|||
48467731|NCT01219959|155903602|FG001|Overall Study|Withdrawal by Subject|2|||
48467732|NCT01219959|155903601|FG000|Overall Study|Renal Transplantation|0|||
48467733|NCT01219959|155903602|FG001|Overall Study|Renal Transplantation|3|||
48467734|NCT01219959|155903601|FG000|Overall Study|Other|1|||
48467735|NCT01219959|155903602|FG001|Overall Study|Other|0|||
48467736|NCT00265109|155903603|FG000|Overall Study|Withdrawal by Subject|5|||
48467737|NCT00265109|155903603|FG000|Overall Study|Adverse Event|1|||
48467738|NCT01955005|155903610|FG000|Overall Study|Withdrawal by Subject|3|||
48467739|NCT01955005|155903611|FG001|Overall Study|Withdrawal by Subject|5|||
48467740|NCT00323479|155903619|FG000|Overall Study|Adverse Event|2|||
48467741|NCT00323479|155903619|FG000|Overall Study|Withdrawal by Subject|2|||
48467742|NCT00323479|155903619|FG000|Overall Study|Protocol Violation|3|||
48467743|NCT00323479|155903619|FG000|Overall Study|house moving|1|||
48467744|NCT02828982|155903620|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48467745|NCT02828982|155903621|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
48467746|NCT00372905|155903623|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
48467747|NCT00372905|155903624|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
48467748|NCT00372905|155903625|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
48467749|NCT00372905|155903626|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
48467750|NCT00372905|155903623|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
48467751|NCT00372905|155903624|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
48467752|NCT00372905|155903625|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
48467753|NCT00372905|155903626|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
48467754|NCT00372905|155903623|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
48467755|NCT00372905|155903624|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
48467756|NCT00372905|155903625|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
48467757|NCT00372905|155903626|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
48467758|NCT00372905|155903623|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
48467759|NCT00372905|155903624|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
48467760|NCT00372905|155903625|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
48467761|NCT00372905|155903626|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
48467762|NCT00372905|155903623|FG000|Follow up Until Relapse or Progression|Study closed|0|||
48467763|NCT00372905|155903624|FG001|Follow up Until Relapse or Progression|Study closed|0|||
48467764|NCT00372905|155903625|FG002|Follow up Until Relapse or Progression|Study closed|0|||
48467765|NCT00372905|155903626|FG003|Follow up Until Relapse or Progression|Study closed|3|||
48467766|NCT00372905|155903623|FG000|Follow up Until Relapse or Progression|Other|0|||
48467767|NCT00372905|155903624|FG001|Follow up Until Relapse or Progression|Other|1|||
48467768|NCT00372905|155903625|FG002|Follow up Until Relapse or Progression|Other|0|||
48467769|NCT00372905|155903626|FG003|Follow up Until Relapse or Progression|Other|0|||
48467770|NCT01883362|155903627|FG000|Treatment|Adverse Event|1|||
48467771|NCT01883362|155903628|FG001|Treatment|Adverse Event|8|||
48467772|NCT01883362|155903627|FG000|Treatment|Withdrawal by Subject|6|||
48467773|NCT01883362|155903628|FG001|Treatment|Withdrawal by Subject|2|||
48467774|NCT01883362|155903627|FG000|Treatment|Administrative problems|4|||
48467775|NCT01883362|155903628|FG001|Treatment|Administrative problems|1|||
48467776|NCT01883362|155903627|FG000|Treatment|Relapse|4|||
48467777|NCT01883362|155903628|FG001|Treatment|Relapse|2|||
48467778|NCT01883362|155903627|FG000|Treatment|Randomized, not treated|1|||
48467779|NCT01883362|155903628|FG001|Treatment|Randomized, not treated|1|||
48467780|NCT01883362|155903627|FG000|Post Treatment Follow-up|Protocol Violation|0|||
48467781|NCT01883362|155903628|FG001|Post Treatment Follow-up|Protocol Violation|1|||
48467782|NCT01883362|155903627|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
48467783|NCT01883362|155903628|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
48467784|NCT01883362|155903627|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
48467785|NCT01883362|155903628|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
48467786|NCT01883362|155903627|FG000|Post Treatment Follow-up|Administrative problems|2|||
48467787|NCT01883362|155903628|FG001|Post Treatment Follow-up|Administrative problems|0|||
48467788|NCT01883362|155903627|FG000|Post Treatment Follow-up|Death|8|||
48467789|NCT01883362|155903628|FG001|Post Treatment Follow-up|Death|4|||
48467790|NCT01883362|155903627|FG000|Post Treatment Follow-up|Relapse|1|||
48467791|NCT01883362|155903628|FG001|Post Treatment Follow-up|Relapse|2|||
48467792|NCT02569996|155903629|FG000|Overall Study|Adverse Event|6|||
48467793|NCT02569996|155903629|FG000|Overall Study|Physician Decision|3|||
48467794|NCT02569996|155903629|FG000|Overall Study|Progression of the disease|18|||
48467795|NCT02569996|155903629|FG000|Overall Study|New anti-lymphoma treatment|1|||
48467796|NCT02569996|155903629|FG000|Overall Study|Non-compliance|9|||
48467797|NCT02569996|155903629|FG000|Overall Study|Withdrawal by Subject|5|||
48467798|NCT02569996|155903629|FG000|Overall Study|Lost to Follow-up|5|||
48467799|NCT02569996|155903629|FG000|Overall Study|Complete remission|7|||
48467800|NCT02569996|155903629|FG000|Overall Study|Unknown reason|1|||
48467801|NCT01349816|155903630|FG000|Overall Study|Withdrawal by Subject|4|||
48467802|NCT01349816|155903630|FG000|Overall Study|Physician Decision|1|||
48467803|NCT01349816|155903630|FG000|Overall Study|Adverse Event|14|||
48467804|NCT01349816|155903630|FG000|Overall Study|Lost to Follow-up|2|||
48467805|NCT01349816|155903630|FG000|Overall Study|Protocol Violation|1|||
48467806|NCT01349816|155903630|FG000|Overall Study|Protocol-specified criteria|8|||
48467807|NCT01383317|155903631|FG000|Overall Study|Lost to Follow-up|2|||
48467808|NCT01383317|155903632|FG001|Overall Study|Lost to Follow-up|1|||
48467809|NCT01383317|155903631|FG000|Overall Study|Death|1|||
48467810|NCT01383317|155903632|FG001|Overall Study|Death|0|||
48467811|NCT01383317|155903631|FG000|Overall Study|Adverse Event|0|||
48467812|NCT01383317|155903632|FG001|Overall Study|Adverse Event|1|||
48467813|NCT01377194|155903637|FG000|Overall Study|Adverse Event|3|||
48467814|NCT01377194|155903638|FG001|Overall Study|Adverse Event|12|||
48467815|NCT01377194|155903639|FG002|Overall Study|Adverse Event|19|||
48467816|NCT01377194|155903637|FG000|Overall Study|Lack of Efficacy|3|||
48467817|NCT01377194|155903638|FG001|Overall Study|Lack of Efficacy|3|||
48467818|NCT01377194|155903639|FG002|Overall Study|Lack of Efficacy|3|||
48467819|NCT01377194|155903637|FG000|Overall Study|Protocol Violation|4|||
48467820|NCT01377194|155903638|FG001|Overall Study|Protocol Violation|10|||
48467821|NCT01377194|155903639|FG002|Overall Study|Protocol Violation|6|||
48467822|NCT01377194|155903637|FG000|Overall Study|Withdrawal by Subject|8|||
48467823|NCT01377194|155903638|FG001|Overall Study|Withdrawal by Subject|10|||
48467824|NCT01377194|155903639|FG002|Overall Study|Withdrawal by Subject|7|||
48467825|NCT01377194|155903637|FG000|Overall Study|Lost to Follow-up|14|||
48467826|NCT01377194|155903638|FG001|Overall Study|Lost to Follow-up|8|||
48467827|NCT01377194|155903639|FG002|Overall Study|Lost to Follow-up|11|||
48467828|NCT01207427|155903640|FG000|Double-blind Treatment Period|Adverse Event|0|||
48467829|NCT01207427|155903641|FG001|Double-blind Treatment Period|Adverse Event|1|||
48467830|NCT01207427|155903642|FG002|Double-blind Treatment Period|Adverse Event|0|||
48467831|NCT01207427|155903640|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48467832|NCT01207427|155903641|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
48467833|NCT01207427|155903642|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
48467834|NCT01207427|155903640|FG000|Double-blind Treatment Period|Protocol Violation|2|||
48467835|NCT01207427|155903641|FG001|Double-blind Treatment Period|Protocol Violation|1|||
48467836|NCT01207427|155903642|FG002|Double-blind Treatment Period|Protocol Violation|1|||
48467837|NCT01207427|155903640|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
48467838|NCT01207427|155903641|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
48467839|NCT01207427|155903642|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48467840|NCT00422227|155903643|FG000|Overall Study|Adverse Event|3|||
48467841|NCT00422227|155903644|FG001|Overall Study|Adverse Event|8|||
48467842|NCT00422227|155903643|FG000|Overall Study|Lost to Follow-up|1|||
48467843|NCT00422227|155903644|FG001|Overall Study|Lost to Follow-up|3|||
48467844|NCT00422227|155903643|FG000|Overall Study|Withdrawal by Subject|0|||
48467845|NCT00422227|155903644|FG001|Overall Study|Withdrawal by Subject|4|||
48467846|NCT03418727|155903645|FG000|Overall Study|Adverse Event|1|||
48467847|NCT03418727|155903646|FG001|Overall Study|Adverse Event|2|||
48467848|NCT03418727|155903647|FG002|Overall Study|Adverse Event|0|||
48467849|NCT03418727|155903645|FG000|Overall Study|Withdrawal by Subject|0|||
48467850|NCT03418727|155903646|FG001|Overall Study|Withdrawal by Subject|0|||
48467851|NCT03418727|155903647|FG002|Overall Study|Withdrawal by Subject|2|||
48467852|NCT01756846|155903652|FG000|Overall Study|Lost to Follow-up|5|||
48467853|NCT01756846|155903653|FG001|Overall Study|Lost to Follow-up|10|||
48467854|NCT01756846|155903652|FG000|Overall Study|Withdrawal by Subject|1|||
48467855|NCT01756846|155903653|FG001|Overall Study|Withdrawal by Subject|2|||
48467856|NCT01230489|155903654|FG000|Overall Study|Death|2|||
48467857|NCT01230489|155903654|FG000|Overall Study|Adverse Event|2|||
48467858|NCT01230489|155903654|FG000|Overall Study|Treatment modality changed|1|||
48467859|NCT03145207|155903655|FG000|Overall Study|volunteer started taking allergy shots|1|||
48467860|NCT03145207|155903655|FG000|Overall Study|baseline blood pressure high|1|||
48467861|NCT00486720|155903656|FG000|Overall Study|Adverse Event|1|||
48467862|NCT00486720|155903657|FG001|Overall Study|Adverse Event|2|||
48467863|NCT00486720|155903656|FG000|Overall Study|Lack of Efficacy|4|||
48467864|NCT00486720|155903657|FG001|Overall Study|Lack of Efficacy|6|||
48467865|NCT00486720|155903656|FG000|Overall Study|Physician Decision|1|||
48467866|NCT00486720|155903657|FG001|Overall Study|Physician Decision|2|||
48467867|NCT00486720|155903656|FG000|Overall Study|Protocol Violation|1|||
48467868|NCT00486720|155903657|FG001|Overall Study|Protocol Violation|0|||
48467869|NCT00486720|155903656|FG000|Overall Study|Withdrawal by Subject|3|||
48467870|NCT00486720|155903657|FG001|Overall Study|Withdrawal by Subject|1|||
48467871|NCT00486720|155903656|FG000|Overall Study|Progressive Disease|0|||
48467872|NCT00486720|155903657|FG001|Overall Study|Progressive Disease|1|||
48467873|NCT03188991|155903660|FG000|Overall Study|Withdrawal by Subject|0|||
48467874|NCT03188991|155903661|FG001|Overall Study|Withdrawal by Subject|0|||
48467875|NCT03188991|155903662|FG002|Overall Study|Withdrawal by Subject|0|||
48467876|NCT03188991|155903663|FG003|Overall Study|Withdrawal by Subject|1|||
48467877|NCT01298661|155903668|FG000|Overall Study|Withdrawal by Subject|2|||
48467878|NCT01298661|155903669|FG001|Overall Study|Withdrawal by Subject|0|||
48467879|NCT01298661|155903670|FG002|Overall Study|Withdrawal by Subject|2|||
48467880|NCT02390167|155905179|FG000|Overall Study|Lost to Follow-up|1|||
48467881|NCT01084096|155905180|FG000|Overall Study|Lost to Follow-up|1501|||
48467882|NCT01084096|155905181|FG001|Overall Study|Lost to Follow-up|1833|||
48467883|NCT01084096|155905180|FG000|Overall Study|Withdrawal by Subject|3|||
48467884|NCT01084096|155905181|FG001|Overall Study|Withdrawal by Subject|0|||
48467885|NCT01084096|155905180|FG000|Overall Study|Woman had a miscarriage|21|||
48467886|NCT01084096|155905181|FG001|Overall Study|Woman had a miscarriage|17|||
48467887|NCT00027846|155905182|FG000|Overall Study|Lost to Follow-up|0|||
48467888|NCT00027846|155905183|FG001|Overall Study|Lost to Follow-up|41|||
48467889|NCT00027846|155905184|FG002|Overall Study|Lost to Follow-up|9|||
48467890|NCT00027846|155905182|FG000|Overall Study|Withdrawal by Subject|0|||
48467891|NCT00027846|155905183|FG001|Overall Study|Withdrawal by Subject|14|||
48467892|NCT00027846|155905184|FG002|Overall Study|Withdrawal by Subject|7|||
48467893|NCT00027846|155905182|FG000|Overall Study|Ineligible for study|2|||
48467894|NCT00027846|155905183|FG001|Overall Study|Ineligible for study|6|||
48467895|NCT00027846|155905184|FG002|Overall Study|Ineligible for study|14|||
48467896|NCT00027846|155905182|FG000|Overall Study|Entry into another COG therapeutic study|0|||
48467897|NCT00027846|155905183|FG001|Overall Study|Entry into another COG therapeutic study|5|||
48467898|NCT00027846|155905184|FG002|Overall Study|Entry into another COG therapeutic study|2|||
48467899|NCT00027846|155905182|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
48468055|NCT02898662|155905251|FG000|Overall Study|Technical issue|0|||
48467900|NCT00027846|155905183|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
48467901|NCT00027846|155905184|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
48467902|NCT02033369|155905186|FG000|Overall Study|Physician Decision|1|||
48467903|NCT02033369|155905187|FG001|Overall Study|Physician Decision|2|||
48467904|NCT02033369|155905186|FG000|Overall Study|Not a good demographic match|0|||
48467905|NCT02033369|155905187|FG001|Overall Study|Not a good demographic match|2|||
48467906|NCT02033369|155905186|FG000|Overall Study|Withdrawal by Subject|1|||
48467907|NCT02033369|155905187|FG001|Overall Study|Withdrawal by Subject|1|||
48467908|NCT02033369|155905186|FG000|Overall Study|Lost to Follow-up|1|||
48467909|NCT02033369|155905187|FG001|Overall Study|Lost to Follow-up|0|||
48467910|NCT02033369|155905186|FG000|Overall Study|Protocol Violation|2|||
48467911|NCT02033369|155905187|FG001|Overall Study|Protocol Violation|0|||
48467912|NCT01503229|155905188|FG000|Overall Study|Withdrew consent|1|||
48467913|NCT01078389|155905189|FG000|Overall Study|Adverse Event|10|||
48467914|NCT01078389|155905190|FG001|Overall Study|Adverse Event|6|||
48467915|NCT01078389|155905189|FG000|Overall Study|Major Protocol Deviation|2|||
48467916|NCT01078389|155905190|FG001|Overall Study|Major Protocol Deviation|0|||
48467917|NCT01078389|155905189|FG000|Overall Study|Lost to Follow-up|23|||
48467918|NCT01078389|155905190|FG001|Overall Study|Lost to Follow-up|23|||
48467919|NCT01078389|155905189|FG000|Overall Study|Voluntary Withdrawal|20|||
48467920|NCT01078389|155905190|FG001|Overall Study|Voluntary Withdrawal|36|||
48467921|NCT01078389|155905189|FG000|Overall Study|Other|9|||
48467922|NCT01078389|155905190|FG001|Overall Study|Other|2|||
48467923|NCT00027027|155905191|FG000|Overall Study|Adverse Event|0|||
48467924|NCT00027027|155905192|FG001|Overall Study|Adverse Event|0|||
48467925|NCT00027027|155905193|FG002|Overall Study|Adverse Event|1|||
48467926|NCT00027027|155905194|FG003|Overall Study|Adverse Event|0|||
48467927|NCT00027027|155905195|FG004|Overall Study|Adverse Event|1|||
48467928|NCT00027027|155905191|FG000|Overall Study|Admitted for Signs of PD|0|||
48467929|NCT00027027|155905192|FG001|Overall Study|Admitted for Signs of PD|0|||
48467930|NCT00027027|155905193|FG002|Overall Study|Admitted for Signs of PD|0|||
48467931|NCT00027027|155905194|FG003|Overall Study|Admitted for Signs of PD|0|||
48467932|NCT00027027|155905195|FG004|Overall Study|Admitted for Signs of PD|1|||
48467933|NCT00027027|155905191|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
48467934|NCT00027027|155905192|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
48467935|NCT00027027|155905193|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
48467936|NCT00027027|155905194|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
48467937|NCT00027027|155905195|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
48467938|NCT00027027|155905191|FG000|Overall Study|PD Requiring Surgery|0|||
48467939|NCT00027027|155905192|FG001|Overall Study|PD Requiring Surgery|0|||
48467940|NCT00027027|155905193|FG002|Overall Study|PD Requiring Surgery|1|||
48467941|NCT00027027|155905194|FG003|Overall Study|PD Requiring Surgery|0|||
48467942|NCT00027027|155905195|FG004|Overall Study|PD Requiring Surgery|0|||
48467943|NCT00027027|155905191|FG000|Overall Study|Physician Decision Due To PD|2|||
48467944|NCT00027027|155905192|FG001|Overall Study|Physician Decision Due To PD|3|||
48467945|NCT00027027|155905193|FG002|Overall Study|Physician Decision Due To PD|2|||
48467946|NCT00027027|155905194|FG003|Overall Study|Physician Decision Due To PD|3|||
48467947|NCT00027027|155905195|FG004|Overall Study|Physician Decision Due To PD|5|||
48467948|NCT00027027|155905191|FG000|Overall Study|Withdrawal by Subject|0|||
48467949|NCT00027027|155905192|FG001|Overall Study|Withdrawal by Subject|0|||
48467950|NCT00027027|155905193|FG002|Overall Study|Withdrawal by Subject|0|||
48467951|NCT00027027|155905194|FG003|Overall Study|Withdrawal by Subject|0|||
48467952|NCT00027027|155905195|FG004|Overall Study|Withdrawal by Subject|1|||
48467953|NCT00724243|155905196|FG000|Overall Study|Lack of Efficacy|10|||
48467954|NCT00724243|155905196|FG000|Overall Study|Adverse Event|5|||
48467955|NCT00532441|155905201|FG000|Overall Study|Death|1|||
48467956|NCT00532441|155905202|FG001|Overall Study|Death|0|||
48467957|NCT01967134|155905203|FG000|Overall Study|Lost to Follow-up|0|||
48467958|NCT01967134|155905204|FG001|Overall Study|Lost to Follow-up|1|||
48467959|NCT01967134|155905205|FG002|Overall Study|Lost to Follow-up|0|||
48467960|NCT01928758|155905212|FG000|Overall Study|Lost to Follow-up|14|||
48467961|NCT01928758|155905213|FG001|Overall Study|Lost to Follow-up|9|||
48467962|NCT01928758|155905212|FG000|Overall Study|Withdrawal by Subject|5|||
48467963|NCT01928758|155905213|FG001|Overall Study|Withdrawal by Subject|2|||
48467964|NCT01928758|155905212|FG000|Overall Study|Adverse Event|3|||
48467965|NCT01928758|155905213|FG001|Overall Study|Adverse Event|5|||
48467966|NCT01928758|155905212|FG000|Overall Study|Protocol Violation|3|||
48467967|NCT01928758|155905213|FG001|Overall Study|Protocol Violation|4|||
48467968|NCT03633461|155905214|FG000|Overall Study|Lost to Follow-up|0|||
48467969|NCT03633461|155905215|FG001|Overall Study|Lost to Follow-up|1|||
48467970|NCT04576702|155905216|FG000|Overall Study|Death|1|||
48467971|NCT04576702|155905217|FG001|Overall Study|Death|0|||
48467972|NCT04576702|155905218|FG002|Overall Study|Death|0|||
48467973|NCT04576702|155905219|FG003|Overall Study|Death|0|||
48467974|NCT04576702|155905216|FG000|Overall Study|Withdrawal by Subject|0|||
48467975|NCT04576702|155905217|FG001|Overall Study|Withdrawal by Subject|2|||
48467976|NCT04576702|155905218|FG002|Overall Study|Withdrawal by Subject|1|||
48467977|NCT04576702|155905219|FG003|Overall Study|Withdrawal by Subject|0|||
48467978|NCT04576702|155905216|FG000|Overall Study|Lost to Follow-up|3|||
48467979|NCT04576702|155905217|FG001|Overall Study|Lost to Follow-up|3|||
48467980|NCT04576702|155905218|FG002|Overall Study|Lost to Follow-up|3|||
48467981|NCT04576702|155905219|FG003|Overall Study|Lost to Follow-up|4|||
48467982|NCT00134563|155905220|FG000|Overall Study|Not treated due to protocol violation|0|||
48467983|NCT00134563|155905221|FG001|Overall Study|Not treated due to protocol violation|1|||
48467984|NCT00134563|155905222|FG002|Overall Study|Not treated due to protocol violation|1|||
48467985|NCT00134563|155905220|FG000|Overall Study|Adverse Event|29|||
48467986|NCT00134563|155905221|FG001|Overall Study|Adverse Event|37|||
48467987|NCT00134563|155905222|FG002|Overall Study|Adverse Event|38|||
48467988|NCT00134563|155905220|FG000|Overall Study|Lack of Efficacy|24|||
48467989|NCT00134563|155905221|FG001|Overall Study|Lack of Efficacy|14|||
48467990|NCT00134563|155905222|FG002|Overall Study|Lack of Efficacy|17|||
48467991|NCT00134563|155905220|FG000|Overall Study|Protocol Violation|3|||
48467992|NCT00134563|155905221|FG001|Overall Study|Protocol Violation|2|||
48467993|NCT00134563|155905222|FG002|Overall Study|Protocol Violation|5|||
48467994|NCT00134563|155905220|FG000|Overall Study|Lost to Follow-up|4|||
48467995|NCT00134563|155905221|FG001|Overall Study|Lost to Follow-up|0|||
48467996|NCT00134563|155905222|FG002|Overall Study|Lost to Follow-up|2|||
48467997|NCT00134563|155905220|FG000|Overall Study|progressive disease|11|||
48467998|NCT00134563|155905221|FG001|Overall Study|progressive disease|4|||
48467999|NCT00134563|155905222|FG002|Overall Study|progressive disease|2|||
48468000|NCT00134563|155905220|FG000|Overall Study|did not wish to continue|33|||
48468001|NCT00134563|155905221|FG001|Overall Study|did not wish to continue|32|||
48468002|NCT00134563|155905222|FG002|Overall Study|did not wish to continue|26|||
48468003|NCT00134563|155905220|FG000|Overall Study|Reason other than above|0|||
48468004|NCT00134563|155905221|FG001|Overall Study|Reason other than above|2|||
48468005|NCT00134563|155905222|FG002|Overall Study|Reason other than above|5|||
48468006|NCT00577382|155905229|FG000|Overall Study|Adverse Event|0|||
48468007|NCT00577382|155905230|FG001|Overall Study|Adverse Event|6|||
48468008|NCT00577382|155905229|FG000|Overall Study|Withdrawal by Subject|0|||
48468009|NCT00577382|155905230|FG001|Overall Study|Withdrawal by Subject|1|||
48468010|NCT00577382|155905229|FG000|Overall Study|Progressive Disease|17|||
48468011|NCT00577382|155905230|FG001|Overall Study|Progressive Disease|19|||
48468012|NCT00577382|155905229|FG000|Overall Study|Intercurrent Illness|1|||
48468013|NCT00577382|155905230|FG001|Overall Study|Intercurrent Illness|2|||
48468014|NCT00577382|155905229|FG000|Overall Study|Death|1|||
48468015|NCT00577382|155905230|FG001|Overall Study|Death|1|||
48468016|NCT00577382|155905229|FG000|Overall Study|Lost to Follow-up|2|||
48468017|NCT00577382|155905230|FG001|Overall Study|Lost to Follow-up|2|||
48468018|NCT00505765|155905233|FG000|Overall Study|Withdrawal by Subject|1|||
48468019|NCT00505765|155905234|FG001|Overall Study|Withdrawal by Subject|0|||
48468020|NCT00505765|155905235|FG002|Overall Study|Withdrawal by Subject|0|||
48468021|NCT00505765|155905233|FG000|Overall Study|Adverse Event|1|||
48468022|NCT00505765|155905234|FG001|Overall Study|Adverse Event|2|||
48468023|NCT00505765|155905235|FG002|Overall Study|Adverse Event|0|||
48468024|NCT00505765|155905233|FG000|Overall Study|Noncompliance|0|||
48468025|NCT00505765|155905234|FG001|Overall Study|Noncompliance|1|||
48468026|NCT00505765|155905235|FG002|Overall Study|Noncompliance|3|||
48468027|NCT02985996|155905239|FG000|Overall Study|Withdrawal by Subject|0|||
48468028|NCT02985996|155905240|FG001|Overall Study|Withdrawal by Subject|0|||
48468029|NCT02985996|155905241|FG002|Overall Study|Withdrawal by Subject|1|||
48468030|NCT02985996|155905242|FG003|Overall Study|Withdrawal by Subject|0|||
48468031|NCT02985996|155905243|FG004|Overall Study|Withdrawal by Subject|0|||
48468032|NCT02985996|155905239|FG000|Overall Study|Protocol Violation|0|||
48468033|NCT02985996|155905240|FG001|Overall Study|Protocol Violation|1|||
48468034|NCT02985996|155905241|FG002|Overall Study|Protocol Violation|0|||
48468035|NCT02985996|155905242|FG003|Overall Study|Protocol Violation|0|||
48468036|NCT02985996|155905243|FG004|Overall Study|Protocol Violation|0|||
48468037|NCT00561795|155905244|FG000|Overall Study|Adverse Event|3|||
48468038|NCT00561795|155905245|FG001|Overall Study|Adverse Event|3|||
48468039|NCT00561795|155905246|FG002|Overall Study|Adverse Event|0|||
48468040|NCT00561795|155905247|FG003|Overall Study|Adverse Event|0|||
48468041|NCT00561795|155905244|FG000|Overall Study|Study Closed/Terminated|0|||
48468042|NCT00561795|155905245|FG001|Overall Study|Study Closed/Terminated|3|||
48468043|NCT00561795|155905246|FG002|Overall Study|Study Closed/Terminated|0|||
48468044|NCT00561795|155905247|FG003|Overall Study|Study Closed/Terminated|0|||
48468045|NCT00561795|155905244|FG000|Overall Study|Physician Decision|1|||
48468046|NCT00561795|155905245|FG001|Overall Study|Physician Decision|0|||
48468047|NCT00561795|155905246|FG002|Overall Study|Physician Decision|0|||
48468048|NCT00561795|155905247|FG003|Overall Study|Physician Decision|0|||
48468049|NCT02898662|155905251|FG000|Overall Study|Adverse Event|1|||
48468050|NCT02898662|155905252|FG001|Overall Study|Adverse Event|0|||
48468051|NCT02898662|155905251|FG000|Overall Study|Loss of asthma control|23|||
48468052|NCT02898662|155905252|FG001|Overall Study|Loss of asthma control|24|||
48468053|NCT02898662|155905251|FG000|Overall Study|Withdrawal by Subject|4|||
48468054|NCT02898662|155905252|FG001|Overall Study|Withdrawal by Subject|1|||
48468056|NCT02898662|155905252|FG001|Overall Study|Technical issue|1|||
48468057|NCT02898662|155905251|FG000|Overall Study|Randomized in error|0|||
48468058|NCT02898662|155905252|FG001|Overall Study|Randomized in error|1|||
48468059|NCT02898662|155905251|FG000|Overall Study|Subject decision|1|||
48468060|NCT02898662|155905252|FG001|Overall Study|Subject decision|0|||
48468061|NCT02898662|155905251|FG000|Overall Study|Other|0|||
48468062|NCT02898662|155905252|FG001|Overall Study|Other|1|||
48468063|NCT03802331|155905253|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
48468064|NCT03802331|155905254|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
48468065|NCT01014442|155905255|FG000|Overall Study|Adverse Event|0|||
48468066|NCT01014442|155905256|FG001|Overall Study|Adverse Event|8|||
48468067|NCT01014442|155905255|FG000|Overall Study|Withdrawal by Subject|4|||
48468068|NCT01014442|155905256|FG001|Overall Study|Withdrawal by Subject|4|||
48468069|NCT01014442|155905255|FG000|Overall Study|Protocol Violation|2|||
48468070|NCT01014442|155905256|FG001|Overall Study|Protocol Violation|5|||
48468071|NCT01014442|155905255|FG000|Overall Study|Lack of Compliance|0|||
48468072|NCT01014442|155905256|FG001|Overall Study|Lack of Compliance|1|||
48468073|NCT01014442|155905255|FG000|Overall Study|Unspecified Reason|1|||
48468074|NCT01014442|155905256|FG001|Overall Study|Unspecified Reason|1|||
48468075|NCT00504595|155905258|FG000|Overall Study|Lack of Efficacy|1|||
48468076|NCT00504595|155905259|FG001|Overall Study|Lack of Efficacy|0|||
48468077|NCT00504595|155905260|FG002|Overall Study|Lack of Efficacy|0|||
48468078|NCT00504595|155905261|FG003|Overall Study|Lack of Efficacy|0|||
48468079|NCT00504595|155905258|FG000|Overall Study|Other|0|||
48468080|NCT00504595|155905259|FG001|Overall Study|Other|0|||
48468081|NCT00504595|155905260|FG002|Overall Study|Other|2|||
48468082|NCT00504595|155905261|FG003|Overall Study|Other|0|||
48468083|NCT02369874|155905262|FG000|Overall Study|Lost to Follow-up|2|||
48468084|NCT02369874|155905263|FG001|Overall Study|Lost to Follow-up|2|||
48468085|NCT02369874|155905264|FG002|Overall Study|Lost to Follow-up|2|||
48468086|NCT02369874|155905262|FG000|Overall Study|Withdrawal by Subject|7|||
48468087|NCT02369874|155905263|FG001|Overall Study|Withdrawal by Subject|9|||
48468088|NCT02369874|155905264|FG002|Overall Study|Withdrawal by Subject|27|||
48468089|NCT02369874|155905262|FG000|Overall Study|Miscellaneous|1|||
48468090|NCT02369874|155905263|FG001|Overall Study|Miscellaneous|1|||
48468091|NCT02369874|155905264|FG002|Overall Study|Miscellaneous|0|||
48468092|NCT02369874|155905262|FG000|Overall Study|On Treatment/Off Study|34|||
48468093|NCT02369874|155905263|FG001|Overall Study|On Treatment/Off Study|45|||
48468094|NCT02369874|155905264|FG002|Overall Study|On Treatment/Off Study|32|||
48468095|NCT01757821|155905268|FG000|Overall Study|Adverse Event|1|||
48468096|NCT00634933|155905269|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
48468097|NCT00634933|155905270|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
48468098|NCT00634933|155905271|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
48468099|NCT00634933|155905272|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
48468100|NCT00634933|155905273|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
48468101|NCT00634933|155905269|FG000|Part A: Baseline to Week 24|Death|1|||
48468102|NCT00634933|155905270|FG001|Part A: Baseline to Week 24|Death|0|||
48468103|NCT00634933|155905271|FG002|Part A: Baseline to Week 24|Death|0|||
48468104|NCT00634933|155905272|FG003|Part A: Baseline to Week 24|Death|0|||
48468105|NCT00634933|155905273|FG004|Part A: Baseline to Week 24|Death|0|||
48468106|NCT00634933|155905269|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
48468107|NCT00634933|155905270|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
48468108|NCT00634933|155905271|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
48468109|NCT00634933|155905272|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
48468110|NCT00634933|155905273|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
48468111|NCT00634933|155905269|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
48468112|NCT00634933|155905270|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
48468113|NCT00634933|155905271|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
48468114|NCT00634933|155905272|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
48468115|NCT00634933|155905273|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
48468116|NCT00634933|155905269|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
48468117|NCT00634933|155905270|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
48468118|NCT00634933|155905271|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
48468119|NCT00634933|155905272|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
48468120|NCT00634933|155905273|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
48468121|NCT00634933|155905269|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
48468122|NCT00634933|155905270|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
48468123|NCT00634933|155905271|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
48468124|NCT00634933|155905272|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
48468125|NCT00634933|155905273|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
48468126|NCT00634933|155905269|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
48468127|NCT00634933|155905270|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
48468128|NCT00634933|155905271|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
48468129|NCT00634933|155905272|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
48468130|NCT00634933|155905273|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
48468131|NCT00634933|155905269|FG000|Part A: Baseline to Week 24|Other|1|||
48468132|NCT00634933|155905270|FG001|Part A: Baseline to Week 24|Other|8|||
48468133|NCT00634933|155905271|FG002|Part A: Baseline to Week 24|Other|5|||
48468134|NCT00634933|155905272|FG003|Part A: Baseline to Week 24|Other|0|||
48468135|NCT00634933|155905273|FG004|Part A: Baseline to Week 24|Other|0|||
48468136|NCT00634933|155905269|FG000|Between Part A and Part B|Physician Decision|0|||
48468137|NCT00634933|155905270|FG001|Between Part A and Part B|Physician Decision|1|||
48468138|NCT00634933|155905271|FG002|Between Part A and Part B|Physician Decision|0|||
48468139|NCT00634933|155905272|FG003|Between Part A and Part B|Physician Decision|0|||
48468140|NCT00634933|155905273|FG004|Between Part A and Part B|Physician Decision|0|||
48468141|NCT00634933|155905269|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
48468142|NCT00634933|155905270|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
48468143|NCT00634933|155905271|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
48468144|NCT00634933|155905272|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
48468145|NCT00634933|155905273|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
48468146|NCT00634933|155905269|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
48468147|NCT00634933|155905270|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
48468148|NCT00634933|155905271|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
48468149|NCT00634933|155905272|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
48468150|NCT00634933|155905273|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
48468151|NCT00634933|155905269|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
48468152|NCT00634933|155905270|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
48468153|NCT00634933|155905271|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
48468154|NCT00634933|155905272|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
48468155|NCT00634933|155905273|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
48468156|NCT00634933|155905269|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
48468157|NCT00634933|155905270|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
48468158|NCT00634933|155905271|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
48468159|NCT00634933|155905272|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
48468160|NCT00634933|155905273|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
48468161|NCT00634933|155905269|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
48468162|NCT00634933|155905270|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
48468163|NCT00634933|155905271|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
48468164|NCT00634933|155905272|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
48468165|NCT00634933|155905273|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
48468166|NCT00634933|155905269|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
48468167|NCT00634933|155905270|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
48468168|NCT00634933|155905271|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
48468169|NCT00634933|155905272|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
48468170|NCT00634933|155905273|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
48468171|NCT00634933|155905269|FG000|Part B: Week 24 to Week 52|Other|0|||
48468172|NCT00634933|155905270|FG001|Part B: Week 24 to Week 52|Other|0|||
48468173|NCT00634933|155905271|FG002|Part B: Week 24 to Week 52|Other|5|||
48468174|NCT00634933|155905272|FG003|Part B: Week 24 to Week 52|Other|0|||
48468175|NCT00634933|155905273|FG004|Part B: Week 24 to Week 52|Other|1|||
48468176|NCT03982069|155905275|FG000|Overall Study|Lost to Follow-up|5|||
48468177|NCT03982069|155905276|FG001|Overall Study|Lost to Follow-up|5|||
48468178|NCT03982069|155905277|FG002|Overall Study|Lost to Follow-up|3|||
48468179|NCT03982069|155905278|FG003|Overall Study|Lost to Follow-up|5|||
48468180|NCT03982069|155905275|FG000|Overall Study|Physician Decision|0|||
48468181|NCT03982069|155905276|FG001|Overall Study|Physician Decision|1|||
48468182|NCT03982069|155905277|FG002|Overall Study|Physician Decision|0|||
48468183|NCT03982069|155905278|FG003|Overall Study|Physician Decision|0|||
48468184|NCT03982069|155905275|FG000|Overall Study|Withdrawal by Subject|2|||
48468185|NCT03982069|155905276|FG001|Overall Study|Withdrawal by Subject|1|||
48468186|NCT03982069|155905277|FG002|Overall Study|Withdrawal by Subject|5|||
48468187|NCT03982069|155905278|FG003|Overall Study|Withdrawal by Subject|2|||
48468188|NCT03982069|155905275|FG000|Overall Study|Specimen loss|3|||
48468189|NCT03982069|155905276|FG001|Overall Study|Specimen loss|3|||
48468190|NCT03982069|155905277|FG002|Overall Study|Specimen loss|1|||
48468191|NCT03982069|155905278|FG003|Overall Study|Specimen loss|1|||
48468192|NCT00764465|155905285|FG000|Overall Study|Adverse Event|2|||
48468193|NCT00764465|155905286|FG001|Overall Study|Adverse Event|0|||
48468194|NCT00764465|155905287|FG002|Overall Study|Adverse Event|0|||
48468195|NCT00764465|155905288|FG003|Overall Study|Adverse Event|1|||
48468196|NCT00764465|155905289|FG004|Overall Study|Adverse Event|1|||
48468197|NCT00764465|155905290|FG005|Overall Study|Adverse Event|1|||
48468198|NCT00764465|155905285|FG000|Overall Study|Withdrawal by Subject|0|||
48468199|NCT00764465|155905286|FG001|Overall Study|Withdrawal by Subject|1|||
48468200|NCT00764465|155905287|FG002|Overall Study|Withdrawal by Subject|1|||
48468201|NCT00764465|155905288|FG003|Overall Study|Withdrawal by Subject|0|||
48468202|NCT00764465|155905289|FG004|Overall Study|Withdrawal by Subject|0|||
48468203|NCT00764465|155905290|FG005|Overall Study|Withdrawal by Subject|0|||
48468204|NCT02030067|155905295|FG000|Overall Study|Disease Progression|1|||
48468205|NCT02030067|155905296|FG001|Overall Study|Disease Progression|1|||
48468206|NCT02030067|155905297|FG002|Overall Study|Disease Progression|2|||
48468207|NCT02030067|155905298|FG003|Overall Study|Disease Progression|2|||
48468208|NCT02030067|155905299|FG004|Overall Study|Disease Progression|3|||
48468209|NCT02030067|155905300|FG005|Overall Study|Disease Progression|2|||
48468210|NCT02030067|155905301|FG006|Overall Study|Disease Progression|3|||
48468211|NCT02030067|155905302|FG007|Overall Study|Disease Progression|3|||
48468212|NCT02030067|155905303|FG008|Overall Study|Disease Progression|4|||
48468213|NCT02030067|155905304|FG009|Overall Study|Disease Progression|3|||
48468214|NCT02030067|155905305|FG010|Overall Study|Disease Progression|7|||
48468215|NCT02030067|155905306|FG011|Overall Study|Disease Progression|2|||
48468216|NCT02030067|155905307|FG012|Overall Study|Disease Progression|59|||
48468217|NCT02030067|155905295|FG000|Overall Study|Withdrawal by Subject|0|||
48468218|NCT02030067|155905296|FG001|Overall Study|Withdrawal by Subject|0|||
48468219|NCT02030067|155905297|FG002|Overall Study|Withdrawal by Subject|0|||
48468220|NCT02030067|155905298|FG003|Overall Study|Withdrawal by Subject|1|||
48468221|NCT02030067|155905299|FG004|Overall Study|Withdrawal by Subject|0|||
48468222|NCT02030067|155905300|FG005|Overall Study|Withdrawal by Subject|0|||
48468223|NCT02030067|155905301|FG006|Overall Study|Withdrawal by Subject|0|||
48468224|NCT02030067|155905302|FG007|Overall Study|Withdrawal by Subject|1|||
48468225|NCT02030067|155905303|FG008|Overall Study|Withdrawal by Subject|0|||
48468226|NCT02030067|155905304|FG009|Overall Study|Withdrawal by Subject|0|||
48468227|NCT02030067|155905305|FG010|Overall Study|Withdrawal by Subject|3|||
48468228|NCT02030067|155905306|FG011|Overall Study|Withdrawal by Subject|0|||
48468229|NCT02030067|155905307|FG012|Overall Study|Withdrawal by Subject|6|||
48468230|NCT02030067|155905295|FG000|Overall Study|Physician Decision|0|||
48468231|NCT02030067|155905296|FG001|Overall Study|Physician Decision|0|||
48468232|NCT02030067|155905297|FG002|Overall Study|Physician Decision|0|||
48468233|NCT02030067|155905298|FG003|Overall Study|Physician Decision|0|||
48468234|NCT02030067|155905299|FG004|Overall Study|Physician Decision|0|||
48468235|NCT02030067|155905300|FG005|Overall Study|Physician Decision|0|||
48468236|NCT02030067|155905301|FG006|Overall Study|Physician Decision|0|||
48468237|NCT02030067|155905302|FG007|Overall Study|Physician Decision|0|||
48468238|NCT02030067|155905303|FG008|Overall Study|Physician Decision|0|||
48468239|NCT02030067|155905304|FG009|Overall Study|Physician Decision|0|||
48468240|NCT02030067|155905305|FG010|Overall Study|Physician Decision|1|||
48468241|NCT02030067|155905306|FG011|Overall Study|Physician Decision|0|||
48468242|NCT02030067|155905307|FG012|Overall Study|Physician Decision|3|||
48468243|NCT02030067|155905295|FG000|Overall Study|other reasons|0|||
48468244|NCT02030067|155905296|FG001|Overall Study|other reasons|0|||
48468245|NCT02030067|155905297|FG002|Overall Study|other reasons|0|||
48468246|NCT02030067|155905298|FG003|Overall Study|other reasons|0|||
48468247|NCT02030067|155905299|FG004|Overall Study|other reasons|0|||
48468248|NCT02030067|155905300|FG005|Overall Study|other reasons|1|||
48468249|NCT02030067|155905301|FG006|Overall Study|other reasons|0|||
48468250|NCT02030067|155905302|FG007|Overall Study|other reasons|0|||
48468251|NCT02030067|155905303|FG008|Overall Study|other reasons|2|||
48468252|NCT02030067|155905304|FG009|Overall Study|other reasons|0|||
48468253|NCT02030067|155905305|FG010|Overall Study|other reasons|0|||
48468254|NCT02030067|155905306|FG011|Overall Study|other reasons|0|||
48468255|NCT02030067|155905307|FG012|Overall Study|other reasons|4|||
48468256|NCT02030067|155905295|FG000|Overall Study|Adverse Event|0|||
48468257|NCT02030067|155905296|FG001|Overall Study|Adverse Event|0|||
48468258|NCT02030067|155905297|FG002|Overall Study|Adverse Event|0|||
48468259|NCT02030067|155905298|FG003|Overall Study|Adverse Event|0|||
48468260|NCT02030067|155905299|FG004|Overall Study|Adverse Event|0|||
48468261|NCT02030067|155905300|FG005|Overall Study|Adverse Event|0|||
48468262|NCT02030067|155905301|FG006|Overall Study|Adverse Event|0|||
48468263|NCT02030067|155905302|FG007|Overall Study|Adverse Event|0|||
48468264|NCT02030067|155905303|FG008|Overall Study|Adverse Event|0|||
48468265|NCT02030067|155905304|FG009|Overall Study|Adverse Event|0|||
48468266|NCT02030067|155905305|FG010|Overall Study|Adverse Event|0|||
48468267|NCT02030067|155905306|FG011|Overall Study|Adverse Event|1|||
48468268|NCT02030067|155905307|FG012|Overall Study|Adverse Event|8|||
48468269|NCT00496782|155905308|FG000|Overall Study|Protocol Violation|1|||
48468270|NCT00496782|155905309|FG001|Overall Study|Protocol Violation|2|||
48468271|NCT02221882|155905310|FG000|Overall Study|Withdrawal by Subject|0|||
48468272|NCT02221882|155905311|FG001|Overall Study|Withdrawal by Subject|0|||
48468273|NCT02221882|155905312|FG002|Overall Study|Withdrawal by Subject|4|||
48468274|NCT02221882|155905313|FG003|Overall Study|Withdrawal by Subject|2|||
48468275|NCT02221882|155905314|FG004|Overall Study|Withdrawal by Subject|2|||
48468276|NCT02221882|155905315|FG005|Overall Study|Withdrawal by Subject|2|||
48468277|NCT02221882|155905310|FG000|Overall Study|Death|0|||
48468278|NCT02221882|155905311|FG001|Overall Study|Death|1|||
48468279|NCT02221882|155905312|FG002|Overall Study|Death|0|||
48468280|NCT02221882|155905313|FG003|Overall Study|Death|0|||
48468281|NCT02221882|155905314|FG004|Overall Study|Death|0|||
48468282|NCT02221882|155905315|FG005|Overall Study|Death|0|||
48468283|NCT01288911|155905316|FG000|Double-blind Period|Death|11|||
48468284|NCT01288911|155905317|FG001|Double-blind Period|Death|7|||
48468285|NCT01288911|155905316|FG000|Double-blind Period|Lost to Follow-up|0|||
48468286|NCT01288911|155905317|FG001|Double-blind Period|Lost to Follow-up|2|||
48468287|NCT01288911|155905316|FG000|Double-blind Period|Progressive Disease|75|||
48468288|NCT01288911|155905317|FG001|Double-blind Period|Progressive Disease|103|||
48468289|NCT01288911|155905316|FG000|Double-blind Period|Protocol Violation|1|||
48468290|NCT01288911|155905317|FG001|Double-blind Period|Protocol Violation|0|||
48468291|NCT01288911|155905316|FG000|Double-blind Period|Withdrawal by Subject|25|||
48468292|NCT01288911|155905317|FG001|Double-blind Period|Withdrawal by Subject|26|||
48468293|NCT01288911|155905316|FG000|Double-blind Period|Miscellaneous Reason|29|||
48468294|NCT01288911|155905317|FG001|Double-blind Period|Miscellaneous Reason|42|||
48468295|NCT01288911|155905316|FG000|Double-blind Period|Randomized but never received study drug|1|||
48468296|NCT01288911|155905317|FG001|Double-blind Period|Randomized but never received study drug|2|||
48468297|NCT01288911|155905316|FG000|Open-label Period (All Enzalutamide)|Death|0|||
48468298|NCT01288911|155905317|FG001|Open-label Period (All Enzalutamide)|Death|1|||
48468299|NCT01288911|155905316|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
48468300|NCT01288911|155905317|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
48468301|NCT01288911|155905316|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
48468302|NCT01288911|155905317|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
48468303|NCT01288911|155905316|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
48468304|NCT01288911|155905317|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
48468305|NCT01288911|155905316|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
48468306|NCT01288911|155905317|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
48468307|NCT01288911|155905316|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
48468308|NCT01288911|155905317|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
48468309|NCT03258710|155905318|FG000|Overall Study|Adverse Event|1|||
48468310|NCT03258710|155905318|FG000|Overall Study|Protocol-defined stopping criteria|1|||
48468311|NCT03258710|155905318|FG000|Overall Study|Physician Decision|1|||
48468312|NCT00686894|155905323|FG000|Overall Study|Relapse|2|||
48468313|NCT00686894|155905323|FG000|Overall Study|Protocol Violation|4|||
48468314|NCT01791543|155905324|FG000|Overall Study|Lost to Follow-up|1|||
48468315|NCT01791543|155905324|FG000|Overall Study|Adverse Event|1|||
48468316|NCT01728194|155905327|FG000|Overall Study|Lost to Follow-up|4|||
48468317|NCT01728194|155905328|FG001|Overall Study|Lost to Follow-up|3|||
48468318|NCT01728194|155905327|FG000|Overall Study|Physician Decision|4|||
48468319|NCT01728194|155905328|FG001|Overall Study|Physician Decision|0|||
48468320|NCT01728194|155905327|FG000|Overall Study|Withdrawal by Subject|7|||
48468321|NCT01728194|155905328|FG001|Overall Study|Withdrawal by Subject|3|||
48468322|NCT01728194|155905327|FG000|Overall Study|Perceived Medication Side Effects|4|||
48468323|NCT01728194|155905328|FG001|Overall Study|Perceived Medication Side Effects|0|||
48468324|NCT01728194|155905327|FG000|Overall Study|Family Member Request|1|||
48468325|NCT01728194|155905328|FG001|Overall Study|Family Member Request|0|||
48468326|NCT01977573|155905333|FG000|Overall Study|Adverse Event|7|||
48468327|NCT01977573|155905334|FG001|Overall Study|Adverse Event|0|||
48468328|NCT01977573|155905335|FG002|Overall Study|Adverse Event|2|||
48468329|NCT01977573|155905336|FG003|Overall Study|Adverse Event|1|||
48468330|NCT01977573|155905333|FG000|Overall Study|Lost to Follow-up|1|||
48468331|NCT01977573|155905334|FG001|Overall Study|Lost to Follow-up|0|||
48468332|NCT01977573|155905335|FG002|Overall Study|Lost to Follow-up|0|||
48468333|NCT01977573|155905336|FG003|Overall Study|Lost to Follow-up|1|||
48468334|NCT01977573|155905333|FG000|Overall Study|Physician Decision|1|||
48468335|NCT01977573|155905334|FG001|Overall Study|Physician Decision|0|||
48468336|NCT01977573|155905335|FG002|Overall Study|Physician Decision|0|||
48468337|NCT01977573|155905336|FG003|Overall Study|Physician Decision|0|||
48468338|NCT01977573|155905333|FG000|Overall Study|Protocol Violation|3|||
48468339|NCT01977573|155905334|FG001|Overall Study|Protocol Violation|1|||
48468340|NCT01977573|155905335|FG002|Overall Study|Protocol Violation|0|||
48468341|NCT01977573|155905336|FG003|Overall Study|Protocol Violation|0|||
48468342|NCT01977573|155905333|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
48468343|NCT01977573|155905334|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
48468344|NCT01977573|155905335|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
48468345|NCT01977573|155905336|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
48468346|NCT01977573|155905333|FG000|Overall Study|Withdrawal by Subject|6|||
48468347|NCT01977573|155905334|FG001|Overall Study|Withdrawal by Subject|1|||
48468348|NCT01977573|155905335|FG002|Overall Study|Withdrawal by Subject|1|||
48468349|NCT01977573|155905336|FG003|Overall Study|Withdrawal by Subject|1|||
48468350|NCT01002573|155906711|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
48468351|NCT01002573|155906712|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
48468352|NCT01354964|155906714|FG000|Overall Study|Lost to Follow-up|2|||
48468353|NCT01354964|155906715|FG001|Overall Study|Lost to Follow-up|0|||
48468354|NCT01354964|155906714|FG000|Overall Study|IV access issues|1|||
48468355|NCT01354964|155906715|FG001|Overall Study|IV access issues|1|||
48468356|NCT01354964|155906714|FG000|Overall Study|Physician Decision|1|||
48468357|NCT01354964|155906715|FG001|Overall Study|Physician Decision|0|||
48468358|NCT03726320|155906716|FG000|Overall Study|Lost to Follow-up|2|||
48468359|NCT03726320|155906717|FG001|Overall Study|Lost to Follow-up|4|||
48468360|NCT03726320|155906718|FG002|Overall Study|Lost to Follow-up|0|||
48468361|NCT03726320|155906716|FG000|Overall Study|Time Constraints|4|||
48468362|NCT03726320|155906717|FG001|Overall Study|Time Constraints|1|||
48468363|NCT03726320|155906718|FG002|Overall Study|Time Constraints|0|||
48468364|NCT03726320|155906716|FG000|Overall Study|Ineligible after enrollment|3|||
48468365|NCT03726320|155906717|FG001|Overall Study|Ineligible after enrollment|3|||
48468366|NCT03726320|155906718|FG002|Overall Study|Ineligible after enrollment|0|||
48468367|NCT03726320|155906716|FG000|Overall Study|Clinic / insurance issue|2|||
48468368|NCT03726320|155906717|FG001|Overall Study|Clinic / insurance issue|0|||
48468369|NCT03726320|155906718|FG002|Overall Study|Clinic / insurance issue|0|||
48468370|NCT03726320|155906716|FG000|Overall Study|Language barrier|1|||
48468371|NCT03726320|155906717|FG001|Overall Study|Language barrier|0|||
48468372|NCT03726320|155906718|FG002|Overall Study|Language barrier|0|||
48468373|NCT03726320|155906716|FG000|Overall Study|Provider left the clinic|0|||
48468374|NCT03726320|155906717|FG001|Overall Study|Provider left the clinic|0|||
48468375|NCT03726320|155906718|FG002|Overall Study|Provider left the clinic|1|||
48468376|NCT00690612|155906719|FG000|Overall Study|Adverse Event|1|||
48468377|NCT00690612|155906719|FG000|Overall Study|Withdrawal by Subject|2|||
48468378|NCT01855919|155906720|FG000|Overall Study|Adverse Event|16|||
48468379|NCT01855919|155906721|FG001|Overall Study|Adverse Event|8|||
48468380|NCT01855919|155906720|FG000|Overall Study|Lack of Efficacy|1|||
48468381|NCT01855919|155906721|FG001|Overall Study|Lack of Efficacy|3|||
48468382|NCT01855919|155906720|FG000|Overall Study|Withdrawal by Subject|4|||
48468383|NCT01855919|155906721|FG001|Overall Study|Withdrawal by Subject|10|||
48468384|NCT01855919|155906720|FG000|Overall Study|Entry Criteria Not Met|1|||
48468385|NCT01855919|155906721|FG001|Overall Study|Entry Criteria Not Met|1|||
48468386|NCT01855919|155906720|FG000|Overall Study|Protocol Violation|1|||
48468387|NCT01855919|155906721|FG001|Overall Study|Protocol Violation|4|||
48468388|NCT05604781|155906722|FG000|Overall Study|Lost to Follow-up|3|||
48468389|NCT05604781|155906722|FG000|Overall Study|Adverse Event|1|||
48468390|NCT02681094|155906735|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
48468391|NCT02681094|155906736|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
48468392|NCT02681094|155906737|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
48468393|NCT02681094|155906735|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
48468394|NCT02681094|155906736|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
48468395|NCT02681094|155906737|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
48468396|NCT02681094|155906735|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
48468397|NCT02681094|155906736|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
48468398|NCT02681094|155906737|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
48468399|NCT02681094|155906735|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
48468400|NCT02681094|155906736|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
48468401|NCT02681094|155906737|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
48468402|NCT02681094|155906735|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
48468403|NCT02681094|155906736|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
48468404|NCT02681094|155906737|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
48468405|NCT02681094|155906735|FG000|1 -Modified Enrolled Participants Set|Other|6|||
48468406|NCT02681094|155906736|FG001|1 -Modified Enrolled Participants Set|Other|6|||
48468407|NCT02681094|155906737|FG002|1 -Modified Enrolled Participants Set|Other|7|||
48468408|NCT02681094|155906735|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
48468409|NCT02681094|155906736|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
48468410|NCT02681094|155906737|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
48468411|NCT02681094|155906735|FG000|2 - Enrolled Participants Set|Participant decision|7|||
48468412|NCT02681094|155906736|FG001|2 - Enrolled Participants Set|Participant decision|10|||
48468413|NCT02681094|155906737|FG002|2 - Enrolled Participants Set|Participant decision|9|||
48468414|NCT02681094|155906735|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
48468415|NCT02681094|155906736|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
48468416|NCT02681094|155906737|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
48468417|NCT02681094|155906735|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
48468418|NCT02681094|155906736|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
48468419|NCT02681094|155906737|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
48468420|NCT02681094|155906735|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
48468421|NCT02681094|155906736|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
48468422|NCT02681094|155906737|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
48468423|NCT02681094|155906735|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
48468424|NCT02681094|155906736|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
48468425|NCT02681094|155906737|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
48468426|NCT02681094|155906735|FG000|2 - Enrolled Participants Set|Other|6|||
48468427|NCT02681094|155906736|FG001|2 - Enrolled Participants Set|Other|6|||
48468428|NCT02681094|155906737|FG002|2 - Enrolled Participants Set|Other|7|||
48468429|NCT02681094|155906735|FG000|2 - Enrolled Participants Set|No treatment given|0|||
48468430|NCT02681094|155906736|FG001|2 - Enrolled Participants Set|No treatment given|1|||
48468431|NCT02681094|155906737|FG002|2 - Enrolled Participants Set|No treatment given|1|||
48468432|NCT00561912|155906738|FG000|Overall Study|ineligible|1|||
48468433|NCT01270139|155906741|FG000|Overall Study|Adverse Event|8|||
48468434|NCT01270139|155906742|FG001|Overall Study|Adverse Event|17|||
48468435|NCT01270139|155906743|FG002|Overall Study|Adverse Event|18|||
48468436|NCT01270139|155906741|FG000|Overall Study|Lost to Follow-up|10|||
48468437|NCT01270139|155906742|FG001|Overall Study|Lost to Follow-up|9|||
48468438|NCT01270139|155906743|FG002|Overall Study|Lost to Follow-up|2|||
48468439|NCT03198559|155906746|FG000|Overall Study|Adverse Event|2|||
48468440|NCT01072175|155906747|FG000|Part A (Drug-Drug Interaction)|Death|1|||
48468441|NCT01072175|155906748|FG001|Part A (Drug-Drug Interaction)|Death|0|||
48468442|NCT01072175|155906749|FG002|Part A (Drug-Drug Interaction)|Death|0|||
48468443|NCT01072175|155906750|FG003|Part A (Drug-Drug Interaction)|Death|0|||
48468444|NCT01072175|155906751|FG004|Part A (Drug-Drug Interaction)|Death|0|||
48468445|NCT01072175|155906752|FG005|Part A (Drug-Drug Interaction)|Death|0|||
48468446|NCT01072175|155906753|FG006|Part A (Drug-Drug Interaction)|Death|0|||
48468447|NCT01072175|155906754|FG007|Part A (Drug-Drug Interaction)|Death|0|||
48468448|NCT01072175|155906755|FG008|Part A (Drug-Drug Interaction)|Death|0|||
48468449|NCT01072175|155906756|FG009|Part A (Drug-Drug Interaction)|Death|0|||
48468450|NCT01072175|155906757|FG010|Part A (Drug-Drug Interaction)|Death|0|||
48468451|NCT01072175|155906758|FG011|Part A (Drug-Drug Interaction)|Death|0|||
48468452|NCT01072175|155906759|FG012|Part A (Drug-Drug Interaction)|Death|0|||
48468453|NCT01072175|155906747|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
48468454|NCT01072175|155906748|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468455|NCT01072175|155906749|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468456|NCT01072175|155906750|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468457|NCT01072175|155906751|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468458|NCT01072175|155906752|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468459|NCT01072175|155906753|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468460|NCT01072175|155906754|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468461|NCT01072175|155906755|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468462|NCT01072175|155906756|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468463|NCT01072175|155906757|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468464|NCT01072175|155906758|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468465|NCT01072175|155906759|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
48468466|NCT01072175|155906747|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
48468467|NCT01072175|155906748|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468468|NCT01072175|155906749|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468469|NCT01072175|155906750|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468470|NCT01072175|155906751|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468471|NCT01072175|155906752|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468472|NCT01072175|155906753|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468473|NCT01072175|155906754|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468474|NCT01072175|155906755|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468475|NCT01072175|155906756|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468476|NCT01072175|155906757|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468477|NCT01072175|155906758|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468478|NCT01072175|155906759|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
48468479|NCT01072175|155906747|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
48468480|NCT01072175|155906748|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
48468481|NCT01072175|155906749|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
48468482|NCT01072175|155906750|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
48468483|NCT01072175|155906751|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
48468484|NCT01072175|155906752|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
48468485|NCT01072175|155906753|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
48468486|NCT01072175|155906754|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
48468487|NCT01072175|155906755|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
48468488|NCT01072175|155906756|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
48468489|NCT01072175|155906757|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
48468490|NCT01072175|155906758|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
48468491|NCT01072175|155906759|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
48468492|NCT01072175|155906747|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468493|NCT01072175|155906748|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468494|NCT01072175|155906749|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
48468495|NCT01072175|155906750|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468496|NCT01072175|155906751|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
48468497|NCT01072175|155906752|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468498|NCT01072175|155906753|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468499|NCT01072175|155906754|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468500|NCT01072175|155906755|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468501|NCT01072175|155906756|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468502|NCT01072175|155906757|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468503|NCT01072175|155906758|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468504|NCT01072175|155906759|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
48468505|NCT01072175|155906747|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468506|NCT01072175|155906748|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
48468507|NCT01072175|155906749|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468508|NCT01072175|155906750|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
48468509|NCT01072175|155906751|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
48468510|NCT01072175|155906752|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468511|NCT01072175|155906753|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468512|NCT01072175|155906754|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468513|NCT01072175|155906755|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468514|NCT01072175|155906756|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468515|NCT01072175|155906757|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468516|NCT01072175|155906758|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468517|NCT01072175|155906759|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
48468518|NCT01072175|155906747|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468519|NCT01072175|155906748|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468520|NCT01072175|155906749|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
48468521|NCT01072175|155906750|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
48468522|NCT01072175|155906751|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
48468523|NCT01072175|155906752|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468524|NCT01072175|155906753|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468525|NCT01072175|155906754|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468526|NCT01072175|155906755|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468527|NCT01072175|155906756|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468528|NCT01072175|155906757|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468529|NCT01072175|155906758|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468530|NCT01072175|155906759|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
48468531|NCT01072175|155906747|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468532|NCT01072175|155906748|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
48468533|NCT01072175|155906749|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468534|NCT01072175|155906750|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
48468535|NCT01072175|155906751|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
48468536|NCT01072175|155906752|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468537|NCT01072175|155906753|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468538|NCT01072175|155906754|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468539|NCT01072175|155906755|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468540|NCT01072175|155906756|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468541|NCT01072175|155906757|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468542|NCT01072175|155906758|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468543|NCT01072175|155906759|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
48468544|NCT01072175|155906747|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
48468545|NCT01072175|155906748|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
48468546|NCT01072175|155906749|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
48468547|NCT01072175|155906750|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
48468548|NCT01072175|155906751|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
48468549|NCT01072175|155906752|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
48468550|NCT01072175|155906753|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
48468551|NCT01072175|155906754|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
48468552|NCT01072175|155906755|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
48468553|NCT01072175|155906756|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
48468554|NCT01072175|155906757|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
48468555|NCT01072175|155906758|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
48468556|NCT01072175|155906759|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
48468557|NCT01072175|155906747|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468558|NCT01072175|155906748|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468559|NCT01072175|155906749|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468560|NCT01072175|155906750|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468561|NCT01072175|155906751|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468562|NCT01072175|155906752|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
48468563|NCT01072175|155906753|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
48468564|NCT01072175|155906754|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
48468773|NCT01710709|155906777|FG000|Overall Study|Protocol Violation|5|||
48468565|NCT01072175|155906755|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468566|NCT01072175|155906756|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468567|NCT01072175|155906757|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468568|NCT01072175|155906758|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468569|NCT01072175|155906759|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
48468570|NCT01072175|155906747|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468571|NCT01072175|155906748|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468572|NCT01072175|155906749|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468573|NCT01072175|155906750|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468574|NCT01072175|155906751|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468575|NCT01072175|155906752|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468576|NCT01072175|155906753|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
48468577|NCT01072175|155906754|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
48468578|NCT01072175|155906755|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468579|NCT01072175|155906756|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468580|NCT01072175|155906757|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468581|NCT01072175|155906758|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468582|NCT01072175|155906759|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
48468583|NCT01072175|155906747|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468584|NCT01072175|155906748|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468585|NCT01072175|155906749|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468586|NCT01072175|155906750|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468587|NCT01072175|155906751|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468588|NCT01072175|155906752|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
48468589|NCT01072175|155906753|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
48468590|NCT01072175|155906754|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
48468591|NCT01072175|155906755|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468592|NCT01072175|155906756|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468593|NCT01072175|155906757|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468594|NCT01072175|155906758|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468595|NCT01072175|155906759|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
48468596|NCT01072175|155906747|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468597|NCT01072175|155906748|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468598|NCT01072175|155906749|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468599|NCT01072175|155906750|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468600|NCT01072175|155906751|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468601|NCT01072175|155906752|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
48468602|NCT01072175|155906753|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
48468603|NCT01072175|155906754|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468604|NCT01072175|155906755|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468605|NCT01072175|155906756|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468606|NCT01072175|155906757|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468607|NCT01072175|155906758|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468608|NCT01072175|155906759|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
48468609|NCT01072175|155906747|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468610|NCT01072175|155906748|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468611|NCT01072175|155906749|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468612|NCT01072175|155906750|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468613|NCT01072175|155906751|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468614|NCT01072175|155906752|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468615|NCT01072175|155906753|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468616|NCT01072175|155906754|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468617|NCT01072175|155906755|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
48468618|NCT01072175|155906756|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468619|NCT01072175|155906757|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468620|NCT01072175|155906758|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468621|NCT01072175|155906759|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
48468622|NCT01072175|155906747|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468623|NCT01072175|155906748|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468624|NCT01072175|155906749|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468625|NCT01072175|155906750|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468626|NCT01072175|155906751|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468627|NCT01072175|155906752|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468628|NCT01072175|155906753|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468629|NCT01072175|155906754|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468630|NCT01072175|155906755|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
48468631|NCT01072175|155906756|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468632|NCT01072175|155906757|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468633|NCT01072175|155906758|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468634|NCT01072175|155906759|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
48468635|NCT01072175|155906747|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468636|NCT01072175|155906748|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468637|NCT01072175|155906749|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468638|NCT01072175|155906750|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468639|NCT01072175|155906751|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468640|NCT01072175|155906752|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468641|NCT01072175|155906753|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468642|NCT01072175|155906754|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468643|NCT01072175|155906755|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
48468644|NCT01072175|155906756|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468645|NCT01072175|155906757|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468646|NCT01072175|155906758|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468647|NCT01072175|155906759|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
48468648|NCT01072175|155906747|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468649|NCT01072175|155906748|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468650|NCT01072175|155906749|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468651|NCT01072175|155906750|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468652|NCT01072175|155906751|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468653|NCT01072175|155906752|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468654|NCT01072175|155906753|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468655|NCT01072175|155906754|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468656|NCT01072175|155906755|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
48468657|NCT01072175|155906756|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468658|NCT01072175|155906757|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468659|NCT01072175|155906758|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468660|NCT01072175|155906759|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
48468661|NCT01072175|155906747|FG000|Part D (HPMC Capsules)|Death|0|||
48468662|NCT01072175|155906748|FG001|Part D (HPMC Capsules)|Death|0|||
48468663|NCT01072175|155906749|FG002|Part D (HPMC Capsules)|Death|0|||
48468664|NCT01072175|155906750|FG003|Part D (HPMC Capsules)|Death|0|||
48468665|NCT01072175|155906751|FG004|Part D (HPMC Capsules)|Death|0|||
48468666|NCT01072175|155906752|FG005|Part D (HPMC Capsules)|Death|0|||
48468667|NCT01072175|155906753|FG006|Part D (HPMC Capsules)|Death|0|||
48468668|NCT01072175|155906754|FG007|Part D (HPMC Capsules)|Death|0|||
48468669|NCT01072175|155906755|FG008|Part D (HPMC Capsules)|Death|0|||
48468670|NCT01072175|155906756|FG009|Part D (HPMC Capsules)|Death|10|||
48468671|NCT01072175|155906757|FG010|Part D (HPMC Capsules)|Death|12|||
48468672|NCT01072175|155906758|FG011|Part D (HPMC Capsules)|Death|28|||
48468673|NCT01072175|155906759|FG012|Part D (HPMC Capsules)|Death|26|||
48468674|NCT01072175|155906747|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
48468675|NCT01072175|155906748|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
48468676|NCT01072175|155906749|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
48468677|NCT01072175|155906750|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
48468678|NCT01072175|155906751|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
48468679|NCT01072175|155906752|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
48468680|NCT01072175|155906753|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
48468681|NCT01072175|155906754|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
48468682|NCT01072175|155906755|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
48468683|NCT01072175|155906756|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
48468684|NCT01072175|155906757|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
48468685|NCT01072175|155906758|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
48468686|NCT01072175|155906759|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
48468687|NCT01072175|155906747|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468688|NCT01072175|155906748|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468689|NCT01072175|155906749|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468690|NCT01072175|155906750|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468691|NCT01072175|155906751|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468692|NCT01072175|155906752|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468693|NCT01072175|155906753|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468694|NCT01072175|155906754|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468695|NCT01072175|155906755|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468696|NCT01072175|155906756|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
48468697|NCT01072175|155906757|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
48468698|NCT01072175|155906758|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
48468699|NCT01072175|155906759|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
48468700|NCT01072175|155906747|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468701|NCT01072175|155906748|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468702|NCT01072175|155906749|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468703|NCT01072175|155906750|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468704|NCT01072175|155906751|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468705|NCT01072175|155906752|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468706|NCT01072175|155906753|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468707|NCT01072175|155906754|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468708|NCT01072175|155906755|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
48468709|NCT01072175|155906756|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
48468710|NCT01072175|155906757|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
48468711|NCT01072175|155906758|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
48468712|NCT01072175|155906759|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
48468713|NCT01072175|155906747|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468714|NCT01072175|155906748|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468715|NCT01072175|155906749|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468716|NCT01072175|155906750|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468717|NCT01072175|155906751|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468718|NCT01072175|155906752|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468719|NCT01072175|155906753|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468720|NCT01072175|155906754|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468721|NCT01072175|155906755|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468722|NCT01072175|155906756|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468723|NCT01072175|155906757|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
48468724|NCT01072175|155906758|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
48468725|NCT01072175|155906759|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
48468726|NCT02577107|155906760|FG000|Overall Study|Protocol deviation|0|||
48468727|NCT02577107|155906761|FG001|Overall Study|Protocol deviation|1|||
48468728|NCT02516605|155906762|FG000|Overall Study|Protocol Violation|0|||
48468729|NCT02516605|155906763|FG001|Overall Study|Protocol Violation|0|||
48468730|NCT02516605|155906764|FG002|Overall Study|Protocol Violation|0|||
48468731|NCT02516605|155906765|FG003|Overall Study|Protocol Violation|0|||
48468732|NCT02516605|155906766|FG004|Overall Study|Protocol Violation|1|||
48468733|NCT02516605|155906762|FG000|Overall Study|Withdrawal by Subject|0|||
48468734|NCT02516605|155906763|FG001|Overall Study|Withdrawal by Subject|0|||
48468735|NCT02516605|155906764|FG002|Overall Study|Withdrawal by Subject|0|||
48468736|NCT02516605|155906765|FG003|Overall Study|Withdrawal by Subject|1|||
48468737|NCT02516605|155906766|FG004|Overall Study|Withdrawal by Subject|0|||
48468738|NCT02643420|155906771|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
48468739|NCT02643420|155906772|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
48468740|NCT02643420|155906771|FG000|Overall Study|Withdrawal by Subject|25|||
48468741|NCT02643420|155906772|FG001|Overall Study|Withdrawal by Subject|19|||
48468742|NCT02643420|155906771|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
48468743|NCT02643420|155906772|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
48468744|NCT02643420|155906771|FG000|Overall Study|Lost to Follow-up|6|||
48468745|NCT02643420|155906772|FG001|Overall Study|Lost to Follow-up|10|||
48468746|NCT02643420|155906771|FG000|Overall Study|Investigator Decision|2|||
48468747|NCT02643420|155906772|FG001|Overall Study|Investigator Decision|4|||
48468748|NCT02643420|155906771|FG000|Overall Study|Sponsor decision|1|||
48468749|NCT02643420|155906772|FG001|Overall Study|Sponsor decision|1|||
48468750|NCT02643420|155906771|FG000|Overall Study|Death|0|||
48468751|NCT02643420|155906772|FG001|Overall Study|Death|2|||
48468752|NCT02643420|155906771|FG000|Overall Study|Reason not Specified|8|||
48468753|NCT02643420|155906772|FG001|Overall Study|Reason not Specified|7|||
48468754|NCT02127970|155906773|FG000|Overall Study|Adverse Event|2|||
48468755|NCT02127970|155906774|FG001|Overall Study|Adverse Event|1|||
48468756|NCT02127970|155906773|FG000|Overall Study|Death|1|||
48468757|NCT02127970|155906774|FG001|Overall Study|Death|1|||
48468758|NCT02127970|155906773|FG000|Overall Study|Lost to Follow-up|14|||
48468759|NCT02127970|155906774|FG001|Overall Study|Lost to Follow-up|14|||
48468760|NCT02127970|155906773|FG000|Overall Study|Reason not Specified|4|||
48468761|NCT02127970|155906774|FG001|Overall Study|Reason not Specified|7|||
48468762|NCT02127970|155906773|FG000|Overall Study|Pregnancy|0|||
48468763|NCT02127970|155906774|FG001|Overall Study|Pregnancy|1|||
48468764|NCT02127970|155906773|FG000|Overall Study|Subject Withdrew Consent|5|||
48468765|NCT02127970|155906774|FG001|Overall Study|Subject Withdrew Consent|3|||
48468766|NCT00643006|155906775|FG000|Overall Study|Lost to Follow-up|5|||
48468767|NCT00643006|155906776|FG001|Overall Study|Lost to Follow-up|4|||
48468768|NCT01710709|155906777|FG000|Overall Study|Lost to Follow-up|29|||
48468769|NCT01710709|155906777|FG000|Overall Study|Adverse Event|48|||
48468770|NCT01710709|155906777|FG000|Overall Study|Participant met withdrawal criteria|33|||
48468771|NCT01710709|155906777|FG000|Overall Study|Participant withdrawn by investigator|2|||
48468772|NCT01710709|155906777|FG000|Overall Study|Withdrawal by Subject|53|||
48468774|NCT01710709|155906777|FG000|Overall Study|Lack of Efficacy|3|||
48468775|NCT02477215|155906779|FG000|Dose Escalation Phase|Physician Decision|1|||
48468776|NCT02477215|155906780|FG001|Dose Escalation Phase|Physician Decision|2|||
48468777|NCT02477215|155906781|FG002|Dose Escalation Phase|Physician Decision|0|||
48468778|NCT02477215|155906779|FG000|Fixed Dose Phase|Physician Decision|0|||
48468779|NCT02477215|155906780|FG001|Fixed Dose Phase|Physician Decision|7|||
48468780|NCT02477215|155906781|FG002|Fixed Dose Phase|Physician Decision|0|||
48468781|NCT04052425|155906782|FG000|24-Week Double-blind Period|Adverse Event|0|||
48468782|NCT04052425|155906783|FG001|24-Week Double-blind Period|Adverse Event|1|||
48468783|NCT04052425|155906784|FG002|24-Week Double-blind Period|Adverse Event|0|||
48468784|NCT04052425|155906785|FG003|24-Week Double-blind Period|Adverse Event|0|||
48468785|NCT04052425|155906782|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
48468786|NCT04052425|155906783|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
48468787|NCT04052425|155906784|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
48468788|NCT04052425|155906785|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
48468789|NCT04052425|155906782|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
48468790|NCT04052425|155906783|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
48468791|NCT04052425|155906784|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
48468792|NCT04052425|155906785|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
48468793|NCT04052425|155906782|FG000|24-Week Double-blind Period|Physician Decision|1|||
48468794|NCT04052425|155906783|FG001|24-Week Double-blind Period|Physician Decision|0|||
48468795|NCT04052425|155906784|FG002|24-Week Double-blind Period|Physician Decision|0|||
48468796|NCT04052425|155906785|FG003|24-Week Double-blind Period|Physician Decision|0|||
48468797|NCT04052425|155906782|FG000|24-Week Double-blind Period|Protocol Violation|1|||
48468798|NCT04052425|155906783|FG001|24-Week Double-blind Period|Protocol Violation|0|||
48468799|NCT04052425|155906784|FG002|24-Week Double-blind Period|Protocol Violation|0|||
48468800|NCT04052425|155906785|FG003|24-Week Double-blind Period|Protocol Violation|0|||
48468801|NCT04052425|155906782|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
48468802|NCT04052425|155906783|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
48468803|NCT04052425|155906784|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
48468804|NCT04052425|155906785|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
48468805|NCT04052425|155906782|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
48468806|NCT04052425|155906783|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
48468807|NCT04052425|155906784|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
48468808|NCT04052425|155906785|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
48468809|NCT04052425|155906782|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
48468810|NCT04052425|155906783|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
48468811|NCT04052425|155906784|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
48468812|NCT04052425|155906785|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
48468813|NCT04052425|155906782|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
48468814|NCT04052425|155906783|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
48468815|NCT04052425|155906784|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
48468816|NCT04052425|155906785|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
48468817|NCT04052425|155906782|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
48468818|NCT04052425|155906783|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
48468819|NCT04052425|155906784|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
48468820|NCT04052425|155906785|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
48468821|NCT04052425|155906782|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
48468822|NCT04052425|155906783|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
48468823|NCT04052425|155906784|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
48468824|NCT04052425|155906785|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
48468825|NCT04052425|155906782|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
48468826|NCT04052425|155906783|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
48468827|NCT04052425|155906784|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
48468828|NCT04052425|155906785|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
48468829|NCT04052425|155906782|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
48468830|NCT04052425|155906783|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
48468831|NCT04052425|155906784|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
48468832|NCT04052425|155906785|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
48468833|NCT04052425|155906782|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
48468834|NCT04052425|155906783|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
48468835|NCT04052425|155906784|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
48468836|NCT04052425|155906785|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
48468837|NCT05102734|155906786|FG000|Overall Study|Did not require vasopressors|1|||
48468838|NCT05102734|155906787|FG001|Overall Study|Did not require vasopressors|0|||
48468839|NCT05102734|155906786|FG000|Overall Study|Did not have functioning PA catheter|1|||
48468840|NCT05102734|155906787|FG001|Overall Study|Did not have functioning PA catheter|0|||
48468841|NCT05102734|155906786|FG000|Overall Study|Inadequate video quality|2|||
48468842|NCT05102734|155906787|FG001|Overall Study|Inadequate video quality|0|||
48468843|NCT00608426|155906788|FG000|Overall Study|Death|32|||
48468844|NCT00608426|155906789|FG001|Overall Study|Death|36|||
48468845|NCT00608426|155906788|FG000|Overall Study|Lost to Follow-up|485|||
48468846|NCT00608426|155906789|FG001|Overall Study|Lost to Follow-up|521|||
48468847|NCT00608426|155906788|FG000|Overall Study|refused, health issues, wrong address|319|||
48468848|NCT00608426|155906789|FG001|Overall Study|refused, health issues, wrong address|348|||
48468849|NCT04837807|155906790|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
48468850|NCT04837807|155906791|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
48468851|NCT00761891|155906792|FG000|Overall Study|Withdrawal by Subject|10|||
48468852|NCT01396434|155906799|FG000|Overall Study|Lost to Follow-up|1|||
48468853|NCT01396434|155906800|FG001|Overall Study|Lost to Follow-up|0|||
48468854|NCT01396434|155906801|FG002|Overall Study|Lost to Follow-up|0|||
48468855|NCT01396434|155906799|FG000|Overall Study|Other|10|||
48468856|NCT01396434|155906800|FG001|Overall Study|Other|0|||
48468857|NCT01396434|155906801|FG002|Overall Study|Other|0|||
48468858|NCT00808665|155906802|FG000|Overall Study|Withdrawal by Subject|1|||
48468859|NCT00808665|155906803|FG001|Overall Study|Withdrawal by Subject|0|||
48468860|NCT00808665|155906802|FG000|Overall Study|only required minimally invasive surgery|1|||
48468861|NCT00808665|155906803|FG001|Overall Study|only required minimally invasive surgery|0|||
48468862|NCT00808665|155906802|FG000|Overall Study|surgery cancelled|1|||
48468863|NCT00808665|155906803|FG001|Overall Study|surgery cancelled|0|||
48468864|NCT00808665|155906802|FG000|Overall Study|required an additional procedure|0|||
48468865|NCT00808665|155906803|FG001|Overall Study|required an additional procedure|1|||
48468866|NCT00808665|155906802|FG000|Overall Study|Physician Decision|3|||
48468867|NCT00808665|155906803|FG001|Overall Study|Physician Decision|1|||
48468868|NCT00808665|155906802|FG000|Overall Study|Medication stopped by resident|0|||
48468869|NCT00808665|155906803|FG001|Overall Study|Medication stopped by resident|1|||
48468870|NCT03326323|155906804|FG000|Overall Study|Unable to receive ANH protocol|3|||
48468871|NCT01220024|155906805|FG000|Overall Study|Lost to Follow-up|1|||
48468872|NCT01220024|155906806|FG001|Overall Study|Lost to Follow-up|1|||
48468873|NCT01539512|155906808|FG000|Overall Study|Adverse Event|9|||
48468874|NCT01539512|155906809|FG001|Overall Study|Adverse Event|7|||
48468875|NCT01539512|155906808|FG000|Overall Study|Physician Decision|1|||
48468876|NCT01539512|155906809|FG001|Overall Study|Physician Decision|1|||
48468877|NCT01539512|155906808|FG000|Overall Study|Withdrawal by Subject|12|||
48468878|NCT01539512|155906809|FG001|Overall Study|Withdrawal by Subject|5|||
48468879|NCT01539512|155906808|FG000|Overall Study|Richter's Transformation|1|||
48468880|NCT01539512|155906809|FG001|Overall Study|Richter's Transformation|0|||
48468881|NCT00265382|155906810|FG000|Overall Study|Adverse Event|21|||
48468882|NCT00265382|155906810|FG000|Overall Study|Laboratory Abnormality|1|||
48468883|NCT00265382|155906810|FG000|Overall Study|Lost to Follow-up|3|||
48468884|NCT00265382|155906810|FG000|Overall Study|Lack of Efficacy|6|||
48468885|NCT00265382|155906810|FG000|Overall Study|Miscellaneous|6|||
48468886|NCT00265382|155906810|FG000|Overall Study|Withdrawal by Subject|13|||
48468887|NCT00265382|155906810|FG000|Overall Study|Study terminated by sponsor|94|||
48468888|NCT00265382|155906810|FG000|Overall Study|Death|1|||
48468889|NCT00972309|155906820|FG000|Overall Study|Switched to alternative treatment|0|||
48468890|NCT00972309|155906821|FG001|Overall Study|Switched to alternative treatment|2|||
48468891|NCT00972309|155906820|FG000|Overall Study|Refused further treatment|0|||
48468892|NCT00972309|155906821|FG001|Overall Study|Refused further treatment|1|||
48468893|NCT00972309|155906820|FG000|Overall Study|Late determination of ineligibility|0|||
48468894|NCT00972309|155906821|FG001|Overall Study|Late determination of ineligibility|1|||
48468895|NCT00972309|155906820|FG000|Overall Study|Second malignancy|1|||
48468896|NCT00972309|155906821|FG001|Overall Study|Second malignancy|1|||
48468897|NCT00972309|155906820|FG000|Overall Study|Visa issues|0|||
48468898|NCT00972309|155906821|FG001|Overall Study|Visa issues|1|||
48468899|NCT00972309|155906820|FG000|Overall Study|Secondary cancer (SCC)|0|||
48468900|NCT00972309|155906821|FG001|Overall Study|Secondary cancer (SCC)|1|||
48468901|NCT00972309|155906820|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
48468902|NCT00972309|155906821|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
48468903|NCT00972309|155906820|FG000|Overall Study|Lost to Follow-up|1|||
48468904|NCT00972309|155906821|FG001|Overall Study|Lost to Follow-up|1|||
48468905|NCT00972309|155906820|FG000|Overall Study|Disease progression on study|10|||
48468906|NCT00972309|155906821|FG001|Overall Study|Disease progression on study|4|||
48468907|NCT00931515|155906822|FG000|Overall Study|Lost to Follow-up|2|||
48468908|NCT00931515|155906823|FG001|Overall Study|Lost to Follow-up|5|||
48468909|NCT00736840|155906832|FG000|Overall Study|Lost to Follow-up|13|||
48468910|NCT01874288|155906833|FG000|Overall Study|Withdrawal by Subject|1|||
48468911|NCT01874288|155906834|FG001|Overall Study|Withdrawal by Subject|0|||
48468912|NCT01874288|155906835|FG002|Overall Study|Withdrawal by Subject|2|||
48468913|NCT01874288|155906836|FG003|Overall Study|Withdrawal by Subject|1|||
48468914|NCT01874288|155906837|FG004|Overall Study|Withdrawal by Subject|1|||
48468915|NCT01874288|155906833|FG000|Overall Study|Physician Decision|0|||
48468916|NCT01874288|155906834|FG001|Overall Study|Physician Decision|0|||
48468917|NCT01874288|155906835|FG002|Overall Study|Physician Decision|0|||
48468918|NCT01874288|155906836|FG003|Overall Study|Physician Decision|1|||
48468919|NCT01874288|155906837|FG004|Overall Study|Physician Decision|0|||
48468920|NCT01874288|155906833|FG000|Overall Study|Progressive disease|2|||
48468921|NCT01874288|155906834|FG001|Overall Study|Progressive disease|0|||
48468922|NCT01874288|155906835|FG002|Overall Study|Progressive disease|3|||
48468923|NCT01874288|155906836|FG003|Overall Study|Progressive disease|5|||
48468924|NCT01874288|155906837|FG004|Overall Study|Progressive disease|1|||
48468925|NCT02062385|155906842|FG000|Overall Study|Adverse Event|19|||
48468926|NCT02062385|155906843|FG001|Overall Study|Adverse Event|13|||
48468927|NCT02062385|155906844|FG002|Overall Study|Adverse Event|1|||
48468928|NCT02062385|155906845|FG003|Overall Study|Adverse Event|0|||
48468929|NCT02062385|155906842|FG000|Overall Study|Protocol Violation|1|||
48468930|NCT02062385|155906843|FG001|Overall Study|Protocol Violation|0|||
48468931|NCT02062385|155906844|FG002|Overall Study|Protocol Violation|0|||
48468932|NCT02062385|155906845|FG003|Overall Study|Protocol Violation|0|||
48468933|NCT02062385|155906842|FG000|Overall Study|Incomplete EPI by database lock|2|||
48468934|NCT02062385|155906843|FG001|Overall Study|Incomplete EPI by database lock|0|||
48468935|NCT02062385|155906844|FG002|Overall Study|Incomplete EPI by database lock|0|||
48468936|NCT02062385|155906845|FG003|Overall Study|Incomplete EPI by database lock|0|||
48468937|NCT02062385|155906842|FG000|Overall Study|Moved|10|||
48468938|NCT02062385|155906843|FG001|Overall Study|Moved|11|||
48468939|NCT02062385|155906844|FG002|Overall Study|Moved|1|||
48468940|NCT02062385|155906845|FG003|Overall Study|Moved|0|||
48468941|NCT02062385|155906842|FG000|Overall Study|Withdrawn by parent/guardian|46|||
48468942|NCT02062385|155906843|FG001|Overall Study|Withdrawn by parent/guardian|41|||
48468943|NCT02062385|155906844|FG002|Overall Study|Withdrawn by parent/guardian|9|||
48468944|NCT02062385|155906845|FG003|Overall Study|Withdrawn by parent/guardian|8|||
48468945|NCT02062385|155906842|FG000|Overall Study|Death|0|||
48468946|NCT02062385|155906843|FG001|Overall Study|Death|0|||
48468947|NCT02062385|155906844|FG002|Overall Study|Death|0|||
48468948|NCT02062385|155906845|FG003|Overall Study|Death|1|||
48468949|NCT02062385|155906842|FG000|Overall Study|Lost to Follow-up|0|||
48468950|NCT02062385|155906843|FG001|Overall Study|Lost to Follow-up|0|||
48468951|NCT02062385|155906844|FG002|Overall Study|Lost to Follow-up|1|||
48468952|NCT02062385|155906845|FG003|Overall Study|Lost to Follow-up|0|||
48468953|NCT02452892|155906846|FG000|Week 1 Initial Randommization|Adverse Event|1|||
48468954|NCT02452892|155906847|FG001|Week 1 Initial Randommization|Adverse Event|0|||
48468955|NCT02452892|155906848|FG002|Week 1 Initial Randommization|Adverse Event|0|||
48468956|NCT02452892|155906849|FG003|Week 1 Initial Randommization|Adverse Event|0|||
48468957|NCT02452892|155906846|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
48468958|NCT02452892|155906847|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
48468959|NCT02452892|155906848|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
48468960|NCT02452892|155906849|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
48468961|NCT02452892|155906846|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
48468962|NCT02452892|155906847|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
48468963|NCT02452892|155906848|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
48468964|NCT02452892|155906849|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
48468965|NCT02452892|155906846|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
48468966|NCT02452892|155906847|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
48468967|NCT02452892|155906848|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
48468968|NCT02452892|155906849|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
48468969|NCT02452892|155906846|FG000|Follow-up|Withdrawal by Subject|0|||
48468970|NCT02452892|155906847|FG001|Follow-up|Withdrawal by Subject|0|||
48468971|NCT02452892|155906848|FG002|Follow-up|Withdrawal by Subject|0|||
48468972|NCT02452892|155906849|FG003|Follow-up|Withdrawal by Subject|1|||
48468973|NCT02452892|155906846|FG000|Follow-up|Subject left town on Day 42|1|||
48468974|NCT02452892|155906847|FG001|Follow-up|Subject left town on Day 42|0|||
48468975|NCT02452892|155906848|FG002|Follow-up|Subject left town on Day 42|0|||
48468976|NCT02452892|155906849|FG003|Follow-up|Subject left town on Day 42|0|||
48468977|NCT02451137|155906850|FG000|Overall Study|Randomized but not treated|19|||
48468978|NCT02451137|155906851|FG001|Overall Study|Randomized but not treated|27|||
48468979|NCT02451137|155906850|FG000|Overall Study|Adverse Event|43|||
48468980|NCT02451137|155906851|FG001|Overall Study|Adverse Event|42|||
48468981|NCT02451137|155906850|FG000|Overall Study|Lack of Efficacy|4|||
48468982|NCT02451137|155906851|FG001|Overall Study|Lack of Efficacy|9|||
48468983|NCT02451137|155906850|FG000|Overall Study|Participant decision:discontinue insulin|41|||
48468984|NCT02451137|155906851|FG001|Overall Study|Participant decision:discontinue insulin|43|||
48468985|NCT02451137|155906850|FG000|Overall Study|Hypoglycemia|2|||
48468986|NCT02451137|155906851|FG001|Overall Study|Hypoglycemia|1|||
48468987|NCT02451137|155906850|FG000|Overall Study|Investigator's decision|23|||
48468988|NCT02451137|155906851|FG001|Overall Study|Investigator's decision|19|||
48468989|NCT02451137|155906850|FG000|Overall Study|Lost to Follow-up|53|||
48468990|NCT02451137|155906851|FG001|Overall Study|Lost to Follow-up|61|||
48468991|NCT02451137|155906850|FG000|Overall Study|Physician Decision|6|||
48468992|NCT02451137|155906851|FG001|Overall Study|Physician Decision|5|||
48468993|NCT02451137|155906850|FG000|Overall Study|Sponsor decision|13|||
48468994|NCT02451137|155906851|FG001|Overall Study|Sponsor decision|25|||
48468995|NCT02451137|155906850|FG000|Overall Study|Withdrawal by Subject|40|||
48468996|NCT02451137|155906851|FG001|Overall Study|Withdrawal by Subject|63|||
48468997|NCT02451137|155906850|FG000|Overall Study|Other than specified above|2|||
48468998|NCT02451137|155906851|FG001|Overall Study|Other than specified above|3|||
48468999|NCT03664804|155906852|FG000|Overall Study|Withdrawal by Subject|7|||
48469000|NCT03053180|155908278|FG000|Overall Study|Failure to Return|1|||
48469001|NCT02198040|155908283|FG000|Overall Study|Work reasons|0|||
48469002|NCT02198040|155908284|FG001|Overall Study|Work reasons|1|||
48469003|NCT02198040|155908285|FG002|Overall Study|Work reasons|0|||
48469004|NCT02198040|155908283|FG000|Overall Study|Withdrawal by Subject|0|||
48469005|NCT02198040|155908284|FG001|Overall Study|Withdrawal by Subject|0|||
48469006|NCT02198040|155908285|FG002|Overall Study|Withdrawal by Subject|1|||
48469007|NCT01265719|155908286|FG000|Overall Study|Does not meet entrance criteria|0|||
48469008|NCT01265719|155908287|FG001|Overall Study|Does not meet entrance criteria|3|||
48469009|NCT01265719|155908286|FG000|Overall Study|Other reasons|2|||
48469010|NCT01265719|155908287|FG001|Overall Study|Other reasons|0|||
48469011|NCT01265719|155908286|FG000|Overall Study|Withdrawal by Subject|8|||
48469012|NCT01265719|155908287|FG001|Overall Study|Withdrawal by Subject|3|||
48469013|NCT01265719|155908286|FG000|Overall Study|Lost to Follow-up|2|||
48469014|NCT01265719|155908287|FG001|Overall Study|Lost to Follow-up|7|||
48469015|NCT01265719|155908286|FG000|Overall Study|Adverse Event|2|||
48469016|NCT01265719|155908287|FG001|Overall Study|Adverse Event|0|||
48469017|NCT02534324|155908291|FG000|Overall Study|Protocol Violation|4|||
48469018|NCT02534324|155908292|FG001|Overall Study|Protocol Violation|1|||
48469019|NCT02534324|155908291|FG000|Overall Study|Lost to Follow-up|20|||
48469020|NCT02534324|155908292|FG001|Overall Study|Lost to Follow-up|7|||
48469021|NCT02534324|155908291|FG000|Overall Study|Adverse Event|1|||
48469022|NCT02534324|155908292|FG001|Overall Study|Adverse Event|0|||
48469023|NCT00303602|155908293|FG000|Overall Study|Adverse Event|2|||
48469024|NCT00303602|155908294|FG001|Overall Study|Adverse Event|2|||
48469025|NCT00303602|155908293|FG000|Overall Study|Withdrawal by Subject|5|||
48469026|NCT00303602|155908294|FG001|Overall Study|Withdrawal by Subject|6|||
48469027|NCT00303602|155908293|FG000|Overall Study|Lost to Follow-up|5|||
48469028|NCT00303602|155908294|FG001|Overall Study|Lost to Follow-up|2|||
48469029|NCT00303602|155908293|FG000|Overall Study|Protocol entry criteria not met|2|||
48469030|NCT00303602|155908294|FG001|Overall Study|Protocol entry criteria not met|2|||
48469031|NCT00303602|155908293|FG000|Overall Study|Physician Decision|2|||
48469032|NCT00303602|155908294|FG001|Overall Study|Physician Decision|1|||
48469033|NCT00303602|155908293|FG000|Overall Study|Noncompliance|2|||
48469034|NCT00303602|155908294|FG001|Overall Study|Noncompliance|2|||
48469035|NCT00303602|155908293|FG000|Overall Study|Protocol Violation|1|||
48469036|NCT00303602|155908294|FG001|Overall Study|Protocol Violation|0|||
48469037|NCT03704194|155908296|FG000|Overall Study|Withdrawal by Subject|0|||
48469038|NCT03704194|155908297|FG001|Overall Study|Withdrawal by Subject|1|||
48469039|NCT02452320|155908298|FG000|Overall Study|Adverse Event|0|||
48469040|NCT02452320|155908299|FG001|Overall Study|Adverse Event|1|||
48469041|NCT03938857|155908300|FG000|Overall Study|Physician Decision|1|||
48469042|NCT03938857|155908301|FG001|Overall Study|Physician Decision|0|||
48469043|NCT03938857|155908302|FG002|Overall Study|Physician Decision|0|||
48469044|NCT03938857|155908303|FG003|Overall Study|Physician Decision|0|||
48469045|NCT02406586|155908304|FG000|Overall Study|Lost to Follow-up|0|||
48469046|NCT02406586|155908305|FG001|Overall Study|Lost to Follow-up|4|||
48469047|NCT02406586|155908306|FG002|Overall Study|Lost to Follow-up|2|||
48469048|NCT02406586|155908304|FG000|Overall Study|Withdrawal by Subject|1|||
48469049|NCT02406586|155908305|FG001|Overall Study|Withdrawal by Subject|0|||
48469050|NCT02406586|155908306|FG002|Overall Study|Withdrawal by Subject|0|||
48469051|NCT00682539|155908307|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
48469052|NCT00682539|155908308|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
48469053|NCT00682539|155908309|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
48469054|NCT00682539|155908307|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
48469055|NCT00682539|155908308|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
48469056|NCT00682539|155908309|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
48469057|NCT03737812|155908310|FG000|Overall Study|Withdrawal by Subject|1|||
48469058|NCT03737812|155908311|FG001|Overall Study|Withdrawal by Subject|2|||
48469059|NCT03737812|155908312|FG002|Overall Study|Withdrawal by Subject|1|||
48469060|NCT03737812|155908310|FG000|Overall Study|Sponsor Discontinued the Study|4|||
48469061|NCT03737812|155908311|FG001|Overall Study|Sponsor Discontinued the Study|3|||
48469062|NCT03737812|155908312|FG002|Overall Study|Sponsor Discontinued the Study|2|||
48469063|NCT03737812|155908310|FG000|Overall Study|Adverse Event|0|||
48469064|NCT03737812|155908311|FG001|Overall Study|Adverse Event|1|||
48469065|NCT03737812|155908312|FG002|Overall Study|Adverse Event|0|||
48469066|NCT03737812|155908310|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
48469067|NCT03737812|155908311|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
48469068|NCT03737812|155908312|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
48469069|NCT02624713|155908315|FG000|Overall Study|Lost to Follow-up|14|||
48469070|NCT02624713|155908316|FG001|Overall Study|Lost to Follow-up|0|||
48469071|NCT04298229|155908320|FG000|Overall Study|Physician Decision|1|||
48469072|NCT04298229|155908321|FG001|Overall Study|Physician Decision|1|||
48469073|NCT04298229|155908320|FG000|Overall Study|Withdrawal by Subject|1|||
48469074|NCT04298229|155908321|FG001|Overall Study|Withdrawal by Subject|1|||
48469075|NCT04298229|155908320|FG000|Overall Study|Did not receive IV loop diuretics|2|||
48469076|NCT04298229|155908321|FG001|Overall Study|Did not receive IV loop diuretics|0|||
48469077|NCT00779506|155908332|FG000|Overall Study|Screening Failed|2|||
48469078|NCT00779506|155908332|FG000|Overall Study|Adverse Event|4|||
48469079|NCT00779506|155908332|FG000|Overall Study|Lack of Efficacy|11|||
48469080|NCT00779506|155908332|FG000|Overall Study|Protocol Violation|5|||
48469081|NCT00779506|155908332|FG000|Overall Study|Withdrawal by Subject|6|||
48469082|NCT00779506|155908332|FG000|Overall Study|Lost to Follow-up|1|||
48469083|NCT01398176|155908333|FG000|Overall Study|Lost to Follow-up|1|||
48469084|NCT01398176|155908334|FG001|Overall Study|Lost to Follow-up|3|||
48469085|NCT01398176|155908333|FG000|Overall Study|Physician Decision|2|||
48469086|NCT01398176|155908334|FG001|Overall Study|Physician Decision|3|||
48469087|NCT01345162|155908335|FG000|Overall Study|Protocol Violation|2|||
48469088|NCT01345162|155908336|FG001|Overall Study|Protocol Violation|4|||
48469089|NCT00285857|155908337|FG000|Overall Study|Withdrawal by Subject|2|||
48469090|NCT00285857|155908337|FG000|Overall Study|Inadequate initial breast cytology|1|||
48469091|NCT00285857|155908337|FG000|Overall Study|Adverse Event|1|||
48469092|NCT00508872|155908338|FG000|Overall Study|Lost to Follow-up|1|||
48469093|NCT00508872|155908338|FG000|Overall Study|Physician Decision|1|||
48469094|NCT02506101|155908339|FG000|Overall Study|Transportation issues|1|||
48469095|NCT02506101|155908340|FG001|Overall Study|Transportation issues|0|||
48469096|NCT02506101|155908339|FG000|Overall Study|No enrollment and staff unavailability|1|||
48469097|NCT02506101|155908340|FG001|Overall Study|No enrollment and staff unavailability|0|||
48469098|NCT00542321|155908342|FG000|Overall Study|Death|0|||
48469099|NCT00542321|155908343|FG001|Overall Study|Death|1|||
48469100|NCT01871870|155908353|FG000|Overall Study|Hardware issues|7|||
48469101|NCT01871870|155908353|FG000|Overall Study|hyperglycemia|2|||
48469102|NCT02283411|155908354|FG000|Overall Study|Withdrawal by Subject|3|||
48469103|NCT02283411|155908354|FG000|Overall Study|Screen Failed|28|||
48469104|NCT00174460|155908356|FG000|Overall Study|Withdrawal by Subject|0|||
48469105|NCT00174460|155908357|FG001|Overall Study|Withdrawal by Subject|1|||
48469106|NCT04225026|155908360|FG000|Overall Study|Withdrawal by Subject|4|||
48469107|NCT04225026|155908360|FG000|Overall Study|Adverse Event|1|||
48469108|NCT04225026|155908360|FG000|Overall Study|Other|1|||
48469109|NCT04225026|155908360|FG000|Overall Study|Death|11|||
48469110|NCT04225026|155908360|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
48469111|NCT05116787|155908363|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
48469112|NCT05116787|155908364|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
48469113|NCT05116787|155908363|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
48469114|NCT05116787|155908364|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
48469115|NCT05116787|155908363|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
48469116|NCT05116787|155908364|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
48469117|NCT05116787|155908363|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
48469118|NCT05116787|155908364|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
48469119|NCT00490815|155908365|FG000|Overall Study|Adverse Event|2|||
48469120|NCT00490815|155908366|FG001|Overall Study|Adverse Event|3|||
48469121|NCT00490815|155908365|FG000|Overall Study|Withdrawal by Subject|4|||
48469122|NCT00490815|155908366|FG001|Overall Study|Withdrawal by Subject|0|||
48469123|NCT00490815|155908365|FG000|Overall Study|Lost to Follow-up|1|||
48469124|NCT00490815|155908366|FG001|Overall Study|Lost to Follow-up|3|||
48469125|NCT00490815|155908365|FG000|Overall Study|Death|1|||
48469126|NCT00490815|155908366|FG001|Overall Study|Death|3|||
48469127|NCT02058849|155908367|FG000|Overall Study|Hospitalization|1|||
48469128|NCT02058849|155908368|FG001|Overall Study|Hospitalization|1|||
48469129|NCT02058849|155908367|FG000|Overall Study|Death|1|||
48469130|NCT02058849|155908368|FG001|Overall Study|Death|0|||
48469131|NCT02058849|155908367|FG000|Overall Study|Lost to Follow-up|1|||
48469132|NCT02058849|155908368|FG001|Overall Study|Lost to Follow-up|0|||
48469133|NCT02058849|155908367|FG000|Overall Study|Withdrawal by Subject|4|||
48469134|NCT02058849|155908368|FG001|Overall Study|Withdrawal by Subject|0|||
48469135|NCT00157157|155908370|FG000|Overall Study|Withdrawal by Subject|6|||
48469136|NCT00157157|155908370|FG000|Overall Study|Physician Decision|1|||
48469137|NCT00157157|155908370|FG000|Overall Study|Lost to Follow-up|1|||
48469138|NCT00157157|155908370|FG000|Overall Study|Enrolled in another study|1|||
48469139|NCT00157157|155908370|FG000|Overall Study|Met exclusion criteria|1|||
48469140|NCT00157157|155908370|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
48469141|NCT03640312|155908372|FG000|Overall Study|Lost to Follow-up|3|||
48469142|NCT03640312|155908373|FG001|Overall Study|Lost to Follow-up|6|||
48469143|NCT04738123|155908374|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
48469144|NCT04738123|155908375|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
48469145|NCT04738123|155908374|FG000|Overall Study|Progressive Disease|0|||
48469146|NCT04738123|155908375|FG001|Overall Study|Progressive Disease|4|||
48469147|NCT04738123|155908374|FG000|Overall Study|Adverse Event|8|||
48469148|NCT04738123|155908375|FG001|Overall Study|Adverse Event|7|||
48469149|NCT04738123|155908374|FG000|Overall Study|Other Reasons|0|||
48469150|NCT04738123|155908375|FG001|Overall Study|Other Reasons|1|||
48469151|NCT04738123|155908374|FG000|Overall Study|Suicidal or assaultive behavior|0|||
48469152|NCT04738123|155908375|FG001|Overall Study|Suicidal or assaultive behavior|2|||
48469153|NCT04738123|155908374|FG000|Overall Study|Protocol Violation|2|||
48469154|NCT04738123|155908375|FG001|Overall Study|Protocol Violation|2|||
48469155|NCT04738123|155908374|FG000|Overall Study|Consent Withdrawn|35|||
48469156|NCT04738123|155908375|FG001|Overall Study|Consent Withdrawn|22|||
48469157|NCT02079077|155908386|FG000|Overall Study|Lost to Follow-up|5|||
48469158|NCT02079077|155908387|FG001|Overall Study|Lost to Follow-up|7|||
48469159|NCT02079077|155908386|FG000|Overall Study|Became STIs Positive|1|||
48469160|NCT02079077|155908387|FG001|Overall Study|Became STIs Positive|2|||
48469161|NCT01083121|155908391|FG000|Overall Study|Use of Humira outside the approved label|81|||
48469162|NCT04409262|155908393|FG000|Overall Study|Adverse Event|0|||
48469163|NCT04409262|155908394|FG001|Overall Study|Adverse Event|2|||
48469164|NCT04409262|155908393|FG000|Overall Study|Death|55|||
48469165|NCT04409262|155908394|FG001|Overall Study|Death|97|||
48469166|NCT04409262|155908393|FG000|Overall Study|Lost to Follow-up|12|||
48469167|NCT04409262|155908394|FG001|Overall Study|Lost to Follow-up|23|||
48469168|NCT04409262|155908393|FG000|Overall Study|Lack of Staff|0|||
48469169|NCT04409262|155908394|FG001|Overall Study|Lack of Staff|1|||
48469170|NCT04409262|155908393|FG000|Overall Study|Protocol Violation|3|||
48469171|NCT04409262|155908394|FG001|Overall Study|Protocol Violation|1|||
48469172|NCT04409262|155908393|FG000|Overall Study|Withdrawal by Subject|5|||
48469173|NCT04409262|155908394|FG001|Overall Study|Withdrawal by Subject|10|||
48469174|NCT04794491|155908395|FG000|Overall Study|Adverse Event|1|||
48469175|NCT04794491|155908395|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
48469176|NCT04794491|155908395|FG000|Overall Study|Noncompliance With Study Intervention|1|||
48469177|NCT04794491|155908395|FG000|Overall Study|Withdrawal by Subject|2|||
48469178|NCT04246996|155908396|FG000|Overall Study|Physician Decision|1|||
48469179|NCT04246996|155908397|FG001|Overall Study|Physician Decision|1|||
48469180|NCT04246996|155908396|FG000|Overall Study|Did not meet eligibility criteria|1|||
48469181|NCT04246996|155908397|FG001|Overall Study|Did not meet eligibility criteria|4|||
48469182|NCT00302731|155908398|FG000|Overall Study|Lost to Follow-up|1|||
48469183|NCT00302731|155908399|FG001|Overall Study|Lost to Follow-up|2|||
48469184|NCT00302731|155908400|FG002|Overall Study|Lost to Follow-up|0|||
48469185|NCT00302731|155908401|FG003|Overall Study|Lost to Follow-up|0|||
48469186|NCT00302731|155908398|FG000|Overall Study|Adverse Event|0|||
48469187|NCT00302731|155908399|FG001|Overall Study|Adverse Event|2|||
48469188|NCT00302731|155908400|FG002|Overall Study|Adverse Event|2|||
48469189|NCT00302731|155908401|FG003|Overall Study|Adverse Event|0|||
48469190|NCT00302731|155908398|FG000|Overall Study|Withdrawal by Subject|1|||
48469191|NCT00302731|155908399|FG001|Overall Study|Withdrawal by Subject|1|||
48469192|NCT00302731|155908400|FG002|Overall Study|Withdrawal by Subject|0|||
48469193|NCT00302731|155908401|FG003|Overall Study|Withdrawal by Subject|0|||
48469194|NCT00302731|155908398|FG000|Overall Study|Protocol Violation|1|||
48469195|NCT00302731|155908399|FG001|Overall Study|Protocol Violation|0|||
48469196|NCT00302731|155908400|FG002|Overall Study|Protocol Violation|0|||
48469197|NCT00302731|155908401|FG003|Overall Study|Protocol Violation|0|||
48469198|NCT00302731|155908398|FG000|Overall Study|cancer unrelated to study discovered|1|||
48469199|NCT00302731|155908399|FG001|Overall Study|cancer unrelated to study discovered|0|||
48469200|NCT00302731|155908400|FG002|Overall Study|cancer unrelated to study discovered|1|||
48469201|NCT00302731|155908401|FG003|Overall Study|cancer unrelated to study discovered|0|||
48469202|NCT01000311|155908402|FG000|Overall Study|Adverse Event|2|||
48469203|NCT01000311|155908403|FG001|Overall Study|Adverse Event|5|||
48469204|NCT01000311|155908402|FG000|Overall Study|Withdrawal by Subject|16|||
48469205|NCT01000311|155908403|FG001|Overall Study|Withdrawal by Subject|24|||
48469206|NCT01000311|155908402|FG000|Overall Study|Lost to Follow-up|15|||
48469207|NCT01000311|155908403|FG001|Overall Study|Lost to Follow-up|24|||
48469208|NCT01000311|155908402|FG000|Overall Study|Protocol Violation|1|||
48469209|NCT01000311|155908403|FG001|Overall Study|Protocol Violation|2|||
48469210|NCT01000311|155908402|FG000|Overall Study|Inappropriate enrollment|2|||
48469211|NCT01000311|155908403|FG001|Overall Study|Inappropriate enrollment|0|||
48469212|NCT01000311|155908402|FG000|Overall Study|Administrative reason|9|||
48469213|NCT01000311|155908403|FG001|Overall Study|Administrative reason|15|||
48469214|NCT01054443|155908404|FG000|Overall Study|Withdrawal by Subject|0|||
48469215|NCT01054443|155908405|FG001|Overall Study|Withdrawal by Subject|0|||
48469216|NCT01054443|155908406|FG002|Overall Study|Withdrawal by Subject|0|||
48469217|NCT01054443|155908407|FG003|Overall Study|Withdrawal by Subject|1|||
48469218|NCT01411917|155908408|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
48469219|NCT01411917|155908409|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
48469220|NCT02815670|155908410|FG000|Overall Study|Prematurely discontinued of the trial|1|||
48469221|NCT00945815|155908413|FG000|Overall Study|Death|3|||
48469222|NCT00945815|155908413|FG000|Overall Study|Not protocol specified|1|||
48469223|NCT00945815|155908413|FG000|Overall Study|Ineligible|3|||
48469224|NCT00945815|155908413|FG000|Overall Study|Did not begin protocol therapy|1|||
48469225|NCT04823494|155910314|FG000|Overall Study|Programming software malfunction.|1|||
48469226|NCT04823494|155910315|FG001|Overall Study|Programming software malfunction.|0|||
48469227|NCT04823494|155910314|FG000|Overall Study|Withdrawal by Subject|1|||
48469228|NCT04823494|155910315|FG001|Overall Study|Withdrawal by Subject|0|||
48469229|NCT04823494|155910314|FG000|Overall Study|Devices lost|0|||
48469230|NCT04823494|155910315|FG001|Overall Study|Devices lost|1|||
48469231|NCT02028182|155910323|FG000|Overall Study|Protocol Violation|2|||
48469232|NCT01684930|155910326|FG000|Overall Study|Withdrawal by Subject|3|||
48469233|NCT01684930|155910327|FG001|Overall Study|Withdrawal by Subject|1|||
48469234|NCT04524663|155910328|FG000|Overall Study|Withdrawal by Subject|0|||
48469235|NCT04524663|155910329|FG001|Overall Study|Withdrawal by Subject|2|||
48469236|NCT00337935|155910330|FG000|Overall Study|Adverse Event|2|||
48469237|NCT00337935|155910331|FG001|Overall Study|Adverse Event|5|||
48469238|NCT00337935|155910330|FG000|Overall Study|Death|2|||
48469239|NCT00337935|155910331|FG001|Overall Study|Death|8|||
48469240|NCT00337935|155910330|FG000|Overall Study|Physician Decision|1|||
48469241|NCT00337935|155910331|FG001|Overall Study|Physician Decision|1|||
48469242|NCT00337935|155910330|FG000|Overall Study|Lost to Follow-up|0|||
48469243|NCT00337935|155910331|FG001|Overall Study|Lost to Follow-up|1|||
48469244|NCT00337935|155910330|FG000|Overall Study|Protocol Violation|4|||
48469245|NCT00337935|155910331|FG001|Overall Study|Protocol Violation|3|||
48469246|NCT00337935|155910330|FG000|Overall Study|Withdrawal by Subject|1|||
48469247|NCT00337935|155910331|FG001|Overall Study|Withdrawal by Subject|7|||
48469248|NCT00337935|155910330|FG000|Overall Study|Other|0|||
48469249|NCT00337935|155910331|FG001|Overall Study|Other|1|||
48469250|NCT00337935|155910330|FG000|Overall Study|Lack of Efficacy|0|||
48469251|NCT00337935|155910331|FG001|Overall Study|Lack of Efficacy|1|||
48469252|NCT01884675|155910332|FG000|Overall Study|Study closed/terminated|3|||
48469253|NCT01884675|155910333|FG001|Overall Study|Study closed/terminated|2|||
48469254|NCT02361307|155910334|FG000|Overall Study|Unstable medical condition.|0|||
48469255|NCT02361307|155910335|FG001|Overall Study|Unstable medical condition.|1|||
48469256|NCT03359811|155910336|FG000|Overall Study|Protocol Violation|2|||
48469257|NCT03359811|155910337|FG001|Overall Study|Protocol Violation|0|||
48469258|NCT04335929|155910338|FG000|Overall Study|Lost to Follow-up|10|||
48469259|NCT01189201|155910343|FG000|Overall Study|Adverse Event|1|||
48469260|NCT01682876|155910350|FG000|Overall Study|Administrative reason|4|||
48469261|NCT01682876|155910351|FG001|Overall Study|Administrative reason|4|||
48469262|NCT01682876|155910352|FG002|Overall Study|Administrative reason|0|||
48469263|NCT01682876|155910353|FG003|Overall Study|Administrative reason|3|||
48469264|NCT01682876|155910350|FG000|Overall Study|Adverse Event|0|||
48469265|NCT01682876|155910351|FG001|Overall Study|Adverse Event|0|||
48469266|NCT01682876|155910352|FG002|Overall Study|Adverse Event|0|||
48469267|NCT01682876|155910353|FG003|Overall Study|Adverse Event|1|||
48469268|NCT01682876|155910350|FG000|Overall Study|Lost to Follow-up|11|||
48469269|NCT01682876|155910351|FG001|Overall Study|Lost to Follow-up|15|||
48469270|NCT01682876|155910352|FG002|Overall Study|Lost to Follow-up|9|||
48469271|NCT01682876|155910353|FG003|Overall Study|Lost to Follow-up|11|||
48469272|NCT01682876|155910350|FG000|Overall Study|Protocol Violation|1|||
48469273|NCT01682876|155910351|FG001|Overall Study|Protocol Violation|1|||
48469274|NCT01682876|155910352|FG002|Overall Study|Protocol Violation|1|||
48469275|NCT01682876|155910353|FG003|Overall Study|Protocol Violation|1|||
48469276|NCT01682876|155910350|FG000|Overall Study|Withdrawal by Subject|4|||
48469277|NCT01682876|155910351|FG001|Overall Study|Withdrawal by Subject|0|||
48469278|NCT01682876|155910352|FG002|Overall Study|Withdrawal by Subject|0|||
48469279|NCT01682876|155910353|FG003|Overall Study|Withdrawal by Subject|2|||
48469280|NCT01682876|155910350|FG000|Overall Study|Other|1|||
48469281|NCT01682876|155910351|FG001|Overall Study|Other|0|||
48469282|NCT01682876|155910352|FG002|Overall Study|Other|1|||
48469283|NCT01682876|155910353|FG003|Overall Study|Other|1|||
48469284|NCT01277757|155910354|FG000|Overall Study|Disease Progression|1|||
48469285|NCT01277757|155910354|FG000|Overall Study|Withdrawal by Subject|1|||
48469286|NCT01459016|155910358|FG000|Overall Study|Withdrawal by Subject|11|||
48469287|NCT01459016|155910358|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
48469288|NCT04623008|155910359|FG000|Baseline to T2|Withdrawal by Subject|4|||
48469289|NCT04623008|155910360|FG001|Baseline to T2|Withdrawal by Subject|2|||
48469290|NCT04623008|155910359|FG000|Baseline to T3|Withdrawal by Subject|4|||
48469291|NCT04623008|155910360|FG001|Baseline to T3|Withdrawal by Subject|2|||
48469292|NCT03922945|155910374|FG000|Overall Study|Adverse Event|1|||
48469293|NCT03922945|155910375|FG001|Overall Study|Adverse Event|1|||
48469294|NCT03922945|155910376|FG002|Overall Study|Adverse Event|2|||
48469295|NCT03922945|155910374|FG000|Overall Study|Lost to Follow-up|13|||
48469296|NCT03922945|155910375|FG001|Overall Study|Lost to Follow-up|9|||
48469297|NCT03922945|155910376|FG002|Overall Study|Lost to Follow-up|20|||
48469298|NCT03922945|155910374|FG000|Overall Study|Lack of Efficacy|2|||
48469299|NCT03922945|155910375|FG001|Overall Study|Lack of Efficacy|0|||
48469300|NCT03922945|155910376|FG002|Overall Study|Lack of Efficacy|1|||
48469301|NCT03922945|155910374|FG000|Overall Study|Protocol Non-Compliance|0|||
48469302|NCT03922945|155910375|FG001|Overall Study|Protocol Non-Compliance|0|||
48469303|NCT03922945|155910376|FG002|Overall Study|Protocol Non-Compliance|1|||
48469304|NCT03922945|155910374|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
48469305|NCT03922945|155910375|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
48469306|NCT03922945|155910376|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
48469307|NCT03922945|155910374|FG000|Overall Study|All Other Personal Reasons|1|||
48469308|NCT03922945|155910375|FG001|Overall Study|All Other Personal Reasons|1|||
48469309|NCT03922945|155910376|FG002|Overall Study|All Other Personal Reasons|2|||
48469310|NCT00911508|155910377|FG000|Overall Study|Lost to Follow-up|27|||
48469311|NCT00911508|155910378|FG001|Overall Study|Lost to Follow-up|18|||
48469312|NCT00911508|155910377|FG000|Overall Study|Withdrawal by Subject|79|||
48469313|NCT00911508|155910378|FG001|Overall Study|Withdrawal by Subject|112|||
48469314|NCT02551874|155910383|FG000|Overall Study|Lost to Follow-up|0|||
48469315|NCT02551874|155910384|FG001|Overall Study|Lost to Follow-up|2|||
48469316|NCT02551874|155910383|FG000|Overall Study|Pregnancy|0|||
48469317|NCT02551874|155910384|FG001|Overall Study|Pregnancy|1|||
48469318|NCT02551874|155910383|FG000|Overall Study|Reason not reported|10|||
48469319|NCT02551874|155910384|FG001|Overall Study|Reason not reported|4|||
48469320|NCT02551874|155910383|FG000|Overall Study|Did not receive randomized treatment|0|||
48469321|NCT02551874|155910384|FG001|Overall Study|Did not receive randomized treatment|7|||
48469322|NCT02551874|155910383|FG000|Overall Study|Did not enter long-term study|18|||
48469323|NCT02551874|155910384|FG001|Overall Study|Did not enter long-term study|25|||
48469324|NCT00313716|155910385|FG000|Overall Study|Death|3|||
48469325|NCT00313716|155910386|FG001|Overall Study|Death|2|||
48469326|NCT00313716|155910387|FG002|Overall Study|Death|9|||
48469327|NCT00313716|155910388|FG003|Overall Study|Death|3|||
48469328|NCT00313716|155910389|FG004|Overall Study|Death|5|||
48469329|NCT00313716|155910390|FG005|Overall Study|Death|9|||
48469330|NCT00313716|155910385|FG000|Overall Study|Lost to Follow-up|2|||
48469331|NCT00313716|155910386|FG001|Overall Study|Lost to Follow-up|5|||
48469332|NCT00313716|155910387|FG002|Overall Study|Lost to Follow-up|2|||
48469333|NCT00313716|155910388|FG003|Overall Study|Lost to Follow-up|1|||
48469334|NCT00313716|155910389|FG004|Overall Study|Lost to Follow-up|0|||
48469335|NCT00313716|155910390|FG005|Overall Study|Lost to Follow-up|4|||
48469336|NCT00313716|155910385|FG000|Overall Study|Withdrawal by Subject|0|||
48469337|NCT00313716|155910386|FG001|Overall Study|Withdrawal by Subject|1|||
48469338|NCT00313716|155910387|FG002|Overall Study|Withdrawal by Subject|1|||
48469339|NCT00313716|155910388|FG003|Overall Study|Withdrawal by Subject|0|||
48469340|NCT00313716|155910389|FG004|Overall Study|Withdrawal by Subject|1|||
48469341|NCT00313716|155910390|FG005|Overall Study|Withdrawal by Subject|0|||
48469342|NCT02491463|155910391|FG000|Overall Study|Withdrawal by Subject|1|||
48469343|NCT02491463|155910392|FG001|Overall Study|Withdrawal by Subject|2|||
48469344|NCT02491463|155910393|FG002|Overall Study|Withdrawal by Subject|0|||
48469345|NCT02491463|155910394|FG003|Overall Study|Withdrawal by Subject|0|||
48469346|NCT02491463|155910391|FG000|Overall Study|Migrated/moved from study area|1|||
48469347|NCT02491463|155910392|FG001|Overall Study|Migrated/moved from study area|5|||
48469348|NCT02491463|155910393|FG002|Overall Study|Migrated/moved from study area|1|||
48469349|NCT02491463|155910394|FG003|Overall Study|Migrated/moved from study area|1|||
48469350|NCT02491463|155910391|FG000|Overall Study|Lost to Follow-up|0|||
48469351|NCT02491463|155910392|FG001|Overall Study|Lost to Follow-up|3|||
48469352|NCT02491463|155910393|FG002|Overall Study|Lost to Follow-up|3|||
48469353|NCT02491463|155910394|FG003|Overall Study|Lost to Follow-up|0|||
48469354|NCT01491802|155910395|FG000|Overall Study|Adverse Event|1|||
48469355|NCT01491802|155910396|FG001|Overall Study|Adverse Event|1|||
48469356|NCT01491802|155910395|FG000|Overall Study|Withdrawal by Subject|0|||
48469357|NCT01491802|155910396|FG001|Overall Study|Withdrawal by Subject|1|||
48469358|NCT01864746|155910399|FG000|Overall Study|Disease recurrence|25|||
48469359|NCT01864746|155910400|FG001|Overall Study|Disease recurrence|40|||
48469360|NCT01864746|155910399|FG000|Overall Study|Second primary invasive nonbreast|2|||
48469361|NCT01864746|155910400|FG001|Overall Study|Second primary invasive nonbreast|3|||
48469362|NCT01864746|155910399|FG000|Overall Study|Death|2|||
48469363|NCT01864746|155910400|FG001|Overall Study|Death|1|||
48469364|NCT01864746|155910399|FG000|Overall Study|Adverse Event|33|||
48469365|NCT01864746|155910400|FG001|Overall Study|Adverse Event|5|||
48469366|NCT01864746|155910399|FG000|Overall Study|Withdrawal by Subject|56|||
48469367|NCT01864746|155910400|FG001|Overall Study|Withdrawal by Subject|41|||
48469368|NCT01864746|155910399|FG000|Overall Study|Physician Decision|5|||
48469369|NCT01864746|155910400|FG001|Overall Study|Physician Decision|6|||
48469370|NCT01005966|155910401|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
48469371|NCT01005966|155910402|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
48469372|NCT01005966|155910403|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
48469373|NCT01005966|155910404|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
48469374|NCT01005966|155910405|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
48469375|NCT01005966|155910401|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
48469376|NCT01005966|155910402|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
48469377|NCT01005966|155910403|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
48469378|NCT01005966|155910404|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
48469379|NCT01005966|155910405|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
48469380|NCT01005966|155910401|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
48469381|NCT01005966|155910402|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
48469382|NCT01005966|155910403|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
48469383|NCT01005966|155910404|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
48469384|NCT01005966|155910405|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
48469385|NCT01005966|155910401|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
48469386|NCT01005966|155910402|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
48469387|NCT01005966|155910403|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
48469388|NCT01005966|155910404|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
48469389|NCT01005966|155910405|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
48469390|NCT01005966|155910401|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48469391|NCT01005966|155910402|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48469392|NCT01005966|155910403|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48469393|NCT01005966|155910404|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
48469394|NCT01005966|155910405|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
48469395|NCT01005966|155910401|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48469396|NCT01005966|155910402|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48469397|NCT01005966|155910403|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
48469398|NCT01005966|155910404|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48469399|NCT01005966|155910405|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
48469400|NCT01005966|155910401|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
48469401|NCT01005966|155910402|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
48469402|NCT01005966|155910403|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
48469403|NCT01005966|155910404|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
48469404|NCT01005966|155910405|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
48469405|NCT01005966|155910401|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
48469406|NCT01005966|155910402|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
48469407|NCT01005966|155910403|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
48469408|NCT01005966|155910404|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
48469409|NCT01005966|155910405|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
48469410|NCT01005966|155910401|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
48469411|NCT01005966|155910402|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
48469412|NCT01005966|155910403|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
48469413|NCT01005966|155910404|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
48469414|NCT01005966|155910405|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
48469415|NCT01451203|155910407|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
48469416|NCT01451203|155910408|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
48469417|NCT01451203|155910407|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
48469418|NCT01451203|155910408|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
48469419|NCT01451203|155910407|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
48469420|NCT01451203|155910408|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
48469421|NCT01451203|155910407|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
48469422|NCT01451203|155910408|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
48469423|NCT01451203|155910407|FG000|Double-blind Treatment Period|Adverse Event|6|||
48469424|NCT01451203|155910408|FG001|Double-blind Treatment Period|Adverse Event|9|||
48469425|NCT01451203|155910407|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
48469426|NCT01451203|155910408|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
48469427|NCT01451203|155910407|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
48469428|NCT01451203|155910408|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
48469429|NCT01451203|155910407|FG000|Double-blind Treatment Period|Investigator decision|2|||
48469430|NCT01451203|155910408|FG001|Double-blind Treatment Period|Investigator decision|0|||
48469431|NCT01451203|155910407|FG000|Post-treatment Period|Consent withdrawn|2|||
48469432|NCT01451203|155910408|FG001|Post-treatment Period|Consent withdrawn|4|||
48469433|NCT01451203|155910407|FG000|Post-treatment Period|Lack of Efficacy|12|||
48469434|NCT01451203|155910408|FG001|Post-treatment Period|Lack of Efficacy|28|||
48469435|NCT01451203|155910407|FG000|Post-treatment Period|Adverse Event|0|||
48469436|NCT01451203|155910408|FG001|Post-treatment Period|Adverse Event|1|||
48469437|NCT01451203|155910407|FG000|Post-treatment Period|Investigator decision|0|||
48469438|NCT01451203|155910408|FG001|Post-treatment Period|Investigator decision|1|||
48469439|NCT00039377|155910409|FG000|Initial Registration|Adverse Event|2|||
48469440|NCT00039377|155910410|FG001|Initial Registration|Adverse Event|0|||
48469441|NCT00039377|155910411|FG002|Initial Registration|Adverse Event|0|||
48469442|NCT00039377|155910412|FG003|Initial Registration|Adverse Event|0|||
48469443|NCT00039377|155910409|FG000|Initial Registration|Relapsed|6|||
48469444|NCT00039377|155910410|FG001|Initial Registration|Relapsed|0|||
48469445|NCT00039377|155910411|FG002|Initial Registration|Relapsed|0|||
48469446|NCT00039377|155910412|FG003|Initial Registration|Relapsed|0|||
48469447|NCT00039377|155910409|FG000|Initial Registration|Received non-protocol therapy|11|||
48469448|NCT00039377|155910410|FG001|Initial Registration|Received non-protocol therapy|0|||
48469449|NCT00039377|155910411|FG002|Initial Registration|Received non-protocol therapy|0|||
48469450|NCT00039377|155910412|FG003|Initial Registration|Received non-protocol therapy|0|||
48469451|NCT00039377|155910409|FG000|Initial Registration|Withdrawal by Subject|3|||
48469452|NCT00039377|155910410|FG001|Initial Registration|Withdrawal by Subject|0|||
48469453|NCT00039377|155910411|FG002|Initial Registration|Withdrawal by Subject|0|||
48469454|NCT00039377|155910412|FG003|Initial Registration|Withdrawal by Subject|0|||
48469455|NCT02927990|155910413|FG000|Overall Study|Protocol Violation|4|||
48469456|NCT02927990|155910413|FG000|Overall Study|Physician Decision|9|||
48469457|NCT02927990|155910413|FG000|Overall Study|Room switched and therefore no study device available|15|||
48469458|NCT02927990|155910413|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
48469459|NCT03382639|155910418|FG000|Overall Study|Adverse Event|2|||
48469460|NCT03382639|155910419|FG001|Overall Study|Adverse Event|0|||
48469461|NCT03382639|155910420|FG002|Overall Study|Adverse Event|1|||
48469462|NCT03382639|155910421|FG003|Overall Study|Adverse Event|1|||
48469463|NCT03382639|155910418|FG000|Overall Study|Lost to Follow-up|1|||
48469464|NCT03382639|155910419|FG001|Overall Study|Lost to Follow-up|0|||
48469465|NCT03382639|155910420|FG002|Overall Study|Lost to Follow-up|0|||
48469466|NCT03382639|155910421|FG003|Overall Study|Lost to Follow-up|0|||
48469467|NCT03382639|155910418|FG000|Overall Study|Withdrawal by Subject|4|||
48469468|NCT03382639|155910419|FG001|Overall Study|Withdrawal by Subject|3|||
48469469|NCT03382639|155910420|FG002|Overall Study|Withdrawal by Subject|2|||
48469470|NCT03382639|155910421|FG003|Overall Study|Withdrawal by Subject|3|||
48469471|NCT03382639|155910418|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
48469472|NCT03382639|155910419|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
48469473|NCT03382639|155910420|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
48469474|NCT03382639|155910421|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
48469475|NCT03382639|155910418|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
48469476|NCT03382639|155910419|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
48469477|NCT03382639|155910420|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
48469478|NCT03382639|155910421|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
48469479|NCT03382639|155910418|FG000|Overall Study|Other|2|||
48469480|NCT03382639|155910419|FG001|Overall Study|Other|0|||
48469481|NCT03382639|155910420|FG002|Overall Study|Other|0|||
48469482|NCT03382639|155910421|FG003|Overall Study|Other|3|||
48469483|NCT02839330|155910422|FG000|Overall Study|Adverse Event|0|||
48469484|NCT02839330|155910423|FG001|Overall Study|Adverse Event|1|||
48469485|NCT02839330|155910424|FG002|Overall Study|Adverse Event|2|||
48469486|NCT02839330|155910425|FG003|Overall Study|Adverse Event|2|||
48469487|NCT02839330|155910422|FG000|Overall Study|Death|4|||
48469488|NCT02839330|155910423|FG001|Overall Study|Death|6|||
48469489|NCT02839330|155910424|FG002|Overall Study|Death|1|||
48469490|NCT02839330|155910425|FG003|Overall Study|Death|1|||
48469491|NCT02839330|155910422|FG000|Overall Study|Withdrawal by Subject|27|||
48469492|NCT02839330|155910423|FG001|Overall Study|Withdrawal by Subject|19|||
48469493|NCT02839330|155910424|FG002|Overall Study|Withdrawal by Subject|11|||
48469494|NCT02839330|155910425|FG003|Overall Study|Withdrawal by Subject|13|||
48469495|NCT02839330|155910422|FG000|Overall Study|Lost to Follow-up|22|||
48469496|NCT02839330|155910423|FG001|Overall Study|Lost to Follow-up|27|||
48469497|NCT02839330|155910424|FG002|Overall Study|Lost to Follow-up|29|||
48469498|NCT02839330|155910425|FG003|Overall Study|Lost to Follow-up|25|||
48469499|NCT02839330|155910422|FG000|Overall Study|Administrative Reason|0|||
48469500|NCT02839330|155910423|FG001|Overall Study|Administrative Reason|0|||
48469501|NCT02839330|155910424|FG002|Overall Study|Administrative Reason|0|||
48469502|NCT02839330|155910425|FG003|Overall Study|Administrative Reason|1|||
48469503|NCT02839330|155910422|FG000|Overall Study|Protocol Violation|1|||
48469504|NCT02839330|155910423|FG001|Overall Study|Protocol Violation|2|||
48469505|NCT02839330|155910424|FG002|Overall Study|Protocol Violation|2|||
48469506|NCT02839330|155910425|FG003|Overall Study|Protocol Violation|3|||
48469507|NCT02839330|155910422|FG000|Overall Study|Other reason, not specified|4|||
48469508|NCT02839330|155910423|FG001|Overall Study|Other reason, not specified|3|||
48469509|NCT02839330|155910424|FG002|Overall Study|Other reason, not specified|3|||
48469510|NCT02839330|155910425|FG003|Overall Study|Other reason, not specified|6|||
48469511|NCT01161173|155910426|FG000|Overall Study|Protocol Violation|13|||
48469512|NCT01161173|155910426|FG000|Overall Study|Lost to Follow-up|7|||
48469513|NCT01161173|155910426|FG000|Overall Study|Progressive Disease|82|||
48469514|NCT01161173|155910426|FG000|Overall Study|Withdrawal of Consent|5|||
48469515|NCT01161173|155910426|FG000|Overall Study|Unacceptable Toxicity|21|||
48469516|NCT01161173|155910426|FG000|Overall Study|Death|194|||
48469517|NCT01161173|155910426|FG000|Overall Study|End of Study|2|||
48469518|NCT01161173|155910426|FG000|Overall Study|Reasons Not Specified|23|||
48469519|NCT00383292|155910429|FG000|Overall Study|Adverse Event|4|||
48469520|NCT00383292|155910430|FG001|Overall Study|Adverse Event|1|||
48469521|NCT00383292|155910431|FG002|Overall Study|Adverse Event|2|||
48469522|NCT00383292|155910429|FG000|Overall Study|Death|3|||
48469523|NCT00383292|155910430|FG001|Overall Study|Death|3|||
48469524|NCT00383292|155910431|FG002|Overall Study|Death|3|||
48469525|NCT00383292|155910429|FG000|Overall Study|Physician Decision|4|||
48469526|NCT00383292|155910430|FG001|Overall Study|Physician Decision|0|||
48469527|NCT00383292|155910431|FG002|Overall Study|Physician Decision|1|||
48469528|NCT00383292|155910429|FG000|Overall Study|Withdrawal by Subject|3|||
48469529|NCT00383292|155910430|FG001|Overall Study|Withdrawal by Subject|2|||
48469530|NCT00383292|155910431|FG002|Overall Study|Withdrawal by Subject|2|||
48469531|NCT00383292|155910429|FG000|Overall Study|Other|1|||
48469532|NCT00383292|155910430|FG001|Overall Study|Other|0|||
48469533|NCT00383292|155910431|FG002|Overall Study|Other|0|||
48469534|NCT04533204|155910432|FG000|Overall Study|Unable to understand training instructions|1|||
48469535|NCT04533204|155910433|FG001|Overall Study|Unable to understand training instructions|1|||
48469536|NCT01911546|155910434|FG000|Overall Study|Lost to Follow-up|1|||
48469537|NCT01911546|155910434|FG000|Overall Study|Everolimus was discontinued|5|||
48469538|NCT03007472|155910436|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
48469539|NCT03007472|155910436|FG000|Overall Study|Death|2|||
48469540|NCT03007472|155910436|FG000|Overall Study|Loss to Follow Up|1|||
48469541|NCT02210559|155910445|FG000|Overall Study|Progressive Disease|3|||
48469542|NCT02210559|155910446|FG001|Overall Study|Progressive Disease|2|||
48469543|NCT02210559|155910445|FG000|Overall Study|Adverse Event|2|||
48469544|NCT02210559|155910446|FG001|Overall Study|Adverse Event|2|||
48469545|NCT02210559|155910445|FG000|Overall Study|Physician Decision|1|||
48469546|NCT02210559|155910446|FG001|Overall Study|Physician Decision|0|||
48469547|NCT02210559|155910445|FG000|Overall Study|Withdrawal by Subject|0|||
48469548|NCT02210559|155910446|FG001|Overall Study|Withdrawal by Subject|1|||
48469549|NCT02210559|155910445|FG000|Overall Study|Other than specified|0|||
48469550|NCT02210559|155910446|FG001|Overall Study|Other than specified|1|||
48469551|NCT01151085|155910450|FG000|Overall Study|Lost to Follow-up|31|||
48469552|NCT01151085|155910450|FG000|Overall Study|Protocol Violation|25|||
48469553|NCT00525499|155910455|FG000|Overall Study|Lost to Follow-up|2|||
48469554|NCT00525499|155910456|FG001|Overall Study|Lost to Follow-up|4|||
48469555|NCT00525499|155910457|FG002|Overall Study|Lost to Follow-up|1|||
48469556|NCT00525499|155910458|FG003|Overall Study|Lost to Follow-up|4|||
48469557|NCT00525499|155910455|FG000|Overall Study|Adverse Event|0|||
48469558|NCT00525499|155910456|FG001|Overall Study|Adverse Event|1|||
48469559|NCT00525499|155910457|FG002|Overall Study|Adverse Event|0|||
48469560|NCT00525499|155910458|FG003|Overall Study|Adverse Event|1|||
48469561|NCT00525499|155910455|FG000|Overall Study|Withdrawal by Subject|5|||
48469562|NCT00525499|155910456|FG001|Overall Study|Withdrawal by Subject|1|||
48469563|NCT00525499|155910457|FG002|Overall Study|Withdrawal by Subject|5|||
48469564|NCT00525499|155910458|FG003|Overall Study|Withdrawal by Subject|2|||
48469565|NCT00525499|155910455|FG000|Overall Study|Protocol Violation|0|||
48469566|NCT00525499|155910456|FG001|Overall Study|Protocol Violation|1|||
48469567|NCT00525499|155910457|FG002|Overall Study|Protocol Violation|1|||
48469568|NCT00525499|155910458|FG003|Overall Study|Protocol Violation|0|||
48469569|NCT03219372|155910470|FG000|Overall Study|Withdrawal by Subject|1|||
48469570|NCT03219372|155910471|FG001|Overall Study|Withdrawal by Subject|0|||
48469571|NCT00267202|155910476|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
48469572|NCT00267202|155910477|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
48469573|NCT00267202|155910476|FG000|Overall Study|Withdrawal by Subject|12|||
48469574|NCT00267202|155910477|FG001|Overall Study|Withdrawal by Subject|15|||
48469575|NCT00267202|155910476|FG000|Overall Study|Adverse Event|13|||
48469576|NCT00267202|155910477|FG001|Overall Study|Adverse Event|7|||
48469577|NCT00267202|155910476|FG000|Overall Study|Protocol Violation|2|||
48469578|NCT00267202|155910477|FG001|Overall Study|Protocol Violation|3|||
48469579|NCT00267202|155910476|FG000|Overall Study|Administrative problems|2|||
48469580|NCT00267202|155910477|FG001|Overall Study|Administrative problems|1|||
48469581|NCT00267202|155910476|FG000|Overall Study|Lost to Follow-up|3|||
48469582|NCT00267202|155910477|FG001|Overall Study|Lost to Follow-up|0|||
48469583|NCT01049360|155910480|FG000|Period 1|Adverse Event|0|||
48469584|NCT01049360|155910481|FG001|Period 1|Adverse Event|1|||
48469585|NCT01049360|155910482|FG002|Period 1|Adverse Event|0|||
48469586|NCT01049360|155910483|FG003|Period 1|Adverse Event|1|||
48469587|NCT01049360|155910484|FG004|Period 1|Adverse Event|0|||
48469588|NCT01049360|155910485|FG005|Period 1|Adverse Event|0|||
48469589|NCT01049360|155910486|FG006|Period 1|Adverse Event|0|||
48469590|NCT01049360|155910487|FG007|Period 1|Adverse Event|1|||
48469591|NCT01049360|155910488|FG008|Period 1|Adverse Event|0|||
48469592|NCT01049360|155910489|FG009|Period 1|Adverse Event|0|||
48469593|NCT01049360|155910490|FG010|Period 1|Adverse Event|0|||
48469594|NCT01049360|155910491|FG011|Period 1|Adverse Event|0|||
48469595|NCT01049360|155910492|FG012|Period 1|Adverse Event|1|||
48469596|NCT01049360|155910493|FG013|Period 1|Adverse Event|1|||
48469597|NCT01049360|155910494|FG014|Period 1|Adverse Event|0|||
48469598|NCT01049360|155910495|FG015|Period 1|Adverse Event|0|||
48469599|NCT01049360|155910496|FG016|Period 1|Adverse Event|1|||
48469600|NCT01049360|155910497|FG017|Period 1|Adverse Event|0|||
48469601|NCT01049360|155910498|FG018|Period 1|Adverse Event|1|||
48469602|NCT01049360|155910499|FG019|Period 1|Adverse Event|0|||
48469603|NCT01049360|155910480|FG000|Period 1|Did not meet inc/exc criteria|0|||
48469604|NCT01049360|155910481|FG001|Period 1|Did not meet inc/exc criteria|0|||
48469605|NCT01049360|155910482|FG002|Period 1|Did not meet inc/exc criteria|0|||
48469606|NCT01049360|155910483|FG003|Period 1|Did not meet inc/exc criteria|0|||
48469607|NCT01049360|155910484|FG004|Period 1|Did not meet inc/exc criteria|0|||
48469608|NCT01049360|155910485|FG005|Period 1|Did not meet inc/exc criteria|0|||
48469609|NCT01049360|155910486|FG006|Period 1|Did not meet inc/exc criteria|0|||
48469610|NCT01049360|155910487|FG007|Period 1|Did not meet inc/exc criteria|1|||
48469611|NCT01049360|155910488|FG008|Period 1|Did not meet inc/exc criteria|1|||
48469612|NCT01049360|155910489|FG009|Period 1|Did not meet inc/exc criteria|0|||
48469613|NCT01049360|155910490|FG010|Period 1|Did not meet inc/exc criteria|0|||
48469614|NCT01049360|155910491|FG011|Period 1|Did not meet inc/exc criteria|0|||
48469615|NCT01049360|155910492|FG012|Period 1|Did not meet inc/exc criteria|0|||
48469616|NCT01049360|155910493|FG013|Period 1|Did not meet inc/exc criteria|0|||
48469617|NCT01049360|155910494|FG014|Period 1|Did not meet inc/exc criteria|0|||
48469618|NCT01049360|155910495|FG015|Period 1|Did not meet inc/exc criteria|0|||
48469619|NCT01049360|155910496|FG016|Period 1|Did not meet inc/exc criteria|0|||
48469620|NCT01049360|155910497|FG017|Period 1|Did not meet inc/exc criteria|0|||
48469621|NCT01049360|155910498|FG018|Period 1|Did not meet inc/exc criteria|0|||
48469622|NCT01049360|155910499|FG019|Period 1|Did not meet inc/exc criteria|0|||
48469623|NCT01049360|155910480|FG000|Period 1|Withdrawal by Subject|0|||
48469624|NCT01049360|155910481|FG001|Period 1|Withdrawal by Subject|0|||
48469625|NCT01049360|155910482|FG002|Period 1|Withdrawal by Subject|0|||
48469626|NCT01049360|155910483|FG003|Period 1|Withdrawal by Subject|0|||
48469627|NCT01049360|155910484|FG004|Period 1|Withdrawal by Subject|0|||
48469628|NCT01049360|155910485|FG005|Period 1|Withdrawal by Subject|0|||
48469629|NCT01049360|155910486|FG006|Period 1|Withdrawal by Subject|0|||
48469630|NCT01049360|155910487|FG007|Period 1|Withdrawal by Subject|0|||
48469631|NCT01049360|155910488|FG008|Period 1|Withdrawal by Subject|1|||
48469632|NCT01049360|155910489|FG009|Period 1|Withdrawal by Subject|0|||
48469633|NCT01049360|155910490|FG010|Period 1|Withdrawal by Subject|1|||
48469634|NCT01049360|155910491|FG011|Period 1|Withdrawal by Subject|0|||
48469635|NCT01049360|155910492|FG012|Period 1|Withdrawal by Subject|1|||
48469636|NCT01049360|155910493|FG013|Period 1|Withdrawal by Subject|0|||
48469637|NCT01049360|155910494|FG014|Period 1|Withdrawal by Subject|0|||
48469638|NCT01049360|155910495|FG015|Period 1|Withdrawal by Subject|0|||
48469639|NCT01049360|155910496|FG016|Period 1|Withdrawal by Subject|0|||
48469640|NCT01049360|155910497|FG017|Period 1|Withdrawal by Subject|0|||
48469641|NCT01049360|155910498|FG018|Period 1|Withdrawal by Subject|0|||
48469642|NCT01049360|155910499|FG019|Period 1|Withdrawal by Subject|0|||
48469643|NCT01049360|155910480|FG000|Period 2|Protocol Violation|0|||
48469644|NCT01049360|155910481|FG001|Period 2|Protocol Violation|0|||
48469645|NCT01049360|155910482|FG002|Period 2|Protocol Violation|0|||
48469646|NCT01049360|155910483|FG003|Period 2|Protocol Violation|1|||
48469647|NCT01049360|155910484|FG004|Period 2|Protocol Violation|0|||
48469648|NCT01049360|155910485|FG005|Period 2|Protocol Violation|0|||
48469649|NCT01049360|155910486|FG006|Period 2|Protocol Violation|0|||
48469650|NCT01049360|155910487|FG007|Period 2|Protocol Violation|0|||
48469651|NCT01049360|155910488|FG008|Period 2|Protocol Violation|0|||
48469652|NCT01049360|155910489|FG009|Period 2|Protocol Violation|0|||
48469653|NCT01049360|155910490|FG010|Period 2|Protocol Violation|0|||
48469654|NCT01049360|155910491|FG011|Period 2|Protocol Violation|0|||
48469655|NCT01049360|155910492|FG012|Period 2|Protocol Violation|0|||
48469656|NCT01049360|155910493|FG013|Period 2|Protocol Violation|0|||
48469657|NCT01049360|155910494|FG014|Period 2|Protocol Violation|1|||
48469658|NCT01049360|155910495|FG015|Period 2|Protocol Violation|1|||
48469659|NCT01049360|155910496|FG016|Period 2|Protocol Violation|0|||
48469660|NCT01049360|155910497|FG017|Period 2|Protocol Violation|0|||
48469661|NCT01049360|155910498|FG018|Period 2|Protocol Violation|0|||
48469662|NCT01049360|155910499|FG019|Period 2|Protocol Violation|0|||
48469663|NCT01049360|155910480|FG000|Period 2|Adverse Event|0|||
48469664|NCT01049360|155910481|FG001|Period 2|Adverse Event|1|||
48469665|NCT01049360|155910482|FG002|Period 2|Adverse Event|0|||
48469666|NCT01049360|155910483|FG003|Period 2|Adverse Event|0|||
48469667|NCT01049360|155910484|FG004|Period 2|Adverse Event|0|||
48469668|NCT01049360|155910485|FG005|Period 2|Adverse Event|0|||
48469669|NCT01049360|155910486|FG006|Period 2|Adverse Event|0|||
48469670|NCT01049360|155910487|FG007|Period 2|Adverse Event|0|||
48469671|NCT01049360|155910488|FG008|Period 2|Adverse Event|1|||
48469672|NCT01049360|155910489|FG009|Period 2|Adverse Event|0|||
48469673|NCT01049360|155910490|FG010|Period 2|Adverse Event|0|||
48469674|NCT01049360|155910491|FG011|Period 2|Adverse Event|0|||
48469675|NCT01049360|155910492|FG012|Period 2|Adverse Event|0|||
48469676|NCT01049360|155910493|FG013|Period 2|Adverse Event|0|||
48469677|NCT01049360|155910494|FG014|Period 2|Adverse Event|0|||
48469678|NCT01049360|155910495|FG015|Period 2|Adverse Event|0|||
48469679|NCT01049360|155910496|FG016|Period 2|Adverse Event|0|||
48469680|NCT01049360|155910497|FG017|Period 2|Adverse Event|0|||
48469681|NCT01049360|155910498|FG018|Period 2|Adverse Event|0|||
48469682|NCT01049360|155910499|FG019|Period 2|Adverse Event|1|||
48469683|NCT01049360|155910480|FG000|Period 2|Withdrawal by Subject|0|||
48469684|NCT01049360|155910481|FG001|Period 2|Withdrawal by Subject|0|||
48469685|NCT01049360|155910482|FG002|Period 2|Withdrawal by Subject|0|||
48469686|NCT01049360|155910483|FG003|Period 2|Withdrawal by Subject|1|||
48469687|NCT01049360|155910484|FG004|Period 2|Withdrawal by Subject|0|||
48469688|NCT01049360|155910485|FG005|Period 2|Withdrawal by Subject|0|||
48469689|NCT01049360|155910486|FG006|Period 2|Withdrawal by Subject|0|||
48469690|NCT01049360|155910487|FG007|Period 2|Withdrawal by Subject|0|||
48469691|NCT01049360|155910488|FG008|Period 2|Withdrawal by Subject|0|||
48469692|NCT01049360|155910489|FG009|Period 2|Withdrawal by Subject|0|||
48469693|NCT01049360|155910490|FG010|Period 2|Withdrawal by Subject|0|||
48469694|NCT01049360|155910491|FG011|Period 2|Withdrawal by Subject|0|||
48469695|NCT01049360|155910492|FG012|Period 2|Withdrawal by Subject|0|||
48469696|NCT01049360|155910493|FG013|Period 2|Withdrawal by Subject|0|||
48469697|NCT01049360|155910494|FG014|Period 2|Withdrawal by Subject|1|||
48469698|NCT01049360|155910495|FG015|Period 2|Withdrawal by Subject|0|||
48469699|NCT01049360|155910496|FG016|Period 2|Withdrawal by Subject|0|||
48469700|NCT01049360|155910497|FG017|Period 2|Withdrawal by Subject|0|||
48469701|NCT01049360|155910498|FG018|Period 2|Withdrawal by Subject|0|||
48469702|NCT01049360|155910499|FG019|Period 2|Withdrawal by Subject|1|||
48469703|NCT01049360|155910480|FG000|Period 2|Lack of Efficacy|0|||
48469704|NCT01049360|155910481|FG001|Period 2|Lack of Efficacy|0|||
48469705|NCT01049360|155910482|FG002|Period 2|Lack of Efficacy|0|||
48469706|NCT01049360|155910483|FG003|Period 2|Lack of Efficacy|0|||
48469707|NCT01049360|155910484|FG004|Period 2|Lack of Efficacy|0|||
48469708|NCT01049360|155910485|FG005|Period 2|Lack of Efficacy|1|||
48469709|NCT01049360|155910486|FG006|Period 2|Lack of Efficacy|0|||
48469710|NCT01049360|155910487|FG007|Period 2|Lack of Efficacy|0|||
48469711|NCT01049360|155910488|FG008|Period 2|Lack of Efficacy|0|||
48469712|NCT01049360|155910489|FG009|Period 2|Lack of Efficacy|0|||
48469713|NCT01049360|155910490|FG010|Period 2|Lack of Efficacy|0|||
48469714|NCT01049360|155910491|FG011|Period 2|Lack of Efficacy|0|||
48469715|NCT01049360|155910492|FG012|Period 2|Lack of Efficacy|0|||
48469716|NCT01049360|155910493|FG013|Period 2|Lack of Efficacy|0|||
48469717|NCT01049360|155910494|FG014|Period 2|Lack of Efficacy|0|||
48469718|NCT01049360|155910495|FG015|Period 2|Lack of Efficacy|0|||
48469719|NCT01049360|155910496|FG016|Period 2|Lack of Efficacy|0|||
48469720|NCT01049360|155910497|FG017|Period 2|Lack of Efficacy|0|||
48469721|NCT01049360|155910498|FG018|Period 2|Lack of Efficacy|0|||
48469722|NCT01049360|155910499|FG019|Period 2|Lack of Efficacy|0|||
48469723|NCT01049360|155910480|FG000|Period 4|Protocol Violation|0|||
48469724|NCT01049360|155910481|FG001|Period 4|Protocol Violation|0|||
48469725|NCT01049360|155910482|FG002|Period 4|Protocol Violation|0|||
48469726|NCT01049360|155910483|FG003|Period 4|Protocol Violation|0|||
48469727|NCT01049360|155910484|FG004|Period 4|Protocol Violation|0|||
48469728|NCT01049360|155910485|FG005|Period 4|Protocol Violation|0|||
48469729|NCT01049360|155910486|FG006|Period 4|Protocol Violation|0|||
48469730|NCT01049360|155910487|FG007|Period 4|Protocol Violation|0|||
48469731|NCT01049360|155910488|FG008|Period 4|Protocol Violation|0|||
48469732|NCT01049360|155910489|FG009|Period 4|Protocol Violation|0|||
48469733|NCT01049360|155910490|FG010|Period 4|Protocol Violation|0|||
48469734|NCT01049360|155910491|FG011|Period 4|Protocol Violation|0|||
48469735|NCT01049360|155910492|FG012|Period 4|Protocol Violation|0|||
48469736|NCT01049360|155910493|FG013|Period 4|Protocol Violation|0|||
48469737|NCT01049360|155910494|FG014|Period 4|Protocol Violation|0|||
48469738|NCT01049360|155910495|FG015|Period 4|Protocol Violation|0|||
48469739|NCT01049360|155910496|FG016|Period 4|Protocol Violation|0|||
48469740|NCT01049360|155910497|FG017|Period 4|Protocol Violation|1|||
48469741|NCT01049360|155910498|FG018|Period 4|Protocol Violation|0|||
48469742|NCT01049360|155910499|FG019|Period 4|Protocol Violation|0|||
48469743|NCT01049360|155910480|FG000|Period 4|Withdrawal by Subject|0|||
48469744|NCT01049360|155910481|FG001|Period 4|Withdrawal by Subject|0|||
48469745|NCT01049360|155910482|FG002|Period 4|Withdrawal by Subject|0|||
48469746|NCT01049360|155910483|FG003|Period 4|Withdrawal by Subject|1|||
48469747|NCT01049360|155910484|FG004|Period 4|Withdrawal by Subject|0|||
48469748|NCT01049360|155910485|FG005|Period 4|Withdrawal by Subject|0|||
48469749|NCT01049360|155910486|FG006|Period 4|Withdrawal by Subject|0|||
48469750|NCT01049360|155910487|FG007|Period 4|Withdrawal by Subject|0|||
48469751|NCT01049360|155910488|FG008|Period 4|Withdrawal by Subject|0|||
48469752|NCT01049360|155910489|FG009|Period 4|Withdrawal by Subject|0|||
48469753|NCT01049360|155910490|FG010|Period 4|Withdrawal by Subject|0|||
48469754|NCT01049360|155910491|FG011|Period 4|Withdrawal by Subject|0|||
48469755|NCT01049360|155910492|FG012|Period 4|Withdrawal by Subject|0|||
48469756|NCT01049360|155910493|FG013|Period 4|Withdrawal by Subject|0|||
48469757|NCT01049360|155910494|FG014|Period 4|Withdrawal by Subject|0|||
48469758|NCT01049360|155910495|FG015|Period 4|Withdrawal by Subject|0|||
48469759|NCT01049360|155910496|FG016|Period 4|Withdrawal by Subject|0|||
48469760|NCT01049360|155910497|FG017|Period 4|Withdrawal by Subject|0|||
48469761|NCT01049360|155910498|FG018|Period 4|Withdrawal by Subject|0|||
48469762|NCT01049360|155910499|FG019|Period 4|Withdrawal by Subject|0|||
48469763|NCT00579059|155910500|FG000|Overall Study|Study Canceled at 1 Year|21|||
48469764|NCT00579059|155910501|FG001|Overall Study|Study Canceled at 1 Year|10|||
48469765|NCT01694849|155910502|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
48469766|NCT01694849|155910503|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
48469767|NCT01694849|155910504|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
48469768|NCT01694849|155910502|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
48469769|NCT01694849|155910503|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
48469770|NCT01694849|155910504|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
48469771|NCT01694849|155910502|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
48469772|NCT01694849|155910503|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
48469773|NCT01694849|155910504|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
48469774|NCT01694849|155910502|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
48469775|NCT01694849|155910503|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
48469776|NCT01694849|155910504|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
48469777|NCT01694849|155910502|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
48469778|NCT01694849|155910503|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
48469779|NCT01694849|155910504|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
48469780|NCT01694849|155910502|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
48469781|NCT01694849|155910503|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
48469782|NCT01694849|155910504|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
48469783|NCT01694849|155910502|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
48469784|NCT01694849|155910503|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
48469785|NCT01694849|155910504|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
48469786|NCT01694849|155910502|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
48469787|NCT01694849|155910503|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
48469788|NCT01694849|155910504|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
48469789|NCT04668157|155910505|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
48469790|NCT04668157|155910506|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
48469791|NCT04668157|155910505|FG000|Treatment Period (52 Weeks)|Other|0|||
48469792|NCT04668157|155910506|FG001|Treatment Period (52 Weeks)|Other|2|||
48469793|NCT00223990|155910507|FG000|Overall Study|Moved from area|2|||
48469794|NCT00223990|155910508|FG001|Overall Study|Moved from area|1|||
48469795|NCT00223990|155910507|FG000|Overall Study|Withdrawal by Subject|4|||
48469796|NCT00223990|155910508|FG001|Overall Study|Withdrawal by Subject|8|||
48469797|NCT00223990|155910507|FG000|Overall Study|Lost to Follow-up|1|||
48469798|NCT00223990|155910508|FG001|Overall Study|Lost to Follow-up|0|||
48469799|NCT03451630|155910509|FG000|Overall Study|Death|15|||
48469800|NCT03451630|155910510|FG001|Overall Study|Death|16|||
48469801|NCT03451630|155910511|FG002|Overall Study|Death|11|||
48469802|NCT03451630|155910509|FG000|Overall Study|Lost to Follow-up|9|||
48469803|NCT03451630|155910510|FG001|Overall Study|Lost to Follow-up|0|||
48469804|NCT03451630|155910511|FG002|Overall Study|Lost to Follow-up|4|||
48469805|NCT03451630|155910509|FG000|Overall Study|Withdrawal by Subject|0|||
48469806|NCT03451630|155910510|FG001|Overall Study|Withdrawal by Subject|3|||
48469807|NCT03451630|155910511|FG002|Overall Study|Withdrawal by Subject|0|||
48469808|NCT03451630|155910509|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
48469809|NCT03451630|155910510|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
48469810|NCT03451630|155910511|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
48469811|NCT05403502|155910514|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
48469812|NCT05403502|155910514|FG000|Humalog Lead-In Period|Physician Decision|2|||
48469813|NCT05403502|155910514|FG000|Humalog Lead-In Period|Protocol Violation|1|||
48469814|NCT05403502|155910514|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
48469815|NCT05403502|155910514|FG000|Lyumjev Treatment Period|Physician Decision|2|||
48469816|NCT03691831|155912318|FG000|Overall Study|Lost to Follow-up|16|||
48469817|NCT03691831|155912319|FG001|Overall Study|Lost to Follow-up|12|||
48469818|NCT03691831|155912318|FG000|Overall Study|Withdrawal by Subject|9|||
48469819|NCT03691831|155912319|FG001|Overall Study|Withdrawal by Subject|17|||
48469820|NCT03691831|155912318|FG000|Overall Study|Investigator Decision|2|||
48469821|NCT03691831|155912319|FG001|Overall Study|Investigator Decision|2|||
48469822|NCT02926833|155912320|FG000|Overall Study|Death|1|||
48469823|NCT02926833|155912321|FG001|Overall Study|Death|1|||
48469824|NCT02926833|155912322|FG002|Overall Study|Death|2|||
48469825|NCT02926833|155912323|FG003|Overall Study|Death|13|||
48469826|NCT02926833|155912320|FG000|Overall Study|Lost to Follow-up|1|||
48469827|NCT02926833|155912321|FG001|Overall Study|Lost to Follow-up|2|||
48469828|NCT02926833|155912322|FG002|Overall Study|Lost to Follow-up|0|||
48469829|NCT02926833|155912323|FG003|Overall Study|Lost to Follow-up|3|||
48469830|NCT02926833|155912320|FG000|Overall Study|Full Consent Withdrawal|0|||
48469831|NCT02926833|155912321|FG001|Overall Study|Full Consent Withdrawal|0|||
48469832|NCT02926833|155912322|FG002|Overall Study|Full Consent Withdrawal|0|||
48469833|NCT02926833|155912323|FG003|Overall Study|Full Consent Withdrawal|2|||
48469834|NCT02926833|155912320|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
48469835|NCT02926833|155912321|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
48469836|NCT02926833|155912322|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
48469837|NCT02926833|155912323|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
48469838|NCT02926833|155912320|FG000|Overall Study|Investigator Decision|0|||
48469839|NCT02926833|155912321|FG001|Overall Study|Investigator Decision|1|||
48469840|NCT02926833|155912322|FG002|Overall Study|Investigator Decision|0|||
48469841|NCT02926833|155912323|FG003|Overall Study|Investigator Decision|0|||
48469842|NCT02926833|155912320|FG000|Overall Study|Adverse Event|0|||
48469843|NCT02926833|155912321|FG001|Overall Study|Adverse Event|0|||
48469844|NCT02926833|155912322|FG002|Overall Study|Adverse Event|1|||
48469845|NCT02926833|155912323|FG003|Overall Study|Adverse Event|0|||
48469846|NCT02926833|155912320|FG000|Overall Study|Partial Withdrawal of Consent|0|||
48469847|NCT02926833|155912321|FG001|Overall Study|Partial Withdrawal of Consent|0|||
48469848|NCT02926833|155912322|FG002|Overall Study|Partial Withdrawal of Consent|0|||
48469849|NCT02926833|155912323|FG003|Overall Study|Partial Withdrawal of Consent|1|||
48469850|NCT00711009|155912324|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
48469851|NCT00711009|155912325|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
48469852|NCT00711009|155912324|FG000|Overall Study|Withdrawal by Subject|4|||
48469853|NCT00711009|155912325|FG001|Overall Study|Withdrawal by Subject|2|||
48469854|NCT00711009|155912324|FG000|Overall Study|Lost to Follow-up|3|||
48469855|NCT00711009|155912325|FG001|Overall Study|Lost to Follow-up|9|||
48469856|NCT00711009|155912324|FG000|Overall Study|Participant Noncompliant|0|||
48469857|NCT00711009|155912325|FG001|Overall Study|Participant Noncompliant|1|||
48469858|NCT00711009|155912324|FG000|Overall Study|Virologic Failure|2|||
48469859|NCT00711009|155912325|FG001|Overall Study|Virologic Failure|1|||
48469860|NCT00711009|155912324|FG000|Overall Study|Pregnancy|1|||
48469861|NCT00711009|155912325|FG001|Overall Study|Pregnancy|0|||
48469862|NCT00711009|155912324|FG000|Overall Study|Site closing|0|||
48469863|NCT00711009|155912325|FG001|Overall Study|Site closing|1|||
48469864|NCT00711009|155912324|FG000|Overall Study|Dose adjustment|1|||
48469865|NCT00711009|155912325|FG001|Overall Study|Dose adjustment|0|||
48469866|NCT02889861|155912329|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
48469867|NCT00240331|155912332|FG000|Overall Study|Withdrawal by Subject|125|||
48469868|NCT00240331|155912333|FG001|Overall Study|Withdrawal by Subject|132|||
48469869|NCT00240331|155912332|FG000|Overall Study|Option selected by investigator|1|||
48469870|NCT00240331|155912333|FG001|Overall Study|Option selected by investigator|2|||
48469871|NCT01409382|155912334|FG000|Overall Study|Lost to Follow-up|1|||
48469872|NCT01409382|155912335|FG001|Overall Study|Lost to Follow-up|1|||
48469873|NCT01409382|155912334|FG000|Overall Study|Protocol Violation|0|||
48469874|NCT01409382|155912335|FG001|Overall Study|Protocol Violation|3|||
48469875|NCT01409382|155912334|FG000|Overall Study|Multiple pregnancy|2|||
48469876|NCT01409382|155912335|FG001|Overall Study|Multiple pregnancy|4|||
48469877|NCT01409382|155912334|FG000|Overall Study|Still pregnant when study ended|13|||
48469878|NCT01409382|155912335|FG001|Overall Study|Still pregnant when study ended|2|||
48469879|NCT01409382|155912334|FG000|Overall Study|Did not manage to get pregnant|64|||
48469880|NCT01409382|155912335|FG001|Overall Study|Did not manage to get pregnant|70|||
48469881|NCT01409382|155912334|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
48469882|NCT01409382|155912335|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
48469883|NCT00663208|155912338|FG000|Treatment Period|Lost to Follow-up|0|||
48469884|NCT00663208|155912339|FG001|Treatment Period|Lost to Follow-up|1|||
48469885|NCT00663208|155912340|FG002|Treatment Period|Lost to Follow-up|0|||
48469886|NCT00663208|155912341|FG003|Treatment Period|Lost to Follow-up|0|||
48469887|NCT00663208|155912342|FG004|Treatment Period|Lost to Follow-up|0|||
48469888|NCT00663208|155912343|FG005|Treatment Period|Lost to Follow-up|0|||
48469889|NCT00663208|155912344|FG006|Treatment Period|Lost to Follow-up|0|||
48469890|NCT00663208|155912338|FG000|Follow-up Period|Lost to Follow-up|2|||
48469891|NCT00663208|155912339|FG001|Follow-up Period|Lost to Follow-up|0|||
48469892|NCT00663208|155912340|FG002|Follow-up Period|Lost to Follow-up|3|||
48469893|NCT00663208|155912341|FG003|Follow-up Period|Lost to Follow-up|2|||
48469894|NCT00663208|155912342|FG004|Follow-up Period|Lost to Follow-up|0|||
48469895|NCT00663208|155912343|FG005|Follow-up Period|Lost to Follow-up|0|||
48469896|NCT00663208|155912344|FG006|Follow-up Period|Lost to Follow-up|0|||
48469897|NCT00663208|155912338|FG000|Follow-up Period|Other reason|1|||
48469898|NCT00663208|155912339|FG001|Follow-up Period|Other reason|0|||
48469899|NCT00663208|155912340|FG002|Follow-up Period|Other reason|0|||
48469900|NCT00663208|155912341|FG003|Follow-up Period|Other reason|0|||
48469901|NCT00663208|155912342|FG004|Follow-up Period|Other reason|0|||
48469902|NCT00663208|155912343|FG005|Follow-up Period|Other reason|0|||
48469903|NCT00663208|155912344|FG006|Follow-up Period|Other reason|1|||
48469904|NCT01347931|155912345|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
48469905|NCT01249404|155912346|FG000|Overall Study|Study treatment not received|0|||
48469906|NCT01249404|155912347|FG001|Overall Study|Study treatment not received|1|||
48469907|NCT01249404|155912348|FG002|Overall Study|Study treatment not received|2|||
48469908|NCT01249404|155912346|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
48469909|NCT01249404|155912347|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
48469910|NCT01249404|155912348|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
48469911|NCT01249404|155912346|FG000|Overall Study|Adverse Event|2|||
48469912|NCT01249404|155912347|FG001|Overall Study|Adverse Event|2|||
48469913|NCT01249404|155912348|FG002|Overall Study|Adverse Event|2|||
48469914|NCT01249404|155912346|FG000|Overall Study|Withdrawal by Subject|2|||
48469915|NCT01249404|155912347|FG001|Overall Study|Withdrawal by Subject|2|||
48469916|NCT01249404|155912348|FG002|Overall Study|Withdrawal by Subject|0|||
48469917|NCT01249404|155912346|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
48469918|NCT01249404|155912347|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
48469919|NCT01249404|155912348|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
48469920|NCT01249404|155912346|FG000|Overall Study|Non compliance to visit schedule|0|||
48469921|NCT01249404|155912347|FG001|Overall Study|Non compliance to visit schedule|1|||
48469922|NCT01249404|155912348|FG002|Overall Study|Non compliance to visit schedule|0|||
48469923|NCT04308668|155912349|FG000|Overall Study|Lost to Follow-up|32|||
48469924|NCT04308668|155912350|FG001|Overall Study|Lost to Follow-up|38|||
48469925|NCT04308668|155912349|FG000|Overall Study|Withdrawal by Subject|4|||
48469926|NCT04308668|155912350|FG001|Overall Study|Withdrawal by Subject|4|||
48469927|NCT01266967|155912351|FG000|Overall Study|Death|69|||
48469928|NCT01266967|155912352|FG001|Overall Study|Death|61|||
48469929|NCT01266967|155912351|FG000|Overall Study|Study Closed/Terminated|15|||
48469930|NCT01266967|155912352|FG001|Overall Study|Study Closed/Terminated|17|||
48469931|NCT01266967|155912351|FG000|Overall Study|Lost to Follow-up|2|||
48469932|NCT01266967|155912352|FG001|Overall Study|Lost to Follow-up|1|||
48469933|NCT01266967|155912351|FG000|Overall Study|Physician Decision|0|||
48469934|NCT01266967|155912352|FG001|Overall Study|Physician Decision|1|||
48469935|NCT01266967|155912351|FG000|Overall Study|Withdrawal by Subject|3|||
48469936|NCT01266967|155912352|FG001|Overall Study|Withdrawal by Subject|3|||
48469937|NCT02493712|155912353|FG000|Overall Study|Withdrawal by Subject|1|||
48469938|NCT02493712|155912354|FG001|Overall Study|Withdrawal by Subject|0|||
48469939|NCT02493712|155912355|FG002|Overall Study|Withdrawal by Subject|2|||
48469940|NCT02493712|155912353|FG000|Overall Study|Protocol Violation|0|||
48469941|NCT02493712|155912354|FG001|Overall Study|Protocol Violation|0|||
48469942|NCT02493712|155912355|FG002|Overall Study|Protocol Violation|1|||
48469943|NCT02493712|155912353|FG000|Overall Study|Lost to Follow-up|1|||
48469944|NCT02493712|155912354|FG001|Overall Study|Lost to Follow-up|0|||
48469945|NCT02493712|155912355|FG002|Overall Study|Lost to Follow-up|0|||
48469946|NCT02493712|155912353|FG000|Overall Study|Physician Decision|0|||
48469947|NCT02493712|155912354|FG001|Overall Study|Physician Decision|1|||
48469948|NCT02493712|155912355|FG002|Overall Study|Physician Decision|0|||
48469949|NCT02493712|155912353|FG000|Overall Study|Lack of Efficacy|0|||
48469950|NCT02493712|155912354|FG001|Overall Study|Lack of Efficacy|5|||
48469951|NCT02493712|155912355|FG002|Overall Study|Lack of Efficacy|3|||
48469952|NCT03890731|155912356|FG000|Overall Study|Progressive disease|1|||
48469953|NCT03890731|155912356|FG000|Overall Study|Patient's decision|1|||
48469954|NCT03890731|155912356|FG000|Overall Study|Adverse Event|4|||
48469955|NCT03758612|155912357|FG000|Washout Period|Withdrawal by Subject|0|||
48469956|NCT03758612|155912358|FG001|Washout Period|Withdrawal by Subject|0|||
48469957|NCT03758612|155912359|FG002|Washout Period|Withdrawal by Subject|2|||
48469958|NCT03758612|155912360|FG003|Washout Period|Withdrawal by Subject|0|||
48469959|NCT03758612|155912361|FG004|Washout Period|Withdrawal by Subject|0|||
48469960|NCT03758612|155912362|FG005|Washout Period|Withdrawal by Subject|0|||
48469961|NCT03758612|155912363|FG006|Washout Period|Withdrawal by Subject|0|||
48469962|NCT03758612|155912364|FG007|Washout Period|Withdrawal by Subject|0|||
48469963|NCT03758612|155912365|FG008|Washout Period|Withdrawal by Subject|0|||
48469964|NCT03758612|155912366|FG009|Washout Period|Withdrawal by Subject|0|||
48469965|NCT03758612|155912367|FG010|Washout Period|Withdrawal by Subject|0|||
48469966|NCT03758612|155912368|FG011|Washout Period|Withdrawal by Subject|0|||
48469967|NCT03758612|155912357|FG000|Period 2|Protocol Violation|0|||
48469968|NCT03758612|155912358|FG001|Period 2|Protocol Violation|0|||
48469969|NCT03758612|155912359|FG002|Period 2|Protocol Violation|0|||
48469970|NCT03758612|155912360|FG003|Period 2|Protocol Violation|0|||
48469971|NCT03758612|155912361|FG004|Period 2|Protocol Violation|1|||
48469972|NCT03758612|155912362|FG005|Period 2|Protocol Violation|0|||
48469973|NCT03758612|155912363|FG006|Period 2|Protocol Violation|0|||
48469974|NCT03758612|155912364|FG007|Period 2|Protocol Violation|0|||
48469975|NCT03758612|155912365|FG008|Period 2|Protocol Violation|0|||
48469976|NCT03758612|155912366|FG009|Period 2|Protocol Violation|0|||
48469977|NCT03758612|155912367|FG010|Period 2|Protocol Violation|0|||
48469978|NCT03758612|155912368|FG011|Period 2|Protocol Violation|0|||
48469979|NCT00772031|155912371|FG000|Overall Study|Early termination of trial|12|||
48469980|NCT00772031|155912372|FG001|Overall Study|Early termination of trial|10|||
48469981|NCT00772031|155912371|FG000|Overall Study|Lost to Follow-up|20|||
48469982|NCT00772031|155912372|FG001|Overall Study|Lost to Follow-up|33|||
48469983|NCT00883896|155912373|FG000|Overall Study|Lost to Follow-up|0|||
48469984|NCT00883896|155912374|FG001|Overall Study|Lost to Follow-up|0|||
48469985|NCT00883896|155912375|FG002|Overall Study|Lost to Follow-up|0|||
48469986|NCT00883896|155912376|FG003|Overall Study|Lost to Follow-up|2|||
48469987|NCT00883896|155912373|FG000|Overall Study|Withdrawal by Subject|5|||
48469988|NCT00883896|155912374|FG001|Overall Study|Withdrawal by Subject|0|||
48469989|NCT00883896|155912375|FG002|Overall Study|Withdrawal by Subject|1|||
48469990|NCT00883896|155912376|FG003|Overall Study|Withdrawal by Subject|3|||
48469991|NCT00883896|155912373|FG000|Overall Study|Lack of Efficacy|0|||
48469992|NCT00883896|155912374|FG001|Overall Study|Lack of Efficacy|0|||
48469993|NCT00883896|155912375|FG002|Overall Study|Lack of Efficacy|0|||
48469994|NCT00883896|155912376|FG003|Overall Study|Lack of Efficacy|2|||
48469995|NCT00883896|155912373|FG000|Overall Study|Other|1|||
48469996|NCT00883896|155912374|FG001|Overall Study|Other|0|||
48469997|NCT00883896|155912375|FG002|Overall Study|Other|0|||
48469998|NCT00883896|155912376|FG003|Overall Study|Other|0|||
48469999|NCT02546193|155912377|FG000|Overall Study|Withdrawal by Subject|2|||
48470000|NCT02546193|155912378|FG001|Overall Study|Withdrawal by Subject|0|||
48470001|NCT02546193|155912379|FG002|Overall Study|Withdrawal by Subject|1|||
48470002|NCT02546193|155912380|FG003|Overall Study|Withdrawal by Subject|0|||
48470003|NCT02546193|155912377|FG000|Overall Study|Not eligible at time of induction|4|||
48470004|NCT02546193|155912378|FG001|Overall Study|Not eligible at time of induction|6|||
48470005|NCT02546193|155912379|FG002|Overall Study|Not eligible at time of induction|1|||
48470006|NCT02546193|155912380|FG003|Overall Study|Not eligible at time of induction|0|||
48470007|NCT01474291|155912383|FG000|Overall Study|Not Evaluable for Efficacy|26|||
48470008|NCT01474291|155912383|FG000|Overall Study|Lack of Treatment Efficacy|88|||
48470009|NCT01474291|155912383|FG000|Overall Study|Adverse Event|53|||
48470010|NCT01474291|155912383|FG000|Overall Study|Lost to Follow-up|29|||
48470011|NCT01474291|155912383|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
48470012|NCT01474291|155912383|FG000|Overall Study|No Reason Reported|10|||
48470013|NCT01474291|155912383|FG000|Overall Study|Death|2|||
48470014|NCT00310440|155912384|FG000|Overall Study|Lost to Follow-up|17|||
48470015|NCT00310440|155912385|FG001|Overall Study|Lost to Follow-up|8|||
48470016|NCT00310440|155912384|FG000|Overall Study|Withdrawal by Subject|2|||
48470017|NCT00310440|155912385|FG001|Overall Study|Withdrawal by Subject|1|||
48470018|NCT00310440|155912384|FG000|Overall Study|Missed 12 Month Visit|7|||
48470019|NCT00310440|155912385|FG001|Overall Study|Missed 12 Month Visit|4|||
48470020|NCT00792467|155912386|FG000|Overall Study|progression of disease|17|||
48470021|NCT00792467|155912386|FG000|Overall Study|Adverse Event|1|||
48470022|NCT00792467|155912386|FG000|Overall Study|patient request|1|||
48470023|NCT00792467|155912386|FG000|Overall Study|Lost to Follow-up|1|||
48470024|NCT00792467|155912386|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
48470025|NCT00792467|155912386|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
48470026|NCT01287403|155912396|FG000|1st Intervention (1 Day)|Adverse Event|1|||
48470027|NCT02988115|155912397|FG000|Overall Study|Adverse Event|6|||
48470028|NCT02988115|155912398|FG001|Overall Study|Adverse Event|1|||
48470029|NCT02988115|155912397|FG000|Overall Study|Sponsor Decision|5|||
48470030|NCT02988115|155912398|FG001|Overall Study|Sponsor Decision|2|||
48470031|NCT02988115|155912397|FG000|Overall Study|Withdrawal by Subject|1|||
48470032|NCT02988115|155912398|FG001|Overall Study|Withdrawal by Subject|1|||
48470033|NCT02988115|155912397|FG000|Overall Study|Withdrawn by Mistake|1|||
48470034|NCT02988115|155912398|FG001|Overall Study|Withdrawn by Mistake|0|||
48470035|NCT02988115|155912397|FG000|Overall Study|Lost to Follow-up|1|||
48470036|NCT02988115|155912398|FG001|Overall Study|Lost to Follow-up|0|||
48470037|NCT00148109|155912399|FG000|Overall Study|Lack of Efficacy|10|||
48470038|NCT00148109|155912400|FG001|Overall Study|Lack of Efficacy|18|||
48470039|NCT00148109|155912399|FG000|Overall Study|Adverse Event|0|||
48470040|NCT00148109|155912400|FG001|Overall Study|Adverse Event|2|||
48470041|NCT00148109|155912399|FG000|Overall Study|Withdrawal by Subject|2|||
48470042|NCT00148109|155912400|FG001|Overall Study|Withdrawal by Subject|0|||
48470043|NCT01731951|155912401|FG000|Overall Study|Documented Disease Progression|1|||
48470044|NCT01731951|155912402|FG001|Overall Study|Documented Disease Progression|0|||
48470045|NCT01731951|155912403|FG002|Overall Study|Documented Disease Progression|0|||
48470046|NCT01731951|155912404|FG003|Overall Study|Documented Disease Progression|0|||
48470047|NCT01731951|155912405|FG004|Overall Study|Documented Disease Progression|0|||
48470048|NCT01731951|155912406|FG005|Overall Study|Documented Disease Progression|0|||
48470049|NCT01731951|155912401|FG000|Overall Study|Lost to Follow-up|2|||
48470050|NCT01731951|155912402|FG001|Overall Study|Lost to Follow-up|0|||
48470051|NCT01731951|155912403|FG002|Overall Study|Lost to Follow-up|0|||
48470052|NCT01731951|155912404|FG003|Overall Study|Lost to Follow-up|1|||
48470053|NCT01731951|155912405|FG004|Overall Study|Lost to Follow-up|3|||
48470054|NCT01731951|155912406|FG005|Overall Study|Lost to Follow-up|1|||
48470055|NCT01731951|155912401|FG000|Overall Study|Withdrawal of Consent|1|||
48470056|NCT01731951|155912402|FG001|Overall Study|Withdrawal of Consent|0|||
48470057|NCT01731951|155912403|FG002|Overall Study|Withdrawal of Consent|0|||
48470058|NCT01731951|155912404|FG003|Overall Study|Withdrawal of Consent|0|||
48470059|NCT01731951|155912405|FG004|Overall Study|Withdrawal of Consent|0|||
48470060|NCT01731951|155912406|FG005|Overall Study|Withdrawal of Consent|2|||
48470061|NCT01731951|155912401|FG000|Overall Study|Death|13|||
48470062|NCT01731951|155912402|FG001|Overall Study|Death|15|||
48470063|NCT01731951|155912403|FG002|Overall Study|Death|9|||
48470064|NCT01731951|155912404|FG003|Overall Study|Death|8|||
48470065|NCT01731951|155912405|FG004|Overall Study|Death|9|||
48470066|NCT01731951|155912406|FG005|Overall Study|Death|6|||
48470067|NCT03339999|155912407|FG000|Overall Study|Adverse Event|1|||
48470068|NCT03339999|155912408|FG001|Overall Study|Adverse Event|2|||
48470069|NCT03339999|155912409|FG002|Overall Study|Adverse Event|2|||
48470070|NCT03339999|155912410|FG003|Overall Study|Adverse Event|1|||
48470071|NCT03339999|155912407|FG000|Overall Study|Lack of Efficacy|0|||
48470072|NCT03339999|155912408|FG001|Overall Study|Lack of Efficacy|1|||
48470073|NCT03339999|155912409|FG002|Overall Study|Lack of Efficacy|0|||
48470074|NCT03339999|155912410|FG003|Overall Study|Lack of Efficacy|0|||
48470075|NCT03339999|155912407|FG000|Overall Study|Lost to Follow-up|0|||
48470076|NCT03339999|155912408|FG001|Overall Study|Lost to Follow-up|0|||
48470077|NCT03339999|155912409|FG002|Overall Study|Lost to Follow-up|0|||
48470078|NCT03339999|155912410|FG003|Overall Study|Lost to Follow-up|1|||
48470079|NCT03339999|155912407|FG000|Overall Study|Study Terminated by Sponsor|6|||
48470080|NCT03339999|155912408|FG001|Overall Study|Study Terminated by Sponsor|3|||
48470081|NCT03339999|155912409|FG002|Overall Study|Study Terminated by Sponsor|4|||
48470082|NCT03339999|155912410|FG003|Overall Study|Study Terminated by Sponsor|3|||
48470083|NCT00438815|155912411|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
48470084|NCT00438815|155912411|FG000|Overall Study|3-month follow-up no longer required|12|||
48470085|NCT00438815|155912411|FG000|Overall Study|Noncompliance with protocol requirements|9|||
48470086|NCT00438815|155912411|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
48470087|NCT00438815|155912411|FG000|Overall Study|Lost to Follow-up|6|||
48470088|NCT00438815|155912411|FG000|Overall Study|Withdrawal by Subject|6|||
48470089|NCT00438815|155912411|FG000|Overall Study|Death|1|||
48470090|NCT01977651|155912412|FG000|4 Month Treatment Period|Adverse Event|34|||
48470091|NCT01977651|155912412|FG000|4 Month Treatment Period|Death|3|||
48470092|NCT01977651|155912412|FG000|4 Month Treatment Period|Progressive Disease|43|||
48470093|NCT01977651|155912412|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
48470094|NCT01977651|155912412|FG000|4 Month Treatment Period|Physician Decision|4|||
48470095|NCT01977651|155912412|FG000|1 Year Extension Period|Adverse Event|14|||
48470096|NCT01977651|155912412|FG000|1 Year Extension Period|Death|10|||
48470097|NCT01977651|155912412|FG000|1 Year Extension Period|Lost to Follow-up|2|||
48470098|NCT01977651|155912412|FG000|1 Year Extension Period|Progressive Disease|86|||
48470099|NCT01977651|155912412|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
48470100|NCT01977651|155912412|FG000|1 Year Extension Period|Physician Decision|6|||
48470101|NCT01977651|155912412|FG000|1 Year Extension Period|Miscellaneous|1|||
48470102|NCT01977651|155912412|FG000|Post 1 Year Extension Period|Adverse Event|5|||
48470103|NCT01977651|155912412|FG000|Post 1 Year Extension Period|Death|13|||
48470104|NCT01977651|155912412|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
48470105|NCT01977651|155912412|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
48470106|NCT01977651|155912412|FG000|Post 1 Year Extension Period|Physician Decision|4|||
48470107|NCT01977651|155912412|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
48470108|NCT00253747|155912415|FG000|Overall Study|Lost to Follow-up|13|||
48470109|NCT00253747|155912416|FG001|Overall Study|Lost to Follow-up|14|||
48470110|NCT00253747|155912415|FG000|Overall Study|Withdrawal by Subject|10|||
48470111|NCT00253747|155912416|FG001|Overall Study|Withdrawal by Subject|11|||
48470112|NCT00253747|155912415|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
48470113|NCT00253747|155912416|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
48470114|NCT01856920|155912417|FG000|Overall Study|Disease Progression On Study|3|||
48470115|NCT01856920|155912418|FG001|Overall Study|Disease Progression On Study|4|||
48470116|NCT01856920|155912417|FG000|Overall Study|Disease Progression before Treatment|1|||
48470117|NCT01856920|155912418|FG001|Overall Study|Disease Progression before Treatment|0|||
48470118|NCT01856920|155912417|FG000|Overall Study|Ineligible|0|||
48470119|NCT01856920|155912418|FG001|Overall Study|Ineligible|1|||
48470120|NCT01856920|155912417|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
48470121|NCT01856920|155912418|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
48470122|NCT01856920|155912417|FG000|Overall Study|Refused further Treatment|5|||
48470123|NCT01856920|155912418|FG001|Overall Study|Refused further Treatment|1|||
48470124|NCT01856920|155912417|FG000|Overall Study|Other Reasons|0|||
48470125|NCT01856920|155912418|FG001|Overall Study|Other Reasons|1|||
48470126|NCT01856920|155912417|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
48470127|NCT01856920|155912418|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
48470128|NCT03764813|155912424|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
48470129|NCT03764813|155912425|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
48470130|NCT03764813|155912426|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
48470131|NCT03764813|155912427|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
48470132|NCT00450814|155912428|FG000|Overall Study|Failed to complete the initial therapy|0|||
48470133|NCT00450814|155912429|FG001|Overall Study|Failed to complete the initial therapy|0|||
48470134|NCT00450814|155912430|FG002|Overall Study|Failed to complete the initial therapy|0|||
48470135|NCT00450814|155912431|FG003|Overall Study|Failed to complete the initial therapy|1|||
48470136|NCT00450814|155912432|FG004|Overall Study|Failed to complete the initial therapy|1|||
48470137|NCT00450814|155912433|FG005|Overall Study|Failed to complete the initial therapy|1|||
48470138|NCT00450814|155912434|FG006|Overall Study|Failed to complete the initial therapy|0|||
48470139|NCT00450814|155912435|FG007|Overall Study|Failed to complete the initial therapy|0|||
48470140|NCT00450814|155912436|FG008|Overall Study|Failed to complete the initial therapy|0|||
48470141|NCT00450814|155912437|FG009|Overall Study|Failed to complete the initial therapy|0|||
48470142|NCT00450814|155912438|FG010|Overall Study|Failed to complete the initial therapy|0|||
48470143|NCT00450814|155912428|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
48470144|NCT00450814|155912429|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
48470145|NCT00450814|155912430|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
48470146|NCT00450814|155912431|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
48470147|NCT00450814|155912432|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
48470148|NCT00450814|155912433|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
48470149|NCT00450814|155912434|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
48470150|NCT00450814|155912435|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
48470151|NCT00450814|155912436|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
48470152|NCT00450814|155912437|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
48470153|NCT00450814|155912438|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
48470154|NCT01654666|155912439|FG000|Overall Study|Protocol Violation|7|||
48470155|NCT01654666|155912440|FG001|Overall Study|Protocol Violation|4|||
48470156|NCT01654666|155912441|FG002|Overall Study|Protocol Violation|8|||
48470157|NCT01654666|155912439|FG000|Overall Study|Lost to Follow-up|4|||
48470158|NCT01654666|155912440|FG001|Overall Study|Lost to Follow-up|5|||
48470159|NCT01654666|155912441|FG002|Overall Study|Lost to Follow-up|5|||
48470160|NCT01654666|155912439|FG000|Overall Study|Withdrawal by Subject|4|||
48470161|NCT01654666|155912440|FG001|Overall Study|Withdrawal by Subject|4|||
48470162|NCT01654666|155912441|FG002|Overall Study|Withdrawal by Subject|1|||
48470163|NCT00429026|155912443|FG000|Overall Study|Inevaluable for response.|40|||
48470164|NCT03831282|155912444|FG000|Overall Study|Could not place sensor|1|||
48470165|NCT00334893|155912447|FG000|Overall Study|Not Treated|1|||
48470166|NCT00334893|155912448|FG001|Overall Study|Not Treated|0|||
48470167|NCT02764229|155912449|FG000|Overall Study|Withdrawal by Subject|15|||
48470168|NCT02764229|155912449|FG000|Overall Study|Adverse Event|9|||
48470169|NCT02764229|155912449|FG000|Overall Study|Physician Decision|5|||
48470170|NCT02764229|155912449|FG000|Overall Study|Lost to Follow-up|3|||
48470171|NCT02764229|155912449|FG000|Overall Study|Lack of Efficacy|1|||
48470172|NCT02764229|155912449|FG000|Overall Study|Study Stopped by Sponsor|69|||
48470173|NCT01258803|155912450|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
48470174|NCT01258803|155912451|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
48470175|NCT01258803|155912452|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
48470176|NCT01258803|155912453|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
48470177|NCT01258803|155912454|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
48470178|NCT01258803|155912455|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
48470179|NCT01258803|155912450|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48470180|NCT01258803|155912451|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
48470181|NCT01258803|155912452|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48470182|NCT01258803|155912453|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48470183|NCT01258803|155912454|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48470184|NCT01258803|155912455|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
48470185|NCT01258803|155912450|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48470186|NCT01258803|155912451|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48470187|NCT01258803|155912452|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
48470188|NCT01258803|155912453|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48470189|NCT01258803|155912454|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48470190|NCT01258803|155912455|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
48470191|NCT00920582|155912456|FG000|Overall Study|Lost to Follow-up|5|||
48470192|NCT00920582|155912457|FG001|Overall Study|Lost to Follow-up|1|||
48470193|NCT00920582|155912458|FG002|Overall Study|Lost to Follow-up|2|||
48470194|NCT00920582|155912459|FG003|Overall Study|Lost to Follow-up|0|||
48470195|NCT00920582|155912456|FG000|Overall Study|Withdrawal by Subject|5|||
48470196|NCT00920582|155912457|FG001|Overall Study|Withdrawal by Subject|4|||
48470197|NCT00920582|155912458|FG002|Overall Study|Withdrawal by Subject|6|||
48470198|NCT00920582|155912459|FG003|Overall Study|Withdrawal by Subject|3|||
48470199|NCT00920582|155912456|FG000|Overall Study|Protocol Violation|1|||
48470200|NCT00920582|155912457|FG001|Overall Study|Protocol Violation|0|||
48470201|NCT00920582|155912458|FG002|Overall Study|Protocol Violation|0|||
48470202|NCT00920582|155912459|FG003|Overall Study|Protocol Violation|0|||
48470203|NCT00920582|155912456|FG000|Overall Study|Other|2|||
48470204|NCT00920582|155912457|FG001|Overall Study|Other|1|||
48470205|NCT00920582|155912458|FG002|Overall Study|Other|3|||
48470206|NCT00920582|155912459|FG003|Overall Study|Other|2|||
48470207|NCT03319160|155912460|FG000|Overall Study|Data not available.|7|||
48470208|NCT05807464|155912461|FG000|Overall Study|Adverse Event|1|||
48470209|NCT02950831|155912463|FG000|Overall Study|Lost to Follow-up|1|||
48470210|NCT02950831|155912463|FG000|Overall Study|Withdrawal by Subject|3|||
48470211|NCT02950831|155912463|FG000|Overall Study|stimulation trail failure|5|||
48470212|NCT01610752|155912464|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
48470213|NCT01610752|155912465|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
48470214|NCT01610752|155912466|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
48470215|NCT02146365|155912471|FG000|Overall Study|Lost to Follow-up|2|||
48470216|NCT02146365|155912472|FG001|Overall Study|Lost to Follow-up|1|||
48470217|NCT02146365|155912473|FG002|Overall Study|Lost to Follow-up|3|||
48470218|NCT02146365|155912474|FG003|Overall Study|Lost to Follow-up|3|||
48470219|NCT02146365|155912475|FG004|Overall Study|Lost to Follow-up|1|||
48470220|NCT02146365|155912476|FG005|Overall Study|Lost to Follow-up|1|||
48470221|NCT02146365|155912477|FG006|Overall Study|Lost to Follow-up|0|||
48470222|NCT02146365|155912478|FG007|Overall Study|Lost to Follow-up|1|||
48470223|NCT02146365|155912471|FG000|Overall Study|Withdrawal by Subject|1|||
48470224|NCT02146365|155912472|FG001|Overall Study|Withdrawal by Subject|2|||
48470225|NCT02146365|155912473|FG002|Overall Study|Withdrawal by Subject|1|||
48470226|NCT02146365|155912474|FG003|Overall Study|Withdrawal by Subject|5|||
48470227|NCT02146365|155912475|FG004|Overall Study|Withdrawal by Subject|1|||
48470228|NCT02146365|155912476|FG005|Overall Study|Withdrawal by Subject|0|||
48470229|NCT02146365|155912477|FG006|Overall Study|Withdrawal by Subject|0|||
48470230|NCT02146365|155912478|FG007|Overall Study|Withdrawal by Subject|0|||
48470231|NCT02146365|155912471|FG000|Overall Study|Unable to Comply with Protocol|0|||
48470232|NCT02146365|155912472|FG001|Overall Study|Unable to Comply with Protocol|1|||
48470233|NCT02146365|155912473|FG002|Overall Study|Unable to Comply with Protocol|1|||
48470234|NCT02146365|155912474|FG003|Overall Study|Unable to Comply with Protocol|0|||
48470235|NCT02146365|155912475|FG004|Overall Study|Unable to Comply with Protocol|0|||
48470236|NCT02146365|155912476|FG005|Overall Study|Unable to Comply with Protocol|0|||
48470237|NCT02146365|155912477|FG006|Overall Study|Unable to Comply with Protocol|0|||
48470238|NCT02146365|155912478|FG007|Overall Study|Unable to Comply with Protocol|0|||
48470239|NCT02146365|155912471|FG000|Overall Study|Other|1|||
48470240|NCT02146365|155912472|FG001|Overall Study|Other|0|||
48470241|NCT02146365|155912473|FG002|Overall Study|Other|2|||
48470242|NCT02146365|155912474|FG003|Overall Study|Other|1|||
48470243|NCT02146365|155912475|FG004|Overall Study|Other|0|||
48470244|NCT02146365|155912476|FG005|Overall Study|Other|0|||
48470245|NCT02146365|155912477|FG006|Overall Study|Other|0|||
48470246|NCT02146365|155912478|FG007|Overall Study|Other|0|||
48470247|NCT04067310|155914188|FG000|Overall Study|Physician Decision|2|||
48470248|NCT04067310|155914189|FG001|Overall Study|Physician Decision|6|||
48470249|NCT04067310|155914188|FG000|Overall Study|Lost to Follow-up|0|||
48470250|NCT04067310|155914189|FG001|Overall Study|Lost to Follow-up|1|||
48470251|NCT04067310|155914188|FG000|Overall Study|Withdrawal by Subject|3|||
48470252|NCT04067310|155914189|FG001|Overall Study|Withdrawal by Subject|0|||
48470253|NCT01233076|155914190|FG000|Period 2, One Week|Lost to Follow-up|1|||
48470254|NCT01233076|155914191|FG001|Period 2, One Week|Lost to Follow-up|0|||
48470255|NCT01041027|155914194|FG000|Overall Study|Withdrawal by Subject|2|||
48470256|NCT01041027|155914194|FG000|Overall Study|Protocol Violation|1|||
48470257|NCT01041027|155914194|FG000|Overall Study|Delayed Radiation Therapy|1|||
48470258|NCT01041027|155914194|FG000|Overall Study|Adverse Event|4|||
48470259|NCT04563845|155914195|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470260|NCT04563845|155914196|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470261|NCT04563845|155914197|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470262|NCT04563845|155914198|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470263|NCT04563845|155914199|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470264|NCT04563845|155914200|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470265|NCT04563845|155914201|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470266|NCT04563845|155914202|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
48470267|NCT04563845|155914203|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470268|NCT04563845|155914204|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470269|NCT04563845|155914205|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470270|NCT04563845|155914206|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470271|NCT04563845|155914207|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470272|NCT04563845|155914208|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
48470273|NCT04563845|155914195|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470274|NCT04563845|155914196|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470275|NCT04563845|155914197|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470276|NCT04563845|155914198|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470277|NCT04563845|155914199|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
48470278|NCT04563845|155914200|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470279|NCT04563845|155914201|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470280|NCT04563845|155914202|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470281|NCT04563845|155914203|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470282|NCT04563845|155914204|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470283|NCT04563845|155914205|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470284|NCT04563845|155914206|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470285|NCT04563845|155914207|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470286|NCT04563845|155914208|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
48470287|NCT01801475|155914209|FG000|Overall Study|Withdrawal by Subject|0|||
48470288|NCT01801475|155914210|FG001|Overall Study|Withdrawal by Subject|0|||
48470289|NCT01801475|155914211|FG002|Overall Study|Withdrawal by Subject|0|||
48470290|NCT01801475|155914212|FG003|Overall Study|Withdrawal by Subject|0|||
48470291|NCT01801475|155914213|FG004|Overall Study|Withdrawal by Subject|1|||
48470292|NCT02213666|155914216|FG000|Overall Study|Withdrawal by Subject|1|||
48470293|NCT01098266|155914217|FG000|Overall Study|Physician Decision|1|||
48470294|NCT01098266|155914218|FG001|Overall Study|Physician Decision|0|||
48470295|NCT01098266|155914217|FG000|Overall Study|Death|3|||
48470296|NCT01098266|155914218|FG001|Overall Study|Death|2|||
48470297|NCT01098266|155914217|FG000|Overall Study|Withdrawal by Subject|3|||
48470298|NCT01098266|155914218|FG001|Overall Study|Withdrawal by Subject|5|||
48470299|NCT01319422|155914219|FG000|Overall Study|Withdrawal by Subject|1|||
48470300|NCT01319422|155914220|FG001|Overall Study|Withdrawal by Subject|0|||
48470301|NCT01308476|155914221|FG000|Overall Study|Lost to Follow-up|2|||
48470302|NCT01308476|155914222|FG001|Overall Study|Lost to Follow-up|2|||
48470303|NCT01308476|155914221|FG000|Overall Study|Other|1|||
48470304|NCT01308476|155914222|FG001|Overall Study|Other|0|||
48470305|NCT00649220|155914229|FG000|Overall Study|Adverse Event|2|||
48470306|NCT00649220|155914229|FG000|Overall Study|Withdrawal by Subject|1|||
48470307|NCT03814746|155914230|FG000|Overall Study|Participant decision|9|||
48470308|NCT03814746|155914231|FG001|Overall Study|Participant decision|6|||
48470309|NCT03814746|155914232|FG002|Overall Study|Participant decision|15|||
48470310|NCT03814746|155914230|FG000|Overall Study|Physician Decision|2|||
48470311|NCT03814746|155914231|FG001|Overall Study|Physician Decision|2|||
48470312|NCT03814746|155914232|FG002|Overall Study|Physician Decision|4|||
48470313|NCT03814746|155914230|FG000|Overall Study|Death|2|||
48470314|NCT03814746|155914231|FG001|Overall Study|Death|2|||
48470315|NCT03814746|155914232|FG002|Overall Study|Death|2|||
48470316|NCT03814746|155914230|FG000|Overall Study|Adverse Event|2|||
48470317|NCT03814746|155914231|FG001|Overall Study|Adverse Event|2|||
48470318|NCT03814746|155914232|FG002|Overall Study|Adverse Event|1|||
48470319|NCT03814746|155914230|FG000|Overall Study|Lost to Follow-up|2|||
48470320|NCT03814746|155914231|FG001|Overall Study|Lost to Follow-up|1|||
48470321|NCT03814746|155914232|FG002|Overall Study|Lost to Follow-up|2|||
48470322|NCT03814746|155914230|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48470323|NCT03814746|155914231|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
48470324|NCT03814746|155914232|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
48470325|NCT03814746|155914230|FG000|Overall Study|Pregnancy|0|||
48470326|NCT03814746|155914231|FG001|Overall Study|Pregnancy|1|||
48470327|NCT03814746|155914232|FG002|Overall Study|Pregnancy|1|||
48470328|NCT03814746|155914230|FG000|Overall Study|Protocol Violation|1|||
48470329|NCT03814746|155914231|FG001|Overall Study|Protocol Violation|0|||
48470330|NCT03814746|155914232|FG002|Overall Study|Protocol Violation|0|||
48470331|NCT01733758|155914235|FG000|Overall Study|Adverse Event|5|||
48470332|NCT01733758|155914236|FG001|Overall Study|Adverse Event|7|||
48470333|NCT01733758|155914237|FG002|Overall Study|Adverse Event|8|||
48470334|NCT01733758|155914238|FG003|Overall Study|Adverse Event|1|||
48470335|NCT01733758|155914235|FG000|Overall Study|Withdrawal by Subject|1|||
48470336|NCT01733758|155914236|FG001|Overall Study|Withdrawal by Subject|1|||
48470337|NCT01733758|155914237|FG002|Overall Study|Withdrawal by Subject|5|||
48470338|NCT01733758|155914238|FG003|Overall Study|Withdrawal by Subject|3|||
48470339|NCT01733758|155914235|FG000|Overall Study|Persistent Hyperglycemia|3|||
48470340|NCT01733758|155914236|FG001|Overall Study|Persistent Hyperglycemia|2|||
48470341|NCT01733758|155914237|FG002|Overall Study|Persistent Hyperglycemia|0|||
48470342|NCT01733758|155914238|FG003|Overall Study|Persistent Hyperglycemia|0|||
48470343|NCT01733758|155914235|FG000|Overall Study|Protocol Violation|0|||
48470344|NCT01733758|155914236|FG001|Overall Study|Protocol Violation|1|||
48470345|NCT01733758|155914237|FG002|Overall Study|Protocol Violation|2|||
48470346|NCT01733758|155914238|FG003|Overall Study|Protocol Violation|2|||
48470347|NCT01733758|155914235|FG000|Overall Study|Non-compliance|1|||
48470348|NCT01733758|155914236|FG001|Overall Study|Non-compliance|0|||
48470349|NCT01733758|155914237|FG002|Overall Study|Non-compliance|0|||
48470350|NCT01733758|155914238|FG003|Overall Study|Non-compliance|0|||
48470351|NCT01733758|155914235|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
48470352|NCT01733758|155914236|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
48470353|NCT01733758|155914237|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
48470354|NCT01733758|155914238|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
48470355|NCT01733758|155914235|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
48470356|NCT01733758|155914236|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
48470357|NCT01733758|155914237|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
48470358|NCT01733758|155914238|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
48470359|NCT01399619|155914239|FG000|Overall Study|Adverse Event|10|||
48470360|NCT01399619|155914240|FG001|Overall Study|Adverse Event|0|||
48470361|NCT01399619|155914241|FG002|Overall Study|Adverse Event|4|||
48470362|NCT01399619|155914242|FG003|Overall Study|Adverse Event|10|||
48470363|NCT01399619|155914239|FG000|Overall Study|Lack of Efficacy|9|||
48470364|NCT01399619|155914240|FG001|Overall Study|Lack of Efficacy|0|||
48470365|NCT01399619|155914241|FG002|Overall Study|Lack of Efficacy|5|||
48470366|NCT01399619|155914242|FG003|Overall Study|Lack of Efficacy|0|||
48470367|NCT01399619|155914239|FG000|Overall Study|Withdrawal by Subject|6|||
48470368|NCT01399619|155914240|FG001|Overall Study|Withdrawal by Subject|0|||
48470369|NCT01399619|155914241|FG002|Overall Study|Withdrawal by Subject|3|||
48470370|NCT01399619|155914242|FG003|Overall Study|Withdrawal by Subject|4|||
48470371|NCT01399619|155914239|FG000|Overall Study|Protocol Violation|0|||
48470372|NCT01399619|155914240|FG001|Overall Study|Protocol Violation|0|||
48470373|NCT01399619|155914241|FG002|Overall Study|Protocol Violation|0|||
48470374|NCT01399619|155914242|FG003|Overall Study|Protocol Violation|1|||
48470375|NCT01399619|155914239|FG000|Overall Study|Not treated|0|||
48470376|NCT01399619|155914240|FG001|Overall Study|Not treated|0|||
48470377|NCT01399619|155914241|FG002|Overall Study|Not treated|0|||
48470378|NCT01399619|155914242|FG003|Overall Study|Not treated|2|||
48470379|NCT02557308|155914245|FG000|Overall Study|Withdrawal by Subject|11|||
48470380|NCT02557308|155914246|FG001|Overall Study|Withdrawal by Subject|3|||
48470381|NCT02557308|155914247|FG002|Overall Study|Withdrawal by Subject|2|||
48470382|NCT02557308|155914248|FG003|Overall Study|Withdrawal by Subject|0|||
48470383|NCT02557308|155914249|FG004|Overall Study|Withdrawal by Subject|1|||
48470384|NCT02557308|155914250|FG005|Overall Study|Withdrawal by Subject|0|||
48470385|NCT02557308|155914251|FG006|Overall Study|Withdrawal by Subject|10|||
48470386|NCT02557308|155914252|FG007|Overall Study|Withdrawal by Subject|1|||
48470387|NCT02557308|155914245|FG000|Overall Study|Disease Progression|0|||
48470388|NCT02557308|155914246|FG001|Overall Study|Disease Progression|1|||
48470389|NCT02557308|155914247|FG002|Overall Study|Disease Progression|0|||
48470390|NCT02557308|155914248|FG003|Overall Study|Disease Progression|0|||
48470391|NCT02557308|155914249|FG004|Overall Study|Disease Progression|0|||
48470392|NCT02557308|155914250|FG005|Overall Study|Disease Progression|0|||
48470393|NCT02557308|155914251|FG006|Overall Study|Disease Progression|0|||
48470394|NCT02557308|155914252|FG007|Overall Study|Disease Progression|0|||
48470395|NCT02557308|155914245|FG000|Overall Study|Lack of Efficacy|3|||
48470396|NCT02557308|155914246|FG001|Overall Study|Lack of Efficacy|0|||
48470397|NCT02557308|155914247|FG002|Overall Study|Lack of Efficacy|0|||
48470398|NCT02557308|155914248|FG003|Overall Study|Lack of Efficacy|0|||
48470399|NCT02557308|155914249|FG004|Overall Study|Lack of Efficacy|0|||
48470400|NCT02557308|155914250|FG005|Overall Study|Lack of Efficacy|0|||
48470401|NCT02557308|155914251|FG006|Overall Study|Lack of Efficacy|1|||
48470402|NCT02557308|155914252|FG007|Overall Study|Lack of Efficacy|0|||
48470403|NCT02557308|155914245|FG000|Overall Study|Adverse Event|4|||
48470404|NCT02557308|155914246|FG001|Overall Study|Adverse Event|1|||
48470405|NCT02557308|155914247|FG002|Overall Study|Adverse Event|2|||
48470406|NCT02557308|155914248|FG003|Overall Study|Adverse Event|0|||
48470407|NCT02557308|155914249|FG004|Overall Study|Adverse Event|0|||
48470408|NCT02557308|155914250|FG005|Overall Study|Adverse Event|0|||
48470409|NCT02557308|155914251|FG006|Overall Study|Adverse Event|4|||
48470410|NCT02557308|155914252|FG007|Overall Study|Adverse Event|1|||
48470411|NCT02557308|155914245|FG000|Overall Study|Lost to Follow-up|2|||
48470412|NCT02557308|155914246|FG001|Overall Study|Lost to Follow-up|0|||
48470413|NCT02557308|155914247|FG002|Overall Study|Lost to Follow-up|1|||
48470414|NCT02557308|155914248|FG003|Overall Study|Lost to Follow-up|0|||
48470415|NCT02557308|155914249|FG004|Overall Study|Lost to Follow-up|0|||
48470416|NCT02557308|155914250|FG005|Overall Study|Lost to Follow-up|0|||
48470417|NCT02557308|155914251|FG006|Overall Study|Lost to Follow-up|2|||
48470418|NCT02557308|155914252|FG007|Overall Study|Lost to Follow-up|0|||
48470419|NCT02557308|155914245|FG000|Overall Study|Death|1|||
48470420|NCT02557308|155914246|FG001|Overall Study|Death|0|||
48470421|NCT02557308|155914247|FG002|Overall Study|Death|0|||
48470422|NCT02557308|155914248|FG003|Overall Study|Death|0|||
48470423|NCT02557308|155914249|FG004|Overall Study|Death|0|||
48470424|NCT02557308|155914250|FG005|Overall Study|Death|0|||
48470425|NCT02557308|155914251|FG006|Overall Study|Death|0|||
48470426|NCT02557308|155914252|FG007|Overall Study|Death|0|||
48470427|NCT02557308|155914245|FG000|Overall Study|Study Close|98|||
48470428|NCT02557308|155914246|FG001|Overall Study|Study Close|18|||
48470429|NCT02557308|155914247|FG002|Overall Study|Study Close|5|||
48470430|NCT02557308|155914248|FG003|Overall Study|Study Close|3|||
48470431|NCT02557308|155914249|FG004|Overall Study|Study Close|1|||
48470432|NCT02557308|155914250|FG005|Overall Study|Study Close|0|||
48470433|NCT02557308|155914251|FG006|Overall Study|Study Close|123|||
48470434|NCT02557308|155914252|FG007|Overall Study|Study Close|5|||
48470435|NCT02557308|155914245|FG000|Overall Study|Except for study close|5|||
48470436|NCT02557308|155914246|FG001|Overall Study|Except for study close|0|||
48470437|NCT02557308|155914247|FG002|Overall Study|Except for study close|0|||
48470438|NCT02557308|155914248|FG003|Overall Study|Except for study close|0|||
48470439|NCT02557308|155914249|FG004|Overall Study|Except for study close|3|||
48470440|NCT02557308|155914250|FG005|Overall Study|Except for study close|0|||
48470441|NCT02557308|155914251|FG006|Overall Study|Except for study close|6|||
48470442|NCT02557308|155914252|FG007|Overall Study|Except for study close|10|||
48470443|NCT03911401|155914255|FG000|Overall Study|Adverse Event|1|||
48470444|NCT03911401|155914256|FG001|Overall Study|Adverse Event|2|||
48470445|NCT03911401|155914257|FG002|Overall Study|Adverse Event|5|||
48470446|NCT03911401|155914255|FG000|Overall Study|Lack of Efficacy|1|||
48470447|NCT03911401|155914256|FG001|Overall Study|Lack of Efficacy|1|||
48470448|NCT03911401|155914257|FG002|Overall Study|Lack of Efficacy|8|||
48470449|NCT03911401|155914255|FG000|Overall Study|Physician Decision|0|||
48470450|NCT03911401|155914256|FG001|Overall Study|Physician Decision|0|||
48470451|NCT03911401|155914257|FG002|Overall Study|Physician Decision|1|||
48470452|NCT03911401|155914255|FG000|Overall Study|Withdrawal by Subject|1|||
48470453|NCT03911401|155914256|FG001|Overall Study|Withdrawal by Subject|2|||
48470454|NCT03911401|155914257|FG002|Overall Study|Withdrawal by Subject|0|||
48470455|NCT03911401|155914255|FG000|Overall Study|Withdrawal by parent/guardian|4|||
48470456|NCT03911401|155914256|FG001|Overall Study|Withdrawal by parent/guardian|4|||
48470457|NCT03911401|155914257|FG002|Overall Study|Withdrawal by parent/guardian|11|||
48470458|NCT05602818|155914261|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
48470459|NCT05602818|155914262|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
48470460|NCT05602818|155914263|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
48470461|NCT05602818|155914264|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
48470462|NCT05602818|155914265|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
48470463|NCT05602818|155914266|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
48470464|NCT05602818|155914267|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
48470465|NCT05602818|155914268|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
48470466|NCT05602818|155914269|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
48470467|NCT05602818|155914270|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
48470468|NCT05602818|155914271|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
48470469|NCT05602818|155914272|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
48470470|NCT05602818|155914261|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
48470471|NCT05602818|155914262|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
48470472|NCT05602818|155914263|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470473|NCT05602818|155914264|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470474|NCT05602818|155914265|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470475|NCT05602818|155914266|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470476|NCT05602818|155914267|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470477|NCT05602818|155914268|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470478|NCT05602818|155914269|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470479|NCT05602818|155914270|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470480|NCT05602818|155914271|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470481|NCT05602818|155914272|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
48470482|NCT05602818|155914261|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
48470483|NCT05602818|155914262|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470484|NCT05602818|155914263|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470485|NCT05602818|155914264|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470486|NCT05602818|155914265|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470487|NCT05602818|155914266|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470488|NCT05602818|155914267|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470489|NCT05602818|155914268|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470490|NCT05602818|155914269|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470491|NCT05602818|155914270|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470492|NCT05602818|155914271|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470493|NCT05602818|155914272|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
48470494|NCT05602818|155914261|FG000|Qualification Phase (3 Days)|Other|1|||
48470495|NCT05602818|155914262|FG001|Qualification Phase (3 Days)|Other|0|||
48470496|NCT05602818|155914263|FG002|Qualification Phase (3 Days)|Other|0|||
48470497|NCT05602818|155914264|FG003|Qualification Phase (3 Days)|Other|0|||
48470498|NCT05602818|155914265|FG004|Qualification Phase (3 Days)|Other|0|||
48470499|NCT05602818|155914266|FG005|Qualification Phase (3 Days)|Other|0|||
48470500|NCT05602818|155914267|FG006|Qualification Phase (3 Days)|Other|0|||
48470501|NCT05602818|155914268|FG007|Qualification Phase (3 Days)|Other|0|||
48470502|NCT05602818|155914269|FG008|Qualification Phase (3 Days)|Other|0|||
48470503|NCT05602818|155914270|FG009|Qualification Phase (3 Days)|Other|0|||
48470504|NCT05602818|155914271|FG010|Qualification Phase (3 Days)|Other|0|||
48470505|NCT05602818|155914272|FG011|Qualification Phase (3 Days)|Other|0|||
48470506|NCT05602818|155914261|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470507|NCT05602818|155914262|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
48470508|NCT05602818|155914263|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470509|NCT05602818|155914264|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470510|NCT05602818|155914265|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470511|NCT05602818|155914266|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470512|NCT05602818|155914267|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470513|NCT05602818|155914268|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470514|NCT05602818|155914269|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470515|NCT05602818|155914270|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470516|NCT05602818|155914271|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470517|NCT05602818|155914272|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
48470518|NCT05602818|155914261|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
48470519|NCT05602818|155914262|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
48470520|NCT05602818|155914263|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
48470521|NCT05602818|155914264|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
48470522|NCT05602818|155914265|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
48470523|NCT05602818|155914266|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
48470524|NCT05602818|155914267|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
48470525|NCT05602818|155914268|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
48470526|NCT05602818|155914269|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
48470527|NCT05602818|155914270|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
48470528|NCT05602818|155914271|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
48470529|NCT05602818|155914272|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
48470530|NCT05602818|155914261|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470531|NCT05602818|155914262|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470532|NCT05602818|155914263|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470533|NCT05602818|155914264|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470534|NCT05602818|155914265|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470535|NCT05602818|155914266|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470536|NCT05602818|155914267|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470537|NCT05602818|155914268|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470538|NCT05602818|155914269|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470539|NCT05602818|155914270|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
48470540|NCT05602818|155914271|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
48470541|NCT05602818|155914272|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
48470542|NCT05602818|155914261|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
48470543|NCT05602818|155914262|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
48470544|NCT05602818|155914263|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
48470545|NCT05602818|155914264|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
48470546|NCT05602818|155914265|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
48470547|NCT05602818|155914266|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
48470548|NCT05602818|155914267|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
48470549|NCT05602818|155914268|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
48470550|NCT05602818|155914269|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
48470551|NCT05602818|155914270|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
48470552|NCT05602818|155914271|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
48470553|NCT05602818|155914272|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
48470554|NCT00535262|155914273|FG000|Overall Study|No funding|3|||
48470555|NCT01707667|155914274|FG000|Period 1|expulsion of colonic sensor catheter|1|||
48470556|NCT01707667|155914275|FG001|Period 1|expulsion of colonic sensor catheter|0|||
48470557|NCT01050998|155914276|FG000|Overall Study|Adverse Event|1|||
48470558|NCT01050998|155914277|FG001|Overall Study|Adverse Event|0|||
48470559|NCT01050998|155914278|FG002|Overall Study|Adverse Event|1|||
48470560|NCT01050998|155914279|FG003|Overall Study|Adverse Event|0|||
48470561|NCT01050998|155914280|FG004|Overall Study|Adverse Event|2|||
48470562|NCT01050998|155914276|FG000|Overall Study|Withdrawal by Subject|0|||
48470563|NCT01050998|155914277|FG001|Overall Study|Withdrawal by Subject|0|||
48470564|NCT01050998|155914278|FG002|Overall Study|Withdrawal by Subject|0|||
48470565|NCT01050998|155914279|FG003|Overall Study|Withdrawal by Subject|1|||
48470566|NCT01050998|155914280|FG004|Overall Study|Withdrawal by Subject|3|||
48470567|NCT01050998|155914276|FG000|Overall Study|Other|3|||
48470568|NCT01050998|155914277|FG001|Overall Study|Other|2|||
48470569|NCT01050998|155914278|FG002|Overall Study|Other|1|||
48470570|NCT01050998|155914279|FG003|Overall Study|Other|1|||
48470571|NCT01050998|155914280|FG004|Overall Study|Other|5|||
48470572|NCT01050998|155914276|FG000|Overall Study|Data integrity issues|0|||
48470573|NCT01050998|155914277|FG001|Overall Study|Data integrity issues|0|||
48470574|NCT01050998|155914278|FG002|Overall Study|Data integrity issues|1|||
48470575|NCT01050998|155914279|FG003|Overall Study|Data integrity issues|1|||
48470576|NCT01050998|155914280|FG004|Overall Study|Data integrity issues|4|||
48470577|NCT01428882|155914281|FG000|Overall Study|Lack of Efficacy|2|||
48470578|NCT01428882|155914282|FG001|Overall Study|Lack of Efficacy|7|||
48470579|NCT01428882|155914281|FG000|Overall Study|Protocol Violation|4|||
48470580|NCT01428882|155914282|FG001|Overall Study|Protocol Violation|3|||
48470581|NCT02331680|155914283|FG000|Overall Study|Adverse Event|3|||
48470582|NCT02331680|155914284|FG001|Overall Study|Adverse Event|0|||
48470583|NCT02331680|155914285|FG002|Overall Study|Adverse Event|2|||
48470584|NCT02331680|155914283|FG000|Overall Study|Physician Decision|1|||
48470585|NCT02331680|155914284|FG001|Overall Study|Physician Decision|1|||
48470586|NCT02331680|155914285|FG002|Overall Study|Physician Decision|2|||
48470587|NCT02331680|155914283|FG000|Overall Study|Withdrawal by Subject|0|||
48470588|NCT02331680|155914284|FG001|Overall Study|Withdrawal by Subject|1|||
48470589|NCT02331680|155914285|FG002|Overall Study|Withdrawal by Subject|2|||
48470590|NCT02331680|155914283|FG000|Overall Study|Met withdrawal criteria|2|||
48470591|NCT02331680|155914284|FG001|Overall Study|Met withdrawal criteria|2|||
48470592|NCT02331680|155914285|FG002|Overall Study|Met withdrawal criteria|5|||
48470593|NCT02331680|155914283|FG000|Overall Study|Non-compliance with study drug|0|||
48470594|NCT02331680|155914284|FG001|Overall Study|Non-compliance with study drug|0|||
48470595|NCT02331680|155914285|FG002|Overall Study|Non-compliance with study drug|1|||
48470596|NCT02331680|155914283|FG000|Overall Study|Protocol Violation|0|||
48470597|NCT02331680|155914284|FG001|Overall Study|Protocol Violation|0|||
48470598|NCT02331680|155914285|FG002|Overall Study|Protocol Violation|3|||
48470599|NCT00779142|155914286|FG000|Overall Study|Screen Failures|3|||
48470600|NCT02431559|155914289|FG000|Overall Study|Adverse Event|0|||
48470601|NCT02431559|155914290|FG001|Overall Study|Adverse Event|1|||
48470602|NCT02431559|155914291|FG002|Overall Study|Adverse Event|0|||
48470603|NCT02431559|155914292|FG003|Overall Study|Adverse Event|4|||
48470604|NCT02431559|155914289|FG000|Overall Study|Progressive disease|2|||
48470605|NCT02431559|155914290|FG001|Overall Study|Progressive disease|1|||
48470606|NCT02431559|155914291|FG002|Overall Study|Progressive disease|4|||
48470607|NCT02431559|155914292|FG003|Overall Study|Progressive disease|22|||
48470608|NCT02431559|155914289|FG000|Overall Study|Withdrawal by Subject|0|||
48470609|NCT02431559|155914290|FG001|Overall Study|Withdrawal by Subject|1|||
48470610|NCT02431559|155914291|FG002|Overall Study|Withdrawal by Subject|0|||
48470611|NCT02431559|155914292|FG003|Overall Study|Withdrawal by Subject|4|||
48470612|NCT02431559|155914289|FG000|Overall Study|Physician Decision|0|||
48470613|NCT02431559|155914290|FG001|Overall Study|Physician Decision|0|||
48470614|NCT02431559|155914291|FG002|Overall Study|Physician Decision|0|||
48470615|NCT02431559|155914292|FG003|Overall Study|Physician Decision|1|||
48470616|NCT02500732|155914293|FG000|Overall Study|Physician Decision|0|||
48470617|NCT02500732|155914294|FG001|Overall Study|Physician Decision|1|||
48470618|NCT04236986|155914295|FG000|Overall Study|Withdrawal by Subject|3|||
48470619|NCT04236986|155914296|FG001|Overall Study|Withdrawal by Subject|1|||
48470620|NCT01233284|155914297|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
48470621|NCT01233284|155914298|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48470622|NCT01233284|155914299|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48470623|NCT01233284|155914300|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48470624|NCT01233284|155914301|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
48470625|NCT01233284|155914297|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48470626|NCT01233284|155914298|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
48470627|NCT01233284|155914299|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48470628|NCT01233284|155914300|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48470629|NCT01233284|155914301|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
48470630|NCT01233284|155914297|FG000|Period 1 (4 Weeks)|Other|0|||
48470631|NCT01233284|155914298|FG001|Period 1 (4 Weeks)|Other|0|||
48470632|NCT01233284|155914299|FG002|Period 1 (4 Weeks)|Other|1|||
48470633|NCT01233284|155914300|FG003|Period 1 (4 Weeks)|Other|0|||
48470634|NCT01233284|155914301|FG004|Period 1 (4 Weeks)|Other|0|||
48470635|NCT01233284|155914297|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48470636|NCT01233284|155914298|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48470637|NCT01233284|155914299|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
48470638|NCT01233284|155914300|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48470639|NCT01233284|155914301|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
48470640|NCT01233284|155914297|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48470641|NCT01233284|155914298|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48470642|NCT01233284|155914299|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
48470643|NCT01233284|155914300|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48470644|NCT01233284|155914301|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
48470645|NCT01233284|155914297|FG000|Period 3 (4 Weeks)|Other|0|||
48470646|NCT01233284|155914298|FG001|Period 3 (4 Weeks)|Other|0|||
48470647|NCT01233284|155914299|FG002|Period 3 (4 Weeks)|Other|0|||
48470648|NCT01233284|155914300|FG003|Period 3 (4 Weeks)|Other|1|||
48470649|NCT01233284|155914301|FG004|Period 3 (4 Weeks)|Other|0|||
48470650|NCT01233284|155914297|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
48470651|NCT01233284|155914298|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
48470652|NCT01233284|155914299|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
48470653|NCT01233284|155914300|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
48470654|NCT01233284|155914301|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
48470655|NCT01233284|155914297|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
48470656|NCT01233284|155914298|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
48470657|NCT01233284|155914299|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
48470658|NCT01233284|155914300|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
48470659|NCT01233284|155914301|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
48470660|NCT01348828|155914302|FG000|Overall Study|Death|20|||
48470661|NCT01348828|155914302|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
48470662|NCT01348828|155914302|FG000|Overall Study|Conversion|2|||
48470663|NCT01348828|155914302|FG000|Overall Study|missed visit|1|||
48470664|NCT02756182|155914303|FG000|Overall Study|StudyTechnical Difficulties|4|||
48470665|NCT00985114|155914304|FG000|Overall Study|Adverse Event|1|||
48470666|NCT00985114|155914305|FG001|Overall Study|Adverse Event|0|||
48470667|NCT00985114|155914304|FG000|Overall Study|Withdrawal by Subject|0|||
48470668|NCT00985114|155914305|FG001|Overall Study|Withdrawal by Subject|2|||
48470669|NCT00167414|155914306|FG000|Overall Study|Death|10|||
48470670|NCT01593761|155914307|FG000|Overall Study|Lost to Follow-up|1|||
48470671|NCT01593761|155914307|FG000|Overall Study|culture negative for MRSA at baseline|5|||
48470672|NCT01593761|155914307|FG000|Overall Study|positive for hepatitis C virus|1|||
48470673|NCT01593761|155914307|FG000|Overall Study|secondary cellulitis|1|||
48470674|NCT01965600|155914308|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
48470675|NCT01965600|155914309|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
48470676|NCT01965600|155914310|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
48470677|NCT01965600|155914311|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
48470678|NCT01965600|155914308|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
48470679|NCT01965600|155914309|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
48470680|NCT01965600|155914310|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
48470681|NCT01965600|155914311|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
48470682|NCT01965600|155914308|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
48470683|NCT01965600|155914309|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
48470684|NCT01965600|155914310|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
48470685|NCT01965600|155914311|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
48470686|NCT01965600|155914308|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
48470687|NCT01965600|155914309|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
48470688|NCT01965600|155914310|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
48470689|NCT01965600|155914311|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
48470690|NCT01965600|155914308|FG000|Second Intervention|Study terminated by Sponsor|0|||
48470691|NCT01965600|155914309|FG001|Second Intervention|Study terminated by Sponsor|0|||
48470692|NCT01965600|155914310|FG002|Second Intervention|Study terminated by Sponsor|2|||
48470693|NCT01965600|155914311|FG003|Second Intervention|Study terminated by Sponsor|2|||
48470694|NCT04502862|155914312|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
48470695|NCT04502862|155914313|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
48470696|NCT04502862|155914312|FG000|Overall Study|Withdrawal by Subject|1|||
48470697|NCT04502862|155914313|FG001|Overall Study|Withdrawal by Subject|0|||
48470698|NCT04502862|155914312|FG000|Overall Study|Adverse Event|1|||
48470699|NCT04502862|155914313|FG001|Overall Study|Adverse Event|1|||
48470700|NCT01945866|155915897|FG000|Overall Study|Eyes did not complete or were dropped|2|||
48470701|NCT01945866|155915898|FG001|Overall Study|Eyes did not complete or were dropped|0|||
48470702|NCT01336647|155915900|FG000|Overall Study|Lost to Follow-up|4|||
48470703|NCT01336647|155915901|FG001|Overall Study|Lost to Follow-up|1|||
48470704|NCT01336647|155915902|FG002|Overall Study|Lost to Follow-up|3|||
48470705|NCT03808298|155915903|FG000|Overall Study|Adverse Event|3|||
48470706|NCT03808298|155915903|FG000|Overall Study|Physician Decision|1|||
48470707|NCT03808298|155915903|FG000|Overall Study|Withdrawal by Subject|1|||
48470708|NCT03808298|155915903|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
48470709|NCT01018680|155915906|FG000|Overall Study|Adverse Event|23|||
48470710|NCT01018680|155915907|FG001|Overall Study|Adverse Event|40|||
48470711|NCT01018680|155915906|FG000|Overall Study|Withdrawal by Subject|10|||
48470712|NCT01018680|155915907|FG001|Overall Study|Withdrawal by Subject|10|||
48470713|NCT01018680|155915906|FG000|Overall Study|Protocol Violation|5|||
48470714|NCT01018680|155915907|FG001|Overall Study|Protocol Violation|8|||
48470715|NCT01018680|155915906|FG000|Overall Study|Sponsor Decision|6|||
48470716|NCT01018680|155915907|FG001|Overall Study|Sponsor Decision|7|||
48470717|NCT01018680|155915906|FG000|Overall Study|Lack of Efficacy|8|||
48470718|NCT01018680|155915907|FG001|Overall Study|Lack of Efficacy|2|||
48470719|NCT01018680|155915906|FG000|Overall Study|Lost to Follow-up|5|||
48470720|NCT01018680|155915907|FG001|Overall Study|Lost to Follow-up|3|||
48470721|NCT01018680|155915906|FG000|Overall Study|Entry Criteria Not Met|1|||
48470722|NCT01018680|155915907|FG001|Overall Study|Entry Criteria Not Met|4|||
48470723|NCT01018680|155915906|FG000|Overall Study|Physician Decision|3|||
48470724|NCT01018680|155915907|FG001|Overall Study|Physician Decision|1|||
48470725|NCT02930889|155915908|FG000|Overall Study|Lost to Follow-up|2|||
48470726|NCT02930889|155915908|FG000|Overall Study|Withdrawal by Subject|6|||
48470727|NCT02930889|155915908|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
48470728|NCT04398030|155915910|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
48470729|NCT04398030|155915911|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
48470730|NCT04398030|155915910|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
48470731|NCT04398030|155915911|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
48470732|NCT01004822|155915912|FG000|Overall Study|Objective progression or relapse|3|||
48470733|NCT01004822|155915913|FG001|Overall Study|Objective progression or relapse|3|||
48470734|NCT01004822|155915914|FG002|Overall Study|Objective progression or relapse|0|||
48470735|NCT01004822|155915915|FG003|Overall Study|Objective progression or relapse|1|||
48470736|NCT01004822|155915916|FG004|Overall Study|Objective progression or relapse|2|||
48470737|NCT01004822|155915917|FG005|Overall Study|Objective progression or relapse|2|||
48470738|NCT01004822|155915918|FG006|Overall Study|Objective progression or relapse|1|||
48470739|NCT01004822|155915919|FG007|Overall Study|Objective progression or relapse|4|||
48470740|NCT01004822|155915912|FG000|Overall Study|Global deterioration of health status|0|||
48470741|NCT01004822|155915913|FG001|Overall Study|Global deterioration of health status|0|||
48470742|NCT01004822|155915914|FG002|Overall Study|Global deterioration of health status|0|||
48470743|NCT01004822|155915915|FG003|Overall Study|Global deterioration of health status|1|||
48470744|NCT01004822|155915916|FG004|Overall Study|Global deterioration of health status|0|||
48470745|NCT01004822|155915917|FG005|Overall Study|Global deterioration of health status|0|||
48470746|NCT01004822|155915918|FG006|Overall Study|Global deterioration of health status|1|||
48470747|NCT01004822|155915919|FG007|Overall Study|Global deterioration of health status|0|||
48470748|NCT01004822|155915912|FG000|Overall Study|No longer willing to continue|0|||
48470749|NCT01004822|155915913|FG001|Overall Study|No longer willing to continue|0|||
48470750|NCT01004822|155915914|FG002|Overall Study|No longer willing to continue|0|||
48470751|NCT01004822|155915915|FG003|Overall Study|No longer willing to continue|1|||
48470752|NCT01004822|155915916|FG004|Overall Study|No longer willing to continue|2|||
48470753|NCT01004822|155915917|FG005|Overall Study|No longer willing to continue|1|||
48470754|NCT01004822|155915918|FG006|Overall Study|No longer willing to continue|1|||
48470755|NCT01004822|155915919|FG007|Overall Study|No longer willing to continue|0|||
48470756|NCT01004822|155915912|FG000|Overall Study|Adverse Event|0|||
48470757|NCT01004822|155915913|FG001|Overall Study|Adverse Event|0|||
48470758|NCT01004822|155915914|FG002|Overall Study|Adverse Event|0|||
48470759|NCT01004822|155915915|FG003|Overall Study|Adverse Event|0|||
48470760|NCT01004822|155915916|FG004|Overall Study|Adverse Event|0|||
48470761|NCT01004822|155915917|FG005|Overall Study|Adverse Event|0|||
48470762|NCT01004822|155915918|FG006|Overall Study|Adverse Event|1|||
48470763|NCT01004822|155915919|FG007|Overall Study|Adverse Event|1|||
48470764|NCT01004822|155915912|FG000|Overall Study|Other|0|||
48470765|NCT01004822|155915913|FG001|Overall Study|Other|0|||
48470766|NCT01004822|155915914|FG002|Overall Study|Other|4|||
48470767|NCT01004822|155915915|FG003|Overall Study|Other|1|||
48470768|NCT01004822|155915916|FG004|Overall Study|Other|0|||
48470769|NCT01004822|155915917|FG005|Overall Study|Other|1|||
48470770|NCT01004822|155915918|FG006|Overall Study|Other|0|||
48470771|NCT01004822|155915919|FG007|Overall Study|Other|0|||
48470772|NCT01858701|155915920|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
48470773|NCT01858701|155915921|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
48470774|NCT01858701|155915920|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
48470775|NCT01858701|155915921|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
48470776|NCT01858701|155915920|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
48470777|NCT01858701|155915921|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
48470778|NCT01858701|155915920|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
48470779|NCT01858701|155915921|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
48470780|NCT01674010|155915922|FG000|Open Treatment Phase 1|Adverse Event|10|||
48470781|NCT01674010|155915923|FG001|Open Treatment Phase 1|Adverse Event|0|||
48470782|NCT01674010|155915924|FG002|Open Treatment Phase 1|Adverse Event|0|||
48470783|NCT01674010|155915922|FG000|Open Treatment Phase 1|Death|1|||
48470784|NCT01674010|155915923|FG001|Open Treatment Phase 1|Death|0|||
48470785|NCT01674010|155915924|FG002|Open Treatment Phase 1|Death|0|||
48470786|NCT01674010|155915922|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
48470787|NCT01674010|155915923|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
48470788|NCT01674010|155915924|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
48470789|NCT01674010|155915922|FG000|Open Treatment Phase 1|Physician Decision|9|||
48470790|NCT01674010|155915923|FG001|Open Treatment Phase 1|Physician Decision|0|||
48470791|NCT01674010|155915924|FG002|Open Treatment Phase 1|Physician Decision|0|||
48470792|NCT01674010|155915922|FG000|Open Treatment Phase 1|Protocol Violation|7|||
48470793|NCT01674010|155915923|FG001|Open Treatment Phase 1|Protocol Violation|0|||
48470794|NCT01674010|155915924|FG002|Open Treatment Phase 1|Protocol Violation|0|||
48470795|NCT01674010|155915922|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
48470796|NCT01674010|155915923|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
48470797|NCT01674010|155915924|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
48470798|NCT01674010|155915922|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
48470799|NCT01674010|155915923|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
48470800|NCT01674010|155915924|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
48470801|NCT01674010|155915922|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
48470802|NCT01674010|155915923|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
48470803|NCT01674010|155915924|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
48470804|NCT01674010|155915922|FG000|Randomization Phase 2|Adverse Event|0|||
48470805|NCT01674010|155915923|FG001|Randomization Phase 2|Adverse Event|1|||
48470806|NCT01674010|155915924|FG002|Randomization Phase 2|Adverse Event|1|||
48470807|NCT01674010|155915922|FG000|Randomization Phase 2|Lost to Follow-up|0|||
48470808|NCT01674010|155915923|FG001|Randomization Phase 2|Lost to Follow-up|1|||
48470809|NCT01674010|155915924|FG002|Randomization Phase 2|Lost to Follow-up|2|||
48470810|NCT01674010|155915922|FG000|Randomization Phase 2|Mood episode recurrence|0|||
48470811|NCT01674010|155915923|FG001|Randomization Phase 2|Mood episode recurrence|8|||
48470812|NCT01674010|155915924|FG002|Randomization Phase 2|Mood episode recurrence|2|||
48470813|NCT01674010|155915922|FG000|Randomization Phase 2|Physician Decision|0|||
48470814|NCT01674010|155915923|FG001|Randomization Phase 2|Physician Decision|0|||
48470815|NCT01674010|155915924|FG002|Randomization Phase 2|Physician Decision|2|||
48470816|NCT01674010|155915922|FG000|Randomization Phase 2|Pregnancy|0|||
48470817|NCT01674010|155915923|FG001|Randomization Phase 2|Pregnancy|1|||
48470818|NCT01674010|155915924|FG002|Randomization Phase 2|Pregnancy|1|||
48470819|NCT01674010|155915922|FG000|Randomization Phase 2|Protocol Violation|0|||
48470820|NCT01674010|155915923|FG001|Randomization Phase 2|Protocol Violation|1|||
48470821|NCT01674010|155915924|FG002|Randomization Phase 2|Protocol Violation|1|||
48470822|NCT01674010|155915922|FG000|Randomization Phase 2|Sponsor Decision|0|||
48470823|NCT01674010|155915923|FG001|Randomization Phase 2|Sponsor Decision|42|||
48470824|NCT01674010|155915924|FG002|Randomization Phase 2|Sponsor Decision|45|||
48470825|NCT01674010|155915922|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
48470826|NCT01674010|155915923|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
48470827|NCT01674010|155915924|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
48470828|NCT01020812|155915925|FG000|Overall Study|Physician Decision|1|||
48470829|NCT01020812|155915925|FG000|Overall Study|Withdrawal by Subject|1|||
48470830|NCT01020812|155915925|FG000|Overall Study|Protocol Violation|1|||
48470831|NCT03159455|155915928|FG000|Overall Study|Adverse Event|0|||
48470832|NCT03159455|155915929|FG001|Overall Study|Adverse Event|0|||
48470833|NCT03159455|155915930|FG002|Overall Study|Adverse Event|0|||
48470834|NCT03159455|155915931|FG003|Overall Study|Adverse Event|0|||
48470835|NCT03159455|155915932|FG004|Overall Study|Adverse Event|0|||
48470836|NCT03159455|155915933|FG005|Overall Study|Adverse Event|1|||
48470837|NCT01302366|155915942|FG000|Overall Study|patient choice or noncompliance|5|||
48470838|NCT01786707|155915947|FG000|Overall Study|Lost to Follow-up|1|||
48470839|NCT01786707|155915948|FG001|Overall Study|Lost to Follow-up|1|||
48470840|NCT02058940|155915952|FG000|Overall Study|Discharged from Critical Care Unit|1|||
48470841|NCT04144140|155915953|FG000|Overall Study|Other|0|||
48470842|NCT04144140|155915954|FG001|Overall Study|Other|0|||
48470843|NCT04144140|155915955|FG002|Overall Study|Other|0|||
48470844|NCT04144140|155915956|FG003|Overall Study|Other|0|||
48470845|NCT04144140|155915957|FG004|Overall Study|Other|0|||
48470846|NCT04144140|155915958|FG005|Overall Study|Other|1|||
48470847|NCT04144140|155915959|FG006|Overall Study|Other|0|||
48470848|NCT01465958|155915960|FG000|Run-in Phase|Protocol Violation|1|||
48470849|NCT01465958|155915961|FG001|Run-in Phase|Protocol Violation|0|||
48470850|NCT01465958|155915960|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
48470851|NCT01465958|155915961|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
48470852|NCT02713490|155915962|FG000|Overall Study|Withdrawal by Subject|2|||
48470853|NCT02713490|155915963|FG001|Overall Study|Withdrawal by Subject|1|||
48470854|NCT02713490|155915962|FG000|Overall Study|Did not receive study drug|1|||
48470855|NCT02713490|155915963|FG001|Overall Study|Did not receive study drug|0|||
48470856|NCT02713490|155915962|FG000|Overall Study|Met exclusion criteria|0|||
48470857|NCT02713490|155915963|FG001|Overall Study|Met exclusion criteria|1|||
48470858|NCT01519700|155915964|FG000|Overall Study|Death|1|||
48470859|NCT01519700|155915965|FG001|Overall Study|Death|0|||
48470860|NCT01519700|155915966|FG002|Overall Study|Death|0|||
48470861|NCT01519700|155915967|FG003|Overall Study|Death|0|||
48470862|NCT01519700|155915964|FG000|Overall Study|Lost to Follow-up|0|||
48470863|NCT01519700|155915965|FG001|Overall Study|Lost to Follow-up|0|||
48470864|NCT01519700|155915966|FG002|Overall Study|Lost to Follow-up|1|||
48470865|NCT01519700|155915967|FG003|Overall Study|Lost to Follow-up|1|||
48470866|NCT01519700|155915964|FG000|Overall Study|Physician Decision|1|||
48470867|NCT01519700|155915965|FG001|Overall Study|Physician Decision|1|||
48470868|NCT01519700|155915966|FG002|Overall Study|Physician Decision|3|||
48470869|NCT01519700|155915967|FG003|Overall Study|Physician Decision|0|||
48470870|NCT01519700|155915964|FG000|Overall Study|Withdrawal by Subject|5|||
48470871|NCT01519700|155915965|FG001|Overall Study|Withdrawal by Subject|3|||
48470872|NCT01519700|155915966|FG002|Overall Study|Withdrawal by Subject|3|||
48470873|NCT01519700|155915967|FG003|Overall Study|Withdrawal by Subject|2|||
48470874|NCT01519700|155915964|FG000|Overall Study|Other Reason|2|||
48470875|NCT01519700|155915965|FG001|Overall Study|Other Reason|2|||
48470876|NCT01519700|155915966|FG002|Overall Study|Other Reason|0|||
48470877|NCT01519700|155915967|FG003|Overall Study|Other Reason|4|||
48470878|NCT00346775|155915968|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
48470879|NCT00346775|155915969|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
48470880|NCT00346775|155915968|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
48470881|NCT00346775|155915969|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
48470882|NCT00346775|155915968|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
48470883|NCT00346775|155915969|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
48470884|NCT02946515|155915970|FG000|Overall Study|Lost to Follow-up|2|||
48470885|NCT02946515|155915971|FG001|Overall Study|Lost to Follow-up|1|||
48470886|NCT03799198|155915972|FG000|Overall Study|Lost to Follow-up|4|||
48470887|NCT03799198|155915973|FG001|Overall Study|Lost to Follow-up|8|||
48470888|NCT03799198|155915972|FG000|Overall Study|Death|0|||
48470889|NCT03799198|155915973|FG001|Overall Study|Death|1|||
48470890|NCT00960869|155915978|FG000|Overall Study|Adverse Event|17|||
48470891|NCT00960869|155915979|FG001|Overall Study|Adverse Event|26|||
48470892|NCT00960869|155915978|FG000|Overall Study|Withdrawal by Subject|16|||
48470893|NCT00960869|155915979|FG001|Overall Study|Withdrawal by Subject|14|||
48470894|NCT00960869|155915978|FG000|Overall Study|Lost to Follow-up|1|||
48470895|NCT00960869|155915979|FG001|Overall Study|Lost to Follow-up|4|||
48470896|NCT00960869|155915978|FG000|Overall Study|Misc|19|||
48470897|NCT00960869|155915979|FG001|Overall Study|Misc|18|||
48470898|NCT02706327|155915982|FG000|Overall Study|Lost to Follow-up|1|||
48470899|NCT02706327|155915983|FG001|Overall Study|Lost to Follow-up|1|||
48470900|NCT02706327|155915984|FG002|Overall Study|Lost to Follow-up|2|||
48470901|NCT00750061|155915991|FG000|Overall Study|Adverse Event|2|||
48470902|NCT00750061|155915992|FG001|Overall Study|Adverse Event|0|||
48470903|NCT00750061|155915991|FG000|Overall Study|Withdrawal by Subject|0|||
48470904|NCT00750061|155915992|FG001|Overall Study|Withdrawal by Subject|1|||
48470905|NCT00750061|155915991|FG000|Overall Study|Physician Decision|0|||
48470906|NCT00750061|155915992|FG001|Overall Study|Physician Decision|1|||
48470907|NCT01012765|155916000|FG000|Treatment Period 1|Adverse Event|1|||
48470908|NCT01012765|155916001|FG001|Treatment Period 1|Adverse Event|0|||
48470909|NCT01012765|155916002|FG002|Treatment Period 1|Adverse Event|1|||
48470910|NCT01012765|155916003|FG003|Treatment Period 1|Adverse Event|0|||
48470911|NCT01012765|155916004|FG004|Treatment Period 1|Adverse Event|0|||
48470912|NCT01012765|155916005|FG005|Treatment Period 1|Adverse Event|0|||
48470913|NCT01012765|155916000|FG000|Treatment Period 1|Withdrawal by Subject|2|||
48470914|NCT01012765|155916001|FG001|Treatment Period 1|Withdrawal by Subject|0|||
48470915|NCT01012765|155916002|FG002|Treatment Period 1|Withdrawal by Subject|0|||
48470916|NCT01012765|155916003|FG003|Treatment Period 1|Withdrawal by Subject|0|||
48470917|NCT01012765|155916004|FG004|Treatment Period 1|Withdrawal by Subject|0|||
48470918|NCT01012765|155916005|FG005|Treatment Period 1|Withdrawal by Subject|0|||
48470919|NCT01012765|155916000|FG000|Treatment Period 1|Administrative problems|0|||
48470920|NCT01012765|155916001|FG001|Treatment Period 1|Administrative problems|0|||
48470921|NCT01012765|155916002|FG002|Treatment Period 1|Administrative problems|1|||
48470922|NCT01012765|155916003|FG003|Treatment Period 1|Administrative problems|1|||
48470923|NCT01012765|155916004|FG004|Treatment Period 1|Administrative problems|1|||
48470924|NCT01012765|155916005|FG005|Treatment Period 1|Administrative problems|0|||
48470925|NCT01012765|155916000|FG000|Treatment Period 1|Protocol Violation|0|||
48470926|NCT01012765|155916001|FG001|Treatment Period 1|Protocol Violation|0|||
48470927|NCT01012765|155916002|FG002|Treatment Period 1|Protocol Violation|0|||
48470928|NCT01012765|155916003|FG003|Treatment Period 1|Protocol Violation|2|||
48470929|NCT01012765|155916004|FG004|Treatment Period 1|Protocol Violation|1|||
48470930|NCT01012765|155916005|FG005|Treatment Period 1|Protocol Violation|0|||
48470931|NCT01012765|155916000|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48470932|NCT01012765|155916001|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48470933|NCT01012765|155916002|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48470934|NCT01012765|155916003|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48470935|NCT01012765|155916004|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
48470936|NCT01012765|155916005|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
48470937|NCT01012765|155916000|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48470938|NCT01012765|155916001|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48470939|NCT01012765|155916002|FG002|Treatment Period 2|Withdrawal by Subject|1|||
48470940|NCT01012765|155916003|FG003|Treatment Period 2|Withdrawal by Subject|0|||
48470941|NCT01012765|155916004|FG004|Treatment Period 2|Withdrawal by Subject|1|||
48470942|NCT01012765|155916005|FG005|Treatment Period 2|Withdrawal by Subject|0|||
48470943|NCT01012765|155916000|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
48470944|NCT01012765|155916001|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
48470945|NCT01012765|155916002|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
48470946|NCT01012765|155916003|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
48470947|NCT01012765|155916004|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
48470948|NCT01012765|155916005|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
48470949|NCT01012765|155916000|FG000|Treatment Period 2|Adverse Event|0|||
48470950|NCT01012765|155916001|FG001|Treatment Period 2|Adverse Event|1|||
48470951|NCT01012765|155916002|FG002|Treatment Period 2|Adverse Event|1|||
48470952|NCT01012765|155916003|FG003|Treatment Period 2|Adverse Event|0|||
48470953|NCT01012765|155916004|FG004|Treatment Period 2|Adverse Event|0|||
48470954|NCT01012765|155916005|FG005|Treatment Period 2|Adverse Event|0|||
48470955|NCT01012765|155916000|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
48470956|NCT01012765|155916001|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
48470957|NCT01012765|155916002|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
48470958|NCT01012765|155916003|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
48470959|NCT01012765|155916004|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
48470960|NCT01012765|155916005|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
48470961|NCT00672490|155916006|FG000|Overall Study|Withdrawal by Subject|8|||
48470962|NCT00672490|155916007|FG001|Overall Study|Withdrawal by Subject|8|||
48470963|NCT00672490|155916006|FG000|Overall Study|Lack of Compliance|2|||
48470964|NCT00672490|155916007|FG001|Overall Study|Lack of Compliance|7|||
48470965|NCT00672490|155916006|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
48470966|NCT00672490|155916007|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
48470967|NCT00672490|155916006|FG000|Overall Study|Adverse Event|5|||
48470968|NCT00672490|155916007|FG001|Overall Study|Adverse Event|8|||
48470969|NCT00672490|155916006|FG000|Overall Study|Violation of Concomitant Medicine|1|||
48470970|NCT00672490|155916007|FG001|Overall Study|Violation of Concomitant Medicine|0|||
48470971|NCT00672490|155916006|FG000|Overall Study|Intolerance|0|||
48470972|NCT00672490|155916007|FG001|Overall Study|Intolerance|2|||
48470973|NCT00672490|155916006|FG000|Overall Study|Lost to Follow-up|1|||
48470974|NCT00672490|155916007|FG001|Overall Study|Lost to Follow-up|5|||
48470975|NCT00672490|155916006|FG000|Overall Study|No reason was provided|6|||
48470976|NCT00672490|155916007|FG001|Overall Study|No reason was provided|2|||
48470977|NCT01326312|155916012|FG000|Overall Study|Adverse Event|11|||
48470978|NCT01326312|155916013|FG001|Overall Study|Adverse Event|11|||
48470979|NCT01326312|155916014|FG002|Overall Study|Adverse Event|1|||
48470980|NCT01326312|155916012|FG000|Overall Study|Withdrawal by Subject|1|||
48470981|NCT01326312|155916013|FG001|Overall Study|Withdrawal by Subject|2|||
48470982|NCT01326312|155916014|FG002|Overall Study|Withdrawal by Subject|1|||
48470983|NCT01326312|155916012|FG000|Overall Study|Protocol Violation|0|||
48470984|NCT01326312|155916013|FG001|Overall Study|Protocol Violation|1|||
48470985|NCT01326312|155916014|FG002|Overall Study|Protocol Violation|0|||
48470986|NCT01326312|155916012|FG000|Overall Study|Lack of Efficacy|13|||
48470987|NCT01326312|155916013|FG001|Overall Study|Lack of Efficacy|7|||
48470988|NCT01326312|155916014|FG002|Overall Study|Lack of Efficacy|1|||
48470989|NCT01326312|155916012|FG000|Overall Study|Death|1|||
48470990|NCT01326312|155916013|FG001|Overall Study|Death|0|||
48470991|NCT01326312|155916014|FG002|Overall Study|Death|1|||
48470992|NCT01326312|155916012|FG000|Overall Study|progressive disease|0|||
48470993|NCT01326312|155916013|FG001|Overall Study|progressive disease|1|||
48470994|NCT01326312|155916014|FG002|Overall Study|progressive disease|1|||
48470995|NCT01326312|155916012|FG000|Overall Study|Study terminated by Sponsor|8|||
48470996|NCT01326312|155916013|FG001|Overall Study|Study terminated by Sponsor|32|||
48470997|NCT01326312|155916014|FG002|Overall Study|Study terminated by Sponsor|46|||
48470998|NCT01326312|155916012|FG000|Overall Study|Treatment arm terminated|19|||
48470999|NCT01326312|155916013|FG001|Overall Study|Treatment arm terminated|0|||
48471000|NCT01326312|155916014|FG002|Overall Study|Treatment arm terminated|0|||
48471001|NCT01326312|155916012|FG000|Overall Study|QTc > 500|0|||
48471002|NCT01326312|155916013|FG001|Overall Study|QTc > 500|1|||
48471003|NCT01326312|155916014|FG002|Overall Study|QTc > 500|0|||
48471004|NCT04652245|155916015|FG000|Wash-Out Period|Adverse Event|0|||
48471005|NCT04652245|155916016|FG001|Wash-Out Period|Adverse Event|2|||
48471006|NCT04652245|155916015|FG000|Wash-Out Period|Withdrawal by Subject|0|||
48471007|NCT04652245|155916016|FG001|Wash-Out Period|Withdrawal by Subject|2|||
48471008|NCT02219477|155916017|FG000|Overall Study|Adverse Event|0|||
48471009|NCT02219477|155916018|FG001|Overall Study|Adverse Event|1|||
48471010|NCT02219477|155916019|FG002|Overall Study|Adverse Event|1|||
48471011|NCT02219477|155916017|FG000|Overall Study|Withdrawal by Subject|0|||
48471012|NCT02219477|155916018|FG001|Overall Study|Withdrawal by Subject|1|||
48471013|NCT02219477|155916019|FG002|Overall Study|Withdrawal by Subject|0|||
48471014|NCT03457701|155916025|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
48471015|NCT03457701|155916026|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
48471016|NCT03457701|155916025|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
48471017|NCT03457701|155916026|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
48471018|NCT01016912|155916027|FG000|End of Treatment Period|Lack of Efficacy|0|||
48471019|NCT01016912|155916028|FG001|End of Treatment Period|Lack of Efficacy|1|||
48471020|NCT01016912|155916029|FG002|End of Treatment Period|Lack of Efficacy|0|||
48471021|NCT01016912|155916030|FG003|End of Treatment Period|Lack of Efficacy|4|||
48471022|NCT01016912|155916031|FG004|End of Treatment Period|Lack of Efficacy|4|||
48471023|NCT01016912|155916027|FG000|End of Treatment Period|Adverse Event|0|||
48471024|NCT01016912|155916028|FG001|End of Treatment Period|Adverse Event|1|||
48471025|NCT01016912|155916029|FG002|End of Treatment Period|Adverse Event|1|||
48471026|NCT01016912|155916030|FG003|End of Treatment Period|Adverse Event|0|||
48471027|NCT01016912|155916031|FG004|End of Treatment Period|Adverse Event|0|||
48471028|NCT01016912|155916027|FG000|End of Treatment Period|Completed double-blind period only|0|||
48471029|NCT01016912|155916028|FG001|End of Treatment Period|Completed double-blind period only|1|||
48471030|NCT01016912|155916029|FG002|End of Treatment Period|Completed double-blind period only|0|||
48471031|NCT01016912|155916030|FG003|End of Treatment Period|Completed double-blind period only|0|||
48471032|NCT01016912|155916031|FG004|End of Treatment Period|Completed double-blind period only|0|||
48471033|NCT01016912|155916027|FG000|Follow-up Period|Other reason|0|||
48471034|NCT01016912|155916028|FG001|Follow-up Period|Other reason|0|||
48471035|NCT01016912|155916029|FG002|Follow-up Period|Other reason|1|||
48471036|NCT01016912|155916030|FG003|Follow-up Period|Other reason|1|||
48471037|NCT01016912|155916031|FG004|Follow-up Period|Other reason|0|||
48471038|NCT00914940|155916032|FG000|D0 to D100 Post-transplant|Death|2|||
48471039|NCT00914940|155916032|FG000|D101 to 2 Years Post-transplant|Death|8|||
48471040|NCT00914940|155916032|FG000|2 Years to 5 Years Post-transplant|Death|3|||
48471041|NCT00796367|155916033|FG000|Overall Study|Adverse Event|6|||
48471042|NCT00796367|155916034|FG001|Overall Study|Adverse Event|4|||
48471043|NCT00796367|155916035|FG002|Overall Study|Adverse Event|7|||
48471044|NCT00796367|155916033|FG000|Overall Study|Lost to Follow-up|5|||
48471045|NCT00796367|155916034|FG001|Overall Study|Lost to Follow-up|4|||
48471046|NCT00796367|155916035|FG002|Overall Study|Lost to Follow-up|21|||
48471047|NCT00796367|155916033|FG000|Overall Study|Withdrawal by Subject|9|||
48471048|NCT00796367|155916034|FG001|Overall Study|Withdrawal by Subject|11|||
48471049|NCT00796367|155916035|FG002|Overall Study|Withdrawal by Subject|12|||
48471050|NCT00796367|155916033|FG000|Overall Study|Lack of Efficacy|2|||
48471051|NCT00796367|155916034|FG001|Overall Study|Lack of Efficacy|1|||
48471052|NCT00796367|155916035|FG002|Overall Study|Lack of Efficacy|0|||
48471053|NCT00796367|155916033|FG000|Overall Study|non compliance|3|||
48471054|NCT00796367|155916034|FG001|Overall Study|non compliance|1|||
48471055|NCT00796367|155916035|FG002|Overall Study|non compliance|1|||
48471056|NCT00796367|155916033|FG000|Overall Study|Pregnancy|1|||
48471057|NCT00796367|155916034|FG001|Overall Study|Pregnancy|0|||
48471058|NCT00796367|155916035|FG002|Overall Study|Pregnancy|1|||
48471059|NCT00796367|155916033|FG000|Overall Study|Requirement for restricted medication|2|||
48471060|NCT00796367|155916034|FG001|Overall Study|Requirement for restricted medication|0|||
48471061|NCT00796367|155916035|FG002|Overall Study|Requirement for restricted medication|2|||
48471062|NCT00796367|155916033|FG000|Overall Study|other|2|||
48471063|NCT00796367|155916034|FG001|Overall Study|other|4|||
48471064|NCT00796367|155916035|FG002|Overall Study|other|3|||
48471065|NCT05664672|155916037|FG000|Overall Study|Adverse Event|0|||
48471066|NCT05664672|155916038|FG001|Overall Study|Adverse Event|0|||
48471067|NCT05664672|155916039|FG002|Overall Study|Adverse Event|0|||
48471068|NCT05664672|155916040|FG003|Overall Study|Adverse Event|0|||
48471069|NCT05664672|155916041|FG004|Overall Study|Adverse Event|0|||
48471070|NCT05664672|155916042|FG005|Overall Study|Adverse Event|1|||
48471071|NCT05664672|155916037|FG000|Overall Study|Withdrawal by Subject|0|||
48471072|NCT05664672|155916038|FG001|Overall Study|Withdrawal by Subject|1|||
48471073|NCT05664672|155916039|FG002|Overall Study|Withdrawal by Subject|3|||
48471074|NCT05664672|155916040|FG003|Overall Study|Withdrawal by Subject|0|||
48471075|NCT05664672|155916041|FG004|Overall Study|Withdrawal by Subject|5|||
48471076|NCT05664672|155916042|FG005|Overall Study|Withdrawal by Subject|6|||
48471077|NCT05664672|155916037|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
48471078|NCT05664672|155916038|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
48471079|NCT05664672|155916039|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
48471080|NCT05664672|155916040|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
48471081|NCT05664672|155916041|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
48471082|NCT05664672|155916042|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
48471083|NCT05664672|155916037|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
48471084|NCT05664672|155916038|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48471085|NCT05664672|155916039|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48471086|NCT05664672|155916040|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48471087|NCT05664672|155916041|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48471088|NCT05664672|155916042|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
48471089|NCT02442284|155916043|FG000|Overall Study|Adverse Event|1|||
48471090|NCT02442284|155916043|FG000|Overall Study|Withdrew Consent|2|||
48471091|NCT02442284|155916043|FG000|Overall Study|Lost to Follow-up|3|||
48471092|NCT02442284|155916043|FG000|Overall Study|Other|1|||
48471093|NCT00948896|155916044|FG000|Randomization to 24 Months of Age|Death|1|||
48471094|NCT00948896|155916045|FG001|Randomization to 24 Months of Age|Death|0|||
48471095|NCT00948896|155916046|FG002|Randomization to 24 Months of Age|Death|0|||
48471096|NCT00948896|155916047|FG003|Randomization to 24 Months of Age|Death|0|||
48471097|NCT00948896|155916048|FG004|Randomization to 24 Months of Age|Death|2|||
48471098|NCT00948896|155916049|FG005|Randomization to 24 Months of Age|Death|1|||
48471099|NCT00948896|155916050|FG006|Randomization to 24 Months of Age|Death|2|||
48471100|NCT00948896|155916051|FG007|Randomization to 24 Months of Age|Death|1|||
48471101|NCT00948896|155916044|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
48471102|NCT00948896|155916045|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
48471103|NCT00948896|155916046|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
48471104|NCT00948896|155916047|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
48471105|NCT00948896|155916048|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
48471106|NCT00948896|155916049|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
48471107|NCT00948896|155916050|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
48471108|NCT00948896|155916051|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
48471109|NCT00948896|155916044|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
48471110|NCT00948896|155916045|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
48471111|NCT00948896|155916046|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
48471112|NCT00948896|155916047|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
48471113|NCT00948896|155916048|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
48471114|NCT00948896|155916049|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
48471115|NCT00948896|155916050|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
48471116|NCT00948896|155916051|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
48471117|NCT00948896|155916044|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
48471118|NCT00948896|155916045|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
48471119|NCT00948896|155916046|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
48471120|NCT00948896|155916047|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
48471121|NCT00948896|155916048|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
48471122|NCT00948896|155916049|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
48471123|NCT00948896|155916050|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
48471124|NCT00948896|155916051|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
48471125|NCT00948896|155916044|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
48471126|NCT00948896|155916045|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
48471127|NCT00948896|155916046|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
48471128|NCT00948896|155916047|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
48471129|NCT00948896|155916048|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
48471130|NCT00948896|155916049|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
48471131|NCT00948896|155916050|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
48471132|NCT00948896|155916051|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
48471133|NCT00948896|155916044|FG000|24 Months of Age to 36 Months of Age|Death|0|||
48471134|NCT00948896|155916045|FG001|24 Months of Age to 36 Months of Age|Death|2|||
48471135|NCT00948896|155916046|FG002|24 Months of Age to 36 Months of Age|Death|2|||
48471136|NCT00948896|155916047|FG003|24 Months of Age to 36 Months of Age|Death|0|||
48471137|NCT00948896|155916048|FG004|24 Months of Age to 36 Months of Age|Death|0|||
48471138|NCT00948896|155916049|FG005|24 Months of Age to 36 Months of Age|Death|1|||
48471139|NCT00948896|155916050|FG006|24 Months of Age to 36 Months of Age|Death|0|||
48471140|NCT00948896|155916051|FG007|24 Months of Age to 36 Months of Age|Death|0|||
48471141|NCT00948896|155916044|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
48471142|NCT00948896|155916045|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48471143|NCT00948896|155916046|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
48471144|NCT00948896|155916047|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
48471145|NCT00948896|155916048|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48471146|NCT00948896|155916049|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48471147|NCT00948896|155916050|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48471148|NCT00948896|155916051|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
48471149|NCT00948896|155916044|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
48471150|NCT00948896|155916045|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
48471151|NCT00948896|155916046|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
48471152|NCT00948896|155916047|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
48471153|NCT00948896|155916048|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
48471154|NCT00948896|155916049|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
48471155|NCT00948896|155916050|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
48471156|NCT00948896|155916051|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
48471157|NCT00948896|155916044|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48471158|NCT00948896|155916045|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48471159|NCT00948896|155916046|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
48471160|NCT00948896|155916047|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48471161|NCT00948896|155916048|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48471162|NCT00948896|155916049|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
48471163|NCT00948896|155916050|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48471164|NCT00948896|155916051|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
48471165|NCT00948896|155916044|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48471166|NCT00948896|155916045|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48471167|NCT00948896|155916046|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48471168|NCT00948896|155916047|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
48471169|NCT00948896|155916048|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48471170|NCT00948896|155916049|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48471171|NCT00948896|155916050|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48471172|NCT00948896|155916051|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
48471173|NCT03795233|155916052|FG000|Overall Study|Withdrawal by Subject|2|||
48471174|NCT03795233|155916053|FG001|Overall Study|Withdrawal by Subject|1|||
48471175|NCT03795233|155916052|FG000|Overall Study|Lost to Follow-up|1|||
48471176|NCT03795233|155916053|FG001|Overall Study|Lost to Follow-up|0|||
48471177|NCT03795233|155916052|FG000|Overall Study|Death|1|||
48471178|NCT03795233|155916053|FG001|Overall Study|Death|0|||
48471179|NCT00421928|155917288|FG000|Overall Study|Adverse Event|61|||
48471180|NCT00421928|155917289|FG001|Overall Study|Adverse Event|140|||
48471181|NCT00421928|155917290|FG002|Overall Study|Adverse Event|22|||
48471182|NCT00421928|155917288|FG000|Overall Study|Lost to Follow-up|5|||
48471183|NCT00421928|155917289|FG001|Overall Study|Lost to Follow-up|0|||
48471184|NCT00421928|155917290|FG002|Overall Study|Lost to Follow-up|3|||
48471185|NCT00421928|155917288|FG000|Overall Study|Withdrawal by Subject|50|||
48471186|NCT00421928|155917289|FG001|Overall Study|Withdrawal by Subject|48|||
48471187|NCT00421928|155917290|FG002|Overall Study|Withdrawal by Subject|43|||
48471188|NCT00421928|155917288|FG000|Overall Study|Lack of Efficacy|15|||
48471189|NCT00421928|155917289|FG001|Overall Study|Lack of Efficacy|7|||
48471190|NCT00421928|155917290|FG002|Overall Study|Lack of Efficacy|35|||
48471191|NCT00421928|155917288|FG000|Overall Study|Study drug non-compliant|6|||
48471192|NCT00421928|155917289|FG001|Overall Study|Study drug non-compliant|7|||
48471193|NCT00421928|155917290|FG002|Overall Study|Study drug non-compliant|4|||
48471194|NCT00421928|155917288|FG000|Overall Study|All other|26|||
48471195|NCT00421928|155917289|FG001|Overall Study|All other|21|||
48471196|NCT00421928|155917290|FG002|Overall Study|All other|27|||
48471197|NCT00421928|155917288|FG000|Overall Study|Death|0|||
48471198|NCT00421928|155917289|FG001|Overall Study|Death|1|||
48471199|NCT00421928|155917290|FG002|Overall Study|Death|0|||
48471200|NCT05056311|155917297|FG000|Overall Study|Lost to Follow-up|14|||
48471201|NCT05056311|155917297|FG000|Overall Study|Withdrawal by Subject|1|||
48471202|NCT05056311|155917297|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
48471203|NCT02528643|155917298|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
48471204|NCT02528643|155917299|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
48471205|NCT02528643|155917298|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
48471206|NCT02528643|155917299|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
48471207|NCT02528643|155917298|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
48471208|NCT02528643|155917299|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
48471209|NCT02528643|155917298|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
48471210|NCT02528643|155917299|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
48471211|NCT02528643|155917298|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
48471212|NCT02528643|155917299|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
48471213|NCT02528643|155917298|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
48471214|NCT02528643|155917299|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
48471215|NCT02528643|155917298|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
48471216|NCT02528643|155917299|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
48471217|NCT00198107|155917300|FG000|Double-Blind Period|Adverse Event|1|||
48471218|NCT00198107|155917301|FG001|Double-Blind Period|Adverse Event|1|||
48471219|NCT00198107|155917302|FG002|Double-Blind Period|Adverse Event|0|||
48471220|NCT00198107|155917300|FG000|Double-Blind Period|Lack of Efficacy|2|||
48471221|NCT00198107|155917301|FG001|Double-Blind Period|Lack of Efficacy|0|||
48471222|NCT00198107|155917302|FG002|Double-Blind Period|Lack of Efficacy|0|||
48471223|NCT00198107|155917300|FG000|Double-Blind Period|Lost to Follow-up|2|||
48471224|NCT00198107|155917301|FG001|Double-Blind Period|Lost to Follow-up|1|||
48471225|NCT00198107|155917302|FG002|Double-Blind Period|Lost to Follow-up|0|||
48471226|NCT00198107|155917300|FG000|Double-Blind Period|Physician Decision|1|||
48471227|NCT00198107|155917301|FG001|Double-Blind Period|Physician Decision|0|||
48471228|NCT00198107|155917302|FG002|Double-Blind Period|Physician Decision|0|||
48471229|NCT00198107|155917300|FG000|Double-Blind Period|Withdrawal by Subject|0|||
48471230|NCT00198107|155917301|FG001|Double-Blind Period|Withdrawal by Subject|1|||
48471231|NCT00198107|155917302|FG002|Double-Blind Period|Withdrawal by Subject|0|||
48471232|NCT00198107|155917300|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
48471233|NCT00198107|155917301|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
48471234|NCT00198107|155917302|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
48471235|NCT04001790|155917303|FG000|Overall Study|Withdrawal by Subject|1|||
48471236|NCT04001790|155917304|FG001|Overall Study|Withdrawal by Subject|2|||
48471237|NCT02528331|155917305|FG000|Overall Study|Withdrawal by Subject|2|||
48471238|NCT03471507|155917306|FG000|Overall Study|Lost to Follow-up|1|||
48471239|NCT03471507|155917307|FG001|Overall Study|Lost to Follow-up|3|||
48471240|NCT03471507|155917306|FG000|Overall Study|Physician Decision|0|||
48471241|NCT03471507|155917307|FG001|Overall Study|Physician Decision|1|||
48471242|NCT03471507|155917306|FG000|Overall Study|Withdrawal by Subject|2|||
48471243|NCT03471507|155917307|FG001|Overall Study|Withdrawal by Subject|1|||
48471244|NCT02545270|155917308|FG000|Overall Study|technical difficulties|0|||
48471245|NCT02545270|155917309|FG001|Overall Study|technical difficulties|1|||
48471246|NCT02545270|155917310|FG002|Overall Study|technical difficulties|0|||
48471247|NCT02545270|155917308|FG000|Overall Study|Videos being too similar to other|0|||
48471248|NCT02545270|155917309|FG001|Overall Study|Videos being too similar to other|0|||
48471249|NCT02545270|155917310|FG002|Overall Study|Videos being too similar to other|2|||
48471250|NCT03287089|155917313|FG000|Overall Study|Lost to Follow-up|0|||
48471251|NCT03287089|155917314|FG001|Overall Study|Lost to Follow-up|2|||
48471252|NCT03287089|155917313|FG000|Overall Study|Physician Decision|0|||
48471253|NCT03287089|155917314|FG001|Overall Study|Physician Decision|2|||
48471254|NCT03287089|155917313|FG000|Overall Study|Withdrawal by Subject|0|||
48471255|NCT03287089|155917314|FG001|Overall Study|Withdrawal by Subject|2|||
48471256|NCT03380091|155917315|FG000|Overall Study|Withdrawal by Subject|2|||
48471257|NCT03380091|155917316|FG001|Overall Study|Withdrawal by Subject|1|||
48471258|NCT03772574|155917317|FG000|Overall Study|Protocol Violation|2|||
48471259|NCT03772574|155917318|FG001|Overall Study|Protocol Violation|0|||
48471260|NCT03772574|155917319|FG002|Overall Study|Protocol Violation|0|||
48471261|NCT03772574|155917317|FG000|Overall Study|Discomfort|0|||
48471262|NCT03772574|155917318|FG001|Overall Study|Discomfort|5|||
48471263|NCT03772574|155917319|FG002|Overall Study|Discomfort|4|||
48471264|NCT02918968|155917320|FG000|1st Line AAT|Progressive disease|9|||
48471265|NCT02918968|155917321|FG001|1st Line AAT|Progressive disease|4|||
48471266|NCT02918968|155917320|FG000|1st Line AAT|Adverse Event|12|||
48471267|NCT02918968|155917321|FG001|1st Line AAT|Adverse Event|3|||
48471268|NCT02918968|155917320|FG000|1st Line AAT|Physician Decision|4|||
48471269|NCT02918968|155917321|FG001|1st Line AAT|Physician Decision|2|||
48471270|NCT02918968|155917320|FG000|1st Line AAT|Withdrawal by Subject|2|||
48471271|NCT02918968|155917321|FG001|1st Line AAT|Withdrawal by Subject|1|||
48471272|NCT02918968|155917320|FG000|1st Line AAT|Lost to Follow-up|0|||
48471273|NCT02918968|155917321|FG001|1st Line AAT|Lost to Follow-up|1|||
48471274|NCT02918968|155917320|FG000|1st Line AAT|Death|1|||
48471275|NCT02918968|155917321|FG001|1st Line AAT|Death|0|||
48471276|NCT02918968|155917320|FG000|1st Line AAT|Miscellaneous|1|||
48471277|NCT02918968|155917321|FG001|1st Line AAT|Miscellaneous|0|||
48471278|NCT02918968|155917320|FG000|2nd Line AAT|Progressive disease|21|||
48471279|NCT02918968|155917321|FG001|2nd Line AAT|Progressive disease|3|||
48471280|NCT02918968|155917320|FG000|2nd Line AAT|Adverse Event|2|||
48471281|NCT02918968|155917321|FG001|2nd Line AAT|Adverse Event|5|||
48471282|NCT02918968|155917320|FG000|2nd Line AAT|Physician Decision|0|||
48471283|NCT02918968|155917321|FG001|2nd Line AAT|Physician Decision|1|||
48471284|NCT02918968|155917320|FG000|2nd Line AAT|Withdrawal by Subject|2|||
48471285|NCT02918968|155917321|FG001|2nd Line AAT|Withdrawal by Subject|2|||
48471286|NCT02918968|155917320|FG000|2nd Line AAT|Death|0|||
48471287|NCT02918968|155917321|FG001|2nd Line AAT|Death|1|||
48471288|NCT00727246|155917322|FG000|Overall Study|could not complete MRI|0|||
48471289|NCT00727246|155917323|FG001|Overall Study|could not complete MRI|1|||
48471290|NCT00727246|155917324|FG002|Overall Study|could not complete MRI|0|||
48471291|NCT00727246|155917325|FG003|Overall Study|could not complete MRI|1|||
48471292|NCT00727246|155917322|FG000|Overall Study|incidental finding|0|||
48471293|NCT00727246|155917323|FG001|Overall Study|incidental finding|0|||
48471294|NCT00727246|155917324|FG002|Overall Study|incidental finding|0|||
48471295|NCT00727246|155917325|FG003|Overall Study|incidental finding|1|||
48471296|NCT00727246|155917322|FG000|Overall Study|withdrawn|0|||
48471297|NCT00727246|155917323|FG001|Overall Study|withdrawn|0|||
48471298|NCT00727246|155917324|FG002|Overall Study|withdrawn|1|||
48471299|NCT00727246|155917325|FG003|Overall Study|withdrawn|0|||
48471300|NCT04594213|155917332|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
48471301|NCT04594213|155917333|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
48471302|NCT04594213|155917334|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
48471303|NCT04594213|155917335|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48471304|NCT04594213|155917336|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48471305|NCT04594213|155917337|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
48471306|NCT04594213|155917332|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48471307|NCT04594213|155917333|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
48471308|NCT04594213|155917334|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48471309|NCT04594213|155917335|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48471310|NCT04594213|155917336|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48471311|NCT04594213|155917337|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
48471312|NCT04594213|155917332|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
48471313|NCT04594213|155917333|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48471314|NCT04594213|155917334|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
48471315|NCT04594213|155917335|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48471316|NCT04594213|155917336|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48471317|NCT04594213|155917337|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
48471318|NCT04594213|155917332|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48471319|NCT04594213|155917333|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48471320|NCT04594213|155917334|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48471321|NCT04594213|155917335|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48471322|NCT04594213|155917336|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
48471323|NCT04594213|155917337|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
48471324|NCT04594213|155917332|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48471325|NCT04594213|155917333|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48471326|NCT04594213|155917334|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
48471327|NCT04594213|155917335|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
48471328|NCT04594213|155917336|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
48471329|NCT04594213|155917337|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
48471330|NCT04594213|155917332|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48471331|NCT04594213|155917333|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48471332|NCT04594213|155917334|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48471333|NCT04594213|155917335|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48471334|NCT04594213|155917336|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
48471335|NCT04594213|155917337|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
48471336|NCT04594213|155917332|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48471337|NCT04594213|155917333|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48471338|NCT04594213|155917334|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48471339|NCT04594213|155917335|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
48471340|NCT04594213|155917336|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48471341|NCT04594213|155917337|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
48471342|NCT04594213|155917332|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48471343|NCT04594213|155917333|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48471344|NCT04594213|155917334|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48471345|NCT04594213|155917335|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
48471346|NCT04594213|155917336|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48471347|NCT04594213|155917337|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
48471348|NCT04594213|155917332|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48471349|NCT04594213|155917333|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48471350|NCT04594213|155917334|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
48471351|NCT04594213|155917335|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
48471352|NCT04594213|155917336|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
48471353|NCT04594213|155917337|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
48471354|NCT04594213|155917332|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48471355|NCT04594213|155917333|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48471356|NCT04594213|155917334|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
48471357|NCT04594213|155917335|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
48471358|NCT04594213|155917336|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
48471359|NCT04594213|155917337|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
48471360|NCT04594213|155917332|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
48471361|NCT04594213|155917333|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
48471362|NCT04594213|155917334|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
48471363|NCT04594213|155917335|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
48471364|NCT04594213|155917336|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
48471365|NCT04594213|155917337|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
48471366|NCT03814499|155917338|FG000|Overall Study|Lost to Follow-up|3|||
48471367|NCT01589185|155917340|FG000|Overall Study|Death|1|||
48471368|NCT01589185|155917341|FG001|Overall Study|Death|2|||
48471369|NCT01589185|155917342|FG002|Overall Study|Death|2|||
48471370|NCT01589185|155917343|FG003|Overall Study|Death|0|||
48471371|NCT01589185|155917344|FG004|Overall Study|Death|1|||
48471372|NCT01589185|155917340|FG000|Overall Study|Lost to Follow-up|1|||
48471373|NCT01589185|155917341|FG001|Overall Study|Lost to Follow-up|0|||
48471374|NCT01589185|155917342|FG002|Overall Study|Lost to Follow-up|2|||
48471375|NCT01589185|155917343|FG003|Overall Study|Lost to Follow-up|3|||
48471376|NCT01589185|155917344|FG004|Overall Study|Lost to Follow-up|0|||
48471377|NCT02046993|155917345|FG000|Overall Study|Withdrawal by Subject|2|||
48471378|NCT02046993|155917346|FG001|Overall Study|Withdrawal by Subject|10|||
48471379|NCT02046993|155917345|FG000|Overall Study|Lost to Follow-up|1|||
48471380|NCT02046993|155917346|FG001|Overall Study|Lost to Follow-up|1|||
48471381|NCT03417245|155917347|FG000|Overall Study|Adverse Event|1|||
48471382|NCT03417245|155917348|FG001|Overall Study|Adverse Event|0|||
48471383|NCT03417245|155917347|FG000|Overall Study|Protocol Violation|1|||
48471384|NCT03417245|155917348|FG001|Overall Study|Protocol Violation|0|||
48471385|NCT03417245|155917347|FG000|Overall Study|Withdrawal by Subject|1|||
48471386|NCT03417245|155917348|FG001|Overall Study|Withdrawal by Subject|1|||
48471387|NCT02743117|155917356|FG000|Overall Study|Lost to Follow-up|0|||
48471388|NCT02743117|155917357|FG001|Overall Study|Lost to Follow-up|1|||
48471389|NCT02743117|155917356|FG000|Overall Study|Other|1|||
48471390|NCT02743117|155917357|FG001|Overall Study|Other|0|||
48471391|NCT02067728|155917358|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
48471392|NCT02067728|155917359|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
48471393|NCT02067728|155917358|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
48471394|NCT02067728|155917359|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
48471395|NCT02067728|155917358|FG000|6 Month Measurements|Unable to attend|114|||
48471396|NCT02067728|155917359|FG001|6 Month Measurements|Unable to attend|97|||
48471397|NCT00933543|155917360|FG000|Overall Study|Adverse Event|2|||
48471398|NCT00933543|155917361|FG001|Overall Study|Adverse Event|1|||
48471399|NCT00933543|155917360|FG000|Overall Study|Lost to Follow-up|0|||
48471400|NCT00933543|155917361|FG001|Overall Study|Lost to Follow-up|1|||
48471401|NCT00933543|155917360|FG000|Overall Study|Withdrawal by Subject|0|||
48471402|NCT00933543|155917361|FG001|Overall Study|Withdrawal by Subject|1|||
48471403|NCT00933543|155917360|FG000|Overall Study|Lack of Efficacy|0|||
48471404|NCT00933543|155917361|FG001|Overall Study|Lack of Efficacy|3|||
48471405|NCT00933543|155917360|FG000|Overall Study|Other|1|||
48471406|NCT00933543|155917361|FG001|Overall Study|Other|1|||
48471407|NCT00368069|155917367|FG000|Overall Study|Adverse Event|5|||
48471408|NCT00368069|155917368|FG001|Overall Study|Adverse Event|2|||
48471409|NCT00368069|155917367|FG000|Overall Study|Lack of Efficacy|0|||
48471410|NCT00368069|155917368|FG001|Overall Study|Lack of Efficacy|1|||
48471411|NCT00368069|155917367|FG000|Overall Study|Lost to Follow-up|1|||
48471412|NCT00368069|155917368|FG001|Overall Study|Lost to Follow-up|0|||
48471413|NCT00368069|155917367|FG000|Overall Study|Protocol Violation|0|||
48471414|NCT00368069|155917368|FG001|Overall Study|Protocol Violation|2|||
48471415|NCT00368069|155917367|FG000|Overall Study|Withdrawal of Consent|2|||
48471416|NCT00368069|155917368|FG001|Overall Study|Withdrawal of Consent|1|||
48471417|NCT00368069|155917367|FG000|Overall Study|no blood sampling possible|0|||
48471418|NCT00368069|155917368|FG001|Overall Study|no blood sampling possible|1|||
48471419|NCT00399542|155917369|FG000|Overall Study|Adverse Event|18|||
48471420|NCT00399542|155917370|FG001|Overall Study|Adverse Event|15|||
48471421|NCT00399542|155917369|FG000|Overall Study|Protocol Violation|13|||
48471422|NCT00399542|155917370|FG001|Overall Study|Protocol Violation|3|||
48471423|NCT00399542|155917369|FG000|Overall Study|Withdrawal by Subject|28|||
48471424|NCT00399542|155917370|FG001|Overall Study|Withdrawal by Subject|10|||
48471425|NCT00399542|155917369|FG000|Overall Study|Lack of Efficacy|18|||
48471426|NCT00399542|155917370|FG001|Overall Study|Lack of Efficacy|8|||
48471427|NCT00399542|155917369|FG000|Overall Study|Lost to Follow-up|6|||
48471428|NCT00399542|155917370|FG001|Overall Study|Lost to Follow-up|6|||
48471429|NCT00399542|155917369|FG000|Overall Study|Other|1|||
48471430|NCT00399542|155917370|FG001|Overall Study|Other|0|||
48471431|NCT00399542|155917369|FG000|Overall Study|Physician Decision|0|||
48471432|NCT00399542|155917370|FG001|Overall Study|Physician Decision|1|||
48471433|NCT02788981|155917380|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
48471434|NCT02788981|155917381|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
48471435|NCT01484691|155917387|FG000|Overall Study|Withdrawal by Subject|1|||
48471436|NCT01484691|155917388|FG001|Overall Study|Withdrawal by Subject|1|||
48471437|NCT01484691|155917389|FG002|Overall Study|Withdrawal by Subject|1|||
48471438|NCT01484691|155917387|FG000|Overall Study|Physician Decision|0|||
48471439|NCT01484691|155917388|FG001|Overall Study|Physician Decision|2|||
48471440|NCT01484691|155917389|FG002|Overall Study|Physician Decision|1|||
48471441|NCT05261126|155917390|FG000|Overall Study|Death|0|||
48471442|NCT05261126|155917391|FG001|Overall Study|Death|0|||
48471443|NCT05261126|155917392|FG002|Overall Study|Death|1|||
48471444|NCT05261126|155917393|FG003|Overall Study|Death|0|||
48471445|NCT05261126|155917394|FG004|Overall Study|Death|0|||
48471446|NCT05261126|155917390|FG000|Overall Study|Lost to Follow-up|0|||
48471447|NCT05261126|155917391|FG001|Overall Study|Lost to Follow-up|0|||
48471448|NCT05261126|155917392|FG002|Overall Study|Lost to Follow-up|0|||
48471449|NCT05261126|155917393|FG003|Overall Study|Lost to Follow-up|0|||
48471450|NCT05261126|155917394|FG004|Overall Study|Lost to Follow-up|1|||
48471451|NCT05261126|155917390|FG000|Overall Study|Physician Decision|1|||
48471452|NCT05261126|155917391|FG001|Overall Study|Physician Decision|0|||
48471453|NCT05261126|155917392|FG002|Overall Study|Physician Decision|0|||
48471454|NCT05261126|155917393|FG003|Overall Study|Physician Decision|0|||
48471455|NCT05261126|155917394|FG004|Overall Study|Physician Decision|0|||
48471456|NCT05261126|155917390|FG000|Overall Study|Screen Failure|0|||
48471457|NCT05261126|155917391|FG001|Overall Study|Screen Failure|0|||
48471458|NCT05261126|155917392|FG002|Overall Study|Screen Failure|0|||
48471459|NCT05261126|155917393|FG003|Overall Study|Screen Failure|0|||
48471460|NCT05261126|155917394|FG004|Overall Study|Screen Failure|1|||
48471461|NCT05261126|155917390|FG000|Overall Study|Withdrawal by Subject|1|||
48471462|NCT05261126|155917391|FG001|Overall Study|Withdrawal by Subject|0|||
48471463|NCT05261126|155917392|FG002|Overall Study|Withdrawal by Subject|1|||
48471464|NCT05261126|155917393|FG003|Overall Study|Withdrawal by Subject|1|||
48471465|NCT05261126|155917394|FG004|Overall Study|Withdrawal by Subject|0|||
48471466|NCT05261126|155917390|FG000|Overall Study|Not Recorded|0|||
48471467|NCT05261126|155917391|FG001|Overall Study|Not Recorded|0|||
48471468|NCT05261126|155917392|FG002|Overall Study|Not Recorded|0|||
48471469|NCT05261126|155917393|FG003|Overall Study|Not Recorded|1|||
48471470|NCT05261126|155917394|FG004|Overall Study|Not Recorded|0|||
48471471|NCT00938366|155917395|FG000|Overall Study|Withdrawal by Subject|1|||
48471472|NCT00938366|155917396|FG001|Overall Study|Withdrawal by Subject|0|||
48471473|NCT05643573|155917399|FG000|Overall Study|Adverse Event|117|||
48471474|NCT05643573|155917400|FG001|Overall Study|Adverse Event|90|||
48471475|NCT05643573|155917399|FG000|Overall Study|Death|53|||
48471476|NCT05643573|155917400|FG001|Overall Study|Death|57|||
48471477|NCT05643573|155917399|FG000|Overall Study|Lost to Follow-up|6|||
48471478|NCT05643573|155917400|FG001|Overall Study|Lost to Follow-up|3|||
48471479|NCT05643573|155917399|FG000|Overall Study|Other|18|||
48471480|NCT05643573|155917400|FG001|Overall Study|Other|15|||
48471481|NCT05643573|155917399|FG000|Overall Study|Outcome event|64|||
48471482|NCT05643573|155917400|FG001|Overall Study|Outcome event|36|||
48471483|NCT05643573|155917399|FG000|Overall Study|Physician Decision|33|||
48471484|NCT05643573|155917400|FG001|Overall Study|Physician Decision|19|||
48471485|NCT05643573|155917399|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
48471486|NCT05643573|155917400|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
48471487|NCT05643573|155917399|FG000|Overall Study|Site terminated by sponsor|10|||
48471488|NCT05643573|155917400|FG001|Overall Study|Site terminated by sponsor|10|||
48471489|NCT05643573|155917399|FG000|Overall Study|Study terminated by sponsor|1|||
48471490|NCT05643573|155917400|FG001|Overall Study|Study terminated by sponsor|0|||
48471491|NCT05643573|155917399|FG000|Overall Study|Withdrawal by Subject|178|||
48471492|NCT05643573|155917400|FG001|Overall Study|Withdrawal by Subject|130|||
48471493|NCT02184988|155917405|FG000|Overall Study|Pregnancy|2|||
48471494|NCT02184988|155917405|FG000|Overall Study|Adverse Event|2|||
48471495|NCT02184988|155917405|FG000|Overall Study|moving away/travelling/unable to complet|6|||
48471496|NCT02184988|155917405|FG000|Overall Study|work scheduling issues|4|||
48471497|NCT02184988|155917405|FG000|Overall Study|various other reasons|9|||
48471498|NCT02184988|155917405|FG000|Overall Study|Lost to Follow-up|32|||
48471499|NCT01958619|155917406|FG000|Overall Study|Protocol Violation|2|||
48471500|NCT01958619|155917407|FG001|Overall Study|Protocol Violation|0|||
48471501|NCT01958619|155917408|FG002|Overall Study|Protocol Violation|1|||
48471502|NCT01958619|155917409|FG003|Overall Study|Protocol Violation|0|||
48471503|NCT00483717|155917411|FG000|Overall Study|Protocol Violation|5|||
48471504|NCT00483717|155917412|FG001|Overall Study|Protocol Violation|7|||
48471505|NCT00483717|155917411|FG000|Overall Study|Time of dosing missing|1|||
48471506|NCT00483717|155917412|FG001|Overall Study|Time of dosing missing|1|||
48471507|NCT00483717|155917411|FG000|Overall Study|No treatment for migraine|16|||
48471508|NCT00483717|155917412|FG001|Overall Study|No treatment for migraine|13|||
48471509|NCT00483717|155917411|FG000|Overall Study|Lost to Follow-up|1|||
48471510|NCT00483717|155917412|FG001|Overall Study|Lost to Follow-up|0|||
48471511|NCT00483717|155917411|FG000|Overall Study|Withdrawal by Subject|1|||
48471512|NCT00483717|155917412|FG001|Overall Study|Withdrawal by Subject|0|||
48471513|NCT03878108|155917413|FG000|Overall Study|Adverse Event|1|||
48471514|NCT03878108|155917414|FG001|Overall Study|Adverse Event|0|||
48471515|NCT00975000|155917418|FG000|Overall Study|Other|1|||
48471516|NCT00975000|155917419|FG001|Overall Study|Other|0|||
48471517|NCT00975000|155917418|FG000|Overall Study|Adverse Event|1|||
48471518|NCT00975000|155917419|FG001|Overall Study|Adverse Event|1|||
48471519|NCT00975000|155917418|FG000|Overall Study|Withdrawal by Subject|2|||
48471520|NCT00975000|155917419|FG001|Overall Study|Withdrawal by Subject|2|||
48471521|NCT00975000|155917418|FG000|Overall Study|Lost to Follow-up|0|||
48471522|NCT00975000|155917419|FG001|Overall Study|Lost to Follow-up|1|||
48471523|NCT00975000|155917418|FG000|Overall Study|Protocol-specified Criteria|1|||
48471524|NCT00975000|155917419|FG001|Overall Study|Protocol-specified Criteria|0|||
48471525|NCT00975000|155917418|FG000|Overall Study|Non-compliance|0|||
48471526|NCT00975000|155917419|FG001|Overall Study|Non-compliance|1|||
48471527|NCT01869959|155917420|FG000|Randomization Period|Physician Decision|0|||
48471528|NCT01869959|155917421|FG001|Randomization Period|Physician Decision|0|||
48471529|NCT01869959|155917422|FG002|Randomization Period|Physician Decision|0|||
48471530|NCT01869959|155917423|FG003|Randomization Period|Physician Decision|0|||
48471531|NCT01869959|155917424|FG004|Randomization Period|Physician Decision|1|||
48471532|NCT01869959|155917420|FG000|Treatment Period|Adverse Event|1|||
48471533|NCT01869959|155917421|FG001|Treatment Period|Adverse Event|0|||
48471534|NCT01869959|155917422|FG002|Treatment Period|Adverse Event|3|||
48471535|NCT01869959|155917423|FG003|Treatment Period|Adverse Event|1|||
48471536|NCT01869959|155917424|FG004|Treatment Period|Adverse Event|0|||
48471537|NCT01869959|155917420|FG000|Treatment Period|Sponsor decision|0|||
48471538|NCT01869959|155917421|FG001|Treatment Period|Sponsor decision|1|||
48471539|NCT01869959|155917422|FG002|Treatment Period|Sponsor decision|0|||
48471540|NCT01869959|155917423|FG003|Treatment Period|Sponsor decision|1|||
48471541|NCT01869959|155917424|FG004|Treatment Period|Sponsor decision|0|||
48471542|NCT01869959|155917420|FG000|Treatment Period|Withdrawal by Subject|0|||
48471543|NCT01869959|155917421|FG001|Treatment Period|Withdrawal by Subject|1|||
48471544|NCT01869959|155917422|FG002|Treatment Period|Withdrawal by Subject|0|||
48471545|NCT01869959|155917423|FG003|Treatment Period|Withdrawal by Subject|0|||
48471546|NCT01869959|155917424|FG004|Treatment Period|Withdrawal by Subject|0|||
48471547|NCT00828009|155917425|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
48471548|NCT00828009|155917425|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
48471549|NCT00828009|155917425|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
48471550|NCT00828009|155917425|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
48471551|NCT00828009|155917425|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
48471552|NCT00828009|155917425|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
48471553|NCT00828009|155917425|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
48471554|NCT00828009|155917425|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
48471555|NCT00828009|155917425|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
48471556|NCT00828009|155917425|FG000|Step 2 - Maintenance Therapy|Death|1|||
48471557|NCT00828009|155917425|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
48471558|NCT00828009|155917425|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
48471559|NCT00828009|155917425|FG000|Step 2 - Maintenance Therapy|Other|1|||
48471560|NCT02501642|155918799|FG000|Overall Study|Lost to Follow-up|7|||
48471561|NCT02501642|155918800|FG001|Overall Study|Lost to Follow-up|11|||
48471562|NCT02513732|155918803|FG000|Overall Study|Lost to Follow-up|11|||
48471563|NCT02513732|155918803|FG000|Overall Study|Death|9|||
48471564|NCT02513732|155918803|FG000|Overall Study|Changing hospital|2|||
48471565|NCT00934661|155918804|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
48471566|NCT00934661|155918805|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
48471567|NCT00467051|155918806|FG000|Overall Study|Adverse Event|2|||
48471568|NCT01740297|155918807|FG000|Overall Study|Withdrawal by Subject|4|||
48471569|NCT01740297|155918808|FG001|Overall Study|Withdrawal by Subject|16|||
48471570|NCT01740297|155918809|FG002|Overall Study|Withdrawal by Subject|17|||
48471571|NCT01740297|155918807|FG000|Overall Study|Death|8|||
48471572|NCT01740297|155918808|FG001|Overall Study|Death|46|||
48471573|NCT01740297|155918809|FG002|Overall Study|Death|40|||
48471574|NCT01740297|155918807|FG000|Overall Study|Lost to Follow-up|1|||
48471575|NCT01740297|155918808|FG001|Overall Study|Lost to Follow-up|2|||
48471576|NCT01740297|155918809|FG002|Overall Study|Lost to Follow-up|4|||
48471577|NCT00761462|155918813|FG000|Treatment|Subjects never received study medication|23|||
48471578|NCT00761462|155918814|FG001|Treatment|Subjects never received study medication|12|||
48471579|NCT00761462|155918813|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
48471580|NCT00761462|155918814|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
48471581|NCT00761462|155918813|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
48471582|NCT00761462|155918814|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
48471583|NCT00761462|155918813|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
48471584|NCT00761462|155918814|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
48471585|NCT00812968|155918828|FG000|Overall Study|Relapse after erythroid response|6|||
48471586|NCT00812968|155918828|FG000|Overall Study|Disease progression|1|||
48471587|NCT00812968|155918828|FG000|Overall Study|No further treatment required|1|||
48471588|NCT00812968|155918828|FG000|Overall Study|Study closed due to marketing approval|3|||
48471589|NCT03586427|155918831|FG000|Overall Study|Lost to Follow-up|0|||
48471590|NCT03586427|155918832|FG001|Overall Study|Lost to Follow-up|3|||
48471591|NCT03586427|155918833|FG002|Overall Study|Lost to Follow-up|1|||
48471592|NCT03586427|155918834|FG003|Overall Study|Lost to Follow-up|3|||
48471593|NCT03586427|155918835|FG004|Overall Study|Lost to Follow-up|3|||
48471594|NCT03586427|155918831|FG000|Overall Study|Withdrawal by Subject|0|||
48471595|NCT03586427|155918832|FG001|Overall Study|Withdrawal by Subject|1|||
48471596|NCT03586427|155918833|FG002|Overall Study|Withdrawal by Subject|2|||
48471597|NCT03586427|155918834|FG003|Overall Study|Withdrawal by Subject|1|||
48471598|NCT03586427|155918835|FG004|Overall Study|Withdrawal by Subject|1|||
48471599|NCT03586427|155918831|FG000|Overall Study|Adverse Event|0|||
48471600|NCT03586427|155918832|FG001|Overall Study|Adverse Event|0|||
48471601|NCT03586427|155918833|FG002|Overall Study|Adverse Event|1|||
48471602|NCT03586427|155918834|FG003|Overall Study|Adverse Event|0|||
48471603|NCT03586427|155918835|FG004|Overall Study|Adverse Event|0|||
48471604|NCT03586427|155918831|FG000|Overall Study|Protocol Violation|0|||
48471605|NCT03586427|155918832|FG001|Overall Study|Protocol Violation|0|||
48471606|NCT03586427|155918833|FG002|Overall Study|Protocol Violation|1|||
48471607|NCT03586427|155918834|FG003|Overall Study|Protocol Violation|0|||
48471608|NCT03586427|155918835|FG004|Overall Study|Protocol Violation|1|||
48471609|NCT03586427|155918831|FG000|Overall Study|Noncompliance with study drug|0|||
48471610|NCT03586427|155918832|FG001|Overall Study|Noncompliance with study drug|0|||
48471611|NCT03586427|155918833|FG002|Overall Study|Noncompliance with study drug|1|||
48471612|NCT03586427|155918834|FG003|Overall Study|Noncompliance with study drug|0|||
48471613|NCT03586427|155918835|FG004|Overall Study|Noncompliance with study drug|0|||
48471614|NCT02696382|155918837|FG000|Overall Study|Death|7|||
48471615|NCT02696382|155918838|FG001|Overall Study|Death|2|||
48471616|NCT02696382|155918837|FG000|Overall Study|Withdrawal by Subject|5|||
48471617|NCT02696382|155918838|FG001|Overall Study|Withdrawal by Subject|12|||
48471618|NCT02696382|155918837|FG000|Overall Study|Lost to Follow-up|4|||
48471619|NCT02696382|155918838|FG001|Overall Study|Lost to Follow-up|7|||
48471620|NCT01980056|155918840|FG000|Overall Study|Death|1|||
48471621|NCT01980056|155918841|FG001|Overall Study|Death|1|||
48471622|NCT01980056|155918842|FG002|Overall Study|Death|0|||
48471623|NCT00351611|155918843|FG000|Overall Study|Adverse Event|11|||
48471624|NCT00351611|155918844|FG001|Overall Study|Adverse Event|3|||
48471625|NCT00351611|155918843|FG000|Overall Study|Death|1|||
48471626|NCT00351611|155918844|FG001|Overall Study|Death|0|||
48471627|NCT00351611|155918843|FG000|Overall Study|Lost to Follow-up|1|||
48471628|NCT00351611|155918844|FG001|Overall Study|Lost to Follow-up|0|||
48471629|NCT00351611|155918843|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
48471709|NCT02116309|155918866|FG000|Overall Study|Lost to Follow-up|0|||
48471630|NCT00351611|155918844|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
48471631|NCT00351611|155918843|FG000|Overall Study|Other|1|||
48471632|NCT00351611|155918844|FG001|Overall Study|Other|0|||
48471633|NCT00351611|155918843|FG000|Overall Study|Protocol Violation|0|||
48471634|NCT00351611|155918844|FG001|Overall Study|Protocol Violation|2|||
48471635|NCT02708524|155918850|FG000|Overall Study|Adverse Event|0|||
48471636|NCT02708524|155918851|FG001|Overall Study|Adverse Event|1|||
48471637|NCT02708524|155918852|FG002|Overall Study|Adverse Event|0|||
48471638|NCT02708524|155918853|FG003|Overall Study|Adverse Event|0|||
48471639|NCT02708524|155918850|FG000|Overall Study|Lens Discomfort|1|||
48471640|NCT02708524|155918851|FG001|Overall Study|Lens Discomfort|0|||
48471641|NCT02708524|155918852|FG002|Overall Study|Lens Discomfort|1|||
48471642|NCT02708524|155918853|FG003|Overall Study|Lens Discomfort|0|||
48471643|NCT02708524|155918850|FG000|Overall Study|Lost to Follow-up|1|||
48471644|NCT02708524|155918851|FG001|Overall Study|Lost to Follow-up|1|||
48471645|NCT02708524|155918852|FG002|Overall Study|Lost to Follow-up|1|||
48471646|NCT02708524|155918853|FG003|Overall Study|Lost to Follow-up|0|||
48471647|NCT02708524|155918850|FG000|Overall Study|Protocol Violation|0|||
48471648|NCT02708524|155918851|FG001|Overall Study|Protocol Violation|1|||
48471649|NCT02708524|155918852|FG002|Overall Study|Protocol Violation|0|||
48471650|NCT02708524|155918853|FG003|Overall Study|Protocol Violation|0|||
48471651|NCT02708524|155918850|FG000|Overall Study|Withdrawal by Subject|1|||
48471652|NCT02708524|155918851|FG001|Overall Study|Withdrawal by Subject|1|||
48471653|NCT02708524|155918852|FG002|Overall Study|Withdrawal by Subject|0|||
48471654|NCT02708524|155918853|FG003|Overall Study|Withdrawal by Subject|0|||
48471655|NCT02708524|155918850|FG000|Overall Study|Dispensed incorrect study lens|0|||
48471656|NCT02708524|155918851|FG001|Overall Study|Dispensed incorrect study lens|1|||
48471657|NCT02708524|155918852|FG002|Overall Study|Dispensed incorrect study lens|1|||
48471658|NCT02708524|155918853|FG003|Overall Study|Dispensed incorrect study lens|0|||
48471659|NCT02708524|155918850|FG000|Overall Study|Did not wear lens at final visit|0|||
48471660|NCT02708524|155918851|FG001|Overall Study|Did not wear lens at final visit|1|||
48471661|NCT02708524|155918852|FG002|Overall Study|Did not wear lens at final visit|0|||
48471662|NCT02708524|155918853|FG003|Overall Study|Did not wear lens at final visit|0|||
48471663|NCT02708524|155918850|FG000|Overall Study|Subject lost study lens|1|||
48471664|NCT02708524|155918851|FG001|Overall Study|Subject lost study lens|0|||
48471665|NCT02708524|155918852|FG002|Overall Study|Subject lost study lens|0|||
48471666|NCT02708524|155918853|FG003|Overall Study|Subject lost study lens|0|||
48471667|NCT00598442|155918854|FG000|Overall Study|Adverse Event|3|||
48471668|NCT00598442|155918855|FG001|Overall Study|Adverse Event|0|||
48471669|NCT00598442|155918856|FG002|Overall Study|Adverse Event|0|||
48471670|NCT00598442|155918854|FG000|Overall Study|Death|19|||
48471671|NCT00598442|155918855|FG001|Overall Study|Death|11|||
48471672|NCT00598442|155918856|FG002|Overall Study|Death|11|||
48471673|NCT00598442|155918854|FG000|Overall Study|Lost to Follow-up|4|||
48471674|NCT00598442|155918855|FG001|Overall Study|Lost to Follow-up|3|||
48471675|NCT00598442|155918856|FG002|Overall Study|Lost to Follow-up|3|||
48471676|NCT00598442|155918854|FG000|Overall Study|Physician Decision|2|||
48471677|NCT00598442|155918855|FG001|Overall Study|Physician Decision|1|||
48471678|NCT00598442|155918856|FG002|Overall Study|Physician Decision|1|||
48471679|NCT00598442|155918854|FG000|Overall Study|Withdrawal by Subject|8|||
48471680|NCT00598442|155918855|FG001|Overall Study|Withdrawal by Subject|16|||
48471681|NCT00598442|155918856|FG002|Overall Study|Withdrawal by Subject|6|||
48471682|NCT00598442|155918854|FG000|Overall Study|Noncompliance|0|||
48471683|NCT00598442|155918855|FG001|Overall Study|Noncompliance|2|||
48471684|NCT00598442|155918856|FG002|Overall Study|Noncompliance|1|||
48471685|NCT00598442|155918854|FG000|Overall Study|Relocation|1|||
48471686|NCT00598442|155918855|FG001|Overall Study|Relocation|4|||
48471687|NCT00598442|155918856|FG002|Overall Study|Relocation|0|||
48471688|NCT00598442|155918854|FG000|Overall Study|Renal transplant|0|||
48471689|NCT00598442|155918855|FG001|Overall Study|Renal transplant|0|||
48471690|NCT00598442|155918856|FG002|Overall Study|Renal transplant|1|||
48471691|NCT00598442|155918854|FG000|Overall Study|Site closed by sponsor|5|||
48471692|NCT00598442|155918855|FG001|Overall Study|Site closed by sponsor|2|||
48471693|NCT00598442|155918856|FG002|Overall Study|Site closed by sponsor|1|||
48471694|NCT00598442|155918854|FG000|Overall Study|Started dialysis|1|||
48471695|NCT00598442|155918855|FG001|Overall Study|Started dialysis|0|||
48471696|NCT00598442|155918856|FG002|Overall Study|Started dialysis|0|||
48471697|NCT03781167|155918864|FG000|Overall Study|Adverse Event|23|||
48471698|NCT03781167|155918865|FG001|Overall Study|Adverse Event|25|||
48471699|NCT03781167|155918864|FG000|Overall Study|Withdrew consent|16|||
48471700|NCT03781167|155918865|FG001|Overall Study|Withdrew consent|12|||
48471701|NCT03781167|155918864|FG000|Overall Study|Lost to Follow-up|0|||
48471702|NCT03781167|155918865|FG001|Overall Study|Lost to Follow-up|1|||
48471703|NCT03781167|155918864|FG000|Overall Study|Lack of Efficacy|4|||
48471704|NCT03781167|155918865|FG001|Overall Study|Lack of Efficacy|5|||
48471705|NCT03781167|155918864|FG000|Overall Study|Difficulty with drug delivery system|2|||
48471706|NCT03781167|155918865|FG001|Overall Study|Difficulty with drug delivery system|3|||
48471707|NCT03781167|155918864|FG000|Overall Study|Other, not specified|2|||
48471708|NCT03781167|155918865|FG001|Overall Study|Other, not specified|2|||
48471710|NCT02116309|155918867|FG001|Overall Study|Lost to Follow-up|1|||
48471711|NCT05147311|155918868|FG000|Overall Study|Did not complete survey|2|||
48471712|NCT05147311|155918869|FG001|Overall Study|Did not complete survey|1|||
48471713|NCT05147311|155918868|FG000|Overall Study|Patient too sick|1|||
48471714|NCT05147311|155918869|FG001|Overall Study|Patient too sick|2|||
48471715|NCT05147311|155918868|FG000|Overall Study|Death|0|||
48471716|NCT05147311|155918869|FG001|Overall Study|Death|1|||
48471717|NCT05147311|155918868|FG000|Overall Study|Declined survey|1|||
48471718|NCT05147311|155918869|FG001|Overall Study|Declined survey|0|||
48471719|NCT00499694|155918874|FG000|Overall Study|Patient never received treatment.|1|||
48471720|NCT02304484|155918876|FG000|Overall Study|Death|9|||
48471721|NCT02304484|155918876|FG000|Overall Study|Withdrawal by Subject|14|||
48471722|NCT02304484|155918876|FG000|Overall Study|Lost to Follow-up|2|||
48471723|NCT04338685|155918877|FG000|Overall Study|Death|3|||
48471724|NCT04338685|155918878|FG001|Overall Study|Death|4|||
48471725|NCT04338685|155918879|FG002|Overall Study|Death|2|||
48471726|NCT04338685|155918880|FG003|Overall Study|Death|4|||
48471727|NCT04338685|155918881|FG004|Overall Study|Death|4|||
48471728|NCT04338685|155918882|FG005|Overall Study|Death|8|||
48471729|NCT04338685|155918883|FG006|Overall Study|Death|1|||
48471730|NCT04338685|155918884|FG007|Overall Study|Death|0|||
48471731|NCT04338685|155918885|FG008|Overall Study|Death|0|||
48471732|NCT04338685|155918877|FG000|Overall Study|Study terminated by Sponsor|0|||
48471733|NCT04338685|155918878|FG001|Overall Study|Study terminated by Sponsor|0|||
48471734|NCT04338685|155918879|FG002|Overall Study|Study terminated by Sponsor|1|||
48471735|NCT04338685|155918880|FG003|Overall Study|Study terminated by Sponsor|4|||
48471736|NCT04338685|155918881|FG004|Overall Study|Study terminated by Sponsor|0|||
48471737|NCT04338685|155918882|FG005|Overall Study|Study terminated by Sponsor|5|||
48471738|NCT04338685|155918883|FG006|Overall Study|Study terminated by Sponsor|2|||
48471739|NCT04338685|155918884|FG007|Overall Study|Study terminated by Sponsor|4|||
48471740|NCT04338685|155918885|FG008|Overall Study|Study terminated by Sponsor|1|||
48471741|NCT04338685|155918877|FG000|Overall Study|Withdrawal by Subject|1|||
48471742|NCT04338685|155918878|FG001|Overall Study|Withdrawal by Subject|2|||
48471743|NCT04338685|155918879|FG002|Overall Study|Withdrawal by Subject|0|||
48471744|NCT04338685|155918880|FG003|Overall Study|Withdrawal by Subject|2|||
48471745|NCT04338685|155918881|FG004|Overall Study|Withdrawal by Subject|0|||
48471746|NCT04338685|155918882|FG005|Overall Study|Withdrawal by Subject|5|||
48471747|NCT04338685|155918883|FG006|Overall Study|Withdrawal by Subject|1|||
48471748|NCT04338685|155918884|FG007|Overall Study|Withdrawal by Subject|1|||
48471749|NCT04338685|155918885|FG008|Overall Study|Withdrawal by Subject|0|||
48471750|NCT00234533|155918886|FG000|Overall Study|Withdrawal by Subject|6|||
48471751|NCT00234533|155918886|FG000|Overall Study|Adverse Event|2|||
48471752|NCT00234533|155918886|FG000|Overall Study|Enrolled but not treated|3|||
48471753|NCT00596466|155918887|FG000|Overall Study|Lack of Efficacy|5|||
48471754|NCT00596466|155918887|FG000|Overall Study|Adverse Event|4|||
48471755|NCT00596466|155918887|FG000|Overall Study|Withdrawal by Subject|2|||
48471756|NCT00596466|155918887|FG000|Overall Study|Protocol Violation|2|||
48471757|NCT00596466|155918887|FG000|Overall Study|Unpecified|2|||
48471758|NCT00596466|155918887|FG000|Overall Study|Enrolled, not treated|2|||
48471759|NCT02967055|155918888|FG000|Overall Study|Excluded|40|||
48471760|NCT02967055|155918888|FG000|Overall Study|Screen fail|3|||
48471761|NCT02967055|155918888|FG000|Overall Study|Lost to Follow-up|2|||
48471762|NCT02967055|155918888|FG000|Overall Study|Stopped due to side effects|3|||
48471763|NCT02967055|155918888|FG000|Overall Study|Stopped due to drug cost|1|||
48471764|NCT00145795|155918889|FG000|Overall Study|Adverse Event|1|||
48471765|NCT00145795|155918890|FG001|Overall Study|Adverse Event|0|||
48471766|NCT00976989|155918891|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
48471767|NCT00976989|155918892|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
48471768|NCT00976989|155918893|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
48471769|NCT00976989|155918891|FG000|Overall Study|Death|5|||
48471770|NCT00976989|155918892|FG001|Overall Study|Death|7|||
48471771|NCT00976989|155918893|FG002|Overall Study|Death|10|||
48471772|NCT00976989|155918891|FG000|Overall Study|Refused Treatment|4|||
48471773|NCT00976989|155918892|FG001|Overall Study|Refused Treatment|3|||
48471774|NCT00976989|155918893|FG002|Overall Study|Refused Treatment|5|||
48471775|NCT00976989|155918891|FG000|Overall Study|Failure to Return|2|||
48471776|NCT00976989|155918892|FG001|Overall Study|Failure to Return|1|||
48471777|NCT00976989|155918893|FG002|Overall Study|Failure to Return|0|||
48471778|NCT00976989|155918891|FG000|Overall Study|Recurrence of Disease|0|||
48471779|NCT00976989|155918892|FG001|Overall Study|Recurrence of Disease|1|||
48471780|NCT00976989|155918893|FG002|Overall Study|Recurrence of Disease|0|||
48471781|NCT00976989|155918891|FG000|Overall Study|Other|1|||
48471782|NCT00976989|155918892|FG001|Overall Study|Other|0|||
48471783|NCT00976989|155918893|FG002|Overall Study|Other|1|||
48471784|NCT00570492|155918894|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
48471785|NCT00570492|155918895|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
48471786|NCT00570492|155918896|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
48471787|NCT00570492|155918894|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
48471788|NCT00570492|155918895|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
48471789|NCT00570492|155918896|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
48471790|NCT00570492|155918894|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
48471791|NCT00570492|155918895|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
48471792|NCT00570492|155918896|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
48471793|NCT00570492|155918894|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
48471794|NCT00570492|155918895|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
48471795|NCT00570492|155918896|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
48471796|NCT00570492|155918894|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
48471797|NCT00570492|155918895|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
48471798|NCT00570492|155918896|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
48471799|NCT00570492|155918894|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
48471800|NCT00570492|155918895|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
48471801|NCT00570492|155918896|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
48471802|NCT00570492|155918894|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
48471803|NCT00570492|155918895|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
48471804|NCT00570492|155918896|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
48471805|NCT00570492|155918894|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
48471806|NCT00570492|155918895|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
48471807|NCT00570492|155918896|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
48471808|NCT00570492|155918894|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
48471809|NCT00570492|155918895|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
48471810|NCT00570492|155918896|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
48471811|NCT00570492|155918894|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
48471812|NCT00570492|155918895|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
48471813|NCT00570492|155918896|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
48471814|NCT00570492|155918894|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
48471815|NCT00570492|155918895|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
48471816|NCT00570492|155918896|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
48471817|NCT00570492|155918894|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
48471818|NCT00570492|155918895|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
48471819|NCT00570492|155918896|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
48471820|NCT00570492|155918894|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
48471821|NCT00570492|155918895|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
48471822|NCT00570492|155918896|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
48471823|NCT00570492|155918894|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
48471824|NCT00570492|155918895|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
48471825|NCT00570492|155918896|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
48471826|NCT05146999|155918898|FG000|Overall Study|Withdrew consent|6|||
48471827|NCT05146999|155918899|FG001|Overall Study|Withdrew consent|1|||
48471828|NCT05146999|155918898|FG000|Overall Study|Lost to Follow-up|3|||
48471829|NCT05146999|155918899|FG001|Overall Study|Lost to Follow-up|2|||
48471830|NCT05146999|155918898|FG000|Overall Study|Other|1|||
48471831|NCT05146999|155918899|FG001|Overall Study|Other|3|||
48471832|NCT04768881|155918900|FG000|Overall Study|Completed Study Follow-up|0|||
48471833|NCT04768881|155918901|FG001|Overall Study|Completed Study Follow-up|2|||
48471834|NCT04768881|155918900|FG000|Overall Study|Death|3|||
48471835|NCT04768881|155918901|FG001|Overall Study|Death|2|||
48471836|NCT04768881|155918900|FG000|Overall Study|Study Terminated by Sponsor|2|||
48471837|NCT04768881|155918901|FG001|Overall Study|Study Terminated by Sponsor|2|||
48471838|NCT04768881|155918900|FG000|Overall Study|Withdrawal by Subject|2|||
48471839|NCT04768881|155918901|FG001|Overall Study|Withdrawal by Subject|0|||
48471840|NCT04768881|155918900|FG000|Overall Study|Other|2|||
48471841|NCT04768881|155918901|FG001|Overall Study|Other|0|||
48471842|NCT02370173|155918902|FG000|Overall Study|Protocol Violation|1|||
48471843|NCT02370173|155918903|FG001|Overall Study|Protocol Violation|1|||
48471844|NCT02370173|155918902|FG000|Overall Study|Withdrawal by Subject|2|||
48471845|NCT02370173|155918903|FG001|Overall Study|Withdrawal by Subject|2|||
48471846|NCT02543918|155918904|FG000|Overall Study|Never treated|0|||
48471847|NCT02543918|155918905|FG001|Overall Study|Never treated|1|||
48471848|NCT02543918|155918904|FG000|Overall Study|Lost to Follow-up|1|||
48471849|NCT02543918|155918905|FG001|Overall Study|Lost to Follow-up|1|||
48471850|NCT02543918|155918904|FG000|Overall Study|Withdrawal by Subject|1|||
48471851|NCT02543918|155918905|FG001|Overall Study|Withdrawal by Subject|1|||
48471852|NCT02543918|155918904|FG000|Overall Study|Adverse Event|1|||
48471853|NCT02543918|155918905|FG001|Overall Study|Adverse Event|1|||
48471854|NCT03743571|155918906|FG000|Overall Study|Withdrawal by Subject|1|||
48471855|NCT03743571|155918907|FG001|Overall Study|Withdrawal by Subject|1|||
48471856|NCT03743571|155918906|FG000|Overall Study|Lost to Follow-up|1|||
48471857|NCT03743571|155918907|FG001|Overall Study|Lost to Follow-up|2|||
48471858|NCT01119118|155918912|FG000|Overall Study|Adverse Event|1|||
48471859|NCT00633217|155918913|FG000|Overall Study|Adverse Event|5|||
48471860|NCT00633217|155918914|FG001|Overall Study|Adverse Event|9|||
48471861|NCT00633217|155918913|FG000|Overall Study|Lack of Efficacy|0|||
48471862|NCT00633217|155918914|FG001|Overall Study|Lack of Efficacy|2|||
48471863|NCT00633217|155918913|FG000|Overall Study|Protocol Violation|3|||
48471864|NCT00633217|155918914|FG001|Overall Study|Protocol Violation|7|||
48471865|NCT00633217|155918913|FG000|Overall Study|Lost to Follow-up|2|||
48471866|NCT00633217|155918914|FG001|Overall Study|Lost to Follow-up|2|||
48471867|NCT00633217|155918913|FG000|Overall Study|Investigator Discretion|2|||
48471868|NCT00633217|155918914|FG001|Overall Study|Investigator Discretion|0|||
48471869|NCT00633217|155918913|FG000|Overall Study|Withdrew Consent|3|||
48471870|NCT00633217|155918914|FG001|Overall Study|Withdrew Consent|3|||
48471871|NCT01714726|155920646|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
48471872|NCT01714726|155920647|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
48471873|NCT01714726|155920648|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
48471874|NCT01714726|155920649|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
48471875|NCT01714726|155920646|FG000|Double-Blinded Induction Period|Adverse Event|0|||
48471876|NCT01714726|155920647|FG001|Double-Blinded Induction Period|Adverse Event|1|||
48471877|NCT01714726|155920648|FG002|Double-Blinded Induction Period|Adverse Event|0|||
48471878|NCT01714726|155920649|FG003|Double-Blinded Induction Period|Adverse Event|0|||
48471879|NCT01714726|155920646|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
48471880|NCT01714726|155920647|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
48471881|NCT01714726|155920648|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
48471882|NCT01714726|155920649|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
48471883|NCT01714726|155920646|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
48471884|NCT01714726|155920647|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
48471885|NCT01714726|155920648|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
48471886|NCT01714726|155920649|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
48471887|NCT01714726|155920646|FG000|Open-Label Period|Other|0|||
48471888|NCT01714726|155920647|FG001|Open-Label Period|Other|0|||
48471889|NCT01714726|155920648|FG002|Open-Label Period|Other|1|||
48471890|NCT01714726|155920649|FG003|Open-Label Period|Other|3|||
48471891|NCT01714726|155920646|FG000|Open-Label Period|Adverse Event|0|||
48471892|NCT01714726|155920647|FG001|Open-Label Period|Adverse Event|0|||
48471893|NCT01714726|155920648|FG002|Open-Label Period|Adverse Event|1|||
48471894|NCT01714726|155920649|FG003|Open-Label Period|Adverse Event|0|||
48471895|NCT01714726|155920646|FG000|Open-Label Period|Withdrawal by Subject|0|||
48471896|NCT01714726|155920647|FG001|Open-Label Period|Withdrawal by Subject|0|||
48471897|NCT01714726|155920648|FG002|Open-Label Period|Withdrawal by Subject|9|||
48471898|NCT01714726|155920649|FG003|Open-Label Period|Withdrawal by Subject|19|||
48471899|NCT01714726|155920646|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
48471900|NCT01714726|155920647|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
48471901|NCT01714726|155920648|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
48471902|NCT01714726|155920649|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
48471903|NCT01714726|155920646|FG000|Open-Label Period|Lost to Follow-up|0|||
48471904|NCT01714726|155920647|FG001|Open-Label Period|Lost to Follow-up|0|||
48471905|NCT01714726|155920648|FG002|Open-Label Period|Lost to Follow-up|3|||
48471906|NCT01714726|155920649|FG003|Open-Label Period|Lost to Follow-up|4|||
48471907|NCT00509223|155920652|FG000|Overall Study|Lost to Follow-up|1|||
48471908|NCT00509223|155920653|FG001|Overall Study|Lost to Follow-up|1|||
48471909|NCT00509223|155920652|FG000|Overall Study|Adverse Event|1|||
48471910|NCT00509223|155920653|FG001|Overall Study|Adverse Event|1|||
48471911|NCT00509223|155920652|FG000|Overall Study|Withdrawal by Subject|25|||
48471912|NCT00509223|155920653|FG001|Overall Study|Withdrawal by Subject|6|||
48471913|NCT00509223|155920652|FG000|Overall Study|Including: subject change of address|5|||
48471914|NCT00509223|155920653|FG001|Overall Study|Including: subject change of address|2|||
48471915|NCT00509223|155920652|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
48471916|NCT00509223|155920653|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
48471917|NCT00548340|155920654|FG000|Overall Study|Protocol Violation|2|||
48471918|NCT00548340|155920655|FG001|Overall Study|Protocol Violation|3|||
48471919|NCT00548340|155920656|FG002|Overall Study|Protocol Violation|3|||
48471920|NCT00548340|155920654|FG000|Overall Study|Adverse Event|2|||
48471921|NCT00548340|155920655|FG001|Overall Study|Adverse Event|2|||
48471922|NCT00548340|155920656|FG002|Overall Study|Adverse Event|2|||
48471923|NCT00548340|155920654|FG000|Overall Study|Lost to Follow-up|1|||
48471924|NCT00548340|155920655|FG001|Overall Study|Lost to Follow-up|1|||
48471925|NCT00548340|155920656|FG002|Overall Study|Lost to Follow-up|0|||
48471926|NCT00548340|155920654|FG000|Overall Study|Withdrawal by Subject|2|||
48471927|NCT00548340|155920655|FG001|Overall Study|Withdrawal by Subject|4|||
48471928|NCT00548340|155920656|FG002|Overall Study|Withdrawal by Subject|3|||
48471929|NCT00548340|155920654|FG000|Overall Study|Other|1|||
48471930|NCT00548340|155920655|FG001|Overall Study|Other|1|||
48471931|NCT00548340|155920656|FG002|Overall Study|Other|1|||
48471932|NCT02985541|155920657|FG000|Overall Study|Withdrawal by Subject|33|||
48471933|NCT02985541|155920657|FG000|Overall Study|Lost to Follow-up|26|||
48471934|NCT02985541|155920657|FG000|Overall Study|Adverse Event|27|||
48471935|NCT02985541|155920657|FG000|Overall Study|Physician Decision|2|||
48471936|NCT02985541|155920657|FG000|Overall Study|Pregnancy|2|||
48471937|NCT02985541|155920657|FG000|Overall Study|Wish for pregnancy|44|||
48471938|NCT02985541|155920657|FG000|Overall Study|Other reason|5|||
48471939|NCT02985541|155920657|FG000|Overall Study|Not valid for analysis|2|||
48471940|NCT01096017|155920661|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
48471941|NCT01096017|155920662|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
48471942|NCT02383966|155920663|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
48471943|NCT02383966|155920664|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
48471944|NCT02383966|155920663|FG000|Overall Study|Randomized, but not treated|1|||
48471945|NCT02383966|155920664|FG001|Overall Study|Randomized, but not treated|3|||
48471946|NCT02163759|155920665|FG000|Overall Study|Withdrawal by Subject|1|||
48471947|NCT02163759|155920666|FG001|Overall Study|Withdrawal by Subject|5|||
48471948|NCT02163759|155920667|FG002|Overall Study|Withdrawal by Subject|1|||
48471949|NCT02163759|155920665|FG000|Overall Study|Adverse Event|0|||
48471950|NCT02163759|155920666|FG001|Overall Study|Adverse Event|0|||
48471951|NCT02163759|155920667|FG002|Overall Study|Adverse Event|1|||
48471952|NCT02163759|155920665|FG000|Overall Study|Death|0|||
48471953|NCT02163759|155920666|FG001|Overall Study|Death|0|||
48471954|NCT02163759|155920667|FG002|Overall Study|Death|1|||
48471955|NCT01846442|155920668|FG000|Overall Study|Adverse Event|2|||
48471956|NCT01846442|155920669|FG001|Overall Study|Adverse Event|4|||
48471957|NCT01846442|155920670|FG002|Overall Study|Adverse Event|2|||
48471958|NCT01846442|155920671|FG003|Overall Study|Adverse Event|1|||
48471959|NCT01846442|155920668|FG000|Overall Study|Lost to Follow-up|0|||
48471960|NCT01846442|155920669|FG001|Overall Study|Lost to Follow-up|0|||
48471961|NCT01846442|155920670|FG002|Overall Study|Lost to Follow-up|1|||
48471962|NCT01846442|155920671|FG003|Overall Study|Lost to Follow-up|0|||
48471963|NCT01846442|155920668|FG000|Overall Study|Withdrawal by Subject|3|||
48471964|NCT01846442|155920669|FG001|Overall Study|Withdrawal by Subject|2|||
48471965|NCT01846442|155920670|FG002|Overall Study|Withdrawal by Subject|0|||
48471966|NCT01846442|155920671|FG003|Overall Study|Withdrawal by Subject|1|||
48471967|NCT01846442|155920668|FG000|Overall Study|Left the city/Lost medication|1|||
48471968|NCT01846442|155920669|FG001|Overall Study|Left the city/Lost medication|0|||
48471969|NCT01846442|155920670|FG002|Overall Study|Left the city/Lost medication|1|||
48471970|NCT01846442|155920671|FG003|Overall Study|Left the city/Lost medication|1|||
48471971|NCT03996694|155920677|FG000|First Washout (7 Days)|positive urine drug screen|0|||
48471972|NCT03996694|155920678|FG001|First Washout (7 Days)|positive urine drug screen|0|||
48471973|NCT03996694|155920679|FG002|First Washout (7 Days)|positive urine drug screen|1|||
48471974|NCT03996694|155920680|FG003|First Washout (7 Days)|positive urine drug screen|0|||
48471975|NCT03996694|155920681|FG004|First Washout (7 Days)|positive urine drug screen|0|||
48471976|NCT03996694|155920682|FG005|First Washout (7 Days)|positive urine drug screen|0|||
48471977|NCT03996694|155920677|FG000|First Washout (7 Days)|Adverse Event|0|||
48471978|NCT03996694|155920678|FG001|First Washout (7 Days)|Adverse Event|1|||
48471979|NCT03996694|155920679|FG002|First Washout (7 Days)|Adverse Event|0|||
48471980|NCT03996694|155920680|FG003|First Washout (7 Days)|Adverse Event|0|||
48471981|NCT03996694|155920681|FG004|First Washout (7 Days)|Adverse Event|0|||
48471982|NCT03996694|155920682|FG005|First Washout (7 Days)|Adverse Event|0|||
48471983|NCT03996694|155920677|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
48471984|NCT03996694|155920678|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
48471985|NCT03996694|155920679|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
48471986|NCT03996694|155920680|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
48471987|NCT03996694|155920681|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
48471988|NCT03996694|155920682|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
48471989|NCT03996694|155920677|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
48471990|NCT03996694|155920678|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
48471991|NCT03996694|155920679|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
48471992|NCT03996694|155920680|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
48471993|NCT03996694|155920681|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
48471994|NCT03996694|155920682|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
48471995|NCT00462501|155920692|FG000|Overall Study|Not treated|3|||
48471996|NCT00462501|155920692|FG000|Overall Study|Adverse Event|2|||
48471997|NCT03193996|155920695|FG000|Overall Study|Withdrawal by Subject|4|||
48471998|NCT03193996|155920695|FG000|Overall Study|Lost to Follow-up|4|||
48471999|NCT03193996|155920695|FG000|Overall Study|Physician Decision|2|||
48472000|NCT03193996|155920695|FG000|Overall Study|Pregnancy|1|||
48472001|NCT03193996|155920695|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
48472002|NCT03193996|155920695|FG000|Overall Study|Complicating disease|1|||
48472003|NCT00494234|155920696|FG000|Overall Study|Withdrawal by Subject|1|||
48472004|NCT00494234|155920697|FG001|Overall Study|Withdrawal by Subject|0|||
48472005|NCT00494234|155920696|FG000|Overall Study|Disease progression|11|||
48472006|NCT00494234|155920697|FG001|Overall Study|Disease progression|8|||
48472007|NCT00494234|155920696|FG000|Overall Study|Death|2|||
48472008|NCT00494234|155920697|FG001|Overall Study|Death|1|||
48472009|NCT01729559|155920698|FG000|Overall Study|Protocol Violation|31|||
48472010|NCT01729559|155920699|FG001|Overall Study|Protocol Violation|28|||
48472011|NCT03246152|155920703|FG000|Overall Study|Lost to Follow-up|2|||
48472012|NCT03246152|155920703|FG000|Overall Study|Protocol Violation|1|||
48472013|NCT00423137|155920704|FG000|Overall Study|Lost to Follow-up|0|||
48472014|NCT00423137|155920705|FG001|Overall Study|Lost to Follow-up|0|||
48472015|NCT00423137|155920706|FG002|Overall Study|Lost to Follow-up|1|||
48472016|NCT00423137|155920707|FG003|Overall Study|Lost to Follow-up|0|||
48472017|NCT00423137|155920704|FG000|Overall Study|Protocol Violation|0|||
48472018|NCT00423137|155920705|FG001|Overall Study|Protocol Violation|0|||
48472019|NCT00423137|155920706|FG002|Overall Study|Protocol Violation|0|||
48472020|NCT00423137|155920707|FG003|Overall Study|Protocol Violation|1|||
48472021|NCT00423137|155920704|FG000|Overall Study|Adverse Event Study disease worse|1|||
48472022|NCT00423137|155920705|FG001|Overall Study|Adverse Event Study disease worse|0|||
48472023|NCT00423137|155920706|FG002|Overall Study|Adverse Event Study disease worse|3|||
48472024|NCT00423137|155920707|FG003|Overall Study|Adverse Event Study disease worse|1|||
48472025|NCT00423137|155920704|FG000|Overall Study|Adverse Event Other|0|||
48472026|NCT00423137|155920705|FG001|Overall Study|Adverse Event Other|0|||
48472027|NCT00423137|155920706|FG002|Overall Study|Adverse Event Other|2|||
48472028|NCT00423137|155920707|FG003|Overall Study|Adverse Event Other|0|||
48472029|NCT03292731|155920709|FG000|Overall Study|Protocol Violation|4|||
48472030|NCT03292731|155920710|FG001|Overall Study|Protocol Violation|11|||
48472031|NCT03292731|155920711|FG002|Overall Study|Protocol Violation|1|||
48472032|NCT01243762|155920721|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
48472033|NCT01243762|155920722|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
48472034|NCT01243762|155920723|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
48472035|NCT01243762|155920724|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
48472036|NCT01243762|155920725|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
48472037|NCT01243762|155920726|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
48472038|NCT01243762|155920727|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
48472039|NCT01243762|155920721|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48472040|NCT01243762|155920722|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
48472041|NCT01243762|155920723|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48472042|NCT01243762|155920724|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
48472043|NCT01243762|155920725|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48472044|NCT01243762|155920726|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48472045|NCT01243762|155920727|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
48472046|NCT01243762|155920721|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
48472047|NCT01243762|155920722|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
48472048|NCT01243762|155920723|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
48472049|NCT01243762|155920724|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
48472050|NCT01243762|155920725|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
48472051|NCT01243762|155920726|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
48472052|NCT01243762|155920727|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
48472053|NCT01243762|155920721|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48472054|NCT01243762|155920722|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
48472055|NCT01243762|155920723|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48472056|NCT01243762|155920724|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48472057|NCT01243762|155920725|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48472058|NCT01243762|155920726|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48472059|NCT01243762|155920727|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
48472060|NCT01243762|155920721|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48472061|NCT01243762|155920722|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
48472062|NCT01243762|155920723|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48472063|NCT01243762|155920724|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48472064|NCT01243762|155920725|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48472065|NCT01243762|155920726|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
48472066|NCT01243762|155920727|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
48472067|NCT01243762|155920721|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
48472068|NCT01243762|155920722|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
48472069|NCT01243762|155920723|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
48472070|NCT01243762|155920724|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
48472071|NCT01243762|155920725|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
48472072|NCT01243762|155920726|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
48472073|NCT01243762|155920727|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
48472074|NCT01243762|155920721|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48472075|NCT01243762|155920722|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
48472076|NCT01243762|155920723|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48472077|NCT01243762|155920724|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48472078|NCT01243762|155920725|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
48472286|NCT01303159|155920782|FG000|Overall Study|Study Termination|7|||
48472079|NCT01243762|155920726|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48472080|NCT01243762|155920727|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
48472081|NCT01243762|155920721|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48472082|NCT01243762|155920722|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48472083|NCT01243762|155920723|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48472084|NCT01243762|155920724|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
48472085|NCT01243762|155920725|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
48472086|NCT01243762|155920726|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48472087|NCT01243762|155920727|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
48472088|NCT00475657|155920728|FG000|Overall Study|Death|1|||
48472089|NCT00475657|155920728|FG000|Overall Study|Sponsor's Decision|3|||
48472090|NCT04359758|155920729|FG000|Overall Study|Protocol Violation|3|||
48472091|NCT04359758|155920730|FG001|Overall Study|Protocol Violation|2|||
48472092|NCT03710824|155920731|FG000|Overall Study|Withdrawal by Subject|1|||
48472093|NCT03710824|155920731|FG000|Overall Study|Lost to Follow-up|3|||
48472094|NCT03710824|155920731|FG000|Overall Study|Adverse Event|25|||
48472095|NCT03710824|155920731|FG000|Overall Study|Treatment discontinuation|2|||
48472096|NCT02992743|155920732|FG000|Overall Study|Withdrawal by Subject|1|||
48472097|NCT02992743|155920733|FG001|Overall Study|Withdrawal by Subject|1|||
48472098|NCT02992743|155920732|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
48472099|NCT02992743|155920733|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
48472100|NCT02992743|155920732|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
48472101|NCT02992743|155920733|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
48472102|NCT02992743|155920732|FG000|Overall Study|No measurable disease|1|||
48472103|NCT02992743|155920733|FG001|Overall Study|No measurable disease|0|||
48472104|NCT02992743|155920732|FG000|Overall Study|Lost to Follow-up|0|||
48472105|NCT02992743|155920733|FG001|Overall Study|Lost to Follow-up|1|||
48472106|NCT01471197|155920734|FG000|Overall Study|Disease Progression|4|||
48472107|NCT01471197|155920735|FG001|Overall Study|Disease Progression|2|||
48472108|NCT01471197|155920734|FG000|Overall Study|Death|1|||
48472109|NCT01471197|155920735|FG001|Overall Study|Death|0|||
48472110|NCT01471197|155920734|FG000|Overall Study|Study Drug Toxicity|1|||
48472111|NCT01471197|155920735|FG001|Overall Study|Study Drug Toxicity|0|||
48472112|NCT00761735|155920736|FG000|Overall Study|Lost to Follow-up|6|||
48472113|NCT00761735|155920736|FG000|Overall Study|Withdrawal by Subject|6|||
48472114|NCT00761735|155920736|FG000|Overall Study|Non-compliance with protocol|1|||
48472115|NCT00761735|155920736|FG000|Overall Study|Administrative|1|||
48472116|NCT03358407|155920737|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472117|NCT03358407|155920738|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472118|NCT03358407|155920739|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
48472119|NCT03358407|155920740|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472120|NCT03358407|155920741|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472121|NCT03358407|155920742|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472122|NCT03358407|155920743|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472123|NCT03358407|155920744|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472124|NCT03358407|155920745|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472125|NCT03358407|155920746|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
48472126|NCT03358407|155920737|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472127|NCT03358407|155920738|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472128|NCT03358407|155920739|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472129|NCT03358407|155920740|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472130|NCT03358407|155920741|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
48472131|NCT03358407|155920742|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472132|NCT03358407|155920743|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472133|NCT03358407|155920744|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472134|NCT03358407|155920745|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472135|NCT03358407|155920746|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472136|NCT03358407|155920737|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48472137|NCT03358407|155920738|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48472138|NCT03358407|155920739|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48472139|NCT03358407|155920740|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48472140|NCT03358407|155920741|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48472141|NCT03358407|155920742|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
48472142|NCT03358407|155920743|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48472143|NCT03358407|155920744|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
48472144|NCT03358407|155920745|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48472145|NCT03358407|155920746|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
48472146|NCT03358407|155920737|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48472147|NCT03358407|155920738|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48472148|NCT03358407|155920739|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48472149|NCT03358407|155920740|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48472150|NCT03358407|155920741|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48472151|NCT03358407|155920742|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
48472152|NCT03358407|155920743|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48472153|NCT03358407|155920744|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
48472154|NCT03358407|155920745|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48472155|NCT03358407|155920746|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
48472156|NCT03358407|155920737|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472157|NCT03358407|155920738|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472158|NCT03358407|155920739|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472159|NCT03358407|155920740|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472160|NCT03358407|155920741|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472161|NCT03358407|155920742|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
48472162|NCT03358407|155920743|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
48472163|NCT03358407|155920744|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472164|NCT03358407|155920745|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472165|NCT03358407|155920746|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
48472166|NCT03358407|155920737|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48472167|NCT03358407|155920738|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48472168|NCT03358407|155920739|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48472169|NCT03358407|155920740|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48472170|NCT03358407|155920741|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48472171|NCT03358407|155920742|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
48472172|NCT03358407|155920743|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
48472173|NCT03358407|155920744|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
48472174|NCT03358407|155920745|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48472175|NCT03358407|155920746|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
48472176|NCT02329834|155920747|FG000|Overall Study|Physician Decision|1|||
48472177|NCT02329834|155920748|FG001|Overall Study|Physician Decision|0|||
48472178|NCT02319642|155920749|FG000|Overall Study|Adverse Event|2|||
48472179|NCT02319642|155920750|FG001|Overall Study|Adverse Event|4|||
48472180|NCT02319642|155920749|FG000|Overall Study|Lack of Efficacy|1|||
48472181|NCT02319642|155920750|FG001|Overall Study|Lack of Efficacy|1|||
48472182|NCT02319642|155920749|FG000|Overall Study|Withdrawal by Subject|1|||
48472183|NCT02319642|155920750|FG001|Overall Study|Withdrawal by Subject|1|||
48472184|NCT04753606|155920751|FG000|Overall Study|Adverse Event|1|||
48472185|NCT04753606|155920752|FG001|Overall Study|Adverse Event|0|||
48472186|NCT04753606|155920753|FG002|Overall Study|Adverse Event|0|||
48472187|NCT01605370|155920756|FG000|Overall Study|Adverse Event|1|||
48472188|NCT01605370|155920757|FG001|Overall Study|Adverse Event|0|||
48472189|NCT04221373|155920758|FG000|Overall Study|Physician Decision|4|||
48472190|NCT04221373|155920759|FG001|Overall Study|Physician Decision|0|||
48472191|NCT00779857|155920762|FG000|Overall Study|Death|1|||
48472192|NCT00779857|155920762|FG000|Overall Study|Withdrawal by Subject|3|||
48472193|NCT00779857|155920762|FG000|Overall Study|Missed Visit|2|||
48472194|NCT03556202|155920763|FG000|Extension Treatment Period|Adverse Event|18|||
48472195|NCT03556202|155920764|FG001|Extension Treatment Period|Adverse Event|14|||
48472196|NCT03556202|155920765|FG002|Extension Treatment Period|Adverse Event|9|||
48472197|NCT03556202|155920763|FG000|Extension Treatment Period|Death|2|||
48472198|NCT03556202|155920764|FG001|Extension Treatment Period|Death|6|||
48472199|NCT03556202|155920765|FG002|Extension Treatment Period|Death|0|||
48472200|NCT03556202|155920763|FG000|Extension Treatment Period|Lack of Efficacy|5|||
48472201|NCT03556202|155920764|FG001|Extension Treatment Period|Lack of Efficacy|12|||
48472202|NCT03556202|155920765|FG002|Extension Treatment Period|Lack of Efficacy|18|||
48472203|NCT03556202|155920763|FG000|Extension Treatment Period|Lost to Follow-up|9|||
48472204|NCT03556202|155920764|FG001|Extension Treatment Period|Lost to Follow-up|20|||
48472205|NCT03556202|155920765|FG002|Extension Treatment Period|Lost to Follow-up|2|||
48472206|NCT03556202|155920763|FG000|Extension Treatment Period|Pregnancy|2|||
48472207|NCT03556202|155920764|FG001|Extension Treatment Period|Pregnancy|4|||
48472208|NCT03556202|155920765|FG002|Extension Treatment Period|Pregnancy|3|||
48472209|NCT03556202|155920763|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
48472210|NCT03556202|155920764|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
48472211|NCT03556202|155920765|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
48472212|NCT03556202|155920763|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
48472213|NCT03556202|155920764|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
48472214|NCT03556202|155920765|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
48472215|NCT03556202|155920763|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
48472216|NCT03556202|155920764|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
48472217|NCT03556202|155920765|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
48472218|NCT03556202|155920763|FG000|Extension Treatment Period|Physician Decision|0|||
48472219|NCT03556202|155920764|FG001|Extension Treatment Period|Physician Decision|8|||
48472220|NCT03556202|155920765|FG002|Extension Treatment Period|Physician Decision|2|||
48472221|NCT03556202|155920763|FG000|Extension Treatment Period|Protocol Violation|0|||
48472222|NCT03556202|155920764|FG001|Extension Treatment Period|Protocol Violation|1|||
48472223|NCT03556202|155920765|FG002|Extension Treatment Period|Protocol Violation|1|||
48472224|NCT03556202|155920763|FG000|Extension Treatment Period|Sponsor Decision|0|||
48472225|NCT03556202|155920764|FG001|Extension Treatment Period|Sponsor Decision|1|||
48472226|NCT03556202|155920765|FG002|Extension Treatment Period|Sponsor Decision|0|||
48472227|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
48472228|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
48472229|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
48472230|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Death|1|||
48472231|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Death|0|||
48472232|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Death|0|||
48472233|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
48472234|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
48472235|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
48472236|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
48472237|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
48472238|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
48472239|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
48472240|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
48472241|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
48472242|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
48472243|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
48472244|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
48472245|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
48472246|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
48472247|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
48472248|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
48472249|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
48472250|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
48472251|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
48472252|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
48472253|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
48472254|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
48472255|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
48472256|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
48472257|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
48472258|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
48472259|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
48472260|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
48472261|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
48472262|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
48472263|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
48472264|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
48472265|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
48472266|NCT03556202|155920763|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
48472267|NCT03556202|155920764|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
48472268|NCT03556202|155920765|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
48472269|NCT00908375|155920766|FG000|Overall Study|Withdrawal by Subject|2|||
48472270|NCT00908375|155920767|FG001|Overall Study|Withdrawal by Subject|4|||
48472271|NCT00908375|155920766|FG000|Overall Study|Lost to Follow-up|8|||
48472272|NCT00908375|155920767|FG001|Overall Study|Lost to Follow-up|6|||
48472273|NCT02734290|155920768|FG000|Overall Study|Adverse Event|1|||
48472274|NCT02734290|155920769|FG001|Overall Study|Adverse Event|0|||
48472275|NCT02734290|155920768|FG000|Overall Study|Death|1|||
48472276|NCT02734290|155920769|FG001|Overall Study|Death|0|||
48472277|NCT01333501|155920780|FG000|Overall Study|Adverse Event|3|||
48472278|NCT01333501|155920781|FG001|Overall Study|Adverse Event|1|||
48472279|NCT01333501|155920780|FG000|Overall Study|Abnormal laboratory value|2|||
48472280|NCT01333501|155920781|FG001|Overall Study|Abnormal laboratory value|1|||
48472281|NCT01333501|155920780|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48472282|NCT01333501|155920781|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
48472283|NCT01333501|155920780|FG000|Overall Study|Withdrawn consent|3|||
48472284|NCT01333501|155920781|FG001|Overall Study|Withdrawn consent|12|||
48472285|NCT01303159|155920782|FG000|Overall Study|Death|16|||
48472287|NCT03329404|155920783|FG000|Overall Study|The study was suspended.|1|||
48472288|NCT03329404|155920784|FG001|Overall Study|The study was suspended.|4|||
48472289|NCT00752895|155920788|FG000|Overall Study|Withdrawal by Subject|8|||
48472290|NCT00752895|155920789|FG001|Overall Study|Withdrawal by Subject|3|||
48472291|NCT00690573|155920795|FG000|Overall Study|Lack of Efficacy|8|||
48472292|NCT00690573|155920795|FG000|Overall Study|Withdrawal by Subject|1|||
48472293|NCT00314262|155920796|FG000|Overall Study|Adverse Event|2|||
48472294|NCT00314262|155920796|FG000|Overall Study|Withdrawal by Subject|2|||
48472295|NCT00314262|155920796|FG000|Overall Study|Physician Decision|1|||
48472296|NCT00083226|155920797|FG000|Overall Study|Lack of Efficacy|19|||
48472297|NCT00083226|155920797|FG000|Overall Study|Adverse Event|9|||
48472298|NCT00083226|155920797|FG000|Overall Study|Death|4|||
48472299|NCT00083226|155920797|FG000|Overall Study|Withdrawal by Subject|4|||
48472300|NCT00083226|155920797|FG000|Overall Study|Other|2|||
48472301|NCT00083226|155920797|FG000|Overall Study|ineligible or not receiving treatment|4|||
48472302|NCT00795886|155920799|FG000|Overall Study|Death|10|||
48472303|NCT02600559|155922660|FG000|Overall Study|Withdrawal by Subject|3|||
48472304|NCT02600559|155922660|FG000|Overall Study|Lost to Follow-up|20|||
48472305|NCT01153971|155922661|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
48472306|NCT01153971|155922661|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
48472307|NCT01153971|155922661|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
48472308|NCT01153971|155922661|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
48472309|NCT01153971|155922661|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
48472310|NCT01153971|155922661|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
48472311|NCT01153971|155922661|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
48472312|NCT04120116|155922662|FG000|Overall Study|Lost to Follow-up|0|||
48472313|NCT04120116|155922663|FG001|Overall Study|Lost to Follow-up|1|||
48472314|NCT04120116|155922664|FG002|Overall Study|Lost to Follow-up|0|||
48472315|NCT04120116|155922665|FG003|Overall Study|Lost to Follow-up|2|||
48472316|NCT04120116|155922662|FG000|Overall Study|Withdrawal by Subject|1|||
48472317|NCT04120116|155922663|FG001|Overall Study|Withdrawal by Subject|0|||
48472318|NCT04120116|155922664|FG002|Overall Study|Withdrawal by Subject|1|||
48472319|NCT04120116|155922665|FG003|Overall Study|Withdrawal by Subject|1|||
48472320|NCT04120116|155922662|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
48472321|NCT04120116|155922663|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
48472322|NCT04120116|155922664|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
48472323|NCT04120116|155922665|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
48472324|NCT03410693|155922666|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
48472325|NCT03410693|155922667|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
48472326|NCT03410693|155922666|FG000|Overall Study|Disc trt: Lost to follow up|0|||
48472327|NCT03410693|155922667|FG001|Overall Study|Disc trt: Lost to follow up|1|||
48472328|NCT03410693|155922666|FG000|Overall Study|Disc trt: radiological progression|58|||
48472329|NCT03410693|155922667|FG001|Overall Study|Disc trt: radiological progression|50|||
48472330|NCT03410693|155922666|FG000|Overall Study|Disc trt: Other|1|||
48472331|NCT03410693|155922667|FG001|Overall Study|Disc trt: Other|0|||
48472332|NCT03410693|155922666|FG000|Overall Study|Study drug never administered|1|||
48472333|NCT03410693|155922667|FG001|Overall Study|Study drug never administered|6|||
48472334|NCT03410693|155922666|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
48472335|NCT03410693|155922667|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
48472336|NCT03410693|155922666|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
48472337|NCT03410693|155922667|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
48472338|NCT03410693|155922666|FG000|Overall Study|Disc trt: Physician decision|0|||
48472339|NCT03410693|155922667|FG001|Overall Study|Disc trt: Physician decision|5|||
48472340|NCT03410693|155922666|FG000|Overall Study|Disc trt: clinical progression|1|||
48472341|NCT03410693|155922667|FG001|Overall Study|Disc trt: clinical progression|5|||
48472342|NCT03410693|155922666|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
48472343|NCT03410693|155922667|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
48472344|NCT03628781|155922675|FG000|Overall Study|Lost to Follow-up|16|||
48472345|NCT03628781|155922676|FG001|Overall Study|Lost to Follow-up|8|||
48472346|NCT03628781|155922675|FG000|Overall Study|Withdrawal by Subject|16|||
48472347|NCT03628781|155922676|FG001|Overall Study|Withdrawal by Subject|1|||
48472348|NCT03575806|155922684|FG000|Overall Study|Withdrawal by Subject|0|||
48472349|NCT03575806|155922685|FG001|Overall Study|Withdrawal by Subject|2|||
48472350|NCT03575806|155922684|FG000|Overall Study|Protocol Violation|0|||
48472351|NCT03575806|155922685|FG001|Overall Study|Protocol Violation|2|||
48472352|NCT01683565|155922688|FG000|Overall Study|Lost to Follow-up|2|||
48472353|NCT01683565|155922689|FG001|Overall Study|Lost to Follow-up|0|||
48472354|NCT01683565|155922688|FG000|Overall Study|Discontinued Intervention|1|||
48472355|NCT01683565|155922689|FG001|Overall Study|Discontinued Intervention|1|||
48472356|NCT02059265|155922690|FG000|Overall Study|Ineligible|4|||
48472357|NCT04196023|155922699|FG000|Overall Study|Withdrawal by Subject|0|||
48472358|NCT04196023|155922700|FG001|Overall Study|Withdrawal by Subject|1|||
48472359|NCT04196023|155922699|FG000|Overall Study|Adverse Event|3|||
48472360|NCT04196023|155922700|FG001|Overall Study|Adverse Event|1|||
48472361|NCT04196023|155922699|FG000|Overall Study|Lost to Follow-up|0|||
48472362|NCT04196023|155922700|FG001|Overall Study|Lost to Follow-up|1|||
48472363|NCT00471237|155922701|FG000|Overall Study|Adverse Event|6|||
48472364|NCT00471237|155922702|FG001|Overall Study|Adverse Event|5|||
48472365|NCT00471237|155922703|FG002|Overall Study|Adverse Event|4|||
48472366|NCT00471237|155922704|FG003|Overall Study|Adverse Event|8|||
48472367|NCT00471237|155922705|FG004|Overall Study|Adverse Event|7|||
48472368|NCT00471237|155922706|FG005|Overall Study|Adverse Event|5|||
48472369|NCT00471237|155922707|FG006|Overall Study|Adverse Event|0|||
48472370|NCT00471237|155922701|FG000|Overall Study|Lost to Follow-up|1|||
48472371|NCT00471237|155922702|FG001|Overall Study|Lost to Follow-up|1|||
48472372|NCT00471237|155922703|FG002|Overall Study|Lost to Follow-up|0|||
48472373|NCT00471237|155922704|FG003|Overall Study|Lost to Follow-up|2|||
48472374|NCT00471237|155922705|FG004|Overall Study|Lost to Follow-up|3|||
48472375|NCT00471237|155922706|FG005|Overall Study|Lost to Follow-up|0|||
48472376|NCT00471237|155922707|FG006|Overall Study|Lost to Follow-up|0|||
48472377|NCT00471237|155922701|FG000|Overall Study|Protocol Violation|3|||
48472378|NCT00471237|155922702|FG001|Overall Study|Protocol Violation|6|||
48472379|NCT00471237|155922703|FG002|Overall Study|Protocol Violation|3|||
48472380|NCT00471237|155922704|FG003|Overall Study|Protocol Violation|2|||
48472381|NCT00471237|155922705|FG004|Overall Study|Protocol Violation|2|||
48472382|NCT00471237|155922706|FG005|Overall Study|Protocol Violation|4|||
48472383|NCT00471237|155922707|FG006|Overall Study|Protocol Violation|1|||
48472384|NCT00471237|155922701|FG000|Overall Study|Withdrawal by Subject|8|||
48472385|NCT00471237|155922702|FG001|Overall Study|Withdrawal by Subject|6|||
48472386|NCT00471237|155922703|FG002|Overall Study|Withdrawal by Subject|5|||
48472387|NCT00471237|155922704|FG003|Overall Study|Withdrawal by Subject|8|||
48472388|NCT00471237|155922705|FG004|Overall Study|Withdrawal by Subject|7|||
48472389|NCT00471237|155922706|FG005|Overall Study|Withdrawal by Subject|4|||
48472390|NCT00471237|155922707|FG006|Overall Study|Withdrawal by Subject|2|||
48472391|NCT00471237|155922701|FG000|Overall Study|Sponsor terminated study|20|||
48472392|NCT00471237|155922702|FG001|Overall Study|Sponsor terminated study|23|||
48472393|NCT00471237|155922703|FG002|Overall Study|Sponsor terminated study|19|||
48472394|NCT00471237|155922704|FG003|Overall Study|Sponsor terminated study|22|||
48472395|NCT00471237|155922705|FG004|Overall Study|Sponsor terminated study|18|||
48472396|NCT00471237|155922706|FG005|Overall Study|Sponsor terminated study|24|||
48472397|NCT00471237|155922707|FG006|Overall Study|Sponsor terminated study|0|||
48472398|NCT00471237|155922701|FG000|Overall Study|Non-compliance|0|||
48472399|NCT00471237|155922702|FG001|Overall Study|Non-compliance|1|||
48472400|NCT00471237|155922703|FG002|Overall Study|Non-compliance|0|||
48472401|NCT00471237|155922704|FG003|Overall Study|Non-compliance|1|||
48472402|NCT00471237|155922705|FG004|Overall Study|Non-compliance|0|||
48472403|NCT00471237|155922706|FG005|Overall Study|Non-compliance|0|||
48472404|NCT00471237|155922707|FG006|Overall Study|Non-compliance|0|||
48472405|NCT00471237|155922701|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
48472406|NCT00471237|155922702|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
48472407|NCT00471237|155922703|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
48472408|NCT00471237|155922704|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
48472409|NCT00471237|155922705|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
48472410|NCT00471237|155922706|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
48472411|NCT00471237|155922707|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
48472412|NCT00471237|155922701|FG000|Overall Study|Early stopping due to non-efficacy|1|||
48472413|NCT00471237|155922702|FG001|Overall Study|Early stopping due to non-efficacy|0|||
48472414|NCT00471237|155922703|FG002|Overall Study|Early stopping due to non-efficacy|0|||
48472415|NCT00471237|155922704|FG003|Overall Study|Early stopping due to non-efficacy|0|||
48472416|NCT00471237|155922705|FG004|Overall Study|Early stopping due to non-efficacy|1|||
48472417|NCT00471237|155922706|FG005|Overall Study|Early stopping due to non-efficacy|0|||
48472418|NCT00471237|155922707|FG006|Overall Study|Early stopping due to non-efficacy|0|||
48472419|NCT00471237|155922701|FG000|Overall Study|Participant planned to travel to abraod|1|||
48472420|NCT00471237|155922702|FG001|Overall Study|Participant planned to travel to abraod|0|||
48472421|NCT00471237|155922703|FG002|Overall Study|Participant planned to travel to abraod|0|||
48472422|NCT00471237|155922704|FG003|Overall Study|Participant planned to travel to abraod|0|||
48472423|NCT00471237|155922705|FG004|Overall Study|Participant planned to travel to abraod|0|||
48472424|NCT00471237|155922706|FG005|Overall Study|Participant planned to travel to abraod|1|||
48472425|NCT00471237|155922707|FG006|Overall Study|Participant planned to travel to abraod|0|||
48472426|NCT00471237|155922701|FG000|Overall Study|High parathyroid hormone|0|||
48472427|NCT00471237|155922702|FG001|Overall Study|High parathyroid hormone|0|||
48472428|NCT00471237|155922703|FG002|Overall Study|High parathyroid hormone|1|||
48472429|NCT00471237|155922704|FG003|Overall Study|High parathyroid hormone|0|||
48472430|NCT00471237|155922705|FG004|Overall Study|High parathyroid hormone|0|||
48472431|NCT00471237|155922706|FG005|Overall Study|High parathyroid hormone|0|||
48472432|NCT00471237|155922707|FG006|Overall Study|High parathyroid hormone|0|||
48472433|NCT00471237|155922701|FG000|Overall Study|Participant lost medication|0|||
48472434|NCT00471237|155922702|FG001|Overall Study|Participant lost medication|0|||
48472435|NCT00471237|155922703|FG002|Overall Study|Participant lost medication|0|||
48472436|NCT00471237|155922704|FG003|Overall Study|Participant lost medication|0|||
48472437|NCT00471237|155922705|FG004|Overall Study|Participant lost medication|1|||
48472438|NCT00471237|155922706|FG005|Overall Study|Participant lost medication|0|||
48472439|NCT00471237|155922707|FG006|Overall Study|Participant lost medication|0|||
48472440|NCT00471237|155922701|FG000|Overall Study|Administration of prohibited medicine|0|||
48472441|NCT00471237|155922702|FG001|Overall Study|Administration of prohibited medicine|0|||
48472442|NCT00471237|155922703|FG002|Overall Study|Administration of prohibited medicine|0|||
48472443|NCT00471237|155922704|FG003|Overall Study|Administration of prohibited medicine|0|||
48472444|NCT00471237|155922705|FG004|Overall Study|Administration of prohibited medicine|1|||
48472445|NCT00471237|155922706|FG005|Overall Study|Administration of prohibited medicine|0|||
48472446|NCT00471237|155922707|FG006|Overall Study|Administration of prohibited medicine|0|||
48472447|NCT00471237|155922701|FG000|Overall Study|Participant shifted residence|0|||
48472448|NCT00471237|155922702|FG001|Overall Study|Participant shifted residence|0|||
48472449|NCT00471237|155922703|FG002|Overall Study|Participant shifted residence|0|||
48472450|NCT00471237|155922704|FG003|Overall Study|Participant shifted residence|0|||
48472451|NCT00471237|155922705|FG004|Overall Study|Participant shifted residence|1|||
48472452|NCT00471237|155922706|FG005|Overall Study|Participant shifted residence|0|||
48472453|NCT00471237|155922707|FG006|Overall Study|Participant shifted residence|0|||
48472454|NCT00471237|155922701|FG000|Overall Study|Participant's decision|0|||
48472455|NCT00471237|155922702|FG001|Overall Study|Participant's decision|0|||
48472456|NCT00471237|155922703|FG002|Overall Study|Participant's decision|0|||
48472457|NCT00471237|155922704|FG003|Overall Study|Participant's decision|0|||
48472458|NCT00471237|155922705|FG004|Overall Study|Participant's decision|0|||
48472459|NCT00471237|155922706|FG005|Overall Study|Participant's decision|1|||
48472460|NCT00471237|155922707|FG006|Overall Study|Participant's decision|0|||
48472461|NCT00593385|155922708|FG000|Overall Study|Death|14|||
48472462|NCT00593385|155922708|FG000|Overall Study|Lost to Follow-up|17|||
48472463|NCT00593385|155922708|FG000|Overall Study|Withdrawal by Subject|9|||
48472464|NCT01590628|155922709|FG000|Overall Study|Death|2|||
48472465|NCT01590628|155922710|FG001|Overall Study|Death|0|||
48472466|NCT00848965|155922712|FG000|Overall Study|Adverse Event|1|||
48472467|NCT00848965|155922712|FG000|Overall Study|Withdrawal by Subject|1|||
48472468|NCT00229931|155922713|FG000|Overall Study|Death|1|||
48472469|NCT00229931|155922714|FG001|Overall Study|Death|0|||
48472470|NCT00229931|155922713|FG000|Overall Study|Lost to Follow-up|3|||
48472471|NCT00229931|155922714|FG001|Overall Study|Lost to Follow-up|2|||
48472472|NCT00348348|155922719|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
48472473|NCT00348348|155922720|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
48472474|NCT00348348|155922719|FG000|Overall Study|Lack of Efficacy|1|||
48472475|NCT00348348|155922720|FG001|Overall Study|Lack of Efficacy|1|||
48472476|NCT00348348|155922719|FG000|Overall Study|Lost to Follow-up|8|||
48472477|NCT00348348|155922720|FG001|Overall Study|Lost to Follow-up|10|||
48472478|NCT00348348|155922719|FG000|Overall Study|Withdrawal by Subject|4|||
48472479|NCT00348348|155922720|FG001|Overall Study|Withdrawal by Subject|1|||
48472480|NCT00348348|155922719|FG000|Overall Study|Other|7|||
48472481|NCT00348348|155922720|FG001|Overall Study|Other|4|||
48472482|NCT00348348|155922719|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
48472483|NCT00348348|155922720|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
48472484|NCT00348348|155922719|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
48472485|NCT00348348|155922720|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
48472486|NCT00348348|155922719|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
48472487|NCT00348348|155922720|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
48472488|NCT00348348|155922719|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
48472489|NCT00348348|155922720|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
48472490|NCT00348348|155922719|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
48472491|NCT00348348|155922720|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
48472492|NCT00348348|155922719|FG000|Overall Study|Adverse event probably related to study|1|||
48472493|NCT00348348|155922720|FG001|Overall Study|Adverse event probably related to study|0|||
48472494|NCT03290131|155922724|FG000|Overall Study|Adverse Event|22|||
48472495|NCT03290131|155922725|FG001|Overall Study|Adverse Event|57|||
48472496|NCT03290131|155922726|FG002|Overall Study|Adverse Event|11|||
48472497|NCT03290131|155922724|FG000|Overall Study|Withdrawal by Subject|18|||
48472498|NCT03290131|155922725|FG001|Overall Study|Withdrawal by Subject|13|||
48472499|NCT03290131|155922726|FG002|Overall Study|Withdrawal by Subject|8|||
48472500|NCT03290131|155922724|FG000|Overall Study|MS Relapse|2|||
48472501|NCT03290131|155922725|FG001|Overall Study|MS Relapse|1|||
48472502|NCT03290131|155922726|FG002|Overall Study|MS Relapse|0|||
48472503|NCT03290131|155922724|FG000|Overall Study|Unknown reason|0|||
48472504|NCT03290131|155922725|FG001|Overall Study|Unknown reason|1|||
48472505|NCT03290131|155922726|FG002|Overall Study|Unknown reason|0|||
48472506|NCT03605758|155922731|FG000|Overall Study|Lost to Follow-up|2|||
48472507|NCT03605758|155922732|FG001|Overall Study|Lost to Follow-up|1|||
48472508|NCT03605758|155922731|FG000|Overall Study|Illness|0|||
48472509|NCT03605758|155922732|FG001|Overall Study|Illness|1|||
48472510|NCT03605758|155922731|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
48472511|NCT03605758|155922732|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
48472512|NCT00924313|155922733|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
48472513|NCT01725217|155922745|FG000|Overall Study|Withdrawal by Subject|1|||
48472514|NCT01725217|155922746|FG001|Overall Study|Withdrawal by Subject|0|||
48472515|NCT01725217|155922747|FG002|Overall Study|Withdrawal by Subject|0|||
48472516|NCT02190604|155922748|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472517|NCT02190604|155922749|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472518|NCT02190604|155922750|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472519|NCT02190604|155922751|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472520|NCT02190604|155922752|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472521|NCT02190604|155922753|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472522|NCT02190604|155922754|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472523|NCT02190604|155922755|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472524|NCT02190604|155922756|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472525|NCT02190604|155922757|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472526|NCT02190604|155922758|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472527|NCT02190604|155922759|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472528|NCT02190604|155922760|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472529|NCT02190604|155922761|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472530|NCT02190604|155922762|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
48472531|NCT02190604|155922763|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472532|NCT02190604|155922764|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472533|NCT02190604|155922765|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472534|NCT02190604|155922766|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
48472535|NCT02190604|155922748|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472536|NCT02190604|155922749|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472537|NCT02190604|155922750|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472538|NCT02190604|155922751|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472539|NCT02190604|155922752|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472540|NCT02190604|155922753|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472541|NCT02190604|155922754|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472542|NCT02190604|155922755|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472543|NCT02190604|155922756|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472544|NCT02190604|155922757|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472545|NCT02190604|155922758|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472546|NCT02190604|155922759|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472547|NCT02190604|155922760|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472548|NCT02190604|155922761|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
48472549|NCT02190604|155922762|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472550|NCT02190604|155922763|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472551|NCT02190604|155922764|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472552|NCT02190604|155922765|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472553|NCT02190604|155922766|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
48472554|NCT00814502|155922767|FG000|Overall Study|Adverse Event|1|||
48472555|NCT00814502|155922768|FG001|Overall Study|Adverse Event|0|||
48472556|NCT00814502|155922767|FG000|Overall Study|Withdrawal by Subject|0|||
48472557|NCT00814502|155922768|FG001|Overall Study|Withdrawal by Subject|2|||
48472558|NCT04281030|155922769|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
48472559|NCT04281030|155922770|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
48472560|NCT04281030|155922769|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
48472561|NCT04281030|155922770|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
48472562|NCT00910000|155922771|FG000|Overall Study|Adverse Event|0|||
48472563|NCT00910000|155922772|FG001|Overall Study|Adverse Event|3|||
48472564|NCT00910000|155922773|FG002|Overall Study|Adverse Event|2|||
48472565|NCT00910000|155922774|FG003|Overall Study|Adverse Event|2|||
48472566|NCT00910000|155922775|FG004|Overall Study|Adverse Event|0|||
48472567|NCT00910000|155922776|FG005|Overall Study|Adverse Event|1|||
48472568|NCT00910000|155922771|FG000|Overall Study|Withdrawal by Subject|0|||
48472569|NCT00910000|155922772|FG001|Overall Study|Withdrawal by Subject|0|||
48472570|NCT00910000|155922773|FG002|Overall Study|Withdrawal by Subject|1|||
48472571|NCT00910000|155922774|FG003|Overall Study|Withdrawal by Subject|0|||
48472572|NCT00910000|155922775|FG004|Overall Study|Withdrawal by Subject|1|||
48472573|NCT00910000|155922776|FG005|Overall Study|Withdrawal by Subject|0|||
48472574|NCT04409509|155922777|FG000|Overall Study|Failure to meet randomization requirement|1|||
48472575|NCT04409509|155922778|FG001|Overall Study|Failure to meet randomization requirement|0|||
48472576|NCT04409509|155922777|FG000|Overall Study|Adverse Event|0|||
48472577|NCT04409509|155922778|FG001|Overall Study|Adverse Event|1|||
48472578|NCT04409509|155922777|FG000|Overall Study|Death|11|||
48472579|NCT04409509|155922778|FG001|Overall Study|Death|10|||
48472580|NCT04409509|155922777|FG000|Overall Study|Non-compliance with study drug|0|||
48472581|NCT04409509|155922778|FG001|Overall Study|Non-compliance with study drug|1|||
48472582|NCT04409509|155922777|FG000|Overall Study|Lost to Follow-up|0|||
48472583|NCT04409509|155922778|FG001|Overall Study|Lost to Follow-up|3|||
48472584|NCT04409509|155922777|FG000|Overall Study|Withdrawal by Subject|0|||
48472585|NCT04409509|155922778|FG001|Overall Study|Withdrawal by Subject|3|||
48472586|NCT04409509|155922777|FG000|Overall Study|Randomized by mistake|0|||
48472587|NCT04409509|155922778|FG001|Overall Study|Randomized by mistake|1|||
48472588|NCT04409509|155922777|FG000|Overall Study|Other|1|||
48472589|NCT04409509|155922778|FG001|Overall Study|Other|1|||
48472590|NCT00903357|155922783|FG000|First Intervention|Withdrawal by Subject|5|||
48472591|NCT00903357|155922784|FG001|First Intervention|Withdrawal by Subject|3|||
48472592|NCT00903357|155922783|FG000|First Intervention|Flu|0|||
48472593|NCT00903357|155922784|FG001|First Intervention|Flu|1|||
48472594|NCT00903357|155922783|FG000|Wash Out Period of 2 Weeks|Flu|0|||
48472595|NCT00903357|155922784|FG001|Wash Out Period of 2 Weeks|Flu|1|||
48472596|NCT00903357|155922783|FG000|Second Intervention|Lost to Follow-up|1|||
48472597|NCT00903357|155922784|FG001|Second Intervention|Lost to Follow-up|0|||
48472598|NCT03426995|155922786|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472599|NCT03426995|155922787|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472600|NCT03426995|155922788|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
48472601|NCT03426995|155922789|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472602|NCT03426995|155922790|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472603|NCT03426995|155922791|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472604|NCT03426995|155922792|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472605|NCT03426995|155922793|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472606|NCT03426995|155922794|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472607|NCT03426995|155922795|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472608|NCT03426995|155922796|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472609|NCT03426995|155922797|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472610|NCT03426995|155922798|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472611|NCT03426995|155922799|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472612|NCT03426995|155922800|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472613|NCT03426995|155922801|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472614|NCT03426995|155922802|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472615|NCT03426995|155922803|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472616|NCT03426995|155922804|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
48472617|NCT03426995|155922786|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472618|NCT03426995|155922787|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472619|NCT03426995|155922788|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472620|NCT03426995|155922789|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472621|NCT03426995|155922790|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472622|NCT03426995|155922791|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
48472623|NCT03426995|155922792|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472624|NCT03426995|155922793|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472625|NCT03426995|155922794|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472626|NCT03426995|155922795|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472627|NCT03426995|155922796|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472628|NCT03426995|155922797|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472629|NCT03426995|155922798|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472630|NCT03426995|155922799|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472631|NCT03426995|155922800|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472632|NCT03426995|155922801|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472633|NCT03426995|155922802|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472634|NCT03426995|155922803|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472635|NCT03426995|155922804|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
48472636|NCT03426995|155922786|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472637|NCT03426995|155922787|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472638|NCT03426995|155922788|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472639|NCT03426995|155922789|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472640|NCT03426995|155922790|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
48472641|NCT03426995|155922791|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
48472642|NCT03426995|155922792|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472643|NCT03426995|155922793|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472644|NCT03426995|155922794|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472645|NCT03426995|155922795|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472646|NCT03426995|155922796|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472647|NCT03426995|155922797|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472648|NCT03426995|155922798|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472649|NCT03426995|155922799|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472650|NCT03426995|155922800|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472651|NCT03426995|155922801|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472652|NCT03426995|155922802|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472653|NCT03426995|155922803|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472654|NCT03426995|155922804|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
48472655|NCT03426995|155922786|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472656|NCT03426995|155922787|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472657|NCT03426995|155922788|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472658|NCT03426995|155922789|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472659|NCT03426995|155922790|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472660|NCT03426995|155922791|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472661|NCT03426995|155922792|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472662|NCT03426995|155922793|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472663|NCT03426995|155922794|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472664|NCT03426995|155922795|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472665|NCT03426995|155922796|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
48472666|NCT03426995|155922797|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472667|NCT03426995|155922798|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472668|NCT03426995|155922799|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472669|NCT03426995|155922800|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472670|NCT03426995|155922801|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472671|NCT03426995|155922802|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472672|NCT03426995|155922803|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472673|NCT03426995|155922804|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
48472674|NCT03426995|155922786|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472675|NCT03426995|155922787|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472676|NCT03426995|155922788|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472677|NCT03426995|155922789|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472678|NCT03426995|155922790|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472679|NCT03426995|155922791|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472680|NCT03426995|155922792|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472681|NCT03426995|155922793|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
48472682|NCT03426995|155922794|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472683|NCT03426995|155922795|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472684|NCT03426995|155922796|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472685|NCT03426995|155922797|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472686|NCT03426995|155922798|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472687|NCT03426995|155922799|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472688|NCT03426995|155922800|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472689|NCT03426995|155922801|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472690|NCT03426995|155922802|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472691|NCT03426995|155922803|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472692|NCT03426995|155922804|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
48472693|NCT03426995|155922786|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472694|NCT03426995|155922787|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472695|NCT03426995|155922788|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472696|NCT03426995|155922789|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472697|NCT03426995|155922790|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472698|NCT03426995|155922791|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472699|NCT03426995|155922792|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472700|NCT03426995|155922793|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472701|NCT03426995|155922794|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472702|NCT03426995|155922795|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472703|NCT03426995|155922796|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472704|NCT03426995|155922797|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472705|NCT03426995|155922798|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472706|NCT03426995|155922799|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472707|NCT03426995|155922800|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
48472708|NCT03426995|155922801|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
48472709|NCT03426995|155922802|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472710|NCT03426995|155922803|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472711|NCT03426995|155922804|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
48472712|NCT03426995|155922786|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472713|NCT03426995|155922787|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472714|NCT03426995|155922788|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472715|NCT03426995|155922789|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472716|NCT03426995|155922790|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472717|NCT03426995|155922791|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472718|NCT03426995|155922792|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472719|NCT03426995|155922793|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472720|NCT03426995|155922794|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472721|NCT03426995|155922795|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472722|NCT03426995|155922796|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472723|NCT03426995|155922797|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472724|NCT03426995|155922798|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472725|NCT03426995|155922799|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472726|NCT03426995|155922800|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
48472727|NCT03426995|155922801|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
48472728|NCT03426995|155922802|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472729|NCT03426995|155922803|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472730|NCT03426995|155922804|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
48472731|NCT02279888|155922805|FG000|Overall Study|Death|326|||
48472732|NCT02279888|155922805|FG000|Overall Study|Withdrawal by Subject|38|||
48472733|NCT02279888|155922805|FG000|Overall Study|Lost to Follow-up|21|||
48472734|NCT02279888|155922805|FG000|Overall Study|Physician Decision|62|||
48472735|NCT02279888|155922805|FG000|Overall Study|Subject Non-compliance|43|||
48472736|NCT02279888|155922805|FG000|Overall Study|Not implanted|14|||
48472737|NCT02279888|155922805|FG000|Overall Study|Visit not performed|26|||
48472738|NCT04505592|155922807|FG000|Overall Study|Death|2|||
48472739|NCT04505592|155922808|FG001|Overall Study|Death|1|||
48472740|NCT02335411|155922809|FG000|Overall Study|Death|223|||
48472741|NCT02335411|155922810|FG001|Overall Study|Death|22|||
48472742|NCT02335411|155922811|FG002|Overall Study|Death|26|||
48472743|NCT02335411|155922809|FG000|Overall Study|Physician Decision|3|||
48472744|NCT02335411|155922810|FG001|Overall Study|Physician Decision|0|||
48472745|NCT02335411|155922811|FG002|Overall Study|Physician Decision|0|||
48472746|NCT02335411|155922809|FG000|Overall Study|Protocol Violation|1|||
48472747|NCT02335411|155922810|FG001|Overall Study|Protocol Violation|0|||
48472748|NCT02335411|155922811|FG002|Overall Study|Protocol Violation|0|||
48472749|NCT02335411|155922809|FG000|Overall Study|Withdrawal by Subject|11|||
48472750|NCT02335411|155922810|FG001|Overall Study|Withdrawal by Subject|0|||
48472751|NCT02335411|155922811|FG002|Overall Study|Withdrawal by Subject|3|||
48472752|NCT02335411|155922809|FG000|Overall Study|Sponsor Decision|12|||
48472753|NCT02335411|155922810|FG001|Overall Study|Sponsor Decision|3|||
48472754|NCT02335411|155922811|FG002|Overall Study|Sponsor Decision|2|||
48472755|NCT02335411|155922809|FG000|Overall Study|Adverse Event|9|||
48472756|NCT02335411|155922810|FG001|Overall Study|Adverse Event|0|||
48472757|NCT02335411|155922811|FG002|Overall Study|Adverse Event|0|||
48472758|NCT00938015|155922812|FG000|Overall Study|Death|2|||
48472759|NCT00938015|155922812|FG000|Overall Study|Lost to Follow-up|32|||
48472760|NCT00938015|155922812|FG000|Overall Study|Adverse Event|32|||
48472761|NCT00938015|155922812|FG000|Overall Study|Non-responder|52|||
48472762|NCT00938015|155922812|FG000|Overall Study|Reason not related to Etanercept|29|||
48472763|NCT01886105|155922813|FG000|Overall Study|Lack of Efficacy|3|||
48472764|NCT02341482|155922814|FG000|Overall Study|Adverse Event|1|||
48472765|NCT01876901|155922815|FG000|Overall Study|Protocol Violation|10|||
48472766|NCT01876901|155922816|FG001|Overall Study|Protocol Violation|2|||
48472767|NCT01876901|155922815|FG000|Overall Study|No or other surgical intervention|7|||
48472768|NCT01876901|155922816|FG001|Overall Study|No or other surgical intervention|5|||
48472769|NCT01418365|155922817|FG000|First Intervention|Withdrawal by Subject|0|||
48472770|NCT01418365|155922818|FG001|First Intervention|Withdrawal by Subject|1|||
48472771|NCT01418365|155922817|FG000|First Intervention|Non-compliance|1|||
48472772|NCT01418365|155922818|FG001|First Intervention|Non-compliance|0|||
48472773|NCT01418365|155922817|FG000|Second Intervention|Withdrawal by Subject|0|||
48472774|NCT01418365|155922818|FG001|Second Intervention|Withdrawal by Subject|1|||
48472775|NCT01283282|155922819|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
48472776|NCT01283282|155922820|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
48472777|NCT01283282|155922819|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
48472778|NCT01283282|155922820|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
48472779|NCT01283282|155922819|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
48472780|NCT01283282|155922820|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
48472781|NCT01977482|155922821|FG000|Overall Study|Adverse Event|0|||
48472782|NCT01977482|155922822|FG001|Overall Study|Adverse Event|1|||
48472783|NCT01977482|155922823|FG002|Overall Study|Adverse Event|1|||
48472784|NCT01977482|155922824|FG003|Overall Study|Adverse Event|0|||
48472785|NCT01977482|155922825|FG004|Overall Study|Adverse Event|2|||
48472786|NCT01977482|155922826|FG005|Overall Study|Adverse Event|0|||
48472787|NCT01977482|155922821|FG000|Overall Study|Lost to Follow-up|1|||
48472788|NCT01977482|155922822|FG001|Overall Study|Lost to Follow-up|0|||
48472789|NCT01977482|155922823|FG002|Overall Study|Lost to Follow-up|0|||
48472790|NCT01977482|155922824|FG003|Overall Study|Lost to Follow-up|0|||
48472791|NCT01977482|155922825|FG004|Overall Study|Lost to Follow-up|0|||
48472792|NCT01977482|155922826|FG005|Overall Study|Lost to Follow-up|0|||
48472793|NCT01977482|155922821|FG000|Overall Study|Physician Decision|0|||
48472794|NCT01977482|155922822|FG001|Overall Study|Physician Decision|1|||
48472795|NCT01977482|155922823|FG002|Overall Study|Physician Decision|0|||
48472796|NCT01977482|155922824|FG003|Overall Study|Physician Decision|0|||
48472797|NCT01977482|155922825|FG004|Overall Study|Physician Decision|0|||
48472798|NCT01977482|155922826|FG005|Overall Study|Physician Decision|0|||
48472799|NCT01977482|155922821|FG000|Overall Study|Protocol Violation|0|||
48472800|NCT01977482|155922822|FG001|Overall Study|Protocol Violation|0|||
48472801|NCT01977482|155922823|FG002|Overall Study|Protocol Violation|1|||
48472802|NCT01977482|155922824|FG003|Overall Study|Protocol Violation|0|||
48472803|NCT01977482|155922825|FG004|Overall Study|Protocol Violation|0|||
48472804|NCT01977482|155922826|FG005|Overall Study|Protocol Violation|0|||
48472805|NCT01977482|155922821|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
48472806|NCT01977482|155922822|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
48472807|NCT01977482|155922823|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
48472808|NCT01977482|155922824|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
48472809|NCT01977482|155922825|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
48472810|NCT01977482|155922826|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
48472811|NCT01977482|155922821|FG000|Overall Study|Withdrawal by Subject|2|||
48472812|NCT01977482|155922822|FG001|Overall Study|Withdrawal by Subject|4|||
48472813|NCT01977482|155922823|FG002|Overall Study|Withdrawal by Subject|1|||
48472814|NCT01977482|155922824|FG003|Overall Study|Withdrawal by Subject|3|||
48472815|NCT01977482|155922825|FG004|Overall Study|Withdrawal by Subject|1|||
48472816|NCT01977482|155922826|FG005|Overall Study|Withdrawal by Subject|5|||
48472817|NCT05022121|155922827|FG000|Overall Study|Lack of Efficacy|1|||
48472818|NCT05022121|155922828|FG001|Overall Study|Lack of Efficacy|0|||
48472819|NCT05022121|155922827|FG000|Overall Study|Lost to Follow-up|0|||
48472820|NCT05022121|155922828|FG001|Overall Study|Lost to Follow-up|2|||
48472821|NCT01361308|155925014|FG000|Overall Study|Withdrawal by Subject|9|||
48472822|NCT01361308|155925015|FG001|Overall Study|Withdrawal by Subject|13|||
48472823|NCT01361308|155925014|FG000|Overall Study|Physician Decision|3|||
48472824|NCT01361308|155925015|FG001|Overall Study|Physician Decision|3|||
48472825|NCT01361308|155925014|FG000|Overall Study|Lack of Efficacy|2|||
48472826|NCT01361308|155925015|FG001|Overall Study|Lack of Efficacy|0|||
48472827|NCT01361308|155925014|FG000|Overall Study|Protocol Violation|1|||
48472828|NCT01361308|155925015|FG001|Overall Study|Protocol Violation|0|||
48472829|NCT01361308|155925014|FG000|Overall Study|Lost to Follow-up|5|||
48472830|NCT01361308|155925015|FG001|Overall Study|Lost to Follow-up|4|||
48472831|NCT01361308|155925014|FG000|Overall Study|Adverse Event|8|||
48472832|NCT01361308|155925015|FG001|Overall Study|Adverse Event|4|||
48472833|NCT01361308|155925014|FG000|Overall Study|Eligibility Criteria Not Met|2|||
48472834|NCT01361308|155925015|FG001|Overall Study|Eligibility Criteria Not Met|3|||
48472835|NCT01361308|155925014|FG000|Overall Study|Failed C-SSRS|5|||
48472836|NCT01361308|155925015|FG001|Overall Study|Failed C-SSRS|2|||
48472837|NCT01361308|155925014|FG000|Overall Study|Other|0|||
48472838|NCT01361308|155925015|FG001|Overall Study|Other|1|||
48472839|NCT01479777|155925018|FG000|Overall Study|Physician Decision|2|||
48472840|NCT01789476|155925019|FG000|Overall Study|Lack of Efficacy|6|||
48472841|NCT01789476|155925020|FG001|Overall Study|Lack of Efficacy|2|||
48472842|NCT01789476|155925019|FG000|Overall Study|Adverse Event|1|||
48472843|NCT01789476|155925020|FG001|Overall Study|Adverse Event|0|||
48472844|NCT01789476|155925019|FG000|Overall Study|Unable to get IV access|1|||
48472845|NCT01789476|155925020|FG001|Overall Study|Unable to get IV access|0|||
48472846|NCT00953576|155925021|FG000|Overall Study|Adverse Event|0|||
48472847|NCT00953576|155925022|FG001|Overall Study|Adverse Event|1|||
48472848|NCT00953576|155925021|FG000|Overall Study|Ineligible after Consent|2|||
48472849|NCT00953576|155925022|FG001|Overall Study|Ineligible after Consent|0|||
48472850|NCT00501969|155925023|FG000|Overall Study|Major Protocol Violation|4|||
48472851|NCT00501969|155925023|FG000|Overall Study|Lack of Efficacy|29|||
48472852|NCT00501969|155925023|FG000|Overall Study|Adverse Event|76|||
48472853|NCT00501969|155925023|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
48472854|NCT00501969|155925023|FG000|Overall Study|Subject withdrew consent|51|||
48472855|NCT00501969|155925023|FG000|Overall Study|Lost to Follow-up|4|||
48472856|NCT00501969|155925023|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
48472857|NCT00501969|155925023|FG000|Overall Study|Other: Sponsors Request|10|||
48472858|NCT00501969|155925023|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
48472859|NCT00501969|155925023|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
48472860|NCT00501969|155925023|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
48472861|NCT00501969|155925023|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
48472862|NCT00501969|155925023|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
48472863|NCT00501969|155925023|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
48472864|NCT00501969|155925023|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
48472865|NCT00501969|155925023|FG000|Overall Study|Other: As Required by Local EC|2|||
48472866|NCT00501969|155925023|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
48472867|NCT00501969|155925023|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
48472868|NCT00451191|155925029|FG000|Overall Study|withdrawal or received alternate tx|15|||
48472869|NCT00451191|155925030|FG001|Overall Study|withdrawal or received alternate tx|11|||
48472870|NCT00665366|155925031|FG000|Overall Study|Lack of Efficacy|11|||
48472871|NCT00665366|155925032|FG001|Overall Study|Lack of Efficacy|10|||
48472872|NCT00665366|155925031|FG000|Overall Study|Adverse Event|25|||
48472873|NCT00665366|155925032|FG001|Overall Study|Adverse Event|23|||
48472874|NCT00665366|155925031|FG000|Overall Study|Withdrawal by Subject|11|||
48472875|NCT00665366|155925032|FG001|Overall Study|Withdrawal by Subject|14|||
48472876|NCT00665366|155925031|FG000|Overall Study|Lost to Follow-up|3|||
48472877|NCT00665366|155925032|FG001|Overall Study|Lost to Follow-up|5|||
48472878|NCT00665366|155925031|FG000|Overall Study|Poor compliance/noncompliance|3|||
48472879|NCT00665366|155925032|FG001|Overall Study|Poor compliance/noncompliance|5|||
48472880|NCT00665366|155925031|FG000|Overall Study|Pregnancy|1|||
48472881|NCT00665366|155925032|FG001|Overall Study|Pregnancy|0|||
48472882|NCT00665366|155925031|FG000|Overall Study|No longer meets study criteria|0|||
48472883|NCT00665366|155925032|FG001|Overall Study|No longer meets study criteria|1|||
48472884|NCT00665366|155925031|FG000|Overall Study|Other reasons|4|||
48472885|NCT00665366|155925032|FG001|Overall Study|Other reasons|1|||
48472886|NCT02087865|155925037|FG000|Overall Study|Withdrawal by Subject|6|||
48472887|NCT02087865|155925038|FG001|Overall Study|Withdrawal by Subject|0|||
48472888|NCT02087865|155925039|FG002|Overall Study|Withdrawal by Subject|1|||
48472889|NCT02087865|155925037|FG000|Overall Study|Lost to Follow-up|0|||
48472890|NCT02087865|155925038|FG001|Overall Study|Lost to Follow-up|0|||
48472891|NCT02087865|155925039|FG002|Overall Study|Lost to Follow-up|1|||
48472892|NCT02087865|155925037|FG000|Overall Study|Drug Non-compliance|0|||
48472893|NCT02087865|155925038|FG001|Overall Study|Drug Non-compliance|2|||
48472894|NCT02087865|155925039|FG002|Overall Study|Drug Non-compliance|0|||
48472895|NCT02087865|155925037|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
48472896|NCT02087865|155925038|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
48472897|NCT02087865|155925039|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
48472898|NCT00965458|155925045|FG000|Overall Study|Adverse Event|1|||
48472899|NCT00965458|155925046|FG001|Overall Study|Adverse Event|0|||
48472900|NCT00965458|155925045|FG000|Overall Study|Lost to Follow-up|1|||
48472901|NCT00965458|155925046|FG001|Overall Study|Lost to Follow-up|3|||
48472902|NCT00965458|155925045|FG000|Overall Study|Withdrawal by Subject|0|||
48472903|NCT00965458|155925046|FG001|Overall Study|Withdrawal by Subject|1|||
48472904|NCT00656669|155925048|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
48472905|NCT00656669|155925048|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
48472906|NCT00656669|155925048|FG000|AC (Cycles 6-9)|Adverse Event|1|||
48472907|NCT00656669|155925048|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
48472908|NCT00219349|155925049|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
48472909|NCT00219349|155925049|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
48472910|NCT00219349|155925049|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
48472911|NCT00219349|155925049|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
48472912|NCT03778021|155925052|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
48472913|NCT03778021|155925053|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
48472914|NCT00679042|155925054|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
48472915|NCT00679042|155925054|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
48472916|NCT00679042|155925054|FG000|5-Year Follow Up|Death|1|||
48472917|NCT00679042|155925054|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
48472918|NCT00679042|155925054|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
48472919|NCT02687815|155925056|FG000|Overall Study|Lost to Follow-up|2|||
48472920|NCT02687815|155925057|FG001|Overall Study|Lost to Follow-up|4|||
48472921|NCT02687815|155925056|FG000|Overall Study|Withdrawal by Subject|2|||
48472922|NCT02687815|155925057|FG001|Overall Study|Withdrawal by Subject|4|||
48472923|NCT02777554|155925058|FG000|Overall Study|Adverse Event|4|||
48472924|NCT02777554|155925059|FG001|Overall Study|Adverse Event|4|||
48472925|NCT02777554|155925060|FG002|Overall Study|Adverse Event|0|||
48472926|NCT02777554|155925061|FG003|Overall Study|Adverse Event|1|||
48472927|NCT02777554|155925062|FG004|Overall Study|Adverse Event|0|||
48472928|NCT02777554|155925063|FG005|Overall Study|Adverse Event|0|||
48472929|NCT02777554|155925058|FG000|Overall Study|Withdrawal by Subject|3|||
48472930|NCT02777554|155925059|FG001|Overall Study|Withdrawal by Subject|1|||
48472931|NCT02777554|155925060|FG002|Overall Study|Withdrawal by Subject|1|||
48472932|NCT02777554|155925061|FG003|Overall Study|Withdrawal by Subject|0|||
48472933|NCT02777554|155925062|FG004|Overall Study|Withdrawal by Subject|0|||
48472934|NCT02777554|155925063|FG005|Overall Study|Withdrawal by Subject|0|||
48472935|NCT02777554|155925058|FG000|Overall Study|Discharged early due to hurricane|22|||
48472936|NCT02777554|155925059|FG001|Overall Study|Discharged early due to hurricane|20|||
48472937|NCT02777554|155925060|FG002|Overall Study|Discharged early due to hurricane|0|||
48472938|NCT02777554|155925061|FG003|Overall Study|Discharged early due to hurricane|0|||
48472939|NCT02777554|155925062|FG004|Overall Study|Discharged early due to hurricane|0|||
48472940|NCT02777554|155925063|FG005|Overall Study|Discharged early due to hurricane|0|||
48472941|NCT02777554|155925058|FG000|Overall Study|Other - Miscellaneous|1|||
48472942|NCT02777554|155925059|FG001|Overall Study|Other - Miscellaneous|0|||
48472943|NCT02777554|155925060|FG002|Overall Study|Other - Miscellaneous|0|||
48472944|NCT02777554|155925061|FG003|Overall Study|Other - Miscellaneous|0|||
48472945|NCT02777554|155925062|FG004|Overall Study|Other - Miscellaneous|0|||
48472946|NCT02777554|155925063|FG005|Overall Study|Other - Miscellaneous|0|||
48472947|NCT00270205|155925072|FG000|Overall Study|Lost to Follow-up|1|||
48472948|NCT00270205|155925073|FG001|Overall Study|Lost to Follow-up|0|||
48472949|NCT00270205|155925074|FG002|Overall Study|Lost to Follow-up|0|||
48472950|NCT00270205|155925075|FG003|Overall Study|Lost to Follow-up|1|||
48472951|NCT00066573|155925081|FG000|Overall Study|Did not received protocol treatment|28|||
48472952|NCT00066573|155925082|FG001|Overall Study|Did not received protocol treatment|28|||
48472953|NCT00869362|155925083|FG000|Overall Study|Death|0|||
48472954|NCT00869362|155925084|FG001|Overall Study|Death|2|||
48472955|NCT00869362|155925083|FG000|Overall Study|Lost to Follow-up|1|||
48472956|NCT00869362|155925084|FG001|Overall Study|Lost to Follow-up|3|||
48472957|NCT04177862|155925085|FG000|Overall Study|Protocol Violation|2|||
48472958|NCT04177862|155925086|FG001|Overall Study|Protocol Violation|7|||
48472959|NCT03053102|155925087|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
48472960|NCT03053102|155925087|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
48472961|NCT00003526|155925098|FG000|Overall Study|Not evaluable|6|||
48472962|NCT04165824|155925099|FG000|Overall Study|Adverse Event|23|||
48472963|NCT04165824|155925099|FG000|Overall Study|Physician Decision|1|||
48472964|NCT04165824|155925099|FG000|Overall Study|Withdrawal by Subject|17|||
48472965|NCT04165824|155925099|FG000|Overall Study|Other|5|||
48472966|NCT00381680|155925100|FG000|Overall Study|Adverse Event|9|||
48472967|NCT00381680|155925101|FG001|Overall Study|Adverse Event|3|||
48472968|NCT00381680|155925100|FG000|Overall Study|Death|10|||
48472969|NCT00381680|155925101|FG001|Overall Study|Death|7|||
48472970|NCT00381680|155925100|FG000|Overall Study|Lost to Follow-up|3|||
48472971|NCT00381680|155925101|FG001|Overall Study|Lost to Follow-up|2|||
48472972|NCT00381680|155925100|FG000|Overall Study|Physician Decision|25|||
48472973|NCT00381680|155925101|FG001|Overall Study|Physician Decision|6|||
48472974|NCT00381680|155925100|FG000|Overall Study|Withdrawal by Subject|3|||
48472975|NCT00381680|155925101|FG001|Overall Study|Withdrawal by Subject|1|||
48472976|NCT00381680|155925100|FG000|Overall Study|Entry onto another COG Trial|1|||
48472977|NCT00381680|155925101|FG001|Overall Study|Entry onto another COG Trial|2|||
48472978|NCT00381680|155925100|FG000|Overall Study|Alternative Therapy|11|||
48472979|NCT00381680|155925101|FG001|Overall Study|Alternative Therapy|5|||
48472980|NCT00381680|155925100|FG000|Overall Study|Secondary Malignancy|3|||
48472981|NCT00381680|155925101|FG001|Overall Study|Secondary Malignancy|0|||
48472982|NCT00381680|155925100|FG000|Overall Study|Delay initiation|1|||
48472983|NCT00381680|155925101|FG001|Overall Study|Delay initiation|0|||
48472984|NCT00381680|155925100|FG000|Overall Study|Stem Cell Transplant|26|||
48472985|NCT00381680|155925101|FG001|Overall Study|Stem Cell Transplant|10|||
48472986|NCT00381680|155925100|FG000|Overall Study|Relapse|18|||
48472987|NCT00381680|155925101|FG001|Overall Study|Relapse|9|||
48472988|NCT00381680|155925100|FG000|Overall Study|Induction Failure|4|||
48472989|NCT00381680|155925101|FG001|Overall Study|Induction Failure|1|||
48472990|NCT00381680|155925100|FG000|Overall Study|Progression|1|||
48472991|NCT00381680|155925101|FG001|Overall Study|Progression|1|||
48472992|NCT00381680|155925100|FG000|Overall Study|Other not otherwise specified|7|||
48472993|NCT00381680|155925101|FG001|Overall Study|Other not otherwise specified|2|||
48472994|NCT00381680|155925100|FG000|Overall Study|Ineligible|3|||
48472995|NCT00381680|155925101|FG001|Overall Study|Ineligible|1|||
48472996|NCT00483574|155925102|FG000|Overall Study|Adverse Event|6|||
48472997|NCT00483574|155925103|FG001|Overall Study|Adverse Event|0|||
48472998|NCT00483574|155925102|FG000|Overall Study|Protocol Violation|28|||
48472999|NCT00483574|155925103|FG001|Overall Study|Protocol Violation|9|||
48473000|NCT00483574|155925102|FG000|Overall Study|Lost to Follow-up|16|||
48473001|NCT00483574|155925103|FG001|Overall Study|Lost to Follow-up|4|||
48473002|NCT00483574|155925102|FG000|Overall Study|Withdrawal by Subject|52|||
48473003|NCT00483574|155925103|FG001|Overall Study|Withdrawal by Subject|0|||
48473004|NCT00465101|155925104|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
48473005|NCT00465101|155925104|FG000|Overall Study|Change in health precluded follow up|4|||
48473006|NCT00465101|155925104|FG000|Overall Study|Did not meet study criteria|4|||
48473007|NCT00465101|155925104|FG000|Overall Study|Lost to Follow-up|5|||
48473008|NCT00465101|155925104|FG000|Overall Study|Other|6|||
48473009|NCT00465101|155925104|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
48473010|NCT00465101|155925104|FG000|Overall Study|Patient postponed procedure|1|||
48473011|NCT00465101|155925104|FG000|Overall Study|Site closed due to IRB expiration|1|||
48473012|NCT00465101|155925104|FG000|Overall Study|Unable to obtain IRB approval|1|||
48473013|NCT00465101|155925104|FG000|Overall Study|Death|3|||
48473014|NCT00465101|155925104|FG000|Overall Study|Withdrawal by Subject|25|||
48473015|NCT00465101|155925104|FG000|Overall Study|Physician Decision|1|||
48473016|NCT00465101|155925104|FG000|Overall Study|Withdrew consent prior to procedure|3|||
48473017|NCT03099096|155925105|FG000|Overall Study|Adverse Event|1|||
48473018|NCT03099096|155925105|FG000|Overall Study|Physician Decision|1|||
48473019|NCT00131937|155925106|FG000|Overall Study|Adverse Event|3|||
48473020|NCT00131937|155925106|FG000|Overall Study|Withdrawal by Subject|2|||
48473021|NCT00131937|155925106|FG000|Overall Study|Physician Decision|1|||
48473022|NCT00131937|155925106|FG000|Overall Study|Disease Progression|7|||
48473023|NCT00131937|155925106|FG000|Overall Study|Alternative therapy|1|||
48473024|NCT00489411|155925107|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
48473025|NCT00489411|155925108|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
48473026|NCT00489411|155925107|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
48473027|NCT00489411|155925108|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
48473028|NCT00489411|155925107|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
48473029|NCT00489411|155925108|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
48473030|NCT00489411|155925107|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
48473031|NCT00489411|155925108|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
48473032|NCT00489411|155925107|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
48473033|NCT00489411|155925108|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
48473034|NCT01976104|155925112|FG000|Overall Study|Adverse Event|0|||
48473035|NCT01976104|155925113|FG001|Overall Study|Adverse Event|0|||
48473036|NCT01976104|155925114|FG002|Overall Study|Adverse Event|1|||
48473037|NCT01976104|155925115|FG003|Overall Study|Adverse Event|0|||
48473038|NCT01976104|155925112|FG000|Overall Study|Lost to Follow-up|3|||
48473039|NCT01976104|155925113|FG001|Overall Study|Lost to Follow-up|0|||
48473040|NCT01976104|155925114|FG002|Overall Study|Lost to Follow-up|1|||
48473041|NCT01976104|155925115|FG003|Overall Study|Lost to Follow-up|1|||
48473042|NCT01976104|155925112|FG000|Overall Study|Subject Choice|0|||
48473043|NCT01976104|155925113|FG001|Overall Study|Subject Choice|1|||
48473044|NCT01976104|155925114|FG002|Overall Study|Subject Choice|0|||
48473045|NCT01976104|155925115|FG003|Overall Study|Subject Choice|1|||
48473046|NCT01976104|155925112|FG000|Overall Study|Withdrawal by Subject|3|||
48473047|NCT01976104|155925113|FG001|Overall Study|Withdrawal by Subject|0|||
48473048|NCT01976104|155925114|FG002|Overall Study|Withdrawal by Subject|0|||
48473049|NCT01976104|155925115|FG003|Overall Study|Withdrawal by Subject|1|||
48473050|NCT01976104|155925112|FG000|Overall Study|Other|0|||
48473051|NCT01976104|155925113|FG001|Overall Study|Other|1|||
48473052|NCT01976104|155925114|FG002|Overall Study|Other|0|||
48473053|NCT01976104|155925115|FG003|Overall Study|Other|0|||
48473054|NCT01317199|155925116|FG000|Dose-escalation Phase 1|Physician Decision|5|||
48473055|NCT01317199|155925117|FG001|Dose-escalation Phase 1|Physician Decision|0|||
48473056|NCT01317199|155925118|FG002|Dose-escalation Phase 1|Physician Decision|0|||
48473057|NCT01317199|155925119|FG003|Dose-escalation Phase 1|Physician Decision|0|||
48473058|NCT01317199|155925116|FG000|Dose-escalation Phase 1|Disease progression|1|||
48473059|NCT01317199|155925117|FG001|Dose-escalation Phase 1|Disease progression|0|||
48473060|NCT01317199|155925118|FG002|Dose-escalation Phase 1|Disease progression|0|||
48473061|NCT01317199|155925119|FG003|Dose-escalation Phase 1|Disease progression|0|||
48473062|NCT01317199|155925116|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
48473063|NCT01317199|155925117|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
48473064|NCT01317199|155925118|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
48473065|NCT01317199|155925119|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
48473066|NCT01317199|155925116|FG000|Randomized Phase 2|Disease progression|0|||
48473067|NCT01317199|155925117|FG001|Randomized Phase 2|Disease progression|3|||
48473068|NCT01317199|155925118|FG002|Randomized Phase 2|Disease progression|7|||
48473069|NCT01317199|155925119|FG003|Randomized Phase 2|Disease progression|5|||
48473070|NCT01317199|155925116|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
48473071|NCT01317199|155925117|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
48473072|NCT01317199|155925118|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
48473073|NCT01317199|155925119|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
48473074|NCT01317199|155925116|FG000|Randomized Phase 2|Adverse Event|0|||
48473075|NCT01317199|155925117|FG001|Randomized Phase 2|Adverse Event|0|||
48473076|NCT01317199|155925118|FG002|Randomized Phase 2|Adverse Event|0|||
48473077|NCT01317199|155925119|FG003|Randomized Phase 2|Adverse Event|1|||
48473078|NCT01317199|155925116|FG000|Randomized Phase 2|Comorbidities|0|||
48473079|NCT01317199|155925117|FG001|Randomized Phase 2|Comorbidities|2|||
48473080|NCT01317199|155925118|FG002|Randomized Phase 2|Comorbidities|2|||
48473081|NCT01317199|155925119|FG003|Randomized Phase 2|Comorbidities|2|||
48473082|NCT01317199|155925116|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
48473083|NCT01317199|155925117|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
48473084|NCT01317199|155925118|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
48473085|NCT01317199|155925119|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
48473086|NCT01317199|155925116|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
48473087|NCT01317199|155925117|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
48473088|NCT01317199|155925118|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
48473089|NCT01317199|155925119|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
48473090|NCT01317199|155925116|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
48473091|NCT01317199|155925117|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
48473092|NCT01317199|155925118|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
48473093|NCT01317199|155925119|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
48473094|NCT01317199|155925116|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
48473095|NCT01317199|155925117|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
48473096|NCT01317199|155925118|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
48473097|NCT01317199|155925119|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
48473098|NCT01283009|155925120|FG000|Overall Study|Death|83|||
48473099|NCT01283009|155925121|FG001|Overall Study|Death|78|||
48473100|NCT01283009|155925120|FG000|Overall Study|Study ended early|23|||
48473101|NCT01283009|155925121|FG001|Overall Study|Study ended early|26|||
48473102|NCT01283009|155925120|FG000|Overall Study|Withdrawal by Subject|10|||
48473103|NCT01283009|155925121|FG001|Overall Study|Withdrawal by Subject|8|||
48473104|NCT01283009|155925120|FG000|Overall Study|Physician Decision|1|||
48473105|NCT01283009|155925121|FG001|Overall Study|Physician Decision|1|||
48473106|NCT01283009|155925120|FG000|Overall Study|Lost to Follow-up|1|||
48473107|NCT01283009|155925121|FG001|Overall Study|Lost to Follow-up|0|||
48473108|NCT01283009|155925120|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
48473109|NCT01283009|155925121|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
48473110|NCT01353209|155925122|FG000|Overall Study|Adverse Event|1|||
48473111|NCT01353209|155925123|FG001|Overall Study|Adverse Event|1|||
48473112|NCT04988035|155925126|FG000|Overall Study|Death|19|||
48473113|NCT04988035|155925127|FG001|Overall Study|Death|13|||
48473114|NCT04988035|155925126|FG000|Overall Study|Lost to Follow-up|12|||
48473115|NCT04988035|155925127|FG001|Overall Study|Lost to Follow-up|6|||
48473116|NCT04988035|155925126|FG000|Overall Study|Protocol Violation|0|||
48473117|NCT04988035|155925127|FG001|Overall Study|Protocol Violation|1|||
48473118|NCT04988035|155925126|FG000|Overall Study|Withdrawal by Subject|2|||
48473119|NCT04988035|155925127|FG001|Overall Study|Withdrawal by Subject|4|||
48473120|NCT04988035|155925126|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
48473121|NCT04988035|155925127|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
48473122|NCT03532048|155925129|FG000|Overall Study|Lost to Follow-up|12|||
48473123|NCT03532048|155925130|FG001|Overall Study|Lost to Follow-up|17|||
48473124|NCT03532048|155925129|FG000|Overall Study|Withdrawal by Subject|7|||
48473125|NCT03532048|155925130|FG001|Overall Study|Withdrawal by Subject|0|||
48473126|NCT00483119|155925133|FG000|Overall Study|Adverse Event|0|||
48473127|NCT00483119|155925134|FG001|Overall Study|Adverse Event|1|||
48473128|NCT00483119|155925133|FG000|Overall Study|Physician Decision|1|||
48473129|NCT00483119|155925134|FG001|Overall Study|Physician Decision|0|||
48473130|NCT04668066|155925137|FG000|Part 1: Treatment Phase|Adverse Event|0|||
48473131|NCT04668066|155925138|FG001|Part 1: Treatment Phase|Adverse Event|0|||
48473132|NCT04668066|155925139|FG002|Part 1: Treatment Phase|Adverse Event|0|||
48473133|NCT04668066|155925140|FG003|Part 1: Treatment Phase|Adverse Event|0|||
48473134|NCT04668066|155925141|FG004|Part 1: Treatment Phase|Adverse Event|0|||
48473135|NCT04668066|155925142|FG005|Part 1: Treatment Phase|Adverse Event|0|||
48473136|NCT04668066|155925143|FG006|Part 1: Treatment Phase|Adverse Event|0|||
48473137|NCT04668066|155925144|FG007|Part 1: Treatment Phase|Adverse Event|0|||
48473138|NCT04668066|155925145|FG008|Part 1: Treatment Phase|Adverse Event|0|||
48473139|NCT04668066|155925146|FG009|Part 1: Treatment Phase|Adverse Event|0|||
48473140|NCT04668066|155925147|FG010|Part 1: Treatment Phase|Adverse Event|0|||
48473141|NCT04668066|155925148|FG011|Part 1: Treatment Phase|Adverse Event|1|||
48473142|NCT04668066|155925149|FG012|Part 1: Treatment Phase|Adverse Event|1|||
48473143|NCT04668066|155925150|FG013|Part 1: Treatment Phase|Adverse Event|0|||
48473144|NCT04668066|155925151|FG014|Part 1: Treatment Phase|Adverse Event|0|||
48473145|NCT04668066|155925152|FG015|Part 1: Treatment Phase|Adverse Event|0|||
48473146|NCT04668066|155925153|FG016|Part 1: Treatment Phase|Adverse Event|0|||
48473147|NCT04668066|155925154|FG017|Part 1: Treatment Phase|Adverse Event|0|||
48473148|NCT04668066|155925155|FG018|Part 1: Treatment Phase|Adverse Event|0|||
48473149|NCT04668066|155925137|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473150|NCT04668066|155925138|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473151|NCT04668066|155925139|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
48473152|NCT04668066|155925140|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473153|NCT04668066|155925141|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473154|NCT04668066|155925142|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473155|NCT04668066|155925143|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473156|NCT04668066|155925144|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473157|NCT04668066|155925145|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473158|NCT04668066|155925146|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473159|NCT04668066|155925147|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473160|NCT04668066|155925148|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473161|NCT04668066|155925149|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473162|NCT04668066|155925150|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473163|NCT04668066|155925151|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473164|NCT04668066|155925152|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473165|NCT04668066|155925153|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473166|NCT04668066|155925154|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473167|NCT04668066|155925155|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
48473168|NCT04668066|155925137|FG000|Part 1: Treatment Phase|Other|0|||
48473169|NCT04668066|155925138|FG001|Part 1: Treatment Phase|Other|0|||
48473170|NCT04668066|155925139|FG002|Part 1: Treatment Phase|Other|0|||
48473171|NCT04668066|155925140|FG003|Part 1: Treatment Phase|Other|0|||
48473172|NCT04668066|155925141|FG004|Part 1: Treatment Phase|Other|0|||
48473173|NCT04668066|155925142|FG005|Part 1: Treatment Phase|Other|0|||
48473174|NCT04668066|155925143|FG006|Part 1: Treatment Phase|Other|0|||
48473175|NCT04668066|155925144|FG007|Part 1: Treatment Phase|Other|0|||
48473176|NCT04668066|155925145|FG008|Part 1: Treatment Phase|Other|0|||
48473177|NCT04668066|155925146|FG009|Part 1: Treatment Phase|Other|0|||
48473178|NCT04668066|155925147|FG010|Part 1: Treatment Phase|Other|0|||
48473179|NCT04668066|155925148|FG011|Part 1: Treatment Phase|Other|1|||
48473180|NCT04668066|155925149|FG012|Part 1: Treatment Phase|Other|0|||
48473181|NCT04668066|155925150|FG013|Part 1: Treatment Phase|Other|0|||
48473182|NCT04668066|155925151|FG014|Part 1: Treatment Phase|Other|0|||
48473183|NCT04668066|155925152|FG015|Part 1: Treatment Phase|Other|0|||
48473184|NCT04668066|155925153|FG016|Part 1: Treatment Phase|Other|0|||
48473185|NCT04668066|155925154|FG017|Part 1: Treatment Phase|Other|0|||
48473186|NCT04668066|155925155|FG018|Part 1: Treatment Phase|Other|0|||
48473187|NCT04668066|155925137|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473188|NCT04668066|155925138|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473189|NCT04668066|155925139|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473190|NCT04668066|155925140|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473191|NCT04668066|155925141|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473192|NCT04668066|155925142|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473193|NCT04668066|155925143|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473194|NCT04668066|155925144|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473195|NCT04668066|155925145|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473196|NCT04668066|155925146|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473197|NCT04668066|155925147|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473198|NCT04668066|155925148|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473199|NCT04668066|155925149|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
48473200|NCT04668066|155925150|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473201|NCT04668066|155925151|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473202|NCT04668066|155925152|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
48473203|NCT04668066|155925153|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473204|NCT04668066|155925154|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473205|NCT04668066|155925155|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
48473206|NCT04668066|155925137|FG000|Part 1: Follow-Up|Adverse Event|0|||
48473207|NCT04668066|155925138|FG001|Part 1: Follow-Up|Adverse Event|0|||
48473208|NCT04668066|155925139|FG002|Part 1: Follow-Up|Adverse Event|0|||
48473209|NCT04668066|155925140|FG003|Part 1: Follow-Up|Adverse Event|0|||
48473210|NCT04668066|155925141|FG004|Part 1: Follow-Up|Adverse Event|0|||
48473211|NCT04668066|155925142|FG005|Part 1: Follow-Up|Adverse Event|0|||
48473212|NCT04668066|155925143|FG006|Part 1: Follow-Up|Adverse Event|0|||
48473213|NCT04668066|155925144|FG007|Part 1: Follow-Up|Adverse Event|0|||
48473214|NCT04668066|155925145|FG008|Part 1: Follow-Up|Adverse Event|0|||
48473215|NCT04668066|155925146|FG009|Part 1: Follow-Up|Adverse Event|0|||
48473216|NCT04668066|155925147|FG010|Part 1: Follow-Up|Adverse Event|0|||
48473217|NCT04668066|155925148|FG011|Part 1: Follow-Up|Adverse Event|1|||
48473218|NCT04668066|155925149|FG012|Part 1: Follow-Up|Adverse Event|0|||
48473219|NCT04668066|155925150|FG013|Part 1: Follow-Up|Adverse Event|0|||
48473220|NCT04668066|155925151|FG014|Part 1: Follow-Up|Adverse Event|0|||
48473221|NCT04668066|155925152|FG015|Part 1: Follow-Up|Adverse Event|0|||
48473222|NCT04668066|155925153|FG016|Part 1: Follow-Up|Adverse Event|0|||
48473223|NCT04668066|155925154|FG017|Part 1: Follow-Up|Adverse Event|0|||
48473224|NCT04668066|155925155|FG018|Part 1: Follow-Up|Adverse Event|0|||
48473225|NCT04668066|155925137|FG000|Part 1: Follow-Up|Other|0|||
48473226|NCT04668066|155925138|FG001|Part 1: Follow-Up|Other|0|||
48473227|NCT04668066|155925139|FG002|Part 1: Follow-Up|Other|0|||
48473228|NCT04668066|155925140|FG003|Part 1: Follow-Up|Other|0|||
48473229|NCT04668066|155925141|FG004|Part 1: Follow-Up|Other|0|||
48473230|NCT04668066|155925142|FG005|Part 1: Follow-Up|Other|0|||
48473231|NCT04668066|155925143|FG006|Part 1: Follow-Up|Other|0|||
48473232|NCT04668066|155925144|FG007|Part 1: Follow-Up|Other|0|||
48473233|NCT04668066|155925145|FG008|Part 1: Follow-Up|Other|0|||
48473234|NCT04668066|155925146|FG009|Part 1: Follow-Up|Other|0|||
48473235|NCT04668066|155925147|FG010|Part 1: Follow-Up|Other|0|||
48473236|NCT04668066|155925148|FG011|Part 1: Follow-Up|Other|1|||
48473237|NCT04668066|155925149|FG012|Part 1: Follow-Up|Other|1|||
48473238|NCT04668066|155925150|FG013|Part 1: Follow-Up|Other|0|||
48473239|NCT04668066|155925151|FG014|Part 1: Follow-Up|Other|0|||
48473240|NCT04668066|155925152|FG015|Part 1: Follow-Up|Other|0|||
48473241|NCT04668066|155925153|FG016|Part 1: Follow-Up|Other|0|||
48473242|NCT04668066|155925154|FG017|Part 1: Follow-Up|Other|0|||
48473243|NCT04668066|155925155|FG018|Part 1: Follow-Up|Other|0|||
48473244|NCT04668066|155925137|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473245|NCT04668066|155925138|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473246|NCT04668066|155925139|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473247|NCT04668066|155925140|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473248|NCT04668066|155925141|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473249|NCT04668066|155925142|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473250|NCT04668066|155925143|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473251|NCT04668066|155925144|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473252|NCT04668066|155925145|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473253|NCT04668066|155925146|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473254|NCT04668066|155925147|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473255|NCT04668066|155925148|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473256|NCT04668066|155925149|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
48473257|NCT04668066|155925150|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473258|NCT04668066|155925151|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473259|NCT04668066|155925152|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
48473260|NCT04668066|155925153|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473261|NCT04668066|155925154|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473262|NCT04668066|155925155|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
48473263|NCT04668066|155925137|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473264|NCT04668066|155925138|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473265|NCT04668066|155925139|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473266|NCT04668066|155925140|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473267|NCT04668066|155925141|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473268|NCT04668066|155925142|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473269|NCT04668066|155925143|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473270|NCT04668066|155925144|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473271|NCT04668066|155925145|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473272|NCT04668066|155925146|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473273|NCT04668066|155925147|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473274|NCT04668066|155925148|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473275|NCT04668066|155925149|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473276|NCT04668066|155925150|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473277|NCT04668066|155925151|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473278|NCT04668066|155925152|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473279|NCT04668066|155925153|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473280|NCT04668066|155925154|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
48473281|NCT04668066|155925155|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
48473282|NCT04668066|155925137|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473283|NCT04668066|155925138|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473284|NCT04668066|155925139|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473285|NCT04668066|155925140|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473286|NCT04668066|155925141|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473287|NCT04668066|155925142|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473288|NCT04668066|155925143|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473289|NCT04668066|155925144|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473290|NCT04668066|155925145|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473291|NCT04668066|155925146|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473292|NCT04668066|155925147|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473293|NCT04668066|155925148|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473294|NCT04668066|155925149|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473295|NCT04668066|155925150|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473296|NCT04668066|155925151|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473297|NCT04668066|155925152|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473298|NCT04668066|155925153|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473299|NCT04668066|155925154|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
48473300|NCT04668066|155925155|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
48473301|NCT04668066|155925137|FG000|Part 2: Treatment Phase|Other|0|||
48473302|NCT04668066|155925138|FG001|Part 2: Treatment Phase|Other|0|||
48473303|NCT04668066|155925139|FG002|Part 2: Treatment Phase|Other|0|||
48473304|NCT04668066|155925140|FG003|Part 2: Treatment Phase|Other|0|||
48473305|NCT04668066|155925141|FG004|Part 2: Treatment Phase|Other|0|||
48473306|NCT04668066|155925142|FG005|Part 2: Treatment Phase|Other|0|||
48473307|NCT04668066|155925143|FG006|Part 2: Treatment Phase|Other|0|||
48473308|NCT04668066|155925144|FG007|Part 2: Treatment Phase|Other|0|||
48473309|NCT04668066|155925145|FG008|Part 2: Treatment Phase|Other|0|||
48473310|NCT04668066|155925146|FG009|Part 2: Treatment Phase|Other|0|||
48473311|NCT04668066|155925147|FG010|Part 2: Treatment Phase|Other|0|||
48473312|NCT04668066|155925148|FG011|Part 2: Treatment Phase|Other|0|||
48473313|NCT04668066|155925149|FG012|Part 2: Treatment Phase|Other|0|||
48473314|NCT04668066|155925150|FG013|Part 2: Treatment Phase|Other|0|||
48473315|NCT04668066|155925151|FG014|Part 2: Treatment Phase|Other|0|||
48473316|NCT04668066|155925152|FG015|Part 2: Treatment Phase|Other|0|||
48473317|NCT04668066|155925153|FG016|Part 2: Treatment Phase|Other|0|||
48473318|NCT04668066|155925154|FG017|Part 2: Treatment Phase|Other|0|||
48473319|NCT04668066|155925155|FG018|Part 2: Treatment Phase|Other|1|||
48473320|NCT04668066|155925137|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473321|NCT04668066|155925138|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473322|NCT04668066|155925139|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473323|NCT04668066|155925140|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473324|NCT04668066|155925141|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473325|NCT04668066|155925142|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473326|NCT04668066|155925143|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473327|NCT04668066|155925144|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473328|NCT04668066|155925145|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473329|NCT04668066|155925146|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473330|NCT04668066|155925147|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473331|NCT04668066|155925148|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473332|NCT04668066|155925149|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473333|NCT04668066|155925150|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473334|NCT04668066|155925151|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473335|NCT04668066|155925152|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473336|NCT04668066|155925153|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473337|NCT04668066|155925154|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
48473338|NCT04668066|155925155|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
48473339|NCT00227591|155925156|FG000|Overall Study|Withdrawal by Subject|1|||
48473340|NCT00859313|155925157|FG000|Overall Study|Lack of Efficacy|2|||
48473341|NCT00859313|155925157|FG000|Overall Study|Adverse Event|1|||
48473342|NCT00859313|155925157|FG000|Overall Study|staff error|1|||
48473343|NCT00965562|155925158|FG000|Overall Study|Lost to Follow-up|1|||
48473344|NCT00965562|155925159|FG001|Overall Study|Lost to Follow-up|2|||
48473345|NCT00965562|155925160|FG002|Overall Study|Lost to Follow-up|3|||
48473346|NCT00965562|155925158|FG000|Overall Study|Withdrawal by Subject|2|||
48473347|NCT00965562|155925159|FG001|Overall Study|Withdrawal by Subject|2|||
48473348|NCT00965562|155925160|FG002|Overall Study|Withdrawal by Subject|0|||
48473349|NCT03186794|155925161|FG000|Overall Study|Physician Decision|2|||
48473350|NCT03186794|155925161|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
48473351|NCT00752206|155925162|FG000|Overall Study|Disease progression|8|||
48473352|NCT00752206|155925163|FG001|Overall Study|Disease progression|11|||
48473353|NCT00752206|155925162|FG000|Overall Study|Pregnancy|1|||
48473354|NCT00752206|155925163|FG001|Overall Study|Pregnancy|0|||
48473355|NCT00678652|155925164|FG000|Overall Study|Protocol Violation|2|||
48473356|NCT00678652|155925165|FG001|Overall Study|Protocol Violation|0|||
48473357|NCT00678652|155925166|FG002|Overall Study|Protocol Violation|0|||
48473358|NCT00678652|155925167|FG003|Overall Study|Protocol Violation|0|||
48473359|NCT00678652|155925164|FG000|Overall Study|Pregnancy|0|||
48473360|NCT00678652|155925165|FG001|Overall Study|Pregnancy|0|||
48473361|NCT00678652|155925166|FG002|Overall Study|Pregnancy|1|||
48473362|NCT00678652|155925167|FG003|Overall Study|Pregnancy|0|||
48473363|NCT00678652|155925164|FG000|Overall Study|Relocation|1|||
48473364|NCT00678652|155925165|FG001|Overall Study|Relocation|0|||
48473365|NCT00678652|155925166|FG002|Overall Study|Relocation|0|||
48473366|NCT00678652|155925167|FG003|Overall Study|Relocation|0|||
48473367|NCT01381068|155925169|FG000|Overall Study|Death|1|||
48473368|NCT01381068|155925170|FG001|Overall Study|Death|0|||
48473369|NCT01329562|155925173|FG000|Overall Study|Protocol Violation|5|||
48473370|NCT01329562|155925174|FG001|Overall Study|Protocol Violation|3|||
48473371|NCT01329562|155925173|FG000|Overall Study|Lost to Follow-up|1|||
48473372|NCT01329562|155925174|FG001|Overall Study|Lost to Follow-up|1|||
48473373|NCT01329562|155925173|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
48473374|NCT01329562|155925174|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
48473375|NCT01329562|155925173|FG000|Overall Study|Physician Decision|0|||
48473376|NCT01329562|155925174|FG001|Overall Study|Physician Decision|1|||
48473377|NCT04115488|155925175|FG000|Overall Study|Adverse Event|8|||
48473378|NCT04115488|155925176|FG001|Overall Study|Adverse Event|4|||
48473379|NCT04115488|155925175|FG000|Overall Study|Withdrawal by Subject|3|||
48473380|NCT04115488|155925176|FG001|Overall Study|Withdrawal by Subject|6|||
48473381|NCT04115488|155925175|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
48473382|NCT04115488|155925176|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
48473383|NCT04115488|155925175|FG000|Overall Study|Patient 's location change|1|||
48473384|NCT04115488|155925176|FG001|Overall Study|Patient 's location change|0|||
48473385|NCT04115488|155925175|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
48473386|NCT04115488|155925176|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
48473387|NCT00096031|155925177|FG000|Overall Study|Adverse Event|3|||
48473388|NCT00096031|155925177|FG000|Overall Study|Lack of Efficacy|42|||
48473389|NCT00096031|155925177|FG000|Overall Study|Death|4|||
48473390|NCT00096031|155925177|FG000|Overall Study|Withdrawal by Subject|1|||
48473391|NCT00096031|155925177|FG000|Overall Study|Ineligible|8|||
48473392|NCT00096031|155925177|FG000|Overall Study|Not protocol specified|5|||
48473393|NCT01241591|155926593|FG000|Overall Study|Lack of Efficacy|5|||
48473394|NCT01241591|155926594|FG001|Overall Study|Lack of Efficacy|2|||
48473395|NCT01241591|155926595|FG002|Overall Study|Lack of Efficacy|2|||
48473396|NCT01241591|155926596|FG003|Overall Study|Lack of Efficacy|3|||
48473397|NCT01241591|155926593|FG000|Overall Study|Protocol Violation|5|||
48473398|NCT01241591|155926594|FG001|Overall Study|Protocol Violation|2|||
48473399|NCT01241591|155926595|FG002|Overall Study|Protocol Violation|3|||
48473400|NCT01241591|155926596|FG003|Overall Study|Protocol Violation|0|||
48473401|NCT01241591|155926593|FG000|Overall Study|Lost to Follow-up|1|||
48473402|NCT01241591|155926594|FG001|Overall Study|Lost to Follow-up|2|||
48473403|NCT01241591|155926595|FG002|Overall Study|Lost to Follow-up|2|||
48473404|NCT01241591|155926596|FG003|Overall Study|Lost to Follow-up|2|||
48473405|NCT01241591|155926593|FG000|Overall Study|Screen Failure|3|||
48473406|NCT01241591|155926594|FG001|Overall Study|Screen Failure|2|||
48473407|NCT01241591|155926595|FG002|Overall Study|Screen Failure|1|||
48473408|NCT01241591|155926596|FG003|Overall Study|Screen Failure|0|||
48473409|NCT01241591|155926593|FG000|Overall Study|Withdrawal by Subject|6|||
48473410|NCT01241591|155926594|FG001|Overall Study|Withdrawal by Subject|4|||
48473411|NCT01241591|155926595|FG002|Overall Study|Withdrawal by Subject|2|||
48473412|NCT01241591|155926596|FG003|Overall Study|Withdrawal by Subject|2|||
48473413|NCT01241591|155926593|FG000|Overall Study|Other|0|||
48473414|NCT01241591|155926594|FG001|Overall Study|Other|1|||
48473415|NCT01241591|155926595|FG002|Overall Study|Other|0|||
48473416|NCT01241591|155926596|FG003|Overall Study|Other|1|||
48473417|NCT01241591|155926593|FG000|Overall Study|Adverse Event|3|||
48473418|NCT01241591|155926594|FG001|Overall Study|Adverse Event|11|||
48473419|NCT01241591|155926595|FG002|Overall Study|Adverse Event|12|||
48473420|NCT01241591|155926596|FG003|Overall Study|Adverse Event|4|||
48473421|NCT05111548|155926597|FG000|Overall Study|Withdrawal by Subject|2|||
48473422|NCT05111548|155926598|FG001|Overall Study|Withdrawal by Subject|1|||
48473423|NCT05111548|155926597|FG000|Overall Study|Adverse Event|1|||
48473424|NCT05111548|155926598|FG001|Overall Study|Adverse Event|0|||
48473425|NCT00379639|155926599|FG000|Overall Study|Disease Progression|3|||
48473426|NCT00379639|155926600|FG001|Overall Study|Disease Progression|3|||
48473427|NCT00379639|155926601|FG002|Overall Study|Disease Progression|3|||
48473428|NCT00379639|155926602|FG003|Overall Study|Disease Progression|4|||
48473429|NCT00379639|155926603|FG004|Overall Study|Disease Progression|4|||
48473430|NCT00379639|155926599|FG000|Overall Study|Physician Decision|0|||
48473431|NCT00379639|155926600|FG001|Overall Study|Physician Decision|2|||
48473432|NCT00379639|155926601|FG002|Overall Study|Physician Decision|1|||
48473433|NCT00379639|155926602|FG003|Overall Study|Physician Decision|1|||
48473434|NCT00379639|155926603|FG004|Overall Study|Physician Decision|0|||
48473435|NCT00379639|155926599|FG000|Overall Study|Symptomatic Deterioration|0|||
48473436|NCT00379639|155926600|FG001|Overall Study|Symptomatic Deterioration|0|||
48473437|NCT00379639|155926601|FG002|Overall Study|Symptomatic Deterioration|1|||
48473438|NCT00379639|155926602|FG003|Overall Study|Symptomatic Deterioration|0|||
48473439|NCT00379639|155926603|FG004|Overall Study|Symptomatic Deterioration|1|||
48473440|NCT00379639|155926599|FG000|Overall Study|Adverse Event|0|||
48473441|NCT00379639|155926600|FG001|Overall Study|Adverse Event|0|||
48473442|NCT00379639|155926601|FG002|Overall Study|Adverse Event|1|||
48473443|NCT00379639|155926602|FG003|Overall Study|Adverse Event|0|||
48473444|NCT00379639|155926603|FG004|Overall Study|Adverse Event|1|||
48473445|NCT00379639|155926599|FG000|Overall Study|Lost to Follow-up|0|||
48473446|NCT00379639|155926600|FG001|Overall Study|Lost to Follow-up|0|||
48473447|NCT00379639|155926601|FG002|Overall Study|Lost to Follow-up|0|||
48473448|NCT00379639|155926602|FG003|Overall Study|Lost to Follow-up|1|||
48473449|NCT00379639|155926603|FG004|Overall Study|Lost to Follow-up|0|||
48473450|NCT00379639|155926599|FG000|Overall Study|Other|0|||
48473451|NCT00379639|155926600|FG001|Overall Study|Other|0|||
48473452|NCT00379639|155926601|FG002|Overall Study|Other|3|||
48473453|NCT00379639|155926602|FG003|Overall Study|Other|0|||
48473454|NCT00379639|155926603|FG004|Overall Study|Other|0|||
48473455|NCT01846039|155926604|FG000|Overall Study|Protocol Violation|1|||
48473456|NCT01846039|155926604|FG000|Overall Study|Subject Withdrew Consent|1|||
48473457|NCT00594958|155926605|FG000|Overall Study|Withdrawal by Subject|1|||
48473458|NCT00594958|155926606|FG001|Overall Study|Withdrawal by Subject|0|||
48473459|NCT00594958|155926607|FG002|Overall Study|Withdrawal by Subject|1|||
48473460|NCT00594958|155926605|FG000|Overall Study|Adverse Event|4|||
48473461|NCT00594958|155926606|FG001|Overall Study|Adverse Event|1|||
48473462|NCT00594958|155926607|FG002|Overall Study|Adverse Event|2|||
48473463|NCT00594958|155926605|FG000|Overall Study|Pregnancy|0|||
48473464|NCT00594958|155926606|FG001|Overall Study|Pregnancy|2|||
48473465|NCT00594958|155926607|FG002|Overall Study|Pregnancy|0|||
48473466|NCT00594958|155926605|FG000|Overall Study|Protocol Violation|1|||
48473467|NCT00594958|155926606|FG001|Overall Study|Protocol Violation|0|||
48473468|NCT00594958|155926607|FG002|Overall Study|Protocol Violation|2|||
48473469|NCT00594958|155926605|FG000|Overall Study|Lost to Follow-up|5|||
48473470|NCT00594958|155926606|FG001|Overall Study|Lost to Follow-up|0|||
48473471|NCT00594958|155926607|FG002|Overall Study|Lost to Follow-up|3|||
48473472|NCT00594958|155926605|FG000|Overall Study|administrative|3|||
48473473|NCT00594958|155926606|FG001|Overall Study|administrative|0|||
48473474|NCT00594958|155926607|FG002|Overall Study|administrative|2|||
48473475|NCT01945034|155926608|FG000|Overall Study|Medication Error|0|||
48473476|NCT01945034|155926609|FG001|Overall Study|Medication Error|1|||
48473477|NCT01945034|155926610|FG002|Overall Study|Medication Error|0|||
48473478|NCT01945034|155926608|FG000|Overall Study|Withdrawal by Subject|0|||
48473479|NCT01945034|155926609|FG001|Overall Study|Withdrawal by Subject|3|||
48473480|NCT01945034|155926610|FG002|Overall Study|Withdrawal by Subject|1|||
48473481|NCT01945034|155926608|FG000|Overall Study|Other|0|||
48473482|NCT01945034|155926609|FG001|Overall Study|Other|1|||
48473483|NCT01945034|155926610|FG002|Overall Study|Other|3|||
48473484|NCT01945034|155926608|FG000|Overall Study|Lost to Follow-up|0|||
48473485|NCT01945034|155926609|FG001|Overall Study|Lost to Follow-up|0|||
48473486|NCT01945034|155926610|FG002|Overall Study|Lost to Follow-up|2|||
48473487|NCT01945034|155926608|FG000|Overall Study|Protocol Violation|1|||
48473488|NCT01945034|155926609|FG001|Overall Study|Protocol Violation|0|||
48473489|NCT01945034|155926610|FG002|Overall Study|Protocol Violation|1|||
48473490|NCT02147132|155926617|FG000|Overall Study|Lost to Follow-up|1|||
48473491|NCT02147132|155926618|FG001|Overall Study|Lost to Follow-up|0|||
48473492|NCT02147132|155926619|FG002|Overall Study|Lost to Follow-up|0|||
48473493|NCT02147132|155926620|FG003|Overall Study|Lost to Follow-up|0|||
48473494|NCT01798056|155926621|FG000|Overall Study|Serious Adverse Event|13|||
48473495|NCT01798056|155926622|FG001|Overall Study|Serious Adverse Event|12|||
48473496|NCT01798056|155926621|FG000|Overall Study|Withdrawal by Subject|12|||
48473497|NCT01798056|155926622|FG001|Overall Study|Withdrawal by Subject|9|||
48473498|NCT01798056|155926621|FG000|Overall Study|Migrated/moved from study area|1|||
48473499|NCT01798056|155926622|FG001|Overall Study|Migrated/moved from study area|1|||
48473500|NCT01798056|155926621|FG000|Overall Study|Lost to Follow-up|1|||
48473501|NCT01798056|155926622|FG001|Overall Study|Lost to Follow-up|1|||
48473502|NCT01798056|155926621|FG000|Overall Study|Other|0|||
48473503|NCT01798056|155926622|FG001|Overall Study|Other|2|||
48473504|NCT01013207|155926623|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
48473505|NCT00700115|155926624|FG000|Overall Study|Withdrawal by Subject|1|||
48473506|NCT00700115|155926625|FG001|Overall Study|Withdrawal by Subject|0|||
48473507|NCT00700115|155926624|FG000|Overall Study|Lost to Follow-up|0|||
48473508|NCT00700115|155926625|FG001|Overall Study|Lost to Follow-up|1|||
48473509|NCT05637515|155926626|FG000|Overall Study|Withdrawal by Subject|17|||
48473510|NCT05637515|155926627|FG001|Overall Study|Withdrawal by Subject|17|||
48473511|NCT02503215|155926628|FG000|Overall Study|Unable to wear compression stockings|1|||
48473512|NCT02503215|155926628|FG000|Overall Study|Unable to use positive airway pressure|2|||
48473513|NCT03233009|155926629|FG000|Overall Study|Lost to Follow-up|1|||
48473514|NCT01541644|155926633|FG000|Overall Study|Withdrawal by Subject|3|||
48473515|NCT01458535|155926636|FG000|Overall Study|Other|0|||
48473516|NCT01458535|155926637|FG001|Overall Study|Other|0|||
48473517|NCT01458535|155926638|FG002|Overall Study|Other|0|||
48473518|NCT01458535|155926639|FG003|Overall Study|Other|0|||
48473519|NCT01458535|155926640|FG004|Overall Study|Other|1|||
48473520|NCT01458535|155926641|FG005|Overall Study|Other|1|||
48473521|NCT01458535|155926636|FG000|Overall Study|Withdrawal by Subject|0|||
48473522|NCT01458535|155926637|FG001|Overall Study|Withdrawal by Subject|0|||
48473523|NCT01458535|155926638|FG002|Overall Study|Withdrawal by Subject|2|||
48473524|NCT01458535|155926639|FG003|Overall Study|Withdrawal by Subject|0|||
48473525|NCT01458535|155926640|FG004|Overall Study|Withdrawal by Subject|1|||
48473526|NCT01458535|155926641|FG005|Overall Study|Withdrawal by Subject|1|||
48473527|NCT01458535|155926636|FG000|Overall Study|Lost to Follow-up|0|||
48473528|NCT01458535|155926637|FG001|Overall Study|Lost to Follow-up|2|||
48473529|NCT01458535|155926638|FG002|Overall Study|Lost to Follow-up|0|||
48473530|NCT01458535|155926639|FG003|Overall Study|Lost to Follow-up|3|||
48473531|NCT01458535|155926640|FG004|Overall Study|Lost to Follow-up|2|||
48473532|NCT01458535|155926641|FG005|Overall Study|Lost to Follow-up|2|||
48473533|NCT01458535|155926636|FG000|Overall Study|Adverse Event|0|||
48473534|NCT01458535|155926637|FG001|Overall Study|Adverse Event|0|||
48473535|NCT01458535|155926638|FG002|Overall Study|Adverse Event|0|||
48473536|NCT01458535|155926639|FG003|Overall Study|Adverse Event|1|||
48473537|NCT01458535|155926640|FG004|Overall Study|Adverse Event|0|||
48473538|NCT01458535|155926641|FG005|Overall Study|Adverse Event|0|||
48473539|NCT02842736|155926642|FG000|Overall Study|Lost to Follow-up|13|||
48473540|NCT02842736|155926642|FG000|Overall Study|Intervention for menstrual bleeding|17|||
48473541|NCT02842736|155926642|FG000|Overall Study|Withdrawal by Subject|4|||
48473542|NCT02842736|155926642|FG000|Overall Study|Pregnancy|3|||
48473543|NCT02842736|155926642|FG000|Overall Study|Hysterectomy for fibroids|2|||
48473544|NCT02842736|155926642|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
48473545|NCT02842736|155926642|FG000|Overall Study|IUD: Mirena|1|||
48473546|NCT00151775|155926644|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
48473547|NCT00151775|155926645|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
48473548|NCT00151775|155926646|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473549|NCT00151775|155926647|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473550|NCT00151775|155926648|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473551|NCT00151775|155926649|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473552|NCT00151775|155926650|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473553|NCT00151775|155926651|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473554|NCT00151775|155926652|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473555|NCT00151775|155926653|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473556|NCT00151775|155926654|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473557|NCT00151775|155926655|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
48473558|NCT00151775|155926644|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
48473559|NCT00151775|155926645|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473560|NCT00151775|155926646|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473561|NCT00151775|155926647|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473562|NCT00151775|155926648|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473563|NCT00151775|155926649|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473564|NCT00151775|155926650|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
48473565|NCT00151775|155926651|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473566|NCT00151775|155926652|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473567|NCT00151775|155926653|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473568|NCT00151775|155926654|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
48473569|NCT00151775|155926655|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
48473570|NCT00151775|155926644|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473571|NCT00151775|155926645|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
48473572|NCT00151775|155926646|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473573|NCT00151775|155926647|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473574|NCT00151775|155926648|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473575|NCT00151775|155926649|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473576|NCT00151775|155926650|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473577|NCT00151775|155926651|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473578|NCT00151775|155926652|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473579|NCT00151775|155926653|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473580|NCT00151775|155926654|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473581|NCT00151775|155926655|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
48473582|NCT00151775|155926644|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
48473583|NCT00151775|155926645|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
48473584|NCT00151775|155926646|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
48473585|NCT00151775|155926647|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
48473586|NCT00151775|155926648|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
48473587|NCT00151775|155926649|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
48473588|NCT00151775|155926650|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
48473589|NCT00151775|155926651|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
48473590|NCT00151775|155926652|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
48473591|NCT00151775|155926653|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
48473592|NCT00151775|155926654|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
48473593|NCT00151775|155926655|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
48473594|NCT00151775|155926644|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473595|NCT00151775|155926645|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473596|NCT00151775|155926646|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473597|NCT00151775|155926647|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473598|NCT00151775|155926648|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473599|NCT00151775|155926649|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
48473600|NCT00151775|155926650|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473601|NCT00151775|155926651|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473602|NCT00151775|155926652|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473603|NCT00151775|155926653|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473604|NCT00151775|155926654|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473605|NCT00151775|155926655|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
48473606|NCT00151775|155926644|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473607|NCT00151775|155926645|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473608|NCT00151775|155926646|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473609|NCT00151775|155926647|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473610|NCT00151775|155926648|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473611|NCT00151775|155926649|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
48473612|NCT00151775|155926650|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473613|NCT00151775|155926651|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473614|NCT00151775|155926652|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473615|NCT00151775|155926653|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473616|NCT00151775|155926654|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473617|NCT00151775|155926655|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
48473618|NCT00151775|155926644|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473619|NCT00151775|155926645|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473620|NCT00151775|155926646|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473621|NCT00151775|155926647|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473622|NCT00151775|155926648|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473623|NCT00151775|155926649|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473624|NCT00151775|155926650|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
48473625|NCT00151775|155926651|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473626|NCT00151775|155926652|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473627|NCT00151775|155926653|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473628|NCT00151775|155926654|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473629|NCT00151775|155926655|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
48473630|NCT00151775|155926644|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473631|NCT00151775|155926645|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473632|NCT00151775|155926646|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473633|NCT00151775|155926647|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473634|NCT00151775|155926648|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473635|NCT00151775|155926649|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
48473636|NCT00151775|155926650|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473637|NCT00151775|155926651|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473638|NCT00151775|155926652|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473639|NCT00151775|155926653|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473640|NCT00151775|155926654|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473641|NCT00151775|155926655|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
48473642|NCT00151775|155926644|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
48473643|NCT00151775|155926645|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
48473644|NCT00151775|155926646|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
48473645|NCT00151775|155926647|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
48473646|NCT00151775|155926648|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
48473647|NCT00151775|155926649|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
48473648|NCT00151775|155926650|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
48473649|NCT00151775|155926651|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
48473650|NCT00151775|155926652|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
48473651|NCT00151775|155926653|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
48473652|NCT00151775|155926654|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
48473653|NCT00151775|155926655|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
48473654|NCT00151775|155926644|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473655|NCT00151775|155926645|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473656|NCT00151775|155926646|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473657|NCT00151775|155926647|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473658|NCT00151775|155926648|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473659|NCT00151775|155926649|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473660|NCT00151775|155926650|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
48473661|NCT00151775|155926651|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473662|NCT00151775|155926652|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473663|NCT00151775|155926653|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473664|NCT00151775|155926654|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473665|NCT00151775|155926655|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
48473666|NCT00151775|155926644|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473667|NCT00151775|155926645|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473668|NCT00151775|155926646|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
48473669|NCT00151775|155926647|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473670|NCT00151775|155926648|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473671|NCT00151775|155926649|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473672|NCT00151775|155926650|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473673|NCT00151775|155926651|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473674|NCT00151775|155926652|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473675|NCT00151775|155926653|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473676|NCT00151775|155926654|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473677|NCT00151775|155926655|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
48473678|NCT00151775|155926644|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473679|NCT00151775|155926645|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473680|NCT00151775|155926646|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
48473681|NCT00151775|155926647|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473682|NCT00151775|155926648|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473683|NCT00151775|155926649|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473684|NCT00151775|155926650|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473685|NCT00151775|155926651|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473686|NCT00151775|155926652|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473687|NCT00151775|155926653|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473688|NCT00151775|155926654|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473689|NCT00151775|155926655|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
48473690|NCT00151775|155926644|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473691|NCT00151775|155926645|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473692|NCT00151775|155926646|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473693|NCT00151775|155926647|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473694|NCT00151775|155926648|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473695|NCT00151775|155926649|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473696|NCT00151775|155926650|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473697|NCT00151775|155926651|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473698|NCT00151775|155926652|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473699|NCT00151775|155926653|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473700|NCT00151775|155926654|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
48473701|NCT00151775|155926655|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
48473702|NCT00151775|155926644|FG000|Period 4: Open Label|Increased blood pressure|0|||
48473703|NCT00151775|155926645|FG001|Period 4: Open Label|Increased blood pressure|0|||
48473704|NCT00151775|155926646|FG002|Period 4: Open Label|Increased blood pressure|0|||
48473705|NCT00151775|155926647|FG003|Period 4: Open Label|Increased blood pressure|0|||
48473706|NCT00151775|155926648|FG004|Period 4: Open Label|Increased blood pressure|1|||
48473707|NCT00151775|155926649|FG005|Period 4: Open Label|Increased blood pressure|0|||
48473708|NCT00151775|155926650|FG006|Period 4: Open Label|Increased blood pressure|0|||
48473709|NCT00151775|155926651|FG007|Period 4: Open Label|Increased blood pressure|0|||
48473710|NCT00151775|155926652|FG008|Period 4: Open Label|Increased blood pressure|0|||
48473711|NCT00151775|155926653|FG009|Period 4: Open Label|Increased blood pressure|1|||
48473712|NCT00151775|155926654|FG010|Period 4: Open Label|Increased blood pressure|0|||
48473713|NCT00151775|155926655|FG011|Period 4: Open Label|Increased blood pressure|0|||
48473714|NCT00151775|155926644|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
48473715|NCT00151775|155926645|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
48473716|NCT00151775|155926646|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
48473717|NCT00151775|155926647|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
48473718|NCT00151775|155926648|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
48473719|NCT00151775|155926649|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
48473720|NCT00151775|155926650|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
48473721|NCT00151775|155926651|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
48473722|NCT00151775|155926652|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
48473723|NCT00151775|155926653|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
48473724|NCT00151775|155926654|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
48473725|NCT00151775|155926655|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
48473726|NCT00151775|155926644|FG000|Period 4: Open Label|Adverse Event|0|||
48473727|NCT00151775|155926645|FG001|Period 4: Open Label|Adverse Event|0|||
48473728|NCT00151775|155926646|FG002|Period 4: Open Label|Adverse Event|0|||
48473729|NCT00151775|155926647|FG003|Period 4: Open Label|Adverse Event|0|||
48473730|NCT00151775|155926648|FG004|Period 4: Open Label|Adverse Event|1|||
48473731|NCT00151775|155926649|FG005|Period 4: Open Label|Adverse Event|0|||
48473732|NCT00151775|155926650|FG006|Period 4: Open Label|Adverse Event|0|||
48473733|NCT00151775|155926651|FG007|Period 4: Open Label|Adverse Event|0|||
48473734|NCT00151775|155926652|FG008|Period 4: Open Label|Adverse Event|0|||
48473735|NCT00151775|155926653|FG009|Period 4: Open Label|Adverse Event|2|||
48473736|NCT00151775|155926654|FG010|Period 4: Open Label|Adverse Event|0|||
48473737|NCT00151775|155926655|FG011|Period 4: Open Label|Adverse Event|0|||
48473738|NCT00151775|155926644|FG000|Period 4: Open Label|Lost to Follow-up|0|||
48473739|NCT00151775|155926645|FG001|Period 4: Open Label|Lost to Follow-up|0|||
48473740|NCT00151775|155926646|FG002|Period 4: Open Label|Lost to Follow-up|0|||
48473741|NCT00151775|155926647|FG003|Period 4: Open Label|Lost to Follow-up|0|||
48473742|NCT00151775|155926648|FG004|Period 4: Open Label|Lost to Follow-up|17|||
48473743|NCT00151775|155926649|FG005|Period 4: Open Label|Lost to Follow-up|0|||
48473744|NCT00151775|155926650|FG006|Period 4: Open Label|Lost to Follow-up|0|||
48473745|NCT00151775|155926651|FG007|Period 4: Open Label|Lost to Follow-up|0|||
48473746|NCT00151775|155926652|FG008|Period 4: Open Label|Lost to Follow-up|0|||
48473747|NCT00151775|155926653|FG009|Period 4: Open Label|Lost to Follow-up|7|||
48473748|NCT00151775|155926654|FG010|Period 4: Open Label|Lost to Follow-up|0|||
48473749|NCT00151775|155926655|FG011|Period 4: Open Label|Lost to Follow-up|0|||
48473750|NCT00151775|155926644|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
48473751|NCT00151775|155926645|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
48473752|NCT00151775|155926646|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
48473753|NCT00151775|155926647|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
48473754|NCT00151775|155926648|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
48473755|NCT00151775|155926649|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
48473907|NCT01215968|155926712|FG000|Overall Study|Protocol Violation|2|||
48473756|NCT00151775|155926650|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
48473757|NCT00151775|155926651|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
48473758|NCT00151775|155926652|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
48473759|NCT00151775|155926653|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
48473760|NCT00151775|155926654|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
48473761|NCT00151775|155926655|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
48473762|NCT00151775|155926644|FG000|Period 4: Open Label|Other|0|||
48473763|NCT00151775|155926645|FG001|Period 4: Open Label|Other|0|||
48473764|NCT00151775|155926646|FG002|Period 4: Open Label|Other|0|||
48473765|NCT00151775|155926647|FG003|Period 4: Open Label|Other|0|||
48473766|NCT00151775|155926648|FG004|Period 4: Open Label|Other|1|||
48473767|NCT00151775|155926649|FG005|Period 4: Open Label|Other|0|||
48473768|NCT00151775|155926650|FG006|Period 4: Open Label|Other|0|||
48473769|NCT00151775|155926651|FG007|Period 4: Open Label|Other|0|||
48473770|NCT00151775|155926652|FG008|Period 4: Open Label|Other|0|||
48473771|NCT00151775|155926653|FG009|Period 4: Open Label|Other|3|||
48473772|NCT00151775|155926654|FG010|Period 4: Open Label|Other|0|||
48473773|NCT00151775|155926655|FG011|Period 4: Open Label|Other|0|||
48473774|NCT00151775|155926644|FG000|Period 4: Open Label|Physician Decision|0|||
48473775|NCT00151775|155926645|FG001|Period 4: Open Label|Physician Decision|0|||
48473776|NCT00151775|155926646|FG002|Period 4: Open Label|Physician Decision|0|||
48473777|NCT00151775|155926647|FG003|Period 4: Open Label|Physician Decision|0|||
48473778|NCT00151775|155926648|FG004|Period 4: Open Label|Physician Decision|0|||
48473779|NCT00151775|155926649|FG005|Period 4: Open Label|Physician Decision|0|||
48473780|NCT00151775|155926650|FG006|Period 4: Open Label|Physician Decision|0|||
48473781|NCT00151775|155926651|FG007|Period 4: Open Label|Physician Decision|0|||
48473782|NCT00151775|155926652|FG008|Period 4: Open Label|Physician Decision|0|||
48473783|NCT00151775|155926653|FG009|Period 4: Open Label|Physician Decision|2|||
48473784|NCT00151775|155926654|FG010|Period 4: Open Label|Physician Decision|0|||
48473785|NCT00151775|155926655|FG011|Period 4: Open Label|Physician Decision|0|||
48473786|NCT00151775|155926644|FG000|Period 4: Open Label|Protocol Violation|0|||
48473787|NCT00151775|155926645|FG001|Period 4: Open Label|Protocol Violation|0|||
48473788|NCT00151775|155926646|FG002|Period 4: Open Label|Protocol Violation|0|||
48473789|NCT00151775|155926647|FG003|Period 4: Open Label|Protocol Violation|0|||
48473790|NCT00151775|155926648|FG004|Period 4: Open Label|Protocol Violation|1|||
48473791|NCT00151775|155926649|FG005|Period 4: Open Label|Protocol Violation|0|||
48473792|NCT00151775|155926650|FG006|Period 4: Open Label|Protocol Violation|0|||
48473793|NCT00151775|155926651|FG007|Period 4: Open Label|Protocol Violation|0|||
48473794|NCT00151775|155926652|FG008|Period 4: Open Label|Protocol Violation|0|||
48473795|NCT00151775|155926653|FG009|Period 4: Open Label|Protocol Violation|0|||
48473796|NCT00151775|155926654|FG010|Period 4: Open Label|Protocol Violation|0|||
48473797|NCT00151775|155926655|FG011|Period 4: Open Label|Protocol Violation|0|||
48473798|NCT01711736|155926656|FG000|Overall Study|Lost to Follow-up|4|||
48473799|NCT01711736|155926657|FG001|Overall Study|Lost to Follow-up|1|||
48473800|NCT01711736|155926656|FG000|Overall Study|Withdrawal by Subject|6|||
48473801|NCT01711736|155926657|FG001|Overall Study|Withdrawal by Subject|6|||
48473802|NCT01711736|155926656|FG000|Overall Study|Migrated/moved from study area|2|||
48473803|NCT01711736|155926657|FG001|Overall Study|Migrated/moved from study area|1|||
48473804|NCT03526549|155926659|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
48473805|NCT03526549|155926660|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
48473806|NCT03526549|155926659|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
48473807|NCT03526549|155926660|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
48473808|NCT03526549|155926659|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
48473809|NCT03526549|155926660|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
48473810|NCT03526549|155926659|FG000|Open-label Phase|Adverse Event|4|||
48473811|NCT03526549|155926660|FG001|Open-label Phase|Adverse Event|0|||
48473812|NCT03526549|155926659|FG000|Open-label Phase|Withdrawal by Subject|54|||
48473813|NCT03526549|155926660|FG001|Open-label Phase|Withdrawal by Subject|0|||
48473814|NCT03526549|155926659|FG000|Open-label Phase|Lost to Follow-up|35|||
48473815|NCT03526549|155926660|FG001|Open-label Phase|Lost to Follow-up|0|||
48473816|NCT03526549|155926659|FG000|Open-label Phase|Other than Specified|5|||
48473817|NCT03526549|155926660|FG001|Open-label Phase|Other than Specified|0|||
48473818|NCT00998166|155926661|FG000|Overall Study|Early Study Termination|8|||
48473819|NCT00578448|155926662|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
48473820|NCT00578448|155926662|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
48473821|NCT00578448|155926662|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
48473822|NCT00578448|155926662|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
48473823|NCT00071006|155926665|FG000|Overall Study|Lack of Efficacy|7|||
48473824|NCT00071006|155926665|FG000|Overall Study|Adverse Event|1|||
48473825|NCT00071006|155926665|FG000|Overall Study|Withdrawal by Subject|1|||
48473826|NCT00071006|155926665|FG000|Overall Study|Other|3|||
48473827|NCT01298362|155926671|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
48473828|NCT01298362|155926672|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
48473908|NCT01215968|155926713|FG001|Overall Study|Protocol Violation|4|||
48473829|NCT01374516|155926677|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
48473830|NCT01374516|155926678|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
48473831|NCT01374516|155926677|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
48473832|NCT01374516|155926678|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
48473833|NCT01374516|155926677|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
48473834|NCT01374516|155926678|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
48473835|NCT01374516|155926677|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
48473836|NCT01374516|155926678|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
48473837|NCT01374516|155926677|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
48473838|NCT01374516|155926678|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
48473839|NCT01374516|155926677|FG000|Surveillance Expansion Period|Protocol Violation|386|||
48473840|NCT01374516|155926678|FG001|Surveillance Expansion Period|Protocol Violation|217|||
48473841|NCT01374516|155926677|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
48473842|NCT01374516|155926678|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
48473843|NCT01374516|155926677|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
48473844|NCT01374516|155926678|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
48473845|NCT01374516|155926677|FG000|Surveillance Expansion Period|Serious adverse event|20|||
48473846|NCT01374516|155926678|FG001|Surveillance Expansion Period|Serious adverse event|5|||
48473847|NCT04822701|155926684|FG000|Overall Study|Not treated|2|||
48473848|NCT04822701|155926685|FG001|Overall Study|Not treated|0|||
48473849|NCT04822701|155926684|FG000|Overall Study|Lost to Follow-up|1|||
48473850|NCT04822701|155926685|FG001|Overall Study|Lost to Follow-up|0|||
48473851|NCT04822701|155926684|FG000|Overall Study|Withdrawal by Subject|1|||
48473852|NCT04822701|155926685|FG001|Overall Study|Withdrawal by Subject|0|||
48473853|NCT04640168|155926689|FG000|Overall Study|Withdrawal by Subject|8|||
48473854|NCT04640168|155926690|FG001|Overall Study|Withdrawal by Subject|7|||
48473855|NCT04640168|155926689|FG000|Overall Study|Lost to Follow-up|1|||
48473856|NCT04640168|155926690|FG001|Overall Study|Lost to Follow-up|0|||
48473857|NCT04640168|155926689|FG000|Overall Study|Enrolled but not treated|12|||
48473858|NCT04640168|155926690|FG001|Overall Study|Enrolled but not treated|12|||
48473859|NCT02057549|155926691|FG000|Overall Study|Lost to Follow-up|1|||
48473860|NCT02057549|155926692|FG001|Overall Study|Lost to Follow-up|0|||
48473861|NCT02057549|155926691|FG000|Overall Study|Physician Decision|1|||
48473862|NCT02057549|155926692|FG001|Overall Study|Physician Decision|0|||
48473863|NCT02057549|155926691|FG000|Overall Study|Withdrawal by Subject|1|||
48473864|NCT02057549|155926692|FG001|Overall Study|Withdrawal by Subject|0|||
48473865|NCT01891669|155926693|FG000|Overall Study|Death|0|||
48473866|NCT01891669|155926694|FG001|Overall Study|Death|0|||
48473867|NCT01891669|155926695|FG002|Overall Study|Death|0|||
48473868|NCT01891669|155926696|FG003|Overall Study|Death|0|||
48473869|NCT01891669|155926697|FG004|Overall Study|Death|0|||
48473870|NCT01891669|155926698|FG005|Overall Study|Death|0|||
48473871|NCT01891669|155926699|FG006|Overall Study|Death|0|||
48473872|NCT01891669|155926700|FG007|Overall Study|Death|1|||
48473873|NCT01891669|155926701|FG008|Overall Study|Death|0|||
48473874|NCT01891669|155926702|FG009|Overall Study|Death|1|||
48473875|NCT01891669|155926693|FG000|Overall Study|Withdrawal by Subject|1|||
48473876|NCT01891669|155926694|FG001|Overall Study|Withdrawal by Subject|1|||
48473877|NCT01891669|155926695|FG002|Overall Study|Withdrawal by Subject|0|||
48473878|NCT01891669|155926696|FG003|Overall Study|Withdrawal by Subject|0|||
48473879|NCT01891669|155926697|FG004|Overall Study|Withdrawal by Subject|0|||
48473880|NCT01891669|155926698|FG005|Overall Study|Withdrawal by Subject|0|||
48473881|NCT01891669|155926699|FG006|Overall Study|Withdrawal by Subject|1|||
48473882|NCT01891669|155926700|FG007|Overall Study|Withdrawal by Subject|2|||
48473883|NCT01891669|155926701|FG008|Overall Study|Withdrawal by Subject|1|||
48473884|NCT01891669|155926702|FG009|Overall Study|Withdrawal by Subject|1|||
48473885|NCT01891669|155926693|FG000|Overall Study|Other|1|||
48473886|NCT01891669|155926694|FG001|Overall Study|Other|0|||
48473887|NCT01891669|155926695|FG002|Overall Study|Other|0|||
48473888|NCT01891669|155926696|FG003|Overall Study|Other|0|||
48473889|NCT01891669|155926697|FG004|Overall Study|Other|0|||
48473890|NCT01891669|155926698|FG005|Overall Study|Other|0|||
48473891|NCT01891669|155926699|FG006|Overall Study|Other|0|||
48473892|NCT01891669|155926700|FG007|Overall Study|Other|1|||
48473893|NCT01891669|155926701|FG008|Overall Study|Other|0|||
48473894|NCT01891669|155926702|FG009|Overall Study|Other|0|||
48473895|NCT00664066|155926703|FG000|Overall Study|Study terminated|3|||
48473896|NCT03958045|155926709|FG000|Overall Study|Withdrawal by Subject|1|||
48473897|NCT00905437|155926710|FG000|Overall Study|Adverse Event|3|||
48473898|NCT00905437|155926711|FG001|Overall Study|Adverse Event|2|||
48473899|NCT00905437|155926710|FG000|Overall Study|Lost to Follow-up|0|||
48473900|NCT00905437|155926711|FG001|Overall Study|Lost to Follow-up|1|||
48473901|NCT00905437|155926710|FG000|Overall Study|Withdrawal by Subject|0|||
48473902|NCT00905437|155926711|FG001|Overall Study|Withdrawal by Subject|1|||
48473903|NCT00905437|155926710|FG000|Overall Study|Other|5|||
48473904|NCT00905437|155926711|FG001|Overall Study|Other|6|||
48473905|NCT01215968|155926712|FG000|Overall Study|Adverse Event|0|||
48473906|NCT01215968|155926713|FG001|Overall Study|Adverse Event|2|||
48473909|NCT01215968|155926712|FG000|Overall Study|Not received study drug|0|||
48473910|NCT01215968|155926713|FG001|Overall Study|Not received study drug|1|||
48473911|NCT01463631|155926714|FG000|Overall Study|Withdrawal by Subject|0|||
48473912|NCT01463631|155926715|FG001|Overall Study|Withdrawal by Subject|0|||
48473913|NCT01463631|155926716|FG002|Overall Study|Withdrawal by Subject|0|||
48473914|NCT01463631|155926717|FG003|Overall Study|Withdrawal by Subject|1|||
48473915|NCT01463631|155926714|FG000|Overall Study|Death|0|||
48473916|NCT01463631|155926715|FG001|Overall Study|Death|0|||
48473917|NCT01463631|155926716|FG002|Overall Study|Death|1|||
48473918|NCT01463631|155926717|FG003|Overall Study|Death|0|||
48473919|NCT01463631|155926714|FG000|Overall Study|Progressive Disease|0|||
48473920|NCT01463631|155926715|FG001|Overall Study|Progressive Disease|0|||
48473921|NCT01463631|155926716|FG002|Overall Study|Progressive Disease|0|||
48473922|NCT01463631|155926717|FG003|Overall Study|Progressive Disease|5|||
48473923|NCT04066894|155926720|FG000|Overall Study|Lack of Efficacy|1|||
48473924|NCT04066894|155926720|FG000|Overall Study|Screen Failure|1|||
48473925|NCT02396849|155926724|FG000|Overall Study|Lost to Follow-up|1|||
48473926|NCT02396849|155926725|FG001|Overall Study|Lost to Follow-up|1|||
48473927|NCT02396849|155926724|FG000|Overall Study|Did not tolerate intervention|1|||
48473928|NCT02396849|155926725|FG001|Overall Study|Did not tolerate intervention|1|||
48473929|NCT01821391|155926726|FG000|Overall Study|Adverse Event|1|||
48473930|NCT01821391|155926727|FG001|Overall Study|Adverse Event|0|||
48473931|NCT01545375|155928668|FG000|Overall Study|Adverse Event|2|||
48473932|NCT01545375|155928669|FG001|Overall Study|Adverse Event|1|||
48473933|NCT01545375|155928668|FG000|Overall Study|Lost to Follow-up|34|||
48473934|NCT01545375|155928669|FG001|Overall Study|Lost to Follow-up|31|||
48473935|NCT01545375|155928668|FG000|Overall Study|Protocol Violation|3|||
48473936|NCT01545375|155928669|FG001|Overall Study|Protocol Violation|3|||
48473937|NCT01545375|155928668|FG000|Overall Study|Withdrawal by Subject|58|||
48473938|NCT01545375|155928669|FG001|Overall Study|Withdrawal by Subject|55|||
48473939|NCT03839693|155928671|FG000|Overall Study|Lost to Follow-up|0|||
48473940|NCT03839693|155928672|FG001|Overall Study|Lost to Follow-up|2|||
48473941|NCT03839693|155928673|FG002|Overall Study|Lost to Follow-up|2|||
48473942|NCT03839693|155928671|FG000|Overall Study|Withdrawal by Subject|1|||
48473943|NCT03839693|155928672|FG001|Overall Study|Withdrawal by Subject|0|||
48473944|NCT03839693|155928673|FG002|Overall Study|Withdrawal by Subject|2|||
48473945|NCT03839693|155928671|FG000|Overall Study|subject moved out of the area|1|||
48473946|NCT03839693|155928672|FG001|Overall Study|subject moved out of the area|0|||
48473947|NCT03839693|155928673|FG002|Overall Study|subject moved out of the area|0|||
48473948|NCT02983305|155928680|FG000|Overall Study|incomplete data|2|||
48473949|NCT02983305|155928681|FG001|Overall Study|incomplete data|0|||
48473950|NCT00706901|155928682|FG000|Overall Study|Lost to Follow-up|2|||
48473951|NCT00706901|155928683|FG001|Overall Study|Lost to Follow-up|3|||
48473952|NCT00706901|155928684|FG002|Overall Study|Lost to Follow-up|2|||
48473953|NCT00706901|155928682|FG000|Overall Study|Withdrawal by Subject|4|||
48473954|NCT00706901|155928683|FG001|Overall Study|Withdrawal by Subject|2|||
48473955|NCT00706901|155928684|FG002|Overall Study|Withdrawal by Subject|5|||
48473956|NCT00706901|155928682|FG000|Overall Study|In Jail|1|||
48473957|NCT00706901|155928683|FG001|Overall Study|In Jail|0|||
48473958|NCT00706901|155928684|FG002|Overall Study|In Jail|1|||
48473959|NCT00706901|155928682|FG000|Overall Study|Death|1|||
48473960|NCT00706901|155928683|FG001|Overall Study|Death|0|||
48473961|NCT00706901|155928684|FG002|Overall Study|Death|0|||
48473962|NCT01319994|155928687|FG000|Overall Study|Protocol Violation|7|||
48473963|NCT01319994|155928688|FG001|Overall Study|Protocol Violation|6|||
48473964|NCT00822237|155928689|FG000|Dose 1 Vaccination|Not vaccinated|3|||
48473965|NCT00822237|155928690|FG001|Dose 1 Vaccination|Not vaccinated|0|||
48473966|NCT00822237|155928689|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
48473967|NCT00822237|155928690|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
48473968|NCT00822237|155928689|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
48473969|NCT00822237|155928690|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
48473970|NCT00822237|155928689|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
48473971|NCT00822237|155928690|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
48473972|NCT00822237|155928689|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
48473973|NCT00822237|155928690|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
48473974|NCT01238861|155928691|FG000|Overall Study|Lost to Follow-up|4|||
48473975|NCT01238861|155928692|FG001|Overall Study|Lost to Follow-up|2|||
48473976|NCT01238861|155928693|FG002|Overall Study|Lost to Follow-up|3|||
48473977|NCT01238861|155928694|FG003|Overall Study|Lost to Follow-up|1|||
48473978|NCT01238861|155928695|FG004|Overall Study|Lost to Follow-up|1|||
48473979|NCT01238861|155928696|FG005|Overall Study|Lost to Follow-up|2|||
48473980|NCT01238861|155928691|FG000|Overall Study|Unplanned surgery|1|||
48473981|NCT01238861|155928692|FG001|Overall Study|Unplanned surgery|0|||
48473982|NCT01238861|155928693|FG002|Overall Study|Unplanned surgery|0|||
48473983|NCT01238861|155928694|FG003|Overall Study|Unplanned surgery|0|||
48473984|NCT01238861|155928695|FG004|Overall Study|Unplanned surgery|0|||
48473985|NCT01238861|155928696|FG005|Overall Study|Unplanned surgery|0|||
48473986|NCT01238861|155928691|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
48473987|NCT01238861|155928692|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
48473988|NCT01238861|155928693|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
48473989|NCT01238861|155928694|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
48473990|NCT01238861|155928695|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
48473991|NCT01238861|155928696|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
48473992|NCT01238861|155928691|FG000|Overall Study|Incorrect enrollment/randomization|0|||
48473993|NCT01238861|155928692|FG001|Overall Study|Incorrect enrollment/randomization|0|||
48473994|NCT01238861|155928693|FG002|Overall Study|Incorrect enrollment/randomization|1|||
48473995|NCT01238861|155928694|FG003|Overall Study|Incorrect enrollment/randomization|0|||
48473996|NCT01238861|155928695|FG004|Overall Study|Incorrect enrollment/randomization|1|||
48473997|NCT01238861|155928696|FG005|Overall Study|Incorrect enrollment/randomization|0|||
48473998|NCT01238861|155928691|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
48473999|NCT01238861|155928692|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
48474000|NCT01238861|155928693|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
48474001|NCT01238861|155928694|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
48474002|NCT01238861|155928695|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
48474003|NCT01238861|155928696|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
48474004|NCT01238861|155928691|FG000|Overall Study|Subject moved out of state/area|0|||
48474005|NCT01238861|155928692|FG001|Overall Study|Subject moved out of state/area|0|||
48474006|NCT01238861|155928693|FG002|Overall Study|Subject moved out of state/area|1|||
48474007|NCT01238861|155928694|FG003|Overall Study|Subject moved out of state/area|1|||
48474008|NCT01238861|155928695|FG004|Overall Study|Subject moved out of state/area|0|||
48474009|NCT01238861|155928696|FG005|Overall Study|Subject moved out of state/area|0|||
48474010|NCT01238861|155928691|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
48474011|NCT01238861|155928692|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
48474012|NCT01238861|155928693|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
48474013|NCT01238861|155928694|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
48474014|NCT01238861|155928695|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
48474015|NCT01238861|155928696|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
48474016|NCT01238861|155928691|FG000|Overall Study|Personal problems|0|||
48474017|NCT01238861|155928692|FG001|Overall Study|Personal problems|0|||
48474018|NCT01238861|155928693|FG002|Overall Study|Personal problems|0|||
48474019|NCT01238861|155928694|FG003|Overall Study|Personal problems|1|||
48474020|NCT01238861|155928695|FG004|Overall Study|Personal problems|0|||
48474021|NCT01238861|155928696|FG005|Overall Study|Personal problems|0|||
48474022|NCT01238861|155928691|FG000|Overall Study|Unable to continue visits|0|||
48474023|NCT01238861|155928692|FG001|Overall Study|Unable to continue visits|0|||
48474024|NCT01238861|155928693|FG002|Overall Study|Unable to continue visits|0|||
48474025|NCT01238861|155928694|FG003|Overall Study|Unable to continue visits|1|||
48474026|NCT01238861|155928695|FG004|Overall Study|Unable to continue visits|0|||
48474027|NCT01238861|155928696|FG005|Overall Study|Unable to continue visits|1|||
48474028|NCT01238861|155928691|FG000|Overall Study|Serious adverse event|0|||
48474029|NCT01238861|155928692|FG001|Overall Study|Serious adverse event|0|||
48474030|NCT01238861|155928693|FG002|Overall Study|Serious adverse event|0|||
48474031|NCT01238861|155928694|FG003|Overall Study|Serious adverse event|0|||
48474032|NCT01238861|155928695|FG004|Overall Study|Serious adverse event|0|||
48474033|NCT01238861|155928696|FG005|Overall Study|Serious adverse event|1|||
48474034|NCT01238861|155928691|FG000|Overall Study|Lack of compliance|0|||
48474035|NCT01238861|155928692|FG001|Overall Study|Lack of compliance|0|||
48474036|NCT01238861|155928693|FG002|Overall Study|Lack of compliance|0|||
48474037|NCT01238861|155928694|FG003|Overall Study|Lack of compliance|0|||
48474038|NCT01238861|155928695|FG004|Overall Study|Lack of compliance|0|||
48474039|NCT01238861|155928696|FG005|Overall Study|Lack of compliance|1|||
48474040|NCT01238861|155928691|FG000|Overall Study|Adverse Event|0|||
48474041|NCT01238861|155928692|FG001|Overall Study|Adverse Event|1|||
48474042|NCT01238861|155928693|FG002|Overall Study|Adverse Event|0|||
48474043|NCT01238861|155928694|FG003|Overall Study|Adverse Event|0|||
48474044|NCT01238861|155928695|FG004|Overall Study|Adverse Event|0|||
48474045|NCT01238861|155928696|FG005|Overall Study|Adverse Event|0|||
48474046|NCT01238861|155928691|FG000|Overall Study|Withdrawal by Subject|6|||
48474047|NCT01238861|155928692|FG001|Overall Study|Withdrawal by Subject|5|||
48474048|NCT01238861|155928693|FG002|Overall Study|Withdrawal by Subject|4|||
48474049|NCT01238861|155928694|FG003|Overall Study|Withdrawal by Subject|8|||
48474050|NCT01238861|155928695|FG004|Overall Study|Withdrawal by Subject|10|||
48474051|NCT01238861|155928696|FG005|Overall Study|Withdrawal by Subject|9|||
48474052|NCT02389621|155928697|FG000|Treatment Period|Withdrawal by Subject|1|||
48474053|NCT02389621|155928698|FG001|Treatment Period|Withdrawal by Subject|1|||
48474054|NCT02389621|155928697|FG000|Posttreatment Period|Adverse Event|3|||
48474055|NCT02389621|155928698|FG001|Posttreatment Period|Adverse Event|1|||
48474056|NCT02389621|155928697|FG000|Posttreatment Period|Withdrawal by Subject|3|||
48474057|NCT02389621|155928698|FG001|Posttreatment Period|Withdrawal by Subject|2|||
48474058|NCT02389621|155928697|FG000|Posttreatment Period|Lost to Follow-up|1|||
48474059|NCT02389621|155928698|FG001|Posttreatment Period|Lost to Follow-up|1|||
48474060|NCT02389621|155928697|FG000|Posttreatment Period|Other - Miscellaneous|2|||
48474061|NCT02389621|155928698|FG001|Posttreatment Period|Other - Miscellaneous|0|||
48474062|NCT01748162|155928708|FG000|Overall Study|no additional croup episodes to evaluate|2|||
48474063|NCT01748162|155928709|FG001|Overall Study|no additional croup episodes to evaluate|2|||
48474064|NCT01748162|155928708|FG000|Overall Study|participant consented but did not begin|0|||
48474065|NCT01748162|155928709|FG001|Overall Study|participant consented but did not begin|1|||
48474066|NCT01748162|155928708|FG000|Overall Study|reasons not available|3|||
48474067|NCT01748162|155928709|FG001|Overall Study|reasons not available|2|||
48474068|NCT03841331|155928712|FG000|Overall Study|Withdrawal by Subject|4|||
48474069|NCT03841331|155928713|FG001|Overall Study|Withdrawal by Subject|9|||
48474070|NCT03841331|155928712|FG000|Overall Study|Lost to Follow-up|5|||
48474071|NCT03841331|155928713|FG001|Overall Study|Lost to Follow-up|1|||
48474072|NCT01301625|155928717|FG000|Overall Study|Death|5|||
48474073|NCT01301625|155928717|FG000|Overall Study|Not Due|21|||
48474074|NCT01301625|155928717|FG000|Overall Study|Expected|8|||
48474075|NCT01301625|155928717|FG000|Overall Study|Lost to Follow-up|1|||
48474076|NCT03237325|155928718|FG000|Overall Study|Lost to Follow-up|3|||
48474077|NCT03237325|155928719|FG001|Overall Study|Lost to Follow-up|5|||
48474078|NCT03237325|155928718|FG000|Overall Study|Physician Decision|2|||
48474079|NCT03237325|155928719|FG001|Overall Study|Physician Decision|4|||
48474080|NCT03237325|155928718|FG000|Overall Study|Withdrawal by Subject|9|||
48474081|NCT03237325|155928719|FG001|Overall Study|Withdrawal by Subject|12|||
48474082|NCT03237325|155928718|FG000|Overall Study|Noncompliance with Study Procedures|1|||
48474083|NCT03237325|155928719|FG001|Overall Study|Noncompliance with Study Procedures|1|||
48474084|NCT03237325|155928718|FG000|Overall Study|Termination by Sponsor|0|||
48474085|NCT03237325|155928719|FG001|Overall Study|Termination by Sponsor|1|||
48474086|NCT03237325|155928718|FG000|Overall Study|Reason other than described|0|||
48474087|NCT03237325|155928719|FG001|Overall Study|Reason other than described|2|||
48474088|NCT01207219|155928721|FG000|Overall Study|changed diagnosis during study period|5|||
48474089|NCT01207219|155928722|FG001|Overall Study|changed diagnosis during study period|3|||
48474090|NCT01207219|155928723|FG002|Overall Study|changed diagnosis during study period|1|||
48474091|NCT01207219|155928721|FG000|Overall Study|Lost to Follow-up|6|||
48474092|NCT01207219|155928722|FG001|Overall Study|Lost to Follow-up|8|||
48474093|NCT01207219|155928723|FG002|Overall Study|Lost to Follow-up|6|||
48474094|NCT04021602|155928724|FG000|Overall Study|Lost to Follow-up|3|||
48474095|NCT04021602|155928725|FG001|Overall Study|Lost to Follow-up|3|||
48474096|NCT04021602|155928726|FG002|Overall Study|Lost to Follow-up|1|||
48474097|NCT04021602|155928724|FG000|Overall Study|Adverse Event|1|||
48474098|NCT04021602|155928725|FG001|Overall Study|Adverse Event|0|||
48474099|NCT04021602|155928726|FG002|Overall Study|Adverse Event|1|||
48474100|NCT01453296|155928727|FG000|Treatment Period 1|Adverse Event|0|||
48474101|NCT01453296|155928728|FG001|Treatment Period 1|Adverse Event|1|||
48474102|NCT01453296|155928727|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
48474103|NCT01453296|155928728|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
48474104|NCT01453296|155928727|FG000|Treatment Period 2|Adverse Event|1|||
48474105|NCT01453296|155928728|FG001|Treatment Period 2|Adverse Event|0|||
48474106|NCT01453296|155928727|FG000|Treatment Period 2|Withdrawal by Subject|1|||
48474107|NCT01453296|155928728|FG001|Treatment Period 2|Withdrawal by Subject|0|||
48474108|NCT04629534|155928731|FG000|Overall Study|Physician Decision|1|||
48474109|NCT04629534|155928732|FG001|Overall Study|Physician Decision|0|||
48474110|NCT04629534|155928731|FG000|Overall Study|Protocol Violation|0|||
48474111|NCT04629534|155928732|FG001|Overall Study|Protocol Violation|2|||
48474112|NCT01353586|155928733|FG000|Overall Study|Procedure terminated prior to ablation|3|||
48474113|NCT01353586|155928734|FG001|Overall Study|Procedure terminated prior to ablation|0|||
48474114|NCT01353586|155928733|FG000|Overall Study|Never had insertion of study catheter|4|||
48474115|NCT01353586|155928734|FG001|Overall Study|Never had insertion of study catheter|1|||
48474116|NCT01353586|155928733|FG000|Overall Study|Neurological exam not done|0|||
48474117|NCT01353586|155928734|FG001|Overall Study|Neurological exam not done|1|||
48474118|NCT00585468|155928735|FG000|First Intervention|Withdrawal by Subject|1|||
48474119|NCT00585468|155928736|FG001|First Intervention|Withdrawal by Subject|1|||
48474120|NCT01023815|155928741|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
48474121|NCT01023815|155928742|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
48474122|NCT01023815|155928743|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
48474123|NCT01023815|155928744|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
48474124|NCT01023815|155928741|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
48474125|NCT01023815|155928742|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
48474126|NCT01023815|155928743|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
48474127|NCT01023815|155928744|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
48474128|NCT01023815|155928741|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
48474129|NCT01023815|155928742|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
48474130|NCT01023815|155928743|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
48474131|NCT01023815|155928744|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
48474132|NCT01023815|155928741|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
48474133|NCT01023815|155928742|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
48474134|NCT01023815|155928743|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
48474135|NCT01023815|155928744|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
48474136|NCT01023815|155928741|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
48474137|NCT01023815|155928742|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
48474138|NCT01023815|155928743|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
48474139|NCT01023815|155928744|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
48474140|NCT00762073|155928745|FG000|Overall Study|Lack of Efficacy|1|||
48474141|NCT00762073|155928746|FG001|Overall Study|Lack of Efficacy|1|||
48474142|NCT00762073|155928747|FG002|Overall Study|Lack of Efficacy|0|||
48474143|NCT00762073|155928748|FG003|Overall Study|Lack of Efficacy|0|||
48474144|NCT00762073|155928745|FG000|Overall Study|Adverse Event|1|||
48474145|NCT00762073|155928746|FG001|Overall Study|Adverse Event|0|||
48474146|NCT00762073|155928747|FG002|Overall Study|Adverse Event|1|||
48474147|NCT00762073|155928748|FG003|Overall Study|Adverse Event|1|||
48474148|NCT00762073|155928745|FG000|Overall Study|Significant Subject Noncompliance|0|||
48474149|NCT00762073|155928746|FG001|Overall Study|Significant Subject Noncompliance|1|||
48474150|NCT00762073|155928747|FG002|Overall Study|Significant Subject Noncompliance|0|||
48474151|NCT00762073|155928748|FG003|Overall Study|Significant Subject Noncompliance|1|||
48474152|NCT00762073|155928745|FG000|Overall Study|Withdrawal by Subject|1|||
48474153|NCT00762073|155928746|FG001|Overall Study|Withdrawal by Subject|2|||
48474154|NCT00762073|155928747|FG002|Overall Study|Withdrawal by Subject|1|||
48474155|NCT00762073|155928748|FG003|Overall Study|Withdrawal by Subject|1|||
48474156|NCT00762073|155928745|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
48474157|NCT00762073|155928746|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
48474158|NCT00762073|155928747|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
48474159|NCT00762073|155928748|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
48474160|NCT03733301|155928749|FG000|Overall Study|Screen Fail|1|||
48474161|NCT03733301|155928750|FG001|Overall Study|Screen Fail|0|||
48474162|NCT03733301|155928751|FG002|Overall Study|Screen Fail|0|||
48474163|NCT03733301|155928749|FG000|Overall Study|Non-compliance|1|||
48474164|NCT03733301|155928750|FG001|Overall Study|Non-compliance|0|||
48474165|NCT03733301|155928751|FG002|Overall Study|Non-compliance|0|||
48474166|NCT03733301|155928749|FG000|Overall Study|Lack of Efficacy|2|||
48474167|NCT03733301|155928750|FG001|Overall Study|Lack of Efficacy|3|||
48474168|NCT03733301|155928751|FG002|Overall Study|Lack of Efficacy|0|||
48474169|NCT03733301|155928749|FG000|Overall Study|Adverse Event|0|||
48474170|NCT03733301|155928750|FG001|Overall Study|Adverse Event|1|||
48474171|NCT03733301|155928751|FG002|Overall Study|Adverse Event|3|||
48474172|NCT03733301|155928749|FG000|Overall Study|Withdrawal by Subject|3|||
48474173|NCT03733301|155928750|FG001|Overall Study|Withdrawal by Subject|5|||
48474174|NCT03733301|155928751|FG002|Overall Study|Withdrawal by Subject|1|||
48474175|NCT00320801|155928752|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
48474176|NCT00320801|155928753|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
48474177|NCT00320801|155928754|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
48474178|NCT00320801|155928755|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
48474179|NCT00320801|155928752|FG000|Open-label Run-in Period|Adverse Event|33|||
48474180|NCT00320801|155928753|FG001|Open-label Run-in Period|Adverse Event|0|||
48474181|NCT00320801|155928754|FG002|Open-label Run-in Period|Adverse Event|0|||
48474182|NCT00320801|155928755|FG003|Open-label Run-in Period|Adverse Event|0|||
48474183|NCT00320801|155928752|FG000|Open-label Run-in Period|Administrative|10|||
48474184|NCT00320801|155928753|FG001|Open-label Run-in Period|Administrative|0|||
48474185|NCT00320801|155928754|FG002|Open-label Run-in Period|Administrative|0|||
48474186|NCT00320801|155928755|FG003|Open-label Run-in Period|Administrative|0|||
48474187|NCT00320801|155928752|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
48474188|NCT00320801|155928753|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
48474189|NCT00320801|155928754|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
48474190|NCT00320801|155928755|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
48474191|NCT00320801|155928752|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
48474192|NCT00320801|155928753|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
48474193|NCT00320801|155928754|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
48474194|NCT00320801|155928755|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
48474195|NCT00320801|155928752|FG000|Open-label Run-in Period|Did not qualify|1|||
48474196|NCT00320801|155928753|FG001|Open-label Run-in Period|Did not qualify|0|||
48474197|NCT00320801|155928754|FG002|Open-label Run-in Period|Did not qualify|0|||
48474198|NCT00320801|155928755|FG003|Open-label Run-in Period|Did not qualify|0|||
48474199|NCT00320801|155928752|FG000|Double-blind Phase|Withdrawal by Subject|0|||
48474200|NCT00320801|155928753|FG001|Double-blind Phase|Withdrawal by Subject|0|||
48474201|NCT00320801|155928754|FG002|Double-blind Phase|Withdrawal by Subject|1|||
48474202|NCT00320801|155928755|FG003|Double-blind Phase|Withdrawal by Subject|0|||
48474203|NCT00320801|155928752|FG000|Double-blind Phase|Adverse Event|0|||
48474204|NCT00320801|155928753|FG001|Double-blind Phase|Adverse Event|2|||
48474205|NCT00320801|155928754|FG002|Double-blind Phase|Adverse Event|8|||
48474206|NCT00320801|155928755|FG003|Double-blind Phase|Adverse Event|0|||
48474207|NCT00320801|155928752|FG000|Double-blind Phase|Administrative|0|||
48474208|NCT00320801|155928753|FG001|Double-blind Phase|Administrative|0|||
48474209|NCT00320801|155928754|FG002|Double-blind Phase|Administrative|4|||
48474210|NCT00320801|155928755|FG003|Double-blind Phase|Administrative|0|||
48474211|NCT00320801|155928752|FG000|Double-blind Phase|Lack of Efficacy|0|||
48474212|NCT00320801|155928753|FG001|Double-blind Phase|Lack of Efficacy|9|||
48474213|NCT00320801|155928754|FG002|Double-blind Phase|Lack of Efficacy|1|||
48474214|NCT00320801|155928755|FG003|Double-blind Phase|Lack of Efficacy|0|||
48474215|NCT00320801|155928752|FG000|Extension Phase|Withdrawal by Subject|0|||
48474216|NCT00320801|155928753|FG001|Extension Phase|Withdrawal by Subject|0|||
48474217|NCT00320801|155928754|FG002|Extension Phase|Withdrawal by Subject|0|||
48474218|NCT00320801|155928755|FG003|Extension Phase|Withdrawal by Subject|6|||
48474219|NCT00320801|155928752|FG000|Extension Phase|Adverse Event|0|||
48474220|NCT00320801|155928753|FG001|Extension Phase|Adverse Event|0|||
48474221|NCT00320801|155928754|FG002|Extension Phase|Adverse Event|0|||
48474222|NCT00320801|155928755|FG003|Extension Phase|Adverse Event|8|||
48474223|NCT00320801|155928752|FG000|Extension Phase|Administrative|0|||
48474224|NCT00320801|155928753|FG001|Extension Phase|Administrative|0|||
48474225|NCT00320801|155928754|FG002|Extension Phase|Administrative|0|||
48474226|NCT00320801|155928755|FG003|Extension Phase|Administrative|29|||
48474227|NCT00320801|155928752|FG000|Extension Phase|Lack of Efficacy|0|||
48474228|NCT00320801|155928753|FG001|Extension Phase|Lack of Efficacy|0|||
48474229|NCT00320801|155928754|FG002|Extension Phase|Lack of Efficacy|0|||
48474230|NCT00320801|155928755|FG003|Extension Phase|Lack of Efficacy|2|||
48474231|NCT00320801|155928752|FG000|Extension Phase|Lost to Follow-up|0|||
48474232|NCT00320801|155928753|FG001|Extension Phase|Lost to Follow-up|0|||
48474233|NCT00320801|155928754|FG002|Extension Phase|Lost to Follow-up|0|||
48474234|NCT00320801|155928755|FG003|Extension Phase|Lost to Follow-up|3|||
48474235|NCT02325739|155928756|FG000|Phase I Part|Adverse Event|1|||
48474236|NCT02325739|155928757|FG001|Phase I Part|Adverse Event|0|||
48474237|NCT02325739|155928758|FG002|Phase I Part|Adverse Event|1|||
48474238|NCT02325739|155928759|FG003|Phase I Part|Adverse Event|2|||
48474239|NCT02325739|155928760|FG004|Phase I Part|Adverse Event|3|||
48474240|NCT02325739|155928761|FG005|Phase I Part|Adverse Event|1|||
48474241|NCT02325739|155928762|FG006|Phase I Part|Adverse Event|0|||
48474242|NCT02325739|155928763|FG007|Phase I Part|Adverse Event|2|||
48474243|NCT02325739|155928764|FG008|Phase I Part|Adverse Event|0|||
48474244|NCT02325739|155928765|FG009|Phase I Part|Adverse Event|0|||
48474245|NCT02325739|155928766|FG010|Phase I Part|Adverse Event|0|||
48474246|NCT02325739|155928756|FG000|Phase I Part|Progressive disease|9|||
48474247|NCT02325739|155928757|FG001|Phase I Part|Progressive disease|6|||
48474248|NCT02325739|155928758|FG002|Phase I Part|Progressive disease|3|||
48474249|NCT02325739|155928759|FG003|Phase I Part|Progressive disease|23|||
48474250|NCT02325739|155928760|FG004|Phase I Part|Progressive disease|14|||
48474251|NCT02325739|155928761|FG005|Phase I Part|Progressive disease|6|||
48474252|NCT02325739|155928762|FG006|Phase I Part|Progressive disease|6|||
48474253|NCT02325739|155928763|FG007|Phase I Part|Progressive disease|3|||
48474254|NCT02325739|155928764|FG008|Phase I Part|Progressive disease|0|||
48474255|NCT02325739|155928765|FG009|Phase I Part|Progressive disease|0|||
48474256|NCT02325739|155928766|FG010|Phase I Part|Progressive disease|0|||
48474257|NCT02325739|155928756|FG000|Phase I Part|Subject/guardian decision|1|||
48474258|NCT02325739|155928757|FG001|Phase I Part|Subject/guardian decision|0|||
48474259|NCT02325739|155928758|FG002|Phase I Part|Subject/guardian decision|1|||
48474260|NCT02325739|155928759|FG003|Phase I Part|Subject/guardian decision|1|||
48474261|NCT02325739|155928760|FG004|Phase I Part|Subject/guardian decision|0|||
48474262|NCT02325739|155928761|FG005|Phase I Part|Subject/guardian decision|0|||
48474263|NCT02325739|155928762|FG006|Phase I Part|Subject/guardian decision|0|||
48474264|NCT02325739|155928763|FG007|Phase I Part|Subject/guardian decision|1|||
48474265|NCT02325739|155928764|FG008|Phase I Part|Subject/guardian decision|0|||
48474266|NCT02325739|155928765|FG009|Phase I Part|Subject/guardian decision|0|||
48474267|NCT02325739|155928766|FG010|Phase I Part|Subject/guardian decision|0|||
48474268|NCT02325739|155928756|FG000|Phase I Part|Death|0|||
48474269|NCT02325739|155928757|FG001|Phase I Part|Death|0|||
48474270|NCT02325739|155928758|FG002|Phase I Part|Death|0|||
48474271|NCT02325739|155928759|FG003|Phase I Part|Death|0|||
48474272|NCT02325739|155928760|FG004|Phase I Part|Death|2|||
48474273|NCT02325739|155928761|FG005|Phase I Part|Death|0|||
48474274|NCT02325739|155928762|FG006|Phase I Part|Death|0|||
48474275|NCT02325739|155928763|FG007|Phase I Part|Death|0|||
48474276|NCT02325739|155928764|FG008|Phase I Part|Death|0|||
48474277|NCT02325739|155928765|FG009|Phase I Part|Death|0|||
48474278|NCT02325739|155928766|FG010|Phase I Part|Death|0|||
48474279|NCT02325739|155928756|FG000|Phase II Part|Adverse Event|0|||
48474280|NCT02325739|155928757|FG001|Phase II Part|Adverse Event|0|||
48474281|NCT02325739|155928758|FG002|Phase II Part|Adverse Event|0|||
48474282|NCT02325739|155928759|FG003|Phase II Part|Adverse Event|0|||
48474283|NCT02325739|155928760|FG004|Phase II Part|Adverse Event|0|||
48474284|NCT02325739|155928761|FG005|Phase II Part|Adverse Event|0|||
48474285|NCT02325739|155928762|FG006|Phase II Part|Adverse Event|0|||
48474286|NCT02325739|155928763|FG007|Phase II Part|Adverse Event|0|||
48474287|NCT02325739|155928764|FG008|Phase II Part|Adverse Event|4|||
48474288|NCT02325739|155928765|FG009|Phase II Part|Adverse Event|5|||
48474289|NCT02325739|155928766|FG010|Phase II Part|Adverse Event|1|||
48474290|NCT02325739|155928756|FG000|Phase II Part|Physician Decision|0|||
48474291|NCT02325739|155928757|FG001|Phase II Part|Physician Decision|0|||
48474292|NCT02325739|155928758|FG002|Phase II Part|Physician Decision|0|||
48474293|NCT02325739|155928759|FG003|Phase II Part|Physician Decision|0|||
48474294|NCT02325739|155928760|FG004|Phase II Part|Physician Decision|0|||
48474295|NCT02325739|155928761|FG005|Phase II Part|Physician Decision|0|||
48474296|NCT02325739|155928762|FG006|Phase II Part|Physician Decision|0|||
48474297|NCT02325739|155928763|FG007|Phase II Part|Physician Decision|0|||
48474298|NCT02325739|155928764|FG008|Phase II Part|Physician Decision|0|||
48474299|NCT02325739|155928765|FG009|Phase II Part|Physician Decision|1|||
48474300|NCT02325739|155928766|FG010|Phase II Part|Physician Decision|0|||
48474301|NCT02325739|155928756|FG000|Phase II Part|Progressive disease|0|||
48474302|NCT02325739|155928757|FG001|Phase II Part|Progressive disease|0|||
48474303|NCT02325739|155928758|FG002|Phase II Part|Progressive disease|0|||
48474304|NCT02325739|155928759|FG003|Phase II Part|Progressive disease|0|||
48474305|NCT02325739|155928760|FG004|Phase II Part|Progressive disease|0|||
48474306|NCT02325739|155928761|FG005|Phase II Part|Progressive disease|0|||
48474307|NCT02325739|155928762|FG006|Phase II Part|Progressive disease|0|||
48474308|NCT02325739|155928763|FG007|Phase II Part|Progressive disease|0|||
48474309|NCT02325739|155928764|FG008|Phase II Part|Progressive disease|22|||
48474310|NCT02325739|155928765|FG009|Phase II Part|Progressive disease|29|||
48474311|NCT02325739|155928766|FG010|Phase II Part|Progressive disease|18|||
48474312|NCT02325739|155928756|FG000|Phase II Part|Subject/guardian decision|0|||
48474313|NCT02325739|155928757|FG001|Phase II Part|Subject/guardian decision|0|||
48474314|NCT02325739|155928758|FG002|Phase II Part|Subject/guardian decision|0|||
48474315|NCT02325739|155928759|FG003|Phase II Part|Subject/guardian decision|0|||
48474316|NCT02325739|155928760|FG004|Phase II Part|Subject/guardian decision|0|||
48474317|NCT02325739|155928761|FG005|Phase II Part|Subject/guardian decision|0|||
48474318|NCT02325739|155928762|FG006|Phase II Part|Subject/guardian decision|0|||
48474319|NCT02325739|155928763|FG007|Phase II Part|Subject/guardian decision|0|||
48474320|NCT02325739|155928764|FG008|Phase II Part|Subject/guardian decision|4|||
48474321|NCT02325739|155928765|FG009|Phase II Part|Subject/guardian decision|1|||
48474322|NCT02325739|155928766|FG010|Phase II Part|Subject/guardian decision|1|||
48474323|NCT01015118|155928773|FG000|Overall Study|Protocol Violation|5|||
48474324|NCT01015118|155928774|FG001|Overall Study|Protocol Violation|6|||
48474325|NCT01015118|155928773|FG000|Overall Study|Withdrawal by Subject|103|||
48474326|NCT01015118|155928774|FG001|Overall Study|Withdrawal by Subject|27|||
48474327|NCT01015118|155928773|FG000|Overall Study|Other Adverse Event (AE)|141|||
48474328|NCT01015118|155928774|FG001|Overall Study|Other Adverse Event (AE)|33|||
48474329|NCT01015118|155928773|FG000|Overall Study|Worsening or AE of underlying disease|5|||
48474330|NCT01015118|155928774|FG001|Overall Study|Worsening or AE of underlying disease|4|||
48474331|NCT01015118|155928773|FG000|Overall Study|Progressive disease|364|||
48474332|NCT01015118|155928774|FG001|Overall Study|Progressive disease|229|||
48474333|NCT01015118|155928773|FG000|Overall Study|Not treated|9|||
48474334|NCT01015118|155928774|FG001|Overall Study|Not treated|5|||
48474335|NCT01015118|155928773|FG000|Overall Study|Other than stated above|42|||
48474336|NCT01015118|155928774|FG001|Overall Study|Other than stated above|23|||
48474337|NCT04882085|155928779|FG000|Overall Study|Death|6|||
48474338|NCT04882085|155928780|FG001|Overall Study|Death|9|||
48474339|NCT04882085|155928779|FG000|Overall Study|Withdrawal by Subject|0|||
48474340|NCT04882085|155928780|FG001|Overall Study|Withdrawal by Subject|3|||
48474341|NCT04882085|155928779|FG000|Overall Study|Randomized not treated|1|||
48474342|NCT04882085|155928780|FG001|Overall Study|Randomized not treated|0|||
48474343|NCT03179462|155928784|FG000|Overall Study|screening failure|1|||
48474344|NCT03179462|155928785|FG001|Overall Study|screening failure|2|||
48474345|NCT03179462|155928786|FG002|Overall Study|screening failure|0|||
48474346|NCT01761565|155928787|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
48474347|NCT00816166|155928788|FG000|Overall Study|Lost to Follow-up|6|||
48474348|NCT00816166|155928789|FG001|Overall Study|Lost to Follow-up|10|||
48474349|NCT00816166|155928788|FG000|Overall Study|Death|4|||
48474350|NCT00816166|155928789|FG001|Overall Study|Death|2|||
48474351|NCT02873195|155928802|FG000|Overall Study|Ineligible|5|||
48474352|NCT02873195|155928803|FG001|Overall Study|Ineligible|0|||
48474353|NCT02268214|155928804|FG000|Overall Study|Subject no longer meets study criteria|0|||
48474354|NCT02268214|155928805|FG001|Overall Study|Subject no longer meets study criteria|2|||
48474355|NCT02268214|155928806|FG002|Overall Study|Subject no longer meets study criteria|0|||
48474356|NCT02268214|155928804|FG000|Overall Study|Pregnancy|2|||
48474357|NCT02268214|155928805|FG001|Overall Study|Pregnancy|2|||
48474358|NCT02268214|155928806|FG002|Overall Study|Pregnancy|1|||
48474359|NCT02268214|155928804|FG000|Overall Study|Lost to Follow-up|3|||
48474360|NCT02268214|155928805|FG001|Overall Study|Lost to Follow-up|3|||
48474361|NCT02268214|155928806|FG002|Overall Study|Lost to Follow-up|4|||
48474362|NCT02268214|155928804|FG000|Overall Study|Lack of Efficacy|1|||
48474363|NCT02268214|155928805|FG001|Overall Study|Lack of Efficacy|0|||
48474364|NCT02268214|155928806|FG002|Overall Study|Lack of Efficacy|2|||
48474365|NCT02268214|155928804|FG000|Overall Study|Adverse Event|11|||
48474366|NCT02268214|155928805|FG001|Overall Study|Adverse Event|14|||
48474367|NCT02268214|155928806|FG002|Overall Study|Adverse Event|9|||
48474368|NCT02268214|155928804|FG000|Overall Study|Withdrawal by Subject|4|||
48474369|NCT02268214|155928805|FG001|Overall Study|Withdrawal by Subject|5|||
48474370|NCT02268214|155928806|FG002|Overall Study|Withdrawal by Subject|10|||
48474371|NCT02268214|155928804|FG000|Overall Study|Subject request to discontinue treatment|10|||
48474372|NCT02268214|155928805|FG001|Overall Study|Subject request to discontinue treatment|8|||
48474373|NCT02268214|155928806|FG002|Overall Study|Subject request to discontinue treatment|6|||
48474374|NCT02268214|155928804|FG000|Overall Study|Poor/non-compliance|2|||
48474375|NCT02268214|155928805|FG001|Overall Study|Poor/non-compliance|1|||
48474376|NCT02268214|155928806|FG002|Overall Study|Poor/non-compliance|2|||
48474377|NCT02268214|155928804|FG000|Overall Study|Other reasons|7|||
48474378|NCT02268214|155928805|FG001|Overall Study|Other reasons|3|||
48474379|NCT02268214|155928806|FG002|Overall Study|Other reasons|3|||
48474380|NCT02268214|155928804|FG000|Overall Study|Not entering long-term period|2|||
48474381|NCT02268214|155928805|FG001|Overall Study|Not entering long-term period|3|||
48474382|NCT02268214|155928806|FG002|Overall Study|Not entering long-term period|5|||
48474383|NCT04342390|155928807|FG000|Overall Study|Lost to Follow-up|3|||
48474384|NCT04342390|155928808|FG001|Overall Study|Lost to Follow-up|0|||
48474385|NCT01058707|155928811|FG000|Overall Study|Disease Progression|15|||
48474386|NCT01058707|155928812|FG001|Overall Study|Disease Progression|20|||
48474387|NCT01058707|155928813|FG002|Overall Study|Disease Progression|20|||
48474388|NCT01058707|155928814|FG003|Overall Study|Disease Progression|15|||
48474389|NCT01058707|155928815|FG004|Overall Study|Disease Progression|23|||
48474390|NCT01058707|155928816|FG005|Overall Study|Disease Progression|10|||
48474391|NCT01058707|155928817|FG006|Overall Study|Disease Progression|12|||
48474392|NCT01058707|155928811|FG000|Overall Study|Adverse Event|11|||
48474393|NCT01058707|155928812|FG001|Overall Study|Adverse Event|4|||
48474394|NCT01058707|155928813|FG002|Overall Study|Adverse Event|7|||
48474395|NCT01058707|155928814|FG003|Overall Study|Adverse Event|6|||
48474396|NCT01058707|155928815|FG004|Overall Study|Adverse Event|7|||
48474397|NCT01058707|155928816|FG005|Overall Study|Adverse Event|3|||
48474398|NCT01058707|155928817|FG006|Overall Study|Adverse Event|1|||
48474399|NCT01058707|155928811|FG000|Overall Study|Subject Decision|5|||
48474400|NCT01058707|155928812|FG001|Overall Study|Subject Decision|3|||
48474401|NCT01058707|155928813|FG002|Overall Study|Subject Decision|3|||
48474402|NCT01058707|155928814|FG003|Overall Study|Subject Decision|1|||
48474403|NCT01058707|155928815|FG004|Overall Study|Subject Decision|2|||
48474404|NCT01058707|155928816|FG005|Overall Study|Subject Decision|3|||
48474405|NCT01058707|155928817|FG006|Overall Study|Subject Decision|6|||
48474406|NCT01058707|155928811|FG000|Overall Study|Lost to Follow-up|0|||
48474407|NCT01058707|155928812|FG001|Overall Study|Lost to Follow-up|0|||
48474408|NCT01058707|155928813|FG002|Overall Study|Lost to Follow-up|1|||
48474409|NCT01058707|155928814|FG003|Overall Study|Lost to Follow-up|0|||
48474410|NCT01058707|155928815|FG004|Overall Study|Lost to Follow-up|0|||
48474411|NCT01058707|155928816|FG005|Overall Study|Lost to Follow-up|0|||
48474412|NCT01058707|155928817|FG006|Overall Study|Lost to Follow-up|0|||
48474413|NCT01058707|155928811|FG000|Overall Study|Reason Not Specified|0|||
48474414|NCT01058707|155928812|FG001|Overall Study|Reason Not Specified|3|||
48474415|NCT01058707|155928813|FG002|Overall Study|Reason Not Specified|2|||
48474416|NCT01058707|155928814|FG003|Overall Study|Reason Not Specified|0|||
48474417|NCT01058707|155928815|FG004|Overall Study|Reason Not Specified|7|||
48474418|NCT01058707|155928816|FG005|Overall Study|Reason Not Specified|1|||
48474419|NCT01058707|155928817|FG006|Overall Study|Reason Not Specified|7|||
48474420|NCT00777920|155928822|FG000|Overall Study|Adverse Event|39|||
48474421|NCT00777920|155928822|FG000|Overall Study|Withdrawal of Consent|4|||
48474422|NCT00777920|155928822|FG000|Overall Study|Lost to Follow-up|1|||
48474423|NCT00777920|155928822|FG000|Overall Study|Investigator's discretion|1|||
48474424|NCT00777920|155928822|FG000|Overall Study|Clinical status did not improve|1|||
48474425|NCT00777920|155928822|FG000|Overall Study|Other, not specified|4|||
48474426|NCT00909857|155928823|FG000|Overall Study|Withdrawal by Subject|6|||
48474427|NCT00909857|155928824|FG001|Overall Study|Withdrawal by Subject|10|||
48474428|NCT00909857|155928823|FG000|Overall Study|Adverse Event|5|||
48474429|NCT00909857|155928824|FG001|Overall Study|Adverse Event|5|||
48474430|NCT00909857|155928823|FG000|Overall Study|Lost to Follow-up|2|||
48474431|NCT00909857|155928824|FG001|Overall Study|Lost to Follow-up|5|||
48474432|NCT00909857|155928823|FG000|Overall Study|Protocol Violation|2|||
48474433|NCT00909857|155928824|FG001|Overall Study|Protocol Violation|1|||
48474434|NCT00909857|155928823|FG000|Overall Study|Pregnancy|1|||
48474435|NCT00909857|155928824|FG001|Overall Study|Pregnancy|0|||
48474436|NCT00909857|155928823|FG000|Overall Study|Other|1|||
48474437|NCT00909857|155928824|FG001|Overall Study|Other|0|||
48474438|NCT00909857|155928823|FG000|Overall Study|Did not receive study medication|19|||
48474439|NCT00909857|155928824|FG001|Overall Study|Did not receive study medication|24|||
48474440|NCT00604175|155928825|FG000|Entry Through Week 28|Death|2|||
48474441|NCT00604175|155928826|FG001|Entry Through Week 28|Death|0|||
48474442|NCT00604175|155928827|FG002|Entry Through Week 28|Death|0|||
48474443|NCT00604175|155928825|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
48474444|NCT00604175|155928826|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
48474445|NCT00604175|155928827|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
48474446|NCT00604175|155928825|FG000|Entry Through Week 28|Lost to Follow-up|4|||
48474447|NCT00604175|155928826|FG001|Entry Through Week 28|Lost to Follow-up|3|||
48474448|NCT00604175|155928827|FG002|Entry Through Week 28|Lost to Follow-up|0|||
48474449|NCT00604175|155928825|FG000|Entry Through Week 28|Ineligible|1|||
48474450|NCT00604175|155928826|FG001|Entry Through Week 28|Ineligible|0|||
48474451|NCT00604175|155928827|FG002|Entry Through Week 28|Ineligible|0|||
48474452|NCT00604175|155928825|FG000|Entry Through Week 28|Did not start intervention|2|||
48474453|NCT00604175|155928826|FG001|Entry Through Week 28|Did not start intervention|0|||
48474454|NCT00604175|155928827|FG002|Entry Through Week 28|Did not start intervention|1|||
48474455|NCT00604175|155928825|FG000|Week 29 Through Week 72|Death|0|||
48474456|NCT00604175|155928826|FG001|Week 29 Through Week 72|Death|0|||
48474457|NCT00604175|155928827|FG002|Week 29 Through Week 72|Death|1|||
48474458|NCT00604175|155928825|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
48474459|NCT00604175|155928826|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
48474460|NCT00604175|155928827|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
48474461|NCT00604175|155928825|FG000|Week 29 Through Week 72|Site closure|0|||
48474462|NCT00604175|155928826|FG001|Week 29 Through Week 72|Site closure|1|||
48474463|NCT00604175|155928827|FG002|Week 29 Through Week 72|Site closure|0|||
48474464|NCT00604175|155928825|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
48474465|NCT00604175|155928826|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
48474466|NCT00604175|155928827|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
48474467|NCT01682681|155928828|FG000|Overall Study|Lack of Efficacy|62|||
48474468|NCT01682681|155928828|FG000|Overall Study|Withdrawal by Subject|1|||
48474469|NCT01682681|155928828|FG000|Overall Study|Moved to other hospital|10|||
48474470|NCT01682681|155928828|FG000|Overall Study|Lost to Follow-up|174|||
48474471|NCT01682681|155928828|FG000|Overall Study|Adverse Event|46|||
48474472|NCT01682681|155928828|FG000|Overall Study|tapering of topiramate|5|||
48474473|NCT01682681|155928828|FG000|Overall Study|Other|21|||
48474474|NCT01682681|155928828|FG000|Overall Study|Low compliance|13|||
48474475|NCT02044094|155928832|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
48474476|NCT02044094|155928832|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
48474477|NCT02044094|155928832|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
48474478|NCT02044094|155928832|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
48474479|NCT02044094|155928832|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
48474480|NCT02044094|155928832|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
48474481|NCT02044094|155928832|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
48474482|NCT02044094|155928832|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
48474483|NCT00883129|155928833|FG000|Overall Study|Adverse Event|7|||
48474484|NCT00883129|155928834|FG001|Overall Study|Adverse Event|15|||
48474485|NCT00883129|155928833|FG000|Overall Study|Withdrawal by Subject|8|||
48474486|NCT00883129|155928834|FG001|Overall Study|Withdrawal by Subject|9|||
48474487|NCT00883129|155928833|FG000|Overall Study|Non-compliance|3|||
48474488|NCT00883129|155928834|FG001|Overall Study|Non-compliance|6|||
48474489|NCT00883129|155928833|FG000|Overall Study|Lost to Follow-up|1|||
48474490|NCT00883129|155928834|FG001|Overall Study|Lost to Follow-up|2|||
48474491|NCT00883129|155928833|FG000|Overall Study|Death|1|||
48474492|NCT00883129|155928834|FG001|Overall Study|Death|2|||
48474493|NCT00883129|155928833|FG000|Overall Study|Defined Treatment Failure|0|||
48474494|NCT00883129|155928834|FG001|Overall Study|Defined Treatment Failure|2|||
48474495|NCT01608321|155928835|FG000|Overall Study|Withdrawal by Subject|1|||
48474496|NCT01608321|155928836|FG001|Overall Study|Withdrawal by Subject|0|||
48474497|NCT01269346|155930120|FG000|Treatment Phase|Disease progression|3|||
48474498|NCT01269346|155930120|FG000|Treatment Phase|Adverse Event|3|||
48474499|NCT01269346|155930120|FG000|Treatment Phase|Withdrawal by Subject|1|||
48474500|NCT01269346|155930120|FG000|Treatment Phase|Other|2|||
48474501|NCT01269346|155930120|FG000|Extension Phase|Adverse Event|6|||
48474502|NCT01269346|155930120|FG000|Extension Phase|Withdrawal by Subject|4|||
48474503|NCT01269346|155930120|FG000|Extension Phase|Disease progression|22|||
48474504|NCT01269346|155930120|FG000|Extension Phase|Physician decision or participant choice|9|||
48474505|NCT01269346|155930120|FG000|Extension Phase|Clinical progression|1|||
48474506|NCT01269346|155930120|FG000|Extension Phase|Started a prohibited con med|1|||
48474507|NCT00247416|155930123|FG000|Overall Study|3 patients were found to be ineligible|1|||
48474508|NCT00247416|155930124|FG001|Overall Study|3 patients were found to be ineligible|2|||
48474509|NCT02815540|155930125|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
48474510|NCT02222246|155930126|FG000|Overall Study|No Emergency Department Visits|27|||
48474511|NCT02222246|155930127|FG001|Overall Study|No Emergency Department Visits|26|||
48474512|NCT02222246|155930126|FG000|Overall Study|Physician Decision|0|||
48474513|NCT02222246|155930127|FG001|Overall Study|Physician Decision|1|||
48474514|NCT01646268|155930128|FG000|Overall Study|Adverse Event|6|||
48474515|NCT01646268|155930129|FG001|Overall Study|Adverse Event|7|||
48474516|NCT01646268|155930128|FG000|Overall Study|Lack of Efficacy|1|||
48474517|NCT01646268|155930129|FG001|Overall Study|Lack of Efficacy|3|||
48474518|NCT01646268|155930128|FG000|Overall Study|Protocol Violation|0|||
48474519|NCT01646268|155930129|FG001|Overall Study|Protocol Violation|1|||
48474520|NCT01646268|155930128|FG000|Overall Study|Withdrawal by Subject|2|||
48474521|NCT01646268|155930129|FG001|Overall Study|Withdrawal by Subject|5|||
48474522|NCT01646268|155930128|FG000|Overall Study|Other|2|||
48474523|NCT01646268|155930129|FG001|Overall Study|Other|0|||
48474524|NCT02064231|155930130|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
48474525|NCT02064231|155930131|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
48474526|NCT02064231|155930132|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
48474527|NCT02064231|155930133|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
48474528|NCT02064231|155930130|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
48474529|NCT02064231|155930131|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
48474530|NCT02064231|155930132|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
48474531|NCT02064231|155930133|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
48474532|NCT02064231|155930130|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
48474533|NCT02064231|155930131|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
48474534|NCT02064231|155930132|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
48474535|NCT02064231|155930133|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
48474536|NCT02064231|155930130|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
48474537|NCT02064231|155930131|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
48474538|NCT02064231|155930132|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
48474539|NCT02064231|155930133|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
48474540|NCT00278473|155930134|FG000|Overall Study|drop out|4|||
48474541|NCT00278473|155930135|FG001|Overall Study|drop out|3|||
48474542|NCT03971422|155930136|FG000|Overall Study|Lost to Follow-up|0|||
48474543|NCT03971422|155930137|FG001|Overall Study|Lost to Follow-up|1|||
48474544|NCT03971422|155930138|FG002|Overall Study|Lost to Follow-up|0|||
48474545|NCT03971422|155930136|FG000|Overall Study|Lack of Efficacy|5|||
48474546|NCT03971422|155930137|FG001|Overall Study|Lack of Efficacy|1|||
48474547|NCT03971422|155930138|FG002|Overall Study|Lack of Efficacy|1|||
48474548|NCT03971422|155930136|FG000|Overall Study|Adverse event, not fatal|2|||
48474549|NCT03971422|155930137|FG001|Overall Study|Adverse event, not fatal|2|||
48474550|NCT03971422|155930138|FG002|Overall Study|Adverse event, not fatal|5|||
48474551|NCT03971422|155930136|FG000|Overall Study|Worsening of MG Symptoms|1|||
48474552|NCT03971422|155930137|FG001|Overall Study|Worsening of MG Symptoms|4|||
48474553|NCT03971422|155930138|FG002|Overall Study|Worsening of MG Symptoms|2|||
48474554|NCT03971422|155930136|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
48474555|NCT03971422|155930137|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
48474556|NCT03971422|155930138|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
48474557|NCT03971422|155930136|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
48474558|NCT03971422|155930137|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
48474559|NCT03971422|155930138|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
48474560|NCT03971422|155930136|FG000|Overall Study|Due to COVID-19 pandemic|0|||
48474561|NCT03971422|155930137|FG001|Overall Study|Due to COVID-19 pandemic|1|||
48474562|NCT03971422|155930138|FG002|Overall Study|Due to COVID-19 pandemic|1|||
48474563|NCT04812548|155930139|FG000|Overall Study|Adverse Event|2|||
48474564|NCT04812548|155930140|FG001|Overall Study|Adverse Event|7|||
48474565|NCT04812548|155930139|FG000|Overall Study|HSCT Planned|2|||
48474566|NCT04812548|155930140|FG001|Overall Study|HSCT Planned|3|||
48474567|NCT04812548|155930139|FG000|Overall Study|Progressive Disease|0|||
48474568|NCT04812548|155930140|FG001|Overall Study|Progressive Disease|2|||
48474569|NCT04812548|155930139|FG000|Overall Study|Death|0|||
48474570|NCT04812548|155930140|FG001|Overall Study|Death|1|||
48474571|NCT04812548|155930139|FG000|Overall Study|Post Study Access to Treatment|0|||
48474572|NCT04812548|155930140|FG001|Overall Study|Post Study Access to Treatment|1|||
48474573|NCT04812548|155930139|FG000|Overall Study|Withdrawal by Subject|0|||
48474574|NCT04812548|155930140|FG001|Overall Study|Withdrawal by Subject|1|||
48474575|NCT04812548|155930139|FG000|Overall Study|Physician Decision|1|||
48474576|NCT04812548|155930140|FG001|Overall Study|Physician Decision|0|||
48474577|NCT05299359|155930141|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
48474578|NCT05299359|155930142|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
48474579|NCT05299359|155930141|FG000|Main Part: Day 1 up to Day 366|Other|2|||
48474580|NCT05299359|155930142|FG001|Main Part: Day 1 up to Day 366|Other|0|||
48474581|NCT05299359|155930141|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
48474582|NCT05299359|155930142|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
48474583|NCT05299359|155930141|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
48474584|NCT05299359|155930142|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
48474585|NCT05299359|155930141|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
48474586|NCT05299359|155930142|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
48474587|NCT05299359|155930141|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
48474588|NCT05299359|155930142|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
48474589|NCT05299359|155930141|FG000|Extension Part: Day 1 to Day 366|Other|0|||
48474590|NCT05299359|155930142|FG001|Extension Part: Day 1 to Day 366|Other|1|||
48474591|NCT04780776|155930143|FG000|Titration Week 1-5|Lost to Follow-up|2|||
48474592|NCT04780776|155930144|FG001|Titration Week 1-5|Lost to Follow-up|8|||
48474593|NCT04780776|155930143|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
48474594|NCT04780776|155930144|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
48474595|NCT04780776|155930143|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
48474596|NCT04780776|155930144|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
48474597|NCT04145531|155930147|FG000|Part A|Adverse Event|2|||
48474598|NCT04145531|155930148|FG001|Part A|Adverse Event|12|||
48474599|NCT04145531|155930149|FG002|Part A|Adverse Event|6|||
48474600|NCT04145531|155930150|FG003|Part A|Adverse Event|0|||
48474601|NCT04145531|155930147|FG000|Part A|Death|1|||
48474602|NCT04145531|155930148|FG001|Part A|Death|2|||
48474603|NCT04145531|155930149|FG002|Part A|Death|0|||
48474604|NCT04145531|155930150|FG003|Part A|Death|0|||
48474605|NCT04145531|155930147|FG000|Part A|Physician Decision|2|||
48474606|NCT04145531|155930148|FG001|Part A|Physician Decision|5|||
48474607|NCT04145531|155930149|FG002|Part A|Physician Decision|2|||
48474608|NCT04145531|155930150|FG003|Part A|Physician Decision|0|||
48474609|NCT04145531|155930147|FG000|Part A|Progressive disease|0|||
48474610|NCT04145531|155930148|FG001|Part A|Progressive disease|2|||
48474611|NCT04145531|155930149|FG002|Part A|Progressive disease|1|||
48474612|NCT04145531|155930150|FG003|Part A|Progressive disease|0|||
48474613|NCT04145531|155930147|FG000|Part A|Protocol deviation|0|||
48474614|NCT04145531|155930148|FG001|Part A|Protocol deviation|0|||
48474615|NCT04145531|155930149|FG002|Part A|Protocol deviation|1|||
48474616|NCT04145531|155930150|FG003|Part A|Protocol deviation|0|||
48474617|NCT04145531|155930147|FG000|Part A|Withdrawal by parent or guardian|1|||
48474618|NCT04145531|155930148|FG001|Part A|Withdrawal by parent or guardian|0|||
48474619|NCT04145531|155930149|FG002|Part A|Withdrawal by parent or guardian|0|||
48474620|NCT04145531|155930150|FG003|Part A|Withdrawal by parent or guardian|0|||
48474621|NCT04145531|155930147|FG000|Part A|Withdrawal by participant|0|||
48474622|NCT04145531|155930148|FG001|Part A|Withdrawal by participant|0|||
48474623|NCT04145531|155930149|FG002|Part A|Withdrawal by participant|1|||
48474624|NCT04145531|155930150|FG003|Part A|Withdrawal by participant|0|||
48474625|NCT04145531|155930147|FG000|Part A|Other|0|||
48474626|NCT04145531|155930148|FG001|Part A|Other|0|||
48474627|NCT04145531|155930149|FG002|Part A|Other|1|||
48474628|NCT04145531|155930150|FG003|Part A|Other|0|||
48474629|NCT04145531|155930147|FG000|Part B|Adverse Event|0|||
48474630|NCT04145531|155930148|FG001|Part B|Adverse Event|0|||
48474631|NCT04145531|155930149|FG002|Part B|Adverse Event|0|||
48474632|NCT04145531|155930150|FG003|Part B|Adverse Event|21|||
48474633|NCT04145531|155930147|FG000|Part B|Physician Decision|0|||
48474634|NCT04145531|155930148|FG001|Part B|Physician Decision|0|||
48474635|NCT04145531|155930149|FG002|Part B|Physician Decision|0|||
48474636|NCT04145531|155930150|FG003|Part B|Physician Decision|7|||
48474637|NCT04145531|155930147|FG000|Part B|Progressive disease|0|||
48474638|NCT04145531|155930148|FG001|Part B|Progressive disease|0|||
48474639|NCT04145531|155930149|FG002|Part B|Progressive disease|0|||
48474640|NCT04145531|155930150|FG003|Part B|Progressive disease|1|||
48474641|NCT04145531|155930147|FG000|Part B|Recurrent disease|0|||
48474642|NCT04145531|155930148|FG001|Part B|Recurrent disease|0|||
48474643|NCT04145531|155930149|FG002|Part B|Recurrent disease|0|||
48474644|NCT04145531|155930150|FG003|Part B|Recurrent disease|1|||
48474645|NCT04145531|155930147|FG000|Part B|Withdrawal by parent or guardian|0|||
48474646|NCT04145531|155930148|FG001|Part B|Withdrawal by parent or guardian|0|||
48474647|NCT04145531|155930149|FG002|Part B|Withdrawal by parent or guardian|0|||
48474648|NCT04145531|155930150|FG003|Part B|Withdrawal by parent or guardian|3|||
48474649|NCT04145531|155930147|FG000|Part B|Withdrawal by participant|0|||
48474650|NCT04145531|155930148|FG001|Part B|Withdrawal by participant|0|||
48474651|NCT04145531|155930149|FG002|Part B|Withdrawal by participant|0|||
48474652|NCT04145531|155930150|FG003|Part B|Withdrawal by participant|1|||
48474653|NCT04145531|155930147|FG000|Part B|Other|0|||
48474654|NCT04145531|155930148|FG001|Part B|Other|0|||
48474655|NCT04145531|155930149|FG002|Part B|Other|0|||
48474656|NCT04145531|155930150|FG003|Part B|Other|1|||
48474657|NCT03446157|155930151|FG000|Overall Study|Death|11|||
48474658|NCT03446157|155930152|FG001|Overall Study|Death|9|||
48474659|NCT03446157|155930151|FG000|Overall Study|Lost to Follow-up|0|||
48474660|NCT03446157|155930152|FG001|Overall Study|Lost to Follow-up|1|||
48474661|NCT03446157|155930151|FG000|Overall Study|Withdrawal by Subject|2|||
48474662|NCT03446157|155930152|FG001|Overall Study|Withdrawal by Subject|1|||
48474663|NCT01012609|155930153|FG000|Overall Study|Withdrawal by Subject|1|||
48474664|NCT01012609|155930154|FG001|Overall Study|Withdrawal by Subject|1|||
48474665|NCT03602976|155930161|FG000|Overall Study|Withdrawal by Subject|1|||
48474666|NCT00620776|155930162|FG000|Overall Study|Did not receive treatment|3|||
48474667|NCT00620776|155930163|FG001|Overall Study|Did not receive treatment|5|||
48474668|NCT00620776|155930162|FG000|Overall Study|Adverse Event|2|||
48474669|NCT00620776|155930163|FG001|Overall Study|Adverse Event|3|||
48474670|NCT00620776|155930162|FG000|Overall Study|Lack of Efficacy|2|||
48474671|NCT00620776|155930163|FG001|Overall Study|Lack of Efficacy|1|||
48474672|NCT00620776|155930162|FG000|Overall Study|Lost to Follow-up|2|||
48474673|NCT00620776|155930163|FG001|Overall Study|Lost to Follow-up|5|||
48474674|NCT00620776|155930162|FG000|Overall Study|Withdrawal by Subject|3|||
48475042|NCT03433482|155931868|FG003|Overall Study|Lost to Follow-up|1|||
48474675|NCT00620776|155930163|FG001|Overall Study|Withdrawal by Subject|2|||
48474676|NCT04366258|155930164|FG000|Baseline Assessments|Screen Failure|21|||
48474677|NCT04366258|155930164|FG000|Baseline Assessments|Early Termination|3|||
48474678|NCT00183170|155930170|FG000|First Intervention|Did not complete study|1|||
48474679|NCT00183170|155930171|FG001|First Intervention|Did not complete study|0|||
48474680|NCT00183170|155930170|FG000|First Intervention|Did not meet targeted BrAC|1|||
48474681|NCT00183170|155930171|FG001|First Intervention|Did not meet targeted BrAC|0|||
48474682|NCT00183170|155930170|FG000|Washout 1 Week|Did not complete study|6|||
48474683|NCT00183170|155930171|FG001|Washout 1 Week|Did not complete study|8|||
48474684|NCT00183170|155930170|FG000|Second Intervention|Did not complete study|1|||
48474685|NCT00183170|155930171|FG001|Second Intervention|Did not complete study|0|||
48474686|NCT00183170|155930170|FG000|Second Intervention|Did not meet targeted BrAC|0|||
48474687|NCT00183170|155930171|FG001|Second Intervention|Did not meet targeted BrAC|2|||
48474688|NCT00924820|155930175|FG000|Overall Study|Death|2|||
48474689|NCT00924820|155930175|FG000|Overall Study|Ineligible, Screen Failure|5|||
48474690|NCT05102162|155930176|FG000|Overall Study|Withdrawal by Subject|3|||
48474691|NCT05102162|155930177|FG001|Overall Study|Withdrawal by Subject|0|||
48474692|NCT05102162|155930176|FG000|Overall Study|Baseline cultures negative|4|||
48474693|NCT05102162|155930177|FG001|Overall Study|Baseline cultures negative|2|||
48474694|NCT05102162|155930176|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
48474695|NCT05102162|155930177|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
48474696|NCT05102162|155930176|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
48474697|NCT05102162|155930177|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
48474698|NCT04983589|155930178|FG000|Overall Study|Withdrawal by Subject|0|||
48474699|NCT04983589|155930179|FG001|Overall Study|Withdrawal by Subject|3|||
48474700|NCT04983589|155930178|FG000|Overall Study|COVID-19 Infection|1|||
48474701|NCT04983589|155930179|FG001|Overall Study|COVID-19 Infection|0|||
48474702|NCT04983589|155930178|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
48474703|NCT04983589|155930179|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
48474704|NCT00761969|155930180|FG000|Overall Study|Death|112|||
48474705|NCT00761969|155930181|FG001|Overall Study|Death|47|||
48474706|NCT00761969|155930180|FG000|Overall Study|Lost to Follow-up|88|||
48474707|NCT00761969|155930181|FG001|Overall Study|Lost to Follow-up|93|||
48474708|NCT02797951|155930184|FG000|Overall Study|Adverse Event|4|||
48474709|NCT02797951|155930184|FG000|Overall Study|Death|1|||
48474710|NCT02797951|155930184|FG000|Overall Study|Lack of Efficacy|19|||
48474711|NCT02797951|155930184|FG000|Overall Study|Lost to Follow-up|4|||
48474712|NCT02797951|155930184|FG000|Overall Study|Physician Decision|6|||
48474713|NCT02797951|155930184|FG000|Overall Study|Withdrawal by Subject|15|||
48474714|NCT02575807|155930185|FG000|Overall Study|Death|8|||
48474715|NCT02575807|155930186|FG001|Overall Study|Death|3|||
48474716|NCT02575807|155930187|FG002|Overall Study|Death|7|||
48474717|NCT02575807|155930188|FG003|Overall Study|Death|0|||
48474718|NCT02575807|155930189|FG004|Overall Study|Death|1|||
48474719|NCT02575807|155930185|FG000|Overall Study|Study terminated by Sponsor|0|||
48474720|NCT02575807|155930186|FG001|Overall Study|Study terminated by Sponsor|1|||
48474721|NCT02575807|155930187|FG002|Overall Study|Study terminated by Sponsor|7|||
48474722|NCT02575807|155930188|FG003|Overall Study|Study terminated by Sponsor|0|||
48474723|NCT02575807|155930189|FG004|Overall Study|Study terminated by Sponsor|1|||
48474724|NCT02575807|155930185|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
48474725|NCT02575807|155930186|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
48474726|NCT02575807|155930187|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
48474727|NCT02575807|155930188|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
48474728|NCT02575807|155930189|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
48474729|NCT02575807|155930185|FG000|Overall Study|Terminated due to physician decision|0|||
48474730|NCT02575807|155930186|FG001|Overall Study|Terminated due to physician decision|0|||
48474731|NCT02575807|155930187|FG002|Overall Study|Terminated due to physician decision|1|||
48474732|NCT02575807|155930188|FG003|Overall Study|Terminated due to physician decision|0|||
48474733|NCT02575807|155930189|FG004|Overall Study|Terminated due to physician decision|0|||
48474734|NCT02575807|155930185|FG000|Overall Study|Subject ineligible - medical implant|0|||
48474735|NCT02575807|155930186|FG001|Overall Study|Subject ineligible - medical implant|0|||
48474736|NCT02575807|155930187|FG002|Overall Study|Subject ineligible - medical implant|0|||
48474737|NCT02575807|155930188|FG003|Overall Study|Subject ineligible - medical implant|1|||
48474738|NCT02575807|155930189|FG004|Overall Study|Subject ineligible - medical implant|0|||
48474739|NCT02575807|155930185|FG000|Overall Study|Withdrawal by Subject|0|||
48474740|NCT02575807|155930186|FG001|Overall Study|Withdrawal by Subject|0|||
48474741|NCT02575807|155930187|FG002|Overall Study|Withdrawal by Subject|1|||
48474742|NCT02575807|155930188|FG003|Overall Study|Withdrawal by Subject|1|||
48474743|NCT02575807|155930189|FG004|Overall Study|Withdrawal by Subject|2|||
48474744|NCT03843775|155930190|FG000|Overall Study|Adverse Event|1|||
48474745|NCT03843775|155930191|FG001|Overall Study|Adverse Event|1|||
48474746|NCT03843775|155930190|FG000|Overall Study|Lack of Efficacy|2|||
48474747|NCT03843775|155930191|FG001|Overall Study|Lack of Efficacy|6|||
48474748|NCT03843775|155930190|FG000|Overall Study|Withdrawal by Subject|0|||
48474749|NCT03843775|155930191|FG001|Overall Study|Withdrawal by Subject|1|||
48474750|NCT03319368|155930192|FG000|Overall Study|Discharge swabs not collected from resident|57|||
48474751|NCT03319368|155930193|FG001|Overall Study|Discharge swabs not collected from resident|46|||
48474752|NCT03000075|155930194|FG000|Part A|Adverse Event|4|||
48474753|NCT03000075|155930195|FG001|Part A|Adverse Event|0|||
48474754|NCT03000075|155930196|FG002|Part A|Adverse Event|0|||
48474755|NCT03000075|155930197|FG003|Part A|Adverse Event|0|||
48474756|NCT03000075|155930198|FG004|Part A|Adverse Event|0|||
48474757|NCT03000075|155930199|FG005|Part A|Adverse Event|0|||
48474758|NCT03000075|155930200|FG006|Part A|Adverse Event|0|||
48474759|NCT03000075|155930194|FG000|Part B|Not dosed due to AE|0|||
48474760|NCT03000075|155930195|FG001|Part B|Not dosed due to AE|0|||
48474761|NCT03000075|155930196|FG002|Part B|Not dosed due to AE|0|||
48474762|NCT03000075|155930197|FG003|Part B|Not dosed due to AE|0|||
48474763|NCT03000075|155930198|FG004|Part B|Not dosed due to AE|0|||
48474764|NCT03000075|155930199|FG005|Part B|Not dosed due to AE|2|||
48474765|NCT03000075|155930200|FG006|Part B|Not dosed due to AE|1|||
48474766|NCT03000075|155930194|FG000|Part B|Adverse Event|0|||
48474767|NCT03000075|155930195|FG001|Part B|Adverse Event|0|||
48474768|NCT03000075|155930196|FG002|Part B|Adverse Event|0|||
48474769|NCT03000075|155930197|FG003|Part B|Adverse Event|0|||
48474770|NCT03000075|155930198|FG004|Part B|Adverse Event|1|||
48474771|NCT03000075|155930199|FG005|Part B|Adverse Event|0|||
48474772|NCT03000075|155930200|FG006|Part B|Adverse Event|0|||
48474773|NCT02180659|155930201|FG000|Overall Study|Adverse Event|1|||
48474774|NCT02180659|155930202|FG001|Overall Study|Adverse Event|0|||
48474775|NCT02180659|155930201|FG000|Overall Study|Lost to Follow-up|4|||
48474776|NCT02180659|155930202|FG001|Overall Study|Lost to Follow-up|2|||
48474777|NCT02180659|155930201|FG000|Overall Study|Subject incarcerated during conduct|1|||
48474778|NCT02180659|155930202|FG001|Overall Study|Subject incarcerated during conduct|0|||
48474779|NCT02180659|155930201|FG000|Overall Study|Withdrawal by Subject|0|||
48474780|NCT02180659|155930202|FG001|Overall Study|Withdrawal by Subject|2|||
48474781|NCT02180659|155930201|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
48474782|NCT02180659|155930202|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
48474783|NCT01525407|155930205|FG000|Overall Study|Change in recipient treatment plan|2|||
48474784|NCT01525407|155930206|FG001|Overall Study|Change in recipient treatment plan|2|||
48474785|NCT01525407|155930205|FG000|Overall Study|Withdrawal by Subject|0|||
48474786|NCT01525407|155930206|FG001|Overall Study|Withdrawal by Subject|1|||
48474787|NCT01525407|155930205|FG000|Overall Study|Transplant was delayed|0|||
48474788|NCT01525407|155930206|FG001|Overall Study|Transplant was delayed|1|||
48474789|NCT01525407|155930205|FG000|Overall Study|Delay in Transplant|1|||
48474790|NCT01525407|155930206|FG001|Overall Study|Delay in Transplant|0|||
48474791|NCT04150107|155930207|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
48474792|NCT04150107|155930208|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
48474793|NCT04150107|155930207|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
48474794|NCT04150107|155930208|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
48474795|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
48474796|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
48474797|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Death|5|||
48474798|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Death|2|||
48474799|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
48474800|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
48474801|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
48474802|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
48474803|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
48474804|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
48474805|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Relapse|1|||
48474806|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Relapse|0|||
48474807|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
48474808|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
48474809|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
48474810|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
48474811|NCT00111007|155930209|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
48474812|NCT00111007|155930210|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
48474813|NCT00111007|155930209|FG000|Active Follow-up|Adverse Event|1|||
48474814|NCT00111007|155930210|FG001|Active Follow-up|Adverse Event|0|||
48474815|NCT00111007|155930209|FG000|Active Follow-up|Death|2|||
48474816|NCT00111007|155930210|FG001|Active Follow-up|Death|0|||
48474817|NCT00111007|155930209|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
48474818|NCT00111007|155930210|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
48474819|NCT00111007|155930209|FG000|Long Term Follow-up|Death|34|||
48474820|NCT00111007|155930210|FG001|Long Term Follow-up|Death|39|||
48474821|NCT00111007|155930209|FG000|Long Term Follow-up|Lost to Follow-up|1|||
48474822|NCT00111007|155930210|FG001|Long Term Follow-up|Lost to Follow-up|1|||
48474823|NCT00111007|155930209|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
48474824|NCT00111007|155930210|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
48474825|NCT00111007|155930209|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
48474826|NCT00111007|155930210|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
48474827|NCT00111007|155930209|FG000|Long Term Follow-up|Missing|10|||
48474828|NCT00111007|155930210|FG001|Long Term Follow-up|Missing|3|||
48474829|NCT00440193|155930211|FG000|Treatment Period|Adverse Event|74|||
48474830|NCT00440193|155930212|FG001|Treatment Period|Adverse Event|67|||
48474831|NCT00440193|155930211|FG000|Treatment Period|Death|19|||
48474832|NCT00440193|155930212|FG001|Treatment Period|Death|22|||
48474833|NCT00440193|155930211|FG000|Treatment Period|Lack of Efficacy|0|||
48474834|NCT00440193|155930212|FG001|Treatment Period|Lack of Efficacy|1|||
48474835|NCT00440193|155930211|FG000|Treatment Period|Lost to Follow-up|12|||
48474836|NCT00440193|155930212|FG001|Treatment Period|Lost to Follow-up|18|||
48474837|NCT00440193|155930211|FG000|Treatment Period|Physician Decision|3|||
48474838|NCT00440193|155930212|FG001|Treatment Period|Physician Decision|6|||
48474839|NCT00440193|155930211|FG000|Treatment Period|Protocol Violation|16|||
48474840|NCT00440193|155930212|FG001|Treatment Period|Protocol Violation|19|||
48474841|NCT00440193|155930211|FG000|Treatment Period|Withdrawal by Subject|36|||
48474842|NCT00440193|155930212|FG001|Treatment Period|Withdrawal by Subject|77|||
48474843|NCT00440193|155930211|FG000|Treatment Period|Clinical endpoint reached|28|||
48474844|NCT00440193|155930212|FG001|Treatment Period|Clinical endpoint reached|25|||
48474845|NCT00440193|155930211|FG000|Treatment Period|Study terminated by sponsor|102|||
48474846|NCT00440193|155930212|FG001|Treatment Period|Study terminated by sponsor|94|||
48474847|NCT00440193|155930211|FG000|Treatment Period|Protocol driven decision point|2|||
48474848|NCT00440193|155930212|FG001|Treatment Period|Protocol driven decision point|2|||
48474849|NCT00440193|155930211|FG000|Treatment Period|Switch to commercial drug|0|||
48474850|NCT00440193|155930212|FG001|Treatment Period|Switch to commercial drug|2|||
48474851|NCT00440193|155930211|FG000|Treatment Period|Technical problems|1|||
48474852|NCT00440193|155930212|FG001|Treatment Period|Technical problems|1|||
48474853|NCT00440193|155930211|FG000|Treatment Period|Participant convenience|5|||
48474854|NCT00440193|155930212|FG001|Treatment Period|Participant convenience|2|||
48474855|NCT00440193|155930211|FG000|Treatment Period|Participant did not receive treatment|7|||
48474856|NCT00440193|155930212|FG001|Treatment Period|Participant did not receive treatment|13|||
48474857|NCT00440193|155930211|FG000|Treatment Period|Site closed by investigator|0|||
48474858|NCT00440193|155930212|FG001|Treatment Period|Site closed by investigator|2|||
48474859|NCT00440193|155930211|FG000|Observational Period|Adverse Event|2|||
48474860|NCT00440193|155930212|FG001|Observational Period|Adverse Event|2|||
48474861|NCT00440193|155930211|FG000|Observational Period|Death|15|||
48474862|NCT00440193|155930212|FG001|Observational Period|Death|20|||
48474863|NCT00440193|155930211|FG000|Observational Period|Lost to Follow-up|12|||
48474864|NCT00440193|155930212|FG001|Observational Period|Lost to Follow-up|8|||
48474865|NCT00440193|155930211|FG000|Observational Period|Protocol Violation|1|||
48474866|NCT00440193|155930212|FG001|Observational Period|Protocol Violation|0|||
48474867|NCT00440193|155930211|FG000|Observational Period|Withdrawal by Subject|11|||
48474868|NCT00440193|155930212|FG001|Observational Period|Withdrawal by Subject|8|||
48474869|NCT00440193|155930211|FG000|Observational Period|Physician Decision|1|||
48474870|NCT00440193|155930212|FG001|Observational Period|Physician Decision|0|||
48474871|NCT00440193|155930211|FG000|Observational Period|Clinical endpoint reached|1|||
48474872|NCT00440193|155930212|FG001|Observational Period|Clinical endpoint reached|0|||
48474873|NCT00440193|155930211|FG000|Observational Period|Participant convenience|2|||
48474874|NCT00440193|155930212|FG001|Observational Period|Participant convenience|0|||
48474875|NCT01495793|155930214|FG000|Overall Study|Lost to Follow-up|1|||
48474876|NCT01495793|155930214|FG000|Overall Study|Violation of inclusion criteria|1|||
48474877|NCT03480243|155930215|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
48474878|NCT03480243|155930215|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
48474879|NCT02851069|155930217|FG000|Overall Study|Failure to Return|3|||
48474880|NCT02851069|155930217|FG000|Overall Study|Other|3|||
48474881|NCT05182840|155930218|FG000|Run-in Period|Not treated|0|||
48474882|NCT05182840|155930219|FG001|Run-in Period|Not treated|1|||
48474883|NCT05182840|155930220|FG002|Run-in Period|Not treated|0|||
48474884|NCT05182840|155930221|FG003|Run-in Period|Not treated|0|||
48474885|NCT05182840|155930222|FG004|Run-in Period|Not treated|0|||
48474886|NCT05182840|155930223|FG005|Run-in Period|Not treated|0|||
48474887|NCT05182840|155930224|FG006|Run-in Period|Not treated|0|||
48474888|NCT05182840|155930225|FG007|Run-in Period|Not treated|0|||
48474889|NCT05182840|155930226|FG008|Run-in Period|Not treated|0|||
48474890|NCT05182840|155930227|FG009|Run-in Period|Not treated|0|||
48474891|NCT05182840|155930218|FG000|Run-in Period|Other reason but not sponsor termination|14|||
48474892|NCT05182840|155930219|FG001|Run-in Period|Other reason but not sponsor termination|18|||
48474893|NCT05182840|155930220|FG002|Run-in Period|Other reason but not sponsor termination|0|||
48474894|NCT05182840|155930221|FG003|Run-in Period|Other reason but not sponsor termination|0|||
48474895|NCT05182840|155930222|FG004|Run-in Period|Other reason but not sponsor termination|0|||
48474896|NCT05182840|155930223|FG005|Run-in Period|Other reason but not sponsor termination|0|||
48474897|NCT05182840|155930224|FG006|Run-in Period|Other reason but not sponsor termination|0|||
48474898|NCT05182840|155930225|FG007|Run-in Period|Other reason but not sponsor termination|0|||
48474899|NCT05182840|155930226|FG008|Run-in Period|Other reason but not sponsor termination|0|||
48474900|NCT05182840|155930227|FG009|Run-in Period|Other reason but not sponsor termination|0|||
48474901|NCT05182840|155930218|FG000|Run-in Period|No reason available|2|||
48474902|NCT05182840|155930219|FG001|Run-in Period|No reason available|2|||
48474903|NCT05182840|155930220|FG002|Run-in Period|No reason available|0|||
48474904|NCT05182840|155930221|FG003|Run-in Period|No reason available|0|||
48474905|NCT05182840|155930222|FG004|Run-in Period|No reason available|0|||
48474906|NCT05182840|155930223|FG005|Run-in Period|No reason available|0|||
48474907|NCT05182840|155930224|FG006|Run-in Period|No reason available|0|||
48474908|NCT05182840|155930225|FG007|Run-in Period|No reason available|0|||
48474909|NCT05182840|155930226|FG008|Run-in Period|No reason available|0|||
48474910|NCT05182840|155930227|FG009|Run-in Period|No reason available|0|||
48474911|NCT05182840|155930218|FG000|Run-in Period|Burden of study procedures|2|||
48474912|NCT05182840|155930219|FG001|Run-in Period|Burden of study procedures|2|||
48474913|NCT05182840|155930220|FG002|Run-in Period|Burden of study procedures|0|||
48474914|NCT05182840|155930221|FG003|Run-in Period|Burden of study procedures|0|||
48474915|NCT05182840|155930222|FG004|Run-in Period|Burden of study procedures|0|||
48474916|NCT05182840|155930223|FG005|Run-in Period|Burden of study procedures|0|||
48474917|NCT05182840|155930224|FG006|Run-in Period|Burden of study procedures|0|||
48474918|NCT05182840|155930225|FG007|Run-in Period|Burden of study procedures|0|||
48474919|NCT05182840|155930226|FG008|Run-in Period|Burden of study procedures|0|||
48474920|NCT05182840|155930227|FG009|Run-in Period|Burden of study procedures|0|||
48474921|NCT05182840|155930218|FG000|Run-in Period|Change of residence|1|||
48474922|NCT05182840|155930219|FG001|Run-in Period|Change of residence|0|||
48474923|NCT05182840|155930220|FG002|Run-in Period|Change of residence|0|||
48474924|NCT05182840|155930221|FG003|Run-in Period|Change of residence|0|||
48474925|NCT05182840|155930222|FG004|Run-in Period|Change of residence|0|||
48474926|NCT05182840|155930223|FG005|Run-in Period|Change of residence|0|||
48474927|NCT05182840|155930224|FG006|Run-in Period|Change of residence|0|||
48474928|NCT05182840|155930225|FG007|Run-in Period|Change of residence|0|||
48474929|NCT05182840|155930226|FG008|Run-in Period|Change of residence|0|||
48474930|NCT05182840|155930227|FG009|Run-in Period|Change of residence|0|||
48474931|NCT05182840|155930218|FG000|Run-in Period|Adverse Event|5|||
48474932|NCT05182840|155930219|FG001|Run-in Period|Adverse Event|5|||
48474933|NCT05182840|155930220|FG002|Run-in Period|Adverse Event|0|||
48474934|NCT05182840|155930221|FG003|Run-in Period|Adverse Event|0|||
48474935|NCT05182840|155930222|FG004|Run-in Period|Adverse Event|0|||
48474936|NCT05182840|155930223|FG005|Run-in Period|Adverse Event|0|||
48474937|NCT05182840|155930224|FG006|Run-in Period|Adverse Event|0|||
48474938|NCT05182840|155930225|FG007|Run-in Period|Adverse Event|0|||
48474939|NCT05182840|155930226|FG008|Run-in Period|Adverse Event|0|||
48474940|NCT05182840|155930227|FG009|Run-in Period|Adverse Event|0|||
48474941|NCT05182840|155930218|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
48474942|NCT05182840|155930219|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
48474943|NCT05182840|155930220|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48474944|NCT05182840|155930221|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48474945|NCT05182840|155930222|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48474946|NCT05182840|155930223|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48474947|NCT05182840|155930224|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48474948|NCT05182840|155930225|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48474949|NCT05182840|155930226|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48474950|NCT05182840|155930227|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
48474951|NCT05182840|155930218|FG000|Treatment Period|Reason missing|0|||
48474952|NCT05182840|155930219|FG001|Treatment Period|Reason missing|0|||
48474953|NCT05182840|155930220|FG002|Treatment Period|Reason missing|1|||
48474954|NCT05182840|155930221|FG003|Treatment Period|Reason missing|0|||
48474955|NCT05182840|155930222|FG004|Treatment Period|Reason missing|0|||
48474956|NCT05182840|155930223|FG005|Treatment Period|Reason missing|0|||
48474957|NCT05182840|155930224|FG006|Treatment Period|Reason missing|0|||
48474958|NCT05182840|155930225|FG007|Treatment Period|Reason missing|0|||
48474959|NCT05182840|155930226|FG008|Treatment Period|Reason missing|0|||
48474960|NCT05182840|155930227|FG009|Treatment Period|Reason missing|0|||
48474961|NCT05182840|155930218|FG000|Treatment Period|Other but not sponsor termination|0|||
48474962|NCT05182840|155930219|FG001|Treatment Period|Other but not sponsor termination|0|||
48474963|NCT05182840|155930220|FG002|Treatment Period|Other but not sponsor termination|8|||
48474964|NCT05182840|155930221|FG003|Treatment Period|Other but not sponsor termination|6|||
48474965|NCT05182840|155930222|FG004|Treatment Period|Other but not sponsor termination|6|||
48474966|NCT05182840|155930223|FG005|Treatment Period|Other but not sponsor termination|7|||
48474967|NCT05182840|155930224|FG006|Treatment Period|Other but not sponsor termination|5|||
48474968|NCT05182840|155930225|FG007|Treatment Period|Other but not sponsor termination|8|||
48474969|NCT05182840|155930226|FG008|Treatment Period|Other but not sponsor termination|7|||
48474970|NCT05182840|155930227|FG009|Treatment Period|Other but not sponsor termination|2|||
48474971|NCT05182840|155930218|FG000|Treatment Period|Protocol deviation|0|||
48474972|NCT05182840|155930219|FG001|Treatment Period|Protocol deviation|0|||
48474973|NCT05182840|155930220|FG002|Treatment Period|Protocol deviation|0|||
48474974|NCT05182840|155930221|FG003|Treatment Period|Protocol deviation|0|||
48474975|NCT05182840|155930222|FG004|Treatment Period|Protocol deviation|0|||
48474976|NCT05182840|155930223|FG005|Treatment Period|Protocol deviation|0|||
48474977|NCT05182840|155930224|FG006|Treatment Period|Protocol deviation|0|||
48474978|NCT05182840|155930225|FG007|Treatment Period|Protocol deviation|0|||
48474979|NCT05182840|155930226|FG008|Treatment Period|Protocol deviation|1|||
48474980|NCT05182840|155930227|FG009|Treatment Period|Protocol deviation|0|||
48474981|NCT05182840|155930218|FG000|Treatment Period|No reason available|0|||
48474982|NCT05182840|155930219|FG001|Treatment Period|No reason available|0|||
48474983|NCT05182840|155930220|FG002|Treatment Period|No reason available|0|||
48474984|NCT05182840|155930221|FG003|Treatment Period|No reason available|1|||
48474985|NCT05182840|155930222|FG004|Treatment Period|No reason available|0|||
48474986|NCT05182840|155930223|FG005|Treatment Period|No reason available|2|||
48474987|NCT05182840|155930224|FG006|Treatment Period|No reason available|0|||
48474988|NCT05182840|155930225|FG007|Treatment Period|No reason available|1|||
48474989|NCT05182840|155930226|FG008|Treatment Period|No reason available|0|||
48474990|NCT05182840|155930227|FG009|Treatment Period|No reason available|0|||
48474991|NCT05182840|155930218|FG000|Treatment Period|Burden of study procedures|0|||
48474992|NCT05182840|155930219|FG001|Treatment Period|Burden of study procedures|0|||
48474993|NCT05182840|155930220|FG002|Treatment Period|Burden of study procedures|0|||
48474994|NCT05182840|155930221|FG003|Treatment Period|Burden of study procedures|0|||
48474995|NCT05182840|155930222|FG004|Treatment Period|Burden of study procedures|1|||
48474996|NCT05182840|155930223|FG005|Treatment Period|Burden of study procedures|0|||
48474997|NCT05182840|155930224|FG006|Treatment Period|Burden of study procedures|0|||
48474998|NCT05182840|155930225|FG007|Treatment Period|Burden of study procedures|0|||
48474999|NCT05182840|155930226|FG008|Treatment Period|Burden of study procedures|0|||
48475000|NCT05182840|155930227|FG009|Treatment Period|Burden of study procedures|0|||
48475001|NCT05182840|155930218|FG000|Treatment Period|Change of residence|0|||
48475002|NCT05182840|155930219|FG001|Treatment Period|Change of residence|0|||
48475003|NCT05182840|155930220|FG002|Treatment Period|Change of residence|0|||
48475004|NCT05182840|155930221|FG003|Treatment Period|Change of residence|0|||
48475005|NCT05182840|155930222|FG004|Treatment Period|Change of residence|0|||
48475006|NCT05182840|155930223|FG005|Treatment Period|Change of residence|1|||
48475007|NCT05182840|155930224|FG006|Treatment Period|Change of residence|0|||
48475008|NCT05182840|155930225|FG007|Treatment Period|Change of residence|0|||
48475009|NCT05182840|155930226|FG008|Treatment Period|Change of residence|0|||
48475010|NCT05182840|155930227|FG009|Treatment Period|Change of residence|0|||
48475011|NCT05182840|155930218|FG000|Treatment Period|Adverse Event|0|||
48475012|NCT05182840|155930219|FG001|Treatment Period|Adverse Event|0|||
48475013|NCT05182840|155930220|FG002|Treatment Period|Adverse Event|4|||
48475014|NCT05182840|155930221|FG003|Treatment Period|Adverse Event|16|||
48475015|NCT05182840|155930222|FG004|Treatment Period|Adverse Event|12|||
48475016|NCT05182840|155930223|FG005|Treatment Period|Adverse Event|6|||
48475017|NCT05182840|155930224|FG006|Treatment Period|Adverse Event|4|||
48475018|NCT05182840|155930225|FG007|Treatment Period|Adverse Event|8|||
48475019|NCT05182840|155930226|FG008|Treatment Period|Adverse Event|16|||
48475020|NCT05182840|155930227|FG009|Treatment Period|Adverse Event|5|||
48475021|NCT05182840|155930218|FG000|Treatment Period|Not treated with study drug|0|||
48475022|NCT05182840|155930219|FG001|Treatment Period|Not treated with study drug|0|||
48475023|NCT05182840|155930220|FG002|Treatment Period|Not treated with study drug|0|||
48475024|NCT05182840|155930221|FG003|Treatment Period|Not treated with study drug|1|||
48475025|NCT05182840|155930222|FG004|Treatment Period|Not treated with study drug|0|||
48475026|NCT05182840|155930223|FG005|Treatment Period|Not treated with study drug|0|||
48475027|NCT05182840|155930224|FG006|Treatment Period|Not treated with study drug|1|||
48475028|NCT05182840|155930225|FG007|Treatment Period|Not treated with study drug|1|||
48475029|NCT05182840|155930226|FG008|Treatment Period|Not treated with study drug|0|||
48475030|NCT05182840|155930227|FG009|Treatment Period|Not treated with study drug|0|||
48475031|NCT05153629|155930229|FG000|Overall Study|Withdrawal by Subject|0|||
48475032|NCT05153629|155930230|FG001|Overall Study|Withdrawal by Subject|2|||
48475033|NCT02061293|155930231|FG000|Overall Study|Elevated Blood Pressure|1|||
48475034|NCT02061293|155930232|FG001|Overall Study|Elevated Blood Pressure|1|||
48475035|NCT02392377|155930233|FG000|Overall Study|Withdrawal by Subject|0|||
48475036|NCT02392377|155930234|FG001|Overall Study|Withdrawal by Subject|1|||
48475037|NCT00209560|155930235|FG000|Overall Study|Lack of Efficacy|1|||
48475038|NCT00209560|155930236|FG001|Overall Study|Lack of Efficacy|0|||
48475039|NCT03433482|155931865|FG000|Overall Study|Lost to Follow-up|1|||
48475040|NCT03433482|155931866|FG001|Overall Study|Lost to Follow-up|0|||
48475041|NCT03433482|155931867|FG002|Overall Study|Lost to Follow-up|1|||
48475043|NCT03433482|155931865|FG000|Overall Study|Withdrawal by Subject|0|||
48475044|NCT03433482|155931866|FG001|Overall Study|Withdrawal by Subject|0|||
48475045|NCT03433482|155931867|FG002|Overall Study|Withdrawal by Subject|1|||
48475046|NCT03433482|155931868|FG003|Overall Study|Withdrawal by Subject|0|||
48475047|NCT03433482|155931865|FG000|Overall Study|Unknown reason|0|||
48475048|NCT03433482|155931866|FG001|Overall Study|Unknown reason|0|||
48475049|NCT03433482|155931867|FG002|Overall Study|Unknown reason|2|||
48475050|NCT03433482|155931868|FG003|Overall Study|Unknown reason|0|||
48475051|NCT00437294|155931871|FG000|Overall Study|Adverse Event|5|||
48475052|NCT00437294|155931872|FG001|Overall Study|Adverse Event|4|||
48475053|NCT00437294|155931871|FG000|Overall Study|Death|5|||
48475054|NCT00437294|155931872|FG001|Overall Study|Death|2|||
48475055|NCT00437294|155931871|FG000|Overall Study|Physician Decision|0|||
48475056|NCT00437294|155931872|FG001|Overall Study|Physician Decision|3|||
48475057|NCT00437294|155931871|FG000|Overall Study|Withdrawal by Subject|5|||
48475058|NCT00437294|155931872|FG001|Overall Study|Withdrawal by Subject|0|||
48475059|NCT00437294|155931871|FG000|Overall Study|Progressive Disease|19|||
48475060|NCT00437294|155931872|FG001|Overall Study|Progressive Disease|23|||
48475061|NCT00437294|155931871|FG000|Overall Study|Sponsor Decision|8|||
48475062|NCT00437294|155931872|FG001|Overall Study|Sponsor Decision|9|||
48475063|NCT00437294|155931871|FG000|Overall Study|Protocol Violation|0|||
48475064|NCT00437294|155931872|FG001|Overall Study|Protocol Violation|1|||
48475065|NCT00437294|155931871|FG000|Overall Study|Entry criteria not met|1|||
48475066|NCT00437294|155931872|FG001|Overall Study|Entry criteria not met|1|||
48475067|NCT03323034|155931874|FG000|Overall Study|Lack of Efficacy|5|||
48475068|NCT03323034|155931875|FG001|Overall Study|Lack of Efficacy|5|||
48475069|NCT03323034|155931876|FG002|Overall Study|Lack of Efficacy|6|||
48475070|NCT03323034|155931877|FG003|Overall Study|Lack of Efficacy|5|||
48475071|NCT03323034|155931878|FG004|Overall Study|Lack of Efficacy|5|||
48475072|NCT03323034|155931874|FG000|Overall Study|Physician Decision|0|||
48475073|NCT03323034|155931875|FG001|Overall Study|Physician Decision|0|||
48475074|NCT03323034|155931876|FG002|Overall Study|Physician Decision|0|||
48475075|NCT03323034|155931877|FG003|Overall Study|Physician Decision|0|||
48475076|NCT03323034|155931878|FG004|Overall Study|Physician Decision|1|||
48475077|NCT03323034|155931874|FG000|Overall Study|Withdrawal by Subject|1|||
48475078|NCT03323034|155931875|FG001|Overall Study|Withdrawal by Subject|1|||
48475079|NCT03323034|155931876|FG002|Overall Study|Withdrawal by Subject|0|||
48475080|NCT03323034|155931877|FG003|Overall Study|Withdrawal by Subject|1|||
48475081|NCT03323034|155931878|FG004|Overall Study|Withdrawal by Subject|0|||
48475082|NCT02646566|155931880|FG000|Overall Study|Lost to Follow-up|5|||
48475083|NCT02646566|155931881|FG001|Overall Study|Lost to Follow-up|4|||
48475084|NCT02646566|155931882|FG002|Overall Study|Lost to Follow-up|5|||
48475085|NCT02646566|155931880|FG000|Overall Study|Treatment failure|1|||
48475086|NCT02646566|155931881|FG001|Overall Study|Treatment failure|0|||
48475087|NCT02646566|155931882|FG002|Overall Study|Treatment failure|0|||
48475088|NCT00474994|155931902|FG000|Overall Study|Patient Not treated|1|||
48475089|NCT00474994|155931902|FG000|Overall Study|Patient evaluable for toxicity only|3|||
48475090|NCT00474994|155931902|FG000|Overall Study|Patient found to be ineligible|1|||
48475091|NCT02660489|155931907|FG000|Overall Study|Lost to Follow-up|1|||
48475092|NCT02660489|155931908|FG001|Overall Study|Lost to Follow-up|1|||
48475093|NCT02660489|155931907|FG000|Overall Study|Adverse Event|1|||
48475094|NCT02660489|155931908|FG001|Overall Study|Adverse Event|3|||
48475095|NCT02660489|155931907|FG000|Overall Study|no rhinovirus infection|4|||
48475096|NCT02660489|155931908|FG001|Overall Study|no rhinovirus infection|4|||
48475097|NCT04516291|155931909|FG000|Treatment Period (24 Weeks)|Other|1|||
48475098|NCT04516291|155931910|FG001|Treatment Period (24 Weeks)|Other|0|||
48475099|NCT04516291|155931911|FG002|Treatment Period (24 Weeks)|Other|0|||
48475100|NCT04516291|155931912|FG003|Treatment Period (24 Weeks)|Other|2|||
48475101|NCT04516291|155931913|FG004|Treatment Period (24 Weeks)|Other|2|||
48475102|NCT04516291|155931914|FG005|Treatment Period (24 Weeks)|Other|4|||
48475103|NCT04516291|155931915|FG006|Treatment Period (24 Weeks)|Other|2|||
48475104|NCT04516291|155931916|FG007|Treatment Period (24 Weeks)|Other|0|||
48475105|NCT04516291|155931909|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48475106|NCT04516291|155931910|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
48475107|NCT04516291|155931911|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
48475108|NCT04516291|155931912|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48475109|NCT04516291|155931913|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
48475110|NCT04516291|155931914|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48475111|NCT04516291|155931915|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48475112|NCT04516291|155931916|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48475113|NCT04516291|155931909|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
48475114|NCT04516291|155931910|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
48475115|NCT04516291|155931911|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
48475116|NCT04516291|155931912|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
48475117|NCT04516291|155931913|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
48475118|NCT04516291|155931914|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
48475119|NCT04516291|155931915|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
48475120|NCT04516291|155931916|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
48475121|NCT04516291|155931909|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48475122|NCT04516291|155931910|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48475123|NCT04516291|155931911|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48475124|NCT04516291|155931912|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48475125|NCT04516291|155931913|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48475126|NCT04516291|155931914|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48475127|NCT04516291|155931915|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48475128|NCT04516291|155931916|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48475129|NCT04516291|155931909|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
48475130|NCT04516291|155931910|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
48475131|NCT04516291|155931911|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
48475132|NCT04516291|155931912|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
48475133|NCT04516291|155931913|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
48475134|NCT04516291|155931914|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
48475135|NCT04516291|155931915|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
48475136|NCT04516291|155931916|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
48475137|NCT04516291|155931909|FG000|Follow-up Period (12 Weeks)|Other|0|||
48475138|NCT04516291|155931910|FG001|Follow-up Period (12 Weeks)|Other|1|||
48475139|NCT04516291|155931911|FG002|Follow-up Period (12 Weeks)|Other|0|||
48475140|NCT04516291|155931912|FG003|Follow-up Period (12 Weeks)|Other|2|||
48475141|NCT04516291|155931913|FG004|Follow-up Period (12 Weeks)|Other|0|||
48475142|NCT04516291|155931914|FG005|Follow-up Period (12 Weeks)|Other|0|||
48475143|NCT04516291|155931915|FG006|Follow-up Period (12 Weeks)|Other|0|||
48475144|NCT04516291|155931916|FG007|Follow-up Period (12 Weeks)|Other|0|||
48475145|NCT04516291|155931909|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48475146|NCT04516291|155931910|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48475147|NCT04516291|155931911|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48475148|NCT04516291|155931912|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48475149|NCT04516291|155931913|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
48475150|NCT04516291|155931914|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48475151|NCT04516291|155931915|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48475152|NCT04516291|155931916|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
48475153|NCT04516291|155931909|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
48475154|NCT04516291|155931910|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
48475155|NCT04516291|155931911|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
48475156|NCT04516291|155931912|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
48475157|NCT04516291|155931913|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
48475158|NCT04516291|155931914|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
48475159|NCT04516291|155931915|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
48475160|NCT04516291|155931916|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
48475161|NCT04887922|155931925|FG000|1st Randomization|Decided not to have surgery|0|||
48475162|NCT04887922|155931926|FG001|1st Randomization|Decided not to have surgery|1|||
48475163|NCT04887922|155931927|FG002|1st Randomization|Decided not to have surgery|0|||
48475164|NCT04887922|155931928|FG003|1st Randomization|Decided not to have surgery|0|||
48475165|NCT04887922|155931929|FG004|1st Randomization|Decided not to have surgery|0|||
48475166|NCT03039686|155931930|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
48475167|NCT03039686|155931931|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
48475168|NCT03039686|155931932|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
48475169|NCT03039686|155931930|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
48475170|NCT03039686|155931931|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
48475171|NCT03039686|155931932|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
48475172|NCT03039686|155931930|FG000|Double-blind Period|Withdrawal by Subject|2|||
48475173|NCT03039686|155931931|FG001|Double-blind Period|Withdrawal by Subject|2|||
48475174|NCT03039686|155931932|FG002|Double-blind Period|Withdrawal by Subject|1|||
48475175|NCT03039686|155931930|FG000|Double-blind Period|Death|0|||
48475176|NCT03039686|155931931|FG001|Double-blind Period|Death|0|||
48475177|NCT03039686|155931932|FG002|Double-blind Period|Death|1|||
48475178|NCT03039686|155931930|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
48475179|NCT03039686|155931931|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
48475180|NCT03039686|155931932|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
48475181|NCT03039686|155931930|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
48475182|NCT03039686|155931931|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
48475183|NCT03039686|155931932|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
48475184|NCT03039686|155931930|FG000|Open Label Period|Withdrawal by Subject|0|||
48475185|NCT03039686|155931931|FG001|Open Label Period|Withdrawal by Subject|3|||
48475186|NCT03039686|155931932|FG002|Open Label Period|Withdrawal by Subject|1|||
48475187|NCT02322866|155931933|FG000|Overall Study|Adverse Event|6|||
48475188|NCT02322866|155931934|FG001|Overall Study|Adverse Event|11|||
48475189|NCT02322866|155931933|FG000|Overall Study|Withdrawal of Consent|16|||
48475190|NCT02322866|155931934|FG001|Overall Study|Withdrawal of Consent|25|||
48475191|NCT02322866|155931933|FG000|Overall Study|Lost to Follow-up|36|||
48475192|NCT02322866|155931934|FG001|Overall Study|Lost to Follow-up|39|||
48475193|NCT02322866|155931933|FG000|Overall Study|Protocol Violation|1|||
48475194|NCT02322866|155931934|FG001|Overall Study|Protocol Violation|0|||
48475195|NCT02322866|155931933|FG000|Overall Study|Noncompliance with Treatment|3|||
48475196|NCT02322866|155931934|FG001|Overall Study|Noncompliance with Treatment|4|||
48475197|NCT02322866|155931933|FG000|Overall Study|Lack of Efficacy|3|||
48475198|NCT02322866|155931934|FG001|Overall Study|Lack of Efficacy|1|||
48475199|NCT02322866|155931933|FG000|Overall Study|Other Miscellaneous Reasons|6|||
48475200|NCT02322866|155931934|FG001|Overall Study|Other Miscellaneous Reasons|6|||
48475201|NCT01855607|155931935|FG000|Overall Study|Withdrawal by Subject|1|||
48475202|NCT01855607|155931935|FG000|Overall Study|Study was terminated|11|||
48475203|NCT00718809|155931936|FG000|Overall Study|Disease progression|9|||
48475204|NCT00718809|155931937|FG001|Overall Study|Disease progression|7|||
48475205|NCT00718809|155931936|FG000|Overall Study|Adverse Event|1|||
48475206|NCT00718809|155931937|FG001|Overall Study|Adverse Event|1|||
48475207|NCT00718809|155931936|FG000|Overall Study|Withdrawal by Subject|0|||
48475208|NCT00718809|155931937|FG001|Overall Study|Withdrawal by Subject|1|||
48475209|NCT00718809|155931936|FG000|Overall Study|Lost to Follow-up|1|||
48475210|NCT00718809|155931937|FG001|Overall Study|Lost to Follow-up|0|||
48475211|NCT00718809|155931936|FG000|Overall Study|Noncompliance|1|||
48475212|NCT00718809|155931937|FG001|Overall Study|Noncompliance|0|||
48475213|NCT00463385|155931938|FG000|Overall Study|Other|4|||
48475214|NCT00463385|155931939|FG001|Overall Study|Other|3|||
48475215|NCT00463385|155931940|FG002|Overall Study|Other|6|||
48475216|NCT00463385|155931941|FG003|Overall Study|Other|4|||
48475217|NCT00463385|155931938|FG000|Overall Study|Adverse Event|5|||
48475218|NCT00463385|155931939|FG001|Overall Study|Adverse Event|8|||
48475219|NCT00463385|155931940|FG002|Overall Study|Adverse Event|4|||
48475220|NCT00463385|155931941|FG003|Overall Study|Adverse Event|2|||
48475221|NCT00463385|155931938|FG000|Overall Study|Lack of Efficacy|6|||
48475222|NCT00463385|155931939|FG001|Overall Study|Lack of Efficacy|6|||
48475223|NCT00463385|155931940|FG002|Overall Study|Lack of Efficacy|7|||
48475224|NCT00463385|155931941|FG003|Overall Study|Lack of Efficacy|9|||
48475225|NCT00463385|155931938|FG000|Overall Study|Withdrawal by Subject|3|||
48475226|NCT00463385|155931939|FG001|Overall Study|Withdrawal by Subject|3|||
48475227|NCT00463385|155931940|FG002|Overall Study|Withdrawal by Subject|3|||
48475228|NCT00463385|155931941|FG003|Overall Study|Withdrawal by Subject|4|||
48475229|NCT00463385|155931938|FG000|Overall Study|Lost to Follow-up|0|||
48475230|NCT00463385|155931939|FG001|Overall Study|Lost to Follow-up|0|||
48475231|NCT00463385|155931940|FG002|Overall Study|Lost to Follow-up|0|||
48475232|NCT00463385|155931941|FG003|Overall Study|Lost to Follow-up|1|||
48475233|NCT00463385|155931938|FG000|Overall Study|Death|2|||
48475234|NCT00463385|155931939|FG001|Overall Study|Death|1|||
48475235|NCT00463385|155931940|FG002|Overall Study|Death|2|||
48475236|NCT00463385|155931941|FG003|Overall Study|Death|0|||
48475237|NCT00463385|155931938|FG000|Overall Study|Missing|2|||
48475238|NCT00463385|155931939|FG001|Overall Study|Missing|0|||
48475239|NCT00463385|155931940|FG002|Overall Study|Missing|0|||
48475240|NCT00463385|155931941|FG003|Overall Study|Missing|2|||
48475241|NCT00463385|155931938|FG000|Overall Study|1 participant received commercial drug|0|||
48475242|NCT00463385|155931939|FG001|Overall Study|1 participant received commercial drug|1|||
48475243|NCT00463385|155931940|FG002|Overall Study|1 participant received commercial drug|0|||
48475244|NCT00463385|155931941|FG003|Overall Study|1 participant received commercial drug|0|||
48475245|NCT00449761|155931945|FG000|Overall Study|Disease progression|12|||
48475246|NCT00449761|155931945|FG000|Overall Study|Death|5|||
48475247|NCT00449761|155931945|FG000|Overall Study|New cancer therapy|1|||
48475248|NCT00798161|155931946|FG000|Overall Study|Adverse Event|3|||
48475249|NCT00798161|155931947|FG001|Overall Study|Adverse Event|4|||
48475250|NCT00798161|155931948|FG002|Overall Study|Adverse Event|6|||
48475251|NCT00798161|155931949|FG003|Overall Study|Adverse Event|6|||
48475252|NCT00798161|155931950|FG004|Overall Study|Adverse Event|5|||
48475253|NCT00798161|155931951|FG005|Overall Study|Adverse Event|2|||
48475254|NCT00798161|155931952|FG006|Overall Study|Adverse Event|4|||
48475255|NCT00798161|155931946|FG000|Overall Study|Protocol Violation|2|||
48475256|NCT00798161|155931947|FG001|Overall Study|Protocol Violation|1|||
48475257|NCT00798161|155931948|FG002|Overall Study|Protocol Violation|3|||
48475258|NCT00798161|155931949|FG003|Overall Study|Protocol Violation|3|||
48475259|NCT00798161|155931950|FG004|Overall Study|Protocol Violation|3|||
48475260|NCT00798161|155931951|FG005|Overall Study|Protocol Violation|2|||
48475261|NCT00798161|155931952|FG006|Overall Study|Protocol Violation|0|||
48475262|NCT00798161|155931946|FG000|Overall Study|Lost to Follow-up|1|||
48475263|NCT00798161|155931947|FG001|Overall Study|Lost to Follow-up|3|||
48475264|NCT00798161|155931948|FG002|Overall Study|Lost to Follow-up|4|||
48475265|NCT00798161|155931949|FG003|Overall Study|Lost to Follow-up|3|||
48475266|NCT00798161|155931950|FG004|Overall Study|Lost to Follow-up|4|||
48475267|NCT00798161|155931951|FG005|Overall Study|Lost to Follow-up|0|||
48475268|NCT00798161|155931952|FG006|Overall Study|Lost to Follow-up|0|||
48475269|NCT00798161|155931946|FG000|Overall Study|Withdrawal by Subject|5|||
48475270|NCT00798161|155931947|FG001|Overall Study|Withdrawal by Subject|4|||
48475271|NCT00798161|155931948|FG002|Overall Study|Withdrawal by Subject|5|||
48475272|NCT00798161|155931949|FG003|Overall Study|Withdrawal by Subject|4|||
48475273|NCT00798161|155931950|FG004|Overall Study|Withdrawal by Subject|2|||
48475274|NCT00798161|155931951|FG005|Overall Study|Withdrawal by Subject|3|||
48475275|NCT00798161|155931952|FG006|Overall Study|Withdrawal by Subject|1|||
48475276|NCT00798161|155931946|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
48475277|NCT00798161|155931947|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
48475278|NCT00798161|155931948|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
48475279|NCT00798161|155931949|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
48475280|NCT00798161|155931950|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
48475281|NCT00798161|155931951|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
48475282|NCT00798161|155931952|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
48475283|NCT00726882|155931953|FG000|Overall Study|Withdrawal by Subject|5|||
48475284|NCT00726882|155931953|FG000|Overall Study|Lost to Follow-up|7|||
48475285|NCT00726882|155931953|FG000|Overall Study|Other|10|||
48475286|NCT01339273|155931954|FG000|Overall Study|Lost to Follow-up|8|||
48475287|NCT01339273|155931955|FG001|Overall Study|Lost to Follow-up|8|||
48475288|NCT00347776|155931956|FG000|1.5 Month Follow-up|Death|2|||
48475289|NCT00347776|155931957|FG001|1.5 Month Follow-up|Death|0|||
48475290|NCT00347776|155931958|FG002|1.5 Month Follow-up|Death|0|||
48475291|NCT00347776|155931956|FG000|1.5 Month Follow-up|reached the endpoint|12|||
48475292|NCT00347776|155931957|FG001|1.5 Month Follow-up|reached the endpoint|8|||
48475293|NCT00347776|155931958|FG002|1.5 Month Follow-up|reached the endpoint|12|||
48475294|NCT00347776|155931956|FG000|6 Month Follow-up|Death|2|||
48475295|NCT00347776|155931957|FG001|6 Month Follow-up|Death|1|||
48475296|NCT00347776|155931958|FG002|6 Month Follow-up|Death|3|||
48475297|NCT00347776|155931956|FG000|6 Month Follow-up|reached endpont|20|||
48475298|NCT00347776|155931957|FG001|6 Month Follow-up|reached endpont|12|||
48475299|NCT00347776|155931958|FG002|6 Month Follow-up|reached endpont|15|||
48475300|NCT00347776|155931956|FG000|12 Month Follow-up|Lost to Follow-up|7|||
48475301|NCT00347776|155931957|FG001|12 Month Follow-up|Lost to Follow-up|6|||
48475302|NCT00347776|155931958|FG002|12 Month Follow-up|Lost to Follow-up|6|||
48475303|NCT00347776|155931956|FG000|12 Month Follow-up|Death|3|||
48475304|NCT00347776|155931957|FG001|12 Month Follow-up|Death|4|||
48475305|NCT00347776|155931958|FG002|12 Month Follow-up|Death|4|||
48475306|NCT00347776|155931956|FG000|12 Month Follow-up|Reached endpoint|13|||
48475307|NCT00347776|155931957|FG001|12 Month Follow-up|Reached endpoint|6|||
48475308|NCT00347776|155931958|FG002|12 Month Follow-up|Reached endpoint|9|||
48475309|NCT01100073|155931961|FG000|Overall Study|Lack of Efficacy|4|||
48475310|NCT01100073|155931961|FG000|Overall Study|Insufficient Tolerability|21|||
48475311|NCT01100073|155931961|FG000|Overall Study|Withdrawal by Subject|13|||
48475312|NCT01100073|155931961|FG000|Overall Study|Lost to Follow-up|39|||
48475313|NCT01100073|155931961|FG000|Overall Study|Lack of effect + patient's wish|2|||
48475314|NCT01100073|155931961|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
48475315|NCT01100073|155931961|FG000|Overall Study|Other|8|||
48475316|NCT01100073|155931961|FG000|Overall Study|Missing|5|||
48475317|NCT04633434|155931965|FG000|Overall Study|Lost to Follow-up|32|||
48475318|NCT04633434|155931966|FG001|Overall Study|Lost to Follow-up|32|||
48475319|NCT05993299|155931967|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
48475320|NCT05993299|155931967|FG000|Overall Study|Ongoing|4|||
48475321|NCT01569594|155931968|FG000|Overall Study|Physician Decision|4|||
48475322|NCT01569594|155931968|FG000|Overall Study|Death|13|||
48475323|NCT01569594|155931968|FG000|Overall Study|Lost to Follow-up|22|||
48475324|NCT01569594|155931968|FG000|Overall Study|Adverse Event|2|||
48475325|NCT01569594|155931968|FG000|Overall Study|Withdrawal by Subject|13|||
48475326|NCT01569594|155931968|FG000|Overall Study|Other|4|||
48475327|NCT01569594|155931968|FG000|Overall Study|No ECM used|9|||
48475328|NCT00422058|155931969|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
48475329|NCT00422058|155931970|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
48475330|NCT00422058|155931971|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
48475331|NCT00422058|155931972|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
48475332|NCT00422058|155931973|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
48475333|NCT00422058|155931974|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
48475334|NCT00422058|155931969|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
48475335|NCT00422058|155931970|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
48475336|NCT00422058|155931971|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
48475337|NCT00422058|155931972|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
48475338|NCT00422058|155931973|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
48475339|NCT00422058|155931974|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
48475340|NCT00422058|155931969|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
48475341|NCT00422058|155931970|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
48475342|NCT00422058|155931971|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
48475343|NCT00422058|155931972|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
48475344|NCT00422058|155931973|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
48475345|NCT00422058|155931974|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
48475346|NCT00422058|155931969|FG000|Double-Blind, Week 0-20|Other|11|||
48475347|NCT00422058|155931970|FG001|Double-Blind, Week 0-20|Other|3|||
48475348|NCT00422058|155931971|FG002|Double-Blind, Week 0-20|Other|8|||
48475349|NCT00422058|155931972|FG003|Double-Blind, Week 0-20|Other|8|||
48475350|NCT00422058|155931973|FG004|Double-Blind, Week 0-20|Other|4|||
48475351|NCT00422058|155931974|FG005|Double-Blind, Week 0-20|Other|10|||
48475352|NCT00422058|155931969|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
48475353|NCT00422058|155931970|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
48475354|NCT00422058|155931971|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
48475355|NCT00422058|155931972|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
48475356|NCT00422058|155931973|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
48475357|NCT00422058|155931974|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
48475358|NCT00422058|155931969|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
48475359|NCT00422058|155931970|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
48475360|NCT00422058|155931971|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
48475361|NCT00422058|155931972|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
48475362|NCT00422058|155931973|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
48475363|NCT00422058|155931974|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
48475364|NCT00422058|155931969|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
48475365|NCT00422058|155931970|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
48475366|NCT00422058|155931971|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
48475367|NCT00422058|155931972|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
48475368|NCT00422058|155931973|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
48475369|NCT00422058|155931974|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
48475370|NCT00422058|155931969|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
48475371|NCT00422058|155931970|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
48475372|NCT00422058|155931971|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
48475373|NCT00422058|155931972|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
48475374|NCT00422058|155931973|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
48475375|NCT00422058|155931974|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
48475376|NCT00422058|155931969|FG000|Open-Label Extension, Week 20-104|Other|13|||
48475377|NCT00422058|155931970|FG001|Open-Label Extension, Week 20-104|Other|14|||
48475378|NCT00422058|155931971|FG002|Open-Label Extension, Week 20-104|Other|6|||
48475379|NCT00422058|155931972|FG003|Open-Label Extension, Week 20-104|Other|13|||
48475380|NCT00422058|155931973|FG004|Open-Label Extension, Week 20-104|Other|16|||
48475381|NCT00422058|155931974|FG005|Open-Label Extension, Week 20-104|Other|18|||
48475382|NCT01165424|155931975|FG000|Overall Study|Clinical adverse experiences|1|||
48475383|NCT01165424|155931975|FG000|Overall Study|Laboratory adverse experiences|1|||
48475384|NCT01165424|155931975|FG000|Overall Study|Did not meet entry criteria|1|||
48475385|NCT01165424|155931975|FG000|Overall Study|Participant moved (relocated)|1|||
48475386|NCT04139642|155931976|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
48475387|NCT04139642|155931977|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
48475388|NCT00276458|155931982|FG000|Overall Study|Adverse Event|0|||
48475389|NCT00276458|155931983|FG001|Overall Study|Adverse Event|2|||
48475390|NCT00276458|155931982|FG000|Overall Study|Lost to Follow-up|2|||
48475391|NCT00276458|155931983|FG001|Overall Study|Lost to Follow-up|2|||
48475392|NCT00276458|155931982|FG000|Overall Study|Protocol Violation|4|||
48475393|NCT00276458|155931983|FG001|Overall Study|Protocol Violation|3|||
48475394|NCT03732534|155931984|FG000|Overall Study|Study terminated by Sponsor|6|||
48475395|NCT03901352|155931985|FG000|Double-blind Phase|Adverse Event|6|||
48475396|NCT03901352|155931986|FG001|Double-blind Phase|Adverse Event|4|||
48475397|NCT03901352|155931985|FG000|Double-blind Phase|Death|1|||
48475398|NCT03901352|155931986|FG001|Double-blind Phase|Death|0|||
48475399|NCT03901352|155931985|FG000|Double-blind Phase|Lack of Efficacy|0|||
48475400|NCT03901352|155931986|FG001|Double-blind Phase|Lack of Efficacy|1|||
48475401|NCT03901352|155931985|FG000|Double-blind Phase|Protocol Violation|0|||
48475402|NCT03901352|155931986|FG001|Double-blind Phase|Protocol Violation|1|||
48475403|NCT03901352|155931985|FG000|Double-blind Phase|Withdrawal by Subject|10|||
48475404|NCT03901352|155931986|FG001|Double-blind Phase|Withdrawal by Subject|8|||
48475405|NCT03901352|155931985|FG000|Open-label Extension Phase|Adverse Event|24|||
48475406|NCT03901352|155931986|FG001|Open-label Extension Phase|Adverse Event|0|||
48475407|NCT03901352|155931985|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
48475408|NCT03901352|155931986|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
48475409|NCT03901352|155931985|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
48475410|NCT03901352|155931986|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
48475411|NCT03901352|155931985|FG000|Open-label Extension Phase|Other|1|||
48475412|NCT03901352|155931986|FG001|Open-label Extension Phase|Other|0|||
48475413|NCT02940392|155931992|FG000|Overall Study|Lost to Follow-up|3|||
48475414|NCT02940392|155931992|FG000|Overall Study|Retreatment|3|||
48475415|NCT02940392|155931992|FG000|Overall Study|Death|2|||
48475416|NCT00978120|155931993|FG000|Overall Study|Death|0|||
48475417|NCT00978120|155931994|FG001|Overall Study|Death|0|||
48475418|NCT00978120|155931995|FG002|Overall Study|Death|0|||
48475419|NCT00978120|155931996|FG003|Overall Study|Death|1|||
48475420|NCT00978120|155931993|FG000|Overall Study|Lost to Follow-up|0|||
48475421|NCT00978120|155931994|FG001|Overall Study|Lost to Follow-up|0|||
48475422|NCT00978120|155931995|FG002|Overall Study|Lost to Follow-up|3|||
48475423|NCT00978120|155931996|FG003|Overall Study|Lost to Follow-up|0|||
48475424|NCT00978120|155931993|FG000|Overall Study|Withdrawal by Subject|2|||
48475425|NCT00978120|155931994|FG001|Overall Study|Withdrawal by Subject|0|||
48475426|NCT00978120|155931995|FG002|Overall Study|Withdrawal by Subject|0|||
48475427|NCT00978120|155931996|FG003|Overall Study|Withdrawal by Subject|0|||
48475428|NCT00978120|155931993|FG000|Overall Study|Moved out of state|0|||
48475429|NCT00978120|155931994|FG001|Overall Study|Moved out of state|0|||
48475430|NCT00978120|155931995|FG002|Overall Study|Moved out of state|0|||
48475431|NCT00978120|155931996|FG003|Overall Study|Moved out of state|1|||
48475432|NCT03992456|155931998|FG000|Overall Study|Withdrawal by Subject|1|||
48475433|NCT03992456|155931999|FG001|Overall Study|Withdrawal by Subject|0|||
48475434|NCT03992456|155931998|FG000|Overall Study|Disease progression|4|||
48475435|NCT03992456|155931999|FG001|Overall Study|Disease progression|5|||
48475436|NCT03992456|155931998|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
48475437|NCT03992456|155931999|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
48475438|NCT01901393|155932000|FG000|Overall Study|Adverse Event|1|||
48475439|NCT01901393|155932001|FG001|Overall Study|Adverse Event|0|||
48475440|NCT02181673|155932002|FG000|Up to Week 24|Adverse Event|2|||
48475441|NCT02181673|155932003|FG001|Up to Week 24|Adverse Event|0|||
48475442|NCT02181673|155932004|FG002|Up to Week 24|Adverse Event|3|||
48475443|NCT02181673|155932002|FG000|Up to Week 24|Death|1|||
48475444|NCT02181673|155932003|FG001|Up to Week 24|Death|0|||
48475445|NCT02181673|155932004|FG002|Up to Week 24|Death|0|||
48475446|NCT02181673|155932002|FG000|Up to Week 24|Lack of Efficacy|1|||
48475447|NCT02181673|155932003|FG001|Up to Week 24|Lack of Efficacy|0|||
48475448|NCT02181673|155932004|FG002|Up to Week 24|Lack of Efficacy|0|||
48475449|NCT02181673|155932002|FG000|Up to Week 24|Lost to Follow-up|1|||
48475450|NCT02181673|155932003|FG001|Up to Week 24|Lost to Follow-up|0|||
48475451|NCT02181673|155932004|FG002|Up to Week 24|Lost to Follow-up|0|||
48475452|NCT02181673|155932002|FG000|Up to Week 24|Physician Decision|0|||
48475453|NCT02181673|155932003|FG001|Up to Week 24|Physician Decision|0|||
48475454|NCT02181673|155932004|FG002|Up to Week 24|Physician Decision|3|||
48475455|NCT02181673|155932002|FG000|Up to Week 24|Withdrawal by Subject|10|||
48475456|NCT02181673|155932003|FG001|Up to Week 24|Withdrawal by Subject|0|||
48475457|NCT02181673|155932004|FG002|Up to Week 24|Withdrawal by Subject|1|||
48475458|NCT02181673|155932002|FG000|Up to Week 24|Other|2|||
48475459|NCT02181673|155932003|FG001|Up to Week 24|Other|0|||
48475460|NCT02181673|155932004|FG002|Up to Week 24|Other|3|||
48475461|NCT02181673|155932002|FG000|Up to Week 24|Randomized not Treated|0|||
48475462|NCT02181673|155932003|FG001|Up to Week 24|Randomized not Treated|0|||
48475463|NCT02181673|155932004|FG002|Up to Week 24|Randomized not Treated|1|||
48475464|NCT02181673|155932002|FG000|Week 24-Week 60|Adverse Event|0|||
48475465|NCT02181673|155932003|FG001|Week 24-Week 60|Adverse Event|4|||
48475466|NCT02181673|155932004|FG002|Week 24-Week 60|Adverse Event|10|||
48475467|NCT02181673|155932002|FG000|Week 24-Week 60|Other|0|||
48475468|NCT02181673|155932003|FG001|Week 24-Week 60|Other|2|||
48475469|NCT02181673|155932004|FG002|Week 24-Week 60|Other|1|||
48475470|NCT02181673|155932002|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
48475471|NCT02181673|155932003|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
48475472|NCT02181673|155932004|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
48475473|NCT02181673|155932002|FG000|Week 24-Week 60|Pregnancy|0|||
48475474|NCT02181673|155932003|FG001|Week 24-Week 60|Pregnancy|0|||
48475475|NCT02181673|155932004|FG002|Week 24-Week 60|Pregnancy|1|||
48475476|NCT02181673|155932002|FG000|Week 24-Week 60|Lack of Efficacy|0|||
48475477|NCT02181673|155932003|FG001|Week 24-Week 60|Lack of Efficacy|0|||
48475478|NCT02181673|155932004|FG002|Week 24-Week 60|Lack of Efficacy|1|||
48475479|NCT02181673|155932002|FG000|Week 24-Week 60|Lost to Follow-up|0|||
48475480|NCT02181673|155932003|FG001|Week 24-Week 60|Lost to Follow-up|0|||
48475481|NCT02181673|155932004|FG002|Week 24-Week 60|Lost to Follow-up|1|||
48475482|NCT02181673|155932002|FG000|Week 24-Week 60|Physician Decision|0|||
48475483|NCT02181673|155932003|FG001|Week 24-Week 60|Physician Decision|0|||
48475484|NCT02181673|155932004|FG002|Week 24-Week 60|Physician Decision|1|||
48475485|NCT03155269|155932005|FG000|Overall Study|Withdrawal by Subject|4|||
48475486|NCT03155269|155932006|FG001|Overall Study|Withdrawal by Subject|5|||
48475487|NCT03155269|155932005|FG000|Overall Study|Lost to Follow-up|1|||
48475488|NCT03155269|155932006|FG001|Overall Study|Lost to Follow-up|2|||
48475489|NCT00824993|155932012|FG000|Overall Study|Withdrawal by Subject|1|||
48475490|NCT00824993|155932013|FG001|Overall Study|Withdrawal by Subject|1|||
48475491|NCT00824993|155932012|FG000|Overall Study|Malignancy Relapse|9|||
48475492|NCT00824993|155932013|FG001|Overall Study|Malignancy Relapse|10|||
48475493|NCT00824993|155932012|FG000|Overall Study|Rapid Bone Loss|0|||
48475494|NCT00824993|155932013|FG001|Overall Study|Rapid Bone Loss|1|||
48475495|NCT00824993|155932012|FG000|Overall Study|Non-Compliant|2|||
48475496|NCT00824993|155932013|FG001|Overall Study|Non-Compliant|1|||
48475497|NCT00824993|155932012|FG000|Overall Study|Insurance Issue|2|||
48475498|NCT00824993|155932013|FG001|Overall Study|Insurance Issue|1|||
48475499|NCT00824993|155932012|FG000|Overall Study|Death|0|||
48475500|NCT00824993|155932013|FG001|Overall Study|Death|3|||
48475501|NCT03075826|155932014|FG000|Overall Study|Withdrawal by Subject|1|||
48475502|NCT03075826|155932014|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
48475503|NCT00834366|155932015|FG000|Treatment Period 1|Adverse Event|1|||
48475504|NCT00834366|155932016|FG001|Treatment Period 1|Adverse Event|1|||
48475505|NCT00650806|155932018|FG000|Overall Study|Adverse Event|0|||
48475506|NCT00650806|155932019|FG001|Overall Study|Adverse Event|5|||
48475507|NCT00650806|155932020|FG002|Overall Study|Adverse Event|3|||
48475508|NCT00650806|155932021|FG003|Overall Study|Adverse Event|4|||
48475509|NCT00650806|155932018|FG000|Overall Study|Lost to Follow-up|7|||
48475510|NCT00650806|155932019|FG001|Overall Study|Lost to Follow-up|6|||
48475511|NCT00650806|155932020|FG002|Overall Study|Lost to Follow-up|11|||
48475512|NCT00650806|155932021|FG003|Overall Study|Lost to Follow-up|10|||
48475513|NCT00650806|155932018|FG000|Overall Study|Protocol Violation|0|||
48475514|NCT00650806|155932019|FG001|Overall Study|Protocol Violation|0|||
48475515|NCT00650806|155932020|FG002|Overall Study|Protocol Violation|0|||
48475516|NCT00650806|155932021|FG003|Overall Study|Protocol Violation|1|||
48475517|NCT00650806|155932018|FG000|Overall Study|Pregnancy|0|||
48475518|NCT00650806|155932019|FG001|Overall Study|Pregnancy|0|||
48475519|NCT00650806|155932020|FG002|Overall Study|Pregnancy|0|||
48475520|NCT00650806|155932021|FG003|Overall Study|Pregnancy|1|||
48475521|NCT00650806|155932018|FG000|Overall Study|Withdrawal by Subject|7|||
48475522|NCT00650806|155932019|FG001|Overall Study|Withdrawal by Subject|5|||
48475523|NCT00650806|155932020|FG002|Overall Study|Withdrawal by Subject|8|||
48475524|NCT00650806|155932021|FG003|Overall Study|Withdrawal by Subject|6|||
48475525|NCT00650806|155932018|FG000|Overall Study|Noncompliance with study drug regimen|1|||
48475526|NCT00650806|155932019|FG001|Overall Study|Noncompliance with study drug regimen|1|||
48475527|NCT00650806|155932020|FG002|Overall Study|Noncompliance with study drug regimen|0|||
48475528|NCT00650806|155932021|FG003|Overall Study|Noncompliance with study drug regimen|0|||
48475529|NCT00650806|155932018|FG000|Overall Study|Study terminated by sponsor|2|||
48475530|NCT00650806|155932019|FG001|Overall Study|Study terminated by sponsor|3|||
48475531|NCT00650806|155932020|FG002|Overall Study|Study terminated by sponsor|5|||
48475532|NCT00650806|155932021|FG003|Overall Study|Study terminated by sponsor|4|||
48475533|NCT00650806|155932018|FG000|Overall Study|Other|1|||
48475534|NCT00650806|155932019|FG001|Overall Study|Other|1|||
48475535|NCT00650806|155932020|FG002|Overall Study|Other|2|||
48475536|NCT00650806|155932021|FG003|Overall Study|Other|0|||
48475537|NCT03522506|155932022|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48475538|NCT03522506|155932023|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48475539|NCT03522506|155932024|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
48475540|NCT03522506|155932025|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
48475541|NCT03522506|155932022|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48475542|NCT03522506|155932023|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48475543|NCT03522506|155932024|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
48475544|NCT03522506|155932025|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
48475545|NCT03014570|155932028|FG000|Overall Study|COVID-19 Restrictions|38|||
48475546|NCT03014570|155932029|FG001|Overall Study|COVID-19 Restrictions|24|||
48475547|NCT03014570|155932028|FG000|Overall Study|Death|70|||
48475548|NCT03014570|155932029|FG001|Overall Study|Death|79|||
48475549|NCT03014570|155932028|FG000|Overall Study|Transfer from facility|11|||
48475550|NCT03014570|155932029|FG001|Overall Study|Transfer from facility|14|||
48475551|NCT03014570|155932028|FG000|Overall Study|Hospitalized|5|||
48475552|NCT03014570|155932029|FG001|Overall Study|Hospitalized|3|||
48475553|NCT03014570|155932028|FG000|Overall Study|Transfer within facility|1|||
48475554|NCT03014570|155932029|FG001|Overall Study|Transfer within facility|0|||
48475555|NCT03014570|155932028|FG000|Overall Study|Site refusal|0|||
48475556|NCT03014570|155932029|FG001|Overall Study|Site refusal|11|||
48475557|NCT02998645|155932032|FG000|Treatment Period 1|Adverse Event|6|||
48475558|NCT02998645|155932032|FG000|Treatment Period 1|Death|5|||
48475559|NCT02998645|155932032|FG000|Treatment Period 1|Technical Problems|4|||
48475560|NCT02998645|155932032|FG000|Treatment Period 1|Lack of Efficacy|2|||
48475561|NCT02998645|155932032|FG000|Treatment Period 1|Progressive disease|1|||
48475562|NCT02998645|155932032|FG000|Treatment Period 1|Subject/guardian decision|1|||
48475563|NCT02998645|155932032|FG000|Treatment Period 2|Lack of Efficacy|5|||
48475564|NCT02998645|155932032|FG000|Treatment Period 2|Adverse Event|2|||
48475565|NCT02998645|155932032|FG000|Treatment Period 2|Progressive disease|2|||
48475566|NCT02998645|155932032|FG000|Treatment Period 2|Physician Decision|1|||
48475567|NCT03930615|155932034|FG000|Overall Study|Death|9|||
48475568|NCT03930615|155932035|FG001|Overall Study|Death|3|||
48475569|NCT03930615|155932034|FG000|Overall Study|Lost to Follow-up|1|||
48475570|NCT03930615|155932035|FG001|Overall Study|Lost to Follow-up|2|||
48475571|NCT03930615|155932034|FG000|Overall Study|Physician Decision|3|||
48475572|NCT03930615|155932035|FG001|Overall Study|Physician Decision|4|||
48475573|NCT03930615|155932034|FG000|Overall Study|Withdrawal by Subject|13|||
48475574|NCT03930615|155932035|FG001|Overall Study|Withdrawal by Subject|2|||
48475575|NCT03930615|155932034|FG000|Overall Study|Not treated|1|||
48475576|NCT03930615|155932035|FG001|Overall Study|Not treated|1|||
48475577|NCT01195662|155932038|FG000|Double Blind Treatment Period|Adverse Event|4|||
48475578|NCT01195662|155932039|FG001|Double Blind Treatment Period|Adverse Event|1|||
48475579|NCT01195662|155932040|FG002|Double Blind Treatment Period|Adverse Event|2|||
48475580|NCT01195662|155932038|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
48475581|NCT01195662|155932039|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
48475582|NCT01195662|155932040|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
48475583|NCT01195662|155932038|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
48475584|NCT01195662|155932039|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
48475585|NCT01195662|155932040|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
48475586|NCT01195662|155932038|FG000|Double Blind Treatment Period|Administrative reason|2|||
48475587|NCT01195662|155932039|FG001|Double Blind Treatment Period|Administrative reason|1|||
48475588|NCT01195662|155932040|FG002|Double Blind Treatment Period|Administrative reason|1|||
48475589|NCT01195662|155932038|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
48475590|NCT01195662|155932039|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
48475591|NCT01195662|155932040|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
48475592|NCT01195662|155932038|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
48475593|NCT01195662|155932039|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
48475594|NCT01195662|155932040|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
48475595|NCT01195662|155932038|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
48475596|NCT01195662|155932039|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
48475597|NCT01195662|155932040|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
48475598|NCT01195662|155932038|FG000|Double Blind Treatment Period|Non-specified|3|||
48475599|NCT01195662|155932039|FG001|Double Blind Treatment Period|Non-specified|0|||
48475600|NCT01195662|155932040|FG002|Double Blind Treatment Period|Non-specified|0|||
48475601|NCT01195662|155932038|FG000|Double Blind Treatment Period|Missing disposition information|0|||
48475602|NCT01195662|155932039|FG001|Double Blind Treatment Period|Missing disposition information|1|||
48475603|NCT01195662|155932040|FG002|Double Blind Treatment Period|Missing disposition information|1|||
48475604|NCT01195662|155932038|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
48475605|NCT01195662|155932039|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
48475606|NCT01195662|155932040|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
48475607|NCT01195662|155932038|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
48475608|NCT01195662|155932039|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
48475609|NCT01195662|155932040|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
48475610|NCT00674440|155932041|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
48475611|NCT00674440|155932041|FG000|Overall Study|did not have surgery, so unevaluable|7|||
48475612|NCT00674440|155932041|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
48475613|NCT03128931|155932042|FG000|Overall Study|Physician Decision|1|||
48475614|NCT03128931|155932042|FG000|Overall Study|Equipment Issues|3|||
48475615|NCT01907516|155932046|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
48475616|NCT01907516|155932047|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
48475617|NCT01907516|155932046|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
48475618|NCT01907516|155932047|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
48475619|NCT01907516|155932046|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
48475620|NCT01907516|155932047|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
48475621|NCT01907516|155932046|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
48475622|NCT01907516|155932047|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
48475623|NCT03205163|155932050|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
48475624|NCT03205163|155932051|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
48475625|NCT00953017|155933467|FG000|Overall Study|DId not show up for colonoscopy|4|||
48475626|NCT00953017|155933468|FG001|Overall Study|DId not show up for colonoscopy|4|||
48475627|NCT00953017|155933469|FG002|Overall Study|DId not show up for colonoscopy|5|||
48475628|NCT00953017|155933470|FG003|Overall Study|DId not show up for colonoscopy|4|||
48475629|NCT00953017|155933467|FG000|Overall Study|Incomplete data|1|||
48475630|NCT00953017|155933468|FG001|Overall Study|Incomplete data|1|||
48475631|NCT00953017|155933469|FG002|Overall Study|Incomplete data|0|||
48475632|NCT00953017|155933470|FG003|Overall Study|Incomplete data|0|||
48475633|NCT00953017|155933467|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
48475634|NCT00953017|155933468|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
48475635|NCT00953017|155933469|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
48475636|NCT00953017|155933470|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
48475637|NCT00953017|155933467|FG000|Overall Study|Brown stool prior to procedure|0|||
48475638|NCT00953017|155933468|FG001|Overall Study|Brown stool prior to procedure|0|||
48475639|NCT00953017|155933469|FG002|Overall Study|Brown stool prior to procedure|1|||
48475640|NCT00953017|155933470|FG003|Overall Study|Brown stool prior to procedure|0|||
48475641|NCT01519635|155933471|FG000|Overall Study|Withdrawal by Subject|0|||
48475642|NCT01519635|155933472|FG001|Overall Study|Withdrawal by Subject|1|||
48475643|NCT01519635|155933471|FG000|Overall Study|No possibility to put a catheter|1|||
48475644|NCT01519635|155933472|FG001|Overall Study|No possibility to put a catheter|2|||
48475645|NCT01300741|155933474|FG000|Overall Study|Lens deposits|1|||
48475646|NCT01300741|155933474|FG000|Overall Study|Lost to Follow-up|1|||
48475647|NCT01300741|155933474|FG000|Overall Study|Discomfort|1|||
48475648|NCT01473602|155933475|FG000|Overall Study|Adverse Event|1|||
48475649|NCT01473602|155933476|FG001|Overall Study|Adverse Event|2|||
48475650|NCT01473602|155933475|FG000|Overall Study|Death|0|||
48475651|NCT01473602|155933476|FG001|Overall Study|Death|1|||
48475652|NCT01473602|155933475|FG000|Overall Study|Lost to Follow-up|1|||
48475653|NCT01473602|155933476|FG001|Overall Study|Lost to Follow-up|1|||
48475654|NCT01473602|155933475|FG000|Overall Study|Withdrawal by Subject|5|||
48475655|NCT01473602|155933476|FG001|Overall Study|Withdrawal by Subject|4|||
48475656|NCT01473602|155933475|FG000|Overall Study|Physician Decision|1|||
48475657|NCT01473602|155933476|FG001|Overall Study|Physician Decision|0|||
48475658|NCT02325414|155933477|FG000|Overall Study|Withdrawal by Subject|3|||
48475659|NCT02325414|155933478|FG001|Overall Study|Withdrawal by Subject|1|||
48475660|NCT02325414|155933477|FG000|Overall Study|Lost to Follow-up|5|||
48475661|NCT02325414|155933478|FG001|Overall Study|Lost to Follow-up|5|||
48475662|NCT04854421|155933479|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
48475663|NCT04854421|155933480|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
48475664|NCT02158949|155933481|FG000|Overall Study|Withdrawal by Subject|1|||
48475665|NCT02158949|155933482|FG001|Overall Study|Withdrawal by Subject|0|||
48475666|NCT02158949|155933481|FG000|Overall Study|Lost to Follow-up|5|||
48475667|NCT02158949|155933482|FG001|Overall Study|Lost to Follow-up|11|||
48475668|NCT01340794|155933486|FG000|Overall Study|Withdrawal by Subject|0|||
48475669|NCT01340794|155933487|FG001|Overall Study|Withdrawal by Subject|1|||
48475670|NCT01422876|155933488|FG000|Week 24|Lost to Follow-up|1|||
48475671|NCT01422876|155933489|FG001|Week 24|Lost to Follow-up|1|||
48475672|NCT01422876|155933490|FG002|Week 24|Lost to Follow-up|2|||
48475673|NCT01422876|155933491|FG003|Week 24|Lost to Follow-up|4|||
48475674|NCT01422876|155933492|FG004|Week 24|Lost to Follow-up|2|||
48475675|NCT01422876|155933493|FG005|Week 24|Lost to Follow-up|0|||
48475676|NCT01422876|155933494|FG006|Week 24|Lost to Follow-up|1|||
48475677|NCT01422876|155933495|FG007|Week 24|Lost to Follow-up|3|||
48475678|NCT01422876|155933496|FG008|Week 24|Lost to Follow-up|3|||
48475679|NCT01422876|155933497|FG009|Week 24|Lost to Follow-up|4|||
48475680|NCT01422876|155933488|FG000|Week 24|Consent withdrawn|5|||
48475681|NCT01422876|155933489|FG001|Week 24|Consent withdrawn|1|||
48475682|NCT01422876|155933490|FG002|Week 24|Consent withdrawn|3|||
48475683|NCT01422876|155933491|FG003|Week 24|Consent withdrawn|4|||
48475684|NCT01422876|155933492|FG004|Week 24|Consent withdrawn|5|||
48475685|NCT01422876|155933493|FG005|Week 24|Consent withdrawn|6|||
48475686|NCT01422876|155933494|FG006|Week 24|Consent withdrawn|5|||
48475687|NCT01422876|155933495|FG007|Week 24|Consent withdrawn|4|||
48475688|NCT01422876|155933496|FG008|Week 24|Consent withdrawn|3|||
48475689|NCT01422876|155933497|FG009|Week 24|Consent withdrawn|6|||
48475690|NCT01422876|155933488|FG000|Week 24|Death|0|||
48475691|NCT01422876|155933489|FG001|Week 24|Death|1|||
48475692|NCT01422876|155933490|FG002|Week 24|Death|0|||
48475693|NCT01422876|155933491|FG003|Week 24|Death|0|||
48475694|NCT01422876|155933492|FG004|Week 24|Death|0|||
48475695|NCT01422876|155933493|FG005|Week 24|Death|0|||
48475696|NCT01422876|155933494|FG006|Week 24|Death|0|||
48475697|NCT01422876|155933495|FG007|Week 24|Death|0|||
48475698|NCT01422876|155933496|FG008|Week 24|Death|0|||
48475699|NCT01422876|155933497|FG009|Week 24|Death|0|||
48475700|NCT01422876|155933488|FG000|Week 52|Lost to Follow-up|3|||
48475701|NCT01422876|155933489|FG001|Week 52|Lost to Follow-up|5|||
48475702|NCT01422876|155933490|FG002|Week 52|Lost to Follow-up|7|||
48475703|NCT01422876|155933491|FG003|Week 52|Lost to Follow-up|5|||
48475704|NCT01422876|155933492|FG004|Week 52|Lost to Follow-up|8|||
48475705|NCT01422876|155933493|FG005|Week 52|Lost to Follow-up|5|||
48475706|NCT01422876|155933494|FG006|Week 52|Lost to Follow-up|5|||
48475707|NCT01422876|155933495|FG007|Week 52|Lost to Follow-up|8|||
48475708|NCT01422876|155933496|FG008|Week 52|Lost to Follow-up|7|||
48475709|NCT01422876|155933497|FG009|Week 52|Lost to Follow-up|8|||
48475710|NCT01422876|155933488|FG000|Week 52|Consent withdrawn|9|||
48475711|NCT01422876|155933489|FG001|Week 52|Consent withdrawn|4|||
48475712|NCT01422876|155933490|FG002|Week 52|Consent withdrawn|6|||
48475713|NCT01422876|155933491|FG003|Week 52|Consent withdrawn|12|||
48475714|NCT01422876|155933492|FG004|Week 52|Consent withdrawn|7|||
48475715|NCT01422876|155933493|FG005|Week 52|Consent withdrawn|12|||
48475716|NCT01422876|155933494|FG006|Week 52|Consent withdrawn|10|||
48475717|NCT01422876|155933495|FG007|Week 52|Consent withdrawn|12|||
48475718|NCT01422876|155933496|FG008|Week 52|Consent withdrawn|13|||
48475719|NCT01422876|155933497|FG009|Week 52|Consent withdrawn|9|||
48475720|NCT01422876|155933488|FG000|Week 52|Death|0|||
48475721|NCT01422876|155933489|FG001|Week 52|Death|1|||
48475722|NCT01422876|155933490|FG002|Week 52|Death|0|||
48475723|NCT01422876|155933491|FG003|Week 52|Death|1|||
48475724|NCT01422876|155933492|FG004|Week 52|Death|0|||
48475725|NCT01422876|155933493|FG005|Week 52|Death|0|||
48475726|NCT01422876|155933494|FG006|Week 52|Death|1|||
48475727|NCT01422876|155933495|FG007|Week 52|Death|3|||
48475728|NCT01422876|155933496|FG008|Week 52|Death|1|||
48475729|NCT01422876|155933497|FG009|Week 52|Death|0|||
48475730|NCT04478994|155933498|FG000|Overall Study|Withdrawal by Subject|1|||
48475731|NCT04478994|155933499|FG001|Overall Study|Withdrawal by Subject|1|||
48475732|NCT00299546|155933504|FG000|Overall Study|Death|3|||
48475733|NCT00299546|155933505|FG001|Overall Study|Death|2|||
48475734|NCT00299546|155933506|FG002|Overall Study|Death|0|||
48475735|NCT00299546|155933504|FG000|Overall Study|Lost to Follow-up|2|||
48475736|NCT00299546|155933505|FG001|Overall Study|Lost to Follow-up|2|||
48475737|NCT00299546|155933506|FG002|Overall Study|Lost to Follow-up|5|||
48475738|NCT00299546|155933504|FG000|Overall Study|Adverse Event|37|||
48475739|NCT00299546|155933505|FG001|Overall Study|Adverse Event|22|||
48475740|NCT00299546|155933506|FG002|Overall Study|Adverse Event|27|||
48475741|NCT00299546|155933504|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
48475742|NCT00299546|155933505|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
48475743|NCT00299546|155933506|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
48475744|NCT00299546|155933504|FG000|Overall Study|Other|24|||
48475745|NCT00299546|155933505|FG001|Overall Study|Other|26|||
48475746|NCT00299546|155933506|FG002|Overall Study|Other|19|||
48475747|NCT00299546|155933504|FG000|Overall Study|Not treated|0|||
48475748|NCT00299546|155933505|FG001|Overall Study|Not treated|1|||
48475749|NCT00299546|155933506|FG002|Overall Study|Not treated|1|||
48475750|NCT03099265|155933507|FG000|Overall Study|Adverse Event|1|||
48475751|NCT02526017|155933513|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48475752|NCT02526017|155933514|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48475753|NCT02526017|155933515|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48475754|NCT02526017|155933516|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48475755|NCT02526017|155933517|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
48475756|NCT02526017|155933518|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48475757|NCT02526017|155933519|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48475758|NCT02526017|155933520|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48475759|NCT02526017|155933521|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
48475760|NCT02181634|155933523|FG000|Overall Study|Lack of Efficacy|33|||
48475761|NCT02181634|155933523|FG000|Overall Study|Adverse Event|17|||
48475762|NCT02181634|155933523|FG000|Overall Study|Physician Decision|8|||
48475763|NCT02181634|155933523|FG000|Overall Study|Withdrawal by Subject|5|||
48475764|NCT02181634|155933523|FG000|Overall Study|Death|2|||
48475765|NCT02181634|155933523|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
48475766|NCT02181634|155933523|FG000|Overall Study|Ineligible|1|||
48475767|NCT02181634|155933523|FG000|Overall Study|Max number of dose reduction|1|||
48475768|NCT02181634|155933523|FG000|Overall Study|Symptomatic progression|1|||
48475769|NCT02181634|155933523|FG000|Overall Study|Patient opted to proceed to surgery|1|||
48475770|NCT00761761|155933533|FG000|Overall Study|Lost to Follow-up|3|||
48475771|NCT00761761|155933534|FG001|Overall Study|Lost to Follow-up|1|||
48475772|NCT00761761|155933533|FG000|Overall Study|Withdrawal by Subject|3|||
48475773|NCT00761761|155933534|FG001|Overall Study|Withdrawal by Subject|0|||
48475774|NCT00536991|155933537|FG000|Overall Study|Withdrawal by Subject|10|||
48475775|NCT00536991|155933537|FG000|Overall Study|Physician Decision|1|||
48475776|NCT00536991|155933537|FG000|Overall Study|patient ineligible|2|||
48475777|NCT00968539|155933541|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
48475778|NCT00968539|155933542|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
48475779|NCT04888377|155933545|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
48475780|NCT04888377|155933546|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
48475781|NCT04888377|155933545|FG000|Overall Study|Physician Decision|6|||
48475782|NCT04888377|155933546|FG001|Overall Study|Physician Decision|6|||
48475783|NCT04888377|155933545|FG000|Overall Study|Withdrawal by Subject|7|||
48475784|NCT04888377|155933546|FG001|Overall Study|Withdrawal by Subject|3|||
48475785|NCT05279807|155933547|FG000|Overall Study|Withdrawal by Subject|1|||
48475786|NCT05279807|155933548|FG001|Overall Study|Withdrawal by Subject|0|||
48475787|NCT05279807|155933547|FG000|Overall Study|Adverse Event|0|||
48475788|NCT05279807|155933548|FG001|Overall Study|Adverse Event|1|||
48475789|NCT05279807|155933547|FG000|Overall Study|Laboratory Abnormal Results|1|||
48475790|NCT05279807|155933548|FG001|Overall Study|Laboratory Abnormal Results|0|||
48475791|NCT02216214|155933549|FG000|Overall Study|Randomized Never Received Study Drug|1|||
48475792|NCT02216214|155933550|FG001|Overall Study|Randomized Never Received Study Drug|0|||
48475793|NCT02216214|155933549|FG000|Overall Study|Adverse Event|10|||
48475794|NCT02216214|155933550|FG001|Overall Study|Adverse Event|8|||
48475795|NCT02216214|155933549|FG000|Overall Study|Lack of Efficacy|2|||
48475796|NCT02216214|155933550|FG001|Overall Study|Lack of Efficacy|2|||
48475797|NCT02216214|155933549|FG000|Overall Study|Lost to Follow-up|3|||
48475798|NCT02216214|155933550|FG001|Overall Study|Lost to Follow-up|2|||
48475799|NCT02216214|155933549|FG000|Overall Study|Protocol Violation|4|||
48475800|NCT02216214|155933550|FG001|Overall Study|Protocol Violation|2|||
48475801|NCT02216214|155933549|FG000|Overall Study|Withdrawal by Subject|22|||
48475802|NCT02216214|155933550|FG001|Overall Study|Withdrawal by Subject|20|||
48475803|NCT02216214|155933549|FG000|Overall Study|Study Terminated By Sponsor|0|||
48475804|NCT02216214|155933550|FG001|Overall Study|Study Terminated By Sponsor|1|||
48475805|NCT02216214|155933549|FG000|Overall Study|Miscellaneous|1|||
48475806|NCT02216214|155933550|FG001|Overall Study|Miscellaneous|1|||
48475807|NCT04484805|155933552|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
48475808|NCT04484805|155933553|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
48475809|NCT04484805|155933552|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
48475810|NCT04484805|155933553|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
48475811|NCT01414062|155933554|FG000|Overall Study|Lost to Follow-up|3|||
48475812|NCT01414062|155933555|FG001|Overall Study|Lost to Follow-up|2|||
48475813|NCT01414062|155933554|FG000|Overall Study|Left Country|1|||
48475814|NCT01414062|155933555|FG001|Overall Study|Left Country|1|||
48475815|NCT01414062|155933554|FG000|Overall Study|Family Disapproval|1|||
48475816|NCT01414062|155933555|FG001|Overall Study|Family Disapproval|0|||
48475817|NCT01414062|155933554|FG000|Overall Study|Withdrawal by Subject|0|||
48475818|NCT01414062|155933555|FG001|Overall Study|Withdrawal by Subject|1|||
48475819|NCT02684370|155933556|FG000|Part A|Adverse Event|2|||
48475820|NCT02684370|155933557|FG001|Part A|Adverse Event|0|||
48475821|NCT02684370|155933558|FG002|Part A|Adverse Event|1|||
48475822|NCT02684370|155933559|FG003|Part A|Adverse Event|0|||
48475823|NCT02684370|155933560|FG004|Part A|Adverse Event|0|||
48475824|NCT02684370|155933561|FG005|Part A|Adverse Event|0|||
48475825|NCT02684370|155933556|FG000|Part A|Lost to Follow-up|1|||
48475826|NCT02684370|155933557|FG001|Part A|Lost to Follow-up|1|||
48475827|NCT02684370|155933558|FG002|Part A|Lost to Follow-up|0|||
48475828|NCT02684370|155933559|FG003|Part A|Lost to Follow-up|0|||
48475829|NCT02684370|155933560|FG004|Part A|Lost to Follow-up|0|||
48475830|NCT02684370|155933561|FG005|Part A|Lost to Follow-up|0|||
48475831|NCT02684370|155933556|FG000|Part A|Subject Withdrawal|1|||
48475832|NCT02684370|155933557|FG001|Part A|Subject Withdrawal|0|||
48475833|NCT02684370|155933558|FG002|Part A|Subject Withdrawal|3|||
48475834|NCT02684370|155933559|FG003|Part A|Subject Withdrawal|0|||
48475835|NCT02684370|155933560|FG004|Part A|Subject Withdrawal|0|||
48475836|NCT02684370|155933561|FG005|Part A|Subject Withdrawal|0|||
48475837|NCT02684370|155933556|FG000|Part A|Other|0|||
48475838|NCT02684370|155933557|FG001|Part A|Other|0|||
48475839|NCT02684370|155933558|FG002|Part A|Other|1|||
48475840|NCT02684370|155933559|FG003|Part A|Other|0|||
48475841|NCT02684370|155933560|FG004|Part A|Other|0|||
48475842|NCT02684370|155933561|FG005|Part A|Other|0|||
48475843|NCT02684370|155933556|FG000|Part B|Adverse Event|0|||
48475844|NCT02684370|155933557|FG001|Part B|Adverse Event|0|||
48475845|NCT02684370|155933558|FG002|Part B|Adverse Event|0|||
48475846|NCT02684370|155933559|FG003|Part B|Adverse Event|0|||
48475847|NCT02684370|155933560|FG004|Part B|Adverse Event|2|||
48475848|NCT02684370|155933561|FG005|Part B|Adverse Event|1|||
48475849|NCT02684370|155933556|FG000|Part B|Lost to Follow-up|0|||
48475850|NCT02684370|155933557|FG001|Part B|Lost to Follow-up|0|||
48475851|NCT02684370|155933558|FG002|Part B|Lost to Follow-up|0|||
48475852|NCT02684370|155933559|FG003|Part B|Lost to Follow-up|1|||
48475853|NCT02684370|155933560|FG004|Part B|Lost to Follow-up|2|||
48475854|NCT02684370|155933561|FG005|Part B|Lost to Follow-up|5|||
48475855|NCT02684370|155933556|FG000|Part B|Subject Withdrawal|0|||
48475856|NCT02684370|155933557|FG001|Part B|Subject Withdrawal|0|||
48475857|NCT02684370|155933558|FG002|Part B|Subject Withdrawal|0|||
48475858|NCT02684370|155933559|FG003|Part B|Subject Withdrawal|1|||
48475859|NCT02684370|155933560|FG004|Part B|Subject Withdrawal|1|||
48475860|NCT02684370|155933561|FG005|Part B|Subject Withdrawal|2|||
48475861|NCT00627094|155933563|FG000|Overall Study|Adverse Event|8|||
48475862|NCT00627094|155933564|FG001|Overall Study|Adverse Event|7|||
48475863|NCT00627094|155933563|FG000|Overall Study|Lost to Follow-up|1|||
48475864|NCT00627094|155933564|FG001|Overall Study|Lost to Follow-up|0|||
48475865|NCT00627094|155933563|FG000|Overall Study|Withdrawal by Subject|1|||
48475866|NCT00627094|155933564|FG001|Overall Study|Withdrawal by Subject|1|||
48475867|NCT00627094|155933563|FG000|Overall Study|ulcer healed|1|||
48475868|NCT00627094|155933564|FG001|Overall Study|ulcer healed|7|||
48475869|NCT00627094|155933563|FG000|Overall Study|Other reason|1|||
48475870|NCT00627094|155933564|FG001|Overall Study|Other reason|0|||
48475871|NCT00442572|155933565|FG000|Overall Study|Relapse|8|||
48475872|NCT00442572|155933566|FG001|Overall Study|Relapse|1|||
48475873|NCT00442572|155933565|FG000|Overall Study|Lost to Follow-up|0|||
48475874|NCT00442572|155933566|FG001|Overall Study|Lost to Follow-up|1|||
48475875|NCT00442572|155933565|FG000|Overall Study|Withdrawal by Subject|0|||
48475876|NCT00442572|155933566|FG001|Overall Study|Withdrawal by Subject|1|||
48475877|NCT03557775|155933567|FG000|Overall Study|Withdrawal by Subject|1|||
48475878|NCT03557775|155933568|FG001|Overall Study|Withdrawal by Subject|2|||
48475879|NCT03557775|155933569|FG002|Overall Study|Withdrawal by Subject|4|||
48475880|NCT03557775|155933567|FG000|Overall Study|Physician Decision|0|||
48475881|NCT03557775|155933568|FG001|Overall Study|Physician Decision|1|||
48475882|NCT03557775|155933569|FG002|Overall Study|Physician Decision|0|||
48475883|NCT00308555|155933570|FG000|Overall Study|Withdrawal by Subject|1|||
48475884|NCT00308555|155933571|FG001|Overall Study|Withdrawal by Subject|0|||
48475885|NCT00308555|155933570|FG000|Overall Study|Physician Decision|2|||
48475886|NCT00308555|155933571|FG001|Overall Study|Physician Decision|0|||
48475887|NCT02120456|155933573|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48475888|NCT02120456|155933574|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48476116|NCT01808508|155934928|FG000|Overall Study|Lost to Follow-up|1|||
48475889|NCT02120456|155933575|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48475890|NCT02120456|155933576|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48475891|NCT02120456|155933577|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48475892|NCT02120456|155933578|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48475893|NCT02120456|155933579|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
48475894|NCT02120456|155933580|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48475895|NCT02120456|155933581|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
48475896|NCT02120456|155933573|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48475897|NCT02120456|155933574|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48475898|NCT02120456|155933575|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48475899|NCT02120456|155933576|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48475900|NCT02120456|155933577|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48475901|NCT02120456|155933578|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48475902|NCT02120456|155933579|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
48475903|NCT02120456|155933580|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48475904|NCT02120456|155933581|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
48475905|NCT02120456|155933573|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48475906|NCT02120456|155933574|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48475907|NCT02120456|155933575|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48475908|NCT02120456|155933576|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48475909|NCT02120456|155933577|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48475910|NCT02120456|155933578|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48475911|NCT02120456|155933579|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48475912|NCT02120456|155933580|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
48475913|NCT02120456|155933581|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
48475914|NCT00530621|155933595|FG000|Overall Study|Adverse Event|11|||
48475915|NCT00530621|155933596|FG001|Overall Study|Adverse Event|8|||
48475916|NCT00530621|155933595|FG000|Overall Study|Physician Decision|2|||
48475917|NCT00530621|155933596|FG001|Overall Study|Physician Decision|4|||
48475918|NCT00530621|155933595|FG000|Overall Study|Progressive Disease (PD)|47|||
48475919|NCT00530621|155933596|FG001|Overall Study|Progressive Disease (PD)|40|||
48475920|NCT00530621|155933595|FG000|Overall Study|Sponsor Decision|12|||
48475921|NCT00530621|155933596|FG001|Overall Study|Sponsor Decision|15|||
48475922|NCT00530621|155933595|FG000|Overall Study|Subject Decision|4|||
48475923|NCT00530621|155933596|FG001|Overall Study|Subject Decision|7|||
48475924|NCT00530621|155933595|FG000|Overall Study|Death|3|||
48475925|NCT00530621|155933596|FG001|Overall Study|Death|6|||
48475926|NCT00530621|155933595|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
48475927|NCT00530621|155933596|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
48475928|NCT02596009|155933597|FG000|Overall Study|Administrative problems|0|||
48475929|NCT02596009|155933598|FG001|Overall Study|Administrative problems|1|||
48475930|NCT02596009|155933599|FG002|Overall Study|Administrative problems|0|||
48475931|NCT02596009|155933600|FG003|Overall Study|Administrative problems|0|||
48475932|NCT02596009|155933601|FG004|Overall Study|Administrative problems|0|||
48475933|NCT02596009|155933602|FG005|Overall Study|Administrative problems|0|||
48475934|NCT00518011|155933603|FG000|Overall Study|Death|1|||
48475935|NCT00518011|155933604|FG001|Overall Study|Death|1|||
48475936|NCT00518011|155933603|FG000|Overall Study|Adverse Event|2|||
48475937|NCT00518011|155933604|FG001|Overall Study|Adverse Event|3|||
48475938|NCT00518011|155933603|FG000|Overall Study|Disease Progression|2|||
48475939|NCT00518011|155933604|FG001|Overall Study|Disease Progression|2|||
48475940|NCT00518011|155933603|FG000|Overall Study|Other Reasons|3|||
48475941|NCT00518011|155933604|FG001|Overall Study|Other Reasons|2|||
48475942|NCT00518011|155933603|FG000|Overall Study|Withdrawal by Subject|1|||
48475943|NCT00518011|155933604|FG001|Overall Study|Withdrawal by Subject|0|||
48475944|NCT03409328|155933605|FG000|Overall Study|Lost to Follow-up|6|||
48475945|NCT03409328|155933606|FG001|Overall Study|Lost to Follow-up|3|||
48475946|NCT00090259|155933609|FG000|Overall Study|Lost to Follow-up|30|||
48475947|NCT00090259|155933610|FG001|Overall Study|Lost to Follow-up|26|||
48475948|NCT00090259|155933609|FG000|Overall Study|Withdrawal by Subject|21|||
48475949|NCT00090259|155933610|FG001|Overall Study|Withdrawal by Subject|15|||
48475950|NCT00090259|155933609|FG000|Overall Study|Investigator site closed|11|||
48475951|NCT00090259|155933610|FG001|Overall Study|Investigator site closed|7|||
48475952|NCT00554788|155933611|FG000|Overall Study|Adverse Event|0|||
48475953|NCT00554788|155933612|FG001|Overall Study|Adverse Event|1|||
48475954|NCT00554788|155933613|FG002|Overall Study|Adverse Event|2|||
48475955|NCT00554788|155933611|FG000|Overall Study|Lost to Follow-up|4|||
48475956|NCT00554788|155933612|FG001|Overall Study|Lost to Follow-up|3|||
48475957|NCT00554788|155933613|FG002|Overall Study|Lost to Follow-up|3|||
48475958|NCT00554788|155933611|FG000|Overall Study|Physician Decision|1|||
48475959|NCT00554788|155933612|FG001|Overall Study|Physician Decision|1|||
48475960|NCT00554788|155933613|FG002|Overall Study|Physician Decision|3|||
48475961|NCT00554788|155933611|FG000|Overall Study|Withdrawal by Subject|0|||
48475962|NCT00554788|155933612|FG001|Overall Study|Withdrawal by Subject|0|||
48475963|NCT00554788|155933613|FG002|Overall Study|Withdrawal by Subject|1|||
48475964|NCT00554788|155933611|FG000|Overall Study|Refusal of further protocol therapy|0|||
48475965|NCT00554788|155933612|FG001|Overall Study|Refusal of further protocol therapy|1|||
48475966|NCT00554788|155933613|FG002|Overall Study|Refusal of further protocol therapy|1|||
48475967|NCT00554788|155933611|FG000|Overall Study|Progressive disease|0|||
48475968|NCT00554788|155933612|FG001|Overall Study|Progressive disease|0|||
48475969|NCT00554788|155933613|FG002|Overall Study|Progressive disease|3|||
48475970|NCT00554788|155933611|FG000|Overall Study|Ineligible|2|||
48475971|NCT00554788|155933612|FG001|Overall Study|Ineligible|0|||
48475972|NCT00554788|155933613|FG002|Overall Study|Ineligible|1|||
48475973|NCT00560573|155934902|FG000|Overall Study|Death|4|||
48475974|NCT00560573|155934903|FG001|Overall Study|Death|1|||
48475975|NCT00560573|155934904|FG002|Overall Study|Death|4|||
48475976|NCT00560573|155934905|FG003|Overall Study|Death|5|||
48475977|NCT00560573|155934906|FG004|Overall Study|Death|1|||
48475978|NCT00560573|155934907|FG005|Overall Study|Death|10|||
48475979|NCT00560573|155934902|FG000|Overall Study|Lost to Follow-up|0|||
48475980|NCT00560573|155934903|FG001|Overall Study|Lost to Follow-up|0|||
48475981|NCT00560573|155934904|FG002|Overall Study|Lost to Follow-up|0|||
48475982|NCT00560573|155934905|FG003|Overall Study|Lost to Follow-up|1|||
48475983|NCT00560573|155934906|FG004|Overall Study|Lost to Follow-up|1|||
48475984|NCT00560573|155934907|FG005|Overall Study|Lost to Follow-up|0|||
48475985|NCT00560573|155934902|FG000|Overall Study|Withdrawal by Subject|0|||
48475986|NCT00560573|155934903|FG001|Overall Study|Withdrawal by Subject|0|||
48475987|NCT00560573|155934904|FG002|Overall Study|Withdrawal by Subject|0|||
48475988|NCT00560573|155934905|FG003|Overall Study|Withdrawal by Subject|1|||
48475989|NCT00560573|155934906|FG004|Overall Study|Withdrawal by Subject|1|||
48475990|NCT00560573|155934907|FG005|Overall Study|Withdrawal by Subject|0|||
48475991|NCT00560573|155934902|FG000|Overall Study|Other|2|||
48475992|NCT00560573|155934903|FG001|Overall Study|Other|2|||
48475993|NCT00560573|155934904|FG002|Overall Study|Other|2|||
48475994|NCT00560573|155934905|FG003|Overall Study|Other|3|||
48475995|NCT00560573|155934906|FG004|Overall Study|Other|3|||
48475996|NCT00560573|155934907|FG005|Overall Study|Other|3|||
48475997|NCT00560573|155934902|FG000|Overall Study|Enrolled, not treated|0|||
48475998|NCT00560573|155934903|FG001|Overall Study|Enrolled, not treated|0|||
48475999|NCT00560573|155934904|FG002|Overall Study|Enrolled, not treated|0|||
48476000|NCT00560573|155934905|FG003|Overall Study|Enrolled, not treated|0|||
48476001|NCT00560573|155934906|FG004|Overall Study|Enrolled, not treated|1|||
48476002|NCT00560573|155934907|FG005|Overall Study|Enrolled, not treated|0|||
48476003|NCT00344968|155934910|FG000|Overall Study|Adverse Event|5|||
48476004|NCT00344968|155934911|FG001|Overall Study|Adverse Event|4|||
48476005|NCT00344968|155934912|FG002|Overall Study|Adverse Event|15|||
48476006|NCT00344968|155934910|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
48476007|NCT00344968|155934911|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
48476008|NCT00344968|155934912|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
48476009|NCT00344968|155934910|FG000|Overall Study|Protocol Violation|2|||
48476010|NCT00344968|155934911|FG001|Overall Study|Protocol Violation|2|||
48476011|NCT00344968|155934912|FG002|Overall Study|Protocol Violation|5|||
48476012|NCT00344968|155934910|FG000|Overall Study|Withdrawal by Subject|14|||
48476013|NCT00344968|155934911|FG001|Overall Study|Withdrawal by Subject|31|||
48476014|NCT00344968|155934912|FG002|Overall Study|Withdrawal by Subject|27|||
48476015|NCT00344968|155934910|FG000|Overall Study|Lost to Follow-up|24|||
48476016|NCT00344968|155934911|FG001|Overall Study|Lost to Follow-up|37|||
48476017|NCT00344968|155934912|FG002|Overall Study|Lost to Follow-up|37|||
48476018|NCT00344968|155934910|FG000|Overall Study|Death|11|||
48476019|NCT00344968|155934911|FG001|Overall Study|Death|27|||
48476020|NCT00344968|155934912|FG002|Overall Study|Death|31|||
48476021|NCT00344968|155934910|FG000|Overall Study|Other|0|||
48476022|NCT00344968|155934911|FG001|Overall Study|Other|1|||
48476023|NCT00344968|155934912|FG002|Overall Study|Other|0|||
48476024|NCT00594568|155934913|FG000|Initial Treatment|Adverse Event|51|||
48476025|NCT00594568|155934914|FG001|Initial Treatment|Adverse Event|121|||
48476026|NCT00594568|155934915|FG002|Initial Treatment|Adverse Event|144|||
48476027|NCT00594568|155934913|FG000|Initial Treatment|Death|6|||
48476028|NCT00594568|155934914|FG001|Initial Treatment|Death|11|||
48476029|NCT00594568|155934915|FG002|Initial Treatment|Death|15|||
48476030|NCT00594568|155934913|FG000|Initial Treatment|Lost to Follow-up|4|||
48476031|NCT00594568|155934914|FG001|Initial Treatment|Lost to Follow-up|1|||
48476032|NCT00594568|155934915|FG002|Initial Treatment|Lost to Follow-up|4|||
48476033|NCT00594568|155934913|FG000|Initial Treatment|Physician Decision|3|||
48476034|NCT00594568|155934914|FG001|Initial Treatment|Physician Decision|2|||
48476035|NCT00594568|155934915|FG002|Initial Treatment|Physician Decision|4|||
48476036|NCT00594568|155934913|FG000|Initial Treatment|Protocol Violation|2|||
48476037|NCT00594568|155934914|FG001|Initial Treatment|Protocol Violation|2|||
48476038|NCT00594568|155934915|FG002|Initial Treatment|Protocol Violation|5|||
48476039|NCT00594568|155934913|FG000|Initial Treatment|Withdrawal by Subject|25|||
48476040|NCT00594568|155934914|FG001|Initial Treatment|Withdrawal by Subject|31|||
48476041|NCT00594568|155934915|FG002|Initial Treatment|Withdrawal by Subject|46|||
48476042|NCT00594568|155934913|FG000|Initial Treatment|Sponsor decision|193|||
48476043|NCT00594568|155934914|FG001|Initial Treatment|Sponsor decision|142|||
48476044|NCT00594568|155934915|FG002|Initial Treatment|Sponsor decision|147|||
48476045|NCT00594568|155934913|FG000|Initial Treatment|Caregiver decision|21|||
48476046|NCT00594568|155934914|FG001|Initial Treatment|Caregiver decision|36|||
48476047|NCT00594568|155934915|FG002|Initial Treatment|Caregiver decision|36|||
48476048|NCT00594568|155934913|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
48476049|NCT00594568|155934914|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
48476050|NCT00594568|155934915|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
48476051|NCT00594568|155934913|FG000|Initial Treatment|Entry criteria exclusion|0|||
48476052|NCT00594568|155934914|FG001|Initial Treatment|Entry criteria exclusion|1|||
48476053|NCT00594568|155934915|FG002|Initial Treatment|Entry criteria exclusion|1|||
48476054|NCT00594568|155934913|FG000|Delayed Start|Death|0|||
48476055|NCT00594568|155934914|FG001|Delayed Start|Death|0|||
48476056|NCT00594568|155934915|FG002|Delayed Start|Death|1|||
48476057|NCT00594568|155934913|FG000|Delayed Start|Adverse Event|12|||
48476058|NCT00594568|155934914|FG001|Delayed Start|Adverse Event|2|||
48476059|NCT00594568|155934915|FG002|Delayed Start|Adverse Event|2|||
48476060|NCT00594568|155934913|FG000|Delayed Start|Withdrawal by Subject|4|||
48476061|NCT00594568|155934914|FG001|Delayed Start|Withdrawal by Subject|3|||
48476062|NCT00594568|155934915|FG002|Delayed Start|Withdrawal by Subject|0|||
48476063|NCT00594568|155934913|FG000|Delayed Start|Physician Decision|0|||
48476064|NCT00594568|155934914|FG001|Delayed Start|Physician Decision|0|||
48476065|NCT00594568|155934915|FG002|Delayed Start|Physician Decision|1|||
48476066|NCT00594568|155934913|FG000|Delayed Start|Lost to Follow-up|0|||
48476067|NCT00594568|155934914|FG001|Delayed Start|Lost to Follow-up|0|||
48476068|NCT00594568|155934915|FG002|Delayed Start|Lost to Follow-up|1|||
48476069|NCT00594568|155934913|FG000|Delayed Start|Caregiver Decision|5|||
48476070|NCT00594568|155934914|FG001|Delayed Start|Caregiver Decision|6|||
48476071|NCT00594568|155934915|FG002|Delayed Start|Caregiver Decision|2|||
48476072|NCT00594568|155934913|FG000|Delayed Start|Sponsor Decision|77|||
48476073|NCT00594568|155934914|FG001|Delayed Start|Sponsor Decision|66|||
48476074|NCT00594568|155934915|FG002|Delayed Start|Sponsor Decision|59|||
48476075|NCT00594568|155934913|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
48476076|NCT00594568|155934914|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
48476077|NCT00594568|155934915|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
48476078|NCT00594568|155934913|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
48476079|NCT00594568|155934914|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
48476080|NCT00594568|155934915|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
48476081|NCT00594568|155934913|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
48476082|NCT00594568|155934914|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
48476083|NCT00594568|155934915|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
48476084|NCT00594568|155934913|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
48476085|NCT00594568|155934914|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
48476086|NCT00594568|155934915|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
48476087|NCT00594568|155934913|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
48476088|NCT00594568|155934914|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
48476089|NCT00594568|155934915|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
48476090|NCT00594568|155934913|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
48476091|NCT00594568|155934914|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
48476092|NCT00594568|155934915|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
48476093|NCT03735680|155934916|FG000|Overall Study|Withdrawal by Subject|0|||
48476094|NCT03735680|155934917|FG001|Overall Study|Withdrawal by Subject|1|||
48476095|NCT03735680|155934918|FG002|Overall Study|Withdrawal by Subject|0|||
48476096|NCT03735680|155934919|FG003|Overall Study|Withdrawal by Subject|0|||
48476097|NCT03735680|155934920|FG004|Overall Study|Withdrawal by Subject|0|||
48476098|NCT03735680|155934921|FG005|Overall Study|Withdrawal by Subject|1|||
48476099|NCT03735680|155934916|FG000|Overall Study|Patient unable or unwilling to continue|0|||
48476100|NCT03735680|155934917|FG001|Overall Study|Patient unable or unwilling to continue|0|||
48476101|NCT03735680|155934918|FG002|Overall Study|Patient unable or unwilling to continue|1|||
48476102|NCT03735680|155934919|FG003|Overall Study|Patient unable or unwilling to continue|0|||
48476103|NCT03735680|155934920|FG004|Overall Study|Patient unable or unwilling to continue|0|||
48476104|NCT03735680|155934921|FG005|Overall Study|Patient unable or unwilling to continue|0|||
48476105|NCT00457249|155934923|FG000|Overall Study|Lost to Follow-up|3|||
48476106|NCT00457249|155934924|FG001|Overall Study|Lost to Follow-up|0|||
48476107|NCT00457249|155934923|FG000|Overall Study|Protocol Violation|4|||
48476108|NCT00457249|155934924|FG001|Overall Study|Protocol Violation|1|||
48476109|NCT00457249|155934923|FG000|Overall Study|Withdrawal by Subject|3|||
48476110|NCT00457249|155934924|FG001|Overall Study|Withdrawal by Subject|1|||
48476111|NCT00457249|155934923|FG000|Overall Study|Serious Adverse Events|2|||
48476112|NCT00457249|155934924|FG001|Overall Study|Serious Adverse Events|0|||
48476113|NCT00396318|155934925|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
48476114|NCT00326118|155934926|FG000|Active Phase|Withdrawal by Subject|4|||
48476115|NCT00326118|155934927|FG001|Active Phase|Withdrawal by Subject|1|||
48476117|NCT01808508|155934929|FG001|Overall Study|Lost to Follow-up|0|||
48476118|NCT01808508|155934930|FG002|Overall Study|Lost to Follow-up|0|||
48476119|NCT01118949|155934931|FG000|Overall Study|Adverse Event|5|||
48476120|NCT01118949|155934931|FG000|Overall Study|Withdrawal by Subject|4|||
48476121|NCT02916056|155934934|FG000|Overall Study|Adverse Event|6|||
48476122|NCT02916056|155934934|FG000|Overall Study|Lost to Follow-up|1|||
48476123|NCT02916056|155934934|FG000|Overall Study|Other|12|||
48476124|NCT02916056|155934934|FG000|Overall Study|Protocol Violation|1|||
48476125|NCT02916056|155934934|FG000|Overall Study|Withdrawal by Subject|8|||
48476126|NCT02916056|155934934|FG000|Overall Study|Study Terminated by Sponsor|269|||
48476127|NCT00290511|155934935|FG000|Overall Study|Adverse Event|1|||
48476128|NCT00290511|155934935|FG000|Overall Study|Death|1|||
48476129|NCT00290511|155934935|FG000|Overall Study|Physician Decision|1|||
48476130|NCT00290511|155934935|FG000|Overall Study|Withdrawal by Subject|1|||
48476131|NCT00124709|155934936|FG000|Overall Study|Randomized but did not take medication|3|||
48476132|NCT00124709|155934937|FG001|Overall Study|Randomized but did not take medication|1|||
48476133|NCT00124709|155934936|FG000|Overall Study|Adverse Event|3|||
48476134|NCT00124709|155934937|FG001|Overall Study|Adverse Event|0|||
48476135|NCT00124709|155934936|FG000|Overall Study|Lack of Efficacy|5|||
48476136|NCT00124709|155934937|FG001|Overall Study|Lack of Efficacy|10|||
48476137|NCT00124709|155934936|FG000|Overall Study|Protocol Violation|3|||
48476138|NCT00124709|155934937|FG001|Overall Study|Protocol Violation|5|||
48476139|NCT00124709|155934936|FG000|Overall Study|Withdrawal by Subject|127|||
48476140|NCT00124709|155934937|FG001|Overall Study|Withdrawal by Subject|136|||
48476141|NCT00124709|155934936|FG000|Overall Study|Lost to Follow-up|114|||
48476142|NCT00124709|155934937|FG001|Overall Study|Lost to Follow-up|120|||
48476143|NCT00122954|155934938|FG000|Overall Study|Withdrawal by Subject|2|||
48476144|NCT00122954|155934939|FG001|Overall Study|Withdrawal by Subject|2|||
48476145|NCT00122954|155934938|FG000|Overall Study|Protocol Violation|0|||
48476146|NCT00122954|155934939|FG001|Overall Study|Protocol Violation|1|||
48476147|NCT03255226|155934940|FG000|Overall Study|Adverse Event|2|||
48476148|NCT03255226|155934940|FG000|Overall Study|Physician Decision|3|||
48476149|NCT03255226|155934940|FG000|Overall Study|Withdrawal by Subject|1|||
48476150|NCT03255226|155934940|FG000|Overall Study|Serum or blood sodium increased|4|||
48476151|NCT03255226|155934940|FG000|Overall Study|Serum or blood potassium increased|4|||
48476152|NCT01017731|155934941|FG000|Overall Study|Lost to Follow-up|2|||
48476153|NCT01017731|155934941|FG000|Overall Study|Withdrawal by Subject|3|||
48476154|NCT01017731|155934941|FG000|Overall Study|Physician Decision|2|||
48476155|NCT01017731|155934941|FG000|Overall Study|Adverse Event|1|||
48476156|NCT03253809|155934946|FG000|Overall Study|Unable to obtain study related data|14|||
48476157|NCT01068418|155934947|FG000|Overall Study|Physician Decision|12|||
48476158|NCT02871921|155934948|FG000|Overall Study|Withdrawal by Subject|34|||
48476159|NCT02871921|155934949|FG001|Overall Study|Withdrawal by Subject|27|||
48476160|NCT02871921|155934950|FG002|Overall Study|Withdrawal by Subject|27|||
48476161|NCT02871921|155934951|FG003|Overall Study|Withdrawal by Subject|30|||
48476162|NCT01826201|155934954|FG000|Overall Study|Non compliance with protocol|4|||
48476163|NCT00539006|155934957|FG000|Pre-treatment|Other|0|||
48476164|NCT00539006|155934958|FG001|Pre-treatment|Other|1|||
48476165|NCT00539006|155934959|FG002|Pre-treatment|Other|0|||
48476166|NCT00539006|155934960|FG003|Pre-treatment|Other|0|||
48476167|NCT00539006|155934957|FG000|Treatment Period 1|Lost to Follow-up|0|||
48476168|NCT00539006|155934958|FG001|Treatment Period 1|Lost to Follow-up|0|||
48476169|NCT00539006|155934959|FG002|Treatment Period 1|Lost to Follow-up|1|||
48476170|NCT00539006|155934960|FG003|Treatment Period 1|Lost to Follow-up|0|||
48476171|NCT00539006|155934957|FG000|Treatment Period 1|Protocol Violation|0|||
48476172|NCT00539006|155934958|FG001|Treatment Period 1|Protocol Violation|0|||
48476173|NCT00539006|155934959|FG002|Treatment Period 1|Protocol Violation|1|||
48476174|NCT00539006|155934960|FG003|Treatment Period 1|Protocol Violation|0|||
48476175|NCT00539006|155934957|FG000|Treatment Period 1|Lack of Efficacy|0|||
48476176|NCT00539006|155934958|FG001|Treatment Period 1|Lack of Efficacy|0|||
48476177|NCT00539006|155934959|FG002|Treatment Period 1|Lack of Efficacy|0|||
48476178|NCT00539006|155934960|FG003|Treatment Period 1|Lack of Efficacy|1|||
48476179|NCT00539006|155934957|FG000|Washout|Adverse Event|2|||
48476180|NCT00539006|155934958|FG001|Washout|Adverse Event|1|||
48476181|NCT00539006|155934959|FG002|Washout|Adverse Event|0|||
48476182|NCT00539006|155934960|FG003|Washout|Adverse Event|0|||
48476183|NCT00539006|155934957|FG000|Washout|Protocol Violation|1|||
48476184|NCT00539006|155934958|FG001|Washout|Protocol Violation|1|||
48476185|NCT00539006|155934959|FG002|Washout|Protocol Violation|0|||
48476186|NCT00539006|155934960|FG003|Washout|Protocol Violation|0|||
48476187|NCT00539006|155934957|FG000|Washout|Withdrawal by Subject|0|||
48476188|NCT00539006|155934958|FG001|Washout|Withdrawal by Subject|2|||
48476189|NCT00539006|155934959|FG002|Washout|Withdrawal by Subject|0|||
48476190|NCT00539006|155934960|FG003|Washout|Withdrawal by Subject|0|||
48476191|NCT00539006|155934957|FG000|Washout|Failed to meet continuation criteria|16|||
48476192|NCT00539006|155934958|FG001|Washout|Failed to meet continuation criteria|5|||
48476193|NCT00539006|155934959|FG002|Washout|Failed to meet continuation criteria|14|||
48476194|NCT00539006|155934960|FG003|Washout|Failed to meet continuation criteria|6|||
48476195|NCT00539006|155934957|FG000|Washout|Other|1|||
48476196|NCT00539006|155934958|FG001|Washout|Other|1|||
48476197|NCT00539006|155934959|FG002|Washout|Other|2|||
48476198|NCT00539006|155934960|FG003|Washout|Other|3|||
48476199|NCT00539006|155934957|FG000|Treatment Period 2|Protocol Violation|1|||
48476200|NCT00539006|155934958|FG001|Treatment Period 2|Protocol Violation|0|||
48476201|NCT00539006|155934959|FG002|Treatment Period 2|Protocol Violation|0|||
48476202|NCT00539006|155934960|FG003|Treatment Period 2|Protocol Violation|0|||
48476203|NCT00539006|155934957|FG000|Treatment Period 2|Other|0|||
48476204|NCT00539006|155934958|FG001|Treatment Period 2|Other|1|||
48476205|NCT00539006|155934959|FG002|Treatment Period 2|Other|0|||
48476206|NCT00539006|155934960|FG003|Treatment Period 2|Other|0|||
48476207|NCT02769832|155934961|FG000|Overall Study|Death|30|||
48476208|NCT01615822|155934962|FG000|Period 1|Withdrawal by Subject|0|||
48476209|NCT01615822|155934963|FG001|Period 1|Withdrawal by Subject|1|||
48476210|NCT01615822|155934964|FG002|Period 1|Withdrawal by Subject|0|||
48476211|NCT01615822|155934962|FG000|Period 1|Adverse Event|1|||
48476212|NCT01615822|155934963|FG001|Period 1|Adverse Event|1|||
48476213|NCT01615822|155934964|FG002|Period 1|Adverse Event|0|||
48476214|NCT01615822|155934962|FG000|Period 2|Lost to Follow-up|0|||
48476215|NCT01615822|155934963|FG001|Period 2|Lost to Follow-up|1|||
48476216|NCT01615822|155934964|FG002|Period 2|Lost to Follow-up|2|||
48476217|NCT00902265|155934971|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
48476218|NCT00902265|155934971|FG000|Overall Study|Adverse Event|2|||
48476219|NCT00902265|155934971|FG000|Overall Study|Lack of Efficacy|2|||
48476220|NCT00902265|155934971|FG000|Overall Study|Protocol Violation|1|||
48476221|NCT04764669|155934976|FG000|Overall Study|Adverse Event|1|||
48476222|NCT04764669|155934977|FG001|Overall Study|Adverse Event|0|||
48476223|NCT04764669|155934978|FG002|Overall Study|Adverse Event|1|||
48476224|NCT04764669|155934979|FG003|Overall Study|Adverse Event|0|||
48476225|NCT04764669|155934976|FG000|Overall Study|Subject Choice|0|||
48476226|NCT04764669|155934977|FG001|Overall Study|Subject Choice|0|||
48476227|NCT04764669|155934978|FG002|Overall Study|Subject Choice|1|||
48476228|NCT04764669|155934979|FG003|Overall Study|Subject Choice|0|||
48476229|NCT04764669|155934976|FG000|Overall Study|Withdrawal by Subject|2|||
48476230|NCT04764669|155934977|FG001|Overall Study|Withdrawal by Subject|0|||
48476231|NCT04764669|155934978|FG002|Overall Study|Withdrawal by Subject|0|||
48476232|NCT04764669|155934979|FG003|Overall Study|Withdrawal by Subject|0|||
48476233|NCT00807040|155934980|FG000|Overall Study|Death|24|||
48476234|NCT00807040|155934981|FG001|Overall Study|Death|29|||
48476235|NCT00807040|155934980|FG000|Overall Study|Withdrawal by Subject|8|||
48476236|NCT00807040|155934981|FG001|Overall Study|Withdrawal by Subject|6|||
48476237|NCT00807040|155934980|FG000|Overall Study|Lost to Follow-up|4|||
48476238|NCT00807040|155934981|FG001|Overall Study|Lost to Follow-up|6|||
48476239|NCT03940742|155934986|FG000|Overall Study|Lost to Follow-up|0|||
48476240|NCT03940742|155934987|FG001|Overall Study|Lost to Follow-up|0|||
48476241|NCT03940742|155934988|FG002|Overall Study|Lost to Follow-up|0|||
48476242|NCT03940742|155934989|FG003|Overall Study|Lost to Follow-up|1|||
48476243|NCT02353572|155934990|FG000|Overall Study|Withdrawal by Subject|1|||
48476244|NCT02353572|155934990|FG000|Overall Study|Study terminated|2|||
48476245|NCT00077766|155934994|FG000|Overall Study|Adverse Event|1|||
48476246|NCT00077766|155934995|FG001|Overall Study|Adverse Event|1|||
48476247|NCT00077766|155934994|FG000|Overall Study|Withdrawal by Subject|4|||
48476248|NCT00077766|155934995|FG001|Overall Study|Withdrawal by Subject|3|||
48476249|NCT00077766|155934994|FG000|Overall Study|Death|12|||
48476250|NCT00077766|155934995|FG001|Overall Study|Death|10|||
48476251|NCT00077766|155934994|FG000|Overall Study|Lost to Follow-up|2|||
48476252|NCT00077766|155934995|FG001|Overall Study|Lost to Follow-up|0|||
48476253|NCT00077766|155934994|FG000|Overall Study|Protocol Violation|1|||
48476254|NCT00077766|155934995|FG001|Overall Study|Protocol Violation|0|||
48476255|NCT00077766|155934994|FG000|Overall Study|Kidney Transplantation|9|||
48476256|NCT00077766|155934995|FG001|Overall Study|Kidney Transplantation|5|||
48476257|NCT00077766|155934994|FG000|Overall Study|Transplantation|5|||
48476258|NCT00077766|155934995|FG001|Overall Study|Transplantation|1|||
48476259|NCT00077766|155934994|FG000|Overall Study|Investigators Discretion|1|||
48476260|NCT00077766|155934995|FG001|Overall Study|Investigators Discretion|0|||
48476261|NCT00077766|155934994|FG000|Overall Study|Participant's decision|1|||
48476262|NCT00077766|155934995|FG001|Overall Study|Participant's decision|0|||
48476263|NCT00077766|155934994|FG000|Overall Study|Dialysis Discontinued|1|||
48476264|NCT00077766|155934995|FG001|Overall Study|Dialysis Discontinued|0|||
48476265|NCT00077766|155934994|FG000|Overall Study|Dialysis|0|||
48476266|NCT00077766|155934995|FG001|Overall Study|Dialysis|1|||
48476267|NCT00077766|155934994|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
48476268|NCT00077766|155934995|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
48476269|NCT00077766|155934994|FG000|Overall Study|Started Nocturnal Dialysis|0|||
48476270|NCT00077766|155934995|FG001|Overall Study|Started Nocturnal Dialysis|1|||
48476271|NCT00077766|155934994|FG000|Overall Study|Stop Dialysis|0|||
48476272|NCT00077766|155934995|FG001|Overall Study|Stop Dialysis|1|||
48476273|NCT00077766|155934994|FG000|Overall Study|Participants Vacation|2|||
48476274|NCT00077766|155934995|FG001|Overall Study|Participants Vacation|1|||
48476275|NCT04611152|155935005|FG000|Overall Study|Adverse Event|9|||
48476276|NCT04611152|155935006|FG001|Overall Study|Adverse Event|8|||
48476277|NCT04611152|155935005|FG000|Overall Study|Non-compliance with study schedule|1|||
48476278|NCT04611152|155935006|FG001|Overall Study|Non-compliance with study schedule|3|||
48476279|NCT04611152|155935005|FG000|Overall Study|Withdrawal by Subject|5|||
48476280|NCT04611152|155935006|FG001|Overall Study|Withdrawal by Subject|6|||
48476281|NCT04611152|155935005|FG000|Overall Study|Lost to Follow-up|11|||
48476282|NCT04611152|155935006|FG001|Overall Study|Lost to Follow-up|2|||
48476283|NCT04456998|155935007|FG000|Overall Study|Adverse Event|0|||
48476284|NCT04456998|155935008|FG001|Overall Study|Adverse Event|4|||
48476285|NCT04456998|155935007|FG000|Overall Study|Protocol Deviation|0|||
48476286|NCT04456998|155935008|FG001|Overall Study|Protocol Deviation|1|||
48476287|NCT04456998|155935007|FG000|Overall Study|Withdrawal by Subject|0|||
48476288|NCT04456998|155935008|FG001|Overall Study|Withdrawal by Subject|1|||
48476289|NCT03917654|155935009|FG000|Year 1|Withdrawal by Subject|1|||
48476290|NCT03917654|155935010|FG001|Year 1|Withdrawal by Subject|0|||
48476291|NCT03917654|155935011|FG002|Year 1|Withdrawal by Subject|0|||
48476292|NCT03917654|155935012|FG003|Year 1|Withdrawal by Subject|0|||
48476293|NCT03917654|155935013|FG004|Year 1|Withdrawal by Subject|0|||
48476294|NCT03917654|155935014|FG005|Year 1|Withdrawal by Subject|1|||
48476295|NCT03917654|155935015|FG006|Year 1|Withdrawal by Subject|6|||
48476296|NCT03917654|155935016|FG007|Year 1|Withdrawal by Subject|2|||
48476297|NCT03917654|155935017|FG008|Year 1|Withdrawal by Subject|5|||
48476298|NCT03917654|155935018|FG009|Year 1|Withdrawal by Subject|3|||
48476299|NCT03917654|155935019|FG010|Year 1|Withdrawal by Subject|1|||
48476300|NCT03917654|155935020|FG011|Year 1|Withdrawal by Subject|0|||
48476301|NCT03917654|155935009|FG000|Year 1|Travel|0|||
48476302|NCT03917654|155935010|FG001|Year 1|Travel|1|||
48476303|NCT03917654|155935011|FG002|Year 1|Travel|1|||
48476304|NCT03917654|155935012|FG003|Year 1|Travel|0|||
48476305|NCT03917654|155935013|FG004|Year 1|Travel|4|||
48476306|NCT03917654|155935014|FG005|Year 1|Travel|4|||
48476307|NCT03917654|155935015|FG006|Year 1|Travel|10|||
48476308|NCT03917654|155935016|FG007|Year 1|Travel|8|||
48476309|NCT03917654|155935017|FG008|Year 1|Travel|2|||
48476310|NCT03917654|155935018|FG009|Year 1|Travel|5|||
48476311|NCT03917654|155935019|FG010|Year 1|Travel|3|||
48476312|NCT03917654|155935020|FG011|Year 1|Travel|3|||
48476313|NCT03917654|155935009|FG000|Year 1|Subject moved away from site|0|||
48476314|NCT03917654|155935010|FG001|Year 1|Subject moved away from site|1|||
48476315|NCT03917654|155935011|FG002|Year 1|Subject moved away from site|0|||
48476316|NCT03917654|155935012|FG003|Year 1|Subject moved away from site|0|||
48476317|NCT03917654|155935013|FG004|Year 1|Subject moved away from site|0|||
48476318|NCT03917654|155935014|FG005|Year 1|Subject moved away from site|0|||
48476319|NCT03917654|155935015|FG006|Year 1|Subject moved away from site|1|||
48476320|NCT03917654|155935016|FG007|Year 1|Subject moved away from site|2|||
48476321|NCT03917654|155935017|FG008|Year 1|Subject moved away from site|1|||
48476322|NCT03917654|155935018|FG009|Year 1|Subject moved away from site|0|||
48476323|NCT03917654|155935019|FG010|Year 1|Subject moved away from site|0|||
48476324|NCT03917654|155935020|FG011|Year 1|Subject moved away from site|3|||
48476325|NCT03917654|155935009|FG000|Year 1|Spouse/Family member request|0|||
48476326|NCT03917654|155935010|FG001|Year 1|Spouse/Family member request|0|||
48476327|NCT03917654|155935011|FG002|Year 1|Spouse/Family member request|1|||
48476328|NCT03917654|155935012|FG003|Year 1|Spouse/Family member request|0|||
48476329|NCT03917654|155935013|FG004|Year 1|Spouse/Family member request|1|||
48476330|NCT03917654|155935014|FG005|Year 1|Spouse/Family member request|0|||
48476331|NCT03917654|155935015|FG006|Year 1|Spouse/Family member request|0|||
48476332|NCT03917654|155935016|FG007|Year 1|Spouse/Family member request|2|||
48476333|NCT03917654|155935017|FG008|Year 1|Spouse/Family member request|0|||
48476334|NCT03917654|155935018|FG009|Year 1|Spouse/Family member request|0|||
48476335|NCT03917654|155935019|FG010|Year 1|Spouse/Family member request|0|||
48476336|NCT03917654|155935020|FG011|Year 1|Spouse/Family member request|1|||
48476337|NCT03917654|155935009|FG000|Year 1|Death|0|||
48476338|NCT03917654|155935010|FG001|Year 1|Death|0|||
48476339|NCT03917654|155935011|FG002|Year 1|Death|0|||
48476340|NCT03917654|155935012|FG003|Year 1|Death|0|||
48476341|NCT03917654|155935013|FG004|Year 1|Death|0|||
48476342|NCT03917654|155935014|FG005|Year 1|Death|0|||
48476343|NCT03917654|155935015|FG006|Year 1|Death|0|||
48476344|NCT03917654|155935016|FG007|Year 1|Death|0|||
48476345|NCT03917654|155935017|FG008|Year 1|Death|1|||
48476346|NCT03917654|155935018|FG009|Year 1|Death|1|||
48476347|NCT03917654|155935019|FG010|Year 1|Death|0|||
48476348|NCT03917654|155935020|FG011|Year 1|Death|0|||
48476349|NCT03917654|155935009|FG000|Year 1|Lost to Follow-up|0|||
48476350|NCT03917654|155935010|FG001|Year 1|Lost to Follow-up|0|||
48476351|NCT03917654|155935011|FG002|Year 1|Lost to Follow-up|0|||
48476352|NCT03917654|155935012|FG003|Year 1|Lost to Follow-up|0|||
48476353|NCT03917654|155935013|FG004|Year 1|Lost to Follow-up|0|||
48476354|NCT03917654|155935014|FG005|Year 1|Lost to Follow-up|0|||
48476355|NCT03917654|155935015|FG006|Year 1|Lost to Follow-up|2|||
48476356|NCT03917654|155935016|FG007|Year 1|Lost to Follow-up|0|||
48476357|NCT03917654|155935017|FG008|Year 1|Lost to Follow-up|0|||
48476358|NCT03917654|155935018|FG009|Year 1|Lost to Follow-up|0|||
48476359|NCT03917654|155935019|FG010|Year 1|Lost to Follow-up|0|||
48476360|NCT03917654|155935020|FG011|Year 1|Lost to Follow-up|0|||
48476361|NCT03917654|155935009|FG000|Year 1|Missed visits|0|||
48476362|NCT03917654|155935010|FG001|Year 1|Missed visits|0|||
48476363|NCT03917654|155935011|FG002|Year 1|Missed visits|0|||
48476364|NCT03917654|155935012|FG003|Year 1|Missed visits|0|||
48476365|NCT03917654|155935013|FG004|Year 1|Missed visits|0|||
48476366|NCT03917654|155935014|FG005|Year 1|Missed visits|0|||
48476367|NCT03917654|155935015|FG006|Year 1|Missed visits|0|||
48476368|NCT03917654|155935016|FG007|Year 1|Missed visits|0|||
48476369|NCT03917654|155935017|FG008|Year 1|Missed visits|0|||
48476370|NCT03917654|155935018|FG009|Year 1|Missed visits|0|||
48476371|NCT03917654|155935019|FG010|Year 1|Missed visits|1|||
48476372|NCT03917654|155935020|FG011|Year 1|Missed visits|1|||
48476373|NCT03917654|155935009|FG000|Year 1|Pregnancy|0|||
48476374|NCT03917654|155935010|FG001|Year 1|Pregnancy|0|||
48476375|NCT03917654|155935011|FG002|Year 1|Pregnancy|0|||
48476376|NCT03917654|155935012|FG003|Year 1|Pregnancy|0|||
48476377|NCT03917654|155935013|FG004|Year 1|Pregnancy|0|||
48476378|NCT03917654|155935014|FG005|Year 1|Pregnancy|0|||
48476379|NCT03917654|155935015|FG006|Year 1|Pregnancy|0|||
48476380|NCT03917654|155935016|FG007|Year 1|Pregnancy|1|||
48476381|NCT03917654|155935017|FG008|Year 1|Pregnancy|0|||
48476382|NCT03917654|155935018|FG009|Year 1|Pregnancy|1|||
48476383|NCT03917654|155935019|FG010|Year 1|Pregnancy|0|||
48476384|NCT03917654|155935020|FG011|Year 1|Pregnancy|0|||
48476385|NCT03917654|155935009|FG000|Year 2|Travel|1|||
48476386|NCT03917654|155935010|FG001|Year 2|Travel|0|||
48476387|NCT03917654|155935011|FG002|Year 2|Travel|0|||
48476388|NCT03917654|155935012|FG003|Year 2|Travel|0|||
48476389|NCT03917654|155935013|FG004|Year 2|Travel|1|||
48476390|NCT03917654|155935014|FG005|Year 2|Travel|1|||
48476391|NCT03917654|155935015|FG006|Year 2|Travel|2|||
48476392|NCT03917654|155935016|FG007|Year 2|Travel|1|||
48476393|NCT03917654|155935017|FG008|Year 2|Travel|0|||
48476394|NCT03917654|155935018|FG009|Year 2|Travel|1|||
48476395|NCT03917654|155935019|FG010|Year 2|Travel|0|||
48476396|NCT03917654|155935020|FG011|Year 2|Travel|1|||
48476397|NCT03917654|155935009|FG000|Year 2|Married|1|||
48476398|NCT03917654|155935010|FG001|Year 2|Married|0|||
48476399|NCT03917654|155935011|FG002|Year 2|Married|0|||
48476400|NCT03917654|155935012|FG003|Year 2|Married|0|||
48476401|NCT03917654|155935013|FG004|Year 2|Married|0|||
48476402|NCT03917654|155935014|FG005|Year 2|Married|0|||
48476403|NCT03917654|155935015|FG006|Year 2|Married|1|||
48476404|NCT03917654|155935016|FG007|Year 2|Married|1|||
48476405|NCT03917654|155935017|FG008|Year 2|Married|0|||
48476406|NCT03917654|155935018|FG009|Year 2|Married|0|||
48476407|NCT03917654|155935019|FG010|Year 2|Married|0|||
48476408|NCT03917654|155935020|FG011|Year 2|Married|0|||
48476409|NCT03917654|155935009|FG000|Year 2|Subject moved away from site|1|||
48476410|NCT03917654|155935010|FG001|Year 2|Subject moved away from site|0|||
48476411|NCT03917654|155935011|FG002|Year 2|Subject moved away from site|0|||
48476412|NCT03917654|155935012|FG003|Year 2|Subject moved away from site|0|||
48476413|NCT03917654|155935013|FG004|Year 2|Subject moved away from site|1|||
48476414|NCT03917654|155935014|FG005|Year 2|Subject moved away from site|0|||
48476415|NCT03917654|155935015|FG006|Year 2|Subject moved away from site|2|||
48476416|NCT03917654|155935016|FG007|Year 2|Subject moved away from site|3|||
48476417|NCT03917654|155935017|FG008|Year 2|Subject moved away from site|0|||
48476418|NCT03917654|155935018|FG009|Year 2|Subject moved away from site|2|||
48476419|NCT03917654|155935019|FG010|Year 2|Subject moved away from site|0|||
48476420|NCT03917654|155935020|FG011|Year 2|Subject moved away from site|1|||
48476421|NCT03917654|155935009|FG000|Year 2|Year 2 Screening failure|0|||
48476422|NCT03917654|155935010|FG001|Year 2|Year 2 Screening failure|1|||
48476423|NCT03917654|155935011|FG002|Year 2|Year 2 Screening failure|0|||
48476424|NCT03917654|155935012|FG003|Year 2|Year 2 Screening failure|0|||
48476425|NCT03917654|155935013|FG004|Year 2|Year 2 Screening failure|2|||
48476426|NCT03917654|155935014|FG005|Year 2|Year 2 Screening failure|0|||
48476427|NCT03917654|155935015|FG006|Year 2|Year 2 Screening failure|4|||
48476428|NCT03917654|155935016|FG007|Year 2|Year 2 Screening failure|3|||
48476429|NCT03917654|155935017|FG008|Year 2|Year 2 Screening failure|10|||
48476430|NCT03917654|155935018|FG009|Year 2|Year 2 Screening failure|2|||
48476431|NCT03917654|155935019|FG010|Year 2|Year 2 Screening failure|1|||
48476432|NCT03917654|155935020|FG011|Year 2|Year 2 Screening failure|1|||
48476433|NCT03917654|155935009|FG000|Year 2|Death|0|||
48476434|NCT03917654|155935010|FG001|Year 2|Death|0|||
48476435|NCT03917654|155935011|FG002|Year 2|Death|0|||
48476436|NCT03917654|155935012|FG003|Year 2|Death|0|||
48476437|NCT03917654|155935013|FG004|Year 2|Death|0|||
48476438|NCT03917654|155935014|FG005|Year 2|Death|1|||
48476439|NCT03917654|155935015|FG006|Year 2|Death|0|||
48476440|NCT03917654|155935016|FG007|Year 2|Death|0|||
48476441|NCT03917654|155935017|FG008|Year 2|Death|1|||
48476442|NCT03917654|155935018|FG009|Year 2|Death|1|||
48476443|NCT03917654|155935019|FG010|Year 2|Death|0|||
48476444|NCT03917654|155935020|FG011|Year 2|Death|0|||
48476445|NCT03917654|155935009|FG000|Year 2|Withdrawal by Subject|0|||
48476446|NCT03917654|155935010|FG001|Year 2|Withdrawal by Subject|0|||
48476447|NCT03917654|155935011|FG002|Year 2|Withdrawal by Subject|0|||
48476448|NCT03917654|155935012|FG003|Year 2|Withdrawal by Subject|0|||
48476449|NCT03917654|155935013|FG004|Year 2|Withdrawal by Subject|0|||
48476450|NCT03917654|155935014|FG005|Year 2|Withdrawal by Subject|0|||
48476451|NCT03917654|155935015|FG006|Year 2|Withdrawal by Subject|3|||
48476452|NCT03917654|155935016|FG007|Year 2|Withdrawal by Subject|0|||
48476453|NCT03917654|155935017|FG008|Year 2|Withdrawal by Subject|2|||
48476454|NCT03917654|155935018|FG009|Year 2|Withdrawal by Subject|5|||
48476455|NCT03917654|155935019|FG010|Year 2|Withdrawal by Subject|0|||
48476456|NCT03917654|155935020|FG011|Year 2|Withdrawal by Subject|0|||
48476457|NCT03917654|155935009|FG000|Year 2|Spouse/family member request|0|||
48476458|NCT03917654|155935010|FG001|Year 2|Spouse/family member request|0|||
48476459|NCT03917654|155935011|FG002|Year 2|Spouse/family member request|0|||
48476460|NCT03917654|155935012|FG003|Year 2|Spouse/family member request|0|||
48476461|NCT03917654|155935013|FG004|Year 2|Spouse/family member request|0|||
48476462|NCT03917654|155935014|FG005|Year 2|Spouse/family member request|0|||
48476463|NCT03917654|155935015|FG006|Year 2|Spouse/family member request|1|||
48476464|NCT03917654|155935016|FG007|Year 2|Spouse/family member request|0|||
48476465|NCT03917654|155935017|FG008|Year 2|Spouse/family member request|0|||
48476466|NCT03917654|155935018|FG009|Year 2|Spouse/family member request|0|||
48476467|NCT03917654|155935019|FG010|Year 2|Spouse/family member request|0|||
48476468|NCT03917654|155935020|FG011|Year 2|Spouse/family member request|0|||
48476469|NCT03917654|155935009|FG000|Year 2|Lost to Follow-up|0|||
48476470|NCT03917654|155935010|FG001|Year 2|Lost to Follow-up|0|||
48476471|NCT03917654|155935011|FG002|Year 2|Lost to Follow-up|0|||
48476472|NCT03917654|155935012|FG003|Year 2|Lost to Follow-up|0|||
48476473|NCT03917654|155935013|FG004|Year 2|Lost to Follow-up|0|||
48476474|NCT03917654|155935014|FG005|Year 2|Lost to Follow-up|0|||
48476475|NCT03917654|155935015|FG006|Year 2|Lost to Follow-up|1|||
48476476|NCT03917654|155935016|FG007|Year 2|Lost to Follow-up|0|||
48476477|NCT03917654|155935017|FG008|Year 2|Lost to Follow-up|1|||
48476478|NCT03917654|155935018|FG009|Year 2|Lost to Follow-up|0|||
48476479|NCT03917654|155935019|FG010|Year 2|Lost to Follow-up|0|||
48476480|NCT03917654|155935020|FG011|Year 2|Lost to Follow-up|1|||
48476481|NCT03917654|155935009|FG000|Year 2|Adverse Event|0|||
48476482|NCT03917654|155935010|FG001|Year 2|Adverse Event|0|||
48476483|NCT03917654|155935011|FG002|Year 2|Adverse Event|0|||
48476484|NCT03917654|155935012|FG003|Year 2|Adverse Event|0|||
48476485|NCT03917654|155935013|FG004|Year 2|Adverse Event|0|||
48476486|NCT03917654|155935014|FG005|Year 2|Adverse Event|0|||
48476487|NCT03917654|155935015|FG006|Year 2|Adverse Event|0|||
48476488|NCT03917654|155935016|FG007|Year 2|Adverse Event|0|||
48476489|NCT03917654|155935017|FG008|Year 2|Adverse Event|0|||
48476490|NCT03917654|155935018|FG009|Year 2|Adverse Event|1|||
48476491|NCT03917654|155935019|FG010|Year 2|Adverse Event|0|||
48476492|NCT03917654|155935020|FG011|Year 2|Adverse Event|0|||
48476493|NCT00621309|155935021|FG000|Overall Study|Withdrawal by Subject|2|||
48476494|NCT00621309|155935022|FG001|Overall Study|Withdrawal by Subject|0|||
48476495|NCT00621309|155935023|FG002|Overall Study|Withdrawal by Subject|1|||
48476496|NCT00621309|155935024|FG003|Overall Study|Withdrawal by Subject|1|||
48476497|NCT00621309|155935025|FG004|Overall Study|Withdrawal by Subject|1|||
48476498|NCT00621309|155935026|FG005|Overall Study|Withdrawal by Subject|1|||
48476499|NCT00285012|155935027|FG000|Assigned to Study Treatment (Tx)|Other|2|||
48476500|NCT00285012|155935028|FG001|Assigned to Study Treatment (Tx)|Other|3|||
48476501|NCT00285012|155935027|FG000|Received Study Tx|Death|2|||
48476502|NCT00285012|155935028|FG001|Received Study Tx|Death|1|||
48476503|NCT00285012|155935027|FG000|Received Study Tx|Adverse Event|5|||
48476504|NCT00285012|155935028|FG001|Received Study Tx|Adverse Event|11|||
48476505|NCT00285012|155935027|FG000|Received Study Tx|Lack of Efficacy|0|||
48476506|NCT00285012|155935028|FG001|Received Study Tx|Lack of Efficacy|3|||
48476507|NCT00285012|155935027|FG000|Received Study Tx|Lost to Follow-up|29|||
48476508|NCT00285012|155935028|FG001|Received Study Tx|Lost to Follow-up|31|||
48476509|NCT00285012|155935027|FG000|Received Study Tx|Withdrawal by Subject|31|||
48476510|NCT00285012|155935028|FG001|Received Study Tx|Withdrawal by Subject|43|||
48476511|NCT00285012|155935027|FG000|Received Study Tx|Other|5|||
48476512|NCT00285012|155935028|FG001|Received Study Tx|Other|5|||
48476513|NCT01250418|155935029|FG000|Overall Study|monitor data failure|1|||
48476514|NCT01250418|155935030|FG001|Overall Study|monitor data failure|1|||
48476515|NCT01071278|155935031|FG000|Overall Study|Premature Discontinuation|254|||
48476516|NCT01071278|155935031|FG000|Overall Study|Completion Status Unknown|459|||
48476517|NCT00352664|155935032|FG000|Overall Study|Withdrawal by Subject|7|||
48476518|NCT00352664|155935033|FG001|Overall Study|Withdrawal by Subject|0|||
48476519|NCT03252756|155935034|FG000|Overall Study|Protocol Violation|2|||
48476520|NCT03252756|155935035|FG001|Overall Study|Protocol Violation|4|||
48476521|NCT03252756|155935034|FG000|Overall Study|COVID-19 Pandemic|1|||
48476522|NCT03252756|155935035|FG001|Overall Study|COVID-19 Pandemic|1|||
48476523|NCT03252756|155935034|FG000|Overall Study|Study Drug Expiration|0|||
48476524|NCT03252756|155935035|FG001|Overall Study|Study Drug Expiration|1|||
48476525|NCT03868059|155935036|FG000|Overall Study|Adverse Event|3|||
48476526|NCT03868059|155935036|FG000|Overall Study|Lost to Follow-up|3|||
48476527|NCT03868059|155935036|FG000|Overall Study|Withdrawal by Subject|6|||
48476528|NCT04278872|155935038|FG000|Overall Study|Adverse Event|1|||
48476529|NCT04278872|155935039|FG001|Overall Study|Adverse Event|0|||
48476530|NCT04278872|155935038|FG000|Overall Study|Protocol Violation|0|||
48476531|NCT04278872|155935039|FG001|Overall Study|Protocol Violation|1|||
48476532|NCT04278872|155935038|FG000|Overall Study|Study Termination|2|||
48476533|NCT04278872|155935039|FG001|Overall Study|Study Termination|0|||
48476534|NCT03075215|155935042|FG000|12-Month Primary Endpoint|Death|152|||
48476535|NCT03075215|155935042|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
48476536|NCT03075215|155935042|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
48476537|NCT03075215|155935042|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
48476538|NCT03353415|155935043|FG000|Masked CGM Wear|Lost to Follow-up|2|||
48476539|NCT03353415|155935043|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
48476540|NCT02395536|155935052|FG000|Overall Study|Lost to Follow-up|4|||
48476541|NCT02395536|155935053|FG001|Overall Study|Lost to Follow-up|4|||
48476542|NCT02395536|155935052|FG000|Overall Study|Death|2|||
48476543|NCT02395536|155935053|FG001|Overall Study|Death|0|||
48476544|NCT02395536|155935052|FG000|Overall Study|Physician Decision|4|||
48476545|NCT02395536|155935053|FG001|Overall Study|Physician Decision|6|||
48476546|NCT02395536|155935052|FG000|Overall Study|Withdrawal by Subject|9|||
48476547|NCT02395536|155935053|FG001|Overall Study|Withdrawal by Subject|17|||
48476548|NCT02395536|155935052|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
48476549|NCT02395536|155935053|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
48476550|NCT02395536|155935052|FG000|Overall Study|Insurance issue|0|||
48476551|NCT02395536|155935053|FG001|Overall Study|Insurance issue|1|||
48476552|NCT01876082|155936851|FG000|Overall Study|Withdrawal by Subject|0|||
48476553|NCT01876082|155936852|FG001|Overall Study|Withdrawal by Subject|2|||
48476554|NCT01876082|155936851|FG000|Overall Study|Protocol Violation|1|||
48476555|NCT01876082|155936852|FG001|Overall Study|Protocol Violation|0|||
48476556|NCT01876082|155936851|FG000|Overall Study|Adverse Event|1|||
48476557|NCT01876082|155936852|FG001|Overall Study|Adverse Event|1|||
48476558|NCT01876082|155936851|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
48476559|NCT01876082|155936852|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
48476560|NCT01392469|155936853|FG000|Overall Study|Adverse Event|2|||
48476561|NCT01392469|155936853|FG000|Overall Study|Withdrawal by Subject|1|||
48476562|NCT01392469|155936853|FG000|Overall Study|Protocol Violation|1|||
48476563|NCT00518531|155936880|FG000|Treatment Period 1|Adverse Event|5|||
48476564|NCT00518531|155936881|FG001|Treatment Period 1|Adverse Event|0|||
48476565|NCT00518531|155936880|FG000|Treatment Period 1|Lost to Follow-up|5|||
48476566|NCT00518531|155936881|FG001|Treatment Period 1|Lost to Follow-up|3|||
48476567|NCT00518531|155936880|FG000|Treatment Period 1|Physician Decision|1|||
48476568|NCT00518531|155936881|FG001|Treatment Period 1|Physician Decision|0|||
48476569|NCT00518531|155936880|FG000|Treatment Period 1|Protocol Violation|2|||
48476570|NCT00518531|155936881|FG001|Treatment Period 1|Protocol Violation|0|||
48476571|NCT00518531|155936880|FG000|Treatment Period 1|Withdrawal by Subject|4|||
48476572|NCT00518531|155936881|FG001|Treatment Period 1|Withdrawal by Subject|6|||
48476573|NCT00518531|155936880|FG000|Treatment Period 1|Early crossover|1|||
48476574|NCT00518531|155936881|FG001|Treatment Period 1|Early crossover|3|||
48476575|NCT00518531|155936880|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48476576|NCT00518531|155936881|FG001|Treatment Period 2|Withdrawal by Subject|8|||
48476577|NCT00518531|155936880|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
48476578|NCT00518531|155936881|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
48476579|NCT00518531|155936880|FG000|Treatment Period 2|Adverse Event|1|||
48476580|NCT00518531|155936881|FG001|Treatment Period 2|Adverse Event|7|||
48476581|NCT00518531|155936880|FG000|Treatment Period 2|Protocol-specified criteria|0|||
48476582|NCT00518531|155936881|FG001|Treatment Period 2|Protocol-specified criteria|1|||
48476583|NCT00518531|155936880|FG000|Treatment Period 2|Non-compliance|1|||
48476584|NCT00518531|155936881|FG001|Treatment Period 2|Non-compliance|2|||
48476585|NCT01656850|155936882|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
48476586|NCT01656850|155936883|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
48476587|NCT00054639|155936884|FG000|Overall Study|Lack of Efficacy|1|||
48476588|NCT00054639|155936884|FG000|Overall Study|Physician Decision|1|||
48476589|NCT02674568|155936885|FG000|Overall Study|Withdrawal by Subject|5|||
48476590|NCT02674568|155936885|FG000|Overall Study|Death|303|||
48476591|NCT02674568|155936885|FG000|Overall Study|Physician Decision|2|||
48476592|NCT02674568|155936885|FG000|Overall Study|Lost to Follow-up|9|||
48476593|NCT02674568|155936885|FG000|Overall Study|Other, Not Specified|20|||
48476594|NCT01600755|155936888|FG000|Overall Study|Withdrawal by Subject|6|||
48476595|NCT04621227|155936895|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
48476596|NCT04621227|155936895|FG000|Period 3 (29 Days)|Adverse Event|1|||
48476597|NCT04621227|155936895|FG000|Period 8 (2 Days)|Adverse Event|1|||
48476598|NCT00938392|155936896|FG000|Overall Study|Adverse Event|0|||
48476599|NCT00938392|155936897|FG001|Overall Study|Adverse Event|1|||
48476600|NCT00938392|155936896|FG000|Overall Study|Withdrawal by Subject|0|||
48476601|NCT00938392|155936897|FG001|Overall Study|Withdrawal by Subject|1|||
48476602|NCT00938392|155936896|FG000|Overall Study|Lost to Follow-up|2|||
48476603|NCT00938392|155936897|FG001|Overall Study|Lost to Follow-up|2|||
48476604|NCT01548573|155936898|FG000|Overall Study|Death|3|||
48476605|NCT01548573|155936898|FG000|Overall Study|Withdrawal by Subject|2|||
48476606|NCT01366846|155936903|FG000|Overall Study|Withdrawal by Subject|2|||
48476607|NCT01366846|155936904|FG001|Overall Study|Withdrawal by Subject|0|||
48476608|NCT01366846|155936905|FG002|Overall Study|Withdrawal by Subject|0|||
48476609|NCT01366846|155936906|FG003|Overall Study|Withdrawal by Subject|0|||
48476610|NCT01366846|155936903|FG000|Overall Study|Communication Difficulties|1|||
48476611|NCT01366846|155936904|FG001|Overall Study|Communication Difficulties|4|||
48476612|NCT01366846|155936905|FG002|Overall Study|Communication Difficulties|0|||
48476613|NCT01366846|155936906|FG003|Overall Study|Communication Difficulties|1|||
48476614|NCT01366846|155936903|FG000|Overall Study|Scheduling Conflicts|0|||
48476615|NCT01366846|155936904|FG001|Overall Study|Scheduling Conflicts|0|||
48476616|NCT01366846|155936905|FG002|Overall Study|Scheduling Conflicts|1|||
48476617|NCT01366846|155936906|FG003|Overall Study|Scheduling Conflicts|0|||
48476618|NCT00602927|155936914|FG000|Period 1: 13 Days|Protocol Violation|2|||
48476619|NCT00602927|155936915|FG001|Period 1: 13 Days|Protocol Violation|4|||
48476620|NCT00602927|155936914|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
48476621|NCT00602927|155936915|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
48476622|NCT00602927|155936914|FG000|Period 1: 13 Days|Time|1|||
48476623|NCT00602927|155936915|FG001|Period 1: 13 Days|Time|0|||
48476624|NCT00602927|155936914|FG000|Period 1: 13 Days|Claustrophobia|0|||
48476625|NCT00602927|155936915|FG001|Period 1: 13 Days|Claustrophobia|1|||
48476626|NCT00602927|155936914|FG000|Period 2: 14 Days|Protocol Violation|0|||
48476627|NCT00602927|155936915|FG001|Period 2: 14 Days|Protocol Violation|2|||
48476628|NCT00602927|155936914|FG000|Period 3: 13 Days|Protocol Violation|0|||
48476629|NCT00602927|155936915|FG001|Period 3: 13 Days|Protocol Violation|1|||
48476630|NCT00602927|155936914|FG000|Period 3: 13 Days|MRI data quality|2|||
48476631|NCT00602927|155936915|FG001|Period 3: 13 Days|MRI data quality|2|||
48476632|NCT05378269|155936916|FG000|Overall Study|Protocol Violation|1|||
48476633|NCT05378269|155936917|FG001|Overall Study|Protocol Violation|0|||
48476634|NCT05378269|155936918|FG002|Overall Study|Protocol Violation|2|||
48476635|NCT05378269|155936919|FG003|Overall Study|Protocol Violation|0|||
48476636|NCT05378269|155936920|FG004|Overall Study|Protocol Violation|0|||
48476637|NCT01728376|155936921|FG000|Overall Study|Adverse Event|1|||
48476638|NCT01728376|155936922|FG001|Overall Study|Adverse Event|1|||
48476639|NCT01728376|155936923|FG002|Overall Study|Adverse Event|1|||
48476640|NCT01728376|155936924|FG003|Overall Study|Adverse Event|1|||
48476641|NCT01728376|155936925|FG004|Overall Study|Adverse Event|1|||
48476642|NCT01728376|155936926|FG005|Overall Study|Adverse Event|0|||
48476643|NCT01728376|155936921|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
48476644|NCT01728376|155936922|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
48476645|NCT01728376|155936923|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
48476646|NCT01728376|155936924|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
48476647|NCT01728376|155936925|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
48476648|NCT01728376|155936926|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
48476649|NCT01728376|155936921|FG000|Overall Study|No relevant bacteria|2|||
48476650|NCT01728376|155936922|FG001|Overall Study|No relevant bacteria|0|||
48476651|NCT01728376|155936923|FG002|Overall Study|No relevant bacteria|0|||
48476652|NCT01728376|155936924|FG003|Overall Study|No relevant bacteria|0|||
48476653|NCT01728376|155936925|FG004|Overall Study|No relevant bacteria|1|||
48476654|NCT01728376|155936926|FG005|Overall Study|No relevant bacteria|1|||
48476655|NCT01728376|155936921|FG000|Overall Study|Did not receive treatment|0|||
48476656|NCT01728376|155936922|FG001|Overall Study|Did not receive treatment|1|||
48476657|NCT01728376|155936923|FG002|Overall Study|Did not receive treatment|0|||
48476658|NCT01728376|155936924|FG003|Overall Study|Did not receive treatment|0|||
48476659|NCT01728376|155936925|FG004|Overall Study|Did not receive treatment|0|||
48476660|NCT01728376|155936926|FG005|Overall Study|Did not receive treatment|0|||
48476661|NCT01728376|155936921|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
48476662|NCT01728376|155936922|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
48476663|NCT01728376|155936923|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
48476664|NCT01728376|155936924|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
48476665|NCT01728376|155936925|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
48476666|NCT01728376|155936926|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
48476667|NCT01035229|155936927|FG000|Overall Study|Adverse Event|61|||
48476668|NCT01035229|155936928|FG001|Overall Study|Adverse Event|14|||
48476669|NCT01035229|155936927|FG000|Overall Study|Withdrawal by Subject|20|||
48476670|NCT01035229|155936928|FG001|Overall Study|Withdrawal by Subject|7|||
48476671|NCT01035229|155936927|FG000|Overall Study|Lost to Follow-up|1|||
48476672|NCT01035229|155936928|FG001|Overall Study|Lost to Follow-up|0|||
48476673|NCT01035229|155936927|FG000|Overall Study|Administrative problems|1|||
48476674|NCT01035229|155936928|FG001|Overall Study|Administrative problems|1|||
48476675|NCT01035229|155936927|FG000|Overall Study|Death|13|||
48476676|NCT01035229|155936928|FG001|Overall Study|Death|5|||
48476677|NCT01035229|155936927|FG000|Overall Study|New cancer therapy|2|||
48476678|NCT01035229|155936928|FG001|Overall Study|New cancer therapy|0|||
48476679|NCT01035229|155936927|FG000|Overall Study|Protocol Violation|0|||
48476680|NCT01035229|155936928|FG001|Overall Study|Protocol Violation|2|||
48476681|NCT01035229|155936927|FG000|Overall Study|Sponsor's decision to end study|3|||
48476682|NCT01035229|155936928|FG001|Overall Study|Sponsor's decision to end study|3|||
48476683|NCT01035229|155936927|FG000|Overall Study|Disease Progression|261|||
48476684|NCT01035229|155936928|FG001|Overall Study|Disease Progression|152|||
48476685|NCT00359073|155936931|FG000|Overall Study|Withdrawal by Subject|1|||
48476686|NCT00359073|155936932|FG001|Overall Study|Withdrawal by Subject|1|||
48476687|NCT00359073|155936931|FG000|Overall Study|Eligibility criteria no longer met|3|||
48476688|NCT00359073|155936932|FG001|Overall Study|Eligibility criteria no longer met|0|||
48476689|NCT00359073|155936931|FG000|Overall Study|developed RV16 antibody|0|||
48476690|NCT00359073|155936932|FG001|Overall Study|developed RV16 antibody|1|||
48476691|NCT00558831|155936935|FG000|Overall Study|Lost to Follow-up|1|||
48476692|NCT00648739|155936942|FG000|Overall Study|Adverse Event|1|||
48476693|NCT00648739|155936943|FG001|Overall Study|Adverse Event|0|||
48476694|NCT00648739|155936944|FG002|Overall Study|Adverse Event|1|||
48476695|NCT00648739|155936945|FG003|Overall Study|Adverse Event|2|||
48476696|NCT00648739|155936946|FG004|Overall Study|Adverse Event|1|||
48476697|NCT00648739|155936947|FG005|Overall Study|Adverse Event|0|||
48476698|NCT00648739|155936948|FG006|Overall Study|Adverse Event|0|||
48476699|NCT00648739|155936942|FG000|Overall Study|Withdrawal by Subject|1|||
48476700|NCT00648739|155936943|FG001|Overall Study|Withdrawal by Subject|0|||
48476701|NCT00648739|155936944|FG002|Overall Study|Withdrawal by Subject|1|||
48476702|NCT00648739|155936945|FG003|Overall Study|Withdrawal by Subject|0|||
48476703|NCT00648739|155936946|FG004|Overall Study|Withdrawal by Subject|0|||
48476704|NCT00648739|155936947|FG005|Overall Study|Withdrawal by Subject|2|||
48476705|NCT00648739|155936948|FG006|Overall Study|Withdrawal by Subject|0|||
48476706|NCT00648739|155936942|FG000|Overall Study|Lack of Efficacy|0|||
48476707|NCT00648739|155936943|FG001|Overall Study|Lack of Efficacy|0|||
48476708|NCT00648739|155936944|FG002|Overall Study|Lack of Efficacy|0|||
48476709|NCT00648739|155936945|FG003|Overall Study|Lack of Efficacy|0|||
48476710|NCT00648739|155936946|FG004|Overall Study|Lack of Efficacy|1|||
48476711|NCT00648739|155936947|FG005|Overall Study|Lack of Efficacy|2|||
48476712|NCT00648739|155936948|FG006|Overall Study|Lack of Efficacy|0|||
48476713|NCT00648739|155936942|FG000|Overall Study|Investigator Considered it Advisable|0|||
48476714|NCT00648739|155936943|FG001|Overall Study|Investigator Considered it Advisable|0|||
48476715|NCT00648739|155936944|FG002|Overall Study|Investigator Considered it Advisable|0|||
48476716|NCT00648739|155936945|FG003|Overall Study|Investigator Considered it Advisable|0|||
48476717|NCT00648739|155936946|FG004|Overall Study|Investigator Considered it Advisable|0|||
48476718|NCT00648739|155936947|FG005|Overall Study|Investigator Considered it Advisable|1|||
48476719|NCT00648739|155936948|FG006|Overall Study|Investigator Considered it Advisable|1|||
48476720|NCT00648739|155936942|FG000|Overall Study|Death|0|||
48476721|NCT00648739|155936943|FG001|Overall Study|Death|1|||
48476722|NCT00648739|155936944|FG002|Overall Study|Death|0|||
48476723|NCT00648739|155936945|FG003|Overall Study|Death|0|||
48476724|NCT00648739|155936946|FG004|Overall Study|Death|0|||
48476725|NCT00648739|155936947|FG005|Overall Study|Death|0|||
48476726|NCT00648739|155936948|FG006|Overall Study|Death|0|||
48476727|NCT00648739|155936942|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
48476728|NCT00648739|155936943|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
48476729|NCT00648739|155936944|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
48476730|NCT00648739|155936945|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
48476731|NCT00648739|155936946|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
48476732|NCT00648739|155936947|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
48476733|NCT00648739|155936948|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
48476734|NCT00648739|155936942|FG000|Overall Study|Follow-up Visits Not Completed|0|||
48476735|NCT00648739|155936943|FG001|Overall Study|Follow-up Visits Not Completed|1|||
48476736|NCT00648739|155936944|FG002|Overall Study|Follow-up Visits Not Completed|0|||
48476737|NCT00648739|155936945|FG003|Overall Study|Follow-up Visits Not Completed|0|||
48476738|NCT00648739|155936946|FG004|Overall Study|Follow-up Visits Not Completed|0|||
48476739|NCT00648739|155936947|FG005|Overall Study|Follow-up Visits Not Completed|0|||
48476740|NCT00648739|155936948|FG006|Overall Study|Follow-up Visits Not Completed|0|||
48476741|NCT00685763|155936950|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
48476742|NCT00685763|155936950|FG000|Overall Study|Protocol Violation|1|||
48476743|NCT01741259|155936955|FG000|Overall Study|Protocol Violation|6|||
48476744|NCT01741259|155936956|FG001|Overall Study|Protocol Violation|4|||
48476745|NCT01741259|155936955|FG000|Overall Study|Withdrawal by Subject|0|||
48476746|NCT01741259|155936956|FG001|Overall Study|Withdrawal by Subject|2|||
48476747|NCT00698009|155936965|FG000|Overall Study|Withdrawal by Subject|1|||
48476748|NCT04285983|155936966|FG000|Overall Study|Protocol Violation|6|||
48476749|NCT04936334|155936967|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
48476750|NCT03205046|155936968|FG000|Overall Study|Death|10|||
48476751|NCT03205046|155936969|FG001|Overall Study|Death|6|||
48476752|NCT03205046|155936968|FG000|Overall Study|Withdrawal by Subject|1|||
48476753|NCT03205046|155936969|FG001|Overall Study|Withdrawal by Subject|2|||
48476754|NCT03205046|155936968|FG000|Overall Study|Lost to Follow-up|0|||
48476755|NCT03205046|155936969|FG001|Overall Study|Lost to Follow-up|1|||
48476756|NCT03205046|155936968|FG000|Overall Study|Study terminated by sponsor|2|||
48476757|NCT03205046|155936969|FG001|Overall Study|Study terminated by sponsor|1|||
48476758|NCT00054275|155936970|FG000|Overall Study|Withdrawal by Subject|4|||
48476759|NCT00054275|155936970|FG000|Overall Study|Adverse Event|5|||
48476760|NCT00054275|155936970|FG000|Overall Study|Progressive disease in cycle 1|1|||
48476761|NCT00054275|155936970|FG000|Overall Study|Physician Decision|1|||
48476762|NCT00433771|155936973|FG000|Overall Study|screen fail|14|||
48476763|NCT00433771|155936973|FG000|Overall Study|Treated and later found to be ineligible|2|||
48476764|NCT00433771|155936973|FG000|Overall Study|Death|2|||
48476765|NCT00433771|155936973|FG000|Overall Study|Failure to deploy stent|1|||
48476766|NCT04637815|155936977|FG000|Overall Study|Death|1|||
48476767|NCT04637815|155936978|FG001|Overall Study|Death|0|||
48476768|NCT04637815|155936977|FG000|Overall Study|Lost to Follow-up|5|||
48476769|NCT04637815|155936978|FG001|Overall Study|Lost to Follow-up|2|||
48476770|NCT00337727|155936979|FG000|Overall Study|Adverse Event|5|||
48476771|NCT00337727|155936980|FG001|Overall Study|Adverse Event|3|||
48476772|NCT00337727|155936979|FG000|Overall Study|Lost to Follow-up|5|||
48476773|NCT00337727|155936980|FG001|Overall Study|Lost to Follow-up|4|||
48476774|NCT00337727|155936979|FG000|Overall Study|Physician Decision|1|||
48476775|NCT00337727|155936980|FG001|Overall Study|Physician Decision|0|||
48476776|NCT00337727|155936979|FG000|Overall Study|Protocol Violation|4|||
48476777|NCT00337727|155936980|FG001|Overall Study|Protocol Violation|0|||
48476778|NCT00337727|155936979|FG000|Overall Study|Withdrawal by Subject|3|||
48476779|NCT00337727|155936980|FG001|Overall Study|Withdrawal by Subject|5|||
48476780|NCT01965431|155936982|FG000|Overall Study|Adverse Event|0|||
48476781|NCT01965431|155936983|FG001|Overall Study|Adverse Event|1|||
48476782|NCT01965431|155936984|FG002|Overall Study|Adverse Event|0|||
48476783|NCT01965431|155936985|FG003|Overall Study|Adverse Event|0|||
48476784|NCT01965431|155936986|FG004|Overall Study|Adverse Event|0|||
48476785|NCT01965431|155936987|FG005|Overall Study|Adverse Event|0|||
48476786|NCT01965431|155936982|FG000|Overall Study|Other than stated above|6|||
48476787|NCT01965431|155936983|FG001|Overall Study|Other than stated above|5|||
48476788|NCT01965431|155936984|FG002|Overall Study|Other than stated above|6|||
48476789|NCT01965431|155936985|FG003|Overall Study|Other than stated above|6|||
48476790|NCT01965431|155936986|FG004|Overall Study|Other than stated above|6|||
48476791|NCT01965431|155936987|FG005|Overall Study|Other than stated above|6|||
48476792|NCT00577031|155936988|FG000|Overall Study|Adverse Event|52|||
48476793|NCT00577031|155936988|FG000|Overall Study|Progression of disease|93|||
48476794|NCT00577031|155936988|FG000|Overall Study|Protocol Violation|5|||
48476795|NCT00577031|155936988|FG000|Overall Study|Participant withdrew consent|13|||
48476796|NCT00577031|155936988|FG000|Overall Study|Participant non-compliance|5|||
48476797|NCT00577031|155936988|FG000|Overall Study|Need for surgery|17|||
48476798|NCT00577031|155936988|FG000|Overall Study|Medical decision|14|||
48476799|NCT00577031|155936988|FG000|Overall Study|Death|6|||
48476800|NCT03707145|155936995|FG000|Overall Study|Lost to Follow-up|0|||
48476801|NCT03707145|155936996|FG001|Overall Study|Lost to Follow-up|1|||
48476802|NCT03707145|155936997|FG002|Overall Study|Lost to Follow-up|1|||
48476803|NCT03707145|155936998|FG003|Overall Study|Lost to Follow-up|0|||
48476804|NCT04513665|155937000|FG000|Overall Study|Adverse Event|2|||
48476805|NCT04513665|155937001|FG001|Overall Study|Adverse Event|0|||
48476806|NCT04513665|155937000|FG000|Overall Study|Lack of Efficacy|14|||
48476807|NCT04513665|155937001|FG001|Overall Study|Lack of Efficacy|0|||
48476808|NCT03252015|155937002|FG000|Overall Study|Withdrawal by Subject|0|||
48476809|NCT03252015|155937003|FG001|Overall Study|Withdrawal by Subject|1|||
48476810|NCT03252015|155937004|FG002|Overall Study|Withdrawal by Subject|1|||
48476811|NCT03252015|155937005|FG003|Overall Study|Withdrawal by Subject|0|||
48476812|NCT03252015|155937002|FG000|Overall Study|Adverse Event|1|||
48476813|NCT03252015|155937003|FG001|Overall Study|Adverse Event|0|||
48476814|NCT03252015|155937004|FG002|Overall Study|Adverse Event|0|||
48476815|NCT03252015|155937005|FG003|Overall Study|Adverse Event|1|||
48476816|NCT04993339|155937006|FG000|Overall Study|Lost to Follow-up|0|||
48476817|NCT04993339|155937007|FG001|Overall Study|Lost to Follow-up|1|||
48476818|NCT04993339|155937006|FG000|Overall Study|no MRI scan|3|||
48476819|NCT04993339|155937007|FG001|Overall Study|no MRI scan|1|||
48476820|NCT04355767|155937012|FG000|Overall Study|Withdrawal by Subject|2|||
48476821|NCT04355767|155937013|FG001|Overall Study|Withdrawal by Subject|2|||
48476822|NCT04355767|155937012|FG000|Overall Study|Death|5|||
48476823|NCT04355767|155937013|FG001|Overall Study|Death|1|||
48476824|NCT00902486|155937014|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
48476825|NCT00902486|155937015|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
48476826|NCT00902486|155937016|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
48476827|NCT00902486|155937017|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
48476828|NCT00902486|155937018|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
48476829|NCT00902486|155937019|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
48476830|NCT00902486|155937014|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
48476831|NCT00902486|155937015|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
48476832|NCT00902486|155937016|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
48476833|NCT00902486|155937017|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
48476834|NCT00902486|155937018|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
48476835|NCT00902486|155937019|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
48476836|NCT00902486|155937014|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
48476837|NCT00902486|155937015|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
48476838|NCT00902486|155937016|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
48476839|NCT00902486|155937017|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
48476840|NCT00902486|155937018|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
48476841|NCT00902486|155937019|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
48476842|NCT00902486|155937014|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48476843|NCT00902486|155937015|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48476844|NCT00902486|155937016|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48476845|NCT00902486|155937017|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
48476846|NCT00902486|155937018|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48476847|NCT00902486|155937019|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
48476848|NCT00902486|155937014|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48476849|NCT00902486|155937015|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48476850|NCT00902486|155937016|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48476851|NCT00902486|155937017|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
48476852|NCT00902486|155937018|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48476853|NCT00902486|155937019|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
48476854|NCT00902486|155937014|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
48476855|NCT00902486|155937015|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
48476856|NCT00902486|155937016|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
48476857|NCT00902486|155937017|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
48476858|NCT00902486|155937018|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
48476859|NCT00902486|155937019|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
48476860|NCT00902486|155937014|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
48476861|NCT00902486|155937015|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
48476862|NCT00902486|155937016|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
48476863|NCT00902486|155937017|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
48476864|NCT00902486|155937018|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
48476865|NCT00902486|155937019|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
48476866|NCT00902486|155937014|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48476867|NCT00902486|155937015|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48476868|NCT00902486|155937016|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48476869|NCT00902486|155937017|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48476870|NCT00902486|155937018|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
48476871|NCT00902486|155937019|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
48476872|NCT00902486|155937014|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48476873|NCT00902486|155937015|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48476874|NCT00902486|155937016|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48476875|NCT00902486|155937017|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
48476876|NCT00902486|155937018|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48476877|NCT00902486|155937019|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
48476878|NCT00902486|155937014|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48476879|NCT00902486|155937015|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48476880|NCT00902486|155937016|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
48476881|NCT00902486|155937017|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48476882|NCT00902486|155937018|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48476883|NCT00902486|155937019|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
48476884|NCT00902486|155937014|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
48476885|NCT00902486|155937015|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
48476886|NCT00902486|155937016|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
48476887|NCT00902486|155937017|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
48476888|NCT00902486|155937018|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
48476889|NCT00902486|155937019|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
48476890|NCT01898884|155937020|FG000|Multiple Dose Period|Adverse Event|0|||
48476891|NCT01898884|155937021|FG001|Multiple Dose Period|Adverse Event|0|||
48476892|NCT01898884|155937022|FG002|Multiple Dose Period|Adverse Event|0|||
48476893|NCT01898884|155937023|FG003|Multiple Dose Period|Adverse Event|0|||
48476894|NCT01898884|155937024|FG004|Multiple Dose Period|Adverse Event|0|||
48476895|NCT01898884|155937025|FG005|Multiple Dose Period|Adverse Event|0|||
48476896|NCT01898884|155937026|FG006|Multiple Dose Period|Adverse Event|1|||
48476897|NCT01898884|155937027|FG007|Multiple Dose Period|Adverse Event|0|||
48476898|NCT01898884|155937028|FG008|Multiple Dose Period|Adverse Event|0|||
48476899|NCT01898884|155937020|FG000|Multiple Dose Period|Randomized Not Treated|0|||
48476900|NCT01898884|155937021|FG001|Multiple Dose Period|Randomized Not Treated|0|||
48476901|NCT01898884|155937022|FG002|Multiple Dose Period|Randomized Not Treated|0|||
48476902|NCT01898884|155937023|FG003|Multiple Dose Period|Randomized Not Treated|0|||
48476903|NCT01898884|155937024|FG004|Multiple Dose Period|Randomized Not Treated|0|||
48476904|NCT01898884|155937025|FG005|Multiple Dose Period|Randomized Not Treated|0|||
48476905|NCT01898884|155937026|FG006|Multiple Dose Period|Randomized Not Treated|0|||
48476906|NCT01898884|155937027|FG007|Multiple Dose Period|Randomized Not Treated|0|||
48476907|NCT01898884|155937028|FG008|Multiple Dose Period|Randomized Not Treated|1|||
48476908|NCT02787746|155937033|FG000|Overall Study|Adverse Event|42|||
48476909|NCT02787746|155937033|FG000|Overall Study|Withdrawal by Subject|65|||
48476910|NCT02787746|155937033|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
48476911|NCT05257109|155937042|FG000|Overall Study|Withdrawal by Subject|1|||
48476912|NCT05257109|155937043|FG001|Overall Study|Withdrawal by Subject|0|||
48476913|NCT05257109|155937044|FG002|Overall Study|Withdrawal by Subject|0|||
48476914|NCT05257109|155937045|FG003|Overall Study|Withdrawal by Subject|0|||
48476915|NCT04341727|155938246|FG000|Overall Study|Withdrawal by Subject|0|||
48476916|NCT04341727|155938247|FG001|Overall Study|Withdrawal by Subject|0|||
48476917|NCT04341727|155938248|FG002|Overall Study|Withdrawal by Subject|1|||
48476918|NCT04341727|155938249|FG003|Overall Study|Withdrawal by Subject|0|||
48476919|NCT04341727|155938246|FG000|Overall Study|Lost to Follow-up|0|||
48476920|NCT04341727|155938247|FG001|Overall Study|Lost to Follow-up|0|||
48476921|NCT04341727|155938248|FG002|Overall Study|Lost to Follow-up|0|||
48476922|NCT04341727|155938249|FG003|Overall Study|Lost to Follow-up|1|||
48476923|NCT01157065|155938252|FG000|Overall Study|Death|0|||
48476924|NCT01157065|155938253|FG001|Overall Study|Death|1|||
48476925|NCT00943826|155938254|FG000|Concurrent Phase|Adverse Event|50|||
48476926|NCT00943826|155938255|FG001|Concurrent Phase|Adverse Event|27|||
48476927|NCT00943826|155938254|FG000|Concurrent Phase|Withdrew consent|3|||
48476928|NCT00943826|155938255|FG001|Concurrent Phase|Withdrew consent|7|||
48476929|NCT00943826|155938254|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
48476930|NCT00943826|155938255|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
48476931|NCT00943826|155938254|FG000|Concurrent Phase|Administrative reasons|2|||
48476932|NCT00943826|155938255|FG001|Concurrent Phase|Administrative reasons|1|||
48476933|NCT00943826|155938254|FG000|Concurrent Phase|Protocol Violation|1|||
48476934|NCT00943826|155938255|FG001|Concurrent Phase|Protocol Violation|0|||
48476935|NCT00943826|155938254|FG000|Maintenance Phase|Adverse Event|31|||
48476936|NCT00943826|155938255|FG001|Maintenance Phase|Adverse Event|30|||
48476937|NCT00943826|155938254|FG000|Maintenance Phase|Withdrew consent|2|||
48476938|NCT00943826|155938255|FG001|Maintenance Phase|Withdrew consent|4|||
48476939|NCT00943826|155938254|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
48476940|NCT00943826|155938255|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
48476941|NCT00943826|155938254|FG000|Maintenance Phase|Administrative reasons|4|||
48476942|NCT00943826|155938255|FG001|Maintenance Phase|Administrative reasons|1|||
48476943|NCT00943826|155938254|FG000|Maintenance Phase|Failure to return|0|||
48476944|NCT00943826|155938255|FG001|Maintenance Phase|Failure to return|1|||
48476945|NCT00943826|155938254|FG000|Monotherapy Phase|Adverse Event|42|||
48476946|NCT00943826|155938255|FG001|Monotherapy Phase|Adverse Event|5|||
48476947|NCT00943826|155938254|FG000|Monotherapy Phase|Administrative reasons|11|||
48476948|NCT00943826|155938255|FG001|Monotherapy Phase|Administrative reasons|5|||
48476949|NCT00943826|155938254|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
48476950|NCT00943826|155938255|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
48476951|NCT00943826|155938254|FG000|Monotherapy Phase|Withdrew Consent|2|||
48476952|NCT00943826|155938255|FG001|Monotherapy Phase|Withdrew Consent|3|||
48476953|NCT00943826|155938254|FG000|Monotherapy Phase|Failure to return|2|||
48476954|NCT00943826|155938255|FG001|Monotherapy Phase|Failure to return|1|||
48476955|NCT00943826|155938254|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
48476956|NCT00943826|155938255|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
48476957|NCT00943826|155938254|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
48476958|NCT00943826|155938255|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
48476959|NCT00943826|155938254|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
48476960|NCT00943826|155938255|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
48476961|NCT00943826|155938254|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
48476962|NCT00943826|155938255|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
48476963|NCT02050373|155938256|FG000|Overall Study|Adverse Event|4|||
48476964|NCT02050373|155938257|FG001|Overall Study|Adverse Event|7|||
48476965|NCT02050373|155938256|FG000|Overall Study|Death|3|||
48476966|NCT02050373|155938257|FG001|Overall Study|Death|3|||
48476967|NCT04113746|155938258|FG000|Overall Study|Lost to Follow-up|4|||
48476968|NCT04113746|155938259|FG001|Overall Study|Lost to Follow-up|4|||
48476969|NCT01977625|155938260|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
48476970|NCT01977625|155938261|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
48476971|NCT01977625|155938260|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
48476972|NCT01977625|155938261|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
48476973|NCT00326625|155938262|FG000|Overall Study|Adverse Event|20|||
48476974|NCT00326625|155938263|FG001|Overall Study|Adverse Event|9|||
48476975|NCT00326625|155938262|FG000|Overall Study|Withdrawal by Subject|15|||
48476976|NCT00326625|155938263|FG001|Overall Study|Withdrawal by Subject|12|||
48476977|NCT00326625|155938262|FG000|Overall Study|Death|18|||
48476978|NCT00326625|155938263|FG001|Overall Study|Death|16|||
48476979|NCT00326625|155938262|FG000|Overall Study|Lost to Follow-up|1|||
48476980|NCT00326625|155938263|FG001|Overall Study|Lost to Follow-up|0|||
48476981|NCT00326625|155938262|FG000|Overall Study|prescheduled medical intervention|0|||
48476982|NCT00326625|155938263|FG001|Overall Study|prescheduled medical intervention|1|||
48476983|NCT03901339|155938264|FG000|Overall Study|Death|220|||
48476984|NCT03901339|155938265|FG001|Overall Study|Death|192|||
48476985|NCT03901339|155938264|FG000|Overall Study|Informed consent withdrawn|13|||
48476986|NCT03901339|155938265|FG001|Overall Study|Informed consent withdrawn|40|||
48476987|NCT03901339|155938264|FG000|Overall Study|Sponsor request|30|||
48476988|NCT03901339|155938265|FG001|Overall Study|Sponsor request|23|||
48476989|NCT03901339|155938264|FG000|Overall Study|Reason not specified|5|||
48476990|NCT03901339|155938265|FG001|Overall Study|Reason not specified|7|||
48476991|NCT03901339|155938264|FG000|Overall Study|Lost to Follow-up|4|||
48476992|NCT03901339|155938265|FG001|Overall Study|Lost to Follow-up|7|||
48476993|NCT03901339|155938264|FG000|Overall Study|Covid19|0|||
48476994|NCT03901339|155938265|FG001|Overall Study|Covid19|2|||
48476995|NCT00491322|155938266|FG000|Overall Study|Protocol Violation|1|||
48476996|NCT00491322|155938267|FG001|Overall Study|Protocol Violation|0|||
48476997|NCT00491322|155938266|FG000|Overall Study|Pregnancy|0|||
48476998|NCT00491322|155938267|FG001|Overall Study|Pregnancy|1|||
48476999|NCT02861534|155938268|FG000|Overall Study|Death|541|||
48477000|NCT02861534|155938269|FG001|Overall Study|Death|552|||
48477001|NCT02861534|155938268|FG000|Overall Study|Lost to Follow-up|14|||
48477002|NCT02861534|155938269|FG001|Overall Study|Lost to Follow-up|14|||
48477003|NCT02861534|155938268|FG000|Overall Study|Site Terminated by Sponsor|4|||
48477004|NCT02861534|155938269|FG001|Overall Study|Site Terminated by Sponsor|3|||
48477005|NCT02861534|155938268|FG000|Overall Study|Withdrawal by Subject|15|||
48477006|NCT02861534|155938269|FG001|Overall Study|Withdrawal by Subject|18|||
48477007|NCT06067191|155938273|FG000|Overall Study|Withdrawal by Subject|0|||
48477008|NCT06067191|155938274|FG001|Overall Study|Withdrawal by Subject|1|||
48477009|NCT02886494|155938277|FG000|Overall Study|Adverse Event|1|||
48477010|NCT02886494|155938278|FG001|Overall Study|Adverse Event|0|||
48477011|NCT02886494|155938277|FG000|Overall Study|Withdrawal by Subject|12|||
48477012|NCT02886494|155938278|FG001|Overall Study|Withdrawal by Subject|3|||
48477013|NCT02886494|155938277|FG000|Overall Study|Protocol Violation|4|||
48477014|NCT02886494|155938278|FG001|Overall Study|Protocol Violation|1|||
48477015|NCT03919669|155938279|FG000|Overall Study|Withdrawal by Subject|1|||
48477016|NCT03919669|155938280|FG001|Overall Study|Withdrawal by Subject|0|||
48477017|NCT03919669|155938281|FG002|Overall Study|Withdrawal by Subject|0|||
48477018|NCT00625846|155938282|FG000|Overall Study|Withdrawal by Subject|2|||
48477019|NCT00625846|155938283|FG001|Overall Study|Withdrawal by Subject|0|||
48477020|NCT00625846|155938284|FG002|Overall Study|Withdrawal by Subject|1|||
48477021|NCT00625846|155938285|FG003|Overall Study|Withdrawal by Subject|2|||
48477022|NCT01067339|155938288|FG000|Overall Study|Withdrawal by Subject|6|||
48477023|NCT01067339|155938289|FG001|Overall Study|Withdrawal by Subject|5|||
48477024|NCT00890409|155938290|FG000|Overall Study|Lost to Follow-up|20|||
48477025|NCT00890409|155938291|FG001|Overall Study|Lost to Follow-up|21|||
48477026|NCT02780115|155938292|FG000|Overall Study|Withdrawal by Subject|0|||
48477027|NCT02780115|155938293|FG001|Overall Study|Withdrawal by Subject|1|||
48477028|NCT02780115|155938294|FG002|Overall Study|Withdrawal by Subject|1|||
48477029|NCT02780115|155938295|FG003|Overall Study|Withdrawal by Subject|0|||
48477030|NCT02780115|155938296|FG004|Overall Study|Withdrawal by Subject|0|||
48477031|NCT02780115|155938292|FG000|Overall Study|Adverse Event|0|||
48477032|NCT02780115|155938293|FG001|Overall Study|Adverse Event|0|||
48477033|NCT02780115|155938294|FG002|Overall Study|Adverse Event|0|||
48477034|NCT02780115|155938295|FG003|Overall Study|Adverse Event|1|||
48477035|NCT02780115|155938296|FG004|Overall Study|Adverse Event|1|||
48477036|NCT04054011|155938306|FG000|Overall Study|COVID|3|||
48477037|NCT03099161|155938309|FG000|Overall Study|Adverse Event|0|||
48477038|NCT03099161|155938310|FG001|Overall Study|Adverse Event|0|||
48477039|NCT03099161|155938311|FG002|Overall Study|Adverse Event|2|||
48477040|NCT03099161|155938309|FG000|Overall Study|Physician Decision|2|||
48477041|NCT03099161|155938310|FG001|Overall Study|Physician Decision|0|||
48477042|NCT03099161|155938311|FG002|Overall Study|Physician Decision|0|||
48477043|NCT03099161|155938309|FG000|Overall Study|Progressive Disease|1|||
48477044|NCT03099161|155938310|FG001|Overall Study|Progressive Disease|4|||
48477045|NCT03099161|155938311|FG002|Overall Study|Progressive Disease|1|||
48477046|NCT04964960|155938314|FG000|Overall Study|Withdrawal by Subject|1|||
48477047|NCT02007512|155938315|FG000|Double Blind Treatment Period|Adverse Event|4|||
48477048|NCT02007512|155938316|FG001|Double Blind Treatment Period|Adverse Event|2|||
48477120|NCT03332212|155938336|FG000|Overall Study|Adverse Event|0|||
48477049|NCT02007512|155938317|FG002|Double Blind Treatment Period|Adverse Event|6|||
48477050|NCT02007512|155938318|FG003|Double Blind Treatment Period|Adverse Event|2|||
48477051|NCT02007512|155938315|FG000|Double Blind Treatment Period|Death|1|||
48477052|NCT02007512|155938316|FG001|Double Blind Treatment Period|Death|0|||
48477053|NCT02007512|155938317|FG002|Double Blind Treatment Period|Death|0|||
48477054|NCT02007512|155938318|FG003|Double Blind Treatment Period|Death|0|||
48477055|NCT02007512|155938315|FG000|Double Blind Treatment Period|Disease progression|44|||
48477056|NCT02007512|155938316|FG001|Double Blind Treatment Period|Disease progression|49|||
48477057|NCT02007512|155938317|FG002|Double Blind Treatment Period|Disease progression|45|||
48477058|NCT02007512|155938318|FG003|Double Blind Treatment Period|Disease progression|51|||
48477059|NCT02007512|155938315|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
48477060|NCT02007512|155938316|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
48477061|NCT02007512|155938317|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
48477062|NCT02007512|155938318|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
48477063|NCT02007512|155938315|FG000|Double Blind Treatment Period|Protocol Violation|0|||
48477064|NCT02007512|155938316|FG001|Double Blind Treatment Period|Protocol Violation|0|||
48477065|NCT02007512|155938317|FG002|Double Blind Treatment Period|Protocol Violation|0|||
48477066|NCT02007512|155938318|FG003|Double Blind Treatment Period|Protocol Violation|1|||
48477067|NCT02007512|155938315|FG000|Double Blind Treatment Period|Other|0|||
48477068|NCT02007512|155938316|FG001|Double Blind Treatment Period|Other|0|||
48477069|NCT02007512|155938317|FG002|Double Blind Treatment Period|Other|1|||
48477070|NCT02007512|155938318|FG003|Double Blind Treatment Period|Other|2|||
48477071|NCT02007512|155938315|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
48477072|NCT02007512|155938316|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
48477073|NCT02007512|155938317|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
48477074|NCT02007512|155938318|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
48477075|NCT02007512|155938315|FG000|Open Label Treatment Period|Adverse Event|0|||
48477076|NCT02007512|155938316|FG001|Open Label Treatment Period|Adverse Event|1|||
48477077|NCT02007512|155938317|FG002|Open Label Treatment Period|Adverse Event|0|||
48477078|NCT02007512|155938318|FG003|Open Label Treatment Period|Adverse Event|0|||
48477079|NCT02007512|155938315|FG000|Open Label Treatment Period|Other|0|||
48477080|NCT02007512|155938316|FG001|Open Label Treatment Period|Other|0|||
48477081|NCT02007512|155938317|FG002|Open Label Treatment Period|Other|0|||
48477082|NCT02007512|155938318|FG003|Open Label Treatment Period|Other|1|||
48477083|NCT02007512|155938315|FG000|Open Label Treatment Period|Disease progression|0|||
48477084|NCT02007512|155938316|FG001|Open Label Treatment Period|Disease progression|17|||
48477085|NCT02007512|155938317|FG002|Open Label Treatment Period|Disease progression|0|||
48477086|NCT02007512|155938318|FG003|Open Label Treatment Period|Disease progression|11|||
48477087|NCT02007512|155938315|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
48477088|NCT02007512|155938316|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
48477089|NCT02007512|155938317|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
48477090|NCT02007512|155938318|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
48477091|NCT03701516|155938324|FG000|Period 1|Lost to Follow-up|0|||
48477092|NCT03701516|155938325|FG001|Period 1|Lost to Follow-up|1|||
48477093|NCT03701516|155938324|FG000|Period 1|Adverse Event|0|||
48477094|NCT03701516|155938325|FG001|Period 1|Adverse Event|2|||
48477095|NCT03701516|155938324|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
48477096|NCT03701516|155938325|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
48477097|NCT03701516|155938324|FG000|Period 1|Non Compliance to Protocol|2|||
48477098|NCT03701516|155938325|FG001|Period 1|Non Compliance to Protocol|1|||
48477099|NCT03701516|155938324|FG000|Period 1|Withdrawal by Subject|0|||
48477100|NCT03701516|155938325|FG001|Period 1|Withdrawal by Subject|1|||
48477101|NCT03701516|155938324|FG000|Period 2|failed to meet all eligibility creiteria|1|||
48477102|NCT03701516|155938325|FG001|Period 2|failed to meet all eligibility creiteria|0|||
48477103|NCT03701516|155938324|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
48477104|NCT03701516|155938325|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
48477105|NCT03644927|155938326|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
48477106|NCT03644927|155938327|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
48477107|NCT00956813|155938330|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
48477108|NCT00956813|155938331|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
48477109|NCT00956813|155938330|FG000|Flaxseed and Placebo|Ineligible|3|||
48477110|NCT00956813|155938331|FG001|Flaxseed and Placebo|Ineligible|1|||
48477111|NCT03151707|155938332|FG000|Overall Study|Lost to Follow-up|6|||
48477112|NCT04797637|155938333|FG000|Overall Study|Lost to Follow-up|23|||
48477113|NCT04797637|155938334|FG001|Overall Study|Lost to Follow-up|32|||
48477114|NCT04797637|155938333|FG000|Overall Study|Withdrawal by Subject|0|||
48477115|NCT04797637|155938334|FG001|Overall Study|Withdrawal by Subject|1|||
48477116|NCT03332212|155938336|FG000|Overall Study|Not treated|0|||
48477117|NCT03332212|155938337|FG001|Overall Study|Not treated|1|||
48477118|NCT03332212|155938338|FG002|Overall Study|Not treated|0|||
48477119|NCT03332212|155938339|FG003|Overall Study|Not treated|0|||
48477121|NCT03332212|155938337|FG001|Overall Study|Adverse Event|0|||
48477122|NCT03332212|155938338|FG002|Overall Study|Adverse Event|0|||
48477123|NCT03332212|155938339|FG003|Overall Study|Adverse Event|1|||
48477124|NCT03332212|155938336|FG000|Overall Study|worsening of disease under study|1|||
48477125|NCT03332212|155938337|FG001|Overall Study|worsening of disease under study|1|||
48477126|NCT03332212|155938338|FG002|Overall Study|worsening of disease under study|0|||
48477127|NCT03332212|155938339|FG003|Overall Study|worsening of disease under study|0|||
48477128|NCT02666768|155938349|FG000|Overall Study|Withdrawal by Subject|4|||
48477129|NCT03728257|155938350|FG000|Overall Study|Death|3|||
48477130|NCT03728257|155938351|FG001|Overall Study|Death|0|||
48477131|NCT00061568|155938352|FG000|Overall Study|Lost to Follow-up|12|||
48477132|NCT00061568|155938353|FG001|Overall Study|Lost to Follow-up|0|||
48477133|NCT00061568|155938352|FG000|Overall Study|Death|6|||
48477134|NCT00061568|155938353|FG001|Overall Study|Death|0|||
48477135|NCT00061568|155938352|FG000|Overall Study|Withdrawal by Subject|1|||
48477136|NCT00061568|155938353|FG001|Overall Study|Withdrawal by Subject|0|||
48477137|NCT04798027|155938358|FG000|Overall Study|Protocol Violation|0|||
48477138|NCT04798027|155938359|FG001|Overall Study|Protocol Violation|0|||
48477139|NCT04798027|155938360|FG002|Overall Study|Protocol Violation|0|||
48477140|NCT04798027|155938361|FG003|Overall Study|Protocol Violation|0|||
48477141|NCT04798027|155938362|FG004|Overall Study|Protocol Violation|1|||
48477142|NCT04798027|155938363|FG005|Overall Study|Protocol Violation|0|||
48477143|NCT04798027|155938364|FG006|Overall Study|Protocol Violation|0|||
48477144|NCT04798027|155938365|FG007|Overall Study|Protocol Violation|1|||
48477145|NCT04798027|155938366|FG008|Overall Study|Protocol Violation|0|||
48477146|NCT04798027|155938358|FG000|Overall Study|Withdrawal by Subject|1|||
48477147|NCT04798027|155938359|FG001|Overall Study|Withdrawal by Subject|0|||
48477148|NCT04798027|155938360|FG002|Overall Study|Withdrawal by Subject|1|||
48477149|NCT04798027|155938361|FG003|Overall Study|Withdrawal by Subject|1|||
48477150|NCT04798027|155938362|FG004|Overall Study|Withdrawal by Subject|1|||
48477151|NCT04798027|155938363|FG005|Overall Study|Withdrawal by Subject|1|||
48477152|NCT04798027|155938364|FG006|Overall Study|Withdrawal by Subject|3|||
48477153|NCT04798027|155938365|FG007|Overall Study|Withdrawal by Subject|2|||
48477154|NCT04798027|155938366|FG008|Overall Study|Withdrawal by Subject|2|||
48477155|NCT04798027|155938358|FG000|Overall Study|Lost to Follow-up|1|||
48477156|NCT04798027|155938359|FG001|Overall Study|Lost to Follow-up|3|||
48477157|NCT04798027|155938360|FG002|Overall Study|Lost to Follow-up|0|||
48477158|NCT04798027|155938361|FG003|Overall Study|Lost to Follow-up|0|||
48477159|NCT04798027|155938362|FG004|Overall Study|Lost to Follow-up|0|||
48477160|NCT04798027|155938363|FG005|Overall Study|Lost to Follow-up|1|||
48477161|NCT04798027|155938364|FG006|Overall Study|Lost to Follow-up|0|||
48477162|NCT04798027|155938365|FG007|Overall Study|Lost to Follow-up|0|||
48477163|NCT04798027|155938366|FG008|Overall Study|Lost to Follow-up|1|||
48477164|NCT04798027|155938358|FG000|Overall Study|Withdrawal by Sponsor|8|||
48477165|NCT04798027|155938359|FG001|Overall Study|Withdrawal by Sponsor|22|||
48477166|NCT04798027|155938360|FG002|Overall Study|Withdrawal by Sponsor|9|||
48477167|NCT04798027|155938361|FG003|Overall Study|Withdrawal by Sponsor|26|||
48477168|NCT04798027|155938362|FG004|Overall Study|Withdrawal by Sponsor|24|||
48477169|NCT04798027|155938363|FG005|Overall Study|Withdrawal by Sponsor|11|||
48477170|NCT04798027|155938364|FG006|Overall Study|Withdrawal by Sponsor|25|||
48477171|NCT04798027|155938365|FG007|Overall Study|Withdrawal by Sponsor|26|||
48477172|NCT04798027|155938366|FG008|Overall Study|Withdrawal by Sponsor|11|||
48477173|NCT00903409|155938367|FG000|Overall Study|Adverse Event|11|||
48477174|NCT00903409|155938368|FG001|Overall Study|Adverse Event|9|||
48477175|NCT00903409|155938367|FG000|Overall Study|Non-compliance with Protocol|1|||
48477176|NCT00903409|155938368|FG001|Overall Study|Non-compliance with Protocol|1|||
48477177|NCT00903409|155938367|FG000|Overall Study|Laboratory Abnormality|2|||
48477178|NCT00903409|155938368|FG001|Overall Study|Laboratory Abnormality|0|||
48477179|NCT00903409|155938367|FG000|Overall Study|Withdrawal by Subject|8|||
48477180|NCT00903409|155938368|FG001|Overall Study|Withdrawal by Subject|8|||
48477181|NCT00903409|155938367|FG000|Overall Study|Other|2|||
48477182|NCT00903409|155938368|FG001|Overall Study|Other|3|||
48477183|NCT00903409|155938367|FG000|Overall Study|Lost to Follow-up|2|||
48477184|NCT00903409|155938368|FG001|Overall Study|Lost to Follow-up|6|||
48477185|NCT00447265|155940043|FG000|Overall Study|Physician Decision|1|||
48477186|NCT00447265|155940044|FG001|Overall Study|Physician Decision|0|||
48477187|NCT03387423|155940050|FG000|Overall Study|Lost to Follow-up|16|||
48477188|NCT03387423|155940051|FG001|Overall Study|Lost to Follow-up|12|||
48477189|NCT03387423|155940052|FG002|Overall Study|Lost to Follow-up|1|||
48477190|NCT03387423|155940053|FG003|Overall Study|Lost to Follow-up|0|||
48477191|NCT03387423|155940050|FG000|Overall Study|Other|0|||
48477192|NCT03387423|155940051|FG001|Overall Study|Other|3|||
48477193|NCT03387423|155940052|FG002|Overall Study|Other|0|||
48477194|NCT03387423|155940053|FG003|Overall Study|Other|0|||
48477195|NCT03387423|155940050|FG000|Overall Study|Administrative Reason|166|||
48477196|NCT03387423|155940051|FG001|Overall Study|Administrative Reason|89|||
48477197|NCT03387423|155940052|FG002|Overall Study|Administrative Reason|17|||
48477198|NCT03387423|155940053|FG003|Overall Study|Administrative Reason|19|||
48477199|NCT03387423|155940050|FG000|Overall Study|Revocation Consent|76|||
48477200|NCT03387423|155940051|FG001|Overall Study|Revocation Consent|32|||
48477201|NCT03387423|155940052|FG002|Overall Study|Revocation Consent|3|||
48477202|NCT03387423|155940053|FG003|Overall Study|Revocation Consent|5|||
48477203|NCT02204449|155940054|FG000|Overall Study|Lost to Follow-up|7|||
48477204|NCT02204449|155940055|FG001|Overall Study|Lost to Follow-up|9|||
48477205|NCT02204449|155940054|FG000|Overall Study|Death|0|||
48477206|NCT02204449|155940055|FG001|Overall Study|Death|1|||
48477207|NCT02204449|155940054|FG000|Overall Study|Withdrawal by Subject|0|||
48477208|NCT02204449|155940055|FG001|Overall Study|Withdrawal by Subject|1|||
48477209|NCT01371006|155940058|FG000|Overall Study|Adverse Event|1|||
48477210|NCT01371006|155940059|FG001|Overall Study|Adverse Event|0|||
48477211|NCT00503035|155940060|FG000|Overall Study|Lost to Follow-up|2|||
48477212|NCT00503035|155940060|FG000|Overall Study|Physician Decision|3|||
48477213|NCT00503035|155940060|FG000|Overall Study|Ineligible|15|||
48477214|NCT05604521|155940065|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
48477215|NCT05604521|155940066|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
48477216|NCT05604521|155940065|FG000|Overall Study|Adverse Event|1|||
48477217|NCT05604521|155940066|FG001|Overall Study|Adverse Event|0|||
48477218|NCT05354206|155940074|FG000|Overall Study|Withdrawal by Subject|1|||
48477219|NCT05354206|155940075|FG001|Overall Study|Withdrawal by Subject|0|||
48477220|NCT02594384|155940080|FG000|Overall Study|Disease Progression|3|||
48477221|NCT02594384|155940081|FG001|Overall Study|Disease Progression|7|||
48477222|NCT02594384|155940082|FG002|Overall Study|Disease Progression|0|||
48477223|NCT02594384|155940083|FG003|Overall Study|Disease Progression|2|||
48477224|NCT02594384|155940084|FG004|Overall Study|Disease Progression|2|||
48477225|NCT02594384|155940085|FG005|Overall Study|Disease Progression|12|||
48477226|NCT02594384|155940086|FG006|Overall Study|Disease Progression|5|||
48477227|NCT02594384|155940087|FG007|Overall Study|Disease Progression|5|||
48477228|NCT02594384|155940080|FG000|Overall Study|Adverse Event|0|||
48477229|NCT02594384|155940081|FG001|Overall Study|Adverse Event|1|||
48477230|NCT02594384|155940082|FG002|Overall Study|Adverse Event|4|||
48477231|NCT02594384|155940083|FG003|Overall Study|Adverse Event|1|||
48477232|NCT02594384|155940084|FG004|Overall Study|Adverse Event|0|||
48477233|NCT02594384|155940085|FG005|Overall Study|Adverse Event|6|||
48477234|NCT02594384|155940086|FG006|Overall Study|Adverse Event|1|||
48477235|NCT02594384|155940087|FG007|Overall Study|Adverse Event|1|||
48477236|NCT02594384|155940080|FG000|Overall Study|Withdrawal by Subject|0|||
48477237|NCT02594384|155940081|FG001|Overall Study|Withdrawal by Subject|0|||
48477238|NCT02594384|155940082|FG002|Overall Study|Withdrawal by Subject|0|||
48477239|NCT02594384|155940083|FG003|Overall Study|Withdrawal by Subject|1|||
48477240|NCT02594384|155940084|FG004|Overall Study|Withdrawal by Subject|0|||
48477241|NCT02594384|155940085|FG005|Overall Study|Withdrawal by Subject|0|||
48477242|NCT02594384|155940086|FG006|Overall Study|Withdrawal by Subject|0|||
48477243|NCT02594384|155940087|FG007|Overall Study|Withdrawal by Subject|1|||
48477244|NCT02594384|155940080|FG000|Overall Study|Physician Decision|0|||
48477245|NCT02594384|155940081|FG001|Overall Study|Physician Decision|0|||
48477246|NCT02594384|155940082|FG002|Overall Study|Physician Decision|0|||
48477247|NCT02594384|155940083|FG003|Overall Study|Physician Decision|0|||
48477248|NCT02594384|155940084|FG004|Overall Study|Physician Decision|0|||
48477249|NCT02594384|155940085|FG005|Overall Study|Physician Decision|1|||
48477250|NCT02594384|155940086|FG006|Overall Study|Physician Decision|2|||
48477251|NCT02594384|155940087|FG007|Overall Study|Physician Decision|0|||
48477252|NCT02594384|155940080|FG000|Overall Study|Progressive Leukocytosis|0|||
48477253|NCT02594384|155940081|FG001|Overall Study|Progressive Leukocytosis|0|||
48477254|NCT02594384|155940082|FG002|Overall Study|Progressive Leukocytosis|1|||
48477255|NCT02594384|155940083|FG003|Overall Study|Progressive Leukocytosis|0|||
48477256|NCT02594384|155940084|FG004|Overall Study|Progressive Leukocytosis|0|||
48477257|NCT02594384|155940085|FG005|Overall Study|Progressive Leukocytosis|0|||
48477258|NCT02594384|155940086|FG006|Overall Study|Progressive Leukocytosis|0|||
48477259|NCT02594384|155940087|FG007|Overall Study|Progressive Leukocytosis|0|||
48477260|NCT02594384|155940080|FG000|Overall Study|Lack of Efficacy|0|||
48477261|NCT02594384|155940081|FG001|Overall Study|Lack of Efficacy|0|||
48477262|NCT02594384|155940082|FG002|Overall Study|Lack of Efficacy|0|||
48477263|NCT02594384|155940083|FG003|Overall Study|Lack of Efficacy|0|||
48477264|NCT02594384|155940084|FG004|Overall Study|Lack of Efficacy|1|||
48477265|NCT02594384|155940085|FG005|Overall Study|Lack of Efficacy|0|||
48477266|NCT02594384|155940086|FG006|Overall Study|Lack of Efficacy|0|||
48477267|NCT02594384|155940087|FG007|Overall Study|Lack of Efficacy|0|||
48477268|NCT02594384|155940080|FG000|Overall Study|Substantial noncompliance|0|||
48477269|NCT02594384|155940081|FG001|Overall Study|Substantial noncompliance|0|||
48477270|NCT02594384|155940082|FG002|Overall Study|Substantial noncompliance|0|||
48477271|NCT02594384|155940083|FG003|Overall Study|Substantial noncompliance|0|||
48477272|NCT02594384|155940084|FG004|Overall Study|Substantial noncompliance|0|||
48477273|NCT02594384|155940085|FG005|Overall Study|Substantial noncompliance|0|||
48477274|NCT02594384|155940086|FG006|Overall Study|Substantial noncompliance|1|||
48477275|NCT02594384|155940087|FG007|Overall Study|Substantial noncompliance|0|||
48477276|NCT00572910|155940090|FG000|Overall Study|Adverse Event|1|||
48477277|NCT00572910|155940091|FG001|Overall Study|Adverse Event|2|||
48477278|NCT00572910|155940092|FG002|Overall Study|Adverse Event|0|||
48477279|NCT00572910|155940093|FG003|Overall Study|Adverse Event|2|||
48477280|NCT00572910|155940094|FG004|Overall Study|Adverse Event|0|||
48477281|NCT00572910|155940095|FG005|Overall Study|Adverse Event|0|||
48477282|NCT00572910|155940096|FG006|Overall Study|Adverse Event|4|||
48477283|NCT00572910|155940097|FG007|Overall Study|Adverse Event|2|||
48477284|NCT00572910|155940098|FG008|Overall Study|Adverse Event|1|||
48477285|NCT00572910|155940099|FG009|Overall Study|Adverse Event|3|||
48477286|NCT00572910|155940100|FG010|Overall Study|Adverse Event|2|||
48477287|NCT00572910|155940090|FG000|Overall Study|Lost to Follow-up|0|||
48477288|NCT00572910|155940091|FG001|Overall Study|Lost to Follow-up|1|||
48477289|NCT00572910|155940092|FG002|Overall Study|Lost to Follow-up|1|||
48477290|NCT00572910|155940093|FG003|Overall Study|Lost to Follow-up|2|||
48477291|NCT00572910|155940094|FG004|Overall Study|Lost to Follow-up|1|||
48477292|NCT00572910|155940095|FG005|Overall Study|Lost to Follow-up|0|||
48477293|NCT00572910|155940096|FG006|Overall Study|Lost to Follow-up|0|||
48477294|NCT00572910|155940097|FG007|Overall Study|Lost to Follow-up|0|||
48477295|NCT00572910|155940098|FG008|Overall Study|Lost to Follow-up|0|||
48477296|NCT00572910|155940099|FG009|Overall Study|Lost to Follow-up|1|||
48477297|NCT00572910|155940100|FG010|Overall Study|Lost to Follow-up|0|||
48477298|NCT00572910|155940090|FG000|Overall Study|Withdrawal by Subject|3|||
48477299|NCT00572910|155940091|FG001|Overall Study|Withdrawal by Subject|0|||
48477300|NCT00572910|155940092|FG002|Overall Study|Withdrawal by Subject|1|||
48477301|NCT00572910|155940093|FG003|Overall Study|Withdrawal by Subject|0|||
48477302|NCT00572910|155940094|FG004|Overall Study|Withdrawal by Subject|1|||
48477303|NCT00572910|155940095|FG005|Overall Study|Withdrawal by Subject|3|||
48477304|NCT00572910|155940096|FG006|Overall Study|Withdrawal by Subject|0|||
48477305|NCT00572910|155940097|FG007|Overall Study|Withdrawal by Subject|2|||
48477306|NCT00572910|155940098|FG008|Overall Study|Withdrawal by Subject|2|||
48477307|NCT00572910|155940099|FG009|Overall Study|Withdrawal by Subject|2|||
48477308|NCT00572910|155940100|FG010|Overall Study|Withdrawal by Subject|1|||
48477309|NCT00916617|155940103|FG000|Overall Study|Adverse Event|3|||
48477310|NCT00916617|155940104|FG001|Overall Study|Adverse Event|2|||
48477311|NCT00916617|155940105|FG002|Overall Study|Adverse Event|6|||
48477312|NCT00916617|155940106|FG003|Overall Study|Adverse Event|3|||
48477313|NCT00916617|155940103|FG000|Overall Study|Withdrawal by Subject|3|||
48477314|NCT00916617|155940104|FG001|Overall Study|Withdrawal by Subject|2|||
48477315|NCT00916617|155940105|FG002|Overall Study|Withdrawal by Subject|0|||
48477316|NCT00916617|155940106|FG003|Overall Study|Withdrawal by Subject|1|||
48477317|NCT00916617|155940103|FG000|Overall Study|Caregiver Request|3|||
48477318|NCT00916617|155940104|FG001|Overall Study|Caregiver Request|2|||
48477319|NCT00916617|155940105|FG002|Overall Study|Caregiver Request|1|||
48477320|NCT00916617|155940106|FG003|Overall Study|Caregiver Request|0|||
48477321|NCT00916617|155940103|FG000|Overall Study|Physician Decision|1|||
48477322|NCT00916617|155940104|FG001|Overall Study|Physician Decision|1|||
48477323|NCT00916617|155940105|FG002|Overall Study|Physician Decision|0|||
48477324|NCT00916617|155940106|FG003|Overall Study|Physician Decision|0|||
48477325|NCT00916617|155940103|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
48477326|NCT00916617|155940104|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
48477327|NCT00916617|155940105|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
48477328|NCT00916617|155940106|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
48477329|NCT00916617|155940103|FG000|Overall Study|Lost to Follow-up|2|||
48477330|NCT00916617|155940104|FG001|Overall Study|Lost to Follow-up|1|||
48477331|NCT00916617|155940105|FG002|Overall Study|Lost to Follow-up|0|||
48477332|NCT00916617|155940106|FG003|Overall Study|Lost to Follow-up|0|||
48477333|NCT00916617|155940103|FG000|Overall Study|Lack of Efficacy|1|||
48477334|NCT00916617|155940104|FG001|Overall Study|Lack of Efficacy|0|||
48477335|NCT00916617|155940105|FG002|Overall Study|Lack of Efficacy|0|||
48477336|NCT00916617|155940106|FG003|Overall Study|Lack of Efficacy|0|||
48477337|NCT00916617|155940103|FG000|Overall Study|Other|2|||
48477338|NCT00916617|155940104|FG001|Overall Study|Other|0|||
48477339|NCT00916617|155940105|FG002|Overall Study|Other|0|||
48477340|NCT00916617|155940106|FG003|Overall Study|Other|2|||
48477341|NCT03668613|155940110|FG000|Overall Study|Adverse Event|1|||
48477342|NCT03668613|155940111|FG001|Overall Study|Adverse Event|2|||
48477343|NCT03668613|155940110|FG000|Overall Study|Lack of Efficacy|5|||
48477344|NCT03668613|155940111|FG001|Overall Study|Lack of Efficacy|1|||
48477345|NCT03668613|155940110|FG000|Overall Study|Pregnancy|0|||
48477346|NCT03668613|155940111|FG001|Overall Study|Pregnancy|2|||
48477347|NCT03668613|155940110|FG000|Overall Study|Protocol Violation|1|||
48477348|NCT03668613|155940111|FG001|Overall Study|Protocol Violation|0|||
48477349|NCT03668613|155940110|FG000|Overall Study|Physician Decision|1|||
48477350|NCT03668613|155940111|FG001|Overall Study|Physician Decision|0|||
48477351|NCT03668613|155940110|FG000|Overall Study|Withdrawal by Subject|2|||
48477352|NCT03668613|155940111|FG001|Overall Study|Withdrawal by Subject|1|||
48477353|NCT03668613|155940110|FG000|Overall Study|Guardian decision|1|||
48477354|NCT03668613|155940111|FG001|Overall Study|Guardian decision|0|||
48477355|NCT02304302|155940112|FG000|Overall Study|Adverse Event|2|||
48477356|NCT02304302|155940113|FG001|Overall Study|Adverse Event|3|||
48477357|NCT02304302|155940112|FG000|Overall Study|Lost to Follow-up|1|||
48477358|NCT02304302|155940113|FG001|Overall Study|Lost to Follow-up|4|||
48477359|NCT02304302|155940112|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
48477360|NCT02304302|155940113|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
48477361|NCT00769132|155940115|FG000|Period 1|Adverse Event|1|||
48477362|NCT00769132|155940116|FG001|Period 1|Adverse Event|0|||
48477363|NCT00769132|155940117|FG002|Period 1|Adverse Event|0|||
48477364|NCT00769132|155940118|FG003|Period 1|Adverse Event|1|||
48477365|NCT00769132|155940115|FG000|Period 2|Withdrawal by Subject|0|||
48477366|NCT00769132|155940116|FG001|Period 2|Withdrawal by Subject|0|||
48477367|NCT00769132|155940117|FG002|Period 2|Withdrawal by Subject|0|||
48477368|NCT00769132|155940118|FG003|Period 2|Withdrawal by Subject|1|||
48477369|NCT00769132|155940115|FG000|Period 3|Withdrawal by Subject|1|||
48477370|NCT00769132|155940116|FG001|Period 3|Withdrawal by Subject|0|||
48477371|NCT00769132|155940117|FG002|Period 3|Withdrawal by Subject|0|||
48477372|NCT00769132|155940118|FG003|Period 3|Withdrawal by Subject|0|||
48477373|NCT00769132|155940115|FG000|Period 4|Withdrawal by Subject|0|||
48477374|NCT00769132|155940116|FG001|Period 4|Withdrawal by Subject|1|||
48477375|NCT00769132|155940117|FG002|Period 4|Withdrawal by Subject|0|||
48477376|NCT00769132|155940118|FG003|Period 4|Withdrawal by Subject|0|||
48477377|NCT00499252|155940121|FG000|Overall Study|Adverse Event|3|||
48477378|NCT00499252|155940121|FG000|Overall Study|Refused further treatment|2|||
48477379|NCT00499252|155940121|FG000|Overall Study|Ineligible|4|||
48477380|NCT00499252|155940121|FG000|Overall Study|<no further label>|3|||
48477381|NCT02230332|155940122|FG000|Overall Study|Adverse Event|2|||
48477382|NCT02230332|155940123|FG001|Overall Study|Adverse Event|1|||
48477383|NCT02230332|155940122|FG000|Overall Study|Lost to Follow-up|1|||
48477384|NCT02230332|155940123|FG001|Overall Study|Lost to Follow-up|0|||
48477385|NCT02230332|155940122|FG000|Overall Study|Protocol Violation|1|||
48477386|NCT02230332|155940123|FG001|Overall Study|Protocol Violation|0|||
48477387|NCT01988337|155940124|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
48477388|NCT01260194|155940126|FG000|Overall Study|Withdrawal of Consent|1|||
48477389|NCT00877799|155940128|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
48477390|NCT00877799|155940129|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
48477391|NCT00877799|155940130|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
48477392|NCT00877799|155940131|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
48477393|NCT00877799|155940132|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
48477394|NCT00877799|155940128|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
48477395|NCT00877799|155940129|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
48477396|NCT00877799|155940130|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
48477397|NCT00877799|155940131|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
48477398|NCT00877799|155940132|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
48477399|NCT00877799|155940128|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
48477400|NCT00877799|155940129|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
48477401|NCT00877799|155940130|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
48477402|NCT00877799|155940131|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
48477403|NCT00877799|155940132|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
48477404|NCT00877799|155940128|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
48477405|NCT00877799|155940129|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
48477406|NCT00877799|155940130|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
48477407|NCT00877799|155940131|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
48477408|NCT00877799|155940132|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
48477409|NCT00877799|155940128|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
48477410|NCT00877799|155940129|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
48477411|NCT00877799|155940130|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
48477412|NCT00877799|155940131|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
48477413|NCT00877799|155940132|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
48477414|NCT00592007|155940133|FG000|Overall Study|Withdrawal by Subject|1|||
48477415|NCT00592007|155940133|FG000|Overall Study|patient ineligible (out of lab range)|1|||
48477416|NCT00595127|155940134|FG000|Overall Study|Death|6|||
48477417|NCT00595127|155940134|FG000|Overall Study|Relapsed|3|||
48477418|NCT00595127|155940134|FG000|Overall Study|joined another trial|1|||
48477419|NCT01785472|155940135|FG000|Overall Study|Adverse Event|5|||
48477420|NCT01785472|155940136|FG001|Overall Study|Adverse Event|4|||
48477421|NCT01785472|155940137|FG002|Overall Study|Adverse Event|6|||
48477422|NCT01785472|155940135|FG000|Overall Study|Lack of Efficacy|2|||
48477423|NCT01785472|155940136|FG001|Overall Study|Lack of Efficacy|0|||
48477424|NCT01785472|155940137|FG002|Overall Study|Lack of Efficacy|1|||
48477425|NCT01785472|155940135|FG000|Overall Study|Lost to Follow-up|1|||
48477426|NCT01785472|155940136|FG001|Overall Study|Lost to Follow-up|2|||
48477427|NCT01785472|155940137|FG002|Overall Study|Lost to Follow-up|0|||
48477428|NCT01785472|155940135|FG000|Overall Study|Physician Decision|1|||
48477429|NCT01785472|155940136|FG001|Overall Study|Physician Decision|1|||
48477430|NCT01785472|155940137|FG002|Overall Study|Physician Decision|1|||
48477431|NCT01785472|155940135|FG000|Overall Study|Protocol deviation|0|||
48477432|NCT01785472|155940136|FG001|Overall Study|Protocol deviation|2|||
48477433|NCT01785472|155940137|FG002|Overall Study|Protocol deviation|2|||
48477434|NCT01785472|155940135|FG000|Overall Study|Subject/guardian decision|15|||
48477435|NCT01785472|155940136|FG001|Overall Study|Subject/guardian decision|10|||
48477436|NCT01785472|155940137|FG002|Overall Study|Subject/guardian decision|11|||
48477437|NCT01785472|155940135|FG000|Overall Study|Technical problems|0|||
48477438|NCT01785472|155940136|FG001|Overall Study|Technical problems|0|||
48477439|NCT01785472|155940137|FG002|Overall Study|Technical problems|1|||
48477440|NCT00557830|155940143|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
48477441|NCT00557830|155940144|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
48477442|NCT00557830|155940145|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
48477443|NCT00557830|155940143|FG000|Screening Treatment Phase|Adverse Event|2|||
48477444|NCT00557830|155940144|FG001|Screening Treatment Phase|Adverse Event|0|||
48477445|NCT00557830|155940145|FG002|Screening Treatment Phase|Adverse Event|0|||
48477446|NCT00557830|155940143|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
48477447|NCT00557830|155940144|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
48477448|NCT00557830|155940145|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
48477449|NCT02086968|155940146|FG000|Overall Study|Adverse Event|1|||
48477450|NCT02086968|155940147|FG001|Overall Study|Adverse Event|5|||
48477451|NCT02086968|155940146|FG000|Overall Study|Lost to Follow-up|2|||
48477452|NCT02086968|155940147|FG001|Overall Study|Lost to Follow-up|3|||
48477453|NCT02086968|155940146|FG000|Overall Study|Study drug received outside protocol|0|||
48477454|NCT02086968|155940147|FG001|Overall Study|Study drug received outside protocol|1|||
48477455|NCT02086968|155940146|FG000|Overall Study|Physician Decision|4|||
48477456|NCT02086968|155940147|FG001|Overall Study|Physician Decision|0|||
48477457|NCT02086968|155940146|FG000|Overall Study|Withdrawal by Subject|1|||
48477458|NCT02086968|155940147|FG001|Overall Study|Withdrawal by Subject|4|||
48477459|NCT00538473|155940151|FG000|Overall Study|Adverse Event|1|||
48477460|NCT00538473|155940152|FG001|Overall Study|Adverse Event|0|||
48477461|NCT04512976|155940153|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
48477462|NCT04512976|155940154|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
48477463|NCT04512976|155940155|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
48477464|NCT04512976|155940156|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
48477465|NCT04512976|155940157|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
48477466|NCT04512976|155940158|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
48477467|NCT01569074|155940162|FG000|Overall Study|Study stopped|6|||
48477468|NCT01569074|155940163|FG001|Overall Study|Study stopped|6|||
48477469|NCT01569074|155940164|FG002|Overall Study|Study stopped|8|||
48477470|NCT01569074|155940165|FG003|Overall Study|Study stopped|7|||
48477471|NCT01569074|155940166|FG004|Overall Study|Study stopped|7|||
48477472|NCT01569074|155940162|FG000|Overall Study|Study-specific discontinuation criteria|0|||
48477473|NCT01569074|155940163|FG001|Overall Study|Study-specific discontinuation criteria|1|||
48477474|NCT01569074|155940164|FG002|Overall Study|Study-specific discontinuation criteria|0|||
48477475|NCT01569074|155940165|FG003|Overall Study|Study-specific discontinuation criteria|0|||
48477476|NCT01569074|155940166|FG004|Overall Study|Study-specific discontinuation criteria|0|||
48477477|NCT01569074|155940162|FG000|Overall Study|Severe non-compliance to protocol|0|||
48477478|NCT01569074|155940163|FG001|Overall Study|Severe non-compliance to protocol|0|||
48477479|NCT01569074|155940164|FG002|Overall Study|Severe non-compliance to protocol|1|||
48477480|NCT01569074|155940165|FG003|Overall Study|Severe non-compliance to protocol|0|||
48477481|NCT01569074|155940166|FG004|Overall Study|Severe non-compliance to protocol|0|||
48477482|NCT01569074|155940162|FG000|Overall Study|eg change in circumstances|0|||
48477483|NCT01569074|155940163|FG001|Overall Study|eg change in circumstances|2|||
48477484|NCT01569074|155940164|FG002|Overall Study|eg change in circumstances|0|||
48477485|NCT01569074|155940165|FG003|Overall Study|eg change in circumstances|1|||
48477486|NCT01569074|155940166|FG004|Overall Study|eg change in circumstances|1|||
48477487|NCT01569074|155940162|FG000|Overall Study|Adverse Event|1|||
48477488|NCT01569074|155940163|FG001|Overall Study|Adverse Event|0|||
48477489|NCT01569074|155940164|FG002|Overall Study|Adverse Event|3|||
48477490|NCT01569074|155940165|FG003|Overall Study|Adverse Event|0|||
48477491|NCT01569074|155940166|FG004|Overall Study|Adverse Event|0|||
48477492|NCT02297438|155940167|FG000|Overall Study|Death|79|||
48477493|NCT02297438|155940168|FG001|Overall Study|Death|86|||
48477494|NCT02297438|155940167|FG000|Overall Study|Lost to Follow-up|9|||
48477495|NCT02297438|155940168|FG001|Overall Study|Lost to Follow-up|7|||
48477496|NCT02297438|155940167|FG000|Overall Study|Withdrawal by Subject|7|||
48477497|NCT02297438|155940168|FG001|Overall Study|Withdrawal by Subject|0|||
48477498|NCT02297438|155940167|FG000|Overall Study|Other|9|||
48477499|NCT02297438|155940168|FG001|Overall Study|Other|5|||
48477500|NCT02297438|155940167|FG000|Overall Study|Ongoing|65|||
48477501|NCT02297438|155940168|FG001|Overall Study|Ongoing|73|||
48477502|NCT03387735|155940169|FG000|Overall Study|Lost to Follow-up|4|||
48477503|NCT03387735|155940170|FG001|Overall Study|Lost to Follow-up|8|||
48477504|NCT03387735|155940169|FG000|Overall Study|Death|4|||
48477505|NCT03387735|155940170|FG001|Overall Study|Death|8|||
48477506|NCT01803464|155940171|FG000|Overall Study|Incomplete data|0|||
48477507|NCT01803464|155940172|FG001|Overall Study|Incomplete data|0|||
48477508|NCT01803464|155940173|FG002|Overall Study|Incomplete data|4|||
48477509|NCT01803464|155940174|FG003|Overall Study|Incomplete data|0|||
48477510|NCT01803464|155940171|FG000|Overall Study|Withdrawal by Subject|1|||
48477511|NCT01803464|155940172|FG001|Overall Study|Withdrawal by Subject|0|||
48477512|NCT01803464|155940173|FG002|Overall Study|Withdrawal by Subject|0|||
48477513|NCT01803464|155940174|FG003|Overall Study|Withdrawal by Subject|0|||
48477514|NCT01833897|155940175|FG000|Overall Study|Lack of Efficacy|1|||
48477515|NCT04856917|155940176|FG000|Overall Study|Withdrawal by Subject|4|||
48477516|NCT04856917|155940177|FG001|Overall Study|Withdrawal by Subject|3|||
48477517|NCT04856917|155940178|FG002|Overall Study|Withdrawal by Subject|1|||
48477518|NCT04856917|155940176|FG000|Overall Study|Lost to Follow-up|3|||
48477519|NCT04856917|155940177|FG001|Overall Study|Lost to Follow-up|1|||
48477520|NCT04856917|155940178|FG002|Overall Study|Lost to Follow-up|1|||
48477521|NCT04856917|155940176|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
48477522|NCT04856917|155940177|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
48477523|NCT04856917|155940178|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
48477524|NCT04856917|155940176|FG000|Overall Study|Other|1|||
48477525|NCT04856917|155940177|FG001|Overall Study|Other|1|||
48477526|NCT04856917|155940178|FG002|Overall Study|Other|0|||
48477527|NCT02380248|155940181|FG000|Overall Study|Lost to Follow-up|11|||
48477528|NCT02380248|155940181|FG000|Overall Study|Withdrawal by Subject|3|||
48477529|NCT03985293|155940182|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
48477530|NCT03985293|155940183|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
48477531|NCT03985293|155940184|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
48477532|NCT03985293|155940185|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
48477533|NCT03985293|155940186|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
48477534|NCT03985293|155940187|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
48477535|NCT03985293|155940182|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
48477536|NCT03985293|155940183|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
48477537|NCT03985293|155940184|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
48477538|NCT03985293|155940185|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
48477539|NCT03985293|155940186|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
48477540|NCT03985293|155940187|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
48477541|NCT03985293|155940182|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
48477542|NCT03985293|155940183|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
48477543|NCT03985293|155940184|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
48477544|NCT03985293|155940185|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
48477545|NCT03985293|155940186|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
48477546|NCT03985293|155940187|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
48477547|NCT03985293|155940182|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
48477548|NCT03985293|155940183|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
48477549|NCT03985293|155940184|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
48477550|NCT03985293|155940185|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
48477551|NCT03985293|155940186|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
48477552|NCT03985293|155940187|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
48477553|NCT03985293|155940182|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
48477554|NCT03985293|155940183|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
48477555|NCT03985293|155940184|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
48477556|NCT03985293|155940185|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
48477557|NCT03985293|155940186|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
48477558|NCT03985293|155940187|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
48477559|NCT03985293|155940182|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
48477560|NCT03985293|155940183|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
48477561|NCT03985293|155940184|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
48477562|NCT03985293|155940185|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
48477563|NCT03985293|155940186|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
48477564|NCT03985293|155940187|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
48477565|NCT03985293|155940182|FG000|FOLLOW-UP|Lost to Follow-up|0|||
48477566|NCT03985293|155940183|FG001|FOLLOW-UP|Lost to Follow-up|0|||
48477567|NCT03985293|155940184|FG002|FOLLOW-UP|Lost to Follow-up|1|||
48477568|NCT03985293|155940185|FG003|FOLLOW-UP|Lost to Follow-up|0|||
48477569|NCT03985293|155940186|FG004|FOLLOW-UP|Lost to Follow-up|0|||
48477570|NCT03985293|155940187|FG005|FOLLOW-UP|Lost to Follow-up|0|||
48477571|NCT03239340|155940188|FG000|Overall Study|Other|26|||
48477572|NCT03239340|155940188|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
48477573|NCT03239340|155940188|FG000|Overall Study|Death|40|||
48477574|NCT03239340|155940188|FG000|Overall Study|Lost to Follow-up|2|||
48477575|NCT03239340|155940188|FG000|Overall Study|Physician Decision|16|||
48477576|NCT03239340|155940188|FG000|Overall Study|Withdrawal by Subject|27|||
48477577|NCT03022799|155940192|FG000|Overall Study|Adverse Event|0|||
48477578|NCT03022799|155940193|FG001|Overall Study|Adverse Event|0|||
48477579|NCT03022799|155940194|FG002|Overall Study|Adverse Event|0|||
48477580|NCT03022799|155940195|FG003|Overall Study|Adverse Event|0|||
48477581|NCT03022799|155940196|FG004|Overall Study|Adverse Event|0|||
48477582|NCT03022799|155940197|FG005|Overall Study|Adverse Event|0|||
48477583|NCT03022799|155940198|FG006|Overall Study|Adverse Event|0|||
48477584|NCT03022799|155940199|FG007|Overall Study|Adverse Event|0|||
48477585|NCT03022799|155940200|FG008|Overall Study|Adverse Event|0|||
48477586|NCT03022799|155940201|FG009|Overall Study|Adverse Event|1|||
48477587|NCT03022799|155940202|FG010|Overall Study|Adverse Event|1|||
48477588|NCT03022799|155940203|FG011|Overall Study|Adverse Event|0|||
48477589|NCT03022799|155940204|FG012|Overall Study|Adverse Event|0|||
48477590|NCT03862807|155941680|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
48477591|NCT04362761|155941681|FG000|Part A (48 Weeks)|Adverse Event|2|||
48477592|NCT04362761|155941681|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
48477593|NCT04362761|155941681|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
48477594|NCT04362761|155941681|FG000|Part A (48 Weeks)|Other|5|||
48477595|NCT04362761|155941681|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
48477596|NCT04362761|155941681|FG000|Part B (86 Weeks)|Other|4|||
48477597|NCT00684645|155941682|FG000|Overall Study|Death|2|||
48477598|NCT00684645|155941682|FG000|Overall Study|Progressive disease|67|||
48477599|NCT00684645|155941682|FG000|Overall Study|Adverse Event|27|||
48477600|NCT00684645|155941682|FG000|Overall Study|Lost to Follow-up|3|||
48477601|NCT00684645|155941682|FG000|Overall Study|Other|15|||
48477602|NCT02856282|155941689|FG000|Overall Study|Withdrawal by Subject|1|||
48477603|NCT00057330|155941690|FG000|Overall Study|Adverse Event|9|||
48477604|NCT00057330|155941691|FG001|Overall Study|Adverse Event|12|||
48477605|NCT00057330|155941690|FG000|Overall Study|Death|1|||
48477606|NCT00057330|155941691|FG001|Overall Study|Death|0|||
48477607|NCT00057330|155941690|FG000|Overall Study|Protocol Violation|1|||
48477608|NCT00057330|155941691|FG001|Overall Study|Protocol Violation|1|||
48477609|NCT00057330|155941690|FG000|Overall Study|Withdrawal by Subject|115|||
48477610|NCT00057330|155941691|FG001|Overall Study|Withdrawal by Subject|84|||
48477611|NCT00057330|155941690|FG000|Overall Study|Lost to Follow-up|745|||
48477612|NCT00057330|155941691|FG001|Overall Study|Lost to Follow-up|617|||
48477613|NCT00057330|155941690|FG000|Overall Study|Physician Decision|1|||
48477614|NCT00057330|155941691|FG001|Overall Study|Physician Decision|0|||
48477615|NCT00057330|155941690|FG000|Overall Study|Other|260|||
48477616|NCT00057330|155941691|FG001|Overall Study|Other|206|||
48477617|NCT02074982|155941692|FG000|Overall Study|Adverse Event|15|||
48477618|NCT02074982|155941693|FG001|Overall Study|Adverse Event|7|||
48477619|NCT02074982|155941692|FG000|Overall Study|Lack of Efficacy|6|||
48477620|NCT02074982|155941693|FG001|Overall Study|Lack of Efficacy|1|||
48477621|NCT02074982|155941692|FG000|Overall Study|Lost to Follow-up|9|||
48477622|NCT02074982|155941693|FG001|Overall Study|Lost to Follow-up|10|||
48477623|NCT02074982|155941692|FG000|Overall Study|Non-compliance with study treatment|0|||
48477624|NCT02074982|155941693|FG001|Overall Study|Non-compliance with study treatment|2|||
48477625|NCT02074982|155941692|FG000|Overall Study|Physician Decision|1|||
48477626|NCT02074982|155941693|FG001|Overall Study|Physician Decision|1|||
48477627|NCT02074982|155941692|FG000|Overall Study|Pregnancy|1|||
48477628|NCT02074982|155941693|FG001|Overall Study|Pregnancy|2|||
48477629|NCT02074982|155941692|FG000|Overall Study|Protocol deviation|4|||
48477630|NCT02074982|155941693|FG001|Overall Study|Protocol deviation|3|||
48477631|NCT02074982|155941692|FG000|Overall Study|Technical problems|0|||
48477632|NCT02074982|155941693|FG001|Overall Study|Technical problems|2|||
48477633|NCT02074982|155941692|FG000|Overall Study|Subject/guardian decision|15|||
48477634|NCT02074982|155941693|FG001|Overall Study|Subject/guardian decision|24|||
48477635|NCT02074982|155941692|FG000|Overall Study|Death|0|||
48477636|NCT02074982|155941693|FG001|Overall Study|Death|2|||
48477637|NCT00798707|155941699|FG000|Overall Study|Adverse Event|6|||
48477638|NCT00798707|155941700|FG001|Overall Study|Adverse Event|8|||
48477639|NCT00798707|155941701|FG002|Overall Study|Adverse Event|8|||
48477640|NCT00798707|155941699|FG000|Overall Study|Failed to return|2|||
48477641|NCT00798707|155941700|FG001|Overall Study|Failed to return|2|||
48477642|NCT00798707|155941701|FG002|Overall Study|Failed to return|0|||
48477643|NCT00798707|155941699|FG000|Overall Study|Investigator|0|||
48477644|NCT00798707|155941700|FG001|Overall Study|Investigator|1|||
48477645|NCT00798707|155941701|FG002|Overall Study|Investigator|2|||
48477646|NCT00798707|155941699|FG000|Overall Study|Lack of Efficacy|2|||
48477647|NCT00798707|155941700|FG001|Overall Study|Lack of Efficacy|2|||
48477648|NCT00798707|155941701|FG002|Overall Study|Lack of Efficacy|1|||
48477649|NCT00798707|155941699|FG000|Overall Study|Lost to Follow-up|5|||
48477650|NCT00798707|155941700|FG001|Overall Study|Lost to Follow-up|6|||
48477651|NCT00798707|155941701|FG002|Overall Study|Lost to Follow-up|6|||
48477652|NCT00798707|155941699|FG000|Overall Study|Other|0|||
48477653|NCT00798707|155941700|FG001|Overall Study|Other|1|||
48477654|NCT00798707|155941701|FG002|Overall Study|Other|0|||
48477655|NCT00798707|155941699|FG000|Overall Study|Protocol Violation|4|||
48477656|NCT00798707|155941700|FG001|Overall Study|Protocol Violation|0|||
48477657|NCT00798707|155941701|FG002|Overall Study|Protocol Violation|2|||
48477658|NCT00798707|155941699|FG000|Overall Study|Withdrawal by Subject|3|||
48477659|NCT00798707|155941700|FG001|Overall Study|Withdrawal by Subject|8|||
48477660|NCT00798707|155941701|FG002|Overall Study|Withdrawal by Subject|2|||
48477661|NCT00798707|155941699|FG000|Overall Study|Randomized not treated|4|||
48477662|NCT00798707|155941700|FG001|Overall Study|Randomized not treated|5|||
48477663|NCT00798707|155941701|FG002|Overall Study|Randomized not treated|1|||
48477664|NCT04635631|155941705|FG000|Overall Study|Adverse Event|1|||
48477665|NCT04635631|155941705|FG000|Overall Study|Progressive disease|13|||
48477666|NCT04635631|155941705|FG000|Overall Study|Withdrawal by Subject|1|||
48477667|NCT01360021|155941712|FG000|Overall Study|Eligibility criteria + other|2|||
48477668|NCT01360021|155941713|FG001|Overall Study|Eligibility criteria + other|1|||
48477669|NCT01360021|155941714|FG002|Overall Study|Eligibility criteria + other|1|||
48477670|NCT01360021|155941712|FG000|Overall Study|Protocol Violation|0|||
48477671|NCT01360021|155941713|FG001|Overall Study|Protocol Violation|0|||
48477672|NCT01360021|155941714|FG002|Overall Study|Protocol Violation|1|||
48477673|NCT01360021|155941712|FG000|Overall Study|Withdrawal by Subject|4|||
48477674|NCT01360021|155941713|FG001|Overall Study|Withdrawal by Subject|0|||
48477675|NCT01360021|155941714|FG002|Overall Study|Withdrawal by Subject|2|||
48477676|NCT01360021|155941712|FG000|Overall Study|Adverse Event|2|||
48477677|NCT01360021|155941713|FG001|Overall Study|Adverse Event|3|||
48477678|NCT01360021|155941714|FG002|Overall Study|Adverse Event|3|||
48477679|NCT00110084|155941715|FG000|Overall Study|Adverse Event|9|||
48477680|NCT00110084|155941715|FG000|Overall Study|Death|1|||
48477681|NCT00110084|155941715|FG000|Overall Study|Patient Refusal|10|||
48477682|NCT00110084|155941715|FG000|Overall Study|Alternate Therapy|5|||
48477683|NCT00110084|155941715|FG000|Overall Study|Intercurrent Illness|1|||
48477684|NCT00110084|155941715|FG000|Overall Study|Other|2|||
48477685|NCT04854707|155941717|FG000|Overall Study|Lack of Efficacy|78|||
48477686|NCT04854707|155941718|FG001|Overall Study|Lack of Efficacy|59|||
48477687|NCT04854707|155941719|FG002|Overall Study|Lack of Efficacy|30|||
48477688|NCT00537056|155941720|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
48477689|NCT01257737|155941722|FG000|Overall Study|Lost to Follow-up|1|||
48477690|NCT01257737|155941723|FG001|Overall Study|Lost to Follow-up|2|||
48477691|NCT01257737|155941722|FG000|Overall Study|Liver transplant|1|||
48477692|NCT01257737|155941723|FG001|Overall Study|Liver transplant|0|||
48477693|NCT01257737|155941722|FG000|Overall Study|Relocation out of the country|0|||
48477694|NCT01257737|155941723|FG001|Overall Study|Relocation out of the country|1|||
48477695|NCT01257737|155941722|FG000|Overall Study|Withdrew from study|0|||
48477696|NCT01257737|155941723|FG001|Overall Study|Withdrew from study|1|||
48477697|NCT02723786|155941732|FG000|Overall Study|Lost to Follow-up|1|||
48477698|NCT00669110|155941733|FG000|Overall Study|Adverse Event|4|||
48477699|NCT00669110|155941734|FG001|Overall Study|Adverse Event|3|||
48477700|NCT00669110|155941733|FG000|Overall Study|Caregiver request|3|||
48477701|NCT00669110|155941734|FG001|Overall Study|Caregiver request|2|||
48477702|NCT00669110|155941733|FG000|Overall Study|Physician Decision|0|||
48477703|NCT00669110|155941734|FG001|Overall Study|Physician Decision|1|||
48477704|NCT00669110|155941733|FG000|Overall Study|Lost to Follow-up|1|||
48477705|NCT00669110|155941734|FG001|Overall Study|Lost to Follow-up|0|||
48477706|NCT00669110|155941733|FG000|Overall Study|Protocol Violation|0|||
48477707|NCT00669110|155941734|FG001|Overall Study|Protocol Violation|5|||
48477708|NCT00669110|155941733|FG000|Overall Study|Withdrawal by Subject|0|||
48477709|NCT00669110|155941734|FG001|Overall Study|Withdrawal by Subject|2|||
48477710|NCT03683719|155941737|FG000|Overall Study|Lack of Efficacy|1|||
48477711|NCT03683719|155941738|FG001|Overall Study|Lack of Efficacy|3|||
48477712|NCT03683719|155941739|FG002|Overall Study|Lack of Efficacy|4|||
48477713|NCT03683719|155941740|FG003|Overall Study|Lack of Efficacy|0|||
48477714|NCT03683719|155941741|FG004|Overall Study|Lack of Efficacy|4|||
48477715|NCT03683719|155941737|FG000|Overall Study|Adverse Event|6|||
48477716|NCT03683719|155941738|FG001|Overall Study|Adverse Event|6|||
48477717|NCT03683719|155941739|FG002|Overall Study|Adverse Event|0|||
48477718|NCT03683719|155941740|FG003|Overall Study|Adverse Event|1|||
48477719|NCT03683719|155941741|FG004|Overall Study|Adverse Event|3|||
48477720|NCT03683719|155941737|FG000|Overall Study|Withdrawal by Subject|4|||
48477721|NCT03683719|155941738|FG001|Overall Study|Withdrawal by Subject|4|||
48477722|NCT03683719|155941739|FG002|Overall Study|Withdrawal by Subject|3|||
48477723|NCT03683719|155941740|FG003|Overall Study|Withdrawal by Subject|5|||
48477724|NCT03683719|155941741|FG004|Overall Study|Withdrawal by Subject|5|||
48477725|NCT03683719|155941737|FG000|Overall Study|Lost to Follow-up|1|||
48477726|NCT03683719|155941738|FG001|Overall Study|Lost to Follow-up|0|||
48477727|NCT03683719|155941739|FG002|Overall Study|Lost to Follow-up|0|||
48477728|NCT03683719|155941740|FG003|Overall Study|Lost to Follow-up|1|||
48477729|NCT03683719|155941741|FG004|Overall Study|Lost to Follow-up|1|||
48477730|NCT03683719|155941737|FG000|Overall Study|Other personal reasons|0|||
48477731|NCT03683719|155941738|FG001|Overall Study|Other personal reasons|0|||
48477732|NCT03683719|155941739|FG002|Overall Study|Other personal reasons|1|||
48477733|NCT03683719|155941740|FG003|Overall Study|Other personal reasons|0|||
48477734|NCT03683719|155941741|FG004|Overall Study|Other personal reasons|1|||
48477735|NCT01870921|155941743|FG000|Overall Study|Subject decision|80|||
48477736|NCT01870921|155941743|FG000|Overall Study|Severe non-compliance to protocol|7|||
48477737|NCT01870921|155941743|FG000|Overall Study|Subject Lost to Follow up|2|||
48477738|NCT01870921|155941743|FG000|Overall Study|Other|1|||
48477739|NCT03170271|155941744|FG000|Overall Study|Adverse Event|7|||
48477740|NCT03170271|155941745|FG001|Overall Study|Adverse Event|2|||
48477741|NCT03170271|155941744|FG000|Overall Study|Lost to Follow-up|0|||
48477742|NCT03170271|155941745|FG001|Overall Study|Lost to Follow-up|1|||
48477743|NCT03170271|155941744|FG000|Overall Study|Physician Decision|1|||
48477744|NCT03170271|155941745|FG001|Overall Study|Physician Decision|0|||
48477745|NCT03170271|155941744|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
48477746|NCT03170271|155941745|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
48477747|NCT03170271|155941744|FG000|Overall Study|Withdrawal by Subject|17|||
48477748|NCT03170271|155941745|FG001|Overall Study|Withdrawal by Subject|5|||
48477749|NCT03170271|155941744|FG000|Overall Study|Other|2|||
48477750|NCT03170271|155941745|FG001|Overall Study|Other|2|||
48477751|NCT03170271|155941744|FG000|Overall Study|Randomized in error|4|||
48477752|NCT03170271|155941745|FG001|Overall Study|Randomized in error|0|||
48477753|NCT03083639|155941746|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
48477754|NCT03083639|155941747|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
48477755|NCT03083639|155941746|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
48477756|NCT03083639|155941747|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
48477757|NCT01591499|155941750|FG000|Baseline Visit|Withdrawal by Subject|0|||
48477758|NCT01591499|155941751|FG001|Baseline Visit|Withdrawal by Subject|2|||
48477759|NCT01591499|155941752|FG002|Baseline Visit|Withdrawal by Subject|0|||
48477760|NCT01591499|155941753|FG003|Baseline Visit|Withdrawal by Subject|2|||
48477761|NCT01591499|155941750|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
48477762|NCT01591499|155941751|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
48477763|NCT01591499|155941752|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
48477764|NCT01591499|155941753|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
48477765|NCT01591499|155941750|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
48477766|NCT01591499|155941751|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
48477767|NCT01591499|155941752|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
48477768|NCT01591499|155941753|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
48477769|NCT01275170|155941754|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
48477770|NCT01275170|155941755|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
48477771|NCT01275170|155941756|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
48477772|NCT01275170|155941757|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
48477773|NCT01275170|155941758|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
48477774|NCT01275170|155941759|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
48477775|NCT01275170|155941760|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
48477776|NCT01275170|155941761|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
48477777|NCT00390572|155941762|FG000|Overall Study|Lost to Follow-up|8|||
48477778|NCT00390572|155941763|FG001|Overall Study|Lost to Follow-up|4|||
48477779|NCT00390572|155941762|FG000|Overall Study|health condition|0|||
48477780|NCT00390572|155941763|FG001|Overall Study|health condition|1|||
48477781|NCT03185949|155941766|FG000|ITT Analysis|Withdrawal by Subject|4|||
48477782|NCT03185949|155941767|FG001|ITT Analysis|Withdrawal by Subject|3|||
48477783|NCT03185949|155941766|FG000|PP Analysis|Protocol Violation|2|||
48477784|NCT03185949|155941767|FG001|PP Analysis|Protocol Violation|2|||
48477785|NCT03185949|155941766|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
48477786|NCT03185949|155941767|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
48477787|NCT03107715|155941769|FG000|Overall Study|did not deliver at the home hospital|4|||
48477788|NCT03107715|155941770|FG001|Overall Study|did not deliver at the home hospital|6|||
48477789|NCT03107715|155941769|FG000|Overall Study|infant stillborn|0|||
48477790|NCT03107715|155941770|FG001|Overall Study|infant stillborn|1|||
48477791|NCT01311505|155941771|FG000|First Intervention Period|Protocol Violation|0|||
48477792|NCT01311505|155941772|FG001|First Intervention Period|Protocol Violation|1|||
48477793|NCT03594175|155941773|FG000|Overall Study|Not treated|8|||
48477794|NCT03594175|155941774|FG001|Overall Study|Not treated|1|||
48477795|NCT03594175|155941775|FG002|Overall Study|Not treated|5|||
48477796|NCT03594175|155941773|FG000|Overall Study|Adverse Event|3|||
48477797|NCT03594175|155941774|FG001|Overall Study|Adverse Event|0|||
48477798|NCT03594175|155941775|FG002|Overall Study|Adverse Event|0|||
48477799|NCT03594175|155941773|FG000|Overall Study|Withdrawal by Subject|3|||
48477800|NCT03594175|155941774|FG001|Overall Study|Withdrawal by Subject|0|||
48477801|NCT03594175|155941775|FG002|Overall Study|Withdrawal by Subject|0|||
48477802|NCT03594175|155941773|FG000|Overall Study|Protocol Violation|2|||
48477803|NCT03594175|155941774|FG001|Overall Study|Protocol Violation|2|||
48477804|NCT03594175|155941775|FG002|Overall Study|Protocol Violation|2|||
48477805|NCT05004181|155941776|FG000|Overall Study|Withdrawal of consent|0|||
48477806|NCT05004181|155941777|FG001|Overall Study|Withdrawal of consent|0|||
48477807|NCT05004181|155941778|FG002|Overall Study|Withdrawal of consent|1|||
48477808|NCT05004181|155941779|FG003|Overall Study|Withdrawal of consent|3|||
48477809|NCT05004181|155941780|FG004|Overall Study|Withdrawal of consent|3|||
48477810|NCT05004181|155941781|FG005|Overall Study|Withdrawal of consent|0|||
48477811|NCT05004181|155941782|FG006|Overall Study|Withdrawal of consent|30|||
48477812|NCT05004181|155941783|FG007|Overall Study|Withdrawal of consent|9|||
48477813|NCT05004181|155941784|FG008|Overall Study|Withdrawal of consent|3|||
48477814|NCT05004181|155941785|FG009|Overall Study|Withdrawal of consent|2|||
48477815|NCT05004181|155941786|FG010|Overall Study|Withdrawal of consent|5|||
48477816|NCT05004181|155941787|FG011|Overall Study|Withdrawal of consent|1|||
48477817|NCT05004181|155941776|FG000|Overall Study|Lost to Follow-up|2|||
48477818|NCT05004181|155941777|FG001|Overall Study|Lost to Follow-up|4|||
48477819|NCT05004181|155941778|FG002|Overall Study|Lost to Follow-up|2|||
48477820|NCT05004181|155941779|FG003|Overall Study|Lost to Follow-up|3|||
48477821|NCT05004181|155941780|FG004|Overall Study|Lost to Follow-up|5|||
48477822|NCT05004181|155941781|FG005|Overall Study|Lost to Follow-up|2|||
48477823|NCT05004181|155941782|FG006|Overall Study|Lost to Follow-up|15|||
48477824|NCT05004181|155941783|FG007|Overall Study|Lost to Follow-up|12|||
48477825|NCT05004181|155941784|FG008|Overall Study|Lost to Follow-up|38|||
48477826|NCT05004181|155941785|FG009|Overall Study|Lost to Follow-up|6|||
48477827|NCT05004181|155941786|FG010|Overall Study|Lost to Follow-up|6|||
48477828|NCT05004181|155941787|FG011|Overall Study|Lost to Follow-up|0|||
48477829|NCT05004181|155941776|FG000|Overall Study|Death|0|||
48477830|NCT05004181|155941777|FG001|Overall Study|Death|0|||
48477831|NCT05004181|155941778|FG002|Overall Study|Death|0|||
48477832|NCT05004181|155941779|FG003|Overall Study|Death|0|||
48477833|NCT05004181|155941780|FG004|Overall Study|Death|0|||
48477834|NCT05004181|155941781|FG005|Overall Study|Death|0|||
48477835|NCT05004181|155941782|FG006|Overall Study|Death|1|||
48477836|NCT05004181|155941783|FG007|Overall Study|Death|0|||
48477837|NCT05004181|155941784|FG008|Overall Study|Death|2|||
48477838|NCT05004181|155941785|FG009|Overall Study|Death|0|||
48477839|NCT05004181|155941786|FG010|Overall Study|Death|0|||
48477840|NCT05004181|155941787|FG011|Overall Study|Death|0|||
48477841|NCT05004181|155941776|FG000|Overall Study|Physician Decision|0|||
48477842|NCT05004181|155941777|FG001|Overall Study|Physician Decision|0|||
48477843|NCT05004181|155941778|FG002|Overall Study|Physician Decision|0|||
48477844|NCT05004181|155941779|FG003|Overall Study|Physician Decision|0|||
48477845|NCT05004181|155941780|FG004|Overall Study|Physician Decision|0|||
48477846|NCT05004181|155941781|FG005|Overall Study|Physician Decision|0|||
48477847|NCT05004181|155941782|FG006|Overall Study|Physician Decision|2|||
48477848|NCT05004181|155941783|FG007|Overall Study|Physician Decision|0|||
48477849|NCT05004181|155941784|FG008|Overall Study|Physician Decision|7|||
48477850|NCT05004181|155941785|FG009|Overall Study|Physician Decision|0|||
48477851|NCT05004181|155941786|FG010|Overall Study|Physician Decision|0|||
48477852|NCT05004181|155941787|FG011|Overall Study|Physician Decision|0|||
48477853|NCT05004181|155941776|FG000|Overall Study|Withdrawal by Subject|2|||
48477854|NCT05004181|155941777|FG001|Overall Study|Withdrawal by Subject|3|||
48477855|NCT05004181|155941778|FG002|Overall Study|Withdrawal by Subject|2|||
48477856|NCT05004181|155941779|FG003|Overall Study|Withdrawal by Subject|2|||
48477857|NCT05004181|155941780|FG004|Overall Study|Withdrawal by Subject|4|||
48477858|NCT05004181|155941781|FG005|Overall Study|Withdrawal by Subject|2|||
48477859|NCT05004181|155941782|FG006|Overall Study|Withdrawal by Subject|4|||
48477860|NCT05004181|155941783|FG007|Overall Study|Withdrawal by Subject|22|||
48477861|NCT05004181|155941784|FG008|Overall Study|Withdrawal by Subject|8|||
48477862|NCT05004181|155941785|FG009|Overall Study|Withdrawal by Subject|1|||
48477863|NCT05004181|155941786|FG010|Overall Study|Withdrawal by Subject|3|||
48477864|NCT05004181|155941787|FG011|Overall Study|Withdrawal by Subject|2|||
48477865|NCT05004181|155941776|FG000|Overall Study|Protocol Violation|2|||
48477866|NCT05004181|155941777|FG001|Overall Study|Protocol Violation|3|||
48477867|NCT05004181|155941778|FG002|Overall Study|Protocol Violation|0|||
48477868|NCT05004181|155941779|FG003|Overall Study|Protocol Violation|0|||
48477869|NCT05004181|155941780|FG004|Overall Study|Protocol Violation|1|||
48477870|NCT05004181|155941781|FG005|Overall Study|Protocol Violation|0|||
48477871|NCT05004181|155941782|FG006|Overall Study|Protocol Violation|16|||
48477872|NCT05004181|155941783|FG007|Overall Study|Protocol Violation|18|||
48477873|NCT05004181|155941784|FG008|Overall Study|Protocol Violation|2|||
48477874|NCT05004181|155941785|FG009|Overall Study|Protocol Violation|2|||
48477875|NCT05004181|155941786|FG010|Overall Study|Protocol Violation|2|||
48477876|NCT05004181|155941787|FG011|Overall Study|Protocol Violation|1|||
48477877|NCT05004181|155941776|FG000|Overall Study|Not further specified|1|||
48477878|NCT05004181|155941777|FG001|Overall Study|Not further specified|0|||
48477879|NCT05004181|155941778|FG002|Overall Study|Not further specified|0|||
48477880|NCT05004181|155941779|FG003|Overall Study|Not further specified|0|||
48477881|NCT05004181|155941780|FG004|Overall Study|Not further specified|0|||
48477882|NCT05004181|155941781|FG005|Overall Study|Not further specified|0|||
48477883|NCT05004181|155941782|FG006|Overall Study|Not further specified|1|||
48477884|NCT05004181|155941783|FG007|Overall Study|Not further specified|0|||
48477885|NCT05004181|155941784|FG008|Overall Study|Not further specified|2|||
48477886|NCT05004181|155941785|FG009|Overall Study|Not further specified|1|||
48477887|NCT05004181|155941786|FG010|Overall Study|Not further specified|0|||
48477888|NCT05004181|155941787|FG011|Overall Study|Not further specified|1|||
48477889|NCT02949219|155941788|FG000|Overall Study|Withdrawal by Subject|1|||
48477890|NCT01843660|155941801|FG000|Overall Study|Other|30|||
48477891|NCT00563706|155943682|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
48477892|NCT00563706|155943683|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
48477961|NCT03746080|155943709|FG000|Overall Study|Death|15|||
48477893|NCT00563706|155943684|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
48477894|NCT00563706|155943685|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
48477895|NCT00563706|155943686|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
48477896|NCT00563706|155943687|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
48477897|NCT00563706|155943688|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
48477898|NCT00563706|155943689|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
48477899|NCT00563706|155943690|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
48477900|NCT00563706|155943682|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
48477901|NCT00563706|155943683|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
48477902|NCT00563706|155943684|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
48477903|NCT00563706|155943685|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
48477904|NCT00563706|155943686|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
48477905|NCT00563706|155943687|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
48477906|NCT00563706|155943688|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
48477907|NCT00563706|155943689|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
48477908|NCT00563706|155943690|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
48477909|NCT00563706|155943682|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
48477910|NCT00563706|155943683|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
48477911|NCT00563706|155943684|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
48477912|NCT00563706|155943685|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
48477913|NCT00563706|155943686|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
48477914|NCT00563706|155943687|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
48477915|NCT00563706|155943688|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
48477916|NCT00563706|155943689|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
48477917|NCT00563706|155943690|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
48477918|NCT00563706|155943682|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
48477919|NCT00563706|155943683|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
48477920|NCT00563706|155943684|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
48477921|NCT00563706|155943685|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
48477922|NCT00563706|155943686|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
48477923|NCT00563706|155943687|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
48477924|NCT00563706|155943688|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
48477925|NCT00563706|155943689|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
48477926|NCT00563706|155943690|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
48477927|NCT00563706|155943682|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
48477928|NCT00563706|155943683|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
48477929|NCT00563706|155943684|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
48477930|NCT00563706|155943685|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
48477931|NCT00563706|155943686|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
48477932|NCT00563706|155943687|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
48477933|NCT00563706|155943688|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
48477934|NCT00563706|155943689|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
48477935|NCT00563706|155943690|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
48477936|NCT00564486|155943695|FG000|Overall Study|Adverse Event|0|||
48477937|NCT00564486|155943696|FG001|Overall Study|Adverse Event|1|||
48477938|NCT00564486|155943697|FG002|Overall Study|Adverse Event|0|||
48477939|NCT00564486|155943698|FG003|Overall Study|Adverse Event|0|||
48477940|NCT00564486|155943695|FG000|Overall Study|Withdrawal by Subject|4|||
48477941|NCT00564486|155943696|FG001|Overall Study|Withdrawal by Subject|0|||
48477942|NCT00564486|155943697|FG002|Overall Study|Withdrawal by Subject|0|||
48477943|NCT00564486|155943698|FG003|Overall Study|Withdrawal by Subject|5|||
48477944|NCT00564486|155943695|FG000|Overall Study|Subject refused to have blood drawn|0|||
48477945|NCT00564486|155943696|FG001|Overall Study|Subject refused to have blood drawn|0|||
48477946|NCT00564486|155943697|FG002|Overall Study|Subject refused to have blood drawn|1|||
48477947|NCT00564486|155943698|FG003|Overall Study|Subject refused to have blood drawn|0|||
48477948|NCT00564486|155943695|FG000|Overall Study|Lost to Follow-up|3|||
48477949|NCT00564486|155943696|FG001|Overall Study|Lost to Follow-up|0|||
48477950|NCT00564486|155943697|FG002|Overall Study|Lost to Follow-up|2|||
48477951|NCT00564486|155943698|FG003|Overall Study|Lost to Follow-up|2|||
48477952|NCT02525627|155943707|FG000|Overall Study|Revision|1|||
48477953|NCT02525627|155943708|FG001|Overall Study|Revision|1|||
48477954|NCT02525627|155943707|FG000|Overall Study|Withdrawal by Subject|1|||
48477955|NCT02525627|155943708|FG001|Overall Study|Withdrawal by Subject|2|||
48477956|NCT02525627|155943707|FG000|Overall Study|Death|1|||
48477957|NCT02525627|155943708|FG001|Overall Study|Death|0|||
48477958|NCT02525627|155943707|FG000|Overall Study|Site terminated|11|||
48477959|NCT02525627|155943708|FG001|Overall Study|Site terminated|10|||
48477960|NCT03746080|155943709|FG000|Overall Study|In follow up|2|||
48477962|NCT02094573|155943710|FG000|Overall Study|Adverse Event|4|||
48477963|NCT02094573|155943711|FG001|Overall Study|Adverse Event|14|||
48477964|NCT02094573|155943710|FG000|Overall Study|Clinical Progressive Disease|9|||
48477965|NCT02094573|155943711|FG001|Overall Study|Clinical Progressive Disease|13|||
48477966|NCT02094573|155943710|FG000|Overall Study|Death|11|||
48477967|NCT02094573|155943711|FG001|Overall Study|Death|3|||
48477968|NCT02094573|155943710|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
48477969|NCT02094573|155943711|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
48477970|NCT02094573|155943710|FG000|Overall Study|Non-compliance with Study Drug|1|||
48477971|NCT02094573|155943711|FG001|Overall Study|Non-compliance with Study Drug|1|||
48477972|NCT02094573|155943710|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
48477973|NCT02094573|155943711|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
48477974|NCT02094573|155943710|FG000|Overall Study|Physician Decision|4|||
48477975|NCT02094573|155943711|FG001|Overall Study|Physician Decision|4|||
48477976|NCT02094573|155943710|FG000|Overall Study|Site Terminated by Sponsor|10|||
48477977|NCT02094573|155943711|FG001|Overall Study|Site Terminated by Sponsor|17|||
48477978|NCT02094573|155943710|FG000|Overall Study|Withdrawal by Subject|6|||
48477979|NCT02094573|155943711|FG001|Overall Study|Withdrawal by Subject|8|||
48477980|NCT02094573|155943710|FG000|Overall Study|Randomized but not Treated|3|||
48477981|NCT02094573|155943711|FG001|Overall Study|Randomized but not Treated|0|||
48477982|NCT01473589|155943712|FG000|Overall Study|Adverse Event|1|||
48477983|NCT01473589|155943713|FG001|Overall Study|Adverse Event|1|||
48477984|NCT01473589|155943712|FG000|Overall Study|Death|2|||
48477985|NCT01473589|155943713|FG001|Overall Study|Death|0|||
48477986|NCT01473589|155943712|FG000|Overall Study|Lost to Follow-up|2|||
48477987|NCT01473589|155943713|FG001|Overall Study|Lost to Follow-up|2|||
48477988|NCT01473589|155943712|FG000|Overall Study|Protocol Violation|1|||
48477989|NCT01473589|155943713|FG001|Overall Study|Protocol Violation|0|||
48477990|NCT01473589|155943712|FG000|Overall Study|Withdrawal by Subject|5|||
48477991|NCT01473589|155943713|FG001|Overall Study|Withdrawal by Subject|11|||
48477992|NCT01473589|155943712|FG000|Overall Study|Physician Decision|0|||
48477993|NCT01473589|155943713|FG001|Overall Study|Physician Decision|1|||
48477994|NCT01473589|155943712|FG000|Overall Study|Entry criteria not met|0|||
48477995|NCT01473589|155943713|FG001|Overall Study|Entry criteria not met|1|||
48477996|NCT01819467|155943714|FG000|Overall Study|Physician Decision|20|||
48477997|NCT01819467|155943715|FG001|Overall Study|Physician Decision|9|||
48477998|NCT01160770|155943716|FG000|Overall Study|Adverse Event|10|||
48477999|NCT01160770|155943716|FG000|Overall Study|Protocol Violation|2|||
48478000|NCT01160770|155943716|FG000|Overall Study|Subject/parent/caregiver request|33|||
48478001|NCT01160770|155943716|FG000|Overall Study|Physician Decision|1|||
48478002|NCT01160770|155943716|FG000|Overall Study|Lost to Follow-up|7|||
48478003|NCT01160770|155943716|FG000|Overall Study|Study termination or sponsor request|1|||
48478004|NCT01160770|155943716|FG000|Overall Study|Death|9|||
48478005|NCT01160770|155943716|FG000|Overall Study|Lack of Efficacy|15|||
48478006|NCT01160770|155943716|FG000|Overall Study|Other Reasons|1|||
48478007|NCT04469465|155943725|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
48478008|NCT04469465|155943726|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
48478009|NCT04469465|155943725|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
48478010|NCT04469465|155943726|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
48478011|NCT04469465|155943725|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
48478012|NCT04469465|155943726|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
48478013|NCT04469465|155943725|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
48478014|NCT04469465|155943726|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
48478015|NCT04469465|155943725|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
48478016|NCT04469465|155943726|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
48478017|NCT04469465|155943725|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
48478018|NCT04469465|155943726|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
48478019|NCT04469465|155943725|FG000|Long-Term Extension (LTE)|Death|0|||
48478020|NCT04469465|155943726|FG001|Long-Term Extension (LTE)|Death|1|||
48478021|NCT04469465|155943725|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
48478022|NCT04469465|155943726|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
48478023|NCT00138658|155943729|FG000|Overall Study|Adverse Event|23|||
48478024|NCT00138658|155943729|FG000|Overall Study|Death|1|||
48478025|NCT00138658|155943729|FG000|Overall Study|Disease Progression|21|||
48478026|NCT00138658|155943729|FG000|Overall Study|Physician Decision|11|||
48478027|NCT00138658|155943729|FG000|Overall Study|Withdrawal by Subject|5|||
48478028|NCT03123120|155943733|FG000|Overall Study|Lost to Follow-up|0|||
48478029|NCT03123120|155943734|FG001|Overall Study|Lost to Follow-up|1|||
48478030|NCT03123120|155943733|FG000|Overall Study|Withdrawal by Subject|0|||
48478031|NCT03123120|155943734|FG001|Overall Study|Withdrawal by Subject|1|||
48478032|NCT00203892|155943735|FG000|Overall Study|Physician Decision|1|||
48478033|NCT00203892|155943736|FG001|Overall Study|Physician Decision|2|||
48478034|NCT00203892|155943737|FG002|Overall Study|Physician Decision|0|||
48478035|NCT00203892|155943735|FG000|Overall Study|Death|1|||
48478036|NCT00203892|155943736|FG001|Overall Study|Death|0|||
48478037|NCT00203892|155943737|FG002|Overall Study|Death|0|||
48478038|NCT00806416|155943738|FG000|Period 1 - Part I|Adverse Event|0|||
48478039|NCT00806416|155943739|FG001|Period 1 - Part I|Adverse Event|1|||
48478040|NCT00806416|155943740|FG002|Period 1 - Part I|Adverse Event|0|||
48478041|NCT00806416|155943741|FG003|Period 1 - Part I|Adverse Event|0|||
48478042|NCT00806416|155943738|FG000|Period 1 - Part I|Lost to Follow-up|0|||
48478043|NCT00806416|155943739|FG001|Period 1 - Part I|Lost to Follow-up|2|||
48478044|NCT00806416|155943740|FG002|Period 1 - Part I|Lost to Follow-up|0|||
48478045|NCT00806416|155943741|FG003|Period 1 - Part I|Lost to Follow-up|0|||
48478046|NCT00806416|155943738|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
48478047|NCT00806416|155943739|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
48478048|NCT00806416|155943740|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
48478049|NCT00806416|155943741|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
48478050|NCT00806416|155943738|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
48478051|NCT00806416|155943739|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
48478052|NCT00806416|155943740|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
48478053|NCT00806416|155943741|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
48478054|NCT01244516|155943748|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
48478055|NCT01244516|155943749|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
48478056|NCT01244516|155943750|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
48478057|NCT01244516|155943748|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
48478058|NCT01244516|155943749|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
48478059|NCT01244516|155943750|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
48478060|NCT01244516|155943748|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
48478061|NCT01244516|155943749|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
48478062|NCT01244516|155943750|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
48478063|NCT01244516|155943748|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
48478064|NCT01244516|155943749|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
48478065|NCT01244516|155943750|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
48478066|NCT01244516|155943748|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
48478067|NCT01244516|155943749|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
48478068|NCT01244516|155943750|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
48478069|NCT01244516|155943748|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
48478070|NCT01244516|155943749|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
48478071|NCT01244516|155943750|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
48478072|NCT01244516|155943748|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
48478073|NCT01244516|155943749|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
48478074|NCT01244516|155943750|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
48478075|NCT02866695|155943751|FG000|Overall Study|Adverse Event|1|||
48478076|NCT02866695|155943751|FG000|Overall Study|Lost to Follow-up|1|||
48478077|NCT01610284|155943754|FG000|Randomization Phase|Adverse Event|1|||
48478078|NCT01610284|155943755|FG001|Randomization Phase|Adverse Event|0|||
48478079|NCT01610284|155943754|FG000|Randomization Phase|Physician Decision|1|||
48478080|NCT01610284|155943755|FG001|Randomization Phase|Physician Decision|1|||
48478081|NCT01610284|155943754|FG000|Randomization Phase|Death|0|||
48478082|NCT01610284|155943755|FG001|Randomization Phase|Death|1|||
48478083|NCT01610284|155943754|FG000|Treatment Phase|Adverse Event|80|||
48478084|NCT01610284|155943755|FG001|Treatment Phase|Adverse Event|12|||
48478085|NCT01610284|155943754|FG000|Treatment Phase|Lost to Follow-up|1|||
48478086|NCT01610284|155943755|FG001|Treatment Phase|Lost to Follow-up|0|||
48478087|NCT01610284|155943754|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
48478088|NCT01610284|155943755|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
48478089|NCT01610284|155943754|FG000|Treatment Phase|Physician Decision|27|||
48478090|NCT01610284|155943755|FG001|Treatment Phase|Physician Decision|24|||
48478091|NCT01610284|155943754|FG000|Treatment Phase|Progressive Disease|377|||
48478092|NCT01610284|155943755|FG001|Treatment Phase|Progressive Disease|486|||
48478093|NCT01610284|155943754|FG000|Treatment Phase|Protocol Deviation|2|||
48478094|NCT01610284|155943755|FG001|Treatment Phase|Protocol Deviation|3|||
48478095|NCT01610284|155943754|FG000|Treatment Phase|Study terminated by Sponsor|18|||
48478096|NCT01610284|155943755|FG001|Treatment Phase|Study terminated by Sponsor|15|||
48478097|NCT01610284|155943754|FG000|Treatment Phase|Subject/Guardian Decision|55|||
48478098|NCT01610284|155943755|FG001|Treatment Phase|Subject/Guardian Decision|23|||
48478099|NCT01610284|155943754|FG000|Treatment Phase|Death|6|||
48478100|NCT01610284|155943755|FG001|Treatment Phase|Death|5|||
48478101|NCT01610284|155943754|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
48478102|NCT01610284|155943755|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
48478103|NCT01610284|155943754|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
48478104|NCT01610284|155943755|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
48478105|NCT01610284|155943754|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
48478106|NCT01610284|155943755|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
48478107|NCT01610284|155943754|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
48478108|NCT01610284|155943755|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
48478109|NCT01610284|155943754|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
48478110|NCT01610284|155943755|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
48478111|NCT01610284|155943754|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
48478112|NCT01610284|155943755|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
48478113|NCT02125734|155943756|FG000|Period 2|Adverse Event|0|||
48478114|NCT02125734|155943757|FG001|Period 2|Adverse Event|1|||
48478115|NCT01308762|155943758|FG000|Overall Study|Protocol Violation|0|||
48478116|NCT01308762|155943759|FG001|Overall Study|Protocol Violation|1|||
48478117|NCT01308762|155943760|FG002|Overall Study|Protocol Violation|0|||
48478118|NCT00605839|155943761|FG000|Overall Study|Protocol Violation|1|||
48478119|NCT00605839|155943762|FG001|Overall Study|Protocol Violation|0|||
48478120|NCT00605839|155943763|FG002|Overall Study|Protocol Violation|0|||
48478121|NCT05166512|155943772|FG000|Randomized|Lost to Follow-up|2|||
48478122|NCT05166512|155943773|FG001|Randomized|Lost to Follow-up|0|||
48478123|NCT05166512|155943772|FG000|Randomized|Withdrawal by Subject|1|||
48478124|NCT05166512|155943773|FG001|Randomized|Withdrawal by Subject|0|||
48478125|NCT05166512|155943772|FG000|Baseline Data Collection|Lost to Follow-up|0|||
48478126|NCT05166512|155943773|FG001|Baseline Data Collection|Lost to Follow-up|3|||
48478127|NCT05166512|155943772|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
48478128|NCT05166512|155943773|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
48478129|NCT05166512|155943772|FG000|Baseline Data Collection|Protocol Violation|2|||
48478130|NCT05166512|155943773|FG001|Baseline Data Collection|Protocol Violation|0|||
48478131|NCT05166512|155943772|FG000|4 Month Data Collection|Lost to Follow-up|1|||
48478132|NCT05166512|155943773|FG001|4 Month Data Collection|Lost to Follow-up|0|||
48478133|NCT05166512|155943772|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
48478134|NCT05166512|155943773|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
48478135|NCT05166512|155943772|FG000|12 Month Data Collection|Lost to Follow-up|3|||
48478136|NCT05166512|155943773|FG001|12 Month Data Collection|Lost to Follow-up|1|||
48478137|NCT05166512|155943772|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
48478138|NCT05166512|155943773|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
48478139|NCT02392559|155943774|FG000|Overall Study|Withdrawal by Subject|0|||
48478140|NCT02392559|155943775|FG001|Overall Study|Withdrawal by Subject|1|||
48478141|NCT02508649|155943778|FG000|Overall Study|Withdrawal by Subject|4|||
48478142|NCT02508649|155943779|FG001|Overall Study|Withdrawal by Subject|6|||
48478143|NCT02508649|155943780|FG002|Overall Study|Withdrawal by Subject|5|||
48478144|NCT02508649|155943781|FG003|Overall Study|Withdrawal by Subject|6|||
48478145|NCT02508649|155943778|FG000|Overall Study|Investigator withdrew the subject|1|||
48478146|NCT02508649|155943779|FG001|Overall Study|Investigator withdrew the subject|2|||
48478147|NCT02508649|155943780|FG002|Overall Study|Investigator withdrew the subject|1|||
48478148|NCT02508649|155943781|FG003|Overall Study|Investigator withdrew the subject|0|||
48478149|NCT02508649|155943778|FG000|Overall Study|Post randomization screening failure|12|||
48478150|NCT02508649|155943779|FG001|Overall Study|Post randomization screening failure|4|||
48478151|NCT02508649|155943780|FG002|Overall Study|Post randomization screening failure|9|||
48478152|NCT02508649|155943781|FG003|Overall Study|Post randomization screening failure|3|||
48478153|NCT02508649|155943778|FG000|Overall Study|Lost to Follow-up|1|||
48478154|NCT02508649|155943779|FG001|Overall Study|Lost to Follow-up|1|||
48478155|NCT02508649|155943780|FG002|Overall Study|Lost to Follow-up|0|||
48478156|NCT02508649|155943781|FG003|Overall Study|Lost to Follow-up|1|||
48478157|NCT00446134|155943782|FG000|Overall Study|Adverse Event|7|||
48478158|NCT00446134|155943783|FG001|Overall Study|Adverse Event|17|||
48478159|NCT00446134|155943784|FG002|Overall Study|Adverse Event|13|||
48478160|NCT00446134|155943785|FG003|Overall Study|Adverse Event|18|||
48478161|NCT00446134|155943782|FG000|Overall Study|Lack of Efficacy|19|||
48478162|NCT00446134|155943783|FG001|Overall Study|Lack of Efficacy|19|||
48478163|NCT00446134|155943784|FG002|Overall Study|Lack of Efficacy|24|||
48478164|NCT00446134|155943785|FG003|Overall Study|Lack of Efficacy|19|||
48478165|NCT00446134|155943782|FG000|Overall Study|Protocol Violation|0|||
48478166|NCT00446134|155943783|FG001|Overall Study|Protocol Violation|2|||
48478167|NCT00446134|155943784|FG002|Overall Study|Protocol Violation|1|||
48478168|NCT00446134|155943785|FG003|Overall Study|Protocol Violation|0|||
48478169|NCT00446134|155943782|FG000|Overall Study|Lost to Follow-up|1|||
48478170|NCT00446134|155943783|FG001|Overall Study|Lost to Follow-up|3|||
48478171|NCT00446134|155943784|FG002|Overall Study|Lost to Follow-up|1|||
48478172|NCT00446134|155943785|FG003|Overall Study|Lost to Follow-up|1|||
48478173|NCT00446134|155943782|FG000|Overall Study|Withdrawal by Subject|3|||
48478174|NCT00446134|155943783|FG001|Overall Study|Withdrawal by Subject|3|||
48478175|NCT00446134|155943784|FG002|Overall Study|Withdrawal by Subject|1|||
48478176|NCT00446134|155943785|FG003|Overall Study|Withdrawal by Subject|3|||
48478177|NCT00446134|155943782|FG000|Overall Study|Physician Decision|0|||
48478178|NCT00446134|155943783|FG001|Overall Study|Physician Decision|0|||
48478179|NCT00446134|155943784|FG002|Overall Study|Physician Decision|0|||
48478180|NCT00446134|155943785|FG003|Overall Study|Physician Decision|2|||
48478181|NCT00446134|155943782|FG000|Overall Study|Adverse Event-Diarrhea|1|||
48478182|NCT00446134|155943783|FG001|Overall Study|Adverse Event-Diarrhea|1|||
48478183|NCT00446134|155943784|FG002|Overall Study|Adverse Event-Diarrhea|2|||
48478184|NCT00446134|155943785|FG003|Overall Study|Adverse Event-Diarrhea|0|||
48478185|NCT00446134|155943782|FG000|Overall Study|Reason Not Completed|3|||
48478186|NCT00446134|155943783|FG001|Overall Study|Reason Not Completed|0|||
48478187|NCT00446134|155943784|FG002|Overall Study|Reason Not Completed|1|||
48478188|NCT00446134|155943785|FG003|Overall Study|Reason Not Completed|2|||
48478189|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478190|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478191|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478192|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
48478193|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
48478194|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478195|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478196|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478197|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478198|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
48478199|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478200|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478201|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
48478202|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
48478203|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
48478204|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
48478205|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
48478206|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
48478207|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
48478208|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478209|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478210|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478211|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478212|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478213|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
48478214|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478215|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478216|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478217|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
48478218|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478219|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478220|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478221|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
48478222|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
48478223|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
48478224|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
48478225|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
48478226|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
48478227|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
48478228|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478229|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478230|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478231|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478232|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
48478233|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478234|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478235|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478236|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478237|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478238|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478239|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478240|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478241|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
48478242|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478243|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478244|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
48478245|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
48478246|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478247|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478248|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478249|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478310|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478250|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478251|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478252|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478253|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478254|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478255|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478256|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
48478257|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478258|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478259|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
48478260|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478261|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478262|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
48478263|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
48478264|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
48478265|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
48478266|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
48478267|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
48478268|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
48478269|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
48478270|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
48478271|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
48478272|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
48478273|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
48478274|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
48478275|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
48478276|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
48478277|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
48478278|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
48478279|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
48478280|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
48478281|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
48478282|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
48478283|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
48478284|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478285|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
48478286|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
48478287|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478288|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478289|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478290|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478291|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
48478292|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
48478293|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
48478294|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478295|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
48478296|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478297|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
48478298|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478299|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
48478300|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
48478301|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
48478302|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
48478303|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478304|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478305|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478306|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478307|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
48478308|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478309|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478311|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478312|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
48478313|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478314|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478315|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478316|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478317|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478318|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478319|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478320|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478321|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
48478322|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
48478323|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
48478324|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
48478325|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
48478326|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
48478327|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
48478328|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
48478329|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
48478330|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
48478331|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
48478332|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
48478333|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
48478334|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
48478335|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
48478336|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
48478337|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
48478338|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
48478339|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
48478340|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
48478341|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478342|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478343|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478344|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478345|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478346|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478347|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478348|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478349|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478350|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478351|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
48478352|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478353|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478354|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478355|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478356|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478357|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478358|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478359|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
48478360|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
48478361|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
48478362|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
48478363|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
48478364|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
48478365|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
48478366|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
48478367|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
48478368|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
48478369|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
48478370|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
48478371|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
48478372|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
48478373|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
48478374|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
48478375|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
48478376|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
48478377|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
48478378|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
48478379|NCT01915498|155943786|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
48478380|NCT01915498|155943787|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
48478381|NCT01915498|155943788|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
48478382|NCT01915498|155943789|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
48478383|NCT01915498|155943790|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
48478384|NCT01915498|155943791|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
48478385|NCT01915498|155943792|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
48478386|NCT01915498|155943793|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
48478387|NCT01915498|155943794|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
48478388|NCT01915498|155943795|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
48478389|NCT01915498|155943796|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
48478390|NCT01915498|155943797|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
48478391|NCT01915498|155943798|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
48478392|NCT01915498|155943799|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
48478393|NCT01915498|155943800|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
48478394|NCT01915498|155943801|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
48478395|NCT01915498|155943802|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
48478396|NCT01915498|155943803|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
48478397|NCT01915498|155943804|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
48478398|NCT01915498|155943786|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478399|NCT01915498|155943787|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478400|NCT01915498|155943788|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478401|NCT01915498|155943789|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478402|NCT01915498|155943790|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478403|NCT01915498|155943791|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478404|NCT01915498|155943792|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478405|NCT01915498|155943793|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478406|NCT01915498|155943794|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478407|NCT01915498|155943795|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478408|NCT01915498|155943796|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478409|NCT01915498|155943797|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478410|NCT01915498|155943798|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478411|NCT01915498|155943799|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478412|NCT01915498|155943800|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478413|NCT01915498|155943801|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478414|NCT01915498|155943802|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478415|NCT01915498|155943803|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
48478416|NCT01915498|155943804|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
48478417|NCT01915498|155943786|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478418|NCT01915498|155943787|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478419|NCT01915498|155943788|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478420|NCT01915498|155943789|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478421|NCT01915498|155943790|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478422|NCT01915498|155943791|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478423|NCT01915498|155943792|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478424|NCT01915498|155943793|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478425|NCT01915498|155943794|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478426|NCT01915498|155943795|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478427|NCT01915498|155943796|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478428|NCT01915498|155943797|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478429|NCT01915498|155943798|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478430|NCT01915498|155943799|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478431|NCT01915498|155943800|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478432|NCT01915498|155943801|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478433|NCT01915498|155943802|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478434|NCT01915498|155943803|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
48478435|NCT01915498|155943804|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
48478436|NCT01915498|155943786|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478437|NCT01915498|155943787|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478438|NCT01915498|155943788|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478439|NCT01915498|155943789|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478440|NCT01915498|155943790|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478441|NCT01915498|155943791|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478442|NCT01915498|155943792|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478443|NCT01915498|155943793|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478444|NCT01915498|155943794|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478445|NCT01915498|155943795|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478446|NCT01915498|155943796|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478447|NCT01915498|155943797|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478448|NCT01915498|155943798|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478449|NCT01915498|155943799|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478450|NCT01915498|155943800|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478451|NCT01915498|155943801|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478452|NCT01915498|155943802|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478453|NCT01915498|155943803|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
48478454|NCT01915498|155943804|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
48478455|NCT03914469|155943805|FG000|Overall Study|Lost to Follow-up|1|||
48478456|NCT03914469|155943806|FG001|Overall Study|Lost to Follow-up|4|||
48478457|NCT03273257|155943818|FG000|Overall Study|Death|0|||
48478458|NCT03273257|155943819|FG001|Overall Study|Death|1|||
48478459|NCT03273257|155943818|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
48478460|NCT03273257|155943819|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
48478461|NCT03273257|155943818|FG000|Overall Study|Study terminated|3|||
48478462|NCT03273257|155943819|FG001|Overall Study|Study terminated|2|||
48478463|NCT01126359|155943820|FG000|First Intervention (20-minutes)|Physician Decision|0|||
48478464|NCT01126359|155943821|FG001|First Intervention (20-minutes)|Physician Decision|1|||
48478465|NCT01966107|155943822|FG000|Overall Study|excluded from FAS|21|||
48478466|NCT01966107|155943823|FG001|Overall Study|excluded from FAS|20|||
48478467|NCT01966107|155943822|FG000|Overall Study|discontinued treatment|345|||
48478468|NCT01966107|155943823|FG001|Overall Study|discontinued treatment|372|||
48478469|NCT01966107|155943822|FG000|Overall Study|due to study closure|164|||
48478470|NCT01966107|155943823|FG001|Overall Study|due to study closure|186|||
48478471|NCT01966107|155943822|FG000|Overall Study|withdrew from the study|272|||
48478472|NCT01966107|155943823|FG001|Overall Study|withdrew from the study|303|||
48478473|NCT00532779|155943826|FG000|Overall Study|Adverse Event|122|||
48478474|NCT00532779|155943827|FG001|Overall Study|Adverse Event|112|||
48478475|NCT00532779|155943828|FG002|Overall Study|Adverse Event|56|||
48478476|NCT00532779|155943826|FG000|Overall Study|Lost to Follow-up|76|||
48478477|NCT00532779|155943827|FG001|Overall Study|Lost to Follow-up|65|||
48478478|NCT00532779|155943828|FG002|Overall Study|Lost to Follow-up|66|||
48478479|NCT00532779|155943826|FG000|Overall Study|Withdrawal by Subject|63|||
48478480|NCT00532779|155943827|FG001|Overall Study|Withdrawal by Subject|60|||
48478481|NCT00532779|155943828|FG002|Overall Study|Withdrawal by Subject|90|||
48478482|NCT00532779|155943826|FG000|Overall Study|Lack of Efficacy|12|||
48478483|NCT00532779|155943827|FG001|Overall Study|Lack of Efficacy|12|||
48478484|NCT00532779|155943828|FG002|Overall Study|Lack of Efficacy|40|||
48478485|NCT00532779|155943826|FG000|Overall Study|Protocol Violation|5|||
48478486|NCT00532779|155943827|FG001|Overall Study|Protocol Violation|9|||
48478487|NCT00532779|155943828|FG002|Overall Study|Protocol Violation|7|||
48478488|NCT00532779|155943826|FG000|Overall Study|Pregnancy|2|||
48478489|NCT00532779|155943827|FG001|Overall Study|Pregnancy|5|||
48478490|NCT00532779|155943828|FG002|Overall Study|Pregnancy|3|||
48478491|NCT00532779|155943826|FG000|Overall Study|Death|0|||
48478492|NCT00532779|155943827|FG001|Overall Study|Death|1|||
48478493|NCT00532779|155943828|FG002|Overall Study|Death|0|||
48478494|NCT00532779|155943826|FG000|Overall Study|Drug noncompliance, moved, other|14|||
48478495|NCT00532779|155943827|FG001|Overall Study|Drug noncompliance, moved, other|23|||
48478496|NCT00532779|155943828|FG002|Overall Study|Drug noncompliance, moved, other|29|||
48478497|NCT02332655|155943830|FG000|Overall Study|Lack of Efficacy|1|||
48478498|NCT02662556|155943831|FG000|Overall Study|Adverse Event|4|||
48478499|NCT02662556|155943831|FG000|Overall Study|Lack of Efficacy|4|||
48478500|NCT01556165|155943832|FG000|Overall Study|Adverse Event|5|||
48478501|NCT01556165|155943833|FG001|Overall Study|Adverse Event|3|||
48478502|NCT01556165|155943832|FG000|Overall Study|Protocol Violation|0|||
48478503|NCT01556165|155943833|FG001|Overall Study|Protocol Violation|3|||
48478504|NCT01556165|155943832|FG000|Overall Study|Withdrawal of Consent|7|||
48478505|NCT01556165|155943833|FG001|Overall Study|Withdrawal of Consent|1|||
48478506|NCT01238172|155943834|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
48478507|NCT01238172|155943835|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
48478508|NCT01238172|155943834|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
48478509|NCT01238172|155943835|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
48478510|NCT01861717|155943837|FG000|Overall Study|Lost to Follow-up|1|||
48478511|NCT01861717|155943837|FG000|Overall Study|Withdrawal by Subject|1|||
48478512|NCT05458895|155943838|FG000|Overall Study|Withdrawal by Subject|8|||
48478513|NCT05458895|155943838|FG000|Overall Study|Lost to Follow-up|17|||
48478514|NCT05458895|155943838|FG000|Overall Study|Pregnancy|2|||
48478592|NCT02118896|155946182|FG002|Overall Study|Pregnancy|0|||
48478515|NCT05458895|155943838|FG000|Overall Study|Withdrawal by Study Team|1|||
48478516|NCT03505606|155946157|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
48478517|NCT03505606|155946158|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
48478518|NCT03505606|155946159|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
48478519|NCT03505606|155946157|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
48478520|NCT03505606|155946158|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
48478521|NCT03505606|155946159|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
48478522|NCT03505606|155946157|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
48478523|NCT03505606|155946158|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
48478524|NCT03505606|155946159|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
48478525|NCT03505606|155946157|FG000|Overall Study|Poor compliance with refractive correction|0|||
48478526|NCT03505606|155946158|FG001|Overall Study|Poor compliance with refractive correction|0|||
48478527|NCT03505606|155946159|FG002|Overall Study|Poor compliance with refractive correction|1|||
48478528|NCT03505606|155946157|FG000|Overall Study|Insufficient anisometropia|0|||
48478529|NCT03505606|155946158|FG001|Overall Study|Insufficient anisometropia|0|||
48478530|NCT03505606|155946159|FG002|Overall Study|Insufficient anisometropia|2|||
48478531|NCT03505606|155946157|FG000|Overall Study|Ectopia Lentis|0|||
48478532|NCT03505606|155946158|FG001|Overall Study|Ectopia Lentis|0|||
48478533|NCT03505606|155946159|FG002|Overall Study|Ectopia Lentis|1|||
48478534|NCT03505606|155946157|FG000|Overall Study|alternation of amblyopic eye|0|||
48478535|NCT03505606|155946158|FG001|Overall Study|alternation of amblyopic eye|1|||
48478536|NCT03505606|155946159|FG002|Overall Study|alternation of amblyopic eye|0|||
48478537|NCT03280628|155946160|FG000|Overall Study|Lost to Follow-up|8|||
48478538|NCT03280628|155946161|FG001|Overall Study|Lost to Follow-up|6|||
48478539|NCT03280628|155946162|FG002|Overall Study|Lost to Follow-up|11|||
48478540|NCT02875340|155946165|FG000|Overall Study|Death|2|||
48478541|NCT02875340|155946165|FG000|Overall Study|Withdrawal by Subject|2|||
48478542|NCT02875340|155946165|FG000|Overall Study|Physician Decision|3|||
48478543|NCT02875340|155946165|FG000|Overall Study|Adverse Event|1|||
48478544|NCT03457727|155946170|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
48478545|NCT03457727|155946171|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
48478546|NCT03457727|155946172|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
48478547|NCT03457727|155946173|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
48478548|NCT00929201|155946174|FG000|Period 1|Withdrawal by Subject|0|||
48478549|NCT00929201|155946175|FG001|Period 1|Withdrawal by Subject|1|||
48478550|NCT02118896|155946180|FG000|Overall Study|Death|4|||
48478551|NCT02118896|155946181|FG001|Overall Study|Death|0|||
48478552|NCT02118896|155946182|FG002|Overall Study|Death|4|||
48478553|NCT02118896|155946183|FG003|Overall Study|Death|6|||
48478554|NCT02118896|155946184|FG004|Overall Study|Death|3|||
48478555|NCT02118896|155946185|FG005|Overall Study|Death|1|||
48478556|NCT02118896|155946186|FG006|Overall Study|Death|0|||
48478557|NCT02118896|155946187|FG007|Overall Study|Death|0|||
48478558|NCT02118896|155946188|FG008|Overall Study|Death|0|||
48478559|NCT02118896|155946189|FG009|Overall Study|Death|0|||
48478560|NCT02118896|155946180|FG000|Overall Study|Adverse Event|5|||
48478561|NCT02118896|155946181|FG001|Overall Study|Adverse Event|4|||
48478562|NCT02118896|155946182|FG002|Overall Study|Adverse Event|4|||
48478563|NCT02118896|155946183|FG003|Overall Study|Adverse Event|5|||
48478564|NCT02118896|155946184|FG004|Overall Study|Adverse Event|5|||
48478565|NCT02118896|155946185|FG005|Overall Study|Adverse Event|9|||
48478566|NCT02118896|155946186|FG006|Overall Study|Adverse Event|1|||
48478567|NCT02118896|155946187|FG007|Overall Study|Adverse Event|1|||
48478568|NCT02118896|155946188|FG008|Overall Study|Adverse Event|4|||
48478569|NCT02118896|155946189|FG009|Overall Study|Adverse Event|0|||
48478570|NCT02118896|155946180|FG000|Overall Study|Consent withdrawn|2|||
48478571|NCT02118896|155946181|FG001|Overall Study|Consent withdrawn|0|||
48478572|NCT02118896|155946182|FG002|Overall Study|Consent withdrawn|3|||
48478573|NCT02118896|155946183|FG003|Overall Study|Consent withdrawn|4|||
48478574|NCT02118896|155946184|FG004|Overall Study|Consent withdrawn|1|||
48478575|NCT02118896|155946185|FG005|Overall Study|Consent withdrawn|4|||
48478576|NCT02118896|155946186|FG006|Overall Study|Consent withdrawn|0|||
48478577|NCT02118896|155946187|FG007|Overall Study|Consent withdrawn|0|||
48478578|NCT02118896|155946188|FG008|Overall Study|Consent withdrawn|0|||
48478579|NCT02118896|155946189|FG009|Overall Study|Consent withdrawn|0|||
48478580|NCT02118896|155946180|FG000|Overall Study|Non-compliance|2|||
48478581|NCT02118896|155946181|FG001|Overall Study|Non-compliance|1|||
48478582|NCT02118896|155946182|FG002|Overall Study|Non-compliance|1|||
48478583|NCT02118896|155946183|FG003|Overall Study|Non-compliance|5|||
48478584|NCT02118896|155946184|FG004|Overall Study|Non-compliance|0|||
48478585|NCT02118896|155946185|FG005|Overall Study|Non-compliance|1|||
48478586|NCT02118896|155946186|FG006|Overall Study|Non-compliance|0|||
48478587|NCT02118896|155946187|FG007|Overall Study|Non-compliance|1|||
48478588|NCT02118896|155946188|FG008|Overall Study|Non-compliance|0|||
48478589|NCT02118896|155946189|FG009|Overall Study|Non-compliance|0|||
48478590|NCT02118896|155946180|FG000|Overall Study|Pregnancy|1|||
48478591|NCT02118896|155946181|FG001|Overall Study|Pregnancy|1|||
48478593|NCT02118896|155946183|FG003|Overall Study|Pregnancy|0|||
48478594|NCT02118896|155946184|FG004|Overall Study|Pregnancy|1|||
48478595|NCT02118896|155946185|FG005|Overall Study|Pregnancy|3|||
48478596|NCT02118896|155946186|FG006|Overall Study|Pregnancy|1|||
48478597|NCT02118896|155946187|FG007|Overall Study|Pregnancy|0|||
48478598|NCT02118896|155946188|FG008|Overall Study|Pregnancy|0|||
48478599|NCT02118896|155946189|FG009|Overall Study|Pregnancy|0|||
48478600|NCT02118896|155946180|FG000|Overall Study|Lost to Follow-up|1|||
48478601|NCT02118896|155946181|FG001|Overall Study|Lost to Follow-up|2|||
48478602|NCT02118896|155946182|FG002|Overall Study|Lost to Follow-up|1|||
48478603|NCT02118896|155946183|FG003|Overall Study|Lost to Follow-up|0|||
48478604|NCT02118896|155946184|FG004|Overall Study|Lost to Follow-up|2|||
48478605|NCT02118896|155946185|FG005|Overall Study|Lost to Follow-up|1|||
48478606|NCT02118896|155946186|FG006|Overall Study|Lost to Follow-up|0|||
48478607|NCT02118896|155946187|FG007|Overall Study|Lost to Follow-up|0|||
48478608|NCT02118896|155946188|FG008|Overall Study|Lost to Follow-up|0|||
48478609|NCT02118896|155946189|FG009|Overall Study|Lost to Follow-up|0|||
48478610|NCT02118896|155946180|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
48478611|NCT02118896|155946181|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
48478612|NCT02118896|155946182|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
48478613|NCT02118896|155946183|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
48478614|NCT02118896|155946184|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
48478615|NCT02118896|155946185|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
48478616|NCT02118896|155946186|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
48478617|NCT02118896|155946187|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
48478618|NCT02118896|155946188|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
48478619|NCT02118896|155946189|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
48478620|NCT02118896|155946180|FG000|Overall Study|Prohibited medication|0|||
48478621|NCT02118896|155946181|FG001|Overall Study|Prohibited medication|0|||
48478622|NCT02118896|155946182|FG002|Overall Study|Prohibited medication|0|||
48478623|NCT02118896|155946183|FG003|Overall Study|Prohibited medication|0|||
48478624|NCT02118896|155946184|FG004|Overall Study|Prohibited medication|1|||
48478625|NCT02118896|155946185|FG005|Overall Study|Prohibited medication|3|||
48478626|NCT02118896|155946186|FG006|Overall Study|Prohibited medication|0|||
48478627|NCT02118896|155946187|FG007|Overall Study|Prohibited medication|0|||
48478628|NCT02118896|155946188|FG008|Overall Study|Prohibited medication|0|||
48478629|NCT02118896|155946189|FG009|Overall Study|Prohibited medication|0|||
48478630|NCT02118896|155946180|FG000|Overall Study|Miscellaneous|1|||
48478631|NCT02118896|155946181|FG001|Overall Study|Miscellaneous|2|||
48478632|NCT02118896|155946182|FG002|Overall Study|Miscellaneous|0|||
48478633|NCT02118896|155946183|FG003|Overall Study|Miscellaneous|2|||
48478634|NCT02118896|155946184|FG004|Overall Study|Miscellaneous|0|||
48478635|NCT02118896|155946185|FG005|Overall Study|Miscellaneous|4|||
48478636|NCT02118896|155946186|FG006|Overall Study|Miscellaneous|0|||
48478637|NCT02118896|155946187|FG007|Overall Study|Miscellaneous|0|||
48478638|NCT02118896|155946188|FG008|Overall Study|Miscellaneous|0|||
48478639|NCT02118896|155946189|FG009|Overall Study|Miscellaneous|0|||
48478640|NCT03130777|155946190|FG000|Overall Study|Death|0|||
48478641|NCT03130777|155946191|FG001|Overall Study|Death|1|||
48478642|NCT03130777|155946190|FG000|Overall Study|Did not meet eligibility criteria|1|||
48478643|NCT03130777|155946191|FG001|Overall Study|Did not meet eligibility criteria|0|||
48478644|NCT00713830|155946192|FG000|Overall Study|Adverse Event|23|||
48478645|NCT00713830|155946193|FG001|Overall Study|Adverse Event|71|||
48478646|NCT00713830|155946192|FG000|Overall Study|Lack of Efficacy|24|||
48478647|NCT00713830|155946193|FG001|Overall Study|Lack of Efficacy|16|||
48478648|NCT00713830|155946192|FG000|Overall Study|Lost to Follow-up|2|||
48478649|NCT00713830|155946193|FG001|Overall Study|Lost to Follow-up|9|||
48478650|NCT00713830|155946192|FG000|Overall Study|Withdrawal by Subject|13|||
48478651|NCT00713830|155946193|FG001|Overall Study|Withdrawal by Subject|23|||
48478652|NCT00713830|155946192|FG000|Overall Study|Poor Compliance to Protocol|7|||
48478653|NCT00713830|155946193|FG001|Overall Study|Poor Compliance to Protocol|14|||
48478654|NCT00713830|155946192|FG000|Overall Study|Familial and Personal Reasons|9|||
48478655|NCT00713830|155946193|FG001|Overall Study|Familial and Personal Reasons|34|||
48478656|NCT00713830|155946192|FG000|Overall Study|Sponsor Decision|4|||
48478657|NCT00713830|155946193|FG001|Overall Study|Sponsor Decision|10|||
48478658|NCT03069365|155946196|FG000|Overall Study|Adverse Event|1|||
48478659|NCT00455923|155946197|FG000|Overall Study|Pregnancy|0|||
48478660|NCT00455923|155946198|FG001|Overall Study|Pregnancy|2|||
48478661|NCT00455923|155946197|FG000|Overall Study|Other|3|||
48478662|NCT00455923|155946198|FG001|Overall Study|Other|1|||
48478663|NCT02860039|155946199|FG000|Overall Study|Death|4|||
48478664|NCT02860039|155946200|FG001|Overall Study|Death|0|||
48478665|NCT02860039|155946199|FG000|Overall Study|Lost to Follow-up|2|||
48478666|NCT02860039|155946200|FG001|Overall Study|Lost to Follow-up|2|||
48478667|NCT02860039|155946199|FG000|Overall Study|Protocol Violation|3|||
48478668|NCT02860039|155946200|FG001|Overall Study|Protocol Violation|1|||
48478669|NCT02860039|155946199|FG000|Overall Study|Withdrawal by Subject|1|||
48478670|NCT02860039|155946200|FG001|Overall Study|Withdrawal by Subject|0|||
48478671|NCT02860039|155946199|FG000|Overall Study|Not otherwise eligible|1|||
48478672|NCT02860039|155946200|FG001|Overall Study|Not otherwise eligible|1|||
48478673|NCT01060007|155946216|FG000|Overall Study|Withdrawal by Subject|1|||
48478674|NCT01060007|155946216|FG000|Overall Study|Inevaluable for response at surgery|3|||
48478675|NCT01036594|155946217|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
48478676|NCT01036594|155946218|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
48478677|NCT01036594|155946217|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
48478678|NCT01036594|155946218|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
48478679|NCT01036594|155946217|FG000|Week 12 Evaluation|Adverse Event|5|||
48478680|NCT01036594|155946218|FG001|Week 12 Evaluation|Adverse Event|0|||
48478681|NCT01036594|155946217|FG000|Week 12 Evaluation|Physician Decision|1|||
48478682|NCT01036594|155946218|FG001|Week 12 Evaluation|Physician Decision|0|||
48478683|NCT01036594|155946217|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
48478684|NCT01036594|155946218|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
48478685|NCT01036594|155946217|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
48478686|NCT01036594|155946218|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
48478687|NCT01036594|155946217|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
48478688|NCT01036594|155946218|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
48478689|NCT01036594|155946217|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
48478690|NCT01036594|155946218|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
48478691|NCT01036594|155946217|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
48478692|NCT01036594|155946218|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
48478693|NCT03224234|155946223|FG000|Main Study|Lost to Follow-up|5|||
48478694|NCT03224234|155946224|FG001|Main Study|Lost to Follow-up|5|||
48478695|NCT03466060|155946225|FG000|Period 1|Test Lens Damage|0|||
48478696|NCT03466060|155946226|FG001|Period 1|Test Lens Damage|2|||
48478697|NCT03466060|155946227|FG002|Period 1|Test Lens Damage|0|||
48478698|NCT03466060|155946228|FG003|Period 1|Test Lens Damage|0|||
48478699|NCT03466060|155946229|FG004|Period 1|Test Lens Damage|0|||
48478700|NCT03466060|155946230|FG005|Period 1|Test Lens Damage|0|||
48478701|NCT03466060|155946225|FG000|Period 1|Withdrawal by Subject|0|||
48478702|NCT03466060|155946226|FG001|Period 1|Withdrawal by Subject|0|||
48478703|NCT03466060|155946227|FG002|Period 1|Withdrawal by Subject|2|||
48478704|NCT03466060|155946228|FG003|Period 1|Withdrawal by Subject|0|||
48478705|NCT03466060|155946229|FG004|Period 1|Withdrawal by Subject|0|||
48478706|NCT03466060|155946230|FG005|Period 1|Withdrawal by Subject|0|||
48478707|NCT03466060|155946225|FG000|Period 1|Lost to Follow-up|0|||
48478708|NCT03466060|155946226|FG001|Period 1|Lost to Follow-up|0|||
48478709|NCT03466060|155946227|FG002|Period 1|Lost to Follow-up|0|||
48478710|NCT03466060|155946228|FG003|Period 1|Lost to Follow-up|1|||
48478711|NCT03466060|155946229|FG004|Period 1|Lost to Follow-up|0|||
48478712|NCT03466060|155946230|FG005|Period 1|Lost to Follow-up|0|||
48478713|NCT03466060|155946225|FG000|Period 1|Grade 2 Conjunctivitis|0|||
48478714|NCT03466060|155946226|FG001|Period 1|Grade 2 Conjunctivitis|0|||
48478715|NCT03466060|155946227|FG002|Period 1|Grade 2 Conjunctivitis|1|||
48478716|NCT03466060|155946228|FG003|Period 1|Grade 2 Conjunctivitis|0|||
48478717|NCT03466060|155946229|FG004|Period 1|Grade 2 Conjunctivitis|0|||
48478718|NCT03466060|155946230|FG005|Period 1|Grade 2 Conjunctivitis|0|||
48478719|NCT03466060|155946225|FG000|Period 2|Lens Handling Difficulties|0|||
48478720|NCT03466060|155946226|FG001|Period 2|Lens Handling Difficulties|0|||
48478721|NCT03466060|155946227|FG002|Period 2|Lens Handling Difficulties|1|||
48478722|NCT03466060|155946228|FG003|Period 2|Lens Handling Difficulties|0|||
48478723|NCT03466060|155946229|FG004|Period 2|Lens Handling Difficulties|0|||
48478724|NCT03466060|155946230|FG005|Period 2|Lens Handling Difficulties|0|||
48478725|NCT02032823|155946231|FG000|Overall Study|Death|75|||
48478726|NCT02032823|155946232|FG001|Overall Study|Death|109|||
48478727|NCT02032823|155946231|FG000|Overall Study|Lost to Follow-up|18|||
48478728|NCT02032823|155946232|FG001|Overall Study|Lost to Follow-up|17|||
48478729|NCT02032823|155946231|FG000|Overall Study|Withdrawal by Subject|70|||
48478730|NCT02032823|155946232|FG001|Overall Study|Withdrawal by Subject|53|||
48478731|NCT02032823|155946231|FG000|Overall Study|Ongoing study at data cut-off|755|||
48478732|NCT02032823|155946232|FG001|Overall Study|Ongoing study at data cut-off|731|||
48478733|NCT02032823|155946231|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
48478734|NCT02032823|155946232|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
48478735|NCT03359473|155946235|FG000|Overall Study|Adverse Event|0|||
48478736|NCT03359473|155946236|FG001|Overall Study|Adverse Event|2|||
48478737|NCT03359473|155946237|FG002|Overall Study|Adverse Event|5|||
48478738|NCT03359473|155946238|FG003|Overall Study|Adverse Event|3|||
48478739|NCT03359473|155946235|FG000|Overall Study|Lost to Follow-up|0|||
48478740|NCT03359473|155946236|FG001|Overall Study|Lost to Follow-up|1|||
48478741|NCT03359473|155946237|FG002|Overall Study|Lost to Follow-up|0|||
48478742|NCT03359473|155946238|FG003|Overall Study|Lost to Follow-up|0|||
48478743|NCT03359473|155946235|FG000|Overall Study|Physician Decision|0|||
48478744|NCT03359473|155946236|FG001|Overall Study|Physician Decision|1|||
48478745|NCT03359473|155946237|FG002|Overall Study|Physician Decision|0|||
48478746|NCT03359473|155946238|FG003|Overall Study|Physician Decision|1|||
48478747|NCT03359473|155946235|FG000|Overall Study|Withdrawal by Subject|1|||
48478748|NCT03359473|155946236|FG001|Overall Study|Withdrawal by Subject|2|||
48478749|NCT03359473|155946237|FG002|Overall Study|Withdrawal by Subject|1|||
48478750|NCT03359473|155946238|FG003|Overall Study|Withdrawal by Subject|0|||
48478751|NCT03359473|155946235|FG000|Overall Study|Protocol-defined stopping criteria|1|||
48478752|NCT03359473|155946236|FG001|Overall Study|Protocol-defined stopping criteria|0|||
48478753|NCT03359473|155946237|FG002|Overall Study|Protocol-defined stopping criteria|0|||
48478754|NCT03359473|155946238|FG003|Overall Study|Protocol-defined stopping criteria|1|||
48478755|NCT05302414|155946239|FG000|Pretest to Posttest|Lost to Follow-up|12|||
48478756|NCT05302414|155946240|FG001|Pretest to Posttest|Lost to Follow-up|8|||
48478757|NCT05302414|155946241|FG002|Pretest to Posttest|Lost to Follow-up|8|||
48478758|NCT05302414|155946239|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
48478759|NCT05302414|155946240|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
48478760|NCT05302414|155946241|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
48478761|NCT01500434|155946242|FG000|Overall Study|Death|1|||
48478762|NCT01500434|155946242|FG000|Overall Study|Withdrawal by Subject|1|||
48478763|NCT01500434|155946242|FG000|Overall Study|Missed 12-month follow-up|5|||
48478764|NCT01154673|155946248|FG000|Overall Study|Lost to Follow-up|1|||
48478765|NCT01154673|155946249|FG001|Overall Study|Lost to Follow-up|0|||
48478766|NCT01154673|155946248|FG000|Overall Study|moved out of province|1|||
48478767|NCT01154673|155946249|FG001|Overall Study|moved out of province|0|||
48478768|NCT00646282|155946250|FG000|Overall Study|Protocol terminated|4|||
48478769|NCT00646282|155946251|FG001|Overall Study|Protocol terminated|4|||
48478770|NCT02617446|155946252|FG000|Overall Study|Withdrawal by Subject|0|||
48478771|NCT02617446|155946253|FG001|Overall Study|Withdrawal by Subject|2|||
48478772|NCT02617446|155946254|FG002|Overall Study|Withdrawal by Subject|0|||
48478773|NCT02617446|155946252|FG000|Overall Study|Adverse Event|1|||
48478774|NCT02617446|155946253|FG001|Overall Study|Adverse Event|0|||
48478775|NCT02617446|155946254|FG002|Overall Study|Adverse Event|5|||
48478776|NCT02617446|155946252|FG000|Overall Study|Lost to Follow-up|3|||
48478777|NCT02617446|155946253|FG001|Overall Study|Lost to Follow-up|0|||
48478778|NCT02617446|155946254|FG002|Overall Study|Lost to Follow-up|0|||
48478779|NCT02617446|155946252|FG000|Overall Study|Death|0|||
48478780|NCT02617446|155946253|FG001|Overall Study|Death|0|||
48478781|NCT02617446|155946254|FG002|Overall Study|Death|2|||
48478782|NCT01556490|155946259|FG000|Randomized Patients Summary|Protocol Violation|22|||
48478783|NCT01556490|155946260|FG001|Randomized Patients Summary|Protocol Violation|23|||
48478784|NCT01556490|155946259|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
48478785|NCT01556490|155946260|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
48478786|NCT03889197|155946272|FG000|Overall Study|Withdrawal by Subject|1|||
48478787|NCT03889197|155946273|FG001|Overall Study|Withdrawal by Subject|0|||
48478788|NCT03889197|155946272|FG000|Overall Study|Physician Decision|0|||
48478789|NCT03889197|155946273|FG001|Overall Study|Physician Decision|1|||
48478790|NCT03889197|155946272|FG000|Overall Study|met exclusion criteria|0|||
48478791|NCT03889197|155946273|FG001|Overall Study|met exclusion criteria|1|||
48478792|NCT03889197|155946272|FG000|Overall Study|Protocol Violation|1|||
48478793|NCT03889197|155946273|FG001|Overall Study|Protocol Violation|0|||
48478794|NCT05899218|155946274|FG000|Overall Study|Lost to Follow-up|2|||
48478795|NCT05899218|155946275|FG001|Overall Study|Lost to Follow-up|2|||
48478796|NCT05899218|155946274|FG000|Overall Study|deemed ineligible out of country|1|||
48478797|NCT05899218|155946275|FG001|Overall Study|deemed ineligible out of country|0|||
48478798|NCT01220128|155946276|FG000|Overall Study|Progressive disease|0|||
48478799|NCT01220128|155946277|FG001|Overall Study|Progressive disease|0|||
48478800|NCT01220128|155946278|FG002|Overall Study|Progressive disease|2|||
48478801|NCT01220128|155946279|FG003|Overall Study|Progressive disease|0|||
48478802|NCT01220128|155946280|FG004|Overall Study|Progressive disease|0|||
48478803|NCT01220128|155946281|FG005|Overall Study|Progressive disease|0|||
48478804|NCT01220128|155946282|FG006|Overall Study|Progressive disease|0|||
48478805|NCT01220128|155946276|FG000|Overall Study|Sponsor study termination|0|||
48478806|NCT01220128|155946277|FG001|Overall Study|Sponsor study termination|1|||
48478807|NCT01220128|155946278|FG002|Overall Study|Sponsor study termination|0|||
48478808|NCT01220128|155946279|FG003|Overall Study|Sponsor study termination|0|||
48478809|NCT01220128|155946280|FG004|Overall Study|Sponsor study termination|0|||
48478810|NCT01220128|155946281|FG005|Overall Study|Sponsor study termination|0|||
48478811|NCT01220128|155946282|FG006|Overall Study|Sponsor study termination|1|||
48478812|NCT01220128|155946276|FG000|Overall Study|Adverse event, serious fatal|2|||
48478813|NCT01220128|155946277|FG001|Overall Study|Adverse event, serious fatal|0|||
48478814|NCT01220128|155946278|FG002|Overall Study|Adverse event, serious fatal|0|||
48478815|NCT01220128|155946279|FG003|Overall Study|Adverse event, serious fatal|0|||
48478816|NCT01220128|155946280|FG004|Overall Study|Adverse event, serious fatal|0|||
48478817|NCT01220128|155946281|FG005|Overall Study|Adverse event, serious fatal|0|||
48478818|NCT01220128|155946282|FG006|Overall Study|Adverse event, serious fatal|1|||
48478819|NCT01220128|155946276|FG000|Overall Study|Adverse event, non-fatal|1|||
48478820|NCT01220128|155946277|FG001|Overall Study|Adverse event, non-fatal|0|||
48478821|NCT01220128|155946278|FG002|Overall Study|Adverse event, non-fatal|0|||
48478822|NCT01220128|155946279|FG003|Overall Study|Adverse event, non-fatal|0|||
48478823|NCT01220128|155946280|FG004|Overall Study|Adverse event, non-fatal|0|||
48478824|NCT01220128|155946281|FG005|Overall Study|Adverse event, non-fatal|0|||
48478825|NCT01220128|155946282|FG006|Overall Study|Adverse event, non-fatal|3|||
48478826|NCT01220128|155946276|FG000|Overall Study|Other|0|||
48478827|NCT01220128|155946277|FG001|Overall Study|Other|0|||
48478828|NCT01220128|155946278|FG002|Overall Study|Other|1|||
48478829|NCT01220128|155946279|FG003|Overall Study|Other|0|||
48478830|NCT01220128|155946280|FG004|Overall Study|Other|0|||
48478831|NCT01220128|155946281|FG005|Overall Study|Other|0|||
48478832|NCT01220128|155946282|FG006|Overall Study|Other|0|||
48478833|NCT01220128|155946276|FG000|Overall Study|Consent withdrawn by subject|1|||
48478834|NCT01220128|155946277|FG001|Overall Study|Consent withdrawn by subject|0|||
48478835|NCT01220128|155946278|FG002|Overall Study|Consent withdrawn by subject|0|||
48478836|NCT01220128|155946279|FG003|Overall Study|Consent withdrawn by subject|0|||
48478837|NCT01220128|155946280|FG004|Overall Study|Consent withdrawn by subject|0|||
48478838|NCT01220128|155946281|FG005|Overall Study|Consent withdrawn by subject|0|||
48478839|NCT01220128|155946282|FG006|Overall Study|Consent withdrawn by subject|0|||
48478840|NCT01345058|155946283|FG000|Overall Study|Withdrawal by Subject|1|||
48478841|NCT01345058|155946284|FG001|Overall Study|Withdrawal by Subject|0|||
48478842|NCT01345058|155946283|FG000|Overall Study|Participant Reported Increase in Events|1|||
48478843|NCT01345058|155946284|FG001|Overall Study|Participant Reported Increase in Events|0|||
48478844|NCT01345058|155946283|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
48478845|NCT01345058|155946284|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
48478846|NCT01345058|155946283|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
48478847|NCT01345058|155946284|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
48478848|NCT01345058|155946283|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
48478849|NCT01345058|155946284|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
48478850|NCT03751124|155946286|FG000|Overall Study|Adverse Event|4|||
48478851|NCT03751124|155946287|FG001|Overall Study|Adverse Event|3|||
48478852|NCT03751124|155946286|FG000|Overall Study|Protocol Deviation|0|||
48478853|NCT03751124|155946287|FG001|Overall Study|Protocol Deviation|1|||
48478854|NCT03751124|155946286|FG000|Overall Study|Lost to Follow-up|6|||
48478855|NCT03751124|155946287|FG001|Overall Study|Lost to Follow-up|4|||
48478856|NCT03751124|155946286|FG000|Overall Study|Withdrawal by Subject|6|||
48478857|NCT03751124|155946287|FG001|Overall Study|Withdrawal by Subject|8|||
48478858|NCT03751124|155946286|FG000|Overall Study|Lack of Efficacy|1|||
48478859|NCT03751124|155946287|FG001|Overall Study|Lack of Efficacy|1|||
48478860|NCT03751124|155946286|FG000|Overall Study|Pregnancy|0|||
48478861|NCT03751124|155946287|FG001|Overall Study|Pregnancy|1|||
48478862|NCT03751124|155946286|FG000|Overall Study|Other|9|||
48478863|NCT03751124|155946287|FG001|Overall Study|Other|9|||
48478864|NCT03751124|155946286|FG000|Overall Study|Participants who did not receive any study drug|0|||
48478865|NCT03751124|155946287|FG001|Overall Study|Participants who did not receive any study drug|1|||
48478866|NCT05037409|155946292|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
48478867|NCT05037409|155946293|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
48478868|NCT05037409|155946294|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
48478869|NCT04881448|155946302|FG000|Overall Study|Study cancelled by sponsor|220|||
48478870|NCT04881448|155946302|FG000|Overall Study|Withdrawal by Subject|2|||
48478871|NCT04881448|155946302|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
48478872|NCT03033069|155946307|FG000|Overall Study|Adverse Event|6|||
48478873|NCT03033069|155946308|FG001|Overall Study|Adverse Event|7|||
48478874|NCT03033069|155946309|FG002|Overall Study|Adverse Event|4|||
48478875|NCT03033069|155946310|FG003|Overall Study|Adverse Event|6|||
48478876|NCT03033069|155946307|FG000|Overall Study|Lack of Efficacy|0|||
48478877|NCT03033069|155946308|FG001|Overall Study|Lack of Efficacy|0|||
48478878|NCT03033069|155946309|FG002|Overall Study|Lack of Efficacy|1|||
48478879|NCT03033069|155946310|FG003|Overall Study|Lack of Efficacy|0|||
48478880|NCT03033069|155946307|FG000|Overall Study|Lost to Follow-up|6|||
48478881|NCT03033069|155946308|FG001|Overall Study|Lost to Follow-up|5|||
48478882|NCT03033069|155946309|FG002|Overall Study|Lost to Follow-up|5|||
48478883|NCT03033069|155946310|FG003|Overall Study|Lost to Follow-up|6|||
48478884|NCT03033069|155946307|FG000|Overall Study|Non-Compliance With Study Drug|1|||
48478885|NCT03033069|155946308|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48478886|NCT03033069|155946309|FG002|Overall Study|Non-Compliance With Study Drug|1|||
48478887|NCT03033069|155946310|FG003|Overall Study|Non-Compliance With Study Drug|0|||
48478888|NCT03033069|155946307|FG000|Overall Study|Protocol Deviation|0|||
48478889|NCT03033069|155946308|FG001|Overall Study|Protocol Deviation|1|||
48478890|NCT03033069|155946309|FG002|Overall Study|Protocol Deviation|0|||
48478891|NCT03033069|155946310|FG003|Overall Study|Protocol Deviation|0|||
48478892|NCT03033069|155946307|FG000|Overall Study|Withdrawal by Subject|10|||
48478893|NCT03033069|155946308|FG001|Overall Study|Withdrawal by Subject|10|||
48478894|NCT03033069|155946309|FG002|Overall Study|Withdrawal by Subject|11|||
48478895|NCT03033069|155946310|FG003|Overall Study|Withdrawal by Subject|6|||
48478896|NCT03033069|155946307|FG000|Overall Study|Withdrawal By Caregiver|1|||
48478897|NCT03033069|155946308|FG001|Overall Study|Withdrawal By Caregiver|0|||
48478898|NCT03033069|155946309|FG002|Overall Study|Withdrawal By Caregiver|0|||
48478899|NCT03033069|155946310|FG003|Overall Study|Withdrawal By Caregiver|0|||
48478900|NCT03033069|155946307|FG000|Overall Study|Reason not Specified|0|||
48478901|NCT03033069|155946308|FG001|Overall Study|Reason not Specified|1|||
48478902|NCT03033069|155946309|FG002|Overall Study|Reason not Specified|0|||
48478903|NCT03033069|155946310|FG003|Overall Study|Reason not Specified|1|||
48478904|NCT03690206|155946312|FG000|Overall Study|Withdrawal by Subject|2|||
48478905|NCT03690206|155946313|FG001|Overall Study|Withdrawal by Subject|0|||
48478906|NCT03690206|155946314|FG002|Overall Study|Withdrawal by Subject|0|||
48478907|NCT03690206|155946312|FG000|Overall Study|ICF withdrawal|2|||
48478908|NCT03690206|155946313|FG001|Overall Study|ICF withdrawal|0|||
48478909|NCT03690206|155946314|FG002|Overall Study|ICF withdrawal|0|||
48478910|NCT03256526|155948143|FG000|Overall Study|Adverse Event|1|||
48478911|NCT03256526|155948144|FG001|Overall Study|Adverse Event|0|||
48478912|NCT03256526|155948145|FG002|Overall Study|Adverse Event|1|||
48478913|NCT03256526|155948143|FG000|Overall Study|Lost to Follow-up|1|||
48478914|NCT03256526|155948144|FG001|Overall Study|Lost to Follow-up|0|||
48478915|NCT03256526|155948145|FG002|Overall Study|Lost to Follow-up|2|||
48478916|NCT01607398|155948150|FG000|Overall Study|Adverse Event|0|||
48478917|NCT01607398|155948151|FG001|Overall Study|Adverse Event|2|||
48478918|NCT01607398|155948150|FG000|Overall Study|Severe COPD|2|||
48478919|NCT01607398|155948151|FG001|Overall Study|Severe COPD|0|||
48478920|NCT03606109|155948152|FG000|Overall Study|Lost to Follow-up|2|||
48478921|NCT03606109|155948153|FG001|Overall Study|Lost to Follow-up|1|||
48478922|NCT01491737|155948154|FG000|Overall Study|Withdrawal by Subject|20|||
48478923|NCT01491737|155948155|FG001|Overall Study|Withdrawal by Subject|17|||
48478924|NCT01491737|155948154|FG000|Overall Study|Lost to Follow-up|2|||
48478925|NCT01491737|155948155|FG001|Overall Study|Lost to Follow-up|10|||
48478926|NCT01491737|155948154|FG000|Overall Study|Death|63|||
48478927|NCT01491737|155948155|FG001|Overall Study|Death|57|||
48478928|NCT01491737|155948154|FG000|Overall Study|Study Termination by Sponsor|36|||
48478929|NCT01491737|155948155|FG001|Overall Study|Study Termination by Sponsor|36|||
48478930|NCT01491737|155948154|FG000|Overall Study|Reason Not Specified|8|||
48478931|NCT01491737|155948155|FG001|Overall Study|Reason Not Specified|9|||
48478932|NCT04311411|155948156|FG000|Overall Study|Adverse Event|2|||
48478933|NCT04311411|155948157|FG001|Overall Study|Adverse Event|3|||
48478934|NCT04311411|155948158|FG002|Overall Study|Adverse Event|2|||
48478935|NCT04311411|155948156|FG000|Overall Study|Withdrawal by Subject|3|||
48478936|NCT04311411|155948157|FG001|Overall Study|Withdrawal by Subject|3|||
48478937|NCT04311411|155948158|FG002|Overall Study|Withdrawal by Subject|0|||
48478938|NCT01976663|155948159|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
48478939|NCT01976663|155948159|FG000|Overall Study|Personal Reasons|6|||
48478940|NCT01976663|155948159|FG000|Overall Study|Withdrawal by Subject|4|||
48478941|NCT01976663|155948159|FG000|Overall Study|Screen Failure|3|||
48478942|NCT01976663|155948159|FG000|Overall Study|Adverse Event|2|||
48478943|NCT01976663|155948159|FG000|Overall Study|Lost to Follow-up|3|||
48478944|NCT03927989|155948160|FG000|Overall Study|Withdrawal by Subject|0|||
48478945|NCT03927989|155948161|FG001|Overall Study|Withdrawal by Subject|1|||
48478946|NCT01563029|155948162|FG000|Overall Study|Adverse Event|1|||
48478947|NCT01563029|155948163|FG001|Overall Study|Adverse Event|0|||
48478948|NCT01563029|155948164|FG002|Overall Study|Adverse Event|1|||
48478949|NCT01563029|155948165|FG003|Overall Study|Adverse Event|2|||
48478950|NCT01563029|155948166|FG004|Overall Study|Adverse Event|1|||
48478951|NCT01563029|155948162|FG000|Overall Study|Lack of Efficacy|42|||
48478952|NCT01563029|155948163|FG001|Overall Study|Lack of Efficacy|16|||
48478953|NCT01563029|155948164|FG002|Overall Study|Lack of Efficacy|23|||
48478954|NCT01563029|155948165|FG003|Overall Study|Lack of Efficacy|21|||
48478955|NCT01563029|155948166|FG004|Overall Study|Lack of Efficacy|19|||
48478956|NCT01563029|155948162|FG000|Overall Study|Protocol Violation|1|||
48478957|NCT01563029|155948163|FG001|Overall Study|Protocol Violation|2|||
48478958|NCT01563029|155948164|FG002|Overall Study|Protocol Violation|3|||
48478959|NCT01563029|155948165|FG003|Overall Study|Protocol Violation|1|||
48478960|NCT01563029|155948166|FG004|Overall Study|Protocol Violation|3|||
48478961|NCT01563029|155948162|FG000|Overall Study|Protocol defined stopping criteria|1|||
48478962|NCT01563029|155948163|FG001|Overall Study|Protocol defined stopping criteria|0|||
48478963|NCT01563029|155948164|FG002|Overall Study|Protocol defined stopping criteria|0|||
48478964|NCT01563029|155948165|FG003|Overall Study|Protocol defined stopping criteria|0|||
48478965|NCT01563029|155948166|FG004|Overall Study|Protocol defined stopping criteria|0|||
48478966|NCT01563029|155948162|FG000|Overall Study|Lost to Follow-up|1|||
48478967|NCT01563029|155948163|FG001|Overall Study|Lost to Follow-up|0|||
48478968|NCT01563029|155948164|FG002|Overall Study|Lost to Follow-up|1|||
48478969|NCT01563029|155948165|FG003|Overall Study|Lost to Follow-up|1|||
48478970|NCT01563029|155948166|FG004|Overall Study|Lost to Follow-up|1|||
48478971|NCT01563029|155948162|FG000|Overall Study|Physician Decision|3|||
48478972|NCT01563029|155948163|FG001|Overall Study|Physician Decision|5|||
48478973|NCT01563029|155948164|FG002|Overall Study|Physician Decision|2|||
48478974|NCT01563029|155948165|FG003|Overall Study|Physician Decision|4|||
48478975|NCT01563029|155948166|FG004|Overall Study|Physician Decision|2|||
48478976|NCT01563029|155948162|FG000|Overall Study|Withdrawal by Subject|4|||
48478977|NCT01563029|155948163|FG001|Overall Study|Withdrawal by Subject|1|||
48478978|NCT01563029|155948164|FG002|Overall Study|Withdrawal by Subject|3|||
48478979|NCT01563029|155948165|FG003|Overall Study|Withdrawal by Subject|4|||
48478980|NCT01563029|155948166|FG004|Overall Study|Withdrawal by Subject|3|||
48478981|NCT01179191|155948169|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
48478982|NCT01179191|155948169|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
48478983|NCT01179191|155948169|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
48478984|NCT01179191|155948169|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
48478985|NCT01179191|155948169|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
48478986|NCT01179191|155948169|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
48478987|NCT01179191|155948169|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
48478988|NCT01179191|155948169|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
48478989|NCT01179191|155948169|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
48478990|NCT01179191|155948169|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
48478991|NCT01179191|155948169|FG000|Maintenance Phase (8 Weeks)|Other|66|||
48478992|NCT00244881|155948175|FG000|Overall Study|Withdrawal by Subject|3|||
48478993|NCT03345485|155948179|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
48478994|NCT03345485|155948180|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
48478995|NCT03345485|155948181|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
48478996|NCT03345485|155948182|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
48478997|NCT03345485|155948183|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
48478998|NCT03345485|155948184|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
48478999|NCT03345485|155948185|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
48479000|NCT03345485|155948186|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
48479001|NCT03345485|155948187|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
48479002|NCT03345485|155948188|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
48479003|NCT03345485|155948189|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
48479004|NCT03345485|155948190|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
48479005|NCT03345485|155948191|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
48479006|NCT02985515|155948192|FG000|Olfaction Testing|Lost to Follow-up|0|||
48479007|NCT02985515|155948193|FG001|Olfaction Testing|Lost to Follow-up|5|||
48479008|NCT02985515|155948192|FG000|Olfaction Testing|Protocol Violation|0|||
48479009|NCT02985515|155948193|FG001|Olfaction Testing|Protocol Violation|3|||
48479010|NCT03020966|155948195|FG000|Overall Study|Withdrawal by Subject|2|||
48479011|NCT03020966|155948196|FG001|Overall Study|Withdrawal by Subject|0|||
48479012|NCT01102972|155948199|FG000|Overall Study|Adverse Event|8|||
48479013|NCT01102972|155948200|FG001|Overall Study|Adverse Event|2|||
48479014|NCT01102972|155948199|FG000|Overall Study|Lack of Efficacy|2|||
48479015|NCT01102972|155948200|FG001|Overall Study|Lack of Efficacy|1|||
48479016|NCT01102972|155948199|FG000|Overall Study|Protocol Violation|1|||
48479017|NCT01102972|155948200|FG001|Overall Study|Protocol Violation|0|||
48479018|NCT01102972|155948199|FG000|Overall Study|Lost to Follow-up|10|||
48479019|NCT01102972|155948200|FG001|Overall Study|Lost to Follow-up|5|||
48479020|NCT01102972|155948199|FG000|Overall Study|Investigator Discretion|2|||
48479021|NCT01102972|155948200|FG001|Overall Study|Investigator Discretion|0|||
48479022|NCT01102972|155948199|FG000|Overall Study|Withdrawal by Subject|6|||
48479023|NCT01102972|155948200|FG001|Overall Study|Withdrawal by Subject|6|||
48479024|NCT01306968|155948201|FG000|Overall Study|Lost to Follow-up|1|||
48479025|NCT01306968|155948202|FG001|Overall Study|Lost to Follow-up|1|||
48479026|NCT01306968|155948203|FG002|Overall Study|Lost to Follow-up|0|||
48479027|NCT01306968|155948204|FG003|Overall Study|Lost to Follow-up|0|||
48479028|NCT01306968|155948201|FG000|Overall Study|Physician Decision|0|||
48479029|NCT01306968|155948202|FG001|Overall Study|Physician Decision|1|||
48479030|NCT01306968|155948203|FG002|Overall Study|Physician Decision|0|||
48479031|NCT01306968|155948204|FG003|Overall Study|Physician Decision|0|||
48479032|NCT01306968|155948201|FG000|Overall Study|Relocated and left active duty|0|||
48479033|NCT01306968|155948202|FG001|Overall Study|Relocated and left active duty|1|||
48479034|NCT01306968|155948203|FG002|Overall Study|Relocated and left active duty|1|||
48479035|NCT01306968|155948204|FG003|Overall Study|Relocated and left active duty|1|||
48479036|NCT01306968|155948201|FG000|Overall Study|Withdrew - time commitment|0|||
48479037|NCT01306968|155948202|FG001|Overall Study|Withdrew - time commitment|0|||
48479038|NCT01306968|155948203|FG002|Overall Study|Withdrew - time commitment|0|||
48479039|NCT01306968|155948204|FG003|Overall Study|Withdrew - time commitment|2|||
48479040|NCT01306968|155948201|FG000|Overall Study|Withdrew over privacy concerns|0|||
48479041|NCT01306968|155948202|FG001|Overall Study|Withdrew over privacy concerns|0|||
48479042|NCT01306968|155948203|FG002|Overall Study|Withdrew over privacy concerns|0|||
48479043|NCT01306968|155948204|FG003|Overall Study|Withdrew over privacy concerns|1|||
48479044|NCT01856257|155948205|FG000|Overall Study|Death|2|||
48479045|NCT01856257|155948206|FG001|Overall Study|Death|0|||
48479046|NCT01856257|155948207|FG002|Overall Study|Death|0|||
48479047|NCT01856257|155948208|FG003|Overall Study|Death|0|||
48479048|NCT01856257|155948205|FG000|Overall Study|Physician Decision|0|||
48479049|NCT01856257|155948206|FG001|Overall Study|Physician Decision|0|||
48479050|NCT01856257|155948207|FG002|Overall Study|Physician Decision|0|||
48479051|NCT01856257|155948208|FG003|Overall Study|Physician Decision|1|||
48479052|NCT01856257|155948205|FG000|Overall Study|Withdrawal by Subject|1|||
48479053|NCT01856257|155948206|FG001|Overall Study|Withdrawal by Subject|1|||
48479054|NCT01856257|155948207|FG002|Overall Study|Withdrawal by Subject|0|||
48479055|NCT01856257|155948208|FG003|Overall Study|Withdrawal by Subject|0|||
48479056|NCT01856257|155948205|FG000|Overall Study|Donor complication|0|||
48479057|NCT01856257|155948206|FG001|Overall Study|Donor complication|0|||
48479058|NCT01856257|155948207|FG002|Overall Study|Donor complication|0|||
48479059|NCT01856257|155948208|FG003|Overall Study|Donor complication|1|||
48479060|NCT01125358|155948217|FG000|Overall Study|Adverse Event|3|||
48479061|NCT01125358|155948218|FG001|Overall Study|Adverse Event|0|||
48479062|NCT01125358|155948219|FG002|Overall Study|Adverse Event|0|||
48479063|NCT01125358|155948220|FG003|Overall Study|Adverse Event|2|||
48479064|NCT01125358|155948217|FG000|Overall Study|Perceived Lack of Efficacy|6|||
48479065|NCT01125358|155948218|FG001|Overall Study|Perceived Lack of Efficacy|3|||
48479066|NCT01125358|155948219|FG002|Overall Study|Perceived Lack of Efficacy|7|||
48479067|NCT01125358|155948220|FG003|Overall Study|Perceived Lack of Efficacy|4|||
48479068|NCT01125358|155948217|FG000|Overall Study|Protocol Violation|1|||
48479069|NCT01125358|155948218|FG001|Overall Study|Protocol Violation|0|||
48479070|NCT01125358|155948219|FG002|Overall Study|Protocol Violation|0|||
48479071|NCT01125358|155948220|FG003|Overall Study|Protocol Violation|0|||
48479072|NCT01125358|155948217|FG000|Overall Study|Sponsor Decision|0|||
48479073|NCT01125358|155948218|FG001|Overall Study|Sponsor Decision|0|||
48479074|NCT01125358|155948219|FG002|Overall Study|Sponsor Decision|1|||
48479075|NCT01125358|155948220|FG003|Overall Study|Sponsor Decision|1|||
48479076|NCT01125358|155948217|FG000|Overall Study|Withdrawal by Subject|2|||
48479077|NCT01125358|155948218|FG001|Overall Study|Withdrawal by Subject|1|||
48479078|NCT01125358|155948219|FG002|Overall Study|Withdrawal by Subject|1|||
48479079|NCT01125358|155948220|FG003|Overall Study|Withdrawal by Subject|1|||
48479080|NCT03664024|155948221|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
48479081|NCT03664024|155948221|FG000|Overall Study|Lost to Follow-up|2|||
48479082|NCT03664024|155948221|FG000|Overall Study|Withdrawal by Subject|2|||
48479083|NCT03664024|155948221|FG000|Overall Study|Death|80|||
48479084|NCT04003103|155948222|FG000|Overall Study|Death|1|||
48479085|NCT04003103|155948223|FG001|Overall Study|Death|0|||
48479086|NCT04003103|155948224|FG002|Overall Study|Death|0|||
48479087|NCT04003103|155948222|FG000|Overall Study|Lost to Follow-up|4|||
48479088|NCT04003103|155948223|FG001|Overall Study|Lost to Follow-up|3|||
48479089|NCT04003103|155948224|FG002|Overall Study|Lost to Follow-up|2|||
48479090|NCT04003103|155948222|FG000|Overall Study|Withdrawal by Subject|10|||
48479091|NCT04003103|155948223|FG001|Overall Study|Withdrawal by Subject|1|||
48479092|NCT04003103|155948224|FG002|Overall Study|Withdrawal by Subject|1|||
48479093|NCT04003103|155948222|FG000|Overall Study|Status not recorded|0|||
48479094|NCT04003103|155948223|FG001|Overall Study|Status not recorded|2|||
48479095|NCT04003103|155948224|FG002|Overall Study|Status not recorded|0|||
48479096|NCT01640964|155948225|FG000|Overall Study|Lost to Follow-up|0|||
48479097|NCT01640964|155948226|FG001|Overall Study|Lost to Follow-up|0|||
48479098|NCT01640964|155948227|FG002|Overall Study|Lost to Follow-up|1|||
48479099|NCT01640964|155948225|FG000|Overall Study|Protocol Deviation|1|||
48479100|NCT01640964|155948226|FG001|Overall Study|Protocol Deviation|1|||
48479101|NCT01640964|155948227|FG002|Overall Study|Protocol Deviation|2|||
48479102|NCT00742859|155948230|FG000|Overall Study|Adverse Event|5|||
48479103|NCT00742859|155948231|FG001|Overall Study|Adverse Event|6|||
48479104|NCT00742859|155948232|FG002|Overall Study|Adverse Event|3|||
48479105|NCT00742859|155948233|FG003|Overall Study|Adverse Event|1|||
48479106|NCT00742859|155948230|FG000|Overall Study|Death|1|||
48479107|NCT00742859|155948231|FG001|Overall Study|Death|0|||
48479108|NCT00742859|155948232|FG002|Overall Study|Death|0|||
48479109|NCT00742859|155948233|FG003|Overall Study|Death|1|||
48479110|NCT00742859|155948230|FG000|Overall Study|Physician Decision|1|||
48479111|NCT00742859|155948231|FG001|Overall Study|Physician Decision|2|||
48479112|NCT00742859|155948232|FG002|Overall Study|Physician Decision|0|||
48479113|NCT00742859|155948233|FG003|Overall Study|Physician Decision|0|||
48479114|NCT00742859|155948230|FG000|Overall Study|Withdrawal by Subject|4|||
48479115|NCT00742859|155948231|FG001|Overall Study|Withdrawal by Subject|2|||
48479116|NCT00742859|155948232|FG002|Overall Study|Withdrawal by Subject|4|||
48479117|NCT00742859|155948233|FG003|Overall Study|Withdrawal by Subject|1|||
48479118|NCT00742859|155948230|FG000|Overall Study|Endpoint|0|||
48479119|NCT00742859|155948231|FG001|Overall Study|Endpoint|1|||
48479120|NCT00742859|155948232|FG002|Overall Study|Endpoint|1|||
48479121|NCT00742859|155948233|FG003|Overall Study|Endpoint|2|||
48479122|NCT00742859|155948230|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
48479123|NCT00742859|155948231|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
48479124|NCT00742859|155948232|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
48479125|NCT00742859|155948233|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
48479126|NCT00742859|155948230|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
48479127|NCT00742859|155948231|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
48479128|NCT00742859|155948232|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
48479207|NCT00756652|155948273|FG001|Re-Op Phase|Withdrawal by Subject|0|||
48479129|NCT00742859|155948233|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
48479130|NCT00742859|155948230|FG000|Overall Study|Sponsor request patient out of town|0|||
48479131|NCT00742859|155948231|FG001|Overall Study|Sponsor request patient out of town|0|||
48479132|NCT00742859|155948232|FG002|Overall Study|Sponsor request patient out of town|1|||
48479133|NCT00742859|155948233|FG003|Overall Study|Sponsor request patient out of town|1|||
48479134|NCT00742859|155948230|FG000|Overall Study|Site error|0|||
48479135|NCT00742859|155948231|FG001|Overall Study|Site error|0|||
48479136|NCT00742859|155948232|FG002|Overall Study|Site error|1|||
48479137|NCT00742859|155948233|FG003|Overall Study|Site error|1|||
48479138|NCT04935931|155948242|FG000|Overall Study|Withdrawal by Subject|1|||
48479139|NCT05168657|155948243|FG000|Overall Study|Adverse Event|0|||
48479140|NCT05168657|155948244|FG001|Overall Study|Adverse Event|0|||
48479141|NCT05168657|155948245|FG002|Overall Study|Adverse Event|1|||
48479142|NCT05168657|155948246|FG003|Overall Study|Adverse Event|0|||
48479143|NCT05168657|155948247|FG004|Overall Study|Adverse Event|0|||
48479144|NCT05168657|155948248|FG005|Overall Study|Adverse Event|0|||
48479145|NCT05168657|155948249|FG006|Overall Study|Adverse Event|0|||
48479146|NCT05168657|155948250|FG007|Overall Study|Adverse Event|0|||
48479147|NCT01346501|155948251|FG000|Overall Study|Initiated Other Biological Agents|3|||
48479148|NCT01346501|155948252|FG001|Overall Study|Initiated Other Biological Agents|1|||
48479149|NCT01346501|155948251|FG000|Overall Study|Other|8|||
48479150|NCT01346501|155948252|FG001|Overall Study|Other|12|||
48479151|NCT03428217|155948253|FG000|Overall Study|Death|89|||
48479152|NCT03428217|155948254|FG001|Overall Study|Death|93|||
48479153|NCT03428217|155948253|FG000|Overall Study|Withdrawal by Subject|8|||
48479154|NCT03428217|155948254|FG001|Overall Study|Withdrawal by Subject|7|||
48479155|NCT03428217|155948253|FG000|Overall Study|Lost to Follow-up|1|||
48479156|NCT03428217|155948254|FG001|Overall Study|Lost to Follow-up|3|||
48479157|NCT03428217|155948253|FG000|Overall Study|Study terminated by sponsor|124|||
48479158|NCT03428217|155948254|FG001|Overall Study|Study terminated by sponsor|118|||
48479159|NCT03428217|155948253|FG000|Overall Study|Other, Not Specified|1|||
48479160|NCT03428217|155948254|FG001|Overall Study|Other, Not Specified|0|||
48479161|NCT00962013|155948257|FG000|Overall Study|Did not have surgery|1|||
48479162|NCT00962013|155948257|FG000|Overall Study|Death|8|||
48479163|NCT00962013|155948257|FG000|Overall Study|Lost to Follow-up|12|||
48479164|NCT00962013|155948257|FG000|Overall Study|Unable/Unwilling to return|6|||
48479165|NCT00962013|155948257|FG000|Overall Study|Withdrawal by Subject|8|||
48479166|NCT00962013|155948257|FG000|Overall Study|Removal of study device|3|||
48479167|NCT00962013|155948257|FG000|Overall Study|Site Termination|24|||
48479168|NCT00962013|155948257|FG000|Overall Study|No 5 year evaluation|6|||
48479169|NCT04527549|155948258|FG000|Overall Study|Withdrawal by Subject|1|||
48479170|NCT04527549|155948259|FG001|Overall Study|Withdrawal by Subject|1|||
48479171|NCT02076113|155948262|FG000|Overall Study|Lost to Follow-up|4|||
48479172|NCT02076113|155948263|FG001|Overall Study|Lost to Follow-up|1|||
48479173|NCT02076113|155948262|FG000|Overall Study|Withdrawal by Subject|2|||
48479174|NCT02076113|155948263|FG001|Overall Study|Withdrawal by Subject|3|||
48479175|NCT02076113|155948262|FG000|Overall Study|Death|1|||
48479176|NCT02076113|155948263|FG001|Overall Study|Death|3|||
48479177|NCT04101721|155948264|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
48479178|NCT04101721|155948265|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
48479179|NCT04101721|155948264|FG000|Overall Study|Death|0|||
48479180|NCT04101721|155948265|FG001|Overall Study|Death|1|||
48479181|NCT04101721|155948264|FG000|Overall Study|Lost to Follow-up|0|||
48479182|NCT04101721|155948265|FG001|Overall Study|Lost to Follow-up|3|||
48479183|NCT01265875|155948266|FG000|Overall Study|Uncooperative/unreliable|1|||
48479184|NCT02564952|155948271|FG000|Overall Study|Adverse Event|6|||
48479185|NCT02564952|155948271|FG000|Overall Study|Lost to Follow-up|1|||
48479186|NCT02564952|155948271|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
48479187|NCT02564952|155948271|FG000|Overall Study|Withdrawal by Subject|1|||
48479188|NCT02564952|155948271|FG000|Overall Study|Low Efficacy|1|||
48479189|NCT02564952|155948271|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
48479190|NCT00756652|155948272|FG000|Original Phase|Withdrawal by Subject|864|||
48479191|NCT00756652|155948273|FG001|Original Phase|Withdrawal by Subject|23|||
48479192|NCT00756652|155948272|FG000|Original Phase|Lost to Follow-up|601|||
48479193|NCT00756652|155948273|FG001|Original Phase|Lost to Follow-up|0|||
48479194|NCT00756652|155948272|FG000|Original Phase|Other Discontinuation|797|||
48479195|NCT00756652|155948273|FG001|Original Phase|Other Discontinuation|5|||
48479196|NCT00756652|155948272|FG000|Original Phase|Participant Noncompliance|18622|||
48479197|NCT00756652|155948273|FG001|Original Phase|Participant Noncompliance|424|||
48479198|NCT00756652|155948272|FG000|Original Phase|Unknown Discontinuation Reason|2|||
48479199|NCT00756652|155948273|FG001|Original Phase|Unknown Discontinuation Reason|0|||
48479200|NCT00756652|155948272|FG000|Original Phase|Participants without data|3259|||
48479201|NCT00756652|155948273|FG001|Original Phase|Participants without data|466|||
48479202|NCT00756652|155948272|FG000|Original Phase|Death|168|||
48479203|NCT00756652|155948273|FG001|Original Phase|Death|1|||
48479204|NCT00756652|155948272|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
48479205|NCT00756652|155948273|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
48479206|NCT00756652|155948272|FG000|Re-Op Phase|Withdrawal by Subject|62|||
48479208|NCT00756652|155948272|FG000|Re-Op Phase|Death|6|||
48479209|NCT00756652|155948273|FG001|Re-Op Phase|Death|0|||
48479210|NCT00756652|155948272|FG000|Re-Op Phase|Lost to Follow-up|340|||
48479211|NCT00756652|155948273|FG001|Re-Op Phase|Lost to Follow-up|0|||
48479212|NCT00756652|155948272|FG000|Re-Op Phase|Site Closed|2454|||
48479213|NCT00756652|155948273|FG001|Re-Op Phase|Site Closed|0|||
48479214|NCT00756652|155948272|FG000|Re-Op Phase|Withdrawn after explant|14|||
48479215|NCT00756652|155948273|FG001|Re-Op Phase|Withdrawn after explant|0|||
48479216|NCT02628418|155948274|FG000|Overall Study|Lost to Follow-up|1|||
48479217|NCT02628418|155948275|FG001|Overall Study|Lost to Follow-up|2|||
48479218|NCT02610842|155948276|FG000|Overall Study|Lost to Follow-up|5|||
48479219|NCT00424632|155948277|FG000|Overall Study|Death|0|||
48479220|NCT00424632|155948278|FG001|Overall Study|Death|0|||
48479221|NCT00424632|155948279|FG002|Overall Study|Death|0|||
48479222|NCT00424632|155948280|FG003|Overall Study|Death|0|||
48479223|NCT00424632|155948281|FG004|Overall Study|Death|0|||
48479224|NCT00424632|155948282|FG005|Overall Study|Death|2|||
48479225|NCT00424632|155948283|FG006|Overall Study|Death|0|||
48479226|NCT00424632|155948284|FG007|Overall Study|Death|0|||
48479227|NCT00424632|155948285|FG008|Overall Study|Death|0|||
48479228|NCT00424632|155948286|FG009|Overall Study|Death|0|||
48479229|NCT00424632|155948277|FG000|Overall Study|Adverse Event|0|||
48479230|NCT00424632|155948278|FG001|Overall Study|Adverse Event|0|||
48479231|NCT00424632|155948279|FG002|Overall Study|Adverse Event|0|||
48479232|NCT00424632|155948280|FG003|Overall Study|Adverse Event|0|||
48479233|NCT00424632|155948281|FG004|Overall Study|Adverse Event|0|||
48479234|NCT00424632|155948282|FG005|Overall Study|Adverse Event|0|||
48479235|NCT00424632|155948283|FG006|Overall Study|Adverse Event|0|||
48479236|NCT00424632|155948284|FG007|Overall Study|Adverse Event|0|||
48479237|NCT00424632|155948285|FG008|Overall Study|Adverse Event|3|||
48479238|NCT00424632|155948286|FG009|Overall Study|Adverse Event|2|||
48479239|NCT00424632|155948277|FG000|Overall Study|Global deterioration of health status|0|||
48479240|NCT00424632|155948278|FG001|Overall Study|Global deterioration of health status|0|||
48479241|NCT00424632|155948279|FG002|Overall Study|Global deterioration of health status|0|||
48479242|NCT00424632|155948280|FG003|Overall Study|Global deterioration of health status|1|||
48479243|NCT00424632|155948281|FG004|Overall Study|Global deterioration of health status|1|||
48479244|NCT00424632|155948282|FG005|Overall Study|Global deterioration of health status|0|||
48479245|NCT00424632|155948283|FG006|Overall Study|Global deterioration of health status|0|||
48479246|NCT00424632|155948284|FG007|Overall Study|Global deterioration of health status|0|||
48479247|NCT00424632|155948285|FG008|Overall Study|Global deterioration of health status|0|||
48479248|NCT00424632|155948286|FG009|Overall Study|Global deterioration of health status|0|||
48479249|NCT00424632|155948277|FG000|Overall Study|Objective progression or relapse|1|||
48479250|NCT00424632|155948278|FG001|Overall Study|Objective progression or relapse|1|||
48479251|NCT00424632|155948279|FG002|Overall Study|Objective progression or relapse|1|||
48479252|NCT00424632|155948280|FG003|Overall Study|Objective progression or relapse|2|||
48479253|NCT00424632|155948281|FG004|Overall Study|Objective progression or relapse|2|||
48479254|NCT00424632|155948282|FG005|Overall Study|Objective progression or relapse|13|||
48479255|NCT00424632|155948283|FG006|Overall Study|Objective progression or relapse|7|||
48479256|NCT00424632|155948284|FG007|Overall Study|Objective progression or relapse|3|||
48479257|NCT00424632|155948285|FG008|Overall Study|Objective progression or relapse|12|||
48479258|NCT00424632|155948286|FG009|Overall Study|Objective progression or relapse|4|||
48479259|NCT00424632|155948277|FG000|Overall Study|Other|0|||
48479260|NCT00424632|155948278|FG001|Overall Study|Other|0|||
48479261|NCT00424632|155948279|FG002|Overall Study|Other|0|||
48479262|NCT00424632|155948280|FG003|Overall Study|Other|1|||
48479263|NCT00424632|155948281|FG004|Overall Study|Other|0|||
48479264|NCT00424632|155948282|FG005|Overall Study|Other|0|||
48479265|NCT00424632|155948283|FG006|Overall Study|Other|0|||
48479266|NCT00424632|155948284|FG007|Overall Study|Other|0|||
48479267|NCT00424632|155948285|FG008|Overall Study|Other|1|||
48479268|NCT00424632|155948286|FG009|Overall Study|Other|0|||
48479269|NCT03972709|155948298|FG000|Overall Study|Withdrawal by Subject|18|||
48479270|NCT03972709|155948299|FG001|Overall Study|Withdrawal by Subject|7|||
48479271|NCT03972709|155948300|FG002|Overall Study|Withdrawal by Subject|14|||
48479272|NCT03972709|155948298|FG000|Overall Study|Study Terminated by Sponsor|48|||
48479273|NCT03972709|155948299|FG001|Overall Study|Study Terminated by Sponsor|25|||
48479274|NCT03972709|155948300|FG002|Overall Study|Study Terminated by Sponsor|50|||
48479275|NCT03972709|155948298|FG000|Overall Study|Physician Decision|1|||
48479276|NCT03972709|155948299|FG001|Overall Study|Physician Decision|0|||
48479277|NCT03972709|155948300|FG002|Overall Study|Physician Decision|0|||
48479278|NCT03972709|155948298|FG000|Overall Study|COVID-19|0|||
48479279|NCT03972709|155948299|FG001|Overall Study|COVID-19|1|||
48479280|NCT03972709|155948300|FG002|Overall Study|COVID-19|1|||
48479281|NCT03972709|155948298|FG000|Overall Study|Lost to Follow-up|6|||
48479282|NCT03972709|155948299|FG001|Overall Study|Lost to Follow-up|1|||
48479283|NCT03972709|155948300|FG002|Overall Study|Lost to Follow-up|2|||
48479284|NCT03972709|155948298|FG000|Overall Study|Death|5|||
48479285|NCT03972709|155948299|FG001|Overall Study|Death|1|||
48479286|NCT03972709|155948300|FG002|Overall Study|Death|4|||
48479287|NCT03972709|155948298|FG000|Overall Study|Adverse Event|3|||
48479288|NCT03972709|155948299|FG001|Overall Study|Adverse Event|1|||
48479289|NCT03972709|155948300|FG002|Overall Study|Adverse Event|4|||
48479290|NCT03972709|155948298|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
48479291|NCT03972709|155948299|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
48479292|NCT03972709|155948300|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
48479293|NCT03972709|155948298|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
48479294|NCT03972709|155948299|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
48479295|NCT03972709|155948300|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
48479296|NCT03972709|155948298|FG000|Overall Study|Subject Unable to be Contacted|0|||
48479297|NCT03972709|155948299|FG001|Overall Study|Subject Unable to be Contacted|1|||
48479298|NCT03972709|155948300|FG002|Overall Study|Subject Unable to be Contacted|0|||
48479299|NCT03972709|155948298|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
48479300|NCT03972709|155948299|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
48479301|NCT03972709|155948300|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
48479302|NCT03972709|155948298|FG000|Overall Study|Subject Moved|0|||
48479303|NCT03972709|155948299|FG001|Overall Study|Subject Moved|1|||
48479304|NCT03972709|155948300|FG002|Overall Study|Subject Moved|0|||
48479305|NCT03972709|155948298|FG000|Overall Study|Missed Study Visits|1|||
48479306|NCT03972709|155948299|FG001|Overall Study|Missed Study Visits|0|||
48479307|NCT03972709|155948300|FG002|Overall Study|Missed Study Visits|0|||
48479308|NCT03159611|155948301|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
48479309|NCT03159611|155948302|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
48479310|NCT03159611|155948301|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
48479311|NCT03159611|155948302|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
48479312|NCT03159611|155948301|FG000|Overall Study|Protocol Violation|7|||
48479313|NCT03159611|155948302|FG001|Overall Study|Protocol Violation|4|||
48479314|NCT03159611|155948301|FG000|Overall Study|Adverse Event|1|||
48479315|NCT03159611|155948302|FG001|Overall Study|Adverse Event|0|||
48479316|NCT03159611|155948301|FG000|Overall Study|Withdrawal by Subject|1|||
48479317|NCT03159611|155948302|FG001|Overall Study|Withdrawal by Subject|1|||
48479318|NCT03159611|155948301|FG000|Overall Study|Non-compliance with protocol requirement|3|||
48479319|NCT03159611|155948302|FG001|Overall Study|Non-compliance with protocol requirement|2|||
48479320|NCT03159611|155948301|FG000|Overall Study|Inability to perform procedures|1|||
48479321|NCT03159611|155948302|FG001|Overall Study|Inability to perform procedures|0|||
48479322|NCT04732728|155948303|FG000|Overall Study|Death|12|||
48479323|NCT04732728|155948303|FG000|Overall Study|Withdrawn|136|||
48479324|NCT01342367|155948307|FG000|Overall Study|Death|1|||
48479325|NCT01342367|155948308|FG001|Overall Study|Death|0|||
48479326|NCT01342367|155948307|FG000|Overall Study|Withdrawal by Subject|1|||
48479327|NCT01342367|155948308|FG001|Overall Study|Withdrawal by Subject|2|||
48479328|NCT00358670|155948310|FG000|Overall Study|Adverse Event|26|||
48479329|NCT00358670|155948311|FG001|Overall Study|Adverse Event|29|||
48479330|NCT00358670|155948310|FG000|Overall Study|Lack of Efficacy|20|||
48479331|NCT00358670|155948311|FG001|Overall Study|Lack of Efficacy|23|||
48479332|NCT00358670|155948310|FG000|Overall Study|Protocol Violation|6|||
48479333|NCT00358670|155948311|FG001|Overall Study|Protocol Violation|9|||
48479334|NCT00358670|155948310|FG000|Overall Study|Lost to Follow-up|4|||
48479335|NCT00358670|155948311|FG001|Overall Study|Lost to Follow-up|5|||
48479336|NCT00358670|155948310|FG000|Overall Study|Withdrawal by Subject|13|||
48479337|NCT00358670|155948311|FG001|Overall Study|Withdrawal by Subject|24|||
48479338|NCT00358670|155948310|FG000|Overall Study|Protocol Defined Clinical Event|0|||
48479339|NCT00358670|155948311|FG001|Overall Study|Protocol Defined Clinical Event|1|||
48479340|NCT00358670|155948310|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
48479341|NCT00358670|155948311|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
48479342|NCT00358670|155948310|FG000|Overall Study|Administrative|153|||
48479343|NCT00358670|155948311|FG001|Overall Study|Administrative|125|||
48479344|NCT00530088|155948312|FG000|Overall Study|Disease Progression|4|||
48479345|NCT00530088|155948312|FG000|Overall Study|Physician Decision|4|||
48479346|NCT00530088|155948312|FG000|Overall Study|Other Not Specified|2|||
48479347|NCT04449354|155948313|FG000|Overall Study|Withdrawal by Subject|1|||
48479348|NCT05789420|155948314|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
48479349|NCT05789420|155948314|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
48479350|NCT00391118|155948315|FG000|Overall Study|Adverse Event|3|||
48479351|NCT00391118|155948316|FG001|Overall Study|Adverse Event|10|||
48479352|NCT00391118|155948317|FG002|Overall Study|Adverse Event|7|||
48479353|NCT00391118|155948315|FG000|Overall Study|Lost to Follow-up|0|||
48479354|NCT00391118|155948316|FG001|Overall Study|Lost to Follow-up|2|||
48479355|NCT00391118|155948317|FG002|Overall Study|Lost to Follow-up|3|||
48479356|NCT00391118|155948315|FG000|Overall Study|Withdrawal by Subject|0|||
48479357|NCT00391118|155948316|FG001|Overall Study|Withdrawal by Subject|9|||
48479358|NCT00391118|155948317|FG002|Overall Study|Withdrawal by Subject|1|||
48479359|NCT00391118|155948315|FG000|Overall Study|Death|0|||
48479360|NCT00391118|155948316|FG001|Overall Study|Death|1|||
48479361|NCT00391118|155948317|FG002|Overall Study|Death|0|||
48479362|NCT00391118|155948315|FG000|Overall Study|Physician Decision|0|||
48479363|NCT00391118|155948316|FG001|Overall Study|Physician Decision|3|||
48479364|NCT00391118|155948317|FG002|Overall Study|Physician Decision|0|||
48479365|NCT00391118|155948315|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
48479366|NCT00391118|155948316|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
48479367|NCT00391118|155948317|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
48479368|NCT00391118|155948315|FG000|Overall Study|Progressive Disease|7|||
48479369|NCT00391118|155948316|FG001|Overall Study|Progressive Disease|26|||
48479370|NCT00391118|155948317|FG002|Overall Study|Progressive Disease|43|||
48479371|NCT00391118|155948315|FG000|Overall Study|Sponsor Decision|0|||
48479372|NCT00391118|155948316|FG001|Overall Study|Sponsor Decision|1|||
48479373|NCT00391118|155948317|FG002|Overall Study|Sponsor Decision|3|||
48479374|NCT00391118|155948315|FG000|Overall Study|Protocol Violation|1|||
48479375|NCT00391118|155948316|FG001|Overall Study|Protocol Violation|0|||
48479376|NCT00391118|155948317|FG002|Overall Study|Protocol Violation|0|||
48479377|NCT00797316|155948318|FG000|Overall Study|Administrative problems|1|||
48479378|NCT00797316|155948319|FG001|Overall Study|Administrative problems|0|||
48479379|NCT00797316|155948318|FG000|Overall Study|Adverse Event|5|||
48479380|NCT00797316|155948319|FG001|Overall Study|Adverse Event|3|||
48479381|NCT00797316|155948318|FG000|Overall Study|Lost to Follow-up|4|||
48479382|NCT00797316|155948319|FG001|Overall Study|Lost to Follow-up|8|||
48479383|NCT00797316|155948318|FG000|Overall Study|Protocol Deviation|1|||
48479384|NCT00797316|155948319|FG001|Overall Study|Protocol Deviation|2|||
48479385|NCT00797316|155948318|FG000|Overall Study|Patient withdrew consent|12|||
48479386|NCT00797316|155948319|FG001|Overall Study|Patient withdrew consent|6|||
48479387|NCT00797316|155948318|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
48479388|NCT00797316|155948319|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
48479389|NCT00944125|155948320|FG000|3 to 6 Months|Withdrawal by Subject|0|||
48479390|NCT00944125|155948321|FG001|3 to 6 Months|Withdrawal by Subject|2|||
48479391|NCT00944125|155948320|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
48479392|NCT00944125|155948321|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
48479393|NCT04489888|155948322|FG000|Overall Study|Death|61|||
48479394|NCT04489888|155948322|FG000|Overall Study|Participant On-going|40|||
48479395|NCT03494816|155948323|FG000|Overall Study|Protocol Violation|2|||
48479396|NCT03494816|155948323|FG000|Overall Study|Physician Decision|2|||
48479397|NCT03494816|155948323|FG000|Overall Study|Did not start trial treatment|1|||
48479398|NCT03494816|155948323|FG000|Overall Study|Adverse Event|1|||
48479399|NCT00242567|155950563|FG000|Overall Study|Adverse Event|70|||
48479400|NCT00242567|155950564|FG001|Overall Study|Adverse Event|43|||
48479401|NCT00242567|155950563|FG000|Overall Study|Disease Progression|17|||
48479402|NCT00242567|155950564|FG001|Overall Study|Disease Progression|22|||
48479403|NCT00242567|155950563|FG000|Overall Study|Symptomatic deterioration|9|||
48479404|NCT00242567|155950564|FG001|Overall Study|Symptomatic deterioration|3|||
48479405|NCT00242567|155950563|FG000|Overall Study|Lack of Efficacy|2|||
48479406|NCT00242567|155950564|FG001|Overall Study|Lack of Efficacy|2|||
48479407|NCT00242567|155950563|FG000|Overall Study|Lost to Follow-up|9|||
48479408|NCT00242567|155950564|FG001|Overall Study|Lost to Follow-up|19|||
48479409|NCT00242567|155950563|FG000|Overall Study|Withdrawal by Subject|33|||
48479410|NCT00242567|155950564|FG001|Overall Study|Withdrawal by Subject|28|||
48479411|NCT00242567|155950563|FG000|Overall Study|Protocol Violation|12|||
48479412|NCT00242567|155950564|FG001|Overall Study|Protocol Violation|12|||
48479413|NCT00242567|155950563|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
48479414|NCT00242567|155950564|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
48479415|NCT00242567|155950563|FG000|Overall Study|Other|14|||
48479416|NCT00242567|155950564|FG001|Overall Study|Other|9|||
48479417|NCT01299272|155950565|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
48479418|NCT01299272|155950566|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
48479419|NCT01299272|155950567|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
48479420|NCT01299272|155950568|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
48479421|NCT01299272|155950565|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
48479422|NCT01299272|155950566|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
48479423|NCT01299272|155950567|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
48479424|NCT01299272|155950568|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
48479425|NCT01299272|155950565|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
48479426|NCT01299272|155950566|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
48479427|NCT01299272|155950567|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
48479428|NCT01299272|155950568|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
48479429|NCT01299272|155950565|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
48479430|NCT01299272|155950566|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
48479431|NCT01299272|155950567|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
48479432|NCT01299272|155950568|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
48479433|NCT01299272|155950565|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
48479434|NCT01299272|155950566|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
48479435|NCT01299272|155950567|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
48479436|NCT01299272|155950568|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
48479437|NCT01299272|155950565|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
48479438|NCT01299272|155950566|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
48479439|NCT01299272|155950567|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
48479440|NCT01299272|155950568|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
48479441|NCT01299272|155950565|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
48479442|NCT01299272|155950566|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
48479443|NCT01299272|155950567|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
48479444|NCT01299272|155950568|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
48479445|NCT01299272|155950565|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
48479446|NCT01299272|155950566|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
48479447|NCT01299272|155950567|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
48479448|NCT01299272|155950568|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
48479449|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
48479450|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
48479451|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
48479452|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
48479453|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
48479454|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
48479455|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
48479456|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
48479457|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
48479458|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
48479459|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
48479460|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
48479461|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
48479462|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
48479463|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
48479464|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
48479465|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
48479466|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
48479467|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
48479468|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
48479469|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
48479470|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
48479471|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
48479472|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
48479473|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
48479474|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
48479475|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
48479476|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
48479477|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
48479478|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
48479479|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
48479480|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
48479481|NCT01299272|155950565|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
48479482|NCT01299272|155950566|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
48479483|NCT01299272|155950567|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
48479484|NCT01299272|155950568|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
48479485|NCT01299272|155950565|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
48479486|NCT01299272|155950566|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
48479487|NCT01299272|155950567|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
48479488|NCT01299272|155950568|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
48479489|NCT01299272|155950565|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
48479490|NCT01299272|155950566|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
48479491|NCT01299272|155950567|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
48479492|NCT01299272|155950568|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
48479493|NCT01299272|155950565|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
48479494|NCT01299272|155950566|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
48479495|NCT01299272|155950567|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
48479496|NCT01299272|155950568|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
48479497|NCT01299272|155950565|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
48479498|NCT01299272|155950566|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
48479499|NCT01299272|155950567|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
48479500|NCT01299272|155950568|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
48479501|NCT01299272|155950565|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
48479502|NCT01299272|155950566|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
48479503|NCT01299272|155950567|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
48479504|NCT01299272|155950568|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
48479505|NCT01299272|155950565|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
48479506|NCT01299272|155950566|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
48479507|NCT01299272|155950567|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
48479508|NCT01299272|155950568|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
48479509|NCT01299272|155950565|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
48479510|NCT01299272|155950566|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
48479511|NCT01299272|155950567|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
48479512|NCT01299272|155950568|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
48479513|NCT01299272|155950565|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
48479514|NCT01299272|155950566|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
48479515|NCT01299272|155950567|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
48479516|NCT01299272|155950568|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
48479517|NCT00464308|155950569|FG000|Overall Study|Adverse Event|22|||
48479518|NCT00464308|155950570|FG001|Overall Study|Adverse Event|27|||
48479519|NCT00464308|155950571|FG002|Overall Study|Adverse Event|16|||
48479520|NCT00464308|155950569|FG000|Overall Study|Lost to Follow-up|29|||
48479521|NCT00464308|155950570|FG001|Overall Study|Lost to Follow-up|19|||
48479522|NCT00464308|155950571|FG002|Overall Study|Lost to Follow-up|20|||
48479523|NCT00464308|155950569|FG000|Overall Study|Patient discontinued and other reasons|17|||
48479524|NCT00464308|155950570|FG001|Overall Study|Patient discontinued and other reasons|17|||
48479525|NCT00464308|155950571|FG002|Overall Study|Patient discontinued and other reasons|23|||
48479526|NCT00464308|155950569|FG000|Overall Study|Physician Decision|1|||
48479527|NCT00464308|155950570|FG001|Overall Study|Physician Decision|0|||
48479528|NCT00464308|155950571|FG002|Overall Study|Physician Decision|0|||
48479529|NCT01721200|155950572|FG000|Overall Study|Lost to Follow-up|3|||
48479530|NCT01721200|155950573|FG001|Overall Study|Lost to Follow-up|5|||
48479531|NCT01513759|155950574|FG000|Overall Study|Protocol Violation|4|||
48479532|NCT01513759|155950574|FG000|Overall Study|Death during catheter placement|1|||
48479533|NCT03926728|155950578|FG000|Overall Study|Withdrawal by Subject|0|||
48479534|NCT03926728|155950579|FG001|Overall Study|Withdrawal by Subject|1|||
48479535|NCT03926728|155950580|FG002|Overall Study|Withdrawal by Subject|1|||
48479536|NCT03926728|155950581|FG003|Overall Study|Withdrawal by Subject|0|||
48479537|NCT03926728|155950582|FG004|Overall Study|Withdrawal by Subject|0|||
48479538|NCT03926728|155950583|FG005|Overall Study|Withdrawal by Subject|1|||
48479539|NCT03926728|155950584|FG006|Overall Study|Withdrawal by Subject|1|||
48479540|NCT03926728|155950585|FG007|Overall Study|Withdrawal by Subject|0|||
48479541|NCT03926728|155950586|FG008|Overall Study|Withdrawal by Subject|0|||
48479542|NCT03926728|155950587|FG009|Overall Study|Withdrawal by Subject|1|||
48479543|NCT03926728|155950588|FG010|Overall Study|Withdrawal by Subject|0|||
48479544|NCT03926728|155950589|FG011|Overall Study|Withdrawal by Subject|0|||
48479545|NCT00891527|155950590|FG000|Overall Study|Withdrawal by Subject|2|||
48479546|NCT00630994|155950595|FG000|Overall Study|Adverse Event|1|||
48479547|NCT00630994|155950595|FG000|Overall Study|Disease Progression|1|||
48479548|NCT00630994|155950595|FG000|Overall Study|Lack of Efficacy|1|||
48479549|NCT00630994|155950595|FG000|Overall Study|Other|1|||
48479550|NCT03669640|155950599|FG000|Overall Study|Study Terminated by Sponsor|0|||
48479551|NCT03669640|155950600|FG001|Overall Study|Study Terminated by Sponsor|0|||
48479552|NCT03669640|155950601|FG002|Overall Study|Study Terminated by Sponsor|0|||
48479553|NCT03669640|155950602|FG003|Overall Study|Study Terminated by Sponsor|0|||
48479554|NCT03669640|155950603|FG004|Overall Study|Study Terminated by Sponsor|1|||
48479555|NCT03669640|155950604|FG005|Overall Study|Study Terminated by Sponsor|0|||
48479556|NCT03669640|155950599|FG000|Overall Study|Lost to Follow-up|0|||
48479557|NCT03669640|155950600|FG001|Overall Study|Lost to Follow-up|0|||
48479558|NCT03669640|155950601|FG002|Overall Study|Lost to Follow-up|2|||
48479559|NCT03669640|155950602|FG003|Overall Study|Lost to Follow-up|0|||
48479560|NCT03669640|155950603|FG004|Overall Study|Lost to Follow-up|0|||
48479561|NCT03669640|155950604|FG005|Overall Study|Lost to Follow-up|0|||
48479562|NCT03669640|155950599|FG000|Overall Study|Death|0|||
48479563|NCT03669640|155950600|FG001|Overall Study|Death|0|||
48479564|NCT03669640|155950601|FG002|Overall Study|Death|1|||
48479565|NCT03669640|155950602|FG003|Overall Study|Death|0|||
48479566|NCT03669640|155950603|FG004|Overall Study|Death|0|||
48479567|NCT03669640|155950604|FG005|Overall Study|Death|0|||
48479568|NCT03669640|155950599|FG000|Overall Study|Withdrawal by Subject|1|||
48479569|NCT03669640|155950600|FG001|Overall Study|Withdrawal by Subject|2|||
48479570|NCT03669640|155950601|FG002|Overall Study|Withdrawal by Subject|1|||
48479571|NCT03669640|155950602|FG003|Overall Study|Withdrawal by Subject|0|||
48479572|NCT03669640|155950603|FG004|Overall Study|Withdrawal by Subject|1|||
48479573|NCT03669640|155950604|FG005|Overall Study|Withdrawal by Subject|3|||
48479574|NCT03669640|155950599|FG000|Overall Study|Protocol Violation|1|||
48479575|NCT03669640|155950600|FG001|Overall Study|Protocol Violation|0|||
48479576|NCT03669640|155950601|FG002|Overall Study|Protocol Violation|0|||
48479577|NCT03669640|155950602|FG003|Overall Study|Protocol Violation|0|||
48479578|NCT03669640|155950603|FG004|Overall Study|Protocol Violation|0|||
48479579|NCT03669640|155950604|FG005|Overall Study|Protocol Violation|0|||
48479580|NCT03669640|155950599|FG000|Overall Study|Physician Decision|0|||
48479581|NCT03669640|155950600|FG001|Overall Study|Physician Decision|2|||
48479582|NCT03669640|155950601|FG002|Overall Study|Physician Decision|0|||
48479583|NCT03669640|155950602|FG003|Overall Study|Physician Decision|0|||
48479584|NCT03669640|155950603|FG004|Overall Study|Physician Decision|0|||
48479585|NCT03669640|155950604|FG005|Overall Study|Physician Decision|0|||
48479586|NCT03669640|155950599|FG000|Overall Study|Disease Relapse|1|||
48479587|NCT03669640|155950600|FG001|Overall Study|Disease Relapse|0|||
48479588|NCT03669640|155950601|FG002|Overall Study|Disease Relapse|0|||
48479589|NCT03669640|155950602|FG003|Overall Study|Disease Relapse|0|||
48479590|NCT03669640|155950603|FG004|Overall Study|Disease Relapse|0|||
48479591|NCT03669640|155950604|FG005|Overall Study|Disease Relapse|0|||
48479592|NCT03669640|155950599|FG000|Overall Study|Adverse Event|2|||
48479593|NCT03669640|155950600|FG001|Overall Study|Adverse Event|1|||
48479594|NCT03669640|155950601|FG002|Overall Study|Adverse Event|0|||
48479595|NCT03669640|155950602|FG003|Overall Study|Adverse Event|0|||
48479596|NCT03669640|155950603|FG004|Overall Study|Adverse Event|1|||
48479597|NCT03669640|155950604|FG005|Overall Study|Adverse Event|0|||
48479598|NCT01186744|155950605|FG000|Overall Study|Lack of Efficacy|156|||
48479599|NCT01186744|155950606|FG001|Overall Study|Lack of Efficacy|99|||
48479600|NCT01186744|155950607|FG002|Overall Study|Lack of Efficacy|0|||
48479601|NCT01186744|155950608|FG003|Overall Study|Lack of Efficacy|2|||
48479602|NCT01186744|155950609|FG004|Overall Study|Lack of Efficacy|2|||
48479603|NCT01186744|155950610|FG005|Overall Study|Lack of Efficacy|5|||
48479604|NCT01186744|155950605|FG000|Overall Study|Protocol Violation|1|||
48479605|NCT01186744|155950606|FG001|Overall Study|Protocol Violation|2|||
48479606|NCT01186744|155950607|FG002|Overall Study|Protocol Violation|0|||
48479607|NCT01186744|155950608|FG003|Overall Study|Protocol Violation|1|||
48479608|NCT01186744|155950609|FG004|Overall Study|Protocol Violation|1|||
48479609|NCT01186744|155950610|FG005|Overall Study|Protocol Violation|2|||
48479610|NCT01186744|155950605|FG000|Overall Study|Lost to Follow-up|15|||
48479611|NCT01186744|155950606|FG001|Overall Study|Lost to Follow-up|16|||
48479612|NCT01186744|155950607|FG002|Overall Study|Lost to Follow-up|2|||
48479613|NCT01186744|155950608|FG003|Overall Study|Lost to Follow-up|1|||
48479614|NCT01186744|155950609|FG004|Overall Study|Lost to Follow-up|1|||
48479615|NCT01186744|155950610|FG005|Overall Study|Lost to Follow-up|4|||
48479616|NCT01186744|155950605|FG000|Overall Study|Screen failure|1|||
48479617|NCT01186744|155950606|FG001|Overall Study|Screen failure|1|||
48479618|NCT01186744|155950607|FG002|Overall Study|Screen failure|0|||
48479619|NCT01186744|155950608|FG003|Overall Study|Screen failure|1|||
48479620|NCT01186744|155950609|FG004|Overall Study|Screen failure|0|||
48479621|NCT01186744|155950610|FG005|Overall Study|Screen failure|0|||
48479622|NCT01186744|155950605|FG000|Overall Study|Withdrawal by Subject|14|||
48479623|NCT01186744|155950606|FG001|Overall Study|Withdrawal by Subject|10|||
48479624|NCT01186744|155950607|FG002|Overall Study|Withdrawal by Subject|2|||
48479625|NCT01186744|155950608|FG003|Overall Study|Withdrawal by Subject|5|||
48479626|NCT01186744|155950609|FG004|Overall Study|Withdrawal by Subject|0|||
48479627|NCT01186744|155950610|FG005|Overall Study|Withdrawal by Subject|6|||
48479628|NCT01186744|155950605|FG000|Overall Study|Study terminated by Sponsor|1|||
48479629|NCT01186744|155950606|FG001|Overall Study|Study terminated by Sponsor|0|||
48479630|NCT01186744|155950607|FG002|Overall Study|Study terminated by Sponsor|0|||
48479631|NCT01186744|155950608|FG003|Overall Study|Study terminated by Sponsor|0|||
48479632|NCT01186744|155950609|FG004|Overall Study|Study terminated by Sponsor|0|||
48479633|NCT01186744|155950610|FG005|Overall Study|Study terminated by Sponsor|0|||
48479634|NCT01186744|155950605|FG000|Overall Study|Other|9|||
48479635|NCT01186744|155950606|FG001|Overall Study|Other|10|||
48479636|NCT01186744|155950607|FG002|Overall Study|Other|1|||
48479637|NCT01186744|155950608|FG003|Overall Study|Other|2|||
48479638|NCT01186744|155950609|FG004|Overall Study|Other|1|||
48479639|NCT01186744|155950610|FG005|Overall Study|Other|5|||
48479640|NCT01186744|155950605|FG000|Overall Study|Adverse Event|10|||
48479641|NCT01186744|155950606|FG001|Overall Study|Adverse Event|14|||
48479642|NCT01186744|155950607|FG002|Overall Study|Adverse Event|1|||
48479643|NCT01186744|155950608|FG003|Overall Study|Adverse Event|0|||
48479644|NCT01186744|155950609|FG004|Overall Study|Adverse Event|1|||
48479645|NCT01186744|155950610|FG005|Overall Study|Adverse Event|4|||
48479646|NCT01186744|155950605|FG000|Overall Study|Death|1|||
48479647|NCT01186744|155950606|FG001|Overall Study|Death|0|||
48479648|NCT01186744|155950607|FG002|Overall Study|Death|0|||
48479649|NCT01186744|155950608|FG003|Overall Study|Death|0|||
48479650|NCT01186744|155950609|FG004|Overall Study|Death|0|||
48479651|NCT01186744|155950610|FG005|Overall Study|Death|0|||
48479652|NCT03237481|155950613|FG000|Overall Study|Lost to Follow-up|1|||
48479653|NCT03237481|155950614|FG001|Overall Study|Lost to Follow-up|0|||
48479654|NCT03237481|155950615|FG002|Overall Study|Lost to Follow-up|0|||
48479655|NCT03237481|155950613|FG000|Overall Study|Protocol Violation|1|||
48479656|NCT03237481|155950614|FG001|Overall Study|Protocol Violation|0|||
48479657|NCT03237481|155950615|FG002|Overall Study|Protocol Violation|0|||
48479658|NCT03237481|155950613|FG000|Overall Study|Withdrawal by Subject|3|||
48479659|NCT03237481|155950614|FG001|Overall Study|Withdrawal by Subject|2|||
48479660|NCT03237481|155950615|FG002|Overall Study|Withdrawal by Subject|1|||
48479661|NCT01211613|155950616|FG000|Overall Study|Lost to Follow-up|2|||
48479662|NCT01211613|155950617|FG001|Overall Study|Lost to Follow-up|2|||
48479663|NCT01211613|155950618|FG002|Overall Study|Lost to Follow-up|2|||
48479664|NCT01211613|155950616|FG000|Overall Study|Withdrawal by Subject|1|||
48479665|NCT01211613|155950617|FG001|Overall Study|Withdrawal by Subject|0|||
48479666|NCT01211613|155950618|FG002|Overall Study|Withdrawal by Subject|0|||
48479667|NCT03722849|155950619|FG000|Overall Study|Withdrawal by Subject|1|||
48479668|NCT03722849|155950620|FG001|Overall Study|Withdrawal by Subject|1|||
48479669|NCT03993288|155950621|FG000|Overall Study|Lost to Follow-up|2|||
48479670|NCT03993288|155950622|FG001|Overall Study|Lost to Follow-up|1|||
48479671|NCT03993288|155950621|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
48479672|NCT03993288|155950622|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
48479673|NCT03993288|155950621|FG000|Overall Study|wrong randomization|0|||
48479674|NCT03993288|155950622|FG001|Overall Study|wrong randomization|1|||
48479675|NCT03993288|155950621|FG000|Overall Study|improper enrollment|0|||
48479676|NCT03993288|155950622|FG001|Overall Study|improper enrollment|1|||
48479677|NCT03993288|155950621|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
48479678|NCT03993288|155950622|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
48479679|NCT03993288|155950621|FG000|Overall Study|developed SAE|2|||
48479680|NCT03993288|155950622|FG001|Overall Study|developed SAE|0|||
48479681|NCT03993288|155950621|FG000|Overall Study|consent withdrawal|1|||
48479682|NCT03993288|155950622|FG001|Overall Study|consent withdrawal|0|||
48479683|NCT03993288|155950621|FG000|Overall Study|did not follow the treatment schedule|1|||
48479684|NCT03993288|155950622|FG001|Overall Study|did not follow the treatment schedule|0|||
48479685|NCT03993288|155950621|FG000|Overall Study|did not follow the treatment regimen|1|||
48479686|NCT03993288|155950622|FG001|Overall Study|did not follow the treatment regimen|0|||
48479687|NCT03993288|155950621|FG000|Overall Study|Adverse Event|1|||
48479688|NCT03993288|155950622|FG001|Overall Study|Adverse Event|0|||
48479689|NCT03993288|155950621|FG000|Overall Study|Withdrawal by Subject|1|||
48479690|NCT03993288|155950622|FG001|Overall Study|Withdrawal by Subject|1|||
48479691|NCT02152631|155950625|FG000|Overall Study|Adverse Event|32|||
48479692|NCT02152631|155950626|FG001|Overall Study|Adverse Event|4|||
48479693|NCT02152631|155950625|FG000|Overall Study|Withdrawal by Subject|13|||
48479694|NCT02152631|155950626|FG001|Overall Study|Withdrawal by Subject|16|||
48479695|NCT02152631|155950625|FG000|Overall Study|Noncompliance with study drug|1|||
48479696|NCT02152631|155950626|FG001|Overall Study|Noncompliance with study drug|0|||
48479697|NCT02152631|155950625|FG000|Overall Study|Physician Decision|1|||
48479698|NCT02152631|155950626|FG001|Overall Study|Physician Decision|2|||
48479699|NCT02152631|155950625|FG000|Overall Study|Lost to Follow-up|0|||
48479700|NCT02152631|155950626|FG001|Overall Study|Lost to Follow-up|1|||
48479701|NCT02152631|155950625|FG000|Overall Study|On Treatment|19|||
48479702|NCT02152631|155950626|FG001|Overall Study|On Treatment|3|||
48479703|NCT03692078|155950627|FG000|Overall Study|Adverse Event|0|||
48479704|NCT03692078|155950628|FG001|Overall Study|Adverse Event|0|||
48479705|NCT03692078|155950629|FG002|Overall Study|Adverse Event|0|||
48479706|NCT03692078|155950630|FG003|Overall Study|Adverse Event|0|||
48479707|NCT03692078|155950631|FG004|Overall Study|Adverse Event|0|||
48479708|NCT03692078|155950632|FG005|Overall Study|Adverse Event|1|||
48479709|NCT03692078|155950633|FG006|Overall Study|Adverse Event|0|||
48479710|NCT03692078|155950627|FG000|Overall Study|Enrollment Closed|5|||
48479711|NCT03692078|155950628|FG001|Overall Study|Enrollment Closed|0|||
48479712|NCT03692078|155950629|FG002|Overall Study|Enrollment Closed|0|||
48479713|NCT03692078|155950630|FG003|Overall Study|Enrollment Closed|0|||
48479714|NCT03692078|155950631|FG004|Overall Study|Enrollment Closed|0|||
48479715|NCT03692078|155950632|FG005|Overall Study|Enrollment Closed|0|||
48479716|NCT03692078|155950633|FG006|Overall Study|Enrollment Closed|0|||
48479717|NCT03692078|155950627|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
48479718|NCT03692078|155950628|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
48479719|NCT03692078|155950629|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
48479720|NCT03692078|155950630|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
48479721|NCT03692078|155950631|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
48479722|NCT03692078|155950632|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
48479723|NCT03692078|155950633|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
48479724|NCT03692078|155950627|FG000|Overall Study|Withdrawal by Subject|0|||
48479725|NCT03692078|155950628|FG001|Overall Study|Withdrawal by Subject|2|||
48479726|NCT03692078|155950629|FG002|Overall Study|Withdrawal by Subject|0|||
48479727|NCT03692078|155950630|FG003|Overall Study|Withdrawal by Subject|1|||
48479728|NCT03692078|155950631|FG004|Overall Study|Withdrawal by Subject|5|||
48479729|NCT03692078|155950632|FG005|Overall Study|Withdrawal by Subject|3|||
48479730|NCT03692078|155950633|FG006|Overall Study|Withdrawal by Subject|3|||
48479731|NCT00556166|155950636|FG000|Overall Study|Withdrawal by Subject|1|||
48479732|NCT01612780|155950637|FG000|Overall Study|Treatment not completed|1|||
48479733|NCT01612780|155950637|FG000|Overall Study|Withdrawal by Subject|5|||
48479734|NCT04736576|155950640|FG000|Overall Study|Progressive disease|3|||
48479735|NCT04736576|155950641|FG001|Overall Study|Progressive disease|1|||
48479736|NCT04736576|155950640|FG000|Overall Study|Death|1|||
48479737|NCT04736576|155950641|FG001|Overall Study|Death|0|||
48479738|NCT01215955|155950646|FG000|Overall Study|Adverse Event|1|||
48479739|NCT01215955|155950647|FG001|Overall Study|Adverse Event|4|||
48479740|NCT01215955|155950648|FG002|Overall Study|Adverse Event|2|||
48479741|NCT01215955|155950649|FG003|Overall Study|Adverse Event|3|||
48479742|NCT01215955|155950646|FG000|Overall Study|Death|2|||
48479743|NCT01215955|155950647|FG001|Overall Study|Death|0|||
48479744|NCT01215955|155950648|FG002|Overall Study|Death|1|||
48479745|NCT01215955|155950649|FG003|Overall Study|Death|3|||
48479746|NCT01215955|155950646|FG000|Overall Study|Entry Criteria Not Met|1|||
48479747|NCT01215955|155950647|FG001|Overall Study|Entry Criteria Not Met|3|||
48479748|NCT01215955|155950648|FG002|Overall Study|Entry Criteria Not Met|4|||
48479749|NCT01215955|155950649|FG003|Overall Study|Entry Criteria Not Met|7|||
48479750|NCT01215955|155950646|FG000|Overall Study|Lack of Efficacy|1|||
48479751|NCT01215955|155950647|FG001|Overall Study|Lack of Efficacy|2|||
48479752|NCT01215955|155950648|FG002|Overall Study|Lack of Efficacy|1|||
48479753|NCT01215955|155950649|FG003|Overall Study|Lack of Efficacy|0|||
48479754|NCT01215955|155950646|FG000|Overall Study|Lost to Follow-up|4|||
48479755|NCT01215955|155950647|FG001|Overall Study|Lost to Follow-up|4|||
48479756|NCT01215955|155950648|FG002|Overall Study|Lost to Follow-up|8|||
48479757|NCT01215955|155950649|FG003|Overall Study|Lost to Follow-up|9|||
48479758|NCT01215955|155950646|FG000|Overall Study|Physician Decision|4|||
48479759|NCT01215955|155950647|FG001|Overall Study|Physician Decision|10|||
48479760|NCT01215955|155950648|FG002|Overall Study|Physician Decision|8|||
48479761|NCT01215955|155950649|FG003|Overall Study|Physician Decision|11|||
48479762|NCT01215955|155950646|FG000|Overall Study|Protocol Violation|17|||
48479763|NCT01215955|155950647|FG001|Overall Study|Protocol Violation|13|||
48479764|NCT01215955|155950648|FG002|Overall Study|Protocol Violation|8|||
48479765|NCT01215955|155950649|FG003|Overall Study|Protocol Violation|8|||
48479766|NCT01215955|155950646|FG000|Overall Study|Sponsor Decision|1|||
48479767|NCT01215955|155950647|FG001|Overall Study|Sponsor Decision|2|||
48479768|NCT01215955|155950648|FG002|Overall Study|Sponsor Decision|0|||
48479769|NCT01215955|155950649|FG003|Overall Study|Sponsor Decision|1|||
48479770|NCT01215955|155950646|FG000|Overall Study|Withdrawal by Subject|14|||
48479771|NCT01215955|155950647|FG001|Overall Study|Withdrawal by Subject|15|||
48479772|NCT01215955|155950648|FG002|Overall Study|Withdrawal by Subject|13|||
48479773|NCT01215955|155950649|FG003|Overall Study|Withdrawal by Subject|9|||
48479774|NCT01215955|155950646|FG000|Overall Study|Quality Issues|0|||
48479775|NCT01215955|155950647|FG001|Overall Study|Quality Issues|0|||
48479776|NCT01215955|155950648|FG002|Overall Study|Quality Issues|3|||
48479777|NCT01215955|155950649|FG003|Overall Study|Quality Issues|2|||
48479778|NCT00445458|155950650|FG000|Overall Study|Disease Progression|3|||
48479779|NCT00445458|155950651|FG001|Overall Study|Disease Progression|4|||
48479780|NCT00445458|155950652|FG002|Overall Study|Disease Progression|54|||
48479781|NCT00445458|155950653|FG003|Overall Study|Disease Progression|27|||
48479782|NCT00445458|155950650|FG000|Overall Study|Withdrawal by Subject|0|||
48479783|NCT00445458|155950651|FG001|Overall Study|Withdrawal by Subject|0|||
48479784|NCT00445458|155950652|FG002|Overall Study|Withdrawal by Subject|7|||
48479785|NCT00445458|155950653|FG003|Overall Study|Withdrawal by Subject|0|||
48479786|NCT00445458|155950650|FG000|Overall Study|Adverse Event|0|||
48479787|NCT00445458|155950651|FG001|Overall Study|Adverse Event|0|||
48479788|NCT00445458|155950652|FG002|Overall Study|Adverse Event|3|||
48479789|NCT00445458|155950653|FG003|Overall Study|Adverse Event|0|||
48479790|NCT00445458|155950650|FG000|Overall Study|Death|0|||
48479791|NCT00445458|155950651|FG001|Overall Study|Death|1|||
48479792|NCT00445458|155950652|FG002|Overall Study|Death|2|||
48479793|NCT00445458|155950653|FG003|Overall Study|Death|0|||
48479794|NCT00445458|155950650|FG000|Overall Study|Physician Decision|0|||
48479795|NCT00445458|155950651|FG001|Overall Study|Physician Decision|0|||
48479796|NCT00445458|155950652|FG002|Overall Study|Physician Decision|1|||
48479797|NCT00445458|155950653|FG003|Overall Study|Physician Decision|1|||
48479798|NCT00445458|155950650|FG000|Overall Study|Surgery|0|||
48479799|NCT00445458|155950651|FG001|Overall Study|Surgery|0|||
48479800|NCT00445458|155950652|FG002|Overall Study|Surgery|1|||
48479801|NCT00445458|155950653|FG003|Overall Study|Surgery|0|||
48479802|NCT01071083|155950654|FG000|Overall Study|Adverse Event|1|||
48479803|NCT01071083|155950655|FG001|Overall Study|Adverse Event|0|||
48479804|NCT01071083|155950656|FG002|Overall Study|Adverse Event|1|||
48479805|NCT01071083|155950657|FG003|Overall Study|Adverse Event|0|||
48479806|NCT01071083|155950658|FG004|Overall Study|Adverse Event|1|||
48479807|NCT01071083|155950654|FG000|Overall Study|Withdrawal by Subject|3|||
48479808|NCT01071083|155950655|FG001|Overall Study|Withdrawal by Subject|0|||
48479809|NCT01071083|155950656|FG002|Overall Study|Withdrawal by Subject|2|||
48479810|NCT01071083|155950657|FG003|Overall Study|Withdrawal by Subject|0|||
48479811|NCT01071083|155950658|FG004|Overall Study|Withdrawal by Subject|3|||
48479812|NCT01071083|155950654|FG000|Overall Study|Physician Decision|1|||
48479813|NCT01071083|155950655|FG001|Overall Study|Physician Decision|0|||
48479814|NCT01071083|155950656|FG002|Overall Study|Physician Decision|0|||
48479815|NCT01071083|155950657|FG003|Overall Study|Physician Decision|1|||
48479816|NCT01071083|155950658|FG004|Overall Study|Physician Decision|1|||
48479817|NCT01071083|155950654|FG000|Overall Study|Early Rescue|1|||
48479818|NCT01071083|155950655|FG001|Overall Study|Early Rescue|0|||
48479819|NCT01071083|155950656|FG002|Overall Study|Early Rescue|0|||
48479820|NCT01071083|155950657|FG003|Overall Study|Early Rescue|0|||
48479821|NCT01071083|155950658|FG004|Overall Study|Early Rescue|1|||
48479822|NCT01071083|155950654|FG000|Overall Study|Subject Moved|0|||
48479823|NCT01071083|155950655|FG001|Overall Study|Subject Moved|1|||
48479824|NCT01071083|155950656|FG002|Overall Study|Subject Moved|0|||
48479825|NCT01071083|155950657|FG003|Overall Study|Subject Moved|0|||
48479826|NCT01071083|155950658|FG004|Overall Study|Subject Moved|0|||
48479827|NCT01071083|155950654|FG000|Overall Study|Images Not Usable (Motion)|0|||
48479828|NCT01071083|155950655|FG001|Overall Study|Images Not Usable (Motion)|1|||
48479829|NCT01071083|155950656|FG002|Overall Study|Images Not Usable (Motion)|0|||
48479830|NCT01071083|155950657|FG003|Overall Study|Images Not Usable (Motion)|0|||
48479831|NCT01071083|155950658|FG004|Overall Study|Images Not Usable (Motion)|0|||
48479832|NCT01071083|155950654|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
48479833|NCT01071083|155950655|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
48479834|NCT01071083|155950656|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
48479835|NCT01071083|155950657|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
48479836|NCT01071083|155950658|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
48479837|NCT01071083|155950654|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
48479838|NCT01071083|155950655|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
48479839|NCT01071083|155950656|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
48479840|NCT01071083|155950657|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
48479841|NCT01071083|155950658|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
48479842|NCT01071083|155950654|FG000|Overall Study|Subject Refused to Continue|1|||
48479843|NCT01071083|155950655|FG001|Overall Study|Subject Refused to Continue|0|||
48479844|NCT01071083|155950656|FG002|Overall Study|Subject Refused to Continue|0|||
48479845|NCT01071083|155950657|FG003|Overall Study|Subject Refused to Continue|0|||
48479846|NCT01071083|155950658|FG004|Overall Study|Subject Refused to Continue|0|||
48479847|NCT00038467|155950659|FG000|Overall Study|Adverse Event|170|||
48479848|NCT00038467|155950660|FG001|Overall Study|Adverse Event|145|||
48479849|NCT00038467|155950659|FG000|Overall Study|Withdrawal by Subject|150|||
48479850|NCT00038467|155950660|FG001|Overall Study|Withdrawal by Subject|107|||
48479851|NCT00038467|155950659|FG000|Overall Study|Protocol Violation|19|||
48479852|NCT00038467|155950660|FG001|Overall Study|Protocol Violation|22|||
48479853|NCT00038467|155950659|FG000|Overall Study|Death|22|||
48479854|NCT00038467|155950660|FG001|Overall Study|Death|16|||
48479855|NCT00038467|155950659|FG000|Overall Study|Lost to Follow-up|15|||
48479856|NCT00038467|155950660|FG001|Overall Study|Lost to Follow-up|10|||
48479857|NCT00038467|155950659|FG000|Overall Study|Recurrence|109|||
48479858|NCT00038467|155950660|FG001|Overall Study|Recurrence|179|||
48479859|NCT00038467|155950659|FG000|Overall Study|Randomized, but not treated|31|||
48479860|NCT00038467|155950660|FG001|Overall Study|Randomized, but not treated|35|||
48479861|NCT00038467|155950659|FG000|Overall Study|Other|26|||
48479862|NCT00038467|155950660|FG001|Overall Study|Other|28|||
48479863|NCT01988493|155950661|FG000|Overall Study|Randomized but not treated|0|||
48479864|NCT01988493|155950662|FG001|Overall Study|Randomized but not treated|0|||
48479865|NCT01988493|155950663|FG002|Overall Study|Randomized but not treated|0|||
48479866|NCT01988493|155950664|FG003|Overall Study|Randomized but not treated|0|||
48479867|NCT01988493|155950665|FG004|Overall Study|Randomized but not treated|1|||
48479868|NCT00297882|155950666|FG000|Day 14|Lack of Efficacy|12|||
48479869|NCT00297882|155950667|FG001|Day 14|Lack of Efficacy|49|||
48479870|NCT00297882|155950666|FG000|Day 28|Lost to Follow-up|13|||
48479871|NCT00297882|155950667|FG001|Day 28|Lost to Follow-up|23|||
48479872|NCT00297882|155950666|FG000|Day 28|Lack of Efficacy|3|||
48479873|NCT00297882|155950667|FG001|Day 28|Lack of Efficacy|0|||
48479874|NCT00720304|155950668|FG000|Overall Study|Withdrawal by Subject|14|||
48479875|NCT00720304|155950669|FG001|Overall Study|Withdrawal by Subject|1|||
48479876|NCT00720304|155950668|FG000|Overall Study|Death|1|||
48479877|NCT00720304|155950669|FG001|Overall Study|Death|0|||
48479878|NCT00720304|155950668|FG000|Overall Study|Physician Decision|5|||
48479879|NCT00720304|155950669|FG001|Overall Study|Physician Decision|2|||
48479880|NCT00720304|155950668|FG000|Overall Study|Adverse Event|3|||
48479881|NCT00720304|155950669|FG001|Overall Study|Adverse Event|1|||
48479882|NCT00720304|155950668|FG000|Overall Study|Disease progression|6|||
48479883|NCT00720304|155950669|FG001|Overall Study|Disease progression|1|||
48479884|NCT00185731|155950672|FG000|Overall Study|Withdrawal by Subject|1|||
48479885|NCT00185731|155950672|FG000|Overall Study|Not Eligible|1|||
48479886|NCT00996918|155950675|FG000|Overall Study|Lack of Efficacy|1|||
48479887|NCT00996918|155950676|FG001|Overall Study|Lack of Efficacy|1|||
48479888|NCT00996918|155950677|FG002|Overall Study|Lack of Efficacy|2|||
48479889|NCT00996918|155950678|FG003|Overall Study|Lack of Efficacy|2|||
48479890|NCT00996918|155950679|FG004|Overall Study|Lack of Efficacy|0|||
48479891|NCT00996918|155950675|FG000|Overall Study|Adverse Event|2|||
48479892|NCT00996918|155950676|FG001|Overall Study|Adverse Event|5|||
48479893|NCT00996918|155950677|FG002|Overall Study|Adverse Event|2|||
48479894|NCT00996918|155950678|FG003|Overall Study|Adverse Event|6|||
48479895|NCT00996918|155950679|FG004|Overall Study|Adverse Event|0|||
48479896|NCT00996918|155950675|FG000|Overall Study|Withdrawal by Subject|1|||
48479897|NCT00996918|155950676|FG001|Overall Study|Withdrawal by Subject|4|||
48479898|NCT00996918|155950677|FG002|Overall Study|Withdrawal by Subject|3|||
48479899|NCT00996918|155950678|FG003|Overall Study|Withdrawal by Subject|3|||
48479900|NCT00996918|155950679|FG004|Overall Study|Withdrawal by Subject|2|||
48479901|NCT00996918|155950675|FG000|Overall Study|Physician Decision|1|||
48479902|NCT00996918|155950676|FG001|Overall Study|Physician Decision|0|||
48479903|NCT00996918|155950677|FG002|Overall Study|Physician Decision|0|||
48479904|NCT00996918|155950678|FG003|Overall Study|Physician Decision|0|||
48479905|NCT00996918|155950679|FG004|Overall Study|Physician Decision|0|||
48479906|NCT00996918|155950675|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
48479907|NCT00996918|155950676|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
48479908|NCT00996918|155950677|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
48479909|NCT00996918|155950678|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
48479910|NCT00996918|155950679|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
48479911|NCT00996918|155950675|FG000|Overall Study|Loss of Caregiver|0|||
48479912|NCT00996918|155950676|FG001|Overall Study|Loss of Caregiver|1|||
48479913|NCT00996918|155950677|FG002|Overall Study|Loss of Caregiver|0|||
48479914|NCT00996918|155950678|FG003|Overall Study|Loss of Caregiver|0|||
48479915|NCT00996918|155950679|FG004|Overall Study|Loss of Caregiver|0|||
48479916|NCT00996918|155950675|FG000|Overall Study|Other|3|||
48479917|NCT00996918|155950676|FG001|Overall Study|Other|1|||
48479918|NCT00996918|155950677|FG002|Overall Study|Other|0|||
48479919|NCT00996918|155950678|FG003|Overall Study|Other|0|||
48479920|NCT00996918|155950679|FG004|Overall Study|Other|0|||
48479921|NCT02864953|155950682|FG000|Overall Study|Adverse Event|22|||
48479922|NCT02864953|155950683|FG001|Overall Study|Adverse Event|19|||
48479923|NCT02864953|155950682|FG000|Overall Study|Withdrawal by Subject|1|||
48479924|NCT02864953|155950683|FG001|Overall Study|Withdrawal by Subject|0|||
48479925|NCT02864953|155950682|FG000|Overall Study|Physician Decision|4|||
48479926|NCT02864953|155950683|FG001|Overall Study|Physician Decision|2|||
48479927|NCT02864953|155950682|FG000|Overall Study|Death|3|||
48479928|NCT02864953|155950683|FG001|Overall Study|Death|13|||
48479929|NCT02864953|155950682|FG000|Overall Study|Reason not specified|14|||
48479930|NCT02864953|155950683|FG001|Overall Study|Reason not specified|12|||
48479931|NCT02864953|155950682|FG000|Overall Study|Withdrew Prior to Dosing|9|||
48479932|NCT02864953|155950683|FG001|Overall Study|Withdrew Prior to Dosing|8|||
48479933|NCT00981019|155950684|FG000|Overall Study|Did not respond|65|||
48479934|NCT00981019|155950684|FG000|Overall Study|Did not match target population|94|||
48479935|NCT00981019|155950684|FG000|Overall Study|Inadvertent exclusion|239|||
48479936|NCT00981019|155950684|FG000|Overall Study|Hit the survey after closure|79|||
48479937|NCT00902278|155950685|FG000|Overall Study|Physician Decision|1|||
48479938|NCT00902278|155950686|FG001|Overall Study|Physician Decision|0|||
48479939|NCT00902278|155950687|FG002|Overall Study|Physician Decision|2|||
48479940|NCT00902278|155950688|FG003|Overall Study|Physician Decision|0|||
48479941|NCT00902278|155950689|FG004|Overall Study|Physician Decision|1|||
48479942|NCT00902278|155950685|FG000|Overall Study|Lost to Follow-up|3|||
48479943|NCT00902278|155950686|FG001|Overall Study|Lost to Follow-up|2|||
48479944|NCT00902278|155950687|FG002|Overall Study|Lost to Follow-up|3|||
48479945|NCT00902278|155950688|FG003|Overall Study|Lost to Follow-up|0|||
48479946|NCT00902278|155950689|FG004|Overall Study|Lost to Follow-up|1|||
48479947|NCT00960687|155950690|FG000|Washout Period of 7 Days|Adverse Event|3|||
48479948|NCT00960687|155950691|FG001|Washout Period of 7 Days|Adverse Event|2|||
48479949|NCT00960687|155950690|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
48479950|NCT00960687|155950691|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
48479951|NCT00865306|155950692|FG000|Controlled Trial|Lost to Follow-up|1|||
48479952|NCT00865306|155950693|FG001|Controlled Trial|Lost to Follow-up|1|||
48479953|NCT00865306|155950692|FG000|Controlled Trial|Difficulty commuting|2|||
48479954|NCT00865306|155950693|FG001|Controlled Trial|Difficulty commuting|0|||
48479955|NCT00865306|155950692|FG000|Controlled Trial|Improved btw baseline and first session|1|||
48479956|NCT00865306|155950693|FG001|Controlled Trial|Improved btw baseline and first session|0|||
48479957|NCT00865306|155950692|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
48479958|NCT00865306|155950693|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
48479959|NCT00865306|155950692|FG000|Controlled Trial|Withdrawal by Subject|0|||
48479960|NCT00865306|155950693|FG001|Controlled Trial|Withdrawal by Subject|1|||
48479961|NCT04980391|155950704|FG000|Overall Study|Death|0|||
48479962|NCT04980391|155950705|FG001|Overall Study|Death|0|||
48479963|NCT04980391|155950706|FG002|Overall Study|Death|1|||
48479964|NCT04980391|155950707|FG003|Overall Study|Death|1|||
48479965|NCT04980391|155950704|FG000|Overall Study|Lost to Follow-up|3|||
48479966|NCT04980391|155950705|FG001|Overall Study|Lost to Follow-up|3|||
48479967|NCT04980391|155950706|FG002|Overall Study|Lost to Follow-up|2|||
48479968|NCT04980391|155950707|FG003|Overall Study|Lost to Follow-up|3|||
48479969|NCT04980391|155950704|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
48479970|NCT04980391|155950705|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
48479971|NCT04980391|155950706|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
48479972|NCT04980391|155950707|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
48479973|NCT04980391|155950704|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48479974|NCT04980391|155950705|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48479975|NCT04980391|155950706|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
48479976|NCT04980391|155950707|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48479977|NCT04980391|155950704|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
48479978|NCT04980391|155950705|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
48479979|NCT04980391|155950706|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
48479980|NCT04980391|155950707|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
48479981|NCT02842086|155950708|FG000|Overall Study|Randomized but Never Treated|6|||
48479982|NCT02842086|155950709|FG001|Overall Study|Randomized but Never Treated|6|||
48479983|NCT02842086|155950708|FG000|Overall Study|Still in Double-Blind Phase|7|||
48479984|NCT02842086|155950709|FG001|Overall Study|Still in Double-Blind Phase|3|||
48479985|NCT02842086|155950708|FG000|Overall Study|Adverse Event|18|||
48479986|NCT02842086|155950709|FG001|Overall Study|Adverse Event|20|||
48479987|NCT02842086|155950708|FG000|Overall Study|Death|3|||
48479988|NCT02842086|155950709|FG001|Overall Study|Death|3|||
48479989|NCT02842086|155950708|FG000|Overall Study|Investigator's Discretion|9|||
48479990|NCT02842086|155950709|FG001|Overall Study|Investigator's Discretion|13|||
48479991|NCT02842086|155950708|FG000|Overall Study|Non-Compliance with Study Drug|9|||
48479992|NCT02842086|155950709|FG001|Overall Study|Non-Compliance with Study Drug|8|||
48479993|NCT02842086|155950708|FG000|Overall Study|Protocol Violation|8|||
48479994|NCT02842086|155950709|FG001|Overall Study|Protocol Violation|4|||
48479995|NCT02842086|155950708|FG000|Overall Study|Withdrew Consent|205|||
48479996|NCT02842086|155950709|FG001|Overall Study|Withdrew Consent|194|||
48479997|NCT02842086|155950708|FG000|Overall Study|Lost to Follow-up|274|||
48479998|NCT02842086|155950709|FG001|Overall Study|Lost to Follow-up|236|||
48479999|NCT02842086|155950708|FG000|Overall Study|HIV-1 Infection|5|||
48480000|NCT02842086|155950709|FG001|Overall Study|HIV-1 Infection|6|||
48480001|NCT02729545|155952372|FG000|Overall Study|Pregnancy|1|||
48480002|NCT02729545|155952373|FG001|Overall Study|Pregnancy|1|||
48480003|NCT02729545|155952372|FG000|Overall Study|Lost to Follow-up|0|||
48480004|NCT02729545|155952373|FG001|Overall Study|Lost to Follow-up|1|||
48480005|NCT02729545|155952372|FG000|Overall Study|Withdrawal by Subject|2|||
48480006|NCT02729545|155952373|FG001|Overall Study|Withdrawal by Subject|3|||
48480007|NCT03533608|155952375|FG000|Overall Study|Withdrawal by Subject|3|||
48480008|NCT03533608|155952375|FG000|Overall Study|Physician Decision|2|||
48480009|NCT00819091|155952376|FG000|Overall Study|Adverse Event|3|||
48480010|NCT00819091|155952377|FG001|Overall Study|Adverse Event|5|||
48480011|NCT00819091|155952376|FG000|Overall Study|Protocol Violation|0|||
48480012|NCT00819091|155952377|FG001|Overall Study|Protocol Violation|1|||
48480013|NCT00819091|155952376|FG000|Overall Study|Lost to Follow-up|2|||
48480014|NCT00819091|155952377|FG001|Overall Study|Lost to Follow-up|0|||
48480015|NCT00819091|155952376|FG000|Overall Study|Withdrawal by Subject|1|||
48480016|NCT00819091|155952377|FG001|Overall Study|Withdrawal by Subject|2|||
48480017|NCT00819091|155952376|FG000|Overall Study|Other|1|||
48480018|NCT00819091|155952377|FG001|Overall Study|Other|2|||
48480019|NCT03286426|155952379|FG000|Overall Study|Physician Decision|3|||
48480020|NCT02325401|155952384|FG000|Overall Study|Withdrawal by Subject|0|||
48480021|NCT02325401|155952385|FG001|Overall Study|Withdrawal by Subject|1|||
48480022|NCT02325401|155952386|FG002|Overall Study|Withdrawal by Subject|1|||
48480023|NCT01788163|155952387|FG000|Overall Study|Other|53|||
48480024|NCT01788163|155952388|FG001|Overall Study|Other|0|||
48480025|NCT01788163|155952389|FG002|Overall Study|Other|0|||
48480026|NCT01788163|155952390|FG003|Overall Study|Other|0|||
48480027|NCT01788163|155952391|FG004|Overall Study|Other|0|||
48480028|NCT01788163|155952392|FG005|Overall Study|Other|7|||
48480029|NCT01788163|155952393|FG006|Overall Study|Other|1|||
48480030|NCT01788163|155952394|FG007|Overall Study|Other|48|||
48480031|NCT01788163|155952395|FG008|Overall Study|Other|15|||
48480032|NCT01788163|155952387|FG000|Overall Study|Withdrawal by Subject|2|||
48480033|NCT01788163|155952388|FG001|Overall Study|Withdrawal by Subject|0|||
48480034|NCT01788163|155952389|FG002|Overall Study|Withdrawal by Subject|0|||
48480035|NCT01788163|155952390|FG003|Overall Study|Withdrawal by Subject|0|||
48480036|NCT01788163|155952391|FG004|Overall Study|Withdrawal by Subject|0|||
48480037|NCT01788163|155952392|FG005|Overall Study|Withdrawal by Subject|0|||
48480038|NCT01788163|155952393|FG006|Overall Study|Withdrawal by Subject|0|||
48480039|NCT01788163|155952394|FG007|Overall Study|Withdrawal by Subject|0|||
48480040|NCT01788163|155952395|FG008|Overall Study|Withdrawal by Subject|1|||
48480041|NCT00545441|155952396|FG000|Overall Study|Fistula draining at 6 months|2|||
48480042|NCT00545441|155952397|FG001|Overall Study|Fistula draining at 6 months|4|||
48480043|NCT00545441|155952396|FG000|Overall Study|Lost to Follow-up|9|||
48480044|NCT00545441|155952397|FG001|Overall Study|Lost to Follow-up|5|||
48480045|NCT00545441|155952396|FG000|Overall Study|Technical failure|0|||
48480046|NCT00545441|155952397|FG001|Overall Study|Technical failure|1|||
48480047|NCT00545441|155952396|FG000|Overall Study|Withdrawal by Subject|1|||
48480048|NCT00545441|155952397|FG001|Overall Study|Withdrawal by Subject|1|||
48480049|NCT00545441|155952396|FG000|Overall Study|Persistence or recurrence of fistula|5|||
48480050|NCT00545441|155952397|FG001|Overall Study|Persistence or recurrence of fistula|2|||
48480051|NCT00545441|155952396|FG000|Overall Study|Patients were not treated|1|||
48480052|NCT00545441|155952397|FG001|Overall Study|Patients were not treated|3|||
48480053|NCT03526679|155952398|FG000|Overall Study|still under treatment|2|||
48480054|NCT01817764|155952399|FG000|Overall Study|Adverse Event|7|||
48480055|NCT01817764|155952400|FG001|Overall Study|Adverse Event|10|||
48480056|NCT01817764|155952399|FG000|Overall Study|Lack of Efficacy|9|||
48480057|NCT01817764|155952400|FG001|Overall Study|Lack of Efficacy|7|||
48480058|NCT01817764|155952399|FG000|Overall Study|Protocol Violation|7|||
48480059|NCT01817764|155952400|FG001|Overall Study|Protocol Violation|5|||
48480060|NCT01817764|155952399|FG000|Overall Study|Lost to Follow-up|1|||
48480061|NCT01817764|155952400|FG001|Overall Study|Lost to Follow-up|4|||
48480062|NCT01817764|155952399|FG000|Overall Study|Withdrawal by Subject|10|||
48480063|NCT01817764|155952400|FG001|Overall Study|Withdrawal by Subject|12|||
48480064|NCT03514121|155952401|FG000|Overall Study|Withdrawal by Subject|0|||
48480065|NCT03514121|155952402|FG001|Overall Study|Withdrawal by Subject|0|||
48480066|NCT03514121|155952403|FG002|Overall Study|Withdrawal by Subject|0|||
48480067|NCT03514121|155952404|FG003|Overall Study|Withdrawal by Subject|0|||
48480068|NCT03514121|155952405|FG004|Overall Study|Withdrawal by Subject|1|||
48480069|NCT03514121|155952406|FG005|Overall Study|Withdrawal by Subject|2|||
48480070|NCT03514121|155952407|FG006|Overall Study|Withdrawal by Subject|1|||
48480071|NCT03514121|155952408|FG007|Overall Study|Withdrawal by Subject|1|||
48480072|NCT03514121|155952409|FG008|Overall Study|Withdrawal by Subject|7|||
48480073|NCT03514121|155952410|FG009|Overall Study|Withdrawal by Subject|2|||
48480074|NCT03514121|155952401|FG000|Overall Study|Death|0|||
48480075|NCT03514121|155952402|FG001|Overall Study|Death|0|||
48480076|NCT03514121|155952403|FG002|Overall Study|Death|0|||
48480077|NCT03514121|155952404|FG003|Overall Study|Death|0|||
48480078|NCT03514121|155952405|FG004|Overall Study|Death|0|||
48480079|NCT03514121|155952406|FG005|Overall Study|Death|3|||
48480080|NCT03514121|155952407|FG006|Overall Study|Death|2|||
48480081|NCT03514121|155952408|FG007|Overall Study|Death|1|||
48480082|NCT03514121|155952409|FG008|Overall Study|Death|26|||
48480083|NCT03514121|155952410|FG009|Overall Study|Death|3|||
48480084|NCT03514121|155952401|FG000|Overall Study|Lost to Follow-up|0|||
48480085|NCT03514121|155952402|FG001|Overall Study|Lost to Follow-up|0|||
48480086|NCT03514121|155952403|FG002|Overall Study|Lost to Follow-up|1|||
48480087|NCT03514121|155952404|FG003|Overall Study|Lost to Follow-up|0|||
48480088|NCT03514121|155952405|FG004|Overall Study|Lost to Follow-up|0|||
48480089|NCT03514121|155952406|FG005|Overall Study|Lost to Follow-up|0|||
48480090|NCT03514121|155952407|FG006|Overall Study|Lost to Follow-up|0|||
48480091|NCT03514121|155952408|FG007|Overall Study|Lost to Follow-up|0|||
48480092|NCT03514121|155952409|FG008|Overall Study|Lost to Follow-up|1|||
48480093|NCT03514121|155952410|FG009|Overall Study|Lost to Follow-up|0|||
48480094|NCT03514121|155952401|FG000|Overall Study|Adverse Event|0|||
48480095|NCT03514121|155952402|FG001|Overall Study|Adverse Event|0|||
48480096|NCT03514121|155952403|FG002|Overall Study|Adverse Event|0|||
48480097|NCT03514121|155952404|FG003|Overall Study|Adverse Event|0|||
48480098|NCT03514121|155952405|FG004|Overall Study|Adverse Event|0|||
48480099|NCT03514121|155952406|FG005|Overall Study|Adverse Event|0|||
48480100|NCT03514121|155952407|FG006|Overall Study|Adverse Event|1|||
48480101|NCT03514121|155952408|FG007|Overall Study|Adverse Event|0|||
48480102|NCT03514121|155952409|FG008|Overall Study|Adverse Event|0|||
48480103|NCT03514121|155952410|FG009|Overall Study|Adverse Event|0|||
48480104|NCT03514121|155952401|FG000|Overall Study|Other|0|||
48480105|NCT03514121|155952402|FG001|Overall Study|Other|1|||
48480106|NCT03514121|155952403|FG002|Overall Study|Other|1|||
48480107|NCT03514121|155952404|FG003|Overall Study|Other|0|||
48480108|NCT03514121|155952405|FG004|Overall Study|Other|1|||
48480109|NCT03514121|155952406|FG005|Overall Study|Other|2|||
48480110|NCT03514121|155952407|FG006|Overall Study|Other|3|||
48480111|NCT03514121|155952408|FG007|Overall Study|Other|2|||
48480112|NCT03514121|155952409|FG008|Overall Study|Other|7|||
48480113|NCT03514121|155952410|FG009|Overall Study|Other|3|||
48480114|NCT03514121|155952401|FG000|Overall Study|Study termination by Sponsor|0|||
48480115|NCT03514121|155952402|FG001|Overall Study|Study termination by Sponsor|0|||
48480116|NCT03514121|155952403|FG002|Overall Study|Study termination by Sponsor|0|||
48480117|NCT03514121|155952404|FG003|Overall Study|Study termination by Sponsor|0|||
48480118|NCT03514121|155952405|FG004|Overall Study|Study termination by Sponsor|0|||
48480119|NCT03514121|155952406|FG005|Overall Study|Study termination by Sponsor|0|||
48480120|NCT03514121|155952407|FG006|Overall Study|Study termination by Sponsor|0|||
48480121|NCT03514121|155952408|FG007|Overall Study|Study termination by Sponsor|0|||
48480122|NCT03514121|155952409|FG008|Overall Study|Study termination by Sponsor|11|||
48480123|NCT03514121|155952410|FG009|Overall Study|Study termination by Sponsor|3|||
48480124|NCT03514121|155952401|FG000|Overall Study|Investigator decision|0|||
48480125|NCT03514121|155952402|FG001|Overall Study|Investigator decision|0|||
48480126|NCT03514121|155952403|FG002|Overall Study|Investigator decision|0|||
48480127|NCT03514121|155952404|FG003|Overall Study|Investigator decision|0|||
48480128|NCT03514121|155952405|FG004|Overall Study|Investigator decision|0|||
48480129|NCT03514121|155952406|FG005|Overall Study|Investigator decision|0|||
48480130|NCT03514121|155952407|FG006|Overall Study|Investigator decision|0|||
48480131|NCT03514121|155952408|FG007|Overall Study|Investigator decision|0|||
48480132|NCT03514121|155952409|FG008|Overall Study|Investigator decision|1|||
48480133|NCT03514121|155952410|FG009|Overall Study|Investigator decision|0|||
48480134|NCT05553600|155952411|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
48480135|NCT05553600|155952412|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
48480136|NCT05553600|155952413|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
48480137|NCT05553600|155952414|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
48480138|NCT05553600|155952411|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
48480139|NCT05553600|155952412|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
48480140|NCT05553600|155952413|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
48480141|NCT05553600|155952414|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
48480142|NCT05553600|155952411|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
48480143|NCT05553600|155952412|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
48480144|NCT05553600|155952413|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
48480145|NCT05553600|155952414|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
48480146|NCT05553600|155952411|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
48480147|NCT05553600|155952412|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
48480148|NCT05553600|155952413|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
48480149|NCT05553600|155952414|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
48480150|NCT05553600|155952411|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
48480151|NCT05553600|155952412|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
48480152|NCT05553600|155952413|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
48480153|NCT05553600|155952414|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
48480154|NCT05553600|155952411|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
48480155|NCT05553600|155952412|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
48480156|NCT05553600|155952413|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
48480157|NCT05553600|155952414|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
48480158|NCT05553600|155952411|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
48480159|NCT05553600|155952412|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
48480160|NCT05553600|155952413|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
48480161|NCT05553600|155952414|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
48480162|NCT05553600|155952411|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
48480163|NCT05553600|155952412|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
48480164|NCT05553600|155952413|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
48480165|NCT05553600|155952414|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
48480166|NCT05553600|155952411|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
48480167|NCT05553600|155952412|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
48480168|NCT05553600|155952413|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
48480169|NCT05553600|155952414|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
48480170|NCT05553600|155952411|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
48480171|NCT05553600|155952412|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
48480172|NCT05553600|155952413|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
48480173|NCT05553600|155952414|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
48480174|NCT05553600|155952411|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
48480175|NCT05553600|155952412|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
48480176|NCT05553600|155952413|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
48480177|NCT05553600|155952414|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
48480178|NCT05553600|155952411|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
48480179|NCT05553600|155952412|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
48480180|NCT05553600|155952413|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
48480181|NCT05553600|155952414|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
48480182|NCT00833976|155952415|FG000|Overall Study|Withdrawal by Subject|5|||
48480183|NCT00833976|155952415|FG000|Overall Study|Lost to Follow-up|4|||
48480184|NCT00833976|155952415|FG000|Overall Study|Did not meet eligibility criteria|41|||
48480185|NCT00833976|155952415|FG000|Overall Study|Physician Decision|1|||
48480186|NCT03911960|155952416|FG000|Overall Study|Lost to Follow-up|5|||
48480187|NCT03911960|155952417|FG001|Overall Study|Lost to Follow-up|3|||
48480188|NCT01956123|155952418|FG000|COS Cycle 2|Protocol Violation|8|||
48480189|NCT01956123|155952419|FG001|COS Cycle 2|Protocol Violation|3|||
48480190|NCT01956123|155952420|FG002|COS Cycle 2|Protocol Violation|0|||
48480191|NCT01956123|155952421|FG003|COS Cycle 2|Protocol Violation|0|||
48480192|NCT01956123|155952418|FG000|COS Cycle 2|Adverse Event|3|||
48480193|NCT01956123|155952419|FG001|COS Cycle 2|Adverse Event|4|||
48480194|NCT01956123|155952420|FG002|COS Cycle 2|Adverse Event|0|||
48480195|NCT01956123|155952421|FG003|COS Cycle 2|Adverse Event|0|||
48480196|NCT01956123|155952418|FG000|COS Cycle 2|Personal Reasons|2|||
48480197|NCT01956123|155952419|FG001|COS Cycle 2|Personal Reasons|0|||
48480198|NCT01956123|155952420|FG002|COS Cycle 2|Personal Reasons|0|||
48480199|NCT01956123|155952421|FG003|COS Cycle 2|Personal Reasons|0|||
48480200|NCT01956123|155952418|FG000|COS Cycle 2|Withdrawal by Subject|1|||
48480201|NCT01956123|155952419|FG001|COS Cycle 2|Withdrawal by Subject|0|||
48480202|NCT01956123|155952420|FG002|COS Cycle 2|Withdrawal by Subject|0|||
48480203|NCT01956123|155952421|FG003|COS Cycle 2|Withdrawal by Subject|0|||
48480204|NCT01956123|155952418|FG000|COS Cycle 3|Protocol Violation|0|||
48480205|NCT01956123|155952419|FG001|COS Cycle 3|Protocol Violation|0|||
48480206|NCT01956123|155952420|FG002|COS Cycle 3|Protocol Violation|2|||
48480207|NCT01956123|155952421|FG003|COS Cycle 3|Protocol Violation|1|||
48480208|NCT01956123|155952418|FG000|COS Cycle 3|Adverse Event|0|||
48480209|NCT01956123|155952419|FG001|COS Cycle 3|Adverse Event|0|||
48480210|NCT01956123|155952420|FG002|COS Cycle 3|Adverse Event|3|||
48480211|NCT01956123|155952421|FG003|COS Cycle 3|Adverse Event|0|||
48480212|NCT01956123|155952418|FG000|COS Cycle 3|Personal Reasons|0|||
48480213|NCT01956123|155952419|FG001|COS Cycle 3|Personal Reasons|0|||
48480214|NCT01956123|155952420|FG002|COS Cycle 3|Personal Reasons|1|||
48480215|NCT01956123|155952421|FG003|COS Cycle 3|Personal Reasons|0|||
48480216|NCT01956123|155952418|FG000|COS Cycle 3|Withdrawal by Subject|0|||
48480217|NCT01956123|155952419|FG001|COS Cycle 3|Withdrawal by Subject|0|||
48480218|NCT01956123|155952420|FG002|COS Cycle 3|Withdrawal by Subject|0|||
48480219|NCT01956123|155952421|FG003|COS Cycle 3|Withdrawal by Subject|1|||
48480220|NCT00791154|155952422|FG000|Overall Study|Noncompliance|0|||
48480221|NCT00791154|155952423|FG001|Overall Study|Noncompliance|1|||
48480222|NCT00791154|155952424|FG002|Overall Study|Noncompliance|0|||
48480223|NCT00791154|155952425|FG003|Overall Study|Noncompliance|0|||
48480224|NCT00791154|155952426|FG004|Overall Study|Noncompliance|1|||
48480225|NCT00791154|155952427|FG005|Overall Study|Noncompliance|1|||
48480226|NCT00791154|155952428|FG006|Overall Study|Noncompliance|1|||
48480227|NCT00791154|155952422|FG000|Overall Study|Adverse Event|0|||
48480228|NCT00791154|155952423|FG001|Overall Study|Adverse Event|0|||
48480229|NCT00791154|155952424|FG002|Overall Study|Adverse Event|0|||
48480230|NCT00791154|155952425|FG003|Overall Study|Adverse Event|0|||
48480231|NCT00791154|155952426|FG004|Overall Study|Adverse Event|2|||
48480232|NCT00791154|155952427|FG005|Overall Study|Adverse Event|0|||
48480233|NCT00791154|155952428|FG006|Overall Study|Adverse Event|1|||
48480234|NCT00791154|155952422|FG000|Overall Study|Full Consent withdrawn|1|||
48480235|NCT00791154|155952423|FG001|Overall Study|Full Consent withdrawn|3|||
48480236|NCT00791154|155952424|FG002|Overall Study|Full Consent withdrawn|0|||
48480237|NCT00791154|155952425|FG003|Overall Study|Full Consent withdrawn|0|||
48480238|NCT00791154|155952426|FG004|Overall Study|Full Consent withdrawn|1|||
48480239|NCT00791154|155952427|FG005|Overall Study|Full Consent withdrawn|3|||
48480240|NCT00791154|155952428|FG006|Overall Study|Full Consent withdrawn|1|||
48480241|NCT00791154|155952422|FG000|Overall Study|Lost to Follow-up|0|||
48480242|NCT00791154|155952423|FG001|Overall Study|Lost to Follow-up|0|||
48480243|NCT00791154|155952424|FG002|Overall Study|Lost to Follow-up|0|||
48480244|NCT00791154|155952425|FG003|Overall Study|Lost to Follow-up|1|||
48480245|NCT00791154|155952426|FG004|Overall Study|Lost to Follow-up|2|||
48480246|NCT00791154|155952427|FG005|Overall Study|Lost to Follow-up|0|||
48480247|NCT00791154|155952428|FG006|Overall Study|Lost to Follow-up|4|||
48480248|NCT00791154|155952422|FG000|Overall Study|Death|5|||
48480249|NCT00791154|155952423|FG001|Overall Study|Death|4|||
48480250|NCT00791154|155952424|FG002|Overall Study|Death|4|||
48480251|NCT00791154|155952425|FG003|Overall Study|Death|7|||
48480252|NCT00791154|155952426|FG004|Overall Study|Death|54|||
48480253|NCT00791154|155952427|FG005|Overall Study|Death|54|||
48480254|NCT00791154|155952428|FG006|Overall Study|Death|52|||
48480255|NCT00791154|155952422|FG000|Overall Study|Other event|0|||
48480256|NCT00791154|155952423|FG001|Overall Study|Other event|0|||
48480257|NCT00791154|155952424|FG002|Overall Study|Other event|2|||
48480258|NCT00791154|155952425|FG003|Overall Study|Other event|0|||
48480259|NCT00791154|155952426|FG004|Overall Study|Other event|2|||
48480260|NCT00791154|155952427|FG005|Overall Study|Other event|4|||
48480261|NCT00791154|155952428|FG006|Overall Study|Other event|2|||
48480262|NCT01268683|155952429|FG000|Overall Study|Lost to Follow-up|1|||
48480263|NCT01268683|155952429|FG000|Overall Study|Death|1|||
48480264|NCT05981365|155952432|FG000|Period 1|Adverse Event|1|||
48480265|NCT05981365|155952433|FG001|Period 1|Adverse Event|0|||
48480266|NCT03425331|155952434|FG000|Overall Study|Withdrawal by Subject|1|||
48480267|NCT03425331|155952434|FG000|Overall Study|Death|1|||
48480268|NCT03425331|155952434|FG000|Overall Study|Adverse Event|1|||
48480269|NCT03425331|155952434|FG000|Overall Study|Disease Progression|2|||
48480270|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
48480271|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
48480272|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
48480273|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
48480274|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
48480275|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
48480276|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
48480277|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
48480278|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
48480279|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
48480280|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
48480281|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
48480282|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
48480283|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
48480284|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
48480285|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
48480286|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
48480287|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
48480288|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
48480289|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
48480290|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
48480291|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
48480292|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
48480293|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
48480294|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
48480295|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
48480296|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
48480297|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
48480298|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
48480299|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
48480300|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
48480301|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
48480302|NCT03747939|155952435|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
48480303|NCT03747939|155952436|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
48480304|NCT03747939|155952437|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
48480305|NCT03747939|155952438|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
48480306|NCT03747939|155952435|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
48480307|NCT03747939|155952436|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
48480308|NCT03747939|155952437|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
48480309|NCT03747939|155952438|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
48480310|NCT03747939|155952435|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
48480311|NCT03747939|155952436|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
48480312|NCT03747939|155952437|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
48480313|NCT03747939|155952438|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
48480314|NCT03747939|155952435|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
48480315|NCT03747939|155952436|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
48480316|NCT03747939|155952437|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
48480317|NCT03747939|155952438|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
48480318|NCT03747939|155952435|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
48480319|NCT03747939|155952436|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
48480320|NCT03747939|155952437|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
48480321|NCT03747939|155952438|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
48480322|NCT03747939|155952435|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
48480323|NCT03747939|155952436|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
48480324|NCT03747939|155952437|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
48480325|NCT03747939|155952438|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
48480326|NCT01850108|155952442|FG000|Overall Study|Lost to Follow-up|4|||
48480327|NCT01850108|155952442|FG000|Overall Study|Not eligible|1|||
48480328|NCT01850108|155952442|FG000|Overall Study|Failed engraftment|2|||
48480329|NCT01850108|155952442|FG000|Overall Study|Physician Decision|1|||
48480330|NCT01523301|155952443|FG000|Overall Study|Adverse Event|25|||
48480331|NCT01523301|155952444|FG001|Overall Study|Adverse Event|16|||
48480332|NCT01523301|155952443|FG000|Overall Study|Lack of Efficacy|0|||
48480333|NCT01523301|155952444|FG001|Overall Study|Lack of Efficacy|2|||
48480334|NCT01523301|155952443|FG000|Overall Study|Protocol Violation|3|||
48480335|NCT01523301|155952444|FG001|Overall Study|Protocol Violation|4|||
48480336|NCT01523301|155952443|FG000|Overall Study|Lost to Follow-up|1|||
48480337|NCT01523301|155952444|FG001|Overall Study|Lost to Follow-up|0|||
48480338|NCT01523301|155952443|FG000|Overall Study|Withdrawal by Subject|6|||
48480339|NCT01523301|155952444|FG001|Overall Study|Withdrawal by Subject|8|||
48480340|NCT01523301|155952443|FG000|Overall Study|Other Reason|0|||
48480341|NCT01523301|155952444|FG001|Overall Study|Other Reason|2|||
48480342|NCT01447628|155952451|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
48480343|NCT01447628|155952452|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
48480344|NCT01447628|155952453|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
48480345|NCT01447628|155952454|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
48480346|NCT03087773|155952455|FG000|Overall Study|Withdrawal by Subject|8|||
48480347|NCT03087773|155952456|FG001|Overall Study|Withdrawal by Subject|4|||
48480348|NCT03087773|155952455|FG000|Overall Study|Lost to Follow-up|12|||
48480349|NCT03087773|155952456|FG001|Overall Study|Lost to Follow-up|8|||
48480350|NCT04330482|155952457|FG000|Overall Study|Lost to Follow-up|2|||
48480351|NCT04330482|155952458|FG001|Overall Study|Lost to Follow-up|1|||
48480352|NCT04330482|155952457|FG000|Overall Study|Withdrawal by Subject|0|||
48480353|NCT04330482|155952458|FG001|Overall Study|Withdrawal by Subject|3|||
48480354|NCT05180630|155952459|FG000|First Intervention|Physician Decision|0|||
48480355|NCT05180630|155952460|FG001|First Intervention|Physician Decision|0|||
48480356|NCT05180630|155952461|FG002|First Intervention|Physician Decision|3|||
48480357|NCT00402779|155952463|FG000|Overall Study|Screen Failure|77|||
48480358|NCT00402779|155952464|FG001|Overall Study|Screen Failure|76|||
48480359|NCT02494583|155952465|FG000|Overall Study|Death|224|||
48480360|NCT02494583|155952466|FG001|Overall Study|Death|214|||
48480361|NCT02494583|155952467|FG002|Overall Study|Death|225|||
48480362|NCT02494583|155952465|FG000|Overall Study|Lost to Follow-up|1|||
48480363|NCT02494583|155952466|FG001|Overall Study|Lost to Follow-up|0|||
48480364|NCT02494583|155952467|FG002|Overall Study|Lost to Follow-up|0|||
48480365|NCT02494583|155952465|FG000|Overall Study|Protocol Violation|1|||
48480366|NCT02494583|155952466|FG001|Overall Study|Protocol Violation|2|||
48480367|NCT02494583|155952467|FG002|Overall Study|Protocol Violation|0|||
48480368|NCT02494583|155952465|FG000|Overall Study|Screen Failure|0|||
48480369|NCT02494583|155952466|FG001|Overall Study|Screen Failure|1|||
48480370|NCT02494583|155952467|FG002|Overall Study|Screen Failure|0|||
48480371|NCT02494583|155952465|FG000|Overall Study|Transferred to Extension Study|15|||
48480372|NCT02494583|155952466|FG001|Overall Study|Transferred to Extension Study|15|||
48480373|NCT02494583|155952467|FG002|Overall Study|Transferred to Extension Study|6|||
48480374|NCT02494583|155952465|FG000|Overall Study|Did Not Continue on Extension Study|8|||
48480375|NCT02494583|155952466|FG001|Overall Study|Did Not Continue on Extension Study|10|||
48480376|NCT02494583|155952467|FG002|Overall Study|Did Not Continue on Extension Study|4|||
48480377|NCT02494583|155952465|FG000|Overall Study|Withdrawal by Subject|7|||
48480378|NCT02494583|155952466|FG001|Overall Study|Withdrawal by Subject|15|||
48480379|NCT02494583|155952467|FG002|Overall Study|Withdrawal by Subject|15|||
48480380|NCT02362646|155952468|FG000|Overall Study|Death|15|||
48480381|NCT02362646|155952469|FG001|Overall Study|Death|8|||
48480382|NCT02362646|155952468|FG000|Overall Study|Withdrawal by Subject|2|||
48480383|NCT02362646|155952469|FG001|Overall Study|Withdrawal by Subject|2|||
48480384|NCT02362646|155952468|FG000|Overall Study|received transplant|21|||
48480385|NCT02362646|155952469|FG001|Overall Study|received transplant|14|||
48480386|NCT05083559|155952472|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
48480387|NCT05083559|155952473|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
48480388|NCT05083559|155952472|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
48480389|NCT05083559|155952473|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
48480390|NCT05083559|155952472|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
48480391|NCT05083559|155952473|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
48480392|NCT03454672|155952474|FG000|Overall Study|Adverse Event|1|||
48480393|NCT03454672|155952475|FG001|Overall Study|Adverse Event|1|||
48480394|NCT03454672|155952474|FG000|Overall Study|Lost to Follow-up|1|||
48480395|NCT03454672|155952475|FG001|Overall Study|Lost to Follow-up|3|||
48480396|NCT03454672|155952474|FG000|Overall Study|painful|1|||
48480397|NCT03454672|155952475|FG001|Overall Study|painful|2|||
48480398|NCT03454672|155952474|FG000|Overall Study|Non-compliance|2|||
48480399|NCT03454672|155952475|FG001|Overall Study|Non-compliance|4|||
48480400|NCT03454672|155952474|FG000|Overall Study|personal reasons|3|||
48480401|NCT03454672|155952475|FG001|Overall Study|personal reasons|2|||
48480402|NCT03454672|155952474|FG000|Overall Study|Withdrawal by Subject|1|||
48480403|NCT03454672|155952475|FG001|Overall Study|Withdrawal by Subject|0|||
48480404|NCT02720094|155952476|FG000|Overall Study|Scheduled exit visit/end of study|2|||
48480405|NCT02720094|155952477|FG001|Overall Study|Scheduled exit visit/end of study|1|||
48480406|NCT02720094|155952476|FG000|Overall Study|Death|4|||
48480407|NCT02720094|155952477|FG001|Overall Study|Death|7|||
48480408|NCT02720094|155952476|FG000|Overall Study|Withdrawal by Subject|55|||
48480409|NCT02720094|155952477|FG001|Overall Study|Withdrawal by Subject|56|||
48480410|NCT02720094|155952476|FG000|Overall Study|Lost to Follow-up|2|||
48480411|NCT02720094|155952477|FG001|Overall Study|Lost to Follow-up|7|||
48480412|NCT02720094|155952476|FG000|Overall Study|Physician Decision|1|||
48480413|NCT02720094|155952477|FG001|Overall Study|Physician Decision|3|||
48480414|NCT02720094|155952476|FG000|Overall Study|Inappropriate enrollment|1|||
48480415|NCT02720094|155952477|FG001|Overall Study|Inappropriate enrollment|3|||
48480416|NCT02720094|155952476|FG000|Overall Study|Ongoing|2210|||
48480417|NCT02720094|155952477|FG001|Overall Study|Ongoing|2203|||
48480418|NCT02720094|155952476|FG000|Overall Study|Relocation|1|||
48480419|NCT02720094|155952477|FG001|Overall Study|Relocation|1|||
48480420|NCT03151226|155952478|FG000|Overall Study|Withdrawal by Subject|2|||
48480421|NCT03151226|155952478|FG000|Overall Study|not wear device correctly|1|||
48480422|NCT03330847|155952479|FG000|Overall Study|Patients ongoing study|62|||
48480423|NCT03330847|155952480|FG001|Overall Study|Patients ongoing study|65|||
48480424|NCT03330847|155952481|FG002|Overall Study|Patients ongoing study|15|||
48480425|NCT04969263|155952482|FG000|Overall Study|Death|1|||
48480426|NCT04969263|155952482|FG000|Overall Study|Lost to Follow-up|2|||
48480427|NCT04969263|155952482|FG000|Overall Study|Withdrawal by Subject|5|||
48480428|NCT04969263|155952482|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
48480429|NCT00928135|155952483|FG000|Overall Study|Withdrawal by Subject|1|||
48480430|NCT00928135|155952484|FG001|Overall Study|Withdrawal by Subject|0|||
48480431|NCT02200614|155952485|FG000|Double Blind Treatment|Adverse Event|86|||
48480432|NCT02200614|155952486|FG001|Double Blind Treatment|Adverse Event|48|||
48480433|NCT02200614|155952485|FG000|Double Blind Treatment|Confirmed metastasis|120|||
48480434|NCT02200614|155952486|FG001|Double Blind Treatment|Confirmed metastasis|140|||
48480435|NCT02200614|155952485|FG000|Double Blind Treatment|Judgment of the investigator|59|||
48480436|NCT02200614|155952486|FG001|Double Blind Treatment|Judgment of the investigator|99|||
48480437|NCT02200614|155952485|FG000|Double Blind Treatment|Metastasis by local reading|1|||
48480438|NCT02200614|155952486|FG001|Double Blind Treatment|Metastasis by local reading|3|||
48480439|NCT02200614|155952485|FG000|Double Blind Treatment|Other reason|6|||
48480440|NCT02200614|155952486|FG001|Double Blind Treatment|Other reason|2|||
48480441|NCT02200614|155952485|FG000|Double Blind Treatment|Personal reason|77|||
48480442|NCT02200614|155952486|FG001|Double Blind Treatment|Personal reason|85|||
48480443|NCT02200614|155952485|FG000|Double Blind Treatment|Protocol deviation|14|||
48480444|NCT02200614|155952486|FG001|Double Blind Treatment|Protocol deviation|7|||
48480445|NCT02200614|155952485|FG000|Double Blind Treatment|Not treated|1|||
48480446|NCT02200614|155952486|FG001|Double Blind Treatment|Not treated|0|||
48480447|NCT02200614|155952485|FG000|Open Label|Adverse Event|41|||
48480448|NCT02200614|155952486|FG001|Open Label|Adverse Event|11|||
48480449|NCT02200614|155952485|FG000|Open Label|Confirmed metastasis|1|||
48480450|NCT02200614|155952486|FG001|Open Label|Confirmed metastasis|0|||
48480451|NCT02200614|155952485|FG000|Open Label|Judgment of the investigator|29|||
48480452|NCT02200614|155952486|FG001|Open Label|Judgment of the investigator|2|||
48480453|NCT02200614|155952485|FG000|Open Label|Metastasis by local reading|138|||
48480454|NCT02200614|155952486|FG001|Open Label|Metastasis by local reading|27|||
48480455|NCT02200614|155952485|FG000|Open Label|Other reason|22|||
48480456|NCT02200614|155952486|FG001|Open Label|Other reason|4|||
48480457|NCT02200614|155952485|FG000|Open Label|Personal reason|60|||
48480458|NCT02200614|155952486|FG001|Open Label|Personal reason|8|||
48480459|NCT02200614|155952485|FG000|Open Label|Protocol deviation|3|||
48480460|NCT02200614|155952486|FG001|Open Label|Protocol deviation|2|||
48480461|NCT02200614|155952485|FG000|Open Label|Missing|2|||
48480462|NCT02200614|155952486|FG001|Open Label|Missing|2|||
48480463|NCT00005879|155952487|FG000|Overall Study|Withdrawal by Subject|8|||
48480464|NCT00005879|155952488|FG001|Overall Study|Withdrawal by Subject|10|||
48480465|NCT00689273|155952489|FG000|Overall Study|Adverse Event|3|||
48480466|NCT00689273|155952490|FG001|Overall Study|Adverse Event|1|||
48480467|NCT00689273|155952489|FG000|Overall Study|Lack of Efficacy|3|||
48480468|NCT00689273|155952490|FG001|Overall Study|Lack of Efficacy|0|||
48480469|NCT00689273|155952489|FG000|Overall Study|Lost to Follow-up|0|||
48480470|NCT00689273|155952490|FG001|Overall Study|Lost to Follow-up|2|||
48480471|NCT00689273|155952489|FG000|Overall Study|Other|6|||
48480472|NCT00689273|155952490|FG001|Overall Study|Other|2|||
48480473|NCT00689273|155952489|FG000|Overall Study|Randomized but not Treated|1|||
48480474|NCT00689273|155952490|FG001|Overall Study|Randomized but not Treated|0|||
48480475|NCT02531698|155952493|FG000|Overall Study|Adverse Event|2|||
48480476|NCT02531698|155952494|FG001|Overall Study|Adverse Event|1|||
48480477|NCT02531698|155952493|FG000|Overall Study|Withdrawal by Subject|6|||
48480478|NCT02531698|155952494|FG001|Overall Study|Withdrawal by Subject|1|||
48480479|NCT02531698|155952493|FG000|Overall Study|Protocol Violation|2|||
48480480|NCT02531698|155952494|FG001|Overall Study|Protocol Violation|0|||
48480481|NCT02531698|155952493|FG000|Overall Study|Lost to Follow-up|1|||
48480482|NCT02531698|155952494|FG001|Overall Study|Lost to Follow-up|0|||
48480483|NCT00701558|155952495|FG000|Overall Study|Death|7|||
48480484|NCT00701558|155952495|FG000|Overall Study|Lost to Follow-up|8|||
48480485|NCT02367781|155952496|FG000|Overall Study|Withdrawal by Subject|20|||
48480486|NCT02367781|155952497|FG001|Overall Study|Withdrawal by Subject|13|||
48480487|NCT02367781|155952496|FG000|Overall Study|Protocol Violation|0|||
48480488|NCT02367781|155952497|FG001|Overall Study|Protocol Violation|1|||
48480489|NCT02367781|155952496|FG000|Overall Study|Physician Decision|7|||
48480490|NCT02367781|155952497|FG001|Overall Study|Physician Decision|0|||
48480491|NCT02367781|155952496|FG000|Overall Study|Randomized in Error|5|||
48480492|NCT02367781|155952497|FG001|Overall Study|Randomized in Error|4|||
48480493|NCT02367781|155952496|FG000|Overall Study|Non-Compliance|1|||
48480494|NCT02367781|155952497|FG001|Overall Study|Non-Compliance|0|||
48480495|NCT02367781|155952496|FG000|Overall Study|Lost to Follow-up|1|||
48480496|NCT02367781|155952497|FG001|Overall Study|Lost to Follow-up|2|||
48480497|NCT02367781|155952496|FG000|Overall Study|Death|330|||
48480498|NCT02367781|155952497|FG001|Overall Study|Death|176|||
48480499|NCT02367781|155952496|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
48480500|NCT02367781|155952497|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
48480501|NCT02367781|155952496|FG000|Overall Study|Prolonged Hospitalization|1|||
48480502|NCT02367781|155952497|FG001|Overall Study|Prolonged Hospitalization|0|||
48480503|NCT02367781|155952496|FG000|Overall Study|Death Prior First Dose|1|||
48480504|NCT02367781|155952497|FG001|Overall Study|Death Prior First Dose|0|||
48480505|NCT02367781|155952496|FG000|Overall Study|Administrative-Change Facility|1|||
48480506|NCT02367781|155952497|FG001|Overall Study|Administrative-Change Facility|0|||
48480507|NCT02367781|155952496|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
48480508|NCT02367781|155952497|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
48480509|NCT02367781|155952496|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
48480510|NCT02367781|155952497|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
48480511|NCT02367781|155952496|FG000|Overall Study|Study Terminated by Sponsor|3|||
48480512|NCT02367781|155952497|FG001|Overall Study|Study Terminated by Sponsor|1|||
48480513|NCT02367781|155952496|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
48480514|NCT02367781|155952497|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
48480515|NCT02367781|155952496|FG000|Overall Study|Sponsor Decision|2|||
48480516|NCT02367781|155952497|FG001|Overall Study|Sponsor Decision|0|||
48480517|NCT02367781|155952496|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
48480518|NCT02367781|155952497|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
48480519|NCT00391092|155953475|FG000|Overall Study|Death|78|||
48480520|NCT00391092|155953476|FG001|Overall Study|Death|81|||
48480521|NCT00391092|155953475|FG000|Overall Study|Lost to Follow-up|13|||
48480522|NCT00391092|155953476|FG001|Overall Study|Lost to Follow-up|18|||
48480523|NCT00391092|155953475|FG000|Overall Study|Alive on treatment|29|||
48480524|NCT00391092|155953476|FG001|Overall Study|Alive on treatment|33|||
48480525|NCT00391092|155953475|FG000|Overall Study|Alive in follow-up|88|||
48480526|NCT00391092|155953476|FG001|Overall Study|Alive in follow-up|84|||
48480527|NCT03443973|155953477|FG000|Double-blind Treatment Period|Adverse Event|5|||
48480528|NCT03443973|155953478|FG001|Double-blind Treatment Period|Adverse Event|19|||
48480529|NCT03443973|155953479|FG002|Double-blind Treatment Period|Adverse Event|0|||
48480530|NCT03443973|155953480|FG003|Double-blind Treatment Period|Adverse Event|0|||
48480531|NCT03443973|155953477|FG000|Double-blind Treatment Period|Death|5|||
48480532|NCT03443973|155953478|FG001|Double-blind Treatment Period|Death|7|||
48480533|NCT03443973|155953479|FG002|Double-blind Treatment Period|Death|0|||
48480534|NCT03443973|155953480|FG003|Double-blind Treatment Period|Death|0|||
48480535|NCT03443973|155953477|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
48480536|NCT03443973|155953478|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
48480537|NCT03443973|155953479|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
48480538|NCT03443973|155953480|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
48480539|NCT03443973|155953477|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
48480540|NCT03443973|155953478|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
48480541|NCT03443973|155953479|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
48480542|NCT03443973|155953480|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
48480543|NCT03443973|155953477|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
48480544|NCT03443973|155953478|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
48480545|NCT03443973|155953479|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
48480546|NCT03443973|155953480|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
48480547|NCT03443973|155953477|FG000|Double-blind Treatment Period|Physician Decision|5|||
48480548|NCT03443973|155953478|FG001|Double-blind Treatment Period|Physician Decision|6|||
48480549|NCT03443973|155953479|FG002|Double-blind Treatment Period|Physician Decision|0|||
48480550|NCT03443973|155953480|FG003|Double-blind Treatment Period|Physician Decision|0|||
48480551|NCT03443973|155953477|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
48480552|NCT03443973|155953478|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
48480553|NCT03443973|155953479|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
48480554|NCT03443973|155953480|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
48480555|NCT03443973|155953477|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
48480556|NCT03443973|155953478|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
48480557|NCT03443973|155953479|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
48480558|NCT03443973|155953480|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
48480559|NCT03443973|155953477|FG000|Open-label Extension Period|Reason Not Specified|0|||
48480560|NCT03443973|155953478|FG001|Open-label Extension Period|Reason Not Specified|0|||
48480561|NCT03443973|155953479|FG002|Open-label Extension Period|Reason Not Specified|3|||
48480562|NCT03443973|155953480|FG003|Open-label Extension Period|Reason Not Specified|0|||
48480563|NCT03443973|155953477|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
48480564|NCT03443973|155953478|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
48480565|NCT03443973|155953479|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
48480566|NCT03443973|155953480|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
48480567|NCT00265239|155953481|FG000|Overall Study|Adverse Event|2|||
48480568|NCT00265239|155953482|FG001|Overall Study|Adverse Event|1|||
48480569|NCT04930536|155953485|FG000|Overall Study|Adverse Event|1|||
48480570|NCT04930536|155953486|FG001|Overall Study|Adverse Event|0|||
48480571|NCT04930536|155953485|FG000|Overall Study|Disease Progression|2|||
48480572|NCT04930536|155953486|FG001|Overall Study|Disease Progression|0|||
48480573|NCT04930536|155953485|FG000|Overall Study|Patient Decision|4|||
48480574|NCT04930536|155953486|FG001|Overall Study|Patient Decision|2|||
48480575|NCT04930536|155953485|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
48480576|NCT04930536|155953486|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
48480577|NCT02803138|155953489|FG000|Overall Study|Failure to return|38|||
48480578|NCT02803138|155953489|FG000|Overall Study|Insufficient virological response|2|||
48480579|NCT02803138|155953489|FG000|Overall Study|Withdrawn consent|1|||
48480580|NCT02803138|155953489|FG000|Overall Study|Death|1|||
48480581|NCT02803138|155953489|FG000|Overall Study|Other, not specified|28|||
48480582|NCT01432600|155953490|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
48480583|NCT01432600|155953491|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
48480584|NCT01432600|155953492|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
48480585|NCT00398632|155953493|FG000|Overall Study|Withdrawal by Subject|1|||
48480586|NCT00398632|155953493|FG000|Overall Study|Lack of Efficacy|1|||
48480587|NCT00424515|155953494|FG000|Overall Study|Progressive Disease|10|||
48480588|NCT00424515|155953495|FG001|Overall Study|Progressive Disease|11|||
48480589|NCT00424515|155953494|FG000|Overall Study|Adverse Event|0|||
48480590|NCT00424515|155953495|FG001|Overall Study|Adverse Event|1|||
48480591|NCT00424515|155953494|FG000|Overall Study|Intercurrent Illness|0|||
48480592|NCT00424515|155953495|FG001|Overall Study|Intercurrent Illness|1|||
48480593|NCT00424515|155953494|FG000|Overall Study|Withdrawal by Subject|1|||
48480594|NCT00424515|155953495|FG001|Overall Study|Withdrawal by Subject|0|||
48480595|NCT03725722|155953496|FG000|Overall Study|Lack of Efficacy|2|||
48480596|NCT03725722|155953497|FG001|Overall Study|Lack of Efficacy|1|||
48480597|NCT03725722|155953498|FG002|Overall Study|Lack of Efficacy|2|||
48480598|NCT03725722|155953499|FG003|Overall Study|Lack of Efficacy|0|||
48480599|NCT03725722|155953500|FG004|Overall Study|Lack of Efficacy|2|||
48480600|NCT03725722|155953496|FG000|Overall Study|Adverse Event|2|||
48480601|NCT03725722|155953497|FG001|Overall Study|Adverse Event|2|||
48480602|NCT03725722|155953498|FG002|Overall Study|Adverse Event|1|||
48480603|NCT03725722|155953499|FG003|Overall Study|Adverse Event|0|||
48480604|NCT03725722|155953500|FG004|Overall Study|Adverse Event|6|||
48480605|NCT03725722|155953496|FG000|Overall Study|Withdrawal by Subject|4|||
48480606|NCT03725722|155953497|FG001|Overall Study|Withdrawal by Subject|1|||
48480607|NCT03725722|155953498|FG002|Overall Study|Withdrawal by Subject|0|||
48480608|NCT03725722|155953499|FG003|Overall Study|Withdrawal by Subject|4|||
48480609|NCT03725722|155953500|FG004|Overall Study|Withdrawal by Subject|4|||
48480610|NCT03725722|155953496|FG000|Overall Study|Lost to Follow-up|3|||
48480611|NCT03725722|155953497|FG001|Overall Study|Lost to Follow-up|1|||
48480612|NCT03725722|155953498|FG002|Overall Study|Lost to Follow-up|2|||
48480613|NCT03725722|155953499|FG003|Overall Study|Lost to Follow-up|2|||
48480614|NCT03725722|155953500|FG004|Overall Study|Lost to Follow-up|1|||
48480615|NCT03725722|155953496|FG000|Overall Study|Personal reasons|0|||
48480616|NCT03725722|155953497|FG001|Overall Study|Personal reasons|0|||
48480617|NCT03725722|155953498|FG002|Overall Study|Personal reasons|1|||
48480618|NCT03725722|155953499|FG003|Overall Study|Personal reasons|0|||
48480619|NCT03725722|155953500|FG004|Overall Study|Personal reasons|1|||
48480620|NCT03725722|155953496|FG000|Overall Study|COVID-19 situation|0|||
48480621|NCT03725722|155953497|FG001|Overall Study|COVID-19 situation|1|||
48480622|NCT03725722|155953498|FG002|Overall Study|COVID-19 situation|0|||
48480623|NCT03725722|155953499|FG003|Overall Study|COVID-19 situation|0|||
48480624|NCT03725722|155953500|FG004|Overall Study|COVID-19 situation|0|||
48480625|NCT02545868|155953511|FG000|Overall Study|Lack of Efficacy|1|||
48480626|NCT02545868|155953512|FG001|Overall Study|Lack of Efficacy|1|||
48480627|NCT02545868|155953513|FG002|Overall Study|Lack of Efficacy|0|||
48480628|NCT02545868|155953511|FG000|Overall Study|Lost to Follow-up|1|||
48480629|NCT02545868|155953512|FG001|Overall Study|Lost to Follow-up|5|||
48480630|NCT02545868|155953513|FG002|Overall Study|Lost to Follow-up|1|||
48480631|NCT02545868|155953511|FG000|Overall Study|Non-compliance|1|||
48480632|NCT02545868|155953512|FG001|Overall Study|Non-compliance|1|||
48480633|NCT02545868|155953513|FG002|Overall Study|Non-compliance|1|||
48480634|NCT02545868|155953511|FG000|Overall Study|Treatment change|21|||
48480635|NCT02545868|155953512|FG001|Overall Study|Treatment change|19|||
48480636|NCT02545868|155953513|FG002|Overall Study|Treatment change|22|||
48480637|NCT02545868|155953511|FG000|Overall Study|Physician Decision|1|||
48480638|NCT02545868|155953512|FG001|Overall Study|Physician Decision|1|||
48480639|NCT02545868|155953513|FG002|Overall Study|Physician Decision|1|||
48480640|NCT02545868|155953511|FG000|Overall Study|Withdrawal by Subject|6|||
48480641|NCT02545868|155953512|FG001|Overall Study|Withdrawal by Subject|7|||
48480642|NCT02545868|155953513|FG002|Overall Study|Withdrawal by Subject|9|||
48480643|NCT01777191|155953514|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
48480644|NCT01777191|155953515|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
48480645|NCT01777191|155953514|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
48480646|NCT01777191|155953515|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
48480647|NCT01777191|155953514|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
48480648|NCT01777191|155953515|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
48480649|NCT01777191|155953514|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
48480650|NCT01777191|155953515|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
48480651|NCT01777191|155953514|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
48480652|NCT01777191|155953515|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
48480653|NCT01777191|155953514|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
48480654|NCT01777191|155953515|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
48480655|NCT01777191|155953514|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
48480656|NCT01777191|155953515|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
48480657|NCT01777191|155953514|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
48480658|NCT01777191|155953515|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
48480659|NCT01777191|155953514|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
48480660|NCT01777191|155953515|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
48480661|NCT01777191|155953514|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
48480662|NCT01777191|155953515|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
48480663|NCT01777191|155953514|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
48480664|NCT01777191|155953515|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
48480665|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Adverse Event|2|||
48480666|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Adverse Event|0|||
48480667|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Adverse Event|0|||
48480668|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Adverse Event|0|||
48480669|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
48480670|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
48480671|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
48480672|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
48480673|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
48480674|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
48480675|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
48480676|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
48480677|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Physician Decision|1|||
48480678|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Physician Decision|0|||
48480679|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Physician Decision|0|||
48480680|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Physician Decision|0|||
48480681|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Pregnancy|1|||
48480682|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Pregnancy|0|||
48480683|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Pregnancy|0|||
48480684|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Pregnancy|0|||
48480685|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
48480686|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
48480687|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
48480688|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
48480689|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
48480690|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
48480691|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
48480692|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
48480693|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
48480694|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
48480695|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
48480696|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
48480697|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
48480698|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
48480699|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
48480700|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
48480701|NCT04057573|155953516|FG000|24-Week Double-Blind Period|Not Treated|1|||
48480702|NCT04057573|155953517|FG001|24-Week Double-Blind Period|Not Treated|0|||
48480703|NCT04057573|155953518|FG002|24-Week Double-Blind Period|Not Treated|0|||
48480704|NCT04057573|155953519|FG003|24-Week Double-Blind Period|Not Treated|0|||
48480705|NCT04057573|155953516|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
48480706|NCT04057573|155953517|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
48480707|NCT04057573|155953518|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
48480708|NCT04057573|155953519|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
48480709|NCT04057573|155953516|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
48480710|NCT04057573|155953517|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
48480711|NCT04057573|155953518|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
48480712|NCT04057573|155953519|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
48480713|NCT04057573|155953516|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
48480714|NCT04057573|155953517|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
48480715|NCT04057573|155953518|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
48480716|NCT04057573|155953519|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
48480717|NCT04057573|155953516|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
48480718|NCT04057573|155953517|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
48480719|NCT04057573|155953518|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
48480720|NCT04057573|155953519|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
48480721|NCT04057573|155953516|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
48480722|NCT04057573|155953517|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
48480723|NCT04057573|155953518|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
48480724|NCT04057573|155953519|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
48480725|NCT03047031|155953520|FG000|Overall Study|Other than listed|1|||
48480726|NCT03047031|155953521|FG001|Overall Study|Other than listed|0|||
48480727|NCT03047031|155953522|FG002|Overall Study|Other than listed|0|||
48480728|NCT03047031|155953520|FG000|Overall Study|Lost to Follow-up|4|||
48480729|NCT03047031|155953521|FG001|Overall Study|Lost to Follow-up|0|||
48480730|NCT03047031|155953522|FG002|Overall Study|Lost to Follow-up|0|||
48480731|NCT03047031|155953520|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
48480732|NCT03047031|155953521|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
48480733|NCT03047031|155953522|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
48480734|NCT03047031|155953520|FG000|Overall Study|Adverse Event|1|||
48480735|NCT03047031|155953521|FG001|Overall Study|Adverse Event|0|||
48480736|NCT03047031|155953522|FG002|Overall Study|Adverse Event|0|||
48480737|NCT03047031|155953520|FG000|Overall Study|Withdrawal by Subject|2|||
48480738|NCT03047031|155953521|FG001|Overall Study|Withdrawal by Subject|0|||
48480739|NCT03047031|155953522|FG002|Overall Study|Withdrawal by Subject|0|||
48480740|NCT03047031|155953520|FG000|Overall Study|Change to other medication|2|||
48480741|NCT03047031|155953521|FG001|Overall Study|Change to other medication|0|||
48480742|NCT03047031|155953522|FG002|Overall Study|Change to other medication|0|||
48480743|NCT03047031|155953520|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
48480744|NCT03047031|155953521|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
48480745|NCT03047031|155953522|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
48480746|NCT04723173|155953523|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
48480747|NCT02996448|155953524|FG000|Overall Study|Study terminated due to adverse effects|3|||
48480748|NCT04465916|155953529|FG000|Overall Study|Withdrawal by Subject|0|||
48480749|NCT04465916|155953530|FG001|Overall Study|Withdrawal by Subject|1|||
48480750|NCT03286400|155953533|FG000|Overall Study|Death|10|||
48480751|NCT03286400|155953533|FG000|Overall Study|Lost to Follow-up|10|||
48480752|NCT03286400|155953533|FG000|Overall Study|Physician Decision|1|||
48480753|NCT03286400|155953533|FG000|Overall Study|Scheduling difficulty|4|||
48480754|NCT04840901|155953540|FG000|Overall Study|Lost to Follow-up|3|||
48480755|NCT04840901|155953541|FG001|Overall Study|Lost to Follow-up|1|||
48480756|NCT04840901|155953540|FG000|Overall Study|Moved|1|||
48480757|NCT04840901|155953541|FG001|Overall Study|Moved|0|||
48480758|NCT04840901|155953540|FG000|Overall Study|Unable to comply with study schedule|0|||
48480759|NCT04840901|155953541|FG001|Overall Study|Unable to comply with study schedule|1|||
48480760|NCT04840901|155953540|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
48480761|NCT04840901|155953541|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
48480762|NCT02058368|155953552|FG000|Overall Study|Adverse Event|15|||
48480763|NCT02058368|155953553|FG001|Overall Study|Adverse Event|20|||
48480764|NCT02058368|155953552|FG000|Overall Study|Lack of Efficacy|0|||
48480765|NCT02058368|155953553|FG001|Overall Study|Lack of Efficacy|1|||
48480766|NCT02058368|155953552|FG000|Overall Study|Protocol Violation|0|||
48480767|NCT02058368|155953553|FG001|Overall Study|Protocol Violation|4|||
48480768|NCT02058368|155953552|FG000|Overall Study|Lost to Follow-up|2|||
48480769|NCT02058368|155953553|FG001|Overall Study|Lost to Follow-up|0|||
48480770|NCT02058368|155953552|FG000|Overall Study|Physician Decision|2|||
48480771|NCT02058368|155953553|FG001|Overall Study|Physician Decision|3|||
48480772|NCT02058368|155953552|FG000|Overall Study|Withdrawal by Subject|22|||
48480773|NCT02058368|155953553|FG001|Overall Study|Withdrawal by Subject|26|||
48480774|NCT02181842|155953555|FG000|Overall Study|Case Report Forms Uncollected|2|||
48480775|NCT06371079|155953556|FG000|Overall Study|Missing data|88|||
48480776|NCT06371079|155953557|FG001|Overall Study|Missing data|247|||
48480777|NCT01216319|155953558|FG000|Overall Study|Lost to Follow-up|2|||
48480778|NCT01216319|155953558|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
48480779|NCT00995488|155953559|FG000|Overall Study|Withdrawal by Subject|1|||
48480780|NCT01892020|155953560|FG000|Period 1|Adverse Event|1|||
48480781|NCT01892020|155953561|FG001|Period 1|Adverse Event|1|||
48480782|NCT01892020|155953560|FG000|Period 1|Protocol Violation|2|||
48480783|NCT01892020|155953561|FG001|Period 1|Protocol Violation|4|||
48480784|NCT01892020|155953560|FG000|Period 1|Unclassified|0|||
48480785|NCT01892020|155953561|FG001|Period 1|Unclassified|1|||
48480786|NCT01892020|155953560|FG000|Period 2|Protocol Violation|1|||
48480787|NCT01892020|155953561|FG001|Period 2|Protocol Violation|0|||
48480788|NCT03078192|155953562|FG000|Overall Study|Withdrawal by Subject|2|||
48480789|NCT03078192|155953563|FG001|Overall Study|Withdrawal by Subject|1|||
48480790|NCT03078192|155953562|FG000|Overall Study|screen failure|0|||
48480791|NCT03078192|155953563|FG001|Overall Study|screen failure|3|||
48480792|NCT01831596|155953564|FG000|Overall Study|Other|8|||
48480793|NCT00567996|155953568|FG000|Overall Study|Adverse Event|18|||
48480794|NCT00567996|155953569|FG001|Overall Study|Adverse Event|16|||
48480795|NCT00567996|155953570|FG002|Overall Study|Adverse Event|13|||
48480796|NCT00567996|155953568|FG000|Overall Study|Protocol Deviation|9|||
48480797|NCT00567996|155953569|FG001|Overall Study|Protocol Deviation|11|||
48480798|NCT00567996|155953570|FG002|Overall Study|Protocol Deviation|13|||
48480799|NCT00567996|155953568|FG000|Overall Study|Withdrawal by Subject|8|||
48480800|NCT00567996|155953569|FG001|Overall Study|Withdrawal by Subject|12|||
48480801|NCT00567996|155953570|FG002|Overall Study|Withdrawal by Subject|22|||
48480802|NCT00567996|155953568|FG000|Overall Study|Abnormal Lab value(s)|2|||
48480803|NCT00567996|155953569|FG001|Overall Study|Abnormal Lab value(s)|1|||
48480804|NCT00567996|155953570|FG002|Overall Study|Abnormal Lab value(s)|2|||
48480805|NCT00567996|155953568|FG000|Overall Study|Abnormal test procedure result(s)|2|||
48480806|NCT00567996|155953569|FG001|Overall Study|Abnormal test procedure result(s)|1|||
48480807|NCT00567996|155953570|FG002|Overall Study|Abnormal test procedure result(s)|1|||
48480808|NCT00567996|155953568|FG000|Overall Study|Lost to Follow-up|2|||
48480809|NCT00567996|155953569|FG001|Overall Study|Lost to Follow-up|5|||
48480810|NCT00567996|155953570|FG002|Overall Study|Lost to Follow-up|2|||
48480811|NCT00567996|155953568|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
48480812|NCT00567996|155953569|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
48480813|NCT00567996|155953570|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
48480814|NCT00567996|155953568|FG000|Overall Study|Administrative problems|1|||
48480815|NCT00567996|155953569|FG001|Overall Study|Administrative problems|1|||
48480816|NCT00567996|155953570|FG002|Overall Study|Administrative problems|0|||
48480817|NCT00567996|155953568|FG000|Overall Study|Death|1|||
48480818|NCT00567996|155953569|FG001|Overall Study|Death|0|||
48480819|NCT00567996|155953570|FG002|Overall Study|Death|2|||
48480820|NCT00567996|155953568|FG000|Overall Study|Patient's inability to use the device|0|||
48480821|NCT00567996|155953569|FG001|Overall Study|Patient's inability to use the device|1|||
48480822|NCT00567996|155953570|FG002|Overall Study|Patient's inability to use the device|0|||
48480823|NCT03338673|155953574|FG000|Overall Study|Lost to Follow-up|1|||
48480824|NCT03338673|155953575|FG001|Overall Study|Lost to Follow-up|1|||
48480825|NCT02173301|155953578|FG000|Overall Study|Adverse Event|7|||
48480826|NCT02173301|155953579|FG001|Overall Study|Adverse Event|8|||
48480827|NCT02173301|155953580|FG002|Overall Study|Adverse Event|13|||
48480828|NCT02173301|155953581|FG003|Overall Study|Adverse Event|5|||
48480829|NCT02173301|155953578|FG000|Overall Study|Withdrawal by Subject|8|||
48480830|NCT02173301|155953579|FG001|Overall Study|Withdrawal by Subject|10|||
48480831|NCT02173301|155953580|FG002|Overall Study|Withdrawal by Subject|4|||
48480832|NCT02173301|155953581|FG003|Overall Study|Withdrawal by Subject|8|||
48480833|NCT02173301|155953578|FG000|Overall Study|Lost to Follow-up|4|||
48480834|NCT02173301|155953579|FG001|Overall Study|Lost to Follow-up|4|||
48480835|NCT02173301|155953580|FG002|Overall Study|Lost to Follow-up|2|||
48480836|NCT02173301|155953581|FG003|Overall Study|Lost to Follow-up|2|||
48480837|NCT02173301|155953578|FG000|Overall Study|Protocol Violation|0|||
48480838|NCT02173301|155953579|FG001|Overall Study|Protocol Violation|1|||
48480839|NCT02173301|155953580|FG002|Overall Study|Protocol Violation|0|||
48480840|NCT02173301|155953581|FG003|Overall Study|Protocol Violation|0|||
48480841|NCT02173301|155953578|FG000|Overall Study|Physician Decision|0|||
48480842|NCT02173301|155953579|FG001|Overall Study|Physician Decision|0|||
48480843|NCT02173301|155953580|FG002|Overall Study|Physician Decision|1|||
48480844|NCT02173301|155953581|FG003|Overall Study|Physician Decision|0|||
48480845|NCT02173301|155953578|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
48480846|NCT02173301|155953579|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
48480847|NCT02173301|155953580|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
48480848|NCT02173301|155953581|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
48480849|NCT03120520|155953586|FG000|Overall Study|Lost to Follow-up|1|||
48480850|NCT03120520|155953587|FG001|Overall Study|Lost to Follow-up|1|||
48480851|NCT03120520|155953588|FG002|Overall Study|Lost to Follow-up|1|||
48480852|NCT03120520|155953589|FG003|Overall Study|Lost to Follow-up|1|||
48480853|NCT03120520|155953586|FG000|Overall Study|Withdrawal by Subject|3|||
48480854|NCT03120520|155953587|FG001|Overall Study|Withdrawal by Subject|2|||
48480855|NCT03120520|155953588|FG002|Overall Study|Withdrawal by Subject|3|||
48480856|NCT03120520|155953589|FG003|Overall Study|Withdrawal by Subject|2|||
48480857|NCT03120520|155953586|FG000|Overall Study|Other|0|||
48480858|NCT03120520|155953587|FG001|Overall Study|Other|1|||
48480859|NCT03120520|155953588|FG002|Overall Study|Other|0|||
48480860|NCT03120520|155953589|FG003|Overall Study|Other|0|||
48480861|NCT04578548|155953590|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
48480862|NCT04578548|155953591|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
48480863|NCT04578548|155953590|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
48480864|NCT04578548|155953591|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
48480865|NCT04578548|155953590|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
48480866|NCT04578548|155953591|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
48480867|NCT04578548|155953590|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
48480868|NCT04578548|155953591|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
48480869|NCT04578548|155953590|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
48480870|NCT04578548|155953591|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
48480871|NCT04578548|155953590|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
48480872|NCT04578548|155953591|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
48480873|NCT00826176|155954744|FG000|Overall Study|Lost to Follow-up|1|||
48480874|NCT00826176|155954745|FG001|Overall Study|Lost to Follow-up|0|||
48480875|NCT00826176|155954744|FG000|Overall Study|Subject Withdrew Consent|3|||
48480876|NCT00826176|155954745|FG001|Overall Study|Subject Withdrew Consent|0|||
48480877|NCT00826176|155954744|FG000|Overall Study|Administrative|9|||
48480878|NCT00826176|155954745|FG001|Overall Study|Administrative|0|||
48480879|NCT00953927|155954746|FG000|Overall Study|Lost to Follow-up|61|||
48480880|NCT00953927|155954747|FG001|Overall Study|Lost to Follow-up|65|||
48480881|NCT00953927|155954746|FG000|Overall Study|Withdrawal by Subject|36|||
48480882|NCT00953927|155954747|FG001|Overall Study|Withdrawal by Subject|25|||
48480883|NCT00953927|155954746|FG000|Overall Study|Death|7|||
48480884|NCT00953927|155954747|FG001|Overall Study|Death|4|||
48480885|NCT00953927|155954746|FG000|Overall Study|Other study discontinuation|1|||
48480886|NCT00953927|155954747|FG001|Overall Study|Other study discontinuation|1|||
48480887|NCT02953262|155954748|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
48480888|NCT02953262|155954749|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
48480889|NCT02953262|155954750|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
48480890|NCT02953262|155954751|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
48480891|NCT01652573|155954752|FG000|Overall Study|Adverse Event|0|||
48480892|NCT01652573|155954753|FG001|Overall Study|Adverse Event|1|||
48480893|NCT00740480|155954754|FG000|Overall Study|Adverse Event|1|||
48480894|NCT00740480|155954754|FG000|Overall Study|Physician Decision|1|||
48480895|NCT00934622|155954756|FG000|Overall Study|Lost to Follow-up|7|||
48480896|NCT00934622|155954756|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
48480897|NCT01856686|155954761|FG000|Overall Study|Lost to Follow-up|5|||
48480898|NCT01856686|155954762|FG001|Overall Study|Lost to Follow-up|11|||
48480899|NCT03284424|155954763|FG000|Overall Study|Death|70|||
48480900|NCT03284424|155954764|FG001|Overall Study|Death|24|||
48480901|NCT03284424|155954763|FG000|Overall Study|Lost to Follow-up|3|||
48480902|NCT03284424|155954764|FG001|Overall Study|Lost to Follow-up|1|||
48480903|NCT03284424|155954763|FG000|Overall Study|Physician Decision|1|||
48480904|NCT03284424|155954764|FG001|Overall Study|Physician Decision|2|||
48480905|NCT03284424|155954763|FG000|Overall Study|Withdrawal by Subject|4|||
48480906|NCT03284424|155954764|FG001|Overall Study|Withdrawal by Subject|5|||
48480907|NCT03284424|155954763|FG000|Overall Study|Sponsor's decision|27|||
48480908|NCT03284424|155954764|FG001|Overall Study|Sponsor's decision|22|||
48480909|NCT00602979|155954773|FG000|Overall Study|Lost to Follow-up|3|||
48480910|NCT00602979|155954774|FG001|Overall Study|Lost to Follow-up|2|||
48480911|NCT00602979|155954775|FG002|Overall Study|Lost to Follow-up|3|||
48480912|NCT00602979|155954776|FG003|Overall Study|Lost to Follow-up|2|||
48480913|NCT00602979|155954777|FG004|Overall Study|Lost to Follow-up|3|||
48480914|NCT00602979|155954773|FG000|Overall Study|Failed Intubation|0|||
48480915|NCT00602979|155954774|FG001|Overall Study|Failed Intubation|1|||
48480916|NCT00602979|155954775|FG002|Overall Study|Failed Intubation|0|||
48480917|NCT00602979|155954776|FG003|Overall Study|Failed Intubation|1|||
48480918|NCT00602979|155954777|FG004|Overall Study|Failed Intubation|0|||
48480919|NCT00468312|155954778|FG000|Overall Study|Adverse Event|2|||
48480920|NCT00468312|155954779|FG001|Overall Study|Adverse Event|1|||
48480921|NCT00468312|155954778|FG000|Overall Study|Lack of Efficacy|0|||
48480922|NCT00468312|155954779|FG001|Overall Study|Lack of Efficacy|1|||
48480923|NCT00468312|155954778|FG000|Overall Study|Withdrawal by Subject|0|||
48480924|NCT00468312|155954779|FG001|Overall Study|Withdrawal by Subject|1|||
48480925|NCT00468312|155954778|FG000|Overall Study|Protocol Violation|2|||
48480926|NCT00468312|155954779|FG001|Overall Study|Protocol Violation|1|||
48480927|NCT00468312|155954778|FG000|Overall Study|Did not meet protocol eligibility|0|||
48480928|NCT00468312|155954779|FG001|Overall Study|Did not meet protocol eligibility|1|||
48480929|NCT02016755|155954780|FG000|Overall Study|Major amputation of index limb|2|||
48480930|NCT02016755|155954780|FG000|Overall Study|Adverse Event|2|||
48480931|NCT02016755|155954780|FG000|Overall Study|Physician Decision|1|||
48480932|NCT02016755|155954780|FG000|Overall Study|Death|2|||
48480933|NCT01052038|155954781|FG000|Overall Study|Lost to Follow-up|2|||
48480934|NCT01052038|155954782|FG001|Overall Study|Lost to Follow-up|3|||
48480935|NCT01052038|155954783|FG002|Overall Study|Lost to Follow-up|1|||
48480936|NCT01052038|155954781|FG000|Overall Study|Protocol Violation|2|||
48480937|NCT01052038|155954782|FG001|Overall Study|Protocol Violation|3|||
48480938|NCT01052038|155954783|FG002|Overall Study|Protocol Violation|3|||
48480939|NCT02499406|155954786|FG000|Overall Study|missed 3 treatment sessions|4|||
48480940|NCT01396161|155954787|FG000|Overall Study|Withdrawal by Subject|0|||
48480941|NCT01396161|155954788|FG001|Overall Study|Withdrawal by Subject|0|||
48480942|NCT01396161|155954789|FG002|Overall Study|Withdrawal by Subject|0|||
48480943|NCT01396161|155954790|FG003|Overall Study|Withdrawal by Subject|0|||
48480944|NCT01396161|155954791|FG004|Overall Study|Withdrawal by Subject|1|||
48480945|NCT01396161|155954792|FG005|Overall Study|Withdrawal by Subject|0|||
48480946|NCT01396161|155954793|FG006|Overall Study|Withdrawal by Subject|0|||
48480947|NCT01396161|155954787|FG000|Overall Study|Other|0|||
48480948|NCT01396161|155954788|FG001|Overall Study|Other|0|||
48480949|NCT01396161|155954789|FG002|Overall Study|Other|0|||
48480950|NCT01396161|155954790|FG003|Overall Study|Other|0|||
48480951|NCT01396161|155954791|FG004|Overall Study|Other|0|||
48480952|NCT01396161|155954792|FG005|Overall Study|Other|0|||
48480953|NCT01396161|155954793|FG006|Overall Study|Other|1|||
48480954|NCT04057118|155954796|FG000|Overall Study|Adverse Event|1|||
48480955|NCT04057118|155954797|FG001|Overall Study|Adverse Event|0|||
48480956|NCT04057118|155954798|FG002|Overall Study|Adverse Event|1|||
48480957|NCT04057118|155954799|FG003|Overall Study|Adverse Event|1|||
48480958|NCT04057118|155954796|FG000|Overall Study|Physician Decision|0|||
48480959|NCT04057118|155954797|FG001|Overall Study|Physician Decision|0|||
48480960|NCT04057118|155954798|FG002|Overall Study|Physician Decision|1|||
48480961|NCT04057118|155954799|FG003|Overall Study|Physician Decision|1|||
48480962|NCT04057118|155954796|FG000|Overall Study|Withdrawal by Subject|2|||
48480963|NCT04057118|155954797|FG001|Overall Study|Withdrawal by Subject|2|||
48480964|NCT04057118|155954798|FG002|Overall Study|Withdrawal by Subject|0|||
48480965|NCT04057118|155954799|FG003|Overall Study|Withdrawal by Subject|2|||
48480966|NCT04057118|155954796|FG000|Overall Study|Not Specific|0|||
48480967|NCT04057118|155954797|FG001|Overall Study|Not Specific|0|||
48480968|NCT04057118|155954798|FG002|Overall Study|Not Specific|1|||
48480969|NCT04057118|155954799|FG003|Overall Study|Not Specific|1|||
48480970|NCT02787785|155954800|FG000|Overall Study|Death|3|||
48480971|NCT02787785|155954801|FG001|Overall Study|Death|4|||
48480972|NCT02787785|155954800|FG000|Overall Study|Lost to Follow-up|1|||
48480973|NCT02787785|155954801|FG001|Overall Study|Lost to Follow-up|1|||
48480974|NCT02787785|155954800|FG000|Overall Study|Withdrawal by Subject|0|||
48480975|NCT02787785|155954801|FG001|Overall Study|Withdrawal by Subject|5|||
48480976|NCT03981614|155954802|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
48480977|NCT03981614|155954803|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
48480978|NCT03981614|155954804|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
48480979|NCT02742818|155954805|FG000|Overall Study|Adverse Event|0|||
48480980|NCT02742818|155954806|FG001|Overall Study|Adverse Event|1|||
48480981|NCT02742818|155954805|FG000|Overall Study|Protocol Violation|0|||
48480982|NCT02742818|155954806|FG001|Overall Study|Protocol Violation|1|||
48480983|NCT04701658|155954807|FG000|Overall Study|Lost to Follow-up|6|||
48480984|NCT00457418|155954808|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
48480985|NCT00457418|155954808|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
48480986|NCT00457418|155954808|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
48480987|NCT00457418|155954808|FG000|Post PK Maintenance|Adverse Event|10|||
48480988|NCT00457418|155954808|FG000|Post PK Maintenance|Progression of Disease|6|||
48480989|NCT00457418|155954808|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
48480990|NCT00457418|155954808|FG000|Post PK Maintenance|Lost to Follow-up|1|||
48480991|NCT05016765|155954809|FG000|Overall Study|Lost to Follow-up|4|||
48480992|NCT05144477|155954810|FG000|Overall Study|Withdrawal by Subject|1|||
48480993|NCT05144477|155954811|FG001|Overall Study|Withdrawal by Subject|1|||
48480994|NCT01339000|155954812|FG000|Overall Study|study closed due to lack of drug supply|1|||
48480995|NCT01339000|155954813|FG001|Overall Study|study closed due to lack of drug supply|0|||
48480996|NCT00728988|155954821|FG000|Overall Study|Not Treated|2|||
48480997|NCT00728988|155954822|FG001|Overall Study|Not Treated|2|||
48480998|NCT00728988|155954821|FG000|Overall Study|Death|1|||
48480999|NCT00728988|155954822|FG001|Overall Study|Death|1|||
48481000|NCT00728988|155954821|FG000|Overall Study|Adverse Event|3|||
48481001|NCT00728988|155954822|FG001|Overall Study|Adverse Event|2|||
48481002|NCT00728988|155954821|FG000|Overall Study|Other|85|||
48481003|NCT00728988|155954822|FG001|Overall Study|Other|77|||
48481004|NCT00728988|155954821|FG000|Overall Study|Withdrawal by Subject|2|||
48481005|NCT00728988|155954822|FG001|Overall Study|Withdrawal by Subject|6|||
48481006|NCT00835068|155954825|FG000|Overall Study|Death|1|||
48481007|NCT00835068|155954826|FG001|Overall Study|Death|0|||
48481008|NCT00835068|155954825|FG000|Overall Study|Adverse Event|0|||
48481009|NCT00835068|155954826|FG001|Overall Study|Adverse Event|1|||
48481010|NCT00835068|155954825|FG000|Overall Study|Other|8|||
48481011|NCT00835068|155954826|FG001|Overall Study|Other|0|||
48481012|NCT00835068|155954825|FG000|Overall Study|Withdrawal by Subject|1|||
48481013|NCT00835068|155954826|FG001|Overall Study|Withdrawal by Subject|0|||
48481014|NCT02704130|155954827|FG000|Overall Study|Physician Decision|5|||
48481015|NCT02704130|155954828|FG001|Overall Study|Physician Decision|3|||
48481016|NCT01652872|155954831|FG000|Overall Study|Death|36|||
48481017|NCT01652872|155954832|FG001|Overall Study|Death|39|||
48481018|NCT01652872|155954831|FG000|Overall Study|Lost to Follow-up|28|||
48481019|NCT01652872|155954832|FG001|Overall Study|Lost to Follow-up|23|||
48481020|NCT01652872|155954831|FG000|Overall Study|Decision by sponsor|5|||
48481021|NCT01652872|155954832|FG001|Overall Study|Decision by sponsor|7|||
48481022|NCT01652872|155954831|FG000|Overall Study|Withdrawal by Subject|76|||
48481023|NCT01652872|155954832|FG001|Overall Study|Withdrawal by Subject|84|||
48481024|NCT05473247|155954839|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
48481025|NCT04816877|155954842|FG000|Overall Study|Withdrawal by Subject|1|||
48481026|NCT04816877|155954843|FG001|Overall Study|Withdrawal by Subject|0|||
48481027|NCT01374906|155954844|FG000|Overall Study|Abnormal laboratory value(s)|0|||
48481028|NCT01374906|155954845|FG001|Overall Study|Abnormal laboratory value(s)|3|||
48481029|NCT01374906|155954844|FG000|Overall Study|Administrative problems|2|||
48481030|NCT01374906|155954845|FG001|Overall Study|Administrative problems|2|||
48481031|NCT01374906|155954844|FG000|Overall Study|Adverse Event|10|||
48481032|NCT01374906|155954845|FG001|Overall Study|Adverse Event|11|||
48481033|NCT01374906|155954844|FG000|Overall Study|Death|0|||
48481034|NCT01374906|155954845|FG001|Overall Study|Death|2|||
48481035|NCT01374906|155954844|FG000|Overall Study|Protocol Violation|2|||
48481036|NCT01374906|155954845|FG001|Overall Study|Protocol Violation|2|||
48481037|NCT01374906|155954844|FG000|Overall Study|Withdrawal by Subject|15|||
48481038|NCT01374906|155954845|FG001|Overall Study|Withdrawal by Subject|9|||
48481039|NCT01374906|155954844|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
48481040|NCT01374906|155954845|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
48481041|NCT00434148|155954846|FG000|Overall Study|Adverse Event|18|||
48481042|NCT00434148|155954847|FG001|Overall Study|Adverse Event|18|||
48481043|NCT00434148|155954846|FG000|Overall Study|Lack of Efficacy|25|||
48481044|NCT00434148|155954847|FG001|Overall Study|Lack of Efficacy|28|||
48481045|NCT00434148|155954846|FG000|Overall Study|Withdrawal by Subject|15|||
48481046|NCT00434148|155954847|FG001|Overall Study|Withdrawal by Subject|15|||
48481047|NCT00434148|155954846|FG000|Overall Study|Protocol Violation|4|||
48481048|NCT00434148|155954847|FG001|Overall Study|Protocol Violation|0|||
48481049|NCT00434148|155954846|FG000|Overall Study|Administrative problems|6|||
48481050|NCT00434148|155954847|FG001|Overall Study|Administrative problems|10|||
48481051|NCT00434148|155954846|FG000|Overall Study|Lost to Follow-up|0|||
48481052|NCT00434148|155954847|FG001|Overall Study|Lost to Follow-up|1|||
48481053|NCT00434148|155954846|FG000|Overall Study|Condition no longer requires study drug|1|||
48481054|NCT00434148|155954847|FG001|Overall Study|Condition no longer requires study drug|0|||
48481055|NCT00434148|155954846|FG000|Overall Study|Abnormal test procedure result|0|||
48481056|NCT00434148|155954847|FG001|Overall Study|Abnormal test procedure result|1|||
48481057|NCT00828516|155954850|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
48481058|NCT00990093|155954851|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
48481059|NCT00990093|155954852|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
48481060|NCT00990093|155954851|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
48481061|NCT00990093|155954852|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
48481062|NCT00990093|155954851|FG000|Test Period 1 (1-14 Days)|Other|1|||
48481063|NCT00990093|155954852|FG001|Test Period 1 (1-14 Days)|Other|0|||
48481064|NCT00990093|155954851|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
48481065|NCT00990093|155954852|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
48481066|NCT00990093|155954851|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
48481067|NCT00990093|155954852|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
48481068|NCT00990093|155954851|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
48481069|NCT00990093|155954852|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
48481070|NCT00990093|155954851|FG000|Test Period 2 (15-28 Days)|Other|0|||
48481071|NCT00990093|155954852|FG001|Test Period 2 (15-28 Days)|Other|1|||
48481072|NCT00435825|155954854|FG000|Overall Study|Abnormality of Laboratory Test|0|||
48481073|NCT00435825|155954855|FG001|Overall Study|Abnormality of Laboratory Test|1|||
48481074|NCT00435825|155954856|FG002|Overall Study|Abnormality of Laboratory Test|0|||
48481075|NCT00435825|155954857|FG003|Overall Study|Abnormality of Laboratory Test|0|||
48481076|NCT00435825|155954854|FG000|Overall Study|Insufficient Therapeutic Response|3|||
48481077|NCT00435825|155954855|FG001|Overall Study|Insufficient Therapeutic Response|1|||
48481078|NCT00435825|155954856|FG002|Overall Study|Insufficient Therapeutic Response|0|||
48481079|NCT00435825|155954857|FG003|Overall Study|Insufficient Therapeutic Response|3|||
48481080|NCT00435825|155954854|FG000|Overall Study|Other Protocol Violation|1|||
48481081|NCT00435825|155954855|FG001|Overall Study|Other Protocol Violation|0|||
48481082|NCT00435825|155954856|FG002|Overall Study|Other Protocol Violation|0|||
48481083|NCT00435825|155954857|FG003|Overall Study|Other Protocol Violation|0|||
48481084|NCT00435825|155954854|FG000|Overall Study|Refused treatment|2|||
48481085|NCT00435825|155954855|FG001|Overall Study|Refused treatment|0|||
48481086|NCT00435825|155954856|FG002|Overall Study|Refused treatment|0|||
48481087|NCT00435825|155954857|FG003|Overall Study|Refused treatment|5|||
48481088|NCT00435825|155954854|FG000|Overall Study|Failure to return|5|||
48481089|NCT00435825|155954855|FG001|Overall Study|Failure to return|0|||
48481090|NCT00435825|155954856|FG002|Overall Study|Failure to return|4|||
48481091|NCT00435825|155954857|FG003|Overall Study|Failure to return|0|||
48481092|NCT00435825|155954854|FG000|Overall Study|Did not receive study drug|1|||
48481093|NCT00435825|155954855|FG001|Overall Study|Did not receive study drug|0|||
48481094|NCT00435825|155954856|FG002|Overall Study|Did not receive study drug|2|||
48481095|NCT00435825|155954857|FG003|Overall Study|Did not receive study drug|0|||
48481096|NCT00435825|155954854|FG000|Overall Study|Did not enter follow-up|0|||
48481097|NCT00435825|155954855|FG001|Overall Study|Did not enter follow-up|4|||
48481098|NCT00435825|155954856|FG002|Overall Study|Did not enter follow-up|1|||
48481099|NCT00435825|155954857|FG003|Overall Study|Did not enter follow-up|3|||
48481100|NCT00435825|155954854|FG000|Overall Study|Did not complete full follow-up period|6|||
48481101|NCT00435825|155954855|FG001|Overall Study|Did not complete full follow-up period|6|||
48481102|NCT00435825|155954856|FG002|Overall Study|Did not complete full follow-up period|4|||
48481103|NCT00435825|155954857|FG003|Overall Study|Did not complete full follow-up period|5|||
48481104|NCT01123980|155954860|FG000|Overall Study|Adverse Event|1|||
48481105|NCT01123980|155954861|FG001|Overall Study|Adverse Event|1|||
48481106|NCT01123980|155954860|FG000|Overall Study|Lack of Efficacy|1|||
48481107|NCT01123980|155954861|FG001|Overall Study|Lack of Efficacy|0|||
48481108|NCT01123980|155954860|FG000|Overall Study|Physician Decision|0|||
48481109|NCT01123980|155954861|FG001|Overall Study|Physician Decision|1|||
48481110|NCT01123980|155954860|FG000|Overall Study|Lost to Follow-up|0|||
48481111|NCT01123980|155954861|FG001|Overall Study|Lost to Follow-up|6|||
48481112|NCT01123980|155954860|FG000|Overall Study|Protocol Violation|6|||
48481113|NCT01123980|155954861|FG001|Overall Study|Protocol Violation|6|||
48481114|NCT01123980|155954860|FG000|Overall Study|Withdrawal by Subject|5|||
48481115|NCT01123980|155954861|FG001|Overall Study|Withdrawal by Subject|3|||
48481116|NCT01123980|155954860|FG000|Overall Study|Unclassified|6|||
48481117|NCT01123980|155954861|FG001|Overall Study|Unclassified|7|||
48481118|NCT02703454|155955834|FG000|Overall Study|Not treated|1|||
48481119|NCT02703454|155955835|FG001|Overall Study|Not treated|3|||
48481120|NCT02703454|155955834|FG000|Overall Study|Withdrawal by Subject|4|||
48481121|NCT02703454|155955835|FG001|Overall Study|Withdrawal by Subject|3|||
48481122|NCT02703454|155955834|FG000|Overall Study|Lost to Follow-up|1|||
48481123|NCT02703454|155955835|FG001|Overall Study|Lost to Follow-up|2|||
48481124|NCT02703454|155955834|FG000|Overall Study|Study discontinuation|5|||
48481125|NCT02703454|155955835|FG001|Overall Study|Study discontinuation|8|||
48481126|NCT02284373|155955836|FG000|Overall Study|Withdrawal by Subject|0|||
48481127|NCT02284373|155955837|FG001|Overall Study|Withdrawal by Subject|1|||
48481128|NCT02284373|155955838|FG002|Overall Study|Withdrawal by Subject|0|||
48481129|NCT02284373|155955836|FG000|Overall Study|Other|0|||
48481130|NCT02284373|155955837|FG001|Overall Study|Other|1|||
48481131|NCT02284373|155955838|FG002|Overall Study|Other|0|||
48481132|NCT02284373|155955836|FG000|Overall Study|Lost to Follow-up|0|||
48481133|NCT02284373|155955837|FG001|Overall Study|Lost to Follow-up|1|||
48481134|NCT02284373|155955838|FG002|Overall Study|Lost to Follow-up|0|||
48481135|NCT03349437|155955842|FG000|Screening|Screen Fail|4|||
48481136|NCT03349437|155955843|FG001|Screening|Screen Fail|0|||
48481137|NCT03349437|155955844|FG002|Screening|Screen Fail|0|||
48481138|NCT03349437|155955842|FG000|Screening|Withdrawn|1|||
48481139|NCT03349437|155955843|FG001|Screening|Withdrawn|0|||
48481140|NCT03349437|155955844|FG002|Screening|Withdrawn|0|||
48481141|NCT01461369|155955845|FG000|Overall Study|Lack of Efficacy|2|||
48481142|NCT01461369|155955846|FG001|Overall Study|Lack of Efficacy|0|||
48481143|NCT01461369|155955847|FG002|Overall Study|Lack of Efficacy|6|||
48481144|NCT01461369|155955845|FG000|Overall Study|Lost to Follow-up|0|||
48481145|NCT01461369|155955846|FG001|Overall Study|Lost to Follow-up|0|||
48481146|NCT01461369|155955847|FG002|Overall Study|Lost to Follow-up|3|||
48481147|NCT01461369|155955845|FG000|Overall Study|Adverse Event|9|||
48481148|NCT01461369|155955846|FG001|Overall Study|Adverse Event|12|||
48481149|NCT01461369|155955847|FG002|Overall Study|Adverse Event|4|||
48481150|NCT01461369|155955845|FG000|Overall Study|Protocol Violation|1|||
48481151|NCT01461369|155955846|FG001|Overall Study|Protocol Violation|2|||
48481152|NCT01461369|155955847|FG002|Overall Study|Protocol Violation|2|||
48481153|NCT01461369|155955845|FG000|Overall Study|Withdrawal by Subject|1|||
48481154|NCT01461369|155955846|FG001|Overall Study|Withdrawal by Subject|3|||
48481155|NCT01461369|155955847|FG002|Overall Study|Withdrawal by Subject|2|||
48481156|NCT03079869|155955848|FG000|Overall Study|Adverse Event|6|||
48481157|NCT03079869|155955849|FG001|Overall Study|Adverse Event|8|||
48481158|NCT03079869|155955848|FG000|Overall Study|Withdrawal by Subject|4|||
48481159|NCT03079869|155955849|FG001|Overall Study|Withdrawal by Subject|1|||
48481160|NCT03079869|155955848|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
48481161|NCT03079869|155955849|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
48481162|NCT03976076|155955850|FG000|Overall Study|Withdrawal by Subject|2|||
48481163|NCT01325701|155955853|FG000|Overall Study|Adverse Event|12|||
48481164|NCT01325701|155955854|FG001|Overall Study|Adverse Event|0|||
48481165|NCT01325701|155955853|FG000|Overall Study|Protocol Violation|1|||
48481166|NCT01325701|155955854|FG001|Overall Study|Protocol Violation|0|||
48481167|NCT01325701|155955853|FG000|Overall Study|Physician Decision|2|||
48481168|NCT01325701|155955854|FG001|Overall Study|Physician Decision|2|||
48481169|NCT01325701|155955853|FG000|Overall Study|Withdrawal by Subject|2|||
48481170|NCT01325701|155955854|FG001|Overall Study|Withdrawal by Subject|1|||
48481171|NCT01325701|155955853|FG000|Overall Study|Rollerover Extension Study|4|||
48481172|NCT01325701|155955854|FG001|Overall Study|Rollerover Extension Study|0|||
48481173|NCT02962739|155955862|FG000|Overall Study|Withdrawal by Subject|0|||
48481174|NCT02962739|155955863|FG001|Overall Study|Withdrawal by Subject|1|||
48481175|NCT02962739|155955864|FG002|Overall Study|Withdrawal by Subject|0|||
48481176|NCT02962739|155955865|FG003|Overall Study|Withdrawal by Subject|0|||
48481177|NCT02962739|155955866|FG004|Overall Study|Withdrawal by Subject|0|||
48481178|NCT02962739|155955867|FG005|Overall Study|Withdrawal by Subject|0|||
48481179|NCT02962739|155955862|FG000|Overall Study|Protocol Violation|0|||
48481180|NCT02962739|155955863|FG001|Overall Study|Protocol Violation|0|||
48481181|NCT02962739|155955864|FG002|Overall Study|Protocol Violation|1|||
48481182|NCT02962739|155955865|FG003|Overall Study|Protocol Violation|0|||
48481183|NCT02962739|155955866|FG004|Overall Study|Protocol Violation|1|||
48481184|NCT02962739|155955867|FG005|Overall Study|Protocol Violation|0|||
48481185|NCT00734617|155955868|FG000|Overall Study|Adverse Event|4|||
48481186|NCT00734617|155955869|FG001|Overall Study|Adverse Event|7|||
48481187|NCT00734617|155955868|FG000|Overall Study|Withdrawal by Subject|103|||
48481188|NCT00734617|155955869|FG001|Overall Study|Withdrawal by Subject|95|||
48481189|NCT00552617|155955870|FG000|Overall Study|Not Treated|0|||
48481190|NCT00552617|155955871|FG001|Overall Study|Not Treated|0|||
48481191|NCT00552617|155955872|FG002|Overall Study|Not Treated|1|||
48481192|NCT00552617|155955873|FG003|Overall Study|Not Treated|0|||
48481193|NCT00552617|155955874|FG004|Overall Study|Not Treated|0|||
48481194|NCT00552617|155955875|FG005|Overall Study|Not Treated|0|||
48481195|NCT00552617|155955876|FG006|Overall Study|Not Treated|0|||
48481196|NCT00552617|155955877|FG007|Overall Study|Not Treated|0|||
48481197|NCT00552617|155955878|FG008|Overall Study|Not Treated|0|||
48481198|NCT00552617|155955879|FG009|Overall Study|Not Treated|1|||
48481199|NCT00552617|155955870|FG000|Overall Study|Lost to Follow-up|0|||
48481200|NCT00552617|155955871|FG001|Overall Study|Lost to Follow-up|0|||
48481201|NCT00552617|155955872|FG002|Overall Study|Lost to Follow-up|0|||
48481202|NCT00552617|155955873|FG003|Overall Study|Lost to Follow-up|1|||
48481203|NCT00552617|155955874|FG004|Overall Study|Lost to Follow-up|0|||
48481204|NCT00552617|155955875|FG005|Overall Study|Lost to Follow-up|2|||
48481205|NCT00552617|155955876|FG006|Overall Study|Lost to Follow-up|0|||
48481206|NCT00552617|155955877|FG007|Overall Study|Lost to Follow-up|0|||
48481207|NCT00552617|155955878|FG008|Overall Study|Lost to Follow-up|2|||
48481208|NCT00552617|155955879|FG009|Overall Study|Lost to Follow-up|0|||
48481209|NCT02411110|155955882|FG000|Treatment Period 1|Adverse Event|4|||
48481210|NCT02411110|155955883|FG001|Treatment Period 1|Adverse Event|2|||
48481211|NCT02411110|155955882|FG000|Treatment Period 1|Lost to Follow-up|1|||
48481212|NCT02411110|155955883|FG001|Treatment Period 1|Lost to Follow-up|0|||
48481213|NCT02411110|155955882|FG000|Treatment Period 1|Personal Reasons|2|||
48481214|NCT02411110|155955883|FG001|Treatment Period 1|Personal Reasons|5|||
48481215|NCT02411110|155955882|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
48481216|NCT02411110|155955883|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
48481217|NCT02411110|155955882|FG000|Treatment Period 2|Adverse Event|1|||
48481218|NCT02411110|155955883|FG001|Treatment Period 2|Adverse Event|0|||
48481219|NCT02411110|155955882|FG000|Treatment Period 2|Lost to Follow-up|0|||
48481220|NCT02411110|155955883|FG001|Treatment Period 2|Lost to Follow-up|2|||
48481221|NCT02411110|155955882|FG000|Treatment Period 2|Personal Reasons|0|||
48481222|NCT02411110|155955883|FG001|Treatment Period 2|Personal Reasons|2|||
48481223|NCT02406742|155955884|FG000|Overall Study|Progression of Disease|5|||
48481224|NCT02406742|155955885|FG001|Overall Study|Progression of Disease|1|||
48481225|NCT02406742|155955886|FG002|Overall Study|Progression of Disease|6|||
48481226|NCT02406742|155955884|FG000|Overall Study|Adverse Event|3|||
48481227|NCT02406742|155955885|FG001|Overall Study|Adverse Event|0|||
48481228|NCT02406742|155955886|FG002|Overall Study|Adverse Event|2|||
48481229|NCT02406742|155955884|FG000|Overall Study|Death|1|||
48481230|NCT02406742|155955885|FG001|Overall Study|Death|0|||
48481231|NCT02406742|155955886|FG002|Overall Study|Death|0|||
48481232|NCT02406742|155955884|FG000|Overall Study|Lack of Efficacy|0|||
48481233|NCT02406742|155955885|FG001|Overall Study|Lack of Efficacy|0|||
48481234|NCT02406742|155955886|FG002|Overall Study|Lack of Efficacy|1|||
48481235|NCT02406742|155955884|FG000|Overall Study|Withdrawal by Participant|1|||
48481236|NCT02406742|155955885|FG001|Overall Study|Withdrawal by Participant|2|||
48481237|NCT02406742|155955886|FG002|Overall Study|Withdrawal by Participant|0|||
48481238|NCT02406742|155955884|FG000|Overall Study|Physician Decision|1|||
48481239|NCT02406742|155955885|FG001|Overall Study|Physician Decision|2|||
48481240|NCT02406742|155955886|FG002|Overall Study|Physician Decision|1|||
48481241|NCT02406742|155955884|FG000|Overall Study|Transition to other treatment|2|||
48481242|NCT02406742|155955885|FG001|Overall Study|Transition to other treatment|0|||
48481243|NCT02406742|155955886|FG002|Overall Study|Transition to other treatment|1|||
48481244|NCT02406742|155955884|FG000|Overall Study|Other Reasons|1|||
48481245|NCT02406742|155955885|FG001|Overall Study|Other Reasons|11|||
48481246|NCT02406742|155955886|FG002|Overall Study|Other Reasons|5|||
48481247|NCT03273712|155955893|FG000|Overall Study|Death|5|||
48481248|NCT03273712|155955893|FG000|Overall Study|Adverse Event|1|||
48481249|NCT03273712|155955893|FG000|Overall Study|Disease Progression|1|||
48481250|NCT02487979|155955894|FG000|Overall Study|Physician Decision|2|||
48481251|NCT02487979|155955894|FG000|Overall Study|Withdrawal by Subject|2|||
48481252|NCT02487979|155955894|FG000|Overall Study|Progressive Disease|17|||
48481253|NCT04333199|155955897|FG000|Evaluated Patients|Lost to Follow-up|0|||
48481254|NCT04333199|155955898|FG001|Evaluated Patients|Lost to Follow-up|1|||
48481255|NCT04333199|155955899|FG002|Evaluated Patients|Lost to Follow-up|2|||
48481256|NCT00627458|155955902|FG000|Overall Study|Migrated from study area|1|||
48481257|NCT00627458|155955903|FG001|Overall Study|Migrated from study area|0|||
48481258|NCT00627458|155955904|FG002|Overall Study|Migrated from study area|1|||
48481259|NCT00627458|155955902|FG000|Overall Study|Withdrawal by Subject|2|||
48481260|NCT00627458|155955903|FG001|Overall Study|Withdrawal by Subject|6|||
48481261|NCT00627458|155955904|FG002|Overall Study|Withdrawal by Subject|5|||
48481262|NCT00627458|155955902|FG000|Overall Study|Lost to Follow-up|1|||
48481263|NCT00627458|155955903|FG001|Overall Study|Lost to Follow-up|1|||
48481264|NCT00627458|155955904|FG002|Overall Study|Lost to Follow-up|0|||
48481265|NCT04529096|155955905|FG000|Overall Study|Adverse Event|6|||
48481266|NCT04529096|155955906|FG001|Overall Study|Adverse Event|1|||
48481267|NCT04529096|155955905|FG000|Overall Study|Lack of Efficacy|1|||
48481268|NCT04529096|155955906|FG001|Overall Study|Lack of Efficacy|0|||
48481269|NCT04529096|155955905|FG000|Overall Study|Lost to Follow-up|1|||
48481270|NCT04529096|155955906|FG001|Overall Study|Lost to Follow-up|1|||
48481271|NCT04529096|155955905|FG000|Overall Study|Non-Compliance With Study Drug|0|||
48481272|NCT04529096|155955906|FG001|Overall Study|Non-Compliance With Study Drug|1|||
48481273|NCT04529096|155955905|FG000|Overall Study|Physician Decision|1|||
48481274|NCT04529096|155955906|FG001|Overall Study|Physician Decision|3|||
48481275|NCT04529096|155955905|FG000|Overall Study|Withdrawal by Subject|5|||
48481276|NCT04529096|155955906|FG001|Overall Study|Withdrawal by Subject|0|||
48481277|NCT01256398|155955907|FG000|Overall Study|Withdrawal by Subject|1|||
48481278|NCT04529499|155955912|FG000|Overall Study|Withdrawal by Subject|9|||
48481279|NCT04529499|155955913|FG001|Overall Study|Withdrawal by Subject|11|||
48481280|NCT04529499|155955912|FG000|Overall Study|Physician Decision|1|||
48481281|NCT04529499|155955913|FG001|Overall Study|Physician Decision|2|||
48481282|NCT04529499|155955912|FG000|Overall Study|Adverse Event|4|||
48481283|NCT04529499|155955913|FG001|Overall Study|Adverse Event|4|||
48481284|NCT04529499|155955912|FG000|Overall Study|Death|14|||
48481285|NCT04529499|155955913|FG001|Overall Study|Death|11|||
48481286|NCT04529499|155955912|FG000|Overall Study|Lost to Follow-up|1|||
48481287|NCT04529499|155955913|FG001|Overall Study|Lost to Follow-up|1|||
48481288|NCT04529499|155955912|FG000|Overall Study|Others|7|||
48481289|NCT04529499|155955913|FG001|Overall Study|Others|11|||
48481290|NCT00683904|155955914|FG000|Dose Level 1|Disease progression|2|||
48481291|NCT00683904|155955915|FG001|Dose Level 1|Disease progression|0|||
48481292|NCT00683904|155955914|FG000|Dose Level 1|Adverse Event|1|||
48481293|NCT00683904|155955915|FG001|Dose Level 1|Adverse Event|0|||
48481294|NCT00683904|155955914|FG000|Dose Level 2|Adverse Event|0|||
48481295|NCT00683904|155955915|FG001|Dose Level 2|Adverse Event|2|||
48481296|NCT00758706|155955916|FG000|Overall Study|Adverse Event|4|||
48481297|NCT00758706|155955917|FG001|Overall Study|Adverse Event|4|||
48481298|NCT05246111|155955921|FG000|Period 01|NOT ELIGIBLE IC5|1|||
48481299|NCT05246111|155955922|FG001|Period 01|NOT ELIGIBLE IC5|0|||
48481300|NCT05293743|155955923|FG000|Overall Study|Withdrawal by Subject|1|||
48481301|NCT05293743|155955924|FG001|Overall Study|Withdrawal by Subject|0|||
48481302|NCT02587325|155955925|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
48481303|NCT02587325|155955926|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
48481304|NCT02587325|155955927|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
48481305|NCT02587325|155955928|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
48481306|NCT02587325|155955929|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
48481307|NCT02587325|155955925|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
48481308|NCT02587325|155955926|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
48481309|NCT02587325|155955927|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
48481310|NCT02587325|155955928|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
48481311|NCT02587325|155955929|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
48481312|NCT02587325|155955925|FG000|32-Week Optional Extension Part|Adverse Event|0|||
48481313|NCT02587325|155955926|FG001|32-Week Optional Extension Part|Adverse Event|0|||
48481314|NCT02587325|155955927|FG002|32-Week Optional Extension Part|Adverse Event|1|||
48481315|NCT02587325|155955928|FG003|32-Week Optional Extension Part|Adverse Event|0|||
48481316|NCT02587325|155955929|FG004|32-Week Optional Extension Part|Adverse Event|0|||
48481317|NCT02587325|155955925|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
48481318|NCT02587325|155955926|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
48481319|NCT02587325|155955927|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
48481320|NCT02587325|155955928|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
48481321|NCT02587325|155955929|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
48481322|NCT02913261|155955930|FG000|Overall Study|Technical problems|0|||
48481323|NCT02913261|155955931|FG001|Overall Study|Technical problems|1|||
48481324|NCT02913261|155955930|FG000|Overall Study|Lack of Efficacy|32|||
48481325|NCT02913261|155955931|FG001|Overall Study|Lack of Efficacy|69|||
48481326|NCT02913261|155955930|FG000|Overall Study|Adverse Event|27|||
48481327|NCT02913261|155955931|FG001|Overall Study|Adverse Event|5|||
48481328|NCT02913261|155955930|FG000|Overall Study|Death|25|||
48481329|NCT02913261|155955931|FG001|Overall Study|Death|22|||
48481330|NCT02913261|155955930|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
48481331|NCT02913261|155955931|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
48481332|NCT02913261|155955930|FG000|Overall Study|Disease relapse|8|||
48481333|NCT02913261|155955931|FG001|Overall Study|Disease relapse|13|||
48481334|NCT02913261|155955930|FG000|Overall Study|Physician Decision|8|||
48481335|NCT02913261|155955931|FG001|Overall Study|Physician Decision|9|||
48481336|NCT02913261|155955930|FG000|Overall Study|Subject/guardian decision|4|||
48481337|NCT02913261|155955931|FG001|Overall Study|Subject/guardian decision|6|||
48481338|NCT02913261|155955930|FG000|Overall Study|Graft loss|2|||
48481339|NCT02913261|155955931|FG001|Overall Study|Graft loss|0|||
48481340|NCT02149199|155955933|FG000|Overall Study|Study specific withdrawal criteria|4|||
48481341|NCT02149199|155955934|FG001|Overall Study|Study specific withdrawal criteria|21|||
48481342|NCT02149199|155955935|FG002|Overall Study|Study specific withdrawal criteria|6|||
48481343|NCT02149199|155955933|FG000|Overall Study|Other|20|||
48481344|NCT02149199|155955934|FG001|Overall Study|Other|25|||
48481345|NCT02149199|155955935|FG002|Overall Study|Other|20|||
48481346|NCT02149199|155955933|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
48481347|NCT02149199|155955934|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
48481348|NCT02149199|155955935|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
48481349|NCT02149199|155955933|FG000|Overall Study|Withdrawal by Subject|75|||
48481350|NCT02149199|155955934|FG001|Overall Study|Withdrawal by Subject|93|||
48481351|NCT02149199|155955935|FG002|Overall Study|Withdrawal by Subject|77|||
48481352|NCT02149199|155955933|FG000|Overall Study|Protocol Violation|16|||
48481353|NCT02149199|155955934|FG001|Overall Study|Protocol Violation|13|||
48481354|NCT02149199|155955935|FG002|Overall Study|Protocol Violation|15|||
48481355|NCT02149199|155955933|FG000|Overall Study|Lost to Follow-up|3|||
48481356|NCT02149199|155955934|FG001|Overall Study|Lost to Follow-up|12|||
48481357|NCT02149199|155955935|FG002|Overall Study|Lost to Follow-up|11|||
48481358|NCT02149199|155955933|FG000|Overall Study|Death|0|||
48481359|NCT02149199|155955934|FG001|Overall Study|Death|0|||
48481360|NCT02149199|155955935|FG002|Overall Study|Death|1|||
48481361|NCT02149199|155955933|FG000|Overall Study|Adverse Event|6|||
48481362|NCT02149199|155955934|FG001|Overall Study|Adverse Event|15|||
48481363|NCT02149199|155955935|FG002|Overall Study|Adverse Event|9|||
48481364|NCT03909971|155955936|FG000|Overall Study|Other Reasons Not Specified|0|||
48481365|NCT03909971|155955937|FG001|Overall Study|Other Reasons Not Specified|1|||
48481366|NCT03909971|155955936|FG000|Overall Study|Global Deterioration of Health Status|2|||
48481367|NCT03909971|155955937|FG001|Overall Study|Global Deterioration of Health Status|1|||
48481368|NCT03909971|155955936|FG000|Overall Study|Progressive Disease|6|||
48481369|NCT03909971|155955937|FG001|Overall Study|Progressive Disease|14|||
48481370|NCT03909971|155955936|FG000|Overall Study|Death|2|||
48481371|NCT03909971|155955937|FG001|Overall Study|Death|6|||
48481372|NCT00808015|155955938|FG000|Overall Study|Death|1|||
48481373|NCT00808015|155955938|FG000|Overall Study|Lack of Efficacy|58|||
48481374|NCT00808015|155955938|FG000|Overall Study|Lost to Follow-up|76|||
48481375|NCT00808015|155955938|FG000|Overall Study|Participants not willing to participate|158|||
48481376|NCT00808015|155955938|FG000|Overall Study|Adverse Event|22|||
48481377|NCT00808015|155955938|FG000|Overall Study|Other|25|||
48481378|NCT00808015|155955938|FG000|Overall Study|Enrolled but not treated|4|||
48481379|NCT00555399|155955941|FG000|Overall Study|Withdrawal by Subject|0|||
48481380|NCT00555399|155955942|FG001|Overall Study|Withdrawal by Subject|0|||
48481381|NCT00555399|155955943|FG002|Overall Study|Withdrawal by Subject|1|||
48481382|NCT00555399|155955944|FG003|Overall Study|Withdrawal by Subject|0|||
48481383|NCT00555399|155955945|FG004|Overall Study|Withdrawal by Subject|0|||
48481384|NCT00555399|155955946|FG005|Overall Study|Withdrawal by Subject|0|||
48481385|NCT00555399|155955947|FG006|Overall Study|Withdrawal by Subject|0|||
48481386|NCT00555399|155955948|FG007|Overall Study|Withdrawal by Subject|0|||
48481387|NCT00555399|155955949|FG008|Overall Study|Withdrawal by Subject|0|||
48481388|NCT00555399|155955950|FG009|Overall Study|Withdrawal by Subject|0|||
48481389|NCT00555399|155955951|FG010|Overall Study|Withdrawal by Subject|0|||
48481390|NCT00555399|155955952|FG011|Overall Study|Withdrawal by Subject|1|||
48481391|NCT00555399|155955941|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
48481392|NCT00555399|155955942|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
48481393|NCT00555399|155955943|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
48481394|NCT00555399|155955944|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
48481395|NCT00555399|155955945|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
48481396|NCT00555399|155955946|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
48481397|NCT00555399|155955947|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
48481398|NCT00555399|155955948|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
48481399|NCT00555399|155955949|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
48481400|NCT00555399|155955950|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
48481401|NCT00555399|155955951|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
48481402|NCT00555399|155955952|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
48481403|NCT04639310|155955953|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
48481404|NCT04639310|155955954|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
48481405|NCT00817778|155957444|FG000|Overall Study|Adverse Event|1|||
48481406|NCT00817778|155957445|FG001|Overall Study|Adverse Event|0|||
48481407|NCT00817778|155957444|FG000|Overall Study|Withdrawal by Subject|1|||
48481408|NCT00817778|155957445|FG001|Overall Study|Withdrawal by Subject|1|||
48481409|NCT00817778|155957444|FG000|Overall Study|Protocol Violation|0|||
48481410|NCT00817778|155957445|FG001|Overall Study|Protocol Violation|1|||
48481411|NCT00817778|155957444|FG000|Overall Study|Study-specific discontinuation criteria|0|||
48481412|NCT00817778|155957445|FG001|Overall Study|Study-specific discontinuation criteria|1|||
48481413|NCT00817778|155957444|FG000|Overall Study|Poor venous access|1|||
48481414|NCT00817778|155957445|FG001|Overall Study|Poor venous access|0|||
48481415|NCT03343054|155957446|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
48481416|NCT03343054|155957447|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
48481417|NCT03343054|155957448|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
48481418|NCT03343054|155957446|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
48481419|NCT03343054|155957447|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
48481420|NCT03343054|155957448|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
48481421|NCT03343054|155957446|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
48481422|NCT03343054|155957447|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
48481423|NCT03343054|155957448|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
48481424|NCT03343054|155957446|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
48481425|NCT03343054|155957447|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
48481426|NCT03343054|155957448|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
48481427|NCT04725240|155957451|FG000|Overall Study|Adverse Event|2|||
48481428|NCT04991311|155957452|FG000|Overall Study|Adverse Event|1|||
48481429|NCT02261974|155957461|FG000|Overall Study|Withdrawal by Subject|3|||
48481430|NCT02261974|155957462|FG001|Overall Study|Withdrawal by Subject|2|||
48481431|NCT02261974|155957461|FG000|Overall Study|Pregnancy|0|||
48481432|NCT02261974|155957462|FG001|Overall Study|Pregnancy|1|||
48481433|NCT02261974|155957461|FG000|Overall Study|Missed treatment cut-off date|6|||
48481434|NCT02261974|155957462|FG001|Overall Study|Missed treatment cut-off date|3|||
48481435|NCT02261974|155957461|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
48481436|NCT02261974|155957462|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
48481437|NCT02261974|155957461|FG000|Overall Study|Lost to Follow-up|2|||
48481438|NCT02261974|155957462|FG001|Overall Study|Lost to Follow-up|0|||
48481439|NCT02261974|155957461|FG000|Overall Study|Adverse Event|1|||
48481440|NCT02261974|155957462|FG001|Overall Study|Adverse Event|0|||
48481441|NCT00447694|155957465|FG000|Overall Study|Adverse Event|2|||
48481442|NCT00447694|155957465|FG000|Overall Study|Abnormal laboratory value|1|||
48481443|NCT00447694|155957465|FG000|Overall Study|Abnormal test procedure result|1|||
48481444|NCT00447694|155957465|FG000|Overall Study|Withdrawal by Subject|2|||
48481445|NCT01984229|155957466|FG000|Safety Follow-up Period|Adverse Event|1|||
48481446|NCT01984229|155957467|FG001|Safety Follow-up Period|Adverse Event|1|||
48481447|NCT01984229|155957466|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
48481448|NCT01984229|155957467|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
48481449|NCT02072174|155957468|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
48481450|NCT02072174|155957469|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
48481451|NCT02072174|155957468|FG000|Overall Study|Protocol Violation|16|||
48481452|NCT02072174|155957469|FG001|Overall Study|Protocol Violation|23|||
48481453|NCT02072174|155957468|FG000|Overall Study|Physician Decision|0|||
48481454|NCT02072174|155957469|FG001|Overall Study|Physician Decision|1|||
48481455|NCT02072174|155957468|FG000|Overall Study|Non-compliance with protocol requirement|2|||
48481456|NCT02072174|155957469|FG001|Overall Study|Non-compliance with protocol requirement|0|||
48481457|NCT00709735|155957471|FG000|Overall Study|Lost to Follow-up|1|||
48481458|NCT00709735|155957472|FG001|Overall Study|Lost to Follow-up|1|||
48481459|NCT00709735|155957471|FG000|Overall Study|Relapse into Opioid Abuse|0|||
48481460|NCT00709735|155957472|FG001|Overall Study|Relapse into Opioid Abuse|1|||
48481461|NCT00709735|155957471|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
48481462|NCT00709735|155957472|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
48481463|NCT05674721|155957473|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
48481464|NCT05674721|155957474|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
48481847|NCT03954184|155959033|FG000|Overall Study|Lost to Follow-up|500|||
48481465|NCT05674721|155957473|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
48481466|NCT05674721|155957474|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
48481467|NCT01333475|155957475|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
48481468|NCT01333475|155957476|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
48481469|NCT01333475|155957475|FG000|Overall Study|Toxicity|1|||
48481470|NCT01333475|155957476|FG001|Overall Study|Toxicity|3|||
48481471|NCT03891875|155957477|FG000|Overall Study|Withdrawal by Subject|20|||
48481472|NCT03891875|155957478|FG001|Overall Study|Withdrawal by Subject|3|||
48481473|NCT03891875|155957477|FG000|Overall Study|Adverse Event|10|||
48481474|NCT03891875|155957478|FG001|Overall Study|Adverse Event|4|||
48481475|NCT03891875|155957477|FG000|Overall Study|Physician Decision|1|||
48481476|NCT03891875|155957478|FG001|Overall Study|Physician Decision|1|||
48481477|NCT03891875|155957477|FG000|Overall Study|Protocol Violation|1|||
48481478|NCT03891875|155957478|FG001|Overall Study|Protocol Violation|0|||
48481479|NCT03891875|155957477|FG000|Overall Study|Lost to Follow-up|1|||
48481480|NCT03891875|155957478|FG001|Overall Study|Lost to Follow-up|0|||
48481481|NCT03891875|155957477|FG000|Overall Study|COVID-19 infection|1|||
48481482|NCT03891875|155957478|FG001|Overall Study|COVID-19 infection|0|||
48481483|NCT04440007|155957482|FG000|Overall Study|Adverse Event|0|||
48481484|NCT04440007|155957483|FG001|Overall Study|Adverse Event|1|||
48481485|NCT04440007|155957482|FG000|Overall Study|Lost to Follow-up|1|||
48481486|NCT04440007|155957483|FG001|Overall Study|Lost to Follow-up|3|||
48481487|NCT04440007|155957482|FG000|Overall Study|Death|7|||
48481488|NCT04440007|155957483|FG001|Overall Study|Death|2|||
48481489|NCT04440007|155957482|FG000|Overall Study|Physician Decision|1|||
48481490|NCT04440007|155957483|FG001|Overall Study|Physician Decision|1|||
48481491|NCT04440007|155957482|FG000|Overall Study|Withdrawal by Subject|2|||
48481492|NCT04440007|155957483|FG001|Overall Study|Withdrawal by Subject|1|||
48481493|NCT04440007|155957482|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
48481494|NCT04440007|155957483|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
48481495|NCT04440007|155957482|FG000|Overall Study|Discontinued prior to dosing|0|||
48481496|NCT04440007|155957483|FG001|Overall Study|Discontinued prior to dosing|2|||
48481497|NCT01787188|155957487|FG000|Overall Study|Adverse Event|2|||
48481498|NCT01787188|155957488|FG001|Overall Study|Adverse Event|4|||
48481499|NCT01787188|155957489|FG002|Overall Study|Adverse Event|6|||
48481500|NCT01787188|155957487|FG000|Overall Study|Lack of Efficacy|7|||
48481501|NCT01787188|155957488|FG001|Overall Study|Lack of Efficacy|3|||
48481502|NCT01787188|155957489|FG002|Overall Study|Lack of Efficacy|5|||
48481503|NCT01787188|155957487|FG000|Overall Study|Non-compliance with Study Drug|0|||
48481504|NCT01787188|155957488|FG001|Overall Study|Non-compliance with Study Drug|1|||
48481505|NCT01787188|155957489|FG002|Overall Study|Non-compliance with Study Drug|0|||
48481506|NCT01787188|155957487|FG000|Overall Study|Withdrawal by Subject|4|||
48481507|NCT01787188|155957488|FG001|Overall Study|Withdrawal by Subject|3|||
48481508|NCT01787188|155957489|FG002|Overall Study|Withdrawal by Subject|2|||
48481509|NCT01787188|155957487|FG000|Overall Study|Protocol Violation|3|||
48481510|NCT01787188|155957488|FG001|Overall Study|Protocol Violation|2|||
48481511|NCT01787188|155957489|FG002|Overall Study|Protocol Violation|3|||
48481512|NCT01787188|155957487|FG000|Overall Study|Lost to Follow-up|1|||
48481513|NCT01787188|155957488|FG001|Overall Study|Lost to Follow-up|2|||
48481514|NCT01787188|155957489|FG002|Overall Study|Lost to Follow-up|2|||
48481515|NCT01787188|155957487|FG000|Overall Study|Other, including patient moved|0|||
48481516|NCT01787188|155957488|FG001|Overall Study|Other, including patient moved|3|||
48481517|NCT01787188|155957489|FG002|Overall Study|Other, including patient moved|0|||
48481518|NCT00854607|155957492|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
48481519|NCT01162135|155957498|FG000|Overall Study|Withdrawal by Subject|1|||
48481520|NCT01162135|155957498|FG000|Overall Study|Severe back pain|1|||
48481521|NCT01162135|155957498|FG000|Overall Study|Ineligible|1|||
48481522|NCT01393626|155957499|FG000|Overall Study|Adverse Event|2|||
48481523|NCT01393626|155957500|FG001|Overall Study|Adverse Event|1|||
48481524|NCT01393626|155957501|FG002|Overall Study|Adverse Event|5|||
48481525|NCT01393626|155957502|FG003|Overall Study|Adverse Event|0|||
48481526|NCT01393626|155957499|FG000|Overall Study|Did not meet entrance criteria|1|||
48481527|NCT01393626|155957500|FG001|Overall Study|Did not meet entrance criteria|0|||
48481528|NCT01393626|155957501|FG002|Overall Study|Did not meet entrance criteria|0|||
48481529|NCT01393626|155957502|FG003|Overall Study|Did not meet entrance criteria|0|||
48481530|NCT01393626|155957499|FG000|Overall Study|Lack of Efficacy|6|||
48481531|NCT01393626|155957500|FG001|Overall Study|Lack of Efficacy|6|||
48481532|NCT01393626|155957501|FG002|Overall Study|Lack of Efficacy|4|||
48481533|NCT01393626|155957502|FG003|Overall Study|Lack of Efficacy|1|||
48481534|NCT01393626|155957499|FG000|Overall Study|Lost to Follow-up|1|||
48481535|NCT01393626|155957500|FG001|Overall Study|Lost to Follow-up|1|||
48481536|NCT01393626|155957501|FG002|Overall Study|Lost to Follow-up|1|||
48481537|NCT01393626|155957502|FG003|Overall Study|Lost to Follow-up|0|||
48481538|NCT01393626|155957499|FG000|Overall Study|Withdrawal by Subject|6|||
48481539|NCT01393626|155957500|FG001|Overall Study|Withdrawal by Subject|4|||
48481540|NCT01393626|155957501|FG002|Overall Study|Withdrawal by Subject|0|||
48481541|NCT01393626|155957502|FG003|Overall Study|Withdrawal by Subject|0|||
48481542|NCT01393626|155957499|FG000|Overall Study|Other|1|||
48481543|NCT01393626|155957500|FG001|Overall Study|Other|0|||
48481544|NCT01393626|155957501|FG002|Overall Study|Other|0|||
48481545|NCT01393626|155957502|FG003|Overall Study|Other|0|||
48481546|NCT01393626|155957499|FG000|Overall Study|Protocol Violation|1|||
48481547|NCT01393626|155957500|FG001|Overall Study|Protocol Violation|0|||
48481548|NCT01393626|155957501|FG002|Overall Study|Protocol Violation|2|||
48481549|NCT01393626|155957502|FG003|Overall Study|Protocol Violation|0|||
48481550|NCT02426125|155957503|FG000|Overall Study|Lost to Follow-up|14|||
48481551|NCT02426125|155957504|FG001|Overall Study|Lost to Follow-up|12|||
48481552|NCT02426125|155957503|FG000|Overall Study|Withdrawal by Subject|13|||
48481553|NCT02426125|155957504|FG001|Overall Study|Withdrawal by Subject|14|||
48481554|NCT02426125|155957503|FG000|Overall Study|Death|185|||
48481555|NCT02426125|155957504|FG001|Overall Study|Death|200|||
48481556|NCT02426125|155957503|FG000|Overall Study|Randomized, But Never Treated|5|||
48481557|NCT02426125|155957504|FG001|Overall Study|Randomized, But Never Treated|2|||
48481558|NCT01610167|155957505|FG000|Overall Study|Scheduling conflict.|0|||
48481559|NCT01610167|155957506|FG001|Overall Study|Scheduling conflict.|0|||
48481560|NCT01610167|155957507|FG002|Overall Study|Scheduling conflict.|2|||
48481561|NCT01289990|155957508|FG000|Overall Study|Death|0|||
48481562|NCT01289990|155957509|FG001|Overall Study|Death|0|||
48481563|NCT01289990|155957510|FG002|Overall Study|Death|0|||
48481564|NCT01289990|155957511|FG003|Overall Study|Death|1|||
48481565|NCT01289990|155957512|FG004|Overall Study|Death|2|||
48481566|NCT01289990|155957513|FG005|Overall Study|Death|1|||
48481567|NCT01289990|155957514|FG006|Overall Study|Death|0|||
48481568|NCT01289990|155957515|FG007|Overall Study|Death|0|||
48481569|NCT01289990|155957516|FG008|Overall Study|Death|0|||
48481570|NCT01289990|155957517|FG009|Overall Study|Death|0|||
48481571|NCT01289990|155957518|FG010|Overall Study|Death|0|||
48481572|NCT01289990|155957519|FG011|Overall Study|Death|1|||
48481573|NCT01289990|155957520|FG012|Overall Study|Death|0|||
48481574|NCT01289990|155957508|FG000|Overall Study|Lost to Follow-up|3|||
48481575|NCT01289990|155957509|FG001|Overall Study|Lost to Follow-up|2|||
48481576|NCT01289990|155957510|FG002|Overall Study|Lost to Follow-up|5|||
48481577|NCT01289990|155957511|FG003|Overall Study|Lost to Follow-up|5|||
48481578|NCT01289990|155957512|FG004|Overall Study|Lost to Follow-up|3|||
48481579|NCT01289990|155957513|FG005|Overall Study|Lost to Follow-up|4|||
48481580|NCT01289990|155957514|FG006|Overall Study|Lost to Follow-up|2|||
48481581|NCT01289990|155957515|FG007|Overall Study|Lost to Follow-up|2|||
48481582|NCT01289990|155957516|FG008|Overall Study|Lost to Follow-up|1|||
48481583|NCT01289990|155957517|FG009|Overall Study|Lost to Follow-up|4|||
48481584|NCT01289990|155957518|FG010|Overall Study|Lost to Follow-up|2|||
48481585|NCT01289990|155957519|FG011|Overall Study|Lost to Follow-up|1|||
48481586|NCT01289990|155957520|FG012|Overall Study|Lost to Follow-up|2|||
48481587|NCT01289990|155957508|FG000|Overall Study|Withdrawal by Subject|15|||
48481588|NCT01289990|155957509|FG001|Overall Study|Withdrawal by Subject|14|||
48481589|NCT01289990|155957510|FG002|Overall Study|Withdrawal by Subject|12|||
48481590|NCT01289990|155957511|FG003|Overall Study|Withdrawal by Subject|13|||
48481591|NCT01289990|155957512|FG004|Overall Study|Withdrawal by Subject|8|||
48481592|NCT01289990|155957513|FG005|Overall Study|Withdrawal by Subject|7|||
48481593|NCT01289990|155957514|FG006|Overall Study|Withdrawal by Subject|13|||
48481594|NCT01289990|155957515|FG007|Overall Study|Withdrawal by Subject|9|||
48481595|NCT01289990|155957516|FG008|Overall Study|Withdrawal by Subject|12|||
48481596|NCT01289990|155957517|FG009|Overall Study|Withdrawal by Subject|13|||
48481597|NCT01289990|155957518|FG010|Overall Study|Withdrawal by Subject|11|||
48481598|NCT01289990|155957519|FG011|Overall Study|Withdrawal by Subject|13|||
48481599|NCT01289990|155957520|FG012|Overall Study|Withdrawal by Subject|16|||
48481600|NCT01289990|155957508|FG000|Overall Study|discontinued in preceding trial|18|||
48481601|NCT01289990|155957509|FG001|Overall Study|discontinued in preceding trial|20|||
48481602|NCT01289990|155957510|FG002|Overall Study|discontinued in preceding trial|41|||
48481603|NCT01289990|155957511|FG003|Overall Study|discontinued in preceding trial|17|||
48481604|NCT01289990|155957512|FG004|Overall Study|discontinued in preceding trial|11|||
48481605|NCT01289990|155957513|FG005|Overall Study|discontinued in preceding trial|12|||
48481606|NCT01289990|155957514|FG006|Overall Study|discontinued in preceding trial|18|||
48481607|NCT01289990|155957515|FG007|Overall Study|discontinued in preceding trial|8|||
48481608|NCT01289990|155957516|FG008|Overall Study|discontinued in preceding trial|17|||
48481609|NCT01289990|155957517|FG009|Overall Study|discontinued in preceding trial|21|||
48481610|NCT01289990|155957518|FG010|Overall Study|discontinued in preceding trial|17|||
48481611|NCT01289990|155957519|FG011|Overall Study|discontinued in preceding trial|17|||
48481612|NCT01289990|155957520|FG012|Overall Study|discontinued in preceding trial|24|||
48481613|NCT01289990|155957508|FG000|Overall Study|did not continue in extension|41|||
48481614|NCT01289990|155957509|FG001|Overall Study|did not continue in extension|45|||
48481615|NCT01289990|155957510|FG002|Overall Study|did not continue in extension|51|||
48481616|NCT01289990|155957511|FG003|Overall Study|did not continue in extension|51|||
48481617|NCT01289990|155957512|FG004|Overall Study|did not continue in extension|48|||
48481618|NCT01289990|155957513|FG005|Overall Study|did not continue in extension|50|||
48481619|NCT01289990|155957514|FG006|Overall Study|did not continue in extension|54|||
48481620|NCT01289990|155957515|FG007|Overall Study|did not continue in extension|36|||
48481621|NCT01289990|155957516|FG008|Overall Study|did not continue in extension|44|||
48481622|NCT01289990|155957517|FG009|Overall Study|did not continue in extension|48|||
48481623|NCT01289990|155957518|FG010|Overall Study|did not continue in extension|45|||
48481624|NCT01289990|155957519|FG011|Overall Study|did not continue in extension|34|||
48481625|NCT01289990|155957520|FG012|Overall Study|did not continue in extension|56|||
48481626|NCT01289990|155957508|FG000|Overall Study|Not treated|0|||
48481627|NCT01289990|155957509|FG001|Overall Study|Not treated|0|||
48481628|NCT01289990|155957510|FG002|Overall Study|Not treated|0|||
48481629|NCT01289990|155957511|FG003|Overall Study|Not treated|0|||
48481630|NCT01289990|155957512|FG004|Overall Study|Not treated|0|||
48481631|NCT01289990|155957513|FG005|Overall Study|Not treated|0|||
48481632|NCT01289990|155957514|FG006|Overall Study|Not treated|1|||
48481633|NCT01289990|155957515|FG007|Overall Study|Not treated|0|||
48481634|NCT01289990|155957516|FG008|Overall Study|Not treated|1|||
48481635|NCT01289990|155957517|FG009|Overall Study|Not treated|0|||
48481636|NCT01289990|155957518|FG010|Overall Study|Not treated|1|||
48481637|NCT01289990|155957519|FG011|Overall Study|Not treated|2|||
48481638|NCT01289990|155957520|FG012|Overall Study|Not treated|0|||
48481639|NCT00061945|155957521|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
48481640|NCT00061945|155957522|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
48481641|NCT00061945|155957521|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
48481642|NCT00061945|155957522|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
48481643|NCT00061945|155957521|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
48481644|NCT00061945|155957522|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
48481645|NCT00061945|155957521|FG000|Course IV: Alemtuzumab|Early exits|6|||
48481646|NCT00061945|155957522|FG001|Course IV: Alemtuzumab|Early exits|15|||
48481647|NCT01039584|155957523|FG000|Overall Study|Withdrawal by Subject|4|||
48481648|NCT01039584|155957524|FG001|Overall Study|Withdrawal by Subject|2|||
48481649|NCT01039584|155957525|FG002|Overall Study|Withdrawal by Subject|1|||
48481650|NCT01039584|155957523|FG000|Overall Study|Protocol Violation|10|||
48481651|NCT01039584|155957524|FG001|Overall Study|Protocol Violation|4|||
48481652|NCT01039584|155957525|FG002|Overall Study|Protocol Violation|6|||
48481653|NCT01039584|155957523|FG000|Overall Study|Lost to Follow-up|5|||
48481654|NCT01039584|155957524|FG001|Overall Study|Lost to Follow-up|3|||
48481655|NCT01039584|155957525|FG002|Overall Study|Lost to Follow-up|4|||
48481656|NCT01039584|155957523|FG000|Overall Study|Negative Baseline culture for Candida|59|||
48481657|NCT01039584|155957524|FG001|Overall Study|Negative Baseline culture for Candida|59|||
48481658|NCT01039584|155957525|FG002|Overall Study|Negative Baseline culture for Candida|24|||
48481659|NCT01039584|155957523|FG000|Overall Study|Lack of Efficacy|7|||
48481660|NCT01039584|155957524|FG001|Overall Study|Lack of Efficacy|6|||
48481661|NCT01039584|155957525|FG002|Overall Study|Lack of Efficacy|10|||
48481662|NCT01039584|155957523|FG000|Overall Study|other|1|||
48481663|NCT01039584|155957524|FG001|Overall Study|other|3|||
48481664|NCT01039584|155957525|FG002|Overall Study|other|1|||
48481665|NCT01039584|155957523|FG000|Overall Study|Pap smear with significant pathology|10|||
48481666|NCT01039584|155957524|FG001|Overall Study|Pap smear with significant pathology|10|||
48481667|NCT01039584|155957525|FG002|Overall Study|Pap smear with significant pathology|3|||
48481668|NCT01039584|155957523|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
48481669|NCT01039584|155957524|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
48481670|NCT01039584|155957525|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
48481671|NCT03197662|155957526|FG000|Overall Study|Withdrawn by family|0|||
48481672|NCT03197662|155957527|FG001|Overall Study|Withdrawn by family|2|||
48481673|NCT03276962|155957530|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
48481674|NCT03276962|155957531|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
48481675|NCT03276962|155957532|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
48481676|NCT03276962|155957533|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
48481677|NCT03276962|155957534|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
48481678|NCT03276962|155957530|FG000|Overall Study|Protocol Deviation|2|||
48481679|NCT03276962|155957531|FG001|Overall Study|Protocol Deviation|0|||
48481680|NCT03276962|155957532|FG002|Overall Study|Protocol Deviation|1|||
48481681|NCT03276962|155957533|FG003|Overall Study|Protocol Deviation|2|||
48481682|NCT03276962|155957534|FG004|Overall Study|Protocol Deviation|1|||
48481683|NCT03276962|155957530|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
48481684|NCT03276962|155957531|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
48481685|NCT03276962|155957532|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
48481686|NCT03276962|155957533|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
48481687|NCT03276962|155957534|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
48481688|NCT03276962|155957530|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
48481689|NCT03276962|155957531|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
48481690|NCT03276962|155957532|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
48481691|NCT03276962|155957533|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
48481692|NCT03276962|155957534|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
48481693|NCT03276962|155957530|FG000|Overall Study|Lost to Follow-up|10|||
48481694|NCT03276962|155957531|FG001|Overall Study|Lost to Follow-up|10|||
48481695|NCT03276962|155957532|FG002|Overall Study|Lost to Follow-up|4|||
48481696|NCT03276962|155957533|FG003|Overall Study|Lost to Follow-up|6|||
48481697|NCT03276962|155957534|FG004|Overall Study|Lost to Follow-up|10|||
48481698|NCT03276962|155957530|FG000|Overall Study|Other|0|||
48481699|NCT03276962|155957531|FG001|Overall Study|Other|2|||
48481700|NCT03276962|155957532|FG002|Overall Study|Other|0|||
48481701|NCT03276962|155957533|FG003|Overall Study|Other|2|||
48481702|NCT03276962|155957534|FG004|Overall Study|Other|1|||
48481703|NCT00411762|155957535|FG000|Overall Study|Withdrawal by Subject|5|||
48481704|NCT02989610|155957537|FG000|Overall Study|Withdrawal by Subject|20|||
48481705|NCT02989610|155957537|FG000|Overall Study|Departure of PI from Site|8|||
48481706|NCT02989610|155957537|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
48481707|NCT02989610|155957537|FG000|Overall Study|Lost to Follow-up|3|||
48481708|NCT02989610|155957537|FG000|Overall Study|Death|3|||
48481709|NCT02989610|155957537|FG000|Overall Study|System Explant|3|||
48481710|NCT02989610|155957537|FG000|Overall Study|Subject Non-Compliance|2|||
48481711|NCT02989610|155957537|FG000|Overall Study|System Revision|2|||
48481712|NCT02989610|155957537|FG000|Overall Study|PI Left, Study Closing|1|||
48481713|NCT02989610|155957537|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
48481714|NCT02989610|155957537|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
48481715|NCT02602080|155957540|FG000|Overall Study|Protocol Violation|6|||
48481716|NCT02602080|155957541|FG001|Overall Study|Protocol Violation|1|||
48481717|NCT02602080|155957542|FG002|Overall Study|Protocol Violation|3|||
48481718|NCT00759759|155957546|FG000|Overall Study|didn't return for period 2|1|||
48481719|NCT00759759|155957547|FG001|Overall Study|didn't return for period 2|0|||
48481720|NCT00759759|155957546|FG000|Overall Study|Didn't receive drug in period 2|1|||
48481721|NCT00759759|155957547|FG001|Overall Study|Didn't receive drug in period 2|0|||
48481722|NCT00759759|155957546|FG000|Overall Study|Withdrawal by Subject|2|||
48481723|NCT00759759|155957547|FG001|Overall Study|Withdrawal by Subject|1|||
48481724|NCT00430638|155957549|FG000|Overall Study|Adverse Event|15|||
48481725|NCT00430638|155957550|FG001|Overall Study|Adverse Event|15|||
48481726|NCT00430638|155957549|FG000|Overall Study|Uncontrolled blood pressure|48|||
48481727|NCT00430638|155957550|FG001|Overall Study|Uncontrolled blood pressure|13|||
48481728|NCT00430638|155957549|FG000|Overall Study|Lost to Follow-up|1|||
48481729|NCT00430638|155957550|FG001|Overall Study|Lost to Follow-up|7|||
48481730|NCT00430638|155957549|FG000|Overall Study|Protocol Violation|6|||
48481731|NCT00430638|155957550|FG001|Overall Study|Protocol Violation|4|||
48481732|NCT00430638|155957549|FG000|Overall Study|Withdrawal by Subject|4|||
48481733|NCT00430638|155957550|FG001|Overall Study|Withdrawal by Subject|6|||
48481734|NCT00430638|155957549|FG000|Overall Study|Non-compliant|2|||
48481735|NCT00430638|155957550|FG001|Overall Study|Non-compliant|1|||
48481736|NCT00430638|155957549|FG000|Overall Study|Other|2|||
48481737|NCT00430638|155957550|FG001|Overall Study|Other|2|||
48481738|NCT04651218|155959002|FG000|Overall Study|Withdrawal by Subject|0|||
48481739|NCT04651218|155959003|FG001|Overall Study|Withdrawal by Subject|2|||
48481740|NCT00765999|155959004|FG000|Overall Study|Adverse Event|203|||
48481741|NCT00765999|155959004|FG000|Overall Study|Insufficient Therapeutic Response|100|||
48481742|NCT00765999|155959004|FG000|Overall Study|Protocol Violation|95|||
48481743|NCT00765999|155959004|FG000|Overall Study|Consent Withdrawn|202|||
48481744|NCT00765999|155959004|FG000|Overall Study|Lost to Follow-up|131|||
48481745|NCT00765999|155959004|FG000|Overall Study|Study Terminated by Sponsor|2|||
48481746|NCT00765999|155959004|FG000|Overall Study|Other Miscellaneous Reasons|51|||
48481747|NCT03591107|155959007|FG000|Overall Study|Same patient in both arms|1|||
48481748|NCT03591107|155959008|FG001|Overall Study|Same patient in both arms|1|||
48481749|NCT03591107|155959007|FG000|Overall Study|Sought care at other clinics|0|||
48481750|NCT03591107|155959008|FG001|Overall Study|Sought care at other clinics|2|||
48481751|NCT03591107|155959007|FG000|Overall Study|Discharged from clinic|0|||
48481752|NCT03591107|155959008|FG001|Overall Study|Discharged from clinic|1|||
48481753|NCT03591107|155959007|FG000|Overall Study|Withdrawal by Subject|0|||
48481754|NCT03591107|155959008|FG001|Overall Study|Withdrawal by Subject|1|||
48481755|NCT02476851|155959011|FG000|Overall Study|Protocol Violation|1|||
48481756|NCT02476851|155959012|FG001|Overall Study|Protocol Violation|1|||
48481757|NCT00337129|155959015|FG000|Overall Study|Adverse Event|4|||
48481758|NCT00337129|155959015|FG000|Overall Study|Withdrawal by Subject|1|||
48481759|NCT00337129|155959015|FG000|Overall Study|Lack of Efficacy|32|||
48481760|NCT00337129|155959015|FG000|Overall Study|Death|2|||
48481761|NCT00337129|155959015|FG000|Overall Study|not protocol specified|1|||
48481762|NCT00647426|155959016|FG000|Overall Study|Withdrawal by Subject|2|||
48481763|NCT02367729|155959019|FG000|Overall Study|Organic disorder diagnosed|2|||
48481764|NCT02367729|155959020|FG001|Overall Study|Organic disorder diagnosed|1|||
48481765|NCT02367729|155959019|FG000|Overall Study|Adverse Event|1|||
48481766|NCT02367729|155959020|FG001|Overall Study|Adverse Event|2|||
48481767|NCT02367729|155959019|FG000|Overall Study|Withdrawal by Subject|0|||
48481768|NCT02367729|155959020|FG001|Overall Study|Withdrawal by Subject|5|||
48481769|NCT00388674|155959021|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
48481770|NCT00388674|155959022|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
48481771|NCT00388674|155959021|FG000|Initial Treatment|Adverse Event|22|||
48481772|NCT00388674|155959022|FG001|Initial Treatment|Adverse Event|87|||
48481773|NCT00388674|155959021|FG000|Initial Treatment|Death|215|||
48481774|NCT00388674|155959022|FG001|Initial Treatment|Death|216|||
48481775|NCT00388674|155959021|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
48481776|NCT00388674|155959022|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
48481777|NCT00388674|155959021|FG000|Initial Treatment|HCC|12|||
48481778|NCT00388674|155959022|FG001|Initial Treatment|HCC|20|||
48481779|NCT00388674|155959021|FG000|Initial Treatment|Lost to Follow-up|526|||
48481780|NCT00388674|155959022|FG001|Initial Treatment|Lost to Follow-up|624|||
48481781|NCT00388674|155959021|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
48481782|NCT00388674|155959022|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
48481783|NCT00388674|155959021|FG000|Initial Treatment|Never Treated with Study Medication|1|||
48481784|NCT00388674|155959022|FG001|Initial Treatment|Never Treated with Study Medication|7|||
48481785|NCT00388674|155959021|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
48481786|NCT00388674|155959022|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
48481787|NCT00388674|155959021|FG000|Initial Treatment|Not Defined|125|||
48481788|NCT00388674|155959022|FG001|Initial Treatment|Not Defined|172|||
48481789|NCT00388674|155959021|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
48481790|NCT00388674|155959022|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
48481791|NCT00388674|155959021|FG000|Initial Treatment|Pregnancy|26|||
48481792|NCT00388674|155959022|FG001|Initial Treatment|Pregnancy|16|||
48481793|NCT00388674|155959021|FG000|Initial Treatment|Study Drug Toxicity|5|||
48481794|NCT00388674|155959022|FG001|Initial Treatment|Study Drug Toxicity|92|||
48481795|NCT00388674|155959021|FG000|Initial Treatment|Participant Request|501|||
48481796|NCT00388674|155959022|FG001|Initial Treatment|Participant Request|673|||
48481797|NCT00388674|155959021|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
48481798|NCT00388674|155959022|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
48481799|NCT00388674|155959021|FG000|Initial Treatment|Not Reported|10|||
48481800|NCT00388674|155959022|FG001|Initial Treatment|Not Reported|12|||
48481801|NCT00388674|155959021|FG000|End of Study|Administrative Reason By Sponsor|299|||
48481802|NCT00388674|155959022|FG001|End of Study|Administrative Reason By Sponsor|253|||
48481803|NCT00388674|155959021|FG000|End of Study|Death|239|||
48481804|NCT00388674|155959022|FG001|End of Study|Death|262|||
48481805|NCT00388674|155959021|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
48481806|NCT00388674|155959022|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
48481807|NCT00388674|155959021|FG000|End of Study|HCC|8|||
48481808|NCT00388674|155959022|FG001|End of Study|HCC|7|||
48481809|NCT00388674|155959021|FG000|End of Study|Lost to Follow-up|587|||
48481810|NCT00388674|155959022|FG001|End of Study|Lost to Follow-up|715|||
48481811|NCT00388674|155959021|FG000|End of Study|Malignancy (Non-HCC)|1|||
48481812|NCT00388674|155959022|FG001|End of Study|Malignancy (Non-HCC)|1|||
48481813|NCT00388674|155959021|FG000|End of Study|Non-Study Related Comorbidities|3|||
48481814|NCT00388674|155959022|FG001|End of Study|Non-Study Related Comorbidities|4|||
48481815|NCT00388674|155959021|FG000|End of Study|Not Defined|135|||
48481816|NCT00388674|155959022|FG001|End of Study|Not Defined|214|||
48481817|NCT00388674|155959021|FG000|End of Study|Participant Withdrew Consent|437|||
48481818|NCT00388674|155959022|FG001|End of Study|Participant Withdrew Consent|673|||
48481819|NCT00388674|155959021|FG000|End of Study|No Off-Treatment Status Data|22|||
48481820|NCT00388674|155959022|FG001|End of Study|No Off-Treatment Status Data|30|||
48481821|NCT00388674|155959021|FG000|End of Study|Not Reported|0|||
48481822|NCT00388674|155959022|FG001|End of Study|Not Reported|1|||
48481823|NCT00563524|155959023|FG000|Overall Study|Adverse Event|0|||
48481824|NCT00563524|155959024|FG001|Overall Study|Adverse Event|1|||
48481825|NCT00563524|155959025|FG002|Overall Study|Adverse Event|0|||
48481826|NCT00563524|155959026|FG003|Overall Study|Adverse Event|0|||
48481827|NCT00563524|155959027|FG004|Overall Study|Adverse Event|2|||
48481828|NCT00563524|155959028|FG005|Overall Study|Adverse Event|0|||
48481829|NCT00563524|155959023|FG000|Overall Study|Lost to Follow-up|1|||
48481830|NCT00563524|155959024|FG001|Overall Study|Lost to Follow-up|0|||
48481831|NCT00563524|155959025|FG002|Overall Study|Lost to Follow-up|0|||
48481832|NCT00563524|155959026|FG003|Overall Study|Lost to Follow-up|0|||
48481833|NCT00563524|155959027|FG004|Overall Study|Lost to Follow-up|0|||
48481834|NCT00563524|155959028|FG005|Overall Study|Lost to Follow-up|0|||
48481835|NCT00563524|155959023|FG000|Overall Study|Protocol Violation|0|||
48481836|NCT00563524|155959024|FG001|Overall Study|Protocol Violation|1|||
48481837|NCT00563524|155959025|FG002|Overall Study|Protocol Violation|0|||
48481838|NCT00563524|155959026|FG003|Overall Study|Protocol Violation|0|||
48481839|NCT00563524|155959027|FG004|Overall Study|Protocol Violation|0|||
48481840|NCT00563524|155959028|FG005|Overall Study|Protocol Violation|0|||
48481841|NCT00563524|155959023|FG000|Overall Study|Withdrawal by Subject|1|||
48481842|NCT00563524|155959024|FG001|Overall Study|Withdrawal by Subject|1|||
48481843|NCT00563524|155959025|FG002|Overall Study|Withdrawal by Subject|3|||
48481844|NCT00563524|155959026|FG003|Overall Study|Withdrawal by Subject|0|||
48481845|NCT00563524|155959027|FG004|Overall Study|Withdrawal by Subject|0|||
48481846|NCT00563524|155959028|FG005|Overall Study|Withdrawal by Subject|1|||
48481848|NCT03954184|155959034|FG001|Overall Study|Lost to Follow-up|0|||
48481849|NCT03398200|155959037|FG000|Overall Study|Withdrawal by Subject|0|||
48481850|NCT03398200|155959038|FG001|Overall Study|Withdrawal by Subject|1|||
48481851|NCT00306852|155959039|FG000|Overall Study|Death|14|||
48481852|NCT00306852|155959040|FG001|Overall Study|Death|14|||
48481853|NCT00306852|155959039|FG000|Overall Study|Lost to Follow-up|15|||
48481854|NCT00306852|155959040|FG001|Overall Study|Lost to Follow-up|24|||
48481855|NCT02239601|155959041|FG000|Overall Study|Withdrawal by Subject|3|||
48481856|NCT02239601|155959042|FG001|Overall Study|Withdrawal by Subject|4|||
48481857|NCT02239601|155959041|FG000|Overall Study|Protocol Violation|4|||
48481858|NCT02239601|155959042|FG001|Overall Study|Protocol Violation|2|||
48481859|NCT04139668|155959043|FG000|Overall Study|Withdrawal by Subject|1|||
48481860|NCT00759174|155959048|FG000|Overall Study|Other|0|||
48481861|NCT00759174|155959049|FG001|Overall Study|Other|2|||
48481862|NCT01508325|155959050|FG000|Overall Study|Withdrawal by Subject|8|||
48481863|NCT01508325|155959051|FG001|Overall Study|Withdrawal by Subject|9|||
48481864|NCT01508325|155959050|FG000|Overall Study|Protocol Violation|0|||
48481865|NCT01508325|155959051|FG001|Overall Study|Protocol Violation|3|||
48481866|NCT01508325|155959050|FG000|Overall Study|Physician Decision|2|||
48481867|NCT01508325|155959051|FG001|Overall Study|Physician Decision|1|||
48481868|NCT01508325|155959050|FG000|Overall Study|Adverse Event|1|||
48481869|NCT01508325|155959051|FG001|Overall Study|Adverse Event|0|||
48481870|NCT01508325|155959050|FG000|Overall Study|Lost to Follow-up|5|||
48481871|NCT01508325|155959051|FG001|Overall Study|Lost to Follow-up|6|||
48481872|NCT01508325|155959050|FG000|Overall Study|Other|2|||
48481873|NCT01508325|155959051|FG001|Overall Study|Other|2|||
48481874|NCT01843374|155959052|FG000|Overall Study|Death|155|||
48481875|NCT01843374|155959053|FG001|Overall Study|Death|313|||
48481876|NCT01843374|155959052|FG000|Overall Study|Withdrawal by Subject|14|||
48481877|NCT01843374|155959053|FG001|Overall Study|Withdrawal by Subject|20|||
48481878|NCT01843374|155959052|FG000|Overall Study|Withdrawing due to Other reason|20|||
48481879|NCT01843374|155959053|FG001|Overall Study|Withdrawing due to Other reason|46|||
48481880|NCT04682639|155959054|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
48481881|NCT04682639|155959055|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
48481882|NCT04682639|155959056|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
48481883|NCT04682639|155959057|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
48481884|NCT04682639|155959058|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
48481885|NCT04682639|155959054|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
48481886|NCT04682639|155959055|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
48481887|NCT04682639|155959056|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
48481888|NCT04682639|155959057|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48481889|NCT04682639|155959058|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
48481890|NCT04682639|155959054|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
48481891|NCT04682639|155959055|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
48481892|NCT04682639|155959056|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48481893|NCT04682639|155959057|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48481894|NCT04682639|155959058|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
48481895|NCT04682639|155959054|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
48481896|NCT04682639|155959055|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
48481897|NCT04682639|155959056|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
48481898|NCT04682639|155959057|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
48481899|NCT04682639|155959058|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
48481900|NCT04682639|155959054|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
48481901|NCT04682639|155959055|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
48481902|NCT04682639|155959056|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
48481903|NCT04682639|155959057|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
48481904|NCT04682639|155959058|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
48481905|NCT04682639|155959054|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
48481906|NCT04682639|155959055|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
48481907|NCT04682639|155959056|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
48481908|NCT04682639|155959057|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48481909|NCT04682639|155959058|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
48481910|NCT04682639|155959054|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
48481911|NCT04682639|155959055|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
48481912|NCT04682639|155959056|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
48481913|NCT04682639|155959057|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
48481914|NCT04682639|155959058|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
48481915|NCT04682639|155959054|FG000|OLE Period (28 Weeks)|Other|1|||
48481916|NCT04682639|155959055|FG001|OLE Period (28 Weeks)|Other|2|||
48481917|NCT04682639|155959056|FG002|OLE Period (28 Weeks)|Other|0|||
48481918|NCT04682639|155959057|FG003|OLE Period (28 Weeks)|Other|0|||
48481919|NCT04682639|155959058|FG004|OLE Period (28 Weeks)|Other|1|||
48481920|NCT04682639|155959054|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
48481921|NCT04682639|155959055|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
48481922|NCT04682639|155959056|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
48481923|NCT04682639|155959057|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
48481924|NCT04682639|155959058|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
48481925|NCT04682639|155959054|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
48481926|NCT04682639|155959055|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
48481927|NCT04682639|155959056|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48481928|NCT04682639|155959057|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48481929|NCT04682639|155959058|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
48481930|NCT04682639|155959054|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
48481931|NCT04682639|155959055|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
48481932|NCT04682639|155959056|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
48481933|NCT04682639|155959057|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
48481934|NCT04682639|155959058|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
48481935|NCT04682639|155959054|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
48481936|NCT04682639|155959055|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
48481937|NCT04682639|155959056|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
48481938|NCT04682639|155959057|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
48481939|NCT04682639|155959058|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
48481940|NCT01392170|155959061|FG000|Overall Study|Withdrawal by Subject|1|||
48481941|NCT01392170|155959061|FG000|Overall Study|Ineligible|1|||
48481942|NCT01890109|155959062|FG000|Overall Study|Withdrawal by Subject|0|||
48481943|NCT01890109|155959063|FG001|Overall Study|Withdrawal by Subject|3|||
48481944|NCT01890109|155959062|FG000|Overall Study|Lost to Follow-up|1|||
48481945|NCT01890109|155959063|FG001|Overall Study|Lost to Follow-up|2|||
48481946|NCT01286207|155959064|FG000|Overall Study|Adverse Event|27|||
48481947|NCT01286207|155959065|FG001|Overall Study|Adverse Event|41|||
48481948|NCT01286207|155959066|FG002|Overall Study|Adverse Event|8|||
48481949|NCT01286207|155959064|FG000|Overall Study|Lost to Follow-up|49|||
48481950|NCT01286207|155959065|FG001|Overall Study|Lost to Follow-up|43|||
48481951|NCT01286207|155959066|FG002|Overall Study|Lost to Follow-up|20|||
48481952|NCT01286207|155959064|FG000|Overall Study|Withdrawal by Subject|93|||
48481953|NCT01286207|155959065|FG001|Overall Study|Withdrawal by Subject|79|||
48481954|NCT01286207|155959066|FG002|Overall Study|Withdrawal by Subject|41|||
48481955|NCT01286207|155959064|FG000|Overall Study|Lack of Response|92|||
48481956|NCT01286207|155959065|FG001|Overall Study|Lack of Response|38|||
48481957|NCT01286207|155959066|FG002|Overall Study|Lack of Response|8|||
48481958|NCT01286207|155959064|FG000|Overall Study|Other|37|||
48481959|NCT01286207|155959065|FG001|Overall Study|Other|47|||
48481960|NCT01286207|155959066|FG002|Overall Study|Other|13|||
48481961|NCT00981409|155959067|FG000|Overall Study|Adverse Event|4|||
48481962|NCT00981409|155959068|FG001|Overall Study|Adverse Event|0|||
48481963|NCT00981409|155959067|FG000|Overall Study|Protocol Violation|0|||
48481964|NCT00981409|155959068|FG001|Overall Study|Protocol Violation|1|||
48481965|NCT00981409|155959067|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
48481966|NCT00981409|155959068|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
48481967|NCT01383954|155959072|FG000|Overall Study|Lack of Efficacy|2|||
48481968|NCT01383954|155959072|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
48481969|NCT01383954|155959072|FG000|Overall Study|Adverse Event|1|||
48481970|NCT01383954|155959072|FG000|Overall Study|Reason Not Specified|9|||
48481971|NCT01643928|155959073|FG000|Overall Study|Lost to Follow-up|1|||
48481972|NCT01643928|155959074|FG001|Overall Study|Lost to Follow-up|0|||
48481973|NCT01643928|155959075|FG002|Overall Study|Lost to Follow-up|2|||
48481974|NCT01643928|155959076|FG003|Overall Study|Lost to Follow-up|0|||
48481975|NCT01643928|155959077|FG004|Overall Study|Lost to Follow-up|0|||
48481976|NCT01643928|155959073|FG000|Overall Study|Withdrawal by Subject|2|||
48481977|NCT01643928|155959074|FG001|Overall Study|Withdrawal by Subject|0|||
48481978|NCT01643928|155959075|FG002|Overall Study|Withdrawal by Subject|0|||
48481979|NCT01643928|155959076|FG003|Overall Study|Withdrawal by Subject|1|||
48481980|NCT01643928|155959077|FG004|Overall Study|Withdrawal by Subject|0|||
48481981|NCT01643928|155959073|FG000|Overall Study|Pregnancy|0|||
48481982|NCT01643928|155959074|FG001|Overall Study|Pregnancy|0|||
48481983|NCT01643928|155959075|FG002|Overall Study|Pregnancy|0|||
48481984|NCT01643928|155959076|FG003|Overall Study|Pregnancy|1|||
48481985|NCT01643928|155959077|FG004|Overall Study|Pregnancy|0|||
48481986|NCT01643928|155959073|FG000|Overall Study|Other|5|||
48481987|NCT01643928|155959074|FG001|Overall Study|Other|1|||
48481988|NCT01643928|155959075|FG002|Overall Study|Other|1|||
48481989|NCT01643928|155959076|FG003|Overall Study|Other|0|||
48481990|NCT01643928|155959077|FG004|Overall Study|Other|0|||
48481991|NCT01643928|155959073|FG000|Overall Study|Adverse Event|2|||
48481992|NCT01643928|155959074|FG001|Overall Study|Adverse Event|1|||
48481993|NCT01643928|155959075|FG002|Overall Study|Adverse Event|0|||
48481994|NCT01643928|155959076|FG003|Overall Study|Adverse Event|1|||
48481995|NCT01643928|155959077|FG004|Overall Study|Adverse Event|2|||
48481996|NCT00450177|155959079|FG000|Overall Study|Adverse Event|7|||
48481997|NCT00450177|155959080|FG001|Overall Study|Adverse Event|4|||
48481998|NCT00450177|155959079|FG000|Overall Study|Withdrawal by Subject|1|||
48481999|NCT00450177|155959080|FG001|Overall Study|Withdrawal by Subject|6|||
48482000|NCT00450177|155959079|FG000|Overall Study|Withdrawal by Primary Team|1|||
48482001|NCT00450177|155959080|FG001|Overall Study|Withdrawal by Primary Team|1|||
48482002|NCT04093362|155959082|FG000|Overall Study|Study Termination|1|||
48482003|NCT04093362|155959083|FG001|Overall Study|Study Termination|1|||
48482004|NCT04093362|155959082|FG000|Overall Study|Withdrawal of Consent|1|||
48482005|NCT04093362|155959083|FG001|Overall Study|Withdrawal of Consent|0|||
48482006|NCT04093362|155959082|FG000|Overall Study|Death|1|||
48482007|NCT04093362|155959083|FG001|Overall Study|Death|3|||
48482008|NCT04093362|155959082|FG000|Overall Study|Reason not Specified|1|||
48482009|NCT04093362|155959083|FG001|Overall Study|Reason not Specified|2|||
48482010|NCT00965263|155959084|FG000|Overall Study|Physician Decision|2|||
48482011|NCT00965263|155959085|FG001|Overall Study|Physician Decision|0|||
48482012|NCT00965263|155959084|FG000|Overall Study|Family emergency|0|||
48482013|NCT00965263|155959085|FG001|Overall Study|Family emergency|1|||
48482014|NCT00965263|155959084|FG000|Overall Study|Protocol Violation|0|||
48482015|NCT00965263|155959085|FG001|Overall Study|Protocol Violation|2|||
48482016|NCT04926740|155959089|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
48482017|NCT04926740|155959090|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
48482018|NCT04926740|155959089|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
48482019|NCT04926740|155959090|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
48482020|NCT00963599|155959091|FG000|Overall Study|Adverse Event|2|||
48482021|NCT00963599|155959092|FG001|Overall Study|Adverse Event|0|||
48482022|NCT00963599|155959093|FG002|Overall Study|Adverse Event|1|||
48482023|NCT00963599|155959094|FG003|Overall Study|Adverse Event|2|||
48482024|NCT00963599|155959091|FG000|Overall Study|Lack of Efficacy|0|||
48482025|NCT00963599|155959092|FG001|Overall Study|Lack of Efficacy|2|||
48482026|NCT00963599|155959093|FG002|Overall Study|Lack of Efficacy|1|||
48482027|NCT00963599|155959094|FG003|Overall Study|Lack of Efficacy|4|||
48482028|NCT00963599|155959091|FG000|Overall Study|Lost to Follow-up|0|||
48482029|NCT00963599|155959092|FG001|Overall Study|Lost to Follow-up|1|||
48482030|NCT00963599|155959093|FG002|Overall Study|Lost to Follow-up|1|||
48482031|NCT00963599|155959094|FG003|Overall Study|Lost to Follow-up|1|||
48482032|NCT00963599|155959091|FG000|Overall Study|Protocol Violation|2|||
48482033|NCT00963599|155959092|FG001|Overall Study|Protocol Violation|2|||
48482034|NCT00963599|155959093|FG002|Overall Study|Protocol Violation|3|||
48482035|NCT00963599|155959094|FG003|Overall Study|Protocol Violation|4|||
48482036|NCT00963599|155959091|FG000|Overall Study|Withdrawal by Subject|2|||
48482037|NCT00963599|155959092|FG001|Overall Study|Withdrawal by Subject|1|||
48482038|NCT00963599|155959093|FG002|Overall Study|Withdrawal by Subject|3|||
48482039|NCT00963599|155959094|FG003|Overall Study|Withdrawal by Subject|3|||
48482040|NCT03672396|155959095|FG000|Overall Study|Withdrawal by Subject|4|||
48482041|NCT03672396|155959095|FG000|Overall Study|Physician Decision|1|||
48482042|NCT03672396|155959095|FG000|Overall Study|Adverse Event|1|||
48482043|NCT00929864|155959096|FG000|Overall Study|Death|1|||
48482044|NCT00929864|155959097|FG001|Overall Study|Death|1|||
48482045|NCT00929864|155959096|FG000|Overall Study|Adverse Event|11|||
48482046|NCT00929864|155959097|FG001|Overall Study|Adverse Event|30|||
48482047|NCT00929864|155959096|FG000|Overall Study|Lack of Efficacy|19|||
48482048|NCT00929864|155959097|FG001|Overall Study|Lack of Efficacy|16|||
48482049|NCT00929864|155959096|FG000|Overall Study|Lost to Follow-up|7|||
48482050|NCT00929864|155959097|FG001|Overall Study|Lost to Follow-up|12|||
48482051|NCT00929864|155959096|FG000|Overall Study|Withdrawal by Subject|20|||
48482052|NCT00929864|155959097|FG001|Overall Study|Withdrawal by Subject|9|||
48482053|NCT00929864|155959096|FG000|Overall Study|No longer met criteria|2|||
48482054|NCT00929864|155959097|FG001|Overall Study|No longer met criteria|1|||
48482055|NCT00929864|155959096|FG000|Overall Study|Poor or non-compliance|3|||
48482056|NCT00929864|155959097|FG001|Overall Study|Poor or non-compliance|3|||
48482057|NCT00929864|155959096|FG000|Overall Study|Pregnancy|0|||
48482058|NCT00929864|155959097|FG001|Overall Study|Pregnancy|3|||
48482059|NCT00929864|155959096|FG000|Overall Study|Administrative reason by Sponsor|1|||
48482060|NCT00929864|155959097|FG001|Overall Study|Administrative reason by Sponsor|1|||
48482061|NCT00929864|155959096|FG000|Overall Study|Non-specified|2|||
48482062|NCT00929864|155959097|FG001|Overall Study|Non-specified|7|||
48482063|NCT01214616|155959098|FG000|Overall Study|Progressive disease|2|||
48482064|NCT01214616|155959099|FG001|Overall Study|Progressive disease|2|||
48482065|NCT01214616|155959100|FG002|Overall Study|Progressive disease|2|||
48482066|NCT01214616|155959101|FG003|Overall Study|Progressive disease|4|||
48482067|NCT01214616|155959098|FG000|Overall Study|Dose limiting toxicity|0|||
48482068|NCT01214616|155959099|FG001|Overall Study|Dose limiting toxicity|2|||
48482069|NCT01214616|155959100|FG002|Overall Study|Dose limiting toxicity|0|||
48482070|NCT01214616|155959101|FG003|Overall Study|Dose limiting toxicity|0|||
48482071|NCT01214616|155959098|FG000|Overall Study|Other adverse events|0|||
48482072|NCT01214616|155959099|FG001|Overall Study|Other adverse events|1|||
48482073|NCT01214616|155959100|FG002|Overall Study|Other adverse events|1|||
48482074|NCT01214616|155959101|FG003|Overall Study|Other adverse events|1|||
48482075|NCT01214616|155959098|FG000|Overall Study|Withdrawal by Subject|1|||
48482076|NCT01214616|155959099|FG001|Overall Study|Withdrawal by Subject|0|||
48482077|NCT01214616|155959100|FG002|Overall Study|Withdrawal by Subject|0|||
48482078|NCT01214616|155959101|FG003|Overall Study|Withdrawal by Subject|1|||
48482079|NCT00000135|155959102|FG000|Overall Study|Death|27|||
48482080|NCT00000135|155959103|FG001|Overall Study|Death|14|||
48482081|NCT04572854|155959105|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
48482082|NCT04572854|155959106|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
48482083|NCT04572854|155959107|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
48482084|NCT04572854|155959108|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
48482085|NCT04572854|155959105|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
48482086|NCT04572854|155959106|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
48482087|NCT04572854|155959107|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
48482088|NCT04572854|155959108|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
48482089|NCT00295620|155959109|FG000|Overall Study|Lost to Follow-up|9|||
48482090|NCT00295620|155959110|FG001|Overall Study|Lost to Follow-up|5|||
48482091|NCT00295620|155959109|FG000|Overall Study|Withdrawal by Subject|37|||
48482092|NCT00295620|155959110|FG001|Overall Study|Withdrawal by Subject|50|||
48482093|NCT00295620|155959109|FG000|Overall Study|Death|206|||
48482094|NCT00295620|155959110|FG001|Overall Study|Death|207|||
48482095|NCT00295620|155959109|FG000|Overall Study|Other reasons|10|||
48482096|NCT00295620|155959110|FG001|Overall Study|Other reasons|9|||
48482097|NCT00295620|155959109|FG000|Overall Study|Discontinuation by sponsor|580|||
48482098|NCT00295620|155959110|FG001|Overall Study|Discontinuation by sponsor|593|||
48482099|NCT00295620|155959109|FG000|Overall Study|Protocol Violation|30|||
48482100|NCT00295620|155959110|FG001|Overall Study|Protocol Violation|32|||
48482101|NCT01066039|155959111|FG000|Overall Study|Adverse Event|6|||
48482102|NCT01066039|155959111|FG000|Overall Study|Withdrawal by Subject|17|||
48482103|NCT01066039|155959111|FG000|Overall Study|Protocol Violation|2|||
48482104|NCT01066039|155959111|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
48482105|NCT01066039|155959111|FG000|Overall Study|Investigator's Request|1|||
48482106|NCT01066039|155959111|FG000|Overall Study|Dropout due to Insulin Administration|1|||
48482107|NCT01066039|155959111|FG000|Overall Study|Additional Antihypertensive Required|4|||
48482108|NCT01066039|155959111|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
48482109|NCT01066039|155959111|FG000|Overall Study|Failure to Control Blood Pressure|1|||
48482110|NCT01066039|155959111|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
48482111|NCT04508621|155959112|FG000|Overall Study|Adverse Event|39|||
48482112|NCT04508621|155959113|FG001|Overall Study|Adverse Event|16|||
48482113|NCT04508621|155959112|FG000|Overall Study|Lack of Efficacy|2|||
48482114|NCT04508621|155959113|FG001|Overall Study|Lack of Efficacy|8|||
48482115|NCT04508621|155959112|FG000|Overall Study|Physician Decision|0|||
48482116|NCT04508621|155959113|FG001|Overall Study|Physician Decision|1|||
48482117|NCT04508621|155959112|FG000|Overall Study|Withdrawal by Subject|10|||
48482118|NCT04508621|155959113|FG001|Overall Study|Withdrawal by Subject|14|||
48482119|NCT04508621|155959112|FG000|Overall Study|Lost to Follow-up|12|||
48482120|NCT04508621|155959113|FG001|Overall Study|Lost to Follow-up|9|||
48482121|NCT04508621|155959112|FG000|Overall Study|COVID-19 related crisis|3|||
48482122|NCT04508621|155959113|FG001|Overall Study|COVID-19 related crisis|0|||
48482123|NCT04508621|155959112|FG000|Overall Study|Subject non-compliance|1|||
48482124|NCT04508621|155959113|FG001|Overall Study|Subject non-compliance|0|||
48482125|NCT01999322|155959115|FG000|Overall Study|Adverse Event|1|||
48482126|NCT01999322|155959116|FG001|Overall Study|Adverse Event|0|||
48482127|NCT00530439|155959119|FG000|Overall Study|GDM|9|||
48482128|NCT00530439|155959120|FG001|Overall Study|GDM|3|||
48482129|NCT00530439|155959119|FG000|Overall Study|Withdraw|18|||
48482130|NCT00530439|155959120|FG001|Overall Study|Withdraw|14|||
48482131|NCT00530439|155959119|FG000|Overall Study|Missed abortion|1|||
48482132|NCT00530439|155959120|FG001|Overall Study|Missed abortion|4|||
48482133|NCT00530439|155959119|FG000|Overall Study|Misclassification|2|||
48482134|NCT00530439|155959120|FG001|Overall Study|Misclassification|0|||
48482135|NCT00530439|155959119|FG000|Overall Study|Twin pregnancy|0|||
48482136|NCT00530439|155959120|FG001|Overall Study|Twin pregnancy|2|||
48482137|NCT00530439|155959119|FG000|Overall Study|Severe malformation/abortion|0|||
48482138|NCT00530439|155959120|FG001|Overall Study|Severe malformation/abortion|3|||
48482139|NCT05788237|155959123|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
48482140|NCT05788237|155959124|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
48482141|NCT05788237|155959125|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
48482142|NCT05788237|155959126|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
48482143|NCT05788237|155959123|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
48482144|NCT05788237|155959124|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
48482145|NCT05788237|155959125|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
48482146|NCT05788237|155959126|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
48482147|NCT05788237|155959123|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
48482148|NCT05788237|155959124|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
48482149|NCT05788237|155959125|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
48482150|NCT05788237|155959126|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
48482151|NCT05788237|155959123|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
48482152|NCT05788237|155959124|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
48482153|NCT05788237|155959125|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
48482154|NCT05788237|155959126|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
48482155|NCT05788237|155959123|FG000|SSA (Approximately 2 Months)|Death|0|||
48482156|NCT05788237|155959124|FG001|SSA (Approximately 2 Months)|Death|1|||
48482157|NCT05788237|155959125|FG002|SSA (Approximately 2 Months)|Death|0|||
48482158|NCT05788237|155959126|FG003|SSA (Approximately 2 Months)|Death|0|||
48482159|NCT05788237|155959123|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
48482160|NCT05788237|155959124|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
48482161|NCT05788237|155959125|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
48482162|NCT05788237|155959126|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
48482163|NCT05788237|155959123|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
48482164|NCT05788237|155959124|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
48482165|NCT05788237|155959125|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
48482166|NCT05788237|155959126|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
48482167|NCT05788237|155959123|FG000|SSB (Approximately 1 Month)|Other|0|||
48482168|NCT05788237|155959124|FG001|SSB (Approximately 1 Month)|Other|0|||
48482169|NCT05788237|155959125|FG002|SSB (Approximately 1 Month)|Other|0|||
48482170|NCT05788237|155959126|FG003|SSB (Approximately 1 Month)|Other|1|||
48482171|NCT05166421|155959127|FG000|Overall Study|Other|3|||
48482172|NCT05166421|155959128|FG001|Overall Study|Other|1|||
48482173|NCT05166421|155959129|FG002|Overall Study|Other|1|||
48482174|NCT05166421|155959127|FG000|Overall Study|Withdrawal by Subject|5|||
48482175|NCT05166421|155959128|FG001|Overall Study|Withdrawal by Subject|3|||
48482176|NCT05166421|155959129|FG002|Overall Study|Withdrawal by Subject|6|||
48482177|NCT05166421|155959127|FG000|Overall Study|Lost to Follow-up|4|||
48482178|NCT05166421|155959128|FG001|Overall Study|Lost to Follow-up|1|||
48482179|NCT05166421|155959129|FG002|Overall Study|Lost to Follow-up|7|||
48482180|NCT00414011|155960210|FG000|Overall Study|Physician Decision|3|||
48482181|NCT00414011|155960210|FG000|Overall Study|Withdrawal by Subject|2|||
48482182|NCT00883740|155960211|FG000|First Intervention|Lost to Follow-up|1|||
48482183|NCT00883740|155960212|FG001|First Intervention|Lost to Follow-up|0|||
48482184|NCT00883740|155960211|FG000|First Intervention|No longer willing to participate|2|||
48482185|NCT00883740|155960212|FG001|First Intervention|No longer willing to participate|0|||
48482186|NCT00883740|155960211|FG000|First Intervention|Protocol Violation|3|||
48482187|NCT00883740|155960212|FG001|First Intervention|Protocol Violation|6|||
48482188|NCT00883740|155960211|FG000|First Intervention|Adverse Event|1|||
48482189|NCT00883740|155960212|FG001|First Intervention|Adverse Event|2|||
48482190|NCT00883740|155960211|FG000|Second Intervention|Protocol Violation|1|||
48482191|NCT00883740|155960212|FG001|Second Intervention|Protocol Violation|0|||
48482192|NCT00883740|155960211|FG000|Second Intervention|No longer willing to participate|0|||
48482193|NCT00883740|155960212|FG001|Second Intervention|No longer willing to participate|1|||
48482194|NCT02562235|155960213|FG000|Overall Study|Adverse Event|3|||
48482195|NCT02652260|155960215|FG000|Base Study|Pregnancy|0|||
48482196|NCT02652260|155960216|FG001|Base Study|Pregnancy|1|||
48482197|NCT02652260|155960215|FG000|Base Study|Withdrawal by Subject|0|||
48482198|NCT02652260|155960216|FG001|Base Study|Withdrawal by Subject|1|||
48482199|NCT02652260|155960215|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
48482200|NCT02652260|155960216|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
48482201|NCT02652260|155960215|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
48482202|NCT02652260|155960216|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
48482203|NCT02652260|155960215|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
48482204|NCT02652260|155960216|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
48482205|NCT02652260|155960215|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
48482206|NCT02652260|155960216|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
48482207|NCT02652260|155960215|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
48482208|NCT02652260|155960216|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
48482209|NCT02652260|155960215|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
48482210|NCT02652260|155960216|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
48482211|NCT02652260|155960215|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
48482212|NCT02652260|155960216|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
48482213|NCT02652260|155960215|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
48482214|NCT02652260|155960216|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
48482215|NCT02652260|155960215|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
48482216|NCT02652260|155960216|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
48482217|NCT02652260|155960215|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
48482218|NCT02652260|155960216|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
48482219|NCT02652260|155960215|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
48482220|NCT02652260|155960216|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
48482221|NCT02652260|155960215|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
48482222|NCT02652260|155960216|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
48482223|NCT03203473|155960217|FG000|Induction Phase|Never started primary treatment|2|||
48482224|NCT03203473|155960218|FG001|Induction Phase|Never started primary treatment|0|||
48482225|NCT03203473|155960219|FG002|Induction Phase|Never started primary treatment|0|||
48482226|NCT03203473|155960217|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
48482227|NCT03203473|155960218|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
48482228|NCT03203473|155960219|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
48482229|NCT03203473|155960217|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
48482230|NCT03203473|155960218|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
48482231|NCT03203473|155960219|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
48482232|NCT03203473|155960217|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
48482233|NCT03203473|155960218|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
48482234|NCT03203473|155960219|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
48482235|NCT03203473|155960217|FG000|Arm Allocation Phase|started salvage therapy|0|||
48482236|NCT03203473|155960218|FG001|Arm Allocation Phase|started salvage therapy|5|||
48482237|NCT03203473|155960219|FG002|Arm Allocation Phase|started salvage therapy|0|||
48482238|NCT03203473|155960217|FG000|Arm Allocation Phase|Disease progression|0|||
48482239|NCT03203473|155960218|FG001|Arm Allocation Phase|Disease progression|0|||
48482240|NCT03203473|155960219|FG002|Arm Allocation Phase|Disease progression|37|||
48482241|NCT03203473|155960217|FG000|Arm Allocation Phase|Adverse Event|0|||
48482242|NCT03203473|155960218|FG001|Arm Allocation Phase|Adverse Event|0|||
48482243|NCT03203473|155960219|FG002|Arm Allocation Phase|Adverse Event|11|||
48482244|NCT03203473|155960217|FG000|Arm Allocation Phase|Physician Decision|0|||
48482245|NCT03203473|155960218|FG001|Arm Allocation Phase|Physician Decision|0|||
48482246|NCT03203473|155960219|FG002|Arm Allocation Phase|Physician Decision|3|||
48482247|NCT03203473|155960217|FG000|Arm Allocation Phase|Death|0|||
48482248|NCT03203473|155960218|FG001|Arm Allocation Phase|Death|0|||
48482249|NCT03203473|155960219|FG002|Arm Allocation Phase|Death|1|||
48482250|NCT03203473|155960217|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
48482251|NCT03203473|155960218|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
48482252|NCT03203473|155960219|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
48482253|NCT03203473|155960217|FG000|Arm Allocation Phase|Intercurrent illness|0|||
48482254|NCT03203473|155960218|FG001|Arm Allocation Phase|Intercurrent illness|0|||
48482255|NCT03203473|155960219|FG002|Arm Allocation Phase|Intercurrent illness|1|||
48482256|NCT03203473|155960217|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
48482257|NCT03203473|155960218|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
48482258|NCT03203473|155960219|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
48482259|NCT02923115|155960226|FG000|Overall Study|Lost to Follow-up|0|||
48482260|NCT02923115|155960227|FG001|Overall Study|Lost to Follow-up|0|||
48482261|NCT02923115|155960228|FG002|Overall Study|Lost to Follow-up|0|||
48482262|NCT02923115|155960229|FG003|Overall Study|Lost to Follow-up|1|||
48482263|NCT02923115|155960230|FG004|Overall Study|Lost to Follow-up|0|||
48482264|NCT02923115|155960231|FG005|Overall Study|Lost to Follow-up|0|||
48482265|NCT02923115|155960226|FG000|Overall Study|Withdrawal by Subject|0|||
48482266|NCT02923115|155960227|FG001|Overall Study|Withdrawal by Subject|1|||
48482267|NCT02923115|155960228|FG002|Overall Study|Withdrawal by Subject|0|||
48482268|NCT02923115|155960229|FG003|Overall Study|Withdrawal by Subject|0|||
48482269|NCT02923115|155960230|FG004|Overall Study|Withdrawal by Subject|0|||
48482270|NCT02923115|155960231|FG005|Overall Study|Withdrawal by Subject|0|||
48482271|NCT02923115|155960226|FG000|Overall Study|Randomized, but not dosed|0|||
48482272|NCT02923115|155960227|FG001|Overall Study|Randomized, but not dosed|0|||
48482273|NCT02923115|155960228|FG002|Overall Study|Randomized, but not dosed|3|||
48482274|NCT02923115|155960229|FG003|Overall Study|Randomized, but not dosed|1|||
48482275|NCT02923115|155960230|FG004|Overall Study|Randomized, but not dosed|5|||
48482276|NCT02923115|155960231|FG005|Overall Study|Randomized, but not dosed|0|||
48482277|NCT04300647|155960234|FG000|Pre-Crossover|Death|19|||
48482278|NCT04300647|155960235|FG001|Pre-Crossover|Death|58|||
48482279|NCT04300647|155960236|FG002|Pre-Crossover|Death|0|||
48482280|NCT04300647|155960234|FG000|Pre-Crossover|Lost to Follow-up|0|||
48482281|NCT04300647|155960235|FG001|Pre-Crossover|Lost to Follow-up|3|||
48482282|NCT04300647|155960236|FG002|Pre-Crossover|Lost to Follow-up|0|||
48482283|NCT04300647|155960234|FG000|Pre-Crossover|Withdrawal by Subject|2|||
48482284|NCT04300647|155960235|FG001|Pre-Crossover|Withdrawal by Subject|4|||
48482285|NCT04300647|155960236|FG002|Pre-Crossover|Withdrawal by Subject|0|||
48482286|NCT04300647|155960234|FG000|Pre-Crossover|On-going in Study|24|||
48482287|NCT04300647|155960235|FG001|Pre-Crossover|On-going in Study|61|||
48482288|NCT04300647|155960236|FG002|Pre-Crossover|On-going in Study|0|||
48482289|NCT04300647|155960234|FG000|Post-Crossover|Death|0|||
48482290|NCT04300647|155960235|FG001|Post-Crossover|Death|0|||
48482291|NCT04300647|155960236|FG002|Post-Crossover|Death|3|||
48482292|NCT04300647|155960234|FG000|Post-Crossover|Lost to Follow-up|0|||
48482293|NCT04300647|155960235|FG001|Post-Crossover|Lost to Follow-up|0|||
48482294|NCT04300647|155960236|FG002|Post-Crossover|Lost to Follow-up|1|||
48482295|NCT04300647|155960234|FG000|Post-Crossover|Withdrawal by Subject|0|||
48482296|NCT04300647|155960235|FG001|Post-Crossover|Withdrawal by Subject|0|||
48482297|NCT04300647|155960236|FG002|Post-Crossover|Withdrawal by Subject|1|||
48482298|NCT04300647|155960234|FG000|Post-Crossover|On-going in Study|0|||
48482299|NCT04300647|155960235|FG001|Post-Crossover|On-going in Study|0|||
48482300|NCT04300647|155960236|FG002|Post-Crossover|On-going in Study|8|||
48482301|NCT00568776|155960239|FG000|Overall Study|Adverse Event|8|||
48482302|NCT00568776|155960240|FG001|Overall Study|Adverse Event|8|||
48482303|NCT00568776|155960241|FG002|Overall Study|Adverse Event|10|||
48482304|NCT00568776|155960242|FG003|Overall Study|Adverse Event|8|||
48482305|NCT00568776|155960239|FG000|Overall Study|Death|0|||
48482306|NCT00568776|155960240|FG001|Overall Study|Death|1|||
48482307|NCT00568776|155960241|FG002|Overall Study|Death|4|||
48482308|NCT00568776|155960242|FG003|Overall Study|Death|3|||
48482309|NCT00568776|155960239|FG000|Overall Study|Physician Decision|0|||
48482310|NCT00568776|155960240|FG001|Overall Study|Physician Decision|2|||
48482311|NCT00568776|155960241|FG002|Overall Study|Physician Decision|0|||
48482312|NCT00568776|155960242|FG003|Overall Study|Physician Decision|0|||
48482313|NCT00568776|155960239|FG000|Overall Study|Lack of Efficacy|2|||
48482314|NCT00568776|155960240|FG001|Overall Study|Lack of Efficacy|2|||
48482315|NCT00568776|155960241|FG002|Overall Study|Lack of Efficacy|2|||
48482316|NCT00568776|155960242|FG003|Overall Study|Lack of Efficacy|4|||
48482317|NCT00568776|155960239|FG000|Overall Study|Lost to Follow-up|1|||
48482318|NCT00568776|155960240|FG001|Overall Study|Lost to Follow-up|1|||
48482319|NCT00568776|155960241|FG002|Overall Study|Lost to Follow-up|1|||
48482320|NCT00568776|155960242|FG003|Overall Study|Lost to Follow-up|1|||
48482321|NCT00568776|155960239|FG000|Overall Study|Protocol Violation|1|||
48482322|NCT00568776|155960240|FG001|Overall Study|Protocol Violation|0|||
48482323|NCT00568776|155960241|FG002|Overall Study|Protocol Violation|1|||
48482324|NCT00568776|155960242|FG003|Overall Study|Protocol Violation|1|||
48482325|NCT00568776|155960239|FG000|Overall Study|Withdrawal by Subject|13|||
48482326|NCT00568776|155960240|FG001|Overall Study|Withdrawal by Subject|15|||
48482327|NCT00568776|155960241|FG002|Overall Study|Withdrawal by Subject|13|||
48482328|NCT00568776|155960242|FG003|Overall Study|Withdrawal by Subject|7|||
48482329|NCT00568776|155960239|FG000|Overall Study|Loss of Caregiver|0|||
48482330|NCT00568776|155960240|FG001|Overall Study|Loss of Caregiver|2|||
48482331|NCT00568776|155960241|FG002|Overall Study|Loss of Caregiver|1|||
48482332|NCT00568776|155960242|FG003|Overall Study|Loss of Caregiver|2|||
48482333|NCT00568776|155960239|FG000|Overall Study|Sponsor Decision|2|||
48482334|NCT00568776|155960240|FG001|Overall Study|Sponsor Decision|2|||
48482335|NCT00568776|155960241|FG002|Overall Study|Sponsor Decision|41|||
48482336|NCT00568776|155960242|FG003|Overall Study|Sponsor Decision|42|||
48482337|NCT00568776|155960239|FG000|Overall Study|Miscellaeneous|3|||
48482338|NCT00568776|155960240|FG001|Overall Study|Miscellaeneous|3|||
48482339|NCT00568776|155960241|FG002|Overall Study|Miscellaeneous|1|||
48482340|NCT00568776|155960242|FG003|Overall Study|Miscellaeneous|4|||
48482341|NCT02349412|155960249|FG000|Overall Study|Withdrawal by Subject|7|||
48482342|NCT02349412|155960250|FG001|Overall Study|Withdrawal by Subject|7|||
48482346|NCT00666718|155960259|FG000|Overall Study|Adverse Event|0|||
48482347|NCT00666718|155960260|FG001|Overall Study|Adverse Event|1|||
48482348|NCT00666718|155960259|FG000|Overall Study|Death|1|||
48482349|NCT00666718|155960260|FG001|Overall Study|Death|0|||
48482350|NCT00666718|155960259|FG000|Overall Study|Lost to Follow-up|1|||
48482351|NCT00666718|155960260|FG001|Overall Study|Lost to Follow-up|0|||
48482352|NCT00666718|155960259|FG000|Overall Study|Entry Criteria Not Met|2|||
48482353|NCT00666718|155960260|FG001|Overall Study|Entry Criteria Not Met|0|||
48482354|NCT00666718|155960259|FG000|Overall Study|Protocol Violation|1|||
48482355|NCT00666718|155960260|FG001|Overall Study|Protocol Violation|3|||
48482356|NCT00666718|155960259|FG000|Overall Study|Withdrawal by Subject|7|||
48482357|NCT00666718|155960260|FG001|Overall Study|Withdrawal by Subject|12|||
48482358|NCT00666718|155960259|FG000|Overall Study|Physician Decision|0|||
48482359|NCT00666718|155960260|FG001|Overall Study|Physician Decision|2|||
48482360|NCT05013749|155960261|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
48482361|NCT05013749|155960262|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
48482362|NCT05013749|155960261|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
48482363|NCT05013749|155960262|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
48482364|NCT02017535|155960263|FG000|Overall Study|Withdrawal by Subject|1|||
48482365|NCT02017535|155960264|FG001|Overall Study|Withdrawal by Subject|0|||
48482366|NCT02017535|155960265|FG002|Overall Study|Withdrawal by Subject|0|||
48482367|NCT02017535|155960266|FG003|Overall Study|Withdrawal by Subject|0|||
48482368|NCT03674827|155960269|FG000|Treatment Phase|Adverse Event|0|||
48482369|NCT03674827|155960270|FG001|Treatment Phase|Adverse Event|0|||
48482370|NCT03674827|155960271|FG002|Treatment Phase|Adverse Event|0|||
48482371|NCT03674827|155960272|FG003|Treatment Phase|Adverse Event|0|||
48482372|NCT03674827|155960273|FG004|Treatment Phase|Adverse Event|0|||
48482373|NCT03674827|155960274|FG005|Treatment Phase|Adverse Event|2|||
48482374|NCT03674827|155960269|FG000|Treatment Phase|Death|2|||
48482375|NCT03674827|155960270|FG001|Treatment Phase|Death|0|||
48482376|NCT03674827|155960271|FG002|Treatment Phase|Death|0|||
48482377|NCT03674827|155960272|FG003|Treatment Phase|Death|0|||
48482378|NCT03674827|155960273|FG004|Treatment Phase|Death|1|||
48482379|NCT03674827|155960274|FG005|Treatment Phase|Death|0|||
48482380|NCT03674827|155960269|FG000|Treatment Phase|Progressive Disease|0|||
48482381|NCT03674827|155960270|FG001|Treatment Phase|Progressive Disease|4|||
48482382|NCT03674827|155960271|FG002|Treatment Phase|Progressive Disease|3|||
48482383|NCT03674827|155960272|FG003|Treatment Phase|Progressive Disease|4|||
48482384|NCT03674827|155960273|FG004|Treatment Phase|Progressive Disease|4|||
48482385|NCT03674827|155960274|FG005|Treatment Phase|Progressive Disease|9|||
48482386|NCT03674827|155960269|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
48482387|NCT03674827|155960270|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
48482388|NCT03674827|155960271|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
48482389|NCT03674827|155960272|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
48482390|NCT03674827|155960273|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
48482391|NCT03674827|155960274|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
48482392|NCT03674827|155960269|FG000|Treatment Phase|Withdrawal by Subject|0|||
48482393|NCT03674827|155960270|FG001|Treatment Phase|Withdrawal by Subject|0|||
48482394|NCT03674827|155960271|FG002|Treatment Phase|Withdrawal by Subject|0|||
48482395|NCT03674827|155960272|FG003|Treatment Phase|Withdrawal by Subject|0|||
48482396|NCT03674827|155960273|FG004|Treatment Phase|Withdrawal by Subject|0|||
48482397|NCT03674827|155960274|FG005|Treatment Phase|Withdrawal by Subject|1|||
48482398|NCT03674827|155960269|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
48482399|NCT03674827|155960270|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
48482400|NCT03674827|155960271|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
48482401|NCT03674827|155960272|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
48482402|NCT03674827|155960273|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
48482403|NCT03674827|155960274|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
48482404|NCT03674827|155960269|FG000|Treatment Phase|Other|0|||
48482405|NCT03674827|155960270|FG001|Treatment Phase|Other|1|||
48482406|NCT03674827|155960271|FG002|Treatment Phase|Other|0|||
48482407|NCT03674827|155960272|FG003|Treatment Phase|Other|0|||
48482408|NCT03674827|155960273|FG004|Treatment Phase|Other|0|||
48482409|NCT03674827|155960274|FG005|Treatment Phase|Other|1|||
48482410|NCT03674827|155960269|FG000|Long-Term Follow-up Phase|Death|2|||
48482411|NCT03674827|155960270|FG001|Long-Term Follow-up Phase|Death|4|||
48482412|NCT03674827|155960271|FG002|Long-Term Follow-up Phase|Death|2|||
48482413|NCT03674827|155960272|FG003|Long-Term Follow-up Phase|Death|3|||
48482414|NCT03674827|155960273|FG004|Long-Term Follow-up Phase|Death|2|||
48482415|NCT03674827|155960274|FG005|Long-Term Follow-up Phase|Death|6|||
48482416|NCT03674827|155960269|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
48482417|NCT03674827|155960270|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
48482418|NCT03674827|155960271|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
48482419|NCT03674827|155960272|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
48482420|NCT03674827|155960273|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
48482421|NCT03674827|155960274|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
48482422|NCT03674827|155960269|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
48482423|NCT03674827|155960270|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
48482424|NCT03674827|155960271|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
48482425|NCT03674827|155960272|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
48482426|NCT03674827|155960273|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
48482427|NCT03674827|155960274|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
48482428|NCT03018288|155960275|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
48482429|NCT03018288|155960276|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
48482430|NCT03018288|155960277|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
48482431|NCT03018288|155960278|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
48482432|NCT03018288|155960275|FG000|Overall Study|Participant withdrew consent.|0|||
48482433|NCT03018288|155960276|FG001|Overall Study|Participant withdrew consent.|0|||
48482434|NCT03018288|155960277|FG002|Overall Study|Participant withdrew consent.|1|||
48482435|NCT03018288|155960278|FG003|Overall Study|Participant withdrew consent.|0|||
48482436|NCT03018288|155960275|FG000|Overall Study|Switched to alternative treatment.|0|||
48482437|NCT03018288|155960276|FG001|Overall Study|Switched to alternative treatment.|0|||
48482438|NCT03018288|155960277|FG002|Overall Study|Switched to alternative treatment.|1|||
48482439|NCT03018288|155960278|FG003|Overall Study|Switched to alternative treatment.|0|||
48482440|NCT03018288|155960275|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
48482441|NCT03018288|155960276|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
48482442|NCT03018288|155960277|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
48482443|NCT03018288|155960278|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
48482444|NCT03018288|155960275|FG000|Overall Study|Screen failures|0|||
48482445|NCT03018288|155960276|FG001|Overall Study|Screen failures|0|||
48482446|NCT03018288|155960277|FG002|Overall Study|Screen failures|0|||
48482447|NCT03018288|155960278|FG003|Overall Study|Screen failures|51|||
48482448|NCT03018288|155960275|FG000|Overall Study|Chose treatment outside of UNC|0|||
48482449|NCT03018288|155960276|FG001|Overall Study|Chose treatment outside of UNC|0|||
48482450|NCT03018288|155960277|FG002|Overall Study|Chose treatment outside of UNC|0|||
48482451|NCT03018288|155960278|FG003|Overall Study|Chose treatment outside of UNC|1|||
48482452|NCT03018288|155960275|FG000|Overall Study|Unable to comply with protocol requirements|1|||
48482453|NCT03018288|155960276|FG001|Overall Study|Unable to comply with protocol requirements|1|||
48482454|NCT03018288|155960277|FG002|Overall Study|Unable to comply with protocol requirements|0|||
48482455|NCT03018288|155960278|FG003|Overall Study|Unable to comply with protocol requirements|1|||
48482456|NCT03018288|155960275|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
48482457|NCT03018288|155960276|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
48482458|NCT03018288|155960277|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
48482459|NCT03018288|155960278|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
48482460|NCT03018288|155960275|FG000|Overall Study|Physician Decision|0|||
48482461|NCT03018288|155960276|FG001|Overall Study|Physician Decision|0|||
48482462|NCT03018288|155960277|FG002|Overall Study|Physician Decision|0|||
48482463|NCT03018288|155960278|FG003|Overall Study|Physician Decision|1|||
48482464|NCT03897465|155960279|FG000|Overall Study|Lost to Follow-up|2|||
48482465|NCT03897465|155960280|FG001|Overall Study|Lost to Follow-up|1|||
48482466|NCT03897465|155960279|FG000|Overall Study|Adverse Event|2|||
48482467|NCT03897465|155960280|FG001|Overall Study|Adverse Event|0|||
48482468|NCT03897465|155960279|FG000|Overall Study|complete healing by V2|1|||
48482469|NCT03897465|155960280|FG001|Overall Study|complete healing by V2|0|||
48482470|NCT03897465|155960279|FG000|Overall Study|occurence of exclusion criterion|1|||
48482471|NCT03897465|155960280|FG001|Overall Study|occurence of exclusion criterion|1|||
48482472|NCT03897465|155960279|FG000|Overall Study|Other|1|||
48482473|NCT03897465|155960280|FG001|Overall Study|Other|0|||
48482474|NCT03611751|155960281|FG000|Pre-treatment|Randomized but not treated|1|||
48482475|NCT03611751|155960282|FG001|Pre-treatment|Randomized but not treated|1|||
48482476|NCT03611751|155960283|FG002|Pre-treatment|Randomized but not treated|0|||
48482477|NCT03611751|155960281|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
48482478|NCT03611751|155960282|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
48482479|NCT03611751|155960283|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
48482480|NCT03611751|155960281|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
48482481|NCT03611751|155960282|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
48482482|NCT03611751|155960283|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
48482483|NCT03611751|155960281|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
48482484|NCT03611751|155960282|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
48482485|NCT03611751|155960283|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
48482486|NCT03611751|155960281|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
48482487|NCT03611751|155960282|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
48482488|NCT03611751|155960283|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
48482489|NCT03611751|155960281|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
48482490|NCT03611751|155960282|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
48482491|NCT03611751|155960283|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
48482492|NCT03611751|155960281|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
48482493|NCT03611751|155960282|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
48482494|NCT03611751|155960283|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
48482495|NCT03611751|155960281|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
48482496|NCT03611751|155960282|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
48482497|NCT03611751|155960283|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
48482498|NCT03611751|155960281|FG000|Treatment Week 0 - Week 16|Death|0|||
48482499|NCT03611751|155960282|FG001|Treatment Week 0 - Week 16|Death|0|||
48482500|NCT03611751|155960283|FG002|Treatment Week 0 - Week 16|Death|1|||
48482501|NCT03611751|155960281|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
48482502|NCT03611751|155960282|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
48482503|NCT03611751|155960283|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
48482504|NCT03611751|155960281|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
48482505|NCT03611751|155960282|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
48482506|NCT03611751|155960283|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
48482507|NCT03611751|155960281|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
48482508|NCT03611751|155960282|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
48482509|NCT03611751|155960283|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
48482510|NCT03611751|155960281|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
48482511|NCT03611751|155960282|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
48482512|NCT03611751|155960283|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
48482513|NCT03611751|155960281|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
48482514|NCT03611751|155960282|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
48482515|NCT03611751|155960283|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
48482516|NCT03611751|155960281|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
48482517|NCT03611751|155960282|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
48482518|NCT03611751|155960283|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
48482519|NCT03611751|155960281|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
48482520|NCT03611751|155960282|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
48482521|NCT03611751|155960283|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
48482522|NCT03611751|155960281|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
48482523|NCT03611751|155960282|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
48482524|NCT03611751|155960283|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
48482525|NCT03611751|155960281|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
48482526|NCT03611751|155960282|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
48482527|NCT03611751|155960283|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
48482528|NCT03611751|155960281|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
48482529|NCT03611751|155960282|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
48482530|NCT03611751|155960283|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
48482531|NCT03611751|155960281|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
48482532|NCT03611751|155960282|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
48482533|NCT03611751|155960283|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
48482534|NCT03611751|155960281|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
48482535|NCT03611751|155960282|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
48482536|NCT03611751|155960283|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
48482537|NCT03611751|155960281|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
48482538|NCT03611751|155960282|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
48482539|NCT03611751|155960283|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
48482540|NCT03611751|155960281|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
48482541|NCT03611751|155960282|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
48482542|NCT03611751|155960283|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
48482543|NCT02441179|155960285|FG000|Overall Study|Withdrawal by Subject|1|||
48482544|NCT02441179|155960286|FG001|Overall Study|Withdrawal by Subject|1|||
48482545|NCT02702271|155960287|FG000|Overall Study|Death|36|||
48482546|NCT02702271|155960288|FG001|Overall Study|Death|7|||
48482547|NCT02702271|155960287|FG000|Overall Study|Lost to Follow-up|12|||
48482548|NCT02702271|155960288|FG001|Overall Study|Lost to Follow-up|0|||
48482549|NCT02702271|155960287|FG000|Overall Study|Withdrawal by Subject|8|||
48482550|NCT02702271|155960288|FG001|Overall Study|Withdrawal by Subject|1|||
48482551|NCT02702271|155960287|FG000|Overall Study|Physician Decision|2|||
48482552|NCT02702271|155960288|FG001|Overall Study|Physician Decision|0|||
48482553|NCT02702271|155960287|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
48482554|NCT02702271|155960288|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
48482555|NCT01494649|155960291|FG000|Overall Study|Lost to Follow-up|0|||
48482556|NCT01494649|155960292|FG001|Overall Study|Lost to Follow-up|1|||
48482557|NCT05014412|155960293|FG000|Overall Study|Death|11|||
48482558|NCT05014412|155960294|FG001|Overall Study|Death|7|||
48482559|NCT05014412|155960295|FG002|Overall Study|Death|4|||
48482560|NCT05014412|155960296|FG003|Overall Study|Death|7|||
48482561|NCT05014412|155960293|FG000|Overall Study|Withdrawal by Subject|1|||
48482562|NCT05014412|155960294|FG001|Overall Study|Withdrawal by Subject|1|||
48482563|NCT05014412|155960295|FG002|Overall Study|Withdrawal by Subject|1|||
48482564|NCT05014412|155960296|FG003|Overall Study|Withdrawal by Subject|2|||
48482565|NCT05014412|155960293|FG000|Overall Study|Ongoing|21|||
48482566|NCT05014412|155960294|FG001|Overall Study|Ongoing|4|||
48482567|NCT05014412|155960295|FG002|Overall Study|Ongoing|6|||
48482568|NCT05014412|155960296|FG003|Overall Study|Ongoing|20|||
48482569|NCT05478603|155960302|FG000|Overall Study|Withdrawal by Subject|0|||
48482570|NCT05478603|155960303|FG001|Overall Study|Withdrawal by Subject|1|||
48482571|NCT05478603|155960304|FG002|Overall Study|Withdrawal by Subject|0|||
48482572|NCT05478603|155960305|FG003|Overall Study|Withdrawal by Subject|0|||
48482573|NCT02524665|155960309|FG000|Overall Study|Lost to Follow-up|1|||
48482574|NCT04136626|155960312|FG000|Treatment Phase|Withdrawal by Subject|1|||
48482575|NCT04136626|155960313|FG001|Treatment Phase|Withdrawal by Subject|9|||
48482576|NCT04136626|155960312|FG000|Treatment Phase|Adverse Event|1|||
48482577|NCT04136626|155960313|FG001|Treatment Phase|Adverse Event|0|||
48482578|NCT04136626|155960312|FG000|Treatment Phase|Lost to Follow-up|1|||
48482579|NCT04136626|155960313|FG001|Treatment Phase|Lost to Follow-up|5|||
48482580|NCT04136626|155960312|FG000|12-month Follow-up|Lost to Follow-up|8|||
48482581|NCT04136626|155960313|FG001|12-month Follow-up|Lost to Follow-up|7|||
48482582|NCT03869684|155961589|FG000|Overall Study|Adverse Event|0|||
48482583|NCT03869684|155961590|FG001|Overall Study|Adverse Event|3|||
48482584|NCT03869684|155961591|FG002|Overall Study|Adverse Event|1|||
48482585|NCT03869684|155961589|FG000|Overall Study|Withdrawal by Subject|1|||
48482586|NCT03869684|155961590|FG001|Overall Study|Withdrawal by Subject|0|||
48482587|NCT03869684|155961591|FG002|Overall Study|Withdrawal by Subject|0|||
48482588|NCT03869684|155961589|FG000|Overall Study|Lost to Follow-up|1|||
48482589|NCT03869684|155961590|FG001|Overall Study|Lost to Follow-up|0|||
48482590|NCT03869684|155961591|FG002|Overall Study|Lost to Follow-up|0|||
48482591|NCT03869684|155961589|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
48482592|NCT03869684|155961590|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
48482593|NCT03869684|155961591|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
48482594|NCT01106352|155961599|FG000|Overall Study|Subjects untreated|0|||
48482595|NCT01106352|155961600|FG001|Overall Study|Subjects untreated|0|||
48482596|NCT01106352|155961601|FG002|Overall Study|Subjects untreated|0|||
48482597|NCT01106352|155961602|FG003|Overall Study|Subjects untreated|3|||
48482598|NCT01106352|155961603|FG004|Overall Study|Subjects untreated|4|||
48482599|NCT01106352|155961599|FG000|Overall Study|Sponsor Decision|1|||
48482600|NCT01106352|155961600|FG001|Overall Study|Sponsor Decision|0|||
48482601|NCT01106352|155961601|FG002|Overall Study|Sponsor Decision|0|||
48482602|NCT01106352|155961602|FG003|Overall Study|Sponsor Decision|0|||
48482603|NCT01106352|155961603|FG004|Overall Study|Sponsor Decision|0|||
48482604|NCT01106352|155961599|FG000|Overall Study|Too ill to come in for the visit|0|||
48482605|NCT01106352|155961600|FG001|Overall Study|Too ill to come in for the visit|0|||
48482606|NCT01106352|155961601|FG002|Overall Study|Too ill to come in for the visit|1|||
48482607|NCT01106352|155961602|FG003|Overall Study|Too ill to come in for the visit|0|||
48482608|NCT01106352|155961603|FG004|Overall Study|Too ill to come in for the visit|0|||
48482609|NCT01106352|155961599|FG000|Overall Study|Lost to Follow-up|0|||
48482610|NCT01106352|155961600|FG001|Overall Study|Lost to Follow-up|0|||
48482611|NCT01106352|155961601|FG002|Overall Study|Lost to Follow-up|0|||
48482612|NCT01106352|155961602|FG003|Overall Study|Lost to Follow-up|0|||
48482613|NCT01106352|155961603|FG004|Overall Study|Lost to Follow-up|1|||
48482614|NCT01106352|155961599|FG000|Overall Study|Death|0|||
48482615|NCT01106352|155961600|FG001|Overall Study|Death|0|||
48482616|NCT01106352|155961601|FG002|Overall Study|Death|1|||
48482617|NCT01106352|155961602|FG003|Overall Study|Death|3|||
48482618|NCT01106352|155961603|FG004|Overall Study|Death|1|||
48482619|NCT01106352|155961599|FG000|Overall Study|Disease progression|0|||
48482620|NCT01106352|155961600|FG001|Overall Study|Disease progression|0|||
48482621|NCT01106352|155961601|FG002|Overall Study|Disease progression|0|||
48482622|NCT01106352|155961602|FG003|Overall Study|Disease progression|1|||
48482623|NCT01106352|155961603|FG004|Overall Study|Disease progression|0|||
48482624|NCT01106352|155961599|FG000|Overall Study|Withdrawal by Subject|0|||
48482625|NCT01106352|155961600|FG001|Overall Study|Withdrawal by Subject|0|||
48482626|NCT01106352|155961601|FG002|Overall Study|Withdrawal by Subject|0|||
48482627|NCT01106352|155961602|FG003|Overall Study|Withdrawal by Subject|3|||
48482628|NCT01106352|155961603|FG004|Overall Study|Withdrawal by Subject|2|||
48482629|NCT01106352|155961599|FG000|Overall Study|Went on hospice|0|||
48482630|NCT01106352|155961600|FG001|Overall Study|Went on hospice|0|||
48482631|NCT01106352|155961601|FG002|Overall Study|Went on hospice|0|||
48482632|NCT01106352|155961602|FG003|Overall Study|Went on hospice|1|||
48482633|NCT01106352|155961603|FG004|Overall Study|Went on hospice|0|||
48482634|NCT01106352|155961599|FG000|Overall Study|Subject entered hospice|0|||
48482635|NCT01106352|155961600|FG001|Overall Study|Subject entered hospice|0|||
48482636|NCT01106352|155961601|FG002|Overall Study|Subject entered hospice|0|||
48482637|NCT01106352|155961602|FG003|Overall Study|Subject entered hospice|1|||
48482638|NCT01106352|155961603|FG004|Overall Study|Subject entered hospice|0|||
48482639|NCT01106352|155961599|FG000|Overall Study|Home hospice since July 2013|0|||
48482640|NCT01106352|155961600|FG001|Overall Study|Home hospice since July 2013|0|||
48482641|NCT01106352|155961601|FG002|Overall Study|Home hospice since July 2013|0|||
48482642|NCT01106352|155961602|FG003|Overall Study|Home hospice since July 2013|1|||
48482643|NCT01106352|155961603|FG004|Overall Study|Home hospice since July 2013|0|||
48482644|NCT03547531|155961604|FG000|Overall Study|not coming in data collection : sick|2|||
48482645|NCT03547531|155961605|FG001|Overall Study|not coming in data collection : sick|2|||
48482646|NCT03547531|155961604|FG000|Overall Study|having family occasion|0|||
48482647|NCT03547531|155961605|FG001|Overall Study|having family occasion|2|||
48482648|NCT03402126|155961606|FG000|Overall Study|Lost to Follow-up|6|||
48482649|NCT03402126|155961606|FG000|Overall Study|Protocol Violation|10|||
48482650|NCT03402126|155961606|FG000|Overall Study|Sponsor request/Study termination|29|||
48482651|NCT03402126|155961606|FG000|Overall Study|Study product no longer in use|1|||
48482652|NCT03402126|155961606|FG000|Overall Study|Technical problems|1|||
48482653|NCT03402126|155961606|FG000|Overall Study|Withdrawal by Subject|6|||
48482654|NCT03402126|155961606|FG000|Overall Study|Physician Decision|2|||
48482655|NCT03402126|155961606|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
48482656|NCT03402126|155961606|FG000|Overall Study|Death|4|||
48482657|NCT00572156|155961607|FG000|Overall Study|Adverse Event|3|||
48482658|NCT00572156|155961608|FG001|Overall Study|Adverse Event|1|||
48482659|NCT00572156|155961609|FG002|Overall Study|Adverse Event|5|||
48482660|NCT00572156|155961610|FG003|Overall Study|Adverse Event|1|||
48482661|NCT00572156|155961607|FG000|Overall Study|Lost to Follow-up|1|||
48482662|NCT00572156|155961608|FG001|Overall Study|Lost to Follow-up|1|||
48482663|NCT00572156|155961609|FG002|Overall Study|Lost to Follow-up|1|||
48482664|NCT00572156|155961610|FG003|Overall Study|Lost to Follow-up|0|||
48482665|NCT00572156|155961607|FG000|Overall Study|Protocol Violation|1|||
48482666|NCT00572156|155961608|FG001|Overall Study|Protocol Violation|2|||
48482667|NCT00572156|155961609|FG002|Overall Study|Protocol Violation|0|||
48482668|NCT00572156|155961610|FG003|Overall Study|Protocol Violation|2|||
48482669|NCT00572156|155961607|FG000|Overall Study|Patient/Parent Decision|1|||
48482670|NCT00572156|155961608|FG001|Overall Study|Patient/Parent Decision|6|||
48482671|NCT00572156|155961609|FG002|Overall Study|Patient/Parent Decision|4|||
48482672|NCT00572156|155961610|FG003|Overall Study|Patient/Parent Decision|3|||
48482673|NCT00572156|155961607|FG000|Overall Study|Sponsor Decision|20|||
48482674|NCT00572156|155961608|FG001|Overall Study|Sponsor Decision|16|||
48482675|NCT00572156|155961609|FG002|Overall Study|Sponsor Decision|17|||
48482676|NCT00572156|155961610|FG003|Overall Study|Sponsor Decision|19|||
48482677|NCT01959230|155961611|FG000|Overall Study|Failure to follow study procedures|0|||
48482678|NCT01959230|155961612|FG001|Overall Study|Failure to follow study procedures|1|||
48482679|NCT01959230|155961611|FG000|Overall Study|Administrative reasons|2|||
48482680|NCT01959230|155961612|FG001|Overall Study|Administrative reasons|0|||
48482681|NCT01959230|155961611|FG000|Overall Study|Withdrawal by Subject|2|||
48482682|NCT01959230|155961612|FG001|Overall Study|Withdrawal by Subject|0|||
48482683|NCT00127192|155961613|FG000|Overall Study|Adverse Event|0|||
48482684|NCT00127192|155961614|FG001|Overall Study|Adverse Event|1|||
48482685|NCT00127192|155961615|FG002|Overall Study|Adverse Event|1|||
48482686|NCT00127192|155961616|FG003|Overall Study|Adverse Event|1|||
48482687|NCT00127192|155961617|FG004|Overall Study|Adverse Event|0|||
48482688|NCT00127192|155961613|FG000|Overall Study|Lack of Efficacy|2|||
48482689|NCT00127192|155961614|FG001|Overall Study|Lack of Efficacy|0|||
48482690|NCT00127192|155961615|FG002|Overall Study|Lack of Efficacy|0|||
48482691|NCT00127192|155961616|FG003|Overall Study|Lack of Efficacy|0|||
48482692|NCT00127192|155961617|FG004|Overall Study|Lack of Efficacy|2|||
48482693|NCT00127192|155961613|FG000|Overall Study|Withdrawal by Subject|0|||
48482694|NCT00127192|155961614|FG001|Overall Study|Withdrawal by Subject|0|||
48482695|NCT00127192|155961615|FG002|Overall Study|Withdrawal by Subject|1|||
48482696|NCT00127192|155961616|FG003|Overall Study|Withdrawal by Subject|0|||
48482697|NCT00127192|155961617|FG004|Overall Study|Withdrawal by Subject|3|||
48482698|NCT00127192|155961613|FG000|Overall Study|Adverse event in pre-treatment period|1|||
48482699|NCT00127192|155961614|FG001|Overall Study|Adverse event in pre-treatment period|0|||
48482700|NCT00127192|155961615|FG002|Overall Study|Adverse event in pre-treatment period|0|||
48482701|NCT00127192|155961616|FG003|Overall Study|Adverse event in pre-treatment period|0|||
48482702|NCT00127192|155961617|FG004|Overall Study|Adverse event in pre-treatment period|0|||
48482703|NCT03907397|155961618|FG000|Overall Study|Lost to Follow-up|0|||
48482704|NCT03907397|155961619|FG001|Overall Study|Lost to Follow-up|1|||
48482705|NCT03907397|155961618|FG000|Overall Study|Physician Decision|2|||
48482706|NCT03907397|155961619|FG001|Overall Study|Physician Decision|1|||
48482707|NCT03907397|155961618|FG000|Overall Study|Withdrawal by Subject|5|||
48482708|NCT03907397|155961619|FG001|Overall Study|Withdrawal by Subject|4|||
48482709|NCT03907397|155961618|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
48482710|NCT03907397|155961619|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
48482711|NCT03611621|155961624|FG000|Overall Study|Graft loss|3|||
48482712|NCT03611621|155961624|FG000|Overall Study|Death|3|||
48482713|NCT03611621|155961624|FG000|Overall Study|Lost to Follow-up|1|||
48482714|NCT01466673|155961625|FG000|Overall Study|Non-compliance with study treatment|2|||
48482715|NCT01466673|155961626|FG001|Overall Study|Non-compliance with study treatment|0|||
48482716|NCT01466673|155961625|FG000|Overall Study|Lost to Follow-up|3|||
48482717|NCT01466673|155961626|FG001|Overall Study|Lost to Follow-up|5|||
48482718|NCT01466673|155961625|FG000|Overall Study|Adverse Event|2|||
48482719|NCT01466673|155961626|FG001|Overall Study|Adverse Event|1|||
48482720|NCT05268393|155961627|FG000|Overall Study|Withdrawal by Subject|2|||
48482721|NCT05268393|155961628|FG001|Overall Study|Withdrawal by Subject|1|||
48482722|NCT02858076|155961631|FG000|Overall Study|Death|6|||
48482723|NCT02858076|155961632|FG001|Overall Study|Death|3|||
48482724|NCT02858076|155961631|FG000|Overall Study|Withdrawal by Subject|1|||
48482725|NCT02858076|155961632|FG001|Overall Study|Withdrawal by Subject|5|||
48482726|NCT02858076|155961631|FG000|Overall Study|Lost to Follow-up|2|||
48482727|NCT02858076|155961632|FG001|Overall Study|Lost to Follow-up|7|||
48482728|NCT02858076|155961631|FG000|Overall Study|Completed Out of Window|1|||
48482729|NCT02858076|155961632|FG001|Overall Study|Completed Out of Window|3|||
48482730|NCT03959137|155961638|FG000|Overall Study|Protocol Violation|6|||
48482731|NCT00659581|155961643|FG000|Overall Study|Adverse Event|1006|||
48482732|NCT00659581|155961643|FG000|Overall Study|Lack of Efficacy|1183|||
48482733|NCT00659581|155961643|FG000|Overall Study|Other|6393|||
48482734|NCT00190684|155961646|FG000|Overall Study|Adverse Event|86|||
48482735|NCT00190684|155961646|FG000|Overall Study|Satisfactory response|80|||
48482736|NCT00190684|155961646|FG000|Overall Study|Lack of efficacy|204|||
48482737|NCT00190684|155961646|FG000|Overall Study|Lost to Follow-up|232|||
48482738|NCT00190684|155961646|FG000|Overall Study|Patient moved|60|||
48482739|NCT00190684|155961646|FG000|Overall Study|Patient Decision|432|||
48482740|NCT00190684|155961646|FG000|Overall Study|Clinical relapse|67|||
48482741|NCT00190684|155961646|FG000|Overall Study|Sponsor's decision|17|||
48482742|NCT00190684|155961646|FG000|Overall Study|Physician Decision|84|||
48482743|NCT00190684|155961646|FG000|Overall Study|Protocol Violation|123|||
48482744|NCT00190684|155961646|FG000|Overall Study|Study Period III Completed|103|||
48482745|NCT00190684|155961646|FG000|Overall Study|Study Period V Completed|1|||
48482746|NCT05349188|155961647|FG000|Overall Study|Withdrawal by Subject|1|||
48482747|NCT05349188|155961648|FG001|Overall Study|Withdrawal by Subject|0|||
48482748|NCT03496207|155961649|FG000|Base Study|Adverse Event|0|||
48482749|NCT03496207|155961650|FG001|Base Study|Adverse Event|0|||
48482750|NCT03496207|155961651|FG002|Base Study|Adverse Event|1|||
48482751|NCT03496207|155961652|FG003|Base Study|Adverse Event|1|||
48482752|NCT03496207|155961653|FG004|Base Study|Adverse Event|4|||
48482753|NCT03496207|155961649|FG000|Base Study|Death|0|||
48482754|NCT03496207|155961650|FG001|Base Study|Death|0|||
48482755|NCT03496207|155961651|FG002|Base Study|Death|0|||
48482756|NCT03496207|155961652|FG003|Base Study|Death|0|||
48482757|NCT03496207|155961653|FG004|Base Study|Death|1|||
48482758|NCT03496207|155961649|FG000|Base Study|Withdrawal by Subject|0|||
48482759|NCT03496207|155961650|FG001|Base Study|Withdrawal by Subject|0|||
48482760|NCT03496207|155961651|FG002|Base Study|Withdrawal by Subject|1|||
48482761|NCT03496207|155961652|FG003|Base Study|Withdrawal by Subject|0|||
48482762|NCT03496207|155961653|FG004|Base Study|Withdrawal by Subject|1|||
48482763|NCT03496207|155961649|FG000|Extension Period|Adverse Event|0|||
48482764|NCT03496207|155961650|FG001|Extension Period|Adverse Event|0|||
48482765|NCT03496207|155961651|FG002|Extension Period|Adverse Event|0|||
48482766|NCT03496207|155961652|FG003|Extension Period|Adverse Event|1|||
48482767|NCT03496207|155961653|FG004|Extension Period|Adverse Event|1|||
48482768|NCT03496207|155961649|FG000|Extension Period|Death|1|||
48482769|NCT03496207|155961650|FG001|Extension Period|Death|0|||
48482770|NCT03496207|155961651|FG002|Extension Period|Death|0|||
48482771|NCT03496207|155961652|FG003|Extension Period|Death|1|||
48482772|NCT03496207|155961653|FG004|Extension Period|Death|2|||
48482773|NCT03496207|155961649|FG000|Extension Period|Withdrawal by Subject|1|||
48482774|NCT03496207|155961650|FG001|Extension Period|Withdrawal by Subject|0|||
48482775|NCT03496207|155961651|FG002|Extension Period|Withdrawal by Subject|0|||
48482776|NCT03496207|155961652|FG003|Extension Period|Withdrawal by Subject|1|||
48482777|NCT03496207|155961653|FG004|Extension Period|Withdrawal by Subject|1|||
48482778|NCT03496207|155961649|FG000|Extension Period|Elevated hemoglobin levels|0|||
48482779|NCT03496207|155961650|FG001|Extension Period|Elevated hemoglobin levels|0|||
48482780|NCT03496207|155961651|FG002|Extension Period|Elevated hemoglobin levels|0|||
48482781|NCT03496207|155961652|FG003|Extension Period|Elevated hemoglobin levels|0|||
48482782|NCT03496207|155961653|FG004|Extension Period|Elevated hemoglobin levels|1|||
48482783|NCT02756078|155961654|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
48482784|NCT02756078|155961655|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
48482785|NCT02756078|155961654|FG000|Period 1|Lost to Follow-up|0|||
48482786|NCT02756078|155961655|FG001|Period 1|Lost to Follow-up|2|||
48482787|NCT02756078|155961654|FG000|Period 1|Protocol Violation|0|||
48482788|NCT02756078|155961655|FG001|Period 1|Protocol Violation|1|||
48482789|NCT02756078|155961654|FG000|Period 1|Adverse Event|1|||
48482790|NCT02756078|155961655|FG001|Period 1|Adverse Event|10|||
48482791|NCT02756078|155961654|FG000|Period 1|Withdrawal by Subject|6|||
48482792|NCT02756078|155961655|FG001|Period 1|Withdrawal by Subject|6|||
48482793|NCT02756078|155961654|FG000|Period 1|Lens Discomfort|2|||
48482794|NCT02756078|155961655|FG001|Period 1|Lens Discomfort|2|||
48482795|NCT02756078|155961654|FG000|Period 2|Adverse Event|3|||
48482796|NCT02756078|155961655|FG001|Period 2|Adverse Event|5|||
48482797|NCT02756078|155961654|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
48482798|NCT02756078|155961655|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
48482799|NCT02756078|155961654|FG000|Period 2|Withdrawal by Subject|3|||
48482800|NCT02756078|155961655|FG001|Period 2|Withdrawal by Subject|1|||
48482801|NCT01396278|155961656|FG000|Overall Study|Adverse Event|0|||
48482802|NCT01396278|155961657|FG001|Overall Study|Adverse Event|0|||
48482803|NCT01396278|155961658|FG002|Overall Study|Adverse Event|0|||
48482804|NCT01396278|155961659|FG003|Overall Study|Adverse Event|2|||
48482805|NCT01396278|155961660|FG004|Overall Study|Adverse Event|0|||
48482806|NCT01396278|155961656|FG000|Overall Study|Withdraw due to trial termination|2|||
48482807|NCT01396278|155961657|FG001|Overall Study|Withdraw due to trial termination|1|||
48482808|NCT01396278|155961658|FG002|Overall Study|Withdraw due to trial termination|1|||
48482809|NCT01396278|155961659|FG003|Overall Study|Withdraw due to trial termination|0|||
48482810|NCT01396278|155961660|FG004|Overall Study|Withdraw due to trial termination|2|||
48482811|NCT01766310|155961661|FG000|Overall Study|Lost to Follow-up|1|||
48482812|NCT01766310|155961662|FG001|Overall Study|Lost to Follow-up|3|||
48482813|NCT03721952|155961664|FG000|Overall Study|Lost to Follow-up|0|||
48482814|NCT03721952|155961665|FG001|Overall Study|Lost to Follow-up|0|||
48482815|NCT03721952|155961666|FG002|Overall Study|Lost to Follow-up|2|||
48482816|NCT03721952|155961667|FG003|Overall Study|Lost to Follow-up|0|||
48482817|NCT03721952|155961668|FG004|Overall Study|Lost to Follow-up|0|||
48482818|NCT03721952|155961664|FG000|Overall Study|Protocol Violation|0|||
48482819|NCT03721952|155961665|FG001|Overall Study|Protocol Violation|1|||
48482820|NCT03721952|155961666|FG002|Overall Study|Protocol Violation|0|||
48482821|NCT03721952|155961667|FG003|Overall Study|Protocol Violation|0|||
48482822|NCT03721952|155961668|FG004|Overall Study|Protocol Violation|0|||
48482823|NCT03721952|155961664|FG000|Overall Study|Withdrawal by Subject|1|||
48482824|NCT03721952|155961665|FG001|Overall Study|Withdrawal by Subject|0|||
48482825|NCT03721952|155961666|FG002|Overall Study|Withdrawal by Subject|40|||
48482826|NCT03721952|155961667|FG003|Overall Study|Withdrawal by Subject|28|||
48482827|NCT03721952|155961668|FG004|Overall Study|Withdrawal by Subject|0|||
48482828|NCT03091400|155961669|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
48482829|NCT03091400|155961670|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
48482830|NCT03467971|155961671|FG000|Treatment Period 2|Withdrawal by Subject|0|||
48482831|NCT03467971|155961672|FG001|Treatment Period 2|Withdrawal by Subject|1|||
48482832|NCT02561000|155961673|FG000|Overall Study|Withdrawal by Subject|2|||
48482833|NCT02561000|155961674|FG001|Overall Study|Withdrawal by Subject|3|||
48482834|NCT02561000|155961675|FG002|Overall Study|Withdrawal by Subject|0|||
48482835|NCT02561000|155961673|FG000|Overall Study|Adverse Event|0|||
48482836|NCT02561000|155961674|FG001|Overall Study|Adverse Event|1|||
48482837|NCT02561000|155961675|FG002|Overall Study|Adverse Event|0|||
48482838|NCT02865538|155961684|FG000|Overall Study|Withdrawal by Subject|0|||
48482839|NCT02865538|155961685|FG001|Overall Study|Withdrawal by Subject|0|||
48482840|NCT02865538|155961686|FG002|Overall Study|Withdrawal by Subject|1|||
48482841|NCT02865538|155961687|FG003|Overall Study|Withdrawal by Subject|0|||
48482842|NCT02865538|155961688|FG004|Overall Study|Withdrawal by Subject|0|||
48482843|NCT02865538|155961684|FG000|Overall Study|Lost to Follow-up|1|||
48482844|NCT02865538|155961685|FG001|Overall Study|Lost to Follow-up|0|||
48482845|NCT02865538|155961686|FG002|Overall Study|Lost to Follow-up|0|||
48482846|NCT02865538|155961687|FG003|Overall Study|Lost to Follow-up|0|||
48482847|NCT02865538|155961688|FG004|Overall Study|Lost to Follow-up|0|||
48482848|NCT01730937|155961692|FG000|Overall Study|Protocol Violation|5|||
48482849|NCT01730937|155961693|FG001|Overall Study|Protocol Violation|11|||
48482850|NCT03174275|155961694|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
48482851|NCT03174275|155961694|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
48482852|NCT03174275|155961694|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
48482853|NCT03174275|155961694|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
48482854|NCT03174275|155961694|FG000|Adjuvant Chemotherapy|Progression|1|||
48482855|NCT03174275|155961694|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
48482856|NCT03174275|155961694|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
48482857|NCT03174275|155961694|FG000|Adjuvant Durvalumab|Progression|1|||
48482858|NCT03174275|155961694|FG000|Adjuvant Durvalumab|Adverse Event|3|||
48482859|NCT03174275|155961694|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
48482860|NCT03174275|155961694|FG000|Adjuvant Radiotherapy|Progression|1|||
48482861|NCT03174275|155961694|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
48482862|NCT00585039|155961695|FG000|Overall Study|medication spilled|2|||
48482863|NCT00585039|155961696|FG001|Overall Study|medication spilled|0|||
48482864|NCT05123027|155961701|FG000|Overall Study|Lost to Follow-up|17|||
48482865|NCT05123027|155961702|FG001|Overall Study|Lost to Follow-up|22|||
48482866|NCT05123027|155961701|FG000|Overall Study|Incarceration|3|||
48482867|NCT05123027|155961702|FG001|Overall Study|Incarceration|4|||
48482868|NCT05123027|155961701|FG000|Overall Study|Death|2|||
48482869|NCT05123027|155961702|FG001|Overall Study|Death|2|||
48482870|NCT05123027|155961701|FG000|Overall Study|Other|2|||
48482871|NCT05123027|155961702|FG001|Overall Study|Other|0|||
48482872|NCT00378482|155961703|FG000|Overall Study|Lost to Follow-up|1|||
48482873|NCT00378482|155961703|FG000|Overall Study|Lack of Efficacy|8|||
48482874|NCT00378482|155961703|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
48482875|NCT00378482|155961703|FG000|Overall Study|Withdrawal by Subject|4|||
48482876|NCT00378482|155961703|FG000|Overall Study|Adverse Event|9|||
48482877|NCT04317053|155961712|FG000|Overall Study|Withdrawn (screen failure)|4|||
48482878|NCT04317053|155961713|FG001|Overall Study|Withdrawn (screen failure)|2|||
48482879|NCT01458132|155962796|FG000|Overall Study|Other|15|||
48482880|NCT01458132|155962797|FG001|Overall Study|Other|3|||
48482881|NCT00763269|155962798|FG000|Overall Study|Lost to Follow-up|12|||
48482882|NCT00763269|155962799|FG001|Overall Study|Lost to Follow-up|13|||
48482883|NCT04056299|155962809|FG000|Overall Study|Sponsor discontinued study|3|||
48482884|NCT04056299|155962810|FG001|Overall Study|Sponsor discontinued study|3|||
48482885|NCT00068406|155962815|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
48482886|NCT00068406|155962815|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
48482887|NCT00589693|155962818|FG000|Overall Study|randomized in error|12|||
48482888|NCT00589693|155962819|FG001|Overall Study|randomized in error|6|||
48482889|NCT00589693|155962818|FG000|Overall Study|Adverse Event|4|||
48482890|NCT00589693|155962819|FG001|Overall Study|Adverse Event|4|||
48482891|NCT00589693|155962818|FG000|Overall Study|Death|26|||
48482892|NCT00589693|155962819|FG001|Overall Study|Death|16|||
48482893|NCT00589693|155962818|FG000|Overall Study|Lack of Efficacy|0|||
48482894|NCT00589693|155962819|FG001|Overall Study|Lack of Efficacy|1|||
48482895|NCT00589693|155962818|FG000|Overall Study|Lost to Follow-up|1|||
48482896|NCT00589693|155962819|FG001|Overall Study|Lost to Follow-up|0|||
48482897|NCT00589693|155962818|FG000|Overall Study|Physician Decision|0|||
48482898|NCT00589693|155962819|FG001|Overall Study|Physician Decision|1|||
48482899|NCT00589693|155962818|FG000|Overall Study|Protocol Violation|1|||
48482900|NCT00589693|155962819|FG001|Overall Study|Protocol Violation|1|||
48482901|NCT01128153|155962821|FG000|Overall Study|Adverse Event|1|||
48482902|NCT01128153|155962822|FG001|Overall Study|Adverse Event|3|||
48482903|NCT01128153|155962821|FG000|Overall Study|Condition under investigation worsened|8|||
48482904|NCT01128153|155962822|FG001|Overall Study|Condition under investigation worsened|7|||
48482905|NCT01128153|155962821|FG000|Overall Study|Withdrawal by Subject|2|||
48482906|NCT01128153|155962822|FG001|Overall Study|Withdrawal by Subject|3|||
48483059|NCT01629693|155962894|FG001|Overall Study|Lost to Follow-up|4|||
48482907|NCT01128153|155962821|FG000|Overall Study|Incorrect enrolment to study|2|||
48482908|NCT01128153|155962822|FG001|Overall Study|Incorrect enrolment to study|1|||
48482909|NCT01128153|155962821|FG000|Overall Study|Protocol Violation|2|||
48482910|NCT01128153|155962822|FG001|Overall Study|Protocol Violation|0|||
48482911|NCT01128153|155962821|FG000|Overall Study|Developed discontinuation criteria|1|||
48482912|NCT01128153|155962822|FG001|Overall Study|Developed discontinuation criteria|1|||
48482913|NCT00755937|155962823|FG000|Recruitment|Unknown if infliximab received|164|||
48482914|NCT00755937|155962823|FG000|Observational Follow-up|Lost to Follow-up|148|||
48482915|NCT04060654|155962824|FG000|Overall Study|Withdrawal by Subject|1|||
48482916|NCT04060654|155962824|FG000|Overall Study|Lost to Follow-up|5|||
48482917|NCT01169987|155962825|FG000|Overall Study|Withdrawal by Subject|3|||
48482918|NCT01169987|155962825|FG000|Overall Study|Lost to Follow-up|24|||
48482919|NCT01169987|155962825|FG000|Overall Study|Other|4|||
48482920|NCT00943384|155962826|FG000|Overall Study|Dispositioned prior to treatment|23|||
48482921|NCT00943384|155962826|FG000|Overall Study|Treated off protocol-protocol violation|5|||
48482922|NCT00943384|155962826|FG000|Overall Study|Lost to Follow-up|16|||
48482923|NCT00943384|155962826|FG000|Overall Study|Withdrawal by Subject|5|||
48482924|NCT00478673|155962827|FG000|30-Days Post-Procedure|Death|2|||
48482925|NCT00478673|155962827|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
48482926|NCT00478673|155962827|FG000|30-Days Post-Procedure|Missed Visit|7|||
48482927|NCT00478673|155962827|FG000|12-Months Post-Procedure|Death|23|||
48482928|NCT00478673|155962827|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
48482929|NCT00478673|155962827|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
48482930|NCT00478673|155962827|FG000|12-Months Post-Procedure|Missed Visit|25|||
48482931|NCT00478673|155962827|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
48482932|NCT01749033|155962830|FG000|Overall Study|Did not receive allocated intervention|3|||
48482933|NCT01749033|155962831|FG001|Overall Study|Did not receive allocated intervention|3|||
48482934|NCT01749033|155962832|FG002|Overall Study|Did not receive allocated intervention|0|||
48482935|NCT01749033|155962830|FG000|Overall Study|Lost to Follow-up|0|||
48482936|NCT01749033|155962831|FG001|Overall Study|Lost to Follow-up|2|||
48482937|NCT01749033|155962832|FG002|Overall Study|Lost to Follow-up|1|||
48482938|NCT00481871|155962833|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
48482939|NCT00481871|155962834|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
48482940|NCT00481871|155962835|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
48482941|NCT00481871|155962836|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
48482942|NCT00481871|155962837|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
48482943|NCT00291330|155962862|FG000|Overall Study|Adverse Event|47|||
48482944|NCT00291330|155962863|FG001|Overall Study|Adverse Event|40|||
48482945|NCT00291330|155962862|FG000|Overall Study|Protocol Violation|13|||
48482946|NCT00291330|155962863|FG001|Overall Study|Protocol Violation|20|||
48482947|NCT00291330|155962862|FG000|Overall Study|Lost to Follow-up|16|||
48482948|NCT00291330|155962863|FG001|Overall Study|Lost to Follow-up|11|||
48482949|NCT00291330|155962862|FG000|Overall Study|Withdrawal by Subject|22|||
48482950|NCT00291330|155962863|FG001|Overall Study|Withdrawal by Subject|25|||
48482951|NCT00291330|155962862|FG000|Overall Study|Other|3|||
48482952|NCT00291330|155962863|FG001|Overall Study|Other|1|||
48482953|NCT01829295|155962864|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
48482954|NCT01829295|155962865|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
48482955|NCT01829295|155962866|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
48482956|NCT01829295|155962867|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
48482957|NCT01829295|155962864|FG000|6-12 Months|Adverse Event|0|||
48482958|NCT01829295|155962865|FG001|6-12 Months|Adverse Event|0|||
48482959|NCT01829295|155962866|FG002|6-12 Months|Adverse Event|3|||
48482960|NCT01829295|155962867|FG003|6-12 Months|Adverse Event|2|||
48482961|NCT01829295|155962864|FG000|6-12 Months|Lost to Follow-up|2|||
48482962|NCT01829295|155962865|FG001|6-12 Months|Lost to Follow-up|0|||
48482963|NCT01829295|155962866|FG002|6-12 Months|Lost to Follow-up|0|||
48482964|NCT01829295|155962867|FG003|6-12 Months|Lost to Follow-up|0|||
48482965|NCT01829295|155962864|FG000|6-12 Months|Withdrawal by Subject|2|||
48482966|NCT01829295|155962865|FG001|6-12 Months|Withdrawal by Subject|2|||
48482967|NCT01829295|155962866|FG002|6-12 Months|Withdrawal by Subject|0|||
48482968|NCT01829295|155962867|FG003|6-12 Months|Withdrawal by Subject|0|||
48482969|NCT00656019|155962871|FG000|Overall Study|Not Eligible|10|||
48482970|NCT00656019|155962872|FG001|Overall Study|Not Eligible|0|||
48482971|NCT00656019|155962873|FG002|Overall Study|Not Eligible|0|||
48482972|NCT00656019|155962874|FG003|Overall Study|Not Eligible|0|||
48482973|NCT00656019|155962871|FG000|Overall Study|Withdrawal by Subject|2|||
48482974|NCT00656019|155962872|FG001|Overall Study|Withdrawal by Subject|0|||
48482975|NCT00656019|155962873|FG002|Overall Study|Withdrawal by Subject|0|||
48482976|NCT00656019|155962874|FG003|Overall Study|Withdrawal by Subject|0|||
48482977|NCT00656019|155962871|FG000|Overall Study|Lost to Follow-up|2|||
48482978|NCT00656019|155962872|FG001|Overall Study|Lost to Follow-up|1|||
48482979|NCT00656019|155962873|FG002|Overall Study|Lost to Follow-up|0|||
48482980|NCT00656019|155962874|FG003|Overall Study|Lost to Follow-up|0|||
48482981|NCT03125915|155962875|FG000|1 Month Follow up|Lost to Follow-up|3|||
48482982|NCT03125915|155962876|FG001|1 Month Follow up|Lost to Follow-up|3|||
48482983|NCT03125915|155962877|FG002|1 Month Follow up|Lost to Follow-up|2|||
48482984|NCT03125915|155962878|FG003|1 Month Follow up|Lost to Follow-up|3|||
48482985|NCT03125915|155962875|FG000|3 Month Follow-up|Lost to Follow-up|6|||
48482986|NCT03125915|155962876|FG001|3 Month Follow-up|Lost to Follow-up|4|||
48482987|NCT03125915|155962877|FG002|3 Month Follow-up|Lost to Follow-up|4|||
48482988|NCT03125915|155962878|FG003|3 Month Follow-up|Lost to Follow-up|2|||
48482989|NCT03125915|155962875|FG000|6 Month Follow-up|Lost to Follow-up|7|||
48482990|NCT03125915|155962876|FG001|6 Month Follow-up|Lost to Follow-up|3|||
48482991|NCT03125915|155962877|FG002|6 Month Follow-up|Lost to Follow-up|6|||
48482992|NCT03125915|155962878|FG003|6 Month Follow-up|Lost to Follow-up|3|||
48482993|NCT02956005|155962879|FG000|Overall Study|Not eligible|1|||
48482994|NCT02956005|155962879|FG000|Overall Study|Withdrawal by Subject|3|||
48482995|NCT02956005|155962879|FG000|Overall Study|Physician Decision|12|||
48482996|NCT01828112|155962880|FG000|Treatment Phase|Adverse Event|7|||
48482997|NCT01828112|155962881|FG001|Treatment Phase|Adverse Event|8|||
48482998|NCT01828112|155962882|FG002|Treatment Phase|Adverse Event|0|||
48482999|NCT01828112|155962880|FG000|Treatment Phase|Death|9|||
48483000|NCT01828112|155962881|FG001|Treatment Phase|Death|5|||
48483001|NCT01828112|155962882|FG002|Treatment Phase|Death|0|||
48483002|NCT01828112|155962880|FG000|Treatment Phase|No longer required treatment|0|||
48483003|NCT01828112|155962881|FG001|Treatment Phase|No longer required treatment|1|||
48483004|NCT01828112|155962882|FG002|Treatment Phase|No longer required treatment|0|||
48483005|NCT01828112|155962880|FG000|Treatment Phase|Physician Decision|6|||
48483006|NCT01828112|155962881|FG001|Treatment Phase|Physician Decision|7|||
48483007|NCT01828112|155962882|FG002|Treatment Phase|Physician Decision|0|||
48483008|NCT01828112|155962880|FG000|Treatment Phase|Pregnancy|1|||
48483009|NCT01828112|155962881|FG001|Treatment Phase|Pregnancy|0|||
48483010|NCT01828112|155962882|FG002|Treatment Phase|Pregnancy|0|||
48483011|NCT01828112|155962880|FG000|Treatment Phase|Progressive disease|79|||
48483012|NCT01828112|155962881|FG001|Treatment Phase|Progressive disease|87|||
48483013|NCT01828112|155962882|FG002|Treatment Phase|Progressive disease|0|||
48483014|NCT01828112|155962880|FG000|Treatment Phase|Study terminated by sponsor|1|||
48483015|NCT01828112|155962881|FG001|Treatment Phase|Study terminated by sponsor|0|||
48483016|NCT01828112|155962882|FG002|Treatment Phase|Study terminated by sponsor|0|||
48483017|NCT01828112|155962880|FG000|Treatment Phase|Subject/guardian decision|12|||
48483018|NCT01828112|155962881|FG001|Treatment Phase|Subject/guardian decision|8|||
48483019|NCT01828112|155962882|FG002|Treatment Phase|Subject/guardian decision|0|||
48483020|NCT01828112|155962880|FG000|Extension Treatment Phase|Adverse Event|0|||
48483021|NCT01828112|155962881|FG001|Extension Treatment Phase|Adverse Event|0|||
48483022|NCT01828112|155962882|FG002|Extension Treatment Phase|Adverse Event|6|||
48483023|NCT01828112|155962880|FG000|Extension Treatment Phase|Death|0|||
48483024|NCT01828112|155962881|FG001|Extension Treatment Phase|Death|0|||
48483025|NCT01828112|155962882|FG002|Extension Treatment Phase|Death|17|||
48483026|NCT01828112|155962880|FG000|Extension Treatment Phase|Physician Decision|0|||
48483027|NCT01828112|155962881|FG001|Extension Treatment Phase|Physician Decision|0|||
48483028|NCT01828112|155962882|FG002|Extension Treatment Phase|Physician Decision|5|||
48483029|NCT01828112|155962880|FG000|Extension Treatment Phase|Progressive disease|0|||
48483030|NCT01828112|155962881|FG001|Extension Treatment Phase|Progressive disease|0|||
48483031|NCT01828112|155962882|FG002|Extension Treatment Phase|Progressive disease|46|||
48483032|NCT01828112|155962880|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
48483033|NCT01828112|155962881|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
48483034|NCT01828112|155962882|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
48483035|NCT01828112|155962880|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
48483036|NCT01828112|155962881|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
48483037|NCT01828112|155962882|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
48483038|NCT01185639|155962885|FG000|Overall Study|Progressed and didn't receive therapy|2|||
48483039|NCT04556838|155962888|FG000|Overall Study|Withdrawal by Subject|3|||
48483040|NCT04556838|155962889|FG001|Overall Study|Withdrawal by Subject|1|||
48483041|NCT04556838|155962890|FG002|Overall Study|Withdrawal by Subject|2|||
48483042|NCT04556838|155962888|FG000|Overall Study|Adverse Event|0|||
48483043|NCT04556838|155962889|FG001|Overall Study|Adverse Event|1|||
48483044|NCT04556838|155962890|FG002|Overall Study|Adverse Event|1|||
48483045|NCT04556838|155962888|FG000|Overall Study|Lost to Follow-up|0|||
48483046|NCT04556838|155962889|FG001|Overall Study|Lost to Follow-up|0|||
48483047|NCT04556838|155962890|FG002|Overall Study|Lost to Follow-up|2|||
48483048|NCT04556838|155962888|FG000|Overall Study|Subject travel|0|||
48483049|NCT04556838|155962889|FG001|Overall Study|Subject travel|1|||
48483050|NCT04556838|155962890|FG002|Overall Study|Subject travel|0|||
48483051|NCT04556838|155962888|FG000|Overall Study|Physician Decision|1|||
48483052|NCT04556838|155962889|FG001|Overall Study|Physician Decision|0|||
48483053|NCT04556838|155962890|FG002|Overall Study|Physician Decision|0|||
48483054|NCT01010230|155962891|FG000|Overall Study|Withdrawal by Subject|6|||
48483055|NCT01010230|155962892|FG001|Overall Study|Withdrawal by Subject|5|||
48483056|NCT01010230|155962891|FG000|Overall Study|Lost to Follow-up|4|||
48483057|NCT01010230|155962892|FG001|Overall Study|Lost to Follow-up|2|||
48483058|NCT01629693|155962893|FG000|Overall Study|Lost to Follow-up|2|||
48483060|NCT01629693|155962893|FG000|Overall Study|Withdrawal by Subject|2|||
48483061|NCT01629693|155962894|FG001|Overall Study|Withdrawal by Subject|2|||
48483062|NCT01629693|155962893|FG000|Overall Study|Adverse Event|1|||
48483063|NCT01629693|155962894|FG001|Overall Study|Adverse Event|0|||
48483064|NCT01629693|155962893|FG000|Overall Study|Investigator decision|0|||
48483065|NCT01629693|155962894|FG001|Overall Study|Investigator decision|1|||
48483066|NCT01629693|155962893|FG000|Overall Study|Poor comfort of study lenses|0|||
48483067|NCT01629693|155962894|FG001|Overall Study|Poor comfort of study lenses|2|||
48483068|NCT01629693|155962893|FG000|Overall Study|Subject decision unrelated to AE|0|||
48483069|NCT01629693|155962894|FG001|Overall Study|Subject decision unrelated to AE|1|||
48483070|NCT01585831|155962895|FG000|Overall Study|Physician Decision|0|||
48483071|NCT01585831|155962896|FG001|Overall Study|Physician Decision|1|||
48483072|NCT01585831|155962895|FG000|Overall Study|Withdrawal by Subject|2|||
48483073|NCT01585831|155962896|FG001|Overall Study|Withdrawal by Subject|1|||
48483074|NCT02046369|155962897|FG000|Overall Study|Adverse Event|3|||
48483075|NCT02046369|155962898|FG001|Overall Study|Adverse Event|3|||
48483076|NCT02046369|155962897|FG000|Overall Study|Lack of Efficacy|3|||
48483077|NCT02046369|155962898|FG001|Overall Study|Lack of Efficacy|3|||
48483078|NCT02046369|155962897|FG000|Overall Study|Lost to Follow-up|3|||
48483079|NCT02046369|155962898|FG001|Overall Study|Lost to Follow-up|3|||
48483080|NCT02046369|155962897|FG000|Overall Study|Protocol Violation|1|||
48483081|NCT02046369|155962898|FG001|Overall Study|Protocol Violation|2|||
48483082|NCT02046369|155962897|FG000|Overall Study|Withdrawal by Subject|3|||
48483083|NCT02046369|155962898|FG001|Overall Study|Withdrawal by Subject|6|||
48483084|NCT02046369|155962897|FG000|Overall Study|never received study drug|0|||
48483085|NCT02046369|155962898|FG001|Overall Study|never received study drug|1|||
48483086|NCT02046369|155962897|FG000|Overall Study|non compliance|1|||
48483087|NCT02046369|155962898|FG001|Overall Study|non compliance|0|||
48483088|NCT01529749|155962899|FG000|Overall Study|Lost to Follow-up|0|||
48483089|NCT01529749|155962900|FG001|Overall Study|Lost to Follow-up|1|||
48483090|NCT01529749|155962901|FG002|Overall Study|Lost to Follow-up|1|||
48483091|NCT01529749|155962902|FG003|Overall Study|Lost to Follow-up|0|||
48483092|NCT01529749|155962899|FG000|Overall Study|Physician Decision|0|||
48483093|NCT01529749|155962900|FG001|Overall Study|Physician Decision|0|||
48483094|NCT01529749|155962901|FG002|Overall Study|Physician Decision|0|||
48483095|NCT01529749|155962902|FG003|Overall Study|Physician Decision|1|||
48483096|NCT01529749|155962899|FG000|Overall Study|Withdrawal by Subject|0|||
48483097|NCT01529749|155962900|FG001|Overall Study|Withdrawal by Subject|1|||
48483098|NCT01529749|155962901|FG002|Overall Study|Withdrawal by Subject|1|||
48483099|NCT01529749|155962902|FG003|Overall Study|Withdrawal by Subject|0|||
48483100|NCT01529749|155962899|FG000|Overall Study|Protocol Violation|0|||
48483101|NCT01529749|155962900|FG001|Overall Study|Protocol Violation|0|||
48483102|NCT01529749|155962901|FG002|Overall Study|Protocol Violation|0|||
48483103|NCT01529749|155962902|FG003|Overall Study|Protocol Violation|1|||
48483104|NCT02623426|155962903|FG000|Overall Study|Lost to Follow-up|0|||
48483105|NCT02623426|155962904|FG001|Overall Study|Lost to Follow-up|0|||
48483106|NCT02623426|155962905|FG002|Overall Study|Lost to Follow-up|1|||
48483107|NCT02623426|155962903|FG000|Overall Study|Withdrawal by Subject|1|||
48483108|NCT02623426|155962904|FG001|Overall Study|Withdrawal by Subject|2|||
48483109|NCT02623426|155962905|FG002|Overall Study|Withdrawal by Subject|2|||
48483110|NCT04505410|155962906|FG000|Overall Study|Adverse Event|2|||
48483111|NCT04505410|155962907|FG001|Overall Study|Adverse Event|0|||
48483112|NCT04505410|155962906|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
48483113|NCT04505410|155962907|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
48483114|NCT04505410|155962906|FG000|Overall Study|did not want to follow diet|1|||
48483115|NCT04505410|155962907|FG001|Overall Study|did not want to follow diet|0|||
48483116|NCT04505410|155962906|FG000|Overall Study|flare up of ulcerative colitis|0|||
48483117|NCT04505410|155962907|FG001|Overall Study|flare up of ulcerative colitis|1|||
48483118|NCT04505410|155962906|FG000|Overall Study|Lost to Follow-up|0|||
48483119|NCT04505410|155962907|FG001|Overall Study|Lost to Follow-up|2|||
48483120|NCT04505410|155962906|FG000|Overall Study|Lost to Follow-up|1|||
48483121|NCT04505410|155962907|FG001|Overall Study|Lost to Follow-up|0|||
48483122|NCT04505410|155962906|FG000|Overall Study|initiated another diet on their own|0|||
48483123|NCT04505410|155962907|FG001|Overall Study|initiated another diet on their own|2|||
48483124|NCT03735979|155962908|FG000|Overall Study|Lost to Follow-up|1|||
48483125|NCT03735979|155962909|FG001|Overall Study|Lost to Follow-up|12|||
48483126|NCT03735979|155962910|FG002|Overall Study|Lost to Follow-up|14|||
48483127|NCT03735979|155962908|FG000|Overall Study|Withdrawal by Subject|1|||
48483128|NCT03735979|155962909|FG001|Overall Study|Withdrawal by Subject|5|||
48483129|NCT03735979|155962910|FG002|Overall Study|Withdrawal by Subject|2|||
48483130|NCT03735979|155962908|FG000|Overall Study|Not due to the above reasons|1|||
48483131|NCT03735979|155962909|FG001|Overall Study|Not due to the above reasons|0|||
48483132|NCT03735979|155962910|FG002|Overall Study|Not due to the above reasons|0|||
48483133|NCT04517435|155962911|FG000|Overall Study|Withdrawal by Subject|0|||
48483134|NCT04517435|155962912|FG001|Overall Study|Withdrawal by Subject|0|||
48483135|NCT04517435|155962913|FG002|Overall Study|Withdrawal by Subject|1|||
48483136|NCT04517435|155962911|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
48483137|NCT04517435|155962912|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
48483138|NCT04517435|155962913|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
48483139|NCT00874757|155962914|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
48483140|NCT04439318|155962915|FG000|Overall Study|Ineligible|1|||
48483141|NCT04439318|155962915|FG000|Overall Study|Never Started Treatment|3|||
48483142|NCT04439318|155962915|FG000|Overall Study|Adverse Event|10|||
48483143|NCT04439318|155962915|FG000|Overall Study|Death|2|||
48483144|NCT04439318|155962915|FG000|Overall Study|Disease Progression|25|||
48483145|NCT04439318|155962915|FG000|Overall Study|Other Complicating Disease|2|||
48483146|NCT04439318|155962915|FG000|Overall Study|Withdrawal by Subject|4|||
48483147|NCT04439318|155962915|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
48483148|NCT04439318|155962915|FG000|Overall Study|Non-Compliance|1|||
48483149|NCT04439318|155962915|FG000|Overall Study|Still on Treatment|1|||
48483150|NCT00915473|155964321|FG000|Screening|Withdrawal by Subject|1|||
48483151|NCT00915473|155964322|FG001|Screening|Withdrawal by Subject|0|||
48483152|NCT00915473|155964321|FG000|4-week Follow Up|Lost to Follow-up|1|||
48483153|NCT00915473|155964322|FG001|4-week Follow Up|Lost to Follow-up|5|||
48483154|NCT01020773|155964323|FG000|Overall Study|Withdrawal by Subject|4|||
48483155|NCT01020773|155964324|FG001|Overall Study|Withdrawal by Subject|3|||
48483156|NCT01389024|155964325|FG000|Overall Study|Withdrawal by Subject|0|||
48483157|NCT01389024|155964326|FG001|Overall Study|Withdrawal by Subject|1|||
48483158|NCT01389024|155964325|FG000|Overall Study|Lost to Follow-up|1|||
48483159|NCT01389024|155964326|FG001|Overall Study|Lost to Follow-up|0|||
48483160|NCT03853213|155964329|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
48483161|NCT03853213|155964330|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
48483162|NCT03853213|155964329|FG000|Overall Study|Other (e.g., too busy)|0|||
48483163|NCT03853213|155964330|FG001|Overall Study|Other (e.g., too busy)|2|||
48483164|NCT03302299|155964331|FG000|Overall Study|Protocol Violation|1|||
48483165|NCT02038959|155964336|FG000|Overall Study|Withdrawal by Subject|6|||
48483166|NCT02038959|155964337|FG001|Overall Study|Withdrawal by Subject|8|||
48483167|NCT03515837|155964344|FG000|Overall Study|Death|219|||
48483168|NCT03515837|155964345|FG001|Overall Study|Death|227|||
48483169|NCT03515837|155964344|FG000|Overall Study|Lost to Follow-up|0|||
48483170|NCT03515837|155964345|FG001|Overall Study|Lost to Follow-up|1|||
48483171|NCT03515837|155964344|FG000|Overall Study|Withdrawal by Subject|0|||
48483172|NCT03515837|155964345|FG001|Overall Study|Withdrawal by Subject|4|||
48483173|NCT03515837|155964344|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
48483174|NCT03515837|155964345|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
48483175|NCT01964898|155964346|FG000|Overall Study|ineligible post-randomization|1|||
48483176|NCT01964898|155964347|FG001|Overall Study|ineligible post-randomization|1|||
48483177|NCT01964898|155964346|FG000|Overall Study|did not receive the allocated interventi|2|||
48483178|NCT01964898|155964347|FG001|Overall Study|did not receive the allocated interventi|1|||
48483179|NCT01964898|155964346|FG000|Overall Study|Lost to Follow-up|3|||
48483180|NCT01964898|155964347|FG001|Overall Study|Lost to Follow-up|5|||
48483181|NCT01964898|155964346|FG000|Overall Study|Withdrawal by Subject|1|||
48483182|NCT01964898|155964347|FG001|Overall Study|Withdrawal by Subject|0|||
48483183|NCT00267020|155964348|FG000|Overall Study|Adverse Event|22|||
48483184|NCT00267020|155964349|FG001|Overall Study|Adverse Event|5|||
48483185|NCT00267020|155964348|FG000|Overall Study|Death|2|||
48483186|NCT00267020|155964349|FG001|Overall Study|Death|1|||
48483187|NCT00267020|155964348|FG000|Overall Study|Withdrawal by Subject|17|||
48483188|NCT00267020|155964349|FG001|Overall Study|Withdrawal by Subject|7|||
48483189|NCT00267020|155964348|FG000|Overall Study|Physician Decision|3|||
48483190|NCT00267020|155964349|FG001|Overall Study|Physician Decision|2|||
48483191|NCT00267020|155964348|FG000|Overall Study|Disease Progression|39|||
48483192|NCT00267020|155964349|FG001|Overall Study|Disease Progression|25|||
48483193|NCT00267020|155964348|FG000|Overall Study|Unrelated Complication|1|||
48483194|NCT00267020|155964349|FG001|Overall Study|Unrelated Complication|1|||
48483195|NCT00267020|155964348|FG000|Overall Study|Sponsor Request|1|||
48483196|NCT00267020|155964349|FG001|Overall Study|Sponsor Request|0|||
48483197|NCT00267020|155964348|FG000|Overall Study|Other|1|||
48483198|NCT00267020|155964349|FG001|Overall Study|Other|2|||
48483199|NCT01227954|155964359|FG000|Overall Study|Protocol Violation|6|||
48483200|NCT01227954|155964359|FG000|Overall Study|No protocol treatment|7|||
48483201|NCT03174925|155964360|FG000|Overall Study|Elastographic images not retrievable|2|||
48483202|NCT03174925|155964360|FG000|Overall Study|Elastography image not interpretable|1|||
48483203|NCT04388527|155964362|FG000|Overall Study|Death|14|||
48483204|NCT04388527|155964362|FG000|Overall Study|Withdrawal by Subject|2|||
48483205|NCT04388527|155964362|FG000|Overall Study|Lost to Follow-up|1|||
48483206|NCT03333382|155964365|FG000|Overall Study|Lost to Follow-up|1|||
48483207|NCT03333382|155964366|FG001|Overall Study|Lost to Follow-up|0|||
48483208|NCT00520494|155964367|FG000|Overall Study|Withdrawal by Subject|1|||
48483209|NCT04247594|155964368|FG000|Overall Study|Withdrawal by Subject|4|||
48483210|NCT01005680|155964369|FG000|Overall Study|Lost to Follow-up|4|||
48483211|NCT01005680|155964370|FG001|Overall Study|Lost to Follow-up|6|||
48483212|NCT01005680|155964369|FG000|Overall Study|Withdrawal by Subject|1|||
48483213|NCT01005680|155964370|FG001|Overall Study|Withdrawal by Subject|4|||
48483214|NCT01005680|155964369|FG000|Overall Study|Physician Decision|1|||
48483215|NCT01005680|155964370|FG001|Overall Study|Physician Decision|1|||
48483216|NCT00550420|155964371|FG000|Overall Study|Adverse Event|28|||
48483217|NCT00550420|155964371|FG000|Overall Study|Lost to Follow-up|8|||
48483218|NCT00550420|155964371|FG000|Overall Study|Protocol Violation|11|||
48483219|NCT00550420|155964371|FG000|Overall Study|Withdrawal by Subject|30|||
48483220|NCT00550420|155964371|FG000|Overall Study|Still in study at termination|206|||
48483221|NCT00550420|155964371|FG000|Overall Study|Missing|2|||
48483222|NCT00550420|155964371|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
48483223|NCT00550420|155964371|FG000|Overall Study|Investigators opinion|1|||
48483224|NCT00550420|155964371|FG000|Overall Study|Lack of curative effect|1|||
48483225|NCT00550420|155964371|FG000|Overall Study|Unethical stop of enrollment|2|||
48483226|NCT00550420|155964371|FG000|Overall Study|Caregiver's decision to withdraw|1|||
48483227|NCT00550420|155964371|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
48483228|NCT00550420|155964371|FG000|Overall Study|Exclusion criteria|1|||
48483229|NCT00550420|155964371|FG000|Overall Study|Prohibited medicine|1|||
48483230|NCT03576131|155964374|FG000|Overall Study|Investigator decision|0|||
48483231|NCT03576131|155964375|FG001|Overall Study|Investigator decision|0|||
48483232|NCT03576131|155964376|FG002|Overall Study|Investigator decision|0|||
48483233|NCT03576131|155964377|FG003|Overall Study|Investigator decision|1|||
48483234|NCT03576131|155964378|FG004|Overall Study|Investigator decision|0|||
48483235|NCT03576131|155964379|FG005|Overall Study|Investigator decision|1|||
48483236|NCT03576131|155964380|FG006|Overall Study|Investigator decision|0|||
48483237|NCT03576131|155964381|FG007|Overall Study|Investigator decision|0|||
48483238|NCT03576131|155964374|FG000|Overall Study|Withdrawal by Subject|1|||
48483239|NCT03576131|155964375|FG001|Overall Study|Withdrawal by Subject|1|||
48483240|NCT03576131|155964376|FG002|Overall Study|Withdrawal by Subject|0|||
48483241|NCT03576131|155964377|FG003|Overall Study|Withdrawal by Subject|1|||
48483242|NCT03576131|155964378|FG004|Overall Study|Withdrawal by Subject|2|||
48483243|NCT03576131|155964379|FG005|Overall Study|Withdrawal by Subject|3|||
48483244|NCT03576131|155964380|FG006|Overall Study|Withdrawal by Subject|1|||
48483245|NCT03576131|155964381|FG007|Overall Study|Withdrawal by Subject|0|||
48483246|NCT03576131|155964374|FG000|Overall Study|Death|3|||
48483247|NCT03576131|155964375|FG001|Overall Study|Death|3|||
48483248|NCT03576131|155964376|FG002|Overall Study|Death|1|||
48483249|NCT03576131|155964377|FG003|Overall Study|Death|5|||
48483250|NCT03576131|155964378|FG004|Overall Study|Death|4|||
48483251|NCT03576131|155964379|FG005|Overall Study|Death|1|||
48483252|NCT03576131|155964380|FG006|Overall Study|Death|0|||
48483253|NCT03576131|155964381|FG007|Overall Study|Death|1|||
48483254|NCT03576131|155964374|FG000|Overall Study|New anti-cancer treatment|5|||
48483255|NCT03576131|155964375|FG001|Overall Study|New anti-cancer treatment|1|||
48483256|NCT03576131|155964376|FG002|Overall Study|New anti-cancer treatment|2|||
48483257|NCT03576131|155964377|FG003|Overall Study|New anti-cancer treatment|3|||
48483258|NCT03576131|155964378|FG004|Overall Study|New anti-cancer treatment|0|||
48483259|NCT03576131|155964379|FG005|Overall Study|New anti-cancer treatment|0|||
48483260|NCT03576131|155964380|FG006|Overall Study|New anti-cancer treatment|0|||
48483261|NCT03576131|155964381|FG007|Overall Study|New anti-cancer treatment|0|||
48483262|NCT03576131|155964374|FG000|Overall Study|Unspecified reason|0|||
48483263|NCT03576131|155964375|FG001|Overall Study|Unspecified reason|0|||
48483264|NCT03576131|155964376|FG002|Overall Study|Unspecified reason|1|||
48483265|NCT03576131|155964377|FG003|Overall Study|Unspecified reason|1|||
48483266|NCT03576131|155964378|FG004|Overall Study|Unspecified reason|1|||
48483267|NCT03576131|155964379|FG005|Overall Study|Unspecified reason|1|||
48483268|NCT03576131|155964380|FG006|Overall Study|Unspecified reason|0|||
48483269|NCT03576131|155964381|FG007|Overall Study|Unspecified reason|0|||
48483270|NCT03576131|155964374|FG000|Overall Study|Subject non-compliance|0|||
48483271|NCT03576131|155964375|FG001|Overall Study|Subject non-compliance|0|||
48483272|NCT03576131|155964376|FG002|Overall Study|Subject non-compliance|0|||
48483273|NCT03576131|155964377|FG003|Overall Study|Subject non-compliance|0|||
48483274|NCT03576131|155964378|FG004|Overall Study|Subject non-compliance|0|||
48483275|NCT03576131|155964379|FG005|Overall Study|Subject non-compliance|1|||
48483276|NCT03576131|155964380|FG006|Overall Study|Subject non-compliance|0|||
48483277|NCT03576131|155964381|FG007|Overall Study|Subject non-compliance|0|||
48483278|NCT03471182|155964383|FG000|Overall Study|Withdrawal by Subject|1|||
48483279|NCT03471182|155964384|FG001|Overall Study|Withdrawal by Subject|1|||
48483280|NCT03471182|155964385|FG002|Overall Study|Withdrawal by Subject|0|||
48483281|NCT03471182|155964383|FG000|Overall Study|Technical failure|2|||
48483282|NCT03471182|155964384|FG001|Overall Study|Technical failure|0|||
48483283|NCT03471182|155964385|FG002|Overall Study|Technical failure|0|||
48483284|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
48483285|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
48483286|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
48483287|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
48483288|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
48483423|NCT00383019|155964440|FG001|Overall Study|Adverse Event|1|||
48483289|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
48483290|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
48483291|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
48483292|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
48483293|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
48483294|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
48483295|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
48483296|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
48483297|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
48483298|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
48483299|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
48483300|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
48483301|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
48483302|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
48483303|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
48483304|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
48483305|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
48483306|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
48483307|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
48483308|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
48483309|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
48483310|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
48483311|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
48483312|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
48483313|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
48483314|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
48483315|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
48483316|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
48483317|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
48483318|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
48483319|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
48483320|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
48483321|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
48483322|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
48483323|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
48483324|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
48483325|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
48483326|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
48483327|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
48483328|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
48483329|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
48483330|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
48483331|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
48483332|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
48483333|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
48483334|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
48483335|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
48483336|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
48483337|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
48483338|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
48483339|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
48483340|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
48483341|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
48483342|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
48483343|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
48483344|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
48483345|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
48483346|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
48483347|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
48483348|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
48483349|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
48483350|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
48483496|NCT02239692|155966232|FG000|Overall Study|Other reason|1|||
48483351|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
48483352|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
48483353|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
48483354|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
48483355|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
48483356|NCT04440163|155964388|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
48483357|NCT04440163|155964389|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
48483358|NCT04440163|155964390|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
48483359|NCT04440163|155964391|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
48483360|NCT04440163|155964392|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
48483361|NCT04440163|155964393|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
48483362|NCT04440163|155964394|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
48483363|NCT04440163|155964395|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
48483364|NCT04440163|155964388|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
48483365|NCT04440163|155964389|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
48483366|NCT04440163|155964390|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
48483367|NCT04440163|155964391|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
48483368|NCT04440163|155964392|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
48483369|NCT04440163|155964393|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
48483370|NCT04440163|155964394|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
48483371|NCT04440163|155964395|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
48483372|NCT04440163|155964388|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
48483373|NCT04440163|155964389|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
48483374|NCT04440163|155964390|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
48483375|NCT04440163|155964391|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
48483376|NCT04440163|155964392|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
48483377|NCT04440163|155964393|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
48483378|NCT04440163|155964394|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
48483379|NCT04440163|155964395|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
48483380|NCT02748616|155964396|FG000|Overall Study|Lost to Follow-up|1|||
48483381|NCT02748616|155964396|FG000|Overall Study|Withdrawal by Subject|2|||
48483382|NCT02748616|155964396|FG000|Overall Study|Physician Decision|2|||
48483383|NCT02748616|155964396|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
48483384|NCT00782275|155964399|FG000|Overall Study|Adverse Event|11|||
48483385|NCT00782275|155964399|FG000|Overall Study|Withdrawal by Subject|1|||
48483386|NCT00782275|155964399|FG000|Overall Study|Progressive Disease|21|||
48483387|NCT00782275|155964399|FG000|Overall Study|Physician Decision|4|||
48483388|NCT00782275|155964399|FG000|Overall Study|Not started treatment|1|||
48483389|NCT00782275|155964399|FG000|Overall Study|Other|3|||
48483390|NCT01296152|155964403|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
48483391|NCT02018042|155964404|FG000|Overall Study|Withdrawal by Subject|1|||
48483392|NCT00996632|155964413|FG000|Overall Study|Physician Decision|0|||
48483393|NCT00996632|155964414|FG001|Overall Study|Physician Decision|0|||
48483394|NCT03231709|155964415|FG000|Treatment Period 1|Reason not Specified|0|||
48483395|NCT03231709|155964416|FG001|Treatment Period 1|Reason not Specified|1|||
48483396|NCT03231709|155964415|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
48483397|NCT03231709|155964416|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
48483398|NCT02609178|155964417|FG000|First Crown|Withdrawal by Subject|0|||
48483399|NCT02609178|155964418|FG001|First Crown|Withdrawal by Subject|0|||
48483400|NCT02609178|155964419|FG002|First Crown|Withdrawal by Subject|1|||
48483401|NCT02609178|155964420|FG003|First Crown|Withdrawal by Subject|1|||
48483402|NCT02609178|155964421|FG004|First Crown|Withdrawal by Subject|0|||
48483403|NCT02609178|155964422|FG005|First Crown|Withdrawal by Subject|0|||
48483404|NCT04059354|155964425|FG000|Overall Study|COVID-19 pandemic|3|||
48483405|NCT03506425|155964430|FG000|Overall Study|Adverse Event|1|||
48483406|NCT03506425|155964431|FG001|Overall Study|Adverse Event|3|||
48483407|NCT03506425|155964432|FG002|Overall Study|Adverse Event|0|||
48483408|NCT03506425|155964430|FG000|Overall Study|Death|1|||
48483409|NCT03506425|155964431|FG001|Overall Study|Death|0|||
48483410|NCT03506425|155964432|FG002|Overall Study|Death|0|||
48483411|NCT03506425|155964430|FG000|Overall Study|Withdrawal by Subject|0|||
48483412|NCT03506425|155964431|FG001|Overall Study|Withdrawal by Subject|0|||
48483413|NCT03506425|155964432|FG002|Overall Study|Withdrawal by Subject|1|||
48483414|NCT00420849|155964438|FG000|Overall Study|Lack of Efficacy|154|||
48483415|NCT00420849|155964438|FG000|Overall Study|Adverse Event|107|||
48483416|NCT00420849|155964438|FG000|Overall Study|Withdrawal by Subject|28|||
48483417|NCT00420849|155964438|FG000|Overall Study|Death|18|||
48483418|NCT00420849|155964438|FG000|Overall Study|Other|14|||
48483419|NCT00420849|155964438|FG000|Overall Study|Transplant|8|||
48483420|NCT00420849|155964438|FG000|Overall Study|Protocol Violation|1|||
48483421|NCT00420849|155964438|FG000|Overall Study|Lost to Follow-up|1|||
48483422|NCT00383019|155964439|FG000|Overall Study|Adverse Event|5|||
48483424|NCT00383019|155964439|FG000|Overall Study|Withdrawal by Subject|0|||
48483425|NCT00383019|155964440|FG001|Overall Study|Withdrawal by Subject|1|||
48483426|NCT02643394|155964441|FG000|Overall Study|Protocol Violation|4|||
48483427|NCT02643394|155964442|FG001|Overall Study|Protocol Violation|5|||
48483428|NCT00975884|155964443|FG000|Overall Study|Adverse Event|1|||
48483429|NCT00975884|155964444|FG001|Overall Study|Adverse Event|0|||
48483430|NCT00975884|155964443|FG000|Overall Study|Lost to Follow-up|5|||
48483431|NCT00975884|155964444|FG001|Overall Study|Lost to Follow-up|3|||
48483432|NCT00975884|155964443|FG000|Overall Study|Withdrawal by Subject|9|||
48483433|NCT00975884|155964444|FG001|Overall Study|Withdrawal by Subject|9|||
48483434|NCT00975884|155964443|FG000|Overall Study|Other|1|||
48483435|NCT00975884|155964444|FG001|Overall Study|Other|3|||
48483436|NCT04071366|155966227|FG000|Part 1: Open-label (29 Days)|Death|4|||
48483437|NCT04071366|155966228|FG001|Part 1: Open-label (29 Days)|Death|2|||
48483438|NCT04071366|155966229|FG002|Part 1: Open-label (29 Days)|Death|8|||
48483439|NCT04071366|155966230|FG003|Part 1: Open-label (29 Days)|Death|0|||
48483440|NCT04071366|155966231|FG004|Part 1: Open-label (29 Days)|Death|0|||
48483441|NCT04071366|155966227|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
48483442|NCT04071366|155966228|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
48483443|NCT04071366|155966229|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
48483444|NCT04071366|155966230|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
48483445|NCT04071366|155966231|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
48483446|NCT04071366|155966227|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
48483447|NCT04071366|155966228|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
48483448|NCT04071366|155966229|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
48483449|NCT04071366|155966230|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
48483450|NCT04071366|155966231|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
48483451|NCT04071366|155966227|FG000|Part 2: Randomized (29 Days)|Death|0|||
48483452|NCT04071366|155966228|FG001|Part 2: Randomized (29 Days)|Death|0|||
48483453|NCT04071366|155966229|FG002|Part 2: Randomized (29 Days)|Death|0|||
48483454|NCT04071366|155966230|FG003|Part 2: Randomized (29 Days)|Death|2|||
48483455|NCT04071366|155966231|FG004|Part 2: Randomized (29 Days)|Death|2|||
48483456|NCT04071366|155966227|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
48483457|NCT04071366|155966228|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
48483458|NCT04071366|155966229|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
48483459|NCT04071366|155966230|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
48483460|NCT04071366|155966231|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
48483461|NCT04071366|155966227|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
48483462|NCT04071366|155966228|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
48483463|NCT04071366|155966229|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
48483464|NCT04071366|155966230|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
48483465|NCT04071366|155966231|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
48483466|NCT04071366|155966227|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
48483467|NCT04071366|155966228|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
48483468|NCT04071366|155966229|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
48483469|NCT04071366|155966230|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
48483470|NCT04071366|155966231|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
48483471|NCT04071366|155966227|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
48483472|NCT04071366|155966228|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
48483473|NCT04071366|155966229|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
48483474|NCT04071366|155966230|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
48483475|NCT04071366|155966231|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
48483476|NCT04071366|155966227|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
48483477|NCT04071366|155966228|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
48483478|NCT04071366|155966229|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
48483479|NCT04071366|155966230|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
48483480|NCT04071366|155966231|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
48483481|NCT04071366|155966227|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
48483482|NCT04071366|155966228|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
48483483|NCT04071366|155966229|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
48483484|NCT04071366|155966230|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
48483485|NCT04071366|155966231|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
48483486|NCT02239692|155966232|FG000|Overall Study|Incomplete colonoscopy|1|||
48483487|NCT02239692|155966233|FG001|Overall Study|Incomplete colonoscopy|2|||
48483488|NCT02239692|155966232|FG000|Overall Study|Adverse Event|0|||
48483489|NCT02239692|155966233|FG001|Overall Study|Adverse Event|1|||
48483490|NCT02239692|155966232|FG000|Overall Study|Physician Decision|0|||
48483491|NCT02239692|155966233|FG001|Overall Study|Physician Decision|1|||
48483492|NCT02239692|155966232|FG000|Overall Study|Lost to Follow-up|1|||
48483493|NCT02239692|155966233|FG001|Overall Study|Lost to Follow-up|4|||
48483494|NCT02239692|155966232|FG000|Overall Study|Withdrawal by Subject|3|||
48483495|NCT02239692|155966233|FG001|Overall Study|Withdrawal by Subject|5|||
48483497|NCT02239692|155966233|FG001|Overall Study|Other reason|0|||
48483498|NCT04318535|155966234|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
48483499|NCT04318535|155966235|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
48483500|NCT04318535|155966236|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
48483501|NCT01678924|155966237|FG000|Overall Study|Adverse Event|1|||
48483502|NCT01678924|155966238|FG001|Overall Study|Adverse Event|1|||
48483503|NCT01678924|155966239|FG002|Overall Study|Adverse Event|0|||
48483504|NCT01678924|155966240|FG003|Overall Study|Adverse Event|1|||
48483505|NCT01678924|155966237|FG000|Overall Study|Lack of Efficacy|7|||
48483506|NCT01678924|155966238|FG001|Overall Study|Lack of Efficacy|2|||
48483507|NCT01678924|155966239|FG002|Overall Study|Lack of Efficacy|0|||
48483508|NCT01678924|155966240|FG003|Overall Study|Lack of Efficacy|5|||
48483509|NCT01678924|155966237|FG000|Overall Study|Lost to Follow-up|0|||
48483510|NCT01678924|155966238|FG001|Overall Study|Lost to Follow-up|4|||
48483511|NCT01678924|155966239|FG002|Overall Study|Lost to Follow-up|0|||
48483512|NCT01678924|155966240|FG003|Overall Study|Lost to Follow-up|2|||
48483513|NCT01678924|155966237|FG000|Overall Study|Personal Reasons|2|||
48483514|NCT01678924|155966238|FG001|Overall Study|Personal Reasons|2|||
48483515|NCT01678924|155966239|FG002|Overall Study|Personal Reasons|2|||
48483516|NCT01678924|155966240|FG003|Overall Study|Personal Reasons|7|||
48483517|NCT01678924|155966237|FG000|Overall Study|Withdrawal by Subject|0|||
48483518|NCT01678924|155966238|FG001|Overall Study|Withdrawal by Subject|3|||
48483519|NCT01678924|155966239|FG002|Overall Study|Withdrawal by Subject|0|||
48483520|NCT01678924|155966240|FG003|Overall Study|Withdrawal by Subject|2|||
48483521|NCT01678924|155966237|FG000|Overall Study|Unable to attend scheduled visits|0|||
48483522|NCT01678924|155966238|FG001|Overall Study|Unable to attend scheduled visits|0|||
48483523|NCT01678924|155966239|FG002|Overall Study|Unable to attend scheduled visits|0|||
48483524|NCT01678924|155966240|FG003|Overall Study|Unable to attend scheduled visits|1|||
48483525|NCT00640614|155966246|FG000|Overall Study|Lost to Follow-up|1|||
48483526|NCT00640614|155966247|FG001|Overall Study|Lost to Follow-up|0|||
48483527|NCT00529802|155966248|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
48483528|NCT00529802|155966248|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
48483529|NCT00529802|155966248|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
48483530|NCT00529802|155966248|FG000|Evaluable for Primary Endpoint|Death|1|||
48483531|NCT00529802|155966248|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
48483532|NCT00529802|155966248|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
48483533|NCT00529802|155966248|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
48483534|NCT02657356|155966250|FG000|Overall Study|Death|1|||
48483535|NCT02657356|155966251|FG001|Overall Study|Death|0|||
48483536|NCT02657356|155966250|FG000|Overall Study|Withdrawal by Subject|5|||
48483537|NCT02657356|155966251|FG001|Overall Study|Withdrawal by Subject|6|||
48483538|NCT02657356|155966250|FG000|Overall Study|Terminated by Sponsor|8|||
48483539|NCT02657356|155966251|FG001|Overall Study|Terminated by Sponsor|5|||
48483540|NCT02657356|155966250|FG000|Overall Study|Rolled over to EAP study|6|||
48483541|NCT02657356|155966251|FG001|Overall Study|Rolled over to EAP study|4|||
48483542|NCT02209454|155966254|FG000|Second Period|Adverse Event|1|||
48483543|NCT02209454|155966255|FG001|Second Period|Adverse Event|0|||
48483544|NCT00021229|155966256|FG000|Overall Study|Adverse Event|10|||
48483545|NCT00021229|155966257|FG001|Overall Study|Adverse Event|5|||
48483546|NCT00021229|155966258|FG002|Overall Study|Adverse Event|2|||
48483547|NCT00021229|155966256|FG000|Overall Study|Death|0|||
48483548|NCT00021229|155966257|FG001|Overall Study|Death|1|||
48483549|NCT00021229|155966258|FG002|Overall Study|Death|0|||
48483550|NCT00021229|155966256|FG000|Overall Study|Withdrawal by Subject|7|||
48483551|NCT00021229|155966257|FG001|Overall Study|Withdrawal by Subject|7|||
48483552|NCT00021229|155966258|FG002|Overall Study|Withdrawal by Subject|1|||
48483553|NCT00021229|155966256|FG000|Overall Study|Progressive Disease|15|||
48483554|NCT00021229|155966257|FG001|Overall Study|Progressive Disease|19|||
48483555|NCT00021229|155966258|FG002|Overall Study|Progressive Disease|12|||
48483556|NCT00021229|155966256|FG000|Overall Study|Protocol Violation|1|||
48483557|NCT00021229|155966257|FG001|Overall Study|Protocol Violation|1|||
48483558|NCT00021229|155966258|FG002|Overall Study|Protocol Violation|0|||
48483559|NCT00021229|155966256|FG000|Overall Study|Physician Decision|0|||
48483560|NCT00021229|155966257|FG001|Overall Study|Physician Decision|0|||
48483561|NCT00021229|155966258|FG002|Overall Study|Physician Decision|1|||
48483562|NCT00021229|155966256|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
48483563|NCT00021229|155966257|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
48483564|NCT00021229|155966258|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
48483565|NCT02675426|155966259|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
48483566|NCT02675426|155966260|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
48483567|NCT02675426|155966261|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
48483568|NCT02675426|155966262|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
48483569|NCT02675426|155966259|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
48483570|NCT02675426|155966260|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
48483571|NCT02675426|155966261|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
48483572|NCT02675426|155966262|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
48483573|NCT02675426|155966259|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
48483574|NCT02675426|155966260|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
48483575|NCT02675426|155966261|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
48483576|NCT02675426|155966262|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
48483577|NCT02675426|155966259|FG000|Period 1: Week 1 to Week 12|Other|2|||
48483578|NCT02675426|155966260|FG001|Period 1: Week 1 to Week 12|Other|1|||
48483579|NCT02675426|155966261|FG002|Period 1: Week 1 to Week 12|Other|0|||
48483580|NCT02675426|155966262|FG003|Period 1: Week 1 to Week 12|Other|2|||
48483581|NCT02675426|155966259|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
48483582|NCT02675426|155966260|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
48483583|NCT02675426|155966261|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
48483584|NCT02675426|155966262|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
48483585|NCT02675426|155966259|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
48483586|NCT02675426|155966260|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
48483587|NCT02675426|155966261|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
48483588|NCT02675426|155966262|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
48483589|NCT02675426|155966259|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
48483590|NCT02675426|155966260|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
48483591|NCT02675426|155966261|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
48483592|NCT02675426|155966262|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
48483593|NCT02675426|155966259|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
48483594|NCT02675426|155966260|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
48483595|NCT02675426|155966261|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
48483596|NCT02675426|155966262|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
48483597|NCT02675426|155966259|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
48483598|NCT02675426|155966260|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
48483599|NCT02675426|155966261|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
48483600|NCT02675426|155966262|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
48483601|NCT02675426|155966259|FG000|Period 2: Week 12 to Week 260|Other|8|||
48483602|NCT02675426|155966260|FG001|Period 2: Week 12 to Week 260|Other|12|||
48483603|NCT02675426|155966261|FG002|Period 2: Week 12 to Week 260|Other|23|||
48483604|NCT02675426|155966262|FG003|Period 2: Week 12 to Week 260|Other|15|||
48483605|NCT02156466|155966267|FG000|Overall Study|Adverse Event|0|||
48483606|NCT02156466|155966268|FG001|Overall Study|Adverse Event|0|||
48483607|NCT02156466|155966269|FG002|Overall Study|Adverse Event|1|||
48483608|NCT02156466|155966270|FG003|Overall Study|Adverse Event|1|||
48483609|NCT02156466|155966271|FG004|Overall Study|Adverse Event|0|||
48483610|NCT02156466|155966267|FG000|Overall Study|Quantiferon Positivity|0|||
48483611|NCT02156466|155966268|FG001|Overall Study|Quantiferon Positivity|0|||
48483612|NCT02156466|155966269|FG002|Overall Study|Quantiferon Positivity|0|||
48483613|NCT02156466|155966270|FG003|Overall Study|Quantiferon Positivity|1|||
48483614|NCT02156466|155966271|FG004|Overall Study|Quantiferon Positivity|0|||
48483615|NCT03543046|155966272|FG000|Overall Study|Adverse Event|1|||
48483616|NCT03543046|155966273|FG001|Overall Study|Adverse Event|1|||
48483617|NCT03543046|155966272|FG000|Overall Study|Physician Decision|1|||
48483618|NCT03543046|155966273|FG001|Overall Study|Physician Decision|1|||
48483619|NCT03543046|155966272|FG000|Overall Study|Protocol Violation|1|||
48483620|NCT03543046|155966273|FG001|Overall Study|Protocol Violation|0|||
48483621|NCT01791127|155966274|FG000|Overall Study|Death|356|||
48483622|NCT01791127|155966274|FG000|Overall Study|Patient has withdrawn from study|293|||
48483623|NCT01791127|155966274|FG000|Overall Study|Lost to Follow-up|42|||
48483624|NCT01791127|155966274|FG000|Overall Study|All Siello leads are explanted|31|||
48483625|NCT01791127|155966274|FG000|Overall Study|Completion of 30 day safety registry|1|||
48483626|NCT01791127|155966274|FG000|Overall Study|Study terminated for EP Passion|749|||
48483627|NCT03451331|155966282|FG000|Overall Study|Withdrawal by Subject|1|||
48483628|NCT03451331|155966283|FG001|Overall Study|Withdrawal by Subject|0|||
48483629|NCT03451331|155966282|FG000|Overall Study|Unable to start treatment.|1|||
48483630|NCT03451331|155966283|FG001|Overall Study|Unable to start treatment.|1|||
48483631|NCT01875991|155966284|FG000|Overall Study|Withdrawal by Subject|6|||
48483632|NCT01875991|155966285|FG001|Overall Study|Withdrawal by Subject|6|||
48483633|NCT01875991|155966284|FG000|Overall Study|Sponsor Decision|1|||
48483634|NCT01875991|155966285|FG001|Overall Study|Sponsor Decision|0|||
48483635|NCT02419469|155966286|FG000|Overall Study|Withdrawal by Subject|1|||
48483636|NCT02773446|155966287|FG000|First Admission|Withdrawal by Subject|0|||
48483637|NCT02773446|155966288|FG001|First Admission|Withdrawal by Subject|0|||
48483638|NCT02773446|155966289|FG002|First Admission|Withdrawal by Subject|0|||
48483639|NCT02773446|155966290|FG003|First Admission|Withdrawal by Subject|1|||
48483640|NCT02773446|155966291|FG004|First Admission|Withdrawal by Subject|0|||
48483641|NCT02773446|155966292|FG005|First Admission|Withdrawal by Subject|0|||
48483642|NCT02773446|155966287|FG000|First Admission|Lost to Follow-up|1|||
48483643|NCT02773446|155966288|FG001|First Admission|Lost to Follow-up|0|||
48483644|NCT02773446|155966289|FG002|First Admission|Lost to Follow-up|0|||
48483645|NCT02773446|155966290|FG003|First Admission|Lost to Follow-up|0|||
48483646|NCT02773446|155966291|FG004|First Admission|Lost to Follow-up|0|||
48483647|NCT02773446|155966292|FG005|First Admission|Lost to Follow-up|0|||
48483648|NCT01682512|155966293|FG000|Overall Study|Adverse Event|6|||
48483649|NCT01682512|155966294|FG001|Overall Study|Adverse Event|5|||
48483650|NCT01682512|155966295|FG002|Overall Study|Adverse Event|2|||
48483651|NCT01682512|155966293|FG000|Overall Study|Withdrawal by Subject|2|||
48483652|NCT01682512|155966294|FG001|Overall Study|Withdrawal by Subject|6|||
48483653|NCT01682512|155966295|FG002|Overall Study|Withdrawal by Subject|3|||
48483654|NCT01682512|155966293|FG000|Overall Study|Physician Decision|0|||
48483655|NCT01682512|155966294|FG001|Overall Study|Physician Decision|2|||
48483656|NCT01682512|155966295|FG002|Overall Study|Physician Decision|0|||
48483657|NCT01682512|155966293|FG000|Overall Study|Study terminated by sponsor|46|||
48483658|NCT01682512|155966294|FG001|Overall Study|Study terminated by sponsor|43|||
48483659|NCT01682512|155966295|FG002|Overall Study|Study terminated by sponsor|0|||
48483660|NCT01682512|155966293|FG000|Overall Study|Lost to Follow-up|3|||
48483661|NCT01682512|155966294|FG001|Overall Study|Lost to Follow-up|0|||
48483662|NCT01682512|155966295|FG002|Overall Study|Lost to Follow-up|2|||
48483663|NCT01682512|155966293|FG000|Overall Study|Protocol Violation|2|||
48483664|NCT01682512|155966294|FG001|Overall Study|Protocol Violation|3|||
48483665|NCT01682512|155966295|FG002|Overall Study|Protocol Violation|2|||
48483666|NCT01682512|155966293|FG000|Overall Study|Primary lack of efficacy|10|||
48483667|NCT01682512|155966294|FG001|Overall Study|Primary lack of efficacy|7|||
48483668|NCT01682512|155966295|FG002|Overall Study|Primary lack of efficacy|7|||
48483669|NCT01682512|155966293|FG000|Overall Study|Secondary lack of efficacy|1|||
48483670|NCT01682512|155966294|FG001|Overall Study|Secondary lack of efficacy|1|||
48483671|NCT01682512|155966295|FG002|Overall Study|Secondary lack of efficacy|0|||
48483672|NCT01682512|155966293|FG000|Overall Study|Other than stated above|2|||
48483673|NCT01682512|155966294|FG001|Overall Study|Other than stated above|4|||
48483674|NCT01682512|155966295|FG002|Overall Study|Other than stated above|2|||
48483675|NCT00289731|155966296|FG000|Overall Study|Adverse Event|1|||
48483676|NCT00289731|155966297|FG001|Overall Study|Adverse Event|2|||
48483677|NCT00289731|155966298|FG002|Overall Study|Adverse Event|2|||
48483678|NCT00289731|155966296|FG000|Overall Study|Other|1|||
48483679|NCT00289731|155966297|FG001|Overall Study|Other|0|||
48483680|NCT00289731|155966298|FG002|Overall Study|Other|0|||
48483681|NCT03876873|155966299|FG000|Overall Study|Physician Decision|0|||
48483682|NCT03876873|155966300|FG001|Overall Study|Physician Decision|1|||
48483683|NCT02030834|155966301|FG000|Overall Study|Death|4|||
48483684|NCT02030834|155966302|FG001|Overall Study|Death|0|||
48483685|NCT02030834|155966303|FG002|Overall Study|Death|0|||
48483686|NCT02030834|155966301|FG000|Overall Study|Manufacturing failure|2|||
48483687|NCT02030834|155966302|FG001|Overall Study|Manufacturing failure|0|||
48483688|NCT02030834|155966303|FG002|Overall Study|Manufacturing failure|1|||
48483689|NCT02030834|155966301|FG000|Overall Study|Disease progression|2|||
48483690|NCT02030834|155966302|FG001|Overall Study|Disease progression|0|||
48483691|NCT02030834|155966303|FG002|Overall Study|Disease progression|2|||
48483692|NCT02030834|155966301|FG000|Overall Study|Lost to Follow-up|1|||
48483693|NCT02030834|155966302|FG001|Overall Study|Lost to Follow-up|0|||
48483694|NCT02030834|155966303|FG002|Overall Study|Lost to Follow-up|0|||
48483695|NCT02030834|155966301|FG000|Overall Study|Withdrawal by Subject|1|||
48483696|NCT02030834|155966302|FG001|Overall Study|Withdrawal by Subject|0|||
48483697|NCT02030834|155966303|FG002|Overall Study|Withdrawal by Subject|0|||
48483698|NCT02030834|155966301|FG000|Overall Study|Lack of funding|1|||
48483699|NCT02030834|155966302|FG001|Overall Study|Lack of funding|0|||
48483700|NCT02030834|155966303|FG002|Overall Study|Lack of funding|0|||
48483701|NCT01453374|155966304|FG000|Overall Study|Adverse Event|7|||
48483702|NCT01453374|155966304|FG000|Overall Study|Lack of Efficacy|1|||
48483703|NCT01453374|155966304|FG000|Overall Study|Lost to Follow-up|3|||
48483704|NCT01453374|155966304|FG000|Overall Study|Withdrawal by Subject|5|||
48483705|NCT01453374|155966304|FG000|Overall Study|Incarcerated|2|||
48483706|NCT00103259|155966305|FG000|Overall Study|Death|3|||
48483707|NCT00103259|155966306|FG001|Overall Study|Death|2|||
48483708|NCT00103259|155966305|FG000|Overall Study|Withdrawal by Subject|2|||
48483709|NCT00103259|155966306|FG001|Overall Study|Withdrawal by Subject|3|||
48483710|NCT00103259|155966305|FG000|Overall Study|alternative therapy|1|||
48483711|NCT00103259|155966306|FG001|Overall Study|alternative therapy|0|||
48483712|NCT00103259|155966305|FG000|Overall Study|other (reasons were not specified)|2|||
48483713|NCT00103259|155966306|FG001|Overall Study|other (reasons were not specified)|1|||
48483714|NCT00103259|155966305|FG000|Overall Study|ineligible/no protocol therapy|4|||
48483715|NCT00103259|155966306|FG001|Overall Study|ineligible/no protocol therapy|6|||
48483716|NCT04088734|155966307|FG000|Overall Study|Other, Not Specified|5|||
48483717|NCT00096200|155966309|FG000|Overall Study|Adverse Event|0|||
48483718|NCT00096200|155966310|FG001|Overall Study|Adverse Event|4|||
48483719|NCT00096200|155966311|FG002|Overall Study|Adverse Event|0|||
48483720|NCT00096200|155966309|FG000|Overall Study|Withdrawal by Subject|1|||
48483721|NCT00096200|155966310|FG001|Overall Study|Withdrawal by Subject|2|||
48483722|NCT00096200|155966311|FG002|Overall Study|Withdrawal by Subject|0|||
48483723|NCT00096200|155966309|FG000|Overall Study|Ineligible pathology|0|||
48483724|NCT00096200|155966310|FG001|Overall Study|Ineligible pathology|1|||
48483725|NCT00096200|155966311|FG002|Overall Study|Ineligible pathology|0|||
48483726|NCT00837577|155966312|FG000|Double-blind Period|Clinical Adverse Event|1|||
48483727|NCT00837577|155966313|FG001|Double-blind Period|Clinical Adverse Event|0|||
48483728|NCT00837577|155966312|FG000|Double-blind Period|Withdrawal by Subject|1|||
48483729|NCT00837577|155966313|FG001|Double-blind Period|Withdrawal by Subject|0|||
48483730|NCT00837577|155966312|FG000|Open-label Period|Clinical Adverse Event|2|||
48483731|NCT00837577|155966313|FG001|Open-label Period|Clinical Adverse Event|2|||
48483732|NCT00837577|155966312|FG000|Open-label Period|Laboratory Adverse Event|0|||
48483733|NCT00837577|155966313|FG001|Open-label Period|Laboratory Adverse Event|1|||
48483734|NCT00837577|155966312|FG000|Open-label Period|Lack of Efficacy|4|||
48483735|NCT00837577|155966313|FG001|Open-label Period|Lack of Efficacy|3|||
48483736|NCT00837577|155966312|FG000|Open-label Period|Withdrawal by Subject|1|||
48483737|NCT00837577|155966313|FG001|Open-label Period|Withdrawal by Subject|2|||
48483738|NCT00837577|155966312|FG000|Open-label Period|Other Reason|1|||
48483739|NCT00837577|155966313|FG001|Open-label Period|Other Reason|1|||
48483740|NCT02525562|155966314|FG000|Overall Study|Death|9|||
48483741|NCT02525562|155966315|FG001|Overall Study|Death|0|||
48483742|NCT02525562|155966316|FG002|Overall Study|Death|0|||
48483743|NCT02525562|155966314|FG000|Overall Study|Lost to Follow-up|19|||
48483744|NCT02525562|155966315|FG001|Overall Study|Lost to Follow-up|0|||
48483745|NCT02525562|155966316|FG002|Overall Study|Lost to Follow-up|0|||
48483746|NCT02525562|155966314|FG000|Overall Study|Withdrawal by Subject|37|||
48483747|NCT02525562|155966315|FG001|Overall Study|Withdrawal by Subject|0|||
48483748|NCT02525562|155966316|FG002|Overall Study|Withdrawal by Subject|0|||
48483749|NCT02525562|155966314|FG000|Overall Study|Revision/Removal of Study Device|4|||
48483750|NCT02525562|155966315|FG001|Overall Study|Revision/Removal of Study Device|0|||
48483751|NCT02525562|155966316|FG002|Overall Study|Revision/Removal of Study Device|0|||
48483752|NCT02525562|155966314|FG000|Overall Study|Study Closed by Sponsor|154|||
48483753|NCT02525562|155966315|FG001|Overall Study|Study Closed by Sponsor|0|||
48483754|NCT02525562|155966316|FG002|Overall Study|Study Closed by Sponsor|0|||
48483755|NCT02567266|155966319|FG000|Overall Study|Withdrawal by Subject|10|||
48483756|NCT02567266|155966320|FG001|Overall Study|Withdrawal by Subject|7|||
48483757|NCT02567266|155966321|FG002|Overall Study|Withdrawal by Subject|6|||
48483758|NCT02567266|155966319|FG000|Overall Study|Lost to Follow-up|13|||
48483759|NCT02567266|155966320|FG001|Overall Study|Lost to Follow-up|8|||
48483760|NCT02567266|155966321|FG002|Overall Study|Lost to Follow-up|10|||
48483761|NCT01238211|155966326|FG000|Overall Study|Continues active treatment|31|||
48483762|NCT01238211|155966326|FG000|Overall Study|Adverse Event|7|||
48483763|NCT01238211|155966326|FG000|Overall Study|Death|4|||
48483764|NCT01238211|155966326|FG000|Overall Study|Relapse/Progression|2|||
48483765|NCT01238211|155966326|FG000|Overall Study|Withdrawal by Subject|7|||
48483766|NCT01238211|155966326|FG000|Overall Study|Non-protocol treatment|4|||
48483767|NCT01238211|155966326|FG000|Overall Study|Investigator/Patient Decision|3|||
48483768|NCT04428502|155966329|FG000|Overall Study|Did not meet entrance criteria|14|||
48483769|NCT01358708|155966330|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
48483770|NCT01358708|155966331|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
48483771|NCT01358708|155966330|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
48483772|NCT01358708|155966331|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
48483773|NCT00051636|155966332|FG000|Period 1 - Core|Adverse Event|2|||
48483774|NCT00051636|155966333|FG001|Period 1 - Core|Adverse Event|2|||
48483775|NCT00051636|155966332|FG000|Period 1 - Core|Protocol Violation|1|||
48483776|NCT00051636|155966333|FG001|Period 1 - Core|Protocol Violation|0|||
48483777|NCT00051636|155966332|FG000|Period 1 - Core|Withdrawal by Subject|1|||
48483778|NCT00051636|155966333|FG001|Period 1 - Core|Withdrawal by Subject|2|||
48483779|NCT00051636|155966332|FG000|Period 1 - Core|Lost to Follow-up|0|||
48483780|NCT00051636|155966333|FG001|Period 1 - Core|Lost to Follow-up|2|||
48483781|NCT00051636|155966332|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
48483782|NCT00051636|155966333|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
48483783|NCT00051636|155966332|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
48483784|NCT00051636|155966333|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
48483785|NCT00051636|155966332|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
48483786|NCT00051636|155966333|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
48483787|NCT00051636|155966332|FG000|Period 2- Extended Observation Period|Death|4|||
48483788|NCT00051636|155966333|FG001|Period 2- Extended Observation Period|Death|5|||
48483789|NCT00051636|155966332|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
48483790|NCT00051636|155966333|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
48483791|NCT01488071|155966334|FG000|Overall Study|Adverse Event|15|||
48483792|NCT01488071|155966335|FG001|Overall Study|Adverse Event|23|||
48483793|NCT01488071|155966334|FG000|Overall Study|Lack of Efficacy|11|||
48483794|NCT01488071|155966335|FG001|Overall Study|Lack of Efficacy|17|||
48483795|NCT01488071|155966334|FG000|Overall Study|Non-compliance with study drug|2|||
48483796|NCT01488071|155966335|FG001|Overall Study|Non-compliance with study drug|0|||
48483797|NCT01488071|155966334|FG000|Overall Study|Protocol Violation|5|||
48483798|NCT01488071|155966335|FG001|Overall Study|Protocol Violation|7|||
48483799|NCT01488071|155966334|FG000|Overall Study|Withdrawal of Consent|14|||
48483800|NCT01488071|155966335|FG001|Overall Study|Withdrawal of Consent|12|||
48483801|NCT01488071|155966334|FG000|Overall Study|Lost to Follow-up|1|||
48483802|NCT01488071|155966335|FG001|Overall Study|Lost to Follow-up|0|||
48483803|NCT01488071|155966334|FG000|Overall Study|Administrative or Other Reason(s)|5|||
48483804|NCT01488071|155966335|FG001|Overall Study|Administrative or Other Reason(s)|4|||
48483805|NCT01656967|155966336|FG000|Overall Study|faulty monitor|1|||
48483806|NCT01656967|155966337|FG001|Overall Study|faulty monitor|0|||
48483807|NCT01656967|155966336|FG000|Overall Study|unsuccessful ETT insertion|3|||
48483808|NCT01656967|155966337|FG001|Overall Study|unsuccessful ETT insertion|2|||
48483809|NCT01174368|155966338|FG000|Overall Study|Withdrawal by Subject|1|||
48483810|NCT00725725|155966339|FG000|Overall Study|Adverse Event|1|||
48483811|NCT00725725|155966340|FG001|Overall Study|Adverse Event|3|||
48483812|NCT00725725|155966341|FG002|Overall Study|Adverse Event|2|||
48483813|NCT00725725|155966339|FG000|Overall Study|Lost to Follow-up|2|||
48483814|NCT00725725|155966340|FG001|Overall Study|Lost to Follow-up|0|||
48483815|NCT00725725|155966341|FG002|Overall Study|Lost to Follow-up|2|||
48483816|NCT00725725|155966339|FG000|Overall Study|Withdrawal by Subject|1|||
48483817|NCT00725725|155966340|FG001|Overall Study|Withdrawal by Subject|0|||
48483818|NCT00725725|155966341|FG002|Overall Study|Withdrawal by Subject|1|||
48483819|NCT00725725|155966339|FG000|Overall Study|Protocol Violation|0|||
48483820|NCT00725725|155966340|FG001|Overall Study|Protocol Violation|1|||
48483821|NCT00725725|155966341|FG002|Overall Study|Protocol Violation|0|||
48483822|NCT00479765|155966347|FG000|Overall Study|study terminated|4|||
48483823|NCT03056001|155966348|FG000|Overall Study|Death|24|||
48483824|NCT01364298|155966351|FG000|Overall Study|Adverse Event|3|||
48483825|NCT01364298|155966352|FG001|Overall Study|Adverse Event|4|||
48483826|NCT01364298|155966351|FG000|Overall Study|Lack of adherence to treatment|1|||
48483827|NCT01364298|155966352|FG001|Overall Study|Lack of adherence to treatment|3|||
48483828|NCT01364298|155966351|FG000|Overall Study|Lack of Efficacy|1|||
48483829|NCT01364298|155966352|FG001|Overall Study|Lack of Efficacy|0|||
48483830|NCT01364298|155966351|FG000|Overall Study|Lost to Follow-up|5|||
48483831|NCT01364298|155966352|FG001|Overall Study|Lost to Follow-up|10|||
48483832|NCT01364298|155966351|FG000|Overall Study|Withdrawal by Subject|3|||
48483833|NCT01364298|155966352|FG001|Overall Study|Withdrawal by Subject|3|||
48483834|NCT01364298|155966351|FG000|Overall Study|Other|1|||
48483835|NCT01364298|155966352|FG001|Overall Study|Other|3|||
48483836|NCT04380701|155966353|FG000|Overall Study|Pregnancy|0|||
48483837|NCT04380701|155966354|FG001|Overall Study|Pregnancy|0|||
48483838|NCT04380701|155966355|FG002|Overall Study|Pregnancy|0|||
48483839|NCT04380701|155966356|FG003|Overall Study|Pregnancy|0|||
48483840|NCT04380701|155966357|FG004|Overall Study|Pregnancy|0|||
48483841|NCT04380701|155966358|FG005|Overall Study|Pregnancy|0|||
48483842|NCT04380701|155966359|FG006|Overall Study|Pregnancy|0|||
48483843|NCT04380701|155966360|FG007|Overall Study|Pregnancy|0|||
48483844|NCT04380701|155966361|FG008|Overall Study|Pregnancy|0|||
48483845|NCT04380701|155966362|FG009|Overall Study|Pregnancy|0|||
48483846|NCT04380701|155966363|FG010|Overall Study|Pregnancy|0|||
48483847|NCT04380701|155966364|FG011|Overall Study|Pregnancy|0|||
48483848|NCT04380701|155966365|FG012|Overall Study|Pregnancy|0|||
48483849|NCT04380701|155966366|FG013|Overall Study|Pregnancy|0|||
48483850|NCT04380701|155966367|FG014|Overall Study|Pregnancy|0|||
48483851|NCT04380701|155966368|FG015|Overall Study|Pregnancy|0|||
48483852|NCT04380701|155966369|FG016|Overall Study|Pregnancy|0|||
48483853|NCT04380701|155966370|FG017|Overall Study|Pregnancy|0|||
48483854|NCT04380701|155966371|FG018|Overall Study|Pregnancy|0|||
48483855|NCT04380701|155966372|FG019|Overall Study|Pregnancy|0|||
48483856|NCT04380701|155966373|FG020|Overall Study|Pregnancy|0|||
48483857|NCT04380701|155966374|FG021|Overall Study|Pregnancy|0|||
48483858|NCT04380701|155966375|FG022|Overall Study|Pregnancy|0|||
48483859|NCT04380701|155966376|FG023|Overall Study|Pregnancy|0|||
48483860|NCT04380701|155966377|FG024|Overall Study|Pregnancy|0|||
48483861|NCT04380701|155966378|FG025|Overall Study|Pregnancy|0|||
48483862|NCT04380701|155966379|FG026|Overall Study|Pregnancy|0|||
48483863|NCT04380701|155966380|FG027|Overall Study|Pregnancy|0|||
48483864|NCT04380701|155966381|FG028|Overall Study|Pregnancy|0|||
48483865|NCT04380701|155966382|FG029|Overall Study|Pregnancy|0|||
48483866|NCT04380701|155966383|FG030|Overall Study|Pregnancy|0|||
48483867|NCT04380701|155966384|FG031|Overall Study|Pregnancy|0|||
48483868|NCT04380701|155966385|FG032|Overall Study|Pregnancy|1|||
48483869|NCT04380701|155966386|FG033|Overall Study|Pregnancy|0|||
48483870|NCT04380701|155966353|FG000|Overall Study|Lost to Follow-up|0|||
48483871|NCT04380701|155966354|FG001|Overall Study|Lost to Follow-up|0|||
48483872|NCT04380701|155966355|FG002|Overall Study|Lost to Follow-up|0|||
48483873|NCT04380701|155966356|FG003|Overall Study|Lost to Follow-up|0|||
48483874|NCT04380701|155966357|FG004|Overall Study|Lost to Follow-up|0|||
48483875|NCT04380701|155966358|FG005|Overall Study|Lost to Follow-up|0|||
48483876|NCT04380701|155966359|FG006|Overall Study|Lost to Follow-up|0|||
48483877|NCT04380701|155966360|FG007|Overall Study|Lost to Follow-up|0|||
48483878|NCT04380701|155966361|FG008|Overall Study|Lost to Follow-up|0|||
48483879|NCT04380701|155966362|FG009|Overall Study|Lost to Follow-up|0|||
48483880|NCT04380701|155966363|FG010|Overall Study|Lost to Follow-up|0|||
48483881|NCT04380701|155966364|FG011|Overall Study|Lost to Follow-up|0|||
48483882|NCT04380701|155966365|FG012|Overall Study|Lost to Follow-up|0|||
48483883|NCT04380701|155966366|FG013|Overall Study|Lost to Follow-up|0|||
48483884|NCT04380701|155966367|FG014|Overall Study|Lost to Follow-up|0|||
48483885|NCT04380701|155966368|FG015|Overall Study|Lost to Follow-up|0|||
48483886|NCT04380701|155966369|FG016|Overall Study|Lost to Follow-up|0|||
48483887|NCT04380701|155966370|FG017|Overall Study|Lost to Follow-up|0|||
48483888|NCT04380701|155966371|FG018|Overall Study|Lost to Follow-up|0|||
48483889|NCT04380701|155966372|FG019|Overall Study|Lost to Follow-up|0|||
48483890|NCT04380701|155966373|FG020|Overall Study|Lost to Follow-up|1|||
48483891|NCT04380701|155966374|FG021|Overall Study|Lost to Follow-up|0|||
48483892|NCT04380701|155966375|FG022|Overall Study|Lost to Follow-up|0|||
48483893|NCT04380701|155966376|FG023|Overall Study|Lost to Follow-up|1|||
48483894|NCT04380701|155966377|FG024|Overall Study|Lost to Follow-up|0|||
48483895|NCT04380701|155966378|FG025|Overall Study|Lost to Follow-up|0|||
48483896|NCT04380701|155966379|FG026|Overall Study|Lost to Follow-up|0|||
48483897|NCT04380701|155966380|FG027|Overall Study|Lost to Follow-up|0|||
48483898|NCT04380701|155966381|FG028|Overall Study|Lost to Follow-up|0|||
48483899|NCT04380701|155966382|FG029|Overall Study|Lost to Follow-up|1|||
48483900|NCT04380701|155966383|FG030|Overall Study|Lost to Follow-up|0|||
48483901|NCT04380701|155966384|FG031|Overall Study|Lost to Follow-up|0|||
48483902|NCT04380701|155966385|FG032|Overall Study|Lost to Follow-up|0|||
48483903|NCT04380701|155966386|FG033|Overall Study|Lost to Follow-up|1|||
48483904|NCT04380701|155966353|FG000|Overall Study|Private reason(s)|0|||
48483905|NCT04380701|155966354|FG001|Overall Study|Private reason(s)|0|||
48483906|NCT04380701|155966355|FG002|Overall Study|Private reason(s)|0|||
48483907|NCT04380701|155966356|FG003|Overall Study|Private reason(s)|0|||
48483908|NCT04380701|155966357|FG004|Overall Study|Private reason(s)|0|||
48483909|NCT04380701|155966358|FG005|Overall Study|Private reason(s)|0|||
48483910|NCT04380701|155966359|FG006|Overall Study|Private reason(s)|1|||
48483911|NCT04380701|155966360|FG007|Overall Study|Private reason(s)|0|||
48483912|NCT04380701|155966361|FG008|Overall Study|Private reason(s)|1|||
48483913|NCT04380701|155966362|FG009|Overall Study|Private reason(s)|1|||
48483914|NCT04380701|155966363|FG010|Overall Study|Private reason(s)|0|||
48483915|NCT04380701|155966364|FG011|Overall Study|Private reason(s)|0|||
48483916|NCT04380701|155966365|FG012|Overall Study|Private reason(s)|0|||
48483917|NCT04380701|155966366|FG013|Overall Study|Private reason(s)|0|||
48483918|NCT04380701|155966367|FG014|Overall Study|Private reason(s)|0|||
48483919|NCT04380701|155966368|FG015|Overall Study|Private reason(s)|0|||
48483920|NCT04380701|155966369|FG016|Overall Study|Private reason(s)|0|||
48483921|NCT04380701|155966370|FG017|Overall Study|Private reason(s)|0|||
48483922|NCT04380701|155966371|FG018|Overall Study|Private reason(s)|0|||
48483923|NCT04380701|155966372|FG019|Overall Study|Private reason(s)|0|||
48483924|NCT04380701|155966373|FG020|Overall Study|Private reason(s)|0|||
48483925|NCT04380701|155966374|FG021|Overall Study|Private reason(s)|0|||
48483926|NCT04380701|155966375|FG022|Overall Study|Private reason(s)|0|||
48483927|NCT04380701|155966376|FG023|Overall Study|Private reason(s)|1|||
48483928|NCT04380701|155966377|FG024|Overall Study|Private reason(s)|0|||
48483929|NCT04380701|155966378|FG025|Overall Study|Private reason(s)|0|||
48483930|NCT04380701|155966379|FG026|Overall Study|Private reason(s)|0|||
48483931|NCT04380701|155966380|FG027|Overall Study|Private reason(s)|0|||
48483932|NCT04380701|155966381|FG028|Overall Study|Private reason(s)|0|||
48483933|NCT04380701|155966382|FG029|Overall Study|Private reason(s)|1|||
48483934|NCT04380701|155966383|FG030|Overall Study|Private reason(s)|0|||
48483935|NCT04380701|155966384|FG031|Overall Study|Private reason(s)|0|||
48483936|NCT04380701|155966385|FG032|Overall Study|Private reason(s)|0|||
48483937|NCT04380701|155966386|FG033|Overall Study|Private reason(s)|0|||
48483938|NCT04380701|155966353|FG000|Overall Study|Withdrawal by Subject|0|||
48483939|NCT04380701|155966354|FG001|Overall Study|Withdrawal by Subject|0|||
48483940|NCT04380701|155966355|FG002|Overall Study|Withdrawal by Subject|0|||
48483941|NCT04380701|155966356|FG003|Overall Study|Withdrawal by Subject|0|||
48483942|NCT04380701|155966357|FG004|Overall Study|Withdrawal by Subject|0|||
48483943|NCT04380701|155966358|FG005|Overall Study|Withdrawal by Subject|0|||
48483944|NCT04380701|155966359|FG006|Overall Study|Withdrawal by Subject|1|||
48483945|NCT04380701|155966360|FG007|Overall Study|Withdrawal by Subject|1|||
48483946|NCT04380701|155966361|FG008|Overall Study|Withdrawal by Subject|0|||
48483947|NCT04380701|155966362|FG009|Overall Study|Withdrawal by Subject|0|||
48483948|NCT04380701|155966363|FG010|Overall Study|Withdrawal by Subject|0|||
48483949|NCT04380701|155966364|FG011|Overall Study|Withdrawal by Subject|1|||
48483950|NCT04380701|155966365|FG012|Overall Study|Withdrawal by Subject|0|||
48483951|NCT04380701|155966366|FG013|Overall Study|Withdrawal by Subject|1|||
48483952|NCT04380701|155966367|FG014|Overall Study|Withdrawal by Subject|0|||
48483953|NCT04380701|155966368|FG015|Overall Study|Withdrawal by Subject|0|||
48483954|NCT04380701|155966369|FG016|Overall Study|Withdrawal by Subject|1|||
48483955|NCT04380701|155966370|FG017|Overall Study|Withdrawal by Subject|0|||
48483956|NCT04380701|155966371|FG018|Overall Study|Withdrawal by Subject|0|||
48483957|NCT04380701|155966372|FG019|Overall Study|Withdrawal by Subject|0|||
48483958|NCT04380701|155966373|FG020|Overall Study|Withdrawal by Subject|0|||
48483959|NCT04380701|155966374|FG021|Overall Study|Withdrawal by Subject|0|||
48483960|NCT04380701|155966375|FG022|Overall Study|Withdrawal by Subject|2|||
48483961|NCT04380701|155966376|FG023|Overall Study|Withdrawal by Subject|2|||
48483962|NCT04380701|155966377|FG024|Overall Study|Withdrawal by Subject|1|||
48483963|NCT04380701|155966378|FG025|Overall Study|Withdrawal by Subject|1|||
48483964|NCT04380701|155966379|FG026|Overall Study|Withdrawal by Subject|0|||
48483965|NCT04380701|155966380|FG027|Overall Study|Withdrawal by Subject|0|||
48483966|NCT04380701|155966381|FG028|Overall Study|Withdrawal by Subject|0|||
48483967|NCT04380701|155966382|FG029|Overall Study|Withdrawal by Subject|0|||
48483968|NCT04380701|155966383|FG030|Overall Study|Withdrawal by Subject|0|||
48483969|NCT04380701|155966384|FG031|Overall Study|Withdrawal by Subject|0|||
48483970|NCT04380701|155966385|FG032|Overall Study|Withdrawal by Subject|0|||
48483971|NCT04380701|155966386|FG033|Overall Study|Withdrawal by Subject|0|||
48483972|NCT04380701|155966353|FG000|Overall Study|Adverse Event|0|||
48483973|NCT04380701|155966354|FG001|Overall Study|Adverse Event|0|||
48483974|NCT04380701|155966355|FG002|Overall Study|Adverse Event|0|||
48483975|NCT04380701|155966356|FG003|Overall Study|Adverse Event|0|||
48483976|NCT04380701|155966357|FG004|Overall Study|Adverse Event|0|||
48483977|NCT04380701|155966358|FG005|Overall Study|Adverse Event|1|||
48483978|NCT04380701|155966359|FG006|Overall Study|Adverse Event|0|||
48483979|NCT04380701|155966360|FG007|Overall Study|Adverse Event|0|||
48483980|NCT04380701|155966361|FG008|Overall Study|Adverse Event|0|||
48483981|NCT04380701|155966362|FG009|Overall Study|Adverse Event|0|||
48483982|NCT04380701|155966363|FG010|Overall Study|Adverse Event|0|||
48483983|NCT04380701|155966364|FG011|Overall Study|Adverse Event|0|||
48483984|NCT04380701|155966365|FG012|Overall Study|Adverse Event|0|||
48483985|NCT04380701|155966366|FG013|Overall Study|Adverse Event|0|||
48483986|NCT04380701|155966367|FG014|Overall Study|Adverse Event|0|||
48483987|NCT04380701|155966368|FG015|Overall Study|Adverse Event|1|||
48483988|NCT04380701|155966369|FG016|Overall Study|Adverse Event|0|||
48483989|NCT04380701|155966370|FG017|Overall Study|Adverse Event|0|||
48483990|NCT04380701|155966371|FG018|Overall Study|Adverse Event|0|||
48483991|NCT04380701|155966372|FG019|Overall Study|Adverse Event|1|||
48483992|NCT04380701|155966373|FG020|Overall Study|Adverse Event|0|||
48483993|NCT04380701|155966374|FG021|Overall Study|Adverse Event|0|||
48483994|NCT04380701|155966375|FG022|Overall Study|Adverse Event|0|||
48483995|NCT04380701|155966376|FG023|Overall Study|Adverse Event|0|||
48483996|NCT04380701|155966377|FG024|Overall Study|Adverse Event|0|||
48483997|NCT04380701|155966378|FG025|Overall Study|Adverse Event|0|||
48483998|NCT04380701|155966379|FG026|Overall Study|Adverse Event|0|||
48483999|NCT04380701|155966380|FG027|Overall Study|Adverse Event|0|||
48484000|NCT04380701|155966381|FG028|Overall Study|Adverse Event|0|||
48484001|NCT04380701|155966382|FG029|Overall Study|Adverse Event|0|||
48484002|NCT04380701|155966383|FG030|Overall Study|Adverse Event|0|||
48484003|NCT04380701|155966384|FG031|Overall Study|Adverse Event|0|||
48484004|NCT04380701|155966385|FG032|Overall Study|Adverse Event|0|||
48484005|NCT04380701|155966386|FG033|Overall Study|Adverse Event|0|||
48484006|NCT04380701|155966353|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
48484007|NCT04380701|155966354|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
48484008|NCT04380701|155966355|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
48484009|NCT04380701|155966356|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
48484010|NCT04380701|155966357|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
48484011|NCT04380701|155966358|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
48484012|NCT04380701|155966359|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
48484013|NCT04380701|155966360|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
48484014|NCT04380701|155966361|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
48484015|NCT04380701|155966362|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
48484016|NCT04380701|155966363|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
48484017|NCT04380701|155966364|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
48484018|NCT04380701|155966365|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
48484019|NCT04380701|155966366|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
48484020|NCT04380701|155966367|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
48484021|NCT04380701|155966368|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
48484022|NCT04380701|155966369|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
48484023|NCT04380701|155966370|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
48484024|NCT04380701|155966371|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
48484025|NCT04380701|155966372|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
48484026|NCT04380701|155966373|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
48484027|NCT04380701|155966374|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
48484028|NCT04380701|155966375|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
48484029|NCT04380701|155966376|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
48484030|NCT04380701|155966377|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
48484031|NCT04380701|155966378|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
48484032|NCT04380701|155966379|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
48484033|NCT04380701|155966380|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
48484034|NCT04380701|155966381|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
48484035|NCT04380701|155966382|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
48587288|NCT02696434|156343168|FG001|Overall Study|Physician Decision|1|||
48484036|NCT04380701|155966383|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
48484037|NCT04380701|155966384|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
48484038|NCT04380701|155966385|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
48484039|NCT04380701|155966386|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
48484040|NCT04380701|155966353|FG000|Overall Study|Physician Decision|0|||
48484041|NCT04380701|155966354|FG001|Overall Study|Physician Decision|0|||
48484042|NCT04380701|155966355|FG002|Overall Study|Physician Decision|0|||
48484043|NCT04380701|155966356|FG003|Overall Study|Physician Decision|0|||
48484044|NCT04380701|155966357|FG004|Overall Study|Physician Decision|0|||
48484045|NCT04380701|155966358|FG005|Overall Study|Physician Decision|0|||
48484046|NCT04380701|155966359|FG006|Overall Study|Physician Decision|0|||
48484047|NCT04380701|155966360|FG007|Overall Study|Physician Decision|0|||
48484048|NCT04380701|155966361|FG008|Overall Study|Physician Decision|0|||
48484049|NCT04380701|155966362|FG009|Overall Study|Physician Decision|0|||
48484050|NCT04380701|155966363|FG010|Overall Study|Physician Decision|0|||
48484051|NCT04380701|155966364|FG011|Overall Study|Physician Decision|0|||
48484052|NCT04380701|155966365|FG012|Overall Study|Physician Decision|0|||
48484053|NCT04380701|155966366|FG013|Overall Study|Physician Decision|0|||
48484054|NCT04380701|155966367|FG014|Overall Study|Physician Decision|0|||
48484055|NCT04380701|155966368|FG015|Overall Study|Physician Decision|0|||
48484056|NCT04380701|155966369|FG016|Overall Study|Physician Decision|0|||
48484057|NCT04380701|155966370|FG017|Overall Study|Physician Decision|0|||
48484058|NCT04380701|155966371|FG018|Overall Study|Physician Decision|0|||
48484059|NCT04380701|155966372|FG019|Overall Study|Physician Decision|0|||
48484060|NCT04380701|155966373|FG020|Overall Study|Physician Decision|0|||
48484061|NCT04380701|155966374|FG021|Overall Study|Physician Decision|0|||
48484062|NCT04380701|155966375|FG022|Overall Study|Physician Decision|0|||
48484063|NCT04380701|155966376|FG023|Overall Study|Physician Decision|0|||
48484064|NCT04380701|155966377|FG024|Overall Study|Physician Decision|2|||
48484065|NCT04380701|155966378|FG025|Overall Study|Physician Decision|0|||
48484066|NCT04380701|155966379|FG026|Overall Study|Physician Decision|0|||
48484067|NCT04380701|155966380|FG027|Overall Study|Physician Decision|0|||
48484068|NCT04380701|155966381|FG028|Overall Study|Physician Decision|0|||
48484069|NCT04380701|155966382|FG029|Overall Study|Physician Decision|0|||
48484070|NCT04380701|155966383|FG030|Overall Study|Physician Decision|0|||
48484071|NCT04380701|155966384|FG031|Overall Study|Physician Decision|0|||
48484072|NCT04380701|155966385|FG032|Overall Study|Physician Decision|0|||
48484073|NCT04380701|155966386|FG033|Overall Study|Physician Decision|0|||
48484074|NCT04380701|155966353|FG000|Overall Study|Death|0|||
48484075|NCT04380701|155966354|FG001|Overall Study|Death|0|||
48484076|NCT04380701|155966355|FG002|Overall Study|Death|0|||
48484077|NCT04380701|155966356|FG003|Overall Study|Death|0|||
48484078|NCT04380701|155966357|FG004|Overall Study|Death|0|||
48484079|NCT04380701|155966358|FG005|Overall Study|Death|0|||
48484080|NCT04380701|155966359|FG006|Overall Study|Death|0|||
48484081|NCT04380701|155966360|FG007|Overall Study|Death|0|||
48484082|NCT04380701|155966361|FG008|Overall Study|Death|0|||
48484083|NCT04380701|155966362|FG009|Overall Study|Death|0|||
48484084|NCT04380701|155966363|FG010|Overall Study|Death|0|||
48484085|NCT04380701|155966364|FG011|Overall Study|Death|0|||
48484086|NCT04380701|155966365|FG012|Overall Study|Death|0|||
48484087|NCT04380701|155966366|FG013|Overall Study|Death|0|||
48484088|NCT04380701|155966367|FG014|Overall Study|Death|0|||
48484089|NCT04380701|155966368|FG015|Overall Study|Death|0|||
48484090|NCT04380701|155966369|FG016|Overall Study|Death|0|||
48484091|NCT04380701|155966370|FG017|Overall Study|Death|0|||
48484092|NCT04380701|155966371|FG018|Overall Study|Death|0|||
48484093|NCT04380701|155966372|FG019|Overall Study|Death|0|||
48484094|NCT04380701|155966373|FG020|Overall Study|Death|0|||
48484095|NCT04380701|155966374|FG021|Overall Study|Death|0|||
48484096|NCT04380701|155966375|FG022|Overall Study|Death|0|||
48484097|NCT04380701|155966376|FG023|Overall Study|Death|0|||
48484098|NCT04380701|155966377|FG024|Overall Study|Death|1|||
48484099|NCT04380701|155966378|FG025|Overall Study|Death|0|||
48484100|NCT04380701|155966379|FG026|Overall Study|Death|0|||
48484101|NCT04380701|155966380|FG027|Overall Study|Death|0|||
48484102|NCT04380701|155966381|FG028|Overall Study|Death|0|||
48484103|NCT04380701|155966382|FG029|Overall Study|Death|0|||
48484104|NCT04380701|155966383|FG030|Overall Study|Death|0|||
48484105|NCT04380701|155966384|FG031|Overall Study|Death|0|||
48484106|NCT04380701|155966385|FG032|Overall Study|Death|0|||
48484107|NCT04380701|155966386|FG033|Overall Study|Death|0|||
48484108|NCT04380701|155966353|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484109|NCT04380701|155966354|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484110|NCT04380701|155966355|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484111|NCT04380701|155966356|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484112|NCT04380701|155966357|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484113|NCT04380701|155966358|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484114|NCT04380701|155966359|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484115|NCT04380701|155966360|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48587289|NCT03003000|156343169|FG000|Overall Study|Adverse Event|1|||
48484116|NCT04380701|155966361|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484117|NCT04380701|155966362|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484118|NCT04380701|155966363|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484119|NCT04380701|155966364|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484120|NCT04380701|155966365|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484121|NCT04380701|155966366|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484122|NCT04380701|155966367|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484123|NCT04380701|155966368|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484124|NCT04380701|155966369|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484125|NCT04380701|155966370|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484126|NCT04380701|155966371|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484127|NCT04380701|155966372|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484128|NCT04380701|155966373|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484129|NCT04380701|155966374|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
48484130|NCT04380701|155966375|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
48484131|NCT04380701|155966376|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
48484132|NCT04380701|155966377|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
48484133|NCT04380701|155966378|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484134|NCT04380701|155966379|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484135|NCT04380701|155966380|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484136|NCT04380701|155966381|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484137|NCT04380701|155966382|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484138|NCT04380701|155966383|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484139|NCT04380701|155966384|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484140|NCT04380701|155966385|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484141|NCT04380701|155966386|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
48484142|NCT03499249|155966389|FG000|Overall Study|Physician Decision|1|||
48484143|NCT03125629|155966391|FG000|Overall Study|Withdrawal by Subject|2|||
48484144|NCT03125629|155966391|FG000|Overall Study|Equipment malfunction|1|||
48484145|NCT00995930|155966394|FG000|Overall Study|Protocol deviation|2|||
48484146|NCT00995930|155966395|FG001|Overall Study|Protocol deviation|5|||
48484147|NCT00995930|155966394|FG000|Overall Study|Death|0|||
48484148|NCT00995930|155966395|FG001|Overall Study|Death|1|||
48484149|NCT00995930|155966394|FG000|Overall Study|Administrative problems|4|||
48484150|NCT00995930|155966395|FG001|Overall Study|Administrative problems|2|||
48484151|NCT00995930|155966394|FG000|Overall Study|Lost to Follow-up|1|||
48484152|NCT00995930|155966395|FG001|Overall Study|Lost to Follow-up|2|||
48484153|NCT00995930|155966394|FG000|Overall Study|Withdrawal by Subject|3|||
48484154|NCT00995930|155966395|FG001|Overall Study|Withdrawal by Subject|4|||
48484155|NCT00995930|155966394|FG000|Overall Study|Adverse Event|11|||
48484156|NCT00995930|155966395|FG001|Overall Study|Adverse Event|14|||
48484157|NCT00665626|155966396|FG000|Overall Study|Lack of Efficacy|8|||
48484158|NCT00665626|155966397|FG001|Overall Study|Lack of Efficacy|5|||
48484159|NCT00665626|155966396|FG000|Overall Study|Lost to Follow-up|0|||
48484160|NCT00665626|155966397|FG001|Overall Study|Lost to Follow-up|2|||
48484161|NCT00665626|155966396|FG000|Overall Study|Withdrawal by Subject|0|||
48484162|NCT00665626|155966397|FG001|Overall Study|Withdrawal by Subject|1|||
48484163|NCT00665626|155966396|FG000|Overall Study|Protocol Violation|0|||
48484164|NCT00665626|155966397|FG001|Overall Study|Protocol Violation|2|||
48484165|NCT00665626|155966396|FG000|Overall Study|Adverse Event|1|||
48484166|NCT00665626|155966397|FG001|Overall Study|Adverse Event|9|||
48484167|NCT00665626|155966396|FG000|Overall Study|Due to exclusion criteria|0|||
48484168|NCT00665626|155966397|FG001|Overall Study|Due to exclusion criteria|1|||
48484169|NCT00665626|155966396|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
48484170|NCT00665626|155966397|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
48484171|NCT00665626|155966396|FG000|Overall Study|Unably to comply with dosing regimen|0|||
48484172|NCT00665626|155966397|FG001|Overall Study|Unably to comply with dosing regimen|1|||
48484173|NCT00665626|155966396|FG000|Overall Study|Death|1|||
48484174|NCT00665626|155966397|FG001|Overall Study|Death|0|||
48484175|NCT05003167|155966398|FG000|Overall Study|Withdrawal by Subject|1|||
48484176|NCT00858234|155967670|FG000|Overall Study|Adverse Event|6|||
48484177|NCT00858234|155967670|FG000|Overall Study|Progressive disease|2|||
48484178|NCT00858234|155967670|FG000|Overall Study|Status unknown|1|||
48484179|NCT01901146|155967676|FG000|Neoadjuvant Phase|Death|1|||
48484180|NCT01901146|155967677|FG001|Neoadjuvant Phase|Death|2|||
48484181|NCT01901146|155967678|FG002|Neoadjuvant Phase|Death|0|||
48484182|NCT01901146|155967679|FG003|Neoadjuvant Phase|Death|0|||
48484183|NCT01901146|155967680|FG004|Neoadjuvant Phase|Death|0|||
48484184|NCT01901146|155967676|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
48484185|NCT01901146|155967677|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
48484186|NCT01901146|155967678|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
48484187|NCT01901146|155967679|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
48484188|NCT01901146|155967680|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
48484189|NCT01901146|155967676|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
48484190|NCT01901146|155967677|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
48484191|NCT01901146|155967678|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
48484192|NCT01901146|155967679|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
48484193|NCT01901146|155967680|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
48484194|NCT01901146|155967676|FG000|Neoadjuvant Phase|Physician Decision|1|||
48484195|NCT01901146|155967677|FG001|Neoadjuvant Phase|Physician Decision|2|||
48484196|NCT01901146|155967678|FG002|Neoadjuvant Phase|Physician Decision|0|||
48484197|NCT01901146|155967679|FG003|Neoadjuvant Phase|Physician Decision|0|||
48484198|NCT01901146|155967680|FG004|Neoadjuvant Phase|Physician Decision|0|||
48484199|NCT01901146|155967676|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
48484200|NCT01901146|155967677|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
48484201|NCT01901146|155967678|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
48484202|NCT01901146|155967679|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
48484203|NCT01901146|155967680|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
48484204|NCT01901146|155967676|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
48484205|NCT01901146|155967677|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
48484206|NCT01901146|155967678|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
48484207|NCT01901146|155967679|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
48484208|NCT01901146|155967680|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
48484209|NCT01901146|155967676|FG000|Adjuvant Phase|Other|0|||
48484210|NCT01901146|155967677|FG001|Adjuvant Phase|Other|0|||
48484211|NCT01901146|155967678|FG002|Adjuvant Phase|Other|1|||
48484212|NCT01901146|155967679|FG003|Adjuvant Phase|Other|0|||
48484213|NCT01901146|155967680|FG004|Adjuvant Phase|Other|0|||
48484214|NCT01901146|155967676|FG000|Adjuvant Phase|Death|0|||
48484215|NCT01901146|155967677|FG001|Adjuvant Phase|Death|0|||
48484216|NCT01901146|155967678|FG002|Adjuvant Phase|Death|0|||
48484217|NCT01901146|155967679|FG003|Adjuvant Phase|Death|0|||
48484218|NCT01901146|155967680|FG004|Adjuvant Phase|Death|3|||
48484219|NCT01901146|155967676|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
48484220|NCT01901146|155967677|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
48484221|NCT01901146|155967678|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
48484222|NCT01901146|155967679|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
48484223|NCT01901146|155967680|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
48484224|NCT01901146|155967676|FG000|Adjuvant Phase|Physician Decision|0|||
48484225|NCT01901146|155967677|FG001|Adjuvant Phase|Physician Decision|0|||
48484226|NCT01901146|155967678|FG002|Adjuvant Phase|Physician Decision|9|||
48484227|NCT01901146|155967679|FG003|Adjuvant Phase|Physician Decision|2|||
48484228|NCT01901146|155967680|FG004|Adjuvant Phase|Physician Decision|4|||
48484229|NCT01901146|155967676|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
48484230|NCT01901146|155967677|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
48484231|NCT01901146|155967678|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
48484232|NCT01901146|155967679|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
48484233|NCT01901146|155967680|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
48484234|NCT00297492|155967681|FG000|Set Quit Date|Lost to Follow-up|7|||
48484235|NCT00297492|155967682|FG001|Set Quit Date|Lost to Follow-up|13|||
48484236|NCT00297492|155967683|FG002|Set Quit Date|Lost to Follow-up|5|||
48484237|NCT00297492|155967681|FG000|6 Month Follow-up|Lost to Follow-up|63|||
48484238|NCT00297492|155967682|FG001|6 Month Follow-up|Lost to Follow-up|49|||
48484239|NCT00297492|155967683|FG002|6 Month Follow-up|Lost to Follow-up|27|||
48484240|NCT02428231|155967684|FG000|Overall Study|Other|10|||
48484241|NCT02428231|155967685|FG001|Overall Study|Other|16|||
48484242|NCT02428231|155967684|FG000|Overall Study|Required Symptomatic Therapy|0|||
48484243|NCT02428231|155967685|FG001|Overall Study|Required Symptomatic Therapy|1|||
48484244|NCT02428231|155967684|FG000|Overall Study|Adverse Event|3|||
48484245|NCT02428231|155967685|FG001|Overall Study|Adverse Event|0|||
48484246|NCT03724968|155967686|FG000|Overall Study|Insurance issues|0|||
48484247|NCT03724968|155967687|FG001|Overall Study|Insurance issues|1|||
48484248|NCT03724968|155967686|FG000|Overall Study|Study closed|0|||
48484249|NCT03724968|155967687|FG001|Overall Study|Study closed|1|||
48484250|NCT01858558|155967690|FG000|Overall Study|Death|1|||
48484251|NCT01858558|155967691|FG001|Overall Study|Death|1|||
48484252|NCT01858558|155967690|FG000|Overall Study|Lost to Follow-up|1|||
48484253|NCT01858558|155967691|FG001|Overall Study|Lost to Follow-up|0|||
48484254|NCT01858558|155967690|FG000|Overall Study|Disease progression|3|||
48484255|NCT01858558|155967691|FG001|Overall Study|Disease progression|1|||
48484256|NCT01858558|155967690|FG000|Overall Study|Product contamination|2|||
48484257|NCT01858558|155967691|FG001|Overall Study|Product contamination|0|||
48484258|NCT01858558|155967690|FG000|Overall Study|Failed expansion of cell product|2|||
48484259|NCT01858558|155967691|FG001|Overall Study|Failed expansion of cell product|0|||
48484260|NCT01784419|155967692|FG000|Overall Study|Adverse Event|3|||
48484261|NCT01336608|155967693|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
48484262|NCT01336608|155967694|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48484263|NCT01336608|155967695|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48484264|NCT01336608|155967696|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
48484265|NCT01336608|155967693|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
48484266|NCT01336608|155967694|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48484267|NCT01336608|155967695|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48484268|NCT01336608|155967696|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
48484269|NCT01336608|155967693|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
48484270|NCT01336608|155967694|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
48484271|NCT01336608|155967695|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
48484272|NCT01336608|155967696|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
48484273|NCT01336608|155967693|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
48484274|NCT01336608|155967694|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
48484275|NCT01336608|155967695|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
48484276|NCT01336608|155967696|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
48484277|NCT01336608|155967693|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
48484278|NCT01336608|155967694|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48484279|NCT01336608|155967695|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48484280|NCT01336608|155967696|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
48484281|NCT01336608|155967693|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
48484282|NCT01336608|155967694|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
48484283|NCT01336608|155967695|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
48484284|NCT01336608|155967696|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
48484285|NCT01336608|155967693|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48484286|NCT01336608|155967694|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
48484287|NCT01336608|155967695|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48484288|NCT01336608|155967696|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
48484289|NCT01336608|155967693|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
48484290|NCT01336608|155967694|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
48484291|NCT01336608|155967695|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
48484292|NCT01336608|155967696|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
48484293|NCT01336608|155967693|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
48484294|NCT01336608|155967694|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
48484295|NCT01336608|155967695|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
48484296|NCT01336608|155967696|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
48484297|NCT01336608|155967693|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
48484298|NCT01336608|155967694|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
48484299|NCT01336608|155967695|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
48484300|NCT01336608|155967696|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
48484301|NCT01336608|155967693|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48484302|NCT01336608|155967694|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
48484303|NCT01336608|155967695|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48484304|NCT01336608|155967696|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
48484305|NCT01336608|155967693|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
48484306|NCT01336608|155967694|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
48484307|NCT01336608|155967695|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
48484308|NCT01336608|155967696|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
48484309|NCT01336608|155967693|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
48484310|NCT01336608|155967694|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
48484311|NCT01336608|155967695|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
48484312|NCT01336608|155967696|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
48484313|NCT02237118|155967697|FG000|Overall Study|Protocol Violation|0|||
48484314|NCT02237118|155967698|FG001|Overall Study|Protocol Violation|1|||
48484315|NCT02237118|155967697|FG000|Overall Study|consent withdrawn|1|||
48484316|NCT02237118|155967698|FG001|Overall Study|consent withdrawn|0|||
48484317|NCT00080288|155967699|FG000|Overall Study|Adverse Event|7|||
48484318|NCT00080288|155967700|FG001|Overall Study|Adverse Event|4|||
48484319|NCT00080288|155967699|FG000|Overall Study|Lost to Follow-up|3|||
48484320|NCT00080288|155967700|FG001|Overall Study|Lost to Follow-up|5|||
48484321|NCT00080288|155967699|FG000|Overall Study|Physician Decision|6|||
48484322|NCT00080288|155967700|FG001|Overall Study|Physician Decision|2|||
48484323|NCT00080288|155967699|FG000|Overall Study|Withdrawal by Subject|3|||
48484324|NCT00080288|155967700|FG001|Overall Study|Withdrawal by Subject|16|||
48484325|NCT00080288|155967699|FG000|Overall Study|Miscellaneous|11|||
48484326|NCT00080288|155967700|FG001|Overall Study|Miscellaneous|11|||
48484327|NCT00366678|155967701|FG000|Infant Series|Withdrawal by Subject|8|||
48484328|NCT00366678|155967702|FG001|Infant Series|Withdrawal by Subject|6|||
48484329|NCT00366678|155967703|FG002|Infant Series|Withdrawal by Subject|0|||
48484330|NCT00366678|155967701|FG000|Infant Series|Protocol Violation|4|||
48484331|NCT00366678|155967702|FG001|Infant Series|Protocol Violation|3|||
48484332|NCT00366678|155967703|FG002|Infant Series|Protocol Violation|0|||
48484333|NCT00366678|155967701|FG000|Infant Series|Failed to return|1|||
48484334|NCT00366678|155967702|FG001|Infant Series|Failed to return|1|||
48484335|NCT00366678|155967703|FG002|Infant Series|Failed to return|0|||
48484336|NCT00366678|155967701|FG000|Infant Series|Adverse Event|1|||
48484337|NCT00366678|155967702|FG001|Infant Series|Adverse Event|0|||
48484338|NCT00366678|155967703|FG002|Infant Series|Adverse Event|0|||
48484339|NCT00366678|155967701|FG000|After Infant|Withdrawal by Subject|8|||
48484340|NCT00366678|155967702|FG001|After Infant|Withdrawal by Subject|4|||
48484341|NCT00366678|155967703|FG002|After Infant|Withdrawal by Subject|0|||
48484342|NCT00366678|155967701|FG000|After Infant|Lost to Follow-up|2|||
48484343|NCT00366678|155967702|FG001|After Infant|Lost to Follow-up|1|||
48484344|NCT00366678|155967703|FG002|After Infant|Lost to Follow-up|0|||
48484345|NCT00366678|155967701|FG000|After Infant|Failed to return|5|||
48484346|NCT00366678|155967702|FG001|After Infant|Failed to return|5|||
48484347|NCT00366678|155967703|FG002|After Infant|Failed to return|0|||
48484348|NCT00366678|155967701|FG000|After Infant|Adverse Event|1|||
48484349|NCT00366678|155967702|FG001|After Infant|Adverse Event|0|||
48484350|NCT00366678|155967703|FG002|After Infant|Adverse Event|0|||
48484351|NCT00366678|155967701|FG000|After Infant|Protocol Violation|1|||
48484352|NCT00366678|155967702|FG001|After Infant|Protocol Violation|0|||
48484353|NCT00366678|155967703|FG002|After Infant|Protocol Violation|0|||
48484354|NCT00366678|155967701|FG000|Toddler Dose|Protocol Violation|2|||
48484355|NCT00366678|155967702|FG001|Toddler Dose|Protocol Violation|1|||
48484356|NCT00366678|155967703|FG002|Toddler Dose|Protocol Violation|0|||
48484357|NCT00366678|155967701|FG000|Toddler Dose|Failed to return|1|||
48484358|NCT00366678|155967702|FG001|Toddler Dose|Failed to return|0|||
48484359|NCT00366678|155967703|FG002|Toddler Dose|Failed to return|0|||
48484360|NCT00366678|155967701|FG000|Toddler Dose|Withdrawal by Subject|1|||
48484361|NCT00366678|155967702|FG001|Toddler Dose|Withdrawal by Subject|0|||
48484362|NCT00366678|155967703|FG002|Toddler Dose|Withdrawal by Subject|0|||
48484363|NCT00366678|155967701|FG000|Toddler Dose|protocol deviation|1|||
48484364|NCT00366678|155967702|FG001|Toddler Dose|protocol deviation|0|||
48484365|NCT00366678|155967703|FG002|Toddler Dose|protocol deviation|0|||
48484366|NCT01963676|155967704|FG000|Overall Study|Withdrawal by Subject|1|||
48484367|NCT01963676|155967705|FG001|Overall Study|Withdrawal by Subject|0|||
48484368|NCT02437890|155967710|FG000|Overall Study|Non-compliance to study drug|0|||
48484369|NCT02437890|155967711|FG001|Overall Study|Non-compliance to study drug|1|||
48484370|NCT02437890|155967712|FG002|Overall Study|Non-compliance to study drug|0|||
48484371|NCT02437890|155967713|FG003|Overall Study|Non-compliance to study drug|0|||
48484372|NCT02437890|155967714|FG004|Overall Study|Non-compliance to study drug|1|||
48484373|NCT02437890|155967710|FG000|Overall Study|Sponsor's decision|1|||
48484374|NCT02437890|155967711|FG001|Overall Study|Sponsor's decision|1|||
48484375|NCT02437890|155967712|FG002|Overall Study|Sponsor's decision|4|||
48484376|NCT02437890|155967713|FG003|Overall Study|Sponsor's decision|0|||
48484377|NCT02437890|155967714|FG004|Overall Study|Sponsor's decision|2|||
48484378|NCT02437890|155967710|FG000|Overall Study|Physician Decision|0|||
48484379|NCT02437890|155967711|FG001|Overall Study|Physician Decision|0|||
48484380|NCT02437890|155967712|FG002|Overall Study|Physician Decision|0|||
48484381|NCT02437890|155967713|FG003|Overall Study|Physician Decision|1|||
48484382|NCT02437890|155967714|FG004|Overall Study|Physician Decision|0|||
48484383|NCT02437890|155967710|FG000|Overall Study|Unable to attend visit(s)|1|||
48484384|NCT02437890|155967711|FG001|Overall Study|Unable to attend visit(s)|0|||
48484385|NCT02437890|155967712|FG002|Overall Study|Unable to attend visit(s)|0|||
48484386|NCT02437890|155967713|FG003|Overall Study|Unable to attend visit(s)|0|||
48484387|NCT02437890|155967714|FG004|Overall Study|Unable to attend visit(s)|0|||
48484388|NCT02437890|155967710|FG000|Overall Study|Lack of Efficacy|1|||
48484389|NCT02437890|155967711|FG001|Overall Study|Lack of Efficacy|3|||
48484390|NCT02437890|155967712|FG002|Overall Study|Lack of Efficacy|0|||
48484391|NCT02437890|155967713|FG003|Overall Study|Lack of Efficacy|3|||
48484392|NCT02437890|155967714|FG004|Overall Study|Lack of Efficacy|1|||
48484393|NCT02437890|155967710|FG000|Overall Study|Adverse Event|4|||
48484394|NCT02437890|155967711|FG001|Overall Study|Adverse Event|9|||
48484395|NCT02437890|155967712|FG002|Overall Study|Adverse Event|5|||
48484396|NCT02437890|155967713|FG003|Overall Study|Adverse Event|11|||
48484397|NCT02437890|155967714|FG004|Overall Study|Adverse Event|7|||
48484398|NCT02437890|155967710|FG000|Overall Study|Withdrawal by Subject|1|||
48484399|NCT02437890|155967711|FG001|Overall Study|Withdrawal by Subject|2|||
48484400|NCT02437890|155967712|FG002|Overall Study|Withdrawal by Subject|6|||
48484401|NCT02437890|155967713|FG003|Overall Study|Withdrawal by Subject|5|||
48484402|NCT02437890|155967714|FG004|Overall Study|Withdrawal by Subject|5|||
48484403|NCT02437890|155967710|FG000|Overall Study|Death|0|||
48484404|NCT02437890|155967711|FG001|Overall Study|Death|0|||
48484405|NCT02437890|155967712|FG002|Overall Study|Death|0|||
48484406|NCT02437890|155967713|FG003|Overall Study|Death|2|||
48484407|NCT02437890|155967714|FG004|Overall Study|Death|0|||
48484408|NCT02328547|155967715|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
48484409|NCT02328547|155967716|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
48484410|NCT02328547|155967715|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
48484411|NCT02328547|155967716|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
48484412|NCT00344305|155967717|FG000|Overall Study|Lost to Follow-up|2|||
48484413|NCT00344305|155967718|FG001|Overall Study|Lost to Follow-up|0|||
48484414|NCT00344305|155967717|FG000|Overall Study|Participant was not contacted in window|0|||
48484415|NCT00344305|155967718|FG001|Overall Study|Participant was not contacted in window|1|||
48484416|NCT00078312|155967719|FG000|Overall Study|Adverse Event|43|||
48484417|NCT00078312|155967719|FG000|Overall Study|Lack of Efficacy|15|||
48484418|NCT00078312|155967719|FG000|Overall Study|Lost to Follow-up|41|||
48484419|NCT00078312|155967719|FG000|Overall Study|Physician Decision|9|||
48484420|NCT00078312|155967719|FG000|Overall Study|Protocol Violation|3|||
48484421|NCT00078312|155967719|FG000|Overall Study|Withdrawal by Subject|33|||
48484422|NCT00078312|155967719|FG000|Overall Study|Miscellaneous|33|||
48484423|NCT00331773|155967722|FG000|Overall Study|Withdrawal by Subject|6|||
48484424|NCT00331773|155967723|FG001|Overall Study|Withdrawal by Subject|4|||
48484425|NCT00331773|155967722|FG000|Overall Study|Protocol Violation|10|||
48484426|NCT00331773|155967723|FG001|Overall Study|Protocol Violation|3|||
48484427|NCT01954082|155967724|FG000|Overall Study|Study Suspension|42|||
48484428|NCT01954082|155967725|FG001|Overall Study|Study Suspension|36|||
48484429|NCT01954082|155967724|FG000|Overall Study|Adverse Event|10|||
48484430|NCT01954082|155967725|FG001|Overall Study|Adverse Event|4|||
48484431|NCT01954082|155967724|FG000|Overall Study|Intolerance|0|||
48484432|NCT01954082|155967725|FG001|Overall Study|Intolerance|1|||
48484433|NCT01954082|155967724|FG000|Overall Study|Non-compliance|6|||
48484434|NCT01954082|155967725|FG001|Overall Study|Non-compliance|4|||
48484435|NCT01954082|155967724|FG000|Overall Study|Physician Decision|2|||
48484436|NCT01954082|155967725|FG001|Overall Study|Physician Decision|0|||
48484437|NCT01954082|155967724|FG000|Overall Study|Parent Decision|1|||
48484438|NCT01954082|155967725|FG001|Overall Study|Parent Decision|0|||
48484439|NCT01954082|155967724|FG000|Overall Study|Withdrawal by Subject|0|||
48484440|NCT01954082|155967725|FG001|Overall Study|Withdrawal by Subject|1|||
48484441|NCT01954082|155967724|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
48484442|NCT01954082|155967725|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
48484443|NCT01954082|155967724|FG000|Overall Study|Redirection of Care|0|||
48484444|NCT01954082|155967725|FG001|Overall Study|Redirection of Care|2|||
48484445|NCT01954082|155967724|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
48484446|NCT01954082|155967725|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
48484447|NCT01954082|155967724|FG000|Overall Study|Comfort Care|0|||
48484448|NCT01954082|155967725|FG001|Overall Study|Comfort Care|1|||
48484449|NCT01954082|155967724|FG000|Overall Study|Infant Moved|0|||
48484450|NCT01954082|155967725|FG001|Overall Study|Infant Moved|1|||
48484451|NCT01954082|155967724|FG000|Overall Study|Randomized not Treated|4|||
48484452|NCT01954082|155967725|FG001|Overall Study|Randomized not Treated|2|||
48484453|NCT03944707|155967726|FG000|Overall Study|Adverse Event|0|||
48484454|NCT03944707|155967727|FG001|Overall Study|Adverse Event|2|||
48484455|NCT03944707|155967726|FG000|Overall Study|Study terminated by sponsor|12|||
48484456|NCT03944707|155967727|FG001|Overall Study|Study terminated by sponsor|7|||
48484457|NCT03944707|155967726|FG000|Overall Study|Subject decision|0|||
48484458|NCT03944707|155967727|FG001|Overall Study|Subject decision|1|||
48484459|NCT02444182|155967730|FG000|Overall Study|non-compliance|2|||
48484460|NCT02444182|155967731|FG001|Overall Study|non-compliance|1|||
48484461|NCT02444182|155967730|FG000|Overall Study|Lost to Follow-up|0|||
48484462|NCT02444182|155967731|FG001|Overall Study|Lost to Follow-up|4|||
48484463|NCT03216954|155967739|FG000|Overall Study|Adverse Event|0|||
48484464|NCT03216954|155967740|FG001|Overall Study|Adverse Event|0|||
48484465|NCT03216954|155967741|FG002|Overall Study|Adverse Event|1|||
48484466|NCT03216954|155967742|FG003|Overall Study|Adverse Event|0|||
48484467|NCT03216954|155967743|FG004|Overall Study|Adverse Event|1|||
48484468|NCT03216954|155967739|FG000|Overall Study|Withdrawal by Subject|2|||
48484469|NCT03216954|155967740|FG001|Overall Study|Withdrawal by Subject|0|||
48484470|NCT03216954|155967741|FG002|Overall Study|Withdrawal by Subject|0|||
48484471|NCT03216954|155967742|FG003|Overall Study|Withdrawal by Subject|0|||
48484472|NCT03216954|155967743|FG004|Overall Study|Withdrawal by Subject|0|||
48484473|NCT03216954|155967739|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
48484474|NCT03216954|155967740|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
48484475|NCT03216954|155967741|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
48484476|NCT03216954|155967742|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
48484477|NCT03216954|155967743|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
48484478|NCT00829439|155967744|FG000|Overall Study|Adverse Event|0|||
48484479|NCT00829439|155967745|FG001|Overall Study|Adverse Event|0|||
48484480|NCT00829439|155967746|FG002|Overall Study|Adverse Event|1|||
48484481|NCT00829439|155967747|FG003|Overall Study|Adverse Event|0|||
48484482|NCT00386100|155967749|FG000|Overall Study|Did not receive study medication|6|||
48484483|NCT00386100|155967750|FG001|Overall Study|Did not receive study medication|4|||
48484484|NCT00386100|155967749|FG000|Overall Study|Adverse Event|15|||
48484485|NCT00386100|155967750|FG001|Overall Study|Adverse Event|25|||
48484486|NCT00386100|155967749|FG000|Overall Study|Death|0|||
48484487|NCT00386100|155967750|FG001|Overall Study|Death|1|||
48484488|NCT00386100|155967749|FG000|Overall Study|Insufficient therapeutic effect|30|||
48484489|NCT00386100|155967750|FG001|Overall Study|Insufficient therapeutic effect|6|||
48484490|NCT00386100|155967749|FG000|Overall Study|Lost to Follow-up|29|||
48484491|NCT00386100|155967750|FG001|Overall Study|Lost to Follow-up|29|||
48484492|NCT00386100|155967749|FG000|Overall Study|Non-compliance|18|||
48484493|NCT00386100|155967750|FG001|Overall Study|Non-compliance|19|||
48484494|NCT00386100|155967749|FG000|Overall Study|Protocol Violation|5|||
48484495|NCT00386100|155967750|FG001|Overall Study|Protocol Violation|3|||
48484496|NCT00386100|155967749|FG000|Overall Study|Withdrawal by Subject|32|||
48484497|NCT00386100|155967750|FG001|Overall Study|Withdrawal by Subject|31|||
48484498|NCT00386100|155967749|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
48484499|NCT00386100|155967750|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
48484500|NCT00386100|155967749|FG000|Overall Study|BMD <2.5|1|||
48484501|NCT00386100|155967750|FG001|Overall Study|BMD <2.5|0|||
48484502|NCT00386100|155967749|FG000|Overall Study|Consecutive elevated Hba1C|1|||
48484503|NCT00386100|155967750|FG001|Overall Study|Consecutive elevated Hba1C|0|||
48484504|NCT00386100|155967749|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
48484505|NCT00386100|155967750|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
48484506|NCT00386100|155967749|FG000|Overall Study|Laboratory findings|1|||
48484507|NCT00386100|155967750|FG001|Overall Study|Laboratory findings|0|||
48484508|NCT00386100|155967749|FG000|Overall Study|Participant's concern due to CPK levels|1|||
48484509|NCT00386100|155967750|FG001|Overall Study|Participant's concern due to CPK levels|0|||
48484510|NCT00386100|155967749|FG000|Overall Study|Participant moving out of state|2|||
48484511|NCT00386100|155967750|FG001|Overall Study|Participant moving out of state|0|||
48484512|NCT00386100|155967749|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
48484513|NCT00386100|155967750|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
48484514|NCT00386100|155967749|FG000|Overall Study|Didn't meet entry criteria|1|||
48484515|NCT00386100|155967750|FG001|Overall Study|Didn't meet entry criteria|1|||
48484516|NCT00386100|155967749|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
48484517|NCT00386100|155967750|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
48484518|NCT00386100|155967749|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
48484519|NCT00386100|155967750|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
48484520|NCT00386100|155967749|FG000|Overall Study|Bad metabolic control & patient security|1|||
48484521|NCT00386100|155967750|FG001|Overall Study|Bad metabolic control & patient security|0|||
48484522|NCT00386100|155967749|FG000|Overall Study|Bone loss by DXA bone scan|1|||
48484523|NCT00386100|155967750|FG001|Overall Study|Bone loss by DXA bone scan|0|||
48484524|NCT00386100|155967749|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
48484525|NCT00386100|155967750|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
48484526|NCT00386100|155967749|FG000|Overall Study|7.6% bone loss|1|||
48484527|NCT00386100|155967750|FG001|Overall Study|7.6% bone loss|0|||
48484528|NCT00386100|155967749|FG000|Overall Study|Osteoporosis|0|||
48484529|NCT00386100|155967750|FG001|Overall Study|Osteoporosis|1|||
48484530|NCT00386100|155967749|FG000|Overall Study|Positive pregnancy test|1|||
48484531|NCT00386100|155967750|FG001|Overall Study|Positive pregnancy test|3|||
48484532|NCT00386100|155967749|FG000|Overall Study|Out of country for 5 months|1|||
48484533|NCT00386100|155967750|FG001|Overall Study|Out of country for 5 months|0|||
48484534|NCT00386100|155967749|FG000|Overall Study|Hb1Ac >8%|0|||
48484535|NCT00386100|155967750|FG001|Overall Study|Hb1Ac >8%|1|||
48484536|NCT00386100|155967749|FG000|Overall Study|Participant randomized in error|1|||
48484537|NCT00386100|155967750|FG001|Overall Study|Participant randomized in error|0|||
48484538|NCT00810615|155967751|FG000|Overall Study|Withdrawal by Subject|1|||
48484539|NCT00810615|155967752|FG001|Overall Study|Withdrawal by Subject|1|||
48484540|NCT02983227|155967755|FG000|Overall Study|Adverse Event|21|||
48484541|NCT02983227|155967756|FG001|Overall Study|Adverse Event|3|||
48484542|NCT02983227|155967755|FG000|Overall Study|Death|3|||
48484543|NCT02983227|155967756|FG001|Overall Study|Death|0|||
48484544|NCT02983227|155967755|FG000|Overall Study|Lack of Efficacy|8|||
48484545|NCT02983227|155967756|FG001|Overall Study|Lack of Efficacy|1|||
48484546|NCT02983227|155967755|FG000|Overall Study|Lost to Follow-up|3|||
48484547|NCT02983227|155967756|FG001|Overall Study|Lost to Follow-up|0|||
48484548|NCT02983227|155967755|FG000|Overall Study|Multiple Reasons|2|||
48484549|NCT02983227|155967756|FG001|Overall Study|Multiple Reasons|1|||
48484550|NCT02983227|155967755|FG000|Overall Study|Physician Decision|3|||
48484551|NCT02983227|155967756|FG001|Overall Study|Physician Decision|1|||
48484552|NCT02983227|155967755|FG000|Overall Study|Withdrawal by Subject|19|||
48484553|NCT02983227|155967756|FG001|Overall Study|Withdrawal by Subject|8|||
48484554|NCT04476017|155967758|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
48484555|NCT04476017|155967759|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
48484556|NCT02354976|155967760|FG000|Overall Study|Other - reason not specified|1|||
48484557|NCT02354976|155967761|FG001|Overall Study|Other - reason not specified|0|||
48484558|NCT02354976|155967762|FG002|Overall Study|Other - reason not specified|1|||
48484559|NCT02354976|155967760|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
48484560|NCT02354976|155967761|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
48484561|NCT02354976|155967762|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
48484562|NCT02354976|155967760|FG000|Overall Study|Adverse Event|1|||
48484563|NCT02354976|155967761|FG001|Overall Study|Adverse Event|0|||
48484564|NCT02354976|155967762|FG002|Overall Study|Adverse Event|2|||
48484565|NCT00771901|155967763|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
48484566|NCT00771901|155967764|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
48484567|NCT00771901|155967765|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
48484568|NCT00986154|155967768|FG000|Overall Study|Death|136|||
48484569|NCT00986154|155967769|FG001|Overall Study|Death|127|||
48484570|NCT00986154|155967768|FG000|Overall Study|Lost to Follow-up|7|||
48484571|NCT00986154|155967769|FG001|Overall Study|Lost to Follow-up|4|||
48484572|NCT00986154|155967768|FG000|Overall Study|Withdrawal by Subject|32|||
48484573|NCT00986154|155967769|FG001|Overall Study|Withdrawal by Subject|33|||
48484574|NCT00986154|155967768|FG000|Overall Study|investigator/subject decide not continue|6|||
48484575|NCT00986154|155967769|FG001|Overall Study|investigator/subject decide not continue|3|||
48484576|NCT00986154|155967768|FG000|Overall Study|never received study drug|25|||
48484577|NCT00986154|155967769|FG001|Overall Study|never received study drug|27|||
48484578|NCT01706770|155967770|FG000|Overall Study|Lost to Follow-up|1|||
48484579|NCT01706770|155967771|FG001|Overall Study|Lost to Follow-up|0|||
48484580|NCT01706770|155967770|FG000|Overall Study|Physician Decision|1|||
48484581|NCT01706770|155967771|FG001|Overall Study|Physician Decision|0|||
48484582|NCT03726437|155967772|FG000|Overall Study|Lost to Follow-up|85|||
48484583|NCT03726437|155967773|FG001|Overall Study|Lost to Follow-up|76|||
48484584|NCT00068445|155967777|FG000|Randomization|Cancel|1|||
48484585|NCT00068445|155967778|FG001|Randomization|Cancel|3|||
48484586|NCT00068445|155967777|FG000|Randomization|Ineligible|1|||
48484587|NCT00068445|155967778|FG001|Randomization|Ineligible|1|||
48484588|NCT00068445|155967777|FG000|Treatment|Refused Further Treatment|13|||
48484589|NCT00068445|155967778|FG001|Treatment|Refused Further Treatment|10|||
48484590|NCT00068445|155967777|FG000|Treatment|Adverse Event|7|||
48484591|NCT00068445|155967778|FG001|Treatment|Adverse Event|1|||
48484592|NCT00068445|155967777|FG000|Treatment|Other (Specifics not available)|9|||
48484593|NCT00068445|155967778|FG001|Treatment|Other (Specifics not available)|5|||
48484594|NCT03550794|155967788|FG000|Overall Study|No longer met inclusion criteria|1|||
48484595|NCT03550794|155967789|FG001|Overall Study|No longer met inclusion criteria|2|||
48484596|NCT03550794|155967788|FG000|Overall Study|Goals of care changed|1|||
48484597|NCT03550794|155967789|FG001|Overall Study|Goals of care changed|0|||
48484598|NCT03550794|155967788|FG000|Overall Study|Withdrawal by Subject|2|||
48484599|NCT03550794|155967789|FG001|Overall Study|Withdrawal by Subject|0|||
48484600|NCT03550794|155967788|FG000|Overall Study|Death|0|||
48484601|NCT03550794|155967789|FG001|Overall Study|Death|1|||
48484602|NCT01864525|155967790|FG000|Overall Study|Adverse Event|1|||
48484603|NCT01864525|155967791|FG001|Overall Study|Adverse Event|0|||
48587258|NCT01004432|156343159|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
48587259|NCT01004432|156343155|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
48587260|NCT01004432|156343156|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
48587261|NCT01004432|156343157|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
48587262|NCT01004432|156343158|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
48587263|NCT01004432|156343159|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
48587264|NCT01004432|156343155|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
48587265|NCT01004432|156343156|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
48587266|NCT01004432|156343157|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
48587267|NCT01004432|156343158|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
48587268|NCT01004432|156343159|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
48587269|NCT02667626|156343160|FG000|Overall Study|Withdrawal by Subject|0|||
48587270|NCT02667626|156343161|FG001|Overall Study|Withdrawal by Subject|1|||
48587271|NCT00473824|156343165|FG000|Overall Study|Virologic Breakthrough|1|||
48587272|NCT00473824|156343166|FG001|Overall Study|Virologic Breakthrough|0|||
48587273|NCT00473824|156343165|FG000|Overall Study|Adverse Event|1|||
48587274|NCT00473824|156343166|FG001|Overall Study|Adverse Event|0|||
48587275|NCT00473824|156343165|FG000|Overall Study|Death|1|||
48587276|NCT00473824|156343166|FG001|Overall Study|Death|0|||
48587277|NCT00473824|156343165|FG000|Overall Study|Lost to Follow-up|1|||
48587278|NCT00473824|156343166|FG001|Overall Study|Lost to Follow-up|0|||
48587279|NCT00473824|156343165|FG000|Overall Study|Withdrawal by physician|1|||
48587280|NCT00473824|156343166|FG001|Overall Study|Withdrawal by physician|0|||
48587281|NCT02696434|156343167|FG000|Overall Study|Adverse Event|3|||
48587282|NCT02696434|156343168|FG001|Overall Study|Adverse Event|1|||
48587283|NCT02696434|156343167|FG000|Overall Study|Lost to Follow-up|5|||
48587284|NCT02696434|156343168|FG001|Overall Study|Lost to Follow-up|4|||
48587285|NCT02696434|156343167|FG000|Overall Study|Withdrawal by Subject|14|||
48587286|NCT02696434|156343168|FG001|Overall Study|Withdrawal by Subject|12|||
48587287|NCT02696434|156343167|FG000|Overall Study|Physician Decision|0|||
48587295|NCT03003000|156343169|FG000|Overall Study|Non-compliant with protocol|0|||
48587296|NCT03003000|156343170|FG001|Overall Study|Non-compliant with protocol|1|||
48587297|NCT03003000|156343171|FG002|Overall Study|Non-compliant with protocol|1|||
48587298|NCT03003000|156343169|FG000|Overall Study|Refused to continue medication|2|||
48587299|NCT03003000|156343170|FG001|Overall Study|Refused to continue medication|0|||
48587300|NCT03003000|156343171|FG002|Overall Study|Refused to continue medication|0|||
48587301|NCT03003000|156343169|FG000|Overall Study|Other than listed|1|||
48587302|NCT03003000|156343170|FG001|Overall Study|Other than listed|1|||
48587303|NCT03003000|156343171|FG002|Overall Study|Other than listed|1|||
48587304|NCT01428115|156343176|FG000|Overall Study|Lack of Efficacy|3|||
48587305|NCT01428115|156343176|FG000|Overall Study|Lost to Follow-up|10|||
48587306|NCT01428115|156343176|FG000|Overall Study|Pregnancy|1|||
48587307|NCT01428115|156343176|FG000|Overall Study|Protocol Violation|3|||
48587308|NCT01428115|156343176|FG000|Overall Study|Withdrawal by Subject|4|||
48587309|NCT00306787|156343177|FG000|Overall Study|Discontinued without taking study drug|208|||
48587310|NCT00306787|156343178|FG001|Overall Study|Discontinued without taking study drug|215|||
48587311|NCT00306787|156343177|FG000|Overall Study|Adverse Event|1|||
48587312|NCT00306787|156343178|FG001|Overall Study|Adverse Event|1|||
48587313|NCT00306787|156343177|FG000|Overall Study|Lack of Efficacy|1|||
48587314|NCT00306787|156343178|FG001|Overall Study|Lack of Efficacy|0|||
48587315|NCT00306787|156343177|FG000|Overall Study|Protocol Violation|8|||
48587316|NCT00306787|156343178|FG001|Overall Study|Protocol Violation|10|||
48587317|NCT00306787|156343177|FG000|Overall Study|Withdrawal by Subject|2|||
48587318|NCT00306787|156343178|FG001|Overall Study|Withdrawal by Subject|9|||
48587319|NCT00306787|156343177|FG000|Overall Study|Lost to Follow-up|9|||
48587320|NCT00306787|156343178|FG001|Overall Study|Lost to Follow-up|6|||
48587321|NCT00306787|156343177|FG000|Overall Study|Administrative problems|4|||
48587322|NCT00306787|156343178|FG001|Overall Study|Administrative problems|0|||
48587323|NCT00306787|156343177|FG000|Overall Study|Abnormal laboratory value(s)|1|||
48587324|NCT00306787|156343178|FG001|Overall Study|Abnormal laboratory value(s)|0|||
48587325|NCT04933617|156343183|FG000|Dose Escalation|Early closure of study|0|||
48587326|NCT04933617|156343184|FG001|Dose Escalation|Early closure of study|3|||
48587327|NCT04933617|156343185|FG002|Dose Escalation|Early closure of study|0|||
48587328|NCT04933617|156343186|FG003|Dose Escalation|Early closure of study|0|||
48587329|NCT04933617|156343187|FG004|Dose Escalation|Early closure of study|0|||
48587330|NCT01438814|156343193|FG000|Overall Study|Adverse Event|3|||
48587331|NCT01438814|156343194|FG001|Overall Study|Adverse Event|3|||
48587332|NCT01438814|156343193|FG000|Overall Study|Protocol Violation|1|||
48587333|NCT01438814|156343194|FG001|Overall Study|Protocol Violation|2|||
48587334|NCT01438814|156343193|FG000|Overall Study|Lost to Follow-up|4|||
48587335|NCT01438814|156343194|FG001|Overall Study|Lost to Follow-up|3|||
48587336|NCT01438814|156343193|FG000|Overall Study|Withdrawal by Subject|4|||
48587337|NCT01438814|156343194|FG001|Overall Study|Withdrawal by Subject|2|||
48587338|NCT01438814|156343193|FG000|Overall Study|Other|2|||
48587339|NCT01438814|156343194|FG001|Overall Study|Other|4|||
48587340|NCT05268016|156343197|FG000|Overall Study|Unacceptable toxicity or AE|2|||
48587341|NCT05268016|156343198|FG001|Overall Study|Unacceptable toxicity or AE|2|||
48587342|NCT05268016|156343199|FG002|Overall Study|Unacceptable toxicity or AE|4|||
48587343|NCT05268016|156343200|FG003|Overall Study|Unacceptable toxicity or AE|3|||
48587344|NCT05268016|156343201|FG004|Overall Study|Unacceptable toxicity or AE|1|||
48587345|NCT05268016|156343197|FG000|Overall Study|Withdrawal by Subject|1|||
48587346|NCT05268016|156343198|FG001|Overall Study|Withdrawal by Subject|3|||
48587347|NCT05268016|156343199|FG002|Overall Study|Withdrawal by Subject|2|||
48587348|NCT05268016|156343200|FG003|Overall Study|Withdrawal by Subject|2|||
48587349|NCT05268016|156343201|FG004|Overall Study|Withdrawal by Subject|1|||
48587350|NCT05268016|156343197|FG000|Overall Study|Lost to Follow-up|4|||
48587351|NCT05268016|156343198|FG001|Overall Study|Lost to Follow-up|7|||
48587352|NCT05268016|156343199|FG002|Overall Study|Lost to Follow-up|1|||
48587353|NCT05268016|156343200|FG003|Overall Study|Lost to Follow-up|3|||
48587354|NCT05268016|156343201|FG004|Overall Study|Lost to Follow-up|5|||
48587355|NCT05268016|156343197|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
48587356|NCT05268016|156343198|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
48587357|NCT05268016|156343199|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
48587358|NCT05268016|156343200|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
48587359|NCT05268016|156343201|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
48587360|NCT05268016|156343197|FG000|Overall Study|Lack of Efficacy|0|||
48587361|NCT05268016|156343198|FG001|Overall Study|Lack of Efficacy|0|||
48587362|NCT05268016|156343199|FG002|Overall Study|Lack of Efficacy|0|||
48587363|NCT05268016|156343200|FG003|Overall Study|Lack of Efficacy|0|||
48587364|NCT05268016|156343201|FG004|Overall Study|Lack of Efficacy|4|||
48587365|NCT05268016|156343197|FG000|Overall Study|Physician Decision|0|||
48587366|NCT05268016|156343198|FG001|Overall Study|Physician Decision|0|||
48587367|NCT05268016|156343199|FG002|Overall Study|Physician Decision|0|||
48587368|NCT05268016|156343200|FG003|Overall Study|Physician Decision|1|||
48587369|NCT05268016|156343201|FG004|Overall Study|Physician Decision|0|||
48587370|NCT05268016|156343197|FG000|Overall Study|Other|1|||
48587379|NCT02273908|156343211|FG000|Overall Study|Did not meet entrance criteria|3|||
48587380|NCT02273908|156343212|FG001|Overall Study|Did not meet entrance criteria|2|||
48587381|NCT02273908|156343211|FG000|Overall Study|Withdrawal by Subject|4|||
48587382|NCT02273908|156343212|FG001|Overall Study|Withdrawal by Subject|2|||
48587383|NCT00564395|156343213|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
48587384|NCT00564395|156343214|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
48587385|NCT00564395|156343213|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
48587386|NCT00564395|156343214|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
48587387|NCT02791438|156343215|FG000|Treatment Period|Adverse Event|1|||
48587388|NCT02791438|156343216|FG001|Treatment Period|Adverse Event|0|||
48587389|NCT02791438|156343215|FG000|Treatment Period|Withdrawal by Subject|0|||
48587390|NCT02791438|156343216|FG001|Treatment Period|Withdrawal by Subject|1|||
48587391|NCT02791438|156343215|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
48587392|NCT02791438|156343216|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
48587393|NCT03887117|156343217|FG000|Overall Study|Discontinued prematurely|0|||
48587394|NCT03887117|156343218|FG001|Overall Study|Discontinued prematurely|1|||
48587395|NCT03887117|156343219|FG002|Overall Study|Discontinued prematurely|1|||
48587396|NCT03887117|156343220|FG003|Overall Study|Discontinued prematurely|2|||
48587397|NCT00830518|156343224|FG000|Overall Study|Progressive Disease|18|||
48587398|NCT00830518|156343225|FG001|Overall Study|Progressive Disease|8|||
48587399|NCT00830518|156343224|FG000|Overall Study|Symptomatic Deterioration|4|||
48587400|NCT00830518|156343225|FG001|Overall Study|Symptomatic Deterioration|1|||
48587401|NCT00830518|156343224|FG000|Overall Study|Adverse Event|14|||
48587402|NCT00830518|156343225|FG001|Overall Study|Adverse Event|1|||
48587403|NCT00830518|156343224|FG000|Overall Study|Withdrawal by Patient|2|||
48587404|NCT00830518|156343225|FG001|Overall Study|Withdrawal by Patient|0|||
48587405|NCT00830518|156343224|FG000|Overall Study|Reason not Specified|8|||
48587406|NCT00830518|156343225|FG001|Overall Study|Reason not Specified|1|||
48587407|NCT02431806|156343226|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
48587408|NCT02431806|156343227|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
48587409|NCT02431806|156343228|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
48587410|NCT02431806|156343229|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
48587411|NCT02431806|156343226|FG000|Double-blind Treatment Period|Adverse Event|4|||
48587412|NCT02431806|156343227|FG001|Double-blind Treatment Period|Adverse Event|7|||
48587413|NCT02431806|156343228|FG002|Double-blind Treatment Period|Adverse Event|11|||
48587414|NCT02431806|156343229|FG003|Double-blind Treatment Period|Adverse Event|7|||
48587415|NCT02431806|156343226|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
48587416|NCT02431806|156343227|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
48587417|NCT02431806|156343228|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
48587418|NCT02431806|156343229|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
48587419|NCT02431806|156343226|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
48587420|NCT02431806|156343227|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
48587421|NCT02431806|156343228|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
48587422|NCT02431806|156343229|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
48587423|NCT02431806|156343226|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
48587424|NCT02431806|156343227|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
48587425|NCT02431806|156343228|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
48587426|NCT02431806|156343229|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
48587427|NCT02431806|156343226|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
48587428|NCT02431806|156343227|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
48587429|NCT02431806|156343228|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
48587430|NCT02431806|156343229|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
48587431|NCT02431806|156343226|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
48587432|NCT02431806|156343227|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
48587433|NCT02431806|156343228|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
48587434|NCT02431806|156343229|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
48587435|NCT01156051|156343231|FG000|Overall Study|Lost to Follow-up|1|||
48587436|NCT01156051|156343232|FG001|Overall Study|Lost to Follow-up|0|||
48587437|NCT01156051|156343231|FG000|Overall Study|patient not compliant with protocol|0|||
48587438|NCT01156051|156343232|FG001|Overall Study|patient not compliant with protocol|1|||
48587439|NCT02028169|156343233|FG000|Overall Study|Lost to Follow-up|21|||
48587440|NCT02028169|156343233|FG000|Overall Study|Lack of Efficacy|2|||
48587441|NCT02028169|156343233|FG000|Overall Study|Withdrawal by Subject|2|||
48587442|NCT02028169|156343233|FG000|Overall Study|Adverse Event|1|||
48587443|NCT02028169|156343233|FG000|Overall Study|Cessation of Drug|1|||
48587444|NCT02028169|156343233|FG000|Overall Study|Concomitant Medication Usage|1|||
48587445|NCT01752634|156343234|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
48587446|NCT01752634|156343235|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
48587447|NCT01752634|156343236|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
48587448|NCT01752634|156343237|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
48587449|NCT01752634|156343238|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
48587450|NCT01752634|156343239|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
48587451|NCT01752634|156343234|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
48587452|NCT01752634|156343235|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
48587453|NCT01752634|156343236|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
48587454|NCT01752634|156343237|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
48587455|NCT01752634|156343238|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
48587456|NCT01752634|156343239|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
48587457|NCT01752634|156343234|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
48587458|NCT01752634|156343235|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
48587459|NCT01752634|156343236|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
48587460|NCT01752634|156343237|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
48587461|NCT01752634|156343238|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
48587462|NCT01752634|156343239|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
48587463|NCT01752634|156343234|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
48587464|NCT01752634|156343235|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
48587465|NCT01752634|156343236|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
48587466|NCT01752634|156343237|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
48587467|NCT01752634|156343238|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
48587468|NCT01752634|156343239|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
48587469|NCT01752634|156343234|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
48587470|NCT01752634|156343235|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
48587471|NCT01752634|156343236|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
48587472|NCT01752634|156343237|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
48587473|NCT01752634|156343238|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
48587474|NCT01752634|156343239|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
48587475|NCT01752634|156343234|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
48587476|NCT01752634|156343235|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
48587477|NCT01752634|156343236|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
48587478|NCT01752634|156343237|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
48587479|NCT01752634|156343238|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
48587480|NCT01752634|156343239|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
48587481|NCT01752634|156343234|FG000|Week 24 to Week 260|Physician Decision|1|||
48587482|NCT01752634|156343235|FG001|Week 24 to Week 260|Physician Decision|2|||
48587483|NCT01752634|156343236|FG002|Week 24 to Week 260|Physician Decision|4|||
48587484|NCT01752634|156343237|FG003|Week 24 to Week 260|Physician Decision|2|||
48587485|NCT01752634|156343238|FG004|Week 24 to Week 260|Physician Decision|1|||
48587486|NCT01752634|156343239|FG005|Week 24 to Week 260|Physician Decision|0|||
48587487|NCT01752634|156343234|FG000|Week 24 to Week 260|Death|0|||
48587488|NCT01752634|156343235|FG001|Week 24 to Week 260|Death|1|||
48587489|NCT01752634|156343236|FG002|Week 24 to Week 260|Death|0|||
48587490|NCT01752634|156343237|FG003|Week 24 to Week 260|Death|0|||
48587491|NCT01752634|156343238|FG004|Week 24 to Week 260|Death|0|||
48587492|NCT01752634|156343239|FG005|Week 24 to Week 260|Death|0|||
48587493|NCT01752634|156343234|FG000|Week 24 to Week 260|Pregnancy|0|||
48587494|NCT01752634|156343235|FG001|Week 24 to Week 260|Pregnancy|0|||
48587495|NCT01752634|156343236|FG002|Week 24 to Week 260|Pregnancy|1|||
48587496|NCT01752634|156343237|FG003|Week 24 to Week 260|Pregnancy|0|||
48587497|NCT01752634|156343238|FG004|Week 24 to Week 260|Pregnancy|0|||
48587498|NCT01752634|156343239|FG005|Week 24 to Week 260|Pregnancy|0|||
48587499|NCT01752634|156343234|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
48587500|NCT01752634|156343235|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
48587501|NCT01752634|156343236|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
48587502|NCT01752634|156343237|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
48587503|NCT01752634|156343238|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
48587504|NCT01752634|156343239|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
48587505|NCT01752634|156343234|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
48587506|NCT01752634|156343235|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
48587507|NCT01752634|156343236|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
48587508|NCT01752634|156343237|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
48587509|NCT01752634|156343238|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
48587510|NCT01752634|156343239|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
48587511|NCT01752634|156343234|FG000|Week 24 to Week 260|Adverse Event|4|||
48587512|NCT01752634|156343235|FG001|Week 24 to Week 260|Adverse Event|8|||
48587513|NCT01752634|156343236|FG002|Week 24 to Week 260|Adverse Event|8|||
48587514|NCT01752634|156343237|FG003|Week 24 to Week 260|Adverse Event|4|||
48587515|NCT01752634|156343238|FG004|Week 24 to Week 260|Adverse Event|2|||
48587516|NCT01752634|156343239|FG005|Week 24 to Week 260|Adverse Event|0|||
48587517|NCT01134263|156343246|FG000|Overall Study|Serious adverse event|2|||
48587518|NCT01134263|156343247|FG001|Overall Study|Serious adverse event|1|||
48587519|NCT01134263|156343248|FG002|Overall Study|Serious adverse event|1|||
48587520|NCT01134263|156343249|FG003|Overall Study|Serious adverse event|1|||
48587521|NCT01134263|156343250|FG004|Overall Study|Serious adverse event|1|||
48587562|NCT00481767|156343260|FG001|Overall Study|Withdrawal by Subject|11|||
48587563|NCT00481767|156343259|FG000|Overall Study|Lost to Follow-up|16|||
48587564|NCT00481767|156343260|FG001|Overall Study|Lost to Follow-up|10|||
48587565|NCT01366638|156343265|FG000|Overall Study|Withdrawal by Subject|0|||
48587566|NCT01366638|156343266|FG001|Overall Study|Withdrawal by Subject|0|||
48587567|NCT01366638|156343267|FG002|Overall Study|Withdrawal by Subject|6|||
48587568|NCT01366638|156343265|FG000|Overall Study|Other|1|||
48587569|NCT01366638|156343266|FG001|Overall Study|Other|0|||
48587570|NCT01366638|156343267|FG002|Overall Study|Other|0|||
48587571|NCT02179749|156343268|FG000|Overall Study|Adverse Event|0|||
48587572|NCT02179749|156343269|FG001|Overall Study|Adverse Event|0|||
48587573|NCT02179749|156343270|FG002|Overall Study|Adverse Event|1|||
48587574|NCT02179749|156343268|FG000|Overall Study|Withdrawal by Subject|0|||
48587575|NCT02179749|156343269|FG001|Overall Study|Withdrawal by Subject|0|||
48587576|NCT02179749|156343270|FG002|Overall Study|Withdrawal by Subject|1|||
48587577|NCT00636636|156343271|FG000|Overall Study|Other reason|4|||
48587578|NCT00636636|156343272|FG001|Overall Study|Other reason|6|||
48587579|NCT00636636|156343271|FG000|Overall Study|Adverse Event|19|||
48587580|NCT00636636|156343272|FG001|Overall Study|Adverse Event|8|||
48587581|NCT00636636|156343271|FG000|Overall Study|Lack of Efficacy|7|||
48587582|NCT00636636|156343272|FG001|Overall Study|Lack of Efficacy|12|||
48587583|NCT00636636|156343271|FG000|Overall Study|Protocol Violation|2|||
48587584|NCT00636636|156343272|FG001|Overall Study|Protocol Violation|2|||
48587585|NCT00636636|156343271|FG000|Overall Study|Lost to Follow-up|0|||
48587586|NCT00636636|156343272|FG001|Overall Study|Lost to Follow-up|1|||
48587587|NCT00636636|156343271|FG000|Overall Study|Death|0|||
48587588|NCT00636636|156343272|FG001|Overall Study|Death|1|||
48587589|NCT00636636|156343271|FG000|Overall Study|Withdrawal by Subject|4|||
48587590|NCT00636636|156343272|FG001|Overall Study|Withdrawal by Subject|9|||
48587591|NCT02223364|156343275|FG000|Overall Study|Protocol Violation|3|||
48587592|NCT02223364|156343276|FG001|Overall Study|Protocol Violation|0|||
48587593|NCT02223364|156343277|FG002|Overall Study|Protocol Violation|3|||
48587594|NCT02223364|156343275|FG000|Overall Study|subject expired before surgery|1|||
48587595|NCT02223364|156343276|FG001|Overall Study|subject expired before surgery|0|||
48587596|NCT02223364|156343277|FG002|Overall Study|subject expired before surgery|0|||
48587597|NCT02223364|156343275|FG000|Overall Study|Physician Decision|1|||
48587598|NCT02223364|156343276|FG001|Overall Study|Physician Decision|0|||
48587599|NCT02223364|156343277|FG002|Overall Study|Physician Decision|0|||
48587600|NCT00494221|156343278|FG000|Overall Study|Death|15|||
48587601|NCT00494221|156343279|FG001|Overall Study|Death|9|||
48587602|NCT00494221|156343280|FG002|Overall Study|Death|14|||
48587603|NCT00494221|156343278|FG000|Overall Study|Withdrawal by Subject|1|||
48587604|NCT00494221|156343279|FG001|Overall Study|Withdrawal by Subject|2|||
48587605|NCT00494221|156343280|FG002|Overall Study|Withdrawal by Subject|0|||
48587606|NCT01969084|156343281|FG000|Overall Study|Adverse Event|0|||
48587607|NCT01969084|156343282|FG001|Overall Study|Adverse Event|1|||
48587608|NCT00866333|156343288|FG000|Overall Study|Withdrawal of consent|0|||
48587609|NCT00866333|156343289|FG001|Overall Study|Withdrawal of consent|1|||
48587610|NCT00866333|156343290|FG002|Overall Study|Withdrawal of consent|2|||
48587611|NCT00866333|156343288|FG000|Overall Study|Reason not Specified|3|||
48587612|NCT00866333|156343289|FG001|Overall Study|Reason not Specified|1|||
48587613|NCT00866333|156343290|FG002|Overall Study|Reason not Specified|1|||
48587614|NCT00866333|156343288|FG000|Overall Study|Study Terminated by Sponsor|2|||
48587615|NCT00866333|156343289|FG001|Overall Study|Study Terminated by Sponsor|5|||
48587616|NCT00866333|156343290|FG002|Overall Study|Study Terminated by Sponsor|9|||
48587617|NCT01653327|156343291|FG000|Overall Study|Withdrawal by Subject|1|||
48587618|NCT00659776|156343292|FG000|Overall Study|Withdrawal by Subject|12|||
48587619|NCT00659776|156343293|FG001|Overall Study|Withdrawal by Subject|2|||
48587620|NCT00659776|156343294|FG002|Overall Study|Withdrawal by Subject|0|||
48587621|NCT01237327|156343295|FG000|Overall Study|Protocol Violation: Core Study|1|||
48587622|NCT01237327|156343296|FG001|Overall Study|Protocol Violation: Core Study|0|||
48587623|NCT01237327|156343295|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
48587624|NCT01237327|156343296|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
48587625|NCT01237327|156343295|FG000|Overall Study|Progression of Disease: Core Study|18|||
48587626|NCT01237327|156343296|FG001|Overall Study|Progression of Disease: Core Study|22|||
48587627|NCT01237327|156343295|FG000|Overall Study|Progression of Disease: Extension Study|15|||
48587628|NCT01237327|156343296|FG001|Overall Study|Progression of Disease: Extension Study|13|||
48587629|NCT01237327|156343295|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
48587630|NCT01237327|156343296|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
48587631|NCT01237327|156343295|FG000|Overall Study|Withdrawal by Subject|1|||
48587632|NCT01237327|156343296|FG001|Overall Study|Withdrawal by Subject|3|||
48587633|NCT01237327|156343295|FG000|Overall Study|Lost to Follow-up|3|||
48587634|NCT01237327|156343296|FG001|Overall Study|Lost to Follow-up|0|||
48587635|NCT00742027|156343297|FG000|Overall Study|Disease Progression|76|||
48587636|NCT00742027|156343297|FG000|Overall Study|New Cancer Therapy|19|||
48587637|NCT00742027|156343297|FG000|Overall Study|Withdrawal by Subject|18|||
48587638|NCT00742027|156343297|FG000|Overall Study|Death|7|||
48587646|NCT01994902|156343299|FG001|Test Period 1|device deficiency with adverse event|1|||
48587647|NCT01994902|156343298|FG000|Test Period 1|Adverse Event|2|||
48587648|NCT01994902|156343299|FG001|Test Period 1|Adverse Event|1|||
48587649|NCT01994902|156343298|FG000|Test Period 1|Lack of Efficacy|0|||
48587650|NCT01994902|156343299|FG001|Test Period 1|Lack of Efficacy|1|||
48587651|NCT01994902|156343298|FG000|Test Period 1|bag too small|1|||
48587652|NCT01994902|156343299|FG001|Test Period 1|bag too small|0|||
48587653|NCT01994902|156343298|FG000|Test Period 2|Withdrawal by Subject|0|||
48587654|NCT01994902|156343299|FG001|Test Period 2|Withdrawal by Subject|2|||
48587655|NCT01994902|156343298|FG000|Test Period 2|Lack of Efficacy|0|||
48587656|NCT01994902|156343299|FG001|Test Period 2|Lack of Efficacy|1|||
48587657|NCT01994902|156343298|FG000|Test Period 2|Other|0|||
48587658|NCT01994902|156343299|FG001|Test Period 2|Other|3|||
48587659|NCT01458951|156344726|FG000|Overall Study|Other|1|||
48587660|NCT01458951|156344727|FG001|Overall Study|Other|0|||
48587661|NCT01458951|156344728|FG002|Overall Study|Other|0|||
48587662|NCT01458951|156344726|FG000|Overall Study|Protocol Violation|5|||
48587663|NCT01458951|156344727|FG001|Overall Study|Protocol Violation|1|||
48587664|NCT01458951|156344728|FG002|Overall Study|Protocol Violation|0|||
48587665|NCT01458951|156344726|FG000|Overall Study|Withdrawal by Subject|2|||
48587666|NCT01458951|156344727|FG001|Overall Study|Withdrawal by Subject|0|||
48587667|NCT01458951|156344728|FG002|Overall Study|Withdrawal by Subject|2|||
48587668|NCT01458951|156344726|FG000|Overall Study|Adverse Event|7|||
48587669|NCT01458951|156344727|FG001|Overall Study|Adverse Event|0|||
48587670|NCT01458951|156344728|FG002|Overall Study|Adverse Event|2|||
48587671|NCT01458951|156344726|FG000|Overall Study|Insufficient Clinical Response|17|||
48587672|NCT01458951|156344727|FG001|Overall Study|Insufficient Clinical Response|0|||
48587673|NCT01458951|156344728|FG002|Overall Study|Insufficient Clinical Response|11|||
48587674|NCT02584959|156344729|FG000|Period 1|Withdrawn from study|3|||
48587675|NCT02584959|156344730|FG001|Period 1|Withdrawn from study|4|||
48587676|NCT02584959|156344731|FG002|Period 1|Withdrawn from study|0|||
48587677|NCT02584959|156344729|FG000|Period 2|Withdrawn from study|6|||
48587678|NCT02584959|156344730|FG001|Period 2|Withdrawn from study|1|||
48587679|NCT02584959|156344731|FG002|Period 2|Withdrawn from study|2|||
48587680|NCT04908475|156344732|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
48587681|NCT04908475|156344733|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
48587682|NCT04908475|156344734|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
48587683|NCT04908475|156344735|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
48587684|NCT04908475|156344736|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
48587685|NCT04908475|156344737|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
48587686|NCT04908475|156344732|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
48587687|NCT04908475|156344733|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
48587688|NCT04908475|156344734|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
48587689|NCT04908475|156344735|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
48587690|NCT04908475|156344736|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
48587691|NCT04908475|156344737|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
48587692|NCT04908475|156344732|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
48587693|NCT04908475|156344733|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
48587694|NCT04908475|156344734|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
48587695|NCT04908475|156344735|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
48587696|NCT04908475|156344736|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
48587697|NCT04908475|156344737|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
48587698|NCT04908475|156344732|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48587699|NCT04908475|156344733|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
48587700|NCT04908475|156344734|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
48587701|NCT04908475|156344735|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
48587702|NCT04908475|156344736|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48587703|NCT04908475|156344737|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
48587704|NCT04908475|156344732|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
48587705|NCT04908475|156344733|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
48587706|NCT04908475|156344734|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
48587707|NCT04908475|156344735|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
48587708|NCT04908475|156344736|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
48587709|NCT04908475|156344737|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
48587710|NCT04908475|156344732|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
48587711|NCT04908475|156344733|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
48587712|NCT04908475|156344734|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
48587713|NCT04908475|156344735|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
48587714|NCT04908475|156344736|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
48587715|NCT04908475|156344737|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
48587716|NCT01870297|156344741|FG000|Overall Study|Adverse Event|0|||
48587717|NCT01870297|156344742|FG001|Overall Study|Adverse Event|0|||
48587718|NCT01870297|156344743|FG002|Overall Study|Adverse Event|0|||
48587731|NCT01870297|156344742|FG001|Overall Study|Withdrawal by Subject|0|||
48587732|NCT01870297|156344743|FG002|Overall Study|Withdrawal by Subject|0|||
48587733|NCT01870297|156344744|FG003|Overall Study|Withdrawal by Subject|0|||
48587734|NCT01870297|156344745|FG004|Overall Study|Withdrawal by Subject|1|||
48587735|NCT01870297|156344746|FG005|Overall Study|Withdrawal by Subject|1|||
48587736|NCT01870297|156344747|FG006|Overall Study|Withdrawal by Subject|1|||
48587737|NCT01870297|156344741|FG000|Overall Study|Sponsor Decision|0|||
48587738|NCT01870297|156344742|FG001|Overall Study|Sponsor Decision|6|||
48587739|NCT01870297|156344743|FG002|Overall Study|Sponsor Decision|0|||
48587740|NCT01870297|156344744|FG003|Overall Study|Sponsor Decision|0|||
48587741|NCT01870297|156344745|FG004|Overall Study|Sponsor Decision|0|||
48587742|NCT01870297|156344746|FG005|Overall Study|Sponsor Decision|0|||
48587743|NCT01870297|156344747|FG006|Overall Study|Sponsor Decision|1|||
48587744|NCT03760458|156344751|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
48587745|NCT03760458|156344752|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
48587746|NCT03760458|156344753|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
48587747|NCT03760458|156344754|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
48587748|NCT03760458|156344755|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
48587749|NCT01739764|156344756|FG000|Overall Study|Adverse Event|0|||
48587750|NCT01739764|156344757|FG001|Overall Study|Adverse Event|3|||
48587751|NCT01739764|156344758|FG002|Overall Study|Adverse Event|4|||
48587752|NCT01739764|156344756|FG000|Overall Study|Death|4|||
48587753|NCT01739764|156344757|FG001|Overall Study|Death|6|||
48587754|NCT01739764|156344758|FG002|Overall Study|Death|38|||
48587755|NCT01739764|156344756|FG000|Overall Study|Lost to Follow-up|0|||
48587756|NCT01739764|156344757|FG001|Overall Study|Lost to Follow-up|0|||
48587757|NCT01739764|156344758|FG002|Overall Study|Lost to Follow-up|5|||
48587758|NCT01739764|156344756|FG000|Overall Study|Non-Compliance|0|||
48587759|NCT01739764|156344757|FG001|Overall Study|Non-Compliance|0|||
48587760|NCT01739764|156344758|FG002|Overall Study|Non-Compliance|1|||
48587761|NCT01739764|156344756|FG000|Overall Study|Multiple Reasons|3|||
48587762|NCT01739764|156344757|FG001|Overall Study|Multiple Reasons|2|||
48587763|NCT01739764|156344758|FG002|Overall Study|Multiple Reasons|3|||
48587764|NCT01739764|156344756|FG000|Overall Study|Physician Decision|2|||
48587765|NCT01739764|156344757|FG001|Overall Study|Physician Decision|2|||
48587766|NCT01739764|156344758|FG002|Overall Study|Physician Decision|4|||
48587767|NCT01739764|156344756|FG000|Overall Study|Progressive Disease|3|||
48587768|NCT01739764|156344757|FG001|Overall Study|Progressive Disease|5|||
48587769|NCT01739764|156344758|FG002|Overall Study|Progressive Disease|16|||
48587770|NCT01739764|156344756|FG000|Overall Study|Protocol Violation|0|||
48587771|NCT01739764|156344757|FG001|Overall Study|Protocol Violation|0|||
48587772|NCT01739764|156344758|FG002|Overall Study|Protocol Violation|2|||
48587773|NCT01739764|156344756|FG000|Overall Study|Study Terminated by Sponsor|8|||
48587774|NCT01739764|156344757|FG001|Overall Study|Study Terminated by Sponsor|13|||
48587775|NCT01739764|156344758|FG002|Overall Study|Study Terminated by Sponsor|26|||
48587776|NCT01739764|156344756|FG000|Overall Study|Withdrawal by Subject|6|||
48587777|NCT01739764|156344757|FG001|Overall Study|Withdrawal by Subject|5|||
48587778|NCT01739764|156344758|FG002|Overall Study|Withdrawal by Subject|27|||
48587779|NCT00750919|156344759|FG000|Overall Study|Adverse Event|9|||
48587780|NCT00750919|156344759|FG000|Overall Study|Withdrawal by Subject|1|||
48587781|NCT00750919|156344759|FG000|Overall Study|Lack of Efficacy|8|||
48587782|NCT00750919|156344759|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
48587783|NCT00750919|156344759|FG000|Overall Study|Other|36|||
48587784|NCT00337779|156344760|FG000|Overall Study|Withdrawal by Subject|10|||
48587785|NCT00337779|156344761|FG001|Overall Study|Withdrawal by Subject|12|||
48587786|NCT00337779|156344760|FG000|Overall Study|Sponsor decision|1|||
48587787|NCT00337779|156344761|FG001|Overall Study|Sponsor decision|1|||
48587788|NCT00337779|156344760|FG000|Overall Study|Physician Decision|3|||
48587789|NCT00337779|156344761|FG001|Overall Study|Physician Decision|6|||
48587790|NCT00337779|156344760|FG000|Overall Study|Protocol Violation|1|||
48587791|NCT00337779|156344761|FG001|Overall Study|Protocol Violation|1|||
48587792|NCT00337779|156344760|FG000|Overall Study|Lost to Follow-up|6|||
48587793|NCT00337779|156344761|FG001|Overall Study|Lost to Follow-up|5|||
48587794|NCT00337779|156344760|FG000|Overall Study|Adverse Event|28|||
48587795|NCT00337779|156344761|FG001|Overall Study|Adverse Event|51|||
48587796|NCT00337779|156344760|FG000|Overall Study|Pregnancy|3|||
48587797|NCT00337779|156344761|FG001|Overall Study|Pregnancy|2|||
48587798|NCT00337779|156344760|FG000|Overall Study|Death|0|||
48587799|NCT00337779|156344761|FG001|Overall Study|Death|1|||
48587800|NCT00427999|156344763|FG000|Overall Study|Adverse Event|6|||
48587801|NCT00427999|156344763|FG000|Overall Study|Abnormal laboratory values|1|||
48587802|NCT00427999|156344763|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
48587803|NCT00427999|156344763|FG000|Overall Study|Protocol Violation|2|||
48587804|NCT00427999|156344763|FG000|Overall Study|Withdrawal by Subject|9|||
48587805|NCT00427999|156344763|FG000|Overall Study|Death|1|||
48587806|NCT01658904|156344768|FG000|Overall Study|Principal Investigator discretion|2|||
48587807|NCT01658904|156344769|FG001|Overall Study|Principal Investigator discretion|0|||
48587808|NCT01658904|156344770|FG002|Overall Study|Principal Investigator discretion|0|||
48587809|NCT02147067|156344775|FG000|Overall Study|Withdrawal by Subject|2|||
48587810|NCT02147067|156344776|FG001|Overall Study|Withdrawal by Subject|2|||
48587811|NCT00195494|156344779|FG000|Year 1|Adverse Event|0|||
48587812|NCT00195494|156344780|FG001|Year 1|Adverse Event|0|||
48587813|NCT00195494|156344781|FG002|Year 1|Adverse Event|0|||
48587814|NCT00195494|156344782|FG003|Year 1|Adverse Event|0|||
48587815|NCT00195494|156344783|FG004|Year 1|Adverse Event|34|||
48587816|NCT00195494|156344784|FG005|Year 1|Adverse Event|27|||
48587817|NCT00195494|156344779|FG000|Year 1|System Toxicity|0|||
48587818|NCT00195494|156344780|FG001|Year 1|System Toxicity|0|||
48587819|NCT00195494|156344781|FG002|Year 1|System Toxicity|0|||
48587820|NCT00195494|156344782|FG003|Year 1|System Toxicity|0|||
48587821|NCT00195494|156344783|FG004|Year 1|System Toxicity|0|||
48587822|NCT00195494|156344784|FG005|Year 1|System Toxicity|1|||
48587823|NCT00195494|156344779|FG000|Year 1|Lack of Efficacy|0|||
48587824|NCT00195494|156344780|FG001|Year 1|Lack of Efficacy|0|||
48587825|NCT00195494|156344781|FG002|Year 1|Lack of Efficacy|0|||
48587826|NCT00195494|156344782|FG003|Year 1|Lack of Efficacy|0|||
48587827|NCT00195494|156344783|FG004|Year 1|Lack of Efficacy|24|||
48587828|NCT00195494|156344784|FG005|Year 1|Lack of Efficacy|9|||
48587829|NCT00195494|156344779|FG000|Year 1|Compliance|0|||
48587830|NCT00195494|156344780|FG001|Year 1|Compliance|0|||
48587831|NCT00195494|156344781|FG002|Year 1|Compliance|0|||
48587832|NCT00195494|156344782|FG003|Year 1|Compliance|0|||
48587833|NCT00195494|156344783|FG004|Year 1|Compliance|5|||
48587834|NCT00195494|156344784|FG005|Year 1|Compliance|1|||
48587835|NCT00195494|156344779|FG000|Year 1|Lost to Follow-up|0|||
48587836|NCT00195494|156344780|FG001|Year 1|Lost to Follow-up|0|||
48587837|NCT00195494|156344781|FG002|Year 1|Lost to Follow-up|0|||
48587838|NCT00195494|156344782|FG003|Year 1|Lost to Follow-up|0|||
48587839|NCT00195494|156344783|FG004|Year 1|Lost to Follow-up|1|||
48587840|NCT00195494|156344784|FG005|Year 1|Lost to Follow-up|0|||
48587841|NCT00195494|156344779|FG000|Year 1|Missed >4 consecutive doses|0|||
48587842|NCT00195494|156344780|FG001|Year 1|Missed >4 consecutive doses|0|||
48587843|NCT00195494|156344781|FG002|Year 1|Missed >4 consecutive doses|0|||
48587844|NCT00195494|156344782|FG003|Year 1|Missed >4 consecutive doses|0|||
48587845|NCT00195494|156344783|FG004|Year 1|Missed >4 consecutive doses|3|||
48587846|NCT00195494|156344784|FG005|Year 1|Missed >4 consecutive doses|2|||
48587847|NCT00195494|156344779|FG000|Year 1|Protocol deviation|0|||
48587848|NCT00195494|156344780|FG001|Year 1|Protocol deviation|0|||
48587849|NCT00195494|156344781|FG002|Year 1|Protocol deviation|0|||
48587850|NCT00195494|156344782|FG003|Year 1|Protocol deviation|0|||
48587851|NCT00195494|156344783|FG004|Year 1|Protocol deviation|2|||
48587852|NCT00195494|156344784|FG005|Year 1|Protocol deviation|3|||
48587853|NCT00195494|156344779|FG000|Year 1|Physician Decision|0|||
48587854|NCT00195494|156344780|FG001|Year 1|Physician Decision|0|||
48587855|NCT00195494|156344781|FG002|Year 1|Physician Decision|0|||
48587856|NCT00195494|156344782|FG003|Year 1|Physician Decision|0|||
48587857|NCT00195494|156344783|FG004|Year 1|Physician Decision|1|||
48587858|NCT00195494|156344784|FG005|Year 1|Physician Decision|0|||
48587859|NCT00195494|156344779|FG000|Year 1|Withdrawal by Subject|0|||
48587860|NCT00195494|156344780|FG001|Year 1|Withdrawal by Subject|0|||
48587861|NCT00195494|156344781|FG002|Year 1|Withdrawal by Subject|0|||
48587862|NCT00195494|156344782|FG003|Year 1|Withdrawal by Subject|0|||
48587863|NCT00195494|156344783|FG004|Year 1|Withdrawal by Subject|8|||
48587864|NCT00195494|156344784|FG005|Year 1|Withdrawal by Subject|9|||
48587865|NCT00195494|156344779|FG000|Year 1|Protocol Violation|0|||
48587866|NCT00195494|156344780|FG001|Year 1|Protocol Violation|0|||
48587867|NCT00195494|156344781|FG002|Year 1|Protocol Violation|0|||
48587868|NCT00195494|156344782|FG003|Year 1|Protocol Violation|0|||
48587869|NCT00195494|156344783|FG004|Year 1|Protocol Violation|1|||
48587870|NCT00195494|156344784|FG005|Year 1|Protocol Violation|1|||
48587871|NCT00195494|156344779|FG000|Year 2|Adverse Event|3|||
48587872|NCT00195494|156344780|FG001|Year 2|Adverse Event|7|||
48587873|NCT00195494|156344781|FG002|Year 2|Adverse Event|5|||
48587874|NCT00195494|156344782|FG003|Year 2|Adverse Event|9|||
48587875|NCT00195494|156344783|FG004|Year 2|Adverse Event|0|||
48587876|NCT00195494|156344784|FG005|Year 2|Adverse Event|0|||
48587877|NCT00195494|156344779|FG000|Year 2|Lack of Efficacy|0|||
48587878|NCT00195494|156344780|FG001|Year 2|Lack of Efficacy|1|||
48587879|NCT00195494|156344781|FG002|Year 2|Lack of Efficacy|7|||
48587880|NCT00195494|156344782|FG003|Year 2|Lack of Efficacy|7|||
48587881|NCT00195494|156344783|FG004|Year 2|Lack of Efficacy|0|||
48587882|NCT00195494|156344784|FG005|Year 2|Lack of Efficacy|0|||
48587883|NCT00195494|156344779|FG000|Year 2|Compliance|1|||
48587884|NCT00195494|156344780|FG001|Year 2|Compliance|0|||
48587885|NCT00195494|156344781|FG002|Year 2|Compliance|0|||
48587886|NCT00195494|156344782|FG003|Year 2|Compliance|2|||
48587887|NCT00195494|156344783|FG004|Year 2|Compliance|0|||
48587888|NCT00195494|156344784|FG005|Year 2|Compliance|0|||
48587889|NCT00195494|156344779|FG000|Year 2|Lost to Follow-up|0|||
48587890|NCT00195494|156344780|FG001|Year 2|Lost to Follow-up|0|||
48587891|NCT00195494|156344781|FG002|Year 2|Lost to Follow-up|1|||
48587892|NCT00195494|156344782|FG003|Year 2|Lost to Follow-up|1|||
48587893|NCT00195494|156344783|FG004|Year 2|Lost to Follow-up|0|||
48587894|NCT00195494|156344784|FG005|Year 2|Lost to Follow-up|0|||
48587895|NCT00195494|156344779|FG000|Year 2|Missed >4 consecutive doses|1|||
48587896|NCT00195494|156344780|FG001|Year 2|Missed >4 consecutive doses|1|||
48587897|NCT00195494|156344781|FG002|Year 2|Missed >4 consecutive doses|1|||
48587898|NCT00195494|156344782|FG003|Year 2|Missed >4 consecutive doses|0|||
48587899|NCT00195494|156344783|FG004|Year 2|Missed >4 consecutive doses|0|||
48587900|NCT00195494|156344784|FG005|Year 2|Missed >4 consecutive doses|0|||
48587901|NCT00195494|156344779|FG000|Year 2|Protocol deviation|0|||
48587902|NCT00195494|156344780|FG001|Year 2|Protocol deviation|1|||
48587903|NCT00195494|156344781|FG002|Year 2|Protocol deviation|0|||
48587904|NCT00195494|156344782|FG003|Year 2|Protocol deviation|0|||
48587905|NCT00195494|156344783|FG004|Year 2|Protocol deviation|0|||
48587906|NCT00195494|156344784|FG005|Year 2|Protocol deviation|0|||
48587907|NCT00195494|156344779|FG000|Year 2|Physician Decision|1|||
48587908|NCT00195494|156344780|FG001|Year 2|Physician Decision|1|||
48587909|NCT00195494|156344781|FG002|Year 2|Physician Decision|0|||
48587910|NCT00195494|156344782|FG003|Year 2|Physician Decision|0|||
48587911|NCT00195494|156344783|FG004|Year 2|Physician Decision|0|||
48587912|NCT00195494|156344784|FG005|Year 2|Physician Decision|0|||
48587913|NCT00195494|156344779|FG000|Year 2|Withdrawal by Subject|1|||
48587914|NCT00195494|156344780|FG001|Year 2|Withdrawal by Subject|5|||
48587915|NCT00195494|156344781|FG002|Year 2|Withdrawal by Subject|4|||
48587916|NCT00195494|156344782|FG003|Year 2|Withdrawal by Subject|3|||
48587917|NCT00195494|156344783|FG004|Year 2|Withdrawal by Subject|0|||
48587918|NCT00195494|156344784|FG005|Year 2|Withdrawal by Subject|0|||
48587919|NCT00195494|156344779|FG000|Year 2|System toxicity|0|||
48587920|NCT00195494|156344780|FG001|Year 2|System toxicity|0|||
48587921|NCT00195494|156344781|FG002|Year 2|System toxicity|0|||
48587922|NCT00195494|156344782|FG003|Year 2|System toxicity|1|||
48587923|NCT00195494|156344783|FG004|Year 2|System toxicity|0|||
48587924|NCT00195494|156344784|FG005|Year 2|System toxicity|0|||
48587925|NCT02137226|156344785|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
48587926|NCT02137226|156344786|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
48587927|NCT02137226|156344787|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
48587928|NCT02137226|156344788|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
48587929|NCT02137226|156344789|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
48587930|NCT02137226|156344785|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
48587931|NCT02137226|156344786|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
48587932|NCT02137226|156344787|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
48587933|NCT02137226|156344788|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
48587934|NCT02137226|156344789|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
48587935|NCT02137226|156344785|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
48587936|NCT02137226|156344786|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
48587937|NCT02137226|156344787|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
48587938|NCT02137226|156344788|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
48587939|NCT02137226|156344789|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
48587940|NCT02137226|156344785|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
48587941|NCT02137226|156344786|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
48587942|NCT02137226|156344787|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
48587943|NCT02137226|156344788|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
48587944|NCT02137226|156344789|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
48587945|NCT02137226|156344785|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
48587946|NCT02137226|156344786|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
48587947|NCT02137226|156344787|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
48587948|NCT02137226|156344788|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
48587949|NCT02137226|156344789|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
48587950|NCT02137226|156344785|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
48587951|NCT02137226|156344786|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
48587952|NCT02137226|156344787|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
48587953|NCT02137226|156344788|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
48587954|NCT02137226|156344789|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
48587955|NCT02137226|156344785|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
48587956|NCT02137226|156344786|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
48587957|NCT02137226|156344787|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
48587958|NCT02137226|156344788|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
48587959|NCT02137226|156344789|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
48587960|NCT02137226|156344785|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
48587961|NCT02137226|156344786|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
48587962|NCT02137226|156344787|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
48587963|NCT02137226|156344788|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
48587964|NCT02137226|156344789|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
48587965|NCT02137226|156344785|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
48587966|NCT02137226|156344786|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
48587967|NCT02137226|156344787|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
48587968|NCT02137226|156344788|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
48588044|NCT01210352|156344819|FG002|Overall Study|Lack of Efficacy|0|||
48587969|NCT02137226|156344789|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
48587970|NCT02137226|156344785|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
48587971|NCT02137226|156344786|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
48587972|NCT02137226|156344787|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
48587973|NCT02137226|156344788|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
48587974|NCT02137226|156344789|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
48587975|NCT02137226|156344785|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
48587976|NCT02137226|156344786|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
48587977|NCT02137226|156344787|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
48587978|NCT02137226|156344788|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
48587979|NCT02137226|156344789|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
48587980|NCT02137226|156344785|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
48587981|NCT02137226|156344786|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
48587982|NCT02137226|156344787|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
48587983|NCT02137226|156344788|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
48587984|NCT02137226|156344789|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
48587985|NCT05119569|156344790|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
48587986|NCT05119569|156344791|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
48587987|NCT05119569|156344792|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
48587988|NCT05119569|156344793|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
48587989|NCT05119569|156344790|FG000|Double Blind Treatment Phase|Adverse Event|6|||
48587990|NCT05119569|156344791|FG001|Double Blind Treatment Phase|Adverse Event|0|||
48587991|NCT05119569|156344792|FG002|Double Blind Treatment Phase|Adverse Event|0|||
48587992|NCT05119569|156344793|FG003|Double Blind Treatment Phase|Adverse Event|0|||
48587993|NCT05119569|156344790|FG000|Open Label Extension Phase|Ongoing in the study|0|||
48587994|NCT05119569|156344791|FG001|Open Label Extension Phase|Ongoing in the study|0|||
48587995|NCT05119569|156344792|FG002|Open Label Extension Phase|Ongoing in the study|65|||
48587996|NCT05119569|156344793|FG003|Open Label Extension Phase|Ongoing in the study|34|||
48587997|NCT03913104|156344794|FG000|Overall Study|Lost to Follow-up|20|||
48587998|NCT03913104|156344794|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
48587999|NCT03913104|156344794|FG000|Overall Study|Withdrawal by Subject|2|||
48588000|NCT01074255|156344795|FG000|Overall Study|Did not receive EMEND|2|||
48588001|NCT01380691|156344800|FG000|Washout (7 Days)|Protocol Violation|0|||
48588002|NCT01380691|156344801|FG001|Washout (7 Days)|Protocol Violation|0|||
48588003|NCT01380691|156344802|FG002|Washout (7 Days)|Protocol Violation|0|||
48588004|NCT01380691|156344803|FG003|Washout (7 Days)|Protocol Violation|1|||
48588005|NCT01380691|156344800|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
48588006|NCT01380691|156344801|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
48588007|NCT01380691|156344802|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
48588008|NCT01380691|156344803|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
48588009|NCT00463840|156344805|FG000|Overall Study|Disease progression|7|||
48588010|NCT00463840|156344805|FG000|Overall Study|Withdrawal by Subject|2|||
48588011|NCT00463840|156344805|FG000|Overall Study|Adverse Event|3|||
48588012|NCT00524173|156344807|FG000|Overall Study|Lost to Follow-up|0|||
48588013|NCT00524173|156344808|FG001|Overall Study|Lost to Follow-up|1|||
48588014|NCT00524173|156344807|FG000|Overall Study|Death|1|||
48588015|NCT00524173|156344808|FG001|Overall Study|Death|0|||
48588016|NCT00524173|156344807|FG000|Overall Study|Had not reached endpoint at study close|4|||
48588017|NCT00524173|156344808|FG001|Overall Study|Had not reached endpoint at study close|1|||
48588018|NCT02634710|156344809|FG000|Overall Study|Death|4|||
48588019|NCT01180049|156344810|FG000|Overall Study|Other|9|||
48588020|NCT01180049|156344811|FG001|Overall Study|Other|7|||
48588021|NCT01180049|156344810|FG000|Overall Study|Lost to Follow-up|8|||
48588022|NCT01180049|156344811|FG001|Overall Study|Lost to Follow-up|6|||
48588023|NCT01180049|156344810|FG000|Overall Study|Death|36|||
48588024|NCT01180049|156344811|FG001|Overall Study|Death|35|||
48588025|NCT02971800|156344812|FG000|Overall Study|Protocol Violation|1|||
48588026|NCT02971800|156344812|FG000|Overall Study|Withdrawal by Subject|1|||
48588027|NCT02971800|156344812|FG000|Overall Study|Exclusion criteria prior intervention|1|||
48588028|NCT02971800|156344812|FG000|Overall Study|Number evaluable participant already reached|4|||
48588029|NCT02380859|156344813|FG000|Overall Study|Withdrawal by Subject|2|||
48588030|NCT02380859|156344814|FG001|Overall Study|Withdrawal by Subject|0|||
48588031|NCT01764659|156344815|FG000|Overall Study|Death|1|||
48588032|NCT01764659|156344815|FG000|Overall Study|Physician Decision|1|||
48588033|NCT01210352|156344817|FG000|Overall Study|Adverse Event|0|||
48588034|NCT01210352|156344818|FG001|Overall Study|Adverse Event|0|||
48588035|NCT01210352|156344819|FG002|Overall Study|Adverse Event|0|||
48588036|NCT01210352|156344820|FG003|Overall Study|Adverse Event|0|||
48588037|NCT01210352|156344821|FG004|Overall Study|Adverse Event|0|||
48588038|NCT01210352|156344822|FG005|Overall Study|Adverse Event|0|||
48588039|NCT01210352|156344823|FG006|Overall Study|Adverse Event|0|||
48588040|NCT01210352|156344824|FG007|Overall Study|Adverse Event|2|||
48588041|NCT01210352|156344825|FG008|Overall Study|Adverse Event|1|||
48588042|NCT01210352|156344817|FG000|Overall Study|Lack of Efficacy|0|||
48588043|NCT01210352|156344818|FG001|Overall Study|Lack of Efficacy|0|||
48588063|NCT01210352|156344820|FG003|Overall Study|Withdrawal by Subject|0|||
48588064|NCT01210352|156344821|FG004|Overall Study|Withdrawal by Subject|0|||
48588065|NCT01210352|156344822|FG005|Overall Study|Withdrawal by Subject|0|||
48588066|NCT01210352|156344823|FG006|Overall Study|Withdrawal by Subject|1|||
48588067|NCT01210352|156344824|FG007|Overall Study|Withdrawal by Subject|0|||
48588068|NCT01210352|156344825|FG008|Overall Study|Withdrawal by Subject|1|||
48588069|NCT01210352|156344817|FG000|Overall Study|Patient Discharged Early|0|||
48588070|NCT01210352|156344818|FG001|Overall Study|Patient Discharged Early|0|||
48588071|NCT01210352|156344819|FG002|Overall Study|Patient Discharged Early|1|||
48588072|NCT01210352|156344820|FG003|Overall Study|Patient Discharged Early|0|||
48588073|NCT01210352|156344821|FG004|Overall Study|Patient Discharged Early|0|||
48588074|NCT01210352|156344822|FG005|Overall Study|Patient Discharged Early|0|||
48588075|NCT01210352|156344823|FG006|Overall Study|Patient Discharged Early|0|||
48588076|NCT01210352|156344824|FG007|Overall Study|Patient Discharged Early|0|||
48588077|NCT01210352|156344825|FG008|Overall Study|Patient Discharged Early|0|||
48588078|NCT02552888|156344828|FG000|Overall Study|Lost to Follow-up|1|||
48588079|NCT02552888|156344829|FG001|Overall Study|Lost to Follow-up|1|||
48588080|NCT00422292|156344834|FG000|Overall Study|Serious adverse events|1|||
48588081|NCT00422292|156344835|FG001|Overall Study|Serious adverse events|4|||
48588082|NCT00422292|156344836|FG002|Overall Study|Serious adverse events|0|||
48588083|NCT00422292|156344837|FG003|Overall Study|Serious adverse events|0|||
48588084|NCT00422292|156344834|FG000|Overall Study|Adverse Event|1|||
48588085|NCT00422292|156344835|FG001|Overall Study|Adverse Event|0|||
48588086|NCT00422292|156344836|FG002|Overall Study|Adverse Event|1|||
48588087|NCT00422292|156344837|FG003|Overall Study|Adverse Event|0|||
48588088|NCT00422292|156344834|FG000|Overall Study|Protocol Violation|4|||
48588089|NCT00422292|156344835|FG001|Overall Study|Protocol Violation|25|||
48588090|NCT00422292|156344836|FG002|Overall Study|Protocol Violation|8|||
48588091|NCT00422292|156344837|FG003|Overall Study|Protocol Violation|5|||
48588092|NCT00422292|156344834|FG000|Overall Study|Lost to Follow-up|6|||
48588093|NCT00422292|156344835|FG001|Overall Study|Lost to Follow-up|12|||
48588094|NCT00422292|156344836|FG002|Overall Study|Lost to Follow-up|6|||
48588095|NCT00422292|156344837|FG003|Overall Study|Lost to Follow-up|6|||
48588096|NCT00422292|156344834|FG000|Overall Study|Withdrawal by Subject|6|||
48588097|NCT00422292|156344835|FG001|Overall Study|Withdrawal by Subject|25|||
48588098|NCT00422292|156344836|FG002|Overall Study|Withdrawal by Subject|7|||
48588099|NCT00422292|156344837|FG003|Overall Study|Withdrawal by Subject|13|||
48588100|NCT03597139|156344838|FG000|Overall Study|Adverse Event|3|||
48588101|NCT03597139|156344839|FG001|Overall Study|Adverse Event|0|||
48588102|NCT03597139|156344838|FG000|Overall Study|Protocol Non-compliance|1|||
48588103|NCT03597139|156344839|FG001|Overall Study|Protocol Non-compliance|0|||
48588104|NCT01249833|156344842|FG000|Overall Study|Lost to Follow-up|0|||
48588105|NCT01249833|156344843|FG001|Overall Study|Lost to Follow-up|1|||
48588106|NCT00723697|156344847|FG000|Overall Study|Physician questionnaires not received|2|||
48588107|NCT00723697|156344847|FG000|Overall Study|Missing Informed Consent Form|10|||
48588108|NCT00723697|156344847|FG000|Overall Study|Other exclusion criteria applied|6|||
48588109|NCT01250171|156347535|FG000|Overall Study|Administrative reasons|1|||
48588110|NCT01250171|156347536|FG001|Overall Study|Administrative reasons|0|||
48588111|NCT01250171|156347537|FG002|Overall Study|Administrative reasons|0|||
48588112|NCT01038752|156347538|FG000|Overall Study|Tumor Progression|2|||
48588113|NCT01038752|156347539|FG001|Overall Study|Tumor Progression|2|||
48588114|NCT01038752|156347538|FG000|Overall Study|Lost to Follow-up|3|||
48588115|NCT01038752|156347539|FG001|Overall Study|Lost to Follow-up|3|||
48588116|NCT00422422|156347543|FG000|Overall Study|Lack of Efficacy|1|||
48588117|NCT00422422|156347543|FG000|Overall Study|Protocol Violation|1|||
48588118|NCT00422422|156347543|FG000|Overall Study|Withdrawal by Subject|2|||
48588119|NCT00422422|156347543|FG000|Overall Study|SAE, non-fatal|1|||
48588120|NCT00422422|156347543|FG000|Overall Study|AE, non-serious non-fatal|5|||
48588121|NCT00089635|156347544|FG000|Overall Study|Adverse Event|2|||
48588122|NCT00089635|156347544|FG000|Overall Study|Death|17|||
48588123|NCT00089635|156347544|FG000|Overall Study|Disease Progression|12|||
48588124|NCT00089635|156347544|FG000|Overall Study|Lost to Follow-up|3|||
48588125|NCT00089635|156347544|FG000|Overall Study|Withdrawal by Subject|6|||
48588126|NCT00089635|156347544|FG000|Overall Study|Ineligibility determined|1|||
48588127|NCT00089635|156347544|FG000|Overall Study|Other|2|||
48588128|NCT01389258|156347545|FG000|Overall Study|Lost to Follow-up|5|||
48588129|NCT02603107|156347547|FG000|Randomized Phase|Withdrew consent|8|||
48588130|NCT02603107|156347548|FG001|Randomized Phase|Withdrew consent|15|||
48588131|NCT02603107|156347547|FG000|Randomized Phase|Lost to Follow-up|1|||
48588132|NCT02603107|156347548|FG001|Randomized Phase|Lost to Follow-up|3|||
48588133|NCT02603107|156347547|FG000|Randomized Phase|Adverse Event|2|||
48588134|NCT02603107|156347548|FG001|Randomized Phase|Adverse Event|0|||
48588135|NCT02603107|156347547|FG000|Randomized Phase|Death|1|||
48588136|NCT02603107|156347548|FG001|Randomized Phase|Death|1|||
48588137|NCT02603107|156347547|FG000|Randomized Phase|Non-compliance with study drug|1|||
48588138|NCT02603107|156347548|FG001|Randomized Phase|Non-compliance with study drug|1|||
48588139|NCT02603107|156347547|FG000|Randomized Phase|Investigator's discretion|0|||
48588140|NCT02603107|156347548|FG001|Randomized Phase|Investigator's discretion|1|||
48588193|NCT04769739|156347584|FG000|Overall Study|Colorectal cancer obstruction|2|||
48588194|NCT04769739|156347585|FG001|Overall Study|Colorectal cancer obstruction|0|||
48588195|NCT04769739|156347586|FG002|Overall Study|Colorectal cancer obstruction|0|||
48588196|NCT04769739|156347587|FG003|Overall Study|Colorectal cancer obstruction|0|||
48588197|NCT04769739|156347584|FG000|Overall Study|Failed cecal intubation|1|||
48588198|NCT04769739|156347585|FG001|Overall Study|Failed cecal intubation|0|||
48588199|NCT04769739|156347586|FG002|Overall Study|Failed cecal intubation|0|||
48588200|NCT04769739|156347587|FG003|Overall Study|Failed cecal intubation|1|||
48588201|NCT04769739|156347584|FG000|Overall Study|Poor bowel preparation|0|||
48588202|NCT04769739|156347585|FG001|Overall Study|Poor bowel preparation|0|||
48588203|NCT04769739|156347586|FG002|Overall Study|Poor bowel preparation|0|||
48588204|NCT04769739|156347587|FG003|Overall Study|Poor bowel preparation|1|||
48588205|NCT01447719|156347590|FG000|Overall Study|Image acquisition failure|2|||
48588206|NCT01447719|156347590|FG000|Overall Study|Invalid image or not imaged|3|||
48588207|NCT01447719|156347590|FG000|Overall Study|Subject still living at end of study|79|||
48588208|NCT01447719|156347590|FG000|Overall Study|Withdrawal by Subject|2|||
48588209|NCT01447719|156347590|FG000|Overall Study|Family withdrew autopsy consent|7|||
48588210|NCT00492232|156347593|FG000|Placebo Run-in|Adverse Event|0|||
48588211|NCT00492232|156347594|FG001|Placebo Run-in|Adverse Event|2|||
48588212|NCT00492232|156347593|FG000|Placebo Run-in|Protocol Violation|0|||
48588213|NCT00492232|156347594|FG001|Placebo Run-in|Protocol Violation|3|||
48588214|NCT00492232|156347593|FG000|Placebo Run-in|Lost to Follow-up|0|||
48588215|NCT00492232|156347594|FG001|Placebo Run-in|Lost to Follow-up|3|||
48588216|NCT00492232|156347593|FG000|Placebo Run-in|Withdrawal by Subject|0|||
48588217|NCT00492232|156347594|FG001|Placebo Run-in|Withdrawal by Subject|8|||
48588218|NCT00492232|156347593|FG000|Placebo Run-in|Pregnancy|0|||
48588219|NCT00492232|156347594|FG001|Placebo Run-in|Pregnancy|1|||
48588220|NCT00492232|156347593|FG000|Placebo Run-in|Entrance criteria not met|0|||
48588221|NCT00492232|156347594|FG001|Placebo Run-in|Entrance criteria not met|45|||
48588222|NCT00492232|156347593|FG000|Placebo Run-in|Other|0|||
48588223|NCT00492232|156347594|FG001|Placebo Run-in|Other|6|||
48588224|NCT00492232|156347593|FG000|Placebo Run-in|Missing|0|||
48588225|NCT00492232|156347594|FG001|Placebo Run-in|Missing|2|||
48588226|NCT00492232|156347593|FG000|Double-Blind Treatment|Adverse Event|1|||
48588227|NCT00492232|156347594|FG001|Double-Blind Treatment|Adverse Event|2|||
48588228|NCT00492232|156347593|FG000|Double-Blind Treatment|Protocol Violation|3|||
48588229|NCT00492232|156347594|FG001|Double-Blind Treatment|Protocol Violation|7|||
48588230|NCT00492232|156347593|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
48588231|NCT00492232|156347594|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
48588232|NCT00492232|156347593|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
48588233|NCT00492232|156347594|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
48588234|NCT00492232|156347593|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
48588235|NCT00492232|156347594|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
48588236|NCT00492232|156347593|FG000|Double-Blind Treatment|Other|6|||
48588237|NCT00492232|156347594|FG001|Double-Blind Treatment|Other|5|||
48588238|NCT00492232|156347593|FG000|Double-Blind Treatment|Randomized not treated|1|||
48588239|NCT00492232|156347594|FG001|Double-Blind Treatment|Randomized not treated|0|||
48588240|NCT00492232|156347593|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
48588241|NCT00492232|156347594|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
48588242|NCT00282152|156347595|FG000|Overall Study|Withdrawal by Subject|1|||
48588243|NCT00282152|156347596|FG001|Overall Study|Withdrawal by Subject|0|||
48588244|NCT02536781|156347597|FG000|Overall Study|Lost to Follow-up|2|||
48588245|NCT02536781|156347598|FG001|Overall Study|Lost to Follow-up|0|||
48588246|NCT03423147|156347603|FG000|Overall Study|Lost to Follow-up|5|||
48588247|NCT03423147|156347604|FG001|Overall Study|Lost to Follow-up|8|||
48588248|NCT03423147|156347603|FG000|Overall Study|Withdrawal by Subject|1|||
48588249|NCT03423147|156347604|FG001|Overall Study|Withdrawal by Subject|0|||
48588250|NCT03423147|156347603|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
48588251|NCT03423147|156347604|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
48588252|NCT03423147|156347603|FG000|Overall Study|Age < 18|1|||
48588253|NCT03423147|156347604|FG001|Overall Study|Age < 18|0|||
48588254|NCT03423147|156347603|FG000|Overall Study|No Trial of Labor|0|||
48588255|NCT03423147|156347604|FG001|Overall Study|No Trial of Labor|1|||
48588256|NCT03084315|156347605|FG000|Overall Study|Lost to Follow-up|8|||
48588257|NCT03084315|156347606|FG001|Overall Study|Lost to Follow-up|7|||
48588258|NCT03084315|156347605|FG000|Overall Study|Withdrawal by Subject|2|||
48588259|NCT03084315|156347606|FG001|Overall Study|Withdrawal by Subject|2|||
48588260|NCT00586898|156347607|FG000|Overall Study|Adverse Event|1|||
48588261|NCT00586898|156347607|FG000|Overall Study|Patiemt Non-compliance|1|||
48588262|NCT00586898|156347607|FG000|Overall Study|Evaluable for Toxicity Only|5|||
48588263|NCT00628927|156347608|FG000|Overall Study|Problems performing blood draw|6|||
48588264|NCT00628927|156347609|FG001|Overall Study|Problems performing blood draw|0|||
48588265|NCT00628927|156347608|FG000|Overall Study|Lost to Follow-up|1|||
48588266|NCT00628927|156347609|FG001|Overall Study|Lost to Follow-up|0|||
48588267|NCT00628927|156347608|FG000|Overall Study|Equipment failure|1|||
48588268|NCT00628927|156347609|FG001|Overall Study|Equipment failure|0|||
48588269|NCT01738191|156347610|FG000|Overall Study|Withdrawal by Subject|4|||
48588270|NCT01738191|156347611|FG001|Overall Study|Withdrawal by Subject|1|||
48588271|NCT01627782|156347612|FG000|Overall Study|Adverse Event|1|||
48588272|NCT01627782|156347613|FG001|Overall Study|Adverse Event|2|||
48588273|NCT01627782|156347614|FG002|Overall Study|Adverse Event|0|||
48588274|NCT01627782|156347615|FG003|Overall Study|Adverse Event|1|||
48588275|NCT01627782|156347612|FG000|Overall Study|Lack of Efficacy|11|||
48588276|NCT01627782|156347613|FG001|Overall Study|Lack of Efficacy|1|||
48588277|NCT01627782|156347614|FG002|Overall Study|Lack of Efficacy|15|||
48588278|NCT01627782|156347615|FG003|Overall Study|Lack of Efficacy|2|||
48588279|NCT01627782|156347612|FG000|Overall Study|Protocol Violation|1|||
48588280|NCT01627782|156347613|FG001|Overall Study|Protocol Violation|0|||
48588281|NCT01627782|156347614|FG002|Overall Study|Protocol Violation|0|||
48588282|NCT01627782|156347615|FG003|Overall Study|Protocol Violation|0|||
48588283|NCT01627782|156347612|FG000|Overall Study|Withdrawal by Subject|2|||
48588284|NCT01627782|156347613|FG001|Overall Study|Withdrawal by Subject|1|||
48588285|NCT01627782|156347614|FG002|Overall Study|Withdrawal by Subject|0|||
48588286|NCT01627782|156347615|FG003|Overall Study|Withdrawal by Subject|0|||
48588287|NCT01627782|156347612|FG000|Overall Study|Other|0|||
48588288|NCT01627782|156347613|FG001|Overall Study|Other|2|||
48588289|NCT01627782|156347614|FG002|Overall Study|Other|0|||
48588290|NCT01627782|156347615|FG003|Overall Study|Other|3|||
48588291|NCT01627782|156347612|FG000|Overall Study|Randomized But Not Treated|1|||
48588292|NCT01627782|156347613|FG001|Overall Study|Randomized But Not Treated|0|||
48588293|NCT01627782|156347614|FG002|Overall Study|Randomized But Not Treated|0|||
48588294|NCT01627782|156347615|FG003|Overall Study|Randomized But Not Treated|0|||
48588295|NCT02243046|156347616|FG000|Overall Study|Lost to Follow-up|1|||
48588296|NCT02243046|156347617|FG001|Overall Study|Lost to Follow-up|1|||
48588297|NCT02243046|156347618|FG002|Overall Study|Lost to Follow-up|4|||
48588298|NCT02483572|156347619|FG000|Overall Study|Withdrawal by Subject|1|||
48588299|NCT02483572|156347620|FG001|Overall Study|Withdrawal by Subject|0|||
48588300|NCT02483572|156347619|FG000|Overall Study|Lost to Follow-up|1|||
48588301|NCT02483572|156347620|FG001|Overall Study|Lost to Follow-up|0|||
48588302|NCT02483572|156347619|FG000|Overall Study|Physician Decision|0|||
48588303|NCT02483572|156347620|FG001|Overall Study|Physician Decision|1|||
48588304|NCT00520767|156347621|FG000|Overall Study|Death|2|||
48588305|NCT02669667|156347625|FG000|Overall Study|Lost to Follow-up|0|||
48588306|NCT02669667|156347626|FG001|Overall Study|Lost to Follow-up|0|||
48588307|NCT02669667|156347627|FG002|Overall Study|Lost to Follow-up|0|||
48588308|NCT02669667|156347628|FG003|Overall Study|Lost to Follow-up|0|||
48588309|NCT02669667|156347629|FG004|Overall Study|Lost to Follow-up|0|||
48588310|NCT02669667|156347630|FG005|Overall Study|Lost to Follow-up|1|||
48588311|NCT02669667|156347631|FG006|Overall Study|Lost to Follow-up|0|||
48588312|NCT03338569|156347632|FG000|Overall Study|Physician Decision|8|||
48588313|NCT03338569|156347633|FG001|Overall Study|Physician Decision|3|||
48588314|NCT03338569|156347632|FG000|Overall Study|Withdrawal by Subject|0|||
48588315|NCT03338569|156347633|FG001|Overall Study|Withdrawal by Subject|1|||
48588316|NCT03338569|156347632|FG000|Overall Study|Lost to Follow-up|0|||
48588317|NCT03338569|156347633|FG001|Overall Study|Lost to Follow-up|1|||
48588318|NCT04811664|156347634|FG000|Overall Study|Lost to Follow-up|78|||
48588319|NCT04811664|156347635|FG001|Overall Study|Lost to Follow-up|125|||
48588320|NCT04811664|156347636|FG002|Overall Study|Lost to Follow-up|46|||
48588321|NCT04811664|156347634|FG000|Overall Study|Withdrawal by Subject|39|||
48588322|NCT04811664|156347635|FG001|Overall Study|Withdrawal by Subject|76|||
48588323|NCT04811664|156347636|FG002|Overall Study|Withdrawal by Subject|12|||
48588324|NCT04811664|156347634|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
48588325|NCT04811664|156347635|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
48588326|NCT04811664|156347636|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
48588327|NCT04811664|156347634|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
48588328|NCT04811664|156347635|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
48588329|NCT04811664|156347636|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
48588330|NCT04811664|156347634|FG000|Overall Study|Protocol Violation|0|||
48588331|NCT04811664|156347635|FG001|Overall Study|Protocol Violation|5|||
48588332|NCT04811664|156347636|FG002|Overall Study|Protocol Violation|11|||
48588333|NCT04811664|156347634|FG000|Overall Study|Study Terminated by Sponsor|4|||
48588334|NCT04811664|156347635|FG001|Overall Study|Study Terminated by Sponsor|3|||
48588335|NCT04811664|156347636|FG002|Overall Study|Study Terminated by Sponsor|34|||
48588336|NCT04811664|156347634|FG000|Overall Study|Early Study Closure|3|||
48588337|NCT04811664|156347635|FG001|Overall Study|Early Study Closure|7|||
48588338|NCT04811664|156347636|FG002|Overall Study|Early Study Closure|79|||
48588339|NCT04811664|156347634|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
48588340|NCT04811664|156347635|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
48588341|NCT04811664|156347636|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
48588342|NCT02717442|156347637|FG000|Overall Study|Study Terminated by Sponsor|31|||
48588343|NCT02717442|156347638|FG001|Overall Study|Study Terminated by Sponsor|29|||
48588344|NCT02717442|156347637|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
48588345|NCT02717442|156347638|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
48588346|NCT02717442|156347637|FG000|Overall Study|Other - Not Specified|2|||
48588347|NCT02717442|156347638|FG001|Overall Study|Other - Not Specified|0|||
48588348|NCT00382109|156347643|FG000|Overall Study|Adverse Event|3|||
48588349|NCT00382109|156347644|FG001|Overall Study|Adverse Event|0|||
48588350|NCT00382109|156347643|FG000|Overall Study|Physician Decision|6|||
48588351|NCT00382109|156347644|FG001|Overall Study|Physician Decision|1|||
48588352|NCT00382109|156347643|FG000|Overall Study|Withdrawal by Subject|1|||
48588353|NCT00382109|156347644|FG001|Overall Study|Withdrawal by Subject|0|||
48588354|NCT00382109|156347643|FG000|Overall Study|ineligible|2|||
48588355|NCT00382109|156347644|FG001|Overall Study|ineligible|0|||
48588356|NCT00382109|156347643|FG000|Overall Study|Other|0|||
48588357|NCT00382109|156347644|FG001|Overall Study|Other|2|||
48588358|NCT00382109|156347643|FG000|Overall Study|consent withdrawal|0|||
48588359|NCT00382109|156347644|FG001|Overall Study|consent withdrawal|1|||
48588360|NCT05052697|156347645|FG000|Substudy A|Lost to Follow-up|0|||
48588361|NCT05052697|156347646|FG001|Substudy A|Lost to Follow-up|0|||
48588362|NCT05052697|156347647|FG002|Substudy A|Lost to Follow-up|0|||
48588363|NCT05052697|156347648|FG003|Substudy A|Lost to Follow-up|0|||
48588364|NCT05052697|156347649|FG004|Substudy A|Lost to Follow-up|0|||
48588365|NCT05052697|156347650|FG005|Substudy A|Lost to Follow-up|1|||
48588366|NCT05052697|156347651|FG006|Substudy A|Lost to Follow-up|0|||
48588367|NCT05052697|156347652|FG007|Substudy A|Lost to Follow-up|0|||
48588368|NCT05052697|156347653|FG008|Substudy A|Lost to Follow-up|0|||
48588369|NCT05052697|156347654|FG009|Substudy A|Lost to Follow-up|0|||
48588370|NCT05052697|156347655|FG010|Substudy A|Lost to Follow-up|0|||
48588371|NCT05052697|156347656|FG011|Substudy A|Lost to Follow-up|0|||
48588372|NCT05052697|156347657|FG012|Substudy A|Lost to Follow-up|0|||
48588373|NCT05052697|156347658|FG013|Substudy A|Lost to Follow-up|0|||
48588374|NCT05052697|156347659|FG014|Substudy A|Lost to Follow-up|0|||
48588375|NCT05052697|156347660|FG015|Substudy A|Lost to Follow-up|2|||
48588376|NCT05052697|156347661|FG016|Substudy A|Lost to Follow-up|0|||
48588377|NCT05052697|156347662|FG017|Substudy A|Lost to Follow-up|0|||
48588378|NCT05052697|156347663|FG018|Substudy A|Lost to Follow-up|0|||
48588379|NCT05052697|156347664|FG019|Substudy A|Lost to Follow-up|0|||
48588380|NCT05052697|156347665|FG020|Substudy A|Lost to Follow-up|0|||
48588381|NCT05052697|156347666|FG021|Substudy A|Lost to Follow-up|0|||
48588382|NCT05052697|156347667|FG022|Substudy A|Lost to Follow-up|0|||
48588383|NCT05052697|156347668|FG023|Substudy A|Lost to Follow-up|0|||
48588384|NCT05052697|156347669|FG024|Substudy A|Lost to Follow-up|0|||
48588385|NCT05052697|156347670|FG025|Substudy A|Lost to Follow-up|0|||
48588386|NCT05052697|156347671|FG026|Substudy A|Lost to Follow-up|0|||
48588387|NCT05052697|156347672|FG027|Substudy A|Lost to Follow-up|0|||
48588388|NCT05052697|156347673|FG028|Substudy A|Lost to Follow-up|0|||
48588389|NCT05052697|156347674|FG029|Substudy A|Lost to Follow-up|0|||
48588390|NCT05052697|156347675|FG030|Substudy A|Lost to Follow-up|0|||
48588391|NCT05052697|156347676|FG031|Substudy A|Lost to Follow-up|0|||
48588392|NCT05052697|156347677|FG032|Substudy A|Lost to Follow-up|0|||
48588393|NCT05052697|156347678|FG033|Substudy A|Lost to Follow-up|0|||
48588394|NCT05052697|156347645|FG000|Substudy A|No longer met eligibility criteria|0|||
48588395|NCT05052697|156347646|FG001|Substudy A|No longer met eligibility criteria|0|||
48588396|NCT05052697|156347647|FG002|Substudy A|No longer met eligibility criteria|0|||
48588397|NCT05052697|156347648|FG003|Substudy A|No longer met eligibility criteria|0|||
48588398|NCT05052697|156347649|FG004|Substudy A|No longer met eligibility criteria|0|||
48588399|NCT05052697|156347650|FG005|Substudy A|No longer met eligibility criteria|0|||
48588400|NCT05052697|156347651|FG006|Substudy A|No longer met eligibility criteria|0|||
48588401|NCT05052697|156347652|FG007|Substudy A|No longer met eligibility criteria|0|||
48588402|NCT05052697|156347653|FG008|Substudy A|No longer met eligibility criteria|0|||
48588403|NCT05052697|156347654|FG009|Substudy A|No longer met eligibility criteria|0|||
48588404|NCT05052697|156347655|FG010|Substudy A|No longer met eligibility criteria|0|||
48588405|NCT05052697|156347656|FG011|Substudy A|No longer met eligibility criteria|0|||
48588406|NCT05052697|156347657|FG012|Substudy A|No longer met eligibility criteria|0|||
48588407|NCT05052697|156347658|FG013|Substudy A|No longer met eligibility criteria|1|||
48588408|NCT05052697|156347659|FG014|Substudy A|No longer met eligibility criteria|0|||
48588409|NCT05052697|156347660|FG015|Substudy A|No longer met eligibility criteria|0|||
48588410|NCT05052697|156347661|FG016|Substudy A|No longer met eligibility criteria|0|||
48588411|NCT05052697|156347662|FG017|Substudy A|No longer met eligibility criteria|0|||
48588412|NCT05052697|156347663|FG018|Substudy A|No longer met eligibility criteria|0|||
48588413|NCT05052697|156347664|FG019|Substudy A|No longer met eligibility criteria|0|||
48588414|NCT05052697|156347665|FG020|Substudy A|No longer met eligibility criteria|0|||
48588415|NCT05052697|156347666|FG021|Substudy A|No longer met eligibility criteria|0|||
48588416|NCT05052697|156347667|FG022|Substudy A|No longer met eligibility criteria|0|||
48588417|NCT05052697|156347668|FG023|Substudy A|No longer met eligibility criteria|0|||
48588418|NCT05052697|156347669|FG024|Substudy A|No longer met eligibility criteria|0|||
48588419|NCT05052697|156347670|FG025|Substudy A|No longer met eligibility criteria|0|||
48588420|NCT05052697|156347671|FG026|Substudy A|No longer met eligibility criteria|0|||
48588421|NCT05052697|156347672|FG027|Substudy A|No longer met eligibility criteria|0|||
48588422|NCT05052697|156347673|FG028|Substudy A|No longer met eligibility criteria|0|||
48588423|NCT05052697|156347674|FG029|Substudy A|No longer met eligibility criteria|0|||
48588424|NCT05052697|156347675|FG030|Substudy A|No longer met eligibility criteria|0|||
48588425|NCT05052697|156347676|FG031|Substudy A|No longer met eligibility criteria|0|||
48588426|NCT05052697|156347677|FG032|Substudy A|No longer met eligibility criteria|0|||
48588427|NCT05052697|156347678|FG033|Substudy A|No longer met eligibility criteria|0|||
48588428|NCT05052697|156347645|FG000|Substudy A|Not vaccinated|0|||
48588429|NCT05052697|156347646|FG001|Substudy A|Not vaccinated|0|||
48588430|NCT05052697|156347647|FG002|Substudy A|Not vaccinated|0|||
48588431|NCT05052697|156347648|FG003|Substudy A|Not vaccinated|1|||
48588432|NCT05052697|156347649|FG004|Substudy A|Not vaccinated|0|||
48588433|NCT05052697|156347650|FG005|Substudy A|Not vaccinated|0|||
48588434|NCT05052697|156347651|FG006|Substudy A|Not vaccinated|0|||
48588435|NCT05052697|156347652|FG007|Substudy A|Not vaccinated|0|||
48588436|NCT05052697|156347653|FG008|Substudy A|Not vaccinated|1|||
48588437|NCT05052697|156347654|FG009|Substudy A|Not vaccinated|0|||
48588438|NCT05052697|156347655|FG010|Substudy A|Not vaccinated|0|||
48588439|NCT05052697|156347656|FG011|Substudy A|Not vaccinated|0|||
48588440|NCT05052697|156347657|FG012|Substudy A|Not vaccinated|0|||
48588441|NCT05052697|156347658|FG013|Substudy A|Not vaccinated|0|||
48588442|NCT05052697|156347659|FG014|Substudy A|Not vaccinated|0|||
48588443|NCT05052697|156347660|FG015|Substudy A|Not vaccinated|0|||
48588444|NCT05052697|156347661|FG016|Substudy A|Not vaccinated|0|||
48588445|NCT05052697|156347662|FG017|Substudy A|Not vaccinated|0|||
48588446|NCT05052697|156347663|FG018|Substudy A|Not vaccinated|0|||
48588447|NCT05052697|156347664|FG019|Substudy A|Not vaccinated|0|||
48588448|NCT05052697|156347665|FG020|Substudy A|Not vaccinated|0|||
48588449|NCT05052697|156347666|FG021|Substudy A|Not vaccinated|0|||
48588450|NCT05052697|156347667|FG022|Substudy A|Not vaccinated|0|||
48588451|NCT05052697|156347668|FG023|Substudy A|Not vaccinated|0|||
48588452|NCT05052697|156347669|FG024|Substudy A|Not vaccinated|0|||
48588453|NCT05052697|156347670|FG025|Substudy A|Not vaccinated|0|||
48588454|NCT05052697|156347671|FG026|Substudy A|Not vaccinated|0|||
48588455|NCT05052697|156347672|FG027|Substudy A|Not vaccinated|0|||
48588456|NCT05052697|156347673|FG028|Substudy A|Not vaccinated|0|||
48588457|NCT05052697|156347674|FG029|Substudy A|Not vaccinated|0|||
48588458|NCT05052697|156347675|FG030|Substudy A|Not vaccinated|0|||
48588459|NCT05052697|156347676|FG031|Substudy A|Not vaccinated|0|||
48588460|NCT05052697|156347677|FG032|Substudy A|Not vaccinated|0|||
48588461|NCT05052697|156347678|FG033|Substudy A|Not vaccinated|0|||
48588462|NCT05052697|156347645|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588463|NCT05052697|156347646|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588464|NCT05052697|156347647|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588465|NCT05052697|156347648|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588466|NCT05052697|156347649|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588467|NCT05052697|156347650|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588468|NCT05052697|156347651|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588469|NCT05052697|156347652|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588470|NCT05052697|156347653|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588471|NCT05052697|156347654|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588472|NCT05052697|156347655|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588473|NCT05052697|156347656|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588474|NCT05052697|156347657|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588475|NCT05052697|156347658|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588476|NCT05052697|156347659|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588477|NCT05052697|156347660|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588478|NCT05052697|156347661|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588479|NCT05052697|156347662|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588480|NCT05052697|156347663|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
48588481|NCT05052697|156347664|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
48588482|NCT05052697|156347665|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588483|NCT05052697|156347666|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
48588484|NCT05052697|156347667|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
48588485|NCT05052697|156347668|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588486|NCT05052697|156347669|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588487|NCT05052697|156347670|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588488|NCT05052697|156347671|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588489|NCT05052697|156347672|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588490|NCT05052697|156347673|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588491|NCT05052697|156347674|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588492|NCT05052697|156347675|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588493|NCT05052697|156347676|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588494|NCT05052697|156347677|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588495|NCT05052697|156347678|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
48588496|NCT05052697|156347645|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588497|NCT05052697|156347646|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588498|NCT05052697|156347647|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588499|NCT05052697|156347648|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588500|NCT05052697|156347649|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588501|NCT05052697|156347650|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588502|NCT05052697|156347651|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588503|NCT05052697|156347652|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588504|NCT05052697|156347653|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588505|NCT05052697|156347654|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588506|NCT05052697|156347655|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588507|NCT05052697|156347656|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588508|NCT05052697|156347657|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588509|NCT05052697|156347658|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588510|NCT05052697|156347659|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588511|NCT05052697|156347660|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588512|NCT05052697|156347661|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588513|NCT05052697|156347662|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
48588514|NCT05052697|156347663|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588515|NCT05052697|156347664|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588516|NCT05052697|156347665|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588517|NCT05052697|156347666|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588518|NCT05052697|156347667|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588519|NCT05052697|156347668|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588520|NCT05052697|156347669|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588521|NCT05052697|156347670|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588522|NCT05052697|156347671|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588523|NCT05052697|156347672|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588524|NCT05052697|156347673|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588525|NCT05052697|156347674|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588526|NCT05052697|156347675|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588527|NCT05052697|156347676|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588528|NCT05052697|156347677|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588529|NCT05052697|156347678|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
48588530|NCT05052697|156347645|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588531|NCT05052697|156347646|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588532|NCT05052697|156347647|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588533|NCT05052697|156347648|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588534|NCT05052697|156347649|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588535|NCT05052697|156347650|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588536|NCT05052697|156347651|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588537|NCT05052697|156347652|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588538|NCT05052697|156347653|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588539|NCT05052697|156347654|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588540|NCT05052697|156347655|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588541|NCT05052697|156347656|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588542|NCT05052697|156347657|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588543|NCT05052697|156347658|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588544|NCT05052697|156347659|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588545|NCT05052697|156347660|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588546|NCT05052697|156347661|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588547|NCT05052697|156347662|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588548|NCT05052697|156347663|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588549|NCT05052697|156347664|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
48588550|NCT05052697|156347665|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588551|NCT05052697|156347666|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588552|NCT05052697|156347667|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588553|NCT05052697|156347668|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588554|NCT05052697|156347669|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588555|NCT05052697|156347670|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588556|NCT05052697|156347671|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588557|NCT05052697|156347672|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588558|NCT05052697|156347673|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588559|NCT05052697|156347674|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588560|NCT05052697|156347675|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588561|NCT05052697|156347676|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588562|NCT05052697|156347677|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588563|NCT05052697|156347678|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
48588564|NCT05052697|156347645|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588565|NCT05052697|156347646|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588566|NCT05052697|156347647|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588567|NCT05052697|156347648|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588568|NCT05052697|156347649|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588569|NCT05052697|156347650|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588570|NCT05052697|156347651|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588571|NCT05052697|156347652|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588572|NCT05052697|156347653|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588573|NCT05052697|156347654|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588574|NCT05052697|156347655|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588575|NCT05052697|156347656|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588576|NCT05052697|156347657|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588577|NCT05052697|156347658|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588578|NCT05052697|156347659|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588579|NCT05052697|156347660|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588580|NCT05052697|156347661|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588581|NCT05052697|156347662|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
48588582|NCT05052697|156347663|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588583|NCT05052697|156347664|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588584|NCT05052697|156347665|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588585|NCT05052697|156347666|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588586|NCT05052697|156347667|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588587|NCT05052697|156347668|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588588|NCT05052697|156347669|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588589|NCT05052697|156347670|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
48588590|NCT05052697|156347671|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588591|NCT05052697|156347672|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
48588592|NCT05052697|156347673|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588593|NCT05052697|156347674|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588594|NCT05052697|156347675|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588595|NCT05052697|156347676|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588596|NCT05052697|156347677|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588597|NCT05052697|156347678|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
48588598|NCT05052697|156347645|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588599|NCT05052697|156347646|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588600|NCT05052697|156347647|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588601|NCT05052697|156347648|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588602|NCT05052697|156347649|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588603|NCT05052697|156347650|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588604|NCT05052697|156347651|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588605|NCT05052697|156347652|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588606|NCT05052697|156347653|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588607|NCT05052697|156347654|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588608|NCT05052697|156347655|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588609|NCT05052697|156347656|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588610|NCT05052697|156347657|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588611|NCT05052697|156347658|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588612|NCT05052697|156347659|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588613|NCT05052697|156347660|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588614|NCT05052697|156347661|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588615|NCT05052697|156347662|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588616|NCT05052697|156347663|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588617|NCT05052697|156347664|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588618|NCT05052697|156347665|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588619|NCT05052697|156347666|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588620|NCT05052697|156347667|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588621|NCT05052697|156347668|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588622|NCT05052697|156347669|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588623|NCT05052697|156347670|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588624|NCT05052697|156347671|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588625|NCT05052697|156347672|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588626|NCT05052697|156347673|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
48588627|NCT05052697|156347674|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588628|NCT05052697|156347675|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
48588629|NCT05052697|156347676|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
48588630|NCT05052697|156347677|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
48588631|NCT05052697|156347678|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
48588632|NCT05052697|156347645|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588633|NCT05052697|156347646|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588634|NCT05052697|156347647|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588635|NCT05052697|156347648|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588636|NCT05052697|156347649|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588637|NCT05052697|156347650|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588638|NCT05052697|156347651|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588639|NCT05052697|156347652|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588640|NCT05052697|156347653|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588641|NCT05052697|156347654|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588642|NCT05052697|156347655|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588643|NCT05052697|156347656|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588644|NCT05052697|156347657|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588645|NCT05052697|156347658|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588646|NCT05052697|156347659|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588647|NCT05052697|156347660|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588648|NCT05052697|156347661|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588649|NCT05052697|156347662|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588650|NCT05052697|156347663|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588651|NCT05052697|156347664|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588652|NCT05052697|156347665|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588653|NCT05052697|156347666|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588654|NCT05052697|156347667|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588655|NCT05052697|156347668|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588656|NCT05052697|156347669|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588657|NCT05052697|156347670|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588658|NCT05052697|156347671|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588659|NCT05052697|156347672|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588660|NCT05052697|156347673|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
48588661|NCT05052697|156347674|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
48588662|NCT05052697|156347675|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
48588663|NCT05052697|156347676|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
48588664|NCT05052697|156347677|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
48588665|NCT05052697|156347678|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
48588666|NCT05052697|156347645|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588667|NCT05052697|156347646|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588668|NCT05052697|156347647|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588669|NCT05052697|156347648|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588670|NCT05052697|156347649|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588671|NCT05052697|156347650|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588672|NCT05052697|156347651|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588673|NCT05052697|156347652|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588674|NCT05052697|156347653|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588675|NCT05052697|156347654|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588676|NCT05052697|156347655|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588677|NCT05052697|156347656|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588678|NCT05052697|156347657|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588679|NCT05052697|156347658|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588680|NCT05052697|156347659|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588681|NCT05052697|156347660|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588682|NCT05052697|156347661|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588683|NCT05052697|156347662|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588684|NCT05052697|156347663|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588685|NCT05052697|156347664|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588686|NCT05052697|156347665|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588687|NCT05052697|156347666|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588688|NCT05052697|156347667|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588689|NCT05052697|156347668|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588690|NCT05052697|156347669|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588691|NCT05052697|156347670|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588692|NCT05052697|156347671|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588693|NCT05052697|156347672|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588694|NCT05052697|156347673|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588695|NCT05052697|156347674|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588696|NCT05052697|156347675|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588697|NCT05052697|156347676|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588698|NCT05052697|156347677|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
48588699|NCT05052697|156347678|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
48588700|NCT05052697|156347645|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588701|NCT05052697|156347646|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588702|NCT05052697|156347647|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588703|NCT05052697|156347648|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588704|NCT05052697|156347649|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588705|NCT05052697|156347650|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588706|NCT05052697|156347651|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588707|NCT05052697|156347652|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588708|NCT05052697|156347653|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588709|NCT05052697|156347654|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588710|NCT05052697|156347655|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588711|NCT05052697|156347656|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588712|NCT05052697|156347657|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588713|NCT05052697|156347658|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588714|NCT05052697|156347659|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588715|NCT05052697|156347660|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588716|NCT05052697|156347661|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588717|NCT05052697|156347662|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588718|NCT05052697|156347663|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588719|NCT05052697|156347664|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588720|NCT05052697|156347665|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588721|NCT05052697|156347666|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588722|NCT05052697|156347667|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588723|NCT05052697|156347668|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588724|NCT05052697|156347669|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588725|NCT05052697|156347670|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588726|NCT05052697|156347671|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588727|NCT05052697|156347672|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588728|NCT05052697|156347673|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
48588729|NCT05052697|156347674|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
48588730|NCT05052697|156347675|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
48588731|NCT05052697|156347676|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588732|NCT05052697|156347677|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588733|NCT05052697|156347678|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
48588734|NCT02440854|156347679|FG000|Overall Study|Relocation of patient|1|||
48588735|NCT02440854|156347679|FG000|Overall Study|Death|6|||
48588736|NCT02440854|156347679|FG000|Overall Study|Lost to Follow-up|10|||
48588737|NCT02440854|156347679|FG000|Overall Study|Afatinib discontinuation|46|||
48588738|NCT02440854|156347679|FG000|Overall Study|stopped study at earlier timepoint|14|||
48588739|NCT02440854|156347679|FG000|Overall Study|Study medication not received|1|||
48588740|NCT02440854|156347679|FG000|Overall Study|Violation of inclusion criteria|2|||
48588741|NCT03796676|156347680|FG000|Overall Study|Adverse Event|2|||
48588742|NCT03796676|156347681|FG001|Overall Study|Adverse Event|1|||
48588743|NCT03796676|156347682|FG002|Overall Study|Adverse Event|2|||
48588744|NCT03796676|156347680|FG000|Overall Study|Lost to Follow-up|2|||
48588745|NCT03796676|156347681|FG001|Overall Study|Lost to Follow-up|1|||
48588746|NCT03796676|156347682|FG002|Overall Study|Lost to Follow-up|0|||
48588747|NCT03796676|156347680|FG000|Overall Study|Protocol Violation|0|||
48588748|NCT03796676|156347681|FG001|Overall Study|Protocol Violation|0|||
48588749|NCT03796676|156347682|FG002|Overall Study|Protocol Violation|1|||
48588750|NCT03796676|156347680|FG000|Overall Study|Withdrawal by Subject|1|||
48588751|NCT03796676|156347681|FG001|Overall Study|Withdrawal by Subject|1|||
48588752|NCT03796676|156347682|FG002|Overall Study|Withdrawal by Subject|0|||
48588753|NCT03796676|156347680|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
48588754|NCT03796676|156347681|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
48588755|NCT03796676|156347682|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
48588756|NCT04607980|156347683|FG000|Overall Study|Adverse Event|3|||
48588757|NCT04607980|156347684|FG001|Overall Study|Adverse Event|4|||
48588758|NCT04607980|156347683|FG000|Overall Study|Death|0|||
48588759|NCT04607980|156347684|FG001|Overall Study|Death|1|||
48588760|NCT04607980|156347683|FG000|Overall Study|Withdrawal by Subject|2|||
48588761|NCT04607980|156347684|FG001|Overall Study|Withdrawal by Subject|5|||
48588762|NCT04607980|156347683|FG000|Overall Study|Lost to Follow-up|4|||
48588763|NCT04607980|156347684|FG001|Overall Study|Lost to Follow-up|8|||
48588764|NCT04607980|156347683|FG000|Overall Study|Protocol Violation|0|||
48588765|NCT04607980|156347684|FG001|Overall Study|Protocol Violation|3|||
48588766|NCT04607980|156347683|FG000|Overall Study|Other|3|||
48588767|NCT04607980|156347684|FG001|Overall Study|Other|0|||
48588768|NCT00528372|156347686|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
48588769|NCT00528372|156347687|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
48588770|NCT00528372|156347688|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
48588771|NCT00528372|156347689|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
48588772|NCT00528372|156347690|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
48588773|NCT00528372|156347691|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
48588774|NCT00528372|156347692|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
48588775|NCT00528372|156347693|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
48693060|NCT01400698|156724658|FG000|Overall Study|Adverse Event|1|||
48588776|NCT00528372|156347694|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
48588777|NCT00528372|156347686|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
48588778|NCT00528372|156347687|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
48588779|NCT00528372|156347688|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
48588780|NCT00528372|156347689|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
48588781|NCT00528372|156347690|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
48588782|NCT00528372|156347691|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
48588783|NCT00528372|156347692|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
48588784|NCT00528372|156347693|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
48588785|NCT00528372|156347694|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
48588786|NCT00528372|156347686|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
48588787|NCT00528372|156347687|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
48588788|NCT00528372|156347688|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
48588789|NCT00528372|156347689|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
48588790|NCT00528372|156347690|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
48588791|NCT00528372|156347691|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
48588792|NCT00528372|156347692|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
48588793|NCT00528372|156347693|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
48588794|NCT00528372|156347694|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
48588795|NCT00528372|156347686|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
48588796|NCT00528372|156347687|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
48588797|NCT00528372|156347688|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
48588798|NCT00528372|156347689|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
48588799|NCT00528372|156347690|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
48588800|NCT00528372|156347691|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
48588801|NCT00528372|156347692|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
48588802|NCT00528372|156347693|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
48588803|NCT00528372|156347694|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
48588804|NCT00528372|156347686|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
48588805|NCT00528372|156347687|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
48588806|NCT00528372|156347688|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
48588807|NCT00528372|156347689|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
48588808|NCT00528372|156347690|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
48588809|NCT00528372|156347691|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
48588810|NCT00528372|156347692|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
48588811|NCT00528372|156347693|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
48588812|NCT00528372|156347694|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
48588813|NCT00528372|156347686|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
48588814|NCT00528372|156347687|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
48588815|NCT00528372|156347688|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
48588816|NCT00528372|156347689|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
48588817|NCT00528372|156347690|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
48588818|NCT00528372|156347691|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
48588819|NCT00528372|156347692|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
48588820|NCT00528372|156347693|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
48588821|NCT00528372|156347694|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
48588822|NCT00528372|156347686|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
48588823|NCT00528372|156347687|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
48588824|NCT00528372|156347688|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
48588825|NCT00528372|156347689|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
48588826|NCT00528372|156347690|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
48588827|NCT00528372|156347691|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
48588828|NCT00528372|156347692|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
48588829|NCT00528372|156347693|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
48588830|NCT00528372|156347694|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
48588831|NCT00528372|156347686|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
48588832|NCT00528372|156347687|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
48588833|NCT00528372|156347688|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
48588834|NCT00528372|156347689|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
48588835|NCT00528372|156347690|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
48588836|NCT00528372|156347691|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
48588837|NCT00528372|156347692|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
48588838|NCT00528372|156347693|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
48588839|NCT00528372|156347694|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
48588840|NCT00528372|156347686|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
48588841|NCT00528372|156347687|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
48588842|NCT00528372|156347688|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
48588843|NCT00528372|156347689|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
48588844|NCT00528372|156347690|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
48588845|NCT00528372|156347691|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
48588846|NCT00528372|156347692|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
48588847|NCT00528372|156347693|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
48588848|NCT00528372|156347694|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
48588849|NCT00528372|156347686|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
48588850|NCT00528372|156347687|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
48588851|NCT00528372|156347688|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
48588852|NCT00528372|156347689|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
48588853|NCT00528372|156347690|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
48588854|NCT00528372|156347691|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
48588855|NCT00528372|156347692|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
48588856|NCT00528372|156347693|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
48588857|NCT00528372|156347694|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
48588858|NCT00528372|156347686|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
48588859|NCT00528372|156347687|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
48588860|NCT00528372|156347688|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
48588861|NCT00528372|156347689|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
48588862|NCT00528372|156347690|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
48588863|NCT00528372|156347691|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
48588864|NCT00528372|156347692|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
48588865|NCT00528372|156347693|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
48588866|NCT00528372|156347694|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
48588867|NCT00528372|156347686|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
48588868|NCT00528372|156347687|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
48588869|NCT00528372|156347688|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
48588870|NCT00528372|156347689|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
48588871|NCT00528372|156347690|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
48588872|NCT00528372|156347691|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
48588873|NCT00528372|156347692|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
48588874|NCT00528372|156347693|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
48588875|NCT00528372|156347694|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
48588876|NCT00528372|156347686|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
48588877|NCT00528372|156347687|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
48588878|NCT00528372|156347688|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
48588879|NCT00528372|156347689|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
48588880|NCT00528372|156347690|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
48588881|NCT00528372|156347691|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
48588882|NCT00528372|156347692|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
48588883|NCT00528372|156347693|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
48588884|NCT00528372|156347694|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
48588885|NCT00528372|156347686|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
48588886|NCT00528372|156347687|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
48588887|NCT00528372|156347688|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
48588888|NCT00528372|156347689|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
48588889|NCT00528372|156347690|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
48588890|NCT00528372|156347691|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
48588891|NCT00528372|156347692|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
48588892|NCT00528372|156347693|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
48588893|NCT00528372|156347694|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
48588894|NCT00528372|156347686|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
48588895|NCT00528372|156347687|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
48588896|NCT00528372|156347688|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
48588897|NCT00528372|156347689|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
48588898|NCT00528372|156347690|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
48588899|NCT00528372|156347691|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
48588900|NCT00528372|156347692|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
48588901|NCT00528372|156347693|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
48693061|NCT01400698|156724659|FG001|Overall Study|Adverse Event|0|||
48588902|NCT00528372|156347694|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
48588903|NCT02756364|156347695|FG000|Overall Study|Site Terminated by Sponsor|24|||
48588904|NCT02756364|156347696|FG001|Overall Study|Site Terminated by Sponsor|30|||
48588905|NCT02756364|156347697|FG002|Overall Study|Site Terminated by Sponsor|21|||
48588906|NCT02756364|156347695|FG000|Overall Study|Death|20|||
48588907|NCT02756364|156347696|FG001|Overall Study|Death|15|||
48588908|NCT02756364|156347697|FG002|Overall Study|Death|18|||
48588909|NCT02756364|156347695|FG000|Overall Study|Withdrawal by Patient|2|||
48588910|NCT02756364|156347696|FG001|Overall Study|Withdrawal by Patient|1|||
48588911|NCT02756364|156347697|FG002|Overall Study|Withdrawal by Patient|8|||
48588912|NCT02756364|156347695|FG000|Overall Study|Lost to Follow-up|0|||
48588913|NCT02756364|156347696|FG001|Overall Study|Lost to Follow-up|1|||
48588914|NCT02756364|156347697|FG002|Overall Study|Lost to Follow-up|1|||
48588915|NCT00248833|156347698|FG000|Overall Study|Adverse Event|2|||
48588916|NCT00248833|156347699|FG001|Overall Study|Adverse Event|0|||
48588917|NCT00248833|156347700|FG002|Overall Study|Adverse Event|0|||
48588918|NCT00248833|156347698|FG000|Overall Study|Withdrawal by Subject|0|||
48588919|NCT00248833|156347699|FG001|Overall Study|Withdrawal by Subject|1|||
48588920|NCT00248833|156347700|FG002|Overall Study|Withdrawal by Subject|1|||
48588921|NCT00248833|156347698|FG000|Overall Study|Lost to Follow-up|1|||
48588922|NCT00248833|156347699|FG001|Overall Study|Lost to Follow-up|1|||
48588923|NCT00248833|156347700|FG002|Overall Study|Lost to Follow-up|1|||
48588924|NCT00248833|156347698|FG000|Overall Study|Other|0|||
48588925|NCT00248833|156347699|FG001|Overall Study|Other|1|||
48588926|NCT00248833|156347700|FG002|Overall Study|Other|0|||
48588927|NCT02772809|156347703|FG000|Overall Study|not completed some tasks|6|||
48588928|NCT00534105|156347704|FG000|Overall Study|Lost to Follow-up|23|||
48588929|NCT00534105|156347705|FG001|Overall Study|Lost to Follow-up|39|||
48588930|NCT01289574|156347707|FG000|Overall Study|Lack of Efficacy|4|||
48588931|NCT01289574|156347708|FG001|Overall Study|Lack of Efficacy|0|||
48588932|NCT01289574|156347709|FG002|Overall Study|Lack of Efficacy|1|||
48588933|NCT01289574|156347707|FG000|Overall Study|Lost to Follow-up|2|||
48588934|NCT01289574|156347708|FG001|Overall Study|Lost to Follow-up|0|||
48588935|NCT01289574|156347709|FG002|Overall Study|Lost to Follow-up|1|||
48588936|NCT01289574|156347707|FG000|Overall Study|Withdrawal by Subject|1|||
48588937|NCT01289574|156347708|FG001|Overall Study|Withdrawal by Subject|1|||
48588938|NCT01289574|156347709|FG002|Overall Study|Withdrawal by Subject|1|||
48588939|NCT01289574|156347707|FG000|Overall Study|Adverse Event|0|||
48588940|NCT01289574|156347708|FG001|Overall Study|Adverse Event|1|||
48588941|NCT01289574|156347709|FG002|Overall Study|Adverse Event|0|||
48588942|NCT01289574|156347707|FG000|Overall Study|Subject wanted alternate treatment|0|||
48588943|NCT01289574|156347708|FG001|Overall Study|Subject wanted alternate treatment|1|||
48588944|NCT01289574|156347709|FG002|Overall Study|Subject wanted alternate treatment|0|||
48588945|NCT01603394|156347710|FG000|Overall Study|Adverse Event|1|||
48588946|NCT03275389|156347711|FG000|Overall Study|Lost to Follow-up|10|||
48588947|NCT03275389|156347712|FG001|Overall Study|Lost to Follow-up|10|||
48588948|NCT03275389|156347713|FG002|Overall Study|Lost to Follow-up|19|||
48588949|NCT03275389|156347714|FG003|Overall Study|Lost to Follow-up|12|||
48588950|NCT03275389|156347715|FG004|Overall Study|Lost to Follow-up|11|||
48588951|NCT03275389|156347716|FG005|Overall Study|Lost to Follow-up|12|||
48588952|NCT03275389|156347717|FG006|Overall Study|Lost to Follow-up|21|||
48588953|NCT03275389|156347718|FG007|Overall Study|Lost to Follow-up|15|||
48588954|NCT03275389|156347719|FG008|Overall Study|Lost to Follow-up|12|||
48588955|NCT03275389|156347720|FG009|Overall Study|Lost to Follow-up|14|||
48588956|NCT03275389|156347711|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
48588957|NCT03275389|156347712|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
48588958|NCT03275389|156347713|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
48588959|NCT03275389|156347714|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
48588960|NCT03275389|156347715|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
48588961|NCT03275389|156347716|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
48588962|NCT03275389|156347717|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
48588963|NCT03275389|156347718|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
48588964|NCT03275389|156347719|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
48588965|NCT03275389|156347720|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
48588966|NCT03275389|156347711|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
48588967|NCT03275389|156347712|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48588968|NCT03275389|156347713|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
48588969|NCT03275389|156347714|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
48588970|NCT03275389|156347715|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
48588971|NCT03275389|156347716|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
48588972|NCT03275389|156347717|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
48588973|NCT03275389|156347718|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
48588974|NCT03275389|156347719|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
48588975|NCT03275389|156347720|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
48588976|NCT03275389|156347711|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48588977|NCT03275389|156347712|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
48588978|NCT03275389|156347713|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48588979|NCT03275389|156347714|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
48588980|NCT03275389|156347715|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48588981|NCT03275389|156347716|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48588982|NCT03275389|156347717|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
48588983|NCT03275389|156347718|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48588984|NCT03275389|156347719|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48588985|NCT03275389|156347720|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
48588986|NCT03275389|156347711|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48588987|NCT03275389|156347712|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48588988|NCT03275389|156347713|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
48588989|NCT03275389|156347714|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48588990|NCT03275389|156347715|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48588991|NCT03275389|156347716|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48588992|NCT03275389|156347717|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48588993|NCT03275389|156347718|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48588994|NCT03275389|156347719|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
48588995|NCT03275389|156347720|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
48588996|NCT03275389|156347711|FG000|Overall Study|Other|0|||
48588997|NCT03275389|156347712|FG001|Overall Study|Other|4|||
48588998|NCT03275389|156347713|FG002|Overall Study|Other|3|||
48588999|NCT03275389|156347714|FG003|Overall Study|Other|2|||
48589000|NCT03275389|156347715|FG004|Overall Study|Other|2|||
48589001|NCT03275389|156347716|FG005|Overall Study|Other|2|||
48589002|NCT03275389|156347717|FG006|Overall Study|Other|0|||
48589003|NCT03275389|156347718|FG007|Overall Study|Other|0|||
48589004|NCT03275389|156347719|FG008|Overall Study|Other|1|||
48589005|NCT03275389|156347720|FG009|Overall Study|Other|0|||
48589006|NCT02432144|156347723|FG000|Overall Study|Participant Non-Compliance|1|||
48589007|NCT02494401|156347725|FG000|Overall Study|Lost to Follow-up|22|||
48589008|NCT02494401|156347726|FG001|Overall Study|Lost to Follow-up|25|||
48589009|NCT02494401|156347725|FG000|Overall Study|Withdrawal by Subject|3|||
48589010|NCT02494401|156347726|FG001|Overall Study|Withdrawal by Subject|2|||
48589011|NCT02452554|156347729|FG000|Overall Study|Death|2|||
48589012|NCT02452554|156347730|FG001|Overall Study|Death|1|||
48589013|NCT02452554|156347731|FG002|Overall Study|Death|0|||
48589014|NCT02452554|156347732|FG003|Overall Study|Death|0|||
48589015|NCT02452554|156347733|FG004|Overall Study|Death|0|||
48589016|NCT02452554|156347734|FG005|Overall Study|Death|0|||
48589017|NCT02452554|156347729|FG000|Overall Study|Lack of Efficacy|13|||
48589018|NCT02452554|156347730|FG001|Overall Study|Lack of Efficacy|14|||
48589019|NCT02452554|156347731|FG002|Overall Study|Lack of Efficacy|9|||
48589020|NCT02452554|156347732|FG003|Overall Study|Lack of Efficacy|1|||
48589021|NCT02452554|156347733|FG004|Overall Study|Lack of Efficacy|5|||
48589022|NCT02452554|156347734|FG005|Overall Study|Lack of Efficacy|8|||
48589023|NCT02452554|156347729|FG000|Overall Study|Physician Decision|0|||
48589024|NCT02452554|156347730|FG001|Overall Study|Physician Decision|1|||
48589025|NCT02452554|156347731|FG002|Overall Study|Physician Decision|0|||
48589026|NCT02452554|156347732|FG003|Overall Study|Physician Decision|0|||
48589027|NCT02452554|156347733|FG004|Overall Study|Physician Decision|0|||
48589028|NCT02452554|156347734|FG005|Overall Study|Physician Decision|0|||
48589029|NCT02452554|156347729|FG000|Overall Study|Withdrawal by Subject|1|||
48589030|NCT02452554|156347730|FG001|Overall Study|Withdrawal by Subject|0|||
48589031|NCT02452554|156347731|FG002|Overall Study|Withdrawal by Subject|2|||
48589032|NCT02452554|156347732|FG003|Overall Study|Withdrawal by Subject|0|||
48589033|NCT02452554|156347733|FG004|Overall Study|Withdrawal by Subject|0|||
48589034|NCT02452554|156347734|FG005|Overall Study|Withdrawal by Subject|1|||
48589035|NCT02452554|156347729|FG000|Overall Study|Ineligible|0|||
48589036|NCT02452554|156347730|FG001|Overall Study|Ineligible|1|||
48589037|NCT02452554|156347731|FG002|Overall Study|Ineligible|0|||
48589038|NCT02452554|156347732|FG003|Overall Study|Ineligible|0|||
48589039|NCT02452554|156347733|FG004|Overall Study|Ineligible|0|||
48589040|NCT02452554|156347734|FG005|Overall Study|Ineligible|0|||
48589041|NCT02452554|156347729|FG000|Overall Study|Never Received Treatment|1|||
48589042|NCT02452554|156347730|FG001|Overall Study|Never Received Treatment|0|||
48589043|NCT02452554|156347731|FG002|Overall Study|Never Received Treatment|0|||
48589044|NCT02452554|156347732|FG003|Overall Study|Never Received Treatment|0|||
48589045|NCT02452554|156347733|FG004|Overall Study|Never Received Treatment|0|||
48589046|NCT02452554|156347734|FG005|Overall Study|Never Received Treatment|0|||
48589047|NCT02109445|156347735|FG000|Overall Study|Symptomatic deterioration|2|||
48589048|NCT02109445|156347735|FG000|Overall Study|Adverse Event|1|||
48692821|NCT03040141|156724614|FG000|Overall Study|Withdrawal by Subject|3|||
48692822|NCT03040141|156724615|FG001|Overall Study|Withdrawal by Subject|1|||
48692823|NCT03040141|156724616|FG002|Overall Study|Withdrawal by Subject|1|||
48692824|NCT03040141|156724614|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
48692825|NCT03040141|156724615|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
48692826|NCT03040141|156724616|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
48692827|NCT03040141|156724614|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
48692828|NCT03040141|156724615|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
48692829|NCT03040141|156724616|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
48692830|NCT03473236|156724617|FG000|Overall Study|Withdrawal by Subject|0|||
48692831|NCT03473236|156724618|FG001|Overall Study|Withdrawal by Subject|0|||
48692832|NCT03473236|156724619|FG002|Overall Study|Withdrawal by Subject|0|||
48692833|NCT03473236|156724620|FG003|Overall Study|Withdrawal by Subject|0|||
48692834|NCT03473236|156724621|FG004|Overall Study|Withdrawal by Subject|0|||
48692835|NCT03473236|156724622|FG005|Overall Study|Withdrawal by Subject|1|||
48692836|NCT03473236|156724623|FG006|Overall Study|Withdrawal by Subject|0|||
48692837|NCT03473236|156724624|FG007|Overall Study|Withdrawal by Subject|0|||
48692838|NCT03473236|156724625|FG008|Overall Study|Withdrawal by Subject|1|||
48692839|NCT03473236|156724626|FG009|Overall Study|Withdrawal by Subject|0|||
48692840|NCT03289208|156724628|FG000|Overall Study|Adverse Event|1|||
48692841|NCT03289208|156724629|FG001|Overall Study|Adverse Event|0|||
48692842|NCT03289208|156724630|FG002|Overall Study|Adverse Event|0|||
48692843|NCT00510835|156724631|FG000|Overall Study|Withdrawal by Subject|6|||
48692844|NCT00510835|156724632|FG001|Overall Study|Withdrawal by Subject|2|||
48692845|NCT00510835|156724633|FG002|Overall Study|Withdrawal by Subject|2|||
48692846|NCT03353675|156724638|FG000|Overall Study|Adverse Event|4|||
48692847|NCT00604565|156724639|FG000|Overall Study|Study terminated|0|||
48692848|NCT00604565|156724640|FG001|Overall Study|Study terminated|3|||
48692849|NCT00395746|156724641|FG000|Overall Study|Adverse Event|5|||
48692850|NCT00395746|156724642|FG001|Overall Study|Adverse Event|2|||
48692851|NCT00395746|156724643|FG002|Overall Study|Adverse Event|2|||
48692852|NCT00395746|156724641|FG000|Overall Study|Protocol Violation|0|||
48692853|NCT00395746|156724642|FG001|Overall Study|Protocol Violation|1|||
48692854|NCT00395746|156724643|FG002|Overall Study|Protocol Violation|0|||
48692855|NCT00395746|156724641|FG000|Overall Study|Lack of Efficacy|2|||
48692856|NCT00395746|156724642|FG001|Overall Study|Lack of Efficacy|0|||
48692857|NCT00395746|156724643|FG002|Overall Study|Lack of Efficacy|17|||
48692858|NCT00395746|156724641|FG000|Overall Study|Hypoglycaemia|2|||
48692859|NCT00395746|156724642|FG001|Overall Study|Hypoglycaemia|1|||
48692860|NCT00395746|156724643|FG002|Overall Study|Hypoglycaemia|0|||
48692861|NCT00395746|156724641|FG000|Overall Study|Subject decision|0|||
48692862|NCT00395746|156724642|FG001|Overall Study|Subject decision|0|||
48692863|NCT00395746|156724643|FG002|Overall Study|Subject decision|1|||
48692864|NCT00395746|156724641|FG000|Overall Study|Withdrawal of consent|0|||
48692865|NCT00395746|156724642|FG001|Overall Study|Withdrawal of consent|0|||
48692866|NCT00395746|156724643|FG002|Overall Study|Withdrawal of consent|1|||
48692867|NCT00395746|156724641|FG000|Overall Study|Difficultulty in use of device|0|||
48692868|NCT00395746|156724642|FG001|Overall Study|Difficultulty in use of device|0|||
48692869|NCT00395746|156724643|FG002|Overall Study|Difficultulty in use of device|1|||
48692870|NCT00395746|156724641|FG000|Overall Study|Unable to visit site on schedule|1|||
48692871|NCT00395746|156724642|FG001|Overall Study|Unable to visit site on schedule|0|||
48692872|NCT00395746|156724643|FG002|Overall Study|Unable to visit site on schedule|0|||
48692873|NCT01300234|156724644|FG000|Overall Study|Adverse Event|1|||
48692874|NCT01300234|156724645|FG001|Overall Study|Adverse Event|1|||
48692875|NCT01300234|156724644|FG000|Overall Study|Protocol Violation|2|||
48692876|NCT01300234|156724645|FG001|Overall Study|Protocol Violation|3|||
48692877|NCT01300234|156724644|FG000|Overall Study|Withdrawal by Subject|5|||
48692878|NCT01300234|156724645|FG001|Overall Study|Withdrawal by Subject|9|||
48692879|NCT01300234|156724644|FG000|Overall Study|Lost to Follow-up|14|||
48692880|NCT01300234|156724645|FG001|Overall Study|Lost to Follow-up|12|||
48692881|NCT01300234|156724644|FG000|Overall Study|Pregnancy|2|||
48692882|NCT01300234|156724645|FG001|Overall Study|Pregnancy|1|||
48692883|NCT01300234|156724644|FG000|Overall Study|Participant reached stopping critera|2|||
48692884|NCT01300234|156724645|FG001|Overall Study|Participant reached stopping critera|0|||
48692885|NCT01300234|156724644|FG000|Overall Study|Participant stopped medication|1|||
48692886|NCT01300234|156724645|FG001|Overall Study|Participant stopped medication|1|||
48692887|NCT01300234|156724644|FG000|Overall Study|Participant refused return to hospital|1|||
48692888|NCT01300234|156724645|FG001|Overall Study|Participant refused return to hospital|0|||
48692889|NCT03137992|156724646|FG000|Washout Period 1|Adverse Event|1|||
48692890|NCT03137992|156724647|FG001|Washout Period 1|Adverse Event|1|||
48692891|NCT03137992|156724648|FG002|Washout Period 1|Adverse Event|0|||
48692892|NCT03137992|156724649|FG003|Washout Period 1|Adverse Event|0|||
48692893|NCT03137992|156724650|FG004|Washout Period 1|Adverse Event|0|||
48692894|NCT03137992|156724651|FG005|Washout Period 1|Adverse Event|1|||
48692895|NCT03137992|156724646|FG000|Washout Period 1|Withdrawal by Subject|0|||
48692896|NCT03137992|156724647|FG001|Washout Period 1|Withdrawal by Subject|1|||
48692897|NCT03137992|156724648|FG002|Washout Period 1|Withdrawal by Subject|1|||
48692898|NCT03137992|156724649|FG003|Washout Period 1|Withdrawal by Subject|0|||
48692899|NCT03137992|156724650|FG004|Washout Period 1|Withdrawal by Subject|0|||
48692900|NCT03137992|156724651|FG005|Washout Period 1|Withdrawal by Subject|0|||
48692911|NCT03137992|156724650|FG004|Washout Period 1|COPD Exacerbation|1|||
48692912|NCT03137992|156724651|FG005|Washout Period 1|COPD Exacerbation|1|||
48692913|NCT03137992|156724646|FG000|Washout Period 1|Subject Noncompliance|1|||
48692914|NCT03137992|156724647|FG001|Washout Period 1|Subject Noncompliance|0|||
48692915|NCT03137992|156724648|FG002|Washout Period 1|Subject Noncompliance|0|||
48692916|NCT03137992|156724649|FG003|Washout Period 1|Subject Noncompliance|0|||
48692917|NCT03137992|156724650|FG004|Washout Period 1|Subject Noncompliance|1|||
48692918|NCT03137992|156724651|FG005|Washout Period 1|Subject Noncompliance|0|||
48692919|NCT03137992|156724646|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
48692920|NCT03137992|156724647|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
48692921|NCT03137992|156724648|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
48692922|NCT03137992|156724649|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
48692923|NCT03137992|156724650|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
48692924|NCT03137992|156724651|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
48692925|NCT03137992|156724646|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
48692926|NCT03137992|156724647|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
48692927|NCT03137992|156724648|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
48692928|NCT03137992|156724649|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
48692929|NCT03137992|156724650|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
48692930|NCT03137992|156724651|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
48692931|NCT03137992|156724646|FG000|Period 2 (Visit 3)|Adverse Event|0|||
48692932|NCT03137992|156724647|FG001|Period 2 (Visit 3)|Adverse Event|1|||
48692933|NCT03137992|156724648|FG002|Period 2 (Visit 3)|Adverse Event|0|||
48692934|NCT03137992|156724649|FG003|Period 2 (Visit 3)|Adverse Event|0|||
48692935|NCT03137992|156724650|FG004|Period 2 (Visit 3)|Adverse Event|0|||
48692936|NCT03137992|156724651|FG005|Period 2 (Visit 3)|Adverse Event|0|||
48692937|NCT03137992|156724646|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692938|NCT03137992|156724647|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692939|NCT03137992|156724648|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692940|NCT03137992|156724649|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
48692941|NCT03137992|156724650|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692942|NCT03137992|156724651|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
48692943|NCT03137992|156724646|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
48692944|NCT03137992|156724647|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
48692945|NCT03137992|156724648|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
48692946|NCT03137992|156724649|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
48692947|NCT03137992|156724650|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
48692948|NCT03137992|156724651|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
48692949|NCT03137992|156724646|FG000|Washout Period 2|COPD Exacerbation|1|||
48692950|NCT03137992|156724647|FG001|Washout Period 2|COPD Exacerbation|1|||
48692951|NCT03137992|156724648|FG002|Washout Period 2|COPD Exacerbation|0|||
48692952|NCT03137992|156724649|FG003|Washout Period 2|COPD Exacerbation|0|||
48692953|NCT03137992|156724650|FG004|Washout Period 2|COPD Exacerbation|1|||
48692954|NCT03137992|156724651|FG005|Washout Period 2|COPD Exacerbation|0|||
48692955|NCT03137992|156724646|FG000|Washout Period 2|Subject Non-compliance|0|||
48692956|NCT03137992|156724647|FG001|Washout Period 2|Subject Non-compliance|1|||
48692957|NCT03137992|156724648|FG002|Washout Period 2|Subject Non-compliance|0|||
48692958|NCT03137992|156724649|FG003|Washout Period 2|Subject Non-compliance|0|||
48692959|NCT03137992|156724650|FG004|Washout Period 2|Subject Non-compliance|0|||
48692960|NCT03137992|156724651|FG005|Washout Period 2|Subject Non-compliance|0|||
48692961|NCT03137992|156724646|FG000|Washout Period 2|Adverse Event|0|||
48692962|NCT03137992|156724647|FG001|Washout Period 2|Adverse Event|0|||
48692963|NCT03137992|156724648|FG002|Washout Period 2|Adverse Event|0|||
48692964|NCT03137992|156724649|FG003|Washout Period 2|Adverse Event|1|||
48692965|NCT03137992|156724650|FG004|Washout Period 2|Adverse Event|1|||
48692966|NCT03137992|156724651|FG005|Washout Period 2|Adverse Event|0|||
48692967|NCT03137992|156724646|FG000|Washout Period 2|Withdrawal by Subject|1|||
48692968|NCT03137992|156724647|FG001|Washout Period 2|Withdrawal by Subject|0|||
48692969|NCT03137992|156724648|FG002|Washout Period 2|Withdrawal by Subject|0|||
48692970|NCT03137992|156724649|FG003|Washout Period 2|Withdrawal by Subject|0|||
48692971|NCT03137992|156724650|FG004|Washout Period 2|Withdrawal by Subject|1|||
48692972|NCT03137992|156724651|FG005|Washout Period 2|Withdrawal by Subject|0|||
48692973|NCT03137992|156724646|FG000|Washout Period 2|Sponsor Decision|0|||
48692974|NCT03137992|156724647|FG001|Washout Period 2|Sponsor Decision|0|||
48692975|NCT03137992|156724648|FG002|Washout Period 2|Sponsor Decision|0|||
48692976|NCT03137992|156724649|FG003|Washout Period 2|Sponsor Decision|0|||
48692977|NCT03137992|156724650|FG004|Washout Period 2|Sponsor Decision|0|||
48692978|NCT03137992|156724651|FG005|Washout Period 2|Sponsor Decision|1|||
48692979|NCT03137992|156724646|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
48692980|NCT03137992|156724647|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
48692981|NCT03137992|156724648|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
48692982|NCT03137992|156724649|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
48692983|NCT03137992|156724650|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
48692984|NCT03137992|156724651|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
48692985|NCT03137992|156724646|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
48692986|NCT03137992|156724647|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
48692987|NCT03137992|156724648|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
48692988|NCT03137992|156724649|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
48692989|NCT03137992|156724650|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
48692990|NCT03137992|156724651|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
48692991|NCT03137992|156724646|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
48692992|NCT03137992|156724647|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
48692993|NCT03137992|156724648|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
48692994|NCT03137992|156724649|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
48692995|NCT03137992|156724650|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
48692996|NCT03137992|156724651|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
48692997|NCT03137992|156724646|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48692998|NCT03137992|156724647|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48692999|NCT03137992|156724648|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48693000|NCT03137992|156724649|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
48693001|NCT03137992|156724650|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48693002|NCT03137992|156724651|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
48693003|NCT03137992|156724646|FG000|Part 2 (Open-label Extension)|Per study team|1|||
48693004|NCT03137992|156724647|FG001|Part 2 (Open-label Extension)|Per study team|0|||
48693005|NCT03137992|156724648|FG002|Part 2 (Open-label Extension)|Per study team|0|||
48693006|NCT03137992|156724649|FG003|Part 2 (Open-label Extension)|Per study team|0|||
48693007|NCT03137992|156724650|FG004|Part 2 (Open-label Extension)|Per study team|0|||
48693008|NCT03137992|156724651|FG005|Part 2 (Open-label Extension)|Per study team|0|||
48693009|NCT03137992|156724646|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693010|NCT03137992|156724647|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693011|NCT03137992|156724648|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693012|NCT03137992|156724649|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693013|NCT03137992|156724650|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
48693014|NCT03137992|156724651|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
48693015|NCT01691794|156724653|FG000|Overall Study|Poor/Non-Compliance|1|||
48693016|NCT01691794|156724654|FG001|Overall Study|Poor/Non-Compliance|4|||
48693017|NCT01691794|156724655|FG002|Overall Study|Poor/Non-Compliance|1|||
48693018|NCT01691794|156724653|FG000|Overall Study|Death|0|||
48693019|NCT01691794|156724654|FG001|Overall Study|Death|0|||
48693020|NCT01691794|156724655|FG002|Overall Study|Death|1|||
48693021|NCT01691794|156724653|FG000|Overall Study|Lack of Efficacy|0|||
48693022|NCT01691794|156724654|FG001|Overall Study|Lack of Efficacy|7|||
48693023|NCT01691794|156724655|FG002|Overall Study|Lack of Efficacy|1|||
48693024|NCT01691794|156724653|FG000|Overall Study|Participant request to discontinue|0|||
48693025|NCT01691794|156724654|FG001|Overall Study|Participant request to discontinue|1|||
48693026|NCT01691794|156724655|FG002|Overall Study|Participant request to discontinue|0|||
48693027|NCT01691794|156724653|FG000|Overall Study|Adverse Event|0|||
48693028|NCT01691794|156724654|FG001|Overall Study|Adverse Event|1|||
48693029|NCT01691794|156724655|FG002|Overall Study|Adverse Event|1|||
48693030|NCT01691794|156724653|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
48693031|NCT01691794|156724654|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
48693032|NCT01691794|156724655|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
48693033|NCT01691794|156724653|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
48693034|NCT01691794|156724654|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
48693035|NCT01691794|156724655|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
48693036|NCT01400698|156724658|FG000|Overall Study|Lost to Follow-up|2|||
48693037|NCT01400698|156724659|FG001|Overall Study|Lost to Follow-up|5|||
48693038|NCT01400698|156724660|FG002|Overall Study|Lost to Follow-up|2|||
48693039|NCT01400698|156724661|FG003|Overall Study|Lost to Follow-up|1|||
48693040|NCT01400698|156724662|FG004|Overall Study|Lost to Follow-up|4|||
48693041|NCT01400698|156724663|FG005|Overall Study|Lost to Follow-up|3|||
48693042|NCT01400698|156724658|FG000|Overall Study|Withdrawal by Subject|8|||
48693043|NCT01400698|156724659|FG001|Overall Study|Withdrawal by Subject|2|||
48693044|NCT01400698|156724660|FG002|Overall Study|Withdrawal by Subject|0|||
48693045|NCT01400698|156724661|FG003|Overall Study|Withdrawal by Subject|4|||
48693046|NCT01400698|156724662|FG004|Overall Study|Withdrawal by Subject|1|||
48693047|NCT01400698|156724663|FG005|Overall Study|Withdrawal by Subject|3|||
48693048|NCT01400698|156724658|FG000|Overall Study|Protocol Violation|0|||
48693049|NCT01400698|156724659|FG001|Overall Study|Protocol Violation|1|||
48693050|NCT01400698|156724660|FG002|Overall Study|Protocol Violation|0|||
48693051|NCT01400698|156724661|FG003|Overall Study|Protocol Violation|0|||
48693052|NCT01400698|156724662|FG004|Overall Study|Protocol Violation|1|||
48693053|NCT01400698|156724663|FG005|Overall Study|Protocol Violation|0|||
48693054|NCT01400698|156724658|FG000|Overall Study|Non-compliance|0|||
48693055|NCT01400698|156724659|FG001|Overall Study|Non-compliance|1|||
48693056|NCT01400698|156724660|FG002|Overall Study|Non-compliance|0|||
48693057|NCT01400698|156724661|FG003|Overall Study|Non-compliance|1|||
48693058|NCT01400698|156724662|FG004|Overall Study|Non-compliance|0|||
48693059|NCT01400698|156724663|FG005|Overall Study|Non-compliance|0|||
48693075|NCT01350999|156724664|FG000|Overall Study|Voluntary withdrawal|3|||
48693076|NCT01350999|156724665|FG001|Overall Study|Voluntary withdrawal|4|||
48693077|NCT01350999|156724666|FG002|Overall Study|Voluntary withdrawal|6|||
48693078|NCT01350999|156724664|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
48693079|NCT01350999|156724665|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
48693080|NCT01350999|156724666|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
48797716|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
48797717|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
48797718|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
48797719|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
48797720|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
48797721|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
48797722|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
48797723|NCT00293267|157097059|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
48797724|NCT00293267|157097060|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
48797725|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
48797726|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
48797727|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
48797728|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
48797729|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
48797730|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
48797731|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
48797732|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
48797733|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Death|3|||
48797734|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Death|0|||
48797735|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
48797736|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
48797737|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
48797738|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
48797739|NCT00293267|157097059|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
48797740|NCT00293267|157097060|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
48797741|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
48797742|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
48797743|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
48797744|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
48797745|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
48797746|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
48797747|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
48797748|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
48797749|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
48797750|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
48797751|NCT00293267|157097059|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
48797752|NCT00293267|157097060|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
48797753|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
48797754|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
48797755|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
48797756|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
48797757|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
48797758|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
48797759|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
48797760|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
48797761|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
48797762|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
48797763|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
48797764|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
48797765|NCT00293267|157097059|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
48797766|NCT00293267|157097060|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
48797767|NCT00483184|157097061|FG000|Overall Study|Withdrawal by Subject|2|||
48797768|NCT00483184|157097062|FG001|Overall Study|Withdrawal by Subject|2|||
48797769|NCT00483184|157097063|FG002|Overall Study|Withdrawal by Subject|0|||
48797770|NCT00483184|157097061|FG000|Overall Study|Lost to Follow-up|1|||
48797771|NCT00483184|157097062|FG001|Overall Study|Lost to Follow-up|0|||
48797772|NCT00483184|157097063|FG002|Overall Study|Lost to Follow-up|0|||
48797773|NCT00483184|157097061|FG000|Overall Study|Adverse Event|1|||
48797774|NCT00483184|157097062|FG001|Overall Study|Adverse Event|2|||
48797775|NCT00483184|157097063|FG002|Overall Study|Adverse Event|2|||
48797783|NCT02570126|157097064|FG000|Overall Study|Violation Of Procedures GSK|0|||
48797784|NCT02570126|157097065|FG001|Overall Study|Violation Of Procedures GSK|1|||
48797785|NCT02570126|157097064|FG000|Overall Study|Protocol Violation|0|||
48797786|NCT02570126|157097065|FG001|Overall Study|Protocol Violation|1|||
48797787|NCT02570126|157097064|FG000|Overall Study|Withdrawal by Subject|3|||
48797788|NCT02570126|157097065|FG001|Overall Study|Withdrawal by Subject|7|||
48797789|NCT01050816|157097066|FG000|Overall Study|Lost to Follow-up|2|||
48797790|NCT01050816|157097066|FG000|Overall Study|patient's refusal|2|||
48797791|NCT00815295|157097069|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
48797792|NCT00815295|157097070|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
48797793|NCT00815295|157097071|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
48797794|NCT01970462|157097072|FG000|Overall Study|Lost to Follow-up|0|||
48797795|NCT01970462|157097073|FG001|Overall Study|Lost to Follow-up|2|||
48797796|NCT01292876|157097074|FG000|Overall Study|Physician Decision|4|||
48797797|NCT01627327|157097075|FG000|Overall Study|Adverse Event|6|||
48797798|NCT01627327|157097076|FG001|Overall Study|Adverse Event|12|||
48797799|NCT01627327|157097075|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
48797800|NCT01627327|157097076|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
48797801|NCT01627327|157097075|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
48797802|NCT01627327|157097076|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
48797803|NCT01627327|157097075|FG000|Overall Study|Protocol Violation|4|||
48797804|NCT01627327|157097076|FG001|Overall Study|Protocol Violation|10|||
48797805|NCT01627327|157097075|FG000|Overall Study|Lost to Follow-up|1|||
48797806|NCT01627327|157097076|FG001|Overall Study|Lost to Follow-up|3|||
48797807|NCT01627327|157097075|FG000|Overall Study|Physician Decision|1|||
48797808|NCT01627327|157097076|FG001|Overall Study|Physician Decision|0|||
48797809|NCT01627327|157097075|FG000|Overall Study|Withdrawal by Subject|3|||
48797810|NCT01627327|157097076|FG001|Overall Study|Withdrawal by Subject|3|||
48797811|NCT00917579|157097077|FG000|Washout >= 2 Weeks|Adverse Event|1|||
48797812|NCT00917579|157097078|FG001|Washout >= 2 Weeks|Adverse Event|0|||
48797813|NCT00917579|157097077|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
48797814|NCT00917579|157097078|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
48797815|NCT00754338|157097079|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
48797816|NCT00754338|157097080|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
48797817|NCT00754338|157097081|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
48797818|NCT00754338|157097082|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
48797819|NCT00754338|157097079|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
48797820|NCT00754338|157097080|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
48797821|NCT00754338|157097081|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
48797822|NCT00754338|157097082|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
48797823|NCT00781391|157097086|FG000|Overall Study|never received study drug|24|||
48797824|NCT00781391|157097087|FG001|Overall Study|never received study drug|23|||
48797825|NCT00781391|157097088|FG002|Overall Study|never received study drug|32|||
48797826|NCT00781391|157097086|FG000|Overall Study|Protocol Violation|19|||
48797827|NCT00781391|157097087|FG001|Overall Study|Protocol Violation|17|||
48797828|NCT00781391|157097088|FG002|Overall Study|Protocol Violation|20|||
48797829|NCT00781391|157097086|FG000|Overall Study|Death|789|||
48797830|NCT00781391|157097087|FG001|Overall Study|Death|730|||
48797831|NCT00781391|157097088|FG002|Overall Study|Death|706|||
48797832|NCT00781391|157097086|FG000|Overall Study|Withdrawal by Subject|47|||
48797833|NCT00781391|157097087|FG001|Overall Study|Withdrawal by Subject|37|||
48797834|NCT00781391|157097088|FG002|Overall Study|Withdrawal by Subject|25|||
48797835|NCT00781391|157097086|FG000|Overall Study|Lost to Follow-up|0|||
48797836|NCT00781391|157097087|FG001|Overall Study|Lost to Follow-up|0|||
48797837|NCT00781391|157097088|FG002|Overall Study|Lost to Follow-up|1|||
48797838|NCT01368965|157097089|FG000|Overall Study|Lost to Follow-up|12|||
48797839|NCT04085328|157097095|FG000|Overall Study|Witihdrew Consent|16|||
48797840|NCT04085328|157097096|FG001|Overall Study|Witihdrew Consent|16|||
48797841|NCT04085328|157097095|FG000|Overall Study|Adverse Event|8|||
48797842|NCT04085328|157097096|FG001|Overall Study|Adverse Event|7|||
48797843|NCT04085328|157097095|FG000|Overall Study|Lost to Follow-up|7|||
48797844|NCT04085328|157097096|FG001|Overall Study|Lost to Follow-up|2|||
48797845|NCT04085328|157097095|FG000|Overall Study|Physician Decision|0|||
48797846|NCT04085328|157097096|FG001|Overall Study|Physician Decision|1|||
48797847|NCT04085328|157097095|FG000|Overall Study|Pregnancy|0|||
48797848|NCT04085328|157097096|FG001|Overall Study|Pregnancy|1|||
48797849|NCT04085328|157097095|FG000|Overall Study|Reasons Related to COVID-19|5|||
48797850|NCT04085328|157097096|FG001|Overall Study|Reasons Related to COVID-19|8|||
48797851|NCT04085328|157097095|FG000|Overall Study|Did not meet inclusion criteria|1|||
48797852|NCT04085328|157097096|FG001|Overall Study|Did not meet inclusion criteria|1|||
48797853|NCT04085328|157097095|FG000|Overall Study|Early termination|1|||
48797854|NCT04085328|157097096|FG001|Overall Study|Early termination|0|||
48797855|NCT02195986|157097102|FG000|Overall Study|Adverse Event|3|||
48797856|NCT02195986|157097103|FG001|Overall Study|Adverse Event|0|||
48797857|NCT02195986|157097104|FG002|Overall Study|Adverse Event|0|||
48797858|NCT02195986|157097102|FG000|Overall Study|Withdrawal by Subject|0|||
48797859|NCT02195986|157097103|FG001|Overall Study|Withdrawal by Subject|3|||
48797860|NCT02195986|157097104|FG002|Overall Study|Withdrawal by Subject|0|||
48797861|NCT02195986|157097102|FG000|Overall Study|Family Emergency|0|||
48797862|NCT02195986|157097103|FG001|Overall Study|Family Emergency|0|||
48797863|NCT02195986|157097104|FG002|Overall Study|Family Emergency|1|||
48797864|NCT02195986|157097102|FG000|Overall Study|Protocol Violation|0|||
48797865|NCT02195986|157097103|FG001|Overall Study|Protocol Violation|1|||
48797866|NCT02195986|157097104|FG002|Overall Study|Protocol Violation|1|||
48797867|NCT02195986|157097102|FG000|Overall Study|Non-compliance|0|||
48797868|NCT02195986|157097103|FG001|Overall Study|Non-compliance|1|||
48797869|NCT02195986|157097104|FG002|Overall Study|Non-compliance|0|||
48797870|NCT00771810|157097105|FG000|Overall Study|Adverse Event|3|||
48797871|NCT00771810|157097106|FG001|Overall Study|Adverse Event|0|||
48797872|NCT00771810|157097107|FG002|Overall Study|Adverse Event|2|||
48797873|NCT00771810|157097105|FG000|Overall Study|Lost to Follow-up|0|||
48797874|NCT00771810|157097106|FG001|Overall Study|Lost to Follow-up|0|||
48797875|NCT00771810|157097107|FG002|Overall Study|Lost to Follow-up|1|||
48797876|NCT00771810|157097105|FG000|Overall Study|Physician Decision|1|||
48797877|NCT00771810|157097106|FG001|Overall Study|Physician Decision|2|||
48797878|NCT00771810|157097107|FG002|Overall Study|Physician Decision|2|||
48797879|NCT00771810|157097105|FG000|Overall Study|Protocol Violation|0|||
48797880|NCT00771810|157097106|FG001|Overall Study|Protocol Violation|1|||
48797881|NCT00771810|157097107|FG002|Overall Study|Protocol Violation|1|||
48797882|NCT00771810|157097105|FG000|Overall Study|Withdrawal by Subject|1|||
48797883|NCT00771810|157097106|FG001|Overall Study|Withdrawal by Subject|2|||
48797884|NCT00771810|157097107|FG002|Overall Study|Withdrawal by Subject|0|||
48797885|NCT00771810|157097105|FG000|Overall Study|Other|0|||
48797886|NCT00771810|157097106|FG001|Overall Study|Other|0|||
48797887|NCT00771810|157097107|FG002|Overall Study|Other|1|||
48797888|NCT00449176|157097108|FG000|Overall Study|Withdrawal by Subject|39|||
48797889|NCT00449176|157097109|FG001|Overall Study|Withdrawal by Subject|43|||
48797890|NCT00449176|157097110|FG002|Overall Study|Withdrawal by Subject|59|||
48797891|NCT00449176|157097108|FG000|Overall Study|Lost to Follow-up|13|||
48797892|NCT00449176|157097109|FG001|Overall Study|Lost to Follow-up|8|||
48797893|NCT00449176|157097110|FG002|Overall Study|Lost to Follow-up|12|||
48797894|NCT00449176|157097108|FG000|Overall Study|Adverse Event|51|||
48797895|NCT00449176|157097109|FG001|Overall Study|Adverse Event|107|||
48797896|NCT00449176|157097110|FG002|Overall Study|Adverse Event|15|||
48797897|NCT00449176|157097108|FG000|Overall Study|Lack of Efficacy|13|||
48797898|NCT00449176|157097109|FG001|Overall Study|Lack of Efficacy|7|||
48797899|NCT00449176|157097110|FG002|Overall Study|Lack of Efficacy|50|||
48797900|NCT00449176|157097108|FG000|Overall Study|Study drug non-compliant|14|||
48797901|NCT00449176|157097109|FG001|Overall Study|Study drug non-compliant|11|||
48797902|NCT00449176|157097110|FG002|Overall Study|Study drug non-compliant|11|||
48797903|NCT00449176|157097108|FG000|Overall Study|all other|22|||
48797904|NCT00449176|157097109|FG001|Overall Study|all other|19|||
48797905|NCT00449176|157097110|FG002|Overall Study|all other|20|||
48797906|NCT00689221|157097111|FG000|Overall Study|Ongoing at cut-off date|39|||
48797907|NCT00689221|157097112|FG001|Overall Study|Ongoing at cut-off date|36|||
48797908|NCT02251990|157097113|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
48797909|NCT02251990|157097114|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
48797910|NCT02251990|157097113|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
48797911|NCT02251990|157097114|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
48797912|NCT02251990|157097113|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
48797913|NCT02251990|157097114|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
48797914|NCT02251990|157097113|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
48797915|NCT02251990|157097114|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
48797916|NCT02251990|157097113|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
48797917|NCT02251990|157097114|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
48797918|NCT02251990|157097113|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
48797919|NCT02251990|157097114|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
48797920|NCT01812655|157097115|FG000|Overall Study|Protocol Violation|1|||
48797921|NCT01812655|157097116|FG001|Overall Study|Protocol Violation|1|||
48797922|NCT01812655|157097117|FG002|Overall Study|Protocol Violation|0|||
48797923|NCT02454101|157097119|FG000|Overall Study|Adverse Event|2|||
48797924|NCT02454101|157097120|FG001|Overall Study|Adverse Event|3|||
48797925|NCT02454101|157097119|FG000|Overall Study|Lost to Follow-up|3|||
48797926|NCT02454101|157097120|FG001|Overall Study|Lost to Follow-up|4|||
48797927|NCT04839965|157097121|FG000|Overall Study|Death|6|||
48797928|NCT04839965|157097122|FG001|Overall Study|Death|6|||
48797929|NCT04839965|157097121|FG000|Overall Study|Lost to Follow-up|1|||
48797930|NCT04839965|157097122|FG001|Overall Study|Lost to Follow-up|0|||
48797931|NCT02291679|157097123|FG000|Overall Study|Adverse Event|2|||
48797932|NCT02291679|157097124|FG001|Overall Study|Adverse Event|12|||
48797933|NCT02291679|157097125|FG002|Overall Study|Adverse Event|19|||
48797934|NCT02291679|157097123|FG000|Overall Study|Protocol Violation|5|||
48797935|NCT02291679|157097124|FG001|Overall Study|Protocol Violation|1|||
48797936|NCT02291679|157097125|FG002|Overall Study|Protocol Violation|7|||
48797937|NCT02291679|157097123|FG000|Overall Study|Withdrew Consent|18|||
48797984|NCT00677833|157098522|FG002|Overall Study|Withdrawal by Subject|1|||
48797985|NCT00677833|157098523|FG003|Overall Study|Withdrawal by Subject|3|||
48797986|NCT00677833|157098520|FG000|Overall Study|Lost to Follow-up|0|||
48797987|NCT00677833|157098521|FG001|Overall Study|Lost to Follow-up|0|||
48797988|NCT00677833|157098522|FG002|Overall Study|Lost to Follow-up|1|||
48797989|NCT00677833|157098523|FG003|Overall Study|Lost to Follow-up|0|||
48797990|NCT01944631|157098524|FG000|Overall Study|Adverse Event|1|||
48797991|NCT01944631|157098525|FG001|Overall Study|Adverse Event|0|||
48797992|NCT01944631|157098524|FG000|Overall Study|Lost to Follow-up|3|||
48797993|NCT01944631|157098525|FG001|Overall Study|Lost to Follow-up|1|||
48797994|NCT01944631|157098524|FG000|Overall Study|Withdrawal by Subject|0|||
48797995|NCT01944631|157098525|FG001|Overall Study|Withdrawal by Subject|1|||
48797996|NCT02690974|157098526|FG000|Overall Study|Adverse Event|16|||
48797997|NCT02690974|157098526|FG000|Overall Study|Death|9|||
48797998|NCT02690974|157098526|FG000|Overall Study|Subject/guardian decision|4|||
48797999|NCT02690974|157098526|FG000|Overall Study|Lost to Follow-up|3|||
48798000|NCT02690974|157098526|FG000|Overall Study|Withdrawal of Informed Consent|3|||
48798001|NCT02690974|157098526|FG000|Overall Study|Physician Decision|2|||
48798002|NCT02690974|157098526|FG000|Overall Study|Non-compliance with study treatment|1|||
48798003|NCT02690974|157098526|FG000|Overall Study|Protocol-defined stopping criteria|1|||
48798004|NCT02690974|157098526|FG000|Overall Study|Protocol Deviation|1|||
48798005|NCT01666951|157098529|FG000|Overall Study|Not dosed|1|||
48798006|NCT01666951|157098530|FG001|Overall Study|Not dosed|1|||
48798007|NCT03284788|157098531|FG000|Overall Study|Withdrawal by Subject|2|||
48798008|NCT02314624|157098532|FG000|Overall Study|No participating patient|16|||
48798009|NCT02314624|157098533|FG001|Overall Study|No participating patient|13|||
48798010|NCT02314624|157098532|FG000|Overall Study|Participant withdrew|7|||
48798011|NCT02314624|157098533|FG001|Overall Study|Participant withdrew|2|||
48798012|NCT02314624|157098532|FG000|Overall Study|Lost to Follow-up|2|||
48798013|NCT02314624|157098533|FG001|Overall Study|Lost to Follow-up|5|||
48798014|NCT02314624|157098532|FG000|Overall Study|Dropped/Excluded by PI|6|||
48798015|NCT02314624|157098533|FG001|Overall Study|Dropped/Excluded by PI|6|||
48798016|NCT02641392|157098534|FG000|Overall Study|Lost to Follow-up|0|||
48798017|NCT02641392|157098535|FG001|Overall Study|Lost to Follow-up|0|||
48798018|NCT02641392|157098536|FG002|Overall Study|Lost to Follow-up|2|||
48798019|NCT02641392|157098534|FG000|Overall Study|Withdrawal by Subject|0|||
48798020|NCT02641392|157098535|FG001|Overall Study|Withdrawal by Subject|0|||
48798021|NCT02641392|157098536|FG002|Overall Study|Withdrawal by Subject|17|||
48798022|NCT02641392|157098534|FG000|Overall Study|Adverse Event|0|||
48798023|NCT02641392|157098535|FG001|Overall Study|Adverse Event|1|||
48798024|NCT02641392|157098536|FG002|Overall Study|Adverse Event|25|||
48798025|NCT02641392|157098534|FG000|Overall Study|Study Terminated by Sponsor|4|||
48798026|NCT02641392|157098535|FG001|Overall Study|Study Terminated by Sponsor|12|||
48798027|NCT02641392|157098536|FG002|Overall Study|Study Terminated by Sponsor|144|||
48798028|NCT02641392|157098534|FG000|Overall Study|Lack of Efficacy|0|||
48798029|NCT02641392|157098535|FG001|Overall Study|Lack of Efficacy|0|||
48798030|NCT02641392|157098536|FG002|Overall Study|Lack of Efficacy|101|||
48798031|NCT02641392|157098534|FG000|Overall Study|Miscellaneous|0|||
48798032|NCT02641392|157098535|FG001|Overall Study|Miscellaneous|0|||
48798033|NCT02641392|157098536|FG002|Overall Study|Miscellaneous|3|||
48798034|NCT02641392|157098534|FG000|Overall Study|Death|0|||
48798035|NCT02641392|157098535|FG001|Overall Study|Death|0|||
48798036|NCT02641392|157098536|FG002|Overall Study|Death|1|||
48798037|NCT00234052|157098537|FG000|Treatment|Withdrawal by Subject|3|||
48798038|NCT00234052|157098537|FG000|Treatment|Adverse Event|5|||
48798039|NCT00234052|157098537|FG000|Treatment|Death|2|||
48798040|NCT00234052|157098537|FG000|Treatment|Progressive Disease|11|||
48798041|NCT00234052|157098537|FG000|Follow-up for 5 Years|Death|41|||
48798042|NCT00234052|157098537|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
48798043|NCT00234052|157098537|FG000|Follow-up for 5 Years|Other|7|||
48798044|NCT00677352|157098540|FG000|Treatment Phase|Adverse Event|14|||
48798045|NCT00677352|157098541|FG001|Treatment Phase|Adverse Event|22|||
48798046|NCT00677352|157098540|FG000|Treatment Phase|Lack of Efficacy|2|||
48798047|NCT00677352|157098541|FG001|Treatment Phase|Lack of Efficacy|3|||
48798048|NCT00677352|157098540|FG000|Treatment Phase|Lost to Follow-up|0|||
48798049|NCT00677352|157098541|FG001|Treatment Phase|Lost to Follow-up|1|||
48798050|NCT00677352|157098540|FG000|Treatment Phase|Withdrawal by Subject|7|||
48798051|NCT00677352|157098541|FG001|Treatment Phase|Withdrawal by Subject|7|||
48798052|NCT00677352|157098540|FG000|Treatment Phase|Physician Decision|1|||
48798053|NCT00677352|157098541|FG001|Treatment Phase|Physician Decision|0|||
48798054|NCT00677352|157098540|FG000|Treatment Phase|Pregnancy|0|||
48798055|NCT00677352|157098541|FG001|Treatment Phase|Pregnancy|1|||
48798056|NCT00677352|157098540|FG000|Treatment Phase|Protocol Violation|1|||
48798057|NCT00677352|157098541|FG001|Treatment Phase|Protocol Violation|1|||
48798058|NCT00677352|157098540|FG000|Treatment Phase|Transference or work related matter|0|||
48798059|NCT00677352|157098541|FG001|Treatment Phase|Transference or work related matter|5|||
48798060|NCT00677352|157098540|FG000|Treatment Phase|Not treated|0|||
48798061|NCT00677352|157098541|FG001|Treatment Phase|Not treated|2|||
48798062|NCT00677352|157098540|FG000|Tapering Phase|Adverse Event|1|||
48798064|NCT00677352|157098540|FG000|Tapering Phase|Withdrawal by Subject|5|||
48798065|NCT00677352|157098541|FG001|Tapering Phase|Withdrawal by Subject|3|||
48798066|NCT00677352|157098540|FG000|Tapering Phase|Pregnancy|0|||
48798067|NCT00677352|157098541|FG001|Tapering Phase|Pregnancy|1|||
48798068|NCT00677352|157098540|FG000|Tapering Phase|Job transfer|0|||
48798069|NCT00677352|157098541|FG001|Tapering Phase|Job transfer|1|||
48798070|NCT00238433|157098542|FG000|Overall Study|Screen failure|1|||
48798071|NCT00238433|157098542|FG000|Overall Study|Lost to Follow-up|1|||
48798072|NCT00238433|157098542|FG000|Overall Study|Death|1|||
48798073|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
48798074|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
48798075|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
48798076|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
48798077|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
48798078|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
48798079|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
48798080|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
48798081|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
48798082|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
48798083|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
48798084|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
48798085|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
48798086|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
48798087|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
48798088|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
48798089|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
48798090|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
48798091|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
48798092|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
48798093|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
48798094|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
48798095|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
48798096|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
48798097|NCT01256411|157098543|FG000|Extension by Maximum Treatment|Adverse Event|4|||
48798098|NCT01256411|157098544|FG001|Extension by Maximum Treatment|Adverse Event|2|||
48798099|NCT01256411|157098545|FG002|Extension by Maximum Treatment|Adverse Event|1|||
48798100|NCT01256411|157098546|FG003|Extension by Maximum Treatment|Adverse Event|0|||
48798101|NCT01256411|157098547|FG004|Extension by Maximum Treatment|Adverse Event|0|||
48798102|NCT01256411|157098548|FG005|Extension by Maximum Treatment|Adverse Event|0|||
48798103|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
48798104|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
48798105|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
48798106|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
48798107|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
48798108|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
48798109|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798110|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798111|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798112|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798113|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
48798114|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
48798115|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798116|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798117|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798118|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798119|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
48798120|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
48798121|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
48798122|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
48798123|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
48798124|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
48798125|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
48798126|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
48798127|NCT01256411|157098543|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
48798128|NCT01256411|157098544|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
48798129|NCT01256411|157098545|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
48798130|NCT01256411|157098546|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
48798131|NCT01256411|157098547|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
48798132|NCT01256411|157098548|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
48798133|NCT04044456|157098549|FG000|Overall Study|Lost to Follow-up|4|||
48798134|NCT04044456|157098550|FG001|Overall Study|Lost to Follow-up|1|||
48798135|NCT04044456|157098549|FG000|Overall Study|Withdrawal by Subject|1|||
48798136|NCT04044456|157098550|FG001|Overall Study|Withdrawal by Subject|0|||
48798137|NCT00409682|157098554|FG000|Open-label Induction Period|Adverse Event|1|||
48798138|NCT00409682|157098555|FG001|Open-label Induction Period|Adverse Event|0|||
48798139|NCT00409682|157098556|FG002|Open-label Induction Period|Adverse Event|0|||
48798140|NCT00409682|157098554|FG000|Open-label Induction Period|Lack of Efficacy|1|||
48798141|NCT00409682|157098555|FG001|Open-label Induction Period|Lack of Efficacy|0|||
48798142|NCT00409682|157098556|FG002|Open-label Induction Period|Lack of Efficacy|0|||
48798143|NCT00409682|157098554|FG000|Open-label Induction Period|Protocol Violation|1|||
48798144|NCT00409682|157098555|FG001|Open-label Induction Period|Protocol Violation|0|||
48798145|NCT00409682|157098556|FG002|Open-label Induction Period|Protocol Violation|0|||
48798146|NCT00409682|157098554|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
48798147|NCT00409682|157098555|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
48798148|NCT00409682|157098556|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
48798149|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
48798150|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
48798151|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
48798152|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
48798153|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
48798154|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
48798155|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
48798156|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
48798157|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
48798158|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
48798159|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
48798160|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
48798161|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
48798162|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
48798163|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
48798164|NCT00409682|157098554|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
48798165|NCT00409682|157098555|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
48798166|NCT00409682|157098556|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
48798167|NCT02436330|157098557|FG000|Cohort 1|Lost to Follow-up|5|||
48798168|NCT02436330|157098558|FG001|Cohort 1|Lost to Follow-up|2|||
48798169|NCT02436330|157098557|FG000|Cohort 1|Withdrawal by Subject|0|||
48798170|NCT02436330|157098558|FG001|Cohort 1|Withdrawal by Subject|1|||
48798171|NCT02436330|157098557|FG000|Cohort 2|Lost to Follow-up|2|||
48798172|NCT02436330|157098558|FG001|Cohort 2|Lost to Follow-up|0|||
48798173|NCT02436330|157098557|FG000|Cohort 2|Withdrawal by Subject|2|||
48798174|NCT02436330|157098558|FG001|Cohort 2|Withdrawal by Subject|3|||
48798175|NCT02436330|157098557|FG000|Cohort 3|Lost to Follow-up|1|||
48798176|NCT02436330|157098558|FG001|Cohort 3|Lost to Follow-up|0|||
48798177|NCT02436330|157098557|FG000|Cohort 3|Withdrawal by Subject|4|||
48798178|NCT02436330|157098558|FG001|Cohort 3|Withdrawal by Subject|0|||
48798179|NCT02436330|157098557|FG000|Cohort 4|Lost to Follow-up|1|||
48798180|NCT02436330|157098558|FG001|Cohort 4|Lost to Follow-up|0|||
48798181|NCT02436330|157098557|FG000|Cohort 4|Withdrawal by Subject|1|||
48798182|NCT02436330|157098558|FG001|Cohort 4|Withdrawal by Subject|0|||
48798183|NCT02436330|157098557|FG000|Cohort 5|Lost to Follow-up|3|||
48798184|NCT02436330|157098558|FG001|Cohort 5|Lost to Follow-up|2|||
48798185|NCT02436330|157098557|FG000|Cohort 5|Withdrawal by Subject|3|||
48798186|NCT02436330|157098558|FG001|Cohort 5|Withdrawal by Subject|2|||
48798187|NCT02436330|157098557|FG000|Cohort 6|Lost to Follow-up|2|||
48798188|NCT02436330|157098558|FG001|Cohort 6|Lost to Follow-up|0|||
48798189|NCT02436330|157098557|FG000|Cohort 6|Withdrawal by Subject|1|||
48798190|NCT02436330|157098558|FG001|Cohort 6|Withdrawal by Subject|1|||
48798191|NCT04721925|157098559|FG000|2-Month Assessment|Lost to Follow-up|5|||
48798192|NCT04721925|157098560|FG001|2-Month Assessment|Lost to Follow-up|3|||
48798193|NCT04721925|157098559|FG000|4-Month Assessment|Lost to Follow-up|3|||
48798194|NCT04721925|157098560|FG001|4-Month Assessment|Lost to Follow-up|6|||
48798195|NCT00441701|157098561|FG000|Overall Study|Adverse Event|3|||
48798196|NCT00441701|157098562|FG001|Overall Study|Adverse Event|2|||
48798197|NCT00441701|157098563|FG002|Overall Study|Adverse Event|1|||
48798198|NCT00441701|157098564|FG003|Overall Study|Adverse Event|0|||
48798199|NCT00441701|157098565|FG004|Overall Study|Adverse Event|2|||
48798200|NCT00441701|157098566|FG005|Overall Study|Adverse Event|2|||
48798201|NCT00441701|157098567|FG006|Overall Study|Adverse Event|0|||
48798202|NCT00441701|157098568|FG007|Overall Study|Adverse Event|0|||
48798203|NCT00441701|157098569|FG008|Overall Study|Adverse Event|0|||
48798204|NCT00441701|157098570|FG009|Overall Study|Adverse Event|0|||
48798205|NCT00441701|157098561|FG000|Overall Study|Lack of Efficacy|2|||
48798255|NCT01274182|157098585|FG001|Overall Study|Withdrawal by Subject|5|||
48798256|NCT01274182|157098586|FG002|Overall Study|Withdrawal by Subject|3|||
48798257|NCT01274182|157098584|FG000|Overall Study|Lost to Follow-up|2|||
48798258|NCT01274182|157098585|FG001|Overall Study|Lost to Follow-up|3|||
48798259|NCT01274182|157098586|FG002|Overall Study|Lost to Follow-up|1|||
48798260|NCT01274182|157098584|FG000|Overall Study|Protocol Violation|3|||
48798261|NCT01274182|157098585|FG001|Overall Study|Protocol Violation|2|||
48798262|NCT01274182|157098586|FG002|Overall Study|Protocol Violation|0|||
48798263|NCT01274182|157098584|FG000|Overall Study|Death|1|||
48798264|NCT01274182|157098585|FG001|Overall Study|Death|0|||
48798265|NCT01274182|157098586|FG002|Overall Study|Death|1|||
48798266|NCT01362439|157098587|FG000|Overall Study|Adverse Event|1|||
48798267|NCT01362439|157098587|FG000|Overall Study|Lack of Efficacy|3|||
48798268|NCT01362439|157098587|FG000|Overall Study|Lost to Follow-up|2|||
48798269|NCT01362439|157098587|FG000|Overall Study|Study medication non-compliant|1|||
48798270|NCT01362439|157098587|FG000|Overall Study|Participant who withdrew consent|8|||
48798271|NCT03494166|157098588|FG000|Overall Study|Death|0|||
48798272|NCT03494166|157098589|FG001|Overall Study|Death|0|||
48798273|NCT03494166|157098590|FG002|Overall Study|Death|0|||
48798274|NCT03494166|157098591|FG003|Overall Study|Death|1|||
48798275|NCT03494166|157098592|FG004|Overall Study|Death|3|||
48798276|NCT03494166|157098593|FG005|Overall Study|Death|0|||
48798277|NCT03494166|157098588|FG000|Overall Study|Lost to Follow-up|2|||
48798278|NCT03494166|157098589|FG001|Overall Study|Lost to Follow-up|2|||
48798279|NCT03494166|157098590|FG002|Overall Study|Lost to Follow-up|2|||
48798280|NCT03494166|157098591|FG003|Overall Study|Lost to Follow-up|2|||
48798281|NCT03494166|157098592|FG004|Overall Study|Lost to Follow-up|14|||
48798282|NCT03494166|157098593|FG005|Overall Study|Lost to Follow-up|0|||
48798283|NCT03494166|157098588|FG000|Overall Study|Withdrawal by Subject|10|||
48798284|NCT03494166|157098589|FG001|Overall Study|Withdrawal by Subject|7|||
48798285|NCT03494166|157098590|FG002|Overall Study|Withdrawal by Subject|0|||
48798286|NCT03494166|157098591|FG003|Overall Study|Withdrawal by Subject|5|||
48798287|NCT03494166|157098592|FG004|Overall Study|Withdrawal by Subject|3|||
48798288|NCT03494166|157098593|FG005|Overall Study|Withdrawal by Subject|17|||
48798289|NCT03494166|157098588|FG000|Overall Study|Screen failure|1|||
48798290|NCT03494166|157098589|FG001|Overall Study|Screen failure|0|||
48798291|NCT03494166|157098590|FG002|Overall Study|Screen failure|0|||
48798292|NCT03494166|157098591|FG003|Overall Study|Screen failure|0|||
48798293|NCT03494166|157098592|FG004|Overall Study|Screen failure|1|||
48798294|NCT03494166|157098593|FG005|Overall Study|Screen failure|0|||
48798295|NCT00952822|157098594|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
48798296|NCT00952822|157098595|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
48798297|NCT00952822|157098596|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
48798298|NCT00952822|157098597|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
48798299|NCT00952822|157098594|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
48798300|NCT00952822|157098595|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
48798301|NCT00952822|157098596|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
48798302|NCT00952822|157098597|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
48798303|NCT01281644|157098598|FG000|Overall Study|Lost to Follow-up|3|||
48798304|NCT01281644|157098598|FG000|Overall Study|Withdrawal by Subject|2|||
48798305|NCT00611858|157098599|FG000|Overall Study|Adverse Event|2|||
48798306|NCT00611858|157098599|FG000|Overall Study|Withdrawal by Subject|2|||
48798307|NCT02633137|157098600|FG000|Overall Study|Adverse Event|1|||
48798308|NCT02633137|157098600|FG000|Overall Study|Lack of Efficacy|2|||
48798309|NCT02633137|157098600|FG000|Overall Study|Withdrawal by Subject|1|||
48798310|NCT01324271|157098601|FG000|Overall Study|Lost to Follow-up|3|||
48798311|NCT01324271|157098602|FG001|Overall Study|Lost to Follow-up|0|||
48798312|NCT01324271|157098601|FG000|Overall Study|Physician Decision|1|||
48798313|NCT01324271|157098602|FG001|Overall Study|Physician Decision|0|||
48798314|NCT02954354|157098603|FG000|Overall Study|Adverse Event|2|||
48798315|NCT02954354|157098604|FG001|Overall Study|Adverse Event|2|||
48798316|NCT02954354|157098605|FG002|Overall Study|Adverse Event|4|||
48798317|NCT02954354|157098603|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
48798318|NCT02954354|157098604|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
48798319|NCT02954354|157098605|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
48798320|NCT02954354|157098603|FG000|Overall Study|Lack of Efficacy|0|||
48798321|NCT02954354|157098604|FG001|Overall Study|Lack of Efficacy|2|||
48798322|NCT02954354|157098605|FG002|Overall Study|Lack of Efficacy|0|||
48798323|NCT02954354|157098603|FG000|Overall Study|Withdrawal by Subject|17|||
48798324|NCT02954354|157098604|FG001|Overall Study|Withdrawal by Subject|9|||
48798325|NCT02954354|157098605|FG002|Overall Study|Withdrawal by Subject|11|||
48798326|NCT02954354|157098603|FG000|Overall Study|Lost to Follow-up|12|||
48798327|NCT02954354|157098604|FG001|Overall Study|Lost to Follow-up|5|||
48798328|NCT02954354|157098605|FG002|Overall Study|Lost to Follow-up|0|||
48798329|NCT02954354|157098603|FG000|Overall Study|Miscellaneous|2|||
48798330|NCT02954354|157098604|FG001|Overall Study|Miscellaneous|2|||
48798331|NCT02954354|157098605|FG002|Overall Study|Miscellaneous|1|||
48798332|NCT04252742|157098607|FG000|Overall Study|Decision by sponsor|0|||
48798348|NCT00377403|157098625|FG001|Overall Study|Unable to contact for telephone intervie|7|||
48798349|NCT01207102|157098629|FG000|Overall Study|Withdrawal by Subject|5|||
48798350|NCT01207102|157098629|FG000|Overall Study|Adverse Event|2|||
48798351|NCT01207102|157098629|FG000|Overall Study|progression|2|||
48798352|NCT01207102|157098629|FG000|Overall Study|Withdrawal by Treating Physician|1|||
48798353|NCT02279043|157098630|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
48798354|NCT02279043|157098631|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
48798355|NCT02279043|157098632|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
48798356|NCT02279043|157098630|FG000|Overall Study|Lost to Follow-up|46|||
48798357|NCT02279043|157098631|FG001|Overall Study|Lost to Follow-up|88|||
48798358|NCT02279043|157098632|FG002|Overall Study|Lost to Follow-up|0|||
48798359|NCT01922076|157098633|FG000|Overall Study|Adverse Event|0|||
48798360|NCT01922076|157098634|FG001|Overall Study|Adverse Event|0|||
48798361|NCT01922076|157098635|FG002|Overall Study|Adverse Event|0|||
48798362|NCT01922076|157098636|FG003|Overall Study|Adverse Event|0|||
48798363|NCT01922076|157098637|FG004|Overall Study|Adverse Event|1|||
48798364|NCT01922076|157098638|FG005|Overall Study|Adverse Event|0|||
48798365|NCT01922076|157098639|FG006|Overall Study|Adverse Event|0|||
48798366|NCT01922076|157098633|FG000|Overall Study|Physician Decision|0|||
48798367|NCT01922076|157098634|FG001|Overall Study|Physician Decision|0|||
48798368|NCT01922076|157098635|FG002|Overall Study|Physician Decision|1|||
48798369|NCT01922076|157098636|FG003|Overall Study|Physician Decision|0|||
48798370|NCT01922076|157098637|FG004|Overall Study|Physician Decision|0|||
48798371|NCT01922076|157098638|FG005|Overall Study|Physician Decision|0|||
48798372|NCT01922076|157098639|FG006|Overall Study|Physician Decision|0|||
48798373|NCT01922076|157098633|FG000|Overall Study|Withdrawal by Subject|0|||
48798374|NCT01922076|157098634|FG001|Overall Study|Withdrawal by Subject|0|||
48798375|NCT01922076|157098635|FG002|Overall Study|Withdrawal by Subject|0|||
48798376|NCT01922076|157098636|FG003|Overall Study|Withdrawal by Subject|1|||
48798377|NCT01922076|157098637|FG004|Overall Study|Withdrawal by Subject|0|||
48798378|NCT01922076|157098638|FG005|Overall Study|Withdrawal by Subject|1|||
48798379|NCT01922076|157098639|FG006|Overall Study|Withdrawal by Subject|1|||
48798380|NCT02114151|157098640|FG000|Overall Study|Death|1|||
48798381|NCT02114151|157098640|FG000|Overall Study|Lost to Follow-up|1|||
48798382|NCT02114151|157098640|FG000|Overall Study|Withdrawal by Subject|5|||
48798383|NCT01499082|157098641|FG000|Overall Study|Randomized but not Treated|0|||
48798384|NCT01499082|157098642|FG001|Overall Study|Randomized but not Treated|1|||
48798385|NCT01499082|157098641|FG000|Overall Study|Adverse Event|12|||
48798386|NCT01499082|157098642|FG001|Overall Study|Adverse Event|16|||
48798387|NCT01499082|157098641|FG000|Overall Study|Lack of Efficacy|1|||
48798388|NCT01499082|157098642|FG001|Overall Study|Lack of Efficacy|1|||
48798389|NCT01499082|157098641|FG000|Overall Study|Protocol Violation|6|||
48798390|NCT01499082|157098642|FG001|Overall Study|Protocol Violation|8|||
48798391|NCT01499082|157098641|FG000|Overall Study|Diverse Reasons|18|||
48798392|NCT01499082|157098642|FG001|Overall Study|Diverse Reasons|14|||
48798393|NCT01499082|157098641|FG000|Overall Study|Site Closure for Noncompliance|5|||
48798394|NCT01499082|157098642|FG001|Overall Study|Site Closure for Noncompliance|2|||
48798395|NCT01499082|157098641|FG000|Overall Study|Hypoglycemia|2|||
48798396|NCT01499082|157098642|FG001|Overall Study|Hypoglycemia|3|||
48798397|NCT01499082|157098641|FG000|Overall Study|Lost to Follow-up|1|||
48798398|NCT01499082|157098642|FG001|Overall Study|Lost to Follow-up|3|||
48798399|NCT02703922|157098648|FG000|Overall Study|Death|5|||
48798400|NCT02703922|157098649|FG001|Overall Study|Death|8|||
48798401|NCT02703922|157098648|FG000|Overall Study|Lost to Follow-up|10|||
48798402|NCT02703922|157098649|FG001|Overall Study|Lost to Follow-up|10|||
48798403|NCT03238300|157098651|FG000|Baseline (Before Intervention)|Physician Decision|0|||
48798404|NCT03238300|157098652|FG001|Baseline (Before Intervention)|Physician Decision|1|||
48798405|NCT03238300|157098651|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
48798406|NCT03238300|157098652|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
48798407|NCT03238300|157098651|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
48798408|NCT03238300|157098652|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
48798409|NCT03238300|157098651|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
48798410|NCT03238300|157098652|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
48798411|NCT01860703|157098653|FG000|Overall Study|Adverse Event|1|||
48798412|NCT01860703|157098654|FG001|Overall Study|Adverse Event|4|||
48798413|NCT01860703|157098655|FG002|Overall Study|Adverse Event|0|||
48798414|NCT01860703|157098656|FG003|Overall Study|Adverse Event|2|||
48798415|NCT01860703|157098653|FG000|Overall Study|Withdrawal by Subject|0|||
48798416|NCT01860703|157098654|FG001|Overall Study|Withdrawal by Subject|1|||
48798417|NCT01860703|157098655|FG002|Overall Study|Withdrawal by Subject|0|||
48798418|NCT01860703|157098656|FG003|Overall Study|Withdrawal by Subject|0|||
48798419|NCT01860703|157098653|FG000|Overall Study|Personal reason|1|||
48798420|NCT01860703|157098654|FG001|Overall Study|Personal reason|0|||
48798421|NCT01860703|157098655|FG002|Overall Study|Personal reason|1|||
48798422|NCT01860703|157098656|FG003|Overall Study|Personal reason|0|||
48798423|NCT02134587|157098659|FG000|Overall Study|Did not completed all meetings|30|||
48798424|NCT02453685|157098660|FG000|Overall Study|Adverse Event|0|||
48798425|NCT02453685|157098661|FG001|Overall Study|Adverse Event|1|||
48798430|NCT02453685|157098660|FG000|Overall Study|Withdrawal by Subject|8|||
48798431|NCT02453685|157098661|FG001|Overall Study|Withdrawal by Subject|4|||
48798432|NCT02453685|157098660|FG000|Overall Study|Unclassified|4|||
48798433|NCT02453685|157098661|FG001|Overall Study|Unclassified|2|||
48798434|NCT01648270|157098664|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
48798435|NCT00572195|157098665|FG000|Overall Study|Withdrawal by Subject|50|||
48798436|NCT00572195|157098665|FG000|Overall Study|Death|9|||
48798437|NCT00572195|157098665|FG000|Overall Study|Adverse Event|4|||
48798438|NCT00572195|157098665|FG000|Overall Study|Lost to Follow-up|5|||
48798439|NCT01024608|157098666|FG000|Overall Study|Adverse Event|1|||
48798440|NCT01024608|157098667|FG001|Overall Study|Adverse Event|0|||
48798441|NCT01024608|157098666|FG000|Overall Study|Withdrawal by Subject|1|||
48798442|NCT01024608|157098667|FG001|Overall Study|Withdrawal by Subject|0|||
48798443|NCT01024608|157098666|FG000|Overall Study|Lost to Follow-up|0|||
48798444|NCT01024608|157098667|FG001|Overall Study|Lost to Follow-up|1|||
48798445|NCT01024608|157098666|FG000|Overall Study|Protocol Violation|0|||
48798446|NCT01024608|157098667|FG001|Overall Study|Protocol Violation|3|||
48798447|NCT01024608|157098666|FG000|Overall Study|Never received study treatment|2|||
48798448|NCT01024608|157098667|FG001|Overall Study|Never received study treatment|0|||
